Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - olfactory bulb [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - olfactory bulb [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627108-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 6 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "NTERA-2: 121.7;RT4: 153.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 29.8 18.4 8.2 4.9 7.4 0.6 34.4 7.7 9.0 26.2 23.3 33.1 19.9 20.7 15.0 47.2 39.9 16.9 7.6 7.0 12.9 36.8 70.8 11.4 3.0 8.4 9.0 5.9 53.8 20.3 34.9 37.2 20.2 7.9 19.0 33.5 6.3 53.1 10.4 4.6 9.7 18.7 7.3 9.5 8.8 14.9 75.5 8.2 4.2 19.5 5.4 6.8 32.5 24.3 11.9 24.8 23.0 80.6 42.2 28.7 16.6 30.4 12.9 17.3 20.3 47.6 54.9 37.7 0.0 53.3 12.2 16.9 19.9 0.3 19.7 25.8 0.1 33.3 3.8 14.9 62.0 17.1 0.1 2.5 30.2 9.3 19.5 6.6 34.4 49.3 0.0 0.0 0.1 21.7 19.8 0.1 0.3 121.7 35.4 18.4 0.0 35.5 0.0 33.0 153.5 4.7 20.3 11.6 10.0 18.5 61.9 16.6 3.3 12.7 16.0 24.4 24.3 8.6 0.1 0.2 0.3 13.4 0.0 11.5 0.3 0.0 0.1 0.3 0.0 1.1 0.1 0.8 0.3 0.0 0.1 2.1 1.2 0.3 0.1 0.1 0.1 0.0 0.3 8.2 7.4 7.7 9.0 7.0 12.9 8.4 9.0 5.9 7.9 9.5 8.2 11.9 147.0 3.2 10.1 14.4 2.3 7.1 41.0 75.7 29.0 0.6 72.5 46.1 8.2 50.1 89.4 93.8 0.0 28.7 1.1 94.9 23.5 80.3 422.5 54.0 21.4 37.4 33.6 4.8 0.9 12.6 40.7 25.6 21.9 19.2 0.0 684.8 47.5 104.0 4.5 0.0 0.8 47.9 193.3 10.2 3.1 1708.3 32.9 3.1 10.6 1.0 1.0 48.2 0.0 9.5 0.4 18.7 55.5 35.7 0.3 33.0 43.5 43.8 193.9 1.9 19.7 17.1 43.1 20.9 32.4 23.3 5.4 13.5 2.5 49.4 94.3 89.7 TNMD "BRICD4, ChM1L, myodulin, TEM, tendin" ENSG00000000005 Tenomodulin Q9H2S6 X 100584936-100599885 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 17.6;breast: 13.0;seminal vesicle: 26.3" "Cell type enriched" "Detected in some" 7 "Adipocytes: 73.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HAP1: 6.9;NTERA-2: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034961, HPA055634" Uncertain NA NA "HPA034961: AB_10670285, HPA055634: AB_2682868" "unprognostic (3.60e-2)" "unprognostic (9.84e-3)" "unprognostic (3.19e-2)" "unprognostic (7.77e-3)" "unprognostic (2.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.36e-2)" "unprognostic (1.37e-1)" "unprognostic (9.40e-2)" "unprognostic (9.60e-4)" "unprognostic (6.82e-2)" "unprognostic (5.67e-2)" "unprognostic (1.48e-1)" 17.6 0.2 0.2 0.6 0.1 0.0 13.0 0.1 0.2 0.5 1.0 0.8 0.1 0.3 0.2 0.3 0.3 0.5 1.0 0.2 0.4 0.9 0.0 0.1 0.1 0.5 0.5 0.1 2.1 0.1 0.0 0.0 2.4 0.2 1.3 0.5 0.0 0.5 26.3 3.3 2.8 0.5 0.7 0.2 0.2 0.1 0.1 0.3 0.4 0.2 5.8 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.4 0.5 0.5 0.1 0.2 0.2 0.3 0.2 73.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 3.9 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.7 0.5 9.3 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 2.7 3.2 0.0 0.1 0.0 1.0 0.0 0.3 0.7 0.6 0.0 DPM1 "CDGIE, MPDS" ENSG00000000419 "Dolichyl-phosphate mannosyltransferase subunit 1, catalytic" O60762 20 50934867-50958555 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051818 Approved NA NA "HPA051818: AB_2681624" "unprognostic (2.21e-2)" "unprognostic (4.94e-2)" "unprognostic (1.16e-1)" "unprognostic (4.24e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (1.10e-1)" "unprognostic (7.49e-2)" "unprognostic (2.53e-2)" "unprognostic (1.29e-2)" "unprognostic (3.61e-2)" "unprognostic (3.02e-3)" "unprognostic (4.98e-2)" "unprognostic (2.59e-1)" "unprognostic (3.58e-1)" "unprognostic (2.74e-1)" 41.3 53.9 25.6 34.7 26.3 59.9 43.1 26.7 32.1 31.8 28.1 39.0 37.2 39.7 48.0 45.7 32.8 36.4 61.2 26.5 29.1 47.4 63.6 30.0 56.4 26.0 25.4 25.6 39.0 49.0 43.3 25.6 45.4 26.3 34.6 43.1 27.4 38.8 31.3 57.8 34.9 39.3 37.7 26.0 37.4 38.4 40.1 25.5 44.3 48.9 55.7 54.0 52.1 33.6 30.0 139.9 55.4 83.6 50.5 72.1 80.8 92.1 52.6 62.1 102.9 80.7 252.1 110.2 84.1 112.9 71.1 141.9 156.2 68.5 129.0 103.9 40.7 53.9 87.7 69.5 171.2 101.6 141.4 50.5 70.0 187.0 71.5 73.7 66.4 80.1 89.0 135.3 104.2 103.3 61.3 127.6 148.9 85.3 131.8 124.8 69.7 120.7 112.6 102.6 83.4 62.5 68.5 135.8 203.8 189.1 64.2 138.8 164.5 66.1 130.8 109.2 76.6 112.6 74.2 99.7 122.0 143.7 92.4 60.4 13.5 16.3 17.6 16.4 18.5 20.0 17.9 18.6 17.9 20.3 16.1 20.0 22.4 20.0 19.1 18.6 21.7 19.5 16.1 25.6 26.3 26.7 32.1 26.5 29.1 26.0 25.4 25.6 26.3 26.0 25.5 30.0 36.8 19.2 42.3 27.1 37.3 116.5 143.4 248.4 29.0 11.7 37.1 24.9 48.8 35.8 119.5 31.3 2.1 153.1 46.4 31.7 117.4 75.9 207.8 49.3 38.0 53.0 23.4 30.7 35.6 73.8 104.9 53.7 18.8 57.5 74.3 25.1 49.2 67.9 87.9 5.0 31.0 52.5 144.5 42.0 58.4 43.8 56.8 36.7 49.8 18.7 65.8 27.3 43.3 20.1 34.2 70.5 50.2 51.6 33.2 73.7 40.7 96.4 135.7 12.6 72.3 50.4 71.5 109.9 103.6 32.0 105.6 245.4 47.8 36.5 55.3 125.9 SCYL3 "PACE-1, PACE1" ENSG00000000457 "SCY1 like pseudokinase 3" Q8IZE3 1 169849631-169894267 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005624 Approved Uncertain "Nuclear bodies,Microtubules" NA NA Microtubules "Nuclear bodies" "HPA005624: AB_1854916" "unprognostic (2.35e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (8.36e-2)" "unprognostic (7.13e-2)" "unprognostic (2.72e-3)" "unprognostic (1.31e-1)" "unprognostic (2.12e-2)" "unprognostic (2.85e-2)" "unprognostic (7.17e-2)" "unprognostic (8.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.20e-3)" "unprognostic (3.54e-1)" "unprognostic (1.75e-1)" "unprognostic (4.60e-2)" "prognostic favorable (8.85e-4)" 5.2 5.9 2.9 7.4 3.0 4.0 11.0 4.0 3.6 6.8 4.7 7.9 7.8 7.1 8.4 7.3 6.3 7.6 5.2 3.1 2.9 7.6 11.4 6.2 10.6 3.3 2.9 2.8 7.7 6.2 12.1 4.2 8.2 3.1 7.7 9.7 11.5 8.3 6.7 7.9 7.8 6.9 6.3 2.9 7.6 7.8 6.7 3.1 9.8 7.7 9.2 9.9 7.3 6.6 4.0 4.1 5.2 7.9 5.5 9.9 7.2 9.1 6.3 8.1 7.2 6.7 4.8 7.7 8.4 4.5 6.5 4.0 9.4 4.7 5.5 6.4 15.5 4.4 5.8 6.1 3.1 7.0 8.5 7.3 7.0 5.4 5.0 6.8 6.7 6.9 9.2 9.4 10.8 6.9 3.2 6.9 6.5 6.4 27.5 2.5 6.3 4.3 10.1 7.6 7.3 5.9 8.6 5.0 16.3 10.1 11.2 9.1 7.8 5.2 5.1 3.4 6.2 5.1 14.4 13.7 9.9 3.9 6.3 5.7 13.5 3.2 8.6 6.3 3.4 8.5 6.7 8.3 7.0 5.1 6.2 7.0 5.8 6.7 10.7 3.8 11.5 8.1 4.8 2.9 3.0 4.0 3.6 3.1 2.9 3.3 2.9 2.8 3.1 2.9 3.1 4.0 5.9 6.4 14.4 11.8 9.6 2.4 2.5 3.6 6.2 10.2 9.6 8.3 4.2 22.8 7.8 1.8 10.4 17.6 19.0 14.0 9.8 7.4 5.1 11.1 8.2 6.6 9.1 4.2 15.8 9.1 5.1 5.1 7.1 5.8 5.7 7.2 11.0 13.2 6.5 10.1 12.5 10.4 8.2 11.4 3.5 2.6 4.4 5.3 1.8 9.4 8.4 10.0 16.5 17.6 14.1 6.2 10.2 5.7 10.5 4.7 13.3 6.4 9.0 19.9 6.6 5.5 5.4 10.9 6.8 8.3 1.8 11.6 11.0 6.3 10.3 3.3 C1orf112 FLJ10706 ENSG00000000460 "Chromosome 1 open reading frame 112" Q9NSG2 1 169662007-169854080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.6" "Cell type enhanced" "Detected in many" "Microglial cells: 30.0;Spermatocytes: 37.1;Spermatogonia: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023778, HPA024451" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023778: AB_1848665, HPA024451: AB_1848667" "unprognostic (4.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (9.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.40e-2)" "unprognostic (2.50e-3)" "unprognostic (2.09e-1)" "unprognostic (9.11e-3)" "unprognostic (8.79e-2)" "unprognostic (3.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.65e-8)" "unprognostic (1.76e-1)" "unprognostic (2.81e-2)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" 1.8 1.2 0.5 3.3 0.7 9.0 2.9 1.7 0.8 2.3 0.5 2.6 1.2 2.9 1.0 2.0 1.5 1.5 0.8 0.5 0.5 1.1 2.6 1.7 6.4 1.0 0.6 0.3 2.2 1.5 13.6 1.0 3.4 0.8 1.8 4.2 5.4 1.6 2.0 0.9 2.4 1.8 2.7 0.7 2.8 1.9 10.4 0.8 11.7 1.7 1.5 7.9 3.1 1.7 1.5 32.7 17.5 21.9 11.3 3.5 4.8 32.2 21.1 10.7 30.0 30.6 19.1 27.7 29.0 9.3 7.0 10.7 26.0 27.6 14.7 34.3 16.9 16.5 27.1 23.0 14.1 1.2 35.8 11.3 1.5 1.9 22.5 5.3 3.5 12.8 16.8 44.9 48.0 24.8 7.9 31.5 10.3 28.8 22.9 12.1 23.3 24.7 19.5 4.0 16.1 16.2 16.9 13.4 22.1 6.9 20.6 21.0 18.3 9.5 24.1 19.1 17.8 28.9 12.9 20.9 30.6 9.0 26.4 24.1 2.2 0.8 1.0 0.6 1.9 0.4 1.4 0.6 0.6 1.2 1.4 0.3 0.5 0.1 2.1 2.3 0.4 0.7 0.6 0.5 0.7 1.7 0.8 0.5 0.5 1.0 0.6 0.3 0.8 0.7 0.8 1.5 1.2 0.0 3.3 4.2 4.0 1.8 2.7 2.6 1.2 4.1 1.7 1.8 0.5 0.0 1.5 0.0 6.2 9.1 1.6 1.9 0.0 2.7 8.7 0.9 2.1 2.2 0.0 3.4 9.9 3.4 9.1 2.5 2.6 1.2 4.5 9.8 2.9 3.8 6.2 1.7 9.6 1.2 6.1 3.5 2.1 4.1 2.1 3.0 3.6 30.0 1.3 2.4 0.0 13.0 13.2 3.0 0.3 3.8 5.5 1.0 0.8 0.7 2.0 6.6 6.6 1.4 2.6 37.1 20.3 2.8 1.0 3.8 3.3 2.2 2.6 2.4 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635185 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 209.8;lung: 87.2;lymphoid tissue: 142.3" "Cell type enhanced" "Detected in many" "Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 86.0;U-266/70: 153.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 24.0 6.8 13.4 62.8 11.6 209.8 16.1 11.9 19.3 7.4 12.5 5.9 3.9 8.2 1.7 5.3 15.8 12.8 8.0 11.2 12.5 6.5 10.9 87.2 27.7 13.4 12.5 10.0 2.9 5.8 1.6 2.8 8.0 14.3 7.3 4.0 0.7 6.6 2.4 3.2 4.5 10.1 16.4 12.1 142.3 5.9 2.5 15.6 8.4 7.5 6.5 20.2 18.0 7.4 13.1 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1.7 29.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 3.8 5.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 153.1 2.1 6.5 0.0 19.5 0.0 30.8 381.4 229.4 189.5 469.1 11.3 54.0 15.8 89.1 196.1 84.0 8.0 78.4 272.9 264.5 405.2 9.0 1.2 494.1 13.4 11.6 11.9 19.3 11.2 12.5 13.4 12.5 10.0 14.3 12.1 15.6 13.1 8.6 6.4 20.0 0.0 24.9 2.8 0.6 0.2 0.0 0.0 0.4 0.6 1.6 1.5 5.7 1.8 0.0 0.5 55.2 0.0 0.0 0.0 0.3 0.1 0.2 14.9 0.0 7.4 0.2 0.2 0.7 2.7 1.5 0.1 13.3 0.1 6.8 1.9 56.8 0.0 0.1 0.0 0.0 182.2 63.8 0.7 0.3 155.9 1.8 6.5 159.7 0.1 259.5 1.0 0.4 0.0 1.2 0.0 4.2 0.4 0.0 0.7 1.5 0.0 0.0 0.7 0.6 0.2 0.5 0.5 1.1 1.0 28.0 0.0 0.0 2.5 CFH "ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS" ENSG00000000971 "Complement factor H" P08603 1 196652043-196747504 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity" "Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "liver: 1690.3" "Group enriched" "Detected in many" 4 "Fibroblasts: 448.0;Hepatocytes: 1114.8;Leydig cells: 283.9" "Cancer enriched" "Detected in all" 9 "liver cancer: 151.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 18.7" "Lineage enriched" "Detected in single" 26 "T-cells: 18.7" "Cell line enhanced" "Detected in many" "HHSteC: 123.1;HSkMC: 119.5;hTERT-RPE1: 374.9;RT4: 227.0" "CAB016385, CAB016769, HPA038922, HPA049176, HPA053326" Supported Approved Vesicles "Secreted to blood" NA NA 396000000000 100000000000 Vesicles "CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113" "unprognostic (2.40e-1)" "unprognostic (9.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.39e-2)" "unprognostic (5.40e-3)" "unprognostic (1.80e-1)" "unprognostic (3.75e-3)" "unprognostic (7.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (9.08e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (6.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" 98.8 42.5 18.2 33.0 19.1 1.3 67.6 19.4 30.9 77.4 57.9 51.5 30.7 13.0 16.0 64.4 24.4 134.8 170.2 17.4 20.0 25.7 1690.3 71.4 27.6 19.1 18.0 15.8 166.4 14.2 6.5 16.1 26.3 18.8 23.2 81.0 4.3 127.7 24.2 21.3 59.4 52.6 32.8 18.9 14.1 47.4 14.4 20.6 12.2 103.4 84.7 26.1 151.3 27.3 20.6 0.0 64.9 0.0 0.0 96.5 54.7 0.1 25.8 63.1 3.5 13.5 0.1 11.9 0.3 9.6 0.1 0.2 2.2 0.0 23.6 2.6 1.3 0.0 20.0 74.7 0.0 123.1 0.9 0.3 119.5 0.3 18.4 7.9 374.9 79.2 0.0 74.4 2.7 89.4 0.1 0.5 0.1 0.4 0.0 0.1 0.2 89.8 21.0 0.0 227.0 0.0 0.1 0.4 0.0 0.1 0.6 0.1 0.0 5.6 73.6 0.9 0.8 0.8 0.8 0.0 0.3 13.1 0.2 5.8 0.0 0.1 0.0 2.0 0.0 18.7 0.0 6.6 4.0 0.2 0.0 0.4 1.5 0.7 0.0 0.0 0.0 0.0 1.1 18.2 19.1 19.4 30.9 17.4 20.0 19.1 18.0 15.8 18.8 18.9 20.6 20.6 73.9 9.6 17.6 0.7 4.2 44.2 63.6 140.6 14.2 2.4 1.3 3.4 10.9 35.8 141.1 5.5 0.0 0.0 3.1 0.1 0.0 6.2 2.6 2.3 3.8 49.8 0.0 52.6 0.6 0.8 0.0 448.0 8.6 1.9 3.8 6.9 47.8 1114.8 1.1 0.0 1.0 0.0 14.2 43.8 62.1 7.4 283.9 5.7 44.4 38.4 0.3 0.3 0.0 0.0 0.2 5.3 0.0 138.8 2.6 13.0 0.0 0.5 115.6 1.4 6.6 94.2 59.6 1.4 1.0 10.9 38.2 0.1 13.2 26.3 0.0 61.5 FUCA2 "dJ20N2.5, MGC1314" ENSG00000001036 "Alpha-L-fucosidase 2" Q9BTY2 6 143494812-143511720 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 167.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031659, HPA031661" Approved "Secreted to blood" NA NA 56000000 "HPA031659: AB_10600661, HPA031661: AB_10601681" "unprognostic (1.83e-2)" "unprognostic (1.70e-3)" "unprognostic (1.11e-2)" "unprognostic (1.01e-2)" "unprognostic (4.89e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (2.70e-9)" "unprognostic (1.54e-3)" "unprognostic (1.08e-1)" "unprognostic (7.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.90e-1)" "unprognostic (8.76e-3)" "unprognostic (9.18e-2)" "unprognostic (2.69e-1)" "unprognostic (7.25e-2)" "unprognostic (5.07e-2)" 29.2 41.8 13.5 25.6 16.5 26.0 26.6 16.4 15.4 29.4 27.5 41.9 43.0 25.9 45.3 14.3 23.9 28.1 27.8 12.7 20.8 55.3 52.8 29.1 17.3 17.5 14.9 12.4 30.7 34.8 167.3 16.0 50.9 17.4 22.1 53.3 6.2 25.6 26.1 7.0 11.7 39.6 27.8 16.2 24.8 38.6 12.7 15.5 6.6 32.3 11.7 17.1 33.8 20.5 21.3 97.4 55.7 47.6 86.9 69.0 134.4 90.1 89.9 95.4 108.1 182.0 107.1 94.8 0.2 66.1 120.8 33.9 0.6 24.1 11.7 148.9 87.2 92.6 32.6 100.1 163.2 99.3 0.3 15.8 72.3 69.4 96.6 41.5 91.6 111.4 0.2 117.6 49.3 123.2 114.6 0.2 75.9 62.1 44.2 76.0 0.2 99.7 72.1 129.0 59.5 36.0 23.6 98.7 65.3 82.3 36.3 32.1 79.6 65.9 64.1 54.0 161.6 175.4 18.3 21.3 0.7 74.1 59.1 22.5 38.8 84.9 26.2 13.2 84.0 15.0 11.3 9.8 11.3 65.4 8.3 4.4 7.9 5.5 29.6 62.0 10.3 19.8 51.9 13.5 16.5 16.4 15.4 12.7 20.8 17.5 14.9 12.4 17.4 16.2 15.5 21.3 27.3 41.7 35.9 9.1 13.5 11.2 12.6 30.3 9.1 3.7 19.2 12.6 28.0 38.6 37.9 25.8 0.0 52.5 10.3 47.6 11.7 81.9 2.0 26.8 55.2 25.0 9.6 18.7 8.7 124.9 109.8 62.6 34.7 28.9 37.4 38.1 23.6 35.2 110.3 1.7 11.8 38.1 46.8 57.5 29.2 2.6 66.8 51.7 42.7 9.4 49.1 11.1 13.4 5.5 14.5 74.6 38.2 45.5 47.7 13.8 60.3 51.4 34.8 1.1 6.6 33.8 35.0 4.8 4.6 13.2 8.0 46.4 11.5 78.8 50.4 18.4 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 153.4" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 220.7;Urothelial cells: 144.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 5800000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 26.9 18.5 19.4 16.7 26.3 38.1 27.5 19.9 23.5 9.6 15.7 23.0 42.3 19.4 10.9 37.3 63.5 32.4 16.5 18.0 20.8 34.4 153.4 11.0 26.4 21.5 21.3 15.9 8.6 16.1 18.4 4.9 9.1 21.7 27.2 26.2 14.5 13.3 16.0 11.5 19.0 32.5 16.1 19.6 39.4 33.2 11.4 22.2 13.8 30.3 14.6 24.2 64.3 14.6 37.9 31.3 205.4 16.5 39.1 19.4 8.6 22.1 15.5 24.9 11.4 13.3 30.5 70.7 59.1 28.7 14.1 86.9 43.3 50.7 112.5 15.3 46.9 31.4 39.6 38.3 178.2 22.1 52.8 23.5 13.5 46.6 12.8 56.8 15.0 17.7 50.9 22.4 18.2 5.6 32.9 45.5 20.9 30.6 287.5 19.2 14.9 10.2 52.1 37.0 189.8 47.5 23.3 25.9 40.9 27.8 23.8 28.2 24.6 24.6 10.2 35.5 26.0 23.4 24.1 39.9 34.0 25.6 37.0 17.5 1.2 0.5 0.3 0.5 0.9 0.4 0.8 0.5 1.1 2.3 0.5 0.3 0.6 0.2 4.2 1.0 1.6 0.9 0.3 19.4 26.3 19.9 23.5 18.0 20.8 21.5 21.3 15.9 21.7 19.6 22.2 37.9 17.1 0.0 2.4 36.9 12.7 34.8 61.6 56.6 47.3 14.4 23.7 13.6 20.9 38.6 47.4 0.0 25.0 6.4 22.9 22.1 11.7 14.6 2.2 34.8 14.9 14.1 220.7 113.2 22.4 12.8 8.6 13.6 43.8 69.8 2.5 50.9 10.4 118.5 22.7 8.4 30.4 19.4 40.7 87.2 10.9 1.5 6.5 32.1 8.8 24.4 10.6 12.5 17.5 30.2 84.1 15.9 13.2 9.4 10.4 88.3 18.2 27.1 66.5 5.0 13.1 14.0 13.5 3.1 9.2 72.6 24.9 7.8 14.9 26.6 14.8 144.8 NFYA "CBF-B, HAP2, NF-YA" ENSG00000001167 "Nuclear transcription factor Y subunit alpha" P23511 6 41072945-41099976 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 41.4;Late spermatids: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009250, HPA050779" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009250: AB_2152107, HPA050779: AB_2681234" "unprognostic (2.56e-1)" "unprognostic (4.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.95e-2)" "unprognostic (4.57e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.23e-3)" "unprognostic (5.62e-3)" "unprognostic (1.03e-1)" "unprognostic (1.92e-3)" "unprognostic (3.11e-1)" "unprognostic (5.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.92e-3)" 10.9 9.0 13.8 14.1 17.7 41.1 15.8 14.2 13.8 11.4 10.9 12.0 10.0 15.0 14.9 10.8 11.7 12.6 8.3 12.1 13.9 10.2 14.4 11.9 19.7 15.5 16.8 9.8 18.9 11.6 15.4 9.1 13.9 17.0 13.7 14.7 21.7 9.5 8.1 9.3 10.6 11.3 10.9 15.4 14.6 12.7 38.9 15.4 41.9 18.6 12.6 20.7 14.7 9.5 24.7 32.8 26.3 49.2 82.7 19.9 19.3 20.9 24.2 22.4 37.2 31.4 34.6 23.3 39.4 19.7 16.0 19.6 21.0 30.1 29.1 40.9 28.4 38.0 51.7 23.2 49.4 14.1 55.0 43.3 12.3 24.4 29.8 40.0 18.1 32.6 64.5 51.4 46.4 36.9 32.4 62.5 22.1 22.1 95.8 25.9 50.3 27.1 29.6 27.2 43.8 49.8 34.3 21.1 18.9 37.5 31.2 17.7 55.1 32.2 65.7 35.6 13.2 46.9 18.2 19.8 64.2 13.0 46.2 26.5 2.7 2.9 4.8 5.8 3.9 7.6 3.7 5.4 6.4 3.3 4.1 5.7 6.3 8.0 6.5 3.5 4.3 6.7 3.2 13.8 17.7 14.2 13.8 12.1 13.9 15.5 16.8 9.8 17.0 15.4 15.4 24.7 7.6 9.6 3.9 6.2 11.1 14.5 9.9 4.2 2.8 4.1 13.2 7.1 4.7 11.5 5.3 11.0 4.2 7.7 11.7 9.3 1.9 11.3 41.4 7.4 7.7 7.5 4.8 12.2 4.4 7.4 12.5 6.8 5.1 8.1 2.5 11.9 7.5 7.0 10.0 0.0 5.1 4.2 4.1 9.3 14.0 44.4 3.7 6.4 7.2 10.3 7.2 3.3 7.2 5.0 13.8 9.6 9.6 3.0 5.6 12.8 5.1 2.6 6.9 5.0 0.0 4.3 8.3 20.0 8.2 6.3 15.9 10.8 10.1 5.6 7.6 18.7 STPG1 "C1orf201, FLJ33340, MAPO2" ENSG00000001460 "Sperm tail PG-rich repeat containing 1" Q5TH74 1 24356999-24416934 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.7" "Group enriched" "Detected in many" 8 "Early spermatids: 282.7;Late spermatids: 660.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024301 Approved Nucleoplasm NA NA Nucleoplasm "HPA024301: AB_1845634" "unprognostic (2.63e-2)" "unprognostic (3.35e-1)" "unprognostic (1.36e-2)" "prognostic favorable (1.33e-4)" "unprognostic (6.06e-4)" "unprognostic (5.14e-2)" "unprognostic (2.91e-3)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-2)" "prognostic favorable (2.31e-4)" "unprognostic (9.14e-2)" "unprognostic (3.93e-2)" "unprognostic (5.21e-2)" "unprognostic (1.42e-1)" 4.6 4.1 10.1 2.1 9.1 1.1 4.1 9.8 11.4 3.4 14.0 6.5 3.5 3.8 5.4 5.1 16.9 3.2 3.2 8.4 10.2 5.5 1.6 4.9 2.1 9.9 11.0 8.2 4.3 3.9 9.2 8.9 1.0 10.8 4.3 5.4 14.8 3.5 3.3 1.4 4.5 4.4 5.0 9.6 1.8 4.1 27.7 12.8 2.7 4.6 2.5 2.7 4.1 4.3 11.3 7.9 4.7 0.6 8.5 5.9 8.5 4.5 11.5 10.8 10.6 11.0 2.1 11.6 1.0 7.6 11.9 8.9 3.3 7.3 8.0 12.2 9.4 7.2 1.4 2.4 2.2 12.2 3.9 1.9 5.1 15.9 15.4 20.2 11.2 8.5 0.0 2.9 0.0 8.1 2.9 0.0 3.3 6.9 8.3 7.7 2.1 0.0 0.3 14.3 2.6 6.9 4.6 6.2 2.5 18.1 7.0 6.2 6.9 5.8 4.0 4.5 1.6 3.4 4.9 5.0 2.8 4.3 0.4 6.3 0.0 0.0 0.5 0.6 0.6 0.1 2.2 0.5 1.9 0.3 1.7 0.5 0.7 0.0 0.0 0.1 1.3 1.2 0.8 10.1 9.1 9.8 11.4 8.4 10.2 9.9 11.0 8.2 10.8 9.6 12.8 11.3 7.6 9.6 9.6 3.9 4.1 4.6 13.0 12.0 7.4 14.9 5.5 6.0 5.3 0.0 13.5 11.0 14.6 3.9 1.6 22.9 15.6 7.5 282.7 32.1 2.3 5.0 4.8 5.7 11.0 7.1 7.8 4.1 4.1 8.5 12.0 3.2 6.8 1.7 3.7 10.1 5.9 5.9 8.2 1.6 6.7 660.7 6.5 2.4 16.0 4.7 3.0 7.1 0.0 4.0 16.1 11.3 14.0 4.5 5.0 6.2 21.0 8.4 55.9 20.0 6.6 2.4 4.8 37.0 11.3 13.0 5.5 4.5 3.7 3.1 6.3 54.2 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415802-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;Oligodendrocytes: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 101.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favorable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.95e-4)" "unprognostic (2.85e-1)" 8.5 7.5 55.2 8.4 67.2 8.5 13.0 69.7 54.1 9.7 28.1 13.9 11.4 6.2 11.8 16.1 14.7 8.9 12.9 46.1 62.0 14.0 3.6 14.0 11.7 64.2 62.3 41.5 7.2 17.3 22.1 7.3 3.5 67.2 56.4 14.6 28.0 15.3 7.7 6.0 13.5 12.8 12.4 61.5 7.9 14.9 5.0 64.9 13.3 29.4 12.0 13.2 8.0 10.5 91.0 32.4 12.1 1.1 4.2 18.9 20.7 4.5 101.8 71.7 35.0 26.2 4.5 36.4 15.4 30.2 55.2 7.3 31.5 12.5 37.1 37.3 29.5 38.1 16.0 18.5 5.4 17.7 14.2 14.4 20.7 36.1 22.3 75.7 34.8 12.2 27.5 9.5 9.7 22.4 7.2 11.5 6.6 8.3 15.4 34.0 5.5 0.1 17.1 41.6 10.1 44.6 4.3 13.1 19.5 26.9 8.6 26.0 10.6 17.9 31.5 6.7 10.9 22.9 29.4 24.1 5.4 21.4 26.8 28.8 16.9 5.8 7.9 16.7 5.7 16.9 22.1 28.8 22.5 11.2 20.1 38.9 24.8 2.5 15.6 4.2 14.6 31.8 16.0 55.2 67.2 69.7 54.1 46.1 62.0 64.2 62.3 41.5 67.2 61.5 64.9 91.0 17.1 48.1 27.5 8.8 15.4 9.2 13.5 25.7 14.8 50.3 15.9 12.2 25.9 15.7 24.7 40.5 110.5 3.8 32.1 25.0 3.9 13.1 3.6 11.0 3.5 10.2 18.7 26.1 29.3 15.5 4.7 7.4 16.8 18.3 13.3 10.5 9.3 3.8 4.5 13.5 32.2 16.7 16.2 7.0 7.8 8.0 4.1 5.5 14.2 10.3 8.6 18.7 23.7 24.6 91.8 22.6 22.6 5.3 16.0 34.5 33.2 4.5 16.5 53.6 0.0 4.4 5.9 2.6 6.0 20.0 16.3 4.2 25.3 8.2 17.2 20.9 LAS1L "FLJ12525, Las1" ENSG00000001497 "LAS1 like ribosome biogenesis factor" Q9Y4W2 X 65438549-65534810 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "rRNA processing" "Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 148.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044431, HPA061463" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA044431: AB_10965695, HPA061463: AB_2684530" "unprognostic (9.71e-2)" "unprognostic (1.62e-3)" "unprognostic (1.57e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-2)" "unprognostic (2.38e-1)" "unprognostic (7.15e-3)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.14e-1)" "unprognostic (5.06e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-1)" "unprognostic (1.17e-3)" "unprognostic (2.00e-3)" "unprognostic (1.53e-1)" 20.3 19.2 38.9 11.5 39.5 16.2 21.4 37.8 54.2 26.9 36.1 22.9 5.9 23.3 6.9 20.2 25.7 6.3 18.6 37.2 37.7 17.0 19.8 17.5 13.2 38.9 39.5 36.3 30.1 21.4 12.3 17.6 9.0 39.1 22.9 8.2 9.5 19.0 12.0 19.5 25.2 18.6 10.4 41.2 22.7 20.1 33.9 38.7 12.9 20.7 6.3 14.1 24.4 21.5 40.7 44.1 63.6 36.3 28.5 12.4 16.1 29.1 28.5 14.9 42.8 36.4 30.4 31.3 95.0 31.3 17.8 28.7 31.3 63.9 39.6 50.6 25.6 52.3 32.2 53.2 32.4 16.6 95.9 26.8 17.8 28.7 40.5 25.6 15.1 26.0 46.1 80.3 71.3 25.5 51.8 62.4 53.6 52.6 49.8 63.1 56.2 67.4 79.9 24.7 17.9 24.6 32.9 51.3 26.0 20.1 25.8 19.5 44.6 22.2 26.4 50.9 73.2 44.4 23.7 37.7 94.6 28.1 92.5 13.6 17.7 17.7 11.2 20.1 24.0 21.3 23.9 18.6 23.5 24.2 26.4 23.2 19.8 2.0 22.9 19.3 19.1 21.7 21.0 38.9 39.5 37.8 54.2 37.2 37.7 38.9 39.5 36.3 39.1 41.2 38.7 40.7 15.5 12.8 22.3 23.2 21.6 18.2 21.4 24.8 9.1 34.9 12.7 13.6 9.2 21.5 27.0 3.7 29.2 32.8 13.3 6.9 15.6 27.9 58.0 17.5 20.0 17.2 16.7 18.1 19.6 26.6 31.4 16.8 11.7 12.9 18.3 26.0 8.9 14.8 16.3 45.4 17.7 9.4 18.3 8.5 13.4 148.2 17.4 11.7 10.6 8.4 18.1 16.1 12.3 13.0 12.5 21.4 7.7 15.4 26.3 23.5 10.2 14.3 26.7 34.2 13.1 21.8 22.8 24.1 19.1 17.8 18.6 17.8 17.5 22.3 14.1 14.8 ENPP4 "AP3Aase, KIAA0879, NPP4" ENSG00000001561 "Ectonucleotide pyrophosphatase/phosphodiesterase 4" Q9Y6X5 6 46129989-46146688 "Enzymes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 21.9;U-266/84: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016594 Approved NA NA "HPA016594: AB_1848171" "unprognostic (9.87e-2)" "unprognostic (1.74e-1)" "unprognostic (2.75e-2)" "unprognostic (2.01e-1)" "unprognostic (2.92e-1)" "unprognostic (1.90e-1)" "unprognostic (8.13e-2)" "unprognostic (5.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-1)" "unprognostic (8.51e-2)" "unprognostic (4.36e-1)" "prognostic favorable (6.95e-7)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (2.56e-1)" 15.2 13.7 14.6 7.4 22.4 38.4 7.9 21.6 19.5 10.4 9.5 12.2 11.0 4.0 11.7 5.2 10.9 8.1 15.2 14.0 20.3 18.6 8.2 20.9 7.8 22.2 22.6 12.9 2.1 12.0 22.5 9.0 3.6 21.9 16.5 12.9 12.3 21.5 19.9 22.3 2.1 10.1 7.1 23.5 14.0 14.9 8.4 20.6 8.6 12.6 25.5 6.5 6.8 2.2 33.2 0.1 1.1 0.7 1.5 0.0 0.0 0.1 1.7 1.6 4.0 0.3 1.9 13.4 15.2 12.7 2.1 9.9 0.2 4.1 0.6 0.8 18.5 11.1 8.5 0.0 0.0 0.5 10.5 14.9 2.1 0.0 0.1 0.0 1.1 1.4 10.5 0.0 0.0 1.5 1.8 7.8 1.0 2.7 16.9 0.5 5.9 2.7 5.7 8.3 1.7 18.0 0.0 0.0 2.8 0.0 4.1 7.6 4.3 0.0 0.0 6.7 0.3 11.2 21.9 26.6 5.2 10.3 0.0 1.4 0.0 0.4 0.9 9.2 1.1 5.4 2.8 3.4 6.8 1.5 1.2 3.2 5.8 0.3 4.4 2.6 1.6 1.2 3.0 14.6 22.4 21.6 19.5 14.0 20.3 22.2 22.6 12.9 21.9 23.5 20.6 33.2 43.5 76.9 27.0 23.5 11.6 0.9 3.2 2.3 0.6 9.3 11.0 2.4 23.1 14.3 25.4 29.5 14.6 0.5 23.5 27.2 0.0 12.9 18.3 28.8 2.0 16.0 15.7 3.0 26.4 12.2 0.3 8.5 10.7 17.3 15.8 4.5 6.1 8.6 5.8 26.9 19.2 13.8 4.1 24.8 11.0 26.0 1.2 19.0 3.6 6.5 15.2 21.6 34.0 32.2 125.3 9.7 16.1 11.3 10.3 12.6 16.3 12.6 70.6 6.2 0.0 22.1 5.4 9.1 9.8 0.3 0.6 0.3 14.7 3.7 11.3 14.8 SEMA3F "Sema4, SEMAK" ENSG00000001617 "Semaphorin 3F" Q13275 3 50155045-50189075 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 101.6" "Cell type enhanced" "Detected in many" "Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035008 Approved "Secreted to blood" NA NA 1700000 7900000 "HPA035008: AB_10604091" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (1.12e-2)" "unprognostic (1.87e-2)" "unprognostic (5.52e-3)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.71e-1)" "unprognostic (9.05e-2)" "unprognostic (4.20e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-1)" "unprognostic (2.23e-2)" "unprognostic (6.19e-2)" "unprognostic (8.56e-2)" "unprognostic (3.88e-3)" "unprognostic (6.87e-3)" 30.0 9.1 9.9 8.7 5.6 2.7 32.2 4.8 7.6 20.6 14.7 9.8 13.5 14.6 5.4 101.6 15.7 10.9 16.9 4.3 9.2 32.6 4.9 46.6 3.7 9.5 11.6 3.2 3.6 6.8 5.6 11.2 30.7 7.9 33.0 6.3 22.2 24.8 32.8 10.5 75.6 12.6 9.1 5.1 51.1 17.5 2.4 19.2 6.2 27.3 6.1 12.7 27.3 55.8 13.0 13.9 3.1 0.7 14.2 0.2 1.3 3.0 8.0 24.2 6.5 10.2 5.4 6.1 0.5 77.9 1.1 0.7 47.5 6.9 100.7 2.4 0.1 1.8 0.8 108.1 18.5 5.7 1.7 3.2 6.2 55.3 15.1 45.4 90.7 187.0 1.2 2.9 0.1 1.3 12.4 1.5 7.5 8.6 6.2 10.1 11.8 0.0 0.5 7.2 112.3 1.1 2.6 12.8 170.2 0.3 10.4 67.2 7.3 338.6 4.2 31.9 29.7 5.5 0.2 0.0 0.9 0.3 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 5.6 4.8 7.6 4.3 9.2 9.5 11.6 3.2 7.9 5.1 19.2 13.0 40.2 0.0 1.1 0.0 0.2 6.8 3.0 9.2 5.7 23.4 10.7 6.0 9.2 1.5 6.6 18.4 10.4 11.2 0.6 5.5 0.0 0.3 0.0 6.5 2.4 24.4 0.0 0.0 0.7 0.8 0.5 1.1 16.3 6.9 0.0 0.2 25.4 0.6 1.4 6.7 1.1 10.7 0.0 0.3 0.8 0.3 0.3 0.2 0.0 3.7 0.0 8.7 0.0 0.0 0.1 6.8 3.8 0.0 0.0 2.5 5.7 0.7 5.4 19.8 0.0 0.5 2.5 0.0 0.4 17.7 8.9 6.3 0.4 0.2 5.2 8.6 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "CF transmembrane conductance regulator" P13569 7 117287120-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 55.1;intestine: 43.1;pancreas: 212.5" "Group enriched" "Detected in many" 4 "Ductal cells: 485.4;Ionocytes: 252.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB001951, HPA021939, HPA079652" Enhanced NA NA "CAB001951: , HPA021939: AB_1846578, HPA079652: " "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.2 0.0 0.5 4.7 1.9 0.0 0.4 0.7 1.0 8.6 0.0 43.1 36.6 1.1 1.1 0.8 2.2 55.1 0.1 0.4 0.8 2.0 1.7 8.3 0.0 1.2 1.1 0.2 0.0 212.5 0.3 0.1 0.6 1.2 2.2 41.1 0.0 21.7 0.5 0.0 1.8 20.1 2.0 1.9 0.0 3.1 1.7 1.1 0.1 0.1 0.0 0.3 0.7 0.0 3.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 98.9 0.1 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 49.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.7 1.0 0.4 0.8 1.2 1.1 0.2 1.2 1.9 1.1 3.1 0.0 6.4 65.6 0.0 0.5 0.0 2.0 2.6 0.0 0.5 0.5 0.0 2.4 55.8 17.8 0.0 0.0 0.0 0.0 45.8 0.0 485.4 3.2 9.6 1.2 0.4 7.2 0.0 2.2 4.5 0.0 0.3 4.1 19.8 1.3 0.1 0.0 0.4 0.0 0.0 1.1 13.9 252.3 0.0 0.0 2.6 0.3 0.1 0.0 1.0 6.7 0.5 0.0 0.5 23.8 14.8 86.4 0.0 0.0 4.0 8.6 0.0 5.6 0.0 0.0 0.0 1.6 2.2 0.5 0.0 0.0 0.0 0.3 0.1 87.3 5.8 ANKIB1 "DKFZP434A0225, KIAA1386" ENSG00000001629 "Ankyrin repeat and IBR domain containing 1" Q9P2G1 7 92245974-92401383 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.5" "Cell type enhanced" "Detected in all" "Excitatory neurons: 182.5;Inhibitory neurons: 218.0;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 590.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019358, HPA021780" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019358: AB_1844831, HPA021780: AB_2670819" "unprognostic (1.77e-1)" "unprognostic (5.96e-3)" "unprognostic (1.23e-1)" "unprognostic (4.97e-3)" "unprognostic (2.75e-1)" "unprognostic (7.67e-2)" "unprognostic (4.88e-3)" "unprognostic (2.14e-1)" "unprognostic (4.24e-2)" "unprognostic (1.87e-2)" "unprognostic (1.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-3)" "unprognostic (4.05e-2)" "unprognostic (3.00e-1)" "unprognostic (3.00e-2)" "unprognostic (3.20e-1)" 12.8 10.8 35.9 10.1 50.3 7.0 12.4 21.7 39.3 12.8 0.0 13.0 11.2 12.1 16.0 11.9 9.9 15.0 10.3 17.5 29.1 25.9 10.7 11.1 13.4 33.3 46.5 7.1 12.7 12.4 24.1 7.6 12.8 42.9 10.1 12.9 9.9 14.0 11.3 7.8 14.5 12.1 13.7 15.0 12.5 11.8 21.0 30.7 14.7 17.3 10.0 11.8 13.3 9.1 68.5 35.7 20.9 18.7 27.3 32.0 34.9 19.2 27.1 30.0 25.4 34.0 15.8 52.0 20.0 23.4 39.7 66.8 16.5 16.5 28.1 38.0 35.1 14.0 13.1 23.7 12.1 22.0 18.8 26.5 23.1 22.8 31.0 38.2 34.6 28.7 17.4 16.9 41.8 30.0 27.5 39.6 17.0 19.6 23.9 23.7 14.6 22.8 21.9 26.6 30.7 25.5 29.4 39.2 41.8 22.4 34.8 17.5 10.2 26.2 48.5 40.2 55.3 27.8 26.7 52.3 25.4 27.7 21.9 56.2 1.4 0.4 1.2 0.9 0.7 0.7 1.7 0.9 1.3 0.4 2.0 0.7 1.0 0.2 1.2 0.6 1.6 1.9 0.4 35.9 50.3 21.7 39.3 17.5 29.1 33.3 46.5 7.1 42.9 15.0 30.7 68.5 24.1 25.6 30.4 97.6 21.8 18.6 17.5 16.4 13.1 20.8 25.6 20.2 33.4 24.3 22.3 27.6 18.8 13.4 27.8 20.7 1.9 21.5 52.8 21.5 37.2 22.4 41.9 8.8 182.5 19.2 25.2 25.9 14.3 27.0 26.6 47.4 27.8 15.1 13.5 30.3 218.0 24.8 10.2 22.2 16.1 61.1 33.2 20.4 17.8 87.1 20.6 27.3 34.0 176.5 590.8 33.5 11.8 40.6 23.4 26.5 20.8 37.3 18.8 16.2 19.7 34.8 26.1 70.9 50.4 20.3 22.7 14.0 22.7 31.2 21.7 21.9 CYP51A1 "CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1" ENSG00000001630 "Cytochrome P450 family 51 subfamily A member 1" Q16850 7 92112153-92134803 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 206.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 67.3;Alveolar cells type 2: 169.7;Early spermatids: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 481.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041325, HPA043508" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA041325: AB_2677411, HPA043508: AB_2678520" "unprognostic (6.68e-2)" "prognostic unfavorable (6.12e-4)" "unprognostic (3.48e-2)" "unprognostic (1.18e-2)" "unprognostic (7.82e-2)" "unprognostic (3.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.84e-2)" "unprognostic (1.36e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.59e-9)" "unprognostic (1.82e-1)" "unprognostic (2.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.09e-3)" 19.6 58.8 24.8 20.8 30.2 30.6 30.9 40.7 33.9 26.6 21.9 53.2 87.4 21.4 36.1 44.0 16.9 24.6 20.9 28.6 40.7 39.0 206.4 53.7 13.2 58.1 45.5 26.2 29.3 49.1 60.1 17.3 22.1 52.2 44.2 41.9 31.7 20.5 17.7 8.0 23.7 40.4 20.6 48.2 13.5 45.5 87.1 43.1 6.7 33.9 11.8 16.7 21.5 26.4 68.8 113.7 54.3 134.0 86.4 92.0 149.6 18.7 37.7 112.7 47.1 128.8 131.8 201.7 98.1 57.9 65.3 481.6 96.2 118.1 237.0 55.3 40.3 82.6 27.9 51.1 99.7 125.7 56.0 39.4 109.1 105.7 185.6 194.0 42.2 49.4 19.8 108.2 217.8 56.4 115.6 12.5 53.8 100.7 45.9 53.4 40.3 27.8 222.8 216.7 187.9 94.1 62.5 80.0 156.3 117.2 60.6 56.9 69.5 59.5 65.0 70.6 95.2 49.8 72.8 70.5 88.1 49.8 75.5 85.2 2.8 11.1 3.9 11.6 16.3 7.7 15.6 8.0 8.9 16.3 12.3 7.1 9.6 1.5 7.8 10.3 14.3 6.7 8.2 24.8 30.2 40.7 33.9 28.6 40.7 58.1 45.5 26.2 52.2 48.2 43.1 68.8 3.1 67.3 169.7 35.9 24.0 2.5 1.6 4.6 48.9 2.6 6.7 3.7 1.6 7.2 44.5 1.8 2.1 1.5 8.9 20.3 1.9 10.7 74.4 10.7 8.1 7.7 10.8 11.6 34.3 19.8 1.0 9.1 43.3 16.4 28.5 4.1 5.3 45.2 1.5 0.0 39.6 13.1 2.0 5.6 1.9 34.4 3.7 9.2 0.0 15.9 1.3 2.4 0.0 39.2 53.1 14.2 11.7 1.5 34.3 1.4 9.6 1.5 15.7 1.9 0.0 4.0 6.5 7.8 4.2 51.4 5.4 4.4 12.2 9.3 11.9 2.5 KRIT1 "CAM, CCM1" ENSG00000001631 "KRIT1 ankyrin repeat containing" O00522 7 92198969-92246166 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 177.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049606 Supported Uncertain Vesicles NA NA Vesicles "HPA049606: AB_2680832" "unprognostic (8.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.83e-2)" "unprognostic (3.75e-2)" "unprognostic (1.94e-1)" "unprognostic (8.93e-2)" "unprognostic (4.10e-3)" "unprognostic (1.06e-2)" "unprognostic (2.30e-3)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "unprognostic (2.82e-1)" "unprognostic (2.61e-1)" "unprognostic (6.18e-2)" "unprognostic (1.04e-1)" 11.4 13.8 6.5 16.3 9.3 8.6 11.9 15.2 11.1 13.2 10.9 12.3 14.7 17.2 14.2 13.5 14.1 15.8 19.0 6.8 8.3 14.3 12.2 10.8 14.8 7.2 7.3 6.3 20.5 16.1 23.9 11.5 13.7 8.3 12.2 12.8 16.5 14.3 11.3 16.4 14.1 12.3 14.3 5.3 14.9 13.8 18.9 7.0 19.6 22.6 17.7 15.9 13.7 10.9 14.2 27.6 22.0 26.8 27.4 21.2 15.9 19.6 25.5 18.3 12.0 12.3 18.8 31.1 25.9 24.6 14.8 25.9 24.1 21.9 12.7 18.5 23.0 31.4 25.2 26.6 13.2 15.2 34.9 34.5 22.3 21.8 15.0 16.9 20.7 16.2 21.8 51.4 40.5 18.9 30.7 40.6 26.0 26.6 22.4 16.3 28.4 35.5 34.1 10.8 30.9 27.4 33.5 27.7 38.3 22.9 28.2 22.0 20.6 25.1 37.3 28.2 46.9 18.3 25.6 31.1 50.4 19.5 29.6 34.4 13.4 5.5 5.4 6.5 4.0 6.6 10.8 7.5 9.5 5.6 8.5 9.5 8.3 2.2 12.0 2.9 7.6 7.7 3.3 6.5 9.3 15.2 11.1 6.8 8.3 7.2 7.3 6.3 8.3 5.3 7.0 14.2 40.6 16.0 34.3 47.0 38.9 19.9 25.7 27.3 40.5 43.7 35.5 34.3 27.6 20.0 26.8 42.3 33.3 37.3 39.2 22.0 46.9 24.0 29.7 30.0 44.1 36.2 20.4 29.2 76.9 24.2 30.0 39.7 35.7 27.9 36.7 49.4 44.6 29.7 19.3 28.6 92.6 23.1 20.3 22.1 16.2 19.5 51.3 23.4 7.2 35.6 29.9 39.9 41.2 46.8 115.4 22.1 33.1 54.2 38.0 22.4 32.2 36.3 36.9 53.1 39.5 43.8 36.8 177.1 90.1 43.1 25.1 28.0 33.0 41.8 23.7 20.5 RAD52 ENSG00000002016 "RAD52 homolog, DNA repair protein" P43351 12 911736-990053 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 34.9;Excitatory neurons: 38.0;Inhibitory neurons: 48.8;Microglial cells: 23.4;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028957 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA028957: AB_2672842" "unprognostic (4.53e-1)" "unprognostic (8.08e-3)" "unprognostic (4.68e-2)" "unprognostic (5.27e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.82e-3)" "unprognostic (1.88e-1)" "unprognostic (2.80e-2)" "unprognostic (8.43e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-1)" "prognostic unfavorable (2.22e-6)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (3.74e-2)" 4.9 4.7 6.2 5.1 8.3 3.6 6.1 7.6 8.5 8.3 5.1 7.3 5.9 7.4 8.5 4.7 6.7 4.2 4.6 6.8 6.8 5.4 6.5 4.1 6.4 7.4 7.3 6.5 10.9 6.7 4.9 5.3 5.4 8.3 6.3 7.1 6.9 4.4 6.0 12.4 9.9 6.6 6.2 5.4 6.1 5.5 4.4 7.1 7.0 8.3 6.8 6.0 6.2 5.8 13.8 4.0 15.2 11.6 13.8 12.1 9.7 12.7 7.9 7.5 9.0 8.7 14.8 14.3 12.8 2.4 8.2 7.4 12.0 9.4 5.4 7.7 17.7 8.2 14.6 16.2 10.0 7.0 15.6 4.2 5.5 9.4 9.1 28.3 17.6 7.4 12.4 9.8 7.5 8.6 8.7 10.8 15.7 15.4 10.0 9.9 10.8 11.6 4.8 9.4 7.1 4.3 5.0 10.3 10.8 6.0 16.8 10.2 7.5 7.4 12.3 14.6 9.8 8.6 2.7 4.6 13.5 6.3 6.9 4.5 7.0 2.1 1.5 2.9 1.9 3.5 2.9 3.0 2.5 2.7 4.0 3.3 3.2 2.0 2.6 2.5 6.0 2.9 1.0 6.2 8.3 7.6 8.5 6.8 6.8 7.4 7.3 6.5 8.3 5.4 7.1 13.8 2.5 3.2 5.9 34.9 3.4 1.8 1.4 1.7 4.0 4.2 2.7 2.7 3.6 2.8 3.2 3.7 2.1 4.8 4.5 5.9 1.9 2.3 4.0 2.3 4.5 3.4 1.8 4.2 38.0 1.6 2.8 3.3 5.1 2.6 5.7 4.5 0.7 2.6 2.5 3.3 48.8 2.0 0.0 1.0 2.9 7.5 0.6 2.6 0.0 23.4 2.8 1.4 1.0 30.2 54.5 0.9 3.4 0.7 2.3 1.6 3.9 1.8 1.7 2.6 6.6 4.2 3.9 4.0 4.7 1.9 1.0 2.1 2.6 2.2 3.3 0.8 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria NA NA Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684" "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 61.1 85.8 81.7 13.3 77.4 23.5 59.3 77.5 134.2 64.5 72.4 77.4 26.7 65.3 12.8 73.5 59.3 15.7 103.9 80.9 75.7 87.3 96.9 59.2 14.8 81.9 80.9 78.6 55.6 54.1 35.9 55.8 21.9 77.8 80.4 15.2 17.4 58.2 27.9 51.1 70.1 45.0 14.1 78.9 45.4 87.8 55.5 84.1 17.4 76.5 15.2 12.5 66.4 58.2 81.1 95.0 85.1 25.2 38.3 30.0 36.4 36.9 38.2 45.9 60.0 47.5 54.8 53.1 19.5 67.7 37.4 46.9 49.9 16.8 62.7 11.9 77.6 58.7 24.9 81.4 26.1 45.9 20.7 45.0 35.3 53.7 45.8 28.3 45.9 37.5 44.1 10.1 42.9 26.6 94.7 49.8 49.7 9.8 27.7 109.6 46.7 13.8 57.9 36.8 44.3 51.2 67.1 39.2 46.8 49.9 9.6 70.5 32.0 30.3 72.8 48.1 112.8 43.8 79.6 64.0 21.3 59.2 15.6 40.6 88.0 69.7 102.3 52.9 56.7 54.7 58.6 55.4 51.9 50.5 57.5 39.8 40.9 92.4 59.5 55.3 94.0 71.8 51.4 81.7 77.4 77.5 134.2 80.9 75.7 81.9 80.9 78.6 77.8 78.9 84.1 81.1 56.3 32.1 45.1 7.8 32.9 103.1 54.1 170.2 51.2 67.7 76.7 74.8 51.6 70.1 66.4 53.3 18.8 162.5 32.4 214.4 137.0 101.2 43.5 71.5 64.8 56.8 104.1 69.2 10.4 109.9 197.8 75.3 53.0 45.4 24.1 58.2 62.4 51.0 73.8 47.1 7.5 141.8 89.5 24.1 72.6 93.3 74.3 32.9 110.3 2.8 52.4 95.9 36.0 4.0 8.9 120.7 210.0 85.4 33.2 62.1 138.1 152.8 83.2 52.0 59.2 36.2 72.6 69.5 25.0 57.7 119.1 255.0 36.0 57.8 117.1 63.4 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577198-17607972 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol Yes No 3500000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 93.6 53.1 30.9 132.6 32.9 59.7 60.8 37.1 43.2 31.0 34.3 60.9 79.0 34.7 25.6 45.0 45.8 67.9 65.6 29.5 41.2 107.3 191.9 101.5 151.6 41.9 33.6 25.9 24.2 31.2 61.5 22.3 71.5 39.6 37.1 62.6 20.2 68.2 31.3 68.6 38.1 61.8 76.9 37.9 94.9 55.8 44.2 38.5 57.3 46.8 64.4 95.1 83.6 25.5 52.0 51.7 44.4 41.6 39.4 80.5 97.9 0.4 79.6 89.1 282.3 340.3 81.4 96.1 202.0 51.7 61.6 167.9 31.3 157.7 56.3 106.7 77.7 45.2 112.1 47.3 107.6 94.1 102.3 69.2 100.0 35.3 92.7 48.6 32.3 99.7 52.2 110.6 139.9 67.6 55.6 91.9 139.5 87.1 96.3 83.9 139.8 39.8 102.7 73.5 59.6 61.4 50.2 72.9 44.4 161.1 57.3 37.9 39.1 65.2 71.3 48.5 76.1 140.6 127.7 208.8 172.7 96.3 167.2 70.8 43.1 200.6 44.7 33.7 210.0 31.0 32.7 31.2 36.3 204.6 23.5 26.7 28.3 28.1 54.0 158.1 116.6 60.2 135.8 30.9 32.9 37.1 43.2 29.5 41.2 41.9 33.6 25.9 39.6 37.9 38.5 52.0 230.6 28.9 49.6 10.7 34.4 22.0 26.1 60.1 21.6 8.1 53.5 41.7 48.9 18.6 44.1 27.6 2.1 35.9 68.3 44.2 117.4 68.6 100.5 67.3 45.7 129.7 16.3 31.7 6.4 109.2 54.7 42.0 29.6 40.7 64.1 29.4 71.0 95.5 262.1 6.7 9.6 35.6 42.7 92.1 50.5 31.7 23.0 141.9 42.7 18.7 195.0 103.8 28.8 9.5 21.2 53.3 31.8 35.0 71.2 26.9 52.4 274.0 92.5 15.4 32.9 31.3 57.8 95.7 13.7 32.5 22.9 55.7 42.4 80.7 45.6 27.1 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691187-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" NA NA 62000000 "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 423.5 144.4 128.1 120.3 131.5 106.3 330.5 152.5 136.5 338.4 139.8 306.4 149.9 308.0 133.6 210.5 251.6 266.8 340.7 125.7 229.0 112.6 229.6 258.7 147.8 214.4 162.2 100.0 305.5 236.6 47.2 133.9 196.4 202.0 272.6 154.4 15.2 185.7 260.9 165.0 273.8 211.8 228.0 228.4 187.5 210.8 201.2 163.2 567.2 153.8 169.8 130.2 298.8 317.3 246.2 259.4 276.5 308.5 424.8 1217.7 939.2 195.0 681.6 1050.1 419.2 604.8 412.3 179.1 18.3 130.0 929.4 217.5 99.4 124.1 168.4 337.5 350.8 321.2 53.1 179.5 353.4 390.1 81.7 375.0 580.1 204.9 223.7 155.6 271.8 766.4 256.3 66.4 0.9 391.9 191.2 672.3 266.8 107.5 28.6 310.0 118.7 273.2 513.5 240.7 165.4 1.0 141.2 168.7 138.2 432.6 744.9 129.6 229.4 750.2 509.7 86.1 487.1 230.2 1.0 0.8 116.1 338.1 203.1 323.8 23.6 526.0 18.3 1089.2 131.2 620.5 340.1 730.3 961.1 496.5 231.8 267.4 549.7 45.1 377.3 32.3 682.1 833.7 1421.2 128.1 131.5 152.5 136.5 125.7 229.0 214.4 162.2 100.0 202.0 228.4 163.2 246.2 297.7 64.1 68.3 20.5 172.0 250.6 207.4 274.4 138.9 5.1 66.9 48.3 86.6 112.9 88.4 71.7 0.0 223.6 507.7 68.4 13.7 145.3 8.8 180.2 279.7 387.7 80.8 136.5 0.9 138.4 189.7 604.7 116.7 188.8 230.4 1614.3 512.9 123.0 799.8 0.0 1.1 150.8 54.9 187.4 579.9 26.4 645.2 342.4 691.9 37.5 175.9 52.0 632.4 1.0 0.9 139.9 158.2 511.2 300.2 385.8 230.9 63.3 117.5 3.2 341.8 231.1 351.9 16.4 56.9 147.9 222.9 123.0 468.9 403.2 262.3 307.0 HS3ST1 3OST1 ENSG00000002587 "Heparan sulfate-glucosamine 3-sulfotransferase 1" O14792 4 11393150-11429564 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;ovary: 32.2" "Cell type enhanced" "Detected in many" "Club cells: 112.0;granulocytes: 96.3;Granulosa cells: 285.0;Peritubular cells: 90.3;Urothelial cells: 92.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "memory B-cell: 14.9;naive B-cell: 26.6;plasmacytoid DC: 42.3" "Group enriched" "Detected in many" 108 "B-cells: 26.6;dendritic cells: 42.3" "Cell line enhanced" "Detected in some" "A-431: 5.8;CAPAN-2: 20.6;HaCaT: 6.0;RPTEC TERT1: 13.2;RT4: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002237 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA002237: AB_1079085" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (4.01e-2)" "prognostic favorable (7.73e-4)" "unprognostic (3.32e-2)" "unprognostic (8.90e-3)" "unprognostic (4.21e-1)" "unprognostic (2.08e-1)" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.99e-8)" "unprognostic (9.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.57e-1)" "prognostic favorable (8.67e-4)" 1.8 2.5 2.7 2.7 1.3 2.0 1.9 24.2 5.9 2.5 0.0 2.1 3.7 3.4 1.3 11.7 4.5 12.8 1.5 1.5 12.3 6.0 0.4 1.8 2.3 4.0 4.2 0.9 32.2 1.0 0.1 4.7 0.7 9.2 2.0 1.1 1.0 5.7 1.5 0.4 0.5 2.9 0.9 4.8 3.3 6.5 1.3 4.5 1.3 1.6 0.2 1.2 14.6 2.6 5.0 5.8 1.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.6 0.0 0.4 0.0 0.0 6.0 0.0 2.8 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.1 1.6 2.2 1.2 0.0 0.0 13.2 14.5 4.6 0.0 0.0 0.1 0.4 0.2 0.0 0.0 2.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.2 14.9 0.0 0.0 0.7 26.6 0.0 0.0 0.0 0.0 0.0 42.3 0.0 1.1 2.7 1.3 24.2 5.9 1.5 12.3 4.0 4.2 0.9 9.2 4.8 4.5 5.0 3.5 3.2 5.8 0.0 13.1 9.1 13.5 70.1 5.2 3.7 2.4 9.3 3.2 32.9 112.0 20.2 4.2 0.5 21.6 5.2 0.0 25.0 1.7 3.6 1.0 28.9 2.4 0.0 13.4 2.1 42.1 13.2 23.9 14.9 96.3 285.0 25.0 0.4 37.6 1.7 35.0 7.2 71.2 3.5 3.7 2.0 8.7 12.5 1.8 6.5 4.9 32.9 8.2 24.1 0.7 51.9 6.5 90.3 0.0 5.6 2.7 19.1 61.2 2.6 0.0 0.5 17.5 5.4 5.6 36.6 8.1 1.4 1.4 68.5 4.3 92.9 AOC1 "ABP, ABP1, DAO" ENSG00000002726 "Amine oxidase copper containing 1" P19801 7 150824627-150861504 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Heparin-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "intestine: 229.1;kidney: 137.8;placenta: 500.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 272.2;Distal enterocytes: 517.5;Paneth cells: 532.1;Proximal enterocytes: 957.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 12 "eosinophil: 31.2" "Lineage enriched" "Detected in many" 22 "granulocytes: 31.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.5;HaCaT: 6.2;NB-4: 6.4;RPMI-8226: 7.7;THP-1: 27.1" "Low region specificity" "Detected in many" "HPA031032, HPA031033" Approved "Secreted in other tissues" NA NA 2500000 "HPA031032: AB_10670150, HPA031033: AB_10669670" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "unprognostic (2.84e-2)" "unprognostic (6.31e-3)" "unprognostic (8.31e-3)" "unprognostic (9.07e-3)" "unprognostic (6.42e-2)" "unprognostic (1.21e-1)" "unprognostic (1.96e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.71e-4)" "unprognostic (5.32e-3)" "unprognostic (3.62e-2)" "unprognostic (1.49e-2)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" 0.7 0.1 0.4 13.1 0.2 1.9 0.2 0.3 0.3 7.2 0.5 143.5 185.7 2.1 1.9 3.3 0.1 1.8 0.7 0.3 0.7 137.8 5.8 0.6 1.3 0.3 0.4 0.0 0.3 1.4 0.0 0.0 500.8 0.3 6.1 95.0 0.1 0.7 1.0 0.1 1.3 229.1 3.5 0.5 0.5 18.2 2.1 0.4 2.1 0.2 0.0 3.9 0.8 0.4 0.5 0.0 0.1 0.1 0.4 0.0 0.0 1.0 0.2 0.0 0.0 0.0 3.2 20.5 0.0 2.7 0.0 1.7 6.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.1 6.4 0.2 1.9 0.0 0.0 0.0 7.7 0.3 0.2 2.2 2.5 0.1 0.9 0.0 0.3 0.8 27.1 0.6 0.2 0.1 0.6 0.0 0.2 0.1 0.1 0.2 1.0 0.1 0.2 0.1 31.2 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.3 0.3 0.7 0.3 0.4 0.0 0.3 0.5 0.4 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.8 272.2 0.0 2.1 0.0 517.5 15.6 0.0 7.1 1.9 0.5 0.4 43.3 0.0 0.1 3.3 63.4 0.5 13.7 4.8 5.7 0.0 0.0 0.0 2.8 0.0 0.1 129.7 2.0 0.0 1.7 18.4 0.0 1.0 0.0 0.0 66.2 0.0 0.0 0.0 0.0 3.7 532.1 0.0 0.0 0.7 957.9 145.2 0.2 0.0 0.0 0.0 0.3 3.7 1.3 0.0 0.1 3.4 0.9 0.0 117.9 0.3 WNT16 ENSG00000002745 "Wnt family member 16" Q9UBV4 7 121325367-121341104 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 5.3;skin 1: 20.7" "Cell type enhanced" "Detected in some" "B-cells: 4.6;Basal keratinocytes: 10.1;Endometrial stromal cells: 3.6;Inhibitory neurons: 6.0;Microglial cells: 3.7;Plasma cells: 2.6;Suprabasal keratinocytes: 11.5" "Cancer enhanced" "Detected in some" "lung cancer: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 145 "memory B-cell: 15.6;naive B-cell: 15.4" "Lineage enriched" "Detected in single" 146 "B-cells: 15.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.3;HEK 293: 5.4;hTEC/SVTERT24-B: 1.6;U-2197: 2.6;U-266/70: 1.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "spinal cord: 4.4" "Secreted to extracellular matrix" NA NA "unprognostic (6.53e-2)" "unprognostic (3.63e-2)" "unprognostic (7.24e-2)" "unprognostic (1.90e-2)" "unprognostic (2.94e-3)" "unprognostic (5.23e-2)" "unprognostic (1.77e-2)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (1.94e-1)" "unprognostic (3.77e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-10)" "unprognostic (5.89e-3)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" 0.1 0.3 0.1 0.3 0.5 0.0 1.4 0.2 0.3 5.3 0.6 0.4 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.2 0.3 1.1 0.2 0.4 0.3 0.0 0.1 0.0 0.3 0.4 0.1 0.6 0.2 0.1 0.1 1.8 0.1 20.7 0.5 0.2 0.5 0.8 0.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 3.2 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.2 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.3 1.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.2 0.4 0.3 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 4.6 10.1 0.1 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 3.6 0.1 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 11.5 0.0 0.1 0.0 0.1 0.0 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112629-43566001 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.5;kidney: 7.9" "Cell type enhanced" "Detected in some" "Early spermatids: 135.6;Excitatory neurons: 533.3;Inhibitory neurons: 157.3;Late spermatids: 72.0;Oligodendrocyte precursor cells: 277.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebral cortex: 16.5" "Group enriched" "Detected in some" 4 "basophil: 4.9;neutrophil: 3.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "A549: 3.8;GAMG: 3.7;U-266/70: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Uncertain Supported Cytosol NA NA Cytosol "HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.1 0.0 0.9 0.2 1.8 0.5 0.2 0.0 16.5 0.1 0.0 0.2 0.0 0.2 0.6 1.0 0.1 1.9 0.0 2.6 2.6 7.9 0.1 0.1 0.4 0.7 0.3 2.2 0.3 0.0 0.2 0.0 0.1 3.1 1.3 0.1 2.2 0.4 0.2 0.9 0.6 0.1 0.1 0.0 0.1 0.3 1.8 0.2 0.0 0.5 2.6 0.2 0.3 0.1 4.0 0.0 3.8 0.3 0.5 0.0 0.0 0.0 1.2 2.2 0.1 0.5 0.0 0.0 0.2 2.3 2.2 3.7 0.2 0.0 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.8 0.9 0.3 12.0 0.4 0.0 2.7 0.3 0.0 4.9 0.8 0.7 0.3 0.5 0.2 0.6 0.3 0.1 0.1 1.0 0.3 0.3 3.3 0.6 0.6 0.9 0.1 0.0 0.9 1.8 0.0 16.5 2.6 2.6 0.7 0.3 2.2 3.1 0.0 0.2 4.0 0.0 0.0 0.0 7.8 0.1 0.4 0.3 0.0 0.0 15.4 0.1 0.3 1.4 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.0 0.0 135.6 1.1 3.6 0.2 0.0 0.0 533.3 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.4 0.1 0.0 45.4 157.3 0.1 0.0 0.0 1.4 72.0 0.3 0.2 0.0 24.4 0.1 0.6 0.0 277.9 4.8 0.0 1.4 0.4 0.0 0.4 4.3 15.8 0.0 1.9 0.0 0.6 0.4 3.2 3.3 0.3 0.3 0.0 0.6 0.2 0.5 0.3 MAD1L1 "HsMAD1, MAD1, PIG9, TP53I9, TXBP181" ENSG00000002822 "Mitotic arrest deficient 1 like 1" Q9Y6D9 7 1815793-2233243 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 316.9;Late spermatids: 685.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003635, CAB015338" Supported Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB015338: AB_627901, HPA003635: AB_1853472" "unprognostic (1.85e-1)" "unprognostic (3.76e-2)" "unprognostic (4.26e-3)" "unprognostic (8.32e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" "unprognostic (2.70e-2)" "unprognostic (1.18e-2)" "unprognostic (4.78e-2)" "unprognostic (5.76e-2)" "unprognostic (1.89e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (5.18e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (4.57e-1)" 8.9 6.0 6.3 11.2 7.9 15.0 9.1 4.1 8.1 10.8 4.3 7.4 6.1 9.4 2.6 9.2 7.5 4.8 8.6 5.1 6.1 6.5 6.4 10.2 17.9 7.2 6.0 3.9 7.4 5.7 4.2 7.1 5.0 8.0 8.3 3.4 4.1 7.4 5.6 13.7 14.1 9.8 5.4 5.1 18.4 6.6 10.8 6.6 15.4 8.6 5.0 10.8 8.4 10.2 8.1 37.2 15.5 16.5 30.1 11.1 11.2 26.5 25.6 13.0 26.0 20.7 28.5 21.5 23.4 10.4 14.7 39.9 28.5 12.4 18.3 15.7 11.1 17.8 30.1 19.4 45.0 15.7 21.1 55.1 13.9 13.3 28.8 14.0 6.3 14.9 13.7 30.3 17.4 10.3 45.4 8.7 61.0 30.7 5.8 20.5 38.5 16.7 17.5 12.7 18.7 10.7 33.4 20.0 24.9 65.2 11.2 17.1 48.9 17.6 21.8 60.0 62.3 26.0 30.3 31.4 27.3 18.1 60.6 80.3 60.4 36.2 25.4 71.3 62.4 66.6 54.6 69.2 72.3 63.4 63.0 92.0 66.0 8.6 22.7 60.1 26.0 131.5 53.6 6.3 7.9 4.1 8.1 5.1 6.1 7.2 6.0 3.9 8.0 5.1 6.6 8.1 9.3 3.2 10.4 12.1 33.8 17.6 13.9 14.0 15.4 8.3 6.2 6.5 7.4 14.3 11.9 7.3 10.4 16.2 35.7 12.4 15.6 12.3 316.9 5.5 6.7 10.7 32.4 19.1 20.9 11.4 16.3 11.4 11.7 6.9 41.8 15.5 6.4 36.4 39.6 23.5 24.4 9.4 16.2 31.4 84.1 685.9 12.5 28.2 37.4 21.5 25.7 24.3 47.4 16.1 32.4 16.5 7.9 10.5 14.9 9.4 5.4 15.2 6.6 13.9 19.7 11.2 10.2 60.3 33.8 9.3 21.5 24.5 43.1 17.5 8.8 9.7 LASP1 "Lasp-1, MLN50" ENSG00000002834 "LIM and SH3 protein 1" Q14847 17 38869859-38921770 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 591.7;Proximal enterocytes: 292.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012072, CAB022049" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 9400000 "Plasma membrane, Cytosol" "Focal adhesion sites" "CAB022049: , HPA012072: AB_1852714" "unprognostic (1.23e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.47e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-1)" "unprognostic (9.60e-2)" "unprognostic (9.87e-3)" "unprognostic (1.01e-1)" "unprognostic (9.65e-3)" "unprognostic (1.29e-3)" "unprognostic (3.95e-2)" "unprognostic (1.60e-3)" "unprognostic (4.53e-2)" 87.2 38.3 59.8 76.6 55.6 127.5 56.0 45.5 57.1 47.3 49.8 93.8 133.1 44.1 32.6 46.2 46.4 57.3 35.5 54.4 58.0 55.9 77.0 69.2 76.7 55.7 60.9 53.5 49.0 59.5 25.7 33.2 82.1 53.5 31.2 93.2 27.0 45.2 34.2 23.9 44.7 170.2 51.7 52.3 75.0 97.1 24.1 64.3 74.8 35.2 28.0 78.8 53.7 37.6 60.2 214.1 441.0 124.1 111.0 182.8 196.9 218.7 267.8 257.8 274.5 198.5 134.3 225.8 98.8 214.1 417.3 154.9 332.4 58.5 204.1 239.6 71.6 31.6 47.5 124.2 235.8 173.0 110.4 134.1 176.3 69.6 234.6 66.1 170.7 188.0 59.0 81.9 30.3 389.4 72.0 127.1 163.6 63.0 189.9 109.4 70.7 67.6 123.8 332.7 187.9 19.0 45.4 159.3 160.5 134.7 233.5 255.7 128.2 331.4 160.0 233.0 189.7 162.0 79.7 115.8 75.2 170.2 96.7 197.2 21.8 31.4 35.0 30.7 33.1 20.3 11.7 15.2 20.4 27.3 10.8 12.7 19.8 67.0 34.2 42.1 20.5 21.4 32.5 59.8 55.6 45.5 57.1 54.4 58.0 55.7 60.9 53.5 53.5 52.3 64.3 60.2 54.5 41.7 27.6 17.6 41.8 41.8 21.5 26.0 51.8 66.4 82.4 43.2 1.1 55.8 30.4 73.5 10.4 7.5 69.5 225.2 17.6 65.7 89.6 27.5 31.7 54.3 86.5 21.0 16.4 76.5 59.1 50.1 119.3 46.4 52.0 37.4 64.6 115.4 83.9 26.9 16.0 101.9 28.5 127.7 73.0 591.7 51.9 71.9 35.6 24.4 94.3 22.2 164.8 11.1 4.4 111.0 116.4 39.9 32.8 24.2 292.7 72.9 57.3 23.1 65.7 65.4 53.4 2.9 5.7 62.2 28.4 6.4 63.4 19.2 97.8 31.8 SNX11 ENSG00000002919 "Sorting nexin 11" Q9Y5W9 17 48103357-48123601 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044787, HPA054660" Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA044787: AB_10795988, HPA054660: AB_2682560" "unprognostic (1.75e-1)" "unprognostic (6.86e-3)" "unprognostic (4.34e-2)" "unprognostic (4.33e-3)" "unprognostic (2.45e-1)" "unprognostic (1.54e-1)" "unprognostic (2.68e-3)" "unprognostic (2.07e-1)" "unprognostic (9.27e-2)" "unprognostic (2.15e-1)" "unprognostic (5.42e-2)" "unprognostic (2.12e-1)" "unprognostic (5.22e-3)" "unprognostic (9.02e-3)" "unprognostic (2.70e-2)" "unprognostic (9.50e-2)" "unprognostic (3.89e-2)" 14.4 12.1 18.1 18.3 19.3 21.7 11.2 18.3 19.6 9.7 16.6 13.4 8.8 10.6 12.6 20.1 9.7 9.0 10.9 18.0 18.5 14.7 14.6 11.5 21.9 20.2 18.9 17.1 8.9 11.8 13.6 10.8 11.4 19.0 12.2 12.6 12.0 12.3 8.8 12.9 11.5 12.5 17.1 19.7 24.2 12.5 11.5 18.9 16.2 20.2 15.4 29.3 13.4 11.7 20.4 20.6 25.4 21.9 21.1 18.1 8.3 22.8 21.8 13.9 26.5 28.8 36.0 17.7 21.6 27.3 24.1 15.5 18.6 21.2 21.0 29.2 52.4 24.5 32.5 17.5 17.5 18.4 36.0 22.7 13.8 20.8 25.1 23.7 16.5 22.4 20.4 19.8 21.7 17.4 17.0 21.8 22.8 12.2 23.6 21.3 13.5 39.7 24.8 16.1 20.1 15.7 28.6 14.2 9.7 37.7 26.6 20.1 25.4 18.8 30.6 18.2 20.3 26.3 34.0 54.1 26.0 22.1 16.4 19.6 28.7 34.6 35.6 19.0 43.3 13.1 22.1 10.5 12.9 28.2 21.2 8.6 14.7 92.9 16.8 54.5 12.9 10.1 24.0 18.1 19.3 18.3 19.6 18.0 18.5 20.2 18.9 17.1 19.0 19.7 18.9 20.4 8.7 6.4 2.0 2.9 15.4 6.0 5.0 5.9 7.4 8.9 6.4 6.2 5.3 1.5 4.3 16.5 2.1 11.7 14.2 13.3 5.9 11.4 1.9 6.2 4.6 8.0 14.9 3.6 4.1 15.3 12.2 6.0 6.6 7.1 2.5 5.4 6.1 6.9 19.9 15.2 3.9 9.0 6.1 23.2 4.6 2.1 5.3 15.9 5.4 2.8 37.5 14.2 14.4 5.0 8.8 18.1 5.6 6.8 6.3 6.9 9.9 9.9 2.9 9.3 13.1 4.6 8.8 10.3 21.2 8.9 5.1 16.4 7.5 7.7 8.0 6.4 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805118 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 381.3;liver: 1180.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 1043.9;Paneth cells: 779.4;Proximal enterocytes: 1294.5;Proximal tubular cells: 1103.9" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 146.5;intermediate monocyte: 98.4" "Lineage enriched" "Detected in many" 5 "monocytes: 146.5" "Cell line enriched" "Detected in some" 31 "HSkMC: 730.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria NA NA Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 75.6 33.4 40.8 125.9 41.2 6.8 49.8 45.4 51.2 46.0 36.5 145.3 114.2 18.8 18.0 28.7 49.4 131.0 64.6 38.6 67.9 381.3 1180.2 59.0 86.3 58.6 47.1 36.2 105.5 30.0 3.9 11.7 67.2 51.3 26.7 152.7 20.8 24.4 16.1 6.4 19.6 204.7 50.7 60.0 51.4 49.1 6.1 47.5 15.6 21.5 17.6 66.5 98.9 54.9 61.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 3.5 14.2 0.2 0.6 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.3 730.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 23.3 0.0 0.0 2.7 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 146.5 12.6 0.3 98.4 0.4 2.1 0.1 0.2 30.9 0.0 0.2 0.0 1.8 0.3 46.0 2.4 0.4 53.3 40.8 41.2 45.4 51.2 38.6 67.9 58.6 47.1 36.2 51.3 60.0 47.5 61.1 15.8 0.0 5.2 3.9 9.8 7.4 0.4 0.9 5.2 56.2 40.6 63.8 24.9 118.7 10.9 200.5 4.2 0.6 2.0 348.5 152.6 64.6 0.3 4.9 14.8 20.5 74.1 6.6 0.0 27.2 0.6 185.3 17.9 2.5 29.0 29.9 23.2 1043.9 52.2 0.0 0.2 237.7 73.2 56.9 26.2 1.5 60.3 109.4 5.4 1.9 313.0 80.8 1.0 1.0 0.0 56.0 779.4 7.5 0.9 1.8 1294.5 1103.9 10.6 5.3 0.0 5.7 32.8 0.9 1.6 2.9 8.4 1.4 6.4 0.1 262.4 2.7 M6PR "CD-M6PR, CD-MPR" ENSG00000003056 "Mannose-6-phosphate receptor, cation dependent" P20645 12 8940361-8949761 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 859.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034464, HPA040445" Approved NA NA 100000 "CAB034464: AB_2139108, HPA040445: AB_2676989" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.54e-1)" "unprognostic (3.00e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (5.82e-3)" "unprognostic (1.44e-2)" "unprognostic (6.82e-2)" "unprognostic (4.53e-3)" "unprognostic (3.79e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (3.98e-1)" 77.3 65.4 85.1 115.0 88.3 105.0 82.4 86.0 96.2 62.0 86.9 79.1 61.6 74.4 63.6 63.9 71.0 74.7 82.8 87.6 98.5 79.9 79.6 98.4 139.9 88.9 87.0 86.6 63.3 60.1 95.8 34.2 79.3 89.0 65.5 92.7 74.3 79.8 75.2 52.4 60.9 65.1 81.8 92.7 133.6 75.4 60.2 93.7 106.4 97.3 56.5 126.5 98.9 37.8 95.8 103.6 159.7 103.0 122.0 187.7 86.8 306.2 129.7 159.4 186.2 210.7 176.4 268.4 188.9 48.9 133.0 374.4 160.0 142.7 131.2 218.8 859.9 86.6 331.3 125.0 122.4 213.7 355.6 566.6 126.0 166.3 184.4 232.5 179.2 105.5 123.3 93.0 114.6 165.2 103.7 120.7 142.3 412.8 189.0 72.4 118.0 248.0 108.4 151.9 241.2 26.5 109.9 159.8 159.4 223.9 363.8 39.0 251.3 106.0 156.3 175.1 186.6 193.2 139.3 253.5 201.4 183.2 226.4 120.5 706.9 292.0 319.1 177.4 477.6 201.5 123.2 210.7 195.5 334.0 111.4 152.7 170.6 44.5 186.3 567.4 205.0 182.3 497.3 85.1 88.3 86.0 96.2 87.6 98.5 88.9 87.0 86.6 89.0 92.7 93.7 95.8 49.9 57.7 57.0 13.4 75.2 44.1 73.0 73.1 43.9 46.1 50.1 40.8 10.7 44.3 68.0 31.3 22.9 64.4 107.0 23.4 19.6 91.8 7.9 31.3 36.7 39.6 38.3 60.1 25.9 66.9 71.4 37.2 30.5 33.7 132.3 39.9 37.1 28.3 242.8 55.5 29.0 30.5 40.7 138.9 95.4 7.9 35.1 166.4 67.6 21.5 212.2 35.8 159.6 17.1 22.7 56.1 29.5 32.0 73.7 65.4 25.7 41.8 53.1 37.4 26.3 52.5 43.7 117.5 54.4 51.6 40.5 53.1 96.4 55.8 43.8 68.2 KLHL13 "BKLHD2, FLJ10262, KIAA1309" ENSG00000003096 "Kelch like family member 13" Q9P2N7 X 117897813-118117340 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 7.3;plasmacytoid DC: 4.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;granulocytes: 7.3" "Cell line enhanced" "Detected in many" "HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (1.07e-2)" "unprognostic (9.54e-2)" "unprognostic (7.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (6.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.09e-3)" "unprognostic (1.24e-2)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (2.31e-1)" 2.7 7.4 4.9 2.7 10.8 0.4 24.8 2.8 4.5 20.6 4.9 4.4 3.1 31.7 7.3 6.0 10.8 5.6 7.8 3.3 4.8 16.2 4.7 1.4 0.6 5.3 9.2 3.3 7.5 4.7 3.4 2.2 0.8 6.6 6.3 4.0 4.2 2.2 12.4 3.6 1.0 4.9 29.5 3.9 1.7 3.3 3.6 6.8 5.1 0.8 5.7 1.2 7.6 5.0 7.7 1.1 0.4 6.9 14.5 0.1 0.0 0.2 0.5 0.0 0.4 0.0 9.1 0.1 0.0 16.5 0.0 0.7 16.9 33.8 5.6 0.0 0.0 12.9 0.4 57.3 0.1 0.8 1.1 2.2 1.8 2.3 0.2 0.7 6.9 25.8 0.0 0.0 0.0 0.0 1.4 5.9 1.6 13.4 0.0 9.6 0.0 37.2 0.1 106.0 4.0 0.0 94.3 0.5 1.2 0.9 2.7 20.9 0.2 0.7 2.4 2.9 2.0 8.6 0.4 0.0 0.2 10.2 0.0 4.1 2.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.6 0.6 0.0 1.1 0.0 4.1 0.2 0.3 4.9 10.8 2.8 4.5 3.3 4.8 5.3 9.2 3.3 6.6 3.9 6.8 7.7 0.7 0.0 0.0 13.7 0.0 0.8 6.8 5.4 12.0 6.2 2.4 19.9 10.5 0.0 4.8 1.8 0.0 0.2 0.1 1.2 29.4 1.1 0.3 8.0 22.7 1.9 1.2 1.3 8.0 3.4 0.1 8.7 0.0 1.3 0.0 10.0 8.6 1.3 0.6 0.0 29.3 2.1 0.0 0.0 1.2 0.9 6.2 1.0 1.8 30.9 0.2 7.2 0.0 102.5 12.3 0.7 3.4 1.9 0.1 2.7 2.9 12.7 22.3 1.2 6.6 18.1 5.3 1.8 10.6 4.8 0.4 0.0 0.6 6.4 4.1 3.6 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72147862 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3" "Group enriched" "Detected in many" 4 "Leydig cells: 75.8;Peritubular cells: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 9.8;HaCaT: 14.8;RH-30: 18.4;U-2 OS: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" No No Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 24.4 4.4 9.7 1.9 3.3 0.1 15.1 11.2 10.2 5.0 0.7 3.1 3.7 2.5 1.5 4.0 5.6 1.1 6.0 7.1 5.0 8.6 1.0 2.7 4.9 40.6 15.2 3.6 4.6 0.7 0.8 9.4 3.3 51.3 2.7 1.2 4.2 10.0 7.4 6.0 30.3 4.8 1.6 0.0 3.5 1.2 13.9 4.5 19.5 14.5 2.3 2.9 3.3 4.3 28.6 0.6 5.9 0.0 0.1 9.8 4.0 5.9 0.9 0.1 0.2 0.2 1.8 0.5 0.0 0.5 0.7 3.0 14.8 8.5 0.0 0.1 0.0 2.7 0.0 7.0 0.9 0.2 0.0 0.3 0.0 0.5 0.0 0.3 3.0 1.1 4.0 0.6 0.1 0.9 2.9 0.0 0.1 0.0 0.1 1.0 0.1 18.4 0.0 0.0 1.3 0.6 0.1 3.0 0.0 3.5 1.2 0.3 0.9 0.0 1.6 19.3 9.0 3.0 0.1 1.2 0.0 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 3.3 11.2 10.2 7.1 5.0 40.6 15.2 3.6 51.3 0.0 4.5 28.6 2.4 0.0 0.0 2.0 1.2 14.7 1.1 0.8 0.6 0.2 2.3 0.8 1.4 4.3 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.2 4.1 0.2 0.2 19.0 1.8 5.3 5.3 0.0 0.9 15.6 0.0 0.3 0.0 1.5 34.6 0.8 0.1 0.0 0.7 0.0 0.0 6.1 19.1 9.6 75.8 0.4 7.2 0.0 0.0 7.4 0.0 2.0 0.5 0.4 1.5 229.9 0.0 0.5 0.2 0.1 0.2 0.3 0.0 5.7 20.7 1.5 3.8 1.6 9.7 0.1 0.8 7.5 0.1 0.4 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 594.7;Late spermatids: 867.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "T-reg: 29.9" "Lineage enriched" "Detected in many" 9 "T-cells: 29.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.1;MCF7: 42.5;OE19: 48.4;RT4: 49.4;SCLC-21H: 66.1;SH-SY5Y: 105.8;SK-BR-3: 52.1;T-47d: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: AB_2684525" "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 15.9 10.5 11.9 5.7 14.1 24.0 21.4 22.1 22.5 16.5 2.5 23.0 13.7 6.9 13.7 9.6 13.8 11.2 44.7 12.8 12.1 16.1 8.9 11.3 13.6 8.7 11.2 13.2 1.7 63.2 21.0 19.9 8.3 11.7 22.3 23.7 2.9 37.5 4.9 2.8 12.9 17.9 5.6 5.4 12.5 30.8 24.4 13.2 5.0 14.2 3.3 9.7 13.9 7.5 15.9 0.0 1.5 1.7 0.2 0.2 0.0 4.2 0.0 0.0 0.6 0.2 1.0 47.1 0.3 5.2 0.1 0.9 0.0 0.8 1.9 0.0 0.0 6.8 9.1 0.9 0.0 0.4 9.1 1.8 0.0 3.0 0.0 0.0 0.5 31.5 8.2 26.4 0.0 0.0 42.5 0.4 0.0 9.9 48.4 0.4 0.0 0.0 19.5 19.0 49.4 66.1 105.8 0.0 52.1 0.7 11.6 43.4 14.3 19.8 0.0 0.9 0.2 1.0 14.1 7.5 0.0 0.0 6.9 10.3 1.0 2.4 0.2 0.3 0.8 0.6 0.4 5.4 0.4 2.4 0.7 0.3 0.2 3.4 0.9 0.4 0.6 29.9 1.3 11.9 14.1 22.1 22.5 12.8 12.1 8.7 11.2 13.2 11.7 5.4 13.2 15.9 73.4 28.9 24.4 6.5 1.6 20.5 16.2 7.1 9.1 10.4 42.8 28.7 43.2 22.8 20.1 22.0 6.2 2.7 2.1 28.2 43.0 38.4 594.7 34.2 5.8 44.1 77.2 16.4 132.1 74.8 0.8 4.5 56.1 65.4 8.2 11.2 42.1 1.3 23.9 0.0 138.0 80.5 44.7 8.1 9.3 867.0 7.5 9.6 14.2 60.0 6.3 0.8 3.1 49.3 3.9 59.8 53.1 3.0 1.7 53.8 23.8 8.3 17.8 1.7 6.6 1.2 5.6 13.9 9.6 18.4 8.9 2.2 9.5 4.7 41.8 42.7 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004871-90019890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 101.4;skeletal muscle: 48.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 22.8;Ductal cells: 16.0;Exocrine glandular cells: 18.8;Horizontal cells: 30.3;Pancreatic endocrine cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "naive B-cell: 12.9" "Lineage enriched" "Detected in many" 4 "B-cells: 12.9" "Cell line enhanced" "Detected in many" "MCF7: 139.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favorable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 1.8 7.5 48.8 2.5 37.3 0.3 4.4 30.4 62.4 2.7 15.3 2.8 1.6 0.9 10.1 28.4 3.6 3.9 3.4 37.7 38.7 13.2 6.6 3.5 4.7 49.1 55.1 39.2 3.2 19.7 9.7 7.8 0.1 53.0 3.9 1.4 7.5 15.7 3.1 48.4 5.5 1.7 1.3 30.4 1.2 7.8 1.0 101.4 1.4 5.3 4.8 5.2 1.7 7.3 47.8 22.8 34.7 3.5 44.7 0.9 0.4 24.7 4.9 6.6 10.5 5.3 32.1 19.7 0.0 2.7 1.1 10.2 24.0 41.3 1.2 10.7 0.1 65.4 0.0 4.4 58.6 1.5 0.3 4.7 1.0 3.3 18.8 0.1 25.2 47.3 0.8 6.7 0.4 4.1 139.7 0.1 33.5 59.5 18.6 13.9 14.5 32.3 0.6 64.2 4.5 51.2 53.0 5.6 5.3 44.8 10.2 34.6 4.8 36.2 7.4 15.1 0.4 24.1 0.3 0.3 0.4 3.5 3.9 20.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.6 0.5 0.0 12.9 2.9 0.5 0.0 0.0 0.0 0.1 0.0 1.0 48.8 37.3 30.4 62.4 37.7 38.7 49.1 55.1 39.2 53.0 30.4 101.4 47.8 0.3 3.2 2.0 2.9 6.0 0.4 0.6 0.6 0.0 1.8 13.5 7.5 2.5 22.8 2.0 9.2 0.0 0.2 0.1 1.4 9.8 16.0 0.0 5.7 0.7 1.1 6.0 0.0 6.1 18.8 0.3 0.2 2.6 7.8 0.0 3.4 1.4 2.5 0.3 30.3 3.6 1.5 2.0 0.0 0.7 0.0 1.2 0.1 3.6 2.8 0.2 10.4 0.0 1.5 0.7 15.0 2.9 0.4 0.5 4.3 0.2 10.8 2.7 1.8 0.0 1.4 1.2 0.1 2.0 8.1 1.0 0.0 1.4 0.3 0.8 1.3 ALS2 ALS2CR6 ENSG00000003393 "Alsin Rho guanine nucleotide exchange factor ALS2" Q96Q42 2 201700267-201782112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 91.8;granulocytes: 46.9;Inhibitory neurons: 66.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 26.0" "Group enriched" "Detected in many" 5 "basophil: 23.0;eosinophil: 6.8" "Lineage enriched" "Detected in all" 8 "granulocytes: 23.0" "Cell line enhanced" "Detected in all" "HMC-1: 50.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA046588: AB_2679709" "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 7.2 5.6 1.9 2.7 3.4 5.7 6.8 26.0 4.4 6.4 3.8 5.9 3.3 6.7 7.8 4.9 6.4 3.8 12.6 3.1 1.9 7.4 14.6 6.8 2.9 1.8 3.3 3.0 6.1 5.8 4.3 10.1 3.6 8.8 6.1 3.4 5.4 5.5 1.6 13.6 7.0 6.7 4.8 0.5 5.3 6.9 5.3 1.7 2.4 6.3 5.9 2.8 6.3 5.7 3.2 6.5 6.7 7.1 5.6 7.0 5.1 7.2 8.6 10.4 14.0 13.2 5.8 8.4 1.2 3.8 11.7 6.1 3.7 4.6 10.6 18.0 3.5 4.8 15.3 6.2 5.2 8.1 16.4 50.4 9.8 4.1 11.5 14.0 5.7 10.0 8.6 9.8 5.7 9.6 7.5 6.7 20.3 9.2 4.6 5.3 5.4 7.7 4.2 9.8 8.8 3.4 7.8 6.4 7.1 9.2 14.3 5.4 7.2 7.9 11.6 7.2 3.5 6.2 7.1 9.2 4.5 8.5 3.4 7.2 23.0 0.9 6.8 1.6 1.7 1.9 1.2 1.3 1.3 1.4 1.0 1.5 1.5 0.9 3.0 1.2 0.8 2.1 0.8 1.9 3.4 26.0 4.4 3.1 1.9 1.8 3.3 3.0 8.8 0.5 1.7 3.2 7.6 12.8 16.7 28.7 2.8 5.4 3.8 4.4 3.4 15.1 5.4 4.3 32.3 8.6 4.3 9.2 29.2 5.7 3.7 3.6 0.0 6.9 16.5 14.0 6.8 10.4 4.8 12.0 91.8 3.3 3.2 6.9 9.7 6.8 46.9 10.1 13.2 20.3 5.9 8.4 66.6 6.9 2.0 3.2 3.0 6.5 7.8 4.8 0.0 27.2 3.1 5.9 4.1 36.2 44.0 6.1 3.9 8.2 2.3 4.4 7.8 6.1 17.5 15.4 0.0 9.3 8.4 7.3 5.6 4.6 6.0 6.7 3.9 5.2 4.7 3.7 CASP10 "FLICE-2, MCH4" ENSG00000003400 "Caspase 10" Q92851 2 201182898-201229406 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 25.3" "Low region specificity" "Detected in all" "CAB003780, HPA017059" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB003780: AB_289592, HPA017059: AB_1846040" "unprognostic (4.01e-2)" "unprognostic (8.24e-2)" "unprognostic (4.80e-1)" "unprognostic (1.28e-3)" "unprognostic (4.74e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.05e-7)" "unprognostic (3.23e-2)" "unprognostic (2.19e-2)" "unprognostic (4.49e-2)" "unprognostic (1.38e-2)" 8.3 2.4 6.4 9.3 5.2 19.6 6.6 4.5 6.5 3.5 5.5 13.3 22.0 3.3 6.3 8.9 5.5 7.5 5.2 5.0 5.0 6.1 6.2 11.6 8.9 6.1 4.9 3.4 1.6 4.9 2.3 1.4 9.7 5.7 3.9 13.5 1.3 5.4 3.1 4.9 5.7 18.6 5.2 5.1 22.8 10.3 1.2 8.1 8.8 5.3 2.8 10.5 9.0 5.1 7.1 4.4 3.5 0.3 0.4 0.1 0.3 7.5 0.7 4.6 0.4 1.8 4.6 9.8 0.5 7.0 2.5 1.7 2.9 0.2 2.3 1.3 2.1 4.8 12.2 4.0 15.1 1.6 8.3 12.7 0.5 2.0 5.3 0.4 0.3 25.3 5.1 14.9 17.4 0.4 0.3 15.9 7.8 0.6 6.0 2.4 8.8 0.5 18.4 8.7 6.2 0.2 0.1 4.1 0.2 1.9 3.0 0.2 7.8 10.0 0.4 0.8 3.4 0.2 18.7 12.1 0.5 4.5 6.3 0.2 5.9 11.7 0.7 6.4 16.5 5.6 8.2 5.2 3.6 6.5 7.7 7.2 6.4 2.1 8.5 19.3 6.6 1.2 7.2 6.4 5.2 4.5 6.5 5.0 5.0 6.1 4.9 3.4 5.7 5.1 8.1 7.1 20.7 19.2 10.0 0.3 15.8 6.0 2.7 10.6 5.2 0.0 1.3 0.9 1.8 8.6 9.4 9.2 0.0 1.1 20.5 71.3 1.9 16.2 1.2 7.7 7.4 29.7 2.4 14.9 0.3 10.4 0.7 4.2 26.5 12.0 7.6 0.8 26.4 7.1 9.4 0.0 0.5 21.6 4.1 26.6 17.5 0.0 0.6 16.2 7.2 33.7 22.0 0.5 44.3 0.0 0.9 8.6 44.5 0.0 49.7 2.5 26.1 8.7 24.4 0.4 0.0 2.9 2.2 0.1 0.1 6.6 4.5 0.4 12.9 4.1 16.4 10.3 CFLAR "c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT" ENSG00000003402 "CASP8 and FADD like apoptosis regulator" O15519 2 201116154-201176687 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 609.9;Urothelial cells: 521.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 392.6" "Lineage enriched" "Detected in all" 6 "granulocytes: 392.6" "Cell line enhanced" "Detected in all" "U-266/70: 214.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019044, CAB022157, CAB025216" Uncertain Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB022157: , CAB025216: , HPA019044: AB_10696204" "unprognostic (4.61e-2)" "unprognostic (5.32e-2)" "unprognostic (2.49e-1)" "unprognostic (1.44e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.46e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (3.08e-2)" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (7.83e-2)" "unprognostic (9.13e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-2)" 123.5 51.0 42.0 104.9 41.9 250.0 83.8 53.3 44.1 55.3 76.2 73.4 59.7 58.4 61.2 68.6 67.2 72.2 179.1 38.7 58.8 55.9 59.7 176.1 91.8 46.3 40.1 26.1 38.7 41.0 32.0 29.7 94.8 42.0 66.1 57.0 12.5 58.5 63.8 224.6 49.9 65.3 59.3 36.3 98.9 57.0 25.5 47.2 54.6 79.5 90.0 108.2 79.5 62.2 61.4 21.5 42.9 30.0 17.9 92.3 71.0 37.5 53.6 92.1 34.3 41.6 50.4 78.4 5.8 49.6 62.5 41.6 15.5 9.8 40.3 53.9 160.7 29.9 32.3 38.4 82.2 63.6 24.2 102.2 76.8 39.6 58.2 50.3 41.7 176.7 7.3 110.8 131.2 63.1 17.9 11.3 96.3 10.2 17.2 32.7 11.7 7.2 46.5 42.5 44.0 6.6 11.8 35.7 31.2 43.2 19.6 22.1 44.8 193.6 71.0 29.5 26.7 26.1 214.6 76.2 35.9 50.6 19.5 36.3 91.8 60.3 70.3 54.4 61.8 48.4 25.6 46.5 52.1 33.4 20.9 29.5 38.3 392.6 45.2 68.5 23.0 60.7 42.0 42.0 41.9 53.3 44.1 38.7 58.8 46.3 40.1 26.1 42.0 36.3 47.2 61.4 191.3 451.9 234.9 30.3 126.4 54.8 229.6 164.9 29.0 10.9 38.9 30.0 205.8 102.9 206.7 69.9 31.3 77.2 166.2 132.5 74.3 148.8 83.3 202.8 75.0 261.0 95.1 59.1 6.9 72.5 34.8 89.5 73.4 219.2 81.6 93.4 201.0 97.5 68.6 13.5 16.8 76.8 40.7 123.2 609.9 44.8 51.9 278.0 97.8 146.1 247.0 23.4 276.0 29.7 56.8 166.4 155.6 49.7 317.8 386.0 116.7 101.5 276.1 30.7 39.5 113.2 77.9 14.4 12.2 33.2 86.1 70.1 168.3 56.1 50.9 521.3 TFPI "EPI, LACI, TFI, TFPI1" ENSG00000003436 "Tissue factor pathway inhibitor" P10646 2 187464230-187565760 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 274.5;placenta: 192.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 2284.2;Hepatic stellate cells: 872.4;Syncytiotrophoblasts: 879.2" "Cancer enhanced" "Detected in all" "liver cancer: 22.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.3;neutrophil: 1.3;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 3.3" "Cell line enhanced" "Detected in many" "HHSteC: 386.2;HUVEC TERT2: 742.5;LHCN-M2: 459.9;TIME: 451.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA005575, CAB020842" Supported "Secreted to blood" NA NA 58100000 87000000 "CAB020842: , HPA005575: AB_1080290" "unprognostic (8.75e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (7.95e-2)" "unprognostic (4.99e-2)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (3.05e-1)" "unprognostic (5.63e-2)" "unprognostic (3.86e-3)" "unprognostic (9.22e-2)" "unprognostic (2.43e-2)" "unprognostic (2.72e-2)" "unprognostic (7.05e-2)" "unprognostic (3.39e-3)" "unprognostic (4.05e-2)" "unprognostic (4.49e-2)" "unprognostic (5.81e-2)" 62.3 12.7 2.7 20.7 3.5 8.3 52.8 4.9 5.9 41.9 10.5 23.5 53.0 25.9 18.7 33.7 35.9 58.2 32.8 4.2 2.4 56.9 274.5 127.8 33.6 6.6 2.9 2.8 26.7 25.2 7.1 6.2 192.8 4.0 15.8 27.6 4.6 15.1 12.9 27.0 18.0 42.1 30.9 3.6 20.8 19.4 6.9 3.3 11.2 36.5 43.1 17.8 53.4 30.1 3.4 38.9 24.7 29.3 0.8 224.3 267.7 0.7 66.0 156.3 42.7 65.1 22.6 192.6 0.7 27.3 52.7 74.7 2.1 15.9 3.6 110.3 1.9 7.6 12.3 73.8 197.3 386.2 0.9 0.4 123.1 5.1 232.8 61.9 93.4 742.5 0.7 31.2 0.7 459.9 35.4 4.6 0.7 22.9 0.8 68.8 0.3 40.2 0.3 72.9 1.4 0.3 0.5 56.7 2.1 3.5 95.8 0.7 0.2 451.4 30.6 29.0 61.4 13.5 1.1 1.7 0.4 239.4 0.6 35.4 3.3 0.2 0.2 0.2 0.1 0.1 0.4 0.1 0.0 0.2 0.5 0.2 0.2 1.3 0.5 0.1 2.7 0.1 2.3 2.7 3.5 4.9 5.9 4.2 2.4 6.6 2.9 2.8 4.0 3.6 3.3 3.4 99.2 35.3 335.5 1.3 4.4 20.8 2.9 33.5 4.6 0.6 16.1 9.1 7.0 173.0 102.5 38.6 0.0 59.5 4.8 0.5 13.7 140.0 41.5 7.3 74.2 287.1 105.0 43.1 0.7 273.1 2284.2 283.0 12.2 5.3 13.9 1.5 872.4 382.1 50.2 1.7 0.2 11.3 158.7 63.7 41.3 15.2 171.8 21.9 26.6 13.1 33.7 33.1 1.0 0.0 0.1 157.6 34.1 70.0 9.5 8.0 36.6 109.4 45.2 1.1 216.9 141.2 127.8 2.7 0.5 10.2 18.5 879.2 8.1 30.6 18.5 16.7 NDUFAF7 "C2orf56, MidA, PRO1853" ENSG00000003509 "NADH:ubiquinone oxidoreductase complex assembly factor 7" Q7L592 2 37231631-37253403 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Group enriched" "Detected in all" 4 "Early spermatids: 196.6;Late spermatids: 109.6;Spermatocytes: 118.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045217 Uncertain NA NA "HPA045217: AB_10960395" "unprognostic (6.38e-2)" "unprognostic (2.92e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.48e-4)" "prognostic favorable (3.08e-4)" "unprognostic (5.44e-2)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (8.12e-3)" "unprognostic (5.94e-2)" "unprognostic (3.48e-2)" "unprognostic (1.03e-1)" "unprognostic (5.73e-2)" "unprognostic (8.67e-3)" 6.1 12.8 6.4 5.5 7.4 6.0 6.1 7.9 8.1 7.8 6.5 10.0 4.6 7.9 8.1 5.6 6.0 6.0 15.2 7.6 7.1 9.4 10.7 5.5 6.9 6.9 6.8 7.0 7.0 5.7 8.2 6.9 6.0 7.6 6.7 5.9 10.0 5.7 5.4 20.5 4.8 5.7 7.4 6.0 6.6 6.3 39.1 6.7 8.3 5.1 24.6 6.0 6.8 6.2 7.4 20.2 10.6 13.2 11.6 8.3 17.6 7.3 6.6 10.5 11.1 14.1 22.9 8.5 17.1 8.1 6.0 18.9 14.8 16.2 8.3 13.1 11.9 12.1 12.6 13.1 21.1 10.2 12.6 6.1 13.8 13.6 9.1 5.6 11.8 17.4 6.4 15.5 11.1 6.7 7.4 12.6 13.5 17.3 15.9 9.5 11.3 10.2 14.4 15.4 7.4 13.7 11.0 8.2 13.9 14.3 18.6 8.4 4.9 3.4 9.2 12.3 11.6 12.1 9.7 6.0 19.8 13.4 16.9 7.9 3.0 4.3 2.6 4.1 3.7 1.8 4.7 3.6 3.5 5.3 4.1 3.5 3.1 2.7 4.1 2.7 4.2 4.6 2.0 6.4 7.4 7.9 8.1 7.6 7.1 6.9 6.8 7.0 7.6 6.0 6.7 7.4 10.9 9.6 10.0 12.7 15.5 4.8 9.5 12.3 11.4 18.1 6.4 5.6 13.4 2.8 8.4 11.0 22.9 15.0 16.1 3.7 17.6 10.5 196.6 6.6 12.1 9.4 2.4 6.5 30.5 6.3 10.8 9.7 8.6 7.2 7.6 11.9 7.5 5.6 9.4 11.8 26.9 5.5 12.2 7.3 7.8 109.6 13.4 9.4 3.6 15.0 10.5 7.6 10.3 13.6 15.4 8.8 2.0 16.6 9.3 5.9 7.7 14.8 11.3 21.8 6.6 10.1 18.0 118.4 14.4 7.4 4.0 11.5 13.6 16.1 6.2 6.3 RBM5 "H37, LUCA-15, LUCA15" ENSG00000003756 "RNA binding motif protein 5" P52756 3 50088919-50119021 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017335, HPA018011" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017335: AB_1856134, HPA018011: AB_1856135" "unprognostic (4.11e-3)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-1)" "unprognostic (2.61e-3)" "prognostic unfavorable (9.77e-4)" "prognostic favorable (6.46e-4)" "unprognostic (1.16e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.58e-4)" "unprognostic (5.58e-2)" "unprognostic (1.49e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-1)" "unprognostic (3.89e-3)" 67.3 54.3 44.9 44.6 47.1 64.1 70.4 50.3 50.0 92.9 50.5 70.5 37.7 75.2 64.5 58.0 86.6 40.4 58.3 43.6 49.3 59.4 58.6 62.4 67.4 47.8 48.1 42.3 121.2 73.7 45.6 85.3 60.6 47.8 86.0 48.2 91.3 64.4 47.7 64.1 82.2 72.7 54.2 41.5 96.0 65.4 63.4 45.5 63.1 81.5 36.7 70.0 67.1 73.9 64.5 31.1 37.3 132.6 58.2 54.3 78.1 31.3 91.9 54.8 67.0 46.9 37.6 34.7 72.4 31.0 60.3 65.6 26.8 90.4 44.5 71.5 67.5 33.2 91.0 136.5 34.2 66.7 84.1 71.0 70.1 49.8 72.7 71.3 114.5 71.9 72.5 63.3 47.4 63.7 27.3 85.6 56.9 47.9 52.3 42.3 46.3 57.9 37.6 48.7 152.1 19.0 43.8 75.6 32.8 46.2 89.5 30.2 79.9 82.0 44.3 45.9 61.7 53.7 64.8 103.2 76.4 32.9 50.8 52.3 54.3 21.4 29.2 24.8 22.2 23.3 20.5 22.2 25.9 18.4 19.6 27.9 22.3 39.0 22.9 22.6 13.9 28.5 17.0 44.9 47.1 50.3 50.0 43.6 49.3 47.8 48.1 42.3 47.8 41.5 45.5 64.5 70.1 70.5 103.3 108.7 69.9 32.0 39.8 31.1 27.3 94.4 43.9 44.2 44.5 25.8 68.2 38.6 183.5 52.5 77.0 51.3 11.7 27.3 128.2 52.4 67.9 67.9 73.5 40.2 100.8 20.9 26.2 54.4 74.5 47.8 68.9 85.1 60.3 40.0 32.4 94.2 107.1 53.7 50.8 42.2 48.4 246.2 64.3 56.4 44.4 96.5 66.9 43.2 75.2 117.6 136.0 30.8 45.8 57.9 64.5 49.5 42.4 11.3 84.0 126.1 32.9 62.4 57.1 57.8 33.0 31.1 34.0 81.7 68.1 52.2 44.7 55.5 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17296794-17413528 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.2;retina: 28.6" "Group enriched" "Detected in some" 8 "Excitatory neurons: 79.2;Inhibitory neurons: 116.4;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.7;SCLC-21H: 9.5;SH-SY5Y: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.2 2.1 6.7 0.7 8.6 1.8 0.8 9.3 9.5 1.0 0.0 0.9 0.7 1.0 0.1 0.6 1.1 0.5 0.7 7.7 6.2 0.9 1.3 1.0 0.6 7.1 7.5 7.4 2.3 1.2 3.9 6.9 0.6 7.4 0.7 0.3 28.6 0.6 0.2 1.0 1.2 1.0 0.2 5.6 0.7 0.9 1.4 9.5 0.1 3.1 0.2 0.0 0.8 0.8 12.2 0.5 0.4 0.8 0.6 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.7 0.2 0.6 0.3 0.0 0.5 0.2 2.6 0.0 0.0 0.1 2.1 0.9 1.2 0.4 0.7 0.5 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.3 0.4 0.5 0.0 0.4 0.9 1.2 3.7 0.5 0.4 0.3 1.1 0.4 0.0 2.3 9.5 5.5 0.4 0.5 0.7 1.3 0.2 0.6 1.1 0.6 0.3 1.4 0.8 0.2 0.3 0.4 1.8 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 8.6 9.3 9.5 7.7 6.2 7.1 7.5 7.4 7.4 5.6 9.5 12.2 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.0 2.3 0.2 0.1 0.0 0.0 14.0 0.5 0.4 0.2 3.6 0.4 79.2 0.5 0.5 0.5 1.5 1.1 0.0 0.0 0.0 0.0 0.4 0.0 116.4 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 5.6 0.0 0.0 0.0 83.9 171.9 0.2 1.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 6.6 0.2 1.5 0.9 1.8 0.4 0.1 1.4 0.1 0.1 0.0 0.0 SLC7A2 "ATRC2, CAT-2, HCAT2" ENSG00000003989 "Solute carrier family 7 member 2" P52569 8 17497088-17570573 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 178.1;parathyroid gland: 225.9" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 93.1;Glandular and luminal cells: 139.8;Hepatocytes: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 204.3;RT4: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009277 Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA009277: AB_2668229" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-2)" "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (7.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.76e-1)" "unprognostic (4.49e-1)" "unprognostic (1.34e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.65e-7)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.46e-2)" "unprognostic (8.98e-2)" "unprognostic (1.79e-1)" 27.9 11.7 8.0 3.5 7.4 0.2 17.4 10.0 10.2 32.8 17.1 5.7 2.4 15.3 18.0 11.4 42.9 11.3 11.5 9.8 16.3 7.9 178.1 7.6 2.7 14.2 6.8 6.1 85.1 83.8 225.9 7.1 9.9 15.2 14.4 4.3 17.7 5.1 7.2 115.4 7.3 4.5 13.5 11.3 3.8 8.4 15.6 7.4 3.1 45.5 46.2 3.6 10.6 15.0 15.8 0.0 3.1 1.0 32.4 0.2 0.3 35.1 0.3 22.1 1.7 2.0 10.7 0.1 0.0 7.4 0.0 4.7 0.0 23.5 5.4 7.4 0.0 12.3 0.0 24.8 23.2 204.3 10.3 0.0 27.7 4.5 27.2 25.7 0.0 10.2 0.0 0.2 0.0 24.9 35.5 1.3 11.7 11.8 7.4 2.9 0.0 16.2 17.6 2.7 55.3 0.4 4.3 1.7 0.8 9.9 23.5 0.0 1.2 22.9 0.0 11.8 0.1 0.1 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 7.4 10.0 10.2 9.8 16.3 14.2 6.8 6.1 15.2 11.3 7.4 15.8 9.4 12.8 78.1 58.8 0.4 8.3 6.6 5.8 20.5 2.9 52.0 25.8 15.5 38.6 16.3 7.3 35.5 22.6 0.1 0.4 0.0 8.3 12.8 67.0 40.4 5.6 87.9 10.7 0.5 93.1 15.1 20.6 0.5 139.8 2.5 0.4 7.1 249.0 5.8 0.0 19.9 3.6 0.0 6.7 2.3 22.9 37.9 1.4 3.6 1.9 0.6 23.5 0.0 11.6 2.6 20.5 0.6 27.8 0.1 50.2 0.3 3.7 53.9 38.0 59.2 8.8 75.7 0.3 1.1 7.8 3.8 26.0 1.6 9.5 3.2 8.4 ARF5 ENSG00000004059 "ADP ribosylation factor 5" P84085 7 127588386-127591700 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3900000 "unprognostic (6.72e-3)" "unprognostic (2.34e-2)" "unprognostic (1.67e-2)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (5.81e-3)" "unprognostic (9.41e-2)" "unprognostic (2.69e-1)" "unprognostic (2.75e-2)" "unprognostic (7.02e-2)" "unprognostic (1.02e-1)" "unprognostic (9.69e-2)" "unprognostic (1.50e-1)" "unprognostic (1.26e-2)" "unprognostic (3.95e-1)" "unprognostic (2.46e-2)" 98.8 94.4 134.9 73.2 143.5 144.3 100.7 124.1 202.2 97.9 119.0 102.4 93.2 105.7 115.1 229.3 98.4 82.4 109.7 143.7 134.9 122.6 140.2 91.5 103.6 128.3 128.2 144.8 72.7 169.5 104.9 101.0 69.9 133.3 99.5 61.8 23.1 103.9 71.7 133.0 199.7 99.3 66.9 123.9 106.7 118.8 83.5 131.0 96.7 81.2 102.3 75.2 93.4 123.1 131.5 157.4 148.9 120.1 386.5 101.6 159.1 163.3 43.9 129.6 118.7 135.8 232.0 211.4 114.7 64.4 132.6 135.9 117.5 92.4 198.0 38.4 104.9 222.8 44.9 137.5 160.2 150.1 69.7 100.1 163.1 196.2 77.7 75.8 94.5 173.2 164.1 105.1 124.1 116.9 531.2 249.0 303.7 179.9 157.1 191.7 148.3 73.9 245.6 198.2 158.7 349.1 226.2 142.8 461.8 116.1 77.6 123.9 108.0 103.7 177.3 75.3 128.0 101.9 115.2 77.5 153.9 181.1 142.0 154.6 289.0 321.4 279.7 144.3 270.3 146.7 129.5 151.1 148.4 409.6 117.2 112.0 122.2 447.5 156.5 216.2 259.6 181.8 381.8 134.9 143.5 124.1 202.2 143.7 134.9 128.3 128.2 144.8 133.3 123.9 131.0 131.5 110.3 3.2 12.1 28.4 81.3 105.7 72.9 217.1 130.9 14.8 111.8 180.7 2.0 91.5 83.0 112.2 0.0 151.6 89.7 89.4 201.5 107.8 39.3 90.3 95.7 73.9 119.9 102.2 46.5 90.7 125.0 82.2 135.5 88.2 21.0 91.1 75.7 51.6 102.7 20.2 42.5 108.8 140.4 129.6 221.9 40.7 93.2 123.9 149.4 28.1 118.6 27.6 82.4 27.2 36.2 86.4 134.0 94.8 75.1 57.2 147.5 160.0 58.4 11.9 72.3 58.7 85.4 99.2 116.7 248.3 153.4 146.3 100.2 69.1 125.4 93.4 SARM1 "KIAA0524, SAMD2, SARM" ENSG00000004139 "Sterile alpha and TIR motif containing 1" Q6SZW1 17 28364356-28404049 "Enzymes, Predicted intracellular proteins" "Differentiation, Immunity, Innate immunity, Neurogenesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.8;Cone photoreceptor cells: 29.2;Inhibitory neurons: 28.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024359, HPA024759" Uncertain Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA024359: AB_1856582, HPA024759: AB_1856581" "unprognostic (1.40e-4)" "unprognostic (9.00e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.87e-2)" "unprognostic (7.01e-2)" "unprognostic (2.49e-4)" "unprognostic (6.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (4.84e-2)" "unprognostic (7.62e-4)" 2.1 6.0 3.9 3.3 3.6 1.4 2.1 6.5 4.3 2.8 1.4 3.0 7.6 4.1 4.1 1.4 3.6 1.5 1.8 3.9 2.8 2.7 3.5 2.1 2.0 3.3 2.6 3.9 2.8 7.2 2.6 6.1 1.2 3.9 3.5 2.2 7.0 2.6 4.3 1.5 2.3 5.2 3.5 2.2 4.5 3.4 1.4 3.0 1.1 2.9 1.0 2.1 3.8 2.0 3.8 0.2 3.0 3.8 4.8 2.7 1.9 0.6 2.1 4.1 4.4 2.9 32.2 0.5 0.6 0.2 3.0 2.6 1.3 2.7 0.1 3.7 7.0 1.8 0.0 5.5 0.8 2.0 0.1 1.9 1.3 0.2 2.1 0.6 4.2 0.2 0.9 0.1 2.4 1.2 2.8 0.4 0.0 2.6 0.6 0.2 1.1 3.2 0.8 1.4 2.2 9.9 9.2 9.2 1.3 3.5 1.6 0.4 0.7 0.4 4.0 0.4 1.4 2.9 4.0 2.9 0.6 4.2 0.3 2.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.3 0.1 0.3 0.5 0.0 0.4 0.1 3.9 3.6 6.5 4.3 3.9 2.8 3.3 2.6 3.9 3.9 2.2 3.0 3.8 2.7 3.2 4.2 19.6 4.0 0.9 1.8 1.2 4.6 27.8 3.1 4.2 0.8 7.2 4.8 3.7 29.2 0.6 2.9 3.0 3.9 4.4 6.6 3.8 5.4 2.9 9.5 0.4 23.5 10.7 0.8 3.5 8.2 3.7 4.5 6.1 3.6 2.3 1.5 21.9 28.9 4.1 2.0 13.8 0.3 3.5 3.4 2.8 3.6 2.8 2.4 6.1 3.1 27.6 14.8 3.4 2.3 1.5 2.6 2.3 9.9 5.9 4.3 17.2 6.6 5.9 4.0 0.3 0.4 3.1 0.6 0.5 4.7 2.0 4.9 1.4 POLDIP2 "DKFZP586F1524, PDIP38" ENSG00000004142 "DNA polymerase delta interacting protein 2" Q9Y2S7 17 28346633-28357527 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 189.8;Proximal tubular cells: 203.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 544.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007700 Approved Mitochondria NA NA Mitochondria "HPA007700: AB_2667900" "unprognostic (5.71e-2)" "unprognostic (4.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.07e-2)" "unprognostic (3.23e-1)" "unprognostic (5.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (2.46e-1)" "unprognostic (1.24e-1)" "unprognostic (2.98e-1)" "unprognostic (1.62e-1)" "unprognostic (3.04e-3)" "unprognostic (1.57e-1)" "unprognostic (2.13e-1)" "unprognostic (8.40e-2)" "unprognostic (4.39e-2)" 50.4 131.2 52.3 35.7 52.7 46.3 48.5 53.5 55.7 39.3 51.3 52.8 45.9 43.5 44.5 76.6 39.9 30.4 114.0 53.2 54.7 102.5 189.9 36.7 34.7 53.5 54.6 52.5 41.5 79.7 66.6 44.7 31.4 52.7 47.9 57.5 30.4 53.2 45.0 275.7 57.6 42.5 53.5 50.5 44.1 63.5 58.8 56.6 50.6 43.7 212.1 51.0 50.3 43.7 51.8 99.4 169.9 65.5 101.1 95.3 95.0 77.6 102.0 107.2 213.2 149.0 544.8 56.7 174.5 94.7 134.0 111.2 127.2 153.1 111.0 162.0 138.9 136.4 63.4 97.0 115.0 152.0 141.5 75.7 106.0 160.4 148.4 124.9 96.1 118.9 123.8 140.8 101.3 130.0 126.8 163.6 73.9 74.8 166.2 75.9 116.8 139.4 172.8 113.0 89.2 88.6 84.3 181.2 357.6 101.8 102.7 189.6 97.6 102.5 94.4 71.2 110.1 179.4 89.0 115.0 125.6 134.4 93.8 95.7 41.6 48.5 42.6 33.5 47.1 33.5 49.0 35.3 43.8 60.1 31.1 37.5 37.1 19.4 33.8 35.0 40.3 42.5 52.6 52.3 52.7 53.5 55.7 53.2 54.7 53.5 54.6 52.5 52.7 50.5 56.6 51.8 20.4 9.6 18.1 13.1 27.7 27.5 32.5 61.6 33.0 24.5 43.1 35.2 96.7 62.9 31.5 47.8 4.2 82.0 17.0 55.9 189.8 102.0 44.9 15.5 22.3 29.1 23.4 54.3 12.7 143.2 97.0 29.5 34.7 20.5 11.4 46.8 22.9 125.1 69.6 28.6 13.1 42.4 32.6 36.5 25.7 132.4 30.7 25.6 58.7 5.6 51.9 39.6 36.0 9.0 8.9 112.7 37.6 33.1 46.1 46.7 74.5 203.6 13.5 18.4 13.1 22.0 47.0 64.3 45.0 55.2 30.1 81.3 22.5 66.1 66.3 38.8 PLXND1 KIAA0620 ENSG00000004399 "Plexin D1" Q9Y4D7 3 129555214-129606676 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 107.3;Endothelial cells: 102.1;Hepatic stellate cells: 132.1;Hofbauer cells: 81.5;Kupffer cells: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 392.3;HSkMC: 286.1;HUVEC TERT2: 346.1;TIME: 414.4" "Group enriched" "Detected in all" 4 "amygdala: 36.6;basal ganglia: 33.1;cerebral cortex: 27.4;hippocampal formation: 26.3" "Low region specificity" "Detected in all" CAB020819 Approved NA NA 120000000 "CAB020819: " "unprognostic (8.97e-3)" "unprognostic (1.95e-1)" "unprognostic (6.30e-2)" "unprognostic (8.35e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-3)" "unprognostic (6.35e-2)" "unprognostic (4.51e-2)" "unprognostic (3.69e-1)" "unprognostic (3.02e-3)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.93e-7)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (3.17e-2)" "unprognostic (1.00e-2)" 73.2 22.3 31.0 37.8 34.8 26.8 47.8 34.6 38.7 58.9 29.9 19.7 6.1 33.8 17.7 21.7 35.3 39.8 37.3 28.5 46.6 24.9 18.4 68.1 35.0 46.9 42.2 26.9 16.4 14.1 18.1 11.2 113.3 43.2 19.2 17.1 3.5 13.4 27.3 13.0 19.7 21.0 53.1 37.7 33.9 15.9 10.9 41.4 63.3 29.7 40.1 23.3 37.5 27.1 41.7 10.0 57.7 47.4 16.3 392.3 167.9 98.4 42.8 123.1 25.5 29.5 13.4 8.1 2.1 179.9 152.9 13.2 0.6 25.9 0.6 7.5 1.9 3.2 40.7 30.2 61.4 44.8 13.5 11.0 286.1 1.7 26.4 2.8 36.6 346.1 2.1 14.5 1.5 34.8 31.0 2.4 44.2 11.8 2.4 8.0 47.4 32.0 51.8 10.2 2.3 27.6 1.1 11.0 3.5 15.9 107.6 15.5 59.7 414.4 21.5 28.5 0.6 32.4 1.9 2.2 19.9 7.5 29.2 19.0 0.0 10.7 0.0 1.7 5.1 6.8 0.0 1.2 1.4 2.9 0.0 0.0 0.1 0.2 3.1 5.2 3.6 0.0 1.7 31.0 34.8 34.6 38.7 28.5 46.6 46.9 42.2 26.9 43.2 37.7 41.4 41.7 107.3 3.2 27.2 12.4 3.6 8.0 0.4 2.1 0.6 0.1 7.6 3.4 10.6 5.7 3.1 0.0 0.0 7.1 16.9 0.2 0.0 1.4 1.4 3.7 52.5 102.1 13.1 12.6 10.4 3.5 16.4 19.5 5.6 6.2 22.2 1.3 132.1 7.7 81.5 0.0 0.6 3.2 6.1 75.6 31.8 1.8 38.8 41.7 8.8 27.2 29.4 6.5 10.3 0.5 27.7 2.7 0.1 13.9 12.9 0.5 0.0 0.3 1.2 0.3 32.9 14.4 37.1 0.6 4.0 1.5 4.4 5.3 14.4 49.5 0.5 0.6 AK2 ENSG00000004455 "Adenylate kinase 2" P54819 1 33007940-33080996 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 440.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018479, CAB079913" Approved Approved Mitochondria NA NA 1100000 Mitochondria "CAB079913: AB_2546087, HPA018479: AB_1844676" "prognostic favorable (4.37e-4)" "unprognostic (3.25e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (8.65e-4)" "unprognostic (3.16e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (7.86e-3)" "unprognostic (1.85e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (6.40e-4)" "unprognostic (4.95e-2)" "unprognostic (8.33e-3)" "unprognostic (9.56e-3)" "unprognostic (2.71e-1)" "unprognostic (1.40e-1)" "unprognostic (5.40e-3)" 83.5 89.4 39.5 77.6 44.4 74.9 81.0 44.5 49.4 80.3 49.3 118.3 141.2 59.1 52.6 109.3 65.9 49.4 109.7 38.6 47.9 183.3 174.3 59.8 73.9 49.5 42.6 35.5 60.4 79.6 124.6 49.8 68.9 49.9 63.8 115.1 51.5 81.8 56.0 155.5 73.2 140.6 68.7 45.4 57.7 93.5 55.3 45.7 86.7 87.3 124.0 114.3 85.0 77.6 50.0 339.1 153.4 131.6 149.7 94.9 116.6 132.8 185.0 143.5 267.7 280.2 283.2 311.9 602.1 218.4 139.8 204.2 235.4 312.5 327.0 276.6 261.6 229.3 396.2 270.0 219.9 218.2 712.5 222.2 118.1 238.2 232.7 471.2 163.3 190.2 245.7 436.9 230.4 165.0 174.2 273.0 392.8 181.2 337.4 222.4 314.7 222.2 415.6 286.2 205.1 190.8 114.8 205.4 235.0 584.8 151.4 194.5 517.2 138.9 165.5 194.3 259.4 357.5 238.0 324.7 565.7 232.4 664.6 195.5 49.2 158.8 198.0 77.1 145.5 81.8 122.3 72.7 74.0 195.8 105.8 72.9 67.9 42.1 115.3 130.4 154.2 96.8 188.1 39.5 44.4 44.5 49.4 38.6 47.9 49.5 42.6 35.5 49.9 45.4 45.7 50.0 60.5 51.3 79.0 19.6 44.0 125.2 101.4 228.1 63.7 21.1 66.5 72.6 106.9 71.4 142.8 112.2 83.4 158.0 37.0 109.6 256.3 120.2 108.3 50.0 42.1 70.7 50.4 50.9 16.2 123.7 164.6 58.0 66.3 47.0 40.0 38.8 41.4 135.5 96.1 8.4 19.7 84.7 89.5 44.8 60.1 42.8 46.9 48.4 87.2 12.2 67.3 22.1 48.4 14.1 22.0 110.5 67.2 44.0 55.7 109.0 236.9 440.0 67.0 41.8 52.6 34.1 108.4 91.0 31.6 88.6 122.7 216.6 40.7 72.2 122.6 120.5 CD38 ENSG00000004468 "CD38 molecule" P28907 4 15778275-15853232 "Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Receptor, Transferase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 63.9" "Cell type enriched" "Detected in many" 4 "Plasma cells: 378.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 18.3" "Group enriched" "Detected in all" 5 "B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3" "Cell line enhanced" "Detected in some" "Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002493, HPA022132, CAB025255, HPA052381" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807" "unprognostic (1.27e-2)" "unprognostic (8.06e-3)" "unprognostic (1.06e-2)" "prognostic favorable (9.68e-4)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (2.74e-1)" "unprognostic (8.51e-2)" "unprognostic (5.87e-2)" "unprognostic (6.15e-6)" "unprognostic (5.23e-1)" "unprognostic (4.34e-1)" "unprognostic (6.63e-6)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (2.12e-2)" "unprognostic (2.13e-1)" 3.1 2.4 3.2 13.2 3.6 13.8 2.0 3.1 2.9 0.6 1.0 4.5 5.8 0.9 1.3 1.1 3.0 1.9 3.7 3.4 5.5 0.7 3.3 6.4 23.6 4.9 5.3 1.3 0.7 0.3 0.1 1.8 0.5 4.7 13.3 3.6 0.2 2.6 19.8 21.6 0.3 5.3 1.4 2.5 17.1 3.0 1.0 4.1 63.9 2.1 3.5 18.2 6.9 0.5 4.8 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 128.0 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 17.0 0.2 34.7 0.0 0.0 32.6 7.9 0.2 0.0 0.0 26.0 0.1 20.9 0.0 0.0 0.2 1.5 0.0 0.2 0.5 0.3 0.1 5.7 0.5 0.0 0.1 0.1 0.0 26.9 0.2 24.3 0.4 6.2 0.3 0.1 1.9 0.1 1.2 2.4 0.3 9.9 1.5 1.2 4.7 7.7 2.4 1.9 1.4 18.3 1.9 5.8 2.4 4.4 3.2 3.6 3.1 2.9 3.4 5.5 4.9 5.3 1.3 4.7 2.5 4.1 4.8 0.8 3.2 15.1 86.5 59.7 0.0 0.4 0.6 0.6 0.1 0.1 0.0 1.0 0.0 11.6 0.0 10.4 0.2 33.8 0.2 0.0 0.0 2.5 4.0 1.4 2.7 0.0 78.6 0.4 0.0 0.2 2.7 2.0 0.3 38.2 0.8 2.9 4.3 4.4 0.0 0.4 1.3 0.0 44.3 0.8 0.7 0.0 17.7 7.2 5.6 3.1 0.0 79.3 1.0 1.8 0.0 0.3 0.0 378.4 8.1 0.2 0.1 42.5 0.1 13.1 1.5 7.6 2.9 1.7 1.6 0.0 0.5 26.5 0.0 1.6 0.2 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FKBP prolyl isomerase 4" Q02790 12 2794970-2805423 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 269.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Supported Enhanced Nucleoplasm,Cytosol NA NA 480000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883" "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.12e-5)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 27.1 38.5 129.9 22.5 103.0 24.4 53.7 133.0 269.2 37.5 106.3 35.6 20.5 32.5 45.0 69.9 38.6 25.0 38.9 165.9 106.8 57.4 58.0 38.3 20.0 120.1 107.2 94.2 50.8 52.5 48.2 36.4 51.1 130.0 44.8 38.2 52.6 48.5 45.4 70.0 48.0 25.8 40.3 115.0 24.5 58.5 58.9 132.5 25.4 44.8 48.9 30.1 45.0 46.4 187.2 91.6 198.6 56.2 94.9 68.5 40.1 268.3 87.5 31.2 141.2 95.0 199.1 108.3 120.9 24.5 56.6 98.2 121.9 353.3 118.5 168.2 222.6 226.1 133.2 141.8 71.4 52.6 105.5 35.0 36.5 106.6 167.2 165.9 84.0 83.5 119.8 124.9 166.4 57.6 261.5 186.2 94.9 480.0 266.5 141.2 110.0 98.7 72.4 119.5 114.2 80.7 116.0 101.6 272.7 45.3 348.8 368.0 70.3 44.9 69.1 216.4 78.6 224.1 40.9 67.9 177.0 61.4 154.7 72.2 17.0 11.5 6.7 12.5 10.5 13.9 14.0 11.0 11.9 6.4 14.3 11.3 13.5 1.5 9.2 15.5 5.6 11.0 11.1 129.9 103.0 133.0 269.2 165.9 106.8 120.1 107.2 94.2 130.0 115.0 132.5 187.2 31.9 6.4 11.5 10.1 39.1 143.9 261.5 38.5 80.8 60.3 133.9 96.3 13.1 54.3 26.8 53.3 75.0 186.1 27.2 111.0 154.6 82.0 125.4 49.7 47.4 43.5 106.1 77.8 12.9 25.9 117.3 42.6 41.8 74.5 38.2 45.3 20.7 49.3 62.0 97.6 15.5 124.9 63.1 17.5 102.1 40.9 34.8 67.7 92.5 4.7 40.2 48.3 25.7 10.1 17.6 60.3 100.1 38.7 47.3 272.4 77.3 141.7 21.1 63.4 85.5 28.3 117.2 149.4 74.4 111.5 132.8 223.3 74.0 38.6 148.7 147.3 KDM1A "AOF2, BHC110, KDM1, KIAA0601, LSD1" ENSG00000004487 "Lysine demethylase 1A" O60341 1 23019443-23083689 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005884, HPA053660" Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 7700 Nucleoplasm Cytosol "CAB005884: AB_443964, HPA053660: AB_2682220" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.31e-4)" "unprognostic (1.50e-1)" "unprognostic (6.83e-2)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.47e-12)" "unprognostic (1.80e-2)" "unprognostic (1.99e-2)" "unprognostic (9.41e-2)" "unprognostic (3.34e-3)" "unprognostic (2.13e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (7.74e-2)" "unprognostic (1.39e-1)" 24.9 31.0 24.1 23.8 26.8 48.5 30.9 27.7 27.2 32.9 20.9 31.3 26.7 36.3 47.3 35.3 34.5 25.5 25.0 25.5 26.8 25.0 22.4 24.7 35.0 20.8 22.0 23.8 41.7 36.6 51.7 41.8 31.7 22.4 32.5 34.2 31.2 36.9 29.7 47.6 38.5 29.5 30.4 20.6 25.4 29.5 87.6 26.0 56.3 28.7 34.3 37.5 34.9 31.7 22.7 128.1 64.7 180.8 160.7 47.0 59.5 128.4 53.1 66.4 106.0 93.7 61.2 120.5 94.5 74.1 87.6 53.7 139.5 169.5 101.0 133.3 86.3 102.7 133.0 105.7 150.6 59.6 103.7 56.0 55.6 71.4 112.8 78.9 93.0 134.1 171.7 148.0 43.4 76.3 75.9 227.3 79.2 118.3 70.8 93.0 214.7 119.1 64.1 89.0 81.0 225.0 169.9 239.4 62.4 80.2 126.1 62.7 76.2 109.5 47.0 78.4 88.1 73.6 55.6 47.1 109.3 49.2 120.4 68.3 2.0 2.5 4.3 4.1 4.3 3.4 7.4 3.5 3.8 3.1 2.1 4.5 4.9 0.2 3.0 5.5 6.8 4.4 1.4 24.1 26.8 27.7 27.2 25.5 26.8 20.8 22.0 23.8 22.4 20.6 26.0 22.7 18.7 19.2 29.1 33.6 15.9 18.6 27.1 19.9 33.0 27.5 20.4 22.1 24.4 11.5 19.0 23.9 27.1 31.6 18.1 15.7 17.6 35.4 43.5 45.9 49.3 20.4 22.8 29.7 51.1 24.7 57.2 24.8 23.4 44.4 12.0 49.5 16.8 17.2 15.0 15.2 51.2 24.9 22.4 15.1 19.7 20.3 21.5 20.2 12.4 30.0 28.1 19.3 12.3 50.3 30.4 28.1 13.5 23.0 28.9 26.3 17.2 15.7 29.5 19.8 0.0 22.2 25.0 131.8 67.1 36.1 12.8 16.6 15.4 34.3 27.6 20.5 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.13e-5)" 57.2 76.1 57.1 44.1 56.7 46.2 58.8 61.6 97.2 99.8 57.6 74.3 43.8 70.6 34.8 52.1 82.5 27.8 68.2 56.7 56.1 74.9 78.7 65.3 60.3 58.9 56.4 53.6 97.0 90.5 37.0 73.3 30.5 57.1 99.0 39.8 64.8 50.8 36.3 44.4 49.6 78.7 42.6 54.3 104.3 69.9 66.6 57.4 49.1 75.6 26.0 50.5 67.8 69.1 57.1 28.6 18.0 73.0 48.1 70.8 38.4 25.9 47.8 41.0 40.8 42.7 31.0 31.4 147.2 27.0 47.0 41.1 23.6 61.2 40.9 51.3 57.3 23.2 68.6 46.1 41.3 40.0 71.3 69.4 36.0 50.5 45.7 50.9 76.4 52.2 37.0 57.0 36.0 39.3 26.9 66.8 106.0 57.9 34.7 32.0 26.1 31.0 38.0 40.4 57.0 28.8 51.6 43.7 31.0 30.9 62.9 25.3 55.7 48.8 41.2 48.0 33.3 48.6 49.7 123.7 84.9 23.7 58.6 40.6 16.4 8.5 5.2 13.3 4.6 11.2 12.3 9.3 8.2 8.8 11.5 9.3 10.2 5.6 7.2 8.8 9.6 7.0 6.1 57.1 56.7 61.6 97.2 56.7 56.1 58.9 56.4 53.6 57.1 54.3 57.4 57.1 76.0 57.7 75.2 172.4 87.4 54.0 43.0 34.2 67.7 120.1 43.5 33.8 35.7 40.0 45.9 62.5 102.2 38.2 91.9 46.4 11.7 33.4 31.9 51.2 69.5 57.2 47.3 51.9 195.6 28.0 33.0 53.9 64.7 46.3 43.0 93.0 45.7 36.0 27.8 92.5 216.8 44.5 36.7 56.1 82.2 25.2 65.6 50.1 60.5 161.1 66.1 43.4 62.8 154.3 177.9 34.3 32.4 60.5 106.9 51.2 60.9 17.7 49.1 145.7 46.0 55.6 63.7 135.3 56.7 46.7 45.3 36.3 66.4 66.3 39.5 35.2 CAMKK1 "CAMKKA, DKFZp761M0423, MGC34095" ENSG00000004660 "Calcium/calmodulin dependent protein kinase kinase 1" Q8N5S9 17 3860315-3894891 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 41.9;Excitatory neurons: 52.7;Rod photoreceptor cells: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 28.3;U-87 MG: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009111, HPA028062" Approved Supported Cytosol No No Cytosol "CAB009111: AB_2068406, HPA028062: AB_1845954" "unprognostic (1.39e-2)" "unprognostic (2.13e-1)" "unprognostic (8.66e-3)" "unprognostic (4.40e-3)" "unprognostic (2.94e-3)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" "unprognostic (4.47e-3)" "unprognostic (8.23e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (7.19e-2)" "unprognostic (8.70e-2)" "unprognostic (8.36e-2)" "unprognostic (3.10e-1)" 6.1 10.7 25.7 5.2 27.9 4.2 5.4 9.5 56.6 12.4 0.7 8.7 2.9 13.2 4.8 6.9 7.0 3.6 5.7 26.6 13.9 3.4 1.0 5.1 2.7 11.7 6.0 27.9 8.2 12.8 4.1 24.5 2.0 15.0 8.3 2.7 12.1 30.2 10.5 3.4 15.5 7.0 5.9 2.5 9.7 4.2 10.2 8.8 5.2 7.7 1.6 2.3 16.2 14.0 34.8 7.0 11.8 1.2 5.9 4.1 7.2 0.4 4.7 5.1 4.4 2.0 4.3 2.1 4.2 5.0 9.1 4.6 20.3 3.2 5.8 2.7 0.1 10.7 4.8 28.3 1.6 4.2 0.7 3.6 5.5 4.9 8.4 2.8 3.8 2.0 6.0 3.8 0.2 2.2 1.9 6.0 2.7 1.3 10.1 11.0 3.0 5.1 4.8 4.8 4.4 6.7 3.8 1.8 13.9 3.1 0.7 5.3 1.6 2.8 7.6 10.2 9.9 4.0 0.5 0.3 0.1 27.9 4.0 1.0 0.0 0.9 1.9 0.2 2.0 0.5 0.0 0.3 0.2 0.8 0.0 0.3 0.1 2.7 0.0 2.1 0.4 0.0 0.7 25.7 27.9 9.5 56.6 26.6 13.9 11.7 6.0 27.9 15.0 2.5 8.8 34.8 5.5 6.4 12.5 8.1 7.0 3.7 2.1 1.5 1.8 41.9 2.5 1.3 6.3 0.0 3.3 1.8 16.7 0.3 3.4 1.7 0.0 0.4 0.1 1.7 7.8 5.6 4.2 0.4 52.7 1.6 0.1 5.5 0.5 1.6 17.1 0.9 2.9 0.6 4.3 8.4 13.9 1.3 2.0 3.2 3.3 1.3 1.2 6.9 8.8 9.4 0.8 4.7 2.1 4.0 3.5 0.6 0.6 1.2 2.2 2.2 0.2 0.3 1.5 25.1 0.0 2.0 1.7 0.1 1.1 4.1 5.4 0.3 2.9 1.2 2.1 1.1 RECQL "RecQ1, RecQL1" ENSG00000004700 "RecQ like helicase" P46063 12 21468910-21501669 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009743, HPA030960, HPA064259" Enhanced Enhanced Nucleoplasm NA NA 25000 Nucleoplasm "CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230" "unprognostic (9.70e-3)" "unprognostic (2.55e-2)" "unprognostic (1.86e-2)" "unprognostic (6.25e-3)" "unprognostic (2.47e-1)" "unprognostic (1.39e-1)" "unprognostic (8.97e-3)" "unprognostic (1.89e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (3.77e-3)" "unprognostic (3.78e-2)" "unprognostic (2.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-1)" "unprognostic (3.69e-2)" 29.2 17.3 6.0 34.2 7.3 18.9 18.8 7.1 7.2 19.3 8.3 15.1 11.5 22.5 13.8 20.0 15.1 20.8 27.2 5.8 8.2 15.0 15.9 23.1 41.3 9.0 7.3 5.2 14.9 10.0 10.9 5.3 22.4 8.2 16.1 18.4 10.0 10.2 18.0 12.6 18.7 13.6 30.6 7.9 31.8 14.7 10.6 7.3 34.6 16.7 19.8 38.7 26.3 10.4 9.0 61.6 61.1 46.5 34.7 94.3 116.1 52.3 119.9 101.6 76.2 88.7 68.5 49.9 73.6 43.5 83.7 94.0 44.3 51.2 60.4 108.5 122.1 31.9 89.8 65.6 30.0 35.9 62.3 66.1 64.8 30.1 109.0 79.1 67.6 87.2 50.6 33.0 36.1 102.3 31.2 70.0 73.6 77.1 18.3 41.6 56.8 184.7 57.2 29.6 42.5 12.8 35.7 86.9 23.6 62.0 159.0 58.3 37.4 115.6 105.9 67.4 93.9 111.6 14.3 46.3 161.3 88.9 35.9 80.2 21.4 18.6 18.0 31.2 32.3 31.5 30.3 29.3 30.9 24.0 26.6 19.1 26.7 8.7 36.9 31.0 17.8 44.8 24.0 6.0 7.3 7.1 7.2 5.8 8.2 9.0 7.3 5.2 8.2 7.9 7.3 9.0 56.1 22.4 18.8 6.2 45.0 23.6 15.4 23.3 22.2 11.8 14.7 14.7 8.7 10.0 22.1 14.7 14.6 13.0 59.0 5.8 9.8 20.3 1.4 15.9 41.0 45.7 9.7 30.3 15.1 24.8 27.5 45.6 7.7 17.6 52.6 23.1 30.7 15.9 27.9 15.2 9.4 6.5 12.2 35.3 26.1 2.2 22.1 50.8 30.2 12.2 50.6 16.9 64.9 10.1 19.1 31.8 4.2 37.6 33.5 7.3 4.3 12.4 25.1 10.8 13.1 33.1 34.9 7.6 12.7 20.8 42.9 3.6 53.6 31.8 8.0 10.5 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50 subunit of EARP/GARPII complex" Q96JG6 7 93232340-93361123 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 7.1 9.1 3.8 3.4 5.2 2.6 8.2 5.7 5.5 7.3 4.7 8.8 2.0 8.3 4.2 9.2 6.9 2.7 7.0 4.5 4.4 7.2 6.2 6.1 4.9 4.3 4.4 4.4 7.7 7.8 6.0 7.8 4.8 4.8 6.5 5.3 5.2 8.9 3.2 12.1 8.8 8.2 3.5 4.4 9.6 7.9 6.6 4.2 4.3 7.4 5.0 4.8 8.0 7.9 5.5 6.5 2.2 2.6 5.0 8.2 7.9 6.3 5.5 5.0 9.1 6.1 5.5 9.0 5.5 5.1 4.2 13.6 3.6 10.4 7.0 11.3 5.8 4.6 14.6 3.1 2.4 4.9 3.4 4.5 3.8 8.7 9.9 9.5 5.9 11.5 3.9 10.2 8.2 11.3 4.7 5.3 4.6 6.2 8.7 5.9 3.5 6.3 8.1 5.1 2.9 3.7 7.8 4.8 13.5 4.4 7.5 6.3 2.8 5.8 12.4 4.4 16.3 4.5 3.3 8.0 9.1 6.9 6.1 6.8 3.1 3.2 2.1 2.6 3.5 4.6 2.4 2.7 2.7 4.5 2.4 2.0 2.5 1.1 1.4 2.5 2.8 2.9 2.0 3.8 5.2 5.7 5.5 4.5 4.4 4.3 4.4 4.4 4.8 4.4 4.2 5.5 10.9 12.8 11.3 0.0 13.5 0.0 3.4 0.0 6.8 14.1 11.7 6.3 0.0 2.8 5.0 5.5 16.7 7.5 11.0 5.5 3.9 6.2 27.9 7.6 10.8 7.9 2.4 10.8 0.0 5.5 11.7 6.4 11.2 8.2 7.6 12.6 9.7 6.1 10.7 10.1 0.0 7.1 0.0 13.7 0.0 14.2 9.0 10.0 0.0 0.0 9.4 10.3 6.2 0.0 0.0 6.9 9.4 7.2 10.2 2.7 6.1 8.3 5.8 14.3 6.6 11.2 6.3 18.1 12.8 7.9 0.0 9.4 8.5 13.9 5.1 2.8 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754566-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 2994.4;tongue: 1774.7" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 310000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 623.6 417.4 34.4 45.8 38.0 0.4 398.3 30.9 49.6 569.2 25.2 499.6 28.3 569.8 102.5 113.3 499.4 98.8 952.4 27.1 40.0 68.6 42.7 127.7 5.7 62.4 39.6 23.4 459.0 50.9 4.2 17.6 40.5 66.5 273.5 44.4 21.3 116.8 196.5 2994.4 35.3 181.5 280.7 49.4 15.9 365.2 61.1 46.8 6.3 100.4 1774.7 2.7 541.8 293.1 48.0 0.6 0.7 2.1 2.5 1774.3 742.0 1.2 83.0 1.3 4.9 9.3 1.1 0.4 0.7 0.6 252.4 0.0 0.2 0.4 0.7 3.9 0.9 0.5 0.4 1.3 0.5 599.9 0.2 0.9 700.3 0.0 19.1 0.9 2.2 5.4 0.3 0.5 1.0 0.2 0.3 0.4 1.9 1.2 2.3 0.6 1.5 0.5 0.7 0.0 0.1 0.8 0.7 0.1 0.2 0.7 0.3 0.3 0.5 0.1 153.2 0.9 17.3 0.6 1.0 2.8 0.3 20.5 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 38.0 30.9 49.6 27.1 40.0 62.4 39.6 23.4 66.5 49.4 46.8 48.0 11.1 3.2 0.6 1.6 0.1 1.8 0.4 0.0 3.4 7.8 0.5 0.5 29.7 0.0 0.0 0.0 0.0 2.5 0.1 0.1 0.0 0.1 27.0 4.9 165.7 3.6 0.0 5.2 0.2 0.0 2.5 125.2 4.1 3.5 0.0 3.6 17.5 0.3 5.0 0.0 0.5 0.0 0.0 0.3 3.6 18.9 271.8 2.7 1.8 0.0 0.6 44.5 0.0 0.0 0.1 0.2 0.0 220.4 0.1 0.4 0.0 0.4 0.0 2.8 26.3 38.0 102.6 2.3 1.4 1.9 2.0 4.8 1.8 311.0 0.0 0.5 ARHGAP33 "FLJ39019, SNX26, TCGAP" ENSG00000004777 "Rho GTPase activating protein 33" O14559 19 35774532-35788822 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.4;Cone photoreceptor cells: 25.0;Horizontal cells: 20.2;Oligodendrocytes: 22.7;Rod photoreceptor cells: 33.7;Spermatocytes: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030117, HPA030118" Supported Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA030117: AB_10599306, HPA030118: AB_10601238" "unprognostic (1.44e-3)" "unprognostic (3.40e-2)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (2.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.61e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" "unprognostic (2.97e-3)" "unprognostic (2.40e-2)" "prognostic unfavorable (3.09e-8)" "unprognostic (5.70e-2)" "unprognostic (2.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-2)" 7.8 8.7 22.3 4.2 24.1 20.7 11.0 12.0 39.4 20.2 6.0 10.4 4.1 14.0 1.3 8.2 17.2 2.8 7.0 28.0 15.0 10.1 5.7 6.8 5.9 19.9 15.7 25.6 27.1 12.0 4.2 33.9 1.7 20.1 12.7 1.3 10.0 7.5 3.3 3.4 9.5 9.2 2.1 12.1 11.2 10.5 39.9 16.7 11.8 18.1 1.3 2.3 9.4 13.8 20.0 9.0 5.6 15.5 11.7 0.6 1.5 1.2 7.2 0.9 2.7 1.9 2.3 6.6 5.2 2.6 2.1 2.3 2.4 1.9 2.0 1.0 16.4 3.6 7.6 8.6 2.1 0.7 2.7 58.1 2.2 0.4 2.1 0.8 2.2 1.6 20.4 3.7 22.1 2.4 6.8 18.8 7.4 3.5 3.4 2.5 25.4 2.5 2.5 1.2 1.4 15.4 9.4 3.2 5.7 1.1 1.9 8.3 7.5 3.1 11.0 10.6 5.8 8.5 19.5 4.0 5.2 4.0 8.9 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 24.1 12.0 39.4 28.0 15.0 19.9 15.7 25.6 20.1 12.1 16.7 20.0 2.7 0.0 1.1 7.8 1.0 1.7 1.0 1.0 4.6 27.4 4.8 4.7 2.3 2.8 2.7 1.8 25.0 0.7 5.1 1.4 0.0 0.4 11.4 6.1 4.8 1.6 3.5 6.5 12.1 0.7 1.0 3.5 3.6 2.5 5.1 7.3 1.1 1.5 1.2 20.2 11.3 2.3 2.0 0.8 1.9 8.9 4.1 0.7 0.0 1.9 0.2 7.3 0.0 19.1 22.7 0.7 0.6 3.0 2.2 0.6 0.3 0.2 4.2 33.7 0.0 4.6 3.1 22.2 6.2 4.2 1.7 0.4 3.6 7.2 2.8 0.6 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581014-23596316 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 540.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1366.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054364, HPA076020" Approved Supported Nucleoplasm,Mitochondria No No 100000 Mitochondria Nucleoplasm "HPA054364: AB_2682463, HPA076020: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favorable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 82.4 128.1 111.4 50.1 114.8 61.0 81.7 122.1 158.8 62.1 120.4 117.7 103.8 69.3 50.5 99.6 67.1 32.3 540.9 114.7 120.3 133.0 167.1 62.4 52.6 119.8 113.8 112.6 54.8 85.2 111.4 94.9 47.9 119.9 64.0 89.9 92.7 76.3 59.2 429.0 68.9 90.9 51.5 114.5 72.7 110.5 62.2 116.4 60.8 66.5 435.8 59.7 80.5 71.3 126.3 172.8 125.6 151.8 136.8 107.5 116.0 212.9 129.4 96.8 129.2 105.7 110.1 135.8 284.0 206.6 94.7 158.2 138.6 271.2 155.4 102.6 161.8 312.6 151.8 203.0 507.0 112.2 284.8 121.0 108.0 212.6 95.2 102.2 120.0 167.0 249.5 326.6 139.6 142.7 262.1 221.6 431.9 394.7 254.5 288.5 299.5 171.0 389.3 120.2 140.6 209.8 163.1 144.6 260.8 258.2 167.2 211.2 235.0 131.1 116.5 122.4 113.4 180.5 175.2 283.2 321.9 130.2 228.7 134.9 77.1 179.9 80.0 127.0 222.8 142.3 171.7 150.7 143.4 239.4 151.6 139.0 145.8 37.9 117.8 175.8 268.1 177.6 204.7 111.4 114.8 122.1 158.8 114.7 120.3 119.8 113.8 112.6 119.9 114.5 116.4 126.3 136.2 99.3 99.7 9.8 96.1 122.1 142.9 416.9 79.6 91.1 131.7 191.5 1366.5 105.8 200.3 112.2 45.9 290.9 101.3 210.9 708.3 187.3 129.5 185.5 113.2 129.4 202.4 125.1 13.1 210.2 312.2 153.3 119.3 110.8 84.9 124.4 93.9 300.6 263.2 52.2 14.3 253.5 321.4 109.0 89.1 39.6 96.9 114.3 156.5 5.6 179.6 165.0 109.2 7.5 13.2 227.1 174.8 121.5 166.9 180.3 316.8 611.4 261.6 127.6 92.1 134.0 261.9 142.9 118.8 181.5 142.2 224.5 94.5 256.6 360.0 190.7 PDK4 ENSG00000004799 "Pyruvate dehydrogenase kinase 4" Q16654 7 95583499-95596516 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2318.9;tongue: 1227.3" "Cell type enhanced" "Detected in many" "Adipocytes: 681.3;Cardiomyocytes: 764.5;Kupffer cells: 464.0;Proximal enterocytes: 654.2;Smooth muscle cells: 489.7" "Cancer enhanced" "Detected in all" "renal cancer: 107.8;thyroid cancer: 89.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 32.5;eosinophil: 38.1;intermediate monocyte: 63.5;myeloid DC: 16.8;non-classical monocyte: 39.8" "Group enriched" "Detected in many" 12 "dendritic cells: 16.8;granulocytes: 38.1;monocytes: 63.5" "Cell line enriched" "Detected in many" 7 "ASC diff: 482.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056731 Approved NA NA "HPA056731: AB_2683218" "unprognostic (3.18e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (5.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.47e-1)" "unprognostic (6.38e-2)" "unprognostic (2.24e-3)" "unprognostic (1.87e-2)" "unprognostic (8.75e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.80e-4)" "unprognostic (9.15e-2)" "unprognostic (4.20e-2)" "unprognostic (1.12e-1)" 455.2 218.3 32.4 33.7 47.4 2.5 392.0 32.9 43.4 73.7 188.5 223.9 72.9 89.7 10.5 152.8 154.8 81.3 371.8 40.7 161.7 129.0 225.3 121.5 24.2 46.9 42.6 25.3 243.0 554.0 18.4 40.2 105.7 45.2 92.0 43.0 2.0 60.7 534.4 2318.9 80.8 164.7 62.7 35.7 99.8 174.6 13.4 38.2 13.9 72.7 1227.3 13.6 189.1 96.0 61.0 0.0 37.7 1.5 9.5 482.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 12.8 0.0 5.3 1.7 1.6 0.0 0.1 0.0 0.0 0.0 1.3 0.2 66.8 0.0 4.5 0.0 0.0 5.3 0.0 0.0 0.0 0.2 2.4 0.0 1.7 0.0 0.2 0.9 0.0 0.4 0.1 0.0 2.1 0.0 0.0 0.3 23.5 2.6 0.5 2.7 0.0 3.0 8.6 2.4 1.3 1.1 0.0 0.0 0.8 2.1 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.3 32.5 38.1 0.0 63.5 0.1 0.4 0.0 0.0 16.8 1.5 0.0 0.0 2.5 3.3 39.8 0.5 0.0 14.2 32.4 47.4 32.9 43.4 40.7 161.7 46.9 42.6 25.3 45.2 35.7 38.2 61.0 681.3 32.1 16.0 154.4 6.0 10.5 279.2 9.2 19.9 0.1 95.9 40.6 764.5 30.0 36.1 378.9 0.0 5.9 3.9 67.7 13.7 7.2 14.9 151.0 52.1 108.0 55.4 9.3 0.4 5.5 0.7 326.9 158.5 347.5 5.1 19.9 199.2 130.5 49.8 0.0 1.2 96.0 6.1 464.0 21.5 6.7 134.2 204.8 90.7 19.7 19.8 8.4 1.0 7.1 26.2 6.2 46.3 44.8 6.4 110.0 654.2 74.2 66.3 0.4 164.3 293.2 489.7 1.8 1.0 12.3 9.2 10.9 5.3 18.7 60.5 157.4 SLC22A16 "CT2, FLIPT2, OAT6, OKB1" ENSG00000004809 "Solute carrier family 22 member 16" Q86VW1 6 110424687-110476641 "Metabolic proteins, Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 20.7;testis: 21.6" "Group enriched" "Detected in some" 10 "Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 0.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 5.7;classical monocyte: 6.9" "Group enriched" "Detected in many" 56 "dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9" "Group enriched" "Detected in some" 18 "NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036902 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036902: AB_10672274" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (5.11e-3)" "unprognostic (2.19e-3)" "unprognostic (2.70e-4)" "unprognostic (1.45e-1)" "unprognostic (8.15e-2)" "unprognostic (6.93e-2)" "unprognostic (1.48e-2)" "unprognostic (4.98e-2)" "unprognostic (1.02e-3)" "unprognostic (2.49e-1)" "unprognostic (2.61e-6)" "unprognostic (5.78e-4)" "unprognostic (2.72e-2)" "unprognostic (2.74e-2)" "unprognostic (2.65e-2)" 0.3 0.0 0.1 0.7 0.2 20.7 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.0 0.0 3.8 0.0 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.1 0.5 0.0 21.6 0.1 1.2 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 30.9 0.0 5.7 6.9 1.3 0.0 1.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.4 0.1 0.0 0.0 60.4 0.1 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 1.8 0.5 31.8 1.5 1.1 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 43.1 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 ZMYND10 "BLU, CILD22, DNAAF7" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50345732 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 121.2;testis: 260.5" "Group enriched" "Detected in many" 11 "Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 5.6;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.3 0.1 9.6 0.2 4.9 0.7 1.1 6.5 3.2 2.9 24.4 0.2 0.2 1.7 1.7 0.2 121.2 0.5 0.2 3.5 15.0 2.0 1.0 11.2 0.2 10.9 11.0 1.9 0.6 1.1 3.8 6.0 0.1 9.1 0.7 0.1 3.3 0.3 0.4 0.4 0.5 0.4 0.5 11.8 0.7 0.3 260.5 5.8 0.5 1.9 0.2 0.1 0.2 0.3 9.6 1.6 0.6 0.2 0.5 0.6 0.9 0.3 0.2 0.9 1.6 0.5 0.0 1.0 0.7 0.6 1.0 0.2 0.2 1.5 0.0 0.1 0.4 0.6 1.5 1.2 0.0 0.0 0.5 0.8 0.0 0.1 2.0 0.1 1.5 0.1 1.3 0.5 0.1 0.2 1.0 0.3 2.7 0.0 0.2 0.7 0.7 0.0 0.5 2.0 0.0 1.8 0.5 0.1 0.5 0.0 0.0 5.6 0.6 0.0 0.3 0.4 0.9 0.1 1.0 0.4 0.1 3.9 2.2 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 9.6 4.9 6.5 3.2 3.5 15.0 10.9 11.0 1.9 9.1 11.8 5.8 9.6 0.5 3.2 5.1 1.3 0.7 0.5 0.4 24.2 1.2 1.2 2.3 1.7 0.8 0.0 33.1 1.8 4.2 0.1 1.7 0.2 0.0 1.1 309.4 221.8 2.4 1.2 0.0 3.2 0.5 0.0 0.2 1.1 0.0 3.6 0.0 0.3 0.7 0.4 0.6 0.0 0.3 0.7 22.4 0.0 0.4 415.3 9.0 1.3 1.8 1.0 0.9 1.2 2.1 0.5 1.3 0.1 0.0 5.7 0.9 0.6 0.0 1.0 390.8 7.6 0.0 0.9 9.8 529.7 9.1 1.1 0.4 0.1 1.7 0.2 0.3 0.1 ABCB5 "ABCB5alpha, ABCB5beta, EST422562" ENSG00000004846 "ATP binding cassette subfamily B member 5" Q2M3G0 7 20615207-20777038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "epididymis: 26.6" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.8;Early spermatids: 8.1;Fibroblasts: 2.4" "Cancer enriched" "Detected in some" 9 "melanoma: 5.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 47.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-3)" "unprognostic (1.55e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-1)" "unprognostic (2.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.05e-1)" "unprognostic (2.63e-1)" "unprognostic (6.23e-2)" "unprognostic (5.26e-3)" "unprognostic (3.56e-3)" "unprognostic (9.30e-4)" "unprognostic (1.29e-1)" "unprognostic (1.80e-2)" "unprognostic (2.70e-2)" 1.8 0.0 0.3 0.2 0.2 0.4 2.1 0.4 0.5 0.9 0.2 1.3 0.1 0.7 26.6 0.1 0.2 2.8 0.3 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.3 0.0 0.2 0.1 0.0 0.1 0.3 0.2 0.5 0.1 0.1 0.3 0.1 0.7 0.4 0.6 0.1 0.0 0.2 0.5 0.2 0.0 0.0 0.1 0.0 0.7 0.5 0.4 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 6.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 47.8 0.0 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.4 0.5 0.2 0.1 0.2 0.2 0.3 0.3 0.1 0.2 0.4 0.1 0.0 0.5 0.3 0.0 0.5 2.8 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 8.1 0.3 0.2 0.4 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 1.5 1.0 0.6 0.4 1.8 1.9 0.0 0.2 1.0 1.0 0.6 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.3 0.0 1.7 0.6 0.6 0.4 0.0 0.6 0.0 0.6 0.0 0.0 0.8 ARX "CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS" ENSG00000004848 "Aristaless related homeobox" Q96QS3 X 25003694-25016420 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.8;ovary: 79.4;skeletal muscle: 27.0" "Group enriched" "Detected in some" 5 "Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (8.28e-2)" "unprognostic (3.06e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.54e-7)" "unprognostic (9.85e-2)" "unprognostic (7.96e-3)" "unprognostic (1.18e-1)" "unprognostic (2.77e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.06e-6)" "unprognostic (6.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" 0.0 0.1 9.2 0.0 11.6 0.0 0.3 0.0 17.8 0.0 0.0 0.9 3.5 0.0 0.1 0.1 1.1 0.0 0.0 10.0 6.3 0.1 0.0 0.4 0.0 1.5 1.0 9.1 79.4 1.4 1.8 0.3 0.0 2.4 0.7 0.9 0.0 0.2 0.0 27.0 0.0 0.7 0.0 0.0 0.2 5.6 7.3 1.4 0.0 0.2 1.9 0.4 0.0 0.2 8.4 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 3.9 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.1 0.0 0.0 8.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.6 0.0 17.8 10.0 6.3 1.5 1.0 9.1 2.4 0.0 1.4 8.4 0.0 0.0 0.0 14.0 0.3 0.0 2.5 0.5 0.0 0.0 0.3 0.0 0.5 0.0 2.2 0.0 0.0 0.2 0.1 1.9 0.0 0.0 1.2 0.0 0.0 0.1 83.7 0.0 0.2 0.0 2.4 4.7 4.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 53.2 3.6 4.1 0.0 0.0 3.6 131.7 0.2 0.0 3.7 0.0 0.0 0.0 3.5 0.6 0.3 0.8 70.0 0.9 1.3 0.1 0.1 11.3 0.0 0.0 1.5 0.3 0.5 0.3 0.0 0.0 0.1 0.3 66.8 1.9 1.6 SLC25A13 "ARALAR2, CITRIN, CTLN2" ENSG00000004864 "Solute carrier family 25 member 13" Q9UJS0 7 96120220-96322147 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 151.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 153.4;Oligodendrocytes: 439.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018997 Enhanced Supported Mitochondria NA NA 21000 Mitochondria "HPA018997: AB_1857023" "unprognostic (3.61e-2)" "unprognostic (7.99e-2)" "unprognostic (6.99e-2)" "unprognostic (7.19e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (1.42e-2)" "unprognostic (6.67e-2)" "unprognostic (2.31e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-1)" "unprognostic (6.99e-2)" "prognostic favorable (9.14e-4)" "unprognostic (1.15e-1)" "unprognostic (1.05e-1)" "unprognostic (3.32e-1)" "unprognostic (7.09e-2)" 9.0 14.4 7.6 9.0 13.0 8.0 10.4 13.7 9.7 7.7 14.0 16.5 16.2 7.7 10.3 9.7 9.6 10.0 6.5 7.0 10.6 32.6 151.3 7.9 7.2 14.8 12.7 6.0 7.8 9.7 13.9 8.4 16.3 14.2 8.3 18.0 19.6 7.8 12.6 7.1 12.0 13.5 6.8 11.6 10.1 14.6 7.4 11.5 4.0 13.8 3.4 8.7 11.1 7.6 20.9 45.3 39.2 44.2 15.5 7.5 6.0 61.8 11.2 8.5 26.5 26.7 70.7 41.2 20.2 51.9 7.2 57.8 26.3 50.1 16.2 31.0 8.0 33.0 23.0 34.4 55.4 17.4 29.5 17.4 15.8 16.9 22.7 20.4 10.1 31.0 3.0 65.9 7.6 13.0 49.6 0.1 27.6 78.0 47.8 24.0 11.6 26.3 46.8 63.7 42.1 21.1 69.0 38.8 81.1 67.3 72.9 24.2 22.4 18.2 19.6 43.6 46.8 34.5 15.2 40.8 12.7 24.1 28.0 32.9 0.4 3.1 2.2 1.4 4.5 1.5 2.4 1.1 1.3 6.1 1.2 0.7 0.9 0.6 2.0 5.1 3.1 1.2 1.4 7.6 13.0 13.7 9.7 7.0 10.6 14.8 12.7 6.0 14.2 11.6 11.5 20.9 31.5 9.6 12.6 60.7 19.7 7.4 8.5 8.6 16.5 36.5 13.6 17.1 8.3 27.1 9.2 18.4 54.2 29.2 8.9 32.1 27.4 19.8 11.0 44.0 23.2 20.7 37.8 15.3 26.6 19.1 26.5 18.8 44.4 34.2 14.5 30.4 11.7 153.4 23.2 10.1 43.7 22.3 12.2 23.8 10.0 11.1 13.1 21.5 21.4 82.4 13.2 17.6 8.2 53.3 439.6 22.6 23.7 15.8 12.7 14.9 27.1 74.9 14.2 47.3 13.1 19.0 16.9 7.0 14.5 25.4 8.0 20.0 7.9 21.6 25.5 15.4 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230176 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 115.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favorable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 13.4 21.9 20.9 6.8 22.3 17.9 15.3 49.6 24.9 20.1 12.8 12.0 12.2 14.6 36.1 9.8 18.8 12.5 22.2 21.3 21.6 29.7 41.6 26.3 7.7 16.8 18.7 21.0 17.6 33.1 19.2 24.7 21.1 26.8 13.9 12.6 12.7 21.8 21.4 12.6 11.3 11.1 12.8 14.9 10.5 17.4 8.8 21.1 8.6 28.7 11.3 8.7 12.7 11.2 22.0 29.4 17.2 28.2 24.4 31.0 20.5 12.3 23.0 30.2 24.4 35.2 24.0 32.8 7.7 25.5 21.4 34.7 24.6 24.2 24.5 31.3 11.1 33.9 23.4 26.5 20.2 21.8 27.4 39.4 16.1 24.3 30.7 21.8 21.6 24.9 5.2 36.0 54.6 22.3 18.1 0.2 21.0 26.9 40.1 19.3 6.7 18.8 33.6 25.5 16.2 42.2 33.8 27.8 115.5 32.0 20.6 10.1 23.3 19.1 27.6 11.0 30.5 23.3 34.7 28.2 29.6 22.9 24.0 28.6 1.5 3.1 0.4 7.3 1.2 5.1 2.2 4.4 6.2 5.7 1.0 2.9 3.0 0.0 7.0 1.1 5.6 10.3 3.0 20.9 22.3 49.6 24.9 21.3 21.6 16.8 18.7 21.0 26.8 14.9 21.1 22.0 6.3 22.4 38.1 184.1 5.0 7.5 8.6 8.8 10.8 12.2 9.0 7.4 13.5 12.8 12.9 5.5 0.0 21.1 6.4 3.1 5.9 6.0 131.4 7.1 5.9 9.5 3.6 15.8 191.5 13.4 22.8 10.6 12.8 14.2 19.6 3.5 8.6 24.5 8.7 3.3 176.0 6.8 8.2 14.4 6.0 53.5 11.1 7.9 7.2 44.0 7.5 12.8 4.1 111.1 46.9 8.8 3.6 6.0 10.3 6.7 3.6 17.3 6.3 1.3 0.0 9.9 12.1 12.8 5.8 7.4 5.5 21.2 4.6 4.6 5.3 8.8 CDC27 "ANAPC3, APC3, D0S1430E, D17S978E, NUC2" ENSG00000004897 "Cell division cycle 27" P30260 17 47117703-47189422 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 149.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016315, HPA028129, HPA052399, HPA065835" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: " "unprognostic (2.34e-2)" "unprognostic (8.83e-3)" "prognostic favorable (1.77e-4)" "unprognostic (4.26e-2)" "unprognostic (7.99e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.38e-4)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (7.95e-2)" "unprognostic (3.66e-2)" 23.2 15.4 9.1 20.2 11.6 27.9 18.3 18.0 14.7 18.2 5.8 15.3 14.8 20.9 13.3 16.7 15.2 18.6 23.5 10.2 11.6 15.4 22.6 18.2 23.6 10.3 10.7 7.4 17.1 14.7 24.6 10.7 25.8 11.4 15.3 17.9 13.9 12.3 15.6 22.6 12.2 14.0 24.7 10.2 19.3 16.1 25.2 11.3 25.2 42.8 29.0 24.2 20.0 11.3 10.7 80.7 84.1 69.1 56.1 45.5 72.0 41.0 110.9 99.0 103.3 105.1 54.2 41.4 107.4 72.7 93.5 66.0 37.5 75.2 62.6 141.2 155.5 77.2 125.0 92.9 48.6 49.2 74.4 54.6 52.4 30.2 93.5 73.1 49.7 108.6 61.6 101.6 58.0 85.2 68.3 91.8 33.5 32.8 45.2 67.8 48.9 177.3 47.8 62.0 50.0 45.8 55.9 55.4 19.4 61.2 58.6 58.6 51.7 116.9 107.1 91.9 68.6 82.9 58.8 110.2 95.8 59.4 43.6 76.0 9.3 3.2 4.9 5.3 7.1 5.2 4.0 4.2 5.5 4.2 6.3 4.2 5.0 4.0 8.7 5.3 5.2 8.3 3.5 9.1 11.6 18.0 14.7 10.2 11.6 10.3 10.7 7.4 11.4 10.2 11.3 10.7 63.7 9.6 26.3 61.0 28.7 26.0 17.8 25.9 38.1 22.1 21.3 17.5 39.8 21.5 27.1 20.2 16.7 31.4 22.5 11.5 15.6 28.1 28.9 20.8 33.9 50.7 13.8 149.8 124.5 26.5 35.6 41.4 21.4 22.1 26.6 24.8 38.9 27.1 27.2 35.3 104.4 12.8 8.2 28.5 22.1 33.6 28.3 30.6 7.2 83.4 31.5 19.4 35.0 89.0 96.1 30.1 9.5 29.7 39.0 18.7 13.5 23.6 16.2 14.9 19.7 41.6 40.8 97.3 38.6 32.6 26.9 11.5 27.8 34.2 16.2 17.1 SLC4A1 "AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR" ENSG00000004939 "Solute carrier family 4 member 1 (Diego blood group)" P02730 17 44248390-44268141 "Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Blood group antigen" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "bone marrow: 410.5" "Cell type enriched" "Detected in some" 80 "Erythroid cells: 1629.2" "Cancer enriched" "Detected in single" 91 "renal cancer: 16.3" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 3.0;neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "K-562: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015584, CAB034438, HPA063911" Enhanced NA NA 22000000 "CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-2)" "unprognostic (2.32e-2)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (6.72e-3)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (1.93e-2)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (2.13e-1)" 0.3 0.3 0.7 0.3 0.6 410.5 0.2 2.0 1.1 0.0 2.3 0.2 0.3 0.1 0.3 0.3 0.1 0.3 0.6 0.5 0.7 71.8 2.2 1.8 0.4 0.8 0.6 0.5 0.1 0.2 0.0 0.6 11.0 0.9 0.1 0.1 0.7 0.4 0.1 2.2 0.5 0.2 0.0 0.3 12.9 0.3 0.3 0.9 0.7 0.3 1.5 0.1 0.1 0.1 1.3 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.4 0.4 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.6 0.0 0.3 0.1 0.1 0.4 0.2 0.3 0.3 0.1 0.1 0.6 0.6 0.1 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.4 0.5 0.2 3.0 0.3 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 2.7 1.1 0.4 0.3 0.1 0.2 0.7 0.6 2.0 1.1 0.5 0.7 0.8 0.6 0.5 0.9 0.3 0.9 1.3 0.8 6.4 0.6 0.3 2.0 0.0 1.3 0.0 0.0 0.4 1.0 1.1 0.7 0.0 0.6 20.2 0.0 0.4 0.1 0.2 3.9 0.1 0.8 0.2 0.4 0.7 0.0 1629.2 0.2 0.0 1.6 0.5 0.0 0.5 0.0 0.1 0.7 0.9 1.4 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 1.9 0.0 1.0 0.6 0.2 2.1 0.0 0.0 0.0 0.0 0.4 0.3 0.9 0.2 0.4 0.0 0.2 0.0 1.2 0.2 0.7 0.5 0.0 0.0 0.8 1.5 0.7 0.1 0.6 CALCR CTR ENSG00000004948 "Calcitonin receptor" 7 93424486-93574730 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;kidney: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 16.5;Late spermatids: 7.7;Microglial cells: 15.9;Skeletal myocytes: 46.0" "Cancer enriched" "Detected in single" 5 "renal cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 1.6;SuSa: 2.9;T-47d: 2.7" "Group enriched" "Detected in many" 5 "basal ganglia: 6.3;hypothalamus: 24.6" "Low region specificity" "Detected in all" "HPA028962, HPA061428" Enhanced Supported Approved "Vesicles,Cell Junctions,Centriolar satellite" NA NA "Cell Junctions" "Vesicles, Centriolar satellite" "HPA028962: AB_10602339, HPA061428: AB_2732661" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (3.88e-2)" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "unprognostic (3.43e-1)" "unprognostic (7.73e-5)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (8.70e-2)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (2.71e-3)" "unprognostic (1.46e-3)" "unprognostic (1.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.05e-2)" 0.1 0.2 2.2 0.0 0.6 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 4.4 1.5 0.0 0.2 0.0 1.9 1.0 0.1 0.2 0.0 0.0 0.1 0.6 3.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.8 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 2.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.2 0.0 4.4 1.9 1.0 0.1 3.5 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.1 0.0 0.0 0.8 0.6 7.7 0.6 0.6 0.0 15.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 3.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 HCCS "CCHL, MLS" ENSG00000004961 "Holocytochrome c synthase" P53701 X 11111301-11123086 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002946 Approved Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA002946: AB_1079041" "prognostic unfavorable (8.69e-5)" "unprognostic (6.89e-3)" "unprognostic (8.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.34e-1)" "unprognostic (5.44e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (9.18e-2)" "unprognostic (2.73e-1)" "unprognostic (2.52e-2)" "unprognostic (2.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.17e-8)" "unprognostic (2.66e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.93e-2)" 13.8 16.2 6.8 13.9 7.2 20.7 12.7 7.6 8.8 8.5 8.9 21.7 23.3 9.6 7.6 19.4 8.6 10.9 39.4 7.7 7.2 17.7 23.1 11.6 15.8 7.1 7.1 6.8 8.4 10.0 25.3 8.4 13.2 6.8 9.6 21.8 13.6 15.3 10.1 65.0 17.1 20.4 12.6 7.0 14.7 15.4 10.3 7.0 13.1 10.9 57.5 17.2 22.5 11.7 8.4 54.3 60.5 31.8 28.5 25.6 25.2 29.2 52.0 43.0 67.8 57.5 70.7 38.5 34.3 26.3 46.1 80.8 49.8 63.2 51.8 70.5 30.8 48.0 34.1 80.8 38.6 47.3 40.9 39.4 24.2 37.4 67.9 46.5 37.9 49.1 26.1 63.1 41.1 46.3 72.5 28.0 31.4 51.5 36.6 70.1 27.3 59.9 65.4 44.0 44.8 20.9 24.2 54.8 58.7 38.2 66.7 45.6 27.1 48.7 42.4 23.6 110.4 47.0 26.9 29.0 47.8 35.5 28.8 42.7 25.6 47.8 30.1 20.2 66.4 19.0 39.0 19.6 18.2 62.2 34.7 17.1 22.1 13.1 19.1 57.4 56.2 23.5 19.0 6.8 7.2 7.6 8.8 7.7 7.2 7.1 7.1 6.8 6.8 7.0 7.0 8.4 15.5 6.4 4.8 2.3 20.8 54.8 53.2 57.0 22.8 5.3 16.1 13.7 49.3 17.2 33.3 16.5 0.0 32.9 12.4 44.6 50.9 34.9 13.7 19.0 10.4 21.0 10.8 32.8 3.8 29.3 37.9 17.1 12.8 16.7 13.3 10.4 15.7 18.5 41.8 8.4 4.5 19.2 67.1 21.0 44.1 2.3 13.4 23.5 24.9 1.9 27.9 13.0 7.2 2.0 2.7 68.4 31.9 10.5 18.4 63.5 46.4 36.0 28.9 7.1 6.6 12.5 20.1 24.4 28.4 21.8 46.0 40.9 12.0 15.6 30.2 88.6 DVL2 ENSG00000004975 "Dishevelled segment polarity protein 2" O14641 17 7225342-7234517 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009312, HPA021611, HPA022914, HPA064732" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338" "unprognostic (7.63e-3)" "unprognostic (6.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.34e-6)" "unprognostic (5.66e-2)" "unprognostic (8.01e-2)" "unprognostic (8.97e-2)" "prognostic favorable (3.85e-4)" "unprognostic (8.90e-2)" "unprognostic (1.28e-1)" "unprognostic (3.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.80e-1)" "unprognostic (5.45e-2)" 16.4 20.9 14.4 11.5 16.3 14.9 18.2 14.7 18.1 30.8 14.0 20.2 13.0 29.9 10.6 23.2 22.5 14.2 13.3 13.8 14.7 16.5 10.7 15.1 16.8 15.8 15.3 13.5 34.2 12.9 17.8 26.2 14.8 15.3 24.9 8.6 14.5 17.9 18.2 16.6 28.4 16.9 18.3 14.3 16.2 14.5 16.5 15.1 22.4 20.2 11.6 13.1 22.3 26.1 18.1 31.0 43.9 52.2 52.0 39.0 35.0 22.5 21.1 38.1 50.0 63.7 37.5 25.6 43.8 31.3 23.5 39.0 43.5 43.5 28.6 19.0 43.6 50.3 28.5 46.0 40.0 68.0 16.0 23.7 52.5 48.2 47.2 25.7 35.0 20.9 50.5 24.6 20.0 30.6 28.9 61.6 16.1 17.8 20.7 17.1 89.5 33.8 26.8 27.8 26.9 22.9 46.4 38.3 18.9 46.7 23.5 27.4 22.1 17.6 28.0 25.1 52.8 39.6 31.1 28.0 20.4 32.6 23.8 44.4 13.5 4.2 10.2 10.0 4.9 8.3 8.5 7.0 9.0 5.0 9.3 8.0 8.5 1.9 7.2 4.9 7.0 4.5 6.2 14.4 16.3 14.7 18.1 13.8 14.7 15.8 15.3 13.5 15.3 14.3 15.1 18.1 11.7 9.6 12.1 12.4 13.1 17.5 22.6 20.9 21.6 15.7 13.2 14.4 7.7 5.7 15.0 18.4 25.0 21.3 11.8 11.2 5.9 11.3 0.9 8.8 12.9 10.5 13.2 6.5 11.2 10.4 15.9 15.7 7.7 13.5 14.7 18.4 9.7 4.9 14.6 10.1 9.4 14.3 24.4 6.0 9.4 1.9 26.1 7.6 10.6 2.8 9.3 13.1 14.4 10.6 10.4 7.2 9.9 22.2 5.9 17.1 10.8 5.5 9.3 30.0 13.1 16.0 14.9 18.4 34.2 21.7 19.2 36.5 11.5 18.4 19.6 15.0 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852730-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.2;salivary gland: 27.1;vagina: 23.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 221.0;Club cells: 343.9;Ionocytes: 207.5;Pancreatic endocrine cells: 380.6;Urothelial cells: 479.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 17.3;MCF7: 14.6;RT4: 10.4;SK-BR-3: 22.9" "Region enhanced" "Detected in some" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA049161: AB_2680660" "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 12.0 0.0 0.5 0.3 0.7 0.4 80.2 1.3 0.8 0.0 0.0 0.0 6.3 0.5 2.9 0.0 0.0 0.0 0.0 0.0 5.8 1.5 2.5 1.1 0.0 6.0 0.5 0.0 27.1 0.3 0.0 2.6 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.3 0.0 2.2 2.5 23.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 17.3 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 22.9 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.2 0.0 0.2 23.2 221.0 128.8 28.5 0.0 42.8 23.7 0.3 38.6 343.9 16.5 0.0 36.7 1.9 18.5 1.9 113.1 0.0 28.4 4.6 1.8 3.6 0.0 0.0 98.3 37.1 1.3 52.5 56.6 0.0 0.0 0.0 0.1 2.3 0.0 0.0 7.5 207.5 0.0 1.4 0.0 0.0 0.9 7.2 0.0 1.0 0.0 0.0 0.0 0.0 380.6 32.3 0.0 0.3 75.4 0.6 0.2 108.0 0.0 0.0 0.0 13.7 0.1 0.2 22.7 27.6 10.5 2.7 0.0 6.9 479.5 UPF1 "HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2" ENSG00000005007 "UPF1 RNA helicase and ATPase" Q92900 19 18831959-18868230 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Nonsense-mediated mRNA decay" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019587, HPA020857" Approved Supported Nucleoplasm,Cytosol NA NA 19000 Nucleoplasm Cytosol "HPA019587: AB_1856174, HPA020857: AB_1856175" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (3.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.66e-1)" "unprognostic (7.77e-2)" "unprognostic (2.09e-1)" "unprognostic (7.98e-2)" "prognostic unfavorable (2.72e-4)" "unprognostic (2.94e-1)" "unprognostic (3.31e-1)" "unprognostic (3.71e-3)" "prognostic favorable (2.97e-6)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (8.90e-3)" "unprognostic (1.01e-2)" 22.1 21.4 10.7 22.4 12.0 26.3 21.4 13.0 14.4 23.1 8.2 23.3 21.7 24.6 8.1 24.2 20.8 17.9 17.4 11.0 11.0 16.3 17.5 21.7 26.0 14.8 11.9 10.8 22.7 42.6 35.4 18.8 22.5 10.9 21.3 10.8 10.2 37.1 22.5 31.6 28.0 21.9 13.9 11.9 25.0 24.0 31.2 11.2 27.3 23.2 19.8 16.7 23.7 23.2 15.0 61.2 39.8 27.4 32.8 41.5 27.1 89.7 50.6 31.1 48.0 37.4 76.9 54.0 54.5 65.4 32.0 25.5 60.0 38.7 55.2 18.2 29.2 76.5 59.9 37.2 49.8 35.7 67.2 34.7 30.3 39.3 37.4 40.3 27.5 30.8 46.6 76.6 51.4 25.8 66.5 78.5 42.2 45.7 42.2 96.0 62.1 44.2 51.4 21.1 54.3 57.8 44.6 46.4 52.2 27.3 21.8 31.4 42.7 43.9 42.6 29.6 52.8 57.3 33.0 27.4 83.7 30.3 64.0 48.0 0.0 0.6 1.1 0.2 0.3 0.2 0.1 0.3 0.0 0.4 0.3 0.2 0.1 1.7 1.0 0.8 0.2 0.2 0.3 10.7 12.0 13.0 14.4 11.0 11.0 14.8 11.9 10.8 10.9 11.9 11.2 15.0 24.2 22.4 13.6 10.1 14.8 15.7 13.3 10.0 10.2 30.8 24.7 24.5 14.5 12.8 11.0 27.6 14.6 16.4 18.7 32.5 0.0 11.1 13.5 46.5 27.8 19.4 21.6 8.8 9.9 9.8 13.7 15.8 29.0 65.9 0.0 24.4 13.9 24.1 14.4 37.0 9.5 27.4 10.2 19.1 12.2 7.9 14.6 19.5 12.4 10.3 11.8 19.5 13.4 9.0 11.4 16.6 16.6 19.2 18.9 22.2 17.5 10.5 29.0 18.5 13.1 15.6 15.0 26.8 18.4 20.1 18.6 20.5 16.5 20.5 22.8 27.2 SKAP2 "RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R" ENSG00000005020 "Src kinase associated phosphoprotein 2" O75563 7 26667068-26995239 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 313.5;Kupffer cells: 192.2;Late spermatids: 354.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 149.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005560, HPA024045" Enhanced Supported Nucleoplasm,Cytosol NA NA 1000000 Nucleoplasm Cytosol "HPA005560: AB_2667360, HPA024045: AB_2671416" "unprognostic (8.52e-2)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (5.62e-2)" "unprognostic (7.91e-3)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (4.15e-3)" "unprognostic (1.82e-1)" "unprognostic (1.41e-2)" "unprognostic (1.26e-2)" "unprognostic (3.80e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (3.51e-2)" 32.4 24.2 6.8 30.4 9.7 21.4 16.4 6.8 8.4 9.9 6.2 23.4 16.1 5.1 17.9 13.9 13.7 14.2 4.0 8.0 8.8 28.2 12.0 25.7 32.2 16.3 9.4 7.4 18.9 6.1 27.1 4.0 8.0 15.3 9.0 22.1 4.0 5.5 12.0 6.7 11.0 21.2 13.1 21.1 36.6 12.6 15.8 9.8 11.5 7.2 3.2 30.2 25.8 9.3 26.3 38.1 19.8 2.0 48.5 9.0 7.4 12.0 15.2 22.5 7.4 18.4 15.8 149.4 29.2 65.2 28.9 54.1 20.2 26.9 15.5 15.6 16.8 43.0 32.3 5.3 20.9 11.9 60.2 109.0 32.3 14.2 21.6 29.2 1.3 45.4 0.0 17.5 14.8 29.6 7.0 0.1 30.2 1.7 33.9 19.3 38.8 4.7 2.3 90.2 29.4 23.7 0.9 27.6 14.8 20.9 10.9 20.4 31.2 67.0 12.2 0.4 41.2 15.9 23.1 31.7 50.8 29.3 76.3 48.0 28.7 33.9 55.8 9.6 42.1 13.2 26.3 5.2 7.8 26.4 21.5 1.2 7.0 100.9 23.5 53.7 33.8 10.1 20.0 6.8 9.7 6.8 8.4 8.0 8.8 16.3 9.4 7.4 15.3 21.1 9.8 26.3 93.0 19.2 28.3 9.4 98.9 26.5 38.7 9.9 42.7 12.5 29.5 27.2 5.3 2.8 12.4 23.9 12.5 13.4 101.2 51.4 64.6 8.3 313.5 20.1 1.8 50.5 43.1 54.7 76.1 23.1 22.7 34.5 9.7 19.9 53.2 11.1 110.7 10.8 91.4 5.0 36.0 65.2 34.6 192.2 58.9 354.2 9.0 149.4 19.6 119.0 115.4 12.3 63.8 3.0 15.9 19.4 37.6 10.9 29.9 18.3 54.4 103.1 20.2 12.8 0.0 11.5 33.5 26.7 45.0 38.1 43.3 18.6 36.4 41.8 48.8 35.1 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468422-119471396 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 640000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.25e-2)" "prognostic favorable (7.35e-4)" "prognostic favorable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 166.9 179.8 113.5 177.6 113.0 263.1 162.9 137.6 121.0 130.8 110.9 462.9 746.9 135.6 64.4 414.3 119.7 101.3 198.0 105.1 132.6 496.4 338.9 218.3 257.5 117.8 114.6 101.1 109.1 634.4 297.8 89.7 139.3 122.9 112.8 507.9 128.8 252.4 104.8 62.1 286.4 567.5 151.8 117.6 184.1 496.1 54.6 123.6 355.1 129.9 65.7 300.1 202.6 237.2 119.5 845.1 789.6 303.3 525.4 189.5 277.3 561.0 306.8 331.3 631.7 560.8 662.4 518.4 1059.3 400.9 296.1 456.1 576.9 752.1 640.5 572.5 281.1 711.2 357.5 418.7 477.0 239.8 984.0 566.1 303.7 705.2 652.2 412.6 240.1 660.4 535.0 292.5 425.9 350.1 1868.4 878.6 995.1 640.4 1147.6 1244.3 474.5 383.4 825.7 486.9 663.6 365.0 344.5 526.7 793.3 646.7 306.7 327.7 491.0 279.5 297.3 428.9 670.8 1122.2 494.6 656.3 847.4 329.5 987.7 492.2 113.4 603.4 170.2 170.7 1045.7 198.1 459.2 248.3 224.6 872.6 376.0 243.3 232.1 99.2 318.1 824.2 476.1 443.1 931.8 113.5 113.0 137.6 121.0 105.1 132.6 117.8 114.6 101.1 122.9 117.6 123.6 119.5 260.4 163.5 308.6 28.7 339.6 815.7 567.0 1615.3 398.9 109.8 406.2 413.5 131.2 301.7 609.2 187.6 60.5 1038.8 336.2 1379.0 2533.6 578.2 4.0 137.3 134.2 257.5 401.0 349.1 16.8 1056.4 463.1 214.4 543.3 157.6 192.9 306.0 146.7 333.6 881.7 26.9 25.5 856.4 1129.1 610.6 650.9 18.1 145.4 473.2 547.8 15.0 441.2 140.8 218.3 24.1 19.2 554.1 1061.8 110.6 419.9 522.3 2785.2 1622.3 239.5 199.0 131.5 163.9 506.7 11.5 119.2 1046.8 960.2 1589.1 291.2 626.6 1053.7 809.7 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative subunit beta" Q9NWR8 4 109560209-109688719 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 32.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 127.7;Exocrine glandular cells: 111.4;Extravillous trophoblasts: 91.9;Hofbauer cells: 106.8;Pancreatic endocrine cells: 67.9;Syncytiotrophoblasts: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 10.2 2.0 2.6 18.6 3.0 10.7 7.6 2.2 3.5 6.7 3.5 5.3 3.8 8.9 1.5 6.9 5.8 7.9 7.2 2.6 5.3 2.5 2.2 7.3 32.4 4.3 2.8 2.4 5.6 1.5 1.2 3.7 6.1 3.0 3.1 6.4 3.8 4.9 2.2 1.4 6.1 7.9 8.3 3.5 13.6 4.6 3.0 4.2 31.7 3.3 3.6 25.9 9.3 7.6 4.4 26.9 11.7 6.4 32.6 6.9 18.1 23.9 23.3 14.2 24.9 22.1 0.6 21.6 93.0 4.6 20.2 13.8 7.6 24.1 14.0 21.9 59.2 18.4 11.3 11.6 1.6 12.1 23.6 0.4 11.7 3.8 15.1 13.0 17.7 33.9 35.0 3.3 59.4 19.2 34.0 54.1 0.4 28.2 4.8 15.6 20.4 47.7 10.8 29.6 12.1 25.6 11.1 24.2 73.4 7.7 5.3 9.2 1.2 23.9 9.8 12.6 51.8 40.2 22.3 16.4 22.7 29.9 4.9 6.9 0.4 51.4 0.8 18.9 32.2 26.6 43.6 79.1 56.5 49.8 50.7 114.7 66.2 3.6 65.0 24.4 35.1 74.9 92.2 2.6 3.0 2.2 3.5 2.6 5.3 4.3 2.8 2.4 3.0 3.5 4.2 4.4 21.5 9.6 5.2 0.0 19.5 0.0 0.0 0.0 0.0 0.0 12.7 9.9 0.0 0.0 2.5 5.5 0.0 127.7 36.0 0.0 0.0 25.2 0.0 7.0 5.9 11.7 0.0 0.0 0.0 111.4 91.9 15.1 0.0 8.9 1.3 9.1 0.0 0.0 106.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 14.5 0.0 0.0 0.0 0.0 67.9 0.0 0.0 5.8 0.0 0.0 0.9 2.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 73.5 28.2 7.4 0.0 0.0 HOXA11 "HOX1, HOX1I" ENSG00000005073 "Homeobox A11" P31270 7 27181157-27185232 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 37.4;endometrium 1: 97.6;smooth muscle: 41.6" "Cell type enriched" "Detected in some" 19 "Endometrial stromal cells: 116.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 36 "spinal cord: 3.5" "HPA006770, HPA035623" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006770: AB_2667672, HPA035623: AB_10601576" "unprognostic (5.95e-2)" "unprognostic (9.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.70e-2)" "unprognostic (6.29e-2)" "unprognostic (9.78e-2)" "unprognostic (2.82e-3)" "unprognostic (4.36e-2)" "unprognostic (1.61e-2)" "unprognostic (3.05e-2)" "unprognostic (2.08e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (2.17e-2)" "unprognostic (6.90e-2)" "unprognostic (2.03e-2)" "unprognostic (2.56e-1)" 2.2 0.7 0.0 1.5 0.0 0.0 0.4 0.0 0.0 37.4 0.0 20.0 0.0 97.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 10.1 0.0 14.8 3.9 0.0 0.1 9.7 8.0 1.3 0.2 41.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 17.2 10.5 0.0 4.8 0.3 0.0 13.1 15.2 11.1 0.0 26.8 32.5 18.9 13.8 0.3 1.7 0.0 6.1 23.5 0.1 3.2 16.3 0.0 14.7 1.6 44.0 5.7 11.2 0.7 0.9 12.5 1.7 6.5 0.6 0.1 0.0 0.0 14.1 1.1 0.4 0.0 2.2 0.4 0.0 9.4 0.0 4.4 13.1 0.7 0.0 0.3 9.6 8.1 5.6 0.0 6.7 0.0 2.0 3.6 1.2 34.7 0.0 0.2 12.9 3.2 1.5 0.0 0.0 0.0 0.2 43.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.1 0.3 1.1 5.9 0.0 0.8 4.0 116.8 1.3 5.3 0.0 0.0 0.0 0.1 3.6 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.8 0.2 0.2 0.0 0.0 0.0 0.9 5.8 1.2 0.1 0.0 0.0 0.0 0.6 0.1 1.1 1.3 POLR2J "hRPB14, POLR2J1, RPB11, RPB11A, RPB11m" ENSG00000005075 "RNA polymerase II subunit J" P52435 7 102473118-102478907 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (1.62e-1)" "unprognostic (1.90e-2)" "unprognostic (4.80e-2)" "unprognostic (6.47e-2)" "unprognostic (4.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.53e-3)" "unprognostic (4.46e-2)" "unprognostic (7.32e-2)" "unprognostic (7.13e-2)" "unprognostic (2.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" 52.9 87.7 73.8 36.8 75.2 90.8 52.1 77.3 108.9 48.6 72.0 58.6 46.8 48.5 55.2 60.5 46.9 33.0 111.7 74.1 77.2 71.4 100.2 43.7 46.5 79.8 75.9 70.9 59.8 59.1 63.4 66.9 32.7 75.8 60.2 34.3 18.0 59.1 38.6 197.3 57.0 51.5 28.6 77.3 59.6 64.1 44.0 77.5 53.7 56.5 128.8 40.4 51.5 48.5 78.2 143.4 143.0 96.2 127.5 89.2 68.5 70.4 77.4 82.3 111.2 94.2 131.1 108.4 65.7 145.9 108.7 160.2 74.8 89.8 95.6 67.8 123.3 160.4 65.9 101.2 129.1 108.9 128.5 94.6 89.6 117.4 100.1 55.8 72.5 100.8 138.3 156.8 190.0 92.5 439.6 212.9 228.5 89.5 141.4 182.2 100.1 94.4 194.0 91.2 93.6 81.4 135.6 93.5 176.1 113.9 97.3 79.1 155.3 82.3 125.0 160.0 198.4 154.5 116.5 183.6 171.0 111.3 157.8 149.1 180.3 116.5 199.5 90.5 122.5 86.2 137.6 96.0 101.0 93.8 122.9 81.4 81.8 174.6 84.7 115.5 127.5 140.8 128.9 73.8 75.2 77.3 108.9 74.1 77.2 79.8 75.9 70.9 75.8 77.3 77.5 78.2 87.9 35.3 46.7 17.9 91.1 95.0 113.5 190.7 79.1 37.0 149.6 195.2 193.2 81.5 107.4 125.0 12.5 197.7 93.0 241.7 273.9 139.0 53.1 84.1 64.4 86.8 103.0 128.2 5.6 199.6 195.5 94.4 78.0 73.2 43.7 90.7 86.0 203.5 202.5 35.3 6.2 164.0 146.5 111.0 107.6 43.2 127.1 99.5 142.3 4.7 154.0 171.3 127.7 8.5 10.8 191.8 281.6 110.6 111.4 128.9 236.3 242.0 107.0 46.7 52.6 76.9 113.2 117.1 229.3 114.3 116.1 182.1 91.4 114.5 131.2 153.9 DHX33 "DDX33, DKFZp762F2011, FLJ21972" ENSG00000005100 "DEAH-box helicase 33" Q9H6R0 17 5440917-5468982 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 81.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073875 Supported Supported Nucleoli NA NA Nucleoli "HPA073875: AB_2686638" "unprognostic (4.96e-2)" "unprognostic (1.35e-1)" "unprognostic (3.41e-2)" "unprognostic (2.51e-2)" "unprognostic (9.24e-2)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" "unprognostic (6.15e-2)" "unprognostic (3.11e-2)" "unprognostic (3.80e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.03e-1)" "unprognostic (4.66e-1)" "unprognostic (3.55e-1)" "unprognostic (4.69e-2)" "unprognostic (3.37e-2)" 5.8 6.0 5.8 6.4 5.9 4.5 7.1 5.3 6.0 5.4 4.0 5.3 4.8 6.5 4.1 6.2 5.9 4.1 4.3 6.0 5.1 4.4 7.8 4.4 6.1 5.2 5.6 6.0 5.6 6.8 7.7 3.9 6.4 5.4 5.4 5.7 6.5 5.7 5.5 8.1 7.0 5.1 6.0 5.2 6.0 5.6 4.5 6.0 5.3 5.1 5.7 5.9 6.6 5.5 5.8 19.0 27.7 17.4 31.1 7.2 14.4 21.6 18.4 11.4 27.6 22.1 17.6 8.1 46.7 12.5 15.1 11.0 22.0 35.4 28.7 35.3 15.0 34.1 18.5 22.4 30.0 14.1 24.9 15.9 12.2 17.3 29.8 40.4 8.3 20.9 22.0 24.9 22.3 15.5 13.4 25.5 13.6 38.5 12.5 14.0 33.5 25.5 25.3 12.8 14.7 15.1 21.7 19.2 16.4 28.0 14.6 12.8 12.9 19.5 19.0 20.2 15.3 39.6 8.3 9.5 23.5 13.6 29.1 27.7 0.2 0.9 0.5 0.5 0.4 0.5 0.7 0.6 0.3 0.4 0.8 0.6 0.6 0.6 0.8 0.3 0.9 0.4 0.2 5.8 5.9 5.3 6.0 6.0 5.1 5.2 5.6 6.0 5.4 5.2 6.0 5.8 11.4 12.8 8.6 6.5 8.6 21.0 15.3 8.6 19.9 15.6 18.3 15.7 16.3 17.2 9.9 7.3 20.9 8.3 10.2 8.5 1.9 9.3 81.8 7.6 23.3 16.2 9.1 23.3 14.5 15.3 10.1 13.7 10.7 12.7 3.8 21.0 13.2 28.1 6.3 13.5 15.2 10.9 2.0 16.9 8.7 11.3 7.8 9.9 14.2 6.5 6.8 13.3 9.2 11.6 13.0 12.1 5.1 9.8 10.4 20.9 5.9 5.9 6.1 10.5 0.0 25.1 11.5 10.6 15.7 22.0 19.9 5.1 6.6 19.7 11.9 14.9 MEOX1 MOX1 ENSG00000005102 "Mesenchyme homeobox 1" P50221 17 43640389-43661922 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.7;breast: 26.3" "Group enriched" "Detected in some" 9 "Adipocytes: 63.5;Endothelial cells: 41.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 4 "T-reg: 17.5" "Lineage enriched" "Detected in single" 48 "T-cells: 17.5" "Cell line enriched" "Detected in some" 14 "HeLa: 25.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045214, HPA063788" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA045214: AB_10959299, HPA063788: " "unprognostic (1.36e-3)" "unprognostic (2.15e-4)" "unprognostic (1.25e-1)" "unprognostic (2.58e-3)" "unprognostic (2.01e-2)" "unprognostic (5.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.55e-3)" "unprognostic (6.71e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-1)" "unprognostic (9.36e-2)" "unprognostic (3.44e-6)" "unprognostic (2.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.82e-1)" "unprognostic (7.47e-3)" 29.7 0.5 0.0 4.7 0.0 0.0 26.3 0.0 0.1 6.8 0.0 4.4 1.6 5.6 1.1 3.8 9.1 5.7 22.4 0.0 0.0 0.1 0.1 1.4 6.6 0.0 0.0 0.0 1.0 1.5 1.2 0.5 0.2 0.0 2.6 2.5 0.0 4.9 1.9 8.4 6.1 5.2 10.7 0.0 10.9 3.1 1.1 0.0 3.0 2.0 17.2 5.3 7.8 7.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 1.8 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.3 2.7 0.0 0.0 1.7 0.5 0.0 0.3 0.0 0.0 17.5 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.5 0.0 0.0 1.0 0.3 4.1 0.0 0.0 1.2 0.0 0.4 0.6 2.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 41.3 0.0 0.0 0.7 0.0 0.3 4.8 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.0 4.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 1.8 0.1 1.5 0.3 0.0 0.0 THSD7A KIAA0960 ENSG00000005108 "Thrombospondin type 1 domain containing 7A" Q9UPZ6 7 11370365-11832198 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 7.6" "Cell type enhanced" "Detected in many" "Astrocytes: 150.5;Bipolar cells: 183.8;Horizontal cells: 208.6;Inhibitory neurons: 494.3;Oligodendrocyte precursor cells: 262.4" "Cancer enhanced" "Detected in many" "renal cancer: 3.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 54 "basophil: 5.3" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "A549: 10.3;HUVEC TERT2: 6.7;REH: 7.1;SH-SY5Y: 10.2;THP-1: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000923 Supported "Secreted to blood" NA NA 6100000 "HPA000923: AB_1080271" "unprognostic (3.01e-1)" "unprognostic (7.90e-2)" "unprognostic (3.09e-2)" "unprognostic (1.96e-1)" "unprognostic (5.88e-1)" "unprognostic (3.33e-2)" "unprognostic (1.44e-1)" "unprognostic (9.66e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "prognostic favorable (2.24e-6)" "unprognostic (2.13e-3)" "unprognostic (1.66e-1)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" 2.2 0.7 3.0 0.8 2.2 0.0 2.1 3.3 4.4 3.4 0.4 0.9 0.3 2.8 0.8 0.5 2.1 2.6 0.7 4.1 2.9 7.6 0.6 1.1 0.3 2.9 4.7 1.1 2.5 0.4 1.3 1.6 4.2 2.4 3.5 0.7 5.1 0.6 2.1 0.2 0.5 0.5 2.4 3.4 0.9 0.5 0.8 4.1 0.2 2.0 1.2 0.2 1.8 1.7 3.1 0.0 10.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.6 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 7.1 0.0 0.0 0.3 0.1 0.7 10.2 0.0 0.3 0.0 1.6 0.1 19.2 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.2 3.3 4.4 4.1 2.9 2.9 4.7 1.1 2.4 3.4 4.1 3.1 46.9 22.4 8.2 150.5 0.0 2.7 1.4 0.0 1.2 183.8 0.8 0.5 1.5 21.5 2.8 55.2 112.6 23.5 0.1 0.4 7.9 7.0 1.2 4.9 22.4 42.6 41.7 0.0 56.6 2.2 4.3 8.1 0.5 18.8 0.0 6.1 28.2 1.3 2.2 208.6 494.3 0.8 0.0 1.5 2.9 0.5 24.2 0.5 12.4 105.9 0.0 20.7 0.0 262.4 5.4 5.5 6.8 1.5 0.1 7.7 0.1 8.8 0.1 9.3 0.0 10.6 5.0 1.6 1.1 0.6 2.4 51.9 0.8 21.5 1.2 1.1 LIG3 "LIG2, LIG3alpha" ENSG00000005156 "DNA ligase 3" P49916 17 34980512-35009743 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006723 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006723: AB_1847781" "unprognostic (6.05e-3)" "unprognostic (2.98e-1)" "unprognostic (1.24e-1)" "unprognostic (2.83e-1)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (2.40e-2)" "unprognostic (2.78e-1)" "unprognostic (2.25e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-3)" "unprognostic (1.31e-1)" "unprognostic (6.67e-3)" "unprognostic (3.39e-1)" "unprognostic (3.28e-1)" "unprognostic (3.29e-2)" "unprognostic (4.71e-2)" 4.9 6.5 3.5 7.4 3.6 7.1 8.8 4.1 4.5 7.9 4.4 8.3 5.9 12.6 6.4 9.0 12.0 5.3 7.7 3.7 3.6 6.7 6.4 5.3 7.3 2.5 2.3 3.1 11.6 8.8 13.8 6.6 8.4 3.3 11.2 9.1 7.3 10.7 9.1 10.7 8.4 6.7 10.3 0.8 7.7 6.7 21.3 2.4 14.0 10.2 9.4 8.6 9.0 7.3 3.5 16.6 32.6 38.3 33.9 7.4 9.3 29.2 15.7 11.4 20.9 20.8 15.8 8.8 27.0 12.7 20.6 20.5 15.2 43.9 20.3 26.7 12.8 29.4 28.4 14.6 23.2 11.7 44.9 48.1 7.0 17.5 15.5 24.0 10.3 25.6 40.8 45.3 30.2 15.2 18.6 56.7 14.1 36.8 20.6 13.7 30.4 35.2 28.6 10.2 17.7 31.2 22.3 23.6 19.0 15.2 55.9 34.5 22.3 12.3 13.5 16.8 16.8 25.6 27.0 31.5 35.1 9.7 20.9 26.5 0.6 3.4 4.2 4.6 5.1 6.7 3.7 3.1 4.1 8.4 3.0 4.1 3.0 0.3 9.3 2.8 4.9 2.1 3.9 3.5 3.6 4.1 4.5 3.7 3.6 2.5 2.3 3.1 3.3 0.8 2.4 3.5 7.6 3.2 10.3 1.6 8.0 5.0 10.5 3.6 12.0 18.2 10.0 7.5 10.1 10.0 9.2 12.9 16.7 14.6 11.9 7.0 9.8 6.7 41.8 18.5 11.9 8.5 6.7 8.2 5.0 6.0 17.8 7.3 16.8 15.8 9.5 16.7 3.6 8.9 7.9 16.8 5.2 7.9 8.2 5.3 2.7 80.0 7.2 6.7 3.6 2.8 6.4 7.6 16.5 4.0 5.8 3.6 7.5 7.9 15.4 11.6 6.8 6.5 5.3 17.7 6.6 11.8 7.0 32.7 13.2 11.2 5.3 21.6 8.9 10.8 9.5 10.2 RPAP3 "FLJ21908, hSpagh, spag, Tah1" ENSG00000005175 "RNA polymerase II associated protein 3" Q9H6T3 12 47661249-47706030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038311, HPA038312" Enhanced Enhanced Cytosol NA NA Cytosol "HPA038311: AB_10671527, HPA038312: AB_10672512" "unprognostic (5.76e-2)" "unprognostic (2.25e-1)" "unprognostic (1.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.28e-2)" "unprognostic (4.47e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (9.89e-2)" "unprognostic (9.87e-3)" "unprognostic (6.34e-2)" "unprognostic (9.48e-2)" "unprognostic (1.28e-2)" "unprognostic (2.01e-2)" "unprognostic (8.35e-2)" "unprognostic (5.11e-1)" "unprognostic (3.29e-1)" "unprognostic (1.35e-2)" 10.1 10.7 6.8 19.3 6.3 12.8 15.9 8.8 7.4 12.9 6.5 11.6 13.9 14.0 14.8 13.7 14.7 12.2 16.3 5.8 7.8 13.1 15.6 10.3 29.8 6.6 7.1 5.5 19.5 8.6 17.5 8.2 13.2 7.4 13.0 12.9 11.2 9.8 12.6 23.0 11.3 12.7 15.5 6.5 17.5 11.1 16.0 7.8 23.7 13.9 23.9 29.4 17.1 9.3 8.1 42.6 39.1 46.5 32.1 24.5 34.7 39.2 41.4 42.5 51.4 43.8 54.5 47.2 93.9 55.6 37.0 37.0 41.5 40.7 24.6 59.5 50.2 38.0 63.3 25.1 26.6 21.1 68.0 42.4 17.1 29.6 60.2 21.7 41.7 32.6 36.2 70.6 28.0 45.9 30.5 58.7 48.9 49.9 39.1 33.2 46.9 56.1 46.0 41.9 38.3 33.5 24.3 48.5 39.4 41.9 49.0 40.5 40.4 23.5 35.4 47.0 39.3 46.5 21.8 43.7 66.5 33.3 148.5 22.3 3.7 10.6 32.9 10.2 20.5 10.5 20.9 11.5 11.1 14.3 17.9 14.5 13.3 19.7 13.3 25.8 9.9 15.7 9.0 6.8 6.3 8.8 7.4 5.8 7.8 6.6 7.1 5.5 7.4 6.5 7.8 8.1 16.8 12.8 17.6 11.4 30.0 13.3 14.8 20.3 24.5 18.1 18.3 19.3 41.7 11.5 21.2 11.0 8.4 23.4 33.7 7.3 23.5 17.3 9.5 51.3 23.4 13.8 13.1 18.3 15.3 19.7 16.3 21.0 15.3 26.9 12.0 22.5 8.6 18.0 18.3 11.8 12.7 12.2 14.2 19.2 16.9 7.1 21.8 24.9 7.2 14.0 44.0 13.4 25.7 16.1 16.8 11.7 16.8 20.7 31.0 7.5 9.6 30.2 30.1 14.8 6.6 16.8 18.2 48.0 37.1 22.7 10.2 17.0 21.3 18.0 14.6 9.1 ACSM3 "SA, SAH" ENSG00000005187 "Acyl-CoA synthetase medium chain family member 3" Q53FZ2 16 20610243-20797581 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 85.9;liver: 180.0" "Cell type enhanced" "Detected in many" "Granulosa cells: 446.7;Hepatic stellate cells: 100.6;Proximal tubular cells: 136.0;Theca cells: 208.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 23.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 95.1;HMC-1: 381.7;K-562: 285.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041013 Uncertain NA NA "HPA041013: AB_10671693" "unprognostic (1.62e-4)" "unprognostic (1.30e-2)" "unprognostic (2.12e-2)" "unprognostic (9.50e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.42e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "prognostic favorable (1.97e-4)" "unprognostic (3.56e-2)" "unprognostic (1.95e-3)" "prognostic favorable (9.88e-6)" "unprognostic (1.27e-1)" "unprognostic (6.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.84e-2)" 2.3 3.2 1.9 2.4 1.9 15.4 60.8 2.1 3.3 10.2 1.6 26.7 7.8 20.1 5.7 3.2 27.1 10.5 7.4 1.8 1.2 85.9 180.0 8.1 3.1 2.2 1.7 1.8 75.5 30.6 15.3 0.9 2.5 2.8 22.2 25.9 1.0 4.9 6.9 0.8 4.0 8.3 5.1 1.1 1.9 28.3 5.9 1.9 2.9 2.9 1.0 3.0 4.9 5.3 4.8 1.0 12.4 2.3 0.7 3.9 2.3 1.5 0.2 1.3 0.3 1.0 1.0 18.2 1.6 20.1 0.4 0.7 1.6 0.2 2.1 1.6 4.5 6.6 95.1 0.2 7.7 1.3 10.9 381.7 3.7 2.2 0.5 1.4 1.9 0.2 0.7 285.1 15.3 0.1 1.5 0.7 3.5 0.7 14.5 3.8 3.1 0.1 20.3 18.3 1.1 0.8 0.7 0.4 5.4 0.3 0.8 6.1 0.9 1.3 1.2 1.2 0.9 0.7 21.9 18.6 1.2 1.2 7.5 0.5 2.6 2.0 23.5 3.6 1.2 4.2 1.6 4.5 3.3 0.2 2.8 6.9 8.2 0.5 2.3 4.0 2.3 5.6 2.9 1.9 1.9 2.1 3.3 1.8 1.2 2.2 1.7 1.8 2.8 1.1 1.9 4.8 0.3 3.2 31.3 1.0 16.5 2.8 34.6 1.5 8.0 0.0 6.3 6.1 3.2 20.0 1.7 12.9 0.0 19.1 1.5 7.0 84.1 84.8 25.0 14.0 4.3 3.4 2.4 25.4 0.3 12.5 2.1 23.7 8.6 32.8 0.0 446.7 100.6 38.2 3.2 0.0 0.3 11.8 0.0 5.4 1.7 12.3 27.7 3.4 0.0 0.0 3.1 0.0 4.1 0.0 0.1 8.9 20.3 12.8 1.0 14.5 4.7 136.0 1.5 0.0 0.0 0.4 52.7 6.9 2.2 3.8 1.8 19.2 4.3 208.3 23.0 11.3 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849665 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 346.9" "Cell type enriched" "Detected in some" 5 "Granulosa cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 15 "basophil: 86.7" "Lineage enriched" "Detected in many" 39 "granulocytes: 86.7" "Cell line enhanced" "Detected in many" "K-562: 44.7;U-266/70: 42.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 2.4 1.8 1.1 1.8 1.2 11.7 3.6 1.3 1.6 1.7 0.3 2.1 3.0 2.3 1.2 2.3 4.2 1.6 3.5 1.1 1.2 1.2 1.8 1.0 2.9 1.7 1.0 1.3 1.9 1.8 40.4 0.9 1.5 1.3 5.4 3.1 4.3 1.7 1.3 1.0 2.2 2.1 2.7 0.5 1.1 5.0 346.9 1.4 7.4 0.9 1.3 2.6 2.0 1.6 1.9 11.3 6.5 10.1 4.5 4.2 7.5 3.4 7.6 8.4 8.2 8.9 4.7 10.0 7.0 11.5 6.7 5.7 5.7 7.7 3.4 8.5 6.5 4.9 11.7 10.2 6.7 0.8 17.2 16.4 3.8 1.5 9.7 12.4 3.5 2.8 0.0 44.7 29.8 20.5 15.1 2.8 13.5 5.5 4.6 6.6 14.0 18.8 12.6 2.5 4.0 8.6 9.7 7.3 9.6 2.4 2.9 16.2 14.8 1.4 6.1 5.4 8.2 9.3 42.5 31.1 2.7 12.6 22.3 5.6 86.7 0.4 5.7 0.3 0.1 0.4 0.0 0.4 0.4 0.7 0.0 0.1 0.3 0.4 2.2 0.2 0.2 1.8 0.4 1.1 1.2 1.3 1.6 1.1 1.2 1.7 1.0 1.3 1.3 0.5 1.4 1.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.4 0.0 0.0 1.3 0.0 0.0 3.2 0.8 0.0 0.0 1.6 0.0 2.8 1.6 0.6 0.0 0.0 0.0 1.5 2.4 1.5 0.0 1.7 1.3 26.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.6 1.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.5 0.5 4.7 0.0 0.0 CIAPIN1 "Anamorsin, CIAE2" ENSG00000005194 "Cytokine induced apoptosis inhibitor 1" Q6FI81 16 57428187-57447420 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 259.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041350, HPA042182" Enhanced Supported Nucleoplasm,Mitochondria No No 21000 Mitochondria Nucleoplasm "HPA041350: AB_10796665, HPA042182: AB_10794646" "unprognostic (1.78e-2)" "unprognostic (9.62e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.41e-3)" "unprognostic (8.15e-3)" "unprognostic (1.99e-1)" "unprognostic (2.48e-2)" "unprognostic (4.70e-3)" "unprognostic (1.62e-1)" "prognostic favorable (4.42e-4)" "unprognostic (5.61e-2)" "unprognostic (3.86e-2)" "unprognostic (8.90e-3)" "unprognostic (1.16e-1)" 19.0 33.1 21.6 19.9 22.8 20.8 19.0 23.4 27.3 15.2 24.8 29.7 21.5 16.4 15.7 30.5 16.2 16.7 38.2 22.6 24.1 30.1 27.5 20.1 24.4 25.0 24.1 22.7 13.0 19.7 37.8 17.9 31.8 24.5 18.1 26.1 21.1 19.9 16.5 41.6 27.9 21.1 22.2 20.8 21.7 22.5 68.6 24.4 31.3 18.6 38.8 34.6 24.6 20.3 25.6 51.8 77.8 80.4 61.4 46.5 31.8 67.5 52.7 51.2 102.6 48.1 87.6 40.3 55.0 75.8 46.9 32.4 95.9 113.2 82.2 86.5 32.7 68.2 71.4 63.6 91.6 74.6 88.2 67.7 48.8 88.7 74.9 94.5 40.5 101.9 69.3 101.4 30.7 60.9 51.5 81.1 71.1 100.8 60.3 114.8 146.0 93.6 112.7 69.6 57.7 68.7 85.8 126.4 86.2 56.6 64.6 61.7 76.5 63.2 42.3 52.1 42.4 64.7 76.8 113.4 175.0 51.1 78.9 68.0 53.6 80.5 54.2 74.2 79.2 68.1 65.7 60.8 78.4 94.6 72.6 128.5 115.1 19.8 91.1 64.7 79.8 74.5 153.8 21.6 22.8 23.4 27.3 22.6 24.1 25.0 24.1 22.7 24.5 20.8 24.4 25.6 25.3 16.0 22.0 7.8 16.0 14.3 13.9 59.4 8.6 29.2 17.5 18.3 36.1 20.0 28.4 22.0 10.4 90.4 21.8 17.0 39.2 55.4 19.3 14.4 19.1 28.5 18.6 21.9 15.7 51.8 50.0 19.2 19.4 15.1 10.8 28.1 17.9 20.3 40.0 23.5 16.4 17.8 52.9 13.9 13.2 33.6 14.0 17.4 24.9 7.5 42.9 27.9 23.7 11.1 10.6 54.6 23.9 20.7 14.4 23.2 25.5 37.4 14.1 17.8 39.5 11.8 21.3 259.9 69.8 23.2 15.9 106.2 19.3 43.4 28.0 15.2 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2355095 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 109.1;Late spermatids: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: AB_2676429" "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favorable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 22.1 23.4 11.2 16.9 11.6 29.4 27.6 14.2 18.7 25.9 13.9 37.0 42.0 26.6 4.4 22.7 34.3 10.8 21.2 9.8 10.0 36.1 33.3 22.4 20.9 17.4 13.9 10.1 27.5 51.1 11.1 64.3 10.5 17.0 32.7 9.3 7.2 27.4 9.9 25.5 28.3 53.0 6.0 11.6 39.4 34.2 64.0 12.3 12.2 40.8 3.2 10.0 22.1 21.1 15.1 16.6 25.9 10.9 19.5 8.8 8.9 27.8 21.1 6.1 7.6 8.1 18.2 18.4 15.7 19.4 9.9 7.1 21.7 3.6 7.3 2.3 18.4 16.0 10.4 44.7 24.9 16.5 18.6 13.1 13.1 8.2 7.2 5.2 11.9 10.7 32.2 17.3 39.0 4.7 18.4 20.2 23.6 20.4 14.7 10.5 33.4 5.8 43.9 8.3 41.0 19.4 18.3 21.2 12.8 16.7 7.1 21.3 30.8 24.3 13.8 9.7 35.3 16.9 51.0 20.1 16.7 17.3 21.4 24.5 11.5 7.7 7.4 6.2 7.7 4.4 8.2 5.6 6.0 9.4 12.5 6.9 7.7 3.3 6.4 5.4 17.0 6.0 6.4 11.2 11.6 14.2 18.7 9.8 10.0 17.4 13.9 10.1 17.0 11.6 12.3 15.1 23.6 3.2 17.2 57.1 30.8 0.0 6.5 0.0 8.0 26.1 21.6 21.5 6.0 20.0 5.0 25.8 47.9 50.6 18.8 79.5 1.9 16.6 51.4 39.3 22.2 14.4 40.7 14.5 25.3 11.5 20.8 14.2 109.1 25.5 7.0 39.9 13.2 15.1 11.8 32.0 30.3 63.2 0.0 9.4 0.0 107.7 14.9 10.8 0.0 9.4 8.0 13.2 19.6 39.7 35.2 10.4 49.9 15.8 11.5 7.3 57.8 7.9 10.9 39.4 0.0 15.0 11.7 57.0 13.5 10.8 0.0 42.8 11.0 36.4 49.8 6.0 FAM214B "bA182N22.6, FLJ11560, KIAA1539" ENSG00000005238 "Family with sequence similarity 214 member B" Q7L5A3 9 35104112-35116341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 54.1;Late spermatids: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.3" "Group enriched" "Detected in many" 5 "dendritic cells: 4.8;granulocytes: 16.3;monocytes: 10.2" "Cell line enhanced" "Detected in many" "TIME: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048831, HPA055751" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA048831: AB_2680535, HPA055751: AB_2682906" "unprognostic (2.91e-3)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.06e-1)" "unprognostic (7.72e-3)" "unprognostic (2.38e-2)" "unprognostic (1.70e-2)" "unprognostic (1.02e-2)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (8.15e-2)" 13.5 15.0 28.4 12.3 28.9 39.2 10.7 28.8 29.7 10.9 22.5 15.0 10.3 10.7 7.0 29.9 9.0 11.8 18.9 27.7 28.6 15.0 11.3 21.8 6.9 32.3 30.8 26.4 8.1 6.8 11.3 15.9 10.0 31.1 13.1 10.6 4.3 11.7 9.8 14.3 14.8 11.3 11.1 28.7 27.9 11.8 8.5 31.9 6.0 11.7 11.6 7.1 12.4 14.6 30.5 6.4 5.2 14.2 10.3 11.0 16.9 3.0 31.2 27.9 17.0 10.9 3.6 4.4 1.6 9.0 50.5 44.0 2.8 2.4 10.0 11.0 8.3 0.6 7.9 12.6 3.4 11.2 2.2 33.4 12.1 17.4 19.9 12.5 39.3 33.1 7.9 4.4 6.3 36.0 1.8 3.1 9.8 2.7 4.8 7.8 3.5 2.4 1.9 22.3 1.4 1.0 9.3 4.9 3.5 16.6 14.8 4.6 5.3 56.0 23.8 11.5 11.5 11.5 4.0 4.1 0.8 37.5 4.0 26.7 5.0 5.9 5.7 2.1 7.7 0.7 0.5 1.3 1.5 4.8 0.2 0.5 0.9 16.3 2.1 10.2 1.2 0.8 3.4 28.4 28.9 28.8 29.7 27.7 28.6 32.3 30.8 26.4 31.1 28.7 31.9 30.5 10.8 0.0 3.9 17.9 3.1 8.4 4.4 11.7 11.4 3.3 8.6 5.2 8.6 2.8 6.2 16.5 14.6 2.8 7.9 43.0 3.9 11.3 12.7 5.5 7.0 11.3 5.4 54.1 5.8 12.5 9.6 6.9 9.2 7.8 8.8 3.8 18.2 6.7 14.9 0.0 5.4 12.3 12.2 28.2 21.3 77.0 3.4 32.5 16.0 4.7 26.2 8.4 16.5 2.5 14.4 40.0 19.8 7.9 3.5 6.9 14.1 11.7 4.4 3.6 6.6 7.3 9.2 3.0 6.5 23.6 14.5 4.2 7.5 5.3 14.0 9.3 COPZ2 MGC23008 ENSG00000005243 "COPI coat complex subunit zeta 2" Q9P299 17 48026167-48038030 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 49.8;Endometrial stromal cells: 63.8;Fibroblasts: 77.7;Leydig cells: 50.4;Smooth muscle cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 167.4;ASC TERT1: 185.6;BJ: 127.1;BJ hTERT+: 133.1;fHDF/TERT166: 271.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055999 Uncertain NA NA "HPA055999: AB_2683003" "unprognostic (2.66e-1)" "unprognostic (9.32e-2)" "unprognostic (2.18e-2)" "unprognostic (1.46e-1)" "unprognostic (6.28e-2)" "unprognostic (1.12e-1)" "unprognostic (2.77e-2)" "unprognostic (1.59e-1)" "unprognostic (9.34e-2)" "unprognostic (2.49e-1)" "unprognostic (7.02e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (3.45e-9)" "unprognostic (7.42e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (2.89e-6)" "prognostic unfavorable (4.66e-4)" 65.8 28.8 12.3 11.8 12.5 1.0 46.8 13.7 17.5 38.6 22.5 42.9 6.2 38.6 21.6 16.0 32.9 23.1 50.2 12.6 20.0 19.3 33.5 22.3 5.8 15.9 12.7 10.4 13.7 19.8 24.5 14.9 22.7 14.9 34.5 14.8 5.2 23.6 37.1 91.5 34.3 18.3 46.0 14.5 11.8 27.4 11.7 12.9 4.9 32.4 49.1 6.9 37.6 33.4 16.4 38.7 7.5 4.1 0.0 167.4 185.6 0.0 127.1 133.1 35.0 38.6 0.0 4.4 0.0 28.3 271.6 0.0 39.5 0.0 0.5 34.9 1.7 0.1 13.6 21.3 0.1 68.4 0.0 0.8 111.7 16.0 26.2 3.5 41.1 5.3 0.3 0.1 0.8 86.9 18.1 0.4 0.0 0.2 2.6 2.5 0.0 0.0 6.1 2.4 0.0 0.2 5.7 24.6 0.0 28.3 1.0 6.0 4.2 34.4 91.5 14.5 72.9 0.5 91.6 11.1 1.3 99.3 0.0 13.1 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 12.3 12.5 13.7 17.5 12.6 20.0 15.9 12.7 10.4 14.9 14.5 12.9 16.4 31.6 9.6 2.2 8.1 2.6 49.8 16.7 9.4 9.1 1.2 7.3 30.1 37.1 0.0 1.4 7.3 0.0 1.0 7.5 0.4 11.7 1.0 7.0 2.1 63.8 15.6 0.0 0.0 1.4 5.1 1.2 77.7 0.0 1.5 1.3 2.7 16.4 39.0 6.9 0.0 1.7 2.3 2.0 4.4 28.4 21.1 50.4 3.4 28.4 7.5 0.8 34.8 4.1 2.5 7.6 2.5 0.0 41.8 3.5 6.0 0.1 19.1 0.6 1.3 6.6 21.6 49.2 14.1 3.7 3.1 26.0 2.3 3.7 8.5 0.4 11.7 PRKAR2B PRKAR2 ENSG00000005249 "Protein kinase cAMP-dependent type II regulatory subunit beta" P31323 7 107044705-107161811 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 137.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 110.2;Excitatory neurons: 146.3;Granulosa cells: 712.1;Theca cells: 271.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 70.7;Daudi: 99.8;K-562: 61.4;U-698: 254.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008421, HPA063879" Enhanced Uncertain Mitochondria NA NA 570000 Mitochondria "HPA008421: AB_1855421, HPA063879: " "unprognostic (3.18e-1)" "unprognostic (2.48e-2)" "prognostic favorable (6.38e-4)" "unprognostic (1.63e-2)" "unprognostic (3.33e-3)" "unprognostic (2.43e-3)" "unprognostic (2.76e-1)" "unprognostic (8.14e-3)" "unprognostic (1.70e-1)" "unprognostic (5.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.50e-1)" "unprognostic (5.12e-3)" "unprognostic (2.39e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (7.15e-2)" 137.0 45.3 11.0 4.9 14.5 14.3 51.7 8.1 16.4 7.8 8.0 10.6 3.6 7.0 4.5 11.3 7.1 4.9 12.8 14.5 12.8 5.9 2.5 7.7 3.8 9.4 12.9 13.3 26.6 8.7 6.6 11.5 15.2 9.8 9.3 6.9 7.6 10.0 4.5 1.5 3.2 11.6 5.2 9.0 16.9 9.1 13.8 10.1 2.6 3.5 6.2 4.1 20.5 6.3 12.5 0.1 1.5 9.1 70.7 36.8 0.0 0.1 3.6 11.5 3.0 2.7 0.0 0.2 99.8 0.8 2.3 8.6 0.1 7.1 0.0 5.5 2.8 7.9 33.3 0.1 0.0 10.3 0.6 4.5 0.5 0.0 0.3 0.0 3.1 42.9 5.4 61.4 2.9 0.1 7.5 14.0 0.4 17.3 0.0 2.8 4.0 0.2 0.0 0.1 0.1 11.6 16.7 5.4 1.2 3.9 22.9 2.1 7.0 24.4 3.5 9.2 0.0 7.1 2.1 0.1 254.8 2.5 17.5 33.9 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.6 11.0 14.5 8.1 16.4 14.5 12.8 9.4 12.9 13.3 9.8 9.0 10.1 12.5 39.6 3.2 1.5 9.8 1.9 2.4 1.6 2.1 0.6 33.5 27.9 10.5 35.9 12.8 5.1 7.3 10.4 0.1 3.7 1.7 0.0 2.5 7.9 1.8 16.2 17.4 0.0 110.2 146.3 0.0 0.6 17.5 3.6 0.9 4.5 712.1 19.2 0.0 1.6 5.0 71.9 1.9 4.1 19.6 26.4 8.5 29.8 64.1 17.8 15.9 17.0 6.4 3.1 60.8 10.9 0.1 2.1 53.0 2.0 3.5 0.0 0.8 5.4 11.9 19.7 5.4 57.7 2.5 6.5 0.7 2.4 0.0 3.7 271.7 2.7 4.6 MSL3 MSL3L1 ENSG00000005302 "MSL complex subunit 3" Q8N5Y2 X 11758159-11775772 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034535, HPA034536" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA034535: AB_10603878, HPA034536: AB_10670973" "unprognostic (2.58e-1)" "unprognostic (1.76e-3)" "unprognostic (1.04e-1)" "unprognostic (9.56e-2)" "unprognostic (5.36e-2)" "prognostic favorable (3.28e-4)" "prognostic unfavorable (4.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.48e-2)" "unprognostic (4.88e-3)" "unprognostic (2.13e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.14e-9)" "unprognostic (1.20e-1)" "unprognostic (2.06e-1)" "unprognostic (4.35e-1)" "prognostic favorable (2.17e-4)" 17.3 11.9 13.2 23.3 14.2 17.1 16.1 12.7 16.7 12.7 14.8 15.2 8.7 13.5 5.4 18.0 14.1 10.1 12.2 15.0 14.4 12.6 14.0 22.1 31.5 13.0 13.7 12.9 12.2 11.1 6.8 11.2 10.5 13.5 14.6 8.6 5.7 14.5 8.6 36.1 16.1 25.6 10.0 13.7 49.7 13.7 15.8 16.1 39.2 14.7 22.8 27.3 14.9 14.7 13.7 18.6 20.3 28.0 15.0 21.6 30.1 10.2 24.0 21.9 25.2 30.9 13.7 16.8 22.5 25.2 21.6 16.2 14.0 29.7 17.0 34.1 12.6 20.2 14.0 23.0 7.0 18.5 19.6 20.8 18.7 21.6 29.1 10.9 20.6 38.4 26.6 22.2 14.2 24.5 18.3 19.0 19.3 22.3 21.2 32.7 10.8 25.8 34.1 16.1 21.2 17.8 20.8 22.0 10.4 16.9 23.5 18.0 13.0 34.4 23.7 18.2 40.0 22.6 10.6 20.1 32.9 18.1 12.4 21.0 46.6 53.6 37.2 36.6 47.0 31.9 41.7 42.6 41.3 42.3 45.9 57.9 52.2 66.2 39.4 60.4 41.5 60.4 62.1 13.2 14.2 12.7 16.7 15.0 14.4 13.0 13.7 12.9 13.5 13.7 16.1 13.7 30.1 9.6 19.2 7.8 52.7 13.3 15.1 10.7 22.2 10.4 19.1 17.9 16.1 17.2 12.7 7.3 8.4 22.9 73.5 12.7 9.8 18.0 57.0 32.0 30.1 29.1 6.7 24.4 10.7 17.1 33.7 18.2 15.8 25.2 26.6 24.3 27.8 16.8 21.9 8.4 7.3 16.4 8.2 58.2 36.1 24.5 12.5 46.9 14.2 14.0 68.4 10.9 41.2 8.5 8.3 22.5 8.7 16.6 41.3 12.6 12.2 15.2 23.2 7.7 6.6 20.5 21.8 41.8 24.8 24.9 18.5 11.8 54.5 21.6 13.6 13.2 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880713 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Supported "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: AB_2682948" "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favorable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 17.5 10.7 5.7 17.2 5.1 53.3 17.0 23.8 11.6 21.1 4.4 16.5 12.6 26.7 12.5 16.6 22.6 16.7 14.6 5.8 1.7 12.2 14.5 16.0 17.8 10.1 6.4 2.3 37.6 29.9 18.6 11.4 17.0 9.8 16.3 14.2 13.9 17.3 16.3 29.9 20.9 16.5 19.8 0.3 21.2 16.4 33.5 5.7 29.4 23.5 29.2 20.9 16.8 16.7 7.5 12.3 31.0 39.3 17.4 23.5 23.1 20.4 17.4 28.9 29.2 28.2 28.2 22.4 33.7 20.1 33.3 18.7 23.2 45.7 14.2 32.9 57.5 18.5 26.6 29.2 17.9 26.0 26.9 36.5 20.7 14.2 32.5 38.9 18.0 22.3 17.0 30.9 44.8 16.0 42.0 17.9 13.0 32.3 11.7 12.7 83.4 31.1 26.1 11.2 16.2 32.6 21.5 29.5 28.7 16.8 25.3 25.6 25.9 34.7 35.5 35.2 18.4 16.0 20.8 24.3 63.7 7.2 15.8 25.6 1.9 1.1 0.9 1.7 1.5 0.8 3.7 0.8 1.3 0.7 2.1 0.8 1.1 6.7 1.4 2.9 1.5 0.8 0.9 5.7 5.1 23.8 11.6 5.8 1.7 10.1 6.4 2.3 9.8 0.3 5.7 7.5 48.1 44.8 51.6 91.1 38.3 56.2 31.0 16.0 27.3 34.2 34.4 25.7 41.2 40.0 28.0 11.0 25.0 17.4 50.1 31.2 5.9 20.9 43.0 37.2 56.4 35.7 15.0 33.4 88.7 20.3 11.3 39.5 32.1 63.5 30.4 53.1 32.5 29.5 20.9 28.6 89.8 25.3 18.3 44.0 42.8 80.2 56.5 49.0 17.8 87.1 52.5 34.5 43.3 111.6 101.2 27.5 19.5 51.1 35.6 39.8 25.2 10.9 28.2 17.6 46.0 75.8 44.9 35.1 42.2 34.6 58.8 30.8 44.2 36.2 24.6 44.2 TSPOAP1 "BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1" ENSG00000005379 "TSPO associated protein 1" O95153 17 58301228-58328795 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.0;Breast glandular cells: 7.1;Breast myoepithelial cells: 8.1;Collecting duct cells: 7.3;dendritic cells: 22.3;Endometrial ciliated cells: 9.3;Respiratory ciliated cells: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 127.5;HL-60: 52.6;NB-4: 52.6;REH: 99.9;THP-1: 33.0;U-266/70: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024662, HPA025244" Enhanced NA NA "HPA024662: AB_2066340, HPA025244: AB_1845509" "unprognostic (2.03e-2)" "unprognostic (5.32e-2)" "unprognostic (4.60e-2)" "unprognostic (2.23e-1)" "unprognostic (2.24e-1)" "unprognostic (8.23e-4)" "unprognostic (1.24e-1)" "unprognostic (3.03e-3)" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.15e-7)" "unprognostic (1.62e-1)" "unprognostic (7.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (3.82e-2)" "unprognostic (1.22e-2)" 7.7 28.8 70.2 5.6 65.1 40.9 18.6 43.3 92.7 42.9 42.9 28.3 4.0 38.8 6.5 11.0 63.1 5.9 17.1 69.1 48.3 28.8 16.8 18.2 10.9 47.8 46.6 70.1 66.5 33.5 14.5 70.4 1.7 51.1 49.5 3.6 18.0 28.0 16.4 9.0 11.5 19.3 6.4 36.1 25.5 26.6 3.7 53.8 13.3 45.3 3.2 5.0 25.2 22.8 58.8 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.8 0.0 2.8 2.6 0.5 0.0 0.4 0.0 0.0 0.1 127.5 1.1 0.7 1.7 0.0 0.2 52.6 5.1 0.0 0.6 0.0 0.0 12.5 0.0 17.8 2.0 9.3 0.0 0.0 18.1 52.6 0.8 0.0 0.1 99.9 0.0 13.7 0.3 0.1 7.2 4.9 0.2 0.2 0.0 0.1 0.2 33.0 0.0 0.0 1.1 0.2 0.1 36.4 7.2 9.5 0.1 1.6 0.0 0.2 0.0 0.0 1.7 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.3 70.2 65.1 43.3 92.7 69.1 48.3 47.8 46.6 70.1 51.1 36.1 53.8 58.8 0.6 9.6 9.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 7.1 8.1 0.0 0.0 4.3 7.3 0.0 0.0 22.3 0.0 1.9 0.9 0.0 9.3 3.1 0.2 0.0 0.0 0.0 0.2 0.7 1.0 0.0 3.7 1.3 4.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.8 8.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 4.0 0.1 0.0 0.0 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269855-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 61 "bone marrow: 4058.2" "Cell type enriched" "Detected in some" 30 "Erythroid cells: 87.4" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 94 "HL-60: 3517.4;NB-4: 4589.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 24000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.4 0.4 0.7 0.7 0.6 4058.2 0.3 0.6 1.1 0.0 0.2 0.1 0.0 0.2 1.1 0.1 0.2 0.3 0.9 0.7 0.6 0.2 1.8 8.4 1.7 0.8 0.8 0.5 0.1 0.1 0.0 1.6 1.4 0.7 0.2 0.2 0.4 66.9 0.1 1.1 4.4 0.2 0.3 0.7 21.9 0.1 0.4 0.6 11.0 0.3 0.3 0.2 0.5 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3517.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4589.9 0.0 0.0 0.0 5.3 3.2 0.6 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 4.0 0.0 0.0 6.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 7.5 0.7 0.6 0.6 1.1 0.7 0.6 0.8 0.8 0.5 0.7 0.7 0.6 0.8 0.0 0.0 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.9 0.0 0.5 0.1 0.0 0.1 0.0 87.4 0.3 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.7 0.3 0.9 0.0 0.2 0.0 0.0 1.2 0.0 1.3 0.0 2.9 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.3 0.1 0.0 0.1 0.6 0.0 0.0 0.0 PON1 "ESA, PON" ENSG00000005421 "Paraoxonase 1" P27169 7 95297676-95324532 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 103 "liver: 536.1" "Cell type enriched" "Detected in some" 23 "Hepatocytes: 440.0" "Cancer enriched" "Detected in some" 78 "liver cancer: 97.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001610 Approved "Secreted to blood" NA NA 96000000000 17000000000 "HPA001610: AB_1079656" "unprognostic (2.02e-2)" "unprognostic (2.41e-2)" "unprognostic (3.04e-1)" "unprognostic (3.54e-2)" "unprognostic (2.70e-1)" "prognostic favorable (7.24e-7)" "unprognostic (2.24e-1)" "unprognostic (1.95e-1)" "unprognostic (9.02e-3)" "unprognostic (1.76e-3)" "unprognostic (3.97e-2)" "unprognostic (6.74e-9)" "unprognostic (1.09e-3)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (5.54e-3)" 0.0 4.2 0.6 0.0 0.6 0.0 0.1 0.7 0.6 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.5 0.2 536.1 0.1 0.0 0.6 0.5 0.5 0.6 0.1 0.0 0.8 0.0 0.6 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.5 5.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.6 0.5 0.5 0.6 0.5 0.5 0.6 0.3 0.5 0.6 0.0 0.0 1.5 7.2 1.1 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.6 18.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.4 3.0 13.5 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.1 8.9 440.0 0.0 0.0 0.2 0.2 0.0 13.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.6 0.5 0.4 0.2 0.0 0.1 0.0 0.6 0.5 0.3 0.1 GCFC2 "C2orf3, DNABF, GCF, TCF9" ENSG00000005436 "GC-rich sequence DNA-binding factor 2" P16383 2 75652000-75710985 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077882 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA077882: AB_2686864" "unprognostic (1.98e-1)" "unprognostic (5.18e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (5.67e-3)" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.80e-2)" "unprognostic (4.21e-2)" "unprognostic (1.63e-1)" "unprognostic (5.71e-2)" "unprognostic (3.20e-2)" "unprognostic (8.37e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.07e-2)" 10.7 10.6 14.5 4.2 16.4 7.4 12.2 15.2 17.3 19.2 10.4 9.1 3.8 11.2 11.5 9.7 13.8 4.7 10.9 12.9 15.2 13.5 28.7 7.9 8.9 15.4 15.6 11.9 14.4 14.2 7.5 11.3 7.0 15.0 14.1 3.8 11.8 7.9 5.6 29.3 15.9 8.1 6.4 15.8 12.4 9.5 12.1 14.6 7.6 12.2 9.1 6.6 9.1 10.5 18.2 14.4 13.9 9.8 11.6 5.3 6.7 12.7 9.5 7.7 9.7 9.2 16.7 10.3 14.2 13.4 6.5 11.9 5.5 11.9 6.5 13.0 20.9 25.5 10.9 13.6 44.9 8.3 18.8 10.2 7.2 8.2 4.8 14.5 11.0 11.6 17.6 16.5 8.2 9.3 11.3 19.6 31.8 15.5 10.5 15.3 22.8 20.1 34.6 16.3 15.7 18.0 22.6 12.8 14.5 16.2 6.9 10.8 10.6 12.6 9.3 12.2 13.4 19.3 9.5 17.7 10.8 9.2 11.7 20.7 0.6 8.1 3.8 10.4 5.7 11.9 18.2 9.7 12.1 9.4 12.6 14.3 13.2 0.4 5.4 9.6 13.3 11.5 8.9 14.5 16.4 15.2 17.3 12.9 15.2 15.4 15.6 11.9 15.0 15.8 14.6 18.2 11.6 16.0 11.2 49.6 15.7 27.8 20.5 14.0 21.6 11.2 14.4 13.5 22.4 17.2 20.2 12.9 0.0 36.7 14.8 7.3 21.5 16.0 31.5 11.4 18.0 15.0 16.2 12.0 60.8 19.0 23.5 21.9 8.2 8.7 13.9 15.6 13.2 24.9 12.5 16.8 51.7 7.5 8.2 13.9 12.0 75.4 16.8 8.8 14.2 20.6 7.1 10.6 16.5 75.9 75.9 13.8 7.8 9.8 11.3 18.0 6.2 19.3 15.1 9.1 13.1 20.2 13.5 15.5 22.7 16.5 24.7 23.7 13.3 17.4 10.6 16.8 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 70.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 207.0;Late spermatids: 124.6;Respiratory ciliated cells: 395.9;Spermatocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 7.8 8.5 11.8 6.6 12.5 6.8 7.8 10.2 11.4 9.8 16.9 6.1 3.2 10.5 5.7 3.5 70.8 8.5 4.1 12.2 13.9 12.1 1.9 10.8 11.7 11.2 11.2 11.4 10.8 6.3 30.3 24.5 6.3 12.3 7.5 4.0 28.2 5.2 9.9 1.3 4.8 7.0 7.8 11.2 12.3 7.1 38.3 11.3 18.7 7.8 1.7 11.3 8.7 6.3 12.1 44.9 78.3 37.9 32.5 14.0 25.7 11.8 22.5 45.8 56.8 52.8 6.9 34.4 39.3 22.5 25.1 34.5 37.6 27.8 100.6 49.8 30.3 16.8 19.4 42.4 4.7 14.3 30.6 15.3 11.6 27.6 58.1 30.3 67.5 30.6 61.6 7.7 45.8 32.4 69.8 48.6 32.3 30.3 10.9 29.8 41.2 44.1 84.4 51.3 22.4 66.4 52.1 17.6 15.9 27.0 11.2 25.6 14.7 15.3 29.2 50.9 32.1 50.7 49.2 26.7 10.1 86.5 18.8 21.6 6.6 8.5 0.6 31.1 11.5 31.4 24.2 35.5 33.7 28.6 22.0 25.1 23.8 0.7 29.1 10.1 46.7 36.8 21.6 11.8 12.5 10.2 11.4 12.2 13.9 11.2 11.2 11.4 12.3 11.2 11.3 12.1 20.0 3.2 12.8 1.3 23.1 7.0 20.1 64.1 10.2 48.3 9.4 10.9 1.7 20.0 39.4 23.9 83.4 9.8 30.1 1.5 19.6 28.5 77.8 207.0 18.5 25.1 28.9 5.5 5.6 6.0 14.6 14.3 7.1 9.2 12.7 23.8 30.0 1.9 8.6 32.0 4.1 6.0 38.7 6.9 17.4 124.6 17.1 7.4 12.4 0.0 29.8 51.9 26.8 3.0 2.4 13.6 4.4 22.2 17.5 9.4 0.8 28.4 395.9 112.5 0.0 8.4 30.6 147.9 19.3 1.7 4.8 2.9 30.5 37.2 3.8 13.3 CROT COT ENSG00000005469 "Carnitine O-octanoyltransferase" Q9UKG9 7 87345664-87399794 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 136.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 71.7;RT4: 72.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019052, HPA019364, HPA019365" Enhanced Approved Vesicles NA NA Vesicles "HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174" "unprognostic (2.80e-2)" "unprognostic (6.47e-2)" "unprognostic (1.75e-1)" "unprognostic (4.56e-2)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (9.93e-3)" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (9.84e-2)" "unprognostic (3.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (3.52e-2)" "unprognostic (1.34e-1)" "unprognostic (7.60e-3)" "prognostic favorable (4.02e-4)" 5.1 10.6 5.3 6.3 6.3 3.2 16.3 6.4 6.3 8.9 7.9 12.8 32.2 7.9 18.7 19.5 10.8 14.2 6.7 5.9 7.2 17.0 35.3 6.6 6.3 5.0 5.4 6.2 8.7 6.7 18.8 6.1 19.2 5.2 21.3 11.2 35.7 9.4 27.8 11.4 24.8 23.8 8.7 5.4 5.4 6.8 3.3 5.5 7.6 40.9 9.6 8.5 25.4 19.1 6.0 15.3 10.9 13.5 4.7 12.6 11.5 9.9 15.7 14.8 9.4 10.1 6.0 7.9 6.4 13.6 13.6 18.9 18.9 2.3 21.2 13.5 9.1 9.5 13.9 7.8 7.6 8.1 8.8 8.3 9.4 71.7 7.6 6.0 12.1 13.7 10.4 0.7 9.0 25.2 15.0 11.2 8.8 3.0 5.5 16.4 5.0 18.6 1.1 12.3 72.1 2.2 10.5 19.2 22.3 10.6 9.2 14.2 3.1 7.2 22.0 9.5 29.8 15.2 13.6 21.0 8.8 14.8 0.1 13.3 2.0 1.3 3.4 6.6 1.7 8.7 2.0 6.7 5.5 1.9 1.9 5.3 5.9 0.8 13.0 6.2 2.2 6.2 2.8 5.3 6.3 6.4 6.3 5.9 7.2 5.0 5.4 6.2 5.2 5.4 5.5 6.0 8.6 22.4 10.0 18.9 5.1 16.8 56.4 45.0 65.4 16.9 17.5 12.7 14.9 14.3 35.0 53.3 45.9 136.5 9.0 21.0 9.8 7.6 28.7 9.5 9.3 7.2 7.3 4.8 26.3 8.7 7.9 12.0 11.2 12.1 7.6 9.5 5.3 29.7 13.6 15.2 11.1 15.8 16.2 6.3 4.8 63.1 15.8 5.9 19.6 7.5 6.3 25.9 22.6 15.6 16.1 11.1 9.9 13.9 4.8 20.1 53.7 19.9 24.1 79.7 6.6 10.0 10.1 2.4 4.8 29.6 15.3 49.0 9.6 8.7 15.1 48.4 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401696-87480435 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 124.2" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 256.1" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "memory B-cell: 4.4;naive B-cell: 8.1" "Lineage enriched" "Detected in many" 7 "B-cells: 8.1" "Group enriched" "Detected in some" 5 "SH-SY5Y: 12.9;WM-115: 25.7" "Low region specificity" "Detected in many" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: AB_2680745, HPA053288: AB_2682102" "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.7 7.5 1.0 2.5 0.7 0.9 0.5 0.7 1.0 0.3 0.5 0.9 0.4 0.2 0.6 0.6 0.2 0.8 6.7 0.9 0.7 0.6 124.2 0.2 5.9 0.9 0.8 0.7 0.4 0.1 0.0 0.2 0.2 1.1 0.5 1.2 0.4 0.6 0.4 7.5 1.4 2.2 0.3 0.7 5.1 0.6 1.0 0.8 0.7 0.5 4.8 5.2 1.2 0.5 0.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 12.9 0.0 0.6 2.6 0.5 0.2 0.6 0.0 0.2 1.7 0.1 0.0 0.0 0.0 3.2 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.2 8.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.7 0.7 1.0 0.9 0.7 0.9 0.8 0.7 1.1 0.7 0.8 0.9 1.3 0.0 0.5 0.3 22.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.0 0.0 1.8 0.0 1.1 0.1 0.2 0.0 0.1 0.6 0.2 0.2 1.0 0.0 0.4 0.6 0.0 0.3 2.0 0.0 0.2 0.0 0.0 3.3 256.1 0.5 38.7 1.8 0.0 0.0 5.0 1.2 0.4 0.0 1.0 10.6 3.7 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.4 0.3 0.0 0.5 0.7 0.0 0.2 0.0 0.6 1.2 1.2 0.2 0.0 0.4 0.1 0.7 0.0 0.2 0.0 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E (inactive)" Q8IZD2 7 105014190-105115019 "Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA042866: , HPA056125: AB_2683044" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 23.2 16.6 17.3 29.1 24.3 70.6 22.7 54.2 26.3 29.2 14.5 29.3 22.9 33.7 22.3 22.9 25.0 24.8 21.3 18.8 19.1 18.8 16.6 28.2 31.7 18.7 20.4 15.5 44.2 23.0 23.3 11.6 27.0 25.0 25.1 28.8 40.9 25.8 23.2 15.2 30.5 22.5 27.1 17.2 33.7 27.0 18.7 18.0 36.0 27.6 23.1 33.3 28.2 14.4 35.5 35.7 24.8 49.3 43.5 29.3 34.5 12.3 24.3 38.2 21.0 25.5 19.0 30.1 28.8 24.7 30.0 27.7 26.2 27.1 25.7 35.0 45.8 17.4 27.0 31.6 19.2 28.1 39.7 34.8 24.2 23.3 28.6 30.6 38.6 40.2 32.3 39.9 76.9 28.7 26.5 62.1 35.0 17.9 19.1 19.1 53.4 30.3 33.5 23.0 34.5 28.8 36.1 35.7 32.3 20.2 32.8 13.6 23.5 47.2 50.0 33.1 57.5 26.4 61.6 50.8 63.5 34.3 29.5 36.3 246.8 73.2 173.1 118.3 56.2 114.6 153.9 109.7 103.0 53.8 152.0 106.0 100.0 290.3 89.9 94.4 103.2 101.5 71.7 17.3 24.3 54.2 26.3 18.8 19.1 18.7 20.4 15.5 25.0 17.2 18.0 35.5 169.3 141.1 158.4 108.4 283.5 146.6 115.5 119.2 118.4 236.4 93.4 81.5 102.9 85.8 124.6 115.8 252.3 40.5 278.0 138.0 35.2 82.2 27.0 77.8 89.3 205.6 100.0 90.5 160.2 68.1 50.4 128.8 91.7 112.4 247.9 78.2 119.2 33.6 60.4 185.1 148.9 96.4 89.5 91.8 348.4 27.3 141.1 152.2 140.5 148.9 147.5 104.1 255.4 189.0 236.2 80.7 102.9 131.7 223.1 149.7 82.6 32.4 78.3 297.5 124.9 136.7 168.3 100.0 76.4 86.1 134.7 65.3 278.3 58.2 115.4 159.9 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 322.7" "Cell type enhanced" "Detected in all" "Late spermatids: 300.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 398.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavorable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favorable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 43.4 234.4 235.2 20.2 247.9 27.1 48.1 169.1 315.5 45.4 206.4 38.6 36.0 36.7 59.8 48.9 47.4 23.4 52.5 248.2 322.7 98.2 100.6 72.7 16.3 213.4 234.6 243.3 61.8 57.3 184.3 301.9 16.6 243.9 79.7 16.1 39.4 53.7 95.7 35.3 49.8 45.2 11.9 176.8 50.6 58.1 87.8 281.3 20.1 91.9 11.7 12.6 45.7 43.9 261.9 24.0 80.2 34.5 57.9 16.3 11.5 12.8 12.8 50.6 26.6 27.2 43.6 59.7 7.5 13.0 26.3 59.4 33.7 22.4 17.6 10.3 25.9 46.3 9.0 48.0 41.4 45.0 13.8 61.5 25.0 35.7 31.1 12.3 43.9 20.4 51.2 19.0 51.6 26.9 165.3 26.1 74.9 31.7 41.0 45.1 19.4 22.7 66.8 47.2 42.9 43.3 88.7 59.3 107.8 47.9 23.2 66.3 23.2 20.4 43.5 39.6 29.2 27.9 48.4 18.5 12.9 50.4 20.4 59.9 398.8 62.8 79.0 80.0 66.1 68.9 51.7 89.1 71.7 63.0 50.8 72.5 65.3 104.7 63.6 35.1 49.7 126.8 61.2 235.2 247.9 169.1 315.5 248.2 322.7 213.4 234.6 243.3 243.9 176.8 281.3 261.9 20.5 41.7 31.9 16.6 23.7 23.2 46.5 127.6 18.2 34.9 42.3 22.4 8.8 55.8 76.8 86.5 33.3 54.8 20.7 48.3 19.6 94.1 171.2 30.2 12.8 26.9 89.8 10.3 27.0 102.1 41.3 34.7 39.8 16.2 192.7 72.4 57.8 43.1 45.5 18.5 31.9 35.1 128.1 35.9 32.7 300.8 42.6 47.8 60.5 5.6 21.4 68.8 29.9 13.0 11.0 78.1 37.6 52.6 27.9 47.8 52.8 52.5 89.3 35.7 6.6 19.0 26.4 57.3 29.7 27.9 23.7 52.0 61.2 198.1 30.2 50.1 SOX8 ENSG00000005513 "SRY-box transcription factor 8" P57073 16 981770-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 131.5" "Group enriched" "Detected in some" 9 "Muller glia cells: 156.1;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 66.0" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 114.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm No NA Nucleoplasm "HPA041640: AB_10964357, HPA058665: AB_2683792" "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 0.9 0.5 60.2 0.9 88.1 0.1 1.7 68.7 65.1 1.2 27.7 2.5 0.1 0.4 0.1 0.4 0.6 0.5 3.2 54.4 64.3 0.4 0.2 0.3 2.1 81.0 82.7 46.7 0.3 1.0 0.1 1.2 0.4 89.0 1.2 0.6 15.0 8.4 0.4 0.8 4.8 1.8 0.2 67.3 1.0 0.9 2.5 73.4 0.4 0.6 0.6 2.4 1.4 1.6 131.5 0.0 0.6 2.2 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.4 5.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 3.3 1.8 0.2 0.0 114.7 4.5 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 0.4 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 60.2 88.1 68.7 65.1 54.4 64.3 81.0 82.7 46.7 89.0 67.3 73.4 131.5 1.5 0.0 0.0 10.1 0.2 0.4 0.5 0.0 0.0 1.8 8.7 10.4 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.5 0.0 0.0 0.6 2.6 0.0 0.0 4.6 0.2 0.1 1.9 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.3 0.5 3.4 0.3 1.8 3.7 0.6 156.1 0.0 64.3 66.0 0.1 0.3 1.9 0.5 1.9 0.0 0.0 0.0 8.0 0.0 9.9 0.9 0.0 3.9 0.4 1.0 0.0 0.9 0.1 0.9 0.3 IBTK "BTBD26, BTKI, DKFZP564B116" ENSG00000005700 "Inhibitor of Bruton tyrosine kinase" Q9P2D0 6 82169986-82247754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 190.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023826, HPA048438" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA023826: AB_1851378, HPA048438: AB_2680392" "unprognostic (3.13e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.72e-2)" "unprognostic (1.75e-2)" "unprognostic (2.48e-1)" "unprognostic (2.78e-1)" "unprognostic (5.93e-2)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (1.90e-2)" "unprognostic (8.81e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (7.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.27e-2)" "unprognostic (9.78e-2)" 7.3 14.4 2.6 8.2 3.2 3.8 8.0 3.2 2.5 9.0 2.8 8.7 8.5 8.0 4.8 8.4 7.7 6.1 10.0 1.9 2.8 10.4 22.4 7.1 6.7 2.8 3.4 1.7 8.9 11.1 12.4 4.8 6.3 3.1 7.8 10.5 8.5 8.9 7.4 21.6 4.0 8.5 7.4 3.3 6.6 11.6 4.0 3.0 7.3 10.4 21.1 7.2 8.7 6.0 3.6 8.3 17.0 12.2 10.3 14.4 19.8 5.5 19.3 21.1 15.5 16.6 9.0 9.6 16.4 11.9 22.8 20.5 8.8 9.8 10.8 18.5 22.5 7.3 17.6 8.8 14.1 20.2 20.7 10.3 17.1 17.6 14.8 36.8 14.5 15.7 11.4 16.4 10.0 16.7 12.7 7.2 6.7 5.5 13.0 9.1 10.2 25.7 6.5 23.2 18.9 8.2 9.0 13.0 16.1 10.3 10.8 15.1 12.5 12.6 9.0 6.7 11.3 15.6 10.3 17.1 7.5 9.9 13.4 11.9 1.3 1.2 1.0 1.8 1.1 2.4 1.6 1.8 1.6 1.9 1.0 1.7 1.6 0.0 1.0 2.3 1.4 2.7 0.8 2.6 3.2 3.2 2.5 1.9 2.8 2.8 3.4 1.7 3.1 3.3 3.0 3.6 26.1 41.7 47.6 46.4 33.5 13.6 42.8 19.4 15.4 55.6 27.4 19.0 64.9 40.0 41.2 38.6 54.2 23.9 25.9 62.2 15.6 37.5 4.2 37.4 28.1 27.3 38.9 37.4 102.6 51.6 16.4 34.1 117.8 57.0 36.8 38.1 21.8 77.0 26.7 52.2 97.9 49.3 6.1 33.4 26.1 4.1 25.7 36.1 23.2 44.0 43.6 32.7 25.7 80.9 190.0 52.1 55.5 21.1 68.2 53.4 31.1 28.3 42.1 39.2 26.3 42.0 29.1 21.2 22.9 41.1 11.6 9.4 29.8 67.0 41.9 64.4 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.24e-4)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.79e-7)" 8.3 10.1 13.6 6.6 13.6 10.9 13.9 14.6 15.9 11.7 13.5 10.8 9.5 8.6 15.7 9.2 8.6 7.1 7.1 13.8 14.3 10.8 13.2 8.8 11.4 15.3 14.3 12.9 6.8 13.2 6.2 10.3 6.4 15.5 13.8 12.2 14.3 10.4 6.2 11.9 8.3 12.5 7.6 13.2 16.7 10.4 4.9 14.4 17.3 10.3 9.6 11.1 10.4 9.3 14.8 15.8 18.6 32.0 38.2 9.9 11.8 37.7 16.7 14.1 16.4 22.6 19.4 24.3 26.7 11.1 10.8 24.2 21.1 34.5 20.0 24.6 14.2 28.4 18.3 15.6 19.1 12.5 32.3 28.7 14.7 17.9 13.4 21.7 12.1 21.7 35.0 32.8 17.3 17.9 12.7 37.6 25.1 66.4 18.4 19.1 35.8 20.4 14.2 27.4 38.3 47.8 49.5 18.5 21.2 15.9 27.8 10.7 29.0 17.2 9.1 14.2 11.6 14.0 14.9 25.5 43.8 7.7 23.6 13.8 2.4 11.6 14.7 15.4 13.0 20.0 18.8 19.0 19.5 17.3 17.8 17.9 20.3 1.8 18.7 11.6 14.5 28.4 11.3 13.6 13.6 14.6 15.9 13.8 14.3 15.3 14.3 12.9 15.5 13.2 14.4 14.8 13.8 16.0 21.9 15.0 16.6 12.1 16.9 18.6 14.2 15.3 9.7 12.8 18.3 11.5 20.8 7.3 10.4 9.7 17.3 9.0 9.8 25.1 3.3 10.3 18.7 12.7 20.4 12.0 19.8 18.9 10.5 12.0 23.4 13.3 6.3 33.9 8.2 7.5 10.9 18.5 24.3 14.0 14.2 12.3 8.4 0.8 5.9 8.8 7.2 6.5 9.8 17.9 15.5 20.1 27.9 25.3 13.5 5.7 16.9 13.6 10.0 12.5 15.6 13.7 0.0 12.6 12.3 12.3 9.6 12.4 6.8 4.0 15.9 15.2 15.8 17.5 MYCBP2 "FLJ10106, KIAA0916, PAM, PHR1" ENSG00000005810 "MYC binding protein 2" O75592 13 77044657-77327094 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 425.4;Inhibitory neurons: 471.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 110.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Cytosol" "HPA058807: AB_2732627" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 60.1 22.3 43.2 19.2 52.9 33.1 49.7 43.9 52.3 39.6 27.7 26.7 9.1 27.5 30.1 46.3 29.5 12.6 29.0 51.4 45.4 21.0 24.7 28.5 40.4 40.7 36.5 49.6 43.5 31.2 15.0 32.5 11.0 43.6 28.2 12.6 29.1 29.4 13.4 26.7 74.9 35.1 12.1 34.1 56.8 25.1 26.6 38.7 34.9 27.5 18.2 38.1 30.6 41.8 51.1 21.6 10.8 12.9 14.1 62.9 27.9 7.5 13.4 19.8 11.5 14.7 9.7 11.0 61.4 8.3 26.6 11.2 19.5 22.4 24.7 15.5 24.5 22.2 52.2 22.2 20.1 21.4 110.8 17.7 31.5 20.2 10.6 20.8 11.4 26.5 22.3 11.3 18.8 20.7 13.1 30.5 74.3 6.8 28.7 13.6 34.2 13.1 15.0 19.6 21.1 20.2 9.4 16.2 23.1 12.8 13.0 8.6 83.8 35.0 10.9 9.1 7.3 13.0 20.3 15.0 42.7 22.1 89.2 11.3 1.4 2.0 2.0 3.2 2.1 2.8 4.9 3.6 2.8 1.9 4.3 4.1 3.2 1.8 2.8 1.6 2.7 4.5 1.4 43.2 52.9 43.9 52.3 51.4 45.4 40.7 36.5 49.6 43.6 34.1 38.7 51.1 92.2 38.5 52.2 158.7 170.3 82.3 39.9 32.6 63.7 229.3 36.8 38.4 69.7 25.8 30.9 35.0 104.3 46.1 109.2 14.2 1.9 26.1 56.0 50.9 61.1 83.8 32.6 46.9 425.4 33.1 31.5 80.6 38.2 66.6 48.2 34.0 44.6 52.4 41.8 218.7 471.3 19.7 26.4 106.9 48.2 23.4 65.9 100.4 32.0 282.9 116.7 121.5 120.5 338.8 212.5 30.2 15.8 96.3 121.9 53.7 15.2 13.2 19.5 94.8 105.2 76.7 76.0 81.5 71.6 129.1 150.7 43.9 121.5 67.4 28.1 42.4 FBXL3 "FBL3, FBL3A, FBXL3A" ENSG00000005812 "F-box and leucine rich repeat protein 3" Q9UKT7 13 76992598-77027195 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053283, HPA065626" Enhanced "Nuclear bodies" NA NA "Nuclear bodies" "HPA053283: AB_2682100, HPA065626: AB_2685523" "unprognostic (3.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.55e-2)" "unprognostic (7.24e-2)" "unprognostic (9.92e-2)" "unprognostic (1.01e-1)" "unprognostic (2.75e-1)" "unprognostic (2.23e-1)" "unprognostic (5.12e-2)" "unprognostic (8.70e-2)" "unprognostic (2.81e-1)" "unprognostic (4.24e-2)" "unprognostic (1.10e-3)" "unprognostic (8.52e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (2.78e-1)" 46.1 25.2 20.5 24.2 22.8 69.7 43.0 26.0 26.3 32.0 16.3 27.7 24.2 31.7 23.3 28.2 27.6 24.4 25.4 19.2 20.9 38.1 31.7 30.0 33.0 19.9 20.1 18.6 45.0 21.0 30.0 9.8 32.8 20.4 30.2 25.3 21.3 23.1 26.5 30.3 30.8 25.2 28.0 21.5 31.5 22.4 30.3 19.5 36.5 48.5 38.2 31.6 25.6 23.3 30.6 43.4 11.1 21.4 14.8 50.7 50.1 17.0 48.6 39.6 28.3 36.0 16.0 30.1 27.9 31.6 43.1 17.1 31.9 21.4 26.1 40.4 55.7 56.8 36.2 32.9 14.3 33.6 46.7 26.9 42.5 34.2 22.6 31.0 33.1 37.7 15.3 14.0 20.8 34.0 15.8 33.7 25.0 8.2 37.0 20.1 27.3 24.3 17.0 30.2 22.7 25.2 20.5 31.0 30.0 28.4 14.5 16.6 51.1 46.7 27.1 17.8 18.6 23.9 26.5 32.9 25.6 46.9 33.1 30.0 8.0 1.9 4.6 2.1 2.9 2.9 2.6 3.8 2.2 1.9 2.8 4.5 3.1 5.2 2.1 3.1 2.0 5.1 1.4 20.5 22.8 26.0 26.3 19.2 20.9 19.9 20.1 18.6 20.4 21.5 19.5 30.6 35.9 44.8 22.2 31.6 48.9 67.3 38.0 17.0 50.1 25.1 36.5 21.6 21.6 12.8 15.4 22.0 10.4 33.0 42.4 54.8 41.1 17.9 41.2 26.8 29.0 38.3 23.9 50.7 30.4 18.8 41.7 42.8 17.3 34.7 28.5 20.4 32.2 28.5 23.3 37.0 29.8 23.9 22.4 36.1 41.5 24.6 74.6 33.3 42.7 37.5 36.5 45.4 20.6 33.7 58.1 19.1 25.7 74.9 33.6 40.2 38.3 29.2 19.9 24.3 59.2 46.1 52.7 52.5 58.9 40.9 56.1 28.5 44.9 22.7 23.1 38.5 ITGAL "CD11A, LFA-1" ENSG00000005844 "Integrin subunit alpha L" P20701 16 30472658-30523567 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction, Phagocytosis" "Integrin, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.1;lymphoid tissue: 65.5" "Cell type enhanced" "Detected in many" "dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 121.7" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "HMC-1: 608.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025011 Enhanced NA NA 1600000 "CAB025011: " "unprognostic (1.10e-2)" "unprognostic (4.26e-3)" "unprognostic (3.72e-3)" "prognostic favorable (5.63e-5)" "unprognostic (2.88e-1)" "prognostic favorable (3.34e-4)" "unprognostic (1.63e-1)" "unprognostic (5.69e-3)" "prognostic favorable (5.57e-4)" "unprognostic (3.37e-2)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (2.89e-1)" "unprognostic (3.05e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-2)" 4.2 1.4 0.5 37.0 0.5 37.1 2.3 0.4 1.0 2.4 1.2 5.5 6.0 2.4 1.0 2.5 3.0 7.1 1.4 0.3 2.2 2.6 10.7 22.2 62.9 1.4 1.2 0.2 1.3 1.1 0.5 1.2 3.0 1.0 2.5 8.7 0.0 5.3 1.4 0.9 1.4 19.8 3.7 1.2 65.5 8.7 1.0 1.3 55.7 3.5 0.9 46.8 7.0 2.3 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.1 0.0 1.1 608.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 134.3 0.0 0.0 43.3 3.5 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 26.0 0.0 0.0 0.0 0.0 0.0 36.6 12.5 0.0 0.1 3.8 0.0 5.3 24.4 17.0 56.6 48.0 27.7 4.8 21.4 42.7 22.3 1.7 9.4 29.7 14.3 24.2 121.7 6.0 15.6 43.6 0.5 0.5 0.4 1.0 0.3 2.2 1.4 1.2 0.2 1.0 1.2 1.3 3.1 1.2 6.4 10.5 0.7 19.1 0.8 0.3 0.0 0.0 0.4 1.2 1.0 1.9 0.0 1.9 1.8 0.0 0.2 118.6 0.3 0.0 0.1 0.5 4.1 0.6 2.3 0.0 4.8 3.6 0.0 0.6 1.4 1.1 0.9 5.1 0.1 5.3 4.9 19.3 0.0 2.8 0.2 0.0 30.0 3.4 0.7 0.0 31.5 1.8 15.9 36.8 0.1 152.4 0.5 1.6 0.0 0.0 0.0 46.6 0.1 0.9 0.3 6.7 0.9 0.0 1.2 0.7 0.2 0.2 0.1 0.3 0.7 84.9 0.1 0.0 0.2 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 218.3;tongue: 287.5" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 123.0;Proximal tubular cells: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 41.1 64.4 47.4 8.8 47.8 5.0 26.6 63.6 58.6 30.6 33.5 40.4 28.3 29.6 125.5 22.0 24.5 18.2 101.8 47.0 39.9 63.3 51.3 15.4 10.2 41.4 42.1 46.2 48.6 44.7 41.1 17.1 14.9 46.7 23.7 21.7 14.8 26.0 27.6 218.3 25.1 32.8 26.0 37.2 18.6 34.0 13.8 42.2 12.8 27.5 287.5 9.3 31.1 22.4 42.4 12.4 17.5 20.6 18.5 21.2 16.5 2.2 13.2 19.3 19.3 18.5 1.7 13.2 15.5 21.7 37.0 13.0 6.4 13.7 5.3 18.8 30.6 19.3 14.0 17.1 13.2 11.3 0.0 15.0 33.6 19.6 12.5 0.9 33.7 17.2 20.0 5.7 15.0 11.0 15.8 11.8 0.0 4.5 37.2 17.1 17.5 45.8 21.1 10.4 10.4 13.8 20.7 18.7 5.9 9.0 25.0 35.0 13.7 8.8 22.5 18.4 16.0 10.1 29.4 29.9 8.2 33.3 4.9 15.4 14.3 16.2 8.9 16.2 12.9 12.8 12.9 14.8 18.0 18.4 13.8 17.2 18.0 2.6 22.9 14.1 25.8 22.4 17.4 47.4 47.8 63.6 58.6 47.0 39.9 41.4 42.1 46.2 46.7 37.2 42.2 42.4 17.9 9.6 10.3 18.3 12.1 15.2 12.3 12.4 17.6 19.0 16.0 26.8 5.4 12.8 11.7 20.2 6.2 19.6 16.7 38.6 58.7 11.7 8.8 6.5 12.1 11.8 13.8 10.8 18.6 9.1 3.6 17.7 13.7 7.8 1.3 19.0 18.2 52.0 19.9 43.7 15.6 50.2 16.2 13.6 9.1 18.9 24.2 12.0 24.9 8.4 14.5 37.3 7.2 6.0 11.3 6.2 55.2 52.6 25.9 6.7 123.0 131.9 6.5 11.0 19.7 15.0 20.5 3.3 11.7 14.6 18.8 7.9 12.9 29.0 36.9 11.3 ITGA3 "CD49c, GAP-B3, MSK18, VCA-2, VLA3a" ENSG00000005884 "Integrin subunit alpha 3" P26006 17 50055968-50090481 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008572, CAB018594" Enhanced Supported "Plasma membrane" NA NA 170000 "Plasma membrane" "CAB018594: AB_668044, HPA008572: AB_2668094" "unprognostic (3.24e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (9.51e-2)" "unprognostic (3.46e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (8.28e-3)" "unprognostic (2.76e-3)" "unprognostic (1.26e-3)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.35e-2)" 16.8 30.0 4.8 10.0 5.4 0.4 17.5 5.7 6.1 13.5 5.8 25.7 30.6 21.5 11.8 24.3 24.7 18.1 13.2 4.4 9.1 68.4 2.2 66.4 3.0 6.5 6.2 5.3 12.9 16.0 17.8 21.2 26.9 8.7 19.7 15.7 4.4 19.6 15.9 9.1 31.1 26.9 15.7 4.0 11.2 24.7 2.1 6.8 5.9 43.8 4.1 6.3 47.2 17.3 7.4 181.8 234.9 1.4 7.5 4.3 17.5 37.3 83.4 177.9 123.1 93.2 5.3 276.2 0.4 507.9 59.5 400.4 126.8 2.2 647.2 73.9 22.9 3.5 0.1 56.8 1.6 105.1 0.3 5.0 21.6 313.5 123.2 540.7 572.8 91.6 9.1 0.1 2.6 236.0 52.9 0.7 0.5 5.5 81.2 141.0 0.4 12.1 13.7 562.0 311.1 9.7 3.9 89.8 12.2 205.0 56.2 21.1 2.4 200.8 541.8 169.4 5.6 329.5 8.1 14.2 5.9 920.8 1.9 570.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 5.4 5.7 6.1 4.4 9.1 6.5 6.2 5.3 8.7 4.0 6.8 7.4 8.5 54.5 30.1 3.6 3.4 57.4 63.5 63.5 48.3 18.0 17.1 32.0 5.3 27.1 26.2 77.3 25.0 2.8 1.3 91.2 0.0 111.9 0.5 26.4 3.1 14.7 14.5 0.0 24.3 105.1 3.2 5.3 47.4 20.7 3.8 3.4 8.9 0.3 1.1 3.3 20.0 25.1 16.2 1.2 8.2 0.6 1.8 2.0 17.8 8.4 4.3 3.1 2.1 3.0 0.8 245.6 26.7 4.1 4.5 72.6 69.6 4.4 21.7 16.2 13.1 5.6 23.4 0.5 1.6 17.0 23.2 1.8 3.8 0.9 44.7 104.2 ZFX ZNF926 ENSG00000005889 "Zinc finger protein X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463" "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 13.3 6.8 10.4 8.8 13.5 29.8 10.6 21.9 11.2 12.6 9.3 8.7 6.8 15.8 9.8 7.3 12.6 7.0 8.9 7.7 12.6 8.1 10.2 8.6 11.7 12.2 12.8 6.0 17.5 10.0 15.6 6.1 13.8 15.0 15.0 6.2 10.4 7.5 11.4 15.2 8.1 8.2 14.6 10.3 12.4 8.0 4.8 10.7 17.4 10.8 12.6 10.1 9.1 11.4 14.9 13.8 17.6 19.3 20.9 23.4 16.4 9.2 12.9 11.9 13.5 14.6 11.4 9.4 15.0 17.1 19.5 31.3 17.5 19.4 23.3 18.1 15.4 26.9 14.4 63.3 6.2 9.8 18.2 24.4 14.3 7.4 27.1 34.1 15.3 17.2 9.4 16.5 16.9 9.7 6.6 14.2 12.5 10.3 6.0 13.7 18.8 15.4 13.9 8.8 21.4 9.6 14.4 37.9 14.5 11.8 11.7 9.6 10.0 18.3 12.6 7.4 18.3 8.9 9.5 13.7 15.3 9.3 7.7 14.4 9.6 6.5 10.2 6.9 7.6 7.2 5.9 6.5 7.1 7.1 9.4 6.5 6.1 11.8 6.8 7.0 4.8 4.1 5.5 10.4 13.5 21.9 11.2 7.7 12.6 12.2 12.8 6.0 15.0 10.3 10.7 14.9 35.4 19.2 12.0 38.2 37.7 22.0 18.1 14.5 19.4 19.1 29.6 17.5 16.6 30.0 19.9 7.3 20.9 56.6 60.7 21.0 5.9 14.4 2.0 29.2 48.1 26.2 20.4 16.4 32.4 16.1 13.6 29.2 16.3 30.6 27.9 39.9 24.7 26.6 17.1 15.2 33.6 16.6 4.1 24.3 26.2 5.7 35.8 31.2 30.2 47.8 28.8 15.7 22.6 49.8 52.6 14.8 17.1 35.7 34.1 21.6 14.8 11.5 15.4 22.7 32.9 47.3 36.2 18.2 27.1 15.1 20.9 20.7 34.0 29.8 14.5 20.5 LAMP2 CD107b ENSG00000005893 "Lysosomal associated membrane protein 2" P13473 X 120426148-120469365 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 507.2;Syncytiotrophoblasts: 402.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 556.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 556.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005272, HPA029100" Supported Supported Vesicles NA NA 520000000 Vesicles "CAB005272: AB_647855, HPA029100: AB_10795022" "unprognostic (2.99e-3)" "unprognostic (5.26e-2)" "unprognostic (2.66e-3)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-2)" "unprognostic (4.84e-1)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (9.73e-2)" "unprognostic (1.11e-2)" "unprognostic (2.50e-2)" "unprognostic (2.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.66e-1)" "unprognostic (5.53e-3)" 51.0 69.3 95.6 38.6 153.1 63.4 56.9 125.1 128.2 58.5 72.1 37.0 44.7 44.7 55.6 80.0 44.5 70.2 39.6 98.9 118.5 86.3 131.0 54.7 34.3 129.6 132.9 82.4 49.5 58.3 64.7 32.5 48.3 132.4 62.7 35.3 32.9 102.9 55.6 112.6 67.8 42.7 43.2 119.1 39.8 52.3 26.5 121.2 59.8 62.3 68.0 36.9 43.8 63.8 230.2 53.8 47.5 40.1 49.7 367.0 140.9 91.5 79.3 130.4 77.1 134.4 42.7 90.3 47.9 73.1 132.7 236.2 84.9 56.7 67.2 125.5 43.6 37.2 35.8 46.4 54.3 148.1 158.9 73.2 151.5 114.8 108.1 75.1 188.6 107.5 32.5 42.1 122.9 117.2 79.3 45.3 80.2 29.0 63.7 42.6 35.1 65.3 73.1 102.3 36.9 14.0 22.6 99.7 93.0 196.5 57.4 64.7 173.0 122.5 114.1 58.7 176.2 261.5 68.5 78.6 30.2 131.4 182.4 284.4 30.6 114.9 224.1 27.1 97.1 20.6 17.1 24.3 24.5 64.2 22.5 23.4 21.8 556.6 31.8 96.2 33.4 33.4 66.3 95.6 153.1 125.1 128.2 98.9 118.5 129.6 132.9 82.4 132.4 119.1 121.2 230.2 75.7 73.7 53.8 52.2 29.8 100.9 92.5 262.7 64.9 17.6 74.0 58.3 37.3 173.0 155.3 66.2 14.6 163.7 44.3 52.1 39.2 217.7 3.3 103.4 74.1 69.9 36.6 14.1 32.4 70.6 128.3 113.7 38.7 168.1 17.7 46.7 87.8 176.8 208.0 18.5 40.7 32.6 134.3 133.1 80.4 8.6 113.7 135.5 131.6 33.7 132.7 116.3 50.4 57.3 507.2 62.5 54.4 109.9 66.6 100.8 97.5 154.7 75.6 11.5 39.5 176.8 61.7 6.4 13.7 78.8 136.2 402.4 34.5 71.0 34.8 92.9 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389649 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.7;epididymis: 10.8;lymphoid tissue: 11.3" "Cell type enhanced" "Detected in many" "Early spermatids: 16.1;Erythroid cells: 43.5;granulocytes: 17.8;Late spermatids: 24.8;Macrophages: 23.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "basophil: 64.5" "Lineage enriched" "Detected in single" 75 "granulocytes: 64.5" "Group enriched" "Detected in some" 14 "HEL: 404.6;HMC-1: 631.7" "Not detected" "Not detected" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" NA NA 90000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.6 0.2 3.2 0.2 3.1 16.7 0.4 3.6 4.8 1.4 3.2 0.3 0.0 0.9 10.8 0.3 1.5 0.8 0.9 3.1 3.1 0.7 0.6 5.1 0.2 3.2 3.0 3.0 1.5 0.1 1.3 1.9 1.1 3.2 0.6 0.2 1.6 0.1 0.8 0.6 0.1 0.3 0.2 2.8 11.3 0.3 2.9 3.0 0.1 3.1 1.1 0.1 0.2 0.7 3.3 0.5 0.7 2.2 0.3 0.1 0.3 18.4 0.3 0.1 0.8 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.6 1.8 0.0 0.4 0.4 1.1 404.6 0.3 1.3 0.0 0.2 631.7 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.7 1.1 0.0 0.7 0.5 36.4 0.8 0.0 0.7 0.7 0.2 0.0 0.0 0.1 0.4 1.0 0.5 0.5 0.1 1.5 4.5 0.9 0.3 0.2 0.7 0.0 0.0 0.4 0.2 0.3 0.4 0.3 0.8 64.5 0.3 4.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 4.5 0.0 0.0 0.8 0.0 19.3 3.2 3.1 3.6 4.8 3.1 3.1 3.2 3.0 3.0 3.2 2.8 3.0 3.3 0.3 0.0 1.5 1.0 0.4 0.3 0.4 0.1 1.8 5.1 0.2 1.1 1.5 1.5 1.3 5.5 8.4 1.3 0.1 0.6 0.0 0.0 16.1 1.0 0.7 2.1 0.0 43.5 4.1 0.0 1.4 1.1 0.0 3.2 17.8 0.1 3.6 0.0 0.2 3.3 2.8 0.0 0.0 3.1 0.7 24.8 1.8 23.0 0.0 1.0 2.9 1.3 0.0 9.5 4.6 0.1 0.0 1.9 0.1 0.3 0.0 0.0 0.0 3.0 0.0 1.8 0.7 3.4 7.4 0.5 0.0 0.7 0.6 0.1 0.3 0.3 ASB4 ASB-4 ENSG00000005981 "Ankyrin repeat and SOCS box containing 4" Q9Y574 7 95478444-95540233 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 47.5;skeletal muscle: 34.5" "Cell type enhanced" "Detected in some" "Astrocytes: 7.2;Cardiomyocytes: 3.2;Early spermatids: 2.3;Late spermatids: 2.0;Respiratory ciliated cells: 2.0" "Cancer enhanced" "Detected in some" "stomach cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.9;Hep G2: 7.9;SCLC-21H: 4.7" "Group enriched" "Detected in many" 4 "basal ganglia: 9.5;hypothalamus: 31.7" "Region enriched" "Detected in single" 10 "midbrain: 4.3" HPA055240 Uncertain NA NA "HPA055240: AB_2682753" "unprognostic (1.41e-1)" "unprognostic (3.67e-1)" "unprognostic (1.88e-2)" "unprognostic (2.66e-1)" "unprognostic (3.71e-1)" "unprognostic (2.85e-3)" "unprognostic (1.17e-1)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "unprognostic (2.92e-2)" "unprognostic (4.24e-1)" "unprognostic (9.13e-7)" "unprognostic (1.71e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-1)" "unprognostic (7.23e-2)" 0.1 47.5 1.8 0.2 2.4 0.6 0.4 2.4 2.1 0.1 1.2 0.1 0.3 0.1 0.2 0.3 0.3 0.2 1.9 1.9 1.8 0.2 1.5 0.6 0.3 3.2 3.4 1.5 0.2 0.7 0.0 8.4 2.1 2.8 0.2 0.1 1.3 0.6 0.2 34.5 0.3 0.5 0.1 1.9 0.3 0.6 0.3 2.4 0.2 0.3 10.6 0.1 0.0 0.0 2.9 0.2 4.9 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 7.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.7 0.1 0.1 0.0 0.1 0.1 4.7 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.4 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 2.4 2.4 2.1 1.9 1.8 3.2 3.4 1.5 2.8 1.9 2.4 2.9 0.1 0.0 0.5 7.2 0.0 0.1 0.1 0.5 0.0 0.0 0.4 0.1 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 2.0 0.6 0.0 0.0 1.0 0.0 0.0 1.0 1.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.7 0.1 0.9 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.1 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501693-19522123 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 270.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077420 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA077420: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favorable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 29.2 26.2 44.2 15.7 46.8 28.0 21.3 43.7 50.3 22.1 40.6 42.0 30.2 20.2 27.8 22.6 17.1 18.6 48.3 46.7 45.7 27.9 25.6 29.6 11.8 47.2 49.4 43.1 12.9 28.7 77.5 19.4 20.7 44.6 27.0 42.0 20.0 28.6 30.6 63.5 26.1 28.0 26.8 44.6 13.6 34.6 14.3 47.0 16.9 20.5 65.0 15.4 30.5 16.7 47.7 38.6 46.2 25.0 29.4 115.3 43.3 34.7 38.3 66.9 30.0 37.1 26.6 67.4 29.2 48.1 57.2 32.8 31.8 35.2 46.6 36.9 31.7 52.8 24.2 41.4 57.2 69.1 32.7 21.5 44.9 73.1 32.2 37.4 54.5 40.6 36.3 13.7 29.1 33.2 70.3 28.3 29.1 29.1 59.9 34.2 40.2 45.7 41.7 72.9 59.7 28.9 25.8 37.0 44.5 37.9 38.5 45.8 37.8 42.7 25.3 22.3 33.9 24.6 27.0 27.4 19.9 38.5 47.2 23.1 52.0 19.3 11.2 8.9 17.7 11.5 7.2 10.4 10.4 12.4 6.1 5.5 8.5 34.0 6.6 22.7 7.5 12.7 8.2 44.2 46.8 43.7 50.3 46.7 45.7 47.2 49.4 43.1 44.6 44.6 47.0 47.7 12.2 38.5 86.8 7.2 18.9 23.5 30.3 56.2 22.8 15.4 38.3 22.4 66.8 34.3 56.0 9.2 27.1 80.4 23.2 123.1 23.5 97.0 35.1 26.9 23.8 17.7 33.5 100.8 12.0 163.9 78.6 27.3 24.5 21.5 3.8 36.4 20.7 23.9 60.8 32.0 15.9 57.5 61.1 48.2 22.9 61.2 28.6 32.3 24.9 8.4 38.2 22.3 24.7 9.5 25.0 77.4 97.6 38.0 19.6 100.5 101.7 45.9 39.7 29.6 13.1 16.7 24.9 87.1 59.6 31.9 29.5 270.4 22.0 45.9 85.3 79.2 REX1BD "C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391" ENSG00000006015 "Required for excision 1-B domain containing" Q96EN9 19 18588685-18592337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 154.6;Extravillous trophoblasts: 147.6;Hofbauer cells: 258.2;Proximal tubular cells: 222.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 64.5;PC-3: 98.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043414 Approved Approved Vesicles NA NA Vesicles "HPA043414: AB_10797141" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (6.78e-3)" "unprognostic (1.22e-1)" "unprognostic (4.87e-3)" "unprognostic (2.52e-2)" "unprognostic (1.45e-1)" "unprognostic (4.60e-1)" "unprognostic (3.10e-1)" "unprognostic (5.50e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-2)" "unprognostic (4.02e-2)" "unprognostic (9.27e-2)" "unprognostic (1.48e-1)" "prognostic favorable (8.47e-4)" 42.5 41.0 20.4 5.0 18.5 8.2 41.7 16.5 45.5 39.4 8.3 37.4 6.8 40.0 0.5 31.9 34.3 1.9 73.7 19.3 19.3 48.5 64.0 34.2 2.4 21.3 18.0 20.3 39.2 53.3 4.3 32.6 3.6 19.8 40.3 1.0 0.6 34.1 6.2 107.3 40.7 34.1 2.4 16.2 48.0 39.3 10.9 21.6 3.9 27.8 9.3 2.2 39.4 38.4 24.9 18.2 20.6 2.0 3.8 2.6 3.1 64.5 19.2 3.0 4.2 4.9 3.8 21.8 18.7 58.4 3.2 1.7 12.9 0.9 4.6 1.1 19.5 47.1 12.1 7.5 9.8 3.7 11.7 28.7 5.2 5.2 2.2 1.1 1.8 5.4 8.4 16.8 6.8 2.2 26.3 19.9 18.6 29.3 9.5 98.5 21.4 5.5 47.2 7.4 15.0 9.5 34.6 9.1 10.8 25.0 0.8 5.2 7.5 18.5 2.4 18.8 25.5 10.7 52.3 17.3 12.7 18.0 18.9 9.7 100.5 150.9 152.5 148.6 140.1 153.1 126.4 151.4 134.5 146.9 91.6 135.4 128.6 89.4 101.3 132.4 125.8 134.6 143.6 20.4 18.5 16.5 45.5 19.3 19.3 21.3 18.0 20.3 19.8 16.2 21.6 24.9 126.2 28.9 41.2 0.0 38.7 0.0 0.0 0.0 0.0 0.0 100.0 136.5 0.0 0.0 21.1 77.3 0.0 127.7 84.0 0.0 154.6 72.9 0.0 52.1 67.8 39.7 0.0 0.0 0.0 116.7 147.6 53.3 0.0 63.7 41.6 122.5 0.0 0.0 258.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 58.4 0.0 0.0 0.0 0.0 74.7 0.0 0.0 25.9 0.0 0.0 222.4 19.7 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 66.5 50.9 93.6 0.0 0.0 CRLF1 "CISS, CISS1, CLF, CLF-1" ENSG00000006016 "Cytokine receptor like factor 1" O75462 19 18572220-18607741 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 61.3" "Cell type enhanced" "Detected in some" "Astrocytes: 15.3;Basal keratinocytes: 9.7;Fibroblasts: 16.0;Respiratory ciliated cells: 11.9;Skeletal myocytes: 19.9;Smooth muscle cells: 10.5" "Group enriched" "Detected in all" 4 "lung cancer: 27.4;thyroid cancer: 36.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "ASC diff: 1048.7;Hep G2: 458.8" "Region enriched" "Detected in many" 7 "hippocampal formation: 21.1" "Group enriched" "Detected in some" 6 "cerebellum: 2.3;spinal cord: 8.6" "HPA041493, HPA041793" Approved "Secreted in other tissues" NA NA "HPA041493: AB_10795637, HPA041793: AB_10804117" "unprognostic (1.97e-1)" "unprognostic (2.29e-1)" "unprognostic (2.34e-3)" "unprognostic (9.31e-3)" "unprognostic (1.58e-2)" "unprognostic (1.71e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (4.69e-2)" "unprognostic (3.34e-3)" "unprognostic (4.95e-2)" "unprognostic (7.92e-2)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.86e-2)" "unprognostic (5.27e-3)" 31.4 14.6 19.6 0.9 19.5 0.0 18.9 21.4 52.1 20.5 7.7 7.9 0.5 12.9 0.9 17.6 11.4 1.4 61.3 16.3 31.7 7.7 1.5 16.2 0.4 19.5 14.2 18.1 4.6 9.0 0.5 9.0 11.4 11.3 8.9 0.4 0.1 15.0 6.2 21.6 23.7 5.0 1.5 13.3 2.4 7.6 1.3 7.3 0.3 50.7 0.9 0.2 9.4 15.6 21.5 0.0 0.0 0.0 10.7 1048.7 15.3 5.2 5.4 0.0 0.0 0.0 0.1 0.0 0.0 66.5 33.2 1.9 0.4 10.8 0.2 0.0 0.0 1.4 0.0 18.1 458.8 7.5 0.1 0.5 12.0 1.0 0.2 0.3 1.6 0.3 0.0 0.1 0.2 0.3 16.6 0.0 0.0 1.2 0.1 0.3 0.0 9.1 0.1 0.0 0.5 0.0 0.1 14.2 0.0 0.0 2.0 13.0 0.6 1.3 0.1 11.1 0.8 0.4 0.1 0.0 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 19.5 21.4 52.1 16.3 31.7 19.5 14.2 18.1 11.3 13.3 7.3 21.5 0.4 0.0 0.0 15.3 0.3 9.7 0.6 6.8 0.0 0.2 0.7 4.2 2.5 0.0 2.6 0.0 0.0 0.1 0.3 0.1 5.9 0.3 6.9 2.6 1.9 0.5 0.0 0.0 7.8 0.2 1.3 16.0 0.5 0.5 0.0 0.2 0.4 0.1 0.3 0.0 1.0 0.0 2.0 0.0 1.0 0.4 0.0 0.4 0.0 0.0 0.1 0.9 1.0 0.5 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.3 11.9 1.3 0.0 19.9 10.5 0.2 2.2 0.6 4.5 0.3 0.6 0.2 0.1 0.3 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 29.5;Gastric mucus-secreting cells: 118.7;Paneth cells: 29.9;Proximal enterocytes: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083, HPA073967" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favorable (1.19e-5)" 4.7 3.7 10.3 5.0 10.1 7.3 5.5 9.1 14.1 11.1 7.2 15.5 22.5 8.7 1.6 3.5 7.7 5.3 6.2 10.0 9.6 9.8 2.2 8.6 7.5 10.6 9.9 10.1 9.7 17.4 2.6 10.2 2.3 10.5 14.5 8.8 3.1 9.1 6.2 20.4 1.7 22.9 3.5 8.9 17.3 34.3 1.4 10.0 5.0 11.4 3.6 3.8 9.2 7.1 10.3 6.0 6.9 3.0 3.4 3.3 4.6 2.5 2.2 3.2 3.7 4.2 7.1 17.8 6.0 8.7 3.2 1.3 43.2 1.7 4.8 1.2 20.8 2.4 4.4 15.0 4.8 3.0 9.4 0.1 7.4 0.9 2.4 1.7 11.5 7.7 10.5 4.4 8.1 5.8 7.8 9.5 10.0 1.8 23.8 8.9 8.6 4.7 8.3 5.0 4.5 3.1 7.0 3.7 1.2 3.3 3.7 6.4 5.9 8.9 5.6 4.9 0.0 1.8 14.6 5.8 5.8 6.1 7.9 2.2 0.0 0.6 0.6 1.8 0.4 0.8 1.0 0.7 1.1 0.6 0.4 0.5 0.8 0.3 0.4 0.0 1.0 0.9 0.9 10.3 10.1 9.1 14.1 10.0 9.6 10.6 9.9 10.1 10.5 8.9 10.0 10.3 5.5 0.0 3.9 10.4 4.5 0.1 1.1 2.5 1.2 6.1 2.9 2.5 2.7 1.5 7.4 3.7 6.2 0.2 15.4 29.5 0.0 2.7 0.1 2.1 2.7 4.3 6.0 3.2 7.3 14.7 0.1 2.0 118.7 1.7 2.5 7.1 5.3 0.5 2.7 11.8 6.3 25.8 4.1 3.4 0.8 0.3 2.8 2.3 1.8 1.0 2.7 7.1 8.2 3.5 9.3 9.3 29.9 2.6 11.4 1.7 34.5 1.2 3.4 8.2 0.0 2.5 1.9 0.0 0.3 1.3 0.1 0.5 10.0 3.3 17.6 1.3 TMEM98 DKFZP564K1964 ENSG00000006042 "Transmembrane protein 98" Q9Y2Y6 17 32927910-32945106 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 250.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "plasmacytoid DC: 4.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 4.1" "Cell line enhanced" "Detected in many" "CACO-2: 277.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040473, HPA053385" Uncertain Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA040473: AB_10794876, HPA053385: AB_2682134" "unprognostic (1.55e-2)" "unprognostic (5.15e-2)" "unprognostic (4.36e-3)" "unprognostic (7.20e-2)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.14e-4)" "prognostic favorable (7.10e-4)" "unprognostic (6.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.41e-1)" "unprognostic (9.18e-3)" "prognostic favorable (3.85e-4)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" 40.7 51.0 50.2 17.5 84.0 4.7 45.0 77.2 63.0 69.2 145.6 90.9 103.4 101.3 74.8 28.1 97.3 94.8 35.2 53.6 62.6 36.0 27.7 58.6 5.8 80.7 81.6 45.9 193.6 89.2 54.2 24.1 28.4 89.8 81.5 97.2 15.9 50.5 24.1 5.3 22.6 119.4 62.8 59.1 19.8 102.5 20.9 79.4 4.4 48.2 14.8 7.8 51.2 43.0 113.9 7.4 27.2 115.5 0.2 154.7 138.0 1.1 114.2 153.2 59.2 126.5 277.6 8.1 1.6 1.7 144.0 2.1 0.9 74.2 30.1 34.5 24.7 92.0 4.6 0.1 124.5 71.5 0.3 1.7 116.3 29.7 74.7 12.1 31.6 154.8 40.7 78.1 0.3 162.9 0.2 0.1 0.7 77.0 83.1 42.0 0.2 108.4 0.5 13.6 49.0 9.8 158.3 2.7 0.0 89.8 72.6 36.5 0.2 128.2 83.8 78.1 1.0 0.2 9.2 3.8 0.1 42.9 0.1 46.2 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.0 0.1 50.2 84.0 77.2 63.0 53.6 62.6 80.7 81.6 45.9 89.8 59.1 79.4 113.9 7.6 41.7 24.8 6.2 0.6 25.1 76.1 111.5 27.3 1.4 32.4 104.5 14.1 72.9 61.0 46.0 0.0 8.1 0.7 109.2 5.9 81.0 18.2 14.7 48.5 7.8 97.9 2.7 0.6 66.4 7.3 127.2 40.8 12.1 3.8 87.8 29.6 13.0 5.7 0.0 0.3 145.7 40.7 0.6 15.9 14.9 120.5 2.0 44.4 1.9 0.0 106.3 0.0 3.0 173.0 88.2 97.9 151.6 0.2 68.1 250.9 37.2 54.6 4.8 65.7 22.1 55.5 40.7 27.7 17.1 12.6 7.1 2.4 132.6 166.6 68.6 YBX2 "Contrin, CSDA3, MSY2" ENSG00000006047 "Y-box binding protein 2" Q9Y2T7 17 7288263-7294639 "Predicted intracellular proteins, Transcription factors" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 119 "testis: 555.4" "Group enriched" "Detected in some" 18 "Early spermatids: 346.9;Late spermatids: 427.3;Spermatocytes: 234.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.8;MCF7: 8.7;SH-SY5Y: 3.2;SK-BR-3: 3.9;T-47d: 12.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB012332, HPA053904, HPA056744" Enhanced NA NA "CAB012332: AB_776541, HPA053904: AB_2682302, HPA056744: AB_2683223" "unprognostic (1.76e-2)" "unprognostic (4.62e-3)" "unprognostic (3.99e-2)" "prognostic unfavorable (6.50e-5)" "unprognostic (9.80e-4)" "unprognostic (4.68e-2)" "unprognostic (2.23e-1)" "unprognostic (3.44e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" "unprognostic (2.20e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-4)" "unprognostic (1.78e-2)" "unprognostic (2.15e-1)" "unprognostic (5.31e-1)" "unprognostic (2.35e-2)" 2.9 0.1 0.3 0.1 0.4 0.2 3.2 0.2 1.1 2.2 0.0 4.6 1.0 1.3 0.0 2.1 2.3 0.0 1.3 0.6 0.2 1.1 1.9 0.1 0.0 0.8 0.3 0.2 0.3 0.3 0.3 0.5 0.0 0.5 1.4 0.4 0.0 1.2 0.8 2.0 1.4 4.0 0.5 0.2 0.1 1.2 555.4 0.6 0.0 1.1 0.1 0.0 1.0 1.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.8 2.3 0.0 2.4 0.0 0.0 0.4 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 8.7 0.3 0.4 1.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.2 1.3 3.9 0.3 2.0 12.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 1.1 0.6 0.2 0.8 0.3 0.2 0.5 0.2 0.6 0.6 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.0 0.2 2.8 3.3 4.4 0.0 0.3 1.8 0.0 0.2 0.5 18.0 0.0 0.1 346.9 0.7 0.1 0.7 4.8 0.0 0.5 0.2 0.4 0.4 0.0 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 8.2 0.0 0.0 0.0 427.3 6.8 0.7 3.6 0.0 0.0 0.8 0.0 0.0 0.1 0.0 9.9 6.8 0.0 0.3 10.0 0.4 0.3 0.5 0.0 0.4 1.2 234.3 12.0 1.8 0.9 0.1 0.1 0.1 15.2 1.1 KRT33A "Ha-3I, Krt1-3, KRTHA3A" ENSG00000006059 "Keratin 33A" O76009 17 41346092-41350828 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 27.7" "Group enriched" "Detected in some" 8 "Basal squamous epithelial cells: 1.8;Early spermatids: 2.2;Late spermatids: 2.1;Squamous epithelial cells: 4.5" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055194 Supported NA NA 160000000 "HPA055194: AB_2682733" "unprognostic (1.93e-1)" "unprognostic (1.30e-2)" "unprognostic (4.58e-2)" "unprognostic (4.34e-1)" "unprognostic (2.16e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 MAP3K14 "FTDCR1B, HS, HSNIK, NIK" ENSG00000006062 "Mitogen-activated protein kinase kinase kinase 14" Q99558 17 45263119-45317029 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 40.6;U-251 MG: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027269, HPA027270" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "HPA027269: AB_2732436, HPA027270: AB_2732437" "unprognostic (1.05e-2)" "prognostic favorable (5.27e-5)" "unprognostic (2.71e-2)" "unprognostic (9.42e-2)" "unprognostic (5.31e-2)" "unprognostic (2.61e-3)" "unprognostic (2.70e-2)" "unprognostic (1.72e-1)" "unprognostic (3.40e-1)" "unprognostic (3.45e-1)" "unprognostic (1.07e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.82e-2)" "unprognostic (3.49e-2)" "unprognostic (1.03e-2)" "unprognostic (2.28e-1)" 5.9 4.8 2.5 12.6 4.6 5.2 6.4 2.7 2.1 6.7 2.3 12.3 8.2 5.8 2.0 7.8 6.6 6.0 8.8 3.1 6.0 5.1 7.4 8.2 17.9 3.5 3.5 1.5 6.0 8.4 4.7 6.0 2.7 2.7 7.0 5.3 2.2 8.2 4.7 28.2 8.6 10.4 6.0 2.2 12.5 7.7 7.0 4.9 13.5 5.9 10.0 16.1 7.3 7.1 2.9 17.1 40.6 3.6 6.5 2.4 7.1 9.4 4.5 3.4 14.9 9.1 5.5 21.0 7.4 24.1 5.3 14.6 11.6 1.5 6.5 7.6 24.3 3.1 1.4 10.1 2.1 7.1 1.1 6.9 10.0 3.6 7.3 3.6 15.6 3.0 3.2 2.7 30.1 8.1 6.1 6.8 1.7 1.8 11.1 5.1 9.5 12.1 17.9 10.5 2.6 3.5 3.0 7.6 3.4 5.0 5.5 2.8 0.4 5.6 6.5 10.2 5.7 43.1 29.1 12.1 4.1 3.9 4.0 9.2 0.0 2.0 0.8 1.6 1.8 1.0 4.2 1.1 1.0 1.4 4.4 1.2 0.9 1.6 2.0 0.6 1.7 2.9 1.6 2.5 4.6 2.7 2.1 3.1 6.0 3.5 3.5 1.5 2.7 2.2 4.9 2.9 5.8 3.2 12.8 23.5 15.3 0.0 14.7 0.0 14.8 4.5 5.6 4.8 2.3 18.6 2.5 0.0 4.2 0.9 14.5 13.9 0.0 4.8 4.7 7.0 4.0 6.1 13.1 1.3 8.9 2.7 1.5 6.3 10.2 5.6 1.3 2.1 6.4 9.2 4.9 1.7 15.6 7.8 0.0 9.4 0.0 6.2 4.7 11.3 0.0 26.2 33.4 1.9 5.2 6.6 5.5 3.3 9.6 1.2 8.5 6.2 13.4 3.8 5.1 2.9 0.0 12.9 2.8 4.2 3.0 7.9 0.0 0.0 10.6 2.4 8.5 6.8 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "pancreas: 20.3;pituitary gland: 34.7" "Group enriched" "Detected in some" 4 "Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 0.3 2.8 2.6 0.0 4.0 0.0 1.8 4.3 5.8 2.6 0.2 0.7 0.5 2.6 1.4 0.1 0.6 0.0 1.6 3.7 2.4 0.5 0.1 5.0 0.0 3.9 2.6 3.7 0.4 20.3 0.2 34.7 0.4 4.0 2.1 0.3 2.2 0.0 1.5 1.6 0.2 1.0 0.2 1.0 0.1 6.1 0.4 1.8 0.0 3.4 0.6 0.0 0.4 1.3 4.1 0.0 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 4.0 4.3 5.8 3.7 2.4 3.9 2.6 3.7 4.0 1.0 1.8 4.1 0.3 0.0 0.0 19.6 0.3 0.0 0.1 0.0 0.0 39.0 5.3 3.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.5 17.9 0.3 22.0 0.0 48.2 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.3 0.1 0.0 39.3 0.7 0.0 0.3 0.5 0.0 0.0 0.1 0.0 3.7 0.0 1.9 0.0 39.2 7.6 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.0 0.7 2.0 0.1 0.8 0.0 0.1 0.0 0.1 2.6 0.1 0.2 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24256335-24362412 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 53.9;retina: 17.8" "Group enriched" "Detected in some" 24 "Excitatory neurons: 157.1;Horizontal cells: 176.7;Inhibitory neurons: 107.6" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077238 Enhanced NA NA "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.0 1.8 15.8 0.0 31.6 0.0 0.0 3.5 53.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 13.2 0.0 0.0 0.0 0.0 9.9 11.3 31.5 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 31.6 3.5 53.9 32.8 13.2 9.9 11.3 31.5 13.9 5.5 7.5 27.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 176.7 107.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 5.6 0.0 0.4 0.0 6.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924460-60937159 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 189.2;choroid plexus: 93.1" "Cell type enhanced" "Detected in many" "Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Supported Approved Mitochondria No No 4100000 Mitochondria "HPA051979: AB_2681681, HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favorable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 5.5 21.2 123.4 8.7 116.1 0.3 7.7 102.4 189.2 12.1 93.1 5.4 2.5 13.8 1.2 19.7 4.8 5.6 10.8 113.0 115.8 11.1 2.1 10.2 1.7 134.3 114.9 117.1 19.0 6.8 12.6 23.8 16.7 108.5 9.5 1.0 28.4 26.1 1.8 3.9 5.4 6.1 3.7 104.2 5.8 32.7 6.7 124.9 1.3 4.9 3.1 5.5 4.2 9.3 123.8 37.0 50.7 44.1 88.0 3.6 1.7 78.1 27.0 84.5 24.6 20.3 18.0 33.3 0.3 174.1 7.8 79.9 67.6 10.3 46.0 9.5 0.5 14.8 1.1 33.3 32.7 30.8 0.5 1.3 7.7 8.6 45.8 7.1 38.7 42.1 7.0 2.3 2.3 7.8 177.8 0.9 0.2 58.5 1.2 26.9 0.4 18.6 4.2 36.4 18.7 43.7 104.1 19.3 176.4 16.7 22.3 123.7 0.6 49.4 9.5 43.2 2.7 52.3 0.4 0.3 2.1 78.5 0.1 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 123.4 116.1 102.4 189.2 113.0 115.8 134.3 114.9 117.1 108.5 104.2 124.9 123.8 11.8 0.0 0.0 82.3 0.6 1.3 2.7 56.2 5.7 62.8 17.1 11.7 0.8 4.3 22.2 5.5 18.8 31.4 0.1 0.7 1.9 80.0 0.5 12.4 7.0 11.9 15.6 0.0 22.6 13.3 28.7 7.7 9.2 27.7 0.0 57.5 11.4 0.0 3.3 254.1 29.1 2.7 20.3 0.3 1.0 1.0 1.8 0.7 0.0 7.5 3.1 188.8 0.0 12.1 3.3 63.2 1.6 3.4 0.0 9.7 0.0 0.4 4.0 165.3 6.6 4.4 15.2 1.2 4.0 5.7 0.9 27.1 0.3 19.2 2.3 7.2 AP2B1 "ADTB2, CLAPB1" ENSG00000006125 "Adaptor related protein complex 2 subunit beta 1" P63010 17 35578046-35726413 "Cancer-related genes, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 503.9;Late spermatids: 739.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017631, HPA056733, HPA067983" Approved Supported Vesicles NA NA 380000 Vesicles "CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777" "unprognostic (1.49e-2)" "unprognostic (4.04e-3)" "unprognostic (2.15e-3)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (1.51e-3)" "unprognostic (2.64e-2)" "unprognostic (1.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.58e-2)" "unprognostic (2.50e-1)" "prognostic favorable (2.62e-4)" "unprognostic (1.70e-1)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-2)" 46.6 42.8 79.4 38.5 90.7 49.6 58.9 72.7 91.2 54.5 76.6 68.3 33.8 42.1 71.3 25.3 47.1 42.7 68.2 93.0 86.0 69.6 35.3 53.9 38.9 72.6 82.2 82.0 57.7 33.5 127.4 55.5 67.3 77.6 41.2 84.8 76.8 42.3 50.6 58.0 28.7 39.1 56.5 80.8 42.4 48.8 94.3 77.3 60.2 65.7 61.5 45.9 47.3 34.7 97.7 188.8 233.9 113.7 132.0 184.4 202.8 51.6 94.3 138.9 131.0 141.1 129.0 154.6 90.5 81.1 175.3 168.8 173.2 162.5 264.8 190.8 108.6 147.0 117.7 161.8 71.0 104.7 119.3 80.8 128.9 104.3 134.5 209.3 151.2 211.4 111.8 190.6 126.9 206.9 36.9 113.7 58.7 94.2 98.9 164.5 94.3 165.1 64.7 166.2 108.3 94.4 114.1 114.5 39.6 126.9 273.3 161.5 78.5 211.5 99.3 93.4 109.8 142.1 53.0 106.1 84.7 124.1 86.9 112.5 19.6 11.8 16.7 16.0 15.3 16.9 12.1 13.9 14.3 10.7 11.9 6.3 8.0 13.3 9.6 16.8 10.7 20.5 11.0 79.4 90.7 72.7 91.2 93.0 86.0 72.6 82.2 82.0 77.6 80.8 77.3 97.7 76.5 16.0 17.0 49.3 45.9 31.1 26.3 57.4 70.6 67.6 88.9 50.9 62.5 68.6 37.4 112.2 56.3 29.7 70.7 97.4 117.4 105.0 503.9 74.5 83.7 56.8 71.3 214.7 105.5 120.2 42.8 47.1 36.2 85.4 41.2 46.5 79.9 64.5 44.1 69.0 109.8 79.4 28.5 54.3 25.9 739.2 58.7 37.2 16.0 60.0 47.3 52.6 74.2 81.4 89.0 177.9 46.6 68.4 32.1 37.4 39.4 102.5 30.4 40.9 59.2 25.3 37.6 258.8 60.0 19.6 14.6 32.8 49.2 37.3 89.8 29.1 TAC1 "NKNA, NPK, TAC2" ENSG00000006128 "Tachykinin precursor 1" P20366 7 97732084-97740472 "Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.9;lymphoid tissue: 46.5" "Cell type enriched" "Detected in some" 7 "Inhibitory neurons: 99.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-266/70: 22.8" "Region enhanced" "Detected in all" "basal ganglia: 560.0" "Region enriched" "Detected in all" 10 "basal ganglia: 388.8" HPA014429 Enhanced "Secreted to blood" NA NA "HPA014429: AB_1857722" "unprognostic (9.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (2.08e-1)" "unprognostic (7.95e-2)" "unprognostic (3.24e-1)" "unprognostic (1.70e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (3.86e-2)" 2.1 8.6 11.2 11.0 27.1 0.0 2.1 4.2 14.2 0.4 4.0 7.6 8.3 0.8 1.6 0.1 1.0 6.7 0.9 8.5 58.9 3.7 0.3 0.5 0.0 56.3 39.7 10.5 0.2 0.6 0.5 1.6 0.0 24.1 1.3 3.6 3.5 6.8 2.2 0.3 1.2 10.4 7.6 13.3 46.5 3.0 0.4 37.2 0.2 7.5 0.0 0.0 1.5 0.8 11.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 27.1 4.2 14.2 8.5 58.9 56.3 39.7 10.5 24.1 13.3 37.2 11.3 0.1 0.0 0.0 2.9 0.5 0.4 0.1 0.0 0.0 0.0 0.4 0.6 0.3 7.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 13.2 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.0 99.4 5.4 0.0 0.0 0.4 0.1 0.3 0.1 0.0 1.9 0.0 0.0 0.0 1.5 3.4 0.5 0.0 0.0 0.0 4.2 0.3 9.1 0.0 0.0 0.0 1.1 1.3 0.2 2.1 0.0 0.1 0.0 0.4 0.0 0.5 0.9 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 20.5 18.5 18.2 17.0 18.2 19.3 24.4 21.2 23.3 19.4 19.9 19.4 14.7 23.1 23.4 15.5 24.7 16.9 15.1 19.6 18.1 17.1 17.8 19.6 22.8 20.9 18.4 17.5 29.5 21.7 31.0 23.6 20.5 18.6 21.6 17.2 24.8 20.3 20.4 17.4 24.0 19.5 18.8 17.9 23.4 22.1 18.2 20.6 22.5 20.2 13.8 21.6 19.7 17.7 21.0 19.7 25.1 27.6 40.8 22.7 28.8 36.6 26.1 38.6 30.0 32.2 27.5 30.3 74.2 26.5 33.6 28.6 25.7 38.6 26.4 29.9 41.6 41.3 31.4 35.6 25.6 25.7 48.8 38.5 34.0 53.3 27.6 40.0 33.5 26.2 44.5 37.9 47.4 24.8 25.5 43.9 37.2 55.7 23.2 19.2 70.4 29.8 57.6 20.7 18.4 40.6 43.8 27.9 30.0 30.9 32.5 32.8 57.7 30.1 31.4 30.9 23.3 25.4 50.8 60.8 88.0 12.9 23.6 23.8 1.4 2.5 6.4 3.5 2.4 4.0 2.5 4.2 4.7 3.5 4.4 5.4 3.8 3.0 4.5 3.4 2.9 3.1 1.9 18.2 18.2 21.2 23.3 19.6 18.1 20.9 18.4 17.5 18.6 17.9 20.6 21.0 15.9 0.0 11.5 8.8 16.6 17.5 17.1 3.7 16.5 12.5 13.9 12.8 4.6 15.7 5.0 1.8 0.0 11.5 16.1 8.7 7.9 10.2 60.9 10.5 8.8 12.8 13.2 6.3 7.9 10.0 11.1 11.9 11.2 13.5 7.0 14.3 10.0 7.1 9.1 3.3 6.7 12.1 10.2 9.4 14.3 35.1 8.1 9.5 16.0 7.5 8.4 9.8 19.6 8.0 7.8 10.3 6.0 7.9 11.8 16.3 7.5 6.3 5.7 9.0 13.1 17.5 17.3 13.0 11.1 14.3 20.6 11.1 15.0 15.2 12.3 13.6 CX3CL1 "ABCD-3, C3Xkine, CXC3, CXC3C, NTN, SCYD1" ENSG00000006210 "C-X3-C motif chemokine ligand 1" P78423 16 57372477-57385044 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Chemotaxis, Host-virus interaction, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 105.7" "Cell type enhanced" "Detected in many" "Adipocytes: 115.4;Basal prostatic cells: 50.8;Basal respiratory cells: 51.8;Breast glandular cells: 62.3;Breast myoepithelial cells: 51.1;Club cells: 54.8;Endothelial cells: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "EFO-21: 30.1;HDLM-2: 86.0;Hep G2: 63.8;RPTEC TERT1: 36.5;SK-BR-3: 21.5" "Low region specificity" "Detected in all" "CAB026192, HPA040361" Approved Supported "Plasma membrane" "Secreted to blood" NA NA 1870000 370000 "Plasma membrane" "CAB026192: , HPA040361: AB_10796453" "unprognostic (6.89e-3)" "prognostic favorable (9.46e-4)" "unprognostic (1.52e-2)" "unprognostic (3.20e-2)" "unprognostic (1.73e-1)" "unprognostic (1.82e-1)" "unprognostic (7.12e-2)" "unprognostic (2.08e-3)" "unprognostic (4.49e-2)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-2)" "prognostic favorable (8.52e-7)" "unprognostic (5.19e-2)" "unprognostic (2.72e-1)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" 58.6 4.8 32.6 5.8 38.5 0.1 105.7 11.6 44.2 17.1 17.8 12.8 5.2 13.9 8.8 14.5 18.3 21.2 33.0 47.2 28.1 34.2 15.0 99.7 8.6 24.2 22.7 40.3 8.3 13.2 7.2 11.3 3.9 27.7 42.5 5.4 4.4 71.4 45.7 15.1 22.4 12.9 10.7 15.7 1.4 14.6 5.7 30.3 5.2 29.9 19.4 6.3 33.3 17.5 30.6 0.0 0.8 8.0 6.8 0.3 0.1 2.0 0.1 0.0 0.0 0.1 3.1 0.0 0.0 30.1 0.1 4.3 0.3 0.0 0.1 0.0 86.0 0.4 0.0 0.0 63.8 0.9 0.0 0.1 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 2.8 0.1 0.0 0.1 1.1 0.2 36.5 0.2 0.2 7.1 0.0 21.5 1.9 5.1 0.1 0.2 0.1 0.3 4.7 0.2 2.1 0.1 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 32.6 38.5 11.6 44.2 47.2 28.1 24.2 22.7 40.3 27.7 15.7 30.3 30.6 115.4 3.2 4.6 3.3 1.2 4.5 50.8 51.8 31.9 9.8 62.3 51.1 8.3 21.5 54.8 3.7 4.2 0.0 0.8 0.5 0.0 35.1 0.4 12.9 3.3 50.7 1.8 0.0 28.1 1.8 0.1 9.0 0.5 27.3 1.3 0.2 6.1 11.7 0.0 5.0 20.5 0.3 20.3 0.8 4.7 0.5 4.7 0.6 0.0 16.9 0.6 0.8 0.0 13.0 3.2 4.3 0.6 27.8 0.0 29.7 0.2 11.8 28.8 2.2 13.1 2.8 15.7 0.1 0.1 10.3 2.6 0.3 0.8 0.3 1.0 32.6 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 118.5" "Group enriched" "Detected in all" 15 "Early spermatids: 594.1;Late spermatids: 1543.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 60.1;MCF7: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favorable (9.69e-5)" 10.0 37.1 22.7 7.2 20.8 4.4 10.6 21.7 33.5 15.7 24.7 14.8 10.1 18.1 9.8 10.2 13.8 13.0 33.6 20.3 23.4 18.5 17.8 8.9 6.4 23.1 24.5 21.1 21.3 22.1 17.1 11.8 6.4 22.5 17.3 6.5 3.2 17.9 11.3 18.7 8.7 10.9 8.4 21.0 14.3 22.2 118.5 26.4 2.3 22.7 18.6 3.8 14.8 10.4 22.1 8.8 39.4 4.8 25.7 7.9 22.7 6.0 14.9 24.2 9.2 7.3 29.1 12.9 9.2 38.4 13.9 8.9 7.0 1.4 6.3 4.2 14.4 5.3 7.4 9.5 60.1 27.8 2.4 17.1 33.3 8.8 4.7 13.0 17.9 11.6 2.4 0.7 16.8 5.5 59.3 0.0 2.1 3.1 19.0 18.0 4.4 6.9 2.9 35.4 39.5 4.5 11.3 13.0 12.1 17.0 5.6 21.0 1.1 19.7 9.8 22.2 5.6 3.7 31.8 14.0 0.2 14.9 1.4 6.9 0.0 5.0 1.0 1.6 4.5 1.9 2.8 1.2 1.1 8.3 1.7 1.5 1.7 0.2 7.3 3.4 1.6 0.8 3.7 22.7 20.8 21.7 33.5 20.3 23.4 23.1 24.5 21.1 22.5 21.0 26.4 22.1 12.6 6.4 5.0 17.3 14.0 10.7 15.1 13.4 25.6 5.3 13.3 17.4 32.5 20.0 13.1 23.9 4.2 17.3 9.8 32.6 27.4 35.6 594.1 13.0 13.2 11.7 37.9 6.1 10.3 39.0 10.3 23.5 66.8 23.2 17.7 38.5 10.8 26.7 34.6 11.8 9.5 28.4 16.2 23.6 14.8 1543.1 38.2 20.0 21.4 6.5 19.3 26.9 12.3 8.5 2.3 23.7 31.1 38.0 17.9 12.2 18.4 38.8 5.9 2.4 6.6 18.1 19.1 10.0 13.8 11.9 8.8 9.9 11.2 39.9 23.8 17.1 CACNA1G "Cav3.1, NBR13" ENSG00000006283 "Calcium voltage-gated channel subunit alpha1 G" O43497 17 50560715-50627474 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.3" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 176.7" "Cancer enhanced" "Detected in some" "glioma: 1.6;testis cancer: 1.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.2;GAMG: 3.2;HeLa: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004714 Uncertain NA NA "HPA004714: AB_1078368" "unprognostic (1.90e-2)" "unprognostic (5.83e-2)" "unprognostic (2.85e-2)" "unprognostic (1.08e-1)" "unprognostic (4.00e-1)" "unprognostic (9.89e-2)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.02e-4)" "unprognostic (1.47e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (4.87e-12)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.56e-3)" "unprognostic (6.63e-2)" 0.8 0.2 7.2 0.2 5.6 0.3 1.0 18.9 8.9 9.3 0.0 0.3 0.2 2.9 0.1 0.4 3.5 0.2 1.9 2.8 8.2 0.0 0.0 0.3 0.3 4.4 19.3 2.7 5.4 0.1 0.0 0.2 0.4 6.2 1.1 0.1 8.9 0.3 0.4 0.1 1.4 0.1 0.7 6.1 0.1 0.2 0.6 38.3 0.1 0.3 0.1 0.2 0.1 3.8 6.6 0.0 9.2 2.1 2.4 0.6 0.1 0.1 0.1 0.0 0.0 0.1 1.8 0.2 0.0 0.6 0.1 3.2 0.3 1.1 0.0 0.2 1.1 0.4 0.6 3.2 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.7 0.5 0.4 1.0 0.8 0.0 0.0 0.1 2.7 1.1 1.8 0.1 0.0 1.5 0.0 0.1 0.2 0.8 2.5 0.3 0.1 0.6 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 5.6 18.9 8.9 2.8 8.2 4.4 19.3 2.7 6.2 6.1 38.3 6.6 0.2 0.0 0.0 0.3 0.0 1.9 0.2 0.0 0.6 176.7 0.3 0.5 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.6 0.6 11.2 0.6 0.0 0.0 16.0 0.0 0.6 4.5 0.0 0.6 0.0 0.1 0.0 0.0 0.4 5.0 21.5 0.0 0.0 0.0 5.7 0.2 0.0 0.9 3.6 1.0 0.0 2.3 0.0 22.6 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 5.9 0.0 0.3 3.7 0.7 0.9 0.8 2.8 0.1 0.3 0.0 0.1 0.1 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 612.4;Basal prostatic cells: 1315.6;Basal respiratory cells: 622.2;Ductal cells: 938.2;Exocrine glandular cells: 698.4;Pancreatic endocrine cells: 1232.3;Prostatic glandular cells: 757.9;Urothelial cells: 695.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 139.6;neutrophil: 102.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 139.6" "Cell line enhanced" "Detected in many" "U-251 MG: 699.6" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 370000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 28.0 46.3 7.1 27.3 5.7 8.4 24.6 6.7 11.4 12.6 11.2 24.1 37.8 35.1 1.2 17.7 19.1 55.7 95.2 6.1 29.9 88.1 61.5 73.2 2.4 8.7 8.0 4.9 8.3 117.3 56.5 59.8 33.2 7.8 33.7 4.5 4.9 48.8 17.3 59.0 17.2 21.8 32.8 9.3 6.7 43.0 5.4 9.7 5.2 37.3 9.4 3.2 74.5 14.0 8.9 217.6 155.6 17.7 31.9 31.0 71.3 109.1 444.3 277.5 316.2 205.5 70.1 336.0 1.5 566.2 270.4 401.3 224.2 4.2 283.4 132.2 8.3 11.2 1.5 52.4 58.4 205.1 3.7 15.2 65.2 196.7 345.1 433.5 298.1 100.9 0.6 24.5 2.4 362.7 394.0 0.6 28.3 85.5 88.7 369.6 1.9 207.1 7.8 355.8 37.6 19.9 7.3 314.7 127.9 255.8 57.7 69.4 5.8 192.2 601.9 303.2 423.8 699.6 6.6 2.9 3.1 190.0 18.9 488.8 12.2 11.4 139.6 6.1 7.3 7.9 0.2 2.8 4.9 14.6 0.2 1.4 2.7 102.9 8.0 4.7 0.6 3.4 4.0 7.1 5.7 6.7 11.4 6.1 29.9 8.7 8.0 4.9 7.8 9.3 9.7 8.9 16.9 102.5 37.7 0.3 6.9 612.4 1315.6 622.2 113.3 1.5 139.0 46.7 63.9 195.9 238.7 182.1 2.1 134.6 10.0 74.2 64.6 938.2 1.3 170.5 29.4 47.5 27.3 1.3 0.2 698.4 169.5 155.1 33.1 173.1 59.1 3.0 24.3 20.7 39.7 0.0 0.5 19.9 152.5 5.6 121.4 0.8 6.2 23.0 112.1 1.9 10.8 23.3 4.1 0.0 0.1 1232.3 155.3 6.8 5.3 757.9 52.9 118.0 118.4 5.9 6.6 190.5 228.6 10.9 9.4 35.5 359.7 189.1 25.3 1.3 50.0 695.6 DLX6 ENSG00000006377 "Distal-less homeobox 6" P56179 7 97005553-97011040 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;testis: 5.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4" "Cancer enriched" "Detected in many" 8 "endometrial cancer: 12.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory bulb: 27.0" "HPA030608, HPA061460" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA030608: AB_10600867, HPA061460: AB_2684529" "unprognostic (7.50e-2)" "unprognostic (1.91e-1)" "unprognostic (5.19e-2)" "unprognostic (8.06e-2)" "unprognostic (8.16e-2)" "unprognostic (3.05e-1)" "unprognostic (4.32e-2)" "unprognostic (2.51e-1)" "unprognostic (2.86e-1)" "unprognostic (6.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.12e-7)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (5.58e-2)" "unprognostic (8.12e-2)" 0.3 0.0 2.5 0.0 6.1 0.3 0.1 0.0 3.6 2.0 0.0 0.2 0.0 2.6 0.8 0.0 0.4 0.0 0.1 0.8 3.9 0.0 0.0 0.0 0.3 2.0 0.0 1.6 0.2 0.0 0.0 0.1 3.0 2.2 0.3 0.0 0.0 1.1 0.9 0.1 1.3 0.0 0.2 0.0 0.1 0.0 5.5 1.9 0.3 0.4 0.1 0.2 0.4 0.2 0.3 0.0 0.0 0.0 10.1 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 1.9 15.3 0.0 0.0 0.0 3.9 0.0 5.9 7.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 2.6 1.6 0.0 0.0 0.0 0.0 2.2 7.3 11.0 1.0 0.0 0.3 19.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.9 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 6.1 0.0 3.6 0.8 3.9 2.0 0.0 1.6 2.2 0.0 1.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 32.9 0.1 0.0 0.0 0.0 22.6 37.3 2.2 0.2 0.0 0.0 0.0 0.0 70.4 0.2 0.0 27.5 0.0 0.0 0.0 0.0 3.3 0.0 8.0 0.0 0.0 0.0 0.0 3.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.8 6.8 10.2 0.0 0.0 17.4 0.3 0.0 0.0 0.1 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;retina: 9.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.6;Inhibitory neurons: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.1 1.0 1.9 1.1 4.3 0.7 1.3 10.5 22.3 0.6 0.2 1.5 1.5 0.4 1.5 5.2 1.0 0.4 0.5 4.0 2.8 1.4 0.7 1.9 1.4 7.6 3.3 4.9 0.6 2.2 2.7 1.1 0.6 10.3 0.9 1.5 9.7 1.7 0.5 0.9 4.0 1.4 0.2 0.1 1.0 1.6 5.5 8.3 0.9 2.7 0.5 3.6 0.8 1.8 13.6 22.3 10.5 2.0 2.5 0.0 0.0 6.7 0.5 0.3 2.1 1.9 7.8 8.6 4.5 2.8 0.1 4.7 10.3 6.5 12.8 2.2 3.0 1.7 0.2 4.1 5.2 0.3 0.5 0.9 0.1 6.5 1.5 12.7 3.7 0.0 4.1 1.7 1.0 0.5 9.4 3.7 0.5 4.2 9.0 4.5 1.3 3.9 0.9 4.6 10.9 13.8 3.0 6.3 7.7 1.2 3.7 6.9 0.8 0.0 0.0 8.5 0.0 3.5 2.2 5.6 2.4 3.4 0.4 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 1.9 4.3 10.5 22.3 4.0 2.8 7.6 3.3 4.9 10.3 0.1 8.3 13.6 0.3 6.4 13.4 6.8 3.9 8.7 13.7 9.4 6.8 17.7 11.2 4.8 2.3 14.3 12.4 7.3 12.5 2.8 1.7 5.7 1.9 6.1 19.8 7.4 0.7 0.8 8.4 0.0 49.6 4.8 1.6 1.0 4.1 8.5 1.3 1.8 1.1 4.8 1.2 30.3 58.1 4.0 4.1 0.8 1.9 20.0 0.6 0.8 3.6 5.6 0.4 3.2 0.0 8.5 1.3 11.1 3.9 0.0 2.8 15.8 2.6 2.8 7.1 12.7 0.0 0.8 1.3 8.0 8.4 12.6 9.1 4.0 3.7 6.0 5.8 27.9 RALA RAL ENSG00000006451 "RAS like proto-oncogene A" P11233 7 39623565-39708120 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Exocytosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 292.4;Pancreatic endocrine cells: 411.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 302.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047037, HPA065232" Approved Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA047037: , HPA065232: AB_2685440" "unprognostic (1.20e-3)" "unprognostic (1.03e-2)" "unprognostic (2.91e-1)" "unprognostic (7.73e-3)" "unprognostic (1.98e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (7.71e-2)" "unprognostic (2.17e-1)" "prognostic favorable (7.46e-4)" "prognostic unfavorable (6.30e-4)" "unprognostic (3.32e-1)" "unprognostic (4.95e-3)" "unprognostic (5.38e-2)" "unprognostic (7.15e-2)" "unprognostic (2.79e-1)" "unprognostic (2.95e-2)" 28.1 32.4 35.3 20.9 37.1 7.5 24.0 37.1 36.6 23.2 31.5 31.2 32.9 20.5 20.2 54.5 19.8 27.1 17.5 34.9 36.0 20.8 21.6 42.1 21.6 38.6 37.6 32.7 22.4 16.1 22.8 10.6 32.8 37.9 15.5 31.9 13.1 19.9 16.0 26.1 27.1 31.2 21.2 40.9 19.0 34.1 12.8 36.3 25.7 17.5 19.3 35.5 23.7 22.2 42.6 81.0 18.3 44.1 38.6 81.7 67.6 30.0 69.7 99.7 61.8 67.9 46.1 39.0 41.5 25.5 54.1 58.1 81.5 62.5 45.0 105.5 40.2 29.6 32.4 28.1 34.1 132.1 56.9 43.8 53.7 54.0 110.0 155.4 76.7 302.4 39.7 65.9 27.0 63.2 26.3 40.3 66.7 123.0 88.0 35.9 49.4 40.2 36.3 63.1 37.3 78.0 75.6 42.8 67.7 49.4 78.7 63.5 60.9 98.0 36.4 32.4 46.3 50.7 47.6 39.1 50.3 40.5 58.0 67.2 38.3 13.5 15.7 12.5 15.6 15.7 15.8 20.1 16.2 22.6 18.0 25.6 22.9 6.1 23.2 12.6 14.5 28.1 15.9 35.3 37.1 37.1 36.6 34.9 36.0 38.6 37.6 32.7 37.9 40.9 36.3 42.6 66.5 83.3 38.1 25.5 40.5 90.1 37.3 75.1 41.5 14.6 41.3 63.5 37.3 40.0 50.3 23.9 6.2 52.1 28.4 80.1 21.5 165.4 98.2 56.5 64.8 121.5 47.8 35.1 47.6 122.0 92.5 52.4 42.3 99.9 31.7 41.8 75.0 27.8 101.9 11.8 48.4 53.1 144.5 33.0 292.4 17.4 47.8 73.0 30.2 44.0 97.0 37.3 23.7 39.2 37.0 411.0 73.8 69.6 48.6 61.0 70.8 38.6 36.6 16.6 32.9 26.5 131.9 59.1 71.6 113.4 109.4 62.0 37.0 53.9 58.7 64.5 BAIAP2L1 IRTKS ENSG00000006453 "BAR/IMD domain containing adaptor protein 2 like 1" Q9UHR4 7 98291650-98401090 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 59.3" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 108.1;Prostatic glandular cells: 114.7;Urothelial cells: 147.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 72.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA019484, HPA021257, HPA023874, HPA029503" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330" "unprognostic (1.75e-1)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.42e-2)" "unprognostic (1.00e-1)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" "unprognostic (8.31e-3)" "unprognostic (4.56e-2)" "unprognostic (1.34e-2)" "unprognostic (9.09e-2)" "unprognostic (2.79e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" 5.2 20.8 1.3 6.3 1.2 0.4 7.9 1.0 1.3 7.2 2.5 23.2 28.9 2.9 1.4 29.5 11.7 15.7 3.9 1.0 1.8 11.8 33.7 14.1 1.4 1.3 1.4 0.8 1.3 31.5 13.2 13.1 10.3 1.7 26.4 21.6 0.6 23.8 2.6 2.9 20.1 25.6 2.6 1.1 1.9 59.3 9.8 1.3 2.1 15.0 1.6 4.7 16.9 17.3 1.3 43.2 33.6 0.9 0.7 0.0 1.5 55.0 10.9 7.1 5.6 4.1 47.0 62.9 1.8 15.9 4.1 47.4 37.3 15.6 46.1 5.0 0.2 20.3 0.0 14.3 27.0 6.7 0.0 14.7 1.5 61.0 3.2 44.4 12.3 0.2 0.1 26.4 0.1 4.8 36.1 0.1 0.1 26.3 61.8 18.5 0.1 0.5 7.0 35.2 37.2 23.5 4.6 25.3 72.2 12.8 35.3 20.2 1.0 1.4 8.3 39.6 1.6 5.1 0.9 13.1 21.8 0.9 5.4 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 1.2 1.0 1.3 1.0 1.8 1.3 1.4 0.8 1.7 1.1 1.3 1.3 16.9 12.8 22.9 23.5 0.8 16.7 64.8 31.5 14.2 0.6 17.4 7.6 2.3 30.0 36.3 22.0 4.2 11.8 5.5 100.3 9.8 60.8 33.1 25.2 3.0 11.2 32.2 2.7 23.1 77.6 78.4 2.2 108.1 33.4 0.0 4.5 0.7 16.6 2.4 1.7 26.1 53.6 18.3 0.3 1.7 52.5 0.9 1.0 8.8 37.5 2.6 1.2 0.0 26.7 31.4 102.6 84.7 0.7 0.6 114.7 35.3 2.4 58.6 0.8 0.0 1.9 6.7 50.0 56.3 22.4 19.5 12.2 1.9 0.2 44.7 147.8 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140176983 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 6.7 2.2 2.3 6.9 2.1 16.5 4.7 4.0 4.1 9.6 2.1 8.4 8.3 6.7 1.4 7.1 3.0 4.6 4.1 2.6 2.1 3.7 6.7 4.8 7.0 2.4 2.8 1.0 2.1 4.5 4.2 1.3 9.2 3.0 3.3 9.4 5.9 5.1 2.1 12.7 7.4 8.4 4.4 2.9 5.6 9.4 7.8 4.3 6.7 2.8 13.3 8.1 5.8 3.7 3.4 0.8 0.4 2.7 2.8 2.4 2.3 5.4 1.2 1.7 0.4 0.5 0.2 0.4 1.9 1.9 1.3 1.4 1.0 3.7 2.3 0.8 10.8 2.3 0.1 0.4 5.1 2.5 1.8 1.9 2.4 5.1 1.4 8.0 1.3 2.6 5.0 6.1 8.2 0.5 0.8 3.6 3.1 4.3 6.3 1.5 3.8 0.2 4.0 0.9 1.2 4.7 5.8 2.8 6.5 2.7 4.3 8.8 0.7 4.6 0.5 1.0 1.7 0.8 2.9 0.4 6.2 1.5 5.0 1.0 0.6 0.8 0.3 0.3 0.4 0.3 0.5 0.5 0.5 1.1 1.1 0.5 0.3 2.2 0.6 0.2 0.4 0.4 0.3 2.3 2.1 4.0 4.1 2.6 2.1 2.4 2.8 1.0 3.0 2.9 4.3 3.4 34.4 16.0 25.5 25.5 30.6 49.8 44.8 17.7 8.0 11.8 11.1 7.4 14.6 8.6 30.1 16.5 27.1 12.3 17.8 36.7 1.9 7.2 5.2 17.0 18.2 23.8 52.7 32.4 35.3 9.4 2.8 20.0 30.5 28.7 8.2 12.2 18.5 18.5 10.7 6.7 34.8 38.0 12.2 31.4 86.7 4.9 7.8 35.4 3.6 96.5 34.7 4.3 10.3 35.7 36.0 12.2 28.7 4.1 11.8 35.3 26.9 3.3 33.3 9.2 6.6 14.9 17.8 31.2 14.3 12.3 46.5 37.9 18.5 3.4 27.2 50.0 ETV1 ER81 ENSG00000006468 "ETS variant transcription factor 1" P50549 7 13891229-13991425 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.1;salivary gland: 92.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 137.7;Astrocytes: 67.3;Cardiomyocytes: 87.7;Enteroendocrine cells: 198.1;Excitatory neurons: 66.9;Oligodendrocyte precursor cells: 135.7" "Cancer enhanced" "Detected in all" "glioma: 22.5" "Region enhanced" "Detected in all" "cerebellum: 118.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 67.8;hTERT-RPE1: 76.2;SCLC-21H: 79.3;U-87 MG: 157.2;WM-115: 78.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 200.7" "HPA068389, HPA077249" Supported Approved Nucleoplasm No No Nucleoplasm "HPA068389: , HPA077249: AB_2686829" "unprognostic (2.45e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-2)" "unprognostic (2.13e-2)" "unprognostic (1.64e-7)" "unprognostic (7.08e-3)" "unprognostic (7.21e-2)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-3)" "unprognostic (2.21e-2)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" 4.9 23.2 13.9 2.0 11.3 0.2 8.3 118.1 11.8 2.3 0.8 3.9 2.2 4.5 2.3 2.7 1.6 17.5 35.9 14.1 18.8 3.2 3.9 29.0 1.4 5.4 20.1 10.2 1.4 3.1 11.6 7.4 3.5 30.0 5.5 4.4 4.5 92.3 12.7 0.8 1.8 3.5 3.5 3.9 9.2 2.6 8.9 35.6 4.7 12.3 2.5 1.9 2.7 1.5 10.0 0.1 4.9 35.5 67.8 12.1 35.4 0.1 3.2 12.1 2.0 8.0 0.0 16.6 0.0 3.6 5.6 9.8 0.4 1.5 3.8 4.3 0.9 1.6 2.1 3.1 0.0 7.1 12.3 4.5 10.7 0.0 23.3 1.9 76.2 15.3 1.1 11.0 0.6 14.6 0.0 0.1 0.0 53.2 2.1 36.5 0.0 21.5 2.9 23.7 0.4 79.3 15.6 0.0 1.2 19.6 12.2 1.2 0.5 8.6 7.0 2.2 13.8 13.4 12.2 4.1 0.0 157.2 0.8 78.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 13.9 11.3 118.1 11.8 14.1 18.8 5.4 20.1 10.2 30.0 3.9 35.6 10.0 16.0 19.2 137.7 67.3 0.0 1.0 2.8 0.9 13.6 4.9 5.8 23.6 87.7 28.6 0.7 3.7 0.0 0.6 0.1 0.8 5.9 3.6 25.4 1.3 3.9 11.1 198.1 0.8 66.9 0.9 0.4 17.7 1.1 2.0 2.5 0.2 2.9 13.1 3.4 5.0 45.3 2.4 0.0 7.2 1.6 8.7 1.5 0.7 12.4 28.1 0.0 12.6 0.0 135.7 4.3 0.9 0.1 34.6 1.2 0.6 0.0 3.0 1.4 0.6 19.7 17.4 12.6 1.2 2.1 3.1 1.3 0.3 2.2 9.7 1.2 0.3 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551278-141655244 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.4;Inhibitory neurons: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 97.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: AB_2682164" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 10.2 14.8 10.1 8.6 11.2 5.7 12.0 8.5 12.9 11.3 10.0 11.3 5.9 11.8 14.6 12.3 12.3 7.9 30.6 10.7 10.9 15.9 14.2 11.7 12.2 8.2 9.2 10.8 11.4 10.2 21.7 13.8 10.1 8.7 12.9 13.2 12.8 13.8 11.5 8.6 9.6 12.1 15.5 8.0 16.7 12.3 6.7 9.3 14.1 12.8 10.1 14.9 10.9 11.6 8.8 23.7 25.6 26.7 21.8 21.2 29.4 16.2 23.5 29.3 44.5 50.9 24.7 18.3 26.3 24.0 26.8 40.5 18.7 41.6 32.8 51.0 33.8 32.7 26.1 10.7 18.7 34.1 15.6 12.5 29.9 26.9 36.3 33.1 19.8 34.1 32.3 36.3 36.9 25.3 24.6 47.3 9.1 25.6 19.9 32.4 29.2 4.2 80.1 33.1 20.8 23.3 29.6 24.6 29.7 27.1 26.1 16.3 20.2 19.5 18.9 14.1 23.8 38.1 29.5 31.9 14.4 30.7 9.1 50.4 0.4 7.1 1.2 22.1 13.9 15.3 10.8 17.3 26.0 16.2 6.5 12.8 23.5 1.2 97.3 8.2 6.3 18.9 15.7 10.1 11.2 8.5 12.9 10.7 10.9 8.2 9.2 10.8 8.7 8.0 9.3 8.8 8.4 0.0 6.0 22.5 11.4 3.1 5.6 7.9 5.2 11.8 5.5 5.1 18.1 2.8 6.6 12.9 8.4 15.7 15.8 3.0 9.8 6.6 9.9 7.4 9.0 7.5 0.0 11.8 43.4 6.9 8.2 7.7 10.7 6.6 8.2 9.9 4.2 4.1 7.0 15.2 43.0 3.9 12.2 5.1 4.9 12.0 6.8 5.6 7.2 26.2 12.4 11.2 27.8 38.7 37.9 6.1 2.1 10.5 22.1 2.9 2.4 8.2 7.6 17.4 0.0 6.2 8.0 6.2 4.9 11.3 2.7 9.2 15.0 14.2 5.6 3.8 ALDH3B1 ALDH7 ENSG00000006534 "Aldehyde dehydrogenase 3 family member B1" P43353 11 68008578-68029282 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 46.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 115.4;Alveolar cells type 2: 58.4;Endometrial ciliated cells: 54.5;Kupffer cells: 59.0;Respiratory ciliated cells: 211.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 163.2" "Group enriched" "Detected in many" 10 "dendritic cells: 67.5;granulocytes: 163.2;monocytes: 125.8" "Cell line enhanced" "Detected in many" "A549: 154.4;CAPAN-2: 154.9;RPMI-8226: 85.9;U-87 MG: 89.1" "Low region specificity" "Detected in all" HPA038525 Uncertain NA NA "HPA038525: AB_2676062" "unprognostic (3.50e-1)" "unprognostic (4.22e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.56e-2)" "unprognostic (9.66e-3)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (2.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (8.27e-2)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (2.75e-2)" "unprognostic (6.69e-3)" "unprognostic (1.06e-1)" 11.2 27.0 3.2 10.7 4.5 46.9 5.6 5.6 4.6 10.6 8.3 9.7 23.6 6.4 0.9 14.0 40.0 8.9 3.9 2.9 5.1 16.0 4.1 44.7 5.6 5.8 5.9 2.4 3.6 8.1 0.6 7.7 11.8 6.5 4.7 6.6 0.5 11.2 4.2 2.0 5.2 18.2 5.7 4.8 20.1 20.9 2.1 4.8 1.4 2.5 1.8 2.6 10.9 9.0 6.5 11.4 154.4 1.1 3.3 9.9 31.0 26.8 15.1 24.8 10.9 5.3 5.7 154.9 0.7 26.9 35.9 15.3 12.9 0.3 2.1 2.7 0.4 0.9 1.6 64.3 13.4 61.0 9.1 0.5 22.5 6.8 5.4 14.6 24.6 0.6 0.8 0.4 27.3 17.8 9.5 0.9 9.0 1.2 76.1 9.2 3.7 5.9 85.9 17.9 1.5 1.8 0.8 35.7 29.7 15.2 0.8 34.3 19.7 16.2 15.7 21.3 76.2 5.3 0.4 3.0 0.2 89.1 24.5 7.4 47.6 91.0 163.2 0.2 125.8 0.3 0.4 0.2 0.2 67.5 0.5 0.2 0.1 26.6 11.8 118.1 7.0 0.1 47.7 3.2 4.5 5.6 4.6 2.9 5.1 5.8 5.9 2.4 6.5 4.8 4.8 6.5 0.4 115.4 58.4 1.0 1.4 2.2 2.7 8.4 1.2 0.5 1.7 1.3 3.1 20.0 53.6 5.5 0.0 0.8 2.9 6.6 0.0 7.4 21.6 54.5 9.2 1.8 2.4 7.8 0.2 2.5 8.2 6.5 12.8 5.1 25.2 2.0 1.4 2.3 34.0 3.3 0.1 9.0 12.2 59.0 10.6 10.0 1.8 33.1 3.6 1.9 30.9 2.1 1.0 0.5 5.7 19.3 7.5 1.5 1.3 3.1 36.2 30.1 211.6 0.4 0.0 6.9 6.5 0.4 0.4 1.0 1.0 0.7 2.2 0.0 9.8 6.2 TTC22 FLJ20619 ENSG00000006555 "Tetratricopeptide repeat domain 22" Q5TAA0 1 54779712-54801323 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;vagina: 48.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 72.4;Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 27.1;Paneth cells: 36.9;Proximal enterocytes: 51.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.0;CAPAN-2: 10.7;HaCaT: 12.3;hTCEpi: 6.9;OE19: 14.7;RPMI-8226: 8.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035072 Uncertain NA NA "HPA035072: AB_10602252" "prognostic favorable (2.06e-4)" "unprognostic (8.52e-2)" "unprognostic (4.84e-2)" "unprognostic (4.98e-2)" "unprognostic (1.01e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.02e-1)" "unprognostic (2.60e-1)" "unprognostic (3.07e-2)" "unprognostic (4.57e-2)" "unprognostic (7.27e-2)" "unprognostic (1.51e-3)" "unprognostic (5.08e-3)" "unprognostic (1.00e-1)" "unprognostic (3.16e-2)" "unprognostic (2.21e-1)" 0.2 1.0 1.0 2.4 3.1 1.4 2.6 0.7 1.7 12.1 2.2 12.5 15.9 1.5 2.7 110.5 3.4 2.7 0.1 0.9 1.9 9.3 6.2 2.1 1.6 1.3 0.6 0.8 0.4 9.5 16.6 6.1 0.2 0.9 6.4 11.3 0.2 17.7 1.7 0.6 24.6 17.6 0.7 0.5 2.0 13.2 0.7 1.6 2.3 4.1 0.0 7.3 3.7 48.5 0.7 9.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 10.7 0.1 0.4 0.0 0.0 12.3 0.0 3.6 0.0 4.0 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.1 0.1 14.7 1.1 0.1 0.1 8.1 0.5 2.2 0.3 0.2 0.7 0.1 0.0 0.2 0.4 0.2 0.1 0.1 0.0 0.2 0.1 0.8 2.2 0.1 0.1 0.1 0.0 1.0 0.0 2.5 3.4 0.0 2.0 0.7 1.6 3.7 0.0 0.5 1.4 1.7 1.3 1.6 0.0 0.0 2.7 0.5 1.0 3.1 0.7 1.7 0.9 1.9 1.3 0.6 0.8 0.9 0.5 1.6 0.7 0.0 0.0 3.1 0.0 1.8 1.3 5.9 3.2 3.4 0.0 3.9 3.6 2.7 15.7 4.5 3.7 0.0 0.3 5.9 72.4 7.9 5.0 2.7 3.3 0.4 0.3 2.4 2.7 0.3 9.1 0.4 0.5 23.0 3.2 0.0 0.0 0.4 2.2 0.0 0.0 0.1 27.1 4.1 0.0 0.3 1.1 0.3 0.4 1.8 0.0 0.0 0.0 7.2 0.0 0.1 10.5 36.9 0.0 1.0 6.0 51.7 8.9 5.7 0.0 0.0 0.0 0.4 0.4 0.9 19.7 4.5 0.0 4.1 0.1 15.4 13.9 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.8;tongue: 58.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 109.1;Inhibitory neurons: 94.6;Oligodendrocyte precursor cells: 91.5;Oligodendrocytes: 144.4" "Cancer enhanced" "Detected in all" "testis cancer: 16.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 25.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012312: AB_2668649" "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (5.53e-2)" 8.0 4.8 4.4 13.2 5.3 12.4 7.1 5.7 6.3 8.8 3.6 6.0 4.0 8.8 5.2 8.7 5.4 10.8 13.1 5.2 4.6 5.7 6.3 7.7 18.2 4.6 4.2 5.1 8.3 4.6 26.5 4.7 11.0 5.0 6.8 6.6 7.2 5.0 8.0 113.8 6.9 8.0 12.0 4.1 12.9 4.5 10.1 4.2 9.2 6.6 58.2 17.8 11.8 5.9 7.9 34.6 15.5 20.9 42.6 17.8 19.5 17.3 59.6 54.1 34.9 39.3 26.6 27.3 31.0 4.8 46.4 37.8 27.9 30.1 15.5 49.3 20.9 24.0 12.7 16.7 7.8 19.3 16.9 33.5 11.6 14.5 20.4 30.4 22.4 12.6 17.1 21.0 53.1 37.7 21.7 14.0 10.9 18.9 9.6 18.2 13.8 42.3 25.4 9.6 45.9 20.0 27.9 33.4 37.5 21.9 30.5 39.7 13.0 12.9 59.7 31.9 34.0 35.5 24.9 31.1 38.3 18.9 26.7 52.5 14.1 2.7 4.6 1.8 11.7 3.7 8.2 5.6 1.7 2.8 5.3 1.7 1.8 1.6 5.1 25.4 1.2 8.2 2.7 4.4 5.3 5.7 6.3 5.2 4.6 4.6 4.2 5.1 5.0 4.1 4.2 7.9 12.8 6.4 15.2 31.6 54.0 15.9 20.9 9.0 21.1 8.7 13.2 10.0 23.8 14.3 10.8 7.3 12.5 13.7 18.4 8.9 0.0 4.4 27.4 8.1 20.9 9.6 5.4 8.4 109.1 6.7 8.6 18.3 7.7 12.5 39.2 26.7 18.9 5.7 11.7 3.3 94.6 6.6 22.4 32.7 32.6 4.5 12.2 39.7 10.6 47.8 11.1 4.7 10.3 91.5 144.4 5.7 5.6 13.5 34.8 9.0 2.3 2.2 9.7 9.0 13.1 15.1 15.3 47.6 39.2 14.4 17.8 14.8 54.2 14.7 4.8 21.5 CCL26 "eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1" ENSG00000006606 "C-C motif chemokine ligand 26" Q9Y258 7 75769533-75789896 "Human disease related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 20.6;pituitary gland: 16.5" "Cell type enhanced" "Detected in some" "Fibroblasts: 7.1;Intestinal goblet cells: 7.7;Leydig cells: 16.8;Sertoli cells: 13.1;Smooth muscle cells: 20.2" "Cancer enhanced" "Detected in many" "testis cancer: 14.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 11.2;hTEC/SVTERT24-B: 14.8;PC-3: 51.1;U-2 OS: 13.7" "Region enriched" "Detected in single" 16 "spinal cord: 1.7" "Secreted to blood" NA NA 117000 "unprognostic (1.14e-1)" "unprognostic (4.17e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (3.52e-2)" "unprognostic (2.18e-2)" "unprognostic (6.17e-2)" "unprognostic (3.02e-1)" "unprognostic (8.71e-2)" "unprognostic (7.93e-2)" "unprognostic (2.47e-1)" "unprognostic (1.05e-11)" "unprognostic (2.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.73e-1)" "unprognostic (6.29e-3)" 2.6 3.1 1.7 0.6 1.7 0.1 1.9 1.7 4.1 2.4 11.0 0.8 0.3 1.2 1.9 1.9 2.7 1.4 2.5 1.6 1.7 1.7 0.4 1.9 3.4 1.8 1.7 1.9 20.6 0.4 3.2 16.5 0.4 1.7 1.0 7.3 2.5 0.7 0.3 0.4 1.8 1.0 1.4 1.8 0.4 0.9 1.2 1.9 0.3 0.6 0.1 0.2 3.6 4.3 1.8 0.2 11.2 0.0 0.0 1.3 1.7 0.0 0.6 5.2 4.3 7.3 0.3 3.2 0.0 7.2 3.5 0.3 2.1 0.0 0.0 5.8 0.0 0.5 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.6 14.8 0.1 2.3 0.0 0.0 5.2 0.0 2.2 0.7 0.0 0.0 8.4 0.5 51.1 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.1 0.0 2.2 0.0 0.0 0.3 8.2 13.7 4.2 2.7 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.7 1.7 4.1 1.6 1.7 1.8 1.7 1.9 1.7 1.8 1.9 1.8 0.5 0.0 0.0 0.0 0.0 1.1 3.5 1.8 0.0 0.5 0.1 0.1 0.4 0.0 0.7 0.0 4.2 0.0 0.0 2.3 0.0 0.0 0.5 0.1 1.1 0.6 0.0 0.0 0.1 0.0 0.0 7.1 0.5 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.1 7.7 0.0 3.2 1.4 0.9 16.8 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 4.9 0.0 0.6 0.1 0.0 0.2 2.2 13.1 0.9 20.2 0.1 0.4 0.6 1.8 0.0 0.2 2.5 1.6 2.6 FARP2 "FIR, FRG, KIAA0793, PLEKHC3" ENSG00000006607 "FERM, ARH/RhoGEF and pleckstrin domain protein 2" O94887 2 241356285-241494841 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 128.2;Oligodendrocytes: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031226, HPA055592" Approved Approved Cytosol NA NA Cytosol "HPA031226: AB_10602808, HPA055592: AB_2682856" "unprognostic (3.07e-1)" "unprognostic (1.39e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (2.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (9.11e-2)" "unprognostic (6.31e-2)" "unprognostic (6.78e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-1)" 9.3 10.3 13.7 11.5 16.6 5.4 9.0 19.4 16.1 9.4 10.1 22.8 20.4 10.7 7.4 14.2 9.3 10.1 7.7 13.7 13.8 11.1 17.3 10.5 12.0 15.6 15.9 12.3 11.1 11.5 13.3 8.5 9.1 17.2 10.1 21.5 10.2 9.3 10.1 10.7 22.3 19.0 11.7 12.9 11.7 20.5 28.3 15.6 8.6 6.8 10.0 13.9 14.3 10.2 21.8 20.0 14.3 25.8 17.7 21.9 29.1 23.1 19.7 16.3 20.0 20.6 15.3 23.4 8.5 5.2 38.8 14.1 22.4 35.0 20.6 30.4 13.3 18.1 18.8 25.4 20.3 16.0 17.0 14.1 29.3 15.2 29.2 23.7 9.3 18.4 16.1 21.7 7.6 16.3 16.7 18.3 12.5 12.8 35.3 11.1 20.3 58.2 25.7 25.9 41.0 30.5 20.3 22.1 15.4 59.5 14.9 8.1 16.8 27.9 18.8 14.3 23.8 16.0 13.0 10.0 18.8 17.2 11.5 39.0 6.1 2.1 7.3 1.3 5.1 1.2 4.4 1.4 1.5 3.1 4.9 0.9 1.0 1.3 1.7 2.8 6.4 2.2 1.6 13.7 16.6 19.4 16.1 13.7 13.8 15.6 15.9 12.3 17.2 12.9 15.6 21.8 8.9 28.9 5.9 27.4 23.9 15.4 11.4 8.0 16.5 12.7 11.1 8.3 29.6 14.3 12.3 18.4 18.8 5.8 9.7 36.3 3.9 9.3 42.7 12.0 10.6 10.5 28.1 3.4 43.1 12.3 5.4 12.9 45.3 14.0 6.3 15.9 11.0 11.6 4.2 20.2 36.7 38.7 10.2 8.4 9.4 25.0 14.9 11.9 39.2 38.4 8.5 4.9 2.1 128.2 114.0 12.6 24.1 10.5 14.4 12.8 20.9 7.1 17.3 15.1 19.7 21.4 14.1 45.6 19.7 13.8 15.2 11.1 6.0 11.3 26.2 22.4 USH1C "AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C" ENSG00000006611 "USH1 protein network component harmonin" Q9Y6N9 11 17493895-17544416 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Hearing" "Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 98.7;kidney: 54.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7" "Group enriched" "Detected in many" 7 "colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 60.6;HeLa: 21.8;OE19: 57.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB013690, HPA027398, HPA027492, HPA028033" Enhanced Enhanced Cytosol No NA Cytosol "CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782" "unprognostic (3.60e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-1)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.51e-2)" "unprognostic (9.65e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" 0.4 0.3 3.2 5.9 7.3 0.0 0.2 3.4 4.2 0.1 1.8 52.0 98.7 0.1 0.3 0.0 2.9 26.1 0.0 8.9 6.7 54.5 0.6 0.1 0.1 6.4 6.3 1.5 0.0 3.9 0.0 6.7 0.0 7.3 0.0 48.8 19.2 0.0 0.3 0.0 0.0 97.3 2.1 4.1 0.0 26.9 0.2 4.5 0.1 1.1 0.0 0.0 0.6 0.1 8.9 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 60.6 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 21.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.3 3.4 4.2 8.9 6.7 6.4 6.3 1.5 7.3 4.1 4.5 8.9 0.0 0.0 0.0 18.3 1.6 0.0 0.1 0.0 0.0 0.7 0.0 1.3 0.6 52.9 0.7 5.5 2.1 0.0 0.0 190.0 21.5 20.5 1.0 1.7 0.0 0.4 64.0 0.0 0.6 27.5 0.0 0.3 53.5 0.0 4.5 0.0 0.0 0.0 0.0 1.7 0.2 92.9 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 163.6 0.0 0.5 36.4 56.0 203.0 0.0 0.2 0.0 430.7 190.3 1.0 4.9 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.8 0.1 115.7 0.1 GGCT "C7orf24, CRF21, GCTG, Ggc, MGC3077" ENSG00000006625 Gamma-glutamylcyclotransferase O75223 7 30496621-30504841 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 414.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020735, HPA029914" Approved NA Yes 2100000 "HPA020735: AB_1845754, HPA029914: AB_10602321" "prognostic unfavorable (7.68e-4)" "unprognostic (2.66e-1)" "unprognostic (2.51e-2)" "unprognostic (2.62e-1)" "unprognostic (2.54e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.33e-3)" "unprognostic (2.19e-2)" "unprognostic (6.42e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-1)" "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (8.12e-3)" "unprognostic (2.00e-3)" "unprognostic (9.92e-2)" 47.9 25.8 19.8 28.7 21.9 22.6 45.2 18.2 24.6 18.8 20.6 39.0 31.6 17.4 106.1 52.1 24.6 26.2 13.1 20.7 21.9 32.2 35.9 16.7 28.0 19.4 19.2 20.1 15.6 23.5 43.9 16.0 35.1 18.4 25.1 39.8 10.8 33.6 16.1 17.1 57.0 26.8 21.4 18.5 16.2 22.9 12.2 20.1 22.1 19.4 20.9 32.5 33.4 31.5 19.9 194.0 50.0 79.4 107.7 32.6 58.8 92.5 64.6 25.1 60.5 72.4 66.6 66.1 123.7 42.0 24.3 68.9 238.8 84.1 67.8 78.6 24.0 93.1 87.7 104.6 88.6 42.6 150.1 65.4 57.6 53.4 63.4 81.0 20.9 62.1 58.7 126.8 69.4 48.6 108.6 91.4 202.1 115.6 198.3 79.5 90.1 91.9 123.8 59.5 174.0 100.3 101.2 58.0 355.9 73.5 102.8 228.7 140.7 37.7 39.6 75.6 75.6 128.6 50.8 129.2 96.7 30.9 201.4 75.9 10.4 19.9 7.0 14.1 20.4 19.9 22.7 18.8 18.4 34.2 17.2 17.8 17.4 1.1 25.0 12.2 30.0 26.1 17.2 19.8 21.9 18.2 24.6 20.7 21.9 19.4 19.2 20.1 18.4 18.5 20.1 19.9 37.9 16.0 39.4 10.1 25.1 77.0 50.1 96.0 60.3 23.4 107.0 109.5 51.6 24.3 67.0 44.1 4.2 414.7 21.8 56.9 123.3 99.8 29.2 129.6 40.4 46.3 28.3 53.0 26.0 80.1 167.7 41.4 44.9 103.8 27.3 53.5 33.5 51.4 129.8 33.7 10.1 90.1 67.1 44.5 57.4 10.0 24.8 42.8 62.2 12.2 36.2 32.2 24.7 8.5 8.9 60.1 50.6 39.1 33.4 68.8 60.6 188.4 69.4 15.1 26.3 25.2 45.1 63.3 46.7 147.0 74.7 135.6 26.7 67.7 138.0 69.6 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909553 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 15.3" "Group enriched" "Detected in all" 4 "Early spermatids: 468.6;Spermatocytes: 569.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.0 0.2 0.3 0.2 0.5 0.6 0.2 0.8 0.5 0.2 0.3 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.1 0.3 0.3 0.2 0.2 0.1 0.5 0.3 0.4 0.4 0.2 0.1 0.1 0.0 0.1 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.2 0.3 0.2 15.3 0.3 0.6 0.3 0.0 0.5 0.1 0.1 0.5 0.9 0.8 2.0 2.5 0.4 0.4 0.5 1.0 0.2 1.0 2.1 1.4 0.6 2.1 0.6 0.6 1.7 0.9 2.2 0.5 1.0 1.6 1.3 1.3 1.0 0.4 0.1 1.7 1.0 0.4 0.6 1.2 1.0 0.3 0.9 1.9 1.2 4.2 1.4 1.7 2.8 2.0 2.0 2.1 1.9 0.7 3.1 2.5 0.8 0.1 3.0 1.8 1.2 2.2 1.0 1.6 0.9 1.6 0.1 1.2 1.4 3.1 2.0 2.3 5.2 2.1 0.8 3.1 2.5 1.0 0.1 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.4 0.1 0.3 0.5 0.8 0.5 0.3 0.3 0.3 0.4 0.4 0.4 0.2 0.3 0.5 13.3 3.2 12.6 5.5 38.4 15.6 16.4 10.7 12.0 6.6 13.0 16.8 3.7 2.8 7.7 9.2 12.5 19.6 59.2 9.7 3.9 8.3 468.6 12.1 23.6 11.1 14.9 40.8 14.7 14.7 36.4 12.4 14.3 17.7 31.0 19.4 6.4 6.5 16.1 3.3 9.1 20.6 16.2 9.1 15.5 116.0 15.5 20.8 12.4 2.8 11.0 2.1 24.7 6.0 6.7 14.1 8.5 9.4 48.9 18.4 4.2 5.8 10.2 16.6 13.1 9.7 11.4 569.4 74.6 20.5 12.6 9.6 44.4 13.5 22.3 11.7 TBXA2R ENSG00000006638 "Thromboxane A2 receptor" P21731 19 3594507-3606875 "Disease related genes, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Adipocytes: 10.8;Endothelial cells: 8.7;Hepatic stellate cells: 30.7;Macrophages: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 9.5;U-2197: 6.8;U-937: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA077366 Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077366: AB_2686836" "unprognostic (1.59e-1)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (8.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.52e-2)" "unprognostic (2.17e-3)" "unprognostic (8.41e-2)" "unprognostic (6.25e-2)" "prognostic favorable (7.17e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (4.32e-2)" "unprognostic (9.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.02e-1)" 3.8 8.8 1.2 1.6 1.2 1.0 2.0 1.7 1.4 5.4 1.4 2.2 0.8 5.2 0.4 1.8 3.4 1.0 3.7 1.1 1.1 6.2 6.2 4.4 1.0 1.7 1.3 1.3 2.0 0.9 1.2 1.1 3.3 1.6 2.5 0.4 0.5 0.6 1.4 1.4 0.9 3.3 1.8 1.0 7.1 2.5 0.6 1.4 0.3 2.7 0.6 0.3 2.6 3.6 1.6 0.2 0.2 0.3 3.4 0.7 1.7 0.5 2.4 0.6 1.8 1.4 0.1 0.3 0.1 3.5 1.0 1.8 0.2 0.7 0.0 0.7 0.2 0.8 2.3 9.5 0.2 0.9 0.2 4.1 0.8 0.0 2.4 0.0 1.4 0.7 0.1 3.8 0.4 0.3 0.1 0.2 1.2 0.3 0.1 2.1 0.1 0.0 0.1 0.0 0.1 0.1 1.3 0.2 0.4 0.1 0.3 1.5 4.2 2.1 3.8 0.8 6.8 2.3 0.2 0.3 0.2 3.1 6.1 0.9 3.7 0.4 0.4 2.5 0.2 0.3 2.0 0.7 2.2 0.1 11.1 4.3 9.4 4.1 3.3 0.3 0.3 0.2 4.0 1.2 1.2 1.7 1.4 1.1 1.1 1.7 1.3 1.3 1.6 1.0 1.4 1.6 10.8 0.0 0.0 0.0 2.6 0.5 0.1 0.0 0.0 0.3 0.1 0.1 1.3 0.0 0.0 1.8 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.6 8.7 0.0 0.0 0.3 0.0 0.2 2.3 0.0 0.1 0.0 0.2 30.7 0.6 0.9 0.0 0.9 0.0 0.0 1.0 0.3 0.0 0.3 19.2 1.8 1.9 0.3 0.5 1.0 0.5 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 2.5 0.4 1.9 0.1 0.6 0.1 0.8 0.4 0.1 0.0 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422887-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 64.2;neutrophil: 112.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 112.3" "Low cell line specificity" "Detected in all" "HPA024122, HPA072413" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA024122: AB_1851452, HPA072413: " "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favorable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 33.5 24.8 14.6 6.6 13.6 58.2 32.6 12.8 16.2 22.1 28.4 27.8 8.2 21.0 4.8 24.2 25.7 4.7 28.2 13.4 22.9 21.5 27.5 40.5 3.9 15.1 10.6 8.8 31.6 103.8 9.9 31.4 8.0 11.6 28.4 5.5 13.5 25.9 6.5 59.3 20.5 22.3 10.3 12.0 20.0 38.7 24.7 13.9 4.6 25.8 3.2 4.0 24.3 26.0 19.3 22.1 26.8 25.9 21.7 44.4 28.2 25.0 23.8 26.6 36.0 29.6 42.7 21.1 12.2 52.9 18.8 64.6 15.0 21.5 29.2 46.9 17.1 31.7 13.8 46.1 37.9 61.5 19.9 9.5 24.7 43.4 39.7 47.1 18.9 18.3 22.2 46.5 17.4 14.2 35.7 24.1 20.1 51.8 26.9 30.1 24.6 9.2 22.9 6.0 6.1 37.9 18.9 28.0 15.5 61.2 57.7 9.8 15.2 12.6 45.8 10.4 35.0 68.5 27.2 34.8 37.1 12.9 43.6 63.8 19.8 7.6 64.2 7.2 6.5 6.2 8.7 7.7 7.9 6.6 7.2 6.8 7.0 112.3 8.0 6.4 4.6 8.6 5.2 14.6 13.6 12.8 16.2 13.4 22.9 15.1 10.6 8.8 11.6 12.0 13.9 19.3 179.3 32.1 31.4 39.2 110.6 197.3 159.3 55.6 259.6 50.3 141.7 142.6 60.6 37.1 55.0 18.4 89.6 66.5 130.9 276.0 17.6 49.6 43.9 123.2 159.7 96.8 138.2 24.6 36.1 56.5 84.2 135.5 162.6 190.1 74.4 51.3 52.8 21.7 126.1 21.9 24.4 183.5 54.9 96.9 153.4 10.1 36.7 141.8 103.2 44.0 55.8 32.4 20.6 24.1 42.6 55.1 287.8 41.0 104.6 143.9 226.9 13.3 34.1 86.8 39.5 138.9 172.7 25.5 14.5 135.1 126.0 151.7 129.8 53.4 180.0 154.4 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704481-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "placenta: 66.1" "Cell type enriched" "Detected in some" 11 "Syncytiotrophoblasts: 88.7" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "EFO-21: 4.3;U-266/70: 9.8" HPA065180 Supported Nucleoplasm NA NA Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.1 0.0 0.7 0.3 0.9 0.6 0.4 2.0 1.4 0.2 0.3 0.1 0.3 0.2 0.3 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.2 0.4 1.2 0.8 1.0 0.2 0.5 0.0 0.0 66.1 1.5 0.2 0.1 0.5 0.1 0.0 0.1 0.9 0.1 0.2 0.3 0.4 0.3 0.2 1.1 0.1 0.1 0.2 0.6 0.1 0.0 1.9 0.1 0.0 0.2 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 4.3 0.1 0.1 0.5 0.0 0.0 0.1 1.2 0.1 0.1 0.5 0.2 0.0 0.1 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.3 0.1 0.8 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.5 0.0 0.1 0.0 0.3 0.4 0.5 0.1 9.8 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.9 2.0 1.4 0.7 0.5 1.2 0.8 1.0 1.5 0.3 1.1 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 88.7 0.2 0.0 0.0 0.0 COX10 ENSG00000006695 "Cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10" Q12887 17 14069490-14231736 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.9;tongue: 44.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 88.2;Late spermatids: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 6.6 7.5 3.2 5.5 3.1 10.5 6.0 4.2 4.4 5.3 4.1 12.6 12.6 5.2 4.5 11.0 5.7 4.2 23.3 3.5 3.9 11.7 10.7 4.4 5.8 3.8 3.7 2.9 4.6 10.0 9.7 3.3 7.0 4.0 5.7 12.4 5.6 7.3 5.6 44.9 7.2 10.2 7.2 3.1 4.9 9.4 21.3 4.2 5.4 6.3 44.7 7.6 8.6 6.7 3.8 10.1 19.7 7.7 11.9 7.7 5.6 19.5 12.3 8.4 21.9 14.6 16.3 6.6 23.5 9.8 13.0 6.8 20.2 16.6 16.3 17.3 13.1 15.7 14.5 12.4 20.0 14.2 15.5 12.3 9.8 19.5 14.0 17.6 7.9 11.4 15.8 20.4 8.2 9.5 13.1 13.5 10.5 12.8 37.6 9.5 10.3 28.8 18.5 15.2 20.1 5.2 9.8 12.0 18.5 16.5 36.1 9.6 9.2 9.9 8.9 8.0 9.9 15.8 10.1 15.6 11.2 14.9 15.7 11.9 3.8 11.3 4.4 9.8 16.1 10.6 13.2 11.3 10.5 14.9 9.2 11.9 11.5 1.2 10.0 13.9 4.6 20.1 11.0 3.2 3.1 4.2 4.4 3.5 3.9 3.8 3.7 2.9 4.0 3.1 4.2 3.8 5.9 0.0 14.7 25.8 9.6 9.7 9.5 9.8 14.2 7.5 8.7 7.4 88.2 5.7 7.3 11.0 10.4 19.7 5.7 13.8 41.1 9.1 41.1 9.6 9.6 7.8 12.6 13.3 33.5 8.7 17.5 8.8 16.3 9.4 5.1 7.5 3.9 9.6 10.8 0.0 43.0 16.4 8.2 4.4 4.7 81.0 2.1 6.7 5.4 22.5 6.3 4.6 8.2 34.7 26.9 8.8 11.4 6.8 12.5 8.7 26.6 17.8 5.8 12.2 0.0 5.2 12.5 22.8 19.2 19.4 10.4 16.1 8.6 6.6 18.9 13.7 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602605 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.7" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 5.9 12.7 7.3 3.4 7.2 0.5 7.0 7.4 8.3 14.6 12.4 12.6 7.8 11.4 8.7 26.9 8.9 5.7 11.0 6.2 8.2 15.9 4.6 11.8 1.0 9.3 8.9 7.6 10.6 10.1 19.1 27.8 5.8 9.0 13.4 5.7 37.1 17.5 8.3 68.7 22.6 6.7 8.4 6.8 2.0 14.0 5.1 10.6 3.4 17.6 29.9 5.5 15.1 20.0 10.5 21.2 12.9 28.1 30.8 22.2 10.8 0.2 8.8 23.7 17.1 17.7 21.7 30.1 5.4 6.5 18.1 41.7 11.6 22.6 10.2 12.6 0.2 13.0 1.1 43.1 26.1 71.2 0.2 0.7 14.7 42.1 12.0 48.9 39.7 8.9 10.4 15.5 0.1 19.2 26.1 2.7 18.9 22.6 25.7 12.8 28.1 16.4 20.0 32.7 14.6 23.1 30.5 21.7 39.0 19.9 14.2 23.4 21.2 4.6 17.5 16.9 11.4 20.5 1.1 3.4 8.9 6.7 0.3 14.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 7.3 7.2 7.4 8.3 6.2 8.2 9.3 8.9 7.6 9.0 6.8 10.6 10.5 0.9 9.6 8.2 48.3 0.1 7.9 9.9 10.5 9.6 30.8 5.6 4.1 10.4 12.8 6.8 9.2 33.3 1.4 1.5 4.5 11.7 7.6 1.6 11.5 8.0 4.1 4.2 0.8 24.6 9.2 1.8 5.6 6.1 17.0 2.5 8.0 2.9 3.1 2.6 21.9 42.1 3.6 8.2 1.2 5.7 0.3 4.1 2.5 7.2 14.0 0.7 5.9 1.0 25.6 24.9 11.6 3.2 5.7 0.0 17.8 3.6 17.4 12.7 41.1 0.0 19.0 5.7 0.1 3.7 18.2 6.7 2.9 1.1 2.4 7.4 15.8 PAF1 "F23149_1, FLJ11123, PD2" ENSG00000006712 "PAF1 homolog, Paf1/RNA polymerase II complex component" Q8N7H5 19 39385629-39391154 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041875, HPA043637" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041875: AB_2677720, HPA043637: AB_2678592" "unprognostic (5.33e-3)" "unprognostic (3.57e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (6.65e-2)" "unprognostic (4.21e-1)" "unprognostic (8.37e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.32e-1)" "unprognostic (4.60e-1)" "unprognostic (2.73e-1)" 36.9 45.7 33.8 26.3 36.8 37.2 37.8 35.7 36.6 40.0 33.2 38.8 23.1 37.3 28.3 45.1 39.2 23.8 45.2 34.0 35.0 35.3 50.0 33.8 29.6 38.7 36.4 30.3 50.5 32.2 38.6 48.9 21.1 40.2 41.0 20.4 26.8 38.5 28.0 62.8 34.4 37.6 23.4 34.5 47.3 39.7 69.1 35.8 31.3 41.7 31.2 31.8 38.2 37.7 41.4 92.1 114.9 74.9 40.3 46.7 39.5 30.5 75.0 69.4 86.1 82.7 95.3 48.3 72.6 51.0 61.6 51.3 31.4 81.3 62.1 70.2 82.4 95.2 71.6 77.0 62.6 50.4 61.5 65.6 39.9 42.0 72.0 46.4 54.3 63.8 63.0 56.7 59.0 71.5 103.3 70.7 40.5 26.5 76.2 38.7 70.8 73.4 51.7 64.7 102.3 63.2 42.6 80.5 52.8 41.6 37.1 50.4 52.5 60.8 51.6 68.1 54.5 84.0 63.2 61.2 61.9 51.6 53.0 49.0 32.3 20.0 33.7 29.4 28.0 30.9 40.1 24.4 29.4 21.8 36.6 27.3 25.3 31.3 30.5 26.6 20.4 26.0 21.6 33.8 36.8 35.7 36.6 34.0 35.0 38.7 36.4 30.3 40.2 34.5 35.8 41.4 26.6 22.4 46.2 9.4 49.9 53.5 63.0 29.9 63.2 14.1 28.9 27.1 37.5 21.5 35.9 22.0 8.4 38.4 33.2 26.0 13.7 27.3 40.4 48.4 25.3 24.4 26.4 16.4 3.8 27.3 30.0 33.0 43.3 62.8 50.7 19.0 18.2 24.1 24.8 8.4 4.8 22.4 26.4 12.9 62.4 30.6 35.1 28.1 23.2 1.9 20.4 23.4 12.3 6.6 8.8 23.3 22.1 27.8 54.2 24.5 22.9 25.9 64.0 16.8 13.1 22.5 29.8 96.0 26.8 41.0 49.2 64.0 48.7 24.6 21.9 34.8 VPS41 HVSP41 ENSG00000006715 "VPS41 subunit of HOPS complex" P49754 7 38722974-38932394 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 118.2;Oligodendrocytes: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020080, HPA020299" Approved NA NA "HPA020080: AB_1858768, HPA020299: AB_1858769" "unprognostic (9.20e-3)" "unprognostic (3.62e-2)" "unprognostic (2.75e-1)" "unprognostic (2.26e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (2.86e-1)" "unprognostic (1.15e-1)" "unprognostic (3.02e-2)" "unprognostic (3.66e-1)" "unprognostic (6.63e-2)" "prognostic favorable (3.40e-8)" "unprognostic (1.62e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-1)" "unprognostic (1.28e-1)" 23.2 17.6 22.7 20.5 30.7 12.4 22.6 22.5 28.7 26.1 32.7 25.5 17.4 24.1 15.0 24.4 23.7 36.2 25.7 29.3 24.8 30.9 26.7 25.4 25.2 23.0 23.2 21.8 31.4 23.6 37.9 15.5 23.2 23.8 23.4 19.9 29.5 13.4 25.2 8.2 16.2 19.2 25.4 26.0 23.6 21.0 15.8 23.6 24.4 31.2 11.5 25.8 23.4 12.6 31.2 31.8 41.7 41.5 44.6 60.6 55.8 21.1 33.3 58.8 26.6 42.5 24.4 46.4 31.0 93.6 42.2 110.8 39.3 61.7 41.3 44.4 41.1 29.7 29.6 24.2 20.6 47.7 37.9 58.6 41.0 33.9 35.7 35.8 46.0 47.4 39.3 46.5 64.7 47.7 28.5 38.4 21.3 45.5 43.3 27.4 41.1 37.9 33.0 48.8 78.0 35.6 62.9 31.8 50.6 31.2 73.6 56.9 45.8 51.5 30.0 29.8 40.5 33.7 65.1 128.3 59.2 64.4 32.7 104.4 26.6 19.5 27.9 15.3 19.4 12.9 16.5 11.6 14.1 23.4 21.5 12.1 13.3 23.2 23.1 27.9 14.0 13.4 13.6 22.7 30.7 22.5 28.7 29.3 24.8 23.0 23.2 21.8 23.8 26.0 23.6 31.2 24.6 22.4 34.6 56.2 23.9 15.2 11.4 16.1 15.4 33.2 14.6 13.0 27.3 38.6 17.5 33.1 18.8 17.7 17.6 14.7 21.5 29.6 2.9 19.9 23.5 21.7 24.0 16.6 118.2 13.8 14.0 19.9 16.8 34.2 42.4 36.4 20.3 25.4 28.6 30.3 78.9 14.1 22.4 28.2 20.1 3.5 15.2 30.3 30.2 49.6 45.2 37.4 12.3 82.4 109.2 18.2 14.6 26.4 15.3 10.5 13.8 26.6 22.7 20.6 0.0 18.7 18.8 10.7 11.0 15.6 17.0 25.9 17.2 29.3 14.9 13.3 ARHGAP44 "KIAA0672, RICH-2, RICH2" ENSG00000006740 "Rho GTPase activating protein 44" Q17R89 17 12789498-12991643 "Predicted intracellular proteins" Exocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Group enriched" "Detected in many" 4 "Excitatory neurons: 205.3;Horizontal cells: 178.4;Inhibitory neurons: 189.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 9.5;JURKAT: 5.9;SK-BR-3: 7.2;SuSa: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038814 Approved NA NA "HPA038814: AB_10673295" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (5.18e-3)" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" "unprognostic (1.83e-1)" "unprognostic (1.68e-2)" "unprognostic (5.35e-2)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (4.02e-2)" "unprognostic (3.95e-2)" "unprognostic (6.31e-3)" "unprognostic (7.53e-3)" "unprognostic (3.98e-1)" "unprognostic (9.58e-2)" 3.0 1.7 15.7 2.3 12.1 0.0 2.0 4.1 35.0 2.6 0.0 15.5 7.3 2.9 3.2 0.8 9.9 5.4 4.2 21.1 4.6 2.6 0.6 12.1 1.5 11.3 7.6 11.7 4.0 3.6 17.6 8.2 9.4 15.4 3.1 12.1 7.1 5.8 4.1 2.4 1.4 7.5 3.1 0.1 0.7 3.3 2.7 20.0 0.7 6.4 2.5 1.6 2.1 2.2 24.7 0.3 1.5 1.2 0.9 0.1 0.6 4.0 0.6 4.8 0.2 0.5 0.6 0.2 3.8 0.4 1.6 2.4 0.5 2.6 0.0 0.1 0.0 9.5 0.0 1.4 1.5 0.1 0.0 0.3 0.2 0.4 0.3 0.0 0.0 0.0 5.9 0.2 0.0 0.0 4.7 0.4 0.0 3.7 2.1 0.2 3.4 0.0 0.9 0.0 1.3 3.8 0.2 0.2 7.2 0.0 12.1 0.8 1.4 0.0 3.7 1.9 1.3 0.0 0.0 0.0 0.4 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 12.1 4.1 35.0 21.1 4.6 11.3 7.6 11.7 15.4 0.1 20.0 24.7 1.4 12.8 12.8 25.8 2.4 2.7 4.8 2.1 1.8 23.1 3.2 2.7 8.7 15.7 2.3 9.2 2.1 2.1 0.2 32.4 0.0 4.8 14.3 8.9 2.2 2.8 12.0 0.8 205.3 4.6 1.2 6.3 3.1 4.2 0.0 5.4 4.6 0.6 0.6 178.4 189.4 15.4 2.0 0.6 1.2 3.4 4.4 0.3 1.8 10.3 0.1 5.4 1.0 38.7 19.0 3.4 14.3 10.9 1.2 4.2 7.4 0.6 8.6 14.7 19.7 3.8 12.4 0.8 7.1 1.6 1.6 0.8 0.9 2.5 32.8 3.2 ELAC2 "FLJ10530, HPC2" ENSG00000006744 "ElaC ribonuclease Z 2" Q9BQ52 17 12991612-13018065 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Disease variant, Primary mitochondrial disease, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 394.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019535 Approved Supported Nucleoplasm NA NA 9500 Nucleoplasm "HPA019535: AB_1848106" "unprognostic (4.24e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "prognostic favorable (3.24e-6)" "unprognostic (8.64e-2)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.47e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-1)" "unprognostic (5.31e-3)" "unprognostic (3.09e-1)" "unprognostic (5.31e-3)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (8.09e-2)" "unprognostic (3.70e-2)" 31.0 36.1 13.5 23.2 14.9 22.9 24.8 15.0 14.4 21.9 16.2 28.9 23.3 24.9 17.2 32.2 26.0 21.3 38.5 13.7 16.2 28.9 32.7 19.9 28.2 16.2 14.5 13.0 20.0 23.3 34.1 12.6 23.7 15.4 26.6 33.0 22.7 20.6 33.9 60.7 24.0 21.3 33.9 15.6 29.0 25.0 28.3 14.3 28.6 26.0 36.0 37.9 24.9 18.4 21.9 76.4 102.1 69.8 81.5 53.3 53.9 44.9 75.4 59.6 119.8 79.8 84.3 34.8 127.7 84.9 69.9 45.0 96.6 133.6 80.6 113.5 65.7 163.7 73.0 82.1 54.7 40.7 64.7 99.4 47.3 70.6 88.2 80.5 51.4 88.3 71.5 108.0 34.8 88.7 58.0 112.0 58.3 62.2 132.9 80.7 84.1 122.2 82.2 62.0 59.2 37.5 54.6 97.4 61.0 39.2 394.4 59.1 26.2 82.7 152.3 47.6 57.0 116.3 24.7 51.6 53.3 57.6 64.2 54.6 26.9 31.1 19.2 41.6 41.2 43.4 37.7 39.1 40.7 48.4 34.4 39.7 36.2 4.7 53.5 46.8 30.1 53.4 46.3 13.5 14.9 15.0 14.4 13.7 16.2 16.2 14.5 13.0 15.4 15.6 14.3 21.9 11.6 6.4 10.8 6.8 18.0 10.3 10.1 16.7 16.5 11.3 12.5 10.8 28.3 12.8 12.9 16.5 2.1 59.3 15.6 13.2 19.6 27.4 6.4 13.0 13.1 14.1 8.4 24.0 9.8 26.0 32.6 16.6 17.3 14.2 9.5 30.4 11.7 28.4 28.2 11.8 9.2 13.5 24.4 14.2 7.0 5.7 10.5 10.0 14.2 3.7 14.7 16.1 14.4 7.1 10.6 25.9 16.6 21.4 21.6 13.5 15.2 19.5 12.2 14.6 52.6 10.1 14.9 26.4 24.4 22.2 14.5 33.5 15.9 59.0 20.7 8.2 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660182 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.8;kidney: 47.5;placenta: 78.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 94.3;SK-BR-3: 102.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020518, HPA024264" Enhanced Approved "Plasma membrane,Cytosol" No No 2300000 "Plasma membrane" Cytosol "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favorable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 2.0 1.0 3.6 1.3 5.8 1.3 0.9 5.3 5.3 1.3 4.0 18.5 27.0 1.4 0.5 18.1 4.1 2.9 0.3 4.0 9.4 47.5 0.3 4.2 0.6 9.6 6.3 2.8 0.7 0.9 1.1 2.6 78.3 9.1 3.3 16.1 2.4 10.8 1.1 0.5 3.7 46.8 1.1 9.3 0.5 19.7 7.1 6.4 0.6 1.1 1.8 4.4 3.6 1.3 10.9 0.2 0.2 0.2 0.8 0.0 0.0 0.3 0.3 0.1 0.1 0.5 0.1 0.5 0.3 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.1 10.4 0.1 1.3 0.2 0.1 0.4 0.3 0.2 1.4 0.4 0.0 0.2 0.1 0.2 0.4 20.8 0.5 0.5 0.2 1.4 0.2 5.7 3.2 0.3 0.5 0.1 94.3 3.6 4.1 0.2 1.0 102.8 0.1 0.7 10.8 0.6 0.1 0.3 0.8 2.0 0.2 3.4 0.2 0.2 0.1 0.4 0.1 1.2 0.2 0.2 0.3 0.2 0.3 1.1 0.3 0.3 0.2 0.5 0.3 0.3 0.6 0.4 0.3 0.3 0.2 0.1 3.6 5.8 5.3 5.3 4.0 9.4 9.6 6.3 2.8 9.1 9.3 6.4 10.9 3.5 0.0 23.6 0.0 0.7 2.8 1.5 1.6 0.6 3.2 3.3 1.7 1.2 4.3 8.5 334.8 0.0 23.8 0.2 100.7 82.2 0.6 124.6 25.5 1.0 6.7 9.1 0.0 0.1 0.2 4.7 2.7 55.5 11.3 39.9 0.0 0.4 0.1 99.9 0.0 0.2 62.9 46.8 3.0 0.5 87.8 0.3 2.8 10.6 15.0 1.7 0.4 0.0 0.0 0.3 8.6 138.6 1.2 1.4 4.7 318.4 3.2 17.2 3.0 0.0 0.9 1.0 3.8 5.5 26.6 6.5 65.8 2.2 0.1 21.4 23.1 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903972-2929349 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.2;EFO-21: 24.5" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: AB_2685132" "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favorable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 7.7 7.8 4.8 6.2 4.2 4.9 23.8 4.6 4.6 24.1 9.7 20.7 21.2 11.3 16.1 10.1 28.2 11.5 4.9 4.0 6.1 39.3 40.4 17.0 3.6 5.8 5.1 3.5 18.8 32.7 12.8 4.3 8.7 5.2 19.5 15.0 1.7 17.6 13.4 1.7 7.2 15.5 7.6 5.8 7.3 30.7 3.8 4.7 2.8 21.3 3.2 4.3 11.8 8.4 5.4 6.9 12.0 3.2 15.4 13.6 7.7 0.1 3.9 7.1 1.7 1.1 0.7 23.2 0.0 24.5 7.9 18.1 0.0 0.6 2.0 1.6 0.2 0.0 0.0 0.0 4.0 7.5 0.0 9.1 12.3 6.3 3.4 3.6 11.1 11.5 0.0 0.0 0.1 7.6 16.9 0.1 1.7 2.7 21.3 5.0 2.9 0.0 0.2 12.3 0.1 0.0 8.5 5.4 6.3 4.1 8.5 17.1 13.1 10.6 0.0 0.5 1.2 1.8 0.1 0.0 0.0 11.1 8.2 8.8 1.5 5.8 4.1 1.7 5.0 0.6 1.3 0.8 1.4 4.4 0.8 0.2 0.9 1.0 2.0 2.0 3.0 0.3 2.5 4.8 4.2 4.6 4.6 4.0 6.1 5.8 5.1 3.5 5.2 5.8 4.7 5.4 13.4 19.2 36.4 9.8 4.5 5.0 13.9 11.3 10.8 4.9 45.0 30.9 5.6 74.4 23.1 44.1 0.0 19.1 8.6 44.3 19.6 35.1 0.7 68.6 19.6 13.8 67.9 3.4 0.9 53.9 25.0 7.9 31.6 67.8 16.5 66.8 11.7 109.9 18.5 0.0 1.7 56.2 10.2 17.8 6.4 1.4 6.2 16.1 14.2 6.5 23.1 5.8 11.3 3.5 1.5 47.4 47.9 6.8 1.6 18.1 53.1 23.4 25.8 0.9 6.6 15.1 10.7 1.3 3.9 16.2 7.2 26.0 4.3 38.3 60.9 16.4 PNPLA4 "DXS1283E, GS2, iPLA2eta" ENSG00000006757 "Patatin like phospholipase domain containing 4" P41247 X 7898247-7927739 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 95.9;Proximal tubular cells: 126.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003656 Approved "Intracellular and membrane" NA NA "HPA003656: AB_1079033" "unprognostic (2.97e-1)" "unprognostic (2.45e-1)" "unprognostic (4.17e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.29e-4)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.15e-1)" "unprognostic (2.05e-1)" "unprognostic (9.42e-2)" "unprognostic (6.30e-2)" "unprognostic (7.83e-2)" "unprognostic (2.27e-1)" "prognostic favorable (2.23e-12)" "unprognostic (5.23e-2)" "unprognostic (6.71e-3)" "unprognostic (6.30e-2)" "unprognostic (2.12e-1)" 20.9 27.9 11.5 9.8 12.3 8.8 22.8 12.2 11.9 14.0 15.2 15.6 19.0 14.1 18.2 21.2 24.9 9.5 42.5 10.9 17.3 41.6 40.5 9.9 10.9 12.2 13.0 9.9 22.6 29.1 25.4 13.6 8.1 11.5 12.9 12.5 16.9 27.1 10.9 78.7 15.1 11.5 12.2 11.8 9.4 19.7 7.8 13.3 16.4 30.2 66.6 10.3 9.0 13.4 11.9 44.7 18.1 2.8 44.4 0.9 0.5 11.9 13.7 1.5 23.0 14.1 18.1 16.1 13.9 0.1 4.5 0.3 25.7 0.0 45.6 39.2 0.4 32.0 10.0 32.8 38.6 28.6 17.8 14.1 29.5 45.7 11.7 27.3 5.5 16.2 0.3 39.9 0.5 0.3 11.8 0.3 17.2 46.9 30.7 38.0 0.3 0.2 15.6 30.6 20.3 25.3 12.7 41.2 16.8 23.7 49.7 26.1 13.0 9.4 0.2 11.4 35.5 0.2 20.3 0.3 27.0 0.2 0.1 3.7 7.4 11.4 9.7 6.1 13.5 7.0 14.7 8.7 6.7 22.2 16.7 11.3 10.8 0.7 11.9 12.5 16.3 6.0 9.3 11.5 12.3 12.2 11.9 10.9 17.3 12.2 13.0 9.9 11.5 11.8 13.3 11.9 10.7 9.6 12.5 3.3 8.2 11.9 16.7 46.0 17.6 11.3 38.2 33.5 55.0 20.0 24.3 20.2 0.0 28.7 7.8 31.2 95.9 34.2 3.1 35.9 20.6 10.6 19.8 15.6 2.8 48.7 21.3 14.6 13.7 15.5 8.2 17.3 13.2 62.1 28.7 10.1 3.6 30.6 38.7 9.2 10.2 3.7 16.4 12.1 17.8 1.0 13.3 36.1 6.2 2.5 1.0 39.8 25.1 20.3 14.2 15.3 47.6 126.4 31.0 15.0 6.6 6.6 14.6 22.2 21.4 24.0 16.8 14.0 6.4 49.0 32.3 16.0 MYH13 MyHC-eo ENSG00000006788 "Myosin heavy chain 13" Q9UKX3 17 10300865-10373130 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.5;stomach 1: 1.6" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2 OS: 2.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA 29000000 "unprognostic (8.86e-2)" "unprognostic (2.45e-2)" "unprognostic (7.81e-2)" "unprognostic (3.95e-1)" "unprognostic (8.35e-2)" "unprognostic (1.42e-2)" "unprognostic (7.50e-3)" "unprognostic (3.15e-2)" "unprognostic (1.08e-1)" "unprognostic (8.74e-2)" "unprognostic (3.40e-9)" "unprognostic (2.44e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADIPOR2 "ACDCR2, PAQR2" ENSG00000006831 "Adiponectin receptor 2" Q86V24 12 1688574-1788674 "Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 321.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043737 Approved NA NA "HPA043737: AB_10964205" "unprognostic (1.52e-1)" "unprognostic (2.11e-1)" "unprognostic (2.44e-1)" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (1.34e-1)" "unprognostic (5.33e-2)" "unprognostic (7.66e-3)" "unprognostic (4.86e-2)" "unprognostic (1.61e-1)" "unprognostic (5.34e-3)" "unprognostic (2.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.15e-1)" "unprognostic (9.79e-2)" "unprognostic (2.00e-2)" "unprognostic (5.85e-2)" 52.8 72.9 42.0 10.7 52.5 9.7 44.6 50.6 45.8 22.9 34.2 29.4 22.4 24.6 8.2 45.5 23.5 9.7 30.7 39.5 46.6 20.9 80.3 45.0 9.8 52.4 52.0 36.1 25.3 31.3 17.0 26.3 13.1 52.6 20.9 17.9 13.2 22.4 12.0 43.2 31.3 33.0 12.1 51.3 20.0 45.1 27.9 49.1 12.9 28.2 20.0 12.7 21.6 29.5 71.9 34.3 28.0 23.1 21.4 21.4 25.6 30.9 24.6 28.4 31.5 44.5 42.1 51.6 24.1 7.8 23.0 56.7 26.1 34.7 35.8 44.9 62.7 28.7 47.3 22.7 30.3 21.2 36.1 29.3 22.6 35.5 39.8 45.6 28.7 23.1 25.8 31.7 50.9 23.7 48.8 23.6 32.8 46.3 28.4 14.8 19.5 43.7 18.3 31.4 19.9 6.9 16.4 22.7 43.8 51.5 39.7 24.6 46.5 23.2 17.8 37.5 28.6 36.2 12.3 16.5 39.5 21.7 32.3 24.7 0.7 0.7 1.8 0.9 0.7 0.7 0.5 0.5 0.8 0.5 0.5 0.6 0.7 0.9 0.6 0.6 0.9 0.7 0.3 42.0 52.5 50.6 45.8 39.5 46.6 52.4 52.0 36.1 52.6 51.3 49.1 71.9 81.5 12.8 32.4 39.2 21.8 23.7 25.0 26.6 22.8 11.3 29.9 20.3 22.3 31.5 36.6 14.7 18.8 13.9 32.4 91.4 11.7 22.6 56.3 17.8 15.4 41.1 37.5 38.1 35.7 31.4 42.2 21.1 61.7 30.2 36.3 28.8 28.9 113.4 18.2 18.5 41.3 49.0 32.6 27.3 18.9 77.0 15.8 32.6 26.6 124.6 27.0 32.5 27.8 32.2 321.0 39.6 49.4 22.6 30.2 27.8 41.5 10.8 21.7 16.0 6.6 21.3 25.7 45.0 42.2 29.7 34.4 29.3 26.1 39.6 33.5 29.8 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Group enriched" "Detected in many" 6 "Early spermatids: 342.0;Late spermatids: 295.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027751 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 0.7 0.8 3.4 0.5 3.1 0.2 0.6 2.8 4.5 0.7 1.6 0.6 0.5 1.1 0.6 0.6 1.3 0.6 2.7 2.6 2.9 1.5 0.8 0.6 0.8 3.3 3.0 2.4 0.8 0.5 1.0 0.6 0.4 3.3 0.7 0.6 4.2 0.4 0.9 3.4 0.6 0.6 1.5 3.6 0.7 0.5 16.3 3.0 1.0 1.3 3.3 0.9 0.6 0.5 5.3 0.5 1.3 1.7 1.2 2.7 2.4 0.7 1.7 1.4 0.7 1.7 1.2 0.8 1.3 1.0 1.1 3.3 0.5 1.5 1.0 1.2 1.6 1.0 0.8 1.7 1.9 1.7 0.3 0.5 1.1 2.5 2.2 0.6 1.2 0.7 3.4 1.1 0.7 1.9 0.6 1.2 4.6 1.2 0.3 0.5 1.9 0.6 0.4 0.9 0.5 2.5 0.8 1.8 0.1 2.1 1.8 1.0 0.9 0.5 1.4 0.3 1.9 0.5 1.8 2.5 2.9 2.1 1.4 1.1 0.0 0.3 0.3 0.3 0.4 1.4 0.5 0.4 0.9 1.0 0.3 1.3 1.3 0.0 0.6 0.1 0.5 0.9 0.4 3.4 3.1 2.8 4.5 2.6 2.9 3.3 3.0 2.4 3.3 3.6 3.0 5.3 4.1 0.0 3.7 50.6 2.0 10.8 6.4 18.8 4.0 13.3 4.5 5.8 2.2 2.8 9.9 5.5 4.2 3.1 3.2 0.5 9.8 3.5 342.0 7.5 6.4 4.6 3.0 4.8 41.6 5.1 1.8 6.2 1.5 3.7 3.8 7.0 3.6 2.3 3.6 6.7 52.0 1.5 18.3 2.1 19.4 295.3 5.0 2.8 10.6 16.9 2.4 10.8 3.1 32.6 50.7 1.5 1.6 9.1 1.4 4.3 1.3 9.5 12.9 9.7 0.0 6.3 7.9 35.3 17.2 1.7 11.1 4.5 3.4 6.2 0.9 3.8 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 46.2;liver: 24.1" "Cell type enhanced" "Detected in some" "Astrocytes: 24.2;Distal tubular cells: 13.7;Excitatory neurons: 32.5;Inhibitory neurons: 20.8;Oligodendrocyte precursor cells: 27.6;Proximal tubular cells: 82.1" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 0.0 0.1 3.5 0.0 3.1 0.0 0.0 1.9 3.2 0.1 1.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 3.9 1.9 46.2 24.1 0.0 0.1 1.7 1.5 3.0 0.3 0.1 0.0 0.2 0.0 1.8 0.0 0.0 0.9 0.5 0.0 0.0 0.3 0.1 0.0 1.2 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.1 1.9 3.2 3.9 1.9 1.7 1.5 3.0 1.8 1.2 1.5 2.6 0.0 0.0 0.0 24.2 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 13.7 0.0 0.1 0.2 0.1 0.1 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 8.2 0.0 0.0 20.8 0.0 0.0 0.9 0.0 0.1 0.3 0.5 0.0 2.8 0.0 0.1 0.0 27.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 82.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 PRSS21 "ESP-1, TEST1" ENSG00000007038 "Serine protease 21" Q9Y6M0 16 2817180-2826304 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 85.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 84.1;Early spermatids: 111.0;Late spermatids: 349.7;Spermatocytes: 453.2;Spermatogonia: 270.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 23.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 16.1;eosinophil: 33.0" "Lineage enriched" "Detected in all" 7 "granulocytes: 33.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 25.0;HEL: 28.5;HeLa: 71.0;K-562: 34.3;U-698: 104.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 38 "basal ganglia: 8.9" HPA008477 Enhanced Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA008477: AB_1079697" "unprognostic (4.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.06e-2)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (2.33e-1)" "unprognostic (5.21e-2)" "unprognostic (8.83e-3)" "unprognostic (1.52e-3)" "unprognostic (2.97e-2)" "unprognostic (1.14e-2)" "unprognostic (5.07e-2)" "unprognostic (7.79e-2)" "unprognostic (2.99e-1)" 0.1 0.0 0.1 0.5 0.1 7.9 1.4 0.0 0.1 1.6 0.0 0.6 0.5 0.2 0.0 1.5 2.7 1.8 0.0 0.1 0.1 0.1 0.1 2.5 1.2 0.1 0.1 0.1 0.1 2.0 1.5 0.1 0.0 0.1 3.8 0.5 0.0 20.6 0.3 0.0 0.8 0.8 0.1 0.0 1.7 0.8 85.3 0.1 1.1 0.0 0.0 1.2 0.4 1.4 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 25.0 0.0 0.1 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 28.5 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 13.8 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 16.1 3.5 33.0 3.1 2.6 4.8 1.2 1.5 2.6 0.9 0.8 2.2 3.2 0.3 1.8 0.5 2.2 1.0 2.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 4.6 1.1 37.9 9.4 13.1 0.0 6.1 8.4 84.1 0.0 2.7 0.0 0.0 0.3 2.1 1.4 0.0 1.1 111.0 0.3 2.6 1.6 0.0 9.7 0.0 0.4 9.0 0.7 0.0 0.4 0.0 0.4 0.0 0.0 11.1 0.0 0.0 1.5 4.1 0.6 0.7 349.7 6.5 5.7 0.0 0.0 1.1 0.0 4.1 0.0 0.1 0.7 0.6 3.8 20.4 32.7 0.1 0.1 0.5 0.0 46.0 0.0 1.0 453.2 270.2 2.8 0.6 0.1 3.4 0.0 2.4 14.5 MARK4 "FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D" ENSG00000007047 "Microtubule affinity regulating kinase 4" Q96L34 19 45079288-45305284 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 119.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039186 Approved Supported Cytosol NA NA Cytosol "HPA039186: AB_10796223" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.31e-8)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.05e-5)" "unprognostic (1.90e-1)" "unprognostic (2.16e-2)" "unprognostic (6.26e-2)" "unprognostic (5.64e-3)" "unprognostic (1.24e-3)" "unprognostic (7.50e-2)" "unprognostic (3.80e-2)" "unprognostic (6.89e-2)" "unprognostic (7.23e-2)" "unprognostic (4.65e-2)" "unprognostic (3.02e-2)" 12.9 13.7 26.4 7.3 30.3 8.6 13.1 15.1 37.9 16.9 11.1 13.5 5.1 15.6 16.7 16.6 14.9 10.7 16.8 30.7 21.8 13.5 22.0 14.0 8.3 23.0 24.4 30.1 21.9 14.2 20.6 16.7 11.7 24.3 16.3 5.9 26.2 12.8 13.1 39.1 26.6 9.1 14.7 12.0 11.5 14.4 40.7 28.4 13.2 12.8 12.1 9.7 19.1 16.9 25.1 20.3 7.7 36.6 23.8 25.3 36.8 8.8 15.3 25.1 21.8 20.8 4.0 10.8 8.5 12.0 28.9 20.6 13.5 26.4 22.5 14.2 15.7 16.0 20.7 8.5 17.0 47.6 4.4 15.1 48.1 31.9 18.7 22.8 43.3 29.5 22.1 22.6 21.8 24.9 14.4 16.7 14.5 12.3 18.6 4.7 61.5 11.4 6.3 23.4 16.0 58.8 27.1 20.5 17.5 12.5 35.9 9.0 29.3 21.6 16.7 12.9 12.2 9.0 22.7 21.8 10.8 17.9 8.4 12.7 1.1 1.0 0.2 1.0 0.7 0.2 0.2 0.3 1.3 0.3 0.2 0.6 0.7 0.9 0.7 0.7 0.9 0.8 0.4 26.4 30.3 15.1 37.9 30.7 21.8 23.0 24.4 30.1 24.3 12.0 28.4 25.1 8.7 12.8 3.1 30.7 6.0 25.0 11.3 7.2 15.4 20.9 10.2 7.0 9.1 11.5 4.4 9.2 25.0 4.3 8.1 3.7 11.7 8.4 2.3 6.6 9.5 12.2 6.1 6.1 31.1 6.1 1.5 8.4 10.2 10.5 2.5 18.9 18.5 10.7 7.0 119.5 36.5 4.7 4.1 9.5 11.0 6.3 16.1 8.2 3.6 16.9 5.9 19.6 12.3 23.1 16.4 9.5 3.5 13.9 7.7 13.0 4.7 6.5 2.5 15.6 0.0 7.6 8.4 1.2 8.3 12.5 24.2 11.5 10.3 26.1 3.2 15.5 PROM1 "AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4" ENSG00000007062 "Prominin 1" O43490 4 15963076-16084378 "CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 275.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004922, CAB011525, HPA031053" Enhanced NA NA "CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713" "unprognostic (6.33e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-1)" "unprognostic (3.39e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-1)" "unprognostic (2.39e-1)" "unprognostic (6.64e-2)" "unprognostic (2.18e-2)" "unprognostic (2.17e-1)" "unprognostic (1.21e-2)" "unprognostic (9.06e-2)" "prognostic favorable (2.56e-5)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (9.38e-2)" "unprognostic (1.17e-1)" 0.3 0.3 4.4 6.2 2.9 4.0 27.9 2.9 3.5 45.3 1.7 31.0 12.5 6.1 4.4 5.1 5.4 31.2 6.8 3.2 2.6 21.1 1.8 3.2 0.0 3.8 3.1 1.7 0.1 14.6 0.0 0.1 30.3 4.1 2.9 16.9 275.3 58.4 7.1 1.0 0.8 23.1 3.6 2.5 0.2 25.0 8.1 4.2 0.1 4.9 0.0 0.1 4.2 0.2 3.4 0.0 0.0 37.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 70.6 28.9 0.6 62.2 0.0 0.0 0.1 7.3 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 97.4 0.0 0.0 1.4 0.1 0.0 91.1 0.1 12.0 3.6 0.0 2.4 1.9 3.5 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 2.9 2.9 3.5 3.2 2.6 3.8 3.1 1.7 4.1 2.5 4.2 3.4 0.2 3.2 4.8 1.3 0.3 0.0 0.1 7.2 0.0 14.8 38.2 30.0 8.6 31.5 29.9 82.8 581.7 0.6 1.0 39.3 0.0 64.1 31.4 71.1 1.7 5.1 44.4 2.1 0.9 15.5 0.1 4.4 31.6 14.8 0.0 3.8 0.7 0.1 0.1 10.1 5.4 15.0 34.6 0.0 0.0 44.3 3.1 0.7 0.0 27.2 0.6 47.5 0.0 45.8 1.2 38.2 28.3 6.4 0.4 1.5 18.8 3.6 144.8 311.3 0.0 0.8 3.1 2.1 1.0 0.7 0.0 0.1 0.7 0.3 26.0 4.1 CCDC124 ENSG00000007080 "Coiled-coil domain containing 124" Q96CT7 19 17933015-17943991 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041708, HPA046765" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041708: AB_2677628, HPA046765: AB_2679793" "unprognostic (9.39e-2)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.32e-2)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.19e-1)" "unprognostic (3.71e-2)" "unprognostic (3.22e-1)" 82.9 68.2 52.1 32.3 48.4 43.1 78.7 50.3 105.3 74.2 39.0 97.3 25.8 79.2 7.2 101.1 68.4 11.3 121.0 49.0 46.2 88.8 88.7 71.4 22.9 50.1 47.8 45.4 65.5 72.8 22.3 56.2 20.4 50.9 78.6 8.4 9.0 69.8 22.4 211.9 92.9 59.0 14.4 43.9 68.0 81.9 48.9 52.7 17.8 66.1 38.6 12.3 85.2 81.6 58.0 242.7 165.3 54.2 111.3 35.4 26.9 178.8 118.9 36.7 59.0 49.8 125.0 97.1 182.8 166.7 47.5 38.8 90.1 60.0 108.3 17.2 194.7 341.8 152.7 140.5 147.0 68.4 174.4 100.6 43.2 70.7 59.7 56.9 33.9 62.7 115.0 196.3 74.4 30.8 232.8 166.1 212.3 126.3 79.2 282.2 163.2 103.6 195.1 48.9 85.7 108.6 155.8 83.4 92.4 121.3 22.0 86.2 62.6 142.0 102.3 128.1 198.0 185.6 102.8 121.7 178.5 128.6 203.1 133.0 81.1 82.2 73.5 85.9 95.1 69.2 61.0 66.8 80.8 85.5 66.4 51.8 63.5 20.5 76.3 71.3 75.4 84.1 66.2 52.1 48.4 50.3 105.3 49.0 46.2 50.1 47.8 45.4 50.9 43.9 52.7 58.0 58.8 19.2 4.8 8.1 41.1 90.5 60.0 115.9 44.9 22.9 49.3 57.3 15.6 35.8 58.7 73.5 2.1 93.8 44.1 108.9 137.0 146.2 33.4 46.7 50.9 57.3 61.0 79.8 7.4 199.0 140.2 58.1 79.0 56.5 27.3 73.9 50.7 57.1 110.3 10.1 6.4 89.0 101.7 60.0 73.2 106.1 32.6 50.3 96.0 4.7 86.4 50.9 50.4 4.5 7.1 227.9 70.0 41.3 68.7 108.7 78.5 142.3 44.8 23.1 19.7 43.4 76.0 30.9 39.9 79.6 109.8 82.8 42.8 184.7 88.6 73.5 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "CEA cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 10.3" "Cell type enriched" "Detected in some" 10 "Granulosa cells: 150.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8" HPA043411 Uncertain NA NA "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favorable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.1 0.7 1.4 2.2 0.9 17.6 0.8 0.9 1.3 2.2 0.7 0.7 0.6 2.7 0.3 0.5 0.7 0.5 0.5 0.9 2.3 0.7 1.2 3.8 5.3 1.9 2.5 0.8 0.4 0.2 0.1 0.4 1.5 1.9 0.6 0.6 0.0 0.5 3.6 0.1 0.1 2.6 0.5 1.5 10.3 0.9 1.1 3.1 2.2 0.6 0.1 3.5 0.8 0.3 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.8 1.0 1.0 0.0 5.8 0.0 0.1 6.0 27.3 29.7 11.7 20.1 10.8 25.6 20.8 6.9 15.1 21.3 21.0 30.2 19.2 7.0 12.4 26.6 17.9 1.4 0.9 0.9 1.3 0.9 2.3 1.9 2.5 0.8 1.9 1.5 3.1 1.7 1.5 0.0 0.0 0.3 5.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.6 1.8 0.0 0.1 7.2 0.0 0.0 0.0 5.4 7.3 0.1 2.0 0.0 5.7 0.1 0.0 0.1 0.3 0.0 2.2 4.5 150.8 10.0 0.3 9.4 0.0 0.7 0.0 0.0 9.0 0.6 10.3 0.0 6.2 1.8 15.0 1.0 0.0 9.2 0.0 0.1 0.0 0.0 0.4 10.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.6 0.0 0.0 0.3 8.8 0.0 0.0 0.0 PAFAH1B1 "LIS1, MDCR, MDS, NudF, PAFAH" ENSG00000007168 "Platelet activating factor acetylhydrolase 1b regulatory subunit 1" P43034 17 2593210-2685615 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport" "Developmental protein" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 640.0;Late spermatids: 1864.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004489, HPA020036" Approved Supported Centrosome NA NA 860000 Centrosome "CAB004489: AB_627889, HPA020036: AB_1854925" "unprognostic (1.54e-3)" "unprognostic (6.84e-2)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (2.13e-1)" "unprognostic (3.19e-3)" "unprognostic (3.17e-2)" "unprognostic (6.36e-2)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" "unprognostic (3.89e-3)" "unprognostic (5.80e-2)" "prognostic favorable (3.16e-4)" "unprognostic (3.31e-1)" "unprognostic (3.51e-1)" "unprognostic (7.45e-2)" "unprognostic (5.58e-2)" 33.4 32.5 32.9 27.4 44.8 4.1 33.0 31.2 46.9 36.8 7.2 42.1 30.7 44.2 27.1 38.3 37.1 32.0 51.6 43.8 43.5 41.7 30.2 37.6 31.2 41.2 40.4 35.5 35.7 26.5 56.8 38.7 32.7 44.9 32.9 33.1 47.6 32.7 39.0 88.4 42.2 36.8 44.8 29.9 31.3 34.9 56.2 40.5 41.9 44.3 73.8 39.1 36.0 38.1 55.9 51.3 53.3 81.8 28.4 66.9 74.1 27.3 76.5 67.1 56.3 53.0 69.7 18.7 64.5 63.5 100.3 27.4 53.5 74.4 59.8 80.6 50.9 48.4 56.4 48.8 27.3 69.3 37.5 66.4 68.8 73.5 58.8 58.1 71.7 58.1 51.8 38.8 32.7 84.8 21.1 58.3 28.6 36.7 30.5 27.0 39.5 67.6 30.0 62.5 30.5 37.4 62.0 63.0 34.5 65.5 51.8 36.5 30.1 84.9 71.5 17.1 57.1 61.0 24.7 32.1 28.8 60.4 33.7 66.2 2.6 1.7 3.4 4.7 2.5 5.2 2.9 4.1 3.3 2.5 2.4 4.9 3.8 2.6 3.6 3.8 1.5 5.1 2.4 32.9 44.8 31.2 46.9 43.8 43.5 41.2 40.4 35.5 44.9 29.9 40.5 55.9 73.7 121.8 92.2 90.8 82.7 118.7 114.8 74.3 63.2 102.4 52.1 42.9 136.3 30.0 101.6 35.0 50.1 56.4 117.2 77.4 35.2 77.2 640.0 82.2 95.5 77.2 34.1 45.9 178.1 56.3 76.7 74.7 87.7 100.9 93.7 45.1 43.2 32.3 60.2 102.6 161.8 43.7 57.0 46.3 77.0 1864.4 64.0 77.6 56.9 104.9 90.3 60.7 97.9 115.1 193.5 100.8 61.5 56.8 91.7 91.6 76.9 55.0 80.7 65.8 46.0 84.5 133.0 256.8 78.1 69.7 132.6 129.6 92.7 54.7 39.2 122.4 NOS2 "HEP-NOS, iNOS, NOS, NOS2A" ENSG00000007171 "Nitric oxide synthase 2" P35228 17 27756766-27800529 "Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 21.3;lymphoid tissue: 14.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 40.3;Extravillous trophoblasts: 27.7;Granulosa cells: 57.3;Proximal enterocytes: 10.7;Undifferentiated cells: 10.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 16.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 16.5;SCLC-21H: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB002014 Enhanced NA NA "CAB002014: " "unprognostic (1.95e-3)" "unprognostic (3.08e-3)" "unprognostic (4.75e-3)" "unprognostic (4.42e-3)" "unprognostic (3.49e-1)" "unprognostic (2.13e-2)" "unprognostic (5.61e-2)" "unprognostic (5.09e-2)" "unprognostic (9.91e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "unprognostic (1.34e-1)" "unprognostic (6.04e-2)" "unprognostic (8.02e-2)" "unprognostic (3.68e-1)" "unprognostic (8.69e-2)" "unprognostic (4.03e-2)" 1.0 0.5 0.3 14.6 0.5 0.0 0.3 0.1 2.2 0.2 0.0 6.9 12.2 0.2 0.0 0.7 0.4 0.4 0.4 0.6 0.4 1.2 0.1 1.8 0.8 0.5 0.3 0.6 0.6 0.3 0.1 1.3 0.6 0.9 0.6 9.0 0.2 0.1 0.2 0.8 0.2 21.3 1.8 0.1 0.1 0.1 0.3 0.8 0.1 0.4 0.7 0.1 3.6 0.2 0.9 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.9 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 2.2 0.6 0.4 0.5 0.3 0.6 0.9 0.1 0.8 0.9 1.2 0.0 0.0 1.3 0.6 0.0 0.2 3.6 0.0 0.5 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.2 0.0 40.3 0.0 0.0 0.2 0.0 0.0 0.7 2.4 0.0 4.1 0.0 27.7 0.2 0.0 0.1 0.0 57.3 0.0 0.0 0.7 0.0 2.2 3.8 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.9 0.4 0.0 1.4 10.7 0.1 0.5 0.1 0.0 0.3 1.2 0.0 1.5 0.0 0.0 0.5 0.3 0.1 10.2 1.0 DNAH9 "DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357" ENSG00000007174 "Dynein axonemal heavy chain 9" Q9NYC9 17 11598470-11969748 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;choroid plexus: 23.3;fallopian tube: 35.7" "Cell type enhanced" "Detected in many" "Early spermatids: 48.7;Endometrial ciliated cells: 97.5;Excitatory neurons: 26.8;Late spermatids: 56.5;Respiratory ciliated cells: 110.5" "Group enriched" "Detected in some" 4 "endometrial cancer: 1.1;glioma: 1.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.1;WM-115: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052641 Enhanced NA NA "HPA052641: AB_2681895" "unprognostic (4.16e-3)" "unprognostic (3.67e-2)" "unprognostic (9.31e-2)" "prognostic favorable (6.79e-5)" "unprognostic (8.37e-3)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (1.68e-1)" "unprognostic (1.26e-1)" "unprognostic (7.35e-2)" "unprognostic (1.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-3)" "unprognostic (5.31e-2)" 2.1 0.8 22.0 0.3 8.9 0.0 1.5 13.8 8.1 1.2 23.3 0.1 0.0 1.4 2.2 0.1 35.7 0.4 0.1 11.3 18.6 1.5 0.1 2.8 0.0 21.2 23.1 6.3 1.4 1.9 3.6 3.3 0.3 18.0 0.8 0.0 6.6 0.3 2.0 0.2 0.3 0.1 0.5 26.0 0.1 0.3 6.3 13.6 0.1 0.9 0.0 0.0 0.3 0.3 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 8.9 13.8 8.1 11.3 18.6 21.2 23.1 6.3 18.0 26.0 13.6 11.4 0.1 3.2 1.1 8.5 0.0 0.8 0.9 3.6 1.2 2.0 0.2 0.4 1.7 0.0 6.1 3.7 2.1 0.0 0.0 0.6 1.9 1.4 48.7 97.5 2.0 0.3 0.0 0.0 26.8 0.2 0.0 1.5 0.0 2.1 1.3 1.2 0.0 0.0 0.1 0.0 17.6 0.2 2.0 0.0 0.4 56.5 0.6 0.2 0.0 3.7 0.0 1.8 0.0 11.1 8.3 0.1 0.0 3.0 0.1 0.6 0.0 0.2 110.5 8.2 0.0 1.5 2.5 5.3 2.4 0.6 1.1 0.1 0.3 1.4 0.0 0.6 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614446-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted to blood" No No "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavorable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 36.4 31.0 22.5 28.8 20.1 31.7 30.9 18.1 23.3 22.9 28.1 31.1 19.9 23.3 26.0 31.6 29.4 20.7 24.2 24.0 20.7 43.4 18.7 31.0 28.6 27.8 25.3 19.7 24.1 24.6 52.2 25.4 29.9 29.8 27.3 35.1 27.7 29.1 27.4 52.4 32.1 26.9 35.6 18.4 29.0 23.5 25.1 26.5 32.6 35.7 42.9 35.2 30.6 16.1 24.2 66.5 123.8 61.4 58.8 109.3 64.8 44.8 60.9 80.1 72.3 67.6 85.9 29.4 92.0 71.2 111.2 75.3 86.2 91.4 89.6 87.1 102.8 88.7 73.2 95.9 47.2 47.0 129.1 121.3 66.5 68.2 98.0 74.1 56.1 104.9 64.1 70.6 29.0 66.8 94.4 94.5 61.1 26.9 119.0 46.6 71.7 69.0 60.0 43.4 116.9 60.2 46.5 76.8 205.5 50.7 76.0 123.2 88.6 98.1 55.0 60.4 74.5 116.2 27.2 33.8 58.0 62.8 81.7 65.4 0.3 1.1 1.5 1.2 1.0 1.2 1.1 0.5 1.0 1.3 0.6 0.6 0.7 0.7 0.8 1.2 2.9 0.7 0.7 22.5 20.1 18.1 23.3 24.0 20.7 27.8 25.3 19.7 29.8 18.4 26.5 24.2 21.5 16.0 17.8 15.0 16.5 10.3 8.9 8.7 15.4 31.7 19.3 14.7 30.2 14.3 13.0 12.9 29.2 15.3 34.4 30.5 5.9 9.9 19.4 20.4 16.1 16.4 12.1 14.1 19.1 11.0 9.4 14.1 21.4 16.4 8.2 20.4 18.5 30.5 10.6 28.6 18.3 16.4 8.2 31.5 18.6 23.2 9.3 19.9 10.6 14.0 25.3 14.3 21.6 11.6 12.7 9.8 12.1 6.4 17.1 15.8 17.9 15.1 15.1 22.5 0.0 20.3 20.1 30.5 28.1 22.9 11.1 45.6 17.0 24.2 22.6 11.7 SLC13A2 NaDC-1 ENSG00000007216 "Solute carrier family 13 member 2" Q13183 17 28473293-28497781 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 120.7;kidney: 38.5;salivary gland: 45.3" "Group enriched" "Detected in some" 6 "Proximal enterocytes: 290.2;Proximal tubular cells: 97.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014963 Enhanced NA NA "HPA014963: AB_1857096" "unprognostic (8.47e-2)" "unprognostic (7.63e-3)" "unprognostic (4.36e-3)" "unprognostic (2.06e-1)" "unprognostic (2.36e-3)" "unprognostic (3.06e-1)" "unprognostic (2.28e-4)" "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "prognostic favorable (9.00e-4)" "unprognostic (2.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.6 6.1 120.7 0.0 3.0 0.0 0.0 6.8 0.0 0.0 0.0 38.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.8 45.3 11.6 0.0 3.0 91.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 13.7 10.9 0.6 27.1 1.6 3.7 12.5 0.0 0.7 29.3 9.8 0.7 0.0 0.0 0.0 0.2 4.8 0.0 0.1 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 31.4 0.0 0.0 0.4 0.0 0.0 0.7 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 15.7 0.0 0.0 0.0 290.2 97.8 0.3 0.4 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 25.8 0.5 GAS7 "KIAA0394, MGC1348" ENSG00000007237 "Growth arrest specific 7" O60861 17 9910606-10198606 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3" "Group enriched" "Detected in all" 4 "glioma: 15.7;melanoma: 54.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 26.2" "Group enriched" "Detected in many" 4 "granulocytes: 17.1;monocytes: 26.2" "Cell line enriched" "Detected in many" 9 "WM-115: 533.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004838, HPA064678" Enhanced Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane" "Actin filaments, Focal adhesion sites" "HPA004838: AB_2667263, HPA064678: AB_2685319" "unprognostic (1.68e-2)" "unprognostic (2.84e-3)" "unprognostic (1.80e-1)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-2)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-2)" "unprognostic (2.48e-1)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" "unprognostic (6.48e-2)" "unprognostic (8.78e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (6.89e-4)" 27.5 8.6 21.5 23.9 75.9 31.4 15.5 79.3 77.7 30.2 0.0 20.9 7.4 13.5 4.4 24.0 18.0 16.4 38.4 58.8 36.3 1.7 2.3 17.2 9.1 24.8 31.2 43.7 7.9 3.4 1.1 2.7 16.3 33.9 8.5 12.1 30.4 7.9 10.9 5.8 31.4 12.0 24.2 22.4 16.3 8.9 17.6 24.5 9.3 4.7 6.8 10.4 18.5 19.6 85.9 0.1 0.5 0.6 1.0 16.5 22.5 0.3 0.8 0.0 2.6 1.1 0.1 0.2 6.6 1.9 6.6 0.3 0.3 0.0 0.0 1.6 0.0 1.5 0.0 1.3 0.7 5.3 1.8 48.7 4.3 0.3 5.1 0.1 0.0 0.0 42.7 0.0 0.6 0.0 0.0 54.3 15.4 2.6 2.1 0.0 14.3 0.1 49.6 0.0 0.2 0.1 3.0 0.2 0.2 60.1 21.0 2.8 24.7 0.0 0.2 3.4 0.1 0.1 0.4 0.0 0.0 0.4 35.1 533.8 0.6 26.2 17.1 2.8 6.9 0.9 0.5 0.3 1.4 5.3 0.6 0.2 1.4 16.4 4.5 4.9 1.0 0.0 7.7 21.5 75.9 79.3 77.7 58.8 36.3 24.8 31.2 43.7 33.9 22.4 24.5 85.9 2.9 0.0 4.2 6.8 3.3 8.3 4.5 1.5 1.2 34.6 1.6 2.3 13.3 0.0 1.1 5.5 27.1 1.0 14.5 0.0 0.0 1.0 62.3 17.7 12.8 5.7 0.0 0.4 133.6 0.0 1.8 79.6 0.0 26.3 17.2 7.9 5.0 0.9 39.2 0.0 76.6 0.0 0.0 66.7 32.2 73.4 10.2 54.3 33.8 52.5 57.2 9.5 18.6 11.1 163.3 0.2 0.0 1.9 5.5 2.0 0.0 0.1 16.3 31.7 0.0 67.0 7.1 1.6 6.7 1.0 16.6 1.9 7.4 0.2 0.0 4.9 TRAPPC6A "HSPC289, MGC2650, TRS33" ENSG00000007255 "Trafficking protein particle complex 6A" O75865 19 45162928-45178237 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 246.5;Proximal tubular cells: 303.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 164.5;U-266/70: 135.3" "Low region specificity" "Detected in all" HPA043043 Approved NA NA "HPA043043: AB_10794650" "unprognostic (2.92e-2)" "unprognostic (1.21e-1)" "unprognostic (5.86e-2)" "unprognostic (8.42e-3)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (1.57e-2)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" "unprognostic (2.47e-1)" "unprognostic (1.46e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.23e-6)" "unprognostic (3.85e-1)" "unprognostic (2.33e-1)" "unprognostic (1.88e-1)" "unprognostic (1.05e-2)" 24.6 33.0 21.4 14.2 24.5 49.2 31.2 24.2 35.4 20.7 16.3 29.2 18.5 21.8 19.7 25.6 29.4 16.1 20.8 20.7 21.2 57.9 60.3 18.8 34.5 25.2 23.6 19.3 23.2 29.1 17.2 20.7 12.8 26.4 39.4 11.6 4.6 30.9 16.9 35.5 54.2 28.3 7.1 23.7 42.7 32.4 25.0 22.8 20.8 38.7 16.0 17.5 23.9 24.7 29.7 7.6 42.1 9.4 18.7 15.7 11.3 18.3 2.3 8.2 2.6 5.8 12.6 38.2 76.1 40.0 4.8 22.0 15.8 3.3 6.8 1.1 42.5 30.8 28.0 3.5 14.0 33.0 12.3 28.2 27.8 37.9 2.0 12.8 10.4 8.9 48.8 27.6 57.7 4.1 104.0 30.5 42.0 11.9 164.5 21.0 52.8 10.2 93.9 27.2 26.6 44.2 18.3 16.4 77.9 29.1 16.0 45.1 39.3 3.5 6.3 6.8 4.4 2.7 135.3 43.0 57.0 14.4 25.6 10.5 25.7 59.5 30.5 78.2 60.3 94.8 92.1 105.5 81.8 91.2 93.7 110.4 95.1 4.8 113.6 62.8 87.6 112.7 86.2 21.4 24.5 24.2 35.4 20.7 21.2 25.2 23.6 19.3 26.4 23.7 22.8 29.7 28.8 44.8 51.7 5.2 61.6 58.1 64.3 149.3 55.2 13.6 66.6 71.4 17.9 68.6 71.5 58.8 2.1 122.7 63.4 41.7 246.5 53.4 15.1 56.8 26.9 33.7 83.8 23.8 2.7 42.1 43.7 24.8 29.6 65.2 40.6 63.9 42.1 113.7 72.0 13.5 2.3 84.6 148.5 56.6 67.3 94.0 19.3 45.3 108.5 5.6 114.2 54.9 60.8 4.5 10.7 24.4 73.8 10.5 39.9 35.1 61.8 303.6 62.0 13.6 13.1 23.9 34.4 14.2 68.9 43.0 83.5 88.5 72.1 72.7 81.8 71.6 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.7;brain: 41.5" "Cell type enhanced" "Detected in many" "dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 76.8" "Group enriched" "Detected in many" 57 "NK-cells: 76.8;T-cells: 46.2" "Cell line enhanced" "Detected in some" "HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favorable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 3.9 1.3 16.6 6.7 20.0 20.7 2.5 1.9 41.5 1.1 1.9 2.0 6.7 0.9 0.1 2.1 4.0 4.4 1.4 25.4 11.4 2.3 3.2 9.9 9.5 10.3 7.1 18.4 0.7 1.2 0.7 2.7 1.0 15.0 1.4 1.1 2.2 3.2 0.7 0.8 1.6 6.2 0.8 3.7 16.6 4.0 3.1 9.7 3.8 1.6 0.2 4.0 1.6 1.2 22.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.2 1.7 0.0 1.0 10.6 13.8 0.4 0.0 0.0 18.1 12.0 1.5 2.9 0.0 108.3 30.9 0.1 0.0 0.2 0.1 0.0 0.0 1.2 48.9 0.1 0.0 34.4 0.3 74.8 8.4 9.0 0.3 0.0 0.1 0.0 0.0 0.0 30.9 0.1 0.1 0.1 0.1 0.9 0.0 27.4 3.3 0.0 0.6 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 46.2 0.0 31.3 0.0 5.7 29.3 0.8 0.9 2.7 16.4 1.0 76.8 0.2 0.3 0.4 7.6 16.6 20.0 1.9 41.5 25.4 11.4 10.3 7.1 18.4 15.0 3.7 9.7 22.7 1.4 0.0 1.1 0.3 11.1 0.4 0.1 0.0 0.0 1.4 4.9 7.2 1.3 0.0 0.0 0.0 12.5 0.3 177.0 0.3 0.0 0.0 2.0 0.2 0.5 1.9 7.1 28.6 17.7 0.0 0.5 0.8 11.7 0.5 44.5 0.1 8.6 1.1 57.4 0.0 8.3 0.3 0.0 6.0 14.6 5.1 0.0 11.5 1.8 4.7 3.0 1.3 422.2 2.0 1.6 0.0 1.1 0.0 17.1 0.1 0.3 0.2 0.7 2.0 0.0 0.5 1.2 0.4 4.5 1.3 1.1 0.3 99.7 0.0 1.1 0.0 CEACAM7 "CEA, CGM2" ENSG00000007306 "CEA cell adhesion molecule 7" Q14002 19 41673303-41706976 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "intestine: 657.9" "Group enriched" "Detected in some" 9 "Distal enterocytes: 1454.0;Paneth cells: 731.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 66.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA069621, HPA073910" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "HPA069621: AB_2686162, HPA073910: " "unprognostic (5.24e-2)" "unprognostic (2.72e-1)" "unprognostic (1.64e-2)" "unprognostic (6.03e-2)" "unprognostic (2.07e-2)" "unprognostic (4.30e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.14e-1)" 0.6 0.0 0.0 72.1 0.0 0.1 2.9 0.0 0.0 6.6 0.0 601.4 0.6 0.3 0.0 53.1 0.6 39.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 657.9 0.0 4.0 0.8 0.1 1.4 0.7 5.7 0.0 0.2 2.0 0.1 0.0 0.0 0.0 0.0 12.1 23.6 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 1454.0 0.0 116.6 0.1 0.0 0.0 0.5 8.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 1.0 731.2 0.0 0.0 1.4 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 38.4 30.3 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932336 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 268.9" "Cell type enriched" "Detected in many" 4 "B-cells: 491.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 4 "memory B-cell: 1132.1;naive B-cell: 1505.8" "Lineage enriched" "Detected in all" 5 "B-cells: 1505.8" "Cell line enhanced" "Detected in some" "Daudi: 1060.0;REH: 350.2;U-698: 1475.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 4.9 1.7 0.9 71.1 0.9 55.0 3.4 0.9 1.4 1.9 1.7 7.8 4.7 1.5 1.6 2.6 1.6 6.8 7.5 0.8 0.9 4.7 3.5 5.0 268.9 1.0 0.9 0.8 0.6 0.7 0.7 25.5 3.8 1.5 2.5 7.3 0.0 7.9 0.8 3.5 1.9 66.7 2.6 0.9 148.9 10.8 1.0 0.9 27.4 4.1 5.8 210.1 13.5 2.2 1.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 1060.0 7.8 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.4 0.6 0.6 0.5 0.0 0.0 0.1 0.0 0.0 1.2 0.4 1.2 56.9 0.0 0.0 0.6 23.0 0.3 0.0 0.0 350.2 0.9 4.4 0.0 0.0 0.5 0.0 1.7 0.0 0.7 5.8 0.0 16.2 1.7 0.1 3.7 0.3 0.6 51.3 54.4 1475.5 0.0 2.2 0.0 6.2 13.0 1.1 44.9 192.2 51.3 1132.1 57.1 30.1 47.0 1505.8 38.4 23.2 5.8 42.4 304.3 6.7 107.9 112.1 0.9 0.9 0.9 1.4 0.8 0.9 1.0 0.9 0.8 1.5 0.9 0.9 1.0 24.9 0.0 1.3 0.0 491.9 4.5 0.4 0.0 1.8 0.0 1.1 4.4 1.4 1.5 0.0 0.0 0.0 0.2 24.2 0.3 0.0 0.1 0.6 0.3 1.0 25.2 1.2 8.6 0.0 0.0 0.4 3.3 0.5 0.3 15.2 0.0 51.4 1.3 5.8 0.0 0.0 0.4 0.0 14.8 5.1 1.4 1.2 13.4 21.4 0.0 14.3 0.0 36.0 0.0 0.0 0.0 0.1 1.9 99.6 0.4 0.0 1.0 0.0 0.0 0.0 4.4 5.4 1.2 0.3 0.7 3.1 0.4 27.0 0.5 0.8 0.2 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 138.7;tongue: 54.5" "Cell type enriched" "Detected in some" 6 "Adipocytes: 46.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "REH: 15.0;RH-30: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA053992 Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA053992: AB_2797249" "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 14.7 0.7 0.0 0.2 0.1 0.0 16.2 0.2 0.1 0.1 0.0 0.8 0.0 0.1 0.0 1.1 0.2 0.3 0.8 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.7 1.5 0.1 0.1 0.5 0.1 0.0 1.8 0.0 138.7 0.7 0.3 0.0 0.0 0.9 0.5 1.7 0.0 0.2 4.3 54.5 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 15.0 45.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 1.4 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 1.1 2.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.1 5.9 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523514-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 36.3" "Cell type enhanced" "Detected in all" "Early spermatids: 189.7;Late spermatids: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome NA NA Centrosome "HPA042324: AB_10794273, HPA075418: AB_2686749" "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favorable (8.34e-5)" "prognostic unfavorable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.16e-4)" "prognostic favorable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 4.7 5.3 2.3 2.2 3.0 5.6 4.9 3.7 3.2 4.6 2.5 3.2 2.9 5.2 5.0 3.5 3.8 3.4 5.5 2.1 2.5 3.6 4.2 2.8 2.9 1.9 2.3 1.8 5.7 3.9 4.7 2.2 3.9 2.2 4.4 4.7 6.8 3.0 4.2 4.8 6.2 2.6 4.2 2.1 2.1 2.3 36.3 2.1 3.4 7.7 4.6 3.3 3.7 3.1 3.6 5.2 1.5 8.8 6.1 11.7 11.6 2.0 5.9 4.8 2.6 3.9 2.8 4.8 2.0 2.4 2.6 7.9 3.3 10.2 8.3 4.0 3.2 6.0 6.2 8.0 2.1 6.7 4.9 6.3 2.3 2.0 3.0 6.3 6.2 8.9 7.4 3.4 6.5 11.1 1.4 2.7 1.9 4.0 2.3 5.3 4.4 4.0 0.8 5.7 6.2 6.2 3.7 3.4 4.8 4.4 1.5 3.6 3.0 8.8 6.0 5.9 7.9 6.0 1.7 1.3 2.1 5.5 8.2 13.5 0.1 0.9 0.1 1.2 1.1 1.9 2.4 1.8 0.9 0.9 1.3 2.5 1.4 0.2 3.7 0.9 1.8 1.4 1.0 2.3 3.0 3.7 3.2 2.1 2.5 1.9 2.3 1.8 2.2 2.1 2.1 3.6 14.4 22.4 9.6 46.0 8.0 17.0 16.7 14.9 23.9 19.7 13.7 15.9 6.7 12.8 12.8 9.2 6.2 13.0 10.8 4.9 9.8 8.5 189.7 8.5 13.8 12.1 5.4 9.9 48.1 8.6 6.7 12.2 8.6 9.5 8.2 15.1 5.0 8.0 8.5 25.2 55.0 9.8 18.3 10.9 8.6 301.2 18.0 12.5 21.4 37.5 6.0 21.8 3.1 68.3 67.9 7.4 5.1 16.1 13.9 12.4 6.8 6.9 10.4 25.2 19.7 15.7 13.3 65.4 14.5 17.6 18.3 6.2 11.3 17.2 9.7 10.6 TKTL1 "TKR, TKT2" ENSG00000007350 "Transketolase like 1" P51854 X 154295795-154330350 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 128.2" "Group enriched" "Detected in some" 7 "Spermatocytes: 166.9;Spermatogonia: 491.5" "Cancer enriched" "Detected in many" 8 "testis cancer: 44.2" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.8;medulla oblongata: 1.8" "Group enriched" "Detected in many" 5 "eosinophil: 60.9;gdT-cell: 24.4" "Group enriched" "Detected in many" 5 "granulocytes: 60.9;T-cells: 24.4" "Cell line enriched" "Detected in some" 163 "THP-1: 495.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 1.2" "HPA000505, HPA029155, CAB032191" Enhanced Enhanced Cytosol NA NA Cytosol "CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (1.98e-1)" "unprognostic (5.80e-3)" "unprognostic (2.43e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.34e-2)" "unprognostic (3.90e-2)" "unprognostic (5.04e-2)" "unprognostic (2.38e-1)" 0.2 0.1 0.2 0.4 0.4 0.9 0.2 0.2 3.8 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.1 0.3 0.3 0.1 0.2 1.0 0.4 1.8 0.2 0.2 0.1 0.0 0.0 0.9 0.3 0.5 0.1 0.0 2.2 0.0 0.0 0.3 0.2 0.1 0.1 0.5 0.7 0.0 128.2 0.4 0.4 0.1 0.5 0.1 0.1 0.1 0.5 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.0 495.2 0.0 0.0 0.0 0.1 0.2 0.0 3.0 2.7 0.0 0.0 0.4 1.6 0.1 60.9 24.4 0.4 3.5 0.1 2.9 2.2 0.0 0.1 6.0 5.4 1.0 7.8 0.3 0.2 3.5 5.8 0.2 0.4 0.2 3.8 0.3 0.3 1.8 0.2 0.2 0.5 0.5 0.4 0.5 0.2 0.0 0.0 0.7 0.5 0.3 0.0 0.0 0.6 0.3 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 44.8 0.0 0.1 0.7 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.2 25.2 0.4 0.0 0.0 0.3 3.7 22.5 4.1 1.9 0.0 1.0 0.6 6.0 20.6 1.0 0.1 0.0 0.0 1.9 1.3 0.0 0.0 0.1 0.0 1.0 26.3 1.4 1.6 166.9 491.5 0.1 0.1 0.0 4.1 0.1 0.0 0.0 PAX6 "AN, AN1, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31817961 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 57.7;retina: 69.5" "Group enriched" "Detected in some" 4 "Horizontal cells: 264.2;Muller glia cells: 462.6" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;AN3-CA: 20.1;HEK 293: 18.0;HeLa: 14.9;hTERT-RPE1: 50.6;U-251 MG: 16.5" "Region enhanced" "Detected in all" "cerebellum: 54.3" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.0 0.6 19.6 0.0 21.2 0.2 0.1 57.7 34.3 0.0 14.7 0.2 1.7 0.0 0.6 0.0 0.0 0.0 0.0 21.9 18.9 0.0 0.1 0.0 0.0 20.0 17.0 17.3 0.0 9.3 0.0 4.3 0.0 30.5 0.0 0.4 69.5 0.1 0.1 0.8 0.5 0.9 0.0 19.5 0.0 9.5 1.6 18.1 0.4 0.0 0.0 0.1 0.1 0.1 24.2 0.0 0.2 15.1 20.1 4.6 6.6 5.9 0.0 0.0 0.2 0.0 1.3 3.7 0.1 6.3 2.3 9.0 0.4 1.8 0.0 0.3 0.0 18.0 8.9 14.9 8.4 0.0 0.5 0.0 0.1 0.7 0.1 0.5 50.6 0.0 5.2 7.6 0.0 0.2 0.0 3.7 0.6 0.3 0.0 10.1 0.0 7.3 0.1 0.8 0.6 0.7 0.0 0.4 0.1 0.0 0.0 4.7 0.0 0.0 5.3 0.4 0.0 16.5 0.1 0.2 0.1 8.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.6 21.2 57.7 34.3 21.9 18.9 20.0 17.0 17.3 30.5 19.5 18.1 24.2 0.2 0.0 0.0 76.7 0.1 0.5 0.0 0.0 0.0 78.8 0.5 0.0 3.8 0.0 0.0 0.0 12.5 0.1 0.1 0.2 0.0 0.0 0.7 0.2 0.5 1.0 74.6 0.0 3.6 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 264.2 1.6 3.1 0.0 0.0 0.4 0.6 0.0 0.2 0.0 3.7 0.6 462.6 0.0 3.5 0.6 2.5 1.3 0.0 0.0 0.0 0.1 0.2 0.0 30.6 0.0 0.9 0.5 21.4 7.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridine synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 11.1 13.0 10.0 9.8 9.7 13.6 12.1 9.3 21.2 10.4 4.8 13.8 9.9 13.2 3.2 18.9 10.7 4.8 10.7 10.4 8.1 13.0 15.4 9.6 11.4 10.7 9.1 10.9 9.3 16.3 4.5 11.2 4.3 10.6 14.8 2.6 2.3 15.3 5.1 11.3 17.6 15.7 3.6 7.6 22.0 17.2 7.2 9.9 8.4 11.1 3.2 5.4 13.2 11.9 9.5 28.2 32.5 7.8 35.7 6.8 7.9 36.2 22.9 13.0 29.4 21.3 76.4 25.8 38.9 24.3 11.1 20.6 47.2 18.1 23.1 5.3 35.7 74.0 19.2 52.1 28.0 10.9 35.8 31.1 11.7 21.9 25.4 6.7 8.7 20.4 22.6 45.7 17.1 10.2 89.2 44.8 37.4 40.0 13.0 55.4 79.0 21.0 80.5 10.9 17.0 40.8 29.4 26.4 42.7 26.1 4.6 22.0 43.9 23.3 29.1 37.9 30.9 33.6 27.2 29.6 45.7 14.1 27.8 24.5 16.5 14.8 13.7 12.7 13.7 12.6 10.2 10.7 14.1 17.0 12.0 10.7 11.1 9.2 13.4 13.6 15.8 14.8 13.1 10.0 9.7 9.3 21.2 10.4 8.1 10.7 9.1 10.9 10.6 7.6 9.9 9.5 9.4 3.2 3.3 3.6 12.9 15.9 3.5 13.2 10.8 42.0 12.8 13.3 4.4 5.7 5.2 9.2 2.1 20.5 13.7 23.0 7.9 19.5 0.4 4.7 7.1 8.1 13.2 6.3 6.0 26.9 25.7 6.8 17.9 8.2 0.0 10.9 9.3 5.1 19.6 1.7 4.2 11.5 10.2 5.7 7.0 1.8 6.8 9.0 14.2 1.9 19.2 11.1 23.7 1.5 3.5 29.9 16.6 6.4 19.5 6.3 21.1 10.2 3.4 3.8 13.1 3.6 9.4 3.6 11.4 11.5 16.8 14.6 11.9 13.3 20.7 5.0 RHBDF1 "C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1" ENSG00000007384 "Rhomboid 5 homolog 1" Q96CC6 16 58059-76355 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077399 Uncertain Vesicles NA NA Vesicles "HPA077399: " "unprognostic (2.62e-1)" "unprognostic (2.86e-2)" "unprognostic (4.76e-2)" "unprognostic (4.04e-2)" "unprognostic (1.51e-2)" "unprognostic (3.69e-2)" "unprognostic (5.60e-3)" "unprognostic (4.54e-3)" "unprognostic (4.51e-2)" "unprognostic (1.02e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.81e-2)" "unprognostic (1.87e-1)" "unprognostic (8.36e-2)" "unprognostic (4.22e-2)" 38.8 11.6 12.3 6.0 12.0 0.5 44.7 11.6 19.6 63.7 11.5 34.3 7.6 38.4 13.1 47.4 36.8 22.3 50.8 12.3 11.8 24.8 13.3 59.0 5.6 12.4 12.4 11.1 56.1 23.6 9.0 13.4 27.7 12.5 61.7 7.1 2.5 38.7 16.6 34.3 45.4 25.0 10.6 11.7 19.5 28.7 8.1 12.6 1.2 33.6 17.0 5.6 45.0 62.0 12.3 10.8 17.3 9.7 22.5 37.2 45.7 31.8 29.1 53.8 20.1 19.1 23.5 36.9 0.6 11.8 31.1 10.2 33.6 4.8 19.6 3.4 0.5 5.3 0.4 18.8 6.6 41.4 0.3 18.3 38.3 20.3 51.9 8.6 35.5 31.4 0.1 4.1 0.4 32.2 60.6 0.1 3.5 8.8 22.7 14.5 0.3 11.5 0.9 22.7 11.0 0.3 2.4 8.4 31.8 18.7 11.9 49.1 3.8 32.6 31.5 21.9 24.8 8.1 0.2 0.7 0.3 22.0 0.6 50.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 12.0 11.6 19.6 12.3 11.8 12.4 12.4 11.1 12.5 11.7 12.6 12.3 10.5 19.2 6.2 9.1 0.3 6.8 9.9 15.2 5.2 0.8 17.8 13.5 9.9 22.8 15.8 9.2 66.7 19.0 0.3 21.9 0.0 21.4 1.1 3.8 9.9 9.2 0.0 0.0 1.7 8.0 16.3 20.6 15.8 11.2 0.0 8.7 8.2 3.0 2.2 0.0 0.6 9.8 18.3 0.6 5.1 1.1 19.6 0.4 16.0 5.6 0.0 6.9 0.0 16.6 0.7 28.4 13.6 13.9 0.2 25.8 2.1 2.3 5.3 4.9 13.1 10.8 22.3 0.3 1.9 6.6 5.5 30.6 0.8 16.4 3.8 17.9 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria NA NA 14000 Nucleoplasm Mitochondria "HPA056424: AB_2683126, HPA069321: AB_2686119" "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 29.2 47.7 51.5 16.6 51.6 24.2 32.4 52.8 63.4 52.2 51.7 39.9 17.2 41.2 28.5 32.1 41.2 19.6 29.4 52.3 50.6 54.9 43.3 32.1 27.8 51.7 50.4 50.8 48.7 49.3 15.1 59.3 18.6 52.4 69.2 13.9 19.8 27.6 18.7 23.5 24.5 41.0 16.3 49.6 64.3 39.6 42.1 51.0 20.5 73.5 13.0 17.1 35.0 37.0 54.1 14.6 62.5 65.1 25.0 24.0 18.8 29.2 26.2 19.7 40.6 29.7 65.8 16.7 27.1 33.5 14.8 22.2 18.5 77.5 23.5 41.2 46.7 53.9 31.7 48.2 77.7 27.4 37.8 34.2 17.0 26.8 33.9 13.3 35.3 31.8 22.1 38.7 16.9 33.8 68.6 60.4 63.8 98.1 32.2 30.0 52.3 28.6 27.8 59.1 15.4 38.8 43.1 28.3 19.6 25.9 38.4 25.2 20.3 27.2 30.5 45.6 13.1 32.2 18.2 25.6 28.2 9.3 26.4 28.1 0.3 9.3 3.9 6.3 11.0 5.1 6.4 6.1 6.4 10.2 2.8 3.5 2.7 1.1 4.5 13.3 11.4 7.5 5.9 51.5 51.6 52.8 63.4 52.3 50.6 51.7 50.4 50.8 52.4 49.6 51.0 54.1 64.2 51.3 67.9 59.4 46.9 53.2 39.9 36.4 47.8 48.9 33.1 32.8 22.3 12.8 46.7 23.9 37.5 30.1 63.1 27.2 11.7 35.8 56.7 48.9 81.6 48.2 42.3 26.9 56.7 21.1 42.9 44.4 52.5 55.5 41.1 66.9 26.0 12.7 24.3 45.4 54.0 26.0 28.5 16.6 54.9 21.5 32.6 34.0 39.2 30.0 32.2 24.4 17.5 54.8 40.6 25.8 28.0 32.4 47.4 43.5 27.9 15.5 34.6 59.7 26.3 50.0 50.4 82.1 56.7 29.3 54.3 49.9 45.4 42.5 26.2 37.6 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362613-50504244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lung: 49.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 192.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles NA NA 9700000 Vesicles "HPA034771: AB_10603555, HPA071829: AB_2686454" "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 0.9 0.6 5.5 1.3 5.1 1.2 1.2 10.0 5.9 1.3 0.2 1.6 1.2 1.6 0.9 0.6 1.1 0.7 5.7 0.9 11.7 2.3 0.3 49.5 1.3 8.4 8.8 1.5 2.1 4.3 2.5 7.1 1.9 9.8 3.0 1.9 8.7 1.4 1.1 1.9 2.6 1.6 1.2 3.2 1.4 4.1 6.6 9.7 1.0 2.3 1.6 0.5 0.5 0.7 10.2 0.0 0.1 3.0 6.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.0 0.6 0.2 24.8 0.0 0.1 0.1 1.8 0.2 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.4 0.0 1.1 0.1 0.2 7.9 0.2 0.5 0.2 0.0 0.7 0.0 0.0 18.6 192.7 0.6 0.4 0.0 5.5 1.5 0.0 0.0 0.1 1.8 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.9 0.7 0.9 0.7 0.0 0.5 1.2 0.7 0.0 0.9 0.0 0.1 1.2 0.4 5.5 5.1 10.0 5.9 0.9 11.7 8.4 8.8 1.5 9.8 3.2 9.7 10.2 0.4 76.9 182.3 4.2 0.4 1.5 0.4 0.0 1.8 21.5 2.5 1.7 4.6 0.0 2.5 1.8 20.9 0.0 6.8 0.8 0.0 0.2 0.7 0.1 0.4 0.6 1.2 2.7 7.8 0.0 0.0 1.5 3.1 0.2 20.3 0.3 0.4 0.0 0.1 0.0 36.0 11.0 0.0 0.0 0.4 4.0 0.3 0.4 0.0 1.9 0.1 4.3 15.5 6.0 0.9 0.4 0.3 1.9 2.9 0.7 0.2 0.7 2.2 9.8 13.1 2.4 2.4 2.6 11.2 0.2 0.6 0.3 2.9 3.4 0.6 0.3 BAIAP3 "BAP3, KIAA0734" ENSG00000007516 "BAI1 associated protein 3" O94812 16 1333638-1349441 "Predicted intracellular proteins" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 138.0;pituitary gland: 370.7" "Cell type enhanced" "Detected in many" "Astrocytes: 21.5;Endometrial ciliated cells: 23.5;Enteroendocrine cells: 50.3;Excitatory neurons: 19.2;Respiratory ciliated cells: 45.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.2;MCF7: 6.2;RT4: 5.6" "Region enhanced" "Detected in many" "hypothalamus: 123.4" "Low region specificity" "Detected in all" "HPA015627, HPA015979" Uncertain Supported NA NA "HPA015627: AB_10603678, HPA015979: " "unprognostic (1.37e-2)" "unprognostic (3.93e-2)" "unprognostic (2.44e-2)" "unprognostic (3.92e-3)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (2.25e-1)" "unprognostic (1.06e-1)" "unprognostic (5.60e-2)" "unprognostic (6.75e-3)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.52e-5)" "unprognostic (5.26e-2)" "unprognostic (3.11e-1)" "unprognostic (7.12e-3)" "unprognostic (6.43e-2)" 2.6 19.5 90.5 1.1 91.5 0.9 5.1 10.3 63.3 3.4 8.3 3.1 4.0 1.2 1.9 2.2 31.4 0.5 2.9 61.8 125.5 10.9 8.2 6.1 1.3 51.3 65.3 75.5 0.8 8.0 3.6 370.7 1.8 41.0 9.8 0.8 0.7 4.8 2.4 2.7 2.0 13.6 0.1 24.1 6.9 6.1 20.6 138.0 0.3 1.6 1.1 0.7 2.6 2.0 32.9 0.1 2.3 4.0 1.3 0.4 0.0 1.0 0.2 0.1 0.2 0.0 3.6 20.2 0.3 2.7 0.0 0.1 0.1 0.0 0.2 0.0 0.2 1.3 0.1 0.4 1.4 0.3 0.0 2.7 0.0 0.0 0.2 0.1 0.2 0.1 0.3 0.7 0.0 0.0 6.2 0.0 0.8 2.3 1.0 3.4 0.6 0.0 4.0 2.3 5.6 0.5 0.2 0.0 1.8 0.1 1.1 4.3 0.3 0.3 0.0 2.2 0.5 0.0 1.5 0.5 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.3 0.0 0.1 1.6 0.1 0.5 0.0 0.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.1 90.5 91.5 10.3 63.3 61.8 125.5 51.3 65.3 75.5 41.0 24.1 138.0 32.9 5.6 0.0 0.0 21.5 7.7 0.5 3.3 2.4 1.8 1.6 2.5 1.9 1.3 0.0 4.9 5.5 0.0 0.2 1.9 2.8 0.0 0.7 4.0 23.5 0.9 2.3 50.3 2.7 19.2 0.2 0.3 0.6 4.1 3.7 0.0 2.0 2.9 4.7 0.1 0.0 13.2 3.2 8.2 0.0 0.4 2.0 0.6 0.2 1.8 1.0 0.1 0.8 0.0 1.5 2.3 0.2 0.8 0.0 4.0 2.9 4.0 0.6 45.7 0.6 6.6 0.9 2.7 2.6 1.8 1.6 0.4 1.1 1.7 0.1 2.9 1.9 TSR3 "C16orf42, MGC24381" ENSG00000007520 "TSR3 ribosome maturation factor" Q9UJK0 16 1349240-1351878 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040760, HPA046265" Uncertain Approved "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA040760: AB_2677122, HPA046265: AB_10963942" "unprognostic (4.04e-1)" "unprognostic (2.00e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (4.74e-2)" "unprognostic (4.44e-1)" "unprognostic (1.40e-2)" "unprognostic (1.12e-2)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (6.07e-2)" "unprognostic (8.32e-2)" "unprognostic (3.92e-2)" "unprognostic (9.72e-2)" "unprognostic (3.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.14e-1)" 43.4 48.0 44.8 19.1 41.5 17.6 40.7 42.4 55.0 34.9 36.5 53.5 25.8 38.9 11.2 51.6 33.7 12.7 64.1 39.4 37.9 51.8 58.8 34.7 20.6 47.3 44.3 36.6 32.5 57.7 18.7 35.2 15.3 43.9 43.0 9.1 8.3 43.0 20.0 87.6 46.6 38.6 11.7 43.4 43.4 49.5 30.7 46.6 16.0 35.3 28.1 11.8 49.3 38.5 45.0 60.0 65.2 26.6 35.7 30.8 37.3 44.7 54.3 23.8 38.1 35.3 72.7 59.6 37.8 70.8 36.7 40.5 61.6 24.2 45.2 13.1 73.8 110.8 16.7 56.3 58.2 56.0 36.2 31.8 39.5 63.8 34.3 33.0 29.5 41.7 60.2 54.1 32.6 31.8 107.4 53.6 61.1 44.6 34.4 78.0 93.5 32.3 103.0 33.5 23.7 41.9 53.9 41.9 52.3 73.0 20.8 50.3 44.8 45.9 63.0 67.3 54.2 67.4 67.8 49.2 51.3 31.9 43.5 43.6 13.8 4.0 12.0 4.7 3.6 5.9 7.4 5.9 4.4 3.4 10.0 6.2 5.7 10.4 2.6 3.9 5.2 4.8 1.7 44.8 41.5 42.4 55.0 39.4 37.9 47.3 44.3 36.6 43.9 43.4 46.6 45.0 45.2 19.2 16.2 3.3 33.7 28.2 44.9 7.4 18.8 27.1 54.3 48.9 9.4 44.3 12.1 25.8 12.5 48.6 37.8 43.1 103.7 36.5 3.5 30.7 30.9 30.7 24.0 32.4 4.3 46.6 48.7 28.5 18.3 26.9 8.2 45.0 33.9 54.1 48.8 18.5 5.2 35.3 10.2 42.4 26.7 4.9 28.0 38.0 48.0 1.9 34.6 53.9 49.4 3.5 9.2 38.5 32.6 32.0 47.3 53.8 41.5 125.6 11.1 33.6 6.6 27.7 40.4 15.7 39.7 50.3 41.5 29.8 34.7 38.4 35.7 49.2 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584109 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 78.9;Late spermatids: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508" "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favorable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 12.7 24.1 5.5 3.9 6.7 30.6 15.1 1.5 12.1 14.8 6.0 15.3 7.5 18.5 1.4 13.3 16.6 2.8 12.8 8.4 3.5 30.7 19.1 18.1 2.6 6.1 8.3 7.6 15.8 22.1 9.5 25.6 3.4 3.5 19.5 1.1 1.2 19.5 5.9 18.6 15.3 12.7 1.6 2.4 15.1 17.1 28.3 4.9 2.8 31.3 1.7 1.2 16.0 12.2 4.6 14.2 21.9 7.3 10.3 4.6 2.7 13.9 14.7 5.6 6.3 6.6 14.6 12.9 7.6 18.6 3.3 5.5 22.2 3.3 6.4 1.3 21.9 30.4 11.4 23.8 10.8 8.9 10.1 10.2 5.2 9.8 10.2 2.0 4.0 6.1 13.7 26.1 4.1 2.1 20.7 18.3 11.4 10.0 3.0 21.9 36.6 6.4 17.7 5.6 5.6 13.2 21.4 16.8 7.6 10.8 2.3 17.3 6.9 14.5 10.4 13.7 11.7 10.4 15.8 5.0 6.0 4.8 5.4 10.4 0.9 2.8 1.6 2.8 3.1 2.4 2.3 2.3 2.6 2.7 2.5 2.5 1.6 3.0 3.3 3.7 5.6 2.4 2.6 5.5 6.7 1.5 12.1 8.4 3.5 6.1 8.3 7.6 3.5 2.4 4.9 4.6 9.7 16.0 20.3 14.0 6.9 4.8 6.6 8.4 5.2 12.1 15.8 11.0 8.4 4.3 10.6 40.5 4.2 10.5 8.8 31.5 3.9 19.3 33.6 21.0 7.8 9.0 20.3 78.9 19.3 17.4 8.4 9.4 16.3 11.4 8.2 19.7 6.4 16.4 9.5 10.1 13.8 13.0 8.2 9.1 4.4 61.4 7.5 8.2 16.0 3.7 7.7 14.6 10.3 7.5 6.6 14.1 11.6 7.2 9.1 6.9 7.6 12.4 23.3 13.7 0.0 7.7 9.9 30.1 13.6 6.2 4.8 5.9 7.8 11.1 16.9 5.0 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612337-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favorable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 7.8 7.5 7.3 5.7 6.2 13.6 9.1 13.8 6.9 10.9 5.3 10.0 8.2 10.4 6.2 9.0 10.8 5.4 8.3 6.5 4.3 8.0 6.4 10.0 7.7 5.8 5.3 5.3 12.6 8.9 5.7 12.5 6.9 9.3 12.1 5.5 10.0 8.5 6.4 7.9 11.1 9.6 6.8 3.6 11.1 9.1 23.1 5.5 10.8 12.8 4.9 6.1 9.7 9.5 7.1 8.5 15.5 15.6 14.5 9.8 9.7 20.3 14.4 7.5 11.5 8.2 11.2 14.0 12.0 12.3 9.9 7.1 15.3 18.7 10.0 10.3 12.7 22.6 14.2 16.0 6.9 7.1 19.0 20.6 8.5 12.6 14.5 12.1 11.2 12.4 17.9 19.6 7.1 6.3 12.4 14.8 10.6 14.9 4.9 8.7 51.2 8.4 16.1 8.2 7.5 16.6 14.0 15.8 11.3 8.3 10.9 9.9 24.3 15.2 11.9 12.8 11.4 13.9 15.0 23.3 24.3 3.7 13.0 10.8 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.3 0.0 0.1 7.3 6.2 13.8 6.9 6.5 4.3 5.8 5.3 5.3 9.3 3.6 5.5 7.1 10.4 16.0 17.0 0.0 2.7 0.0 5.2 0.0 12.0 8.6 9.3 8.0 0.0 4.3 8.6 9.2 18.8 4.7 12.8 6.1 1.9 5.5 28.0 11.1 14.5 6.8 2.4 4.6 0.0 2.0 3.0 5.4 5.1 15.3 5.1 11.0 6.8 4.3 5.6 3.3 0.0 6.6 0.0 8.2 0.0 9.6 4.4 4.3 0.0 0.0 6.6 6.2 4.1 0.0 0.0 7.1 4.7 6.8 4.7 9.9 6.0 1.6 2.9 17.9 6.6 7.1 5.2 17.3 18.4 9.4 0.0 5.3 5.2 5.6 5.5 5.9 TEAD3 "ETFR-1, TEAD5, TEF-5" ENSG00000007866 "TEA domain transcription factor 3" Q99594 6 35473597-35497079 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 66.7;Cytotrophoblasts: 56.4;Extravillous trophoblasts: 70.3;Syncytiotrophoblasts: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 93.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA028906 Uncertain NA NA "HPA028906: AB_10603347" "unprognostic (1.77e-3)" "unprognostic (2.40e-2)" "unprognostic (3.11e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (2.03e-1)" "unprognostic (4.17e-2)" "unprognostic (1.76e-2)" "unprognostic (1.83e-2)" "unprognostic (9.58e-3)" "unprognostic (1.68e-1)" "unprognostic (9.27e-3)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.01e-7)" "unprognostic (2.58e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (5.92e-2)" 17.4 6.4 2.3 12.9 2.1 0.2 17.7 2.1 2.6 40.7 3.9 65.5 18.8 80.0 8.6 37.7 51.3 20.1 23.1 2.0 5.3 13.9 12.5 24.4 2.6 4.0 2.5 1.4 28.7 10.8 19.6 7.3 34.8 2.3 36.6 16.8 8.2 24.7 42.8 33.5 43.2 26.7 50.7 2.1 9.3 33.7 5.9 2.8 3.7 14.1 11.4 6.7 60.1 38.6 1.7 22.9 3.8 32.4 16.6 14.3 28.2 93.7 30.6 69.2 30.5 31.4 52.6 12.9 0.0 14.6 32.2 12.5 24.6 5.3 17.6 18.6 0.4 5.2 0.1 14.3 36.4 29.7 3.0 0.7 35.7 27.6 27.1 18.7 27.2 1.8 2.2 8.1 0.5 32.3 52.3 1.2 7.7 7.5 21.3 3.7 0.5 12.0 2.1 8.6 42.8 0.6 6.6 9.3 19.9 7.3 39.8 30.6 13.0 2.2 25.8 24.4 9.7 2.4 4.0 4.2 0.1 4.6 0.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.1 2.1 2.6 2.0 5.3 4.0 2.5 1.4 2.3 2.1 2.8 1.7 2.1 22.4 10.2 7.8 0.3 18.9 27.6 7.8 18.8 3.1 18.2 16.8 14.9 10.0 12.6 7.3 66.7 56.4 0.3 23.6 3.9 5.7 0.4 8.2 16.9 2.2 3.6 0.0 0.1 7.0 70.3 14.6 9.7 7.9 0.0 5.4 2.2 10.8 5.9 1.7 0.1 13.4 10.2 0.0 2.2 0.7 23.0 1.1 0.0 2.8 1.0 4.0 0.0 5.0 0.2 13.3 12.3 30.5 0.3 26.6 17.7 4.3 10.6 14.5 32.9 17.2 26.8 2.3 4.3 12.6 24.9 159.5 0.9 1.6 15.8 34.3 SELE "CD62E, ELAM, ELAM1, ESEL" ENSG00000007908 "Selectin E" P16581 1 169722640-169764705 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 56.6" "Cell type enriched" "Detected in some" 4 "Endothelial cells: 379.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 7.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HUVEC TERT2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" CAB002143 Enhanced NA NA 8140000 180000000 "CAB002143: AB_563608" "unprognostic (2.39e-1)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.09e-2)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (1.59e-1)" "unprognostic (2.94e-1)" "unprognostic (3.63e-1)" "unprognostic (3.88e-1)" "unprognostic (9.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.56e-2)" "unprognostic (8.13e-3)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" 17.1 5.6 1.2 12.7 0.8 0.5 12.1 0.4 1.7 3.7 3.6 3.0 0.7 5.3 0.5 4.0 24.0 10.8 7.7 0.7 7.5 4.6 7.0 10.4 3.0 1.7 1.1 0.6 3.3 1.2 12.6 4.1 1.4 1.6 28.0 2.7 0.3 3.1 3.8 0.8 5.5 2.4 18.9 1.3 0.0 5.3 2.5 2.3 8.5 13.9 1.0 3.6 56.6 5.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.4 1.7 0.7 7.5 1.7 1.1 0.6 1.6 1.3 2.3 2.5 34.6 0.0 3.8 0.0 0.0 46.1 1.1 0.0 1.2 0.0 0.5 0.3 4.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.2 0.3 379.5 0.0 0.0 0.1 0.0 0.0 12.7 0.0 0.2 1.3 0.0 3.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 81.9 3.0 0.0 0.9 46.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 1.3 4.1 0.2 0.0 1.2 47.7 0.0 3.4 0.1 0.1 2.5 DNAJC11 FLJ10737 ENSG00000007923 "DnaJ heat shock protein family (Hsp40) member C11" Q9NVH1 1 6634168-6701924 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023707, HPA028705" Uncertain Supported Mitochondria No No Mitochondria "HPA023707: , HPA028705: AB_10603662" "unprognostic (3.74e-2)" "unprognostic (3.19e-2)" "unprognostic (4.06e-2)" "unprognostic (6.05e-3)" "unprognostic (9.55e-2)" "unprognostic (6.65e-2)" "unprognostic (4.38e-3)" "unprognostic (6.10e-2)" "unprognostic (6.34e-2)" "unprognostic (2.89e-1)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.30e-2)" "unprognostic (1.76e-1)" "unprognostic (9.77e-2)" "unprognostic (1.04e-1)" 17.1 28.5 14.5 19.3 14.9 14.6 16.4 13.1 20.2 15.1 10.4 28.8 27.5 17.3 12.8 24.4 15.7 12.6 33.6 16.5 13.3 35.6 29.0 13.7 19.1 16.4 15.5 14.7 18.9 19.2 24.7 12.8 17.8 16.9 15.5 32.0 16.6 17.3 13.9 44.5 20.5 23.5 17.7 12.0 23.5 21.8 16.6 16.4 15.5 14.7 36.3 18.6 18.8 16.4 16.4 44.5 41.5 47.6 44.3 40.5 28.6 44.7 42.6 36.5 82.7 58.9 51.2 61.7 70.0 41.2 49.2 35.3 58.1 82.9 69.1 72.1 40.0 57.6 71.0 84.1 51.4 40.7 85.4 37.6 42.3 19.0 74.8 48.7 29.2 39.6 52.2 92.6 29.7 42.3 35.5 53.6 45.1 49.9 60.2 71.9 60.0 41.7 50.9 53.0 37.3 64.9 46.0 49.3 98.2 55.4 39.9 39.1 44.6 40.5 48.9 26.1 40.9 51.7 34.5 40.7 91.2 48.1 93.5 25.0 10.2 9.6 3.4 8.7 12.8 8.8 7.5 6.2 9.4 12.1 8.4 6.6 5.2 0.3 10.0 14.4 5.3 7.6 9.2 14.5 14.9 13.1 20.2 16.5 13.3 16.4 15.5 14.7 16.9 12.0 16.4 16.4 11.9 9.6 11.8 17.3 9.7 19.6 4.4 9.1 4.6 18.5 8.6 9.8 9.7 2.8 9.7 12.9 29.2 21.4 5.3 33.4 35.2 14.2 14.9 8.6 13.1 9.3 14.6 25.2 28.6 13.7 22.8 10.3 23.0 10.5 5.1 27.4 5.0 14.1 16.7 20.2 35.8 22.9 14.2 8.2 24.2 9.3 8.1 9.6 28.4 18.7 8.4 11.8 6.2 15.6 23.3 11.1 19.6 4.5 13.3 6.5 37.2 32.4 12.0 17.7 6.6 11.8 13.7 17.0 11.6 14.5 18.3 23.8 8.9 24.9 36.4 5.3 FMO3 FMOII ENSG00000007933 "Flavin containing dimethylaniline monoxygenase 3" P31513 1 171090901-171117819 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 60 "liver: 1132.4" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 412.3" "Cancer enriched" "Detected in many" 13 "liver cancer: 94.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 34.6;ASC TERT1: 26.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA013750 Enhanced NA NA "HPA013750: AB_1848968" "unprognostic (1.87e-2)" "unprognostic (6.30e-2)" "unprognostic (1.00e-1)" "unprognostic (6.81e-3)" "unprognostic (2.64e-1)" "unprognostic (1.31e-3)" "prognostic favorable (3.46e-4)" "prognostic favorable (5.60e-5)" "unprognostic (2.95e-1)" "unprognostic (9.34e-2)" "unprognostic (3.02e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (7.27e-2)" 18.6 12.5 2.5 0.9 2.5 0.4 6.9 2.5 3.6 1.2 2.3 1.1 1.8 1.4 3.0 5.2 13.4 1.9 4.1 2.2 2.4 13.5 1132.4 18.9 5.0 4.6 2.4 1.9 0.3 4.6 4.3 4.4 0.2 2.9 1.1 0.7 0.1 5.1 0.4 4.6 3.1 2.3 1.6 3.9 0.4 3.9 0.5 3.0 1.4 2.7 3.1 9.2 1.0 0.9 2.7 0.0 0.0 0.0 0.0 34.6 26.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 7.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.5 2.5 3.6 2.2 2.4 4.6 2.4 1.9 2.9 3.9 3.0 2.7 2.7 12.8 0.5 0.0 0.7 0.4 0.4 2.7 0.0 0.0 0.1 0.3 0.4 7.2 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 4.7 0.0 29.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 6.8 412.3 0.0 0.0 0.0 0.0 4.1 9.5 0.8 0.0 0.3 0.1 1.8 1.0 0.0 0.5 0.0 7.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 22.7 0.2 6.6 1.3 6.3 0.4 0.1 0.4 0.4 0.0 0.8 0.2 0.0 0.1 MYLIP "IDOL, MIR" ENSG00000007944 "Myosin regulatory light chain interacting protein" Q8WY64 6 16129086-16148248 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 352.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 57.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.54e-1)" "unprognostic (4.84e-3)" "unprognostic (2.79e-1)" "unprognostic (9.65e-3)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.75e-2)" "unprognostic (2.67e-2)" "unprognostic (5.44e-3)" "unprognostic (1.03e-2)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.11e-5)" 33.2 19.1 13.4 12.9 19.7 92.9 30.4 13.4 15.7 38.2 16.3 24.2 13.0 40.6 30.9 18.3 32.9 21.5 14.2 14.0 14.3 21.8 4.9 29.8 23.0 13.9 15.3 12.6 36.1 15.6 24.8 8.3 63.9 17.0 16.6 16.7 4.8 25.9 23.3 41.5 25.5 24.7 28.7 13.3 31.1 22.9 15.1 16.6 15.4 50.7 23.0 15.5 25.3 24.9 23.4 3.4 6.0 2.8 3.3 28.3 6.9 7.3 2.4 5.4 5.4 12.0 18.4 3.3 16.0 11.5 3.9 4.0 8.2 13.0 4.4 4.9 5.2 12.8 10.2 7.1 3.8 4.1 7.4 10.0 11.5 5.5 2.6 2.2 2.8 12.5 3.4 29.8 18.6 2.1 12.6 0.2 40.6 8.0 8.4 5.7 3.5 12.9 57.9 6.7 40.0 13.5 6.2 2.9 31.2 17.1 23.9 5.8 18.8 3.5 2.6 6.2 2.2 6.1 16.0 7.5 8.1 1.6 20.9 9.0 6.1 1.5 7.8 5.8 1.8 5.4 4.2 3.7 4.1 1.1 3.3 4.0 3.9 9.4 2.6 1.5 0.5 2.3 1.2 13.4 19.7 13.4 15.7 14.0 14.3 13.9 15.3 12.6 17.0 13.3 16.6 23.4 102.6 22.4 50.2 5.5 67.7 98.0 38.9 8.8 126.3 9.3 67.6 117.0 90.7 50.1 17.7 22.0 0.0 134.2 78.5 49.5 9.8 22.1 47.5 82.7 56.2 70.9 84.3 52.6 17.1 18.4 80.0 79.6 54.0 77.7 35.5 35.1 41.4 1.4 32.0 11.8 8.4 41.1 10.2 61.7 121.2 20.2 38.5 56.0 80.0 7.5 27.3 16.9 56.7 3.0 55.3 7.6 32.4 61.7 30.2 28.1 27.8 21.1 25.7 7.8 138.1 90.8 96.7 53.0 22.6 100.9 84.0 352.3 103.8 3.9 45.4 35.1 NOX1 "GP91-2, MOX1, NOH-1, NOH1" ENSG00000007952 "NADPH oxidase 1" Q9Y5S8 X 100843324-100874359 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "intestine: 72.4" "Group enriched" "Detected in some" 8 "Distal enterocytes: 45.8;Intestinal goblet cells: 21.4;Paneth cells: 29.1;Undifferentiated cells: 64.8" "Cancer enriched" "Detected in many" 18 "colorectal cancer: 82.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "CACO-2: 30.9;OE19: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (8.31e-2)" "unprognostic (2.07e-3)" "prognostic favorable (9.71e-4)" "unprognostic (1.67e-2)" "unprognostic (3.37e-1)" "unprognostic (6.55e-3)" "unprognostic (5.48e-3)" "unprognostic (8.68e-3)" "unprognostic (1.32e-1)" "unprognostic (5.23e-2)" "unprognostic (1.18e-1)" "unprognostic (3.86e-3)" "unprognostic (2.56e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-3)" 0.3 0.5 0.0 2.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 59.4 0.6 0.3 0.0 0.5 0.2 0.7 0.1 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.3 72.4 0.3 0.2 2.5 0.1 0.6 1.6 1.6 0.0 0.1 0.1 0.2 0.1 0.3 0.4 0.0 0.0 1.3 0.0 0.0 0.4 1.1 0.4 0.4 0.2 0.0 0.3 0.3 0.0 0.0 0.0 30.9 0.4 0.4 0.7 0.0 0.2 0.7 0.0 0.0 0.0 0.4 1.4 0.5 0.6 0.9 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.3 0.0 0.3 1.3 1.2 0.8 11.6 1.1 0.7 0.7 0.5 0.0 1.1 0.5 0.6 0.7 0.3 0.7 0.3 0.2 1.0 0.3 0.4 0.3 0.5 0.8 0.3 0.7 0.3 0.8 1.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 64.8 0.6 E2F2 E2F-2 ENSG00000007968 "E2F transcription factor 2" Q14209 1 23506438-23531233 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 25.3;esophagus: 8.8;lymphoid tissue: 16.0" "Group enriched" "Detected in many" 4 "Early spermatids: 50.2;Erythroid cells: 45.7;Late spermatids: 110.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 46.7;Karpas-707: 38.9;U-266/84: 37.2;U-698: 38.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB016313 Uncertain NA Yes "CAB016313: AB_2096794" "unprognostic (3.14e-2)" "unprognostic (5.74e-3)" "unprognostic (1.31e-3)" "unprognostic (4.18e-2)" "unprognostic (8.54e-2)" "unprognostic (1.70e-3)" "unprognostic (6.43e-6)" "unprognostic (7.83e-3)" "unprognostic (1.53e-2)" "unprognostic (7.33e-2)" "unprognostic (1.51e-3)" "unprognostic (1.86e-2)" "unprognostic (0.00e+0)" "unprognostic (1.00e-3)" "unprognostic (2.82e-1)" "unprognostic (8.67e-3)" "unprognostic (1.84e-1)" 0.2 0.2 0.0 1.8 0.0 25.3 0.1 0.1 0.1 0.5 0.1 2.1 1.5 0.1 0.0 8.8 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.8 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 2.1 0.0 0.8 0.0 0.1 3.4 2.1 0.3 0.0 5.1 0.7 3.6 0.1 16.0 0.2 0.0 3.7 0.3 1.9 0.2 5.4 3.9 6.4 10.2 0.2 0.2 4.5 2.5 1.2 2.4 3.1 2.5 3.1 46.7 3.0 1.3 1.1 10.6 12.9 0.6 2.2 11.8 4.2 7.4 10.7 2.8 0.0 5.4 9.3 0.0 0.1 1.7 0.2 0.3 0.7 21.4 5.8 38.9 1.1 3.2 24.3 5.0 1.4 5.8 1.9 26.4 13.7 15.7 0.9 1.4 8.3 11.6 4.3 5.4 1.3 0.8 4.0 3.9 0.5 2.2 6.1 7.0 3.6 28.5 37.2 38.0 2.1 5.8 4.3 4.1 0.2 0.8 0.0 0.6 0.0 0.4 0.3 0.2 0.5 0.3 0.0 0.0 0.1 0.1 0.9 0.4 1.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 3.4 0.8 0.2 0.2 1.8 0.0 1.0 1.3 0.6 0.0 0.3 1.8 0.0 3.4 0.7 14.5 0.0 0.1 50.2 0.3 0.3 0.6 1.2 45.7 0.1 0.0 4.8 1.1 3.1 1.1 0.0 4.2 0.4 0.4 2.3 0.0 0.1 5.9 0.0 3.1 0.8 110.3 0.3 2.7 0.0 1.0 1.4 0.0 0.0 0.5 0.1 0.1 7.3 0.4 14.5 0.6 1.8 0.1 0.0 0.0 0.0 0.1 0.8 2.5 5.2 10.2 1.0 0.5 1.7 0.7 9.5 1.3 PSMB1 "HC5, PMSB1" ENSG00000008018 "Proteasome 20S subunit beta 1" P20618 6 170535120-170553307 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1197.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029635, HPA029637, CAB033911" Enhanced Supported Nucleoplasm NA NA 15000000 Nucleoplasm "CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793" "unprognostic (2.78e-2)" "unprognostic (3.10e-2)" "unprognostic (6.73e-2)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "unprognostic (2.36e-2)" "unprognostic (3.32e-2)" "unprognostic (8.39e-2)" "unprognostic (4.28e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (3.63e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-3)" "unprognostic (9.62e-2)" 203.0 192.8 132.0 139.4 134.2 208.5 188.0 132.2 151.8 141.5 134.8 169.6 148.8 176.4 281.9 176.6 158.5 115.5 208.3 129.9 138.6 181.4 311.1 159.7 177.3 133.4 133.4 130.4 137.7 154.4 170.6 153.0 175.2 134.9 132.1 168.5 99.4 142.9 152.7 358.1 189.1 150.4 165.7 138.7 167.0 158.1 115.2 135.3 182.2 143.7 241.3 208.5 170.4 144.6 146.9 309.8 284.9 396.2 514.9 347.3 271.2 421.6 288.3 422.7 471.6 478.5 628.9 259.3 449.1 366.2 390.0 430.8 303.7 446.0 459.8 488.7 460.2 502.1 384.4 277.6 799.6 406.3 455.8 327.1 311.5 277.6 455.6 293.1 322.4 409.9 278.1 774.3 373.2 436.9 835.1 343.5 633.0 362.7 558.1 387.9 326.9 314.1 571.6 495.1 183.6 394.5 321.6 277.1 424.5 231.5 351.1 290.9 648.4 313.3 190.4 304.8 466.9 543.2 315.8 454.8 565.8 443.7 510.9 417.5 258.4 431.9 290.2 265.2 416.1 313.5 386.4 306.0 290.7 523.1 305.7 288.1 279.8 249.3 408.2 384.4 297.4 442.6 652.5 132.0 134.2 132.2 151.8 129.9 138.6 133.4 133.4 130.4 134.9 138.7 135.3 146.9 242.7 112.2 148.5 19.9 182.1 217.2 351.4 750.7 117.8 120.2 168.2 236.3 232.3 208.8 335.5 141.6 41.7 876.6 175.0 222.0 401.1 498.3 332.4 224.6 190.2 243.8 165.3 223.9 23.5 651.4 790.8 245.5 109.6 215.1 189.5 226.1 168.8 349.8 394.3 119.5 25.1 251.6 417.1 165.3 222.3 81.9 256.3 207.3 231.3 20.6 364.5 237.8 206.0 19.6 43.3 525.5 240.1 235.9 253.4 334.9 327.6 537.0 310.0 135.9 190.7 181.2 500.2 247.8 196.3 153.3 215.8 1197.8 182.1 283.7 276.7 365.4 SYN1 MRX50 ENSG00000008056 "Synapsin I" P17600 X 47571901-47619857 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 292.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.1;Excitatory neurons: 37.3;Horizontal cells: 28.6;Inhibitory neurons: 34.1" "Cancer enriched" "Detected in many" 4 "glioma: 11.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 9.0;HHSteC: 8.1;NTERA-2: 17.4;SCLC-21H: 30.2;SH-SY5Y: 7.9;SuSa: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000397, CAB021929" Enhanced NA NA 48000 "CAB021929: , HPA000397: AB_1080146" "unprognostic (1.22e-1)" "unprognostic (9.25e-2)" "unprognostic (2.16e-3)" "unprognostic (4.48e-3)" "unprognostic (3.05e-3)" "unprognostic (7.57e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-1)" "unprognostic (3.49e-2)" "unprognostic (6.68e-2)" "unprognostic (3.97e-3)" "unprognostic (1.32e-1)" "unprognostic (2.64e-4)" "unprognostic (2.73e-3)" "unprognostic (5.79e-2)" "unprognostic (2.95e-3)" "unprognostic (5.27e-2)" 2.3 11.1 79.8 3.5 149.9 2.0 0.9 25.4 292.9 1.0 0.0 3.2 0.6 1.3 1.4 0.7 1.9 2.7 13.6 125.7 73.7 1.4 3.1 2.9 0.4 54.8 24.6 139.3 2.9 2.2 0.7 35.9 4.4 68.8 2.3 1.8 44.3 1.2 1.7 1.9 1.3 1.9 1.7 0.7 1.1 1.9 2.6 38.7 0.9 0.5 3.8 0.7 4.1 1.6 172.6 0.0 0.0 5.0 0.7 0.2 1.0 0.0 0.9 0.2 1.4 0.4 0.0 0.0 0.0 1.6 0.1 1.6 9.0 0.5 0.0 0.4 0.6 0.1 0.5 0.0 0.0 8.1 0.0 2.1 1.9 0.0 1.5 0.3 0.0 0.1 0.7 0.6 0.3 0.2 0.2 0.3 0.3 17.4 0.0 0.1 0.1 0.1 0.3 0.0 0.0 30.2 7.9 0.0 0.1 0.1 7.2 2.2 0.0 0.2 0.0 0.9 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.8 149.9 25.4 292.9 125.7 73.7 54.8 24.6 139.3 68.8 0.7 38.7 172.6 0.2 0.0 0.0 5.5 0.0 0.9 0.6 0.6 0.6 27.1 0.2 0.1 3.7 1.5 0.1 0.0 10.4 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.6 0.4 4.2 0.8 37.3 0.7 0.0 2.7 1.1 0.1 0.0 1.6 3.3 1.5 0.2 28.6 34.1 0.3 2.0 1.6 3.4 1.0 2.8 5.1 0.0 7.5 4.7 6.4 0.0 10.6 5.1 0.6 0.2 3.4 0.0 1.2 0.0 0.1 0.1 7.3 6.6 0.8 2.1 3.6 2.1 0.0 0.6 0.0 0.1 3.2 0.5 0.3 JARID2 JMJ ENSG00000008083 "Jumonji and AT-rich interaction domain containing 2" Q92833 6 15246069-15522042 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.3" "Cell type enhanced" "Detected in all" "Langerhans cells: 195.0" "Cancer enhanced" "Detected in all" "testis cancer: 34.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 73.8;SuSa: 78.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063889, CAB069890" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB069890: AB_10000529, HPA063889: AB_2685143" "unprognostic (5.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (4.87e-3)" "unprognostic (6.35e-2)" "unprognostic (2.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (3.26e-3)" "unprognostic (7.04e-2)" "unprognostic (4.48e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-1)" 7.4 4.7 6.5 9.3 7.3 58.3 6.1 20.9 8.9 4.6 4.4 4.9 5.8 5.0 6.7 13.8 3.9 4.4 5.6 7.4 6.6 3.4 3.7 7.3 9.1 7.6 7.5 5.6 5.8 3.5 3.6 4.4 7.2 10.2 4.6 4.6 20.2 6.4 3.4 11.9 13.5 6.9 4.1 5.5 10.7 7.1 16.2 7.9 20.2 3.9 4.3 9.9 5.8 6.8 8.2 12.4 8.5 34.0 19.6 4.1 4.0 33.5 3.5 8.3 4.5 5.5 8.8 9.4 6.5 12.3 7.1 6.8 6.3 8.0 20.1 4.1 13.0 12.4 23.3 10.6 11.6 4.6 23.9 26.3 5.7 12.3 6.6 26.2 13.4 4.7 73.8 30.5 10.8 2.7 12.6 47.6 44.6 36.4 6.1 3.8 20.9 10.4 18.6 4.2 13.0 26.2 15.0 7.3 24.9 32.1 78.1 8.7 25.0 8.5 20.6 11.4 11.5 12.3 6.9 17.8 11.7 7.0 21.9 26.6 10.1 3.8 3.2 3.4 2.4 2.9 2.5 1.6 2.1 3.1 3.4 2.1 2.9 13.2 4.9 2.7 4.4 1.4 2.1 6.5 7.3 20.9 8.9 7.4 6.6 7.6 7.5 5.6 10.2 5.5 7.9 8.2 30.1 6.4 12.8 175.3 40.7 80.4 10.7 23.0 31.9 74.2 28.3 23.1 10.5 15.7 17.1 5.5 87.6 27.0 62.9 10.0 1.9 8.2 89.2 30.7 18.0 27.1 26.8 50.9 125.9 4.4 25.0 17.6 19.9 77.5 25.3 14.8 15.7 13.8 24.0 154.8 124.4 16.4 16.2 61.3 195.0 40.8 8.7 89.5 26.6 97.4 49.1 134.0 54.6 136.7 136.6 15.6 9.3 8.6 34.9 6.8 16.6 3.8 8.7 89.7 6.6 18.1 23.6 9.4 71.1 43.4 151.6 25.2 43.2 17.4 14.7 15.4 CDKL5 "CFAP247, EIEE2, STK9" ENSG00000008086 "Cyclin dependent kinase like 5" O76039 X 18425583-18653629 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 5.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "A549: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002847, CAB011577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB011577: AB_727019, HPA002847: AB_1080107" "unprognostic (7.01e-2)" "unprognostic (4.86e-2)" "unprognostic (1.41e-1)" "unprognostic (1.25e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" "unprognostic (9.63e-3)" "unprognostic (2.05e-3)" "unprognostic (1.66e-1)" "prognostic favorable (5.54e-4)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.99e-1)" 1.8 1.6 2.5 1.1 5.0 2.5 2.6 0.0 9.3 3.2 0.0 1.6 0.9 2.7 1.9 3.6 1.7 1.8 3.8 4.8 5.6 3.6 1.2 4.7 0.8 1.4 2.9 3.2 3.8 2.5 2.4 1.7 3.2 2.2 3.7 1.2 12.3 2.2 2.3 1.7 2.3 0.9 2.5 0.0 1.3 2.4 7.1 4.5 1.7 3.0 2.0 1.1 2.7 3.4 3.3 1.1 10.0 2.6 2.2 2.4 3.6 1.7 1.7 3.0 2.0 2.5 3.3 1.5 1.5 0.3 1.0 4.5 0.5 3.2 1.8 4.3 0.4 1.7 0.1 5.5 2.1 1.1 0.2 0.7 1.7 1.9 5.4 4.9 1.3 1.0 1.6 0.2 1.5 2.7 1.0 0.6 0.8 5.2 0.9 2.3 0.6 3.0 0.1 1.8 7.1 0.5 3.2 2.7 0.9 1.5 4.4 1.3 0.4 6.2 2.5 1.7 5.5 1.3 0.3 0.1 0.3 1.4 0.4 3.0 5.7 0.5 1.1 0.3 0.3 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 2.0 0.2 0.3 0.5 0.1 0.1 2.5 5.0 0.0 9.3 4.8 5.6 1.4 2.9 3.2 2.2 0.0 4.5 3.3 9.4 25.6 24.8 37.5 2.8 0.9 10.7 0.7 4.6 19.0 7.9 6.3 12.9 5.7 5.3 7.3 33.3 27.4 3.8 1.3 7.9 7.7 34.3 6.5 8.4 6.3 2.4 2.7 216.6 9.6 3.1 7.4 7.7 7.9 1.3 3.9 6.1 3.4 4.2 80.8 116.1 1.6 2.0 4.4 0.5 55.3 5.9 4.9 0.0 34.7 4.6 23.5 0.0 41.7 79.7 8.2 0.8 5.3 4.3 16.2 0.6 8.9 4.0 20.4 32.9 7.2 8.4 5.8 10.1 4.2 1.3 47.3 2.3 5.7 1.8 22.9 CAMK1G "CLICKIII, dJ272L16.1, VWS1" ENSG00000008118 "Calcium/calmodulin dependent protein kinase IG" Q96NX5 1 209583714-209613939 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 43.6;ovary: 21.7" "Group enriched" "Detected in some" 6 "Excitatory neurons: 20.0;Inhibitory neurons: 15.5;Peritubular cells: 6.8;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.7;hTERT-RPE1: 4.1;SK-MEL-30: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (9.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.49e-3)" "unprognostic (2.56e-2)" "unprognostic (1.93e-1)" "unprognostic (6.79e-2)" "unprognostic (3.98e-1)" "unprognostic (3.59e-3)" "unprognostic (8.55e-3)" "unprognostic (3.17e-2)" "unprognostic (1.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.27e-1)" "unprognostic (9.10e-2)" "unprognostic (3.43e-2)" 0.1 2.3 19.1 0.3 30.6 0.4 0.1 4.3 43.6 0.4 4.8 0.4 0.2 1.0 4.3 0.0 0.6 0.7 0.2 24.2 18.4 6.0 0.3 0.7 0.2 12.4 11.8 27.5 21.7 0.6 0.0 4.0 1.8 14.0 3.6 0.1 0.5 0.0 5.4 0.3 0.3 0.2 1.3 6.2 5.6 0.1 0.8 24.6 0.1 0.1 0.1 0.2 0.4 0.6 24.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.7 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 30.6 4.3 43.6 24.2 18.4 12.4 11.8 27.5 14.0 6.2 24.6 24.3 0.0 0.0 0.0 0.3 0.2 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.0 0.0 20.0 0.2 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 15.5 0.0 0.0 0.0 0.3 0.1 1.2 0.5 0.0 1.9 0.0 0.3 0.0 0.0 1.2 0.1 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.1 6.6 0.2 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 CDK11A "CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE" ENSG00000008128 "Cyclin dependent kinase 11A" Q9UQ88 1 1702379-1724357 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 85.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010467, HPA025061, HPA073626" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619" "unprognostic (6.25e-2)" "unprognostic (8.32e-2)" "unprognostic (1.47e-2)" "unprognostic (2.74e-1)" "unprognostic (9.32e-3)" "unprognostic (3.54e-2)" "unprognostic (2.25e-3)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.28e-1)" "unprognostic (5.58e-3)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.15e-6)" "unprognostic (1.97e-1)" "unprognostic (5.98e-2)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" 17.8 17.1 15.4 25.0 15.6 42.1 17.9 18.9 16.9 21.7 15.3 24.2 29.5 19.6 8.8 15.8 20.8 9.5 13.4 15.0 14.3 15.6 18.8 27.6 23.5 16.5 15.2 12.9 20.5 17.4 9.4 18.7 12.6 17.0 20.4 14.9 13.2 16.9 7.9 26.3 19.3 37.0 8.8 13.5 37.0 20.5 21.7 15.7 17.2 20.1 7.7 13.9 17.9 19.2 17.1 26.6 16.3 18.7 16.9 20.5 14.5 13.4 25.4 14.3 18.7 20.1 21.9 30.1 31.8 15.2 10.0 19.8 27.1 14.3 15.0 14.3 25.4 19.4 28.8 42.6 20.4 13.3 29.6 45.9 17.1 10.7 13.5 12.2 20.3 22.2 21.4 35.7 27.4 11.1 15.5 19.0 33.4 18.1 18.4 16.0 27.7 19.0 18.9 12.3 13.0 17.7 22.6 25.0 36.3 37.9 7.6 20.4 19.4 22.7 24.3 18.5 10.9 17.2 38.0 31.1 35.3 9.8 33.1 7.2 64.1 16.7 22.0 14.5 9.0 12.1 19.3 12.4 10.7 5.6 19.5 12.0 9.9 85.3 12.0 11.6 33.3 10.9 3.5 15.4 15.6 18.9 16.9 15.0 14.3 16.5 15.2 12.9 17.0 13.5 15.7 17.1 27.7 51.3 59.0 5.9 33.9 14.0 16.0 12.5 22.2 33.0 11.3 10.4 1.0 14.3 38.3 14.7 27.1 16.2 54.1 28.8 9.8 19.7 37.6 18.0 24.2 26.4 9.1 29.0 5.3 15.3 22.6 16.6 52.5 21.8 84.6 18.9 18.5 15.6 12.2 40.4 5.0 29.1 12.2 12.2 26.9 16.3 35.4 28.5 10.6 2.8 25.6 16.1 44.3 4.5 8.7 25.9 51.0 21.4 42.7 16.3 62.0 11.7 34.5 42.4 13.1 21.3 19.1 124.0 93.7 15.3 14.6 30.5 48.1 16.5 23.0 14.3 NADK FLJ13052 ENSG00000008130 "NAD kinase" O95544 1 1751232-1780457 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 506.2" "Group enriched" "Detected in all" 7 "granulocytes: 506.2;monocytes: 162.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048909, HPA053368" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048909: AB_2680553, HPA053368: AB_2682130" "unprognostic (1.29e-1)" "unprognostic (4.29e-1)" "unprognostic (7.07e-2)" "unprognostic (6.82e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (3.32e-1)" "unprognostic (9.03e-2)" "unprognostic (7.81e-2)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (4.54e-3)" "unprognostic (1.40e-1)" "unprognostic (5.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" 52.6 82.4 23.0 37.8 25.2 101.7 45.1 20.3 29.2 27.8 25.8 38.7 38.3 31.1 13.4 30.1 36.4 23.6 28.8 22.1 22.6 30.4 135.1 40.6 41.6 23.3 22.6 21.1 37.5 39.2 17.4 26.6 26.2 23.1 33.2 25.6 11.0 40.5 17.6 19.8 28.4 43.6 20.0 22.1 93.9 43.5 27.8 24.0 16.5 31.9 19.4 26.9 32.6 27.3 24.5 41.6 39.3 34.4 50.7 47.8 34.5 44.2 40.9 35.5 45.6 40.3 42.1 74.2 54.5 30.4 30.5 14.7 34.6 37.3 32.5 20.3 53.5 59.1 44.7 65.0 73.6 46.2 63.4 72.1 40.6 28.9 28.4 40.3 24.8 44.9 42.6 55.9 75.8 34.4 47.4 48.1 54.8 23.5 69.4 43.8 60.4 29.4 113.1 39.7 33.9 46.2 35.2 45.8 99.2 43.7 20.3 34.2 43.6 43.8 33.1 23.7 34.6 37.5 67.1 32.7 121.8 32.7 69.3 17.6 84.2 141.3 329.7 7.4 158.6 8.8 10.8 4.3 5.9 45.9 12.1 2.8 4.1 506.2 3.8 162.6 37.9 7.0 82.9 23.0 25.2 20.3 29.2 22.1 22.6 23.3 22.6 21.1 23.1 22.1 24.0 24.5 29.0 12.8 30.7 14.4 27.2 9.8 15.7 11.2 13.6 7.9 21.4 17.9 6.8 25.8 21.6 14.7 16.7 24.5 46.8 57.8 15.6 19.1 14.9 18.7 22.2 20.8 22.8 15.8 10.2 29.4 26.3 18.7 52.0 22.8 2.5 21.2 22.5 94.3 36.6 6.7 10.4 38.7 16.2 58.4 13.7 26.7 37.6 45.0 8.8 9.4 67.3 5.7 27.8 10.6 11.1 28.7 34.6 34.6 26.0 34.7 28.6 24.3 13.5 17.7 13.1 12.6 18.2 12.4 22.4 19.5 12.8 42.8 15.4 44.2 31.0 27.5 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847619 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 33.6;retina: 14.9" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in many" 5 "cerebellum: 3.5;medulla oblongata: 3.7;midbrain: 4.6;pons: 5.9;white matter: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 109.6;SH-SY5Y: 208.1" "Region enhanced" "Detected in many" "cerebellum: 10.0" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.1 3.5 0.3 0.0 0.4 0.0 8.3 3.5 0.7 0.1 0.0 0.1 0.0 0.0 33.6 3.9 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 3.7 4.6 0.0 0.0 0.0 0.0 0.6 0.2 5.9 0.0 0.0 14.9 6.5 0.7 0.0 8.7 0.0 0.0 0.6 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 109.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 35.5 0.1 0.2 208.1 0.0 0.8 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 3.5 0.7 0.0 0.1 3.7 4.6 0.0 5.9 0.6 0.8 2.4 0.2 0.0 0.0 0.0 0.0 11.7 0.0 0.0 145.7 76.4 43.0 29.7 0.9 0.0 0.0 51.5 8.4 14.9 0.1 0.0 54.8 0.0 17.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 437.4 0.0 0.0 0.0 0.0 1.5 2.0 0.0 0.5 106.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.7 0.0 11.8 0.0 0.0 0.3 1.9 0.6 31.1 4.3 4.9 0.2 0.0 0.0 0.0 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713526-50773033 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "brain: 5.3" "Cell type enhanced" "Detected in single" "Horizontal cells: 1.7" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Region enriched" "Detected in some" 5 "midbrain: 5.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Region enriched" "Detected in many" 4 "midbrain: 11.8" "Region enriched" "Detected in some" 6 "midbrain: 9.4" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.2 0.2 0.0 0.5 5.3 0.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DLEC1 "CFAP81, DLC1, FAP81" ENSG00000008226 "DLEC1 cilia and flagella associated protein" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 12.4;fallopian tube: 28.2;testis: 13.3" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 45.0;Respiratory ciliated cells: 74.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 0.9 0.3 5.7 0.3 2.0 0.9 0.4 3.0 1.6 2.0 12.4 0.3 0.4 0.6 4.1 0.1 28.2 0.6 0.1 2.0 5.9 0.3 0.1 4.9 0.4 5.3 6.0 0.9 0.9 0.1 0.1 9.7 0.1 4.6 0.9 0.4 0.0 0.9 0.5 0.0 0.5 0.4 0.1 6.5 0.5 0.4 13.3 3.0 0.1 1.1 0.0 0.3 0.2 0.1 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.7 2.0 3.0 1.6 2.0 5.9 5.3 6.0 0.9 4.6 6.5 3.0 2.5 0.0 3.2 3.0 2.9 0.4 0.5 0.5 3.0 1.2 1.2 0.4 0.4 0.7 0.0 14.1 0.0 0.0 0.1 0.4 1.2 0.0 0.1 4.5 45.0 1.2 0.6 1.2 0.8 1.1 0.2 0.1 1.3 0.0 1.4 2.5 0.2 0.0 0.3 0.5 0.0 0.9 0.7 6.1 0.6 1.2 6.6 0.9 1.1 0.0 2.8 0.8 0.2 2.1 0.5 0.3 0.1 1.4 0.0 2.8 0.5 0.7 0.5 74.4 0.8 0.0 0.7 1.5 6.7 1.3 1.0 0.3 0.1 1.3 0.4 0.2 0.4 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 66.5;Inhibitory neurons: 96.5;Microglial cells: 57.1" "Cancer enriched" "Detected in all" 5 "melanoma: 47.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 28.5 9.6 16.0 5.4 16.7 7.7 26.7 15.5 21.0 16.5 11.9 16.1 16.6 17.6 6.7 14.2 15.8 11.9 28.0 17.4 14.3 11.9 4.2 19.9 5.4 13.8 14.7 15.1 14.0 7.6 11.6 9.9 32.0 16.5 10.3 7.0 5.7 12.0 8.7 15.3 20.5 16.8 12.2 13.1 11.0 14.0 18.7 14.2 5.9 27.9 19.9 4.8 14.0 16.0 16.5 64.7 16.1 15.0 10.4 68.4 80.0 21.2 37.4 32.3 36.1 34.2 25.0 31.3 8.7 22.1 75.5 46.4 59.5 10.4 27.1 23.8 0.6 14.8 2.4 19.8 3.2 32.4 2.7 4.0 57.0 12.1 19.3 27.6 16.2 6.4 12.6 10.3 1.4 26.7 10.6 2.2 11.5 10.4 8.6 21.5 11.5 40.0 5.0 28.0 7.7 9.6 18.4 23.2 79.7 67.0 12.7 4.8 18.1 23.3 24.6 64.4 26.9 23.2 2.9 1.1 9.1 7.9 6.9 102.8 0.3 0.2 0.0 0.9 0.0 2.5 0.1 0.4 1.0 0.1 0.2 0.0 0.6 0.1 1.5 0.2 0.8 0.3 0.2 16.0 16.7 15.5 21.0 17.4 14.3 13.8 14.7 15.1 16.5 13.1 14.2 16.5 40.1 16.0 5.8 14.7 3.1 15.2 2.1 1.8 4.0 6.5 9.2 7.5 17.4 2.8 3.2 3.7 8.4 15.4 8.7 9.7 5.9 4.1 14.1 9.4 10.2 14.6 3.0 2.1 66.5 2.8 9.1 24.0 8.2 15.9 12.7 15.8 18.5 1.4 11.9 15.2 96.5 5.5 4.1 4.1 10.9 16.7 16.4 5.9 32.0 57.1 1.9 10.8 3.1 23.1 10.8 10.0 5.4 13.2 4.4 3.9 14.6 1.4 3.7 2.0 39.5 6.1 39.2 24.3 11.2 7.0 11.4 15.2 10.2 10.9 7.1 2.1 ADAM22 MDC2 ENSG00000008277 "ADAM metallopeptidase domain 22" Q9P0K1 7 87934143-88202889 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 77.1" "Group enriched" "Detected in many" 4 "Excitatory neurons: 286.7;Inhibitory neurons: 304.9;Oligodendrocyte precursor cells: 184.0;Oligodendrocytes: 125.6" "Cancer enhanced" "Detected in many" "glioma: 4.0" "Region enhanced" "Detected in all" "cerebellum: 77.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 81.8;SH-SY5Y: 76.9;U-266/84: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050325, CAB079064" Supported Approved "Cell Junctions" "Intracellular and membrane" NA NA 180000 "Cell Junctions" "CAB079064: , HPA050325: AB_2681087" "unprognostic (1.20e-2)" "unprognostic (8.61e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.89e-2)" "unprognostic (3.09e-1)" "unprognostic (7.84e-3)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-1)" "unprognostic (3.47e-2)" "unprognostic (4.13e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-4)" "unprognostic (4.70e-2)" 2.0 9.1 4.7 0.9 9.3 0.9 1.3 77.1 30.3 6.0 1.9 1.5 0.6 4.7 8.5 0.8 2.4 2.5 2.1 12.4 12.2 3.8 0.2 1.2 2.2 13.1 11.1 6.8 3.9 1.0 2.1 3.5 0.3 21.8 11.1 1.4 10.4 0.7 5.1 2.5 1.0 1.1 3.5 3.7 2.1 0.7 1.9 13.2 2.5 3.2 1.2 1.1 1.6 2.7 21.7 2.5 0.7 4.8 5.8 1.4 0.3 3.5 0.1 0.5 0.4 0.5 5.1 8.3 7.4 2.0 0.0 3.5 0.2 7.0 0.1 0.1 20.5 9.0 5.6 5.4 1.5 0.1 6.9 0.1 0.7 0.0 0.1 0.3 6.3 0.5 8.1 0.2 81.8 0.2 6.7 8.9 1.4 11.6 0.6 2.6 5.2 18.8 10.7 0.1 4.1 25.9 76.9 4.1 0.1 0.8 3.7 3.5 0.8 0.1 4.8 3.3 0.9 3.6 18.8 33.2 5.9 4.1 14.2 7.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 4.7 9.3 77.1 30.3 12.4 12.2 13.1 11.1 6.8 21.8 3.7 13.2 21.7 2.4 0.0 2.0 45.7 1.1 0.5 1.7 0.0 2.8 28.4 0.5 0.6 3.1 0.0 0.6 1.8 22.9 0.4 1.9 0.3 1.9 0.0 7.8 2.2 6.9 1.5 1.2 1.3 286.7 0.0 0.1 4.8 1.1 3.3 0.0 0.7 0.7 0.0 0.1 15.2 304.9 0.6 0.0 0.3 0.6 1.5 2.5 0.2 1.8 18.7 0.0 1.4 2.1 184.0 125.6 0.0 3.1 2.6 0.9 0.4 0.3 1.0 0.8 10.9 0.0 2.9 3.2 0.8 1.9 0.4 0.4 0.0 2.2 3.7 1.3 0.3 SYPL1 SYPL ENSG00000008282 "Synaptophysin like 1" Q16563 7 106090505-106112576 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 633.6;Spermatocytes: 536.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014141 Approved NA NA "HPA014141: AB_1857716" "unprognostic (8.88e-2)" "unprognostic (8.10e-2)" "unprognostic (3.39e-3)" "unprognostic (1.47e-1)" "unprognostic (4.76e-2)" "unprognostic (4.61e-2)" "unprognostic (8.74e-2)" "unprognostic (9.15e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.32e-1)" "prognostic favorable (1.25e-9)" "unprognostic (2.09e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-1)" 79.4 70.7 42.7 49.6 56.4 51.6 99.3 63.4 63.0 94.3 43.4 79.8 61.0 101.0 89.7 148.4 105.0 70.7 74.0 41.2 54.2 128.3 67.2 67.5 86.7 76.8 58.9 37.2 72.7 54.8 126.8 26.5 84.8 72.7 97.7 77.8 13.1 137.0 120.9 151.0 94.8 58.7 110.3 70.9 60.3 82.4 98.5 53.5 57.3 118.5 102.5 122.4 108.5 95.5 96.0 187.1 85.3 44.9 74.4 188.8 142.9 65.0 115.0 128.3 105.8 128.5 58.5 323.6 187.0 150.9 144.2 179.5 154.9 72.4 186.0 174.8 51.6 85.5 82.6 49.5 57.4 148.0 140.7 65.5 107.5 236.7 111.1 142.8 140.9 147.9 69.5 85.5 0.4 212.7 161.3 149.3 167.1 49.8 214.5 112.6 18.4 75.7 97.7 224.4 300.4 22.1 50.1 111.3 266.4 115.6 106.8 81.6 111.0 133.2 210.3 107.3 226.0 132.4 82.1 102.2 193.7 92.6 239.8 121.0 66.9 39.8 44.8 13.6 37.9 28.2 130.3 36.3 27.3 32.5 125.1 53.5 34.3 15.2 71.3 31.2 31.3 33.9 40.9 42.7 56.4 63.4 63.0 41.2 54.2 76.8 58.9 37.2 72.7 70.9 53.5 96.0 186.9 54.5 63.4 27.1 238.6 171.7 285.3 326.6 252.6 8.9 111.5 70.4 69.7 181.6 172.9 187.6 16.7 211.6 45.9 51.6 113.5 167.0 633.6 96.6 57.3 153.3 37.8 81.2 8.4 107.5 144.7 125.1 88.7 87.7 91.4 47.9 152.4 96.5 90.5 20.2 7.6 82.7 175.0 83.4 95.3 170.3 95.1 69.4 145.9 16.9 39.4 103.9 15.5 8.5 70.8 130.0 66.2 94.0 23.8 213.6 61.0 221.4 131.2 12.8 157.8 76.3 144.4 536.4 126.3 309.0 173.0 184.0 79.5 113.6 101.1 271.8 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446354 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Transport" Translocase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 432.2;SK-BR-3: 209.2;T-47d: 168.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Enhanced NA NA "HPA014753: AB_1847364" "prognostic unfavorable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 13.8 126.8 23.2 12.5 26.2 4.1 33.1 10.0 24.8 45.4 60.4 26.7 37.0 12.4 57.7 52.4 56.3 17.5 13.1 20.7 31.4 23.3 21.2 31.2 8.4 16.6 43.4 23.7 9.5 119.0 76.7 74.7 16.3 81.8 63.9 21.3 9.9 85.7 38.2 6.1 36.7 32.1 9.3 10.2 8.7 48.5 6.0 24.6 3.5 41.2 4.6 12.9 16.6 27.6 34.0 99.3 31.9 2.6 20.5 11.5 52.7 43.3 10.3 12.0 12.3 4.9 29.2 96.9 0.2 23.0 75.5 3.3 83.1 20.3 8.0 4.8 26.1 8.7 12.7 20.4 2.0 21.7 1.3 4.3 8.6 84.1 11.2 1.5 17.9 23.9 0.1 41.2 17.7 4.0 140.3 0.5 4.9 20.9 80.5 49.9 0.3 0.2 31.0 40.0 49.8 73.7 432.2 26.0 209.2 10.4 7.3 168.6 6.2 3.6 25.9 29.4 60.6 3.1 0.4 0.4 0.1 22.6 5.1 14.0 0.3 2.0 0.2 19.2 5.7 24.6 0.6 14.4 13.2 2.1 0.6 1.3 4.2 5.2 20.3 7.7 0.1 0.0 5.8 23.2 26.2 10.0 24.8 20.7 31.4 16.6 43.4 23.7 81.8 10.2 24.6 34.0 14.6 28.9 37.8 3.6 3.5 16.4 23.7 16.0 26.2 6.1 37.4 24.6 12.8 20.0 36.7 23.9 0.0 25.1 7.0 22.2 3.9 41.1 6.9 74.5 12.5 18.3 21.6 3.4 14.1 50.5 29.2 15.0 30.1 53.9 15.9 7.3 11.4 11.1 4.7 0.0 10.7 31.7 18.3 7.0 9.8 6.2 3.7 4.1 3.6 9.4 6.0 5.2 2.1 0.5 0.6 30.8 11.4 3.4 15.3 41.6 32.1 11.9 68.5 26.8 6.6 5.1 7.6 6.9 7.2 34.2 27.8 24.8 11.4 0.4 26.2 22.6 SPAG9 "CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1" ENSG00000008294 "Sperm associated antigen 9" O60271 17 50962174-51120868 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 9.2;neutrophil: 12.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 12.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040446, HPA061458" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA040446: AB_10671691, HPA061458: AB_2684528" "unprognostic (1.36e-1)" "unprognostic (6.61e-2)" "unprognostic (6.04e-3)" "unprognostic (4.65e-2)" "unprognostic (3.52e-2)" "unprognostic (9.73e-2)" "unprognostic (8.13e-2)" "unprognostic (3.72e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.83e-2)" "unprognostic (9.71e-2)" "unprognostic (2.23e-3)" "unprognostic (2.27e-2)" "unprognostic (9.53e-2)" "unprognostic (7.67e-2)" "prognostic unfavorable (8.10e-4)" 32.5 22.9 52.8 19.1 64.7 27.0 22.6 63.6 58.8 21.1 39.9 23.3 20.6 27.8 12.4 29.3 18.9 26.9 22.7 47.0 57.2 33.3 33.2 30.7 13.7 66.9 58.9 41.5 30.4 30.9 27.6 17.6 32.3 65.8 18.1 19.9 37.0 14.5 19.5 66.8 22.1 21.2 27.3 70.9 18.6 16.0 51.4 61.7 19.5 40.5 41.0 15.9 29.9 20.2 101.4 53.3 58.5 73.3 36.0 68.0 59.9 64.7 42.6 41.5 46.8 57.9 53.0 35.7 28.6 29.1 70.3 94.1 44.7 48.5 35.8 86.4 43.5 57.7 23.9 46.4 39.5 51.1 34.9 26.8 43.4 40.7 63.3 112.4 44.9 38.9 14.2 53.6 30.9 66.9 26.6 22.0 14.5 19.5 35.5 74.8 24.7 81.8 25.3 42.8 99.4 56.6 78.8 37.6 34.5 38.8 44.0 28.5 40.9 54.6 129.6 30.3 101.0 63.4 43.5 67.4 46.2 44.3 20.4 46.0 9.2 1.2 0.7 1.2 0.8 0.9 1.0 1.0 1.2 1.3 0.9 0.6 0.8 12.1 0.4 0.5 1.0 1.7 0.5 52.8 64.7 63.6 58.8 47.0 57.2 66.9 58.9 41.5 65.8 70.9 61.7 101.4 162.5 131.4 121.3 190.3 53.1 165.1 149.7 37.5 107.6 96.0 45.7 38.7 62.6 41.5 41.1 25.8 125.1 43.2 60.2 189.0 27.4 56.7 243.0 151.6 142.1 122.9 69.8 20.4 110.2 57.6 28.4 106.5 81.6 337.1 43.1 52.8 74.3 48.7 36.7 67.3 130.5 56.0 24.4 43.3 246.6 137.8 76.1 123.1 71.2 104.9 49.8 32.7 25.7 192.5 304.7 89.6 123.5 67.0 59.7 156.9 69.6 86.9 39.0 85.5 65.7 109.0 86.4 215.1 54.8 93.8 172.3 138.9 59.4 56.3 56.3 182.5 CELSR3 "ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2" ENSG00000008300 "Cadherin EGF LAG seven-pass G-type receptor 3" Q9NYQ7 3 48636463-48662886 "G-protein coupled receptors, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2;pituitary gland: 7.4;retina: 3.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 16.9;Cone photoreceptor cells: 16.7;Enteroendocrine cells: 9.0;Excitatory neurons: 10.1;Horizontal cells: 30.3;Inhibitory neurons: 10.8;Rod photoreceptor cells: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 16.9;HeLa: 16.2;SH-SY5Y: 18.4;SiHa: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062866 Approved NA NA "HPA062866: AB_2684886" "unprognostic (7.80e-2)" "unprognostic (3.80e-2)" "unprognostic (4.89e-1)" "unprognostic (9.12e-4)" "unprognostic (1.51e-1)" "unprognostic (1.59e-6)" "unprognostic (3.61e-6)" "unprognostic (1.86e-1)" "unprognostic (1.46e-3)" "unprognostic (5.07e-2)" "unprognostic (2.13e-3)" "unprognostic (2.87e-3)" "unprognostic (3.26e-3)" "unprognostic (9.53e-2)" "unprognostic (1.42e-1)" "unprognostic (3.86e-2)" "unprognostic (1.73e-1)" 0.1 1.2 1.6 0.3 2.6 0.6 0.2 6.2 5.4 0.2 0.0 0.3 0.3 0.3 0.3 0.1 0.2 0.1 0.1 2.7 0.6 0.1 0.1 0.2 0.4 0.4 0.4 4.1 0.2 0.8 0.2 7.4 0.2 2.8 0.2 0.3 3.9 0.1 0.2 0.1 0.3 0.4 0.2 0.0 0.3 0.6 2.2 0.3 0.1 0.2 0.0 0.2 0.1 0.2 1.4 5.0 3.7 6.0 3.6 0.7 1.1 1.6 0.3 0.7 0.8 1.1 7.0 3.7 1.1 0.9 0.2 3.1 0.6 1.9 0.3 0.4 16.9 1.0 1.7 16.2 2.5 1.1 1.6 2.6 0.5 4.7 0.4 8.5 0.2 0.1 3.5 0.6 5.0 1.2 5.4 0.1 0.1 3.4 1.8 1.6 0.4 0.8 5.2 0.0 3.4 13.5 18.4 16.6 0.3 0.6 0.8 8.1 3.2 0.1 5.9 5.6 7.8 2.9 0.4 9.5 4.4 4.2 1.2 9.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 2.6 6.2 5.4 2.7 0.6 0.4 0.4 4.1 2.8 0.0 0.3 1.4 0.7 0.0 0.5 0.7 0.7 0.4 0.1 0.3 1.2 16.9 1.8 2.0 2.7 0.0 0.1 0.0 16.7 0.2 0.8 1.0 0.0 0.2 3.5 0.7 0.9 0.8 9.0 2.1 10.1 0.0 0.3 0.3 0.5 2.5 1.3 0.5 0.4 0.6 0.2 30.3 10.8 1.9 0.0 0.0 0.3 2.3 0.3 0.3 0.0 0.0 0.1 1.0 0.0 1.5 3.6 0.2 0.1 0.0 0.9 0.2 0.2 0.1 0.2 10.9 0.0 0.3 0.7 5.7 3.9 0.6 0.4 0.1 0.6 0.5 0.5 0.1 AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122064583-122144308 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.7" "Cell type enhanced" "Detected in many" "Astrocytes: 145.9;Hepatocytes: 113.9;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 132.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 41.5;NTERA-2: 55.3;SuSa: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Approved Nucleoplasm,Vesicles,Mitochondria Yes No 19000 Mitochondria "Nucleoplasm, Vesicles" "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favorable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 9.8 6.0 11.6 1.8 13.6 0.2 8.4 12.0 13.0 7.8 16.2 4.3 0.9 9.6 7.5 3.2 11.8 2.2 8.2 11.0 14.4 14.0 44.7 6.3 1.4 14.0 12.4 10.2 25.4 4.8 7.1 3.5 3.3 12.9 5.4 1.5 3.8 3.6 4.9 8.7 2.8 3.7 4.4 11.8 2.9 5.6 2.2 12.7 1.5 4.8 6.2 1.4 7.0 6.3 13.3 0.1 0.0 21.9 41.5 27.3 13.5 9.4 5.4 8.0 7.3 9.1 12.6 0.1 0.0 0.2 6.6 8.3 4.1 33.5 16.8 9.6 0.0 12.2 9.4 4.3 12.5 22.0 0.0 2.9 12.2 0.5 9.2 7.1 18.9 19.8 12.1 2.7 15.5 5.1 0.1 0.9 0.0 55.3 0.1 1.7 11.8 16.3 0.3 5.3 2.4 2.7 0.7 1.5 0.0 5.3 37.8 0.5 0.0 8.1 13.6 3.4 7.0 8.3 3.5 3.0 0.0 4.9 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.6 13.6 12.0 13.0 11.0 14.4 14.0 12.4 10.2 12.9 11.8 12.7 13.3 16.0 9.6 37.8 145.9 2.1 6.2 9.0 2.8 14.8 7.0 8.7 6.3 9.7 14.3 5.6 14.7 16.7 11.6 1.5 0.6 0.0 2.7 12.2 4.1 24.0 11.7 3.0 5.2 5.0 1.8 3.3 14.4 5.6 7.7 3.8 18.1 24.7 113.9 1.5 11.8 4.4 2.6 2.0 2.2 2.5 7.4 19.0 1.4 12.4 35.6 0.0 8.9 0.0 106.1 132.5 2.3 2.5 24.5 1.6 4.7 5.4 8.6 0.9 3.3 19.7 38.9 15.8 12.4 2.4 7.8 4.7 5.1 2.1 8.0 1.9 4.8 PLEKHG6 "FLJ10665, MYOGEF" ENSG00000008323 "Pleckstrin homology and RhoGEF domain containing G6" Q3KR16 12 6310436-6328506 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.2;intestine: 43.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 117.9;Extravillous trophoblasts: 56.2;Paneth cells: 67.5;Proximal enterocytes: 62.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 153.2;CACO-2: 50.1;CAPAN-2: 27.3;OE19: 48.0;RT4: 53.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041459, HPA058230" Uncertain Supported "Cell Junctions,Centrosome" NA NA "Cell Junctions" Centrosome "HPA041459: AB_10794518, HPA058230: AB_2683645" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" "unprognostic (1.44e-1)" "unprognostic (8.03e-3)" "unprognostic (5.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.20e-2)" "unprognostic (1.22e-1)" "unprognostic (3.13e-1)" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (4.18e-2)" "unprognostic (5.73e-2)" 15.3 0.3 1.5 4.4 1.3 2.7 13.0 1.7 2.2 4.2 2.1 31.3 36.8 0.5 0.5 34.2 1.0 5.1 0.3 1.1 0.9 1.6 4.5 1.3 0.6 1.4 1.4 0.7 0.2 5.6 7.9 5.2 8.6 1.5 3.1 18.0 0.2 13.4 1.3 0.4 11.0 43.8 1.2 1.0 0.5 11.1 0.8 2.0 0.7 4.0 0.2 2.5 15.8 15.1 2.2 0.7 6.0 0.8 0.1 2.9 0.2 153.2 0.3 0.0 0.4 0.3 50.1 27.3 0.3 0.4 0.0 0.2 13.0 0.0 0.4 0.2 0.1 0.1 0.2 1.5 10.2 0.5 0.5 0.4 0.0 0.7 0.2 0.0 0.5 0.1 0.2 0.4 0.3 0.0 7.9 0.0 0.7 12.7 48.0 1.0 0.2 0.2 0.3 0.1 53.2 0.3 0.2 1.2 23.1 0.3 10.9 7.5 0.0 1.2 0.2 0.5 0.6 0.2 0.0 0.1 0.1 0.8 0.7 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 1.1 0.0 0.0 1.5 1.3 1.7 2.2 1.1 0.9 1.4 1.4 0.7 1.5 1.0 2.0 2.2 0.6 0.0 0.0 0.0 0.2 5.0 7.0 2.8 20.5 0.0 4.6 2.9 0.4 8.6 2.5 1.8 0.0 17.6 0.4 117.9 0.0 12.1 1.4 2.9 1.1 0.8 8.4 0.0 0.2 1.8 56.2 1.5 16.3 4.2 0.0 0.5 0.4 2.3 2.7 0.0 0.2 19.3 0.0 0.0 0.7 2.0 2.5 0.3 0.0 0.0 0.2 0.8 2.1 0.0 0.1 2.2 67.5 0.7 0.2 8.4 62.6 0.8 3.0 0.1 0.0 4.7 3.1 0.2 0.5 14.2 7.0 23.9 0.3 0.0 27.9 21.6 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42596934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 19.9 17.3 30.8 18.6 31.7 34.2 22.0 31.7 37.4 19.5 29.8 15.0 19.2 12.7 17.9 21.4 15.9 10.5 18.0 31.4 31.4 22.7 32.6 19.7 35.7 31.3 31.0 31.3 19.3 21.8 13.6 25.3 10.0 31.3 36.2 13.7 13.8 19.3 8.7 16.3 23.2 25.8 7.5 32.2 31.9 22.9 10.2 31.1 23.8 20.6 11.1 30.4 19.6 18.7 34.6 32.3 14.0 29.0 26.4 34.9 27.8 17.3 20.6 22.4 28.7 32.2 27.1 29.1 43.3 18.2 13.6 31.6 17.9 33.9 28.0 30.9 21.7 40.5 46.9 28.9 45.3 25.4 62.5 36.2 22.1 17.7 23.7 21.9 20.6 31.4 39.1 43.2 65.4 23.1 29.3 44.8 76.4 45.9 42.7 34.2 23.6 20.6 61.2 32.3 38.2 16.2 23.0 17.6 27.2 29.8 30.2 35.8 57.4 19.5 18.0 29.0 42.8 38.0 46.5 76.3 73.5 26.3 66.1 17.0 60.4 56.4 84.9 88.4 66.0 121.0 120.3 116.3 106.2 62.1 104.3 99.5 101.1 75.8 83.0 50.9 74.5 139.2 90.4 30.8 31.7 31.7 37.4 31.4 31.4 31.3 31.0 31.3 31.3 32.2 31.1 34.6 39.3 12.8 16.7 5.5 96.3 107.1 70.1 101.5 91.0 16.2 78.6 77.8 19.3 42.9 46.1 27.6 8.4 57.1 102.9 39.2 56.7 43.4 4.3 47.0 37.9 37.0 55.1 67.3 13.6 49.2 75.8 39.0 39.8 71.9 45.7 39.6 32.5 61.0 66.8 23.5 11.2 51.1 79.3 38.6 51.2 3.7 34.5 43.0 51.6 6.5 69.3 38.1 88.6 3.0 25.8 50.6 58.9 15.8 72.4 75.6 121.4 85.2 28.2 26.8 13.1 26.4 32.5 19.4 24.7 84.5 138.1 37.4 103.2 34.5 53.7 99.2 MPND FLJ14981 ENSG00000008382 "MPN domain containing" Q8N594 19 4343527-4360086 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 84.7;Paneth cells: 42.7;Proximal enterocytes: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043274, HPA045475" Approved Approved "Nucleoplasm,Nucleoli rim" No No "Nucleoli rim" Nucleoplasm "HPA043274: AB_2678403, HPA045475: AB_2679339" "unprognostic (3.16e-2)" "prognostic favorable (2.99e-4)" "unprognostic (4.85e-2)" "prognostic favorable (6.12e-4)" "unprognostic (8.60e-2)" "unprognostic (5.37e-3)" "unprognostic (3.16e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.23e-1)" "unprognostic (2.87e-2)" "unprognostic (3.94e-3)" "unprognostic (5.18e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (5.44e-2)" "unprognostic (9.04e-2)" 10.6 22.1 24.4 9.4 21.6 15.9 10.8 24.5 35.3 12.6 19.7 23.8 30.9 12.0 8.7 18.2 11.6 9.6 20.8 24.2 21.0 22.7 46.9 12.7 11.8 21.2 20.2 21.5 13.2 24.6 15.5 11.0 7.0 23.8 19.2 16.4 4.0 17.3 9.7 23.4 15.0 19.9 6.6 19.3 15.4 20.3 6.6 21.1 10.3 13.5 14.5 7.1 15.3 12.8 24.8 16.0 13.2 21.3 24.6 13.1 6.1 21.7 7.6 7.2 6.2 7.6 25.6 8.1 14.4 23.3 9.9 18.2 16.1 9.8 13.2 3.4 16.4 21.5 11.0 18.4 37.4 10.0 14.9 19.1 9.4 9.4 6.8 7.1 9.3 18.9 37.4 6.0 36.4 7.8 41.8 35.4 12.6 9.8 26.5 18.2 28.8 6.5 21.0 15.5 25.4 23.7 24.3 13.5 19.4 9.9 12.1 13.0 18.1 7.3 9.8 10.4 60.4 15.4 30.1 20.1 9.7 10.9 8.3 11.5 9.3 3.1 1.5 1.3 3.7 2.1 1.0 1.6 1.9 2.9 1.6 1.0 1.1 0.8 1.7 1.8 2.9 3.7 1.3 24.4 21.6 24.5 35.3 24.2 21.0 21.2 20.2 21.5 23.8 19.3 21.1 24.8 6.1 0.0 3.7 1.6 5.1 5.4 8.4 1.4 3.4 8.2 9.5 8.5 13.9 11.5 2.7 11.0 2.1 13.6 9.8 84.7 0.0 4.1 0.8 8.0 6.1 6.0 16.7 2.5 2.6 5.1 11.9 5.2 9.2 8.9 4.5 7.8 5.7 23.5 14.8 6.7 2.4 31.2 2.0 26.0 9.6 3.9 6.2 14.4 3.6 1.9 8.8 8.6 21.6 3.5 2.1 4.3 42.7 3.8 7.7 6.9 50.7 15.0 2.3 5.6 6.6 6.1 11.7 0.2 7.6 7.8 8.4 10.4 6.3 9.1 34.6 9.6 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1106.7;adrenal gland: 1146.6;liver: 3130.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1205.9;Club cells: 1308.7;Hepatocytes: 4345.6;Proximal tubular cells: 1265.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 170.2;myeloid DC: 123.5" "Group enriched" "Detected in many" 13 "dendritic cells: 123.5;monocytes: 170.2" "Cell line enhanced" "Detected in many" "ASC diff: 5391.4;ASC TERT1: 2078.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA 19000 Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favorable (1.97e-4)" "unprognostic (4.19e-1)" 1106.7 1146.6 137.4 76.8 136.3 80.0 579.6 132.4 202.3 66.2 109.6 318.5 130.1 32.9 44.3 196.9 79.1 202.7 98.3 131.2 192.1 396.6 3130.3 178.7 3.6 155.1 147.7 121.4 11.5 132.4 0.8 53.0 14.4 149.3 162.7 214.9 7.1 156.6 56.3 25.8 72.4 120.5 45.1 140.4 7.4 132.4 20.4 157.2 14.1 274.5 43.7 7.7 270.3 115.6 214.7 1.4 495.2 115.6 139.4 5391.4 2078.4 1.5 408.5 418.5 220.6 339.1 186.0 838.6 0.4 48.5 535.8 694.2 2.4 317.0 663.5 202.9 1.1 41.4 175.7 256.6 664.8 1252.0 350.4 1.2 1375.9 714.7 671.2 710.5 540.4 393.1 0.1 126.7 0.6 486.3 101.2 0.3 137.0 987.6 0.7 391.2 0.4 69.3 229.3 503.3 982.1 21.8 17.1 645.8 411.8 17.5 630.1 442.5 190.8 248.0 226.1 30.5 447.3 541.1 0.6 1.7 1.5 748.1 538.5 7.1 11.3 170.2 1.8 0.1 26.3 0.5 1.0 0.2 0.1 123.5 0.0 0.1 0.1 5.9 0.2 5.9 34.1 1.1 55.9 137.4 136.3 132.4 202.3 131.2 192.1 155.1 147.7 121.4 149.3 140.4 157.2 214.7 39.6 266.0 651.3 130.2 14.0 25.6 130.2 1205.9 91.0 0.0 383.8 262.6 5.1 574.7 1308.7 71.7 0.0 2.9 9.8 288.1 181.9 26.9 25.4 299.9 198.2 19.6 45.6 92.8 4.4 434.1 218.1 404.5 153.9 947.9 34.1 26.3 67.5 4345.6 160.2 0.0 0.5 280.5 740.6 176.4 52.0 17.9 33.2 75.7 39.2 6.5 224.4 1.0 5.2 1.0 0.8 322.7 175.0 113.2 6.0 467.2 209.5 1265.6 526.1 1.3 0.0 11.3 124.3 0.7 2.3 510.3 17.6 7.9 22.1 152.4 534.1 883.3 CRY1 PHLL1 ENSG00000008405 "Cryptochrome circadian regulator 1" Q16526 12 106991364-107093549 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018762 Approved Supported "Nucleoplasm,Nuclear membrane,Microtubules" NA NA "Nucleoplasm, Nuclear membrane, Microtubules" "CAB018762: AB_2083970" "unprognostic (1.21e-3)" "unprognostic (4.74e-2)" "unprognostic (6.50e-2)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.84e-1)" "unprognostic (3.48e-2)" "unprognostic (3.61e-1)" "unprognostic (4.29e-3)" "unprognostic (1.34e-2)" "unprognostic (6.85e-3)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.82e-2)" "unprognostic (5.08e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" 13.0 12.5 10.3 7.6 10.3 12.5 11.3 17.0 11.0 11.1 15.8 11.4 11.6 14.3 6.4 11.1 16.5 16.9 11.4 9.0 13.4 11.3 13.7 19.5 5.8 10.9 11.2 8.1 9.1 13.6 8.9 8.5 12.2 11.4 11.4 8.6 21.5 9.1 11.6 11.0 8.8 12.8 16.9 10.7 8.8 16.3 37.7 11.3 19.1 17.2 11.1 6.8 15.7 8.7 13.3 17.3 16.9 20.6 23.0 14.6 9.1 36.9 17.9 19.1 36.0 24.2 19.9 10.1 0.0 11.1 16.7 22.7 11.6 26.8 9.3 39.6 17.3 16.6 16.9 15.3 13.8 18.6 17.3 14.2 8.6 9.6 26.4 24.9 17.8 30.5 31.4 19.3 14.6 22.7 12.1 39.2 19.7 25.1 16.5 24.6 34.5 52.3 6.1 25.3 20.2 37.1 19.2 33.6 22.1 10.9 20.0 15.6 9.6 13.5 20.9 22.2 14.6 16.2 26.6 26.6 7.8 10.2 16.3 17.5 12.0 3.2 5.8 12.8 4.7 16.1 1.9 9.6 8.2 4.3 1.9 8.9 8.8 1.4 6.4 8.9 2.8 13.5 5.7 10.3 10.3 17.0 11.0 9.0 13.4 10.9 11.2 8.1 11.4 10.7 11.3 13.3 16.3 16.0 16.2 20.5 9.7 69.2 47.9 4.3 55.2 16.8 30.4 14.7 11.1 11.5 6.1 11.0 20.9 8.3 29.1 12.7 17.6 11.4 12.8 27.3 19.3 20.1 19.6 11.2 22.4 16.3 13.4 24.5 45.9 33.2 5.1 6.2 12.1 20.2 6.3 26.9 38.4 9.7 6.1 7.3 21.0 4.8 11.5 8.8 16.0 13.1 16.3 22.8 19.6 35.2 32.8 21.5 7.0 17.3 15.3 29.7 7.7 16.1 18.7 13.7 6.6 24.3 19.2 108.0 32.4 24.3 59.5 15.1 29.7 5.7 6.8 27.0 PGLYRP1 "PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L" ENSG00000008438 "Peptidoglycan recognition protein 1" O75594 19 46019153-46023053 "Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 635.3" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Excitatory neurons: 1.7;Inhibitory neurons: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 202 "eosinophil: 443.7;neutrophil: 494.6" "Lineage enriched" "Detected in many" 213 "granulocytes: 494.6" "Cell line enhanced" "Detected in some" "A549: 3.1;HEK 293: 1.8;HeLa: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045702, HPA070227" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 35000000 Vesicles "Nucleoplasm, Cytosol" "HPA045702: AB_10960204, HPA070227: " "unprognostic (2.87e-2)" "unprognostic (4.26e-1)" "unprognostic (1.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.58e-1)" "unprognostic (4.93e-3)" "unprognostic (2.20e-1)" "unprognostic (6.46e-2)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (8.51e-3)" "unprognostic (7.18e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (4.37e-3)" 1.4 0.3 0.5 1.8 1.1 635.3 0.3 2.8 1.9 0.1 0.0 0.3 0.6 0.2 0.0 0.5 0.6 0.2 1.3 0.8 0.0 0.8 2.5 8.7 0.5 0.0 0.9 0.2 0.1 0.5 0.0 0.7 0.9 1.4 0.2 0.0 0.0 0.5 0.0 0.3 1.0 0.7 0.1 0.0 42.8 0.4 1.1 0.2 3.4 0.5 2.3 0.0 0.4 0.2 0.8 0.3 3.1 0.5 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.2 0.8 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.8 1.8 0.3 1.7 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.3 0.0 0.2 0.2 0.9 0.2 0.0 1.2 0.7 0.1 0.0 0.0 1.2 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.7 0.6 0.3 0.4 0.7 0.0 0.2 0.4 443.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 494.6 0.0 2.3 0.0 0.1 3.9 0.5 1.1 2.8 1.9 0.8 0.0 0.0 0.9 0.2 1.4 0.0 0.2 0.8 0.0 0.0 0.6 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 NFIX NF1A ENSG00000008441 "Nuclear factor I X" Q14938 19 12995475-13098796 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 414.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007533 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007533: AB_2667855" "unprognostic (3.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (8.12e-2)" "prognostic favorable (4.66e-4)" "prognostic favorable (2.35e-4)" "unprognostic (1.26e-1)" "unprognostic (2.01e-2)" "unprognostic (3.25e-1)" "unprognostic (2.63e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.92e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-2)" 77.1 15.0 18.9 19.8 57.0 15.0 48.4 79.0 80.7 67.1 0.1 47.4 21.1 89.2 11.0 73.0 70.1 54.3 61.5 43.1 36.9 9.0 20.4 50.4 6.3 51.3 35.5 0.5 74.5 24.0 13.3 19.0 11.9 45.3 85.7 19.9 11.8 151.7 60.5 414.2 100.0 24.5 68.4 31.0 11.4 37.7 16.2 31.9 11.7 31.3 139.5 6.2 45.4 53.2 94.5 39.2 16.2 1.0 119.9 111.7 149.5 1.3 48.1 68.6 45.7 31.8 1.3 3.3 0.6 13.4 211.3 31.4 17.5 12.8 37.4 20.1 25.8 19.7 20.2 7.6 17.2 53.8 8.5 10.3 99.0 10.9 44.1 24.6 80.3 12.4 8.6 6.7 6.2 29.3 12.1 14.9 5.7 0.5 8.6 132.3 43.5 22.2 23.1 0.4 8.5 17.9 47.6 34.5 0.3 43.0 0.0 22.7 17.3 12.2 191.5 23.5 185.1 68.5 4.5 1.7 0.3 49.9 12.1 62.0 0.1 0.1 0.0 0.5 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 18.9 57.0 79.0 80.7 43.1 36.9 51.3 35.5 0.5 45.3 31.0 31.9 94.5 19.5 12.8 59.3 62.7 6.8 58.8 45.5 22.4 134.9 13.3 57.9 74.2 33.2 27.1 15.9 14.7 4.2 0.2 3.7 16.5 1.9 24.3 64.0 12.1 40.1 20.0 12.1 145.2 69.0 12.7 0.3 89.7 32.6 3.0 3.8 4.3 17.9 33.9 1.0 0.0 38.1 25.8 2.0 4.1 15.2 43.1 112.2 5.8 26.6 17.8 1.9 93.7 0.0 52.3 140.9 15.2 12.0 126.0 2.5 60.3 8.4 10.0 19.0 3.0 6.6 174.7 38.3 15.6 13.2 99.4 51.4 0.3 3.8 56.0 29.5 31.8 ST3GAL1 "SIAT4A, SIATFL, ST3GalA.1, ST3O" ENSG00000008513 "ST3 beta-galactoside alpha-2,3-sialyltransferase 1" Q11201 8 133454848-133571940 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 159.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 75.9;PC-3: 131.8;RT4: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040466 Approved "Intracellular and membrane" NA NA 860000 "HPA040466: AB_10805712" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.66e-2)" "unprognostic (1.83e-3)" "unprognostic (5.53e-3)" "unprognostic (4.43e-2)" "unprognostic (4.79e-2)" "unprognostic (2.66e-1)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (1.10e-1)" "unprognostic (1.83e-3)" "unprognostic (1.67e-2)" "unprognostic (3.29e-2)" "unprognostic (8.64e-3)" "unprognostic (2.95e-2)" 25.9 22.7 8.6 23.0 8.4 22.8 12.3 4.8 9.2 11.5 11.8 5.9 3.6 11.7 12.8 14.1 15.6 19.1 46.1 9.4 23.5 45.0 68.3 19.4 23.3 7.8 10.6 7.6 13.5 15.5 11.0 9.9 13.9 7.2 8.1 5.5 10.1 25.1 10.3 44.1 5.3 10.0 10.7 6.3 21.3 16.2 4.3 7.0 17.5 66.7 49.8 21.8 34.7 11.0 9.5 14.0 6.6 3.0 8.3 28.6 15.0 14.4 15.4 35.5 5.7 4.4 13.3 15.1 3.3 10.3 28.2 2.7 4.2 9.4 11.3 4.9 37.6 1.7 28.4 22.5 25.4 22.0 5.9 22.1 17.8 5.7 19.5 11.7 27.2 26.4 7.5 0.5 42.5 4.4 14.9 8.4 8.0 2.1 75.9 131.8 9.9 3.7 24.3 2.7 102.2 0.7 2.0 6.8 23.3 6.9 15.4 4.3 8.1 26.3 18.3 28.5 15.7 6.9 53.0 39.3 3.6 41.7 19.8 18.5 47.8 8.8 41.7 24.1 8.1 22.9 22.7 25.2 28.3 5.3 38.6 34.4 32.4 16.1 43.2 20.4 12.6 17.2 18.9 8.6 8.4 4.8 9.2 9.4 23.5 7.8 10.6 7.6 7.2 6.3 7.0 9.5 29.4 6.4 56.8 38.2 68.4 5.7 14.4 14.8 21.1 13.4 13.7 8.4 63.2 12.8 22.2 1.8 2.1 9.7 65.5 4.6 5.9 41.3 3.4 8.9 29.2 44.3 0.0 38.5 36.7 25.4 53.5 47.8 10.7 28.1 8.8 12.1 37.9 159.8 37.8 60.6 34.6 0.6 16.2 52.5 29.0 2.1 36.7 48.8 14.2 49.6 59.8 11.5 47.4 5.0 2.4 39.4 0.0 71.8 29.1 10.9 0.0 48.5 6.5 23.3 13.1 28.1 23.6 0.2 2.8 30.0 3.4 26.4 79.9 6.5 0.3 43.6 MMP25 "MMP20, MMPL1, MT6-MMP" ENSG00000008516 "Matrix metallopeptidase 25" Q9NPA2 16 3046062-3060726 "Enzymes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.4;lymphoid tissue: 82.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 6.7;Langerhans cells: 5.8;monocytes: 15.0" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "basophil: 18.3;neutrophil: 20.3" "Lineage enriched" "Detected in single" 39 "granulocytes: 20.3" "Cell line enriched" "Detected in some" 15 "HMC-1: 102.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025177, HPA055640" Uncertain Supported "Plasma membrane" "Secreted to blood" NA NA 120000 "Plasma membrane" "CAB025177: , HPA055640: " "unprognostic (4.51e-3)" "unprognostic (9.28e-3)" "unprognostic (7.57e-2)" "unprognostic (2.95e-3)" "unprognostic (2.26e-1)" "prognostic favorable (1.09e-5)" "unprognostic (1.36e-1)" "unprognostic (7.39e-3)" "unprognostic (7.63e-3)" "unprognostic (2.29e-2)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.37e-3)" "unprognostic (1.17e-2)" "unprognostic (8.30e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" 4.8 0.5 0.4 15.2 0.3 33.4 1.4 0.3 1.4 0.7 1.0 1.6 1.1 0.5 0.1 1.3 6.2 1.1 2.0 0.3 0.3 1.3 3.0 14.5 2.6 0.6 0.5 0.2 0.4 1.2 0.2 0.8 1.0 0.6 1.0 1.5 0.0 1.2 0.1 0.5 0.7 3.5 0.9 0.2 82.5 1.9 0.4 0.6 1.4 1.2 3.5 1.9 2.2 0.9 0.5 0.0 0.0 1.2 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.7 0.1 0.0 6.7 0.5 0.0 0.0 0.0 0.0 0.2 102.2 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.7 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.3 7.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 1.1 0.1 18.3 0.2 4.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 20.3 0.5 0.0 0.4 0.2 0.0 0.4 0.3 0.3 1.4 0.3 0.3 0.6 0.5 0.2 0.6 0.2 0.6 0.5 1.0 3.2 6.7 0.0 0.7 0.4 0.4 0.2 0.0 0.8 2.0 1.3 1.0 0.0 0.8 1.8 0.0 0.0 1.8 0.2 0.0 0.4 0.0 1.2 1.2 1.0 0.0 2.7 1.6 0.6 0.2 0.6 1.1 3.8 1.3 0.2 0.0 0.3 0.1 0.0 1.9 0.2 0.0 3.5 5.8 0.0 0.0 3.3 0.0 1.0 15.0 0.3 3.1 1.5 0.5 1.3 0.0 0.7 0.8 0.4 1.2 0.2 0.1 0.0 0.0 0.7 0.9 0.1 0.2 0.6 0.3 0.0 4.0 0.1 0.3 0.3 IL32 "NK4, TAIF, TAIFb, TAIFd" ENSG00000008517 "Interleukin 32" P24001 16 3065297-3082192 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 836.1;pancreas: 680.1" "Cell type enhanced" "Detected in many" "Ductal cells: 1696.0;Exocrine glandular cells: 1490.0;Pancreatic endocrine cells: 2546.1;Proximal enterocytes: 4916.6;Proximal tubular cells: 4315.8;T-cells: 1711.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 4625.7" "Lineage enriched" "Detected in all" 8 "T-cells: 4625.7" "Cell line enhanced" "Detected in many" "CACO-2: 514.7;CAPAN-2: 328.6;HDLM-2: 707.9;Hep G2: 504.3;Karpas-707: 404.6;MOLT-4: 319.9;RH-30: 348.0;U-937: 314.5" "HPA029397, CAB030029" Uncertain "Secreted to blood" NA NA 46100 "CAB030029: AB_1089175, HPA029397: AB_10612120" "unprognostic (2.00e-2)" "unprognostic (2.89e-2)" "unprognostic (2.86e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.95e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.58e-2)" "unprognostic (1.73e-3)" "unprognostic (2.19e-2)" "unprognostic (3.32e-3)" "unprognostic (3.51e-1)" "unprognostic (3.30e-2)" "unprognostic (8.08e-2)" "unprognostic (3.86e-2)" "unprognostic (3.16e-2)" "unprognostic (4.29e-3)" 91.9 37.0 24.2 208.6 18.9 49.5 59.2 18.6 27.9 19.4 21.4 208.4 342.9 30.6 13.6 45.9 20.8 118.5 161.8 18.0 18.9 417.3 836.1 273.9 406.0 22.6 18.7 15.8 22.5 680.1 10.3 17.8 63.4 22.6 54.7 144.1 1.0 87.8 42.7 548.9 27.2 563.5 89.2 19.4 444.5 88.2 19.3 26.5 199.7 85.0 331.6 201.9 119.9 23.3 28.6 254.1 10.7 1.2 0.3 0.5 28.4 19.5 12.4 31.3 14.9 24.8 514.7 328.6 0.6 59.8 7.0 92.1 10.7 1.0 29.6 18.0 707.9 2.7 1.2 49.8 504.3 55.7 1.4 20.5 34.2 3.4 12.9 54.9 12.1 60.0 7.9 0.7 404.6 19.5 1.7 319.9 8.2 7.2 3.2 7.6 0.7 348.0 34.4 239.3 16.7 0.7 3.9 109.9 7.4 1.9 50.9 7.2 4.0 161.6 56.9 67.2 3.1 36.5 4.7 10.7 1.6 1.1 314.5 29.7 30.8 10.9 12.7 2570.7 9.1 2584.2 9.3 2337.1 2483.4 9.2 7.8 884.8 1712.5 46.9 553.7 11.3 13.4 4625.7 2238.1 24.2 18.9 18.6 27.9 18.0 18.9 22.6 18.7 15.8 22.6 19.4 26.5 28.6 334.4 198.7 64.9 0.0 81.7 59.5 68.0 462.2 12.0 0.4 50.3 44.3 5.6 221.6 119.6 119.5 0.0 9.0 550.3 1038.3 252.4 1696.0 0.2 46.5 36.7 286.4 135.1 64.6 0.1 1490.0 14.1 136.7 118.3 53.7 52.6 1.5 68.6 124.1 4.2 0.0 0.1 273.1 244.1 40.5 116.1 1.9 35.1 60.7 65.8 5.6 225.8 0.0 518.0 0.0 0.1 2546.1 1004.5 45.9 81.7 101.2 4916.6 4315.8 55.1 0.6 19.7 278.5 117.4 5.8 1.3 7.1 51.6 6.6 1711.8 27.8 182.2 105.7 PKD1 "PBP, Pc-1, TRPP1" ENSG00000008710 "Polycystin 1, transient receptor potential channel interacting" P98161 16 2088708-2135898 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 72.9" "Cell type enhanced" "Detected in all" "Excitatory neurons: 138.1;Horizontal cells: 119.5;Inhibitory neurons: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046448 Approved NA NA 840000 "CAB046448: AB_2163360" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (1.35e-1)" "unprognostic (1.79e-1)" "prognostic favorable (3.35e-4)" "unprognostic (1.98e-2)" "unprognostic (1.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "prognostic favorable (3.38e-5)" "unprognostic (7.86e-2)" "unprognostic (4.07e-1)" "unprognostic (3.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" 14.5 9.6 5.4 4.9 9.9 3.9 13.9 53.3 31.5 20.6 0.0 31.0 3.9 30.9 2.0 11.4 26.1 3.8 22.9 9.6 2.1 7.6 9.0 13.5 3.5 15.7 5.1 11.8 24.0 10.5 2.3 72.9 3.7 32.0 20.1 1.6 7.5 10.5 8.7 48.1 16.5 15.4 6.2 0.0 9.9 19.2 10.4 7.9 2.8 10.4 8.4 1.5 24.7 15.6 14.4 4.2 8.9 4.8 10.9 8.2 8.8 9.3 14.2 5.9 4.0 4.0 8.0 3.1 6.3 8.9 7.3 4.3 10.4 1.4 2.1 1.5 7.4 7.1 3.9 25.8 3.2 16.1 5.4 7.8 8.2 7.0 7.5 4.6 5.6 3.1 6.6 5.7 6.2 2.6 6.9 7.7 16.5 4.3 1.7 6.6 21.6 7.7 9.6 2.1 2.8 19.9 22.2 12.9 8.5 8.9 1.7 7.0 18.3 7.4 12.7 10.3 9.6 10.5 9.0 4.3 7.0 7.1 5.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 9.9 53.3 31.5 9.6 2.1 15.7 5.1 11.8 32.0 0.0 7.9 14.4 21.3 12.8 12.2 61.7 6.9 24.3 10.3 14.7 30.7 79.8 15.4 18.9 26.4 4.3 10.9 9.2 41.7 6.0 11.2 13.6 9.8 5.2 51.9 16.0 32.1 17.1 30.5 4.8 138.1 3.1 4.0 30.4 8.2 16.9 8.2 21.3 15.7 24.2 5.2 119.5 101.0 17.6 4.1 7.2 12.6 10.6 27.7 7.8 23.2 18.7 6.2 36.4 11.3 38.2 29.5 4.5 5.9 45.9 9.0 10.3 8.9 7.7 32.9 35.2 32.9 41.4 25.2 10.1 15.8 26.0 20.0 3.1 10.9 10.1 14.2 6.9 MAPK8IP2 "IB2, JIP2, PRKM8IPL" ENSG00000008735 "Mitogen-activated protein kinase 8 interacting protein 2" Q13387 22 50600793-50613981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 86.9;pituitary gland: 35.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 57.8;Enteroendocrine cells: 32.3;Horizontal cells: 99.3;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 19.3;HEK 293: 11.0;SCLC-21H: 15.7;SH-SY5Y: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034780 Uncertain NA NA "HPA034780: AB_10670283" "unprognostic (7.82e-2)" "unprognostic (7.62e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (5.80e-2)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (2.90e-1)" "unprognostic (5.23e-2)" "unprognostic (9.19e-2)" "unprognostic (8.57e-3)" "unprognostic (8.78e-3)" "unprognostic (6.33e-3)" "unprognostic (6.77e-2)" "unprognostic (1.72e-1)" "unprognostic (5.29e-2)" "unprognostic (4.75e-2)" 1.0 9.3 52.8 0.3 50.9 0.0 1.4 28.2 68.2 1.2 0.0 1.7 0.2 2.1 0.3 1.2 1.5 0.0 0.4 55.1 37.8 0.6 0.5 0.5 0.0 72.6 37.9 60.0 7.1 1.9 2.0 35.4 0.4 86.9 2.0 0.1 9.7 2.8 0.2 0.3 1.5 1.0 0.2 15.5 0.8 1.5 7.1 49.6 0.2 1.0 0.1 0.0 0.3 1.0 80.3 0.3 1.1 4.7 4.1 0.4 0.0 3.7 0.0 0.0 1.0 0.6 2.4 0.8 0.6 1.0 0.0 19.3 0.0 6.6 0.0 0.0 0.3 11.0 0.0 0.4 1.2 0.5 0.0 0.8 0.3 5.5 0.0 0.1 0.0 0.0 0.1 1.1 1.8 0.0 0.0 0.0 0.0 3.4 0.8 1.8 1.1 0.7 0.0 0.0 0.1 15.7 19.8 3.7 4.6 0.2 0.9 0.9 0.0 0.0 0.1 0.1 0.6 0.0 1.1 3.1 0.5 0.5 0.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 50.9 28.2 68.2 55.1 37.8 72.6 37.9 60.0 86.9 15.5 49.6 80.3 0.6 3.2 2.0 6.5 0.1 0.4 1.6 0.5 0.6 57.8 2.3 3.9 2.3 2.8 2.7 0.0 16.7 0.2 0.0 0.5 0.0 3.0 0.6 0.7 1.7 0.7 32.3 0.0 15.6 2.5 1.1 0.7 0.0 1.5 0.0 0.5 0.0 0.3 0.1 99.3 13.1 0.5 4.1 0.0 0.4 1.8 5.9 0.3 7.2 3.7 0.2 11.2 0.0 6.0 3.2 0.7 0.1 0.7 0.1 1.2 0.3 0.7 0.3 26.7 0.0 1.3 1.0 3.4 2.7 0.6 0.6 1.1 0.3 0.5 0.6 0.5 MED24 "CRSP100, CRSP4, DRIP100, KIAA0130, MED5, THRAP4, TRAP100" ENSG00000008838 "Mediator complex subunit 24" O75448 17 40019097-40061215 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 178.1;Club cells: 100.6;Ionocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 244.1;SK-BR-3: 283.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.93e-2)" "unprognostic (1.65e-1)" "unprognostic (4.10e-2)" "unprognostic (8.27e-2)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.56e-1)" "unprognostic (1.33e-1)" "unprognostic (1.19e-2)" "unprognostic (4.04e-2)" "unprognostic (3.18e-3)" "unprognostic (4.36e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (3.97e-1)" 27.1 30.8 18.7 25.0 20.6 37.6 29.4 18.2 29.5 36.7 15.9 28.8 28.8 34.2 19.2 32.9 32.1 17.0 33.4 21.8 18.5 29.1 25.9 46.9 26.9 17.3 19.0 21.5 39.2 25.9 31.5 39.4 24.0 16.9 28.3 24.8 26.6 31.7 18.1 84.6 35.0 30.3 24.6 14.2 30.4 30.7 36.1 17.1 33.0 29.2 49.3 28.1 26.1 30.4 18.7 31.8 63.3 57.3 59.1 38.7 36.1 44.6 41.7 32.5 56.7 50.4 63.1 42.2 65.0 71.6 46.5 28.2 72.8 89.7 244.1 45.3 59.8 147.2 34.0 59.2 84.0 32.2 84.4 63.0 45.0 45.5 56.3 34.1 36.8 75.0 42.8 98.1 41.9 38.6 42.1 93.7 55.2 37.7 36.7 72.4 71.2 45.2 54.5 29.7 36.5 79.9 57.8 43.9 283.0 33.4 49.3 62.4 75.4 45.2 31.1 26.0 34.5 53.6 39.0 41.4 49.5 56.5 42.2 42.7 0.5 4.8 6.0 5.3 6.0 4.2 4.6 3.7 6.1 6.8 4.0 3.5 4.2 0.3 3.5 3.9 2.8 3.9 5.1 18.7 20.6 18.2 29.5 21.8 18.5 17.3 19.0 21.5 16.9 14.2 17.1 18.7 14.9 22.4 51.3 13.1 12.7 11.3 25.1 178.1 13.1 11.9 31.4 24.9 16.3 20.0 100.6 23.9 16.7 28.9 8.3 24.8 15.6 15.1 14.8 20.6 10.2 43.3 28.1 27.0 17.6 18.0 23.3 12.2 42.3 27.0 10.8 28.5 9.3 14.8 20.0 10.1 20.3 34.1 99.7 12.0 19.2 8.6 9.9 8.6 14.2 9.4 15.4 10.8 6.2 13.6 13.9 18.5 43.7 9.4 14.2 10.4 23.7 17.6 66.3 11.5 6.6 10.9 13.5 13.4 15.5 12.0 18.6 22.6 10.7 18.0 33.3 28.6 RHOBTB2 "DBC2, KIAA0717" ENSG00000008853 "Rho related BTB domain containing 2" Q9BYZ6 8 22987417-23020199 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 50.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 64.1;Alveolar cells type 2: 77.7;Excitatory neurons: 33.3;Proximal enterocytes: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 85.7;hTCEpi: 73.6;RT4: 126.9" "Low region specificity" "Detected in all" HPA060938 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060938: AB_2684391" "unprognostic (2.67e-3)" "unprognostic (1.64e-1)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (7.83e-3)" "unprognostic (2.13e-2)" "unprognostic (8.13e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-3)" "unprognostic (1.93e-2)" "unprognostic (1.60e-2)" "unprognostic (1.46e-2)" "prognostic favorable (2.98e-4)" "unprognostic (2.01e-1)" "unprognostic (1.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.43e-1)" 6.6 8.9 18.2 7.6 27.5 2.4 8.5 4.2 27.2 6.2 6.5 5.4 8.5 7.8 5.4 4.8 9.8 6.6 20.6 22.0 7.8 11.0 2.5 50.9 15.0 9.3 10.5 19.5 26.0 8.0 9.7 14.3 11.3 14.3 7.8 2.5 5.7 6.5 23.2 16.7 4.7 21.4 6.6 0.8 12.7 8.3 8.2 23.3 9.0 18.7 13.7 16.9 10.5 4.6 18.1 6.8 13.2 10.4 16.7 12.4 8.7 14.0 9.2 12.0 14.2 10.7 34.2 6.6 85.7 13.8 13.3 18.5 13.2 5.0 51.5 6.8 7.4 3.0 9.3 17.8 9.7 6.0 5.5 18.5 11.3 73.6 14.8 7.4 9.8 10.4 6.1 2.3 8.2 9.5 19.7 3.5 8.8 11.0 19.7 9.2 4.7 16.8 5.9 10.1 126.9 6.8 12.5 7.1 21.2 14.5 7.7 4.0 14.0 12.8 17.7 12.8 32.0 10.6 20.7 21.5 30.2 17.2 7.9 14.0 2.9 0.6 0.8 1.7 1.0 1.1 5.1 0.4 0.8 0.6 4.3 0.6 0.6 0.1 2.9 1.1 1.8 0.9 0.8 18.2 27.5 4.2 27.2 22.0 7.8 9.3 10.5 19.5 14.3 0.8 23.3 18.1 4.1 64.1 77.7 13.1 7.6 2.9 2.5 5.2 2.8 31.1 2.9 3.2 10.2 5.7 9.1 7.3 4.2 14.7 4.5 0.2 1.9 2.1 0.8 1.9 4.8 6.2 6.0 1.3 33.3 3.7 8.5 5.5 6.1 3.2 4.5 2.4 7.9 1.9 14.3 16.8 13.1 5.8 0.0 2.5 2.6 0.8 6.2 3.5 1.8 5.6 1.5 7.3 8.2 7.1 1.8 4.1 2.6 6.4 4.2 1.2 57.2 6.2 3.1 6.1 0.0 7.2 4.2 0.9 1.9 0.5 0.6 5.6 2.5 2.9 2.8 0.9 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084372 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 62.3;Inhibitory neurons: 58.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved "Nuclear speckles,Vesicles,Cytosol" NA NA 6800 "Nuclear speckles, Vesicles, Cytosol" "HPA042025: AB_10959880, HPA055639: AB_2682870" "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 9.5 8.9 7.7 15.2 7.8 24.5 14.6 11.3 9.7 10.0 4.9 10.0 10.9 9.6 17.0 11.8 8.2 10.8 9.8 7.6 5.9 9.4 9.3 10.9 32.2 7.4 6.1 7.8 9.9 18.4 13.5 6.4 10.3 7.2 11.5 13.6 24.5 14.4 7.8 4.9 18.3 11.6 8.4 3.4 19.2 12.4 9.7 6.8 24.9 11.9 9.5 31.4 10.2 8.6 9.5 16.2 8.1 11.7 17.8 11.9 11.7 14.9 10.1 7.4 9.0 9.1 9.6 10.9 34.6 7.1 8.6 11.9 13.4 11.6 8.2 11.7 17.0 12.6 22.6 11.3 13.1 7.4 24.5 28.5 10.8 11.2 13.0 12.3 9.9 15.5 18.3 21.6 29.8 10.9 9.6 21.5 17.4 7.7 16.7 5.6 20.5 11.9 26.3 10.5 13.8 14.3 12.6 10.6 16.7 7.8 11.7 12.0 7.9 17.2 13.5 7.7 9.9 7.9 18.5 16.2 39.0 11.0 14.3 9.0 18.3 5.0 12.3 7.7 2.8 7.1 9.7 8.5 8.7 9.0 14.0 8.7 7.6 5.2 7.5 4.4 11.2 9.7 5.9 7.7 7.8 11.3 9.7 7.6 5.9 7.4 6.1 7.8 7.2 3.4 6.8 9.5 12.9 22.4 10.3 35.9 20.8 9.8 4.2 4.7 6.8 13.0 11.9 8.3 20.8 8.6 7.1 5.5 10.4 7.0 24.4 11.3 1.9 4.6 6.3 14.8 10.0 9.5 5.4 18.7 62.3 6.2 6.2 9.4 25.5 11.1 7.0 9.8 11.7 7.8 6.3 16.8 58.9 8.9 6.1 17.0 15.7 2.6 9.0 13.2 7.2 56.2 9.2 6.5 16.5 57.3 69.7 8.8 6.3 6.4 17.6 5.5 12.7 5.4 12.8 16.2 19.7 6.5 10.6 3.6 11.2 11.7 11.6 5.6 14.5 7.7 8.7 4.9 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" NA NA "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: AB_2684524" "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 105.9 87.3 90.5 59.1 99.3 95.3 65.2 94.3 121.6 75.0 80.7 61.4 59.0 75.4 133.1 44.8 52.8 59.0 49.5 88.1 95.9 119.7 195.3 68.2 63.8 100.1 95.8 77.1 76.6 117.5 110.6 41.8 71.6 108.1 83.3 57.2 130.0 131.5 84.3 55.9 27.6 59.9 68.9 102.9 84.2 91.9 34.9 99.1 51.6 122.0 60.7 67.5 64.3 32.0 106.6 140.4 96.6 74.2 66.3 217.9 114.7 46.7 175.5 128.3 80.0 82.5 104.0 143.9 156.8 190.7 125.9 132.5 130.3 92.3 84.8 124.7 123.1 89.2 108.6 57.2 105.6 157.9 111.6 68.5 115.0 79.7 88.0 85.3 108.8 80.1 47.3 68.0 147.2 96.3 117.2 58.9 59.0 76.4 110.8 62.5 77.6 107.6 212.8 115.1 88.5 76.1 71.9 143.7 155.8 125.3 71.3 233.5 101.0 107.8 113.1 51.0 95.6 143.1 168.8 134.9 240.8 118.5 85.1 108.0 17.2 34.8 62.3 44.2 37.1 49.2 77.6 40.6 43.5 30.9 82.1 50.9 46.6 52.0 31.8 29.0 35.1 39.1 27.6 90.5 99.3 94.3 121.6 88.1 95.9 100.1 95.8 77.1 108.1 102.9 99.1 106.6 419.0 237.2 291.5 64.6 362.7 254.4 252.8 511.1 144.0 362.0 223.3 278.5 582.1 320.3 431.7 680.5 277.3 218.7 209.5 144.7 195.6 256.4 31.6 302.9 424.8 363.7 261.1 874.1 79.3 347.6 215.0 396.3 104.5 455.3 293.5 105.2 463.7 1081.6 214.7 452.6 86.8 285.4 364.2 237.2 268.0 43.4 560.1 208.4 279.3 48.7 280.0 486.8 183.4 47.3 103.1 283.4 217.4 435.6 469.8 223.5 233.7 416.9 385.8 418.4 295.9 358.9 423.4 206.5 142.2 90.2 172.3 434.1 205.5 175.9 182.2 176.8 RPS20 "S20, uS10" ENSG00000008988 "Ribosomal protein S20" P60866 8 56067254-56074510 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003570 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 210000 "Endoplasmic reticulum, Cytosol" "HPA003570: AB_1856466" "unprognostic (2.57e-2)" "unprognostic (6.91e-2)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.99e-1)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (6.75e-2)" "unprognostic (9.78e-2)" "unprognostic (4.83e-2)" "unprognostic (3.46e-1)" "prognostic unfavorable (1.21e-8)" "unprognostic (3.64e-2)" "unprognostic (8.80e-3)" "unprognostic (2.33e-3)" "unprognostic (2.19e-2)" 2430.6 1427.1 1348.2 1450.8 1388.0 4387.9 2986.4 1344.9 2038.3 2327.0 1422.4 1696.3 1085.6 1555.2 1883.3 1746.4 1788.4 1376.7 1719.8 1289.9 1416.5 1480.9 1691.1 1546.0 3712.6 1388.9 1348.3 1277.7 4867.1 2331.7 975.9 1166.1 1226.2 1393.8 1862.8 1173.6 651.8 2405.9 1164.0 2354.6 2619.9 1625.9 1066.8 1463.0 2038.4 1790.7 776.6 1394.3 2443.4 1645.6 1671.4 2590.7 1957.8 2019.1 1453.5 3154.0 2878.4 2662.3 2623.1 3875.2 4572.0 2296.1 2060.3 3243.9 2550.2 2328.3 3056.4 2994.9 4688.2 2496.8 2293.0 1686.1 1922.9 1731.7 3416.4 2167.2 2011.7 2418.6 3834.9 2434.8 3830.1 3733.9 2152.1 2396.3 4425.9 3555.4 1638.9 4725.2 3971.6 3184.3 3477.9 3210.0 2689.0 2585.6 4101.1 5915.4 4351.3 3574.7 4325.3 1233.6 3196.9 977.9 2459.6 3093.5 3500.9 896.6 2761.2 891.7 2403.8 4246.6 2210.3 3493.0 4411.0 1954.8 1824.1 3074.6 2401.4 3337.6 2829.2 2756.3 3479.1 2754.4 3895.2 1655.6 2076.5 2125.0 869.1 2514.0 1746.2 3620.8 5471.6 4594.4 3362.7 2643.7 4621.2 5940.0 4391.6 374.5 2151.7 1671.8 3772.4 3333.2 8768.9 1348.2 1388.0 1344.9 2038.3 1289.9 1416.5 1388.9 1348.3 1277.7 1393.8 1463.0 1394.3 1453.5 531.6 1259.6 2162.2 18.6 2262.9 3750.0 3713.6 2367.9 409.2 140.6 956.6 590.0 1017.9 1684.3 1791.9 693.4 112.6 2885.6 1645.2 793.6 2201.1 1970.4 1979.3 746.1 1507.7 1533.9 1208.0 1268.8 13.3 4091.1 4246.0 1266.3 189.1 983.9 1670.0 570.3 2543.6 2301.4 2511.0 55.5 11.6 2235.2 679.5 3405.9 3567.2 1769.8 4496.9 1619.2 1949.5 15.0 3676.2 815.3 2747.7 10.1 16.2 3313.5 1714.9 1990.1 364.9 3196.6 1259.1 3235.5 956.0 354.6 1400.3 1958.0 1531.1 1536.1 1483.5 473.0 3924.2 3019.4 2078.3 664.6 2291.2 4097.9 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1421.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 2403.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" NA NA 100000 "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: AB_2681767" "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 416.2 168.4 155.9 172.4 172.2 278.9 244.3 167.5 160.4 195.4 175.1 259.1 188.9 228.9 197.9 249.5 164.3 173.5 418.6 144.4 208.3 230.3 235.5 184.4 173.8 173.3 173.3 129.8 261.1 218.0 276.0 86.5 183.9 176.5 231.8 201.6 179.2 232.0 247.9 1421.9 203.2 197.7 238.5 182.0 178.0 203.5 259.7 170.7 220.9 265.0 1048.6 209.9 240.6 138.1 193.7 658.8 226.6 395.5 396.1 440.7 561.4 550.1 566.7 420.5 373.0 301.1 334.0 193.7 514.9 465.6 543.1 217.0 272.3 442.4 439.6 539.2 632.1 302.8 506.1 390.3 299.9 388.2 380.7 288.7 414.7 468.2 447.0 583.2 502.2 433.5 426.5 523.3 327.3 458.9 2403.4 513.8 242.0 755.0 274.0 302.5 378.4 1221.9 244.0 295.4 508.4 485.6 320.7 553.9 455.8 433.3 411.9 234.5 599.4 526.9 437.8 597.3 579.6 629.1 495.7 587.9 567.7 564.9 422.2 1365.1 217.2 241.4 230.8 146.4 233.1 199.7 161.6 186.5 180.7 226.8 130.4 219.3 189.1 155.2 191.0 270.8 87.2 222.2 389.4 155.9 172.2 167.5 160.4 144.4 208.3 173.3 173.3 129.8 176.5 182.0 170.7 193.7 193.2 198.7 194.2 41.8 198.3 216.2 219.7 149.0 235.6 134.0 218.2 161.5 572.0 160.2 181.1 128.8 58.4 172.4 155.2 160.8 226.9 198.2 405.5 130.4 178.8 191.3 219.9 232.8 70.8 202.9 208.2 181.7 143.2 174.3 219.1 234.7 156.4 189.1 156.8 99.3 73.7 220.3 120.1 277.9 202.0 639.7 161.8 216.8 220.5 55.3 241.8 195.5 117.4 54.3 86.5 213.8 150.6 225.7 283.6 269.0 240.1 235.5 143.2 121.3 164.3 232.4 274.2 263.3 189.8 247.2 234.0 272.9 193.3 208.2 210.5 283.8 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138916-157269370 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favorable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 25.9 17.5 11.8 21.7 13.0 16.3 22.0 17.1 13.8 18.6 17.6 22.5 20.2 19.5 13.6 28.5 18.7 19.3 28.7 12.5 13.6 20.5 23.1 19.2 21.1 13.8 13.2 12.0 20.1 22.6 36.5 11.2 17.6 14.9 20.1 23.5 20.4 22.9 22.9 66.3 20.9 21.0 29.4 13.4 18.1 21.1 26.5 14.1 18.7 17.4 59.0 23.0 28.3 17.1 14.9 68.8 53.3 33.5 67.3 58.8 61.3 37.1 74.0 63.4 61.1 61.3 48.3 55.7 36.8 64.0 82.1 79.6 42.4 52.6 68.3 72.0 67.6 48.3 37.6 35.6 35.0 58.4 56.9 52.8 54.8 61.6 68.0 55.9 46.4 72.2 30.3 55.7 39.9 87.6 59.8 56.2 35.9 53.3 61.1 63.6 31.9 37.7 75.9 63.2 74.1 53.5 55.2 72.8 61.9 54.5 37.2 32.0 39.3 65.3 76.6 16.5 190.0 93.3 39.7 42.9 37.0 87.7 83.0 89.5 0.3 1.8 1.1 2.2 2.3 3.0 1.1 2.4 2.4 2.0 1.2 2.2 2.7 0.6 2.1 2.5 1.8 2.8 1.5 11.8 13.0 17.1 13.8 12.5 13.6 13.8 13.2 12.0 14.9 13.4 14.1 14.9 23.8 22.4 19.7 52.2 14.2 27.5 17.3 19.0 17.6 34.7 22.4 16.9 33.7 22.8 14.2 25.8 66.7 14.9 25.3 27.3 9.8 20.3 11.6 21.6 27.4 23.4 24.5 14.9 98.9 17.7 17.4 19.6 27.0 24.5 9.5 23.0 23.6 48.3 15.4 32.0 100.7 21.8 12.2 27.6 15.2 10.1 15.5 20.6 5.4 52.5 22.0 9.9 26.8 81.4 96.2 27.5 13.4 25.6 17.5 31.5 20.6 19.1 19.8 39.9 0.0 23.1 21.4 26.6 27.3 37.5 33.2 15.1 20.9 22.3 26.2 28.1 REV3L "POLZ, REV3" ENSG00000009413 "REV3 like, DNA directed polymerase zeta catalytic subunit" O60673 6 111299028-111483715 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Cell type enhanced" "Detected in all" "Astrocytes: 290.6;Endometrial stromal cells: 610.1;Inhibitory neurons: 360.2;Oligodendrocyte precursor cells: 594.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064853, HPA069382" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064853: AB_2685369, HPA069382: AB_2686134" "unprognostic (5.54e-2)" "unprognostic (2.06e-1)" "unprognostic (5.09e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (8.59e-3)" "unprognostic (4.42e-2)" "unprognostic (1.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.17e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.34e-2)" "unprognostic (2.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-3)" 6.1 3.6 10.1 6.5 9.4 7.2 3.2 28.6 11.3 16.8 9.2 4.8 4.3 10.4 2.3 4.7 6.3 5.0 4.5 7.5 9.0 4.1 3.5 4.5 5.7 4.7 5.0 7.1 7.6 4.2 3.2 0.9 6.9 12.0 4.9 3.5 26.4 3.2 5.1 5.1 4.7 3.6 8.0 1.6 4.7 4.6 7.6 6.0 6.0 6.7 12.3 2.5 4.9 1.0 13.4 9.2 6.3 11.4 13.3 35.2 35.0 11.9 13.6 16.7 6.4 9.6 8.1 5.0 17.0 9.3 15.9 12.0 9.4 17.6 5.7 10.7 13.9 10.0 13.9 13.9 13.3 9.1 13.5 6.9 21.0 3.2 12.0 15.4 10.3 10.2 10.0 18.3 13.9 10.8 7.2 16.7 3.6 3.2 3.8 10.2 11.6 12.7 6.6 2.5 7.9 15.7 11.8 17.5 3.2 12.4 8.5 7.1 14.2 13.7 9.6 9.6 47.0 15.4 14.0 17.1 17.6 9.1 10.5 12.4 0.6 0.6 1.2 1.0 0.5 1.6 1.0 0.8 1.0 0.6 1.6 0.5 1.0 1.9 0.4 0.9 0.9 0.7 0.3 10.1 9.4 28.6 11.3 7.5 9.0 4.7 5.0 7.1 12.0 1.6 6.0 13.4 133.4 48.1 82.4 290.6 65.7 30.5 19.5 12.8 45.5 117.5 20.2 17.9 34.5 11.5 29.1 20.2 56.3 27.2 35.3 11.8 3.9 17.3 40.0 151.1 610.1 57.4 59.8 27.5 161.7 11.5 11.9 82.7 41.3 107.5 46.9 61.5 21.8 16.0 11.8 35.3 360.2 18.6 10.2 19.9 87.4 16.3 50.4 57.2 21.4 105.9 23.7 59.6 33.0 594.7 190.3 8.5 12.3 39.1 41.3 21.3 18.4 15.9 43.5 57.6 39.5 122.3 62.3 68.5 70.4 26.1 26.9 33.0 46.4 30.3 21.5 8.2 TENM1 "ODZ1, ODZ3, TEN-M1, TEN1, TNM" ENSG00000009694 "Teneurin transmembrane protein 1" Q9UKZ4 X 124375903-124963817 "Predicted membrane proteins, Transporters" "Stress response, Transcription, Transcription regulation" "Neuropeptide, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6" "Group enriched" "Detected in many" 11 "Excitatory neurons: 126.0;Inhibitory neurons: 463.2;Oligodendrocyte precursor cells: 434.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.0" "Region enhanced" "Detected in all" "cerebellum: 23.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.2;MOLT-4: 5.9;RPTEC TERT1: 2.0;SCLC-21H: 1.9;U-138 MG: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002848 Uncertain NA NA "HPA002848: AB_1079523" "unprognostic (1.71e-3)" "unprognostic (8.25e-2)" "unprognostic (3.14e-1)" "unprognostic (8.68e-4)" "unprognostic (5.76e-3)" "unprognostic (3.51e-2)" "unprognostic (7.07e-2)" "unprognostic (2.68e-4)" "unprognostic (6.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.49e-3)" "unprognostic (3.58e-1)" "unprognostic (2.71e-2)" "unprognostic (4.41e-2)" "unprognostic (1.99e-1)" "unprognostic (3.25e-3)" "unprognostic (4.44e-2)" 1.6 1.6 4.3 0.2 4.6 2.2 1.2 23.6 2.5 0.2 0.0 1.4 0.1 1.9 1.2 0.2 1.7 0.7 0.3 4.4 5.2 1.3 8.0 1.4 0.6 2.0 4.3 3.8 0.1 0.1 0.1 4.7 0.0 7.2 4.6 0.2 2.5 1.4 1.0 1.0 1.2 1.2 0.6 1.0 0.6 0.8 0.4 3.3 8.2 1.7 0.8 0.4 0.5 0.3 2.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.6 0.0 0.0 5.9 0.0 0.3 0.0 0.8 0.0 0.0 0.0 2.0 0.0 1.9 0.0 0.0 0.4 0.0 1.2 0.4 0.0 0.0 3.2 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 4.3 4.6 23.6 2.5 4.4 5.2 2.0 4.3 3.8 7.2 1.0 3.3 2.3 0.7 0.0 0.0 29.0 0.2 3.3 0.1 0.0 1.8 10.2 0.6 0.3 1.6 1.5 0.0 1.8 0.0 0.0 3.4 0.1 0.0 0.0 1.2 0.2 0.0 0.9 0.0 2.7 126.0 0.0 0.0 6.8 0.0 0.2 7.6 2.2 0.4 22.9 0.0 6.7 463.2 0.0 0.0 1.0 0.8 0.4 5.0 0.3 3.6 5.6 0.6 0.7 2.1 434.8 7.7 0.0 0.0 0.0 3.0 13.7 0.0 4.0 0.0 0.6 0.0 0.6 1.8 0.0 3.4 0.1 1.8 0.0 2.2 0.0 0.0 0.3 PAX7 Hup1 ENSG00000009709 "Paired box 7" P23759 1 18630846-18748866 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 5.1;skeletal muscle: 5.8;tongue: 4.4" "Cell type enriched" "Detected in some" 284 "Skeletal myocytes: 341.4" "Group enriched" "Detected in some" 6 "breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 1.4;CAPAN-2: 1.4;U-2 OS: 3.0" "Region enriched" "Detected in single" 17 "midbrain: 4.6" "Region enhanced" "Detected in some" "thalamus: 4.3" NA NA "unprognostic (8.41e-4)" "unprognostic (2.07e-1)" "unprognostic (5.35e-2)" "unprognostic (3.96e-2)" "unprognostic (4.21e-1)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.2 5.1 0.3 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.6 0.0 0.0 4.4 0.0 0.0 0.0 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.5 1.4 0.2 0.1 3.2 5.1 0.3 1.5 2.0 0.6 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 341.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 MASP2 MASP1P1 ENSG00000009724 "Mannan binding lectin serine peptidase 2" O00187 1 11026523-11047239 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "liver: 480.4" "Cell type enriched" "Detected in some" 52 "Hepatocytes: 658.6" "Cancer enriched" "Detected in some" 71 "liver cancer: 41.9" "Group enriched" "Detected in some" 5 "cerebellum: 5.6;pons: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029313, HPA029314" Uncertain Supported "Golgi apparatus" "Secreted to blood" NA NA 340000000 820000000 "Golgi apparatus" "HPA029313: AB_10669654, HPA029314: AB_10670029" "unprognostic (7.00e-2)" "unprognostic (8.37e-2)" "unprognostic (2.75e-2)" "unprognostic (2.89e-1)" "unprognostic (1.86e-1)" "unprognostic (3.26e-3)" "prognostic favorable (1.60e-4)" "unprognostic (2.92e-3)" "unprognostic (3.13e-2)" "unprognostic (4.04e-2)" "unprognostic (6.90e-3)" "unprognostic (8.30e-4)" "unprognostic (7.14e-2)" "unprognostic (3.91e-1)" "unprognostic (2.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-4)" 1.7 1.3 0.0 1.8 0.0 7.5 2.3 5.6 0.7 2.3 0.0 2.7 1.6 2.8 0.0 1.2 2.8 1.2 1.3 0.4 0.0 1.0 480.4 1.9 2.7 0.0 0.0 0.0 2.9 2.9 0.0 2.4 0.6 2.3 1.6 0.0 7.0 2.5 0.0 5.2 5.3 3.5 0.0 0.0 2.5 2.4 1.5 0.0 0.0 1.9 0.0 0.0 2.1 1.7 0.0 0.5 0.3 2.6 1.6 0.0 0.1 0.4 0.7 0.0 0.0 0.0 1.2 1.0 2.3 0.6 0.0 0.5 0.7 0.0 0.0 0.0 0.6 2.3 1.3 2.7 16.4 0.0 2.0 1.5 0.0 0.0 0.1 0.0 1.8 0.0 1.7 0.7 0.5 0.0 0.5 0.6 1.1 0.3 0.2 0.7 1.6 0.9 0.6 0.0 1.3 1.7 0.7 0.9 0.4 0.4 1.6 0.6 1.2 1.2 0.9 0.5 0.8 0.5 0.5 0.9 1.5 0.5 1.7 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.7 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.1 0.9 0.2 0.0 0.6 0.2 0.2 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 5.3 9.5 0.0 0.0 0.1 0.0 0.1 1.3 0.0 8.2 658.6 0.1 0.0 8.3 0.0 0.0 12.6 0.3 0.0 0.0 0.0 1.8 1.9 0.0 0.1 0.0 8.0 10.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.4 0.0 0.7 0.2 0.0 0.0 0.4 0.6 0.0 0.8 0.1 0.0 0.1 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "thyroid gland: 477.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2" "Group enriched" "Detected in some" 13 "hippocampal formation: 7.4;thalamus: 2.4" "Low region specificity" "Detected in all" HPA059627 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059627: AB_2684086" "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.0 0.5 0.6 0.4 0.3 0.5 0.8 0.7 0.1 0.2 6.5 18.3 0.2 0.6 0.0 0.0 8.9 0.5 0.5 0.3 26.9 33.9 0.7 0.5 0.6 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.8 0.2 6.6 0.2 0.1 0.0 0.0 0.2 19.8 0.2 0.0 0.1 2.0 0.2 0.7 0.0 477.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.6 0.5 0.3 0.2 0.4 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.9 0.7 0.2 0.3 0.2 1.3 0.5 0.4 0.8 0.7 0.5 0.3 0.6 0.5 0.5 0.8 0.0 0.7 0.7 0.7 3.2 7.8 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.3 0.4 0.8 14.3 8.9 0.0 0.0 0.1 0.0 23.7 1.9 0.3 0.0 0.9 0.3 0.4 3.6 2.7 0.1 0.2 0.0 0.7 0.0 2.2 1.3 0.1 1.1 25.1 0.1 0.0 0.1 21.8 0.0 0.0 1.2 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 22.5 0.0 0.0 1.0 89.1 35.4 3.6 1.3 0.0 1.7 0.3 0.1 0.1 0.0 0.4 0.3 0.9 0.4 11.5 0.7 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725961-27763116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 131.5;Late spermatids: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: AB_2686867" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favorable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 21.2 5.9 7.0 8.6 7.1 13.8 11.8 8.5 9.4 8.9 9.8 10.2 8.8 13.1 10.0 11.8 9.8 10.9 10.2 6.0 7.1 11.7 12.1 10.6 10.8 6.5 5.8 6.5 9.7 11.4 13.8 7.8 11.2 7.0 10.1 13.6 15.6 8.0 10.5 40.8 12.1 8.9 10.4 5.0 11.1 11.9 18.7 6.6 8.0 16.1 12.9 11.0 7.2 8.0 12.8 10.0 7.8 8.8 9.1 10.9 9.4 15.9 9.1 9.5 13.1 12.9 9.1 13.0 18.1 5.9 10.2 12.5 12.8 11.2 10.1 10.2 9.4 8.2 5.6 11.7 10.7 8.7 8.9 8.4 9.7 10.8 14.6 14.5 6.7 6.7 9.5 10.9 16.5 9.6 9.5 21.4 8.3 13.9 9.6 7.8 12.8 10.4 10.3 10.6 14.1 12.7 5.7 10.5 11.1 11.3 10.7 7.8 3.5 7.3 15.5 6.7 18.1 6.4 14.9 17.7 14.6 9.7 11.5 6.7 9.8 8.8 11.0 10.4 9.4 11.3 9.2 10.8 10.2 8.1 9.7 10.1 11.2 6.1 9.4 10.1 11.3 8.9 5.3 7.0 7.1 8.5 9.4 6.0 7.1 6.5 5.8 6.5 7.0 5.0 6.6 12.8 20.0 28.9 17.0 9.4 20.3 19.1 9.4 8.1 23.3 28.5 14.8 12.1 15.9 14.3 8.8 23.9 27.1 31.3 26.7 12.1 21.5 11.7 131.5 19.6 19.6 14.8 4.2 13.5 15.9 9.7 11.5 26.0 17.3 13.9 11.4 8.5 22.1 18.4 11.8 28.6 15.2 10.4 6.1 15.8 25.2 110.7 16.8 15.2 39.2 13.1 11.4 19.1 16.5 5.0 11.6 9.6 9.1 37.2 10.9 5.4 10.3 20.1 25.3 39.6 19.7 25.4 27.6 35.3 55.4 17.3 27.0 45.4 18.9 11.0 9.2 5.3 TRAF3IP3 T3JAM ENSG00000009790 "TRAF3 interacting protein 3" Q9Y228 1 209756032-209782320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 131.7" "Cell type enhanced" "Detected in many" "B-cells: 133.8;dendritic cells: 124.7;NK-cells: 407.8;T-cells: 162.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 115.2;JURKAT: 64.2;Karpas-707: 46.2;MOLT-4: 60.9;NB-4: 68.7;THP-1: 64.1;U-266/70: 68.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040796 Enhanced Approved Vesicles NA NA Vesicles "HPA040796: AB_10794861" "prognostic favorable (4.11e-4)" "unprognostic (1.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.36e-4)" "unprognostic (2.67e-1)" "unprognostic (1.91e-5)" "unprognostic (3.83e-3)" "prognostic favorable (8.15e-4)" "unprognostic (5.30e-2)" "unprognostic (3.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.39e-1)" "unprognostic (1.38e-4)" "unprognostic (3.08e-1)" "unprognostic (2.93e-2)" "unprognostic (3.16e-2)" "unprognostic (4.21e-2)" 3.7 2.4 1.7 52.1 1.9 32.1 4.2 1.7 3.5 3.5 2.6 8.3 7.5 2.8 2.7 3.5 2.0 10.6 1.7 1.9 2.2 4.2 5.8 10.9 100.5 2.6 2.0 1.4 2.2 0.9 0.7 0.8 2.0 2.8 3.4 10.5 0.3 5.7 2.8 1.1 2.4 30.9 3.8 2.7 60.6 13.5 3.8 2.4 131.7 3.0 2.0 91.2 11.8 2.3 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 115.2 0.0 11.0 0.0 0.0 0.2 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 64.2 0.1 46.2 0.0 0.0 60.9 68.7 0.2 0.0 0.0 7.1 0.0 20.8 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 64.1 0.0 0.0 0.1 0.0 0.1 68.1 25.6 4.7 0.0 31.9 0.1 456.2 155.3 169.6 296.7 171.1 317.7 300.5 410.4 343.1 164.1 287.8 459.3 365.0 41.2 345.1 209.8 121.6 587.1 414.3 1.7 1.9 1.7 3.5 1.9 2.2 2.6 2.0 1.4 2.8 2.7 2.4 2.8 1.6 3.2 9.6 0.3 133.8 2.3 4.8 1.2 1.2 1.7 1.5 1.9 0.7 2.8 0.2 0.0 0.0 0.5 124.7 0.4 11.7 0.1 11.3 14.8 0.9 2.1 0.0 22.9 0.4 0.2 0.3 1.4 2.0 48.0 58.2 0.0 6.1 3.8 22.3 0.0 0.4 0.4 0.0 24.7 12.6 9.0 0.3 40.8 10.6 39.4 69.8 0.2 407.8 0.0 0.7 0.0 0.1 0.0 64.1 2.4 0.4 12.8 0.9 0.4 0.0 0.7 1.2 8.0 0.6 2.6 2.3 0.4 162.8 0.0 0.6 1.8 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320883 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.8" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1;Oligodendrocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 5.4 12.5 12.3 4.2 13.5 2.5 5.8 12.8 13.5 7.4 11.1 6.2 2.6 6.7 9.9 5.5 5.8 4.1 7.3 11.4 11.8 9.3 9.4 5.7 1.8 14.2 13.6 10.1 6.2 8.9 8.7 12.7 7.0 12.6 7.9 3.3 5.6 6.4 7.0 19.3 4.6 4.9 4.6 13.0 5.7 6.0 37.8 13.4 2.9 11.0 8.5 1.9 8.0 5.4 13.9 15.6 19.4 18.6 21.1 13.0 10.3 14.8 13.4 10.8 19.3 16.6 9.6 13.6 4.6 10.6 12.6 27.1 17.1 8.8 13.3 13.5 6.9 12.1 2.8 8.9 7.9 15.8 3.2 8.9 10.5 13.9 18.3 17.8 13.6 11.5 4.5 7.4 10.5 13.0 30.7 5.4 15.0 5.3 21.4 16.2 5.3 18.0 4.1 20.4 11.3 15.6 15.2 8.7 14.6 11.3 12.0 15.1 6.5 9.6 14.6 22.8 17.1 12.0 6.8 14.5 2.1 7.4 4.8 13.2 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.1 12.3 13.5 12.8 13.5 11.4 11.8 14.2 13.6 10.1 12.6 13.0 13.4 13.9 3.2 6.4 2.8 27.1 2.0 3.1 2.7 3.4 2.8 7.5 7.2 7.6 4.3 4.3 1.6 1.8 16.7 6.0 1.2 6.5 0.0 7.6 14.3 5.8 6.7 3.1 18.0 0.0 12.9 7.5 10.2 6.1 4.1 7.0 2.5 6.4 2.5 5.7 5.5 8.4 14.5 3.2 2.0 2.2 2.6 17.2 1.8 2.4 1.8 9.4 2.3 5.9 0.0 20.1 30.5 5.5 3.2 4.1 2.1 5.2 2.5 3.6 5.1 15.1 0.0 6.2 5.0 11.3 8.2 5.2 1.8 5.7 1.2 13.9 3.6 1.9 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224685 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 220000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavorable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 22.4 21.1 17.2 25.9 19.1 30.9 32.0 20.2 20.5 23.4 13.1 35.2 38.6 23.7 25.6 39.5 27.5 23.2 34.2 19.3 18.5 34.8 45.8 21.7 33.7 17.9 19.3 16.5 21.2 19.5 28.5 10.0 32.4 17.7 22.7 40.3 29.4 18.4 19.8 56.3 31.0 37.3 26.6 20.0 23.3 23.7 18.5 18.8 45.8 27.9 58.8 39.4 36.1 20.4 22.0 56.5 47.5 75.8 116.8 65.3 71.4 52.3 124.7 74.0 111.6 105.8 80.9 43.0 91.2 82.1 112.6 84.6 70.2 81.5 85.1 153.4 62.3 71.7 99.2 46.2 97.0 48.2 155.6 55.2 59.4 97.7 111.8 71.7 59.8 72.4 69.7 93.7 44.5 94.5 82.1 101.8 80.7 57.0 72.1 53.8 92.1 60.8 55.8 86.4 61.5 79.0 61.5 70.1 53.3 63.7 62.9 57.8 104.4 53.0 50.0 69.6 84.7 90.8 43.5 80.9 103.8 32.7 85.5 77.8 222.4 90.0 151.9 64.3 114.5 83.5 85.6 72.8 76.0 90.9 84.8 79.8 80.4 56.0 97.5 120.3 55.9 79.0 121.5 17.2 19.1 20.2 20.5 19.3 18.5 17.9 19.3 16.5 17.7 20.0 18.8 22.0 16.7 22.4 20.3 22.5 25.8 25.2 19.2 25.5 25.6 9.7 16.5 18.3 47.8 12.8 24.5 16.5 0.0 32.7 23.9 40.2 17.6 31.5 4.5 30.7 30.4 17.5 21.6 23.1 40.1 28.0 36.4 25.4 16.8 28.0 12.6 18.1 11.4 24.7 27.9 11.8 38.7 24.7 14.2 20.9 14.3 2.2 11.8 20.0 8.8 40.3 28.0 23.9 35.0 25.6 48.7 30.1 18.3 12.4 16.4 17.2 30.0 31.6 36.6 12.6 6.6 16.8 18.4 23.6 24.9 28.8 31.0 31.7 23.8 25.3 25.9 18.8 MLXIPL "bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH" ENSG00000009950 "MLX interacting protein like" Q9NP71 7 73593194-73624543 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 614.7" "Group enriched" "Detected in many" 4 "Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 60.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064640 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA064640: AB_2685309" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "unprognostic (2.18e-2)" "unprognostic (4.86e-2)" "unprognostic (5.04e-1)" "unprognostic (1.06e-3)" "unprognostic (3.46e-3)" "unprognostic (9.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (6.13e-3)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (2.46e-2)" "unprognostic (7.72e-3)" 68.4 85.8 4.0 0.7 4.3 0.2 51.6 14.6 9.4 1.9 0.3 6.3 59.4 0.6 16.5 3.4 13.0 5.6 3.0 5.0 2.0 35.3 614.7 2.7 0.0 5.5 2.2 4.1 4.9 23.3 6.3 13.5 0.0 8.2 3.7 1.6 0.7 8.8 0.8 58.6 4.3 47.2 0.5 1.4 0.3 4.7 31.2 2.5 0.9 7.3 13.9 0.0 2.0 2.7 5.1 0.2 2.5 0.0 5.9 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 7.5 0.0 0.3 0.0 0.6 1.2 0.0 0.0 0.0 0.2 6.1 0.0 4.8 46.5 1.3 0.2 1.7 0.8 0.0 0.0 0.0 0.1 0.0 0.0 15.2 0.0 0.1 6.3 0.1 0.0 0.7 8.2 1.0 0.0 0.0 1.2 0.0 0.1 25.5 0.7 1.0 4.4 0.0 0.1 11.4 6.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.3 14.6 9.4 5.0 2.0 5.5 2.2 4.1 8.2 1.4 2.5 5.1 0.6 0.0 16.2 2.3 1.6 1.1 4.8 0.6 0.6 9.9 1.4 1.3 3.4 84.4 4.7 3.7 20.9 0.1 0.3 3.2 1.9 2.9 3.2 0.7 0.2 2.5 90.1 16.0 33.4 1.0 0.1 6.5 4.6 0.8 0.0 0.1 12.8 286.6 0.4 1.7 29.1 19.6 0.0 11.2 1.5 1.2 2.8 2.8 7.2 30.9 0.2 2.0 1.0 2.0 0.9 1.4 13.9 1.2 0.1 2.2 108.9 14.1 3.2 6.5 0.0 23.9 1.0 5.1 1.1 0.5 0.9 0.5 1.7 0.0 31.9 4.0 BAZ1B "WBSCR10, WBSCR9, WSTF" ENSG00000009954 "Bromodomain adjacent to zinc finger domain 1B" Q9UIG0 7 73440406-73522293 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037081, CAB037158, HPA058068" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: " "unprognostic (1.17e-1)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (2.06e-2)" "unprognostic (1.37e-1)" "unprognostic (5.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.89e-1)" "unprognostic (1.09e-1)" "unprognostic (2.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.12e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 22.8 19.5 25.8 22.3 28.8 24.9 16.9 30.1 26.0 22.7 22.7 20.7 16.2 24.6 17.9 18.2 19.5 16.2 19.7 23.2 26.1 16.9 24.3 20.4 28.1 26.7 27.6 20.5 31.1 21.1 27.8 19.3 22.9 27.7 22.8 20.7 28.6 17.2 25.7 28.2 14.3 18.3 24.9 25.6 23.6 19.1 17.4 26.6 41.0 24.0 31.0 29.9 22.1 17.6 29.9 75.6 76.1 102.5 115.3 52.0 55.1 34.1 71.7 54.7 67.4 70.5 62.4 55.6 141.6 16.3 64.1 102.6 51.7 126.1 47.7 100.9 80.3 63.8 84.4 89.3 54.3 57.9 128.8 68.5 39.6 45.5 83.2 101.6 50.4 54.5 75.9 149.9 86.4 76.7 71.7 132.8 59.1 66.7 57.6 56.2 133.1 89.9 94.5 38.5 58.2 102.4 87.2 102.1 112.4 59.8 87.1 69.1 63.6 64.4 116.1 66.5 70.6 123.2 49.7 84.7 235.7 65.9 119.1 107.7 4.0 1.5 1.0 3.0 1.1 2.6 1.2 2.3 2.2 1.1 2.5 1.7 1.9 1.1 2.8 0.8 3.1 2.5 0.9 25.8 28.8 30.1 26.0 23.2 26.1 26.7 27.6 20.5 27.7 25.6 26.6 29.9 46.3 76.9 129.8 28.7 52.8 29.8 34.5 16.7 38.1 69.9 28.1 24.6 81.7 27.1 59.0 20.2 43.8 57.3 50.4 33.1 7.9 35.5 8.4 47.4 72.2 53.5 34.7 89.8 35.0 23.1 59.6 58.7 34.7 52.6 51.8 59.5 34.6 59.1 33.0 60.6 35.3 34.6 22.4 33.4 24.8 12.5 61.2 38.7 12.4 34.7 47.3 54.4 61.8 28.6 43.9 26.5 13.6 76.3 65.3 40.5 25.2 12.9 49.2 53.8 32.9 67.1 57.5 75.7 127.0 47.0 25.3 34.6 56.5 46.1 43.3 35.2 RANBP9 RanBPM ENSG00000010017 "RAN binding protein 9" Q96S59 6 13621498-13711835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 113.6;Excitatory neurons: 132.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033767, HPA050007, HPA076784" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: " "unprognostic (3.59e-2)" "unprognostic (6.57e-2)" "unprognostic (4.37e-2)" "unprognostic (2.67e-1)" "unprognostic (1.78e-1)" "prognostic favorable (9.97e-4)" "unprognostic (1.30e-1)" "unprognostic (4.61e-2)" "unprognostic (5.87e-3)" "prognostic favorable (2.47e-4)" "unprognostic (1.61e-1)" "unprognostic (6.74e-2)" "unprognostic (3.51e-1)" "unprognostic (7.19e-3)" "unprognostic (1.52e-1)" "unprognostic (3.49e-1)" "unprognostic (3.09e-1)" 21.2 20.5 24.6 16.9 27.4 57.9 18.5 24.6 31.0 22.5 24.1 23.4 13.3 20.8 22.4 69.7 15.5 24.9 20.2 27.0 26.6 18.8 26.6 18.1 18.7 22.8 26.6 25.7 19.8 17.6 24.3 16.8 20.2 24.1 21.5 18.2 21.2 24.5 17.4 61.0 27.9 15.6 23.7 24.1 15.2 18.1 107.4 24.7 30.0 16.6 39.8 31.1 21.8 38.5 27.3 38.1 16.3 38.7 39.3 51.9 47.8 41.0 45.6 51.6 47.2 49.5 24.8 21.9 33.4 73.0 54.0 35.7 20.3 30.5 26.8 64.6 58.0 27.5 33.6 29.9 45.9 71.7 53.0 24.5 48.7 33.8 56.0 45.9 37.4 39.0 58.3 73.3 26.2 53.1 38.5 62.1 42.0 17.1 36.2 22.6 49.1 30.2 47.1 37.7 43.2 47.9 33.7 36.9 66.3 67.0 73.4 35.6 44.6 38.3 42.3 30.2 34.7 47.4 63.5 82.3 44.9 19.4 32.8 80.1 0.3 0.5 1.8 0.7 0.7 1.4 0.7 1.5 0.7 0.5 0.7 1.3 0.9 0.8 1.2 0.8 0.8 3.6 0.4 24.6 27.4 24.6 31.0 27.0 26.6 22.8 26.6 25.7 24.1 24.1 24.7 27.3 17.2 19.2 30.5 58.1 12.5 24.9 7.8 13.5 13.1 25.1 23.3 15.0 40.1 12.8 19.2 18.4 14.6 17.9 22.3 21.7 1.9 8.2 113.6 23.5 21.8 24.0 13.2 11.6 132.9 10.8 9.1 19.8 10.2 29.6 10.1 19.5 16.8 18.3 18.0 6.7 78.3 14.5 12.2 28.0 32.3 99.9 15.8 21.8 17.8 73.1 14.9 22.8 15.5 74.9 75.6 16.6 7.3 24.8 18.3 15.5 12.2 11.4 19.8 17.5 6.6 16.5 18.5 85.4 41.9 19.3 26.1 28.5 22.9 14.3 12.0 17.7 ETV7 "TEL-2, TEL2" ENSG00000010030 "ETS variant transcription factor 7" Q9Y603 6 36354091-36387800 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 16.1;skin 1: 15.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 18.9;T-reg: 16.3" "Group enriched" "Detected in many" 4 "granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3" "Cell line enhanced" "Detected in some" "BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7" "Low region specificity" "Detected in all" HPA029033 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029033: AB_10601375" "unprognostic (1.67e-2)" "prognostic favorable (5.16e-4)" "unprognostic (9.48e-2)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-3)" "unprognostic (9.08e-2)" "unprognostic (4.11e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.32e-4)" "unprognostic (6.81e-3)" "unprognostic (1.11e-1)" "unprognostic (1.69e-3)" "unprognostic (5.54e-2)" "unprognostic (4.93e-1)" "unprognostic (1.27e-2)" "prognostic favorable (2.95e-6)" 1.4 2.1 1.4 7.0 1.5 0.9 2.1 0.9 1.7 1.6 1.2 3.3 16.1 1.0 1.3 3.6 2.3 3.4 0.4 1.3 1.9 1.7 2.9 4.9 5.4 1.8 1.1 1.1 1.6 1.7 2.2 3.8 3.6 2.0 3.0 2.6 0.4 8.7 1.5 0.2 15.5 12.8 1.0 1.1 3.1 6.3 1.1 1.2 4.0 1.2 0.3 4.0 5.5 2.6 2.0 3.2 0.0 0.2 0.1 0.0 0.2 27.1 0.0 9.2 14.7 27.8 0.5 6.2 0.1 0.7 0.2 2.3 3.3 0.4 1.7 0.7 59.7 0.5 0.5 0.0 0.0 1.8 0.0 0.3 1.2 2.4 0.7 0.2 0.0 0.4 0.0 0.1 0.2 0.3 0.1 0.2 0.3 0.2 0.3 0.1 6.1 0.1 0.2 0.2 1.1 0.8 0.0 0.6 2.1 0.5 0.0 3.1 0.6 0.2 0.3 0.7 0.3 0.1 0.1 0.1 0.2 0.0 2.7 0.4 0.0 3.7 0.3 1.6 5.7 3.9 3.3 5.4 2.2 0.9 2.4 1.0 1.4 18.9 0.6 1.9 0.0 16.3 2.5 1.4 1.5 0.9 1.7 1.3 1.9 1.8 1.1 1.1 2.0 1.1 1.2 2.0 1.4 19.2 14.8 0.3 1.2 2.0 2.2 8.0 6.2 0.2 2.5 2.7 0.5 7.2 7.1 0.0 0.0 28.8 0.7 6.6 0.0 12.4 0.4 0.4 1.4 1.1 3.6 0.0 0.5 23.8 6.6 2.7 8.2 0.7 2.5 1.7 0.0 0.4 2.9 0.0 0.3 6.5 6.1 1.3 1.6 0.5 1.5 1.0 3.6 0.0 6.5 3.1 1.0 0.0 0.3 13.4 7.8 1.2 5.6 4.8 21.5 1.3 3.0 0.6 0.0 1.0 5.5 0.9 26.8 6.4 3.7 8.5 3.6 0.7 7.6 4.8 SPRTN "C1orf124, DKFZP547N043, DVC1, Spartan" ENSG00000010072 "SprT-like N-terminal domain" Q9H040 1 231337104-231355023 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 85.5;Rod photoreceptor cells: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025073 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA025073: AB_1847695" "unprognostic (2.63e-1)" "unprognostic (5.41e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (1.72e-1)" "unprognostic (1.33e-2)" "unprognostic (4.75e-3)" "unprognostic (1.26e-1)" "unprognostic (3.25e-1)" "unprognostic (7.51e-3)" "unprognostic (1.19e-1)" "unprognostic (3.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.35e-2)" 4.4 3.7 3.4 5.1 3.9 12.0 5.5 4.3 3.5 4.2 3.8 3.7 4.0 4.9 4.2 5.7 3.5 4.5 4.5 3.0 4.0 4.6 5.2 3.7 6.4 3.8 3.7 2.6 3.1 2.7 4.8 2.8 7.9 3.8 3.9 3.8 4.9 3.6 3.6 8.6 5.9 3.7 5.0 3.7 5.0 4.2 14.7 3.5 7.2 5.1 5.4 6.3 4.9 3.3 5.0 13.7 11.4 10.5 11.5 9.6 6.8 12.7 12.1 10.5 13.6 11.8 13.2 11.4 12.4 12.8 10.1 5.4 19.6 15.2 12.2 14.7 10.6 26.1 7.8 11.1 9.1 10.2 13.3 11.0 9.3 12.7 15.0 12.2 6.2 13.8 11.1 19.0 11.8 13.9 7.5 14.1 7.5 10.4 15.6 10.0 12.3 13.6 14.7 12.0 10.2 13.2 12.8 13.0 9.8 13.9 4.7 17.9 19.3 10.5 11.7 11.8 17.1 19.9 9.1 10.0 17.0 9.1 11.2 20.4 8.6 4.6 9.8 5.1 6.6 5.7 4.9 5.1 5.8 4.6 3.2 6.1 6.8 9.5 6.6 4.8 4.3 5.9 3.6 3.4 3.9 4.3 3.5 3.0 4.0 3.8 3.7 2.6 3.8 3.7 3.5 5.0 14.5 16.0 4.2 8.8 19.9 32.0 11.4 9.3 27.3 22.6 11.6 13.1 5.2 10.0 11.4 3.7 85.5 12.0 25.2 10.3 9.8 8.7 20.5 16.6 13.2 16.1 12.0 12.4 12.5 9.3 10.6 12.3 12.2 9.8 26.1 11.4 13.6 7.0 9.6 15.2 11.9 7.0 12.2 9.5 12.5 8.4 9.0 10.1 7.2 8.4 15.8 13.6 34.0 10.6 21.3 12.1 7.1 7.9 10.2 10.5 11.0 8.1 16.8 73.7 13.1 14.4 13.7 51.8 21.4 20.5 28.4 15.2 20.9 11.6 8.5 14.5 EEF1AKNMT "CGI-01, DFNM1, FEAT, KIAA0859, METTL13" ENSG00000010165 "EEF1A lysine and N-terminal methyltransferase" Q8N6R0 1 171781660-171814023 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 8.1;Cytotrophoblasts: 16.9;Extravillous trophoblasts: 22.3;Hofbauer cells: 17.5;Syncytiotrophoblasts: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044498, HPA053705" Approved Approved Cytosol NA NA Cytosol "HPA044498: AB_10960884, HPA053705: AB_2682235" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (3.78e-1)" "unprognostic (4.40e-1)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.86e-1)" "unprognostic (3.12e-1)" "unprognostic (8.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.65e-1)" "unprognostic (4.12e-1)" "unprognostic (6.86e-3)" "unprognostic (7.49e-2)" "unprognostic (3.01e-1)" "unprognostic (1.13e-1)" 10.6 12.7 8.0 11.4 8.4 8.3 11.2 9.2 8.2 10.5 8.0 10.8 12.2 10.3 18.7 9.9 12.2 7.2 8.9 7.7 8.2 10.1 10.5 9.7 13.9 9.0 8.2 7.6 11.1 10.1 10.7 5.4 9.1 8.2 9.5 11.5 6.2 10.3 10.5 16.6 11.3 11.3 11.6 8.8 11.4 10.1 13.1 8.6 13.3 9.4 13.2 14.3 10.2 8.6 9.0 27.3 63.3 16.7 17.2 23.1 20.7 44.7 33.5 26.2 39.5 30.7 48.2 27.5 49.5 39.3 22.9 26.0 27.3 51.3 26.8 31.2 32.4 29.1 34.3 33.0 21.3 17.0 46.2 33.4 18.5 24.5 41.1 17.7 18.1 23.9 26.6 69.7 16.6 30.3 20.7 36.9 31.3 63.6 54.0 84.1 33.3 21.9 45.8 22.7 27.7 27.3 37.5 25.3 56.8 31.0 40.3 42.0 39.8 19.8 26.6 24.4 27.6 40.0 42.7 51.2 56.7 20.2 31.5 24.5 1.6 8.0 3.0 8.3 7.7 9.6 8.4 8.3 7.1 7.7 6.1 7.4 10.0 2.3 10.5 7.1 8.9 6.7 7.5 8.0 8.4 9.2 8.2 7.7 8.2 9.0 8.2 7.6 8.2 8.8 8.6 9.0 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 16.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 22.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 DYRK4 ENSG00000010219 "Dual specificity tyrosine phosphorylation regulated kinase 4" Q9NR20 12 4562204-4615302 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.1" "Group enriched" "Detected in all" 5 "Early spermatids: 392.2;Late spermatids: 393.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028065, HPA056073" Enhanced Enhanced Vesicles No No Vesicles "HPA028065: AB_10601212, HPA056073: AB_2683028" "unprognostic (2.50e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (3.56e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-3)" "unprognostic (2.03e-2)" "unprognostic (4.69e-2)" "unprognostic (1.29e-1)" "unprognostic (7.13e-2)" "unprognostic (1.22e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (1.86e-1)" "unprognostic (9.71e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" 1.9 4.3 4.7 3.4 4.9 4.7 6.4 5.7 7.7 5.9 5.2 5.4 4.7 5.1 17.2 4.1 5.0 4.4 4.7 4.8 5.0 3.5 4.2 4.8 6.0 5.0 5.0 4.1 5.2 3.1 5.1 3.7 6.9 5.2 5.0 6.2 7.7 3.7 7.2 2.3 4.9 4.0 5.2 5.1 6.2 3.2 37.1 5.1 4.3 9.2 4.1 5.4 4.7 2.0 7.0 2.0 3.2 3.9 4.3 5.8 7.1 4.7 2.4 4.8 5.4 5.9 0.6 3.2 6.1 0.3 6.9 3.7 4.2 3.0 4.5 4.2 4.7 6.8 4.2 1.0 3.6 16.4 3.7 3.3 4.9 9.6 3.8 12.4 10.1 7.8 6.5 1.8 6.7 4.9 4.3 3.5 9.1 5.3 1.0 1.8 0.7 2.8 2.6 6.7 1.9 0.0 1.5 0.5 2.4 3.3 8.4 1.9 3.3 0.5 6.3 4.9 0.6 3.1 1.9 2.6 3.8 3.3 5.8 3.3 0.3 1.7 0.8 0.5 1.3 0.6 4.4 0.8 0.9 1.6 3.0 0.8 0.9 0.0 0.7 3.5 0.8 0.7 0.8 4.7 4.9 5.7 7.7 4.8 5.0 5.0 5.0 4.1 5.2 5.1 5.1 7.0 13.0 12.8 16.2 11.1 15.8 8.9 13.2 31.2 14.8 20.7 21.2 30.4 23.8 7.2 19.9 16.5 10.4 15.7 16.7 5.2 31.3 25.1 392.2 14.0 22.5 15.5 5.4 12.2 10.3 27.1 12.0 17.3 14.3 13.3 17.7 19.0 8.2 9.8 49.7 13.5 10.4 75.4 14.2 16.1 9.3 393.1 15.2 18.7 16.0 9.4 14.5 19.4 13.4 14.1 16.1 20.1 14.2 31.6 22.9 16.4 7.3 35.6 13.9 21.7 6.6 15.2 17.6 23.7 39.0 20.4 7.5 9.9 12.7 40.6 17.3 11.8 ZNF207 BuGZ ENSG00000010244 "Zinc finger protein 207" O43670 17 32350132-32381885 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017013, HPA063908" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017013: AB_1859124, HPA063908: AB_2685149" "unprognostic (8.40e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.81e-4)" "unprognostic (7.57e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.30e-8)" "unprognostic (2.68e-1)" "unprognostic (4.75e-3)" "unprognostic (8.53e-2)" "unprognostic (5.18e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.17e-8)" "unprognostic (1.28e-2)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" 72.0 66.0 35.4 74.6 38.2 241.6 68.4 48.7 45.7 66.3 42.1 69.3 55.6 71.2 72.7 112.0 62.9 59.0 59.9 37.2 40.8 57.1 63.9 72.9 101.8 38.3 37.1 35.1 72.3 55.7 72.6 61.8 79.3 39.2 57.6 82.1 62.5 72.2 56.9 85.2 76.8 64.2 78.5 37.8 69.8 64.2 66.9 36.9 104.8 63.5 62.6 129.7 94.1 78.8 46.6 169.9 203.5 215.8 122.4 113.0 121.3 172.6 165.5 231.9 230.1 205.3 195.2 157.3 231.5 124.8 204.6 178.5 170.6 282.1 200.6 258.1 120.0 188.9 237.9 183.8 202.9 118.2 305.0 209.4 141.3 118.3 162.0 89.6 129.4 215.9 115.5 245.9 173.2 223.9 154.6 245.2 142.5 187.1 160.8 114.8 217.5 193.5 217.0 191.5 324.9 150.6 167.7 155.8 113.2 148.1 183.9 204.8 178.7 154.1 129.4 153.4 132.5 227.8 146.7 235.6 369.5 110.6 141.9 204.9 110.5 75.7 78.1 67.6 84.8 70.2 59.7 61.7 62.7 99.8 44.7 50.8 59.1 38.6 83.9 92.5 47.1 86.9 90.6 35.4 38.2 48.7 45.7 37.2 40.8 38.3 37.1 35.1 39.2 37.8 36.9 46.6 119.3 80.1 114.7 135.8 131.1 149.4 195.5 120.8 149.1 134.2 108.8 64.1 32.9 65.8 146.1 64.4 225.2 123.3 191.1 118.2 54.8 94.9 62.0 101.9 116.9 110.1 115.9 125.1 171.2 105.7 175.5 101.3 124.9 144.2 75.3 152.8 85.3 58.4 98.7 101.0 163.0 95.2 93.6 98.8 130.2 26.1 107.2 133.1 55.2 123.7 175.8 55.0 168.9 215.7 257.4 146.5 91.2 97.8 144.9 160.3 101.7 57.7 115.0 141.0 124.9 146.3 145.6 136.3 113.5 175.9 148.5 178.7 143.8 90.0 109.9 250.3 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 774.0;tongue: 890.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 662.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria NA NA 250000 Mitochondria "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favorable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 66.6 58.8 91.4 47.3 90.9 62.9 55.5 112.8 111.0 51.2 112.2 158.4 157.7 35.8 50.8 79.7 66.8 34.2 391.4 90.5 106.9 132.5 150.2 42.4 43.1 105.3 97.0 87.9 36.4 88.1 193.9 30.8 56.4 111.2 52.3 130.8 53.4 106.8 78.2 774.0 79.3 126.5 63.4 92.4 41.3 104.2 52.6 102.6 73.4 48.8 890.5 58.4 64.1 40.3 113.1 118.2 169.6 136.7 145.0 147.5 117.0 225.2 129.4 206.1 196.5 178.9 272.8 107.1 193.4 94.4 143.2 274.1 123.6 171.6 280.9 91.7 138.3 173.8 214.7 186.7 317.1 186.9 164.4 152.2 150.9 293.6 183.2 274.6 167.5 172.5 173.7 110.5 107.1 152.5 192.0 156.7 241.6 157.6 229.6 324.2 103.4 138.1 273.5 235.8 178.7 84.4 107.5 182.8 218.7 211.8 92.0 163.1 178.0 112.5 107.7 153.7 179.5 272.4 124.8 121.4 136.5 192.7 233.9 319.0 251.3 643.7 325.4 204.7 665.7 193.7 260.0 203.5 206.1 593.3 227.7 177.1 175.2 158.2 194.4 608.0 235.0 258.1 988.2 91.4 90.9 112.8 111.0 90.5 106.9 105.3 97.0 87.9 111.2 92.4 102.6 113.1 31.5 57.7 50.4 17.3 59.0 117.6 164.6 339.4 103.6 41.9 59.3 46.1 662.2 140.2 139.2 121.4 29.2 334.4 28.0 550.2 365.9 163.7 155.0 64.0 41.6 53.4 144.5 80.6 16.9 166.3 311.1 78.2 167.7 61.5 82.4 72.5 49.6 188.0 238.2 40.4 22.0 319.6 223.8 118.1 85.4 331.9 58.4 107.7 119.2 12.2 129.1 67.1 51.5 14.6 12.5 163.5 333.3 70.7 117.6 78.4 553.4 398.4 104.7 65.0 59.2 61.2 153.0 110.3 74.7 173.0 105.4 336.7 50.8 172.1 416.8 153.4 STARD3NL "MENTHO, MGC3251" ENSG00000010270 "STARD3 N-terminal like" O95772 7 38178245-38230670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019204 Enhanced Supported Vesicles NA NA Vesicles "HPA019204: AB_2197800" "unprognostic (1.55e-3)" "unprognostic (2.80e-3)" "unprognostic (2.22e-1)" "unprognostic (2.58e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (1.44e-5)" "unprognostic (9.64e-2)" "unprognostic (1.89e-1)" "unprognostic (5.37e-2)" "prognostic favorable (8.48e-4)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" "unprognostic (8.09e-3)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 27.0 22.0 37.1 23.3 38.7 38.2 22.2 41.1 42.1 31.6 32.8 21.6 18.7 32.9 27.4 12.4 27.8 22.2 27.3 36.9 44.7 34.3 17.5 33.1 21.5 43.2 44.6 35.6 24.4 16.5 18.0 25.7 49.8 47.0 41.0 23.7 26.5 15.1 21.9 17.5 6.4 20.5 33.3 43.5 27.3 17.8 33.0 43.7 22.5 33.0 17.7 15.4 29.7 15.0 45.2 40.9 42.7 92.6 60.4 62.8 62.2 32.4 65.2 67.2 63.2 82.4 34.3 63.0 31.9 64.0 59.9 192.0 42.9 51.4 49.5 95.2 29.0 45.1 64.8 22.1 47.4 55.3 71.5 72.7 58.8 24.0 67.0 53.0 72.0 116.7 86.1 75.0 53.7 98.4 25.1 40.9 115.2 65.5 33.7 33.9 49.6 85.9 14.9 89.0 37.5 36.9 86.7 22.4 58.8 64.1 127.0 40.9 93.8 80.0 43.0 61.0 67.8 93.5 57.4 62.2 12.1 87.0 125.6 142.4 33.5 46.8 56.2 52.2 43.3 23.9 30.8 21.6 39.3 42.3 28.4 18.1 35.6 53.1 71.8 47.0 30.3 24.8 47.1 37.1 38.7 41.1 42.1 36.9 44.7 43.2 44.6 35.6 47.0 43.5 43.7 45.2 45.8 19.2 47.3 15.0 33.2 20.8 57.3 43.4 20.5 8.7 26.8 15.0 18.2 14.3 25.9 31.3 12.5 48.3 67.2 15.5 31.3 31.4 125.3 37.0 42.5 45.5 21.5 28.2 21.9 34.3 91.2 34.2 19.9 33.1 23.5 36.0 51.0 12.4 65.8 5.0 24.5 20.9 32.6 63.2 77.9 115.2 18.3 56.8 26.6 17.8 24.2 34.6 114.4 27.6 26.0 34.0 21.6 25.9 34.3 55.2 19.4 50.1 22.8 13.0 13.1 23.4 38.4 48.8 37.3 12.2 16.2 42.3 47.5 24.5 19.5 46.4 CD9 "BA2, MIC3, MRP-1, P24, TSPAN29" ENSG00000010278 "CD9 molecule" P21926 12 6199715-6238271 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 25 "basophil: 1957.3;eosinophil: 1156.4" "Lineage enriched" "Detected in all" 32 "granulocytes: 1957.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002490 Supported Supported "Plasma membrane" "Intracellular and membrane" NA NA 1200000 "Plasma membrane" "CAB002490: AB_563643" "unprognostic (1.38e-1)" "unprognostic (6.36e-3)" "unprognostic (8.27e-3)" "unprognostic (6.98e-3)" "unprognostic (3.89e-1)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (2.90e-1)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (6.10e-2)" "unprognostic (1.77e-1)" "prognostic favorable (8.93e-5)" "unprognostic (9.26e-2)" 173.0 290.1 131.6 97.4 170.6 17.5 302.0 158.0 195.0 325.2 169.1 458.4 128.4 244.4 273.3 1008.2 244.4 103.3 220.1 138.7 172.1 269.0 80.1 406.6 37.7 179.7 159.2 122.1 69.6 94.2 889.3 98.9 86.1 167.9 492.8 470.7 32.9 619.5 460.6 75.0 443.8 213.0 198.7 160.4 70.1 179.7 26.6 153.3 66.7 340.8 117.6 291.8 376.7 571.1 222.3 417.6 173.7 3.5 108.7 167.7 170.8 150.1 241.1 477.8 80.8 121.9 128.5 1521.6 1.4 59.2 51.4 239.0 885.6 92.7 475.5 62.7 21.5 63.1 2.0 117.1 26.6 71.3 1.1 497.0 0.6 347.0 147.3 126.0 225.3 976.3 28.9 19.3 1.7 51.5 578.6 1.8 45.4 136.0 504.3 175.7 4.1 290.1 529.7 802.1 1126.8 0.5 34.0 240.9 195.8 215.8 789.0 91.1 42.1 2266.0 8.6 214.6 8.8 29.5 1.7 1.3 63.2 137.2 1.0 221.7 1957.3 61.1 1156.4 1.3 23.6 2.2 5.5 1.4 1.6 10.2 20.5 4.2 11.5 30.9 2.6 0.6 3.7 0.4 71.7 131.6 170.6 158.0 195.0 138.7 172.1 179.7 159.2 122.1 167.9 160.4 153.3 222.3 250.0 794.9 403.1 35.6 27.8 1037.8 1864.4 2822.0 804.1 4.9 433.5 379.5 20.9 84.4 1403.7 1075.9 0.0 21.5 8.7 929.9 137.0 599.1 3.0 457.8 66.8 496.5 172.9 10.5 0.4 178.2 271.0 356.9 60.6 722.6 653.4 42.3 522.6 43.1 618.0 0.0 0.6 744.8 4461.6 35.2 685.3 13.1 32.0 253.4 940.9 11.2 151.7 375.1 2.1 56.3 169.5 352.9 896.4 70.7 59.3 1576.4 330.0 21.7 1409.8 14.7 664.0 322.6 397.5 7.3 74.1 1214.3 1279.8 54.0 77.8 838.5 761.1 2594.9 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702824 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 243.3;heart muscle: 526.1;skeletal muscle: 285.0;tongue: 155.6" "Group enriched" "Detected in some" 8 "Astrocytes: 59.1;Bipolar cells: 119.6;Cardiomyocytes: 65.2;Muller glia cells: 49.9;Oligodendrocytes: 168.0" "Cancer enhanced" "Detected in many" "melanoma: 14.2;thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018174 Enhanced NA NA "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 0.4 0.7 82.3 0.0 157.6 0.0 1.4 128.5 115.7 0.4 41.5 0.2 0.0 0.9 0.4 4.0 1.9 0.4 526.1 79.4 112.9 0.2 0.3 0.7 0.3 140.6 158.1 61.6 0.1 1.3 2.9 3.8 0.1 171.5 1.7 0.1 38.1 10.8 0.2 285.0 1.1 0.2 0.2 131.6 0.2 0.2 1.1 127.1 2.2 21.6 155.6 0.1 0.1 0.3 243.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.3 157.6 128.5 115.7 79.4 112.9 140.6 158.1 61.6 171.5 131.6 127.1 243.3 0.0 0.0 0.0 59.1 0.0 0.4 0.0 0.0 0.0 119.6 0.0 0.0 65.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.1 1.2 0.0 0.0 4.8 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 11.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 5.4 2.8 0.0 49.9 0.0 1.5 168.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.2 0.0 5.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 77.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 48.0;Late spermatids: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes 34000 Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 8.4 7.4 7.0 21.7 10.5 35.8 11.1 9.7 8.1 10.3 7.3 18.1 17.2 10.8 10.7 16.0 11.3 9.9 7.7 7.0 8.1 7.4 4.8 10.7 38.5 10.8 10.0 5.7 8.1 7.8 11.4 5.5 17.7 10.9 9.4 20.6 11.2 11.9 10.3 7.9 22.1 16.2 13.5 9.2 16.2 12.2 18.4 9.2 77.5 11.4 10.3 45.2 10.2 9.4 13.8 125.3 99.3 134.6 97.9 29.9 28.4 159.2 76.1 69.8 138.3 109.1 123.5 150.8 135.8 24.2 63.2 126.7 128.6 188.0 105.4 194.1 214.1 92.8 112.2 113.8 79.4 12.5 145.0 96.5 20.5 31.6 112.4 107.8 61.9 89.9 94.0 71.0 63.4 104.7 79.6 162.2 73.8 207.5 129.9 78.2 153.7 260.6 77.7 39.5 64.1 54.0 61.9 121.5 64.9 44.3 189.1 27.0 101.7 51.0 94.1 149.6 60.8 168.4 45.3 51.7 181.0 55.7 92.2 126.1 11.0 1.7 3.7 7.1 2.8 5.3 5.1 6.4 7.3 3.4 3.5 7.3 7.3 1.4 8.1 2.2 4.1 8.3 3.9 7.0 10.5 9.7 8.1 7.0 8.1 10.8 10.0 5.7 10.9 9.2 9.2 13.8 4.3 6.4 7.4 4.9 11.0 3.6 3.8 4.4 17.1 3.7 4.7 6.9 4.1 5.7 3.4 1.8 8.4 13.5 8.9 7.3 0.0 4.5 18.3 5.3 6.3 5.4 1.2 48.0 5.6 3.7 17.8 6.4 7.1 5.8 3.8 20.0 8.9 3.3 10.1 5.0 5.0 9.9 6.1 16.4 4.4 34.3 5.9 10.8 0.0 2.8 9.5 11.8 15.5 2.5 17.8 5.3 4.6 6.0 22.6 4.1 6.0 2.4 4.2 8.4 0.0 4.2 5.2 21.3 13.7 19.3 3.4 6.3 12.0 6.1 14.7 4.1 IFFO1 "HOM-TES-103, IFFO" ENSG00000010295 "Intermediate filament family orphan 1" Q0D2I5 12 6538961-6556073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069344 Approved NA NA "HPA069344: AB_2686126" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (4.38e-2)" "unprognostic (3.33e-3)" "unprognostic (2.69e-2)" "unprognostic (1.43e-3)" "unprognostic (4.37e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (5.25e-2)" "prognostic favorable (6.53e-5)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.47e-7)" "unprognostic (5.71e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (5.58e-2)" 8.4 7.7 4.8 5.7 5.4 6.3 6.0 5.7 10.9 10.2 2.7 7.5 3.0 10.4 1.5 2.5 8.2 4.4 7.8 5.7 5.8 4.7 5.7 8.1 7.4 6.2 5.1 5.3 8.0 3.2 0.6 7.4 4.9 8.0 5.7 2.5 3.7 3.0 5.0 10.7 3.1 6.3 5.4 4.5 11.6 3.7 7.2 6.0 5.0 4.0 4.7 4.8 8.9 6.8 7.1 0.1 0.0 6.1 0.0 9.1 15.0 0.0 9.2 8.3 7.3 6.4 1.2 0.1 1.7 0.0 8.9 2.3 0.0 4.6 1.3 2.4 13.8 15.2 7.2 0.2 10.2 6.3 7.3 11.5 9.2 0.0 5.5 0.0 8.6 7.2 7.7 0.0 2.0 18.2 0.0 6.5 5.8 14.1 0.0 0.0 9.7 10.6 3.3 2.4 0.0 0.0 5.5 0.0 0.0 4.6 6.2 0.0 7.1 11.1 7.0 0.0 5.7 5.2 3.0 0.8 5.6 5.2 3.1 18.7 0.1 4.8 2.8 1.6 3.3 1.5 0.8 1.4 1.7 3.1 0.9 0.5 0.9 1.3 2.7 6.6 1.6 1.1 2.4 4.8 5.4 5.7 10.9 5.7 5.8 6.2 5.1 5.3 8.0 4.5 6.0 7.1 14.9 0.0 2.4 16.0 8.9 2.5 0.3 0.7 0.0 15.0 1.3 2.7 10.9 1.5 0.7 0.0 4.2 4.4 17.7 0.6 1.9 0.7 13.2 0.5 9.2 12.6 0.0 3.8 28.9 1.4 3.1 14.1 1.5 0.6 1.3 11.6 11.7 6.5 21.6 21.9 20.5 1.4 0.0 23.1 9.1 11.2 19.0 17.4 19.6 15.9 12.7 11.1 16.5 13.0 10.5 0.4 1.4 13.5 12.0 0.3 1.2 2.8 0.2 12.7 32.9 15.8 13.2 5.6 5.0 0.6 2.0 1.2 12.9 10.1 1.1 0.2 GIPR ENSG00000010310 "Gastric inhibitory polypeptide receptor" P48546 19 45668221-45683722 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 22.9" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 29.9;Gastric mucus-secreting cells: 28.1;Respiratory ciliated cells: 44.5;Rod photoreceptor cells: 17.4" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 4.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 9.8;HMC-1: 20.6;SCLC-21H: 13.9;U-266/70: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB022710, HPA068054" Uncertain Uncertain Vesicles NA NA Vesicles "CAB022710: , HPA068054: " "unprognostic (2.40e-2)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.70e-4)" "unprognostic (1.82e-2)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.85e-3)" "unprognostic (2.78e-1)" "unprognostic (1.72e-2)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-2)" "unprognostic (2.59e-2)" 8.1 0.4 2.4 3.1 3.4 2.1 9.1 2.9 3.4 2.2 3.2 4.1 3.8 0.3 0.7 2.6 10.3 1.4 10.0 2.3 3.5 2.0 0.7 5.6 2.7 4.1 4.0 1.9 0.1 10.9 5.6 0.4 0.2 5.3 7.2 4.9 13.2 7.9 0.4 0.3 4.0 4.2 0.3 2.2 4.1 22.9 0.2 4.3 0.6 2.5 0.0 2.4 2.6 3.4 5.4 0.7 0.4 1.3 0.7 0.6 0.0 0.1 1.0 0.8 0.0 0.7 0.4 3.9 1.9 0.6 0.8 0.7 2.0 0.3 0.2 0.1 9.8 0.3 1.6 1.0 0.3 0.1 0.6 20.6 0.0 0.3 0.1 0.0 1.8 0.0 2.1 4.5 2.2 0.0 0.2 0.1 1.1 0.0 2.9 0.7 0.5 0.4 4.4 0.5 0.9 13.9 1.2 0.0 0.8 0.2 0.5 2.0 3.1 0.4 0.0 0.5 0.3 0.2 16.7 0.2 0.4 0.6 1.5 0.3 1.1 0.1 0.5 0.5 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.5 0.9 0.0 0.2 0.4 0.2 2.4 3.4 2.9 3.4 2.3 3.5 4.1 4.0 1.9 5.3 2.2 4.3 5.4 1.4 3.2 6.3 0.0 1.0 0.9 3.4 2.9 0.0 0.3 2.0 0.5 4.0 5.7 9.8 5.5 0.0 0.0 3.7 13.2 0.0 2.2 0.4 7.1 0.1 0.5 29.9 0.0 0.2 3.6 0.1 0.5 28.1 0.7 1.3 0.1 0.0 0.0 0.1 0.0 0.4 6.8 4.1 0.0 7.8 0.2 0.0 1.4 0.0 0.0 0.5 0.2 1.0 0.0 5.0 5.6 11.3 0.0 4.0 1.5 0.3 0.1 44.5 17.4 13.1 0.3 3.5 0.2 0.3 1.5 0.4 0.1 2.1 0.1 1.9 2.8 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410660-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 212 "testis: 1227.7" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.8;U-266/70: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: AB_2686248" "prognostic favorable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favorable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 3.9 2.8 0.6 1.3 0.7 4.1 5.0 0.8 1.3 1.9 0.6 3.6 2.8 1.6 3.4 2.6 2.0 1.1 1.8 0.6 0.7 2.9 4.8 2.4 2.2 1.1 0.8 0.6 1.4 4.4 5.7 1.7 2.0 1.0 4.3 4.6 0.6 3.5 1.7 2.3 4.9 4.3 1.4 0.7 3.3 2.5 1227.7 0.7 2.9 2.2 0.9 2.2 2.4 2.3 0.8 2.2 0.6 1.6 6.8 1.1 1.6 2.8 2.1 2.2 1.7 2.1 1.1 0.9 3.6 0.2 1.6 1.0 1.2 1.2 3.4 2.9 4.5 1.6 4.1 0.6 2.5 1.1 4.6 7.5 1.0 3.7 1.6 3.5 0.5 2.5 8.3 2.5 14.8 1.3 1.0 5.4 1.7 0.7 0.7 4.6 2.4 1.5 4.5 1.8 0.9 1.1 1.3 2.0 0.1 1.6 2.0 1.0 2.3 1.8 2.8 1.9 3.0 4.5 17.4 9.0 2.1 1.2 10.4 1.7 0.3 1.1 1.8 0.9 1.2 1.1 3.4 1.0 1.6 0.5 1.8 0.7 1.5 0.2 1.1 0.6 1.1 2.5 0.9 0.6 0.7 0.8 1.3 0.6 0.7 1.1 0.8 0.6 1.0 0.7 0.7 0.8 4.3 3.2 4.6 15.7 7.8 4.6 4.8 3.5 13.6 11.2 6.2 5.0 9.7 4.3 1.3 7.3 8.4 3.5 5.8 7.7 13.7 3.6 2630.6 5.3 3.1 6.7 11.5 14.7 10.9 2.8 2.0 5.7 6.1 2.1 7.0 3.7 3.3 4.5 4.2 13.5 12.4 4.2 2.0 4.1 2.3 8698.5 77.0 7.9 8.8 1.9 4.4 8.1 7.2 5.5 16.3 3.7 2.4 63.2 7.6 1.7 12.7 7.3 6.0 15.3 52.6 6.0 4.5 1456.7 71.6 7.6 3.0 0.5 5.5 7.2 10.2 2.2 SEMA3G "FLJ00014, sem2" ENSG00000010319 "Semaphorin 3G" Q9NS98 3 52433035-52445103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.9;breast: 64.7" "Cell type enriched" "Detected in many" 6 "Adipocytes: 151.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "T-reg: 1.4" "Lineage enriched" "Detected in single" 15 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "ASC diff: 26.1;Hep G2: 7.1;HUVEC TERT2: 7.4;THP-1: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001761 Uncertain "Secreted to blood" NA NA 5600000 "HPA001761: AB_1079902" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "unprognostic (7.08e-2)" "unprognostic (1.47e-2)" "unprognostic (2.85e-1)" "unprognostic (5.79e-4)" "unprognostic (5.20e-3)" "unprognostic (9.14e-2)" "unprognostic (5.54e-2)" "unprognostic (5.64e-2)" "unprognostic (1.34e-3)" "unprognostic (4.14e-1)" "prognostic favorable (8.86e-5)" "unprognostic (5.63e-2)" "unprognostic (2.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.14e-1)" 69.9 2.0 9.8 3.4 8.7 0.1 64.7 17.8 10.9 4.9 10.0 6.2 3.0 6.0 1.3 4.6 5.2 5.9 14.6 8.1 8.6 19.8 1.3 24.1 1.6 10.8 10.0 6.7 3.2 3.1 1.8 2.4 26.9 10.7 4.7 3.7 0.4 10.7 2.5 12.9 11.7 9.7 4.0 9.3 8.0 5.8 1.3 11.3 1.7 7.8 18.8 1.8 8.4 7.9 9.1 0.0 0.1 0.1 0.2 26.1 0.2 2.5 0.0 0.0 0.0 0.0 0.7 0.3 3.3 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 3.9 0.2 7.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 7.4 2.6 0.0 0.4 0.0 0.3 0.2 4.3 1.2 0.7 0.1 0.0 0.0 4.1 0.0 0.3 0.5 0.5 0.0 0.4 0.5 0.1 1.9 6.5 2.9 0.1 2.4 0.0 0.0 0.5 2.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 9.8 8.7 17.8 10.9 8.1 8.6 10.8 10.0 6.7 10.7 9.3 11.3 9.1 151.5 3.2 1.3 0.0 0.3 0.4 0.1 0.1 0.0 1.7 5.1 5.5 10.7 0.0 0.0 3.7 0.0 1.7 0.9 0.3 0.0 0.0 3.0 2.8 1.6 20.4 9.6 0.0 0.0 0.0 0.2 3.6 1.1 5.8 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.3 5.0 0.3 0.5 0.0 24.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.0 9.4 0.0 0.1 0.2 0.0 4.1 3.0 0.1 0.1 0.5 0.1 7.5 0.4 0.1 0.2 0.0 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493068 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 169.3;Peritubular cells: 246.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 54.0 70.3 34.8 29.0 47.1 39.1 61.0 73.3 56.1 101.0 18.6 61.3 24.5 76.8 34.3 51.7 72.6 30.1 48.9 55.8 36.5 54.7 46.0 56.6 32.7 28.2 33.5 49.4 93.7 54.6 32.8 183.2 39.4 38.6 108.4 20.8 19.2 54.0 52.1 36.6 80.3 55.8 33.3 4.7 54.5 53.1 85.2 28.0 30.4 61.3 16.4 23.5 78.7 72.2 38.1 15.6 16.0 48.8 40.1 35.7 39.2 40.0 32.8 21.5 25.7 26.0 24.2 22.8 21.7 9.0 45.6 21.0 20.4 26.1 35.7 15.1 22.3 28.2 39.2 65.2 23.9 32.4 23.2 33.6 61.9 28.2 27.7 23.5 54.0 42.0 42.4 21.1 23.4 24.3 22.2 41.8 51.2 30.1 19.8 27.1 24.5 13.4 25.4 29.2 30.6 20.6 35.9 35.6 9.3 23.1 42.3 28.9 38.5 46.3 36.0 34.1 36.9 24.1 38.7 23.8 27.3 24.7 37.3 22.4 5.2 4.5 3.5 3.0 4.0 3.1 2.5 2.6 4.0 2.3 2.8 3.1 3.3 1.5 3.2 0.6 3.4 3.0 3.6 34.8 47.1 73.3 56.1 55.8 36.5 28.2 33.5 49.4 38.6 4.7 28.0 38.1 26.1 25.6 32.3 34.0 14.9 27.5 14.6 23.3 40.5 40.9 29.2 37.1 20.4 8.6 19.1 14.7 8.4 32.4 24.2 20.5 9.8 12.1 10.3 14.5 26.7 22.1 169.3 4.6 64.9 9.4 14.0 23.4 23.4 18.9 25.3 40.2 46.1 15.3 30.5 28.6 44.0 19.1 22.4 50.5 14.5 25.9 88.3 24.3 19.6 15.0 13.0 12.1 17.5 21.1 26.1 10.0 14.2 246.0 12.4 12.6 16.5 15.6 15.2 22.4 26.3 17.2 24.8 31.2 18.0 16.7 22.3 24.2 18.4 47.6 15.7 11.7 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins, Transporters" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 443.1" "Cell type enriched" "Detected in many" 4 "Hepatic stellate cells: 745.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 59 "classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5" "Group enriched" "Detected in many" 60 "dendritic cells: 2.5;monocytes: 9.4" "Group enriched" "Detected in some" 46 "HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 96000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 161.4 161.7 37.7 50.8 41.1 13.9 85.2 38.7 58.8 51.2 70.7 82.7 29.9 45.7 8.6 29.4 80.0 26.0 70.7 38.6 70.1 85.7 103.0 105.6 13.1 47.3 42.1 36.5 32.5 32.4 5.1 52.4 55.9 45.5 58.1 31.3 0.7 46.0 16.1 26.1 23.4 95.9 34.1 39.3 443.1 53.7 21.2 56.5 6.8 55.6 4.7 8.2 106.6 49.0 49.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.2 0.2 0.6 0.0 0.0 1.8 0.1 0.0 0.1 0.0 103.1 0.1 0.3 0.1 0.0 0.0 0.0 146.9 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.1 0.0 0.0 128.8 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.0 9.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 37.7 41.1 38.7 58.8 38.6 70.1 47.3 42.1 36.5 45.5 39.3 56.5 49.0 31.3 0.0 3.8 0.0 5.5 6.0 0.6 0.0 1.8 1.0 1.5 2.7 2.4 11.5 0.0 3.7 0.0 1.7 1.9 0.0 0.0 0.0 0.5 0.4 0.5 43.0 1.2 21.5 0.3 0.0 2.0 3.3 0.5 0.3 18.3 0.0 745.0 19.7 130.7 0.0 0.3 0.0 0.0 185.4 30.3 2.9 4.4 147.0 12.4 30.0 21.9 0.5 2.1 0.5 0.1 0.0 0.0 20.3 2.0 0.2 0.0 0.8 0.0 0.1 19.7 2.0 1.4 0.9 2.2 1.5 4.8 2.2 2.3 0.5 0.0 0.2 FUZ "CPLANE3, FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806866-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 79.3" "Group enriched" "Detected in many" 18 "Early spermatids: 1243.5;Late spermatids: 2329.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol No NA Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 7.8 17.7 15.2 2.8 17.9 6.3 9.4 17.2 21.0 10.4 16.6 9.9 4.2 11.1 7.3 6.8 19.7 5.2 11.8 14.4 17.2 16.9 7.2 7.8 4.6 18.1 16.9 12.9 15.6 12.5 7.1 12.6 4.0 16.4 11.3 2.0 4.9 7.5 7.3 20.6 6.1 7.0 4.1 17.3 8.9 10.3 79.3 16.2 6.0 11.6 12.5 2.2 9.0 8.3 18.5 0.1 10.6 9.5 12.2 8.9 9.5 2.7 5.2 5.4 7.9 11.0 0.9 17.2 3.1 10.6 4.9 2.5 4.3 2.7 9.2 3.5 11.7 20.5 13.0 7.6 0.0 10.1 7.6 7.0 10.1 6.3 16.1 4.0 6.2 7.5 18.6 3.0 8.7 4.1 0.5 14.1 15.4 15.7 8.4 6.3 24.4 7.7 7.4 9.7 2.7 26.5 31.0 1.0 10.8 17.9 3.7 6.2 4.7 3.7 6.6 5.9 1.9 1.9 24.9 26.5 8.4 7.6 0.2 8.4 7.0 4.6 17.7 4.9 2.2 4.1 5.3 3.1 4.2 3.8 6.0 3.8 4.3 10.6 3.8 1.6 15.0 3.8 2.6 15.2 17.9 17.2 21.0 14.4 17.2 18.1 16.9 12.9 16.4 17.3 16.2 18.5 9.2 0.0 2.8 6.2 8.4 3.8 19.3 10.1 8.6 7.2 14.5 14.6 3.9 17.2 7.3 7.3 4.2 17.5 12.2 1.9 66.5 15.3 1243.5 61.6 8.0 6.5 2.4 19.3 2.7 5.1 12.1 11.1 6.1 8.1 10.2 11.5 13.6 5.8 13.2 10.1 3.0 3.5 12.2 7.1 7.6 2329.6 27.7 6.7 0.0 2.8 7.9 26.1 5.2 2.0 9.9 4.5 6.1 17.7 10.9 8.0 7.3 86.1 35.4 11.3 0.0 17.1 9.9 95.3 13.5 5.0 4.1 12.0 6.4 13.7 5.5 14.1 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 154.5" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 324.9" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 4.6;SuSa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.2 0.3 14.5 0.0 17.0 0.1 0.1 11.4 18.5 0.1 14.7 0.1 2.6 0.1 0.3 0.0 7.1 0.0 2.5 12.7 12.0 154.5 37.1 0.9 0.0 12.7 13.0 12.0 0.2 0.0 0.0 3.0 0.0 13.5 0.5 0.0 1.1 0.1 0.1 0.5 0.2 0.6 0.0 12.5 0.3 0.1 3.1 13.7 0.1 6.4 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 17.0 11.4 18.5 12.7 12.0 12.7 13.0 12.0 13.5 12.5 13.7 13.0 0.0 0.0 0.6 1.3 1.9 0.0 0.0 0.4 0.0 0.4 0.1 0.1 1.5 0.0 0.1 18.4 2.1 0.0 0.1 0.0 49.0 0.0 1.4 0.6 0.1 0.2 0.0 5.3 3.6 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.8 27.0 0.0 0.0 1.2 0.0 2.0 1.6 0.0 0.6 0.3 1.7 0.0 17.8 0.0 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.1 0.5 324.9 0.7 0.7 0.0 0.4 0.1 0.6 0.4 0.0 0.0 0.3 0.9 0.0 0.0 0.0 IDS "ID2S, SIDS" ENSG00000010404 "Iduronate 2-sulfatase" P22304 X 149476988-149521096 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 328.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078003 Approved "Intracellular and membrane" NA NA 17000000 "HPA078003: " "unprognostic (9.88e-2)" "unprognostic (1.10e-2)" "unprognostic (6.59e-2)" "unprognostic (1.45e-3)" "unprognostic (2.83e-2)" "unprognostic (4.52e-3)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (1.20e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-1)" "unprognostic (9.76e-3)" "unprognostic (3.61e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" 29.3 43.7 194.0 29.8 208.4 48.0 28.1 0.0 328.3 37.7 0.0 30.6 21.3 35.4 43.8 26.4 36.0 26.6 38.9 326.8 68.3 22.9 15.9 40.9 31.2 36.9 19.6 191.8 45.8 23.5 57.5 68.3 16.5 70.2 29.7 21.0 49.0 24.9 41.4 25.3 35.3 28.1 30.8 0.3 34.4 23.2 6.1 25.8 17.3 27.5 39.3 36.3 33.1 31.8 111.9 46.4 50.7 19.6 12.7 22.1 40.9 9.2 26.6 67.8 23.3 43.9 10.2 32.7 110.0 69.6 38.3 49.1 22.6 21.3 40.5 30.1 40.8 17.7 11.5 14.7 5.7 17.8 18.8 101.3 21.4 19.6 50.9 33.1 95.5 37.8 20.2 5.7 76.6 34.7 57.9 19.6 9.3 17.5 28.8 34.3 12.4 19.4 20.7 27.8 10.5 28.9 67.6 9.8 22.1 32.0 33.2 6.9 7.9 44.3 29.9 31.3 50.1 70.8 54.5 47.3 79.3 138.0 44.3 22.1 117.5 56.9 171.7 70.9 63.0 53.2 35.2 43.1 54.0 48.7 27.0 28.4 42.9 261.1 37.2 73.9 36.8 74.0 63.0 194.0 208.4 0.0 328.3 326.8 68.3 36.9 19.6 191.8 70.2 0.3 25.8 111.9 53.7 99.3 64.4 55.8 150.9 33.1 60.6 44.0 20.5 178.3 43.2 43.8 44.1 27.1 58.9 82.8 45.9 34.2 158.5 66.9 21.5 50.2 1.3 59.8 36.8 44.7 168.4 19.6 232.3 74.0 25.7 78.3 31.1 49.5 226.2 25.5 60.3 33.0 44.0 222.1 243.7 29.0 73.2 94.8 109.8 3.7 72.7 98.4 51.6 63.7 120.9 55.0 146.2 39.2 95.8 85.0 50.3 89.5 98.8 71.3 74.6 22.3 112.4 59.5 59.2 68.1 65.2 3.5 6.6 22.2 43.8 143.0 183.9 16.4 17.1 96.9 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750679-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 268 "pancreas: 31377.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 104 "basophil: 158.7" "Lineage enriched" "Detected in many" 104 "granulocytes: 158.7" "Group enriched" "Detected in many" 5 "OE19: 316.6;PC-3: 852.5" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 700000000 Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 2.9 4.6 22.2 7.2 27.1 0.6 1.7 25.6 35.7 14.8 16.9 87.8 93.4 0.4 0.0 117.2 0.3 23.0 6.3 26.6 24.7 3.6 12.5 0.6 0.7 24.4 25.1 25.8 13.0 31377.8 0.0 0.8 1.7 25.8 1.1 78.5 0.3 21.0 0.3 0.5 72.0 106.3 3.1 19.1 0.7 23.0 5.2 24.2 0.8 0.4 0.0 15.3 4.2 57.3 24.5 12.0 13.7 0.7 0.0 0.2 5.9 0.1 33.6 7.7 4.1 1.6 34.3 3.0 0.0 0.2 14.9 0.2 15.0 0.0 31.7 10.1 0.4 0.2 0.0 1.1 0.0 2.7 0.0 0.0 0.2 0.0 10.8 110.2 0.3 68.8 0.2 0.0 0.0 0.0 0.2 0.7 0.4 0.2 316.6 852.5 0.0 0.0 0.0 0.0 1.7 0.3 81.2 0.2 0.0 0.0 0.5 0.0 0.0 78.3 0.0 0.0 12.8 0.0 0.0 0.0 0.1 18.1 0.0 0.1 158.7 0.0 0.0 0.2 1.5 1.2 0.0 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.3 22.2 27.1 25.6 35.7 26.6 24.7 24.4 25.1 25.8 25.8 19.1 24.2 24.5 0.1 0.0 0.0 0.7 1.9 57.1 0.6 1.3 0.0 0.2 0.1 2.8 1.0 47.1 1.2 1.8 0.0 0.0 0.1 1022.9 3.9 43.2 31.4 0.0 0.0 3.2 192.6 0.0 32.8 2040.4 0.0 0.8 39.3 0.0 8.9 0.0 0.7 4.2 0.0 0.0 4.7 146.4 0.0 0.3 12.1 79.7 1.5 1.2 7.2 3.7 5.7 0.0 0.0 3.5 1.2 478.8 969.9 0.7 0.3 12.1 1127.1 14.7 0.1 0.2 0.0 0.0 1.7 0.5 0.9 1.1 134.1 0.1 2.1 0.0 329.0 56.2 ZNF200 ENSG00000010539 "Zinc finger protein 200" P98182 16 3222325-3236221 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 17.8" "Cell type enhanced" "Detected in many" "Early spermatids: 51.8;Spermatocytes: 39.0;Spermatogonia: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018981, HPA059310" Uncertain Approved Mitochondria No No Mitochondria "HPA018981: AB_1859021, HPA059310: AB_2683974" "unprognostic (1.74e-1)" "unprognostic (5.74e-2)" "unprognostic (3.21e-2)" "unprognostic (8.78e-2)" "unprognostic (9.72e-2)" "unprognostic (3.71e-2)" "unprognostic (1.31e-1)" "unprognostic (2.20e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.80e-2)" "unprognostic (2.98e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (1.89e-1)" "unprognostic (1.11e-1)" "unprognostic (5.23e-3)" 3.7 3.1 2.3 5.9 2.4 2.4 4.4 3.2 3.3 3.5 2.7 3.4 4.1 3.8 3.7 3.4 4.3 3.6 3.4 2.4 2.5 3.2 3.9 4.0 7.1 2.6 2.5 2.4 4.5 2.2 4.7 2.5 6.3 2.4 3.4 3.7 4.1 2.8 3.4 2.2 3.2 3.2 3.9 2.6 6.1 3.3 17.8 2.5 5.2 3.3 3.7 6.6 4.3 2.9 2.5 7.1 7.3 16.1 11.6 5.9 6.1 19.2 9.1 11.2 12.2 11.2 11.2 5.9 13.6 6.8 7.4 7.2 5.3 13.2 9.8 14.6 12.7 12.2 11.3 9.6 9.5 7.8 19.9 26.0 6.2 8.3 9.0 8.1 7.0 10.8 9.7 12.8 10.3 11.1 6.5 14.0 10.8 25.3 8.8 6.9 16.9 22.0 16.0 7.6 4.0 9.1 13.3 8.6 6.5 7.5 11.0 9.3 21.9 7.4 12.4 11.4 4.5 8.0 25.8 27.1 11.9 3.0 12.3 9.8 32.4 5.3 18.4 10.6 6.8 10.3 7.2 9.4 12.5 6.6 6.9 9.6 10.9 22.1 11.6 6.6 4.2 12.1 7.2 2.3 2.4 3.2 3.3 2.4 2.5 2.6 2.5 2.4 2.4 2.6 2.5 2.5 10.7 3.2 3.7 4.2 6.4 3.2 4.5 4.2 1.2 5.4 5.2 5.8 3.9 5.7 5.1 3.7 12.5 7.5 7.4 3.3 3.9 5.0 51.8 3.6 3.2 8.1 6.7 9.1 5.2 4.0 6.7 5.0 0.5 3.1 5.1 5.7 10.4 3.8 7.1 0.0 4.1 3.8 4.1 6.6 5.4 22.6 5.6 6.6 7.2 1.9 6.3 6.7 13.4 5.0 3.4 3.6 6.3 3.0 5.7 4.6 3.7 2.8 3.5 8.1 6.6 7.4 4.5 39.0 44.9 4.3 3.1 5.9 8.5 6.1 3.5 4.0 CD4 ENSG00000010610 "CD4 molecule" P01730 12 6786858-6820799 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 154.2;lymphoid tissue: 221.4;parathyroid gland: 175.0" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5" "Group enriched" "Detected in many" 20 "dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5" "Group enriched" "Detected in some" 6 "HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7" "Region enriched" "Detected in many" 14 "basal ganglia: 46.2" "Low region specificity" "Detected in many" "CAB000011, HPA004252, HPA004472, CAB068180" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465" "unprognostic (1.39e-2)" "unprognostic (1.12e-2)" "unprognostic (2.75e-2)" "prognostic favorable (2.16e-4)" "unprognostic (7.76e-2)" "unprognostic (4.82e-3)" "unprognostic (3.70e-2)" "unprognostic (2.74e-2)" "unprognostic (7.04e-2)" "unprognostic (2.40e-1)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.06e-1)" "unprognostic (4.65e-3)" "unprognostic (9.08e-3)" "unprognostic (2.95e-1)" 45.9 16.4 13.9 82.9 15.3 26.7 14.9 15.0 17.5 20.6 17.5 26.3 18.9 8.0 7.0 15.2 21.5 35.6 10.1 14.1 25.7 10.1 154.2 72.7 120.0 22.1 16.3 12.0 8.7 7.7 175.0 6.2 47.8 19.4 7.4 31.3 10.6 8.5 10.4 2.9 12.7 27.6 26.7 19.9 165.8 21.2 7.6 18.1 221.4 8.9 5.8 76.3 41.4 5.8 23.8 0.0 0.0 3.6 0.1 0.1 0.2 0.3 0.1 2.4 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 103.2 0.0 0.6 10.5 42.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 15.4 60.0 1.0 0.0 0.0 0.0 0.2 12.8 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.7 0.1 116.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 109.7 0.0 0.8 247.3 1.9 2.0 241.4 6.3 0.5 153.4 0.8 166.3 0.5 128.1 0.7 11.1 2.0 204.2 263.8 154.5 240.6 13.9 15.3 15.0 17.5 14.1 25.7 22.1 16.3 12.0 19.4 19.9 18.1 23.8 4.5 0.0 5.2 1.6 5.2 3.4 0.3 0.4 0.0 1.5 2.9 5.8 2.1 8.6 2.1 3.7 0.0 0.9 61.9 0.0 5.9 0.0 0.1 3.5 8.7 9.6 0.0 7.8 0.9 0.4 1.2 3.7 0.0 0.4 7.6 0.4 278.8 34.3 139.3 5.0 0.7 0.0 0.0 247.1 80.1 0.5 16.8 109.0 5.4 29.0 104.5 22.0 6.2 0.5 0.2 0.0 0.0 15.1 2.5 0.2 0.0 3.3 20.3 0.2 13.1 0.7 13.5 0.0 0.2 0.4 2.3 1.2 34.0 0.0 0.0 0.4 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 102.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 204.6;Respiratory ciliated cells: 244.2;Rod photoreceptor cells: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 2.5 3.2 14.4 1.1 11.1 2.5 3.6 12.8 11.3 4.3 17.6 2.8 0.9 5.0 12.6 1.8 102.7 3.1 4.8 10.0 15.8 6.3 2.6 9.0 1.8 16.6 16.1 8.3 4.8 2.1 6.7 7.4 2.2 15.5 3.6 2.1 25.3 2.8 3.8 6.3 2.4 2.0 3.7 17.5 2.5 3.5 26.5 12.8 3.2 6.3 5.9 2.7 2.9 2.6 12.6 5.2 9.9 1.6 3.6 7.2 5.4 5.8 2.0 7.0 3.3 6.3 2.1 10.4 4.5 2.2 5.4 9.6 1.3 2.9 4.3 7.1 3.6 1.5 3.2 3.7 4.1 5.8 1.8 3.0 3.8 7.8 6.4 5.7 8.6 4.6 11.0 1.9 2.5 3.9 5.9 4.0 1.2 1.0 7.7 2.8 3.7 8.1 5.3 6.6 1.5 2.6 6.3 3.2 4.3 6.6 10.2 2.2 4.1 2.0 3.3 8.6 3.8 2.3 2.3 1.6 3.8 8.1 2.3 4.8 0.6 2.7 6.4 2.2 2.6 3.0 5.7 2.2 1.9 2.6 2.8 2.4 2.4 0.5 4.0 2.6 3.9 0.1 1.3 14.4 11.1 12.8 11.3 10.0 15.8 16.6 16.1 8.3 15.5 17.5 12.8 12.6 12.6 0.0 22.4 11.4 12.6 6.5 10.0 15.1 11.4 17.8 15.3 19.3 8.2 20.0 34.4 12.9 50.1 8.2 9.4 5.2 37.2 13.6 43.4 204.6 13.1 9.7 18.0 7.4 5.8 17.3 12.5 12.6 10.7 12.9 5.7 12.1 14.6 7.5 13.5 13.5 4.4 8.6 16.2 11.9 8.9 47.0 8.4 13.7 8.8 6.5 11.0 38.6 11.3 1.5 6.4 15.3 4.7 12.4 10.5 6.4 4.5 46.5 244.2 138.1 13.1 21.1 13.5 63.6 13.1 8.4 5.8 4.5 11.8 7.1 5.6 7.3 BTK "AGMX1, ATK, IMD1, PSCTK1, XLA" ENSG00000010671 "Bruton tyrosine kinase" Q06187 X 101349447-101390796 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.9;lymphoid tissue: 78.6" "Cell type enhanced" "Detected in some" "B-cells: 84.7;granulocytes: 211.4;Hofbauer cells: 56.6;Kupffer cells: 63.5;Macrophages: 61.1;monocytes: 71.1;Plasma cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 557.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 557.5" "Cell line enhanced" "Detected in some" "Daudi: 206.7;HEL: 287.4;HMC-1: 990.3;U-937: 149.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001198, HPA002028, CAB016689" Enhanced Supported "Plasma membrane,Cytosol" NA NA 2300000 "Plasma membrane, Cytosol" "CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306" "unprognostic (3.19e-2)" "unprognostic (2.51e-3)" "unprognostic (1.06e-2)" "unprognostic (3.66e-2)" "unprognostic (5.69e-2)" "unprognostic (3.76e-3)" "unprognostic (6.55e-2)" "unprognostic (3.58e-3)" "unprognostic (6.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (2.08e-3)" "unprognostic (7.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (8.14e-2)" 6.3 2.9 2.2 31.0 2.6 32.9 4.4 2.9 3.4 3.9 3.8 6.7 4.8 2.5 1.5 3.7 1.9 7.6 1.6 2.2 4.3 1.3 5.4 19.8 55.9 4.7 2.9 1.8 0.8 1.2 1.0 0.9 7.0 4.4 1.9 9.2 0.3 2.8 2.3 0.6 3.0 14.8 7.1 4.2 38.8 7.0 1.4 3.4 9.4 1.3 2.0 78.6 9.4 1.5 5.5 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 206.7 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.3 287.4 0.0 0.0 0.0 116.7 990.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 61.9 2.3 0.0 0.0 0.6 81.5 1.6 0.0 0.0 87.2 0.1 13.2 0.0 0.0 0.2 0.0 0.3 0.1 0.5 1.0 0.0 68.5 0.4 0.0 0.3 0.2 0.1 2.6 1.4 98.3 0.5 149.8 0.3 557.5 62.2 110.5 0.2 99.9 0.2 72.4 0.2 0.1 72.7 73.0 0.4 0.1 24.7 0.2 123.9 33.1 0.1 38.4 2.2 2.6 2.9 3.4 2.2 4.3 4.7 2.9 1.8 4.4 4.2 3.4 5.5 1.5 3.2 8.9 0.3 84.7 1.0 0.2 0.0 0.6 0.0 0.9 1.4 0.6 0.0 0.6 0.0 0.0 1.4 30.1 0.1 0.0 0.0 0.2 1.3 0.3 0.8 0.0 27.1 0.5 0.0 0.5 0.9 1.1 2.3 211.4 0.0 0.7 0.3 56.6 0.0 0.3 0.3 0.0 63.5 31.0 0.1 0.3 61.1 3.6 10.3 71.1 0.0 2.1 0.0 0.1 0.1 0.5 0.0 43.8 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.7 1.7 0.5 0.3 1.9 5.7 0.2 0.1 0.1 HFE "HFE1, HLA-H" ENSG00000010704 "Homeostatic iron regulator" Q30201 6 26087281-26098343 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Kupffer cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 39.2;T-47d: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: AB_2682163" "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 9.6 8.0 1.3 5.3 1.8 0.6 7.9 1.2 1.7 6.7 7.8 5.9 5.9 5.0 12.5 4.9 4.6 8.2 3.7 1.2 1.8 6.7 15.5 7.6 3.6 2.0 1.5 1.0 7.4 6.3 15.6 1.2 6.1 1.8 6.8 6.9 1.3 7.0 9.7 2.3 2.8 5.0 6.1 1.7 8.7 8.3 1.7 1.5 1.7 10.0 3.0 3.1 7.4 3.3 2.7 17.2 39.2 0.7 18.6 27.3 21.1 0.1 12.2 28.5 15.1 23.6 3.3 34.3 1.8 32.4 20.2 22.9 10.7 0.0 14.2 19.1 4.6 0.2 0.5 8.1 2.6 5.6 0.0 0.7 21.6 4.0 16.7 1.4 13.2 10.4 0.0 0.7 0.4 13.0 7.2 0.1 0.2 0.9 8.1 0.0 2.3 0.0 0.3 12.5 11.5 0.1 0.1 7.3 0.0 10.2 0.3 54.0 1.9 8.2 10.6 1.1 10.7 10.6 0.2 0.4 0.2 15.9 0.2 23.5 1.3 10.7 0.0 1.5 10.4 1.2 3.3 1.6 2.1 4.7 1.3 0.4 1.0 1.9 0.2 9.2 0.3 0.3 3.8 1.3 1.8 1.2 1.7 1.2 1.8 2.0 1.5 1.0 1.8 1.7 1.5 2.7 3.9 3.2 5.1 1.0 1.7 1.7 2.6 3.7 6.2 1.0 3.7 2.2 3.2 2.8 6.7 5.5 2.1 1.7 0.5 3.8 0.0 4.1 0.1 1.8 2.3 3.4 1.8 2.7 0.1 3.4 0.8 4.6 8.2 1.5 2.5 3.0 6.8 12.2 11.1 0.0 0.1 4.0 4.1 25.4 7.6 0.2 3.7 7.4 0.0 2.8 3.8 2.9 2.1 0.0 3.3 2.4 0.9 6.0 0.3 2.6 2.9 2.7 5.9 1.7 0.0 5.7 2.4 0.2 1.1 3.4 3.4 1.8 1.0 2.8 3.3 1.9 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: AB_2797246" "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favorable (5.80e-4)" 21.9 24.2 14.4 11.4 15.0 18.0 23.4 15.7 18.2 29.8 16.3 42.8 12.8 35.7 20.7 14.1 33.3 16.0 39.6 15.3 14.3 29.9 19.8 20.8 10.5 12.8 13.2 13.3 36.7 40.4 35.0 27.8 11.1 13.4 40.8 17.1 21.2 27.7 31.0 45.3 12.8 23.6 24.8 9.9 15.6 32.8 33.0 14.3 16.8 24.3 34.5 10.6 39.2 21.5 13.4 19.5 12.8 29.9 27.5 13.4 25.4 0.1 15.4 26.7 25.2 26.0 12.3 24.6 35.4 11.4 28.1 21.1 4.8 23.3 20.6 21.6 24.7 17.8 16.6 17.7 31.2 58.2 35.7 26.2 27.7 20.5 16.7 40.2 30.5 25.7 43.3 15.7 26.8 25.0 10.6 36.0 30.8 27.7 16.4 13.5 39.3 31.3 21.0 20.4 24.1 21.0 22.5 26.7 21.1 22.1 20.2 18.8 90.7 19.0 26.3 20.4 16.4 28.5 27.1 16.2 38.6 16.5 31.5 24.4 0.6 0.6 1.2 1.6 1.1 2.0 2.4 1.9 1.5 1.9 1.1 1.3 1.1 0.0 1.6 0.2 3.9 1.4 0.9 14.4 15.0 15.7 18.2 15.3 14.3 12.8 13.2 13.3 13.4 9.9 14.3 13.4 7.1 9.6 10.8 125.4 9.4 6.6 25.8 11.5 26.7 17.0 16.4 17.0 14.9 18.6 7.4 12.9 16.7 7.3 10.8 7.2 1.9 11.4 9.4 7.2 13.8 9.6 8.4 16.0 161.3 21.3 3.3 11.4 15.3 13.1 5.1 11.9 8.9 7.3 6.2 8.4 213.0 7.4 8.2 3.3 6.5 12.4 16.4 3.2 8.8 102.1 2.7 6.9 2.1 154.3 77.9 12.4 6.2 18.0 20.2 23.3 10.4 18.1 5.8 14.2 19.7 11.9 10.3 54.3 26.1 6.1 3.7 4.8 7.4 3.5 12.4 14.5 FYN "MGC45350, SLK, SYN" ENSG00000010810 "FYN proto-oncogene, Src family tyrosine kinase" P06241 6 111660332-111873452 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8" "Cancer enhanced" "Detected in all" "glioma: 42.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 16 "NK-cells: 69.0;T-cells: 174.8" "Cell line enhanced" "Detected in many" "U-2197: 538.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005034, CAB018387, HPA023887, HPA063770" Approved Enhanced "Plasma membrane,Cytosol" NA NA 820000 "Plasma membrane" Cytosol "CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119" "unprognostic (8.62e-3)" "unprognostic (8.25e-2)" "unprognostic (2.11e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.60e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "prognostic favorable (4.78e-4)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.95e-2)" "unprognostic (3.10e-1)" "unprognostic (6.62e-3)" "unprognostic (2.40e-1)" 73.5 10.9 118.8 52.9 98.7 32.6 47.2 83.7 105.2 44.3 36.7 30.4 16.6 45.9 34.1 16.1 51.8 32.4 37.3 103.7 112.3 23.7 20.5 64.0 109.8 138.7 92.2 94.8 29.1 8.6 18.8 23.1 30.0 111.9 17.7 15.7 27.1 13.0 12.6 12.4 37.2 47.5 38.3 99.5 72.5 29.5 16.6 97.0 86.9 46.1 18.5 68.2 48.8 33.7 107.3 10.4 1.5 178.6 30.2 133.4 81.4 3.2 29.1 90.8 24.2 42.9 1.3 1.6 21.0 18.3 56.1 21.0 1.3 25.8 39.9 46.8 0.7 66.5 57.0 13.6 2.7 78.7 19.5 19.0 78.8 59.1 90.5 76.8 62.9 99.5 99.6 4.9 140.3 86.8 1.5 92.7 17.9 26.0 3.3 18.0 29.1 24.0 1.4 0.0 9.1 124.6 50.7 5.7 2.4 124.7 39.6 1.3 57.0 63.9 72.3 13.5 538.7 18.5 20.0 19.7 32.5 136.0 44.3 128.9 1.1 6.4 0.2 137.0 5.6 174.8 4.8 83.9 152.7 7.4 6.4 27.9 72.3 3.0 69.0 4.2 4.3 79.2 51.5 118.8 98.7 83.7 105.2 103.7 112.3 138.7 92.2 94.8 111.9 99.5 97.0 107.3 87.8 0.0 8.3 382.6 26.0 17.1 2.5 0.6 1.8 57.2 2.9 6.9 11.3 14.3 2.1 7.3 0.0 2.7 291.6 1.2 17.6 9.3 3.7 5.6 51.7 70.3 13.2 20.9 118.7 1.0 2.4 61.9 17.9 4.9 52.0 20.9 76.4 60.3 3.0 47.1 127.6 3.8 2.0 35.8 96.1 3.2 26.4 42.7 37.4 88.1 64.5 89.1 228.6 342.8 162.3 9.7 0.1 7.2 96.2 3.9 17.7 212.2 4.4 8.3 13.1 48.8 32.9 3.9 8.6 0.7 13.4 52.0 275.8 71.1 2.9 1.1 HIVEP2 "HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B" ENSG00000010818 "HIVEP zinc finger 2" P31629 6 142751469-142956698 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 326.2;Inhibitory neurons: 223.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055954 Supported Nucleoplasm NA NA Nucleoplasm "HPA055954: " "unprognostic (1.35e-2)" "unprognostic (1.61e-2)" "unprognostic (8.48e-2)" "unprognostic (2.03e-2)" "unprognostic (2.55e-1)" "unprognostic (1.20e-2)" "unprognostic (7.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (1.19e-2)" "unprognostic (1.93e-1)" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (5.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.10e-1)" 7.6 7.0 2.6 10.5 6.8 3.1 6.2 9.2 16.3 4.2 0.0 4.8 4.5 6.2 5.1 8.6 11.5 9.9 6.9 10.4 2.6 6.0 5.6 8.0 12.1 1.2 4.8 4.3 13.2 10.2 8.3 5.9 7.3 4.7 5.0 4.4 5.7 8.8 5.1 21.2 7.8 6.1 5.6 0.0 8.3 4.9 1.8 4.9 19.2 8.2 14.1 12.2 13.9 5.6 10.0 6.0 1.1 1.4 5.2 11.1 12.3 4.1 8.5 21.8 5.2 6.3 0.4 4.9 9.5 5.2 37.7 9.9 3.8 2.3 17.4 12.7 3.7 2.7 2.6 3.9 2.4 8.4 8.4 0.1 11.4 16.9 21.3 24.3 12.1 2.8 7.5 0.1 8.4 8.9 6.8 11.1 3.6 1.3 1.4 8.5 14.4 9.3 0.8 4.8 10.4 14.0 5.9 11.3 9.2 6.3 2.5 1.7 4.9 3.0 17.5 4.4 14.8 7.5 17.4 3.1 19.8 4.9 6.4 8.3 0.0 0.1 0.0 0.6 0.2 1.4 0.9 1.4 1.2 0.4 0.4 1.4 1.1 0.9 0.7 0.2 0.2 1.2 0.5 2.6 6.8 9.2 16.3 10.4 2.6 1.2 4.8 4.3 4.7 0.0 4.9 10.0 22.2 22.4 25.5 65.6 18.4 94.3 45.2 9.1 5.2 15.1 13.7 7.6 18.3 5.7 27.6 7.3 25.0 2.8 22.4 5.1 0.0 12.5 2.1 53.2 29.4 26.5 3.5 4.2 326.2 14.8 1.2 30.5 2.0 101.0 3.8 6.1 8.6 4.5 2.8 30.3 223.0 4.9 16.2 4.4 52.7 1.2 11.8 17.5 24.9 67.5 5.1 2.5 4.1 98.0 75.3 22.8 6.6 15.8 22.1 53.6 5.3 3.3 25.1 2.2 0.0 37.6 25.7 0.6 0.9 11.5 94.6 4.7 29.5 2.6 3.4 56.8 FMO1 ENSG00000010932 "Flavin containing dimethylaniline monoxygenase 1" Q01740 1 171248471-171285978 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "kidney: 200.9" "Group enriched" "Detected in many" 7 "Proximal enterocytes: 97.9;Proximal tubular cells: 196.9" "Cancer enriched" "Detected in many" 8 "renal cancer: 18.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HSkMC: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078132 Approved NA NA "HPA078132: " "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (5.87e-2)" "unprognostic (1.34e-1)" "unprognostic (5.32e-3)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-1)" "unprognostic (9.16e-2)" "unprognostic (9.03e-2)" "unprognostic (1.36e-2)" "unprognostic (2.23e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.49e-4)" "unprognostic (1.40e-1)" "unprognostic (3.58e-1)" "unprognostic (1.37e-1)" 4.8 5.6 0.1 0.5 0.1 0.0 10.1 0.1 0.3 6.4 0.2 0.3 0.1 3.1 0.1 3.5 4.2 5.2 0.7 0.1 0.1 200.9 3.0 1.5 0.4 0.1 0.1 0.1 5.1 2.4 1.1 1.8 2.3 0.1 0.4 0.2 0.0 5.4 0.7 0.1 10.5 20.4 4.3 0.1 0.0 0.9 1.6 0.1 7.5 2.3 0.8 10.9 2.5 1.8 0.1 0.0 0.0 0.0 0.0 2.7 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.0 0.0 0.0 0.3 3.0 3.2 0.5 0.0 12.5 0.0 0.5 1.1 10.0 2.8 0.0 3.7 0.0 0.3 0.0 0.0 13.7 0.0 0.7 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.1 18.7 0.0 0.0 0.0 3.2 0.0 0.3 0.4 0.0 0.1 2.9 0.0 0.0 0.0 1.5 10.8 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 2.6 0.0 0.1 97.9 196.9 0.0 0.0 6.6 0.5 4.7 0.0 0.1 1.4 2.3 0.8 1.0 2.6 1.4 0.1 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 83.9;Ductal cells: 41.3;Syncytiotrophoblasts: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.9 12.8 10.1 19.0 10.8 33.7 16.6 13.2 11.6 15.8 10.6 14.9 12.7 13.4 10.2 24.1 13.0 15.6 15.6 10.1 11.6 14.5 29.9 26.0 17.8 11.1 10.8 8.8 16.2 42.7 27.2 11.6 19.3 11.0 15.0 16.7 12.8 17.6 13.4 33.5 20.2 14.0 17.0 10.4 16.3 26.7 19.1 11.2 21.8 21.5 26.6 23.8 24.7 14.7 12.0 52.0 28.3 40.2 34.6 46.2 28.6 25.3 52.4 46.9 76.2 66.1 34.9 44.1 27.0 62.7 53.3 42.8 48.5 83.0 55.2 84.4 77.8 41.1 60.9 42.2 41.1 40.9 64.7 35.3 30.6 43.6 83.3 63.2 28.2 46.4 43.7 91.8 45.3 61.6 39.3 33.5 26.1 46.8 57.7 42.4 49.8 50.9 51.3 35.8 34.8 76.2 42.9 47.7 47.5 58.5 44.3 34.4 23.5 49.5 59.5 52.8 106.9 62.5 46.8 56.4 59.2 52.1 63.2 60.7 28.2 24.6 19.6 16.5 24.9 16.3 23.5 13.8 15.1 22.6 18.5 11.2 14.9 6.5 13.7 24.1 18.4 17.1 17.7 10.1 10.8 13.2 11.6 10.1 11.6 11.1 10.8 8.8 11.0 10.4 11.2 12.0 24.1 28.9 83.9 0.0 7.9 0.0 0.0 0.0 0.0 0.0 19.6 16.0 0.0 0.0 18.0 18.4 0.0 28.1 17.5 0.0 5.9 41.3 0.0 15.4 27.4 12.5 0.0 0.0 0.0 32.7 35.7 10.1 0.0 23.3 13.9 21.5 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 35.2 0.0 0.0 0.0 0.0 37.9 0.0 0.0 4.9 0.0 0.0 19.0 16.8 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 41.3 9.6 32.5 0.0 0.0 LYPLA2 APT-2 ENSG00000011009 "Lysophospholipase 2" O95372 1 23791145-23795539 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063151 Uncertain Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "HPA063151: " "unprognostic (8.84e-2)" "unprognostic (6.87e-2)" "unprognostic (2.65e-1)" "unprognostic (7.81e-3)" "unprognostic (2.12e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (3.06e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-2)" "unprognostic (2.52e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.99e-4)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (1.24e-1)" 31.3 41.5 27.8 33.6 29.1 55.7 33.6 28.0 44.2 32.0 67.3 42.6 50.0 28.5 13.8 76.8 43.5 32.6 37.9 36.8 27.4 79.6 82.8 41.1 43.9 27.3 28.7 27.2 28.6 44.0 77.8 35.2 37.4 27.1 45.5 29.6 15.8 51.6 24.9 43.8 51.3 51.7 20.3 27.4 61.6 48.0 23.5 28.4 43.2 39.3 25.4 33.5 46.7 40.6 26.3 80.3 54.2 61.0 70.6 30.4 37.0 83.7 50.8 49.4 50.0 42.6 75.2 130.1 45.8 67.7 49.4 34.9 78.2 45.7 141.2 19.8 88.4 67.9 58.1 87.1 127.5 49.8 54.0 72.5 48.1 85.3 74.9 27.5 61.9 118.8 52.6 84.2 45.4 55.0 89.4 67.3 90.0 120.3 72.6 76.6 78.9 35.0 79.1 122.6 64.6 87.2 149.4 57.7 87.0 88.5 43.5 71.7 58.6 98.6 46.5 61.2 56.7 43.2 116.4 104.1 62.6 74.3 125.1 58.5 82.7 95.3 125.0 105.8 96.0 87.1 62.9 89.1 93.9 77.9 67.9 75.6 80.0 113.2 83.5 80.2 58.8 88.7 113.6 27.8 29.1 28.0 44.2 36.8 27.4 27.3 28.7 27.2 27.1 27.4 28.4 26.3 21.3 9.6 27.3 6.2 27.7 38.9 31.0 80.0 23.3 34.1 36.9 35.4 16.1 35.8 36.5 36.8 18.8 118.7 29.9 105.0 68.4 105.8 15.5 44.9 13.7 33.8 44.3 26.9 5.1 112.8 108.8 19.1 40.8 27.5 36.8 23.1 21.0 35.0 69.3 23.5 5.7 53.5 52.9 17.2 23.3 13.4 10.5 27.6 19.6 4.7 62.1 30.2 46.4 7.5 5.2 130.2 71.9 6.4 20.8 33.3 77.1 92.2 57.6 26.0 26.3 8.6 23.3 8.0 19.1 33.1 41.5 115.9 36.2 64.0 56.6 42.4 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11848079 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 12.4 14.9 18.5 7.6 17.8 7.8 12.0 16.8 21.4 14.4 8.0 12.3 6.3 12.7 8.7 7.4 12.7 5.0 13.0 17.5 21.2 11.9 13.8 13.9 7.5 27.3 22.7 17.4 18.7 9.2 6.1 20.3 6.4 30.4 12.6 4.8 15.4 7.8 5.6 11.7 9.4 13.1 7.3 15.9 12.1 10.6 17.3 23.8 5.3 14.5 8.2 6.1 11.6 11.2 28.5 5.1 6.4 13.9 11.1 15.2 15.4 3.8 4.1 11.1 7.1 11.7 8.6 15.9 7.9 4.4 5.5 19.3 8.8 9.0 8.8 6.7 3.6 4.5 9.4 13.8 12.1 20.1 3.9 7.6 10.1 6.2 12.7 7.7 9.4 6.9 9.6 10.6 11.7 7.8 3.1 5.7 13.4 5.7 3.3 4.5 7.0 7.4 8.6 9.7 4.4 5.7 9.6 3.9 5.1 13.0 9.5 5.0 10.6 7.4 6.5 7.0 10.1 3.3 7.2 4.0 17.6 8.5 10.2 5.3 0.0 0.8 0.0 0.4 0.6 0.3 0.6 0.2 0.3 0.6 0.9 0.2 0.3 0.0 0.1 1.6 0.6 0.0 0.4 18.5 17.8 16.8 21.4 17.5 21.2 27.3 22.7 17.4 30.4 15.9 23.8 28.5 6.4 19.2 23.6 6.8 12.5 3.4 3.7 5.1 6.2 21.7 5.6 4.7 23.5 8.6 7.0 3.7 14.6 3.7 2.5 5.8 0.0 4.5 15.0 7.7 6.6 6.5 6.6 8.2 9.0 4.6 2.9 8.5 12.2 9.8 2.5 12.6 7.1 7.9 7.5 26.9 9.4 2.9 4.1 10.8 7.8 9.0 7.5 10.2 1.8 9.4 7.4 7.7 3.1 9.0 8.8 5.6 4.4 7.2 3.9 4.7 6.3 3.9 8.9 17.0 0.0 8.9 6.4 9.3 9.8 4.8 3.1 4.1 3.8 8.0 3.2 4.5 MRC2 "CD280, CLEC13E, ENDO180, KIAA0709" ENSG00000011028 "Mannose receptor C type 2" Q9UBG0 17 62627670-62693597 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 93.9;Endometrial stromal cells: 65.2;Fibroblasts: 141.6;Late spermatids: 82.8;Leydig cells: 71.7;Peritubular cells: 102.3;Theca cells: 71.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 210.9;fHDF/TERT166: 164.9;HSkMC: 148.6;hTERT-RPE1: 150.6;U-138 MG: 216.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041991 Enhanced NA NA 36000000 "HPA041991: AB_10794166" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (4.45e-2)" "unprognostic (2.59e-2)" "unprognostic (4.29e-2)" "unprognostic (2.67e-2)" "unprognostic (6.21e-2)" "unprognostic (1.80e-1)" "unprognostic (7.39e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (7.70e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (5.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" 24.7 8.7 7.7 13.8 7.4 5.3 16.3 6.7 6.9 38.4 22.4 10.8 6.6 31.6 9.7 21.4 26.5 32.7 33.7 4.1 16.2 11.9 2.9 35.3 4.5 9.0 7.7 3.0 46.2 7.5 1.2 17.6 9.7 8.5 25.9 3.3 0.7 9.1 21.0 12.4 29.0 11.0 21.5 13.9 16.4 9.1 16.3 5.3 4.6 7.0 6.6 2.0 18.1 28.5 10.3 0.1 35.1 23.3 29.7 64.1 115.4 3.1 210.9 138.8 34.3 40.8 2.1 0.4 0.0 15.2 164.9 15.1 17.8 4.0 19.0 8.8 26.7 5.4 17.6 27.2 0.0 97.2 22.9 0.2 148.6 9.5 29.6 3.4 150.6 15.4 10.6 9.3 0.0 47.8 6.3 6.6 70.6 4.9 0.0 2.4 22.3 15.4 0.2 3.2 0.4 2.9 52.2 14.1 0.4 0.3 14.3 0.6 97.1 68.5 216.6 83.9 36.2 43.6 0.2 0.0 0.0 66.8 22.6 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.7 7.4 6.7 6.9 4.1 16.2 9.0 7.7 3.0 8.5 13.9 5.3 10.3 8.6 3.2 35.9 5.9 0.4 11.3 5.8 20.7 25.0 11.1 1.6 11.4 4.4 0.0 2.3 1.8 0.0 0.7 0.6 0.1 0.0 0.3 93.9 22.6 65.2 5.2 0.0 28.4 3.3 0.2 2.7 141.6 2.0 2.9 2.5 13.8 5.3 0.0 6.8 0.0 0.9 0.1 0.0 9.2 11.1 82.8 71.7 7.0 5.4 57.1 0.6 0.8 1.0 3.5 0.9 0.6 0.0 102.3 0.3 2.1 0.0 0.0 1.4 0.6 0.0 31.4 23.3 11.7 9.3 34.6 7.7 1.9 2.7 71.0 0.2 1.4 NME1-NME2 "NM23-LV, NMELV" ENSG00000011052 "NME1-NME2 readthrough" 17 51153590-51171744 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 51.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 43.5;Basal keratinocytes: 38.4;Basal respiratory cells: 23.3;Club cells: 31.1;granulocytes: 22.7;Langerhans cells: 35.0;Melanocytes: 23.2;Suprabasal keratinocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002169, HPA008467, HPA041113, CAB076057" Approved Approved Cytosol NA NA Cytosol "CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.39e-1)" "unprognostic (5.29e-2)" "unprognostic (9.70e-2)" "unprognostic (5.13e-2)" "prognostic favorable (6.66e-4)" "unprognostic (2.46e-2)" "unprognostic (4.82e-3)" "unprognostic (8.39e-2)" "unprognostic (2.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.58e-6)" "unprognostic (1.03e-1)" "unprognostic (2.74e-6)" "unprognostic (1.84e-1)" "unprognostic (9.72e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" 10.4 21.2 7.0 15.3 7.6 11.0 8.8 6.7 10.3 7.0 6.4 6.7 3.7 9.4 0.8 14.9 9.5 2.3 9.7 8.6 6.9 8.9 16.5 9.2 8.7 7.9 7.1 7.6 5.7 16.8 6.5 12.0 7.2 8.0 6.9 2.9 51.6 13.9 2.3 13.0 11.7 4.9 6.8 6.9 8.0 9.1 3.1 7.8 6.2 7.4 3.6 3.7 13.2 10.0 8.3 22.4 5.5 21.2 48.3 27.9 13.1 7.7 32.3 20.8 15.9 9.5 11.1 8.6 30.1 34.3 41.3 33.2 21.9 25.1 44.7 8.8 51.0 46.6 15.2 9.1 22.7 30.5 25.5 42.2 25.4 36.2 21.2 31.4 49.6 28.0 38.8 21.2 36.7 12.3 14.6 141.2 37.4 19.6 66.5 9.5 49.5 21.0 85.0 23.0 9.4 70.1 56.4 13.9 112.7 38.3 37.8 87.8 86.3 34.1 57.0 14.6 76.8 26.2 60.8 52.2 41.4 26.7 24.6 46.4 0.4 16.0 0.7 18.2 24.1 26.9 14.1 15.7 17.1 45.9 23.4 13.9 16.9 1.7 14.4 11.9 28.4 16.9 20.8 7.0 7.6 6.7 10.3 8.6 6.9 7.9 7.1 7.6 8.0 6.9 7.8 8.3 0.0 16.0 43.5 0.0 1.5 38.4 0.0 23.3 2.2 0.0 0.0 0.0 2.2 0.0 31.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.2 0.2 5.1 1.8 0.4 3.9 0.0 0.1 12.1 1.5 0.2 22.7 0.1 0.4 0.6 0.0 0.0 3.5 7.2 10.2 0.0 35.0 0.0 0.3 6.8 23.2 0.0 0.0 0.0 0.0 2.0 0.9 0.0 1.1 0.0 2.0 0.0 0.0 0.1 16.3 0.0 0.0 0.0 16.4 0.1 0.0 3.8 51.9 0.0 3.0 0.0 7.8 0.1 SLC6A7 PROT ENSG00000011083 "Solute carrier family 6 member 7" Q99884 5 150190062-150222788 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 22.4" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 41.5" "Cancer enhanced" "Detected in single" "colorectal cancer: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028907 Uncertain NA NA "HPA028907: AB_10602404" "unprognostic (3.01e-1)" "unprognostic (1.97e-2)" "unprognostic (3.70e-2)" "unprognostic (1.42e-3)" "unprognostic (1.09e-2)" "unprognostic (1.82e-4)" "unprognostic (6.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.55e-1)" "unprognostic (3.50e-1)" "unprognostic (3.73e-4)" "unprognostic (8.11e-2)" "unprognostic (5.46e-2)" "unprognostic (2.73e-1)" "unprognostic (3.70e-3)" 0.1 0.0 7.3 0.3 14.2 0.0 0.1 15.4 22.4 0.0 0.4 3.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 11.7 6.3 0.0 0.0 0.1 0.1 3.0 6.5 12.8 0.0 0.0 0.0 0.1 0.0 10.6 0.0 4.0 0.1 0.2 0.0 0.0 0.0 3.3 0.1 2.1 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.2 15.4 22.4 11.7 6.3 3.0 6.5 12.8 10.6 2.1 8.0 16.7 0.0 0.0 0.0 2.9 0.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 0.0 0.0 0.0 0.2 3.6 0.0 41.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 2.6 5.4 0.0 0.0 0.4 0.0 0.3 0.5 0.0 2.8 0.0 0.0 0.0 0.5 1.6 0.1 8.7 0.0 0.0 0.1 1.9 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.1 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 129.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 88.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 213.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.1" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 25.4 13.0 11.3 7.1 10.3 0.6 25.2 88.2 12.6 27.9 10.6 15.5 8.0 32.5 11.6 15.5 23.4 35.5 129.9 6.4 12.0 45.9 55.2 36.2 5.5 10.8 19.8 6.1 35.6 13.2 28.3 8.7 59.2 35.4 27.8 6.2 15.0 18.1 24.6 16.9 28.1 12.4 23.8 7.2 20.8 13.6 5.1 17.8 19.3 18.5 12.5 7.1 18.6 22.4 7.2 1.5 12.7 20.1 16.1 19.2 15.5 48.3 26.7 82.3 20.1 26.1 30.6 11.6 0.8 23.9 14.6 19.7 3.1 9.5 9.6 11.8 5.0 9.3 36.3 8.5 20.6 42.2 0.2 3.0 17.7 7.4 40.4 16.9 50.4 55.7 1.1 1.0 1.1 17.6 16.7 0.0 0.8 25.5 7.8 7.4 9.9 213.0 3.1 61.7 7.4 36.8 22.6 18.8 36.6 16.4 45.9 13.7 0.2 27.2 8.5 28.8 14.8 25.7 0.2 0.6 0.3 20.3 0.5 10.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 1.2 11.3 10.3 88.2 12.6 6.4 12.0 10.8 19.8 6.1 35.4 7.2 17.8 7.2 60.1 0.0 4.1 10.4 0.8 19.2 13.3 22.4 13.1 68.7 19.8 9.0 50.1 11.5 6.5 12.9 2.1 53.1 0.2 1.7 5.9 21.1 3.0 2.3 24.9 43.1 6.0 5.3 16.8 9.1 105.1 22.2 2.0 5.7 0.0 13.0 41.0 36.7 6.2 33.7 45.5 2.3 2.0 3.2 3.5 4.1 17.4 7.1 12.4 30.9 0.8 4.0 0.0 9.0 2.0 9.9 0.6 17.3 1.4 13.8 2.4 22.4 2.5 4.7 19.7 1.4 20.9 1.3 3.4 9.7 11.9 80.7 1.5 6.4 2.5 10.5 BTBD7 "FLJ10648, FUP1" ENSG00000011114 "BTB domain containing 7" Q9P203 14 93237550-93333092 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049926, HPA053406" Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA049926: AB_2680956, HPA053406: AB_2682137" "unprognostic (3.36e-1)" "unprognostic (4.36e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-2)" "unprognostic (2.69e-1)" "unprognostic (6.55e-2)" "unprognostic (1.31e-1)" "unprognostic (8.97e-3)" "unprognostic (4.34e-2)" "prognostic favorable (1.69e-6)" "unprognostic (7.27e-2)" "unprognostic (1.97e-1)" "unprognostic (4.72e-2)" "unprognostic (9.52e-2)" 3.9 2.7 1.6 2.2 1.8 5.6 3.5 3.6 1.6 3.3 0.0 3.3 1.8 3.6 1.5 4.6 3.5 2.0 2.8 1.1 2.5 4.0 2.9 3.8 1.2 3.1 2.6 0.9 3.6 3.4 4.0 2.0 2.6 2.2 2.9 2.3 2.5 3.7 1.7 4.8 4.1 3.3 2.1 1.5 2.3 3.1 8.1 2.5 1.2 3.5 1.7 1.4 3.6 4.0 4.2 6.6 4.0 5.2 1.8 2.9 2.5 9.0 6.0 3.8 5.0 3.0 4.5 4.9 4.3 4.9 6.5 3.6 6.1 4.6 10.4 7.7 5.1 3.5 2.9 2.5 3.3 1.7 7.6 3.6 3.6 2.0 5.1 7.3 3.8 7.5 1.7 3.1 3.5 5.2 7.2 2.0 2.9 3.2 3.3 11.2 5.9 7.6 0.9 6.1 15.5 6.7 6.2 7.9 3.0 2.1 5.6 5.3 5.4 8.9 4.2 4.3 3.0 5.3 2.5 3.5 3.9 2.1 2.1 3.0 0.8 0.1 1.3 0.3 0.2 0.1 0.6 0.2 0.3 0.1 0.4 0.1 0.2 0.5 0.1 0.3 0.4 0.4 0.0 1.6 1.8 3.6 1.6 1.1 2.5 3.1 2.6 0.9 2.2 1.5 2.5 4.2 53.6 51.3 27.7 76.4 29.0 32.4 29.0 18.1 26.7 27.9 31.9 23.9 20.9 30.0 19.6 55.2 37.5 24.2 31.6 34.5 13.7 32.3 47.9 58.2 55.7 48.5 28.8 23.4 80.2 24.6 22.5 35.6 29.0 75.5 24.7 33.3 51.4 18.6 17.8 26.9 81.6 26.2 14.2 27.7 39.5 45.7 23.6 36.1 10.6 99.3 39.5 23.9 26.8 89.0 175.7 45.2 22.0 39.5 36.0 45.8 22.1 39.3 22.9 30.4 13.1 58.3 56.4 23.7 36.6 32.9 36.9 30.6 28.2 33.1 27.7 64.5 APBA3 "mint3, X11L2" ENSG00000011132 "Amyloid beta precursor protein binding family A member 3" O96018 19 3750772-3761692 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045577 Approved Approved Vesicles NA NA Vesicles "HPA045577: AB_10964881" "unprognostic (3.47e-2)" "unprognostic (3.58e-2)" "unprognostic (5.00e-2)" "prognostic favorable (5.97e-4)" "unprognostic (1.69e-1)" "prognostic favorable (4.91e-4)" "unprognostic (6.64e-2)" "unprognostic (7.60e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.83e-4)" 6.6 6.8 2.3 3.6 3.0 2.0 7.1 2.9 5.4 7.6 2.1 7.6 3.5 8.0 0.1 7.5 6.9 1.1 7.2 2.0 2.3 8.3 10.4 6.7 3.8 3.5 2.8 1.8 9.5 7.9 1.5 7.2 2.0 3.0 7.6 0.6 0.4 8.5 2.5 15.5 7.5 8.5 1.4 2.6 11.3 8.3 3.3 2.7 2.8 8.3 2.8 1.9 7.5 6.9 4.7 8.0 6.0 1.3 2.3 2.4 1.8 6.4 5.1 3.0 2.7 3.7 5.8 2.7 5.4 4.4 2.0 6.3 3.8 1.4 4.3 0.6 20.5 4.5 3.1 4.9 4.6 8.1 1.9 11.2 3.6 5.3 3.4 2.2 2.2 3.7 5.5 5.2 8.4 1.2 4.7 6.1 7.8 3.5 2.6 8.9 6.3 2.6 8.9 1.9 5.0 4.6 4.8 3.2 4.6 7.9 0.8 2.0 4.6 6.4 4.5 4.6 7.9 6.3 17.0 6.8 4.9 4.1 6.2 4.8 11.3 7.3 11.4 13.0 5.6 11.9 9.5 12.9 12.9 8.3 11.6 8.2 10.0 10.2 6.9 5.1 7.8 19.8 8.4 2.3 3.0 2.9 5.4 2.0 2.3 3.5 2.8 1.8 3.0 2.6 2.7 4.7 4.9 6.4 5.6 2.9 12.1 4.2 6.5 18.1 4.0 3.9 7.0 6.2 4.7 4.3 7.9 7.3 8.4 10.6 9.0 8.0 7.9 14.2 0.9 2.9 4.8 6.4 4.8 1.3 3.4 9.0 10.0 7.6 13.3 5.4 2.5 5.4 5.3 8.2 8.6 3.3 3.2 9.1 10.2 6.7 9.3 0.5 6.2 5.9 5.4 1.0 16.4 3.3 13.4 3.0 5.2 12.6 5.8 3.0 13.4 9.3 19.5 11.3 3.8 6.4 6.6 4.0 5.1 2.5 6.2 7.7 7.5 15.3 12.4 3.5 7.5 6.4 MKS1 "BBS13, FLJ20345, MKS, POC12" ENSG00000011143 "MKS transition zone complex subunit 1" Q9NXB0 17 58205441-58219605 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021372, HPA021812" Enhanced NA NA "HPA021372: AB_1848746, HPA021812: AB_2142654" "unprognostic (3.57e-1)" "unprognostic (4.12e-2)" "unprognostic (8.58e-2)" "unprognostic (3.06e-2)" "unprognostic (5.79e-2)" "unprognostic (5.05e-2)" "unprognostic (7.06e-3)" "unprognostic (6.27e-2)" "unprognostic (9.40e-2)" "unprognostic (4.64e-3)" "prognostic favorable (1.25e-4)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (9.86e-3)" "unprognostic (4.25e-1)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" 6.2 10.0 4.0 3.7 4.1 5.8 8.3 6.3 6.2 10.1 3.0 7.8 4.5 9.6 4.3 9.1 14.0 4.0 6.4 3.8 3.9 9.4 8.8 6.2 4.7 4.8 4.2 3.7 13.5 11.5 5.7 12.3 3.6 4.4 9.2 3.2 6.1 9.3 3.4 6.8 10.7 7.7 5.1 3.3 8.2 8.5 13.4 3.9 5.9 9.0 3.1 3.9 7.8 8.5 5.2 14.2 12.0 14.5 15.9 5.2 6.4 14.7 7.0 5.9 15.6 9.5 8.4 10.2 7.3 29.5 9.0 9.2 7.7 14.8 10.1 10.8 24.5 16.5 10.2 10.6 14.1 12.5 16.0 6.4 7.0 9.4 8.7 9.3 6.6 8.7 25.5 20.1 5.4 9.2 22.5 27.8 9.7 6.4 12.3 12.0 20.8 18.5 14.6 10.8 7.9 21.4 13.7 10.7 5.9 11.9 6.7 27.8 10.5 6.5 10.6 15.7 8.1 8.8 6.9 7.6 8.6 9.7 9.2 8.3 10.4 6.3 4.2 6.0 6.2 8.7 7.3 9.6 9.3 13.1 4.1 8.9 8.4 1.9 15.7 5.1 8.3 7.8 5.9 4.0 4.1 6.3 6.2 3.8 3.9 4.8 4.2 3.7 4.4 3.3 3.9 5.2 4.0 3.2 3.1 10.1 3.3 2.5 5.1 7.9 8.6 6.4 6.6 6.9 3.6 5.7 4.6 9.2 12.5 11.5 1.8 2.9 15.6 7.4 9.5 17.7 6.1 5.1 2.4 14.9 5.8 4.0 9.6 5.6 6.1 4.4 5.7 10.9 5.0 6.3 6.0 0.0 5.3 4.9 8.2 2.5 1.8 8.3 5.3 3.1 1.8 5.6 1.7 5.5 5.2 8.0 9.2 4.8 3.1 6.8 4.3 1.5 5.0 8.2 27.4 10.5 0.0 4.9 4.6 14.0 10.7 5.5 3.3 3.1 3.8 10.2 7.8 2.1 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 67.8;neutrophil: 42.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 67.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 34.1 12.6 7.3 8.6 8.9 40.0 28.1 11.8 9.3 8.4 6.6 12.4 9.9 5.7 4.1 31.4 5.1 11.7 12.1 7.3 8.4 11.4 21.9 16.6 3.5 10.0 9.0 6.8 4.7 16.1 12.3 5.7 10.2 9.7 7.1 7.6 6.3 27.6 8.5 15.1 36.4 10.6 9.3 10.1 9.5 12.2 10.8 8.7 6.9 15.6 18.7 8.0 16.8 17.0 13.0 18.9 6.8 8.2 9.7 32.0 12.8 17.1 77.4 27.1 18.8 14.9 9.4 6.4 16.2 10.9 23.2 15.8 5.8 16.5 18.5 22.6 58.4 13.2 36.6 24.4 7.5 15.7 9.2 13.2 13.0 64.6 31.3 28.5 18.8 33.3 10.8 23.9 14.2 46.9 11.0 7.6 6.9 22.8 16.7 20.4 3.1 24.1 8.6 27.9 40.4 10.6 13.6 36.9 20.5 9.8 9.8 18.9 8.9 19.3 18.1 13.6 35.0 34.5 11.1 34.0 7.7 20.3 17.3 16.0 67.8 14.7 9.5 2.3 7.9 1.7 3.5 1.7 2.7 6.8 4.0 1.6 2.5 42.5 2.0 5.7 1.9 4.8 5.3 7.3 8.9 11.8 9.3 7.3 8.4 10.0 9.0 6.8 9.7 10.1 8.7 13.0 117.5 25.6 51.8 12.7 44.8 39.9 27.5 25.9 88.8 11.9 149.9 116.2 10.3 14.3 49.6 27.6 27.1 16.7 80.3 65.0 33.2 57.5 19.5 47.5 49.0 34.6 36.2 69.0 24.1 61.5 24.9 53.7 67.8 114.0 16.5 8.8 18.2 12.7 18.0 3.3 24.1 23.7 34.6 44.1 17.4 17.1 5.3 79.8 7.2 11.2 35.9 11.0 12.3 18.1 28.8 75.2 49.8 5.7 41.8 25.5 98.5 39.8 19.1 17.4 0.0 32.0 46.4 47.3 41.9 111.7 40.9 205.4 42.6 15.2 21.9 71.6 ANOS1 "ADMLX, KAL, KAL1, KALIG-1, WFDC19" ENSG00000011201 "Anosmin 1" P23352 X 8528874-8732137 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cell adhesion, Chemotaxis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 43.5" "Cell type enriched" "Detected in many" 11 "Alveolar cells type 1: 240.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 40.4;NTERA-2: 37.0;U-2 OS: 17.6" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (2.93e-1)" "unprognostic (5.33e-2)" "unprognostic (9.54e-2)" "unprognostic (4.16e-3)" "unprognostic (7.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.55e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-2)" "unprognostic (6.43e-2)" "unprognostic (2.09e-2)" "unprognostic (6.24e-2)" "unprognostic (1.71e-2)" "unprognostic (9.38e-3)" "unprognostic (6.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.56e-2)" 6.6 4.0 8.9 1.1 9.4 0.3 3.7 6.7 7.4 4.4 1.2 0.7 0.3 0.5 3.1 1.3 1.1 1.7 5.1 7.8 11.2 0.8 0.8 43.5 1.9 13.4 11.3 6.7 0.3 0.4 15.2 0.5 1.2 13.9 4.2 1.0 19.8 2.4 4.4 10.6 3.1 0.6 0.7 19.0 0.8 0.8 3.9 10.6 4.0 9.4 6.9 0.9 1.2 1.2 18.1 0.1 0.0 1.9 0.0 0.0 0.0 2.2 0.8 0.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.7 4.0 0.2 5.5 0.5 5.6 0.0 0.0 0.0 1.5 0.1 3.1 0.3 0.1 40.4 0.0 0.1 0.0 0.0 0.5 0.4 0.3 0.0 37.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 2.1 0.1 1.9 0.5 0.0 4.8 0.0 1.0 0.0 0.0 17.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 9.4 6.7 7.4 7.8 11.2 13.4 11.3 6.7 13.9 19.0 10.6 18.1 1.7 240.4 12.6 0.0 0.0 0.0 4.7 0.0 13.1 20.5 6.2 3.4 6.2 0.0 19.8 0.0 4.2 0.1 0.0 0.0 0.0 0.9 0.2 0.4 1.5 1.6 0.0 0.0 0.0 0.0 0.3 10.9 0.0 0.1 1.3 2.2 6.1 0.0 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.3 0.6 3.0 0.0 0.0 0.2 17.8 0.0 0.0 0.0 1.5 0.1 1.2 0.0 3.1 0.0 0.2 3.6 1.6 0.0 8.7 3.3 0.6 1.6 1.5 0.0 0.1 0.3 0.8 0.4 1.1 AKAP8L "HAP95, NAKAP95" ENSG00000011243 "A-kinase anchoring protein 8 like" Q9ULX6 19 15380050-15419141 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042485, HPA042546" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA042485: AB_2678019, HPA042546: AB_2678046" "unprognostic (9.52e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (3.53e-2)" "unprognostic (1.38e-2)" "unprognostic (2.87e-2)" "unprognostic (1.08e-1)" "unprognostic (3.57e-2)" "prognostic favorable (8.04e-4)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.77e-1)" "unprognostic (1.07e-1)" "unprognostic (8.80e-2)" "unprognostic (2.34e-3)" 25.7 33.0 26.6 4.1 25.7 32.6 27.2 26.3 32.5 32.1 22.7 28.1 2.6 23.7 12.0 23.6 32.1 7.6 41.8 26.2 25.7 29.2 29.0 33.8 9.5 26.4 25.2 24.2 36.5 22.7 11.2 40.7 9.4 25.8 32.6 5.9 37.8 23.4 6.4 61.0 34.0 24.2 6.5 26.2 31.7 24.9 49.2 26.9 20.8 34.1 24.3 10.8 27.1 28.3 28.8 25.4 25.8 32.3 17.2 32.3 34.0 18.8 21.0 25.1 34.0 30.9 41.5 35.2 23.2 38.8 23.4 31.8 29.9 51.2 28.3 29.8 39.8 44.2 40.3 21.9 34.0 57.3 38.8 26.6 29.6 52.0 27.2 35.3 31.3 25.4 38.0 51.3 41.9 21.3 34.3 39.0 32.6 31.9 32.0 41.9 46.6 22.8 25.2 28.7 8.5 37.2 23.5 26.2 28.3 37.5 42.4 20.8 42.2 30.4 20.5 15.4 34.4 36.7 60.1 48.0 49.5 19.2 39.8 23.5 0.1 1.8 1.7 0.9 0.8 1.8 1.7 0.8 1.0 1.5 2.3 1.3 1.2 3.5 0.5 1.0 1.4 2.8 0.8 26.6 25.7 26.3 32.5 26.2 25.7 26.4 25.2 24.2 25.8 26.2 26.9 28.8 34.7 6.4 15.9 55.5 39.1 31.6 48.2 22.6 26.2 60.9 34.6 29.3 7.7 17.2 30.0 35.0 77.2 35.6 47.3 22.5 25.4 32.6 34.6 52.7 33.7 29.8 25.6 114.9 59.1 31.8 28.6 26.0 50.0 42.6 13.9 69.6 17.5 17.0 16.3 79.1 45.1 22.0 26.4 18.6 32.8 9.9 26.4 31.3 26.6 19.7 24.0 42.0 30.9 29.7 38.5 32.5 19.9 29.3 38.2 33.2 13.6 17.3 32.1 83.2 26.3 27.8 45.2 83.3 63.9 26.4 39.2 62.4 44.0 60.2 18.3 40.2 MBTD1 "FLJ20055, SA49P01" ENSG00000011258 "Mbt domain containing 1" Q05BQ5 17 51177425-51260163 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021876 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021876: AB_2140367" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-2)" "unprognostic (1.81e-2)" "unprognostic (2.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-2)" "unprognostic (5.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.61e-2)" "unprognostic (7.90e-3)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-3)" 6.7 5.3 5.5 5.5 6.6 10.9 11.5 8.9 6.9 8.5 5.2 7.2 8.0 8.6 7.8 7.2 7.0 5.1 4.5 5.6 5.5 6.2 9.8 6.2 8.7 5.9 6.1 5.4 11.9 8.7 5.7 5.6 8.7 6.2 6.9 7.9 10.1 7.0 4.9 6.4 14.5 8.2 5.7 5.5 8.8 8.4 25.6 5.8 14.6 8.4 6.9 8.0 6.9 8.3 7.7 6.6 6.1 32.0 12.9 7.5 8.8 16.7 5.0 6.2 5.3 6.4 7.2 8.3 25.7 11.5 3.8 3.9 6.3 14.8 3.7 9.8 7.4 13.4 26.7 7.5 11.1 5.0 18.0 7.7 7.5 7.0 4.0 7.2 10.5 9.4 22.3 21.0 6.3 4.3 6.7 24.8 18.8 18.1 14.0 5.5 28.4 19.3 12.9 8.0 12.4 20.1 30.7 4.5 8.6 10.7 26.6 12.2 35.0 5.7 5.7 5.8 4.2 5.4 15.4 10.5 22.8 3.4 11.8 3.3 2.6 0.1 0.7 0.2 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.1 0.1 0.3 0.3 0.0 5.5 6.6 8.9 6.9 5.6 5.5 5.9 6.1 5.4 6.2 5.5 5.8 7.7 11.2 16.0 15.0 47.7 10.3 17.2 6.5 5.4 17.1 9.0 14.7 11.7 7.3 17.2 7.1 7.3 16.7 7.9 9.6 7.8 1.9 5.4 51.6 11.8 15.0 11.3 13.8 17.7 61.5 5.1 5.1 10.8 17.9 16.0 5.1 18.8 10.4 12.8 5.8 10.1 59.9 13.5 6.1 12.3 8.5 12.4 14.6 11.5 10.6 56.2 16.4 4.1 11.3 78.4 94.9 6.4 9.0 10.5 5.1 10.8 10.1 4.6 6.2 12.0 0.0 10.2 13.0 47.8 19.2 10.5 22.0 8.6 8.6 15.6 12.1 9.7 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18 small subunit processome component" Q9Y5J1 17 51260546-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 190.6;Late spermatids: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear membrane" "HPA052378: AB_2681805" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 17.7 20.3 13.2 25.1 14.6 40.4 26.0 20.1 15.8 18.1 14.2 17.6 18.0 15.9 15.9 21.2 17.6 12.9 9.8 14.1 14.8 22.0 22.5 17.5 33.4 13.9 13.8 13.6 24.0 21.5 23.5 20.6 26.5 14.5 16.3 18.9 17.6 17.6 14.3 24.6 32.1 16.7 13.0 14.2 24.7 18.2 59.2 14.0 27.9 24.6 16.4 34.7 25.0 18.2 16.4 90.5 87.7 54.6 50.3 35.1 52.2 142.2 48.9 40.2 83.5 79.7 55.4 49.3 113.5 67.8 36.6 89.0 48.1 89.7 52.0 123.3 74.8 117.0 119.4 52.6 97.3 48.0 127.9 56.4 33.9 39.5 71.1 57.0 42.1 50.7 55.6 98.7 50.6 63.5 56.1 115.6 86.9 78.5 127.5 91.8 103.2 124.2 89.4 61.3 59.1 60.7 76.9 56.7 66.6 114.7 67.4 82.3 64.4 44.7 85.3 71.8 71.1 102.9 97.4 192.5 131.5 53.0 87.6 62.4 19.0 48.2 27.9 40.2 46.9 49.9 54.1 50.7 49.2 55.9 52.4 53.6 51.1 8.2 40.0 49.0 35.0 56.8 56.2 13.2 14.6 20.1 15.8 14.1 14.8 13.9 13.8 13.6 14.5 14.2 14.0 16.4 20.6 16.0 23.4 11.8 37.4 60.2 62.9 40.6 33.0 15.6 19.6 17.9 4.4 20.0 25.2 14.7 14.6 66.7 27.4 11.4 39.2 38.4 190.6 26.3 27.3 25.1 16.1 20.8 18.5 46.9 71.2 24.5 14.3 24.1 31.7 19.6 8.9 17.1 62.8 10.1 18.0 20.7 34.6 37.7 26.1 182.0 26.8 33.3 23.2 15.0 42.2 21.3 25.7 17.6 24.6 34.2 16.3 22.2 24.2 50.2 13.8 37.5 38.8 11.8 13.1 24.8 35.7 140.2 104.5 27.7 52.7 79.6 30.4 30.8 25.3 48.1 RNF216 "TRIAD3, UBCE7IP1, ZIN" ENSG00000011275 "Ring finger protein 216" Q9NWF9 7 5620047-5781696 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018955, HPA021123" Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018955: AB_1858500, HPA021123: AB_1858501" "unprognostic (3.31e-2)" "unprognostic (4.24e-2)" "unprognostic (1.28e-2)" "unprognostic (1.58e-2)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.35e-1)" "unprognostic (2.40e-1)" "unprognostic (1.40e-2)" "prognostic favorable (6.24e-5)" "unprognostic (2.88e-2)" "unprognostic (9.01e-2)" "unprognostic (3.49e-1)" "unprognostic (1.73e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-3)" 13.8 12.4 13.5 12.9 15.2 15.7 13.2 11.6 13.4 12.9 9.6 20.5 8.2 22.1 8.2 12.4 15.9 8.8 21.9 12.8 14.8 10.0 10.2 12.9 17.1 14.0 13.9 12.0 16.6 15.0 14.0 15.5 7.8 13.9 14.7 5.9 7.2 11.5 13.9 19.8 12.8 18.0 15.1 12.2 19.4 14.7 30.3 14.3 12.9 12.8 12.0 11.6 16.5 11.0 13.4 22.0 23.6 17.0 32.8 21.6 14.6 11.5 20.7 19.3 17.6 15.8 16.7 12.3 17.3 11.4 22.0 38.7 17.1 13.6 15.3 10.3 11.4 19.3 12.5 13.6 18.0 27.7 19.5 25.3 21.4 20.4 16.2 14.6 18.4 15.0 19.2 28.4 12.9 18.9 35.2 8.8 44.7 25.7 13.1 20.0 26.1 23.4 12.2 13.9 13.9 14.1 25.3 11.8 33.9 13.2 15.3 14.2 28.2 20.5 24.9 39.9 25.2 22.8 11.4 9.0 16.0 19.6 21.7 37.4 3.5 7.7 24.2 10.1 8.3 9.4 8.3 9.3 8.7 6.3 8.8 10.9 11.3 13.2 12.7 8.7 7.1 8.3 6.9 13.5 15.2 11.6 13.4 12.8 14.8 14.0 13.9 12.0 13.9 12.2 14.3 13.4 33.4 6.4 23.9 34.9 33.6 16.6 20.8 11.9 15.9 36.4 16.1 17.8 33.3 8.6 13.6 12.9 52.1 14.1 47.7 10.3 25.4 17.6 145.5 14.6 33.7 29.7 6.0 8.8 50.2 13.7 12.9 26.7 16.3 16.9 19.6 34.0 26.4 15.1 22.9 28.6 61.7 15.4 6.1 23.0 29.3 257.6 37.3 23.1 12.4 49.6 37.0 30.2 56.7 46.3 64.2 15.6 7.0 30.1 20.3 24.2 13.0 14.9 13.7 48.5 26.3 46.0 30.0 159.8 124.2 12.9 16.2 15.2 40.2 22.8 11.8 15.2 TTC19 "FLJ20343, MGC19520" ENSG00000011295 "Tetratricopeptide repeat domain 19" Q6DKK2 17 15999784-16045015 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 5.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023010, HPA052380" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA023010: AB_1858429, HPA052380: AB_2681806" "unprognostic (1.04e-2)" "unprognostic (4.90e-3)" "unprognostic (2.87e-2)" "unprognostic (4.80e-3)" "unprognostic (8.09e-2)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.84e-2)" "unprognostic (8.34e-2)" "unprognostic (1.72e-2)" "unprognostic (2.30e-3)" "unprognostic (5.14e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.31e-1)" "unprognostic (3.22e-1)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" 6.4 11.5 8.1 3.8 7.7 11.3 7.6 17.9 11.7 6.2 8.0 7.3 10.4 6.9 5.2 6.9 5.8 5.3 8.3 8.1 8.5 8.6 7.7 6.7 4.6 7.5 7.8 7.2 7.0 12.5 11.3 8.1 5.9 10.6 6.8 5.8 10.0 9.2 4.2 8.9 9.6 9.8 3.9 6.3 4.5 8.5 3.6 7.4 4.0 10.7 4.5 3.3 6.3 6.7 10.4 7.0 4.1 7.6 12.1 6.4 5.6 4.0 3.1 4.6 3.1 3.8 6.5 12.8 8.9 9.8 4.3 4.6 9.1 9.9 8.3 3.8 12.5 10.2 8.2 9.2 6.3 9.1 9.3 11.6 5.6 7.0 2.6 11.4 9.6 7.1 12.4 4.6 7.7 6.8 7.6 7.5 6.8 10.0 11.8 3.0 7.8 8.0 8.2 11.6 10.5 6.6 5.5 7.6 9.8 16.6 24.6 6.9 4.6 13.1 4.2 1.2 6.1 7.5 4.8 1.5 4.2 9.8 9.8 9.5 5.2 0.7 1.8 0.7 0.7 1.2 0.9 0.9 1.2 0.7 1.1 1.0 1.3 0.7 0.6 0.7 1.1 1.0 0.4 8.1 7.7 17.9 11.7 8.1 8.5 7.5 7.8 7.2 10.6 6.3 7.4 10.4 51.0 41.7 38.6 69.5 60.8 105.3 83.5 30.8 70.6 147.8 65.1 47.9 34.8 42.9 35.4 46.0 143.9 75.7 62.8 59.7 70.5 50.0 59.4 49.4 41.5 60.3 45.6 32.4 115.1 41.2 41.9 34.2 43.8 67.9 31.1 46.8 42.8 36.0 25.6 129.5 100.9 52.3 26.4 25.8 76.7 7.2 41.0 46.5 55.2 35.6 34.8 73.9 70.0 54.3 57.8 47.7 57.9 33.4 34.5 89.1 75.4 47.1 26.5 180.4 46.0 56.5 40.2 30.2 31.1 56.9 116.8 65.5 68.9 69.9 63.3 72.7 PTBP1 "HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4" ENSG00000011304 "Polypyrimidine tract binding protein 1" P26599 19 797075-812327 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013507 Supported Supported Nucleoplasm NA NA 4500000 Nucleoplasm "CAB013507: AB_2533082" "unprognostic (2.82e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (6.01e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (2.71e-4)" "unprognostic (4.06e-3)" "unprognostic (2.08e-2)" "unprognostic (1.92e-2)" "unprognostic (5.47e-2)" "unprognostic (4.62e-3)" "unprognostic (2.41e-2)" "unprognostic (7.91e-3)" "unprognostic (4.28e-2)" "unprognostic (8.31e-2)" "unprognostic (3.72e-2)" 98.7 85.4 29.0 105.7 30.9 139.4 95.7 32.6 35.2 90.3 46.8 96.8 92.2 91.3 49.4 138.8 87.7 54.5 63.2 27.3 56.9 102.5 124.5 103.2 90.9 38.4 31.5 23.1 100.3 101.7 66.9 81.5 79.7 34.6 87.1 56.5 11.9 91.4 46.1 35.5 123.8 97.5 50.2 32.5 118.1 86.7 45.9 37.0 92.7 98.8 19.9 79.9 81.0 102.4 33.0 517.8 377.1 242.8 224.3 70.1 90.3 385.1 299.7 128.8 230.2 169.2 394.1 243.6 428.0 192.5 188.9 88.0 299.8 342.7 260.0 239.3 433.8 361.2 352.9 362.6 429.8 141.8 479.4 355.1 83.5 179.0 265.5 164.2 84.4 232.2 201.3 523.0 223.0 385.6 434.8 610.4 258.5 446.4 190.2 245.2 648.8 182.0 254.2 140.4 467.5 272.9 317.4 358.4 213.4 174.8 168.5 228.9 286.4 335.4 247.5 286.9 306.0 557.4 238.0 500.7 591.2 153.2 357.7 307.9 12.9 32.5 23.1 31.8 38.6 32.3 23.7 26.3 30.0 36.0 23.7 25.1 26.2 13.4 33.5 36.7 22.3 29.1 38.3 29.0 30.9 32.6 35.2 27.3 56.9 38.4 31.5 23.1 34.6 32.5 37.0 33.0 99.8 41.7 66.9 11.8 88.7 76.7 91.8 47.0 84.8 19.6 114.5 91.9 39.1 82.9 44.3 47.8 35.5 116.5 96.1 134.3 35.2 73.3 22.3 62.2 62.2 92.1 101.1 87.7 12.4 87.5 172.7 70.4 70.3 80.5 90.8 92.0 74.6 87.9 78.7 33.7 12.1 145.0 36.7 60.6 62.7 20.6 79.9 75.1 39.2 20.6 59.8 29.9 59.8 10.1 12.9 99.4 107.5 65.8 90.0 90.5 89.9 46.9 49.9 21.3 59.2 74.8 71.1 40.5 54.3 97.2 82.0 133.4 89.7 68.7 144.9 100.7 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 23.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.9;Early spermatids: 25.4;Excitatory neurons: 24.6;Horizontal cells: 45.4;Inhibitory neurons: 16.3;Late spermatids: 23.4" "Group enriched" "Detected in some" 5 "glioma: 5.6;testis cancer: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 19.7;SCLC-21H: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA049148: AB_2680653" "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 0.1 0.3 11.0 0.4 16.0 0.1 0.1 2.3 23.6 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.4 17.3 7.5 0.0 0.0 0.3 0.1 5.0 5.7 15.2 0.3 0.1 0.0 2.5 0.1 8.3 0.1 0.0 2.5 0.2 0.0 0.2 0.3 0.1 0.2 2.1 0.1 0.1 2.5 8.0 0.2 0.0 0.0 0.1 0.1 0.1 15.4 4.6 3.8 15.8 11.7 1.1 0.8 1.6 4.8 2.7 8.0 6.7 2.7 0.4 7.5 3.2 3.7 3.2 2.8 19.7 2.6 3.6 7.2 3.9 2.5 2.0 1.1 0.4 1.9 2.1 0.9 0.1 4.7 1.5 1.0 1.5 5.5 5.6 0.4 7.7 6.4 4.1 0.5 2.9 1.3 4.4 7.5 8.0 1.6 0.8 1.4 22.9 7.8 5.4 0.5 1.0 1.9 2.4 0.4 1.8 11.5 3.7 2.8 4.4 2.9 10.3 9.9 6.1 2.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 16.0 2.3 23.6 17.3 7.5 5.0 5.7 15.2 8.3 2.1 8.0 15.4 0.4 0.0 0.0 3.3 0.1 2.3 0.1 1.1 0.0 17.9 0.2 0.6 1.2 0.0 0.1 0.0 8.4 0.1 0.0 0.1 0.0 0.0 25.4 1.5 2.2 0.9 0.0 0.0 24.6 0.0 2.0 1.5 0.0 0.7 0.0 4.3 0.4 0.0 0.2 45.4 16.3 0.0 0.0 0.3 0.4 23.4 0.6 0.1 0.0 1.0 0.0 3.3 0.0 12.5 4.8 0.1 0.0 2.6 0.0 0.1 0.0 0.1 1.4 3.1 0.0 0.7 1.9 6.7 12.6 0.0 1.1 0.1 0.2 1.6 0.0 0.1 SYT7 "IPCA-7, MGC150517, PCANAP7, SYT-VII" ENSG00000011347 "Synaptotagmin 7" O43581 11 61513714-61581148 "Predicted intracellular proteins, Predicted membrane proteins" Exocytosis Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 80.3;liver: 87.4;salivary gland: 57.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 45.2;Enteroendocrine cells: 49.8;Excitatory neurons: 82.1;Hepatocytes: 70.7;Prostatic glandular cells: 36.8;Syncytiotrophoblasts: 66.4" "Cancer enhanced" "Detected in all" "prostate cancer: 54.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.0;hTERT-HME1: 89.5;RT4: 37.8;SCLC-21H: 28.4;SK-BR-3: 40.7;T-47d: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012869 Enhanced NA NA "HPA012869: AB_1857698" "unprognostic (7.09e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.10e-2)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.37e-2)" "unprognostic (5.08e-2)" "unprognostic (2.74e-3)" "unprognostic (1.79e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (2.23e-3)" "unprognostic (2.47e-1)" 3.0 4.4 10.6 1.3 33.1 0.1 9.3 0.0 80.3 3.1 0.0 5.1 2.3 2.6 1.8 3.6 3.5 1.2 16.7 26.5 13.9 5.6 87.4 2.0 0.3 8.5 3.8 44.3 1.4 16.9 5.7 52.0 18.6 9.9 51.3 5.4 8.1 57.5 0.9 3.6 3.9 5.3 1.8 0.0 2.1 3.7 4.1 12.1 0.4 8.1 1.9 0.3 1.9 3.4 39.6 13.4 1.9 0.5 0.2 1.0 14.1 10.4 0.2 35.0 0.6 0.5 3.5 6.9 0.0 0.6 0.2 1.3 6.9 0.9 0.2 0.2 0.2 1.7 0.0 1.7 2.1 0.9 0.1 0.1 0.4 7.8 4.2 89.5 0.2 0.2 0.8 0.1 0.2 0.5 21.6 0.1 0.3 2.4 24.8 14.1 0.0 0.7 1.7 0.0 37.8 28.4 5.2 1.9 40.7 0.3 5.6 39.8 0.0 0.0 8.6 3.1 10.1 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 33.1 0.0 80.3 26.5 13.9 8.5 3.8 44.3 9.9 0.0 12.1 39.6 10.6 0.0 0.5 4.2 0.2 0.3 0.4 5.1 0.0 22.6 23.2 16.3 22.3 1.5 5.0 5.5 0.0 45.2 0.6 1.9 5.9 1.2 8.4 0.3 4.3 4.9 49.8 2.7 82.1 1.6 3.4 3.0 0.0 0.5 0.0 5.9 4.6 70.7 4.0 21.9 17.8 30.2 6.1 1.0 0.0 7.6 3.4 0.1 1.8 7.5 0.0 0.6 0.0 6.0 2.5 1.0 4.6 2.2 0.0 36.8 3.5 0.1 1.3 3.5 0.0 2.8 1.4 0.8 3.9 0.9 0.1 66.4 0.2 0.6 2.4 1.7 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388561-45554726 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612" "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favorable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 3.3 4.8 9.4 3.4 10.0 2.4 4.0 9.9 11.8 3.7 8.6 7.0 3.9 4.6 4.3 4.2 4.5 3.1 5.6 9.0 10.0 7.6 8.2 2.9 4.3 9.4 9.9 8.9 3.9 2.5 12.5 3.8 4.2 9.4 4.4 7.0 4.3 3.6 4.2 6.3 3.4 2.9 4.5 8.5 3.2 3.6 2.2 11.1 7.0 4.5 6.5 4.9 5.1 3.7 9.3 6.3 11.2 10.7 9.3 11.8 13.0 11.1 11.6 15.7 24.7 16.2 20.3 8.8 13.8 8.9 18.0 18.2 5.8 49.0 30.4 16.0 9.5 12.7 12.9 13.6 18.4 12.1 20.9 4.4 19.0 16.8 26.0 12.5 13.1 14.9 19.5 25.1 5.5 19.0 9.7 21.1 11.6 28.4 15.0 21.9 8.9 9.8 16.9 23.6 18.8 7.6 9.7 17.3 7.9 11.8 13.5 14.6 14.7 9.1 12.1 8.3 8.5 12.3 5.3 12.3 15.4 14.0 16.9 9.5 0.0 0.6 0.6 1.2 0.9 1.5 1.0 0.7 1.1 1.2 0.5 0.8 1.0 0.3 1.9 0.8 1.0 0.6 0.7 9.4 10.0 9.9 11.8 9.0 10.0 9.4 9.9 8.9 9.4 8.5 11.1 9.3 3.9 0.0 2.0 28.7 4.8 1.1 1.5 1.8 3.4 5.5 3.2 2.8 9.0 1.5 1.8 5.5 4.2 5.0 3.5 4.4 5.9 2.9 0.6 7.6 5.7 4.2 4.8 5.2 35.4 2.7 5.2 3.2 6.6 4.9 1.3 9.8 2.2 7.7 5.4 1.7 37.8 4.5 0.0 2.9 1.3 1.2 1.2 2.6 1.8 19.7 2.3 4.0 2.1 22.6 25.2 3.2 7.0 2.2 5.0 1.9 2.6 2.4 2.9 4.7 0.0 3.1 2.9 0.7 2.4 4.8 1.3 2.9 3.2 8.3 6.8 1.7 PIK3C2A PI3K-C2alpha ENSG00000011405 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha" O00443 11 17077730-17207983 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Endocytosis, Exocytosis" "Kinase, Transferase" "Cataract, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 217.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037641, HPA037642" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037641: AB_10671878, HPA037642: AB_10697081" "unprognostic (2.35e-1)" "unprognostic (2.16e-2)" "unprognostic (3.71e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (6.63e-2)" "unprognostic (2.47e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (1.86e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" 22.7 13.9 18.0 12.4 23.9 9.5 16.1 23.9 15.0 16.3 18.2 13.3 15.1 18.2 15.9 15.6 14.6 19.2 12.5 12.1 18.0 23.8 15.7 16.7 11.4 21.0 17.3 11.3 14.2 12.4 44.0 10.4 23.3 18.2 16.5 13.1 22.6 11.9 15.0 6.5 12.4 11.9 18.4 14.4 13.1 18.1 19.5 16.9 9.5 31.0 12.2 11.0 15.0 12.1 17.1 53.8 24.1 39.6 24.8 28.0 28.3 35.3 33.2 35.7 23.9 33.2 58.9 6.0 15.6 16.2 28.6 39.1 34.8 31.9 25.4 42.1 13.5 27.6 9.8 28.4 23.3 30.6 12.3 14.9 22.2 17.5 23.6 45.8 22.2 57.7 9.9 23.4 14.7 18.6 16.6 6.6 7.7 22.6 30.1 18.5 6.9 41.1 11.0 29.6 47.0 23.2 20.5 50.6 21.4 23.2 33.0 12.7 12.3 72.5 19.1 27.4 50.1 20.4 5.9 14.1 12.8 22.8 11.3 22.6 1.7 1.5 1.1 1.7 1.0 1.1 1.4 1.3 1.3 2.1 1.5 1.7 1.0 2.3 1.8 3.2 1.4 0.9 0.6 18.0 23.9 23.9 15.0 12.1 18.0 21.0 17.3 11.3 18.2 14.4 16.9 17.1 93.2 76.9 62.0 217.4 25.0 35.3 26.1 18.7 24.5 49.1 34.7 25.0 29.7 25.8 33.1 36.8 70.9 29.6 29.5 22.6 19.6 19.8 35.9 51.8 35.1 87.6 28.7 11.2 57.0 25.1 17.9 28.6 45.3 72.4 32.2 22.8 106.7 32.4 19.2 35.3 81.1 23.5 18.3 46.3 33.1 18.6 25.7 27.0 19.6 69.3 19.6 73.0 17.5 62.8 79.4 26.1 13.1 31.2 29.9 42.7 15.2 22.4 26.4 40.4 39.5 33.7 35.1 52.6 26.8 23.5 34.0 143.5 25.3 25.1 20.7 37.3 PLAUR "CD87, UPAR, URKR" ENSG00000011422 "Plasminogen activator, urokinase receptor" Q03405 19 43646095-43670547 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 694.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 820.7;Langerhans cells: 1833.9;Macrophages: 864.3;Urothelial cells: 2274.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1172.3" "Group enriched" "Detected in all" 4 "granulocytes: 1172.3;monocytes: 550.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 311.7;U-251 MG: 413.1;U-87 MG: 346.9;WM-115: 346.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050843, CAB073533" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA 4100000 "Plasma membrane" "CAB073533: , HPA050843: AB_2681255" "unprognostic (9.28e-2)" "unprognostic (9.65e-3)" "unprognostic (1.39e-1)" "unprognostic (1.29e-3)" "unprognostic (3.59e-3)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "prognostic unfavorable (2.33e-5)" "unprognostic (8.08e-3)" "unprognostic (4.30e-2)" "unprognostic (2.29e-3)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.83e-9)" "unprognostic (4.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.45e-2)" "unprognostic (9.33e-2)" 52.5 10.5 9.6 82.5 9.9 694.6 14.6 10.2 29.6 31.1 13.4 26.9 10.1 30.5 4.9 11.7 23.0 78.8 19.3 7.4 15.9 12.3 20.0 70.1 10.7 12.2 9.4 6.1 15.1 13.7 5.4 9.1 36.2 12.3 11.6 20.3 2.8 21.9 5.9 3.6 7.6 10.7 26.5 9.6 20.5 28.6 3.1 21.3 10.3 9.5 4.7 8.7 110.8 16.0 20.7 83.9 31.0 26.1 1.9 23.4 83.3 16.2 180.7 189.6 114.6 141.4 2.4 95.1 2.4 43.0 116.9 66.8 35.2 7.0 46.4 127.9 5.3 5.3 15.8 44.7 3.9 30.6 18.8 195.2 87.4 9.0 311.7 46.5 160.6 129.0 19.1 16.4 2.2 107.7 6.1 21.0 55.3 8.7 156.1 64.7 24.0 17.4 5.6 35.9 3.8 1.3 22.2 82.0 17.4 25.0 12.6 3.2 59.4 129.7 230.0 121.1 109.8 413.1 3.0 9.0 0.6 346.9 36.0 346.5 87.7 476.5 745.5 6.8 427.9 8.3 2.7 8.9 5.7 213.6 1.4 3.2 4.0 1172.3 6.7 550.7 69.3 3.6 253.9 9.6 9.9 10.2 29.6 7.4 15.9 12.2 9.4 6.1 12.3 9.6 21.3 20.7 23.1 73.7 76.6 2.3 15.5 105.2 820.7 274.2 72.3 0.7 45.8 22.5 4.5 24.3 151.9 20.2 0.0 6.5 17.4 314.5 1.9 219.3 0.9 188.1 68.0 64.9 14.8 5.2 2.5 106.5 58.8 145.4 156.0 519.1 305.2 4.2 19.2 1.7 428.9 10.1 3.3 85.3 22.4 155.4 1833.9 2.0 6.8 864.3 72.9 5.6 52.1 1.2 4.1 1.5 0.9 558.8 435.5 4.1 14.5 479.4 12.7 2.7 52.7 0.7 6.6 38.5 90.0 1.2 4.7 202.6 63.1 13.1 33.2 3.1 29.3 2274.4 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389821-36453791 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 267.0" "Group enriched" "Detected in many" 5 "Early spermatids: 156.4;Oligodendrocytes: 441.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HBF TERT88: 655.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.2 0.7 61.8 5.2 124.8 36.7 2.0 121.0 92.9 1.6 22.7 6.1 4.5 1.8 0.2 10.5 0.9 2.1 0.8 59.0 92.3 0.4 1.2 1.5 6.8 139.7 109.8 41.9 0.9 0.6 0.2 0.2 8.9 149.9 0.9 8.1 0.3 1.7 0.4 0.3 13.8 4.4 15.0 116.4 1.2 4.8 12.5 108.6 16.1 0.8 0.3 9.6 3.2 3.2 267.0 476.1 96.5 79.3 61.0 10.7 26.9 85.6 292.5 169.3 344.4 256.0 66.4 142.7 23.9 82.1 148.6 182.8 237.0 63.4 170.7 655.4 16.1 46.0 32.7 104.8 55.8 1.7 47.3 36.7 6.0 7.7 225.3 147.2 40.8 109.3 31.2 69.6 48.8 284.4 71.0 40.0 54.8 88.5 71.9 102.3 29.1 238.2 15.9 76.5 76.5 33.5 39.5 154.1 175.8 26.1 109.6 119.0 53.6 104.5 214.2 239.0 127.6 346.6 20.1 34.2 43.2 72.9 74.9 460.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 61.8 124.8 121.0 92.9 59.0 92.3 139.7 109.8 41.9 149.9 116.4 108.6 267.0 0.4 0.0 1.1 2.3 1.0 14.1 1.9 8.3 7.4 0.0 1.9 2.0 0.6 0.0 3.2 0.0 0.0 13.8 1.1 2.8 0.0 0.7 156.4 18.9 3.2 1.9 0.0 35.3 3.4 0.2 23.2 6.9 10.2 12.8 0.0 15.4 1.1 0.5 9.8 0.0 5.7 3.4 6.1 1.6 5.9 53.3 1.2 2.7 0.0 0.0 0.0 0.0 0.0 1.5 441.3 0.6 0.1 0.0 8.8 1.6 0.8 0.3 10.4 0.0 0.0 0.4 5.2 20.0 17.7 27.1 9.2 2.9 2.6 1.7 6.0 3.3 WIZ ZNF803 ENSG00000011451 "WIZ zinc finger" O95785 19 15419978-15449956 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: AB_2671308" "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 13.8 13.8 19.6 10.3 15.3 7.5 13.3 8.5 28.4 13.3 6.5 14.0 9.7 18.9 3.7 12.3 13.5 6.6 17.0 18.6 9.6 13.3 12.4 10.0 6.6 13.9 13.3 16.5 14.2 19.9 9.4 8.0 6.8 12.6 12.1 3.5 3.6 10.5 10.4 14.5 13.8 10.3 8.3 9.1 9.5 16.0 21.5 14.9 6.7 9.2 7.4 4.1 16.1 11.7 13.3 23.0 13.1 22.6 28.0 32.2 13.4 17.0 23.2 10.8 19.8 13.4 14.1 43.0 18.8 36.7 22.9 12.1 20.3 12.5 17.3 5.0 13.8 21.3 14.6 13.5 11.3 21.2 15.2 19.9 23.8 22.9 14.7 16.4 12.3 18.3 14.4 22.5 16.8 13.8 48.4 30.2 15.9 28.7 23.8 38.2 27.7 10.4 19.9 13.2 18.5 31.0 36.4 20.2 19.5 15.7 8.3 21.4 16.0 29.2 45.4 16.7 36.0 32.0 22.8 15.6 21.2 18.0 19.1 31.5 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.1 0.5 1.0 0.3 0.2 0.1 19.6 15.3 8.5 28.4 18.6 9.6 13.9 13.3 16.5 12.6 9.1 14.9 13.3 11.3 12.8 6.9 6.5 4.1 15.8 7.2 7.8 5.7 9.4 16.2 17.8 10.9 8.6 5.6 12.9 0.0 7.1 8.4 8.4 3.9 14.9 9.0 6.3 15.3 14.9 6.7 3.0 3.2 20.0 9.9 10.3 9.2 12.1 1.3 17.3 14.3 14.7 7.8 6.7 3.2 9.0 4.1 11.3 7.2 10.0 15.8 8.7 7.2 3.7 6.7 8.5 2.1 2.0 2.8 19.1 3.9 19.2 3.1 14.1 6.2 5.3 2.5 7.4 13.1 9.5 12.7 34.8 21.9 9.3 20.3 7.4 5.4 16.8 10.0 12.8 RABGAP1 "GAPCenA, TBC1D11" ENSG00000011454 "RAB GTPase activating protein 1" Q9Y3P9 9 122940833-123104866 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.1;Oligodendrocytes: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064860, HPA072273" Enhanced Enhanced Cytosol NA NA Cytosol "HPA064860: AB_2685372, HPA072273: AB_2686504" "prognostic unfavorable (8.09e-4)" "unprognostic (3.45e-1)" "unprognostic (3.85e-3)" "unprognostic (3.90e-1)" "unprognostic (4.16e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (5.19e-2)" "unprognostic (3.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.06e-6)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (8.72e-2)" "unprognostic (3.05e-2)" 22.7 15.7 28.4 17.0 29.4 7.4 21.9 24.8 31.5 22.0 20.3 33.1 12.3 29.1 25.6 32.0 22.1 19.1 26.6 28.8 28.4 20.1 11.8 19.5 19.7 28.7 30.8 25.9 24.0 16.5 31.5 16.9 21.6 29.8 29.7 22.9 25.1 24.5 30.4 34.8 23.6 17.4 32.0 27.7 18.6 21.8 22.0 28.3 19.8 39.6 31.0 19.5 26.2 22.0 31.3 19.5 25.7 39.6 33.0 44.8 36.2 24.5 20.0 35.8 30.3 28.2 29.9 18.6 26.6 15.6 31.3 40.4 64.7 25.6 25.0 32.4 25.1 15.4 20.8 40.4 22.9 38.3 17.2 17.5 35.2 37.6 26.1 29.3 43.5 34.8 26.2 18.3 19.9 36.9 43.3 22.5 13.5 14.6 55.7 19.6 36.7 72.3 23.0 25.2 21.3 22.3 17.2 35.7 31.9 18.6 29.5 60.7 9.4 26.9 25.6 15.1 28.3 20.3 19.3 33.9 27.7 24.0 8.7 22.9 3.4 1.3 1.8 0.9 2.1 0.7 1.1 0.9 0.9 1.1 1.4 1.6 1.1 2.1 0.8 1.0 1.5 1.2 0.5 28.4 29.4 24.8 31.5 28.8 28.4 28.7 30.8 25.9 29.8 27.7 28.3 31.3 47.2 25.6 50.8 115.2 26.6 18.0 23.0 20.8 40.5 44.9 26.7 26.4 46.9 11.5 31.9 11.0 50.1 25.5 26.0 24.9 3.9 11.8 15.4 31.5 30.3 33.1 16.9 17.0 179.1 14.5 8.7 22.9 18.3 47.7 14.0 34.2 27.1 15.4 15.9 57.2 129.7 16.7 24.4 28.6 14.4 17.5 40.7 25.1 14.2 78.7 35.9 33.6 33.0 101.0 147.7 13.0 18.6 51.6 11.9 39.7 11.7 10.1 30.6 34.6 85.5 31.0 51.4 73.8 37.4 27.6 17.3 41.6 16.4 22.5 21.6 27.8 DCN "DSPG2, SLRR1B" ENSG00000011465 Decorin P07585 12 91140484-91183217 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "basophil: 24.5" "Lineage enriched" "Detected in single" 35 "granulocytes: 24.5" "Cell line enhanced" "Detected in many" "ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "spinal cord: 544.7" "HPA003315, CAB017118, HPA064736, CAB068930" Enhanced "Secreted to extracellular matrix" NA NA 1900000 "CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (1.43e-1)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-2)" "unprognostic (2.68e-1)" "unprognostic (1.98e-1)" "unprognostic (6.12e-2)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "prognostic unfavorable (1.46e-5)" "unprognostic (3.06e-3)" "unprognostic (5.37e-2)" "unprognostic (1.59e-3)" "unprognostic (7.56e-3)" 1475.4 1182.8 61.9 274.4 69.6 4.4 2366.4 61.0 142.4 1505.7 244.3 555.1 165.0 1320.8 1313.4 941.4 1224.3 1818.6 1527.0 62.8 141.3 398.4 463.4 964.3 131.4 68.5 60.1 55.6 2705.6 260.1 80.9 112.9 1547.6 84.1 455.7 497.9 3.1 365.5 466.6 473.5 624.6 339.4 1036.7 68.6 20.1 438.2 282.0 69.0 184.7 483.3 1340.0 296.0 1914.0 790.3 65.1 0.2 0.4 4.4 0.6 3291.1 2371.6 6.2 608.7 2546.6 28.8 28.5 0.3 0.9 1.1 0.5 523.5 0.6 2.1 0.8 1.9 4.9 0.7 0.5 0.6 20.4 0.1 717.4 1.3 1.4 2289.4 8.9 78.3 38.5 12.1 1.0 0.2 0.8 0.7 63.0 0.6 1.5 10.8 1.2 0.4 1.6 0.7 2.3 2.8 3.4 0.5 2.7 11.9 10.3 1.1 0.9 1.8 0.6 0.4 0.9 132.3 1.2 497.5 0.6 3.3 3.1 2.0 8.0 2.0 0.8 24.5 0.3 0.6 0.3 0.1 0.3 0.3 0.3 0.2 0.1 0.6 0.4 0.4 2.7 0.4 0.2 0.7 0.2 0.0 61.9 69.6 61.0 142.4 62.8 141.3 68.5 60.1 55.6 84.1 68.6 69.0 65.1 351.1 41.7 44.1 2.3 4.1 609.1 5.4 0.0 264.6 1.9 25.5 31.5 154.7 10.0 11.8 20.2 0.0 31.2 12.8 0.0 1.9 1.0 25.0 39.4 1218.7 158.7 0.0 2.7 0.8 0.0 30.0 7960.2 54.0 22.0 21.5 0.2 214.9 1.4 58.8 0.0 17.1 0.1 0.0 2.8 962.7 103.0 6281.9 52.5 606.5 122.7 0.0 3.3 0.0 0.0 1.4 2.7 0.5 1856.9 23.2 5.8 0.0 0.4 5.8 0.7 210.4 236.8 408.2 13.4 9.2 36.8 482.5 63.9 72.3 70.2 0.0 10.7 QPCTL FLJ20084 ENSG00000011478 "Glutaminyl-peptide cyclotransferase like" Q9NXS2 19 45692403-45703989 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040797 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA040797: AB_10794148" "unprognostic (6.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.09e-1)" "unprognostic (7.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.26e-1)" "unprognostic (8.41e-3)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (3.14e-2)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.15e-8)" "unprognostic (1.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.02e-2)" "unprognostic (5.71e-2)" 4.0 7.9 3.8 3.1 3.9 4.1 4.9 3.5 4.7 4.7 3.8 5.1 4.8 4.8 3.8 4.7 4.9 2.5 3.2 4.2 4.0 5.3 9.2 6.3 4.8 4.4 3.8 4.3 6.6 7.5 4.4 7.0 3.8 4.8 6.5 3.9 2.1 6.8 3.5 1.5 5.2 5.5 2.5 3.1 8.6 6.1 4.4 4.1 2.4 6.7 0.8 3.5 4.6 4.5 4.9 16.7 10.8 8.5 36.9 8.6 4.1 6.4 10.3 15.7 15.0 24.7 11.2 12.3 19.7 11.1 11.5 15.4 9.5 10.0 11.9 8.9 5.0 12.7 6.7 10.9 24.6 14.6 7.5 12.0 7.6 14.9 12.6 17.3 10.7 13.6 10.8 9.7 32.1 9.5 13.0 7.0 7.7 5.5 14.2 5.4 7.8 6.4 16.5 16.2 8.0 7.6 4.7 10.6 8.8 18.2 3.7 6.4 10.6 8.4 7.4 12.4 7.3 10.4 28.6 20.2 18.2 26.0 17.2 5.8 1.4 0.3 0.2 1.4 0.5 0.9 0.9 0.6 0.3 0.8 0.6 0.5 0.7 1.3 1.4 0.3 1.0 0.3 0.2 3.8 3.9 3.5 4.7 4.2 4.0 4.4 3.8 4.3 4.8 3.1 4.1 4.9 0.5 0.0 1.5 2.3 3.3 1.3 1.2 1.1 0.6 1.1 0.7 0.6 0.8 1.5 1.2 0.0 0.0 0.8 2.1 1.2 0.0 0.6 5.4 0.9 1.4 0.7 0.0 1.3 5.5 0.4 1.4 0.7 1.5 1.4 5.7 0.7 0.0 1.3 0.9 1.7 6.5 0.4 0.0 0.6 1.8 1.3 0.0 1.6 1.8 0.0 0.7 0.3 1.0 3.5 1.6 0.6 0.1 0.0 9.8 1.2 0.7 0.1 2.2 2.4 0.0 0.6 1.1 1.0 0.3 1.4 1.1 0.8 2.4 1.5 1.0 0.5 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46347087-46392981 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol NA NA 120000 "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278" "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 26.9 37.8 23.8 17.8 26.3 14.4 26.5 25.1 36.8 26.7 22.8 30.4 17.0 35.2 9.9 30.6 32.0 13.4 52.0 25.6 25.4 29.2 33.0 28.2 19.9 28.1 25.9 24.7 24.9 23.9 32.8 36.9 15.9 30.3 23.9 15.6 14.5 23.2 18.3 59.4 27.3 26.1 21.0 21.6 33.8 33.9 17.0 26.9 20.7 26.4 46.1 15.1 28.0 26.5 32.1 61.9 114.9 66.0 50.1 48.3 50.9 30.6 75.4 59.6 88.2 78.2 82.4 47.9 94.3 39.9 54.0 48.4 49.9 86.2 88.5 24.7 65.9 120.5 76.4 80.9 59.4 54.5 106.6 52.8 47.8 40.9 62.1 45.9 34.2 77.2 79.3 76.0 47.3 49.4 67.5 59.5 203.4 50.2 109.6 61.7 89.0 56.6 76.5 52.8 81.8 93.1 69.7 62.6 78.8 26.9 28.6 49.7 67.8 65.5 38.3 64.3 29.1 79.1 38.0 93.0 111.5 41.7 89.4 65.9 0.0 10.3 3.0 27.8 18.0 17.8 15.1 12.8 22.0 16.8 11.7 12.2 16.8 0.2 22.0 23.4 11.7 14.3 15.4 23.8 26.3 25.1 36.8 25.6 25.4 28.1 25.9 24.7 30.3 21.6 26.9 32.1 28.1 6.4 12.5 22.9 16.5 9.4 16.6 20.9 19.9 19.7 13.1 13.5 5.6 44.3 14.2 16.5 16.7 26.4 12.3 25.2 33.2 29.9 1.2 31.3 25.2 19.6 14.9 11.6 18.5 19.5 36.2 17.6 26.0 19.6 4.5 18.6 24.3 24.9 21.6 16.8 23.2 17.0 22.4 12.3 8.2 3.2 17.4 11.9 16.0 11.2 12.1 21.0 17.5 17.6 14.5 26.4 17.0 18.4 25.5 12.1 16.3 21.4 14.6 17.9 39.5 14.6 19.9 26.6 32.0 20.8 13.2 25.7 20.4 23.1 25.0 11.7 CEP68 KIAA0582 ENSG00000011523 "Centrosomal protein 68" Q76N32 2 65056366-65087004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040493, HPA040620" Enhanced Supported "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA040493: AB_10673411, HPA040620: AB_10794144" "unprognostic (7.99e-2)" "unprognostic (6.15e-2)" "unprognostic (5.09e-2)" "unprognostic (4.90e-3)" "unprognostic (1.31e-2)" "unprognostic (1.75e-2)" "unprognostic (4.84e-3)" "unprognostic (8.25e-3)" "unprognostic (9.94e-2)" "unprognostic (5.09e-2)" "unprognostic (9.22e-2)" "unprognostic (1.77e-1)" "prognostic favorable (3.93e-4)" "unprognostic (2.25e-1)" "unprognostic (2.50e-1)" "unprognostic (8.45e-2)" "unprognostic (1.71e-1)" 14.2 5.9 10.9 7.0 11.5 4.7 14.2 13.9 11.4 15.4 8.3 10.3 5.5 17.1 6.2 9.9 13.8 10.2 14.0 12.3 9.6 6.8 2.6 7.9 10.1 10.8 9.8 11.4 21.8 9.2 10.0 5.9 10.2 11.1 11.1 7.1 7.4 10.8 12.5 27.0 11.8 7.5 14.5 8.0 9.3 8.2 6.0 10.1 10.7 9.7 27.9 8.6 10.4 10.6 11.3 3.9 6.9 13.2 9.7 11.6 13.0 24.2 3.7 6.5 5.6 4.9 5.4 3.4 6.6 4.5 6.7 5.7 5.3 8.7 5.6 5.8 8.0 7.5 9.0 2.5 6.5 3.2 5.1 6.1 12.3 7.8 5.1 7.1 9.8 16.1 13.5 8.4 20.7 7.1 4.5 8.6 9.4 13.3 7.1 5.5 8.9 15.9 7.8 5.0 5.1 23.1 15.7 7.3 5.3 7.9 8.0 3.1 3.3 6.4 5.2 7.1 8.2 3.7 22.4 6.5 15.3 2.8 3.9 6.4 0.9 1.3 0.3 2.3 2.5 2.6 2.6 5.4 4.3 3.5 3.6 8.3 5.2 1.1 4.4 5.0 7.2 4.4 2.5 10.9 11.5 13.9 11.4 12.3 9.6 10.8 9.8 11.4 11.1 8.0 10.1 11.3 72.0 28.9 10.9 17.9 13.2 7.1 14.2 15.5 22.2 26.7 11.8 13.6 16.7 8.6 15.5 9.2 25.0 15.4 15.4 3.6 9.8 10.3 3.7 11.2 22.2 47.1 13.1 7.2 28.8 21.4 7.5 17.8 9.2 19.8 6.3 24.9 28.5 6.9 9.4 23.5 31.6 5.8 8.2 7.2 14.4 6.2 37.9 18.9 7.2 22.5 18.4 15.5 8.2 22.6 21.2 8.9 4.3 27.1 6.9 8.9 2.8 9.0 15.0 21.3 32.9 30.5 18.5 11.6 23.9 10.1 5.8 34.1 16.1 9.9 11.2 7.3 MAP4K3 "GLK, MAPKKKK3, RAB8IPL1" ENSG00000011566 "Mitogen-activated protein kinase kinase kinase kinase 3" Q8IVH8 2 39249266-39437301 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 118.8;Excitatory neurons: 201.0;Inhibitory neurons: 198.3;Microglial cells: 144.3;Oligodendrocyte precursor cells: 160.4;Oligodendrocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "AF22: 102.3;RT4: 97.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030380 Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA030380: AB_10601132" "unprognostic (4.82e-2)" "unprognostic (7.22e-2)" "unprognostic (5.87e-3)" "unprognostic (7.34e-3)" "unprognostic (6.77e-2)" "unprognostic (2.57e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.66e-1)" "unprognostic (6.73e-2)" "unprognostic (4.33e-3)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (2.43e-1)" "unprognostic (5.08e-2)" 14.8 17.3 13.4 6.8 14.3 10.6 16.8 23.7 16.9 15.1 16.6 13.6 13.3 17.4 13.5 10.3 13.7 14.8 19.4 15.5 14.2 24.7 15.2 13.5 6.1 12.0 12.1 13.1 20.4 12.3 25.5 12.3 27.6 13.6 17.1 13.1 28.3 10.9 14.1 31.2 16.5 14.5 14.6 12.2 11.7 26.9 21.5 11.7 8.2 24.6 22.4 6.1 18.5 11.4 16.2 25.6 15.6 102.3 16.3 16.3 32.4 28.0 22.1 28.3 21.6 18.3 13.3 12.6 5.5 24.3 15.3 22.1 13.6 39.0 19.7 32.6 6.3 16.0 9.2 10.8 30.9 42.3 4.0 14.5 29.3 19.0 28.1 30.1 22.6 18.8 5.0 12.1 9.9 29.2 13.9 9.0 6.0 30.7 24.0 23.4 9.9 33.3 4.2 28.3 97.3 18.2 20.7 12.9 20.7 58.8 32.0 13.9 5.6 15.4 16.7 19.7 15.0 12.1 15.1 9.3 1.9 20.5 6.6 19.0 0.7 0.1 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 13.4 14.3 23.7 16.9 15.5 14.2 12.0 12.1 13.1 13.6 12.2 11.7 16.2 36.2 3.2 8.4 118.8 8.1 17.6 17.9 11.0 16.5 24.7 14.1 12.3 38.2 21.5 16.5 22.0 25.0 13.1 4.1 12.5 19.6 10.3 45.1 22.3 19.9 20.6 9.6 4.6 201.0 12.4 6.7 18.2 25.5 59.4 2.5 15.6 14.3 18.6 9.7 6.7 198.3 13.9 2.0 10.9 20.6 103.0 20.8 14.4 5.4 144.3 4.4 13.2 3.1 160.4 129.2 17.5 5.7 17.7 14.3 18.6 14.0 11.9 19.5 37.9 19.7 18.7 17.6 22.6 19.8 11.8 19.2 10.4 5.9 17.4 10.6 30.2 ZBTB32 "FAXF, FAZF, Rog, TZFP, ZNF538" ENSG00000011590 "Zinc finger and BTB domain containing 32" Q9Y2Y4 19 35704558-35717038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 49.4" "Cell type enhanced" "Detected in some" "B-cells: 24.0;Early spermatids: 39.6;granulocytes: 17.7;Late spermatids: 73.0;Plasma cells: 25.6;Spermatocytes: 115.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Immune cell enhanced" "Detected in some" "memory B-cell: 10.5" "Lineage enriched" "Detected in many" 5 "B-cells: 10.5" "Cell line enhanced" "Detected in some" "HDLM-2: 4.3;hTEC/SVTERT24-B: 2.0;U-266/70: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076730 Enhanced NA NA "HPA076730: AB_2732320" "unprognostic (2.11e-3)" "unprognostic (1.08e-4)" "unprognostic (3.87e-2)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-5)" "unprognostic (2.59e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (1.63e-3)" "unprognostic (1.01e-2)" "unprognostic (3.78e-1)" "unprognostic (1.02e-8)" "unprognostic (2.44e-3)" "unprognostic (2.25e-1)" "unprognostic (6.26e-5)" "unprognostic (1.94e-3)" 0.1 0.2 0.2 2.0 0.1 0.6 0.0 1.5 0.3 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.3 3.4 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.2 0.4 0.0 0.0 0.1 1.7 0.1 0.0 2.6 0.5 49.4 0.1 0.3 0.1 0.0 1.3 0.5 0.0 0.3 0.7 0.6 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.1 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.4 0.1 0.3 0.0 1.2 1.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.5 0.6 0.0 3.8 0.1 0.3 0.0 0.0 0.0 0.0 2.3 0.6 0.2 0.1 1.5 0.3 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.3 0.1 0.0 1.3 0.0 24.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 39.6 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.5 0.0 17.7 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 73.0 1.2 0.3 1.8 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 1.2 25.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 115.5 0.8 0.0 0.0 0.0 4.1 0.0 0.1 0.0 TYROBP "DAP12, KARAP, PLO-SL, PLOSL" ENSG00000011600 "Transmembrane immune signaling adaptor TYROBP" O43914 19 35904401-35908295 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 602.1;lymphoid tissue: 426.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 6415.4" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 9 "HMC-1: 678.1;THP-1: 390.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009493, HPA041899" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB009493: AB_638987, HPA041899: AB_10795266" "unprognostic (7.09e-2)" "unprognostic (8.38e-3)" "unprognostic (7.87e-2)" "unprognostic (4.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (5.27e-2)" "unprognostic (8.04e-2)" "unprognostic (2.07e-2)" "unprognostic (2.47e-1)" "unprognostic (2.91e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.47e-2)" "unprognostic (1.72e-2)" "unprognostic (4.27e-2)" "unprognostic (4.39e-2)" 119.5 76.8 56.8 236.3 62.5 602.1 59.6 61.9 117.7 44.6 72.1 62.6 71.2 26.1 15.2 28.3 44.1 105.9 35.5 54.1 86.0 34.5 86.2 263.7 162.4 79.6 61.7 49.4 18.4 24.9 22.2 27.2 125.7 76.0 31.9 50.2 4.0 38.7 26.9 10.7 21.0 79.4 68.6 82.2 426.7 43.5 15.1 75.0 52.9 22.1 31.9 36.9 132.9 21.7 94.1 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 56.7 0.0 0.0 0.5 33.2 678.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 49.1 0.3 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.9 0.0 390.6 0.0 0.0 0.3 0.8 0.1 0.4 0.1 1.0 0.1 10.8 0.1 974.2 4983.5 2573.9 468.0 3367.8 246.5 22.4 9.5 64.2 1912.0 8.4 11.7 51.2 6415.4 1664.1 3413.8 1653.1 9.5 5260.2 56.8 62.5 61.9 117.7 54.1 86.0 79.6 61.7 49.4 76.0 82.2 75.0 94.1 24.5 57.7 168.4 0.0 50.9 55.2 2.0 0.0 1.2 0.1 11.5 43.3 6.8 34.3 43.4 20.2 0.0 19.8 987.6 1.7 1.9 2.1 3.9 1.3 1.4 47.1 0.0 87.8 0.1 5.8 28.0 24.9 5.6 1.5 753.7 0.3 73.2 25.0 3777.1 0.0 0.1 0.2 0.0 3698.1 1990.8 11.6 9.3 2837.1 56.9 18.7 3371.2 0.6 1772.4 0.0 0.1 1.3 2.3 1.2 19.4 1.5 0.5 8.9 20.5 1.8 78.9 5.3 10.0 0.9 3.0 4.9 44.6 38.9 236.5 0.1 0.5 1.8 TMEM159 promethin ENSG00000011638 "Transmembrane protein 159" Q96B96 16 21158377-21180616 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 121.2;Basal squamous epithelial cells: 176.4;Squamous epithelial cells: 127.5;Suprabasal keratinocytes: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 67.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018033, HPA063509" Approved Approved Vesicles NA NA Vesicles "HPA018033: AB_2204762, HPA063509: AB_2685026" "unprognostic (7.62e-3)" "unprognostic (2.42e-1)" "unprognostic (1.99e-2)" "unprognostic (1.06e-1)" "unprognostic (8.68e-2)" "unprognostic (6.80e-2)" "unprognostic (3.32e-1)" "unprognostic (2.93e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-3)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (8.11e-5)" "unprognostic (8.28e-2)" "unprognostic (1.28e-1)" "unprognostic (1.84e-2)" "unprognostic (1.57e-2)" 32.0 33.2 3.5 5.4 7.8 3.2 27.2 6.1 4.0 39.2 2.5 36.5 4.4 28.8 8.0 62.4 26.5 20.3 71.0 3.3 4.1 16.5 2.6 20.1 11.8 2.7 3.6 3.9 41.1 12.5 14.2 3.3 4.0 3.4 22.3 12.2 5.7 37.1 10.5 129.7 95.3 18.0 17.9 3.2 7.2 21.3 10.5 4.6 5.1 15.6 101.5 16.9 48.3 57.8 3.1 14.3 7.1 7.6 28.7 67.9 44.1 3.4 7.4 27.6 2.9 4.9 5.6 21.4 20.2 7.9 21.6 12.9 23.1 11.7 13.0 3.4 7.7 4.5 9.1 1.9 11.1 15.4 7.2 24.2 17.3 58.8 15.4 48.1 12.2 15.0 10.8 6.9 6.1 5.8 25.2 5.6 6.7 7.0 14.1 3.5 28.9 4.2 7.3 38.1 41.1 1.2 1.1 18.2 25.8 9.8 13.5 46.0 6.5 10.6 5.4 5.4 25.6 1.9 0.5 1.7 7.2 22.2 6.4 5.3 19.5 8.8 7.0 9.7 6.9 9.8 12.2 12.7 8.2 5.4 9.6 9.9 9.6 3.9 7.3 10.3 14.3 14.8 6.6 3.5 7.8 6.1 4.0 3.3 4.1 2.7 3.6 3.9 3.4 3.2 4.6 3.1 17.3 9.6 20.9 0.0 12.9 121.2 38.5 31.9 176.4 1.0 53.3 55.2 59.4 15.7 31.8 22.0 0.0 4.8 9.1 34.5 7.9 19.7 0.8 11.4 12.8 13.7 14.5 11.8 1.9 21.3 2.1 44.3 19.4 19.3 15.8 14.0 17.5 0.2 10.2 1.7 0.8 30.6 12.2 15.7 39.0 2.2 67.4 13.8 30.2 4.7 22.7 44.7 7.2 1.0 0.1 24.7 41.8 37.2 3.8 45.3 23.1 21.1 11.2 1.5 32.9 26.5 35.7 2.0 9.9 127.5 150.2 1.9 14.8 5.1 29.9 66.6 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor subunit alpha3" P34903 X 152166234-152451315 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.6;choroid plexus: 13.6;retina: 9.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000839, HPA029363" Approved Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA000839: AB_1078929, HPA029363: " "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.0 0.0 6.7 0.0 14.6 0.0 0.0 0.0 13.2 0.9 13.6 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 8.6 10.2 0.0 0.0 0.0 0.0 1.2 3.7 10.1 0.0 0.0 0.0 0.6 2.9 2.1 0.1 0.0 9.1 0.1 0.7 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.7 7.3 0.0 0.0 0.0 0.1 0.4 0.2 4.2 0.0 0.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 14.4 0.0 0.0 0.0 0.0 2.6 6.4 8.4 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 5.3 0.4 0.3 0.1 1.3 0.1 5.3 7.0 0.3 1.6 7.7 13.6 0.0 8.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.6 0.0 13.2 8.6 10.2 1.2 3.7 10.1 2.1 0.2 7.3 4.2 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.6 1.2 0.0 0.0 0.3 0.0 0.0 0.0 2.1 3.2 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.0 0.0 70.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.2 1.7 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 3.0 0.0 58.3 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 1.2 0.9 0.0 1.9 0.0 0.0 0.0 0.5 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1 DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3" "Group enriched" "Detected in all" 6 "dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611" "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 3.1 1.8 3.9 7.6 6.8 13.2 3.6 4.4 4.5 2.7 2.6 6.9 3.2 3.1 2.3 4.1 3.8 1.9 3.1 3.3 3.6 2.0 5.7 3.2 10.4 5.7 5.2 2.7 2.8 2.8 6.0 2.9 3.9 5.7 2.4 7.5 8.3 3.2 1.7 4.3 6.1 5.1 3.9 3.7 3.9 3.7 13.1 4.7 14.7 7.8 3.7 11.2 2.9 2.4 10.8 44.1 69.1 37.8 30.1 6.0 13.4 36.6 50.6 21.5 41.9 39.3 42.3 33.4 100.8 9.1 19.0 49.0 49.5 51.9 28.3 69.5 46.9 38.0 48.1 54.0 37.1 1.3 86.0 39.9 3.8 4.5 63.1 20.0 10.6 22.3 46.6 73.7 42.2 39.7 30.0 72.0 27.8 20.5 29.1 18.7 49.0 79.8 40.8 15.4 42.1 25.8 27.4 38.8 12.5 19.4 25.5 33.9 39.6 13.8 37.2 29.6 49.0 53.2 20.1 51.2 75.5 29.6 49.6 39.4 6.8 14.7 2.2 1.5 4.7 1.5 1.2 1.5 1.2 10.9 2.1 1.3 1.5 11.3 1.5 2.0 1.7 0.5 17.5 3.9 6.8 4.4 4.5 3.3 3.6 5.7 5.2 2.7 5.7 3.7 4.7 10.8 5.0 0.0 2.8 9.4 5.8 2.9 4.5 1.9 1.2 10.3 4.4 5.2 10.1 5.7 3.5 1.8 22.9 12.8 8.1 6.2 0.0 3.0 11.9 14.0 6.3 4.7 0.0 42.5 3.0 1.1 18.2 7.4 6.1 4.2 8.2 38.2 5.3 18.3 10.1 11.8 4.4 7.5 0.0 3.9 2.8 8.0 2.5 6.4 0.0 4.7 4.9 2.4 5.2 3.0 18.7 1.7 2.4 1.5 16.6 2.3 1.1 1.0 10.0 22.8 6.6 13.7 5.5 105.8 73.5 8.2 2.3 4.0 4.7 9.7 12.7 3.4 ERCC1 RAD10 ENSG00000012061 "ERCC excision repair 1, endonuclease non-catalytic subunit" P07992 19 45407334-45478828 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cataract" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004390, HPA029773, HPA050182, CAB072859, CAB072860" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044" "unprognostic (1.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.41e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.57e-1)" "unprognostic (5.80e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (6.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" 45.9 50.2 34.1 28.2 33.9 31.7 51.1 37.2 42.9 50.0 40.9 41.2 26.5 48.3 40.6 43.5 44.0 30.6 105.5 35.1 34.5 48.3 38.6 40.8 30.2 36.2 34.9 32.0 54.6 57.6 49.3 57.4 23.1 37.4 55.6 20.9 23.4 71.2 29.5 84.7 62.8 40.5 33.7 35.9 43.4 43.3 28.0 36.6 24.3 47.3 83.9 30.7 41.9 44.7 38.3 61.1 104.0 84.2 125.8 57.8 108.1 27.3 90.1 119.1 106.4 141.4 12.0 58.8 34.5 24.9 94.2 57.2 45.0 26.0 277.7 65.1 79.1 28.6 57.9 39.3 36.2 120.2 55.9 96.8 81.0 60.3 111.7 99.5 89.0 117.3 40.8 33.8 69.8 167.9 40.3 50.9 44.4 20.9 54.4 42.4 77.7 40.5 46.3 78.5 36.7 36.6 76.2 58.4 47.3 79.6 27.7 55.0 103.7 70.3 97.7 91.4 59.2 93.8 49.5 43.2 39.5 105.3 45.8 296.6 30.7 131.9 26.3 61.3 142.8 41.7 75.8 37.3 48.6 134.7 84.1 29.4 47.4 17.8 60.6 107.9 315.8 49.8 90.2 34.1 33.9 37.2 42.9 35.1 34.5 36.2 34.9 32.0 37.4 35.9 36.6 38.3 43.2 22.4 36.3 13.1 53.4 70.9 109.7 82.7 41.5 0.0 73.9 76.8 39.1 37.1 43.9 20.2 0.0 36.1 67.8 26.9 90.1 54.5 27.1 50.4 43.5 37.5 39.6 20.2 32.9 65.9 33.3 62.4 22.4 24.5 50.0 103.4 38.9 29.6 96.2 0.0 21.9 41.2 34.6 61.5 71.7 107.1 79.2 69.6 67.6 17.8 49.0 0.0 38.1 16.6 13.8 85.3 33.5 57.2 49.1 94.9 69.2 73.1 67.5 0.0 46.0 60.5 60.0 37.0 37.1 51.4 52.8 35.6 36.0 98.6 43.2 89.0 CD22 "SIGLEC-2, SIGLEC2" ENSG00000012124 "CD22 molecule" P20273 19 35319261-35347361 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 141.7;lymphoid tissue: 232.1;ovary: 134.0" "Group enriched" "Detected in many" 7 "B-cells: 143.6;granulocytes: 95.8;Granulosa cells: 51.3;Oligodendrocytes: 91.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 24 "memory B-cell: 97.6;naive B-cell: 120.3" "Lineage enriched" "Detected in many" 26 "B-cells: 120.3" "Cell line enhanced" "Detected in some" "Daudi: 280.6;REH: 83.8;U-698: 219.9;WM-115: 50.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB002418, HPA024353, HPA066523" Enhanced NA NA 13000 "CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: " "unprognostic (2.80e-3)" "unprognostic (3.99e-2)" "unprognostic (6.79e-3)" "unprognostic (9.17e-2)" "unprognostic (3.07e-1)" "unprognostic (6.45e-3)" "unprognostic (3.79e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.47e-1)" "unprognostic (1.75e-3)" "unprognostic (1.98e-2)" "unprognostic (1.48e-2)" "unprognostic (9.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" 2.7 5.5 42.8 76.0 62.3 13.7 1.8 40.9 51.2 2.8 17.9 5.0 2.3 3.7 2.5 2.2 31.2 4.2 1.3 39.2 45.2 2.0 1.5 7.5 220.9 58.8 52.8 30.1 134.0 0.6 0.7 2.1 1.9 64.2 2.9 6.4 0.0 3.6 1.1 0.2 0.2 53.8 2.1 43.7 162.9 7.0 3.9 54.6 11.5 6.3 0.4 232.1 5.7 1.6 141.7 0.9 1.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.4 0.0 5.1 280.6 5.6 0.3 15.0 0.5 0.0 0.0 0.1 1.5 0.0 0.0 0.2 2.2 0.1 0.3 12.4 0.0 0.0 0.2 4.1 0.1 0.0 0.0 1.5 0.1 2.6 0.5 0.1 0.0 0.1 0.4 0.4 83.8 0.3 0.2 0.0 0.0 0.0 0.0 0.3 1.4 6.6 0.2 0.5 0.1 0.3 2.6 1.5 0.0 0.0 0.0 0.1 219.9 2.2 0.9 50.1 0.1 0.1 0.1 0.0 1.1 0.0 97.6 0.0 0.0 4.6 120.3 0.0 0.0 1.0 0.2 0.7 3.8 0.0 4.9 42.8 62.3 40.9 51.2 39.2 45.2 58.8 52.8 30.1 64.2 43.7 54.6 141.7 1.7 3.2 3.0 0.0 143.6 0.3 0.4 0.0 0.0 0.0 1.0 3.3 0.7 0.0 0.6 0.0 0.0 0.2 4.1 0.1 0.0 0.0 0.6 0.2 0.4 2.1 0.0 2.7 0.3 0.2 1.3 2.8 0.5 0.5 95.8 51.3 3.3 0.2 6.8 0.0 0.3 0.0 0.0 5.6 2.0 0.2 3.7 6.9 1.8 0.0 0.9 0.0 1.0 0.0 91.5 0.2 0.1 0.7 2.3 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.8 0.4 1.1 0.0 0.4 0.1 4.1 12.2 0.0 0.1 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 175.9;brain: 176.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 163.5;Distal enterocytes: 129.1;Gastric mucus-secreting cells: 208.0;Oligodendrocytes: 157.8;Proximal enterocytes: 336.4;Syncytiotrophoblasts: 111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 73.7;Hep G2: 105.7;SK-BR-3: 54.5;WM-115: 173.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 27.9" HPA030651 Uncertain "Secreted in other tissues" NA NA 790000 "HPA030651: AB_10602224" "prognostic favorable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 23.9 175.9 46.4 9.0 105.6 0.2 17.4 78.4 57.6 40.2 28.6 46.8 41.6 46.1 2.2 9.2 37.3 10.1 30.8 42.3 66.0 70.5 6.2 49.6 0.3 115.5 95.0 22.9 24.8 41.8 10.7 10.5 35.6 134.8 34.2 10.6 2.0 12.8 20.8 7.4 7.7 63.3 14.3 81.8 5.2 57.3 14.9 88.0 0.6 24.4 8.8 0.3 19.8 32.6 176.3 12.7 8.2 0.8 8.0 0.6 1.0 2.0 16.3 22.3 4.7 7.9 5.5 29.7 0.0 14.3 15.3 0.0 1.8 0.4 26.2 1.8 0.2 0.7 0.0 73.7 105.7 16.8 0.0 0.8 5.1 0.5 5.4 4.1 19.9 0.0 0.1 0.2 2.2 0.8 22.4 0.0 0.7 1.1 23.4 4.5 0.3 1.2 0.6 7.4 1.4 1.0 3.8 4.2 54.5 9.2 2.4 3.6 0.1 0.5 1.3 15.4 4.3 5.3 4.4 0.2 0.2 7.9 0.2 173.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 105.6 78.4 57.6 42.3 66.0 115.5 95.0 22.9 134.8 81.8 88.0 176.3 6.5 163.5 18.6 45.1 1.8 0.0 8.3 0.0 6.2 3.7 19.3 8.5 14.5 44.3 18.6 64.4 0.0 3.6 1.2 129.1 1.9 38.3 11.2 29.8 11.6 6.1 10.3 0.0 0.6 23.1 1.0 35.3 208.0 73.1 11.4 11.4 5.7 1.2 1.9 0.0 0.8 45.7 0.0 1.6 0.0 21.4 4.1 2.8 0.0 12.2 0.7 17.3 0.0 3.0 157.8 32.5 79.9 3.0 0.6 14.1 336.4 40.4 5.1 1.6 6.6 19.0 7.5 6.6 11.4 2.0 0.0 111.6 2.4 0.2 31.5 32.7 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839617-21885423 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 8.7 10.7 4.2 5.2 4.5 1.7 8.9 8.3 5.0 7.5 4.7 5.1 5.3 9.8 6.0 5.8 7.3 6.8 7.8 4.1 4.6 9.5 18.8 5.5 5.0 4.9 5.0 3.8 12.6 7.4 11.1 3.8 11.7 5.3 10.6 6.1 8.8 6.7 8.5 7.2 3.7 4.2 10.2 4.5 4.9 5.8 4.2 4.6 4.9 9.1 9.1 4.8 6.8 4.0 6.5 16.9 34.5 16.1 16.5 19.8 24.4 7.7 24.4 24.7 22.7 19.7 13.8 22.5 14.6 12.4 26.2 44.4 15.4 22.4 14.0 27.9 10.9 17.8 7.2 19.7 11.4 27.1 15.6 6.8 23.2 14.8 34.3 25.1 23.0 17.8 8.4 20.3 15.8 26.1 10.5 6.4 8.1 15.0 8.8 25.1 7.9 29.8 16.4 15.7 8.4 3.9 32.8 34.3 21.5 30.5 21.3 28.9 13.2 21.2 28.4 6.6 41.9 18.5 19.1 26.0 6.9 31.6 6.4 28.0 0.0 2.2 0.8 2.2 2.5 2.0 1.9 1.6 2.0 3.6 1.7 2.2 2.6 0.2 2.6 2.6 2.4 3.2 1.7 4.2 4.5 8.3 5.0 4.1 4.6 4.9 5.0 3.8 5.3 4.5 4.6 6.5 5.5 9.6 11.5 16.6 5.8 5.5 4.8 7.0 8.0 11.8 7.5 5.1 13.3 8.6 7.1 7.3 18.8 7.0 2.2 3.8 0.0 5.9 0.3 4.0 11.5 5.6 2.4 2.1 16.8 8.9 7.1 10.8 6.1 3.7 10.8 14.5 7.5 18.7 9.4 30.3 25.0 3.4 12.2 9.2 4.0 1.9 10.5 4.8 10.6 11.2 5.0 7.3 3.1 21.6 22.2 6.1 2.4 13.2 9.1 7.4 4.9 7.2 10.7 14.5 0.0 8.6 8.3 2.7 1.5 6.5 2.7 4.8 5.1 12.3 4.3 4.9 PRICKLE3 LMO6 ENSG00000012211 "Prickle planar cell polarity protein 3" O43900 X 49174802-49186528 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 60.8;Late spermatids: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA000998 Uncertain NA NA "HPA000998: AB_1079258" "unprognostic (9.83e-3)" "unprognostic (7.02e-2)" "unprognostic (6.97e-3)" "unprognostic (2.54e-1)" "unprognostic (1.12e-2)" "unprognostic (5.61e-2)" "unprognostic (2.53e-2)" "unprognostic (2.55e-1)" "unprognostic (1.89e-1)" "unprognostic (2.41e-2)" "unprognostic (3.78e-2)" "unprognostic (1.14e-3)" "prognostic unfavorable (5.73e-6)" "unprognostic (2.28e-3)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.84e-5)" 4.2 3.9 2.2 3.6 2.2 2.2 4.0 2.3 2.6 4.1 3.6 3.7 3.0 4.1 1.7 10.3 4.7 2.9 5.7 1.8 3.8 2.5 3.1 4.1 3.4 2.4 2.3 1.5 2.6 5.1 4.1 2.2 3.8 2.4 4.6 3.0 0.6 4.6 5.8 11.7 12.1 3.5 3.3 2.6 3.8 4.0 1.1 2.4 3.5 4.0 10.6 4.5 5.1 6.7 2.8 17.7 20.3 0.5 1.7 8.4 9.1 19.0 6.8 10.2 5.1 7.9 6.2 10.9 0.0 6.1 8.4 1.6 24.8 15.6 25.1 2.3 21.9 8.4 7.4 12.2 4.7 12.2 5.0 24.3 8.3 19.3 6.4 15.7 3.3 5.3 4.5 12.4 6.6 8.6 27.8 6.0 7.4 3.0 10.6 21.7 8.3 5.3 9.8 6.7 24.7 3.4 0.0 9.4 8.6 6.7 6.0 17.4 5.6 6.2 0.1 8.0 7.2 2.6 11.6 8.3 4.1 8.0 6.6 0.1 2.4 8.3 9.2 2.3 9.1 3.2 7.0 3.1 3.8 7.5 4.1 2.5 2.6 4.7 3.0 12.1 3.5 4.2 5.1 2.2 2.2 2.3 2.6 1.8 3.8 2.4 2.3 1.5 2.4 2.6 2.4 2.8 2.7 0.0 1.5 1.0 4.2 15.2 5.5 13.7 10.8 0.3 1.4 2.2 1.5 0.0 6.6 1.8 2.1 3.2 1.0 1.9 1.9 3.4 60.8 2.7 2.0 3.2 1.2 2.5 0.2 2.7 6.8 2.8 6.6 2.4 0.0 1.7 1.4 1.4 2.5 0.0 0.1 3.3 8.2 1.3 8.1 100.8 1.5 2.8 8.8 0.0 2.9 0.9 1.0 2.0 1.0 2.2 2.7 0.7 3.2 4.8 1.7 2.0 3.3 0.2 0.0 1.5 2.6 0.4 0.5 15.9 19.0 3.3 2.2 2.2 2.5 4.6 LTF HLF2 ENSG00000012223 Lactotransferrin P02788 3 46435645-46485234 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport" "Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 4295.9;salivary gland: 1172.0" "Cell type enriched" "Detected in many" 5 "Breast glandular cells: 1519.6" "Group enriched" "Detected in all" 5 "breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "neutrophil: 5.4;non-classical monocyte: 17.0" "Group enriched" "Detected in many" 23 "granulocytes: 5.4;monocytes: 17.0" "Group enriched" "Detected in some" 11 "RPMI-8226: 43.2;TIME: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB008646, CAB016201, HPA057177, HPA059976" Enhanced "Secreted to blood" NA NA 350000000 "CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185" "unprognostic (7.24e-3)" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (3.41e-2)" "unprognostic (7.14e-3)" "unprognostic (3.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (3.43e-1)" "unprognostic (1.04e-1)" "prognostic favorable (6.30e-5)" "unprognostic (1.66e-2)" "unprognostic (3.53e-1)" "unprognostic (2.05e-1)" "unprognostic (9.09e-3)" 4.9 1.2 2.3 36.4 3.2 4295.9 336.8 6.5 4.2 663.9 2.5 2.8 1.2 4.2 158.8 23.2 4.4 7.6 4.2 3.0 6.8 102.3 3.3 29.7 8.7 4.6 20.2 0.7 0.5 18.8 6.2 7.0 3.1 10.5 155.5 2.2 0.9 1172.0 382.4 1.7 11.9 5.2 1.9 7.2 71.0 334.6 0.4 16.1 30.0 10.2 1.7 348.4 2.4 1.2 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.6 43.2 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 14.3 0.0 0.3 1.2 0.1 0.6 0.0 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 17.0 0.4 0.0 29.5 2.3 3.2 6.5 4.2 3.0 6.8 4.6 20.2 0.7 10.5 7.2 16.1 9.6 15.5 0.0 2.8 0.7 4.3 1.1 8.6 82.8 0.0 0.0 1519.6 198.4 1.0 2.8 298.0 71.7 0.0 0.0 6.2 0.1 0.0 1.4 1.2 0.3 0.2 8.8 0.0 3.0 0.1 0.9 0.2 2.5 56.1 2.3 1.3 0.1 5.0 0.0 0.0 0.0 0.0 0.2 14.2 0.0 0.7 1.5 5.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.1 78.6 0.0 18.6 14.9 0.0 0.0 0.3 9.9 0.2 0.1 15.4 0.1 0.1 4.0 0.1 0.1 101.7 EXTL3 "botv, REGR" ENSG00000012232 "Exostosin like glycosyltransferase 3" O43909 8 28600469-28755599 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025387 Approved NA NA "CAB025387: " "unprognostic (1.35e-1)" "unprognostic (1.31e-1)" "unprognostic (5.53e-2)" "unprognostic (1.19e-3)" "unprognostic (9.83e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (4.25e-2)" "unprognostic (9.29e-3)" "unprognostic (1.05e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-3)" "prognostic favorable (2.47e-5)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (8.91e-2)" "unprognostic (1.39e-2)" 10.9 16.7 10.1 7.3 11.0 3.8 6.4 6.6 12.6 8.6 3.9 9.4 5.6 13.9 5.5 12.4 11.4 8.0 31.4 12.9 9.5 6.6 6.2 8.7 5.4 9.1 13.2 10.3 10.1 12.0 19.0 10.4 14.0 8.7 8.6 5.5 11.3 8.2 11.9 21.0 11.2 6.8 18.0 7.8 8.7 9.0 10.4 16.6 6.5 7.8 22.9 4.8 10.6 7.3 11.6 45.3 33.6 70.1 37.0 18.8 18.5 15.6 33.7 32.6 20.3 16.4 28.9 15.9 12.2 46.6 40.1 28.2 29.7 34.5 55.1 22.4 8.9 18.9 17.2 15.7 14.3 9.8 8.6 46.9 22.2 36.7 15.9 14.6 16.9 44.3 17.4 16.2 15.4 16.5 8.5 15.5 4.7 49.2 13.3 13.6 18.4 31.3 7.1 31.2 29.0 15.2 26.6 14.3 8.6 17.3 22.0 8.4 9.4 34.9 26.6 62.7 25.4 28.9 7.9 17.9 13.5 22.5 10.3 23.7 3.0 1.3 2.0 1.7 0.9 0.8 0.3 0.7 0.9 1.3 0.4 0.5 0.4 5.7 0.5 1.4 1.1 0.3 0.8 10.1 11.0 6.6 12.6 12.9 9.5 9.1 13.2 10.3 8.7 7.8 16.6 11.6 6.3 3.2 4.4 10.4 2.4 5.0 2.9 8.7 6.8 17.5 4.8 4.2 26.8 7.2 5.0 1.8 25.0 3.7 7.1 4.9 3.9 9.7 32.0 4.2 7.0 7.3 4.2 1.3 20.0 10.6 16.9 6.5 4.1 5.9 5.7 3.0 8.2 9.0 4.4 8.4 19.0 2.4 2.0 6.6 2.5 10.1 9.9 6.1 5.4 16.9 5.7 6.7 23.7 13.0 16.6 12.3 2.4 14.3 4.2 6.3 2.1 3.5 4.9 16.2 26.3 8.4 9.6 4.3 9.1 4.3 3.0 2.2 4.5 8.6 3.1 3.1 NR1H4 "FXR, HRR-1, HRR1, RIP14" ENSG00000012504 "Nuclear receptor subfamily 1 group H member 4" Q96RI1 12 100473708-100564414 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease variant, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 39.4;liver: 121.6" "Cell type enhanced" "Detected in some" "Cholangiocytes: 92.9;Hepatocytes: 105.1;Proximal enterocytes: 331.0;Proximal tubular cells: 153.8" "Group enriched" "Detected in some" 11 "liver cancer: 18.7;renal cancer: 12.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "Hep G2: 28.3;HHSteC: 14.1;RPTEC TERT1: 44.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA047699 Approved Nucleoplasm NA NA Nucleoplasm "HPA047699: AB_10965320" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (6.68e-2)" "unprognostic (2.49e-1)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (2.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (3.77e-3)" 0.2 22.8 0.1 1.4 0.1 0.4 1.0 0.4 0.4 0.1 1.4 7.6 29.9 0.1 0.1 0.3 0.2 12.7 0.4 0.2 0.1 28.5 121.6 0.4 0.3 0.1 0.1 0.1 14.2 3.1 0.0 1.4 0.0 0.1 0.3 1.6 0.3 0.3 0.0 0.3 0.5 39.4 0.8 0.1 0.4 0.5 0.7 0.1 0.1 0.3 0.1 0.2 6.6 0.1 0.5 0.0 0.9 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 28.3 14.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 44.9 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 92.9 0.0 22.0 0.0 0.0 0.0 8.0 43.0 11.5 0.7 0.0 0.0 0.3 0.0 2.7 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.6 8.9 105.1 0.0 0.0 1.6 17.0 0.0 3.5 0.0 2.0 0.9 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 19.9 0.0 0.0 0.0 331.0 153.8 0.0 0.0 0.0 0.0 0.1 0.4 1.3 0.0 0.0 0.0 0.9 1.1 30.4 3.7 ELOVL5 "dJ483K16.1, HELO1, SCA38" ENSG00000012660 "ELOVL fatty acid elongase 5" Q9NYP7 6 53267398-53349179 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017042, HPA047752, HPA054197" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413" "unprognostic (7.33e-2)" "unprognostic (5.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.43e-2)" "unprognostic (3.23e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (1.58e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (2.76e-2)" 244.5 136.0 54.2 75.6 68.1 115.6 201.2 76.0 79.9 49.3 56.0 34.1 28.5 40.2 50.1 28.6 46.4 51.7 35.5 54.3 109.9 39.3 109.8 68.9 107.6 83.7 75.8 47.6 32.5 15.6 24.5 28.8 40.5 78.1 129.1 18.5 36.8 25.0 103.9 10.0 26.8 47.8 52.9 77.2 56.6 23.0 83.2 68.3 108.3 45.4 19.7 103.3 67.7 27.3 101.6 137.2 98.1 168.0 309.0 436.0 250.8 71.3 155.8 174.2 123.2 171.5 87.4 154.5 154.4 110.3 163.3 193.1 78.9 168.0 142.6 183.7 131.2 117.5 153.1 85.0 122.9 239.0 122.2 107.2 233.6 109.8 123.6 153.9 124.5 139.1 301.4 194.2 87.3 90.3 14.9 364.4 107.9 91.2 5.2 73.6 139.9 115.3 54.3 232.7 80.6 155.7 107.1 129.3 66.9 135.2 108.7 152.3 112.9 133.0 134.7 118.5 242.2 208.8 72.8 72.1 116.2 70.2 173.6 97.8 47.6 49.2 183.7 34.9 34.9 56.5 88.4 58.1 42.7 77.9 101.5 27.8 26.3 261.5 36.7 45.0 20.4 110.0 50.6 54.2 68.1 76.0 79.9 54.3 109.9 83.7 75.8 47.6 78.1 77.2 68.3 101.6 48.6 80.1 50.7 75.4 118.3 52.4 108.2 36.8 44.3 11.6 177.3 70.9 23.3 21.5 40.2 12.9 2.1 25.3 55.5 2.1 15.6 34.9 94.2 37.4 53.2 54.4 25.0 77.0 25.8 36.1 58.2 54.8 3.1 66.4 99.0 28.4 39.3 88.7 35.5 8.4 29.8 1.6 16.2 57.3 114.6 181.0 20.8 55.5 48.0 39.4 53.5 83.2 39.1 49.3 111.2 27.8 1.4 32.0 45.2 169.2 21.9 48.4 58.5 6.0 65.7 27.3 77.5 27.0 18.9 35.7 60.9 31.2 97.2 60.0 4.4 73.4 ALOX5 5-LOX ENSG00000012779 "Arachidonate 5-lipoxygenase" P09917 10 45374176-45446119 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Leukotriene biosynthesis" "Dioxygenase, Hydrolase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 73.4;lymphoid tissue: 94.7" "Cell type enhanced" "Detected in many" "B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0" "Region enriched" "Detected in single" 4 "white matter: 2.9" "Low region specificity" "Detected in all" HPA071285 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA071285: AB_2686379" "unprognostic (2.57e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.75e-2)" "unprognostic (7.98e-3)" "unprognostic (1.26e-1)" "unprognostic (5.32e-2)" "unprognostic (8.69e-2)" "unprognostic (1.86e-2)" "unprognostic (6.91e-2)" "unprognostic (5.04e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.53e-1)" "prognostic favorable (7.18e-4)" 13.7 8.5 1.4 8.4 1.3 31.4 12.8 3.1 2.9 5.2 1.6 8.9 3.0 7.0 0.3 10.8 11.2 3.5 6.1 1.3 4.2 8.2 5.5 73.4 6.8 4.3 1.5 1.1 2.6 23.4 0.9 3.3 3.6 2.7 11.9 2.3 0.1 14.2 1.5 2.1 5.5 36.1 4.9 2.6 94.7 9.4 2.2 2.7 2.6 4.8 3.7 8.9 40.3 8.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 7.4 40.9 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 8.6 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 2.7 0.0 5.2 0.7 0.0 0.0 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.2 0.0 0.0 30.8 2.8 11.0 0.0 0.1 0.0 462.5 225.6 317.6 0.3 198.4 0.6 133.9 5.3 1.7 119.7 98.5 0.7 0.5 457.8 0.2 210.5 2.4 1.2 136.1 1.4 1.3 3.1 2.9 1.3 4.2 4.3 1.5 1.1 2.7 2.6 2.7 4.6 0.7 16.0 38.4 1.3 63.7 1.1 7.3 0.2 1.2 1.3 7.3 4.3 2.2 12.8 9.5 9.2 2.1 0.7 1.7 1.7 0.0 20.9 0.5 0.7 0.5 3.0 7.1 1.7 2.8 21.6 2.0 1.7 13.7 4.4 201.3 2.2 3.6 1.1 85.0 0.0 1.1 2.0 14.2 78.5 17.8 1.1 0.3 86.5 0.0 47.8 59.5 0.7 4.1 4.0 1.4 18.4 0.6 0.0 13.8 4.0 9.4 0.2 2.6 0.3 13.1 0.3 1.1 0.3 1.1 9.2 1.4 4.1 5.9 0.7 3.2 45.3 KDM5D "HY, HYA, JARID1D, KIAA0234, SMCY" ENSG00000012817 "Lysine demethylase 5D" Q9BY66 Y 19703865-19744939 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.6" "Cell type enhanced" "Detected in many" "Plasma cells: 46.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "white matter: 69.6" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 60.4;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049086 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA049086: " "unprognostic (8.38e-2)" "unprognostic (2.20e-1)" "prognostic favorable (3.58e-5)" "unprognostic (6.08e-3)" "unprognostic (1.50e-2)" "unprognostic (3.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-2)" "unprognostic (4.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.30e-2)" "unprognostic (1.80e-2)" 15.6 30.2 7.3 12.0 7.7 17.5 12.9 0.0 29.6 0.0 0.3 20.3 18.2 0.0 15.3 12.4 0.0 11.8 13.0 12.3 0.0 12.1 12.8 16.8 8.8 9.1 0.0 0.0 0.0 19.1 4.9 16.3 9.3 12.1 25.7 21.9 9.1 15.7 18.2 15.8 12.9 35.5 0.0 0.0 31.0 16.1 12.1 21.8 0.0 18.7 25.9 20.6 20.0 0.0 69.6 0.1 8.0 0.0 0.0 0.0 0.0 15.9 15.4 12.9 8.6 9.4 0.0 0.0 0.3 0.0 12.6 0.0 0.0 0.0 0.0 9.4 22.6 0.0 60.4 0.0 18.5 11.5 0.1 0.0 12.9 12.9 0.0 0.0 0.0 0.0 10.6 0.0 0.0 20.1 0.0 24.6 0.1 11.6 0.0 0.1 0.0 10.1 10.9 17.0 28.7 13.2 0.1 0.0 0.0 5.9 27.2 0.0 12.5 18.9 25.9 0.2 0.2 6.6 24.2 16.6 51.4 2.5 0.1 0.0 0.0 1.8 2.1 2.3 1.1 1.7 3.2 2.2 2.2 1.7 2.6 2.4 1.9 0.2 1.9 0.9 2.6 1.8 1.3 7.3 7.7 0.0 29.6 12.3 0.0 9.1 0.0 0.0 12.1 0.0 21.8 69.6 0.0 19.2 16.5 9.4 22.2 6.4 9.2 5.3 18.2 39.9 0.0 0.0 12.2 2.8 7.7 18.4 20.9 7.0 14.6 2.8 5.9 5.4 0.8 0.0 0.0 10.8 3.5 22.7 26.0 0.0 2.5 10.6 19.9 0.0 11.4 0.0 13.2 3.1 4.8 13.5 23.2 5.8 2.0 7.6 12.1 3.8 36.7 10.3 10.6 10.3 14.5 7.5 13.4 12.1 15.2 1.7 5.0 33.8 46.3 8.6 13.9 4.2 5.5 30.5 26.3 8.5 8.5 3.3 9.7 12.2 10.9 5.6 16.4 0.0 6.6 8.8 CALCOCO1 "calphoglin, Cocoa, KIAA1536" ENSG00000012822 "Calcium binding and coiled-coil domain 1" Q9P1Z2 12 53708517-53727745 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 109.6;hTERT-RPE1: 146.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038313, HPA038314" Approved Enhanced Vesicles,Cytosol NA NA Cytosol Vesicles "HPA038313: AB_10675794, HPA038314: AB_10672587" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (3.11e-2)" "unprognostic (8.42e-2)" "unprognostic (3.03e-1)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (9.66e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-3)" "unprognostic (8.01e-2)" "unprognostic (2.80e-1)" "unprognostic (5.63e-3)" "unprognostic (9.88e-3)" 126.4 71.9 84.2 25.2 95.0 35.3 116.2 95.4 101.1 100.4 94.8 134.8 31.3 106.1 69.7 71.8 102.6 56.1 133.9 85.7 85.1 73.3 57.5 99.2 34.1 89.0 85.9 85.8 111.8 109.2 66.1 80.8 50.7 90.2 91.4 35.8 48.0 120.8 56.0 266.4 178.5 89.1 53.7 81.6 91.7 127.5 49.9 87.0 36.6 90.0 121.6 37.8 126.1 97.2 91.7 12.1 13.8 20.4 26.8 109.6 71.5 13.1 26.4 56.2 19.4 26.6 6.7 52.7 4.9 23.7 61.3 10.0 15.8 8.2 22.3 20.7 20.1 17.1 9.9 31.5 5.4 53.3 4.2 22.0 99.8 58.2 20.3 19.8 146.7 35.2 22.0 8.1 46.7 34.2 5.2 13.5 15.9 4.2 10.9 15.1 13.6 11.3 17.2 31.9 8.4 11.7 21.0 15.1 8.3 26.7 42.5 24.6 13.0 41.2 10.0 13.0 9.5 3.8 42.5 12.8 1.8 46.1 4.9 12.8 85.2 19.6 76.7 26.1 22.4 18.7 14.5 17.8 20.8 11.6 17.1 15.7 17.6 72.0 20.2 23.7 8.8 33.4 23.8 84.2 95.0 95.4 101.1 85.7 85.1 89.0 85.9 85.8 90.2 81.6 87.0 91.7 33.0 35.3 14.4 18.9 19.8 32.4 19.0 16.7 30.1 34.3 32.8 27.6 11.7 25.8 16.8 22.0 35.5 23.8 26.0 13.6 5.9 16.7 40.7 27.1 19.4 23.4 28.6 32.0 31.1 11.7 8.8 29.2 16.8 17.5 7.6 29.1 31.8 17.9 15.9 26.9 33.3 18.7 24.4 26.0 15.3 54.0 47.5 28.6 19.6 11.2 21.9 25.3 64.9 20.6 22.6 22.0 17.5 41.3 53.5 20.1 25.9 14.0 26.5 44.6 19.7 28.6 29.5 24.2 9.3 16.7 50.7 45.6 27.3 27.5 13.0 26.4 UBR7 C14orf130 ENSG00000012963 "Ubiquitin protein ligase E3 component n-recognin 7" Q8N806 14 93207241-93229215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 300.9;Late spermatids: 372.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000861 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000861: AB_1078321" "unprognostic (9.60e-2)" "unprognostic (5.12e-3)" "unprognostic (1.11e-1)" "unprognostic (9.20e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.12e-5)" "unprognostic (1.14e-1)" "unprognostic (9.83e-2)" "unprognostic (1.04e-2)" "unprognostic (4.30e-2)" "unprognostic (5.94e-2)" "prognostic favorable (9.76e-5)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" 12.8 10.5 18.1 13.3 19.3 21.3 19.3 17.3 20.4 17.8 18.0 17.1 11.9 14.6 14.1 13.1 14.5 13.2 22.2 19.3 17.1 16.7 15.3 12.8 22.4 17.1 17.0 18.2 17.8 23.1 25.9 9.0 10.4 16.7 14.7 18.5 24.5 12.8 15.5 17.7 15.8 13.3 15.4 17.3 14.3 14.4 19.1 17.9 34.3 17.0 26.1 27.6 13.7 11.0 19.6 26.1 33.0 52.2 44.2 24.2 24.0 18.6 54.0 38.6 57.1 43.9 23.5 28.2 60.9 42.6 28.3 26.0 30.7 55.8 30.1 60.7 46.4 29.2 45.7 33.1 23.7 11.2 65.7 47.5 15.5 20.7 33.8 21.2 21.7 33.1 54.8 41.5 60.5 57.7 77.3 104.5 35.7 24.1 69.4 61.9 81.9 92.9 33.6 20.6 42.0 65.3 45.4 39.5 32.1 16.3 31.1 58.4 44.6 24.0 43.1 23.0 37.0 56.3 69.0 103.4 61.1 37.0 49.8 38.7 34.5 11.3 18.2 17.8 14.2 19.5 26.4 16.4 16.4 11.4 20.4 13.6 15.1 16.6 18.1 18.3 15.0 26.7 13.4 18.1 19.3 17.3 20.4 19.3 17.1 17.1 17.0 18.2 16.7 17.3 17.9 19.6 13.8 16.0 6.4 9.4 16.1 19.9 8.3 8.0 6.8 6.1 11.6 11.0 19.7 11.5 8.5 11.0 10.4 12.3 15.1 15.6 11.7 9.9 300.9 8.2 8.5 11.0 5.4 20.2 16.3 12.9 15.2 12.0 9.7 9.1 5.1 8.8 12.8 11.3 14.0 3.3 12.7 8.4 12.2 10.7 10.9 372.2 9.3 9.0 14.2 7.5 9.3 13.5 13.4 10.6 13.9 8.9 5.4 12.4 26.0 4.7 10.3 9.3 5.5 13.9 6.6 11.2 10.1 38.7 23.2 10.7 13.5 6.6 12.4 6.2 12.4 6.0 MAP4K5 "GCKR, KHS, KHS1" ENSG00000012983 "Mitogen-activated protein kinase kinase kinase kinase 5" Q9Y4K4 14 50418501-50561126 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 332.7;Oligodendrocytes: 707.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 66.7;eosinophil: 26.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036696, HPA078030" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036696: AB_10672362, HPA078030: " "unprognostic (1.39e-1)" "unprognostic (1.00e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-1)" "unprognostic (8.58e-3)" "unprognostic (4.13e-2)" "unprognostic (6.31e-2)" "unprognostic (2.24e-2)" "unprognostic (1.53e-3)" "unprognostic (7.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.71e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (2.02e-2)" 20.7 12.9 17.3 13.3 29.9 22.3 22.5 20.1 25.8 29.8 5.9 17.7 13.2 33.7 13.0 20.6 19.1 21.7 10.1 18.2 22.6 12.0 10.0 17.3 12.5 26.1 22.8 13.5 32.6 14.3 14.9 11.9 20.0 28.2 18.1 16.8 18.7 18.1 21.3 12.4 28.8 14.9 24.9 20.0 15.9 16.9 8.0 24.8 11.7 17.1 14.3 13.3 20.4 24.0 60.0 51.7 15.2 36.5 31.5 33.0 34.5 35.6 59.2 53.0 39.4 34.9 19.3 35.2 35.3 34.3 54.6 20.9 36.1 34.3 31.9 59.7 29.4 24.8 21.7 27.1 17.5 27.9 19.6 33.0 25.2 25.7 34.8 36.1 63.0 52.6 31.7 20.8 22.5 58.6 19.4 26.6 18.7 17.7 16.6 29.5 31.8 55.4 13.5 39.2 39.5 11.7 26.5 33.5 23.0 23.4 29.3 25.8 14.7 53.8 50.9 35.7 35.2 28.2 16.3 18.0 23.6 19.2 13.5 37.2 66.7 2.8 26.3 6.7 3.3 3.8 6.1 4.2 5.9 3.0 9.7 4.4 4.6 1.0 10.1 2.2 4.9 1.0 1.9 17.3 29.9 20.1 25.8 18.2 22.6 26.1 22.8 13.5 28.2 20.0 24.8 60.0 40.5 41.7 20.8 135.2 29.9 70.0 42.9 21.4 56.3 56.7 32.6 26.5 10.5 30.0 27.4 27.6 47.9 11.4 30.6 27.5 19.6 29.5 3.7 25.7 52.2 40.4 23.4 46.7 144.2 20.9 19.5 50.1 43.8 49.1 29.8 37.8 38.6 9.0 8.1 33.7 144.1 16.4 8.2 12.3 24.8 3.7 42.6 25.1 23.2 101.2 18.3 19.5 18.6 332.7 707.2 25.9 20.2 51.1 27.0 57.4 10.9 12.0 25.6 33.1 13.1 49.7 41.7 10.6 14.1 54.9 86.1 6.6 31.5 22.4 18.6 61.7 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234152-31269451 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.8;esophagus: 44.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 24.3;Hepatic stellate cells: 120.3;Syncytiotrophoblasts: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 5.6" "Lineage enriched" "Detected in many" 7 "B-cells: 20.8" "Cell line enhanced" "Detected in many" "BJ: 79.7;BJ hTERT+: 192.2;HEL: 77.4;U-266/70: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" NA NA 15000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.4 9.2 19.3 5.9 28.7 2.0 3.2 11.3 39.8 5.0 1.3 2.5 1.6 4.5 3.0 44.2 4.6 3.4 16.0 29.7 16.5 19.6 11.1 5.7 6.9 12.5 19.9 30.0 2.5 1.3 21.3 9.2 11.8 16.4 5.5 1.8 9.0 6.0 4.4 2.4 2.8 3.7 4.6 8.3 7.4 2.2 1.3 32.2 2.8 3.3 5.2 11.2 6.7 6.0 27.1 1.8 8.4 4.5 3.9 7.5 11.3 0.7 79.7 192.2 7.5 6.9 0.0 0.9 0.6 2.9 26.0 6.5 0.8 0.2 5.2 5.3 3.2 7.1 77.4 0.4 0.0 25.7 0.0 0.2 18.1 2.3 7.3 3.0 20.0 0.1 0.2 0.3 0.4 5.6 12.6 1.0 0.1 17.7 0.0 4.3 2.8 0.3 1.8 5.8 8.9 2.2 12.1 0.8 1.3 0.0 14.1 1.2 0.0 0.0 5.8 5.4 0.3 6.5 48.7 6.5 0.1 14.8 0.0 12.4 0.6 0.5 0.5 2.1 1.0 1.1 20.8 1.0 1.4 0.5 5.6 0.9 0.5 1.2 0.8 2.8 0.0 0.5 10.2 19.3 28.7 11.3 39.8 29.7 16.5 12.5 19.9 30.0 16.4 8.3 32.2 27.1 1.9 0.0 0.0 2.6 16.2 0.8 1.8 1.7 10.2 9.7 0.6 6.2 24.3 5.7 0.9 0.0 0.0 4.1 0.6 0.0 0.0 0.5 0.1 0.7 2.3 8.4 1.8 6.1 17.1 0.2 8.4 3.3 1.1 0.5 0.0 0.4 120.3 5.0 1.7 0.0 11.1 0.1 0.0 16.1 0.4 0.0 1.2 5.9 0.0 4.7 1.1 9.0 0.0 22.6 5.4 0.2 0.1 3.0 5.8 2.6 0.0 0.2 0.4 5.9 19.7 3.0 7.0 0.6 2.7 10.7 0.9 43.9 1.4 0.7 0.1 4.7 PSMC4 "MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7" ENSG00000013275 "Proteasome 26S subunit, ATPase 4" P43686 19 39971165-39981764 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002044, HPA005471" Approved Supported Nucleoplasm,Cytosol NA NA 200000 "Nucleoplasm, Cytosol" "HPA002044: AB_1079707, HPA005471: AB_1855838" "unprognostic (1.66e-1)" "unprognostic (9.08e-2)" "unprognostic (1.69e-1)" "unprognostic (1.83e-2)" "unprognostic (7.46e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.53e-2)" "unprognostic (4.45e-1)" "unprognostic (4.42e-2)" "unprognostic (9.90e-2)" "unprognostic (8.45e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.81e-1)" "unprognostic (2.32e-1)" 41.5 55.2 21.3 21.2 22.4 14.7 38.5 23.8 25.0 36.6 20.9 41.8 20.6 51.3 27.1 55.2 38.5 16.9 55.0 22.9 24.0 48.5 69.7 36.2 18.3 24.4 23.2 21.6 32.3 32.8 31.1 37.4 19.5 25.0 35.5 19.2 13.9 36.8 20.5 113.6 47.9 39.3 21.0 23.5 40.6 43.9 43.5 23.7 22.5 41.4 30.4 23.3 42.0 38.3 27.4 68.7 221.3 43.8 53.5 38.0 31.3 47.0 38.6 50.4 87.0 66.4 129.0 46.8 33.0 72.7 49.2 50.5 35.6 61.6 52.7 72.1 60.6 63.0 46.9 39.2 110.4 52.5 52.2 54.7 31.3 46.0 69.1 48.6 25.8 60.5 42.3 63.0 48.5 57.2 108.3 62.4 32.1 80.5 88.3 66.8 54.6 49.7 48.2 64.3 105.7 56.9 74.8 42.3 69.3 38.9 41.9 47.8 45.5 36.2 53.2 54.9 52.2 97.1 62.2 114.6 51.9 69.7 54.0 62.8 38.0 41.5 33.5 44.8 64.8 39.0 35.8 39.8 46.6 66.9 34.7 32.6 32.8 22.3 43.8 89.8 34.8 59.8 61.9 21.3 22.4 23.8 25.0 22.9 24.0 24.4 23.2 21.6 25.0 23.5 23.7 27.4 52.5 32.1 19.8 8.1 53.6 64.0 84.8 191.9 40.9 50.1 31.2 31.9 38.1 52.9 96.2 44.1 14.6 174.7 53.7 119.7 92.0 143.3 203.9 70.3 46.3 63.2 59.2 48.8 8.5 110.9 118.9 55.8 53.5 57.1 41.2 41.9 29.6 50.9 163.7 42.1 8.5 41.7 126.1 42.7 66.3 120.0 55.0 57.4 44.4 12.2 91.6 59.5 63.8 6.6 10.7 127.0 103.1 70.0 58.3 65.4 95.2 179.2 88.0 49.9 92.1 49.0 152.1 114.6 45.7 44.7 58.2 399.5 57.5 69.5 69.1 79.8 MAN2B2 KIAA0935 ENSG00000013288 "Mannosidase alpha class 2B member 2" Q9Y2E5 4 6575189-6623362 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 15000000 "unprognostic (1.30e-1)" "unprognostic (3.32e-1)" "unprognostic (1.28e-1)" "prognostic favorable (7.59e-4)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.72e-1)" "unprognostic (6.53e-2)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (2.66e-3)" "unprognostic (2.18e-1)" 18.3 13.7 10.7 14.0 15.7 15.0 16.6 7.3 13.1 17.7 23.3 14.4 13.5 18.8 14.2 11.4 17.8 16.0 18.7 12.1 12.9 15.0 23.9 18.4 13.6 12.4 12.3 12.8 26.8 22.2 9.3 18.1 13.0 11.8 18.2 7.9 5.3 16.8 11.6 4.7 13.1 15.9 10.4 9.6 17.9 20.3 4.4 12.3 9.0 23.3 4.7 8.6 19.4 16.0 11.1 17.5 15.6 2.9 21.0 44.7 30.9 19.7 35.0 40.5 16.8 22.9 9.0 32.3 8.7 16.5 38.2 39.2 17.4 1.0 11.1 9.2 10.4 8.8 11.7 10.9 10.2 19.5 22.0 51.8 41.0 10.9 13.4 3.6 30.3 19.7 10.8 5.1 21.9 22.1 10.8 10.9 13.9 3.8 21.8 11.9 10.7 14.4 10.4 8.8 17.4 5.0 5.5 23.4 13.9 8.9 10.0 27.7 29.1 36.3 30.3 9.1 38.2 22.5 9.0 8.4 4.2 35.4 25.5 26.7 15.4 9.0 14.3 11.7 13.2 8.9 4.2 7.0 10.7 8.6 4.4 6.3 8.2 11.0 6.8 17.5 3.3 10.7 11.0 10.7 15.7 7.3 13.1 12.1 12.9 12.4 12.3 12.8 11.8 9.6 12.3 11.1 9.8 16.0 18.9 7.8 11.6 5.0 5.5 4.9 11.4 8.9 8.2 5.6 17.0 20.0 11.1 11.0 6.2 13.5 12.9 18.3 1.9 9.7 0.6 18.7 15.8 8.2 7.8 5.7 9.4 10.7 10.2 18.4 11.7 36.8 10.8 11.1 17.5 44.1 20.9 10.1 8.3 11.0 2.0 30.2 8.2 1.1 19.6 18.0 3.6 8.4 11.2 13.0 5.2 6.0 8.9 10.1 9.0 24.5 15.1 7.1 11.7 4.2 9.5 7.4 13.1 7.5 8.5 1.1 0.6 8.0 3.8 8.5 15.6 4.4 8.9 4.6 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459548-170586075 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.6;pituitary gland: 7.3;retina: 6.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 3.2;SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 0.0 2.3 6.7 0.4 8.4 0.1 0.0 5.6 8.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.4 11.9 0.1 0.0 0.0 0.0 12.6 7.5 8.3 0.1 0.7 0.0 7.3 0.0 11.7 0.1 0.4 6.2 0.0 0.0 0.1 0.1 0.3 0.1 3.9 0.0 0.2 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.1 15.6 0.0 0.0 0.1 0.0 0.5 0.9 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 8.4 5.6 8.1 8.4 11.9 12.6 7.5 8.3 11.7 3.9 8.5 15.6 0.8 3.2 2.2 4.6 0.1 0.4 0.3 0.1 0.0 28.4 0.1 0.0 1.0 0.0 2.5 0.0 2.1 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 0.5 1.8 0.0 61.9 0.0 0.1 0.4 0.0 0.1 2.5 0.1 0.4 0.9 0.0 28.6 90.2 0.1 0.0 0.0 1.2 0.6 2.1 0.4 3.6 6.5 0.0 1.8 0.0 9.5 67.4 0.1 1.2 2.6 0.1 0.3 0.1 0.2 3.0 4.3 0.0 0.7 0.5 0.0 0.2 0.0 0.6 0.0 0.4 0.1 0.0 0.2 CLDN11 "OSP, OTM" ENSG00000013297 "Claudin 11" O75508 3 170418868-170454733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 111.8;ovary: 96.2;testis: 117.8" "Cell type enhanced" "Detected in many" "Fibroblasts: 56.4;Leydig cells: 105.3;Oligodendrocytes: 394.5;Peritubular cells: 67.7" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 141.3;ASC TERT1: 174.2;EFO-21: 91.8;HUVEC TERT2: 162.2;TIME: 252.1" "Region enriched" "Detected in all" 5 "white matter: 2084.8" "CAB009789, HPA013166, HPA013657" Enhanced Supported "Lipid droplets,Cell Junctions" NA NA "Cell Junctions" "Lipid droplets" "CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: " "prognostic favorable (6.31e-4)" "unprognostic (3.18e-1)" "unprognostic (2.32e-2)" "unprognostic (5.28e-4)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" "unprognostic (5.48e-2)" "unprognostic (8.70e-11)" "unprognostic (2.50e-3)" "unprognostic (1.93e-1)" "unprognostic (6.68e-3)" "unprognostic (2.29e-1)" 19.4 5.5 15.2 0.0 43.3 0.0 15.4 41.4 32.4 6.0 6.2 7.4 0.1 8.2 1.5 5.1 18.2 8.8 5.0 17.1 71.5 6.3 2.2 4.8 0.2 111.8 41.5 9.6 96.2 0.8 0.0 21.1 1.2 71.0 11.3 0.3 0.2 5.2 1.0 1.5 5.7 6.6 0.4 54.8 1.2 3.1 117.8 39.6 0.0 1.8 0.7 0.1 13.3 13.3 89.8 0.0 0.0 0.1 0.0 141.3 174.2 0.0 1.2 8.5 11.0 19.6 0.0 19.2 0.0 91.8 14.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 10.6 42.8 0.0 0.0 61.0 0.0 60.9 0.0 0.4 162.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 43.3 41.4 32.4 17.1 71.5 111.8 41.5 9.6 71.0 54.8 39.6 89.8 16.4 0.0 0.6 2.3 0.4 14.4 15.6 1.0 0.0 0.5 5.7 27.7 1.4 1.5 0.1 1.8 0.0 0.9 0.8 0.3 0.0 0.1 8.3 0.5 0.2 37.3 0.0 2.7 1.5 0.0 1.6 56.4 0.0 0.6 0.0 27.2 49.2 1.1 0.9 0.0 2.8 0.0 0.0 1.2 23.8 24.3 105.3 1.1 14.2 24.4 0.0 0.4 0.0 3.5 394.5 0.7 0.0 67.7 0.0 15.4 0.2 0.2 0.2 0.1 0.0 2.9 6.6 11.6 4.1 1.0 10.2 0.8 0.6 1.6 0.1 2.0 SLC25A39 "CGI-69, FLJ22407" ENSG00000013306 "Solute carrier family 25 member 39" Q9BZJ4 17 44319625-44324870 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Heme biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 491.0;Erythroid cells: 1310.3;Late spermatids: 756.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026785 Approved NA NA "HPA026785: AB_10601715" "unprognostic (8.10e-2)" "unprognostic (2.46e-1)" "unprognostic (1.41e-2)" "unprognostic (1.29e-1)" "unprognostic (6.04e-2)" "unprognostic (2.35e-3)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "prognostic favorable (3.58e-5)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (3.21e-2)" 47.8 124.2 63.4 49.8 62.2 308.1 50.0 63.3 85.1 49.0 75.2 74.8 74.6 47.7 40.1 144.5 45.0 42.0 65.0 58.9 63.1 177.7 144.0 56.5 49.1 66.1 63.9 57.0 45.3 121.8 99.8 74.0 46.6 64.8 75.9 47.7 9.5 78.4 44.3 45.0 85.1 63.3 30.6 63.5 89.9 82.5 90.1 66.8 35.9 87.8 48.3 40.6 56.4 62.8 66.6 247.0 152.9 47.0 198.0 89.3 68.8 163.0 79.9 71.8 101.8 78.3 151.9 116.0 131.0 137.7 114.0 180.6 124.0 147.2 242.6 35.9 154.9 236.2 68.9 131.2 281.2 97.1 120.9 145.0 104.8 211.9 95.5 122.2 92.2 105.2 195.3 205.7 204.0 87.4 463.5 153.3 118.0 92.5 187.3 417.4 182.6 129.1 375.6 177.9 128.8 316.1 118.2 92.5 146.5 166.8 85.9 281.3 102.4 76.2 132.9 185.9 229.6 160.3 126.9 165.1 122.6 119.7 93.8 82.4 36.5 56.2 29.2 73.7 83.5 83.0 96.1 79.1 79.0 89.5 78.0 80.3 74.1 8.2 139.6 87.7 103.5 80.3 93.2 63.4 62.2 63.3 85.1 58.9 63.1 66.1 63.9 57.0 64.8 63.5 66.8 66.6 36.1 9.6 25.4 17.6 52.2 53.3 71.2 117.2 42.1 18.8 93.2 77.0 27.0 52.9 79.9 69.9 10.4 93.1 42.3 123.7 491.0 188.1 223.6 28.6 24.7 44.5 65.3 1310.3 20.7 310.6 166.3 35.2 71.9 54.1 32.9 44.4 30.0 75.7 134.7 13.5 19.5 120.9 132.2 62.5 44.7 756.5 39.7 61.6 92.5 10.3 99.9 45.3 62.8 8.0 16.0 176.7 88.9 38.7 80.0 162.4 130.9 322.8 41.3 15.3 19.7 27.9 52.3 134.4 105.5 110.7 64.6 117.5 51.8 75.4 157.7 108.2 MVP "LRP, VAULT1" ENSG00000013364 "Major vault protein" Q14764 16 29820394-29848039 "Cancer-related genes, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" Ribonucleoprotein "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 504.7;Exocrine glandular cells: 310.8;Paneth cells: 338.3;Proximal enterocytes: 514.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 429.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002321, CAB002752, CAB022717, HPA064740" Enhanced Supported Cytosol NA NA 110000 Cytosol "CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342" "prognostic favorable (4.51e-4)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (8.17e-2)" "unprognostic (3.03e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-1)" "unprognostic (6.85e-3)" "unprognostic (2.86e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.22e-1)" "unprognostic (5.19e-2)" "unprognostic (5.69e-3)" "unprognostic (2.65e-2)" 83.1 183.1 24.7 96.9 31.4 46.8 71.6 27.3 33.9 74.9 30.9 149.2 156.1 73.7 14.4 76.0 73.9 74.9 61.9 22.3 47.8 113.2 67.5 123.0 71.7 40.6 33.6 18.2 104.2 102.8 19.1 47.8 38.3 32.8 60.2 97.4 6.4 77.7 39.3 51.0 59.6 160.2 69.7 30.0 114.9 108.7 39.7 35.0 31.6 61.2 32.7 48.0 80.7 73.5 35.8 64.8 191.8 0.8 1.7 212.0 275.0 25.9 163.4 258.5 88.0 121.4 24.7 216.8 3.1 134.9 231.0 108.9 78.1 0.8 129.5 42.2 166.4 1.8 3.0 81.6 87.6 190.1 2.3 60.2 366.9 96.1 207.0 58.3 170.5 274.5 6.2 0.5 92.1 167.7 18.3 0.8 4.3 2.4 93.4 11.6 2.1 0.7 32.5 229.1 114.6 10.5 7.6 41.8 53.8 31.8 6.5 9.5 18.7 429.3 124.2 59.4 119.9 62.0 66.6 45.1 2.7 294.6 4.8 24.9 50.4 140.8 56.3 70.9 214.3 55.1 36.6 80.7 73.6 113.1 27.2 59.4 54.0 160.0 73.7 204.0 69.2 90.7 164.4 24.7 31.4 27.3 33.9 22.3 47.8 40.6 33.6 18.2 32.8 30.0 35.0 35.8 34.2 48.1 115.5 9.8 31.2 19.6 39.3 120.3 16.5 4.8 17.9 10.0 12.9 82.9 112.0 69.9 2.1 113.6 31.2 504.7 45.0 272.7 4.9 43.9 25.9 40.9 56.5 8.6 3.2 310.8 71.4 52.8 120.8 65.9 33.7 14.8 36.4 23.8 78.0 8.4 3.4 177.1 95.6 41.0 27.1 21.1 57.5 55.0 32.0 9.4 223.3 3.0 59.8 0.0 23.1 278.5 338.3 47.8 36.4 25.0 514.8 194.8 110.3 4.9 19.7 23.8 51.3 2.7 1.8 20.7 21.9 264.5 45.1 24.7 206.8 56.7 NUB1 "BS4, NUB1L, NYREN18" ENSG00000013374 "Negative regulator of ubiquitin like proteins 1" Q9Y5A7 7 151341772-151378449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 249.4;monocytes: 559.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021220, HPA050722, HPA053648" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217" "unprognostic (7.04e-3)" "unprognostic (2.47e-2)" "unprognostic (1.84e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (8.76e-2)" "unprognostic (2.69e-2)" "unprognostic (9.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.64e-2)" "unprognostic (5.83e-3)" 37.0 33.5 22.9 47.4 23.4 30.9 31.6 24.0 23.2 32.0 23.4 36.4 62.7 33.0 18.3 28.0 31.9 34.1 33.9 20.8 23.5 29.2 35.8 36.7 63.3 25.1 24.2 21.0 35.5 40.4 41.0 26.0 30.9 24.6 31.7 30.5 32.0 42.2 28.8 53.3 29.5 57.4 21.3 24.2 55.2 36.9 52.5 23.2 46.6 47.7 32.7 40.9 30.5 28.2 26.1 78.0 34.8 45.9 26.9 47.0 56.6 38.7 61.2 55.8 45.5 52.2 34.2 67.3 84.5 78.5 38.8 58.3 38.0 27.9 40.0 29.2 74.2 46.4 30.8 32.1 21.9 65.2 72.0 38.0 36.4 46.4 32.9 31.3 56.4 30.6 41.4 81.5 2.5 37.3 42.0 126.9 55.0 73.0 79.4 45.6 69.4 47.9 12.8 33.3 37.9 42.9 71.8 116.3 48.7 60.4 31.7 33.9 40.6 62.7 38.2 13.7 51.8 58.9 78.5 64.0 73.7 77.9 60.6 64.4 18.2 20.5 28.5 25.9 27.1 30.8 26.9 22.6 26.6 18.1 26.0 24.5 23.5 37.6 33.6 34.9 25.2 19.8 23.8 22.9 23.4 24.0 23.2 20.8 23.5 25.1 24.2 21.0 24.6 24.2 23.2 26.1 61.0 73.7 66.4 14.0 52.7 24.9 33.8 36.4 39.9 38.4 31.0 32.3 57.4 34.3 51.4 25.8 12.5 49.3 91.8 53.4 60.7 52.1 249.4 59.5 46.5 45.8 29.3 17.1 13.6 69.8 43.0 42.3 29.0 47.9 72.2 45.1 33.2 40.5 30.0 48.8 19.4 40.9 18.3 37.1 45.8 34.2 44.1 46.7 16.0 18.7 559.4 57.7 74.2 11.1 23.0 52.3 20.5 41.0 22.3 48.7 56.5 37.8 55.7 41.4 26.3 39.5 43.3 160.4 12.5 25.8 29.0 50.1 60.0 40.2 26.0 33.1 PGM3 "AGM1, DKFZP434B187, PAGM" ENSG00000013375 "Phosphoglucomutase 3" O95394 6 83161150-83193936 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004998, HPA029759, HPA029760" Enhanced Approved Nucleoplasm,Cytosol NA NA 220000 "Nucleoplasm, Cytosol" "CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109" "prognostic unfavorable (8.78e-4)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.45e-2)" "unprognostic (3.03e-2)" "unprognostic (1.51e-2)" "unprognostic (4.04e-2)" "unprognostic (1.09e-3)" "unprognostic (6.72e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.96e-4)" "unprognostic (4.00e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (2.21e-1)" "unprognostic (7.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.22e-3)" 23.8 21.2 11.0 18.3 12.9 9.4 18.2 20.2 15.1 24.6 17.0 18.2 16.0 17.3 34.9 12.4 13.5 24.8 12.2 9.6 29.6 13.8 38.6 16.9 11.3 11.1 12.2 8.0 22.9 46.5 13.4 28.4 47.9 13.0 51.4 23.6 27.0 36.1 20.5 6.7 11.0 18.4 18.7 7.4 11.6 25.1 32.6 11.3 8.3 25.8 8.7 15.3 19.2 12.5 16.2 35.1 23.4 41.8 51.0 68.9 72.9 48.9 118.1 82.9 55.2 83.3 60.1 16.1 18.3 24.7 112.3 53.0 20.1 38.4 49.5 104.6 14.6 37.8 22.7 41.9 105.0 77.6 22.6 11.2 46.2 40.1 96.6 120.0 55.5 64.6 12.1 74.9 19.6 61.0 39.1 3.7 14.7 18.8 31.8 31.6 16.2 92.5 11.3 42.0 36.0 16.9 26.3 34.8 28.5 20.9 61.8 27.0 25.5 94.2 38.3 21.2 74.9 60.5 36.5 16.1 13.0 29.7 17.7 58.4 10.8 4.1 2.7 2.6 3.5 3.9 4.6 2.8 3.4 3.6 2.5 4.5 4.7 1.8 3.5 4.5 4.2 2.1 2.3 11.0 12.9 20.2 15.1 9.6 29.6 11.1 12.2 8.0 13.0 7.4 11.3 16.2 14.3 28.9 27.7 14.4 13.0 15.8 29.2 28.5 5.7 16.4 19.9 15.0 6.8 15.7 36.1 11.0 10.4 32.4 12.7 15.9 7.9 31.7 67.7 17.0 35.1 13.8 16.1 6.9 25.1 49.6 71.1 46.1 23.9 36.4 5.1 25.4 14.3 32.6 17.6 8.4 29.4 35.5 18.3 6.0 8.7 20.9 33.5 8.6 10.6 15.9 10.1 25.9 2.1 41.2 36.8 37.9 19.7 18.4 44.1 56.5 16.1 23.2 22.2 21.1 6.6 22.1 26.6 75.5 34.2 11.6 15.6 64.4 10.1 12.2 17.6 25.6 RWDD2A "dJ747H23.2, MGC13523, RWDD2" ENSG00000013392 "RWD domain containing 2A" Q9UIY3 6 83193357-83198935 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 52.3;Spermatocytes: 65.2" "Cancer enhanced" "Detected in all" "prostate cancer: 11.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030105, HPA030106, HPA030107" Uncertain Approved Vesicles NA NA Vesicles "HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009" "unprognostic (2.51e-3)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "prognostic favorable (3.82e-5)" "prognostic favorable (1.38e-4)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.57e-2)" "unprognostic (1.85e-3)" "unprognostic (2.59e-2)" 2.8 6.9 7.0 2.1 7.2 0.5 3.2 6.4 8.1 3.1 6.1 2.7 2.5 3.3 9.4 1.7 3.8 4.6 4.5 6.8 7.5 4.5 6.0 2.9 2.5 5.9 5.9 7.0 4.0 9.7 4.0 5.7 2.5 6.1 11.6 2.5 4.7 6.1 4.7 2.3 2.0 2.8 3.3 5.7 2.9 3.9 9.0 7.7 1.8 6.2 4.0 2.7 2.6 1.8 6.7 2.1 1.9 4.4 8.3 5.2 3.7 3.0 4.8 10.1 3.5 4.2 2.8 1.1 1.6 3.8 5.8 8.0 2.1 3.7 2.8 5.4 2.0 3.8 1.9 3.0 6.2 8.0 0.5 1.5 4.9 4.6 4.4 9.2 11.5 6.6 4.5 3.1 2.8 4.3 3.1 0.7 1.5 1.5 1.9 1.9 2.4 9.1 1.0 7.4 2.4 1.5 5.3 2.9 4.5 4.4 6.3 2.8 2.9 7.1 2.4 1.5 3.5 2.1 6.2 2.7 0.9 2.8 0.8 2.9 0.3 0.9 0.0 1.2 0.8 1.8 1.9 1.7 1.7 1.0 1.0 2.2 2.1 0.3 0.4 2.2 3.5 2.2 1.0 7.0 7.2 6.4 8.1 6.8 7.5 5.9 5.9 7.0 6.1 5.7 7.7 6.7 2.4 0.0 6.7 9.8 4.2 3.7 3.6 5.3 3.4 5.6 3.7 3.2 5.4 2.8 3.3 1.8 0.0 7.7 3.9 2.4 5.9 8.9 52.3 4.8 4.5 3.5 5.4 0.4 10.8 9.1 3.3 6.5 3.6 4.0 0.0 7.0 5.0 6.8 5.0 1.7 11.2 6.1 8.2 1.6 2.5 14.8 9.0 2.2 8.8 3.7 3.8 11.0 0.0 13.6 4.5 5.8 2.5 6.0 11.2 8.7 4.1 13.3 4.9 5.0 6.6 7.0 5.2 65.2 10.5 1.2 2.4 5.7 2.9 6.3 3.4 2.8 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: AB_2684753" "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.28e-4)" 87.6 83.5 140.2 25.6 142.5 179.6 72.9 146.4 192.8 119.0 143.3 66.6 21.0 66.3 51.5 59.0 86.2 57.0 79.7 144.3 149.7 77.3 85.1 91.1 56.3 144.2 139.6 135.4 141.5 64.1 29.2 83.0 65.4 143.5 110.6 24.4 135.0 69.5 50.0 81.0 62.8 52.0 31.1 141.5 113.9 53.7 28.3 142.9 76.7 93.2 72.1 42.4 78.4 113.7 182.5 17.9 13.5 22.6 6.5 24.4 26.1 17.1 19.2 26.8 19.3 25.5 24.6 11.8 5.5 13.1 11.4 11.1 19.7 27.9 8.8 38.2 27.3 24.0 18.1 35.9 30.7 14.7 19.5 31.1 12.3 39.9 23.4 41.8 20.6 11.4 9.5 23.3 77.1 27.0 12.3 23.0 58.4 13.9 11.4 29.8 24.8 25.7 31.8 13.0 11.2 22.0 17.8 16.4 6.1 32.7 12.9 5.3 13.2 19.5 21.4 14.8 21.5 22.0 46.8 20.9 13.7 14.2 15.4 14.9 40.0 7.2 18.6 14.5 5.0 17.3 17.4 15.7 15.8 4.8 11.7 15.6 12.9 16.9 9.5 6.0 11.1 17.2 10.4 140.2 142.5 146.4 192.8 144.3 149.7 144.2 139.6 135.4 143.5 141.5 142.9 182.5 122.1 44.8 85.4 112.0 164.2 168.8 263.0 73.6 114.4 59.0 112.9 97.0 96.6 41.5 87.1 27.6 100.1 46.7 213.5 110.9 19.6 31.4 2.3 111.2 108.8 113.6 134.3 87.5 51.7 26.9 56.6 142.5 81.1 173.6 136.9 77.9 82.1 43.3 58.5 52.2 53.6 124.2 50.8 100.5 285.8 9.4 92.9 192.3 154.7 62.8 56.2 54.6 76.2 58.3 169.0 32.0 117.7 75.6 169.0 133.3 88.2 14.9 70.1 99.6 111.7 97.8 128.4 33.1 27.7 117.0 151.7 90.3 261.2 43.0 88.6 184.2 POLR3B "C128, FLJ10388, RPC2" ENSG00000013503 "RNA polymerase III subunit B" Q9NW08 12 106357748-106510198 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036466 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036466: AB_10671842" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-1)" "unprognostic (4.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" "unprognostic (3.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.09e-2)" "prognostic favorable (1.21e-4)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" 4.5 8.8 2.8 4.9 3.8 5.3 5.1 4.3 4.6 4.8 3.0 5.3 4.3 4.7 5.2 8.7 5.2 3.7 5.9 2.9 3.2 6.8 9.0 4.7 4.1 2.2 2.0 3.0 7.5 4.9 11.2 2.4 6.8 3.0 5.7 5.7 6.3 4.7 4.0 6.6 11.1 3.4 5.4 1.6 3.4 5.4 6.1 3.0 4.7 6.0 8.4 5.6 4.9 4.4 4.1 16.2 7.6 16.4 7.8 13.9 13.1 22.9 21.9 13.0 15.2 11.6 14.0 4.4 20.6 7.7 14.2 5.6 14.8 19.5 19.2 18.5 16.6 13.1 15.7 10.1 12.0 9.2 26.1 17.0 11.7 13.4 15.1 17.3 10.3 11.5 9.8 24.5 6.5 11.2 12.0 19.1 8.7 17.8 11.9 28.5 11.6 9.8 13.5 8.6 21.8 17.3 9.6 13.6 18.2 13.4 10.8 17.0 7.9 11.0 8.3 10.0 13.6 13.1 8.1 22.4 30.3 3.8 15.9 9.2 5.6 2.0 1.5 2.0 2.2 2.7 2.1 2.2 2.2 2.6 1.3 3.0 1.9 1.3 2.1 2.2 0.9 2.7 1.7 2.8 3.8 4.3 4.6 2.9 3.2 2.2 2.0 3.0 3.0 1.6 3.0 4.1 2.4 0.0 9.2 14.4 4.7 1.8 1.7 4.5 4.6 6.0 3.4 3.7 10.3 2.8 7.0 5.5 6.2 11.0 3.8 3.8 1.9 5.1 7.1 3.9 7.0 3.3 4.2 3.8 22.3 4.6 9.3 4.4 9.2 3.9 5.1 4.8 3.6 11.0 3.1 3.3 24.1 5.6 2.0 1.6 0.3 5.2 3.7 2.4 3.6 9.4 1.0 2.4 2.1 17.1 22.4 3.8 1.1 4.9 4.9 1.5 1.7 3.4 7.2 7.2 6.6 6.9 4.1 16.5 10.9 8.9 3.0 7.4 4.1 7.2 5.1 1.2 ANGEL1 "Ccr4e, KIAA0759" ENSG00000013523 "Angel homolog 1" Q9UNK9 14 76786009-76826246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 64.3;Late spermatids: 75.1;Oligodendrocyte precursor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000948 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA000948: AB_2227189" "unprognostic (4.81e-2)" "unprognostic (2.37e-2)" "unprognostic (2.67e-1)" "unprognostic (2.46e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-1)" "unprognostic (7.33e-2)" "prognostic favorable (3.43e-4)" "unprognostic (9.24e-2)" "unprognostic (1.01e-1)" "prognostic favorable (5.46e-4)" "unprognostic (3.03e-1)" "unprognostic (6.92e-3)" "unprognostic (1.42e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-1)" "unprognostic (6.32e-2)" 10.9 18.7 16.8 11.9 18.8 6.9 12.8 15.5 18.7 12.2 14.0 10.0 9.3 14.9 24.0 7.0 12.3 11.5 15.7 18.4 18.9 9.2 19.4 14.1 12.3 21.4 18.5 15.3 19.4 51.2 17.3 21.3 10.5 21.3 9.4 11.0 26.6 15.9 8.5 12.3 6.5 10.4 12.4 17.4 29.6 15.9 52.9 18.7 8.2 13.8 9.9 11.0 9.6 8.6 22.7 13.1 14.0 15.2 13.6 12.2 11.1 14.1 7.7 11.0 7.8 9.9 13.5 18.2 23.8 11.1 6.7 10.6 16.2 14.6 13.7 13.1 10.1 13.1 14.8 9.7 10.3 7.9 7.8 8.7 11.8 16.8 7.3 14.5 11.3 20.0 24.8 14.5 6.2 8.2 25.3 14.0 11.6 17.5 20.7 18.4 17.0 10.4 14.1 11.8 18.4 21.5 9.6 11.6 15.8 7.1 13.8 31.1 8.4 9.6 9.1 8.0 6.9 6.4 15.9 12.9 14.7 7.7 13.7 11.8 0.8 4.8 1.6 5.9 5.5 7.2 6.8 5.3 5.6 7.5 5.5 7.5 5.6 1.4 5.5 7.1 4.9 4.5 5.9 16.8 18.8 15.5 18.7 18.4 18.9 21.4 18.5 15.3 21.3 17.4 18.7 22.7 7.4 6.4 10.5 17.6 4.7 1.1 1.8 1.5 2.2 2.4 5.7 5.0 6.7 5.7 2.2 3.7 10.4 1.5 1.5 2.1 0.0 3.3 64.3 3.7 3.9 10.0 4.2 4.2 18.3 3.2 2.8 4.3 1.5 3.3 1.3 15.9 7.1 9.5 7.2 0.0 19.7 4.4 4.1 5.7 2.0 75.1 2.1 5.5 1.8 23.4 1.4 4.9 1.0 64.8 30.2 2.5 1.0 4.9 8.9 3.4 1.7 1.3 1.4 8.9 6.6 5.1 2.4 15.9 4.9 2.8 0.4 1.2 3.0 12.9 4.6 1.5 RNF14 "ARA54, HFB30, TRIAD2" ENSG00000013561 "Ring finger protein 14" Q9UBS8 5 141958328-141990292 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 257.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008716, HPA064746" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008716: AB_1856337, HPA064746: " "unprognostic (7.45e-3)" "unprognostic (1.38e-1)" "unprognostic (8.56e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-2)" "unprognostic (7.24e-3)" "unprognostic (2.35e-1)" "unprognostic (4.05e-2)" "unprognostic (5.22e-2)" "unprognostic (7.42e-2)" "unprognostic (7.92e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.71e-4)" "unprognostic (6.89e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.06e-2)" 48.9 52.3 35.8 26.2 36.1 20.3 46.1 35.2 41.5 36.9 33.8 41.1 33.5 33.9 43.6 32.9 29.9 32.9 71.8 35.4 38.5 65.9 68.2 30.4 32.5 37.6 41.3 32.2 32.6 37.5 104.9 23.9 40.2 38.8 44.4 41.6 40.8 37.5 40.6 67.4 23.7 36.7 43.6 37.1 29.1 35.7 75.2 38.4 37.0 55.6 86.6 34.0 32.4 23.6 37.6 38.3 62.5 43.1 85.1 75.7 78.8 29.0 76.8 42.6 52.8 58.1 52.4 43.4 67.1 87.5 79.3 79.4 20.6 55.6 75.4 47.0 51.1 48.5 42.9 30.2 24.0 83.2 47.7 36.9 59.7 64.9 70.3 87.6 45.6 66.2 46.0 53.0 91.7 109.4 45.7 46.6 15.3 18.3 46.2 71.0 30.2 47.8 73.8 71.7 65.2 47.5 38.3 67.3 121.3 133.2 47.8 85.0 36.7 69.3 69.6 22.6 33.2 74.0 56.8 72.1 61.8 59.7 57.4 87.9 79.6 22.0 23.2 26.9 26.9 26.0 19.5 23.2 26.9 27.4 18.1 17.6 25.9 5.5 30.1 33.9 28.9 29.1 19.7 35.8 36.1 35.2 41.5 35.4 38.5 37.6 41.3 32.2 38.8 37.1 38.4 37.6 18.1 9.6 19.3 12.7 12.5 10.7 15.9 19.6 11.4 20.2 18.4 15.0 45.4 11.5 18.1 22.0 16.7 29.1 13.3 22.9 68.4 29.2 257.1 14.1 20.8 21.7 15.0 59.1 25.1 24.9 26.1 18.2 18.3 16.4 22.2 32.0 20.7 33.1 24.5 23.5 22.9 14.9 24.4 29.7 10.4 39.3 19.3 17.1 32.0 13.1 14.8 28.7 29.9 15.6 18.6 26.3 14.0 33.4 13.5 19.2 28.3 50.5 15.8 16.3 39.5 15.8 23.0 38.7 25.8 15.6 10.5 60.5 16.4 25.0 15.0 15.0 DNASE1L1 "DNAS1L1, DNASEX, DNL1L, XIB" ENSG00000013563 "Deoxyribonuclease 1 like 1" P49184 X 154401236-154412112 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 148.2" "Cell type enhanced" "Detected in many" "Kupffer cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072635 Approved "Intracellular and membrane" NA NA 96000 "HPA072635: AB_2686542" "unprognostic (5.27e-2)" "unprognostic (1.95e-1)" "unprognostic (4.57e-3)" "unprognostic (2.97e-1)" "unprognostic (1.27e-2)" "unprognostic (1.59e-3)" "unprognostic (3.82e-2)" "unprognostic (3.08e-2)" "unprognostic (2.88e-1)" "unprognostic (1.96e-1)" "unprognostic (1.32e-1)" "unprognostic (4.98e-1)" "prognostic favorable (2.19e-4)" "unprognostic (7.02e-2)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "unprognostic (6.75e-2)" 18.4 26.8 11.4 13.2 11.6 24.4 18.0 11.4 14.2 14.6 24.8 13.4 15.3 15.9 22.7 21.8 14.1 13.2 39.2 12.9 13.1 20.9 19.0 22.2 16.6 12.5 11.8 10.7 13.8 13.0 22.9 20.2 16.3 13.0 15.2 12.5 3.9 22.2 11.4 148.2 11.4 19.5 11.4 11.5 28.7 18.2 7.7 12.9 9.0 24.3 95.6 13.3 13.6 17.0 11.8 19.7 19.6 6.3 12.2 56.6 74.5 7.7 54.5 85.3 17.6 34.6 5.7 28.0 32.9 68.2 103.0 67.4 9.6 7.6 31.0 12.8 9.9 13.0 4.8 20.6 7.1 38.8 8.6 33.4 55.6 35.7 39.6 40.0 47.9 76.4 5.3 6.5 34.0 61.1 33.0 3.6 4.2 5.0 35.5 22.1 7.3 28.5 52.9 31.0 9.7 20.2 12.0 17.1 29.9 22.5 13.9 11.9 7.8 112.9 17.7 20.3 25.6 10.9 64.2 15.4 34.4 26.6 14.4 22.4 13.0 12.0 17.1 3.5 21.6 4.0 6.2 3.3 3.1 14.5 4.1 2.4 2.2 7.0 4.6 20.9 8.3 4.9 6.4 11.4 11.6 11.4 14.2 12.9 13.1 12.5 11.8 10.7 13.0 11.5 12.9 11.8 20.1 6.4 6.5 3.3 8.0 1.3 7.1 11.1 9.6 1.8 5.1 3.8 2.0 5.7 5.4 5.5 0.0 5.3 6.7 15.5 9.8 6.1 0.1 5.8 5.7 17.7 6.1 6.5 3.2 10.2 23.3 5.2 11.7 7.5 13.3 4.9 23.2 8.6 29.1 0.0 2.2 10.4 6.1 36.6 11.7 1.2 3.4 25.4 16.0 4.7 22.9 12.8 7.2 0.0 0.5 13.5 18.1 2.6 6.8 5.9 27.0 9.6 7.0 1.4 0.0 16.7 3.3 0.4 0.4 10.4 1.7 8.9 6.0 3.2 10.9 10.9 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073860-31104799 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA065197 Supported Supported Nucleoplasm,Nucleoli No Yes Nucleoplasm Nucleoli "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 5.8 6.5 7.0 10.3 7.0 29.4 7.2 7.2 7.4 10.6 7.3 8.4 8.0 7.6 4.4 9.6 8.1 6.0 5.2 6.3 6.8 8.1 9.4 6.2 13.3 7.1 6.8 6.0 11.1 17.7 5.8 9.5 5.5 7.7 10.1 10.2 6.7 8.6 5.3 10.7 16.9 13.5 3.6 6.5 13.9 9.6 8.9 7.1 24.3 8.1 6.6 11.2 7.0 9.9 8.0 36.5 35.0 42.2 34.5 5.8 11.0 58.7 21.8 10.4 25.2 28.5 44.1 58.6 49.2 23.9 10.8 23.6 35.0 31.7 28.9 21.3 43.4 66.6 47.4 71.0 25.4 2.1 37.4 35.0 11.9 13.0 32.6 24.8 16.9 12.6 55.2 26.6 103.3 17.6 30.9 64.5 60.7 84.0 39.9 19.5 55.0 53.3 66.2 13.3 38.5 30.2 21.7 23.4 33.2 10.4 65.0 27.3 25.5 8.2 22.0 42.1 42.2 40.0 39.4 29.6 95.3 24.6 32.5 20.3 0.0 1.3 0.8 2.0 1.2 1.5 2.5 1.9 1.5 1.5 2.6 2.0 2.6 0.5 2.2 4.4 2.4 2.0 1.3 7.0 7.0 7.2 7.4 6.3 6.8 7.1 6.8 6.0 7.7 6.5 7.1 8.0 10.1 3.2 9.5 1.6 9.0 6.0 4.0 6.0 2.2 9.4 8.3 7.1 2.5 4.3 6.0 0.0 14.6 7.6 8.8 7.8 0.0 2.0 1.7 5.5 8.9 5.4 0.0 15.3 2.5 3.3 7.5 5.7 9.7 7.4 5.7 15.6 6.1 7.7 5.2 8.4 3.6 6.5 10.2 4.1 5.4 1.3 7.2 4.4 7.2 3.7 3.5 2.7 4.1 1.5 1.7 3.2 2.7 4.5 17.2 6.0 2.3 1.4 6.7 25.8 0.0 4.9 4.8 5.3 18.0 5.5 6.5 2.6 8.4 4.1 9.5 5.1 HEBP1 "HBP, HEBP" ENSG00000013583 "Heme binding protein 1" Q9NRV9 12 12974870-13000265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 245.1" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 837.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056417, HPA075277" Approved Approved Nucleoplasm,Vesicles NA NA 290000 Vesicles Nucleoplasm "HPA056417: AB_2683122, HPA075277: AB_2686741" "unprognostic (1.65e-1)" "unprognostic (2.31e-2)" "unprognostic (9.28e-2)" "unprognostic (5.67e-3)" "unprognostic (4.45e-3)" "unprognostic (5.42e-3)" "unprognostic (2.70e-1)" "unprognostic (2.44e-1)" "unprognostic (6.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.94e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.71e-2)" "unprognostic (1.64e-1)" "unprognostic (4.02e-2)" "unprognostic (4.43e-2)" 72.2 109.0 41.8 21.2 49.2 58.4 67.2 47.2 46.3 51.9 47.5 44.0 245.1 44.2 17.5 43.0 50.4 41.7 58.2 39.9 46.4 65.4 147.0 55.1 28.5 50.2 45.6 39.9 80.6 76.5 50.7 28.0 34.9 48.3 42.8 22.0 15.3 44.1 37.1 39.6 60.1 167.1 39.0 49.0 59.0 45.4 30.0 47.0 19.7 123.7 38.0 21.6 51.6 50.7 53.7 74.2 46.2 29.3 54.8 229.6 167.6 20.5 65.0 91.0 60.2 79.7 29.8 26.6 21.2 25.2 128.8 51.9 64.7 37.6 54.2 69.1 3.0 30.0 12.0 51.0 74.2 159.1 22.3 11.3 134.7 47.9 80.7 101.9 187.0 124.3 25.1 13.6 19.4 103.9 48.1 18.3 34.9 42.5 71.5 30.0 40.2 85.3 22.1 50.8 74.1 16.6 14.8 85.6 41.1 86.5 84.2 21.3 33.6 140.2 45.7 53.1 72.6 36.2 16.4 14.4 7.9 73.2 38.5 18.8 15.6 65.7 17.2 9.6 49.4 13.5 11.5 16.5 10.4 51.2 11.8 20.6 12.1 21.0 18.7 69.8 25.3 9.7 25.9 41.8 49.2 47.2 46.3 39.9 46.4 50.2 45.6 39.9 48.3 49.0 47.0 53.7 120.1 54.5 21.3 2.0 14.9 37.5 56.2 38.3 39.9 43.0 73.3 95.8 26.7 115.8 19.8 57.0 4.2 36.2 14.5 56.5 99.7 89.5 33.8 8.6 27.4 80.4 20.4 174.4 1.5 100.3 27.1 68.6 28.5 14.6 1.3 31.6 162.4 121.7 82.0 6.7 1.7 45.3 18.3 85.4 43.1 13.0 89.2 53.7 62.2 0.0 78.1 44.2 10.3 4.5 3.5 71.1 90.5 94.0 8.0 79.8 837.6 93.0 7.0 6.7 52.6 35.7 40.8 13.8 7.5 44.5 36.1 26.3 14.5 84.3 93.6 54.3 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12891559-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 203.7;urinary bladder: 132.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 939.1;Club cells: 357.8;Distal enterocytes: 477.9;Pancreatic endocrine cells: 600.7;Paneth cells: 359.8;Urothelial cells: 1252.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 355.6;A549: 285.7;CAPAN-2: 1347.4;HaCaT: 351.2;SiHa: 492.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 23.8 3.7 1.2 11.6 0.9 1.8 9.7 0.9 2.4 21.9 4.6 56.9 18.9 9.0 0.4 23.2 9.9 25.1 10.9 1.7 2.4 8.9 1.8 203.7 0.2 2.6 3.0 1.0 21.6 2.8 0.9 2.6 13.6 1.2 10.3 48.9 1.6 23.6 1.3 0.7 5.5 21.0 5.1 0.5 0.4 33.9 1.5 3.3 0.3 56.0 0.6 4.5 132.1 30.8 2.4 355.6 285.7 0.1 1.3 3.4 1.5 18.4 105.2 39.5 66.2 49.4 49.1 1347.4 0.1 8.6 83.3 67.2 351.2 1.0 50.1 101.7 0.4 4.3 0.2 105.4 2.2 23.8 0.1 0.3 1.8 66.5 27.5 6.7 82.3 40.9 0.0 0.5 0.3 2.9 251.7 0.2 0.3 1.6 130.0 43.5 0.2 6.7 0.3 133.6 69.6 0.5 0.6 492.0 36.8 15.9 52.3 10.9 1.0 4.0 2.6 83.9 156.1 4.3 0.2 0.3 0.3 34.6 0.3 2.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.2 0.9 0.9 2.4 1.7 2.4 2.6 3.0 1.0 1.2 0.5 3.3 2.4 10.0 939.1 200.2 0.0 1.0 12.5 329.6 202.8 4.6 0.1 80.6 41.7 1.9 11.5 357.8 46.0 0.0 3.8 1.5 477.9 0.0 46.9 0.1 91.8 54.1 15.8 8.3 0.0 0.2 72.1 11.7 108.5 176.9 288.1 10.1 0.2 8.6 0.2 1.6 0.0 0.4 43.5 61.1 0.3 18.0 0.4 13.4 9.6 51.6 0.0 0.6 3.5 0.0 0.0 0.1 600.7 359.8 10.1 0.5 320.1 114.0 0.2 86.3 0.4 0.0 23.0 38.8 1.5 0.3 22.7 9.1 1.1 4.9 0.7 110.4 1252.7 MAMLD1 "CG1, CXorf6, F18" ENSG00000013619 "Mastermind like domain containing 1" Q13495 X 150361422-150514178 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 33.0;Excitatory neurons: 27.5;Leydig cells: 33.8;Oligodendrocyte precursor cells: 81.4;Peritubular cells: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 23.3;U-2197: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003923 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003923: AB_10602034" "unprognostic (4.18e-3)" "unprognostic (1.74e-1)" "unprognostic (1.63e-1)" "unprognostic (4.29e-2)" "unprognostic (4.16e-2)" "unprognostic (5.09e-2)" "unprognostic (2.31e-1)" "unprognostic (7.68e-2)" "unprognostic (2.08e-2)" "unprognostic (9.74e-2)" "unprognostic (9.86e-3)" "unprognostic (4.82e-2)" "unprognostic (1.86e-1)" "unprognostic (3.33e-2)" "unprognostic (3.58e-2)" "unprognostic (1.41e-3)" "unprognostic (9.76e-3)" 4.7 2.6 4.4 1.5 5.8 1.6 3.4 0.1 3.6 4.0 0.0 2.5 0.9 5.4 2.2 1.7 5.0 2.4 1.9 4.0 6.0 1.7 1.7 4.8 1.6 1.6 2.2 4.3 13.0 3.1 2.0 4.4 1.8 2.5 3.1 1.1 2.9 1.8 6.7 4.5 1.7 1.3 3.1 0.5 1.4 2.0 10.3 7.3 0.8 1.1 1.9 1.1 3.7 2.4 1.3 7.3 2.9 3.8 7.6 10.9 4.1 0.0 6.8 14.3 10.3 23.3 0.0 0.4 0.0 3.4 16.3 8.1 0.2 4.2 3.2 14.0 10.4 0.3 0.1 8.8 0.2 8.1 0.4 0.0 5.6 0.6 11.7 1.4 5.2 2.2 0.6 0.2 0.0 9.9 1.4 0.0 0.1 0.7 0.0 5.4 0.5 14.7 0.4 1.7 0.1 0.9 0.8 2.4 0.2 3.8 0.9 0.2 0.1 2.8 5.5 6.9 36.8 12.2 0.4 0.5 0.2 15.2 2.9 7.6 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.4 0.3 0.0 0.2 0.3 0.7 0.1 0.1 0.0 0.0 0.5 0.2 4.4 5.8 0.1 3.6 4.0 6.0 1.6 2.2 4.3 2.5 0.5 7.3 1.3 3.3 0.0 0.5 33.0 0.4 3.4 0.9 1.2 0.0 1.5 1.9 0.9 1.9 5.7 0.2 0.0 10.4 0.0 0.1 0.0 1.9 3.2 1.1 1.4 5.2 5.5 3.6 3.2 27.5 2.5 0.0 4.8 0.0 3.3 0.0 5.4 4.6 4.8 0.5 13.5 18.3 0.6 0.0 0.8 20.5 4.6 33.8 2.3 3.6 11.2 0.6 2.2 0.0 81.4 5.0 2.2 0.1 24.0 0.3 3.1 0.0 0.4 0.1 0.6 6.6 2.8 3.4 0.3 0.4 0.2 4.1 0.0 1.9 8.3 0.0 0.4 CD6 Tp120 ENSG00000013725 "CD6 molecule" P30203 11 60971680-61020377 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.7;lymphoid tissue: 43.5" "Cell type enhanced" "Detected in many" "dendritic cells: 25.7;NK-cells: 49.4;Plasma cells: 18.5;T-cells: 107.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "gdT-cell: 27.7;MAIT T-cell: 24.7;memory CD4 T-cell: 51.4;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.4;naive CD8 T-cell: 25.2;T-reg: 25.5" "Lineage enriched" "Detected in many" 51 "T-cells: 51.4" "Group enriched" "Detected in some" 12 "JURKAT: 10.2;MOLT-4: 39.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002489, CAB016252" Enhanced "Secreted to blood" NA NA 5270000 160000 "CAB002489: AB_563605, CAB016252: AB_631163" "prognostic favorable (1.95e-4)" "prognostic favorable (1.57e-5)" "unprognostic (4.47e-2)" "prognostic favorable (2.41e-4)" "unprognostic (2.06e-2)" "prognostic favorable (5.10e-6)" "unprognostic (8.45e-3)" "unprognostic (8.21e-3)" "unprognostic (2.87e-3)" "unprognostic (5.32e-3)" "unprognostic (2.07e-1)" "unprognostic (5.35e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "unprognostic (6.19e-2)" "unprognostic (5.96e-2)" 1.2 0.9 1.2 22.1 0.8 11.4 1.2 0.4 0.9 1.3 0.8 3.2 4.1 0.9 0.7 1.8 1.4 4.0 0.5 0.5 1.2 0.9 1.4 6.7 43.5 1.4 1.4 0.9 0.9 0.6 0.2 0.4 0.3 1.6 1.1 3.1 0.2 3.3 0.4 0.8 1.3 13.7 0.8 1.0 18.1 6.6 0.7 2.0 40.0 1.4 0.3 29.2 4.8 1.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.2 0.0 0.0 0.0 39.2 0.1 0.2 0.2 0.1 0.1 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.4 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.7 0.0 24.7 1.0 51.4 48.4 0.3 0.9 34.4 25.2 0.7 0.2 0.0 0.0 25.5 13.8 1.2 0.8 0.4 0.9 0.5 1.2 1.4 1.4 0.9 1.6 1.0 2.0 0.9 3.2 0.0 2.5 0.3 10.8 2.0 0.2 0.1 0.0 1.4 0.9 0.8 2.6 1.5 0.1 0.0 0.0 0.2 25.7 0.2 0.0 0.2 0.9 0.4 0.3 1.2 0.0 0.0 0.8 0.6 0.2 1.5 8.2 0.3 0.0 0.1 2.5 0.8 2.0 1.7 0.9 0.0 0.0 1.9 4.4 0.4 0.3 3.4 3.6 1.0 2.4 0.0 49.4 0.0 0.2 0.7 0.2 0.0 18.5 0.0 0.1 0.2 0.1 0.2 0.0 1.0 0.9 0.4 0.9 1.0 1.4 0.3 107.3 0.7 0.5 0.4 TACC3 "ERIC-1, ERIC1, maskin, Tacc4" ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1712891-1745171 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 59.4;lymphoid tissue: 52.9;testis: 51.0" "Cell type enhanced" "Detected in many" "Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes Yes 11000 "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 5.3 3.9 4.1 25.2 3.9 59.4 3.5 4.5 5.9 3.0 4.6 10.4 6.7 3.3 4.9 15.0 2.8 4.2 3.1 5.1 4.0 2.7 3.6 6.6 43.6 4.3 3.9 3.3 2.3 1.5 2.3 2.6 8.8 4.4 2.4 10.7 1.9 3.9 2.5 2.0 6.5 13.0 6.4 3.8 22.2 6.5 51.0 4.4 52.9 2.8 3.4 39.6 5.1 5.4 6.1 106.7 88.7 129.5 72.2 6.7 15.2 72.9 114.6 62.1 135.4 87.6 93.5 122.8 133.8 48.0 65.4 149.9 71.4 142.5 86.8 131.1 59.8 77.0 113.8 67.2 85.8 5.9 146.6 85.5 5.2 5.7 85.6 46.0 26.0 102.2 110.3 106.3 90.8 123.8 87.1 207.5 204.0 139.3 89.2 111.6 139.1 90.5 55.0 73.8 125.5 99.8 62.8 70.1 42.3 33.1 95.2 83.3 90.5 56.4 75.4 90.0 65.4 176.7 69.5 102.5 207.1 43.2 141.1 109.1 45.5 30.0 37.9 8.5 12.5 11.1 7.8 16.5 11.5 15.3 10.8 28.3 13.1 91.8 12.2 9.6 8.3 42.5 32.5 4.1 3.9 4.5 5.9 5.1 4.0 4.3 3.9 3.3 4.4 3.8 4.4 6.1 6.0 0.0 6.7 2.0 16.5 2.2 1.2 3.2 1.2 1.7 2.4 3.0 2.6 2.8 3.4 9.2 8.4 19.5 6.4 11.2 0.0 2.2 70.4 4.2 2.8 5.2 1.2 37.2 2.3 0.7 20.4 6.0 12.8 4.3 5.1 24.5 8.9 5.1 43.9 5.0 3.2 9.5 4.1 23.2 10.8 69.9 2.8 34.1 0.0 4.7 24.4 1.4 6.2 0.5 0.8 2.9 4.2 2.6 18.0 1.3 2.6 2.8 0.9 2.7 6.6 2.0 4.8 94.3 37.7 12.8 1.4 4.0 23.2 2.2 16.1 2.7 UFL1 "KIAA0776, Maxer, NLBP, RCAD" ENSG00000014123 "UFM1 specific ligase 1" O94874 6 96521595-96555276 "Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030558, HPA030559, HPA030560" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000" "unprognostic (5.40e-2)" "unprognostic (7.48e-3)" "unprognostic (1.06e-2)" "unprognostic (1.99e-1)" "unprognostic (8.12e-2)" "unprognostic (9.04e-2)" "unprognostic (9.99e-2)" "unprognostic (4.67e-2)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (1.49e-1)" "unprognostic (1.50e-1)" "unprognostic (4.46e-2)" "unprognostic (4.10e-2)" "unprognostic (5.92e-2)" "unprognostic (8.65e-2)" "unprognostic (4.46e-1)" 17.1 20.8 11.0 19.1 14.3 18.1 21.7 13.3 15.5 20.9 10.8 18.9 22.9 19.2 23.6 20.9 17.0 18.1 23.9 10.7 15.0 21.5 29.9 15.6 22.3 15.1 13.4 9.3 22.6 25.4 25.1 10.0 18.3 16.0 24.6 19.7 31.9 23.7 18.1 21.3 20.5 23.0 17.2 14.0 18.1 22.0 14.3 12.4 21.0 28.3 21.6 22.0 20.3 11.3 21.1 16.9 8.8 18.3 30.7 25.8 39.2 27.2 23.3 23.6 14.6 13.6 11.0 19.2 40.7 28.9 23.5 16.2 32.0 15.0 22.0 21.3 21.9 13.6 17.9 13.3 20.2 34.3 34.0 25.6 28.2 20.1 17.4 47.9 27.1 24.2 25.7 24.1 43.7 27.9 16.3 12.5 21.0 6.6 14.5 9.9 15.6 21.4 32.6 26.5 30.5 12.9 12.5 19.2 22.4 21.5 16.2 54.4 28.7 24.0 20.3 11.0 20.8 24.7 25.7 14.2 30.9 31.2 22.5 19.0 8.7 7.9 8.9 8.7 10.1 10.0 9.6 9.2 9.4 10.2 8.6 11.4 9.3 1.6 13.1 10.4 10.7 11.1 7.2 11.0 14.3 13.3 15.5 10.7 15.0 15.1 13.4 9.3 16.0 14.0 12.4 21.1 42.8 57.7 50.2 54.2 53.9 19.5 34.4 52.2 36.5 48.8 33.3 33.8 60.4 31.5 64.9 46.0 45.9 64.1 57.2 31.6 19.6 42.0 61.0 64.3 60.8 35.1 19.8 30.7 26.5 50.7 34.3 45.2 32.1 62.2 30.9 43.0 32.5 69.5 35.4 43.7 33.0 48.9 36.7 33.2 13.9 44.1 50.1 37.5 14.2 30.9 42.5 34.9 39.1 58.3 103.1 40.4 29.9 50.4 72.7 29.8 46.1 30.7 76.1 74.9 19.7 49.0 44.2 85.3 37.8 37.6 19.2 91.0 46.5 59.5 35.9 29.8 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261920-65305589 "Metabolic proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.2;Spermatocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 3.0 2.6 1.8 5.3 3.0 7.0 3.5 4.8 3.3 4.5 1.8 5.4 3.6 5.1 3.3 4.5 3.8 1.8 2.7 2.0 2.2 3.5 3.7 3.5 10.1 4.0 3.0 1.7 5.2 3.4 3.2 1.9 2.1 3.8 3.0 4.9 3.7 4.2 3.1 3.1 5.2 4.2 4.2 3.2 5.7 3.9 5.3 2.7 16.0 3.3 3.4 13.3 3.2 3.2 7.2 32.6 21.9 47.3 20.4 3.7 3.6 19.5 25.6 15.9 64.4 43.3 6.9 24.0 48.1 20.4 11.0 35.5 18.9 38.8 25.1 61.1 21.3 14.7 32.4 39.4 10.4 0.9 33.5 25.6 3.7 2.9 47.4 8.5 10.3 14.6 20.2 30.2 25.3 44.4 34.9 62.6 13.2 38.6 16.1 16.2 33.4 29.9 40.7 14.1 21.8 32.5 18.1 14.9 15.9 7.9 29.7 28.6 14.1 3.9 25.4 18.7 19.8 16.0 12.0 14.7 45.0 14.9 18.8 33.7 10.0 5.2 2.3 3.8 3.2 4.5 3.9 4.2 4.2 7.4 3.9 3.5 3.1 1.4 3.8 1.7 5.9 4.6 5.3 1.8 3.0 4.8 3.3 2.0 2.2 4.0 3.0 1.7 3.8 3.2 2.7 7.2 2.6 0.0 3.4 1.0 5.1 1.7 4.2 5.7 2.2 2.2 3.0 2.3 2.9 7.2 3.7 5.5 2.1 15.6 4.3 3.0 3.9 5.3 2.7 1.8 2.9 3.7 3.0 23.2 4.3 3.4 19.0 7.7 5.6 2.5 0.0 11.0 5.3 2.1 9.7 3.3 3.6 3.5 2.0 2.8 3.7 4.0 7.5 5.3 0.0 12.2 8.0 2.2 5.2 1.5 8.7 4.9 2.2 7.5 10.4 3.4 1.7 2.0 3.2 5.4 6.6 19.6 5.0 23.7 17.7 4.3 1.4 7.3 5.5 4.0 6.3 3.7 ZC3H3 "KIAA0150, ZC3HDC3" ENSG00000014164 "Zinc finger CCCH-type containing 3" Q8IXZ2 8 143437659-143541447 "Predicted intracellular proteins" "mRNA transport, Transport" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023658, HPA050577" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023658: AB_1858973, HPA050577: " "unprognostic (1.15e-1)" "unprognostic (7.74e-2)" "unprognostic (1.87e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.18e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (4.38e-7)" "unprognostic (3.59e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "unprognostic (2.18e-1)" 15.9 12.8 5.1 5.7 5.1 17.4 14.5 4.6 9.5 11.8 1.7 13.1 11.8 12.4 1.0 14.7 11.4 2.2 10.3 5.7 3.0 24.6 46.2 14.7 5.1 5.2 3.8 4.4 12.1 10.6 3.0 8.2 3.7 5.3 12.2 1.6 1.9 11.1 3.6 21.2 16.6 21.7 2.6 2.9 19.3 11.9 19.5 5.0 5.4 14.1 2.9 2.5 12.3 12.1 5.7 11.3 16.1 5.1 12.4 3.1 3.6 13.7 6.4 4.5 8.0 6.5 8.8 10.3 8.0 11.2 5.3 4.3 12.9 4.1 6.6 1.7 16.7 14.2 10.0 10.6 14.2 7.6 5.0 8.9 8.0 6.1 6.6 4.7 3.7 5.9 7.6 17.1 14.5 3.3 29.3 24.1 9.7 9.4 9.2 26.0 13.9 4.1 25.6 5.9 6.8 13.1 8.7 12.4 10.9 7.1 2.6 17.5 9.4 8.2 7.0 21.1 15.4 11.3 13.2 9.4 6.8 9.1 11.6 7.8 6.5 4.6 6.3 3.9 5.5 4.5 3.2 4.6 4.8 3.7 2.7 5.8 4.8 9.1 2.2 3.6 3.2 3.4 5.4 5.1 5.1 4.6 9.5 5.7 3.0 5.2 3.8 4.4 5.3 2.9 5.0 5.7 6.9 0.0 2.3 10.7 8.4 7.0 3.4 4.5 5.7 7.3 5.1 3.4 1.4 4.3 3.4 5.5 8.4 7.9 4.0 14.2 1.9 6.5 8.8 5.6 6.1 5.5 10.7 12.8 9.8 7.3 9.4 5.4 20.4 7.2 5.7 28.1 5.0 13.2 8.5 5.0 9.9 11.2 6.1 9.8 6.0 7.9 5.3 10.9 3.6 6.5 6.4 6.1 7.2 4.0 10.5 7.6 2.3 5.7 8.4 4.4 16.7 11.2 3.5 7.5 13.1 4.0 5.8 22.8 14.8 6.3 8.7 12.3 7.2 3.8 9.0 5.5 CAPN1 "CANP, CANPL1, muCANP, muCL" ENSG00000014216 "Calpain 1" P07384 11 65180566-65212006 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 278.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 516.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005992 Enhanced Supported Cytosol NA NA 9100000 Cytosol "HPA005992: AB_1845924" "unprognostic (2.07e-1)" "unprognostic (2.15e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (4.06e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (7.23e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.33e-1)" "prognostic favorable (7.06e-8)" "unprognostic (5.70e-3)" "unprognostic (1.51e-1)" "unprognostic (1.86e-1)" "unprognostic (2.98e-1)" 42.6 43.5 26.2 52.3 23.8 67.1 48.8 28.3 29.7 73.2 24.7 79.4 81.1 56.8 27.7 278.4 93.1 56.0 53.6 26.0 30.4 53.3 44.7 57.4 57.5 36.1 29.7 24.1 44.9 72.3 36.9 41.1 56.7 41.4 62.6 58.1 9.7 119.7 68.0 85.6 126.1 88.8 45.7 29.1 50.6 66.1 6.2 33.3 49.9 72.1 55.8 87.1 84.2 118.4 32.1 285.6 147.9 42.9 97.2 77.9 104.3 127.0 84.1 144.2 103.0 74.9 94.8 250.2 71.2 136.0 179.3 111.1 409.8 60.9 366.9 32.2 76.4 44.1 170.8 80.4 93.7 76.2 40.6 228.0 107.3 196.8 85.9 43.2 92.6 178.5 50.6 103.1 55.9 87.4 181.8 83.1 130.6 120.5 145.2 133.8 80.7 43.0 43.2 138.1 516.5 76.2 55.7 87.4 331.4 80.3 45.8 142.8 77.9 147.1 73.1 50.5 159.0 38.5 33.8 26.9 86.6 127.5 48.8 82.3 87.6 57.5 77.9 39.4 51.2 31.0 30.8 30.7 35.8 48.4 31.7 17.6 24.9 33.1 34.8 30.4 38.1 35.9 74.8 26.2 23.8 28.3 29.7 26.0 30.4 36.1 29.7 24.1 41.4 29.1 33.3 32.1 27.3 25.6 27.9 21.5 39.6 59.9 127.3 120.5 56.9 10.7 44.7 36.6 22.0 74.4 81.0 77.3 20.9 238.5 61.4 184.2 39.2 180.5 0.5 41.9 26.3 31.3 44.3 58.3 15.9 115.8 111.7 39.6 57.6 58.2 46.9 48.6 37.9 36.7 88.7 21.9 15.2 76.9 59.0 51.2 34.0 2.0 43.5 67.1 48.0 14.0 112.7 38.5 61.8 6.6 1.9 179.4 124.1 50.8 17.7 78.6 155.6 34.6 71.1 16.2 39.5 25.3 36.7 0.5 2.8 102.0 68.9 196.6 40.2 35.4 125.3 156.6 ACP3 "ACP-3, ACPP, PAP, TM-PAP" ENSG00000014257 "Acid phosphatase 3" P15309 3 132317369-132368298 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 76 "prostate: 3676.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 13.9;Hofbauer cells: 4.7;Syncytiotrophoblasts: 8.9" "Cancer enriched" "Detected in many" 275 "prostate cancer: 1227.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 139.7" "Lineage enhanced" "Detected in many" "granulocytes: 139.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 17.7;OE19: 22.3;RPMI-8226: 58.0;U-698: 17.2;U-87 MG: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000071, HPA004335, HPA063916" Enhanced "Secreted to blood" NA NA 460000 480000 "CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152" "unprognostic (6.67e-2)" "unprognostic (4.70e-2)" "unprognostic (1.76e-1)" "unprognostic (7.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.58e-2)" "unprognostic (2.46e-1)" "unprognostic (7.41e-2)" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (2.14e-1)" "unprognostic (5.95e-2)" "unprognostic (9.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-1)" "unprognostic (3.91e-2)" "unprognostic (1.71e-1)" 3.1 5.4 0.9 7.4 1.3 17.7 3.4 0.8 1.4 3.4 1.4 3.7 3.2 1.4 17.4 48.1 2.2 1.5 0.5 1.1 1.8 29.1 1.4 4.5 1.9 1.5 1.0 0.8 1.1 2.7 3.9 0.5 10.9 1.4 3676.7 6.5 0.4 10.7 0.8 0.2 27.2 3.4 1.8 1.1 1.8 3.2 2.4 1.2 1.0 2.4 0.2 6.6 1.8 12.2 2.2 0.5 0.1 0.0 0.0 0.2 0.9 11.7 0.3 17.7 0.1 0.0 0.4 0.4 10.6 0.8 0.0 0.1 4.8 0.0 0.1 0.0 0.1 0.5 2.0 0.4 0.2 0.2 7.3 0.1 1.1 1.6 0.1 0.0 0.2 0.0 0.0 0.1 2.7 0.2 0.1 0.0 13.5 0.7 22.3 2.1 0.1 0.0 58.0 5.0 6.5 0.0 4.1 0.1 2.0 0.6 1.7 0.3 6.5 0.0 0.1 0.1 2.5 0.1 0.8 0.4 17.2 14.9 12.7 0.2 0.1 30.2 139.7 0.2 26.9 0.2 0.7 0.0 0.0 35.3 0.0 0.0 0.0 26.4 2.6 25.8 2.4 0.0 10.1 0.9 1.3 0.8 1.4 1.1 1.8 1.5 1.0 0.8 1.4 1.1 1.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 MDH1 ENSG00000014641 "Malate dehydrogenase 1" P40925 2 63588609-63607197 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1362.1;tongue: 1860.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027296, CAB047333, HPA054276" Uncertain Supported Centrosome,Cytosol NA NA 49000000 "Centrosome, Cytosol" "CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434" "unprognostic (1.01e-1)" "unprognostic (6.52e-3)" "unprognostic (1.61e-2)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.83e-1)" "unprognostic (8.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.79e-2)" "unprognostic (9.52e-2)" "unprognostic (2.05e-1)" "unprognostic (3.26e-1)" "unprognostic (8.80e-2)" "prognostic favorable (9.95e-4)" "unprognostic (6.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.97e-2)" "unprognostic (3.05e-1)" 277.1 215.6 245.7 87.5 280.3 79.8 139.3 275.1 352.7 90.3 251.0 169.3 156.1 82.8 162.7 126.4 115.5 88.0 1362.1 274.5 297.6 375.1 268.5 90.6 133.0 271.6 257.1 281.4 81.2 70.5 415.4 108.1 93.3 284.8 126.6 192.7 242.8 123.0 143.3 800.0 88.4 134.2 173.0 238.9 72.2 194.4 71.1 280.6 171.9 126.6 1860.1 166.7 132.7 63.3 381.6 268.2 219.5 257.8 173.2 369.6 280.9 282.3 215.1 295.9 300.6 304.1 252.5 215.4 355.2 112.8 264.1 358.8 214.3 303.0 355.0 425.5 207.6 253.1 337.0 173.2 376.8 202.1 384.1 223.9 277.7 241.3 271.5 152.7 236.2 235.3 308.1 183.7 217.3 395.1 157.8 300.6 317.5 158.0 376.3 266.5 235.2 349.7 310.5 460.9 251.0 249.9 153.6 182.5 257.7 384.1 205.6 191.9 341.9 149.6 220.3 211.9 187.1 252.9 264.6 264.8 407.6 266.2 312.2 184.1 271.3 186.3 200.2 202.7 267.8 218.8 258.5 236.6 224.6 241.0 258.5 230.3 221.6 28.1 214.6 253.4 184.3 320.9 321.2 245.7 280.3 275.1 352.7 274.5 297.6 271.6 257.1 281.4 284.8 238.9 280.6 381.6 44.4 60.9 54.3 54.9 78.7 81.6 109.4 562.9 50.7 165.4 81.0 86.7 1926.9 95.8 227.2 134.3 70.9 248.7 78.4 128.4 630.0 186.2 12.4 116.1 72.6 61.0 62.8 62.9 120.2 108.1 257.0 134.7 112.7 68.8 80.5 95.0 36.0 153.2 397.0 122.8 130.0 115.9 380.5 85.2 65.8 15.1 100.0 98.4 177.9 43.1 155.0 136.3 73.2 51.3 58.8 91.3 99.8 109.1 82.1 48.8 177.4 1428.3 224.5 164.1 59.2 68.3 167.8 58.0 65.6 82.7 84.0 149.5 84.3 137.4 167.8 102.6 SLC30A9 "C4orf1, GAC63, HUEL, ZNT9" ENSG00000014824 "Solute carrier family 30 member 9" Q6PML9 4 41990502-42090461 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transcription, Transcription regulation, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004014 Approved NA NA "HPA004014: AB_1080005" "unprognostic (4.26e-2)" "unprognostic (2.20e-1)" "unprognostic (1.31e-3)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-2)" "unprognostic (1.43e-1)" "unprognostic (1.55e-1)" "unprognostic (6.99e-2)" "prognostic favorable (2.86e-14)" "unprognostic (4.67e-2)" "unprognostic (1.34e-1)" "unprognostic (2.22e-2)" "unprognostic (1.39e-2)" 8.9 15.5 12.9 7.0 14.3 5.9 13.9 13.9 15.4 11.9 13.4 13.6 12.7 10.4 16.2 9.4 9.9 8.7 21.3 14.2 14.2 30.8 14.4 9.0 7.5 13.3 13.3 12.8 11.2 13.0 22.8 14.7 9.4 13.8 13.7 14.1 20.0 12.3 10.1 14.9 9.7 11.6 8.6 12.4 8.0 13.0 6.9 13.2 9.2 17.4 20.7 7.9 9.6 8.1 14.8 12.7 6.2 20.3 23.2 15.3 21.3 11.4 17.3 20.8 14.8 17.5 6.4 16.2 13.0 12.2 20.0 19.1 6.3 17.3 14.3 21.1 4.4 10.2 14.9 10.7 10.9 27.1 20.8 10.3 17.0 14.4 12.7 16.5 23.8 16.3 12.9 20.4 6.0 26.2 6.1 12.0 19.6 15.6 19.7 8.5 5.9 18.4 10.8 30.2 10.6 22.5 25.3 12.3 13.5 15.9 14.3 17.2 15.5 17.7 17.4 10.1 17.6 20.3 11.9 9.5 12.3 23.8 17.4 15.5 3.1 1.8 1.0 1.2 2.3 1.3 1.3 1.3 1.5 2.5 1.1 1.7 1.4 0.8 2.1 1.9 1.8 1.6 1.4 12.9 14.3 13.9 15.4 14.2 14.2 13.3 13.3 12.8 13.8 12.4 13.2 14.8 19.7 48.1 44.5 48.3 26.5 15.2 22.8 24.7 24.5 34.9 30.3 16.9 90.7 32.9 33.8 38.6 25.0 44.4 11.4 33.8 103.7 35.9 7.1 27.3 29.2 22.1 33.5 32.2 70.0 36.4 34.0 27.7 37.8 26.8 34.2 33.3 21.4 25.4 24.2 50.5 74.7 36.7 30.5 22.2 21.1 8.7 20.8 23.8 24.9 43.1 28.0 29.7 9.2 63.3 84.7 34.3 17.4 22.6 35.8 27.1 25.5 111.7 43.6 39.3 6.6 29.3 28.1 16.1 18.0 40.8 22.7 49.4 21.2 44.8 38.3 24.2 MTMR11 CRA ENSG00000014914 "Myotubularin related protein 11" A4FU01 1 149928651-149936879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 139.2;Intestinal goblet cells: 79.2;Paneth cells: 98.9;Proximal enterocytes: 133.2;Undifferentiated cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.7;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 16 "dendritic cells: 1.7;monocytes: 1.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 17.0;OE19: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030351, HPA072906" Enhanced Approved Centrosome NA NA Centrosome "HPA030351: AB_10602185, HPA072906: " "unprognostic (1.14e-1)" "unprognostic (3.01e-3)" "unprognostic (1.42e-1)" "unprognostic (1.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.37e-2)" "unprognostic (5.81e-2)" "unprognostic (7.94e-2)" "unprognostic (2.98e-1)" "unprognostic (2.88e-2)" "unprognostic (1.22e-1)" "unprognostic (5.83e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (1.80e-2)" "unprognostic (9.12e-2)" 3.4 12.4 4.2 2.9 3.6 0.1 4.2 3.3 4.0 10.3 6.7 22.4 20.5 9.6 7.0 4.4 8.5 13.0 2.7 3.0 9.2 6.9 1.4 3.8 0.7 5.3 3.9 2.9 15.4 2.1 5.1 5.4 4.3 3.6 4.7 27.0 1.0 2.2 7.7 1.0 9.5 23.6 14.0 5.0 1.9 3.9 4.9 3.7 0.7 1.6 2.7 1.0 6.9 7.0 5.2 3.1 7.3 3.1 2.6 8.6 10.1 6.6 3.1 10.0 4.0 4.9 0.2 12.9 0.0 6.7 10.6 4.9 4.3 0.3 5.2 2.4 0.2 0.1 0.0 2.3 0.9 2.2 0.0 0.2 6.3 1.7 4.1 6.8 17.0 4.8 0.1 0.2 0.3 7.8 9.9 0.0 0.1 0.7 20.5 2.9 0.0 1.0 0.1 5.8 0.9 0.2 0.2 1.7 2.9 1.1 2.0 3.0 0.0 3.3 4.5 5.4 4.0 2.7 0.6 1.5 0.0 3.9 0.0 0.5 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 4.2 3.6 3.3 4.0 3.0 9.2 5.3 3.9 2.9 3.6 5.0 3.7 5.2 2.2 0.0 0.6 2.6 0.5 4.1 3.8 8.9 5.2 0.0 3.0 4.1 6.4 5.7 3.6 14.7 0.0 14.1 0.4 139.2 1.9 15.0 0.6 1.7 3.1 4.5 15.7 0.0 4.0 17.0 10.7 7.0 19.4 2.2 0.0 3.0 3.9 1.5 4.8 0.0 4.9 79.2 0.0 11.3 6.1 0.3 5.6 15.7 1.8 1.0 43.8 0.0 0.0 0.0 3.6 45.1 98.9 12.0 0.3 4.9 133.2 18.5 4.5 0.0 6.6 0.5 7.3 0.4 0.6 3.4 6.5 28.5 0.9 6.4 56.5 4.1 COX15 CEMCOX2 ENSG00000014919 "Cytochrome c oxidase assembly homolog COX15" Q7KZN9 10 99710868-99732127 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616" "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.6 31.5 13.5 9.8 14.3 6.6 14.0 13.6 16.5 16.0 14.1 16.3 12.7 15.7 14.4 19.0 15.3 10.5 18.6 13.3 13.5 21.3 23.6 11.5 13.8 13.2 13.6 12.9 19.2 16.4 14.7 16.3 10.9 13.7 14.6 16.2 15.5 14.3 11.1 34.8 14.8 15.7 11.0 13.1 18.0 16.4 12.1 14.3 13.6 13.7 27.4 16.2 19.8 15.1 14.8 22.7 50.3 19.6 42.9 28.4 22.4 15.9 16.9 22.1 25.0 23.9 37.6 30.2 42.8 26.6 15.4 15.6 32.1 44.2 25.7 26.5 19.2 21.0 25.1 23.5 39.6 30.0 33.5 22.3 23.3 23.9 27.7 40.9 36.6 26.3 36.1 27.3 29.6 24.2 24.8 24.7 27.6 21.0 22.1 22.0 30.2 29.5 27.9 24.8 16.6 16.7 26.4 29.9 16.6 29.5 15.7 61.2 13.2 22.1 12.4 17.1 18.7 25.6 25.2 36.2 28.5 22.7 53.2 10.7 19.6 12.8 12.4 7.4 15.2 8.8 12.7 8.6 8.4 13.9 11.3 8.6 8.9 7.9 8.7 18.5 5.7 9.9 9.7 13.5 14.3 13.6 16.5 13.3 13.5 13.2 13.6 12.9 13.7 13.1 14.3 14.8 11.4 22.4 8.4 32.0 14.1 6.1 10.3 13.2 12.0 14.7 14.2 11.2 25.2 14.3 15.9 14.7 10.4 23.7 9.0 16.5 29.4 17.6 1.9 14.0 15.4 10.8 17.5 9.4 18.7 15.8 20.7 9.6 11.7 14.6 2.5 21.5 7.9 27.2 17.4 13.5 23.7 13.4 6.1 27.4 8.6 1.9 10.5 14.7 12.4 12.2 18.5 13.4 13.4 16.6 26.1 13.2 11.9 10.1 9.0 7.5 16.5 24.5 27.7 15.5 0.0 11.0 9.4 10.1 9.5 12.2 9.2 22.7 10.3 35.8 16.6 9.3 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.5;lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" "dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 37.0" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favorable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 4.5 1.4 5.9 19.6 20.7 31.5 6.9 3.6 6.2 3.7 2.8 9.5 13.4 3.1 1.7 12.6 12.3 6.3 2.9 3.5 4.9 6.8 3.6 9.8 34.2 8.5 5.9 3.8 1.0 8.3 5.4 5.2 2.4 10.7 9.5 7.1 1.0 10.2 3.9 2.4 7.0 11.8 2.3 4.4 21.9 12.5 8.0 5.6 20.5 2.5 2.7 20.6 8.1 7.6 3.6 8.5 6.9 7.5 9.5 0.0 0.0 34.9 0.0 0.0 0.0 0.0 6.8 13.4 45.1 6.1 0.0 0.4 0.4 11.3 6.4 0.0 28.8 4.7 10.0 4.8 9.9 0.7 23.0 8.4 0.0 11.4 0.0 0.0 0.7 8.6 55.6 11.2 50.1 0.1 24.9 24.2 29.6 7.1 6.2 11.5 19.5 0.2 14.2 2.6 10.2 53.6 11.6 4.6 16.9 4.6 5.6 10.2 20.7 2.6 0.0 0.2 0.1 0.1 58.5 76.2 22.8 0.0 20.1 0.1 7.8 3.3 1.3 9.4 1.9 8.8 2.5 6.0 9.2 1.8 2.1 3.8 5.8 2.3 4.0 3.0 2.0 10.7 4.1 5.9 20.7 3.6 6.2 3.5 4.9 8.5 5.9 3.8 10.7 4.4 5.6 3.6 26.6 3.2 28.8 7.8 54.1 9.3 15.9 19.0 27.9 0.0 15.3 7.6 19.8 10.0 22.1 14.7 0.0 3.6 80.1 29.6 0.0 4.4 9.6 62.6 1.4 17.3 23.9 20.6 7.1 5.9 2.2 4.2 20.4 12.1 2.5 1.3 20.3 1.6 6.3 0.0 2.5 15.3 22.4 21.0 12.4 18.7 4.1 18.9 1.8 9.4 20.1 8.0 142.2 8.0 5.2 7.8 18.2 3.0 93.2 16.8 13.1 13.2 112.5 0.1 0.0 2.9 4.4 4.7 17.4 31.2 9.5 1.8 89.2 3.3 19.4 19.8 YAF2 ENSG00000015153 "YY1 associated factor 2" Q8IY57 12 42157104-42238349 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 1187.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026867 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA026867: AB_1858911" "unprognostic (1.41e-1)" "unprognostic (2.24e-1)" "unprognostic (9.30e-2)" "unprognostic (3.06e-1)" "unprognostic (2.06e-2)" "unprognostic (4.12e-1)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.86e-3)" "unprognostic (2.44e-2)" "unprognostic (3.58e-2)" "unprognostic (5.57e-2)" "unprognostic (4.57e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-1)" "unprognostic (5.76e-2)" "unprognostic (1.20e-2)" 10.8 9.6 11.2 8.2 12.1 10.9 10.1 15.6 13.3 9.7 6.3 7.5 6.0 9.5 8.8 7.0 8.9 8.7 36.9 12.7 14.8 9.6 18.2 8.2 12.6 10.8 11.5 11.2 9.1 6.3 7.9 8.7 9.1 12.0 8.3 7.4 14.3 6.7 8.4 29.6 6.3 8.0 10.4 11.4 10.7 6.9 7.4 14.1 13.6 11.2 21.3 10.1 10.0 9.0 14.3 13.5 10.6 15.3 12.1 19.1 16.9 9.9 19.1 17.1 15.5 15.1 14.4 10.7 8.6 14.0 16.6 6.2 11.5 15.0 10.7 21.7 20.5 14.9 18.0 4.6 6.8 11.0 17.6 11.1 12.1 14.9 12.8 25.3 15.7 16.3 8.3 17.2 20.1 20.1 5.6 20.4 21.2 3.9 16.0 14.1 15.0 16.6 13.9 20.1 10.1 11.6 14.6 16.0 18.3 14.8 6.9 12.4 13.0 14.4 13.6 12.1 16.7 9.5 16.6 26.4 31.7 15.0 82.3 6.8 43.2 15.6 28.9 18.2 18.9 18.6 20.6 17.6 20.9 12.5 24.2 13.4 14.5 56.6 27.1 17.2 19.3 26.5 9.7 11.2 12.1 15.6 13.3 12.7 14.8 10.8 11.5 11.2 12.0 11.4 14.1 14.3 41.9 22.4 13.4 68.2 41.1 58.1 40.8 31.0 33.0 75.0 45.2 35.1 1187.5 31.5 27.6 20.2 85.5 40.1 71.2 22.7 62.6 32.2 33.6 27.7 43.1 61.7 38.9 36.2 105.5 45.5 22.4 49.7 18.3 37.0 70.5 88.4 50.7 104.7 27.8 144.7 89.4 33.1 46.8 44.7 61.3 15.9 58.1 37.6 42.7 83.4 48.8 94.6 84.5 97.0 57.8 35.3 26.8 76.8 44.6 37.2 29.9 66.0 20.1 99.7 105.2 44.8 63.8 38.0 38.2 30.5 51.1 45.3 58.7 36.2 27.5 32.7 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm NA NA Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favorable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 42.1 37.4 56.0 26.6 63.7 11.4 46.3 65.8 60.9 47.8 44.3 44.2 30.2 55.6 47.0 43.2 40.1 36.0 58.5 56.4 58.3 51.6 35.2 39.3 26.5 62.5 58.2 50.6 55.8 46.8 100.4 27.9 35.1 59.4 53.2 34.1 43.6 46.5 56.5 58.6 33.4 31.1 51.3 58.4 32.9 39.5 33.4 58.5 24.1 88.8 65.3 25.0 47.1 31.3 65.0 64.0 64.6 53.8 42.9 57.3 55.0 33.3 63.0 35.8 43.7 40.5 39.2 62.3 0.1 19.8 78.4 13.8 38.3 28.9 44.2 55.8 25.1 25.1 71.8 33.4 42.3 64.6 19.5 38.8 38.4 60.6 42.3 38.3 56.8 55.6 32.8 19.5 44.7 76.0 75.4 29.3 27.3 17.4 69.3 10.7 28.4 34.4 34.5 58.0 72.7 24.3 44.3 72.3 83.3 34.1 29.4 74.9 37.8 72.2 43.4 15.8 89.2 48.8 37.0 48.4 4.6 44.2 36.1 30.3 15.6 2.3 19.5 11.9 3.5 10.4 5.2 8.3 11.9 3.8 3.1 9.2 9.1 1.0 14.7 1.7 4.5 8.9 5.0 56.0 63.7 65.8 60.9 56.4 58.3 62.5 58.2 50.6 59.4 58.4 58.5 65.0 51.2 60.9 51.4 90.8 25.3 25.9 27.0 17.5 34.1 37.5 46.3 33.8 103.0 31.5 31.9 33.1 12.5 15.2 39.4 14.6 50.9 29.3 28.6 27.0 50.3 45.7 25.9 25.0 110.8 31.8 4.6 45.7 27.5 37.1 46.2 42.1 35.3 28.1 14.4 20.2 118.0 26.2 16.2 25.1 14.9 27.1 39.1 21.7 24.9 94.6 13.9 62.5 34.0 128.2 131.5 28.1 14.5 56.1 31.1 44.1 19.1 41.9 23.7 22.0 13.1 56.9 49.8 26.8 25.6 32.2 27.8 12.4 32.6 28.5 22.1 29.8 WAS "IMD2, THC, WASP, WASPA" ENSG00000015285 "WASP actin nucleation promoting factor" P42768 X 48676596-48691427 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 59.0;lymphoid tissue: 83.7" "Cell type enhanced" "Detected in many" "B-cells: 83.2;dendritic cells: 91.7;Hofbauer cells: 111.5;Kupffer cells: 110.7;Macrophages: 118.1;monocytes: 88.2;NK-cells: 84.5;Plasma cells: 57.8;T-cells: 99.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 37.4" "Group enriched" "Detected in all" 4 "granulocytes: 37.4;monocytes: 9.5" "Cell line enhanced" "Detected in some" "Daudi: 76.5;HEL: 67.6;HMC-1: 157.0;MOLT-4: 70.8;NB-4: 75.7;RPMI-8226: 94.0;THP-1: 68.8;U-266/70: 83.1;U-937: 87.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002022, CAB004290" Enhanced Approved "Plasma membrane,Cytosol" NA NA 600000 "Plasma membrane" Cytosol "CAB004290: AB_628445, HPA002022: AB_1080581" "unprognostic (1.43e-3)" "unprognostic (2.09e-3)" "unprognostic (2.36e-2)" "prognostic favorable (4.95e-4)" "unprognostic (9.89e-2)" "prognostic favorable (3.78e-4)" "unprognostic (5.12e-3)" "unprognostic (7.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (7.40e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (2.24e-1)" "unprognostic (2.37e-2)" "unprognostic (3.55e-2)" "unprognostic (1.71e-1)" 10.3 5.3 5.3 52.6 6.2 59.0 4.4 5.6 8.2 3.4 7.3 5.3 8.1 2.8 3.0 3.5 5.7 7.0 3.3 5.4 8.9 4.3 7.3 19.2 54.6 8.3 6.2 4.2 1.9 2.4 1.4 2.9 9.1 8.1 4.2 5.1 0.4 4.9 2.8 1.4 2.8 23.2 6.1 7.5 83.7 7.1 1.9 7.9 42.4 3.5 3.4 36.5 10.4 3.0 9.6 0.8 0.2 0.4 1.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.6 0.9 76.5 0.3 0.0 0.3 2.0 0.3 0.2 0.0 44.2 0.4 67.6 0.9 0.0 0.8 34.9 157.0 0.3 0.1 0.1 0.0 0.0 0.0 40.3 0.7 45.7 0.0 7.6 70.8 75.7 0.4 1.1 0.4 61.1 0.3 94.0 0.1 0.0 0.5 0.9 1.0 0.7 0.5 0.2 0.4 68.8 0.5 0.1 0.4 1.2 0.1 83.1 43.6 53.7 0.5 87.4 0.2 3.3 7.6 37.4 4.6 8.4 3.4 3.0 3.5 3.9 5.7 3.3 3.1 3.5 29.2 3.6 9.5 3.1 5.4 4.0 5.3 6.2 5.6 8.2 5.4 8.9 8.3 6.2 4.2 8.1 7.5 7.9 9.6 1.5 3.2 14.3 0.7 83.2 2.4 0.2 0.2 2.2 0.2 1.1 1.8 1.1 0.0 0.1 0.0 0.0 0.9 91.7 0.3 1.9 0.4 0.6 0.4 0.4 2.6 1.2 14.1 0.3 0.4 1.1 1.5 5.6 0.3 48.1 0.2 3.9 1.6 111.5 0.0 0.3 0.2 0.0 110.7 54.5 1.1 0.0 118.1 3.6 4.7 88.2 0.2 84.5 0.5 0.0 0.1 0.1 0.0 57.8 0.2 0.1 1.8 1.6 0.2 0.0 1.0 1.3 1.3 1.1 0.8 1.4 1.4 99.3 0.4 0.1 0.2 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 380.5;kidney: 258.2;pancreas: 444.4" "Cell type enhanced" "Detected in many" "Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Region enhanced" "Detected in single" "thalamus: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 370000 "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.5 2.4 0.6 1.8 0.1 0.5 0.5 0.4 0.2 4.1 0.0 1.7 86.2 0.6 0.9 0.3 0.6 3.9 0.2 0.1 0.3 258.2 0.5 0.9 2.8 0.2 0.3 0.0 0.8 444.4 0.0 0.5 0.9 0.5 0.5 0.5 0.3 1.2 1.1 0.0 1.8 380.5 0.3 0.5 4.5 1.6 46.9 2.5 0.9 0.9 0.0 0.9 2.2 0.9 0.5 0.0 0.9 0.2 0.0 1.7 0.2 4.4 0.0 0.0 0.0 0.0 8.5 0.2 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.6 0.0 0.0 33.1 13.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 1.1 1.1 3.4 0.0 0.0 0.0 3.0 0.0 0.1 0.9 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 1.4 0.0 0.0 0.2 0.1 0.0 46.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.2 0.1 0.3 0.2 0.3 0.0 0.5 0.5 2.5 0.5 0.1 3.2 1.8 0.0 9.2 0.5 0.0 0.0 0.0 5.8 1.7 0.0 0.3 0.0 0.6 23.9 0.0 0.2 0.0 2.0 56.7 0.5 13.2 0.2 0.2 7.0 8.9 0.0 0.3 192.1 0.8 8.9 1.1 0.1 1.3 0.7 1.1 0.0 0.5 0.0 0.3 142.3 0.0 0.3 0.3 45.2 289.8 4.8 5.4 0.0 1.0 0.1 0.0 0.0 0.1 27.4 187.4 1217.5 61.2 0.0 4683.5 829.6 0.0 0.2 6.6 0.0 0.7 17.3 2.8 0.0 0.3 0.4 2.5 0.2 151.7 0.0 BID ENSG00000015475 "BH3 interacting domain death agonist" P55957 22 17734138-17774770 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 104.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 273.2;Langerhans cells: 658.8;monocytes: 491.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 6 "dendritic cells: 345.8;granulocytes: 925.5;monocytes: 985.3" "Cell line enhanced" "Detected in all" "MCF7: 241.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000722, CAB003771" Enhanced Supported Cytosol NA NA 800000 Cytosol "CAB003771: AB_365478, HPA000722: AB_1078283" "unprognostic (1.59e-1)" "unprognostic (5.51e-2)" "unprognostic (5.02e-2)" "unprognostic (3.04e-2)" "unprognostic (4.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.84e-2)" "unprognostic (5.21e-3)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-13)" "unprognostic (4.66e-3)" "unprognostic (1.59e-1)" "unprognostic (3.55e-3)" "unprognostic (2.18e-2)" 13.8 7.0 19.4 30.8 18.7 104.4 10.8 18.2 22.6 6.1 14.0 14.9 15.2 5.8 7.2 7.5 6.2 14.8 13.2 21.1 18.7 9.9 28.5 12.1 35.9 18.7 18.9 17.2 5.7 9.6 3.6 6.4 7.9 20.0 8.2 11.2 37.2 8.1 4.2 23.5 7.5 17.6 6.9 22.7 30.3 12.4 3.6 20.0 26.6 5.9 7.9 16.9 34.7 7.6 19.8 117.5 90.6 14.4 43.7 15.2 27.7 20.4 59.1 45.4 44.8 38.4 55.4 67.2 22.8 41.5 25.7 52.3 97.8 14.5 14.7 24.7 37.0 73.4 101.3 39.7 81.3 19.1 110.4 107.0 26.7 31.4 49.8 11.3 35.6 46.8 64.8 84.0 27.2 23.0 241.6 161.0 148.2 47.2 130.2 62.8 76.6 37.3 32.8 12.0 141.2 91.3 65.9 12.5 38.2 37.1 6.2 80.3 132.9 80.4 26.0 36.0 43.9 46.7 39.8 57.2 75.7 74.6 113.0 33.8 156.9 417.0 691.4 82.1 748.3 81.7 53.0 75.8 92.5 345.8 33.0 61.2 72.2 925.5 124.1 985.3 245.8 108.0 428.1 19.4 18.7 18.2 22.6 21.1 18.7 18.7 18.9 17.2 20.0 22.7 20.0 19.8 49.0 16.0 14.5 16.0 34.5 71.9 53.1 273.2 21.1 3.0 30.0 30.5 17.5 17.2 142.6 9.2 2.1 9.3 70.3 25.1 7.9 67.9 0.6 10.5 14.5 47.4 34.1 23.3 17.6 51.4 5.6 24.9 13.7 11.4 25.3 34.3 23.2 44.0 134.1 0.0 15.6 38.7 63.1 69.1 658.8 1.6 5.3 164.2 58.7 13.1 491.3 3.0 65.9 4.5 2.1 78.5 85.1 4.1 45.2 186.4 16.5 28.6 59.7 1.7 0.0 12.0 24.3 1.3 11.9 13.2 64.5 5.1 38.3 13.6 49.8 213.0 MATR3 "KIAA0723, MGC9105, MPD2, VCPDM" ENSG00000015479 "Matrin 3" P43243 5 139293674-139331677 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" RNA-binding "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 155.9;Inhibitory neurons: 160.2;Langerhans cells: 122.3;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 162.4;Respiratory ciliated cells: 127.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB033552, HPA036564, HPA036565" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA 260000 Nucleoplasm "CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (9.33e-2)" "unprognostic (6.57e-2)" "unprognostic (8.37e-2)" "unprognostic (7.53e-2)" "unprognostic (7.20e-2)" "unprognostic (4.32e-3)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (2.96e-2)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (7.90e-2)" 113.9 129.1 166.2 94.4 186.1 326.4 162.6 201.9 207.2 145.4 142.9 107.3 77.6 168.2 125.1 104.3 132.2 116.3 112.4 180.9 179.0 151.5 113.8 116.3 159.1 156.0 164.8 169.2 201.1 103.6 169.9 95.8 123.9 159.1 131.3 107.5 225.3 94.3 134.4 120.6 82.7 90.7 143.6 162.0 125.6 89.9 115.9 167.2 223.7 192.2 115.0 171.6 134.7 91.9 184.1 209.0 191.1 559.5 260.7 192.4 212.5 283.2 172.2 300.9 300.4 347.5 273.1 208.8 351.2 236.8 244.1 284.8 135.8 376.8 269.6 403.0 278.4 189.1 236.5 205.0 285.0 183.2 262.5 174.4 222.5 203.7 247.4 226.3 247.1 296.1 219.4 216.9 170.3 313.8 186.7 496.0 285.8 303.6 205.2 182.6 304.7 416.4 217.8 278.0 316.5 279.5 348.7 248.3 176.7 264.6 426.3 194.4 254.5 192.2 272.0 177.7 180.6 246.3 171.0 300.4 423.0 189.8 226.5 268.0 187.0 71.2 116.3 109.6 82.2 134.8 116.3 114.3 124.6 92.6 97.7 124.4 116.5 34.7 150.9 106.7 50.7 136.1 159.8 166.2 186.1 201.9 207.2 180.9 179.0 156.0 164.8 169.2 159.1 162.0 167.2 184.1 0.1 44.8 50.2 83.6 17.6 114.6 0.8 99.2 15.9 1.8 0.3 0.3 0.7 0.0 92.0 0.0 2.1 1.2 0.0 27.6 0.0 0.0 0.3 0.2 0.2 13.6 83.5 15.5 155.9 0.0 1.0 17.5 5.1 0.4 100.3 0.1 0.0 0.0 1.3 1.7 160.2 35.3 87.5 0.0 122.3 0.6 0.6 4.7 103.2 60.9 0.1 0.7 0.0 117.6 162.4 0.1 12.4 0.7 7.3 0.7 0.8 0.2 127.9 1.3 0.0 1.0 33.3 1.1 0.5 15.1 111.2 0.8 21.8 0.5 41.9 1.0 NPC1L1 SLC65A2 ENSG00000015520 "NPC1 like intracellular cholesterol transporter 1" Q9UHC9 7 44512535-44541330 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 54.7;liver: 48.5" "Group enriched" "Detected in some" 5 "Early spermatids: 12.3;Hepatocytes: 44.7" "Group enriched" "Detected in many" 5 "liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB070127, CAB070128" Enhanced NA NA "CAB070127: AB_10002744, CAB070128: AB_10000815" "unprognostic (2.96e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-3)" "unprognostic (8.43e-2)" "unprognostic (1.62e-1)" "unprognostic (2.07e-1)" "unprognostic (9.40e-2)" "unprognostic (6.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.96e-2)" "unprognostic (4.51e-2)" "unprognostic (7.59e-2)" "unprognostic (8.08e-10)" "unprognostic (1.64e-2)" "unprognostic (2.83e-1)" "unprognostic (3.62e-2)" "unprognostic (5.83e-2)" 0.5 0.1 0.7 0.0 0.4 0.0 0.4 0.8 1.2 0.5 0.2 1.1 54.7 0.4 0.0 0.4 0.5 5.9 0.1 0.8 0.3 0.9 48.5 0.2 0.0 1.2 0.3 0.3 0.6 0.6 0.0 0.0 0.0 1.4 0.4 0.1 0.0 0.1 0.1 0.1 0.2 50.9 0.1 0.6 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.5 0.5 1.1 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 14.3 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 1.2 0.8 0.3 1.2 0.3 0.3 1.4 0.6 0.4 1.1 0.2 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.8 0.8 5.7 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.3 12.3 0.3 0.1 0.2 1.8 2.7 0.3 0.5 0.0 0.2 0.0 0.5 0.0 0.0 1.4 44.7 0.0 0.0 0.1 0.3 0.0 1.0 0.3 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.2 3.4 1.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.3 0.1 0.3 0.7 0.2 0.1 XYLT2 "PXYLT2, XT-II" ENSG00000015532 "Xylosyltransferase 2" Q9H1B5 17 50346126-50363138 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "stomach 1: 87.4" "Group enriched" "Detected in many" 6 "Early spermatids: 316.4;Late spermatids: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1100000 "unprognostic (1.52e-1)" "unprognostic (2.84e-1)" "unprognostic (1.65e-1)" "unprognostic (8.07e-2)" "unprognostic (1.90e-3)" "unprognostic (1.90e-1)" "unprognostic (7.29e-3)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.63e-2)" "unprognostic (5.15e-2)" "unprognostic (7.38e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-2)" 7.2 9.8 4.3 6.7 4.4 4.5 8.2 6.7 6.7 12.3 6.5 9.6 9.7 11.5 5.4 8.5 11.9 6.7 9.0 5.1 2.2 8.9 7.6 7.4 9.4 3.6 5.3 3.3 13.7 13.0 9.5 6.4 8.7 4.8 13.8 3.6 4.5 12.3 10.2 5.9 15.4 8.7 5.3 1.7 10.2 87.4 6.8 6.2 8.7 9.4 2.4 4.0 12.1 11.0 4.4 21.1 26.2 7.0 5.9 9.7 9.4 18.4 19.3 17.4 17.2 19.1 28.3 15.5 10.9 47.6 17.3 14.9 15.8 2.4 27.0 3.7 54.3 18.5 24.6 8.6 12.4 13.3 7.8 12.5 12.8 16.4 13.6 6.3 16.9 14.9 9.4 4.4 8.8 11.3 27.5 14.4 10.7 6.5 14.0 18.0 7.2 20.4 9.0 9.5 10.8 3.6 9.0 12.9 11.9 20.3 8.0 57.4 7.5 17.4 38.4 19.2 20.9 17.3 48.0 23.6 3.9 40.4 12.3 10.6 3.7 2.0 1.5 2.7 1.2 2.7 1.3 2.7 3.6 2.4 2.2 2.7 2.5 1.9 3.6 1.1 1.6 2.5 2.9 4.3 4.4 6.7 6.7 5.1 2.2 3.6 5.3 3.3 4.8 1.7 6.2 4.4 7.5 9.6 6.1 13.1 3.9 5.7 3.2 7.3 5.7 8.3 3.9 5.7 8.4 10.0 4.4 1.8 29.2 7.0 3.8 7.5 0.0 7.1 316.4 4.6 6.7 6.8 10.8 0.8 4.9 6.2 5.4 9.1 17.3 6.8 1.3 9.6 10.4 8.0 3.6 6.7 7.2 9.4 2.0 6.0 1.4 91.4 12.5 3.8 7.2 6.5 2.7 5.9 5.2 6.6 4.7 6.8 3.5 17.3 4.7 2.0 4.6 2.8 3.2 6.1 26.3 6.9 6.7 2.4 4.3 3.4 3.1 1.5 4.8 5.3 11.1 1.4 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2 like and GRIP domain containing 5" Q99666 2 109792758-109857705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 10.2 8.3 11.0 5.8 19.8 13.9 10.4 8.1 24.7 8.1 11.4 8.2 7.4 10.5 17.6 5.5 7.7 7.3 9.0 17.0 13.8 7.4 6.9 10.4 6.0 7.8 5.6 15.8 13.1 13.6 14.9 8.3 11.2 13.5 12.4 7.3 22.4 7.0 9.7 6.6 11.7 7.5 7.5 3.8 6.5 7.1 41.6 11.7 3.9 14.6 9.8 5.4 7.6 3.9 18.3 24.3 7.8 26.0 19.5 7.7 8.0 1.2 19.3 16.1 13.8 11.2 20.9 7.8 0.6 12.4 11.7 14.6 8.0 14.3 7.0 17.3 3.7 6.4 18.5 4.1 10.2 8.8 1.5 3.1 8.5 9.5 13.3 14.2 14.5 9.4 7.6 8.8 5.4 10.7 4.5 4.0 0.6 12.7 3.0 9.9 4.3 14.4 0.1 10.4 13.7 31.9 4.5 10.0 1.5 14.0 16.5 0.5 5.4 15.6 14.3 21.1 1.0 14.1 12.2 0.5 0.6 11.7 0.2 4.6 5.4 2.0 2.5 1.9 1.0 3.6 1.7 1.5 2.1 1.4 4.2 2.0 2.1 5.5 2.0 1.2 2.5 1.9 0.6 11.0 19.8 8.1 24.7 17.0 13.8 7.8 5.6 15.8 13.5 3.8 11.7 18.3 12.9 3.2 11.8 0.0 9.0 3.4 5.0 0.8 2.8 17.7 2.5 1.4 13.8 0.0 3.7 12.9 16.7 2.4 15.9 1.7 0.0 1.7 4.1 12.3 12.0 7.4 5.3 0.0 7.3 1.0 1.8 7.4 5.1 18.6 0.0 9.4 4.2 0.9 1.8 3.3 4.5 1.4 0.0 2.9 6.5 1.7 2.5 6.6 1.8 1.0 0.9 3.8 0.0 0.0 0.2 1.5 1.7 1.2 10.7 5.5 1.7 0.4 2.6 20.3 0.0 9.7 7.8 4.1 2.9 1.2 3.3 4.4 12.4 1.6 1.0 7.3 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 317.7;choroid plexus: 128.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 86.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 0.2 10.3 183.1 0.2 225.9 0.1 0.2 205.9 304.8 0.5 128.7 3.6 0.6 0.4 0.9 0.1 0.3 0.2 0.1 204.8 240.8 0.1 0.1 0.1 0.0 240.4 215.2 197.3 0.2 0.1 0.0 1.1 0.0 232.8 0.5 1.4 21.6 0.1 0.2 0.2 0.4 1.6 0.6 222.6 0.0 0.9 0.6 227.8 0.0 0.1 0.0 0.0 0.6 0.7 317.7 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 86.8 3.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 183.1 225.9 205.9 304.8 204.8 240.8 240.4 215.2 197.3 232.8 222.6 227.8 317.7 0.1 0.0 0.0 4.6 0.0 0.4 0.1 0.0 0.0 45.6 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 92.5 18.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.6 0.0 9.7 0.0 27.6 217.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.8 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379119-44490658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favorable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 2.9 2.8 6.1 1.3 8.1 2.8 2.8 2.9 6.9 2.5 0.0 2.2 1.2 2.3 2.4 2.8 3.5 2.2 7.6 6.4 5.0 2.2 1.8 2.5 2.2 4.5 5.4 6.4 3.1 3.3 3.8 1.9 1.7 5.4 2.8 1.8 4.8 2.4 3.3 8.3 3.0 2.0 3.1 3.3 1.9 2.7 3.9 5.0 2.1 2.8 5.7 2.3 2.3 1.8 6.1 2.6 4.9 3.4 6.3 4.2 3.4 1.3 4.1 4.0 4.8 4.9 3.3 1.8 8.1 3.0 5.5 6.6 3.0 4.8 5.6 2.8 4.8 4.9 2.2 2.9 2.3 3.8 3.9 1.3 3.1 3.7 3.6 4.1 2.8 5.9 2.4 6.1 2.6 3.6 2.3 1.6 3.7 4.3 2.5 6.3 2.3 3.7 3.0 2.7 4.0 3.6 10.6 2.4 4.5 1.8 3.4 3.4 5.7 5.7 3.3 3.4 2.2 3.3 7.3 8.1 4.0 3.6 4.5 5.9 0.6 0.8 0.9 1.0 0.8 1.1 1.0 0.9 0.9 0.7 1.0 0.9 0.9 0.5 0.8 1.0 0.6 1.0 0.9 6.1 8.1 2.9 6.9 6.4 5.0 4.5 5.4 6.4 5.4 3.3 5.0 6.1 30.5 12.8 19.2 35.9 26.4 11.3 13.0 16.5 20.5 40.9 29.3 25.3 44.5 17.2 16.0 38.6 54.2 19.6 21.9 22.7 23.5 29.6 87.7 27.4 34.4 25.3 17.4 22.3 59.6 21.6 18.1 23.9 23.9 30.9 9.5 35.8 22.5 32.8 18.3 48.8 58.8 25.1 26.4 17.9 9.5 98.3 30.4 13.9 16.0 46.9 21.2 24.8 34.0 36.2 61.2 27.4 18.8 28.2 14.3 15.9 27.2 26.8 21.9 40.2 32.9 17.8 25.2 106.6 21.1 25.5 16.2 14.4 26.2 18.9 27.8 13.3 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383448-51394730 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 23.1;seminal vesicle: 19.4;vagina: 16.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2" "Group enriched" "Detected in some" 5 "cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4" "Group enriched" "Detected in many" 4 "hypothalamus: 7.8;thalamus: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 297.1" "Group enriched" "Detected in many" 8 "basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0" "Group enriched" "Detected in some" 9 "basal ganglia: 5.8;hypothalamus: 5.4" "HPA048613, HPA057416" Approved Approved "Nucleoplasm,Nuclear speckles,Mitochondria" NA NA Nucleoplasm "Nuclear speckles, Mitochondria" "HPA048613: , HPA057416: AB_2683431" "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 1.3 1.4 0.8 0.0 1.3 0.0 0.1 0.0 1.4 4.7 0.0 1.1 2.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.0 4.8 0.0 2.2 7.9 1.2 12.1 2.4 23.1 1.2 19.4 0.0 1.1 0.7 0.1 0.1 0.0 10.1 1.6 3.6 4.3 0.3 0.0 0.4 0.7 16.0 0.2 0.0 0.0 0.0 3.4 0.0 0.0 0.2 3.0 3.8 0.0 0.0 0.3 2.7 0.0 2.5 0.0 0.0 2.2 4.6 3.4 0.0 0.0 7.1 0.0 12.6 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.9 3.2 0.0 3.0 0.0 0.0 0.0 19.1 297.1 0.0 0.0 0.0 11.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.4 0.0 7.8 0.7 0.3 0.5 1.2 0.1 3.6 0.2 0.0 0.0 0.0 0.0 0.1 1.5 5.1 11.8 0.0 207.5 0.0 0.0 0.2 0.0 2.8 0.0 4.2 34.4 0.0 0.5 0.0 0.1 17.3 0.0 0.0 1.7 91.6 0.0 0.0 0.0 10.9 6.1 11.7 0.0 0.0 0.0 0.0 0.0 2.7 43.7 0.0 1.9 8.2 0.0 0.4 3.2 0.3 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.1 0.0 0.0 0.8 11.8 0.0 0.0 4.0 2.5 7.3 0.0 1.0 34.2 0.0 0.0 0.2 5.6 CHDH ENSG00000016391 "Choline dehydrogenase" Q8NE62 3 53812335-53846419 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.0;liver: 36.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 52.9;Hepatocytes: 51.8;Proximal enterocytes: 70.1;Proximal tubular cells: 87.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 3.1;T-reg: 1.3" "Group enriched" "Detected in many" 17 "granulocytes: 3.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "CACO-2: 11.4;Hep G2: 35.8;OE19: 25.3;T-47d: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036633, HPA058130" Enhanced NA NA "HPA036633: AB_10670841, HPA058130: AB_2683615" "unprognostic (3.40e-3)" "unprognostic (1.17e-2)" "unprognostic (2.26e-3)" "unprognostic (7.17e-3)" "unprognostic (9.15e-2)" "unprognostic (1.17e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-1)" "unprognostic (4.35e-3)" "unprognostic (4.57e-2)" "unprognostic (5.12e-2)" "prognostic favorable (1.88e-8)" "unprognostic (3.37e-2)" "unprognostic (2.42e-1)" "unprognostic (8.26e-2)" "unprognostic (2.29e-2)" 0.6 2.9 12.9 1.8 13.4 0.6 7.4 12.3 11.2 3.6 13.8 9.0 8.4 2.7 1.5 0.9 2.6 2.7 2.2 12.1 10.6 38.0 36.1 2.4 1.0 15.6 13.8 9.5 1.3 16.6 8.3 7.9 0.4 12.1 5.8 9.3 1.5 15.1 1.0 4.0 2.3 14.8 0.9 10.9 0.5 8.0 6.9 16.5 0.2 2.6 1.2 1.2 0.4 0.9 11.8 0.4 4.6 1.2 0.1 0.0 0.0 5.2 0.3 0.5 0.0 0.0 11.4 0.8 0.4 0.8 0.8 0.1 0.0 7.4 0.0 0.0 0.0 4.0 0.0 1.7 35.8 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 5.7 0.7 0.0 6.9 0.0 0.1 7.2 25.3 0.8 0.0 1.8 8.2 5.1 4.0 3.0 4.0 1.8 0.1 0.0 0.9 11.2 0.1 0.0 0.0 0.8 0.2 1.0 1.0 1.6 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 12.9 13.4 12.3 11.2 12.1 10.6 15.6 13.8 9.5 12.1 10.9 16.5 11.8 0.6 3.2 6.8 19.6 1.3 6.6 5.6 1.1 1.2 23.8 23.5 19.8 11.3 52.9 5.9 11.0 14.6 3.7 0.4 16.6 7.9 19.4 28.9 3.2 11.0 1.4 47.9 0.0 2.4 13.8 2.3 2.3 21.4 9.4 7.0 2.2 1.4 51.8 0.3 1.7 3.5 38.9 0.0 1.9 2.5 46.2 5.9 2.6 3.6 1.0 0.1 18.8 0.0 27.2 5.2 8.0 15.1 15.4 5.3 19.8 70.1 87.8 3.8 13.4 0.0 1.0 3.4 15.1 2.3 0.7 5.3 0.8 2.4 2.0 45.4 2.2 IL20RA "IL-20R1, ZCYTOR7" ENSG00000016402 "Interleukin 20 receptor subunit alpha" Q9UHF4 6 136999971-137045180 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 26.7;skin 1: 38.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 58.6;Endometrial ciliated cells: 110.4;Glandular and luminal cells: 69.8;Muller glia cells: 54.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;HaCaT: 6.9;OE19: 10.1;RT4: 11.5;SH-SY5Y: 10.8;T-47d: 10.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB024990, HPA042281" Approved Approved Cytosol NA NA Cytosol "CAB024990: , HPA042281: AB_10806235" "unprognostic (3.75e-2)" "unprognostic (8.23e-2)" "unprognostic (1.96e-2)" "prognostic favorable (1.43e-6)" "unprognostic (1.57e-2)" "prognostic favorable (2.29e-5)" "unprognostic (9.87e-3)" "unprognostic (1.64e-1)" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (8.03e-3)" "unprognostic (2.18e-1)" "unprognostic (1.85e-6)" "unprognostic (9.38e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-3)" "unprognostic (1.64e-3)" 0.6 8.8 3.3 0.7 3.2 0.1 26.7 3.8 2.7 17.3 4.3 4.6 3.1 5.9 4.5 7.0 17.4 4.9 2.0 2.3 6.8 0.4 0.4 5.9 0.0 3.6 4.1 2.0 4.9 8.0 2.8 1.6 0.2 3.8 8.7 4.7 5.0 9.8 5.5 0.7 38.0 1.4 3.0 4.4 0.0 6.2 2.1 3.8 1.6 1.1 2.4 2.6 6.1 12.0 3.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 9.5 0.0 0.1 1.5 0.1 6.9 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 10.1 1.4 0.0 0.4 0.0 0.0 11.5 0.7 10.8 0.5 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.2 3.8 2.7 2.3 6.8 3.6 4.1 2.0 3.8 4.4 3.8 3.4 1.4 3.2 26.1 6.2 0.0 21.9 12.0 12.7 6.2 3.5 58.6 39.5 4.6 37.1 22.3 3.7 0.0 2.7 0.5 12.1 0.0 15.3 0.8 110.4 8.0 1.1 7.3 0.0 0.1 0.7 10.6 5.0 19.9 69.8 2.5 0.1 0.4 0.0 0.5 0.0 1.3 23.1 28.5 0.0 1.6 0.9 8.7 0.8 14.2 0.0 0.0 54.6 0.0 3.0 0.3 13.1 11.7 15.1 0.0 18.7 1.7 1.2 36.0 1.3 0.0 2.3 1.7 0.3 3.8 25.3 18.0 8.2 1.3 6.4 12.3 21.1 CLCA1 "CaCC, CLCRG1" ENSG00000016490 "Chloride channel accessory 1" A8K7I4 1 86468368-86500259 "Predicted secreted proteins, Transporters" "Calcium transport, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "intestine: 1411.7" "Cell type enriched" "Detected in some" 16 "Intestinal goblet cells: 3524.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 86.8;pancreatic cancer: 27.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;NB-4: 2.5;RPMI-8226: 2.9;SH-SY5Y: 1.8;U-2197: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052787, HPA059301" Enhanced "Secreted to digestive system" NA NA 77000 "HPA052787: AB_2681947, HPA059301: AB_2683971" "prognostic favorable (2.98e-4)" "unprognostic (3.42e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-1)" 1.2 0.0 0.0 110.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 746.9 917.9 1.2 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 1072.4 0.0 0.0 0.5 0.0 0.0 1411.7 15.6 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 3524.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 54.8 0.0 0.0 0.0 213.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 68.3 0.1 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins, Transporters" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 376.9;intestine: 260.2" "Group enriched" "Detected in many" 6 "Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4;urothelial cancer: 15.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 1368 "RT4: 430.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 150000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.6 0.0 6.3 14.0 9.1 0.0 2.2 6.8 8.1 21.4 3.4 260.2 0.1 0.1 0.1 376.9 0.2 0.2 0.1 6.1 6.6 0.1 0.1 0.0 0.0 9.3 7.5 5.3 0.0 0.1 0.0 0.5 0.0 8.5 2.5 144.9 0.0 23.3 0.2 0.1 17.3 29.3 3.0 7.0 0.1 0.6 0.3 7.4 0.1 0.0 0.0 30.3 100.3 67.4 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 430.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 9.1 6.8 8.1 6.1 6.6 9.3 7.5 5.3 8.5 7.0 7.4 13.1 0.1 0.0 0.0 0.0 2.9 3.3 40.3 6.5 2.8 0.0 1.9 1.8 0.4 0.0 17.5 1.8 0.0 0.0 0.2 597.0 0.0 0.0 0.4 7.3 0.1 0.3 8.3 0.0 0.1 0.0 0.0 0.4 0.0 3.5 8.9 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 183.2 0.0 1.2 9.7 4.7 0.0 1.9 0.0 0.0 0.0 0.4 0.1 0.0 158.7 11.9 0.0 1.5 0.0 12.0 176.9 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694486-52706032 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria NA NA Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 31.7 40.1 27.0 22.7 26.9 9.3 36.0 26.4 29.5 47.9 34.5 28.0 26.1 35.4 41.6 18.5 54.8 30.0 31.1 27.3 28.5 40.8 70.1 29.9 25.5 25.7 26.3 26.1 54.3 36.0 46.4 65.3 48.7 25.9 30.8 32.7 32.5 30.2 33.0 21.0 22.1 23.6 32.5 26.4 24.8 29.1 65.1 26.1 29.5 64.6 24.9 27.1 31.9 28.8 29.7 28.7 33.2 65.7 52.0 142.6 179.8 36.8 70.3 107.8 60.6 69.1 15.5 52.6 24.0 19.7 122.7 73.3 31.9 42.1 72.0 79.5 43.5 30.6 22.8 61.4 71.7 68.3 34.0 68.5 104.1 62.9 52.1 66.8 139.8 91.3 40.6 29.4 53.6 80.6 29.2 23.4 51.8 33.8 49.8 61.5 17.4 37.3 81.9 71.3 30.8 26.9 46.5 58.6 27.9 48.9 61.2 47.7 44.2 67.1 43.7 33.9 63.9 39.6 60.2 73.7 26.4 76.0 53.2 56.2 38.4 13.0 21.8 19.1 8.5 18.3 14.1 22.2 20.0 11.8 9.8 22.3 15.6 6.9 30.3 9.3 23.1 16.8 10.9 27.0 26.9 26.4 29.5 27.3 28.5 25.7 26.3 26.1 25.9 26.4 26.1 29.7 25.8 0.0 9.6 16.0 16.0 12.1 16.1 40.3 13.6 41.5 18.1 19.7 15.3 17.2 23.8 18.4 12.5 58.4 26.5 9.4 23.5 34.4 71.4 38.5 38.4 22.7 18.6 8.6 17.9 27.1 63.5 59.2 14.8 15.2 5.7 35.6 34.2 38.2 26.9 21.9 16.8 21.1 30.5 13.6 12.0 23.0 53.7 12.3 24.9 8.4 26.5 37.0 34.0 15.6 14.6 23.3 16.9 48.5 39.1 14.7 22.8 21.5 44.4 21.3 26.3 31.6 25.2 149.5 50.0 10.3 8.0 26.1 21.4 74.2 17.3 10.0 ATP2C1 "ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1" ENSG00000017260 "ATPase secretory pathway Ca2+ transporting 1" P98194 3 130850595-131016712 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010207, HPA035116, HPA069684" Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.06e-6)" "unprognostic (7.66e-2)" "unprognostic (6.52e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.44e-2)" "prognostic favorable (1.55e-4)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "unprognostic (3.06e-1)" 32.5 33.1 38.4 25.5 40.2 39.0 33.3 35.4 57.5 33.7 74.5 36.9 24.1 31.1 28.2 23.8 37.5 27.5 32.2 48.1 39.5 45.1 28.7 51.8 22.0 40.4 43.9 36.5 29.1 22.8 78.7 22.9 32.9 43.6 86.5 36.3 59.9 29.4 25.5 28.3 32.1 27.1 31.2 42.6 19.7 31.8 25.4 54.6 36.5 35.3 21.3 26.4 31.8 18.3 51.9 133.1 51.1 49.9 48.5 136.7 110.0 53.9 141.2 186.8 69.4 87.0 83.5 106.3 47.6 95.6 134.4 96.4 153.6 95.1 77.9 100.8 104.4 34.2 127.2 51.5 39.0 87.2 51.2 148.4 86.8 76.6 73.2 82.2 126.3 74.6 59.3 37.3 84.1 86.7 59.0 50.6 40.9 57.0 71.7 54.8 36.3 49.9 75.6 127.5 87.7 76.7 45.9 121.4 37.8 72.8 70.8 55.7 41.7 102.6 73.3 40.8 95.5 65.8 54.6 71.1 69.9 75.8 38.0 62.6 30.6 8.9 15.9 7.4 7.6 7.0 5.6 7.3 6.6 9.5 3.6 4.9 4.9 4.3 11.5 9.6 8.2 9.3 6.5 38.4 40.2 35.4 57.5 48.1 39.5 40.4 43.9 36.5 43.6 42.6 54.6 51.9 30.2 38.5 53.0 162.6 17.4 39.4 34.5 34.8 26.7 25.9 34.4 22.4 30.2 35.8 41.1 46.0 20.9 16.3 15.5 39.0 5.9 35.3 17.5 26.9 34.1 27.8 35.6 23.3 172.5 38.0 27.6 25.9 33.1 55.8 28.5 28.2 26.7 27.4 27.7 82.4 136.5 32.4 36.7 26.2 34.8 18.9 16.1 39.5 21.4 128.4 20.5 26.4 19.6 148.3 154.3 51.1 27.5 14.7 18.5 69.0 16.3 19.8 52.7 33.4 6.6 27.7 25.9 16.2 14.1 24.7 52.8 17.6 19.5 17.3 31.2 36.9 IGF1 "IGF, IGF-I, IGF1A, IGFI" ENSG00000017427 "Insulin like growth factor 1" P05019 12 102395874-102481744 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 87.5;cervix: 89.7" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 1279.3;Leydig cells: 1103.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "ASC diff: 37.9;HDLM-2: 49.6;K-562: 22.4;Karpas-707: 11.3;U-266/70: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048946 Approved "Secreted to blood" NA NA 103000000 330000000 "HPA048946: AB_2680566" "unprognostic (1.25e-1)" "unprognostic (2.86e-3)" "unprognostic (1.46e-1)" "prognostic favorable (1.04e-4)" "unprognostic (1.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.59e-3)" "unprognostic (2.26e-1)" "unprognostic (9.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (2.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-3)" 87.5 5.2 1.3 27.3 1.7 0.9 39.0 0.2 2.3 89.7 2.0 6.9 5.4 47.4 10.7 6.7 13.1 21.7 11.8 1.9 0.8 3.0 84.2 11.7 6.6 1.9 0.9 1.3 9.0 4.0 1.4 1.2 24.4 2.0 38.9 6.7 5.5 7.7 33.7 8.6 4.3 5.8 74.9 0.9 9.9 7.8 7.7 1.2 3.1 25.6 5.9 3.7 21.5 22.9 2.5 0.3 0.0 0.0 0.0 37.9 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 49.6 0.0 0.1 0.7 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 22.4 11.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.2 1.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.4 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.3 1.7 0.2 2.3 1.9 0.8 1.9 0.9 1.3 2.0 0.9 1.2 2.5 11.8 3.2 2.2 1.0 8.5 2.5 0.7 0.0 1.8 168.1 4.0 6.2 0.4 2.8 0.7 0.0 0.0 1.1 0.6 0.2 0.0 0.0 17.5 35.8 1279.3 38.9 0.0 5.3 1.2 0.6 1.5 259.7 2.6 34.5 0.0 0.3 6.4 243.0 122.0 0.0 123.9 0.0 16.2 25.8 12.5 58.0 1103.2 42.0 14.2 27.2 3.6 4.4 0.0 0.5 0.9 0.1 0.0 193.4 66.9 1.2 0.0 1.4 0.1 9.0 0.0 139.3 19.6 1.9 1.2 1.6 2.7 1.2 9.1 69.4 0.2 0.4 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470260 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 239.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 3.3 1.9 26.3 13.1 19.4 56.2 2.6 21.0 23.4 9.5 10.6 13.3 13.4 4.3 2.7 10.3 4.9 3.7 4.8 19.1 20.7 1.5 0.9 25.5 8.8 32.4 21.9 13.2 6.7 239.2 0.4 0.9 1.1 26.9 5.7 16.3 3.4 9.4 8.7 0.6 21.5 9.3 7.1 19.4 13.9 16.0 0.7 25.3 8.6 20.5 1.3 9.2 9.5 8.8 19.5 143.0 0.3 0.1 1.6 2.8 11.6 0.3 9.4 0.0 0.3 0.1 0.4 0.3 147.8 0.2 61.7 0.3 214.0 164.4 326.7 0.0 47.4 0.2 80.7 300.0 102.4 23.2 166.7 0.2 22.0 237.8 2.9 0.6 0.2 2.8 35.5 150.7 282.8 32.2 0.2 36.3 57.9 74.2 0.0 0.7 131.5 0.7 539.6 0.0 0.1 13.1 0.7 0.1 0.9 0.2 1.1 0.5 6.9 4.7 0.6 0.4 0.4 0.4 0.4 1.0 53.0 1.6 0.8 0.7 0.1 0.4 0.4 17.3 0.6 24.2 11.4 18.6 16.4 2.3 8.9 8.7 11.3 0.5 9.6 0.1 13.1 21.7 9.1 26.3 19.4 21.0 23.4 19.1 20.7 32.4 21.9 13.2 26.9 19.4 25.3 19.5 2.3 0.0 0.6 0.3 15.4 26.6 2.7 196.3 17.1 3.2 0.2 0.3 0.4 0.0 33.6 5.5 18.8 0.2 6.7 9.9 0.0 5.5 0.4 1.1 9.1 11.8 0.0 74.3 0.3 80.8 0.6 8.9 3.6 2.7 4.5 1.0 0.4 0.4 2.4 0.0 0.5 17.5 4.1 0.3 3.9 1.3 2.5 2.1 8.8 32.8 1.8 0.3 8.2 0.5 0.2 129.4 5.5 1.2 62.3 4.5 1.2 0.0 4.2 0.3 0.0 0.7 4.6 0.1 0.4 6.4 8.5 0.0 9.5 4.6 21.4 1.9 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538114 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "neutrophil: 195.6" "Lineage enriched" "Detected in all" 10 "granulocytes: 195.6" "Cell line enhanced" "Detected in all" "OE19: 239.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" NA NA Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: AB_2679738" "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favorable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favorable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 30.0 20.6 44.3 23.6 45.0 31.0 28.1 47.6 82.9 23.7 41.1 30.8 18.9 22.3 23.7 50.7 25.0 20.4 28.7 43.0 46.3 43.1 20.0 22.8 24.2 46.5 49.2 40.7 26.5 15.5 48.3 16.9 31.6 45.5 32.9 25.6 13.6 25.3 48.7 38.9 75.4 20.6 21.3 45.6 26.7 25.9 13.1 48.9 29.6 23.1 32.8 25.6 34.1 33.6 46.7 58.9 37.6 34.2 39.0 38.3 60.7 43.3 67.7 38.1 35.6 38.0 42.6 57.5 70.5 47.0 64.8 50.2 32.8 48.1 52.7 44.2 71.4 38.5 38.5 34.6 32.7 31.2 114.8 43.0 42.0 52.2 49.6 48.7 47.7 60.6 64.6 53.7 67.7 56.2 46.3 70.7 50.9 25.4 239.5 31.9 93.6 59.4 54.2 48.4 80.7 44.7 34.8 58.2 52.8 30.9 52.3 32.9 53.8 67.4 105.0 76.9 72.3 81.9 38.7 42.9 77.9 45.6 53.4 40.5 13.0 9.6 15.7 10.3 10.6 8.7 9.9 8.7 8.8 8.7 7.5 7.3 9.4 195.6 14.8 17.8 19.8 6.4 4.5 44.3 45.0 47.6 82.9 43.0 46.3 46.5 49.2 40.7 45.5 45.6 48.9 46.7 101.8 57.7 35.7 15.3 48.0 156.4 80.9 59.9 112.7 42.6 96.0 102.2 64.8 88.6 64.6 480.1 29.2 104.2 70.9 122.6 123.3 119.4 16.1 99.1 82.6 86.9 74.2 175.7 25.4 90.7 518.6 71.6 56.1 179.4 40.5 85.8 78.9 88.3 70.1 52.2 26.7 87.7 109.9 92.8 69.7 9.5 72.7 78.4 58.7 20.6 99.6 47.6 83.4 17.1 25.3 166.3 78.2 87.3 63.2 174.4 61.0 115.0 38.6 37.3 65.7 76.8 105.6 66.7 80.0 149.6 242.5 44.6 62.6 128.4 90.1 216.4 RUFY3 "KIAA0871, RIPx, Singar1, ZFYVE30" ENSG00000018189 "RUN and FYVE domain containing 3" Q7L099 4 70704204-70808619 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 121.4" "Cell type enhanced" "Detected in all" "Astrocytes: 189.4;Cone photoreceptor cells: 264.8;Excitatory neurons: 192.9;Oligodendrocytes: 197.8;Rod photoreceptor cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022952, HPA022970" Enhanced Supported Cytosol NA NA Cytosol "HPA022952: AB_2671005, HPA022970: AB_1856307" "unprognostic (4.33e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (8.95e-4)" "unprognostic (1.69e-2)" "unprognostic (2.00e-1)" "unprognostic (3.50e-2)" "prognostic favorable (8.02e-5)" "unprognostic (7.90e-3)" "unprognostic (1.31e-3)" "unprognostic (1.26e-1)" "unprognostic (1.21e-2)" "unprognostic (7.45e-3)" "unprognostic (5.41e-1)" 18.7 35.2 63.9 18.3 72.1 11.7 18.9 69.6 75.7 27.1 37.7 16.8 12.1 29.7 23.5 24.6 18.2 17.9 15.3 72.2 80.7 22.1 22.4 22.0 21.9 84.1 73.1 68.2 36.1 19.3 8.3 41.4 17.7 86.3 19.4 16.2 121.4 19.0 15.8 25.8 46.9 15.1 20.9 71.7 25.6 19.3 39.3 69.2 32.8 46.1 11.8 17.5 20.1 25.9 107.4 8.5 5.8 67.0 15.9 30.8 35.2 26.6 26.6 10.2 8.5 9.4 9.9 20.2 33.2 10.8 22.4 19.1 8.4 10.3 11.8 13.6 18.2 13.4 7.2 8.4 11.6 18.0 8.4 4.3 24.7 18.0 11.4 13.3 39.5 18.3 35.4 20.2 32.9 18.8 10.4 52.8 9.6 16.1 14.7 7.3 12.8 21.0 15.2 16.7 8.0 61.7 30.6 9.7 17.0 16.2 25.8 11.7 4.2 15.7 28.8 20.0 8.8 6.2 37.2 18.0 35.7 29.4 6.1 6.0 0.6 3.4 0.3 1.5 4.8 1.9 3.5 1.2 1.3 4.9 2.6 1.2 1.3 0.1 2.6 4.9 6.6 0.5 0.8 63.9 72.1 69.6 75.7 72.2 80.7 84.1 73.1 68.2 86.3 71.7 69.2 107.4 31.9 35.3 82.1 189.4 18.7 19.4 23.3 9.9 15.9 126.9 22.1 11.8 19.3 12.8 30.6 23.9 264.8 15.0 19.5 7.5 7.9 14.7 70.0 32.9 63.6 32.6 15.0 7.4 192.9 21.1 7.0 43.7 23.4 36.0 21.0 53.1 32.9 25.7 10.5 139.7 175.0 8.4 14.2 37.3 36.4 122.5 47.2 31.0 42.7 72.1 67.0 43.9 13.4 136.7 197.8 19.1 5.2 50.8 17.2 40.2 11.6 19.6 28.3 198.6 26.3 53.2 35.9 14.8 27.6 36.7 28.8 7.7 11.5 40.9 10.1 19.3 CNTN1 "F3, GP135" ENSG00000018236 "Contactin 1" Q12860 12 40692439-41072415 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 161.7" "Group enriched" "Detected in many" 5 "Astrocytes: 763.9;Excitatory neurons: 844.8;Inhibitory neurons: 699.0;Oligodendrocyte precursor cells: 1021.4" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 224.4;HaCaT: 40.3;SCLC-21H: 68.5;SH-SY5Y: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025200, HPA070467" Enhanced Approved "Intracellular and membrane" NA NA 450000000 "CAB025200: , HPA070467: AB_2732156" "unprognostic (3.18e-2)" "unprognostic (5.96e-3)" "unprognostic (3.66e-2)" "unprognostic (7.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (9.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.32e-2)" "unprognostic (8.15e-4)" "unprognostic (6.98e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (3.75e-4)" 3.9 33.5 68.8 2.5 76.3 0.2 8.9 124.0 80.5 14.2 0.0 3.1 1.7 11.6 2.6 9.1 2.2 11.8 0.8 90.4 57.3 12.6 1.2 4.4 4.6 92.7 85.3 68.8 49.7 6.1 1.5 10.5 0.3 71.7 28.0 3.9 27.0 5.5 28.0 0.8 12.9 3.0 10.7 124.8 8.2 5.0 9.5 71.3 1.0 1.2 1.6 3.9 21.7 6.7 161.7 0.1 224.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.1 0.1 0.0 0.0 40.3 6.0 11.2 0.0 0.2 2.4 0.0 0.7 0.0 0.0 0.0 0.7 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.2 1.5 0.2 0.1 0.0 1.0 0.3 0.0 0.0 68.5 40.3 0.1 2.5 2.7 1.0 0.1 0.6 0.0 0.1 4.3 0.1 10.0 2.8 0.1 0.0 0.3 0.0 0.9 2.6 0.5 0.7 0.3 0.2 0.3 0.4 0.2 0.2 0.1 0.4 0.4 0.2 1.2 0.7 0.4 0.9 0.2 0.0 68.8 76.3 124.0 80.5 90.4 57.3 92.7 85.3 68.8 71.7 124.8 71.3 161.7 0.3 0.0 5.9 763.9 0.1 5.2 1.1 1.6 4.0 32.1 0.4 1.8 0.7 0.0 4.5 5.5 29.2 0.0 0.0 0.0 1.9 0.0 34.9 4.3 7.1 0.7 0.0 0.0 844.8 0.0 0.0 13.3 0.0 0.3 0.0 5.0 0.0 0.0 0.1 11.8 699.0 0.0 2.0 0.0 4.0 149.5 62.7 0.1 10.6 54.4 0.0 34.6 0.0 1021.4 23.9 0.7 0.0 60.2 0.0 0.3 0.0 0.0 0.4 5.9 0.0 0.5 3.6 0.6 0.8 2.1 13.5 0.0 0.5 0.3 0.0 0.2 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lung: 79.3;lymphoid tissue: 47.0" "Cell type enhanced" "Detected in many" "Hofbauer cells: 108.0;Kupffer cells: 166.8;Macrophages: 209.4;monocytes: 101.2" "Cancer enhanced" "Detected in many" "glioma: 7.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.1;non-classical monocyte: 6.0" "Group enriched" "Detected in many" 11 "dendritic cells: 1.9;granulocytes: 4.1;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HEL: 1.2;HMC-1: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 12.2 8.6 4.2 7.1 5.4 6.8 5.0 4.8 11.2 2.1 5.9 3.1 0.2 2.2 0.1 1.6 7.4 1.0 6.2 4.1 9.7 3.4 5.2 79.3 0.2 7.8 5.4 3.6 1.7 3.2 0.3 3.1 2.7 6.5 3.2 0.0 0.6 3.2 0.1 1.8 1.3 2.2 1.9 5.6 47.0 3.0 0.9 14.8 0.3 2.7 1.3 0.0 7.3 2.4 8.6 0.1 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.2 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 6.1 0.6 0.3 4.5 0.2 0.1 0.2 0.1 1.9 0.2 0.3 0.2 4.1 0.2 6.0 0.2 0.2 2.0 4.2 5.4 4.8 11.2 4.1 9.7 7.8 5.4 3.6 6.5 5.6 14.8 8.6 1.5 22.4 38.5 1.6 4.1 0.9 4.3 1.9 1.2 3.1 4.5 4.6 8.6 2.8 13.8 9.2 0.0 1.8 3.1 1.8 9.8 1.3 1.8 6.1 2.3 17.0 1.2 1.7 1.3 2.1 7.8 5.8 2.0 2.8 25.3 0.9 6.8 7.3 108.0 1.7 0.9 4.0 6.1 166.8 6.3 0.5 2.1 209.4 1.8 4.7 101.2 12.9 10.3 0.5 1.4 0.4 1.6 0.7 5.6 3.9 2.5 11.7 11.0 3.3 19.7 2.9 4.2 0.8 1.8 2.1 1.0 8.1 6.7 3.3 2.9 3.3 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 229.3;Endothelial cells: 221.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 41.8 13.9 22.4 22.6 20.7 0.2 37.5 24.1 19.5 40.1 33.8 56.3 8.0 42.5 13.5 36.1 34.0 39.9 32.1 21.1 101.3 46.4 19.1 41.6 7.3 52.7 30.8 10.1 44.3 32.0 14.2 13.7 44.3 38.8 34.8 13.6 4.3 27.8 32.4 13.3 24.0 21.7 44.1 40.4 19.7 33.0 7.3 30.1 4.8 31.9 15.2 6.2 59.7 34.6 46.8 58.9 80.5 40.6 48.7 48.6 86.8 43.0 32.6 57.5 17.7 17.8 46.7 53.2 0.1 212.1 45.0 53.3 36.1 28.4 28.5 17.9 22.0 19.3 0.0 18.6 37.8 27.3 0.0 0.1 45.3 7.4 61.8 26.6 65.4 136.3 0.0 0.0 0.2 61.7 9.2 0.2 0.2 8.2 0.2 96.6 0.0 50.6 0.4 151.1 9.4 0.0 0.4 21.1 17.2 160.2 31.5 26.5 1.6 94.2 29.0 16.2 24.8 67.4 0.6 0.5 0.8 66.8 0.1 78.8 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.1 22.4 20.7 24.1 19.5 21.1 101.3 52.7 30.8 10.1 38.8 40.4 30.1 46.8 125.7 64.1 89.7 60.4 1.1 51.7 229.3 34.6 60.9 2.2 58.1 56.8 46.8 141.5 87.8 49.7 4.2 12.2 2.0 0.5 7.9 72.0 21.9 136.3 89.1 221.2 0.0 3.2 8.7 27.1 82.3 77.9 10.2 144.4 7.6 45.0 111.4 21.9 4.1 0.0 6.1 1.2 10.2 6.0 32.3 7.9 57.8 4.6 30.2 94.6 2.1 11.0 0.0 7.5 12.7 45.8 0.0 126.4 2.9 86.7 1.2 59.8 53.9 2.0 59.2 76.1 58.0 2.2 0.8 46.3 35.5 14.8 6.5 48.4 2.4 93.5 AGPS "ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY" ENSG00000018510 "Alkylglycerone phosphate synthase" O00116 2 177392746-177567024 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030209, HPA030210, HPA030211" Supported Supported Peroxisomes "Intracellular and membrane" NA NA 69000 Peroxisomes "HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195" "unprognostic (7.10e-2)" "unprognostic (1.20e-2)" "unprognostic (1.76e-3)" "unprognostic (3.79e-2)" "unprognostic (8.34e-2)" "unprognostic (3.78e-2)" "prognostic unfavorable (8.62e-6)" "unprognostic (1.23e-2)" "unprognostic (7.23e-2)" "unprognostic (5.41e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (7.74e-2)" "prognostic favorable (9.45e-4)" "unprognostic (7.18e-2)" "unprognostic (3.46e-1)" "unprognostic (4.94e-3)" "unprognostic (1.92e-2)" 14.5 9.3 4.6 15.7 6.9 19.8 14.0 7.0 6.9 14.4 5.1 20.2 11.2 14.7 6.6 12.8 9.9 11.4 10.5 5.1 6.9 18.3 19.5 13.8 12.0 9.0 6.7 4.4 7.9 11.5 18.6 3.4 13.3 8.4 7.1 22.1 6.5 8.3 8.9 11.8 4.5 13.2 21.2 8.7 8.7 10.0 16.5 7.0 16.2 12.7 12.8 12.9 14.7 5.2 11.9 43.1 36.3 23.3 19.0 32.2 33.2 33.3 29.6 21.9 34.5 34.8 70.6 34.0 58.5 59.5 45.0 46.3 47.5 64.4 45.1 47.8 51.4 16.7 77.6 56.5 75.8 31.9 82.3 63.5 28.6 28.7 58.6 44.6 33.3 75.3 42.1 44.9 26.3 45.7 0.1 59.9 22.4 33.3 42.7 30.9 47.0 65.1 32.7 60.0 65.0 22.0 31.3 66.2 5.8 43.0 58.1 0.4 35.4 70.0 29.4 61.9 26.8 64.2 28.7 59.0 23.6 29.4 43.1 11.8 2.6 3.3 5.8 1.9 4.0 2.9 1.7 3.0 2.4 3.6 1.1 2.7 1.6 1.5 2.8 3.6 0.1 4.3 2.2 4.6 6.9 7.0 6.9 5.1 6.9 9.0 6.7 4.4 8.4 8.7 7.0 11.9 20.2 16.0 13.1 29.4 10.7 10.8 6.5 15.5 12.0 11.5 19.2 6.7 20.0 20.0 13.0 14.7 2.1 14.1 15.5 25.6 13.7 20.9 262.2 25.2 17.2 14.0 19.8 20.8 53.0 23.2 20.6 23.0 18.8 25.4 64.1 16.6 11.7 31.0 31.8 15.2 61.7 30.4 16.2 30.0 31.8 41.4 14.6 28.7 14.2 56.2 36.0 12.0 21.6 45.8 83.8 23.9 17.4 13.9 14.1 3.8 15.3 46.5 21.6 7.6 6.6 16.8 16.4 41.7 22.2 16.2 9.8 7.0 19.0 22.7 26.0 6.1 CXorf56 FLJ22965 ENSG00000018610 "Chromosome X open reading frame 56" Q9H5V9 X 119538149-119565409 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038245, HPA038617, HPA064831" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: AB_2685364" "prognostic unfavorable (3.45e-4)" "unprognostic (3.88e-3)" "unprognostic (7.82e-2)" "unprognostic (1.03e-3)" "unprognostic (8.92e-2)" "unprognostic (7.74e-3)" "unprognostic (6.38e-3)" "unprognostic (3.89e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-2)" "unprognostic (9.63e-3)" "unprognostic (1.68e-3)" "unprognostic (9.26e-3)" "unprognostic (4.68e-3)" "unprognostic (1.45e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-1)" 11.1 9.9 9.0 7.7 9.4 16.3 12.6 9.1 9.5 9.7 8.2 10.0 7.8 11.7 9.1 9.4 10.0 6.1 10.6 8.8 10.1 10.8 8.9 8.9 10.8 8.9 8.8 8.6 13.9 8.9 11.8 7.2 10.3 9.4 8.9 8.8 11.6 10.0 8.8 13.1 12.3 9.0 8.8 8.9 9.9 9.1 6.8 9.9 11.6 11.9 13.3 11.7 9.3 9.1 10.5 27.3 26.2 16.8 19.8 17.9 12.5 22.9 17.1 15.4 22.3 20.7 23.4 26.7 41.3 43.2 16.9 53.9 16.9 40.1 21.0 30.5 24.8 30.3 14.9 25.2 16.2 13.8 41.3 22.1 14.7 17.9 29.1 24.0 14.2 16.3 24.0 32.2 25.4 11.1 40.5 24.8 24.7 27.3 33.4 28.4 23.9 19.0 29.9 15.8 19.8 12.1 22.0 35.9 19.3 25.3 18.0 15.0 17.9 20.4 16.9 12.0 31.2 39.6 21.9 42.7 42.0 14.2 39.7 20.3 5.0 10.3 13.9 9.0 12.6 8.2 10.9 7.7 9.5 9.5 15.6 7.9 7.7 4.8 6.4 11.9 8.7 10.4 9.4 9.0 9.4 9.1 9.5 8.8 10.1 8.9 8.8 8.6 9.4 8.9 9.9 10.5 2.6 3.2 13.9 1.6 10.6 6.2 8.0 4.8 5.7 15.7 4.8 5.0 13.4 7.2 5.4 3.7 6.2 20.5 3.5 8.3 21.5 9.2 1.3 8.7 10.3 7.5 8.5 10.3 9.4 6.6 20.1 5.3 4.1 10.5 17.2 7.7 6.8 6.4 10.1 8.4 10.8 6.0 8.2 12.9 8.3 1.2 9.6 6.5 12.4 2.8 17.1 15.8 6.2 7.5 6.8 6.8 6.5 11.3 7.8 5.2 9.8 13.2 6.8 11.3 13.1 9.5 11.1 5.4 10.0 6.5 5.8 35.6 9.2 7.6 7.9 8.6 ATP1A2 "FHM2, MHP2" ENSG00000018625 "ATPase Na+/K+ transporting subunit alpha 2" P50993 1 160115759-160143591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 445.1;skeletal muscle: 890.5;tongue: 482.2" "Cell type enhanced" "Detected in some" "Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5" "Cancer enriched" "Detected in many" 18 "glioma: 91.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3" "Low region specificity" "Detected in all" CAB022230 Enhanced NA NA 170000 "CAB022230: " "unprognostic (1.08e-2)" "unprognostic (4.42e-2)" "unprognostic (3.41e-2)" "unprognostic (2.83e-1)" "unprognostic (2.83e-1)" "unprognostic (7.98e-2)" "unprognostic (2.16e-2)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.85e-2)" "unprognostic (8.63e-4)" "unprognostic (1.70e-2)" "unprognostic (9.40e-3)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (7.16e-2)" "unprognostic (5.32e-3)" 35.0 4.1 390.1 1.5 405.2 0.0 27.7 409.8 416.2 9.0 153.9 42.8 3.6 5.6 12.6 33.8 14.6 8.1 120.6 326.9 355.7 3.8 1.2 6.5 0.3 414.3 416.8 278.7 19.0 1.4 0.3 32.6 3.4 441.4 28.8 8.2 59.0 18.4 28.8 890.5 4.0 16.0 7.9 315.8 1.8 15.8 5.8 445.1 0.6 3.5 482.2 0.5 30.1 9.9 297.4 0.0 0.0 51.9 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 4.6 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 390.1 405.2 409.8 416.2 326.9 355.7 414.3 416.8 278.7 441.4 315.8 445.1 297.4 1.4 0.0 0.0 515.8 0.1 0.5 1.6 0.0 0.6 1.3 2.5 0.9 158.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 1.2 11.1 0.0 0.0 5.5 0.0 0.0 4.8 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 1.3 1.4 28.9 0.5 0.0 141.5 0.5 73.0 0.0 94.0 2.5 0.0 0.0 39.5 0.0 0.8 0.0 0.1 0.1 3.9 85.5 54.9 45.8 0.3 0.2 0.2 0.6 0.1 0.1 5.8 0.0 0.6 TTC27 FLJ20272 ENSG00000018699 "Tetratricopeptide repeat domain 27" Q6P3X3 2 32628032-32821051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031246 Approved Approved Nucleoli,Mitochondria No No Mitochondria Nucleoli "HPA031246: AB_10603139" "unprognostic (3.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.21e-3)" "unprognostic (6.28e-3)" "unprognostic (8.90e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (7.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.13e-1)" "unprognostic (2.07e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" 7.5 8.2 3.3 8.1 4.3 7.6 12.3 4.1 4.9 7.6 3.6 7.3 5.8 9.2 9.0 9.3 9.7 5.5 8.6 3.1 5.8 7.3 8.0 6.4 9.5 4.4 3.7 2.4 11.8 8.4 10.8 4.4 8.4 4.6 6.9 8.7 5.2 8.9 5.7 10.0 8.4 5.9 9.4 3.3 8.6 6.8 12.6 3.7 7.5 10.0 8.5 11.4 9.6 7.2 8.3 43.0 20.6 13.9 10.5 11.5 23.1 6.7 17.5 14.2 26.3 22.9 31.6 25.3 37.3 15.2 26.3 27.3 21.2 22.4 27.4 38.1 17.9 27.4 42.0 10.3 43.7 21.9 40.7 21.3 15.3 24.5 32.0 34.5 12.9 24.4 9.2 59.5 10.7 23.6 17.0 32.4 14.0 25.3 18.9 21.3 21.2 29.9 32.1 20.2 24.8 11.4 16.6 14.3 13.1 16.7 16.1 16.2 9.6 20.6 16.4 18.2 19.8 30.3 15.0 4.1 41.8 17.8 31.2 17.9 0.0 4.7 0.0 9.1 10.0 10.1 9.9 10.1 9.1 10.5 9.7 12.6 9.8 0.2 9.3 7.1 4.9 9.6 5.9 3.3 4.3 4.1 4.9 3.1 5.8 4.4 3.7 2.4 4.6 3.3 3.7 8.3 6.8 9.6 10.4 19.9 10.1 5.6 9.2 7.2 8.0 5.1 6.3 4.3 8.2 4.3 8.8 0.0 4.2 13.4 4.8 2.2 7.9 10.1 18.2 5.6 6.7 8.0 7.3 6.3 27.6 9.5 12.7 8.8 7.7 5.2 12.0 12.0 3.9 4.9 7.6 3.3 33.7 4.5 2.0 8.1 4.6 2.7 8.4 4.0 5.4 27.2 6.5 5.5 1.0 32.2 66.7 5.1 4.7 7.2 6.5 7.0 2.2 4.8 12.4 6.0 6.6 9.7 6.4 28.3 11.3 7.4 5.7 6.4 8.2 9.9 7.9 6.8 ZNF582 FLJ30927 ENSG00000018869 "Zinc finger protein 582" Q96NG8 19 56375846-56393545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 13.7;Muller glia cells: 13.2;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028858 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA028858: AB_10603247" "unprognostic (1.19e-3)" "unprognostic (9.86e-4)" "unprognostic (3.88e-1)" "unprognostic (3.46e-2)" "unprognostic (4.08e-3)" "unprognostic (1.04e-2)" "unprognostic (2.12e-2)" "unprognostic (6.05e-2)" "unprognostic (3.10e-2)" "unprognostic (4.12e-2)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (2.02e-7)" "unprognostic (3.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.54e-2)" "unprognostic (5.00e-3)" 2.3 4.6 6.7 2.2 7.3 1.6 3.3 7.8 8.6 3.2 6.3 2.5 1.1 4.2 7.0 2.5 3.2 3.3 4.5 6.1 6.6 3.7 2.6 2.7 4.8 6.5 6.6 6.0 5.2 2.1 3.9 5.1 2.9 6.5 4.3 1.3 10.5 2.1 2.7 1.8 3.0 2.0 2.3 6.7 4.1 1.9 5.2 6.5 2.7 7.4 1.6 1.9 3.0 2.1 7.6 0.0 1.3 6.9 1.4 1.6 1.7 0.0 2.9 3.0 1.8 1.4 0.0 0.4 0.0 1.8 1.6 4.0 0.0 0.9 0.4 1.3 0.0 28.3 7.0 0.0 0.5 2.9 1.8 5.4 6.1 1.5 1.1 0.0 1.8 1.1 0.7 1.6 0.0 1.1 0.0 4.1 4.5 3.9 0.1 0.0 1.9 2.3 2.5 1.5 3.9 0.0 4.5 0.0 0.9 0.0 5.1 3.1 3.8 1.2 3.6 7.4 0.9 3.9 6.0 7.0 4.4 0.2 0.4 2.1 2.9 1.4 4.2 2.8 2.3 4.2 4.3 3.4 2.8 2.3 3.2 2.4 3.1 0.4 7.6 1.7 2.3 1.1 1.9 6.7 7.3 7.8 8.6 6.1 6.6 6.5 6.6 6.0 6.5 6.7 6.5 7.6 4.9 0.0 0.0 4.2 4.0 1.3 2.4 2.3 1.2 4.4 2.5 2.8 3.5 1.5 2.1 7.3 2.1 2.7 2.9 0.2 13.7 2.5 1.0 2.8 1.7 4.6 0.0 0.4 4.5 0.6 0.7 2.6 1.1 1.9 8.2 3.2 4.6 2.4 2.8 1.7 4.9 0.5 6.1 1.0 2.0 0.9 2.1 2.3 3.6 0.0 1.6 13.2 5.2 7.1 9.2 1.4 0.3 4.1 0.1 4.2 0.7 4.9 2.2 5.5 13.1 3.5 2.8 2.8 7.9 0.9 1.0 3.6 2.7 4.5 0.6 2.3 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747474-124752255 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "stomach 1: 624.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 87.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "OE19: 429.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm NA NA 78000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 4.0 0.8 2.8 7.1 5.1 3.4 9.6 0.6 6.5 29.9 0.5 137.5 6.2 4.9 0.4 26.6 17.7 26.7 4.2 2.9 2.3 6.3 3.0 46.1 0.9 1.9 3.1 1.9 1.1 2.0 2.0 1.7 6.1 2.8 58.7 139.1 0.7 32.0 4.4 2.3 1.5 2.8 4.8 0.7 1.6 624.9 0.9 2.5 0.2 44.1 2.5 2.5 85.3 9.4 3.3 0.4 0.1 4.8 3.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 1.5 2.4 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.3 16.6 0.0 7.9 0.7 0.5 3.0 0.1 0.0 0.0 0.0 0.3 2.8 0.3 0.3 0.6 0.0 1.6 0.1 0.1 0.6 429.0 3.7 0.4 3.6 0.1 0.1 69.2 0.3 0.9 0.1 4.6 0.0 0.7 0.4 2.4 4.1 1.8 1.1 0.3 0.8 0.3 0.0 0.0 0.6 1.7 0.9 0.0 1.2 0.0 0.0 0.1 0.5 0.0 0.5 0.1 0.4 0.0 0.6 0.4 0.1 0.3 0.2 0.0 0.7 0.9 2.8 5.1 0.6 6.5 2.9 2.3 1.9 3.1 1.9 2.8 0.7 2.5 3.3 4.6 125.0 51.6 0.0 1.5 0.8 19.2 25.3 2.8 1.5 31.5 18.4 0.7 82.9 99.3 3.7 0.0 0.0 0.6 514.3 1.9 14.6 0.0 12.1 1.8 5.0 66.8 0.0 0.2 90.9 0.1 0.9 623.4 18.3 1.3 0.1 3.9 0.2 0.1 0.0 0.1 285.6 20.3 0.3 2.7 0.0 1.5 2.4 3.6 1.0 0.0 0.0 0.0 0.0 0.1 260.2 509.9 0.0 0.7 61.6 1.3 0.1 36.7 0.0 0.0 0.3 6.2 0.2 0.7 0.7 0.4 0.0 2.2 0.3 207.0 285.3 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 128.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 87.2;Late spermatids: 87.7;Oligodendrocytes: 244.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 105.2;ASC TERT1: 105.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA No "Vesicles, Cytosol" "Plasma membrane" "HPA037959: AB_10673651, HPA038448: AB_10697390" "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 50.3 8.2 29.1 11.6 66.6 0.5 39.2 34.2 44.3 38.7 2.7 21.3 9.3 38.7 2.6 9.2 30.5 21.8 29.4 31.0 61.5 14.2 3.2 27.1 4.7 61.8 57.7 16.3 32.2 22.4 4.5 8.8 24.8 85.6 16.8 6.5 1.6 11.1 16.0 13.5 14.4 15.4 18.7 30.1 12.6 14.4 12.1 52.9 3.2 20.5 13.7 2.3 22.1 23.1 128.9 4.8 7.5 28.9 14.2 105.2 105.9 10.1 21.9 26.6 12.7 7.4 11.2 31.8 0.0 40.2 44.3 17.2 18.6 6.6 44.8 2.0 0.7 4.2 8.6 5.7 5.5 27.2 0.0 15.8 55.8 9.6 17.8 12.5 28.3 36.6 0.7 7.5 0.3 16.7 3.4 0.1 0.5 10.2 0.4 3.8 1.1 7.5 0.7 12.5 6.8 6.5 14.5 55.8 4.7 15.6 11.3 20.1 2.7 45.4 25.9 22.9 13.2 18.3 0.2 0.0 0.1 7.5 1.5 29.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 29.1 66.6 34.2 44.3 31.0 61.5 61.8 57.7 16.3 85.6 30.1 52.9 128.9 34.4 6.4 13.7 53.2 1.6 18.4 9.2 13.7 14.2 4.0 7.2 19.6 5.6 1.5 6.3 31.3 0.0 1.0 2.5 34.2 0.0 9.4 78.3 11.6 87.2 32.1 8.4 0.0 4.1 4.4 1.5 54.9 11.7 8.6 1.3 25.6 26.4 0.9 5.9 3.3 8.3 20.4 0.0 2.5 34.4 87.7 67.1 8.2 12.4 23.4 2.2 7.6 0.0 67.3 244.5 24.3 29.8 44.4 0.7 4.2 10.7 7.8 0.5 2.3 39.5 42.9 53.8 21.9 10.1 1.9 9.1 1.5 5.4 11.0 16.8 2.4 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942194-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 95.7;lung: 201.4;lymphoid tissue: 88.7" "Cell type enriched" "Detected in many" 6 "Kupffer cells: 1269.8" "Cancer enhanced" "Detected in many" "lung cancer: 21.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 33.7;intermediate monocyte: 56.5" "Lineage enriched" "Detected in many" 5 "monocytes: 56.5" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 30000000 "Golgi apparatus" Vesicles "HPA063793: AB_2685123" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 65.3 31.3 0.7 88.7 0.9 3.5 7.5 0.7 5.2 0.5 9.5 5.3 2.0 0.7 1.3 2.5 25.7 2.5 11.2 0.7 6.1 1.6 95.7 201.4 17.9 1.1 1.5 0.4 7.6 0.8 0.3 1.5 2.8 0.8 1.8 2.1 0.0 4.5 2.4 1.5 2.3 3.1 30.1 1.1 37.4 3.5 2.1 9.5 1.4 1.5 5.0 1.1 25.5 1.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.6 0.4 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 33.7 0.0 0.0 56.5 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.7 0.0 7.2 1.0 0.0 9.2 0.7 0.9 0.7 5.2 0.7 6.1 1.1 1.5 0.4 0.8 1.1 9.5 3.1 0.7 25.6 45.1 0.0 1.0 1.1 0.1 0.0 0.0 0.0 3.4 1.8 0.4 1.5 16.7 3.7 0.0 0.7 1.4 0.1 0.0 3.9 0.0 0.0 0.0 5.2 0.0 8.0 0.0 0.2 1.1 2.6 0.0 0.0 12.6 0.0 11.4 3.4 169.6 0.0 0.0 0.0 0.0 1269.8 46.4 0.1 0.0 199.3 0.0 2.8 23.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.5 0.1 0.0 0.2 13.1 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.9 1.9 4.1 0.0 0.0 0.1 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153446-54173986 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "endometrium 1: 15.1;kidney: 35.5;lymphoid tissue: 10.6;placenta: 10.1;urinary bladder: 29.0" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7" "Cancer enhanced" "Detected in many" "lung cancer: 18.3;urothelial cancer: 21.0" "Region enhanced" "Detected in some" "midbrain: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "A549: 411.5;Hep G2: 122.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA022261, HPA063771" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.0 0.0 0.2 0.4 0.3 0.0 3.8 0.0 0.3 1.6 0.0 0.0 0.1 15.1 0.2 3.8 0.2 0.0 0.0 0.1 1.0 35.5 0.4 0.7 0.2 0.3 2.0 0.1 0.0 0.0 0.0 0.3 10.1 0.3 2.9 0.0 0.0 0.3 2.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.2 1.3 0.0 10.6 29.0 1.3 0.2 0.5 411.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 12.6 0.0 3.2 0.0 0.9 15.8 0.0 0.1 0.1 0.0 0.0 0.0 6.5 122.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 7.0 1.3 0.0 2.6 0.6 0.0 0.1 0.1 0.0 0.0 0.0 16.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.1 1.0 0.3 2.0 0.1 0.3 0.1 0.6 0.2 0.0 0.0 0.0 0.0 1.3 22.8 48.3 142.7 74.0 0.0 11.0 8.6 0.4 0.0 47.0 0.0 0.0 0.1 0.1 0.1 5.9 0.1 0.0 0.7 0.5 0.3 0.0 0.0 0.2 0.0 0.1 2.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 9.8 0.0 61.3 13.1 0.0 0.0 0.0 0.6 0.0 0.0 3.3 19.6 0.1 0.1 0.0 0.2 36.7 PRDM11 PFM8 ENSG00000019485 "PR/SET domain 11" Q9NQV5 11 45095806-45235110 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 60.0;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057072 Approved NA NA "HPA057072: AB_2683328" "unprognostic (3.32e-4)" "unprognostic (3.94e-2)" "unprognostic (3.01e-1)" "unprognostic (1.71e-3)" "unprognostic (4.27e-2)" "unprognostic (2.23e-2)" "unprognostic (7.10e-4)" "unprognostic (7.06e-2)" "unprognostic (1.41e-1)" "unprognostic (2.23e-1)" "unprognostic (9.57e-5)" "unprognostic (1.60e-1)" "unprognostic (4.93e-6)" "unprognostic (9.25e-2)" "unprognostic (2.88e-1)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" 5.2 4.3 9.2 2.6 7.6 2.5 4.5 7.0 9.7 11.0 4.8 9.0 2.1 13.1 3.1 6.7 10.2 3.4 10.0 7.8 8.2 4.7 2.6 5.6 2.6 6.6 7.7 8.0 10.4 5.3 2.8 8.6 4.2 10.1 9.0 2.3 2.5 4.2 7.8 6.8 3.7 5.5 9.2 5.1 5.4 6.5 1.9 7.8 2.4 9.1 8.3 2.6 8.8 9.1 7.4 4.6 12.7 3.1 1.6 5.1 4.3 0.7 2.3 5.1 7.7 5.0 11.7 1.7 5.1 5.2 3.3 9.9 5.5 6.2 2.8 2.5 1.6 4.8 3.8 18.3 2.2 8.1 4.5 4.9 5.5 10.2 0.4 8.1 5.4 7.7 0.9 1.7 0.0 3.8 2.3 0.0 6.0 3.7 4.1 8.3 5.8 11.6 0.1 4.2 4.2 4.0 4.9 5.3 0.8 5.8 1.9 19.3 2.4 4.1 16.5 7.8 4.0 5.2 3.9 4.7 4.7 0.7 1.0 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 9.2 7.6 7.0 9.7 7.8 8.2 6.6 7.7 8.0 10.1 5.1 7.8 7.4 3.1 6.4 6.2 11.4 2.9 2.2 5.4 0.9 2.8 5.7 3.1 3.7 8.2 0.0 6.0 5.5 2.1 0.8 2.8 1.1 0.0 1.4 1.3 4.8 4.3 4.3 0.0 2.1 11.4 1.1 0.3 4.4 3.6 2.7 0.0 3.2 6.8 1.4 0.8 10.1 10.3 1.9 2.0 0.8 0.3 7.8 5.3 1.3 0.0 60.0 1.6 3.6 1.0 9.5 8.2 0.5 0.6 7.2 0.6 3.5 0.5 1.4 3.0 1.6 19.7 6.5 5.5 0.4 0.7 1.8 0.9 0.3 2.9 3.9 2.9 2.4 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240302-45286341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2;gallbladder: 21.0;pituitary gland: 16.9" "Cell type enriched" "Detected in many" 7 "Enteroendocrine cells: 336.8" "Group enriched" "Detected in many" 5 "breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles NA NA Vesicles "HPA046224: AB_10961288, HPA056602: AB_2683185" "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.1 4.7 4.9 1.5 12.5 0.0 0.2 1.5 30.7 0.0 0.0 12.4 12.7 0.2 0.0 0.0 0.2 21.0 5.2 15.7 14.0 9.0 0.3 0.5 0.0 6.8 8.3 17.3 0.0 7.1 0.4 16.9 0.0 12.2 1.9 12.7 11.4 1.9 0.0 0.1 0.2 12.9 0.8 0.0 0.1 11.1 1.7 9.0 0.3 1.6 0.1 0.0 0.0 0.0 31.2 0.0 19.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 8.8 0.0 0.2 0.0 0.0 0.0 56.8 0.0 15.0 0.7 0.0 0.0 0.1 0.7 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 12.5 1.5 30.7 15.7 14.0 6.8 8.3 17.3 12.2 0.0 9.0 31.2 0.0 0.0 0.0 4.6 0.1 0.0 0.2 0.0 0.0 3.3 0.1 0.3 15.3 17.2 0.0 3.7 25.0 0.0 0.0 10.2 5.9 1.2 3.1 0.4 0.2 0.1 336.8 0.0 41.6 0.6 0.0 1.7 3.6 2.0 0.0 2.5 0.0 0.0 0.0 1.7 43.8 37.3 4.1 0.0 0.0 9.7 0.3 0.0 0.0 5.6 0.0 0.7 0.0 1.5 3.5 8.2 14.3 0.0 0.0 2.3 13.9 0.5 0.0 2.7 0.0 0.0 0.2 2.0 0.2 0.0 0.0 0.0 0.0 0.0 32.8 0.2 SNAI2 "SLUG, SLUGH, SLUGH1, SNAIL2" ENSG00000019549 "Snail family transcriptional repressor 2" O43623 8 48917598-48921740 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Deafness, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 162.8;Basal prostatic cells: 119.4;Basal respiratory cells: 98.9;Endometrial stromal cells: 129.2;Melanocytes: 87.2;Suprabasal keratinocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 243.2;ASC TERT1: 247.8;HSkMC: 181.3;hTERT-HME1: 180.3;LHCN-M2: 228.8;U-138 MG: 206.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB011671 Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB011671: AB_777968" "unprognostic (3.52e-2)" "unprognostic (3.95e-1)" "unprognostic (1.55e-1)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (1.74e-2)" "unprognostic (1.79e-1)" "unprognostic (1.04e-2)" "unprognostic (4.24e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.83e-4)" "unprognostic (2.38e-1)" "prognostic unfavorable (4.69e-8)" "unprognostic (1.65e-3)" "unprognostic (3.76e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.16e-4)" 24.8 10.7 0.7 15.8 0.9 0.4 23.1 3.4 1.4 48.1 2.1 10.9 4.3 43.3 11.4 15.9 34.7 22.0 12.6 0.8 0.6 12.5 9.7 11.2 8.1 0.8 0.7 0.7 41.2 8.1 3.7 2.3 16.4 1.2 19.9 7.7 0.1 17.0 23.5 4.6 39.1 11.6 27.7 0.5 14.3 9.5 3.7 0.7 7.0 9.6 7.8 7.9 38.1 51.8 0.6 17.7 0.6 38.5 0.4 243.2 247.8 0.1 38.6 69.0 38.1 52.3 0.0 17.4 0.0 0.0 50.1 56.7 28.9 0.4 111.8 40.2 0.0 0.8 0.0 7.2 0.1 88.5 0.1 0.1 181.3 116.8 31.9 180.3 5.4 1.3 0.0 0.0 18.5 228.8 0.3 0.0 0.1 2.3 0.0 34.7 0.0 122.2 0.2 0.1 6.8 5.1 3.8 3.3 0.1 69.2 18.9 0.2 0.2 10.6 206.6 7.4 36.6 20.9 0.0 0.1 4.2 74.9 0.0 78.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 3.4 1.4 0.8 0.6 0.8 0.7 0.7 1.2 0.5 0.7 0.6 11.7 0.0 0.0 0.0 0.1 162.8 119.4 98.9 60.9 1.9 2.1 22.0 1.2 1.5 14.0 0.0 0.0 1.7 0.3 0.0 0.0 3.0 0.6 5.2 129.2 19.5 0.0 0.0 0.6 2.3 0.5 69.9 0.0 4.8 0.0 0.0 40.0 6.8 1.7 0.0 0.5 0.0 10.2 0.8 30.7 1.7 73.7 1.9 87.2 0.0 0.0 0.0 0.0 1.0 0.0 6.1 0.0 67.4 1.4 18.4 0.0 0.0 2.4 0.2 52.6 24.7 59.2 0.2 0.4 32.3 147.9 2.2 2.3 21.8 0.0 25.0 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150400041-150412969 "Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 5301.9" "Cell type enhanced" "Detected in many" "B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0" "Group enriched" "Detected in all" 6 "B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002506, HPA010592, CAB079994" Enhanced Supported "Golgi apparatus" NA NA 210000 "Golgi apparatus" "CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482" "prognostic favorable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favorable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 1327.5 984.5 308.0 2766.6 392.9 992.7 1167.2 362.5 478.2 1575.9 483.2 1001.8 1842.7 599.2 494.9 624.4 1149.1 1491.1 534.3 287.1 569.9 1270.9 1151.4 3819.2 5036.6 584.8 366.0 228.8 468.4 395.7 393.9 472.9 308.3 509.4 561.5 1167.0 58.6 2017.7 920.3 310.1 687.9 2459.3 1023.5 533.0 4940.5 1524.9 209.4 481.3 2180.3 860.6 377.6 5301.9 1571.9 487.6 620.4 35.7 0.3 1.5 2.4 2.3 2.5 11.0 0.0 0.0 0.7 0.6 443.0 2171.7 3523.2 124.2 0.0 9.2 9.4 0.0 0.0 0.1 4787.6 0.0 109.1 1.2 250.2 6.6 9.2 6.5 24.5 0.0 0.8 0.0 0.6 0.0 0.0 8.0 1270.7 0.4 0.0 4.2 14.0 5.3 0.0 0.1 3026.0 5.2 2014.2 9.0 133.5 5.1 8.2 5.5 4.7 94.9 19.2 81.2 414.4 5.6 10.3 9.9 9.0 4.5 1443.4 170.7 1978.6 745.9 154.2 678.6 410.8 11041.2 3996.9 808.7 15961.1 899.9 26889.3 688.4 1188.4 23750.6 27930.3 378.9 646.6 839.6 2378.1 8003.3 16940.0 2157.2 17779.7 308.0 392.9 362.5 478.2 287.1 569.9 584.8 366.0 228.8 509.4 533.0 481.3 620.4 2080.4 419.9 2160.4 0.7 10167.0 715.9 154.0 762.2 398.4 1.7 220.3 437.5 69.6 401.7 1063.3 502.1 0.0 28.3 3199.0 139.7 117.4 1264.4 10.4 111.3 11.5 1787.6 242.9 562.5 0.7 527.5 32.6 278.6 538.2 85.5 417.2 113.4 514.7 52.5 4361.8 1.7 0.6 475.7 390.6 5201.6 23363.4 31.3 117.1 7290.2 1197.1 137.7 10305.9 16.8 403.7 0.5 1.4 384.2 487.3 17.7 2068.3 174.9 5034.4 815.8 1153.1 10.0 164.3 45.1 146.7 2.8 12.6 170.9 575.8 41.6 790.7 12.9 450.7 743.4 HGF "DFNB39, F-TCF, HGFB, HPTA, SF" ENSG00000019991 "Hepatocyte growth factor" P14210 7 81699010-81770438 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Serine protease homolog" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 314.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 23.8;Fibroblasts: 95.8;Hepatic stellate cells: 25.0;Muller glia cells: 36.2;Smooth muscle cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 94.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 94.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 171.6;HHSteC: 135.8;HL-60: 82.4;hTEC/SVTERT24-B: 87.4;Karpas-707: 240.7;U-87 MG: 62.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010333, HPA040360, HPA044088" Approved "Secreted to blood" NA NA 4110000 14000 "CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804" "unprognostic (5.24e-2)" "unprognostic (6.77e-2)" "unprognostic (1.72e-2)" "unprognostic (5.12e-2)" "unprognostic (1.85e-2)" "unprognostic (7.45e-5)" "unprognostic (1.66e-1)" "unprognostic (9.28e-3)" "unprognostic (3.28e-2)" "unprognostic (2.97e-2)" "unprognostic (2.74e-1)" "unprognostic (5.29e-2)" "prognostic unfavorable (5.59e-4)" "unprognostic (7.90e-3)" "unprognostic (2.92e-2)" "unprognostic (1.14e-2)" "unprognostic (2.06e-2)" 7.4 20.0 2.1 6.4 3.6 12.4 5.2 2.0 7.9 6.9 3.2 3.4 2.6 8.2 3.7 2.9 5.5 16.7 4.4 3.3 4.1 9.6 30.5 19.7 2.2 3.8 3.1 2.5 1.8 2.1 2.1 2.4 314.6 4.4 7.3 3.5 14.3 2.4 6.5 0.9 0.9 2.4 7.2 2.5 6.5 4.0 2.4 2.9 1.5 5.7 3.9 1.5 10.5 6.3 7.3 0.0 0.0 0.1 0.0 21.6 171.6 0.1 0.7 33.4 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 135.8 82.4 0.4 41.4 0.0 87.4 0.3 0.0 2.2 0.0 0.1 240.7 0.6 0.0 0.0 56.4 0.0 0.0 0.2 0.8 0.0 7.5 0.0 0.0 0.2 9.3 0.0 0.1 0.0 0.2 0.0 3.5 0.4 2.0 0.0 0.1 0.0 0.1 0.0 0.0 62.6 16.9 0.1 94.0 15.2 3.9 0.0 18.7 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 3.2 0.0 17.3 1.0 0.0 4.3 2.1 3.6 2.0 7.9 3.3 4.1 3.8 3.1 2.5 4.4 2.5 2.9 7.3 6.2 0.0 4.1 16.3 0.0 1.0 0.2 0.0 1.8 0.2 0.3 0.5 1.3 1.5 0.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 15.2 1.0 23.8 6.2 0.0 2.1 0.3 0.0 4.9 95.8 0.5 0.9 1.3 0.0 25.0 0.5 18.4 0.0 22.4 0.0 0.0 12.5 1.9 2.3 18.3 14.0 1.8 7.5 10.5 36.2 1.0 0.0 0.1 0.0 0.0 10.9 0.3 0.4 0.0 0.0 0.0 0.7 13.1 0.9 26.2 0.2 0.3 0.3 0.1 12.0 0.6 1.3 0.0 0.4 ZRANB1 TRABID ENSG00000019995 "Zinc finger RANBP2-type containing 1" Q9UGI0 10 124942123-124988189 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029239, HPA029240, HPA029241" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205" "unprognostic (2.06e-1)" "unprognostic (5.16e-2)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (1.40e-1)" "unprognostic (9.53e-3)" "unprognostic (4.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (4.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.47e-2)" 14.0 21.3 19.2 6.7 19.8 22.7 13.2 28.0 21.1 14.5 19.8 11.3 5.1 14.6 12.6 10.6 10.9 9.8 18.5 19.1 18.7 11.0 25.0 10.7 8.2 19.2 19.4 18.0 19.4 8.9 16.9 8.8 10.7 20.1 11.3 8.8 17.7 9.0 13.7 53.4 14.2 7.8 15.4 19.5 8.7 8.4 19.9 19.5 13.7 10.2 46.8 10.8 10.4 11.8 20.6 15.1 8.6 17.8 13.1 27.1 22.7 7.5 14.5 39.6 27.1 31.3 12.8 11.7 15.7 10.6 18.4 8.8 10.7 22.8 10.7 36.2 16.8 11.3 9.0 9.7 13.8 57.6 13.6 6.6 25.2 30.8 19.9 42.2 37.7 17.3 14.2 1.3 12.7 14.8 12.1 16.2 11.9 6.5 8.2 9.1 13.7 12.7 7.2 12.0 10.9 9.1 15.2 12.3 9.4 16.4 16.7 10.4 11.5 12.9 11.5 11.8 9.7 18.3 13.4 12.5 18.1 13.1 9.5 5.8 0.9 0.4 1.2 0.8 0.1 0.6 0.9 0.9 0.7 0.3 1.3 1.5 1.2 1.7 1.3 0.2 0.5 0.9 0.3 19.2 19.8 28.0 21.1 19.1 18.7 19.2 19.4 18.0 20.1 19.5 19.5 20.6 28.6 19.2 25.3 61.7 17.9 24.6 22.8 10.7 22.2 36.9 29.0 21.2 22.9 15.7 17.3 18.4 50.1 12.3 26.3 16.2 0.0 13.1 80.2 29.4 38.6 21.7 26.8 25.7 58.2 11.6 9.8 21.4 14.3 38.5 26.0 34.3 14.6 43.8 12.5 37.0 58.5 19.0 4.1 16.7 22.4 30.3 23.9 24.3 16.0 52.5 13.2 24.2 19.6 56.3 76.0 19.3 11.5 23.0 21.0 31.4 11.9 10.5 19.2 26.0 13.1 34.6 27.6 28.8 19.1 20.5 27.8 27.5 21.4 23.7 13.1 31.1 NCDN "NCDN-1, NCDN-2" ENSG00000020129 Neurochondrin Q9UBB6 1 35557473-35567274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "brain: 417.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 39.7;Inhibitory neurons: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023676 Enhanced Supported Supported Cytosol NA NA Cytosol "HPA023676: AB_1854325" "unprognostic (1.15e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (4.66e-2)" "unprognostic (1.41e-1)" "unprognostic (4.36e-2)" "prognostic favorable (3.73e-4)" "unprognostic (5.91e-3)" "unprognostic (5.34e-3)" "unprognostic (5.88e-3)" "unprognostic (2.87e-1)" "unprognostic (3.24e-2)" "unprognostic (2.23e-2)" 9.3 24.1 211.5 9.5 417.4 5.0 9.9 60.8 372.1 20.1 5.4 14.3 5.4 17.2 6.5 12.2 16.2 9.8 23.2 385.9 151.4 13.5 10.4 11.9 9.7 152.4 136.9 239.4 19.0 10.1 10.7 39.0 6.7 134.7 17.4 3.4 21.5 11.1 11.4 14.8 9.8 10.7 9.7 98.5 11.5 15.0 15.4 242.9 7.5 16.7 9.1 6.7 16.4 16.0 221.7 17.3 20.5 16.8 26.6 23.8 29.4 11.6 22.3 22.9 23.0 18.3 20.6 24.8 19.6 21.1 20.7 16.5 26.0 16.6 27.1 8.4 19.2 34.3 24.4 32.2 10.7 33.0 22.3 26.9 28.2 22.2 40.7 16.3 18.9 12.3 11.6 26.9 30.4 18.9 31.0 20.5 14.2 75.7 19.1 35.6 16.6 9.4 25.4 15.6 19.0 20.9 30.0 25.4 23.2 32.1 13.3 22.2 14.4 17.0 29.1 20.9 21.5 30.9 42.4 32.6 14.7 36.3 35.1 27.1 0.0 2.6 0.4 1.6 1.5 2.0 3.7 2.5 2.5 1.5 1.4 3.3 2.9 0.3 1.8 2.6 0.9 1.5 3.8 211.5 417.4 60.8 372.1 385.9 151.4 152.4 136.9 239.4 134.7 98.5 242.9 221.7 3.8 3.2 12.0 15.7 1.9 3.4 0.5 4.0 1.8 4.7 5.8 7.1 13.8 2.8 12.6 7.3 0.0 5.6 2.0 2.9 1.9 3.7 2.5 3.9 8.1 4.4 3.6 2.1 39.7 4.4 2.6 6.1 8.6 5.1 3.8 6.5 3.3 4.3 3.5 6.7 35.0 3.5 6.1 6.7 1.0 1.4 6.5 2.6 5.4 12.2 1.7 2.1 2.1 9.5 16.4 3.8 2.1 4.1 6.5 0.6 0.8 4.7 14.7 2.9 0.0 1.7 5.4 5.1 2.2 2.7 3.0 5.6 4.9 8.0 1.7 0.6 ADGRA2 "DKFZp434C211, DKFZp434J0911, FLJ14390, GPR124, KIAA1531, TEM5" ENSG00000020181 "Adhesion G protein-coupled receptor A2" Q96PE1 8 37784191-37844896 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 30.6;Endometrial stromal cells: 49.4;Fibroblasts: 36.4;Hepatic stellate cells: 31.4;Leydig cells: 56.5;Microglial cells: 24.4;Muller glia cells: 25.0;Peritubular cells: 41.8;Sertoli cells: 46.0;Smooth muscle cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 83.6;ASC TERT1: 64.8;BJ hTERT+: 75.2;fHDF/TERT166: 77.6;HSkMC: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012393 Uncertain NA NA 270000 "HPA012393: AB_1849256" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.38e-1)" "unprognostic (3.75e-2)" "unprognostic (1.15e-2)" "unprognostic (1.20e-2)" "unprognostic (3.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.18e-7)" "unprognostic (2.65e-2)" "unprognostic (4.90e-2)" "unprognostic (6.12e-2)" "unprognostic (4.60e-3)" 29.4 4.9 11.0 12.3 7.3 2.0 26.6 8.6 10.8 54.2 8.0 19.3 7.8 45.5 18.3 25.1 44.2 26.5 17.3 9.3 6.1 8.0 4.3 16.4 7.8 7.8 8.0 5.9 36.2 5.5 2.3 10.1 49.1 8.8 44.8 8.2 6.8 9.1 55.4 6.6 13.2 12.9 28.0 6.4 12.0 12.4 3.5 9.6 5.3 11.4 8.4 5.6 40.0 32.3 7.6 0.2 2.3 0.3 4.7 83.6 64.8 0.6 38.5 75.2 4.6 12.4 0.5 0.2 0.0 6.9 77.6 3.1 0.9 3.5 0.2 1.5 1.6 1.8 0.2 2.2 0.2 38.1 0.0 0.0 39.4 0.4 3.4 0.8 3.3 22.3 3.0 0.2 0.7 1.2 1.2 0.1 8.0 3.5 0.0 0.6 6.5 4.2 0.4 0.0 0.1 0.3 18.1 1.0 0.2 5.7 17.7 0.2 16.9 18.2 7.6 9.6 11.2 3.5 6.2 0.5 0.1 1.0 20.3 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 7.3 8.6 10.8 9.3 6.1 7.8 8.0 5.9 8.8 6.4 9.6 7.6 30.6 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.0 1.0 1.0 1.1 1.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.9 0.1 0.2 1.5 49.4 17.8 0.0 0.0 7.8 1.6 0.6 36.4 0.0 2.2 0.0 0.1 31.4 0.1 2.1 0.0 7.8 0.2 0.0 1.6 0.0 3.1 56.5 1.5 0.0 24.4 1.0 25.0 1.0 3.0 0.8 0.3 0.1 41.8 0.1 0.3 0.0 0.0 0.0 0.7 46.0 5.5 36.0 0.3 0.8 0.5 0.0 2.3 0.4 2.6 0.3 0.2 ZFP64 "dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338" ENSG00000020256 "ZFP64 zinc finger protein" Q9NTW7 20 52051663-52204308 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035112, HPA058387" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035112: AB_10672859, HPA058387: AB_2683702" "unprognostic (3.86e-2)" "unprognostic (8.84e-2)" "unprognostic (2.34e-1)" "unprognostic (4.61e-3)" "unprognostic (9.22e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (4.68e-2)" "unprognostic (5.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" "unprognostic (2.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" 4.2 4.9 4.1 5.7 5.1 5.3 4.7 4.3 5.3 5.7 2.4 6.3 6.7 5.7 4.2 7.1 6.7 5.4 4.9 4.7 3.4 4.7 5.3 4.6 6.7 4.5 2.9 4.5 7.9 5.7 7.2 4.7 4.4 4.7 6.4 5.7 5.0 5.8 5.8 5.4 11.3 6.0 5.5 1.7 5.7 6.0 6.6 3.6 7.4 6.9 4.5 5.4 5.6 6.1 5.1 35.1 19.6 14.7 35.1 7.2 13.0 21.0 11.9 17.3 25.5 21.1 18.8 14.3 15.5 23.2 21.5 21.1 46.2 12.0 26.6 15.6 6.6 37.5 9.3 35.0 20.1 19.9 10.4 6.6 11.3 39.4 13.0 14.8 13.0 17.6 16.4 11.2 19.5 6.4 14.6 14.5 8.9 14.8 19.0 15.1 15.9 7.6 15.6 12.1 13.9 15.2 18.0 23.1 28.6 22.5 12.0 19.2 12.3 11.6 18.0 26.1 19.7 7.7 21.1 20.6 12.6 17.2 10.3 12.2 5.1 3.3 8.1 4.5 1.8 3.3 5.1 3.4 3.6 4.2 3.2 3.8 3.7 1.8 5.3 4.8 4.1 3.3 2.8 4.1 5.1 4.3 5.3 4.7 3.4 4.5 2.9 4.5 4.7 1.7 3.6 5.1 4.7 3.2 3.3 7.2 5.4 8.7 4.3 5.4 19.9 5.1 5.1 3.9 4.0 4.3 2.5 0.0 2.1 4.3 6.2 7.5 7.9 8.2 7.4 3.9 4.4 4.2 6.7 5.5 18.0 5.8 8.5 5.9 9.7 3.9 7.0 5.2 9.3 6.1 4.0 1.7 15.5 9.5 8.2 4.1 4.2 9.1 6.5 2.9 3.6 14.0 4.0 2.7 7.2 15.6 18.6 5.4 6.0 7.2 11.6 3.5 5.3 4.9 4.0 4.7 6.6 3.8 5.5 19.7 2.9 11.3 13.4 1.2 5.8 3.9 9.0 2.6 MNAT1 "MAT1, RNF66" ENSG00000020426 "MNAT1 component of CDK activating kinase" P51948 14 60734742-60969965 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000701, HPA001154, CAB004495" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212" "unprognostic (4.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (6.11e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.17e-2)" "unprognostic (2.73e-1)" "unprognostic (2.62e-2)" "unprognostic (3.52e-2)" "unprognostic (3.48e-2)" "unprognostic (6.34e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.68e-1)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (7.14e-3)" 21.5 20.6 25.8 9.5 25.2 14.1 26.0 28.7 31.9 21.2 17.8 15.7 8.9 18.3 19.1 16.9 24.9 14.2 21.2 25.3 25.4 27.2 23.7 14.4 13.6 23.8 23.7 24.3 22.6 14.8 55.8 22.4 16.1 23.3 21.0 12.8 29.4 26.0 15.9 80.7 12.8 10.8 19.4 22.2 11.7 17.0 12.3 25.5 26.4 18.4 65.8 17.4 20.0 16.6 29.8 203.9 38.5 47.0 33.3 53.5 58.6 51.3 73.1 78.4 87.5 70.2 30.9 69.4 48.6 53.9 53.9 47.3 63.2 53.0 84.1 124.7 61.0 55.0 32.9 36.2 45.9 66.4 77.0 16.8 36.0 60.5 56.5 62.1 84.1 84.6 69.6 49.6 45.3 98.5 69.5 48.2 48.2 25.8 38.3 85.1 49.4 127.9 30.9 102.9 94.3 41.9 28.5 56.0 46.6 71.7 54.0 72.2 37.0 64.9 66.8 70.7 31.8 55.6 19.7 17.8 70.4 53.9 12.9 49.4 12.2 6.1 22.3 14.3 8.6 14.7 26.9 15.3 15.3 11.9 19.8 17.6 17.8 0.5 34.6 10.1 46.6 13.6 6.6 25.8 25.2 28.7 31.9 25.3 25.4 23.8 23.7 24.3 23.3 22.2 25.5 29.8 30.1 32.1 25.5 91.1 31.1 24.9 59.4 88.3 23.3 43.0 28.0 35.6 58.4 22.8 50.8 29.5 31.3 50.6 51.1 6.1 80.3 35.2 6.1 85.6 34.6 28.9 17.4 14.5 365.2 44.5 36.3 33.9 25.5 60.4 32.9 23.3 18.5 23.3 20.2 23.5 223.4 13.8 52.9 6.9 10.7 6.9 30.1 13.3 14.2 119.9 12.6 50.3 44.3 196.6 148.1 59.3 9.3 30.5 30.1 48.1 4.3 74.3 81.4 59.2 52.6 77.5 52.2 50.9 41.2 26.6 18.2 36.0 35.3 26.9 16.0 44.2 SAMD4A "DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA" ENSG00000020577 "Sterile alpha motif domain containing 4A" Q9UPU9 14 54566117-54793315 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.4;skeletal muscle: 95.2;testis: 108.7" "Group enriched" "Detected in many" 4 "Early spermatids: 1176.0;Late spermatids: 2275.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.2;non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043061, HPA065309" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA043061: AB_2678299, HPA065309: AB_2685462" "unprognostic (1.46e-1)" "unprognostic (8.10e-3)" "unprognostic (9.66e-3)" "unprognostic (1.18e-4)" "unprognostic (2.79e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (1.09e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" 15.3 4.2 42.9 9.0 32.4 0.4 13.2 44.0 28.8 13.1 16.3 27.6 3.2 26.3 4.0 6.8 12.1 6.1 48.2 24.0 49.9 7.0 16.8 21.4 4.6 81.4 45.4 19.5 4.5 6.3 3.9 6.2 9.2 65.8 14.6 4.8 2.6 7.1 9.5 95.2 7.9 10.4 17.3 71.8 7.2 11.0 108.7 50.7 1.1 7.0 39.7 3.1 17.8 12.9 81.0 32.9 2.9 6.7 3.4 14.0 21.3 11.7 27.4 41.4 22.3 22.0 36.8 7.8 1.8 14.0 41.7 8.8 22.6 6.6 14.2 32.8 16.5 2.8 0.0 4.0 7.7 7.7 0.0 0.2 12.6 5.3 15.9 23.4 6.5 17.1 0.0 2.6 0.0 11.0 2.4 0.4 0.1 3.1 0.2 7.5 0.9 13.5 0.1 11.0 10.8 1.0 10.7 4.0 5.2 15.9 13.8 21.0 0.3 37.1 26.6 41.1 6.6 8.7 0.1 0.1 0.0 7.5 0.6 8.4 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 42.9 32.4 44.0 28.8 24.0 49.9 81.4 45.4 19.5 65.8 71.8 50.7 81.0 16.0 25.6 1.5 170.1 7.4 39.6 47.0 12.0 1.2 2.4 6.2 6.1 278.5 14.3 9.9 18.4 8.4 10.5 1.6 4.4 3.9 9.9 1176.0 13.7 45.3 30.9 6.0 5.7 64.6 8.0 1.8 47.3 1.5 29.3 22.8 0.8 10.8 62.6 11.6 10.1 173.7 1.5 6.1 15.3 28.9 2275.7 14.6 13.0 24.9 72.1 12.8 1.5 1.0 380.5 140.7 19.8 5.5 23.7 0.3 55.1 5.6 22.9 4.0 5.4 13.1 79.7 37.1 17.1 7.6 0.4 24.3 1.9 5.7 0.3 1.7 44.5 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "RUNX family transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 69.4;lymphoid tissue: 35.4" "Cell type enhanced" "Detected in many" "dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4" "Cancer enhanced" "Detected in all" "melanoma: 25.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB025416: , HPA004195: , HPA059006: AB_2683877" "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavorable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 2.9 1.4 3.3 21.3 3.4 69.4 3.5 3.5 5.4 19.8 4.3 3.8 5.1 1.6 0.7 2.6 1.6 5.3 0.9 3.4 3.6 1.6 3.7 9.6 35.0 4.1 3.7 2.7 0.6 0.9 0.4 0.7 0.9 3.9 1.9 4.3 0.1 4.8 0.8 3.8 10.8 15.1 1.7 3.5 35.4 5.6 2.3 3.9 11.3 1.8 0.7 29.2 6.5 1.5 4.1 0.3 10.4 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.5 0.0 0.5 0.0 19.3 18.4 16.4 0.1 0.4 11.1 0.0 0.7 124.9 1.9 0.4 1.8 0.1 0.0 4.5 42.8 0.1 0.0 0.0 1.1 0.0 0.0 3.1 0.1 155.6 0.0 0.0 1.5 37.9 0.7 0.0 3.2 0.0 0.1 22.7 0.0 0.5 3.5 0.0 7.3 0.1 92.4 2.9 0.0 25.7 0.0 0.0 1.9 0.0 0.5 54.6 40.4 18.2 0.1 42.0 4.4 0.7 1.1 7.0 21.7 4.5 11.3 6.7 7.9 18.7 1.4 5.7 3.9 14.6 1.3 28.7 7.7 1.5 9.2 5.5 3.3 3.4 3.5 5.4 3.4 3.6 4.1 3.7 2.7 3.9 3.5 3.9 4.1 4.4 0.0 3.6 0.0 57.7 7.6 0.8 4.6 2.2 0.0 9.8 11.3 2.4 0.0 1.5 1.8 0.0 0.1 336.4 0.5 0.0 0.2 2.3 1.1 1.2 2.4 0.0 13.7 0.0 0.2 0.1 3.3 13.3 2.3 45.2 0.0 2.2 1.5 4.6 0.0 0.0 0.5 0.0 22.9 133.9 1.0 0.0 55.6 46.2 1.0 51.1 0.0 251.3 0.0 0.1 0.1 0.1 0.7 87.1 1.2 0.0 0.3 0.5 0.0 0.0 3.5 3.6 0.3 4.1 2.3 5.8 0.3 215.4 0.1 0.4 0.4 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415570-94493885 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 9.2 6.2 4.4 11.8 4.0 22.8 14.1 7.0 3.6 8.3 5.6 7.6 6.9 11.8 8.9 7.2 7.9 7.4 5.0 2.9 5.3 6.1 6.4 7.8 12.7 5.0 4.0 2.5 11.2 7.5 5.7 3.2 12.2 4.1 9.4 11.6 6.4 7.9 7.4 5.0 15.7 7.8 10.0 5.0 12.8 7.4 8.4 3.6 14.4 7.4 5.4 16.2 8.6 7.5 6.8 21.5 21.5 39.9 5.0 13.1 18.2 22.8 29.4 19.0 25.9 30.6 39.4 43.3 55.8 47.0 15.3 32.5 40.1 33.7 22.1 34.1 37.5 20.0 48.7 31.5 22.7 6.0 32.7 33.6 12.8 13.4 33.7 21.0 11.7 23.0 26.8 34.9 35.6 20.9 15.5 33.2 30.5 13.0 49.3 23.3 29.0 35.3 28.1 16.8 29.6 14.1 19.8 40.6 26.0 8.6 33.2 43.4 19.3 16.9 38.7 28.6 33.9 21.5 8.8 33.2 54.4 10.4 50.3 31.5 5.7 8.0 6.5 8.2 10.0 8.3 6.4 6.0 8.9 11.6 6.9 5.1 8.4 3.8 8.6 8.4 8.7 8.8 6.7 4.4 4.0 7.0 3.6 2.9 5.3 5.0 4.0 2.5 4.1 5.0 3.6 6.8 23.6 28.9 14.3 0.0 6.3 0.0 0.0 0.0 0.0 0.0 12.5 13.7 0.0 0.0 9.3 9.2 0.0 39.2 20.8 0.0 3.9 11.4 0.0 19.5 22.2 8.4 0.0 0.0 0.0 8.1 15.8 8.9 0.0 16.3 17.7 34.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 8.8 0.0 0.0 6.1 0.0 0.0 6.5 11.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 28.0 7.2 16.8 0.0 0.0 PLEKHB1 "KPL1, PHR1, PHRET1" ENSG00000021300 "Pleckstrin homology domain containing B1" Q9UF11 11 73646178-73662819 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 1579.9;choroid plexus: 781.4;retina: 764.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 344.0;Early spermatids: 145.6;Late spermatids: 184.4;Muller glia cells: 496.6;Rod photoreceptor cells: 460.4" "Cancer enhanced" "Detected in all" "glioma: 59.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 83.7" "Lineage enriched" "Detected in many" 5 "T-cells: 83.7" "Cell line enhanced" "Detected in many" "Hep G2: 77.2;OE19: 53.3;U-266/84: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (5.07e-1)" "unprognostic (2.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-2)" "unprognostic (1.41e-3)" "unprognostic (3.01e-1)" "unprognostic (3.94e-2)" "prognostic favorable (6.02e-4)" "unprognostic (3.59e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (4.47e-1)" "unprognostic (7.44e-2)" 2.7 6.7 1128.3 7.8 1326.7 1.3 10.5 1328.3 1074.1 6.6 781.4 39.7 11.7 3.0 15.1 4.7 24.6 10.4 13.6 971.7 1148.1 12.4 2.1 15.4 8.9 1454.0 1292.5 868.4 3.1 23.1 88.8 136.2 0.9 1421.2 13.3 9.1 764.7 59.5 8.7 9.5 5.0 20.0 3.0 1436.9 4.3 20.7 20.3 1212.8 5.6 29.1 12.0 7.7 8.2 5.6 1579.9 0.7 2.0 4.8 3.8 2.0 0.6 0.2 0.2 0.1 0.3 0.3 8.5 16.2 0.1 20.0 0.5 0.6 0.4 2.6 0.4 0.4 11.0 12.5 0.0 1.0 77.2 1.2 0.0 0.2 0.7 0.0 0.3 0.0 4.1 0.1 19.4 0.3 10.5 0.3 6.3 5.3 0.3 3.1 53.3 1.0 3.8 0.1 2.6 0.7 1.4 11.8 2.8 0.0 0.3 1.7 3.5 5.6 1.0 0.0 0.0 2.2 0.1 1.6 17.5 30.4 11.3 2.8 0.0 0.8 0.2 0.5 1.1 17.1 0.0 41.5 18.3 41.4 30.6 0.5 7.9 83.7 47.3 0.9 4.3 0.1 0.9 26.9 27.4 1128.3 1326.7 1328.3 1074.1 971.7 1148.1 1454.0 1292.5 868.4 1421.2 1436.9 1212.8 1579.9 0.7 6.4 13.5 25.5 5.3 0.4 1.1 1.7 0.6 53.6 19.1 11.8 8.1 25.8 4.5 7.3 344.0 0.5 1.9 0.8 11.7 30.6 145.6 27.4 0.5 3.9 62.8 0.0 1.1 0.8 0.1 2.0 13.7 3.7 11.4 10.4 1.8 0.2 2.7 20.2 0.6 11.2 22.4 0.3 0.3 184.4 2.5 0.9 10.6 7.5 1.6 496.6 6.2 15.6 96.4 2.9 3.9 0.7 1.0 4.0 0.9 13.9 42.8 460.4 0.0 2.5 1.8 2.6 1.7 0.3 0.1 0.1 9.7 0.1 6.5 1.6 SERPINB1 "anti-elastase, EI, ELANH2, PI2" ENSG00000021355 "Serpin family B member 1" P30740 6 2832332-2841959 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 471.0;esophagus: 482.1" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9" "Low region specificity" "Detected in all" "HPA018871, HPA018882, HPA052642" Enhanced Supported "Cytoplasmic bodies" "Secreted to blood" NA NA 24000000 "Cytoplasmic bodies" "HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896" "unprognostic (1.13e-2)" "unprognostic (1.93e-1)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (5.14e-3)" "unprognostic (9.67e-2)" "unprognostic (3.59e-3)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.88e-2)" "unprognostic (1.08e-3)" "unprognostic (9.07e-2)" "unprognostic (1.05e-1)" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" 36.9 54.9 11.4 70.4 15.0 471.0 25.2 12.1 14.1 34.3 18.2 78.4 141.6 15.8 22.4 482.1 36.2 57.9 25.0 11.4 23.1 31.0 32.4 82.4 51.7 15.9 13.5 10.4 18.3 234.0 30.1 33.2 27.2 15.6 16.1 88.4 13.5 100.4 17.1 54.7 16.0 108.2 25.1 14.2 68.0 98.8 7.2 13.8 32.2 31.0 23.1 123.8 89.4 113.3 15.6 42.9 49.7 2.7 0.3 10.6 21.8 41.2 11.8 36.1 14.5 26.1 47.1 125.3 0.3 86.6 26.6 15.6 26.8 4.8 11.4 11.1 59.4 7.5 76.6 16.0 37.0 37.2 13.5 46.2 26.8 18.4 7.3 3.3 7.2 48.7 0.0 27.1 9.9 13.4 19.9 1.7 35.4 4.5 162.5 22.1 3.9 0.5 44.4 51.0 9.3 8.8 4.8 28.8 11.2 64.2 5.9 5.6 43.2 29.1 4.6 10.4 10.2 3.6 0.1 2.2 0.5 17.4 144.9 2.4 118.0 207.1 109.4 53.3 103.7 45.8 43.5 48.1 48.4 150.4 32.3 47.4 50.6 182.3 85.1 82.8 48.6 58.5 175.8 11.4 15.0 12.1 14.1 11.4 23.1 15.9 13.5 10.4 15.6 14.2 13.8 15.6 79.9 240.4 269.9 0.7 90.7 35.1 165.1 699.1 38.1 4.2 55.0 51.2 17.6 72.9 420.9 46.0 2.1 124.5 120.8 264.1 56.7 490.3 1.7 210.6 28.7 118.9 96.3 176.3 0.9 1424.3 149.1 89.1 345.1 104.5 452.2 32.1 124.9 20.2 183.0 10.1 0.9 263.1 109.9 332.7 308.2 3.5 34.8 387.3 71.2 15.9 589.7 48.3 139.0 4.5 6.6 1067.8 308.4 27.8 65.2 147.5 333.7 81.3 343.8 17.2 13.1 109.7 67.2 2.0 11.2 461.5 38.1 99.7 112.9 59.2 242.6 984.3 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 45.0" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 45.0 0.1 0.1 0.1 0.1 0.0 0.1 5.8 0.0 0.0 0.0 0.1 0.6 0.1 0.5 0.2 0.1 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.8 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.0 0.3 0.4 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 6.4 0.1 1.7 1.9 0.0 0.0 0.6 1.9 3.3 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.5 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.7 0.1 2.4 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.2 SLC7A9 CSNU3 ENSG00000021488 "Solute carrier family 7 member 9" P82251 19 32830509-32869767 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 125.6;kidney: 68.8" "Cell type enriched" "Detected in some" 7 "Proximal enterocytes: 772.0" "Group enriched" "Detected in some" 7 "liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042591 Enhanced NA NA "HPA042591: AB_10962500" "unprognostic (4.12e-2)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" "unprognostic (3.37e-3)" "unprognostic (1.69e-1)" "unprognostic (1.54e-1)" "unprognostic (4.17e-2)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (9.69e-2)" "unprognostic (5.97e-2)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (5.10e-5)" 0.2 0.1 0.8 0.1 0.8 0.0 0.3 0.8 0.9 0.6 0.6 0.7 79.0 0.4 1.5 0.2 0.5 0.2 0.1 0.7 0.8 68.8 17.4 0.2 0.1 0.7 0.7 0.7 0.6 0.3 0.0 0.7 0.1 0.9 1.0 0.2 1.0 0.2 0.2 0.0 0.2 125.6 0.2 0.7 0.3 0.2 0.4 0.7 0.2 0.8 0.0 0.0 0.3 0.5 0.9 0.0 0.1 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 0.9 0.7 0.8 0.7 0.7 0.7 0.9 0.7 0.7 0.9 0.1 0.0 0.0 2.3 0.5 0.0 0.1 0.0 0.0 1.3 0.2 0.6 0.4 0.0 0.0 5.5 4.2 0.2 0.1 0.0 1.9 0.1 1.6 0.3 0.2 0.1 0.0 0.0 3.1 7.2 8.8 0.2 0.0 0.2 0.0 0.4 0.0 12.2 0.2 0.0 3.0 18.2 0.0 0.0 0.0 0.1 0.6 0.5 0.0 2.8 0.0 0.2 0.0 0.0 1.7 0.6 27.5 0.0 0.0 0.0 772.0 97.8 1.8 1.2 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.1 11.7 0.0 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063556-32157637 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 5.9 5.9 10.6 7.3 13.6 10.0 6.3 12.1 12.2 8.7 3.4 7.2 7.5 7.7 5.1 7.0 6.5 6.5 4.0 10.9 11.3 6.0 9.6 6.3 9.8 12.8 13.0 8.8 9.2 5.3 6.2 4.4 6.9 14.1 6.4 7.6 7.0 4.3 5.4 7.9 7.4 8.1 7.4 13.4 7.1 6.3 9.9 12.3 14.2 8.6 10.1 9.3 7.4 4.4 15.8 17.5 12.2 19.7 19.5 12.0 14.2 17.8 9.4 13.7 9.7 8.6 16.9 14.8 30.2 8.5 13.1 14.2 12.0 19.5 9.6 11.9 20.7 11.8 33.3 6.0 20.5 11.0 23.2 22.4 7.9 12.3 12.4 11.6 11.7 21.5 9.6 27.6 10.0 10.7 7.4 37.8 19.4 20.5 19.2 7.1 19.8 27.9 19.5 13.0 10.7 27.9 29.9 16.0 13.2 15.9 16.0 8.7 15.8 18.8 10.6 16.2 9.5 11.1 14.7 29.7 23.8 11.6 19.9 13.0 1.8 3.5 3.8 1.8 4.9 2.5 2.4 2.8 2.9 3.9 1.9 2.9 3.0 5.3 3.9 3.8 1.7 4.2 2.5 10.6 13.6 12.1 12.2 10.9 11.3 12.8 13.0 8.8 14.1 13.4 12.3 15.8 15.0 9.6 4.4 26.4 12.2 9.6 5.9 7.9 11.4 15.4 11.7 6.9 8.0 8.6 7.9 5.5 22.9 9.6 21.4 11.4 0.0 6.6 4.4 16.9 11.8 11.3 10.8 10.3 38.9 8.0 7.4 8.1 9.7 13.7 10.1 16.7 7.9 12.0 9.7 10.1 55.2 10.8 10.2 17.5 9.9 8.5 8.7 17.6 1.8 36.5 21.1 7.9 18.6 59.3 62.7 10.4 9.8 10.1 12.5 8.7 10.9 7.0 13.0 14.1 0.0 11.9 11.9 16.7 21.2 11.7 13.1 8.1 13.3 10.9 10.4 7.2 NRXN3 "C14orf60, KIAA0743" ENSG00000021645 "Neurexin 3" "Q9HDB5, Q9Y4C0" 14 78170373-79868291 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 108.2;retina: 43.3" "Group enriched" "Detected in many" 10 "Excitatory neurons: 3526.5;Inhibitory neurons: 5083.8;Oligodendrocytes: 2145.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 9.7;RT4: 24.7;SK-BR-3: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002727 Approved NA NA 710000 "HPA002727: AB_1079468" "unprognostic (7.96e-2)" "unprognostic (5.70e-4)" "unprognostic (8.18e-3)" "unprognostic (2.19e-2)" "unprognostic (2.31e-4)" "unprognostic (9.56e-2)" "unprognostic (2.80e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-2)" "unprognostic (7.91e-2)" "unprognostic (2.40e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.83e-7)" "unprognostic (4.81e-2)" "unprognostic (2.61e-1)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" 0.8 5.9 8.2 2.8 17.2 0.1 1.6 108.2 47.5 4.0 0.0 16.5 2.3 5.5 1.7 4.8 5.0 2.5 2.0 21.6 21.1 1.7 0.4 2.6 0.4 20.4 26.9 30.1 0.7 3.1 8.9 4.9 1.3 35.8 6.8 4.1 43.3 2.8 11.4 0.3 1.8 8.5 21.3 0.0 5.9 9.4 7.6 8.8 1.1 0.5 0.5 0.4 4.4 2.7 27.7 0.0 0.0 7.6 0.0 0.2 0.3 0.0 3.0 2.2 9.7 7.3 2.6 0.0 0.1 0.0 0.3 0.0 2.8 0.1 0.3 6.8 3.0 6.0 0.0 0.2 0.0 0.7 0.0 0.0 1.8 0.3 4.3 1.4 4.6 2.5 0.0 0.0 0.2 0.1 0.1 0.2 0.2 1.6 0.0 0.0 0.2 0.0 0.0 5.2 24.7 1.3 0.0 0.0 9.3 0.5 3.1 0.0 0.0 0.0 0.1 6.2 0.0 3.2 0.0 0.0 0.0 1.8 0.3 5.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.2 17.2 108.2 47.5 21.6 21.1 20.4 26.9 30.1 35.8 0.0 8.8 27.7 0.2 12.8 5.5 100.2 0.0 4.6 7.0 0.4 0.6 180.7 3.2 3.0 3.9 1.5 3.4 3.7 12.5 9.2 0.0 1.1 0.0 2.2 15.9 36.3 2.2 0.8 6.0 0.0 3526.5 3.1 0.5 1.8 0.0 31.5 0.0 0.8 1.4 0.1 0.7 116.1 5083.8 0.6 4.1 0.0 0.3 18.9 7.5 0.3 17.8 88.1 0.0 54.3 0.0 328.2 2145.0 0.7 0.2 6.4 1.2 7.5 0.0 0.1 9.3 10.7 0.0 0.4 2.2 2.1 0.8 0.1 0.9 37.9 0.6 0.0 1.0 3.0 OSBPL5 "KIAA1534, OBPH1, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087107-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles NA NA Vesicles "HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 19.9 8.0 8.1 7.3 6.3 13.7 19.4 7.2 15.0 39.1 2.0 25.3 6.0 26.8 2.9 12.6 22.4 5.0 13.5 4.9 8.2 12.2 3.1 17.7 2.4 42.7 12.6 3.1 14.7 10.5 2.4 10.4 5.1 57.1 25.8 3.2 1.9 16.6 10.0 10.0 25.3 16.7 7.7 4.3 25.1 15.7 3.3 18.3 22.2 15.1 5.9 1.4 24.8 28.5 24.0 3.7 5.6 6.6 7.6 18.9 8.8 0.1 17.9 8.8 7.1 5.0 0.0 10.4 0.0 5.3 10.1 4.9 13.3 1.3 5.0 1.1 3.5 6.0 15.1 19.2 0.0 15.9 13.6 2.3 13.9 5.7 2.5 2.6 5.2 4.8 26.7 5.5 0.0 3.5 10.3 30.7 75.5 4.8 2.4 11.5 15.9 9.0 2.2 3.0 3.3 10.8 1.3 7.6 26.1 7.0 3.7 10.8 35.9 16.4 8.8 12.1 21.2 3.1 3.8 0.0 0.5 9.5 25.3 11.5 0.2 3.6 1.2 9.0 4.7 1.2 0.0 0.9 3.3 3.0 0.0 0.6 3.4 0.4 11.0 11.5 1.3 0.1 5.2 8.1 6.3 7.2 15.0 4.9 8.2 42.7 12.6 3.1 57.1 4.3 18.3 24.0 19.5 0.0 5.5 8.1 0.5 4.8 2.6 4.2 5.2 11.5 7.7 5.2 6.9 2.8 4.8 3.7 8.4 0.4 34.6 8.3 1.9 3.0 0.1 2.2 22.1 12.1 0.0 5.7 25.6 2.0 0.6 12.3 5.1 2.5 1.3 3.5 3.9 0.5 1.7 62.2 20.6 8.0 2.0 8.7 3.1 1.2 9.0 3.9 3.6 17.8 2.3 4.1 56.7 20.1 28.2 2.2 8.5 17.0 4.9 3.2 6.1 3.2 5.5 1.2 13.1 7.4 11.4 0.1 0.6 3.8 6.8 0.0 9.1 2.5 8.2 2.5 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969742 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm No No Nucleoplasm "HPA040624: AB_2677050, HPA055647: AB_2682874" "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 3.7 3.9 4.5 3.5 5.5 4.1 6.0 7.9 5.4 5.7 3.8 4.2 3.4 4.5 4.2 3.5 4.4 3.1 2.7 4.5 5.0 5.2 4.1 3.6 4.2 4.4 5.1 4.3 5.0 4.1 5.3 2.5 4.4 4.9 4.0 4.3 8.1 3.4 3.7 2.8 4.2 3.6 3.9 4.5 4.7 3.9 5.6 4.8 7.0 5.5 3.6 4.8 4.0 3.5 5.8 5.3 13.5 8.7 9.3 11.6 10.7 4.5 6.4 8.1 8.3 7.4 6.1 3.2 4.3 4.0 10.8 5.4 8.2 14.8 9.1 9.1 6.1 6.0 13.8 11.4 5.6 6.6 11.3 6.2 8.4 5.9 6.5 6.9 7.7 7.1 3.3 9.9 4.2 8.3 3.6 6.6 7.5 8.7 12.2 5.5 8.9 15.0 4.3 8.3 9.2 9.5 7.4 10.3 9.7 2.3 7.6 6.9 8.7 9.3 6.1 3.4 4.3 5.7 5.0 6.6 8.5 7.7 9.6 6.3 3.6 2.0 1.2 2.6 2.2 2.3 1.6 2.3 2.6 1.7 2.3 2.3 2.6 1.0 2.1 1.4 2.3 2.0 1.4 4.5 5.5 7.9 5.4 4.5 5.0 4.4 5.1 4.3 4.9 4.5 4.8 5.8 27.0 12.8 26.0 45.4 27.9 9.6 13.7 17.0 15.4 28.6 19.9 15.6 14.7 17.2 28.1 14.7 114.7 16.4 31.4 18.2 3.9 13.4 38.2 20.6 26.7 24.1 13.2 21.0 39.8 14.3 14.4 18.6 20.4 22.1 24.1 28.8 31.1 18.5 14.9 25.2 44.0 19.1 12.2 18.6 5.1 8.4 20.8 21.8 16.0 29.0 27.9 14.3 22.6 42.3 42.2 18.5 12.1 18.4 22.9 18.8 17.4 12.9 27.1 41.1 6.6 42.8 16.9 19.4 22.2 22.4 9.7 13.3 27.0 46.5 21.6 13.5 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 1071.9" "Cell type enriched" "Detected in many" 19 "Hepatocytes: 2075.1" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA 8300000 "Nucleoli, Nucleoli rim" "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favorable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 2.6 0.4 1.1 0.4 9.0 0.1 1.5 5.1 4.1 0.9 0.2 0.8 213.7 1.6 2.8 1.5 0.9 1.6 1.1 0.8 3.3 1.9 1071.9 1.1 0.3 7.3 6.2 0.7 3.0 0.8 0.1 0.9 2.5 7.0 0.8 0.4 0.3 0.5 0.8 0.6 1.3 124.4 2.2 3.7 1.2 0.6 6.0 5.8 0.3 1.8 0.5 0.2 0.6 0.7 6.7 0.9 9.7 14.0 11.7 11.6 16.5 18.0 6.1 6.4 6.3 9.2 1.8 0.0 2.7 0.4 5.3 9.6 3.0 0.5 10.8 15.9 0.0 4.5 10.0 347.6 15.2 2.8 4.0 0.0 9.2 6.2 12.8 13.0 18.7 0.4 4.2 10.3 0.8 10.4 2.8 0.3 0.7 6.3 0.0 1.8 0.7 14.6 1.6 13.2 0.2 0.5 1.1 65.1 98.9 8.1 20.0 0.1 1.6 7.7 17.5 5.8 5.9 13.0 0.0 0.7 0.0 12.5 11.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.0 5.1 4.1 0.8 3.3 7.3 6.2 0.7 7.0 3.7 5.8 6.7 0.4 12.8 8.4 6.2 3.6 2.2 0.6 0.9 1.2 1.4 1.3 1.5 1.1 15.7 3.9 1.8 8.4 0.4 0.4 0.1 0.0 0.2 35.5 1.0 2.1 2.0 0.0 18.7 12.1 0.2 0.4 2.6 0.0 1.6 3.8 0.3 16.8 2075.1 0.2 0.0 6.2 13.5 0.0 27.2 2.9 6.5 2.5 0.8 1.8 3.7 0.2 0.7 0.0 3.0 8.8 0.0 2.5 1.2 0.1 1.1 105.6 1.0 1.3 2.3 0.0 1.8 2.3 0.6 1.8 1.5 1.8 20.8 1.8 3.5 41.2 0.4 C8B ENSG00000021852 "Complement C8 beta chain" P07358 1 56929207-56966140 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 156 "liver: 847.0" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 295.1" "Cancer enriched" "Detected in some" 181 "liver cancer: 107.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 22 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Cell line enriched" "Detected in single" 4 "Hep G2: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023694 Supported "Secreted to blood" NA NA 6700000000 "HPA023694: AB_1847128" "unprognostic (6.65e-2)" "prognostic favorable (9.31e-5)" "unprognostic (2.37e-1)" "unprognostic (2.37e-1)" "unprognostic (1.29e-2)" "unprognostic (6.57e-2)" "unprognostic (5.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 847.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.2 1.0 0.0 0.1 0.0 5.3 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 7.1 295.1 0.1 0.0 0.1 0.0 0.0 7.6 0.0 11.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 11575.8;tongue: 9857.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9" "Cancer enhanced" "Detected in all" "renal cancer: 88.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 36.1" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 303.7;fHDF/TERT166: 258.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" NA NA 12000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavorable (2.11e-4)" 946.7 66.4 119.2 76.2 116.4 11.8 445.5 100.8 127.3 263.2 95.7 503.8 83.9 468.5 108.7 543.0 284.0 128.8 1475.9 124.8 187.5 45.3 43.4 288.1 42.0 104.5 120.9 117.5 103.6 39.8 198.1 93.6 107.5 110.4 412.5 162.9 76.8 162.6 546.4 11575.8 91.9 237.5 490.9 114.3 43.4 371.5 60.6 117.6 25.4 313.0 9857.4 32.3 473.6 255.2 99.9 0.4 44.3 60.7 57.8 127.2 52.3 1.5 183.7 303.7 34.8 81.3 0.3 12.7 0.7 55.8 258.8 95.0 0.5 119.2 148.0 28.2 0.4 136.7 0.7 34.4 0.0 121.6 0.3 26.8 96.6 24.4 41.2 128.7 14.1 36.6 34.5 0.1 26.0 81.9 2.5 26.1 1.6 19.1 0.2 52.2 69.8 2.6 38.2 1.1 0.1 43.5 63.8 6.6 0.2 12.4 24.1 0.3 2.4 102.5 150.2 71.0 5.9 44.7 6.8 16.0 1.1 11.9 1.4 18.2 0.1 0.7 0.0 5.2 0.1 13.8 5.8 18.2 7.2 3.1 3.6 12.0 4.0 1.2 36.1 0.0 19.4 2.2 11.1 119.2 116.4 100.8 127.3 124.8 187.5 104.5 120.9 117.5 110.4 114.3 117.6 99.9 203.0 48.1 11.7 32.0 8.1 56.5 26.9 15.1 14.2 36.2 1.4 8.3 1145.1 0.0 4.9 11.0 8.4 0.6 8.6 0.5 1.9 3.0 373.8 4.3 32.3 61.1 13.8 17.9 70.2 0.2 1.1 236.0 2.0 2.0 15.8 41.0 113.6 6.1 4.3 99.3 55.6 0.8 0.0 5.1 47.0 1206.9 123.9 35.6 32.0 16.9 7.4 209.6 2.1 35.2 8.2 0.6 7.6 152.4 15.5 20.1 0.6 11.6 4.8 19.4 105.2 248.1 235.7 7.4 88.6 2.7 44.8 2.7 15.5 9.6 2.0 2.6 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053986: AB_2682333" "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 74.4 73.3 102.2 66.5 111.2 129.6 66.3 117.6 107.6 65.0 90.2 71.6 61.1 71.2 49.3 64.7 65.4 49.7 86.7 98.2 108.6 67.7 64.3 58.6 71.2 114.1 110.1 93.1 71.7 59.8 63.5 68.3 55.9 113.7 58.7 54.7 61.8 51.7 62.8 183.1 68.6 61.3 65.9 116.9 68.3 59.8 57.5 108.8 79.9 61.1 112.1 76.8 74.4 57.9 123.8 132.8 93.3 91.1 91.3 111.1 97.9 85.9 198.5 148.1 280.0 158.5 192.6 125.2 110.4 232.0 161.5 139.7 144.9 92.4 153.8 190.7 52.6 72.9 138.9 97.4 150.8 127.9 201.3 186.6 88.1 156.5 126.0 106.9 119.7 121.3 118.1 109.6 114.3 139.1 253.9 171.6 173.0 68.8 185.2 175.9 116.3 247.2 149.5 119.1 86.1 95.1 103.1 208.2 355.0 199.0 66.7 165.0 191.7 131.5 242.2 156.0 133.0 165.1 94.6 116.1 156.9 190.7 134.7 135.1 309.4 205.4 562.3 125.6 192.8 106.2 115.7 106.4 122.5 223.6 134.0 119.7 110.6 580.4 197.4 200.5 189.6 152.2 254.1 102.2 111.2 117.6 107.6 98.2 108.6 114.1 110.1 93.1 113.7 116.9 108.8 123.8 87.2 51.3 61.2 0.0 20.9 0.0 0.0 0.0 0.0 0.0 54.1 56.9 0.0 0.0 34.0 66.2 0.0 162.8 50.9 0.0 156.5 104.5 0.0 47.8 51.2 38.8 0.0 0.0 0.0 96.3 109.5 37.3 0.0 47.7 90.8 57.9 0.0 0.0 110.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 92.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 5.3 0.0 0.0 149.9 34.2 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 182.9 26.4 89.8 0.0 0.0 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor subunit alpha1" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "brain: 46.9;retina: 18.0" "Group enriched" "Detected in some" 11 "Bipolar cells: 198.0;Excitatory neurons: 220.5;Inhibitory neurons: 215.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 0.0 1.2 4.0 0.0 7.9 0.0 0.0 25.7 46.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.3 24.1 0.0 0.0 0.0 0.0 0.0 2.1 17.4 0.0 0.0 0.0 0.1 0.0 3.3 0.1 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 21.0 0.6 0.0 0.0 0.2 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.9 25.7 46.9 16.3 24.1 0.0 2.1 17.4 3.3 0.0 21.0 16.9 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 198.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 220.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 215.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 17.8 0.0 3.5 0.0 8.0 16.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP2 "CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2" ENSG00000022556 "NLR family pyrin domain containing 2" Q9NX02 19 54953130-55001142 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 45.2;Extravillous trophoblasts: 216.1;Syncytiotrophoblasts: 97.3" "Cancer enriched" "Detected in many" 7 "testis cancer: 78.1" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 42.2;BEWO: 177.9;OE19: 79.7;SuSa: 80.3;T-47d: 46.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA021183 Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA021183: AB_2670615" "unprognostic (1.66e-2)" "unprognostic (9.28e-2)" "unprognostic (6.60e-2)" "unprognostic (6.50e-3)" "unprognostic (1.09e-2)" "unprognostic (4.57e-3)" "unprognostic (4.27e-1)" "unprognostic (1.79e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.86e-2)" "unprognostic (7.57e-2)" 0.4 0.3 1.0 2.7 0.8 1.1 1.0 0.0 0.9 2.6 0.2 1.7 1.8 1.1 1.8 8.0 1.9 0.9 0.4 0.8 0.3 1.2 0.4 1.6 2.1 0.6 0.2 0.2 0.3 1.6 0.4 1.2 7.1 0.6 1.5 1.9 3.2 2.4 1.1 0.6 2.5 1.7 0.8 0.0 2.1 2.5 7.2 0.3 3.4 4.5 0.0 2.0 7.2 4.4 0.4 20.4 42.2 15.8 0.4 0.2 0.1 177.9 0.1 0.0 0.6 0.2 35.9 0.7 14.7 0.1 0.1 0.1 8.1 0.0 24.4 0.3 1.7 0.2 9.8 0.5 0.1 0.4 0.1 0.4 0.2 0.3 0.0 0.1 0.1 0.9 0.0 32.7 0.2 0.0 0.3 0.1 1.3 5.0 79.7 0.0 8.8 0.0 24.0 26.4 0.7 5.3 0.7 0.0 8.1 0.0 80.3 46.7 0.2 0.0 0.3 0.7 0.4 0.3 5.2 16.6 0.7 0.4 1.0 0.0 0.1 0.2 0.0 1.8 0.3 1.3 0.6 0.4 0.7 0.2 0.6 0.3 0.8 0.2 3.0 0.1 1.0 1.3 0.4 1.0 0.8 0.0 0.9 0.8 0.3 0.6 0.2 0.2 0.6 0.0 0.3 0.4 0.0 9.6 7.3 0.3 1.5 0.5 1.9 8.1 0.0 2.7 1.9 1.5 0.8 4.3 10.1 1.8 4.2 45.2 3.5 2.9 0.0 5.3 23.1 8.6 1.3 0.7 2.4 0.8 3.0 1.9 216.1 1.1 2.0 13.1 4.5 0.7 0.0 0.0 11.6 0.0 1.9 3.0 6.1 0.3 0.5 7.2 0.9 1.1 0.0 0.0 3.0 0.7 8.2 0.5 0.5 6.7 1.0 0.0 1.5 2.5 0.8 0.4 8.4 2.7 0.0 0.3 0.8 16.8 11.7 0.0 1.3 97.3 2.4 0.3 3.0 4.7 SLC45A4 KIAA1126 ENSG00000022567 "Solute carrier family 45 member 4" Q5BKX6 8 141207166-141308305 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 49.7;Cone photoreceptor cells: 54.2;Endometrial ciliated cells: 57.6;Glandular and luminal cells: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 8.3;neutrophil: 7.0" "Lineage enriched" "Detected in single" 22 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "HMC-1: 18.3;OE19: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023154 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023154: AB_2191204" "unprognostic (7.79e-3)" "unprognostic (1.06e-1)" "unprognostic (4.30e-2)" "unprognostic (1.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.96e-2)" "unprognostic (1.26e-1)" "unprognostic (4.49e-3)" "unprognostic (1.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.73e-6)" "unprognostic (8.79e-3)" "unprognostic (1.13e-1)" "unprognostic (1.77e-2)" "unprognostic (2.40e-2)" 2.8 2.6 2.8 3.7 5.5 5.9 2.9 1.6 17.0 7.2 12.3 4.1 2.3 4.4 1.5 3.3 7.1 2.7 6.4 7.6 1.5 8.5 0.9 6.8 2.8 6.3 1.5 3.7 3.1 8.0 2.5 15.1 5.1 11.7 6.6 1.7 5.4 7.8 5.4 4.7 5.4 4.2 1.7 0.8 4.9 12.6 13.8 3.2 2.3 5.8 1.4 2.0 3.5 2.8 6.5 4.6 9.8 3.7 5.9 0.3 0.3 16.1 2.5 1.5 2.2 1.7 6.4 12.2 0.9 11.8 1.0 3.1 3.7 2.1 1.2 1.0 7.2 3.3 2.7 3.1 0.0 1.7 1.1 18.3 0.8 1.9 1.6 0.9 0.5 1.5 5.0 5.6 0.7 0.8 11.9 11.0 2.5 4.7 30.8 4.1 3.3 0.2 3.1 8.9 7.9 5.5 4.6 2.7 0.8 4.5 2.6 1.9 7.2 0.8 0.0 2.4 3.8 4.9 3.9 12.7 1.3 2.1 4.3 4.0 1.1 0.1 8.3 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 7.0 0.2 0.1 0.3 0.2 0.1 2.8 5.5 1.6 17.0 7.6 1.5 6.3 1.5 3.7 11.7 0.8 3.2 6.5 3.3 9.6 12.7 6.5 3.0 2.7 6.6 3.6 5.2 33.1 6.4 5.8 13.5 15.7 8.9 49.7 54.2 8.7 7.5 14.7 0.0 9.3 12.5 57.6 10.8 3.4 2.4 0.0 29.0 2.7 0.8 2.9 37.2 97.1 1.3 1.8 1.1 0.0 6.7 3.3 21.7 7.7 8.2 2.5 3.3 5.9 2.1 8.6 3.6 7.5 1.8 4.3 5.2 6.6 0.9 7.8 4.5 2.2 5.3 6.0 3.7 3.2 22.3 9.2 0.0 1.5 3.2 5.7 2.6 4.4 2.4 16.3 4.6 4.0 5.1 11.3 RNF10 "KIAA0262, RIE2" ENSG00000022840 "Ring finger protein 10" Q8N5U6 12 120533480-120577588 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 286.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052643 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA052643: AB_2681897" "unprognostic (1.54e-1)" "unprognostic (3.04e-1)" "unprognostic (5.40e-2)" "unprognostic (2.83e-3)" "unprognostic (1.09e-2)" "unprognostic (3.58e-2)" "prognostic unfavorable (5.30e-5)" "unprognostic (5.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.40e-1)" 76.0 105.2 105.5 53.1 105.0 186.5 68.7 101.5 136.1 64.3 111.9 80.6 59.3 62.1 96.9 103.8 59.0 50.5 163.8 106.0 104.9 96.6 82.3 75.1 54.1 103.6 107.0 99.7 66.2 75.9 76.4 71.8 66.5 103.6 69.6 66.4 77.3 68.6 62.3 309.7 76.0 61.7 78.4 105.4 79.3 81.6 97.7 105.5 58.4 61.2 210.6 70.1 73.8 69.8 111.7 109.7 141.6 68.3 109.3 130.9 103.0 80.6 100.7 113.9 81.8 86.4 117.1 49.3 129.5 89.4 167.3 64.0 73.9 126.6 136.5 116.0 127.5 71.0 132.1 77.5 123.0 175.3 120.0 89.5 105.5 155.0 115.1 156.8 141.8 168.5 95.7 134.2 86.7 124.3 125.3 79.4 131.1 104.0 101.7 139.9 69.8 87.5 185.4 164.4 221.1 66.9 72.7 140.0 89.5 78.9 94.2 144.2 68.6 134.8 59.3 65.7 95.5 65.9 74.7 146.8 90.8 97.5 80.2 65.0 154.2 53.8 173.8 45.5 45.8 48.9 35.7 44.7 52.4 60.0 31.2 39.5 40.6 118.0 46.1 54.3 30.7 60.7 52.9 105.5 105.0 101.5 136.1 106.0 104.9 103.6 107.0 99.7 103.6 105.4 105.5 111.7 56.2 25.6 32.6 30.3 54.0 61.9 51.1 27.1 52.3 39.9 63.8 42.9 99.3 32.9 28.4 47.8 22.9 62.1 58.9 93.5 164.4 49.7 72.7 54.1 53.2 45.9 49.2 286.5 43.1 58.7 69.4 47.8 64.7 78.9 36.8 42.0 42.8 48.8 36.9 55.5 42.9 50.3 34.6 52.5 63.1 41.7 56.8 54.7 56.9 16.9 48.7 43.3 56.7 32.2 52.4 59.8 49.1 54.9 71.2 63.1 73.8 70.0 21.6 54.5 52.6 52.3 55.0 118.0 55.2 74.5 65.8 111.8 59.1 74.1 47.3 77.8 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favorable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favorable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 7.2 9.4 9.7 6.8 8.5 11.6 13.8 5.7 9.1 9.3 7.1 7.9 7.1 8.2 9.4 7.3 17.2 6.9 7.7 8.7 9.3 10.4 14.7 6.2 10.9 8.4 7.9 8.4 11.0 12.2 10.9 9.3 5.6 8.7 9.0 8.2 8.1 10.5 9.6 18.7 19.5 9.9 5.3 5.8 15.2 8.1 31.5 8.1 12.3 11.3 12.2 8.9 7.1 6.1 10.6 13.5 12.1 15.4 27.8 7.0 11.8 26.2 10.3 8.4 12.6 10.3 4.6 11.2 13.8 8.3 7.0 5.2 13.0 10.0 25.9 9.7 18.6 19.1 9.6 12.7 7.7 6.3 9.1 8.1 9.5 18.9 24.4 22.6 19.1 17.0 19.3 21.0 17.6 17.9 25.1 13.9 14.6 20.6 7.3 12.0 29.7 9.4 8.8 11.2 10.9 8.2 25.7 8.5 10.7 9.6 14.5 24.5 14.7 6.7 8.1 7.3 11.3 9.3 17.3 13.5 16.2 6.3 10.7 13.6 0.0 0.2 0.7 0.6 0.6 0.7 0.5 0.4 0.4 0.3 0.4 0.7 0.6 1.0 0.1 0.1 0.6 0.6 0.1 9.7 8.5 5.7 9.1 8.7 9.3 8.4 7.9 8.4 8.7 5.8 8.1 10.6 4.6 0.0 10.0 12.1 4.1 3.1 2.6 2.2 2.8 7.6 6.7 7.1 1.9 7.2 3.7 11.0 8.4 6.3 6.5 3.3 11.7 2.9 27.4 6.1 4.3 3.5 1.2 7.4 7.9 2.8 3.1 4.0 5.6 4.5 3.8 10.6 4.6 4.7 3.1 3.3 7.8 5.7 4.1 2.2 1.5 3.8 5.0 3.5 3.6 3.7 1.9 6.9 1.0 5.0 8.2 2.8 1.6 4.1 4.5 2.5 5.3 7.0 7.9 9.6 0.0 3.6 3.3 19.9 11.6 3.7 2.6 5.6 4.5 5.7 5.4 1.5 ZDHHC6 "FLJ21952, ZNF376" ENSG00000023041 "Zinc finger DHHC-type palmitoyltransferase 6" Q9H6R6 10 112424428-112446917 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014357 Approved NA NA "HPA014357: AB_2304658" "unprognostic (1.21e-1)" "unprognostic (1.00e-1)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (3.29e-2)" "unprognostic (6.24e-2)" "unprognostic (5.21e-1)" "unprognostic (3.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (9.30e-2)" "unprognostic (8.87e-2)" "unprognostic (7.64e-2)" "unprognostic (1.22e-2)" 19.7 20.0 15.8 24.8 16.5 22.0 22.9 17.3 19.1 20.8 20.2 24.7 45.0 24.2 33.5 23.9 19.5 23.4 17.0 15.7 17.2 58.6 29.8 20.2 30.8 16.2 16.3 15.3 26.0 21.5 21.6 15.5 26.1 16.5 22.6 30.2 21.5 24.1 20.8 15.1 20.6 46.1 18.0 16.9 25.0 26.2 13.7 16.9 25.3 26.5 18.2 30.8 24.1 21.0 18.5 51.7 39.4 40.3 50.2 38.2 28.8 28.5 49.3 46.7 38.2 45.3 37.7 89.6 28.4 22.1 30.2 43.0 60.0 33.8 31.5 44.3 67.0 41.4 29.4 46.4 47.3 24.7 67.9 49.5 21.9 20.7 41.9 48.9 58.7 48.6 42.0 32.4 46.1 41.7 43.3 38.1 75.6 23.6 57.0 32.1 31.4 51.1 26.6 45.3 28.1 15.0 20.9 25.5 40.1 49.1 31.4 22.4 49.2 34.8 43.7 27.6 29.5 47.3 25.7 31.7 37.5 38.7 118.0 29.0 10.4 17.4 21.6 14.7 16.2 18.9 16.7 16.7 18.5 16.6 14.0 14.1 15.9 11.3 16.0 13.7 13.6 23.9 15.9 15.8 16.5 17.3 19.1 15.7 17.2 16.2 16.3 15.3 16.5 16.9 16.9 18.5 21.0 22.4 20.1 11.8 35.9 20.3 31.9 23.2 23.9 11.0 21.9 16.1 14.3 31.5 27.4 35.0 8.4 34.8 25.7 31.3 60.7 35.8 72.4 14.9 15.5 18.7 11.4 26.1 15.0 29.8 46.9 17.9 16.3 23.8 23.5 17.8 19.2 21.2 34.4 15.2 15.7 22.7 10.2 20.2 35.9 17.7 16.1 28.6 12.4 12.2 22.2 21.0 23.7 15.1 14.4 31.2 27.9 19.5 23.7 25.7 66.9 39.7 13.4 15.5 6.6 13.9 18.2 11.7 12.5 27.6 22.3 36.5 33.0 10.9 28.5 47.7 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 260.9;retina: 97.5" "Cell type enhanced" "Detected in many" "Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 7.0" "Group enriched" "Detected in many" 4 "A549: 62.4;HDLM-2: 168.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008557, HPA075204" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" Vesicles "HPA008557: AB_1079197, HPA075204: " "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 260.9 19.1 4.4 24.1 18.8 1.1 76.7 47.3 0.9 69.8 1.4 34.9 1.1 9.5 0.6 3.6 12.2 8.4 53.0 14.3 15.7 1.5 2.6 5.4 21.2 21.3 19.3 15.3 2.5 0.7 16.7 5.1 33.9 1.1 1.1 97.5 1.9 2.1 3.5 0.5 25.4 1.2 3.9 3.6 11.5 16.9 32.0 6.6 5.0 2.2 3.6 1.2 0.8 27.1 0.1 62.4 3.5 0.1 0.3 0.7 9.5 20.5 14.6 4.1 1.8 2.6 0.4 3.8 10.4 10.1 6.8 0.0 6.2 0.0 4.3 168.5 5.0 0.0 28.3 0.7 0.0 22.1 0.0 1.0 0.1 7.1 0.0 5.2 1.8 1.6 0.0 0.2 3.7 0.5 3.8 7.2 7.6 28.3 23.0 10.8 9.8 6.8 0.2 0.0 20.0 16.3 4.9 0.5 0.1 8.1 0.5 12.0 12.3 23.8 3.2 4.2 1.0 0.0 0.0 0.0 4.6 20.5 1.1 0.0 1.2 0.4 0.4 0.7 0.2 0.0 1.5 1.2 1.7 0.0 0.2 0.2 0.1 1.6 0.7 7.0 0.7 0.5 19.1 24.1 76.7 47.3 53.0 14.3 21.2 21.3 19.3 33.9 3.9 32.0 27.1 1.4 0.0 0.5 94.7 0.6 0.0 0.0 0.1 1.2 44.3 1.1 1.0 5.7 21.5 0.2 5.5 114.7 6.9 17.9 0.1 3.9 0.7 9.6 1.6 0.6 1.0 0.0 0.0 120.7 0.4 3.7 1.6 16.3 0.9 0.0 41.9 0.7 0.0 2.6 45.4 102.8 1.8 0.0 3.8 2.6 2.7 0.6 7.5 0.0 37.5 2.5 23.4 0.0 95.0 5.5 3.9 1.3 0.7 2.4 0.1 17.3 8.9 0.4 92.3 0.0 3.0 4.2 3.9 1.9 0.1 0.4 2.5 7.2 109.3 1.5 0.0 RNH1 "RAI, RNH" ENSG00000023191 "Ribonuclease/angiogenin inhibitor 1" P13489 11 494512-507300 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 262.3;monocytes: 299.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039223, HPA040781" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 22000000 "Nucleoplasm, Cytosol" "HPA039223: AB_10795581, HPA040781: AB_10796227" "unprognostic (1.87e-1)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.48e-3)" "unprognostic (6.09e-2)" "unprognostic (4.82e-3)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.44e-1)" "prognostic favorable (2.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-2)" "unprognostic (4.35e-2)" 164.0 138.4 23.0 29.3 34.0 46.7 134.8 36.1 34.2 140.7 23.3 114.3 27.3 142.0 10.1 216.7 120.6 29.9 181.2 21.3 27.7 118.9 112.8 148.0 31.1 42.8 34.8 18.1 120.1 90.3 25.8 81.3 27.5 34.8 101.8 8.9 5.6 113.4 31.3 147.1 249.4 91.8 25.6 33.7 114.2 101.9 90.8 30.3 15.8 107.5 21.9 14.1 145.7 161.6 44.6 86.5 123.9 13.2 39.8 66.3 93.8 43.9 70.6 51.3 68.9 58.3 61.9 92.9 41.8 54.3 175.1 41.9 72.7 20.6 76.5 10.4 51.3 104.9 28.2 28.5 65.7 243.3 39.8 90.0 77.1 108.2 40.2 46.7 29.2 47.9 27.7 36.2 71.3 37.7 86.6 30.5 78.4 19.8 45.3 112.6 37.7 22.3 55.8 40.7 34.6 35.7 23.2 41.8 59.1 73.7 7.4 44.6 122.2 77.3 109.3 32.8 39.8 49.5 44.9 53.0 32.2 117.5 81.9 74.3 37.6 246.2 57.3 51.1 298.9 59.9 63.0 55.3 51.1 262.3 48.4 49.8 45.1 17.1 54.2 299.1 71.7 58.4 236.5 23.0 34.0 36.1 34.2 21.3 27.7 42.8 34.8 18.1 34.8 33.7 30.3 44.6 156.0 112.2 83.5 18.9 92.3 202.1 239.0 265.0 89.4 102.4 82.0 105.5 83.3 88.6 138.6 79.1 110.5 222.2 85.3 126.6 225.0 188.8 105.1 72.8 132.4 136.1 57.4 59.7 10.9 164.4 217.4 194.9 64.2 82.8 140.2 93.8 101.7 68.6 374.0 168.2 14.5 115.6 148.5 191.8 323.0 42.7 211.6 230.3 193.9 12.2 334.2 144.6 79.3 10.1 70.8 171.6 120.5 179.8 101.7 161.0 139.4 242.3 97.9 146.4 177.5 99.1 178.0 153.4 157.8 140.0 260.0 305.5 96.5 199.7 114.4 217.4 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159509 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 223.4;tongue: 227.2" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 582.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Enhanced Supported Mitochondria NA NA 48000 Mitochondria "CAB070844: , HPA064605: AB_2685297" "prognostic unfavorable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 26.5 62.1 8.8 13.4 10.1 13.3 24.0 14.7 15.8 17.2 32.5 31.2 30.2 19.5 10.9 36.5 16.4 10.6 141.1 9.6 12.4 48.5 52.2 18.5 12.7 10.2 10.7 8.6 14.7 19.4 47.6 20.4 14.5 11.2 16.0 30.3 24.6 27.9 15.7 223.4 26.4 26.3 16.6 7.6 17.0 37.4 21.0 12.8 15.7 18.1 227.2 17.0 22.6 22.6 12.9 28.3 27.6 39.2 28.6 35.8 28.9 45.4 40.4 43.4 66.0 47.6 72.0 32.1 31.7 34.8 50.8 65.5 38.5 52.9 39.2 58.2 14.6 24.9 63.5 65.1 64.9 37.0 46.2 27.5 35.3 22.5 51.9 40.4 29.6 52.3 39.3 69.8 31.1 43.6 35.2 38.5 30.7 36.5 47.2 48.6 38.3 54.7 55.1 54.7 50.7 38.1 29.8 46.7 45.1 67.1 53.3 39.8 44.2 40.1 36.2 32.0 35.8 39.1 29.8 38.4 46.9 36.3 37.5 37.8 14.1 12.9 15.7 12.4 15.2 9.6 9.6 10.8 11.8 14.7 9.0 9.6 11.1 9.2 12.5 22.5 7.8 15.9 9.5 8.8 10.1 14.7 15.8 9.6 12.4 10.2 10.7 8.6 11.2 7.6 12.8 12.9 32.4 60.9 33.0 45.1 23.8 16.2 21.7 40.8 30.1 97.1 19.3 14.0 582.5 48.6 42.8 38.6 120.9 48.4 18.8 74.5 93.9 44.2 14.5 49.8 49.8 36.6 51.0 42.0 67.8 28.2 33.7 42.3 48.4 54.5 37.3 42.3 29.3 94.5 34.0 117.8 72.8 47.9 54.9 31.2 10.7 7.0 33.5 27.7 30.2 28.1 37.2 62.7 27.8 45.2 41.6 32.1 46.4 44.8 31.0 19.9 77.8 102.3 53.5 81.5 32.9 55.2 60.8 58.2 49.5 40.8 16.6 52.5 23.7 71.5 69.9 26.6 RB1CC1 "ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131" ENSG00000023287 "RB1 inducible coiled-coil 1" Q8TDY2 8 52622458-52745843 "Predicted intracellular proteins" "Autophagy, Cell cycle, Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024391, HPA053049" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA024391: AB_2671554, HPA053049: AB_2682025" "unprognostic (1.58e-2)" "unprognostic (7.51e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.22e-1)" "unprognostic (4.21e-2)" "unprognostic (7.39e-2)" "unprognostic (1.38e-2)" "unprognostic (9.34e-2)" "unprognostic (1.21e-1)" "unprognostic (8.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.56e-3)" "unprognostic (7.67e-2)" "unprognostic (4.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.42e-1)" 17.7 15.2 41.4 11.9 33.7 52.8 17.2 31.1 38.1 15.3 21.6 12.3 13.0 17.6 13.1 17.0 12.2 14.0 24.4 32.0 30.1 17.3 21.7 15.0 13.4 35.1 31.3 33.1 20.3 16.9 22.4 8.1 15.6 32.5 15.7 11.4 20.5 16.3 12.3 39.2 15.1 14.4 15.1 28.7 14.4 14.6 35.0 38.0 22.4 17.9 32.4 13.0 14.4 11.2 48.1 23.8 20.8 25.2 22.1 27.4 31.0 14.4 17.7 36.1 18.4 22.8 14.6 26.3 17.4 29.0 26.2 46.4 31.0 31.4 16.5 34.5 13.1 27.4 29.7 20.8 20.2 33.7 10.7 16.0 29.1 33.4 18.3 49.6 38.2 25.2 26.8 35.8 27.4 22.6 15.6 27.2 15.7 24.9 22.4 10.3 13.7 12.1 17.7 16.9 18.5 24.0 25.0 18.4 20.9 39.8 29.3 23.8 19.3 29.9 17.5 24.2 27.8 15.7 26.8 24.8 17.0 27.6 18.2 20.0 47.9 12.9 24.6 11.6 12.2 11.8 12.3 9.7 11.9 12.6 9.5 11.9 11.0 40.3 14.2 17.1 6.3 14.1 11.9 41.4 33.7 31.1 38.1 32.0 30.1 35.1 31.3 33.1 32.5 28.7 38.0 48.1 83.8 195.5 121.7 73.8 66.3 88.3 60.2 32.0 51.2 82.0 45.5 39.5 163.8 20.0 57.4 18.4 68.8 27.0 74.2 45.4 9.8 52.4 61.9 103.6 112.7 66.0 44.2 117.7 104.0 49.3 26.3 78.2 36.2 143.5 25.9 78.1 36.8 44.5 23.6 87.5 123.2 31.9 30.5 44.5 41.4 49.8 77.3 60.5 42.7 76.8 67.6 33.0 64.9 106.1 104.2 63.5 43.3 73.4 86.1 99.0 47.2 27.0 115.3 57.3 46.0 132.2 76.9 238.8 132.7 59.4 91.9 60.5 66.2 68.6 27.7 88.2 ERP44 "KIAA0573, PDIA10, TXNDC4" ENSG00000023318 "Endoplasmic reticulum protein 44" Q9BS26 9 99979185-100099000 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001318 Supported "Intracellular and membrane" NA NA 5300000 "HPA001318: AB_1080427" "unprognostic (8.28e-2)" "unprognostic (1.32e-1)" "unprognostic (5.56e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.58e-1)" "unprognostic (2.00e-2)" "unprognostic (5.38e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-1)" "unprognostic (2.31e-1)" 18.5 17.5 7.9 17.9 8.5 21.5 16.4 12.9 10.6 19.7 10.1 22.2 22.6 15.3 39.7 18.0 13.8 16.8 16.1 8.2 8.8 18.2 34.4 18.8 18.0 8.2 8.6 7.6 12.5 27.7 18.8 13.4 32.8 9.7 19.0 23.8 15.9 21.0 18.4 11.7 13.0 24.0 17.0 8.5 18.5 24.3 10.7 8.4 14.7 27.3 11.7 18.7 19.5 14.2 8.9 18.5 14.7 20.7 23.6 73.5 34.9 37.6 39.9 54.2 27.6 36.3 31.2 52.4 47.3 25.7 45.5 41.1 65.9 25.7 28.1 24.9 24.5 14.4 17.8 14.3 22.8 64.3 32.2 27.0 39.4 41.5 24.2 34.7 26.2 34.2 15.7 34.7 35.7 22.7 28.8 22.1 22.6 21.5 72.0 18.9 19.2 34.7 32.9 35.9 20.9 16.2 18.9 32.8 40.2 28.9 30.5 15.0 32.8 23.8 20.5 19.2 27.4 17.7 20.5 19.3 15.8 31.3 21.0 28.3 32.8 45.7 42.7 20.2 49.2 19.5 28.1 19.9 22.1 37.4 26.5 15.1 17.6 41.5 27.4 62.3 23.4 23.5 37.7 7.9 8.5 12.9 10.6 8.2 8.8 8.2 8.6 7.6 9.7 8.5 8.4 8.9 72.3 54.5 41.8 38.8 77.5 43.3 80.3 146.6 29.0 34.3 33.9 25.3 34.7 54.3 84.6 33.1 18.8 141.4 72.5 90.0 17.6 104.4 8.4 42.2 61.4 62.5 53.1 38.3 69.4 111.8 150.5 72.0 57.1 62.3 71.0 54.2 64.6 73.3 165.7 30.3 70.0 118.1 73.2 79.5 101.9 7.7 61.2 102.2 64.0 85.3 128.5 32.7 61.8 45.8 68.9 92.8 90.0 67.7 97.9 75.9 111.2 51.4 60.2 30.6 72.3 48.9 95.9 83.3 41.4 40.0 49.6 229.3 60.3 87.5 88.9 84.2 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 726.4;liver: 553.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 233.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 233.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favorable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 32.8 726.4 25.3 24.1 24.7 178.3 28.9 37.4 76.2 20.6 38.3 44.0 45.4 19.1 28.4 36.7 15.4 33.0 100.8 25.8 27.5 45.9 553.2 48.2 23.1 26.5 25.2 23.4 17.3 19.8 60.9 15.9 37.1 33.1 23.3 42.0 20.8 43.1 27.5 111.9 23.8 39.6 24.1 27.6 19.7 46.3 18.8 29.6 23.8 22.3 107.6 28.4 74.5 23.7 31.2 36.2 55.0 38.0 35.4 57.9 43.1 103.1 51.8 47.7 67.6 65.3 73.6 66.2 33.6 12.7 36.4 137.0 20.9 55.1 42.6 54.7 65.9 21.6 43.2 41.2 56.4 81.8 70.8 83.0 54.0 39.1 107.7 35.7 25.0 62.8 57.7 25.8 27.0 62.4 29.5 33.9 107.3 33.0 41.1 93.4 20.0 23.9 53.3 59.8 213.9 20.2 13.3 83.9 40.9 47.2 30.5 23.5 99.9 45.7 37.6 37.1 78.5 76.2 39.5 73.8 50.5 42.1 75.5 61.1 233.9 33.4 103.2 22.9 42.9 37.4 23.1 23.9 26.0 29.8 21.5 21.1 23.3 49.6 30.9 39.0 17.1 35.7 25.1 25.3 24.7 37.4 76.2 25.8 27.5 26.5 25.2 23.4 33.1 27.6 29.6 31.2 28.4 35.3 60.3 5.2 14.9 17.3 17.2 36.1 15.9 16.6 28.6 19.6 107.5 25.8 37.7 23.9 4.2 81.9 25.1 68.5 56.7 35.5 10.2 20.2 9.3 27.6 34.6 11.2 6.2 31.3 28.2 19.6 42.3 25.3 95.4 13.1 18.5 243.1 69.1 11.8 6.2 24.3 34.6 13.0 20.8 4.1 13.4 36.4 5.4 8.4 49.1 9.7 11.3 4.0 8.4 42.3 28.1 16.6 14.0 16.0 35.6 36.1 40.6 9.2 13.1 9.1 27.5 25.5 22.3 21.4 16.2 309.2 25.1 187.2 24.3 26.4 BIRC3 "API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49" ENSG00000023445 "Baculoviral IAP repeat containing 3" Q13489 11 102317450-102339403 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.8;lymphoid tissue: 142.6" "Cell type enhanced" "Detected in many" "granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "memory B-cell: 209.0;naive B-cell: 159.9" "Group enriched" "Detected in all" 13 "B-cells: 209.0;T-cells: 83.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8" "Low region specificity" "Detected in all" HPA002317 Enhanced Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002317: AB_1846748" "prognostic favorable (3.60e-4)" "unprognostic (2.89e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.28e-4)" "unprognostic (5.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.88e-3)" "unprognostic (9.62e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.03e-4)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.66e-6)" "unprognostic (6.42e-2)" "unprognostic (6.23e-3)" "unprognostic (1.00e-1)" "unprognostic (3.85e-2)" 9.0 14.8 2.3 105.7 2.7 26.6 18.6 1.5 3.3 19.3 4.4 25.1 26.9 10.6 3.8 16.2 8.6 51.4 6.5 2.6 2.8 12.4 26.5 24.9 142.6 2.4 2.5 2.4 6.6 12.1 4.4 3.6 5.3 2.0 10.7 24.9 0.6 12.8 11.5 2.8 7.8 89.8 10.8 2.3 73.8 54.9 8.2 2.8 59.8 3.9 4.4 135.5 47.3 4.9 3.4 26.4 24.5 0.2 0.4 0.7 3.9 2.4 2.5 17.5 3.3 3.7 4.6 146.5 140.7 74.3 1.4 22.8 13.0 0.1 4.6 7.8 140.1 0.3 0.5 7.3 1.4 30.7 2.4 3.7 3.5 18.1 8.4 140.2 4.9 0.4 10.2 0.5 0.0 3.0 0.1 8.3 1.3 0.3 14.2 1.0 0.1 0.8 6.8 34.3 12.9 0.1 0.3 2.1 2.1 1.8 0.5 6.4 1.8 7.5 25.6 3.4 1.4 28.3 89.2 85.8 48.8 4.0 7.4 3.0 8.6 3.9 2.2 5.8 10.1 9.8 209.0 41.7 14.1 3.6 159.9 28.4 8.3 2.6 9.9 11.0 1.7 83.6 11.9 2.3 2.7 1.5 3.3 2.6 2.8 2.4 2.5 2.4 2.0 2.3 2.8 3.4 41.2 144.2 70.8 0.0 420.1 101.2 324.9 267.2 51.2 0.3 26.6 22.9 12.5 134.4 146.9 40.5 0.0 2.0 71.2 142.4 7.9 230.3 1.8 231.3 16.8 101.4 15.0 23.6 1.1 179.7 0.5 63.4 184.5 289.4 554.8 1.8 6.4 4.4 11.7 0.0 3.2 38.0 75.3 25.4 1400.9 2.1 5.0 170.0 192.1 2.8 1117.0 0.5 14.4 0.0 0.4 207.4 281.1 2.2 288.4 455.1 817.3 19.5 88.1 0.0 0.0 60.8 90.9 0.7 0.5 31.8 84.5 0.5 278.0 0.7 49.4 193.3 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272152-42323261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 12.7 14.1 15.7 11.6 31.3 3.8 11.7 14.3 21.2 16.8 0.6 9.5 7.6 13.6 15.5 10.7 10.5 10.3 11.7 24.2 19.4 13.4 10.8 11.0 15.9 9.8 18.4 17.9 14.8 6.9 11.8 9.4 7.8 10.9 11.4 10.6 32.8 8.1 12.4 5.6 10.0 8.4 12.3 13.3 13.4 10.4 20.8 17.5 13.3 14.1 11.0 13.9 10.5 8.7 19.7 15.2 15.3 18.4 11.0 23.6 28.7 8.0 20.2 16.7 11.9 11.1 16.9 12.4 31.2 7.6 22.7 12.5 17.7 16.1 16.9 22.7 33.4 7.5 8.8 10.6 8.4 18.5 22.2 20.8 21.2 17.0 24.4 21.2 17.5 17.8 15.5 29.5 12.3 24.3 11.4 13.0 7.2 10.9 22.3 7.1 10.7 12.9 15.1 11.9 11.1 7.8 11.3 15.5 10.1 7.1 8.5 8.7 11.8 24.8 20.1 10.4 30.7 15.4 4.7 6.3 15.8 25.7 11.1 14.4 1.7 0.3 0.4 0.5 0.3 0.7 0.9 0.8 0.5 0.3 1.1 0.6 0.6 0.1 1.6 0.5 0.5 1.0 0.2 15.7 31.3 14.3 21.2 24.2 19.4 9.8 18.4 17.9 10.9 13.3 17.5 19.7 41.9 25.6 30.5 58.8 42.8 12.2 13.7 15.4 14.8 67.3 20.4 14.6 44.9 12.8 32.6 29.5 37.5 4.4 21.2 12.9 1.9 12.7 14.0 24.3 33.1 25.5 21.0 16.6 105.4 9.5 3.8 27.5 24.5 25.7 34.2 25.9 29.3 22.6 12.5 42.1 105.4 14.9 20.3 24.8 21.6 14.6 21.8 25.0 8.8 46.9 21.6 69.8 16.5 69.9 91.3 12.7 15.4 33.4 27.0 12.2 9.4 20.5 33.1 38.3 19.7 33.9 27.1 49.2 32.8 20.6 16.9 2.5 25.4 28.3 12.3 13.4 GLRX2 "bA101E13.1, GRX2" ENSG00000023572 "Glutaredoxin 2" Q9NS18 1 193090866-193106114 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 17 "Early spermatids: 796.4;Late spermatids: 1841.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 240.2" "Low region specificity" "Detected in all" "HPA023087, HPA057224" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA023087: AB_1849778, HPA057224: AB_2683373" "unprognostic (4.80e-2)" "unprognostic (3.77e-2)" "unprognostic (8.04e-2)" "unprognostic (2.33e-1)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "unprognostic (2.40e-3)" "unprognostic (5.11e-2)" "unprognostic (3.21e-2)" "unprognostic (2.38e-2)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (3.30e-7)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (6.21e-2)" "unprognostic (4.48e-2)" 14.6 22.4 17.1 7.9 18.4 9.6 12.5 18.8 26.4 9.2 17.3 14.2 11.8 8.3 10.8 16.8 7.3 6.9 30.0 18.0 19.3 16.3 26.1 9.9 5.3 19.1 19.2 17.9 6.3 9.7 5.6 8.5 7.6 19.7 18.1 9.1 2.5 11.2 8.5 38.0 12.4 10.7 8.8 19.5 9.9 13.0 30.4 18.5 3.8 7.3 25.0 7.4 14.0 11.8 22.8 47.2 57.8 14.6 32.8 52.2 33.9 24.0 67.2 29.8 55.6 45.9 36.3 44.2 20.0 36.1 28.6 67.1 44.4 17.5 39.4 56.7 45.6 30.4 40.4 39.0 42.6 55.9 32.8 39.0 23.1 33.8 76.5 38.4 21.6 35.7 13.7 60.8 21.9 68.4 66.3 26.9 60.6 16.8 75.6 38.2 23.7 22.9 48.3 53.7 31.4 13.8 12.4 26.9 81.2 240.2 21.6 35.2 37.5 21.6 42.8 11.2 93.7 70.5 42.6 48.7 41.4 40.8 38.1 61.2 13.6 18.8 26.6 12.7 23.1 14.2 13.2 13.4 11.7 22.5 10.8 11.7 13.4 9.6 16.1 30.0 9.2 18.6 14.5 17.1 18.4 18.8 26.4 18.0 19.3 19.1 19.2 17.9 19.7 19.5 18.5 22.8 24.2 9.6 10.1 5.5 14.8 18.2 21.1 39.1 14.2 7.2 21.7 23.6 62.8 12.8 21.5 16.5 6.2 39.2 19.5 25.8 29.4 41.1 796.4 16.1 24.2 18.7 13.8 15.6 11.3 41.4 41.6 25.2 14.8 17.7 46.9 16.4 11.0 30.3 44.2 1.7 10.1 26.5 32.6 15.0 26.9 1841.1 17.4 26.8 26.6 5.6 25.9 9.9 28.8 5.0 10.1 38.3 31.5 18.0 20.5 39.2 40.3 74.3 13.9 11.5 6.6 15.5 36.2 12.3 25.4 21.3 19.9 24.8 14.0 33.1 24.1 20.5 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762420-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 171.9;Spermatocytes: 215.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 153.7;hTERT-HME1: 153.7;U-2 OS: 207.6;U-251 MG: 146.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA067076: AB_2732757, HPA072276: AB_2732199" "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 6.2 9.1 3.3 6.5 3.7 6.0 6.0 4.9 3.4 10.2 3.9 3.1 3.7 7.0 5.0 6.1 6.4 7.8 8.4 2.8 4.2 6.4 5.3 4.8 8.2 3.9 3.8 2.6 6.1 3.6 8.0 5.8 8.8 4.3 6.9 3.0 6.7 5.3 6.9 4.4 5.3 3.3 4.8 3.2 6.8 3.2 20.1 3.0 7.2 7.2 4.8 7.0 10.1 5.3 4.7 57.6 11.0 10.7 22.8 11.7 13.6 12.7 47.4 31.4 53.3 31.4 3.9 11.5 11.9 61.5 20.3 153.7 17.7 10.6 14.3 87.3 13.0 7.6 7.1 5.7 8.1 30.8 7.5 15.2 13.1 9.5 45.0 153.7 20.7 20.7 16.2 8.0 10.6 51.4 7.4 18.3 12.0 10.3 6.4 35.9 13.9 28.3 4.4 43.9 8.8 7.6 18.3 31.3 5.5 39.0 13.2 11.0 11.7 31.8 58.4 207.6 38.2 146.6 7.0 7.8 10.5 39.7 9.5 35.3 7.7 5.0 4.5 4.4 4.3 5.7 8.4 5.4 3.8 5.2 8.8 8.8 5.7 4.9 7.0 3.8 6.9 6.5 3.6 3.3 3.7 4.9 3.4 2.8 4.2 3.9 3.8 2.6 4.3 3.2 3.0 4.7 22.6 35.3 18.3 10.1 28.0 95.3 56.2 171.9 43.3 10.2 11.5 18.0 24.6 11.5 53.6 29.5 2.1 16.8 31.2 3.4 7.9 28.6 70.7 70.1 28.7 29.3 4.2 10.7 12.8 15.9 31.5 31.1 4.1 47.6 41.8 20.2 26.7 6.9 17.3 8.4 13.3 4.0 42.7 11.7 32.6 17.1 22.1 31.6 17.8 10.3 12.4 40.4 4.1 10.6 14.6 20.3 1.9 20.3 7.9 28.8 5.6 13.3 83.9 12.6 19.7 38.3 34.7 215.0 67.7 23.5 64.5 5.6 29.0 20.6 6.8 20.8 DERA "CGI-26, DEOC" ENSG00000023697 "Deoxyribose-phosphate aldolase" Q9Y315 12 15911302-16037381 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 105.4" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055897 Supported Nucleoplasm NA NA 320000 Nucleoplasm "HPA055897: AB_2682963" "unprognostic (3.05e-1)" "unprognostic (1.26e-1)" "unprognostic (1.06e-2)" "unprognostic (7.26e-2)" "unprognostic (8.12e-2)" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (8.74e-2)" "unprognostic (2.17e-2)" "prognostic favorable (3.64e-5)" "unprognostic (3.66e-2)" 21.3 16.5 14.1 17.4 15.9 17.8 21.3 16.2 17.2 16.9 20.5 40.3 41.5 16.4 27.3 30.6 15.1 20.5 18.3 13.3 16.9 74.8 105.4 25.2 20.4 16.8 15.1 12.5 6.9 27.4 15.8 12.2 20.9 16.4 13.6 42.5 28.4 18.1 14.3 28.1 25.5 54.5 20.6 15.9 17.2 21.9 9.8 15.5 19.9 28.2 29.9 22.9 18.5 18.4 17.5 63.6 51.4 40.0 36.6 27.1 60.3 80.6 36.6 35.2 48.7 63.2 63.9 118.1 44.3 31.3 47.2 44.1 43.8 43.4 47.6 84.7 71.3 25.6 37.6 24.1 60.6 38.7 40.7 25.2 40.8 54.9 40.9 81.0 42.2 71.6 36.2 5.3 13.1 92.1 24.1 30.6 34.5 86.8 37.3 25.6 45.8 85.5 26.8 125.0 23.2 29.5 49.9 69.3 23.4 75.4 158.2 124.5 50.6 66.3 53.6 33.5 24.4 39.0 13.6 21.4 76.9 66.6 41.1 39.6 15.2 58.4 36.2 16.6 68.4 18.2 29.4 17.7 17.7 74.9 29.9 19.3 15.5 15.8 46.0 76.4 40.4 38.1 41.9 14.1 15.9 16.2 17.2 13.3 16.9 16.8 15.1 12.5 16.4 15.9 15.5 17.5 37.2 44.8 28.4 20.2 19.4 29.3 31.6 55.3 21.6 4.8 22.4 18.8 13.5 27.1 43.1 12.9 14.6 65.7 22.1 51.6 109.5 64.3 55.8 27.8 32.3 28.3 26.5 28.2 8.6 59.3 69.9 23.9 14.3 52.9 8.8 30.6 36.4 52.2 61.0 3.3 5.9 44.7 54.9 46.7 26.4 6.7 24.5 44.8 72.9 30.9 47.4 29.8 14.4 28.6 18.9 74.6 49.6 30.5 30.7 19.1 140.0 152.3 27.3 29.9 6.6 17.4 27.5 8.5 16.7 35.5 25.9 71.3 13.9 49.0 42.9 34.0 STRAP "MAWD, pt-wd, UNRIP" ENSG00000023734 "Serine/threonine kinase receptor associated protein" Q9Y3F4 12 15882387-15903478 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027320, HPA055557, HPA073876" Approved Enhanced Cytosol NA NA 200000 Cytosol "HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639" "unprognostic (4.64e-3)" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (1.42e-2)" "unprognostic (2.88e-1)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.69e-2)" "unprognostic (3.71e-1)" "unprognostic (2.15e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (3.60e-3)" "unprognostic (5.93e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.07e-4)" "prognostic unfavorable (5.10e-4)" 71.0 70.8 44.3 55.2 49.3 52.3 50.2 40.8 64.3 52.2 38.8 56.0 46.6 52.7 50.9 61.5 44.8 47.3 94.0 51.9 58.7 85.7 81.0 47.2 55.4 47.4 50.5 46.1 40.7 72.7 84.6 58.9 65.2 53.5 49.7 53.3 86.3 49.2 49.1 137.1 44.3 45.3 69.4 46.9 40.7 48.9 50.8 51.6 67.1 78.4 115.6 57.6 71.1 41.7 60.4 195.6 226.2 209.7 179.8 182.3 180.6 280.5 227.9 158.2 200.8 186.4 325.9 167.2 215.6 110.6 233.5 199.3 138.0 254.6 251.0 293.2 291.3 206.1 218.6 163.8 144.7 298.8 258.2 102.0 176.9 209.7 224.6 248.6 221.6 237.9 139.6 170.9 63.9 264.3 137.3 215.6 122.6 743.6 124.8 145.8 162.4 289.7 124.5 232.5 197.8 134.8 228.8 184.7 125.5 258.7 415.8 235.5 135.9 201.3 149.0 177.0 160.3 284.7 73.0 106.1 351.5 183.7 140.1 193.9 74.2 73.9 65.8 66.3 87.4 75.1 76.1 67.8 64.2 92.5 66.7 65.8 70.0 33.7 64.3 80.5 56.8 92.2 84.5 44.3 49.3 40.8 64.3 51.9 58.7 47.4 50.5 46.1 53.5 46.9 51.6 60.4 111.7 38.5 45.2 19.9 111.2 243.4 177.6 131.5 116.7 90.1 87.8 65.9 104.0 51.5 84.8 66.2 35.5 154.3 121.2 41.5 275.9 171.1 44.3 63.2 82.1 100.3 106.2 103.7 42.8 137.2 201.2 109.7 61.7 78.6 46.3 112.1 71.7 82.1 108.8 60.6 43.4 59.7 128.1 86.2 143.8 86.2 69.9 89.4 128.1 22.5 99.2 207.9 93.7 24.1 33.9 144.2 66.1 102.0 119.5 218.3 56.0 228.5 58.9 100.9 78.9 96.4 139.0 168.1 80.4 115.6 227.9 295.1 111.3 135.2 95.6 192.5 ABCC2 "CMOAT, cMRP, DJS, MRP2" ENSG00000023839 "ATP binding cassette subfamily C member 2" Q92887 10 99782640-99852594 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.6;liver: 122.7" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 70.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 24.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "A549: 204.4;Hep G2: 208.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071145 Enhanced NA NA "HPA071145: " "unprognostic (1.49e-3)" "unprognostic (5.92e-2)" "unprognostic (1.59e-1)" "unprognostic (3.67e-1)" "unprognostic (1.93e-2)" "unprognostic (2.33e-1)" "unprognostic (2.51e-1)" "unprognostic (7.15e-3)" "unprognostic (5.68e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (1.40e-3)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.95e-1)" "unprognostic (1.26e-2)" 1.3 0.4 0.3 0.7 0.4 0.8 3.1 0.5 0.4 0.5 0.2 0.5 39.4 0.4 0.2 0.3 0.7 24.6 0.2 0.3 0.3 18.7 122.7 0.5 0.7 0.4 0.3 0.2 0.3 1.1 0.1 0.1 0.5 0.4 0.4 0.4 3.9 0.5 0.2 1.1 1.7 40.6 0.2 0.3 1.4 0.7 0.7 0.3 0.8 0.4 0.8 0.5 1.3 0.5 0.6 0.3 204.4 3.5 10.2 15.3 12.0 3.4 0.5 1.3 0.5 0.6 44.6 0.3 0.4 0.3 0.7 0.5 1.3 0.3 0.4 0.6 0.5 0.3 0.0 1.0 208.7 0.5 0.3 0.7 1.9 13.9 1.5 1.4 0.2 0.4 0.6 0.0 0.3 0.2 1.0 0.2 1.4 0.3 39.8 0.3 0.3 0.2 0.4 1.4 0.3 0.1 0.2 0.5 3.4 25.9 0.4 0.1 0.4 0.7 0.6 0.6 0.9 0.6 0.8 0.1 0.2 16.1 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.4 0.3 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.6 0.7 0.0 0.0 2.3 0.4 0.0 0.2 0.2 0.0 0.3 0.1 0.0 0.5 1.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 2.6 2.9 0.2 0.3 0.0 0.4 1.0 0.4 0.0 1.7 0.0 0.6 1.3 0.1 1.4 70.7 0.2 0.0 1.3 0.6 0.0 1.0 0.0 1.1 0.3 0.4 5.4 1.9 0.3 0.1 0.0 1.0 2.2 0.1 0.0 0.0 0.1 0.2 15.5 10.7 2.8 1.5 0.0 0.4 0.5 1.2 0.7 0.1 0.0 1.6 0.4 0.1 0.4 0.0 DEF6 "IBP, SLAT, SWAP70L" ENSG00000023892 "DEF6 guanine nucleotide exchange factor" Q9H4E7 6 35297818-35321771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7;lymphoid tissue: 63.4" "Cell type enhanced" "Detected in many" "Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA038975, HPA038976" Enhanced Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA038975: AB_10697544, HPA038976: AB_10673409" "prognostic favorable (3.02e-6)" "prognostic favorable (1.08e-4)" "prognostic unfavorable (1.71e-4)" "prognostic favorable (2.37e-4)" "unprognostic (1.93e-1)" "unprognostic (3.63e-3)" "unprognostic (2.24e-1)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (2.12e-1)" "unprognostic (2.14e-1)" "unprognostic (6.21e-3)" "prognostic unfavorable (1.02e-8)" "unprognostic (1.78e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-3)" 5.1 3.6 5.6 33.8 6.1 63.7 6.1 6.3 7.3 6.4 8.1 8.1 10.3 2.9 8.6 28.5 4.4 7.3 2.5 5.7 7.6 4.7 5.3 14.8 49.0 7.9 6.4 4.8 3.1 21.8 1.4 8.3 7.8 7.6 21.2 7.5 2.2 16.0 4.9 1.7 27.4 31.0 3.6 7.7 63.4 16.5 27.0 7.5 50.7 8.4 1.1 38.4 10.3 16.7 7.7 24.0 0.0 0.8 0.6 0.1 0.3 29.0 2.6 3.6 0.6 0.7 1.5 10.0 28.1 8.3 1.3 0.1 15.5 0.0 19.6 0.4 1.0 1.1 31.7 0.4 12.6 0.7 57.5 40.0 4.5 24.6 0.3 22.0 0.1 0.0 83.3 14.3 65.7 0.1 12.3 75.5 99.3 1.3 3.0 2.8 68.8 0.6 38.4 2.5 17.8 0.4 0.2 2.1 5.8 5.5 1.1 15.9 78.9 3.8 0.3 0.6 0.1 0.3 37.2 37.1 23.3 0.0 117.7 0.2 49.2 39.5 119.7 78.6 29.7 62.4 34.2 63.3 76.8 55.2 31.3 65.1 65.2 69.3 72.9 27.8 36.6 73.1 64.3 5.6 6.1 6.3 7.3 5.7 7.6 7.9 6.4 4.8 7.6 7.7 7.5 7.7 1.7 6.4 8.0 1.3 49.2 11.9 16.9 15.0 20.5 2.5 5.4 7.2 0.8 2.8 8.2 5.5 0.0 25.0 52.3 4.2 0.0 0.9 56.3 2.2 0.8 3.1 4.2 6.7 2.0 10.0 17.2 2.2 26.0 3.0 17.7 1.5 2.9 0.9 94.0 3.3 1.0 9.9 2.0 28.0 26.4 151.4 2.8 31.7 7.2 17.8 30.0 0.8 88.6 0.5 0.5 8.0 8.9 1.9 57.9 6.0 3.1 0.3 5.8 1.7 0.0 0.6 1.2 40.0 0.9 20.0 11.8 12.6 78.3 1.0 9.1 13.0 PLEKHO1 "CKIP-1, OC120" ENSG00000023902 "Pleckstrin homology domain containing O1" Q53GL0 1 150149183-150164720 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 141.2" "Cell type enhanced" "Detected in many" "Early spermatids: 245.9;Langerhans cells: 159.2;Late spermatids: 390.5;Macrophages: 147.9;monocytes: 151.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061018 Supported Mitochondria NA NA Mitochondria "HPA061018: AB_2684416" "unprognostic (1.41e-2)" "unprognostic (7.04e-3)" "unprognostic (2.01e-2)" "unprognostic (1.78e-2)" "unprognostic (3.23e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-2)" "unprognostic (8.33e-2)" "unprognostic (3.84e-2)" "unprognostic (3.18e-2)" "unprognostic (8.71e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.47e-11)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (1.87e-1)" "unprognostic (6.52e-2)" 27.3 43.5 44.5 54.3 44.5 18.1 22.8 47.9 62.1 30.7 41.0 141.2 18.0 51.1 5.3 17.6 43.9 20.8 48.5 44.5 44.3 15.9 8.8 35.2 49.9 44.4 42.7 44.3 28.4 5.2 4.2 15.0 15.2 43.8 45.8 11.6 4.2 11.1 16.4 39.9 10.2 58.9 40.8 44.7 60.4 56.3 83.9 42.7 34.2 13.1 15.3 26.2 98.3 23.8 44.1 14.3 3.4 46.3 36.0 14.4 12.7 3.8 24.8 32.9 31.8 28.1 1.0 0.4 0.4 4.7 28.5 23.9 1.2 23.3 1.1 10.3 86.7 12.1 2.8 1.9 8.9 27.1 20.0 77.7 18.5 1.0 39.8 6.2 30.6 30.6 38.5 5.4 35.9 43.9 6.7 76.0 40.0 43.7 0.0 6.4 68.1 25.2 16.2 5.6 4.1 28.8 46.9 2.0 0.2 18.7 22.1 2.4 19.4 43.4 20.8 24.1 21.9 30.1 14.0 0.4 9.2 83.4 0.2 8.2 2.6 25.9 0.5 5.6 24.8 6.0 20.0 8.2 5.9 20.1 17.2 5.6 4.7 30.9 4.1 23.4 27.3 6.7 9.2 44.5 44.5 47.9 62.1 44.5 44.3 44.4 42.7 44.3 43.8 44.7 42.7 44.1 23.5 35.3 8.9 32.3 65.1 21.5 92.7 2.9 4.6 7.9 11.8 17.9 36.4 2.8 2.9 0.0 0.0 1.7 97.5 0.5 1.9 8.8 245.9 17.9 50.2 58.9 17.8 4.2 13.5 7.8 3.3 29.4 4.6 22.0 5.7 24.5 42.5 1.8 107.1 8.4 24.3 0.9 10.2 85.5 159.2 390.5 17.4 147.9 24.9 21.5 151.1 34.0 23.7 9.0 1.6 10.7 0.0 24.5 23.7 50.1 0.2 0.5 1.3 6.2 72.3 7.5 105.0 122.5 17.5 2.9 14.2 1.5 45.6 8.6 0.4 23.0 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885199-93909456 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 48.9" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 207.9;Erythroid cells: 301.9;Prostatic glandular cells: 762.3;Urothelial cells: 374.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1100000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 12.3 13.2 6.2 6.6 5.5 15.1 6.6 6.1 6.2 4.5 5.9 6.2 19.4 3.6 4.0 6.7 14.5 14.2 4.8 5.4 8.1 11.4 48.9 5.9 4.6 6.9 7.3 5.3 2.8 7.8 6.7 3.4 10.3 7.2 5.6 5.6 3.6 4.6 6.0 16.1 3.0 12.9 3.6 5.9 6.8 5.7 3.2 6.7 5.0 16.9 11.9 10.2 7.0 3.7 6.9 37.7 58.6 6.4 12.6 20.9 13.0 24.4 43.7 27.3 32.8 24.3 9.9 21.7 14.2 84.8 28.8 106.7 37.3 9.6 18.0 26.2 38.6 12.7 98.9 37.4 42.8 39.1 36.8 15.2 16.1 6.7 67.0 10.7 13.2 36.4 16.0 40.0 20.5 24.0 7.3 26.8 8.5 21.5 36.0 27.4 12.3 19.0 20.9 23.6 43.4 14.8 6.1 41.3 32.2 15.4 71.8 7.2 22.7 38.4 34.1 20.1 64.5 66.7 18.1 25.0 14.7 28.2 20.4 12.2 2.1 0.3 0.7 2.6 0.2 1.5 1.3 2.5 3.4 0.3 2.0 1.5 1.6 1.5 2.3 0.3 1.0 0.7 0.7 6.2 5.5 6.1 6.2 5.4 8.1 6.9 7.3 5.3 7.2 5.9 6.7 6.9 28.7 41.7 19.1 16.0 14.6 11.5 207.9 33.2 24.5 24.8 24.2 34.2 16.4 61.5 29.0 29.5 6.2 63.5 39.3 21.7 25.4 25.1 3.9 66.3 27.6 55.5 52.5 301.9 32.0 12.3 19.6 44.5 15.8 50.1 19.7 17.3 31.4 102.4 19.9 33.7 30.7 19.9 22.4 20.7 51.4 4.0 21.5 32.0 8.8 15.0 9.3 21.2 34.0 11.1 11.6 24.2 8.0 12.4 21.6 762.3 47.2 65.1 64.3 13.1 0.0 48.4 37.1 32.0 36.7 33.5 9.2 45.0 34.1 26.5 17.8 374.9 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564029-42693505 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 138.5;Inhibitory neurons: 142.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 38.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 10.7 10.8 9.6 12.8 11.0 18.0 13.0 14.8 13.7 9.9 12.8 12.8 14.6 11.1 11.3 9.6 9.5 8.7 11.0 10.0 9.3 12.2 17.4 12.0 12.8 9.3 9.8 9.6 12.3 15.7 15.1 8.9 11.8 11.2 10.6 14.0 29.9 12.1 10.1 23.0 12.3 14.0 10.7 9.0 15.4 12.3 6.3 10.0 13.7 13.4 22.5 11.6 10.9 10.5 15.0 18.5 9.0 10.4 16.4 20.9 20.0 14.0 13.8 14.9 12.0 12.4 13.2 7.4 12.5 10.7 15.0 13.9 18.1 15.1 11.8 15.2 17.1 10.6 20.0 13.3 17.3 17.0 19.6 13.1 14.1 12.7 12.0 12.9 14.8 13.7 17.9 23.7 15.4 11.7 14.9 15.4 17.1 9.5 36.2 8.7 13.6 15.5 19.0 13.8 15.7 12.4 9.8 14.0 13.3 13.9 15.7 13.0 18.7 19.8 10.8 8.4 13.5 10.1 14.1 13.4 18.9 5.7 14.5 6.8 17.7 7.1 15.2 6.5 7.3 5.4 5.2 4.2 5.1 5.5 5.2 4.3 4.8 38.5 5.9 9.8 4.1 5.3 3.4 9.6 11.0 14.8 13.7 10.0 9.3 9.3 9.8 9.6 11.2 9.0 10.0 15.0 33.5 16.0 24.6 82.6 33.9 16.6 18.1 14.9 28.5 43.0 20.4 15.9 39.3 30.0 22.1 20.2 60.5 17.4 46.6 51.6 17.6 18.5 12.4 27.5 30.8 24.8 12.6 75.1 138.5 15.3 13.4 26.5 34.1 32.9 20.3 31.3 21.8 35.0 13.2 63.9 142.7 22.5 14.2 26.7 28.6 3.9 25.4 26.1 19.6 87.1 43.0 23.5 32.0 123.1 131.4 15.0 29.1 24.0 50.6 22.8 37.2 11.7 27.9 53.5 39.5 30.0 27.2 11.2 10.9 28.1 16.2 17.2 44.0 24.0 21.5 22.7 EHD2 PAST2 ENSG00000024422 "EH domain containing 2" Q9NZN4 19 47713422-47743134 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 161.9;Leydig cells: 99.1;Peritubular cells: 107.2;Sertoli cells: 236.7;Smooth muscle cells: 139.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 312.2;BJ: 238.5;fHDF/TERT166: 258.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047394, HPA049890, HPA049986, HPA066751" Approved Supported "Plasma membrane" NA NA 1500000 "Plasma membrane" "HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (1.50e-1)" "unprognostic (2.11e-2)" "unprognostic (3.16e-3)" "unprognostic (1.54e-1)" "unprognostic (3.33e-2)" "unprognostic (5.42e-3)" "unprognostic (3.36e-2)" "unprognostic (1.33e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (8.75e-4)" "unprognostic (5.49e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (6.59e-3)" "unprognostic (6.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.06e-3)" 196.7 60.4 18.5 33.1 15.0 0.4 135.1 15.0 21.4 103.7 14.3 92.6 14.5 120.9 13.4 53.9 76.1 31.5 73.3 14.0 21.0 24.3 14.5 103.7 9.1 21.5 15.6 11.5 68.9 28.4 6.2 12.7 50.7 18.2 62.7 14.8 3.0 34.5 51.5 40.0 52.5 54.9 80.4 15.0 40.6 56.7 11.3 22.0 5.1 49.9 28.5 8.4 113.3 89.5 25.0 62.7 142.7 0.1 1.7 312.2 236.0 0.2 238.5 114.0 86.0 70.0 9.3 31.2 0.0 0.3 258.6 20.3 78.1 1.5 126.5 51.9 0.1 0.8 8.4 78.4 0.7 197.0 0.0 16.6 230.1 109.5 72.5 70.6 113.7 168.4 0.7 26.6 0.2 91.7 11.4 13.3 0.7 1.8 9.2 25.9 1.4 10.0 0.2 69.5 2.9 0.1 0.8 212.5 8.2 6.2 19.1 20.2 4.3 192.6 128.0 27.8 112.5 52.2 0.2 0.2 0.2 119.3 3.3 27.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 18.5 15.0 15.0 21.4 14.0 21.0 21.5 15.6 11.5 18.2 15.0 22.0 25.0 161.9 60.9 20.6 10.7 0.3 20.3 29.4 31.0 12.5 5.5 7.3 10.8 11.6 10.0 22.5 5.5 0.0 1.1 0.8 0.1 0.0 21.2 0.6 3.4 60.5 75.4 0.0 8.6 4.0 14.1 1.6 55.8 5.1 4.5 2.5 24.7 48.9 3.1 1.9 0.0 0.9 0.0 2.0 1.3 8.8 4.3 99.1 1.6 8.8 7.5 0.6 1.8 0.0 3.5 0.3 31.1 0.0 107.2 0.1 28.8 0.0 0.1 5.5 0.8 236.7 24.8 139.4 0.9 3.0 15.8 13.5 1.5 1.5 27.2 0.0 33.4 DEPDC1 "DEP.8, DEPDC1A, FLJ20354, SDP35" ENSG00000024526 "DEP domain containing 1" Q5TB30 1 68474152-68497221 "Predicted intracellular proteins" "Transcription, Transcription regulation" "GTPase activation, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.0;lymphoid tissue: 8.2;testis: 8.1" "Cell type enhanced" "Detected in many" "Early spermatids: 44.9;Erythroid cells: 31.8;Extravillous trophoblasts: 35.2;Late spermatids: 73.0;Spermatocytes: 86.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017845 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes Nucleoplasm "Nucleoli fibrillar center" "CAB017845: " "unprognostic (2.73e-1)" "unprognostic (7.40e-2)" "prognostic favorable (8.70e-5)" "unprognostic (1.23e-3)" "unprognostic (3.06e-1)" "unprognostic (7.73e-3)" "unprognostic (4.37e-6)" "unprognostic (3.39e-3)" "unprognostic (1.57e-3)" "unprognostic (8.59e-2)" "unprognostic (9.04e-6)" "unprognostic (2.18e-1)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.83e-2)" "unprognostic (1.11e-1)" 0.3 0.1 0.0 2.6 0.0 5.0 0.6 0.0 0.1 0.3 0.0 2.9 2.5 0.5 0.1 2.4 0.1 0.5 0.1 0.0 0.2 0.0 0.4 0.2 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.3 0.0 2.1 3.5 0.0 0.3 0.1 0.0 1.6 2.4 1.5 0.0 0.6 1.2 8.1 0.1 8.2 0.3 0.2 4.9 0.9 0.7 0.2 47.2 21.5 40.0 18.5 2.5 5.6 31.3 58.9 26.9 49.1 42.1 17.9 19.3 0.0 42.8 24.4 78.6 30.8 58.6 30.7 82.4 41.2 38.2 38.3 35.9 10.5 0.6 33.4 0.0 2.1 1.6 56.3 31.2 10.0 36.0 16.5 26.6 36.1 88.3 10.7 0.1 12.5 34.6 19.5 28.9 0.0 118.7 15.3 19.8 12.7 44.8 20.7 59.0 24.9 30.3 25.6 22.5 16.6 21.3 31.5 35.5 56.0 69.2 22.5 52.2 0.5 29.7 11.4 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.3 2.0 3.3 0.8 3.3 1.2 0.4 1.3 1.8 0.8 0.0 0.5 1.8 0.0 20.6 0.4 2.1 0.0 0.2 44.9 4.0 1.6 1.6 0.0 31.8 0.5 0.0 35.2 4.4 8.2 2.0 0.0 17.5 2.2 1.2 8.6 0.0 2.2 5.3 4.1 3.5 1.0 73.0 0.3 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 6.9 2.2 0.5 0.1 0.9 0.2 0.0 0.6 4.0 86.8 19.6 12.2 1.3 2.9 1.6 0.5 8.8 1.7 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" 6 138773769-138793319 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055125: AB_2682705" "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 20.7 48.9 44.3 19.8 45.1 40.4 28.4 41.0 49.1 24.0 48.1 24.0 30.7 16.8 38.5 16.5 36.1 24.1 18.6 45.8 45.4 60.4 68.4 26.4 35.7 40.8 41.1 43.1 22.0 35.8 53.5 29.8 32.3 41.6 25.2 24.5 25.9 52.8 20.4 15.8 17.7 31.0 16.0 41.2 30.0 29.5 24.0 42.6 47.0 54.7 21.5 33.9 26.4 17.3 43.5 7.2 12.9 9.5 17.4 17.5 24.4 19.4 11.7 20.3 15.2 24.6 11.1 14.1 31.1 22.3 11.8 21.3 12.3 15.6 16.2 24.4 35.9 35.7 25.3 16.3 22.1 27.6 43.8 25.6 15.7 20.2 10.9 32.0 31.0 25.1 43.1 25.8 42.2 17.1 15.9 36.3 58.0 8.9 28.9 13.2 21.7 9.5 29.2 18.3 10.6 11.8 18.4 15.6 13.8 34.9 18.6 6.7 47.6 19.5 11.9 13.5 22.3 18.0 55.8 53.0 23.1 12.7 27.1 10.6 137.8 91.6 120.6 84.5 96.5 76.4 107.1 88.4 92.8 102.1 106.6 101.5 93.3 249.6 115.8 85.0 90.0 159.8 93.6 44.3 45.1 41.0 49.1 45.8 45.4 40.8 41.1 43.1 41.6 41.2 42.6 43.5 24.5 32.1 35.4 12.7 36.5 13.4 25.0 36.9 29.0 16.0 24.6 25.1 11.0 24.3 31.6 36.8 18.8 82.7 42.7 31.7 123.3 19.3 146.8 83.5 11.4 20.7 24.7 39.2 25.6 31.6 49.2 23.2 16.3 15.6 43.1 25.3 29.3 50.8 38.0 10.1 22.3 30.6 38.7 41.5 31.5 99.9 16.8 36.1 32.0 3.7 39.5 24.6 42.2 5.5 17.9 16.8 35.9 15.1 29.7 31.2 81.0 130.9 89.0 14.2 13.1 14.0 15.8 48.6 27.2 15.5 14.9 108.9 35.4 18.1 23.1 36.2 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364616-89412273 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 129.1;Distal tubular cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 7 "granulocytes: 3.3;monocytes: 2.4" "Cell line enhanced" "Detected in many" "Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA068664: AB_2686016" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 9.9 9.2 14.4 2.3 20.1 11.7 8.3 32.7 16.1 9.5 16.0 3.3 1.7 1.5 7.0 13.9 13.8 3.6 38.8 15.8 20.6 26.7 4.5 7.1 2.8 16.6 13.3 14.0 1.6 6.5 22.9 11.5 3.3 17.4 6.2 1.9 22.0 52.7 2.9 85.3 6.6 2.1 2.1 22.5 4.8 1.7 7.0 15.4 5.5 28.3 60.8 2.6 5.9 6.2 24.8 0.1 1.7 4.4 3.3 0.4 0.0 0.3 0.0 0.0 0.5 0.9 0.1 0.1 0.0 1.5 0.0 22.6 0.1 24.5 0.1 0.0 0.0 12.1 5.8 0.1 0.1 1.8 16.9 19.0 0.4 1.5 0.0 0.1 0.0 0.0 16.9 0.5 63.9 0.1 1.8 8.2 8.4 3.6 0.0 1.8 16.8 23.1 0.2 5.8 0.6 33.1 1.8 0.6 2.2 28.8 1.3 0.7 13.2 0.0 1.8 2.8 11.5 3.0 80.0 39.8 0.0 6.1 12.5 1.9 2.6 0.6 1.4 0.0 0.5 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.3 3.3 0.1 2.4 0.3 0.0 0.1 14.4 20.1 32.7 16.1 15.8 20.6 16.6 13.3 14.0 17.4 22.5 15.4 24.8 1.4 9.6 16.7 5.2 3.7 16.2 17.0 5.8 4.0 21.7 17.4 9.7 129.1 17.2 13.9 14.7 31.3 0.6 4.7 0.1 117.4 20.2 25.6 10.4 2.5 4.8 1.2 5.0 17.6 16.9 1.5 10.0 1.1 15.0 4.5 2.9 2.5 9.7 51.9 47.1 20.6 0.5 42.7 25.8 9.2 15.5 3.1 23.2 39.2 3.7 10.4 29.6 0.0 13.0 17.2 8.1 0.0 4.1 8.0 28.4 0.0 18.6 19.4 16.3 0.0 11.8 7.0 21.7 30.3 32.4 22.6 0.7 3.9 0.2 0.2 30.2 HSF2 ENSG00000025156 "Heat shock transcription factor 2" Q03933 6 122399551-122433119 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016067, HPA031455" Approved Supported Nucleoplasm No No Nucleoplasm "CAB016067: AB_627754, HPA031455: AB_10670702" "unprognostic (1.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-1)" "unprognostic (5.42e-2)" "unprognostic (2.27e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (3.40e-3)" "unprognostic (2.60e-1)" "unprognostic (2.58e-1)" "unprognostic (1.25e-3)" "unprognostic (3.03e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (9.27e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" 8.5 15.3 13.2 7.9 13.4 29.8 12.8 16.1 13.6 13.2 15.8 9.9 7.0 14.6 10.4 8.3 12.0 7.6 23.5 12.3 13.3 6.9 5.6 8.9 12.8 11.7 12.1 12.2 14.8 6.4 14.2 10.7 8.3 12.1 11.2 7.0 44.9 8.5 12.8 49.0 12.4 9.1 14.1 11.1 9.2 9.5 38.3 13.3 18.1 8.9 64.9 12.6 9.7 9.1 14.8 8.5 8.7 44.5 35.8 19.6 15.6 12.2 14.6 35.5 26.9 41.6 13.0 7.0 32.2 12.4 18.9 30.2 10.5 30.1 14.4 37.4 32.7 36.4 31.8 8.6 27.1 19.9 23.5 15.4 20.0 21.6 22.3 25.2 24.9 16.4 28.8 34.0 15.5 25.6 11.5 38.8 30.9 13.6 12.2 12.3 35.6 18.0 10.3 20.5 9.7 46.5 31.5 15.1 12.5 14.5 32.5 10.8 25.5 10.4 14.3 16.2 16.1 22.6 22.1 22.7 41.4 15.5 15.3 18.9 6.9 3.9 6.1 11.7 4.7 12.6 9.2 11.0 10.3 5.5 7.0 27.9 22.0 0.6 11.0 6.8 3.8 13.2 11.4 13.2 13.4 16.1 13.6 12.3 13.3 11.7 12.1 12.2 12.1 11.1 13.3 14.8 10.6 19.2 10.3 17.0 11.9 31.7 11.4 8.1 27.3 21.8 12.1 10.9 36.6 4.3 11.1 0.0 27.1 15.5 14.4 1.9 11.7 7.7 97.1 21.3 14.6 10.3 6.6 16.2 26.6 4.2 7.4 16.2 10.2 9.6 8.8 19.4 6.1 4.9 7.9 21.9 29.4 6.1 24.4 4.8 7.8 21.3 10.2 6.0 19.6 14.0 2.9 15.2 7.2 24.1 23.5 4.8 5.2 9.8 7.9 8.7 3.2 7.5 23.3 34.2 26.3 14.9 12.1 73.8 97.0 16.1 25.7 3.1 20.5 39.6 5.4 6.4 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950370 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 452.5;Late spermatids: 661.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 13.0 8.3 10.6 12.1 11.5 11.9 12.6 15.5 13.1 10.9 10.4 9.4 6.0 11.9 7.3 12.0 9.2 10.8 11.6 10.9 12.0 7.9 8.3 10.1 14.3 11.7 11.4 10.5 13.3 6.9 12.2 5.4 11.8 11.4 10.4 8.4 14.5 9.6 10.9 32.6 8.1 7.9 11.7 10.4 14.8 8.3 11.9 11.6 14.8 10.3 17.8 14.0 10.6 8.6 14.7 18.1 14.2 24.4 36.0 17.3 19.7 22.5 20.2 19.1 19.8 17.2 41.4 13.1 30.1 17.9 27.1 24.4 10.7 22.6 28.2 24.1 13.7 9.6 55.8 26.3 15.6 17.3 27.2 20.8 15.6 38.8 21.0 32.2 23.5 22.1 21.0 23.3 18.8 23.1 10.8 27.6 15.9 12.0 11.9 17.5 20.0 35.9 17.9 15.9 12.4 21.9 17.9 36.0 41.0 18.4 21.8 32.6 20.0 31.1 43.7 9.9 23.0 21.0 17.2 22.0 21.5 32.2 19.5 22.9 17.3 11.2 33.1 12.4 11.5 13.6 15.0 12.5 14.6 10.6 11.1 14.0 14.7 25.9 16.0 16.9 9.9 7.2 9.0 10.6 11.5 15.5 13.1 10.9 12.0 11.7 11.4 10.5 11.4 10.4 11.6 14.7 51.2 38.5 41.8 28.4 131.1 34.8 76.6 52.5 31.3 77.4 49.8 53.5 62.2 31.5 43.5 38.6 98.0 106.7 191.0 16.3 37.2 29.8 452.5 39.8 41.6 46.3 36.0 37.6 49.7 19.9 52.5 53.6 23.0 34.7 142.4 41.2 47.2 18.2 54.5 114.4 49.5 27.9 30.5 62.7 84.3 661.6 35.8 87.1 39.2 62.8 62.6 50.0 105.0 34.2 55.2 24.1 26.5 53.4 76.9 60.0 14.0 24.8 50.2 80.7 19.7 65.5 50.6 60.4 47.0 29.8 28.3 22.3 127.8 30.1 28.8 55.4 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "liver: 1819.2" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 1969.3" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 13.4;U-266/84: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059141: AB_2683922" "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favorable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 5.4 2.5 12.6 7.0 14.0 0.5 0.7 12.9 19.1 25.7 9.2 16.0 3.3 21.0 1.6 10.0 6.6 9.1 0.5 11.7 12.0 2.5 1819.2 63.7 0.8 12.2 13.5 12.0 6.0 0.6 0.5 0.7 5.4 14.0 51.7 7.6 0.8 0.4 69.8 0.4 1.0 4.8 13.2 11.5 47.9 5.8 23.5 13.2 0.9 31.7 0.5 0.9 37.0 14.7 12.2 0.3 0.8 1.9 0.4 1.9 1.4 2.3 4.1 3.5 1.9 1.9 0.4 0.4 12.0 1.7 0.5 0.5 0.3 6.1 1.1 1.1 7.7 2.2 3.7 1.2 0.6 1.2 1.9 6.0 1.0 0.4 1.2 0.6 0.6 0.0 10.3 1.1 13.4 0.9 2.4 5.6 1.3 7.5 0.7 0.7 7.4 0.8 2.9 0.2 1.4 11.0 2.3 2.0 3.6 0.9 0.7 0.6 1.5 0.3 0.9 0.8 4.0 1.0 11.7 18.0 7.8 1.3 6.9 0.6 0.0 0.0 0.0 1.0 0.2 1.2 0.7 0.8 0.8 0.2 0.3 1.1 0.7 0.0 0.0 0.5 0.7 1.0 0.3 12.6 14.0 12.9 19.1 11.7 12.0 12.2 13.5 12.0 14.0 11.5 13.2 12.2 0.4 173.1 130.6 21.2 6.1 1.3 3.1 0.6 0.6 0.4 0.7 0.6 0.2 27.1 9.3 0.0 0.0 1.4 0.4 0.0 0.0 0.1 4.6 0.7 3.5 1.3 0.0 29.5 1.4 0.0 2.6 5.0 0.0 0.1 0.0 1.6 26.0 1969.3 0.4 0.0 2.1 0.4 0.0 40.2 0.3 4.5 12.5 0.5 0.0 1.0 1.0 1.3 0.0 3.0 5.5 0.1 0.0 1.5 0.8 16.1 0.0 0.3 1.5 0.6 13.1 0.6 3.5 16.4 11.4 1.2 1.6 0.4 2.2 36.0 0.7 1.1 NR1H3 "LXR-a, LXRa, RLD-1" ENSG00000025434 "Nuclear receptor subfamily 1 group H member 3" Q13133 11 47248300-47269033 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 13.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 45.3;HSkMC: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036443, CAB037109" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037109: AB_1840991, HPA036443: AB_10966142" "unprognostic (2.95e-3)" "unprognostic (5.31e-3)" "unprognostic (5.19e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.19e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "unprognostic (7.73e-2)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (3.56e-1)" "unprognostic (4.42e-2)" "unprognostic (2.84e-1)" "prognostic favorable (3.40e-4)" 57.0 20.0 10.8 19.5 10.9 3.3 51.5 10.4 14.5 25.3 9.7 20.3 48.8 13.7 17.8 7.6 20.5 19.8 17.3 9.4 10.2 23.3 84.5 24.3 47.1 10.7 11.0 8.9 15.3 16.9 6.8 7.3 25.6 11.6 19.6 12.1 2.3 14.9 11.6 9.2 11.3 41.3 7.9 9.7 53.6 16.4 22.0 12.3 11.1 20.5 6.3 13.7 22.6 17.7 12.7 3.5 13.8 6.4 6.1 41.0 45.3 31.1 3.5 17.9 5.7 8.8 17.0 43.2 6.1 6.5 2.8 2.1 9.2 7.6 6.1 3.8 5.8 6.1 8.3 18.7 26.1 17.5 2.9 1.0 61.2 3.7 8.7 5.5 9.7 5.0 9.4 10.2 2.5 4.5 14.8 5.8 17.0 7.1 18.7 4.5 8.4 8.3 4.1 5.0 31.9 6.1 2.3 12.2 7.9 10.4 6.1 19.5 8.8 1.3 4.5 6.1 9.1 2.0 11.9 18.3 7.6 8.2 3.9 2.2 7.8 2.7 2.5 1.4 13.3 1.9 1.0 1.5 1.3 4.3 0.7 1.7 1.4 1.6 5.8 4.2 0.7 3.8 1.9 10.8 10.9 10.4 14.5 9.4 10.2 10.7 11.0 8.9 11.6 9.7 12.3 12.7 27.2 0.0 11.3 8.1 3.0 3.3 8.6 4.6 2.2 2.4 12.7 12.1 6.6 15.7 4.9 5.5 2.1 11.0 1.5 24.4 11.7 5.8 31.0 2.4 15.3 12.5 1.8 7.0 9.2 8.7 13.3 14.1 17.9 2.8 13.3 7.1 24.7 66.6 54.4 1.7 10.9 14.6 2.0 100.9 3.3 49.0 9.0 24.7 3.6 1.0 5.4 4.4 2.1 3.0 5.6 4.2 10.7 6.0 2.4 4.1 69.5 26.1 2.5 0.8 19.7 7.4 16.3 32.4 16.8 3.0 2.4 6.6 2.1 5.4 19.0 6.3 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530032 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1" "Group enriched" "Detected in all" 10 "dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6" "Not detected" "Not detected" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 11000000 "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 45.8 19.6 11.5 78.4 10.2 22.2 38.3 8.1 8.2 21.3 12.6 18.6 26.4 7.9 0.5 58.9 30.3 7.3 24.0 5.0 25.5 38.1 82.6 63.9 31.8 15.2 13.2 2.9 4.0 13.9 4.6 8.9 15.5 11.3 21.2 3.7 0.0 40.4 5.6 10.8 22.6 32.8 9.2 11.9 86.8 31.5 3.1 14.9 15.8 25.7 1.6 15.4 23.1 27.2 13.5 27.0 2.5 0.4 0.8 1.8 2.2 5.1 3.7 0.5 6.1 17.4 0.1 40.0 1.8 4.1 5.8 1.3 21.0 0.2 1.0 0.0 9.0 16.5 1.8 3.9 3.5 95.2 1.3 26.9 4.7 4.6 5.4 0.0 0.1 0.1 0.5 2.8 68.6 0.9 1.9 1.5 9.9 0.6 1.9 9.1 5.7 0.4 35.1 0.3 1.2 0.7 5.6 22.9 17.3 6.5 0.2 4.2 13.8 6.7 0.8 4.7 1.5 1.5 68.6 15.9 5.7 1.9 1.5 1.6 19.5 135.8 74.9 2.0 98.4 1.2 6.7 2.9 1.2 39.5 6.9 1.6 1.3 114.1 9.5 77.1 9.3 3.1 10.1 11.5 10.2 8.1 8.2 5.0 25.5 15.2 13.2 2.9 11.3 11.9 14.9 13.5 122.6 12.8 29.0 0.3 122.9 58.5 57.4 169.9 53.5 3.4 101.5 90.8 3.2 50.1 88.6 33.1 4.2 17.2 65.8 154.8 29.4 340.2 2.2 55.7 56.0 55.7 16.8 19.6 0.3 643.9 300.8 81.9 38.7 59.2 53.4 3.0 38.2 93.0 477.4 0.0 0.4 50.2 24.4 371.8 409.4 8.7 5.0 561.7 113.8 4.7 2174.6 2.9 71.1 0.5 0.2 364.0 86.4 1.9 102.1 109.8 214.5 105.1 78.0 6.6 26.3 93.3 62.4 1.5 8.0 71.7 56.7 33.5 62.5 3.7 51.1 76.0 NCAPH2 "384D8-2, CAP-H2, hCAP-H2" ENSG00000025770 "Non-SMC condensin II complex subunit H2" Q6IBW4 22 50508224-50524780 "Predicted intracellular proteins" "DNA condensation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067932, HPA069056" Enhanced Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA067932: AB_2685926, HPA069056: AB_2686076" "unprognostic (2.01e-1)" "prognostic favorable (2.24e-8)" "unprognostic (3.65e-2)" "unprognostic (2.81e-1)" "unprognostic (5.04e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.92e-2)" "unprognostic (8.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-2)" "unprognostic (6.31e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" 25.4 22.1 29.8 24.8 30.7 79.4 27.1 29.7 39.5 31.9 22.7 28.2 17.9 30.0 12.5 30.5 30.3 13.1 32.4 29.9 27.6 26.8 27.9 28.4 27.8 30.4 27.1 30.2 37.9 41.1 16.8 38.9 17.2 28.0 28.7 11.8 15.6 25.9 16.8 31.0 32.2 28.7 14.8 25.4 33.4 30.4 52.7 26.5 29.9 29.1 19.5 20.4 26.1 27.1 31.6 60.7 32.1 53.8 57.1 15.8 18.4 71.6 45.8 31.6 81.8 89.5 67.2 41.4 68.8 25.5 32.9 45.5 47.1 49.0 44.2 23.5 40.3 82.8 39.8 86.7 63.6 19.1 90.3 69.5 16.1 27.6 64.4 22.2 12.2 26.2 59.4 51.5 132.5 33.4 83.9 61.7 109.9 39.3 34.9 37.9 103.3 71.0 77.2 23.8 40.6 35.6 47.5 36.7 55.4 44.3 16.5 37.5 86.7 17.6 64.2 80.5 54.4 72.3 67.7 45.8 110.1 48.8 45.7 62.3 11.9 9.8 18.2 18.7 11.6 22.9 16.0 19.4 19.1 8.0 14.2 19.9 17.3 11.4 13.9 14.4 11.8 19.3 15.5 29.8 30.7 29.7 39.5 29.9 27.6 30.4 27.1 30.2 28.0 25.4 26.5 31.6 10.1 22.4 24.5 12.1 15.9 18.9 23.8 17.5 6.2 18.3 11.5 12.6 19.6 15.7 10.4 9.2 4.2 36.3 15.5 24.6 15.6 16.6 36.8 8.5 7.5 12.9 13.1 31.5 8.6 23.5 55.1 13.8 14.8 14.5 17.1 16.3 8.9 10.6 19.3 8.4 8.8 18.8 6.1 7.9 16.3 111.5 17.4 9.2 12.4 3.7 16.2 14.7 18.6 3.0 8.2 17.3 13.5 17.3 26.6 15.2 18.4 9.5 5.9 16.1 19.7 17.8 16.9 36.2 39.7 10.9 18.5 31.5 15.9 7.6 22.6 18.2 TOMM34 "HTOM34P, TOM34" ENSG00000025772 "Translocase of outer mitochondrial membrane 34" Q15785 20 44942130-44960397 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 120.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 128.3;monocytes: 176.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018845, HPA056875" Enhanced Supported Vesicles,Mitochondria,Cytosol NA NA 26000 Cytosol "Vesicles, Mitochondria" "HPA018845: AB_1858184, HPA056875: AB_2683264" "unprognostic (4.96e-2)" "unprognostic (6.88e-2)" "unprognostic (5.05e-2)" "unprognostic (1.36e-3)" "unprognostic (4.91e-2)" "prognostic unfavorable (4.47e-5)" "prognostic unfavorable (8.71e-6)" "unprognostic (2.55e-1)" "unprognostic (5.04e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.11e-2)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.45e-4)" "unprognostic (5.79e-3)" 12.9 46.4 33.3 13.7 41.3 20.2 14.8 26.7 53.4 14.6 29.3 14.8 11.9 14.9 49.4 19.7 49.5 13.8 15.5 53.5 32.9 25.9 19.0 14.1 15.3 30.7 28.0 34.0 26.6 18.1 24.6 26.8 29.9 31.0 18.9 18.5 9.0 15.9 17.0 18.1 14.5 13.8 15.5 26.8 15.0 16.0 120.4 32.4 18.5 16.6 15.3 22.1 26.5 12.8 37.4 133.6 46.0 40.1 85.6 36.3 35.6 90.2 75.6 109.6 92.8 67.1 187.4 48.6 90.9 63.5 59.6 94.2 82.1 98.8 164.0 107.3 16.1 46.2 71.7 58.2 133.7 46.2 47.5 42.3 38.7 45.2 129.8 230.8 80.9 95.8 36.6 82.6 36.4 89.3 88.2 50.2 65.4 47.1 70.7 172.8 43.1 42.2 98.9 76.1 73.7 68.3 40.4 103.5 71.0 91.8 30.7 53.5 40.8 57.2 121.5 80.0 58.9 114.8 31.2 40.1 75.4 110.9 55.8 48.2 15.9 16.9 15.3 14.8 17.5 15.4 25.4 15.3 15.7 39.7 28.6 17.1 13.7 4.6 14.8 18.8 21.1 19.3 17.3 33.3 41.3 26.7 53.4 53.5 32.9 30.7 28.0 34.0 31.0 26.8 32.4 37.4 7.3 6.4 11.5 3.6 15.0 13.8 84.6 17.2 14.8 3.1 14.1 11.2 10.3 5.7 15.5 12.9 4.2 128.3 8.7 7.7 31.3 38.4 18.5 17.5 7.2 13.0 12.0 17.2 6.8 30.7 38.0 14.8 16.8 14.8 9.5 28.2 6.4 9.1 22.7 3.3 4.8 9.3 8.2 5.9 47.2 32.9 6.8 10.3 7.2 5.6 176.9 17.4 7.2 3.5 2.7 46.2 9.5 6.4 16.9 69.1 6.9 22.5 44.3 4.2 0.0 5.6 13.6 43.0 56.2 15.7 11.1 56.5 8.8 24.0 13.6 55.9 SEC63 "DNAJC23, ERdj2, PRO2507, SEC63L" ENSG00000025796 "SEC63 homolog, protein translocation regulator" Q9UGP8 6 107867756-107958208 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 354.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053295, HPA060535" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053295: AB_2682105, HPA060535: AB_2684312" "prognostic unfavorable (3.32e-4)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.08e-1)" "unprognostic (1.56e-1)" "unprognostic (4.36e-3)" "unprognostic (1.51e-2)" "unprognostic (8.33e-3)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (6.16e-4)" "unprognostic (2.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.56e-1)" "unprognostic (4.41e-2)" 27.8 33.3 12.4 22.2 14.8 33.2 23.5 15.0 13.3 30.5 24.0 19.3 17.0 25.4 29.9 19.6 22.0 22.2 19.2 12.5 17.8 20.1 47.0 21.9 16.9 13.6 12.4 11.4 40.8 61.8 32.0 14.5 21.1 14.2 27.9 18.8 21.4 78.5 23.5 14.5 15.6 18.1 22.4 13.6 16.2 23.3 33.2 12.8 22.8 52.5 14.3 17.5 22.0 14.2 18.1 28.5 17.1 46.0 57.6 47.1 55.2 41.4 59.2 65.0 27.8 39.2 30.8 34.6 52.8 49.4 53.7 34.4 40.9 32.3 38.3 42.5 63.8 35.7 57.2 25.2 31.6 73.2 65.9 32.5 43.5 61.4 44.5 97.6 50.0 39.3 31.7 48.5 82.8 57.7 22.7 20.6 29.5 36.4 30.0 18.1 65.2 54.4 43.7 33.5 37.1 40.3 45.7 32.9 48.8 59.1 31.2 34.9 95.8 42.5 41.6 25.8 42.2 46.6 31.4 25.0 52.9 45.9 56.4 48.7 5.6 5.2 5.0 4.8 4.7 7.5 4.4 3.9 3.9 5.4 4.0 4.3 3.4 1.7 7.1 9.8 6.9 2.2 3.5 12.4 14.8 15.0 13.3 12.5 17.8 13.6 12.4 11.4 14.2 13.6 12.8 18.1 55.6 118.6 143.3 38.2 64.4 85.0 70.5 90.9 42.7 57.7 67.8 54.2 78.8 81.5 125.5 53.3 39.6 80.8 71.6 39.2 11.7 86.0 40.3 48.7 102.8 61.6 53.5 31.5 52.5 125.4 96.4 107.1 46.9 54.8 68.9 84.8 59.6 126.7 62.7 47.1 50.8 80.0 83.4 56.7 78.9 23.9 106.2 54.8 80.0 42.2 54.3 61.0 59.8 60.3 64.8 81.9 53.5 118.8 144.6 91.1 37.2 38.4 116.7 49.9 46.0 108.2 77.2 143.1 75.0 44.7 80.0 91.0 52.3 354.8 60.8 73.8 KPNA6 "FLJ11249, IPOA7, KPNA7, MGC17918" ENSG00000025800 "Karyopherin subunit alpha 6" O60684 1 32108056-32176563 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 294.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018863 Supported Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018863: AB_1852632" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.30e-2)" "unprognostic (8.35e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.51e-2)" "unprognostic (3.18e-1)" "unprognostic (5.32e-2)" "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.80e-1)" "unprognostic (1.57e-2)" 14.2 15.5 12.7 11.1 14.2 20.7 13.3 12.2 15.3 14.6 11.9 15.7 8.9 17.3 12.9 18.9 14.4 8.9 20.6 14.0 16.6 13.9 15.9 15.3 11.2 15.3 15.7 13.9 13.5 13.5 24.8 14.4 16.7 17.4 14.1 13.1 17.2 13.6 14.5 39.7 18.6 12.6 18.0 12.7 12.1 14.9 20.4 15.3 12.9 13.7 23.9 14.9 15.7 15.7 20.3 32.0 24.8 21.6 28.0 32.5 28.4 25.3 25.2 29.5 36.0 34.5 27.8 33.9 26.5 29.1 45.6 21.6 26.7 33.5 38.5 45.6 27.0 18.4 27.4 36.4 22.6 28.7 30.4 21.5 28.9 35.8 44.6 42.3 30.3 38.1 20.5 27.0 23.7 34.4 17.5 24.6 17.3 50.5 20.6 18.3 24.5 31.0 21.7 31.4 28.9 20.7 17.4 45.8 27.1 25.0 52.6 19.2 15.9 44.5 33.1 22.7 43.8 36.6 16.9 20.7 20.3 36.3 27.8 32.4 3.2 7.4 7.2 7.7 9.1 7.5 5.3 6.5 6.0 6.0 6.1 7.4 7.2 4.2 3.8 9.9 6.7 7.3 5.3 12.7 14.2 12.2 15.3 14.0 16.6 15.3 15.7 13.9 17.4 12.7 15.3 20.3 27.9 41.7 41.5 33.0 36.1 63.6 36.9 37.6 22.2 48.6 44.7 26.7 32.7 37.1 32.4 29.5 58.4 45.4 42.4 29.5 17.6 36.2 294.2 41.0 44.6 40.4 46.1 52.8 62.5 31.6 41.6 35.7 25.5 49.3 13.9 31.3 36.0 77.3 30.4 52.2 58.4 36.0 24.4 36.8 44.8 65.2 34.2 29.3 24.9 30.0 41.4 29.0 47.4 40.7 54.3 46.1 26.4 40.6 24.1 56.7 25.3 33.2 48.2 44.7 32.9 53.1 36.7 78.7 56.2 31.2 85.1 135.7 31.7 31.8 35.6 59.0 VIM ENSG00000026025 Vimentin P08670 10 17228241-17237593 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18287.8;fHDF/TERT166: 10084.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000080, HPA001762, CAB058687" Enhanced Supported "Intermediate filaments" NA NA 35000000 "Intermediate filaments" "CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (2.87e-2)" "prognostic favorable (9.75e-6)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (9.29e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.87e-3)" "unprognostic (7.32e-2)" "unprognostic (1.82e-1)" "unprognostic (9.47e-3)" 3067.4 426.6 319.4 616.1 348.0 1468.5 2383.1 268.7 531.8 1806.5 570.7 827.7 220.3 1236.7 403.5 455.7 1471.4 968.6 1000.4 302.8 824.3 471.2 194.4 1143.1 812.9 665.1 295.2 280.3 3721.8 373.2 226.4 579.0 1038.6 379.2 574.9 404.7 737.4 633.7 557.1 366.7 1053.6 680.5 1118.7 424.7 827.1 527.2 254.0 399.2 416.0 1402.6 560.8 750.8 991.9 1378.3 395.6 21.2 1119.0 1981.0 3180.7 6407.4 18287.8 3.0 5238.5 3458.9 3859.2 3421.5 8.5 70.4 2.9 273.2 10084.4 1804.7 8.4 283.8 147.0 3734.1 3567.5 387.2 563.2 523.5 0.3 1967.3 301.1 222.8 6746.8 6.5 5712.0 3213.4 9020.8 6366.3 372.4 889.3 1575.4 6939.5 4.5 736.6 911.2 632.4 1.4 1394.0 564.8 2745.9 95.7 3925.3 0.8 8.1 946.6 1.4 6.9 5447.5 1133.1 8.6 341.8 5459.0 3819.8 1644.5 3244.7 6311.5 1754.4 953.7 130.4 5775.4 28.9 3726.3 667.8 751.8 215.2 219.5 469.3 278.7 176.3 357.0 285.0 866.0 117.5 217.1 217.2 409.3 99.2 471.2 342.3 481.5 615.4 319.4 348.0 268.7 531.8 302.8 824.3 665.1 295.2 280.3 379.2 424.7 399.2 395.6 3211.7 157.0 349.4 53.5 605.8 725.8 21.6 361.2 58.1 74.2 108.8 539.1 109.5 94.4 157.3 108.5 50.1 22.1 1110.1 9.1 5.9 198.8 58.1 922.9 2314.1 2923.2 309.1 236.5 0.4 569.0 45.8 3443.0 101.4 693.7 2776.4 4879.0 2195.6 19.2 3541.4 33.7 0.3 1.8 16.2 2841.2 4893.1 131.6 5013.2 3177.8 3082.5 85.3 3893.1 8977.0 259.5 1.0 0.4 525.9 1.5 2336.6 2097.2 79.5 3.1 181.6 90.7 284.1 1420.0 3171.9 3714.2 55.1 27.5 39.4 473.0 52.7 1566.3 1791.1 6.2 28.9 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990531-89017059 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 114.7" "Group enriched" "Detected in all" 5 "granulocytes: 114.7;T-cells: 96.2" "Cell line enhanced" "Detected in many" "HDLM-2: 83.4;Karpas-707: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" NA NA 11900000 420000 "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 11.2 26.5 3.3 17.1 3.3 21.0 11.0 2.9 4.8 12.8 2.9 16.6 7.1 12.9 10.4 10.9 15.0 15.9 6.7 3.4 3.8 7.1 23.5 21.9 19.1 4.4 3.0 2.8 20.2 3.7 2.7 3.7 10.5 3.6 9.0 23.5 3.3 6.5 9.4 2.4 7.9 9.2 15.1 3.3 11.3 4.4 2.6 3.5 14.6 7.3 2.7 15.8 13.0 10.3 4.0 22.7 8.2 5.4 13.9 37.0 51.3 0.0 51.8 50.2 1.7 9.1 0.1 23.4 4.7 19.0 52.1 9.6 4.0 1.0 44.8 3.2 83.4 8.7 0.4 5.2 14.7 31.6 3.4 1.6 69.2 38.7 31.4 66.0 24.5 4.7 17.8 0.0 109.0 44.0 1.4 6.4 3.4 0.6 0.2 1.8 1.4 0.5 5.0 60.7 7.3 0.4 0.2 7.7 0.0 0.8 7.0 13.9 1.0 9.5 15.8 9.0 15.2 12.3 45.3 5.3 0.4 11.8 10.2 4.5 43.1 9.4 30.9 9.9 12.3 13.8 7.5 27.6 19.6 11.5 4.0 3.1 10.0 114.7 3.1 22.1 0.2 96.2 12.8 3.3 3.3 2.9 4.8 3.4 3.8 4.4 3.0 2.8 3.6 3.3 3.5 4.0 10.3 57.7 13.8 40.1 12.8 45.9 109.7 53.1 39.9 0.0 5.5 9.5 3.5 12.8 27.5 9.2 0.0 0.4 16.3 24.9 0.0 6.3 11.3 9.2 22.3 8.9 8.4 9.5 8.8 4.3 0.2 35.4 8.6 15.5 3.8 4.9 2.2 19.3 5.5 1.7 2.8 14.4 8.2 7.0 31.7 4.9 19.0 17.7 12.4 17.8 20.9 14.5 10.3 8.0 0.7 6.5 8.7 13.9 32.2 46.0 15.6 14.4 26.3 0.7 6.6 26.8 29.1 11.3 1.1 28.5 43.9 0.4 48.4 11.8 24.4 30.0 RNASET2 "bA514O12.3, FLJ10907, RNASE6PL" ENSG00000026297 "Ribonuclease T2" O00584 6 166922113-166957191 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Endonuclease, Hydrolase, Lyase, Nuclease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 490.2;Glandular and luminal cells: 761.3;Hofbauer cells: 382.2;Kupffer cells: 484.7;Macrophages: 418.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 497.9" "HPA029013, HPA066509" Approved "Secreted to blood" NA NA 15000000 "HPA029013: AB_10602922, HPA066509: AB_2685682" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.13e-2)" "unprognostic (9.33e-2)" "unprognostic (1.76e-2)" "unprognostic (1.30e-1)" "unprognostic (1.15e-2)" "unprognostic (8.11e-2)" "unprognostic (1.79e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.70e-14)" "unprognostic (5.03e-2)" "unprognostic (7.34e-2)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" 35.2 35.3 46.6 69.2 49.6 125.5 50.7 50.5 66.4 162.9 51.4 74.7 58.1 49.5 142.0 25.0 135.8 70.2 17.3 46.8 59.1 24.8 52.8 47.7 118.4 65.5 49.2 43.6 36.5 145.9 41.0 26.5 43.9 61.8 52.4 90.8 8.4 113.8 95.0 7.3 23.4 66.0 28.0 61.6 196.6 73.5 13.4 54.7 44.2 77.4 12.2 87.6 55.4 32.5 66.4 12.8 14.2 12.6 37.8 57.0 40.6 8.4 15.8 21.2 7.3 7.4 33.7 19.9 11.1 149.8 41.3 16.7 41.0 20.8 18.6 4.3 15.9 35.1 10.2 20.6 84.6 19.1 152.7 37.3 23.9 33.6 4.3 2.7 30.4 10.1 21.7 20.9 94.5 10.9 44.9 12.6 109.5 6.4 140.0 13.0 25.0 16.6 131.7 136.3 9.9 4.4 28.7 32.0 100.4 8.3 22.3 13.1 497.9 19.3 14.9 9.8 43.7 13.5 15.0 19.5 1.4 32.3 149.2 10.3 116.9 185.6 674.8 29.1 277.0 53.4 136.7 159.9 72.3 226.4 119.6 128.4 41.4 438.9 30.7 368.8 369.3 90.8 179.8 46.6 49.6 50.5 66.4 46.8 59.1 65.5 49.2 43.6 61.8 61.6 54.7 66.4 21.8 19.2 29.3 10.1 270.1 43.3 116.4 45.1 72.3 10.5 97.0 95.1 9.5 47.1 28.0 38.6 0.0 63.4 286.8 133.7 23.5 59.2 10.3 490.2 78.9 44.9 75.4 27.6 13.6 27.4 58.8 45.8 80.0 761.3 71.7 38.6 19.2 20.0 382.2 13.5 37.1 204.0 24.4 484.7 187.7 11.3 35.4 418.2 58.7 113.4 146.1 24.4 64.9 14.6 1.7 74.1 324.8 29.3 158.6 61.2 178.5 19.6 19.0 7.1 26.3 31.9 18.6 10.0 23.1 58.3 34.5 27.8 149.2 15.3 193.0 103.9 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138882-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 508.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1650.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 1200000000 "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 117.4 42.8 49.8 219.9 33.1 310.9 166.4 69.1 25.3 147.2 25.1 92.0 53.5 202.1 20.3 229.6 69.6 130.8 23.8 32.9 121.2 31.4 31.2 216.0 109.7 114.7 86.7 11.3 11.8 265.4 6.1 8.2 74.7 107.9 88.0 112.6 38.3 508.5 57.5 17.2 413.9 61.3 177.4 115.8 84.5 62.1 6.6 77.8 64.8 76.8 28.0 190.3 237.5 195.0 138.7 493.0 448.6 4.3 1.2 252.6 691.5 1.6 962.2 740.3 521.3 288.2 30.4 150.4 0.7 126.5 1350.2 1065.4 820.1 9.9 1013.9 716.4 110.3 6.2 18.9 198.3 0.3 262.3 254.6 1124.3 315.4 778.3 693.2 552.7 1650.0 184.3 0.1 4.0 157.9 518.9 3.0 25.6 166.9 9.8 8.7 136.4 1.4 89.3 7.5 777.4 138.1 2.0 1.4 185.2 5.5 462.8 38.6 25.7 15.1 547.3 646.6 120.0 815.8 1006.0 281.6 327.7 3.7 980.4 145.1 969.8 127.4 403.0 35.4 140.6 257.8 196.5 122.5 210.1 186.5 229.0 90.0 179.7 153.6 92.6 322.3 356.1 79.9 309.7 437.3 49.8 33.1 69.1 25.3 32.9 121.2 114.7 86.7 11.3 107.9 115.8 77.8 138.7 41.0 96.1 361.8 54.5 250.1 999.7 297.7 335.3 228.2 0.6 139.6 71.2 8.6 27.1 125.6 20.2 2.1 4.5 257.0 14.0 1.9 992.1 41.3 43.6 395.4 50.9 100.1 94.4 0.4 869.6 3.6 282.2 39.8 196.9 763.2 25.2 13.2 3.6 226.6 0.0 0.4 93.3 30.5 474.3 1934.2 24.3 22.4 523.9 604.7 8.4 594.2 29.6 62.8 0.5 11.2 813.1 10.9 0.4 216.3 386.7 6.0 1.6 18.8 2.0 157.8 197.2 227.9 0.4 0.4 279.3 1024.9 17.9 430.8 1.0 79.1 330.7 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023107 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;endometrium 1: 88.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 53.7;Granulosa cells: 34.0;Syncytiotrophoblasts: 97.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "naive B-cell: 7.1" "Lineage enriched" "Detected in single" 71 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "hTCEpi: 53.5;U-138 MG: 40.4;WM-115: 34.6" "Group enriched" "Detected in many" 5 "amygdala: 20.6;basal ganglia: 19.1;cerebral cortex: 14.9;hippocampal formation: 18.1;white matter: 9.1" "Group enriched" "Detected in all" 5 "amygdala: 12.6;basal ganglia: 11.1;cerebral cortex: 22.4;hippocampal formation: 16.8" "HPA039530, HPA040024" Approved Approved Vesicles NA NA Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.3 3.1 16.8 2.3 28.0 0.0 0.4 0.6 10.1 11.8 0.2 4.3 0.2 88.2 0.8 6.7 19.4 0.9 1.0 15.5 5.3 0.3 0.2 0.3 2.3 24.8 10.1 18.8 0.7 2.7 4.2 0.8 7.2 6.8 5.6 0.8 0.1 2.2 12.9 0.0 0.5 5.3 4.2 2.5 2.8 0.7 9.6 5.5 0.2 0.2 0.0 0.9 3.5 6.3 5.0 0.9 3.6 2.7 13.3 1.5 3.4 0.2 11.6 0.1 6.7 5.3 0.2 0.2 0.0 7.1 3.5 18.8 3.4 1.7 3.5 6.9 0.4 4.7 0.0 13.6 0.0 23.2 0.0 0.4 6.8 53.5 25.7 26.1 1.3 1.8 0.1 0.2 0.0 0.6 13.4 0.0 0.4 13.7 0.0 25.0 0.0 0.0 0.0 0.0 4.1 3.9 15.0 25.5 29.3 19.9 4.3 2.1 1.9 0.7 40.4 23.9 0.3 3.4 0.1 0.0 0.0 11.8 1.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.8 28.0 0.6 10.1 15.5 5.3 24.8 10.1 18.8 6.8 2.5 5.5 5.0 0.2 3.2 1.1 0.3 10.5 1.1 11.0 0.6 13.6 0.3 1.1 2.3 1.1 7.2 0.9 0.0 0.0 53.7 0.0 7.5 0.0 2.6 18.2 9.3 2.0 1.2 0.0 0.0 2.0 0.0 2.7 1.5 0.5 15.9 0.0 34.0 0.4 0.3 3.3 1.7 2.2 0.6 0.0 0.0 0.3 20.3 1.5 0.3 0.0 1.0 0.0 0.2 1.0 0.0 0.6 0.2 3.4 4.1 0.0 18.1 12.8 0.1 0.9 0.2 0.0 1.1 7.1 12.7 0.7 5.4 0.3 97.0 0.4 0.3 0.4 9.9 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129967-161274061 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 54.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 407.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.5;HEL: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: AB_2682101, HPA060525: AB_2684306" "unprognostic (5.69e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 4.7 2.1 17.9 1.8 30.6 5.3 4.5 25.2 25.5 7.1 6.9 5.1 1.2 7.8 2.2 3.7 6.1 4.3 2.4 17.2 22.9 3.4 0.8 6.8 0.9 41.9 28.6 16.3 7.5 2.1 0.3 11.5 8.8 35.4 3.7 2.2 2.2 2.7 2.4 1.0 2.1 2.6 4.7 31.8 4.6 2.4 2.8 27.2 1.3 4.1 1.0 1.0 3.1 5.1 54.4 0.5 1.0 25.5 5.1 4.7 9.5 1.1 0.9 0.3 1.9 3.2 1.5 4.6 0.7 1.8 4.2 11.8 0.5 4.8 4.0 1.8 2.9 8.1 19.4 4.9 0.1 3.7 0.2 2.8 11.4 1.9 5.0 2.7 9.1 6.1 3.1 9.8 8.9 2.4 0.0 1.4 2.2 6.2 0.0 9.7 0.0 1.1 0.5 5.6 0.4 14.8 5.6 4.0 2.1 1.1 9.9 1.1 1.2 6.8 2.6 3.3 1.8 4.4 0.7 1.0 0.0 9.9 1.0 1.6 0.0 1.8 0.0 3.4 1.5 1.1 0.2 1.6 2.1 1.0 0.5 0.8 1.2 0.3 2.9 1.3 0.8 1.7 1.3 17.9 30.6 25.2 25.5 17.2 22.9 41.9 28.6 16.3 35.4 31.8 27.2 54.4 12.0 3.2 5.5 7.5 4.5 3.2 5.5 9.7 6.2 2.4 3.5 2.7 5.6 5.7 6.9 5.5 0.0 20.3 31.1 6.1 0.0 5.2 52.1 23.8 12.5 13.5 1.8 31.5 87.9 8.2 12.0 17.8 4.6 5.1 11.4 20.6 10.4 0.2 18.2 0.0 95.8 0.7 10.2 7.2 16.4 72.8 5.9 17.0 3.6 23.4 9.4 4.0 9.2 56.3 407.6 5.5 18.7 8.6 15.7 1.3 0.0 0.6 21.4 1.2 19.7 5.3 6.9 4.9 2.8 1.1 2.6 22.2 14.1 3.7 1.4 3.6 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.9;lymphoid tissue: 62.5;stomach 1: 34.5" "Cell type enhanced" "Detected in many" "dendritic cells: 58.3;monocytes: 120.2;NK-cells: 76.2;Plasma cells: 240.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "U-266/70: 283.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles NA NA 1200000 Vesicles "CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 2.3 3.0 0.2 34.9 0.2 9.7 11.4 0.2 0.6 3.5 0.9 32.9 32.5 2.2 1.7 5.9 2.1 8.8 1.7 0.2 0.3 1.4 8.0 14.7 51.2 0.4 0.4 0.1 2.4 1.1 0.4 0.3 1.4 0.6 2.6 28.9 0.0 13.8 2.5 0.5 1.7 25.7 3.8 0.4 42.6 34.5 1.4 0.4 14.8 1.6 0.3 62.5 22.4 2.1 0.6 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 1.0 0.8 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.2 0.0 7.6 0.0 2.5 0.7 0.0 0.2 0.0 7.2 0.0 0.0 0.1 0.0 0.2 1.4 0.0 0.1 0.1 10.0 0.0 0.8 0.0 0.1 0.0 0.0 59.5 0.0 0.0 0.1 0.2 0.0 3.8 0.0 0.2 283.7 26.4 0.2 7.9 0.2 0.0 0.2 5.1 1.4 100.5 34.8 77.3 11.0 10.2 69.0 23.6 2.3 3.0 40.1 3.5 55.5 53.1 89.7 0.0 33.6 0.2 0.2 0.2 0.6 0.2 0.3 0.4 0.4 0.1 0.6 0.4 0.4 0.6 0.4 9.6 6.0 0.0 37.4 0.8 1.6 0.3 0.0 0.0 0.2 0.6 1.3 1.5 1.0 0.0 0.0 0.1 58.3 0.2 0.0 0.7 0.0 0.2 0.2 1.4 0.0 3.6 0.0 2.7 0.1 1.7 1.5 0.4 8.8 0.0 0.7 0.6 8.4 0.0 0.0 0.0 0.0 7.3 9.2 0.1 0.0 28.2 19.6 1.0 120.2 0.0 76.2 0.0 0.0 8.6 0.0 0.0 240.9 2.5 0.0 0.2 1.7 0.0 0.0 4.8 1.3 0.0 0.1 0.7 0.4 0.3 37.1 0.0 0.4 3.7 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415208 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 59.1;NK-cells: 73.2;Plasma cells: 47.6;T-cells: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA012565 Approved Uncertain Vesicles NA NA Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavorable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favorable (4.81e-4)" 19.4 20.9 10.4 45.2 11.6 29.9 20.3 10.4 11.6 20.8 11.1 25.0 28.7 28.3 16.1 12.0 22.7 30.8 11.5 10.0 12.6 12.7 19.1 41.8 63.9 14.4 11.6 8.5 35.4 13.2 13.2 13.8 19.3 13.1 16.6 29.1 3.6 24.1 13.6 13.0 25.1 35.4 21.4 11.2 84.7 31.5 5.1 12.8 33.4 11.6 14.6 53.1 20.2 17.6 15.1 7.4 6.2 9.3 9.5 25.9 27.5 1.2 6.2 24.1 13.5 39.4 0.3 16.7 19.7 20.4 11.2 20.9 5.1 3.0 9.7 8.2 19.5 6.4 10.4 8.5 4.7 11.8 9.5 9.3 15.0 5.6 11.8 5.4 20.4 19.3 31.0 2.5 25.3 5.5 0.6 17.6 6.6 1.0 3.3 2.1 24.2 4.0 45.2 8.3 9.4 4.9 9.8 3.4 7.1 13.5 1.4 6.5 4.0 4.8 10.3 2.6 3.1 5.9 41.8 45.9 7.3 15.6 21.4 8.4 53.8 11.1 28.8 44.7 11.7 40.4 18.8 27.8 42.3 9.1 10.5 24.1 32.0 23.9 40.5 12.9 4.3 36.0 28.0 10.4 11.6 10.4 11.6 10.0 12.6 14.4 11.6 8.5 13.1 11.2 12.8 15.1 24.8 16.0 6.5 0.0 27.1 4.2 3.9 3.5 2.2 4.3 8.6 8.1 4.2 11.5 8.5 5.5 0.0 5.5 59.1 8.2 0.0 7.4 0.1 5.5 10.4 18.0 4.8 13.3 0.0 3.2 4.3 9.9 9.2 10.3 25.9 14.0 11.7 3.9 7.2 0.0 0.0 17.3 2.0 19.2 6.1 0.8 3.7 15.4 1.8 0.0 13.7 1.9 73.2 0.0 0.0 2.2 6.3 2.6 47.6 5.4 15.9 1.3 6.7 0.4 0.0 6.7 5.5 0.0 0.1 3.6 3.3 1.5 50.1 8.4 7.4 5.0 MIPEP MIP ENSG00000027001 "Mitochondrial intermediate peptidase" Q99797 13 23730189-23889400 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 108.0;Oligodendrocytes: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030676, HPA031669, HPA031670" Approved Enhanced Mitochondria NA NA Mitochondria "HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198" "unprognostic (2.05e-1)" "unprognostic (3.17e-2)" "unprognostic (3.75e-3)" "unprognostic (3.72e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-2)" "unprognostic (1.12e-1)" "unprognostic (7.54e-2)" "unprognostic (4.76e-1)" "prognostic favorable (7.66e-12)" "unprognostic (1.62e-2)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (6.90e-3)" 6.4 9.6 4.7 6.2 4.1 5.4 11.2 3.5 4.8 7.6 11.2 13.0 8.9 7.2 12.5 11.6 17.5 7.8 18.6 14.2 4.3 25.7 12.1 7.1 5.2 3.8 3.9 3.2 5.5 8.2 14.7 5.4 4.7 4.1 11.0 13.3 6.1 9.8 8.8 14.0 21.6 7.6 7.9 4.0 4.3 8.7 9.9 3.4 6.1 11.2 17.0 7.9 7.8 6.5 4.6 14.6 16.1 7.8 18.4 17.4 23.4 16.6 10.3 16.0 15.1 12.7 21.7 28.1 17.0 10.2 8.4 13.3 35.8 18.1 21.6 18.8 9.9 11.5 7.4 7.0 18.8 14.3 17.5 3.9 11.6 26.4 15.7 13.9 12.7 19.2 12.7 14.5 2.7 24.0 10.8 12.6 9.8 10.8 64.8 16.1 13.8 21.0 14.8 33.7 9.6 18.2 6.1 11.0 17.8 21.8 9.8 18.3 9.7 10.7 9.2 7.6 15.3 11.2 2.6 4.0 9.1 15.9 8.8 11.7 0.0 3.0 1.3 7.4 3.7 9.3 8.7 7.1 6.8 6.5 7.2 6.7 6.7 0.0 10.3 12.0 5.5 5.2 4.0 4.7 4.1 3.5 4.8 14.2 4.3 3.8 3.9 3.2 4.1 4.0 3.4 4.6 2.5 16.0 8.6 18.9 5.9 39.9 7.7 13.8 6.2 3.6 6.2 5.8 108.0 11.5 12.6 9.2 6.2 9.8 2.4 8.2 29.4 23.4 8.2 26.0 8.5 5.4 6.0 4.6 43.8 10.6 9.3 8.0 7.1 8.5 2.5 4.2 3.6 5.9 9.7 15.2 47.5 7.1 14.2 3.5 5.0 7.4 6.8 4.3 5.4 12.2 3.4 5.5 5.2 18.1 62.8 8.6 7.0 8.6 4.9 7.5 6.6 25.6 46.3 11.4 0.0 7.3 5.7 9.7 19.0 10.1 42.3 5.1 4.0 8.9 13.6 5.6 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8" "Group enriched" "Detected in all" 14 "NK-cells: 117.1;T-cells: 137.0" "Cell line enhanced" "Detected in many" "BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0" "Group enriched" "Detected in all" 6 "basal ganglia: 28.0;thalamus: 17.9" "Low region specificity" "Detected in all" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: AB_2682237" "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 24.8 7.9 23.8 22.1 29.2 24.4 22.1 11.9 14.4 20.8 13.1 9.0 9.6 14.6 11.0 30.2 13.7 19.9 18.7 12.2 20.5 11.5 10.3 35.6 55.6 18.2 20.7 6.6 5.9 8.5 14.3 15.2 32.8 20.6 15.9 8.9 3.1 28.5 11.5 14.3 23.6 16.7 18.3 16.1 38.9 9.7 7.5 33.1 66.4 21.3 18.3 38.8 25.5 21.9 21.2 18.1 6.3 0.8 4.9 2.8 0.6 81.8 0.3 1.5 0.8 0.8 1.9 10.5 0.3 12.4 0.1 1.6 12.3 0.6 13.5 1.4 2.2 7.9 0.1 2.0 0.7 1.2 0.0 2.4 2.2 13.8 0.7 9.4 1.2 108.7 35.4 0.2 0.4 6.2 32.7 75.8 0.7 1.4 12.9 8.4 6.3 3.2 0.2 0.2 46.4 3.2 5.1 2.1 16.2 10.2 14.5 15.9 1.4 72.0 2.1 14.0 2.1 0.9 1.4 0.2 0.6 3.1 1.1 3.6 0.8 3.0 2.4 116.5 1.9 91.3 2.2 88.0 137.0 9.2 1.4 106.9 105.5 5.9 117.1 1.1 3.0 79.8 84.0 23.8 29.2 11.9 14.4 12.2 20.5 18.2 20.7 6.6 20.6 16.1 33.1 21.2 59.7 6.4 11.4 2.0 6.6 18.7 16.4 8.3 15.9 0.4 15.0 9.3 9.0 10.0 15.5 0.0 0.0 27.6 128.4 0.6 3.9 6.0 32.6 10.3 2.1 70.8 11.9 18.1 1.7 6.8 21.2 5.0 7.1 20.9 1.3 15.4 68.9 2.0 6.0 0.0 3.1 2.7 2.0 14.4 6.9 6.0 1.8 15.4 16.0 267.9 8.9 7.0 229.6 4.5 1.8 5.4 4.3 6.8 26.6 14.7 4.6 1.2 9.2 0.5 0.0 4.4 5.2 0.1 2.4 18.1 26.7 48.3 130.5 1.6 1.3 26.0 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859117 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.1;kidney: 3.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.9;Cardiomyocytes: 2.3;Early spermatids: 2.8;Spermatocytes: 4.1;Spermatogonia: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 4.6;SH-SY5Y: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA025285 Uncertain NA NA "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.2 1.4 0.3 0.0 1.1 0.0 0.2 1.2 4.2 1.0 0.4 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 1.4 3.7 0.0 0.0 0.0 11.2 2.7 0.1 0.0 0.2 0.0 0.6 0.0 14.1 0.6 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 2.0 1.8 0.3 0.1 0.0 0.1 0.0 0.3 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.2 4.2 0.0 1.4 11.2 2.7 0.1 14.1 0.0 1.8 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 5.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IFNGR1 "CD119, IFNGR" ENSG00000027697 "Interferon gamma receptor 1" P15260 6 137197485-137219449 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 867.1;Club cells: 405.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025889, HPA029213, HPA063871" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138" "unprognostic (1.73e-1)" "unprognostic (8.86e-2)" "unprognostic (9.85e-3)" "unprognostic (1.71e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" "unprognostic (6.97e-2)" "unprognostic (9.86e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (5.38e-3)" 156.9 59.9 59.0 132.6 63.5 147.6 122.6 69.7 72.7 74.7 64.3 75.4 98.8 58.6 68.0 65.6 56.2 89.1 104.6 56.9 67.5 44.8 104.9 155.1 141.3 76.2 66.1 52.9 43.7 44.9 47.8 26.5 86.8 77.9 53.6 75.1 40.7 58.2 58.0 58.8 66.7 102.0 76.6 78.2 167.3 51.7 28.2 64.6 69.9 58.9 76.1 136.4 113.7 58.5 87.2 23.2 23.4 25.1 33.4 166.8 86.7 23.0 67.0 90.0 38.0 53.3 148.7 39.8 24.5 99.2 36.1 55.1 130.0 24.1 62.6 51.5 49.4 37.4 36.1 23.3 192.9 97.3 112.9 46.6 195.9 232.6 33.3 51.4 36.1 48.7 29.1 32.0 34.9 29.2 27.7 17.7 47.0 22.0 191.9 18.6 51.3 28.4 32.1 65.5 104.4 27.4 39.5 77.3 41.9 57.5 47.8 15.5 68.7 71.1 36.2 27.7 48.5 31.8 25.3 25.5 23.8 19.4 69.2 36.5 158.6 518.4 356.3 106.9 502.6 224.7 91.3 60.0 90.0 309.4 98.3 39.2 43.1 736.0 48.4 375.6 85.1 48.0 519.3 59.0 63.5 69.7 72.7 56.9 67.5 76.2 66.1 52.9 77.9 78.2 64.6 87.2 298.7 80.1 59.9 21.5 76.4 127.6 177.6 867.1 84.2 15.4 49.8 37.3 49.6 37.1 405.7 27.6 12.5 78.5 240.8 111.0 7.9 74.2 11.6 91.4 52.7 110.7 13.1 25.7 21.4 101.4 67.1 94.7 33.6 112.8 63.3 10.3 62.8 56.5 149.8 10.1 24.2 25.5 270.6 326.2 220.0 6.1 44.1 261.7 49.8 147.1 138.4 23.5 52.5 25.1 44.9 76.0 57.6 49.2 74.5 129.6 82.0 17.2 150.6 28.1 13.1 45.7 75.7 14.6 22.4 47.3 113.2 209.9 121.5 48.3 33.9 140.2 B4GALT7 "beta4Gal-T7, XGALT-1" ENSG00000027847 "Beta-1,4-galactosyltransferase 7" Q9UBV7 5 177600132-177610330 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042330 Supported NA NA "HPA042330: AB_10796576" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (3.12e-1)" "unprognostic (5.97e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.53e-2)" "unprognostic (4.19e-3)" "unprognostic (3.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (2.00e-2)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (4.44e-2)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" 18.9 44.0 19.4 15.4 18.2 25.1 17.1 18.6 25.7 17.9 18.3 14.7 17.1 20.3 12.6 16.7 16.1 12.6 22.8 18.5 19.5 20.4 30.7 13.5 20.3 22.8 20.2 19.4 20.0 37.9 24.5 31.7 14.2 21.4 22.7 12.0 5.9 24.4 19.0 20.4 13.7 14.9 11.9 16.0 21.5 22.0 24.1 19.6 10.7 18.6 10.2 11.9 18.0 14.1 18.3 20.2 34.5 14.2 35.6 28.0 20.7 63.7 30.1 31.9 26.9 30.7 32.6 30.8 25.2 54.7 30.9 47.3 22.9 9.8 64.9 11.7 85.4 25.8 13.3 27.5 23.4 40.0 13.8 22.4 31.8 22.7 29.0 23.5 24.7 30.3 16.9 11.8 23.7 27.4 46.0 11.9 17.1 13.9 17.7 50.0 24.1 10.3 27.8 20.6 29.6 12.5 14.4 15.0 29.8 27.6 11.3 19.4 16.3 23.5 34.0 19.5 22.6 30.6 29.5 14.9 18.4 28.8 33.0 31.8 16.8 16.7 9.7 14.0 19.7 12.6 14.4 12.8 12.2 19.3 18.4 11.4 11.3 1.3 11.1 19.4 15.2 9.2 10.9 19.4 18.2 18.6 25.7 18.5 19.5 22.8 20.2 19.4 21.4 16.0 19.6 18.3 16.3 3.2 5.6 5.2 24.5 6.6 15.4 27.8 15.9 12.1 16.5 19.3 6.9 12.8 15.8 16.5 4.2 43.8 16.4 13.8 7.9 34.1 13.9 12.5 17.8 15.6 14.5 8.2 4.3 38.9 132.4 21.2 8.2 13.5 10.2 30.0 10.8 15.9 31.7 11.8 6.0 22.2 8.2 17.8 8.9 9.8 14.0 18.8 21.4 3.7 25.6 13.7 13.4 3.0 3.4 34.0 12.4 18.4 52.8 30.7 17.4 19.6 9.3 16.1 0.0 13.9 16.4 14.3 11.3 13.9 8.8 43.9 12.8 33.4 23.3 16.3 SH2D2A "F2771, TSAd" ENSG00000027869 "SH2 domain containing 2A" Q9NP31 1 156806243-156816848 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.9;dendritic cells: 139.5;NK-cells: 113.3;T-cells: 103.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 30 "NK-cells: 28.5;T-cells: 66.5" "Cell line enhanced" "Detected in many" "HDLM-2: 46.5;HMC-1: 33.3;Karpas-707: 81.0;RPMI-8226: 24.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.5;hippocampal formation: 1.6" HPA074482 Enhanced NA NA "HPA074482: " "prognostic favorable (4.96e-4)" "unprognostic (2.76e-2)" "unprognostic (7.50e-2)" "unprognostic (3.03e-3)" "unprognostic (1.14e-3)" "unprognostic (2.73e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (3.08e-1)" "unprognostic (1.64e-1)" "unprognostic (9.34e-3)" "unprognostic (1.70e-1)" "prognostic unfavorable (5.26e-12)" "unprognostic (1.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.79e-1)" "prognostic favorable (1.31e-4)" 2.2 0.9 1.2 11.5 1.2 4.3 1.4 3.9 1.6 1.4 2.0 2.1 2.5 1.7 0.3 1.2 1.5 3.3 2.4 1.0 1.4 1.7 2.2 5.5 9.5 2.0 1.8 0.8 0.6 1.0 0.3 1.8 0.8 1.6 2.5 2.1 3.4 0.9 0.7 0.4 0.4 5.4 1.6 1.3 13.2 2.9 0.3 1.2 15.0 1.6 0.0 5.9 3.7 1.2 1.6 2.6 0.4 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 1.7 2.4 0.0 6.8 0.0 0.0 0.0 0.4 1.3 0.1 46.5 0.1 6.8 0.5 0.9 0.2 0.4 33.3 0.5 0.0 0.2 3.3 0.0 0.3 11.8 1.9 81.0 0.0 0.2 5.9 0.7 4.9 4.1 8.3 0.9 0.0 24.5 0.1 0.3 7.5 0.0 1.6 0.9 0.8 0.5 0.2 1.3 2.2 0.0 0.0 0.3 0.5 11.6 16.6 8.3 0.0 6.9 0.2 1.0 0.1 0.0 66.5 0.0 61.8 1.1 27.6 40.8 0.1 0.3 10.4 27.2 1.5 28.5 0.2 0.1 34.1 18.6 1.2 1.2 3.9 1.6 1.0 1.4 2.0 1.8 0.8 1.6 1.3 1.2 1.6 1.2 3.2 2.3 0.0 4.6 2.2 0.3 0.4 1.2 33.9 1.0 1.9 0.9 0.0 1.3 0.0 0.0 0.1 139.5 1.2 0.0 0.3 0.2 0.2 2.5 0.6 1.2 6.1 0.0 0.6 1.0 4.8 9.2 0.5 8.2 0.3 1.8 0.9 1.1 0.0 0.0 0.9 0.0 1.9 2.1 0.0 0.0 4.1 0.0 1.9 1.1 1.3 113.3 0.0 0.5 6.1 1.4 0.0 24.2 0.5 0.3 0.2 0.7 1.6 0.0 0.5 2.9 0.1 4.9 3.0 1.3 0.1 103.2 0.1 1.8 0.5 VRK2 ENSG00000028116 "VRK serine/threonine kinase 2" Q86Y07 2 57907629-58159920 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "Oligodendrocytes: 540.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046459, HPA047503" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB046459: AB_1858773, HPA047503: AB_2680071" "unprognostic (1.87e-1)" "unprognostic (5.84e-2)" "unprognostic (4.65e-2)" "unprognostic (1.33e-3)" "unprognostic (1.27e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (3.90e-2)" "unprognostic (4.76e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (3.48e-1)" "unprognostic (1.62e-1)" "unprognostic (2.99e-1)" "unprognostic (3.56e-1)" 14.9 13.3 15.1 20.4 23.7 19.0 17.4 14.8 15.1 10.9 8.7 14.1 11.0 15.5 16.9 19.7 13.5 12.0 15.7 11.5 15.3 10.8 16.9 16.1 22.6 20.4 20.3 7.1 10.8 19.9 14.8 7.7 14.7 25.1 14.4 16.6 4.9 14.0 11.5 14.4 13.4 11.1 19.6 16.1 18.1 13.8 13.4 18.4 12.9 18.8 15.3 26.2 14.8 12.7 40.9 37.1 24.3 2.7 16.3 16.7 30.6 48.4 32.8 33.3 22.7 22.9 49.8 38.5 44.3 43.0 29.8 37.1 27.4 34.9 36.7 33.7 80.9 23.1 50.9 19.0 35.8 27.8 44.1 29.0 17.7 42.6 36.3 52.8 26.1 64.9 6.2 50.2 28.5 38.2 21.2 0.3 32.9 29.9 56.9 11.6 49.4 12.0 30.6 36.8 30.2 9.4 0.3 52.5 31.2 27.5 26.2 22.0 26.1 37.0 0.5 74.4 20.6 0.6 40.5 33.9 24.0 18.2 52.7 38.4 31.0 24.5 35.3 15.1 32.2 18.4 30.6 14.2 17.7 25.5 31.7 10.6 13.6 9.0 18.7 34.3 26.4 18.5 15.4 15.1 23.7 14.8 15.1 11.5 15.3 20.4 20.3 7.1 25.1 16.1 18.4 40.9 17.9 22.4 11.2 1.3 26.4 9.8 12.6 21.8 14.8 1.0 14.0 10.2 21.8 7.2 22.4 18.4 0.0 21.2 13.7 6.5 15.6 27.1 23.0 12.7 10.9 15.8 6.6 39.1 2.7 26.2 21.1 14.0 16.3 12.7 17.7 9.6 8.9 8.4 18.4 0.0 4.7 5.1 30.5 19.1 19.1 8.4 5.9 26.2 10.6 54.4 41.7 5.3 16.5 32.2 540.8 24.8 8.7 6.0 25.7 18.4 2.5 9.5 30.7 4.0 6.6 7.4 14.3 22.0 10.9 19.2 8.4 19.4 16.5 6.8 7.9 16.4 TNFRSF1B "CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80" ENSG00000028137 "TNF receptor superfamily member 1B" P20333 1 12166991-12209228 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.0" "Cell type enhanced" "Detected in many" "dendritic cells: 268.7;Kupffer cells: 200.5;Langerhans cells: 288.0;Macrophages: 230.2;monocytes: 175.3;T-cells: 138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 387.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.0;K-562: 45.7;THP-1: 51.8;U-87 MG: 30.8;U-937: 37.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004796 Approved "Secreted to blood" NA NA 3230000 8100000 "HPA004796: AB_1078436" "unprognostic (4.45e-2)" "unprognostic (2.27e-3)" "unprognostic (7.62e-2)" "unprognostic (3.82e-3)" "unprognostic (6.30e-2)" "unprognostic (4.47e-3)" "unprognostic (5.28e-3)" "unprognostic (2.79e-1)" "unprognostic (1.69e-2)" "unprognostic (1.73e-2)" "unprognostic (7.26e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.26e-2)" "unprognostic (1.10e-1)" 43.1 5.5 3.9 69.0 4.9 52.6 35.0 4.8 15.3 12.9 8.6 13.0 17.0 11.7 0.4 5.5 14.7 15.7 10.9 3.2 13.9 6.2 15.9 32.3 32.3 18.3 5.4 1.5 6.4 5.9 2.4 4.6 36.1 9.1 6.4 10.9 0.8 6.6 2.6 10.8 7.0 24.1 17.0 8.0 53.8 16.5 2.3 10.3 12.8 7.6 6.3 21.4 29.1 8.9 12.6 0.0 0.3 4.1 0.0 9.6 13.5 8.9 1.1 2.0 4.0 4.3 1.8 34.0 0.2 0.6 3.9 5.6 0.0 0.8 0.0 2.2 14.5 0.0 0.0 0.2 0.0 25.2 0.3 3.8 14.8 0.0 13.0 0.0 7.2 19.6 0.2 45.7 6.4 1.5 0.0 0.0 8.1 0.2 4.9 1.4 1.2 0.4 25.9 0.0 0.8 0.0 0.1 0.6 0.4 1.4 6.4 0.0 51.8 7.8 5.3 0.2 27.0 0.0 1.9 0.0 0.0 30.8 37.0 1.4 0.6 127.1 18.2 48.4 260.5 26.5 13.5 34.4 40.5 71.7 8.4 9.8 15.5 138.0 13.4 387.1 15.1 70.9 150.4 3.9 4.9 4.8 15.3 3.2 13.9 18.3 5.4 1.5 9.1 8.0 10.3 12.6 99.4 9.6 15.9 0.7 42.8 16.8 3.9 1.0 1.2 0.2 3.2 4.1 3.6 5.7 6.5 3.7 0.0 0.9 268.7 12.8 0.0 0.5 0.6 1.7 5.1 46.0 0.0 7.4 0.2 0.6 6.3 13.2 12.8 4.9 2.5 1.4 31.1 17.0 72.6 0.0 0.2 3.0 0.0 200.5 288.0 1.2 2.1 230.2 16.0 30.9 175.3 0.3 109.2 0.0 0.1 0.7 4.2 0.4 72.5 8.0 25.8 0.4 1.5 1.2 32.9 6.8 9.8 0.0 0.9 0.7 10.5 30.1 138.4 1.9 4.8 8.8 VEZT DKFZP761C241 ENSG00000028203 "Vezatin, adherens junctions transmembrane protein" Q9HBM0 12 95217746-95302799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004811, HPA017066" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004811: AB_1080563, HPA017066: AB_1858742" "unprognostic (3.91e-1)" "unprognostic (6.34e-3)" "unprognostic (3.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.28e-1)" "unprognostic (9.93e-2)" "unprognostic (4.18e-1)" "unprognostic (1.10e-3)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.93e-5)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.51e-1)" "unprognostic (4.06e-1)" "unprognostic (5.02e-2)" 7.3 10.0 7.8 5.8 9.5 3.4 9.0 12.7 9.9 8.1 5.3 6.9 5.9 8.3 9.6 6.6 7.8 7.5 9.6 9.3 8.7 6.9 6.2 7.9 6.5 6.8 7.1 9.2 11.3 9.1 8.7 13.5 9.5 7.5 9.7 6.4 20.5 5.4 7.7 24.0 10.3 5.9 7.1 4.6 4.2 5.6 4.5 7.2 6.7 19.1 21.4 6.5 7.6 8.5 9.6 14.4 12.9 18.0 9.5 14.7 9.2 6.8 10.3 13.3 8.7 12.9 4.8 6.6 18.6 6.5 8.8 4.3 7.4 13.3 9.2 15.2 12.6 7.3 7.2 3.3 5.2 7.5 14.2 4.1 12.7 15.6 7.6 21.9 19.0 17.1 8.9 4.2 7.0 7.6 4.0 12.4 6.7 9.2 4.5 13.1 11.1 8.4 6.0 23.8 10.3 12.1 10.6 10.1 14.9 4.9 15.8 18.4 2.4 13.9 7.2 2.8 3.5 5.8 6.8 11.4 16.3 2.8 5.1 3.8 0.2 1.5 0.5 1.5 1.6 2.1 2.5 2.2 0.9 2.0 1.8 1.0 0.9 0.1 1.1 0.4 0.8 1.8 0.5 7.8 9.5 12.7 9.9 9.3 8.7 6.8 7.1 9.2 7.5 4.6 7.2 9.6 36.5 70.5 49.3 88.8 31.1 77.8 58.1 37.5 63.2 67.9 46.3 28.6 49.0 37.1 44.5 33.1 85.5 39.6 26.3 40.0 9.8 50.1 16.5 30.1 48.4 44.6 38.4 22.1 151.8 45.2 22.3 31.0 27.5 53.8 29.2 59.9 47.8 36.7 21.6 62.2 149.1 36.1 30.5 27.1 37.5 11.4 32.6 23.2 37.4 74.9 25.2 24.1 14.4 101.0 98.4 76.4 39.4 33.1 40.5 54.6 33.0 21.5 33.1 146.6 6.6 39.0 37.3 39.4 21.3 57.8 72.5 110.7 29.1 32.7 24.9 71.7 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.5" "Cell type enhanced" "Detected in many" "B-cells: 225.5;Kupffer cells: 119.6;Langerhans cells: 104.4;Macrophages: 105.0;monocytes: 137.6;Plasma cells: 96.7;Spermatocytes: 75.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 94.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.3;Daudi: 113.0;hTEC/SVTERT24-B: 42.7;U-266/70: 75.5;U-266/84: 80.2;U-698: 88.4;U-87 MG: 41.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404, HPA073998" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 2.6 2.8 6.4 28.3 6.9 8.5 1.8 14.5 10.7 1.0 4.6 4.0 3.2 1.2 1.5 2.0 1.6 3.5 0.8 5.8 13.6 1.3 2.0 3.8 52.5 8.0 7.6 5.1 0.8 1.7 0.3 2.0 3.8 10.6 3.1 3.1 2.0 2.7 3.2 1.1 1.4 14.1 2.9 8.2 27.7 5.1 9.2 10.9 6.6 1.5 0.5 48.7 7.2 1.2 17.0 0.9 1.5 1.8 0.1 0.0 2.9 0.5 8.2 52.3 5.1 10.0 0.5 1.4 113.0 2.8 2.9 0.9 1.0 0.6 8.6 23.2 0.3 0.5 2.7 0.3 0.1 0.6 1.1 2.2 2.2 1.6 42.7 2.8 0.4 3.2 2.4 1.3 25.4 1.1 0.8 0.3 6.1 0.4 0.2 0.6 1.3 0.2 0.4 0.2 0.5 1.8 0.8 0.4 0.7 0.8 0.7 0.1 14.1 3.9 22.0 2.3 0.2 1.1 75.5 80.2 88.4 41.3 2.8 3.1 2.6 28.3 0.5 3.1 51.5 2.7 29.3 4.4 4.0 20.9 33.0 2.3 3.3 4.3 1.7 94.9 3.4 7.2 14.4 6.4 6.9 14.5 10.7 5.8 13.6 8.0 7.6 5.1 10.6 8.2 10.9 17.0 2.7 0.0 7.0 0.7 225.5 7.8 8.3 14.1 4.6 63.5 7.2 7.6 3.7 2.8 3.2 0.0 6.2 0.9 29.3 2.8 0.0 1.4 15.2 4.0 1.1 7.3 9.5 10.7 19.7 2.8 0.8 2.7 1.5 8.5 6.3 0.5 4.2 1.1 49.5 1.7 10.0 1.6 4.1 119.6 104.4 9.8 0.9 105.0 8.8 32.8 137.6 1.9 37.0 4.5 1.0 3.5 0.1 0.4 96.7 3.8 2.8 0.4 2.4 6.6 0.0 1.7 5.0 75.1 28.8 13.3 8.8 3.7 31.7 0.6 1.0 5.0 BRD9 FLJ13441 ENSG00000028310 "Bromodomain containing 9" Q9H8M2 5 850291-892801 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 110.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021465, HPA023197" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021465: AB_1845441, HPA023197: AB_2671106" "unprognostic (3.10e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-3)" "unprognostic (4.61e-2)" "unprognostic (5.89e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (5.88e-7)" "unprognostic (6.28e-2)" "unprognostic (7.53e-3)" "unprognostic (3.84e-2)" "unprognostic (8.82e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.37e-6)" "unprognostic (6.64e-2)" "unprognostic (1.07e-1)" "unprognostic (6.62e-3)" "unprognostic (1.02e-2)" 7.8 7.5 14.8 9.2 14.2 8.1 8.5 13.5 15.6 7.0 12.8 7.4 6.8 8.6 7.3 6.6 7.5 6.0 10.6 13.7 13.7 5.8 5.6 7.9 10.1 14.7 14.8 12.7 8.9 8.8 9.1 4.6 6.9 14.5 6.7 7.1 3.6 8.9 8.3 17.1 6.9 7.7 8.0 14.1 8.0 8.0 7.6 15.6 13.3 8.1 10.0 8.5 8.7 6.0 15.3 14.4 14.2 27.5 28.6 11.7 23.7 32.5 28.2 19.4 29.7 23.5 26.6 19.5 17.9 46.0 30.4 33.3 14.1 20.4 27.7 27.5 110.2 17.0 22.2 37.0 17.9 23.7 34.0 20.3 17.7 9.9 20.8 19.0 22.1 29.6 34.2 29.5 12.8 25.4 22.9 40.0 32.1 18.5 15.0 22.4 26.9 16.4 16.5 17.2 21.5 16.8 29.7 56.3 19.1 13.4 14.9 17.1 43.1 28.7 24.2 18.8 12.4 29.3 23.3 10.0 32.5 22.7 35.5 32.3 7.0 3.3 3.7 3.0 1.5 4.0 4.9 4.2 4.5 3.0 6.0 3.8 3.2 2.0 4.2 2.9 3.1 5.2 1.4 14.8 14.2 13.5 15.6 13.7 13.7 14.7 14.8 12.7 14.5 14.1 15.6 15.3 36.8 19.2 14.4 13.1 32.1 25.4 18.2 12.5 39.3 70.2 23.5 21.7 25.2 25.8 13.8 23.9 45.9 17.1 39.5 33.9 23.5 23.4 93.5 46.7 80.7 25.0 16.3 21.0 9.3 20.0 30.3 24.0 42.8 52.7 19.0 40.9 27.8 22.2 21.0 101.0 8.2 33.9 4.1 25.4 14.9 56.8 22.7 25.3 14.2 6.5 31.3 29.1 42.2 9.0 11.8 31.1 27.4 19.5 44.8 20.6 21.3 18.7 7.7 87.8 26.3 28.5 25.0 49.2 68.2 32.0 20.3 19.7 47.8 27.1 27.6 16.5 SNX1 "HsT17379, MGC8664, SNX1A, Vps5" ENSG00000028528 "Sorting nexin 1" Q13596 15 64094123-64146090 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA047373, HPA052761" Approved Enhanced Endosomes,Lysosomes NA NA 6100000 "Endosomes, Lysosomes" "HPA047373: AB_2680018, HPA052761: AB_2681939" "unprognostic (3.99e-2)" "unprognostic (8.65e-3)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (7.13e-2)" "unprognostic (2.73e-1)" "unprognostic (7.15e-2)" "unprognostic (6.49e-3)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.47e-2)" "unprognostic (3.26e-1)" "prognostic favorable (9.88e-6)" "unprognostic (2.27e-1)" "unprognostic (3.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.95e-1)" 64.0 69.6 49.5 59.6 62.6 35.1 46.6 61.3 49.7 53.3 47.0 60.8 50.2 48.1 68.3 61.1 37.8 43.3 50.9 46.3 54.3 57.4 69.9 55.2 67.6 66.8 65.5 41.8 39.3 44.7 72.7 32.3 58.3 65.0 52.3 48.0 27.2 55.8 65.0 69.7 48.6 52.8 53.5 67.6 61.6 55.3 34.5 57.6 80.2 103.8 37.1 67.4 62.7 51.6 78.5 75.4 93.5 69.1 60.8 116.4 81.3 23.0 93.5 91.5 81.4 94.5 64.6 115.6 74.4 100.5 86.7 79.7 113.8 102.6 95.2 63.5 136.1 56.0 101.2 110.4 98.2 63.6 94.7 108.0 102.9 62.6 65.2 50.2 59.7 86.1 77.0 74.0 29.2 85.1 107.8 111.4 80.2 54.5 103.2 52.1 100.0 65.3 118.1 127.1 170.5 56.3 56.4 91.4 61.1 86.3 59.5 87.0 86.6 103.0 80.1 120.2 50.8 52.5 93.4 220.5 120.1 72.9 123.5 85.8 144.1 149.1 162.1 83.4 143.1 70.9 101.1 70.4 82.2 127.3 101.9 67.0 66.6 113.7 98.1 144.2 86.1 95.8 156.0 49.5 62.6 61.3 49.7 46.3 54.3 66.8 65.5 41.8 65.0 67.6 57.6 78.5 34.4 115.4 74.2 35.6 32.9 26.5 38.1 39.3 29.0 18.9 29.7 29.2 50.6 34.3 52.8 18.4 22.9 51.5 51.6 32.1 33.2 40.9 3.7 36.4 36.7 34.2 26.5 26.5 44.2 37.2 35.1 36.2 27.5 44.9 39.2 44.9 35.3 34.2 72.2 15.2 39.3 28.3 28.5 46.8 27.4 4.0 32.3 42.7 32.0 44.0 56.3 19.7 35.0 121.7 177.7 34.6 30.3 37.6 34.0 32.7 39.2 53.6 31.9 16.5 46.0 36.0 64.0 33.3 23.4 33.8 27.1 47.7 35.0 39.3 28.8 33.9 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 127.8" "Group enriched" "Detected in all" 5 "Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 11.2 11.8 15.3 12.2 20.2 37.9 10.6 20.2 21.0 10.5 13.6 11.8 13.4 12.4 8.2 11.8 13.2 11.9 12.0 19.7 18.6 8.7 13.9 9.8 21.5 14.9 14.2 16.4 12.7 8.2 10.5 11.8 15.0 16.5 12.3 14.4 15.2 9.2 12.4 6.5 8.9 13.0 11.2 12.6 12.7 11.8 127.8 18.6 20.0 16.9 9.3 17.0 15.2 9.9 19.6 16.5 19.6 43.9 28.5 32.6 33.3 24.5 29.9 31.5 39.1 51.1 23.0 13.0 49.8 20.2 24.1 43.8 21.2 28.0 32.3 46.8 38.3 35.9 87.8 11.5 25.5 33.0 46.4 32.8 20.8 32.2 43.8 47.1 30.7 37.6 43.3 129.3 33.4 28.1 37.0 39.2 27.8 49.2 23.6 25.1 26.7 26.4 19.5 23.2 14.3 56.5 56.2 17.7 23.2 37.8 36.9 10.5 18.5 34.4 22.5 32.4 50.0 33.6 27.2 31.5 32.8 37.7 30.0 27.4 133.1 31.7 81.8 62.7 33.3 69.8 67.6 53.1 67.1 29.8 60.2 50.6 59.5 74.8 52.5 38.3 35.4 60.5 64.0 15.3 20.2 20.2 21.0 19.7 18.6 14.9 14.2 16.4 16.5 12.6 18.6 19.6 35.6 6.4 12.2 10.7 43.2 70.7 27.0 46.7 46.1 22.8 29.8 34.2 12.8 28.6 21.1 7.3 18.8 40.7 59.1 16.8 29.4 29.1 407.5 20.6 17.1 40.8 71.0 51.4 35.3 25.2 69.7 30.8 36.7 14.8 40.0 13.5 22.9 11.2 24.4 15.2 25.2 26.5 48.8 14.8 43.2 75.1 21.1 38.3 32.0 22.5 21.3 23.3 42.2 27.2 27.7 31.4 24.2 18.4 35.2 39.7 17.9 28.4 28.2 12.3 19.7 27.3 35.1 557.4 72.8 36.7 65.8 244.9 50.0 11.0 24.3 37.6 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.4;lymphoid tissue: 22.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 121.9;U-2197: 159.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.0 1.1 1.5 10.1 5.7 2.3 2.1 0.1 3.9 3.0 0.0 2.0 2.8 1.2 0.2 28.4 0.9 3.6 0.9 2.9 1.4 0.7 4.8 2.3 5.2 1.5 0.8 3.7 0.2 1.3 1.5 0.8 2.8 0.9 1.1 3.2 0.4 7.3 0.6 0.2 7.7 2.7 4.6 0.0 1.0 11.0 2.8 1.0 4.5 0.6 0.8 22.4 14.8 12.0 3.7 76.0 19.2 4.2 1.6 3.6 11.0 58.3 26.3 34.5 16.8 26.2 18.2 57.4 0.6 14.4 12.6 51.9 30.6 12.3 92.1 42.7 121.9 15.7 14.6 11.7 15.2 4.8 29.6 6.1 4.0 8.1 58.8 45.6 28.9 80.0 17.7 7.5 29.8 19.6 9.2 16.2 16.2 32.1 25.7 65.8 29.8 68.2 4.7 14.1 42.8 13.6 2.2 13.5 2.1 0.4 10.0 2.9 9.7 54.6 54.2 31.4 159.5 110.0 4.4 8.4 0.1 46.5 23.5 10.9 1.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 1.5 5.7 0.1 3.9 2.9 1.4 1.5 0.8 3.7 0.9 0.0 1.0 3.7 2.1 3.2 1.3 1.3 0.4 0.8 45.6 8.6 1.2 0.9 1.6 0.8 0.9 11.5 7.5 9.2 0.0 1.9 0.3 1.5 0.0 22.1 3.8 7.9 0.7 6.9 1.2 3.4 78.8 27.4 4.0 3.2 28.1 11.8 0.0 5.3 2.5 3.5 1.4 0.0 24.8 3.3 2.0 2.5 5.4 4.4 0.0 2.9 1.8 7.5 15.7 0.0 0.0 8.5 2.3 86.9 1.4 0.0 3.4 109.0 1.7 0.6 2.7 0.1 0.0 1.7 3.6 3.1 4.7 6.6 2.3 4.2 1.3 0.2 2.1 128.2 BCLAF1 "BTF, KIAA0164" ENSG00000029363 "BCL2 associated transcription factor 1" Q9NYF8 6 136256627-136289851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 136.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006484, HPA006669, HPA027770" Enhanced Enhanced "Nuclear speckles" NA NA 21000 "Nuclear speckles" "HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484" "prognostic unfavorable (1.64e-4)" "unprognostic (1.60e-1)" "prognostic favorable (3.44e-4)" "unprognostic (1.45e-1)" "unprognostic (9.46e-3)" "unprognostic (2.29e-1)" "unprognostic (2.13e-3)" "unprognostic (1.63e-1)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (4.19e-3)" 24.6 22.4 14.4 27.1 18.6 136.2 33.2 24.8 17.9 21.6 19.9 29.7 18.9 23.4 24.2 24.5 21.5 14.9 16.8 16.0 21.0 21.7 27.6 24.9 28.4 12.4 13.9 14.7 24.6 25.8 33.6 18.2 21.4 13.6 21.4 28.7 35.1 21.4 20.7 27.8 20.7 21.3 28.6 15.2 25.0 28.1 21.5 16.4 35.5 30.6 24.5 33.1 23.2 19.5 19.4 82.4 70.0 162.5 136.2 50.4 42.6 82.3 153.0 94.4 100.6 106.5 100.4 54.4 172.7 92.8 117.9 112.8 78.0 183.5 101.1 125.5 95.1 114.2 213.7 96.0 110.3 58.6 362.6 131.0 58.3 49.2 142.8 88.6 37.2 90.9 77.6 193.6 82.3 107.0 97.4 145.3 40.2 120.2 55.2 72.0 130.3 203.2 76.4 76.3 155.0 137.2 94.5 150.0 71.3 60.4 60.6 66.9 71.5 125.7 79.2 116.7 95.9 151.2 69.5 134.8 227.9 47.2 113.3 94.2 32.6 27.1 42.1 32.4 33.2 32.7 36.6 29.9 28.1 42.3 32.9 37.7 34.5 57.9 49.5 35.3 24.7 25.5 24.5 14.4 18.6 24.8 17.9 16.0 21.0 12.4 13.9 14.7 13.6 15.2 16.4 19.4 165.3 205.1 178.7 68.9 174.3 68.2 118.9 99.5 104.2 129.7 86.9 71.5 88.4 65.8 131.6 57.0 210.6 111.9 173.3 86.3 33.2 96.8 12.6 157.2 173.5 117.5 118.9 134.6 80.5 65.2 99.4 138.0 128.0 169.8 156.4 130.5 74.3 60.0 74.0 102.6 82.6 106.0 93.6 92.5 88.9 13.8 122.1 121.8 69.4 56.2 136.9 91.6 118.4 63.3 93.4 77.5 81.4 109.4 197.8 128.6 83.3 42.9 147.1 139.9 111.7 259.8 130.7 102.2 129.7 121.4 71.2 128.3 174.8 154.8 101.6 123.8 SLC39A9 FLJ11274 ENSG00000029364 "Solute carrier family 39 member 9" Q9NUM3 14 69398015-69462390 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007921, HPA075390" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA007921: AB_1080007, HPA075390: AB_2686748" "unprognostic (2.37e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.20e-1)" "unprognostic (1.83e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" 15.4 21.7 19.3 12.2 19.2 10.8 24.6 19.5 24.8 18.4 22.0 20.5 21.7 14.9 25.8 23.3 15.8 14.5 12.0 19.0 20.3 30.1 43.4 15.7 12.8 18.9 20.0 18.1 13.8 28.8 26.6 22.9 17.8 18.7 19.2 21.7 12.8 34.1 15.2 8.0 17.9 19.6 15.7 20.7 16.2 22.0 8.9 19.7 18.2 22.4 11.7 17.9 15.4 15.5 22.0 55.0 46.3 26.9 28.7 46.2 34.6 25.1 31.9 40.2 30.7 34.8 35.4 49.7 49.3 23.8 39.8 14.2 45.3 30.9 30.5 37.4 31.9 17.0 28.9 23.0 24.8 36.0 20.9 38.1 30.3 50.3 27.1 40.5 30.6 30.8 38.1 22.2 44.2 32.5 33.6 33.0 26.1 20.9 47.7 31.2 32.8 37.6 30.3 40.9 56.1 28.3 46.1 32.2 55.1 22.2 20.2 76.9 37.8 30.4 50.8 36.2 22.1 24.6 48.8 27.4 36.6 47.1 25.4 42.0 11.2 10.3 9.4 7.9 9.7 8.1 6.9 6.8 7.7 11.3 4.8 6.7 7.0 8.7 6.8 9.4 5.9 5.5 6.8 19.3 19.2 19.5 24.8 19.0 20.3 18.9 20.0 18.1 18.7 20.7 19.7 22.0 13.3 19.2 12.6 37.9 13.4 12.1 8.0 19.2 17.1 8.4 27.7 14.1 7.9 18.6 18.0 16.5 6.2 14.1 7.3 42.8 5.9 15.0 16.2 16.0 16.1 17.0 29.4 15.4 31.0 25.1 17.3 14.3 22.4 17.8 12.0 13.8 22.1 67.7 15.9 10.1 30.9 30.3 14.2 24.5 8.7 22.4 13.1 13.8 7.2 24.4 16.4 9.5 12.3 30.2 37.0 28.6 22.4 12.8 18.6 18.7 34.6 15.8 24.6 11.2 6.6 12.6 12.0 13.9 9.2 18.3 12.5 17.8 9.2 14.2 25.7 20.2 ANK1 "ANK, SPH1" ENSG00000029534 "Ankyrin 1" P16157 8 41653220-41896762 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 1002.8;tongue: 634.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 9.2;dendritic cells: 3.4" "Group enriched" "Detected in many" 4 "HEL: 125.2;K-562: 134.3;RH-30: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004842, HPA056953" Supported Supported "Intracellular and membrane" NA NA 4200000 "HPA004842: AB_1844827, HPA056953: AB_2683284" "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (4.22e-3)" "unprognostic (2.31e-3)" "unprognostic (1.76e-7)" "unprognostic (2.03e-1)" "unprognostic (2.15e-1)" "unprognostic (2.52e-1)" "unprognostic (2.95e-1)" "unprognostic (3.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-1)" "unprognostic (1.40e-1)" "unprognostic (3.86e-1)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" 1.8 1.1 7.3 1.6 2.4 96.0 1.0 33.4 16.8 0.3 0.5 0.5 1.5 0.1 0.1 8.8 0.4 0.8 95.3 1.5 11.5 0.6 0.3 0.7 4.5 21.6 29.4 0.0 0.3 0.8 62.6 1.2 2.1 26.9 4.2 0.2 6.4 8.1 0.7 1002.8 0.4 0.9 0.3 8.8 2.2 4.4 0.7 7.3 0.7 0.6 634.6 4.1 1.8 0.5 30.3 0.0 16.8 0.5 0.0 0.2 2.9 0.0 4.9 32.8 1.5 0.7 0.1 0.0 7.7 1.5 3.5 0.6 2.8 0.8 0.5 0.7 3.2 0.1 125.2 0.7 0.0 0.1 0.3 0.4 4.2 0.6 0.4 0.0 0.7 0.1 0.0 134.3 2.8 2.1 0.3 0.0 1.6 1.7 0.1 0.1 0.9 160.2 0.8 0.7 0.5 2.2 1.4 0.1 2.3 0.0 5.9 2.0 3.2 0.8 0.5 0.9 27.6 0.2 0.0 0.2 4.7 2.9 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.4 9.2 0.3 0.4 0.1 7.8 0.0 0.0 0.4 0.1 0.0 3.4 1.0 0.7 7.3 2.4 33.4 16.8 1.5 11.5 21.6 29.4 0.0 26.9 8.8 7.3 30.3 5.5 0.0 0.0 1.3 8.3 0.6 1.4 2.2 0.6 15.4 0.3 0.1 164.7 0.0 1.0 0.0 87.6 1.1 0.2 0.1 1.9 0.1 7.0 0.1 0.1 4.6 1.2 250.2 12.9 0.0 0.5 2.9 5.6 0.5 0.0 2.2 0.4 0.1 19.7 3.3 176.8 0.7 2.0 0.8 3.7 6.3 0.3 2.6 0.0 3.7 0.4 1.0 0.0 7.1 2.0 1.1 1.2 0.4 5.7 1.3 0.1 0.3 0.6 5.5 0.0 51.6 5.7 0.2 1.0 0.1 0.0 0.4 1.7 0.1 0.0 1.8 IBSP "BSP, BSP-II, SP-II" ENSG00000029559 "Integrin binding sialoprotein" P21815 4 87799554-87812435 "Cancer-related genes, Predicted secreted proteins" "Biomineralization, Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;pituitary gland: 2.0" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.8" "Group enriched" "Detected in many" 4 "breast cancer: 3.8;glioma: 12.2" "Region enhanced" "Detected in some" "hypothalamus: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-138 MG: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.53e-2)" "unprognostic (3.55e-2)" "unprognostic (1.49e-2)" "unprognostic (3.93e-1)" "unprognostic (3.75e-2)" "unprognostic (9.48e-3)" "unprognostic (1.03e-3)" "unprognostic (4.07e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-11)" "unprognostic (6.20e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-3)" "unprognostic (2.11e-1)" 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.1 2.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.2 0.0 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 3.4 0.3 0.6 0.0 0.3 0.2 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TFB1M "CGI-75, mtTFB" ENSG00000029639 "Transcription factor B1, mitochondrial" Q8WVM0 6 155256134-155314493 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in all" 5 "Early spermatids: 239.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029428 Approved NA NA "HPA029428: AB_2673038" "unprognostic (2.20e-2)" "unprognostic (1.07e-1)" "unprognostic (2.33e-3)" "unprognostic (7.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (1.32e-1)" "unprognostic (3.54e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.95e-3)" "unprognostic (3.39e-2)" "unprognostic (2.68e-1)" "unprognostic (7.68e-3)" "unprognostic (7.77e-2)" 4.6 17.4 1.9 3.1 2.9 1.5 5.2 3.1 4.0 5.7 0.9 6.9 5.1 5.1 4.0 9.5 4.8 2.8 9.5 2.7 1.9 6.9 15.1 4.6 5.6 1.2 1.6 2.5 6.1 7.1 3.9 7.4 2.1 1.8 5.7 4.9 5.3 6.8 3.2 17.4 8.0 6.5 3.9 1.0 8.5 6.9 11.4 2.1 3.9 7.2 5.5 5.0 7.1 6.9 2.8 7.3 3.5 7.9 12.5 5.9 11.8 6.5 8.9 8.4 8.9 11.9 5.8 6.3 11.6 5.4 3.5 6.5 11.8 5.6 8.8 15.1 11.1 7.3 5.2 4.2 33.2 16.4 6.9 3.8 11.7 3.8 13.3 11.8 10.9 10.6 9.0 13.5 3.1 11.4 4.5 5.2 10.0 8.3 7.3 9.4 6.5 4.7 11.3 9.7 4.9 5.9 14.4 2.4 8.2 8.1 10.6 5.1 9.6 4.2 3.6 7.6 8.5 9.3 5.2 7.0 7.0 12.5 11.8 9.2 5.9 2.8 4.5 4.1 5.0 6.4 7.5 6.3 5.7 6.5 7.0 7.9 6.2 2.5 6.7 5.2 5.3 7.8 3.6 1.9 2.9 3.1 4.0 2.7 1.9 1.2 1.6 2.5 1.8 1.0 2.1 2.8 5.9 22.4 12.0 25.8 16.5 6.2 14.1 31.7 16.5 16.2 9.6 10.2 21.6 8.6 14.6 12.9 22.9 19.6 8.9 4.8 31.3 20.9 239.4 7.4 6.2 5.1 6.0 19.1 41.9 17.8 19.0 9.0 11.2 5.1 27.8 10.7 4.2 24.3 14.9 30.3 47.4 8.9 24.4 10.7 5.1 24.6 5.0 9.9 3.6 44.0 13.3 13.4 9.2 42.3 46.3 13.8 8.5 8.6 9.3 8.0 5.9 21.4 11.5 21.6 13.1 7.1 11.6 35.1 17.2 17.1 11.4 7.3 14.2 28.6 13.7 9.6 RABEP1 "neurocrescin, RAB5EP, rabaptin-5, RABPT5" ENSG00000029725 "Rabaptin, RAB GTPase binding effector protein 1" Q15276 17 5282265-5386340 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Endocytosis, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004549, HPA019669, HPA024235, HPA024691" Supported Supported Vesicles NA NA Vesicles "CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021" "unprognostic (3.22e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-1)" "unprognostic (8.75e-3)" "unprognostic (1.64e-1)" "unprognostic (8.25e-2)" "unprognostic (3.71e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (7.73e-2)" "prognostic favorable (6.43e-4)" "unprognostic (1.14e-1)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (9.00e-3)" 30.4 23.8 44.9 23.4 48.9 17.3 44.3 44.2 46.2 22.4 34.6 18.9 16.6 27.0 25.3 18.7 16.9 21.9 32.7 42.5 44.2 23.7 33.0 19.7 33.8 44.9 48.4 38.3 21.9 18.2 48.3 19.9 31.1 51.1 31.3 20.9 58.7 22.9 22.0 69.1 16.4 19.0 27.7 47.1 28.5 24.3 18.9 46.3 37.7 26.0 52.9 40.6 23.3 15.3 54.4 45.5 57.5 59.6 33.3 60.9 60.5 31.2 58.3 44.5 61.8 58.5 51.4 19.7 98.3 46.0 61.2 35.0 35.9 87.8 50.0 86.4 60.7 75.0 60.9 73.1 39.4 56.4 41.3 37.9 47.2 33.3 59.6 76.5 37.7 54.4 49.9 52.3 48.3 54.2 32.7 66.1 30.4 26.8 25.8 24.9 61.2 70.8 32.4 30.6 43.1 25.3 39.4 52.4 52.8 49.5 52.3 95.9 17.2 46.9 53.1 24.2 52.6 69.6 26.9 31.0 52.4 41.2 62.3 37.5 14.9 21.1 22.4 25.0 22.7 21.9 80.4 19.5 24.0 22.6 96.7 24.6 21.5 30.4 22.6 50.9 35.0 20.0 16.6 44.9 48.9 44.2 46.2 42.5 44.2 44.9 48.4 38.3 51.1 47.1 46.3 54.4 36.4 35.3 45.1 57.5 53.8 24.0 30.1 17.0 25.6 51.5 87.3 46.0 91.1 14.3 32.9 18.4 39.6 39.7 47.2 18.6 41.1 30.4 7.6 19.8 55.5 37.9 16.3 58.3 123.7 23.8 35.0 38.5 23.4 25.3 12.6 47.0 34.2 31.7 89.8 35.3 115.9 17.1 30.5 32.1 38.2 6.0 33.8 36.5 30.2 90.9 32.8 89.7 63.8 78.4 114.1 28.3 65.5 28.2 28.2 52.8 16.5 38.1 19.0 52.5 26.3 34.3 47.7 82.2 75.7 25.5 20.3 25.9 34.4 61.2 18.9 33.6 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990771 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 137.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 11.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 738.7;U-698: 675.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062583, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA062583: AB_2684800, HPA073663: " "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 9.0 13.8 10.3 19.9 10.3 86.4 15.7 10.7 18.9 34.3 6.2 44.4 27.3 16.5 45.2 26.3 17.1 9.8 9.5 14.2 11.7 19.4 102.2 16.1 25.4 12.6 10.1 9.2 5.9 17.3 86.1 4.2 137.8 10.0 14.0 32.7 3.1 24.0 16.0 53.9 18.3 28.4 13.9 9.7 21.4 16.2 40.4 10.9 65.8 14.5 9.0 36.1 18.8 10.6 9.1 263.5 115.5 351.9 184.2 14.5 42.9 437.4 112.9 73.6 127.9 66.1 91.6 106.0 183.0 354.8 87.5 72.3 123.3 324.4 738.7 143.3 125.6 94.7 159.4 110.2 145.6 21.5 243.9 78.0 33.9 171.6 52.5 131.5 32.7 168.3 110.5 84.5 105.4 154.2 201.9 269.3 186.2 209.2 171.0 138.1 325.4 286.3 103.6 95.2 125.3 252.7 164.4 167.4 177.7 56.0 199.3 157.8 158.5 128.0 53.0 123.9 169.9 253.1 94.9 128.7 675.7 63.1 121.3 109.9 0.0 4.3 11.3 0.4 3.0 0.1 2.7 2.0 2.9 6.1 0.5 0.0 0.2 0.7 0.8 5.0 3.1 5.8 2.5 10.3 10.3 10.7 18.9 14.2 11.7 12.6 10.1 9.2 10.0 9.7 10.9 9.1 10.4 38.5 31.2 0.7 15.1 23.7 18.9 158.6 12.5 0.5 24.2 16.0 16.0 8.6 123.5 31.3 2.1 419.1 4.5 32.1 37.2 82.4 232.3 61.9 18.9 19.6 65.7 136.1 1.3 86.5 820.7 17.6 22.4 55.9 8.2 44.2 13.6 84.4 101.0 0.0 3.7 37.0 219.7 20.8 43.7 75.9 3.7 22.1 21.4 2.8 23.6 4.1 1.0 1.5 0.5 91.5 35.7 3.4 47.1 27.5 31.8 66.5 113.3 1.8 0.0 39.8 29.0 22.7 50.2 41.1 20.3 1400.2 10.1 10.4 60.7 18.5 NUP160 "FLJ22583, KIAA0197" ENSG00000030066 "Nucleoporin 160" Q12769 11 47778087-47848555 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 15000 "unprognostic (8.72e-2)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.23e-1)" "unprognostic (3.59e-3)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.94e-1)" "unprognostic (3.78e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-2)" "unprognostic (1.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" 12.9 9.5 5.9 17.5 6.8 20.2 16.7 9.6 6.5 13.6 8.4 12.2 11.9 17.7 11.5 11.1 15.6 11.0 8.7 5.2 8.6 14.3 14.6 14.1 20.8 6.3 6.6 4.8 19.7 14.8 16.4 9.9 20.8 7.1 12.8 15.0 15.3 11.8 11.7 11.1 12.7 11.6 16.6 6.0 15.2 10.9 14.7 6.1 31.2 17.1 9.4 21.8 14.7 11.8 9.4 24.4 31.7 52.2 36.6 30.3 34.8 67.3 30.7 22.7 40.8 46.8 40.3 36.2 33.2 20.3 28.0 41.0 52.1 96.5 30.4 45.3 29.1 66.7 36.6 131.3 44.1 20.2 108.1 24.0 27.4 18.7 29.0 56.5 16.6 32.5 52.9 103.7 45.5 22.0 41.9 72.9 47.6 78.4 53.7 33.1 86.2 78.3 29.8 20.9 42.2 43.0 49.0 72.8 35.6 27.6 45.7 44.6 41.1 22.1 44.6 38.4 75.2 41.7 19.7 19.9 83.8 22.0 45.2 45.2 8.6 7.5 13.3 9.9 9.5 13.6 15.3 11.7 10.8 12.3 14.8 15.4 11.5 4.3 9.7 6.8 16.3 9.8 7.1 5.9 6.8 9.6 6.5 5.2 8.6 6.3 6.6 4.8 7.1 6.0 6.1 9.4 15.0 22.4 18.8 39.5 31.0 22.9 35.7 18.6 20.5 24.8 14.8 11.2 7.8 12.8 19.4 20.2 43.8 33.1 31.4 10.3 15.6 17.7 27.6 17.9 16.3 17.9 19.2 19.6 35.2 16.7 30.4 19.2 15.3 20.3 19.7 23.3 19.2 12.0 15.2 6.7 50.1 14.6 20.3 10.1 19.8 11.5 24.2 14.4 10.6 44.0 15.7 19.7 24.7 61.9 53.8 16.4 8.6 21.8 21.8 32.9 10.9 10.5 15.0 48.4 19.7 19.6 17.2 18.2 22.0 16.4 27.7 30.8 25.3 20.5 15.7 34.8 BAK1 "BAK, BCL2L7, CDN1" ENSG00000030110 "BCL2 antagonist/killer 1" Q16611 6 33572547-33580293 "Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 75.4;Proximal enterocytes: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005029 Enhanced NA NA "CAB005029: AB_562051" "unprognostic (3.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (5.67e-2)" "unprognostic (6.58e-3)" "prognostic unfavorable (4.52e-4)" "prognostic unfavorable (5.64e-4)" "unprognostic (2.36e-1)" "unprognostic (1.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (6.07e-2)" "unprognostic (3.36e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" 9.4 29.9 11.0 20.8 11.4 27.9 7.6 10.9 13.1 9.4 12.0 32.7 47.4 10.2 9.2 34.2 8.0 10.7 18.8 10.9 11.8 16.1 11.6 13.8 22.2 12.2 11.4 10.6 7.2 12.9 13.6 12.1 11.2 11.5 11.3 25.1 3.7 12.0 9.1 19.0 18.3 37.4 13.6 11.3 30.7 22.1 7.9 11.9 19.4 7.8 18.3 23.5 22.0 12.1 12.1 37.6 20.4 21.3 32.2 14.3 14.0 27.1 19.1 15.3 53.7 41.8 42.2 28.7 32.5 32.6 28.1 24.8 38.3 41.0 77.7 23.6 37.7 43.6 20.6 18.8 34.4 36.6 44.5 32.3 23.0 60.7 45.1 52.6 15.7 29.4 28.7 18.9 28.6 20.1 55.0 38.8 29.7 23.7 26.4 50.0 37.0 20.5 59.9 45.6 30.6 26.3 19.6 24.4 77.3 37.1 26.6 25.4 74.5 28.2 28.3 30.0 18.5 24.9 75.4 100.4 27.5 9.6 52.6 31.7 63.5 45.2 85.1 34.7 64.8 39.5 25.3 32.1 34.7 42.8 18.4 17.6 23.2 30.6 22.4 57.3 15.0 56.1 53.2 11.0 11.4 10.9 13.1 10.9 11.8 12.2 11.4 10.6 11.5 11.3 11.9 12.1 8.6 3.2 3.4 3.9 24.6 27.1 11.6 15.5 14.2 6.6 10.7 8.3 6.4 11.5 8.0 3.7 8.4 16.3 22.1 75.4 13.7 20.5 4.7 7.2 8.9 10.1 22.1 6.1 4.5 18.7 41.8 7.5 17.9 10.0 11.4 11.1 10.0 6.3 30.2 5.0 3.6 32.5 14.2 21.9 30.2 1.7 7.8 16.9 21.4 2.8 25.8 4.7 12.3 1.0 2.7 27.7 47.9 11.7 54.5 10.4 79.6 9.6 5.6 6.9 13.1 5.6 11.8 0.3 1.0 19.1 21.6 9.9 24.6 25.2 40.6 20.1 MUSK ENSG00000030304 "Muscle associated receptor tyrosine kinase" O15146 9 110668779-110806558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 4.1;skeletal muscle: 4.1" "Cell type enhanced" "Detected in some" "Late spermatids: 4.8;Leydig cells: 5.3;Oligodendrocytes: 17.0;Peritubular cells: 19.5;Skeletal myocytes: 23.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "LHCN-M2: 24.7;RH-30: 23.7" "Region enhanced" "Detected in some" "basal ganglia: 5.0" "Not detected" "Not detected" NA NA "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (5.39e-2)" "unprognostic (3.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.20e-2)" "unprognostic (1.50e-2)" "unprognostic (2.46e-1)" "unprognostic (3.13e-1)" "unprognostic (7.58e-2)" "unprognostic (6.03e-5)" "unprognostic (4.58e-2)" "unprognostic (1.62e-1)" "unprognostic (9.67e-2)" "unprognostic (5.11e-2)" 0.1 0.2 2.6 1.7 2.4 0.0 0.0 2.1 1.4 0.0 1.1 1.9 1.2 0.0 0.0 1.4 0.0 1.1 1.5 0.9 1.6 0.0 0.3 1.0 0.6 2.1 3.6 0.4 0.1 0.1 0.0 0.0 0.3 2.5 0.2 2.5 0.0 0.1 0.0 4.1 0.1 2.4 0.5 2.9 0.0 1.3 1.6 2.5 0.1 0.0 2.0 2.0 1.3 0.0 4.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 23.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 2.1 1.4 0.9 1.6 2.1 3.6 0.4 2.5 2.9 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.1 0.0 0.0 1.3 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 5.3 0.0 0.0 1.9 0.0 0.0 0.0 2.5 17.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.1 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.7" "Cell type enhanced" "Detected in many" "Astrocytes: 77.4;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 78.3;Squamous epithelial cells: 47.8;Urothelial cells: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;NK-cells: 5.5;T-cells: 5.8" "Cell line enhanced" "Detected in many" "JURKAT: 70.5;MOLT-4: 31.1;RT4: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 2.1 2.0 2.8 3.8 5.3 5.5 2.4 2.8 3.2 3.4 0.7 1.8 0.8 1.9 3.2 19.6 2.9 3.1 1.9 2.6 3.4 1.5 1.5 3.0 7.0 5.1 3.4 2.0 2.1 2.0 5.3 1.9 2.1 5.4 3.3 1.7 5.6 8.5 4.3 4.2 9.2 1.2 0.9 3.0 5.5 4.4 2.5 3.9 40.7 7.9 1.7 6.8 9.7 8.3 7.5 2.8 1.0 5.3 0.3 17.1 17.2 3.3 3.4 3.9 0.8 1.7 1.4 4.6 3.7 4.4 2.0 0.4 6.5 0.1 1.8 2.7 0.0 0.9 1.9 3.6 0.5 0.1 8.9 0.6 16.9 1.6 0.1 0.5 4.3 0.0 70.5 1.2 3.1 1.6 5.2 31.1 8.9 1.1 2.2 0.8 18.1 3.5 0.0 1.5 28.6 1.6 1.0 0.0 3.6 0.0 4.4 4.8 0.9 9.2 4.9 3.8 2.3 0.7 6.0 2.0 20.6 2.4 0.0 1.1 3.9 0.0 4.8 1.8 0.0 4.9 0.2 0.6 1.4 0.0 1.0 0.3 1.5 0.0 5.5 0.0 0.5 5.8 0.3 2.8 5.3 2.8 3.2 2.6 3.4 5.1 3.4 2.0 5.4 3.0 3.9 7.5 2.1 9.6 12.6 77.4 5.2 5.9 23.2 7.9 11.4 4.8 5.1 2.2 7.6 1.5 19.5 7.3 4.2 4.3 27.4 2.8 0.0 2.3 1.3 16.1 1.8 2.4 3.0 9.0 17.7 3.1 1.2 2.7 8.6 18.1 3.8 2.5 2.5 2.2 2.1 0.0 19.9 2.3 4.1 2.4 2.1 0.7 1.8 2.8 1.8 31.9 1.3 3.0 39.1 100.5 78.3 3.6 1.0 2.2 13.9 15.9 1.1 1.0 31.7 7.3 0.0 10.2 4.5 0.8 0.7 47.8 8.7 4.0 22.1 2.0 1.4 51.8 GRN "CLN11, PCDGF, PGRN" ENSG00000030582 "Granulin precursor" P28799 17 44345246-44353106 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 1420.7;Kupffer cells: 892.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 2057.5;intermediate monocyte: 1122.4;myeloid DC: 1534.2;neutrophil: 851.2;non-classical monocyte: 548.1;plasmacytoid DC: 1331.9" "Group enriched" "Detected in all" 9 "dendritic cells: 1534.2;granulocytes: 851.2;monocytes: 2057.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008763, CAB019394, HPA028747" Uncertain Enhanced Endosomes,Lysosomes "Secreted to blood" NA NA 138000000 110000000 Lysosomes Endosomes "CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "unprognostic (8.38e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (7.41e-2)" "unprognostic (3.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-1)" "unprognostic (6.34e-2)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" 157.9 124.2 66.7 161.8 66.6 482.8 121.7 68.0 99.6 125.2 81.7 170.8 132.1 109.2 135.2 538.3 87.9 158.6 152.3 61.3 95.7 167.4 119.9 312.2 184.7 77.7 66.1 55.9 74.4 109.8 88.6 85.0 184.8 74.5 112.7 111.4 12.6 265.1 101.5 61.1 191.2 180.5 92.8 76.0 352.7 129.0 59.8 87.6 68.4 128.7 46.3 108.7 151.4 200.0 96.8 119.3 197.5 52.7 159.5 443.2 231.8 181.2 147.3 447.5 231.6 309.8 86.3 294.0 364.0 299.4 217.6 312.9 185.3 68.6 334.5 75.8 55.8 186.8 38.4 93.8 175.2 245.5 61.6 493.6 332.4 450.5 188.1 106.0 391.2 269.8 64.3 75.1 51.3 148.8 183.1 32.8 172.8 44.3 110.5 334.0 97.7 180.8 433.0 248.2 145.9 54.7 74.7 201.0 92.7 360.9 138.0 209.4 229.0 340.7 437.6 104.6 300.5 97.8 116.3 313.9 122.3 268.1 149.6 124.2 215.1 2057.5 176.5 35.1 1122.4 27.8 174.0 37.1 31.1 1534.2 112.2 27.8 26.5 851.2 30.6 548.1 1331.9 55.4 1613.4 66.7 66.6 68.0 99.6 61.3 95.7 77.7 66.1 55.9 74.5 76.0 87.6 96.8 113.0 86.6 83.3 12.7 82.8 112.7 151.1 574.2 97.9 23.6 85.7 69.7 90.7 133.0 332.7 218.8 18.8 429.1 195.7 494.8 9.8 447.7 2.1 103.8 83.8 170.9 124.3 38.7 6.8 307.3 324.1 149.4 83.6 372.5 75.5 90.0 207.8 84.7 1420.7 47.1 6.6 214.6 146.5 892.0 360.8 6.8 60.9 699.2 208.1 20.6 501.6 58.9 20.6 11.1 11.8 285.3 581.7 57.2 65.8 70.7 312.1 120.5 70.0 11.8 85.5 45.4 83.3 25.1 72.2 255.5 96.5 640.0 30.8 89.6 274.5 175.6 FAM13B "ARHGAP49, C5orf5, FAM13B1, KHCHP, N61" ENSG00000031003 "Family with sequence similarity 13 member B" Q9NYF5 5 137937960-138051961 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 140.6;Inhibitory neurons: 140.0;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036525, HPA041819, HPA071936" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474" "unprognostic (8.09e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-3)" "unprognostic (9.61e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (6.51e-2)" "unprognostic (6.31e-2)" "unprognostic (1.69e-2)" "unprognostic (3.60e-1)" "prognostic favorable (3.55e-5)" "unprognostic (9.56e-2)" "unprognostic (4.46e-1)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" 13.5 22.9 14.4 15.9 19.9 24.2 16.0 20.2 16.9 15.6 8.8 12.2 9.9 22.6 14.1 14.2 14.9 15.0 20.8 14.3 20.3 13.8 8.7 13.8 21.6 16.9 15.1 15.5 24.8 9.6 15.8 8.7 16.4 18.0 24.6 12.4 12.8 11.4 36.1 4.4 11.1 11.0 32.7 10.7 17.9 11.7 34.3 20.6 17.9 15.2 7.6 23.6 17.2 11.7 20.0 18.1 9.0 26.2 21.6 34.3 10.7 20.6 39.1 31.7 29.3 33.8 24.1 16.0 40.7 12.8 34.3 37.4 13.8 16.3 12.6 38.0 30.9 17.6 18.3 21.7 7.6 11.6 30.0 24.3 13.7 6.9 22.4 13.0 15.4 10.2 14.6 10.7 20.2 27.4 13.3 30.5 16.4 10.4 14.0 10.7 21.7 26.1 8.1 17.7 31.6 29.6 26.0 30.5 9.3 38.8 37.6 25.4 30.2 13.5 31.3 13.5 23.2 29.9 16.2 42.2 38.2 17.6 24.3 27.3 10.7 2.2 8.6 4.6 3.3 3.9 5.3 3.3 4.2 1.7 5.6 3.4 4.5 7.1 6.0 5.9 2.9 3.5 1.7 14.4 19.9 20.2 16.9 14.3 20.3 16.9 15.1 15.5 18.0 10.7 20.6 20.0 21.2 22.4 19.8 63.6 56.7 15.4 15.7 10.0 64.9 19.4 23.2 20.7 43.3 14.3 15.2 5.5 20.9 12.4 44.9 8.7 3.9 6.8 40.8 28.1 25.2 17.8 10.3 18.5 140.6 3.5 4.0 21.7 16.8 36.0 30.4 29.2 18.9 5.4 13.9 11.8 140.0 9.9 6.1 24.6 28.9 30.5 16.1 31.2 12.4 73.1 17.6 5.9 28.8 130.2 227.6 6.4 7.0 25.6 37.5 12.5 7.6 5.6 12.9 15.2 26.3 29.8 24.8 29.9 21.7 39.6 13.8 5.2 46.9 49.6 8.4 12.8 ARHGAP31 CDGAP ENSG00000031081 "Rho GTPase activating protein 31" Q2M1Z3 3 119294383-119420714 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 47.8;Astrocytes: 123.1;Endothelial cells: 46.9;Langerhans cells: 54.1;Microglial cells: 125.5;Oligodendrocyte precursor cells: 159.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 6.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 35.0;TIME: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036380 Approved NA NA "HPA036380: AB_10673129" "unprognostic (2.22e-2)" "unprognostic (1.93e-2)" "unprognostic (9.90e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-2)" "unprognostic (1.11e-1)" "unprognostic (8.75e-3)" "unprognostic (3.22e-2)" "unprognostic (2.57e-1)" "unprognostic (7.18e-3)" "unprognostic (5.86e-2)" "unprognostic (1.30e-1)" "prognostic favorable (8.45e-4)" "unprognostic (3.57e-2)" "unprognostic (6.32e-2)" "unprognostic (1.38e-1)" "unprognostic (7.79e-3)" 17.1 2.1 8.6 7.6 9.0 0.8 9.1 10.5 9.4 6.0 4.4 5.5 3.1 6.3 3.1 6.0 5.1 8.7 12.0 8.5 11.6 4.9 3.6 19.6 5.7 11.8 9.6 4.4 6.2 2.9 4.0 2.1 11.3 10.5 3.0 5.4 1.5 2.8 3.4 4.3 6.4 4.7 11.9 8.5 7.1 3.2 1.3 11.5 6.9 12.8 9.3 6.8 8.2 3.9 10.0 0.4 2.5 6.2 12.2 3.5 2.9 1.9 7.5 8.6 5.8 4.2 0.1 0.5 0.1 8.7 19.5 10.0 0.2 5.9 1.9 6.7 11.0 0.8 1.7 0.8 0.0 5.8 0.4 7.0 7.8 0.2 15.1 1.7 4.5 35.0 1.2 0.0 3.0 13.1 0.2 0.1 0.3 2.1 0.0 7.6 0.0 2.9 0.0 1.7 0.0 0.0 22.7 3.8 0.0 15.6 3.3 0.7 0.6 38.5 16.0 6.4 2.0 5.9 5.1 5.6 6.2 10.9 5.6 16.4 0.0 2.6 0.0 0.4 2.8 0.8 1.6 0.3 0.5 6.0 0.6 0.3 0.2 0.0 1.1 1.1 5.2 0.8 1.2 8.6 9.0 10.5 9.4 8.5 11.6 11.8 9.6 4.4 10.5 8.5 11.5 10.0 47.8 19.2 24.6 123.1 7.3 5.2 0.7 3.1 1.8 0.6 0.5 1.7 16.0 1.5 3.1 0.0 0.0 1.2 9.8 0.2 0.0 2.1 0.4 0.4 2.1 46.9 0.0 7.4 3.4 2.0 10.3 7.3 0.0 0.4 9.5 8.4 30.7 0.6 10.1 0.0 18.4 3.9 0.0 14.5 54.1 0.7 2.8 16.7 10.6 125.5 13.8 3.9 4.1 159.8 0.9 1.9 0.3 2.6 4.9 1.1 0.0 2.1 1.4 0.4 0.0 2.5 11.3 0.3 0.7 1.3 5.1 1.0 3.7 3.3 0.4 0.7 CENPQ "C6orf139, CENP-Q, FLJ10545" ENSG00000031691 "Centromere protein Q" Q7L2Z9 6 49463370-49493107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029043, HPA046634, HPA054965" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653" "unprognostic (7.39e-2)" "unprognostic (7.33e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.49e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.76e-2)" "prognostic favorable (6.26e-4)" "unprognostic (2.89e-1)" "unprognostic (8.19e-2)" "unprognostic (1.48e-3)" "unprognostic (8.93e-2)" "unprognostic (7.47e-2)" "unprognostic (2.74e-3)" "unprognostic (2.56e-1)" 4.8 4.8 5.2 5.5 6.3 4.9 5.5 6.3 7.0 3.2 4.7 3.9 2.8 4.8 3.1 4.3 4.1 3.5 6.5 5.0 5.7 3.8 4.5 3.8 7.0 6.4 6.2 4.6 6.3 2.5 3.6 2.3 5.9 6.5 4.5 4.7 4.2 2.8 3.3 5.0 4.1 3.3 4.5 5.9 4.7 3.9 6.0 5.5 9.5 3.7 8.4 8.5 3.7 3.4 8.3 35.3 9.7 30.1 18.9 8.0 12.4 26.4 44.6 25.5 41.9 58.4 11.9 13.8 23.7 21.7 12.7 32.8 12.5 15.8 16.2 61.6 25.9 22.0 17.5 14.6 19.2 3.4 37.4 21.2 5.7 8.7 51.5 17.9 10.7 15.5 20.4 27.3 22.9 31.4 10.2 26.4 17.6 18.8 30.6 8.7 18.8 35.6 25.8 12.3 14.3 16.2 16.0 21.0 12.4 23.9 29.6 15.9 33.8 9.2 32.3 25.2 25.7 40.4 10.4 28.9 21.4 21.9 27.8 32.0 2.2 1.2 4.1 2.0 1.4 2.0 4.4 2.1 2.3 1.3 4.5 2.3 2.3 0.9 2.4 1.8 2.7 3.2 1.2 5.2 6.3 6.3 7.0 5.0 5.7 6.4 6.2 4.6 6.5 5.9 5.5 8.3 8.6 0.0 2.7 7.2 9.5 8.7 9.9 10.4 8.6 6.3 4.1 4.7 6.2 4.3 5.2 7.3 2.1 17.3 8.7 4.2 7.9 7.8 1.3 8.8 5.6 8.0 2.4 5.9 3.0 7.9 30.8 9.3 6.6 5.4 4.5 6.3 14.3 3.4 10.1 6.7 3.1 3.7 2.0 11.4 6.0 2.3 8.7 5.9 3.6 11.2 7.6 14.5 13.4 6.6 13.5 7.8 8.0 10.9 7.5 5.4 1.7 4.4 9.4 5.1 6.6 15.2 6.5 17.7 34.6 6.5 7.0 12.4 5.9 4.2 5.9 6.2 SARS1 "SARS, SERS" ENSG00000031698 "Seryl-tRNA synthetase 1" P49591 1 109213918-109238182 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "Aminoacyl-tRNA synthetase, DNA-binding, Ligase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 98.8;Cytotrophoblasts: 186.0;Extravillous trophoblasts: 147.6;Hofbauer cells: 88.1;Syncytiotrophoblasts: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016939, HPA064668" Approved Enhanced Cytosol NA NA 330000 Cytosol "HPA016939: AB_1856585, HPA064668: AB_2685316" "unprognostic (4.92e-2)" "unprognostic (2.61e-1)" "unprognostic (5.87e-2)" "unprognostic (6.78e-2)" "prognostic favorable (9.47e-4)" "prognostic unfavorable (5.75e-4)" "prognostic unfavorable (6.13e-5)" "unprognostic (3.02e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.23e-1)" "unprognostic (2.06e-1)" "unprognostic (1.69e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-1)" "unprognostic (3.85e-2)" "unprognostic (3.45e-3)" 84.2 90.1 79.4 56.4 80.7 36.0 81.2 78.2 97.5 76.8 62.8 88.1 64.2 86.6 64.7 97.8 72.1 54.1 93.1 82.3 87.4 69.5 103.3 103.2 61.4 89.4 83.7 76.4 79.2 151.4 103.0 89.3 76.8 99.4 66.8 75.5 68.6 86.8 74.6 114.2 110.8 70.5 80.0 77.8 65.0 113.3 46.6 82.0 67.3 141.0 88.7 77.0 89.0 82.8 99.4 208.5 82.1 152.3 230.3 224.2 201.4 261.6 213.1 222.1 183.7 227.1 161.4 62.7 224.1 107.7 307.2 102.8 111.6 241.1 305.9 212.4 159.0 150.4 86.6 96.3 118.4 448.1 110.5 93.7 249.4 526.5 217.1 467.7 155.9 221.9 279.5 201.9 273.2 181.3 205.8 124.8 57.5 63.4 125.6 193.5 101.1 192.5 102.6 139.9 111.0 210.0 111.2 102.5 164.7 601.4 114.9 93.5 131.2 174.5 108.3 135.0 155.5 151.8 205.6 89.6 183.7 341.3 119.8 376.7 191.5 193.9 219.6 228.6 212.2 240.0 235.8 238.2 227.3 198.8 252.4 246.4 229.4 89.7 193.5 226.6 128.2 300.9 460.5 79.4 80.7 78.2 97.5 82.3 87.4 89.4 83.7 76.4 99.4 77.8 82.0 99.4 30.6 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.8 0.0 0.0 0.0 0.0 186.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 147.6 23.9 0.0 0.0 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 188.4 5.9 0.0 0.0 0.0 RANBP3 ENSG00000031823 "RAN binding protein 3" Q9H6Z4 19 5916139-5978142 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043375, HPA043389" Enhanced Enhanced Nucleoplasm NA NA 17000 Nucleoplasm "HPA043375: AB_10959889, HPA043389: AB_10963696" "unprognostic (1.81e-1)" "unprognostic (1.18e-3)" "unprognostic (3.61e-1)" "prognostic favorable (1.22e-5)" "unprognostic (4.24e-2)" "unprognostic (1.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.14e-4)" "unprognostic (2.27e-1)" "unprognostic (3.80e-2)" "unprognostic (2.91e-1)" "unprognostic (5.15e-2)" "prognostic favorable (8.14e-4)" "unprognostic (1.06e-2)" 24.6 40.7 28.0 24.2 26.2 21.7 24.9 26.8 33.9 30.4 22.3 36.8 22.4 35.4 10.7 26.8 29.2 18.0 34.2 27.8 26.2 24.8 24.6 25.4 26.7 29.7 31.4 24.8 28.4 29.8 20.9 32.3 16.9 28.8 32.5 12.3 19.5 25.8 23.1 36.9 28.8 27.9 19.2 27.7 30.3 32.2 45.0 28.4 26.5 26.1 21.5 18.0 36.9 28.1 28.1 73.8 50.4 42.3 47.6 31.2 31.3 30.0 45.9 43.1 52.7 56.7 64.9 25.4 69.0 50.4 35.8 33.1 44.8 38.2 44.8 32.0 71.0 62.3 37.1 38.8 77.6 33.7 54.9 52.2 30.9 30.4 33.0 37.3 24.5 38.9 37.0 68.4 63.6 30.3 30.7 91.8 26.6 77.6 31.8 64.3 67.0 40.6 63.3 34.3 56.3 46.4 52.1 41.1 42.9 41.1 24.7 32.7 41.0 40.6 44.2 32.2 78.2 68.4 65.4 72.1 59.2 55.9 68.0 55.6 14.5 23.1 29.2 23.2 23.2 24.1 17.6 22.7 23.5 23.4 24.5 19.5 25.8 26.0 17.9 24.3 22.3 32.1 24.5 28.0 26.2 26.8 33.9 27.8 26.2 29.7 31.4 24.8 28.8 27.7 28.4 28.1 14.0 25.6 26.6 9.8 18.4 12.2 20.5 27.1 9.6 16.7 12.0 10.2 16.4 18.6 19.9 7.3 25.0 29.2 18.6 16.9 43.0 28.8 59.5 14.3 12.6 19.2 13.2 8.6 9.4 20.8 29.5 17.1 17.3 15.4 17.7 14.1 9.3 10.8 25.0 23.5 11.7 20.2 32.6 14.9 16.8 73.3 16.8 16.5 21.4 8.4 31.5 21.9 25.7 13.6 17.5 22.7 11.4 24.8 21.7 18.8 20.2 21.0 21.4 20.8 19.7 13.5 15.8 86.8 40.8 10.4 11.8 35.4 20.6 19.1 15.1 23.0 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298504-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 9.7 6.9 9.6 11.2 10.3 35.0 9.2 16.0 10.1 8.6 9.9 7.8 8.9 9.6 6.9 7.5 6.9 9.1 8.8 9.1 10.5 9.4 18.9 10.4 15.1 8.4 8.9 7.8 12.6 7.4 9.9 5.5 9.8 8.8 8.6 8.9 14.1 6.8 7.7 5.5 8.7 9.2 8.3 7.7 14.2 9.0 7.0 11.7 14.7 10.7 6.4 11.3 8.4 7.5 11.8 8.5 7.0 19.2 9.5 9.3 11.2 9.7 9.9 8.4 6.6 10.4 8.3 13.1 20.4 10.3 8.4 6.3 9.6 8.6 4.8 9.6 14.3 5.5 9.2 8.2 8.0 5.6 19.7 12.8 8.4 5.2 6.4 6.6 10.5 10.6 11.6 10.7 16.3 7.1 11.5 14.3 17.7 3.8 8.2 8.7 14.5 16.6 6.1 7.1 14.9 16.5 14.3 16.9 8.4 12.0 9.4 14.3 17.8 15.3 11.2 8.7 9.1 4.6 5.3 4.2 18.3 6.7 12.3 5.8 65.8 19.5 59.1 20.6 20.1 23.3 31.5 25.3 22.1 14.9 42.3 27.0 26.5 109.4 29.1 40.8 19.8 19.8 10.1 9.6 10.3 16.0 10.1 9.1 10.5 8.4 8.9 7.8 8.8 7.7 11.7 11.8 57.7 83.3 100.9 68.9 73.5 38.4 21.2 22.1 64.3 111.0 29.5 35.8 55.0 24.3 32.3 27.6 52.1 19.9 74.0 33.0 19.6 23.3 18.2 40.5 37.6 47.1 22.8 45.8 94.2 21.7 21.3 40.1 26.0 52.6 65.2 39.9 37.5 41.9 34.7 112.7 78.6 35.5 20.3 47.7 49.5 8.8 36.4 59.3 26.6 63.7 75.8 63.9 49.4 86.5 91.4 24.9 38.6 36.1 55.1 20.9 43.4 14.9 11.2 64.2 19.7 40.0 43.0 38.6 33.8 55.4 33.4 20.4 77.0 34.1 32.9 17.7 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 8.2 15.3 23.1 14.0 24.9 18.3 9.9 23.6 27.5 8.9 19.4 13.7 12.4 10.0 19.6 19.9 13.3 7.8 12.0 24.6 24.7 18.0 16.6 9.4 19.3 22.0 23.1 25.0 7.0 10.6 15.9 28.0 9.1 22.5 9.6 12.0 16.0 11.3 7.8 14.1 13.2 10.7 10.7 21.5 14.8 10.9 11.7 23.6 22.4 22.6 15.3 18.1 10.9 11.1 23.9 25.4 48.2 25.9 28.2 15.7 21.1 56.2 26.8 27.8 32.0 24.2 32.5 32.6 45.3 46.8 28.3 30.1 25.9 20.9 39.3 17.3 35.5 37.5 40.7 28.4 76.2 29.9 40.2 49.9 19.5 35.1 32.2 43.6 17.6 41.9 79.0 45.2 30.9 29.7 48.5 37.6 57.9 29.4 61.5 38.1 43.6 26.6 61.6 39.6 35.7 54.5 62.6 18.5 31.7 30.1 13.8 29.0 36.9 29.9 25.3 13.1 21.2 36.9 34.9 88.0 37.8 30.0 40.8 24.1 22.2 15.2 12.8 19.7 17.9 19.6 16.8 16.1 20.6 27.4 20.6 17.6 18.8 6.5 22.2 16.7 30.3 22.2 18.6 23.1 24.9 23.6 27.5 24.6 24.7 22.0 23.1 25.0 22.5 21.5 23.6 23.9 5.6 3.2 9.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 8.5 7.0 0.0 0.0 6.2 20.2 0.0 48.6 7.0 0.0 50.9 28.7 0.0 14.9 7.5 7.0 0.0 0.0 0.0 16.0 36.9 5.0 0.0 11.5 3.8 13.7 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 16.5 0.0 0.0 0.0 0.0 20.7 0.0 0.0 2.3 0.0 0.0 41.6 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 26.7 5.7 24.5 0.0 0.0 PNPLA6 "iPLA2delta, NTE, SPG39, sws" ENSG00000032444 "Patatin like phospholipase domain containing 6" Q8IY17 19 7534004-7561764 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 73.4;Late spermatids: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007522, HPA064773" Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA007522: AB_1079649, HPA064773: " "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (3.23e-2)" "unprognostic (2.78e-1)" "prognostic favorable (5.25e-4)" "unprognostic (3.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.51e-5)" "unprognostic (3.36e-1)" "prognostic favorable (7.53e-4)" "unprognostic (3.10e-3)" "unprognostic (3.50e-1)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" 17.2 27.5 14.9 26.5 18.0 26.4 16.5 10.3 31.7 19.7 8.5 24.7 27.1 20.9 5.3 20.5 17.0 13.8 19.7 17.8 11.8 25.7 22.0 40.7 19.6 18.7 16.6 17.3 19.0 16.6 15.7 33.0 13.7 25.8 21.6 8.5 10.7 16.0 12.9 33.8 17.4 29.8 14.6 7.0 42.3 19.4 36.7 16.5 11.0 22.9 19.6 9.0 24.8 17.5 24.8 32.4 80.1 14.7 36.1 25.5 37.0 34.3 42.2 41.9 31.4 28.8 18.6 43.7 27.3 69.1 55.3 19.7 40.8 13.1 39.4 16.3 68.5 29.2 17.7 41.8 13.9 29.2 20.2 53.0 31.6 22.2 41.8 23.8 49.2 62.7 31.4 14.9 36.5 28.6 15.7 22.2 26.0 16.2 15.5 71.7 17.3 9.0 31.9 27.9 31.2 19.0 32.5 34.9 15.7 45.6 20.4 14.1 27.6 67.0 38.5 22.1 53.3 44.2 42.6 30.1 12.2 64.2 23.2 36.7 15.7 11.3 37.6 5.4 20.0 5.5 6.5 3.8 5.7 12.1 4.3 3.3 4.5 3.2 7.9 35.0 3.8 6.9 8.8 14.9 18.0 10.3 31.7 17.8 11.8 18.7 16.6 17.3 25.8 7.0 16.5 24.8 12.6 6.4 12.0 16.6 11.9 4.8 4.1 9.3 8.6 12.1 10.9 8.3 10.0 15.7 10.1 33.1 27.1 18.2 14.4 48.5 1.9 15.8 73.4 8.2 7.2 13.5 17.4 25.4 14.0 7.1 15.5 7.3 14.8 10.7 12.0 19.5 13.6 20.2 27.4 21.9 16.1 14.6 10.2 68.3 16.0 106.1 9.6 42.4 8.8 15.0 23.6 9.2 21.6 9.0 16.4 9.5 17.9 7.5 8.8 4.9 67.0 12.1 14.4 16.5 0.0 7.1 7.7 60.8 10.5 8.5 5.5 12.4 15.9 10.0 20.9 3.6 IFT88 "D13S1056E, hTg737, MGC26259, Tg737, TTC10" ENSG00000032742 "Intraflagellar transport 88" Q13099 13 20567138-20691444 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.8" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 118.9;Respiratory ciliated cells: 117.9;Rod photoreceptor cells: 138.2;Spermatocytes: 259.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-2)" "unprognostic (6.57e-2)" "unprognostic (3.22e-2)" "unprognostic (7.71e-3)" "unprognostic (2.94e-1)" "unprognostic (3.21e-1)" "unprognostic (2.60e-1)" "unprognostic (7.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (5.17e-4)" "unprognostic (4.11e-1)" "prognostic favorable (1.33e-4)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (2.57e-1)" "unprognostic (4.53e-2)" 5.2 8.9 15.0 5.8 16.2 6.4 7.6 13.4 11.6 8.0 16.2 7.4 8.6 12.1 11.4 4.2 18.8 8.4 5.4 10.2 18.1 22.5 15.9 8.5 5.4 14.9 14.8 9.4 13.7 8.1 12.9 15.2 5.1 14.8 7.5 8.1 32.9 4.6 8.5 6.5 5.0 7.0 6.7 16.4 6.7 6.2 70.8 13.2 9.6 18.9 6.0 5.9 6.1 5.3 19.7 8.2 10.9 15.7 19.3 8.3 16.6 10.8 6.5 9.8 9.5 6.7 6.5 14.5 7.0 6.5 10.0 10.6 15.3 11.1 9.3 14.3 7.2 4.9 9.3 5.6 12.2 12.7 9.6 6.7 9.0 9.6 21.8 11.8 18.9 14.1 13.7 12.2 3.1 17.0 7.8 11.8 8.3 5.5 19.1 3.8 13.5 11.2 1.4 19.1 4.6 7.1 15.1 12.6 5.9 14.0 11.4 16.4 12.1 8.7 6.6 6.2 11.0 8.2 3.8 8.4 5.8 8.4 4.4 10.8 1.3 3.5 2.8 3.6 4.0 3.2 5.5 3.7 3.7 2.9 6.0 3.9 5.8 7.4 6.3 4.5 2.4 3.5 2.2 15.0 16.2 13.4 11.6 10.2 18.1 14.9 14.8 9.4 14.8 16.4 13.2 19.7 15.9 32.1 15.4 67.3 11.7 3.3 12.3 10.3 9.6 24.5 12.7 15.2 14.7 18.6 21.4 35.0 118.9 12.0 8.2 17.7 27.4 14.5 110.4 86.9 27.9 13.4 9.6 7.8 33.5 6.0 6.9 14.9 17.3 12.3 12.0 11.3 10.4 21.7 7.4 21.9 52.3 14.4 4.1 7.2 2.3 93.1 26.8 9.2 3.6 23.4 9.5 30.5 9.2 33.7 102.9 8.5 14.8 20.3 5.3 6.1 15.7 58.1 117.9 138.2 26.3 20.4 14.5 259.9 61.0 4.1 3.3 5.9 9.2 24.7 13.2 4.2 ALG1 "CDG1K, HMAT1, HMT-1, Mat-1" ENSG00000033011 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase" Q9BT22 16 5033923-5087379 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060392 Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.66e-2)" "unprognostic (5.18e-1)" "prognostic favorable (5.79e-4)" "unprognostic (1.55e-2)" "unprognostic (2.10e-2)" "unprognostic (3.22e-2)" "unprognostic (2.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (5.27e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.58e-3)" "unprognostic (3.86e-2)" 11.4 19.8 6.2 12.9 6.7 7.8 10.0 6.3 7.9 12.5 11.2 19.0 16.0 11.1 14.6 11.3 12.5 9.9 7.9 6.6 6.4 12.7 21.2 9.4 12.5 6.6 6.1 6.7 8.9 27.1 17.6 11.0 9.6 7.1 10.5 16.5 6.8 18.9 10.6 7.5 8.6 13.2 12.1 5.9 15.1 19.8 20.9 6.5 12.1 11.7 5.5 12.2 12.5 8.4 7.1 24.0 53.7 10.8 25.5 40.7 24.2 26.4 50.6 50.6 46.9 46.4 44.8 72.4 44.4 43.1 48.0 20.7 58.2 30.1 36.2 31.6 42.0 43.3 20.7 40.1 87.1 33.4 37.6 37.3 29.7 26.9 36.2 23.0 18.5 28.7 32.2 29.5 44.7 34.5 50.1 28.9 40.7 51.2 31.7 33.6 48.8 16.0 124.9 28.3 18.7 20.7 21.7 49.3 67.8 27.4 14.3 45.1 29.2 29.8 22.5 25.6 134.7 40.1 39.8 59.3 30.2 20.5 39.8 38.1 11.5 79.9 28.8 87.2 80.6 77.1 72.9 74.9 86.3 86.7 73.9 66.7 75.0 4.3 79.8 80.0 75.6 81.1 126.6 6.2 6.7 6.3 7.9 6.6 6.4 6.6 6.1 6.7 7.1 5.9 6.5 7.1 4.6 16.0 6.1 4.2 11.2 2.4 3.4 15.7 5.2 7.4 6.8 6.0 0.7 8.6 14.3 7.3 12.5 16.2 7.2 8.5 3.9 19.5 10.7 5.4 8.1 8.7 13.3 12.0 4.0 28.3 18.7 9.3 13.7 5.5 1.3 8.1 8.6 17.7 21.7 3.3 4.6 21.0 8.2 10.6 2.4 25.5 9.6 7.6 10.6 1.0 9.3 7.5 9.2 3.5 3.4 21.6 11.1 6.8 22.7 4.5 11.8 10.4 11.7 6.3 6.6 5.4 7.1 28.0 16.0 7.7 1.6 8.5 8.6 13.8 18.0 4.4 ZCCHC8 DKFZp434E2220 ENSG00000033030 "Zinc finger CCHC-type containing 8" Q6NZY4 12 122471599-122501073 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.1" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037483, HPA037484" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037483: AB_10671502, HPA037484: AB_10672485" "unprognostic (1.96e-3)" "unprognostic (8.48e-2)" "unprognostic (5.55e-2)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (6.30e-3)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.40e-4)" "unprognostic (1.03e-1)" "unprognostic (6.95e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.36e-4)" "unprognostic (8.86e-2)" "unprognostic (2.88e-1)" "unprognostic (2.55e-2)" "unprognostic (1.48e-2)" 9.8 8.3 3.8 9.0 4.2 44.1 10.0 7.4 4.8 10.9 5.2 9.2 9.1 9.9 8.9 9.9 10.3 6.6 6.3 3.6 4.1 7.2 10.3 8.6 10.6 3.9 3.8 3.5 11.6 9.5 8.9 8.9 8.2 4.8 8.0 8.1 10.9 9.8 6.6 16.9 11.7 10.5 7.5 3.1 11.1 10.8 12.2 3.9 10.8 10.9 8.7 11.9 9.0 9.7 5.7 14.8 14.4 21.7 21.0 8.4 10.8 25.2 18.0 11.3 21.5 16.1 13.9 13.0 26.6 10.9 7.6 12.5 17.4 23.1 9.8 19.6 20.9 14.0 17.5 21.0 11.5 19.8 30.5 16.9 9.4 15.7 12.9 18.2 19.2 10.9 26.8 24.3 17.0 11.3 8.4 20.7 23.9 18.5 10.0 15.3 24.2 17.8 21.4 10.5 9.3 15.6 17.2 20.5 9.5 23.0 21.1 20.0 20.3 12.2 14.3 15.3 14.2 17.7 18.2 11.6 36.6 7.8 19.6 8.6 5.5 3.4 2.2 3.5 3.6 3.6 4.5 4.1 4.3 2.8 4.0 4.6 3.8 2.9 4.3 4.3 2.9 5.7 2.5 3.8 4.2 7.4 4.8 3.6 4.1 3.9 3.8 3.5 4.8 3.1 3.9 5.7 21.6 32.1 22.6 20.5 26.8 20.5 27.2 13.5 27.3 30.5 23.1 21.5 9.4 21.5 27.0 9.2 125.1 17.4 32.6 13.3 1.9 11.8 78.5 30.7 40.6 21.0 19.6 48.2 21.7 9.5 17.6 22.8 26.0 41.4 19.0 22.5 10.4 17.9 12.8 15.2 24.6 15.5 14.2 15.6 20.2 48.1 14.9 22.4 16.0 26.2 23.5 12.4 21.6 27.6 25.3 14.1 12.2 14.7 29.6 21.3 18.8 6.6 20.4 72.7 6.6 33.6 21.0 34.4 17.1 24.0 25.7 32.3 26.2 19.0 17.3 22.9 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000033050 "ATP binding cassette subfamily F member 2" Q9UG63 7 151211484-151227205 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, CAB020682, HPA021815, HPA030388" Approved Enhanced Cytosol NA NA 51000 Cytosol "CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" "unprognostic (6.80e-2)" "unprognostic (4.23e-1)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.73e-1)" "unprognostic (6.31e-2)" "unprognostic (5.58e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-2)" "unprognostic (1.95e-1)" "unprognostic (6.07e-2)" "unprognostic (7.84e-3)" 16.4 18.9 16.6 11.2 17.0 7.6 14.9 16.1 20.6 13.4 14.8 17.7 6.1 16.8 12.2 19.3 14.5 9.0 24.8 16.6 17.4 15.7 12.4 14.7 11.7 19.1 17.7 17.1 15.2 15.1 14.4 17.1 10.4 18.4 16.2 10.9 10.9 14.3 10.3 61.7 16.2 13.5 14.2 17.1 15.7 16.7 18.8 18.3 11.6 14.0 20.4 15.3 19.6 14.1 18.1 33.0 50.3 18.8 66.0 36.6 31.1 25.1 40.6 33.0 49.9 42.1 47.9 22.1 57.4 34.3 42.8 40.9 25.2 58.9 47.8 49.5 28.1 48.8 23.1 26.3 27.4 43.3 58.0 35.7 42.3 39.6 54.6 34.4 21.2 40.7 32.5 68.4 22.9 43.2 80.1 60.4 70.3 46.8 37.6 54.5 40.3 30.1 50.5 35.4 24.0 32.9 31.0 39.5 37.5 26.8 19.5 16.2 29.0 40.7 31.7 12.8 39.6 61.7 46.9 54.5 42.7 43.5 56.4 60.3 7.9 11.3 3.8 13.8 13.3 19.5 11.9 14.2 13.7 13.1 13.1 13.3 13.8 1.6 14.5 15.1 9.8 15.8 14.7 16.6 17.0 16.1 20.6 16.6 17.4 19.1 17.7 17.1 18.4 17.1 18.3 18.1 4.7 0.0 0.5 10.1 15.9 27.1 25.9 22.5 14.2 17.4 0.3 0.6 23.5 7.2 9.5 0.0 8.4 29.5 10.0 28.4 0.0 0.0 47.0 0.1 0.1 12.8 6.7 18.3 12.6 0.0 28.8 13.8 16.3 0.0 10.2 0.0 12.5 12.9 20.7 10.1 12.6 9.1 12.2 10.4 11.5 55.9 10.5 6.7 19.6 7.5 6.2 14.1 14.4 7.1 10.4 0.0 18.9 14.7 14.0 29.8 15.7 0.0 6.6 16.9 13.1 25.7 15.1 31.0 12.4 21.5 25.1 32.3 10.9 0.1 15.1 19.6 CHPF2 "ChSy-3, CSGlcA-T, KIAA1402" ENSG00000033100 "Chondroitin polymerizing factor 2" Q9P2E5 7 151232489-151238827 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020992 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA020992: AB_1847267" "unprognostic (8.31e-2)" "unprognostic (2.14e-3)" "unprognostic (1.02e-3)" "unprognostic (1.14e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (4.07e-1)" "unprognostic (1.71e-1)" "unprognostic (4.54e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.04e-1)" "unprognostic (2.68e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-2)" "unprognostic (8.59e-3)" 13.5 31.9 8.1 17.6 8.4 23.3 13.8 3.0 13.1 14.3 10.4 15.3 13.1 19.6 10.4 14.1 14.7 15.2 19.0 8.6 8.7 15.0 20.6 17.8 16.7 10.0 7.0 8.7 14.1 26.4 13.3 44.0 16.2 7.7 19.2 9.1 2.9 22.4 13.0 8.2 14.6 19.0 15.0 4.2 29.2 20.2 9.6 8.1 11.0 17.8 5.1 10.8 16.8 13.7 8.0 27.9 22.3 14.7 43.1 50.0 49.2 22.2 57.3 88.4 30.5 37.1 14.9 46.1 8.4 98.7 91.6 41.5 34.3 6.5 40.8 13.1 32.1 20.3 8.9 25.4 21.0 46.7 18.2 70.9 75.8 22.7 28.9 10.3 63.1 48.6 13.8 8.6 23.7 49.2 45.7 17.0 70.6 19.7 11.6 25.6 15.8 8.7 28.1 29.6 21.7 15.9 28.1 30.7 29.8 15.2 11.0 11.6 29.4 66.9 33.6 5.6 45.2 49.3 43.3 6.8 12.3 122.3 23.9 46.6 0.9 4.4 6.2 4.0 3.6 3.7 1.9 2.1 3.6 4.7 2.0 1.4 1.6 7.2 2.0 3.9 6.9 2.4 3.3 8.1 8.4 3.0 13.1 8.6 8.7 10.0 7.0 8.7 7.7 4.2 8.1 8.0 8.3 9.6 11.8 2.3 11.2 4.6 6.6 15.1 6.2 8.8 10.5 5.6 1.9 10.0 11.7 11.0 4.2 11.5 23.4 21.3 1.9 12.4 0.6 6.5 11.0 8.9 8.4 8.6 6.1 16.8 16.3 13.3 18.8 9.0 6.3 14.6 12.5 9.6 12.6 25.2 5.0 12.0 14.2 10.9 6.8 1.0 17.1 11.1 7.2 3.7 11.0 5.3 11.3 5.5 1.8 17.7 17.4 15.1 26.5 11.5 8.5 3.5 8.8 7.4 19.7 7.8 14.6 5.0 3.1 6.6 4.4 10.3 13.0 15.8 9.8 10.5 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" 1 69567922-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 21.5" "Group enriched" "Detected in many" 20 "Excitatory neurons: 1132.4;Inhibitory neurons: 996.9;Oligodendrocyte precursor cells: 1038.0;Oligodendrocytes: 408.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 12.6;HEL: 44.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 0.1 0.2 7.6 0.1 15.9 0.2 0.0 0.0 21.5 0.2 0.0 0.5 0.1 0.2 0.1 0.2 0.0 1.0 0.8 19.3 6.3 0.8 0.2 0.0 0.1 3.1 2.8 11.4 0.1 0.8 0.1 0.0 0.2 6.8 0.3 0.6 1.6 0.0 0.1 1.0 0.2 0.2 0.2 0.0 0.0 0.2 1.6 9.6 0.0 2.2 0.0 0.0 0.1 0.1 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 4.4 0.0 0.0 12.6 0.3 0.0 0.0 0.0 0.6 44.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 4.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.1 0.0 0.0 0.0 0.0 7.6 15.9 0.0 21.5 19.3 6.3 3.1 2.8 11.4 6.8 0.0 9.6 7.7 0.8 0.0 0.0 41.4 2.5 0.8 0.6 0.4 1.8 44.4 0.3 0.3 6.2 2.8 0.2 0.0 2.1 0.4 2.4 0.0 0.0 0.0 29.4 0.5 1.4 1.2 0.0 3.2 1132.4 0.0 0.5 1.8 0.0 1.4 0.0 0.6 2.9 6.5 0.3 6.7 996.9 0.0 0.0 2.8 3.6 6.3 0.6 0.5 5.4 17.8 1.7 1.0 2.1 1038.0 408.2 0.0 0.0 3.0 1.3 0.9 0.0 1.6 0.1 8.3 0.0 1.4 1.5 9.2 3.0 0.5 1.3 0.1 2.3 0.1 0.0 0.1 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1019.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 8.0 8.2 22.2 12.0 36.3 3.6 10.6 44.5 28.2 6.9 2.1 11.5 17.6 9.1 5.4 6.9 15.8 11.2 4.8 19.7 27.4 6.9 3.4 8.2 11.7 30.0 30.4 15.5 7.3 10.0 9.7 4.6 17.5 32.4 5.8 11.7 8.3 43.0 10.6 2.5 5.4 17.6 11.1 31.6 10.3 32.1 16.5 29.2 11.4 8.5 6.4 18.8 13.4 4.5 65.3 115.9 22.5 12.6 110.6 49.5 38.4 61.6 35.9 64.8 30.3 32.6 16.9 44.8 30.7 29.2 40.1 79.4 9.0 29.9 11.4 45.6 124.2 11.0 33.5 7.2 23.0 26.8 7.6 23.9 96.0 6.8 39.3 19.4 124.4 69.6 17.1 14.1 28.8 20.8 60.8 36.6 16.7 14.7 59.6 66.6 26.9 10.3 17.2 46.5 33.1 23.4 16.6 20.8 9.8 8.0 70.6 10.2 12.9 141.8 34.5 36.0 15.3 30.5 47.3 18.5 74.3 68.6 13.6 11.1 0.7 2.0 0.7 3.6 0.9 3.8 15.6 6.2 5.6 2.6 8.3 6.6 6.6 0.3 14.8 1.4 2.6 10.0 2.9 22.2 36.3 44.5 28.2 19.7 27.4 30.0 30.4 15.5 32.4 31.6 29.2 65.3 19.0 12.8 32.5 227.5 43.1 12.1 7.4 11.5 17.1 10.1 18.3 11.7 5.9 8.6 18.9 12.9 4.2 45.5 8.3 5.9 0.0 9.1 37.9 9.9 14.6 16.0 5.4 15.8 169.0 31.7 28.1 22.7 78.0 10.2 7.6 3.3 14.6 3.5 13.0 8.4 166.4 26.5 2.0 12.2 8.6 15.3 12.8 10.2 1.8 70.3 3.6 27.8 9.2 138.7 1019.1 54.7 10.3 13.5 124.3 8.8 24.5 8.4 15.3 9.1 0.0 14.3 13.2 34.6 26.8 7.4 9.8 14.1 18.9 10.6 21.7 7.2 UBA6 "FLJ10808, UBE1L2" ENSG00000033178 "Ubiquitin like modifier activating enzyme 6" A0AVT1 4 67612652-67701155 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037001 Approved Enhanced Nucleoplasm,Cytosol NA NA 12000 "Nucleoplasm, Cytosol" "HPA037001: AB_10672787" "unprognostic (2.52e-1)" "unprognostic (4.89e-2)" "unprognostic (3.97e-3)" "unprognostic (2.81e-1)" "unprognostic (3.67e-2)" "unprognostic (4.92e-2)" "unprognostic (3.55e-3)" "unprognostic (6.06e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.38e-2)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.05e-3)" 6.8 6.7 6.1 10.0 8.5 17.2 8.4 8.2 9.3 8.6 6.2 7.1 8.2 6.8 6.2 11.5 5.8 8.0 5.3 6.4 9.7 6.4 10.8 7.9 12.5 10.5 9.5 6.1 7.8 6.3 8.0 12.1 9.9 10.3 7.8 8.5 14.5 6.8 5.6 5.3 8.5 8.7 8.8 8.1 10.3 9.4 10.1 8.3 10.5 8.0 6.5 13.7 10.2 10.7 17.0 34.4 18.8 30.5 24.0 14.8 17.4 20.6 69.5 27.1 31.1 36.2 19.8 45.1 43.4 24.2 28.7 31.8 19.8 31.9 34.6 46.6 50.0 8.9 27.8 30.7 18.7 12.6 49.3 20.4 12.5 10.9 40.3 24.3 21.2 27.8 21.9 67.2 25.0 37.2 13.0 51.5 11.2 18.0 24.3 22.6 30.0 62.6 16.1 25.3 38.3 14.9 18.8 39.2 27.5 13.0 25.3 18.4 13.0 40.6 28.6 31.9 23.6 30.8 17.8 15.0 43.0 50.9 13.5 28.1 6.4 1.8 2.9 2.4 2.3 2.7 3.0 2.8 3.2 2.2 3.0 2.0 2.4 1.3 5.7 2.6 3.1 2.5 1.4 6.1 8.5 8.2 9.3 6.4 9.7 10.5 9.5 6.1 10.3 8.1 8.3 17.0 34.6 25.6 21.7 54.5 46.5 70.1 65.2 43.0 37.5 45.8 30.8 17.0 13.5 10.0 34.6 16.5 54.2 29.2 45.0 34.7 3.9 24.6 2.3 28.6 24.8 39.0 32.3 23.8 66.3 17.1 17.8 26.6 39.8 45.3 31.0 62.3 20.0 20.9 23.2 33.7 78.1 27.0 28.5 29.9 54.0 5.8 21.5 31.4 24.9 37.5 34.6 14.6 26.8 77.9 115.7 53.3 36.6 19.9 44.8 87.0 21.2 15.9 34.9 39.9 19.7 28.0 24.0 57.7 43.9 30.9 46.2 58.8 37.6 40.4 22.8 149.0 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215293-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 93.6" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 147.9;Microglial cells: 204.2;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 480.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.0;neutrophil: 20.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 17.0 8.3 84.1 13.0 84.0 40.3 11.7 65.4 65.4 13.8 41.6 9.5 14.5 20.0 3.1 9.0 13.7 9.4 14.6 63.4 69.1 6.7 4.5 20.1 7.1 85.9 78.7 50.2 20.1 6.9 6.9 8.9 15.6 89.2 7.1 11.1 3.5 7.2 7.2 6.4 11.9 10.8 17.4 78.4 13.2 8.3 5.7 76.2 21.5 6.6 6.9 5.9 10.7 10.9 93.6 3.7 3.1 8.8 1.0 12.7 5.4 39.1 5.7 6.8 4.0 3.3 23.8 1.9 1.1 24.8 7.9 1.0 5.9 21.2 0.5 5.2 36.3 2.2 14.6 5.9 4.2 6.3 5.6 2.8 6.1 1.9 15.6 2.4 11.8 23.4 4.2 38.8 1.2 6.7 1.5 2.8 13.8 2.8 8.4 4.4 27.4 8.5 0.5 7.3 13.4 7.6 62.1 1.4 2.9 14.4 12.7 13.2 15.5 19.4 1.8 4.5 15.2 1.4 9.8 1.5 0.6 1.5 8.6 16.8 13.0 3.1 0.9 0.0 1.7 0.0 0.7 0.0 0.0 1.0 0.4 0.0 0.0 20.1 0.0 4.9 2.2 0.2 1.0 84.1 84.0 65.4 65.4 63.4 69.1 85.9 78.7 50.2 89.2 78.4 76.2 93.6 6.6 3.2 20.7 57.5 8.7 2.0 0.7 0.5 0.6 4.3 3.6 2.7 10.9 1.5 1.1 0.0 0.0 5.0 4.0 9.2 0.0 2.5 7.0 5.5 9.1 7.6 10.7 4.2 80.7 6.4 16.6 6.9 6.6 10.6 5.7 50.4 5.3 0.8 12.1 16.8 147.9 4.0 4.1 29.5 17.5 5.1 8.1 22.8 7.2 204.2 17.5 0.5 1.0 142.7 480.3 8.2 3.3 10.9 4.2 4.3 10.5 0.8 2.6 2.1 13.1 8.3 5.4 3.7 1.7 1.8 2.8 22.2 3.5 3.5 8.9 2.2 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522582 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 131.8" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 17.8 28.4 23.9 18.2 38.6 21.7 16.5 19.6 43.3 13.5 0.4 22.3 34.9 21.1 19.8 17.5 17.2 22.9 19.1 40.7 38.2 37.8 21.2 24.3 13.2 27.0 29.0 35.9 20.2 17.6 86.6 39.3 21.4 36.1 17.6 20.7 131.8 13.6 18.7 59.8 28.4 24.5 21.7 13.7 22.0 16.5 18.9 34.7 15.3 30.6 25.5 15.0 12.0 12.9 59.6 18.4 37.0 22.1 40.1 36.5 31.7 12.9 12.7 23.3 26.4 34.2 23.9 39.9 3.4 22.6 26.2 36.2 38.7 34.5 21.5 30.4 28.3 36.2 29.2 27.3 19.0 22.7 12.8 50.9 23.5 30.3 42.4 18.0 32.6 18.9 13.2 108.0 111.3 39.7 15.8 5.1 11.3 14.3 23.9 0.4 0.2 23.0 51.2 30.2 14.4 60.9 32.0 19.7 17.7 37.1 28.8 43.0 19.0 11.4 22.3 0.9 33.0 15.3 45.0 66.1 6.8 29.7 0.2 26.5 21.6 14.5 11.2 1.0 4.4 1.6 4.7 0.7 0.2 12.2 7.3 1.2 0.9 18.7 0.1 3.3 6.2 3.7 6.6 23.9 38.6 19.6 43.3 40.7 38.2 27.0 29.0 35.9 36.1 13.7 34.7 59.6 20.0 19.2 48.0 47.0 23.0 19.8 56.7 15.7 32.5 164.8 15.7 16.5 21.1 28.6 18.3 14.7 294.0 34.3 16.7 46.2 11.7 16.3 4.0 32.8 27.4 22.2 84.9 45.8 125.0 18.5 15.7 31.0 23.4 74.0 24.1 74.5 16.4 37.8 53.8 95.9 112.3 27.3 12.2 37.8 29.2 3.9 17.4 42.8 40.9 38.4 17.7 59.3 3.1 61.3 80.5 24.2 37.6 23.7 13.8 32.7 56.9 32.5 11.4 403.4 6.6 39.4 32.3 38.8 18.2 21.7 20.2 99.9 6.9 35.0 24.5 14.9 PIAS1 "DDXBP1, GBP, GU/RH-II, ZMIZ3" ENSG00000033800 "Protein inhibitor of activated STAT 1" O75925 15 68054309-68198603 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 248.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005743, CAB012304" Supported Approved Microtubules NA NA Microtubules "CAB012304: AB_777265, HPA005743: " "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.40e-1)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.75e-1)" "unprognostic (4.21e-2)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-3)" "unprognostic (6.93e-2)" "unprognostic (6.35e-2)" "unprognostic (1.31e-1)" "unprognostic (9.28e-2)" 9.5 10.3 5.8 14.2 7.2 23.4 11.8 12.1 9.5 15.5 6.4 10.8 12.1 14.8 14.0 15.2 14.1 12.8 11.6 7.3 6.2 10.9 9.8 15.1 18.3 5.0 4.9 5.9 22.9 11.4 12.6 6.5 13.0 5.9 15.6 11.2 21.5 10.5 17.9 12.5 12.2 12.4 13.7 4.2 15.4 12.8 20.7 5.9 25.1 19.0 16.4 17.7 14.2 10.9 7.1 13.1 17.6 27.9 13.6 16.4 16.8 8.4 19.6 19.8 21.1 23.6 14.7 19.2 24.6 13.1 16.5 13.5 35.5 41.5 10.7 22.7 14.2 15.5 29.6 17.3 16.3 10.7 29.0 23.0 15.2 30.5 13.7 12.4 16.2 15.1 14.1 20.7 18.3 16.3 10.7 24.1 15.0 15.8 14.4 9.9 21.2 26.8 24.1 13.8 16.4 23.3 9.8 13.1 12.1 13.4 25.4 10.7 26.9 13.5 18.3 19.3 10.6 14.6 13.6 19.2 26.2 11.4 30.2 13.7 33.8 31.4 41.9 18.7 23.9 19.3 20.8 18.7 19.8 30.7 19.5 22.3 19.6 70.8 19.2 25.7 16.7 21.5 27.3 5.8 7.2 12.1 9.5 7.3 6.2 5.0 4.9 5.9 5.9 4.2 5.9 7.1 38.7 109.0 58.4 106.7 91.5 38.0 58.2 29.4 132.1 72.2 30.3 25.1 28.3 45.8 35.9 12.9 106.3 35.5 61.3 35.2 21.5 32.5 67.1 23.5 48.2 42.0 27.6 41.0 165.7 22.6 20.4 37.5 43.8 27.2 56.3 30.6 40.0 34.9 45.8 48.8 136.6 30.2 14.2 102.4 38.8 33.4 123.6 62.6 21.4 248.3 104.9 57.8 56.7 120.1 126.2 25.5 25.0 113.6 59.3 48.3 38.1 20.0 25.0 64.8 32.9 47.7 31.6 66.7 45.4 51.1 33.0 36.0 67.6 22.6 22.4 64.5 SLC4A7 "NBC3, SBC2, SLC4A6" ENSG00000033867 "Solute carrier family 4 member 7" Q9Y6M7 3 27372721-27484420 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 58.1;retina: 73.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTERT-HME1: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022494, HPA035857" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "CAB022494: , HPA035857: AB_10795135" "unprognostic (2.94e-2)" "unprognostic (6.34e-2)" "unprognostic (1.80e-3)" "unprognostic (1.91e-1)" "unprognostic (8.48e-3)" "unprognostic (2.68e-1)" "unprognostic (6.79e-4)" "unprognostic (4.13e-2)" "unprognostic (1.40e-1)" "unprognostic (1.64e-1)" "unprognostic (1.83e-1)" "unprognostic (8.58e-3)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.09e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" 8.3 5.2 2.0 9.1 5.0 4.0 18.9 3.4 16.4 10.0 4.0 12.7 58.1 6.4 8.3 8.7 6.1 13.8 6.5 18.7 4.0 6.6 3.9 8.4 11.3 0.3 3.2 2.9 6.8 3.5 1.7 3.4 5.8 1.4 7.9 7.5 73.6 5.8 8.8 5.1 4.4 17.6 6.7 1.7 7.1 6.0 7.1 3.5 5.9 5.0 27.4 10.4 12.2 8.9 2.0 13.0 23.8 21.0 9.8 9.6 17.2 15.0 43.3 20.0 16.3 12.6 6.5 6.6 29.4 3.6 16.8 15.7 5.5 20.2 21.1 25.7 25.1 6.6 13.5 15.4 7.1 16.5 30.9 11.3 13.7 9.0 24.8 78.9 34.2 27.1 19.0 9.1 10.1 33.8 4.7 31.1 7.2 13.8 1.6 23.4 21.0 16.7 5.9 38.1 9.2 5.3 13.1 19.7 14.4 6.9 17.9 32.9 11.8 19.0 38.2 10.6 26.7 33.7 3.8 4.3 16.6 33.3 21.4 17.8 0.0 0.2 0.0 1.0 0.2 0.7 0.4 1.3 1.4 0.5 0.5 0.5 0.9 0.0 1.0 0.3 0.7 1.2 0.3 2.0 5.0 3.4 16.4 18.7 4.0 0.3 3.2 2.9 1.4 1.7 3.5 2.0 30.0 0.0 11.2 10.7 37.5 29.3 39.5 23.4 11.4 130.2 72.4 30.4 23.1 21.5 22.8 62.5 733.9 5.8 51.8 5.5 9.8 15.5 10.2 73.6 40.7 53.6 38.2 7.2 46.2 7.1 29.3 52.2 15.8 124.1 23.5 24.6 17.5 6.2 17.0 6.7 88.7 58.5 36.7 48.4 61.6 7.6 9.0 46.5 35.6 185.5 26.7 45.7 20.6 60.8 20.9 19.1 23.4 9.8 27.8 93.1 142.5 10.2 9.6 704.2 39.5 56.4 43.7 40.0 21.7 21.7 30.7 8.1 56.1 19.0 26.7 35.2 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;lymphoid tissue: 10.8" "Cell type enhanced" "Detected in many" "Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6" "Lineage enriched" "Detected in many" 4 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 0.8 1.6 4.9 0.7 5.1 0.7 0.9 9.3 10.1 2.3 0.0 1.0 0.4 1.2 0.4 1.7 1.6 0.3 0.4 7.8 3.6 0.9 0.9 3.3 0.6 13.9 3.1 4.4 1.1 5.9 0.0 7.6 0.1 8.9 2.5 0.2 1.1 0.4 0.1 0.1 1.0 5.0 0.0 2.6 10.8 1.4 5.8 5.7 1.5 2.7 0.0 0.7 1.3 1.5 12.0 0.0 1.6 0.7 3.7 0.0 0.0 0.0 0.9 1.4 0.1 0.5 0.0 0.0 0.0 3.5 0.0 2.3 0.0 0.5 0.0 0.0 0.0 3.1 8.4 0.0 0.1 3.1 0.0 0.2 0.4 2.5 0.4 0.0 0.4 4.4 1.8 5.0 0.2 0.0 0.5 0.2 2.4 1.1 0.0 3.3 0.0 0.4 0.2 0.0 0.0 5.4 20.0 0.0 0.0 0.2 0.1 0.0 1.0 4.4 0.0 4.4 0.0 0.9 0.0 0.1 0.0 0.1 14.9 1.7 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.5 3.3 0.0 0.0 5.4 5.6 0.1 1.3 0.0 0.0 0.0 2.0 4.9 5.1 9.3 10.1 7.8 3.6 13.9 3.1 4.4 8.9 2.6 5.7 12.0 0.5 0.0 0.6 53.2 1.8 0.4 0.2 0.0 0.0 21.5 1.9 2.3 1.4 0.0 0.1 0.0 0.0 0.1 36.5 0.1 1.9 1.8 18.9 2.9 6.4 1.2 0.0 2.1 142.7 5.8 0.2 2.2 0.0 2.1 0.0 1.9 3.6 0.5 1.2 89.2 106.1 0.3 0.0 1.6 0.4 10.4 1.8 0.8 3.6 33.7 1.9 1.3 63.8 97.0 74.1 3.3 0.0 3.8 12.3 0.1 0.0 0.3 0.2 4.5 0.0 0.4 2.1 1.6 14.5 0.4 0.3 0.1 30.7 10.6 0.0 0.1 MAP2K3 "MAPKK3, MEK3, MKK3, PRKMK3" ENSG00000034152 "Mitogen-activated protein kinase kinase 3" P46734 17 21284672-21315232 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 214.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 325.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018548 Approved Supported Nucleoplasm,Cytosol NA NA 28000 "Nucleoplasm, Cytosol" "CAB018548: AB_631927" "unprognostic (2.31e-1)" "unprognostic (6.39e-2)" "unprognostic (4.63e-2)" "unprognostic (3.68e-1)" "unprognostic (3.54e-3)" "unprognostic (1.60e-1)" "unprognostic (2.97e-2)" "unprognostic (1.35e-2)" "unprognostic (5.25e-3)" "unprognostic (1.88e-2)" "unprognostic (3.16e-2)" "unprognostic (2.18e-2)" "unprognostic (1.33e-1)" "unprognostic (6.48e-2)" "unprognostic (1.22e-2)" "unprognostic (2.92e-1)" "unprognostic (1.77e-1)" 39.4 32.8 14.5 35.6 12.5 214.2 30.9 16.2 21.5 21.7 24.1 32.8 49.4 17.2 14.7 63.2 30.1 40.3 66.8 11.3 42.2 40.9 96.5 68.1 34.3 13.4 14.2 11.1 12.7 33.9 18.0 37.4 29.1 14.4 29.1 24.4 6.0 45.7 16.7 133.9 52.8 41.3 22.7 13.5 60.9 43.2 6.2 15.7 21.0 24.2 75.3 41.4 54.6 33.7 17.1 75.5 73.9 9.7 44.5 57.7 36.6 36.3 113.0 121.8 88.3 80.5 82.9 46.6 68.1 44.7 178.3 74.2 72.4 31.0 100.5 62.1 69.5 56.9 39.2 42.0 76.1 18.2 51.9 76.7 28.5 28.2 120.6 35.9 27.7 40.0 38.6 7.7 33.2 74.7 74.1 25.5 49.3 28.1 134.1 42.3 53.0 62.2 50.0 50.5 77.4 26.3 9.4 41.7 45.9 82.0 95.7 22.5 17.7 36.8 83.0 68.4 90.1 73.9 39.8 21.8 88.1 80.2 44.3 44.1 54.1 49.3 77.8 35.9 72.1 31.1 33.3 29.1 33.6 49.6 25.5 17.9 24.1 145.6 15.3 104.7 35.4 44.5 35.6 14.5 12.5 16.2 21.5 11.3 42.2 13.4 14.2 11.1 14.4 13.5 15.7 17.1 44.2 38.5 53.6 2.6 51.5 258.0 188.4 57.0 97.9 7.1 69.3 51.3 21.9 44.3 50.5 22.0 4.2 73.3 117.4 109.1 74.3 99.1 1.5 130.5 44.8 49.4 120.4 325.0 7.2 79.8 82.0 43.7 68.3 237.8 94.0 11.5 22.1 73.1 49.0 18.5 8.0 77.0 28.5 59.4 278.7 1.8 12.2 118.1 87.2 4.7 48.3 17.3 35.0 5.5 2.0 129.1 135.3 16.6 85.2 158.7 60.8 44.2 40.4 7.4 0.0 61.9 42.4 1.1 5.3 97.3 218.1 67.0 62.6 10.5 58.5 255.7 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 92.4;testis: 37.8" "Group enriched" "Detected in many" 19 "Early spermatids: 538.8;Endometrial ciliated cells: 159.1;Late spermatids: 552.0;Respiratory ciliated cells: 310.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.5;ASC diff: 2.6;ASC TERT1: 6.2;CAPAN-2: 3.1;hTEC/SVTERT24-B: 2.6;SCLC-21H: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.3 1.5 9.8 0.1 5.0 0.7 3.0 4.2 2.9 9.3 19.0 0.5 0.6 12.5 2.6 0.7 92.4 0.7 0.2 3.3 12.6 0.4 0.7 10.7 0.1 12.3 10.9 2.4 19.5 3.3 0.0 3.2 0.5 7.3 5.4 0.4 0.0 2.1 5.9 0.0 4.7 1.0 2.9 11.5 0.3 0.6 37.8 6.0 0.4 0.1 0.2 0.2 2.4 3.5 9.1 6.5 0.0 0.8 0.0 2.6 6.2 0.0 0.1 0.6 0.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.2 2.6 1.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.5 4.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.1 0.0 1.2 0.3 0.0 0.0 0.1 0.0 9.8 5.0 4.2 2.9 3.3 12.6 12.3 10.9 2.4 7.3 11.5 6.0 9.1 0.4 0.0 5.9 0.0 0.0 6.8 9.7 14.7 4.0 0.0 0.4 9.1 0.4 0.0 20.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 538.8 159.1 4.7 1.2 0.0 0.0 0.7 1.5 0.1 2.2 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.2 0.0 0.3 552.0 4.7 0.8 1.8 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 5.7 0.0 3.4 0.0 0.3 310.7 0.0 0.0 0.7 6.2 16.9 4.5 0.1 1.8 0.3 0.4 3.9 0.0 2.5 TMSB10 TB10 ENSG00000034510 "Thymosin beta 10" P63313 2 84905656-84906671 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 16401.2;Pancreatic endocrine cells: 17155.8;Paneth cells: 14859.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (3.60e-1)" "unprognostic (4.52e-2)" "unprognostic (7.03e-2)" "unprognostic (6.19e-3)" "unprognostic (2.61e-2)" "unprognostic (4.73e-2)" "unprognostic (1.17e-3)" "unprognostic (3.26e-3)" "unprognostic (2.99e-2)" "unprognostic (2.76e-3)" "unprognostic (2.20e-3)" "unprognostic (7.24e-2)" "prognostic unfavorable (8.49e-7)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "prognostic favorable (4.97e-5)" "unprognostic (3.16e-2)" 2581.0 799.6 2670.1 2342.3 2783.6 2170.2 2256.9 2455.9 3493.3 1880.2 2633.0 3131.2 1053.2 1094.9 3599.6 2072.1 942.8 1693.5 1359.1 2854.9 2690.5 1477.0 759.7 2709.4 3316.9 2609.7 2581.8 2733.4 3026.1 780.0 425.8 672.8 1883.4 2616.9 938.1 2753.5 166.0 1436.3 631.1 429.3 1024.7 2171.4 1761.5 2575.5 2333.3 1236.6 732.5 2720.5 3916.8 1059.4 1010.1 2636.2 2659.4 1391.3 2702.7 4179.1 4879.7 4367.9 2450.2 5716.2 11866.8 2267.0 6207.1 8860.4 6955.7 8321.0 3926.0 6366.0 2141.4 4396.8 12906.3 4202.7 1577.1 1269.9 14656.3 7495.5 7204.8 1203.6 969.6 3115.0 3298.9 3576.8 922.9 869.4 10328.2 7273.4 8459.2 4525.9 7545.5 10791.9 1117.3 371.3 3548.2 11749.0 3349.8 3276.5 3837.4 1546.6 11202.2 4994.4 2449.8 6704.6 1757.5 10528.0 804.1 2320.1 2096.0 4162.9 3586.1 5349.0 3999.0 1082.4 1596.4 10174.1 5455.4 3862.3 5018.4 6361.9 700.7 1262.7 1992.4 9124.5 3943.6 4390.2 10530.4 18217.1 11082.3 9181.1 15870.9 5713.8 16178.6 13824.2 9777.6 19825.0 16572.3 14273.3 12095.8 2524.9 7907.9 13950.4 11840.7 24168.9 49770.5 2670.1 2783.6 2455.9 3493.3 2854.9 2690.5 2609.7 2581.8 2733.4 2616.9 2575.5 2720.5 2702.7 8162.0 1189.1 1204.5 38.5 3447.0 2152.8 1551.7 6421.9 1175.8 28.5 3535.0 3219.3 162.5 1265.3 2597.6 1923.8 14.6 4025.2 4651.7 3067.5 1013.5 7642.4 124.4 5122.3 2856.2 5762.7 2298.3 1028.8 73.5 7323.5 12194.2 3030.8 2692.7 6575.0 1398.4 7787.7 3750.9 382.6 6521.7 18.5 20.9 5508.5 2370.1 9660.7 10699.9 381.9 1523.5 7008.1 3317.3 122.7 16401.2 56.4 5596.3 24.1 36.4 17155.8 14859.3 1188.2 2808.9 2936.5 10487.4 2720.9 1187.9 103.8 1012.4 1252.2 3039.8 84.8 210.0 2596.4 1958.8 1560.0 4498.5 2022.2 6534.2 3048.3 ASTE1 HT001 ENSG00000034533 "Asteroid homolog 1" Q2TB18 3 131013875-131027649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037010, HPA037011" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA037010: AB_10673629, HPA037011: AB_10696929" "unprognostic (7.42e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.56e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (2.27e-3)" "unprognostic (2.80e-2)" "unprognostic (1.89e-2)" "unprognostic (2.22e-1)" "unprognostic (1.38e-2)" "unprognostic (2.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.64e-2)" 3.4 3.3 3.1 4.9 3.6 6.8 5.5 6.5 5.3 6.0 3.4 5.4 5.9 3.8 6.0 3.8 4.5 4.0 2.9 4.1 2.8 3.7 6.2 4.2 7.0 3.0 3.2 3.4 5.8 3.3 5.0 3.3 3.9 3.9 3.8 5.8 4.7 3.1 4.2 2.3 4.1 7.2 3.5 3.2 4.5 4.8 6.2 3.7 7.3 7.1 2.8 6.9 4.0 2.9 4.8 9.7 7.1 4.5 4.7 7.7 8.4 1.9 5.4 4.6 6.4 7.0 11.4 4.2 10.8 8.2 5.5 5.5 10.5 9.1 4.4 9.6 5.8 5.3 6.4 3.6 5.4 7.9 9.9 3.6 5.3 6.1 5.2 4.9 5.7 5.4 8.7 5.9 5.3 6.7 6.6 9.0 5.2 4.1 11.6 6.8 9.4 6.4 9.4 5.2 5.9 7.7 7.2 10.5 2.4 7.6 4.3 6.3 6.9 3.8 7.2 4.8 12.1 4.3 6.6 6.5 14.0 5.6 8.5 3.6 51.2 13.0 28.4 20.4 15.3 21.3 15.5 22.0 17.7 14.5 16.5 28.3 21.2 9.4 29.4 20.9 10.7 28.2 11.8 3.1 3.6 6.5 5.3 4.1 2.8 3.0 3.2 3.4 3.9 3.2 3.7 4.8 6.5 12.8 5.8 7.5 14.6 3.2 3.7 4.8 2.2 9.2 5.1 7.4 1.8 4.3 6.3 3.7 14.6 6.0 17.5 11.1 5.9 4.9 42.1 4.5 5.8 6.9 6.7 6.1 8.3 6.0 4.8 5.1 8.6 4.6 8.8 7.0 10.0 5.6 4.8 3.3 6.3 7.0 4.1 5.7 2.0 12.6 7.2 7.2 1.8 5.6 3.9 5.8 18.6 7.5 10.5 3.6 7.8 4.9 8.7 2.9 15.6 3.5 2.1 13.9 0.0 3.6 6.1 4.4 4.9 3.6 1.4 4.0 15.7 6.1 7.1 2.8 RNF19A "DKFZp566B1346, dorfin, RNF19" ENSG00000034677 "Ring finger protein 19A, RBR E3 ubiquitin protein ligase" Q9NV58 8 100257060-100336218 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 178.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011455, HPA023652" Approved NA NA "CAB011455: AB_2180446, HPA023652: AB_1847836" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (1.84e-1)" "unprognostic (7.09e-2)" "unprognostic (3.36e-1)" "unprognostic (2.12e-2)" "unprognostic (7.96e-2)" "unprognostic (8.92e-2)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (5.20e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (7.99e-5)" "unprognostic (8.44e-2)" "unprognostic (8.19e-2)" "unprognostic (2.02e-1)" "prognostic favorable (3.28e-5)" 30.0 18.9 32.1 33.0 28.4 57.9 28.9 23.5 30.4 52.4 19.6 25.6 24.3 41.7 16.6 21.8 30.8 43.5 25.2 25.0 60.2 30.2 49.7 35.0 55.9 41.2 34.3 21.0 27.7 26.1 16.2 15.3 27.1 32.4 22.2 26.7 27.4 22.5 18.9 28.3 32.0 38.2 32.9 38.0 31.7 27.6 53.5 35.3 34.6 18.9 31.3 44.2 36.3 27.6 41.6 26.7 16.9 14.8 16.9 27.7 23.1 18.7 23.4 22.5 22.0 19.9 9.0 17.3 15.7 41.6 24.7 10.2 18.9 11.6 17.4 29.6 65.3 9.4 26.1 86.8 13.5 22.8 5.3 15.6 23.3 26.1 17.5 33.1 26.9 34.3 17.3 14.8 178.6 21.8 13.5 24.6 9.0 5.4 18.2 15.5 9.8 10.0 30.7 60.2 41.7 11.4 24.6 24.5 14.9 23.3 30.6 13.1 20.5 33.9 25.3 19.9 18.7 14.3 85.5 59.3 10.4 16.2 17.4 15.4 26.3 8.6 8.1 16.3 6.8 10.4 15.5 13.4 12.6 5.7 13.9 6.9 9.8 19.6 6.2 14.2 14.1 14.7 5.8 32.1 28.4 23.5 30.4 25.0 60.2 41.2 34.3 21.0 32.4 38.0 35.3 41.6 70.8 51.3 51.6 106.7 101.7 40.1 83.4 56.9 18.8 29.9 44.7 32.5 40.6 110.1 83.6 44.1 60.5 11.0 184.8 61.6 7.9 65.0 183.8 165.9 78.2 66.3 20.8 124.8 76.9 40.2 14.5 62.5 67.8 242.1 43.0 172.0 32.2 42.9 23.0 58.9 69.7 25.9 42.7 30.5 41.8 259.4 58.4 39.2 21.4 73.1 24.1 43.5 65.9 35.7 39.9 49.0 32.0 68.8 161.7 66.3 50.9 54.1 106.2 48.4 19.7 77.4 46.3 77.8 47.2 26.1 60.4 8.2 204.6 46.3 21.8 144.9 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450805-143490616 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Approved Nucleoplasm,Peroxisomes NA NA "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favorable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 8.7 38.7 4.2 7.6 5.2 3.3 11.9 4.9 5.6 10.1 6.7 7.0 6.0 9.9 12.6 18.0 9.7 7.3 12.7 4.7 5.0 18.5 24.6 8.0 8.9 4.2 4.3 4.3 10.8 6.8 24.7 9.0 9.4 4.4 11.8 6.3 10.0 10.7 11.3 11.7 12.3 7.5 9.0 3.3 7.3 9.8 12.3 4.0 8.4 15.7 9.6 9.6 9.0 13.5 7.8 21.4 4.6 11.0 21.1 17.8 15.6 12.2 17.8 13.8 23.7 28.3 31.5 12.8 31.7 21.1 17.4 27.8 17.3 14.4 23.9 30.8 19.4 16.5 22.8 10.2 20.0 15.0 38.7 9.6 18.1 16.6 22.4 17.2 10.3 13.0 18.5 21.1 15.7 24.0 14.1 20.2 15.3 6.1 12.6 18.2 15.3 22.2 14.0 28.0 9.2 15.3 5.3 23.0 19.3 14.7 9.5 10.2 12.7 10.3 16.7 15.9 26.9 20.9 10.7 16.4 36.1 21.1 26.0 13.3 12.9 6.3 6.4 15.5 10.1 17.2 23.2 16.3 15.5 9.9 18.6 21.1 20.7 1.0 15.6 13.4 10.6 21.2 9.8 4.2 5.2 4.9 5.6 4.7 5.0 4.2 4.3 4.3 4.4 3.3 4.0 7.8 13.1 16.0 14.4 23.8 19.7 26.6 12.7 19.2 14.8 14.5 9.9 11.8 14.8 5.7 19.0 9.2 4.2 41.7 9.0 4.1 19.6 12.3 12.6 15.2 10.4 12.0 6.0 5.9 61.0 9.5 11.6 13.5 10.2 13.1 25.3 9.6 13.6 20.5 11.5 16.8 67.4 5.4 16.2 7.6 6.6 4.9 13.7 6.0 8.8 28.1 8.0 15.4 10.3 40.7 59.6 9.6 2.3 11.3 18.1 6.6 8.2 28.8 27.2 12.1 6.6 12.2 13.6 80.0 18.5 20.2 34.8 58.7 13.7 20.9 7.6 8.5 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566375-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 124.8 168.3 283.9 68.6 292.1 102.5 123.3 311.4 313.4 102.6 256.7 110.9 67.7 102.2 159.5 92.7 106.9 84.9 282.5 272.5 301.1 149.4 114.5 112.3 95.5 296.7 298.7 269.9 109.7 82.1 211.2 170.3 114.7 301.6 114.7 82.2 203.1 101.6 103.1 265.0 130.3 90.9 99.5 326.2 112.9 100.5 78.9 292.9 103.0 125.7 188.4 99.7 96.1 105.7 338.4 103.4 85.9 142.7 67.7 217.1 189.9 72.6 118.2 169.9 158.0 176.4 79.8 129.1 148.1 143.0 135.3 95.2 86.6 107.6 110.6 193.9 64.8 208.7 86.9 72.2 119.1 118.2 84.1 151.3 132.0 153.5 133.3 98.6 143.0 130.5 130.5 130.3 58.4 160.2 145.7 125.4 161.0 85.8 114.5 95.8 139.4 69.0 179.6 166.2 66.4 167.7 175.5 184.7 43.7 177.4 113.3 140.1 130.4 119.5 67.9 104.7 100.0 64.5 166.2 172.8 310.6 163.6 80.6 102.6 345.1 148.8 370.8 128.4 140.3 163.0 215.0 135.2 146.8 176.8 199.0 121.4 114.6 502.5 115.3 157.0 274.1 208.1 241.5 283.9 292.1 311.4 313.4 272.5 301.1 296.7 298.7 269.9 301.6 326.2 292.9 338.4 341.0 86.6 136.2 30.7 163.9 274.9 278.8 311.4 141.7 247.9 196.5 236.2 361.4 145.8 212.5 174.7 45.9 251.3 188.5 201.5 686.7 183.9 48.2 209.6 112.8 270.1 277.8 457.6 37.0 175.4 120.6 203.5 80.5 162.4 110.1 85.9 239.8 128.5 223.9 307.9 39.6 156.4 297.0 169.6 428.8 59.7 243.5 197.2 257.9 21.5 404.6 491.0 145.2 27.6 63.6 223.6 237.0 261.1 137.5 306.1 195.7 552.4 263.0 208.1 157.8 182.1 187.9 288.1 219.9 136.6 273.9 390.1 159.3 182.5 121.2 328.6 MYOC "GLC1A, JOAG1, TIGR" ENSG00000034971 Myocilin Q99972 1 171635417-171652688 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Disease variant, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 111.8" "Cell type enriched" "Detected in some" 6 "Fibroblasts: 244.4" "Cancer enriched" "Detected in many" 6 "melanoma: 13.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA027364 Uncertain "Secreted to extracellular matrix" NA NA 25000000 "HPA027364: AB_10602036" "unprognostic (2.02e-2)" "unprognostic (4.65e-2)" "unprognostic (4.44e-2)" "unprognostic (6.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.42e-2)" "unprognostic (3.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.94e-4)" "unprognostic (5.35e-2)" "unprognostic (1.87e-1)" "unprognostic (3.87e-2)" "unprognostic (1.24e-1)" 46.0 1.1 0.0 0.0 0.0 0.0 19.4 0.2 0.0 1.7 0.0 11.1 3.5 16.6 5.0 19.8 15.5 1.5 18.4 0.0 0.1 0.2 0.1 7.5 0.1 0.4 0.1 0.0 1.4 3.0 0.1 0.2 0.2 0.3 5.3 3.5 0.0 14.1 6.4 34.2 3.6 4.8 2.9 0.1 0.0 50.6 1.4 0.1 14.2 28.9 111.8 0.2 22.8 9.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.0 0.3 0.1 0.1 0.1 12.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.1 3.1 0.0 0.0 0.1 0.0 0.0 244.4 11.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 1.0 8.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.6 2.4 0.1 0.0 0.0 0.0 0.0 0.0 15.1 6.3 0.1 0.1 1.1 0.0 0.0 1.1 0.2 0.0 0.0 SH3YL1 "DKFZP586F1318, Ray" ENSG00000035115 "SH3 and SYLF domain containing 1" Q96HL8 2 217730-266398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 606.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 223.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030926, HPA030927" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030926: AB_10670148, HPA030927: AB_10669874" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (5.10e-2)" "unprognostic (2.28e-3)" "unprognostic (5.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.46e-1)" "unprognostic (6.57e-3)" "unprognostic (9.25e-2)" "unprognostic (6.40e-2)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-3)" "unprognostic (1.10e-1)" "unprognostic (1.47e-1)" "unprognostic (3.22e-3)" 13.7 32.3 31.2 12.0 32.6 11.7 55.4 32.6 36.0 32.1 31.7 46.1 35.5 27.2 41.1 44.2 44.0 45.6 9.6 31.1 31.7 147.0 11.7 36.0 22.3 32.2 31.4 30.3 28.9 163.0 56.2 34.1 27.1 33.7 34.7 53.7 10.7 115.0 24.5 13.5 75.6 52.1 12.0 31.8 16.1 72.9 17.2 32.7 15.6 59.7 8.4 28.2 49.8 27.3 37.8 12.7 2.4 13.5 6.0 18.1 16.8 9.0 15.7 17.4 5.8 6.0 33.6 46.3 0.6 7.3 13.8 3.9 51.6 3.4 67.6 5.4 10.2 2.4 3.0 3.9 10.9 14.5 1.5 3.8 18.6 68.2 3.5 11.0 28.7 8.7 17.2 0.9 2.3 12.0 37.1 13.4 6.9 4.4 223.4 2.6 6.4 4.1 0.9 41.4 69.8 5.5 9.1 2.6 64.1 11.9 17.5 44.0 10.6 6.6 2.9 0.8 16.9 6.9 1.7 0.1 1.2 28.8 20.7 9.8 38.9 2.5 1.9 4.5 3.1 14.3 12.6 22.4 11.5 6.1 10.1 33.9 20.5 1.5 22.9 4.9 5.5 30.6 8.2 31.2 32.6 32.6 36.0 31.1 31.7 32.2 31.4 30.3 33.7 31.8 32.7 37.8 14.8 57.7 116.7 51.2 29.7 82.7 173.5 174.4 42.7 19.3 140.2 130.3 6.6 313.1 139.7 101.2 22.9 197.7 15.8 84.5 291.6 129.2 136.6 148.5 32.3 15.9 49.1 3.8 62.3 143.9 69.9 22.6 31.1 216.6 15.8 51.9 19.2 7.9 26.5 26.9 57.1 97.4 109.9 9.5 17.0 113.1 36.7 14.9 72.9 23.4 15.2 9.4 30.9 44.2 87.2 104.6 115.3 41.0 4.7 166.3 125.1 606.2 85.2 9.7 26.3 20.4 20.5 63.3 23.2 29.5 115.4 247.0 35.7 37.1 123.8 245.3 FAM136A FLJ14668 ENSG00000035141 "Family with sequence similarity 136 member A" Q96C01 2 70295975-70302090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030103, HPA030104" Enhanced Approved Mitochondria NA NA Mitochondria "HPA030103: AB_10600194, HPA030104: AB_10600534" "unprognostic (2.81e-1)" "unprognostic (5.76e-2)" "unprognostic (9.16e-2)" "unprognostic (3.69e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" "unprognostic (5.91e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (4.95e-3)" "unprognostic (3.03e-1)" "unprognostic (4.03e-1)" "unprognostic (2.00e-3)" 10.8 12.3 16.3 18.0 17.2 20.6 17.0 17.1 19.6 15.3 16.6 26.1 26.4 10.1 14.8 19.3 14.4 9.8 21.7 16.4 18.2 20.3 32.8 10.6 17.7 17.3 17.0 16.4 10.7 31.7 20.8 10.4 18.1 18.7 15.9 27.4 16.6 27.3 14.2 24.8 14.8 21.8 14.1 16.6 13.7 19.8 9.0 18.1 17.9 20.8 22.4 21.6 18.0 10.6 18.7 94.8 83.4 51.5 72.4 26.5 39.1 78.4 50.2 47.7 67.8 46.8 222.0 53.3 64.9 44.5 43.6 58.9 42.5 106.8 40.0 69.2 67.1 121.3 99.7 62.1 138.8 38.1 166.5 62.7 27.0 27.3 63.9 54.0 36.3 73.8 93.0 161.1 51.0 51.0 138.0 107.6 143.9 129.2 127.7 88.7 71.2 96.2 107.1 104.9 65.4 119.7 52.3 37.7 90.6 76.1 47.3 37.6 47.9 44.9 28.9 85.1 44.7 96.2 42.3 70.0 75.2 72.0 93.2 50.1 35.8 27.9 21.0 21.3 39.8 31.9 37.0 23.6 25.9 37.8 33.2 27.3 27.6 2.6 53.4 27.9 24.8 20.5 29.6 16.3 17.2 17.1 19.6 16.4 18.2 17.3 17.0 16.4 18.7 16.6 18.1 18.7 16.7 41.7 31.6 8.8 49.5 28.0 35.4 41.3 35.3 26.3 46.6 46.1 54.7 11.5 38.9 33.1 25.0 89.5 46.0 52.3 70.5 71.8 1.3 39.3 28.3 20.1 32.9 50.5 8.6 99.1 107.5 31.9 40.8 47.1 27.9 46.1 18.9 59.3 69.8 8.4 9.4 61.2 44.7 22.4 29.2 3.6 13.4 31.9 28.4 3.7 42.0 29.1 49.4 6.0 3.6 95.0 58.1 18.4 88.6 54.8 69.7 73.5 31.8 26.7 13.1 19.8 32.5 14.0 53.8 49.8 41.9 29.6 36.8 49.2 66.7 45.7 VCL ENSG00000035403 Vinculin P18206 10 73995193-74121363 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Actin-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 339.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 568.3;hTERT-RPE1: 547.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002131, CAB002453, HPA063777" Enhanced Enhanced "Focal adhesion sites" NA NA 750000000 "Focal adhesion sites" "CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121" "unprognostic (8.49e-2)" "unprognostic (1.61e-2)" "unprognostic (3.14e-1)" "unprognostic (6.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.62e-3)" "unprognostic (2.72e-3)" "unprognostic (2.67e-3)" "unprognostic (3.42e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (4.03e-2)" "unprognostic (4.02e-2)" "unprognostic (1.89e-1)" "unprognostic (1.37e-3)" 86.6 19.3 10.0 52.6 9.8 41.9 45.7 8.0 12.7 74.2 33.9 141.9 35.7 169.0 46.3 93.1 76.6 70.0 133.4 10.1 15.1 37.6 24.4 69.3 18.9 10.3 10.2 8.2 45.6 40.6 51.7 13.9 89.3 11.6 132.9 73.8 12.6 31.8 153.3 138.0 35.2 53.2 226.6 9.3 42.2 64.1 41.7 12.5 12.9 39.9 145.4 24.1 136.8 56.8 9.4 147.2 97.0 174.2 123.8 213.2 246.2 95.8 188.5 568.3 126.3 141.9 88.4 124.0 6.5 153.1 331.6 86.3 183.3 115.7 95.0 132.5 12.3 49.6 69.4 92.2 37.2 116.5 14.1 101.8 205.0 25.0 171.5 154.8 547.4 171.0 11.6 50.7 14.3 213.1 25.2 2.0 16.6 82.8 69.9 342.4 24.0 90.9 18.6 180.4 185.8 6.5 25.8 104.7 117.2 53.9 152.8 54.5 21.2 230.9 136.9 57.0 67.0 179.4 2.6 6.0 28.4 160.0 38.9 39.7 15.0 13.6 36.2 14.9 17.1 10.4 5.6 7.1 7.8 20.7 2.3 2.6 5.3 11.2 4.4 19.0 8.0 1.9 28.3 10.0 9.8 8.0 12.7 10.1 15.1 10.3 10.2 8.2 11.6 9.3 12.5 9.4 68.0 99.3 39.7 56.5 13.4 114.7 161.4 68.4 30.7 13.4 39.4 58.5 339.5 37.1 79.8 42.3 85.5 51.5 46.7 91.2 3.9 60.8 5.0 98.2 152.6 60.4 38.3 5.9 63.2 61.6 78.6 74.4 66.3 149.1 35.4 45.5 56.7 34.4 23.6 16.8 47.5 44.5 22.4 31.9 51.0 7.5 50.1 77.9 26.6 55.3 44.7 9.7 61.8 18.6 4.6 125.5 48.3 76.8 8.0 100.1 13.7 14.8 37.7 34.5 105.2 49.6 179.9 18.6 13.7 45.6 93.1 39.7 18.3 44.5 48.7 94.8 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 21.2;lymphoid tissue: 20.9;testis: 12.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.3 0.2 0.5 3.9 0.8 11.2 0.9 0.6 0.9 0.6 0.3 4.1 6.1 0.6 0.0 2.5 0.2 21.2 0.0 0.4 0.8 3.0 0.4 0.4 9.1 1.3 1.0 0.4 0.2 0.1 0.0 0.0 7.6 1.3 0.2 5.6 0.1 0.5 0.1 0.0 2.1 6.5 0.9 0.8 1.6 1.4 12.7 0.7 20.9 1.3 0.0 9.7 1.1 1.1 1.6 61.0 20.3 60.5 37.2 1.3 1.9 66.2 16.1 10.9 27.7 35.8 34.0 37.5 34.6 38.5 5.0 36.0 19.8 49.2 36.1 36.9 49.5 35.5 43.3 22.7 42.6 1.0 36.7 40.3 1.2 3.7 9.0 12.9 5.4 26.1 36.3 31.4 45.8 24.7 38.0 59.8 31.9 44.7 13.0 32.6 65.4 49.2 29.4 22.8 29.9 33.6 15.4 37.7 13.4 17.7 27.0 24.9 28.8 12.1 11.7 34.2 9.5 41.6 23.0 43.3 68.0 14.7 53.2 33.3 1.5 0.1 0.9 0.2 0.0 0.2 0.4 1.0 0.7 0.3 0.0 0.1 0.1 0.0 0.6 0.0 0.0 3.2 0.4 0.5 0.8 0.6 0.9 0.4 0.8 1.3 1.0 0.4 1.3 0.8 0.7 1.6 0.2 0.0 1.8 0.0 1.9 4.7 1.0 1.5 0.0 0.1 0.5 0.8 0.1 18.6 0.3 0.0 0.0 7.4 1.1 3.1 0.0 0.3 1.9 3.3 1.4 0.9 0.0 23.8 5.5 0.2 21.6 1.1 2.6 11.7 3.8 5.2 0.0 0.3 6.4 0.0 1.7 2.3 0.0 1.6 2.9 2.4 0.3 1.9 0.0 4.7 0.1 0.2 0.0 2.0 7.0 0.9 5.8 0.0 15.9 0.7 3.7 1.0 0.1 0.1 6.6 0.3 1.4 37.2 12.7 5.8 2.0 46.9 4.5 0.6 7.9 0.9 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 50.6;thyroid gland: 42.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9" "Lineage enriched" "Detected in many" 25 "granulocytes: 213.0" "Cell line enhanced" "Detected in many" "ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA071581: AB_2686421" "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 12.6 2.2 6.6 2.7 8.1 16.1 8.9 6.5 7.8 5.3 5.3 9.9 20.8 1.7 0.2 3.3 1.7 1.5 23.2 6.2 6.7 3.2 2.0 20.2 3.1 7.4 7.6 5.8 0.9 2.7 0.9 1.6 0.4 8.1 5.2 6.7 0.4 7.6 3.6 50.6 7.4 21.5 1.7 6.7 7.9 10.0 3.1 7.1 1.6 42.3 19.8 2.6 2.4 9.6 10.4 3.1 2.3 6.1 1.5 10.6 0.5 0.0 2.1 6.7 1.1 1.2 1.0 1.6 0.2 0.7 6.7 3.7 9.2 3.8 0.1 0.6 0.2 0.2 1.3 4.5 0.1 0.1 0.1 18.3 1.1 7.9 0.4 0.2 7.0 0.7 0.1 0.4 0.1 0.7 9.7 0.0 0.4 0.7 3.1 2.2 2.9 0.0 0.3 0.0 3.2 0.4 0.3 0.4 1.2 0.0 1.5 5.2 0.4 0.4 0.9 1.0 1.4 1.8 0.6 0.2 0.0 0.0 3.0 0.3 94.3 0.2 213.0 2.1 0.1 0.9 1.3 0.6 2.2 0.2 0.4 0.0 1.4 65.9 2.7 0.1 8.6 0.1 1.3 6.6 8.1 6.5 7.8 6.2 6.7 7.4 7.6 5.8 8.1 6.7 7.1 10.4 24.9 86.6 22.3 5.2 4.8 11.6 7.0 8.7 0.6 0.1 9.4 7.4 46.2 1.5 14.6 0.0 0.0 0.1 22.6 45.2 1.9 9.1 25.3 3.0 1.6 6.4 8.4 0.8 15.9 35.6 0.2 8.7 16.3 7.8 15.2 1.3 5.7 1.3 0.4 5.0 2.1 17.0 6.1 1.3 0.8 112.5 3.1 3.2 0.0 15.0 0.3 2.1 2.1 11.1 99.9 9.4 30.6 5.7 0.4 12.0 64.0 0.3 2.8 0.3 13.1 7.6 4.5 2.6 4.9 0.5 4.1 0.1 14.9 1.9 19.6 14.0 NSMAF "FAN, GRAMD5" ENSG00000035681 "Neutral sphingomyelinase activation associated factor" Q92636 8 58583508-58659853 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 89.7;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023067, HPA023148, HPA023151" Uncertain Approved Nucleoli NA NA Nucleoli "HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.75e-1)" "unprognostic (8.86e-3)" "unprognostic (2.69e-1)" "unprognostic (8.73e-2)" "unprognostic (2.96e-3)" "unprognostic (9.03e-2)" "unprognostic (2.29e-1)" "unprognostic (8.11e-2)" "unprognostic (1.52e-1)" "unprognostic (4.44e-1)" "prognostic unfavorable (4.61e-9)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (2.38e-1)" "unprognostic (1.69e-1)" 15.7 15.0 8.9 16.3 9.9 8.0 13.6 9.5 9.9 14.0 10.3 14.7 9.4 14.0 9.2 13.3 10.9 10.8 11.8 8.9 10.4 7.7 5.7 12.1 21.8 9.8 9.4 8.8 12.3 17.2 17.7 10.5 13.5 9.8 12.2 14.6 4.8 11.4 12.6 18.6 19.3 14.9 14.3 9.4 16.9 14.1 5.5 10.7 36.2 13.6 15.6 22.3 16.3 13.4 10.1 33.7 32.7 14.3 20.1 53.8 43.3 24.8 26.8 58.5 36.3 33.9 17.8 20.6 40.5 21.6 41.6 37.6 26.6 24.7 21.2 41.3 46.0 13.7 75.7 19.8 20.5 67.8 33.7 51.1 29.2 33.7 26.2 99.5 29.6 36.5 36.9 32.9 29.1 41.6 25.7 71.5 26.6 25.7 27.0 12.6 26.7 21.2 11.6 19.8 26.4 13.1 16.5 22.4 8.3 24.8 18.6 20.1 41.8 34.4 35.7 21.7 48.2 27.3 5.5 2.6 31.6 52.3 25.6 23.1 8.3 7.1 4.7 6.0 5.0 6.2 4.2 6.4 6.5 14.0 4.0 4.4 4.3 14.6 6.4 3.6 4.7 8.6 4.7 8.9 9.9 9.5 9.9 8.9 10.4 9.8 9.4 8.8 9.8 9.4 10.7 10.1 9.6 9.6 5.9 68.9 28.4 18.4 10.4 7.2 26.2 9.7 7.8 6.9 15.8 1.5 9.6 9.2 4.2 12.1 17.4 8.9 3.9 7.7 0.3 5.9 14.5 12.1 14.4 12.2 89.7 8.8 8.3 13.8 14.8 7.8 28.5 15.8 5.3 4.0 17.8 32.0 94.9 10.4 2.0 31.0 35.3 2.1 16.4 33.9 10.6 54.4 22.6 6.3 13.4 102.1 51.2 7.4 9.1 12.8 18.3 13.0 8.0 4.9 3.8 6.3 6.6 18.0 10.8 2.0 3.5 16.1 17.8 9.3 22.7 10.6 10.7 11.0 ADSS2 ADSS ENSG00000035687 "Adenylosuccinate synthase 2" P30520 1 244408494-244451909 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 26.4;Cytotrophoblasts: 49.3;dendritic cells: 59.6;Extravillous trophoblasts: 97.2;Hofbauer cells: 35.8;Syncytiotrophoblasts: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024400 Supported Approved "Plasma membrane,Cytosol" NA NA 690000 Cytosol "Plasma membrane" "HPA024400: AB_1844623" "unprognostic (4.24e-3)" "unprognostic (2.63e-1)" "unprognostic (3.95e-2)" "unprognostic (8.68e-2)" "unprognostic (6.91e-2)" "unprognostic (2.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" 20.0 20.7 21.4 28.3 24.8 44.3 34.9 24.8 25.8 26.1 20.8 29.0 29.0 23.6 30.0 32.9 24.2 21.2 8.3 22.4 24.4 33.2 24.5 25.5 32.2 25.1 23.9 20.8 21.9 20.0 27.8 14.7 28.8 26.0 25.5 30.0 11.5 23.0 25.8 10.9 33.5 27.3 25.4 24.3 23.9 35.3 71.0 23.4 34.1 35.2 8.5 35.2 36.5 21.7 32.0 89.9 48.6 41.6 36.9 47.6 67.8 76.2 88.5 74.4 62.3 47.0 64.6 84.5 79.7 57.1 68.9 26.6 66.1 45.9 58.0 69.5 59.6 81.0 53.1 47.8 49.3 57.1 127.1 65.6 46.8 68.5 58.1 58.3 72.1 225.6 43.3 94.0 57.7 62.7 21.6 82.3 85.0 110.5 85.0 53.1 74.9 39.4 86.5 103.8 55.2 56.2 49.2 75.2 69.0 91.4 43.9 48.0 66.7 99.4 57.1 31.3 67.0 93.7 69.1 97.2 60.0 47.2 146.8 86.3 48.3 22.8 20.0 20.4 29.9 22.0 15.3 18.6 17.8 20.1 12.3 15.6 17.9 17.5 23.6 33.6 7.9 22.3 18.8 21.4 24.8 24.8 25.8 22.4 24.4 25.1 23.9 20.8 26.0 24.3 23.4 32.0 26.4 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 49.3 59.6 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 97.2 9.3 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 54.0 11.0 0.0 0.0 0.0 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558727-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 51.4" "Group enriched" "Detected in some" 5 "B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 88.1;naive B-cell: 107.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 185.4;U-698: 83.2" "Region enriched" "Detected in single" 5 "cerebellum: 2.3" "Low region specificity" "Detected in all" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.4 0.1 0.0 15.6 0.0 5.9 0.8 0.0 0.0 0.3 0.0 2.4 1.8 0.6 1.9 0.7 0.1 1.5 0.2 0.4 0.1 9.3 0.4 1.4 41.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.9 2.3 0.0 1.3 2.8 0.1 0.1 8.2 0.4 0.0 16.2 2.3 2.8 0.0 6.5 0.4 0.0 51.4 1.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 24.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 83.2 0.0 24.7 0.0 5.3 0.1 24.3 0.9 0.1 1.9 88.1 2.0 0.8 1.2 107.8 7.9 0.2 1.0 38.9 0.1 5.2 0.4 4.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 5.7 0.0 60.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 5.5 0.0 0.0 5.8 0.0 9.8 0.0 13.0 0.1 0.0 0.6 0.0 2.5 0.3 0.0 0.0 0.1 0.0 0.0 80.8 0.0 0.4 0.0 0.8 0.0 0.2 0.1 65.1 0.3 0.7 7.1 0.3 1.2 16.0 0.0 0.2 0.0 6.2 0.0 0.3 0.0 0.0 0.4 147.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.1 0.0 4.3 0.1 0.0 0.2 TIMP2 CSC-21K ENSG00000035862 "TIMP metallopeptidase inhibitor 2" P16035 17 78852977-78925387 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 949.5" "Cell type enhanced" "Detected in many" "Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.6" "Group enriched" "Detected in many" 4 "granulocytes: 13.6;monocytes: 5.0" "Cell line enhanced" "Detected in many" "ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010203 Approved "Secreted to extracellular matrix" NA NA 110000000 "CAB010203: AB_2204966" "unprognostic (1.03e-1)" "unprognostic (1.71e-2)" "unprognostic (9.81e-2)" "unprognostic (1.76e-3)" "unprognostic (3.24e-2)" "unprognostic (3.05e-1)" "unprognostic (4.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.38e-3)" "unprognostic (4.62e-2)" "unprognostic (2.05e-1)" "unprognostic (2.77e-3)" 387.1 186.9 175.9 93.1 143.7 20.3 293.1 112.8 121.5 547.2 131.8 239.4 71.7 529.8 117.8 177.7 275.1 401.4 195.1 126.1 145.3 120.3 63.4 233.8 78.3 149.2 136.3 123.2 949.5 79.8 64.5 104.4 219.9 157.9 197.9 108.7 43.8 108.1 270.0 57.1 215.3 150.7 384.9 131.8 173.5 142.1 151.8 163.8 80.8 156.9 120.9 39.0 263.4 333.8 171.4 170.0 84.0 93.0 178.8 1327.4 1618.4 50.2 585.0 960.2 280.1 221.1 30.8 288.6 0.2 200.8 1070.2 307.4 32.9 29.1 25.2 291.4 3.4 16.6 0.1 156.0 48.1 392.7 2.6 1.2 641.1 12.0 276.8 44.3 722.5 375.9 54.4 0.2 0.5 292.5 19.5 176.8 29.7 16.6 34.2 122.8 118.0 213.2 73.4 178.7 2.3 47.6 290.3 366.6 170.8 776.3 111.6 86.8 42.2 450.3 744.2 140.5 438.0 102.8 84.1 74.9 1.5 171.0 32.0 367.6 0.0 5.0 7.4 0.0 3.4 0.0 0.1 0.1 0.0 2.2 0.2 0.2 0.3 13.6 0.2 4.3 1.4 0.1 0.9 175.9 143.7 112.8 121.5 126.1 145.3 149.2 136.3 123.2 157.9 131.8 163.8 171.4 147.9 112.2 34.3 24.2 18.7 98.9 9.0 5.7 9.1 37.5 9.7 37.6 41.9 52.9 20.8 25.8 8.4 4.3 6.1 46.0 0.0 78.0 143.7 17.0 190.3 115.0 7.8 12.4 9.8 22.0 87.7 475.9 17.9 24.4 7.0 97.5 259.5 7.9 208.8 3.3 107.7 14.3 12.2 177.4 171.4 491.0 353.6 184.8 275.7 96.5 87.3 39.9 5.2 60.8 143.5 83.3 6.0 770.7 33.1 10.1 12.8 0.8 5.4 12.7 92.1 111.8 171.9 8.5 7.7 5.6 75.9 14.8 17.5 96.0 2.3 6.9 RFC1 "A1, MHCBFB, PO-GA, RFC140" ENSG00000035928 "Replication factor C subunit 1" P35251 4 39287456-39366375 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" Neuropathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009520, HPA046116, HPA069306" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115" "unprognostic (8.23e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.43e-5)" "unprognostic (4.15e-2)" "unprognostic (4.08e-2)" "unprognostic (3.38e-2)" "unprognostic (7.48e-2)" "unprognostic (3.30e-1)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-2)" "unprognostic (4.14e-2)" "unprognostic (1.62e-3)" "unprognostic (4.48e-2)" "unprognostic (1.31e-1)" "unprognostic (5.41e-2)" "unprognostic (1.47e-2)" 15.8 19.2 14.2 16.8 19.0 33.4 22.4 15.8 15.5 17.1 12.9 14.6 13.4 19.4 17.6 13.9 14.7 12.3 16.6 14.2 15.6 20.9 25.7 18.3 30.5 17.0 16.4 12.7 26.4 29.3 31.7 14.8 14.7 18.2 17.9 14.9 24.5 16.8 16.3 11.7 14.8 13.9 17.3 16.1 17.1 15.1 11.9 15.7 28.2 23.3 16.1 30.5 13.6 14.2 26.3 43.5 19.4 53.7 44.1 25.4 32.0 27.5 49.1 44.6 49.2 58.2 37.8 43.1 106.5 32.4 33.2 52.8 20.7 49.8 42.6 78.5 19.5 33.9 48.0 35.6 34.7 30.6 67.5 30.7 24.6 33.8 49.9 55.3 39.1 38.8 52.1 48.0 22.1 37.9 17.5 99.7 43.4 33.0 26.8 24.2 78.1 97.8 33.7 21.4 30.1 37.6 36.4 29.1 11.3 37.6 33.4 29.8 37.5 30.0 40.3 49.6 37.8 63.1 31.0 45.8 101.3 33.1 69.3 41.2 8.2 8.6 3.8 13.7 6.9 10.1 14.6 11.7 11.9 6.9 16.1 13.8 12.2 3.9 12.6 8.9 14.3 11.5 5.5 14.2 19.0 15.8 15.5 14.2 15.6 17.0 16.4 12.7 18.2 16.1 15.7 26.3 65.5 64.1 120.6 33.0 62.9 20.6 37.9 26.5 47.3 67.8 60.5 62.4 86.1 45.8 37.0 57.0 60.5 43.1 83.8 30.6 72.4 54.8 73.0 45.9 79.1 56.1 30.0 57.9 22.0 66.0 48.5 54.9 28.1 60.0 25.9 82.2 57.8 82.0 30.7 85.8 32.1 58.2 12.2 44.3 16.6 32.3 82.0 35.1 16.0 22.5 58.1 82.7 107.1 38.7 95.7 51.1 34.2 91.7 75.0 50.0 36.1 124.2 32.6 83.3 59.2 61.6 54.6 49.0 66.5 38.2 21.3 32.2 63.7 70.8 49.1 44.5 TBC1D23 FLJ11046 ENSG00000036054 "TBC1 domain family member 23" Q9NUY8 3 100260992-100325251 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038151, HPA038152" Approved Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA038151: AB_10672405, HPA038152: AB_10672620" "unprognostic (9.23e-3)" "unprognostic (6.01e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (1.79e-2)" "unprognostic (6.18e-2)" "unprognostic (7.87e-3)" "unprognostic (6.16e-2)" "unprognostic (7.92e-2)" "unprognostic (2.02e-2)" "unprognostic (2.98e-3)" "unprognostic (3.66e-3)" "unprognostic (1.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.51e-1)" "unprognostic (5.64e-2)" "unprognostic (2.32e-1)" 15.2 17.5 5.2 12.8 7.0 23.2 15.0 11.0 7.4 13.7 5.9 15.2 18.1 14.4 10.2 16.4 9.4 14.1 14.5 6.0 6.3 17.2 22.9 12.7 12.6 6.6 5.9 5.2 16.3 18.4 18.0 5.1 21.8 6.9 11.8 15.7 16.9 15.3 9.9 17.4 13.6 18.6 14.3 6.7 12.6 15.3 17.2 6.4 14.5 14.2 15.4 15.6 15.8 8.2 11.0 72.9 15.0 17.4 9.8 34.4 44.3 17.5 40.4 45.7 46.6 53.6 28.6 13.3 18.3 20.6 46.9 26.0 25.5 64.5 29.4 72.4 9.0 15.1 49.9 16.6 19.3 33.9 23.2 39.1 35.9 23.7 23.3 38.1 39.0 25.2 14.1 41.0 26.8 30.1 16.3 17.9 11.4 20.3 26.2 27.8 14.8 37.9 21.6 27.3 16.3 24.8 13.5 23.4 18.4 29.8 22.7 19.6 22.0 24.1 32.9 30.9 15.5 26.9 25.6 28.1 31.8 42.1 21.2 27.4 27.8 17.8 22.7 12.2 20.5 12.4 12.0 11.7 10.7 18.7 12.7 10.3 10.9 10.2 21.8 24.8 8.2 17.4 17.4 5.2 7.0 11.0 7.4 6.0 6.3 6.6 5.9 5.2 6.9 6.7 6.4 11.0 24.0 41.7 12.6 19.6 24.5 31.5 18.6 14.8 16.5 18.6 17.9 11.7 26.1 11.5 20.5 12.9 14.6 20.1 19.1 24.8 31.3 26.8 46.8 17.5 28.4 22.5 7.2 54.1 50.9 29.5 19.3 31.9 13.7 31.7 29.8 19.0 13.9 19.0 13.9 35.3 42.4 17.5 18.3 17.1 20.2 44.2 20.5 21.9 24.9 48.7 14.0 18.7 12.3 41.7 56.4 36.1 16.9 14.3 34.5 22.3 21.1 19.9 19.3 30.2 13.1 27.6 25.9 20.8 15.2 20.4 38.8 65.8 21.1 21.8 14.3 30.2 CUL3 ENSG00000036257 "Cullin 3" Q13618 2 224470150-224585397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, ER-Golgi transport, Mitosis, Transport, Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 226.8" "Cell type enhanced" "Detected in all" "Late spermatids: 309.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002678 Supported NA NA 65000 "CAB002678: " "unprognostic (1.22e-2)" "unprognostic (2.35e-1)" "unprognostic (7.05e-2)" "unprognostic (6.29e-2)" "unprognostic (2.82e-1)" "unprognostic (7.03e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-3)" "unprognostic (2.65e-2)" "unprognostic (1.01e-2)" "unprognostic (6.16e-2)" "unprognostic (4.86e-3)" "unprognostic (2.16e-2)" "unprognostic (8.74e-3)" "unprognostic (9.61e-2)" "unprognostic (1.87e-2)" 30.9 33.9 27.1 36.6 28.4 63.0 41.0 30.6 35.0 35.6 30.0 38.6 36.4 33.9 42.1 54.7 29.0 33.1 39.3 27.9 30.5 49.9 52.8 31.5 56.0 26.8 26.5 25.1 33.5 34.6 57.0 25.4 37.4 25.9 33.7 39.7 46.7 36.4 28.9 113.6 54.5 34.5 33.8 27.1 34.1 35.8 226.8 26.1 48.9 46.1 82.5 76.3 41.0 36.8 31.1 61.7 61.3 87.8 72.6 71.9 62.7 82.7 73.9 74.3 72.6 67.7 72.7 60.2 67.0 44.5 76.1 70.3 53.6 99.8 85.0 112.0 66.5 54.5 95.9 61.3 100.7 87.6 95.1 69.3 62.6 68.9 67.7 74.0 72.2 74.3 61.9 90.2 67.0 96.9 104.5 88.5 91.5 90.4 100.9 38.0 76.5 109.8 50.0 108.5 141.0 79.9 58.6 51.1 73.7 85.7 124.5 58.6 79.3 66.2 77.2 58.5 52.1 74.1 69.2 55.3 115.3 59.9 58.2 83.7 9.4 2.8 7.6 3.5 3.5 4.6 5.3 3.9 5.4 3.0 6.5 4.7 5.2 6.6 8.7 4.2 3.6 7.6 1.7 27.1 28.4 30.6 35.0 27.9 30.5 26.8 26.5 25.1 25.9 27.1 26.1 31.1 48.3 51.3 69.6 92.1 73.9 28.3 67.8 25.1 20.5 48.5 40.8 34.7 39.9 30.0 49.7 27.6 29.2 25.7 85.3 46.7 35.2 20.2 211.2 58.9 66.9 35.2 40.9 30.9 86.7 24.9 17.8 35.0 32.6 76.2 38.0 37.1 28.5 39.6 20.7 60.6 93.4 39.2 20.3 43.2 28.3 309.7 27.4 45.2 24.9 95.5 39.4 48.4 28.8 107.1 126.4 34.5 39.3 27.4 58.1 59.8 43.8 43.2 38.7 41.3 52.6 71.8 41.5 116.4 50.7 35.7 32.7 39.5 61.2 40.1 34.0 90.1 MYOM2 ENSG00000036448 "Myomesin 2" P54296 8 2045046-2165552 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 302.4;skeletal muscle: 391.1" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 632.6;dendritic cells: 234.9;NK-cells: 268.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEK 293: 5.3;SCLC-21H: 2.2;U-266/84: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001765, HPA005953" Enhanced Approved Mitochondria NA NA 290000 Mitochondria "HPA001765: AB_1079443, HPA005953: AB_1854258" "unprognostic (2.81e-2)" "unprognostic (1.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.86e-2)" "unprognostic (2.30e-5)" "unprognostic (1.10e-1)" "unprognostic (5.17e-2)" "unprognostic (1.34e-2)" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (3.89e-2)" "unprognostic (2.71e-2)" "unprognostic (9.01e-2)" "unprognostic (3.22e-1)" "unprognostic (1.14e-1)" 0.1 0.2 0.2 0.1 0.9 0.2 6.2 1.5 1.4 0.2 0.0 0.5 0.2 0.4 0.7 1.2 0.3 0.1 302.4 0.8 0.2 2.7 0.4 0.7 0.1 0.1 0.1 0.7 0.1 0.2 0.0 0.2 0.3 0.6 3.8 0.1 0.4 2.0 0.6 391.1 0.8 0.4 0.4 0.0 2.2 0.3 0.4 0.0 0.0 0.1 63.0 0.0 0.4 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 1.5 1.4 0.8 0.2 0.1 0.1 0.7 0.6 0.0 0.0 1.2 3.7 6.4 3.0 11.8 1.6 3.6 2.7 2.0 1.2 3.2 2.7 5.1 632.6 20.0 1.0 3.7 0.0 0.0 234.9 1.8 13.7 4.6 15.2 2.7 1.8 5.6 0.0 3.6 21.8 1.7 0.1 26.7 0.5 1.9 5.7 1.5 4.6 6.8 1.4 6.7 2.8 2.1 2.0 2.7 5.1 8.3 0.6 4.8 3.6 3.7 3.0 7.3 268.8 1.5 2.0 2.5 0.8 1.5 11.1 1.2 1.2 26.0 5.3 4.8 0.0 11.6 13.9 55.9 21.4 1.3 2.8 0.1 22.3 1.5 1.2 1.4 OTC OTCase ENSG00000036473 "Ornithine carbamoyltransferase" P00480 X 38352586-38421446 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 124 "intestine: 113.5;liver: 380.9" "Group enriched" "Detected in some" 5 "Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3" "Cancer enriched" "Detected in some" 20 "liver cancer: 59.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA000243, HPA000570" Enhanced Supported Mitochondria NA NA 2200000 Mitochondria "HPA000243: AB_1079535, HPA000570: AB_1079534" "unprognostic (6.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.89e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.70e-3)" "unprognostic (5.61e-2)" 1.2 0.0 0.2 0.5 0.3 0.0 0.2 0.3 0.4 0.4 0.2 5.0 113.5 0.7 0.0 0.4 0.5 0.4 0.1 0.2 0.3 0.1 380.9 0.9 0.1 0.4 0.3 0.2 0.1 1.7 0.0 0.0 0.0 0.4 0.0 2.5 0.1 0.1 0.1 0.0 0.0 88.1 0.5 0.3 0.0 1.9 0.4 0.3 0.0 0.3 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.4 0.3 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 7.4 0.1 0.0 1.7 1.2 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 38.9 99.6 0.0 0.0 0.5 8.3 0.0 3.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.9 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.3 0.0 25.3 0.0 CYP46A1 CYP46 ENSG00000036530 "Cytochrome P450 family 46 subfamily A member 1" Q9Y6A2 14 99684298-99727301 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 78.8" "Cell type enhanced" "Detected in many" "Astrocytes: 58.1;Cone photoreceptor cells: 66.7;Excitatory neurons: 53.0;Inhibitory neurons: 41.6;Rod photoreceptor cells: 28.4" "Cancer enriched" "Detected in single" 5 "glioma: 1.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 23 "dendritic cells: 3.4" "Group enriched" "Detected in some" 4 "AF22: 2.4;U-937: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.16e-1)" "unprognostic (4.30e-1)" "unprognostic (2.50e-5)" "unprognostic (9.48e-5)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (5.37e-2)" "unprognostic (4.01e-2)" "unprognostic (1.32e-5)" "unprognostic (5.21e-2)" "unprognostic (2.44e-4)" "unprognostic (5.97e-4)" "unprognostic (1.59e-1)" "unprognostic (1.15e-2)" "unprognostic (3.88e-3)" 2.0 2.0 40.9 0.3 78.8 0.0 0.8 18.3 67.2 1.4 14.6 0.6 0.2 1.5 0.9 0.2 1.1 0.4 4.6 49.8 37.2 1.4 1.3 0.6 0.6 38.3 28.7 52.4 1.6 2.2 1.9 16.7 0.0 45.9 1.5 0.2 5.2 1.4 0.6 1.2 0.4 0.5 0.8 18.4 0.2 0.7 2.5 34.4 0.4 1.8 0.5 0.1 0.9 0.7 36.5 0.0 0.0 2.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 40.9 78.8 18.3 67.2 49.8 37.2 38.3 28.7 52.4 45.9 18.4 34.4 36.5 3.5 3.2 6.0 58.1 0.7 1.7 6.4 0.0 1.2 11.5 1.8 3.3 7.0 2.8 1.8 1.8 66.7 0.2 8.7 0.0 1.9 0.2 0.7 0.9 5.0 7.6 0.0 0.0 53.0 1.1 0.3 4.0 0.5 0.6 1.3 2.1 2.9 3.4 0.6 8.4 41.6 0.0 0.0 2.1 3.0 1.3 4.7 0.9 3.6 6.5 1.1 20.8 0.0 23.6 11.8 0.1 0.1 4.1 2.2 4.1 0.0 7.4 0.9 28.4 0.0 8.1 3.9 9.4 5.3 0.0 1.4 0.1 1.5 2.7 0.1 3.5 ZZZ3 "ATAC1, DKFZP564I052" ENSG00000036549 "Zinc finger ZZ-type containing 3" Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 73.8;Excitatory neurons: 102.1;Inhibitory neurons: 100.7;Microglial cells: 77.8;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 280.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635" "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 9.0 12.3 5.9 10.2 10.3 9.7 17.3 5.7 7.0 13.1 3.0 9.7 9.0 13.2 9.3 9.9 11.3 8.7 11.2 5.2 6.5 14.6 16.8 8.2 12.9 6.2 7.1 4.0 17.1 9.8 14.0 6.1 10.6 8.0 12.0 9.6 11.4 10.5 12.3 8.8 10.9 8.2 12.1 7.9 9.9 10.5 6.6 7.8 14.4 19.9 10.3 12.5 10.5 6.6 16.1 27.9 12.4 22.4 17.9 21.3 30.3 26.0 32.6 27.9 27.7 31.3 15.5 12.9 34.8 29.3 27.2 32.3 24.3 29.3 22.2 44.4 25.9 26.9 41.1 26.9 19.8 33.2 45.5 12.0 26.0 34.2 31.0 63.4 30.1 31.2 24.2 41.4 24.0 27.3 13.1 22.0 13.7 35.1 15.9 29.5 25.9 40.3 17.1 22.5 26.1 30.0 26.5 19.2 23.0 60.6 16.4 13.0 25.7 24.9 23.7 29.9 40.2 44.6 20.3 30.8 36.7 27.2 39.2 19.3 0.1 4.3 5.3 6.1 4.5 9.6 7.3 7.6 7.7 7.4 9.0 9.5 8.6 0.8 7.8 5.0 4.9 10.4 5.1 5.9 10.3 5.7 7.0 5.2 6.5 6.2 7.1 4.0 8.0 7.9 7.8 16.1 11.3 0.0 0.0 73.8 22.2 17.2 13.6 10.9 27.9 18.1 0.0 0.0 0.0 15.7 5.6 0.0 8.4 13.3 14.3 6.9 0.0 0.0 5.1 0.0 0.0 10.5 19.8 17.4 102.1 0.0 12.3 11.0 16.3 0.0 0.0 0.0 15.0 15.1 14.1 16.8 100.7 14.1 6.1 13.2 11.8 3.9 16.8 8.2 12.4 77.8 7.5 16.1 17.5 141.8 280.3 0.0 14.0 19.5 14.9 18.7 10.1 0.0 4.2 19.7 6.6 29.6 11.4 7.8 9.7 28.1 19.6 8.5 14.2 0.0 14.2 14.2 SLC18A1 "CGAT, VAT1, VMAT1" ENSG00000036565 "Solute carrier family 18 member A1" P54219 8 20144855-20183206 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "adrenal gland: 25.3" "Cell type enriched" "Detected in some" 27 "Enteroendocrine cells: 139.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.8" "Region enriched" "Detected in single" 4 "midbrain: 1.7" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.8" "Lineage enriched" "Detected in single" 19 "monocytes: 2.8" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 67.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA006877, HPA063797" Enhanced NA NA "HPA006877: AB_2667690, HPA063797: AB_2685125" "unprognostic (8.03e-4)" "unprognostic (1.02e-1)" "unprognostic (3.75e-3)" "unprognostic (3.50e-1)" "unprognostic (6.61e-2)" "unprognostic (3.09e-3)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (3.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-2)" "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" 0.1 25.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 1.2 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 3.8 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.7 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 139.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381711 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 169.9;testis: 87.2" "Group enriched" "Detected in many" 5 "Early spermatids: 460.0;Late spermatids: 1094.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 14.5;U-266/70: 56.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 5.7 13.5 11.8 1.6 18.9 1.9 4.2 16.5 18.4 4.8 26.2 10.3 14.1 5.2 5.7 9.9 11.7 2.4 58.3 18.8 14.4 53.9 19.0 3.4 0.1 12.8 12.0 10.7 6.2 18.3 24.4 19.0 1.3 14.5 4.1 6.1 76.9 7.7 3.0 169.9 11.9 17.5 6.8 7.9 0.6 6.2 87.2 14.9 0.6 3.8 63.3 0.6 4.5 4.9 17.1 6.0 0.5 0.9 3.2 0.1 0.2 1.3 0.7 0.4 0.0 0.6 6.1 0.8 10.2 1.8 1.1 1.4 1.0 7.9 2.9 0.2 7.2 1.0 2.8 4.4 12.5 2.7 0.0 2.8 0.9 0.6 0.7 2.0 1.3 0.6 7.6 14.5 0.8 1.7 4.1 0.0 0.6 1.6 2.0 1.3 0.1 2.1 1.5 4.6 0.3 11.9 3.6 3.4 2.6 0.7 1.7 8.8 6.2 0.0 0.0 1.5 0.8 1.0 56.9 13.5 0.2 0.1 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 16.5 18.4 18.8 14.4 12.8 12.0 10.7 14.5 7.9 14.9 17.1 0.6 3.2 2.7 10.7 0.6 2.4 5.3 1.5 1.2 75.2 3.3 2.4 85.2 7.2 6.1 5.5 95.9 0.5 1.6 25.5 113.5 3.1 460.0 39.0 3.0 3.6 0.0 0.4 15.7 1.6 0.9 7.4 2.0 8.4 0.0 2.0 2.2 23.0 17.2 10.1 11.6 2.0 0.0 1.3 2.9 1094.1 6.5 2.1 0.0 1.9 0.0 49.7 0.0 8.0 12.5 1.2 11.8 7.2 0.1 1.1 41.3 41.6 35.0 140.0 19.7 43.3 24.0 50.5 16.5 12.9 4.0 1.4 1.3 0.5 2.6 2.9 CASR "FHH, GPRC2A, HHC, HHC1, NSHPT" ENSG00000036828 "Calcium sensing receptor" P41180 3 122183668-122291629 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "parathyroid gland: 659.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 5.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039686, HPA050335" Enhanced NA NA "HPA039686: AB_10673536, HPA050335: AB_2681092" "unprognostic (1.97e-2)" "unprognostic (7.40e-2)" "unprognostic (8.20e-4)" "unprognostic (3.15e-1)" "unprognostic (8.55e-4)" "unprognostic (1.58e-1)" "unprognostic (7.32e-2)" "unprognostic (7.67e-2)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (1.91e-5)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.24e-2)" 0.1 0.1 1.2 0.1 1.0 0.8 0.0 1.7 1.6 0.0 0.2 0.1 0.8 0.0 0.1 0.0 0.1 4.2 0.0 0.9 0.5 22.6 0.2 0.0 0.2 1.0 1.1 1.3 0.5 9.6 659.4 0.2 0.0 1.4 0.1 0.2 1.5 0.1 0.0 0.1 0.2 0.5 0.0 0.2 0.1 2.8 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 2.8 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 1.0 1.7 1.6 0.9 0.5 1.0 1.1 1.3 1.4 0.2 1.7 2.8 0.0 25.6 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 27.1 5.6 3.7 0.0 0.0 0.0 0.0 13.7 4.3 0.5 0.0 0.0 0.5 11.5 0.0 0.3 0.2 0.0 1.6 0.0 0.0 1.3 20.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 1.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.0 0.0 0.2 15.3 1.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.9 0.8 0.0 0.0 TUBG2 ENSG00000037042 "Tubulin gamma 2" Q9NRH3 17 42659284-42667006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB011495 Approved Supported "Centriolar satellite" NA NA "Centriolar satellite" "CAB011495: AB_443396" "unprognostic (2.60e-1)" "unprognostic (5.85e-3)" "unprognostic (6.21e-3)" "unprognostic (5.79e-2)" "unprognostic (1.33e-3)" "unprognostic (5.11e-2)" "prognostic unfavorable (4.68e-5)" "unprognostic (3.53e-2)" "unprognostic (2.20e-2)" "unprognostic (7.88e-3)" "unprognostic (1.82e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.31e-2)" "unprognostic (3.59e-2)" "unprognostic (3.73e-1)" "unprognostic (7.61e-3)" 20.7 39.1 84.2 6.5 87.3 3.1 21.5 74.7 105.6 35.9 64.1 26.1 6.2 28.4 14.7 13.9 28.8 11.0 23.8 86.2 79.9 34.8 18.2 18.8 7.9 87.4 81.7 82.6 28.4 76.7 18.3 44.2 9.6 90.6 33.9 5.5 14.0 17.2 23.2 8.9 13.4 14.5 14.4 73.9 17.2 30.7 19.2 91.7 5.9 23.9 9.1 5.6 33.4 31.7 95.3 10.2 20.2 9.9 14.6 38.4 20.8 6.4 17.7 19.8 13.8 13.7 11.4 7.0 5.0 10.6 25.6 14.8 36.8 0.0 16.1 11.3 9.9 11.5 3.8 29.0 23.3 16.6 0.0 13.0 22.7 16.1 15.7 17.5 24.0 10.1 11.4 1.1 10.8 27.3 20.9 9.8 8.2 3.5 10.1 5.1 7.5 6.2 11.3 15.0 10.4 11.2 7.6 11.3 18.0 12.1 17.7 34.7 4.8 11.7 43.9 3.1 11.0 10.3 56.5 10.8 1.5 15.6 0.0 26.3 0.0 0.9 0.2 3.0 0.5 1.4 1.2 3.3 1.1 0.9 0.5 3.5 2.3 0.2 1.0 0.1 4.5 1.6 1.8 84.2 87.3 74.7 105.6 86.2 79.9 87.4 81.7 82.6 90.6 73.9 91.7 95.3 6.9 3.2 4.2 22.9 3.6 5.5 15.9 7.8 36.5 17.6 9.6 13.7 11.3 4.3 5.6 3.7 4.2 5.5 3.0 0.5 17.6 5.1 7.7 1.8 7.9 7.3 1.2 24.4 44.9 9.1 4.2 13.4 14.3 1.9 11.4 6.7 9.3 3.7 3.6 20.2 33.1 1.7 2.0 2.5 3.7 11.1 17.4 2.8 16.0 10.3 3.1 7.8 1.0 19.6 25.8 5.1 0.4 21.4 9.7 5.2 0.1 24.3 7.1 5.4 13.1 10.3 11.4 5.1 5.0 9.4 4.0 2.5 3.9 7.9 0.5 7.3 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 408.0;Spermatocytes: 316.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 25.3 46.2 30.5 29.2 31.7 39.4 27.6 32.0 39.4 23.5 29.3 24.7 25.4 28.7 38.0 37.8 26.8 22.3 38.2 32.8 33.1 42.2 48.3 22.3 34.7 31.8 31.0 30.7 25.9 25.1 34.8 30.5 24.0 33.1 25.7 26.5 18.0 24.8 29.2 38.1 21.3 22.0 26.2 31.5 27.0 26.4 91.9 31.5 34.3 29.8 28.3 29.3 30.7 25.7 32.1 129.8 114.7 101.9 140.8 68.9 72.3 131.7 120.6 70.6 170.5 151.1 141.1 135.3 96.6 301.5 166.6 181.6 82.1 170.1 239.8 156.4 124.1 220.9 71.6 122.8 174.5 135.1 105.7 60.8 91.0 99.2 176.1 122.3 69.1 99.2 93.6 100.3 79.0 123.1 286.6 129.5 165.6 65.2 59.7 180.5 93.3 157.5 128.4 101.0 80.1 102.0 62.7 110.6 100.2 167.6 64.7 122.8 111.5 105.4 193.2 109.0 114.3 92.5 70.3 119.0 182.3 152.6 130.2 117.6 25.4 86.6 39.9 33.1 80.5 42.7 50.4 40.4 46.1 99.5 38.1 32.9 42.0 42.9 39.5 72.2 68.1 55.8 55.7 30.5 31.7 32.0 39.4 32.8 33.1 31.8 31.0 30.7 33.1 31.5 31.5 32.1 41.5 41.7 32.8 4.6 29.8 48.8 56.9 191.3 32.5 18.8 50.2 61.8 45.5 41.5 82.7 58.8 18.8 111.6 28.7 36.2 181.9 119.0 408.0 98.4 70.0 47.7 40.2 49.2 4.5 113.0 124.5 45.3 29.6 70.6 26.6 60.2 41.4 132.1 115.0 15.2 5.2 48.6 93.6 48.6 51.9 79.9 37.9 45.6 51.6 2.8 93.5 61.7 49.4 2.0 5.0 138.0 38.6 41.0 59.2 67.9 48.2 216.2 92.4 20.2 19.7 35.6 56.1 316.7 178.6 70.5 52.8 78.9 28.9 81.1 59.1 57.7 FLT4 "PCL, VEGFR-3, VEGFR3" ENSG00000037280 "Fms related receptor tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 31 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 20000000 290000000 "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.4 11.4 3.6 4.7 4.0 0.9 14.8 2.3 3.5 9.0 2.7 4.7 2.8 8.1 3.0 4.4 9.9 3.8 6.9 4.8 2.4 19.9 6.3 17.1 5.5 3.1 2.7 1.6 4.5 2.0 2.3 7.9 6.5 3.2 5.6 1.3 0.3 2.0 2.5 4.8 3.8 7.3 4.1 2.3 17.8 3.5 3.1 3.8 1.0 26.0 4.1 1.4 5.7 5.6 3.3 0.1 2.5 3.2 10.1 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.4 0.3 0.3 0.9 0.1 0.6 0.4 3.4 0.2 0.3 0.1 15.6 1.2 0.5 0.5 0.1 9.5 0.3 0.2 0.1 0.2 0.4 0.3 9.9 12.3 0.4 0.4 2.1 5.6 0.1 0.5 7.0 0.3 0.6 8.2 0.1 0.1 0.1 0.3 0.3 1.1 0.1 0.2 0.1 3.1 14.6 0.3 15.7 0.2 6.9 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.5 0.0 3.8 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 3.6 4.0 2.3 3.5 4.8 2.4 3.1 2.7 1.6 3.2 2.3 3.8 3.3 27.4 0.0 1.7 0.7 0.7 0.9 0.2 0.0 1.2 0.2 1.4 1.4 4.5 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 27.1 0.0 0.0 0.2 0.0 37.1 0.8 0.0 0.1 2.5 2.4 64.6 0.6 1.2 0.0 0.1 0.0 0.0 3.3 0.8 0.7 0.3 0.6 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.7 0.7 0.1 5.2 0.1 1.1 1.0 1.8 0.2 0.0 0.1 NSUN2 "FLJ20303, Misu, MRT5, TRM4" ENSG00000037474 "NOP2/Sun RNA methyltransferase 2" Q08J23 5 6599239-6633291 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037896 Supported Approved Nucleoplasm "Intracellular and membrane" NA NA 110000 Nucleoplasm "HPA037896: AB_10670532" "unprognostic (3.99e-2)" "unprognostic (5.73e-2)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (8.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.44e-3)" "unprognostic (5.12e-2)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (2.48e-2)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.98e-1)" "unprognostic (1.47e-1)" "unprognostic (4.30e-3)" "unprognostic (1.70e-2)" 21.8 16.2 10.6 29.4 11.0 28.4 39.0 11.3 13.5 16.3 12.2 25.0 21.0 18.4 19.6 24.4 17.8 17.9 23.2 10.9 12.0 16.5 37.0 19.6 34.6 11.8 11.4 10.1 18.2 20.1 25.1 11.6 20.0 12.7 20.8 28.0 11.0 18.0 17.2 39.3 22.8 20.6 22.6 10.5 23.2 21.6 19.1 11.5 26.7 18.1 30.5 37.1 29.6 15.1 13.4 97.6 85.8 49.9 45.4 31.7 36.1 112.9 72.5 48.6 84.4 71.5 113.0 75.6 170.6 74.0 63.8 101.6 70.7 102.1 90.6 114.6 115.1 73.4 100.8 199.0 67.0 44.8 176.8 77.4 40.2 67.5 91.8 80.5 33.6 60.6 70.3 132.3 66.3 79.9 71.1 93.2 89.3 80.0 69.3 101.3 121.1 50.5 54.7 61.7 112.1 45.8 65.4 184.4 101.2 79.1 65.0 85.0 84.2 66.6 66.8 82.0 68.4 111.1 51.2 100.1 159.9 52.9 143.9 77.6 16.2 18.6 21.2 21.1 22.4 27.9 22.4 22.1 25.0 21.5 20.6 23.2 23.5 3.9 24.4 21.2 20.2 17.0 17.0 10.6 11.0 11.3 13.5 10.9 12.0 11.8 11.4 10.1 12.7 10.5 11.5 13.4 13.2 19.2 17.6 27.7 26.3 37.7 16.4 15.7 21.6 6.2 15.5 14.2 18.7 17.2 30.3 18.4 14.6 20.1 17.1 16.2 9.8 19.6 3.1 11.2 12.9 16.2 14.9 22.3 37.2 15.3 21.2 14.5 17.9 14.1 20.8 17.8 10.0 33.9 14.4 3.3 30.2 16.5 16.2 18.5 21.1 2.9 13.1 16.4 16.0 20.6 21.9 7.2 21.6 24.1 45.4 24.8 14.8 14.3 23.0 18.9 10.2 9.8 17.4 7.3 6.6 20.2 15.4 14.9 17.7 30.1 30.5 23.1 20.7 17.2 19.8 17.0 FBXO42 "Fbx42, KIAA1332" ENSG00000037637 "F-box protein 42" Q6P3S6 1 16246840-16352480 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025071 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025071: AB_1848461" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (3.72e-4)" "unprognostic (3.22e-2)" "unprognostic (4.00e-2)" "unprognostic (4.22e-2)" "unprognostic (3.96e-2)" "unprognostic (4.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-1)" "unprognostic (5.78e-3)" "unprognostic (3.91e-2)" 14.2 12.7 16.3 8.9 16.0 9.4 13.0 19.6 16.5 19.7 14.3 13.4 7.6 20.0 13.0 18.3 18.8 12.0 16.7 15.9 16.7 11.0 14.4 13.7 12.6 16.3 15.9 16.9 18.4 15.4 14.1 16.4 12.2 17.7 19.4 10.7 16.9 13.6 15.2 22.8 28.3 11.2 18.1 14.9 13.9 12.2 11.7 16.1 18.3 14.7 22.5 14.4 19.1 18.1 17.8 15.4 8.2 19.4 19.8 23.1 15.0 8.5 15.6 23.5 22.0 21.4 7.7 13.9 16.2 13.6 21.7 15.1 13.6 19.8 14.8 17.9 18.7 9.3 15.2 12.5 8.8 27.5 18.1 19.0 16.1 33.5 19.4 27.8 20.0 22.3 20.0 16.5 22.1 15.8 10.5 17.5 15.8 8.5 20.3 9.2 19.6 11.9 14.5 14.8 4.3 18.3 12.0 17.6 14.6 18.8 17.7 11.9 14.0 14.0 11.1 9.8 18.4 12.3 10.9 11.9 16.3 14.7 23.5 15.6 9.0 11.8 18.5 11.7 16.3 8.7 8.5 8.7 7.5 14.0 14.1 9.8 8.7 10.5 12.4 12.7 6.1 12.4 7.9 16.3 16.0 19.6 16.5 15.9 16.7 16.3 15.9 16.9 17.7 14.9 16.1 17.8 9.2 12.8 11.8 47.0 16.0 25.9 6.1 13.5 22.2 21.7 7.1 7.1 20.6 15.7 9.4 12.9 45.9 11.0 16.6 6.7 0.0 8.5 9.4 21.7 15.5 9.9 10.7 10.8 63.9 7.6 15.6 14.7 11.7 33.1 2.5 12.8 9.7 9.6 13.8 28.6 65.9 5.6 10.2 15.1 28.1 10.2 14.9 13.4 1.8 35.6 19.2 11.0 15.5 60.8 53.0 8.4 7.6 11.3 17.7 10.4 8.8 3.8 6.4 20.4 13.1 23.1 13.4 13.5 9.7 18.9 34.7 26.3 16.0 9.8 8.3 5.5 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038959-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.3;Inhibitory neurons: 24.5;Microglial cells: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: AB_2680672" "unprognostic (6.02e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 16.1 8.6 5.5 13.3 5.7 12.3 12.6 8.3 7.0 13.3 10.0 10.9 9.6 12.1 9.9 14.8 9.8 11.9 14.2 5.4 8.0 13.7 13.8 11.4 10.6 6.2 6.2 4.6 9.5 7.1 24.5 3.1 19.8 7.3 9.5 10.9 12.3 7.2 9.0 10.5 7.7 9.6 16.7 6.6 11.5 9.7 5.7 6.8 11.9 13.5 17.2 13.1 16.3 6.6 7.4 14.9 19.7 36.5 37.7 29.8 24.7 31.5 26.4 28.0 27.0 37.1 27.4 34.1 25.0 30.6 26.3 25.8 33.5 32.5 35.6 41.9 9.5 21.0 15.7 26.5 12.9 29.5 27.7 16.0 29.2 32.4 35.0 29.1 22.6 38.4 19.9 17.5 20.5 21.4 11.0 15.2 9.9 20.0 16.0 9.9 14.6 40.7 20.8 20.8 21.0 32.1 40.3 27.4 35.0 31.1 30.1 34.6 14.8 32.9 34.3 26.4 19.4 26.9 25.7 33.5 21.4 18.7 19.2 27.4 6.7 7.5 11.9 5.0 7.9 6.9 2.4 4.0 3.5 8.1 2.5 5.2 4.1 6.8 6.5 5.6 3.7 3.9 4.3 5.5 5.7 8.3 7.0 5.4 8.0 6.2 6.2 4.6 7.3 6.6 6.8 7.4 9.7 0.0 0.5 14.0 3.5 6.0 1.0 6.1 6.2 3.2 1.6 1.5 2.7 0.0 3.9 5.5 6.2 4.3 2.7 1.9 1.9 1.4 7.1 1.4 4.3 7.6 0.0 9.1 24.3 1.1 3.0 3.9 4.1 2.2 4.5 2.1 1.4 1.9 1.9 3.3 24.5 1.2 8.2 0.6 4.4 4.9 1.8 2.7 8.8 17.8 0.7 6.9 1.0 12.1 15.1 1.1 0.3 0.0 9.5 1.3 2.1 1.1 4.6 4.6 0.0 1.5 3.3 3.9 2.0 4.3 5.5 6.0 4.0 1.2 1.0 1.5 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764522-13774282 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No 880000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: AB_2678141" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 15.7 19.4 8.3 9.1 8.3 9.6 18.7 9.2 8.9 24.9 7.1 17.2 9.6 21.7 4.2 20.7 22.0 5.4 12.9 7.8 7.9 22.2 23.9 16.0 10.6 9.1 8.0 8.6 24.6 19.8 7.8 18.2 12.0 8.5 19.5 6.5 5.3 20.7 8.8 11.7 25.0 21.3 5.3 7.4 23.3 18.4 3.7 8.0 7.9 23.2 4.4 8.8 17.7 22.6 11.2 14.7 9.3 5.5 13.1 6.1 9.5 13.0 17.9 9.3 13.8 12.4 9.9 11.5 7.9 6.5 6.6 7.3 25.4 24.5 15.5 10.8 12.6 39.3 6.6 18.5 12.0 4.7 20.3 14.8 9.9 9.4 7.1 6.0 14.3 13.7 7.9 11.6 0.6 7.4 18.7 21.9 14.3 9.1 6.0 27.2 20.5 7.6 17.4 8.1 11.4 10.4 9.9 6.6 13.9 14.5 7.7 11.1 8.2 8.2 8.2 7.6 29.3 8.8 11.0 11.3 2.4 6.8 22.5 9.7 3.4 1.8 0.7 1.7 1.7 1.8 1.5 1.7 2.2 1.4 1.6 1.3 1.1 1.6 1.8 1.1 2.7 1.5 1.3 8.3 8.3 9.2 8.9 7.8 7.9 9.1 8.0 8.6 8.5 7.4 8.0 11.2 9.2 9.6 19.8 15.0 10.8 11.1 8.9 10.8 6.8 4.3 9.0 8.4 0.9 8.6 13.4 16.5 8.4 13.2 17.2 8.1 5.9 9.2 0.7 11.5 14.4 13.8 9.1 13.3 22.3 12.7 8.7 12.3 14.3 14.2 13.3 9.9 12.8 10.0 7.2 1.7 19.6 9.3 6.1 7.2 8.4 1.7 17.4 7.4 1.8 9.4 10.5 5.0 17.5 18.1 15.2 6.8 11.0 15.1 13.3 4.7 16.5 10.5 19.2 9.3 26.3 10.8 13.3 0.3 4.5 13.3 11.4 5.3 16.0 22.2 9.8 6.8 METTL1 "C12orf1, TRM8, TRMT8" ENSG00000037897 "Methyltransferase like 1" Q9UBP6 12 57768471-57772119 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "RH-30: 293.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020914, HPA050450" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020914: AB_1853830, HPA050450: AB_2681130" "unprognostic (5.24e-2)" "unprognostic (2.60e-1)" "unprognostic (9.43e-2)" "unprognostic (3.46e-1)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (4.25e-6)" "unprognostic (5.67e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.55e-6)" "unprognostic (7.75e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" 11.2 23.4 9.4 9.9 9.7 11.0 12.9 9.3 12.0 9.7 10.2 8.2 4.0 10.9 21.0 13.2 10.3 5.5 10.0 9.8 9.9 22.2 17.7 9.4 8.2 9.8 9.8 9.6 11.4 28.3 9.2 12.8 8.8 9.7 13.5 10.9 3.7 10.7 7.2 15.6 10.7 7.0 12.4 9.6 9.0 9.9 10.0 9.9 4.8 14.4 7.0 9.3 16.7 9.5 9.7 24.7 44.1 17.7 14.9 22.6 15.7 23.4 24.8 23.1 41.9 24.7 32.0 32.6 28.8 45.7 33.0 23.1 27.9 27.4 39.8 38.0 17.2 32.6 34.9 17.4 35.0 17.9 39.0 17.4 14.7 32.7 47.8 33.5 18.9 22.2 17.8 34.1 28.2 23.1 47.0 26.1 39.6 40.6 29.1 41.5 23.0 293.1 43.1 33.6 29.8 18.7 16.2 26.9 29.6 22.9 16.0 38.5 32.0 17.1 17.4 18.0 29.6 34.0 13.2 9.3 32.6 24.4 25.3 34.5 0.0 7.1 0.0 8.0 10.8 27.4 6.9 10.0 9.6 16.3 10.5 13.4 13.2 1.1 12.9 1.8 19.3 5.1 7.5 9.4 9.7 9.3 12.0 9.8 9.9 9.8 9.8 9.6 9.7 9.6 9.9 9.7 6.3 9.6 3.3 0.7 8.3 10.5 17.1 14.8 13.6 3.7 12.2 12.4 4.3 10.0 14.1 5.5 0.0 18.7 3.1 6.3 25.4 16.8 12.1 5.3 13.2 8.2 6.6 6.3 0.8 24.1 25.3 11.3 10.2 8.9 12.7 8.7 3.3 7.9 22.7 3.3 0.6 8.4 12.2 2.2 9.8 10.9 11.1 6.4 7.2 0.0 16.7 2.6 3.1 3.5 1.1 12.3 2.3 4.9 14.9 15.4 1.1 60.4 2.6 5.4 0.0 9.7 13.0 8.0 17.7 12.1 10.4 9.7 4.1 14.0 10.7 11.3 HOXC8 "HOX3, HOX3A" ENSG00000037965 "Homeobox C8" P31273 12 54008985-54012769 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 15.6;skeletal muscle: 17.0" "Cell type enhanced" "Detected in some" "Fibroblasts: 12.2;Granulosa cells: 11.0;Melanocytes: 10.6;Peritubular cells: 7.9;Proximal tubular cells: 7.4;Skeletal myocytes: 17.9;Smooth muscle cells: 7.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 41.6;ASC TERT1: 27.6;fHDF/TERT166: 49.8;HSkMC: 33.2;LHCN-M2: 38.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "spinal cord: 10.5" "HPA028911, CAB037020" Uncertain Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "CAB037020: AB_1840935, HPA028911: AB_10602236" "unprognostic (1.03e-1)" "unprognostic (5.90e-2)" "unprognostic (6.26e-6)" "unprognostic (4.89e-2)" "unprognostic (5.20e-4)" "unprognostic (5.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (1.45e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-2)" "unprognostic (1.14e-2)" 5.2 5.3 0.0 0.8 0.0 0.0 5.6 0.0 0.0 0.3 0.0 0.3 0.0 0.4 15.6 0.2 8.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 1.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.3 0.0 0.1 17.0 3.0 5.7 7.7 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 1.0 2.7 0.0 15.0 41.6 27.6 0.2 2.8 0.1 4.9 3.1 4.4 2.4 0.0 0.3 49.8 0.8 2.0 3.9 1.2 5.4 5.3 5.3 0.9 2.1 0.0 4.9 0.0 5.8 33.2 3.9 15.7 9.0 0.5 0.4 0.8 0.6 0.0 38.7 1.2 0.0 0.4 0.0 0.3 0.7 0.0 0.0 0.0 6.1 0.0 0.0 2.0 5.4 1.0 13.8 3.6 1.6 0.0 0.0 1.0 8.0 6.8 1.7 0.1 0.0 0.0 0.9 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 4.6 0.1 0.0 1.2 0.0 1.5 2.9 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 12.2 0.0 0.0 0.0 11.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.2 6.2 0.2 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.3 7.4 0.0 1.3 6.6 17.9 7.6 5.6 3.1 0.2 4.3 0.3 0.3 3.2 0.1 0.1 AGA ASRG ENSG00000038002 Aspartylglucosaminidase P20933 4 177430774-177442437 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 77.5;Karpas-707: 111.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031415, HPA031417" Enhanced "Intracellular and membrane" NA NA 36000000 "HPA031415: AB_10603578, HPA031417: AB_10670967" "unprognostic (8.76e-2)" "unprognostic (1.56e-1)" "unprognostic (2.22e-3)" "unprognostic (2.11e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (8.61e-4)" "prognostic unfavorable (1.99e-4)" "unprognostic (3.79e-1)" "unprognostic (6.44e-2)" "unprognostic (4.23e-2)" "unprognostic (4.28e-2)" "unprognostic (1.09e-1)" "unprognostic (7.49e-2)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (7.42e-2)" "unprognostic (1.47e-2)" 9.5 13.4 8.9 9.2 10.9 15.5 21.3 10.6 12.1 9.3 15.9 13.3 9.7 8.6 30.5 16.0 8.4 13.2 7.5 9.1 13.4 15.4 18.8 11.7 12.3 12.0 10.0 8.6 10.3 15.2 17.2 6.2 8.5 11.7 11.9 13.2 6.6 15.0 9.9 9.1 20.8 12.5 9.6 10.1 10.4 16.4 13.3 9.7 11.2 16.0 5.8 15.8 11.0 8.3 14.7 5.4 11.9 13.3 18.8 14.9 13.2 9.0 39.5 77.5 20.1 24.8 6.2 26.2 26.9 7.2 30.0 9.7 6.5 11.3 13.0 39.4 17.3 7.5 11.2 11.9 17.3 10.0 19.6 7.4 9.6 22.5 14.7 6.5 18.0 18.7 11.4 10.3 111.6 8.0 14.6 15.9 12.0 5.2 10.5 12.2 5.0 5.4 4.0 20.5 12.9 7.3 16.4 11.9 10.3 32.2 9.9 23.3 39.8 6.1 13.9 12.3 6.6 15.2 21.2 17.4 14.0 22.3 22.0 16.0 26.4 15.3 23.9 15.6 27.5 17.9 13.9 16.6 18.8 14.8 12.9 14.8 21.3 3.3 12.7 35.8 15.8 17.8 15.1 8.9 10.9 10.6 12.1 9.1 13.4 12.0 10.0 8.6 11.7 10.1 9.7 14.7 12.6 12.8 13.5 2.6 20.5 24.0 17.4 26.9 12.5 3.9 19.8 16.9 7.5 15.7 21.7 14.7 2.1 26.3 17.6 8.4 5.9 28.2 13.6 8.9 8.5 10.9 5.4 7.8 3.7 31.3 32.0 16.0 13.7 12.5 14.0 13.9 8.2 23.5 23.1 6.7 2.3 18.2 14.2 15.4 23.3 9.2 11.1 15.9 39.2 2.8 23.8 19.1 11.3 3.5 19.3 21.4 9.1 9.8 48.8 13.4 15.1 22.1 10.5 4.8 0.0 8.4 14.1 35.8 36.6 23.7 27.3 22.7 22.5 14.1 13.6 17.7 PI4K2B "FLJ11105, PI4KIIB, PIK42B" ENSG00000038210 "Phosphatidylinositol 4-kinase type 2 beta" Q8TCG2 4 25160663-25279204 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004099 Enhanced Supported Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (1.02e-1)" "unprognostic (6.34e-3)" "prognostic favorable (9.64e-5)" "unprognostic (2.75e-2)" "unprognostic (1.98e-2)" "unprognostic (2.68e-2)" "unprognostic (7.54e-2)" "unprognostic (7.75e-2)" "unprognostic (5.06e-1)" "unprognostic (6.39e-3)" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (9.07e-2)" "unprognostic (9.61e-2)" "unprognostic (2.39e-2)" "unprognostic (2.02e-2)" "unprognostic (4.47e-2)" 8.0 9.0 3.6 14.1 4.1 14.2 16.7 4.0 4.5 11.5 6.0 18.9 39.4 8.1 5.9 16.9 8.8 8.4 4.5 3.5 5.2 13.0 58.3 16.6 18.3 4.6 3.9 3.1 5.3 9.6 7.8 3.4 12.1 4.6 11.6 20.6 4.9 23.7 8.0 2.4 13.2 31.8 9.2 4.6 13.6 22.9 12.2 4.1 19.9 24.3 4.9 19.1 14.4 8.2 5.7 33.8 9.9 16.7 14.6 18.2 33.9 31.3 50.8 48.6 48.4 58.1 14.0 37.7 86.3 11.5 45.3 37.5 14.7 37.3 24.6 41.7 28.9 12.2 30.4 23.3 26.1 14.2 61.9 21.0 21.6 17.9 18.6 19.2 12.9 28.0 27.0 20.7 76.2 37.0 18.8 58.3 39.7 23.6 40.5 13.6 34.4 58.1 47.5 32.2 32.2 28.9 6.2 24.5 17.1 12.0 17.0 25.7 27.3 33.8 31.8 8.4 18.3 32.5 76.3 49.5 77.4 34.5 45.4 30.6 5.3 1.1 3.4 1.5 1.2 1.0 1.4 1.5 1.5 0.8 1.2 1.2 1.4 1.7 0.9 0.9 1.5 3.5 0.6 3.6 4.1 4.0 4.5 3.5 5.2 4.6 3.9 3.1 4.6 4.6 4.1 5.7 5.6 6.4 18.5 21.5 14.9 15.0 15.8 9.9 8.0 2.1 8.4 5.3 0.0 5.7 12.2 9.2 0.0 21.6 6.7 20.2 5.9 5.5 1.0 10.0 3.4 7.1 8.4 25.7 8.7 7.1 12.6 6.1 16.3 8.5 0.0 3.5 6.8 40.4 10.3 1.7 13.7 13.7 8.2 15.4 13.9 1.0 4.4 8.6 5.4 11.2 10.3 0.7 4.1 30.2 20.1 5.8 8.2 4.5 27.4 14.1 16.8 20.3 10.4 3.4 0.0 5.3 7.2 9.6 10.3 18.3 15.6 13.5 10.3 4.4 13.9 18.2 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627725 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 15.5 10.7 12.5 17.7 13.2 42.0 16.4 18.5 15.1 14.4 10.8 15.6 10.9 16.8 17.0 12.9 14.9 12.5 11.8 12.1 11.9 11.6 11.2 13.0 21.9 14.2 13.3 9.7 23.2 13.8 22.7 9.2 16.8 13.7 12.5 12.6 22.2 14.6 12.8 11.4 17.8 19.0 11.9 11.9 22.1 14.4 16.8 12.6 25.5 13.8 14.2 21.0 12.8 14.1 16.4 17.6 23.2 22.7 16.3 27.0 28.4 17.4 20.0 21.0 16.3 18.1 17.6 18.7 23.6 8.9 22.0 30.2 11.7 18.7 19.9 31.2 16.3 10.7 33.2 31.0 21.6 16.6 50.5 26.4 22.9 22.1 33.7 25.9 22.3 17.0 16.4 23.8 27.4 20.6 10.5 26.2 33.4 29.2 11.3 19.9 19.8 33.6 9.6 30.6 17.5 13.5 24.6 22.0 7.7 18.2 24.3 9.1 19.3 38.9 25.1 13.2 15.6 26.7 32.3 20.3 29.0 24.6 23.4 20.3 2.5 1.1 2.3 1.1 1.1 0.9 1.3 0.7 0.8 0.7 1.5 1.0 0.8 9.2 0.6 0.7 1.9 0.7 0.4 12.5 13.2 18.5 15.1 12.1 11.9 14.2 13.3 9.7 13.7 11.9 12.6 16.4 113.2 83.3 95.8 72.1 93.7 26.3 22.6 17.4 33.0 170.8 39.6 67.8 88.5 51.5 49.7 36.8 89.6 16.5 105.8 31.0 3.9 30.2 20.8 135.4 108.7 68.7 34.7 57.4 56.1 25.3 18.6 60.0 29.6 193.7 63.3 110.1 41.0 32.7 21.5 161.5 62.8 29.1 6.1 41.5 29.0 17.6 50.4 70.9 24.9 56.2 64.1 87.6 57.7 57.8 96.5 33.2 23.8 57.9 68.4 24.8 22.4 7.6 40.0 198.3 46.0 103.4 78.8 83.1 32.1 29.7 28.8 18.6 73.5 106.7 24.3 27.4 MAT2B "MATIIbeta, SDR23E1" ENSG00000038274 "Methionine adenosyltransferase 2B" Q9NZL9 5 163503114-163519354 "Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037721, HPA037722" Uncertain Approved "Plasma membrane" NA NA 1100000 "Plasma membrane" "HPA037721: AB_10672389, HPA037722: AB_10671718" "unprognostic (1.22e-2)" "unprognostic (2.80e-2)" "unprognostic (1.80e-3)" "unprognostic (1.64e-1)" "unprognostic (5.06e-1)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (9.72e-2)" "unprognostic (1.68e-1)" "unprognostic (5.19e-3)" "unprognostic (3.57e-2)" "prognostic favorable (4.51e-7)" "unprognostic (1.06e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-3)" 36.9 55.1 33.8 65.3 34.6 31.3 51.0 37.4 40.2 47.2 38.7 62.1 87.7 45.8 59.9 41.3 67.3 42.4 76.0 34.1 35.6 105.8 83.4 56.6 103.5 35.3 38.3 31.1 74.0 24.1 69.8 22.1 49.3 35.1 46.5 67.1 48.2 64.8 53.7 58.3 34.9 85.1 44.8 36.6 85.2 57.7 32.0 34.2 90.5 82.1 64.2 93.5 61.4 33.5 37.7 72.4 60.0 100.6 55.1 73.4 72.9 62.2 61.8 68.5 67.7 99.4 41.5 128.5 74.8 127.6 66.0 99.5 56.6 84.8 125.4 89.1 254.5 69.6 67.3 63.3 62.1 95.9 71.0 44.7 60.4 101.1 86.1 66.4 81.8 149.5 76.6 54.8 90.8 84.0 40.7 99.2 85.9 38.6 43.9 40.0 112.4 49.2 123.4 111.7 76.6 40.4 57.9 82.8 58.2 93.8 44.1 76.5 95.1 121.2 73.6 48.5 51.8 107.7 78.4 82.3 68.3 54.1 129.1 51.3 619.4 227.5 477.4 321.5 274.3 355.8 359.1 351.2 349.3 204.6 345.3 352.7 341.4 357.8 401.5 302.4 167.2 528.3 689.9 33.8 34.6 37.4 40.2 34.1 35.6 35.3 38.3 31.1 35.1 36.6 34.2 37.7 24.9 48.1 43.3 8.8 90.1 42.7 35.1 75.6 129.1 23.2 26.0 20.7 57.7 41.5 48.1 44.1 8.4 61.3 62.8 49.2 62.6 38.8 39.0 63.5 36.2 38.9 15.0 79.3 15.0 26.2 29.7 34.6 36.2 44.2 28.4 28.1 35.7 58.3 45.3 18.5 12.8 40.8 61.1 83.3 55.3 13.3 34.5 48.5 42.7 18.7 70.6 41.7 80.3 9.0 16.2 28.9 38.1 31.2 65.7 46.8 53.4 103.7 72.6 17.6 46.0 21.7 35.6 23.6 30.5 69.8 36.2 37.6 84.2 23.3 51.3 45.7 TLL1 ENSG00000038295 "Tolloid like 1" O43897 4 165873237-166104457 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Atrial septal defect, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.8;placenta: 6.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 115.1" "Cancer enhanced" "Detected in some" "renal cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 45.8" HPA060767 Approved Vesicles "Secreted to extracellular matrix" NA NA 560000 Vesicles "HPA060767: AB_2684357" "unprognostic (2.17e-1)" "unprognostic (6.45e-4)" "unprognostic (8.60e-2)" "unprognostic (2.65e-5)" "unprognostic (9.85e-2)" "unprognostic (2.51e-4)" "unprognostic (3.37e-2)" "unprognostic (3.61e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-4)" "unprognostic (2.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.76e-2)" "unprognostic (6.91e-3)" "unprognostic (1.21e-5)" 3.0 0.5 0.7 1.0 5.0 0.0 2.7 19.8 8.9 1.7 0.0 1.1 0.7 1.2 0.3 0.7 1.3 2.4 0.7 10.1 3.8 1.6 0.1 1.2 1.1 3.0 8.4 1.5 0.3 2.3 0.8 0.9 6.4 5.9 0.9 0.9 1.8 0.8 0.8 0.4 1.3 1.8 1.4 0.0 0.0 0.7 0.4 3.3 0.3 1.4 0.4 0.8 1.6 1.5 3.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 1.3 0.0 0.9 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.9 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.0 19.8 8.9 10.1 3.8 3.0 8.4 1.5 5.9 0.0 3.3 3.9 10.2 0.0 0.6 0.0 0.0 1.8 0.3 1.3 0.6 14.1 0.2 0.1 7.1 1.5 1.8 0.0 0.0 4.4 0.0 0.0 0.0 1.5 0.1 0.0 2.0 18.9 0.0 0.0 24.9 2.0 1.4 2.4 0.0 0.1 0.0 0.0 2.5 0.0 0.3 8.4 8.0 0.1 0.0 0.0 1.0 0.0 3.1 0.1 1.8 10.3 0.0 0.1 0.0 115.1 0.5 0.1 0.0 4.5 0.0 1.1 4.0 1.1 0.8 0.7 0.0 0.2 0.3 0.1 0.2 0.1 1.7 1.9 0.8 0.0 0.6 0.2 EDC4 "Ge-1, HEDLS, RCD-8" ENSG00000038358 "Enhancer of mRNA decapping 4" Q6P2E9 16 67873052-67884499 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041164, HPA043038" Supported Enhanced "Nucleoplasm,Cytoplasmic bodies" NA NA 9700 "Cytoplasmic bodies" Nucleoplasm "HPA041164: AB_2677339, HPA043038: AB_2678281" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.87e-1)" "unprognostic (7.93e-2)" "unprognostic (3.75e-3)" "unprognostic (1.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.48e-1)" "unprognostic (3.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.17e-1)" 10.1 11.9 35.5 12.1 36.5 24.6 10.7 36.6 42.5 11.7 34.2 15.6 13.8 13.0 9.6 12.2 13.3 12.2 13.9 35.2 35.5 12.2 11.0 10.9 16.4 34.8 35.3 37.6 15.9 18.3 13.7 14.1 10.9 35.3 11.4 11.3 8.6 11.4 10.3 22.0 16.2 14.3 9.8 33.8 13.8 15.9 18.5 34.4 20.8 11.0 11.4 16.2 13.2 10.5 38.2 23.8 33.6 22.0 19.9 19.6 14.8 43.6 21.1 17.8 42.4 33.9 55.2 22.4 38.2 22.6 29.1 17.9 32.4 43.1 17.2 21.3 14.8 54.6 27.2 21.9 29.5 23.7 33.2 29.8 20.3 23.2 42.7 19.8 24.9 32.8 28.3 48.2 7.1 25.4 36.5 44.9 83.6 21.8 15.9 18.4 66.1 26.1 42.3 17.0 17.7 38.5 20.8 56.0 15.9 15.8 17.3 29.4 45.2 21.5 17.7 24.7 16.3 28.6 34.9 22.2 94.7 13.6 39.4 16.3 0.7 5.8 4.2 8.9 6.2 7.9 5.6 7.6 8.4 6.0 4.1 7.5 5.4 2.6 8.3 10.9 4.2 11.2 6.6 35.5 36.5 36.6 42.5 35.2 35.5 34.8 35.3 37.6 35.3 33.8 34.4 38.2 0.6 22.4 24.8 8.5 4.8 0.0 0.3 0.2 7.4 1.2 0.3 0.4 1.5 0.0 3.2 0.0 4.2 0.2 1.1 1.6 0.0 0.4 0.0 1.0 1.1 2.1 1.2 8.8 14.2 0.0 0.4 2.6 15.3 1.3 3.8 0.8 1.4 0.2 0.4 0.0 12.6 0.4 0.0 0.3 0.3 0.2 0.3 4.5 0.0 11.2 0.0 0.7 1.0 8.5 13.6 0.3 1.2 0.0 8.3 0.2 2.0 0.1 4.4 1.2 6.6 1.0 0.9 0.2 0.2 8.3 0.1 0.0 5.5 0.8 0.4 0.1 TRIO ARHGEF23 ENSG00000038382 "Trio Rho guanine nucleotide exchange factor" O75962 5 14143342-14532128 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 205.7;Excitatory neurons: 400.9;Inhibitory neurons: 443.4;Microglial cells: 308.2;Oligodendrocyte precursor cells: 476.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 215.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008157, HPA064664" Supported Approved Vesicles,Cytosol No No Cytosol Vesicles "HPA008157: AB_1858327, HPA064664: AB_2685315" "unprognostic (6.65e-2)" "unprognostic (4.21e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.39e-2)" "unprognostic (4.13e-1)" "unprognostic (2.18e-3)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (4.58e-3)" "unprognostic (2.23e-1)" 33.0 20.7 33.1 11.7 35.2 5.5 32.0 33.6 39.0 23.1 35.4 35.0 6.9 39.2 15.7 14.7 21.4 18.9 27.2 37.1 32.7 19.5 22.3 25.9 10.3 29.7 30.0 33.7 53.3 20.7 9.2 29.1 11.7 30.5 28.5 13.8 10.3 17.5 11.2 21.1 18.8 28.1 19.4 28.4 39.2 23.1 17.3 32.6 13.4 17.2 17.5 10.7 27.3 20.7 32.0 43.7 15.9 37.2 18.0 78.6 101.0 41.3 40.4 49.2 32.6 36.9 10.3 17.4 10.4 28.0 56.6 79.6 13.0 6.5 19.4 66.6 25.8 8.0 5.5 46.1 13.2 40.0 13.9 14.8 47.6 19.9 114.4 36.4 30.3 28.8 6.8 1.4 6.8 78.7 8.3 0.1 9.5 9.3 4.8 13.7 9.9 22.9 34.2 31.6 20.5 17.1 67.5 34.3 9.0 18.9 47.1 5.3 2.0 66.4 61.4 38.3 44.7 48.4 0.3 2.2 12.9 215.1 8.8 14.8 0.1 0.5 0.0 0.0 0.7 0.1 0.7 0.0 0.0 0.5 1.8 0.0 0.0 0.0 1.6 0.6 1.1 0.3 0.1 33.1 35.2 33.6 39.0 37.1 32.7 29.7 30.0 33.7 30.5 28.4 32.6 32.0 33.0 19.2 25.9 205.7 16.6 16.4 13.0 15.6 17.1 30.5 21.9 15.0 19.3 10.0 21.0 11.0 14.6 9.7 5.6 24.8 0.0 21.2 2.9 11.7 24.8 28.7 18.0 6.5 400.9 14.2 22.0 38.9 7.7 34.2 17.7 17.2 14.6 17.1 14.2 28.6 443.4 20.6 14.2 15.4 22.1 6.6 78.6 20.2 5.4 308.2 12.1 7.3 2.1 476.5 80.4 38.5 14.9 42.9 29.2 52.8 9.2 5.4 18.3 2.7 6.6 27.5 20.0 3.5 6.2 7.2 13.8 8.2 3.8 11.7 19.4 20.3 VCAN "CSPG2, PG-M" ENSG00000038427 Versican P13611 5 83471618-83582303 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.5;placenta: 74.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 975.7;Granulosa cells: 1131.8;Kupffer cells: 547.3;Macrophages: 605.6;monocytes: 948.1;Oligodendrocyte precursor cells: 1644.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 240.0;myeloid DC: 88.9" "Group enriched" "Detected in many" 20 "dendritic cells: 88.9;monocytes: 240.0" "Cell line enhanced" "Detected in many" "AF22: 300.5;HSkMC: 199.5;hTERT-RPE1: 959.0;RPTEC TERT1: 381.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004726, CAB008979" Supported Approved Vesicles "Secreted to blood" NA NA 12000000 Vesicles "CAB008979: , HPA004726: AB_1080561" "unprognostic (7.90e-2)" "unprognostic (9.03e-3)" "unprognostic (7.09e-2)" "unprognostic (6.06e-3)" "unprognostic (1.87e-1)" "unprognostic (4.49e-2)" "unprognostic (1.23e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (4.36e-3)" "unprognostic (2.68e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.17e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.15e-1)" "unprognostic (4.44e-2)" "unprognostic (5.30e-3)" 42.4 24.1 16.8 75.5 18.4 32.9 15.7 23.8 20.9 29.7 8.5 9.7 3.9 18.0 1.8 3.9 8.6 30.8 30.0 24.6 26.6 6.5 2.7 34.7 2.4 30.9 19.9 11.6 2.2 3.2 2.4 2.1 74.2 34.2 6.8 10.8 0.2 7.6 4.3 3.9 10.3 5.8 48.5 29.7 14.0 7.7 4.8 34.4 2.7 6.6 6.9 1.9 48.7 7.2 40.0 0.2 5.6 300.5 0.1 119.8 81.5 0.1 2.3 6.2 2.1 1.5 3.1 0.2 0.0 45.2 111.5 3.9 0.0 0.4 0.4 1.7 0.1 9.8 2.1 0.0 2.3 5.5 0.1 0.0 199.5 0.1 127.6 1.2 959.0 0.1 0.0 0.0 0.1 64.6 0.0 0.5 0.0 51.1 0.0 10.3 0.0 63.0 0.1 381.0 0.0 3.6 15.5 0.0 0.0 0.2 33.2 0.2 0.5 116.5 90.6 0.5 168.3 179.0 0.0 0.1 0.2 41.8 0.1 16.4 8.3 240.0 0.5 0.5 31.3 0.3 0.2 0.1 0.1 88.9 0.1 0.1 0.0 3.9 0.5 3.5 1.7 0.0 94.0 16.8 18.4 23.8 20.9 24.6 26.6 30.9 19.9 11.6 34.2 29.7 34.4 40.0 23.4 19.2 19.8 128.9 5.5 38.6 10.6 14.9 1.2 0.0 1.8 1.9 8.2 44.3 17.5 25.8 0.0 5.9 7.4 0.0 0.0 1.9 3.0 64.4 975.7 29.9 0.0 5.2 1.5 0.7 7.0 348.1 3.6 241.3 12.6 1131.8 16.8 3.6 25.6 0.0 30.7 0.2 0.0 547.3 83.1 2.5 18.6 605.6 44.4 20.6 948.1 0.0 13.4 1644.7 1.5 32.3 1.1 117.8 2.5 2.5 0.0 1.8 16.2 0.0 0.0 11.0 80.6 0.9 1.2 1.1 28.7 11.5 12.7 1.6 0.3 0.9 CLEC16A "Gop-1, KIAA0350" ENSG00000038532 "C-type lectin domain containing 16A" Q2KHT3 16 10944564-11182186 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 130.9;Early spermatids: 118.7;Excitatory neurons: 93.3;Inhibitory neurons: 135.1;Late spermatids: 84.8;Oligodendrocyte precursor cells: 69.4;Oligodendrocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HDLM-2: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035814, HPA035815, HPA061385" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498" "unprognostic (3.41e-1)" "unprognostic (4.58e-2)" "unprognostic (7.36e-2)" "unprognostic (1.56e-2)" "unprognostic (3.44e-1)" "unprognostic (1.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.22e-3)" "unprognostic (4.54e-2)" "unprognostic (7.78e-3)" "unprognostic (2.08e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.92e-6)" "unprognostic (2.69e-1)" "unprognostic (1.79e-1)" "unprognostic (8.22e-2)" "unprognostic (3.03e-1)" 9.3 13.0 11.3 7.3 12.6 13.3 9.5 15.5 16.9 10.6 18.3 9.2 8.2 9.0 6.9 14.0 9.5 4.8 13.5 10.6 8.6 15.1 16.3 12.9 9.3 12.9 12.6 7.1 8.3 9.0 11.8 17.4 7.1 15.7 11.4 6.0 11.6 9.2 5.7 17.6 14.2 10.9 6.3 8.4 12.5 10.4 47.2 19.4 11.0 13.4 8.3 8.9 9.2 10.5 11.2 11.6 12.1 9.0 11.9 14.8 10.3 8.0 11.7 11.4 9.6 12.5 13.5 21.1 22.8 26.6 14.3 10.6 10.1 11.6 21.7 12.3 110.3 12.5 10.4 16.4 14.4 10.4 11.5 21.5 12.3 10.4 15.9 13.4 8.8 13.3 12.4 17.6 13.8 11.5 19.0 18.2 9.1 7.2 10.0 9.5 24.6 7.6 13.5 20.1 8.4 11.5 15.3 16.8 17.1 9.1 10.4 12.1 17.7 14.2 12.4 16.1 18.3 10.4 9.7 9.2 18.7 15.5 16.4 13.1 2.7 1.9 1.4 2.2 1.5 1.3 1.7 1.8 1.5 1.5 2.8 2.1 1.8 2.6 1.8 3.0 2.0 1.4 1.1 11.3 12.6 15.5 16.9 10.6 8.6 12.9 12.6 7.1 15.7 8.4 19.4 11.2 7.1 16.0 10.0 130.9 12.8 7.1 3.7 5.9 11.4 11.7 5.2 5.1 5.9 8.6 8.8 3.7 37.5 3.4 5.5 12.1 0.0 6.0 118.7 7.5 6.0 6.1 7.7 8.6 93.3 6.4 2.6 6.2 9.2 8.0 8.2 5.7 9.7 12.6 4.8 11.8 135.1 7.9 6.1 5.4 6.2 84.8 5.6 6.8 3.6 40.3 8.6 3.9 4.1 69.4 72.9 6.5 4.0 8.6 8.8 3.5 10.3 3.5 8.9 18.3 0.0 7.4 4.5 27.1 8.4 13.4 8.2 3.8 8.6 3.3 6.7 4.9 MSR1 "CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII" ENSG00000038945 "Macrophage scavenger receptor 1" P21757 8 16107878-16567490 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lung: 121.2" "Group enriched" "Detected in many" 5 "Hofbauer cells: 137.3;Kupffer cells: 322.8;Langerhans cells: 86.0;Macrophages: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 16.9" "Lineage enriched" "Detected in many" 5 "monocytes: 16.9" "Group enriched" "Detected in many" 7 "BJ hTERT+: 105.2;REH: 40.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000272, CAB032491" Enhanced NA NA 67000 "CAB032491: AB_672722, HPA000272: AB_1846269" "unprognostic (8.19e-3)" "unprognostic (4.87e-2)" "unprognostic (1.93e-2)" "unprognostic (2.10e-1)" "unprognostic (9.24e-2)" "unprognostic (1.32e-2)" "unprognostic (5.85e-3)" "unprognostic (2.89e-1)" "unprognostic (9.70e-2)" "unprognostic (1.62e-2)" "unprognostic (7.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.76e-2)" "unprognostic (9.16e-2)" "unprognostic (7.39e-2)" "unprognostic (6.85e-2)" "unprognostic (4.69e-2)" 26.1 18.6 2.8 17.6 5.7 13.1 9.8 4.4 13.9 11.7 13.8 8.6 6.7 8.1 6.4 6.3 5.7 30.0 8.7 2.8 13.6 6.7 25.2 121.2 7.0 11.0 4.2 1.0 6.2 11.5 6.3 2.6 27.6 8.8 3.6 10.7 5.9 6.3 6.5 2.3 3.5 9.5 18.0 8.4 16.1 6.2 6.3 12.5 4.4 5.3 1.4 2.9 17.5 1.9 15.4 1.5 2.1 3.0 1.5 1.4 1.3 1.4 0.7 105.2 0.3 0.6 3.7 0.4 3.4 5.1 1.0 0.7 0.7 0.7 1.0 2.0 0.4 4.3 4.6 5.1 4.2 0.9 2.4 2.5 0.7 0.8 0.8 1.5 1.8 0.2 1.9 1.7 2.9 1.9 4.3 1.4 1.4 0.5 1.6 1.3 40.7 2.3 1.0 2.0 5.8 2.8 1.2 1.0 2.8 0.2 5.0 0.4 1.2 2.4 2.8 0.9 10.8 2.8 9.5 8.6 7.4 1.1 1.5 2.2 1.7 3.3 0.6 1.0 16.9 0.4 1.1 0.7 0.7 1.1 1.5 1.3 0.9 3.2 0.4 8.8 0.5 0.7 0.8 2.8 5.7 4.4 13.9 2.8 13.6 11.0 4.2 1.0 8.8 8.4 12.5 15.4 2.0 22.4 35.9 0.0 2.7 2.7 0.0 0.0 0.0 1.6 0.5 1.4 2.0 2.8 8.1 3.7 25.0 0.5 0.1 0.0 1.9 0.0 2.9 0.0 0.0 6.3 0.0 2.7 0.3 0.0 1.0 2.1 0.0 0.0 17.7 0.1 4.6 1.7 137.3 0.0 3.0 0.1 0.0 322.8 86.0 3.6 1.8 172.5 0.0 28.1 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.4 6.6 0.7 19.7 1.0 0.7 4.2 1.3 0.1 2.0 0.8 2.6 0.2 0.0 0.3 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737292-68835537 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 199.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "myeloid DC: 1.7;plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" "Cell line enhanced" "Detected in many" "BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA 78000000 "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.0 0.2 1.3 16.2 1.8 6.5 64.8 0.5 1.8 30.3 16.1 128.7 135.2 9.7 39.8 77.5 51.9 46.1 0.3 1.3 1.1 40.2 98.0 37.1 5.6 2.3 1.2 1.3 1.3 84.7 199.3 8.1 61.4 1.8 92.5 132.3 0.1 72.5 42.1 0.3 108.6 129.0 5.1 1.6 10.4 105.1 0.4 1.7 20.3 164.2 0.1 29.2 58.8 38.5 2.1 147.0 14.8 0.0 0.5 0.0 0.0 683.3 0.0 0.0 0.0 0.0 241.9 328.1 0.0 3.1 0.0 0.0 318.7 0.0 156.3 0.0 28.6 3.5 0.1 0.7 48.0 0.0 0.0 0.6 0.0 217.2 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 199.6 0.2 1.0 5.5 207.2 0.8 0.1 0.1 2.1 53.9 237.7 8.5 0.8 1.4 0.2 58.9 91.8 209.2 0.4 0.0 0.4 0.9 0.7 0.6 0.1 0.3 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.1 1.3 1.8 0.5 1.8 1.3 1.1 2.3 1.2 1.3 1.8 1.6 1.7 2.1 0.6 131.4 69.8 0.7 1.4 94.1 130.3 73.8 45.5 0.0 137.6 83.6 0.9 128.7 95.3 163.7 0.0 117.6 2.5 451.6 1.9 129.1 0.1 159.3 29.2 4.4 86.7 9.0 0.7 113.5 29.6 3.4 132.0 321.0 1.3 2.8 0.4 63.4 11.7 0.0 1.4 208.3 75.3 1.2 13.4 0.0 0.3 3.2 53.4 1.0 3.3 0.0 0.0 0.5 32.1 264.6 204.6 0.4 2.2 195.5 159.5 4.5 118.2 0.0 0.0 0.0 7.1 0.1 0.1 100.6 131.6 50.5 2.7 0.0 154.8 251.5 MTREX "Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2" ENSG00000039123 "Mtr4 exosome RNA helicase" P42285 5 55307989-55425579 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037379 Supported Supported Nucleoplasm NA NA 13000 Nucleoplasm "HPA037379: AB_10601713" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (1.32e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "unprognostic (5.08e-1)" "unprognostic (4.17e-2)" "unprognostic (1.46e-2)" "unprognostic (5.05e-2)" "unprognostic (7.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.09e-1)" "unprognostic (3.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.11e-1)" 20.0 22.9 11.3 22.1 12.8 18.7 22.2 18.5 12.8 21.8 14.7 17.7 24.9 22.3 14.2 19.2 18.0 19.9 24.5 11.0 12.2 21.0 19.8 16.9 26.1 11.8 12.1 9.8 20.3 21.4 26.8 17.4 19.1 12.9 21.8 20.1 18.0 19.1 14.9 30.1 21.0 24.3 13.9 12.5 19.4 21.0 23.6 11.8 22.1 26.0 22.7 22.0 21.2 20.0 16.1 40.9 49.2 38.4 39.9 32.8 35.0 49.5 33.4 28.3 39.7 50.1 57.1 51.2 79.3 37.4 33.1 52.9 28.5 76.8 50.3 59.9 14.2 53.2 51.6 45.4 45.9 31.3 33.4 44.8 27.5 31.3 42.9 51.6 33.6 35.1 29.7 60.9 45.0 37.9 35.8 32.3 36.5 38.4 16.8 46.6 39.5 44.1 33.9 41.3 56.9 42.0 28.8 40.4 24.5 35.4 42.4 52.5 44.8 33.2 10.0 27.5 28.4 62.0 31.5 33.6 59.0 27.0 69.5 40.8 3.6 5.0 5.4 7.2 4.7 6.9 6.1 5.7 6.8 6.4 6.4 6.1 6.2 1.3 4.5 7.9 6.7 5.6 4.1 11.3 12.8 18.5 12.8 11.0 12.2 11.8 12.1 9.8 12.9 12.5 11.8 16.1 27.6 32.1 42.3 0.0 10.1 0.0 0.0 0.0 0.0 0.0 22.3 13.8 0.0 0.0 21.7 20.2 0.0 25.0 24.6 0.0 11.7 32.0 0.0 28.2 44.0 10.0 0.0 0.0 0.0 40.7 21.5 16.2 0.0 26.2 25.2 30.8 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 13.9 0.0 0.0 0.0 0.0 35.7 0.0 0.0 8.3 0.0 0.0 22.3 26.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 34.9 11.6 31.7 0.0 0.0 DNAH5 "CILD3, Dnahc5, HL1, KTGNR, PCD" ENSG00000039139 "Dynein axonemal heavy chain 5" Q8TE73 5 13690328-14011818 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;choroid plexus: 11.9;fallopian tube: 3.9" "Cell type enhanced" "Detected in many" "Club cells: 61.7;Endometrial ciliated cells: 190.3;Respiratory ciliated cells: 258.7" "Cancer enhanced" "Detected in many" "prostate cancer: 3.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;LHCN-M2: 1.1;PC-3: 2.7;RPTEC TERT1: 1.3;TIME: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA037469, HPA037470" Enhanced NA NA "HPA037469: AB_10672791, HPA037470: AB_10672348" "unprognostic (3.85e-1)" "unprognostic (8.17e-2)" "unprognostic (5.94e-2)" "unprognostic (1.12e-1)" "unprognostic (4.58e-3)" "unprognostic (6.23e-2)" "unprognostic (3.33e-3)" "unprognostic (2.86e-2)" "unprognostic (9.94e-2)" "unprognostic (4.39e-2)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (9.97e-3)" "unprognostic (8.87e-2)" "unprognostic (8.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" 0.0 0.1 3.2 0.0 1.1 0.0 1.6 1.5 0.8 0.3 11.9 0.1 0.0 0.1 0.1 0.0 3.9 0.1 0.0 0.8 3.1 0.8 1.0 1.7 0.0 3.8 4.4 0.4 0.0 0.9 0.0 2.0 0.0 3.8 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.4 0.3 2.8 0.0 1.1 0.0 0.0 0.8 0.0 1.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.1 0.0 0.5 0.0 0.5 0.2 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 1.3 0.4 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.1 1.5 0.8 0.8 3.1 3.8 4.4 0.4 3.8 2.4 2.8 1.5 0.3 3.2 24.4 7.2 0.2 0.0 1.7 5.6 0.0 0.0 11.7 7.0 1.5 14.3 61.7 5.5 0.0 0.0 0.1 0.0 0.0 6.7 7.3 190.3 1.9 1.2 1.8 0.0 12.9 3.6 0.2 1.8 0.0 12.4 2.5 0.0 0.0 10.9 0.0 0.0 7.8 0.0 6.1 0.0 0.0 5.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 4.0 0.4 2.6 0.0 0.0 0.1 14.8 0.0 4.3 258.7 0.0 0.0 1.6 2.6 2.6 3.6 0.0 0.0 0.0 0.4 0.1 0.0 3.8 ZFYVE16 "KIAA0305, PPP1R69" ENSG00000039319 "Zinc finger FYVE-type containing 16" Q7Z3T8 5 80408013-80483379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 620.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 21.2;neutrophil: 21.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 80.7" "Low region specificity" "Detected in all" "HPA035935, HPA035936" Supported Enhanced Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA035935: AB_10672076, HPA035936: AB_10669662" "unprognostic (1.11e-1)" "unprognostic (3.98e-2)" "unprognostic (1.78e-2)" "unprognostic (3.26e-1)" "unprognostic (7.19e-2)" "unprognostic (2.57e-2)" "unprognostic (7.25e-3)" "unprognostic (6.91e-2)" "unprognostic (4.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.15e-1)" "unprognostic (3.04e-1)" "unprognostic (4.64e-2)" "unprognostic (4.95e-2)" "unprognostic (6.91e-2)" "unprognostic (4.23e-2)" 8.4 8.8 4.5 8.2 11.8 5.3 8.8 5.6 6.8 15.2 3.9 6.5 5.1 12.8 2.6 7.3 7.2 11.3 14.1 4.0 7.1 9.6 10.3 9.2 5.6 7.7 9.3 3.2 12.4 6.4 9.0 4.0 13.1 10.3 8.6 6.3 8.7 5.0 6.7 6.2 4.4 6.9 10.0 6.3 9.1 6.7 9.4 8.1 5.1 9.6 8.5 4.5 9.5 4.7 15.7 11.9 13.4 23.4 21.9 14.0 14.3 15.5 17.6 15.2 15.4 20.7 9.9 16.5 7.9 12.5 14.6 16.4 11.9 17.2 14.4 16.9 5.1 10.9 8.6 16.3 11.3 11.6 2.6 6.3 15.4 7.5 12.9 12.4 12.4 18.0 7.3 8.5 12.0 16.8 14.9 5.7 2.5 5.3 6.1 6.5 11.7 48.3 8.4 12.9 22.1 8.8 19.5 25.3 11.6 80.7 14.1 20.2 7.7 16.0 9.2 10.3 14.3 14.6 3.6 7.6 7.8 12.1 8.0 21.0 21.2 4.5 2.5 1.8 2.8 1.0 3.6 0.9 1.6 1.8 3.2 0.7 0.9 21.3 3.0 5.4 3.0 1.0 0.4 4.5 11.8 5.6 6.8 4.0 7.1 7.7 9.3 3.2 10.3 6.3 8.1 15.7 49.3 25.6 22.2 127.0 25.8 18.2 14.0 16.4 15.4 94.9 23.4 18.2 52.3 14.3 33.8 31.3 114.7 22.1 28.9 20.3 9.8 16.2 7.4 47.6 85.6 33.1 21.6 7.8 87.7 12.3 11.8 33.7 23.9 37.5 10.1 59.7 35.7 16.8 26.5 80.8 114.0 11.3 2.0 59.8 71.5 7.0 37.9 71.4 19.6 64.6 34.7 26.3 17.5 182.0 620.2 16.4 20.2 44.4 19.0 16.5 16.3 13.6 49.9 75.3 32.9 58.6 43.3 49.0 22.0 15.6 25.4 37.4 17.5 44.7 12.9 20.1 RIPOR1 "FAM65A, FLJ13725" ENSG00000039523 "RHO family interacting cell polarization regulator 1" Q6ZS17 16 67518418-67546788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005923 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA005923: AB_1078809" "unprognostic (7.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.56e-3)" "unprognostic (3.71e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.38e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.82e-8)" "unprognostic (8.51e-2)" "unprognostic (3.52e-2)" "unprognostic (1.19e-1)" "unprognostic (7.46e-2)" 44.7 28.4 27.1 23.6 27.9 27.4 38.1 24.5 38.9 39.7 8.8 30.2 8.9 45.6 6.1 18.7 36.5 21.7 49.2 33.1 16.7 66.9 16.9 56.2 21.0 24.6 17.8 28.7 33.5 30.4 20.8 26.8 30.1 29.2 30.9 7.5 44.2 22.9 20.3 35.2 20.0 33.0 25.4 11.0 61.7 26.1 18.8 22.8 10.9 36.7 22.5 17.6 37.4 30.7 23.9 44.0 36.6 16.1 25.3 40.0 35.7 35.7 45.7 44.9 51.6 43.0 75.7 31.5 6.0 62.4 78.8 26.0 24.4 32.7 41.3 33.2 19.3 17.0 57.9 53.6 17.4 44.7 4.6 28.0 35.5 18.8 69.7 47.1 36.8 55.2 10.2 6.5 6.4 38.7 47.7 13.8 14.4 4.4 8.5 29.1 46.8 29.0 31.2 39.0 22.1 12.1 31.9 85.1 13.8 28.6 15.9 30.2 10.7 96.8 58.3 34.2 49.8 32.2 9.0 6.8 17.8 38.8 11.1 31.7 0.1 11.2 9.3 1.2 15.6 1.8 15.8 1.0 0.5 10.2 9.4 0.7 0.7 6.6 1.7 15.1 14.4 0.8 6.0 27.1 27.9 24.5 38.9 33.1 16.7 24.6 17.8 28.7 29.2 11.0 22.8 23.9 49.2 16.0 16.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 12.1 8.8 0.0 0.0 1.8 7.3 0.0 0.8 3.7 0.0 0.0 15.8 0.0 9.3 17.9 23.6 0.0 0.0 0.0 12.5 1.3 6.9 0.0 18.5 10.1 7.9 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 2.3 0.0 0.0 5.8 2.2 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 2.1 2.3 16.6 0.0 0.0 C6 ENSG00000039537 "Complement C6" P13671 5 41142116-41261438 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "liver: 671.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0" "Group enriched" "Detected in many" 7 "liver cancer: 49.0;pancreatic cancer: 12.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043823, CAB069427" Enhanced "Secreted to blood" NA NA 45000000000 9200000000 "CAB069427: AB_1614336, HPA043823: AB_10960262" "unprognostic (9.79e-2)" "unprognostic (1.96e-2)" "unprognostic (5.94e-3)" "unprognostic (3.02e-2)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (4.66e-2)" "unprognostic (3.72e-2)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (3.04e-3)" "prognostic favorable (4.31e-4)" "unprognostic (2.69e-4)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" 12.9 1.1 0.2 0.0 0.3 0.0 5.4 0.3 0.3 0.6 1.5 0.8 0.9 0.4 0.9 0.3 44.2 12.1 45.4 0.2 1.0 4.3 671.4 3.2 0.4 0.0 1.0 0.1 6.2 43.1 0.1 0.7 2.8 0.5 0.9 0.6 0.0 0.9 0.6 0.6 0.5 1.4 0.9 0.1 0.3 2.2 4.2 1.2 0.6 2.0 0.7 0.5 0.9 0.6 0.7 0.0 0.0 0.0 0.0 4.5 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.3 0.2 1.0 0.0 1.0 0.1 0.5 0.1 1.2 0.7 0.8 0.0 0.0 0.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.9 127.2 7.5 0.0 0.0 0.0 0.1 0.3 0.0 9.3 11.3 37.5 0.8 0.9 0.0 8.0 1.4 0.4 0.0 6.7 0.0 0.7 0.0 0.1 5.0 376.9 0.0 0.0 2.7 1.0 0.0 9.7 0.3 54.8 120.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.5 1.3 0.4 0.0 0.0 11.6 0.8 58.0 0.0 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.0 0.4 0.5 0.6 0.0 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656328-34832612 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 208.2;Early spermatids: 210.1;Late spermatids: 364.3;Syncytiotrophoblasts: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 267.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 23.8" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 10.3 9.1 11.7 21.8 14.4 2.4 9.9 14.0 9.9 51.6 17.3 16.6 7.0 54.1 6.2 10.1 13.9 18.9 6.8 8.7 13.1 19.1 27.8 26.4 14.8 17.0 14.3 6.7 9.6 8.0 10.9 5.0 34.9 16.4 11.5 10.4 10.3 16.6 25.6 1.9 19.6 7.5 58.5 18.4 39.8 10.9 39.6 13.8 6.4 10.2 2.3 10.3 43.4 14.4 22.5 12.5 48.5 55.2 37.1 29.0 100.9 70.3 147.0 118.3 83.3 83.0 36.7 15.6 2.9 57.0 72.5 90.5 8.2 64.0 109.0 179.2 0.2 30.5 20.6 43.3 22.9 90.0 0.5 1.9 94.8 34.0 149.4 118.1 136.7 267.4 4.6 29.4 1.0 110.1 10.0 2.3 0.7 43.3 7.8 47.0 18.2 84.1 0.6 97.4 70.1 14.4 7.9 86.8 12.8 39.5 80.5 14.9 2.3 173.2 134.1 71.7 33.5 65.1 3.1 0.1 0.4 113.5 0.4 53.5 0.9 0.2 0.1 0.9 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.1 0.0 0.0 11.7 14.4 14.0 9.9 8.7 13.1 17.0 14.3 6.7 16.4 18.4 13.8 22.5 16.2 105.8 208.2 33.3 0.9 12.0 32.2 46.7 23.9 3.2 27.8 9.9 5.2 7.2 81.8 35.0 68.8 32.3 0.6 17.9 7.9 36.1 210.1 35.7 36.1 96.1 1.8 2.7 6.6 28.5 75.3 25.0 11.2 36.1 3.8 22.7 17.2 23.0 7.2 15.2 6.0 1.1 16.2 1.6 4.3 364.3 72.1 4.6 5.4 15.0 1.0 19.3 0.0 31.2 60.1 53.3 5.1 31.6 0.1 26.6 6.3 25.3 24.8 5.1 0.0 6.0 33.4 9.0 9.2 6.4 15.8 156.1 3.4 11.4 2.6 61.5 SOX30 ENSG00000039600 "SRY-box transcription factor 30" O94993 5 157625679-157671480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 81.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 351.1" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006159, CAB009382" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB009382: AB_2195963, HPA006159: AB_1080062" "unprognostic (3.51e-2)" "unprognostic (4.72e-2)" "unprognostic (7.31e-2)" "unprognostic (4.70e-4)" "unprognostic (2.53e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-2)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (1.36e-1)" "unprognostic (4.73e-2)" "unprognostic (7.85e-2)" "unprognostic (4.64e-4)" "unprognostic (5.88e-2)" "unprognostic (1.64e-1)" "unprognostic (3.72e-2)" "unprognostic (3.45e-1)" 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.7 0.1 0.0 0.1 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.2 0.1 81.3 0.2 0.7 0.0 0.0 0.1 0.1 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.5 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.1 0.0 0.6 0.0 0.0 351.1 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 71.4 1.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 42.8 11.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favorable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 19.0 45.5 10.7 21.2 11.0 26.6 21.3 11.0 16.4 21.1 19.6 19.2 16.2 21.5 13.6 19.6 23.1 10.7 23.5 12.5 11.4 27.4 22.6 22.4 17.7 11.8 11.7 10.1 23.9 28.8 16.8 37.1 11.2 12.9 25.5 13.2 10.2 21.8 12.5 18.6 17.6 22.9 11.6 10.5 37.5 25.2 21.4 11.0 12.4 32.2 7.9 15.4 19.6 18.1 12.1 27.5 17.4 19.1 27.2 15.8 13.4 28.6 43.4 21.2 18.7 17.7 17.5 34.2 18.4 13.6 13.6 11.3 23.5 6.1 25.9 10.9 22.3 27.2 30.0 36.7 14.8 12.2 25.8 36.3 13.2 13.0 17.9 11.0 16.9 26.3 23.4 14.9 34.3 24.7 18.8 28.7 23.5 16.0 28.3 37.4 24.3 15.9 34.7 21.0 68.5 20.6 33.4 19.3 52.5 9.2 14.5 10.2 14.8 36.0 37.6 24.9 9.6 35.8 38.7 16.5 13.0 33.8 12.3 30.8 1.8 12.3 16.7 9.2 11.5 7.9 9.1 7.8 7.3 9.8 12.2 5.7 5.0 23.4 3.9 18.1 5.5 9.1 5.8 10.7 11.0 11.0 16.4 12.5 11.4 11.8 11.7 10.1 12.9 10.5 11.0 12.1 23.6 16.0 23.6 5.9 47.2 13.4 35.4 29.9 25.6 40.9 28.1 23.7 11.1 21.5 19.1 20.2 81.3 44.5 37.7 40.0 23.5 42.5 15.0 25.2 28.5 26.6 30.5 17.1 6.0 39.9 35.1 19.1 31.6 28.0 29.1 54.6 35.0 20.1 39.5 33.7 6.0 31.7 24.4 27.7 19.0 32.9 59.4 26.8 14.2 8.4 46.1 18.4 96.8 6.0 5.7 44.6 22.3 44.8 40.4 33.6 27.1 36.1 33.8 73.9 19.7 17.9 20.1 19.4 28.9 23.3 13.1 49.3 39.2 83.0 34.1 35.6 BEST2 "FLJ20132, VMD2L1" ENSG00000039987 "Bestrophin 2" Q8NFU1 19 12751702-12758458 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 26.0;skin 1: 17.0" "Cell type enriched" "Detected in some" 36 "Intestinal goblet cells: 136.4" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.7" HPA046229 Approved NA NA "HPA046229: AB_10966140" "unprognostic (3.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.54e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-2)" "unprognostic (4.02e-3)" "unprognostic (2.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (2.43e-1)" "unprognostic (3.46e-3)" "unprognostic (9.18e-6)" "unprognostic (3.45e-2)" "unprognostic (6.95e-2)" "unprognostic (2.90e-1)" "unprognostic (1.64e-5)" 0.2 0.2 0.7 0.7 0.7 2.3 0.5 2.6 0.8 0.2 0.4 26.0 0.1 0.5 0.7 0.2 0.3 0.6 0.4 0.6 1.4 0.2 0.3 0.4 0.5 0.9 0.7 0.4 0.5 0.3 0.3 0.0 0.4 1.3 0.3 14.1 1.5 1.0 0.3 0.3 17.0 15.6 0.7 0.6 0.5 0.3 0.4 0.7 0.2 0.6 0.1 4.9 0.2 1.4 1.6 0.3 0.2 0.7 1.3 0.0 0.0 0.6 0.3 0.0 0.2 0.1 0.8 1.3 1.1 0.3 0.0 0.2 0.7 0.0 0.2 0.2 1.3 0.6 0.9 1.2 0.3 0.1 0.4 1.9 0.1 0.1 0.1 0.1 0.4 0.1 0.2 0.2 0.5 0.2 1.1 0.3 0.6 1.0 0.1 0.7 0.1 0.4 0.2 0.3 0.3 0.7 0.7 0.5 0.0 0.1 0.8 0.6 0.1 1.0 0.3 0.3 0.6 0.7 0.3 0.5 0.3 0.5 1.0 0.7 0.5 0.1 0.1 0.3 0.1 0.2 0.5 0.2 0.1 0.0 0.7 0.5 0.4 0.4 0.4 0.1 0.6 0.1 0.2 0.7 0.7 2.6 0.8 0.6 1.4 0.9 0.7 0.4 1.3 0.6 0.7 1.6 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.0 0.2 0.1 3.7 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 136.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.5 0.0 0.1 0.3 0.1 0.0 1.8 0.1 PHLPP2 "KIAA0931, PHLPPL, PPM3B" ENSG00000040199 "PH domain and leucine rich repeat protein phosphatase 2" Q6ZVD8 16 71637835-71724701 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.1;retina: 32.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040761, HPA041837, HPA048598" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No Cytosol "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA040761: , HPA041837: , HPA048598: AB_2680459" "unprognostic (5.67e-2)" "unprognostic (2.00e-1)" "unprognostic (2.29e-2)" "unprognostic (2.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.22e-1)" "unprognostic (3.43e-1)" "unprognostic (1.97e-4)" "unprognostic (3.08e-2)" "unprognostic (8.85e-3)" "unprognostic (6.41e-2)" "unprognostic (4.92e-2)" "unprognostic (8.46e-3)" "unprognostic (8.27e-2)" 4.2 2.8 4.9 2.8 7.7 6.6 2.7 6.1 7.1 3.3 0.1 11.8 11.2 3.7 2.9 1.5 3.2 2.5 2.3 6.9 5.6 3.4 3.0 3.1 3.5 4.5 3.0 6.7 4.3 3.1 4.5 4.0 2.7 5.6 2.8 12.3 32.4 1.7 3.4 1.9 1.7 22.1 4.5 0.2 2.5 2.4 6.9 4.7 1.9 6.6 2.6 3.2 3.3 2.4 6.3 6.0 7.8 8.3 9.3 6.5 7.8 4.8 8.8 8.0 12.5 10.1 7.2 1.9 11.8 3.4 14.6 9.0 12.4 12.1 4.5 16.1 4.2 6.5 3.3 7.3 4.8 5.1 2.9 5.0 5.8 2.5 17.7 5.7 5.2 4.7 4.1 3.0 3.2 8.7 12.7 3.9 2.3 6.5 1.9 2.1 6.3 7.3 3.9 5.9 4.5 7.2 3.8 18.9 5.1 3.1 6.4 6.3 1.6 6.5 12.5 9.0 5.3 7.4 7.1 5.4 11.9 7.7 2.3 2.8 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.3 0.1 0.3 0.2 0.2 0.2 0.7 0.1 0.5 0.3 0.1 4.9 7.7 6.1 7.1 6.9 5.6 4.5 3.0 6.7 5.6 0.2 4.7 6.3 4.0 9.6 2.2 26.1 7.4 9.3 5.1 3.5 7.4 20.6 6.9 5.6 3.3 0.0 3.6 3.7 104.3 4.3 3.8 75.5 0.0 2.7 12.0 2.9 6.1 5.3 6.0 22.9 69.5 2.3 0.4 7.7 1.1 5.1 10.2 11.3 2.9 4.1 1.5 23.5 45.9 6.7 4.1 7.0 12.7 6.3 5.3 2.7 14.2 10.3 3.2 6.5 1.0 30.7 32.7 2.5 31.4 5.3 4.0 8.2 73.7 5.1 3.1 68.6 6.6 7.8 7.9 31.6 20.4 1.9 9.1 1.4 4.9 1.7 9.2 2.2 SPDL1 "CCDC99, FLJ20364, hSpindly" ENSG00000040275 "Spindle apparatus coiled-coil protein 1" Q96EA4 5 169583636-169604778 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 35.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 38.4;Spermatocytes: 112.9;Spermatogonia: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA044700, HPA048146" Enhanced Approved Cytosol NA Yes Cytosol "HPA044700: AB_2679052, HPA048146: AB_2680284" "unprognostic (2.61e-2)" "unprognostic (1.94e-1)" "unprognostic (8.59e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.24e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.48e-6)" "unprognostic (2.63e-3)" "unprognostic (5.70e-3)" "unprognostic (8.27e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.93e-1)" 3.9 3.7 6.5 9.5 6.5 11.0 5.6 6.9 6.3 3.5 4.1 5.5 5.8 6.2 3.8 5.8 4.4 4.5 3.4 5.6 5.8 4.8 3.2 4.0 15.0 6.7 6.5 4.7 6.8 2.5 5.1 2.4 8.4 7.6 3.3 5.7 3.4 3.2 3.1 5.3 5.6 5.3 7.5 8.4 6.6 5.4 35.8 6.3 21.7 4.4 5.9 14.1 4.8 3.8 8.0 57.0 69.2 67.4 47.6 17.6 18.5 59.1 181.1 22.9 128.1 119.0 89.6 38.8 54.3 116.9 147.0 90.3 39.3 56.8 76.0 139.6 58.1 65.2 59.6 117.0 36.2 8.3 66.9 51.3 9.2 6.2 62.2 34.0 29.0 59.9 60.5 41.3 39.3 142.4 58.5 54.1 28.2 50.1 28.9 63.2 64.8 67.6 38.5 89.7 19.8 43.7 31.4 84.9 23.6 34.5 46.9 27.0 44.9 46.3 146.6 46.8 43.4 140.0 30.1 69.2 69.1 35.4 61.9 50.2 4.0 2.7 3.8 8.4 3.6 8.9 11.2 7.9 8.9 2.8 12.7 10.8 9.1 0.5 8.4 6.2 19.7 8.6 4.1 6.5 6.5 6.9 6.3 5.6 5.8 6.7 6.5 4.7 7.6 8.4 6.3 8.0 6.1 3.2 6.3 3.9 8.7 4.0 1.7 4.8 4.6 6.9 6.2 7.5 7.1 2.8 7.0 1.8 0.0 14.1 9.8 3.6 5.9 6.6 9.6 5.3 8.0 6.5 1.8 22.3 6.2 4.8 26.1 7.7 12.2 4.9 8.8 38.4 13.2 3.2 12.2 3.3 6.5 3.2 2.0 4.7 3.6 11.1 4.4 4.7 3.6 2.8 5.0 7.4 13.4 5.0 6.8 6.6 1.9 6.4 10.2 1.6 0.5 8.2 4.1 4.4 6.6 6.4 9.9 112.9 59.2 5.8 4.4 4.9 5.2 9.6 7.4 2.5 STAU2 39K2 ENSG00000040341 "Staufen double-stranded RNA binding protein 2" Q9NUL3 8 73420369-73747708 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 278.9;Inhibitory neurons: 298.3;Oligodendrocyte precursor cells: 157.8;Oligodendrocytes: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 152.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019155, CAB020836" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020836: , HPA019155: AB_1857565" "unprognostic (5.75e-2)" "unprognostic (3.39e-1)" "unprognostic (2.31e-3)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (6.27e-2)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (6.36e-2)" "unprognostic (4.01e-2)" "unprognostic (3.31e-2)" "unprognostic (1.89e-1)" "unprognostic (3.62e-3)" "unprognostic (9.94e-2)" "unprognostic (2.98e-1)" "unprognostic (6.44e-3)" "unprognostic (4.25e-2)" 20.3 23.0 20.0 15.9 30.8 24.9 17.9 36.3 39.8 15.4 9.2 17.7 15.1 18.4 19.2 35.4 16.8 24.4 71.3 31.9 28.6 29.8 25.9 17.5 19.4 24.6 28.5 24.3 18.4 16.2 29.9 12.6 17.7 30.0 21.1 18.8 34.9 20.6 21.0 111.6 15.1 20.9 23.6 18.0 16.8 16.5 17.0 24.0 35.3 23.1 111.0 22.1 21.0 14.3 35.6 34.7 40.7 63.5 34.5 35.5 25.2 19.3 30.4 27.5 27.1 35.4 15.6 36.0 55.1 31.5 23.9 24.3 27.2 44.5 29.2 39.1 56.1 21.2 74.7 19.4 25.5 18.6 28.4 25.8 18.1 21.6 23.2 15.1 55.8 54.8 48.2 50.5 24.2 36.8 22.6 152.7 22.5 31.4 57.5 26.8 44.9 29.6 46.3 57.6 38.1 24.0 40.2 16.4 43.1 27.4 46.8 51.2 33.3 43.4 26.3 46.0 26.2 22.7 39.4 41.7 51.8 29.3 42.3 22.1 24.4 18.0 42.8 28.6 17.9 21.5 15.7 19.0 24.3 18.4 17.9 16.6 21.7 30.8 44.4 22.8 25.1 26.0 12.8 20.0 30.8 36.3 39.8 31.9 28.6 24.6 28.5 24.3 30.0 18.0 24.0 35.6 20.4 9.6 31.1 120.8 22.5 10.6 15.4 16.7 8.6 29.1 24.6 11.8 75.7 21.5 40.7 20.2 41.7 18.4 27.1 22.5 43.0 22.7 22.0 18.6 11.6 26.2 29.9 14.7 278.9 21.7 10.0 20.2 21.4 25.5 20.3 21.8 38.2 58.0 16.1 28.6 298.3 17.6 18.3 24.1 16.8 32.2 9.0 22.5 16.0 129.3 16.9 26.9 43.3 157.8 149.9 17.6 16.5 9.4 20.2 10.9 102.1 37.6 27.6 22.2 0.0 15.8 21.8 12.5 13.8 22.1 19.2 12.2 21.6 20.5 16.1 18.5 SLC66A1 "FLJ20320, LAAT-1, LAAT1, PQLC2" ENSG00000040487 "Solute carrier family 66 member 1" Q6ZP29 1 19312326-19329300 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 26.9;Extravillous trophoblasts: 17.0;Hofbauer cells: 37.4;Syncytiotrophoblasts: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057810 Approved Supported Vesicles NA NA Vesicles "HPA057810: AB_2683535" "unprognostic (7.84e-3)" "unprognostic (6.56e-2)" "unprognostic (6.54e-2)" "prognostic favorable (3.50e-4)" "unprognostic (3.77e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.64e-5)" "unprognostic (2.61e-1)" "unprognostic (4.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.42e-3)" "unprognostic (3.82e-2)" "unprognostic (4.70e-3)" "unprognostic (8.64e-2)" "unprognostic (2.07e-1)" "unprognostic (6.56e-2)" "unprognostic (4.46e-2)" 10.3 25.0 12.6 5.7 13.4 13.2 10.8 17.6 14.2 12.7 10.3 10.9 10.8 10.9 9.2 9.9 10.2 7.0 10.2 12.1 12.6 14.5 26.8 10.8 8.0 15.1 13.3 12.3 11.1 17.5 7.9 23.4 7.2 15.4 14.3 4.7 12.2 10.5 6.3 14.3 14.0 16.9 5.7 11.9 14.7 14.6 18.7 13.3 4.4 13.6 6.1 5.7 9.9 10.7 14.1 14.6 15.0 13.9 22.4 13.3 12.4 17.6 18.0 24.6 24.7 20.7 22.1 18.0 4.7 23.0 13.3 34.2 10.6 13.7 16.2 11.1 9.9 16.5 3.6 13.4 24.0 37.8 3.1 6.3 20.6 16.7 34.9 11.1 13.8 9.6 8.1 26.8 10.7 24.0 12.8 2.1 10.2 13.3 5.2 13.3 8.1 17.5 8.2 18.9 9.4 17.2 14.3 13.5 9.1 35.5 12.4 15.1 35.8 12.8 20.4 11.8 35.0 16.1 18.4 13.8 2.7 25.1 18.3 17.3 1.3 10.5 10.3 3.7 9.1 2.6 6.0 3.9 3.1 13.7 5.4 1.1 2.3 6.4 4.1 13.8 20.5 3.8 4.5 12.6 13.4 17.6 14.2 12.1 12.6 15.1 13.3 12.3 15.4 11.9 13.3 14.1 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 26.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 60.5 0.1 0.0 0.0 0.0 CTNS "CTNS-LSB, PQLC4, SLC66A4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636459-3663103 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Protein transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 35.5;Late spermatids: 29.3;Theca cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 34.3;granulocytes: 27.9;monocytes: 10.4" "Cell line enhanced" "Detected in all" "HDLM-2: 144.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" NA NA "Vesicles, Intermediate filaments" "HPA046947: AB_2679872" "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favorable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favorable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 10.0 19.7 9.6 10.1 14.5 10.3 9.7 13.1 11.0 20.4 9.5 8.1 12.3 11.4 6.5 8.8 10.4 13.2 10.6 8.1 8.3 15.3 16.0 11.7 10.1 14.0 12.3 4.1 12.2 27.2 13.7 9.7 13.0 14.8 10.9 7.2 6.8 12.1 11.7 15.4 19.3 11.0 8.7 10.9 12.2 15.1 25.1 10.7 8.9 9.3 7.5 9.6 9.2 9.5 26.8 17.6 37.0 22.6 18.2 34.5 16.9 13.0 19.6 28.8 21.1 26.0 21.0 16.0 10.2 17.8 11.6 55.9 40.1 19.8 12.1 12.6 144.3 33.7 10.8 32.2 19.3 46.5 8.0 81.3 23.8 14.2 20.2 15.4 28.1 22.2 18.7 12.6 15.9 16.6 15.1 7.8 7.9 9.8 12.2 16.8 16.4 9.3 23.0 15.3 16.2 3.9 17.2 19.2 24.4 20.3 19.0 17.1 7.7 24.2 17.2 11.6 40.3 13.3 12.4 20.0 4.2 28.1 7.8 11.8 27.9 10.4 21.8 3.0 6.9 4.9 5.8 4.0 5.7 9.7 4.9 4.5 5.5 3.1 5.2 7.1 34.3 4.3 7.3 9.6 14.5 13.1 11.0 8.1 8.3 14.0 12.3 4.1 14.8 10.9 10.7 26.8 4.4 3.2 2.2 6.5 4.8 1.7 3.5 2.5 4.0 1.6 6.3 5.0 5.2 5.7 2.7 12.9 10.4 6.1 5.2 3.6 0.0 6.7 35.5 5.7 4.4 5.3 2.4 4.0 3.4 6.4 7.1 6.0 7.7 4.3 8.2 6.7 9.3 7.6 25.2 5.0 3.4 2.5 4.1 7.2 5.9 29.3 9.6 12.1 5.4 3.7 10.0 6.5 3.1 5.5 11.1 6.4 3.3 12.8 4.5 6.5 3.2 9.5 7.0 3.9 6.6 3.7 3.5 19.7 8.7 2.9 2.4 8.5 3.3 30.9 1.8 3.2 RTN4R NOGOR ENSG00000040608 "Reticulon 4 receptor" Q9BZR6 22 20241415-20283246 "Disease related genes, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.5;liver: 12.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.1;Excitatory neurons: 14.1;Muller glia cells: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 10.8" "Lineage enriched" "Detected in many" 9 "T-cells: 10.8" "Cell line enhanced" "Detected in many" "NB-4: 38.2;REH: 53.9;SCLC-21H: 31.3;SK-MEL-30: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012443 Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 1900000 "Plasma membrane, Focal adhesion sites" "Actin filaments" "CAB012443: " "unprognostic (1.28e-1)" "unprognostic (1.28e-2)" "unprognostic (8.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.19e-1)" "unprognostic (1.56e-1)" "unprognostic (3.44e-1)" "unprognostic (8.90e-3)" "unprognostic (1.21e-2)" "unprognostic (9.89e-2)" "unprognostic (1.80e-2)" "unprognostic (1.34e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-2)" "unprognostic (3.07e-1)" 1.1 2.6 7.2 0.5 14.6 0.6 1.0 16.7 24.5 3.0 0.0 1.2 2.2 5.2 0.0 3.6 1.9 0.1 2.2 10.8 3.1 1.6 12.9 2.2 0.4 4.2 0.5 16.9 2.4 3.7 0.4 4.9 0.4 5.8 1.5 0.1 0.6 2.0 0.4 0.6 7.8 2.1 0.2 0.0 8.6 1.8 1.9 0.5 0.8 3.5 0.2 0.2 0.6 2.8 7.8 7.9 3.8 2.3 5.5 0.0 0.0 1.2 0.8 0.0 0.6 0.3 6.0 2.2 0.4 2.5 0.1 3.7 12.8 1.4 3.2 0.0 0.2 13.4 0.1 3.2 0.9 1.3 0.3 0.4 0.0 4.1 0.0 0.3 0.0 0.0 3.7 0.4 0.3 0.0 11.0 4.1 38.2 8.7 2.3 6.7 53.9 0.0 0.4 0.5 3.3 31.3 5.0 3.7 2.7 25.9 0.5 3.1 1.1 0.0 0.5 14.2 0.1 0.2 0.1 1.0 0.9 0.4 7.8 0.1 0.0 0.0 0.0 4.6 0.0 10.8 0.0 4.0 4.6 0.2 0.1 2.4 5.1 0.0 0.8 0.0 1.2 3.0 1.7 7.2 14.6 16.7 24.5 10.8 3.1 4.2 0.5 16.9 5.8 0.0 0.5 7.8 1.4 3.2 0.0 7.5 0.2 5.1 4.0 1.6 1.8 12.1 2.9 2.4 2.2 0.0 0.6 0.0 4.2 0.2 1.9 3.0 0.0 2.9 2.0 1.2 4.8 2.0 0.0 0.4 14.1 4.3 7.6 1.6 0.0 1.6 0.0 0.4 1.1 3.0 1.3 6.7 2.6 2.6 0.0 0.0 0.7 0.5 0.3 1.7 1.8 2.8 0.7 11.3 2.1 2.5 2.4 3.4 0.4 0.0 0.1 3.9 0.6 0.0 0.0 4.9 0.0 0.2 1.0 0.1 1.2 2.0 5.5 0.0 2.5 0.1 2.1 3.5 PHF23 "FLJ16355, MGC2941" ENSG00000040633 "PHD finger protein 23" Q9BUL5 17 7235029-7239722 "Disease related genes, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052410 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052410: AB_2681822" "unprognostic (1.76e-2)" "unprognostic (6.12e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.96e-2)" "unprognostic (2.41e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-1)" "unprognostic (2.67e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (4.40e-1)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" 19.1 40.0 21.3 24.8 20.7 10.2 19.3 21.6 25.0 22.0 19.5 23.8 23.0 23.8 23.5 35.6 20.4 20.3 16.9 22.4 21.6 22.5 26.5 18.5 30.7 25.1 28.9 20.3 19.2 18.1 24.5 20.9 23.2 24.2 24.3 17.8 15.3 19.3 23.0 22.8 19.4 21.6 23.1 22.0 28.6 19.9 25.0 22.8 37.1 24.5 22.1 34.5 29.4 23.5 23.5 49.6 78.1 85.2 56.0 54.4 54.7 33.4 65.8 72.2 78.5 66.7 42.5 34.2 72.5 39.7 71.2 55.4 46.6 81.1 54.1 64.6 73.7 67.4 54.6 51.5 47.8 87.5 26.4 82.7 75.9 51.5 68.4 45.6 82.3 75.6 34.8 61.1 17.4 92.7 37.9 45.7 53.5 80.7 35.7 34.3 61.5 41.5 35.4 83.9 27.4 28.0 89.0 47.0 37.9 75.2 50.9 46.0 30.7 69.5 69.0 47.9 41.2 82.8 32.0 35.2 37.6 62.0 42.9 60.6 23.1 8.2 15.5 16.2 6.6 13.9 12.0 12.3 17.9 9.3 15.6 10.0 12.5 15.9 10.7 9.5 16.7 11.2 7.9 21.3 20.7 21.6 25.0 22.4 21.6 25.1 28.9 20.3 24.2 22.0 22.8 23.5 22.3 6.4 9.2 2.0 21.9 84.1 22.7 21.6 56.9 13.6 36.5 17.7 18.7 15.7 17.2 22.0 6.2 32.1 31.2 24.0 39.2 39.2 19.8 20.2 25.7 26.0 18.6 33.6 3.7 21.5 21.0 20.0 8.6 22.1 17.7 15.2 17.5 13.8 37.0 16.8 2.8 18.5 26.4 20.9 40.3 24.8 24.8 20.8 33.8 4.7 37.3 14.5 35.0 3.5 2.5 35.1 26.0 17.3 23.7 28.9 16.6 30.1 11.4 11.0 39.5 14.8 29.1 30.9 22.4 39.2 83.3 76.8 21.3 30.5 16.5 27.1 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 13.5;prostate: 4.5" "Group enriched" "Detected in some" 20 "Astrocytes: 169.4;Excitatory neurons: 423.4;Inhibitory neurons: 216.9;Oligodendrocyte precursor cells: 488.6" "Cancer enriched" "Detected in some" 4 "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 7.1;HAP1: 4.6;hTERT-RPE1: 4.2;SuSa: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010651, HPA012085" Approved Approved "Nucleoplasm,Cell Junctions" NA NA 270000 "Cell Junctions" Nucleoplasm "HPA010651: AB_1078370, HPA012085: " "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.0 0.7 3.4 0.0 8.5 0.0 0.1 13.5 9.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.0 3.3 0.0 0.0 0.1 0.0 1.2 2.7 6.9 0.0 0.1 0.0 0.4 0.0 3.9 4.5 0.2 1.0 0.0 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.3 0.9 0.0 0.0 1.1 0.0 0.0 0.1 5.1 0.0 0.0 7.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 11.7 0.0 0.0 0.0 1.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 8.5 13.5 9.2 8.0 3.3 1.2 2.7 6.9 3.9 1.3 0.9 5.1 0.0 0.0 0.0 169.4 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.4 0.1 0.0 0.0 423.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 216.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.9 0.0 0.6 0.0 488.6 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594392 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 8.7 8.3 9.3 13.4 19.3 12.8 6.1 19.4 21.3 6.8 0.7 9.7 7.4 7.6 5.3 7.8 6.7 10.0 10.6 13.6 13.6 5.2 4.2 9.6 17.3 8.9 6.6 17.1 7.0 6.6 8.9 7.8 8.2 9.7 6.1 8.0 10.8 5.6 6.3 8.5 4.2 8.9 9.9 4.3 16.9 7.3 6.0 6.6 20.5 6.0 11.7 12.6 10.9 5.5 14.9 12.7 11.0 18.2 14.8 10.4 11.1 19.2 10.0 9.4 10.9 11.3 14.6 11.5 7.8 13.3 15.4 14.0 12.6 12.6 11.1 8.5 27.7 10.9 9.5 9.7 6.5 8.8 17.3 34.3 9.9 9.9 10.6 9.0 9.5 15.1 44.9 8.5 67.4 8.3 16.2 26.3 16.8 17.6 7.4 11.3 12.0 12.5 51.9 5.6 41.6 12.8 15.7 12.1 10.1 9.5 18.7 4.8 13.8 14.3 12.7 17.9 10.1 7.5 50.2 31.1 5.8 10.5 16.2 11.5 1.1 1.0 2.3 2.8 2.2 3.3 0.4 1.6 1.8 1.1 0.1 2.2 2.5 1.1 3.2 3.4 3.3 0.9 1.0 9.3 19.3 19.4 21.3 13.6 13.6 8.9 6.6 17.1 9.7 4.3 6.6 14.9 14.6 6.4 13.1 50.9 11.2 8.0 6.4 2.8 9.1 49.7 5.3 4.2 12.6 2.8 7.8 5.5 8.4 10.2 64.6 4.1 3.9 4.0 13.5 6.2 9.1 14.2 5.4 7.2 150.5 1.5 8.7 9.9 6.6 6.3 0.0 22.4 14.3 3.4 10.5 33.7 124.4 5.6 4.1 36.4 18.4 10.9 9.3 25.3 10.6 73.1 26.8 8.4 71.1 55.8 26.1 3.8 2.5 12.0 48.6 5.9 1.2 3.3 5.1 14.1 6.6 9.9 12.4 8.6 14.0 5.2 6.1 9.4 48.3 9.4 3.6 6.8 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 44.5" "Cell type enhanced" "Detected in many" "Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.2;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 6500000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 0.3 2.6 4.5 1.1 10.7 1.0 12.0 0.0 6.8 2.0 0.0 5.0 5.1 0.9 0.4 14.1 1.1 3.8 0.1 11.3 6.8 0.3 1.3 7.2 0.5 0.0 1.5 10.6 0.2 4.1 2.3 1.0 1.1 1.6 20.7 5.4 1.0 14.1 1.0 0.2 15.7 4.9 1.0 0.0 1.7 44.5 4.6 2.0 1.4 0.3 0.5 5.3 6.3 5.3 4.5 7.8 22.4 0.8 0.0 1.5 19.3 0.0 1.7 13.5 1.8 1.3 0.0 8.6 1.3 0.1 3.9 16.7 14.5 0.2 9.0 0.5 0.0 0.5 63.3 5.0 0.0 2.6 3.4 7.0 15.3 46.6 25.5 56.0 21.1 1.2 0.3 0.0 3.9 16.1 7.9 0.2 7.4 0.2 14.0 14.7 0.0 0.0 0.3 4.1 28.9 0.2 10.3 2.2 13.4 0.0 0.1 8.3 0.3 0.3 18.8 0.6 9.8 2.0 0.4 0.0 0.0 165.2 35.6 0.9 0.6 0.0 0.1 2.2 0.0 0.5 0.0 0.7 1.1 0.0 0.0 0.2 1.0 0.2 2.6 0.0 0.0 0.0 1.6 4.5 10.7 0.0 6.8 11.3 6.8 0.0 1.5 10.6 1.6 0.0 2.0 4.5 0.3 48.1 37.6 3.3 0.9 25.6 8.6 18.2 8.0 2.4 59.8 25.3 0.5 8.6 36.9 5.5 2.1 6.5 15.0 5.7 1.9 7.2 259.3 30.9 4.4 1.9 4.2 3.4 101.0 41.0 4.5 2.0 178.4 64.0 246.6 0.4 2.5 0.9 0.6 6.7 75.8 31.3 20.3 0.6 2.7 209.9 2.1 38.1 7.2 2.8 2.1 1.4 29.9 98.5 2.6 34.0 18.6 0.4 3.2 78.9 3.0 0.0 15.8 0.4 6.6 0.3 2.2 7.9 1.4 79.2 49.2 2.9 13.9 0.5 7.9 42.2 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome 20S subunit alpha 4" P25789 15 78540405-78552417 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol No No 13000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332" "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 92.4 105.9 68.6 107.3 70.5 108.5 88.3 71.3 99.6 79.2 71.6 106.1 109.9 90.3 75.1 119.2 72.2 66.6 93.1 69.9 73.6 98.3 153.3 88.7 138.0 73.1 71.3 68.1 65.1 67.9 74.0 54.8 86.5 73.1 98.1 110.7 50.7 70.8 64.8 182.1 76.4 102.1 100.2 73.6 116.3 89.2 110.8 70.9 157.9 71.2 122.7 129.7 119.9 81.8 76.8 274.2 386.9 327.7 290.8 202.1 189.5 256.3 250.2 199.9 301.4 320.6 404.9 386.9 590.8 359.7 232.5 337.4 363.9 669.1 271.8 289.1 244.2 465.7 497.6 271.6 330.1 326.9 512.6 294.5 154.6 166.8 255.0 250.9 185.4 330.7 319.1 544.2 225.0 249.6 392.3 347.5 477.4 309.7 315.3 224.5 297.7 432.9 198.9 309.5 469.4 287.6 209.9 401.3 289.5 327.5 402.2 267.8 414.7 265.8 223.7 298.6 249.3 434.2 204.0 517.9 556.2 209.9 756.7 252.6 126.0 251.9 172.9 136.2 403.9 140.3 156.0 142.0 144.7 327.4 119.9 111.7 137.0 112.8 209.4 394.8 185.4 216.8 405.6 68.6 70.5 71.3 99.6 69.9 73.6 73.1 71.3 68.1 73.1 73.6 70.9 76.8 119.0 128.2 118.5 17.3 124.1 231.6 269.6 765.7 84.2 57.8 88.5 95.8 163.7 105.8 327.0 121.4 10.4 478.9 128.4 145.3 311.0 296.2 689.4 158.0 183.6 162.5 146.2 153.2 18.0 292.7 450.6 159.9 78.0 126.0 174.2 152.9 114.9 178.9 320.4 72.3 19.6 216.2 506.6 143.2 201.7 399.0 151.0 176.9 133.4 23.4 308.6 63.5 149.3 11.1 21.5 256.0 165.7 147.4 108.0 249.3 195.8 367.2 280.0 39.8 151.2 95.4 241.1 417.1 181.0 106.4 212.8 447.1 128.6 166.7 234.7 258.4 MYO16 "KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107" ENSG00000041515 "Myosin XVI" Q9Y6X6 13 108596152-109208005 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2" "Group enriched" "Detected in some" 8 "Inhibitory neurons: 460.0;Oligodendrocyte precursor cells: 299.6" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;SH-SY5Y: 4.5;U-2197: 2.7" "Region enhanced" "Detected in all" "olfactory bulb: 72.6" "Low region specificity" "Detected in all" "HPA040110, HPA058769, HPA071948" Uncertain Approved Vesicles NA NA Vesicles "HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475" "unprognostic (7.55e-3)" "unprognostic (7.74e-3)" "unprognostic (4.52e-4)" "unprognostic (5.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.53e-1)" "unprognostic (6.50e-2)" "unprognostic (9.01e-3)" "unprognostic (5.29e-2)" "unprognostic (4.68e-4)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "unprognostic (7.06e-2)" "unprognostic (2.34e-2)" 1.4 0.7 1.8 0.2 5.2 0.0 0.2 1.4 3.3 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.9 5.0 2.5 0.0 1.9 0.2 0.2 0.9 2.0 3.6 0.0 0.1 0.0 1.7 0.1 1.3 0.2 0.1 0.4 0.1 0.7 0.0 0.1 0.0 0.4 1.4 0.0 0.0 1.1 1.7 0.0 0.0 0.2 0.3 0.0 0.2 3.3 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.2 1.4 3.3 5.0 2.5 0.9 2.0 3.6 1.3 1.4 1.7 3.3 1.0 0.0 0.6 19.6 0.0 0.3 0.0 0.4 0.0 4.2 0.1 0.3 3.7 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 11.3 0.5 1.1 0.1 0.0 3.4 44.6 0.0 0.1 0.8 0.0 0.3 1.3 0.1 0.0 5.9 0.1 0.0 460.0 0.0 0.0 0.0 0.3 11.4 0.9 0.1 1.8 8.4 0.0 2.8 0.0 299.6 4.7 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.1 5.0 7.7 0.0 0.0 0.3 0.3 1.6 0.0 0.0 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640791-194672463 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 14.6 12.9 14.3 16.0 14.2 28.4 16.0 14.3 16.0 12.8 14.2 15.2 17.4 15.3 20.0 16.1 14.6 12.7 13.1 13.5 15.0 16.7 21.9 13.0 18.8 15.3 16.0 13.5 14.4 15.6 16.9 11.2 17.3 16.2 14.7 18.3 14.2 14.0 14.0 23.2 19.5 15.0 14.6 14.6 15.6 13.8 14.5 14.7 17.3 15.7 19.1 21.5 18.4 14.4 15.9 55.6 36.0 21.2 35.3 32.3 17.8 43.1 31.0 30.1 42.9 37.6 47.9 25.1 43.1 93.5 29.4 75.5 39.5 68.2 35.0 52.1 56.3 32.5 46.8 38.4 27.6 22.9 51.1 42.4 17.3 31.5 44.4 41.7 16.0 47.1 29.4 39.5 46.2 36.0 76.6 46.3 30.8 57.7 73.5 65.6 56.2 35.0 49.3 23.7 46.9 40.5 27.9 39.9 38.2 40.0 39.7 90.3 32.9 36.5 32.4 37.3 46.2 66.6 50.6 71.1 97.7 26.2 64.7 52.4 3.5 10.1 13.6 15.3 13.2 17.1 16.6 12.5 13.9 17.2 14.3 14.4 12.9 1.3 21.0 8.9 9.0 15.4 10.6 14.3 14.2 14.3 16.0 13.5 15.0 15.3 16.0 13.5 16.2 14.6 14.7 15.9 25.0 19.2 29.6 10.4 22.5 16.2 13.4 8.9 25.0 18.3 12.1 11.9 17.2 18.6 27.9 9.2 12.5 25.1 21.2 14.0 5.9 23.3 12.0 22.1 24.5 23.7 7.8 16.2 10.5 22.4 19.4 17.7 21.9 24.0 53.7 21.9 11.7 14.0 13.0 15.2 8.3 14.2 12.2 4.4 10.2 8.9 15.5 15.5 12.4 8.4 14.0 18.2 12.3 12.5 12.2 19.7 8.0 14.7 23.8 11.5 10.8 9.7 34.3 18.6 19.7 22.1 14.6 26.4 35.7 30.5 16.1 28.5 24.0 23.2 17.6 9.0 PARP3 "ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3" ENSG00000041880 "Poly(ADP-ribose) polymerase family member 3" Q9Y6F1 3 51942345-51948867 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020984, HPA067657" Supported Supported "Nucleoplasm,Nuclear bodies" Yes No "Nucleoplasm, Nuclear bodies" "HPA020984: , HPA067657: AB_2685881" "prognostic favorable (6.39e-5)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (2.85e-2)" "unprognostic (7.31e-2)" "unprognostic (1.56e-1)" "unprognostic (4.13e-1)" "unprognostic (3.53e-2)" "unprognostic (2.26e-1)" "unprognostic (2.01e-1)" "unprognostic (7.44e-3)" "unprognostic (4.30e-1)" "prognostic favorable (1.25e-8)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-3)" 16.2 33.7 11.7 9.9 12.7 3.1 15.5 12.3 14.7 9.6 12.8 16.3 28.4 11.5 6.0 10.5 11.3 11.4 13.5 10.9 13.5 21.2 29.5 13.5 11.0 13.0 12.9 10.6 8.9 4.5 36.1 11.0 5.9 12.5 14.7 10.3 4.7 14.6 15.6 16.0 7.5 25.5 9.4 11.8 14.9 16.6 5.5 12.8 8.3 19.7 17.7 8.1 15.5 10.9 11.6 10.0 6.6 2.0 17.3 17.8 30.0 4.8 15.4 29.0 23.1 24.9 3.9 28.1 14.1 4.5 29.4 12.6 1.6 5.0 14.5 9.1 34.8 1.2 7.8 15.1 13.2 18.8 5.3 10.9 24.4 12.4 16.2 9.1 35.7 10.8 10.2 3.5 14.7 19.9 3.4 4.6 12.5 2.4 4.2 16.4 7.3 2.8 13.9 14.0 13.5 2.0 6.4 16.3 4.8 10.7 1.4 6.5 5.9 24.0 42.5 9.9 7.4 10.4 22.5 26.0 6.0 27.2 14.4 13.6 0.0 1.6 1.2 2.4 3.0 2.2 6.3 2.6 1.8 2.6 2.5 3.6 3.5 0.1 5.7 1.6 0.9 3.2 1.8 11.7 12.7 12.3 14.7 10.9 13.5 13.0 12.9 10.6 12.5 11.8 12.8 11.6 5.3 6.4 10.0 6.2 8.1 2.7 10.6 15.9 21.1 2.0 8.6 8.9 7.4 8.6 8.6 0.0 0.0 0.6 2.1 13.1 7.9 9.7 7.8 2.4 3.8 5.3 3.0 1.7 2.6 6.3 0.4 4.7 17.3 2.7 4.5 0.8 2.5 9.5 3.7 0.0 3.0 11.3 6.1 3.2 2.2 15.3 4.7 3.7 7.2 3.7 5.0 3.8 0.0 1.0 1.8 11.5 6.5 1.5 4.9 4.3 33.4 20.6 9.5 2.1 6.6 4.1 5.7 3.4 3.3 7.8 1.4 0.5 5.9 1.6 13.8 9.3 TNC "DFNA56, HXB, MGC167029, TN" ENSG00000041982 "Tenascin C" P24821 9 115019575-115118257 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 171.9;smooth muscle: 379.8" "Cell type enhanced" "Detected in many" "Astrocytes: 160.3;Basal prostatic cells: 72.1;Basal respiratory cells: 150.6;Basal squamous epithelial cells: 126.3;Prostatic glandular cells: 69.2;Smooth muscle cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 798.5;hTEC/SVTERT24-B: 634.4;U-138 MG: 526.0;U-251 MG: 484.5;U-87 MG: 711.8;WM-115: 1253.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004592, HPA004823" Approved "Secreted to extracellular matrix" NA NA 560000000 840000000 "CAB004592: AB_628342, HPA004823: AB_1080243" "unprognostic (5.46e-2)" "unprognostic (3.76e-2)" "unprognostic (7.57e-2)" "unprognostic (1.69e-1)" "unprognostic (9.20e-2)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (7.86e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (4.87e-3)" "unprognostic (1.79e-2)" "unprognostic (1.92e-2)" "unprognostic (7.60e-2)" "unprognostic (1.97e-3)" 61.6 4.8 17.2 171.9 22.1 0.9 41.6 15.0 10.7 39.6 2.0 134.6 16.8 107.7 12.3 24.1 25.7 14.2 25.0 14.8 40.3 29.4 7.8 54.7 40.1 21.2 36.3 0.7 5.4 4.8 2.4 7.3 4.0 23.7 39.5 28.6 4.8 20.0 33.7 6.2 23.0 57.0 379.8 14.3 41.1 63.0 4.8 49.7 17.2 13.4 3.2 22.8 97.7 16.0 19.3 25.1 6.0 6.9 1.3 37.5 10.1 0.1 205.7 798.5 425.4 203.6 5.3 55.3 0.0 32.8 291.7 6.9 89.9 0.0 12.0 241.3 0.4 2.2 0.0 4.8 0.0 0.7 0.4 3.9 6.2 1.7 634.4 289.9 42.9 0.1 0.0 0.0 5.2 11.4 0.0 0.1 0.3 65.2 0.9 85.3 0.2 451.9 0.1 373.3 0.1 0.6 5.9 91.4 0.2 19.3 140.9 1.0 1.4 0.1 526.0 88.4 94.2 484.5 14.3 0.4 0.4 711.8 0.6 1253.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 17.2 22.1 15.0 10.7 14.8 40.3 21.2 36.3 0.7 23.7 14.3 49.7 19.3 0.7 12.8 43.5 160.3 0.4 12.1 72.1 150.6 126.3 0.1 9.3 33.3 1.4 0.0 14.8 1.8 0.0 1.1 0.3 0.0 0.0 25.8 15.4 6.7 47.8 11.1 0.0 0.0 7.0 4.5 0.6 19.0 0.0 24.9 2.5 0.5 6.1 0.0 1.2 0.0 0.9 0.0 0.0 0.6 4.7 18.4 3.4 0.9 5.4 1.9 0.1 1.3 0.0 4.0 0.8 3.9 0.0 0.4 0.3 69.2 0.0 0.3 3.5 0.2 0.0 1.3 58.9 0.4 0.2 4.8 4.5 1.0 2.6 0.1 0.1 5.8 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 17.5 24.9 21.7 6.6 21.1 9.7 18.1 21.9 26.0 23.3 17.6 18.3 7.9 19.0 8.4 15.8 19.6 7.8 24.0 20.0 20.2 27.2 29.2 14.2 11.6 22.4 20.7 19.8 22.5 24.2 14.1 19.8 7.5 21.2 23.1 4.5 5.1 16.6 10.0 23.0 16.6 15.2 7.1 20.5 21.7 19.3 17.0 21.1 9.8 20.1 13.5 8.7 19.1 18.4 23.8 13.6 12.8 11.2 16.3 18.2 16.3 10.8 12.0 15.6 31.2 19.4 17.1 8.4 11.9 15.7 13.2 11.6 10.5 17.9 10.7 10.8 20.6 30.1 13.7 18.5 15.5 22.8 9.8 13.6 15.3 13.4 19.7 17.2 19.0 13.6 20.5 14.1 14.9 11.7 9.7 17.2 22.2 9.7 15.8 21.7 16.2 13.6 17.3 14.3 3.2 14.7 16.7 14.6 19.9 28.6 9.3 12.8 17.4 12.4 16.5 9.9 11.4 19.0 16.7 19.3 15.9 13.9 20.9 9.5 16.6 19.4 15.2 25.2 16.2 25.7 22.1 25.0 26.8 24.4 31.0 27.3 23.1 12.0 24.7 12.9 22.2 27.1 20.9 21.7 21.1 21.9 26.0 20.0 20.2 22.4 20.7 19.8 21.2 20.5 21.1 23.8 12.1 0.0 7.5 5.5 10.8 14.0 12.0 13.2 9.1 11.1 10.4 14.2 7.2 10.0 6.9 9.2 6.2 16.0 9.7 10.7 19.6 10.5 6.5 9.2 11.8 12.8 7.7 11.0 4.6 10.4 17.5 15.8 5.6 9.0 5.7 17.6 11.7 11.6 15.5 5.0 5.8 10.4 10.2 10.9 15.9 4.7 18.6 7.1 10.6 2.8 19.2 12.2 12.3 5.0 7.9 9.8 13.1 23.3 18.1 21.5 21.1 19.3 12.3 8.8 13.1 13.8 15.8 18.2 18.0 8.7 14.8 16.4 9.3 17.7 13.0 15.6 RIPOR3 "C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C" ENSG00000042062 "RIPOR family member 3" Q96MK2 20 50586108-50691542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Collecting duct cells: 3.7;Endometrial stromal cells: 6.5;Fibroblasts: 3.8;monocytes: 2.0;Proximal tubular cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.0;ASC TERT1: 16.7;HEL: 55.9;HSkMC: 33.0;K-562: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051823, HPA054759" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051823: AB_2681626, HPA054759: AB_2682596" "unprognostic (7.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.66e-5)" "unprognostic (4.96e-4)" "unprognostic (1.32e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-1)" "unprognostic (2.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.98e-1)" "unprognostic (9.21e-3)" "unprognostic (1.67e-2)" "unprognostic (4.58e-2)" 18.0 13.4 3.0 3.4 2.9 22.6 11.8 2.7 3.5 38.2 4.4 8.4 2.5 18.3 1.0 5.3 28.0 3.3 11.3 2.6 2.5 22.2 14.2 5.4 4.8 2.9 2.8 2.0 8.4 3.1 0.8 9.2 1.9 2.8 6.0 1.5 0.1 7.0 0.6 7.8 5.3 11.4 4.4 2.8 7.5 5.8 6.1 2.7 4.8 7.5 3.8 1.3 8.3 16.7 2.9 0.0 0.0 0.9 0.0 36.0 16.7 0.1 0.0 11.6 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.2 4.3 0.0 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.9 0.0 3.2 0.0 0.0 5.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 3.0 2.9 2.7 3.5 2.6 2.5 2.9 2.8 2.0 2.8 2.8 2.7 2.9 1.1 3.2 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.6 3.7 0.0 0.6 0.4 0.0 0.0 0.5 0.0 0.8 6.5 0.2 0.0 0.0 0.0 0.4 0.4 3.8 0.0 1.6 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.9 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 TDP1 "FLJ11090, SCAN1" ENSG00000042088 "Tyrosyl-DNA phosphodiesterase 1" Q9NUW8 14 89954939-90044764 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071317 Approved Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA071317: AB_2686388" "unprognostic (5.60e-3)" "unprognostic (3.53e-1)" "unprognostic (7.03e-3)" "unprognostic (1.34e-1)" "unprognostic (7.45e-2)" "unprognostic (7.22e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (2.61e-1)" "unprognostic (1.46e-2)" "unprognostic (5.84e-3)" "unprognostic (2.51e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.91e-2)" "unprognostic (1.26e-1)" 5.5 4.0 4.8 11.9 4.3 14.0 9.0 6.5 5.0 6.7 6.5 7.9 6.6 5.9 5.8 8.3 9.3 6.7 2.6 4.0 4.4 7.0 6.5 4.7 19.2 4.2 3.5 4.1 6.5 4.8 5.1 4.6 8.3 4.2 5.0 10.2 5.0 5.6 4.3 2.1 6.5 7.0 6.3 3.3 10.7 8.0 22.4 4.5 28.6 4.9 1.7 23.9 8.2 5.1 4.4 33.8 18.6 40.9 37.5 10.1 14.0 32.7 31.7 25.9 38.4 34.6 13.6 35.5 42.9 23.3 21.7 12.9 33.9 18.2 29.5 55.2 44.1 19.6 43.9 16.7 16.6 8.7 73.2 24.1 10.1 12.9 26.9 24.9 21.9 49.5 57.3 30.6 43.5 45.9 35.0 56.3 39.2 10.0 39.8 43.7 42.3 77.3 34.0 24.6 27.3 30.7 20.9 26.9 77.6 10.1 27.0 31.0 30.8 39.9 16.5 15.7 23.0 28.7 31.8 60.4 52.3 35.5 32.3 24.6 28.7 8.9 15.1 18.8 14.6 18.3 21.1 19.8 20.8 14.2 20.0 21.7 23.1 5.7 23.8 14.1 15.0 32.2 14.8 4.8 4.3 6.5 5.0 4.0 4.4 4.2 3.5 4.1 4.2 3.3 4.5 4.4 2.9 0.0 1.1 4.2 15.2 4.7 4.9 7.4 4.0 3.0 6.4 7.1 1.4 1.5 5.0 14.7 8.4 11.4 14.6 3.8 5.9 9.2 123.5 13.2 6.1 3.6 3.6 12.8 13.4 5.6 14.9 4.3 7.7 9.2 2.5 8.9 3.9 4.2 8.8 3.3 13.9 4.9 0.0 6.8 10.2 36.7 2.8 7.8 1.8 1.9 8.0 1.5 8.2 8.0 24.2 6.4 4.8 3.0 16.9 5.7 2.9 7.8 11.0 2.7 0.0 3.4 5.4 33.7 22.8 8.7 4.5 10.1 15.0 10.3 7.9 4.0 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 40.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 173.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.92e-4)" 40.0 13.6 7.2 6.4 7.6 1.9 31.5 6.9 8.1 6.5 7.8 11.6 9.4 7.9 9.1 13.4 6.8 5.1 14.0 6.7 7.2 10.3 22.0 9.4 5.2 7.7 6.5 6.9 8.0 5.0 3.2 5.7 4.1 6.8 10.0 7.2 2.5 7.6 7.8 9.9 5.4 11.6 5.0 5.8 7.8 9.9 3.9 7.3 2.5 14.7 7.4 3.6 12.1 6.4 6.6 26.5 45.2 1.1 11.3 26.2 9.8 0.3 10.4 25.5 21.0 23.6 35.3 49.8 3.8 25.8 14.5 27.5 27.9 12.7 3.8 5.9 50.8 1.9 0.2 27.3 173.3 56.1 0.3 6.4 13.3 8.4 33.8 7.2 13.2 9.5 1.7 20.5 21.9 11.0 33.5 1.2 1.3 4.5 21.2 14.6 0.8 4.2 12.4 11.4 19.2 3.6 0.8 19.1 16.6 29.8 1.8 0.7 7.2 12.0 0.5 25.3 15.6 30.8 16.2 32.7 7.3 14.0 0.9 13.9 1.0 0.5 0.5 1.8 0.5 1.5 1.7 0.6 1.5 0.4 1.5 0.8 1.3 0.5 4.0 0.5 0.2 1.3 0.7 7.2 7.6 6.9 8.1 6.7 7.2 7.7 6.5 6.9 6.8 5.8 7.3 6.6 11.6 6.4 14.1 7.2 5.0 2.3 15.0 8.4 2.8 5.7 5.5 4.7 13.8 8.6 10.5 18.4 0.0 13.9 1.4 53.1 3.9 40.7 24.1 6.0 7.7 4.8 12.0 7.0 8.2 21.9 3.0 11.2 14.3 6.2 11.4 22.3 1.8 25.0 10.2 1.7 5.2 7.1 14.2 3.3 3.3 47.0 5.3 6.7 8.8 4.7 34.4 4.8 1.0 5.5 3.5 40.8 22.7 4.5 17.0 14.6 28.7 22.6 9.5 2.1 19.7 11.8 12.8 6.2 3.9 5.1 1.4 18.6 3.8 8.8 13.7 20.4 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.5" "Group enriched" "Detected in many" 9 "Early spermatids: 946.9;Late spermatids: 1152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 5.9 6.1 8.8 1.7 9.6 1.7 6.1 28.8 9.6 7.2 6.2 5.2 2.2 6.7 7.0 2.8 8.4 5.6 5.1 8.2 9.3 9.6 5.2 4.7 1.9 8.4 9.2 7.0 12.4 8.0 7.7 11.2 2.9 11.8 6.6 3.1 10.2 4.2 4.7 5.1 5.7 3.2 4.7 8.2 3.6 5.1 57.5 9.1 3.0 12.2 4.5 1.3 5.4 4.9 11.4 2.3 3.7 5.5 7.5 8.8 16.5 6.0 5.2 9.3 5.1 3.4 1.2 4.5 2.2 2.5 5.7 3.8 2.3 2.5 4.0 4.8 3.2 1.8 0.5 1.9 2.1 12.7 3.9 0.5 7.8 6.6 2.1 3.9 16.8 9.4 5.0 1.3 2.7 4.8 2.8 2.8 3.7 1.4 2.9 4.6 3.9 5.6 1.3 8.1 1.9 3.9 4.9 5.1 6.7 5.0 6.5 6.0 4.2 4.9 3.7 4.0 5.2 2.9 2.6 2.1 1.3 6.2 1.1 2.6 0.0 1.0 0.2 2.1 1.4 2.5 1.9 1.7 1.0 2.1 0.4 1.0 1.8 0.8 0.4 0.9 2.1 0.7 1.0 8.8 9.6 28.8 9.6 8.2 9.3 8.4 9.2 7.0 11.8 8.2 9.1 11.4 7.8 12.8 7.3 38.5 1.5 2.4 7.6 9.8 7.4 10.8 6.3 8.5 12.0 7.2 8.8 3.7 20.9 2.6 5.3 1.1 9.8 11.0 946.9 22.3 13.2 6.8 16.3 1.3 113.0 7.2 3.6 11.8 4.1 4.2 1.3 19.4 7.9 4.5 5.7 15.2 91.6 4.0 12.2 17.2 2.8 1152.6 20.5 6.7 8.8 25.3 4.0 12.5 2.1 49.8 54.7 5.6 4.3 17.0 0.9 3.0 1.4 26.0 32.7 20.5 6.6 15.0 7.9 37.5 14.7 3.0 2.0 1.1 3.3 20.5 4.5 3.3 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavorable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 1.3 0.9 0.1 1.5 0.4 1.5 1.1 2.1 1.3 1.3 0.9 1.5 0.4 1.8 1.0 1.0 1.5 0.6 1.8 0.3 1.5 0.7 0.6 1.2 1.2 0.3 0.6 0.2 1.6 1.4 0.5 0.8 1.3 0.8 1.1 0.5 1.2 1.0 0.8 1.6 1.1 2.1 1.0 0.0 2.3 1.7 0.9 0.7 1.3 0.9 1.1 1.0 1.1 1.0 1.7 3.3 1.1 2.7 5.9 3.3 0.4 5.3 7.3 2.5 4.7 2.8 5.9 6.6 5.3 11.6 0.6 1.3 9.8 2.5 1.4 1.3 6.5 2.9 6.0 3.7 1.7 1.7 10.5 10.1 1.3 3.4 3.5 2.1 1.1 1.9 1.4 5.5 3.4 2.7 1.0 12.3 3.1 5.1 0.7 0.8 9.5 7.8 4.4 2.8 2.3 9.7 12.3 5.8 4.7 2.8 0.6 7.2 2.5 6.5 7.2 5.7 9.9 6.3 4.9 10.1 3.9 1.9 7.2 8.5 3.3 3.0 7.6 4.0 3.7 4.5 8.2 5.1 5.0 3.8 5.8 5.2 2.9 3.3 6.7 2.2 4.5 5.3 3.5 0.1 0.4 2.1 1.3 0.3 1.5 0.3 0.6 0.2 0.8 0.0 0.7 1.7 7.7 6.4 9.3 16.3 32.1 30.1 39.6 19.4 25.6 24.6 10.1 4.6 15.5 14.3 19.5 7.3 16.7 39.3 25.5 12.4 1.9 15.8 1.0 9.3 14.9 14.2 26.8 9.7 25.8 9.7 27.4 17.2 17.3 13.6 10.8 22.9 16.8 8.6 14.5 15.2 27.7 13.4 16.2 15.5 27.0 3.0 15.8 12.8 14.2 19.7 18.4 13.4 23.7 22.1 25.1 10.4 14.8 21.4 25.6 26.9 13.8 2.7 19.4 43.9 65.7 19.3 16.4 23.1 16.3 18.1 25.7 34.1 28.1 10.4 17.6 36.3 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85341955-85354531 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 249.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 264.9;Proximal enterocytes: 249.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 197.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA007961: AB_1079802, HPA046513: AB_2679680" "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 249.1 52.7 15.0 17.7 18.6 3.9 64.4 18.7 14.8 19.0 23.4 90.4 168.6 16.2 38.8 37.2 15.9 32.3 20.5 13.5 20.2 55.4 116.8 24.8 11.8 21.4 18.4 11.4 17.2 37.8 37.2 7.3 11.7 17.7 32.8 74.2 9.6 28.0 23.8 68.9 49.2 143.6 22.1 18.4 11.8 61.5 14.7 19.7 12.3 47.8 55.6 20.0 19.2 23.9 22.7 52.7 30.1 16.8 40.0 197.8 37.0 22.1 37.8 46.5 22.5 31.5 20.9 36.2 18.5 30.3 29.6 17.9 42.6 22.9 65.6 21.6 22.8 15.9 9.0 23.5 50.6 47.6 17.9 19.3 48.6 87.2 28.7 38.1 51.4 37.6 15.4 9.7 43.1 42.0 11.0 12.5 9.0 5.6 52.6 36.2 8.1 33.7 23.9 39.1 30.1 8.3 13.8 31.4 59.9 101.8 11.2 28.2 2.9 30.0 25.3 13.8 23.5 19.9 23.0 22.9 7.2 30.9 20.5 17.6 0.0 3.8 1.8 4.8 4.0 6.2 2.6 3.5 6.0 4.0 1.5 2.5 2.5 3.7 5.1 8.7 2.7 4.2 3.4 15.0 18.6 18.7 14.8 13.5 20.2 21.4 18.4 11.4 17.7 18.4 19.7 22.7 7.3 28.9 29.6 5.9 4.5 11.3 10.8 18.6 12.5 3.7 13.0 7.9 21.7 21.5 15.5 12.9 18.8 10.9 4.3 264.9 0.0 23.7 27.6 9.7 6.8 9.7 10.8 2.5 5.7 36.1 6.5 9.0 56.1 16.6 10.8 5.5 7.5 54.7 9.9 11.8 4.5 45.0 8.2 10.4 8.6 60.0 14.6 7.4 30.2 7.5 8.3 8.3 10.3 6.6 12.1 32.7 79.2 12.4 10.3 11.8 249.9 17.8 11.9 4.9 0.0 7.7 8.8 2.9 3.1 24.9 14.9 8.5 7.7 9.9 56.6 9.8 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394753-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm Yes No 5400000 Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 80.6 26.5 43.1 83.2 46.6 160.8 95.7 47.6 80.2 92.8 39.5 51.3 30.6 50.4 46.6 291.8 49.1 44.8 14.3 42.1 62.3 179.7 8.9 177.2 118.9 57.4 46.6 38.5 19.9 45.3 152.9 27.4 26.3 55.1 77.1 43.3 4.2 112.7 38.4 16.6 205.4 54.7 24.7 61.4 46.5 95.2 26.2 58.1 58.5 163.6 5.9 110.4 97.9 176.2 65.5 165.5 75.9 0.7 6.9 50.2 102.8 83.7 59.6 6.1 51.2 49.8 9.4 563.6 28.1 96.6 116.0 64.0 181.1 0.2 113.7 23.0 142.0 4.4 74.3 128.0 29.3 40.6 44.8 972.7 93.8 80.5 53.8 70.3 3.6 37.5 143.8 8.2 60.1 38.1 150.1 101.3 414.8 23.2 166.5 112.8 87.3 13.3 11.8 220.6 77.7 0.8 1.4 86.9 128.4 722.2 44.2 40.0 513.5 148.7 111.6 26.8 4.6 2.4 1.4 6.2 10.3 259.5 569.5 1.5 1136.5 1139.3 712.7 12.2 431.6 39.2 575.6 107.8 41.1 1363.2 516.8 30.5 13.9 162.9 605.5 131.3 959.7 122.1 977.9 43.1 46.6 47.6 80.2 42.1 62.3 57.4 46.6 38.5 55.1 61.4 58.1 65.5 6.6 19.2 24.5 3.3 84.7 121.2 167.5 265.0 60.9 0.8 86.8 70.4 1.3 51.5 119.6 316.3 0.0 34.3 91.5 211.0 211.3 113.8 4.1 33.0 10.3 16.2 28.8 16.0 0.2 91.5 324.0 34.7 124.9 63.9 548.8 1.2 3.6 1.1 1107.4 1.7 0.2 55.9 50.8 141.6 337.2 15.2 46.9 432.1 147.7 1.0 432.4 43.6 11.3 0.5 0.1 405.8 205.4 22.6 17.2 106.0 74.1 168.5 48.8 1.7 13.1 2.0 54.0 9.6 33.1 167.4 169.5 35.7 101.9 0.9 83.9 253.1 AP2S1 "CLAPS2, FBH3, FBHOk, HHC3" ENSG00000042753 "Adaptor related protein complex 2 subunit sigma 1" P53680 19 46838136-46850846 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 991.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.34e-1)" "unprognostic (5.93e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-1)" "unprognostic (1.30e-1)" "unprognostic (6.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.11e-2)" "unprognostic (9.54e-2)" "unprognostic (2.19e-1)" "unprognostic (5.25e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (5.79e-2)" "unprognostic (3.56e-1)" "unprognostic (3.07e-1)" "unprognostic (6.05e-2)" 109.7 137.6 106.4 81.3 121.0 127.5 96.7 105.5 139.6 69.9 100.6 87.5 67.9 62.7 41.4 190.4 59.1 46.5 101.9 118.3 119.9 107.6 150.1 91.0 62.9 109.8 105.2 116.2 52.8 77.8 52.3 73.0 79.7 112.8 91.6 57.9 27.9 100.7 49.3 102.5 126.1 80.4 60.7 107.5 125.6 85.8 69.8 112.0 67.8 62.0 64.3 68.2 83.6 104.3 121.4 380.3 363.2 181.6 198.7 227.1 248.7 122.2 311.0 383.2 349.2 411.0 277.1 189.3 121.1 168.6 476.2 153.6 178.8 144.9 450.6 263.9 115.1 418.6 210.4 220.6 204.0 306.7 142.1 150.0 317.9 259.0 337.9 281.1 259.0 471.1 199.5 186.1 180.4 331.1 403.2 181.1 1060.2 295.7 341.8 268.8 142.8 167.0 170.8 269.2 299.9 177.2 258.8 239.1 298.4 377.0 113.9 248.6 336.4 343.2 246.0 293.8 135.3 375.7 130.8 302.0 134.8 439.0 292.3 437.6 278.6 640.3 406.6 174.3 708.8 145.2 211.5 167.3 174.5 716.8 198.4 153.1 156.3 204.6 188.5 544.6 431.5 233.8 673.1 106.4 121.0 105.5 139.6 118.3 119.9 109.8 105.2 116.2 112.8 107.5 112.0 121.4 129.0 38.5 57.2 10.4 85.9 171.6 103.9 341.6 73.4 39.5 179.0 227.8 79.4 137.2 163.9 95.6 16.7 415.2 100.9 397.7 348.3 215.6 80.7 67.8 106.7 190.6 163.7 250.7 14.6 247.2 257.4 130.2 95.8 82.5 92.7 176.1 396.9 308.4 991.6 45.4 13.3 259.6 164.8 515.0 389.5 232.8 92.6 389.5 200.9 4.7 661.1 109.4 160.6 4.5 14.8 249.8 333.9 95.5 94.8 157.6 442.9 432.4 89.0 42.5 98.6 59.1 173.9 78.9 52.5 252.2 253.3 440.5 87.9 230.6 282.1 164.3 USH2A "RP39, USH2" ENSG00000042781 Usherin O75445 1 215622891-216423448 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "liver: 7.0;retina: 19.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 202.3;Early spermatids: 49.3;Rod photoreceptor cells: 165.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.97e-2)" "unprognostic (5.38e-2)" "unprognostic (9.19e-2)" "unprognostic (2.04e-1)" "unprognostic (6.62e-4)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "unprognostic (6.07e-3)" "unprognostic (3.15e-2)" "unprognostic (3.28e-11)" "unprognostic (2.02e-2)" "unprognostic (1.91e-1)" "unprognostic (3.35e-2)" "unprognostic (9.09e-4)" 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 7.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 5.0 1.5 0.0 0.0 202.3 0.0 0.0 0.0 0.0 0.0 49.3 0.3 0.0 0.6 0.0 0.0 17.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 12.3 0.0 3.3 10.4 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 6.1 0.0 3.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 165.8 0.0 0.2 0.2 1.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ZPBP "SP38, ZPBP1" ENSG00000042813 "Zona pellucida binding protein" Q9BS86 7 49850421-50121329 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 144.4" "Group enriched" "Detected in some" 7 "Early spermatids: 973.0;Spermatocytes: 691.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058673 Enhanced "Secreted in male reproductive system" NA NA "HPA058673: AB_2683794" "unprognostic (1.16e-1)" "unprognostic (6.46e-2)" "unprognostic (7.80e-2)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.15e-7)" "unprognostic (9.49e-2)" "unprognostic (2.34e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 144.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 15.0 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 973.0 0.1 0.1 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 22.9 0.0 0.0 0.0 0.0 116.0 11.1 0.4 0.0 1.9 0.0 1.9 0.0 9.0 0.5 0.1 0.0 7.9 0.0 0.2 0.0 0.5 0.6 20.2 6.6 0.0 0.0 691.6 17.1 0.0 0.3 0.0 0.0 0.2 0.0 0.2 TG "AITD3, TGN" ENSG00000042832 Thyroglobulin P01266 8 132866958-133134903 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Thyroid hormones biosynthesis" "Hormone, Thyroid hormone" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 685 "thyroid gland: 9416.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 5.5;Cardiomyocytes: 3.0;Early spermatids: 2.3;Late spermatids: 2.2;Microglial cells: 1.9;Proximal tubular cells: 4.0" "Cancer enriched" "Detected in some" 1672 "thyroid cancer: 3072.8" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HSkMC: 2.4;Karpas-707: 5.6;PC-3: 2.8;U-266/70: 2.0;U-266/84: 1.8" "Region enriched" "Detected in single" 5 "cerebellum: 1.1" "Low region specificity" "Detected in some" "CAB000077, HPA002740, CAB056155" Enhanced "Secreted in other tissues" NA NA 1600000 "CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277" "unprognostic (1.18e-1)" "unprognostic (6.86e-2)" "unprognostic (7.40e-4)" "unprognostic (1.20e-2)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.77e-2)" "unprognostic (7.38e-2)" "unprognostic (4.96e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (5.11e-2)" "unprognostic (3.64e-2)" 1.6 3.2 2.9 0.5 0.4 7.9 1.4 0.3 1.6 1.2 1.4 1.7 0.0 1.8 1.0 2.0 0.4 8.6 13.7 1.6 0.4 2.9 3.7 4.2 12.1 0.4 0.6 0.6 1.3 8.1 2.7 1.2 0.2 0.5 3.6 0.1 0.1 3.9 1.8 2.8 5.9 1.8 0.1 0.2 1.9 2.2 3.0 0.4 0.4 9416.4 0.0 0.6 0.6 1.7 0.5 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 1.7 0.6 0.0 0.5 0.0 0.7 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.2 0.1 1.6 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 2.0 1.8 0.0 0.1 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.1 0.1 2.9 0.4 0.3 1.6 1.6 0.4 0.4 0.6 0.6 0.5 0.2 0.4 0.5 0.3 0.0 0.6 0.3 0.2 0.0 5.5 0.1 0.0 0.0 0.1 0.1 3.0 0.0 1.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.3 0.1 0.4 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 1.2 0.4 0.4 0.3 0.0 0.7 0.3 0.0 0.0 0.0 2.2 0.0 0.1 0.0 1.9 0.7 0.3 0.0 0.5 0.1 0.1 0.0 0.4 0.1 0.5 0.0 4.0 0.0 0.0 0.0 0.3 0.3 0.8 0.3 0.0 0.6 0.0 0.2 1.1 0.0 1.2 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294069-24359014 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 360.7;stomach 1: 111.3" "Cell type enhanced" "Detected in many" "B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 71.6;naive B-cell: 87.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 27.8;OE19: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.1 2.2 5.2 24.9 5.4 9.4 3.9 7.3 6.0 16.2 4.5 14.5 8.9 6.9 360.7 2.8 12.4 40.6 1.0 5.5 9.1 5.2 1.2 3.9 27.0 11.8 6.9 2.5 2.3 3.5 1.1 18.7 3.7 11.0 5.3 12.2 1.3 16.0 5.7 0.3 3.3 24.9 2.9 12.5 20.1 111.3 0.7 8.2 5.1 1.9 0.4 32.6 11.4 1.8 14.1 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.1 27.8 0.3 0.8 0.0 0.9 0.1 0.0 0.8 0.1 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.7 0.7 8.8 0.1 0.1 0.0 0.4 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.2 2.5 0.1 2.1 1.0 0.2 42.4 2.5 18.5 0.0 0.6 0.0 71.6 0.1 0.0 21.0 87.0 0.1 0.0 4.3 2.7 0.2 1.1 0.1 2.5 5.2 5.4 7.3 6.0 5.5 9.1 11.8 6.9 2.5 11.0 12.5 8.2 14.1 1.5 3.2 6.0 0.7 240.9 0.9 3.0 36.9 0.0 0.1 2.3 2.2 2.0 28.6 62.9 3.7 0.0 0.4 9.9 0.7 0.0 7.9 1.3 7.6 1.0 3.7 0.0 8.2 4.3 3.5 8.7 3.9 141.7 18.4 2.5 0.0 0.0 0.0 9.4 0.0 2.7 0.4 28.5 12.3 30.9 1.8 0.6 46.4 5.4 233.3 7.8 0.1 23.7 3.5 1.6 55.7 0.1 0.4 43.3 1.5 0.6 4.4 13.1 0.1 6.6 0.0 1.1 0.4 0.2 0.7 0.6 0.5 9.0 6.4 1.3 7.6 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375848-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 159.3;salivary gland: 132.5;vagina: 72.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 163.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.8;hippocampal formation: 1.7" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.3 0.0 0.8 1.4 0.4 0.0 15.1 1.1 0.3 11.8 4.4 7.1 18.0 0.1 0.2 159.3 16.9 4.7 0.1 0.3 0.9 5.4 0.0 0.3 0.7 3.1 1.0 0.0 0.0 10.4 0.3 1.7 3.6 2.8 4.9 4.9 0.2 132.5 0.6 2.2 28.9 13.1 0.2 1.5 0.0 6.5 2.5 0.7 0.4 0.3 39.6 8.8 0.4 72.8 2.9 23.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 0.0 1.0 20.9 0.0 5.1 0.0 163.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 3.9 0.0 6.2 0.0 0.0 0.0 20.6 0.9 0.0 0.0 39.8 0.0 0.3 0.2 0.0 0.0 19.4 0.1 0.4 3.8 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 1.1 0.3 0.3 0.9 3.1 1.0 0.0 2.8 1.5 0.7 2.9 0.2 0.0 1.1 0.3 0.5 43.1 128.5 8.7 3.4 0.6 50.4 16.9 0.5 4.3 8.0 0.0 0.0 13.4 0.8 29.4 7.9 23.7 7.2 11.3 0.6 1.2 1.8 0.0 1.8 0.7 5.8 2.7 6.6 4.6 0.0 0.0 0.0 0.2 1.9 0.0 0.3 13.4 0.0 0.3 2.2 1.6 0.0 0.7 10.6 0.0 0.1 0.7 0.0 0.0 0.3 6.2 29.8 0.4 0.9 25.6 34.0 3.4 11.8 0.3 0.0 0.6 1.7 0.1 5.3 136.4 82.5 4.2 1.7 0.0 19.4 84.8 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 248.1" "Cell type enriched" "Detected in all" 5 "Late spermatids: 13031.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol NA NA 130000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 14.9 12.4 12.4 12.5 15.7 22.6 13.1 15.1 16.5 11.7 7.0 14.1 13.8 13.0 9.5 18.3 10.5 12.9 15.8 11.8 12.2 19.4 31.7 10.7 15.5 13.0 14.2 9.8 12.5 10.3 12.1 8.5 12.7 15.1 13.7 13.2 11.4 11.1 14.1 34.8 14.5 14.5 15.5 13.6 12.6 11.5 248.1 14.1 13.8 17.9 38.5 17.7 15.1 10.3 20.1 54.3 23.5 31.0 13.1 32.4 30.8 26.3 33.9 37.8 37.4 36.2 34.9 39.0 63.6 72.5 32.2 56.4 29.4 27.6 28.5 49.8 52.2 14.3 61.1 17.2 14.8 20.2 36.6 44.3 23.3 32.6 22.3 20.7 28.3 26.7 38.0 20.6 32.6 27.9 28.8 36.2 19.0 25.3 40.4 21.7 27.9 32.4 41.6 27.5 37.6 22.4 22.3 59.7 41.9 33.1 32.6 86.0 29.0 25.6 22.9 22.2 31.7 40.3 26.5 53.3 64.0 29.0 33.8 33.8 10.2 8.5 16.3 6.7 9.2 6.6 6.4 5.6 6.6 10.0 4.1 6.2 6.8 13.7 10.5 6.2 7.5 7.4 5.5 12.4 15.7 15.1 16.5 11.8 12.2 13.0 14.2 9.8 15.1 13.6 14.1 20.1 23.5 22.4 29.5 54.2 22.3 43.3 26.0 28.3 23.3 13.2 26.6 15.4 32.5 21.5 30.1 47.8 10.4 18.8 36.3 29.1 37.2 28.3 2437.8 24.0 29.9 23.7 26.9 98.1 52.7 30.5 18.7 29.0 18.3 26.3 29.8 22.1 17.9 52.6 28.6 18.5 40.9 19.6 30.5 45.9 54.2 13031.2 86.6 39.5 12.4 30.0 45.9 18.1 20.6 37.7 91.9 31.9 24.1 64.3 20.2 42.0 27.3 42.3 24.0 22.6 78.9 35.9 37.4 124.6 58.7 25.7 42.5 20.0 27.1 15.3 20.7 43.6 JADE2 "JADE-2, KIAA0239, PHF15" ENSG00000043143 "Jade family PHD finger 2" Q9NQC1 5 134524312-134583230 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025959, HPA055789" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA025959: AB_1855289, HPA055789: AB_2682922" "unprognostic (8.98e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (7.69e-2)" "unprognostic (5.56e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.58e-2)" "unprognostic (3.49e-2)" "prognostic favorable (5.36e-6)" "unprognostic (3.73e-1)" "unprognostic (1.76e-3)" "unprognostic (2.68e-1)" "unprognostic (2.87e-2)" 14.0 20.3 12.2 15.4 15.2 9.9 13.8 10.1 14.0 16.0 2.0 13.1 10.3 13.0 6.4 9.8 16.2 10.8 11.6 10.9 14.5 11.9 5.5 13.9 27.0 14.2 12.4 11.9 24.2 13.4 20.5 13.2 7.2 15.8 13.1 6.2 9.0 14.7 14.2 12.9 11.3 18.5 9.9 8.9 22.0 12.8 6.8 13.3 16.0 16.3 8.6 16.3 18.0 11.7 17.0 66.6 46.2 1.3 2.0 13.8 18.5 19.6 10.7 28.9 21.0 26.4 35.2 50.4 75.2 24.7 13.4 21.3 13.0 6.4 60.8 8.2 44.2 2.3 18.0 30.0 7.7 17.5 19.2 2.5 11.8 27.3 26.3 29.5 14.5 15.1 21.4 10.5 24.4 13.1 26.4 35.6 18.5 14.7 19.5 23.9 29.9 1.2 29.8 19.9 18.1 9.0 5.6 30.2 0.8 42.2 11.4 12.1 25.3 22.5 13.9 12.7 43.2 30.1 10.6 49.7 68.3 24.1 34.1 22.6 0.9 0.6 2.0 3.2 0.6 3.4 3.8 3.1 3.1 1.1 2.3 3.0 3.1 0.7 1.9 1.6 0.5 3.1 1.3 12.2 15.2 10.1 14.0 10.9 14.5 14.2 12.4 11.9 15.8 8.9 13.3 17.0 13.6 9.6 11.2 4.2 35.1 4.2 7.0 6.5 21.6 24.4 10.3 7.1 13.3 12.8 6.0 7.3 35.5 7.3 41.0 7.7 7.9 5.5 0.6 4.6 5.4 12.5 11.5 4.6 15.3 16.9 9.7 10.2 5.6 3.6 2.5 16.0 18.2 3.5 4.2 10.1 16.0 8.8 6.1 30.5 15.7 0.8 20.5 12.1 1.8 5.6 19.4 7.4 42.2 9.0 16.5 8.8 4.9 19.2 22.4 4.6 13.8 10.4 9.5 22.9 0.0 6.7 11.6 0.3 3.3 6.0 3.7 7.3 35.0 4.2 10.7 4.3 ZIC2 HPE5 ENSG00000043355 "Zic family member 2" O95409 13 99981784-99986765 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "brain: 120.5;choroid plexus: 30.7" "Cell type enhanced" "Detected in some" "Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 120.5;pons: 46.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 113.3" HPA055031 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA055031: AB_2682676" "unprognostic (6.43e-6)" "prognostic favorable (2.64e-4)" "unprognostic (5.73e-2)" "unprognostic (1.99e-2)" "unprognostic (4.39e-1)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (4.66e-2)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (9.36e-3)" "unprognostic (7.42e-2)" "unprognostic (0.00e+0)" "unprognostic (3.26e-1)" "unprognostic (2.11e-1)" "unprognostic (5.36e-3)" 0.0 0.2 16.6 0.0 18.8 0.0 0.0 120.5 16.5 0.0 30.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 15.1 9.9 0.0 0.0 0.0 0.0 18.6 17.2 8.2 0.0 0.0 0.0 1.2 0.0 46.2 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.0 1.2 17.7 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.5 4.9 86.2 5.5 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.5 5.8 0.0 7.3 0.0 4.6 0.1 3.9 0.0 0.0 43.5 66.1 6.4 4.0 4.4 0.0 0.0 4.3 0.0 6.2 0.0 3.9 0.4 0.0 2.2 6.5 0.0 0.0 2.9 0.4 34.3 80.5 0.0 2.0 19.8 3.3 0.1 0.4 2.2 179.7 0.0 2.8 0.5 0.0 3.3 4.2 33.5 0.0 20.2 0.0 3.6 5.8 0.6 0.0 0.0 4.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 18.8 120.5 16.5 15.1 9.9 18.6 17.2 8.2 46.2 8.6 17.7 17.1 0.2 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.3 0.7 0.0 0.0 1.8 6.2 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.0 0.0 10.3 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 1.5 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 LCP2 "SLP-76, SLP76" ENSG00000043462 "Lymphocyte cytosolic protein 2" Q13094 5 170246233-170297815 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 165.5;lymphoid tissue: 116.2" "Cell type enhanced" "Detected in many" "granulocytes: 129.6;Kupffer cells: 154.4;Macrophages: 158.2;NK-cells: 91.6;T-cells: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 147.0;HL-60: 152.5;HMC-1: 375.9;Karpas-707: 80.4;MOLT-4: 91.4;THP-1: 80.8;U-937: 99.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004574, HPA036396, HPA036397" Enhanced NA NA 2900000 "CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436" "unprognostic (1.33e-2)" "unprognostic (3.88e-2)" "unprognostic (7.52e-3)" "prognostic favorable (5.08e-4)" "unprognostic (1.43e-1)" "unprognostic (1.30e-2)" "unprognostic (2.03e-1)" "unprognostic (8.84e-2)" "unprognostic (1.44e-1)" "unprognostic (4.87e-2)" "unprognostic (1.37e-1)" "unprognostic (3.10e-1)" "prognostic unfavorable (6.22e-5)" "unprognostic (1.87e-1)" "unprognostic (3.56e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" 23.2 14.2 6.4 76.3 6.7 165.5 8.5 5.6 21.0 10.4 8.9 14.7 16.0 8.2 5.0 9.7 6.9 28.8 5.7 4.7 8.2 5.7 26.5 31.8 78.2 9.5 7.2 3.3 3.8 7.8 3.3 2.2 22.1 11.4 8.0 16.6 0.8 6.7 6.5 3.2 3.9 24.6 16.8 8.7 81.8 17.7 3.9 8.6 116.2 4.7 6.2 47.7 28.5 3.7 15.6 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.0 147.0 0.0 0.0 0.0 152.5 375.9 0.0 0.0 0.0 0.0 0.0 0.1 49.7 1.1 80.4 0.0 0.0 91.4 53.2 0.5 0.0 0.0 14.0 0.0 45.5 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.0 80.8 0.1 0.0 0.1 0.2 0.1 1.4 14.6 0.2 0.3 99.9 1.7 56.8 20.4 76.6 40.5 42.5 40.2 2.7 32.4 38.6 26.6 1.0 29.8 31.0 68.9 41.7 65.8 5.3 39.8 22.9 6.4 6.7 5.6 21.0 4.7 8.2 9.5 7.2 3.3 11.4 8.7 8.6 15.6 13.4 16.0 29.2 0.7 12.2 3.2 0.2 0.1 0.0 0.2 0.9 2.8 4.8 1.5 5.6 1.8 0.0 0.5 35.2 0.1 0.0 0.2 1.6 0.4 2.4 14.2 0.0 24.0 2.8 0.0 0.8 9.5 5.1 0.7 129.6 0.0 18.9 2.4 57.9 0.0 7.9 0.7 0.0 154.4 49.4 0.9 2.5 158.2 1.8 31.9 48.2 0.0 91.6 0.5 0.5 0.0 0.0 3.0 12.6 0.4 0.0 0.3 2.9 0.0 26.3 1.3 3.1 0.0 0.2 1.0 1.8 0.8 104.6 0.5 0.0 0.3 TRIT1 "FLJ20061, IPT" ENSG00000043514 "TRNA isopentenyltransferase 1" Q9H3H1 1 39838110-39883511 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Transferase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024174, HPA027330" Approved Supported Mitochondria NA NA Mitochondria "HPA024174: AB_1858346, HPA027330: " "unprognostic (4.61e-2)" "unprognostic (1.77e-1)" "unprognostic (8.38e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (4.00e-2)" "unprognostic (8.55e-2)" "prognostic unfavorable (5.34e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-3)" "unprognostic (3.18e-2)" "unprognostic (3.54e-1)" "unprognostic (6.68e-3)" "prognostic unfavorable (7.08e-8)" "unprognostic (6.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (6.90e-2)" 9.0 9.9 14.0 7.1 14.3 5.7 13.0 15.8 16.3 15.1 13.6 12.8 6.4 14.9 15.4 18.6 13.2 6.1 14.8 14.1 14.4 12.4 13.1 9.2 8.5 13.3 13.4 14.0 14.4 21.7 9.8 16.8 11.9 13.8 20.1 10.6 14.8 13.7 11.0 9.6 21.7 11.2 10.1 12.9 12.7 12.1 12.0 14.4 11.9 16.9 4.4 9.9 15.4 17.0 15.8 20.5 9.4 23.0 18.4 10.6 16.5 29.8 11.1 17.3 22.0 21.8 20.0 20.6 11.5 17.4 11.3 12.2 18.9 29.4 22.7 29.7 17.0 15.6 25.6 22.8 13.5 21.8 21.0 14.4 13.3 21.3 25.0 26.9 25.9 18.0 27.1 31.7 14.1 13.8 11.5 14.3 30.7 31.6 17.4 6.2 21.1 21.6 23.3 21.1 27.3 21.9 16.6 15.2 10.3 17.7 23.0 12.5 37.5 11.0 12.8 18.2 21.1 21.3 19.4 13.2 22.5 14.2 24.6 12.1 0.0 5.4 0.6 2.0 3.9 3.7 2.9 1.8 2.2 10.4 2.2 1.9 2.7 0.2 2.0 5.3 10.1 2.3 2.4 14.0 14.3 15.8 16.3 14.1 14.4 13.3 13.4 14.0 13.8 12.9 14.4 15.8 4.9 22.4 7.8 16.6 8.0 14.8 17.1 14.4 10.2 4.6 7.8 9.1 10.8 5.7 11.7 7.3 2.1 34.1 10.3 2.9 7.9 12.2 5.9 13.5 10.8 6.2 10.2 13.3 31.3 9.3 32.8 9.6 3.1 6.1 2.5 9.4 8.9 7.0 8.2 15.2 26.6 8.8 16.2 5.9 5.1 3.1 9.6 7.3 5.4 26.2 12.3 4.9 3.1 34.7 31.3 9.5 5.8 11.3 3.3 8.8 4.5 9.2 25.7 7.3 0.0 8.8 6.9 24.9 16.2 13.2 17.0 16.6 6.1 10.7 9.0 11.2 ADRB1 ADRB1R ENSG00000043591 "Adrenoceptor beta 1" P08588 10 114043866-114046904 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 20.4;lung: 13.2;placenta: 29.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 85.7;Cytotrophoblasts: 84.5;Sertoli cells: 52.6;Syncytiotrophoblasts: 38.4" "Cancer enriched" "Detected in many" 10 "prostate cancer: 12.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.1;PC-3: 2.6;THP-1: 4.5;TIME: 5.8;U-937: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067972 Enhanced NA NA "HPA067972: AB_2685936" "unprognostic (1.45e-3)" "unprognostic (1.18e-3)" "unprognostic (1.44e-1)" "unprognostic (4.92e-2)" "unprognostic (3.22e-1)" "unprognostic (8.88e-2)" "unprognostic (9.28e-2)" "unprognostic (3.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-2)" "unprognostic (2.77e-4)" "unprognostic (1.33e-1)" "unprognostic (7.80e-3)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.59e-2)" "unprognostic (1.44e-1)" 3.1 0.3 4.7 0.3 10.1 0.6 2.3 1.0 11.0 0.0 0.3 2.4 0.9 0.1 0.1 0.9 0.1 0.1 20.4 6.6 3.9 1.1 1.4 13.2 0.2 3.0 3.8 7.1 0.0 1.3 0.8 0.8 29.3 4.0 4.5 0.6 2.1 5.4 0.1 2.3 0.3 1.9 0.1 0.8 1.5 0.7 0.5 4.0 0.1 0.6 0.0 0.3 0.7 0.1 7.8 1.4 0.8 0.1 0.8 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.3 1.0 0.2 0.2 0.0 0.4 0.3 0.1 0.1 0.1 7.1 0.4 0.3 0.1 0.1 0.0 0.2 0.4 0.0 0.7 0.0 1.3 0.1 0.1 1.0 0.0 0.1 0.1 0.8 1.1 0.9 0.3 0.2 2.6 0.2 0.2 0.1 0.0 1.1 0.1 0.2 0.0 0.5 0.0 0.3 0.2 4.5 5.8 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 3.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 10.1 1.0 11.0 6.6 3.9 3.0 3.8 7.1 4.0 0.8 4.0 7.8 1.1 19.2 7.8 15.0 0.5 1.0 3.9 0.8 1.2 21.8 1.0 0.5 85.7 2.8 9.8 0.0 0.0 84.5 3.0 0.1 1.9 0.1 0.1 0.4 0.6 11.3 0.0 0.0 12.8 0.2 5.2 5.3 0.0 0.3 0.0 0.0 0.4 0.2 4.4 13.5 2.5 3.3 2.0 2.2 1.6 0.2 0.0 2.8 1.8 7.5 0.6 0.7 3.1 1.0 0.3 0.1 1.4 0.4 1.2 6.1 0.8 0.0 12.1 1.7 52.6 0.4 8.2 0.5 0.2 0.1 0.0 38.4 4.8 0.0 0.6 3.9 GUCA2B ENSG00000044012 "Guanylate cyclase activator 2B" Q16661 1 42153410-42155820 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 144.2" "Cell type enriched" "Detected in some" 7 "Paneth cells: 18841.5" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 1.4;CACO-2: 3.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Secreted to blood" NA NA 77700 1200000 "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (6.22e-2)" "unprognostic (1.86e-1)" 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 90.2 36.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 23.5 0.0 0.0 0.6 0.0 0.1 144.2 0.6 0.0 0.0 18.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 1098.8 0.0 0.9 1.0 0.0 0.0 0.0 22.8 0.0 0.0 47.9 0.3 0.0 0.0 0.0 22.3 0.0 0.4 3.1 0.1 0.0 0.0 107.2 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 18841.5 0.0 0.0 0.0 2568.9 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 1.3 0.0 55.3 0.9 CUL7 "dJ20C7.5, KIAA0076" ENSG00000044090 "Cullin 7" Q14999 6 43037617-43053943 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015449, HPA030095, HPA030096" Approved NA NA "CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997" "unprognostic (2.32e-2)" "unprognostic (4.79e-2)" "unprognostic (1.01e-3)" "unprognostic (6.06e-2)" "unprognostic (5.41e-3)" "unprognostic (4.95e-2)" "unprognostic (3.72e-2)" "unprognostic (1.94e-2)" "unprognostic (1.01e-1)" "unprognostic (9.81e-2)" "unprognostic (2.13e-3)" "unprognostic (4.81e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (8.92e-2)" "unprognostic (6.78e-2)" "unprognostic (2.23e-1)" "unprognostic (3.35e-1)" 7.4 13.8 4.7 6.6 4.9 4.4 8.9 5.7 5.0 13.9 6.9 7.5 7.8 11.8 9.1 6.9 14.3 7.7 6.0 5.1 6.2 11.1 9.8 7.5 6.3 3.7 4.6 4.9 16.0 15.8 7.0 26.2 10.3 4.2 11.1 5.4 5.5 8.6 8.8 13.3 7.5 8.1 9.3 3.4 9.8 9.5 5.8 5.6 6.2 13.0 10.8 5.5 9.0 9.7 4.2 10.6 8.2 27.1 32.0 27.9 40.7 2.2 15.7 21.0 18.8 19.0 18.0 7.9 4.9 35.2 27.0 19.1 3.9 9.9 13.9 8.8 12.4 10.5 12.2 9.1 25.5 23.2 4.4 14.2 42.5 13.1 16.2 17.4 33.7 18.0 5.6 10.7 12.3 24.1 21.8 5.6 10.9 4.5 32.2 6.7 9.1 6.5 12.7 16.6 14.4 14.6 18.2 12.2 11.3 11.1 12.4 16.6 8.3 18.9 28.1 12.0 9.1 6.9 25.6 7.0 12.9 11.2 4.8 16.5 0.0 0.7 0.4 0.6 0.6 0.4 0.5 0.4 0.2 0.7 0.7 0.2 0.4 0.2 0.6 0.5 0.9 0.3 0.6 4.7 4.9 5.7 5.0 5.1 6.2 3.7 4.6 4.9 4.2 3.4 5.6 4.2 3.9 6.4 10.5 6.5 4.5 2.5 1.7 5.2 4.0 6.0 7.2 6.0 4.6 1.5 4.6 3.7 6.2 4.8 1.7 3.8 0.0 6.4 0.6 8.4 7.7 5.8 7.2 2.1 6.0 4.8 3.7 6.9 10.7 6.3 4.5 15.9 5.7 2.2 5.0 1.7 5.9 8.2 6.1 2.2 1.8 0.2 9.3 2.7 1.8 5.6 1.2 4.1 1.0 3.0 3.1 4.6 2.6 7.5 3.9 2.2 6.4 4.9 12.9 7.8 0.0 7.5 4.9 0.8 2.5 4.2 1.7 4.4 2.8 17.3 4.6 1.5 CTNNA1 CAP102 ENSG00000044115 "Catenin alpha 1" P35221 5 138610967-138935034 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021089, HPA046119, HPA063535" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA 57000 "Plasma membrane, Cell Junctions" "CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033" "unprognostic (2.25e-3)" "unprognostic (3.32e-2)" "unprognostic (2.82e-3)" "unprognostic (1.80e-1)" "unprognostic (8.40e-2)" "unprognostic (2.35e-1)" "unprognostic (1.66e-3)" "unprognostic (4.83e-2)" "unprognostic (2.28e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (6.18e-2)" "prognostic favorable (7.34e-7)" "unprognostic (1.54e-1)" "unprognostic (2.31e-1)" "unprognostic (7.62e-2)" "unprognostic (1.04e-1)" 135.3 138.2 87.6 66.4 108.6 33.4 127.5 104.4 101.5 103.6 102.4 157.3 116.6 100.0 116.7 210.6 114.4 96.4 185.1 84.3 119.2 138.4 83.1 135.6 35.9 108.4 100.9 74.9 102.4 84.5 121.4 54.8 125.7 103.8 97.2 124.1 54.5 128.8 104.9 87.8 135.8 116.1 116.5 100.1 66.6 126.4 35.3 98.2 33.3 124.0 62.5 69.9 128.0 127.4 141.1 225.3 161.1 237.9 353.6 202.2 220.8 362.0 222.0 277.9 208.1 261.1 337.9 297.4 0.8 182.9 334.3 228.0 167.7 165.9 366.0 240.0 129.6 144.0 94.3 245.7 206.5 243.6 1.7 88.2 140.5 286.0 249.1 269.6 230.6 397.7 66.0 52.9 94.3 227.2 199.4 2.3 28.9 96.2 237.4 3.6 88.8 138.0 135.7 441.9 295.5 94.9 124.8 409.7 568.2 344.3 503.4 201.5 64.4 341.1 217.1 117.4 136.5 156.5 33.8 69.9 13.5 207.0 40.3 286.7 5.1 37.8 3.4 5.8 46.4 3.8 7.9 4.1 4.3 32.3 6.6 0.3 2.1 20.9 0.6 46.8 7.9 11.1 17.8 87.6 108.6 104.4 101.5 84.3 119.2 108.4 100.9 74.9 103.8 100.1 98.2 141.1 137.3 259.6 161.0 57.1 19.4 78.5 119.5 134.4 82.0 7.3 74.6 52.3 230.8 87.2 201.8 121.4 20.9 124.8 21.1 320.7 68.4 184.9 17.2 158.0 67.9 141.1 51.0 41.7 37.6 175.5 137.8 97.1 167.1 206.9 40.5 83.3 92.4 66.6 92.8 3.3 31.5 139.0 87.5 80.5 80.9 23.6 77.9 77.9 78.2 104.0 158.5 46.2 6.2 66.4 159.7 328.7 201.4 84.7 24.8 128.7 165.6 140.1 210.1 24.5 98.6 74.9 109.1 18.1 21.0 111.3 77.3 189.9 20.4 44.4 130.6 181.4 PHKA2 "PHK, PYK" ENSG00000044446 "Phosphorylase kinase regulatory subunit alpha 2" P46019 X 18892298-18984114 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 42.7;Hepatocytes: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002912 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA002912: AB_10961321" "unprognostic (3.90e-2)" "unprognostic (2.06e-2)" "unprognostic (5.10e-2)" "unprognostic (1.43e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.07e-2)" "unprognostic (3.42e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.68e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (2.05e-1)" "unprognostic (1.58e-2)" "unprognostic (7.16e-2)" "prognostic favorable (2.96e-5)" 12.8 9.7 4.7 6.9 5.9 15.1 7.7 6.2 5.3 8.7 6.7 6.3 12.6 10.6 6.6 6.4 9.9 8.1 11.3 5.0 5.3 6.8 34.6 6.4 7.7 6.6 5.6 3.7 16.9 15.3 8.1 12.9 10.6 6.1 9.8 6.5 10.7 9.6 7.2 7.9 8.8 10.2 6.2 5.4 9.4 8.7 9.8 5.5 12.7 10.2 14.4 7.5 6.2 8.1 7.0 11.3 10.6 6.1 10.2 8.2 7.5 16.6 4.9 4.1 7.1 7.7 11.3 7.3 13.3 3.6 6.4 11.2 10.3 11.0 12.8 7.6 6.5 11.2 15.9 17.6 13.8 5.8 15.2 19.7 12.6 8.3 8.7 12.5 11.8 7.4 13.8 5.3 8.0 5.0 12.0 16.0 25.2 7.5 5.2 11.2 12.4 12.5 14.9 4.6 5.0 5.2 8.0 14.8 15.3 6.8 20.3 18.9 8.8 13.2 9.6 5.3 10.3 7.6 7.6 6.7 10.1 5.4 8.1 5.2 4.3 3.2 7.2 2.0 3.8 2.1 1.6 1.7 1.5 2.1 1.7 1.9 1.9 5.4 3.0 2.5 1.1 2.3 1.9 4.7 5.9 6.2 5.3 5.0 5.3 6.6 5.6 3.7 6.1 5.4 5.5 7.0 6.1 9.6 12.9 27.7 5.7 6.5 5.4 6.0 8.6 11.1 8.0 7.4 20.1 12.8 5.1 9.2 10.4 16.8 3.4 9.6 0.0 7.5 7.2 6.4 11.8 7.3 4.2 14.5 15.2 5.1 17.5 5.3 4.1 7.2 1.3 42.7 20.3 57.4 8.0 5.0 19.9 7.4 4.1 18.9 3.8 5.3 7.5 10.5 5.4 13.1 8.3 17.0 7.2 16.6 16.9 6.3 12.6 7.9 7.4 6.9 12.4 4.8 4.1 13.3 0.0 7.4 5.9 7.9 7.9 8.6 4.7 10.5 7.4 12.1 10.7 3.6 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8;Spermatocytes: 84.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.9" "Lineage enriched" "Detected in single" 5 "monocytes: 3.9" "Cell line enhanced" "Detected in many" "HEL: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 4.3 2.5 2.2 2.2 2.5 7.3 3.6 7.9 2.3 5.0 3.4 3.5 1.2 7.2 2.4 2.7 4.4 4.2 2.0 1.9 2.7 2.4 10.6 2.8 2.8 2.9 3.2 1.4 8.9 1.7 4.4 2.2 3.7 4.0 2.7 2.2 2.2 1.6 3.2 1.6 2.0 2.2 4.5 2.8 4.0 2.0 5.2 2.7 2.8 3.2 2.5 1.6 3.5 3.5 3.0 8.3 5.6 12.1 6.8 5.8 13.6 0.4 9.5 6.3 7.0 9.5 0.4 2.7 6.0 1.5 6.6 7.5 0.3 14.1 3.9 10.9 0.3 4.9 35.5 11.7 2.0 6.4 4.9 7.4 8.6 2.0 5.8 5.7 6.5 10.0 2.2 1.3 1.1 11.3 0.6 4.0 7.8 9.4 1.4 10.3 5.8 11.2 3.0 4.1 2.0 7.6 7.9 11.6 0.2 3.0 4.8 2.3 12.3 7.5 9.5 3.7 10.4 8.3 4.7 6.1 0.1 4.4 6.1 4.4 0.2 1.3 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.1 0.5 3.9 0.7 0.1 0.2 2.2 2.5 7.9 2.3 1.9 2.7 2.9 3.2 1.4 4.0 2.8 2.7 3.0 32.0 6.4 17.6 59.7 1.6 8.8 13.7 6.1 13.1 12.3 3.6 5.8 13.4 7.2 3.4 9.2 0.0 2.5 1.1 2.4 5.9 10.1 16.3 23.4 30.7 24.9 2.4 17.1 20.3 12.0 5.2 29.2 4.1 17.0 7.6 42.4 20.0 38.8 18.4 20.2 37.2 5.9 4.1 40.3 11.6 8.8 45.7 24.0 8.8 91.8 31.0 21.4 1.0 70.4 29.6 4.0 0.8 30.9 1.8 3.8 5.3 8.5 6.7 8.1 13.1 34.2 21.3 84.3 48.9 5.3 5.5 1.0 1.7 31.6 5.5 6.3 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107621-89482134 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 31.8" "Group enriched" "Detected in some" 4 "Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 197.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 5.5 1.0 1.8 1.8 1.5 0.0 2.4 0.2 3.5 12.4 0.9 3.5 2.3 5.5 0.2 3.3 1.3 19.0 8.3 2.2 1.3 1.3 4.9 2.5 3.6 3.0 2.0 1.6 4.2 2.1 1.0 0.9 20.3 4.1 31.8 6.3 8.1 2.3 7.2 0.8 0.7 2.4 8.0 0.8 0.9 2.5 1.0 1.7 1.0 11.1 6.4 3.3 14.4 6.5 3.3 0.0 0.0 197.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 11.2 0.2 0.7 0.0 2.4 0.0 0.0 11.8 0.0 0.0 1.7 2.0 0.0 3.9 0.0 0.0 0.6 0.0 2.5 0.1 0.3 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.5 0.1 0.1 36.1 0.1 0.0 0.0 1.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.2 3.5 2.2 1.3 3.0 2.0 1.6 4.1 0.8 1.7 3.3 2.2 0.0 0.0 5.5 0.0 0.5 0.3 0.0 0.6 6.4 0.0 0.1 2.4 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.5 1.8 0.0 0.0 70.6 0.0 0.1 18.1 0.5 0.0 0.0 0.0 1.1 0.0 0.1 20.2 106.6 0.0 0.0 0.0 0.7 1.6 2.1 0.1 0.0 103.0 0.0 4.7 0.0 2.5 48.0 0.0 0.0 8.2 0.0 0.1 0.0 0.0 0.0 18.7 6.6 0.7 19.2 0.1 0.0 0.3 0.3 0.5 0.2 1.3 0.0 0.1 HSPA5 "BiP, GRP78" ENSG00000044574 "Heat shock protein family A (Hsp70) member 5" P11021 9 125234853-125241382 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005221, HPA038845, HPA038846" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 790000000 Cytosol "CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478" "unprognostic (3.98e-2)" "unprognostic (2.50e-3)" "unprognostic (6.64e-2)" "unprognostic (9.60e-3)" "unprognostic (1.54e-3)" "unprognostic (6.02e-3)" "unprognostic (9.08e-3)" "unprognostic (9.11e-3)" "unprognostic (4.50e-2)" "unprognostic (7.45e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (7.28e-2)" "unprognostic (3.66e-2)" 170.8 171.8 91.8 278.6 89.8 863.6 148.4 106.5 108.1 204.7 115.2 183.4 168.0 185.3 382.4 151.9 179.4 131.7 247.1 95.1 163.4 169.0 330.5 184.4 146.6 144.1 133.1 76.1 143.3 262.8 225.1 184.1 313.9 122.3 194.5 185.5 106.1 212.8 169.0 88.4 113.5 177.2 207.0 115.7 130.8 179.5 175.0 152.3 117.3 698.9 85.9 181.5 199.6 106.0 164.9 593.4 380.3 480.2 631.3 505.6 592.0 1152.8 1047.6 728.2 675.9 778.5 558.4 1093.4 649.5 644.7 682.4 1564.0 732.5 403.3 839.4 684.7 403.7 213.8 396.7 392.9 945.1 2692.4 547.4 730.2 363.6 1515.2 551.3 2309.4 728.1 1065.6 129.0 291.9 870.3 482.2 382.6 249.7 297.8 559.1 1327.5 362.2 233.2 492.4 1061.2 608.4 352.7 248.5 448.0 648.1 653.4 1079.3 715.5 694.3 378.0 791.8 439.5 433.0 462.7 484.2 939.0 994.7 551.2 1070.4 435.9 689.0 455.5 366.3 305.3 384.7 361.8 390.0 209.0 276.7 360.1 322.0 173.9 224.6 277.2 280.9 362.9 252.5 349.5 213.6 758.2 91.8 89.8 106.5 108.1 95.1 163.4 144.1 133.1 76.1 122.3 115.7 152.3 164.9 227.1 185.9 273.5 38.5 254.0 292.9 1225.2 573.2 192.9 97.3 193.7 166.2 803.4 97.2 416.9 112.2 352.3 505.9 408.7 426.5 45.0 415.0 86.2 372.1 402.2 247.9 508.8 82.3 19.7 258.4 955.2 455.5 258.4 467.4 334.2 304.6 147.4 379.4 449.4 63.9 34.6 508.2 195.3 133.4 271.0 50.3 175.2 261.6 181.5 30.0 135.0 134.6 80.3 29.7 41.1 313.7 408.3 174.5 1041.5 360.8 196.9 121.2 267.6 176.6 118.3 245.9 673.8 435.7 204.3 167.4 236.4 1327.5 323.8 243.0 376.4 795.4 DSG2 CDHF5 ENSG00000046604 "Desmoglein 2" Q14126 18 31498177-31549008 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.2;parathyroid gland: 159.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 13 "basophil: 8.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 8.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004896, CAB025122" Enhanced Supported "Cell Junctions" NA NA 140000000 "Cell Junctions" "CAB025122: , HPA004896: AB_1078643" "unprognostic (1.56e-3)" "prognostic unfavorable (8.22e-4)" "prognostic favorable (7.81e-4)" "unprognostic (8.77e-3)" "unprognostic (3.53e-4)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.86e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (5.21e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.94e-5)" "unprognostic (3.40e-1)" "prognostic favorable (3.14e-10)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-1)" "unprognostic (8.57e-3)" 23.8 1.2 0.3 14.8 0.2 0.8 40.6 0.6 0.5 13.1 21.5 106.2 79.8 8.6 10.7 10.3 22.6 31.7 31.7 0.8 0.7 34.1 15.2 15.1 1.6 0.3 0.6 0.0 13.8 39.8 159.1 1.6 23.1 1.1 31.8 101.0 0.4 69.2 6.6 1.2 6.7 85.2 7.4 0.1 0.4 77.8 3.8 0.4 24.5 42.6 0.7 4.6 42.0 5.8 0.5 119.2 45.3 4.0 0.1 0.6 7.2 143.0 0.0 0.0 0.3 0.0 31.7 172.9 0.0 64.2 0.0 54.4 269.2 54.7 201.2 0.0 0.2 33.9 0.1 46.7 35.9 20.2 15.2 0.3 9.9 136.7 4.2 212.1 102.4 0.0 34.7 47.8 0.2 0.0 31.5 32.2 2.0 55.4 229.5 23.1 52.8 0.0 76.2 65.8 58.5 23.9 0.2 88.3 61.8 0.3 117.8 44.3 12.7 0.1 0.2 25.0 0.3 29.3 5.7 0.2 0.2 19.8 0.1 25.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.2 0.6 0.5 0.8 0.7 0.3 0.6 0.0 1.1 0.1 0.4 0.5 120.8 54.5 45.4 0.0 1.3 13.5 79.4 76.2 28.5 0.4 68.9 49.3 57.3 101.5 79.6 12.9 0.0 80.1 4.4 404.6 3.9 105.5 1.0 48.6 9.4 13.1 79.9 9.0 3.3 76.1 116.2 12.0 70.3 82.1 4.5 18.8 2.2 26.4 10.3 1.7 0.3 165.7 79.3 0.8 4.0 2.5 1.5 2.2 17.8 0.0 6.3 5.3 1.0 0.5 0.1 254.9 152.0 0.4 0.3 133.5 145.1 10.0 75.4 0.7 0.0 0.6 8.2 2.7 8.9 23.1 6.0 59.9 2.6 6.6 216.8 179.9 GEMIN8 "FAM51A1, FLJ20514" ENSG00000046647 "Gem nuclear organelle associated protein 8" Q9NWZ8 X 14006726-14029893 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028613 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028613: AB_10602905" "unprognostic (7.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.83e-1)" "unprognostic (1.87e-3)" "unprognostic (2.58e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (3.87e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-2)" "unprognostic (5.52e-2)" "unprognostic (2.40e-1)" "unprognostic (4.74e-2)" "unprognostic (4.23e-2)" "unprognostic (2.07e-2)" "unprognostic (7.75e-2)" "prognostic favorable (7.73e-5)" 15.3 15.1 17.3 11.0 18.2 14.4 21.6 19.5 17.0 19.5 19.4 16.7 8.7 22.5 19.0 15.8 22.3 15.4 15.4 15.5 20.9 17.9 15.8 14.5 16.3 20.3 19.5 15.1 28.3 20.5 15.1 21.6 10.6 20.6 15.9 12.5 28.8 23.6 18.4 9.6 16.7 12.4 19.0 20.6 14.8 16.4 6.9 17.3 13.0 20.9 6.1 14.2 15.7 15.9 23.8 12.7 12.7 15.2 3.2 26.9 38.6 7.9 11.8 11.7 10.1 7.5 6.0 20.7 29.3 25.7 10.5 11.1 16.0 10.7 21.3 13.1 14.8 17.1 7.5 8.9 14.2 13.8 18.9 15.3 29.5 32.1 18.0 32.1 30.3 25.2 22.0 13.2 24.6 17.0 16.2 17.2 26.6 15.2 16.5 6.6 26.3 9.7 51.4 15.6 12.9 13.0 37.1 14.6 21.5 13.8 35.7 28.4 16.3 16.6 7.1 4.2 19.7 4.6 16.7 8.7 19.1 16.2 10.5 4.3 1.0 10.1 0.4 13.1 9.9 15.2 17.2 20.5 12.2 18.9 13.3 17.4 13.5 1.2 15.4 10.9 22.1 13.0 11.5 17.3 18.2 19.5 17.0 15.5 20.9 20.3 19.5 15.1 20.6 20.6 17.3 23.8 9.5 6.4 8.9 23.2 8.1 7.6 11.7 16.8 13.6 3.4 13.3 15.4 5.2 11.5 15.0 9.2 0.0 15.2 7.2 5.1 19.6 22.7 19.9 20.7 6.7 8.4 3.5 5.5 13.2 11.8 16.0 11.3 9.7 14.8 6.3 8.0 4.6 7.5 10.9 10.1 18.0 11.1 10.2 6.0 6.1 3.4 10.2 5.0 1.8 4.7 7.6 6.7 7.2 16.1 44.0 11.2 7.4 8.6 15.8 6.5 5.5 36.6 15.9 6.4 0.0 11.2 9.4 7.4 5.5 12.9 9.5 8.3 7.2 14.0 12.2 9.4 OFD1 "71-7A, CXorf5, JBTS10, RP23" ENSG00000046651 "OFD1 centriole and centriolar satellite protein" O75665 X 13734745-13769357 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "plasmacytoid DC: 64.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 64.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031102, HPA031103, HPA031104" Approved Supported Microtubules NA NA Microtubules "HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655" "unprognostic (3.10e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.10e-1)" "unprognostic (7.42e-3)" "unprognostic (2.20e-3)" "unprognostic (3.03e-3)" "unprognostic (1.82e-2)" "unprognostic (1.43e-3)" "unprognostic (2.82e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (3.32e-2)" "unprognostic (3.90e-2)" "unprognostic (1.04e-2)" "prognostic favorable (2.76e-7)" 5.9 6.0 8.7 11.8 9.1 15.7 14.7 10.8 9.9 11.3 10.0 9.5 10.3 10.6 11.6 10.0 9.6 7.4 5.8 8.6 9.3 9.3 7.3 9.3 19.2 9.9 8.6 7.8 11.3 11.3 15.4 11.0 5.3 8.9 11.8 8.3 11.3 15.8 6.6 5.3 11.9 12.9 7.7 8.5 14.0 12.3 10.0 8.6 10.2 13.0 4.1 17.0 8.6 10.5 10.3 16.0 7.1 10.3 18.4 8.4 13.0 7.7 4.9 11.3 5.7 7.3 12.8 17.7 23.2 12.5 5.9 10.6 15.3 7.5 13.7 9.2 11.6 18.9 10.8 22.3 10.8 6.4 14.4 19.1 10.4 9.1 12.9 12.7 10.6 6.4 4.2 16.5 20.4 6.4 12.6 9.9 17.3 10.8 5.8 10.2 24.9 11.9 46.6 8.9 13.5 10.5 16.6 23.2 18.5 11.6 22.7 17.5 13.0 5.8 10.0 5.2 12.1 6.3 15.1 15.1 26.9 8.3 6.4 8.3 4.3 1.7 6.2 11.6 2.2 13.4 13.7 10.1 14.2 3.8 15.4 8.3 12.5 4.7 14.1 3.1 64.2 8.6 4.4 8.7 9.1 10.8 9.9 8.6 9.3 9.9 8.6 7.8 8.9 8.5 8.6 10.3 40.2 70.5 64.1 60.4 90.8 22.4 89.3 51.8 38.1 47.9 65.9 64.1 17.8 35.8 66.7 31.3 89.6 34.5 219.8 82.3 7.9 60.2 178.6 232.2 33.0 39.5 48.6 30.1 43.3 59.3 23.4 31.2 58.1 180.8 27.3 41.1 24.7 13.3 25.2 37.0 50.2 60.3 42.7 19.8 43.0 187.4 52.2 35.1 17.8 32.8 38.2 41.3 145.2 76.9 64.5 60.7 72.9 33.8 50.5 84.4 83.8 15.3 81.3 107.2 39.5 42.4 25.2 72.7 59.9 32.6 27.3 87.0 102.2 30.7 52.2 82.8 GPM6B "M6B, MGC17150, MGC54284" ENSG00000046653 "Glycoprotein M6B" Q13491 X 13770939-13938638 "Predicted membrane proteins" "Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 816.8;choroid plexus: 229.7;retina: 209.5" "Cell type enhanced" "Detected in many" "Astrocytes: 633.3;Excitatory neurons: 361.3;Melanocytes: 357.5;Muller glia cells: 1722.4;Oligodendrocyte precursor cells: 408.1;Oligodendrocytes: 1476.6" "Cancer enriched" "Detected in many" 5 "glioma: 192.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 220 "plasmacytoid DC: 77.7" "Lineage enriched" "Detected in single" 268 "dendritic cells: 77.7" "Cell line enhanced" "Detected in many" "AF22: 154.8;AN3-CA: 150.1;ASC TERT1: 74.2;HSkMC: 110.0;SK-MEL-30: 154.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002913 Approved NA NA "HPA002913: AB_2263553" "unprognostic (1.56e-2)" "unprognostic (3.42e-1)" "unprognostic (1.83e-1)" "unprognostic (3.70e-2)" "unprognostic (8.55e-2)" "unprognostic (2.75e-3)" "unprognostic (2.12e-2)" "unprognostic (1.92e-2)" "unprognostic (4.27e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (2.38e-3)" "unprognostic (8.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" 7.6 9.4 451.7 6.1 537.9 1.1 26.7 573.1 525.7 22.6 229.7 24.6 5.0 6.4 12.2 11.6 6.5 5.9 10.9 477.5 560.3 6.6 1.1 17.0 2.8 589.9 499.7 408.7 4.4 3.3 0.6 17.3 1.3 572.8 22.0 7.9 209.5 14.9 35.5 2.5 14.0 9.3 5.4 625.2 14.7 11.8 3.5 462.5 0.8 5.1 7.6 1.9 9.2 19.9 816.8 0.4 0.4 154.8 150.1 41.6 74.2 0.4 0.9 6.9 0.1 0.0 0.4 0.5 0.7 0.3 0.0 0.6 1.3 7.6 0.8 0.0 0.6 25.2 0.4 10.0 0.4 1.5 0.5 0.9 110.0 0.9 0.0 1.9 0.6 0.0 3.0 0.4 6.8 1.5 0.6 3.4 0.7 48.5 0.1 2.5 2.0 13.7 23.9 0.0 0.5 7.8 4.4 0.8 4.4 154.4 41.9 0.7 3.6 0.3 1.0 1.3 0.3 2.0 0.5 0.3 0.3 1.4 0.3 12.4 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.2 0.1 77.7 0.1 0.7 451.7 537.9 573.1 525.7 477.5 560.3 589.9 499.7 408.7 572.8 625.2 462.5 816.8 13.8 0.0 5.1 633.3 15.8 33.0 22.7 5.9 6.8 74.4 37.1 47.1 1.3 1.5 7.8 22.0 87.6 5.0 50.7 3.0 0.0 5.4 1.5 45.8 32.7 12.5 1.2 5.3 361.3 3.7 3.7 54.2 0.0 30.4 4.5 19.7 10.8 0.4 1.2 26.9 144.0 5.0 8.2 1.9 33.5 3.2 24.2 3.7 357.5 40.3 4.6 1722.4 50.4 408.1 1476.6 2.3 6.0 32.0 7.3 26.5 6.1 1.1 11.0 151.4 46.0 137.7 43.6 9.6 13.3 7.0 17.0 13.7 20.5 8.6 3.2 14.8 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202342-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 198 "testis: 19.8" "Group enriched" "Detected in some" 13 "Spermatocytes: 84.6;Spermatogonia: 91.5" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 87.3;U-266/84: 99.8" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA062230: AB_2684718" "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.9 3.7 0.0 0.0 0.0 0.2 5.7 0.9 11.3 0.0 0.1 99.8 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 84.6 91.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PREX2 "DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129" ENSG00000046889 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2" Q70Z35 8 67952046-68237032 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in many" "Astrocytes: 717.6;Microglial cells: 120.9;Oligodendrocyte precursor cells: 422.2;Oligodendrocytes: 222.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.0;HUVEC TERT2: 19.2;JURKAT: 8.3;NTERA-2: 12.1;RH-30: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015234, HPA075956" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA015234: AB_1847604, HPA075956: AB_2686769" "unprognostic (2.25e-1)" "unprognostic (3.32e-2)" "unprognostic (1.30e-2)" "unprognostic (3.39e-2)" "unprognostic (1.79e-1)" "unprognostic (2.37e-2)" "unprognostic (4.19e-1)" "unprognostic (8.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.98e-2)" "unprognostic (2.53e-2)" "unprognostic (8.77e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.30e-3)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (6.64e-2)" 9.4 1.0 11.5 1.2 14.5 0.1 5.5 16.8 11.1 4.5 1.1 2.3 1.7 2.6 1.7 1.7 5.5 3.3 3.5 12.9 10.7 1.6 1.2 4.5 0.8 16.4 13.7 5.4 2.0 1.1 1.1 2.0 8.2 15.2 2.5 1.7 3.7 1.3 2.2 2.2 1.7 1.8 2.5 12.7 1.3 1.6 0.9 13.3 0.9 7.3 5.1 1.0 2.7 2.6 14.7 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 8.3 0.0 0.0 0.0 0.0 3.0 0.0 12.1 0.0 0.0 0.0 5.5 0.0 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 14.5 16.8 11.1 12.9 10.7 16.4 13.7 5.4 15.2 12.7 13.3 14.7 103.3 3.2 5.0 717.6 0.3 4.0 3.6 0.0 0.0 21.8 0.6 0.8 6.1 1.5 3.1 1.8 2.1 0.0 0.6 0.0 0.0 0.2 52.7 15.2 3.2 57.0 0.0 0.0 2.2 0.0 0.0 19.7 0.0 26.2 1.3 0.0 56.4 0.7 0.1 5.0 81.3 0.0 0.0 2.7 5.1 9.6 11.1 0.8 8.8 120.9 0.0 65.8 0.0 422.2 222.1 0.0 0.0 10.5 1.3 0.8 0.0 0.0 0.7 4.1 26.3 3.9 13.8 0.9 1.2 0.5 2.6 0.0 1.1 0.2 0.0 1.6 WDR37 KIAA0982 ENSG00000047056 "WD repeat domain 37" Q9Y2I8 10 1049538-1132384 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 184.8;Late spermatids: 92.9;NK-cells: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037376, HPA037565" Enhanced Approved "Intermediate filaments" No No "Intermediate filaments" "HPA037376: AB_10672789, HPA037565: AB_10696937" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (9.08e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.75e-5)" "unprognostic (2.59e-3)" "unprognostic (3.56e-2)" "unprognostic (1.80e-1)" "unprognostic (1.62e-2)" "prognostic favorable (1.46e-6)" "unprognostic (3.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (5.98e-2)" 8.0 16.6 7.4 9.4 9.8 22.4 7.9 0.3 17.7 8.1 1.5 8.2 7.4 8.0 9.0 9.2 7.8 6.2 17.8 10.8 5.1 8.8 10.4 10.4 12.6 2.4 2.2 9.8 9.7 10.2 9.8 14.7 6.4 3.9 8.2 6.7 15.1 7.7 5.2 18.5 11.6 11.3 6.7 0.0 21.1 10.4 21.3 2.6 10.4 9.6 15.8 9.9 7.0 8.0 8.9 12.4 9.0 11.6 9.4 10.9 15.8 8.2 15.5 8.4 9.5 9.4 11.3 10.4 6.1 9.2 20.3 2.0 11.2 6.1 18.1 8.1 7.4 10.0 14.8 9.6 7.7 7.7 8.8 16.0 19.8 13.6 13.6 4.8 11.3 21.0 12.1 9.1 7.3 15.2 10.9 9.8 6.9 6.4 9.6 4.8 14.9 6.5 10.5 13.2 13.8 5.2 10.1 7.2 13.3 11.9 8.8 12.8 17.9 27.7 7.5 2.5 24.8 12.5 13.4 13.3 8.2 17.4 9.9 5.4 6.0 4.8 3.5 10.0 6.2 8.7 5.5 5.6 7.4 5.2 4.4 6.3 7.3 3.8 11.2 7.1 4.8 5.3 5.2 7.4 9.8 0.3 17.7 10.8 5.1 2.4 2.2 9.8 3.9 0.0 2.6 8.9 10.5 3.2 8.1 33.6 14.5 13.4 13.0 7.5 10.2 16.3 8.4 7.2 23.3 5.7 7.9 11.0 12.5 6.2 27.4 8.6 0.0 4.8 184.8 5.7 8.6 13.6 10.7 6.5 65.3 6.1 4.2 9.0 13.3 11.1 12.0 7.3 30.7 7.0 9.0 8.4 59.7 8.1 8.2 18.8 13.7 92.9 12.5 14.8 16.0 43.1 23.7 5.3 86.5 36.7 47.3 9.5 8.3 18.0 9.6 13.6 7.2 4.8 4.9 14.7 6.6 13.0 8.5 11.6 14.3 11.9 12.4 11.4 19.1 10.1 5.9 19.7 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513694-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 129.8;Inhibitory neurons: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" NA NA Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: AB_2686548" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 8.1 9.8 5.9 11.4 6.5 10.0 10.2 9.6 7.8 8.6 8.5 8.8 9.4 9.3 8.7 9.4 8.4 8.1 7.3 6.6 6.5 8.6 12.7 7.5 13.9 6.1 6.6 6.1 11.1 8.7 15.7 8.8 6.9 6.4 8.1 10.1 18.4 9.0 7.4 11.6 11.4 10.2 7.9 5.5 11.5 9.3 14.9 5.6 10.3 9.3 11.0 13.0 9.9 9.0 7.9 16.0 14.2 18.1 30.7 9.8 12.9 19.7 12.1 13.4 15.2 23.6 10.0 8.8 29.1 8.5 10.2 19.5 15.3 22.0 27.2 19.8 12.6 19.9 15.8 25.8 13.6 14.5 12.8 13.4 10.6 10.3 9.6 17.4 14.3 21.5 13.0 15.8 13.0 13.6 5.3 17.8 9.1 8.4 4.7 9.2 7.4 15.6 22.7 12.7 20.9 14.4 12.0 16.3 11.7 12.7 11.3 16.6 11.4 18.8 23.2 8.1 12.1 16.7 13.3 18.0 18.0 13.3 14.4 10.1 0.0 2.8 2.9 2.8 1.9 3.3 7.3 3.2 3.0 2.4 5.1 3.4 2.9 1.0 4.3 3.3 3.6 2.6 1.2 5.9 6.5 9.6 7.8 6.6 6.5 6.1 6.6 6.1 6.4 5.5 5.6 7.9 27.4 28.9 32.8 61.0 39.6 13.3 21.8 14.7 15.9 59.9 17.6 17.7 17.7 14.3 25.3 12.9 83.4 13.7 34.0 12.3 0.0 17.8 47.5 15.5 24.5 24.0 7.2 16.6 129.8 18.6 8.3 22.4 34.1 17.2 12.6 69.0 20.0 25.7 17.3 52.2 146.3 14.2 20.3 30.0 13.2 44.2 19.9 26.8 12.4 95.5 23.9 21.4 16.5 94.5 97.6 18.0 7.8 14.7 20.0 14.4 16.0 17.8 24.9 88.9 26.3 34.0 26.6 93.8 37.8 19.2 14.3 18.1 33.0 33.4 16.7 18.5 CTPS2 ENSG00000047230 "CTP synthase 2" Q9NRF8 X 16587999-16712936 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017437, HPA075930" Approved Approved Mitochondria,Cytosol NA NA 40000 "Mitochondria, Cytosol" "HPA017437: AB_1847326, HPA075930: " "unprognostic (1.40e-1)" "unprognostic (6.69e-2)" "unprognostic (3.37e-2)" "unprognostic (7.38e-2)" "unprognostic (1.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (6.57e-3)" "unprognostic (8.52e-2)" "unprognostic (4.31e-3)" "unprognostic (4.43e-1)" "unprognostic (1.89e-2)" "unprognostic (7.22e-2)" "unprognostic (6.04e-2)" "unprognostic (8.93e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.56e-4)" 5.5 7.1 6.0 4.3 7.6 7.0 10.5 7.9 6.2 9.6 6.2 8.1 12.4 10.4 6.7 5.1 9.1 6.8 4.3 5.5 7.2 6.1 7.6 6.6 6.7 7.8 6.7 5.1 13.4 9.3 12.2 4.0 6.6 7.7 9.6 9.6 10.0 7.4 7.1 4.3 7.2 10.4 7.4 6.7 4.4 8.4 2.0 7.0 6.1 6.9 4.7 8.2 6.2 6.3 9.7 13.7 12.6 20.3 16.9 10.1 7.6 0.2 7.3 6.2 12.1 11.0 13.0 14.2 0.4 23.2 7.9 11.0 11.0 28.9 13.9 14.3 0.1 18.9 7.9 17.0 19.2 5.3 5.7 0.2 8.4 4.7 11.3 9.5 13.6 16.5 0.3 11.1 0.5 11.2 18.9 0.2 4.6 34.7 5.2 14.6 0.3 11.6 4.4 13.3 15.5 12.5 22.8 23.5 1.8 14.2 21.9 32.8 16.2 10.3 6.2 3.3 16.5 6.6 0.3 0.2 45.6 5.0 4.9 7.0 0.1 0.6 0.5 0.4 0.3 0.9 0.6 0.8 0.5 1.3 0.5 0.6 0.6 0.0 1.7 2.7 0.9 0.9 0.6 6.0 7.6 7.9 6.2 5.5 7.2 7.8 6.7 5.1 7.7 6.7 7.0 9.7 6.7 9.6 6.7 13.4 3.4 3.2 6.0 4.8 4.6 5.4 8.0 6.5 6.0 8.6 8.9 5.5 0.0 3.5 4.4 5.5 3.9 9.8 4.0 7.2 6.4 5.4 11.3 3.8 10.4 9.4 7.9 5.9 6.1 9.0 6.3 9.1 6.8 7.9 5.3 6.7 18.2 7.5 4.1 4.4 2.7 8.6 9.0 3.3 8.8 24.4 6.0 4.4 1.0 26.2 35.5 11.3 9.0 4.1 4.0 3.9 19.2 3.0 6.1 5.1 6.6 4.1 6.6 0.1 0.3 3.7 3.8 1.5 2.7 4.3 8.8 5.8 ATP6V1H "CGI-11, SFD, SFDalpha, SFDbeta, VMA13" ENSG00000047249 "ATPase H+ transporting V1 subunit H" Q9UI12 8 53715543-53843558 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009532, HPA023421" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 8300 "Actin filaments, Cytosol" "Plasma membrane" "CAB009532: AB_667834, HPA023421: AB_1845202" "unprognostic (1.67e-3)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (2.16e-2)" "unprognostic (2.38e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (2.01e-1)" "unprognostic (1.95e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-1)" "unprognostic (5.30e-2)" "prognostic favorable (1.46e-7)" "unprognostic (1.06e-1)" "unprognostic (3.37e-2)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" 24.2 44.9 46.2 16.0 51.3 25.8 26.3 30.6 59.6 22.0 32.7 28.3 13.0 25.6 33.2 34.4 22.8 20.9 31.5 58.2 49.4 61.1 19.3 24.4 21.6 33.7 35.1 55.5 24.3 17.5 48.1 42.7 24.1 36.8 30.5 20.6 37.7 29.0 27.6 38.2 35.2 19.2 24.3 32.7 20.4 32.1 18.7 35.4 26.8 52.8 27.6 22.2 28.8 26.6 49.0 42.8 35.6 29.8 31.8 50.9 32.9 23.4 40.5 44.5 54.8 56.7 33.5 54.1 27.2 38.7 40.9 69.7 67.8 52.6 58.9 56.1 39.9 35.8 28.8 34.3 40.9 69.1 19.6 31.8 46.5 82.3 37.2 66.4 52.5 37.8 28.9 39.4 14.0 81.6 36.0 30.6 32.5 27.4 37.0 17.4 28.2 10.6 18.6 88.4 67.4 23.5 34.9 28.7 54.6 79.5 34.4 64.0 16.3 43.2 24.4 19.7 54.6 25.5 25.9 30.4 32.3 57.8 27.4 27.5 25.7 14.8 36.2 13.2 16.6 14.9 13.6 14.3 15.4 20.2 12.0 14.4 16.0 14.5 22.6 23.4 15.9 20.7 11.8 46.2 51.3 30.6 59.6 58.2 49.4 33.7 35.1 55.5 36.8 32.7 35.4 49.0 18.2 38.5 27.4 84.2 39.0 29.6 40.1 55.5 42.1 72.8 27.8 21.0 28.9 38.6 50.3 58.8 112.6 76.0 35.9 39.0 105.7 49.1 8.3 94.1 27.7 25.4 35.3 27.0 154.7 31.1 43.6 23.6 26.0 145.7 15.8 22.0 28.9 21.9 64.7 62.2 105.8 17.4 75.3 43.0 103.6 8.5 43.2 52.9 30.2 42.2 35.1 48.4 37.0 58.3 57.7 44.1 30.1 48.2 20.9 32.5 31.4 64.9 39.6 76.4 19.7 16.8 24.6 28.5 52.9 37.6 31.4 100.0 38.1 36.4 21.8 41.4 POLR2B RPB2 ENSG00000047315 "RNA polymerase II subunit B" P30876 4 56977722-57031158 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037506 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA037506: AB_10672597" "unprognostic (9.88e-3)" "unprognostic (4.38e-2)" "unprognostic (1.83e-3)" "unprognostic (7.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.21e-3)" "unprognostic (1.24e-3)" "unprognostic (3.51e-1)" "unprognostic (6.39e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-1)" "unprognostic (1.95e-1)" "prognostic favorable (7.17e-4)" "unprognostic (1.91e-1)" "unprognostic (1.51e-1)" "unprognostic (3.43e-1)" "unprognostic (7.35e-2)" 28.5 29.4 11.4 38.7 14.0 34.4 34.5 21.1 17.8 33.2 16.6 35.0 32.9 35.2 26.8 30.3 33.2 30.4 48.5 13.5 15.1 36.0 30.3 27.9 50.3 13.6 12.3 11.8 31.9 28.5 50.7 17.9 33.2 15.3 32.7 36.6 37.2 30.8 32.7 65.3 28.3 31.2 38.6 12.7 36.8 31.3 40.1 13.1 61.8 37.9 57.2 51.8 42.8 19.9 17.4 78.9 64.3 110.5 98.2 89.3 80.3 61.2 94.6 101.3 98.3 91.1 82.9 80.1 126.5 86.1 94.3 71.4 52.2 140.5 77.2 139.8 54.2 66.3 96.9 70.0 71.5 102.2 156.0 100.6 86.8 76.1 114.3 68.5 81.0 119.5 95.0 145.4 100.0 115.9 56.8 142.3 60.5 92.0 101.5 77.9 105.9 75.7 68.4 66.8 90.7 95.3 106.8 67.5 120.3 89.6 90.7 65.8 88.3 91.2 74.4 95.2 75.8 132.2 77.3 75.5 172.8 82.4 83.1 92.4 51.9 17.0 22.8 27.7 17.0 29.5 27.9 26.6 28.8 22.2 18.9 25.9 30.8 14.4 26.5 19.8 17.6 30.9 19.8 11.4 14.0 21.1 17.8 13.5 15.1 13.6 12.3 11.8 15.3 12.7 13.1 17.4 39.5 28.9 52.0 26.8 61.5 41.3 60.9 60.3 39.9 45.5 31.5 26.5 35.7 35.8 56.3 36.8 43.8 49.2 77.1 36.9 19.6 60.9 5.9 53.4 52.7 39.5 29.9 50.5 31.1 55.0 30.7 42.8 59.1 45.8 58.2 36.8 30.7 30.8 29.1 45.4 32.0 36.9 50.8 45.8 36.8 8.8 57.5 42.5 44.4 33.7 74.3 26.7 115.4 23.6 40.4 54.0 36.2 38.0 50.5 59.4 36.6 32.7 80.6 49.0 72.3 46.5 45.7 74.0 63.6 32.7 39.9 41.0 75.2 46.2 35.4 74.6 FAM214A "FLJ10980, KIAA1370" ENSG00000047346 "Family with sequence similarity 214 member A" Q32MH5 15 52581317-52709817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-698: 63.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039369, HPA040180" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039369: AB_10795250, HPA040180: AB_10794736" "unprognostic (1.75e-1)" "unprognostic (6.40e-2)" "unprognostic (4.54e-1)" "prognostic favorable (7.27e-6)" "unprognostic (1.08e-2)" "unprognostic (5.96e-3)" "unprognostic (1.32e-3)" "prognostic favorable (8.68e-4)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.91e-2)" "unprognostic (2.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.22e-1)" "unprognostic (3.79e-2)" "unprognostic (6.94e-3)" 37.6 20.5 6.4 15.2 12.7 21.5 28.5 25.4 9.8 12.7 35.1 15.6 14.3 17.7 10.3 27.9 16.7 12.7 16.1 7.4 8.8 12.2 39.1 14.6 24.7 9.8 10.1 4.5 12.6 22.0 43.8 11.6 8.6 12.4 15.4 17.1 17.6 17.0 16.0 50.5 11.6 14.3 13.5 6.5 16.2 18.5 21.4 8.8 18.3 25.5 27.2 30.9 12.8 12.4 14.3 5.1 6.8 6.9 12.0 20.7 12.4 8.1 12.5 21.8 6.6 8.6 3.9 5.4 35.3 14.7 11.9 3.1 10.2 5.0 11.6 5.8 28.4 7.1 8.9 15.9 3.3 7.3 4.3 4.6 29.6 18.2 6.5 7.2 12.4 22.0 10.9 5.2 36.1 9.4 20.1 6.8 10.9 1.3 8.7 8.1 16.3 7.2 27.1 10.8 23.7 7.8 13.6 12.6 23.5 9.5 21.1 36.6 9.3 16.4 6.6 2.0 7.4 2.7 55.2 35.8 63.6 11.4 5.7 2.2 0.7 0.6 5.3 3.6 0.2 3.9 6.3 2.7 2.4 0.7 5.4 3.0 2.8 3.8 4.9 0.3 8.4 4.7 1.1 6.4 12.7 25.4 9.8 7.4 8.8 9.8 10.1 4.5 12.4 6.5 8.8 14.3 43.5 44.8 27.1 60.7 53.5 16.3 13.2 23.7 28.5 19.3 50.8 30.2 27.7 24.3 35.6 3.7 62.6 2.6 49.2 25.4 3.9 11.4 2.8 78.1 34.7 28.0 29.2 20.4 80.0 14.9 3.0 25.3 30.5 123.9 3.8 19.3 24.7 39.0 7.3 26.9 90.1 27.0 28.5 18.0 9.9 3.7 28.3 15.8 26.6 57.1 7.4 24.7 16.5 73.4 123.7 15.2 13.2 32.0 100.5 20.1 12.3 7.6 46.2 28.6 13.1 36.6 20.9 36.5 9.4 28.7 14.3 20.2 34.6 26.9 11.5 42.0 ARAP2 "CENTD1, PARX" ENSG00000047365 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2" Q8WZ64 4 35948221-36244514 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 40.3;brain: 93.9" "Cell type enhanced" "Detected in many" "Astrocytes: 285.4;Late spermatids: 167.5;Oligodendrocytes: 781.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.7;hTCEpi: 12.7;MOLT-4: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035925 Approved Approved "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "HPA035925: AB_10672075" "unprognostic (2.97e-2)" "unprognostic (8.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.04e-1)" "unprognostic (8.86e-2)" "unprognostic (2.72e-3)" "unprognostic (1.09e-1)" "unprognostic (3.78e-3)" "unprognostic (2.04e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-3)" "unprognostic (2.96e-1)" "unprognostic (4.48e-2)" "unprognostic (4.54e-2)" "unprognostic (3.43e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" 3.4 2.2 22.9 10.1 68.0 40.3 5.1 19.7 44.0 3.0 0.0 5.3 8.9 3.3 3.9 13.2 3.3 9.4 1.2 24.0 52.5 3.7 9.5 13.5 15.9 32.8 38.8 19.1 1.5 7.1 5.4 2.9 3.5 36.0 2.2 5.7 1.4 4.6 3.0 0.7 16.2 9.0 4.4 18.5 11.6 6.2 6.2 33.5 24.8 23.5 0.8 11.1 10.0 6.4 93.9 8.6 0.7 0.8 0.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 4.2 13.7 4.1 3.2 0.4 0.0 3.2 1.3 6.7 0.0 0.0 7.6 0.1 2.9 0.2 1.6 5.5 0.0 0.4 12.7 0.0 2.7 4.9 0.0 11.1 0.2 0.7 0.0 3.6 12.8 4.5 1.0 6.0 2.6 6.5 0.0 4.7 9.3 8.7 7.3 0.0 0.4 2.1 2.7 0.4 5.6 1.6 0.0 2.3 7.5 0.0 1.1 0.0 0.0 8.0 0.9 6.1 1.9 0.0 0.5 0.0 3.8 1.8 3.5 1.8 2.1 2.7 0.3 0.9 0.7 1.9 0.4 6.7 4.7 1.2 1.1 0.6 22.9 68.0 19.7 44.0 24.0 52.5 32.8 38.8 19.1 36.0 18.5 33.5 93.9 18.6 153.8 23.3 285.4 46.1 39.1 32.9 13.5 21.6 0.8 11.2 7.0 2.1 17.2 33.2 7.3 0.0 0.2 100.4 15.5 7.9 7.9 123.6 31.4 3.0 15.8 3.0 8.6 140.8 10.0 0.4 9.4 20.4 50.0 9.5 5.9 3.3 4.2 8.7 0.0 29.9 11.3 6.1 33.2 24.9 167.5 2.8 35.1 5.4 40.3 26.7 5.4 95.8 161.4 781.2 21.5 23.3 0.7 43.0 30.0 17.4 5.8 18.0 1.2 0.0 8.1 3.6 4.2 3.0 37.0 67.5 0.8 90.7 0.1 6.9 44.1 TPR ENSG00000047410 "Translocated promoter region, nuclear basket protein" P12270 1 186311652-186375693 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 772.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019661, HPA019663, HPA024336" Enhanced Enhanced "Nuclear membrane" NA NA 30000000 "Nuclear membrane" "HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217" "unprognostic (4.51e-2)" "unprognostic (9.87e-3)" "unprognostic (2.48e-1)" "unprognostic (7.56e-2)" "unprognostic (9.88e-3)" "prognostic favorable (4.71e-4)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.71e-1)" "unprognostic (3.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-2)" "unprognostic (3.63e-2)" "unprognostic (1.31e-3)" "unprognostic (3.75e-1)" "unprognostic (4.19e-2)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" 19.0 14.6 12.5 23.6 14.0 29.1 19.9 14.7 11.3 17.8 17.8 17.2 15.7 20.5 19.8 14.9 15.1 16.3 17.2 9.7 13.9 16.1 15.5 18.2 26.2 13.7 12.2 8.3 23.3 15.6 34.4 13.5 26.9 13.3 17.3 20.1 20.0 15.9 17.8 20.5 24.4 19.4 17.8 13.4 23.1 19.3 44.2 13.2 31.3 22.9 22.4 26.2 19.8 14.6 15.5 55.9 46.7 68.2 39.8 53.4 47.4 73.2 62.0 41.2 42.8 40.4 70.5 45.9 64.0 47.1 42.1 29.4 70.9 51.9 42.4 52.1 51.8 58.6 86.8 78.3 49.7 28.7 93.1 53.5 36.4 25.0 64.4 49.4 39.3 51.3 36.5 106.0 57.3 45.8 47.5 46.2 24.5 76.1 49.9 16.0 54.3 54.3 56.5 34.8 65.0 37.7 59.5 72.9 47.1 37.6 92.5 53.1 58.0 73.0 42.5 40.6 47.7 76.6 63.2 77.6 57.0 27.5 45.8 38.7 121.4 34.1 69.0 43.8 30.0 37.7 48.9 38.6 36.8 20.6 55.4 47.3 32.8 145.7 33.0 50.4 58.7 49.1 17.3 12.5 14.0 14.7 11.3 9.7 13.9 13.7 12.2 8.3 13.3 13.4 13.2 15.5 126.4 218.0 119.6 43.1 122.9 101.2 105.5 98.6 114.9 89.8 65.8 79.8 180.0 54.3 110.0 58.8 79.2 136.9 136.8 51.2 23.5 107.1 199.3 129.1 151.7 123.8 67.7 102.4 42.5 74.7 99.9 126.5 80.5 134.4 81.0 134.2 74.6 40.8 72.8 99.3 42.6 61.9 93.6 64.2 79.3 50.4 125.6 92.6 55.2 39.4 137.3 101.1 139.0 48.2 62.8 90.1 56.7 117.4 113.7 95.1 52.4 27.7 120.9 111.4 131.5 172.5 152.1 772.9 250.4 85.6 99.2 150.8 145.8 160.0 77.7 96.0 CP ENSG00000047457 Ceruloplasmin P00450 3 149162410-149221829 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Copper transport, Ion transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 1886.9" "Cell type enhanced" "Detected in many" "Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4" "Cancer enhanced" "Detected in many" "liver cancer: 98.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "EFO-21: 318.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001834, CAB008591" Supported "Secreted to blood" NA NA 160000000000 440000000000 "CAB008591: AB_1613734, HPA001834: AB_1078502" "unprognostic (3.58e-1)" "unprognostic (4.24e-1)" "unprognostic (9.61e-2)" "unprognostic (1.80e-2)" "unprognostic (4.14e-2)" "unprognostic (1.02e-2)" "unprognostic (1.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "unprognostic (6.03e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.68e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (2.70e-1)" 10.6 2.3 16.8 2.2 16.7 0.9 21.0 18.2 30.1 70.8 114.4 13.1 9.9 14.9 0.0 5.6 8.4 1.1 21.8 16.1 45.8 9.3 1886.9 13.6 19.1 27.4 21.9 13.5 0.8 6.5 3.9 28.8 3.4 24.5 7.9 16.5 248.7 40.2 0.9 2.7 10.4 21.0 2.5 18.7 23.3 3.0 1.5 20.3 0.5 16.3 8.3 20.2 24.1 2.3 26.3 0.2 18.8 15.6 0.0 3.3 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 318.8 0.0 29.4 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.4 32.7 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 2.5 5.4 0.0 0.0 0.0 0.4 6.7 16.2 0.0 0.2 0.3 1.0 0.1 0.4 0.0 0.4 0.0 0.2 1.7 0.2 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.8 16.7 18.2 30.1 16.1 45.8 27.4 21.9 13.5 24.5 18.7 20.3 26.3 2.3 19.2 76.6 3.3 10.6 3.3 8.3 28.6 0.6 6.9 14.0 0.6 0.6 65.8 558.1 9.2 6.2 0.1 0.3 0.1 0.0 83.4 0.9 190.5 51.0 12.6 0.0 34.7 1.5 21.4 0.2 16.3 0.0 406.0 2.5 0.1 34.6 1687.2 0.6 5.0 1.4 0.2 8.2 44.6 6.9 1.2 0.3 4.0 0.0 6.5 1.6 720.5 1.0 0.5 2.0 69.3 0.0 0.4 0.3 19.5 0.0 0.3 318.4 24.8 0.0 0.8 15.3 0.0 0.1 0.8 2.6 0.3 4.9 0.1 0.1 79.0 KATNIP "JBTS26, KIAA0556" ENSG00000047578 "Katanin interacting protein" O60303 16 27550133-27780369 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 2.7;Cardiomyocytes: 4.5;Cytotrophoblasts: 3.0;dendritic cells: 1.4;Extravillous trophoblasts: 2.6;Hofbauer cells: 2.6;Syncytiotrophoblasts: 2.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 14.3;eosinophil: 3.6;neutrophil: 9.9;NK-cell: 5.0" "Group enriched" "Detected in all" 5 "granulocytes: 14.3;NK-cells: 5.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 4.4 4.8 6.6 4.7 5.5 6.7 5.4 4.6 7.0 6.1 18.9 6.2 4.9 6.4 6.3 9.7 29.9 5.2 5.3 5.2 6.6 7.9 4.1 6.4 4.4 5.9 6.7 4.3 5.2 9.1 7.8 11.6 4.5 5.3 8.9 7.3 31.6 8.0 5.7 3.4 8.6 6.1 5.6 5.3 6.2 9.4 10.0 4.8 5.7 16.1 1.7 4.1 5.3 5.8 6.4 6.7 13.5 7.5 7.0 11.1 10.1 12.4 8.9 9.6 7.7 10.4 12.0 10.9 5.7 12.4 12.8 15.0 11.0 9.7 11.5 15.4 26.5 6.7 4.5 14.9 7.0 6.6 6.1 11.0 10.8 9.9 17.1 18.2 10.0 15.5 6.3 7.3 4.7 11.1 15.3 6.7 7.5 4.6 8.6 5.5 9.6 9.1 6.2 14.5 9.2 9.5 6.1 8.9 7.9 5.0 10.3 17.8 5.3 13.5 9.8 6.2 7.7 7.9 6.3 5.7 6.4 11.3 5.9 8.9 14.3 1.8 3.6 0.7 1.2 0.7 0.8 0.4 1.2 1.2 1.1 1.6 0.3 9.9 5.0 0.4 1.4 1.6 0.3 6.6 5.5 4.6 7.0 5.2 6.6 5.9 6.7 4.3 5.3 5.3 4.8 6.4 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522807-15663058 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 128.1" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Yes No Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favorable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.72e-4)" "prognostic favorable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 15.2 9.4 40.3 17.8 59.2 16.9 14.9 34.8 46.9 13.0 32.8 22.1 11.9 13.6 18.4 11.4 11.7 12.8 21.2 41.4 43.7 18.2 8.7 14.8 29.5 40.0 40.9 40.7 11.1 12.0 21.1 11.6 15.0 39.8 13.9 16.5 128.1 13.8 14.9 27.0 13.7 17.5 18.0 37.2 22.3 17.2 12.1 42.4 21.6 13.3 16.1 31.1 19.9 12.6 38.7 30.6 12.9 10.9 23.7 15.5 17.8 16.6 15.3 20.0 36.0 32.4 17.6 13.7 42.9 40.5 21.8 29.6 10.4 21.8 16.3 32.6 27.3 28.9 30.2 15.4 25.7 27.3 30.6 24.8 16.9 24.7 18.5 26.8 16.6 32.2 29.0 29.3 10.2 22.1 35.9 31.9 48.7 7.7 25.4 18.6 37.7 21.2 33.4 33.7 31.7 22.1 9.5 12.1 28.4 36.4 25.1 20.6 19.4 15.2 20.5 13.4 21.2 28.6 27.7 57.3 30.9 9.5 27.1 39.5 11.1 10.1 14.4 19.5 12.4 13.1 24.8 16.5 17.2 11.0 31.3 15.5 12.6 11.6 49.3 9.0 30.8 12.1 11.5 40.3 59.2 34.8 46.9 41.4 43.7 40.0 40.9 40.7 39.8 37.2 42.4 38.7 23.2 12.8 11.3 35.3 42.6 29.1 16.5 12.5 11.4 47.2 14.3 13.1 29.3 15.7 11.4 14.7 58.4 41.4 29.6 18.6 37.2 37.5 50.5 16.3 9.8 31.7 13.8 5.5 36.3 35.8 17.9 16.9 14.3 14.5 54.6 54.1 20.0 6.0 54.8 25.2 38.6 17.5 8.2 18.5 32.4 26.6 10.2 22.1 37.4 39.4 29.8 55.2 64.9 26.7 36.3 26.5 12.1 15.4 20.2 12.9 27.2 81.6 13.0 173.4 6.6 12.3 20.8 22.3 18.3 8.6 22.0 16.7 29.1 11.0 19.2 12.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685791-37732130 "Blood group antigen proteins, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.4;intestine: 12.3;stomach 1: 11.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 26.7;Erythroid cells: 63.5;Gastric mucus-secreting cells: 17.9;Proximal enterocytes: 21.5;Undifferentiated cells: 14.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 6.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 53 "basophil: 10.2;eosinophil: 5.8" "Lineage enriched" "Detected in single" 102 "granulocytes: 10.2" "Cell line enhanced" "Detected in many" "HEL: 44.4;HL-60: 23.2;K-562: 29.1;NB-4: 21.1;RPMI-8226: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria No No Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.2 2.1 1.9 1.4 2.9 14.4 0.7 2.7 3.2 1.2 0.4 12.3 10.9 0.7 0.5 2.0 3.8 0.9 4.4 3.0 3.8 0.9 0.8 1.0 0.2 1.8 1.6 2.7 0.7 4.9 0.7 1.3 0.7 2.1 1.5 11.3 2.1 1.2 0.9 5.4 0.7 10.6 1.8 0.8 0.5 11.6 1.5 2.5 0.2 0.9 5.8 0.5 1.1 0.8 3.1 17.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 14.7 0.3 0.0 0.8 2.7 15.4 0.1 0.0 0.0 4.2 44.4 2.4 0.0 0.0 23.2 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 29.1 10.9 0.1 1.7 0.2 21.1 5.5 0.7 5.6 0.0 0.0 20.2 0.0 1.1 4.1 0.1 0.8 1.4 0.1 0.9 2.1 5.6 0.0 0.0 0.8 0.0 2.4 9.3 16.5 0.0 0.2 12.1 0.1 10.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.9 2.9 2.7 3.2 3.0 3.8 1.8 1.6 2.7 2.1 0.8 2.5 3.1 0.0 0.0 1.1 2.6 0.8 0.4 0.4 0.1 1.2 0.7 1.1 0.8 7.9 0.0 0.1 0.0 6.2 0.3 0.1 26.7 0.0 0.0 1.2 4.0 0.1 0.3 6.1 63.5 11.0 3.1 0.1 0.6 17.9 0.9 0.0 0.1 0.0 0.9 0.1 3.3 12.6 10.9 2.0 0.3 0.0 0.4 0.0 0.2 1.8 1.9 0.0 0.0 0.0 4.5 1.2 1.1 9.2 0.7 2.2 0.9 21.5 0.1 1.7 1.4 0.0 0.7 1.3 10.2 6.1 3.8 1.1 0.0 0.3 0.1 14.7 1.5 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "retina: 228.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "basophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1" "Region enriched" "Detected in many" 4 "basal ganglia: 19.6" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 7.2 0.4 4.0 0.4 3.8 0.0 6.6 2.3 3.7 4.2 5.8 1.9 0.7 1.8 1.5 1.7 3.2 1.1 6.9 2.5 2.6 1.1 0.2 7.2 0.1 3.2 4.6 1.5 1.5 0.9 1.3 0.7 4.1 3.5 2.5 0.6 228.0 1.3 1.0 2.0 1.1 1.8 1.5 2.8 3.4 2.2 10.2 3.8 0.3 2.4 4.4 0.2 2.4 3.6 4.2 2.5 0.0 4.4 0.0 0.0 0.2 2.0 0.0 9.6 0.5 1.0 0.0 0.2 0.2 0.3 0.0 0.1 0.3 0.0 0.1 0.7 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.5 0.0 0.0 1.9 0.0 1.0 0.0 0.0 4.6 2.3 0.0 1.9 0.0 1.0 0.1 0.1 0.0 0.0 2.3 1.6 0.0 3.9 1.3 0.0 0.2 0.0 24.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 3.8 2.3 3.7 2.5 2.6 3.2 4.6 1.5 3.5 2.8 3.8 4.2 9.7 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.6 11.5 0.3 0.1 1.9 0.0 0.0 0.0 81.3 1.4 0.0 0.0 0.0 0.0 57.3 0.4 0.4 9.1 0.0 0.0 1.7 0.0 2.0 0.3 0.0 0.5 0.0 0.0 4.6 0.0 0.2 10.1 2.0 0.0 0.0 0.0 0.0 283.2 0.3 0.1 0.0 143.4 0.0 13.0 0.0 31.2 9.9 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 179.9 0.0 1.3 0.6 1.4 1.8 0.0 0.1 2.5 0.0 0.2 0.2 0.0 C12orf4 ENSG00000047621 "Chromosome 12 open reading frame 4" Q9NQ89 12 4487735-4538508 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037871 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA037871: AB_10670531" "unprognostic (5.88e-2)" "unprognostic (2.81e-1)" "unprognostic (5.64e-2)" "unprognostic (2.51e-2)" "unprognostic (3.07e-2)" "unprognostic (6.69e-2)" "unprognostic (2.96e-3)" "unprognostic (8.59e-2)" "unprognostic (6.85e-2)" "unprognostic (2.75e-2)" "unprognostic (2.26e-2)" "unprognostic (5.93e-2)" "unprognostic (1.26e-2)" "unprognostic (7.83e-2)" "unprognostic (2.74e-1)" "unprognostic (5.02e-2)" "unprognostic (3.92e-1)" 7.5 5.4 6.3 9.0 7.9 9.3 7.4 8.0 9.2 6.7 6.2 7.0 4.4 6.7 5.4 7.2 5.6 6.5 7.5 7.6 6.7 6.0 5.9 6.7 10.1 6.2 6.6 7.3 5.4 4.8 6.2 4.8 9.7 6.5 7.5 8.2 10.1 4.9 6.7 10.6 5.9 5.2 9.5 6.1 7.9 5.7 9.3 7.4 9.3 8.0 10.9 10.2 8.7 5.1 8.4 14.6 11.0 13.4 15.9 13.1 19.5 28.4 27.6 11.4 24.9 30.3 19.5 11.8 12.4 5.6 17.9 20.5 10.6 19.0 15.9 33.6 37.1 13.0 21.5 10.3 9.6 19.0 18.7 19.4 17.4 8.8 29.9 33.4 15.6 14.4 15.1 12.8 20.9 23.5 7.0 14.9 7.9 19.8 12.6 10.4 16.0 21.1 7.9 15.3 15.1 5.3 10.4 18.9 13.6 11.9 36.4 5.7 15.9 15.0 21.6 19.9 23.8 29.3 4.8 6.8 30.2 16.0 15.1 20.4 0.0 7.5 2.8 4.2 12.7 4.6 4.7 4.1 4.3 6.6 5.2 4.5 4.0 2.4 4.4 15.1 6.9 6.9 4.3 6.3 7.9 8.0 9.2 7.6 6.7 6.2 6.6 7.3 6.5 6.1 7.4 8.4 9.8 16.0 12.0 21.5 9.2 2.9 3.0 5.5 7.4 11.8 5.2 5.3 14.3 2.8 8.9 3.7 29.2 7.4 11.4 5.2 3.9 7.6 40.9 7.3 11.8 8.2 6.0 16.0 43.0 8.2 8.5 8.1 1.5 4.4 1.3 9.7 7.5 5.4 28.2 8.4 32.4 5.3 4.1 13.3 4.7 29.9 8.1 11.4 1.8 30.0 8.5 6.8 8.2 32.6 39.2 8.3 3.2 6.8 15.5 2.2 4.6 5.4 8.6 12.3 6.6 9.7 9.6 22.0 16.2 6.4 3.3 6.2 8.2 8.0 6.0 1.9 SCML1 ENSG00000047634 "Scm polycomb group protein like 1" Q9UN30 X 17737449-17754988 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 581.3;Spermatogonia: 205.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 19.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 88.1" "HPA035270, HPA035271, HPA061397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: AB_2684503" "unprognostic (6.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.83e-1)" "unprognostic (3.18e-1)" "unprognostic (1.73e-1)" "unprognostic (5.18e-1)" "unprognostic (2.12e-3)" "unprognostic (9.49e-2)" "unprognostic (8.40e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.44e-3)" "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-3)" 10.0 11.6 6.1 6.4 6.5 3.1 8.2 6.4 9.0 10.9 7.3 7.7 8.2 7.9 3.1 6.1 9.9 5.4 7.8 6.2 8.3 9.5 29.0 9.9 8.4 7.1 6.4 6.0 21.0 8.3 4.0 9.3 10.1 6.6 9.3 7.3 31.0 3.8 6.3 12.8 5.8 7.7 7.6 6.0 8.5 6.8 26.8 6.3 7.7 5.4 14.8 5.6 6.5 8.2 6.7 23.2 6.1 19.4 6.8 18.0 23.7 2.2 22.2 21.4 23.8 30.2 11.9 10.6 0.0 9.4 15.0 15.7 13.3 25.4 15.6 35.4 0.0 50.0 1.7 18.6 25.6 23.6 0.0 12.0 15.6 14.1 30.7 23.2 5.3 0.4 8.9 3.9 0.0 22.7 7.0 0.0 0.0 3.0 17.2 24.6 0.0 9.9 10.7 9.6 5.5 3.8 4.9 10.0 0.1 8.9 11.2 3.5 0.5 10.8 23.4 9.6 88.1 14.5 13.4 13.1 0.0 18.7 2.1 6.7 0.0 1.2 1.0 0.2 3.5 0.2 1.7 3.3 0.3 2.6 3.7 19.0 9.0 1.0 9.6 4.2 0.6 0.5 2.1 6.1 6.5 6.4 9.0 6.2 8.3 7.1 6.4 6.0 6.6 6.0 6.3 6.7 42.4 19.2 25.7 25.5 16.1 95.0 36.7 10.0 58.6 55.6 21.5 14.7 26.6 15.7 14.1 16.5 68.8 5.1 6.1 14.8 9.8 5.8 26.8 23.5 24.4 41.1 11.3 1.7 13.9 8.7 2.3 42.0 25.5 40.0 10.8 35.3 16.1 60.5 19.5 38.7 26.8 20.0 12.2 17.0 62.8 20.3 59.4 32.3 28.4 22.5 6.2 33.3 2.1 15.6 24.5 4.3 21.1 34.3 2.5 33.8 28.4 5.6 10.4 86.9 52.6 71.5 40.4 581.3 205.9 38.6 114.1 5.6 15.1 44.4 31.3 31.1 WWC3 "BM042, KIAA1280" ENSG00000047644 "WWC family member 3" Q9ULE0 X 10015254-10144474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 131.5" "Low region specificity" "Detected in all" HPA039814 Uncertain Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA039814: AB_10674987" "unprognostic (2.53e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (9.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (3.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.58e-2)" "unprognostic (4.91e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.90e-2)" "unprognostic (2.09e-1)" "unprognostic (5.03e-2)" "unprognostic (4.50e-2)" 11.1 13.9 14.2 9.6 15.7 5.5 11.0 12.8 11.0 10.7 11.9 12.4 4.1 11.4 19.5 11.4 9.8 9.8 15.7 10.1 11.1 7.3 3.4 21.9 12.7 16.2 14.9 8.6 18.3 8.6 7.8 6.6 15.8 16.6 11.4 4.8 1.9 9.3 27.0 8.5 13.4 11.7 8.4 12.5 11.7 10.9 5.4 13.9 7.2 12.3 6.5 9.6 11.1 11.4 16.2 17.2 19.1 22.7 7.5 9.4 13.2 21.6 9.6 16.5 5.7 6.2 2.5 17.5 1.8 0.2 12.8 22.0 8.8 5.3 9.9 4.7 13.0 1.9 3.9 13.1 1.7 20.1 0.0 5.8 8.5 20.4 14.1 14.8 30.0 26.7 3.2 0.3 22.4 13.7 35.2 4.2 1.1 21.4 9.0 6.7 12.5 1.1 7.5 5.5 8.7 2.4 6.4 11.7 14.9 10.2 42.0 131.5 1.4 36.0 16.4 0.5 24.4 10.8 18.2 13.3 6.3 10.0 6.3 24.7 4.0 0.8 0.2 5.8 0.7 4.9 2.0 2.8 4.3 0.4 5.0 2.5 3.0 10.7 2.6 0.7 0.6 1.4 1.8 14.2 15.7 12.8 11.0 10.1 11.1 16.2 14.9 8.6 16.6 12.5 13.9 16.2 41.0 22.4 68.4 20.2 15.4 5.6 12.9 8.2 7.4 6.1 22.9 15.9 20.5 5.7 13.0 5.5 6.2 14.3 7.1 7.9 0.0 6.2 0.7 6.3 15.4 26.9 16.1 24.8 29.0 9.5 6.3 15.3 2.6 7.5 3.8 12.7 31.8 5.6 11.6 3.3 21.1 4.2 8.2 19.4 11.8 1.4 12.8 12.2 16.0 12.2 6.8 4.1 10.3 13.0 35.7 9.5 7.4 24.8 10.2 14.8 8.1 2.5 11.5 2.0 19.7 11.9 20.2 0.7 2.5 8.8 13.1 7.9 12.0 15.8 3.6 9.4 ARHGAP6 rhoGAPX-1 ENSG00000047648 "Rho GTPase activating protein 6" O43182 X 11117651-11665920 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 44.3;Microglial cells: 127.4;Oligodendrocyte precursor cells: 60.3;Prostatic glandular cells: 54.4;Sertoli cells: 46.0;Skeletal myocytes: 62.3;Smooth muscle cells: 44.4" "Cancer enhanced" "Detected in many" "prostate cancer: 12.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 26.2;ASC TERT1: 34.2;HEL: 36.4;HMC-1: 24.7;HSkMC: 33.8;K-562: 26.5;RT4: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001798, HPA036779, HPA064390" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 350000 Cytosol "HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253" "unprognostic (2.36e-1)" "unprognostic (1.68e-2)" "unprognostic (3.49e-2)" "unprognostic (7.31e-2)" "unprognostic (6.34e-2)" "unprognostic (1.69e-2)" "unprognostic (4.70e-2)" "unprognostic (2.79e-1)" "unprognostic (1.70e-1)" "unprognostic (7.46e-4)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.60e-2)" "unprognostic (5.96e-2)" "unprognostic (1.28e-2)" "unprognostic (7.99e-4)" 9.3 1.1 9.2 1.7 5.3 0.7 5.7 2.2 3.8 7.1 3.3 10.7 2.1 10.6 8.2 3.8 8.5 4.2 3.8 4.6 5.4 6.6 0.9 9.7 1.2 3.2 3.6 4.0 16.6 2.0 1.2 3.2 7.1 3.5 27.9 3.9 1.0 2.6 31.2 9.7 2.2 4.8 13.1 3.0 6.0 4.1 1.9 4.8 1.0 25.6 8.2 0.8 10.5 5.7 3.9 0.0 0.0 2.4 0.0 26.2 34.2 0.6 0.4 0.6 1.4 0.9 0.4 0.0 0.0 0.0 5.0 0.0 0.1 0.9 0.0 1.2 0.6 0.5 36.4 0.4 0.0 9.7 0.1 24.7 33.8 0.0 2.5 0.1 3.1 0.7 0.1 26.5 12.3 1.5 0.0 0.0 0.2 0.7 0.2 0.4 0.1 11.6 15.7 8.3 20.3 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.4 0.3 1.6 0.7 7.1 0.2 0.7 0.0 0.0 0.5 0.2 4.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 9.2 5.3 2.2 3.8 4.6 5.4 3.2 3.6 4.0 3.5 3.0 4.8 3.9 9.6 0.0 1.7 10.4 5.3 2.0 16.9 0.3 2.8 4.3 2.3 3.3 4.7 0.0 2.6 33.1 0.0 0.6 0.4 0.0 25.4 0.0 0.1 0.1 5.1 9.2 1.2 2.1 5.5 1.1 0.7 29.1 3.6 0.2 40.0 3.0 8.2 0.0 4.9 0.0 44.3 0.4 0.0 2.2 18.9 0.9 16.1 29.1 5.4 127.4 3.4 7.2 0.0 60.3 3.5 0.7 0.0 10.1 4.9 54.4 0.0 7.4 5.6 0.7 46.0 62.3 44.4 0.2 0.4 4.5 1.7 0.0 1.2 2.1 0.0 22.3 FAM184B KIAA1276 ENSG00000047662 "Family with sequence similarity 184 member B" Q9ULE4 4 17629306-17781621 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;retina: 1.8;skeletal muscle: 4.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.0;Horizontal cells: 32.0;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 27.1" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044119, HPA048458" Enhanced NA NA "HPA044119: AB_2678817, HPA048458: AB_2680401" "unprognostic (1.20e-2)" "unprognostic (4.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (9.64e-2)" "unprognostic (1.71e-2)" "unprognostic (5.13e-4)" "unprognostic (2.04e-2)" "unprognostic (7.46e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (1.54e-4)" 0.0 0.1 1.9 0.1 1.9 0.2 0.1 1.2 2.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 1.7 0.3 0.0 0.0 0.1 1.9 1.4 1.6 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.2 1.8 0.1 0.0 4.2 0.2 0.0 0.0 1.0 0.1 0.0 0.1 1.5 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.2 2.0 1.9 1.7 1.9 1.4 1.6 1.6 1.0 1.5 1.7 1.1 0.0 2.0 4.2 3.8 4.5 5.2 0.2 2.8 33.0 2.7 2.0 0.6 2.8 0.8 0.0 14.6 4.8 1.7 2.4 0.0 1.1 0.8 1.1 2.2 2.7 4.2 2.7 15.5 1.0 3.9 2.8 0.0 2.8 13.4 3.6 0.4 2.4 1.2 32.0 23.0 1.8 0.0 2.2 8.2 1.7 11.5 1.5 3.6 1.9 0.0 19.8 2.1 75.9 7.1 1.5 0.5 7.5 0.4 7.0 0.0 1.1 0.2 27.1 0.0 9.7 2.2 9.1 9.5 0.9 9.7 5.3 4.8 3.4 0.6 5.4 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 596.4;skeletal muscle: 750.0" "Cell type enhanced" "Detected in all" "Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA 880000 "Microtubules, Cytosol" "Plasma membrane" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 121.6 56.1 553.5 50.8 483.4 16.2 98.9 449.8 413.7 110.8 240.6 153.2 35.4 112.6 70.3 91.4 95.6 53.4 330.1 370.6 418.5 88.9 66.6 105.9 35.3 596.4 501.3 310.2 90.8 72.0 31.7 56.6 65.4 527.6 93.5 48.0 150.3 72.0 88.9 750.0 116.1 81.3 95.3 573.4 64.5 94.7 80.7 559.8 42.5 61.6 495.4 38.1 136.6 116.2 558.4 121.9 95.7 117.1 89.3 168.6 298.5 49.5 222.6 241.2 184.1 204.9 81.3 74.4 102.3 50.7 337.9 172.8 79.2 151.4 201.6 204.7 148.7 63.8 69.3 102.8 106.0 228.6 48.6 53.9 251.4 246.4 224.0 271.6 167.1 245.1 70.6 91.2 115.3 146.9 69.1 69.5 58.9 70.9 59.9 195.0 36.6 110.1 128.1 118.2 100.1 46.4 72.3 171.0 68.3 118.6 163.0 50.1 44.8 334.5 172.7 132.3 182.9 144.4 80.4 66.9 47.8 222.2 58.6 167.3 10.5 6.6 3.7 15.6 10.6 7.5 12.3 10.2 12.7 7.1 11.5 4.9 7.6 2.6 13.4 27.3 10.8 13.0 9.7 553.5 483.4 449.8 413.7 370.6 418.5 596.4 501.3 310.2 527.6 573.4 559.8 558.4 147.9 70.5 48.2 124.4 45.1 74.8 55.4 53.1 42.7 392.2 34.7 36.2 921.5 48.6 53.4 80.9 625.5 33.8 54.6 43.7 27.4 97.8 116.2 78.2 143.2 110.4 28.8 21.6 63.7 65.3 81.0 105.5 39.8 93.4 27.8 81.6 50.0 57.3 38.0 47.1 71.2 31.7 34.6 28.3 50.5 38.8 77.0 40.0 78.2 95.5 72.0 82.8 47.4 77.9 167.2 92.0 28.0 103.0 47.2 89.0 37.1 39.2 43.6 97.5 72.3 149.0 119.0 65.6 64.3 58.7 69.6 22.4 60.5 137.4 39.5 44.7 GOPC "CAL, dJ94G16.2, FIG, GOPC1, PIST" ENSG00000047932 "Golgi associated PDZ and coiled-coil motif containing" Q9HD26 6 117560269-117602542 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019477, HPA024018" Approved Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA019477: AB_1849890, HPA024018: AB_1849891" "unprognostic (2.48e-2)" "unprognostic (1.63e-3)" "unprognostic (1.71e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (3.12e-2)" "unprognostic (9.21e-2)" "unprognostic (6.22e-2)" "unprognostic (6.77e-2)" "unprognostic (8.23e-2)" "unprognostic (9.46e-2)" "unprognostic (1.40e-2)" "unprognostic (2.67e-2)" "unprognostic (1.38e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-2)" 15.6 14.3 14.8 15.9 16.1 7.1 20.4 16.9 17.4 23.6 12.6 18.9 12.3 23.7 18.2 12.3 17.5 16.4 22.3 16.5 15.1 14.7 16.5 13.7 20.1 14.0 14.1 14.3 25.9 12.8 22.3 16.2 20.0 14.1 16.4 20.5 13.6 14.4 17.4 16.0 18.9 15.2 18.5 14.1 17.1 15.0 17.8 13.8 21.1 24.1 17.5 17.3 15.2 14.9 18.0 14.1 15.0 19.1 25.6 40.1 47.9 30.3 57.1 41.7 30.6 31.5 23.1 15.5 42.2 24.3 32.4 60.4 31.2 37.2 27.6 42.8 21.2 20.8 38.7 39.9 37.5 42.4 52.2 24.8 57.4 74.9 22.8 65.7 60.6 26.5 29.0 36.7 16.8 62.2 12.9 21.8 40.3 16.5 24.0 16.0 33.0 37.0 30.8 23.3 12.9 26.7 21.0 57.6 19.7 15.8 36.3 14.3 49.7 31.8 2.2 27.9 28.5 62.6 29.9 28.8 35.4 37.9 43.4 23.9 10.5 4.2 3.2 6.7 3.9 9.3 7.9 7.1 7.1 5.5 7.7 8.2 8.5 2.9 9.2 4.7 9.2 7.7 4.1 14.8 16.1 16.9 17.4 16.5 15.1 14.0 14.1 14.3 14.1 14.1 13.8 18.0 43.2 22.4 22.7 46.4 33.4 46.7 25.1 63.9 46.7 59.2 47.0 67.3 46.2 34.3 32.2 20.2 22.9 77.0 28.6 40.4 27.4 27.9 35.1 30.4 77.4 38.1 33.6 26.5 52.9 25.6 62.4 48.3 30.1 30.6 31.1 50.4 35.0 38.7 38.5 74.0 46.2 65.2 24.4 24.2 22.9 13.7 42.3 27.0 28.4 32.8 24.1 39.3 35.0 73.9 64.5 21.1 40.9 42.2 38.7 40.3 20.9 27.1 35.3 35.9 32.9 50.0 44.3 115.6 51.4 36.7 59.8 52.3 38.7 43.3 37.7 27.3 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117287353-117425942 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "epididymis: 59.1;lung: 32.0" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 78.5" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 19.3;HSkMC: 10.1;hTCEpi: 21.7;LHCN-M2: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles NA NA Vesicles "HPA049098: AB_2680628, HPA072424: AB_2686519" "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.4 0.0 0.0 59.1 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.1 32.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.5 0.0 0.0 2.2 0.4 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 10.1 21.7 0.2 1.9 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.0 0.0 3.1 1.7 0.2 2.1 0.0 0.0 0.0 1.9 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.0 16.0 78.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.8 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 1.8 0.2 0.0 0.0 0.0 17.8 0.0 0.0 0.2 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 USP28 KIAA1515 ENSG00000048028 "Ubiquitin specific peptidase 28" Q96RU2 11 113797874-113875570 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 63.3;skeletal muscle: 69.0;tongue: 67.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006778, HPA006779" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006778: AB_1080520, HPA006779: AB_1080517" "unprognostic (2.54e-1)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" "unprognostic (3.72e-2)" "unprognostic (5.51e-2)" "unprognostic (2.30e-1)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.04e-3)" "unprognostic (1.82e-3)" "unprognostic (3.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.11e-2)" "unprognostic (2.06e-2)" "unprognostic (9.03e-2)" "unprognostic (1.35e-3)" "unprognostic (5.03e-2)" 5.5 6.7 3.4 9.6 4.9 5.8 10.5 19.3 10.0 21.3 1.0 9.6 9.7 11.6 11.4 9.7 9.8 7.8 63.3 4.7 2.6 10.0 11.4 7.6 15.7 2.7 3.5 4.4 14.2 8.3 15.7 7.4 8.1 7.1 11.4 11.9 27.3 12.1 14.3 69.0 7.0 10.5 13.2 1.4 13.9 9.3 9.3 2.8 9.1 10.2 67.1 15.6 9.9 8.5 7.7 18.3 20.2 26.7 35.4 21.3 20.9 18.8 13.2 18.0 17.5 29.7 30.2 25.6 24.2 29.3 18.0 40.1 35.1 37.9 24.8 24.1 27.1 17.2 12.9 13.8 16.3 13.0 16.8 12.4 12.6 18.5 20.2 23.8 25.4 32.0 11.9 22.7 15.3 18.5 9.3 12.9 27.1 32.0 33.6 14.4 31.3 37.1 29.4 19.3 17.8 11.6 12.6 31.4 10.7 10.1 82.7 25.8 5.8 17.1 19.2 28.3 17.8 13.8 10.4 15.9 20.1 1.9 32.1 12.8 0.2 5.0 3.4 23.2 3.7 12.1 15.5 5.7 16.8 6.4 12.3 3.8 13.1 1.4 28.6 6.4 1.9 9.2 10.3 3.4 4.9 19.3 10.0 4.7 2.6 2.7 3.5 4.4 7.1 1.4 2.8 7.7 7.3 9.6 8.8 18.3 17.8 1.7 7.3 9.9 13.6 18.7 9.7 9.8 152.2 5.7 9.9 5.5 18.8 4.4 32.1 3.3 5.9 6.7 1.7 6.6 11.6 7.9 4.9 2.5 57.0 3.9 4.7 12.2 11.7 8.7 1.3 18.9 7.5 8.8 4.4 5.0 34.1 9.6 4.1 6.5 2.5 2.0 6.8 7.4 1.8 10.3 8.2 10.3 73.2 29.1 21.3 3.5 5.3 13.9 21.7 7.1 7.3 7.1 14.6 21.5 6.6 10.3 11.0 15.8 11.4 7.7 2.0 1.1 18.6 9.0 8.9 5.8 HDAC9 "HD7, HDAC, HDAC7B, KIAA0744, MITR" ENSG00000048052 "Histone deacetylase 9" Q9UKV0 7 18086949-19002416 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 39.4" "Group enriched" "Detected in many" 4 "Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 74.1" "Group enriched" "Detected in all" 9 "B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4" "Cell line enhanced" "Detected in many" "HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028926 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028926: AB_10602327" "unprognostic (2.06e-2)" "unprognostic (2.67e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.74e-1)" "unprognostic (5.54e-2)" "unprognostic (2.20e-2)" "unprognostic (2.32e-1)" "unprognostic (2.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.01e-1)" "unprognostic (7.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" 8.3 12.4 6.9 8.9 7.7 6.0 5.1 5.9 8.1 10.2 39.4 5.4 3.4 13.4 6.0 2.9 9.3 6.8 14.4 6.3 5.4 2.8 2.9 5.2 19.1 5.9 7.5 4.7 2.4 1.5 1.9 6.5 6.4 7.0 11.1 5.6 25.7 7.1 14.6 16.9 2.2 4.5 13.1 6.6 17.7 8.7 5.6 15.6 6.8 2.9 5.8 18.8 5.3 4.9 7.7 40.2 0.2 6.3 0.1 0.9 8.4 0.2 2.4 23.0 9.5 16.1 0.3 12.7 16.7 41.9 26.0 51.6 5.8 163.6 3.2 24.2 0.2 1.1 0.0 0.2 0.0 0.2 3.5 0.1 3.0 3.1 29.7 79.4 8.4 0.4 2.7 0.0 25.1 13.3 0.0 1.6 3.5 20.3 0.0 3.9 4.7 2.5 10.2 5.2 10.6 11.6 65.7 0.5 0.3 12.7 9.7 0.6 15.2 1.8 34.4 11.1 1.9 22.3 28.8 13.3 64.5 9.0 1.6 69.2 0.3 24.4 0.1 4.2 16.5 4.1 52.6 1.4 2.0 74.1 43.2 0.0 2.1 1.4 5.5 10.3 15.9 5.6 12.9 6.9 7.7 5.9 8.1 6.3 5.4 5.9 7.5 4.7 7.0 6.6 15.6 7.7 31.4 6.4 2.8 28.1 46.1 2.4 0.7 6.8 6.2 33.0 1.4 0.8 15.2 0.0 12.9 0.0 16.7 0.1 16.3 15.3 3.9 6.8 244.6 24.2 2.3 16.5 7.2 5.7 376.2 0.7 0.2 5.3 13.7 26.1 1.3 0.0 8.9 1.0 12.9 20.2 442.3 0.7 4.1 51.2 64.2 80.1 1.5 34.8 16.0 334.5 21.0 5.1 11.3 322.7 233.1 10.6 6.7 0.7 46.7 1.6 0.0 0.1 17.5 26.2 6.6 2.3 9.0 34.3 8.7 0.7 2.0 0.1 7.8 0.1 0.3 12.1 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved NA NA "HPA030447: AB_2673484" "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 13.5 40.8 22.1 16.5 23.5 58.7 13.0 17.7 25.5 13.9 19.5 18.1 16.1 12.2 8.4 24.7 13.1 14.9 22.5 22.8 19.5 24.6 20.7 17.8 17.7 18.9 19.2 24.3 11.5 26.5 18.4 23.7 12.4 19.5 17.7 14.0 21.0 16.1 10.5 42.0 16.8 18.1 13.4 17.9 22.2 21.3 21.1 20.5 7.1 14.3 26.0 15.3 18.5 14.0 19.8 48.9 48.3 31.8 58.2 43.0 36.8 49.4 35.8 52.0 51.7 51.3 15.0 54.6 21.8 63.5 62.0 106.9 36.4 15.9 83.2 31.6 161.0 33.5 8.3 20.9 17.7 39.1 17.7 29.3 44.0 46.2 41.3 24.9 35.2 71.6 16.6 41.8 22.8 53.1 80.2 3.8 7.8 25.6 47.3 52.5 18.8 27.0 12.1 48.3 35.5 47.9 33.9 38.8 44.6 49.6 26.4 36.7 22.4 56.2 55.9 57.5 42.5 45.8 12.9 17.9 9.7 61.1 37.6 33.3 0.0 2.4 0.6 3.8 2.4 3.1 1.1 2.9 6.2 2.4 1.8 1.9 2.7 0.3 3.0 3.9 0.6 7.5 2.8 22.1 23.5 17.7 25.5 22.8 19.5 18.9 19.2 24.3 19.5 17.9 20.5 19.8 11.3 12.8 9.8 5.5 8.0 2.9 11.3 10.7 10.2 23.7 11.5 4.8 16.0 17.2 10.2 11.0 12.5 1.0 11.4 31.1 5.9 37.2 0.8 10.3 6.7 14.1 14.4 51.1 9.5 56.7 18.8 10.5 20.9 12.1 0.0 25.7 10.8 13.5 15.2 1.7 4.2 18.3 14.2 12.4 4.1 1.3 6.8 9.7 7.2 6.5 12.9 7.1 16.5 2.0 3.5 46.6 21.5 7.2 6.6 17.5 29.1 14.6 6.2 24.8 0.0 4.7 11.7 1.9 2.5 12.0 5.4 1.2 14.2 41.1 25.0 13.5 NOP16 "HSPC111, HSPC185, LOC51491" ENSG00000048162 "NOP16 nucleolar protein" Q9Y3C1 5 176383938-176388927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 202.1;Suprabasal keratinocytes: 205.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036506, HPA058147" Approved Enhanced Nucleoli NA NA Nucleoli "HPA036506: AB_10672223, HPA058147: AB_2683620" "unprognostic (4.55e-2)" "unprognostic (1.72e-1)" "unprognostic (2.21e-2)" "unprognostic (1.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.19e-2)" "unprognostic (2.27e-2)" "unprognostic (1.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.75e-6)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" 27.4 24.5 16.4 23.9 16.8 25.0 21.8 16.8 18.3 13.8 14.4 22.3 18.1 14.1 10.8 43.9 15.7 12.7 26.7 17.4 17.5 18.2 31.9 14.2 27.1 16.5 16.3 16.8 15.7 21.6 15.5 10.7 15.8 16.8 14.3 19.0 4.9 14.9 12.1 71.5 28.2 16.4 14.6 16.4 17.5 20.1 15.3 17.0 16.8 11.7 30.9 30.1 45.0 21.3 17.5 85.2 135.1 30.3 134.2 49.6 53.3 122.1 70.2 42.4 103.1 89.4 190.7 85.6 145.6 91.6 53.4 101.0 76.5 162.7 242.7 74.5 184.5 115.8 77.7 103.5 159.5 98.7 156.5 80.4 51.8 113.5 98.3 126.1 31.5 79.2 64.4 155.5 69.6 78.9 261.2 121.8 208.7 111.9 127.9 170.3 95.5 44.7 152.1 101.2 75.9 96.0 76.5 41.1 165.1 94.3 28.8 71.9 110.8 68.4 76.9 75.9 68.8 177.1 85.7 122.4 165.1 58.0 218.7 67.2 7.6 51.9 9.5 52.9 86.5 69.4 81.9 58.5 56.7 78.9 85.4 62.6 65.2 4.4 80.0 45.9 97.1 44.1 44.7 16.4 16.8 16.8 18.3 17.4 17.5 16.5 16.3 16.8 16.8 16.4 17.0 17.5 21.8 6.4 19.6 2.3 34.4 202.1 145.6 66.4 114.4 3.7 37.2 35.3 35.6 25.8 48.8 1.8 4.2 46.2 17.3 31.8 37.2 53.6 11.0 13.8 30.6 37.6 20.9 20.8 3.1 53.6 60.3 43.3 53.0 20.2 26.6 15.1 12.1 36.9 38.1 0.0 2.9 32.3 32.6 8.3 46.4 5.5 19.6 17.1 56.9 1.9 20.8 4.9 4.1 3.0 1.7 56.4 18.0 14.7 23.8 134.2 20.1 72.6 16.5 3.0 6.6 90.5 46.1 38.4 32.1 112.9 205.3 38.3 22.2 35.9 57.7 116.6 CC2D2A "JBTS9, KIAA1345, MKS6" ENSG00000048342 "Coiled-coil and C2 domain containing 2A" Q9P2K1 4 15469865-15601552 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 85.5" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 569.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044124 Approved NA NA "HPA044124: AB_10969197" "unprognostic (1.88e-1)" "unprognostic (2.05e-3)" "unprognostic (6.01e-3)" "unprognostic (4.23e-3)" "unprognostic (2.13e-2)" "unprognostic (1.10e-1)" "unprognostic (8.63e-2)" "unprognostic (4.49e-2)" "unprognostic (1.46e-1)" "unprognostic (2.57e-2)" "unprognostic (2.23e-2)" "unprognostic (7.33e-2)" "prognostic favorable (3.42e-9)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (2.18e-2)" 8.4 9.4 13.9 2.8 13.2 2.7 8.9 14.2 16.7 14.4 20.4 13.1 5.0 12.9 11.2 8.3 34.5 12.5 7.0 13.5 14.4 23.8 2.9 10.8 2.0 13.8 13.6 12.1 11.9 5.1 10.1 12.8 8.6 13.0 10.0 6.0 85.5 3.3 12.6 2.5 2.2 5.1 15.6 12.3 3.3 8.2 4.9 13.3 1.2 8.3 11.2 1.4 9.4 6.5 16.6 5.4 11.3 15.6 7.0 18.4 34.4 3.8 6.8 11.5 12.7 15.5 5.1 13.2 0.5 7.3 13.1 27.7 3.4 13.1 8.7 15.9 0.0 7.3 5.5 10.1 7.1 13.5 0.5 0.1 25.0 22.8 20.7 15.5 23.3 5.9 0.2 14.7 0.4 24.4 3.9 0.2 0.9 25.9 0.2 23.3 3.5 4.9 1.1 32.1 2.6 9.7 11.1 4.3 3.1 32.2 14.6 4.9 1.3 2.2 20.2 12.0 8.6 14.4 0.4 0.5 0.3 24.3 0.3 13.1 1.9 2.4 0.2 0.4 1.6 0.6 0.3 0.3 0.1 3.8 0.3 0.2 0.4 4.8 0.9 0.8 0.2 0.9 0.6 13.9 13.2 14.2 16.7 13.5 14.4 13.8 13.6 12.1 13.0 12.3 13.3 16.6 8.4 12.8 14.6 39.8 0.7 2.2 5.6 5.7 14.2 15.1 6.5 9.0 22.9 10.0 23.5 25.8 569.2 10.2 0.3 0.8 33.2 6.6 12.0 96.8 14.0 7.0 6.0 2.7 20.9 0.9 3.1 18.7 4.1 9.0 0.0 15.2 8.9 1.6 5.0 8.4 43.4 0.9 8.2 5.7 4.6 6.7 9.3 4.4 12.4 16.9 1.2 18.4 0.0 62.8 19.5 1.0 0.5 16.6 1.3 4.4 2.1 57.1 128.4 136.4 6.6 14.7 17.7 2.6 0.7 6.4 1.3 1.5 1.9 12.9 2.9 4.0 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102238961 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.6 21.4 12.2 11.6 13.5 7.2 12.2 15.5 12.6 12.6 24.9 15.5 15.1 11.7 15.2 11.3 13.6 12.0 16.9 11.7 15.1 24.6 22.7 22.2 20.3 15.3 13.8 10.5 12.1 13.6 45.3 10.4 13.9 16.2 15.8 15.6 22.0 11.0 13.9 30.7 11.1 10.2 11.8 15.7 14.4 9.6 9.8 14.5 10.2 40.3 35.2 19.7 11.3 5.5 18.4 15.3 26.5 30.7 18.3 43.7 41.3 24.6 34.8 41.4 18.1 21.0 9.6 11.9 97.5 31.8 38.7 18.5 5.7 15.1 35.2 25.3 15.8 16.2 24.4 10.3 20.9 35.3 7.6 50.0 53.1 66.1 20.2 30.5 43.0 51.8 16.3 18.2 14.6 59.1 15.2 13.1 14.6 17.7 16.5 19.2 8.2 12.7 20.1 43.1 17.1 7.8 15.4 17.9 9.7 21.1 76.3 25.5 17.1 39.4 27.8 53.7 19.6 9.6 15.3 15.3 88.0 41.0 11.5 30.2 15.7 6.3 7.0 2.7 5.4 3.8 6.6 2.3 3.2 7.7 8.6 2.6 2.8 23.1 4.1 11.5 2.2 1.8 3.3 12.2 13.5 15.5 12.6 11.7 15.1 15.3 13.8 10.5 16.2 15.7 14.5 18.4 16.2 57.7 29.3 10.1 33.5 19.4 8.2 11.8 34.1 13.5 17.0 9.4 22.8 20.0 23.9 40.5 14.6 13.8 13.9 7.3 25.4 6.8 2.3 36.2 11.1 14.9 29.4 3.8 14.6 8.2 5.9 14.8 6.1 11.8 11.4 11.2 18.5 23.6 12.6 10.1 17.6 9.7 10.2 26.2 39.5 1.4 14.3 23.8 17.8 20.6 18.2 24.5 7.2 16.1 12.1 5.7 5.7 14.7 9.3 10.7 8.1 22.7 39.9 18.3 6.6 16.2 16.8 13.2 14.5 26.2 18.5 4.8 12.2 8.6 12.1 6.7 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA023090: AB_1859457, HPA052194: AB_2681757" "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 10.8 7.3 6.7 11.7 7.1 75.3 12.1 20.5 5.3 8.4 1.7 10.9 10.5 9.7 7.9 12.7 7.9 11.4 6.1 3.3 4.5 8.3 14.8 10.3 16.8 6.3 6.3 1.5 10.3 12.7 11.4 3.5 9.3 7.8 9.4 10.2 10.0 8.3 7.8 5.8 10.7 10.8 9.5 5.8 13.4 11.5 20.7 7.4 13.4 11.1 7.3 14.5 10.6 5.5 7.7 16.0 8.4 9.5 16.5 13.5 17.3 9.2 14.9 17.5 15.1 14.6 7.8 15.0 27.1 9.0 14.6 16.3 11.1 15.7 15.6 20.9 23.9 9.5 17.7 8.5 7.1 16.9 24.2 32.3 15.4 14.9 16.2 22.0 12.5 16.5 16.3 22.3 27.0 16.9 12.4 26.5 17.2 7.9 14.5 10.8 16.7 13.3 18.0 11.0 19.8 13.6 13.9 14.8 58.7 19.8 12.9 7.0 16.3 18.0 25.0 8.0 17.2 18.1 31.7 15.2 39.0 18.8 21.5 21.8 22.1 8.7 13.6 16.1 8.0 16.3 15.4 11.8 16.5 9.0 17.3 19.2 21.0 7.5 25.0 9.0 15.3 18.6 8.0 6.7 7.1 20.5 5.3 3.3 4.5 6.3 6.3 1.5 7.8 5.8 7.4 7.7 49.0 38.5 23.5 27.7 65.1 44.7 51.7 14.7 52.3 29.0 28.3 20.6 16.8 11.5 20.1 12.9 22.9 12.0 70.5 30.2 11.7 24.1 44.8 22.2 30.8 37.2 16.2 52.0 46.4 19.2 14.0 32.0 40.2 26.3 29.2 26.3 26.7 17.5 14.4 77.4 35.5 29.3 8.2 25.3 34.1 11.3 27.1 41.7 28.4 45.9 37.9 17.5 79.3 41.7 71.8 24.5 22.0 31.6 57.8 48.3 26.8 13.3 18.3 27.9 26.3 54.9 30.1 111.9 39.9 44.4 47.9 22.0 65.5 30.1 25.5 68.5 TNFRSF17 "BCM, BCMA, CD269, TNFRSF13A" ENSG00000048462 "TNF receptor superfamily member 17" Q02223 16 11965210-11968068 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.3;lymphoid tissue: 48.3;stomach 1: 24.6" "Cell type enriched" "Detected in some" 4 "Plasma cells: 449.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 62 "memory B-cell: 124.9;naive B-cell: 108.5;plasmacytoid DC: 103.3" "Group enriched" "Detected in many" 63 "B-cells: 124.9;dendritic cells: 103.3" "Cell line enhanced" "Detected in some" "Karpas-707: 179.6;RPMI-8226: 296.0;U-266/70: 829.4;U-266/84: 453.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 2000000 "prognostic favorable (1.35e-5)" "unprognostic (3.41e-2)" "unprognostic (4.00e-3)" "unprognostic (1.41e-2)" "unprognostic (6.47e-2)" "prognostic favorable (1.58e-6)" "unprognostic (9.75e-3)" "unprognostic (5.93e-2)" "unprognostic (2.13e-2)" "unprognostic (7.96e-3)" "unprognostic (2.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.85e-6)" "unprognostic (2.06e-1)" "unprognostic (2.48e-1)" "unprognostic (3.54e-2)" "unprognostic (1.10e-1)" 0.4 1.2 0.2 15.1 0.5 1.9 14.2 0.6 0.5 1.4 0.1 29.1 29.3 0.5 0.2 1.9 0.6 3.1 0.5 0.2 0.2 0.3 1.0 2.0 32.2 0.4 0.1 0.0 0.8 0.5 0.1 0.1 0.1 0.5 0.4 22.3 0.1 15.6 0.9 0.0 0.3 15.3 0.6 0.0 20.5 24.6 2.2 0.4 14.9 0.7 0.1 48.3 10.0 0.3 1.5 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.8 0.3 0.1 0.0 0.0 49.2 0.1 0.3 0.1 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 179.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.6 0.0 296.0 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.1 0.0 0.6 0.0 0.5 0.5 0.0 0.5 829.4 453.4 68.1 0.7 0.2 0.0 1.2 0.4 0.2 0.3 0.1 0.4 124.9 0.2 0.2 0.2 108.5 0.1 0.2 1.8 0.7 0.1 103.3 0.1 12.6 0.2 0.5 0.6 0.5 0.2 0.2 0.4 0.1 0.0 0.5 0.0 0.4 1.5 0.0 0.0 0.0 0.0 91.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 10.9 0.0 0.0 0.7 0.0 5.3 0.1 0.0 0.0 0.4 2.0 0.0 0.0 0.4 1.8 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 5.0 0.0 0.3 106.7 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 449.5 0.2 0.0 0.1 0.0 0.0 6.6 0.0 0.1 0.7 0.6 0.0 0.6 0.0 6.0 0.0 1.0 0.0 SNX29 "FLJ12363, RUNDC2A" ENSG00000048471 "Sorting nexin 29" Q8TEQ0 16 11976734-12574287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 354.5;Late spermatids: 430.7;Microglial cells: 169.6;Oligodendrocytes: 241.6;Rod photoreceptor cells: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive B-cell: 22.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008889, HPA062810" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli, Cytosol" "HPA008889: AB_1079856, HPA062810: " "unprognostic (2.50e-1)" "unprognostic (4.12e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (9.82e-3)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" "unprognostic (6.08e-2)" "prognostic favorable (1.38e-7)" "unprognostic (3.85e-3)" "unprognostic (4.54e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.03e-4)" 7.8 3.5 8.1 8.3 16.8 9.6 6.2 12.8 11.6 6.7 7.6 4.6 2.3 5.8 2.6 8.3 8.4 4.8 4.6 7.2 12.3 19.2 2.3 6.9 13.2 15.2 15.0 4.8 10.3 3.6 22.7 7.1 8.0 22.1 3.5 3.5 24.0 5.6 4.9 6.1 6.6 4.6 5.7 11.8 9.1 4.3 8.5 14.6 21.2 6.5 5.8 16.2 6.4 5.0 26.6 5.0 2.9 4.4 3.5 25.4 20.8 5.7 10.7 29.1 4.3 4.7 0.6 5.7 18.7 13.9 16.6 2.8 4.2 2.9 6.8 6.2 7.2 3.0 2.5 2.5 6.4 4.9 2.7 6.6 19.1 4.4 6.3 2.8 6.5 7.6 6.1 3.9 5.2 4.4 6.7 5.0 3.1 2.4 3.2 2.6 11.3 5.6 15.2 19.3 4.6 5.2 4.4 12.2 7.2 2.5 3.8 4.1 3.2 11.7 7.6 3.0 5.8 2.1 29.5 24.4 11.5 14.1 2.8 4.9 3.8 6.9 1.6 2.0 4.5 2.5 10.6 4.3 2.7 2.5 22.3 5.2 3.6 2.5 1.3 2.3 7.4 4.0 1.9 8.1 16.8 12.8 11.6 7.2 12.3 15.2 15.0 4.8 22.1 11.8 14.6 26.6 14.4 12.8 22.9 71.2 61.0 15.3 6.5 5.3 19.9 63.9 8.5 7.4 9.7 4.3 10.8 16.5 354.5 18.6 26.9 4.4 21.5 4.6 124.0 35.3 27.8 13.8 13.1 6.1 59.0 2.9 5.0 20.8 14.8 62.6 42.5 15.2 17.9 4.8 28.7 92.5 54.6 4.6 8.2 29.3 39.6 430.7 21.5 36.7 12.4 169.6 24.3 23.1 16.5 51.8 241.6 7.7 4.3 15.4 23.9 3.6 3.3 42.6 27.2 256.1 6.6 20.8 14.2 20.0 10.8 21.9 15.5 17.1 15.4 14.1 4.0 5.5 LMO3 "DAT1, RBTNL2, Rhom-3" ENSG00000048540 "LIM domain only 3" Q8TAP4 12 16548372-16610594 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 173.1;Alveolar cells type 2: 210.2;Astrocytes: 293.8;Excitatory neurons: 226.2;Oligodendrocyte precursor cells: 112.6" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 32.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "ASC diff: 189.3;LHCN-M2: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-2)" "unprognostic (2.84e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.10e-7)" "unprognostic (3.62e-2)" "unprognostic (5.44e-2)" "unprognostic (6.56e-3)" "unprognostic (4.91e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-5)" "unprognostic (4.41e-2)" "unprognostic (1.61e-1)" "unprognostic (2.13e-3)" "unprognostic (4.83e-2)" 25.0 8.1 67.8 2.3 97.4 0.0 13.5 38.3 94.5 33.4 29.2 58.3 1.0 18.6 2.7 2.6 7.3 5.2 4.7 86.5 53.9 3.0 0.4 34.1 0.2 46.9 64.2 85.7 8.7 39.6 0.7 20.4 1.1 53.4 13.2 9.8 2.7 3.2 28.9 1.6 1.8 14.1 11.4 41.9 0.5 7.2 0.9 58.1 15.4 51.0 1.8 0.0 55.4 18.7 64.4 0.0 0.0 0.2 0.1 189.3 7.4 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.2 0.0 0.0 0.8 0.6 2.5 0.0 0.0 4.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 91.9 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.1 3.6 1.3 14.3 0.0 0.0 0.0 0.2 0.8 0.0 0.7 0.0 0.4 0.2 0.2 0.1 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.8 97.4 38.3 94.5 86.5 53.9 46.9 64.2 85.7 53.4 41.9 58.1 64.4 8.3 173.1 210.2 293.8 0.1 0.3 0.2 5.8 0.0 0.3 2.8 1.4 1.1 0.0 62.8 53.3 18.8 0.2 0.1 0.0 3.9 0.0 5.7 1.8 0.4 0.3 0.0 0.0 226.2 3.6 0.0 23.5 0.0 0.1 5.1 2.5 0.0 0.0 0.2 0.0 46.8 0.0 8.2 0.0 0.5 0.8 0.9 0.7 3.6 18.7 0.0 0.8 0.0 112.6 7.0 0.5 0.0 0.4 0.1 0.2 0.0 0.1 63.7 0.6 0.0 6.3 10.4 1.7 0.8 0.2 0.1 0.3 0.6 0.0 0.0 0.2 MRPS10 FLJ10567 ENSG00000048544 "Mitochondrial ribosomal protein S10" P82664 6 42206807-42217861 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 295.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029133, HPA029134" Supported Approved "Actin filaments,Mitochondria" NA NA Mitochondria "Actin filaments" "HPA029133: AB_10600084, HPA029134: AB_10600058" "unprognostic (1.06e-1)" "unprognostic (3.90e-2)" "unprognostic (5.55e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-1)" "unprognostic (1.78e-3)" "unprognostic (2.37e-2)" "unprognostic (8.65e-2)" "unprognostic (1.50e-3)" "unprognostic (5.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.29e-2)" "unprognostic (3.17e-2)" "unprognostic (8.54e-2)" "unprognostic (3.45e-1)" "unprognostic (3.36e-2)" "unprognostic (5.04e-2)" 24.9 24.2 17.0 20.5 18.1 24.3 21.8 17.7 18.6 19.5 16.9 20.5 19.3 18.5 18.2 43.6 14.6 16.0 47.0 17.8 18.3 29.4 37.8 15.9 24.5 17.7 17.8 17.1 14.7 17.3 23.1 13.3 21.8 17.7 18.5 23.9 18.4 20.1 17.2 74.3 18.4 17.9 22.3 17.0 18.9 18.5 16.3 18.0 25.2 24.4 62.3 27.9 24.4 23.9 18.8 99.4 35.1 36.1 61.8 49.4 47.6 32.2 64.3 63.3 61.0 53.3 40.3 38.2 70.2 41.7 60.2 68.3 35.3 60.3 87.5 81.6 64.5 49.3 62.5 30.9 67.2 51.4 93.1 38.8 41.3 65.9 57.2 121.1 41.4 62.8 73.5 110.5 53.4 74.7 63.5 61.0 67.1 30.7 295.3 57.1 51.7 54.3 66.8 105.1 44.2 55.0 40.6 36.9 49.9 122.0 33.5 83.0 125.2 40.7 51.7 51.0 50.3 96.9 39.6 64.4 149.1 35.3 91.7 52.6 22.4 26.0 20.1 23.9 30.4 28.2 30.1 29.2 28.7 29.4 27.1 29.6 28.9 13.1 29.8 28.8 37.7 35.1 28.0 17.0 18.1 17.7 18.6 17.8 18.3 17.7 17.8 17.1 17.7 17.0 18.0 18.8 40.4 22.4 21.6 6.8 41.8 40.5 53.6 61.5 22.8 26.8 35.3 33.4 131.8 20.0 39.6 38.6 31.3 102.0 48.0 25.2 92.0 66.5 7.6 35.3 52.4 41.3 14.9 74.5 7.6 47.0 67.5 42.9 23.4 26.8 32.9 46.1 24.7 58.9 52.8 32.0 9.0 27.6 67.1 24.4 28.0 8.8 28.9 34.8 30.2 2.8 110.6 47.8 60.8 7.5 9.5 61.1 30.5 36.5 41.9 64.9 30.0 86.9 60.5 57.3 19.7 35.2 43.0 75.5 83.8 62.2 40.6 75.4 33.8 65.7 35.3 69.4 GUCA1A "C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1" ENSG00000048545 "Guanylate cyclase activator 1A" P43080 6 42155406-42181338 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 91 "retina: 811.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 667.2;Late spermatids: 432.4;Muller glia cells: 219.9;Rod photoreceptor cells: 1191.6" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.5" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Group enriched" "Detected in some" 8 "NTERA-2: 3.8;SH-SY5Y: 4.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005561, HPA075056" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA005561: AB_2667361, HPA075056: " "unprognostic (1.91e-2)" "unprognostic (3.92e-3)" "unprognostic (2.49e-2)" "unprognostic (9.16e-2)" "unprognostic (1.04e-4)" "unprognostic (9.70e-2)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (3.08e-3)" "unprognostic (2.79e-1)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" 0.0 0.0 1.5 0.1 3.3 0.1 0.0 0.7 1.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.9 0.0 0.0 0.0 0.1 1.3 1.6 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 811.8 0.0 0.0 0.1 0.1 0.1 0.1 0.6 0.0 0.0 8.9 4.4 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.0 0.0 4.9 0.0 0.0 1.5 3.3 0.7 1.6 1.2 3.9 1.3 1.6 1.4 1.0 0.6 4.4 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 140.7 0.0 0.0 0.3 0.0 0.0 0.0 667.2 0.6 1.3 0.0 0.0 0.0 106.5 0.0 0.0 8.2 0.0 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.2 65.6 1.0 0.0 4.1 0.0 0.0 432.4 1.8 0.1 0.0 0.0 5.2 219.9 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 1191.6 0.0 0.0 1.2 3.2 3.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 12.6 18.1 11.8 16.7 13.4 26.0 15.5 45.1 14.3 17.3 2.9 12.9 9.5 20.2 8.9 14.3 14.6 16.8 14.1 9.7 9.8 14.4 11.8 13.3 15.4 10.5 9.8 6.6 26.5 17.1 17.4 6.5 18.6 11.0 15.5 12.7 26.1 10.3 13.5 11.8 9.4 10.9 17.6 8.0 16.5 13.6 24.0 10.9 22.8 22.5 13.6 13.7 17.1 8.4 16.1 27.7 18.2 62.0 33.3 20.6 25.9 23.3 31.7 31.0 25.5 31.4 48.0 37.5 46.7 33.2 22.3 39.4 28.1 36.8 23.8 47.7 33.4 16.3 43.9 25.1 13.0 19.6 42.2 30.0 21.8 17.5 35.0 55.8 29.7 32.7 15.2 72.8 43.0 29.7 18.7 29.7 23.4 36.1 32.9 24.8 49.1 107.5 30.6 13.5 35.5 37.3 37.6 48.8 19.1 18.5 32.2 34.3 20.6 41.2 45.0 38.8 71.0 23.1 25.7 35.7 106.3 11.9 28.1 34.5 49.3 17.8 32.8 27.4 16.9 18.8 34.3 16.6 17.6 14.2 35.0 22.7 22.9 46.4 23.7 30.1 32.0 17.0 7.5 11.8 13.4 45.1 14.3 9.7 9.8 10.5 9.8 6.6 11.0 8.0 10.9 16.1 100.3 118.6 113.5 99.6 98.0 90.5 69.3 89.7 93.9 123.0 68.8 85.1 97.1 54.3 84.3 73.5 75.0 57.8 85.1 53.0 46.9 79.2 112.4 72.9 95.2 96.5 85.6 71.8 129.4 55.3 50.6 90.5 51.0 86.0 95.5 132.5 79.9 46.2 45.6 146.4 129.3 64.7 71.2 62.9 68.5 40.3 126.8 66.5 56.9 98.4 93.9 124.6 120.5 157.8 144.7 73.1 63.4 118.1 74.8 97.6 44.1 38.2 69.7 97.6 105.2 99.3 100.4 114.8 109.4 57.2 84.0 67.5 99.9 141.7 58.1 91.6 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230030-12512047 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 181.4;Inhibitory neurons: 149.2;Late spermatids: 208.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA027332: AB_2672223, HPA051621: AB_2681555" "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favorable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 10.8 7.0 15.1 4.4 16.6 5.0 10.4 15.3 18.2 11.8 18.0 11.0 3.8 8.2 8.7 12.7 9.0 5.3 16.5 16.8 15.0 10.1 10.5 8.9 6.4 17.5 17.4 15.6 9.0 11.0 13.5 7.8 5.3 16.5 17.6 6.4 14.3 10.9 9.3 18.2 24.9 8.8 6.1 14.5 9.3 11.2 6.1 18.7 6.6 15.6 15.5 6.3 9.6 10.7 17.4 9.3 5.2 5.8 4.4 15.1 11.9 2.7 4.4 7.7 7.4 7.0 3.5 6.4 8.7 5.4 12.6 6.2 8.3 10.1 8.7 10.3 4.7 3.4 7.4 8.1 2.8 6.3 10.8 3.7 10.1 11.9 9.5 9.3 9.2 12.0 8.2 15.5 4.3 6.9 4.3 6.4 4.2 2.3 5.0 6.5 5.5 6.9 2.6 5.3 5.4 2.8 3.8 12.9 9.4 9.0 5.4 8.1 3.6 13.1 4.6 4.7 12.0 3.7 3.8 3.3 13.4 5.2 7.5 7.1 3.2 0.7 0.5 1.1 0.7 1.2 0.9 1.2 0.8 0.6 1.6 1.1 0.9 0.9 0.7 0.5 1.5 0.6 0.3 15.1 16.6 15.3 18.2 16.8 15.0 17.5 17.4 15.6 16.5 14.5 18.7 17.4 28.9 19.2 23.4 111.0 19.8 21.7 45.1 23.2 19.9 38.1 18.8 12.8 68.0 14.3 35.7 18.4 73.0 8.4 20.3 24.7 3.9 9.1 83.1 20.6 23.5 23.0 14.4 9.4 181.4 14.4 7.2 19.4 28.1 48.1 12.6 26.3 17.9 21.2 11.5 47.1 149.2 15.1 18.3 17.3 15.5 208.7 23.0 17.5 12.4 79.6 16.7 23.0 17.5 78.4 107.4 17.0 11.2 21.8 11.8 32.0 18.2 9.8 32.0 34.1 46.0 23.4 46.5 18.8 12.3 38.2 31.4 14.8 21.4 20.3 15.5 37.3 CELF2 "BRUNOL3, CUGBP2, Etr-3, NAPOR-2" ENSG00000048740 "CUGBP Elav-like family member 2" O95319 10 10798397-11336675 "Predicted intracellular proteins" "mRNA processing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 79.6" "Cell type enhanced" "Detected in many" "Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 200.2;HMC-1: 186.2;REH: 86.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016395, HPA035813" Enhanced Supported "Nucleoplasm,Vesicles,Midbody ring" Yes No Nucleoplasm "Vesicles, Midbody ring" "CAB016395: AB_2086271, HPA035813: AB_2674797" "unprognostic (1.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-2)" "unprognostic (9.00e-2)" "prognostic favorable (7.61e-4)" "unprognostic (1.57e-1)" "unprognostic (3.77e-2)" "unprognostic (4.20e-2)" "unprognostic (5.22e-2)" "unprognostic (2.60e-3)" "unprognostic (2.83e-2)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.45e-1)" 39.9 5.8 26.3 31.0 45.5 79.6 17.9 0.7 40.5 14.3 0.0 15.7 9.3 15.1 5.0 21.6 13.4 17.3 37.8 41.2 17.4 3.0 4.4 28.5 42.7 8.0 14.7 40.8 47.2 4.5 3.6 6.5 8.6 12.3 14.2 18.1 35.7 9.7 12.3 17.7 8.1 23.6 23.4 4.6 31.4 10.3 7.7 16.5 61.2 8.5 15.1 29.6 16.3 8.0 27.3 0.1 0.0 47.6 0.0 7.4 2.7 5.3 7.0 0.2 1.1 0.2 0.1 0.0 0.1 5.3 6.1 0.0 0.1 6.8 0.2 0.4 40.4 11.9 200.2 0.7 0.0 1.7 58.0 186.2 3.0 0.3 0.4 0.0 0.7 6.7 70.6 9.3 80.7 59.6 0.0 71.9 42.0 19.3 0.0 0.0 86.7 50.8 18.0 3.4 0.0 7.1 0.5 0.1 0.2 51.1 15.2 0.0 39.0 0.1 8.9 2.5 29.9 0.1 30.7 30.1 9.3 2.9 68.8 21.6 68.0 43.2 90.8 54.8 57.5 69.2 48.1 54.1 60.5 53.4 51.0 56.1 52.7 115.1 73.5 67.8 37.9 60.9 63.5 26.3 45.5 0.7 40.5 41.2 17.4 8.0 14.7 40.8 12.3 4.6 16.5 27.3 20.4 160.3 147.3 558.0 165.6 19.9 3.4 5.8 12.5 68.2 18.8 13.7 122.7 5.7 22.4 12.9 102.2 1.1 233.5 11.8 15.6 1.6 135.9 5.3 11.3 34.7 59.3 45.2 1676.4 2.1 0.9 106.0 11.2 17.0 128.5 0.7 13.2 5.1 90.0 134.6 576.9 37.5 24.4 261.4 134.3 110.3 111.6 192.9 115.6 376.6 263.6 90.5 256.4 324.7 21.6 1.5 16.9 89.5 124.3 10.1 2.4 1.0 5.8 99.2 52.6 117.6 33.7 4.1 11.5 5.7 14.5 1.9 232.5 8.5 23.8 2.4 FAM120A "C9orf10, KIAA0183, OSSA" ENSG00000048828 "Family with sequence similarity 120A" Q9NZB2 9 93451685-93566112 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019734, HPA055800" Approved Enhanced Cytosol NA NA 12000 Cytosol "HPA019734: AB_1848369, HPA055800: AB_2682925" "unprognostic (5.92e-2)" "unprognostic (2.15e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.03e-4)" "unprognostic (3.36e-1)" "unprognostic (2.33e-2)" "unprognostic (8.93e-2)" "unprognostic (5.84e-2)" "unprognostic (3.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.27e-2)" "unprognostic (3.71e-3)" "prognostic favorable (1.08e-7)" "unprognostic (8.16e-2)" "unprognostic (1.60e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" 48.6 48.1 30.2 60.2 32.2 50.3 38.2 27.5 27.9 45.4 50.6 75.1 59.5 39.6 36.4 47.0 51.3 42.7 61.5 27.0 31.2 48.2 56.1 42.3 56.9 36.5 29.7 25.4 39.4 58.4 88.0 27.0 60.8 30.1 43.1 69.8 30.9 56.6 41.2 82.5 42.3 58.9 51.4 27.6 49.4 69.9 17.5 29.8 45.9 49.4 72.0 46.0 53.9 33.2 42.4 179.7 145.4 32.0 92.8 93.7 116.6 100.3 123.2 107.8 92.9 68.0 47.5 108.2 116.1 68.9 156.2 73.7 188.8 86.5 144.3 71.1 117.0 62.8 63.8 126.1 75.3 104.6 109.0 83.5 114.3 87.2 105.7 166.3 90.9 133.7 81.0 74.4 94.9 101.3 202.8 108.2 61.4 41.2 212.7 134.3 62.1 85.6 97.4 112.3 107.2 85.8 52.5 139.5 166.4 86.0 31.4 91.0 70.6 140.6 99.6 71.6 123.8 136.4 74.2 78.6 44.8 107.9 96.6 90.9 3.1 6.6 5.2 4.9 7.5 4.1 4.4 4.3 4.8 6.1 3.5 3.0 4.4 13.1 4.3 9.3 3.9 8.3 4.1 30.2 32.2 27.5 27.9 27.0 31.2 36.5 29.7 25.4 30.1 27.6 29.8 42.4 64.0 44.8 93.9 67.9 42.7 102.2 49.6 56.6 70.6 30.0 86.5 49.0 112.3 77.2 75.2 75.4 50.1 73.8 49.2 164.3 21.5 50.1 26.1 77.5 76.2 64.9 91.8 60.2 92.1 74.7 104.9 60.5 123.8 92.3 48.8 66.1 63.1 186.6 71.0 40.4 62.5 176.8 36.7 146.4 78.6 9.8 66.8 103.4 53.4 80.6 111.0 35.7 35.0 64.3 80.9 86.4 92.0 65.5 60.8 125.8 81.0 75.7 87.8 33.7 39.5 63.5 68.6 12.3 12.4 91.1 114.2 103.4 49.3 94.4 177.2 109.0 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 1088.8;Inhibitory neurons: 296.7;Oligodendrocyte precursor cells: 198.0;Oligodendrocytes: 173.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 48.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavorable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 10.4 10.6 0.5 13.7 12.8 23.4 8.3 0.0 48.1 9.6 0.0 11.9 7.2 10.2 9.7 9.6 8.3 9.7 7.6 14.0 7.4 9.1 9.8 8.0 18.3 0.0 0.4 13.5 7.8 13.2 23.0 20.3 6.7 12.4 8.1 15.3 17.9 7.0 8.9 22.9 8.4 9.1 13.3 0.0 10.9 8.7 23.0 0.0 44.0 13.3 15.8 21.0 12.2 7.3 5.1 50.7 30.5 42.1 49.0 22.2 30.0 24.8 31.1 32.2 30.5 33.2 54.7 34.2 79.8 24.0 44.3 22.2 22.3 55.6 57.5 53.3 50.4 27.9 64.3 37.0 55.1 26.5 55.4 39.9 28.5 25.2 53.7 68.5 27.7 49.8 85.2 67.9 66.4 35.4 52.0 96.5 38.0 32.6 37.6 35.4 56.8 29.1 47.6 30.3 43.9 42.9 33.3 49.9 20.2 22.0 36.5 27.1 29.4 37.0 28.1 27.8 35.7 39.3 52.7 78.8 74.1 31.6 44.7 36.7 3.5 6.9 2.8 5.1 7.3 4.9 5.5 5.3 7.6 9.9 3.6 5.1 5.9 1.0 9.1 6.7 11.2 8.5 4.4 0.5 12.8 0.0 48.1 14.0 7.4 0.0 0.4 13.5 12.4 0.0 0.0 5.1 18.3 6.4 3.1 125.7 20.1 7.9 7.2 9.9 10.8 39.3 11.0 9.7 16.0 14.3 14.1 7.3 20.9 8.1 31.2 5.4 19.6 8.8 46.7 6.8 27.0 15.6 22.9 30.7 1088.8 7.4 10.4 11.5 15.8 12.6 18.3 25.9 11.7 14.2 12.2 26.9 296.7 11.7 14.2 19.5 13.8 44.7 13.7 18.8 7.2 98.4 21.9 8.6 22.6 198.0 173.5 8.3 6.3 11.3 33.7 10.0 5.3 13.4 4.3 40.5 0.0 14.7 25.3 26.5 24.5 20.3 9.7 3.1 23.4 36.6 11.5 6.8 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300489-40317813 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease variant, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.0;pituitary gland: 108.9" "Cell type enhanced" "Detected in many" "Muller glia cells: 295.4;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 128.1" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 3.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 3.2" "Group enriched" "Detected in many" 4 "HDLM-2: 98.6;Hep G2: 27.6;HMC-1: 90.3;THP-1: 105.0" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 510000 Vesicles Nucleoplasm "HPA056316: AB_2683099, HPA075286: AB_2732288" "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 1.7 3.4 46.9 3.7 69.0 11.0 6.0 60.9 49.4 12.2 26.6 4.7 5.8 5.1 1.7 1.6 11.5 8.5 1.4 40.1 53.2 17.0 0.9 4.3 6.0 78.2 76.7 32.8 1.3 2.3 21.2 108.9 1.1 83.3 13.8 3.2 23.3 16.5 24.4 0.3 4.2 10.5 1.4 58.2 9.9 16.6 2.6 62.5 1.8 12.3 0.4 3.2 12.2 2.0 89.0 12.0 0.3 1.8 0.8 2.6 1.3 7.8 0.0 0.0 0.6 1.3 0.4 6.8 3.4 10.0 0.3 0.0 2.0 0.1 0.0 0.3 98.6 1.4 2.0 0.8 27.6 1.5 0.9 90.3 4.8 0.0 0.1 0.0 0.7 0.0 1.5 0.1 19.8 0.0 2.7 1.2 2.1 2.2 0.0 1.2 2.3 0.0 6.9 0.0 14.3 1.4 2.3 0.1 11.8 1.3 6.6 15.0 105.0 0.1 0.0 11.6 0.2 0.4 1.4 0.2 3.4 1.0 12.3 0.6 0.0 0.1 3.2 0.0 0.2 0.0 0.2 0.1 0.0 1.2 0.2 0.0 0.0 0.5 0.2 0.3 0.1 0.1 0.0 46.9 69.0 60.9 49.4 40.1 53.2 78.2 76.7 32.8 83.3 58.2 62.5 89.0 0.5 0.0 3.3 26.1 10.8 1.0 3.0 8.5 0.0 2.0 7.1 9.7 1.0 7.2 10.0 25.8 0.0 3.2 2.5 7.2 0.0 11.7 0.2 13.6 0.9 0.6 12.7 0.4 0.3 0.8 0.6 2.1 26.0 20.0 26.1 1.6 1.1 0.0 3.4 0.0 0.3 6.6 2.0 0.3 22.4 0.9 2.1 6.4 1.8 3.7 22.1 295.4 1.0 62.4 128.1 4.9 9.6 0.0 4.0 6.1 5.0 0.3 12.9 10.9 0.0 1.3 1.8 3.4 6.2 0.2 0.6 1.4 2.7 1.8 13.4 13.4 KITLG "DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF" ENSG00000049130 "KIT ligand" P21583 12 88492793-88580851 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Cell adhesion" "Growth factor" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 83.6;Collecting duct cells: 69.9;Excitatory neurons: 46.5;Inhibitory neurons: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 299.8;SK-BR-3: 118.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070395 Approved Approved Vesicles "Intracellular and membrane" NA NA 260000 Vesicles "HPA070395: AB_2686264" "unprognostic (7.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.70e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (2.22e-3)" "unprognostic (5.61e-3)" "unprognostic (7.89e-2)" "unprognostic (5.47e-3)" "unprognostic (5.03e-2)" "prognostic favorable (5.81e-7)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.54e-2)" 13.3 3.9 3.0 8.3 3.6 0.3 10.7 0.4 3.1 13.0 0.8 18.9 9.7 15.3 2.8 14.4 4.0 18.7 7.0 2.6 2.7 16.1 2.3 31.9 3.3 0.0 3.1 1.9 6.1 3.7 3.7 0.2 15.2 0.4 15.2 22.8 2.3 8.9 14.9 3.1 7.2 11.7 19.0 0.3 3.6 17.6 6.4 6.0 5.1 6.0 14.6 10.4 12.4 1.3 6.0 14.3 7.1 7.1 0.9 29.0 61.5 0.0 77.6 60.1 13.5 6.4 299.8 11.0 0.0 2.2 73.3 14.9 49.5 11.5 20.1 14.2 0.1 9.5 0.0 9.5 2.6 4.4 1.9 0.0 53.5 20.6 41.6 26.8 6.3 17.9 0.0 0.0 0.3 6.8 2.5 0.2 0.0 4.8 17.7 17.9 0.0 12.6 0.0 25.0 6.5 2.3 4.8 18.5 118.9 2.2 6.5 57.2 4.3 10.0 60.7 7.4 69.0 6.8 0.0 0.0 0.0 8.4 0.2 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.6 0.4 3.1 2.6 2.7 0.0 3.1 1.9 0.4 0.3 6.0 6.0 42.5 19.2 38.3 9.4 0.5 13.5 11.2 7.5 83.6 2.7 12.2 8.1 4.4 1.5 16.5 69.9 0.0 0.1 0.0 12.0 1.9 4.4 0.4 3.1 6.8 43.1 9.5 0.0 46.5 18.2 0.1 34.5 43.3 3.4 0.0 2.1 5.0 0.4 1.2 21.9 61.4 8.5 18.3 3.2 5.7 0.9 14.0 1.9 12.4 18.7 0.0 0.3 0.0 3.0 0.6 8.7 3.0 3.8 1.4 11.2 2.3 1.4 9.8 1.2 13.1 2.2 27.2 0.2 0.5 18.5 5.3 0.0 1.0 4.4 14.7 3.2 ERCC8 "CKN1, CSA" ENSG00000049167 "ERCC excision repair 8, CSA ubiquitin ligase complex subunit" Q13216 5 60866454-60945073 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cockayne syndrome, Deafness, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 47.3;Excitatory neurons: 51.8;Inhibitory neurons: 47.9;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029328 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029328: AB_2673000" "unprognostic (5.45e-2)" "unprognostic (1.90e-1)" "unprognostic (2.56e-2)" "unprognostic (6.59e-2)" "unprognostic (1.68e-2)" "unprognostic (4.96e-2)" "unprognostic (2.10e-3)" "unprognostic (9.68e-2)" "unprognostic (3.85e-2)" "unprognostic (3.23e-1)" "unprognostic (7.49e-2)" "unprognostic (1.09e-1)" "unprognostic (4.75e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (7.19e-2)" 3.4 3.1 2.4 1.6 2.7 2.0 3.2 3.3 3.3 2.5 1.6 2.6 1.7 3.0 1.4 2.8 2.4 1.9 3.1 2.5 1.9 4.0 3.2 2.2 1.6 2.3 2.1 2.3 2.7 2.7 3.0 2.5 2.1 2.5 2.3 2.4 2.7 2.7 2.1 3.0 2.4 2.2 2.3 1.6 2.6 2.5 4.1 2.3 2.8 3.0 2.9 2.2 2.5 2.6 3.5 4.8 4.9 7.3 9.5 6.0 4.2 8.2 7.6 6.4 8.9 9.2 6.9 8.6 7.3 9.4 4.2 14.4 4.0 10.6 7.4 11.1 7.6 6.0 5.3 7.3 7.7 5.0 4.9 4.5 6.5 6.5 6.1 7.5 3.3 9.9 8.8 8.0 4.2 5.2 8.1 6.9 8.0 6.5 2.8 3.1 11.0 9.6 9.1 4.7 5.9 6.1 11.3 8.6 3.6 6.5 7.6 11.2 3.6 3.8 3.8 7.4 7.6 10.1 5.5 11.9 12.7 5.9 10.1 8.3 0.5 4.2 0.9 3.1 3.4 2.5 2.7 2.4 2.8 7.1 1.8 2.8 3.2 0.7 2.2 1.4 3.5 3.3 2.1 2.4 2.7 3.3 3.3 2.5 1.9 2.3 2.1 2.3 2.5 1.6 2.3 3.5 3.4 3.2 4.6 28.4 6.6 2.9 3.1 6.9 9.6 0.0 4.9 5.5 4.1 7.2 3.3 16.5 0.0 7.7 4.2 1.6 15.6 5.0 47.3 4.3 7.2 3.9 0.0 10.5 51.8 5.2 9.2 5.2 5.1 3.1 5.7 8.1 3.9 5.0 6.4 0.0 47.9 3.8 4.1 7.1 5.5 11.2 4.7 6.5 7.2 20.6 7.9 0.0 6.2 44.2 57.4 5.2 2.2 3.0 11.1 3.8 2.0 7.1 6.3 0.0 0.0 4.0 4.6 22.5 9.2 10.4 4.3 3.4 6.5 8.9 4.4 3.5 ADAMTS6 ADAM-TS6 ENSG00000049192 "ADAM metallopeptidase with thrombospondin type 1 motif 6" Q9UKP5 5 65148738-65481920 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 1.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.6;Inhibitory neurons: 63.6;Microglial cells: 31.9;Oligodendrocyte precursor cells: 139.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in many" "BJ: 12.6;HBF TERT88: 13.4;hTEC/SVTERT24-B: 12.6;hTERT-HME1: 14.9;TIME: 14.5;U-2197: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043441 Enhanced "Secreted to extracellular matrix" NA Yes "HPA043441: AB_2678484" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.70e-3)" "unprognostic (4.33e-2)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (8.24e-2)" "unprognostic (1.65e-2)" "unprognostic (4.77e-2)" "unprognostic (8.04e-2)" "unprognostic (1.56e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-6)" "unprognostic (3.23e-5)" "unprognostic (2.09e-1)" "unprognostic (3.02e-4)" "unprognostic (4.18e-3)" 0.4 0.1 0.3 0.6 0.2 0.0 0.3 0.2 0.3 0.3 0.5 0.3 0.1 1.1 0.8 0.2 0.6 1.5 0.3 0.3 0.5 0.2 0.0 0.5 0.4 0.3 0.4 0.1 0.3 0.0 0.0 0.1 1.9 0.3 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.6 0.6 0.4 0.7 0.3 0.5 0.4 0.2 0.2 0.1 0.3 0.7 0.3 0.3 2.7 0.0 0.6 0.6 0.0 2.0 0.0 12.6 7.4 7.7 9.0 0.0 0.3 0.0 0.1 4.8 5.3 0.5 0.1 2.4 13.4 2.0 0.0 0.2 5.1 0.3 0.4 0.0 0.7 0.9 0.0 12.6 14.9 3.7 6.9 1.3 0.0 0.0 4.8 0.0 0.7 0.0 0.1 0.3 0.1 0.4 2.6 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.0 1.6 0.0 0.1 14.5 3.0 4.5 16.2 10.2 0.1 0.0 0.0 3.4 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.4 2.1 0.1 0.2 0.0 1.3 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.2 0.3 0.3 0.5 0.3 0.4 0.1 0.3 0.4 0.4 0.3 11.3 0.0 0.0 4.9 16.1 0.3 0.0 0.6 0.6 13.9 0.3 0.5 1.8 1.5 0.1 3.7 0.0 34.6 3.2 0.2 0.0 1.4 15.2 8.5 7.4 13.3 0.0 0.0 16.7 0.0 4.7 5.5 0.0 25.7 1.3 18.7 8.9 0.3 2.4 0.0 63.6 0.5 2.0 0.3 1.0 8.0 12.2 3.2 0.0 31.9 0.3 17.4 1.0 139.7 2.1 2.6 0.0 18.0 2.5 0.1 0.1 1.0 0.1 1.1 6.6 5.1 10.5 6.1 8.9 0.3 0.0 14.2 5.1 2.2 0.6 0.0 H6PD "GDH, H6PDH" ENSG00000049239 "Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase" O95479 1 9234774-9271337 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004824, HPA005440" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 140000000 Cytosol "HPA004824: AB_1079037, HPA005440: AB_1079036" "unprognostic (4.83e-3)" "unprognostic (3.91e-2)" "unprognostic (1.18e-1)" "unprognostic (3.49e-1)" "unprognostic (5.53e-3)" "unprognostic (2.86e-2)" "unprognostic (8.35e-2)" "unprognostic (5.18e-2)" "unprognostic (9.73e-2)" "unprognostic (1.26e-3)" "unprognostic (2.16e-2)" "unprognostic (7.35e-3)" "unprognostic (8.20e-2)" "unprognostic (3.61e-1)" "unprognostic (1.30e-1)" "unprognostic (8.65e-2)" "unprognostic (1.95e-1)" 27.4 30.7 7.7 12.7 9.7 9.8 23.2 7.3 6.8 21.2 16.0 14.6 11.3 25.9 14.5 13.6 28.6 12.7 18.5 5.3 10.3 11.1 95.3 20.4 12.5 12.7 9.8 4.0 45.2 19.1 10.7 12.8 14.3 14.2 19.7 9.2 4.3 56.6 13.2 48.8 36.0 16.9 16.8 8.5 14.7 18.9 8.2 8.7 13.2 14.9 21.2 11.4 16.8 16.6 9.3 9.9 8.0 6.8 25.5 68.9 78.9 6.4 9.8 24.0 7.1 10.9 1.5 20.1 10.9 11.2 15.3 9.1 10.3 1.8 4.8 10.3 32.8 2.2 0.0 2.8 6.7 38.6 3.5 4.1 77.7 9.1 17.2 11.1 15.6 32.9 5.9 2.9 18.2 14.0 5.7 3.9 8.2 3.7 7.5 4.6 1.2 0.9 9.3 9.1 4.0 2.3 12.0 12.9 10.0 12.0 4.7 7.5 17.4 32.9 24.3 3.9 6.2 2.8 24.1 7.6 2.5 40.8 15.6 15.7 1.6 2.3 0.3 1.6 2.4 1.3 1.3 1.2 1.5 1.0 1.6 1.2 1.1 1.5 1.2 2.3 1.4 1.1 1.5 7.7 9.7 7.3 6.8 5.3 10.3 12.7 9.8 4.0 14.2 8.5 8.7 9.3 24.1 25.6 29.5 17.9 10.1 14.3 13.2 16.9 18.8 19.6 10.3 8.3 17.5 58.6 18.8 20.2 27.1 11.2 9.1 16.6 0.0 22.9 0.8 11.2 36.0 19.8 7.8 9.0 8.4 21.3 8.5 33.6 5.6 15.5 3.8 29.9 19.6 164.0 12.1 16.8 9.1 15.1 8.2 25.4 11.4 2.9 48.1 14.2 12.4 13.1 51.6 10.4 19.6 16.6 18.6 20.0 17.0 36.9 4.5 17.2 23.1 7.4 19.1 10.9 0.0 50.5 11.7 4.6 5.5 10.5 12.8 5.9 11.6 26.1 23.6 14.2 VAMP3 CEB ENSG00000049245 "Vesicle associated membrane protein 3" Q15836 1 7771296-7781432 "Cancer-related genes, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 260000 "unprognostic (1.09e-2)" "unprognostic (4.03e-1)" "unprognostic (3.39e-3)" "unprognostic (2.95e-1)" "unprognostic (9.15e-3)" "unprognostic (3.86e-3)" "unprognostic (9.49e-3)" "unprognostic (2.00e-1)" "unprognostic (7.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-3)" "unprognostic (2.17e-1)" "prognostic favorable (2.36e-4)" "unprognostic (1.02e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-2)" "unprognostic (3.30e-2)" 109.3 79.9 87.2 50.6 104.6 114.5 77.5 105.4 101.4 74.5 78.8 68.6 64.0 74.8 66.6 82.8 65.7 65.3 79.3 82.6 101.5 77.7 64.2 92.5 44.4 114.0 107.7 76.5 78.9 33.3 74.6 47.1 87.9 112.1 60.7 74.8 26.4 46.1 82.5 90.2 70.8 70.3 86.2 108.3 57.2 61.2 44.2 100.3 37.5 68.6 99.8 52.7 87.3 61.3 128.7 92.3 64.3 67.9 81.4 181.9 204.1 47.7 162.5 183.3 170.8 160.5 70.8 116.1 12.1 89.1 205.8 86.9 78.5 75.2 109.9 218.1 9.6 93.5 59.2 56.8 99.3 118.0 35.4 56.2 167.2 80.7 121.8 98.7 168.4 209.6 26.8 61.9 54.5 241.7 41.2 26.7 31.5 30.0 102.9 111.6 21.9 98.7 37.4 133.7 52.4 18.6 70.8 141.2 68.5 152.2 81.1 69.4 37.3 186.9 152.5 52.3 160.0 79.4 44.7 65.2 35.1 174.7 140.9 122.9 63.7 63.0 63.0 15.9 71.7 16.5 13.8 14.9 14.1 43.1 11.2 11.9 13.0 84.0 19.0 65.0 14.0 20.9 30.2 87.2 104.6 105.4 101.4 82.6 101.5 114.0 107.7 76.5 112.1 108.3 100.3 128.7 88.0 48.1 46.1 11.8 18.6 43.6 58.2 38.8 50.1 12.5 30.5 29.1 44.8 37.1 31.8 40.5 4.2 85.6 24.2 60.1 64.6 67.9 24.3 24.7 35.4 88.1 31.2 28.8 9.6 50.5 113.7 46.1 26.5 28.8 58.2 31.1 73.2 37.5 78.0 8.4 9.9 42.8 42.7 78.2 63.3 12.5 32.3 65.9 56.9 8.4 72.0 76.0 27.8 12.5 24.4 89.8 44.5 47.0 21.6 62.0 65.5 100.0 29.4 8.6 46.0 52.2 53.0 61.3 49.3 61.7 51.3 114.5 21.3 53.3 43.0 86.1 PER3 ENSG00000049246 "Period circadian regulator 3" P56645 1 7784320-7845177 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 137.8;Bipolar cells: 241.0;Horizontal cells: 124.5;Rod photoreceptor cells: 138.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 36.0" "Low region specificity" "Detected in all" HPA019530 Approved Supported Cytosol NA NA Cytosol "HPA019530: AB_1855201" "unprognostic (5.11e-2)" "prognostic favorable (7.14e-4)" "unprognostic (2.45e-2)" "unprognostic (2.97e-3)" "unprognostic (1.74e-1)" "prognostic favorable (1.34e-4)" "unprognostic (3.87e-1)" "unprognostic (5.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (3.46e-1)" "unprognostic (1.62e-1)" 14.0 11.2 9.8 4.6 13.9 0.7 12.8 43.4 13.2 11.7 3.2 13.8 6.4 19.1 10.7 17.2 12.8 12.4 22.5 9.7 10.4 12.6 25.8 12.1 4.7 14.5 13.9 8.3 18.7 17.2 20.0 17.1 2.7 19.4 15.7 6.6 56.4 25.6 20.7 29.0 12.4 9.5 10.8 11.3 9.1 17.5 8.9 14.0 4.7 23.5 24.5 7.2 10.4 10.5 25.7 7.2 2.1 6.1 1.8 1.1 0.6 1.8 3.0 5.5 5.5 7.6 8.6 27.7 3.2 1.6 12.4 9.4 3.3 22.1 1.4 8.3 0.2 1.2 22.7 8.3 1.3 6.8 0.7 7.6 3.0 2.4 6.0 6.1 11.4 2.0 1.6 18.7 5.8 2.4 5.7 12.7 10.2 3.3 16.0 5.9 11.0 2.2 0.2 3.1 1.3 7.9 8.5 26.3 0.1 11.0 6.1 6.6 1.0 4.2 14.9 21.4 4.6 4.0 0.8 0.5 2.7 10.5 36.0 21.2 0.3 0.6 0.4 1.5 0.7 1.8 0.6 0.7 1.4 0.7 0.2 0.6 0.7 0.0 0.3 1.3 0.5 1.3 0.6 9.8 13.9 43.4 13.2 9.7 10.4 14.5 13.9 8.3 19.4 11.3 14.0 25.7 45.0 19.2 12.1 137.8 3.9 30.1 13.1 4.3 40.5 241.0 14.3 17.3 17.0 8.6 9.9 9.2 81.3 1.7 3.0 5.0 9.8 3.2 16.5 4.4 19.6 17.5 6.6 0.0 42.8 4.8 0.5 33.6 20.4 4.3 26.0 6.9 10.8 28.1 9.4 124.5 64.1 4.0 12.2 8.5 14.8 5.8 12.5 11.2 12.4 40.3 3.4 91.2 2.1 62.4 91.6 5.7 1.6 27.4 3.3 9.7 5.0 5.2 9.7 138.5 6.6 39.2 25.4 22.2 23.2 32.9 25.6 0.5 5.9 11.5 1.7 8.6 UTS2 "PRO1068, U-II, UCN2, UII" ENSG00000049247 "Urotensin 2" O95399 1 7843083-7853512 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 37.0" "Cell type enhanced" "Detected in many" "dendritic cells: 15.3;granulocytes: 41.2;monocytes: 17.9;NK-cells: 88.6;T-cells: 18.2" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "medulla oblongata: 37.0;pons: 27.1;white matter: 29.9" "Immune cell enriched" "Detected in many" 5 "T-reg: 45.2" "Lineage enriched" "Detected in many" 5 "T-cells: 45.2" "Cell line enhanced" "Detected in some" "CACO-2: 22.6;HEL: 7.1;HMC-1: 5.7;THP-1: 26.2" "Region enriched" "Detected in single" 19 "pons and medulla: 6.1" "Region enriched" "Detected in some" 12 "spinal cord: 79.7" HPA017000 Uncertain "Secreted to blood" NA NA 2590000 "HPA017000: AB_1858656" "unprognostic (2.10e-3)" "unprognostic (1.35e-1)" "unprognostic (3.89e-3)" "unprognostic (1.33e-3)" "unprognostic (2.32e-5)" "unprognostic (1.09e-4)" "unprognostic (4.95e-2)" "unprognostic (6.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.28e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-5)" "unprognostic (1.75e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (3.30e-3)" 0.5 3.7 0.1 0.5 1.2 2.9 0.1 1.4 3.9 0.3 0.0 0.7 0.6 0.1 0.0 0.1 0.4 0.5 0.0 0.2 3.0 0.1 0.1 0.5 1.9 37.0 3.9 0.0 0.3 0.0 0.0 0.0 0.0 27.1 1.4 1.2 0.9 0.0 0.0 0.3 0.3 0.5 1.2 6.6 1.1 0.2 0.0 0.6 0.9 0.1 0.0 0.3 0.2 0.1 29.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.1 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.5 0.1 0.6 5.0 0.0 6.7 0.0 4.4 4.5 0.8 0.0 0.4 1.3 0.1 6.1 0.0 0.0 45.2 1.7 0.1 1.2 1.4 3.9 0.2 3.0 37.0 3.9 0.0 27.1 6.6 0.6 29.9 0.1 0.0 1.9 0.0 5.1 1.5 0.1 0.1 1.8 3.2 0.0 0.0 0.1 0.0 0.7 1.8 0.0 0.0 15.3 2.7 0.0 0.0 0.0 0.0 0.1 0.3 1.2 1.7 0.4 0.0 0.0 0.6 1.1 0.1 41.2 0.0 0.0 0.0 0.1 5.0 0.5 3.7 0.0 0.0 1.3 0.0 0.0 5.5 0.0 1.0 17.9 0.8 88.6 0.5 0.2 0.1 4.7 0.0 4.3 1.2 3.0 0.6 0.0 1.2 0.0 0.2 0.3 0.0 0.0 0.8 0.4 0.1 18.2 0.0 8.0 0.0 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915871-7943165 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 9.9" "Cell type enhanced" "Detected in some" "dendritic cells: 15.0;granulocytes: 63.4;Langerhans cells: 17.5;monocytes: 31.6;T-cells: 29.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 9.4;neutrophil: 7.8;NK-cell: 5.2;T-reg: 18.5" "Group enriched" "Detected in many" 5 "granulocytes: 7.8;NK-cells: 5.2;T-cells: 18.5" "Cell line enriched" "Detected in some" 9 "HDLM-2: 111.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.5 0.2 0.5 3.9 0.4 2.2 0.2 1.0 0.5 0.2 0.3 0.5 0.5 0.3 0.2 0.6 0.1 1.6 0.2 0.4 0.2 0.2 0.7 0.8 9.1 0.3 0.2 0.4 0.2 0.7 0.0 0.0 0.2 0.5 0.3 1.1 0.5 0.3 0.2 0.2 0.5 0.8 0.2 0.2 4.1 0.8 0.2 0.3 3.7 0.2 0.2 9.9 2.0 0.0 1.1 2.5 0.9 0.2 0.2 0.0 0.1 0.1 0.1 0.4 0.5 0.5 3.1 0.5 0.1 1.2 0.1 1.8 0.4 0.0 0.4 1.9 111.5 0.2 0.6 0.5 0.1 1.8 0.0 0.9 0.3 0.7 0.5 0.2 0.4 0.1 0.1 0.4 0.3 0.1 0.2 0.0 0.3 0.1 0.1 0.2 0.1 0.7 0.2 0.3 0.1 0.2 0.2 0.4 0.2 0.0 1.3 0.1 0.3 0.3 0.3 3.2 0.1 0.5 0.2 0.2 0.2 13.0 0.8 0.1 1.5 1.9 0.2 1.7 0.6 0.3 0.3 1.1 9.4 1.4 0.4 0.2 1.7 7.8 5.2 0.1 0.3 18.5 1.4 0.5 0.4 1.0 0.5 0.4 0.2 0.3 0.2 0.4 0.5 0.2 0.3 1.1 0.6 0.0 1.7 0.0 1.6 0.3 0.9 0.3 0.6 0.0 0.3 0.5 0.4 0.0 1.9 0.0 0.0 0.0 15.0 0.1 0.0 1.3 0.0 0.6 1.0 0.8 0.0 0.0 0.2 1.1 0.0 1.0 3.6 1.4 63.4 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.3 17.5 0.0 0.0 3.6 5.4 0.0 31.6 0.0 1.0 0.0 0.1 2.0 0.1 0.0 9.4 0.5 0.0 0.1 0.0 0.0 0.0 7.7 1.0 0.4 0.1 0.1 0.4 0.0 29.2 0.0 0.5 0.3 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532682-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.2;stomach 1: 37.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055546: AB_2682844, HPA063224: AB_2684964" "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.1 8.9 2.1 0.9 1.5 0.6 2.3 5.7 5.6 3.6 0.9 7.1 6.9 0.4 3.2 36.2 7.6 5.9 6.3 0.6 1.6 5.2 0.1 0.3 0.1 9.3 5.5 0.1 13.6 23.2 21.4 0.8 4.3 13.0 10.0 4.5 0.2 11.2 5.7 0.1 27.5 3.2 0.1 0.3 0.0 37.6 2.8 15.3 3.2 1.1 0.0 3.7 5.5 13.0 6.5 20.5 0.3 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 14.7 12.1 0.0 0.2 0.0 0.1 28.6 0.0 40.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 0.1 21.8 0.1 3.0 0.0 0.0 0.1 0.0 0.0 0.0 66.4 0.3 0.0 0.0 62.8 0.4 0.0 0.0 0.1 0.2 50.2 0.4 0.0 0.0 25.8 0.0 0.4 57.4 0.2 1.5 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.5 5.7 5.6 0.6 1.6 9.3 5.5 0.1 13.0 0.3 15.3 6.5 0.2 0.0 0.0 0.0 0.4 2.3 4.4 4.1 10.8 2.9 6.5 3.4 5.4 8.6 8.3 18.4 0.0 77.9 0.0 27.6 5.9 9.2 1.0 3.8 0.6 0.4 3.6 0.0 1.0 11.5 7.4 0.8 44.9 5.5 0.0 3.1 0.0 0.0 5.9 0.0 1.7 24.9 2.0 0.0 0.0 2.1 2.8 0.5 0.0 1.0 0.6 0.6 0.0 0.0 0.0 3.4 10.3 0.0 1.3 4.9 2.1 0.3 4.3 0.9 0.0 0.0 0.8 0.0 0.5 30.0 5.5 10.7 0.2 12.4 19.3 7.8 LTBP1 ENSG00000049323 "Latent transforming growth factor beta binding protein 1" Q14766 2 32946953-33399509 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 162.8" "Cell type enhanced" "Detected in many" "Astrocytes: 108.4;Fibroblasts: 116.1;Leydig cells: 90.4;Peritubular cells: 161.0;Skeletal myocytes: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "basophil: 3.1" "Lineage enriched" "Detected in single" 14 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 569.4;HSkMC: 185.3;HUVEC TERT2: 194.5;U-2197: 181.1;U-87 MG: 255.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB025428 Approved "Secreted to extracellular matrix" NA NA 96000000 "CAB025428: " "unprognostic (1.02e-2)" "unprognostic (1.12e-1)" "unprognostic (5.29e-2)" "unprognostic (6.23e-2)" "unprognostic (3.11e-3)" "unprognostic (1.83e-1)" "unprognostic (1.06e-3)" "unprognostic (5.67e-2)" "unprognostic (7.48e-2)" "unprognostic (1.14e-1)" "unprognostic (9.96e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.79e-6)" "unprognostic (4.61e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.62e-4)" 23.1 13.2 8.5 22.3 8.8 11.6 14.6 8.3 11.9 162.8 19.1 23.5 10.3 59.5 38.1 21.4 37.4 73.6 89.9 8.7 12.1 23.6 18.7 27.7 7.0 12.0 8.3 5.0 30.5 8.0 2.4 9.1 73.8 10.6 47.3 16.7 0.7 14.7 74.3 15.8 9.5 15.1 97.5 9.1 8.3 33.0 18.0 8.5 8.3 6.5 28.6 18.8 54.4 28.6 13.6 0.3 12.5 31.3 0.3 26.1 569.4 13.5 46.5 95.7 6.4 9.3 25.3 4.6 41.3 1.0 6.0 8.8 2.4 0.7 1.5 22.0 0.6 15.3 135.6 15.0 4.1 118.6 0.5 15.7 185.3 4.4 141.2 6.9 61.8 194.5 6.3 8.7 0.3 51.1 19.9 5.5 0.2 22.4 1.0 39.2 4.7 65.8 0.6 0.4 22.4 6.3 3.4 9.5 72.1 0.8 49.1 27.9 0.4 126.4 6.4 26.2 181.1 37.6 74.8 80.0 58.8 255.9 5.2 10.8 3.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 5.3 8.5 8.8 8.3 11.9 8.7 12.1 12.0 8.3 5.0 10.6 9.1 8.5 13.6 33.6 0.0 0.6 108.4 0.4 13.5 5.6 13.0 10.2 0.0 6.9 6.6 80.9 4.3 3.6 1.8 0.0 45.2 0.3 12.9 0.0 9.6 6.3 7.3 18.3 28.1 1.2 30.3 30.4 6.5 23.4 116.1 10.2 10.5 0.0 11.8 20.3 11.0 7.6 0.0 54.3 2.8 2.0 0.3 18.1 7.1 90.4 12.0 19.6 39.4 0.4 0.2 0.0 70.4 52.4 19.1 3.3 161.0 1.3 19.1 0.7 0.3 6.3 0.3 59.2 85.8 67.9 0.7 11.9 6.9 9.8 43.5 2.0 2.6 4.1 33.4 RCN1 "FLJ37041, PIG20, Rcal, RCN" ENSG00000049449 "Reticulocalbin 1" Q15293 11 32091074-32105722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "epididymis: 666.0" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 288.2;Muller glia cells: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038474, HPA062104" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 9400000 "Endoplasmic reticulum" "HPA038474: AB_10672595, HPA062104: AB_2684683" "unprognostic (1.65e-1)" "unprognostic (7.69e-3)" "unprognostic (1.24e-1)" "unprognostic (2.03e-2)" "unprognostic (7.20e-3)" "unprognostic (1.70e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (7.13e-6)" "unprognostic (8.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.12e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (2.70e-13)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.14e-1)" "unprognostic (6.93e-3)" 77.2 54.9 27.3 58.8 40.1 8.2 65.2 24.8 29.5 74.5 37.8 55.2 43.8 80.5 666.0 25.9 70.1 50.6 42.7 26.9 38.4 37.1 101.5 51.1 29.5 31.2 26.4 24.3 84.4 22.1 62.7 67.8 130.1 29.1 86.4 54.3 49.1 90.7 83.3 32.9 25.6 41.8 80.2 32.9 36.2 41.1 22.7 32.1 19.2 64.0 29.0 23.3 114.2 41.5 32.1 130.0 143.7 335.9 217.4 720.2 548.1 340.4 425.5 501.5 286.6 515.6 123.6 157.2 0.4 293.3 718.4 380.4 157.6 118.0 135.2 450.2 63.9 231.9 28.2 104.7 58.4 519.7 21.7 42.0 780.1 154.8 197.1 215.4 333.7 647.7 60.6 17.4 25.8 342.1 116.0 61.4 50.2 137.2 2.7 143.9 45.1 393.5 39.2 270.1 355.8 82.1 42.6 117.1 26.2 333.1 227.2 171.0 77.5 350.8 417.0 215.8 338.5 364.6 1.0 0.9 1.7 514.2 28.3 224.9 0.3 13.6 0.5 14.9 16.2 11.8 6.2 6.9 12.3 15.2 4.8 5.1 9.5 0.6 10.9 10.3 8.2 2.7 9.3 27.3 40.1 24.8 29.5 26.9 38.4 31.2 26.4 24.3 29.1 32.9 32.1 32.1 131.3 54.5 34.8 9.8 11.8 41.6 80.8 78.2 34.1 40.4 47.9 37.5 9.0 42.9 55.1 47.8 12.5 172.6 10.5 14.3 7.9 143.4 210.4 60.7 154.9 112.1 53.2 16.4 8.0 45.7 288.2 152.1 23.0 110.2 12.7 100.3 85.3 61.7 44.2 15.2 5.9 80.9 38.7 17.8 33.9 173.8 80.5 19.9 32.0 8.4 50.3 327.4 19.6 16.6 1.3 39.7 30.8 73.0 38.6 184.9 6.7 14.1 30.4 17.0 26.3 80.8 91.7 17.0 7.2 33.2 28.3 217.0 13.6 55.8 75.3 99.8 ELN "SVAS, WBS, WS" ENSG00000049540 Elastin P15502 7 74027789-74069907 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010750, HPA018111, HPA056941" Supported Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 2900000 "Plasma membrane" "CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280" "unprognostic (1.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-2)" "unprognostic (2.72e-2)" "unprognostic (3.70e-3)" "unprognostic (1.23e-1)" "unprognostic (3.33e-2)" "unprognostic (2.00e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.62e-3)" 126.2 21.8 12.3 41.2 11.1 0.1 95.0 18.4 26.9 84.4 43.0 51.8 8.9 74.2 18.6 53.5 71.3 77.4 129.4 11.1 18.9 12.8 13.5 216.0 14.6 14.0 15.0 6.9 37.3 91.7 2.8 25.1 59.4 13.7 107.3 11.4 2.9 67.4 35.4 18.1 75.8 41.0 90.8 13.1 41.3 63.7 13.2 12.8 5.1 48.8 17.0 4.5 86.2 85.0 16.4 0.0 2.0 0.8 0.0 97.6 0.6 0.6 143.7 0.1 0.0 0.0 0.6 0.1 0.0 0.0 205.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.5 0.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.6 0.6 8.3 0.8 0.8 0.4 58.0 1.0 0.0 0.0 28.0 68.9 0.0 1.2 0.1 10.0 0.6 0.0 0.0 0.2 0.3 817.9 0.0 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 11.1 18.4 26.9 11.1 18.9 14.0 15.0 6.9 13.7 13.1 12.8 16.4 34.6 0.0 6.4 34.9 0.1 11.0 13.5 33.9 4.0 2.8 0.9 1.1 9.7 2.8 4.3 7.3 2.1 0.1 0.3 0.2 0.0 0.3 3.5 3.5 70.4 28.4 1.8 0.0 4.6 3.9 0.3 115.9 7.1 2.3 0.0 0.2 47.2 4.2 0.5 6.7 8.1 1.3 0.0 0.6 20.4 7.5 110.6 1.2 14.2 23.4 0.0 15.9 0.0 14.1 18.5 1.1 0.2 148.2 0.4 1.4 0.0 0.1 3.0 0.8 0.0 12.2 34.1 1.1 1.2 2.1 10.9 0.1 1.2 0.6 0.2 1.1 RFC2 "A1, RFC40" ENSG00000049541 "Replication factor C subunit 2" P35250 7 74231499-74254458 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029493 Approved Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "HPA029493: AB_10603991" "unprognostic (1.25e-1)" "prognostic favorable (9.91e-4)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (2.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.09e-7)" "unprognostic (2.22e-1)" "unprognostic (6.65e-2)" "unprognostic (3.61e-2)" "unprognostic (2.59e-1)" 11.7 9.6 10.9 13.5 11.3 27.7 15.7 11.7 11.6 12.0 11.5 13.5 9.1 9.7 8.5 18.8 10.2 8.7 9.6 10.8 12.3 10.8 21.4 11.4 23.7 11.7 11.4 10.7 11.4 13.4 11.9 7.9 18.5 11.5 11.6 15.1 8.9 12.3 7.7 18.9 20.0 11.3 12.7 11.7 14.3 13.7 10.1 11.3 20.3 9.2 12.3 31.1 11.7 12.7 13.1 74.3 55.6 65.2 64.6 13.1 15.2 29.4 42.5 46.7 85.2 101.4 62.6 67.3 69.2 11.5 30.7 78.7 49.7 53.3 69.2 87.5 49.6 91.5 42.9 76.4 46.7 10.1 64.6 25.3 15.4 15.9 79.8 55.0 18.5 46.0 63.9 89.4 41.9 66.4 87.2 65.1 124.7 74.1 116.3 47.4 95.0 72.0 85.8 45.7 58.1 52.4 65.5 50.7 94.8 34.7 79.2 68.7 58.0 17.4 83.4 54.9 64.6 96.3 25.1 35.1 120.6 42.4 98.4 89.3 33.4 36.7 27.3 18.0 42.3 18.1 31.6 15.5 16.5 31.9 36.8 19.5 14.3 46.4 42.9 40.1 17.1 23.9 29.1 10.9 11.3 11.7 11.6 10.8 12.3 11.7 11.4 10.7 11.5 11.7 11.3 13.1 15.4 12.8 11.1 2.6 19.0 23.8 24.3 24.3 19.9 13.2 12.6 17.4 6.1 5.7 16.5 5.5 2.1 68.6 17.5 12.4 5.9 21.0 2.8 8.1 13.3 13.5 4.8 38.3 3.0 19.0 65.0 17.4 10.7 11.5 23.4 25.1 13.6 14.0 37.7 3.3 2.6 13.1 20.3 14.4 28.2 2.5 8.7 18.2 21.4 1.9 26.3 16.1 23.7 1.5 2.2 13.8 6.9 10.9 17.5 11.0 13.2 13.8 8.8 9.5 6.6 14.6 17.5 33.8 44.6 20.1 17.0 46.1 16.9 12.9 19.1 15.3 ARID1B "6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R" ENSG00000049618 "AT-rich interaction domain 1B" Q8NFD5 6 156776020-157210779 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 404.3;Inhibitory neurons: 475.4;Microglial cells: 327.0;Oligodendrocyte precursor cells: 417.7;Oligodendrocytes: 503.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016511, HPA075291" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016511: AB_1845008, HPA075291: AB_2686743" "prognostic unfavorable (1.04e-4)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (5.42e-2)" "unprognostic (7.47e-2)" "unprognostic (1.40e-2)" "unprognostic (2.73e-2)" "unprognostic (2.89e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (2.53e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-1)" 15.3 12.1 15.5 14.6 14.3 29.0 15.8 30.5 17.2 18.5 4.4 14.3 14.3 17.2 11.4 15.8 18.8 14.6 14.4 21.3 10.0 11.9 9.7 14.7 18.4 14.0 11.8 9.7 27.8 17.3 28.4 12.3 11.8 15.5 14.7 12.2 11.8 20.5 12.9 33.9 23.4 15.4 16.0 8.3 18.5 12.6 9.9 11.5 25.6 22.2 25.7 19.0 17.5 17.6 18.3 13.0 19.4 29.6 41.2 24.7 21.5 20.4 14.6 18.6 18.1 18.0 17.7 20.0 43.0 8.1 23.9 22.4 16.5 25.2 23.3 18.1 40.4 18.1 30.6 19.6 22.1 17.1 25.3 21.8 25.5 18.4 27.1 24.6 20.4 25.6 26.8 35.8 32.3 13.2 15.9 29.1 30.5 15.3 18.3 10.5 66.3 12.7 22.9 12.7 24.3 28.0 34.7 28.3 29.4 15.8 15.7 19.6 40.2 26.4 23.4 23.6 22.0 27.5 21.8 18.2 52.7 19.7 30.3 32.0 5.0 2.3 2.3 4.1 1.9 3.7 5.3 3.5 2.8 1.8 6.9 2.9 4.1 4.2 2.4 2.1 9.4 3.7 1.2 15.5 14.3 30.5 17.2 21.3 10.0 14.0 11.8 9.7 15.5 8.3 11.5 18.3 85.7 48.1 51.8 282.7 83.3 47.5 22.3 22.3 41.5 36.0 70.9 44.4 36.9 27.1 32.6 126.9 29.2 14.7 103.7 21.8 7.9 40.8 15.0 70.8 124.5 43.9 40.8 37.8 404.3 34.5 7.5 49.9 31.1 78.0 38.7 137.1 33.9 27.3 14.1 47.1 475.4 33.7 20.3 32.6 36.1 19.4 56.8 49.1 30.2 327.0 59.4 21.9 24.7 417.7 503.7 46.6 26.9 62.8 70.2 28.1 26.8 18.4 29.5 29.6 46.0 43.1 56.7 8.0 12.2 39.7 55.7 17.5 51.9 72.9 36.3 27.1 CLPTM1L "CRR9, FLJ14400" ENSG00000049656 "CLPTM1 like" Q96KA5 5 1317752-1345099 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 474.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014791 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA014791: AB_1847250" "unprognostic (2.92e-2)" "unprognostic (1.34e-1)" "unprognostic (9.53e-2)" "unprognostic (8.43e-2)" "unprognostic (5.16e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (3.42e-2)" "unprognostic (1.41e-1)" "unprognostic (5.47e-3)" "unprognostic (9.14e-3)" "unprognostic (1.06e-1)" "unprognostic (5.77e-3)" "unprognostic (8.57e-2)" "unprognostic (4.92e-2)" "unprognostic (4.54e-2)" "unprognostic (4.17e-2)" 37.4 37.5 23.1 29.1 23.2 29.2 35.9 22.8 26.8 28.1 31.8 38.4 45.8 32.3 15.3 36.2 29.4 18.2 33.1 23.8 24.5 58.1 135.0 50.1 37.8 24.5 30.3 23.3 25.0 74.7 22.5 36.4 20.3 23.5 33.7 20.3 5.3 65.6 21.7 24.0 36.6 43.7 17.3 25.0 59.7 68.3 43.5 25.4 41.8 49.1 10.1 29.8 36.0 28.1 24.1 71.1 117.6 39.5 106.8 63.0 26.9 103.9 71.0 46.9 62.9 61.8 129.3 109.8 67.2 212.7 67.2 138.3 60.8 53.7 59.4 28.6 275.4 147.8 35.7 261.5 86.2 70.5 93.6 87.0 43.4 66.6 57.6 53.9 46.1 51.6 149.7 81.7 222.9 48.0 116.5 104.2 121.7 72.9 77.2 126.2 86.6 64.1 207.5 49.0 66.8 41.4 82.0 123.5 106.0 56.6 32.8 177.7 138.7 38.5 74.2 211.0 51.9 103.4 399.4 474.2 109.0 55.4 139.9 86.7 5.1 4.9 10.1 5.6 4.8 6.6 7.6 5.9 5.6 4.6 10.3 5.6 6.6 3.9 10.1 8.1 9.3 7.7 4.0 23.1 23.2 22.8 26.8 23.8 24.5 24.5 30.3 23.3 23.5 25.0 25.4 24.1 33.4 57.7 64.7 7.2 50.2 22.3 23.3 24.3 8.0 10.1 40.4 36.4 12.7 51.5 30.4 29.5 14.6 11.2 35.1 49.0 5.9 17.9 2.8 32.1 27.5 25.4 44.5 17.0 13.7 32.3 26.6 23.2 27.5 35.0 24.7 40.4 26.0 113.8 23.7 21.9 10.7 52.2 14.2 39.5 16.0 6.2 17.4 27.9 16.0 7.5 22.4 28.7 27.8 12.1 12.7 45.6 29.0 19.2 95.6 48.3 46.1 66.2 31.0 11.5 13.1 19.4 21.3 28.9 40.3 14.4 23.4 10.9 24.4 60.3 39.8 33.3 NEDD4L "KIAA0439, NEDD4-2, RSP5" ENSG00000049759 "NEDD4 like E3 ubiquitin protein ligase" Q96PU5 18 58044226-58401540 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 253.2;Excitatory neurons: 280.9" "Cancer enhanced" "Detected in all" "prostate cancer: 29.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "T-reg: 5.1" "Lineage enriched" "Detected in many" 4 "T-cells: 5.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 146.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024618 Approved "Intracellular and membrane" NA NA "HPA024618: AB_1854362" "unprognostic (2.56e-1)" "unprognostic (2.41e-2)" "unprognostic (1.58e-2)" "unprognostic (3.14e-1)" "unprognostic (3.90e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-3)" "unprognostic (2.26e-2)" "unprognostic (9.24e-3)" "unprognostic (4.39e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.55e-15)" "unprognostic (2.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.49e-3)" "unprognostic (4.75e-2)" 10.6 17.0 18.2 6.8 31.3 27.2 26.1 27.4 30.3 7.7 4.1 39.2 18.9 5.4 10.1 12.1 9.2 9.6 21.4 33.4 22.4 53.0 36.8 48.3 4.1 15.5 21.0 25.1 6.5 61.0 13.8 28.6 12.1 17.5 64.8 43.2 20.7 27.7 20.6 34.3 11.1 34.1 6.2 11.4 8.0 51.9 7.9 18.2 4.5 17.5 13.2 8.0 19.5 5.9 19.4 70.7 24.5 14.6 20.9 5.1 2.1 49.8 19.2 88.2 48.6 74.6 28.6 37.1 15.1 57.7 7.4 51.3 50.3 19.5 86.1 100.8 34.9 15.5 10.6 14.3 111.3 2.4 0.5 6.0 13.0 54.6 66.4 78.8 39.1 4.0 13.2 18.7 6.3 20.0 16.2 1.0 1.0 12.2 26.7 33.3 14.3 20.1 17.6 47.0 88.7 17.5 5.0 16.1 5.1 146.1 28.3 29.4 5.6 28.8 131.5 38.5 7.5 83.4 8.3 15.3 9.5 27.6 10.8 10.8 0.7 0.3 1.2 0.2 0.3 0.5 0.8 0.6 0.1 0.1 0.3 0.3 0.2 0.2 0.3 0.1 0.1 5.1 0.3 18.2 31.3 27.4 30.3 33.4 22.4 15.5 21.0 25.1 17.5 11.4 18.2 19.4 6.0 253.2 144.8 110.4 5.1 112.8 161.2 34.0 86.6 18.1 99.5 65.9 47.8 64.3 112.8 62.5 173.0 13.0 3.6 144.5 49.0 35.7 22.6 64.0 7.3 14.7 45.2 57.9 280.9 49.2 4.7 9.5 114.7 75.0 3.8 4.7 17.5 41.3 7.3 62.2 173.3 201.5 101.7 8.4 8.2 6.6 3.4 13.3 14.2 88.1 7.3 45.2 2.1 11.1 105.0 49.9 145.3 17.7 12.7 126.9 127.3 91.6 72.7 10.0 0.0 34.3 6.0 1.1 12.5 62.3 53.0 80.0 6.6 8.2 72.9 155.5 FOXP3 "AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID" ENSG00000049768 "Forkhead box P3" Q9BZS1 X 49250438-49270477 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 7.2;lymphoid tissue: 7.5" "Cell type enhanced" "Detected in some" "granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 11 "T-reg: 53.3" "Lineage enriched" "Detected in single" 394 "T-cells: 53.3" "Cell line enhanced" "Detected in some" "HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026301, HPA045943" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026301: , HPA045943: AB_2679508" "unprognostic (2.46e-2)" "prognostic favorable (1.91e-4)" "unprognostic (4.95e-3)" "prognostic favorable (7.02e-4)" "unprognostic (2.55e-4)" "prognostic favorable (4.90e-4)" "unprognostic (2.42e-2)" "unprognostic (3.46e-1)" "unprognostic (1.04e-2)" "unprognostic (1.99e-3)" "unprognostic (8.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.73e-14)" "unprognostic (5.93e-2)" "unprognostic (4.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-1)" 0.2 0.2 0.9 7.5 0.7 1.3 0.7 1.3 0.8 0.4 0.0 0.6 0.7 0.2 7.2 1.2 0.2 1.7 0.2 0.8 0.5 0.3 2.5 1.0 6.2 0.8 0.7 0.5 0.4 0.2 0.4 0.6 0.1 0.7 0.6 0.7 0.7 1.1 0.8 0.3 2.3 1.9 0.3 0.5 2.4 1.6 1.4 0.7 7.2 0.6 0.1 5.3 2.9 0.3 1.4 0.1 0.3 0.2 0.9 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.8 0.2 0.6 0.3 0.5 0.6 0.3 0.8 0.0 0.1 2.9 0.5 0.2 0.3 0.2 0.4 0.3 0.4 0.1 0.8 0.9 1.7 0.0 0.0 0.9 0.9 0.7 0.0 5.2 0.1 0.3 0.8 0.1 0.7 0.4 0.3 0.2 0.2 0.2 0.6 0.5 4.7 0.5 2.0 0.5 1.5 0.8 0.8 0.3 1.4 0.5 0.1 0.4 1.1 0.4 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 4.7 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 53.3 1.3 0.9 0.7 1.3 0.8 0.8 0.5 0.8 0.7 0.5 0.7 0.5 0.7 1.4 0.1 0.0 0.6 0.3 0.4 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 1.3 0.1 0.0 1.4 0.1 3.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.0 0.4 0.0 5.3 0.2 0.0 0.0 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269793-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 27.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 38.6;Horizontal cells: 48.8;Oligodendrocytes: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "T-reg: 9.4" "Lineage enriched" "Detected in single" 12 "T-cells: 9.4" "Cell line enhanced" "Detected in many" "GAMG: 13.6;HDLM-2: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000244: AB_2665949, HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favorable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.1 4.1 15.7 2.4 16.2 1.5 3.2 15.7 19.4 5.5 9.6 5.6 1.4 5.8 5.9 4.3 7.1 1.5 17.4 16.6 16.0 4.1 3.5 3.3 2.8 16.3 15.4 17.0 8.3 2.6 1.1 15.6 1.0 18.8 5.6 0.6 9.8 3.2 1.4 27.8 3.3 3.5 1.3 14.3 4.0 3.5 4.2 15.9 1.3 5.4 12.9 1.4 6.8 4.7 20.4 2.1 4.7 2.9 3.6 2.4 1.8 2.3 2.8 1.8 1.3 2.2 3.0 1.8 2.2 0.6 0.6 13.6 3.6 0.9 0.5 0.9 13.2 4.4 0.2 4.0 0.3 1.5 0.6 1.5 1.4 1.4 1.5 0.5 2.2 0.1 2.8 0.6 0.9 0.9 6.2 1.2 2.5 9.8 0.1 5.8 6.1 3.2 1.1 1.4 1.1 3.8 3.7 0.9 0.1 6.2 4.5 3.3 2.3 2.5 4.1 1.0 3.0 2.0 3.6 4.4 1.5 1.6 5.2 4.8 0.0 0.2 0.0 0.2 0.3 0.6 0.3 1.8 0.6 0.2 0.0 1.5 0.6 0.0 0.3 0.7 0.2 9.4 0.3 15.7 16.2 15.7 19.4 16.6 16.0 16.3 15.4 17.0 18.8 14.3 15.9 20.4 2.1 0.0 0.5 14.0 2.8 1.9 2.4 1.0 4.0 38.6 2.5 3.4 16.8 0.0 0.7 3.7 8.4 1.1 1.7 0.3 7.9 0.3 0.1 3.6 2.8 2.2 3.0 0.8 9.6 0.2 0.1 3.8 0.0 2.0 0.0 4.3 3.3 1.1 0.7 48.8 10.7 0.1 0.0 0.6 1.8 0.7 4.7 1.5 0.0 3.7 0.2 11.9 0.0 12.5 34.3 0.4 0.1 3.0 2.0 2.2 0.0 7.6 2.6 17.8 0.0 4.0 3.9 2.0 8.5 7.3 1.3 1.2 5.6 2.4 0.2 2.3 HEXB ENSG00000049860 "Hexosaminidase subunit beta" P07686 5 74640023-74722647 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 746.0;GAMG: 646.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055409, HPA056010" Enhanced "Intracellular and membrane" NA NA 40000000 "HPA055409: AB_2682808, HPA056010: AB_2683008" "unprognostic (3.45e-1)" "unprognostic (5.84e-2)" "unprognostic (1.85e-2)" "unprognostic (8.72e-2)" "unprognostic (1.12e-2)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (2.21e-1)" "unprognostic (5.01e-2)" "unprognostic (1.58e-3)" "unprognostic (6.45e-2)" "unprognostic (2.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (1.31e-2)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" 89.0 72.7 23.7 60.2 26.1 60.4 83.8 23.3 32.8 98.5 40.2 106.0 99.9 72.1 324.2 38.8 67.3 99.9 81.1 23.7 37.0 82.3 138.6 112.3 47.4 25.0 24.1 23.2 62.9 104.4 95.0 47.0 322.1 24.7 99.6 118.0 33.9 124.4 54.5 43.7 52.7 76.0 76.7 25.3 65.2 89.2 19.8 28.1 29.4 90.4 38.8 40.7 95.5 64.6 28.8 147.3 111.0 39.4 131.8 746.0 232.3 122.3 173.5 590.4 175.0 375.2 130.6 194.5 0.0 133.0 152.2 646.3 115.2 43.2 185.2 228.7 79.2 72.6 19.1 101.4 101.5 216.5 16.2 152.3 206.7 108.0 180.7 121.3 275.9 204.5 47.3 54.3 236.9 194.9 145.7 19.8 36.6 36.8 142.7 47.8 43.9 56.2 191.8 119.8 130.4 24.5 30.4 134.2 92.6 180.0 68.8 99.1 108.6 118.5 112.1 26.6 207.8 165.6 102.6 191.3 0.9 257.9 143.6 209.8 86.2 343.2 99.1 69.3 129.9 80.7 45.2 56.1 64.0 310.8 28.1 52.6 51.3 125.2 42.4 82.5 93.4 73.2 269.0 23.7 26.1 23.3 32.8 23.7 37.0 25.0 24.1 23.2 24.7 25.3 28.1 28.8 49.6 41.7 38.4 5.9 31.5 44.0 82.8 103.2 21.6 10.2 26.3 27.6 19.8 82.9 63.8 29.5 8.4 466.5 32.8 68.2 19.6 151.3 1.3 21.0 21.4 56.2 22.8 23.1 32.2 125.6 175.4 107.2 33.6 26.9 69.8 19.8 74.3 70.1 340.2 10.1 24.3 56.7 107.8 127.3 134.3 3.4 85.1 168.8 72.9 17.8 114.2 35.4 29.9 22.6 13.3 65.8 54.8 72.2 71.5 74.2 99.5 79.6 36.3 16.3 46.0 32.6 49.5 0.3 1.4 23.8 32.5 493.6 35.3 31.4 81.8 71.0 PTCD2 FLJ12598 ENSG00000049883 "Pentatricopeptide repeat domain 2" Q8WV60 5 72320367-72368395 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043686 Approved NA NA "HPA043686: AB_10962485" "unprognostic (1.59e-2)" "unprognostic (2.64e-1)" "unprognostic (2.30e-3)" "unprognostic (2.38e-2)" "unprognostic (2.19e-1)" "unprognostic (8.23e-2)" "unprognostic (1.73e-1)" "unprognostic (8.91e-2)" "unprognostic (6.62e-2)" "unprognostic (7.60e-4)" "unprognostic (7.68e-3)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" "unprognostic (9.91e-3)" "unprognostic (3.68e-2)" "unprognostic (9.24e-4)" "unprognostic (2.53e-1)" 4.0 4.8 3.9 1.7 4.1 1.3 3.2 4.2 4.7 2.2 5.7 2.3 1.0 2.3 3.6 2.9 2.7 2.0 7.5 4.0 4.1 3.9 4.6 1.5 2.4 4.2 4.3 3.9 3.2 1.9 4.8 3.1 3.3 4.4 2.5 2.6 4.7 2.2 2.6 8.8 2.9 1.8 2.8 3.8 2.0 2.2 2.1 4.2 2.7 4.1 13.9 2.6 3.1 2.6 4.9 5.1 7.7 4.9 6.0 9.9 8.7 6.2 7.5 4.9 7.4 6.2 6.1 6.0 7.9 10.3 5.0 14.2 3.8 9.5 14.6 7.9 3.6 5.1 5.5 9.7 3.5 14.7 2.7 1.5 9.7 7.6 9.7 20.3 8.4 5.4 11.2 6.5 4.9 11.2 4.7 6.6 6.3 4.6 2.3 6.5 4.6 5.7 17.6 8.6 3.5 5.2 3.5 6.6 4.2 6.8 5.6 11.7 5.5 4.0 3.8 4.3 5.6 7.6 6.3 8.2 5.0 7.3 8.1 7.6 0.0 0.9 0.2 1.1 1.2 1.3 1.1 1.2 1.0 1.9 1.6 1.5 1.9 0.3 3.1 1.4 1.6 2.1 0.6 3.9 4.1 4.2 4.7 4.0 4.1 4.2 4.3 3.9 4.4 3.8 4.2 4.9 2.9 3.2 4.8 16.0 5.5 0.8 3.1 3.1 3.4 5.2 3.5 2.7 13.5 4.3 1.8 3.7 25.0 14.9 7.8 1.2 11.7 4.2 0.3 3.0 7.4 4.6 1.2 3.8 10.7 2.3 7.3 5.4 1.5 2.8 1.3 8.6 3.3 8.4 4.6 5.0 10.2 2.1 6.1 4.4 1.3 1.4 4.1 3.3 0.0 8.4 4.8 8.3 7.2 12.1 19.2 2.7 1.1 4.9 1.5 1.5 3.2 5.5 3.1 14.8 0.0 5.3 4.9 4.9 8.6 4.2 0.1 7.1 4.4 9.9 3.6 1.7 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925472 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.1 0.9 2.2 0.1 3.3 0.0 0.3 1.1 2.6 0.4 0.0 0.6 0.1 0.5 0.2 0.3 0.3 0.1 0.0 2.3 4.7 0.7 0.0 0.2 0.1 0.3 0.8 2.4 0.4 1.5 1.9 1.7 0.1 0.5 0.9 0.3 1.0 0.4 0.6 0.0 0.3 0.4 0.7 0.0 0.1 0.6 0.2 3.3 0.0 0.4 0.1 0.1 0.2 0.2 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.9 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 1.1 2.6 2.3 4.7 0.3 0.8 2.4 0.5 0.0 3.3 1.3 0.3 0.0 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 26.1 35.2 26.6 17.8 28.3 23.1 32.8 30.8 29.9 23.2 33.3 29.9 17.5 30.8 26.6 18.0 31.5 31.1 26.1 24.6 32.2 44.9 34.3 31.0 25.4 30.7 30.1 24.2 26.0 20.9 57.0 28.8 34.1 32.2 30.2 29.8 35.0 25.6 27.2 17.2 17.6 24.2 27.9 29.2 23.2 24.7 30.7 29.2 22.3 34.9 21.2 20.9 26.7 16.4 33.9 54.8 68.0 57.3 46.8 40.9 59.0 42.8 85.9 76.6 52.6 62.9 21.8 108.1 27.7 75.6 85.5 55.3 40.0 41.2 52.8 72.1 82.8 24.0 30.3 38.5 42.3 56.0 45.6 53.6 60.9 56.6 45.9 32.6 82.1 55.7 35.8 25.4 54.9 100.7 54.1 25.6 37.8 31.2 45.9 60.4 31.4 73.6 27.9 92.1 59.3 23.7 40.9 82.8 68.4 45.1 40.0 66.4 32.3 72.4 54.9 65.6 53.0 58.0 21.7 45.5 32.7 80.7 33.2 68.0 86.3 59.3 82.3 34.4 74.8 34.3 36.1 37.0 37.0 51.9 34.1 38.9 36.5 89.4 50.2 83.0 70.5 47.0 57.8 26.6 28.3 30.8 29.9 24.6 32.2 30.7 30.1 24.2 32.2 29.2 29.2 33.9 25.5 22.4 31.2 29.7 23.6 30.0 32.8 132.9 54.1 30.3 31.6 27.1 10.2 41.5 66.3 46.0 18.8 64.2 42.0 27.4 7.9 45.4 174.5 43.3 31.7 26.9 31.2 40.8 30.3 54.8 64.8 37.4 27.5 20.9 34.9 28.0 26.4 41.9 57.8 28.6 26.8 26.7 89.5 60.3 31.4 61.2 35.4 40.4 48.0 19.7 34.2 40.1 29.9 28.1 34.5 51.4 21.3 31.6 50.2 26.3 22.4 53.0 110.6 30.3 13.1 27.5 58.8 85.1 41.1 30.7 29.1 29.8 27.6 30.3 24.6 20.9 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11956207-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1235.3" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 884.3;Muller glia cells: 1960.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 6.2;memory CD8 T-cell: 3.8" "Lineage enriched" "Detected in single" 62 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 18000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 24.1 79.8 107.0 10.1 152.4 0.2 26.2 11.5 136.3 90.5 83.0 43.9 14.7 47.4 16.8 29.9 23.3 67.5 1235.3 135.4 68.9 16.0 5.6 124.8 8.5 86.3 49.0 93.8 38.4 18.3 34.4 38.5 25.2 43.7 59.9 13.1 205.8 31.2 78.8 7.9 28.9 24.8 43.5 84.1 33.5 32.0 31.1 79.8 4.8 16.5 19.0 5.5 41.3 48.7 111.5 1.5 13.1 18.1 0.1 15.3 29.7 0.6 418.9 643.0 182.4 205.5 9.6 3.2 0.0 44.8 614.4 96.8 64.4 1.5 181.9 69.5 0.1 0.5 0.0 1.7 0.0 113.6 0.0 0.3 45.3 60.0 61.9 151.3 370.2 195.3 0.0 0.2 0.4 256.4 0.0 0.1 0.4 8.6 0.0 0.5 0.1 1.2 0.1 62.5 0.6 0.5 53.2 2.0 0.0 0.2 47.9 0.2 0.5 349.7 107.5 82.8 11.2 110.3 0.1 0.0 0.3 18.1 0.0 103.5 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.6 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 107.0 152.4 11.5 136.3 135.4 68.9 86.3 49.0 93.8 43.7 84.1 79.8 111.5 5.8 3.2 3.0 94.3 0.1 45.6 59.5 70.3 93.4 31.6 3.2 103.2 884.3 0.0 12.8 0.0 12.5 0.5 0.4 0.0 0.0 0.8 104.3 0.7 8.4 32.9 1.8 0.0 90.4 0.2 0.8 106.1 7.1 0.6 1.3 17.0 66.8 0.4 20.4 13.5 83.7 0.1 0.0 1.3 12.5 88.5 20.5 1.4 64.0 38.4 0.0 1960.4 0.0 27.6 14.7 1.1 0.1 57.6 1.7 32.8 0.0 0.2 2.9 67.5 190.7 12.7 83.4 1.2 3.2 5.8 14.8 0.8 4.1 0.5 0.3 3.0 ARHGEF5 "GEF5, P60, TIM, TIM1" ENSG00000050327 "Rho guanine nucleotide exchange factor 5" Q12774 7 144355288-144380632 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 46.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 61.7;Glandular and luminal cells: 47.4;Paneth cells: 53.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 29.4;CAPAN-2: 21.9;HaCaT: 16.7;hTCEpi: 18.0;RPTEC TERT1: 17.5;WM-115: 17.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA020980, HPA029504, HPA044188, HPA045619, HPA045699" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423" "unprognostic (1.45e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-2)" "unprognostic (1.94e-1)" "unprognostic (9.45e-2)" "unprognostic (2.69e-2)" "unprognostic (9.95e-3)" "unprognostic (9.21e-2)" "unprognostic (1.05e-2)" "unprognostic (2.27e-1)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.28e-7)" "unprognostic (4.67e-2)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "unprognostic (7.76e-2)" 4.5 2.6 1.8 1.6 2.3 2.4 12.4 1.6 1.6 8.1 5.9 11.9 10.2 3.4 6.9 36.9 4.7 4.8 2.6 0.8 5.2 17.0 14.5 8.5 2.2 1.9 2.3 0.8 5.7 19.2 7.3 9.6 3.3 1.8 14.8 5.7 1.8 18.2 2.0 0.7 46.6 13.2 1.2 1.3 3.8 13.9 2.0 1.9 1.8 24.2 0.3 3.1 5.3 17.7 1.4 29.4 3.3 0.0 0.0 0.0 0.0 8.7 3.8 2.3 1.5 1.9 11.5 21.9 0.1 10.3 0.9 0.3 16.7 0.0 10.6 1.5 0.1 3.8 0.0 4.2 0.8 3.1 0.0 0.0 5.5 18.0 0.7 9.9 4.8 0.1 0.0 0.0 0.0 1.5 9.7 0.1 0.0 4.5 7.9 5.2 1.1 0.0 0.4 17.5 1.3 0.1 0.1 11.5 13.4 5.1 2.3 6.8 0.3 0.2 0.5 0.8 0.0 0.1 0.0 0.1 0.1 0.6 0.0 17.7 0.0 0.0 0.0 0.3 0.0 0.4 0.8 0.8 0.7 0.0 0.9 0.9 0.2 0.3 0.0 0.0 0.0 1.5 0.1 1.8 2.3 1.6 1.6 0.8 5.2 1.9 2.3 0.8 1.8 1.3 1.9 1.4 3.0 6.4 14.8 0.3 2.3 18.5 37.3 9.4 26.2 0.0 17.5 18.7 1.4 11.5 12.1 22.0 4.2 11.8 1.4 61.7 5.9 14.8 2.3 28.9 5.5 1.6 9.6 2.7 0.0 16.5 15.2 3.6 37.2 47.4 0.0 4.0 1.8 7.5 1.8 0.0 0.0 24.0 6.1 0.3 1.9 0.6 1.5 1.2 5.4 0.0 0.0 2.7 0.0 0.5 0.1 27.7 53.7 1.5 3.1 14.3 42.0 5.4 13.5 3.1 0.0 1.1 1.8 0.7 1.5 28.7 16.8 14.2 2.5 1.1 23.5 33.6 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152198-26187137 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2;placenta: 34.7" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 305.9;Syncytiotrophoblasts: 698.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 133.5;NTERA-2: 113.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA055889: AB_2682958" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavorable (7.58e-12)" "prognostic favorable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.6 3.1 5.2 10.7 7.9 2.5 2.3 19.9 20.2 1.4 3.5 6.4 8.1 2.2 0.2 2.4 1.7 4.3 1.2 8.1 5.4 2.5 1.6 4.9 8.0 7.4 8.1 4.3 1.1 4.8 0.4 1.4 34.7 7.8 1.4 4.8 5.2 3.2 0.6 2.7 7.4 5.8 1.0 6.6 7.7 7.4 1.4 6.3 6.0 1.0 0.2 7.1 4.9 1.5 11.0 40.9 3.5 1.6 4.0 0.0 0.0 133.5 7.9 15.2 15.0 27.3 26.2 68.8 3.0 51.2 0.8 57.5 8.6 6.0 13.4 33.7 27.9 8.5 5.7 7.0 19.8 10.5 5.0 52.3 1.3 1.6 6.2 2.3 22.4 35.0 11.3 8.6 69.9 3.0 5.5 3.5 8.8 113.9 11.1 13.9 5.0 0.4 20.5 20.5 40.5 12.3 14.7 0.2 3.2 1.2 37.5 1.9 3.0 76.0 1.4 2.3 0.6 32.6 42.0 72.2 3.4 0.2 17.5 53.1 0.0 0.2 0.0 0.1 0.2 0.3 0.2 0.4 0.2 0.6 0.2 0.2 0.1 0.1 0.2 0.0 0.2 0.6 0.1 5.2 7.9 19.9 20.2 8.1 5.4 7.4 8.1 4.3 7.8 6.6 6.3 11.0 14.6 6.4 2.8 3.9 4.6 1.8 4.2 12.7 5.2 1.4 3.1 2.3 1.9 14.3 6.9 11.0 0.0 305.9 1.6 6.1 0.0 13.0 1.0 6.1 1.8 7.6 1.2 12.0 3.8 5.3 33.9 2.8 14.3 6.4 27.9 35.2 2.2 0.3 24.3 0.0 4.4 6.6 12.2 15.6 17.2 0.3 0.0 16.7 1.8 2.8 11.1 1.1 4.1 1.5 11.6 15.6 4.1 0.0 18.2 10.4 2.7 0.5 8.9 1.9 0.0 2.9 2.7 0.6 7.1 5.5 1.6 698.6 9.0 4.8 9.8 6.7 MCUR1 "C6orf79, CCDC90A, FLJ20958" ENSG00000050393 "Mitochondrial calcium uniporter regulator 1" Q96AQ8 6 13786557-13814568 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 82.3" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 238.5;Rod photoreceptor cells: 293.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078654 Approved NA NA "HPA078654: " "unprognostic (1.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-3)" "unprognostic (8.62e-2)" "unprognostic (2.25e-3)" "unprognostic (2.01e-3)" "unprognostic (2.16e-1)" "unprognostic (4.83e-2)" "prognostic favorable (5.51e-4)" "unprognostic (3.40e-1)" "unprognostic (5.77e-2)" "prognostic favorable (3.32e-4)" "unprognostic (5.86e-2)" "unprognostic (2.68e-1)" "unprognostic (4.05e-2)" "unprognostic (2.39e-1)" 9.8 5.5 20.7 7.2 21.5 7.1 10.1 20.0 32.9 7.8 18.6 10.9 19.2 7.0 13.2 10.1 4.7 5.5 10.1 20.9 21.7 22.9 9.3 8.7 6.7 21.3 21.1 20.7 4.0 12.7 9.0 6.0 8.8 22.5 6.5 9.8 82.3 9.1 7.7 19.5 18.5 16.7 5.1 20.5 7.7 6.5 4.8 23.1 8.2 16.1 16.0 9.5 6.2 7.7 22.6 23.4 6.9 34.4 34.6 19.8 17.0 21.8 21.0 19.9 22.4 23.4 24.0 11.3 31.6 41.0 15.1 35.2 10.2 21.5 17.7 25.4 21.2 13.1 32.3 12.2 24.0 19.4 32.4 12.6 11.9 16.9 29.1 20.9 16.7 8.1 38.7 24.4 16.3 15.8 9.7 40.1 49.0 22.2 59.9 9.0 29.2 30.3 45.2 27.4 14.2 22.0 24.9 14.0 35.4 58.1 53.1 13.2 14.6 11.5 33.5 18.8 24.2 29.3 20.0 71.9 45.4 15.6 19.0 46.4 4.2 1.3 0.3 1.5 1.2 1.8 1.9 2.1 2.2 3.2 1.7 1.6 1.5 0.8 1.7 1.7 2.0 1.3 2.9 20.7 21.5 20.0 32.9 20.9 21.7 21.3 21.1 20.7 22.5 20.5 23.1 22.6 40.5 16.0 25.0 13.1 33.2 44.7 24.2 16.9 39.3 48.0 62.8 54.1 43.6 28.6 15.1 57.0 120.9 45.3 27.2 75.0 138.9 27.4 48.9 29.3 83.5 38.7 15.6 62.9 16.7 31.7 66.9 30.5 7.1 31.3 7.0 16.7 28.2 72.4 91.6 26.9 11.5 49.6 24.4 34.7 80.2 6.8 22.1 60.1 51.6 10.3 36.6 50.4 25.7 7.5 13.4 29.2 91.3 27.1 80.7 60.2 161.6 238.5 11.2 293.7 19.7 20.7 34.5 13.1 52.4 47.3 57.4 86.2 21.0 31.0 37.5 31.1 LIMA1 EPLIN ENSG00000050405 "LIM domain and actin binding 1" Q9UHB6 12 50175788-50283546 "Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 553.9;Basal prostatic cells: 646.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 523.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023871, HPA052645" Enhanced Enhanced "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" NA NA 90000 "Plasma membrane, Actin filaments" "Focal adhesion sites, Cytosol" "HPA023871: AB_1852875, HPA052645: AB_2681898" "unprognostic (6.22e-2)" "unprognostic (9.39e-3)" "unprognostic (8.13e-2)" "unprognostic (1.42e-1)" "unprognostic (8.08e-2)" "prognostic unfavorable (1.76e-6)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (1.28e-3)" "unprognostic (6.27e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.12e-2)" "unprognostic (9.26e-3)" "unprognostic (1.46e-1)" "unprognostic (1.43e-1)" 113.2 47.5 13.2 40.3 14.8 4.2 90.2 40.2 15.5 56.6 15.3 126.8 113.2 57.3 33.5 37.4 48.3 69.9 29.0 13.0 15.1 45.7 20.9 63.0 32.9 16.4 16.5 12.3 38.9 31.3 31.3 24.2 51.1 26.3 46.1 131.8 32.5 47.6 42.6 22.1 47.6 122.8 49.0 15.1 41.2 97.6 16.3 14.9 38.4 33.5 28.5 34.1 97.6 53.7 17.7 154.3 4.5 47.2 69.7 211.9 211.0 177.7 377.2 264.4 296.9 235.8 57.7 220.2 6.8 34.1 523.4 99.7 170.8 42.8 348.7 258.1 98.1 45.1 64.2 16.2 20.5 135.3 23.2 87.5 142.2 100.8 104.6 297.8 89.0 106.2 28.3 45.6 30.3 96.9 26.5 29.0 7.1 24.3 81.0 20.5 28.7 115.2 2.4 68.7 180.3 35.2 75.4 51.5 102.7 166.6 50.0 49.0 14.1 166.7 126.5 98.0 118.4 62.1 16.5 2.0 28.0 137.6 25.3 55.6 0.2 0.2 1.5 6.6 1.1 2.6 0.2 8.2 8.1 4.9 0.6 3.3 6.0 0.1 5.9 2.7 1.2 15.3 3.0 13.2 14.8 40.2 15.5 13.0 15.1 16.4 16.5 12.3 26.3 15.1 14.9 17.7 123.2 44.8 91.2 13.4 4.8 553.9 646.1 175.4 283.4 14.6 62.2 73.0 7.3 61.5 179.1 119.5 160.6 128.1 15.5 413.7 15.6 145.6 67.1 75.7 183.9 91.8 122.8 17.5 12.9 307.6 376.9 170.9 126.9 132.6 24.7 15.9 117.8 19.8 34.4 6.7 30.1 138.0 187.2 11.7 59.3 11.7 75.5 19.3 90.7 41.2 9.9 22.7 28.8 78.9 48.4 219.0 244.5 77.5 6.9 221.6 214.8 22.3 67.8 95.4 65.7 54.9 118.0 30.8 10.4 100.0 291.5 64.0 33.3 62.4 244.3 385.1 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 31.5 27.2 20.5 11.8 21.4 22.5 30.2 20.0 24.4 19.8 24.3 24.5 36.4 19.6 24.0 13.3 32.7 17.3 19.0 21.6 21.5 33.0 40.6 17.8 18.4 21.3 20.0 19.5 36.9 37.4 32.7 19.5 13.8 22.3 19.1 28.6 21.1 27.8 19.6 23.8 19.6 24.7 20.0 20.2 16.7 24.7 13.4 20.1 22.6 37.6 28.1 20.9 17.2 15.6 21.7 19.1 16.7 12.7 33.5 54.9 89.9 12.6 19.4 31.7 19.9 22.2 41.2 38.6 50.2 23.4 20.9 14.2 34.7 25.8 26.1 22.6 18.3 32.4 36.5 23.6 32.8 36.1 32.8 25.6 75.4 82.3 23.7 55.5 60.4 20.3 47.7 38.1 35.4 27.5 29.5 23.2 33.1 8.4 23.6 45.2 19.5 15.0 27.4 25.2 28.3 37.3 16.7 14.7 32.2 45.4 12.4 51.1 29.2 15.6 12.8 13.4 20.9 11.2 32.2 53.8 21.6 23.1 21.1 9.1 3.7 9.6 3.9 10.1 10.8 15.1 15.0 17.0 12.8 9.3 9.2 20.5 19.1 3.0 12.6 16.2 8.3 17.0 12.5 20.5 21.4 20.0 24.4 21.6 21.5 21.3 20.0 19.5 22.3 20.2 20.1 21.7 27.0 22.4 29.5 41.1 38.8 49.6 40.0 51.9 66.0 20.9 66.2 64.8 12.6 35.8 20.5 23.9 10.4 49.6 31.7 20.3 92.0 17.2 9.3 23.6 22.2 26.2 27.7 35.5 22.6 32.7 23.3 32.9 31.6 18.4 25.4 29.7 25.7 19.1 30.3 18.5 26.5 36.0 28.5 56.3 35.7 17.0 32.6 27.9 39.2 13.1 31.5 31.8 23.7 16.1 25.4 15.6 26.8 30.5 29.5 26.0 87.0 65.7 25.1 18.9 26.3 33.5 31.8 20.5 26.0 44.2 44.3 27.9 38.8 55.4 52.7 26.6 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Metabolic proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.6;pituitary gland: 18.0;retina: 11.2;testis: 11.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 92.6;Cone photoreceptor cells: 179.3;Excitatory neurons: 115.0;Horizontal cells: 116.1;Inhibitory neurons: 127.8;Oligodendrocytes: 248.9;Spermatocytes: 91.9" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 21.0;HMC-1: 14.8;SCLC-21H: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 0.2 3.1 4.4 0.9 6.5 0.6 1.3 8.8 16.7 1.1 0.0 0.3 0.4 0.3 2.5 0.1 1.7 0.3 0.3 9.9 8.9 1.3 0.1 1.2 1.4 20.4 9.7 4.2 3.3 1.0 2.3 18.0 0.2 23.5 0.4 0.4 11.2 0.9 0.6 0.1 0.2 0.8 0.3 2.3 1.0 1.3 11.7 12.2 0.6 0.2 0.0 1.2 0.2 0.1 27.6 0.2 1.0 11.9 0.1 0.5 0.6 21.0 3.3 5.5 5.2 3.3 7.2 0.2 4.5 0.5 4.5 2.9 0.1 4.7 0.2 4.8 0.9 0.6 2.3 0.3 0.0 0.0 0.7 14.8 0.2 0.2 2.7 0.5 3.1 6.2 1.9 0.1 7.6 2.7 2.6 6.6 1.4 5.1 1.4 3.6 0.1 0.0 0.0 0.6 0.1 15.7 10.7 1.3 1.6 0.0 3.6 2.0 0.5 5.7 3.3 1.7 0.2 4.3 3.8 1.3 0.2 4.6 0.6 0.4 0.4 0.5 0.9 0.4 0.3 0.0 0.1 0.1 0.4 0.7 0.2 0.1 0.2 0.5 0.5 0.8 0.2 0.0 0.2 4.4 6.5 8.8 16.7 9.9 8.9 20.4 9.7 4.2 23.5 2.3 12.2 27.6 1.2 0.0 8.7 33.6 3.1 0.0 0.8 0.2 0.0 92.6 5.0 1.5 1.9 0.0 5.4 1.8 179.3 1.4 4.9 0.5 7.9 0.1 61.9 1.7 0.6 2.4 6.0 0.8 115.0 1.3 5.2 2.1 13.3 0.7 7.6 11.5 1.1 0.2 2.2 116.1 127.8 0.4 0.0 4.7 2.2 32.8 2.8 4.5 1.8 18.7 3.4 11.5 7.2 20.1 248.9 0.1 5.4 3.8 3.5 1.0 1.9 1.0 25.0 19.9 0.0 0.7 1.0 91.9 8.2 0.1 0.1 0.4 4.3 0.9 0.2 1.1 LAMC3 DKFZp434E202 ENSG00000050555 "Laminin subunit gamma 3" Q9Y6N6 9 131009174-131094473 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 49.1" "Group enriched" "Detected in many" 4 "Leydig cells: 118.4;Peritubular cells: 364.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;EFO-21: 17.3;Hep G2: 6.1;SiHa: 6.7;U-2 OS: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022814 Enhanced "Secreted to extracellular matrix" NA NA 1100000 "HPA022814: AB_2670960" "unprognostic (9.77e-2)" "unprognostic (1.90e-1)" "unprognostic (9.55e-3)" "unprognostic (2.09e-1)" "unprognostic (2.15e-1)" "unprognostic (1.22e-2)" "unprognostic (1.38e-2)" "unprognostic (2.28e-3)" "unprognostic (6.27e-2)" "unprognostic (1.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.38e-1)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (1.63e-1)" "unprognostic (3.34e-1)" "unprognostic (7.83e-2)" 1.1 13.6 1.3 0.3 1.9 0.0 1.6 1.3 3.8 20.5 4.0 0.9 0.4 3.3 3.5 1.7 1.2 2.7 0.8 1.4 1.4 9.2 5.0 23.5 0.0 1.5 1.4 0.7 1.7 3.5 0.9 11.7 49.1 1.4 4.2 0.1 0.0 1.5 3.8 0.3 8.0 0.3 0.3 1.3 11.4 0.5 19.2 1.5 0.2 1.2 1.1 0.0 15.1 8.2 1.6 0.0 0.5 4.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.5 6.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 2.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.4 0.1 6.7 0.0 2.6 0.4 0.0 0.7 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.3 1.9 1.3 3.8 1.4 1.4 1.5 1.4 0.7 1.4 1.3 1.5 1.6 1.5 0.0 0.0 1.0 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.4 1.3 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.1 1.9 1.6 48.5 1.7 0.0 0.0 1.7 0.0 0.8 20.7 0.0 1.1 0.0 27.8 3.6 0.1 1.5 0.0 4.1 0.2 0.0 0.0 10.2 12.6 118.4 0.5 10.6 36.5 0.1 0.0 0.0 0.0 1.0 0.1 0.0 364.1 0.0 0.2 0.0 0.2 0.0 0.0 46.0 0.1 10.0 1.0 3.5 0.0 4.4 1.0 0.8 38.1 0.0 0.1 PTGER3 "EP3, lnc003875" ENSG00000050628 "Prostaglandin E receptor 3" P43115 1 70852353-71047808 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 55.0;endometrium 1: 96.0;kidney: 81.9;smooth muscle: 68.6" "Group enriched" "Detected in many" 7 "Distal tubular cells: 225.0;Langerhans cells: 79.8" "Group enriched" "Detected in some" 7 "breast cancer: 4.1;renal cancer: 9.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 59 "basophil: 43.3" "Lineage enriched" "Detected in single" 59 "granulocytes: 43.3" "Cell line enhanced" "Detected in some" "ASC diff: 28.6;HAP1: 20.9;HDLM-2: 32.8;HEL: 15.6;T-47d: 72.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010689 Uncertain NA NA "HPA010689: AB_1855883" "unprognostic (1.53e-3)" "unprognostic (3.48e-1)" "unprognostic (1.11e-1)" "unprognostic (3.86e-3)" "unprognostic (1.47e-1)" "unprognostic (3.37e-2)" "unprognostic (4.80e-2)" "unprognostic (2.01e-2)" "unprognostic (1.24e-1)" "unprognostic (4.64e-3)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (8.83e-3)" "unprognostic (1.86e-1)" "unprognostic (1.92e-2)" "unprognostic (1.41e-4)" 55.0 6.7 7.4 5.0 4.8 0.2 28.9 0.0 6.1 4.7 8.7 11.1 1.2 96.0 3.7 3.9 10.2 9.0 1.6 4.6 8.1 81.9 0.3 1.1 1.3 6.0 0.7 7.7 1.7 6.7 0.9 0.6 0.6 3.4 3.1 2.4 0.7 12.0 8.0 0.5 12.6 3.8 68.6 1.8 0.3 22.6 1.0 3.3 0.9 1.1 1.4 1.4 6.7 6.1 1.7 0.0 0.0 0.0 0.0 28.6 0.7 0.1 0.7 0.0 0.1 0.7 0.0 0.0 0.0 0.0 3.5 0.0 0.0 20.9 0.0 0.1 32.8 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.1 0.0 0.3 0.0 0.2 72.5 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.1 7.2 0.0 43.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 7.4 4.8 0.0 6.1 4.6 8.1 6.0 0.7 7.7 3.4 1.8 3.3 1.7 6.9 0.0 0.5 0.0 0.0 5.0 0.2 0.0 0.0 1.6 13.7 6.1 1.8 1.5 0.0 20.2 0.0 0.0 0.2 0.4 225.0 3.0 1.6 0.6 4.6 1.7 2.4 0.0 2.2 0.0 2.4 12.2 1.5 1.2 9.5 0.0 0.7 0.0 0.1 3.3 3.4 1.0 12.2 0.0 79.8 1.0 1.2 3.2 8.8 0.0 0.6 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.1 1.3 0.1 7.2 0.0 0.2 6.6 0.5 11.7 0.1 0.1 0.1 7.5 0.1 1.2 6.2 0.0 0.2 TNIP3 "ABIN-3, FLJ21162, LIND" ENSG00000050730 "TNFAIP3 interacting protein 3" Q96KP6 4 121131408-121227466 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.5;urinary bladder: 4.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 21.7;Distal enterocytes: 19.1;Early spermatids: 13.8;Late spermatids: 46.2;T-cells: 17.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 6.2" "Lineage enriched" "Detected in single" 10 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;hTEC/SVTERT24-B: 8.0;U-138 MG: 30.9;U-266/70: 8.8;U-266/84: 9.3;U-87 MG: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043063 Uncertain NA NA "HPA043063: AB_10793989" "unprognostic (2.89e-3)" "unprognostic (2.60e-1)" "unprognostic (5.23e-3)" "unprognostic (8.75e-5)" "unprognostic (9.62e-3)" "unprognostic (2.14e-2)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (2.80e-1)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.35e-2)" "unprognostic (2.84e-7)" "unprognostic (3.35e-2)" "unprognostic (6.51e-2)" "unprognostic (3.51e-1)" "unprognostic (8.78e-2)" 0.3 0.1 0.4 6.5 0.6 1.1 0.1 0.4 0.9 1.3 0.2 0.5 0.6 0.2 0.1 0.4 0.1 1.1 0.1 1.0 0.5 0.2 0.4 1.6 2.6 1.7 1.2 0.5 0.1 0.2 0.0 0.0 0.0 2.3 0.1 0.4 0.9 0.7 0.0 0.5 0.2 0.9 0.5 0.2 0.9 0.7 0.6 0.4 1.9 0.1 0.0 3.3 4.2 0.1 1.5 0.0 0.2 0.1 0.1 0.0 0.3 0.1 0.4 0.5 0.1 0.1 1.1 0.1 0.1 0.2 2.8 4.6 0.0 0.0 0.7 0.9 7.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 8.0 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.1 30.9 0.6 2.5 0.1 8.8 9.3 0.2 6.3 0.3 1.0 0.6 0.1 0.0 2.5 0.0 1.8 0.0 1.1 6.2 0.0 0.1 0.5 2.8 0.3 0.0 0.1 0.0 0.7 0.6 0.4 0.6 0.4 0.9 1.0 0.5 1.7 1.2 0.5 2.3 0.2 0.4 1.5 0.2 3.2 21.7 0.7 1.8 0.1 0.2 5.7 0.0 0.0 0.4 0.1 0.6 0.0 4.9 0.0 6.2 0.0 2.4 19.1 0.0 0.2 13.8 0.0 0.1 1.4 0.0 0.0 1.5 1.1 0.0 0.3 2.0 0.2 7.0 0.0 0.0 0.0 0.3 0.0 0.4 0.5 4.1 0.8 2.7 46.2 0.3 9.5 0.0 0.0 0.1 0.3 2.1 0.5 0.1 0.7 3.7 0.0 2.4 0.1 0.0 0.1 1.7 1.3 0.0 0.7 1.1 0.4 0.4 0.0 0.4 0.0 17.8 0.0 9.8 0.1 MAPK9 "JNK2, p54a, PRKM9, SAPK" ENSG00000050748 "Mitogen-activated protein kinase 9" P45984 5 180233143-180292099 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 16.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.3" "Cell line enhanced" "Detected in all" "HDLM-2: 211.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008910, HPA072462" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nuclear speckles" "CAB008910: , HPA072462: " "unprognostic (5.04e-3)" "unprognostic (2.06e-2)" "prognostic favorable (1.11e-4)" "unprognostic (8.53e-2)" "unprognostic (1.75e-1)" "unprognostic (5.06e-3)" "unprognostic (6.83e-3)" "unprognostic (3.16e-1)" "unprognostic (4.93e-2)" "unprognostic (3.76e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "unprognostic (2.13e-1)" "unprognostic (2.29e-1)" "unprognostic (9.38e-3)" "unprognostic (2.40e-1)" 19.5 21.3 24.1 18.5 34.8 21.5 17.7 39.9 42.8 17.8 10.4 22.6 18.6 15.4 16.4 15.6 15.4 14.1 26.0 33.4 35.7 21.3 17.8 19.7 20.0 26.3 26.5 30.2 14.7 46.1 30.4 13.0 19.9 29.1 20.2 26.6 21.6 19.3 21.8 41.2 11.8 19.5 20.1 21.0 16.8 22.7 18.0 27.4 22.7 27.0 35.1 21.2 17.5 11.2 42.8 52.7 42.7 37.0 46.5 35.7 39.3 79.4 49.6 43.5 40.5 40.5 56.4 36.7 55.9 83.1 52.6 89.3 39.6 38.4 82.8 47.5 211.8 36.9 23.2 46.8 40.3 27.1 49.0 39.2 29.3 36.5 39.5 38.0 42.5 48.9 43.0 26.2 39.5 55.9 68.9 49.2 20.4 25.8 64.8 25.0 46.9 62.7 26.9 30.8 49.7 42.5 29.9 58.2 55.8 40.4 45.8 56.9 41.7 35.5 48.3 49.2 69.3 75.2 28.2 35.6 37.9 51.5 44.8 32.9 16.3 0.5 2.2 1.6 1.1 1.6 0.8 1.2 1.4 0.8 1.3 0.8 0.9 0.7 1.2 2.3 1.2 2.7 0.3 24.1 34.8 39.9 42.8 33.4 35.7 26.3 26.5 30.2 29.1 21.0 27.4 42.8 20.5 32.1 14.4 26.1 10.5 10.1 7.0 6.5 9.1 21.9 16.8 12.2 27.6 12.8 8.5 9.2 16.7 15.3 20.5 20.7 5.9 8.0 1.2 17.6 14.2 12.2 16.7 9.5 62.5 16.0 23.3 11.1 15.8 18.6 11.4 14.5 12.5 16.7 11.7 13.5 64.3 17.9 4.1 24.2 20.5 3.1 10.5 15.0 5.4 31.9 13.9 11.4 15.5 25.1 32.9 13.1 12.3 13.5 15.6 10.2 13.4 11.0 6.9 14.8 13.1 13.5 13.7 17.0 17.1 9.4 11.4 17.8 14.7 8.2 15.4 8.8 COL23A1 DKFZp434K0621 ENSG00000050767 "Collagen type XXIII alpha 1 chain" Q86Y22 5 178237476-178590393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "thyroid gland: 79.2" "Cell type enhanced" "Detected in many" "Astrocytes: 20.2;Cardiomyocytes: 11.3;Excitatory neurons: 21.8;Muller glia cells: 62.6" "Group enriched" "Detected in many" 4 "renal cancer: 41.3;testis cancer: 16.0;thyroid cancer: 14.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 8.4;NB-4: 9.6;THP-1: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067824 Uncertain NA NA "HPA067824: AB_2685907" "unprognostic (5.24e-2)" "unprognostic (2.65e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (3.04e-1)" "unprognostic (8.67e-3)" "unprognostic (1.14e-1)" "unprognostic (3.62e-1)" "unprognostic (2.12e-1)" "unprognostic (3.52e-2)" "unprognostic (3.96e-2)" "unprognostic (5.93e-3)" "unprognostic (8.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.90e-2)" "unprognostic (2.11e-3)" "unprognostic (2.37e-1)" 1.1 1.2 0.6 0.0 0.8 1.8 2.4 1.3 1.1 3.1 0.0 2.2 1.0 1.5 0.0 1.3 2.0 0.1 14.1 0.2 0.2 4.5 1.6 2.5 0.1 1.2 0.4 0.3 0.3 0.4 0.8 1.6 0.0 1.0 8.9 0.1 2.1 2.0 1.4 2.1 7.6 5.6 0.0 0.1 2.1 2.8 5.2 0.8 0.0 79.2 0.0 0.1 0.7 3.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 9.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.3 1.1 0.2 0.2 1.2 0.4 0.3 1.0 0.1 0.8 0.3 1.8 0.0 0.0 20.2 0.0 2.2 4.2 0.4 1.2 1.0 0.2 3.2 11.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.3 6.3 2.2 0.0 0.0 21.8 0.0 0.4 3.7 0.0 0.7 0.0 0.6 2.2 0.1 0.5 0.0 9.1 0.0 0.0 2.1 5.0 0.4 0.3 1.8 0.0 4.7 0.1 62.6 0.0 1.0 2.2 0.1 0.0 2.6 0.0 1.9 0.0 0.6 0.0 3.4 6.6 0.1 4.8 1.4 2.5 0.1 4.7 0.1 0.5 0.1 0.0 0.2 BCAR1 "CAS, CASS1, Crkas, P130Cas" ENSG00000050820 "BCAR1 scaffold protein, Cas family member" P56945 16 75228181-75268053 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000443, HPA042282" Approved Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB000443: , HPA042282: AB_2677929" "unprognostic (5.44e-2)" "unprognostic (2.96e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-2)" "unprognostic (2.17e-1)" "unprognostic (5.43e-3)" "prognostic unfavorable (9.11e-5)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.15e-1)" "unprognostic (3.49e-2)" "unprognostic (5.18e-2)" "unprognostic (1.77e-2)" "prognostic favorable (4.55e-8)" "unprognostic (3.38e-1)" "unprognostic (3.60e-2)" "unprognostic (8.20e-2)" "unprognostic (2.20e-1)" 33.2 22.4 2.7 4.2 3.4 0.0 28.2 12.6 6.6 34.7 4.1 30.4 16.0 39.5 2.6 22.7 25.5 9.5 44.1 2.8 2.6 47.5 34.5 39.2 2.2 3.8 1.1 0.5 19.9 32.7 5.9 29.7 14.2 2.7 25.8 3.6 1.3 25.7 5.7 94.5 17.4 33.3 3.8 0.0 33.9 45.0 34.6 1.8 0.9 27.0 6.9 1.1 25.1 26.4 14.3 21.8 36.8 17.5 6.0 6.7 6.3 34.1 29.5 17.1 20.9 16.4 46.5 32.1 1.9 38.2 33.3 23.6 18.2 6.1 34.0 6.0 0.1 20.0 0.0 23.7 37.2 16.7 0.1 15.1 19.1 16.3 25.3 12.5 12.3 57.9 0.0 20.0 1.0 12.6 48.9 0.1 1.3 23.4 16.1 24.0 0.8 7.9 8.2 19.1 27.9 21.4 31.5 28.7 6.6 11.2 8.4 15.0 5.4 53.6 34.4 29.5 8.8 44.2 8.0 4.7 0.7 22.2 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 12.6 6.6 2.8 2.6 3.8 1.1 0.5 2.7 0.0 1.8 14.3 30.1 22.4 6.9 9.4 1.2 28.0 59.7 36.8 12.0 26.5 20.3 14.4 22.9 31.5 21.8 22.0 6.2 46.8 0.7 75.7 27.4 51.9 19.0 13.7 27.9 49.2 34.8 0.0 13.1 61.8 25.7 21.1 71.9 22.5 8.9 15.0 46.8 21.0 6.0 13.5 11.7 42.1 12.2 1.4 6.3 26.8 16.4 2.1 32.0 10.3 0.6 12.9 0.0 19.1 31.2 68.5 59.6 33.4 1.4 58.4 57.4 38.9 13.1 6.8 19.7 8.5 38.5 20.6 17.1 12.5 17.6 36.1 2.2 10.9 33.7 62.7 FAM160A2 "C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759" ENSG00000051009 "Family with sequence similarity 160 member A2" Q8N612 11 6211345-6234711 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055994, HPA063987" Approved Approved Mitochondria NA NA Mitochondria "HPA055994: AB_2682999, HPA063987: AB_2685166" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-2)" "unprognostic (9.59e-3)" "unprognostic (2.20e-2)" "unprognostic (1.51e-1)" "unprognostic (4.16e-2)" "unprognostic (2.64e-1)" "unprognostic (2.19e-1)" "unprognostic (5.02e-2)" "unprognostic (2.16e-1)" "unprognostic (8.04e-2)" "unprognostic (6.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (9.58e-2)" "unprognostic (1.85e-1)" 16.1 14.6 5.3 14.3 6.1 42.6 18.3 6.5 7.3 19.6 7.9 25.0 34.4 21.8 9.6 13.3 20.4 18.0 12.5 5.8 4.2 13.8 21.0 16.2 13.4 3.6 3.7 6.3 21.4 25.0 16.4 15.0 12.2 4.2 15.9 27.9 9.7 18.8 14.8 14.1 22.7 34.0 15.9 2.6 14.3 19.1 27.4 3.7 11.4 22.9 10.6 9.0 16.6 16.7 5.4 13.5 13.1 9.0 13.4 11.9 12.8 19.5 7.6 9.1 11.1 10.6 11.2 24.4 10.5 8.2 8.9 18.3 17.4 9.2 13.8 6.7 11.6 13.1 3.6 24.1 6.0 9.8 8.9 11.6 11.7 17.0 10.0 17.7 14.5 11.4 16.2 11.5 12.7 7.0 10.7 8.5 17.0 13.4 17.5 12.2 9.3 4.7 8.6 10.4 9.6 12.0 7.9 10.9 12.7 6.9 9.3 8.7 12.4 9.8 13.6 10.4 20.4 8.1 17.0 15.7 8.1 15.0 7.0 12.3 1.3 3.1 3.4 3.0 1.3 1.8 1.3 1.2 2.2 2.0 1.3 0.9 1.6 3.3 1.1 1.0 0.6 0.2 2.0 5.3 6.1 6.5 7.3 5.8 4.2 3.6 3.7 6.3 4.2 2.6 3.7 5.4 19.0 19.2 16.2 28.1 10.1 12.5 11.1 12.5 10.8 12.6 17.8 12.3 4.5 14.3 12.2 12.9 16.7 13.5 15.9 76.8 7.9 11.4 24.2 15.6 10.1 15.2 25.0 18.5 21.3 11.3 10.1 12.9 33.6 11.2 7.0 27.6 9.3 23.7 9.6 6.7 15.8 37.9 16.2 17.6 28.5 6.5 9.9 12.3 14.2 11.2 16.9 7.6 37.0 14.1 15.6 17.6 47.8 7.5 8.3 10.8 65.0 8.8 18.6 24.4 13.1 10.6 11.6 38.5 21.7 8.5 14.9 11.5 14.7 21.9 39.5 10.4 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932142-56944864 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 2680.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 497.6;U-266/70: 533.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 72.8 109.3 71.8 102.9 74.3 114.6 130.2 76.0 93.4 128.2 95.9 150.9 99.1 66.3 222.1 53.6 87.2 78.5 92.9 70.2 87.2 194.9 194.6 92.8 115.1 80.7 74.1 63.9 190.5 380.2 208.7 79.5 97.9 76.6 214.9 143.1 40.0 171.5 102.9 103.8 57.2 85.6 78.4 82.2 115.7 145.4 25.2 79.2 58.5 215.5 122.0 248.7 95.4 45.3 84.8 28.6 30.9 29.8 61.8 66.9 86.9 105.2 65.9 104.6 83.5 64.9 43.1 63.5 115.0 82.7 64.6 84.6 47.9 51.0 23.3 82.4 67.1 30.8 9.9 48.3 156.3 364.6 21.1 49.5 106.0 219.2 38.0 119.6 100.4 64.4 125.9 15.9 159.6 236.3 24.1 39.8 42.7 19.1 164.8 68.9 27.0 74.9 497.6 179.8 31.8 32.7 37.5 57.5 278.8 308.2 41.9 31.3 77.4 40.0 34.8 34.4 30.8 26.8 533.9 191.0 182.6 49.3 28.7 46.4 224.0 291.2 139.5 113.2 238.1 124.0 383.2 120.1 149.7 230.6 340.4 77.2 117.8 215.9 179.6 175.0 915.5 263.8 417.7 71.8 74.3 76.0 93.4 70.2 87.2 80.7 74.1 63.9 76.6 82.2 79.2 84.8 316.4 70.5 105.9 16.6 964.5 364.0 561.8 316.3 203.7 134.6 191.3 185.2 221.5 91.5 193.4 71.7 281.5 131.9 577.3 369.1 170.2 192.7 73.3 162.5 121.3 199.8 434.4 40.8 29.9 197.7 182.4 223.8 251.8 260.5 151.8 108.8 134.2 164.0 194.7 47.1 32.2 569.7 290.9 241.6 395.9 251.6 104.1 507.7 948.0 88.1 197.0 94.3 81.4 21.1 30.7 144.8 336.5 95.5 2680.7 447.4 156.1 209.0 95.6 117.1 98.6 178.8 215.6 54.7 10.6 146.6 255.3 693.8 342.6 137.4 311.4 456.8 HOMER3 HOMER-3 ENSG00000051128 "Homer scaffold protein 3" Q9NSC5 19 18929201-18941261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 126.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 76.4;Muller glia cells: 72.6;Proximal tubular cells: 84.2;Theca cells: 322.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 15.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 353.6;THP-1: 420.0;U-266/84: 375.4" "Region enriched" "Detected in all" 6 "cerebellum: 189.2" "Low region specificity" "Detected in all" "CAB032656, HPA040999, CAB079015" Enhanced Supported Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242" "unprognostic (3.41e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.24e-5)" "unprognostic (1.19e-1)" "unprognostic (2.06e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.07e-1)" "unprognostic (8.88e-2)" "unprognostic (5.78e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (5.99e-2)" "unprognostic (3.76e-2)" "unprognostic (2.33e-1)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" 30.6 29.8 30.8 9.9 38.1 22.5 26.4 75.1 40.3 31.3 43.3 22.4 7.0 24.8 6.4 15.4 16.9 16.6 24.3 37.2 35.8 52.6 6.1 25.8 7.9 41.5 39.6 23.9 20.3 12.5 37.8 8.7 14.8 45.4 22.1 6.1 5.9 27.9 9.5 115.5 34.9 14.5 10.7 39.2 126.1 17.2 9.3 38.1 7.5 49.7 18.8 3.9 30.0 26.2 45.1 112.1 28.5 53.1 44.4 48.3 48.6 26.2 108.1 94.9 106.4 53.4 14.6 41.8 0.9 49.9 122.1 76.1 68.6 18.4 140.4 58.9 4.0 11.0 0.1 9.7 27.5 44.9 21.5 1.7 39.3 89.4 59.0 79.1 113.0 130.3 7.9 3.2 28.6 78.1 30.3 1.9 353.6 27.3 6.1 115.5 55.2 16.2 53.4 38.2 28.3 0.2 44.8 26.6 31.2 78.5 10.2 14.0 420.0 105.3 94.0 42.0 114.5 132.2 274.2 375.4 93.6 148.0 270.6 69.8 0.1 15.0 2.9 0.1 5.3 0.0 2.3 0.8 0.3 1.3 2.7 0.1 0.0 5.8 0.0 1.6 0.2 0.8 4.2 30.8 38.1 75.1 40.3 37.2 35.8 41.5 39.6 23.9 45.4 39.2 38.1 45.1 21.7 3.2 0.0 9.4 9.3 11.9 22.4 24.4 6.8 2.2 14.3 22.5 4.1 2.8 8.0 12.9 0.0 1.0 0.6 0.1 11.7 22.9 2.0 4.3 18.7 38.0 1.8 0.4 0.3 13.6 2.4 20.5 0.0 6.3 10.2 34.8 21.8 0.7 76.4 1.7 3.9 0.9 22.4 16.2 7.6 1.7 13.7 32.2 12.4 1.9 8.3 72.6 0.0 1.0 13.4 42.0 0.0 10.9 13.8 25.2 0.0 84.2 3.6 4.1 0.0 14.4 27.8 4.7 6.7 4.2 14.5 1.1 2.5 322.4 0.3 21.4 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732340 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.8;testis: 24.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3" "Cancer enhanced" "Detected in all" "testis cancer: 19.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010381, HPA039310" Enhanced Supported "Nucleoli rim,Cytosol" NA Yes "Nucleoli rim" Cytosol "CAB010381: AB_2253533, HPA039310: AB_2676434" "prognostic unfavorable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 0.9 0.6 0.4 5.6 0.5 10.6 2.0 1.6 0.8 0.8 0.5 8.4 3.3 1.2 0.4 4.2 0.7 1.3 0.6 0.4 0.3 0.5 1.3 1.2 11.1 0.4 0.4 0.5 0.6 1.4 0.5 0.2 6.9 0.7 0.8 9.1 0.3 1.0 0.3 1.0 3.1 4.1 2.4 0.2 2.4 1.8 24.5 0.3 15.8 0.6 0.5 13.4 1.8 1.5 0.5 33.8 16.1 33.4 16.3 4.4 7.8 31.1 54.9 16.5 43.3 43.8 35.4 22.1 20.4 26.8 20.9 18.9 67.7 56.6 22.1 42.3 39.0 22.2 47.7 28.2 30.4 0.4 37.9 28.5 1.7 2.9 30.0 13.5 6.4 22.5 48.5 59.6 55.8 36.6 28.5 54.4 43.6 35.2 69.2 19.0 61.0 49.0 30.7 15.4 45.3 15.4 27.0 23.6 41.4 8.5 39.2 27.0 39.4 9.9 32.8 22.2 48.7 27.2 12.0 65.1 59.8 16.3 78.0 33.5 1.3 0.6 1.7 2.4 1.3 0.6 1.7 2.5 3.2 1.0 1.1 0.6 1.2 1.2 1.8 1.4 0.9 5.9 1.2 0.4 0.5 1.6 0.8 0.4 0.3 0.4 0.4 0.5 0.7 0.2 0.3 0.5 0.0 0.0 0.0 0.3 1.9 3.6 1.5 2.0 0.0 0.8 0.1 0.0 0.9 0.0 1.0 0.0 0.0 35.3 1.4 3.0 0.0 0.0 5.7 0.2 0.2 1.0 0.0 16.0 1.6 0.0 67.2 1.3 2.0 0.2 0.0 0.6 2.2 0.2 12.7 0.0 1.2 5.3 2.0 1.6 1.7 5.3 0.6 0.5 0.0 1.0 0.3 0.3 2.1 0.5 0.6 0.1 5.0 0.7 8.2 0.9 1.0 0.0 0.1 0.0 0.0 0.5 0.9 53.6 24.8 3.9 1.6 25.3 1.2 0.1 8.0 2.1 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.5" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.1 0.2 0.0 1.6 0.1 6.0 0.4 1.0 0.3 0.1 0.0 1.3 1.2 0.2 0.0 2.0 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 2.0 0.0 0.3 0.0 0.0 1.4 0.9 0.4 0.0 0.8 0.5 2.2 0.0 4.5 0.0 0.0 2.3 0.3 0.5 0.2 18.2 12.1 10.2 7.2 0.9 1.2 9.2 8.5 3.2 9.7 12.9 9.8 6.6 21.5 3.7 4.6 11.7 14.0 12.2 5.4 16.4 6.3 6.7 13.8 8.0 6.1 0.1 15.1 12.1 0.2 0.4 8.9 5.4 1.7 4.9 7.9 9.3 15.9 10.3 7.1 13.7 8.8 9.7 5.5 5.9 11.4 12.2 7.6 3.1 10.3 5.5 5.0 9.8 5.2 3.4 8.8 4.8 14.8 3.8 8.6 11.2 3.4 11.1 8.0 6.9 21.8 4.1 11.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.3 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.5 1.6 0.7 0.9 0.5 0.6 0.0 0.9 0.6 0.6 1.6 0.0 2.0 0.0 0.0 3.1 0.6 1.6 0.0 0.1 0.4 0.9 1.0 0.5 0.0 16.4 9.5 0.0 3.3 1.2 4.6 1.0 0.0 12.6 0.0 0.2 2.3 0.0 7.8 1.6 2.0 1.3 1.2 0.7 0.3 1.7 0.0 1.0 0.6 0.4 0.0 1.5 1.3 0.2 1.2 0.0 12.2 0.5 0.2 0.1 2.4 0.2 0.0 0.1 1.0 6.8 3.4 4.9 0.1 0.3 1.8 0.9 3.2 0.8 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652698-138834928 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 115.2;HMC-1: 185.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Yes No Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212" "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 11.7 7.5 2.6 12.5 4.5 24.0 12.0 8.4 8.2 12.5 11.9 18.0 18.0 8.3 7.1 18.1 12.2 10.4 15.9 5.0 5.9 26.7 11.1 11.3 12.4 4.8 3.2 2.9 9.3 22.5 19.5 2.7 18.8 6.1 15.1 18.3 23.2 20.0 12.1 19.7 23.9 18.0 9.1 2.9 10.9 13.1 8.1 4.1 17.1 43.6 13.3 13.3 10.0 5.4 7.9 64.1 21.9 11.7 9.4 10.6 13.0 79.2 14.2 14.5 15.1 16.7 26.0 25.2 25.0 38.0 13.7 29.1 27.5 15.1 24.1 27.3 31.8 12.5 115.2 14.8 17.3 11.8 30.1 185.1 12.4 17.6 10.2 21.9 26.4 21.5 12.3 43.0 19.0 18.1 28.6 17.8 20.7 16.6 49.2 19.5 11.5 12.2 19.6 24.5 35.5 9.8 7.4 37.6 18.0 56.2 34.7 44.8 73.0 20.3 8.4 11.7 21.2 21.1 30.3 22.1 23.7 22.8 27.7 14.0 4.4 5.1 6.9 2.4 2.8 1.6 2.8 2.8 1.8 5.9 2.6 3.5 2.4 6.4 0.8 2.8 1.0 1.5 2.0 2.6 4.5 8.4 8.2 5.0 5.9 4.8 3.2 2.9 6.1 2.9 4.1 7.9 19.7 9.6 21.3 40.1 12.1 19.1 18.7 12.5 14.2 16.2 13.1 7.7 37.3 12.8 18.3 18.4 25.0 35.5 6.9 30.3 5.9 11.1 1.1 18.3 4.0 13.9 16.3 8.0 96.5 19.4 61.1 7.3 21.4 18.8 14.5 6.7 9.7 19.1 14.4 21.9 92.4 17.1 4.1 33.3 23.1 1.7 3.7 28.1 7.2 37.5 29.5 8.9 11.3 48.2 88.2 20.0 25.9 6.8 10.2 25.8 21.9 23.4 17.4 19.5 6.6 8.6 5.9 16.0 19.9 22.1 23.3 47.9 11.6 4.2 15.1 17.5 CYBA p22-PHOX ENSG00000051523 "Cytochrome b-245 alpha chain" P13498 16 88643289-88651054 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport" Oxidoreductase "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 748.6;lymphoid tissue: 698.7" "Cell type enhanced" "Detected in many" "dendritic cells: 1632.1;Hofbauer cells: 2171.9;Kupffer cells: 1734.2;Macrophages: 1682.8;monocytes: 1688.5;NK-cells: 1805.4;Plasma cells: 1990.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 733.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 1058.3;RPMI-8226: 1631.2;THP-1: 1231.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009492 Enhanced NA NA "CAB009492: AB_2090309" "prognostic favorable (8.19e-4)" "unprognostic (1.05e-1)" "unprognostic (8.32e-2)" "prognostic favorable (4.75e-5)" "unprognostic (2.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.88e-2)" "unprognostic (9.16e-2)" "unprognostic (1.72e-1)" "unprognostic (1.11e-1)" "unprognostic (3.08e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.91e-1)" "unprognostic (5.22e-2)" "unprognostic (2.57e-2)" "unprognostic (1.63e-2)" 127.3 68.6 36.3 347.6 50.1 748.6 94.1 45.8 58.5 76.3 66.6 186.7 198.4 61.3 38.8 81.6 96.2 123.6 79.9 34.8 72.3 186.3 72.1 236.6 336.6 64.3 44.2 26.7 40.3 109.5 13.5 40.9 55.3 59.0 75.8 80.7 1.8 117.7 26.8 42.2 39.7 247.3 51.8 64.7 698.7 238.0 10.5 66.6 87.9 137.6 20.0 194.4 146.0 74.7 73.1 2.5 663.0 2.6 1.5 1.3 0.4 329.5 155.7 77.3 39.3 24.1 447.2 819.6 510.5 420.7 56.4 0.0 250.5 21.4 0.9 5.8 146.1 564.1 99.0 217.7 694.9 75.7 156.3 397.6 80.7 0.0 1.6 0.3 1.9 23.9 103.6 278.5 567.5 3.2 1058.3 147.9 822.3 106.2 248.7 1.5 437.9 1.6 1631.2 324.9 490.9 84.2 76.5 482.7 78.8 138.5 60.8 1.4 1231.3 129.8 1.5 6.1 1.8 2.2 362.9 459.9 543.6 195.5 464.9 53.4 120.2 103.8 733.7 76.7 150.1 55.8 109.8 36.7 70.4 107.0 110.7 28.9 36.7 192.3 36.4 143.3 196.3 41.2 47.3 36.3 50.1 45.8 58.5 34.8 72.3 64.3 44.2 26.7 59.0 64.7 66.6 73.1 157.8 16.0 12.4 0.0 1290.9 119.4 233.4 420.8 53.5 0.4 131.7 133.2 12.8 368.9 487.1 285.1 2.1 45.3 1632.1 807.2 127.2 636.8 4.2 219.5 137.5 137.1 230.5 162.7 0.2 155.3 299.0 184.8 285.4 312.5 279.0 104.3 317.0 23.9 2171.9 0.0 0.2 540.3 233.9 1734.2 1370.8 14.0 50.1 1682.8 1152.6 32.8 1688.5 1.6 1805.4 1.0 0.2 682.8 1045.8 21.4 1990.6 191.8 390.4 1057.4 529.7 2.7 59.2 44.0 164.3 0.9 15.6 75.2 85.7 118.2 838.6 20.5 805.2 436.9 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 132.1;Early spermatids: 187.0;Squamous epithelial cells: 226.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009, HPA045071" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 11.8 14.6 25.2 11.5 18.8 35.4 21.6 26.4 44.0 18.3 20.9 27.2 12.6 13.6 63.7 83.6 15.2 8.1 9.1 42.3 19.2 16.5 22.3 12.1 29.3 18.5 17.1 22.3 18.9 15.4 10.1 16.0 17.6 19.5 14.7 21.3 12.2 22.6 15.1 12.8 26.7 16.4 12.3 17.3 17.9 17.6 51.7 18.0 39.6 20.7 17.8 45.9 17.6 33.7 22.2 82.1 44.7 47.0 102.7 44.1 39.3 168.0 48.4 44.6 104.5 120.4 63.5 65.2 105.6 68.3 27.9 112.6 69.2 71.6 206.0 109.7 73.5 103.3 57.3 46.2 70.7 14.6 94.6 49.2 33.3 85.9 90.0 45.2 23.3 58.3 98.0 88.1 46.5 66.9 98.7 64.0 57.9 40.1 82.3 160.3 110.7 59.3 110.4 75.2 60.7 89.5 51.4 100.0 48.5 52.5 67.4 55.3 86.1 45.1 35.9 40.8 55.6 88.2 23.2 44.1 64.4 26.7 90.1 28.5 16.5 26.9 15.1 39.3 33.5 48.4 49.6 81.7 48.9 43.1 70.6 99.7 62.4 3.9 42.3 31.5 39.8 133.6 59.1 25.2 18.8 26.4 44.0 42.3 19.2 18.5 17.1 22.3 19.5 17.3 18.0 22.2 14.9 12.8 8.6 2.0 35.8 44.5 34.1 64.5 132.1 12.3 17.7 18.0 4.0 10.0 24.4 25.8 10.4 40.8 25.1 8.1 41.1 25.1 187.0 50.2 18.4 16.1 16.8 63.9 5.2 19.2 84.3 15.2 26.5 44.9 12.0 18.8 13.9 20.3 24.6 6.7 3.7 16.3 26.4 13.2 14.9 122.0 14.6 14.3 8.8 1.9 15.4 8.9 27.8 4.5 2.0 21.9 11.6 19.2 55.9 18.4 10.4 46.8 15.8 12.0 19.7 10.6 22.8 107.9 48.3 226.5 40.9 20.0 33.3 25.0 27.7 31.1 HEBP2 "C6orf34, SOUL" ENSG00000051620 "Heme binding protein 2" Q9Y5Z4 6 138403531-138422197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 678.8;Urothelial cells: 1174.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 219.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016928 Approved NA NA 690000 "HPA016928: AB_1850572" "unprognostic (8.53e-2)" "unprognostic (1.54e-1)" "unprognostic (7.92e-2)" "unprognostic (6.88e-2)" "unprognostic (7.96e-2)" "unprognostic (1.48e-1)" "unprognostic (5.60e-2)" "unprognostic (1.62e-2)" "unprognostic (1.50e-1)" "unprognostic (2.48e-1)" "unprognostic (3.49e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (2.47e-5)" "unprognostic (2.76e-3)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "prognostic favorable (3.07e-4)" 167.7 34.7 13.1 15.1 13.5 32.0 148.6 12.8 13.9 38.6 14.3 48.0 22.1 35.5 28.2 132.2 30.7 12.9 67.4 10.0 14.4 37.9 72.9 26.7 7.0 12.7 15.8 8.9 28.1 37.5 14.7 27.4 13.4 13.5 53.1 19.4 10.2 72.8 10.6 134.1 80.8 33.0 13.4 12.9 17.8 54.7 7.6 20.4 8.7 27.3 33.8 12.4 51.9 82.2 13.9 42.8 8.6 13.6 45.4 42.5 17.1 88.2 45.7 12.8 6.0 9.9 23.2 28.3 1.3 74.0 24.0 29.0 40.0 13.2 22.7 3.4 31.0 60.8 17.4 8.7 42.9 24.8 27.4 0.1 20.8 25.8 6.5 22.6 32.2 23.7 31.5 40.7 23.4 10.5 34.9 9.0 83.7 17.7 22.2 33.1 29.1 20.5 26.1 26.5 31.8 31.0 5.7 47.5 85.5 29.4 21.0 27.6 219.5 28.9 14.5 40.8 18.7 46.1 36.5 31.5 17.2 25.2 41.6 9.4 5.6 7.9 5.6 1.5 8.2 2.0 5.0 4.3 2.5 7.4 2.9 2.0 1.7 14.6 1.9 5.0 4.6 6.4 2.3 13.1 13.5 12.8 13.9 10.0 14.4 12.7 15.8 8.9 13.5 12.9 20.4 13.9 106.3 19.2 31.6 5.9 48.7 117.5 387.1 73.4 71.7 28.6 274.7 262.4 160.8 190.1 98.1 121.4 14.6 273.3 49.2 231.9 295.4 304.3 4.5 167.0 104.2 91.7 102.2 38.3 1.1 578.1 408.5 70.7 72.9 229.9 45.1 38.4 74.6 547.6 93.6 18.5 1.0 169.4 79.3 84.7 58.5 10.9 67.7 70.9 58.7 8.4 98.3 90.5 51.5 3.5 1.8 678.8 224.6 66.5 68.2 510.0 115.2 353.0 72.7 38.9 59.2 78.4 89.0 11.7 58.2 201.2 204.9 291.3 59.9 29.2 141.8 1174.8 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 4.6 5.4 15.1 8.1 16.0 26.5 5.1 22.7 20.0 4.7 18.6 6.2 6.9 5.3 11.2 3.2 5.4 3.7 5.7 15.5 14.4 6.2 9.7 4.0 12.2 14.9 15.2 15.7 4.6 4.0 8.9 4.4 5.3 16.8 4.7 6.8 21.5 5.5 4.4 6.9 5.0 5.2 5.3 14.8 8.2 5.1 12.5 14.8 33.1 5.2 7.8 10.4 4.2 2.0 17.2 15.0 15.9 23.9 28.0 10.7 10.1 9.1 15.7 7.8 18.7 15.2 15.1 7.2 29.6 10.6 10.1 15.7 10.2 30.3 11.1 26.0 17.6 20.7 30.5 17.9 15.0 6.6 27.0 24.6 10.5 4.7 18.2 16.1 15.6 19.5 40.1 21.4 12.7 17.3 12.9 32.6 44.6 17.1 9.4 17.2 27.6 24.9 19.1 14.7 14.8 31.4 15.0 23.7 9.3 15.4 22.4 17.5 21.2 11.1 15.3 21.5 17.5 22.1 19.0 33.8 24.4 12.2 26.4 32.4 11.5 3.7 5.4 10.1 3.7 7.2 6.5 8.4 9.5 3.7 6.0 11.6 12.0 0.8 10.1 3.3 5.3 7.8 2.8 15.1 16.0 22.7 20.0 15.5 14.4 14.9 15.2 15.7 16.8 14.8 14.8 17.2 7.3 9.6 9.5 50.3 15.6 4.5 4.5 5.7 8.6 43.5 5.8 5.2 16.3 10.0 7.2 7.3 114.7 12.2 25.3 2.8 5.9 4.8 57.9 21.2 12.4 8.5 14.3 33.6 87.7 1.8 7.1 10.6 5.1 6.5 2.5 23.6 7.9 31.1 8.6 53.8 84.7 5.6 6.1 15.3 7.4 73.3 7.2 10.4 3.6 24.4 17.0 14.7 32.0 46.3 48.1 1.8 1.6 11.3 21.4 3.0 4.3 11.0 14.9 65.9 0.0 11.6 7.2 31.7 20.4 8.4 2.3 1.6 26.8 17.2 9.8 2.7 PLEKHA5 "FLJ10667, KIAA1686, PEPP2" ENSG00000052126 "Pleckstrin homology domain containing A5" Q9HAU0 12 19129733-19376400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 555.7;Inhibitory neurons: 506.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 22.6;MAIT T-cell: 5.7" "Group enriched" "Detected in many" 6 "granulocytes: 22.6;T-cells: 5.7" "Cell line enhanced" "Detected in many" "HDLM-2: 65.5;NTERA-2: 64.4;SuSa: 61.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035923, HPA035924, HPA041455" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490" "unprognostic (3.16e-1)" "unprognostic (8.35e-3)" "unprognostic (1.30e-1)" "unprognostic (4.85e-3)" "unprognostic (6.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-2)" "unprognostic (3.62e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (5.41e-5)" "unprognostic (3.71e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.27e-1)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (1.07e-2)" 10.3 61.8 11.9 5.2 15.0 3.8 15.4 6.4 18.1 30.2 3.2 12.2 13.1 30.1 32.6 20.9 20.2 18.7 35.6 13.1 29.3 43.1 16.3 12.9 3.1 16.9 13.4 13.3 33.0 15.0 22.1 12.7 12.8 12.6 17.5 13.7 35.4 15.6 28.3 2.4 17.9 13.4 15.4 15.4 3.4 18.7 20.6 13.8 8.7 14.8 5.1 4.9 23.6 25.2 16.0 25.8 12.5 45.2 0.4 14.9 20.1 15.8 10.8 23.7 6.5 10.2 19.1 22.8 0.5 3.5 12.1 13.2 10.9 30.8 20.3 13.5 65.5 10.8 15.4 28.1 9.1 14.0 0.3 2.0 11.8 20.4 18.6 35.2 35.5 7.1 12.9 6.7 0.7 7.0 8.0 10.2 1.8 64.4 21.1 6.5 0.2 21.0 0.2 45.6 30.5 4.1 9.1 10.6 5.9 40.3 61.0 7.4 3.5 10.8 4.0 17.3 0.9 0.4 0.6 0.5 0.3 9.8 0.2 8.3 22.6 0.3 0.3 2.4 0.4 5.7 0.2 2.2 2.1 1.8 0.3 0.3 1.6 0.8 1.6 0.2 2.5 2.1 0.4 11.9 15.0 6.4 18.1 13.1 29.3 16.9 13.4 13.3 12.6 15.4 13.8 16.0 19.9 25.6 28.2 145.9 3.2 20.5 46.6 42.2 25.0 86.2 27.8 49.7 157.9 57.2 49.5 46.0 137.6 26.8 9.0 25.6 35.2 33.7 25.8 84.2 187.3 17.2 32.4 7.8 555.7 33.1 38.7 79.8 37.8 98.8 3.8 11.3 20.3 38.9 6.6 126.2 506.4 17.9 22.4 10.5 94.1 15.3 40.4 11.4 117.4 178.0 168.2 97.5 0.0 158.8 82.0 52.6 30.9 28.2 4.9 33.4 30.4 115.3 60.6 139.7 32.9 24.7 38.1 45.5 48.8 39.4 25.7 26.4 12.0 75.3 36.9 47.2 PRSS8 ENSG00000052344 "Serine protease 8" Q16651 16 31131433-31135727 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 247.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 403.5;Extravillous trophoblasts: 648.4;Paneth cells: 262.6;Proximal enterocytes: 358.0;Syncytiotrophoblasts: 450.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 243.7;CACO-2: 165.9;CAPAN-2: 111.9;hTCEpi: 157.8;OE19: 79.6;SK-BR-3: 186.3" "Region enriched" "Detected in single" 8 "hippocampal formation: 1.4" "Low region specificity" "Detected in single" HPA030436 Uncertain "Secreted - unknown location" NA NA 4400000 "HPA030436: AB_10602291" "unprognostic (1.88e-1)" "unprognostic (2.97e-1)" "unprognostic (9.34e-2)" "unprognostic (4.08e-1)" "unprognostic (6.83e-2)" "unprognostic (5.07e-3)" "unprognostic (5.78e-2)" "unprognostic (2.05e-1)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (8.74e-3)" "unprognostic (1.58e-1)" "prognostic favorable (2.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-1)" "unprognostic (3.63e-3)" 0.8 0.4 0.4 15.1 0.3 0.2 25.7 2.0 0.7 31.3 5.3 128.3 157.2 10.0 114.0 137.3 15.6 48.1 0.4 0.7 0.2 82.0 28.2 54.5 0.3 0.4 0.4 0.2 0.6 140.6 56.5 8.5 51.4 0.7 49.4 73.3 0.0 247.5 8.6 0.3 115.5 153.0 3.6 0.2 0.2 157.5 0.5 0.2 15.5 51.2 0.0 11.9 5.0 56.5 0.4 63.4 0.2 0.1 0.2 0.0 0.0 243.7 0.0 0.0 0.0 0.0 165.9 111.9 0.0 1.3 0.0 0.0 73.5 0.1 69.7 0.0 0.3 0.4 0.1 0.3 6.5 0.0 0.0 0.3 0.0 157.8 0.0 2.4 0.0 0.0 0.1 1.9 0.1 0.0 68.1 0.6 1.4 20.5 79.6 0.1 0.5 0.0 1.2 7.5 13.1 0.9 0.7 0.0 186.3 0.1 18.8 42.8 0.8 0.0 0.1 1.9 0.6 0.4 0.3 0.5 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.0 0.7 0.7 0.2 0.4 0.4 0.2 0.7 0.2 0.2 0.4 0.4 99.3 60.1 0.0 1.0 37.9 82.7 108.9 76.2 0.5 74.4 39.2 0.3 62.9 107.4 42.3 0.0 168.8 0.8 403.5 29.4 192.4 0.0 35.2 11.4 2.6 9.6 2.7 0.1 224.4 648.4 3.5 82.6 109.5 7.0 0.0 0.0 18.2 22.8 0.0 0.2 132.1 87.5 0.3 2.7 0.0 0.6 1.9 3.6 0.0 4.2 0.3 0.0 0.0 0.0 240.7 262.6 0.0 0.1 66.0 358.0 28.6 21.2 0.1 0.0 0.1 4.7 0.0 0.2 81.9 54.0 450.7 2.2 0.0 150.8 91.0 SIKE1 "FLJ21168, SIKE" ENSG00000052723 "Suppressor of IKBKE 1" Q9BRV8 1 114769479-114780685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024177, HPA025726" Supported Approved "Vesicles,Focal adhesion sites" NA NA "Focal adhesion sites" Vesicles "HPA024177: AB_1848798, HPA025726: AB_1848800" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (3.53e-2)" "unprognostic (4.52e-3)" "unprognostic (4.10e-1)" "unprognostic (6.04e-2)" "unprognostic (3.37e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-2)" "unprognostic (2.52e-2)" "unprognostic (1.94e-2)" "unprognostic (7.91e-2)" "unprognostic (2.38e-2)" "unprognostic (3.86e-2)" "unprognostic (9.06e-2)" "unprognostic (2.95e-3)" "unprognostic (1.05e-1)" 8.9 7.0 6.3 9.8 6.8 9.9 9.7 9.0 6.7 9.2 6.2 8.7 9.9 9.5 7.6 7.8 6.1 6.9 7.3 5.4 8.0 10.9 12.3 6.9 12.2 7.4 7.5 5.1 8.7 6.8 9.8 4.9 9.6 7.5 7.6 9.5 8.1 7.4 7.6 6.8 13.5 8.6 9.3 7.3 9.5 8.5 5.6 8.5 13.7 10.2 7.4 12.1 7.3 5.7 7.8 16.3 4.4 22.9 21.2 27.6 21.4 22.0 13.9 12.4 18.9 25.3 12.2 9.1 30.6 12.5 11.8 8.0 15.7 24.3 16.7 27.0 19.4 13.3 16.4 13.9 15.6 26.3 18.8 12.9 21.0 19.6 14.1 22.4 13.6 17.5 26.2 25.2 17.7 15.7 62.7 37.1 19.9 52.1 10.5 12.3 21.2 43.7 15.3 16.0 13.5 15.7 18.5 20.0 23.2 25.5 20.8 12.6 72.0 13.9 15.6 19.0 26.8 19.0 16.4 14.1 29.1 23.7 31.1 34.0 6.0 1.7 2.0 2.2 2.3 2.8 2.0 2.2 2.2 2.2 2.1 2.6 2.8 1.2 2.6 2.4 2.7 1.7 1.4 6.3 6.8 9.0 6.7 5.4 8.0 7.4 7.5 5.1 7.5 7.3 8.5 7.8 29.2 25.6 14.8 13.1 32.7 31.9 26.7 40.0 30.1 10.7 22.7 23.2 41.0 20.0 30.2 31.3 10.4 29.7 43.9 30.3 50.9 27.1 34.8 20.1 34.9 26.3 18.6 29.9 16.2 25.7 33.6 27.9 18.8 26.8 19.7 77.1 27.1 40.0 27.7 8.4 19.7 21.4 48.8 19.7 26.6 58.1 28.3 24.8 23.2 4.7 25.4 15.8 32.0 10.1 16.6 31.1 18.3 19.9 37.7 30.5 25.7 62.8 21.3 16.1 19.7 26.5 28.8 35.5 39.6 33.0 36.4 36.0 37.4 48.3 21.2 23.6 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 91.8;skeletal muscle: 38.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 26.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" No No Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: AB_2680965, HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 8.2 10.2 2.5 9.3 2.8 91.8 5.6 1.4 8.0 5.3 2.0 4.9 6.0 7.5 3.7 8.6 7.4 7.2 10.6 3.3 2.4 4.4 5.8 6.7 6.7 3.9 2.4 2.9 6.1 16.1 9.4 10.3 4.4 4.6 6.3 3.8 3.5 8.3 4.0 38.8 10.2 4.7 6.1 0.3 7.6 6.4 11.0 5.0 4.7 5.5 9.8 6.1 9.4 5.7 4.9 38.9 50.8 13.2 28.6 10.0 11.6 28.9 24.2 14.4 24.2 18.7 55.6 35.0 42.3 30.4 15.1 21.6 48.7 36.3 28.0 16.3 23.1 44.2 32.8 19.5 43.6 16.5 51.7 41.5 12.2 38.6 59.9 54.6 27.0 13.7 23.5 47.7 27.4 14.0 50.8 35.0 33.0 57.0 20.4 34.0 38.1 18.0 42.1 16.8 21.4 17.7 37.9 19.2 18.1 24.1 10.4 43.7 26.5 18.2 16.1 27.9 36.5 76.4 55.7 52.7 48.6 23.2 64.9 17.9 0.4 11.2 6.9 2.7 13.6 3.3 3.9 1.6 2.2 6.2 4.2 2.5 2.8 26.7 1.9 16.9 5.0 1.2 6.0 2.5 2.8 1.4 8.0 3.3 2.4 3.9 2.4 2.9 4.6 0.3 5.0 4.9 8.8 35.3 31.1 5.9 18.5 23.5 14.2 5.1 25.0 5.8 12.7 9.9 11.6 7.2 21.5 14.7 41.7 5.2 7.7 10.6 0.0 8.7 7.2 17.1 10.6 10.6 21.5 7.2 15.1 8.7 7.5 13.5 27.0 20.1 41.7 12.9 3.9 8.9 11.5 5.0 9.5 13.8 4.1 12.5 7.1 4.8 3.7 30.3 7.2 2.8 12.3 1.9 3.1 5.0 4.4 8.5 6.4 2.6 31.8 17.1 3.7 6.8 24.6 12.7 0.0 19.4 6.7 10.6 20.6 22.7 19.6 9.2 11.0 13.5 11.5 13.6 FNIP2 "FNIPL, KIAA1450, MAPO1" ENSG00000052795 "Folliculin interacting protein 2" Q9P278 4 158769026-158908050 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 288.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 3.3;myeloid DC: 2.1;non-classical monocyte: 7.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.1;monocytes: 7.2" "Cell line enhanced" "Detected in many" "HDLM-2: 179.0;U-266/70: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042779, HPA052758, HPA072420" Approved Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200" "unprognostic (3.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "unprognostic (4.02e-1)" "unprognostic (1.46e-1)" "unprognostic (3.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (7.93e-2)" "unprognostic (1.77e-1)" "prognostic favorable (3.96e-11)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (7.10e-2)" 26.5 7.8 8.5 10.1 13.4 8.9 12.3 7.5 17.4 12.9 7.9 22.0 7.5 11.2 9.4 14.6 8.1 20.6 25.5 13.4 14.3 48.2 58.8 25.1 7.7 10.5 11.6 9.1 10.8 19.6 16.0 3.3 30.3 12.0 10.9 22.6 8.9 14.0 11.4 11.5 10.2 9.4 18.1 9.2 13.4 23.0 10.1 19.9 7.3 18.7 20.1 5.5 13.8 5.3 19.0 4.0 4.5 19.2 10.1 14.1 8.9 21.0 8.6 9.1 8.7 9.8 5.3 4.0 0.2 2.1 31.2 10.7 3.7 18.4 8.9 10.5 179.0 6.6 18.7 2.5 7.3 8.8 7.9 36.0 6.5 7.3 5.9 7.7 12.8 9.9 9.8 11.4 0.8 14.6 1.3 18.4 1.0 6.1 12.7 4.6 10.8 9.5 5.1 7.0 10.2 12.3 10.9 4.7 3.2 19.5 6.1 4.0 4.3 12.5 14.0 8.7 9.6 6.5 57.3 26.0 3.8 13.9 9.5 10.0 0.4 0.7 0.2 0.5 3.3 0.3 0.0 0.3 0.2 2.1 0.0 0.2 0.6 0.1 0.6 7.2 0.4 0.1 0.4 8.5 13.4 7.5 17.4 13.4 14.3 10.5 11.6 9.1 12.0 9.2 19.9 19.0 93.7 19.2 129.2 20.9 6.5 35.6 30.9 7.2 14.2 17.7 18.4 16.4 55.4 58.6 23.2 40.5 54.2 13.1 17.8 80.9 23.5 38.5 17.6 51.6 13.8 78.1 62.4 25.4 109.0 79.9 7.4 35.1 30.1 82.0 27.9 15.7 95.3 114.7 65.4 10.1 95.5 44.9 8.2 90.6 288.0 9.9 13.4 101.5 40.9 64.6 28.4 4.9 11.3 56.8 151.8 80.5 77.2 9.8 5.4 55.7 11.1 72.9 15.3 27.9 52.6 72.3 34.0 25.8 22.8 13.6 36.8 8.2 13.0 10.4 46.8 41.2 MSMO1 "DESP4, ERG25, SC4MOL" ENSG00000052802 "Methylsterol monooxygenase 1" Q15800 4 165327667-165343164 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 580.5" "Cell type enhanced" "Detected in all" "Hepatocytes: 532.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 416.2;Karpas-707: 412.3;RPTEC TERT1: 399.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055073, HPA056127" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA055073: , HPA056127: AB_2683045" "unprognostic (5.76e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.35e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" "unprognostic (1.20e-2)" "unprognostic (7.14e-2)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (9.21e-4)" "unprognostic (2.39e-1)" "unprognostic (1.56e-2)" "unprognostic (3.54e-1)" "unprognostic (1.40e-1)" 16.3 96.0 40.9 21.1 53.8 10.5 66.8 47.0 54.5 33.7 37.7 39.5 76.4 19.2 97.9 146.9 21.1 21.9 17.1 48.4 56.7 50.2 580.5 71.0 20.8 74.3 67.5 42.4 26.0 22.8 43.3 18.6 23.1 79.4 59.4 33.2 26.3 35.0 12.2 5.6 67.7 38.4 16.6 48.2 11.1 31.8 53.3 62.9 13.5 22.6 6.6 27.2 20.4 67.5 98.5 89.1 21.7 198.8 36.4 97.7 312.0 37.5 35.3 159.0 44.7 123.4 41.5 372.9 43.4 20.6 43.1 416.2 71.7 101.6 366.3 49.4 37.7 63.0 20.0 20.0 127.6 194.9 35.8 26.8 192.6 237.6 163.6 100.6 61.1 58.8 55.7 35.3 412.3 74.6 45.7 32.6 58.2 115.6 46.9 21.0 16.8 21.8 132.3 399.5 102.5 39.7 30.0 54.5 77.9 33.9 121.7 36.1 44.7 67.6 20.6 36.1 18.5 24.7 75.9 86.5 58.6 43.9 36.0 28.5 13.7 8.6 8.8 34.0 11.6 25.4 40.6 31.8 31.4 15.0 37.6 34.3 35.6 6.1 24.9 20.5 19.3 31.0 29.2 40.9 53.8 47.0 54.5 48.4 56.7 74.3 67.5 42.4 79.4 48.2 62.9 98.5 16.9 51.3 168.0 70.5 28.9 36.1 70.1 189.2 21.6 33.8 81.9 23.0 10.7 40.0 160.0 69.9 27.1 55.6 20.7 130.8 35.2 67.9 6.4 27.6 12.2 30.4 60.7 53.9 33.6 71.7 87.0 24.1 35.2 44.4 47.7 83.0 27.8 532.0 28.3 35.3 22.8 72.8 170.9 28.0 11.5 7.0 24.8 18.3 32.0 10.3 23.6 27.2 17.5 42.7 49.6 86.8 85.7 18.8 10.9 138.3 46.0 38.4 103.2 50.4 19.7 5.6 35.1 8.7 15.4 84.6 115.1 123.0 22.3 136.1 36.9 129.0 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358920-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 20.9 18.9 10.2 16.2 10.7 15.6 28.9 15.9 12.3 22.2 19.5 21.4 21.8 27.2 25.2 14.3 28.7 22.5 13.7 10.3 11.3 19.6 38.9 24.5 20.4 10.8 11.2 9.0 41.2 49.9 27.9 12.4 29.5 12.5 25.6 23.1 25.3 41.1 21.6 16.5 19.6 25.7 23.2 9.5 23.6 27.7 25.1 11.4 24.8 37.2 20.2 22.6 18.9 15.8 11.7 15.0 30.4 31.3 49.3 77.2 63.6 22.1 35.6 47.6 29.3 35.1 21.1 21.7 31.6 34.9 35.9 33.7 31.1 22.3 23.5 35.2 24.5 29.0 24.2 19.5 20.8 95.3 36.6 29.9 59.5 69.8 21.3 68.4 66.2 29.5 22.7 35.5 26.2 29.8 18.1 27.1 20.3 46.8 58.0 25.0 25.1 33.3 36.9 37.2 21.4 16.7 39.7 27.7 73.1 44.6 31.4 68.6 40.8 39.6 41.7 18.4 47.1 52.1 51.1 44.5 29.8 26.9 21.6 45.3 20.0 21.7 19.0 14.9 22.4 15.9 16.4 16.2 14.5 16.9 14.8 16.3 15.1 18.5 16.5 20.8 17.6 16.1 18.0 10.2 10.7 15.9 12.3 10.3 11.3 10.8 11.2 9.0 12.5 9.5 11.4 11.7 43.0 64.1 62.7 159.6 53.3 42.1 35.0 36.4 30.7 44.1 40.3 35.7 20.5 31.5 51.9 22.0 60.5 32.6 43.8 30.7 3.9 23.1 52.6 35.8 44.5 40.9 22.3 44.0 204.6 43.4 28.8 44.4 40.2 48.6 36.6 56.2 40.0 57.5 26.2 47.1 203.2 42.1 34.6 48.0 32.3 18.4 57.2 37.1 28.4 181.8 47.8 24.8 37.0 192.0 200.6 29.7 31.5 36.5 48.9 50.1 47.7 15.5 54.3 47.3 52.6 45.5 36.2 51.8 35.0 34.6 43.2 30.8 45.6 33.5 35.8 42.7 ALX4 "FPP, KIAA1788, PFM, PFM2" ENSG00000052850 "ALX homeobox 4" Q9H161 11 44260440-44310139 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 1.9;choroid plexus: 1.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0" "Region enriched" "Detected in some" 8 "olfactory bulb: 9.0" "Region enriched" "Detected in single" 31 "olfactory bulb: 9.0" HPA001903 Supported Nucleoplasm NA NA Nucleoplasm "HPA001903: AB_2666495" "unprognostic (7.56e-5)" "unprognostic (1.69e-1)" "unprognostic (5.40e-2)" "unprognostic (2.74e-1)" "unprognostic (7.24e-3)" "unprognostic (2.63e-4)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-4)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-1)" "unprognostic (1.34e-6)" "unprognostic (3.62e-2)" "unprognostic (2.85e-1)" "unprognostic (2.02e-3)" "unprognostic (2.03e-1)" 0.4 0.0 0.4 0.0 0.1 0.0 1.9 0.1 0.5 0.5 1.9 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.7 0.0 1.0 0.8 0.0 0.3 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.5 0.0 4.0 0.0 0.0 0.0 3.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 1.0 4.8 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.5 0.2 0.0 0.2 0.5 0.0 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.1 1.3 20.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.6 4.7 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612541 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.1" "Cell type enriched" "Detected in many" 6 "Excitatory neurons: 390.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 57.2;U-266/70: 19.3;U-266/84: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045920 Uncertain Uncertain Mitochondria "Secreted to blood" NA NA Mitochondria "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.1 1.3 4.7 0.6 4.7 1.9 0.6 8.4 11.1 0.2 0.0 1.1 0.7 0.2 1.5 1.9 1.0 0.5 0.4 2.7 3.1 2.9 0.1 1.2 0.3 1.6 6.3 3.0 0.4 1.9 3.1 2.3 3.8 3.9 1.6 1.1 3.9 0.7 0.0 0.9 3.4 0.8 0.2 0.0 0.4 1.4 1.8 21.1 1.3 0.8 0.5 1.1 6.1 0.9 7.7 7.5 13.1 1.4 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 12.5 1.7 0.7 10.5 0.0 1.3 0.2 1.7 0.5 0.0 0.9 0.6 0.6 13.9 1.1 0.0 0.0 0.7 0.3 1.8 0.0 0.1 0.3 0.0 0.5 5.9 7.0 0.0 12.7 1.5 0.6 14.4 14.2 1.6 0.6 1.3 14.1 0.0 15.0 57.2 1.6 2.9 2.4 0.3 12.2 4.6 0.5 0.3 0.6 2.4 0.8 0.4 19.3 20.7 0.5 0.2 0.1 0.4 1.1 0.2 0.1 0.2 0.0 0.5 0.6 0.4 0.3 0.1 0.5 0.4 0.2 0.5 0.2 0.2 0.3 0.3 0.3 4.7 4.7 8.4 11.1 2.7 3.1 1.6 6.3 3.0 3.9 0.0 21.1 7.7 0.0 0.0 3.1 21.5 1.0 1.7 2.5 0.2 4.0 10.1 0.6 0.3 9.6 0.0 4.4 0.0 14.6 0.4 0.1 0.0 0.0 0.2 35.9 1.2 0.2 0.6 9.0 0.0 390.3 0.0 0.0 0.4 0.0 0.1 0.0 1.4 0.0 0.0 0.1 1.7 57.9 0.4 0.0 0.0 0.0 20.4 0.3 1.2 10.6 8.4 0.0 3.0 0.0 21.1 4.5 0.6 0.0 0.7 0.0 0.4 0.2 2.5 3.7 2.6 6.6 0.0 1.1 0.5 0.7 3.3 1.6 0.0 0.4 0.9 0.1 2.9 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 517.2;Oligodendrocyte precursor cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.2;U-266/84: 112.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA059209: AB_2683949" "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 46.9 27.3 16.7 23.8 16.6 84.4 23.0 69.4 15.1 25.2 31.3 24.0 37.0 26.7 9.3 39.8 23.4 23.1 38.5 12.1 14.6 12.9 31.1 24.1 29.3 21.9 20.0 7.7 51.0 25.0 47.2 5.1 22.9 33.0 20.4 22.0 16.7 18.6 22.3 80.4 41.7 35.5 35.4 18.0 21.8 29.3 16.9 23.0 42.0 9.5 73.3 31.2 25.7 20.8 19.3 0.5 7.7 19.7 11.3 78.1 24.8 14.2 15.7 15.4 13.8 22.7 7.8 6.3 24.0 7.8 25.0 9.5 5.6 33.5 22.3 20.4 109.2 6.2 8.3 14.6 25.0 25.3 16.6 14.1 59.4 12.6 1.3 9.4 16.6 30.2 34.1 10.0 69.0 22.9 9.4 32.2 16.6 21.2 14.2 13.8 51.4 67.0 22.8 1.7 26.6 10.7 35.1 23.0 21.9 6.4 64.8 12.8 45.3 55.0 23.5 32.1 23.6 23.6 58.4 112.6 44.6 8.5 28.2 13.8 48.8 23.8 35.8 41.9 25.7 33.3 13.5 27.8 35.9 35.2 16.4 35.8 34.6 9.6 32.2 17.3 7.9 35.9 31.2 16.7 16.6 69.4 15.1 12.1 14.6 21.9 20.0 7.7 33.0 18.0 23.0 19.3 108.7 32.1 33.9 229.5 65.4 89.3 22.4 27.4 41.5 123.2 21.0 21.7 103.2 47.1 53.4 9.2 0.0 36.9 105.9 37.2 21.5 11.5 86.2 38.8 36.3 67.3 59.3 52.5 125.6 20.9 21.3 75.2 45.9 36.4 12.7 112.4 55.6 92.9 43.5 79.1 195.2 37.5 30.5 100.3 174.9 38.5 96.3 87.9 32.0 517.2 65.3 38.6 94.7 291.6 143.8 15.5 32.1 85.4 71.3 16.8 77.4 12.2 16.0 9.9 39.5 133.6 57.9 4.3 11.6 51.4 147.6 29.6 85.0 37.2 46.6 29.1 METTL24 "C6orf186, dJ71D21.2" ENSG00000053328 "Methyltransferase like 24" Q5JXM2 6 110245928-110358272 "Predicted secreted proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "smooth muscle: 14.3" "Group enriched" "Detected in some" 4 "Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 3.5" "Lineage enriched" "Detected in single" 29 "T-cells: 3.5" "Cell line enhanced" "Detected in some" "HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037441, HPA037442" Uncertain "Secreted - unknown location" NA NA "HPA037441: AB_10670933, HPA037442: AB_10696931" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (9.31e-3)" "unprognostic (5.02e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (6.12e-2)" "unprognostic (2.06e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.45e-2)" "unprognostic (5.96e-2)" "unprognostic (1.54e-4)" "unprognostic (4.08e-2)" "unprognostic (1.23e-2)" "unprognostic (1.63e-2)" "unprognostic (4.78e-3)" 1.8 1.6 1.5 1.6 2.1 0.0 1.7 2.0 2.0 3.9 6.8 4.4 1.5 7.6 2.2 4.1 6.0 5.8 3.0 1.7 1.9 3.9 0.9 1.6 0.1 1.6 2.1 1.3 5.7 1.3 2.5 2.1 0.4 1.6 5.0 4.3 1.4 0.4 7.2 0.0 0.5 2.1 14.3 1.7 0.7 2.5 2.2 1.6 1.0 1.3 1.1 0.6 4.7 1.6 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 2.1 2.0 2.0 1.7 1.9 1.6 2.1 1.3 1.6 1.7 1.6 1.5 0.0 0.0 0.0 30.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.4 1.5 0.1 0.0 0.0 23.8 0.0 0.0 0.8 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.7 28.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 3.7 0.0 0.6 0.0 31.7 5.4 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.3 2.1 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 AKR7A2 AFAR ENSG00000053371 "Aldo-keto reductase family 7 member A2" O43488 1 19303965-19312144 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 711.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB032587, CAB032841, HPA064638" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 950000 Cytosol "Golgi apparatus" "CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307" "unprognostic (1.06e-1)" "unprognostic (3.48e-2)" "unprognostic (7.23e-2)" "unprognostic (5.76e-2)" "unprognostic (9.92e-2)" "unprognostic (1.09e-1)" "unprognostic (1.14e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (5.11e-2)" "unprognostic (7.11e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.72e-2)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.59e-4)" 32.9 68.5 40.9 17.7 41.8 25.2 34.1 44.7 44.6 53.1 56.1 40.3 81.8 35.0 22.6 48.2 48.9 29.4 36.8 40.9 48.0 76.0 63.2 24.8 25.5 45.7 42.9 35.9 46.1 48.3 33.0 32.9 19.2 41.2 31.9 27.7 16.2 31.6 27.9 55.8 36.8 57.3 22.8 44.2 28.5 43.0 33.4 43.0 31.6 28.8 40.0 20.7 29.8 38.8 50.3 65.3 40.2 43.3 40.2 67.0 64.7 28.8 47.6 57.6 65.0 58.2 51.5 53.6 46.8 49.6 64.2 36.6 50.8 48.7 71.5 30.5 37.5 77.4 29.4 37.5 83.3 51.9 32.9 22.9 64.8 55.5 50.0 30.6 61.5 55.8 60.2 43.6 42.6 67.7 64.9 64.2 31.9 12.4 90.8 50.1 66.7 54.0 83.2 64.2 28.3 80.9 30.2 51.8 46.1 84.6 24.6 91.9 112.7 44.2 40.6 42.7 44.0 36.2 51.4 34.8 57.9 87.6 74.4 58.5 0.7 82.2 40.6 61.4 69.7 71.7 63.8 54.4 54.2 113.5 57.6 61.7 54.1 9.5 69.4 54.1 98.8 78.9 73.7 40.9 41.8 44.7 44.6 40.9 48.0 45.7 42.9 35.9 41.2 44.2 43.0 50.3 47.6 16.0 22.3 15.3 42.6 24.3 73.2 56.4 37.5 33.1 94.6 98.8 27.7 98.7 31.7 77.3 6.2 167.5 52.8 95.0 254.3 64.0 94.6 85.8 35.8 35.3 99.7 33.4 8.6 36.2 99.8 67.9 44.9 33.4 10.2 62.5 43.2 90.6 104.6 21.9 7.5 97.9 46.8 58.4 34.2 57.6 77.3 47.6 53.4 5.6 64.6 128.7 63.8 5.5 9.2 39.4 131.5 67.7 36.3 39.3 273.8 711.5 61.0 30.1 46.0 57.8 54.4 56.3 24.9 76.0 34.1 102.6 40.4 88.4 136.4 62.3 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251805-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.1 18.6 16.8 17.0 17.3 13.5 20.4 14.9 18.2 13.1 13.8 13.7 16.9 16.0 13.0 23.9 17.8 9.0 13.3 17.6 16.1 11.2 20.5 11.2 20.1 16.0 16.5 17.6 17.1 23.6 12.6 9.0 12.2 16.5 13.0 16.7 7.3 12.4 10.6 22.9 17.3 19.6 16.9 15.5 14.0 15.7 14.1 16.7 14.9 11.2 11.5 23.0 21.6 14.2 17.5 90.9 65.9 51.1 67.0 24.2 38.6 44.7 69.0 38.9 116.7 76.1 92.9 92.0 133.6 56.7 60.5 50.4 70.1 142.7 104.6 114.0 47.4 109.6 98.4 55.4 80.8 30.3 133.4 38.7 34.0 69.8 131.6 69.6 31.7 66.1 59.0 151.1 42.3 68.9 68.0 106.3 96.5 65.0 95.6 95.4 99.3 62.7 100.5 64.8 31.3 82.9 59.2 54.0 73.0 75.4 37.6 50.8 76.5 44.2 61.9 77.5 97.6 118.0 33.8 64.3 178.2 61.2 172.4 102.5 1.4 11.6 1.3 11.4 12.7 22.9 23.1 13.7 15.9 17.6 19.7 18.4 16.7 1.4 16.6 10.2 19.7 10.6 11.4 16.8 17.3 14.9 18.2 17.6 16.1 16.0 16.5 17.6 16.5 15.5 16.7 17.5 30.0 6.4 14.5 6.2 31.2 37.3 59.1 45.8 42.7 20.4 23.6 37.7 10.3 38.6 26.4 7.3 10.4 50.4 14.9 15.7 41.1 61.8 23.3 19.1 46.8 32.1 21.6 31.3 8.4 55.0 69.9 29.5 19.4 21.1 26.0 36.8 15.4 16.3 47.1 15.2 7.3 25.4 36.7 13.3 18.2 36.5 23.0 21.0 19.6 1.9 32.0 25.7 16.5 4.5 4.3 57.5 17.0 20.3 29.0 57.4 6.0 37.9 15.8 16.4 19.7 44.8 35.9 55.6 49.7 48.2 33.5 26.0 18.6 58.1 34.8 36.7 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521206-37523690 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "pituitary gland: 1599.2" "Cell type enhanced" "Detected in many" "Early spermatids: 42.0;Excitatory neurons: 33.9;Late spermatids: 65.5;Muller glia cells: 177.1" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 22 "SH-SY5Y: 720.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 27.6 15.3 118.3 2.5 153.1 2.5 32.8 21.5 66.4 6.0 55.6 51.3 4.0 5.0 0.2 3.4 3.6 4.7 2.4 105.9 89.6 1.4 2.0 2.2 1.4 49.4 47.2 71.0 1.6 1.4 0.0 1599.2 107.3 49.6 4.4 4.0 31.6 6.6 0.6 13.6 4.5 14.7 5.2 30.8 1.4 17.0 5.0 71.4 11.2 2.0 0.3 0.1 14.6 5.6 50.1 2.2 1.7 12.6 1.7 0.0 0.0 4.5 0.5 0.0 0.1 0.0 4.2 2.2 1.0 0.7 0.0 0.2 10.2 0.0 0.0 0.0 0.1 0.3 0.3 12.9 2.4 3.2 1.3 1.1 2.9 0.0 0.0 0.0 0.2 32.5 0.3 0.2 2.4 0.1 1.0 5.7 1.3 0.9 0.3 1.6 0.5 4.0 0.5 0.0 20.6 1.9 720.8 1.1 5.0 0.0 0.6 1.3 0.2 0.8 5.7 0.8 1.6 1.1 0.9 0.2 0.1 1.7 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.3 153.1 21.5 66.4 105.9 89.6 49.4 47.2 71.0 49.6 30.8 71.4 50.1 0.3 0.0 0.0 1.6 0.2 4.0 0.8 0.1 19.9 4.5 0.3 5.8 0.1 0.0 0.7 0.0 0.0 0.6 0.3 0.1 0.0 0.2 42.0 0.1 3.0 21.6 0.0 0.0 33.9 0.0 1.1 3.1 0.0 0.1 1.3 2.2 0.0 0.0 1.6 0.0 9.6 0.2 0.0 0.3 1.1 65.5 0.6 0.1 1.8 4.7 0.0 177.1 0.0 2.0 1.8 0.0 0.0 1.2 0.0 2.5 0.0 0.0 1.1 6.5 0.0 1.4 1.9 1.5 5.6 3.6 1.0 0.3 0.1 0.1 0.0 4.8 USE1 "D12, MDS032, p31, SLT1" ENSG00000053501 "Unconventional SNARE in the ER 1" Q9NZ43 19 17215346-17219829 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026851, HPA047562" Approved NA NA "HPA026851: AB_10602903, HPA047562: AB_2680089" "unprognostic (3.03e-3)" "unprognostic (2.61e-3)" "unprognostic (2.24e-2)" "unprognostic (3.09e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.04e-2)" "unprognostic (4.24e-1)" "unprognostic (2.94e-2)" "unprognostic (1.15e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (8.14e-2)" "unprognostic (3.23e-1)" "unprognostic (6.61e-2)" "unprognostic (1.31e-2)" 32.2 40.5 44.9 20.4 46.1 29.0 30.7 45.2 58.4 30.4 42.6 28.1 17.5 24.7 19.1 26.1 24.3 20.4 39.6 45.2 44.8 31.7 42.4 25.9 28.5 46.8 45.6 44.3 32.2 43.6 14.3 22.3 15.8 46.6 27.0 11.0 11.9 38.7 15.0 56.5 26.6 25.6 15.0 45.6 40.0 32.0 19.8 45.1 25.5 24.8 36.5 18.5 29.6 24.6 50.8 34.5 20.1 10.9 45.4 36.4 34.4 37.7 24.5 28.3 27.0 33.7 26.4 40.4 23.0 55.5 33.6 9.5 19.6 9.7 33.4 9.3 49.5 44.2 42.5 37.6 28.3 74.4 47.9 37.7 47.2 17.6 23.4 46.3 30.7 18.1 55.8 27.6 77.8 28.5 41.3 46.2 35.2 21.2 26.6 70.1 36.2 12.1 89.6 31.4 27.5 29.4 25.9 27.1 39.1 42.5 10.9 25.2 74.5 26.6 17.8 17.2 32.5 30.9 87.4 86.7 30.9 47.9 76.2 30.2 43.9 58.1 18.0 54.3 51.6 61.8 139.4 80.9 65.8 71.5 128.9 115.6 86.4 10.5 54.4 38.8 87.0 85.0 66.6 44.9 46.1 45.2 58.4 45.2 44.8 46.8 45.6 44.3 46.6 45.6 45.1 50.8 34.0 32.1 27.2 6.8 48.8 45.2 53.0 48.5 44.3 24.5 48.4 58.8 45.0 30.0 30.0 16.5 18.8 45.0 32.4 47.2 72.4 37.4 39.5 20.3 35.0 28.4 13.8 19.6 9.2 62.0 35.1 37.3 32.6 24.9 48.9 35.3 34.6 48.4 40.7 11.8 8.1 35.0 26.4 39.0 29.2 137.4 48.1 29.9 21.4 3.7 33.5 41.5 28.8 17.1 12.1 31.2 53.7 26.7 34.1 38.5 51.2 118.2 22.7 34.7 39.5 39.2 62.9 20.7 25.5 29.5 34.8 75.7 36.8 42.4 31.8 38.9 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.1;retina: 28.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "T-reg: 1.6" "Lineage enriched" "Detected in single" 15 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947, HPA061485" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: " "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.1 7.8 7.7 0.3 17.1 0.2 0.1 1.1 34.1 0.3 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.3 0.2 14.3 9.0 0.3 0.0 0.2 0.5 10.5 8.5 13.7 0.2 0.2 3.9 5.4 0.0 13.6 0.7 0.3 28.4 0.2 0.4 0.3 0.1 0.3 0.3 0.0 2.5 0.2 2.6 5.8 0.3 0.1 0.2 0.7 0.4 0.3 22.0 0.0 0.4 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.0 1.2 0.0 0.2 0.1 0.0 6.0 0.9 2.5 0.2 0.0 0.1 0.8 0.5 0.1 0.0 0.0 0.4 0.0 0.4 1.5 0.8 5.0 0.3 0.7 0.8 0.5 0.8 0.0 1.0 3.4 0.0 0.9 0.2 0.1 1.5 0.5 0.6 0.0 1.3 0.3 0.3 0.5 0.3 0.0 0.5 0.0 0.0 2.0 2.3 1.1 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 7.7 17.1 1.1 34.1 14.3 9.0 10.5 8.5 13.7 13.6 0.0 5.8 22.0 12.3 0.0 2.2 17.0 0.2 0.4 0.5 0.2 8.6 79.0 0.3 0.6 1.8 0.0 0.1 5.5 221.0 0.2 0.8 2.1 0.0 0.1 92.9 4.6 2.1 2.0 0.0 0.4 177.2 0.2 0.1 2.0 5.1 4.3 1.3 7.7 1.8 0.4 0.5 8.4 149.9 0.3 2.0 0.8 1.2 16.4 0.9 4.3 1.8 43.1 1.6 3.8 1.0 185.5 69.1 0.1 2.2 0.4 0.6 0.3 0.4 0.1 2.8 124.0 0.0 4.1 0.9 1.4 4.2 11.2 0.4 1.4 2.9 2.9 0.2 1.1 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "basophil: 3.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 4.0 8.5 3.6 12.4 4.1 5.1 24.1 10.9 6.9 5.7 5.0 2.4 7.5 7.3 2.4 4.9 5.9 5.1 6.6 8.5 10.8 1.6 1.9 4.1 13.0 11.3 6.0 8.5 3.0 0.6 2.9 2.7 13.4 4.1 3.0 3.9 3.6 4.9 4.9 2.7 4.8 4.9 8.0 9.2 3.6 2.1 13.5 3.0 5.6 7.6 2.6 4.3 4.7 14.1 0.4 0.9 1.5 0.8 0.0 0.0 1.8 1.1 0.0 0.0 0.0 2.3 1.1 1.2 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.9 1.3 2.0 2.9 0.2 0.0 2.4 1.4 0.0 0.0 0.0 0.0 2.2 0.0 1.3 1.1 2.7 0.0 1.0 1.5 1.2 1.5 0.9 0.4 0.9 1.6 0.7 0.0 1.5 1.1 1.7 0.8 1.2 0.3 2.7 0.8 0.4 1.2 0.6 0.7 0.9 1.6 0.4 0.1 1.8 1.5 1.1 0.8 3.7 0.3 0.1 0.5 0.2 0.3 0.7 0.4 0.5 0.2 0.6 0.8 0.3 0.1 0.4 0.1 0.3 0.1 0.1 8.5 12.4 24.1 10.9 6.6 8.5 13.0 11.3 6.0 13.4 8.0 13.5 14.1 0.6 0.0 1.1 0.0 0.2 0.1 0.5 0.0 0.0 5.0 0.1 0.9 1.3 0.0 0.0 1.8 6.2 0.3 0.3 0.0 0.0 0.0 1.6 0.2 0.9 0.6 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.4 0.0 0.1 3.3 3.3 0.0 0.0 0.6 0.3 1.8 0.3 0.5 0.0 2.8 0.0 0.6 3.1 0.5 4.9 0.0 0.0 5.3 0.0 0.3 0.0 0.2 0.0 8.8 26.3 0.5 23.1 0.1 0.3 0.1 0.1 0.0 1.1 0.4 0.0 0.1 LAMA3 "BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa" ENSG00000053747 "Laminin subunit alpha 3" Q16787 18 23689453-23956222 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 171.0;Gastric mucus-secreting cells: 138.1;Pancreatic endocrine cells: 585.5;Paneth cells: 170.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 40.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "HBEC3-KT: 1237.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009309, CAB010757" Uncertain Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 1800000 "Endoplasmic reticulum" "CAB010757: AB_477162, HPA009309: AB_1079224" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (6.36e-2)" "unprognostic (3.82e-3)" "unprognostic (2.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-3)" "unprognostic (1.59e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.98e-1)" "unprognostic (2.36e-1)" "unprognostic (3.15e-1)" "unprognostic (9.91e-3)" "unprognostic (3.98e-2)" "unprognostic (1.13e-1)" 10.0 1.2 8.0 8.6 2.9 0.1 20.5 2.5 5.9 14.8 5.1 13.8 17.9 15.8 4.8 14.7 12.1 7.4 4.0 3.6 2.9 3.1 1.8 21.1 4.1 3.3 4.9 2.9 5.8 4.7 11.0 3.0 25.0 3.0 12.3 8.5 3.7 21.5 13.6 2.0 31.9 19.9 6.9 2.8 0.8 32.1 3.3 3.4 9.6 2.3 1.7 4.1 12.3 23.3 2.5 140.5 15.7 0.1 0.1 6.9 1.3 0.3 2.6 1.8 1.3 1.7 5.4 159.5 0.1 17.3 1.8 0.4 248.5 0.2 1237.9 0.9 0.2 8.8 0.0 5.6 2.8 1.2 0.0 0.6 1.6 139.1 0.8 140.0 0.9 5.2 0.2 0.0 0.2 1.6 0.4 0.1 0.1 1.4 42.6 14.4 2.6 0.1 0.2 51.8 15.4 0.6 2.5 4.9 2.0 0.4 0.3 4.5 1.8 12.3 0.9 1.0 6.7 0.6 0.2 0.1 0.6 2.9 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 2.9 2.5 5.9 3.6 2.9 3.3 4.9 2.9 3.0 2.8 3.4 2.5 28.8 115.4 26.4 13.1 0.7 31.4 104.2 117.1 100.7 6.0 21.8 41.8 2.3 4.3 20.4 1.8 0.0 0.6 0.5 171.0 0.0 30.2 3.9 21.5 4.3 7.5 8.3 0.0 8.3 34.4 0.4 3.6 138.1 24.0 5.7 9.5 2.5 0.9 0.2 0.0 18.5 23.7 4.1 0.0 1.5 4.5 5.9 2.0 1.8 68.4 0.6 0.2 0.0 1.0 2.0 585.5 170.1 3.4 0.2 45.6 39.5 0.0 15.6 2.2 6.6 1.5 22.1 4.5 4.0 28.2 9.9 0.1 1.5 5.9 28.4 18.2 AP5M1 "C14orf108, FLJ10813, mu5, MuD, MUDENG" ENSG00000053770 "Adaptor related protein complex 5 subunit mu 1" Q9H0R1 14 57268924-57298742 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055768, HPA057098" Approved NA NA "HPA055768: AB_2682913, HPA057098: AB_2683335" "unprognostic (7.95e-2)" "unprognostic (5.37e-2)" "prognostic favorable (7.91e-4)" "unprognostic (1.52e-1)" "unprognostic (2.68e-1)" "unprognostic (2.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-1)" "unprognostic (5.51e-3)" "unprognostic (1.23e-1)" "prognostic favorable (1.11e-14)" "unprognostic (6.26e-2)" "unprognostic (1.38e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" 11.6 12.2 6.8 13.3 8.7 15.5 13.9 11.6 10.1 14.4 17.2 25.9 29.1 11.8 15.5 16.5 9.9 12.2 16.6 7.1 13.0 28.8 21.3 11.8 17.2 12.7 9.2 5.2 8.4 10.1 31.8 6.6 11.1 12.4 12.4 29.8 22.7 16.8 12.7 15.6 11.3 25.4 14.2 8.5 14.6 15.0 10.5 9.5 22.4 18.5 28.5 22.9 13.4 7.5 12.3 19.0 16.1 22.3 21.5 20.2 22.6 17.8 21.0 20.7 18.5 24.5 16.1 27.8 26.7 20.4 20.7 16.5 27.6 32.1 18.5 27.8 27.9 9.4 14.8 15.3 18.7 14.0 44.9 23.6 20.9 23.8 17.6 13.3 19.2 21.0 23.2 18.4 17.6 29.8 16.6 41.6 11.2 16.9 34.6 22.4 27.9 29.4 20.3 42.7 44.1 36.4 20.0 24.3 38.9 16.3 21.8 23.8 20.4 13.5 26.3 24.9 13.9 12.0 9.7 15.9 24.1 23.2 21.1 19.8 20.5 17.8 36.4 19.1 15.4 20.8 22.8 21.0 22.0 24.9 15.9 21.4 22.9 14.9 28.6 15.3 13.2 25.6 17.9 6.8 8.7 11.6 10.1 7.1 13.0 12.7 9.2 5.2 12.4 8.5 9.5 12.3 15.4 32.1 13.1 19.2 30.7 20.1 18.8 30.5 21.6 21.0 17.8 11.6 32.6 17.2 25.3 23.9 39.6 21.5 22.6 40.6 86.1 20.9 115.1 11.5 12.9 19.0 29.9 23.4 42.3 16.2 18.9 17.0 29.0 13.1 17.7 13.4 18.9 31.1 24.5 35.3 45.6 29.0 44.7 25.6 11.5 88.1 17.7 17.9 21.4 21.5 32.1 19.3 34.0 19.1 31.0 16.6 23.7 20.3 26.8 19.9 44.8 74.4 16.2 31.3 19.7 12.7 13.4 31.5 10.7 37.8 21.5 19.3 22.3 17.2 39.6 23.7 ANAPC4 APC4 ENSG00000053900 "Anaphase promoting complex subunit 4" Q9UJX5 4 25377263-25418498 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 266.1;Glandular and luminal cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032519, HPA038395, HPA038396" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356" "unprognostic (1.36e-1)" "unprognostic (9.15e-2)" "unprognostic (6.06e-3)" "prognostic favorable (5.73e-7)" "unprognostic (1.14e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.18e-3)" "unprognostic (5.44e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "unprognostic (8.86e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.95e-2)" "prognostic favorable (1.12e-6)" 13.3 15.8 15.7 15.8 16.3 18.7 16.0 16.0 19.2 23.7 16.4 15.1 11.9 26.9 18.2 13.6 35.4 11.9 11.7 15.9 15.8 13.8 13.1 13.9 20.8 15.8 15.5 15.4 18.8 15.9 15.7 13.0 15.7 15.7 16.8 16.8 16.8 13.0 21.4 13.9 14.8 15.9 14.0 15.8 19.4 14.2 10.9 15.8 16.3 13.8 8.6 18.4 18.9 14.4 18.2 21.5 12.4 21.4 22.4 22.0 24.4 30.5 25.0 18.5 23.2 22.3 20.0 33.4 34.9 13.1 21.4 29.5 16.9 22.9 21.1 26.5 12.5 17.5 33.9 23.2 18.9 14.8 26.7 26.6 18.9 15.6 20.5 12.4 16.4 20.4 30.4 49.7 10.2 29.8 16.7 34.6 43.5 29.7 18.9 15.2 24.4 35.7 25.7 19.6 23.0 23.8 14.3 18.7 11.0 16.1 21.8 16.4 28.3 20.9 19.7 12.4 15.3 29.1 13.4 25.3 33.3 21.4 37.6 19.0 2.4 7.4 14.9 9.6 8.8 13.1 8.6 8.7 11.4 6.5 6.9 7.7 9.8 3.0 10.3 12.5 4.2 11.6 6.4 15.7 16.3 16.0 19.2 15.9 15.8 15.8 15.5 15.4 15.7 15.8 15.8 18.2 11.1 9.6 14.5 26.8 15.2 12.9 16.5 13.1 14.2 12.9 7.6 7.5 14.0 14.3 17.2 7.3 10.4 56.9 17.5 8.9 5.9 10.3 4.3 266.1 20.6 11.1 12.6 10.3 28.8 12.0 14.2 16.3 17.3 79.0 25.3 15.3 15.0 7.1 17.5 21.9 38.4 8.4 10.2 13.7 8.0 3.4 10.2 13.7 17.8 18.7 15.0 12.2 16.5 34.2 49.0 8.9 6.5 15.1 19.5 4.9 9.8 7.0 45.9 13.9 19.7 15.7 16.3 13.4 15.4 13.0 9.2 23.8 19.7 12.7 11.8 7.8 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849105 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 198.7;stomach 1: 99.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8" "Cancer enhanced" "Detected in all" "colorectal cancer: 42.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB018656, HPA048553, HPA071107" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: " "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favorable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 5.5 198.7 1.7 9.1 1.8 14.3 3.0 2.0 2.0 16.7 5.3 22.8 48.3 3.0 14.3 2.9 9.0 19.6 28.6 2.0 3.4 25.5 1.8 16.0 5.0 3.6 2.3 1.1 1.4 61.7 21.6 5.5 7.6 3.5 6.1 15.4 0.7 20.2 50.6 1.0 1.1 40.1 3.1 3.2 8.3 99.7 1.7 3.0 3.6 72.2 1.6 2.9 14.8 1.6 3.3 0.0 0.1 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 2.6 1.9 5.2 0.0 0.4 0.1 0.7 0.0 0.0 0.4 1.3 0.0 3.7 0.4 0.3 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.7 1.3 41.4 0.2 0.1 0.0 23.2 8.0 2.7 0.7 5.6 0.7 0.0 0.0 0.5 0.2 10.3 0.0 0.0 0.3 0.2 0.0 11.5 0.0 0.0 0.0 13.4 0.0 0.7 3.1 3.1 0.0 1.8 0.0 0.8 0.4 0.1 3.8 0.3 1.0 1.2 3.3 0.0 2.8 1.3 0.3 1.0 1.7 1.8 2.0 2.0 2.0 3.4 3.6 2.3 1.1 3.5 3.2 3.0 3.3 7.1 3.2 12.9 0.3 8.4 0.6 8.0 4.2 0.0 1.7 6.1 1.8 18.6 14.3 7.1 29.5 0.0 1.1 0.3 34.0 15.6 23.2 2.0 3.3 0.4 6.3 6.6 0.4 13.7 21.7 1.4 1.0 23.4 4.9 19.7 47.6 9.3 1.1 17.3 0.0 20.0 26.1 8.2 25.4 15.9 0.9 0.3 19.6 1.8 71.2 11.0 0.5 1.0 43.7 34.9 15.3 20.2 0.0 6.4 5.2 30.9 2.0 4.4 0.5 6.6 0.4 1.7 0.2 0.2 0.1 1.0 2.1 4.0 16.6 57.8 20.4 TRAPPC3 BET3 ENSG00000054116 "Trafficking protein particle complex 3" O43617 1 36136570-36156053 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028408 Approved Approved "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA028408: AB_10601826" "unprognostic (3.54e-3)" "unprognostic (1.17e-1)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (7.39e-3)" "unprognostic (1.15e-1)" "unprognostic (7.12e-3)" "unprognostic (7.38e-2)" "unprognostic (2.94e-1)" "unprognostic (9.25e-3)" "unprognostic (2.61e-2)" "unprognostic (9.47e-2)" "unprognostic (2.10e-3)" "unprognostic (6.53e-2)" 43.3 75.3 45.3 31.5 45.6 29.0 47.1 49.8 51.1 36.8 55.0 51.6 33.9 41.5 61.3 62.1 37.4 32.8 48.6 45.0 48.7 55.8 51.6 36.7 38.6 50.7 47.2 44.4 28.5 46.4 54.9 47.4 38.2 49.5 39.6 42.9 40.3 46.8 45.9 49.3 51.9 38.8 50.4 50.7 41.9 48.6 53.6 48.4 51.8 60.5 45.0 54.8 46.6 41.6 51.5 95.7 65.6 44.9 70.2 114.2 91.4 87.9 85.2 109.0 100.0 97.0 55.9 90.0 40.4 79.0 95.0 79.6 68.8 69.9 114.1 113.8 79.8 103.7 75.8 77.2 81.7 132.6 80.0 76.7 78.3 98.5 93.8 91.5 103.6 126.7 101.2 93.2 67.0 122.0 71.4 95.6 74.6 60.5 79.5 93.7 65.8 63.8 90.9 128.4 76.1 67.8 49.7 69.2 78.5 140.1 115.2 50.2 59.6 95.6 59.1 66.7 116.0 116.3 80.1 87.0 67.3 100.7 88.7 60.5 161.9 130.2 148.7 85.0 142.5 89.4 93.6 100.4 90.4 132.6 89.0 96.0 86.9 134.3 95.8 116.3 109.4 135.4 155.3 45.3 45.6 49.8 51.1 45.0 48.7 50.7 47.2 44.4 49.5 50.7 48.4 51.5 41.9 25.6 27.6 12.1 45.6 101.1 111.5 152.1 52.3 41.8 97.8 78.5 57.8 55.8 75.7 38.6 16.7 145.7 43.0 55.1 170.2 157.0 286.1 51.8 38.3 59.1 48.3 63.3 15.4 188.5 146.0 52.1 29.0 55.6 45.7 40.5 33.2 49.8 145.0 53.8 16.9 51.2 132.2 56.1 74.7 131.0 42.9 60.6 96.0 10.3 104.4 68.0 61.8 8.5 17.9 178.4 72.1 51.9 80.7 196.9 73.3 115.9 49.2 30.7 32.9 37.4 69.2 172.5 89.4 63.4 123.6 191.4 50.4 50.3 54.3 134.1 THRAP3 "BCLAF2, TRAP150" ENSG00000054118 "Thyroid hormone receptor associated protein 3" Q9Y2W1 1 36224432-36305357 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012041, CAB017472, HPA063765" Supported Enhanced "Nuclear speckles" NA NA 59000 "Nuclear speckles" "CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117" "unprognostic (8.53e-2)" "unprognostic (1.68e-1)" "unprognostic (9.29e-2)" "unprognostic (2.11e-1)" "unprognostic (1.71e-2)" "unprognostic (4.70e-2)" "unprognostic (2.65e-3)" "unprognostic (1.67e-1)" "unprognostic (9.30e-2)" "unprognostic (1.16e-1)" "unprognostic (5.08e-2)" "unprognostic (4.82e-2)" "unprognostic (3.34e-2)" "prognostic favorable (5.36e-4)" "unprognostic (7.56e-2)" "unprognostic (7.52e-2)" "unprognostic (1.23e-1)" 42.3 40.9 25.8 46.3 25.8 45.0 44.2 29.5 27.2 35.1 30.9 37.7 34.2 39.8 35.2 41.0 39.6 29.9 47.7 25.0 29.1 32.6 46.2 37.7 57.6 26.2 26.2 23.0 45.7 35.9 52.4 30.2 40.4 27.3 50.8 39.1 41.3 39.2 31.6 116.2 38.0 35.4 42.5 25.4 48.4 38.2 34.6 24.6 63.7 46.4 64.6 61.3 37.4 36.5 29.0 100.7 63.9 110.1 94.9 88.0 69.7 90.9 104.6 107.4 107.2 109.8 74.7 91.5 187.5 38.5 113.8 73.8 89.1 125.2 106.9 131.3 97.4 70.1 157.7 94.3 85.6 94.6 157.2 102.5 105.7 65.7 107.1 86.7 75.2 118.4 107.5 127.8 93.5 77.6 57.8 180.4 92.7 130.5 64.2 50.4 163.6 133.4 99.4 77.0 125.4 69.6 83.9 117.5 77.0 92.7 108.7 73.1 69.3 122.4 89.2 100.4 82.5 111.6 56.7 80.7 162.4 82.2 109.2 92.7 85.8 36.9 64.7 51.5 43.9 46.0 53.6 43.9 46.5 42.4 61.0 46.4 43.1 80.8 51.2 48.6 46.7 40.7 47.3 25.8 25.8 29.5 27.2 25.0 29.1 26.2 26.2 23.0 27.3 25.4 24.6 29.0 101.0 115.4 101.7 32.3 136.1 56.7 94.5 126.9 78.0 98.0 76.4 65.5 113.7 75.8 106.2 47.8 31.3 150.7 151.9 64.3 97.8 155.7 9.7 92.1 114.7 96.2 72.4 114.9 65.6 104.1 147.2 98.3 58.6 106.0 92.9 120.5 80.7 78.8 101.6 87.5 63.2 70.1 89.5 77.1 71.7 12.0 80.2 89.9 72.9 53.4 155.5 129.4 196.7 47.7 53.4 111.5 61.9 83.5 119.7 125.2 51.6 76.0 87.6 93.2 92.1 114.6 116.5 145.9 118.4 89.6 68.5 144.1 129.0 141.0 87.1 86.4 PHPT1 "bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14" ENSG00000054148 "Phosphohistidine phosphatase 1" Q9NRX4 9 136848724-136851027 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 445.4" "Cell type enhanced" "Detected in all" "Late spermatids: 953.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013584, HPA020952" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 590000 Cytosol "Nucleoplasm, Nuclear bodies, Plasma membrane" "CAB013584: , HPA020952: AB_1855331" "unprognostic (7.34e-2)" "unprognostic (9.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.30e-1)" "unprognostic (4.64e-2)" "unprognostic (1.69e-2)" "unprognostic (3.23e-2)" "unprognostic (1.82e-1)" "unprognostic (1.26e-3)" "unprognostic (5.85e-2)" "unprognostic (9.66e-3)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (3.95e-2)" "unprognostic (8.49e-2)" 72.2 110.1 171.5 55.0 172.2 65.1 63.0 180.2 247.6 76.6 164.3 74.7 54.5 45.0 103.9 71.3 100.2 62.5 269.7 165.9 193.1 82.9 48.3 57.8 57.9 172.9 166.0 163.8 65.6 154.7 162.3 85.9 50.3 171.8 90.0 51.0 26.6 145.2 87.4 436.8 46.1 63.5 78.8 176.1 41.9 62.0 57.4 176.0 69.1 87.5 445.4 40.4 72.5 41.7 192.4 53.6 452.5 225.6 199.1 153.4 266.0 412.8 147.6 170.8 158.8 138.6 165.7 138.0 145.1 142.8 168.6 180.0 155.0 51.2 293.9 50.2 116.9 132.5 45.4 276.8 380.3 177.5 82.6 176.4 322.8 248.7 91.8 109.5 145.8 218.8 93.1 102.9 129.7 257.2 328.2 156.9 176.7 216.0 372.5 206.6 106.5 106.6 196.7 255.6 113.3 137.6 132.8 146.7 155.8 75.1 107.0 127.2 226.4 177.0 390.6 130.8 91.5 166.5 60.5 93.4 94.0 174.3 59.7 235.8 38.2 290.0 31.0 197.6 318.4 170.7 241.3 173.9 184.6 321.8 178.9 126.0 175.8 13.7 196.7 231.7 425.4 223.6 324.1 171.5 172.2 180.2 247.6 165.9 193.1 172.9 166.0 163.8 171.8 176.1 176.0 192.4 125.7 96.1 159.8 24.8 111.8 150.3 187.7 659.2 204.9 43.9 223.1 317.7 384.8 178.7 326.5 217.0 22.9 322.1 111.8 337.1 747.4 196.1 271.3 122.2 168.1 111.9 265.1 80.2 8.1 252.4 489.5 213.1 140.6 170.3 123.5 367.4 83.6 201.9 286.5 67.3 12.5 370.9 309.3 97.2 197.1 953.5 205.0 133.6 334.4 5.6 273.2 194.7 146.2 10.6 25.0 185.3 359.8 223.4 187.8 257.5 540.1 817.4 250.6 77.7 85.5 137.1 249.6 141.8 143.8 140.3 161.8 264.1 106.4 352.5 336.0 199.5 ENTPD2 "CD39L1, NTPDase-2" ENSG00000054179 "Ectonucleoside triphosphate diphosphohydrolase 2" Q9Y5L3 9 137048107-137054061 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" "Leydig cells: 192.3;Paneth cells: 35.5;Peritubular cells: 96.7;Proximal enterocytes: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 24.3;hTCEpi: 12.7;MCF7: 16.7;OE19: 26.6;SK-BR-3: 21.6;T-47d: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017676 Approved NA NA "HPA017676: AB_1848179" "unprognostic (1.64e-1)" "unprognostic (3.35e-2)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (2.15e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.71e-2)" "unprognostic (4.97e-2)" "unprognostic (3.23e-1)" "unprognostic (2.99e-1)" "unprognostic (1.89e-1)" "prognostic favorable (3.51e-6)" "prognostic favorable (1.38e-4)" "unprognostic (2.51e-1)" "unprognostic (8.43e-2)" "unprognostic (1.12e-3)" 1.0 0.8 17.1 0.9 11.5 0.2 5.0 16.4 14.9 5.9 3.2 6.2 12.3 1.8 1.6 3.3 6.1 4.6 3.1 11.7 28.2 4.6 0.9 0.5 0.1 14.0 20.0 8.9 0.7 1.8 0.9 3.0 0.7 21.3 7.4 3.8 1.0 5.5 1.6 2.0 9.2 7.8 1.0 15.6 0.1 6.1 3.5 20.2 0.2 0.6 3.5 0.3 1.2 3.6 13.3 6.5 1.7 0.0 0.1 0.1 0.0 3.9 0.0 0.0 0.0 0.0 1.2 1.9 0.0 1.4 0.0 0.0 5.1 0.5 3.7 0.0 0.0 0.2 0.0 0.8 24.3 0.0 0.0 0.3 0.0 12.7 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 26.6 3.6 0.0 1.1 2.5 2.8 0.6 3.5 0.1 0.3 21.6 0.0 0.1 23.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 11.5 16.4 14.9 11.7 28.2 14.0 20.0 8.9 21.3 15.6 20.2 13.3 1.1 0.0 0.0 19.2 0.5 1.7 1.9 2.8 4.0 0.2 8.0 13.2 0.5 11.5 1.8 0.0 0.0 0.3 0.0 26.2 0.0 6.2 1.4 12.1 1.5 1.2 25.2 0.0 0.2 4.3 1.1 1.5 5.1 2.8 0.0 0.0 0.4 1.1 0.2 0.0 0.1 9.4 6.1 0.0 0.0 6.2 192.3 0.3 5.4 1.9 0.6 6.8 0.0 0.5 0.1 6.0 35.5 96.7 0.0 4.4 61.8 8.6 3.2 0.1 0.0 0.4 4.1 1.2 4.4 1.8 1.4 1.0 0.2 0.0 16.0 1.5 LY75 "CD205, CLEC13B, DEC-205" ENSG00000054219 "Lymphocyte antigen 75" O60449 2 159803355-159904756 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 79.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 27.8;monocytes: 96.5;Proximal enterocytes: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 21.8;HDLM-2: 21.7;Karpas-707: 85.3;RT4: 30.1;THP-1: 22.3" "CAB001450, HPA049108, HPA054073" Enhanced Approved "Golgi apparatus" NA NA 1300000 "Golgi apparatus" "CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370" "unprognostic (7.29e-3)" "unprognostic (1.92e-3)" "unprognostic (3.15e-1)" "unprognostic (1.52e-2)" "unprognostic (4.60e-3)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.80e-1)" "unprognostic (2.36e-1)" "unprognostic (8.74e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (1.94e-2)" "prognostic favorable (3.86e-4)" 1.8 1.9 1.1 18.8 1.2 9.7 9.5 1.1 1.2 7.4 0.9 12.5 18.2 2.6 0.7 5.1 8.5 7.8 1.0 0.9 1.4 3.7 2.0 7.8 30.6 1.5 1.2 0.6 1.1 1.4 1.1 0.6 1.3 1.6 1.8 12.0 0.7 7.9 2.6 0.3 7.5 17.7 2.3 1.7 18.5 7.2 0.4 1.5 79.1 17.4 0.9 22.3 10.4 2.2 1.8 3.5 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 21.8 15.7 0.7 0.0 0.0 0.4 0.0 0.1 0.0 21.7 0.0 4.4 0.2 0.1 0.4 3.3 0.1 0.3 0.1 0.6 0.2 0.0 11.1 0.0 0.0 85.3 0.0 0.0 0.0 5.8 0.5 0.5 0.0 6.0 0.0 3.8 6.4 30.1 0.0 0.0 7.0 5.0 0.0 0.2 0.0 22.3 16.7 0.0 0.0 0.0 0.0 13.2 2.4 3.0 0.0 7.7 0.0 2.6 1.2 2.4 4.2 1.7 4.6 3.7 3.8 4.8 2.9 2.7 4.3 5.1 3.7 5.2 0.7 1.0 3.0 1.4 1.1 1.2 1.1 1.2 0.9 1.4 1.5 1.2 0.6 1.6 1.7 1.5 1.8 1.7 0.0 3.4 0.0 15.4 7.5 2.2 5.6 7.4 0.2 9.9 12.1 0.5 4.3 6.3 23.9 2.1 0.1 10.6 27.8 0.0 0.8 0.6 15.4 1.3 3.3 1.8 6.9 0.0 5.5 0.1 1.8 8.6 9.4 11.4 1.7 2.2 0.2 3.9 0.0 0.0 9.8 4.1 10.1 11.3 0.3 2.5 11.5 5.4 0.0 96.5 0.2 13.4 0.0 0.0 4.9 10.9 0.4 8.1 1.3 33.5 2.0 20.7 0.2 0.0 3.7 1.3 0.0 0.7 4.5 6.7 0.3 14.2 0.9 12.3 5.6 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 486.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 11.3 11.0 11.1 14.2 12.7 33.3 13.7 14.7 11.7 15.1 9.7 9.4 8.2 16.1 14.5 9.9 11.0 13.3 7.5 10.0 11.4 10.7 12.0 12.1 21.1 11.7 12.2 9.2 17.3 11.5 13.7 11.0 12.9 12.2 14.4 9.2 14.8 11.6 10.9 9.1 9.0 10.4 10.3 11.9 18.5 13.3 17.3 11.6 21.6 17.1 9.9 17.1 13.0 10.7 14.8 15.8 10.5 18.0 16.5 15.3 15.5 17.5 17.6 15.1 11.3 10.9 12.2 16.9 18.1 19.9 12.0 8.7 13.4 16.4 7.4 17.8 23.5 17.3 14.7 14.7 10.9 11.9 15.8 21.0 10.8 10.4 13.5 12.7 16.1 18.2 11.4 19.3 25.4 11.9 7.5 21.9 15.3 18.9 12.1 8.2 9.4 13.4 15.3 14.1 13.2 15.9 22.4 22.1 20.3 18.3 6.2 19.1 27.4 21.6 14.4 11.5 18.2 17.7 25.1 22.1 18.2 9.8 11.9 19.4 61.7 13.7 41.1 29.9 15.0 27.5 32.2 31.6 26.0 13.8 34.0 31.2 26.7 72.5 33.8 25.6 23.6 28.3 12.6 11.1 12.7 14.7 11.7 10.0 11.4 11.7 12.2 9.2 12.2 11.9 11.6 14.8 156.8 102.5 106.8 107.7 150.1 124.3 83.8 61.2 103.0 125.5 86.2 78.5 77.4 47.1 91.7 31.3 120.9 64.0 218.9 47.9 19.6 76.4 334.7 119.3 127.9 128.9 90.1 45.2 157.0 47.9 70.2 101.6 59.1 169.2 110.1 78.0 67.8 27.6 44.4 112.7 158.4 53.2 65.1 61.2 127.6 486.5 101.2 97.3 83.6 107.7 122.8 67.7 204.9 144.8 304.2 68.6 57.3 77.5 104.1 108.7 48.3 20.6 82.3 150.7 46.0 130.2 121.4 236.7 161.9 66.5 106.4 156.7 209.8 84.8 44.7 149.6 OPN3 "ECPN, encephalopsin, ERO, NMO-1, PPP1R116" ENSG00000054277 "Opsin 3" Q9H1Y3 1 241590102-241677376 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.8" "Cell type enhanced" "Detected in many" "Early spermatids: 133.9;Extravillous trophoblasts: 252.9;Langerhans cells: 206.8;Syncytiotrophoblasts: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 10.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 72.4" "Low region specificity" "Detected in all" "CAB013682, HPA064443" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB013682: , HPA064443: AB_2685267" "unprognostic (2.41e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (1.75e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (7.12e-2)" "unprognostic (5.10e-3)" "unprognostic (1.24e-2)" "unprognostic (2.39e-1)" "unprognostic (4.96e-1)" "unprognostic (2.66e-2)" "unprognostic (3.44e-1)" "unprognostic (9.13e-2)" "unprognostic (9.15e-3)" "unprognostic (2.61e-2)" "unprognostic (7.12e-2)" "unprognostic (9.44e-3)" 2.6 2.3 6.1 3.4 6.4 1.2 3.1 5.1 8.9 2.7 4.9 6.4 1.7 3.8 4.5 4.3 4.5 3.1 2.1 6.4 5.7 4.2 11.1 8.5 4.5 4.5 7.4 5.9 2.2 1.9 1.4 2.7 18.8 5.0 1.0 5.5 0.5 2.3 1.3 1.8 2.2 2.9 1.9 4.5 4.5 3.3 2.5 7.5 4.9 3.2 4.1 5.2 4.2 2.9 6.4 4.5 15.0 10.7 0.8 38.3 72.4 8.2 8.0 6.0 5.6 5.6 1.1 12.5 0.6 0.4 9.7 6.3 25.9 3.4 5.7 5.6 16.7 0.8 0.0 3.2 9.5 19.4 3.9 8.3 37.0 15.5 3.5 8.4 37.7 11.5 13.4 7.6 2.3 9.1 2.4 1.4 5.0 29.1 19.3 8.0 6.3 0.6 14.6 38.5 6.7 2.8 10.9 5.0 15.6 4.6 21.5 0.8 14.9 13.9 1.3 1.0 2.2 8.6 5.3 8.7 0.7 4.3 12.4 16.7 0.0 0.8 0.7 0.0 1.1 0.0 1.8 0.1 0.1 2.2 1.7 0.2 0.3 0.3 0.5 1.1 10.0 0.2 0.5 6.1 6.4 5.1 8.9 6.4 5.7 4.5 7.4 5.9 5.0 4.5 7.5 6.4 3.7 6.4 5.4 4.9 35.5 14.7 13.5 12.7 18.8 3.3 12.4 10.5 0.8 15.7 7.0 12.9 0.0 80.6 60.1 41.4 13.7 16.8 133.9 10.5 5.8 5.9 4.2 15.1 56.7 10.5 252.9 7.7 12.8 22.2 2.5 22.4 8.6 26.3 26.6 0.0 15.7 8.8 20.3 31.9 206.8 89.7 11.1 56.9 28.4 9.4 30.2 4.3 5.2 10.1 7.2 19.3 10.8 16.6 18.4 20.1 7.6 21.5 2.7 2.1 0.0 5.4 13.3 7.8 8.3 29.7 12.4 171.6 6.4 6.6 7.1 15.2 SDCCAG8 "BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7" ENSG00000054282 "SHH signaling and ciliogenesis regulator SDCCAG8" Q86SQ7 1 243256034-243500091 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 284.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025737, HPA044477, HPA072495" Approved Enhanced Centrosome NA NA Centrosome "HPA025737: AB_2671761, HPA044477: AB_2678955, HPA072495: AB_2686527" "unprognostic (4.12e-1)" "unprognostic (3.94e-2)" "unprognostic (7.58e-2)" "unprognostic (2.86e-2)" "unprognostic (2.61e-1)" "unprognostic (3.78e-2)" "unprognostic (9.34e-2)" "unprognostic (3.95e-2)" "unprognostic (4.37e-2)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-2)" "unprognostic (1.38e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (3.68e-3)" "unprognostic (4.69e-2)" 11.3 9.9 6.3 3.9 6.4 3.5 11.4 6.1 7.4 9.6 5.7 8.0 2.9 8.0 7.3 8.1 9.5 7.6 8.2 6.3 7.2 9.4 7.5 11.9 5.3 7.4 6.4 5.7 11.0 14.4 7.1 11.7 4.5 6.7 9.0 3.2 3.7 8.5 3.9 12.2 7.8 7.6 3.0 7.3 8.3 8.5 5.3 6.3 3.3 17.2 2.3 2.7 9.0 9.0 8.0 6.2 5.4 2.0 3.8 7.3 3.4 6.3 4.4 3.4 2.1 1.7 4.9 10.9 2.4 6.5 3.7 0.7 2.2 0.6 4.9 2.0 3.7 6.9 2.3 3.7 2.0 3.7 2.2 5.1 7.0 6.2 4.8 7.7 7.9 5.5 5.2 3.2 3.3 3.9 1.9 0.9 4.9 1.2 9.4 9.5 3.1 1.1 2.1 7.5 4.1 5.6 5.7 4.3 2.6 10.6 0.9 4.3 2.8 5.2 6.8 1.5 2.4 2.5 5.1 2.7 1.2 3.0 4.1 29.9 7.6 7.8 6.6 3.8 8.0 2.8 5.2 4.3 5.3 7.1 6.9 6.1 4.2 4.7 9.0 4.5 5.6 3.8 3.8 6.3 6.4 6.1 7.4 6.3 7.2 7.4 6.4 5.7 6.7 7.3 6.3 8.0 30.6 41.7 103.6 139.7 39.0 37.2 39.6 59.1 56.9 69.8 34.9 37.1 28.5 50.1 52.0 40.5 87.6 48.1 16.1 16.5 76.3 63.1 17.8 60.9 31.6 36.2 31.9 23.3 170.5 30.0 86.3 38.5 24.5 31.4 49.9 29.8 45.7 27.8 130.1 65.6 153.2 18.1 63.1 51.0 32.5 33.8 52.8 51.7 35.6 188.3 45.9 67.1 22.6 165.4 284.0 50.1 26.4 44.4 30.8 33.6 31.5 39.0 73.5 80.3 39.5 34.8 32.0 51.4 20.7 38.8 49.2 26.3 23.1 50.0 25.2 29.9 PTPRN "IA-2, ICA512" ENSG00000054356 "Protein tyrosine phosphatase receptor type N" Q16849 2 219289623-219309648 "Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Receptor "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 164.1;pituitary gland: 183.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 59.0;Cone photoreceptor cells: 60.5;Enteroendocrine cells: 47.1;Excitatory neurons: 44.6;Horizontal cells: 97.6;Inhibitory neurons: 48.1;Rod photoreceptor cells: 38.4" "Group enriched" "Detected in some" 12 "glioma: 5.3;pancreatic cancer: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "U-2 OS: 66.4;U-87 MG: 249.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007152, HPA007179" Enhanced Approved "Endoplasmic reticulum" NA NA 38000 "Endoplasmic reticulum" "HPA007152: AB_2667759, HPA007179: AB_1079714" "unprognostic (1.43e-1)" "unprognostic (1.33e-4)" "unprognostic (2.91e-3)" "unprognostic (5.83e-3)" "prognostic unfavorable (1.45e-7)" "unprognostic (3.64e-2)" "unprognostic (1.24e-4)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (6.20e-4)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-10)" "unprognostic (1.43e-2)" "unprognostic (2.49e-1)" "unprognostic (1.10e-2)" "unprognostic (8.61e-2)" 0.7 25.5 85.0 4.8 90.7 0.6 0.2 7.8 140.1 0.1 0.0 4.3 1.7 0.3 0.0 0.3 0.1 0.3 0.3 97.2 164.1 0.3 0.2 0.2 0.1 56.8 70.4 107.4 0.2 36.6 0.0 183.7 0.2 93.7 0.4 0.9 21.6 0.1 0.0 0.1 0.9 2.0 1.6 7.1 0.1 6.1 0.7 103.0 0.0 0.4 0.0 0.0 0.9 0.9 121.9 0.1 0.0 0.1 0.0 0.0 0.0 0.2 2.5 0.0 0.8 0.0 0.1 0.0 0.0 1.2 4.6 6.8 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.8 1.9 0.0 0.6 8.4 0.0 20.8 0.0 0.2 0.0 0.0 0.4 0.5 1.5 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 10.8 0.0 0.0 0.0 9.0 0.0 0.1 0.0 0.1 66.4 0.0 0.2 0.1 0.3 1.1 249.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 85.0 90.7 7.8 140.1 97.2 164.1 56.8 70.4 107.4 93.7 7.1 103.0 121.9 0.0 0.0 0.0 5.5 0.1 0.1 0.1 0.1 0.0 59.0 0.1 0.1 2.0 0.0 0.0 0.0 60.5 0.0 0.1 0.1 1.9 0.1 0.3 0.1 0.2 0.7 47.1 2.7 44.6 0.0 0.3 1.9 2.6 0.0 0.0 0.0 0.0 0.3 0.1 97.6 48.1 0.7 2.0 0.0 0.4 0.8 0.3 1.8 1.8 4.7 0.0 6.0 0.0 1.5 4.0 2.7 0.0 0.0 0.1 0.2 0.0 0.1 0.0 38.4 0.0 0.1 1.9 4.2 2.7 0.0 0.1 0.0 0.1 0.0 0.1 0.2 HHAT "FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn" ENSG00000054392 "Hedgehog acyltransferase" Q5VTY9 1 210328252-210676296 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA016462 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA016462: AB_2669360" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (5.02e-3)" "unprognostic (8.89e-3)" "unprognostic (4.81e-2)" "unprognostic (3.32e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (1.67e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-3)" "prognostic favorable (8.47e-7)" "unprognostic (2.55e-1)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (5.67e-2)" 1.8 6.5 1.1 0.6 1.1 0.4 3.3 0.5 1.6 3.3 3.1 2.2 1.1 2.5 3.1 2.8 2.8 2.2 2.2 1.0 2.2 3.4 2.7 2.2 0.8 0.8 0.8 1.0 2.2 2.3 1.7 3.3 1.3 0.6 4.1 1.4 1.7 4.5 2.1 0.3 3.1 2.5 1.1 1.0 2.2 1.8 2.5 0.5 2.0 4.7 0.2 0.8 3.1 2.9 1.0 0.8 0.9 2.3 1.3 1.0 1.3 4.8 1.2 1.1 1.9 3.1 0.2 0.9 0.0 1.2 0.9 3.1 0.6 0.5 0.5 2.2 1.7 1.2 0.0 0.1 1.1 0.2 0.3 13.6 1.2 2.7 1.6 1.2 3.2 0.3 1.2 0.0 0.0 11.6 1.2 0.6 0.0 0.6 0.7 0.1 1.3 12.4 0.0 7.5 2.6 1.9 7.8 2.1 0.0 6.0 5.9 4.0 0.7 1.7 2.8 8.5 1.6 4.7 3.8 0.2 0.0 1.1 0.8 2.3 0.0 0.3 0.0 0.7 0.4 1.3 1.5 0.9 0.8 0.4 1.8 0.0 0.2 0.0 0.1 0.1 3.7 0.2 0.4 1.1 1.1 0.5 1.6 1.0 2.2 0.8 0.8 1.0 0.6 1.0 0.5 1.0 2.0 0.0 2.4 25.8 5.3 2.2 5.7 2.8 6.8 0.5 5.8 2.4 2.4 4.3 1.2 9.2 0.0 4.6 13.9 1.9 3.9 2.6 1.2 8.8 2.6 2.0 0.0 0.4 47.7 0.7 3.6 3.0 2.6 5.8 0.0 4.6 3.6 2.5 1.9 0.0 11.8 2.7 4.1 2.9 0.5 0.5 1.2 1.5 0.0 20.6 1.0 15.6 0.0 17.1 26.0 1.2 2.1 0.4 2.2 3.7 2.3 0.6 12.9 0.5 0.0 1.7 1.7 0.3 1.3 3.1 2.6 2.2 2.8 0.4 2.0 5.2 KIF1B "CMT2, CMT2A, HMSNII, KIAA0591, KLP" ENSG00000054523 "Kinesin family member 1B" O60333 1 10210570-10381603 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Motor protein" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 101.3;retina: 128.5;skeletal muscle: 204.3;tongue: 152.3" "Cell type enhanced" "Detected in many" "Astrocytes: 413.9;Cone photoreceptor cells: 579.6;Excitatory neurons: 297.4;Inhibitory neurons: 281.6;Oligodendrocytes: 521.3;Rod photoreceptor cells: 389.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 5.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015177 Approved Approved "Nucleoli fibrillar center,Microtubules" NA NA Microtubules "Nucleoli fibrillar center" "CAB015177: AB_2296564" "unprognostic (1.30e-1)" "unprognostic (6.88e-2)" "unprognostic (4.96e-2)" "unprognostic (9.82e-3)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (8.72e-2)" "unprognostic (3.26e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.91e-6)" "unprognostic (1.51e-1)" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" 10.7 14.9 61.0 8.3 68.2 16.2 12.6 66.9 67.3 10.2 0.0 14.6 9.6 15.7 6.9 18.5 10.6 10.4 29.9 63.1 55.2 14.7 12.2 11.1 4.2 73.2 60.2 55.4 15.8 13.3 20.7 12.7 10.3 76.6 12.0 9.3 128.5 12.9 9.4 204.3 13.7 10.7 15.4 47.5 7.4 9.5 19.9 54.1 4.9 10.9 152.3 5.1 11.7 12.6 101.3 25.0 17.7 81.3 31.8 22.0 24.6 7.0 24.0 16.6 24.8 25.0 19.5 12.2 3.6 23.4 38.9 13.2 17.7 58.9 18.8 34.2 35.1 19.3 14.7 25.8 23.0 17.6 5.2 4.5 19.0 18.8 42.3 26.7 18.0 31.1 15.4 16.6 14.4 27.7 7.5 5.9 5.2 17.9 10.9 13.0 24.6 47.2 6.6 10.3 12.2 55.3 27.0 33.8 16.1 32.9 33.5 11.5 7.0 36.4 29.1 18.4 33.0 23.1 7.8 13.9 7.7 25.1 15.8 14.9 2.3 1.0 5.5 0.6 0.9 0.3 0.5 0.6 0.7 0.7 0.5 0.4 0.4 4.7 0.6 1.2 0.5 0.8 0.5 61.0 68.2 66.9 67.3 63.1 55.2 73.2 60.2 55.4 76.6 47.5 54.1 101.3 38.3 60.9 21.6 413.9 9.3 50.9 24.5 15.2 25.0 248.2 33.6 26.5 120.0 14.3 18.1 22.0 579.6 6.9 17.5 26.4 0.0 18.8 85.8 34.6 41.8 39.8 28.8 4.2 297.4 18.1 6.1 42.6 22.4 63.1 7.0 104.6 20.3 37.6 22.1 139.7 281.6 17.7 20.3 22.0 43.5 48.4 18.6 36.8 51.6 75.9 19.5 56.1 6.2 238.8 521.3 23.8 23.4 20.7 21.1 25.8 31.7 14.2 19.9 389.3 19.7 85.4 42.3 37.3 37.7 40.8 59.1 6.7 14.4 63.0 21.3 20.8 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609915-1613897 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease variant, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "salivary gland: 155.7" "Cell type enhanced" "Detected in many" "Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 18.0" HPA040670 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 10.1 6.1 8.8 1.2 7.0 0.6 9.1 6.8 9.4 6.3 12.6 1.7 0.9 3.7 1.7 4.8 5.1 7.6 9.1 5.6 6.1 19.8 1.2 3.3 1.7 8.7 7.0 4.4 4.7 3.7 1.6 9.6 4.1 9.1 8.7 0.9 0.3 155.7 6.5 2.4 10.6 1.6 2.3 6.4 0.4 1.7 2.0 10.0 8.4 5.6 2.9 2.2 9.5 5.6 7.9 18.0 2.0 0.6 92.4 4.2 4.6 2.9 8.9 10.3 5.4 4.3 6.7 3.7 0.0 10.0 5.2 3.9 19.9 8.8 6.5 4.5 5.7 91.8 3.7 5.3 3.3 2.8 1.4 6.0 15.6 8.7 7.3 8.3 2.8 7.9 0.6 2.7 0.1 2.3 3.8 0.0 2.0 0.3 8.9 7.6 0.0 3.7 0.5 35.9 13.3 3.4 8.0 10.9 0.1 6.4 4.5 2.6 1.5 2.0 11.5 7.1 5.9 9.6 0.4 0.8 0.0 3.2 4.5 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.8 7.0 6.8 9.4 5.6 6.1 8.7 7.0 4.4 9.1 6.4 10.0 7.9 93.7 0.0 0.6 0.0 0.4 17.7 31.9 26.3 13.6 0.0 42.2 59.4 7.1 0.0 23.6 11.0 0.0 5.3 1.9 0.9 1.9 3.9 0.6 8.6 1.1 64.7 0.0 0.0 0.0 17.1 0.6 21.2 1.5 3.8 0.0 0.7 65.7 0.4 1.3 0.0 0.0 1.5 8.2 1.3 5.5 1.4 16.1 2.7 1.8 23.4 0.0 0.3 0.0 0.5 0.1 16.2 0.1 28.2 0.1 9.5 0.0 7.4 34.9 0.0 0.0 19.2 40.4 0.7 3.1 11.2 6.5 0.8 1.1 4.4 0.6 64.9 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 252.9;Oligodendrocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 13.3 12.4 9.9 14.6 9.4 10.5 11.9 8.5 10.6 11.2 7.8 11.5 15.0 10.6 6.9 18.3 12.2 9.3 11.9 9.9 8.7 13.4 11.1 12.8 19.5 10.7 9.8 8.4 9.9 14.8 12.1 11.3 12.1 11.8 9.4 9.6 4.9 14.2 7.9 18.1 17.7 15.2 7.7 9.2 19.2 14.9 7.3 10.1 14.8 12.4 11.4 18.5 11.1 12.4 10.6 19.1 13.0 8.1 9.9 11.6 16.1 9.9 12.8 17.2 14.3 15.3 14.8 14.5 16.6 13.9 19.5 8.9 20.7 7.0 20.0 9.9 7.2 19.6 9.5 11.1 28.6 17.7 20.9 7.4 18.9 23.0 9.8 13.6 17.2 23.7 10.4 6.2 17.4 13.1 9.8 9.3 10.7 8.0 17.9 14.6 11.8 9.5 17.9 16.7 9.7 6.6 12.3 11.8 4.5 20.1 10.0 10.5 13.7 19.5 10.9 15.3 11.5 8.2 11.5 3.9 10.5 27.0 10.6 6.9 2.5 10.7 6.3 6.4 15.5 6.0 11.6 5.9 6.1 12.5 13.0 3.9 4.3 15.5 5.5 18.6 6.1 10.2 6.6 9.9 9.4 8.5 10.6 9.9 8.7 10.7 9.8 8.4 11.8 9.2 10.1 10.6 20.3 25.6 18.3 81.0 47.0 6.4 12.1 21.1 21.6 18.6 9.9 7.9 8.6 14.3 20.2 7.3 18.8 24.4 22.7 27.9 11.7 25.8 13.9 20.1 14.2 19.0 3.6 13.5 82.0 23.5 19.6 12.2 39.3 14.5 17.1 13.3 23.2 7.9 33.1 21.9 94.2 16.2 18.3 23.0 16.7 3.5 9.9 32.7 10.6 252.9 39.4 13.7 29.9 76.9 113.2 30.2 25.2 11.7 28.8 10.5 39.4 19.8 15.0 27.3 13.1 12.3 11.8 7.9 10.5 18.5 8.0 29.0 22.7 12.7 18.4 11.8 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63761899-64226433 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 200.3" "Cell type enhanced" "Detected in all" "Granulosa cells: 454.6;Rod photoreceptor cells: 568.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 73.8" "Group enriched" "Detected in many" 11 "granulocytes: 73.8;T-cells: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 48.8;SiHa: 29.8;U-698: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 28.4 6.0 9.2 3.4 8.6 8.0 28.2 20.4 9.8 14.7 76.4 12.8 4.6 18.2 10.0 24.5 14.4 5.6 46.1 9.5 17.2 29.1 19.6 18.5 8.5 7.9 10.0 5.0 36.3 38.1 67.1 16.8 10.0 10.8 11.6 4.5 25.1 16.3 3.7 200.3 35.2 11.5 4.6 6.5 10.1 12.5 13.2 10.7 5.6 24.6 97.5 6.1 13.7 19.2 6.8 23.2 8.7 11.0 3.5 11.3 3.2 12.3 1.3 1.6 2.7 4.2 2.8 3.3 48.8 2.3 1.7 2.6 11.0 6.2 3.5 3.2 8.9 3.5 0.4 7.9 0.7 3.0 1.0 0.3 4.4 15.1 3.4 2.2 2.6 7.0 7.5 0.4 4.8 1.8 11.2 6.2 0.3 3.4 5.4 3.3 6.9 14.5 1.8 20.0 13.6 9.9 8.2 29.8 3.8 7.0 5.5 5.0 0.3 7.3 4.2 7.5 1.5 4.5 4.9 3.5 27.5 1.8 0.0 5.7 0.5 0.1 73.8 38.5 0.3 27.6 5.2 24.3 28.0 0.0 5.3 11.8 18.5 30.1 3.9 0.3 1.2 30.1 3.4 9.2 8.6 20.4 9.8 9.5 17.2 7.9 10.0 5.0 10.8 6.5 10.7 6.8 414.4 307.7 140.1 8.5 44.9 111.3 138.9 46.4 174.2 27.4 70.3 59.1 261.4 105.8 184.5 202.3 183.5 168.8 226.8 51.0 19.6 108.2 9.4 249.9 71.2 238.8 46.2 10.5 9.5 55.4 65.7 59.6 126.9 365.2 25.9 454.6 73.5 33.3 17.7 6.7 13.9 60.9 59.0 5.7 13.2 14.3 100.9 12.8 48.0 128.4 8.9 107.2 300.7 33.2 6.6 71.7 27.9 53.4 180.3 65.0 35.9 72.2 196.1 568.7 111.7 73.5 167.0 13.0 17.0 104.6 87.5 224.0 222.1 69.5 80.6 80.6 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533290-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 150.2;thyroid gland: 39.2" "Cell type enriched" "Detected in many" 8 "Oligodendrocytes: 607.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 10.2;BEWO: 9.7;RT4: 10.2;SK-MEL-30: 12.0;T-47d: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome NA NA Centrosome "HPA047707: AB_2680126, HPA051964: AB_2681675" "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favorable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" 0.9 4.0 12.5 1.3 55.5 0.0 2.6 32.6 33.3 2.9 0.0 6.8 11.8 1.4 8.3 1.2 3.4 2.1 0.7 14.3 31.0 2.1 0.4 0.7 0.1 68.4 51.9 5.6 0.2 7.7 9.6 4.4 1.1 71.4 10.3 6.8 7.3 23.0 2.3 0.9 4.1 9.4 0.8 39.1 0.9 6.4 1.9 43.1 1.1 39.2 0.4 0.3 1.4 0.9 150.2 5.3 1.2 2.0 10.2 0.2 0.0 9.7 0.0 0.0 0.1 0.1 3.2 1.6 0.0 1.6 0.0 0.9 2.3 3.6 0.9 0.1 0.3 3.5 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.3 4.0 0.0 0.0 7.6 0.0 0.2 3.0 6.0 0.6 0.1 0.3 1.5 1.1 10.2 2.7 2.5 0.9 1.9 12.0 4.7 9.7 2.1 0.0 0.8 3.6 1.0 0.6 0.0 0.0 0.0 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 55.5 32.6 33.3 14.3 31.0 68.4 51.9 5.6 71.4 39.1 43.1 150.2 0.1 3.2 6.4 19.9 0.7 0.1 0.7 3.1 1.2 16.7 5.8 6.0 3.6 2.8 3.4 9.2 39.6 3.0 1.4 21.2 3.9 2.2 0.6 19.1 2.0 0.7 7.3 0.0 13.4 4.0 0.3 0.6 29.0 18.0 0.0 67.7 0.0 0.2 0.8 3.3 21.9 16.9 0.0 0.6 0.3 0.7 0.3 1.5 3.6 12.2 0.0 4.6 0.0 34.2 607.7 2.9 7.7 0.4 0.0 4.1 12.8 1.7 3.9 36.6 0.0 1.5 1.0 0.7 1.6 2.3 2.3 10.7 0.3 2.0 16.4 1.2 ATP9A "ATPIIA, KIAA0611" ENSG00000054793 "ATPase phospholipid transporting 9A (putative)" O75110 20 51596514-51768390 "Enzymes, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 112.2;Inhibitory neurons: 87.1;Oligodendrocytes: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "EFO-21: 74.0;SK-BR-3: 69.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020699, HPA035630" Enhanced NA NA "CAB020699: , HPA035630: AB_10669526" "unprognostic (5.19e-2)" "unprognostic (5.28e-2)" "unprognostic (3.46e-1)" "unprognostic (1.05e-1)" "unprognostic (3.76e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-2)" "unprognostic (4.79e-2)" "unprognostic (7.45e-2)" "unprognostic (1.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "prognostic favorable (5.67e-5)" "unprognostic (5.82e-2)" "unprognostic (5.81e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" 30.9 11.7 51.6 5.8 64.3 2.7 14.2 27.2 52.0 8.4 0.0 18.7 13.8 12.5 18.6 13.0 25.0 12.1 11.7 62.9 50.8 9.2 7.6 9.8 3.7 43.3 53.8 60.1 18.9 15.2 29.8 16.3 5.0 50.3 20.7 16.6 20.6 25.9 15.6 16.5 6.9 18.0 12.8 33.2 2.9 20.6 19.0 50.7 7.4 28.4 17.7 3.2 12.1 9.9 53.2 25.8 21.7 17.2 38.8 49.0 36.8 0.4 9.1 17.1 5.8 1.7 50.4 51.9 0.0 74.0 37.2 29.1 20.1 22.9 12.9 5.7 20.2 7.1 0.0 23.2 19.8 6.7 0.0 0.1 12.1 25.6 1.3 3.5 13.3 31.4 4.7 0.1 0.2 6.6 35.9 2.0 0.2 3.1 25.4 27.0 4.1 0.0 0.1 11.6 35.7 32.7 23.2 36.3 69.9 13.2 6.0 13.5 0.6 20.7 48.1 12.7 19.1 3.9 0.0 0.3 0.8 12.7 0.1 4.4 4.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.7 51.6 64.3 27.2 52.0 62.9 50.8 43.3 53.8 60.1 50.3 33.2 50.7 53.2 4.8 16.0 13.6 43.4 0.5 2.9 14.6 13.8 4.0 35.9 16.0 11.3 12.7 31.5 19.1 18.4 4.2 0.4 2.5 64.3 1.9 21.4 0.8 20.4 4.7 9.8 55.2 0.8 112.2 17.2 0.5 9.9 26.5 28.8 1.3 14.3 11.0 12.8 5.4 43.7 87.1 34.9 18.3 2.2 2.1 3.4 13.4 12.1 3.6 40.3 0.2 5.0 2.1 60.8 90.3 24.6 28.8 23.3 2.1 33.7 36.3 1.4 34.9 7.4 6.6 10.1 8.0 1.2 8.2 9.9 4.1 0.3 2.3 0.7 24.8 27.3 SPO11 "CT35, SPATA43, TOPVIA" ENSG00000054796 "SPO11 initiator of meiotic double stranded breaks" Q9Y5K1 20 57329803-57343994 "Enzymes, Plasma proteins, Predicted intracellular proteins" Meiosis "DNA-binding, Hydrolase, Isomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 86 "testis: 8.5" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 98.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CBLN4 "CBLNL1, dJ885A10.1" ENSG00000054803 "Cerebellin 4 precursor" Q9NTU7 20 55997357-56005519 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 18.0;brain: 20.1;epididymis: 8.9" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 8.9;Excitatory neurons: 26.9;Inhibitory neurons: 31.6;Peritubular cells: 38.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "SH-SY5Y: 9.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074497 Supported "Secreted in brain" NA NA 10000000 "HPA074497: " "unprognostic (3.61e-1)" "unprognostic (8.43e-3)" "unprognostic (2.43e-1)" "unprognostic (1.61e-2)" "unprognostic (1.99e-1)" "unprognostic (4.00e-1)" "unprognostic (3.25e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (3.88e-1)" "unprognostic (9.63e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-3)" "unprognostic (3.22e-4)" "unprognostic (7.50e-2)" "unprognostic (3.58e-2)" "unprognostic (1.79e-3)" 0.7 18.0 15.6 0.1 4.4 0.0 1.4 0.0 10.3 1.3 0.0 0.0 0.0 0.7 8.9 0.1 3.9 0.5 0.0 13.2 4.2 0.6 0.9 0.7 0.0 1.2 20.1 7.0 2.0 0.7 0.3 0.1 0.2 3.8 0.1 0.0 0.3 0.1 0.4 0.3 0.0 0.1 0.3 0.0 0.0 0.3 2.0 12.7 0.1 0.9 0.0 0.0 0.1 0.1 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 4.4 0.0 10.3 13.2 4.2 1.2 20.1 7.0 3.8 0.0 12.7 8.8 0.1 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.2 8.9 0.0 26.9 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 1.3 0.1 1.7 31.6 0.0 0.0 0.0 0.0 1.0 2.1 0.2 0.0 1.9 0.0 0.2 0.0 1.0 2.0 0.0 0.0 38.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CHRDL2 BNF1 ENSG00000054938 "Chordin like 2" Q6WN34 11 74696429-74731426 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 146.3;gallbladder: 107.0;lymphoid tissue: 116.8;smooth muscle: 123.2" "Cell type enhanced" "Detected in some" "Breast glandular cells: 194.1;Hepatocytes: 112.2;Skeletal myocytes: 533.4" "Cancer enhanced" "Detected in many" "stomach cancer: 14.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.4;PC-3: 1.3;SiHa: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021771, HPA076522" Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 9700000 Vesicles "HPA021771: AB_1846689, HPA076522: " "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (7.24e-2)" "unprognostic (3.41e-3)" "unprognostic (9.45e-2)" "unprognostic (2.09e-1)" "unprognostic (4.08e-2)" "unprognostic (4.33e-2)" "unprognostic (6.64e-2)" "unprognostic (2.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.23e-1)" "unprognostic (7.58e-6)" "unprognostic (8.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (6.08e-4)" 2.7 0.2 0.6 116.8 0.4 0.0 5.2 0.4 0.7 61.1 0.1 61.6 4.1 146.3 0.8 4.2 9.5 107.0 23.3 0.4 0.7 2.9 46.6 2.9 0.4 0.9 0.5 0.4 2.5 3.1 0.4 0.4 4.6 0.6 22.8 2.6 0.5 0.5 9.0 6.7 1.0 10.9 123.2 1.2 1.3 58.2 3.5 0.6 0.0 0.9 4.8 2.8 46.7 21.4 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.4 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.4 0.7 0.4 0.7 0.9 0.5 0.4 0.6 1.2 0.6 0.8 1.2 0.0 2.6 0.7 0.3 0.3 0.5 0.2 0.0 0.0 194.1 3.8 2.2 15.7 0.1 9.2 0.0 0.0 0.8 0.0 0.0 13.8 31.4 0.6 0.2 2.1 0.0 0.0 0.1 10.3 0.1 5.3 0.0 0.5 0.0 0.2 2.9 112.2 0.1 0.0 0.2 0.0 0.0 2.4 0.0 2.4 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.5 0.1 4.1 0.0 0.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 533.4 1.2 0.6 4.3 0.0 0.0 0.1 0.5 0.4 0.0 0.5 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 125.0;Excitatory neurons: 171.0;Inhibitory neurons: 161.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.70e-4)" 13.7 11.0 44.0 10.9 41.6 11.1 13.5 48.1 48.8 14.7 4.8 13.6 8.2 15.5 18.2 8.9 14.2 14.0 13.4 42.8 45.4 12.2 11.4 10.5 9.1 56.0 48.9 38.4 16.8 9.8 22.1 12.5 9.8 54.6 13.0 9.7 50.2 12.8 15.9 20.1 8.8 12.1 18.3 49.6 9.5 10.8 8.5 55.6 13.4 14.9 15.4 8.4 12.9 8.9 48.3 13.4 15.6 33.6 19.0 24.2 27.0 5.1 19.6 22.5 21.5 20.5 17.6 17.4 14.9 16.9 34.9 20.1 12.3 19.4 19.3 26.3 10.3 14.3 17.1 17.3 9.6 9.4 9.2 30.8 25.3 13.5 21.3 11.2 29.2 13.8 23.9 4.3 10.9 22.3 20.2 21.4 9.4 11.5 27.4 19.7 30.3 56.7 8.1 12.8 12.0 22.3 34.6 23.1 17.5 37.8 12.3 28.4 10.7 17.8 24.5 20.6 31.9 16.2 24.9 18.7 25.7 13.0 11.3 22.9 6.0 1.3 0.9 0.8 2.3 0.4 0.4 0.3 0.6 1.1 0.5 0.6 0.6 2.9 0.5 1.5 1.4 0.6 0.3 44.0 41.6 48.1 48.8 42.8 45.4 56.0 48.9 38.4 54.6 49.6 55.6 48.3 18.3 3.2 8.2 125.0 4.0 3.8 2.3 7.1 3.4 21.8 11.0 9.7 20.3 15.7 9.9 7.3 45.9 2.3 5.7 5.2 0.0 3.3 22.4 13.1 12.5 9.7 12.7 2.1 171.0 2.7 3.6 9.4 5.6 19.2 22.9 31.9 11.0 16.6 9.8 3.3 161.2 8.6 2.0 14.8 6.8 25.4 7.5 10.0 5.4 59.0 7.3 26.7 5.2 166.9 149.1 3.4 2.8 12.8 2.9 1.8 8.4 4.2 7.2 24.4 6.6 12.3 19.1 7.0 6.1 5.3 3.8 2.7 4.9 6.9 6.7 1.7 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT TNF receptor" Q969Z4 11 73376399-73397474 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 156.2" "Cell type enhanced" "Detected in many" "Langerhans cells: 43.9;Macrophages: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.9 2.3 4.1 13.0 6.4 156.2 2.5 7.0 9.1 1.3 2.0 1.9 2.4 1.4 0.5 3.9 1.9 4.5 4.5 3.6 9.4 2.7 2.1 11.0 12.0 8.9 6.9 1.7 1.8 0.9 1.2 3.5 4.7 8.8 2.1 1.4 2.3 1.9 0.4 24.5 3.2 7.2 2.7 6.7 21.0 2.3 3.2 7.0 4.6 2.2 6.5 7.0 4.9 2.3 13.1 9.1 8.9 7.0 6.8 0.8 1.0 7.5 9.6 6.2 11.1 6.7 8.5 3.9 16.4 30.9 6.4 8.8 13.1 4.4 4.7 4.3 9.9 8.3 15.4 12.4 3.1 1.8 15.6 26.3 1.1 2.0 11.9 3.5 2.6 4.1 8.4 11.8 21.0 3.1 8.5 11.5 16.5 6.1 6.9 11.0 21.9 11.7 14.2 2.3 3.9 8.9 8.5 8.3 7.5 10.0 1.7 4.1 13.9 5.4 13.8 9.7 23.1 17.6 7.5 6.1 18.2 8.5 15.5 14.8 0.7 12.5 22.2 0.9 25.4 2.0 7.6 1.0 1.7 11.8 5.8 1.3 0.6 19.9 0.4 35.3 11.7 0.5 6.3 4.1 6.4 7.0 9.1 3.6 9.4 8.9 6.9 1.7 8.8 6.7 7.0 13.1 5.7 6.4 2.2 3.6 24.2 26.5 15.4 2.8 2.8 3.5 6.1 5.5 2.7 1.5 3.4 0.0 12.5 1.6 33.0 4.7 0.0 3.6 0.9 5.4 5.2 7.2 3.5 5.7 3.1 0.9 10.7 10.1 11.2 10.8 24.8 6.8 1.8 0.2 23.0 30.3 4.5 2.8 6.1 24.2 43.9 1.2 0.0 43.9 5.4 2.8 32.8 8.9 3.1 1.5 4.8 6.7 2.4 0.0 19.2 9.9 1.0 0.5 1.4 2.8 6.6 7.2 14.5 11.7 10.5 4.6 18.3 21.1 16.1 0.6 3.1 17.8 GALC ENSG00000054983 Galactosylceramidase P54803 14 87837820-87993665 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism, Sphingolipid metabolism" "Glycosidase, Hydrolase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 84.3;HMC-1: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022196 Approved "Intracellular and membrane" NA NA 53000 "CAB022196: " "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (9.39e-2)" "unprognostic (3.08e-1)" "unprognostic (9.70e-2)" "unprognostic (1.73e-1)" "unprognostic (6.56e-2)" "unprognostic (8.44e-3)" "unprognostic (8.08e-2)" "unprognostic (1.84e-2)" "unprognostic (6.00e-2)" "unprognostic (2.13e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-2)" 15.1 17.3 22.2 15.0 24.5 23.4 13.4 24.0 26.4 12.1 21.9 15.2 33.6 11.2 12.3 6.7 20.9 18.6 13.6 20.2 23.4 21.5 12.2 24.1 11.8 24.6 24.4 18.9 16.0 10.9 9.5 9.9 17.0 25.1 14.4 17.5 18.5 8.1 9.4 8.1 9.1 34.6 9.7 24.1 15.5 16.6 24.2 22.8 9.8 24.8 13.0 8.0 13.7 7.6 32.5 0.0 19.5 7.2 0.0 23.8 21.3 0.0 9.1 17.9 8.3 9.9 10.8 84.3 5.3 26.4 8.7 0.0 1.3 0.0 1.0 10.2 2.7 0.6 29.8 0.7 0.0 19.5 0.1 78.4 20.7 6.6 5.6 0.0 3.4 22.6 0.0 10.0 3.9 14.4 1.9 0.0 4.5 6.5 35.4 2.2 0.0 0.5 0.3 13.4 7.8 6.7 15.6 24.6 4.0 0.2 17.2 20.4 20.5 19.7 0.0 12.9 5.6 0.2 4.2 8.0 0.0 2.3 6.8 19.2 25.3 15.2 34.2 11.1 16.6 24.0 2.5 8.3 10.8 8.9 1.2 6.0 7.0 11.9 16.3 13.4 1.6 5.3 11.7 22.2 24.5 24.0 26.4 20.2 23.4 24.6 24.4 18.9 25.1 24.1 22.8 32.5 11.3 25.6 19.0 26.8 8.0 8.4 5.6 9.4 3.4 10.1 9.1 5.2 9.2 10.0 8.9 14.7 12.5 6.2 27.6 15.3 3.9 9.8 51.6 17.3 10.9 11.4 6.1 13.7 17.8 11.4 12.7 15.2 7.7 5.8 68.4 15.9 18.2 6.1 26.6 3.3 21.2 10.2 4.1 72.1 11.8 77.9 16.1 25.0 10.6 8.4 26.7 7.3 40.2 33.2 42.6 14.1 20.0 10.1 9.3 6.1 15.9 6.7 22.1 10.4 0.0 9.8 10.6 14.9 10.0 3.5 11.5 6.6 21.2 12.9 16.7 7.9 NOP58 "HSPC120, NOP5" ENSG00000055044 "NOP58 ribonucleoprotein" Q9Y2X3 2 202265736-202303661 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018472, HPA021062" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA018472: AB_1854564, HPA021062: AB_1854565" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (9.20e-2)" "unprognostic (2.15e-3)" "unprognostic (2.39e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (6.64e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.86e-4)" "unprognostic (4.52e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.38e-9)" "unprognostic (1.79e-2)" "unprognostic (3.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.60e-1)" 30.1 35.5 31.8 44.2 32.1 76.9 44.1 37.1 58.9 29.7 32.9 30.7 28.4 32.5 33.7 38.1 31.8 23.8 25.2 32.9 33.3 24.1 41.1 26.7 60.8 31.0 30.9 30.8 37.7 38.2 25.0 30.4 32.9 32.3 29.8 36.2 28.4 26.7 23.3 42.1 31.0 30.0 27.5 30.9 34.2 29.8 25.1 32.5 42.3 27.3 21.7 60.3 43.7 30.4 33.8 126.4 86.0 85.1 106.8 62.0 55.6 199.2 118.5 62.9 89.1 82.9 191.5 110.9 193.1 95.4 72.5 111.6 114.0 170.1 144.7 158.4 75.0 152.5 233.6 133.3 193.7 91.5 234.7 108.6 72.1 85.3 124.6 284.6 48.6 81.2 112.3 260.4 144.1 113.4 131.4 215.1 258.7 212.9 139.4 146.5 179.5 128.3 257.1 107.1 148.5 130.5 95.8 109.0 156.6 140.8 136.2 106.4 181.8 70.3 113.5 133.8 102.5 206.0 115.7 226.1 274.8 84.2 163.7 138.5 13.4 24.0 7.4 37.2 35.6 55.0 56.1 53.1 51.2 37.4 45.0 57.5 58.9 2.3 52.1 28.3 53.1 58.0 32.5 31.8 32.1 37.1 58.9 32.9 33.3 31.0 30.9 30.8 32.3 30.9 32.5 33.8 56.3 109.0 116.2 22.2 111.6 85.8 150.5 98.0 78.0 28.1 53.8 70.2 82.7 37.1 116.8 40.5 41.7 78.1 87.1 35.7 29.4 59.9 39.2 59.6 75.9 62.3 35.2 65.2 39.0 67.8 96.9 82.6 51.0 97.0 137.3 47.7 32.2 46.1 47.7 25.2 47.5 61.5 61.1 23.2 43.5 11.1 43.2 51.5 24.9 20.6 59.6 18.8 35.0 20.6 27.0 50.3 17.3 29.7 118.6 89.9 18.3 37.8 70.6 44.2 26.3 112.2 116.8 70.4 58.4 77.5 74.7 68.0 124.1 45.4 79.6 94.6 SZRD1 "C1orf144, DKFZp566C0424" ENSG00000055070 "SUZ RNA binding domain containing 1" Q7Z422 1 16352575-16398145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024221 Uncertain Approved Nucleoplasm,Cytosol NA NA 17000 "Nucleoplasm, Cytosol" "HPA024221: AB_10603450" "unprognostic (3.52e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (5.98e-6)" "unprognostic (2.53e-1)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "unprognostic (7.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" "unprognostic (7.60e-2)" 52.5 57.8 41.0 50.6 43.9 83.2 46.3 43.2 41.9 48.0 38.8 54.6 44.4 69.5 25.9 66.5 50.8 41.6 59.8 37.3 45.3 49.0 49.0 48.5 57.4 50.2 44.2 33.3 59.8 37.0 69.9 29.1 46.7 45.5 46.5 38.8 20.2 39.1 41.4 121.9 48.1 50.7 58.8 43.9 52.1 50.2 23.0 46.4 57.5 44.5 69.4 51.5 60.5 43.4 42.4 126.2 94.6 127.5 89.7 106.1 121.8 42.3 126.4 161.4 145.2 112.6 95.2 108.8 109.9 137.9 168.5 80.1 68.3 115.1 140.0 106.6 189.7 100.1 126.4 96.6 75.9 96.0 124.6 118.9 123.7 113.0 160.0 105.7 102.2 128.0 93.5 115.3 100.3 134.8 121.7 122.2 93.1 90.2 92.0 106.6 123.5 135.8 129.8 98.8 57.8 101.0 105.0 111.0 70.6 161.6 52.4 73.3 80.4 145.2 98.8 116.1 156.8 127.0 55.0 65.2 131.1 111.3 166.3 135.1 37.0 46.4 68.2 44.1 65.2 43.9 58.2 37.7 41.6 36.9 67.4 34.5 37.3 51.2 41.2 78.1 28.4 52.2 65.3 41.0 43.9 43.2 41.9 37.3 45.3 50.2 44.2 33.3 45.5 43.9 46.4 42.4 42.5 19.2 23.6 7.5 48.2 45.6 51.6 47.6 39.3 21.4 41.5 32.9 44.3 52.9 28.5 40.5 2.1 56.2 49.4 74.0 70.5 64.4 21.5 31.5 44.5 45.2 47.8 27.8 7.0 53.4 79.8 42.1 31.1 53.5 36.8 31.9 35.7 55.0 72.9 43.7 7.0 47.7 46.8 48.9 45.9 55.4 36.1 47.9 44.4 10.3 78.8 30.4 77.2 7.5 12.0 68.1 47.8 35.7 35.6 63.9 62.5 50.4 18.4 18.5 39.5 31.3 56.3 28.1 20.3 43.9 58.4 84.0 44.5 39.1 49.8 68.3 KCNH2 "erg1, HERG, Kv11.1, LQT2" ENSG00000055118 "Potassium voltage-gated channel subfamily H member 2" Q12809 7 150944961-150978321 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.7;pituitary gland: 43.6" "Group enriched" "Detected in many" 4 "Bipolar cells: 217.3;Cardiomyocytes: 83.2;Erythroid cells: 76.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 197.7;NB-4: 97.8;SH-SY5Y: 78.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (9.79e-3)" "unprognostic (1.95e-2)" "unprognostic (3.40e-2)" "unprognostic (3.84e-2)" "unprognostic (3.53e-2)" "unprognostic (3.52e-1)" "prognostic favorable (5.61e-4)" "unprognostic (6.08e-2)" "unprognostic (2.26e-2)" "unprognostic (4.90e-2)" "unprognostic (2.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.02e-2)" 0.6 3.8 11.5 2.6 7.3 42.7 0.1 12.7 8.4 3.4 3.2 25.5 2.7 17.0 1.7 1.5 7.3 3.2 26.7 5.2 13.8 1.1 0.2 2.0 0.3 19.6 18.2 5.0 3.2 3.4 18.2 43.6 1.4 22.4 9.8 1.0 6.8 1.1 8.1 0.2 0.3 8.4 7.9 5.5 1.8 11.0 31.0 18.1 0.5 0.2 0.0 0.1 13.0 2.7 17.1 0.0 0.3 0.9 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 8.0 2.9 0.0 0.2 0.0 3.1 0.0 0.0 0.8 0.4 18.3 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 197.7 0.0 0.0 0.9 1.6 97.8 1.3 0.2 0.0 0.1 0.1 10.1 0.0 0.0 3.8 78.2 0.0 0.1 0.0 1.1 0.0 1.8 0.6 0.0 1.5 0.0 0.0 5.3 0.2 2.1 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 7.3 12.7 8.4 5.2 13.8 19.6 18.2 5.0 22.4 5.5 18.1 17.1 0.0 0.0 0.0 1.6 1.6 0.0 0.2 0.1 0.0 217.3 0.4 0.3 83.2 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 2.1 2.0 0.5 0.8 0.9 16.3 76.4 5.2 0.2 0.9 5.0 0.5 0.1 26.1 6.3 1.4 0.1 0.3 16.8 13.9 0.7 12.2 0.0 0.3 4.8 2.5 0.0 0.0 2.8 0.0 4.5 0.0 5.5 1.7 0.3 0.0 13.2 1.4 0.1 0.2 0.1 0.4 10.3 0.0 1.7 2.6 2.5 5.1 0.0 0.0 0.3 0.9 0.7 0.3 0.4 CUL1 ENSG00000055130 "Cullin 1" Q13616 7 148697914-148801110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 466.3;Late spermatids: 567.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002676, HPA064584" Supported Supported Nucleoplasm,Nucleoli NA NA 220000 Nucleoplasm Nucleoli "CAB002676: , HPA064584: AB_2685294" "unprognostic (3.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-1)" "unprognostic (1.19e-1)" "unprognostic (5.06e-3)" "unprognostic (9.45e-2)" "unprognostic (1.41e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-2)" "unprognostic (3.65e-2)" "unprognostic (3.40e-2)" "unprognostic (2.84e-2)" "unprognostic (2.18e-2)" "unprognostic (3.88e-2)" "unprognostic (1.48e-1)" "unprognostic (2.40e-1)" "unprognostic (7.24e-3)" 32.4 27.5 22.4 29.7 23.1 15.6 30.5 22.6 26.7 27.8 24.7 34.0 23.2 30.1 29.1 30.9 29.7 23.4 36.3 23.7 24.4 21.8 45.5 26.6 39.3 23.6 23.2 21.7 31.2 20.8 36.6 25.8 33.0 22.6 27.6 24.7 52.5 26.4 30.4 89.5 28.9 27.6 32.5 23.0 30.3 30.0 96.0 22.9 30.5 27.7 75.3 35.9 35.2 26.8 23.7 79.9 61.6 59.5 93.6 46.6 51.6 72.8 64.8 77.7 65.8 61.4 64.5 53.9 109.6 49.5 65.9 104.4 52.5 87.0 59.9 76.4 72.8 71.9 65.2 39.6 64.5 50.5 74.8 58.9 40.0 58.5 45.9 46.0 59.9 71.3 52.8 100.8 78.2 72.2 76.4 64.1 81.0 111.6 68.6 58.8 78.7 52.3 106.3 54.2 55.4 83.3 61.0 74.5 92.3 51.4 69.9 29.0 57.5 56.6 44.1 15.4 87.7 75.8 70.4 54.2 96.7 94.3 82.5 66.2 15.5 17.0 14.1 16.5 18.3 21.8 17.3 18.9 21.2 26.6 15.0 22.4 18.5 1.4 27.9 18.5 6.7 18.5 20.0 22.4 23.1 22.6 26.7 23.7 24.4 23.6 23.2 21.7 22.6 23.0 22.9 23.7 24.0 35.3 40.9 41.4 26.0 27.9 31.1 19.5 22.2 33.4 13.8 17.5 29.2 12.8 32.2 9.2 29.2 66.6 19.1 12.0 17.6 28.1 466.3 20.4 23.4 25.1 15.6 23.1 76.3 26.2 77.1 29.9 19.4 21.9 23.4 31.6 18.5 41.5 29.8 21.9 89.5 19.7 22.4 18.5 16.8 567.7 21.8 25.7 28.4 60.9 51.7 32.7 37.0 52.8 74.3 28.5 15.0 30.5 25.3 29.8 11.7 13.5 33.6 48.9 32.9 30.3 38.9 59.6 34.0 20.6 25.4 73.2 26.5 24.1 18.8 21.7 FAM114A2 "133K02, C5orf3" ENSG00000055147 "Family with sequence similarity 114 member A2" Q9NRY5 5 153990148-154038936 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035869, HPA035870" Approved Approved Vesicles NA NA Vesicles "HPA035869: AB_10669534, HPA035870: AB_10673222" "unprognostic (1.81e-1)" "unprognostic (2.65e-1)" "unprognostic (3.45e-2)" "unprognostic (3.27e-1)" "unprognostic (7.99e-2)" "unprognostic (8.21e-2)" "unprognostic (5.18e-3)" "unprognostic (6.70e-2)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" "unprognostic (9.70e-3)" "unprognostic (4.37e-1)" "unprognostic (7.80e-2)" "unprognostic (1.38e-3)" "unprognostic (4.17e-2)" "unprognostic (5.90e-3)" "unprognostic (2.85e-2)" 14.3 12.7 8.1 13.9 7.4 9.2 12.8 7.0 8.6 10.8 10.3 10.0 12.2 10.9 16.8 13.6 9.6 10.2 19.5 6.6 8.8 15.5 16.4 11.8 16.1 8.4 8.2 5.8 10.2 14.7 22.3 8.5 13.5 8.7 12.2 10.9 13.3 14.4 11.7 20.1 9.4 11.9 15.5 8.2 14.4 12.9 37.9 10.4 14.3 13.6 16.2 17.3 12.1 8.2 10.9 15.7 20.4 21.5 33.8 29.6 27.5 19.5 37.1 25.8 26.9 37.2 15.2 22.6 19.7 34.7 27.5 18.8 13.1 18.8 36.1 32.5 22.1 21.0 25.2 12.2 11.1 34.8 22.3 25.0 24.9 22.0 24.3 43.5 19.7 38.3 25.6 16.2 30.1 35.3 15.1 25.5 9.2 9.7 16.7 9.9 21.9 29.6 30.4 20.5 10.8 5.0 17.8 26.8 28.7 38.2 22.6 38.5 16.1 35.7 24.9 17.6 23.0 22.5 45.4 39.7 27.9 29.5 30.4 27.3 38.1 14.6 35.7 15.6 18.2 17.9 15.5 12.6 18.2 14.5 17.9 16.0 15.4 7.2 17.6 23.3 13.2 16.0 11.9 8.1 7.4 7.0 8.6 6.6 8.8 8.4 8.2 5.8 8.7 8.2 10.4 10.9 22.6 9.6 11.5 9.1 14.9 6.2 5.7 9.5 11.4 10.5 9.2 6.5 26.9 10.0 8.2 11.0 4.2 22.4 8.5 4.8 7.9 12.3 45.3 9.6 13.1 19.8 5.4 24.0 10.4 12.5 16.2 15.0 11.7 8.7 17.2 12.9 10.4 19.8 17.7 10.1 12.9 8.2 6.1 17.7 8.7 14.8 11.1 11.5 14.2 15.0 13.2 25.0 12.3 18.1 11.7 9.1 2.9 9.8 19.2 5.4 12.4 15.4 12.3 15.6 6.6 10.4 14.5 109.6 38.5 11.4 6.8 18.3 11.2 14.1 6.0 3.6 CYFIP2 PIR121 ENSG00000055163 "Cytoplasmic FMR1 interacting protein 2" Q96F07 5 157266079-157395595 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 104.2;kidney: 141.2;lymphoid tissue: 86.7" "Cell type enhanced" "Detected in many" "Astrocytes: 133.5;Collecting duct cells: 158.2;Distal tubular cells: 174.1;Excitatory neurons: 117.7;Inhibitory neurons: 147.5;Oligodendrocyte precursor cells: 120.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 202.4;JURKAT: 145.2;MOLT-4: 204.8;U-266/70: 153.6;U-698: 142.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB055519, HPA068106, HPA071459" Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Plasma membrane, Cytosol" "CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (3.76e-1)" "unprognostic (4.58e-2)" "unprognostic (1.14e-1)" "unprognostic (6.91e-3)" "unprognostic (3.97e-2)" "unprognostic (5.25e-2)" "prognostic favorable (1.18e-4)" "unprognostic (3.81e-2)" "prognostic favorable (3.21e-12)" "unprognostic (2.90e-1)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.49e-2)" 3.3 12.4 60.0 31.0 53.3 56.0 2.8 25.2 104.2 2.9 13.2 9.0 6.4 6.7 25.3 3.9 9.3 8.9 10.5 102.3 26.2 141.2 18.5 12.3 57.5 14.4 35.9 55.3 4.8 7.1 65.4 40.4 9.4 19.4 5.9 9.9 35.7 4.0 5.1 7.1 2.3 17.7 5.6 0.0 35.3 21.1 5.4 72.7 86.7 10.0 1.8 55.7 8.4 2.3 37.4 0.3 31.8 47.3 28.8 1.1 1.3 81.5 6.1 9.6 2.5 6.8 6.2 0.6 202.4 14.5 3.4 7.4 0.4 38.0 27.1 5.8 48.8 60.8 28.4 42.3 24.9 4.1 29.1 71.8 5.4 10.9 8.1 0.5 18.8 8.8 145.2 0.4 81.1 7.0 7.7 204.8 5.5 22.3 0.5 8.5 50.6 1.4 102.3 24.5 30.2 70.5 27.4 0.6 28.3 4.6 46.8 19.9 0.8 11.3 2.0 21.4 7.1 5.4 153.6 40.2 142.8 21.4 33.5 11.8 64.8 12.6 90.1 85.9 57.4 61.0 35.8 60.6 75.7 17.8 35.9 63.2 73.2 41.0 53.9 133.7 43.9 53.5 78.0 60.0 53.3 25.2 104.2 102.3 26.2 14.4 35.9 55.3 19.4 0.0 72.7 37.4 1.8 3.2 26.9 133.5 76.6 1.1 2.2 2.8 3.4 62.0 3.5 3.4 17.9 8.6 7.4 158.2 16.7 37.2 78.8 6.0 174.1 9.7 15.3 2.8 1.8 2.6 14.4 11.6 117.7 1.6 43.0 3.6 6.1 6.2 2.5 23.1 5.7 30.8 5.3 90.9 147.5 5.6 4.1 6.5 11.4 24.2 1.8 15.7 7.2 23.4 20.3 14.0 101.0 120.6 33.8 1.9 9.9 6.8 41.1 1.3 5.4 55.0 4.7 35.2 0.0 12.2 11.0 3.2 13.1 0.8 1.4 21.1 88.8 2.1 9.1 1.7 TAB2 "KIAA0733, MAP3K7IP2" ENSG00000055208 "TGF-beta activated kinase 1 (MAP3K7) binding protein 2" Q9NYJ8 6 149218641-149411613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 238.0;Microglial cells: 188.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065436, HPA070137" Approved NA NA "HPA065436: AB_2732735, HPA070137: AB_2732148" "unprognostic (1.08e-2)" "unprognostic (4.81e-3)" "unprognostic (1.27e-2)" "unprognostic (1.07e-2)" "unprognostic (7.05e-2)" "unprognostic (3.85e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-1)" "unprognostic (3.08e-2)" "unprognostic (3.08e-2)" "unprognostic (8.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.29e-3)" "unprognostic (1.93e-1)" "unprognostic (7.57e-2)" "unprognostic (2.49e-1)" 27.9 25.9 55.1 33.2 52.9 48.8 33.6 50.1 59.0 36.7 44.8 40.0 24.3 33.0 28.2 36.1 27.5 26.3 32.6 55.5 88.4 34.8 59.3 31.3 39.1 98.4 60.6 45.6 41.2 33.4 42.0 15.4 27.8 65.0 33.1 33.2 20.2 55.3 36.4 70.1 24.8 26.5 37.4 81.3 35.4 27.5 21.5 61.7 47.7 36.0 60.3 38.1 37.9 28.5 74.9 32.0 19.8 51.8 56.0 49.6 42.7 40.1 35.8 65.6 55.4 71.6 30.1 44.9 33.8 44.8 42.8 72.0 31.8 42.3 49.2 86.1 112.0 30.2 55.0 25.8 43.4 49.1 47.8 32.4 51.4 68.8 55.9 73.8 85.1 53.1 33.4 42.1 32.9 57.6 39.8 44.9 27.0 33.0 27.2 22.2 37.7 36.4 21.7 51.9 45.7 39.3 35.7 49.0 81.4 27.6 59.4 50.8 52.1 57.6 42.2 51.8 47.0 63.5 28.9 18.2 50.4 70.8 29.9 44.7 0.0 0.9 0.3 1.4 1.7 1.3 1.9 4.1 2.7 2.1 0.9 2.6 2.3 4.7 4.7 1.4 2.4 4.6 1.2 55.1 52.9 50.1 59.0 55.5 88.4 98.4 60.6 45.6 65.0 81.3 61.7 74.9 19.9 67.3 28.3 238.0 27.5 47.0 26.5 17.0 17.1 9.1 29.3 19.4 48.0 11.5 19.5 16.5 2.1 13.1 24.3 42.1 11.7 15.0 40.0 28.5 31.9 22.8 16.3 23.1 82.1 19.8 11.8 26.7 21.9 47.8 28.5 28.0 22.9 41.4 28.9 11.8 83.3 21.5 14.2 43.1 81.7 13.7 29.2 42.4 17.8 188.3 42.8 10.9 21.6 82.9 81.3 26.3 17.2 28.6 23.1 43.7 19.9 19.7 18.5 5.9 19.7 29.9 19.0 16.4 12.4 18.2 42.9 10.7 40.0 12.7 22.2 57.2 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 369.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 35000 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: AB_2677611" "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 56.5 44.4 28.8 24.2 34.3 41.5 45.4 37.1 35.3 48.3 40.8 38.7 26.1 46.9 45.0 32.5 39.5 38.6 59.1 28.1 34.5 93.5 46.1 36.3 26.4 33.6 32.8 28.2 51.0 37.1 55.7 24.9 63.1 32.7 40.7 35.2 22.1 32.4 47.9 47.5 36.7 28.3 50.9 31.6 35.4 34.4 48.4 30.6 21.9 74.6 42.7 24.9 42.6 34.3 42.1 27.2 19.5 30.5 41.4 162.6 96.1 48.3 89.0 107.5 68.1 85.1 25.4 35.7 19.4 46.9 87.6 62.9 53.8 20.1 46.0 89.0 33.6 39.6 18.9 17.5 30.5 62.0 37.2 17.2 107.8 39.1 58.0 39.6 74.7 74.7 27.0 24.6 31.8 65.1 35.3 22.9 27.9 10.1 40.2 20.1 25.2 54.0 15.1 97.7 23.9 19.2 18.1 90.1 53.2 18.9 33.5 32.9 38.4 51.3 35.9 37.0 92.9 60.9 30.6 38.6 24.5 67.4 33.1 34.3 21.0 18.5 25.1 8.8 17.8 10.5 22.8 10.2 9.7 13.9 17.0 9.8 8.0 32.1 11.4 23.4 16.9 10.7 10.6 28.8 34.3 37.1 35.3 28.1 34.5 33.6 32.8 28.2 32.7 31.6 30.6 42.1 120.5 80.1 53.7 10.1 44.6 46.8 58.6 75.1 46.7 21.3 50.1 50.3 54.1 38.6 53.4 66.2 29.2 81.1 31.4 64.5 39.2 92.7 191.0 42.2 77.3 78.9 26.8 32.2 11.9 80.7 77.1 103.4 18.3 60.7 29.1 48.2 104.6 41.9 45.6 16.8 13.9 23.1 46.8 56.0 47.7 369.6 129.5 46.6 42.7 5.6 75.7 86.5 18.6 17.1 25.0 67.8 33.5 112.8 45.3 65.0 49.8 132.1 33.8 22.6 98.6 85.9 71.1 166.5 82.8 48.7 47.0 122.7 32.0 65.7 22.4 64.0 EIF2AK2 "EIF2AK1, PKR, PPP1R83, PRKR" ENSG00000055332 "Eukaryotic translation initiation factor 2 alpha kinase 2" P19525 2 37099210-37157522 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003845, HPA019795, HPA063893" Approved Enhanced Cytosol NA NA 44000 Cytosol "CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144" "unprognostic (1.70e-2)" "unprognostic (2.26e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.77e-3)" "unprognostic (8.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.19e-1)" "unprognostic (3.15e-3)" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (4.65e-2)" "unprognostic (5.32e-2)" 11.2 9.1 7.5 10.6 7.9 30.4 8.7 7.2 9.5 9.9 8.7 8.9 7.7 10.6 8.1 6.4 8.4 9.5 6.4 6.9 10.1 8.6 7.8 8.9 8.1 10.6 7.8 5.0 10.9 7.5 11.2 6.6 11.3 8.6 10.2 8.7 6.7 17.9 8.5 4.5 4.6 10.0 11.2 7.0 12.0 9.6 3.3 11.1 11.8 10.0 5.8 7.2 8.1 5.9 15.4 38.4 22.1 16.7 17.4 21.5 28.3 20.1 21.2 29.1 56.3 41.1 23.0 23.2 27.4 27.0 29.8 66.2 27.4 24.2 27.1 29.5 45.7 12.0 33.8 19.2 18.7 17.9 32.2 0.2 22.5 13.1 23.7 19.3 17.7 18.0 10.7 19.1 23.6 20.3 13.4 35.5 17.0 15.8 8.4 10.8 27.6 40.9 12.1 15.3 18.7 14.1 20.4 32.0 24.0 50.7 12.7 9.2 9.0 31.4 25.7 24.9 15.1 36.2 19.0 30.8 0.3 15.9 20.0 23.1 10.7 5.3 6.3 5.4 7.9 5.2 5.3 4.5 5.2 4.8 4.2 3.0 4.3 15.7 6.5 8.0 3.1 6.5 2.1 7.5 7.9 7.2 9.5 6.9 10.1 10.6 7.8 5.0 8.6 7.0 11.1 15.4 94.5 67.3 34.0 25.1 35.9 19.5 42.3 33.0 31.3 38.8 26.6 26.0 29.9 32.9 46.0 22.0 14.6 47.8 44.8 32.2 21.5 40.2 2.4 55.8 68.7 76.3 15.0 36.0 39.6 48.5 89.2 52.6 22.4 41.7 41.1 93.5 33.5 21.9 38.2 47.1 42.9 24.0 16.2 29.9 20.8 4.2 57.2 50.7 21.4 48.7 47.1 50.9 45.3 51.3 16.8 54.7 21.8 84.2 46.0 39.5 33.6 33.0 48.9 24.8 39.5 60.5 45.9 2.4 5.5 22.5 10.1 40.8 40.0 61.3 28.6 40.5 USP36 "FLJ12851, KIAA1453" ENSG00000055483 "Ubiquitin specific peptidase 36" Q9P275 17 78787381-78841441 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012082, HPA012395, HPA052860" Uncertain Supported Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nucleoli, Nucleoli rim" "Nuclear speckles" "HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974" "unprognostic (1.94e-2)" "unprognostic (2.80e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.18e-5)" "unprognostic (9.35e-2)" "unprognostic (1.98e-1)" "unprognostic (2.50e-3)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "unprognostic (1.68e-2)" "unprognostic (2.78e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (4.03e-3)" "unprognostic (1.78e-1)" 38.1 38.3 22.3 21.7 24.3 47.0 33.2 29.6 27.1 32.5 28.2 29.1 13.5 27.1 23.1 25.2 34.5 18.9 27.5 23.2 32.1 30.1 30.6 36.4 20.8 25.0 22.3 21.9 68.0 44.9 18.2 50.7 26.2 23.2 36.5 16.0 26.5 25.1 13.2 30.6 40.1 26.8 16.5 21.9 31.0 31.5 22.4 23.8 15.2 31.8 11.8 20.7 29.6 30.1 32.5 42.7 50.3 14.6 26.9 30.5 33.7 27.8 34.1 34.5 32.1 21.5 49.2 21.0 54.0 16.9 30.6 34.8 30.6 34.5 25.4 57.0 13.0 52.1 49.4 81.0 51.9 31.3 54.7 26.0 29.5 41.0 45.8 101.6 24.7 28.3 24.1 40.0 55.3 26.8 32.6 50.1 55.1 22.6 31.6 39.9 38.1 31.8 36.3 20.2 44.1 42.8 25.8 24.5 112.5 63.7 31.3 29.2 34.4 24.3 75.2 35.3 44.3 61.1 40.7 17.4 66.1 29.6 41.9 24.0 10.1 3.0 2.4 5.5 4.2 6.5 5.1 5.2 4.8 1.8 4.7 5.7 5.6 4.3 4.5 2.7 9.7 3.8 1.9 22.3 24.3 29.6 27.1 23.2 32.1 25.0 22.3 21.9 23.2 21.9 23.8 32.5 27.4 12.8 37.4 23.5 55.9 51.7 28.4 8.2 40.9 33.2 18.1 16.9 14.1 18.6 18.8 14.7 33.3 8.3 66.3 14.4 5.9 10.2 20.7 22.3 24.0 28.4 18.5 14.7 19.0 9.6 11.3 26.6 25.0 42.7 20.3 12.8 12.1 16.5 43.3 26.9 22.5 18.6 10.2 24.5 72.8 8.5 11.8 49.4 30.2 10.3 14.9 13.2 16.5 13.6 19.8 13.2 8.4 12.4 57.1 32.4 7.3 5.0 11.1 32.1 6.6 22.1 23.1 18.4 16.5 24.4 43.3 12.9 73.6 13.1 18.6 22.2 KMT2C "HALR, KIAA1506, MLL3" ENSG00000055609 "Lysine methyltransferase 2C" Q8NEZ4 7 152134922-152436641 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 363.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074736 Approved Nucleoplasm NA NA Nucleoplasm "HPA074736: AB_2686709" "unprognostic (7.75e-2)" "unprognostic (3.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.31e-1)" "unprognostic (5.23e-3)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.01e-6)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (3.04e-2)" "unprognostic (2.64e-1)" 11.9 11.3 17.3 7.3 23.0 16.6 13.0 16.3 13.5 15.4 6.6 12.6 5.8 14.4 13.9 14.2 12.0 7.8 10.2 13.4 15.8 9.0 10.4 12.9 8.1 27.4 19.4 7.7 17.0 18.7 12.5 12.2 10.4 20.4 9.4 7.7 21.9 14.3 9.1 26.1 17.5 12.9 7.6 13.4 12.3 15.3 13.5 18.2 16.3 14.7 17.1 9.6 11.4 12.9 29.5 13.4 6.1 11.6 11.7 19.0 13.9 10.2 4.7 6.4 5.0 5.5 10.9 4.7 22.4 8.9 11.3 9.2 5.2 14.3 7.5 9.2 12.7 6.5 14.0 7.3 4.5 8.9 22.9 12.8 6.6 9.1 7.1 8.2 7.2 8.4 9.7 22.5 15.0 11.7 12.7 14.8 11.1 6.8 8.5 7.9 9.5 12.3 8.4 5.8 10.9 19.6 12.8 13.4 15.8 6.3 10.6 4.6 15.7 12.8 8.0 4.4 9.0 8.9 15.3 7.7 22.4 10.7 14.7 8.4 6.1 3.0 4.4 1.9 2.7 1.6 6.9 2.0 1.5 1.4 3.9 1.9 1.4 15.2 2.2 2.6 3.7 1.3 0.8 17.3 23.0 16.3 13.5 13.4 15.8 27.4 19.4 7.7 20.4 13.4 18.2 29.5 62.4 76.9 71.9 292.8 75.0 89.1 38.3 31.5 62.0 89.0 59.6 35.2 65.8 44.3 72.4 46.0 173.0 38.0 61.9 61.7 5.9 37.6 32.1 94.4 92.1 58.9 67.9 55.5 180.7 33.1 51.7 58.3 89.2 200.5 65.2 52.8 56.7 46.0 33.7 80.8 172.2 53.5 42.7 54.7 79.6 17.3 67.4 90.5 42.7 202.4 77.1 57.7 59.8 299.6 363.2 37.6 49.0 60.2 90.3 53.6 36.3 14.7 46.9 73.0 26.3 83.0 55.5 42.3 33.9 80.9 96.3 127.2 76.8 54.8 39.1 61.4 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048500 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 43.9;epididymis: 14.0;parathyroid gland: 35.6" "Group enriched" "Detected in many" 7 "Enteroendocrine cells: 113.6;Melanocytes: 151.2" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Group enriched" "Detected in some" 4 "cerebral cortex: 4.2;hippocampal formation: 3.6;hypothalamus: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.9;HAP1: 12.7;RH-30: 15.7;SK-MEL-30: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: AB_2684695" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 3.1 43.9 0.7 0.2 0.2 0.0 2.2 0.0 4.2 5.1 2.9 0.8 5.5 5.8 14.0 0.3 1.7 0.3 2.3 3.6 1.3 5.0 0.1 4.5 0.1 0.1 0.2 0.0 2.1 7.5 35.6 7.0 2.5 0.1 0.3 1.0 0.1 3.8 0.6 0.2 4.3 2.2 1.9 0.1 0.9 2.6 0.6 0.3 4.3 1.9 1.1 0.2 0.4 2.5 0.2 9.0 2.0 0.0 0.0 6.6 5.9 2.4 0.1 12.9 3.2 8.8 0.6 1.5 0.0 0.9 0.1 3.0 0.0 12.7 4.2 2.0 3.6 8.6 0.0 0.7 0.0 0.0 0.0 0.0 0.6 1.5 2.6 1.5 3.2 0.0 0.0 0.0 0.0 6.3 0.7 0.0 0.0 1.0 0.0 1.1 0.0 15.7 0.0 0.4 0.0 0.5 0.0 0.4 0.0 29.3 0.9 5.2 6.5 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 4.2 3.6 1.3 0.1 0.2 0.0 0.1 0.1 0.3 0.2 16.6 16.0 1.7 0.0 0.0 8.7 3.5 7.0 0.6 0.0 4.2 1.9 6.8 11.5 2.5 3.7 0.0 9.0 0.1 0.3 0.0 1.7 0.4 0.8 8.1 2.0 113.6 0.0 1.2 9.6 0.2 18.4 1.5 1.9 0.0 0.3 0.0 0.1 3.5 0.0 0.4 2.5 6.1 0.0 7.1 0.1 1.8 3.2 151.2 2.8 1.6 0.0 0.0 0.0 0.1 3.6 12.9 0.0 0.3 1.4 4.1 3.4 0.7 0.0 6.6 6.3 1.2 1.8 4.1 0.4 3.4 2.6 1.4 1.0 3.8 0.6 CCDC85A KIAA1912 ENSG00000055813 "Coiled-coil domain containing 85A" Q96PX6 2 56183990-56386172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in some" "Adipocytes: 57.7;Excitatory neurons: 228.7;Inhibitory neurons: 160.5;Microglial cells: 60.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 45.9;fHDF/TERT166: 74.5;U-266/70: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043106, HPA057020" Uncertain "Intracellular and membrane" NA NA "HPA043106: AB_10794770, HPA057020: AB_2683311" "unprognostic (2.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.87e-2)" "unprognostic (3.66e-2)" "unprognostic (7.87e-2)" "unprognostic (7.62e-2)" "unprognostic (3.07e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-1)" "unprognostic (6.55e-5)" "unprognostic (3.28e-2)" "unprognostic (1.00e-1)" "unprognostic (2.88e-2)" "unprognostic (1.83e-2)" 12.7 0.6 7.1 0.7 8.7 0.0 3.6 2.6 8.1 2.5 0.0 0.7 0.3 6.4 0.8 0.7 2.1 1.2 4.6 7.3 7.3 1.0 0.1 5.6 0.6 19.5 7.1 7.3 0.5 0.7 1.3 0.2 10.1 8.0 2.0 0.7 4.0 1.2 2.7 5.4 1.7 0.4 4.7 9.9 0.7 0.5 0.4 5.8 0.6 9.2 7.6 0.7 0.7 0.7 15.6 0.0 0.8 0.1 0.0 13.9 0.8 0.0 11.6 1.1 9.8 0.9 0.0 0.1 45.9 1.7 74.5 0.0 2.0 0.0 0.0 5.6 0.0 0.3 0.0 0.6 0.0 0.7 0.0 0.1 3.3 0.3 0.0 1.2 5.5 9.7 0.0 0.0 6.1 1.3 0.2 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.7 1.3 0.0 0.3 0.1 0.0 2.1 5.3 0.0 15.3 7.9 2.3 0.1 0.9 32.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 8.7 2.6 8.1 7.3 7.3 19.5 7.1 7.3 8.0 9.9 5.8 15.6 57.7 25.6 0.6 15.3 0.8 3.3 0.5 0.0 0.0 7.8 0.6 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.3 3.6 0.2 1.9 14.8 1.2 0.0 228.7 0.4 0.1 3.7 0.0 0.5 0.0 0.2 8.6 0.0 2.3 0.0 160.5 0.2 0.0 0.3 2.0 11.9 0.3 0.3 5.4 60.0 0.0 0.7 0.0 33.7 7.2 0.7 0.1 0.0 0.1 0.3 0.0 0.3 0.0 1.5 0.0 10.0 2.7 0.2 0.8 0.1 1.3 0.1 0.1 3.6 0.9 0.3 PUM2 "KIAA0235, PUMH2" ENSG00000055917 "Pumilio RNA binding family member 2" Q8TB72 2 20248691-20352234 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030316, HPA049670" Approved Enhanced Cytosol NA NA Cytosol "HPA030316: AB_10610289, HPA049670: AB_2680845" "unprognostic (2.41e-1)" "unprognostic (8.77e-2)" "unprognostic (1.97e-1)" "unprognostic (2.31e-2)" "unprognostic (9.89e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.86e-2)" "unprognostic (1.23e-1)" "unprognostic (4.49e-3)" "unprognostic (1.05e-2)" "unprognostic (6.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (2.41e-1)" "unprognostic (4.81e-2)" "unprognostic (2.87e-2)" 27.8 30.0 32.5 33.7 34.6 33.7 42.1 45.9 34.7 36.5 35.2 36.8 34.7 36.6 33.1 39.6 29.9 27.3 33.5 33.4 32.5 37.2 43.5 33.5 48.9 29.8 32.4 31.0 45.0 27.6 41.7 8.4 40.7 30.9 37.6 37.4 67.4 33.3 33.4 21.7 47.6 35.9 32.6 33.6 43.0 36.1 25.1 31.9 71.2 58.1 32.9 48.0 38.3 18.4 40.3 72.4 50.0 65.3 46.1 40.2 40.5 65.9 49.2 53.6 48.4 42.2 43.5 33.0 96.3 11.0 44.9 58.2 38.9 61.4 35.6 71.2 87.0 38.2 105.0 35.3 62.2 43.4 107.2 93.3 29.7 79.7 42.1 77.4 45.5 53.1 57.1 75.0 82.9 57.3 35.5 93.6 65.9 55.8 68.3 31.5 80.6 110.9 73.8 45.0 68.1 55.9 76.6 42.2 58.3 48.1 43.4 33.0 61.5 52.5 58.6 58.5 38.3 64.6 93.3 123.0 181.8 35.3 75.8 51.4 11.5 4.0 5.8 6.0 5.2 7.1 4.8 6.7 7.5 4.2 5.3 7.3 6.0 11.6 7.7 7.3 3.7 5.8 3.7 32.5 34.6 45.9 34.7 33.4 32.5 29.8 32.4 31.0 30.9 33.6 31.9 40.3 43.6 35.3 51.6 89.5 57.6 79.7 32.2 26.4 74.0 94.6 46.9 30.5 46.5 32.9 33.8 47.8 62.6 36.3 43.6 44.0 11.7 16.6 10.1 33.9 35.6 45.0 34.6 41.0 134.7 15.5 16.9 36.5 43.8 45.9 20.3 53.0 41.4 56.3 29.1 58.9 153.5 43.2 38.7 70.7 44.2 5.8 34.2 44.9 32.0 144.3 42.7 26.8 43.3 155.3 186.0 22.6 28.1 26.4 54.7 57.8 33.9 29.7 39.5 72.3 32.9 40.5 47.6 16.8 16.6 75.2 106.3 52.0 50.1 31.2 40.2 56.6 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 58.8 85.6 22.5 21.2 25.5 25.6 62.1 29.2 37.9 63.2 22.9 65.5 28.9 56.8 7.5 64.2 58.2 19.1 62.3 21.3 26.9 79.9 83.5 45.4 23.8 26.4 25.5 19.5 72.0 77.0 27.8 52.1 21.8 26.4 63.1 7.0 9.3 66.3 31.1 119.0 72.0 51.1 7.5 26.8 51.1 68.6 41.4 26.1 12.7 65.8 18.4 7.5 67.1 58.0 30.4 102.5 113.6 23.3 41.5 24.0 30.6 72.4 69.7 62.2 52.9 53.4 65.1 78.0 87.1 92.8 29.3 28.9 62.8 8.5 58.1 7.0 66.4 146.1 68.9 76.6 102.6 51.1 55.1 53.2 47.8 44.6 45.1 19.8 25.2 50.0 54.7 34.9 43.3 16.3 107.7 51.4 124.5 37.9 27.7 105.8 54.7 77.8 59.4 29.4 51.9 26.1 67.6 51.0 24.5 80.7 7.5 130.9 26.1 62.4 49.4 65.9 53.4 74.4 89.9 73.5 44.5 63.1 101.5 36.4 100.4 62.2 70.8 58.0 58.8 59.4 67.1 63.5 57.7 69.7 62.8 59.9 54.9 20.9 72.3 58.7 54.3 77.0 68.0 22.5 25.5 29.2 37.9 21.3 26.9 26.4 25.5 19.5 26.4 26.8 26.1 30.4 84.3 44.8 49.6 9.8 64.5 55.7 70.6 97.2 60.3 44.0 93.6 130.8 34.3 88.6 74.7 75.4 41.7 135.3 63.7 47.2 180.0 101.1 114.1 74.3 53.2 58.8 61.1 52.6 8.9 127.2 140.6 68.9 53.5 44.5 46.9 64.8 69.3 75.7 98.4 18.5 13.4 77.7 67.1 51.5 43.6 51.5 85.4 47.6 64.0 7.5 67.6 91.5 71.1 12.1 31.0 91.0 77.4 73.7 70.8 72.0 94.3 221.0 79.7 62.4 52.6 66.1 82.2 277.1 76.6 82.6 68.5 103.7 61.6 98.1 80.6 79.2 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain 4" Q14624 3 52812962-52830688 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "liver: 1878.6" "Group enriched" "Detected in many" 5 "Early spermatids: 119.2;Hepatocytes: 134.6;Late spermatids: 126.5" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;JURKAT: 2.0;U-266/70: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" NA NA 3060000 58000000000 Vesicles "CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 3.6 18.7 4.4 1.3 4.4 10.1 3.0 3.9 5.1 4.2 3.9 3.1 1.0 2.9 1.7 1.4 3.8 1.1 3.0 4.2 3.8 5.3 1878.6 4.9 1.7 4.2 4.2 4.3 2.5 49.3 0.1 4.3 0.8 4.5 4.0 1.0 3.3 2.1 1.8 40.6 2.3 3.4 1.5 3.8 7.5 3.9 1.9 4.0 2.2 5.3 2.8 1.2 5.3 3.3 4.4 0.0 0.1 0.4 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.4 0.0 0.0 0.2 2.4 0.1 1.0 0.0 1.2 0.4 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.0 0.3 0.8 0.0 0.1 0.2 0.3 0.4 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.4 0.3 0.0 0.1 0.4 0.5 0.3 0.1 0.0 0.4 0.4 0.0 3.0 1.4 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.4 4.4 3.9 5.1 4.2 3.8 4.2 4.2 4.3 4.5 3.8 4.0 4.4 0.7 0.0 1.1 22.5 0.9 0.8 0.3 0.3 0.0 10.0 0.6 1.3 1.1 2.8 0.8 0.0 12.5 0.0 0.4 0.1 0.0 0.3 119.2 0.7 0.7 0.8 0.0 8.4 11.6 2.6 0.0 0.6 1.1 0.4 0.0 2.7 2.5 134.6 0.5 5.0 8.6 0.2 0.0 2.2 1.0 126.5 1.2 1.3 0.0 5.6 1.9 2.3 2.1 3.0 3.1 2.3 0.5 1.9 0.7 0.2 0.0 0.3 0.3 6.0 6.6 6.2 2.4 1.3 1.5 0.0 0.3 0.3 1.2 3.2 0.1 0.1 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777595-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 782 "liver: 1517.2" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 1087.0" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.3;Hep G2: 1.7;HL-60: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" NA NA 4490000 59000000000 Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favorable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.7 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.2 1517.2 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 1.9 0.4 0.4 0.1 0.4 0.1 0.1 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.1 0.0 29.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.5 1087.0 0.1 0.0 0.0 0.0 0.0 20.2 0.0 1.7 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.1 HPF1 "C4orf27, FLJ20534" ENSG00000056050 "Histone PARylation factor 1" Q9NWY4 4 169729470-169757944 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043467 Uncertain Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA043467: AB_10793949" "unprognostic (1.09e-1)" "unprognostic (1.15e-2)" "unprognostic (1.72e-2)" "unprognostic (1.47e-1)" "unprognostic (2.70e-1)" "unprognostic (1.09e-1)" "unprognostic (8.68e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (5.63e-4)" "prognostic favorable (7.47e-4)" "unprognostic (6.34e-2)" "unprognostic (4.55e-1)" "unprognostic (3.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.32e-1)" "unprognostic (5.51e-2)" "unprognostic (1.09e-1)" 18.0 18.7 20.0 16.5 21.3 16.9 21.4 20.8 26.2 19.1 22.4 18.9 12.3 23.5 25.0 15.8 17.2 13.2 22.7 20.4 20.8 18.3 22.3 14.4 21.3 21.7 21.0 18.8 22.9 14.5 16.1 19.7 16.9 21.8 17.4 17.9 21.5 13.3 15.8 21.5 19.8 12.9 25.0 20.4 17.6 15.9 14.2 20.4 27.2 19.0 21.1 21.3 16.9 16.9 23.4 33.7 21.0 71.2 37.7 42.6 52.4 30.3 59.9 58.8 72.8 76.7 14.3 35.5 17.5 15.7 39.2 53.3 14.7 49.5 43.6 76.7 55.1 33.7 57.0 30.0 20.5 29.9 48.7 20.1 34.1 43.2 47.1 14.5 44.1 64.1 59.1 43.7 66.2 64.4 27.3 102.7 42.4 29.2 32.2 27.0 44.7 33.8 21.2 41.9 21.9 17.2 63.1 39.7 17.2 56.3 49.1 34.0 43.1 31.3 24.8 39.2 58.4 54.3 31.3 49.8 52.4 68.3 47.0 40.3 19.3 20.0 22.4 28.7 24.0 34.6 22.0 33.0 35.1 26.1 18.1 32.1 33.3 5.3 25.4 23.7 17.9 38.1 21.9 20.0 21.3 20.8 26.2 20.4 20.8 21.7 21.0 18.8 21.8 20.4 20.4 23.4 41.6 44.8 26.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 19.9 29.6 0.0 0.0 17.3 27.6 0.0 71.0 14.3 0.0 92.0 45.7 0.0 31.9 36.9 20.1 0.0 0.0 0.0 46.3 61.2 26.1 0.0 21.9 17.7 56.4 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 31.1 0.0 0.0 1.6 0.0 0.0 63.9 15.3 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 16.3 10.5 56.0 0.0 0.0 ZFR "SPG71, ZFR1" ENSG00000056097 "Zinc finger RNA binding protein" Q96KR1 5 32354350-32444740 "Predicted intracellular proteins" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016666 Supported Approved Nucleoplasm NA NA 8100 Nucleoplasm "HPA016666: AB_1859060" "unprognostic (7.45e-3)" "unprognostic (8.46e-2)" "unprognostic (4.07e-3)" "unprognostic (4.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.38e-1)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (1.58e-1)" "unprognostic (3.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.47e-2)" "unprognostic (5.46e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" 26.9 28.6 35.8 22.0 39.2 31.1 27.0 35.3 39.6 26.8 26.8 22.0 18.7 28.1 21.8 26.2 28.1 23.8 34.8 36.4 34.0 29.8 25.1 19.7 26.9 34.7 35.1 32.5 38.8 26.2 31.5 14.3 35.8 34.8 26.4 22.8 37.1 27.9 25.0 42.7 15.6 21.2 27.6 36.1 22.8 21.4 30.4 34.8 31.9 34.4 41.7 26.5 29.0 17.4 39.4 45.1 65.8 75.4 47.2 81.4 59.3 65.8 68.0 57.3 70.5 50.3 65.9 39.0 65.7 43.2 66.8 92.0 34.4 99.0 48.1 98.4 62.4 55.3 80.5 66.9 65.3 71.2 83.7 63.6 56.7 59.1 74.7 135.8 63.9 53.9 31.9 82.0 53.9 73.1 34.0 73.7 35.4 55.5 47.3 48.7 59.2 101.3 36.1 52.7 73.1 41.9 44.2 101.1 58.2 60.8 53.1 36.1 102.0 61.4 69.5 65.0 51.9 57.4 26.7 50.3 72.6 51.4 66.2 86.2 35.3 15.5 19.8 15.6 24.2 18.1 16.6 14.9 16.1 17.3 13.1 14.2 14.3 10.1 22.9 24.9 9.1 15.1 13.2 35.8 39.2 35.3 39.6 36.4 34.0 34.7 35.1 32.5 34.8 36.1 34.8 39.4 48.0 51.3 55.4 80.0 55.1 26.0 70.6 47.0 61.5 61.2 39.4 34.9 108.7 34.3 63.7 31.3 22.9 40.1 51.4 28.3 49.0 51.7 53.1 47.7 62.1 51.6 39.5 36.6 109.5 35.9 31.3 66.0 34.1 48.6 76.5 50.4 40.4 35.8 32.7 77.4 98.5 26.1 52.9 35.8 31.3 35.6 53.1 47.3 30.2 74.0 53.9 70.8 52.5 117.6 171.4 44.9 39.6 60.9 52.3 69.8 28.7 45.6 56.3 55.4 39.5 81.2 70.9 118.5 71.8 53.1 24.6 55.5 50.1 65.3 34.1 55.7 ZNF280C "FLJ20095, SUHW3, ZNF633, ZPET" ENSG00000056277 "Zinc finger protein 280C" Q8ND82 X 130202707-130268899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.4" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 20.1;Spermatocytes: 27.5;Spermatogonia: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051494, HPA055788" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA051494: AB_2681506, HPA055788: AB_2682921" "unprognostic (2.97e-1)" "unprognostic (2.02e-1)" "unprognostic (3.97e-1)" "unprognostic (5.69e-3)" "unprognostic (2.98e-2)" "unprognostic (8.52e-2)" "unprognostic (1.16e-6)" "unprognostic (1.96e-2)" "unprognostic (3.33e-2)" "unprognostic (9.77e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-2)" "unprognostic (3.27e-8)" "unprognostic (1.71e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (6.85e-2)" 1.5 1.4 0.7 1.7 1.2 2.6 1.7 1.6 1.3 2.6 0.5 1.3 1.3 2.7 5.2 1.4 1.5 1.9 0.9 0.8 0.9 1.1 1.3 1.5 2.3 0.8 0.9 0.6 1.8 1.3 1.7 1.6 1.8 0.8 1.5 1.4 1.9 1.2 1.2 1.4 1.7 1.4 1.8 0.5 1.7 1.1 9.4 0.8 2.2 1.6 1.1 2.6 1.6 1.7 1.3 3.3 4.1 10.7 9.6 3.1 4.3 4.0 3.1 4.0 3.2 4.8 2.5 5.2 7.8 12.0 2.2 6.3 3.2 7.5 2.4 5.7 6.9 2.1 3.4 3.2 1.9 2.5 11.1 3.0 3.2 1.1 4.6 4.7 3.2 3.7 5.0 1.7 4.6 3.8 4.2 6.0 4.5 6.2 4.9 3.4 8.2 3.6 3.0 3.4 5.2 5.2 7.1 3.0 1.7 3.4 4.3 1.9 3.7 3.7 3.5 2.9 5.8 8.2 1.9 1.3 4.3 3.3 9.9 3.3 1.0 0.5 0.6 1.0 0.8 1.7 1.4 1.2 1.2 0.7 1.0 0.9 1.3 0.2 1.8 1.1 0.8 1.8 0.4 0.7 1.2 1.6 1.3 0.8 0.9 0.8 0.9 0.6 0.8 0.5 0.8 1.3 3.1 3.2 3.6 8.8 6.8 0.9 2.1 1.3 3.4 2.4 2.1 3.2 1.3 0.0 1.4 1.8 2.1 2.0 8.1 1.2 0.0 1.3 0.3 2.9 7.4 2.8 4.8 3.4 13.1 1.8 1.7 2.9 5.1 3.6 0.0 7.4 3.6 2.7 1.6 5.0 11.2 0.9 4.1 3.2 1.0 0.3 3.4 2.4 0.0 9.4 4.3 0.9 0.0 20.1 11.8 1.1 1.8 3.0 3.2 2.1 1.0 2.1 3.2 3.1 6.6 3.8 3.2 27.5 33.8 4.3 1.6 0.8 4.3 5.0 2.3 2.5 NPFFR2 "GPR74, NPFF2, NPGPR" ENSG00000056291 "Neuropeptide FF receptor 2" Q9Y5X5 4 72031804-72148067 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.3;seminal vesicle: 3.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 22.1;Cytotrophoblasts: 6.6;Excitatory neurons: 14.5;Extravillous trophoblasts: 12.3;Muller glia cells: 4.9;Syncytiotrophoblasts: 9.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "GAMG: 28.1;NTERA-2: 9.2;RPTEC TERT1: 11.9;SH-SY5Y: 14.0;U-2 OS: 13.7" "Region enriched" "Detected in some" 4 "olfactory bulb: 4.3" "Low region specificity" "Detected in all" HPA026825 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA026825: AB_10603123" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (6.07e-2)" "unprognostic (4.68e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.51e-1)" "unprognostic (2.40e-5)" "unprognostic (5.75e-2)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-1)" 0.0 0.0 1.2 0.2 1.0 0.0 0.2 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.9 0.0 0.2 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.1 1.6 0.5 0.1 0.2 0.7 0.0 3.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.6 7.3 0.3 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 14.0 0.0 0.0 0.0 2.0 0.0 0.0 1.3 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.6 1.0 1.0 0.8 0.0 0.8 0.5 0.0 0.6 0.6 0.1 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 22.1 0.0 0.5 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.3 0.0 0.0 14.5 0.2 12.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.3 3.5 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 1.7 0.0 0.0 9.7 0.0 0.0 0.0 0.1 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45010005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 9.0;pituitary gland: 19.0" "Cell type enhanced" "Detected in some" "Astrocytes: 96.6;Cone photoreceptor cells: 22.9;Horizontal cells: 28.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 29.1;Rod photoreceptor cells: 23.3" "Cancer enhanced" "Detected in some" "glioma: 1.9;prostate cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.2;AN3-CA: 10.0;JURKAT: 8.8;SCLC-21H: 8.7;SH-SY5Y: 37.5;U-2 OS: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA053834: AB_2682276, HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.1 1.2 6.4 0.1 6.3 0.0 0.4 4.8 6.1 9.0 1.0 0.2 0.1 3.2 0.4 0.4 2.6 0.1 0.6 5.0 4.2 1.9 0.0 0.1 0.0 8.1 6.5 2.7 4.0 0.5 0.9 19.0 0.0 5.0 5.2 0.0 6.2 0.3 0.5 0.2 0.1 0.2 0.7 3.7 0.1 0.6 5.5 6.6 0.2 2.0 0.3 0.0 0.2 3.2 5.8 0.0 0.0 11.2 10.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.0 0.1 2.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.6 0.0 0.0 8.8 0.0 0.0 0.1 0.9 1.3 0.0 6.7 0.0 0.4 0.0 2.6 0.2 0.0 0.1 8.7 37.5 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.5 8.5 0.0 0.2 0.4 0.0 5.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.3 4.8 6.1 5.0 4.2 8.1 6.5 2.7 5.0 3.7 6.6 5.8 0.0 0.0 0.0 96.6 0.0 0.1 0.6 0.0 0.0 14.1 0.0 0.3 2.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 1.9 0.0 16.2 0.1 3.2 0.4 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.3 0.0 0.6 0.0 0.0 0.1 28.6 9.1 0.0 0.0 0.0 0.0 41.9 0.6 0.1 0.0 5.6 0.0 5.0 0.0 29.1 9.3 0.1 0.0 1.9 0.0 1.7 0.0 0.0 0.7 23.3 0.0 1.1 0.5 1.2 2.9 0.0 0.0 0.0 0.3 1.9 0.0 0.1 TRAF1 EBI6 ENSG00000056558 "TNF receptor associated factor 1" Q13077 9 120902393-120929173 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 33.8" "Group enriched" "Detected in many" 8 "Langerhans cells: 319.7;monocytes: 316.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 12.9" "Lineage enriched" "Detected in many" 4 "T-cells: 12.9" "Group enriched" "Detected in many" 6 "HDLM-2: 92.5;WM-115: 113.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001852, CAB009593" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB009593: , HPA001852: AB_1080344" "unprognostic (1.45e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-3)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.02e-2)" "unprognostic (1.39e-1)" "prognostic favorable (2.19e-5)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.42e-5)" "unprognostic (1.85e-3)" "unprognostic (5.70e-3)" "unprognostic (2.64e-1)" "unprognostic (9.87e-3)" 6.9 10.0 7.9 21.0 10.5 9.0 6.8 7.5 8.6 8.3 7.2 7.6 3.6 6.2 4.6 5.7 9.7 7.6 6.7 7.3 8.0 9.6 6.4 9.5 33.8 9.5 9.1 6.3 12.2 4.8 3.0 12.5 2.8 9.3 11.9 4.1 10.9 5.2 5.6 2.6 7.4 11.0 3.6 7.2 15.0 8.0 3.2 8.8 15.2 9.2 1.8 23.3 15.0 7.5 14.1 3.2 2.0 0.4 0.1 3.7 9.1 0.0 0.8 5.0 1.4 2.7 0.2 1.7 6.1 1.0 1.0 14.7 1.1 0.5 0.3 1.9 92.5 0.0 0.5 1.5 0.4 2.6 0.2 6.9 4.6 4.8 5.8 4.2 1.8 0.9 1.7 0.2 12.6 0.9 0.3 0.2 2.6 1.2 1.4 0.2 1.5 1.5 12.2 0.5 0.2 1.1 0.1 0.8 0.3 0.3 2.7 0.7 1.1 0.9 1.2 0.8 4.9 16.1 9.3 3.5 3.2 3.0 0.5 113.0 0.0 0.3 0.0 3.8 0.4 6.7 0.3 9.7 8.2 0.4 0.1 3.1 4.5 0.0 1.7 0.3 2.8 12.9 2.1 7.9 10.5 7.5 8.6 7.3 8.0 9.5 9.1 6.3 9.3 7.2 8.8 14.1 1.6 6.4 0.0 9.8 9.6 9.7 6.2 1.0 2.8 2.0 2.2 2.4 2.5 4.3 4.0 3.7 18.8 0.0 19.0 0.5 1.9 24.3 0.6 0.8 2.5 5.0 1.8 2.7 1.4 2.0 0.1 7.1 3.1 1.0 36.8 1.3 1.4 1.4 2.7 0.0 2.1 1.1 0.0 3.7 319.7 0.8 1.8 26.0 7.2 3.7 316.7 1.4 4.1 2.5 8.3 15.6 0.3 1.9 10.7 6.7 0.6 1.5 0.3 5.9 0.0 3.6 4.1 1.9 0.4 1.6 10.4 0.0 36.7 3.0 0.8 1.8 RC3H2 "FLJ20301, FLJ20713, MNAB, RNF164" ENSG00000056586 "Ring finger and CCCH-type domains 2" Q9HBD1 9 122844556-122905359 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" "Repressor, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042863, HPA062144" Approved Enhanced Vesicles NA NA Vesicles "HPA042863: AB_2678204, HPA062144: AB_2732677" "unprognostic (6.05e-2)" "unprognostic (7.87e-2)" "unprognostic (7.24e-2)" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "prognostic favorable (5.50e-4)" "unprognostic (1.36e-1)" "unprognostic (1.68e-1)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" 11.9 8.9 8.0 12.2 10.8 32.8 10.5 14.6 10.1 13.6 5.6 10.5 10.0 12.0 8.2 13.1 9.7 11.1 14.0 10.3 8.5 12.8 13.5 11.6 18.7 7.8 8.2 9.0 11.3 6.9 15.9 9.7 14.7 7.8 9.7 11.3 16.1 9.1 9.2 11.9 10.0 9.4 14.1 7.7 14.3 11.9 11.7 8.6 18.9 13.0 15.5 17.3 14.6 9.1 10.8 17.3 26.2 33.5 18.2 17.4 19.8 17.8 22.0 24.4 25.2 21.8 31.2 18.8 28.8 16.7 29.8 30.1 40.9 35.4 25.1 27.7 13.4 13.5 16.4 44.4 21.3 23.1 19.9 26.5 19.9 25.5 24.3 34.6 22.0 35.6 25.4 24.1 21.6 32.9 23.9 20.2 14.7 17.7 24.9 21.8 19.7 54.8 19.4 25.8 13.9 38.3 25.8 39.2 24.9 21.2 22.8 29.2 17.2 33.9 20.5 17.3 27.7 39.8 14.0 25.4 32.1 22.3 18.2 23.1 10.0 4.6 6.0 6.1 7.3 5.1 4.3 4.8 6.0 4.1 5.8 4.5 4.5 8.0 4.0 6.7 6.5 5.1 2.8 8.0 10.8 14.6 10.1 10.3 8.5 7.8 8.2 9.0 7.8 7.7 8.6 10.8 33.8 41.7 32.8 20.9 27.7 11.0 13.6 20.0 20.5 19.2 15.6 10.5 34.8 12.8 17.3 9.2 37.5 15.7 26.6 18.9 3.9 12.0 5.9 27.6 30.9 28.3 23.3 22.7 38.4 11.4 15.2 18.4 23.9 40.1 17.1 21.9 29.6 19.5 9.6 28.6 35.1 19.8 12.2 27.4 19.4 9.5 13.4 21.4 14.2 30.9 26.1 16.9 24.7 35.2 39.3 23.5 9.0 18.0 22.5 24.3 14.8 12.0 17.7 20.2 19.7 16.3 24.1 30.7 17.9 23.3 14.8 23.0 28.8 15.4 14.7 27.3 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846568-53865794 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;kidney: 60.4;liver: 33.5" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005482 Enhanced Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Vesicles, Plasma membrane" "HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 0.9 2.0 19.1 2.3 19.9 0.6 5.8 21.6 29.1 18.2 15.1 6.9 5.9 5.1 0.7 1.7 3.3 2.4 2.7 19.8 18.8 60.4 33.5 3.9 2.6 19.4 19.1 17.3 1.5 7.9 1.1 4.3 0.9 19.3 2.4 6.9 4.9 4.9 0.7 1.3 2.3 5.9 0.8 17.4 1.3 3.6 2.5 21.2 0.4 2.9 0.2 0.7 0.9 1.3 22.7 1.5 3.1 4.5 3.4 0.1 0.0 7.1 3.1 0.1 0.1 0.0 20.2 1.4 4.6 1.0 1.0 1.7 0.8 12.2 0.0 0.0 1.6 3.5 6.0 6.1 59.5 0.0 5.6 3.2 0.0 0.0 0.0 0.0 3.8 0.0 1.6 4.9 2.1 0.1 4.2 0.9 2.3 12.1 46.2 2.6 1.7 1.9 5.3 1.4 5.3 6.4 3.7 10.1 2.4 1.9 3.3 9.2 2.0 2.5 3.0 3.3 2.6 3.9 4.7 5.6 2.9 2.7 3.3 1.7 1.3 0.2 0.0 0.2 0.2 0.1 0.1 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.3 0.9 0.1 19.1 19.9 21.6 29.1 19.8 18.8 19.4 19.1 17.3 19.3 17.4 21.2 22.7 0.2 0.0 4.1 48.3 0.2 0.3 2.0 0.0 0.0 0.1 8.2 4.4 4.1 17.2 1.3 0.0 0.0 1.4 0.3 4.3 9.8 4.8 1.0 0.5 1.0 0.2 29.2 0.0 0.5 1.6 1.0 0.6 4.6 1.7 2.5 0.4 0.4 13.1 0.1 0.0 2.5 8.7 2.0 0.0 1.1 0.7 1.2 1.2 0.0 1.9 0.0 4.4 0.0 37.7 4.3 1.8 3.0 0.4 0.0 4.4 2.9 78.0 0.0 0.1 0.0 0.3 0.5 0.4 1.0 0.0 0.1 0.4 0.9 0.0 10.2 0.6 TRAF3IP2 "ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522" ENSG00000056972 "TRAF3 interacting protein 2" O43734 6 111555381-111606906 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Inflammatory response, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 149.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036352 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA036352: AB_10672085" "unprognostic (1.94e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-1)" "prognostic favorable (4.73e-5)" "unprognostic (2.81e-2)" "unprognostic (3.03e-2)" "unprognostic (1.01e-2)" "unprognostic (9.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.13e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (1.11e-1)" "unprognostic (4.88e-1)" "unprognostic (2.34e-2)" "unprognostic (1.31e-1)" 19.9 16.5 22.9 19.6 22.4 32.7 20.1 21.7 29.6 25.2 20.8 34.3 28.8 36.6 47.7 26.8 35.0 14.4 8.4 22.4 24.7 9.0 8.6 17.7 16.4 26.0 24.2 20.6 14.0 21.8 13.7 9.4 14.3 26.0 19.4 26.7 5.9 25.5 31.1 11.5 33.9 25.3 22.3 19.3 6.8 35.8 3.1 24.1 21.2 14.9 14.9 22.7 26.7 18.2 26.7 32.2 11.0 6.8 15.7 35.9 39.0 15.6 39.8 62.2 9.9 14.1 8.7 14.1 6.2 13.2 33.5 35.5 58.2 8.0 86.2 18.4 43.2 11.6 12.7 10.6 11.9 13.9 6.9 22.6 47.1 57.5 29.9 110.1 24.9 20.0 15.2 13.6 1.9 13.2 22.0 51.2 19.4 9.0 30.6 8.8 53.3 12.4 2.7 29.5 52.4 27.3 6.9 12.1 71.8 47.8 12.7 31.6 18.0 9.2 19.2 7.6 149.7 35.5 0.8 12.4 16.8 45.8 10.8 50.1 25.8 2.5 5.3 3.8 0.8 12.7 6.4 7.6 5.6 2.6 8.6 7.6 7.4 3.5 5.7 0.3 0.8 17.9 3.1 22.9 22.4 21.7 29.6 22.4 24.7 26.0 24.2 20.6 26.0 19.3 24.1 26.7 24.7 3.2 13.8 26.1 10.8 30.1 61.5 46.3 11.4 7.5 8.3 8.6 4.9 7.2 21.6 3.7 12.5 19.3 3.8 30.0 5.9 35.4 0.1 20.9 14.5 18.3 13.2 5.2 5.9 31.9 28.8 14.4 18.3 32.7 20.2 7.7 3.9 5.5 6.0 6.7 10.8 16.9 16.2 1.3 10.7 0.5 7.2 5.8 12.4 7.5 6.2 14.2 8.2 19.6 6.6 20.2 26.3 7.5 4.5 42.9 18.5 5.9 18.3 5.5 0.0 14.7 10.5 0.8 2.1 16.2 24.6 20.9 7.9 4.6 21.9 45.0 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828822-2882820 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "adipose tissue: 157.6" "Cell type enhanced" "Detected in many" "Astrocytes: 10.7;Enteroendocrine cells: 20.4;Granulosa cells: 10.2;Hepatocytes: 20.2" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.1;CACO-2: 30.4;Hep G2: 32.6;NTERA-2: 38.4;SK-MEL-30: 87.6;SuSa: 59.0" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 157.6 2.2 13.5 1.9 11.0 0.2 39.2 19.4 9.3 3.0 7.8 4.0 1.5 6.6 1.0 1.0 5.1 2.3 1.4 11.0 23.8 2.0 18.6 0.5 0.6 29.6 22.4 7.1 2.5 5.4 1.0 0.8 2.2 25.9 4.0 2.8 1.4 4.7 6.7 0.3 1.7 2.2 3.7 34.4 0.3 4.6 0.9 18.1 0.4 1.7 0.5 0.3 3.7 2.0 38.1 0.1 11.5 39.1 0.2 20.5 0.0 28.5 2.0 6.3 6.1 8.2 30.4 0.6 0.0 3.1 5.2 6.6 0.0 22.5 0.5 6.8 0.2 6.3 0.1 0.7 32.6 6.7 0.0 8.9 8.1 0.4 1.0 0.0 0.2 0.0 0.0 0.3 0.1 6.6 1.9 0.0 1.0 38.4 0.4 0.2 6.1 13.0 0.0 0.0 0.1 0.0 0.7 0.1 0.3 87.6 59.0 4.1 25.4 0.0 0.0 6.7 3.8 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.5 11.0 19.4 9.3 11.0 23.8 29.6 22.4 7.1 25.9 34.4 18.1 38.1 0.3 0.0 0.0 10.7 0.2 0.4 1.1 0.5 0.0 1.2 2.1 0.8 1.2 4.3 0.2 0.0 4.2 6.0 0.0 1.2 5.9 1.0 0.4 3.8 1.0 0.3 20.4 0.0 5.9 4.0 7.9 1.6 4.6 0.7 0.0 10.2 0.0 20.2 1.1 0.0 4.9 1.7 0.0 1.0 0.0 0.5 0.6 0.1 3.6 0.0 0.0 1.6 0.0 0.5 0.1 2.1 0.6 3.0 0.0 1.0 0.4 2.4 1.1 0.1 0.0 0.3 1.2 0.3 1.5 0.0 0.3 2.3 0.0 3.2 3.5 0.7 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901695 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 83.8;Oligodendrocyte precursor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 455.0;hTERT-RPE1: 648.9;LHCN-M2: 776.8;RPTEC TERT1: 479.0;U-87 MG: 581.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 2200000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.32e-5)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 12.3 13.4 4.7 4.6 4.0 1.2 8.3 8.5 6.7 8.4 6.1 8.9 2.9 14.8 8.0 6.4 14.6 12.6 27.8 3.7 11.2 11.1 9.9 11.6 3.7 6.5 7.8 3.5 17.9 5.8 13.3 6.7 8.0 18.1 11.6 7.0 22.6 10.2 15.0 5.3 8.4 4.1 16.4 5.3 1.7 6.6 24.0 7.2 7.0 15.9 8.5 4.0 7.9 5.2 10.4 55.3 397.0 52.3 41.2 67.8 160.1 22.7 122.0 57.9 81.4 91.9 33.9 171.6 0.1 373.7 211.5 249.0 50.3 24.1 198.8 186.2 0.8 8.4 19.4 12.1 51.5 41.6 9.3 8.7 63.8 30.3 234.3 455.0 648.9 54.6 7.1 4.0 5.0 776.8 14.6 7.7 5.5 36.5 0.4 135.6 8.1 98.2 4.8 479.0 14.4 14.0 24.3 33.5 6.9 145.9 35.2 26.4 7.3 90.4 208.0 166.6 53.8 433.0 6.3 9.7 7.4 581.3 3.4 92.8 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 4.0 8.5 6.7 3.7 11.2 6.5 7.8 3.5 18.1 5.3 7.2 10.4 5.9 32.1 52.8 18.3 2.7 22.8 15.5 18.2 17.1 12.9 15.5 16.3 83.8 17.2 19.0 18.4 77.2 12.4 1.6 4.3 0.0 30.5 3.1 32.2 39.5 7.7 3.6 5.9 51.6 8.0 9.7 33.8 6.1 38.3 38.0 52.2 6.8 20.5 4.0 13.5 51.3 8.0 20.3 3.2 6.2 5.8 22.1 4.0 8.8 25.3 1.4 40.9 2.1 88.4 38.9 26.3 4.6 50.4 1.6 11.9 0.7 7.9 22.8 48.9 0.0 12.3 31.3 15.8 24.2 14.1 15.6 4.0 1.8 34.4 8.2 7.1 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661893 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 817.2;vagina: 675.1" "Group enriched" "Detected in some" 6 "Basal respiratory cells: 6903.4;Club cells: 6726.1" "Group enriched" "Detected in many" 4 "cervical cancer: 186.5;head and neck cancer: 69.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" NA NA 9100000 Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.1 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 203.5 0.0 0.1 0.0 3.3 0.0 817.2 0.2 0.2 0.4 0.0 0.0 0.1 0.2 3.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 7.6 0.0 0.0 100.8 0.0 0.1 43.3 0.1 0.0 0.0 0.1 0.5 1.9 0.0 4.8 0.1 0.0 19.8 74.4 675.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.1 6.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 35.2 6903.4 2.2 0.0 0.0 0.0 0.0 0.0 6726.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 31.4 0.1 0.2 0.5 0.0 0.0 0.0 8.9 0.0 3.0 0.0 0.9 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 986.7 0.0 0.0 55.4 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.4 0.0 60.2 0.0 0.2 447.6 0.0 0.0 0.0 178.1 1.0 0.3 413.5 0.0 0.3 0.8 0.0 0.0 265.9 SOAT1 "ACAT, SOAT, STAT" ENSG00000057252 "Sterol O-acyltransferase 1" P35610 1 179293714-179358680 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "adrenal gland: 166.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009533, HPA047171" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009533: AB_633499, HPA047171: AB_2679967" "unprognostic (3.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.81e-3)" "unprognostic (7.81e-3)" "unprognostic (3.29e-1)" "unprognostic (9.00e-2)" "unprognostic (9.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.45e-3)" "unprognostic (7.02e-3)" "unprognostic (4.67e-3)" "unprognostic (9.64e-2)" "unprognostic (4.67e-2)" "unprognostic (1.82e-1)" 14.8 166.9 3.8 18.3 6.5 17.7 8.2 5.6 8.6 13.8 8.6 13.1 12.3 11.8 6.7 4.9 18.1 20.6 5.1 3.3 11.1 12.8 14.2 21.1 15.2 7.9 6.1 2.3 10.8 27.2 13.5 6.4 19.3 7.6 27.9 15.0 10.4 39.7 9.4 4.0 4.7 12.8 16.6 8.1 15.2 16.4 11.1 6.3 8.1 9.3 3.7 13.2 11.8 4.5 10.6 74.6 34.1 27.7 41.0 104.7 56.6 147.3 35.1 61.7 76.2 88.3 35.2 82.6 42.0 53.9 64.4 92.6 26.8 88.6 20.9 81.8 48.0 18.2 19.5 26.7 36.9 42.9 33.5 7.5 45.4 13.3 89.2 75.8 32.1 33.3 50.5 42.7 21.0 120.0 15.9 35.9 10.8 13.4 11.8 11.2 44.4 35.8 24.4 66.1 45.9 8.4 21.5 54.3 22.9 20.1 32.3 24.0 22.8 31.9 89.8 43.1 99.5 78.2 29.4 115.3 35.5 35.7 17.9 170.6 55.4 53.4 1.6 26.4 34.2 25.0 12.9 24.0 24.8 48.9 10.4 23.0 23.3 39.3 37.9 23.7 8.8 33.2 32.5 3.8 6.5 5.6 8.6 3.3 11.1 7.9 6.1 2.3 7.6 8.1 6.3 10.6 14.9 22.4 33.4 11.4 16.0 9.9 10.1 11.3 8.0 7.3 7.2 4.6 8.5 30.0 14.5 20.2 14.6 17.6 21.2 16.0 1.9 42.5 29.5 34.9 32.8 16.0 59.9 9.0 12.1 25.0 51.6 21.3 18.3 34.5 14.0 9.2 15.4 24.2 70.3 6.7 15.0 25.5 22.4 77.4 41.9 14.5 32.6 74.9 23.2 29.0 55.4 7.6 19.6 10.6 7.3 20.3 13.3 25.9 17.7 26.7 8.7 14.9 46.2 14.5 26.3 9.2 13.5 6.8 9.7 5.0 5.3 8.8 24.8 44.3 15.5 8.5 PKP2 ENSG00000057294 "Plakophilin 2" Q99959 12 32790755-32896777 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 189.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 8.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 198.8;OE19: 72.7;SuSa: 149.0" "Region enriched" "Detected in many" 4 "hippocampal formation: 20.2" "Low region specificity" "Detected in all" "HPA014314, CAB037336, HPA056908" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272" "unprognostic (1.89e-1)" "unprognostic (1.70e-2)" "prognostic favorable (8.55e-4)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.90e-1)" "unprognostic (1.83e-2)" "unprognostic (5.94e-3)" "unprognostic (2.22e-1)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (3.76e-2)" 4.5 2.7 2.0 6.5 2.2 5.8 11.3 3.0 3.9 20.4 8.7 50.3 23.8 5.0 4.0 5.3 73.6 7.4 189.9 7.6 7.9 7.9 26.2 1.3 4.5 1.3 0.5 1.3 15.2 16.6 33.8 10.0 20.7 1.0 9.1 45.7 2.6 59.0 7.0 6.0 2.7 26.7 5.6 0.7 2.0 17.9 6.5 1.1 12.5 0.3 1.7 10.7 5.3 3.4 1.4 56.5 10.8 0.4 0.3 0.2 0.0 0.5 0.0 0.0 0.2 0.1 198.8 49.6 0.0 32.9 0.0 7.1 48.8 6.8 43.3 0.0 0.2 15.7 0.3 2.3 52.6 29.5 3.1 0.6 0.2 40.2 0.1 46.2 21.4 1.8 0.1 10.4 15.3 4.8 14.9 0.2 0.4 29.7 72.7 9.5 0.0 23.6 16.8 14.3 26.3 5.9 5.3 2.3 11.4 0.1 149.0 24.7 0.7 0.3 0.1 21.1 0.0 13.5 12.6 0.2 0.4 0.1 0.2 2.6 5.8 0.9 8.1 0.2 1.1 0.6 0.1 0.4 0.3 2.9 0.3 0.5 0.3 0.6 1.0 1.7 0.5 0.4 0.4 2.0 2.2 3.0 3.9 7.6 7.9 1.3 0.5 1.3 1.0 0.7 1.1 1.4 0.4 0.0 0.0 0.3 2.2 7.0 48.1 20.7 32.5 3.2 22.1 13.1 393.9 21.5 17.7 1.8 4.2 57.9 0.9 105.5 3.9 12.7 4.0 61.2 11.6 3.7 27.1 2.1 1.3 10.1 185.9 12.9 43.3 52.1 4.5 23.2 5.0 46.0 8.6 1.7 58.8 67.0 26.4 17.0 20.4 1.8 11.8 28.6 10.6 4.7 1.4 14.3 0.0 2.0 1.0 23.6 65.5 2.2 1.6 32.8 30.8 11.0 14.2 1.1 0.0 13.0 9.8 6.9 5.7 12.1 3.3 41.5 2.7 1.0 135.6 28.2 MSH4 ENSG00000057468 "MutS homolog 4" O15457 1 75796882-75913242 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1;epididymis: 1.8;testis: 4.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 22.8;Inhibitory neurons: 23.3;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 14.6;Spermatocytes: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.64e-2)" "unprognostic (2.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-2)" "unprognostic (6.88e-3)" "unprognostic (1.74e-2)" "unprognostic (4.37e-2)" "unprognostic (3.00e-1)" "unprognostic (3.58e-3)" "unprognostic (9.72e-2)" "unprognostic (6.88e-8)" "unprognostic (5.33e-2)" "unprognostic (4.90e-2)" "unprognostic (5.08e-2)" "unprognostic (4.63e-2)" 0.2 0.1 0.2 0.1 0.5 0.1 0.2 1.9 1.1 0.3 0.0 0.2 0.0 0.3 1.8 0.0 0.3 0.1 0.3 0.5 0.1 0.1 0.1 0.2 0.1 0.2 0.3 0.3 0.4 0.1 0.0 0.1 0.1 1.1 0.2 0.1 0.6 0.1 0.1 0.7 0.2 0.2 0.1 0.3 0.5 0.1 4.3 0.8 0.0 0.1 0.1 0.0 0.3 0.2 2.1 0.2 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.9 1.1 0.5 0.1 0.2 0.3 0.3 1.1 0.3 0.8 2.1 0.1 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 5.5 0.0 0.1 0.1 1.2 0.0 22.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.1 5.0 23.3 0.1 0.0 0.3 0.0 2.4 0.0 0.0 0.0 6.5 0.0 0.0 0.0 8.0 14.6 0.1 1.2 0.7 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.1 21.2 4.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 F7 ENSG00000057593 "Coagulation factor VII" P08709 13 113105788-113120685 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "liver: 161.5" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 149.3" "Cancer enriched" "Detected in some" 17 "liver cancer: 41.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 11.5;Hep G2: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA004826 Approved Mitochondria "Secreted to blood" NA NA 351000000 1300000000 Mitochondria "HPA004826: AB_10602805" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-3)" "unprognostic (3.81e-1)" "unprognostic (4.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.35e-3)" "unprognostic (3.36e-3)" "unprognostic (1.09e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" 0.2 0.0 0.4 0.1 0.3 0.0 0.2 0.5 0.7 0.9 0.2 0.0 0.5 0.1 0.6 0.1 0.5 0.0 0.1 0.3 0.8 0.4 161.5 0.1 0.0 0.3 0.4 0.3 0.4 0.1 0.2 0.4 0.1 0.4 0.4 0.0 0.2 0.3 0.0 0.0 0.3 0.8 0.0 0.1 0.1 0.1 1.5 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.5 0.7 0.3 0.8 0.3 0.4 0.3 0.4 0.1 0.5 0.4 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.6 0.3 0.5 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.0 8.0 0.3 0.2 0.0 0.4 0.0 0.2 0.0 0.3 2.2 149.3 0.1 0.0 0.5 0.4 0.0 2.8 0.7 0.2 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 1.1 0.3 0.0 0.2 0.0 0.5 0.1 3.2 4.1 0.0 0.1 0.1 0.2 0.1 0.3 0.0 GDI2 RABGDIB ENSG00000057608 "GDP dissociation inhibitor 2" P50395 10 5765223-5842132 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049290, HPA057668" Supported Approved Cytosol NA NA 53000000 Cytosol "HPA049290: AB_2680700, HPA057668: AB_2683498" "unprognostic (1.08e-2)" "unprognostic (8.33e-3)" "unprognostic (5.25e-2)" "unprognostic (1.13e-1)" "prognostic favorable (9.26e-4)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.56e-7)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-2)" "unprognostic (6.97e-2)" "unprognostic (3.10e-1)" "unprognostic (4.09e-2)" "unprognostic (1.71e-2)" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" 126.3 112.6 64.0 152.9 70.2 127.7 139.5 75.8 91.0 121.7 73.8 154.3 177.0 97.2 116.3 132.3 97.6 113.6 87.6 60.8 75.4 147.3 243.1 99.2 219.3 87.7 74.5 58.3 117.9 166.5 92.0 60.1 136.6 83.7 89.6 162.2 69.7 98.5 93.1 107.9 108.4 161.5 125.2 82.5 139.9 109.5 75.0 69.5 150.4 115.1 100.6 241.1 146.9 82.4 95.2 343.4 245.8 341.1 241.2 298.2 347.5 191.4 325.0 170.8 287.3 312.0 351.8 287.3 553.2 198.2 340.5 88.1 320.8 368.3 289.3 288.0 212.2 174.7 380.0 152.0 428.4 276.9 252.1 230.7 292.6 235.8 249.6 148.9 324.0 400.6 340.1 398.5 203.4 331.6 291.1 390.9 208.0 242.5 355.1 159.3 466.7 181.9 389.8 330.7 250.1 138.0 210.0 257.5 468.5 358.3 289.9 382.3 299.0 342.0 142.3 243.4 420.3 282.2 180.0 314.8 526.5 212.0 275.5 130.0 154.9 280.8 169.0 109.9 347.8 136.4 210.7 136.9 121.6 329.1 204.2 124.8 119.3 138.4 177.5 445.1 146.1 181.5 416.8 64.0 70.2 75.8 91.0 60.8 75.4 87.7 74.5 58.3 83.7 82.5 69.5 95.2 101.5 25.6 83.8 31.0 208.1 161.7 131.3 144.8 145.7 37.1 124.5 81.8 76.6 107.2 109.0 57.0 18.8 252.1 148.5 156.6 133.1 185.7 29.5 69.1 138.0 125.4 118.4 177.1 27.7 212.2 312.0 151.5 109.6 84.3 132.5 121.7 121.3 145.9 284.5 92.5 32.1 184.7 91.6 354.2 302.8 40.4 152.2 255.7 149.4 36.5 485.8 75.0 97.9 34.7 49.2 158.1 141.9 141.8 151.3 129.2 271.0 194.1 63.0 36.8 111.7 96.1 125.8 126.2 119.3 177.6 165.1 247.4 120.1 136.9 213.5 131.9 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 105993463-106109939 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.7" "Cell type enhanced" "Detected in many" "dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.5;T-cells: 34.0" "Cell line enhanced" "Detected in many" "Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0" "Region enriched" "Detected in single" 6 "olfactory bulb: 3.6" "Low region specificity" "Detected in many" "HPA030033, HPA075427" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA030033: AB_10601050, HPA075427: " "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavorable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 6.4 2.1 1.8 20.2 1.5 20.5 6.9 4.7 2.9 14.0 3.7 15.3 9.3 17.4 1.3 55.7 5.5 12.8 1.6 1.7 4.5 2.5 4.5 10.2 16.0 3.3 1.6 0.6 4.9 1.9 2.5 1.5 5.2 2.4 3.4 17.4 1.3 9.3 2.4 4.3 8.9 12.7 5.5 2.1 13.7 15.3 1.2 2.8 4.2 9.1 2.2 28.0 19.8 20.4 5.0 1.4 0.5 1.1 0.0 1.6 2.1 0.2 7.2 23.3 2.3 3.7 1.4 9.2 2.0 0.4 13.8 0.3 0.5 0.0 3.6 2.5 21.7 0.1 0.4 4.9 0.0 3.6 0.8 1.6 2.3 11.6 3.3 9.7 0.7 2.9 1.0 1.4 212.1 0.4 0.0 0.1 0.5 0.8 1.4 0.0 0.5 0.0 42.4 2.1 0.3 0.0 0.3 1.0 0.9 0.0 1.6 1.0 2.4 1.5 3.1 1.8 2.1 7.2 81.5 57.0 4.9 5.1 1.3 2.1 2.4 0.8 11.1 22.1 1.2 34.0 2.5 20.5 20.2 0.5 1.0 1.8 11.3 12.5 4.7 0.3 0.4 29.4 2.6 1.8 1.5 4.7 2.9 1.7 4.5 3.3 1.6 0.6 2.4 2.1 2.8 5.0 93.1 0.0 5.1 0.3 42.1 19.5 8.6 15.0 3.4 0.6 2.8 3.4 1.5 0.0 19.1 3.7 52.1 0.7 199.8 129.8 0.0 0.3 0.9 15.9 101.0 41.1 1.8 6.1 1.8 0.2 0.7 18.5 19.4 62.6 3.8 9.9 6.4 2.5 19.8 0.0 19.2 15.0 10.2 38.0 199.2 0.3 0.0 64.5 37.4 23.4 30.4 0.5 89.6 0.5 0.1 7.8 103.7 1.2 786.9 4.0 3.2 0.3 13.0 1.1 0.0 5.3 30.1 0.5 2.3 43.9 41.5 0.7 184.3 1.6 8.7 91.9 ATG5 "APG5, APG5L, ASP, hAPG5" ENSG00000057663 "Autophagy related 5" Q9H1Y0 6 106045423-106325791 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Host-virus interaction, Immunity" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034432, CAB037309, HPA042973" Approved Approved Centrosome "Intracellular and membrane" NA NA Centrosome "CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246" "unprognostic (1.21e-3)" "unprognostic (6.53e-3)" "unprognostic (2.68e-3)" "unprognostic (4.14e-1)" "unprognostic (1.13e-1)" "unprognostic (6.35e-3)" "prognostic unfavorable (8.84e-4)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.86e-1)" "unprognostic (2.37e-1)" "unprognostic (2.51e-1)" "unprognostic (6.42e-2)" 12.4 19.4 10.5 6.8 10.7 8.2 15.5 11.0 13.3 15.4 11.3 15.9 12.9 15.1 16.8 12.4 14.8 9.6 9.7 10.5 10.6 14.5 17.8 10.9 8.5 11.1 10.6 9.8 14.4 12.2 11.9 8.0 13.3 10.5 15.4 15.4 10.6 11.9 13.2 15.8 7.6 13.2 14.3 9.9 10.7 12.1 8.4 10.6 9.5 17.7 15.3 9.8 13.5 12.0 10.8 14.6 6.0 10.3 14.0 23.2 24.0 10.7 15.4 24.6 22.2 27.2 6.2 8.6 10.2 12.0 23.7 25.0 10.2 15.2 22.2 39.2 4.6 7.3 11.8 6.8 7.8 25.0 14.6 6.0 19.3 24.8 16.1 20.0 29.7 23.9 9.4 17.6 10.0 25.7 6.4 6.0 17.5 11.9 19.4 8.3 6.0 23.7 7.9 24.0 10.3 7.1 6.9 9.4 17.8 14.6 18.6 8.5 27.5 19.8 8.6 4.8 10.1 26.7 4.1 4.2 9.3 31.7 19.6 16.1 4.7 4.8 9.6 2.9 6.1 8.4 5.1 5.6 4.6 5.3 3.3 6.0 5.0 4.1 4.8 8.8 1.9 6.9 3.3 10.5 10.7 11.0 13.3 10.5 10.6 11.1 10.6 9.8 10.5 9.9 10.6 10.8 35.8 22.4 18.9 24.2 41.3 26.3 28.5 45.2 25.6 14.8 25.5 26.5 18.1 25.8 36.7 25.8 16.7 47.3 46.5 48.3 29.4 39.6 35.7 33.0 27.4 25.9 19.2 27.0 79.2 44.9 63.8 25.8 42.3 34.5 20.3 20.4 21.8 20.7 38.1 20.2 71.5 38.4 36.7 26.9 32.3 13.7 20.5 33.6 23.2 43.1 44.6 18.3 44.3 43.7 49.1 40.5 59.8 18.0 85.9 40.8 49.2 43.2 30.0 17.9 26.3 23.6 32.1 36.5 39.6 28.5 27.1 66.5 47.3 21.9 36.6 43.0 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567122-94650557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.0" "Cell type enhanced" "Detected in many" "Adipocytes: 81.2;Distal enterocytes: 98.3;Microglial cells: 70.3;Oligodendrocytes: 119.8;Paneth cells: 70.1;Urothelial cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 46.9;neutrophil: 69.7" "Lineage enriched" "Detected in all" 9 "granulocytes: 69.7" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 31.3;Karpas-707: 41.9;U-266/84: 30.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 11.8 4.5 15.1 9.5 24.7 10.1 9.7 23.0 15.8 11.7 6.4 22.8 15.0 7.8 3.1 6.1 5.7 5.3 2.3 12.7 19.8 8.2 4.1 5.4 4.5 25.8 25.5 8.5 4.8 3.2 4.6 3.4 17.9 29.7 8.4 16.5 0.9 2.8 5.4 18.5 5.8 21.1 7.9 21.8 12.3 7.4 2.0 25.5 4.0 13.4 7.1 6.3 7.6 4.8 37.0 7.8 0.4 1.9 0.0 0.7 2.7 13.6 0.0 0.0 0.5 1.9 0.0 1.7 0.2 0.1 0.0 6.8 19.1 10.7 12.9 2.6 3.5 2.6 5.1 0.8 0.0 0.5 0.0 10.2 1.7 1.7 7.2 10.1 11.3 31.3 0.0 0.2 41.9 1.0 0.4 0.0 0.4 1.0 2.7 6.5 0.0 0.6 5.1 2.0 16.4 0.2 0.8 0.2 8.0 0.4 8.8 0.0 0.4 19.0 0.0 0.2 0.1 3.4 19.4 30.1 0.3 3.9 1.6 1.7 16.4 4.3 46.9 3.3 6.0 0.3 5.4 1.2 1.9 2.5 3.1 0.0 2.2 69.7 3.3 7.8 2.8 0.0 3.1 15.1 24.7 23.0 15.8 12.7 19.8 25.8 25.5 8.5 29.7 21.8 25.5 37.0 81.2 0.0 2.7 2.9 5.7 20.6 32.7 3.2 9.6 4.4 2.1 1.3 2.0 4.3 3.2 7.3 0.0 16.0 16.3 98.3 0.0 1.9 5.8 24.5 3.6 31.9 12.0 0.0 0.6 3.8 3.2 4.8 10.2 39.8 0.0 17.1 31.8 0.6 4.1 0.0 15.0 13.0 0.0 15.0 9.2 8.3 1.8 20.3 3.6 70.3 19.0 0.1 11.3 11.6 119.8 12.9 70.1 1.2 7.8 16.8 48.1 8.9 3.0 0.3 6.6 19.7 6.1 0.0 2.2 30.4 16.2 7.1 7.7 2.5 8.2 83.3 PITHD1 "C1orf128, HT014, TXNL1CL" ENSG00000057757 "PITH domain containing 1" Q9GZP4 1 23778418-23788232 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016936 Uncertain NA NA 640000 "HPA016936: AB_2067141" "unprognostic (2.11e-2)" "unprognostic (5.58e-2)" "unprognostic (1.60e-2)" "unprognostic (1.20e-1)" "unprognostic (9.69e-3)" "unprognostic (6.75e-2)" "unprognostic (1.18e-2)" "unprognostic (7.23e-3)" "unprognostic (1.31e-3)" "unprognostic (1.39e-1)" "unprognostic (9.93e-2)" "unprognostic (9.84e-2)" "unprognostic (2.17e-2)" "unprognostic (2.21e-2)" "unprognostic (5.70e-2)" "unprognostic (9.57e-2)" "unprognostic (1.38e-1)" 41.4 50.2 107.0 28.5 115.2 101.5 43.1 104.0 120.7 43.4 86.2 41.5 28.4 37.2 55.5 70.5 38.9 24.7 40.1 113.6 121.9 38.4 53.4 35.7 46.3 113.9 123.3 113.0 43.6 43.6 125.3 48.7 38.1 129.6 49.4 41.2 47.9 43.1 38.4 79.2 69.0 37.5 38.0 108.6 44.9 46.7 53.5 118.9 143.9 36.8 55.4 53.0 40.7 58.4 144.7 49.9 27.6 44.6 84.4 66.9 48.2 33.5 70.5 51.2 61.1 47.2 43.9 55.4 132.8 58.7 64.7 25.1 55.8 89.4 55.4 61.5 67.6 68.8 124.1 83.9 61.2 40.3 128.8 45.7 39.1 69.8 47.9 67.2 55.0 53.3 79.8 185.9 68.1 72.2 38.1 82.3 71.1 57.9 79.5 67.0 89.3 49.3 87.4 56.7 34.6 105.0 42.3 50.2 74.8 90.7 47.0 45.7 56.8 47.8 41.9 54.4 86.3 60.4 58.8 64.6 153.1 73.3 140.7 65.9 20.4 22.0 49.4 36.6 29.5 40.7 53.3 42.2 42.8 22.7 48.2 51.2 49.1 22.5 43.0 35.6 35.3 39.2 33.7 107.0 115.2 104.0 120.7 113.6 121.9 113.9 123.3 113.0 129.6 108.6 118.9 144.7 59.6 9.6 19.6 15.3 66.3 129.1 48.0 30.6 68.9 65.2 58.9 66.9 39.9 35.8 21.4 22.0 22.9 97.6 116.7 31.8 52.8 38.4 12.3 46.8 30.7 46.6 32.9 162.9 24.6 33.9 63.1 50.5 42.3 35.8 24.1 34.6 33.2 37.5 78.0 104.3 24.4 42.6 42.7 37.4 64.3 16.3 42.9 51.5 120.9 9.4 63.5 118.3 61.8 9.5 21.7 36.4 28.8 57.6 46.3 61.9 28.7 48.9 11.9 41.0 78.9 52.3 47.1 139.3 116.4 86.5 134.7 116.4 80.1 66.9 44.1 34.6 MTA3 KIAA1266 ENSG00000057935 "Metastasis associated 1 family member 3" Q9BTC8 2 42494569-42756947 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 137.0;Oligodendrocyte precursor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039433 Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039433: AB_10794747" "unprognostic (5.40e-2)" "unprognostic (4.89e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.13e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (5.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-2)" "unprognostic (9.03e-2)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (1.28e-2)" 11.5 42.2 16.8 5.7 19.6 1.6 15.1 9.7 19.0 17.2 7.7 16.4 7.9 17.0 27.8 22.0 16.2 10.1 11.7 21.7 16.5 13.7 8.0 8.8 10.8 12.9 15.1 18.9 29.4 19.0 17.4 15.2 15.4 15.8 14.6 13.3 9.4 13.7 17.0 9.2 18.9 11.5 12.2 11.3 7.8 16.9 21.2 15.2 71.0 12.7 10.0 14.6 15.4 18.0 15.2 13.0 16.6 20.1 14.3 17.4 28.0 46.6 7.4 18.6 21.7 19.2 22.2 26.2 45.4 12.6 22.1 15.9 8.2 51.6 25.2 34.2 14.1 21.0 6.7 8.8 36.4 21.9 5.0 29.0 29.5 29.1 13.4 16.6 28.1 30.4 23.9 16.5 6.1 25.7 27.8 30.3 22.0 84.4 20.8 9.7 18.4 18.9 0.0 25.7 12.1 12.3 37.1 13.5 45.5 17.8 61.6 23.2 7.0 14.2 8.9 12.1 7.2 8.1 11.5 4.7 63.5 12.6 5.7 11.1 2.5 0.9 0.0 1.7 0.6 2.6 1.2 2.0 2.9 1.5 1.3 4.4 3.0 0.2 1.8 0.9 0.4 1.1 1.5 16.8 19.6 9.7 19.0 21.7 16.5 12.9 15.1 18.9 15.8 11.3 15.2 15.2 12.7 12.8 12.5 60.4 10.8 15.3 21.1 33.0 15.4 0.0 24.6 19.6 12.5 15.7 25.7 22.0 0.0 58.5 5.1 19.1 17.6 22.9 10.7 44.5 23.1 13.1 9.6 2.5 137.0 28.0 42.0 21.7 31.1 32.3 12.0 72.3 20.7 13.3 12.4 0.0 81.8 20.0 50.8 6.6 7.1 26.0 33.8 5.2 17.8 53.4 6.9 0.0 9.2 106.1 65.9 20.2 21.8 39.9 10.9 17.7 25.2 33.1 18.4 0.0 13.1 15.8 35.9 25.5 41.1 24.5 18.3 59.9 12.6 44.5 21.5 17.3 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179653032-179804366 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 150.4;tongue: 109.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 93.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.06e-4)" 5.9 12.0 2.9 2.9 12.1 1.5 5.4 7.1 13.7 3.2 0.0 2.4 1.2 5.8 3.4 4.0 3.4 4.6 42.9 3.3 8.0 3.1 4.7 5.4 3.6 10.3 10.4 3.2 12.6 4.1 4.0 5.8 2.7 12.3 4.4 2.2 7.2 6.2 2.7 150.4 2.1 2.0 6.3 8.6 2.2 1.7 6.0 9.2 2.5 9.8 109.8 3.5 3.5 2.2 34.0 27.6 11.3 20.0 14.8 8.9 14.1 11.6 18.6 17.4 23.7 18.8 17.1 9.6 35.6 18.0 17.2 27.6 2.6 21.4 9.1 26.4 93.3 14.8 9.0 23.6 14.4 6.3 26.5 1.1 10.5 3.0 18.8 18.5 9.1 16.6 11.9 4.7 43.0 15.7 15.0 22.5 3.0 17.9 1.3 13.1 29.3 20.2 27.4 11.7 7.9 13.0 14.5 14.1 16.9 7.2 5.4 37.0 12.7 24.1 28.6 27.6 23.7 64.1 29.5 21.2 78.3 13.0 15.0 27.2 0.1 0.3 0.0 2.6 0.5 15.6 3.2 1.8 3.8 1.5 0.9 1.2 1.3 0.0 0.0 0.7 4.5 0.7 1.3 2.9 12.1 7.1 13.7 3.3 8.0 10.3 10.4 3.2 12.3 8.6 9.2 34.0 45.0 9.6 35.9 14.0 5.3 2.5 1.9 1.4 0.6 13.7 7.1 5.2 208.5 5.7 5.4 1.8 6.2 10.7 5.6 1.4 15.6 1.1 2.6 13.9 11.4 10.1 9.6 5.5 23.2 4.4 2.4 12.0 4.1 2.5 2.5 35.5 22.1 7.6 4.3 16.8 52.2 2.9 0.0 4.8 3.5 3.6 9.3 5.0 14.2 16.9 1.7 7.0 3.1 36.2 42.5 1.0 12.2 9.4 4.5 4.4 0.1 2.7 3.7 10.2 13.1 17.8 12.0 6.1 2.8 4.8 1.6 5.1 4.1 58.8 4.5 1.4 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793503-182921629 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 20.8 10.8 4.0 25.1 6.5 71.2 17.6 15.1 8.1 19.3 12.8 26.6 24.6 18.9 14.8 45.8 13.9 21.3 14.2 5.3 6.2 18.2 18.4 16.6 28.1 6.9 5.9 4.0 20.7 21.2 29.6 10.4 14.7 6.9 28.6 29.3 31.0 19.5 13.5 11.5 28.5 24.2 19.7 6.1 22.0 51.6 31.8 5.8 45.0 17.0 16.9 28.6 26.0 22.7 15.6 69.7 9.7 20.5 28.7 42.6 46.1 19.3 32.8 41.6 23.2 27.1 23.7 34.0 31.3 53.5 44.0 48.2 40.4 24.6 31.3 40.2 73.9 20.9 76.7 13.1 5.2 24.8 62.3 47.3 31.5 34.7 26.1 37.4 34.1 37.0 48.7 27.7 94.3 37.8 22.9 50.3 19.1 14.5 38.1 19.2 21.2 59.8 37.8 28.1 55.8 12.5 22.0 86.2 10.7 36.9 18.3 11.9 43.7 36.6 35.0 38.7 30.5 56.2 131.0 125.5 58.1 24.1 25.3 20.9 5.5 1.0 4.3 1.7 1.0 1.7 2.1 1.4 1.7 1.1 1.3 1.2 1.8 3.8 1.8 1.0 2.4 1.2 0.8 4.0 6.5 15.1 8.1 5.3 6.2 6.9 5.9 4.0 6.9 6.1 5.8 15.6 26.8 16.0 13.2 34.6 27.8 34.3 25.7 15.9 26.2 12.2 13.8 9.7 15.6 18.6 16.5 20.2 14.6 12.8 43.0 44.6 0.0 12.5 34.1 19.0 22.9 15.7 6.7 26.1 81.6 16.5 3.8 19.5 46.4 22.1 11.4 14.0 16.1 16.4 10.4 38.7 64.3 30.5 16.2 19.4 26.4 23.8 19.3 29.3 14.2 45.9 19.9 8.4 27.8 67.8 132.6 25.2 27.0 21.1 55.5 35.8 24.3 7.8 19.8 31.4 19.7 24.1 17.7 18.7 11.4 43.8 44.6 9.6 40.9 7.0 27.3 45.4 LAMC2 "BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa" ENSG00000058085 "Laminin subunit gamma 2" Q13753 1 183186238-183245127 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 39.7" "Cell type enriched" "Detected in many" 5 "Pancreatic endocrine cells: 1531.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 231.3" "Region enhanced" "Detected in some" "cerebellum: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004257, HPA024638, HPA046539, CAB078165" Enhanced Uncertain "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" No No 130000 "Endoplasmic reticulum, Golgi apparatus" "CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: " "unprognostic (7.27e-3)" "unprognostic (7.21e-3)" "unprognostic (3.24e-1)" "unprognostic (6.20e-3)" "unprognostic (9.43e-2)" "unprognostic (4.94e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.25e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (7.11e-5)" "unprognostic (2.77e-1)" "unprognostic (7.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" 3.2 0.1 0.2 16.4 1.9 0.1 21.1 2.4 0.5 15.2 0.2 12.2 2.7 12.4 2.2 7.8 35.2 13.2 2.5 0.2 0.4 9.9 0.7 25.1 8.0 0.1 0.2 0.2 1.0 3.3 0.0 4.3 11.0 0.7 5.4 13.0 0.1 13.0 6.2 1.7 16.5 15.1 3.3 0.0 0.9 15.0 2.8 0.1 11.4 18.7 2.3 12.4 39.7 6.4 0.2 574.7 25.4 0.0 0.7 4.9 11.9 40.2 4.3 4.7 2.1 0.7 41.4 501.6 0.0 207.9 1.4 16.4 252.4 0.1 2492.2 2.7 0.7 0.2 0.0 0.5 0.1 1.2 0.0 0.2 6.1 189.7 6.0 1487.5 2.3 32.6 0.0 0.0 0.2 2.5 1.1 0.0 0.1 4.5 206.7 35.2 0.1 1.2 0.0 579.4 147.1 30.5 0.1 14.7 0.4 0.9 14.9 2.0 2.7 3.8 2.2 30.2 15.0 7.8 0.9 0.7 0.7 4.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.9 2.4 0.5 0.2 0.4 0.1 0.2 0.2 0.7 0.0 0.1 0.2 0.5 218.0 17.8 0.0 0.2 86.3 227.1 232.7 105.3 0.0 8.2 26.2 2.3 10.0 56.8 23.9 0.0 30.7 0.4 74.4 0.0 183.4 19.6 68.9 3.6 7.8 9.0 0.0 0.4 94.0 11.7 17.2 59.7 97.4 0.0 0.0 0.0 0.0 2.5 0.0 0.3 34.1 14.2 0.0 4.9 11.8 3.4 3.1 8.8 1.0 2.6 0.0 0.0 0.0 0.3 1531.1 91.2 0.4 0.3 302.0 16.7 0.2 69.3 0.0 0.0 3.4 9.6 3.6 1.0 60.3 29.7 83.3 5.3 0.1 15.3 169.9 CDK14 "PFTAIRE1, PFTK1" ENSG00000058091 "Cyclin dependent kinase 14" O94921 7 90466424-91210590 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 545.4;Horizontal cells: 173.3;Inhibitory neurons: 426.8;Oligodendrocyte precursor cells: 320.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 9.0;memory B-cell: 8.5;naive B-cell: 4.8;neutrophil: 4.8" "Group enriched" "Detected in many" 10 "B-cells: 8.5;granulocytes: 9.0" "Cell line enhanced" "Detected in many" "Karpas-707: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015267 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015267: AB_1855249" "prognostic favorable (5.86e-4)" "unprognostic (3.96e-1)" "unprognostic (1.91e-2)" "unprognostic (2.09e-3)" "unprognostic (1.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-1)" "unprognostic (4.48e-2)" "unprognostic (3.60e-2)" "unprognostic (3.09e-2)" "unprognostic (2.77e-3)" "unprognostic (2.91e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (7.79e-4)" "unprognostic (2.46e-1)" "unprognostic (2.86e-1)" "unprognostic (4.39e-3)" 8.6 4.5 11.3 7.9 14.2 7.2 8.7 13.6 32.6 10.2 0.0 4.8 2.7 8.6 3.1 3.1 12.3 12.3 12.0 18.1 8.8 20.9 13.5 9.7 12.5 8.7 19.9 11.9 14.6 15.3 3.1 9.2 6.2 11.7 11.3 3.4 17.5 8.4 6.8 4.7 2.3 3.8 7.6 4.1 8.2 8.0 7.9 17.4 5.6 13.5 7.2 13.0 5.8 5.2 21.9 18.0 0.2 35.0 4.5 31.9 32.0 8.0 14.7 14.0 8.8 9.5 0.4 8.6 58.9 1.8 14.6 13.1 5.2 1.8 20.7 16.9 0.1 8.3 0.0 11.2 0.4 14.7 18.3 0.3 22.7 5.3 26.5 9.4 14.7 11.6 0.4 0.3 78.4 18.4 0.1 0.1 7.3 21.8 0.1 9.6 49.3 47.4 50.2 4.6 4.9 7.7 21.9 37.3 0.2 0.7 15.4 4.7 9.2 28.4 37.8 48.5 32.1 23.0 43.1 36.3 41.9 14.6 23.8 37.9 9.0 0.3 0.5 0.0 0.6 0.0 8.5 0.0 0.0 0.8 4.8 0.0 0.0 4.8 0.1 0.5 0.1 0.2 0.5 11.3 14.2 13.6 32.6 18.1 8.8 8.7 19.9 11.9 11.7 4.1 17.4 21.9 11.0 19.2 5.1 118.2 37.4 0.8 7.7 6.0 2.2 6.9 7.0 8.9 18.3 12.8 9.1 11.0 0.0 0.2 0.2 0.4 7.9 9.8 53.9 1.7 13.4 2.8 1.8 4.0 545.4 6.7 0.1 16.1 4.1 1.5 0.0 11.2 1.4 11.3 3.7 173.3 426.8 0.3 4.1 3.4 4.9 46.4 15.5 7.0 5.4 66.5 1.7 9.4 0.0 320.7 32.9 13.4 1.3 15.8 78.1 12.8 0.1 22.7 3.9 9.7 0.0 6.3 15.9 5.4 6.6 1.2 1.3 0.0 1.9 6.5 0.3 4.2 SEC61A1 ENSG00000058262 "SEC61 translocon subunit alpha 1" P61619 3 128051641-128071683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022076 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB022076: " "unprognostic (1.84e-1)" "unprognostic (8.00e-2)" "unprognostic (8.21e-2)" "prognostic favorable (7.82e-4)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (2.84e-2)" "unprognostic (4.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.85e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.84e-9)" "unprognostic (2.73e-2)" "unprognostic (3.18e-2)" "unprognostic (8.33e-2)" "unprognostic (2.51e-2)" 79.6 101.5 28.9 89.1 30.9 80.2 76.0 32.3 35.0 145.7 47.0 91.6 82.6 89.6 130.0 89.4 78.8 82.4 69.6 29.5 49.6 65.2 135.9 94.2 60.7 38.8 33.4 24.1 67.9 274.4 112.6 94.3 113.8 33.8 90.8 90.9 37.3 177.8 97.9 71.1 66.6 76.5 111.7 35.5 74.3 106.4 39.2 40.7 62.0 105.7 59.9 81.3 97.9 69.3 35.2 272.8 136.5 132.0 240.3 367.9 317.3 256.9 426.9 470.8 349.0 371.2 259.1 186.9 184.7 259.5 534.8 266.2 232.6 209.0 291.3 334.2 168.1 126.2 213.5 143.5 273.6 542.9 264.1 225.9 348.1 345.4 329.3 422.4 265.0 314.3 122.2 136.9 415.3 412.8 237.7 135.1 87.5 184.6 231.6 202.8 144.2 125.5 349.8 181.4 229.3 155.8 162.4 216.0 193.5 270.7 152.0 184.2 215.1 327.3 278.3 164.7 333.7 201.4 386.6 210.6 265.8 456.3 166.2 369.1 160.3 88.6 67.0 89.0 79.6 120.0 43.8 62.9 78.2 82.6 26.1 38.8 46.2 22.5 65.0 84.2 114.0 45.1 116.9 28.9 30.9 32.3 35.0 29.5 49.6 38.8 33.4 24.1 33.8 35.5 40.7 35.2 31.9 32.1 33.1 18.6 46.6 37.0 25.7 44.4 30.7 17.0 63.5 41.3 15.0 37.1 43.3 49.7 35.5 64.3 59.2 107.2 3.9 81.0 42.2 28.2 72.9 45.9 73.6 19.5 12.6 154.5 136.3 57.4 77.5 68.6 26.0 55.6 49.6 118.2 75.9 26.9 18.5 150.8 38.7 34.8 32.1 25.7 41.0 38.2 33.8 26.2 32.1 22.4 28.8 19.1 17.2 104.9 50.2 43.6 192.8 69.6 63.5 26.8 31.0 15.5 32.9 25.6 47.2 12.3 18.4 42.5 29.5 127.9 32.4 52.6 100.4 44.6 PPP1R12A "M130, MBS, MYPT1" ENSG00000058272 "Protein phosphatase 1 regulatory subunit 12A" O14974 12 79773563-79935460 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 353.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041296, HPA071956" Approved Supported "Actin filaments,Cytosol" NA NA 270000 "Actin filaments, Cytosol" "HPA041296: AB_2677394, HPA071956: AB_2732192" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-1)" "unprognostic (5.60e-3)" "unprognostic (6.19e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.61e-1)" "unprognostic (9.69e-3)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-3)" "unprognostic (5.50e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (1.38e-1)" 31.8 18.8 21.7 32.6 27.8 58.0 21.9 26.5 65.8 34.4 19.2 55.8 23.0 66.8 31.4 71.9 41.2 36.9 28.3 26.8 22.1 18.4 14.3 24.9 32.2 16.3 16.3 22.5 27.6 11.1 18.7 11.3 41.9 17.9 68.2 35.8 14.8 19.2 85.6 20.7 17.0 27.8 84.4 15.6 31.1 29.4 23.7 20.7 34.6 25.1 27.4 28.0 65.1 27.9 27.5 42.9 36.5 49.3 28.5 36.8 36.2 45.8 84.0 46.5 53.1 35.2 34.9 20.7 36.9 33.4 113.8 21.4 33.4 38.6 32.9 63.8 51.3 24.3 98.2 40.5 24.1 29.1 64.8 59.5 30.7 24.3 53.6 49.1 60.1 37.2 36.7 41.1 43.0 57.0 27.7 71.4 34.3 39.1 18.8 25.2 57.9 54.4 27.8 31.4 66.6 23.8 17.9 66.3 23.2 28.5 45.1 32.4 30.9 56.8 56.3 29.9 40.1 48.2 28.3 27.8 48.6 19.2 36.3 49.3 155.1 44.4 197.4 62.8 47.5 56.5 56.8 59.7 66.8 41.8 52.8 47.3 61.3 187.2 98.2 70.4 35.3 69.6 46.3 21.7 27.8 26.5 65.8 26.8 22.1 16.3 16.3 22.5 17.9 15.6 20.7 27.5 108.4 76.9 65.9 168.5 79.7 84.5 69.0 59.1 57.5 82.2 30.7 69.0 127.4 32.9 61.5 53.3 35.5 66.7 113.4 44.9 15.6 50.9 111.3 47.5 113.6 93.6 44.9 66.3 240.4 40.0 82.0 82.4 42.8 81.2 121.4 66.6 55.0 27.5 78.0 102.6 135.4 37.7 44.7 57.5 100.8 64.2 86.3 92.8 60.5 132.1 112.0 52.2 120.5 353.9 132.9 55.9 42.7 147.4 60.7 52.0 34.3 26.3 41.0 61.4 210.4 74.6 332.7 133.4 89.8 50.9 81.1 83.7 119.7 81.5 41.3 63.6 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959906-79090780 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 27.6;lung: 7.6;retina: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 0.1 0.1 6.4 1.0 5.8 0.0 0.1 25.4 24.1 0.6 0.0 0.2 0.2 0.4 0.1 0.1 0.4 0.1 0.0 15.4 7.7 0.7 0.0 7.6 1.3 13.8 13.7 5.9 0.8 2.3 0.6 1.1 0.2 15.9 0.5 0.2 7.4 0.1 0.2 0.0 0.0 1.4 0.1 11.3 0.6 0.2 0.3 21.7 0.5 0.0 0.0 1.5 0.3 0.1 27.6 8.5 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.5 1.2 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 10.4 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.9 13.0 0.1 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.7 0.0 0.0 15.1 0.0 0.3 0.0 3.8 2.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.8 25.4 24.1 15.4 7.7 13.8 13.7 5.9 15.9 11.3 21.7 27.6 0.2 3.2 80.6 8.5 4.5 0.6 0.6 0.2 0.0 13.7 0.2 0.1 1.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.6 0.4 0.5 0.0 0.0 80.9 0.0 2.7 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.0 25.2 91.2 0.0 0.0 0.3 16.1 0.0 0.0 1.8 3.6 5.6 0.6 1.1 0.0 1.5 121.5 0.3 0.0 0.4 2.1 0.2 0.0 6.8 2.0 2.5 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.8 0.1 1.6 0.0 0.4 CAMK2B "CAM2, CAMK2, CAMKB, CaMKIIβ" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 253.4;skeletal muscle: 133.8" "Cell type enriched" "Detected in many" 7 "Bipolar cells: 857.4" "Cancer enhanced" "Detected in many" "glioma: 6.0;thyroid cancer: 6.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA 600000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 0.5 11.4 65.8 0.6 93.8 0.1 1.5 113.3 253.4 0.1 0.0 0.8 1.0 0.2 28.6 1.4 1.1 0.2 66.0 197.6 35.1 1.6 7.8 0.3 1.3 32.1 19.6 77.3 0.3 3.8 6.1 51.7 0.1 42.2 3.2 0.4 21.6 1.4 1.6 133.8 1.2 0.9 0.1 1.6 0.3 2.3 2.2 24.0 0.8 20.5 59.7 1.6 0.0 0.3 83.6 0.0 0.8 0.4 0.6 0.0 0.4 0.4 0.3 0.1 0.3 0.0 0.3 0.1 0.2 1.6 0.4 0.1 0.3 0.4 1.4 0.1 2.0 4.5 0.1 0.2 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.8 0.1 10.1 0.0 0.4 0.2 0.1 4.4 0.2 1.7 0.3 0.0 0.0 75.5 4.0 0.4 0.0 0.0 0.1 3.5 0.3 0.4 0.5 0.7 0.4 0.1 0.9 0.8 0.2 0.2 0.0 0.5 1.0 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.4 0.7 0.3 0.2 0.2 0.2 65.8 93.8 113.3 253.4 197.6 35.1 32.1 19.6 77.3 42.2 1.6 24.0 83.6 0.1 0.0 0.0 67.3 0.2 1.1 21.5 0.0 10.8 857.4 3.1 17.5 88.9 2.8 0.0 0.0 45.9 0.1 0.0 0.5 9.8 0.0 0.9 2.3 0.4 1.6 40.7 0.0 111.4 0.0 0.2 2.9 4.1 5.6 4.5 15.4 0.0 4.3 0.2 60.6 90.9 1.5 2.0 0.6 0.4 2.9 1.8 0.5 1.8 5.6 0.0 23.2 0.0 19.6 5.4 0.1 1.2 0.0 0.1 3.3 0.1 1.9 0.0 53.1 0.0 6.9 1.7 0.2 7.8 0.9 0.4 0.3 0.2 0.2 0.3 6.6 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972964 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" NA NA "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favorable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favorable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 7.6 7.7 7.2 2.4 6.2 1.6 8.0 9.2 6.8 13.4 23.9 8.6 1.7 10.5 0.7 10.1 22.9 1.4 6.2 5.3 6.6 7.7 3.4 8.5 2.4 8.2 8.2 3.3 13.4 10.8 1.7 10.3 1.3 6.9 10.4 0.4 11.4 7.7 1.8 6.2 12.6 7.9 1.1 5.8 10.3 9.0 5.3 6.4 2.8 8.1 1.2 0.7 9.3 11.5 6.5 4.1 1.7 3.1 3.1 2.1 1.9 1.2 2.9 0.9 0.9 1.0 0.2 1.8 10.9 2.7 1.3 0.3 4.9 0.7 2.2 0.1 0.9 5.6 5.0 6.1 0.8 3.7 0.3 4.9 1.7 5.0 0.9 0.8 1.7 1.5 7.7 0.7 2.7 0.3 3.5 3.4 1.2 11.1 0.9 2.6 3.1 4.1 3.8 0.7 1.1 9.4 10.2 3.1 2.0 9.7 0.9 4.1 1.4 4.3 2.6 3.4 6.8 2.3 4.7 3.7 2.2 2.6 0.7 3.3 0.0 0.0 0.3 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.0 0.3 0.0 0.1 0.3 0.1 7.2 6.2 9.2 6.8 5.3 6.6 8.2 8.2 3.3 6.9 5.8 6.4 6.5 9.0 0.0 4.6 14.0 5.4 6.2 4.1 4.4 17.1 26.3 7.9 7.7 5.8 5.7 4.1 5.5 27.1 1.3 8.2 2.3 0.0 4.7 5.5 35.2 6.3 7.1 3.6 2.5 27.9 2.3 6.5 11.3 6.1 5.9 1.3 28.2 6.4 1.8 2.4 3.3 24.0 4.3 4.1 1.6 5.3 2.6 19.3 3.4 5.4 11.2 3.1 11.7 12.3 13.0 19.9 2.4 1.9 12.8 2.1 2.0 0.8 1.5 34.0 109.7 0.0 12.8 9.4 1.2 12.8 13.1 5.1 1.1 8.0 3.5 2.7 2.2 POLR3E "C37, FLJ10509, RPC5, SIN" ENSG00000058600 "RNA polymerase III subunit E" Q9NVU0 16 22297375-22335101 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041419, HPA041477" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA041419: AB_2677468, HPA041477: AB_10796345" "unprognostic (3.09e-2)" "unprognostic (8.59e-2)" "unprognostic (8.23e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (7.28e-2)" "unprognostic (2.42e-2)" "unprognostic (7.73e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (8.14e-2)" "unprognostic (1.91e-1)" "unprognostic (8.96e-2)" "unprognostic (8.19e-3)" "unprognostic (3.41e-2)" 11.7 17.1 2.4 6.7 3.4 7.9 12.1 3.3 3.0 10.6 12.7 12.0 6.3 12.8 2.5 13.1 11.9 4.6 13.8 3.5 6.9 8.4 13.4 10.3 5.3 3.6 3.5 2.3 11.4 16.3 10.7 12.9 4.7 4.0 11.4 3.0 3.1 12.3 8.3 63.1 14.5 10.1 5.0 2.8 9.0 14.3 11.3 3.5 8.6 12.9 15.6 5.7 12.1 10.5 4.7 21.1 29.0 6.9 19.5 12.1 9.7 27.5 16.1 6.1 9.4 4.2 36.3 14.8 41.7 21.8 11.1 7.9 18.7 35.6 20.6 7.6 28.7 52.3 21.0 31.8 70.9 15.1 34.4 23.0 8.7 19.5 22.1 25.8 3.5 25.9 17.1 63.1 17.0 10.9 34.5 33.6 11.8 37.5 20.2 22.8 45.0 16.7 54.2 8.0 12.4 28.9 20.6 15.6 29.2 14.0 4.2 17.2 16.3 17.3 11.0 12.4 9.2 18.3 23.6 45.6 40.3 11.1 23.0 21.1 0.0 4.7 2.8 8.6 4.8 9.1 7.4 9.1 8.7 7.7 6.0 8.4 7.3 0.5 7.4 4.5 4.4 10.0 6.9 2.4 3.4 3.3 3.0 3.5 6.9 3.6 3.5 2.3 4.0 2.8 3.5 4.7 9.4 3.2 14.7 14.4 20.3 32.5 23.0 10.9 12.5 24.0 16.4 19.7 18.9 11.5 13.4 18.4 31.3 25.2 27.3 8.9 5.9 12.0 34.9 21.0 13.3 13.3 15.0 10.5 12.8 12.8 20.2 14.1 13.7 28.5 27.9 23.1 8.9 11.1 13.1 20.2 16.3 13.7 10.2 10.1 22.2 20.9 12.5 11.0 14.2 11.2 9.7 10.4 21.6 18.6 17.9 15.0 11.7 9.1 26.0 28.5 13.6 11.8 16.6 40.9 13.1 21.0 12.2 19.7 16.1 16.5 39.6 28.3 30.3 20.5 16.2 26.3 ATP2B4 "ATP2B2, MXRA1, PMCA4" ENSG00000058668 "ATPase plasma membrane Ca2+ transporting 4" P23634 1 203626787-203744081 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 176.8" "Cell type enhanced" "Detected in many" "Adipocytes: 171.6;Oligodendrocyte precursor cells: 199.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ: 200.0;BJ hTERT+: 276.4;fHDF/TERT166: 212.8;SuSa: 222.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016118, HPA040431" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB016118: AB_2061729, HPA040431: AB_2676980" "unprognostic (7.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.60e-2)" "unprognostic (8.17e-2)" "unprognostic (2.53e-2)" "unprognostic (9.23e-3)" "unprognostic (8.68e-2)" "unprognostic (3.81e-2)" "unprognostic (9.74e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (3.52e-3)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-3)" 59.4 25.3 41.5 25.8 38.7 16.1 16.8 0.6 30.3 47.9 0.5 42.9 12.6 105.5 20.2 32.8 48.8 25.4 60.1 36.9 15.8 10.0 9.4 35.4 12.9 9.6 6.2 32.3 40.9 10.0 11.9 3.9 41.0 9.9 33.3 30.5 42.9 7.1 70.3 14.6 55.3 14.5 176.8 0.6 12.4 15.5 27.6 27.7 21.9 15.3 27.9 19.6 37.6 15.4 13.3 45.7 7.8 15.6 15.1 120.4 175.1 84.5 200.0 276.4 32.1 27.4 3.8 22.8 9.8 28.8 212.8 43.5 43.5 22.6 27.7 34.3 126.5 8.0 28.7 37.4 2.5 43.1 42.0 51.3 130.5 26.9 102.9 16.2 81.6 63.5 57.1 12.9 20.3 25.1 2.5 44.3 14.5 9.7 8.7 24.2 22.3 11.6 16.7 11.3 4.0 4.6 6.7 68.3 10.5 30.2 222.1 9.3 21.4 54.9 80.5 11.4 136.6 48.3 13.4 20.9 5.4 80.7 31.0 24.5 3.2 2.0 0.0 8.7 1.3 6.4 0.9 5.4 7.2 2.2 0.3 1.3 3.4 4.0 3.8 2.2 3.7 5.7 2.7 41.5 38.7 0.6 30.3 36.9 15.8 9.6 6.2 32.3 9.9 0.6 27.7 13.3 171.6 89.8 68.2 127.6 9.9 97.1 18.9 43.1 41.5 4.8 11.2 9.4 76.5 7.2 35.0 18.4 2.1 27.9 56.2 2.2 0.0 35.3 5.8 78.0 92.4 67.6 23.9 35.9 55.9 14.9 18.9 56.0 13.7 89.7 10.1 30.6 58.9 18.2 38.5 117.8 9.8 2.4 14.2 14.7 38.8 4.8 43.8 20.4 26.6 37.5 18.1 136.1 66.9 199.0 40.4 31.4 11.1 38.0 27.6 48.2 7.2 3.3 39.7 7.8 19.7 50.7 81.2 21.7 2.8 54.7 150.9 26.0 59.7 8.0 3.3 62.0 ZC3H11A "KIAA0663, ZC3HDC11A" ENSG00000058673 "Zinc finger CCCH-type containing 11A" O75152 1 203795623-203854999 "Predicted intracellular proteins" "mRNA transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA026439, HPA028490, HPA028526" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (8.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.51e-1)" "unprognostic (3.67e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "unprognostic (2.38e-1)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-2)" "unprognostic (1.41e-1)" 15.0 15.8 8.2 21.0 11.3 29.0 15.6 10.9 11.1 14.3 12.7 14.8 20.6 18.8 12.9 17.0 16.2 15.4 14.0 8.0 7.3 16.7 16.3 14.6 26.4 9.8 8.7 5.7 19.1 15.6 19.9 5.7 17.6 11.8 16.3 17.9 20.4 19.6 13.3 23.6 26.4 22.7 16.8 5.8 23.3 20.6 23.1 9.3 33.7 22.8 23.3 25.8 16.2 6.6 15.4 29.7 23.8 45.2 28.8 28.7 22.9 49.7 33.6 24.0 27.0 30.2 32.7 36.2 37.6 19.9 35.7 22.0 41.0 35.8 19.7 37.2 56.6 25.8 36.3 39.3 16.5 15.4 50.9 62.3 19.1 23.5 29.0 28.2 34.2 25.5 40.4 74.0 51.6 24.0 24.2 56.2 20.3 42.6 20.8 19.4 40.1 52.1 24.7 19.1 50.0 33.1 31.4 33.8 27.5 29.8 51.7 29.5 38.1 39.2 39.2 34.7 33.1 32.3 36.8 37.3 58.5 25.2 29.1 30.7 15.6 3.6 5.5 5.2 3.5 7.2 5.0 4.7 4.8 4.2 3.5 5.9 4.4 7.9 5.1 5.8 2.3 5.0 4.2 8.2 11.3 10.9 11.1 8.0 7.3 9.8 8.7 5.7 11.8 5.8 9.3 15.4 2.4 12.8 22.5 105.8 49.2 101.5 61.7 50.6 112.7 46.2 1.1 0.9 54.2 58.6 38.4 0.0 45.9 31.1 18.2 43.6 0.0 0.3 54.7 3.1 2.9 49.9 46.7 67.1 71.9 0.2 27.3 51.5 53.0 3.9 25.3 0.9 54.7 70.0 32.5 84.1 69.0 64.2 28.5 54.6 60.8 14.3 60.3 37.2 48.0 82.4 31.7 40.5 41.2 103.0 169.4 0.6 42.2 67.4 64.1 104.0 52.1 0.3 43.9 49.8 78.9 83.3 42.1 63.6 40.2 84.5 111.5 51.0 41.4 0.5 52.1 114.2 RIOK2 FLJ11159 ENSG00000058729 "RIO kinase 2" Q9BVS4 5 97160867-97183247 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005681 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA005681: AB_1856286" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-2)" "unprognostic (8.04e-2)" "unprognostic (1.38e-1)" "unprognostic (4.51e-2)" "unprognostic (2.71e-3)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.76e-2)" "unprognostic (6.63e-2)" "unprognostic (1.26e-3)" "unprognostic (3.60e-1)" "unprognostic (9.98e-2)" "unprognostic (1.43e-2)" "unprognostic (1.39e-2)" 13.6 14.8 12.3 13.6 13.4 21.7 14.9 16.3 21.5 12.8 14.4 13.4 13.2 11.7 12.3 13.6 12.4 7.9 15.8 12.1 13.6 10.0 18.3 10.4 14.4 13.2 13.9 12.1 14.9 16.8 11.4 15.2 12.2 13.2 12.1 12.8 19.6 11.9 9.4 21.6 10.9 11.3 9.4 12.9 14.7 13.4 12.7 13.4 13.8 12.0 14.4 13.8 13.3 12.2 15.7 19.0 22.0 20.3 38.5 25.9 28.6 32.1 48.1 29.0 33.0 43.2 30.4 32.5 41.7 53.1 21.3 51.6 21.7 34.2 27.4 44.9 29.3 18.5 20.3 44.0 42.9 23.6 38.5 27.2 18.5 20.8 40.1 39.8 25.0 27.0 30.8 31.7 25.4 38.0 31.9 46.4 47.8 22.5 10.6 23.9 51.9 38.3 61.9 25.7 16.9 23.7 17.9 27.5 28.3 35.6 29.6 29.6 36.4 28.5 41.2 28.9 33.0 51.8 25.3 36.4 95.2 24.0 39.7 38.4 17.9 26.2 15.8 24.6 30.7 34.4 24.0 31.5 27.8 29.4 18.6 33.9 36.5 5.0 30.7 23.8 29.2 31.7 22.7 12.3 13.4 16.3 21.5 12.1 13.6 13.2 13.9 12.1 13.2 12.9 13.4 15.7 14.9 9.6 12.8 7.8 16.9 26.4 17.9 25.2 12.5 16.2 11.1 11.4 20.5 10.0 17.4 7.3 12.5 19.6 26.9 6.4 17.6 17.3 1.3 10.7 18.0 14.0 9.6 8.4 10.9 14.9 24.8 21.1 14.8 10.5 27.9 12.7 8.2 8.1 18.3 13.5 11.0 12.7 18.3 9.4 9.2 3.0 13.4 11.0 5.4 3.7 16.5 13.4 14.4 9.0 15.0 11.4 10.1 16.1 19.1 10.4 11.8 17.3 13.3 17.7 6.6 17.4 22.9 23.5 20.7 10.1 18.9 17.4 19.6 19.4 12.6 12.0 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889798 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 6.8 9.2 5.5 6.3 5.7 5.7 8.6 5.8 15.4 6.7 6.9 8.0 6.9 4.2 7.7 9.1 6.3 5.5 6.4 5.7 6.2 11.1 13.7 7.8 7.1 6.7 6.2 5.4 7.1 6.9 7.0 6.2 9.8 6.9 11.4 9.2 7.3 11.8 4.8 14.8 9.1 7.0 6.1 6.6 8.2 8.8 7.3 6.5 8.9 22.3 10.5 10.8 7.7 7.2 7.1 11.0 6.4 10.1 7.1 11.9 13.1 9.0 7.7 12.0 14.0 18.3 7.1 3.3 3.8 12.9 9.2 21.6 13.2 12.9 17.0 14.4 27.4 10.3 8.9 6.4 11.6 15.9 10.0 8.1 13.3 15.8 11.3 13.5 12.0 15.0 13.2 9.6 10.0 14.0 9.2 10.8 14.2 7.7 12.7 10.4 6.6 9.3 15.4 11.5 5.8 4.5 5.6 7.4 13.8 35.4 31.0 21.4 11.1 7.1 5.7 5.8 10.4 6.8 20.1 24.7 7.0 9.3 8.1 5.0 19.1 18.4 20.2 11.8 16.5 11.0 10.4 10.0 12.1 16.6 13.8 9.5 9.2 38.3 11.0 23.3 11.5 24.3 16.5 5.5 5.7 5.8 15.4 5.7 6.2 6.7 6.2 5.4 6.9 6.6 6.5 7.1 11.6 6.4 12.6 9.8 9.0 8.5 17.6 19.2 9.6 6.6 20.0 12.4 9.6 24.3 24.0 9.2 0.0 80.0 8.5 14.6 11.7 28.3 30.5 11.4 10.9 10.9 9.6 12.2 9.8 32.6 28.4 9.9 9.7 14.7 9.5 6.3 11.7 20.8 39.7 10.1 8.2 27.5 30.5 19.4 7.7 54.9 5.9 18.9 10.6 11.2 20.2 16.5 21.6 8.5 11.5 32.5 10.8 9.4 28.1 33.2 12.3 17.7 19.7 6.5 0.0 5.6 17.7 22.2 20.9 12.3 10.9 129.6 10.8 17.7 10.8 29.0 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765478-53838463 "Metabolic proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" NA NA "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: AB_2686189, HPA070882: AB_2686320" "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favorable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavorable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 5.5 5.3 3.7 9.6 3.7 8.4 11.2 3.9 4.2 5.7 3.7 12.1 9.0 6.6 7.5 7.7 7.6 4.6 4.6 3.7 3.6 7.0 7.9 4.7 15.8 3.5 3.7 3.6 5.9 4.8 9.6 1.7 8.1 3.6 4.8 14.3 6.1 4.2 5.2 4.3 7.4 8.3 7.2 3.8 5.7 6.5 7.6 3.8 14.3 6.8 5.3 18.5 7.2 4.3 4.2 61.6 31.2 42.8 43.7 15.5 15.5 49.3 40.9 31.0 63.8 51.1 47.5 40.4 119.0 26.2 18.6 51.2 72.0 73.2 43.3 89.8 29.8 50.9 58.5 42.9 40.5 14.3 95.3 31.9 9.4 17.0 62.9 37.5 18.6 39.1 44.2 67.7 16.9 35.6 22.2 47.2 38.2 101.0 52.2 49.9 52.0 68.4 66.0 29.8 41.7 25.4 32.2 36.5 71.5 35.9 45.3 55.3 50.2 22.7 32.9 32.6 45.5 74.9 17.9 48.8 84.7 27.3 71.6 42.2 0.0 2.3 1.5 3.0 5.0 4.7 3.6 2.8 2.7 2.6 2.8 5.3 4.1 0.1 3.1 3.3 2.3 3.4 2.4 3.7 3.7 3.9 4.2 3.7 3.6 3.5 3.7 3.6 3.6 3.8 3.8 4.2 4.4 6.4 6.3 12.4 8.7 10.1 6.4 9.0 12.0 4.5 10.1 6.3 8.1 4.3 5.4 5.5 2.1 11.5 5.9 7.9 0.0 8.5 2.3 5.0 5.6 6.1 0.0 19.4 13.8 9.1 20.2 6.3 8.6 4.6 7.6 21.5 5.3 7.1 11.8 3.3 11.0 10.3 16.2 8.2 8.9 2.1 2.8 7.1 7.2 13.1 4.7 3.3 3.1 11.6 19.4 7.0 5.8 3.4 20.1 8.9 2.9 4.5 5.5 2.9 6.6 6.3 15.7 11.8 14.3 18.2 8.5 6.8 6.7 4.3 18.2 6.5 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362234 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0" "Cell type enhanced" "Detected in many" "Astrocytes: 223.0;Excitatory neurons: 111.0;Inhibitory neurons: 63.5;Oligodendrocyte precursor cells: 334.8" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 2.1;eosinophil: 1.2;intermediate monocyte: 1.2;myeloid DC: 1.5;neutrophil: 2.6;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 7 "dendritic cells: 1.5;granulocytes: 2.6;monocytes: 2.1" "Cell line enhanced" "Detected in some" "HDLM-2: 23.9;HL-60: 7.7;U-266/84: 9.4;U-87 MG: 14.3;U-937: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 1.5 4.3 12.4 0.8 17.5 9.4 1.1 27.0 11.7 2.0 0.0 2.4 1.4 1.2 8.1 4.6 4.2 0.9 9.0 20.4 3.4 1.3 0.8 3.9 0.9 17.6 6.9 9.3 1.2 0.5 5.7 6.0 7.9 20.3 1.3 0.8 1.7 0.8 1.8 1.8 0.7 1.7 2.5 0.6 0.9 2.2 0.3 6.9 0.5 1.8 1.1 0.8 3.4 1.7 13.1 3.2 4.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.7 0.0 3.3 0.2 0.0 0.0 0.0 23.9 0.0 3.2 0.0 3.5 0.0 7.7 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.6 0.0 0.4 0.4 0.1 0.1 2.6 0.4 0.0 1.4 1.7 0.0 2.6 0.0 0.0 0.6 0.0 0.9 0.0 2.0 0.0 0.1 4.9 0.0 0.0 0.8 2.4 2.9 0.0 9.4 0.0 14.3 7.0 2.6 0.0 2.1 1.2 0.0 1.2 0.0 0.3 0.0 0.0 1.5 0.1 0.0 0.0 2.6 0.0 1.5 0.2 0.0 0.7 12.4 17.5 27.0 11.7 20.4 3.4 17.6 6.9 9.3 20.3 0.6 6.9 13.1 0.1 0.0 1.7 223.0 3.1 0.4 0.2 0.0 0.6 0.1 0.1 0.4 19.4 1.5 0.0 1.8 0.0 0.1 0.0 0.0 0.0 1.4 2.6 0.3 0.1 5.0 0.0 0.4 111.0 1.2 0.0 0.5 0.5 0.1 0.0 0.3 22.1 0.0 2.1 1.7 63.5 0.1 0.0 3.2 1.4 4.2 1.8 3.4 0.0 12.2 5.2 6.8 0.0 334.8 7.8 1.0 0.1 0.4 0.2 0.4 0.1 0.9 0.0 0.1 13.1 1.8 14.5 0.0 0.2 0.4 0.4 0.1 0.1 0.9 0.1 0.4 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911931-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 14.9 14.7 21.7 11.8 18.0 12.6 14.3 18.3 27.2 18.0 10.6 16.5 13.0 17.9 4.8 12.9 17.1 13.1 18.7 16.1 17.6 12.8 8.4 14.1 11.3 29.6 20.8 16.3 20.8 10.7 14.8 16.5 8.2 26.2 17.4 3.7 13.4 13.8 12.6 33.0 20.6 14.5 7.7 16.6 18.8 13.6 4.0 23.3 9.2 15.6 10.8 6.3 22.0 16.3 22.1 10.0 34.8 7.8 23.2 12.4 12.5 23.6 18.2 14.1 9.0 9.2 5.8 31.8 24.4 47.3 14.0 14.7 20.5 6.5 12.2 1.8 40.8 19.6 8.2 30.9 19.5 27.7 10.9 27.3 11.2 37.9 19.1 13.8 16.7 12.9 16.0 18.6 25.0 7.0 23.8 25.1 13.3 12.7 7.5 23.6 43.5 11.6 44.0 10.6 6.7 16.7 15.5 19.1 20.6 24.1 4.3 16.1 19.6 24.4 15.0 13.6 29.4 12.4 37.1 34.5 22.7 16.4 17.8 17.9 1.2 0.8 0.3 1.3 0.4 2.3 0.9 2.1 2.7 0.8 2.6 1.7 1.5 0.1 0.5 0.4 0.5 1.1 1.1 21.7 18.0 18.3 27.2 16.1 17.6 29.6 20.8 16.3 26.2 16.6 23.3 22.1 16.7 0.0 4.2 34.3 10.4 12.4 9.3 9.2 23.3 42.1 8.6 11.3 12.3 8.6 5.1 22.0 35.5 21.2 14.3 6.5 1.9 6.1 0.4 6.0 7.7 13.4 2.4 6.5 26.9 6.5 8.5 13.9 12.2 8.9 0.0 48.3 11.0 6.8 8.5 33.7 29.0 4.9 4.1 9.9 5.1 1.2 11.1 8.9 8.8 13.1 7.9 18.8 9.2 18.6 25.6 7.1 2.9 14.3 10.4 5.3 8.9 6.3 8.3 39.3 0.0 16.6 20.9 0.9 3.2 13.1 13.9 8.8 11.9 5.3 7.4 5.6 UNKL "C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L" ENSG00000059145 "Unk like zinc finger" Q9H9P5 16 1363205-1414751 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055801, HPA073949" Uncertain Supported Cytosol NA NA Cytosol "HPA055801: AB_2682926, HPA073949: AB_2686647" "unprognostic (5.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (8.88e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-2)" "unprognostic (3.90e-3)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "unprognostic (4.85e-3)" "unprognostic (1.13e-1)" "unprognostic (3.86e-3)" "unprognostic (1.89e-1)" "unprognostic (6.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.55e-1)" 6.0 7.6 5.0 4.0 3.5 5.7 7.3 7.1 8.5 7.2 0.3 5.9 4.2 9.0 0.7 4.5 8.4 1.9 4.3 4.5 2.1 3.9 4.4 5.3 4.3 7.3 5.1 2.3 10.8 4.3 2.0 5.1 3.0 8.6 7.1 1.5 2.7 6.9 3.0 11.6 7.3 7.5 1.7 1.4 8.3 5.7 6.6 4.6 5.4 8.0 2.3 2.8 7.4 6.2 9.4 4.7 12.3 2.8 7.2 2.1 2.6 21.5 12.0 3.6 3.2 2.8 10.1 10.7 1.8 24.4 4.1 5.5 8.6 3.6 1.3 2.2 22.0 10.4 3.7 14.8 8.3 1.6 2.1 7.5 3.4 1.6 5.1 2.1 3.8 5.7 5.4 10.6 6.5 1.5 7.4 5.5 6.0 7.8 2.0 13.4 14.7 3.2 13.7 2.0 1.3 9.4 5.6 7.1 4.4 1.3 2.0 7.1 3.4 6.9 7.1 10.9 6.1 5.1 14.2 8.0 8.4 5.7 4.2 8.3 3.5 1.1 2.7 2.1 0.4 1.0 0.7 0.7 0.5 0.4 0.9 1.5 0.7 4.1 1.4 0.4 1.8 0.9 0.7 5.0 3.5 7.1 8.5 4.5 2.1 7.3 5.1 2.3 8.6 1.4 4.6 9.4 7.6 6.4 7.5 18.3 16.0 5.5 6.2 5.0 3.4 30.0 8.1 9.5 2.7 7.2 8.3 5.5 14.6 12.8 16.2 5.3 1.9 5.4 5.7 4.9 6.4 8.9 3.6 6.1 13.3 3.0 6.6 8.7 6.6 7.0 5.1 20.6 12.5 6.8 4.1 6.7 15.7 6.5 6.1 7.3 3.8 20.8 16.4 6.2 7.2 9.4 13.9 16.6 23.7 13.0 17.2 7.3 11.3 15.4 17.1 22.7 11.5 2.0 8.0 37.3 6.6 12.5 8.3 14.2 20.0 4.5 8.2 20.5 11.8 9.4 4.9 11.7 TBXAS1 "CYP5, CYP5A1, THAS, TS, TXAS, TXS" ENSG00000059377 "Thromboxane A synthase 1" P24557 7 139777051-140020325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 58.3" "Group enriched" "Detected in many" 4 "granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 14 "basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1" "Group enriched" "Detected in all" 22 "dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0" "Cell line enhanced" "Detected in many" "NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA031257, HPA031258, HPA031259" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 890000 "Endoplasmic reticulum, Cytosol" "HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814" "unprognostic (4.46e-2)" "unprognostic (3.07e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (9.41e-2)" "unprognostic (5.10e-2)" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.52e-1)" "unprognostic (5.00e-3)" "unprognostic (8.53e-2)" "unprognostic (5.34e-2)" 13.3 10.9 4.7 28.4 5.4 25.1 8.3 5.7 7.3 5.4 7.3 10.2 10.4 3.3 2.0 5.4 5.0 21.4 3.4 4.2 10.4 5.7 12.9 24.1 12.5 9.3 5.9 2.9 2.9 3.6 2.9 2.3 14.4 8.1 6.5 13.1 1.6 9.1 4.0 1.0 1.2 12.0 12.7 8.7 58.3 11.3 1.4 7.8 15.2 1.9 3.3 8.4 14.0 2.2 12.8 0.2 5.4 0.3 0.1 1.2 3.9 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 12.1 0.0 0.3 0.0 0.0 0.0 0.0 9.4 0.7 17.8 0.0 0.0 1.6 6.2 15.3 2.1 0.0 0.0 0.9 1.1 2.3 0.1 0.6 2.2 0.6 0.2 2.4 76.7 0.2 18.0 23.7 2.6 0.0 1.2 21.0 0.0 0.2 1.1 0.2 0.0 0.8 0.0 0.0 14.4 2.0 0.6 0.2 1.4 1.0 4.6 0.9 0.3 0.4 60.8 1.7 324.3 322.4 333.6 7.3 466.0 11.9 8.3 13.5 3.7 129.0 4.5 2.3 1.3 271.1 11.9 423.1 22.6 13.9 216.7 4.7 5.4 5.7 7.3 4.2 10.4 9.3 5.9 2.9 8.1 8.7 7.8 12.8 3.9 3.2 10.8 8.1 9.9 0.4 1.2 0.5 2.8 1.0 3.0 3.0 1.1 5.7 1.7 1.8 6.2 0.6 16.4 0.8 9.8 5.2 0.4 1.0 0.6 5.0 1.8 12.8 1.2 9.5 0.5 2.9 7.1 3.8 71.0 0.5 16.8 8.6 88.8 3.3 1.8 1.9 12.2 193.6 19.5 0.7 0.3 132.9 3.6 191.1 63.7 4.9 26.8 3.0 5.9 4.4 7.9 0.0 16.4 5.8 0.2 6.3 1.0 4.1 19.7 1.3 1.7 0.5 0.7 26.2 0.6 0.5 13.4 0.3 2.7 1.2 PARP12 "ARTD12, FLJ22693, PARP-12, ZC3H1, ZC3HDC1" ENSG00000059378 "Poly(ADP-ribose) polymerase family member 12" Q9H0J9 7 140023749-140062951 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003584, HPA063872" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003584: AB_1079568, HPA063872: AB_2685139" "unprognostic (1.46e-3)" "unprognostic (2.93e-2)" "unprognostic (1.73e-1)" "unprognostic (2.71e-2)" "unprognostic (6.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (2.30e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (7.51e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.12e-7)" "unprognostic (3.31e-2)" "unprognostic (2.76e-1)" "unprognostic (1.75e-2)" "unprognostic (6.01e-2)" 6.4 4.7 5.2 12.4 4.8 16.0 6.7 3.9 5.4 4.1 5.9 12.2 18.4 7.6 9.7 4.9 8.2 9.4 6.0 3.6 4.8 5.0 7.9 15.6 13.5 6.8 4.6 2.5 6.3 9.2 10.3 2.3 10.0 5.3 7.1 11.7 1.8 17.3 4.8 3.0 15.1 18.3 8.0 4.5 17.3 13.2 10.4 5.8 10.8 5.8 2.5 9.6 8.8 2.4 8.4 20.8 7.6 0.6 0.8 2.4 5.7 15.1 4.7 10.4 36.3 42.5 4.9 12.6 8.6 11.5 3.9 28.0 9.3 5.4 17.6 6.0 33.4 8.7 9.2 4.9 6.8 15.2 2.4 6.2 5.7 6.7 12.7 15.5 9.9 28.2 10.4 19.0 6.0 2.7 8.4 25.7 14.3 1.3 10.7 18.0 15.2 0.0 2.7 7.1 7.9 4.6 0.0 14.2 7.7 11.2 0.7 9.2 5.6 31.0 4.3 10.2 0.3 14.5 0.5 1.5 2.0 7.9 12.2 5.2 1.2 3.0 4.3 1.5 5.5 1.3 1.7 2.1 1.6 2.1 2.4 0.9 0.7 1.0 2.5 6.4 0.2 5.8 1.2 5.2 4.8 3.9 5.4 3.6 4.8 6.8 4.6 2.5 5.3 4.5 5.8 8.4 24.1 6.4 10.6 2.6 17.9 6.5 7.2 4.4 8.0 2.9 6.2 5.5 5.4 7.2 5.8 11.0 2.1 6.0 13.0 48.9 1.9 13.9 0.7 7.0 6.4 18.1 24.0 4.8 1.2 26.0 19.1 6.9 18.3 6.3 19.7 38.2 7.9 10.9 24.2 0.0 2.6 19.4 4.1 13.6 9.7 0.9 7.2 20.5 7.2 26.2 17.5 2.9 11.3 9.5 3.1 35.2 37.0 7.2 8.3 12.4 44.2 6.9 9.0 2.5 0.0 7.3 7.9 35.0 15.6 8.7 9.9 2.1 15.6 8.4 11.6 10.6 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605941-95656711 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 121.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 48000 Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 15.4 16.2 12.8 21.4 12.7 16.9 20.4 13.0 13.2 33.7 20.4 52.4 90.1 18.7 31.1 21.1 22.1 25.4 10.4 12.5 14.7 17.9 24.5 10.9 22.2 12.8 13.3 12.3 16.9 62.3 33.8 28.4 26.5 13.6 24.4 49.8 11.5 121.1 25.1 4.4 22.6 73.8 26.5 12.9 12.2 40.9 11.8 14.9 17.3 37.8 5.6 27.2 25.5 14.4 14.0 66.5 61.6 57.9 152.7 76.0 72.9 62.2 75.6 112.8 75.1 93.7 124.4 51.6 223.7 68.9 119.7 36.2 85.6 117.1 77.8 84.6 64.0 92.0 71.2 40.5 177.9 49.7 125.6 76.1 77.0 46.8 61.5 119.1 124.5 79.9 82.6 67.5 46.0 57.1 95.0 114.5 80.5 68.6 109.2 60.7 105.9 66.3 76.9 88.3 49.7 57.5 56.9 60.1 47.1 56.9 66.0 70.5 57.9 66.7 31.1 49.0 80.9 88.2 52.4 41.7 135.8 60.4 142.8 40.7 0.1 2.6 0.2 27.3 5.2 28.7 23.0 24.5 28.3 9.6 16.1 20.7 23.1 0.5 26.3 8.3 5.9 25.8 15.5 12.8 12.7 13.0 13.2 12.5 14.7 12.8 13.3 12.3 13.6 12.9 14.9 14.0 4.6 6.4 9.2 7.2 12.6 11.2 8.3 8.9 14.2 6.3 15.6 12.4 4.6 11.5 14.3 20.2 0.0 43.9 6.7 80.5 1.9 13.7 1.3 12.7 18.1 8.0 19.8 17.9 15.7 21.1 31.6 16.2 18.8 16.9 8.2 81.6 5.3 27.3 11.5 10.1 13.6 41.3 8.2 3.5 3.8 1.6 9.3 3.5 16.0 11.2 2.6 7.1 8.2 17.6 12.8 11.7 56.4 12.0 30.1 18.4 79.4 8.4 15.2 3.4 0.0 10.5 10.1 8.2 9.9 17.6 8.1 30.2 9.0 10.8 38.7 9.4 TARBP1 "TRM3, TRMT3, TRP-185" ENSG00000059588 "TAR (HIV-1) RNA binding protein 1" Q13395 1 234391313-234479179 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 209.4;Inhibitory neurons: 161.5;Oligodendrocyte precursor cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020810, HPA024632" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB020810: , HPA024632: AB_1857770" "unprognostic (3.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.75e-1)" "unprognostic (3.47e-1)" "unprognostic (8.26e-2)" "unprognostic (2.44e-3)" "unprognostic (8.45e-3)" "unprognostic (5.22e-3)" "unprognostic (3.72e-2)" "unprognostic (5.52e-2)" "unprognostic (2.56e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.14e-10)" "unprognostic (5.72e-2)" "unprognostic (1.82e-1)" "unprognostic (4.38e-2)" "unprognostic (4.27e-2)" 4.9 5.3 2.2 7.5 3.5 11.2 9.2 5.1 4.8 5.0 0.0 6.2 6.5 4.9 7.6 6.4 7.7 5.8 3.8 3.1 2.9 5.6 3.9 6.3 10.4 2.2 1.6 4.5 2.7 7.8 6.2 6.3 8.3 2.2 7.4 9.0 7.4 9.3 4.5 6.4 7.9 5.9 4.7 0.0 7.6 8.4 4.8 3.0 6.8 6.2 7.1 11.5 3.7 4.2 4.5 18.9 12.9 8.3 9.7 13.6 18.5 17.2 7.9 5.9 10.1 7.4 6.2 12.0 16.3 8.2 6.0 8.7 12.1 9.7 9.9 9.7 16.0 14.9 9.0 14.0 9.1 4.3 39.7 7.6 7.7 8.9 7.3 4.1 7.8 10.5 21.6 11.5 10.2 7.1 3.9 16.5 19.4 17.7 20.1 5.3 28.7 4.9 16.0 6.8 10.8 8.9 10.6 10.8 14.0 12.1 5.5 9.0 39.9 7.1 9.3 1.2 10.4 16.1 27.0 19.0 7.2 6.0 18.3 14.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.5 0.3 0.0 0.3 0.0 1.1 0.0 0.0 2.2 3.5 5.1 4.8 3.1 2.9 2.2 1.6 4.5 2.2 0.0 3.0 4.5 12.4 41.7 22.7 53.8 14.6 6.2 4.1 7.4 7.4 35.1 18.4 18.9 5.8 5.7 13.3 7.3 37.5 20.1 23.3 7.2 1.9 4.7 21.5 13.8 13.6 11.1 11.5 16.4 209.4 5.7 17.6 10.1 16.3 9.9 3.8 13.2 12.1 7.7 9.0 57.2 161.5 12.2 10.2 6.6 9.2 3.6 5.6 11.4 10.6 39.4 8.0 7.7 10.3 115.1 72.3 8.8 6.5 6.0 6.3 6.5 5.8 4.3 27.9 17.1 0.0 12.7 7.8 4.1 8.6 11.5 8.2 11.9 12.8 12.8 19.6 4.8 GATB "PET112, PET112L" ENSG00000059691 "Glutamyl-tRNA amidotransferase subunit B" O75879 4 151670504-151761007 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042610 Uncertain Supported Mitochondria NA NA Mitochondria "HPA042610: AB_10797502" "unprognostic (2.52e-1)" "unprognostic (3.33e-1)" "unprognostic (1.01e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (2.06e-1)" "unprognostic (6.76e-2)" "unprognostic (1.37e-1)" "unprognostic (8.17e-2)" "prognostic favorable (1.20e-10)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-1)" 11.9 15.8 15.6 5.6 17.2 9.6 8.4 18.0 20.6 6.7 14.2 9.9 5.9 5.6 8.4 10.3 8.8 5.5 33.7 15.9 16.4 21.8 22.4 5.4 7.6 17.1 16.6 15.9 11.4 5.4 18.5 5.2 8.6 16.9 5.5 9.7 17.2 8.0 6.5 23.2 9.4 6.5 8.1 17.6 6.5 8.2 8.1 16.7 12.3 7.5 40.7 9.8 7.0 6.2 20.2 14.9 11.6 16.1 15.7 22.9 21.7 13.9 19.3 24.9 33.3 25.8 19.5 23.8 20.2 5.0 20.1 20.3 13.7 34.5 36.6 35.3 11.4 21.1 9.4 15.2 40.7 22.4 19.1 9.0 22.8 23.1 32.0 11.2 19.2 25.1 28.0 36.8 17.1 26.0 16.7 24.1 20.8 16.6 12.4 21.1 20.4 15.5 16.1 30.2 12.3 16.5 18.5 15.8 21.1 23.1 15.4 17.9 13.7 14.1 16.8 9.1 11.7 13.4 20.3 28.2 16.8 23.7 16.9 12.5 0.9 11.6 2.0 4.5 16.9 7.3 11.4 6.1 6.5 20.9 9.9 7.8 7.3 1.1 8.7 12.1 8.1 7.0 10.8 15.6 17.2 18.0 20.6 15.9 16.4 17.1 16.6 15.9 16.9 17.6 16.7 20.2 4.3 9.6 4.8 11.4 6.7 0.0 6.0 0.0 5.7 9.8 6.3 7.1 64.8 1.5 3.7 11.0 8.4 23.4 2.9 3.2 27.4 11.2 8.0 6.7 7.3 4.4 2.4 15.6 28.4 7.4 16.6 8.8 6.6 7.1 1.3 12.3 2.5 17.2 17.1 10.1 16.4 4.2 0.0 7.3 0.0 10.6 5.3 7.6 0.0 15.9 10.8 333.3 1.0 14.1 27.5 6.9 4.9 4.5 5.6 3.1 6.3 22.7 1.5 17.1 6.6 6.5 5.9 14.3 14.0 10.6 0.0 13.4 3.6 12.5 7.1 4.5 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 175.1;esophagus: 131.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 507.0;Langerhans cells: 224.8;Paneth cells: 369.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 496.3" "Lineage enriched" "Detected in all" 49 "granulocytes: 496.3" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 13.6 3.7 7.3 40.8 7.3 175.1 7.1 10.1 15.6 19.5 7.1 30.6 29.1 5.4 2.0 131.1 8.2 9.5 6.9 7.8 9.2 6.7 11.4 36.8 4.0 7.9 7.0 6.5 6.1 4.6 6.8 6.8 11.0 8.9 5.5 29.1 15.7 17.6 2.1 6.0 12.1 44.1 9.2 6.1 33.0 17.1 6.4 10.9 14.1 7.5 6.6 15.2 17.5 51.0 13.5 5.0 2.1 3.0 2.2 6.5 3.2 11.2 5.5 3.1 2.6 1.9 6.8 3.8 2.8 2.8 2.1 2.5 17.3 5.8 10.7 2.7 1.6 6.9 5.9 6.6 7.0 21.9 7.3 5.7 3.7 17.8 5.9 27.0 3.2 3.4 2.8 10.4 10.9 1.6 4.0 3.4 14.1 0.8 7.3 3.5 1.6 3.1 7.1 3.4 5.8 9.8 4.1 7.3 9.3 3.9 3.4 1.4 4.1 13.2 3.7 1.0 4.1 5.2 7.5 13.7 1.1 3.8 12.5 1.4 124.0 10.2 105.7 2.3 6.4 2.5 1.1 1.6 1.7 5.2 1.3 1.8 1.9 496.3 2.8 5.5 1.6 1.5 4.5 7.3 7.3 10.1 15.6 7.8 9.2 7.9 7.0 6.5 8.9 6.1 10.9 13.5 18.0 38.5 23.7 16.0 25.4 25.7 31.6 61.8 21.6 29.8 51.6 29.3 6.9 10.0 44.7 1.8 54.2 10.1 46.2 507.0 7.9 12.9 17.0 34.3 17.5 12.0 97.5 17.7 23.6 16.5 8.0 17.9 110.1 81.6 27.3 3.0 5.7 6.8 28.6 10.1 20.2 155.5 71.2 56.5 224.8 17.8 4.7 190.8 16.0 11.2 40.7 62.1 18.6 20.1 21.7 70.1 369.6 2.6 33.1 43.3 178.8 6.9 24.2 21.7 0.0 14.7 18.3 19.9 2.7 88.2 56.4 105.9 30.3 5.2 65.9 126.7 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400480 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 101.5;Oligodendrocytes: 259.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 134.8;TIME: 160.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 21.6 11.3 26.9 19.0 49.1 48.5 18.6 27.1 35.8 13.0 14.7 14.1 12.1 26.5 9.1 14.7 14.1 16.3 11.4 39.0 34.1 11.7 16.4 20.8 21.9 28.5 26.2 30.8 15.8 10.5 10.7 8.1 32.0 27.6 14.1 12.3 19.5 8.8 11.2 8.9 11.0 11.6 29.8 26.5 22.0 10.6 26.8 29.9 25.1 11.7 12.4 22.3 17.3 12.9 57.4 15.4 12.5 32.5 8.9 15.9 41.2 24.1 34.8 46.9 29.1 27.2 7.7 8.8 22.7 23.0 24.5 15.6 13.8 19.8 20.9 39.5 24.9 15.5 32.7 8.5 10.9 34.4 17.9 18.4 30.0 21.3 43.0 77.1 51.8 134.8 18.9 24.7 18.1 66.8 9.5 17.0 28.1 14.4 7.6 22.8 29.2 18.0 19.8 35.1 12.7 17.1 11.7 19.9 18.4 25.9 24.7 14.0 15.7 160.5 25.6 10.0 13.8 18.7 26.0 21.1 24.1 9.6 7.6 19.2 66.7 6.4 17.1 22.2 9.3 24.0 17.5 17.9 25.1 10.0 16.6 25.0 21.7 23.2 31.4 9.0 7.3 15.8 16.6 26.9 49.1 27.1 35.8 39.0 34.1 28.5 26.2 30.8 27.6 26.5 29.9 57.4 58.1 16.0 6.5 54.5 37.3 26.8 10.7 8.6 19.4 11.8 13.8 9.8 11.9 7.2 10.3 9.2 16.7 12.0 64.4 7.2 0.0 4.9 3.3 17.6 10.0 51.7 15.0 17.9 101.5 3.6 27.9 24.0 21.4 17.2 18.3 8.9 34.2 10.8 12.1 5.0 59.2 7.9 4.1 14.5 20.7 4.1 9.9 16.7 17.8 64.6 8.6 22.6 32.0 52.3 259.2 7.4 3.4 9.4 64.7 12.5 6.5 8.6 15.4 9.6 6.6 22.7 22.0 8.8 21.6 24.2 25.9 13.7 63.2 10.7 6.0 15.1 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631334-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 32.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favorable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 3.3 5.2 1.2 2.3 1.3 1.0 2.0 1.2 1.9 1.4 2.4 3.0 2.9 1.8 4.5 1.5 1.8 2.1 2.5 1.3 1.7 5.1 32.3 1.3 0.7 1.4 1.3 1.1 1.4 2.9 4.3 1.5 2.7 1.3 3.8 1.7 0.6 4.2 2.3 2.2 1.0 2.5 1.7 1.1 0.7 2.4 1.4 1.2 0.2 2.2 1.7 0.8 3.0 1.3 1.1 2.7 2.0 1.3 2.3 14.1 6.2 5.3 10.4 4.8 3.9 3.7 3.7 1.6 2.4 4.0 7.0 6.1 8.5 1.5 2.9 3.7 1.9 2.0 2.4 0.0 8.0 4.5 4.5 3.3 5.3 8.2 3.0 5.6 3.0 3.3 1.3 4.9 1.8 5.0 2.9 1.3 0.2 2.3 5.1 4.9 2.3 7.3 2.2 8.2 2.8 2.3 1.2 5.7 7.7 3.6 2.3 4.1 0.8 6.5 4.7 2.3 12.9 6.0 3.6 6.0 1.3 8.1 2.1 4.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 1.2 1.3 1.2 1.9 1.3 1.7 1.4 1.3 1.1 1.3 1.1 1.2 1.1 9.9 6.4 11.9 0.0 8.3 10.6 16.2 13.8 6.8 7.9 14.1 12.4 13.9 8.6 16.0 11.0 20.9 14.2 16.7 16.2 13.7 17.1 10.8 18.6 18.2 7.9 17.3 3.0 0.0 16.3 24.7 15.3 10.2 19.5 1.3 8.8 6.4 85.3 12.1 13.5 0.0 21.3 6.1 6.4 10.2 2.5 10.2 10.0 12.4 0.0 6.7 4.6 5.2 0.0 0.0 11.7 7.3 10.1 22.6 29.4 21.7 13.5 18.9 19.9 13.1 13.3 15.7 29.5 16.6 7.0 9.2 13.8 8.8 10.6 15.0 22.7 SLC2A3 GLUT3 ENSG00000059804 "Solute carrier family 2 member 3" P11169 12 7919230-7936187 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 432.0" "Cell type enhanced" "Detected in many" "Adipocytes: 362.1;Endothelial cells: 356.2;Extravillous trophoblasts: 382.4;granulocytes: 485.1;Langerhans cells: 710.4;Macrophages: 305.2;T-cells: 328.9" "Cancer enriched" "Detected in all" 7 "testis cancer: 107.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 166.1;neutrophil: 223.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 223.4" "Group enriched" "Detected in many" 5 "BEWO: 1473.1;CACO-2: 1646.2;SuSa: 1119.9" "CAB002763, HPA006539" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002763: , HPA006539: AB_1078984" "unprognostic (9.20e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (2.65e-1)" "unprognostic (5.29e-3)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (8.27e-2)" "unprognostic (2.35e-1)" "unprognostic (3.83e-2)" "unprognostic (8.47e-3)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.36e-8)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.70e-1)" "unprognostic (1.14e-2)" "unprognostic (2.91e-3)" 112.7 19.5 27.2 58.7 27.9 432.0 77.6 24.5 40.3 16.5 25.7 23.8 6.8 21.0 2.0 12.8 27.6 56.6 50.0 32.1 30.3 37.2 28.3 93.6 29.7 29.5 21.9 26.2 26.6 11.3 7.9 28.3 103.7 29.2 19.9 12.8 88.1 12.4 5.7 24.3 19.3 15.8 41.8 22.9 46.1 20.0 4.9 31.2 18.6 43.6 10.1 21.0 99.6 26.4 39.0 0.3 7.9 68.5 27.4 25.2 85.9 1473.1 24.7 26.7 23.9 55.9 1646.2 11.0 1.6 0.0 17.1 33.1 0.6 2.4 3.9 43.0 48.4 2.0 96.3 6.5 219.3 67.3 35.0 135.4 36.2 2.8 63.6 28.5 55.8 22.6 7.5 44.8 22.8 21.9 0.1 2.6 38.4 300.9 1.2 0.0 2.1 8.0 1.4 0.1 0.1 0.3 0.6 0.0 2.4 32.8 1119.9 0.0 4.9 23.1 29.7 15.6 57.4 2.5 0.2 68.8 5.2 86.9 15.9 16.6 166.1 19.3 29.7 25.3 2.3 20.2 7.4 16.9 19.5 10.0 7.0 10.8 14.8 223.4 15.6 1.0 0.8 24.9 17.4 27.2 27.9 24.5 40.3 32.1 30.3 29.5 21.9 26.2 29.2 22.9 31.2 39.0 362.1 144.2 98.8 5.5 301.0 129.5 3.5 1.7 8.6 33.0 5.1 7.6 21.0 7.2 26.8 3.7 62.6 69.6 112.1 0.2 0.0 0.2 3.1 5.0 84.3 356.2 1.2 13.7 24.4 0.0 382.4 188.9 12.2 4.3 485.1 6.5 96.4 2.4 113.4 5.0 20.8 0.3 0.0 76.4 710.4 3.1 10.2 305.2 183.2 34.7 43.4 28.5 41.2 6.6 5.0 0.7 1.3 7.9 93.2 5.3 0.1 1.4 10.3 70.2 118.3 21.5 187.1 2.4 1.2 4.9 82.0 111.4 328.9 41.7 0.1 4.0 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 236.3;intestine: 175.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.7;Cone photoreceptor cells: 95.9;Endometrial stromal cells: 47.7;Excitatory neurons: 41.1;Inhibitory neurons: 29.9;Rod photoreceptor cells: 70.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 7.7;MOLT-4: 4.4;SCLC-21H: 7.4;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 0.8 9.2 157.3 3.9 136.3 0.7 1.5 4.5 236.3 42.0 4.9 175.8 6.1 79.0 1.4 1.6 46.6 9.0 2.6 223.0 55.3 2.0 2.4 1.2 0.9 36.7 23.7 160.4 15.4 5.0 1.5 100.1 0.8 63.9 4.4 3.5 37.2 1.0 1.2 0.4 1.6 41.7 17.9 5.5 1.5 44.5 12.5 52.8 1.4 1.1 0.0 0.4 106.6 14.9 103.8 0.2 0.0 3.0 2.7 1.1 0.6 0.3 0.2 0.0 0.1 0.0 2.1 0.3 0.2 1.8 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.1 1.6 0.0 0.1 7.7 0.2 0.5 0.1 1.2 0.0 1.0 0.4 0.7 0.0 1.7 4.4 0.2 0.4 0.3 0.0 1.2 0.0 0.1 0.0 0.1 7.4 6.4 0.1 0.1 0.2 0.2 0.5 0.4 0.0 2.2 3.5 0.2 0.0 1.9 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 157.3 136.3 4.5 236.3 223.0 55.3 36.7 23.7 160.4 63.9 5.5 52.8 103.8 0.7 3.2 0.5 6.8 1.0 0.6 0.3 0.3 0.0 50.7 1.1 0.5 1.5 2.8 1.5 0.0 95.9 0.2 0.6 0.8 1.9 0.2 6.6 4.8 47.7 1.0 18.0 0.0 41.1 1.9 0.2 4.0 2.6 1.8 0.0 0.4 0.0 1.3 0.7 13.5 29.9 0.9 0.0 0.6 0.7 2.7 3.7 0.5 0.0 3.7 0.1 13.2 0.0 9.0 2.4 0.7 1.4 4.1 0.1 0.4 1.3 1.2 0.5 70.8 0.0 2.0 1.1 4.0 3.7 0.7 0.1 0.7 1.9 8.8 1.3 0.1 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679803-79754510 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cataract, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 113.1;Late spermatids: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155" "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favorable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 8.7 7.4 3.4 7.3 3.5 13.8 8.9 2.9 4.0 7.6 3.5 10.2 7.3 10.4 1.4 10.8 8.2 4.1 6.5 3.0 3.1 7.9 9.6 9.4 8.8 4.9 3.8 2.4 5.0 9.1 3.3 6.9 4.2 4.0 8.3 3.1 1.5 9.6 3.9 12.0 19.4 11.0 3.1 3.1 13.6 10.0 22.3 4.4 6.6 8.1 3.2 3.7 9.7 8.7 4.1 13.4 14.0 7.7 11.0 6.0 5.0 25.9 9.6 6.1 7.6 7.5 9.4 8.0 17.2 4.2 5.6 9.1 16.4 6.6 8.8 3.1 16.9 12.4 8.5 6.6 12.9 8.7 37.6 20.5 8.4 8.3 8.1 3.8 4.6 9.2 12.2 11.2 8.1 3.0 11.5 25.4 29.5 12.7 4.2 19.1 20.7 10.1 20.0 5.6 13.1 12.0 12.4 10.2 9.8 13.9 5.8 8.0 21.7 12.9 12.9 19.4 5.3 9.7 7.4 27.6 16.1 11.0 18.8 9.3 0.0 0.4 3.2 0.5 0.4 0.4 0.2 0.4 0.8 0.6 0.1 0.5 0.3 1.0 1.1 0.4 0.1 0.1 0.2 3.4 3.5 2.9 4.0 3.0 3.1 4.9 3.8 2.4 4.0 3.1 4.4 4.1 7.4 0.0 4.1 3.6 9.2 8.5 5.0 4.0 11.4 9.5 7.7 6.5 3.8 4.3 4.5 3.7 14.6 8.8 24.2 20.0 1.9 5.4 113.1 18.6 8.0 7.5 6.0 13.5 7.7 7.2 8.0 4.8 19.9 24.0 7.0 7.8 6.4 5.7 8.8 23.5 6.6 16.6 6.1 7.5 9.5 123.2 7.8 13.8 7.2 6.5 6.5 6.5 19.6 3.0 8.9 10.2 14.9 10.5 15.2 11.8 10.0 6.8 9.6 14.8 0.0 5.9 7.4 18.0 10.5 10.5 10.1 19.0 18.3 8.0 11.7 12.6 YBX3 "CSDA, CSDA1, dbpA, ZONAB" ENSG00000060138 "Y-box binding protein 3" P16989 12 10699089-10723323 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "skeletal muscle: 4956.1;tongue: 1650.1" "Cell type enhanced" "Detected in many" "Early spermatids: 1418.1;Prostatic glandular cells: 1553.4;Skeletal myocytes: 1316.7;Urothelial cells: 1339.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034838 Approved Supported Cytosol NA NA 230000 Cytosol "HPA034838: AB_10670980" "unprognostic (1.93e-2)" "unprognostic (6.20e-2)" "unprognostic (3.56e-1)" "unprognostic (3.61e-2)" "unprognostic (4.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-1)" "unprognostic (2.41e-1)" "unprognostic (3.23e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.17e-13)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.44e-1)" 229.2 97.4 18.9 78.2 18.9 152.4 201.9 20.5 28.7 144.4 38.3 199.1 37.8 137.9 47.7 273.1 168.2 65.6 402.1 16.5 62.1 143.4 54.2 211.3 33.2 26.9 19.8 13.7 135.8 293.5 18.7 84.7 73.1 23.2 178.7 59.3 83.5 219.9 68.2 4956.1 357.9 99.9 101.8 22.0 80.1 151.0 267.8 27.4 37.1 137.3 1650.1 55.0 227.3 206.5 27.1 117.2 90.3 41.4 136.1 165.7 310.7 307.4 173.4 142.7 138.7 132.0 160.4 259.5 109.3 57.7 130.3 96.5 215.5 173.3 338.1 124.6 1.2 325.2 91.3 123.6 108.4 198.3 171.7 10.4 343.3 452.3 124.2 414.6 148.9 313.6 152.3 123.1 0.4 154.7 112.6 137.8 141.9 435.5 103.7 76.9 76.9 192.6 127.4 192.6 150.0 52.2 0.3 129.1 130.9 174.1 288.0 37.1 133.9 221.3 94.5 282.6 108.4 201.5 0.5 38.1 13.4 133.1 0.2 104.8 0.0 4.2 0.0 0.6 4.2 0.0 1.6 0.0 1.5 3.2 6.5 0.0 1.6 0.8 0.8 2.4 0.1 0.1 1.0 18.9 18.9 20.5 28.7 16.5 62.1 26.9 19.8 13.7 23.2 22.0 27.4 27.1 680.9 150.6 164.4 14.0 192.8 764.9 1226.9 212.9 552.7 36.1 288.8 292.7 497.7 105.8 177.8 145.3 89.6 145.7 39.2 94.3 133.1 125.3 1418.1 563.0 402.1 563.1 67.6 1081.5 2.4 143.3 84.3 484.8 119.8 551.3 63.3 291.0 235.6 23.1 97.7 16.8 1.0 139.5 120.1 223.2 494.7 470.2 264.7 292.2 259.7 21.5 83.9 67.2 2.1 4.5 0.1 122.0 76.3 223.8 80.6 1553.4 43.9 240.4 240.4 365.4 124.9 1316.7 643.1 594.6 158.4 638.6 1050.5 125.7 72.5 70.8 157.4 1339.7 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618923-10674318 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.3;prostate: 11.7;stomach 1: 17.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040468: AB_2676998, HPA048569: AB_2680446" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.3 0.3 0.9 1.9 3.7 1.1 4.0 0.0 3.3 1.7 0.0 16.0 2.4 0.5 1.3 7.4 2.2 3.5 0.1 3.5 1.8 0.4 0.3 1.3 1.4 0.1 0.5 4.8 0.3 0.3 0.0 2.4 0.7 0.7 11.7 17.3 0.9 6.8 0.9 0.1 2.8 11.3 0.6 0.0 0.9 17.7 0.2 0.4 0.2 0.4 0.0 2.5 5.2 3.3 1.5 4.8 0.2 0.0 0.6 0.0 0.0 1.3 7.3 0.7 3.5 3.4 2.6 28.7 0.3 4.7 1.8 4.5 1.4 1.6 8.0 7.4 17.5 0.4 1.0 2.4 0.2 0.0 2.2 18.3 0.4 0.4 5.1 0.3 0.5 25.5 0.2 0.3 0.3 8.1 3.1 0.2 1.3 4.2 11.8 2.0 0.1 2.0 0.3 2.5 14.6 0.9 0.1 4.5 4.9 0.0 6.7 3.5 0.6 23.8 1.0 3.8 0.5 0.8 0.0 1.0 0.2 3.5 0.2 5.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.1 12.5 0.0 0.0 0.0 0.3 0.9 3.7 0.0 3.3 3.5 1.8 0.1 0.5 4.8 0.7 0.0 0.4 1.5 0.3 0.0 2.2 0.0 0.0 0.3 0.8 3.1 1.2 0.6 3.3 2.0 0.7 1.5 3.3 0.0 0.0 0.1 1.8 19.6 0.0 0.5 0.2 7.3 0.5 0.4 4.2 0.8 20.6 0.2 0.6 0.2 15.3 4.5 1.3 6.3 0.0 0.0 0.0 0.0 1.6 8.9 2.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 6.2 0.0 0.5 5.9 12.6 0.0 0.9 4.7 10.6 0.0 8.8 0.4 0.0 1.2 0.2 0.2 0.8 3.1 1.0 0.3 1.9 0.0 6.9 5.5 WNK1 "HSAN2, HSN2, PPP1R167, PRKWNK1" ENSG00000060237 "WNK lysine deficient protein kinase 1" Q9H4A3 12 752579-911452 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 310.3" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 336.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046541, HPA059157" Enhanced Supported Cytosol NA NA 92000 Cytosol "HPA046541: AB_2679690, HPA059157: AB_2683935" "unprognostic (1.40e-1)" "unprognostic (1.54e-2)" "unprognostic (4.82e-2)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (7.68e-2)" "unprognostic (1.05e-3)" "unprognostic (1.57e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.67e-4)" "unprognostic (1.84e-1)" "unprognostic (2.49e-1)" "unprognostic (4.38e-1)" "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (5.17e-2)" "unprognostic (1.30e-2)" 57.2 20.8 232.7 36.8 221.8 54.7 33.8 184.4 167.1 33.1 109.7 22.0 14.5 27.0 30.6 72.8 29.7 27.4 64.3 139.3 149.8 84.7 31.9 45.0 39.5 239.4 244.2 96.8 30.3 22.7 51.5 17.2 36.3 310.3 30.0 24.4 88.1 24.2 33.7 80.5 51.2 17.5 36.4 243.7 30.4 27.9 48.8 217.9 61.8 28.0 80.5 47.3 36.2 44.2 259.2 53.9 97.5 131.8 11.3 88.1 80.0 52.2 48.3 61.6 58.2 51.3 59.4 55.7 71.0 16.8 107.8 73.5 39.8 93.8 56.7 84.3 124.7 51.4 169.4 122.2 46.1 66.7 86.9 68.2 64.0 82.1 97.6 164.4 61.6 73.4 68.0 76.4 158.2 77.8 54.1 154.6 15.6 105.8 47.8 24.3 78.0 138.8 20.8 80.6 96.8 35.1 40.7 121.8 82.9 33.6 183.3 86.8 97.2 78.3 67.1 77.3 86.2 70.8 23.8 43.1 103.8 59.4 44.6 53.2 0.7 1.8 1.6 1.9 2.1 1.9 1.7 1.9 2.1 1.4 1.2 1.2 1.9 5.6 1.4 4.7 1.2 3.4 1.6 232.7 221.8 184.4 167.1 139.3 149.8 239.4 244.2 96.8 310.3 243.7 217.9 259.2 261.1 102.5 141.6 77.1 65.3 112.8 42.3 38.3 85.4 87.9 50.6 39.5 241.6 50.1 47.1 90.1 150.1 32.5 83.0 27.8 86.1 28.0 29.7 63.0 68.6 106.7 58.7 304.2 182.3 24.4 32.9 58.3 37.2 70.2 52.6 46.2 52.5 71.7 57.3 84.1 165.0 26.3 16.2 121.4 80.8 21.2 61.8 96.7 37.4 114.3 95.7 64.0 61.8 126.7 336.4 41.7 34.8 55.7 76.5 59.0 24.2 21.8 64.6 96.1 13.1 69.6 63.8 186.5 74.6 147.2 136.0 28.5 112.9 33.2 25.8 55.2 CCAR1 "CARP-1, CARP1, FLJ10590" ENSG00000060339 "Cell division cycle and apoptosis regulator 1" Q8IX12 10 68721012-68792377 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007856, HPA048513" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA007856: AB_1078415, HPA048513: AB_2680424" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.86e-1)" "unprognostic (5.15e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "prognostic favorable (4.05e-5)" "unprognostic (2.89e-2)" "unprognostic (3.21e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.67e-1)" "unprognostic (2.36e-1)" "unprognostic (2.24e-1)" "unprognostic (1.41e-2)" 17.4 21.6 13.9 20.4 15.0 23.6 17.3 19.0 25.6 16.0 14.6 18.1 17.0 16.9 16.3 20.3 14.6 16.7 15.6 12.9 15.2 18.3 19.3 16.0 30.5 15.7 14.1 12.6 20.0 20.6 16.0 14.7 21.9 15.6 17.5 22.4 21.1 18.7 13.6 20.8 24.1 19.6 16.1 12.4 21.7 17.9 14.4 15.9 30.1 18.4 18.1 29.0 21.9 17.2 18.5 64.0 64.8 73.9 49.7 31.4 30.3 57.7 56.0 47.4 59.3 40.0 87.2 50.8 74.7 29.9 39.1 29.8 49.3 78.4 44.3 64.8 51.5 48.2 60.1 46.1 54.5 35.7 96.2 67.5 30.5 54.2 50.1 61.7 36.7 48.5 37.5 83.5 46.8 58.8 46.5 64.2 60.7 74.1 49.7 58.4 74.2 44.1 44.7 52.5 48.6 42.7 36.9 55.1 89.1 57.1 57.6 60.6 58.9 48.1 36.8 46.3 40.1 61.4 32.2 45.5 78.5 30.8 63.8 35.6 6.1 14.6 14.3 16.3 13.0 14.6 14.2 11.3 15.8 21.0 17.3 13.5 14.3 3.3 10.6 15.5 13.1 18.4 11.3 13.9 15.0 19.0 25.6 12.9 15.2 15.7 14.1 12.6 15.6 12.4 15.9 18.5 50.5 35.3 85.5 61.4 69.2 37.0 49.6 54.7 66.0 51.0 36.1 40.0 65.5 41.5 49.0 46.0 58.4 73.1 62.9 44.1 23.5 68.0 28.8 55.2 68.5 54.0 46.1 61.2 49.7 78.1 83.8 49.2 45.3 62.2 67.2 76.8 39.3 40.4 49.2 55.5 51.2 55.1 30.5 47.4 36.3 14.5 53.7 49.8 21.4 41.2 65.4 36.5 66.9 47.7 66.1 77.7 34.2 50.4 61.0 45.3 36.0 18.3 49.1 68.7 65.7 53.2 62.3 128.7 77.2 50.4 37.4 109.5 61.3 83.2 67.2 49.4 OGFR 7-60 ENSG00000060491 "Opioid growth factor receptor" Q9NZT2 20 62804835-62814000 "Predicted intracellular proteins" "Growth regulation" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 12.5;neutrophil: 3.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017899 Supported Approved Nucleoplasm NA NA 20000 Nucleoplasm "HPA017899: AB_1854774" "unprognostic (1.33e-2)" "unprognostic (3.28e-2)" "unprognostic (2.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-1)" "unprognostic (1.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.39e-3)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.46e-3)" "unprognostic (1.60e-2)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "prognostic favorable (5.19e-4)" 33.1 25.9 21.2 27.0 23.5 34.8 31.9 16.5 45.8 36.9 17.6 35.4 28.8 31.0 5.4 27.5 34.9 11.6 27.6 24.7 19.4 38.7 80.0 55.0 26.8 21.6 18.5 22.6 41.8 33.7 13.2 37.1 13.5 20.8 42.7 8.6 17.4 31.1 14.3 29.8 32.6 43.2 10.6 15.8 68.8 34.6 21.2 19.8 15.3 39.6 10.0 15.3 35.4 34.4 23.9 51.5 34.2 19.8 26.5 16.4 16.5 56.1 30.9 25.3 91.3 41.0 77.3 36.9 58.6 57.2 21.5 56.8 58.8 20.2 32.8 25.9 19.3 37.5 29.4 42.9 71.1 28.7 36.9 69.6 23.4 23.6 24.9 10.4 30.9 20.4 37.9 29.0 30.6 13.5 76.4 78.9 69.8 13.3 24.5 65.1 62.1 34.5 27.5 14.2 25.5 19.8 30.2 42.5 59.5 49.6 17.9 29.7 56.5 34.8 61.1 54.1 48.1 45.6 38.8 11.5 30.9 47.9 39.6 24.5 1.8 1.5 12.5 0.7 1.4 0.4 1.0 0.9 0.8 1.0 1.5 0.9 0.5 3.1 0.6 1.4 0.7 0.6 0.4 21.2 23.5 16.5 45.8 24.7 19.4 21.6 18.5 22.6 20.8 15.8 19.8 23.9 25.2 9.6 15.0 19.6 52.8 27.0 35.7 20.2 35.3 59.5 18.6 16.8 5.9 40.0 12.6 16.5 93.8 27.8 47.0 35.5 11.7 35.7 1.9 19.9 24.4 25.1 18.0 26.1 29.1 32.9 52.1 25.3 28.5 20.2 0.0 24.5 28.9 49.2 57.5 43.7 23.5 30.4 12.2 79.5 37.6 3.5 32.6 51.7 16.0 11.2 70.3 35.7 74.2 19.1 10.2 31.4 39.7 18.8 44.2 36.5 60.4 27.4 19.4 42.3 19.7 18.2 22.1 5.7 8.9 19.2 23.3 27.9 44.7 20.5 24.2 32.3 GNA15 GNA16 ENSG00000060558 "G protein subunit alpha 15" P30679 19 3136033-3163749 "Plasma proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 76.2;esophagus: 109.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8" "Group enriched" "Detected in all" 4 "cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 67.1" "Group enriched" "Detected in many" 4 "dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043113 Approved NA NA "HPA043113: AB_10967343" "prognostic favorable (7.57e-5)" "unprognostic (6.06e-2)" "unprognostic (3.43e-1)" "prognostic favorable (2.01e-4)" "unprognostic (4.34e-2)" "unprognostic (2.09e-1)" "unprognostic (1.14e-2)" "unprognostic (5.38e-3)" "unprognostic (1.82e-1)" "unprognostic (3.22e-2)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (4.26e-6)" "unprognostic (1.04e-1)" "unprognostic (2.16e-3)" "unprognostic (2.36e-1)" "unprognostic (2.07e-1)" 5.7 3.2 3.6 12.5 3.7 76.2 4.7 3.8 6.6 7.3 5.5 2.4 1.7 1.3 0.4 109.7 2.4 4.7 1.9 4.6 5.7 2.0 1.4 13.2 4.2 5.2 4.0 3.2 0.8 1.2 0.4 1.4 7.7 4.5 11.7 1.8 0.1 19.6 2.5 0.6 47.7 2.5 3.1 4.8 8.8 4.4 1.4 5.7 32.3 1.2 0.9 12.2 28.3 42.0 5.3 44.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 18.7 0.1 0.1 0.0 0.1 36.2 0.0 65.4 0.0 0.1 0.0 19.1 0.1 0.0 0.0 27.2 152.1 0.0 40.0 0.2 26.2 0.0 0.0 16.6 0.1 0.3 0.0 0.0 162.4 59.8 0.1 2.9 0.0 119.3 0.0 0.2 0.0 23.6 0.2 0.0 4.6 0.2 0.2 0.0 0.0 62.1 0.1 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.3 29.8 0.1 19.4 29.1 14.3 0.0 21.8 1.1 0.0 2.0 0.3 28.8 0.0 0.0 0.0 6.9 4.4 15.5 67.1 8.7 13.3 3.6 3.7 3.8 6.6 4.6 5.7 5.2 4.0 3.2 4.5 4.8 5.7 5.3 1.0 9.6 8.8 0.0 2.2 67.2 141.5 65.5 9.1 0.2 7.4 3.7 0.5 0.0 39.0 3.7 0.0 0.5 27.6 0.5 0.0 0.7 0.5 1.4 0.5 3.1 6.6 21.0 1.3 0.0 0.8 2.5 3.6 3.9 34.3 0.0 0.7 0.0 66.5 0.0 0.4 2.2 57.0 36.2 190.6 0.8 0.0 78.3 21.4 7.5 32.0 0.0 0.0 0.0 0.2 13.2 0.3 0.0 3.6 69.3 0.0 0.1 21.7 0.1 19.7 0.3 3.3 4.0 2.0 38.0 95.8 0.4 19.6 0.1 1.4 173.8 CREB3L3 "CREB-H, CREBH" ENSG00000060566 "CAMP responsive element binding protein 3 like 3" Q68CJ9 19 4153631-4173054 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 71 "intestine: 259.3;liver: 418.9" "Group enriched" "Detected in some" 17 "Hepatocytes: 111.9;Proximal enterocytes: 426.0" "Cancer enriched" "Detected in many" 18 "liver cancer: 91.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;HDLM-2: 49.0;Hep G2: 15.6;HMC-1: 8.5;U-266/70: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040671, HPA056228" Enhanced NA NA 32000 "HPA040671: AB_2677072, HPA056228: AB_2683072" "unprognostic (1.86e-2)" "unprognostic (2.13e-1)" "unprognostic (2.81e-1)" "unprognostic (1.66e-2)" "unprognostic (8.41e-4)" "unprognostic (1.79e-4)" "unprognostic (1.88e-1)" "unprognostic (5.28e-4)" "unprognostic (3.01e-1)" "unprognostic (3.61e-2)" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.53e-6)" "unprognostic (3.18e-3)" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (3.35e-2)" 0.0 4.7 0.3 0.3 0.3 0.3 0.0 0.1 0.6 0.0 0.0 2.0 246.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 1.4 418.9 0.0 0.1 0.7 0.4 0.3 0.1 0.5 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 259.3 0.3 0.1 0.2 1.8 0.5 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 15.6 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 4.0 0.4 0.0 0.1 0.0 2.0 0.0 1.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 10.1 4.5 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.6 0.4 0.3 0.7 0.4 0.3 1.0 0.1 0.5 0.5 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 15.1 3.3 111.9 0.0 0.0 0.5 13.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 14.6 0.0 0.0 0.0 426.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 8.2 0.0 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787054-26800659 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 50.8;Late spermatids: 96.0;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favorable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.4 14.0 4.9 3.4 5.2 3.0 7.6 5.1 4.9 9.6 3.9 7.4 6.6 8.2 14.0 9.1 10.3 6.2 4.4 4.2 5.2 11.0 24.3 6.2 4.3 6.0 5.1 3.7 7.9 10.4 14.0 10.1 6.3 5.2 8.4 8.5 3.7 10.1 8.1 4.4 11.4 7.4 6.7 5.3 7.0 9.0 30.2 4.9 6.8 10.6 4.9 6.5 8.6 8.3 5.5 10.6 4.4 4.1 4.7 7.3 10.8 5.8 6.7 14.0 7.6 7.9 2.3 25.9 6.7 7.3 7.7 8.2 20.3 4.2 8.6 8.6 11.5 2.5 5.6 5.1 5.1 10.3 7.7 10.0 11.8 43.8 9.8 12.2 12.0 5.1 9.4 10.0 12.2 14.0 3.9 3.7 3.0 9.9 20.9 3.0 3.8 6.2 15.0 11.0 1.0 7.6 3.9 9.2 4.3 8.7 9.8 14.1 6.5 8.1 10.8 6.5 6.0 1.8 3.8 2.2 2.9 10.7 10.0 8.2 33.1 14.1 11.0 14.0 13.0 21.1 8.8 9.9 14.4 12.5 8.8 10.2 12.4 14.2 21.5 18.5 4.5 9.7 10.8 4.9 5.2 5.1 4.9 4.2 5.2 6.0 5.1 3.7 5.2 5.3 4.9 5.5 5.2 3.2 6.0 7.5 6.0 4.2 11.0 27.5 6.2 3.3 10.0 7.6 1.9 4.3 12.7 7.3 8.4 27.4 10.6 5.0 7.9 7.2 50.8 6.7 4.7 4.6 3.5 13.5 2.8 4.6 14.8 8.8 6.1 6.4 0.0 6.8 6.4 16.6 9.2 8.4 3.2 6.5 12.2 5.2 3.2 96.0 7.2 4.2 7.2 2.8 8.2 11.1 7.2 0.0 5.5 4.9 4.8 9.8 6.5 7.6 12.1 10.2 16.3 2.7 0.0 5.7 4.9 80.8 15.1 7.3 4.1 14.1 8.2 12.1 9.2 8.4 PTPRU "FMI, hPTP-J, PCP-2, PTP, PTPRO" ENSG00000060656 "Protein tyrosine phosphatase receptor type U" Q92729 1 29236516-29326813 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 22.1;Respiratory ciliated cells: 24.3;Rod photoreceptor cells: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 95.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011476, HPA039832" Approved NA NA "CAB011476: AB_442989, HPA039832: AB_10793923" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-3)" "unprognostic (6.13e-2)" "prognostic unfavorable (7.92e-4)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.17e-1)" "unprognostic (1.83e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-3)" "unprognostic (3.39e-3)" "unprognostic (6.83e-2)" "unprognostic (1.19e-2)" "unprognostic (6.82e-2)" "unprognostic (4.92e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-1)" 6.2 2.1 9.1 1.1 15.6 0.1 7.0 5.6 15.8 29.4 5.8 4.2 0.7 12.0 3.3 4.3 11.6 4.9 8.4 14.4 7.2 4.5 9.2 10.0 0.7 25.8 17.8 9.0 13.1 11.2 9.3 10.2 11.5 28.5 14.1 1.4 18.9 14.7 13.1 17.7 9.0 2.4 1.9 5.9 2.1 5.9 4.1 8.8 1.0 5.2 10.0 1.3 12.4 12.3 19.7 8.1 10.8 0.6 1.6 28.7 1.0 95.7 8.4 7.4 0.3 0.5 9.4 34.7 1.4 16.2 1.6 1.0 42.3 38.5 27.1 0.1 0.5 19.7 1.7 12.1 39.8 12.1 0.0 1.7 13.3 14.4 0.0 2.5 11.3 0.2 4.7 0.3 1.3 7.6 13.2 0.5 0.2 15.8 15.9 4.9 0.0 11.3 0.5 11.7 39.4 32.3 42.0 8.5 26.3 5.8 6.6 15.6 1.8 7.1 1.4 9.3 2.6 1.2 0.8 1.1 0.1 18.8 1.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 15.6 5.6 15.8 14.4 7.2 25.8 17.8 9.0 28.5 5.9 8.8 19.7 1.0 9.6 13.6 0.7 0.1 1.5 6.7 22.1 1.8 5.3 4.8 5.6 5.2 5.7 20.2 5.5 12.5 18.7 0.5 0.3 0.0 6.2 1.3 8.6 9.4 1.3 0.0 0.0 12.1 2.7 10.5 4.6 0.0 10.1 1.3 0.7 1.8 5.3 2.6 0.0 8.0 0.2 6.1 0.6 1.1 1.2 4.7 0.4 8.8 3.7 0.0 16.7 0.0 8.5 4.4 7.3 0.0 7.2 1.2 6.5 0.0 0.3 24.3 42.6 6.6 5.5 4.1 2.1 6.4 0.2 0.6 9.0 0.6 0.0 0.2 10.0 SNRNP40 "HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57" ENSG00000060688 "Small nuclear ribonucleoprotein U5 subunit 40" Q96DI7 1 31259568-31296788 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026527, HPA027345" Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026527: AB_1858814, HPA027345: AB_2239703" "unprognostic (2.31e-3)" "unprognostic (5.63e-2)" "unprognostic (5.24e-3)" "unprognostic (1.36e-1)" "unprognostic (1.14e-3)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.73e-6)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" "unprognostic (2.50e-1)" "unprognostic (1.22e-1)" "unprognostic (8.57e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-2)" "unprognostic (5.93e-2)" "unprognostic (4.31e-2)" "unprognostic (6.24e-2)" 17.8 19.1 9.8 21.4 13.1 30.2 20.9 14.3 12.7 17.8 9.8 20.8 16.5 20.3 21.9 19.3 22.7 13.2 14.2 9.5 12.1 17.7 19.4 16.0 35.7 13.7 13.1 8.6 21.0 13.1 18.1 16.0 22.5 14.8 20.2 22.4 19.3 15.1 21.0 21.0 18.5 17.8 21.9 13.1 21.5 16.8 21.3 11.8 40.6 18.2 18.2 40.5 24.3 16.9 19.3 71.6 53.6 95.5 78.6 46.7 38.4 66.2 58.8 57.4 104.7 101.9 76.7 69.8 91.8 56.4 46.1 53.9 66.4 145.7 69.8 105.9 99.2 109.3 135.2 72.1 83.9 58.4 150.0 59.3 36.2 54.7 102.1 75.6 34.4 86.1 80.2 129.0 52.9 60.5 51.6 111.3 87.9 171.6 71.1 76.5 87.3 134.5 71.1 44.2 57.7 65.1 63.6 92.3 47.4 116.2 88.0 47.2 94.9 59.5 57.9 85.2 81.5 112.9 43.5 57.1 126.1 47.1 139.3 96.4 102.8 75.8 82.3 98.6 97.3 113.1 93.8 95.1 98.2 93.0 82.6 101.1 115.1 16.4 110.5 92.0 78.4 110.2 161.1 9.8 13.1 14.3 12.7 9.5 12.1 13.7 13.1 8.6 14.8 13.1 11.8 19.3 44.1 3.2 6.1 14.7 51.5 53.0 50.2 90.8 41.5 15.6 24.4 30.6 16.5 21.5 32.5 16.5 18.8 108.7 35.7 11.9 43.0 42.5 7.1 21.0 27.5 39.4 34.8 80.8 23.7 35.9 91.3 38.1 28.5 13.9 34.3 36.2 28.9 22.3 56.2 10.1 24.3 18.6 69.2 20.7 48.6 5.4 26.8 31.5 42.7 15.0 44.7 23.8 44.3 23.6 49.0 36.4 20.2 34.3 40.6 55.0 17.0 45.0 27.6 22.2 32.9 31.0 35.1 105.5 89.7 39.6 54.8 61.3 52.4 45.9 36.9 40.6 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;parathyroid gland: 24.8;pituitary gland: 32.4" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 28.9;SH-SY5Y: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.6 14.7 5.5 0.9 13.0 0.2 0.3 0.0 20.0 7.3 15.0 1.5 2.9 2.8 2.5 0.5 7.9 0.9 0.0 28.0 13.9 3.2 0.2 0.4 0.1 2.1 12.8 15.2 2.1 2.5 24.8 32.4 0.0 14.2 1.1 1.8 11.2 0.3 1.3 0.2 2.7 2.6 2.4 0.0 1.1 5.9 2.6 1.8 0.3 0.6 3.9 0.1 0.3 0.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.0 0.4 7.3 0.0 0.0 28.9 55.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 13.0 0.0 20.0 28.0 13.9 2.1 12.8 15.2 14.2 0.0 1.8 8.6 0.4 0.0 0.0 5.9 0.0 2.0 0.1 0.0 0.6 19.4 0.0 0.1 1.4 0.0 0.0 0.0 31.3 0.0 0.0 0.4 0.0 0.0 3.8 3.0 1.4 0.4 75.5 0.0 128.2 0.0 0.0 0.7 4.1 6.4 0.0 0.0 0.0 0.0 0.0 10.1 191.4 2.6 6.1 0.0 0.5 2.1 0.9 0.0 0.0 1.0 0.0 3.2 0.0 19.6 5.3 0.1 0.1 0.7 0.0 0.1 0.0 0.1 0.7 14.0 0.0 0.0 0.2 1.7 1.5 0.1 0.6 0.0 0.1 0.0 0.8 0.0 COL11A1 "CO11A1, COLL6, DFNA37, STL2" ENSG00000060718 "Collagen type XI alpha 1 chain" P12107 1 102876467-103108872 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 20.3;retina: 9.7" "Cell type enhanced" "Detected in some" "Astrocytes: 83.9;Excitatory neurons: 99.5;Oligodendrocyte precursor cells: 557.4;Theca cells: 139.6" "Cancer enhanced" "Detected in many" "breast cancer: 27.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 116.9;BJ: 43.2;BJ hTERT+ SV40 Large T+ RasG12V: 85.3;HBF TERT88: 48.7;HSkMC: 142.5;SuSa: 60.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058335 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" No No 640000 "Endoplasmic reticulum" "HPA058335: AB_2683682" "unprognostic (2.60e-3)" "unprognostic (6.61e-4)" "unprognostic (9.58e-2)" "unprognostic (5.06e-5)" "unprognostic (2.83e-1)" "unprognostic (2.85e-2)" "unprognostic (6.03e-3)" "unprognostic (2.23e-3)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (1.94e-2)" "unprognostic (3.01e-12)" "unprognostic (1.27e-2)" "unprognostic (3.53e-1)" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" 0.3 0.6 4.8 0.3 3.4 0.0 0.4 1.8 4.5 0.9 4.2 0.3 0.1 0.5 0.1 0.0 0.0 3.1 0.0 2.7 2.1 0.1 0.0 0.3 0.1 2.9 3.4 2.6 0.6 0.7 0.2 3.3 20.3 2.9 0.2 0.3 9.7 1.5 0.8 0.1 1.0 0.1 0.3 1.5 0.5 0.1 1.4 2.8 0.0 0.1 0.1 0.0 0.2 0.1 2.3 0.0 0.8 116.9 0.0 4.6 5.9 0.0 43.2 16.1 23.3 85.3 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 142.5 0.0 1.1 0.0 17.7 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 8.1 0.0 0.1 0.0 7.4 0.0 15.2 0.0 0.1 0.0 0.0 0.1 0.0 60.5 0.0 0.1 0.0 0.6 27.0 0.0 4.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 3.4 1.8 4.5 2.7 2.1 2.9 3.4 2.6 2.9 1.5 2.8 2.3 0.0 0.0 2.2 83.9 0.0 1.8 0.0 0.0 0.0 9.4 0.1 4.2 0.5 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 21.0 0.1 0.9 2.2 0.0 0.0 99.5 0.0 0.8 18.7 0.0 0.0 2.5 8.3 0.0 0.0 0.3 0.0 32.9 0.0 0.0 0.0 1.3 4.0 1.2 0.2 10.6 29.0 0.0 29.8 0.0 557.4 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 2.6 0.5 0.8 0.0 1.1 0.3 0.2 139.6 0.0 0.0 QSER1 FLJ21924 ENSG00000060749 "Glutamine and serine rich 1" Q2KHR3 11 32892811-32993316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005682 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005682: AB_1855985" "unprognostic (2.94e-1)" "unprognostic (6.55e-2)" "unprognostic (1.36e-1)" "unprognostic (2.76e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (7.94e-5)" "unprognostic (1.14e-1)" "unprognostic (4.75e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (6.77e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (8.12e-2)" "unprognostic (7.96e-2)" 5.4 4.5 5.4 5.5 6.4 4.1 8.9 15.4 5.3 7.6 8.9 5.1 3.5 8.4 6.8 7.7 6.2 5.9 5.9 5.3 6.1 5.6 5.9 4.5 5.5 6.0 6.3 3.5 12.8 7.0 6.6 3.9 5.7 7.1 4.6 5.5 7.1 10.1 5.2 4.7 11.9 4.2 6.5 5.9 6.2 5.5 9.1 6.0 8.7 8.9 7.0 6.5 6.3 6.2 7.4 23.4 28.7 32.4 30.5 12.2 23.2 15.7 20.0 17.9 14.0 17.3 24.5 10.8 24.2 12.5 23.9 23.5 29.4 30.9 17.6 30.3 10.7 19.5 22.9 26.7 21.0 9.8 27.7 11.9 11.6 18.9 17.7 29.5 16.8 19.9 14.2 35.2 10.6 22.2 20.5 14.3 10.8 34.1 14.4 17.9 22.5 64.6 10.1 14.5 24.6 16.7 23.9 37.8 19.4 12.3 23.7 20.2 14.3 20.3 34.0 34.2 62.9 44.0 6.8 10.3 22.5 21.9 12.7 22.6 0.0 0.2 0.0 0.2 0.4 0.1 0.5 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.4 0.0 0.1 5.4 6.4 15.4 5.3 5.3 6.1 6.0 6.3 3.5 7.1 5.9 6.0 7.4 22.0 19.2 13.4 35.6 10.6 27.9 12.0 14.2 35.9 17.7 21.6 18.7 31.0 14.3 15.9 7.3 14.6 12.9 7.7 5.9 3.9 10.6 14.0 9.9 37.0 19.5 0.0 17.7 51.6 12.1 12.2 27.2 15.8 17.1 3.8 39.3 15.7 10.5 14.5 10.1 50.6 11.7 14.2 16.0 16.1 11.0 24.5 19.1 16.0 54.4 15.9 12.9 5.2 50.3 48.6 10.7 9.3 21.1 23.1 15.0 5.3 8.9 12.2 15.0 6.6 37.9 17.8 21.3 20.5 43.1 27.6 4.2 8.4 21.5 13.6 14.3 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 746.8;tongue: 564.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA045119: AB_10960421, HPA055790: AB_2682923" "unprognostic (3.30e-2)" "prognostic favorable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favorable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favorable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 62.2 40.0 119.3 33.7 132.0 57.5 53.3 143.2 154.3 52.8 119.3 98.6 85.5 36.0 45.2 72.1 35.0 42.1 746.8 114.9 137.9 262.3 414.6 45.0 44.6 136.5 137.5 111.7 43.8 66.6 143.0 38.3 23.9 131.4 43.9 90.7 57.8 88.5 42.7 322.4 41.3 64.3 38.9 132.7 35.3 97.0 22.4 134.0 49.1 83.6 564.2 44.5 47.9 35.2 146.4 25.6 7.5 31.3 107.7 88.4 49.8 45.2 29.1 47.1 45.1 43.9 38.8 17.9 53.6 50.9 45.4 36.1 24.5 47.0 36.7 31.9 36.1 79.0 27.5 35.4 132.6 36.6 104.9 34.1 40.0 51.0 36.8 26.7 13.7 36.9 80.8 94.2 84.1 28.6 40.5 73.1 193.7 16.1 148.0 35.5 39.1 51.7 134.9 85.4 20.5 96.7 85.7 33.6 145.8 34.0 25.9 34.5 154.3 25.3 25.7 26.8 91.6 30.0 55.8 42.2 46.3 23.5 127.0 42.1 60.7 60.0 90.1 41.7 98.3 39.4 33.1 48.5 45.1 72.2 25.4 44.7 43.3 54.6 40.5 128.5 43.0 69.1 49.8 119.3 132.0 143.2 154.3 114.9 137.9 136.5 137.5 111.7 131.4 132.7 134.0 146.4 56.1 118.6 48.0 64.6 51.7 45.6 44.2 83.6 29.0 61.1 74.2 79.1 950.0 187.3 67.6 106.7 10.4 22.0 54.2 219.1 1721.8 89.3 66.8 73.7 50.7 51.7 37.2 72.6 49.0 140.3 78.3 74.1 63.7 93.2 71.0 28.0 47.5 391.0 121.4 48.8 74.7 122.1 166.8 89.6 81.7 10.2 66.5 80.3 129.9 20.6 104.7 199.9 58.7 32.2 108.0 65.2 125.0 89.9 114.5 32.0 162.0 573.6 46.3 66.7 92.1 76.9 80.4 163.2 79.6 67.3 55.8 24.4 58.4 39.9 146.7 53.6 ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 214.6;liver: 664.6" "Cell type enhanced" "Detected in all" "Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 224.0;SK-BR-3: 342.9" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4700000 Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 43.2 54.6 43.0 24.2 47.7 45.1 41.6 50.0 49.9 26.5 37.5 57.5 101.9 21.0 45.0 57.2 19.5 30.1 74.7 40.1 47.8 214.6 664.6 35.2 26.3 51.3 45.8 38.1 21.0 59.8 48.3 25.0 17.4 47.8 55.6 51.7 4.9 39.3 25.5 48.6 29.8 90.3 18.9 47.0 41.7 42.4 15.6 47.1 28.3 32.4 54.2 30.3 44.1 33.8 52.3 35.5 39.8 13.0 40.7 55.6 32.2 44.6 32.2 47.0 36.3 34.5 52.8 38.8 21.1 22.6 52.0 17.4 24.5 34.9 54.0 20.0 31.0 37.2 27.0 35.4 155.5 35.3 63.3 59.8 59.0 39.3 31.2 22.5 23.9 49.9 49.7 26.2 24.2 41.3 49.2 60.3 45.3 13.3 224.0 47.0 13.9 25.0 34.3 103.4 110.4 10.9 16.5 31.7 342.9 23.7 18.0 35.1 48.9 36.8 21.9 21.1 43.2 44.2 31.9 21.7 16.1 34.8 54.4 34.7 79.9 114.4 130.4 48.8 159.1 41.2 33.9 45.7 47.4 178.1 36.0 45.2 42.5 76.3 71.9 187.7 104.5 77.2 82.1 43.0 47.7 50.0 49.9 40.1 47.8 51.3 45.8 38.1 47.8 47.0 47.1 52.3 30.7 41.7 38.7 50.6 45.6 33.3 56.5 57.6 40.9 36.9 48.7 37.1 3.2 98.7 44.3 66.2 14.6 91.6 61.7 356.8 166.3 98.0 4.5 40.7 38.6 25.4 55.1 40.4 25.6 78.4 64.5 34.4 76.5 39.1 19.0 32.5 37.1 686.0 81.7 8.4 24.7 73.1 48.8 93.5 86.8 9.6 35.8 83.2 58.7 14.0 89.5 43.1 53.5 12.5 30.9 100.9 270.6 33.1 44.5 60.6 441.1 721.8 26.3 16.7 32.9 28.5 27.4 19.8 11.7 48.1 35.5 99.3 44.4 186.7 84.3 87.0 BCAT1 BCT1 ENSG00000060982 "Branched chain amino acid transaminase 1" P54687 12 24810024-24949101 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 58.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3" "Group enriched" "Detected in all" 4 "endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 17.1" "Group enriched" "Detected in many" 10 "dendritic cells: 5.8;monocytes: 17.1" "Cell line enhanced" "Detected in many" "HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048592 Uncertain NA NA 97000 "HPA048592: AB_2680454" "unprognostic (1.90e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (3.05e-5)" "unprognostic (9.49e-3)" "unprognostic (4.22e-2)" "unprognostic (4.77e-3)" "unprognostic (1.97e-3)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.38e-4)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.44e-2)" "unprognostic (7.55e-2)" "prognostic unfavorable (8.54e-4)" 6.7 5.9 5.2 7.1 7.1 2.4 2.1 9.8 9.7 3.7 1.0 2.8 0.8 8.7 1.0 2.0 7.3 4.5 1.5 2.5 15.1 1.2 1.3 9.7 6.4 17.0 18.2 2.3 7.3 58.7 0.4 6.6 15.3 19.4 0.9 2.6 14.6 1.7 0.8 0.7 0.6 3.6 5.8 6.6 2.0 1.8 7.1 13.6 5.3 1.2 2.0 5.3 4.2 1.3 23.1 30.3 12.1 106.8 0.2 30.5 59.0 54.9 60.9 40.6 33.4 55.2 67.1 83.1 114.0 0.3 100.7 6.5 12.0 77.2 0.5 88.2 261.3 15.4 91.1 2.0 37.3 112.3 105.9 31.6 77.4 2.0 85.1 17.8 73.0 114.3 56.9 88.5 1.1 28.7 0.6 65.2 30.1 287.4 0.0 8.1 0.1 310.3 1.4 0.1 10.4 0.1 60.1 0.1 0.2 0.5 114.8 0.2 45.2 150.8 19.7 72.9 80.4 58.1 13.2 13.9 152.7 69.9 62.4 0.3 0.0 2.3 0.0 0.0 3.6 0.1 1.1 0.0 0.1 5.8 0.0 0.0 0.0 1.0 0.1 17.1 3.4 0.2 1.0 5.2 7.1 9.8 9.7 2.5 15.1 17.0 18.2 2.3 19.4 6.6 13.6 23.1 1.7 16.0 26.0 1.6 1.3 8.7 0.1 2.5 0.0 203.2 0.3 0.3 1.6 1.5 2.2 0.0 2.1 61.2 4.3 0.0 1.9 1.8 161.4 41.5 92.6 16.8 0.0 20.8 39.6 139.9 23.2 27.6 0.0 89.1 11.4 117.4 7.9 0.3 72.3 42.1 81.8 0.0 14.2 87.1 265.8 370.3 7.2 59.9 7.2 38.4 22.3 7.1 0.0 84.4 57.4 49.6 0.0 4.1 0.7 0.2 0.0 0.1 3.3 12.2 6.6 14.9 17.4 1.9 1.6 0.5 7.2 22.4 2.8 41.3 0.1 0.1 HDAC7 "DKFZP586J0917, HDAC7A" ENSG00000061273 "Histone deacetylase 7" Q8WUI4 12 47782722-47833132 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "neutrophil: 6.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004775 Supported Cytosol NA NA Cytosol "HPA004775: AB_1850548" "unprognostic (3.83e-1)" "unprognostic (9.49e-3)" "unprognostic (1.37e-2)" "unprognostic (4.46e-2)" "unprognostic (6.56e-3)" "unprognostic (2.22e-2)" "unprognostic (2.50e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.28e-1)" "unprognostic (2.07e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (6.24e-2)" "unprognostic (4.38e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.65e-4)" 49.6 42.2 8.9 28.8 5.1 23.8 45.6 2.6 9.8 45.0 20.8 35.7 8.9 51.8 13.7 23.7 50.8 17.0 31.3 3.2 11.9 29.5 6.0 55.5 27.5 16.3 5.8 0.9 45.2 14.6 20.2 20.8 19.6 9.0 34.7 4.9 2.8 30.8 17.2 16.3 38.1 28.8 17.1 2.8 38.7 27.4 8.0 8.5 80.7 39.5 9.5 15.3 44.6 38.9 16.4 41.6 28.1 28.6 46.9 21.9 60.2 25.3 39.4 30.7 28.3 18.8 37.4 38.4 80.5 126.8 37.1 13.9 37.8 6.7 31.4 10.5 38.8 13.6 27.6 29.9 8.6 23.6 9.1 1.2 39.4 10.8 28.6 15.4 51.6 58.6 45.9 29.9 33.4 18.6 18.0 83.2 21.8 39.4 9.1 29.1 64.2 14.7 29.6 12.1 26.9 8.1 18.8 30.6 14.1 14.4 18.4 13.4 12.0 66.6 56.9 61.0 47.6 28.9 70.8 58.8 67.4 23.8 41.9 19.1 0.0 1.4 0.0 0.8 0.5 0.9 0.8 0.7 0.7 0.4 0.5 0.8 0.6 6.5 0.9 0.5 0.3 0.3 1.5 8.9 5.1 2.6 9.8 3.2 11.9 16.3 5.8 0.9 9.0 2.8 8.5 16.4 80.6 41.7 32.1 34.9 32.7 13.8 26.8 28.7 8.6 20.3 22.5 17.4 13.4 28.6 28.6 36.8 0.0 4.8 18.6 5.3 1.9 31.6 15.5 26.2 39.4 79.3 7.3 40.4 19.9 23.0 3.5 37.8 25.5 58.4 8.8 20.2 101.7 2.0 15.6 28.6 17.5 9.6 24.4 32.7 14.1 6.9 55.0 13.3 14.2 46.9 20.5 11.7 28.8 10.6 13.6 66.8 7.3 33.1 42.9 69.1 0.6 3.8 31.8 4.0 26.3 18.3 26.9 1.1 3.7 10.3 21.6 2.9 28.2 9.3 8.1 46.8 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 15.2;parathyroid gland: 54.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 3.4 1.8 12.8 1.5 11.7 0.1 3.1 0.0 15.2 1.7 0.1 1.1 0.5 2.9 0.9 5.3 1.6 3.5 3.6 14.8 5.4 2.9 0.7 7.1 1.1 3.1 1.0 13.7 1.2 1.5 54.6 2.2 6.6 7.1 2.9 0.4 3.6 1.4 1.2 1.9 4.6 1.0 2.5 0.0 0.5 1.4 7.6 2.2 2.0 2.7 2.0 0.5 2.4 1.7 9.5 0.1 0.0 9.7 8.3 0.0 0.0 1.2 5.0 0.1 4.3 3.7 0.3 0.1 11.1 3.5 3.1 1.6 0.2 0.5 0.2 2.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 1.7 0.9 0.1 1.8 0.0 0.6 0.0 11.7 0.0 0.1 14.4 0.0 19.7 0.1 12.2 0.0 0.0 0.0 15.6 0.0 2.7 0.4 14.8 12.9 0.0 0.0 75.0 8.2 0.1 0.4 0.0 5.1 3.5 0.1 1.5 0.1 0.1 23.2 0.1 1.1 50.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 11.7 0.0 15.2 14.8 5.4 3.1 1.0 13.7 7.1 0.0 2.2 9.5 3.9 0.0 0.0 1.6 0.0 1.3 0.8 1.0 17.6 1.8 0.3 11.3 4.6 0.0 0.1 0.0 4.2 7.1 0.4 0.0 1.9 0.0 0.5 0.6 1.3 3.2 0.0 0.0 26.2 0.0 2.3 2.4 0.0 0.5 0.0 3.5 0.0 0.0 0.9 20.2 2.9 0.0 2.0 0.0 0.0 0.8 1.2 0.2 19.6 1.9 0.0 0.9 0.0 6.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 18.5 65.7 1.1 15.4 0.2 1.1 7.3 0.1 0.8 1.4 2.5 0.0 0.0 PRDM6 "KMT8C, PRISM" ENSG00000061455 "PR/SET domain 6" Q9NQX0 5 123089241-123194266 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "urinary bladder: 9.1" "Cell type enhanced" "Detected in some" "Astrocytes: 15.0;Endometrial stromal cells: 6.5;Excitatory neurons: 7.9;Fibroblasts: 10.7;Late spermatids: 7.1;Oligodendrocytes: 11.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.6;HEK 293: 5.2;HEL: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 2.3" HPA030324 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030324: AB_10670032" "unprognostic (2.33e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (3.12e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" "unprognostic (1.54e-2)" "unprognostic (4.66e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-7)" "unprognostic (9.30e-4)" "unprognostic (1.10e-1)" "unprognostic (3.43e-4)" "unprognostic (1.27e-1)" 0.7 0.1 0.2 0.3 0.2 0.0 0.6 0.2 0.4 0.7 0.8 3.3 0.2 0.7 0.1 0.6 0.4 3.4 0.4 0.1 0.2 0.3 0.1 2.9 0.0 0.4 0.4 0.1 1.9 0.3 0.1 0.3 4.2 0.4 1.4 1.0 0.2 0.1 0.1 0.1 0.2 0.6 0.7 0.3 0.0 0.6 0.3 0.2 0.0 0.8 0.2 0.2 9.1 0.6 0.4 0.0 0.0 0.0 0.3 0.3 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.1 5.2 1.1 0.5 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.1 0.2 0.4 0.4 0.1 0.4 0.3 0.2 0.4 0.5 0.0 0.0 15.0 0.0 1.9 0.1 0.0 0.0 1.0 0.6 0.3 1.4 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.1 3.3 0.6 6.5 0.5 0.0 0.0 7.9 0.2 0.3 10.7 0.0 0.5 0.0 2.4 0.0 0.5 0.8 0.0 6.4 0.1 0.0 0.8 3.5 7.1 2.1 0.4 3.6 4.7 0.8 0.2 0.0 3.0 11.0 0.1 0.0 1.2 0.1 0.2 0.0 0.8 0.2 1.0 0.0 0.7 2.2 2.3 4.4 0.2 1.3 0.4 0.4 6.1 0.0 0.1 WNT8A WNT8D ENSG00000061492 "Wnt family member 8A" Q9H1J5 5 138083990-138092365 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.8;Inhibitory neurons: 1.5;Microglial cells: 1.0" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA038539 Uncertain "Secreted to extracellular matrix" NA NA "HPA038539: AB_10669646" "unprognostic (1.11e-5)" "unprognostic (4.11e-2)" "unprognostic (4.11e-2)" "unprognostic (5.32e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.7 0.4 0.0 0.7 0.0 0.1 0.5 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG4 "CT127, SUN4" ENSG00000061656 "Sperm associated antigen 4" Q9NPE6 20 35615829-35621094 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "pancreas: 90.9;testis: 32.3" "Group enriched" "Detected in many" 4 "Early spermatids: 177.9;Late spermatids: 139.8;Plasma cells: 138.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 26.0;hTERT-RPE1: 18.4;U-87 MG: 47.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048393, HPA061789" Approved NA NA "HPA048393: AB_2680385, HPA061789: AB_2684609" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.09e-5)" "prognostic favorable (9.52e-8)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.05e-1)" "unprognostic (2.56e-3)" "unprognostic (1.21e-2)" "unprognostic (2.29e-1)" "unprognostic (4.77e-2)" "unprognostic (4.49e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.59e-2)" "unprognostic (1.66e-1)" "unprognostic (1.79e-1)" "prognostic favorable (6.66e-4)" 2.0 5.3 2.5 3.1 2.6 5.0 2.3 1.8 4.0 3.5 2.2 4.9 6.5 2.2 5.6 2.1 4.6 4.2 3.2 2.1 2.6 5.1 4.9 3.2 3.2 3.8 2.3 1.5 8.5 90.9 3.1 8.3 1.4 3.4 3.7 2.6 5.4 7.2 2.2 0.6 0.6 5.9 1.4 1.7 12.4 7.4 32.3 2.5 0.9 2.2 0.1 5.5 7.0 2.5 3.0 3.8 1.6 0.8 2.0 2.0 0.7 10.5 1.4 1.9 1.5 2.2 3.4 8.3 0.3 26.0 2.1 6.0 1.0 0.5 5.2 1.6 4.1 0.5 2.9 3.2 3.7 10.2 2.2 4.7 4.9 1.1 1.6 1.2 18.4 3.1 0.9 0.8 7.0 3.9 8.0 0.8 5.4 0.1 7.2 6.9 0.6 0.7 11.4 2.7 1.6 0.6 3.9 1.8 1.2 3.0 0.3 5.2 0.9 3.3 7.2 1.1 1.6 1.5 13.8 5.7 3.2 47.4 0.8 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.4 0.0 2.5 2.6 1.8 4.0 2.1 2.6 3.8 2.3 1.5 3.4 1.7 2.5 3.0 3.2 0.0 0.5 0.3 26.6 0.4 1.0 6.3 1.2 3.2 1.7 1.5 2.3 0.0 7.6 0.0 2.1 2.0 7.6 0.6 0.0 13.2 177.9 7.5 2.3 3.4 4.2 0.4 1.9 7.6 15.9 3.3 5.1 6.0 4.5 0.9 5.7 6.7 1.5 1.7 1.2 1.7 24.4 1.4 2.1 139.8 1.8 2.0 26.6 1.9 2.1 14.7 0.0 0.0 0.3 15.5 1.4 3.0 138.0 1.6 0.3 6.0 19.3 2.5 0.0 1.0 3.6 35.0 4.9 0.4 0.1 20.2 7.2 2.3 0.8 3.9 NCKAP1 "HEM2, Nap1, NAP125" ENSG00000061676 "NCK associated protein 1" Q9Y2A7 2 182909115-183038858 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020449 Enhanced Approved Cytosol NA NA 60000 Cytosol "HPA020449: AB_1854327" "unprognostic (7.92e-3)" "unprognostic (1.24e-2)" "unprognostic (3.35e-2)" "unprognostic (8.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.24e-1)" "unprognostic (2.12e-3)" "prognostic unfavorable (9.71e-4)" "unprognostic (5.06e-2)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-2)" "unprognostic (2.41e-1)" "unprognostic (1.36e-1)" "unprognostic (3.61e-2)" 51.9 44.7 48.6 25.9 62.4 1.0 49.2 50.8 62.2 55.5 47.4 50.7 56.4 53.3 53.3 82.1 42.5 42.7 72.5 74.3 55.9 71.3 41.5 40.6 10.4 42.2 51.6 56.3 45.4 43.4 89.1 34.3 50.5 46.0 55.9 49.0 58.9 43.6 66.0 90.3 51.5 51.7 74.8 41.3 20.7 58.2 32.4 49.4 15.3 86.1 88.1 24.8 61.4 49.6 51.1 107.1 66.0 99.1 63.6 136.8 132.3 110.2 136.5 123.4 90.6 113.3 102.9 89.2 0.6 89.2 163.1 136.1 99.0 84.6 128.6 150.2 25.7 66.1 23.7 69.4 85.4 140.5 0.2 19.9 99.5 155.4 131.4 213.8 123.7 146.3 6.4 58.7 0.4 173.3 68.5 2.3 0.4 102.1 85.8 112.7 6.9 108.2 0.4 127.9 141.9 72.7 69.3 123.6 97.0 130.0 156.2 52.0 0.7 160.0 153.2 86.1 87.1 84.7 13.4 26.5 0.5 118.6 0.1 79.5 0.4 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 48.6 62.4 50.8 62.2 74.3 55.9 42.2 51.6 56.3 46.0 41.3 49.4 51.1 75.3 48.1 47.1 129.9 2.1 87.2 64.7 50.1 38.1 83.9 54.2 39.9 103.9 48.6 57.0 80.9 70.9 33.1 3.7 52.4 27.4 54.3 4.5 56.4 57.9 82.8 50.4 0.8 174.2 62.0 50.2 62.3 49.5 106.6 14.0 43.8 72.8 42.4 5.3 122.8 143.9 58.8 50.8 5.5 23.1 9.0 78.6 4.6 55.2 72.1 0.7 90.7 6.2 136.7 98.8 95.7 69.8 105.3 1.4 116.8 64.3 66.4 40.2 59.9 59.2 86.1 84.1 42.4 28.7 83.6 112.5 52.1 5.5 55.6 55.5 117.3 MRPS35 "MDS023, MRPS28" ENSG00000061794 "Mitochondrial ribosomal protein S35" P82673 12 27710822-27756295 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 242.6;Proximal tubular cells: 231.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038513 Supported Approved Mitochondria,Cytosol No No Mitochondria Cytosol "HPA038513: AB_10794084" "prognostic unfavorable (9.41e-4)" "unprognostic (8.35e-2)" "prognostic favorable (5.01e-4)" "unprognostic (2.59e-2)" "unprognostic (5.31e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (7.32e-2)" "unprognostic (2.12e-3)" "unprognostic (2.05e-1)" "unprognostic (3.24e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.51e-5)" "unprognostic (4.63e-2)" "unprognostic (2.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" 27.5 42.5 26.8 27.0 27.7 31.5 43.2 28.3 33.6 24.0 28.9 59.7 53.1 26.1 29.7 36.1 29.7 24.3 62.7 27.0 28.4 79.3 78.3 21.8 32.2 27.7 27.7 26.1 26.4 28.0 47.3 14.1 29.3 27.9 31.8 61.7 18.5 29.8 24.3 84.1 23.7 46.7 30.1 27.8 21.2 44.3 18.2 28.0 28.6 44.6 73.2 32.4 35.6 20.5 29.4 95.0 102.1 42.4 65.1 58.9 71.8 156.0 61.4 52.6 84.4 76.2 125.0 132.4 88.2 87.5 63.3 65.5 70.0 88.0 77.9 99.1 74.2 82.8 100.2 39.2 103.7 58.5 138.1 51.1 61.4 95.1 71.1 143.2 77.3 69.6 73.0 110.1 58.6 77.9 57.9 96.7 227.0 158.9 231.8 147.7 101.1 109.8 145.3 130.8 77.3 24.0 48.5 84.4 131.0 106.1 93.9 133.6 108.2 54.5 51.4 54.9 117.8 111.4 22.8 36.9 186.8 68.6 104.5 68.5 11.0 21.5 7.8 15.1 38.3 24.1 20.7 18.9 18.7 30.5 19.7 22.3 20.4 1.2 25.9 46.4 14.4 26.4 23.8 26.8 27.7 28.3 33.6 27.0 28.4 27.7 27.7 26.1 27.9 27.8 28.0 29.4 25.0 73.7 40.3 13.4 38.2 47.3 42.3 65.0 46.1 20.8 49.8 43.8 94.8 50.1 55.4 51.5 4.2 104.0 21.2 51.8 242.6 92.0 12.6 42.0 42.4 30.1 60.3 26.3 28.0 59.2 113.4 35.9 72.4 40.0 54.5 34.5 18.9 67.1 73.1 18.5 28.0 81.2 40.7 38.4 28.8 9.1 25.4 42.9 42.7 8.4 64.7 27.1 34.0 19.6 25.4 62.2 52.3 24.5 32.1 55.4 63.6 231.4 70.2 18.0 26.3 35.8 39.8 23.9 27.2 68.7 52.1 61.7 34.8 83.8 116.5 46.1 GUCY1B1 "GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3" ENSG00000061918 "Guanylate cyclase 1 soluble subunit beta 1" Q02153 4 155758992-155807811 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "intermediate monocyte: 7.2;non-classical monocyte: 23.9" "Lineage enriched" "Detected in many" 13 "monocytes: 23.9" "Cell line enhanced" "Detected in many" "HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010890, HPA020870" Approved Approved Cytosol NA NA Cytosol "CAB010890: AB_259911, HPA020870: AB_1850444" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (9.10e-3)" "unprognostic (4.69e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (6.69e-3)" "unprognostic (3.03e-3)" "unprognostic (1.47e-1)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (7.35e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.14e-1)" "unprognostic (6.36e-3)" 13.4 7.2 17.8 15.7 32.5 2.2 10.1 6.9 38.0 12.1 1.5 21.9 5.8 16.6 6.1 8.2 13.8 13.4 18.9 28.1 29.1 13.3 7.8 16.6 10.5 11.8 20.3 26.7 5.8 11.0 50.7 6.0 43.9 21.4 13.7 8.8 35.0 5.5 12.3 5.9 3.1 11.2 25.3 5.8 11.1 13.9 2.4 15.0 7.3 7.3 15.0 7.4 10.1 11.2 28.4 0.0 0.5 6.5 0.0 2.2 11.4 0.0 2.0 3.6 0.2 0.1 0.0 0.0 0.0 3.0 1.1 5.0 0.1 13.6 0.3 0.8 0.0 4.6 46.0 0.0 0.0 1.2 0.0 0.0 5.1 0.4 0.0 0.2 4.2 0.1 10.2 0.0 23.7 3.0 2.1 29.9 0.1 0.4 0.0 3.2 3.5 0.9 0.7 42.9 4.4 0.7 7.8 0.0 0.2 0.0 6.4 0.0 0.0 0.0 7.3 1.6 12.4 9.5 0.3 0.0 0.0 15.6 0.0 0.0 1.4 0.5 0.5 0.0 7.2 0.0 0.1 0.0 0.0 1.8 0.2 0.0 0.0 0.5 1.3 23.9 1.6 0.0 5.8 17.8 32.5 6.9 38.0 28.1 29.1 11.8 20.3 26.7 21.4 5.8 15.0 28.4 20.2 6.4 7.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 2.2 0.0 0.0 0.0 9.2 0.0 1.1 1.1 0.0 5.9 22.9 0.0 3.7 4.3 3.4 0.0 0.0 0.0 4.2 0.2 5.4 0.0 15.5 1.3 4.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 22.2 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.7 0.4 0.7 0.0 0.0 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 25.5 18.4 17.9 10.2 19.6 28.4 26.5 17.8 25.0 26.9 13.4 24.3 10.2 24.8 4.1 23.4 24.7 4.8 18.9 17.5 17.4 22.7 19.6 20.5 11.4 20.2 18.7 16.3 29.3 22.0 7.4 21.9 8.2 23.2 22.0 4.3 9.3 20.4 6.8 29.7 32.8 24.8 5.6 17.0 28.7 20.9 16.5 20.7 12.7 24.7 6.7 7.7 22.4 24.5 24.7 26.1 23.0 16.0 17.0 12.6 10.3 35.8 19.7 13.6 22.9 15.6 22.6 12.3 31.9 18.0 14.8 11.9 23.9 22.7 18.1 13.2 9.9 36.0 29.0 12.9 27.0 13.4 37.8 27.4 11.7 20.4 20.8 24.9 18.2 14.3 24.3 40.9 12.3 10.4 32.7 31.9 57.1 41.9 14.0 38.0 36.7 16.2 25.2 13.3 18.8 25.1 28.3 18.7 15.6 25.1 12.5 22.5 29.1 18.6 19.0 24.8 14.8 22.3 35.0 41.2 31.7 18.7 25.5 25.9 2.0 4.1 1.9 3.0 2.7 3.0 2.1 2.8 2.6 2.9 3.7 3.0 3.4 5.6 5.4 3.4 7.2 2.4 1.8 17.9 19.6 17.8 25.0 17.5 17.4 20.2 18.7 16.3 23.2 17.0 20.7 24.7 46.4 73.7 44.5 48.6 37.9 38.9 41.5 19.0 42.1 49.7 25.4 25.9 19.3 21.5 38.6 14.7 66.7 30.4 52.6 22.1 0.0 23.1 21.4 27.0 48.8 39.3 21.6 38.7 55.1 26.6 31.8 39.2 37.8 39.7 38.0 47.1 21.4 16.7 22.1 42.1 43.2 24.9 14.2 27.4 21.4 12.9 30.1 30.3 23.2 36.5 35.4 33.7 50.4 58.3 85.1 28.6 24.1 29.7 43.6 44.7 20.8 11.8 30.7 62.4 46.0 52.1 38.1 39.5 42.8 39.7 46.9 43.6 45.9 48.4 22.9 48.2 TNK2 "ACK, ACK1, p21cdc42Hs" ENSG00000061938 "Tyrosine kinase non receptor 2" Q07912 3 195863364-195911945 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 103.7" "Cell type enhanced" "Detected in many" "Horizontal cells: 99.3;Oligodendrocyte precursor cells: 245.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041954, HPA069561" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA041954: AB_10794164, HPA069561: " "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-3)" "prognostic unfavorable (8.96e-4)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (8.89e-3)" "unprognostic (1.13e-1)" "unprognostic (8.92e-3)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.82e-2)" "unprognostic (9.76e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.00e-4)" 14.4 10.1 71.8 25.0 58.1 72.8 15.1 33.4 103.7 16.0 8.5 14.6 9.5 13.9 11.2 19.3 17.2 10.6 17.5 69.8 43.9 7.6 10.6 14.2 30.2 72.1 53.3 59.8 13.5 12.2 6.2 36.7 12.9 66.9 21.3 6.4 9.4 26.6 11.9 55.3 62.8 16.2 9.3 34.8 27.3 19.9 12.1 54.0 16.2 10.1 16.8 20.3 19.6 19.5 54.6 93.4 16.3 15.4 13.4 15.3 11.5 80.0 17.7 16.7 11.7 9.4 15.6 79.3 25.9 55.1 24.2 17.4 34.1 14.9 22.2 3.5 61.8 15.4 22.0 36.2 10.4 7.9 13.5 10.2 7.8 30.7 11.7 17.9 26.7 13.3 9.2 11.3 30.6 9.4 67.1 5.3 39.7 12.3 24.6 29.1 13.8 15.6 26.0 7.2 51.2 16.2 16.5 9.5 37.6 21.3 11.3 71.4 11.9 18.9 19.1 13.0 11.4 48.6 70.8 9.2 17.0 22.1 38.0 15.4 1.4 1.2 0.3 0.9 1.5 0.4 1.3 0.8 0.4 0.5 2.5 0.5 0.5 2.7 0.4 1.4 1.5 0.1 0.7 71.8 58.1 33.4 103.7 69.8 43.9 72.1 53.3 59.8 66.9 34.8 54.0 54.6 9.3 6.4 7.7 44.4 14.6 6.9 8.1 6.0 4.6 30.6 13.0 12.6 16.1 7.2 8.9 0.0 50.1 13.4 11.0 18.0 1.9 4.0 1.0 4.1 5.4 11.1 6.1 12.8 42.7 5.3 3.3 4.6 14.3 4.1 1.3 4.5 11.7 19.2 8.1 99.3 45.3 2.3 6.1 16.0 11.7 1.2 6.5 13.7 5.4 20.6 16.2 5.9 21.6 245.3 25.1 29.5 9.6 6.4 10.7 8.2 0.9 1.6 7.6 20.3 0.0 4.8 5.7 6.4 11.2 11.0 10.5 4.2 12.5 1.7 6.4 19.0 MON2 KIAA1040 ENSG00000061987 "MON2 homolog, regulator of endosome-to-Golgi trafficking" Q7Z3U7 12 62466817-62600476 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 197.9;Inhibitory neurons: 172.7;Oligodendrocyte precursor cells: 177.9;Oligodendrocytes: 271.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038697, HPA057607" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA038697: AB_10697396, HPA057607: AB_2683482" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (9.91e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "prognostic favorable (2.03e-4)" "unprognostic (7.69e-2)" "unprognostic (5.99e-2)" "unprognostic (2.24e-2)" "unprognostic (6.20e-2)" "unprognostic (5.57e-2)" "unprognostic (1.58e-2)" "unprognostic (1.93e-1)" "unprognostic (1.77e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-3)" "unprognostic (4.36e-2)" 9.9 8.7 5.4 9.2 11.4 9.2 9.6 10.7 9.0 11.8 10.6 9.1 8.4 10.8 8.7 9.1 8.4 8.8 6.4 6.5 9.1 10.4 14.3 8.8 9.5 9.4 8.2 4.5 12.9 13.9 15.6 7.1 10.5 10.3 10.0 10.6 17.6 12.5 8.1 6.5 9.2 7.8 9.3 8.0 9.5 10.8 7.1 7.8 12.8 13.1 7.6 9.9 9.0 6.9 21.7 13.5 20.3 15.0 7.9 19.0 17.8 13.6 14.2 12.0 12.9 12.7 9.2 5.3 9.6 10.8 13.8 10.0 12.6 15.0 10.4 17.4 12.2 11.7 15.0 15.2 9.6 8.1 13.1 10.2 12.0 7.8 14.0 17.1 17.1 12.6 8.6 14.3 22.2 11.4 15.4 11.6 6.2 8.9 8.3 11.1 10.6 13.4 13.3 7.1 17.9 6.4 7.0 24.0 12.9 9.8 15.3 28.0 9.5 17.7 12.4 9.0 15.9 9.3 12.3 12.1 10.7 13.2 8.1 14.2 1.1 3.0 3.2 2.4 3.1 3.2 2.5 2.0 3.4 2.7 2.8 2.8 3.2 4.4 1.9 2.3 1.5 2.6 1.8 5.4 11.4 10.7 9.0 6.5 9.1 9.4 8.2 4.5 10.3 8.0 7.8 21.7 29.4 35.3 22.9 113.9 31.5 16.8 13.9 11.7 29.0 36.2 21.5 14.4 16.9 15.7 22.5 27.6 58.4 14.1 29.9 21.9 0.0 7.2 2.7 20.7 38.1 22.6 14.4 18.5 197.9 11.0 7.0 26.9 47.4 28.7 17.1 49.8 23.2 34.8 10.7 21.9 172.7 23.0 12.2 21.4 13.4 2.6 21.8 27.3 8.8 99.3 21.0 11.9 15.5 177.9 271.5 10.9 18.4 18.0 48.7 17.6 17.0 6.7 22.4 55.8 26.3 38.7 24.3 8.0 9.5 26.7 19.6 20.4 28.0 21.1 16.7 18.1 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68727468 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease variant, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 38.7;ovary: 33.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 60.8;Basal prostatic cells: 67.2;Basal respiratory cells: 161.4;Basal squamous epithelial cells: 71.7;Granulosa cells: 77.6;Melanocytes: 60.5;Pancreatic endocrine cells: 85.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 100.6;HaCaT: 263.9;HBEC3-KT: 126.9;hTCEpi: 94.3;hTERT-HME1: 72.7;RPTEC TERT1: 116.8" "Region enhanced" "Detected in single" "olfactory bulb: 1.7" "Low region specificity" "Detected in all" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 510000 "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 1.7 0.2 1.3 3.4 1.4 0.1 8.2 1.9 1.6 9.6 38.7 0.4 0.5 10.1 8.9 27.0 12.1 1.6 0.2 3.6 0.7 5.9 0.0 2.0 2.5 1.2 0.9 1.6 33.0 0.6 1.5 4.4 4.5 0.8 13.7 0.7 0.8 12.5 4.6 0.2 26.0 0.7 4.0 1.1 11.0 1.0 1.6 1.0 19.0 1.3 0.0 11.8 3.9 11.3 1.1 100.6 0.2 0.9 0.1 0.1 0.0 8.6 0.0 0.0 0.3 0.1 61.4 36.6 0.0 0.4 0.0 0.2 263.9 2.6 126.9 0.4 0.0 1.2 0.0 0.2 0.0 0.2 0.2 0.5 0.0 94.3 0.1 72.7 0.3 0.0 0.0 0.0 0.2 0.0 48.8 0.1 0.1 5.3 0.9 8.8 0.0 0.0 0.0 116.8 44.5 0.5 0.2 0.8 0.0 50.0 45.6 29.2 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.4 1.9 1.6 3.6 0.7 1.2 0.9 1.6 0.8 1.1 1.0 1.1 0.2 16.0 4.6 0.7 0.0 60.8 67.2 161.4 71.7 1.2 6.8 39.2 1.4 0.0 35.9 14.7 2.1 23.4 0.5 0.5 0.0 35.7 0.5 0.9 8.2 1.3 1.2 0.0 6.0 32.1 2.1 3.7 0.0 0.9 1.3 77.6 0.0 0.0 2.8 0.0 9.1 1.5 20.3 0.0 1.9 0.2 0.6 0.7 60.5 0.0 1.0 0.4 1.0 3.0 2.2 85.7 0.1 9.4 1.2 44.5 0.0 0.1 12.6 0.5 0.0 0.6 5.9 0.4 1.0 26.5 30.7 6.3 1.2 0.1 1.5 43.1 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112727 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.8;kidney: 7.7;skin 1: 5.7" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Distal tubular cells: 1.9;Inhibitory neurons: 4.6;Oligodendrocyte precursor cells: 2.5;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 3.0 2.6 0.0 3.2 0.1 0.2 3.1 2.8 0.2 1.5 0.0 0.0 0.0 1.6 2.6 0.0 0.0 0.0 3.0 2.2 7.7 1.6 0.0 0.0 4.8 2.9 2.2 0.0 0.6 0.3 0.0 0.0 3.2 0.1 0.0 0.1 0.2 0.0 0.1 5.7 0.0 0.0 2.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.5 0.2 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.6 3.2 3.1 2.8 3.0 2.2 4.8 2.9 2.2 3.2 2.6 2.9 2.8 0.0 0.0 0.0 9.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 GPBP1 DKFZp761C169 ENSG00000062194 "GC-rich promoter binding protein 1" Q86WP2 5 57173948-57264679 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 622.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037773 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Plasma membrane" "HPA037773: AB_10671721" "unprognostic (1.53e-1)" "unprognostic (2.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.49e-1)" "unprognostic (8.30e-2)" "unprognostic (9.68e-3)" "unprognostic (1.24e-2)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (3.70e-1)" "unprognostic (5.93e-2)" "unprognostic (5.48e-2)" "unprognostic (3.75e-2)" "unprognostic (1.65e-1)" "unprognostic (4.89e-2)" "unprognostic (2.57e-1)" "prognostic favorable (4.15e-5)" 37.5 49.0 70.9 38.1 74.1 66.6 56.2 90.6 84.8 46.0 71.2 38.0 31.5 43.0 48.4 37.2 47.4 36.9 39.5 71.4 70.2 41.2 44.3 43.9 58.2 70.9 72.0 65.0 65.7 36.0 50.5 42.1 43.7 71.9 42.5 37.2 84.5 42.9 36.9 59.5 38.2 40.7 33.0 71.7 48.5 37.9 75.9 70.4 69.6 52.0 57.0 53.5 44.3 38.3 88.5 56.4 45.3 83.7 70.1 53.8 51.6 75.9 42.9 72.4 68.6 88.4 73.0 63.2 74.2 48.0 44.0 84.9 37.5 71.9 48.6 86.8 41.7 48.1 61.9 49.6 61.5 62.9 45.2 60.8 43.6 74.8 56.1 78.1 65.8 56.7 59.5 62.3 117.6 56.4 72.3 70.3 78.6 51.2 28.2 31.3 75.4 68.5 72.7 53.7 58.7 72.7 56.0 62.1 53.4 69.6 54.3 104.9 75.8 37.3 25.0 50.2 35.1 62.0 90.0 79.6 81.6 40.7 66.7 46.9 93.8 38.2 76.4 59.6 41.0 76.3 71.5 72.1 72.6 43.7 61.9 78.5 73.8 73.2 79.5 45.5 29.8 84.9 68.8 70.9 74.1 90.6 84.8 71.4 70.2 70.9 72.0 65.0 71.9 71.7 70.4 88.5 132.9 60.9 88.3 129.3 272.2 227.5 241.1 102.6 206.1 139.8 146.1 87.9 89.0 65.8 121.9 84.6 148.0 99.0 246.9 149.6 99.7 76.5 249.9 246.6 134.0 123.1 107.7 82.7 106.4 55.9 74.3 143.2 115.2 267.8 142.8 119.0 68.2 47.0 56.2 134.6 96.4 103.3 118.0 70.3 622.0 102.4 133.9 162.8 188.5 112.4 160.7 95.7 178.2 168.9 221.6 70.5 176.3 91.4 261.6 246.5 87.9 72.6 154.6 199.0 52.6 129.7 139.9 379.3 279.6 195.6 237.7 161.7 285.2 107.0 102.0 304.1 DGAT2 ENSG00000062282 "Diacylglycerol O-acyltransferase 2" Q96PD7 11 75759512-75801535 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 480.3;breast: 134.7;liver: 334.5;skin 1: 150.7" "Cell type enhanced" "Detected in many" "Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5" "Cancer enhanced" "Detected in many" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "eosinophil: 137.7;neutrophil: 348.6" "Lineage enriched" "Detected in many" 16 "granulocytes: 348.6" "Cell line enhanced" "Detected in many" "ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 22.0" HPA013351 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA013351: AB_1847630" "unprognostic (2.28e-1)" "unprognostic (3.69e-1)" "unprognostic (9.38e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.63e-1)" "unprognostic (4.99e-2)" "unprognostic (1.10e-2)" "unprognostic (7.59e-2)" "unprognostic (4.46e-1)" "unprognostic (4.12e-3)" "unprognostic (2.87e-1)" "unprognostic (2.99e-1)" "unprognostic (1.49e-7)" "unprognostic (2.03e-1)" "unprognostic (2.85e-1)" "unprognostic (2.74e-2)" "unprognostic (5.60e-2)" 480.3 5.1 5.5 19.5 10.5 7.3 134.7 3.4 6.1 1.5 5.1 9.1 14.7 1.2 1.8 24.3 2.1 5.9 10.1 5.8 5.8 3.4 334.5 5.6 4.0 6.5 4.9 6.3 1.8 4.6 2.1 1.6 1.5 5.0 2.2 5.0 0.6 10.6 1.6 4.1 150.7 16.6 2.8 3.5 15.2 12.9 38.4 6.3 4.3 8.9 5.7 18.3 21.5 12.7 6.2 13.3 6.4 0.4 11.2 80.4 6.4 1.0 1.3 1.7 1.6 1.0 46.6 13.5 21.1 16.8 0.3 11.9 0.5 1.8 6.5 4.4 62.5 1.2 1.5 4.0 64.9 0.9 7.4 7.2 26.8 33.6 7.3 10.6 4.4 1.2 20.9 1.2 27.6 0.7 8.5 5.1 16.7 3.6 124.0 31.5 0.0 0.1 24.8 1.2 35.8 22.6 1.4 12.3 1.9 2.9 2.7 4.4 26.6 1.6 14.1 7.0 0.3 9.1 16.3 40.0 28.8 10.2 23.7 25.3 19.4 22.1 137.7 0.0 4.4 0.4 7.4 0.4 0.0 6.1 7.6 0.1 0.2 348.6 0.0 5.0 1.8 0.0 5.7 5.5 10.5 3.4 6.1 5.8 5.8 6.5 4.9 6.3 5.0 3.5 6.3 6.2 3.2 6.4 5.4 0.3 5.0 1.1 0.9 3.0 0.6 0.9 5.2 7.0 3.5 0.0 2.7 0.0 2.1 0.5 0.3 0.6 0.0 1.7 259.3 3.3 0.2 0.5 1.2 2.7 2.9 0.5 0.1 0.7 10.7 0.2 0.0 2.1 2.9 116.4 2.2 1.7 1.3 4.8 0.0 4.1 13.1 64.1 2.1 4.2 1.8 0.0 4.0 0.4 0.0 0.0 1.0 3.7 2.2 0.7 0.9 2.8 1.2 2.2 3.4 0.0 6.6 0.6 1.0 53.9 53.5 0.3 8.0 0.8 0.5 0.2 3.0 15.7 ZNF112 "ZFP112, ZNF228" ENSG00000062370 "Zinc finger protein 112" Q9UJU3 19 44326555-44367217 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 10.8;Inhibitory neurons: 9.9;Oligodendrocyte precursor cells: 10.6;Oligodendrocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 17.3" "Low region specificity" "Detected in all" HPA023856 Approved Approved Centrosome NA NA Centrosome "HPA023856: AB_1859018" "unprognostic (1.99e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "unprognostic (1.04e-1)" "unprognostic (4.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.34e-2)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (2.53e-2)" "unprognostic (1.65e-3)" "prognostic favorable (1.54e-5)" "unprognostic (1.65e-1)" "unprognostic (9.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.57e-3)" 1.6 3.0 4.9 0.8 5.0 0.1 4.3 8.5 5.1 2.3 4.4 2.7 2.6 3.8 3.8 2.6 3.9 2.3 3.5 4.5 4.6 2.9 1.6 2.5 0.9 5.1 5.0 4.2 4.4 2.5 4.5 3.4 2.5 5.1 3.9 2.9 5.2 3.0 3.9 1.9 2.8 2.7 2.9 5.0 2.0 3.2 7.6 4.9 1.4 4.2 2.5 1.5 2.3 2.2 6.4 4.4 2.7 7.5 4.4 4.4 3.9 1.8 4.1 6.8 3.8 5.7 1.9 3.1 0.0 2.9 3.5 3.5 3.9 4.5 2.8 6.0 0.0 5.5 5.1 4.6 1.8 3.5 0.0 0.0 4.1 4.9 2.9 6.0 6.5 4.5 0.0 1.9 11.9 4.5 1.0 0.0 0.0 4.1 1.1 1.6 0.0 8.1 2.3 3.6 4.8 3.6 5.8 5.4 1.0 2.9 6.3 2.2 0.0 6.2 6.0 4.5 17.3 3.4 0.0 0.0 0.1 3.6 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.9 5.0 8.5 5.1 4.5 4.6 5.1 5.0 4.2 5.1 5.0 4.9 6.4 2.8 0.0 0.5 6.2 0.1 0.4 1.1 1.7 0.6 6.9 1.7 1.9 4.4 1.5 1.7 0.0 0.0 1.2 0.0 1.5 1.9 1.7 5.5 1.2 1.8 1.7 1.2 1.3 10.8 1.2 0.7 1.8 0.0 0.9 0.0 6.1 1.8 0.2 0.5 8.4 9.9 1.6 0.0 0.0 0.4 1.0 0.6 0.5 0.0 7.5 0.4 4.3 0.0 10.6 13.4 0.7 0.5 1.5 0.0 0.7 1.3 1.2 2.8 2.5 0.0 2.3 1.5 2.9 2.0 2.1 0.4 0.3 0.1 3.5 1.1 0.3 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300391 "Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 555.3;tongue: 606.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 239.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria NA NA 670000 Mitochondria "CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 155.6 94.3 28.7 62.2 31.4 112.0 66.8 34.3 49.9 55.8 37.5 111.2 98.6 56.9 32.5 96.5 58.8 42.8 322.3 30.1 34.0 87.4 39.3 58.5 67.7 38.0 33.5 29.4 56.5 62.0 128.6 29.1 46.0 41.5 59.6 125.4 130.1 74.4 61.1 555.3 69.7 81.8 78.2 23.7 49.4 67.1 24.6 42.9 70.1 53.5 606.0 107.0 70.9 58.7 47.1 168.9 176.8 141.6 198.2 188.4 173.8 93.3 136.9 132.0 231.1 160.6 271.2 158.2 322.9 128.2 172.6 99.3 182.1 396.8 200.8 234.9 109.3 200.2 222.9 136.1 261.4 107.3 288.4 166.6 188.2 201.6 182.4 232.0 202.2 268.6 163.7 233.2 193.7 214.7 160.8 229.8 121.9 117.5 128.0 247.8 222.3 167.1 247.6 166.2 194.6 189.3 125.2 175.2 251.7 157.7 137.5 297.6 174.3 178.3 127.1 165.3 167.4 147.4 124.5 200.4 206.2 120.4 206.4 119.5 59.6 73.3 205.7 47.0 93.0 61.9 60.6 56.5 45.1 119.3 51.8 59.2 47.9 31.3 51.6 94.0 65.6 63.4 71.2 28.7 31.4 34.3 49.9 30.1 34.0 38.0 33.5 29.4 41.5 23.7 42.9 47.1 14.5 16.0 39.5 32.3 31.6 39.0 23.5 26.9 46.7 22.8 38.3 29.7 239.9 15.7 21.5 12.9 62.6 18.5 24.1 66.9 35.2 32.5 6.6 25.1 31.5 27.2 16.9 36.0 21.5 45.1 31.3 25.8 42.3 53.5 27.9 21.3 18.9 29.7 34.3 10.1 24.6 43.9 20.3 39.4 35.0 4.8 20.2 34.6 10.6 9.4 44.8 16.7 16.5 18.6 18.8 44.6 35.7 19.9 46.7 33.1 50.4 22.0 14.9 38.3 13.1 27.8 38.2 29.7 25.8 74.8 52.1 16.8 25.8 32.0 71.3 34.5 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503637-41513887 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lung: 15.2;salivary gland: 11.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 25.3;Gastric mucus-secreting cells: 18.8;Hepatic stellate cells: 11.4;Intestinal goblet cells: 7.9;Proximal enterocytes: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MAIT T-cell: 5.7;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 10 "dendritic cells: 5.0;T-cells: 5.7" "Cell line enhanced" "Detected in some" "HEL: 5.0;NB-4: 9.7;RH-30: 4.6;THP-1: 14.7" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 0.5 0.6 1.0 1.4 1.4 4.6 0.5 1.2 1.7 0.8 0.7 5.2 12.6 0.2 0.0 0.3 0.4 2.4 1.6 1.3 0.8 3.9 3.0 15.2 1.2 0.9 0.7 1.1 0.1 0.3 0.6 0.7 10.5 0.9 0.4 5.7 0.1 11.9 0.3 1.8 1.4 13.3 0.3 0.6 5.6 10.0 2.6 0.7 0.4 0.7 0.0 2.1 0.7 0.7 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.6 0.8 1.2 2.2 0.0 0.0 0.0 0.6 0.0 0.0 2.6 0.0 0.4 0.2 1.3 5.0 0.1 0.0 2.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 1.9 0.0 1.8 0.0 0.0 9.7 0.4 1.8 0.2 0.2 4.6 0.1 0.0 0.0 0.4 2.9 0.1 0.2 0.0 2.6 0.2 14.7 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.5 0.8 0.0 0.0 0.0 0.4 0.0 5.7 0.5 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 1.0 1.4 1.2 1.7 1.3 0.8 0.9 0.7 1.1 0.9 0.6 0.7 0.9 0.3 0.0 0.0 0.3 1.6 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.8 2.8 0.9 0.0 0.0 0.3 5.5 25.3 0.0 0.0 2.8 0.1 0.4 1.8 1.8 3.2 2.9 0.2 1.5 0.2 18.8 0.2 0.0 0.3 11.4 0.5 0.1 0.0 0.2 7.9 0.0 1.9 0.6 2.1 0.0 0.4 3.6 0.0 0.4 0.0 1.0 0.5 0.4 0.7 5.5 0.0 2.7 0.0 15.3 0.0 5.6 0.0 0.0 0.3 0.5 2.2 1.2 0.0 0.1 0.4 4.0 0.0 3.8 0.0 MRPS24 "HSPC335, MRP-S24" ENSG00000062582 "Mitochondrial ribosomal protein S24" Q96EL2 7 43866558-43869893 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 460.1" "Group enriched" "Detected in many" 5 "Basal squamous epithelial cells: 109.3;Erythroid cells: 54.7;Gastric mucus-secreting cells: 84.6;Plasma cells: 184.7;Squamous epithelial cells: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073947 Approved NA NA "HPA073947: " "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (1.30e-1)" "unprognostic (3.44e-1)" "unprognostic (7.32e-2)" "unprognostic (8.63e-3)" "unprognostic (9.42e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (2.03e-1)" "unprognostic (6.86e-3)" "unprognostic (9.58e-3)" "unprognostic (1.71e-2)" "prognostic favorable (9.89e-4)" "unprognostic (2.87e-1)" "unprognostic (9.08e-2)" "unprognostic (7.37e-2)" "unprognostic (1.95e-1)" 79.0 162.0 95.3 42.0 94.0 94.4 82.6 99.5 117.0 78.0 97.2 104.3 72.3 79.9 43.6 149.7 80.4 34.3 203.4 94.3 99.6 130.8 174.0 64.9 49.8 92.5 93.6 93.4 96.6 152.4 92.8 68.8 40.0 94.8 83.1 47.5 31.6 102.0 40.5 460.1 92.0 78.4 38.2 93.1 77.5 127.9 84.2 98.5 48.3 65.8 283.5 48.6 88.0 89.1 92.8 165.2 260.4 80.2 165.8 82.7 141.4 132.3 155.4 386.0 206.2 203.3 236.7 152.8 140.1 182.8 160.1 278.8 204.7 115.8 142.9 160.9 131.8 287.2 86.1 286.2 287.7 122.7 140.5 106.5 133.8 142.6 161.0 192.1 130.8 120.3 136.8 281.4 103.3 131.6 262.7 170.6 313.4 200.5 184.8 261.0 137.3 113.9 540.5 150.9 139.3 159.5 180.4 156.7 386.3 162.2 102.9 261.5 252.1 96.8 191.6 263.6 116.1 225.7 310.4 258.8 182.5 232.3 186.1 305.7 41.4 175.4 95.6 114.1 181.6 124.8 222.5 167.5 137.5 241.0 195.6 165.0 142.6 14.7 124.1 181.0 162.8 214.1 177.5 95.3 94.0 99.5 117.0 94.3 99.6 92.5 93.6 93.4 94.8 93.1 98.5 92.8 1.2 6.4 19.1 0.0 24.1 4.5 2.6 2.5 109.3 4.9 8.2 5.3 0.4 8.6 13.2 5.5 6.2 1.4 2.9 1.8 3.9 7.1 1.8 9.4 16.5 7.8 4.2 54.7 0.0 0.7 3.8 20.4 84.6 12.1 3.8 2.3 8.9 21.7 1.2 0.0 0.0 1.5 0.0 8.6 6.3 1.0 0.3 24.4 3.6 0.0 3.1 0.9 4.1 0.0 0.0 2.9 0.7 0.7 184.7 1.8 1.6 1.9 21.9 7.7 0.0 1.7 13.8 1.0 1.4 204.4 5.8 1.9 19.4 1.7 2.1 3.2 ELMO2 "CED-12, CED12, ELMO-2, FLJ11656, KIAA1834" ENSG00000062598 "Engulfment and cell motility 2" Q96JJ3 20 46366050-46432985 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018811 Approved Supported Cytosol NA NA Cytosol "HPA018811: AB_1848126" "unprognostic (1.19e-2)" "unprognostic (4.24e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (3.71e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (8.81e-2)" "unprognostic (3.06e-2)" "unprognostic (1.92e-1)" "prognostic favorable (6.10e-4)" "unprognostic (4.53e-1)" "unprognostic (4.42e-2)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "unprognostic (3.99e-2)" "unprognostic (1.20e-2)" 20.4 25.8 51.0 16.0 52.1 41.3 20.2 54.1 55.9 27.8 42.7 20.4 10.0 24.3 20.9 32.7 21.5 11.7 23.2 60.3 49.0 23.1 18.7 25.5 21.4 51.0 52.0 49.8 17.7 28.3 27.8 26.4 16.7 49.7 29.3 11.3 25.9 20.9 26.9 35.5 24.5 20.3 24.3 50.3 35.4 19.1 31.6 53.1 16.0 20.6 23.4 21.4 23.7 29.7 56.5 10.0 29.0 33.7 27.9 57.8 37.0 17.3 22.7 31.1 31.2 30.2 39.5 11.0 12.4 35.5 38.2 52.6 23.2 29.0 33.9 24.1 20.5 12.9 20.2 18.7 29.2 43.5 11.3 41.1 36.5 29.7 33.2 23.4 21.4 25.5 29.8 20.4 40.0 29.4 26.3 22.4 29.1 13.0 18.8 28.1 18.8 32.8 25.0 30.7 22.9 20.3 18.3 32.8 28.7 44.2 31.8 22.2 44.6 29.9 64.0 36.0 26.5 15.0 16.0 25.8 12.6 26.5 17.8 19.9 121.8 25.0 42.1 42.0 47.9 51.7 9.9 37.8 40.6 23.6 13.4 23.9 27.2 26.9 58.2 73.3 32.7 27.2 43.9 51.0 52.1 54.1 55.9 60.3 49.0 51.0 52.0 49.8 49.7 50.3 53.1 56.5 5.7 3.2 12.5 33.3 5.3 4.8 5.0 2.3 5.2 9.7 7.3 4.8 10.9 8.6 3.6 1.8 29.2 6.0 14.6 2.3 0.0 4.3 6.3 3.9 6.8 6.4 8.3 4.8 15.2 3.3 5.2 7.3 6.1 6.0 8.8 5.3 5.0 2.9 13.7 11.8 13.9 2.9 16.2 8.2 5.3 5.6 11.1 6.1 7.2 15.0 8.0 15.2 18.6 14.1 31.0 4.7 3.4 12.8 6.4 8.7 2.9 4.7 1.7 8.5 26.3 4.7 12.6 11.0 14.5 5.2 6.7 4.1 11.8 6.3 2.7 3.9 WAPL "FOE, KIAA0261, WAPAL" ENSG00000062650 "WAPL cohesin release factor" Q7Z5K2 10 86435256-86521792 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037874, HPA037875, HPA066141" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: " "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.91e-2)" "unprognostic (6.63e-2)" "unprognostic (3.51e-1)" "unprognostic (3.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (5.78e-2)" "unprognostic (5.56e-2)" "unprognostic (7.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (4.56e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 15.6 13.3 8.1 19.8 9.5 27.4 16.8 12.0 9.3 13.0 7.9 15.5 15.3 15.0 8.7 16.0 11.8 13.3 10.4 7.5 8.9 16.9 22.8 16.6 25.2 8.5 8.6 6.1 13.8 14.5 17.1 5.0 18.6 8.1 13.1 15.3 36.3 11.3 11.8 21.0 18.0 16.1 14.9 9.1 19.2 16.7 35.4 8.6 34.0 18.1 22.7 27.9 18.1 9.3 10.4 42.6 19.6 33.5 44.4 26.1 27.6 29.6 36.4 44.2 30.3 32.4 42.9 36.6 64.3 24.1 32.5 26.7 39.1 38.3 31.3 46.3 42.1 25.3 38.9 30.9 47.4 29.7 79.8 43.1 21.9 35.7 38.9 64.9 34.5 34.6 36.8 41.7 37.6 35.2 36.3 49.9 29.6 29.9 26.4 19.5 35.2 27.1 25.6 26.3 37.2 13.1 25.2 32.3 21.4 40.9 33.2 47.1 41.9 33.5 29.1 34.4 25.8 48.6 36.8 54.9 66.9 26.7 55.8 20.9 15.0 3.5 7.7 3.4 4.1 4.9 3.9 4.5 4.7 4.8 4.0 5.1 4.0 5.5 3.2 7.4 3.6 6.1 2.4 8.1 9.5 12.0 9.3 7.5 8.9 8.5 8.6 6.1 8.1 9.1 8.6 10.4 38.3 83.3 54.8 0.0 48.3 0.0 57.4 0.0 35.3 49.1 41.3 27.9 0.0 20.0 21.1 16.5 20.9 42.8 62.4 17.4 21.5 60.8 86.8 36.7 44.4 33.9 18.2 94.1 0.0 52.5 28.3 30.0 37.8 52.2 25.2 40.3 32.5 47.6 40.4 55.5 0.0 21.5 0.0 56.5 0.0 42.0 32.0 58.3 0.0 0.0 81.0 48.7 55.6 0.0 0.0 52.1 27.5 32.4 50.5 56.6 25.0 35.5 13.8 113.4 65.7 70.3 33.6 153.4 90.2 48.4 0.0 76.1 51.4 35.2 24.8 74.1 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 984.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 3000.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 3000.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: AB_2685348" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 37.1 47.7 23.6 56.7 27.9 23.0 37.0 16.8 30.5 30.6 6.4 59.1 56.5 32.7 23.4 33.3 16.1 60.4 22.2 16.8 23.6 37.0 59.0 29.9 31.7 29.4 22.3 13.6 23.1 31.0 38.7 10.5 39.5 27.5 34.3 60.4 30.5 23.7 23.3 20.1 19.7 60.9 34.2 24.7 53.0 48.0 22.5 27.8 22.6 32.8 29.2 20.8 48.3 16.5 35.3 65.8 128.2 43.8 82.2 88.3 54.8 77.3 87.4 87.4 64.3 98.0 85.1 166.1 42.2 143.9 70.6 81.5 79.8 62.4 59.5 80.5 102.7 80.9 55.5 89.2 97.3 89.6 68.5 51.4 77.4 46.7 87.3 76.2 93.2 67.6 41.3 69.8 70.2 68.7 177.9 66.7 21.9 63.0 146.6 75.3 41.8 79.8 101.1 92.5 72.1 36.4 89.1 57.5 62.4 83.8 62.6 124.4 49.0 89.8 81.3 75.0 68.8 83.6 105.4 145.0 66.8 84.4 37.6 92.8 131.6 570.4 76.0 62.8 393.0 69.2 56.6 59.3 65.4 174.3 49.5 53.9 60.5 3000.2 69.0 666.9 59.2 73.9 501.6 23.6 27.9 16.8 30.5 16.8 23.6 29.4 22.3 13.6 27.5 24.7 27.8 35.3 164.8 89.8 124.1 35.3 68.6 161.1 984.4 188.9 665.9 36.1 429.1 187.1 27.9 125.8 273.3 275.8 58.4 91.7 71.0 511.1 23.5 223.1 7.2 372.8 197.7 148.2 310.6 29.9 80.1 137.9 123.5 193.6 367.0 708.6 135.4 111.2 48.2 108.4 121.7 28.6 84.6 254.1 168.9 335.2 270.7 11.5 35.8 322.6 129.9 45.0 231.1 50.4 51.5 51.8 141.2 160.7 508.1 35.3 92.5 553.1 361.1 72.6 289.7 51.6 92.1 59.2 293.5 83.6 44.6 672.6 129.7 175.8 127.3 67.5 241.7 629.2 APPBP2 "Hs.84084, KIAA0228, PAT1" ENSG00000062725 "Amyloid beta precursor protein binding protein 2" Q92624 17 60443158-60526242 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 391.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 110.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066852, HPA078370" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066852: , HPA078370: " "unprognostic (1.43e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.97e-2)" "unprognostic (2.93e-2)" "unprognostic (4.53e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (7.67e-2)" "unprognostic (9.24e-2)" "unprognostic (2.39e-1)" "unprognostic (2.90e-3)" "unprognostic (6.87e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-1)" "unprognostic (1.31e-1)" "unprognostic (9.36e-2)" 15.0 11.3 14.6 10.3 16.1 4.2 11.4 16.0 15.5 11.8 12.6 10.5 7.4 13.0 9.6 10.4 10.1 11.7 7.1 13.1 15.0 13.2 11.1 9.6 8.8 14.2 15.3 12.9 19.8 11.6 14.5 8.0 12.3 14.6 13.8 9.2 17.5 8.6 10.2 9.4 8.8 7.2 11.9 15.3 12.2 10.9 23.7 15.3 10.4 12.9 9.9 8.3 10.1 8.9 23.0 16.5 21.9 22.6 19.0 23.7 24.7 12.6 25.4 17.5 13.9 17.6 10.7 14.0 17.0 41.7 21.4 24.0 13.8 16.2 8.8 24.4 15.3 12.4 21.6 20.1 22.5 25.2 18.1 23.1 24.4 11.4 14.6 14.1 21.6 21.9 10.5 16.5 19.3 20.4 110.4 25.5 9.2 5.0 17.9 9.7 16.8 37.8 20.0 21.5 26.7 24.6 21.0 22.0 3.7 18.2 12.5 30.4 12.3 28.4 31.1 37.6 21.7 19.5 20.5 70.8 14.3 20.6 10.5 22.4 13.8 9.5 12.0 7.4 7.1 8.4 7.2 8.7 8.2 9.3 9.7 11.8 8.9 11.9 12.5 12.2 5.6 9.3 7.5 14.6 16.1 16.0 15.5 13.1 15.0 14.2 15.3 12.9 14.6 15.3 15.3 23.0 32.8 28.9 24.0 55.5 20.9 18.0 15.6 18.6 21.6 59.4 18.8 15.0 27.3 20.0 20.8 14.7 18.8 27.4 24.0 17.0 19.6 19.7 391.3 21.3 33.6 29.3 33.0 5.9 57.8 16.6 8.9 30.1 13.7 27.3 22.9 40.6 40.0 21.7 19.8 37.0 65.4 22.1 20.3 19.4 14.9 126.2 35.4 17.7 17.8 44.0 22.5 44.4 16.5 55.8 132.0 16.9 13.2 39.1 17.1 24.7 15.9 30.2 19.5 34.9 39.5 32.1 31.6 56.3 33.3 15.3 18.5 63.2 20.8 42.0 20.4 18.1 POLD1 "CDC2, POLD" ENSG00000062822 "DNA polymerase delta 1, catalytic subunit" P28340 19 50384204-50418018 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Paneth cells: 51.3;Spermatogonia: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004375, HPA046524" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004375: AB_675487, HPA046524: AB_2679684" "unprognostic (2.45e-1)" "unprognostic (7.02e-3)" "unprognostic (1.59e-1)" "unprognostic (4.35e-2)" "unprognostic (2.55e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (2.87e-6)" "unprognostic (4.12e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-1)" "unprognostic (5.08e-1)" "unprognostic (3.92e-3)" "unprognostic (4.01e-3)" "unprognostic (1.28e-2)" "unprognostic (1.61e-1)" "unprognostic (2.89e-1)" "unprognostic (3.70e-2)" 5.6 5.2 3.1 9.3 2.9 26.5 6.4 3.6 3.8 7.6 1.6 7.9 5.5 8.5 0.4 10.8 6.6 2.1 5.2 2.1 2.3 6.6 6.5 9.6 11.3 4.2 2.9 1.4 7.1 8.0 2.3 4.7 6.0 3.4 6.2 2.2 1.9 7.5 2.6 5.7 8.8 10.2 2.3 3.2 12.9 6.3 13.4 2.7 11.1 9.9 1.5 5.2 6.0 7.8 4.0 52.1 77.9 27.9 22.4 3.0 2.8 45.6 34.0 9.6 30.0 34.9 42.4 39.2 84.6 19.4 7.1 13.9 45.1 27.4 25.1 6.8 64.4 145.0 66.1 73.0 54.6 3.7 67.0 57.7 6.4 7.1 26.1 6.5 6.0 14.2 58.2 77.4 54.3 9.1 40.6 92.2 110.6 48.7 25.3 55.4 105.4 62.2 67.7 7.4 44.9 39.3 38.6 33.0 35.9 8.8 10.1 21.1 50.7 17.4 21.4 70.7 22.0 56.5 60.0 91.3 76.3 21.2 66.9 20.8 1.3 4.3 1.5 4.3 5.6 4.0 6.0 4.0 3.5 3.9 5.4 4.0 3.9 0.6 4.2 6.9 7.1 3.1 4.0 3.1 2.9 3.6 3.8 2.1 2.3 4.2 2.9 1.4 3.4 3.2 2.7 4.0 3.5 3.2 3.9 0.7 8.7 6.4 2.3 3.5 3.4 4.0 4.3 5.3 3.4 2.8 3.8 3.7 6.2 19.2 3.8 12.2 0.0 4.8 1.9 2.8 1.6 3.4 7.2 15.2 1.2 4.0 15.0 4.1 3.1 3.0 0.0 9.5 1.1 2.2 15.1 0.0 0.9 7.4 0.0 5.7 5.3 1.9 3.1 5.8 5.4 1.0 4.8 1.2 6.2 1.5 2.2 4.7 51.3 5.3 10.6 2.8 6.3 2.8 3.0 4.3 0.0 3.5 4.0 11.5 25.6 5.5 5.3 7.7 5.4 3.4 14.3 1.3 SEZ6 ENSG00000063015 "Seizure related 6 homolog" Q53EL9 17 28954901-29006440 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 54.1;pituitary gland: 15.9;retina: 27.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 58.7;Cone photoreceptor cells: 47.9;Excitatory neurons: 15.9;Horizontal cells: 43.7;Inhibitory neurons: 24.6;Rod photoreceptor cells: 18.2" "Cancer enriched" "Detected in many" 11 "glioma: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.1;neutrophil: 2.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011777 Enhanced NA NA 310000 "HPA011777: AB_1856758" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (5.75e-3)" "unprognostic (5.33e-3)" "unprognostic (1.84e-2)" "unprognostic (1.76e-3)" "unprognostic (2.82e-2)" "unprognostic (2.22e-2)" "unprognostic (3.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.22e-3)" "unprognostic (3.15e-3)" "unprognostic (3.63e-6)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 0.0 0.6 52.0 0.2 54.1 0.4 0.0 50.4 36.6 0.0 8.3 0.7 1.0 0.0 0.3 0.0 0.0 0.0 0.1 39.3 27.6 0.1 0.0 0.1 0.0 26.3 38.2 37.9 0.1 0.6 0.0 15.9 0.0 41.0 0.2 0.5 27.2 0.0 0.1 0.2 0.2 0.5 0.1 13.7 0.1 0.5 0.5 28.4 0.0 0.1 0.0 0.0 0.1 0.0 29.1 0.0 0.4 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.1 0.1 0.1 0.0 0.0 53.5 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.1 1.1 0.2 0.3 0.0 0.1 0.3 0.3 0.1 0.2 0.2 0.1 0.2 0.2 2.0 0.1 0.2 0.3 0.0 0.1 52.0 54.1 50.4 36.6 39.3 27.6 26.3 38.2 37.9 41.0 13.7 28.4 29.1 0.4 0.0 0.0 3.3 0.9 0.4 0.7 0.0 0.0 58.7 0.1 0.1 0.6 1.5 0.0 0.0 47.9 0.3 5.0 0.3 0.0 0.2 0.1 0.1 0.2 0.7 7.3 0.0 15.9 0.4 0.3 0.3 0.0 0.2 8.9 1.0 0.4 0.0 0.2 43.7 24.6 0.1 0.0 1.9 1.0 0.4 0.9 1.1 0.0 4.7 5.0 6.1 5.2 3.5 4.7 0.5 0.1 0.0 0.1 0.8 0.7 0.1 0.0 18.2 0.0 0.9 0.3 1.3 1.8 0.0 0.0 0.3 1.4 0.2 0.6 0.2 EIF4B ENSG00000063046 "Eukaryotic translation initiation factor 4B" P23588 12 53006282-53042215 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039072, HPA046164" Approved Enhanced Cytosol NA NA 340000 Cytosol "HPA039072: AB_2676333, HPA046164: AB_2679567" "unprognostic (1.91e-2)" "unprognostic (2.63e-2)" "unprognostic (4.50e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" "unprognostic (2.68e-1)" "unprognostic (1.55e-2)" "unprognostic (2.83e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.44e-1)" "unprognostic (3.57e-1)" "unprognostic (4.69e-1)" "unprognostic (8.20e-3)" 183.1 175.0 96.6 138.7 112.0 228.6 254.1 123.2 102.1 224.1 117.7 168.6 194.1 254.2 136.5 166.6 272.9 167.2 181.1 85.4 110.3 202.0 220.0 136.5 235.6 109.6 100.2 73.4 643.1 281.1 204.4 91.4 156.8 112.5 153.8 174.6 115.5 265.0 143.6 515.3 179.5 163.0 178.7 128.9 179.4 164.6 80.9 110.3 290.6 236.0 364.6 295.6 188.6 149.6 120.7 214.9 341.1 233.9 296.6 416.3 787.8 300.6 204.0 492.1 188.9 170.8 352.0 340.4 1318.2 296.3 311.4 160.4 234.2 420.0 460.4 238.3 256.6 244.3 503.4 450.6 401.5 320.0 723.3 282.4 787.1 473.2 219.2 682.1 1144.5 377.1 385.9 561.1 515.8 319.6 468.0 443.5 488.4 438.3 232.9 178.6 447.7 321.9 558.8 267.8 347.1 238.8 326.7 213.7 456.4 432.2 298.9 521.9 485.3 339.6 128.6 272.0 142.8 184.6 450.2 529.3 330.0 219.3 318.7 180.7 40.8 76.2 40.8 105.0 79.0 152.5 96.1 126.9 116.3 94.9 69.9 159.2 148.3 19.7 100.0 97.9 61.3 114.2 146.9 96.6 112.0 123.2 102.1 85.4 110.3 109.6 100.2 73.4 112.5 128.9 110.3 120.7 140.5 147.4 227.1 20.2 283.6 207.9 244.9 179.3 270.4 86.8 246.1 177.4 144.2 215.9 166.5 93.8 31.3 139.7 220.6 108.7 181.9 131.7 242.5 120.6 186.1 168.5 186.3 209.4 33.0 174.6 244.5 145.4 154.5 124.8 235.5 201.5 208.1 211.3 109.4 63.9 35.5 188.0 71.2 276.1 185.3 638.6 202.3 182.9 140.5 18.7 254.0 127.0 178.2 22.6 37.7 129.2 117.6 195.6 227.5 214.8 204.1 257.6 121.6 85.5 111.7 205.1 160.7 79.6 48.6 281.3 235.8 178.7 243.3 203.7 234.0 244.0 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325215 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 95.1" "Group enriched" "Detected in many" 8 "Early spermatids: 125.9;Late spermatids: 46.8;Spermatocytes: 153.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 18.2;SuSa: 9.9" "Not detected" "Not detected" HPA076812 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA076812: AB_2686816" "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 4.0 2.0 4.4 2.9 2.5 4.5 3.2 1.7 2.8 4.5 15.2 3.0 1.2 4.1 2.4 1.7 5.8 2.3 2.2 2.4 3.1 5.5 10.0 5.0 7.4 4.5 4.0 1.9 7.0 6.9 0.9 1.6 3.2 5.0 5.0 1.1 5.0 1.5 2.9 1.0 2.2 3.8 1.9 3.5 4.7 3.5 95.1 2.3 2.3 3.2 0.5 5.5 3.6 3.5 3.3 0.0 7.3 18.2 6.5 0.3 2.8 3.3 0.9 1.5 0.6 2.0 0.2 0.6 8.5 1.1 0.8 0.3 0.3 2.0 0.3 2.2 1.3 2.1 0.7 0.7 1.7 1.4 0.6 3.0 2.8 1.1 1.4 1.0 5.2 1.6 1.5 1.7 1.1 2.4 1.6 0.5 0.3 6.4 0.3 0.9 0.3 4.4 1.6 1.0 0.0 0.2 0.4 2.9 0.1 0.6 9.9 2.9 0.3 9.3 1.4 6.7 4.2 0.0 4.0 4.6 7.5 0.1 2.0 0.4 0.2 0.3 2.6 1.6 1.2 1.5 4.5 0.5 1.6 0.4 2.2 1.4 0.9 1.9 1.8 2.1 1.1 0.9 1.3 4.4 2.5 1.7 2.8 2.4 3.1 4.5 4.0 1.9 5.0 3.5 2.3 3.3 4.4 0.0 1.1 3.6 5.8 1.5 0.9 0.4 2.2 8.6 1.7 1.7 1.5 2.8 0.1 1.8 2.1 0.0 1.7 0.1 11.7 0.8 125.9 2.3 1.6 3.9 0.0 0.0 4.1 0.6 0.0 1.7 0.0 1.5 1.3 0.3 2.2 5.5 0.9 0.0 8.1 0.1 0.0 1.4 1.8 46.8 3.7 0.8 5.4 12.2 1.2 0.5 5.2 2.5 1.7 0.2 0.0 3.4 1.5 0.5 0.0 0.3 11.3 1.2 0.0 1.7 4.9 153.5 8.3 0.3 1.3 0.0 1.1 1.8 0.1 0.3 BICRA GLTSCR1 ENSG00000063169 "BRD4 interacting chromatin remodeling complex associated protein" Q9NZM4 19 47608196-47703277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Breast myoepithelial cells: 6.1;Collecting duct cells: 7.3;Endometrial stromal cells: 6.4;Glandular and luminal cells: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056211 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA056211: AB_2683068" "unprognostic (2.36e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-2)" "unprognostic (9.58e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.34e-4)" "unprognostic (8.38e-2)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-2)" "unprognostic (1.56e-3)" "unprognostic (2.21e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (9.72e-2)" "unprognostic (7.98e-2)" "unprognostic (1.61e-1)" "prognostic favorable (9.34e-4)" 6.5 5.1 1.5 5.0 1.3 5.4 6.9 2.9 3.5 9.3 0.6 8.0 6.5 10.7 1.6 7.0 9.1 2.4 5.9 3.3 0.2 3.9 4.9 7.0 3.9 1.7 0.4 0.4 8.7 4.4 4.0 5.6 4.8 2.0 8.2 3.6 4.3 7.1 4.2 13.8 9.9 7.3 5.3 0.0 6.2 6.3 3.1 1.2 5.7 7.5 5.6 3.5 8.6 8.4 5.0 6.8 6.6 12.3 9.5 6.0 6.1 7.0 5.8 4.9 6.4 4.3 7.3 3.5 7.3 3.0 6.7 5.4 6.9 7.7 4.1 6.4 7.5 6.5 4.3 5.3 3.1 7.7 5.1 7.5 5.2 5.6 7.0 6.3 5.3 6.5 6.2 6.7 8.4 3.9 4.8 9.1 16.3 8.6 8.7 5.4 9.7 4.2 2.1 2.5 4.6 7.4 9.6 14.4 8.3 3.7 10.0 3.4 4.0 8.1 5.3 10.8 4.4 7.9 6.8 11.8 7.1 1.2 3.6 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.5 1.3 2.9 3.5 3.3 0.2 1.7 0.4 0.4 2.0 0.0 1.2 5.0 5.1 9.6 6.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.2 6.1 0.0 0.0 0.6 7.3 0.0 4.3 3.8 0.0 0.0 3.2 0.0 4.9 6.4 2.0 0.0 0.0 0.0 3.8 3.9 1.6 0.0 6.0 1.3 4.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 5.5 2.0 3.3 0.0 0.0 SPHK2 ENSG00000063176 "Sphingosine kinase 2" Q9NRA0 19 48619291-48630717 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 68.5;Cone photoreceptor cells: 77.2;Rod photoreceptor cells: 79.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049062 Supported Nucleoplasm NA NA Nucleoplasm "HPA049062: " "unprognostic (5.33e-2)" "unprognostic (4.11e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.10e-1)" "unprognostic (7.19e-3)" "unprognostic (3.04e-1)" "unprognostic (4.45e-3)" "unprognostic (7.28e-2)" "unprognostic (2.80e-1)" "prognostic favorable (9.30e-4)" "unprognostic (1.25e-1)" "prognostic favorable (2.59e-5)" "unprognostic (1.18e-2)" "unprognostic (9.97e-2)" "unprognostic (4.21e-2)" "unprognostic (7.06e-2)" 9.3 10.6 20.4 6.9 17.4 3.4 9.7 20.1 29.3 9.4 6.9 13.3 22.3 12.1 2.1 9.3 11.7 3.1 7.1 22.6 17.2 22.9 32.0 8.6 6.0 29.8 27.1 12.9 15.6 9.0 7.5 16.6 2.2 33.8 13.4 3.6 3.2 7.6 4.4 7.9 4.7 19.1 2.7 20.3 11.5 14.9 24.3 26.7 5.3 16.1 3.2 3.1 10.8 7.3 28.2 8.4 22.3 8.2 15.3 8.5 3.6 16.3 8.5 6.8 9.3 11.1 39.8 10.4 15.0 5.9 5.3 5.6 6.4 7.5 6.9 1.3 17.5 19.4 16.9 11.5 13.7 13.5 11.1 17.3 6.5 3.6 6.5 4.4 4.4 5.2 20.9 11.7 12.5 4.7 8.3 27.2 64.7 11.2 6.0 10.7 23.3 6.5 10.0 4.3 5.3 29.3 23.1 8.3 12.7 8.3 4.5 7.1 6.9 8.5 13.6 7.7 10.9 17.1 24.5 31.0 16.4 7.9 12.2 12.6 11.7 6.2 2.9 4.3 7.1 4.0 5.0 3.4 4.2 5.5 8.6 4.8 4.8 2.4 5.6 6.2 5.4 3.7 3.5 20.4 17.4 20.1 29.3 22.6 17.2 29.8 27.1 12.9 33.8 20.3 26.7 28.2 3.7 6.4 7.7 8.5 13.3 3.3 5.7 5.6 4.6 68.5 6.8 6.5 1.5 12.8 6.2 11.0 77.2 6.8 13.6 20.6 1.9 6.2 11.0 6.2 6.1 6.5 16.2 2.1 9.1 5.0 6.3 5.3 15.3 6.9 4.5 14.5 6.4 19.8 8.3 45.4 11.2 11.3 4.1 12.3 7.3 18.4 16.4 6.5 3.6 6.5 11.4 20.8 33.0 6.0 11.9 6.8 16.7 12.8 7.1 6.2 44.2 18.6 4.9 79.9 6.6 6.3 5.4 18.1 6.3 7.3 2.8 4.5 12.3 8.9 17.3 4.3 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619184 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 16079.5" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 290000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: AB_2679705" "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 968.3 1083.7 854.0 760.7 842.3 1993.4 1346.3 808.0 1179.5 1444.4 814.1 992.9 920.4 1060.3 789.4 1800.9 1427.3 725.9 750.8 800.4 837.6 759.2 982.7 736.9 1754.5 856.0 827.8 778.1 3112.5 2363.3 585.5 912.7 753.0 847.9 1272.8 822.1 140.2 1794.7 708.5 1066.9 1923.6 964.6 716.0 893.0 1160.8 1131.7 334.8 884.8 1101.6 887.3 648.7 1410.6 1026.6 1367.4 861.9 1874.4 2697.1 1148.7 1520.6 1267.0 2299.6 1455.1 1042.7 1489.0 1754.3 1471.6 2497.8 1407.6 3436.1 874.1 1007.2 803.9 1400.0 1211.2 2056.9 844.3 1349.6 3380.2 1286.3 1234.0 2438.1 2166.6 1793.6 1309.6 2633.8 3015.8 1031.9 1603.7 1760.0 1836.8 2149.2 1629.3 2043.5 1297.6 2236.5 1926.2 16079.5 1421.6 3171.4 1469.5 2058.1 1073.4 2438.4 1527.9 2370.7 1410.8 1739.1 850.4 2306.0 2082.3 641.1 1241.4 2618.1 1220.9 1032.3 1275.0 727.4 2119.8 1970.9 2939.2 1934.2 649.6 2246.7 1257.7 381.1 1022.8 217.6 1066.6 890.3 1889.0 2384.8 1921.2 1461.0 1380.1 2368.0 2373.9 1981.4 140.7 1357.8 681.2 1451.1 1707.2 3192.5 854.0 842.3 808.0 1179.5 800.4 837.6 856.0 827.8 778.1 847.9 893.0 884.8 861.9 1729.2 593.0 983.1 22.9 4066.2 4468.5 4767.6 3561.4 4933.7 393.5 3680.3 5354.2 264.0 1637.1 1809.1 708.1 143.9 3891.0 2534.2 1344.7 1387.2 1853.2 80.5 1067.0 2619.6 1812.4 1673.5 1713.1 21.7 4530.2 5344.1 1765.9 1597.9 1584.8 1021.6 2791.1 1810.1 1426.6 2225.3 134.6 28.2 3186.8 1253.2 2491.6 3341.9 221.3 3248.9 2059.4 2278.5 16.9 2958.8 1413.2 2345.1 22.6 51.3 3022.6 2516.1 1459.7 2801.6 4727.0 2534.3 1832.5 697.3 433.7 1032.1 2596.1 2246.5 283.4 558.4 5421.3 5559.5 4138.0 2961.3 3084.2 3163.6 5183.8 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637946-48646187 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 332.5;choroid plexus: 171.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 46.1;hTERT-RPE1: 47.1;SCLC-21H: 32.6;U-266/84: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" NA NA "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favorable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favorable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favorable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 8.8 17.4 259.5 3.3 258.1 1.6 8.6 234.9 332.5 14.5 171.2 14.6 8.4 33.3 28.4 8.1 21.6 5.6 8.5 273.4 207.8 11.9 1.7 5.8 5.0 201.5 195.5 266.6 49.2 5.9 58.5 37.5 1.1 220.6 14.1 2.5 30.3 8.9 13.7 9.3 13.5 9.4 18.3 186.7 6.2 13.1 6.5 200.4 6.7 12.2 7.5 5.4 9.3 12.3 252.5 2.0 12.7 22.9 46.1 3.1 1.2 0.6 1.5 14.9 1.5 3.3 3.1 15.7 7.5 1.7 1.7 4.2 4.9 9.4 4.6 1.3 1.6 13.5 3.3 7.2 0.2 3.0 0.3 9.8 5.4 9.2 1.4 2.0 47.1 1.8 19.8 6.1 20.5 0.7 5.0 4.1 1.4 9.9 7.5 4.7 2.6 0.9 16.1 10.1 0.4 32.6 18.2 1.7 1.6 2.7 6.1 6.3 0.8 0.2 3.9 14.2 0.1 0.4 18.9 33.9 1.3 5.7 4.3 2.0 0.0 0.4 0.0 1.5 0.5 1.5 1.0 1.2 1.2 0.7 1.3 1.5 1.3 0.0 1.3 0.0 1.9 1.5 0.7 259.5 258.1 234.9 332.5 273.4 207.8 201.5 195.5 266.6 220.6 186.7 200.4 252.5 5.1 3.2 8.1 11.1 9.3 7.1 9.1 13.2 12.5 81.0 15.5 12.1 5.4 21.5 9.6 31.3 16.7 0.7 9.8 3.9 25.4 11.5 15.0 6.7 6.3 6.7 13.1 3.6 47.0 10.0 0.4 11.6 5.6 7.9 6.3 3.1 8.9 47.5 6.0 28.6 18.1 6.4 16.2 20.4 26.4 7.9 22.1 6.8 8.8 5.6 5.6 50.4 12.3 7.1 6.8 3.4 2.9 26.7 4.3 4.3 20.7 38.7 7.5 30.8 6.6 4.2 8.9 1.3 4.9 5.9 10.9 0.4 6.9 8.7 5.2 6.4 ISOC2 FLJ23469 ENSG00000063241 "Isochorismatase domain containing 2" Q96AB3 19 55452985-55462343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 286.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 272.2;Proximal tubular cells: 479.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 270.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043142 Enhanced Approved Mitochondria,Cytosol NA NA 220000 Mitochondria Cytosol "HPA043142: AB_10794653" "unprognostic (2.74e-1)" "unprognostic (8.38e-3)" "unprognostic (7.34e-2)" "unprognostic (3.09e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-1)" "unprognostic (3.09e-1)" "unprognostic (5.82e-2)" "unprognostic (8.59e-2)" "unprognostic (9.90e-3)" "unprognostic (2.24e-1)" "unprognostic (2.42e-1)" "unprognostic (9.20e-2)" "unprognostic (2.09e-2)" 43.7 56.0 36.0 20.1 35.4 21.6 38.6 37.5 52.8 25.2 39.9 60.1 36.5 28.6 8.1 52.6 26.1 17.3 69.8 34.2 37.7 100.2 286.6 26.6 19.4 41.5 38.3 34.0 23.5 44.7 40.2 46.6 9.3 37.8 41.2 16.5 3.3 42.1 28.9 96.6 36.4 37.5 16.9 38.1 51.2 41.7 66.1 36.4 10.0 39.4 49.4 14.1 41.9 30.5 39.9 52.8 78.1 20.1 55.6 13.6 28.4 67.7 37.9 36.7 45.7 46.4 40.0 88.2 98.6 66.2 42.2 44.0 51.1 39.7 46.6 14.6 38.9 270.2 57.6 17.8 128.0 55.6 63.2 163.5 42.5 44.2 29.4 22.0 20.4 42.4 39.3 93.6 61.1 28.9 101.9 0.3 73.6 32.4 113.2 217.9 72.1 44.4 126.0 75.0 47.7 24.7 70.5 35.5 75.3 41.4 11.9 63.8 109.4 32.4 34.0 48.5 38.8 44.7 78.7 73.0 78.7 52.2 79.4 58.3 0.7 16.0 0.9 12.7 33.8 12.6 18.7 11.6 16.2 29.5 12.6 11.5 11.8 0.7 24.3 27.8 24.1 15.2 15.0 36.0 35.4 37.5 52.8 34.2 37.7 41.5 38.3 34.0 37.8 38.1 36.4 39.9 25.4 6.4 6.3 5.5 38.0 59.5 65.3 148.8 32.5 12.5 51.7 56.5 20.8 48.6 50.3 62.5 2.1 32.5 19.1 200.1 162.4 65.1 44.5 37.8 39.0 36.9 71.3 46.9 3.5 68.1 105.5 44.2 63.7 25.1 45.2 43.2 28.5 272.2 96.0 13.5 5.4 225.4 87.5 44.5 50.6 43.6 38.8 39.0 62.2 2.8 28.0 53.1 21.6 6.6 12.8 56.4 125.8 30.9 80.5 128.7 253.7 479.9 26.1 10.0 26.3 32.0 39.0 183.8 16.4 69.6 68.6 21.6 19.4 123.4 190.7 74.8 U2AF2 U2AF65 ENSG00000063244 "U2 small nuclear RNA auxiliary factor 2" P26368 19 55654146-55674716 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010910, HPA041943, HPA043562" Supported Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA 73000 "Nuclear speckles" Nucleoplasm "CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555" "unprognostic (2.37e-1)" "unprognostic (2.22e-1)" "unprognostic (3.12e-1)" "unprognostic (9.60e-2)" "unprognostic (6.94e-2)" "unprognostic (4.01e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (9.46e-2)" "unprognostic (1.36e-2)" "unprognostic (8.00e-2)" "unprognostic (3.33e-2)" "unprognostic (4.25e-3)" "unprognostic (2.19e-2)" "unprognostic (4.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.08e-2)" 69.1 81.6 66.2 102.8 68.6 149.0 70.8 70.7 83.1 91.5 70.1 80.2 85.9 88.1 57.2 99.0 83.5 54.5 69.1 66.2 73.9 75.1 80.9 74.8 120.3 71.5 67.2 65.4 99.1 75.7 70.7 94.4 64.2 67.8 75.5 54.5 46.4 72.6 66.5 67.8 80.6 93.1 62.7 69.7 116.6 76.1 82.5 67.7 133.7 79.6 46.3 94.4 78.9 81.4 77.9 244.5 394.0 235.9 191.1 108.3 109.8 249.3 191.9 174.1 314.2 305.3 231.3 222.3 284.5 149.5 164.9 160.5 193.0 299.3 268.3 149.1 218.0 501.9 245.2 176.1 221.5 176.7 287.4 263.5 148.8 161.0 239.5 166.8 120.0 190.8 195.9 293.1 181.3 169.9 239.2 388.0 261.1 260.4 217.1 307.2 414.5 149.7 233.0 189.7 290.0 270.6 211.0 208.6 197.1 125.7 134.6 190.5 296.9 161.5 279.7 203.7 130.0 415.9 165.0 239.3 344.5 124.3 279.5 245.2 0.1 1.1 0.8 1.3 1.5 1.0 0.8 1.1 0.9 1.0 1.1 0.8 0.8 2.1 0.6 1.2 1.8 1.1 0.9 66.2 68.6 70.7 83.1 66.2 73.9 71.5 67.2 65.4 67.8 69.7 67.7 77.9 31.0 3.2 9.1 10.4 46.0 45.4 41.4 34.8 57.5 41.8 29.7 21.3 2.7 24.3 20.6 27.6 31.3 58.5 34.1 44.0 19.6 33.0 6.4 33.8 36.0 31.4 45.5 32.6 6.8 23.8 63.0 29.4 51.0 40.9 34.3 30.4 27.5 26.8 37.6 35.3 7.6 42.4 30.5 22.0 32.3 8.4 44.4 31.6 19.6 11.2 37.4 25.3 30.9 4.0 12.0 31.8 29.3 34.3 62.4 41.9 31.9 21.3 15.3 52.0 0.0 26.1 46.6 22.5 32.0 53.5 39.2 71.8 42.7 30.8 43.6 44.9 EPN1 ENSG00000063245 "Epsin 1" Q9Y6I3 19 55675226-55709858 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 387.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 263.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009729, HPA061136, HPA071503" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: " "unprognostic (6.93e-2)" "unprognostic (2.47e-1)" "unprognostic (5.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.94e-2)" "unprognostic (8.76e-2)" "unprognostic (1.23e-2)" "unprognostic (7.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (6.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (2.78e-3)" "unprognostic (7.92e-3)" 56.4 76.0 57.2 27.5 50.4 22.3 53.5 23.8 82.8 48.7 10.4 63.8 89.5 48.2 9.3 81.2 49.2 14.4 131.9 59.0 30.0 83.0 138.3 50.9 19.4 33.2 34.2 53.3 76.8 105.1 22.5 51.5 17.5 36.4 65.4 16.3 9.0 51.3 20.2 157.4 69.7 81.0 11.1 21.0 73.4 153.8 81.5 35.5 11.7 49.4 35.6 11.2 50.5 54.9 41.2 95.5 128.8 31.5 64.8 35.6 33.8 64.6 69.3 39.0 48.2 48.0 54.1 58.7 58.1 46.1 55.6 42.5 71.5 27.7 52.9 17.4 20.4 263.2 42.8 67.4 65.3 48.9 27.8 39.3 43.9 45.6 41.7 30.1 34.7 46.4 40.7 64.7 48.0 32.2 53.6 44.4 45.2 72.3 71.4 179.6 29.5 42.8 103.2 36.8 55.3 45.2 109.9 64.1 68.8 48.0 21.7 51.6 95.7 78.4 133.0 63.8 48.4 101.3 52.2 50.9 41.7 97.9 55.0 67.5 1.4 1.8 2.3 0.6 2.2 0.4 1.0 0.6 0.6 1.1 0.8 0.6 0.6 2.1 0.3 3.6 1.7 0.9 1.5 57.2 50.4 23.8 82.8 59.0 30.0 33.2 34.2 53.3 36.4 21.0 35.5 41.2 62.6 3.2 20.4 9.8 44.2 31.4 29.0 25.9 44.3 33.3 32.7 25.8 15.5 55.8 17.9 44.1 66.7 46.1 28.1 227.7 119.3 57.1 63.2 39.5 37.5 46.1 45.0 35.3 7.8 88.5 80.8 37.2 145.2 45.9 10.8 87.0 83.9 106.1 62.9 28.6 7.8 115.6 22.4 136.5 21.4 169.4 47.5 55.4 23.2 6.5 40.8 33.6 28.8 4.5 8.9 106.5 167.7 53.0 57.7 37.6 387.2 81.8 20.9 41.3 13.1 41.2 34.6 50.2 62.7 46.6 27.4 52.3 26.3 48.2 132.5 39.2 MED29 "DKFZp434H247, IXL, MED2" ENSG00000063322 "Mediator complex subunit 29" Q9NX70 19 39391303-39400641 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055956 Supported Nucleoplasm NA NA Nucleoplasm "HPA055956: AB_2682986" "unprognostic (3.30e-2)" "unprognostic (3.51e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.68e-1)" "unprognostic (1.92e-1)" "unprognostic (2.85e-2)" "unprognostic (1.71e-1)" "unprognostic (5.36e-3)" "unprognostic (1.46e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.15e-5)" "unprognostic (9.51e-2)" "unprognostic (4.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.87e-2)" 18.5 28.8 37.1 16.1 36.4 18.3 19.2 35.4 39.8 22.7 25.7 20.8 17.3 23.4 21.6 16.4 29.0 17.2 22.4 36.1 35.3 21.8 28.2 17.6 19.2 40.2 38.5 34.3 32.2 24.2 42.3 28.1 15.8 36.5 23.3 13.2 18.5 23.3 23.0 38.3 17.5 17.6 18.6 34.1 19.9 20.3 16.6 37.8 18.8 30.1 14.2 16.9 20.9 17.7 37.7 28.3 73.2 21.7 22.3 31.0 23.5 17.3 29.9 31.9 27.1 21.8 36.2 26.6 20.9 38.9 27.7 23.7 14.5 20.3 25.4 16.1 40.8 37.3 26.9 28.8 24.6 25.2 25.8 22.7 25.0 20.3 28.5 31.5 29.3 21.8 39.4 18.1 25.3 27.9 36.7 25.3 7.7 16.6 34.5 25.4 41.3 29.8 29.6 26.3 47.0 33.3 30.1 60.8 39.4 26.6 13.1 30.8 27.9 25.2 22.9 23.8 29.0 30.4 32.5 40.3 35.2 32.3 19.2 37.7 48.2 48.3 41.2 38.3 59.7 38.2 46.5 35.7 35.2 36.9 43.0 42.4 40.6 54.2 40.0 77.5 30.0 46.8 47.0 37.1 36.4 35.4 39.8 36.1 35.3 40.2 38.5 34.3 36.5 34.1 37.8 37.7 33.6 28.9 41.1 8.8 36.5 22.2 30.2 31.9 25.6 24.9 45.0 57.9 36.5 25.8 30.1 31.3 12.5 36.6 34.9 53.3 52.8 28.0 49.8 46.6 40.6 30.4 32.8 27.8 8.1 28.4 31.4 36.3 126.9 46.7 43.7 28.0 37.5 43.4 40.7 23.5 10.1 40.2 40.7 40.3 72.5 71.6 38.5 46.9 28.4 8.4 38.1 37.5 26.8 5.5 13.5 25.5 60.2 32.4 47.8 17.6 86.8 62.3 37.1 15.9 52.6 33.3 52.5 34.8 16.4 29.3 20.3 28.9 40.1 27.9 32.7 17.9 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 321759-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.7" "Group enriched" "Detected in some" 10 "Early spermatids: 299.1;Late spermatids: 168.8;Spermatocytes: 123.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 59.6;HMC-1: 76.8;NB-4: 91.1;WM-115: 53.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA021483 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 1.0 0.7 1.8 0.6 2.1 0.4 0.8 0.0 6.4 3.1 1.0 1.8 0.7 1.6 0.5 2.2 0.7 1.2 0.5 5.4 0.8 0.8 0.7 2.2 0.4 0.7 0.7 3.4 2.7 0.6 0.1 1.5 2.0 1.7 1.0 1.1 0.1 0.8 0.1 0.6 6.0 1.9 0.3 0.2 5.8 1.1 46.7 1.8 0.2 1.4 0.0 0.4 3.5 2.3 1.8 0.4 5.8 1.4 1.0 6.1 11.9 11.0 22.5 30.0 10.7 18.4 0.6 6.7 0.6 10.1 38.6 2.2 0.5 0.9 0.5 5.1 1.2 2.8 8.6 59.6 0.9 3.5 1.6 76.8 1.4 0.8 7.3 1.3 17.3 3.4 0.8 1.0 0.6 11.8 0.7 0.3 91.1 0.5 2.6 8.9 1.3 0.5 0.4 0.5 0.2 10.0 0.4 27.6 3.7 14.7 0.1 0.5 36.4 6.1 20.5 1.6 21.5 0.4 2.6 3.6 0.8 8.3 0.8 53.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 2.1 0.0 6.4 5.4 0.8 0.7 0.7 3.4 1.7 0.2 1.8 1.8 0.6 0.0 0.0 2.0 0.2 2.2 0.0 0.1 0.0 0.4 0.2 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 299.1 0.3 0.8 3.6 0.0 0.0 11.1 0.2 5.8 2.7 0.5 0.7 0.0 0.3 0.0 0.0 0.8 0.0 9.5 0.1 0.0 0.0 9.7 168.8 3.4 1.5 19.6 3.7 5.7 0.2 0.0 3.5 2.9 0.2 0.0 1.2 0.1 0.3 0.1 0.1 0.2 0.2 6.6 0.0 3.0 123.7 6.9 0.1 1.4 0.8 1.2 0.7 0.1 0.2 GSC2 GSCL ENSG00000063515 "Goosecoid homeobox 2" O15499 22 19146993-19150292 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 1.1;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "THP-1: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA043011 Uncertain NA NA "HPA043011: AB_10959883" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF275 ENSG00000063587 "Zinc finger protein 275" Q9NSD4 X 153334147-153360110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell type enhanced" "Detected in many" "Granulosa cells: 76.3;Peritubular cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 57.3" HPA000566 Approved Approved Nucleoli NA NA Nucleoli "HPA000566: AB_1080700" "unprognostic (6.96e-2)" "unprognostic (8.97e-2)" "unprognostic (3.10e-2)" "unprognostic (1.11e-3)" "unprognostic (5.25e-2)" "unprognostic (1.45e-1)" "unprognostic (9.59e-2)" "unprognostic (9.37e-2)" "unprognostic (2.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (4.33e-2)" "unprognostic (2.69e-1)" "unprognostic (1.95e-1)" "unprognostic (3.74e-2)" "unprognostic (1.14e-2)" 8.0 78.1 10.4 5.1 10.4 3.1 7.7 10.7 9.8 7.9 9.8 5.0 3.9 8.5 17.7 2.8 8.6 7.3 4.4 9.4 10.9 5.5 13.6 4.2 6.3 11.5 10.3 9.2 43.0 10.2 32.6 11.0 3.2 10.9 7.3 4.4 5.3 6.5 14.7 4.8 2.2 6.1 7.4 11.4 11.2 6.0 8.6 11.5 6.4 6.9 7.4 8.1 4.8 3.0 12.9 10.2 4.1 8.4 6.1 10.0 9.6 4.1 7.0 11.7 4.4 6.6 4.3 2.1 17.0 14.0 13.3 6.7 1.7 10.1 6.2 6.5 4.1 7.8 5.7 3.8 6.6 13.4 7.0 4.8 11.4 4.5 3.7 7.2 7.2 5.5 9.2 8.5 0.0 8.1 7.4 8.2 5.8 3.7 10.3 7.2 9.6 9.3 6.0 3.3 6.1 4.3 5.8 3.5 0.3 8.4 5.2 1.5 13.0 5.8 6.5 7.8 10.9 9.1 57.3 16.9 32.9 5.9 13.5 4.6 0.3 0.8 0.1 1.6 0.7 1.9 1.9 1.5 1.5 0.7 2.0 2.1 1.8 0.0 1.4 0.7 1.3 2.4 1.0 10.4 10.4 10.7 9.8 9.4 10.9 11.5 10.3 9.2 10.9 11.4 11.5 12.9 26.1 0.0 4.6 7.8 10.9 3.3 4.0 3.6 3.4 6.5 6.2 3.9 5.2 10.0 2.3 9.2 12.5 1.4 9.8 2.6 7.9 2.8 1.3 4.5 15.3 6.6 0.0 8.2 3.8 5.0 4.4 10.5 8.6 8.8 2.5 76.3 7.5 28.3 2.5 0.0 4.8 5.8 4.1 6.0 3.5 4.4 14.3 3.5 3.6 2.8 4.5 6.5 6.2 7.5 3.7 3.9 3.2 39.5 28.7 6.1 2.1 8.3 1.6 2.8 13.1 12.8 11.8 3.5 3.7 4.3 2.3 0.8 7.0 21.5 5.3 2.1 MTMR1 ENSG00000063601 "Myotubularin related protein 1" Q13613 X 150692971-150765108 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 79.3;Excitatory neurons: 61.2;Inhibitory neurons: 58.1;Oligodendrocyte precursor cells: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 104.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018502, HPA075953" Approved Approved Vesicles NA NA Vesicles "HPA018502: AB_1854185, HPA075953: " "unprognostic (2.37e-2)" "unprognostic (1.64e-3)" "unprognostic (2.07e-1)" "unprognostic (1.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (4.35e-2)" "unprognostic (3.16e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-2)" "unprognostic (1.67e-2)" "unprognostic (1.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.19e-1)" "unprognostic (8.40e-2)" 6.6 7.2 11.2 11.2 12.9 12.0 12.6 11.8 12.9 8.3 7.0 9.3 9.1 8.0 7.1 20.8 9.7 7.3 12.4 16.4 10.7 8.4 9.0 9.6 22.0 7.4 9.9 11.7 8.5 10.1 18.0 9.3 14.4 9.9 11.0 9.5 22.2 12.5 11.0 23.1 21.5 10.5 7.3 7.8 14.4 10.8 8.1 11.0 31.6 10.1 16.1 25.7 12.7 13.7 9.9 32.3 20.3 21.5 17.7 4.9 5.7 28.8 28.1 36.0 28.0 39.4 19.8 24.9 70.2 40.1 22.9 27.1 28.4 43.9 40.8 43.2 28.4 26.3 4.4 31.6 8.5 14.5 20.7 14.6 15.6 27.7 30.8 0.4 26.8 17.1 22.9 13.8 17.5 20.3 27.7 30.6 5.3 9.9 35.9 30.3 16.0 34.1 31.2 22.0 36.4 31.9 19.9 10.7 23.7 8.8 17.0 30.3 11.8 21.7 18.3 14.6 2.3 42.1 22.2 24.6 104.8 3.7 13.3 14.4 0.0 0.5 5.0 2.1 0.9 1.5 1.7 2.3 1.9 1.4 1.9 2.0 2.8 1.5 3.9 0.9 5.0 3.2 1.2 11.2 12.9 11.8 12.9 16.4 10.7 7.4 9.9 11.7 9.9 7.8 11.0 9.9 3.7 16.0 6.5 79.3 11.4 11.2 11.0 8.0 6.8 0.0 7.8 5.5 8.2 2.8 7.5 5.5 0.0 10.1 19.3 4.6 0.0 5.9 0.0 10.0 3.7 3.6 9.6 6.5 61.2 6.6 7.3 4.5 7.7 9.2 1.3 4.8 2.9 8.0 4.6 0.0 58.1 5.5 8.2 9.4 8.8 1.7 5.6 4.8 3.6 30.0 6.2 0.0 8.2 54.8 22.6 10.6 8.6 5.3 7.9 11.0 3.8 3.1 8.4 0.0 6.6 6.7 3.9 2.5 3.0 10.3 16.8 10.4 8.8 5.9 5.9 12.5 GPC1 glypican ENSG00000063660 "Glypican 1" P35052 2 240435663-240468076 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 227.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 199.8;Syncytiotrophoblasts: 102.7;Urothelial cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030571, HPA070449" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 9500000 "Plasma membrane, Cytosol" "HPA030571: AB_10602322, HPA070449: " "unprognostic (1.22e-2)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.78e-5)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.95e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (1.00e-2)" "unprognostic (2.15e-1)" "unprognostic (5.08e-3)" "unprognostic (2.28e-1)" "unprognostic (4.38e-1)" "unprognostic (1.91e-1)" "unprognostic (4.40e-2)" "unprognostic (2.92e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-2)" 35.2 79.1 40.0 9.1 33.2 0.4 30.9 20.1 64.9 43.3 0.8 30.2 5.8 37.4 9.3 89.2 31.0 8.6 111.8 39.2 21.6 33.1 36.0 22.1 1.4 24.4 26.7 40.7 45.5 26.0 9.9 56.2 29.2 26.4 68.4 3.6 5.0 35.5 22.7 135.3 227.8 17.6 16.6 5.3 15.7 23.2 49.1 30.4 9.2 15.9 35.6 6.6 35.4 62.9 21.1 69.0 92.9 21.6 56.7 64.3 61.5 87.3 161.5 78.8 18.3 21.2 33.3 74.9 1.8 21.8 172.0 100.1 186.0 11.7 114.7 3.8 33.3 9.8 0.1 80.7 41.7 92.2 1.6 6.2 54.3 73.4 41.2 21.3 38.1 9.7 3.4 0.4 3.3 47.5 36.0 1.3 0.6 33.7 7.7 20.5 12.3 98.2 16.1 15.0 109.6 21.5 14.4 105.7 91.9 10.1 19.3 29.1 7.0 45.6 97.3 162.3 46.9 67.8 0.7 0.4 0.8 69.4 1.7 111.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 33.2 20.1 64.9 39.2 21.6 24.4 26.7 40.7 26.4 5.3 30.4 21.1 1.2 16.0 6.1 45.7 0.7 45.9 69.6 62.2 56.3 22.4 8.3 18.2 53.2 21.5 34.0 25.8 2.1 73.7 0.3 3.7 7.9 27.8 0.9 6.2 24.7 2.8 0.0 0.0 53.0 10.8 199.8 21.0 1.5 8.9 4.5 49.4 11.0 26.3 9.1 25.2 45.0 7.0 16.2 0.6 7.7 3.8 19.0 1.2 35.6 5.6 1.6 24.9 1.0 18.6 8.9 17.6 0.9 7.5 0.9 67.0 0.5 2.3 30.2 6.4 26.3 33.9 38.2 2.2 9.9 44.8 46.2 102.7 1.9 14.5 3.6 110.5 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800109-77935014 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Oligodendrocytes: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Uncertain Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA051012: AB_2681310, HPA055014: AB_2682672" "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.70e-4)" "prognostic favorable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 4.4 8.1 8.2 3.7 8.8 5.3 4.3 8.3 10.0 4.2 8.9 6.7 7.5 4.8 5.2 6.1 4.4 3.9 8.2 8.7 8.6 6.7 8.6 4.0 4.1 10.0 8.5 8.7 4.8 6.8 6.6 8.4 5.2 9.8 6.5 5.9 3.8 6.7 5.4 9.0 5.9 5.7 6.4 8.0 7.3 6.1 4.6 9.0 5.2 6.0 5.3 4.8 5.2 4.0 11.2 5.5 9.1 4.4 17.4 13.0 6.5 6.2 5.7 7.9 4.5 5.6 4.7 12.4 12.0 8.5 9.5 7.5 10.2 27.0 9.3 2.9 6.3 9.1 2.8 4.9 7.5 12.2 4.5 6.6 7.7 16.2 1.9 5.7 4.4 7.1 10.1 11.4 7.4 5.9 24.5 5.8 7.6 9.6 17.5 10.2 9.1 0.7 9.0 6.6 13.9 10.4 6.0 10.6 14.7 5.9 6.8 20.9 9.4 6.8 4.6 3.4 8.9 4.6 6.4 7.7 6.3 6.6 7.7 5.8 1.3 4.0 1.4 4.2 6.0 2.9 1.4 1.6 2.4 7.4 3.0 1.9 3.4 0.3 3.2 2.5 5.5 3.1 2.5 8.2 8.8 8.3 10.0 8.7 8.6 10.0 8.5 8.7 9.8 8.0 9.0 11.2 1.9 0.0 3.7 10.1 1.8 0.9 1.8 3.9 2.8 5.9 2.9 3.0 5.7 4.3 2.8 0.0 20.9 8.2 4.2 4.0 3.9 4.4 1.5 2.0 2.4 1.4 1.8 2.1 10.3 5.1 4.2 2.4 6.6 2.4 1.3 5.0 1.8 6.6 9.6 8.4 11.7 4.0 4.1 4.4 1.5 0.8 1.5 5.1 0.0 5.6 2.5 4.0 3.1 11.6 29.0 2.8 1.3 1.9 3.2 1.5 3.0 3.8 2.4 9.3 0.0 2.1 1.6 1.8 9.9 4.3 1.4 5.3 2.2 4.6 5.4 1.2 HAGH "GLO2, GLXII, HAGH1" ENSG00000063854 "Hydroxyacylglutathione hydrolase" Q16775 16 1795620-1827157 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 378.7;Proximal tubular cells: 501.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043041, HPA061143" Approved NA NA 2800000 "HPA043041: AB_2678284, HPA061143: AB_2684439" "unprognostic (3.11e-1)" "prognostic favorable (5.82e-5)" "unprognostic (2.54e-1)" "unprognostic (1.93e-2)" "unprognostic (5.84e-2)" "unprognostic (1.54e-1)" "prognostic favorable (5.33e-6)" "unprognostic (5.78e-3)" "unprognostic (3.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.34e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.81e-6)" "unprognostic (1.20e-1)" "unprognostic (6.24e-2)" "unprognostic (7.18e-3)" "prognostic favorable (5.19e-4)" 40.6 109.9 78.5 20.4 82.4 82.8 35.4 81.0 104.6 23.0 75.3 48.4 45.7 24.8 31.3 29.2 28.8 22.1 139.9 88.3 83.2 101.0 238.1 39.5 24.8 81.1 79.4 82.0 22.2 64.1 54.4 73.2 23.3 82.3 33.8 23.5 32.5 32.7 38.0 200.7 30.9 45.1 25.0 78.6 35.4 53.3 92.4 81.9 36.1 35.4 157.5 18.5 35.1 24.8 89.0 31.1 46.1 40.9 46.5 35.1 13.8 37.0 38.1 35.2 57.7 46.1 23.7 26.5 6.4 76.5 32.9 39.6 33.2 39.1 38.2 17.2 64.5 63.4 12.0 47.9 69.3 50.2 15.7 62.6 16.9 80.6 28.8 19.6 50.6 50.1 79.8 16.1 56.3 18.3 51.2 41.1 34.0 15.7 32.0 42.3 34.2 25.8 73.6 74.5 13.8 54.7 47.4 41.8 52.9 84.9 30.8 38.7 52.0 38.7 17.5 21.5 36.9 44.6 63.3 64.7 19.8 29.8 14.5 28.5 37.3 33.3 64.9 26.0 59.1 19.0 31.3 34.0 27.3 30.7 30.4 32.0 27.4 29.7 25.5 88.2 64.8 42.8 30.3 78.5 82.4 81.0 104.6 88.3 83.2 81.1 79.4 82.0 82.3 78.6 81.9 89.0 46.2 9.6 39.0 11.8 33.7 23.8 45.1 59.7 12.0 117.1 39.5 31.1 84.2 65.8 39.7 46.0 64.6 52.4 43.2 60.9 158.5 45.6 193.1 75.0 12.1 35.3 39.6 378.7 24.6 38.3 38.5 25.6 23.9 35.5 30.4 36.0 41.0 186.9 76.2 138.0 22.2 41.2 93.6 49.0 41.6 60.1 46.9 47.6 55.2 12.2 50.1 95.2 64.9 7.1 19.7 49.7 68.8 54.9 50.4 48.3 168.9 501.7 70.2 117.0 72.3 33.3 61.1 245.2 68.3 29.1 45.6 68.7 44.1 45.3 39.9 49.9 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" NA NA "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: AB_2680726" "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavorable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 30.1 31.1 23.8 36.3 24.6 46.8 29.4 25.7 25.2 29.1 25.3 27.8 29.3 29.7 28.6 30.9 28.7 28.5 25.8 24.1 24.4 30.6 26.1 28.1 50.3 25.8 25.6 23.6 31.3 31.4 33.8 27.0 28.6 25.1 28.4 27.7 24.2 28.2 28.3 27.9 29.7 30.7 33.4 23.4 40.7 30.3 32.1 28.3 50.6 31.0 23.4 50.4 35.3 27.1 25.2 60.9 57.0 57.9 42.0 50.6 52.2 65.6 73.3 83.4 77.3 70.0 65.1 56.8 77.6 42.0 76.0 101.5 39.7 63.5 58.6 72.7 37.6 38.5 92.4 54.6 62.6 76.6 66.7 77.8 61.0 69.7 72.3 59.4 53.6 73.1 64.8 50.0 103.2 80.4 43.5 105.0 92.5 89.8 52.3 70.9 76.6 55.3 40.8 52.6 74.5 54.3 51.0 50.5 40.4 52.1 62.9 63.1 50.6 60.0 65.8 32.0 64.2 115.4 131.3 189.5 82.6 64.6 72.7 69.5 44.7 70.0 104.6 97.7 95.4 97.2 85.0 82.2 97.0 84.1 59.1 78.8 80.3 77.2 99.2 103.8 56.5 98.8 128.6 23.8 24.6 25.7 25.2 24.1 24.4 25.8 25.6 23.6 25.1 23.4 28.3 25.2 31.1 22.4 17.5 17.0 36.0 27.5 18.4 17.7 31.3 11.9 24.0 16.0 20.7 12.8 21.3 22.0 16.7 21.3 45.9 16.5 21.5 22.2 14.0 17.0 22.8 21.7 12.1 15.4 15.9 23.3 35.0 19.5 23.0 23.9 14.5 22.7 16.4 20.4 19.7 13.5 17.8 16.8 8.2 34.0 28.5 22.4 17.1 27.8 7.2 18.7 35.1 11.5 43.3 13.0 16.3 29.8 14.3 20.7 47.8 27.1 23.1 21.2 17.6 17.7 26.3 18.2 22.0 31.2 48.6 27.0 32.1 21.8 39.7 16.4 18.9 32.9 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 67.2" "Cell type enhanced" "Detected in many" "dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535" "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favorable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 11.6 10.3 3.0 28.9 2.1 67.2 14.0 1.5 2.5 9.6 4.9 16.3 20.7 8.6 13.3 13.0 14.2 13.3 5.2 1.9 2.3 10.8 14.2 19.8 38.0 2.5 2.7 1.8 7.8 7.9 2.9 3.4 10.0 2.3 7.0 17.8 4.7 8.5 7.4 3.3 12.2 26.2 10.0 3.2 37.4 16.1 4.4 2.2 24.6 8.0 3.1 29.9 18.2 8.7 2.5 33.6 26.6 7.7 22.2 20.7 29.7 12.0 13.8 13.2 16.0 26.2 36.1 54.9 3.7 29.6 10.7 28.7 16.2 17.2 16.1 31.3 21.1 15.4 31.0 21.9 35.1 17.1 25.6 33.8 25.9 38.0 30.1 23.9 13.4 15.1 26.9 28.6 69.1 14.7 13.1 32.1 25.9 12.6 17.5 23.7 24.7 15.9 55.4 30.8 35.3 2.3 1.1 17.9 29.8 18.0 7.0 8.0 19.1 19.6 17.3 18.0 9.0 10.9 63.1 30.2 21.2 25.3 33.1 16.6 76.1 39.5 77.1 70.7 51.2 66.0 40.9 57.8 75.9 41.6 24.0 37.0 47.2 153.6 70.6 51.5 18.6 75.0 40.6 3.0 2.1 1.5 2.5 1.9 2.3 2.5 2.7 1.8 2.3 3.2 2.2 2.5 8.5 25.6 26.7 0.7 50.0 7.5 13.0 6.1 10.2 2.1 12.9 9.3 2.5 10.0 13.0 5.5 10.4 8.5 107.4 37.0 15.6 12.3 5.9 25.6 8.1 10.1 4.2 10.5 2.5 8.4 12.1 9.5 19.4 27.2 24.6 10.4 5.3 11.7 11.9 0.0 1.3 15.2 4.1 25.3 15.7 1.9 2.5 25.0 7.2 10.3 35.6 0.2 132.8 1.0 0.5 11.2 30.1 0.7 73.4 9.7 22.3 23.6 14.2 0.4 0.0 4.5 3.7 0.8 0.4 13.1 7.7 3.4 86.9 10.6 17.4 12.7 LIMCH1 "DKFZP686A01247, LIMCH1A, LMO7B" ENSG00000064042 "LIM and calponin homology domains 1" Q9UPQ0 4 41359607-41700044 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 205.8;tongue: 280.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 650.7;Excitatory neurons: 434.8;Inhibitory neurons: 551.3;Oligodendrocytes: 1102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "myeloid DC: 1.3" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.3" "Cell line enhanced" "Detected in many" "EFO-21: 106.2;HeLa: 180.0;hTERT-RPE1: 146.9;RT4: 181.0;SiHa: 102.5;WM-115: 144.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004184, HPA063840" Uncertain Approved "Actin filaments" NA NA 5600 "Actin filaments" "HPA004184: AB_1078673, HPA063840: AB_2685133" "prognostic unfavorable (5.55e-6)" "unprognostic (3.63e-2)" "unprognostic (1.67e-1)" "unprognostic (5.42e-3)" "unprognostic (8.30e-2)" "unprognostic (1.27e-1)" "unprognostic (7.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.05e-1)" "unprognostic (7.00e-2)" "unprognostic (1.95e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.82e-7)" "unprognostic (2.84e-1)" "unprognostic (6.77e-2)" "unprognostic (2.01e-2)" "unprognostic (2.24e-3)" 43.0 36.7 86.2 5.0 113.4 0.2 22.2 99.0 84.2 11.5 27.3 8.0 4.6 6.5 5.8 17.3 17.5 21.9 97.1 77.7 94.9 29.2 11.9 122.6 2.4 101.8 112.8 65.3 35.9 10.6 72.2 16.4 9.6 114.3 56.0 7.5 36.0 73.0 25.0 205.8 12.3 7.3 10.4 106.6 108.7 10.1 9.5 98.2 7.4 41.4 280.0 3.4 25.5 7.6 145.3 2.4 26.7 40.3 2.7 0.1 0.1 3.9 33.9 17.1 33.2 16.7 4.1 10.5 0.1 106.2 90.5 1.0 18.8 23.1 15.6 37.2 0.2 3.1 0.1 180.0 0.2 33.4 0.0 0.2 0.6 44.5 0.0 10.3 146.9 3.3 0.0 0.0 0.1 9.6 14.9 0.1 0.1 2.8 5.8 2.9 0.0 49.2 0.7 27.9 181.0 37.9 76.8 102.5 40.2 0.6 32.2 3.0 0.2 0.1 0.4 38.6 9.3 26.0 0.1 0.1 0.3 2.6 0.0 144.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.2 113.4 99.0 84.2 77.7 94.9 101.8 112.8 65.3 114.3 106.6 98.2 145.3 101.4 650.7 211.5 205.3 0.8 39.0 50.9 5.9 33.6 32.1 80.0 32.3 242.4 28.6 90.1 95.6 37.5 16.4 0.4 4.8 21.5 40.3 107.7 31.0 10.6 77.6 9.6 0.0 434.8 14.0 45.7 51.8 16.3 44.3 5.1 13.8 128.5 11.5 13.0 0.0 551.3 11.7 6.1 13.3 30.9 29.0 1.8 5.2 14.2 121.8 19.5 82.6 0.0 64.8 1102.9 5.5 9.3 7.5 0.3 103.3 4.4 10.6 75.7 69.7 0.0 37.5 12.9 5.0 15.6 25.2 30.5 46.1 2.8 67.9 5.5 52.8 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 9.3 21.5 10.6 11.4 14.5 17.4 11.8 14.2 14.4 9.9 9.8 9.8 10.0 10.1 10.4 14.7 8.6 8.3 11.2 10.8 12.9 13.3 15.2 7.9 16.9 16.0 13.5 9.8 8.1 11.6 8.1 8.2 10.1 15.5 8.5 10.8 22.0 9.1 7.1 19.2 11.9 8.6 12.0 16.4 13.0 15.5 12.2 14.0 18.8 10.0 18.2 17.0 12.9 10.7 21.4 33.4 38.1 21.5 46.4 30.5 48.9 30.9 44.9 27.4 43.3 48.1 58.4 43.1 82.7 45.0 25.1 40.6 46.2 56.1 43.6 72.8 39.5 37.4 66.7 44.5 44.9 53.9 110.6 38.4 26.3 32.2 69.5 147.0 53.5 56.8 35.6 71.5 31.9 46.7 40.9 57.9 197.8 94.6 45.6 68.9 40.8 62.3 114.0 36.4 31.0 17.8 16.7 39.1 30.6 47.4 72.8 42.6 23.4 36.5 50.1 36.2 85.6 55.1 15.6 19.6 119.4 33.1 75.8 36.2 7.8 8.1 7.8 14.6 5.7 22.1 9.7 18.2 18.2 9.9 11.3 12.7 15.7 2.5 25.9 5.2 6.7 28.1 10.5 10.6 14.5 14.2 14.4 10.8 12.9 16.0 13.5 9.8 15.5 16.4 14.0 21.4 7.2 22.4 7.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 7.9 8.3 0.0 0.0 2.5 5.5 0.0 11.8 8.8 0.0 3.9 13.7 0.0 8.7 16.7 3.9 0.0 0.0 0.0 11.9 16.1 8.3 0.0 8.2 7.6 13.9 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.6 0.0 0.0 11.6 2.9 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 13.1 6.5 18.5 0.0 0.0 TM7SF3 ENSG00000064115 "Transmembrane 7 superfamily member 3" Q9NS93 12 26971579-27014434 "Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 260.4" "Cell type enhanced" "Detected in all" "Late spermatids: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 553.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057640 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA057640: " "unprognostic (4.24e-1)" "unprognostic (1.90e-2)" "unprognostic (1.04e-3)" "unprognostic (8.80e-2)" "unprognostic (5.82e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-2)" "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" 38.4 49.3 24.0 28.5 24.7 66.6 33.5 19.5 27.0 38.2 32.1 61.1 40.8 30.2 49.0 61.8 41.0 58.9 18.5 23.4 25.2 260.4 139.6 54.2 29.4 24.4 23.3 21.5 33.2 118.9 42.7 20.2 36.3 23.0 36.4 69.8 39.2 41.9 44.3 13.9 40.8 35.6 46.2 26.3 33.0 49.2 30.8 24.3 102.4 44.4 35.7 40.2 47.9 28.8 31.0 70.0 147.8 82.6 104.7 122.1 74.3 438.7 74.3 132.8 65.1 109.9 73.3 289.2 80.9 92.3 78.1 61.1 71.5 85.9 553.0 77.0 84.1 46.7 126.9 168.2 134.1 76.7 439.5 84.9 48.7 382.6 144.3 111.7 191.8 177.2 242.2 53.8 60.1 97.1 114.9 232.4 189.3 170.5 266.8 75.4 216.9 131.8 164.2 93.7 278.2 14.4 72.9 84.8 56.6 121.0 391.6 151.8 77.2 62.4 53.9 92.1 140.3 93.4 38.5 97.3 152.9 115.5 133.7 78.5 11.2 7.4 19.0 6.0 8.1 5.4 8.7 8.0 7.8 12.4 13.5 11.1 7.1 6.2 13.7 3.8 10.1 13.9 4.7 24.0 24.7 19.5 27.0 23.4 25.2 24.4 23.3 21.5 23.0 26.3 24.3 31.0 23.2 12.8 27.6 28.4 20.2 28.8 52.4 78.7 96.8 50.0 17.2 19.8 10.3 127.2 46.0 42.3 43.8 40.0 35.2 22.2 17.6 62.1 82.4 23.0 5.7 19.4 13.2 49.0 83.1 39.6 15.2 23.5 32.1 21.1 14.0 48.5 22.5 42.5 39.5 23.5 50.4 24.0 28.5 25.7 11.1 148.8 15.5 27.1 65.8 26.2 27.4 30.8 27.8 63.8 40.0 25.3 28.1 23.0 38.2 18.1 25.5 143.7 24.9 38.4 6.6 27.4 18.4 10.1 22.3 65.0 27.8 16.3 21.8 21.6 31.3 37.6 DLX3 ENSG00000064195 "Distal-less homeobox 3" O60479 17 49990005-49995224 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 50.6" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 35.9;Extravillous trophoblasts: 69.1;Syncytiotrophoblasts: 96.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 135.9;SK-BR-3: 44.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA031164 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031164: AB_10603565" "unprognostic (1.20e-1)" "unprognostic (1.75e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (1.95e-1)" "unprognostic (2.63e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (1.77e-2)" "unprognostic (7.98e-2)" "unprognostic (1.44e-5)" "unprognostic (3.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" 0.4 0.2 0.0 0.1 0.0 0.0 1.3 0.2 0.5 1.0 0.1 0.1 0.0 0.0 0.3 3.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.0 0.3 0.2 0.6 0.2 7.5 0.4 0.5 0.0 0.0 1.5 0.7 0.0 50.6 0.3 0.0 0.3 0.0 0.0 0.6 0.1 0.2 1.9 0.0 3.0 0.4 4.0 0.0 0.5 0.0 0.0 2.6 0.8 0.6 135.9 0.1 0.0 0.0 0.0 1.3 0.2 0.0 1.5 1.6 0.0 17.1 7.1 0.1 0.0 0.0 0.3 0.0 4.2 0.2 0.0 0.0 0.5 0.0 12.7 0.4 0.0 0.0 0.0 0.9 0.1 0.0 1.7 4.1 0.0 0.4 0.5 0.3 0.6 0.0 0.0 0.3 0.0 1.9 15.1 0.1 1.5 44.1 0.0 9.1 17.5 0.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.3 0.4 0.0 0.4 0.3 0.1 0.0 0.2 0.0 0.5 0.0 0.0 5.0 0.4 1.1 9.1 0.0 3.5 5.3 2.0 0.0 0.2 0.0 0.0 35.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.0 69.1 0.7 0.0 0.2 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.0 2.0 3.4 5.1 96.0 0.1 0.0 0.0 0.5 SPA17 "CT22, SP17" ENSG00000064199 "Sperm autoantigenic protein 17" Q15506 11 124673844-124697518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 233.1" "Cell type enhanced" "Detected in many" "Early spermatids: 1583.7;Endometrial ciliated cells: 371.2;Late spermatids: 2667.9;Respiratory ciliated cells: 368.6;Spermatocytes: 580.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037568 Enhanced Approved Vesicles NA NA Vesicles "HPA037568: AB_10672905" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (2.39e-3)" "prognostic favorable (1.03e-4)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-4)" "unprognostic (2.64e-1)" "unprognostic (3.80e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.71e-3)" "unprognostic (6.78e-2)" "unprognostic (9.78e-3)" "unprognostic (8.52e-2)" "unprognostic (2.71e-1)" 2.8 4.2 3.8 1.1 2.9 1.6 3.8 3.1 2.7 3.7 8.0 4.9 1.4 4.4 10.6 5.1 24.8 2.3 4.1 2.8 4.9 10.1 2.1 7.7 1.0 4.5 3.9 2.4 1.6 4.4 4.7 13.6 0.9 4.0 4.3 3.3 1.0 3.5 2.2 1.2 2.4 3.0 1.6 4.5 1.8 4.1 233.1 3.3 2.6 9.0 0.2 1.4 3.2 3.0 3.5 4.1 5.4 12.6 4.3 4.2 6.4 4.7 3.8 8.4 5.4 4.4 1.4 11.5 2.8 2.2 6.7 4.3 3.4 4.9 8.0 7.3 2.6 3.6 3.6 0.8 2.4 2.3 1.0 1.6 2.6 4.8 7.9 4.1 4.2 4.5 5.7 5.5 2.2 12.4 5.5 0.5 0.2 4.7 8.3 4.3 3.8 1.5 0.1 12.8 3.1 6.6 5.8 9.1 2.7 1.8 4.6 17.1 3.1 3.2 4.8 3.8 2.8 4.5 1.4 0.9 1.1 5.0 0.9 5.1 0.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.2 3.8 2.9 3.1 2.7 2.8 4.9 4.5 3.9 2.4 4.0 4.5 3.3 3.5 5.9 3.2 12.6 3.6 0.9 2.7 4.7 26.9 1.8 2.6 6.2 6.5 2.1 17.2 54.2 20.2 4.2 6.7 2.3 13.0 19.6 29.2 1583.7 371.2 13.8 7.2 7.2 3.2 5.8 15.5 10.8 5.8 8.2 19.4 0.0 7.1 1.8 1.5 11.9 0.0 2.8 9.2 32.6 3.1 1.0 2667.9 28.0 6.6 1.8 1.9 2.6 8.1 0.0 1.0 0.7 12.7 10.0 18.0 1.4 2.9 6.3 47.0 368.6 1.2 13.1 6.2 10.5 580.0 63.6 4.9 2.3 2.7 2.6 8.4 10.4 5.6 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318204 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 20.1;heart muscle: 11.6;lymphoid tissue: 5.6" "Cell type enhanced" "Detected in some" "dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 0.5 0.5 0.2 1.6 0.2 20.1 0.3 0.5 0.2 1.1 0.0 0.5 0.3 0.7 0.2 0.4 0.5 1.4 11.6 0.1 0.5 0.2 0.4 2.1 5.6 0.3 0.3 0.0 0.5 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.2 0.9 0.5 0.3 0.6 0.5 0.0 0.1 3.5 0.9 0.2 0.2 0.9 0.2 0.2 2.5 0.7 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 15.0 0.0 0.1 0.6 6.6 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.9 0.0 40.5 31.8 4.2 25.8 40.9 16.5 2.4 9.1 22.7 32.2 1.1 7.2 27.1 17.3 58.6 46.0 1.6 13.2 21.7 0.2 0.2 0.5 0.2 0.1 0.5 0.3 0.3 0.0 0.3 0.1 0.2 0.5 0.5 0.0 6.7 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.2 0.1 15.9 0.0 0.6 0.0 0.0 0.1 44.6 0.0 0.0 0.0 0.8 0.1 0.3 0.8 0.0 20.6 0.0 0.0 0.3 1.3 0.5 0.0 30.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 6.5 19.6 4.1 0.9 13.6 1.8 1.0 14.4 0.2 87.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 21.9 0.0 0.0 0.1 CCN5 "CT58, CTGF-L, WISP-2, WISP2" ENSG00000064205 "Cellular communication network factor 5" O76076 20 44714844-44728509 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 253.2;cervix: 321.0" "Cell type enriched" "Detected in some" 6 "Fibroblasts: 165.2" "Cancer enhanced" "Detected in many" "melanoma: 8.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 42.6;ASC TERT1: 113.8;HeLa: 62.7;HSkMC: 46.5;U-2197: 375.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB019273 Approved "Secreted to extracellular matrix" NA NA 1200000 "CAB019273: " "unprognostic (1.87e-1)" "unprognostic (2.64e-1)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.70e-1)" "unprognostic (2.83e-1)" "unprognostic (1.83e-1)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.42e-2)" "unprognostic (2.81e-1)" "unprognostic (7.95e-3)" "unprognostic (1.76e-10)" "unprognostic (1.55e-3)" "unprognostic (7.21e-2)" "unprognostic (4.84e-2)" "unprognostic (1.28e-1)" 253.2 41.9 1.5 0.7 1.5 0.2 117.5 0.7 2.9 321.0 0.8 18.4 0.7 35.5 0.7 25.6 39.4 7.7 96.8 1.3 0.9 0.7 5.6 137.6 1.9 1.4 1.3 1.3 148.4 4.4 0.6 0.8 1.5 1.2 37.3 1.6 0.1 30.9 25.7 39.5 163.6 11.6 6.5 0.7 4.0 11.5 33.4 1.2 1.3 14.4 5.2 0.4 37.0 112.5 1.4 0.0 3.7 0.1 0.0 42.6 113.8 0.0 0.2 1.2 0.1 0.2 0.0 0.0 0.1 0.5 0.7 3.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 62.7 0.0 0.1 0.1 0.1 46.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 1.1 0.3 0.0 1.9 0.2 0.0 0.1 0.2 375.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 0.7 2.9 1.3 0.9 1.4 1.3 1.3 1.2 0.7 1.2 1.4 25.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 165.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRT3 DMRTA3 ENSG00000064218 "Doublesex and mab-3 related transcription factor 3" Q9NQL9 9 976655-991732 "Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.1;parathyroid gland: 27.1;testis: 10.2" "Cell type enhanced" "Detected in some" "Early spermatids: 4.8;Smooth muscle cells: 2.3;Spermatocytes: 13.9;Spermatogonia: 5.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 4.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.0;HEK 293: 1.4;hTERT-RPE1: 2.1;THP-1: 2.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" HPA077685 Approved NA NA "HPA077685: AB_2732357" "unprognostic (2.42e-1)" "unprognostic (2.26e-1)" "unprognostic (1.51e-2)" "unprognostic (2.13e-4)" "unprognostic (1.73e-2)" "unprognostic (3.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (3.84e-1)" "unprognostic (2.12e-3)" "unprognostic (2.91e-2)" "unprognostic (5.84e-1)" "unprognostic (1.05e-2)" "unprognostic (1.11e-1)" 2.0 0.0 0.8 0.0 0.2 0.0 1.7 0.0 1.0 0.0 8.1 0.1 0.0 0.1 0.0 0.3 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.3 0.2 0.2 0.0 0.0 27.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.7 0.5 0.0 0.2 0.2 0.0 0.0 10.2 0.1 0.1 5.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 1.0 1.4 0.0 0.3 0.2 0.2 0.2 0.2 0.1 1.2 1.5 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.3 0.5 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 13.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST3GAL6 "SIAT10, ST3GALVI" ENSG00000064225 "ST3 beta-galactoside alpha-2,3-sialyltransferase 6" Q9Y274 3 98732236-98821201 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 128.8;Hepatocytes: 86.8;Microglial cells: 134.0;Oligodendrocyte precursor cells: 171.4" "Cancer enriched" "Detected in many" 5 "melanoma: 17.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 49.6;neutrophil: 57.6" "Group enriched" "Detected in many" 143 "dendritic cells: 24.2;granulocytes: 57.6;monocytes: 17.4" "Group enriched" "Detected in many" 4 "RPMI-8226: 96.5;SK-MEL-30: 114.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018792 Approved NA NA 5800000 "HPA018792: AB_10964349" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (4.17e-2)" "unprognostic (5.20e-3)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-3)" "unprognostic (2.40e-1)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "unprognostic (4.32e-1)" "unprognostic (3.91e-3)" "unprognostic (6.15e-3)" "unprognostic (9.44e-2)" "unprognostic (9.47e-3)" "unprognostic (6.79e-4)" 14.8 8.0 10.1 3.8 10.3 2.5 6.4 14.6 10.9 4.9 4.2 3.1 2.0 2.2 12.1 1.9 6.3 2.2 26.7 10.3 10.3 14.2 56.5 7.9 1.6 19.9 10.6 8.0 1.2 3.5 1.1 4.1 8.6 14.9 3.3 2.8 1.5 19.7 2.1 8.0 16.8 1.9 2.1 15.4 3.2 4.6 1.7 9.8 10.7 2.9 6.5 2.8 1.6 1.4 14.3 0.3 1.3 1.8 2.7 3.3 1.1 12.5 0.4 1.5 1.2 2.2 8.7 0.5 6.4 3.3 0.0 4.6 2.1 3.9 2.0 1.1 0.0 2.7 0.2 0.6 15.1 14.0 13.2 23.7 1.5 0.1 3.5 6.6 22.4 14.2 2.6 0.0 6.3 1.3 0.0 2.1 22.6 3.5 0.0 3.5 1.3 1.5 96.5 3.4 0.0 3.8 19.2 5.1 0.5 114.2 3.6 0.4 23.1 10.8 2.9 2.4 0.8 1.3 24.1 2.0 0.0 4.6 18.6 10.3 18.5 17.4 49.6 0.0 9.6 0.0 0.1 0.0 0.0 24.2 0.0 0.2 0.0 57.6 0.1 4.9 5.5 0.0 4.7 10.1 10.3 14.6 10.9 10.3 10.3 19.9 10.6 8.0 14.9 15.4 9.8 14.3 10.1 12.8 35.2 2.3 2.3 11.5 2.6 7.0 2.2 1.2 6.4 5.7 40.4 2.8 2.8 3.7 8.4 45.2 0.0 0.0 13.7 6.8 0.3 128.8 4.2 20.2 16.1 6.6 78.5 2.0 69.5 3.8 9.2 41.0 39.1 1.8 32.5 86.8 34.4 0.0 64.2 0.1 30.5 29.5 64.2 1.0 2.8 38.4 65.8 134.0 38.0 0.9 0.0 171.4 51.6 6.2 0.1 6.8 18.0 5.2 0.0 10.0 27.5 3.5 6.6 1.7 2.2 0.1 1.0 2.1 12.8 27.0 2.0 0.3 0.3 1.8 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.7;skin 1: 26.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.0 0.0 1.2 2.5 1.4 11.1 2.6 0.6 1.1 6.5 0.4 30.3 27.5 1.0 0.1 4.8 6.9 4.7 0.0 1.3 0.9 1.8 0.1 10.6 0.0 1.1 0.9 1.2 0.0 0.7 3.3 1.1 0.9 1.0 12.6 37.7 1.0 19.8 0.2 0.1 26.2 20.4 0.6 0.6 0.4 5.9 0.4 0.9 0.0 9.0 0.0 0.5 4.1 4.6 0.9 6.2 0.4 0.9 0.1 0.0 0.0 6.4 0.2 0.0 0.0 0.0 5.8 5.2 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 44.4 0.1 0.0 0.0 0.2 0.0 19.3 4.9 0.0 0.0 33.0 0.2 0.9 11.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.6 1.1 1.3 0.9 1.1 0.9 1.2 1.0 0.6 0.9 0.9 0.0 32.1 56.2 4.2 0.0 0.6 14.3 39.9 0.6 1.3 20.8 3.2 0.8 5.7 50.0 0.0 0.0 2.0 0.1 44.4 0.0 9.0 3.2 26.8 2.5 0.7 34.2 0.0 8.3 2.5 2.4 0.5 22.4 28.0 8.9 0.0 0.0 0.1 0.3 0.0 1.8 82.3 8.2 0.0 1.2 1.9 0.0 0.6 1.8 1.0 0.0 1.9 0.0 58.8 2.4 4.7 29.2 0.0 0.0 13.8 10.2 1.8 78.2 5.2 0.0 0.1 1.8 0.8 1.0 1.5 1.1 24.1 0.9 0.2 77.1 9.9 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515008 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 52.4;Basal squamous epithelial cells: 36.5;Ionocytes: 89.5;Leydig cells: 96.0;Muller glia cells: 151.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.2" "Group enriched" "Detected in some" 7 "RH-30: 200.1;WM-115: 225.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 10.1" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 490000 "Nucleoplasm, Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavorable (3.40e-4)" 27.5 20.9 4.4 8.3 11.1 0.4 20.5 15.9 42.6 11.8 4.5 13.7 2.4 12.1 4.1 6.5 20.4 9.5 30.3 3.2 40.9 8.0 23.0 2.9 5.1 16.3 15.6 7.5 4.1 11.0 1.3 10.6 14.8 13.2 19.3 2.4 45.5 21.3 7.6 4.8 15.3 8.0 8.3 12.1 23.1 7.9 7.8 12.3 2.0 29.1 1.3 3.9 15.5 13.3 23.2 0.0 0.1 6.3 10.2 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.1 0.0 2.1 0.1 3.4 4.8 1.5 4.6 0.0 0.4 0.7 0.4 0.0 3.8 0.4 0.3 0.3 20.9 0.3 0.6 1.5 0.1 0.0 0.0 0.0 0.1 29.5 0.6 0.0 0.1 3.8 0.0 0.2 3.9 200.1 0.2 0.0 0.0 1.9 1.3 0.1 0.0 14.0 7.4 0.4 0.2 0.0 0.1 3.4 0.6 10.2 0.2 0.3 0.1 0.2 1.9 225.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 4.4 11.1 15.9 42.6 3.2 40.9 16.3 15.6 7.5 13.2 12.1 12.3 23.2 1.2 0.0 0.0 0.0 1.1 3.6 33.1 52.4 36.5 4.8 2.4 10.9 0.7 0.0 3.8 0.0 4.2 0.5 4.0 0.0 0.0 0.1 0.7 0.2 0.6 1.3 0.0 0.0 0.1 0.0 0.5 7.3 0.5 0.2 0.0 0.0 1.8 0.2 0.1 0.0 0.0 0.0 89.5 0.0 3.1 2.9 96.0 0.7 16.0 0.0 0.0 151.7 0.0 0.0 6.5 0.0 0.0 27.8 1.0 3.7 0.0 0.1 1.7 7.0 32.9 1.7 12.9 0.4 0.9 1.8 1.7 0.1 2.3 0.4 0.0 2.9 CDON "CDO, CDON1, ORCAM" ENSG00000064309 "Cell adhesion associated, oncogene regulated" Q4KMG0 11 125955796-126063335 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 58.3;Fibroblasts: 23.5;Inhibitory neurons: 49.5;Muller glia cells: 39.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;ASC diff: 32.7;RH-30: 48.9;SuSa: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB012422, HPA017377" Uncertain NA NA 15000000 "CAB012422: AB_2260246, HPA017377: AB_1846453" "prognostic favorable (1.35e-4)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.25e-4)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (5.77e-3)" "unprognostic (2.78e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.78e-7)" "unprognostic (5.39e-2)" "unprognostic (1.51e-1)" "unprognostic (5.83e-3)" "unprognostic (1.86e-4)" 8.6 0.7 1.7 1.7 2.1 0.0 5.2 22.9 3.9 6.8 1.0 8.7 1.0 14.1 2.1 1.7 14.3 4.8 3.0 1.7 1.9 0.8 1.2 2.7 1.1 2.2 3.2 1.6 20.8 1.2 2.5 3.0 2.8 7.6 1.3 1.6 10.2 1.7 2.8 1.2 10.0 2.9 17.1 0.5 0.7 4.7 3.6 1.6 2.8 18.6 1.6 1.5 2.5 3.0 2.5 1.6 3.2 28.4 2.8 32.7 14.5 0.4 0.5 2.9 0.9 0.3 1.1 9.4 1.4 6.8 0.6 3.3 0.4 7.1 1.0 0.8 5.5 6.3 0.5 6.5 2.9 6.4 0.4 1.8 4.5 1.2 0.6 0.0 12.2 0.3 4.8 0.1 1.9 2.7 0.4 3.6 1.0 2.6 0.8 3.7 1.1 48.9 0.9 1.7 0.5 2.4 9.6 3.7 0.3 4.7 23.8 2.4 1.0 0.5 3.2 2.2 6.3 3.3 2.5 5.5 0.2 2.0 1.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.1 22.9 3.9 1.7 1.9 2.2 3.2 1.6 7.6 0.5 1.6 2.5 3.0 6.4 9.9 11.1 0.1 15.2 1.4 0.8 2.2 5.1 5.4 1.9 5.2 2.8 5.6 0.0 16.7 0.6 0.1 0.2 0.0 1.3 3.1 1.7 0.5 3.0 7.7 0.4 58.3 0.6 0.4 23.5 1.5 1.1 0.0 1.8 1.1 2.1 0.3 0.0 49.5 0.3 0.0 0.0 7.6 2.7 14.9 0.2 3.6 2.8 0.1 39.3 0.0 14.1 5.8 2.4 0.4 11.3 0.8 1.1 0.6 0.5 4.2 4.6 0.0 2.9 2.7 1.8 3.8 0.5 10.7 0.7 0.6 13.2 0.4 1.6 TAF2 "CIF150, TAF2B, TAFII150" ENSG00000064313 "TATA-box binding protein associated factor 2" Q6P1X5 8 119730774-119832841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.69e-2)" "unprognostic (9.33e-3)" "unprognostic (3.79e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (8.12e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.44e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-3)" "unprognostic (1.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" 9.3 11.0 4.0 11.3 5.4 14.7 10.8 12.1 6.4 10.4 6.3 9.2 8.9 12.7 11.1 9.6 8.7 9.9 7.1 4.3 5.3 10.7 12.2 8.0 14.4 4.7 5.0 4.1 11.3 8.3 11.8 6.6 13.2 6.3 9.5 10.5 10.1 7.8 9.8 7.1 10.9 8.7 11.4 4.6 11.4 10.0 13.8 4.8 15.9 10.7 8.5 14.9 12.7 8.5 7.1 41.3 24.0 27.1 25.1 22.3 24.1 16.9 31.9 26.3 34.7 43.6 15.3 22.9 46.4 27.5 29.1 19.5 26.2 42.1 19.3 49.3 53.2 25.4 58.0 21.7 17.1 35.3 27.9 33.8 22.6 16.9 34.3 39.9 19.0 34.6 24.0 44.4 25.3 32.8 23.2 52.9 12.0 20.4 29.6 27.2 30.6 22.4 25.2 20.7 29.7 35.9 21.1 28.5 88.3 22.6 23.5 26.3 20.7 27.0 23.6 39.1 22.7 46.3 43.2 55.3 57.5 29.0 36.5 22.8 12.5 4.2 7.4 6.0 5.5 5.4 4.7 6.2 6.2 5.5 4.1 5.6 5.8 2.6 6.5 8.1 3.3 7.8 4.4 4.0 5.4 12.1 6.4 4.3 5.3 4.7 5.0 4.1 6.3 4.6 4.8 7.1 19.6 12.8 18.8 41.4 23.5 18.7 18.7 14.2 23.3 15.8 15.8 11.7 12.3 11.5 16.7 22.0 20.9 18.1 18.0 10.2 3.9 10.1 2.6 16.7 27.9 19.0 9.6 15.8 56.0 10.7 12.8 18.5 21.4 26.4 21.5 18.2 13.2 17.9 12.5 8.4 52.7 12.8 10.2 14.7 12.9 3.9 15.5 15.8 8.8 37.5 11.7 7.7 21.6 53.3 59.0 11.5 9.8 18.0 23.6 18.2 9.0 15.7 22.3 14.9 13.1 21.3 17.4 34.8 35.5 27.8 20.6 21.1 21.0 17.8 12.0 19.7 HIPK2 ENSG00000064393 "Homeodomain interacting protein kinase 2" Q9H2X6 7 139561570-139777998 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "brain: 390.9" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 463.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "basophil: 27.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 27.5" "Cell line enhanced" "Detected in many" "HDLM-2: 120.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007611 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007611: AB_1850730" "unprognostic (1.35e-3)" "unprognostic (1.49e-2)" "unprognostic (1.65e-1)" "unprognostic (7.65e-2)" "unprognostic (5.50e-2)" "unprognostic (9.44e-2)" "unprognostic (2.76e-1)" "unprognostic (4.66e-2)" "unprognostic (1.44e-1)" "unprognostic (2.76e-2)" "unprognostic (3.42e-3)" "unprognostic (4.58e-2)" "prognostic favorable (9.99e-4)" "unprognostic (1.38e-1)" "unprognostic (7.82e-2)" "unprognostic (3.93e-3)" "unprognostic (1.03e-2)" 20.0 9.3 324.6 6.9 319.6 15.2 10.4 145.7 195.3 4.3 47.2 6.7 7.5 6.1 4.2 9.3 8.9 4.7 30.6 153.7 179.8 25.8 15.0 10.8 4.2 292.9 275.1 89.3 5.5 11.6 11.6 9.0 10.2 390.9 9.4 4.9 28.1 12.2 5.7 23.7 3.0 6.4 4.0 198.3 6.9 14.6 1.9 290.1 7.0 9.4 17.2 4.3 6.0 5.2 342.7 11.7 51.4 23.2 14.3 55.2 39.4 2.7 6.4 6.3 7.0 7.3 3.8 6.3 0.0 14.3 12.1 43.2 0.6 10.7 16.6 17.5 120.9 4.3 53.7 8.7 18.4 31.0 14.9 14.0 60.3 10.5 32.4 47.9 16.5 17.6 10.0 31.7 14.4 54.3 8.9 18.9 10.6 5.9 6.6 34.3 22.1 12.7 1.6 31.5 2.0 14.1 12.9 14.4 0.5 7.0 4.3 7.9 6.0 59.5 24.5 11.6 28.5 31.4 68.7 44.3 10.2 49.4 7.7 13.4 27.5 1.3 3.5 0.2 1.1 0.3 0.6 0.5 0.2 0.6 0.5 1.6 0.5 1.7 0.2 4.1 0.2 0.1 0.7 324.6 319.6 145.7 195.3 153.7 179.8 292.9 275.1 89.3 390.9 198.3 290.1 342.7 107.8 16.0 31.2 82.6 45.8 9.3 30.6 24.9 16.5 116.0 65.6 32.6 213.9 55.8 35.6 64.4 152.2 8.8 72.0 38.4 35.2 32.5 3.1 39.1 12.2 80.3 67.2 18.5 17.8 67.0 1.5 28.1 70.8 41.7 44.9 24.3 151.0 145.2 15.7 222.1 36.3 32.2 63.1 119.5 10.9 4.0 13.1 53.2 44.4 49.6 47.6 78.0 95.8 145.3 463.7 63.4 24.6 18.8 97.9 118.9 22.5 75.0 48.7 62.9 46.0 96.6 60.8 2.7 4.8 42.5 9.5 9.6 30.5 20.1 29.3 43.9 TNPO3 "IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2" ENSG00000064419 "Transportin 3" Q9Y5L0 7 128954180-129055173 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039555, HPA041537" Approved Enhanced Vesicles NA NA Vesicles "HPA039555: AB_10672000, HPA041537: AB_2677539" "unprognostic (5.76e-2)" "unprognostic (1.72e-2)" "unprognostic (1.97e-1)" "unprognostic (5.49e-3)" "unprognostic (1.05e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (1.86e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-2)" "unprognostic (2.27e-2)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (2.04e-1)" "unprognostic (4.24e-2)" 16.3 17.0 17.1 19.5 17.8 34.6 15.8 19.1 18.8 14.2 16.8 18.5 16.6 15.8 17.9 21.3 16.3 13.1 15.5 17.0 19.5 19.3 23.1 16.2 23.6 17.5 17.6 16.0 20.6 15.2 21.2 10.1 14.9 18.5 16.7 20.3 16.6 15.6 18.2 32.8 18.2 16.7 19.6 18.0 17.8 19.9 26.6 18.7 30.3 23.1 27.3 29.1 18.8 15.3 20.7 59.1 65.3 49.7 84.3 47.3 40.5 42.3 51.8 45.0 47.4 55.5 53.7 52.9 73.3 23.6 55.7 89.7 42.3 101.6 49.8 67.6 61.3 45.0 54.0 52.2 42.2 45.0 99.8 44.2 38.1 49.7 57.9 51.4 41.4 59.9 59.5 124.7 51.3 61.2 43.7 86.9 73.4 142.6 64.4 59.7 61.0 46.3 60.0 48.0 54.6 61.5 48.7 55.2 25.7 58.3 71.4 29.0 61.3 45.2 59.7 29.4 71.1 71.5 65.3 54.6 99.3 86.3 100.5 106.1 26.7 14.1 22.0 16.4 17.3 14.6 16.1 13.3 14.8 16.1 15.5 13.0 15.2 15.5 14.5 23.9 7.7 15.1 11.7 17.1 17.8 19.1 18.8 17.0 19.5 17.5 17.6 16.0 18.5 18.0 18.7 20.7 20.4 16.0 16.7 30.7 31.4 6.8 15.6 5.7 27.3 23.4 20.3 13.8 21.4 20.0 11.6 18.4 22.9 24.7 26.9 20.4 7.9 23.2 41.4 19.1 17.7 18.8 11.5 38.5 45.8 24.8 37.2 17.4 22.4 27.7 10.8 30.5 19.6 27.9 27.8 37.0 46.8 22.2 2.0 25.7 9.5 25.4 16.8 24.9 8.8 31.9 44.4 13.6 17.5 37.7 47.5 30.3 17.7 17.7 28.5 17.6 21.7 18.7 13.1 21.7 13.1 18.5 19.4 76.3 31.8 32.5 8.2 35.0 23.5 33.1 24.8 30.4 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145569-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.0;U-266/70: 3.1" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.1 0.6 0.3 0.1 0.2 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.6 0.2 0.2 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.0 0.6 0.2 0.2 0.1 0.3 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.2 0.3 0.8 0.0 0.1 0.1 0.7 0.2 0.1 0.1 0.4 0.3 0.4 0.0 1.4 0.3 0.1 0.0 0.5 0.5 0.2 0.1 0.2 0.1 0.5 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.9 0.1 2.0 0.5 0.2 1.3 0.1 0.6 0.0 0.7 0.7 0.1 0.0 0.1 1.6 0.1 0.5 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.5 0.3 0.0 0.0 1.5 0.0 3.1 0.6 1.7 0.3 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.6 0.3 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.3 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.1 1.4 0.8 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.2 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.5 0.0 1.2 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.6 0.0 RFXANK "ANKRA1, BLS, F14150_1, MGC138628, RFX-B" ENSG00000064490 "Regulatory factor X associated ankyrin containing protein" O14593 19 19192229-19201869 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049157, HPA053330" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049157: AB_2680658, HPA053330: AB_2682114" "unprognostic (3.16e-2)" "unprognostic (6.39e-3)" "unprognostic (1.47e-2)" "unprognostic (1.22e-1)" "unprognostic (5.23e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (3.40e-2)" "unprognostic (3.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (3.62e-2)" "unprognostic (3.52e-1)" "unprognostic (2.73e-2)" "unprognostic (2.04e-3)" 28.0 20.3 23.2 21.6 25.9 41.4 29.8 25.5 35.1 28.6 21.8 30.3 21.6 28.6 14.2 40.5 35.1 13.8 24.6 22.8 29.9 35.1 20.8 26.0 31.4 26.7 24.1 20.8 27.3 29.8 23.2 24.5 18.3 24.6 32.5 11.2 8.7 34.4 14.3 31.9 34.5 27.8 13.2 24.3 39.2 32.1 12.8 26.7 28.6 38.4 15.1 22.3 26.3 27.4 26.1 60.0 36.6 25.6 50.2 8.7 24.2 64.5 29.0 30.3 48.8 47.7 30.7 121.4 58.2 72.9 30.2 20.8 43.6 21.9 56.2 21.5 40.4 33.7 46.7 36.7 45.1 89.4 66.8 94.6 44.7 32.4 42.8 31.0 29.8 49.1 56.8 94.4 64.2 27.1 119.3 88.0 88.3 30.7 62.6 82.0 73.5 26.1 101.9 41.5 39.8 21.0 43.6 30.3 38.2 70.4 17.1 54.1 134.8 49.1 25.4 27.9 63.3 47.6 73.5 86.9 87.7 37.6 82.3 52.2 48.5 29.4 52.2 23.9 32.7 20.4 41.7 27.2 26.5 34.2 41.4 27.1 26.6 13.4 33.3 24.6 54.2 40.5 29.0 23.2 25.9 25.5 35.1 22.8 29.9 26.7 24.1 20.8 24.6 24.3 26.7 26.1 33.4 32.1 36.9 6.5 28.9 22.0 33.8 77.9 28.5 10.0 30.5 33.5 3.4 31.5 39.5 31.3 2.1 63.5 24.9 46.2 76.3 44.0 6.4 48.4 29.7 35.7 37.2 45.8 1.2 57.4 61.3 26.8 35.2 37.7 31.8 31.4 33.2 16.7 63.1 15.2 1.4 40.0 40.7 44.5 27.8 11.1 30.4 34.1 21.4 8.4 57.8 27.6 36.0 3.5 3.3 59.3 44.4 19.2 27.9 27.0 56.5 70.7 57.6 12.3 39.5 14.6 37.5 6.3 20.1 35.4 24.6 45.6 29.4 28.5 46.9 27.1 TMEM161A "FLJ20422, FLJ39645" ENSG00000064545 "Transmembrane protein 161A" Q9NX61 19 19119169-19138513 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043365 Approved Approved Cytosol NA NA Cytosol "HPA043365: AB_10796793" "unprognostic (4.31e-2)" "unprognostic (9.13e-2)" "unprognostic (2.34e-2)" "unprognostic (7.42e-3)" "unprognostic (6.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-2)" "unprognostic (3.51e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (9.42e-2)" "unprognostic (2.46e-1)" "unprognostic (9.15e-2)" "prognostic favorable (2.99e-4)" "unprognostic (4.18e-1)" "unprognostic (2.79e-1)" "unprognostic (4.89e-3)" 12.6 22.7 4.7 4.4 4.5 5.5 13.8 4.9 6.9 19.2 6.4 14.5 3.6 21.9 1.5 14.9 17.8 5.5 17.5 4.4 6.2 15.3 26.1 12.4 4.8 6.9 4.6 4.8 17.8 15.9 13.8 8.3 3.4 5.2 14.4 3.8 2.5 15.1 7.2 51.1 16.5 11.3 6.4 4.7 10.5 14.9 6.4 5.8 5.8 19.7 13.4 4.9 14.4 16.0 5.7 28.9 19.3 12.6 20.1 24.8 17.1 12.8 13.4 12.8 16.4 20.1 17.5 30.8 26.4 57.9 9.4 11.3 23.9 20.6 29.3 11.4 9.9 47.6 10.0 10.6 24.0 30.9 9.1 14.7 26.9 23.9 15.6 25.9 14.9 17.9 30.5 31.6 27.2 12.5 33.8 19.5 24.7 9.9 37.1 19.6 33.4 9.4 44.8 13.0 13.0 13.0 13.6 20.2 20.1 15.7 9.1 17.1 24.0 7.6 13.3 5.3 34.4 21.1 27.8 14.9 16.1 13.9 22.5 20.7 1.3 6.1 1.4 8.2 5.3 6.7 4.3 7.5 6.2 8.4 5.6 8.8 6.3 1.1 5.4 7.1 19.4 11.4 4.1 4.7 4.5 4.9 6.9 4.4 6.2 6.9 4.6 4.8 5.2 4.7 5.8 5.7 15.7 6.4 18.3 5.5 9.5 6.1 15.1 27.1 14.8 15.7 13.4 15.4 8.7 20.0 18.3 11.0 10.4 19.8 14.8 6.5 7.9 20.5 1.2 8.8 14.1 11.3 5.4 6.7 10.9 12.9 15.1 14.6 14.8 9.5 15.9 15.1 9.7 25.3 16.3 16.8 11.4 10.0 10.2 9.5 4.1 1.5 11.8 7.5 12.4 5.6 6.8 15.8 8.2 4.5 8.4 11.9 7.5 17.7 13.6 14.9 12.5 29.1 11.8 14.5 13.1 13.5 14.3 8.7 8.4 12.4 8.7 12.3 11.4 33.8 19.3 10.0 LPAR2 "EDG-4, EDG4, LPA2" ENSG00000064547 "Lysophosphatidic acid receptor 2" Q9HBW0 19 19623655-19628930 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.6" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 73.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA019616 Approved NA NA "HPA019616: AB_1847988" "unprognostic (1.60e-2)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" "unprognostic (1.19e-2)" "unprognostic (1.05e-1)" "unprognostic (2.29e-3)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.32e-1)" "unprognostic (1.05e-3)" "unprognostic (8.07e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.61e-7)" "prognostic favorable (1.43e-4)" "unprognostic (2.40e-1)" "unprognostic (5.87e-2)" "unprognostic (2.29e-2)" 9.0 3.4 7.3 18.9 7.9 52.3 8.3 6.1 9.4 8.7 9.2 8.9 9.7 4.3 2.5 16.0 10.7 13.1 3.6 7.5 8.3 9.0 6.5 28.7 17.2 8.4 7.9 6.8 10.5 27.9 7.8 10.1 4.3 7.9 17.9 7.9 1.7 17.4 4.3 1.4 16.8 23.9 1.9 7.6 76.6 33.9 49.9 8.7 10.1 18.5 1.6 14.8 10.9 11.4 14.0 31.4 3.4 35.7 8.0 9.1 4.4 30.2 2.0 2.9 1.4 2.6 22.0 29.6 19.8 19.5 2.9 1.8 32.1 5.6 11.0 1.4 8.5 9.2 4.4 6.9 1.7 1.2 7.4 73.3 4.9 26.9 1.4 2.0 5.0 0.8 9.7 4.4 7.7 1.2 51.4 4.5 12.3 35.3 42.0 14.2 19.6 2.9 9.1 22.1 45.5 12.6 23.0 8.2 6.6 4.9 19.6 16.9 47.0 9.1 6.8 5.7 12.0 3.0 3.4 10.7 6.8 1.5 53.3 3.4 0.2 1.0 3.8 9.2 1.1 16.2 5.5 20.7 11.8 0.7 2.7 18.2 13.5 10.1 2.8 1.7 1.8 25.7 6.3 7.3 7.9 6.1 9.4 7.5 8.3 8.4 7.9 6.8 7.9 7.6 8.7 14.0 0.9 3.2 7.2 0.7 7.1 6.2 11.7 12.4 9.1 0.3 9.7 10.8 2.2 5.7 9.9 7.3 2.1 1.0 6.6 12.2 3.9 14.3 0.4 10.2 2.4 1.0 2.4 3.2 1.9 20.1 6.0 1.9 39.3 18.3 3.8 6.9 1.1 0.6 2.5 1.7 2.2 11.5 6.1 5.6 4.0 2.1 0.6 8.3 0.0 5.6 6.4 4.7 2.1 1.0 0.1 16.9 7.1 0.4 8.7 14.9 10.1 0.7 6.0 1.4 0.0 0.4 2.1 1.3 4.2 7.2 5.1 0.1 20.4 0.2 7.6 11.2 CTSA "GSL, PPGB" ENSG00000064601 "Cathepsin A" P10619 20 45890144-45898824 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 371.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 445.6;Proximal enterocytes: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 856.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024930, HPA031068, HPA072487" Enhanced Enhanced Vesicles "Intracellular and membrane" NA NA 28000000 Vesicles "CAB024930: , HPA031068: AB_10601205, HPA072487: " "unprognostic (8.61e-2)" "unprognostic (3.37e-1)" "unprognostic (4.30e-2)" "unprognostic (2.13e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (6.33e-2)" "unprognostic (9.53e-3)" "unprognostic (7.19e-2)" "unprognostic (1.83e-1)" "unprognostic (6.85e-2)" "unprognostic (7.57e-2)" "unprognostic (1.09e-1)" "unprognostic (6.05e-2)" "unprognostic (1.71e-1)" "unprognostic (8.40e-2)" 81.1 371.4 55.2 75.9 55.3 76.2 62.4 61.7 66.1 46.8 85.6 180.3 101.9 55.5 39.4 60.9 39.6 90.5 97.6 55.5 63.9 185.1 96.5 91.7 62.1 61.8 55.6 52.5 62.7 53.3 105.3 44.1 77.0 58.4 38.8 172.0 44.4 61.8 48.9 56.5 90.7 110.2 67.9 57.1 109.4 63.9 33.8 62.5 23.2 47.8 62.2 59.3 83.6 49.6 62.9 111.9 114.1 17.6 89.2 856.5 438.6 47.0 150.3 424.0 169.6 217.5 214.4 291.8 24.1 176.2 299.9 638.1 168.6 55.9 105.6 95.7 47.6 53.6 54.3 53.4 375.9 187.3 98.0 240.9 349.0 123.6 107.9 22.5 421.9 190.1 28.2 61.0 355.1 186.9 232.1 25.8 82.4 19.4 172.6 272.1 37.8 107.3 135.7 138.2 96.7 36.9 37.8 263.2 450.3 444.4 51.5 108.5 141.8 172.5 335.0 76.2 178.9 123.7 162.1 238.5 15.7 599.3 128.6 142.4 480.7 305.9 530.5 44.9 168.8 185.5 42.0 75.6 78.3 102.4 25.7 26.6 39.8 152.4 81.2 120.1 40.6 155.4 378.1 55.2 55.3 61.7 66.1 55.5 63.9 61.8 55.6 52.5 58.4 57.1 62.5 62.9 53.7 35.3 32.6 26.1 38.2 24.2 38.9 88.8 17.6 58.4 18.4 15.9 12.6 65.8 64.1 71.7 60.5 104.1 27.5 445.6 39.2 246.0 3.3 22.3 39.5 56.0 54.0 22.1 20.4 166.4 109.2 86.8 29.6 62.4 9.5 50.8 102.1 67.9 297.1 47.1 25.2 74.5 95.6 177.1 25.1 4.8 32.9 273.1 112.1 12.2 135.6 86.6 37.0 7.1 10.2 135.0 216.0 27.4 41.9 18.6 301.8 245.8 34.2 46.1 26.3 33.7 54.5 15.3 31.9 24.0 22.9 144.1 49.1 91.3 113.9 36.2 SUGP2 "KIAA0365, SFRS14" ENSG00000064607 "SURP and G-patch domain containing 2" Q8IX01 19 18990888-19034023 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 237.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041557, HPA061111" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA041557: AB_10794301, HPA061111: AB_2684432" "unprognostic (1.35e-1)" "unprognostic (2.94e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.94e-2)" "unprognostic (4.60e-2)" "unprognostic (3.28e-1)" "unprognostic (4.41e-3)" "unprognostic (2.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.17e-2)" "unprognostic (1.51e-1)" "unprognostic (5.11e-2)" "unprognostic (3.60e-2)" 24.5 36.5 28.2 18.4 29.2 42.1 28.6 29.4 36.3 37.8 24.9 33.4 17.3 30.5 20.7 25.8 35.8 12.8 35.8 33.9 24.1 36.1 32.0 33.2 23.7 22.3 23.4 30.9 39.8 24.1 17.1 54.7 14.3 26.4 47.3 16.6 45.5 32.6 16.2 38.1 21.2 31.8 15.7 15.9 37.7 27.2 88.4 23.7 22.9 61.4 24.6 20.3 31.2 33.1 29.7 27.7 25.7 64.6 46.7 29.7 29.2 32.2 33.8 25.4 38.8 33.1 16.9 24.0 54.3 27.3 27.2 45.8 20.1 53.2 20.6 35.2 19.3 47.0 34.3 42.6 22.2 21.4 29.2 33.3 30.4 21.5 23.7 19.3 51.8 20.6 41.8 52.6 38.1 42.6 23.5 34.3 54.5 33.5 32.4 36.1 33.8 33.2 30.6 19.7 27.5 71.5 29.4 29.9 20.7 14.8 49.5 21.6 26.9 22.6 38.0 22.8 44.6 40.2 48.0 39.1 40.0 38.3 45.0 40.9 4.1 1.4 1.3 2.1 1.5 1.1 1.1 1.3 1.2 1.5 1.8 1.2 1.4 1.3 4.4 1.3 1.9 1.3 0.8 28.2 29.2 29.4 36.3 33.9 24.1 22.3 23.4 30.9 26.4 15.9 23.7 29.7 24.5 41.7 45.1 69.9 22.9 17.6 22.6 17.9 18.8 91.2 30.0 23.5 34.7 22.8 33.3 27.6 93.8 16.7 57.0 19.2 9.8 16.2 84.9 44.4 44.7 25.2 41.5 35.3 106.5 10.5 10.2 29.1 31.6 40.7 27.1 94.9 21.8 28.5 23.4 106.0 90.3 22.5 26.4 31.4 19.9 132.0 40.4 29.1 12.4 34.7 31.2 44.5 57.7 42.7 45.2 18.7 23.2 37.6 36.1 26.1 14.5 11.3 42.5 108.6 52.6 33.5 22.8 237.7 56.2 17.2 18.8 7.5 29.3 79.8 26.9 23.6 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189677 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 76.2" "Cell type enhanced" "Detected in all" "Intestinal goblet cells: 480.6;Oligodendrocytes: 566.6;Undifferentiated cells: 370.0" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 153.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: AB_2685094" "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favorable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 8.5 17.6 17.4 10.9 43.3 4.4 44.3 43.3 24.5 7.2 33.5 49.0 42.1 8.5 2.4 4.7 6.0 39.7 6.2 13.8 30.2 6.6 4.3 10.4 5.6 37.6 44.6 8.2 5.5 6.1 14.8 5.5 4.9 42.8 23.8 59.5 16.9 76.2 2.6 15.5 25.5 49.5 10.3 34.0 4.5 62.4 8.1 32.8 4.1 8.7 8.3 6.0 7.3 3.5 64.5 13.5 65.3 65.8 25.6 16.1 10.4 13.6 12.2 9.1 8.6 8.9 26.4 20.9 19.9 16.1 10.6 7.8 39.5 12.7 14.0 13.2 20.0 15.8 5.7 11.4 3.8 4.9 7.3 9.5 11.1 5.0 19.1 11.2 6.4 14.2 8.5 9.4 13.2 13.4 14.2 13.0 6.1 7.7 153.6 21.1 7.1 18.5 8.2 10.0 45.0 11.5 7.3 24.6 10.6 9.9 7.0 5.9 3.7 24.1 21.2 14.2 16.3 15.7 11.0 10.7 21.6 11.2 4.2 17.6 0.3 0.4 0.2 1.1 0.7 1.9 1.7 1.0 1.4 0.6 2.1 1.1 1.6 0.2 2.4 0.5 6.4 1.1 0.3 17.4 43.3 43.3 24.5 13.8 30.2 37.6 44.6 8.2 42.8 34.0 32.8 64.5 38.3 16.0 46.2 23.8 20.5 22.9 20.1 44.9 10.8 76.6 186.9 86.7 18.0 137.2 52.1 33.1 127.2 1.4 34.4 48.2 1.9 68.6 55.8 33.1 43.1 44.2 74.4 2.5 160.6 48.2 2.7 21.3 199.3 38.4 18.4 28.8 12.8 8.8 4.2 80.8 73.2 480.6 57.0 8.6 12.0 95.3 85.4 11.4 204.5 105.9 2.5 22.6 11.3 55.3 566.6 50.1 60.6 29.0 20.2 131.6 38.8 10.6 19.6 86.4 72.3 33.9 64.3 29.1 27.1 14.9 30.0 1.4 21.1 14.1 370.0 21.5 SNX24 SBBI31 ENSG00000064652 "Sorting nexin 24" Q9Y343 5 122843439-123029354 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044566, HPA073934" Approved Approved Vesicles NA NA Vesicles "HPA044566: AB_10797034, HPA073934: AB_2686644" "unprognostic (2.63e-1)" "unprognostic (2.50e-1)" "unprognostic (2.73e-1)" "prognostic unfavorable (7.93e-6)" "unprognostic (2.31e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (8.88e-4)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (3.42e-1)" "unprognostic (5.77e-2)" "unprognostic (3.69e-2)" "prognostic favorable (1.28e-4)" "unprognostic (2.03e-1)" "unprognostic (1.10e-1)" "unprognostic (6.94e-2)" "unprognostic (1.50e-2)" 8.1 8.2 13.3 5.6 15.8 4.5 7.5 19.9 15.6 8.1 13.6 11.2 15.3 6.6 12.0 37.1 7.7 10.6 12.4 12.6 16.0 20.7 14.2 17.5 6.6 19.5 16.8 11.2 5.9 10.7 25.8 7.8 25.6 19.0 6.2 12.6 12.6 12.4 6.6 9.6 16.9 11.5 11.1 19.7 7.7 16.6 8.8 17.7 2.5 18.7 14.1 8.9 9.3 14.3 25.8 33.2 14.7 23.5 15.8 8.5 21.7 47.2 28.7 26.7 32.9 42.1 20.8 30.0 0.0 24.0 28.3 31.9 6.7 15.2 36.8 50.3 17.8 9.3 4.7 13.4 29.8 43.4 0.2 5.4 18.3 53.4 16.6 64.4 28.5 16.0 5.7 6.1 26.3 25.1 29.5 0.8 1.3 9.6 6.0 9.3 4.2 37.3 16.3 47.8 19.8 14.4 17.2 27.1 19.7 31.2 30.4 35.5 10.4 13.9 35.4 27.3 14.0 46.6 9.1 12.9 5.0 30.3 0.6 73.4 0.0 1.4 0.0 0.6 2.8 0.3 0.3 0.6 0.5 0.7 0.2 0.2 0.1 0.0 1.3 3.2 0.1 1.4 0.5 13.3 15.8 19.9 15.6 12.6 16.0 19.5 16.8 11.2 19.0 19.7 17.7 25.8 7.8 44.8 24.6 45.4 1.1 10.5 7.5 10.6 3.4 18.3 8.7 5.8 14.9 14.3 6.3 20.2 6.2 45.1 3.7 17.7 35.2 15.6 75.8 18.6 11.1 6.5 1.2 4.0 51.8 11.8 57.1 12.6 7.1 15.0 0.0 19.1 8.6 12.9 66.1 11.8 52.1 6.7 6.1 51.9 4.7 95.9 9.0 21.0 3.6 60.9 16.0 12.4 4.1 46.8 63.5 21.9 4.4 9.4 2.7 16.2 35.2 39.9 12.0 18.0 13.1 7.0 9.1 5.0 9.6 19.5 16.8 39.7 3.9 39.2 8.9 11.8 EYA2 EAB1 ENSG00000064655 "EYA transcriptional coactivator and phosphatase 2" O00167 20 46894624-47188844 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 56.1" "Cell type enhanced" "Detected in many" "Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 69.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027024, HPA059291" Uncertain Supported Cytosol NA NA Cytosol "HPA027024: AB_1848334, HPA059291: AB_2683967" "unprognostic (1.08e-1)" "unprognostic (5.71e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.30e-5)" "unprognostic (3.32e-2)" "unprognostic (1.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.65e-1)" "unprognostic (7.06e-2)" "unprognostic (2.15e-1)" "unprognostic (2.78e-1)" "unprognostic (4.17e-3)" "unprognostic (1.56e-1)" 12.1 1.5 11.0 2.4 11.3 0.1 11.1 14.9 12.4 56.1 9.4 7.1 0.3 17.4 3.7 34.5 34.3 1.8 3.2 9.8 9.8 4.7 2.1 2.2 0.8 15.6 11.3 9.0 0.7 1.9 9.4 5.3 6.4 12.0 23.8 3.1 1.2 31.5 9.4 2.5 5.0 1.1 1.8 9.7 0.6 8.9 5.7 12.0 19.0 14.7 3.4 6.7 4.9 16.6 15.3 0.2 4.4 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 2.5 1.9 0.3 40.1 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.1 0.3 2.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 7.7 0.1 0.0 0.6 0.1 0.0 0.1 0.8 0.5 0.0 0.0 58.3 0.0 0.0 24.8 0.0 3.0 5.3 0.2 0.0 0.0 4.5 0.3 8.8 110.9 139.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 11.3 14.9 12.4 9.8 9.8 15.6 11.3 9.0 12.0 9.7 12.0 15.3 0.4 0.0 0.0 153.8 0.9 0.6 47.5 50.4 14.8 0.4 7.8 7.6 0.5 2.8 33.0 0.0 6.2 27.7 0.0 2.5 0.0 0.9 0.2 43.7 3.9 0.6 1.2 0.0 1.5 0.0 3.0 4.8 9.2 53.8 1.3 9.8 0.4 3.3 7.4 0.0 5.1 0.6 34.6 0.0 0.4 0.3 0.0 1.1 3.6 13.1 2.6 0.0 0.0 48.7 1.0 1.1 1.7 0.7 3.4 10.9 0.0 6.3 22.2 0.4 0.0 0.3 2.8 0.2 7.4 16.0 0.3 10.8 0.6 4.2 3.6 34.6 CNN2 ENSG00000064666 "Calponin 2" Q99439 19 1026586-1039068 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 274.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049095 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 8400000 Cytosol "Nucleoplasm, Actin filaments" "HPA049095: AB_2680627" "unprognostic (2.52e-2)" "unprognostic (2.69e-1)" "unprognostic (1.74e-1)" "unprognostic (4.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-1)" "unprognostic (4.58e-2)" "unprognostic (6.56e-2)" "unprognostic (3.60e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.70e-7)" "unprognostic (1.28e-2)" "unprognostic (1.87e-1)" "unprognostic (2.50e-1)" "unprognostic (1.54e-1)" 75.1 22.3 7.5 151.2 6.9 210.7 82.8 8.4 22.4 87.0 29.5 60.1 25.8 119.0 20.2 132.7 89.5 79.5 53.9 6.4 8.1 64.9 43.3 153.5 185.7 9.4 7.4 4.5 166.1 69.8 8.7 22.6 38.1 8.9 84.8 33.9 7.6 90.1 69.0 8.2 75.7 65.4 56.5 7.6 155.2 75.7 12.1 9.9 52.7 79.7 7.7 171.3 87.2 80.4 13.1 230.7 75.6 206.9 257.3 104.5 196.9 162.6 204.3 221.8 249.2 192.5 263.0 191.8 151.2 203.9 367.9 58.9 221.3 123.9 324.1 164.7 104.7 10.6 109.6 122.0 205.9 415.0 97.4 230.1 337.2 150.9 158.1 118.5 405.6 142.9 110.1 64.0 225.2 206.0 44.0 8.9 91.5 256.2 184.0 35.0 52.8 72.5 170.9 247.5 265.9 0.5 14.8 252.6 34.3 27.5 149.6 247.6 163.6 349.4 134.8 140.0 210.0 208.9 105.2 86.8 297.8 79.6 117.7 220.9 560.2 142.2 631.5 243.1 180.6 393.5 231.0 301.6 324.2 217.5 201.9 250.1 252.0 845.4 213.8 209.4 96.7 347.3 393.3 7.5 6.9 8.4 22.4 6.4 8.1 9.4 7.4 4.5 8.9 7.6 9.9 13.1 10.3 60.9 60.6 0.0 140.4 97.6 274.2 142.9 178.2 1.2 36.5 66.4 6.1 15.7 78.4 36.8 10.4 12.0 66.4 47.0 62.6 63.6 0.5 29.1 52.9 26.3 15.4 44.1 0.1 138.6 99.8 50.4 49.5 40.0 59.5 44.3 37.9 29.8 54.9 0.0 0.1 51.2 42.7 87.9 103.1 1.8 8.1 90.7 14.2 2.8 129.9 0.9 91.6 0.0 0.6 186.9 27.1 76.8 85.8 60.9 3.3 5.9 37.8 7.5 32.9 10.4 70.6 1.7 3.8 135.0 87.8 11.4 160.8 1.7 32.1 170.9 ABCA7 ABCX ENSG00000064687 "ATP binding cassette subfamily A member 7" Q8IZY2 19 1039997-1065572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Phagocytosis, Transport" Translocase "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;lymphoid tissue: 26.8;pituitary gland: 29.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 20.4;HMC-1: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA041564 Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus, Plasma membrane" "Cell Junctions" "HPA041564: AB_2677550" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (7.26e-4)" "prognostic favorable (1.12e-4)" "unprognostic (8.88e-2)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (4.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "unprognostic (1.51e-3)" "unprognostic (3.68e-2)" "unprognostic (8.99e-3)" "unprognostic (2.08e-2)" "unprognostic (3.66e-1)" "unprognostic (7.88e-2)" "unprognostic (7.85e-2)" 3.4 3.0 2.7 5.5 3.3 27.6 3.3 3.4 6.2 2.6 10.0 2.7 2.3 1.2 0.2 7.7 2.1 2.1 2.5 3.2 2.8 6.4 4.3 9.6 8.5 5.0 3.4 2.9 0.5 7.7 2.7 29.0 1.3 4.6 5.4 1.2 25.7 8.7 1.1 3.9 5.5 10.2 0.5 2.2 26.8 3.8 1.7 3.3 10.1 5.7 0.3 3.2 2.3 2.9 4.5 4.7 6.4 0.5 4.4 7.2 2.2 7.3 0.8 1.0 0.4 0.6 5.2 2.8 13.9 5.6 1.3 0.6 8.0 1.3 6.2 0.4 10.2 2.5 6.7 20.4 5.6 1.8 3.9 40.3 3.8 1.8 0.9 1.2 4.4 1.4 7.7 10.2 6.9 1.3 2.2 4.3 2.2 0.9 3.3 2.5 3.1 0.8 11.6 3.8 6.0 0.3 1.3 8.2 1.9 1.2 1.1 4.6 7.1 2.2 0.4 1.6 3.7 0.8 9.9 6.6 5.7 2.1 7.4 2.0 2.8 1.4 5.9 1.8 1.2 1.1 0.6 0.9 1.2 2.1 0.9 0.8 1.5 3.3 1.1 1.3 7.3 0.4 1.3 2.7 3.3 3.4 6.2 3.2 2.8 5.0 3.4 2.9 4.6 2.2 3.3 4.5 4.1 73.7 21.9 8.5 13.2 3.3 0.8 10.7 5.2 70.6 4.8 2.2 6.0 4.3 14.0 5.5 175.2 4.6 9.1 14.7 1.9 2.7 7.3 8.9 1.4 2.9 3.5 13.3 12.9 2.5 303.3 1.5 5.6 6.9 10.1 2.0 2.5 4.9 7.9 15.2 11.5 4.7 16.2 12.6 7.5 4.8 0.0 12.7 0.0 4.7 19.6 13.1 9.2 1.5 2.4 7.0 9.6 0.0 12.0 1.5 1.7 1.3 17.5 149.1 0.0 2.7 2.7 0.7 2.0 6.6 3.4 25.7 12.6 1.0 5.3 1.9 SNCAIP SYPH1 ENSG00000064692 "Synuclein alpha interacting protein" Q9Y6H5 5 122311354-122464219 "Disease related genes, Predicted intracellular proteins" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 19.7;ovary: 37.8" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Early spermatids: 68.1;Endometrial stromal cells: 56.9;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 50 "basophil: 7.6" "Lineage enriched" "Detected in single" 50 "granulocytes: 7.6" "Cell line enhanced" "Detected in some" "AF22: 5.2;BJ hTERT+: 5.1;HBF TERT88: 3.2;OE19: 3.0;RPMI-8226: 5.2" "Low region specificity" "Detected in all" HPA064687 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA064687: AB_2685324" "unprognostic (7.28e-3)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (6.56e-2)" "unprognostic (2.18e-2)" "unprognostic (1.56e-1)" "unprognostic (1.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.95e-2)" "unprognostic (3.73e-1)" "unprognostic (3.52e-2)" "unprognostic (3.00e-1)" "unprognostic (5.98e-2)" "unprognostic (1.82e-3)" "unprognostic (5.77e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-1)" 3.0 1.0 5.3 2.5 7.7 0.3 1.4 7.5 2.8 17.3 8.9 1.1 1.2 19.7 1.3 0.6 5.1 2.5 1.3 3.0 3.7 0.9 0.1 1.2 2.1 3.9 4.4 1.4 37.8 0.5 0.2 1.2 2.0 3.5 1.9 1.1 0.5 0.4 2.7 0.3 1.8 0.7 12.1 3.5 5.2 1.1 4.5 4.4 1.7 0.8 1.7 1.5 4.1 2.5 4.4 0.0 0.0 5.2 0.1 0.0 0.0 0.1 2.2 5.1 0.8 0.4 0.0 0.1 0.1 0.1 2.2 0.4 0.0 2.1 0.3 3.2 1.9 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.2 0.0 0.6 0.1 0.0 0.8 0.0 0.0 0.0 0.1 2.5 3.0 0.0 0.1 0.0 5.2 0.2 0.6 0.9 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.2 0.5 0.3 0.4 0.0 0.0 0.2 0.2 0.0 0.1 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.3 7.7 7.5 2.8 3.0 3.7 3.9 4.4 1.4 3.5 3.5 4.4 4.4 6.1 0.0 0.5 84.5 0.0 1.8 3.8 0.5 1.8 0.4 0.4 1.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 6.1 68.1 4.6 56.9 7.1 0.0 0.0 21.8 0.0 0.1 5.6 0.0 1.4 1.3 0.1 18.9 0.2 0.3 0.0 62.8 0.0 0.0 0.8 0.4 16.6 5.3 0.6 1.8 13.1 0.0 0.5 0.0 30.7 1.9 0.4 0.7 5.7 0.0 3.0 0.0 0.3 14.9 0.0 0.0 0.5 2.3 4.1 2.1 1.8 2.7 0.1 0.4 0.1 0.2 1.5 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111754832-111775602 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 53.2" "Group enriched" "Detected in all" 5 "Early spermatids: 738.2;Late spermatids: 718.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favorable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 4.3 3.7 0.8 1.3 0.7 2.4 4.4 0.4 0.9 4.0 0.2 3.9 0.5 4.9 0.9 3.3 4.5 1.6 3.2 0.8 0.7 2.6 2.6 3.2 3.0 0.7 0.7 0.9 4.4 3.6 2.5 1.9 2.4 0.5 3.0 1.9 0.8 3.3 2.5 8.9 3.6 4.3 2.8 0.4 4.8 3.8 53.2 0.6 3.7 3.2 1.8 4.2 4.0 3.3 1.4 7.0 3.8 7.1 7.3 4.7 5.0 7.0 3.3 9.1 16.3 18.6 5.8 4.5 17.7 5.2 6.4 3.9 5.8 13.5 9.4 18.2 7.3 9.2 7.4 3.2 3.0 4.6 8.4 6.1 3.0 10.4 9.2 12.2 2.4 12.8 7.2 10.8 5.9 12.0 6.5 11.8 0.9 14.1 5.2 8.5 11.3 12.7 5.3 4.8 5.2 11.7 9.5 6.7 7.0 12.7 5.7 7.0 8.5 3.5 7.9 8.2 13.2 8.6 1.2 5.3 12.3 7.5 8.1 18.5 14.9 6.2 6.0 8.2 5.6 10.7 9.3 9.1 8.4 6.8 9.1 10.6 8.6 3.4 9.1 6.6 3.5 10.0 6.9 0.8 0.7 0.4 0.9 0.8 0.7 0.7 0.7 0.9 0.5 0.4 0.6 1.4 8.5 12.8 9.4 6.8 13.0 10.8 9.7 6.0 9.6 14.3 6.5 6.6 7.7 5.7 10.0 5.5 2.1 10.2 9.4 2.9 3.9 9.5 738.2 8.1 12.0 9.3 4.2 5.9 7.4 6.9 7.5 6.9 5.1 5.4 7.6 12.3 5.7 5.9 9.3 6.7 7.7 5.8 8.2 7.2 7.0 718.9 16.4 7.3 1.8 3.7 7.5 6.9 6.2 3.0 3.6 6.3 2.3 13.2 9.0 5.2 3.0 7.6 11.8 10.4 6.6 9.7 11.7 121.7 26.3 7.0 7.2 5.1 11.1 14.0 6.6 5.5 BTBD1 ENSG00000064726 "BTB domain containing 1" Q9H0C5 15 83016423-83067252 "Predicted intracellular proteins" "Differentiation, Myogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 328.1;tongue: 232.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024263, HPA067671" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA024263: , HPA067671: AB_2685882" "unprognostic (1.63e-1)" "unprognostic (4.61e-2)" "unprognostic (1.35e-1)" "unprognostic (5.54e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (4.80e-2)" "unprognostic (1.65e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-7)" "unprognostic (8.94e-3)" "unprognostic (8.27e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" 37.2 27.0 43.2 25.2 43.1 36.6 29.1 43.4 48.6 25.0 30.0 33.7 32.8 24.5 25.9 30.7 31.7 28.9 108.2 44.9 45.8 38.1 34.6 24.1 37.0 43.7 44.5 40.8 23.8 17.3 46.8 22.2 24.3 42.1 30.4 35.8 28.7 21.2 24.3 328.1 16.6 30.2 26.7 47.5 26.1 24.2 58.9 47.8 35.8 37.5 232.9 34.5 36.5 18.3 49.2 45.8 43.1 37.3 37.0 57.5 98.2 19.5 64.9 88.0 54.8 60.6 27.4 46.4 91.0 78.4 73.2 45.6 56.4 82.7 52.0 64.4 73.4 67.1 77.7 62.6 39.6 67.6 74.2 82.9 80.6 45.8 37.2 55.4 71.0 82.0 35.2 70.2 49.9 117.2 24.1 55.8 38.5 52.2 39.9 47.0 57.1 94.4 45.5 55.0 106.7 64.9 46.6 75.1 61.6 111.2 50.7 46.5 61.6 82.9 61.9 46.1 86.0 91.2 50.6 84.0 88.4 66.7 123.6 43.8 1.3 2.9 5.7 3.1 3.2 2.7 2.7 2.9 4.0 5.2 3.4 3.2 3.2 1.6 2.4 4.2 2.2 3.0 1.3 43.2 43.1 43.4 48.6 44.9 45.8 43.7 44.5 40.8 42.1 47.5 47.8 49.2 24.2 16.0 5.8 30.7 22.0 15.2 13.7 9.6 13.6 9.4 11.4 6.9 84.9 8.6 18.1 11.0 6.2 8.4 23.6 20.8 17.6 14.2 35.8 19.9 16.6 16.8 23.3 18.7 36.0 10.5 13.5 15.8 18.8 14.5 17.7 11.0 17.2 11.0 18.0 11.8 38.4 10.8 14.2 23.6 24.6 24.5 8.7 21.2 12.4 37.5 22.8 11.1 9.2 32.2 28.6 15.1 19.8 11.3 22.6 11.8 15.8 15.7 24.7 8.6 6.6 21.0 15.3 46.2 14.9 16.0 12.1 8.1 18.8 22.0 18.4 18.7 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.5;intestine: 34.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 114.3;Inhibitory neurons: 172.1;Microglial cells: 63.7;Syncytiotrophoblasts: 193.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 50.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 76.2;HUVEC TERT2: 84.0;NB-4: 74.2;SK-BR-3: 89.6;TIME: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 8.3 9.1 2.6 9.4 5.9 17.2 9.4 1.1 7.6 4.4 0.6 34.8 17.8 5.7 36.5 7.5 3.6 5.3 6.7 5.3 7.9 3.5 3.8 11.4 7.9 1.4 2.8 4.0 2.3 3.3 1.3 2.4 18.2 2.0 2.7 28.5 9.5 4.4 1.9 6.3 7.1 19.4 7.7 0.9 12.3 5.0 9.3 4.2 7.1 4.4 2.6 3.0 6.6 3.8 5.1 2.5 4.9 4.9 1.2 6.8 26.9 2.1 21.3 24.7 5.8 5.4 8.2 28.0 3.7 5.4 3.4 4.3 1.5 13.4 0.2 1.4 1.8 32.2 76.2 10.7 2.7 14.7 30.0 24.0 7.5 0.2 8.7 11.0 14.3 84.0 2.9 6.6 2.7 0.9 0.8 19.9 74.2 19.3 1.6 54.5 16.1 7.9 3.1 25.7 7.2 8.6 7.9 4.8 89.6 37.8 9.7 4.1 28.2 68.2 15.6 4.6 5.6 9.3 4.4 4.9 1.8 24.5 38.5 13.7 3.8 22.8 50.0 5.0 13.9 3.4 2.0 8.3 6.2 8.1 1.8 2.9 3.2 41.0 4.0 8.0 3.1 16.1 9.6 2.6 5.9 1.1 7.6 5.3 7.9 1.4 2.8 4.0 2.0 0.9 4.2 5.1 9.1 0.0 3.3 7.8 0.6 1.3 0.1 0.2 0.6 2.0 1.4 0.8 12.1 0.0 1.4 0.0 0.0 16.0 1.1 35.7 0.0 0.1 31.5 0.4 2.9 11.9 7.2 4.6 114.3 0.2 19.6 4.8 5.6 0.4 10.8 0.0 9.7 0.0 19.3 5.0 172.1 21.8 0.0 22.2 3.7 6.4 1.2 12.2 16.0 63.7 6.9 0.5 1.0 24.6 6.9 3.3 36.8 0.4 8.0 0.4 15.1 0.4 3.2 1.2 0.0 4.2 3.6 16.6 1.0 0.3 0.3 193.9 4.2 0.9 23.7 0.3 BCAS1 "AIBC1, NABC1, PMES-2" ENSG00000064787 "Brain enriched myelin associated protein 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 835.0;choroid plexus: 430.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles NA NA Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.0 0.3 706.6 6.4 705.4 0.1 3.4 665.0 742.2 7.3 430.5 70.1 19.2 1.4 2.3 7.2 1.6 8.7 0.4 535.4 589.3 1.4 0.4 2.9 0.6 832.2 771.0 476.2 0.4 0.9 0.0 1.0 0.1 826.1 33.7 75.0 0.2 22.4 0.3 0.5 1.4 31.4 2.8 736.0 0.5 161.3 3.4 681.4 0.7 0.3 0.8 6.6 36.0 7.5 835.0 0.0 8.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.0 27.8 0.2 0.0 0.3 4.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 44.2 0.1 0.2 0.2 90.0 0.0 2.3 0.0 1.2 0.0 179.5 0.2 0.1 0.0 368.6 0.4 0.0 12.2 0.0 0.0 0.0 0.1 3.2 0.0 0.9 0.5 1.0 0.9 0.0 0.3 0.3 0.1 0.0 0.2 0.0 1.2 0.6 0.4 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.1 2.1 0.1 706.6 705.4 665.0 742.2 535.4 589.3 832.2 771.0 476.2 826.1 736.0 681.4 835.0 0.8 9.6 1.1 1.6 2.8 0.8 6.3 8.5 0.6 0.1 6.2 1.9 2.2 7.2 35.9 3.7 0.0 0.2 0.4 182.6 1.9 2.9 15.6 9.4 11.1 0.4 8.4 0.0 1.6 22.5 0.1 0.8 202.9 11.8 4.5 0.0 0.4 0.1 0.1 0.0 2.5 371.4 18.3 0.0 2.5 16.1 0.3 1.7 16.0 0.0 0.0 0.8 0.0 538.8 718.8 22.9 102.0 0.0 1.0 21.3 12.0 0.1 100.5 0.5 0.0 1.4 2.2 15.4 6.1 0.3 0.3 0.0 1.7 0.4 35.6 56.7 POU1F1 "GHF-1, PIT-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276584 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 137 "pituitary gland: 60.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041646, HPA050624" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CHI3L2 "YKL-39, YKL39" ENSG00000064886 "Chitinase 3 like 2" Q15782 1 111200771-111243440 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 173.8;lymphoid tissue: 202.5;salivary gland: 143.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 118.1;B-cells: 76.4;Breast glandular cells: 32.2;Breast myoepithelial cells: 30.4;Leydig cells: 74.9" "Cancer enriched" "Detected in many" 8 "glioma: 104.0" "Region enhanced" "Detected in all" "hypothalamus: 173.8" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 91.6" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "JURKAT: 634.6;MOLT-4: 346.8" "Low region specificity" "Detected in all" HPA005443 Approved "Secreted to blood" NA NA 420000 "HPA005443: AB_1078510" "unprognostic (1.02e-2)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (9.10e-5)" "prognostic favorable (2.19e-4)" "unprognostic (7.12e-2)" "unprognostic (1.39e-1)" "unprognostic (1.49e-3)" "unprognostic (1.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.44e-2)" "prognostic unfavorable (8.59e-7)" "unprognostic (7.15e-3)" "unprognostic (7.68e-2)" "unprognostic (1.39e-3)" "unprognostic (1.20e-1)" 22.3 3.1 12.7 113.7 14.6 2.4 45.1 10.2 41.9 0.9 12.0 2.6 1.2 1.8 0.2 5.1 2.2 11.9 13.4 12.4 173.8 3.1 0.9 66.6 60.3 67.6 29.6 12.1 2.1 0.8 37.0 4.6 13.8 20.0 7.5 2.7 1.8 143.3 0.7 2.0 10.9 10.1 3.8 19.6 21.7 5.9 11.8 30.0 202.5 11.9 7.6 120.0 54.0 4.5 93.8 0.3 0.0 0.4 0.5 100.3 19.1 0.2 0.1 1.3 0.2 0.2 0.0 0.3 0.8 0.2 0.1 8.8 0.6 3.5 0.2 0.1 29.0 0.1 0.2 0.5 1.6 1.5 0.2 1.7 27.9 0.3 0.4 0.5 5.5 0.0 634.6 0.2 1.2 0.3 0.2 346.8 0.5 0.0 0.1 0.1 1.8 0.9 0.6 0.0 0.7 0.1 0.3 0.4 0.9 0.3 2.1 0.3 0.3 0.5 7.5 1.4 0.2 0.7 5.2 0.6 76.8 23.4 0.5 2.3 1.0 3.6 0.2 22.4 0.8 5.5 45.0 16.0 37.5 0.8 43.2 91.6 34.4 2.2 17.2 0.3 1.4 10.8 27.3 12.7 14.6 10.2 41.9 12.4 173.8 67.6 29.6 12.1 20.0 19.6 30.0 93.8 0.5 9.6 118.1 1.0 76.4 2.3 1.6 8.3 0.0 0.1 32.2 30.4 0.5 0.0 3.1 0.0 0.0 0.2 7.8 0.1 0.0 20.1 3.8 0.3 7.0 0.9 1.2 0.0 0.2 0.4 0.9 10.8 0.0 0.7 2.5 0.0 0.4 0.0 1.1 0.0 0.1 0.0 0.0 2.2 0.7 12.0 74.9 2.2 16.0 0.0 0.8 0.0 23.7 0.0 0.3 0.9 0.0 1.5 2.6 3.5 0.0 0.5 0.2 0.0 0.0 1.8 0.7 0.5 0.6 0.3 1.3 3.1 12.8 1.5 0.0 1.3 SBNO2 "FLJ00173, KIAA0963, Sno, Stno" ENSG00000064932 "Strawberry notch homolog 2" Q9Y2G9 19 1107637-1174268 "Predicted intracellular proteins" "Differentiation, Osteogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "A-431: 45.3;HDLM-2: 65.2;U-266/70: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041867 Approved NA NA "HPA041867: AB_2677715" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (6.20e-3)" "unprognostic (4.68e-2)" "unprognostic (8.48e-3)" "unprognostic (1.19e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (1.58e-3)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (7.98e-8)" "unprognostic (1.34e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.88e-1)" 47.9 43.2 4.8 8.6 2.1 11.5 40.5 1.3 4.2 33.2 5.7 29.4 1.9 28.2 0.2 52.2 34.1 3.0 24.8 0.6 11.4 46.4 41.9 69.0 2.7 12.3 3.2 0.4 31.2 21.6 0.2 38.1 2.4 5.5 43.0 0.3 0.1 43.2 0.7 38.9 42.8 31.0 2.1 3.2 60.4 30.2 19.4 6.4 1.5 34.5 0.5 2.6 32.4 36.0 16.1 45.3 5.7 0.8 0.5 0.1 2.8 16.1 13.0 1.4 2.9 1.6 0.3 7.3 9.0 18.2 2.2 2.3 14.6 0.0 2.0 1.0 65.2 9.8 9.9 18.3 0.1 2.4 5.8 28.7 6.8 1.8 4.3 1.7 2.2 2.8 3.9 15.3 12.4 1.1 5.5 5.7 7.4 12.3 0.9 19.1 13.1 7.9 11.0 4.0 2.1 10.3 16.1 7.9 14.2 15.8 1.1 5.0 4.6 15.0 7.9 6.2 23.6 22.1 49.0 24.8 7.8 15.7 5.3 9.0 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.5 0.1 0.1 0.1 0.0 0.1 4.8 2.1 1.3 4.2 0.6 11.4 12.3 3.2 0.4 5.5 3.2 6.4 16.1 28.8 9.6 22.8 4.6 8.8 14.9 13.2 10.7 11.4 5.7 39.7 23.9 5.4 5.7 18.8 3.7 2.1 4.7 13.2 22.3 3.9 9.4 2.8 19.3 21.9 25.3 3.0 0.4 4.4 6.8 5.7 13.1 33.6 39.1 3.8 10.4 13.9 10.8 10.3 6.7 3.4 10.2 14.2 15.9 20.7 1.6 9.3 20.2 8.8 5.6 13.0 3.3 5.2 3.5 5.8 17.9 15.1 4.1 16.2 20.8 7.9 1.8 14.5 4.9 6.6 12.0 12.9 7.7 9.0 10.6 18.8 10.9 14.4 9.5 12.3 22.1 PMS1 "MLH2, PMSL1" ENSG00000064933 "PMS1 homolog 1, mismatch repair system component" P54277 2 189784085-189877629 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.8" "Group enriched" "Detected in many" 6 "Early spermatids: 474.4;Late spermatids: 570.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031013 Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA031013: AB_2673696" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (9.31e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (2.38e-6)" "unprognostic (5.31e-2)" "unprognostic (1.60e-2)" "unprognostic (7.29e-3)" "unprognostic (3.55e-1)" "unprognostic (2.30e-1)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.29e-1)" "unprognostic (3.77e-2)" "unprognostic (1.92e-2)" "prognostic favorable (3.73e-4)" 9.3 9.1 9.4 12.1 8.3 12.2 11.7 15.0 9.7 10.9 7.6 7.8 7.5 13.5 15.9 6.4 9.8 8.4 7.0 7.9 9.7 6.4 7.8 8.0 13.8 9.0 9.5 7.7 12.0 8.4 7.3 9.9 8.8 9.4 9.6 9.2 18.6 10.0 10.3 9.5 11.6 8.4 10.2 7.1 13.4 13.1 48.8 9.0 8.1 10.7 6.6 10.8 7.5 7.5 11.2 13.8 11.8 29.9 23.8 16.1 24.3 26.6 25.3 12.3 21.2 25.4 19.6 18.1 39.7 14.0 10.6 15.1 19.2 29.9 18.7 29.5 30.3 17.4 39.5 24.1 30.3 22.5 23.3 17.3 15.6 18.4 19.3 39.7 18.8 22.4 27.6 34.0 20.8 26.1 9.7 27.6 32.2 31.6 14.1 27.6 31.9 19.5 38.8 20.9 19.6 27.8 19.3 18.5 12.5 19.6 36.2 13.4 20.1 17.3 22.8 15.4 14.7 23.2 16.6 21.9 34.4 13.1 20.4 14.7 2.9 6.4 3.7 13.6 4.2 13.3 14.4 10.1 15.5 6.4 15.9 10.6 13.0 3.0 12.0 5.2 10.0 10.8 4.8 9.4 8.3 15.0 9.7 7.9 9.7 9.0 9.5 7.7 9.4 7.1 9.0 11.2 18.5 16.0 14.4 45.1 22.7 6.9 8.9 12.9 21.6 30.8 13.7 14.6 16.3 10.0 15.8 5.5 8.4 16.4 18.7 3.6 0.0 7.6 474.4 17.3 26.6 14.8 12.0 10.9 68.6 8.0 11.7 18.5 13.7 11.7 13.3 27.7 8.2 9.6 9.2 10.1 80.2 7.3 16.2 16.0 5.1 570.1 21.8 14.9 7.2 43.1 9.8 11.2 22.6 80.9 64.8 6.4 4.3 19.5 30.1 7.5 4.9 6.1 27.0 28.0 13.1 16.3 15.0 25.3 25.9 19.3 7.0 5.2 20.9 22.2 11.1 4.3 HMG20B "BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL" ENSG00000064961 "High mobility group 20B" Q9P0W2 19 3572777-3579088 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 265.7;Melanocytes: 229.5;Syncytiotrophoblasts: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 411.1;WM-115: 405.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050220, HPA053157, HPA069832" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210" "unprognostic (2.97e-1)" "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.72e-7)" "unprognostic (2.18e-2)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-1)" "unprognostic (1.66e-1)" "unprognostic (4.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.91e-3)" "unprognostic (2.78e-2)" "unprognostic (1.84e-1)" "prognostic favorable (2.89e-5)" 45.7 41.7 25.8 18.4 26.3 30.4 50.3 27.5 34.0 51.2 27.0 56.3 28.4 55.0 15.8 48.5 45.1 17.0 33.9 23.1 29.9 56.1 54.8 38.6 20.3 30.3 25.7 21.3 38.4 38.4 30.6 18.3 22.9 28.6 69.5 17.4 8.8 50.3 25.9 26.1 57.9 48.0 20.1 27.6 39.5 54.6 36.2 29.0 48.6 39.6 12.1 16.1 49.4 44.2 32.0 93.1 39.0 34.6 83.0 42.2 38.1 64.1 58.7 42.4 52.6 40.0 14.1 33.5 50.5 53.7 42.6 47.5 44.4 20.3 40.0 31.3 45.1 46.6 24.8 132.2 37.7 27.2 33.9 117.5 32.5 47.0 30.2 20.0 53.4 53.4 44.8 42.0 81.9 35.0 126.3 64.7 62.0 39.7 78.5 78.4 42.3 60.4 69.5 39.0 58.4 21.7 66.0 81.7 141.3 411.1 32.4 106.8 90.5 77.4 27.7 62.1 99.3 50.8 76.4 43.0 36.2 72.0 85.6 405.1 44.9 68.1 66.2 40.1 70.1 35.8 35.2 34.1 43.6 66.1 30.2 36.3 35.3 37.9 59.5 77.0 59.5 41.4 51.8 25.8 26.3 27.5 34.0 23.1 29.9 30.3 25.7 21.3 28.6 27.6 29.0 32.0 50.1 28.9 19.3 9.8 27.9 70.5 52.1 67.4 47.8 3.4 75.0 70.9 8.7 28.6 40.0 18.4 10.4 122.9 34.1 50.0 92.0 65.0 26.7 39.7 41.4 42.5 66.8 24.4 0.7 45.5 265.7 35.4 32.6 44.4 37.5 58.1 38.6 20.9 81.9 8.4 0.7 170.8 57.0 29.6 93.4 49.6 37.3 47.1 229.5 3.7 86.2 41.2 42.2 0.5 11.7 58.6 68.5 44.8 34.9 62.8 74.7 76.2 29.5 18.7 32.9 22.4 53.4 39.9 17.4 53.0 79.8 303.7 30.8 49.6 68.7 62.9 CALCRL "CGRPR, CRLR" ENSG00000064989 "Calcitonin receptor like receptor" Q16602 2 187341964-187448460 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.4;lung: 77.4" "Cell type enhanced" "Detected in many" "Adipocytes: 138.3;Endometrial stromal cells: 92.7;Endothelial cells: 248.7;Hepatic stellate cells: 259.2;Oligodendrocyte precursor cells: 293.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 9.2;monocytes: 2.6" "Cell line enriched" "Detected in some" 4 "HUVEC TERT2: 173.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008070, HPA046515" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA008070: AB_1845912, HPA046515: AB_2679681" "unprognostic (7.06e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (3.44e-3)" "unprognostic (7.60e-3)" "unprognostic (9.25e-3)" "unprognostic (4.14e-2)" "unprognostic (7.71e-3)" "unprognostic (3.32e-1)" "unprognostic (3.77e-1)" "unprognostic (3.44e-1)" "unprognostic (1.51e-3)" "unprognostic (1.90e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" 71.4 6.3 4.8 12.4 4.6 0.4 16.0 6.1 6.0 28.1 4.9 6.9 6.0 21.7 4.6 8.7 11.5 24.6 20.6 4.1 17.7 14.1 12.7 77.4 8.0 11.3 5.4 2.9 15.8 4.4 13.1 3.7 11.8 10.3 7.3 9.6 0.9 7.1 7.8 6.3 4.0 6.3 27.3 15.4 8.7 7.1 2.7 5.1 4.7 28.5 20.4 9.2 14.2 4.7 15.8 0.2 0.0 8.8 0.0 6.2 1.6 0.0 0.8 1.3 0.1 1.0 0.0 1.0 0.0 2.3 0.7 0.2 0.0 0.0 0.6 0.2 1.5 0.5 1.5 0.0 0.2 4.9 0.2 0.0 4.6 0.2 0.3 2.1 0.5 173.6 0.1 0.0 2.5 1.2 0.0 0.8 0.1 0.5 0.0 0.0 0.0 3.1 0.5 40.5 0.0 0.4 0.2 0.0 0.0 0.4 0.5 0.0 0.2 25.3 0.7 0.1 0.1 0.4 6.2 0.1 0.7 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 9.2 0.0 0.8 0.1 0.1 1.0 1.0 2.6 0.0 0.9 4.8 4.6 6.1 6.0 4.1 17.7 11.3 5.4 2.9 10.3 15.4 5.1 15.8 138.3 0.0 11.9 19.6 1.2 9.3 2.3 1.7 21.6 0.2 0.8 1.8 12.3 2.8 3.6 0.0 0.0 0.4 2.4 0.0 3.9 0.3 0.8 3.1 92.7 248.7 0.0 4.8 15.4 0.4 0.2 56.5 1.1 1.7 5.1 12.3 259.2 1.8 0.9 0.0 2.1 0.0 2.0 10.3 29.7 1.0 7.8 15.4 10.6 47.8 16.1 0.0 1.0 293.0 1.0 0.1 0.0 2.6 4.9 1.9 0.0 13.2 2.8 0.1 6.6 4.1 21.5 1.3 0.7 18.2 6.8 0.3 3.0 6.0 0.0 1.8 TAF11 "TAF2I, TAFII28" ENSG00000064995 "TATA-box binding protein associated factor 11" Q15544 6 34877462-34888071 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029326, HPA049127" Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA029326: AB_2672999, HPA049127: AB_2680645" "unprognostic (4.02e-2)" "unprognostic (5.36e-3)" "unprognostic (7.41e-2)" "unprognostic (5.18e-3)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (2.56e-3)" "unprognostic (1.45e-2)" "unprognostic (1.68e-3)" "prognostic favorable (5.87e-4)" "unprognostic (2.91e-1)" "unprognostic (6.77e-3)" "unprognostic (1.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.87e-2)" "unprognostic (4.92e-1)" "unprognostic (3.32e-1)" 23.3 28.1 23.0 19.7 24.1 47.5 23.2 26.2 26.7 24.1 23.5 27.5 19.4 22.8 18.6 26.0 25.4 15.6 26.5 23.1 22.8 24.2 28.7 25.7 27.4 23.5 23.5 23.0 28.1 27.4 16.8 20.0 22.8 23.8 26.4 20.8 25.0 21.1 17.1 32.8 28.3 26.7 20.9 23.1 34.1 25.3 33.7 23.8 23.9 24.6 21.8 25.6 25.1 23.3 27.3 37.2 15.4 50.2 91.4 29.5 30.8 44.5 29.5 23.1 47.2 44.8 35.9 23.0 49.5 37.8 27.3 23.1 23.4 61.5 25.1 37.7 30.3 49.6 55.7 30.7 58.8 41.3 74.9 38.6 35.8 41.2 32.2 25.2 28.8 57.6 55.0 89.0 38.1 22.6 65.6 48.1 63.4 45.9 74.3 26.0 51.6 44.9 39.7 34.4 23.0 60.6 55.3 33.9 37.9 68.6 41.5 59.4 88.6 34.6 33.3 44.6 20.1 36.9 35.2 90.5 72.4 12.2 86.3 49.9 43.6 27.8 24.5 14.3 25.8 13.8 13.8 14.9 15.4 24.1 17.1 17.4 15.6 17.5 17.6 21.7 21.5 21.4 15.9 23.0 24.1 26.2 26.7 23.1 22.8 23.5 23.5 23.0 23.8 23.1 23.8 27.3 49.9 28.9 19.5 18.3 44.9 46.0 31.4 36.1 24.5 29.0 55.1 44.3 24.0 25.8 31.3 42.3 12.5 71.9 50.4 33.5 64.6 47.9 6.6 37.4 49.7 43.8 39.5 39.5 20.8 63.2 68.9 33.5 29.6 47.7 22.2 57.8 61.1 58.8 44.2 32.0 23.7 38.4 50.8 52.2 32.2 10.6 33.8 36.5 24.9 13.1 48.5 37.8 48.4 16.6 33.6 50.8 51.2 37.2 44.0 32.9 43.5 48.9 17.1 32.9 32.9 34.0 35.5 130.9 71.2 36.3 58.4 76.8 44.3 38.2 40.6 31.2 ANKS1A "ANKS1, KIAA0229" ENSG00000064999 "Ankyrin repeat and sterile alpha motif domain containing 1A" Q92625 6 34889255-35091406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.0;Inhibitory neurons: 160.5;Microglial cells: 168.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036768, HPA036769" Approved Approved Nucleoplasm,Cytosol NA NA 17000 Nucleoplasm Cytosol "HPA036768: AB_10670923, HPA036769: AB_10672473" "unprognostic (3.75e-2)" "unprognostic (2.67e-1)" "unprognostic (2.59e-2)" "unprognostic (7.79e-3)" "unprognostic (5.73e-2)" "prognostic favorable (7.48e-4)" "unprognostic (1.18e-3)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "prognostic favorable (8.05e-5)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.23e-2)" "unprognostic (7.80e-2)" 15.1 19.3 14.8 8.1 12.8 5.8 15.2 14.8 15.2 10.0 12.5 23.8 10.6 10.8 7.5 15.5 20.3 10.1 16.9 11.7 12.6 13.1 10.8 18.9 9.3 14.4 16.2 10.0 17.5 9.4 16.5 8.5 28.0 14.1 11.8 9.1 23.1 9.2 15.6 20.3 15.3 14.4 14.4 11.9 23.2 14.9 16.6 19.2 7.7 13.9 9.6 5.8 27.4 13.2 14.3 15.4 7.3 14.8 14.2 6.5 6.4 22.3 6.0 6.7 7.2 8.7 18.4 9.7 10.4 10.0 6.4 13.1 15.7 17.4 17.6 8.3 8.0 21.9 7.3 9.2 13.7 4.0 11.8 6.7 7.4 14.9 9.3 12.3 7.7 15.9 10.7 12.6 4.4 6.4 10.0 7.4 12.8 10.7 20.3 8.4 8.9 8.3 10.6 14.5 27.9 58.5 14.8 10.3 14.1 43.7 18.1 11.1 13.0 13.9 7.3 9.2 7.6 8.9 6.7 10.9 5.5 5.6 16.8 20.3 0.0 0.6 0.5 0.2 0.9 0.4 0.4 0.2 0.4 0.5 0.1 0.3 0.2 1.1 0.2 1.5 1.1 0.3 0.4 14.8 12.8 14.8 15.2 11.7 12.6 14.4 16.2 10.0 14.1 11.9 19.2 14.3 48.2 80.1 11.4 54.2 4.4 12.1 9.1 4.2 4.0 28.8 11.3 14.4 25.3 11.5 8.3 12.9 64.6 8.9 5.5 17.2 0.0 7.3 12.7 32.1 7.4 31.7 13.2 5.7 94.0 5.9 7.5 10.0 13.3 35.6 2.5 17.2 47.5 6.6 11.9 8.4 160.5 11.0 18.3 29.2 10.9 11.3 12.8 18.9 5.4 168.6 8.1 21.7 10.3 90.5 75.9 10.2 7.6 30.1 6.4 13.3 10.0 7.0 29.0 45.4 19.7 10.3 13.5 6.9 5.9 8.5 20.5 12.4 4.8 5.9 9.2 14.9 AP3D1 ADTD ENSG00000065000 "Adaptor related protein complex 3 subunit delta 1" O14617 19 2100988-2164468 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074408 Approved Cytosol No No 28000 Cytosol "HPA074408: AB_2686686" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.24e-3)" "unprognostic (1.37e-1)" "unprognostic (6.35e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (4.24e-2)" "unprognostic (8.05e-2)" "unprognostic (5.70e-2)" "unprognostic (6.68e-3)" "unprognostic (9.37e-2)" "prognostic favorable (2.61e-6)" "unprognostic (8.11e-3)" "unprognostic (1.22e-1)" "unprognostic (6.25e-2)" "unprognostic (1.73e-2)" 29.9 41.0 32.7 36.6 32.8 27.9 29.0 23.2 55.5 29.7 28.8 36.1 36.1 35.4 16.8 38.5 32.8 28.3 44.1 37.4 31.0 35.9 41.2 31.4 37.5 31.8 36.0 31.0 30.1 64.4 40.3 56.9 33.7 35.9 31.5 22.7 29.8 48.4 34.3 61.6 29.7 35.7 33.1 17.4 35.1 38.0 45.3 34.4 33.5 44.3 40.7 27.9 34.6 25.7 32.6 114.8 117.5 68.5 105.0 85.7 71.8 83.9 90.3 87.9 94.2 85.2 134.8 61.8 61.7 51.0 134.1 115.7 76.4 99.2 109.7 61.1 89.9 94.6 80.5 74.7 106.3 149.9 88.4 102.5 89.5 72.3 98.1 141.6 79.7 92.6 44.2 84.2 210.9 84.1 84.4 85.6 46.8 102.8 78.2 74.2 90.3 75.0 83.4 70.7 162.7 97.4 81.1 82.3 85.7 154.2 62.5 83.2 101.0 121.7 89.7 37.7 123.4 106.7 176.5 184.6 78.6 122.5 57.4 91.5 0.2 3.3 2.9 3.5 3.6 5.6 2.4 3.4 4.1 3.9 2.9 2.7 3.4 3.4 5.5 3.0 7.5 2.1 2.2 32.7 32.8 23.2 55.5 37.4 31.0 31.8 36.0 31.0 35.9 17.4 34.4 32.6 29.5 60.9 61.7 41.4 35.5 20.3 41.3 20.3 36.5 66.6 39.5 26.5 77.7 44.3 34.1 40.5 35.5 55.3 32.5 79.5 21.5 53.3 70.7 34.4 36.9 37.1 47.8 42.9 24.1 74.2 71.9 38.2 69.8 48.9 17.1 38.9 29.6 49.2 66.9 48.8 30.2 68.8 18.3 38.4 30.2 68.6 37.9 43.4 39.2 18.7 31.7 55.5 29.9 21.1 28.3 67.7 54.0 38.0 67.6 65.5 52.6 36.0 30.3 43.9 19.7 37.8 33.6 105.3 129.5 38.0 23.3 78.0 36.9 39.6 56.8 59.4 ZNF76 "D6S229E, Zfp523, ZNF523" ENSG00000065029 "Zinc finger protein 76" P36508 6 35258909-35295985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030090, HPA030091" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030090: AB_10603334, HPA030091: AB_10602593" "unprognostic (8.29e-3)" "unprognostic (3.61e-2)" "unprognostic (7.71e-2)" "unprognostic (8.70e-3)" "unprognostic (2.76e-1)" "unprognostic (6.51e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (5.09e-4)" "unprognostic (3.66e-3)" "unprognostic (1.20e-3)" "unprognostic (5.31e-3)" "unprognostic (1.14e-1)" "unprognostic (3.76e-1)" "unprognostic (1.20e-3)" 15.8 33.3 17.5 11.8 18.4 10.1 18.4 17.3 18.7 22.2 19.7 20.0 12.7 17.6 18.7 15.6 21.1 10.0 27.0 17.3 17.6 27.6 25.8 17.9 17.6 19.4 18.3 17.0 31.1 23.6 21.7 45.5 11.1 19.0 28.1 10.5 23.1 21.5 14.6 55.2 13.0 23.3 10.8 16.9 33.9 20.5 24.9 18.2 15.4 39.4 32.0 14.7 20.4 18.1 18.1 10.7 9.6 20.7 23.0 8.6 13.2 14.8 9.0 15.1 14.9 11.9 7.3 14.0 23.1 13.1 13.5 14.2 5.9 17.5 13.6 8.6 34.5 26.7 22.2 15.7 11.6 17.1 11.2 12.6 16.2 8.5 17.2 16.0 9.1 13.7 23.1 16.6 23.7 13.7 23.5 19.1 13.1 10.2 8.5 9.2 18.1 10.7 21.4 13.5 14.7 32.5 11.9 11.0 13.9 27.3 6.8 20.8 36.1 10.6 10.4 8.9 7.2 13.2 23.8 17.8 21.6 9.0 17.4 28.0 5.2 7.2 6.3 16.8 9.5 13.2 10.9 12.1 12.0 8.2 10.4 12.6 13.2 2.2 10.8 10.9 4.1 10.3 10.3 17.5 18.4 17.3 18.7 17.3 17.6 19.4 18.3 17.0 19.0 16.9 18.2 18.1 9.6 16.0 9.6 16.3 19.3 5.7 8.3 10.2 15.9 28.5 14.0 10.2 20.3 8.6 9.7 9.2 50.1 23.7 11.6 13.4 21.5 12.5 20.6 9.2 7.7 10.5 12.1 6.9 19.7 15.5 12.4 10.0 7.7 10.1 12.7 19.5 10.0 8.7 11.3 30.3 22.0 13.9 8.2 7.2 6.9 13.4 11.1 7.6 5.4 21.5 6.1 15.3 16.5 24.1 23.9 7.6 13.1 6.0 16.1 6.8 12.1 12.5 9.2 31.2 19.7 8.8 10.2 21.9 10.4 8.7 6.3 22.7 12.6 14.8 10.1 7.9 SLC9A3R2 "E3KARP, NHERF-2, SIP-1, TKA-1" ENSG00000065054 "SLC9A3 regulator 2" Q15599 16 2025356-2039026 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 1013.8;Endothelial cells: 398.9;Hepatic stellate cells: 374.4;Hepatocytes: 227.4;Pancreatic endocrine cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;intermediate monocyte: 1.6;myeloid DC: 3.9;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 5 "dendritic cells: 3.9;monocytes: 2.2" "Cell line enhanced" "Detected in many" "A549: 188.6;MCF7: 306.8;PC-3: 281.2;SK-BR-3: 188.3;U-251 MG: 193.6;WM-115: 202.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001672, HPA066520" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA001672: AB_1080017, HPA066520: AB_2732748" "unprognostic (6.99e-2)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-3)" "unprognostic (9.17e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.70e-2)" "unprognostic (2.20e-2)" "unprognostic (6.20e-3)" "unprognostic (9.10e-2)" "unprognostic (2.40e-1)" "unprognostic (2.80e-2)" 198.0 82.4 94.2 20.9 76.3 0.7 183.3 67.3 120.6 88.2 54.2 74.6 27.4 93.5 10.8 47.7 78.4 35.1 389.1 66.8 72.3 207.3 411.6 291.6 22.2 81.5 79.4 55.8 58.4 48.1 24.2 96.4 51.8 99.0 130.2 12.0 3.0 150.4 42.8 146.0 42.7 81.9 19.0 67.8 145.0 110.4 36.6 91.9 8.0 189.9 110.0 7.5 78.1 73.2 78.9 32.5 188.6 5.0 38.6 6.2 8.6 5.7 138.1 81.9 67.9 22.5 25.4 41.9 0.1 63.4 59.2 9.1 30.9 15.0 13.7 7.1 0.4 45.0 3.1 80.8 61.6 44.3 0.5 13.9 9.2 13.7 20.2 5.9 32.1 68.2 15.0 24.0 2.9 4.8 306.8 0.6 35.7 7.5 76.8 281.2 27.6 8.1 50.5 16.0 2.9 35.3 33.1 9.7 188.3 12.8 5.0 152.6 16.8 176.4 21.5 30.7 1.9 193.6 5.1 4.6 0.7 2.5 3.6 202.4 0.0 2.2 0.0 0.5 1.6 0.2 0.0 0.1 0.1 3.9 0.0 0.4 0.5 0.0 0.0 0.5 2.9 0.1 0.7 94.2 76.3 67.3 120.6 66.8 72.3 81.5 79.4 55.8 99.0 67.8 91.9 78.9 1013.8 3.2 10.5 4.2 7.3 15.2 19.6 17.1 7.4 2.6 79.5 65.0 25.5 88.6 47.3 12.9 0.0 1.0 11.4 13.3 5.9 36.1 16.1 37.2 36.8 398.9 21.5 17.3 3.4 8.8 0.8 53.5 33.6 67.8 0.0 5.1 374.4 227.4 2.6 3.3 5.5 77.0 22.4 30.9 35.1 35.8 82.0 7.0 33.8 31.9 2.2 17.2 7.2 4.0 3.6 326.8 9.3 44.4 4.9 51.8 1.2 14.7 27.3 5.0 26.3 22.3 69.1 7.0 15.4 3.4 11.4 1.0 8.8 9.5 18.0 66.6 NTHL1 "NTH1, OCTS3" ENSG00000065057 "Nth like DNA glycosylase 1" P78549 16 2039815-2047866 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase, Lyase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 866.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025152 Supported NA NA "CAB025152: " "unprognostic (1.06e-1)" "unprognostic (9.71e-2)" "unprognostic (1.23e-1)" "unprognostic (2.54e-1)" "unprognostic (7.89e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" "unprognostic (2.46e-2)" "unprognostic (4.98e-2)" "unprognostic (1.11e-1)" "unprognostic (2.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.53e-2)" "unprognostic (2.27e-1)" "unprognostic (1.34e-1)" "unprognostic (5.08e-2)" "unprognostic (1.62e-2)" 10.9 9.4 12.3 6.2 12.7 4.8 11.1 12.9 19.9 15.0 9.5 16.2 6.6 15.5 3.2 11.4 14.0 6.1 12.7 11.7 12.2 9.8 22.1 10.8 8.4 13.6 12.1 11.3 16.2 10.0 4.9 11.5 5.7 13.9 11.3 5.7 1.8 16.2 11.6 9.8 9.2 11.2 5.3 11.7 16.8 13.3 8.8 13.2 7.7 9.6 6.8 6.0 11.9 12.7 12.8 29.8 74.2 20.8 32.2 8.5 15.9 22.8 12.1 13.2 23.1 14.6 53.0 28.8 63.0 25.2 10.7 15.1 26.2 26.1 29.0 4.0 28.9 63.3 19.5 47.7 60.9 11.5 22.4 22.3 13.2 14.9 12.3 13.2 15.4 33.4 37.0 22.2 22.6 9.0 34.9 33.9 88.3 46.2 37.3 47.3 80.8 22.0 103.5 17.2 10.7 43.9 43.5 13.2 41.0 25.4 7.6 29.6 23.5 12.9 19.9 21.5 17.5 23.1 30.3 38.0 26.9 8.8 31.7 24.9 4.2 15.0 3.4 14.4 26.0 16.2 37.5 17.3 16.7 25.7 32.8 12.8 15.4 0.7 19.1 22.5 26.3 34.0 14.4 12.3 12.7 12.9 19.9 11.7 12.2 13.6 12.1 11.3 13.9 11.7 13.2 12.8 47.2 28.9 27.5 2.9 12.9 8.7 16.4 21.6 8.0 8.8 18.9 23.4 14.1 44.3 28.3 3.7 0.0 10.5 8.1 75.6 17.6 16.3 8.1 20.4 19.5 36.5 67.4 26.7 3.0 9.1 18.3 17.6 16.3 23.3 5.7 20.5 51.0 866.4 13.4 6.7 3.6 85.3 54.9 25.5 17.6 23.8 33.8 9.3 21.4 2.8 9.7 10.7 18.6 3.0 4.9 12.1 81.6 25.2 16.0 6.4 12.8 28.8 23.5 8.1 13.1 8.1 23.6 5.4 32.0 11.7 10.1 2.7 12.2 20.6 56.8 21.0 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 4.3 4.4 3.3 4.4 2.9 14.3 3.7 6.9 3.8 2.7 4.5 2.9 3.3 3.3 2.5 3.3 2.8 2.6 6.8 2.5 3.3 3.7 3.9 4.2 4.9 3.5 3.7 2.3 3.3 8.0 8.6 3.0 5.3 4.7 3.7 4.0 7.6 6.0 3.0 14.4 3.1 3.6 3.9 3.3 4.5 4.0 12.1 3.7 5.8 6.1 7.6 4.3 3.6 2.4 4.0 12.9 9.1 7.9 25.9 4.1 3.0 14.3 7.4 5.0 7.1 10.0 18.2 3.4 19.4 7.9 7.7 12.3 9.6 29.2 4.2 9.6 10.0 9.4 17.2 8.7 15.2 16.7 15.7 10.3 6.8 12.0 5.7 12.0 6.6 9.1 16.6 29.3 7.5 3.1 12.3 12.2 10.2 3.6 9.3 6.3 7.3 12.7 11.8 9.6 11.8 9.5 9.7 18.7 9.7 24.7 8.1 18.5 20.3 5.6 3.5 12.7 5.5 8.2 11.1 18.6 12.0 1.9 21.5 8.8 0.1 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 0.4 1.3 0.1 0.1 0.2 3.3 2.9 6.9 3.8 2.5 3.3 3.5 3.7 2.3 4.7 3.3 3.7 4.0 5.1 16.0 6.3 16.0 5.0 1.0 3.0 3.9 5.7 10.1 5.2 2.9 16.8 4.3 9.1 0.0 20.9 6.9 3.7 3.0 1.9 5.4 10.0 5.8 4.9 6.3 9.5 6.7 20.8 5.8 3.8 4.9 10.2 11.5 1.3 14.3 15.0 6.0 15.6 5.0 39.3 4.9 10.2 19.0 6.0 18.2 5.6 11.9 0.0 22.5 9.4 4.6 4.1 25.6 14.1 7.2 3.3 2.6 11.4 9.9 4.1 3.9 5.1 10.8 13.1 7.5 5.4 16.4 10.8 8.3 2.8 4.9 3.9 4.0 3.8 8.5 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548615-109600195 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 350.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 1400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 12.8 8.3 6.1 14.4 6.5 27.9 12.0 7.7 7.6 11.0 8.7 11.9 10.4 12.2 8.1 22.0 8.0 11.4 4.3 6.2 7.3 11.3 15.5 9.7 14.2 7.1 6.5 6.2 8.9 9.4 9.0 1.8 14.9 7.0 10.4 11.9 18.0 7.7 9.1 3.8 18.6 10.7 13.7 6.9 11.5 9.1 8.8 6.4 14.4 8.1 5.5 16.0 15.6 4.1 7.7 48.3 16.4 31.0 17.3 28.4 35.0 25.7 35.3 28.6 36.0 35.5 24.4 16.1 25.3 22.4 37.6 21.6 24.5 30.0 35.3 49.4 29.2 18.0 22.1 26.3 21.9 25.1 34.9 18.8 25.2 30.4 41.3 27.8 24.2 42.8 19.1 29.8 24.2 35.5 32.9 27.3 28.4 31.3 23.0 19.1 19.2 73.6 16.6 37.4 35.4 19.5 34.9 24.7 27.6 39.4 22.8 21.1 30.5 36.7 29.4 40.7 44.9 39.2 25.6 30.2 29.2 47.6 34.4 47.1 32.4 29.7 57.8 21.1 44.3 22.4 20.1 20.4 20.6 31.9 17.1 16.8 19.4 53.8 19.9 44.6 14.2 23.8 36.3 6.1 6.5 7.7 7.6 6.2 7.3 7.1 6.5 6.2 7.0 6.9 6.4 7.7 104.0 44.8 31.5 17.0 76.6 151.2 104.3 92.2 63.2 29.9 67.7 45.3 14.3 37.1 61.0 58.8 350.3 80.3 98.8 63.9 64.6 97.9 14.7 65.5 71.5 82.6 84.3 43.8 37.5 101.7 153.7 69.2 55.5 110.9 46.3 50.1 56.7 57.2 107.9 25.2 36.4 72.3 59.0 115.0 106.9 9.4 48.7 127.4 74.7 31.9 102.4 47.9 45.3 35.7 31.3 101.6 58.9 47.4 66.3 72.5 48.9 53.5 51.7 26.2 52.6 59.0 77.6 68.6 54.7 82.1 188.4 106.9 94.3 51.7 63.5 143.0 IPO5 "IMB3, KPNB3, MGC2068, Pse1, RANBP5" ENSG00000065150 "Importin 5" O00410 13 97953658-98024296 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 211.7" "Group enriched" "Detected in all" 11 "Early spermatids: 1152.2;Late spermatids: 2185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009110, HPA040983, HPA056548" Approved Supported Nucleoplasm,Cytosol NA NA 790000 Cytosol Nucleoplasm "CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169" "unprognostic (5.20e-2)" "unprognostic (6.94e-2)" "unprognostic (9.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.96e-3)" "unprognostic (2.16e-3)" "unprognostic (2.19e-2)" "unprognostic (5.27e-3)" "unprognostic (6.19e-2)" "unprognostic (2.51e-1)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (9.64e-2)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (2.73e-1)" 53.5 27.7 25.6 38.1 30.2 38.0 45.3 23.3 32.7 46.7 18.1 35.5 24.1 45.6 27.6 42.0 45.5 30.4 61.0 29.3 25.4 44.8 43.0 28.8 43.3 24.0 23.5 28.4 77.1 63.8 37.1 17.2 36.4 23.2 35.7 40.4 41.8 31.8 47.6 136.4 26.0 25.1 58.4 27.4 30.3 32.0 211.7 21.3 48.9 55.8 116.7 55.3 46.0 23.9 32.1 168.9 111.8 205.0 188.7 136.4 344.0 124.7 241.8 190.3 334.3 235.7 231.4 127.0 485.4 82.3 294.2 75.4 142.5 430.0 166.6 456.6 123.6 135.8 265.1 197.4 183.0 97.4 287.3 90.8 194.5 107.6 271.9 225.4 142.3 193.3 147.0 186.3 63.9 288.1 46.8 219.2 78.4 206.0 253.3 132.3 277.9 232.5 143.4 79.6 109.3 151.0 123.5 123.8 143.6 90.9 247.2 109.5 156.9 137.4 224.0 111.8 113.6 223.3 84.2 102.9 146.8 230.4 179.6 156.9 0.5 5.0 1.3 7.0 8.2 12.3 7.8 8.3 9.1 11.7 7.6 11.5 9.7 0.4 11.4 5.8 5.7 9.3 6.8 25.6 30.2 23.3 32.7 29.3 25.4 24.0 23.5 28.4 23.2 27.4 21.3 32.1 27.0 19.2 27.8 27.7 27.0 41.4 45.9 24.3 44.3 32.9 29.9 22.4 76.6 40.0 22.3 22.0 6.2 41.0 19.9 14.5 27.4 31.8 1152.2 24.9 37.5 39.5 35.3 72.8 53.4 42.3 47.5 45.1 21.4 29.3 14.5 75.6 32.9 44.2 23.9 63.9 39.5 24.8 18.3 33.3 31.6 2185.2 52.8 24.7 26.6 14.0 28.4 44.3 16.5 27.6 36.1 35.3 11.9 44.0 46.5 79.4 9.5 42.7 20.7 22.6 26.3 63.7 49.0 142.9 57.8 40.7 36.9 32.3 23.6 47.2 41.1 39.7 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 788.3" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 1222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria NA NA 12000 Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343" "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 60.5 120.7 77.2 41.2 79.7 107.3 151.6 82.1 93.8 100.6 81.2 69.1 756.8 83.2 64.3 106.0 56.5 69.3 52.8 78.7 86.2 115.6 163.7 43.1 38.4 83.8 82.6 76.9 77.7 36.4 46.4 53.9 65.6 89.5 74.9 67.8 51.6 227.4 95.5 58.7 72.2 788.3 98.7 79.5 34.4 70.8 56.7 81.5 30.5 68.4 60.5 69.7 59.5 64.3 102.5 241.5 42.8 27.5 98.7 272.4 260.8 93.4 142.2 288.0 124.2 135.2 110.5 30.8 0.5 101.0 241.8 118.0 249.4 126.5 265.7 134.0 42.4 174.9 268.1 28.1 82.7 139.9 0.4 169.3 172.1 134.5 111.9 129.5 204.9 147.1 48.4 470.8 50.0 175.5 62.6 72.1 15.3 55.1 73.2 59.6 66.3 104.5 65.3 119.8 3.9 57.3 60.9 89.7 235.1 209.5 156.6 78.6 65.8 114.3 70.5 65.3 117.9 90.2 42.4 47.6 64.6 97.4 72.0 34.4 38.0 39.6 36.0 28.8 35.3 31.2 15.2 24.0 30.5 44.3 16.2 29.5 29.8 40.0 16.9 37.2 9.4 24.6 29.6 77.2 79.7 82.1 93.8 78.7 86.2 83.8 82.6 76.9 89.5 79.5 81.5 102.5 49.0 19.2 49.7 37.9 44.7 151.3 144.0 362.8 185.5 35.2 154.2 163.7 21.8 18.6 182.7 35.0 27.1 120.8 80.3 38.2 90.1 34.6 30.4 37.0 90.4 37.7 43.1 317.0 31.8 13.4 90.5 124.2 55.5 40.6 43.8 32.2 37.5 152.2 66.2 43.7 33.4 104.1 197.4 31.8 68.1 15.2 104.1 56.7 85.4 17.8 34.8 37.4 18.6 22.1 41.9 12.6 74.6 120.0 32.9 82.6 1222.6 196.4 76.4 24.4 78.9 106.1 115.1 46.3 33.2 161.8 126.0 48.2 65.0 92.4 214.5 82.2 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 9.2 6.4 2.6 8.5 2.8 2.9 9.4 2.9 2.6 7.4 6.4 5.9 5.5 6.7 4.2 6.7 7.4 3.2 4.5 2.6 2.6 6.0 11.3 4.6 7.1 2.3 2.4 2.0 7.7 5.2 9.2 3.0 6.2 2.2 5.9 7.8 4.3 4.4 4.9 10.3 4.9 4.9 8.1 2.3 6.3 6.6 11.8 2.6 8.6 6.1 7.4 11.9 9.5 4.3 2.6 35.6 22.2 21.7 33.5 23.0 18.8 24.9 24.1 15.9 27.8 24.3 23.8 11.6 42.4 32.4 18.2 17.7 23.1 55.0 28.4 44.4 34.3 28.1 39.7 22.7 19.0 19.1 74.8 20.0 18.5 19.8 35.4 53.3 16.3 27.2 29.1 49.7 20.2 24.2 20.4 35.9 15.5 78.7 30.7 34.7 33.9 75.5 32.5 13.8 23.4 33.4 30.1 27.8 33.6 39.6 29.6 13.5 29.9 24.0 20.9 33.1 38.4 54.9 29.3 36.8 64.5 30.5 47.2 55.0 0.1 6.8 0.6 9.3 7.1 12.0 9.3 8.4 11.0 13.5 8.6 12.9 11.9 0.6 9.6 8.1 7.4 12.4 7.4 2.6 2.8 2.9 2.6 2.6 2.6 2.3 2.4 2.0 2.2 2.3 2.6 2.6 11.4 9.6 14.3 5.9 13.1 20.9 21.9 13.1 15.4 11.3 11.2 9.7 14.9 8.6 23.4 7.3 6.2 10.7 8.6 4.6 9.8 12.8 33.2 11.7 20.4 13.2 3.6 10.7 12.4 13.8 9.9 14.9 8.2 7.5 16.4 11.9 8.9 27.4 7.9 15.2 12.5 6.4 14.2 7.3 5.7 43.6 12.5 7.1 10.6 5.6 8.2 7.4 10.3 13.0 7.5 12.3 4.1 11.7 10.9 31.4 3.0 7.4 17.6 7.3 13.1 23.0 13.8 52.3 50.8 21.7 22.4 5.1 10.6 31.1 9.8 15.4 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 80.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 80.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 19.5 16.6 9.9 17.8 14.6 49.2 24.4 21.5 11.4 16.6 17.3 24.1 30.8 23.9 25.2 24.9 18.3 17.2 14.2 10.0 10.4 17.0 20.7 20.6 18.3 12.8 11.2 7.8 31.5 15.6 22.4 10.2 24.9 13.0 20.5 30.3 26.9 16.4 15.5 9.9 20.5 31.0 18.6 11.2 19.2 21.1 10.6 11.2 18.0 26.3 13.5 17.6 21.5 15.6 18.3 61.1 23.8 45.2 27.3 29.8 33.6 29.6 35.3 32.2 38.5 39.8 25.3 42.5 23.9 41.0 33.6 47.3 46.7 44.7 26.6 52.4 8.6 33.0 17.7 49.3 21.4 26.2 17.6 5.1 27.7 27.1 30.2 36.3 30.6 44.7 18.6 29.9 16.8 42.2 12.2 20.5 15.2 22.8 23.1 27.1 19.3 68.8 9.8 34.3 117.9 22.0 14.5 52.7 29.8 45.7 33.9 22.5 15.7 42.2 32.5 29.2 42.1 37.2 9.2 8.6 16.6 13.6 17.1 12.6 15.3 9.9 16.6 5.7 5.9 5.1 8.0 5.1 5.3 5.0 9.3 6.6 5.6 80.5 3.5 8.0 8.6 4.6 2.7 9.9 14.6 21.5 11.4 10.0 10.4 12.8 11.2 7.8 13.0 11.2 11.2 18.3 104.7 41.7 57.8 102.5 52.5 48.4 44.3 33.3 75.1 85.4 60.2 67.9 50.8 38.6 47.9 69.9 89.6 42.9 48.1 101.5 11.7 61.2 2.6 63.7 68.7 59.5 44.3 57.7 134.2 60.7 33.1 53.1 85.6 84.6 15.8 107.0 47.5 39.4 24.2 65.6 130.8 64.3 32.6 35.8 27.9 6.6 54.3 44.9 32.0 178.0 57.3 50.5 22.6 117.1 146.4 77.6 98.1 48.2 54.8 64.7 84.0 26.7 49.1 150.5 39.5 62.8 55.5 43.6 34.6 83.0 52.4 37.4 44.8 90.2 65.0 124.2 WDR18 Ipi3 ENSG00000065268 "WD repeat domain 18" Q9BV38 19 984332-998438 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 162.0;Proximal tubular cells: 207.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050193, HPA050200" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050193: AB_2681047, HPA050200: AB_2681049" "unprognostic (7.94e-2)" "unprognostic (3.08e-1)" "unprognostic (2.51e-1)" "unprognostic (2.13e-3)" "unprognostic (8.58e-2)" "unprognostic (2.03e-1)" "unprognostic (7.14e-2)" "unprognostic (4.88e-2)" "unprognostic (6.69e-2)" "unprognostic (2.70e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.60e-2)" "unprognostic (2.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" 14.2 21.8 10.7 12.1 10.6 11.4 15.4 10.7 18.4 13.8 9.0 16.2 11.7 15.0 3.3 26.2 14.0 4.9 17.7 10.6 10.1 25.2 32.0 12.8 8.9 11.6 10.5 10.8 13.8 18.4 8.4 19.0 10.2 11.6 16.5 4.3 7.2 16.1 9.4 23.9 21.0 14.7 4.1 9.9 18.3 15.9 17.8 10.9 8.4 15.7 8.8 6.8 15.3 15.7 11.3 58.3 55.2 16.7 28.2 15.7 14.4 68.0 25.6 14.3 30.5 22.6 62.8 19.6 68.9 29.8 37.2 3.6 46.6 45.4 53.3 11.8 36.1 75.3 33.3 34.1 79.8 36.7 71.7 30.1 18.5 28.1 18.2 42.5 15.5 28.3 32.7 74.9 25.7 11.4 62.3 53.2 102.9 96.1 39.7 35.8 99.1 39.8 107.0 19.4 35.8 63.7 60.4 24.3 20.0 26.5 11.5 47.5 42.6 28.8 34.3 41.7 67.8 40.7 83.0 74.9 33.7 29.6 44.3 37.0 11.5 77.5 18.9 53.4 84.8 52.8 56.6 53.7 58.0 117.8 69.7 53.2 48.4 3.6 57.1 70.8 74.6 65.2 66.7 10.7 10.6 10.7 18.4 10.6 10.1 11.6 10.5 10.8 11.6 9.9 10.9 11.3 20.8 9.6 13.0 10.4 19.5 19.4 28.4 57.9 25.0 28.6 23.1 22.6 13.6 15.7 31.1 31.3 22.9 90.3 14.5 22.4 70.5 73.2 35.6 18.0 17.4 24.6 32.3 20.8 9.8 54.4 162.0 22.3 23.0 18.9 16.5 47.7 23.6 43.0 46.0 26.9 7.9 33.0 44.7 19.2 17.2 38.2 15.5 19.2 16.0 5.6 47.7 32.2 23.7 1.5 6.0 47.8 23.9 16.1 30.0 27.9 28.8 207.8 27.2 24.8 13.1 16.2 31.7 36.5 30.6 29.8 20.3 60.1 18.7 43.7 48.3 24.2 TRAM2 KIAA0057 ENSG00000065308 "Translocation associated membrane protein 2" Q15035 6 52497408-52577060 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 122.0;Plasma cells: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 250.1;ASC TERT1: 265.8;fHDF/TERT166: 253.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035092, HPA057925" Approved Approved Cytosol NA NA Cytosol "HPA035092: AB_10610562, HPA057925: AB_2683557" "unprognostic (2.32e-2)" "unprognostic (2.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.12e-1)" "unprognostic (4.07e-2)" "unprognostic (8.90e-3)" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.03e-1)" "unprognostic (3.01e-1)" "unprognostic (5.05e-1)" "prognostic unfavorable (1.41e-9)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "unprognostic (6.64e-2)" "unprognostic (1.19e-2)" 18.5 4.9 3.7 14.9 4.5 5.3 13.9 3.1 5.9 14.6 8.6 12.7 14.1 13.2 11.6 5.6 13.6 17.4 10.4 3.3 3.9 7.2 16.3 14.2 7.6 4.5 3.6 3.0 12.6 7.1 2.9 3.9 36.1 3.5 6.1 14.9 3.9 6.4 5.9 3.7 11.6 12.8 17.7 3.4 19.3 9.6 13.4 4.6 4.6 12.5 5.9 13.4 13.5 9.7 5.0 45.4 19.8 22.7 22.6 250.1 265.8 39.8 130.0 130.8 106.7 98.2 43.2 9.2 11.0 21.4 253.4 76.0 10.0 14.9 81.3 133.6 24.8 8.0 24.1 20.5 54.9 71.3 6.2 13.1 97.4 8.0 93.5 41.2 155.1 124.1 9.1 15.1 78.4 154.5 16.2 8.9 17.7 10.4 17.9 8.8 10.9 59.8 91.0 25.3 7.5 5.5 8.7 29.9 13.2 31.6 47.7 20.6 12.9 198.8 177.6 38.4 65.0 72.1 53.4 97.7 31.1 64.7 16.1 110.8 0.1 1.0 1.0 0.9 1.1 0.5 1.2 0.7 0.5 1.1 0.8 0.3 0.6 0.2 0.7 2.1 0.5 0.2 0.7 3.7 4.5 3.1 5.9 3.3 3.9 4.5 3.6 3.0 3.5 3.4 4.6 5.0 12.8 6.4 3.2 6.8 15.9 8.2 2.8 8.5 3.4 3.1 4.0 5.1 9.9 4.3 4.1 7.3 25.0 36.2 6.6 7.8 3.9 3.6 38.3 4.0 28.9 17.9 9.0 8.6 12.0 3.2 30.8 26.2 6.1 5.0 2.5 34.0 19.6 36.1 15.7 5.0 9.2 19.6 6.1 12.0 6.9 122.0 20.8 5.7 26.6 13.1 4.3 1.8 8.2 3.5 3.1 6.2 1.7 23.3 69.5 2.8 7.0 3.1 4.9 12.7 13.1 16.2 15.7 23.4 8.6 1.2 4.1 20.7 6.0 14.3 5.7 1.5 NTN1 NTN1L ENSG00000065320 "Netrin 1" O95631 17 9021510-9244000 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;heart muscle: 35.8" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 137.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056419 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Secreted to extracellular matrix" NA NA 110000 Cytosol "Nucleoplasm, Actin filaments" "HPA056419: AB_2683124" "unprognostic (2.72e-1)" "unprognostic (2.59e-2)" "unprognostic (7.12e-2)" "unprognostic (5.25e-2)" "unprognostic (2.51e-1)" "unprognostic (9.33e-3)" "unprognostic (9.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.15e-1)" "unprognostic (2.49e-2)" "unprognostic (2.20e-2)" "unprognostic (2.60e-1)" "unprognostic (6.07e-3)" "unprognostic (8.31e-3)" 4.4 0.5 8.0 3.6 5.5 0.1 5.4 10.5 5.0 8.1 3.4 12.6 6.8 9.7 3.5 19.1 10.4 7.4 35.8 3.8 11.2 1.9 7.0 4.3 0.2 12.8 31.8 2.7 0.9 2.3 4.4 3.0 0.9 10.8 4.0 4.0 0.4 11.0 2.0 2.1 7.3 10.6 6.0 14.9 0.1 17.6 3.2 8.7 2.9 2.0 2.6 2.1 10.3 5.5 14.0 0.1 0.0 1.3 4.6 4.2 0.1 27.5 0.3 0.4 0.3 0.5 0.1 5.7 0.0 6.2 0.0 9.0 0.1 1.2 0.9 0.0 6.4 10.4 1.4 0.0 0.0 0.1 0.5 0.1 0.1 2.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.1 5.6 0.1 0.6 1.8 0.0 0.0 3.4 4.8 0.0 0.0 0.3 0.0 0.0 0.1 4.7 1.1 4.5 16.6 0.3 0.0 6.7 14.4 0.0 22.1 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 5.5 10.5 5.0 3.8 11.2 12.8 31.8 2.7 10.8 14.9 8.7 14.0 0.7 0.0 0.0 10.7 0.3 3.3 6.6 21.8 9.6 2.9 4.7 4.4 28.1 0.0 23.9 1.8 0.0 0.3 0.2 0.5 0.0 3.1 9.3 5.8 2.0 3.1 0.0 0.0 4.8 1.7 1.2 9.7 1.1 7.9 0.0 0.0 2.2 12.4 0.1 0.0 7.1 1.4 24.4 0.6 5.9 4.6 0.3 0.1 1.8 9.4 0.6 0.3 0.0 137.2 1.0 1.4 0.1 0.0 0.0 4.0 0.7 0.2 11.1 0.2 0.0 3.9 6.8 1.6 2.0 12.7 2.8 0.5 0.5 0.0 0.6 3.5 GLP2R ENSG00000065325 "Glucagon like peptide 2 receptor" O95838 17 9822206-9892099 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 12.3;intestine: 11.7;urinary bladder: 11.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Excitatory neurons: 6.4;Leydig cells: 3.1;Rod photoreceptor cells: 23.3" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HeLa: 78.1" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.1;hippocampal formation: 2.4" "Low region specificity" "Detected in all" "CAB022690, HPA049244" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022690: , HPA049244: AB_2680690" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (2.66e-3)" "unprognostic (2.21e-2)" "unprognostic (3.81e-3)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (5.15e-2)" "unprognostic (7.63e-2)" "unprognostic (7.14e-2)" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (3.40e-8)" "unprognostic (9.53e-5)" "unprognostic (5.51e-2)" "unprognostic (3.92e-1)" "unprognostic (6.48e-3)" 4.2 0.3 1.3 0.8 3.2 0.0 0.8 0.0 3.6 5.6 0.0 11.7 10.0 1.2 0.0 0.7 1.6 12.3 0.4 2.8 1.3 0.2 2.7 1.0 0.6 0.1 0.1 1.4 0.4 1.6 0.0 0.0 1.1 0.2 0.1 6.1 3.5 0.0 0.1 0.1 0.1 8.3 1.9 0.0 0.1 3.8 0.4 0.0 0.1 0.2 0.2 0.2 11.9 1.6 2.3 0.0 16.6 0.0 0.0 0.8 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 2.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 78.1 0.6 1.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.0 3.6 2.8 1.3 0.1 0.1 1.4 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 6.4 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.5 0.0 1.5 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 23.3 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161558-13211110 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.3;lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 1.0 0.1 0.0 3.3 0.1 9.3 0.8 0.1 0.1 0.2 0.1 1.7 1.5 0.4 0.1 1.9 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.3 4.8 0.0 0.1 0.1 0.2 0.1 0.2 0.1 2.1 0.1 0.1 2.2 0.1 0.3 0.0 0.5 1.1 1.2 0.8 0.0 1.0 0.8 1.5 0.1 8.1 0.3 0.1 4.5 0.7 0.7 0.4 38.0 42.0 48.6 36.9 1.6 2.9 21.2 38.7 5.9 42.7 44.0 41.3 26.4 56.7 17.1 9.9 15.7 43.3 69.0 22.8 39.2 29.7 32.9 70.9 17.6 27.7 0.0 36.6 30.8 0.6 0.8 43.3 4.0 3.5 14.0 45.0 85.2 37.6 23.4 34.0 87.7 15.7 28.9 36.3 10.3 68.3 43.0 34.6 9.8 13.7 9.7 36.6 31.3 22.0 5.9 25.2 27.7 24.9 8.6 27.0 50.3 41.0 42.4 11.7 49.0 74.3 17.2 39.6 21.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.9 0.3 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.4 1.7 0.0 0.0 0.0 1.8 1.7 0.4 0.8 0.0 0.0 0.8 0.5 2.4 0.0 0.8 0.0 0.0 11.8 0.8 2.4 0.0 0.4 1.0 0.3 1.2 1.4 0.0 23.5 0.4 0.2 20.9 1.8 1.1 1.0 0.0 7.2 0.0 0.2 5.3 0.0 0.4 1.2 2.0 0.6 0.4 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.4 15.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 6.4 15.8 12.9 3.6 0.4 3.4 1.2 0.8 3.1 0.4 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 102.3;lymphoid tissue: 200.0" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 49.0;Squamous epithelial cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 86.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 130.4;hTERT-HME1: 133.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Vesicles "Nucleoplasm, Mitochondria" "HPA041645: AB_2677595, HPA045462: AB_2679335" "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 11.8 12.9 8.6 50.4 10.6 32.2 11.1 7.7 9.3 19.0 8.0 25.8 51.6 13.2 10.0 102.3 11.5 15.9 6.8 7.9 7.5 6.9 3.8 18.7 96.3 6.2 6.1 8.4 11.0 14.7 12.1 7.0 15.0 6.8 25.0 27.2 2.9 35.8 9.7 2.3 85.4 65.4 14.3 5.9 54.3 12.5 12.4 6.0 200.0 10.6 4.2 102.7 28.6 39.4 7.7 22.2 13.2 9.3 12.4 22.4 29.0 2.8 47.2 47.8 18.2 13.5 6.9 35.2 13.5 11.1 31.5 6.2 38.7 10.3 130.4 21.4 14.4 2.5 21.1 26.8 3.6 19.1 6.7 20.9 25.1 68.4 25.2 133.9 60.6 37.9 78.8 2.4 18.7 49.4 2.3 54.3 8.6 2.0 18.1 15.5 23.8 2.9 2.0 43.7 60.9 1.6 5.6 15.5 0.9 1.7 23.8 9.3 6.4 34.0 12.0 8.4 2.8 1.7 2.9 1.2 32.4 13.8 17.5 3.4 17.0 7.4 15.3 18.5 5.2 35.5 20.4 70.6 33.0 10.5 16.2 86.9 51.5 13.3 14.1 3.5 10.5 86.7 36.2 8.6 10.6 7.7 9.3 7.9 7.5 6.2 6.1 8.4 6.8 5.9 6.0 7.7 4.5 3.2 6.5 1.6 25.7 15.0 9.7 21.1 26.7 1.2 4.0 4.6 2.9 4.3 19.1 5.5 0.0 16.3 12.2 35.4 0.0 5.1 9.4 1.9 6.5 5.3 2.4 11.2 11.2 9.4 4.3 8.2 15.3 3.0 7.0 2.4 4.2 0.2 4.2 0.0 5.2 7.7 2.0 6.9 21.6 7.0 3.7 14.0 0.0 5.6 15.7 2.6 10.3 9.0 0.8 25.3 14.4 3.0 14.8 8.2 49.0 0.3 5.2 0.5 6.6 1.5 4.2 6.6 4.2 40.4 13.9 26.4 37.4 1.6 9.7 20.1 ERBB3 "HER3, LCCS2" ENSG00000065361 "Erb-b2 receptor tyrosine kinase 3" P21860 12 56076799-56103505 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.4;neutrophil: 1.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enhanced" "Detected in many" "Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025331, HPA045396, HPA070524" Approved Supported "Plasma membrane,Actin filaments" "Secreted - unknown location" NA NA 450000 "Plasma membrane" "Actin filaments" "CAB025331: , HPA045396: AB_2679312, HPA070524: " "unprognostic (2.97e-1)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (8.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (9.89e-2)" "unprognostic (4.30e-2)" "unprognostic (4.76e-3)" "unprognostic (5.77e-2)" "unprognostic (1.06e-2)" "unprognostic (4.56e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-3)" "unprognostic (2.07e-2)" 2.2 2.7 38.7 8.1 70.9 0.9 57.1 50.2 61.6 16.2 18.5 63.5 89.3 5.6 12.4 82.6 12.2 30.9 6.1 43.2 51.6 36.5 99.4 29.6 0.6 75.4 61.9 33.8 1.6 57.4 24.0 2.4 13.1 76.8 38.1 64.7 1.3 83.8 18.4 2.4 75.7 83.2 3.8 45.3 0.6 75.4 2.3 58.8 1.0 9.4 1.7 12.6 22.0 44.6 113.0 39.8 2.1 3.2 1.4 0.2 0.1 63.2 3.9 7.2 4.5 4.1 20.4 70.4 0.2 0.8 1.0 0.6 32.2 5.0 7.7 2.3 0.7 3.0 0.1 1.1 116.4 0.1 0.1 0.5 1.3 9.3 0.7 0.3 0.7 0.1 0.8 2.6 1.0 0.4 71.6 0.4 1.3 10.4 119.1 1.9 0.4 7.4 2.1 7.9 89.7 3.3 1.3 2.6 106.5 149.5 9.1 122.2 0.7 0.3 0.5 4.0 1.9 0.5 0.9 0.6 0.6 0.4 0.3 153.4 2.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.4 1.0 0.4 0.2 0.2 0.3 0.1 38.7 70.9 50.2 61.6 43.2 51.6 75.4 61.9 33.8 76.8 45.3 58.8 113.0 0.8 118.6 81.0 1.0 1.5 18.2 15.3 21.6 19.4 1.5 106.4 47.8 1.9 171.6 74.6 35.0 2.1 52.6 2.0 254.3 1.9 60.1 1.3 36.1 10.9 2.7 93.1 2.7 0.7 88.1 84.6 4.5 96.4 95.9 1.3 0.7 5.0 112.0 6.1 0.0 2.0 145.2 40.7 1.9 3.7 0.5 1.5 1.5 55.2 1.0 1.7 7.7 0.0 49.8 187.0 94.8 184.6 0.0 0.3 103.3 240.2 30.0 54.8 1.1 6.6 4.5 3.4 9.5 13.4 87.7 36.9 100.6 2.5 0.1 136.9 135.4 ROPN1 "CT91, ODF6, ROPN1A, ropporin" ENSG00000065371 "Rhophilin associated tail protein 1" Q9HAT0 3 123968521-123992178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 160.1" "Group enriched" "Detected in some" 9 "Early spermatids: 1370.6;Late spermatids: 629.0;Spermatocytes: 355.0" "Cancer enriched" "Detected in some" 4 "melanoma: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-MEL-30: 28.7" "Low region specificity" "Detected in single" HPA052530 Supported NA NA "HPA052530: AB_2681861" "unprognostic (1.75e-5)" "unprognostic (2.24e-1)" "unprognostic (4.77e-2)" "unprognostic (7.66e-2)" "unprognostic (1.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.08e-2)" "unprognostic (8.35e-4)" 0.0 0.0 0.2 0.0 0.1 0.0 20.7 0.1 0.2 0.0 0.0 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.5 0.3 6.1 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 160.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 49.4 81.7 7.8 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1370.6 0.2 0.0 1.4 2.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 629.0 8.7 1.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 355.0 5.7 0.0 0.0 0.0 0.4 0.0 0.5 0.0 ANKRD44 PP6-ARS-B ENSG00000065413 "Ankyrin repeat domain 44" Q8N8A2 2 196967017-197311173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.8" "Cell type enhanced" "Detected in many" "B-cells: 153.3;Microglial cells: 390.7;NK-cells: 146.2;Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 199.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 46.4;HMC-1: 33.8;Karpas-707: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030122, HPA056549" Approved Approved "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA030122: AB_10600980, HPA056549: AB_2683170" "unprognostic (3.64e-1)" "unprognostic (1.70e-2)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-1)" "unprognostic (7.04e-5)" "unprognostic (1.97e-2)" "unprognostic (1.58e-3)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" "unprognostic (3.67e-2)" 5.9 6.5 7.0 24.8 9.8 17.5 4.1 8.7 7.7 7.3 7.2 5.1 3.9 4.9 2.9 3.2 3.9 8.5 3.7 6.5 11.1 3.3 4.9 11.7 36.8 12.3 9.4 4.3 3.3 3.7 4.2 3.9 7.6 12.9 4.4 5.5 3.3 4.0 5.0 2.2 3.6 11.6 6.2 11.3 23.2 6.9 5.7 11.4 28.5 3.3 2.2 33.5 6.9 6.3 14.3 1.9 1.1 2.8 2.9 6.2 2.5 0.6 4.1 1.8 2.1 1.9 0.7 1.0 15.4 1.9 3.5 3.9 0.2 1.0 0.8 1.7 46.4 3.7 0.5 5.6 0.3 0.4 11.4 33.8 1.3 0.5 2.1 0.1 3.1 2.9 3.8 2.6 25.1 3.2 2.6 5.4 9.7 0.4 0.6 2.8 9.7 3.1 20.3 5.4 1.4 2.8 12.2 1.4 1.0 12.0 2.1 1.5 11.0 15.0 7.1 4.2 2.2 3.0 6.2 8.0 19.6 5.0 14.0 4.5 55.0 19.6 45.3 24.5 19.5 23.3 23.5 18.2 21.3 19.2 28.6 20.9 25.2 68.7 25.0 25.2 12.6 19.0 15.1 7.0 9.8 8.7 7.7 6.5 11.1 12.3 9.4 4.3 12.9 11.3 11.4 14.3 8.4 16.0 23.9 79.7 153.3 3.4 4.5 0.4 2.2 9.9 4.4 3.9 9.3 20.0 8.0 11.0 4.2 5.9 90.6 0.6 1.9 4.0 14.0 10.7 6.7 10.2 2.4 12.8 32.6 4.6 0.8 9.7 8.2 15.5 53.8 4.8 49.2 8.9 18.5 3.3 126.4 1.9 0.0 64.2 34.9 17.5 15.5 72.5 37.4 390.7 84.1 8.0 146.2 174.9 199.5 5.0 2.6 17.7 70.4 3.9 2.9 1.5 10.6 10.4 19.7 15.5 16.4 2.9 3.4 5.2 3.7 1.4 123.0 4.3 1.8 4.9 KARS1 "DFNB89, KARS, KARS2" ENSG00000065427 "Lysyl-tRNA synthetase 1" Q15046 16 75627474-75648643 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041345, HPA041550" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 82000 Cytosol "Plasma membrane" "HPA041345: AB_10795589, HPA041550: AB_10794520" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-2)" "unprognostic (1.02e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (8.84e-6)" "unprognostic (6.24e-3)" "unprognostic (8.97e-3)" "unprognostic (1.18e-1)" "unprognostic (9.11e-3)" "unprognostic (8.71e-3)" "unprognostic (8.46e-2)" "unprognostic (7.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" 67.4 50.0 46.5 72.2 47.7 86.8 83.9 47.8 63.7 60.8 51.5 76.5 63.0 54.4 75.7 73.2 70.1 50.8 93.2 46.1 49.2 72.8 77.4 53.5 89.0 48.6 48.1 43.7 75.6 87.2 77.3 51.9 62.7 47.8 55.7 86.4 70.2 80.3 61.1 215.2 67.4 63.2 70.2 47.3 58.1 66.8 99.8 47.5 97.5 65.8 188.5 108.7 92.9 55.5 51.0 164.2 187.0 133.5 185.4 140.1 140.3 262.4 135.0 164.9 290.2 217.0 332.8 209.0 292.4 145.4 180.8 138.4 229.4 272.0 246.7 314.4 86.0 139.8 161.4 153.1 348.5 255.8 245.5 174.1 166.4 173.8 257.4 414.6 147.7 240.0 253.5 273.4 68.5 222.5 378.0 254.1 262.2 284.3 238.4 135.9 329.2 120.0 358.4 235.4 136.3 200.2 162.9 339.5 122.8 152.2 144.8 166.1 229.2 133.8 159.8 164.9 123.6 196.7 145.1 178.6 696.6 139.5 206.5 199.7 88.6 112.7 130.0 110.7 155.7 202.6 109.5 137.1 132.0 135.7 91.6 126.6 117.1 24.9 127.6 163.1 85.7 155.5 160.5 46.5 47.7 47.8 63.7 46.1 49.2 48.6 48.1 43.7 47.8 47.3 47.5 51.0 14.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.7 0.0 0.0 0.0 0.0 122.7 10.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 143.3 14.4 0.0 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 110.0 2.1 0.0 0.0 0.0 ADAT1 ENSG00000065457 "Adenosine deaminase tRNA specific 1" Q9BUB4 16 75596868-75623300 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 101.9;Late spermatids: 213.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040713, HPA040903" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA040713: AB_10795371, HPA040903: AB_10794071" "unprognostic (7.71e-3)" "unprognostic (5.35e-2)" "unprognostic (7.62e-2)" "unprognostic (9.00e-2)" "unprognostic (9.99e-2)" "unprognostic (4.69e-2)" "unprognostic (4.54e-2)" "unprognostic (6.65e-3)" "unprognostic (3.38e-1)" "unprognostic (1.14e-2)" "unprognostic (9.75e-2)" "unprognostic (2.97e-1)" "unprognostic (4.60e-3)" "unprognostic (7.21e-2)" "unprognostic (4.92e-1)" "unprognostic (5.58e-3)" "unprognostic (8.27e-2)" 13.5 16.5 12.3 9.6 12.7 7.8 14.2 12.7 15.2 11.9 11.7 11.4 5.2 14.1 12.8 11.8 11.9 6.7 10.9 12.1 11.8 16.0 18.7 12.9 10.9 13.0 12.6 12.6 10.4 12.7 14.7 14.3 7.4 13.5 15.4 9.2 9.7 12.2 8.7 9.5 14.1 14.1 6.0 11.8 20.5 12.1 27.1 12.3 11.9 14.9 5.3 8.8 13.2 11.7 14.4 14.7 23.1 15.0 15.5 26.4 20.3 11.5 20.2 21.0 26.1 17.7 15.4 22.4 15.7 19.8 20.6 14.0 17.6 16.4 25.0 24.6 11.7 8.6 8.8 16.0 13.3 21.2 19.6 19.6 21.7 23.8 42.7 32.1 7.5 23.1 24.7 13.7 7.6 21.2 35.9 18.8 14.3 12.2 19.8 10.7 23.6 12.1 21.5 24.6 22.0 18.1 18.6 47.8 12.2 11.2 15.0 24.6 9.3 16.3 32.4 14.6 17.1 16.9 15.1 24.3 58.9 16.3 15.6 28.5 8.5 4.3 11.5 8.5 6.4 11.3 7.9 7.3 11.3 5.8 7.3 4.5 6.3 4.9 10.8 9.9 4.6 9.0 6.2 12.3 12.7 12.7 15.2 12.1 11.8 13.0 12.6 12.6 13.5 11.8 12.3 14.4 9.9 9.6 5.8 2.3 11.6 4.6 5.9 5.7 6.8 13.5 10.7 6.6 5.6 11.5 6.6 7.3 27.1 11.8 9.8 6.8 17.6 8.6 101.9 11.8 8.2 11.9 14.4 16.0 6.0 7.6 8.9 6.4 8.6 10.5 8.2 12.6 6.1 10.5 10.3 13.5 6.4 4.7 10.2 14.4 10.6 213.0 9.9 10.2 3.6 2.8 12.8 7.8 15.5 3.0 8.0 9.8 3.3 7.9 8.1 8.3 6.9 11.3 9.9 21.6 6.6 6.8 7.0 17.5 13.4 8.4 5.4 9.7 14.8 12.9 9.1 7.6 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067025-123225227 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 133.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "hypothalamus: 3.7" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA 4700000 "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favorable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 15.5 23.8 0.2 15.4 0.3 18.1 14.0 0.2 1.0 14.6 2.2 20.3 14.0 12.5 30.5 6.1 14.1 19.8 8.4 0.4 3.7 14.6 80.8 17.9 11.2 0.3 0.4 0.2 11.6 26.8 10.8 12.8 47.7 0.3 32.6 25.3 4.2 13.9 8.0 4.2 8.3 12.9 17.1 0.2 10.2 33.7 15.4 0.6 4.6 31.0 4.3 12.1 18.0 9.6 0.6 24.0 14.6 17.7 21.5 80.3 71.9 95.0 44.9 74.5 24.5 66.9 47.8 21.6 0.0 57.6 69.9 15.7 12.5 7.8 27.4 25.7 1.1 8.8 10.4 3.9 56.7 33.2 26.5 1.4 62.3 40.2 16.6 34.5 26.1 84.0 10.1 13.6 60.4 16.9 29.6 7.2 31.3 13.1 54.5 15.6 6.7 13.0 67.5 20.7 13.9 19.3 11.4 22.0 24.0 40.4 28.7 21.4 32.3 47.2 6.2 19.5 29.4 12.3 18.1 5.0 10.8 20.2 21.0 21.5 0.0 9.3 0.3 1.4 2.4 2.3 3.5 1.0 0.8 5.5 1.1 0.6 0.6 0.2 0.5 0.5 12.8 0.0 2.3 0.2 0.3 0.2 1.0 0.4 3.7 0.3 0.4 0.2 0.3 0.2 0.6 0.6 17.2 19.2 30.7 2.6 5.6 5.0 6.0 6.4 3.4 13.1 6.9 4.7 2.7 35.8 11.3 5.5 39.6 41.8 3.1 5.4 0.0 32.2 1.6 5.4 13.1 24.3 8.4 5.5 9.6 28.6 133.6 20.7 30.5 21.1 3.8 7.3 37.5 50.1 12.1 0.0 7.1 36.9 0.0 7.8 5.5 2.0 24.2 4.4 8.8 5.6 5.0 2.3 0.0 1.0 2.5 11.9 7.6 22.2 40.1 18.1 3.5 5.3 6.4 28.4 13.1 3.6 17.6 1.3 1.5 3.4 4.1 50.2 3.1 23.3 15.1 4.5 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 5.5 12.2 8.2 5.2 8.3 18.5 5.8 8.2 8.2 7.2 8.3 6.5 8.0 6.4 7.4 14.2 8.3 6.0 7.4 8.0 8.1 8.6 6.1 8.1 5.9 7.7 7.9 7.9 9.5 12.9 10.8 6.7 6.1 7.8 8.3 7.8 7.8 11.9 5.6 15.2 15.1 8.6 6.8 7.0 7.2 7.6 10.1 8.2 13.6 7.7 7.9 7.2 7.5 9.4 7.9 13.2 5.5 9.9 10.9 9.1 9.1 14.2 7.2 15.0 13.2 16.2 12.6 8.5 12.3 7.4 9.2 17.9 8.9 12.7 11.6 14.8 19.9 10.4 19.5 9.0 17.2 13.0 11.1 15.9 7.8 16.6 13.0 15.4 12.6 18.9 20.4 22.5 3.1 9.6 11.9 16.6 8.4 13.0 15.0 5.1 10.7 9.1 9.6 13.6 9.5 13.0 8.4 7.9 11.2 14.3 13.3 8.2 19.7 18.4 8.0 12.2 5.5 9.6 11.1 12.4 80.8 5.5 16.5 12.6 1.4 2.6 4.4 2.3 3.5 2.7 1.7 2.6 2.3 4.0 2.0 2.8 2.4 1.1 3.0 1.5 1.1 1.9 2.6 8.2 8.3 8.2 8.2 8.0 8.1 7.7 7.9 7.9 7.8 7.0 8.2 7.9 4.1 3.2 5.6 17.9 6.3 8.2 8.5 7.5 8.0 5.0 6.0 3.7 5.8 7.2 10.1 1.8 4.2 6.3 4.6 15.1 3.9 12.3 5.6 10.6 3.6 4.9 1.8 10.5 20.3 15.4 9.2 4.2 3.1 8.1 5.7 5.0 3.6 3.9 5.8 0.0 22.0 4.9 10.2 4.4 7.8 5.0 3.1 4.1 1.8 6.5 6.0 3.6 6.2 14.1 24.1 15.0 6.8 1.2 5.6 10.0 11.2 9.0 15.8 4.5 0.0 4.2 3.6 6.5 6.4 10.8 15.9 6.7 6.6 3.2 6.3 11.2 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596328-120602507 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 954.3" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1493.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 146.3 341.2 162.6 91.1 171.5 113.4 146.3 176.7 204.8 119.6 172.0 168.0 149.2 118.9 135.0 160.8 114.0 86.5 506.9 164.0 181.5 234.0 188.9 103.8 94.6 171.2 168.6 159.7 120.8 138.6 262.5 171.6 77.4 170.9 119.1 150.2 101.0 149.7 118.5 954.3 140.9 136.7 104.3 172.9 113.0 163.6 107.4 169.4 126.7 114.1 567.2 115.1 134.6 143.3 175.3 294.8 204.3 246.7 248.5 151.0 181.4 199.2 157.0 212.1 205.4 224.5 200.9 219.8 147.8 311.6 177.8 255.6 272.5 191.3 202.7 155.7 227.5 212.6 226.1 205.7 208.1 90.4 202.7 256.8 161.3 268.5 98.9 125.8 246.0 258.5 271.7 138.5 219.2 220.9 224.1 398.6 294.8 193.9 478.9 554.7 228.8 141.0 325.8 337.3 177.9 273.8 283.4 186.5 205.7 360.0 162.0 348.0 319.9 199.8 179.0 233.2 76.9 226.5 263.2 260.1 454.3 283.6 279.8 250.8 205.0 164.8 197.2 156.0 229.5 162.2 231.6 215.2 176.8 213.9 176.3 182.2 181.8 101.6 152.7 238.2 267.9 300.6 205.7 162.6 171.5 176.7 204.8 164.0 181.5 171.2 168.6 159.7 170.9 172.9 169.4 175.3 274.1 163.5 162.6 36.9 167.0 222.3 289.0 612.6 190.6 137.8 290.1 351.3 1493.1 311.7 348.3 320.0 58.4 366.0 158.1 472.4 1226.7 556.7 999.2 259.9 188.9 235.7 298.7 196.9 22.6 620.9 421.0 213.7 175.3 293.5 174.8 139.4 183.5 513.9 330.3 84.1 22.0 526.3 451.6 240.2 247.9 164.6 275.2 196.2 434.0 15.9 339.2 340.7 186.4 13.0 31.2 567.9 581.8 277.2 283.2 243.2 613.4 1225.1 266.2 168.4 256.4 208.1 259.0 418.9 87.5 288.4 251.5 352.4 168.1 271.3 462.8 344.0 SPEN "KIAA0929, MINT, RBM15C, SHARP" ENSG00000065526 "Spen family transcriptional repressor" Q96T58 1 15836095-15940456 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015825, HPA050257" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015825: AB_1856823, HPA050257: AB_2681065" "unprognostic (3.91e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (3.06e-2)" "unprognostic (6.93e-3)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (4.88e-3)" "unprognostic (1.71e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (1.83e-1)" 14.2 8.6 12.2 11.6 14.4 23.4 14.1 21.1 13.0 13.3 6.4 11.6 8.9 14.6 8.6 13.4 15.6 8.1 10.6 10.4 10.4 9.6 11.1 15.0 13.0 15.2 12.6 7.4 21.5 17.6 16.5 10.8 11.9 12.2 11.2 9.1 15.2 12.9 10.0 20.7 17.1 13.5 9.9 9.1 12.8 11.1 10.4 12.4 16.8 15.7 20.0 13.4 13.1 13.7 21.3 25.4 20.9 26.1 19.6 25.0 15.2 13.8 12.9 16.6 13.5 11.4 19.3 19.5 35.6 15.0 25.1 15.9 36.0 24.0 22.6 21.4 32.1 68.5 44.6 20.5 12.4 11.3 37.1 20.8 11.2 15.9 20.2 28.9 12.9 15.5 26.5 47.1 35.9 11.1 14.0 30.7 14.7 11.6 14.4 15.9 29.5 25.1 21.9 7.5 22.4 20.5 19.9 36.2 17.4 14.8 11.6 6.5 18.4 28.9 12.8 15.5 24.4 18.5 21.5 15.0 39.6 12.2 29.2 17.9 7.4 1.9 1.6 1.4 1.7 0.9 1.3 1.1 1.0 0.5 3.0 0.9 1.0 8.5 1.1 1.3 2.8 0.9 0.5 12.2 14.4 21.1 13.0 10.4 10.4 15.2 12.6 7.4 12.2 9.1 12.4 21.3 55.7 80.1 85.3 68.9 69.4 104.6 44.9 18.3 90.5 67.1 35.0 27.9 52.6 30.0 43.2 5.5 52.1 12.2 52.8 44.4 3.9 18.5 7.0 90.4 67.4 51.6 31.7 47.1 57.2 17.6 15.0 45.9 41.8 146.5 62.6 34.3 20.0 32.6 15.2 95.9 66.0 27.4 8.2 34.6 69.6 4.9 27.4 53.2 21.4 64.6 56.3 28.3 68.0 51.8 88.7 23.6 34.6 35.7 74.5 46.7 16.8 7.5 29.4 53.2 19.7 85.7 56.6 59.5 45.9 89.8 101.6 15.7 52.3 33.1 32.8 56.3 MYLK "MLCK, MLCK1, MYLK1, smMLCK" ENSG00000065534 "Myosin light chain kinase" Q15746 3 123610049-123884332 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 1716.4;smooth muscle: 2156.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020789, HPA031677, HPA048055" Enhanced Enhanced "Plasma membrane,Actin filaments" NA NA 1500000 "Actin filaments" "Plasma membrane" "CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543" "unprognostic (2.80e-2)" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (2.85e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.40e-1)" "unprognostic (8.21e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.26e-3)" "unprognostic (9.60e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.46e-4)" 145.0 57.9 39.3 190.4 63.0 3.3 165.0 72.7 44.1 283.7 24.3 401.8 111.9 675.4 234.9 424.5 292.4 252.6 32.0 33.6 70.4 65.0 67.8 86.0 33.9 103.9 65.5 26.7 96.8 15.4 11.7 2.7 70.8 91.5 915.7 301.8 13.7 141.4 1716.4 10.1 17.6 126.2 2156.6 68.6 90.2 123.8 51.0 53.6 8.1 22.3 15.0 19.2 510.8 85.5 112.4 14.4 38.4 10.8 7.8 10.8 1.9 4.7 200.0 298.2 137.3 92.1 8.1 7.4 0.6 42.5 260.2 67.0 4.8 5.2 1.8 149.0 0.2 0.7 102.4 0.9 28.9 56.1 0.6 9.8 36.9 3.5 24.4 34.4 202.7 8.9 1.3 1.2 0.5 90.9 1.7 0.2 2.5 12.0 0.5 5.1 13.5 6.8 36.7 291.9 8.5 1.4 6.4 21.8 1.9 3.1 25.0 1.0 0.3 33.4 39.5 13.9 10.3 30.7 3.4 4.2 0.3 104.0 1.0 9.6 7.4 1.6 0.4 0.1 0.2 0.0 0.2 0.0 0.0 3.5 0.1 0.2 0.1 5.0 0.0 0.0 3.3 0.2 20.9 39.3 63.0 72.7 44.1 33.6 70.4 103.9 65.5 26.7 91.5 68.6 53.6 112.4 45.9 16.0 38.3 43.4 2.5 20.5 27.2 24.8 1.2 2.9 19.9 728.5 25.2 37.1 5.7 27.6 125.1 0.8 3.5 88.1 3.9 6.0 40.7 45.9 46.6 56.9 11.4 3.2 25.2 3.9 0.8 40.1 3.1 54.4 2.5 3.2 45.3 208.7 4.9 3.3 3.4 3.9 8.2 7.9 37.0 33.8 104.7 20.8 19.6 8.4 1.2 4.7 0.0 5.5 37.0 4.0 18.7 690.5 3.3 8.6 14.2 17.2 17.6 19.9 276.1 5.6 448.7 4.7 4.6 1.3 20.2 2.5 3.2 4.5 4.2 3.7 ZC3H15 LEREPO4 ENSG00000065548 "Zinc finger CCCH-type containing 15" Q8WU90 2 186486253-186509361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031099, HPA031100, HPA031101" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669" "unprognostic (1.51e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.24e-1)" "unprognostic (3.11e-3)" "unprognostic (5.92e-2)" "unprognostic (8.15e-2)" "prognostic unfavorable (1.48e-7)" "unprognostic (9.08e-3)" "unprognostic (4.95e-2)" "prognostic favorable (3.98e-4)" "prognostic unfavorable (9.75e-4)" "unprognostic (5.72e-3)" "unprognostic (5.69e-2)" "unprognostic (1.87e-1)" "unprognostic (1.82e-1)" "unprognostic (8.89e-2)" "unprognostic (3.45e-2)" 43.0 48.0 42.4 44.7 46.2 130.0 46.4 47.4 49.9 35.4 43.1 41.2 48.7 40.2 47.4 40.6 26.5 36.8 37.4 46.3 46.4 54.3 67.9 28.7 54.3 46.0 44.3 42.3 32.9 48.3 41.5 27.4 49.2 46.0 37.4 46.4 53.4 45.7 32.7 50.7 44.6 46.5 37.2 43.9 38.9 37.2 41.0 45.0 50.7 49.8 45.3 51.8 54.5 29.4 49.3 103.5 68.9 83.3 107.8 93.0 93.4 124.9 112.7 76.7 102.3 91.5 202.9 81.8 140.3 100.2 80.9 130.9 73.6 155.8 137.5 144.0 128.7 118.1 201.9 101.1 221.9 124.9 208.7 118.6 77.2 149.6 111.4 157.2 89.9 111.9 86.0 197.0 106.8 108.4 93.5 133.7 146.5 157.6 135.7 171.8 105.2 113.0 131.6 127.6 124.0 100.3 73.6 71.5 96.4 167.3 124.3 68.1 149.7 95.7 114.7 99.1 70.9 136.4 92.0 167.0 199.8 101.7 145.7 102.3 59.9 47.9 49.1 44.7 61.6 55.8 55.0 54.8 57.4 54.7 42.2 50.5 53.9 28.8 60.4 75.1 48.0 66.6 41.5 42.4 46.2 47.4 49.9 46.3 46.4 46.0 44.3 42.3 46.0 43.9 45.0 49.3 107.1 73.7 83.6 26.4 137.0 212.2 169.1 116.6 99.6 75.0 101.9 118.9 95.8 57.2 104.8 115.8 60.5 131.3 116.1 131.4 256.3 112.0 153.1 110.1 125.5 106.4 101.7 98.7 38.0 104.3 167.0 107.4 67.8 127.1 112.2 220.1 62.4 137.0 124.3 57.2 39.8 136.1 87.5 107.4 104.8 307.1 78.6 113.2 64.0 33.7 142.5 82.6 126.7 19.6 32.8 111.6 106.2 87.3 128.0 179.5 164.1 330.2 68.3 130.2 32.9 156.2 127.6 215.6 174.4 116.1 209.1 177.6 117.3 319.6 151.2 163.5 MAP2K4 "JNKK1, MEK4, MKK4, PRKMK4, SERK1" ENSG00000065559 "Mitogen-activated protein kinase kinase 4" P45985 17 12020829-12143830 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 226.9;Inhibitory neurons: 189.3;Oligodendrocyte precursor cells: 148.3;Oligodendrocytes: 203.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 10.4" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SuSa: 177.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007751, HPA060074" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "CAB007751: , HPA060074: AB_2684197" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (4.47e-2)" "unprognostic (1.02e-2)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (2.89e-1)" "unprognostic (2.16e-1)" "unprognostic (1.93e-3)" "unprognostic (2.53e-1)" "unprognostic (2.76e-3)" "unprognostic (4.82e-2)" "unprognostic (5.32e-3)" "unprognostic (3.13e-1)" "unprognostic (2.30e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" 11.5 13.2 27.3 10.2 35.8 3.6 14.6 24.3 42.8 11.9 13.9 12.2 10.2 12.2 17.6 19.0 11.5 11.0 16.0 37.8 34.0 16.4 22.0 11.8 11.8 33.8 28.3 32.8 12.7 11.6 19.6 13.9 15.9 36.9 14.4 13.2 15.5 10.6 12.8 24.4 15.2 10.5 13.9 24.7 11.8 11.3 11.1 33.3 15.3 16.9 28.4 14.5 14.9 13.1 46.5 31.1 26.2 33.8 17.5 18.3 23.5 21.3 20.6 27.1 23.1 21.9 15.6 10.4 12.8 16.4 32.4 15.2 20.2 29.7 28.8 34.3 22.7 33.7 14.2 14.1 29.8 21.4 13.7 20.5 19.6 27.9 27.0 28.0 23.9 21.3 17.8 15.4 7.3 29.4 11.5 16.8 12.9 19.6 33.2 12.4 20.3 37.8 8.9 31.6 19.7 6.8 19.9 23.8 12.7 20.3 177.7 16.1 10.0 19.6 11.3 17.4 15.8 24.9 14.2 16.9 9.9 21.3 10.7 16.8 0.4 2.1 1.7 2.2 1.2 1.9 2.1 1.8 1.8 1.5 2.7 1.5 2.4 10.4 2.7 3.9 1.5 2.2 1.8 27.3 35.8 24.3 42.8 37.8 34.0 33.8 28.3 32.8 36.9 24.7 33.3 46.5 13.9 9.6 19.4 71.8 27.1 41.4 36.1 12.7 66.0 15.3 20.4 16.3 22.6 7.2 18.3 14.7 8.4 12.6 17.7 19.1 25.4 12.3 7.2 16.9 16.4 12.0 12.0 14.5 226.9 14.3 10.3 19.4 42.3 27.3 1.3 20.1 11.0 20.8 11.7 18.5 189.3 13.1 20.3 19.9 14.7 8.9 11.8 15.4 12.4 68.4 24.1 11.3 14.4 148.3 203.0 16.9 9.3 12.8 26.9 37.7 11.0 25.2 8.6 10.0 13.1 19.2 20.2 7.3 9.3 56.7 39.2 25.3 20.7 15.0 13.3 41.5 PACC1 "C1orf75, FLJ10874, PAC, TMEM206" ENSG00000065600 "Proton activated chloride channel 1" Q9H813 1 212363928-212414901 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 13.1;Extravillous trophoblasts: 7.0;Hofbauer cells: 28.2;Syncytiotrophoblasts: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008540 Uncertain NA NA "HPA008540: AB_10794083" "unprognostic (2.18e-1)" "unprognostic (2.22e-1)" "unprognostic (9.23e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-2)" "unprognostic (3.09e-2)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.06e-3)" "unprognostic (6.33e-2)" "unprognostic (1.02e-1)" "unprognostic (9.10e-2)" "unprognostic (6.98e-2)" 2.9 2.6 15.7 4.1 24.0 5.8 2.6 24.5 23.1 2.7 11.6 2.0 2.0 2.8 1.9 3.9 1.7 2.9 2.4 16.2 20.9 10.3 1.5 3.8 8.0 25.7 23.7 14.3 1.7 3.3 3.7 3.4 4.2 24.9 2.9 2.2 6.0 2.8 1.5 2.1 2.2 3.1 2.9 25.2 5.5 1.8 5.6 22.0 8.7 2.0 1.5 5.3 4.5 3.0 36.4 11.6 8.8 13.0 21.6 7.5 4.0 12.9 6.6 5.2 10.8 9.5 7.4 8.4 13.6 5.3 3.3 10.5 10.1 12.5 6.0 10.7 10.3 13.5 12.8 5.8 9.2 10.7 20.8 19.5 3.6 6.2 9.9 7.2 10.8 12.3 19.7 11.8 7.8 7.5 4.6 23.2 21.4 17.3 5.4 11.5 18.9 14.5 13.1 5.5 5.7 20.1 31.2 7.7 11.3 30.2 12.8 16.8 25.2 10.9 7.0 8.0 16.8 17.3 10.2 17.3 19.1 9.4 18.9 19.9 21.3 8.7 5.3 5.3 11.8 7.0 8.5 4.1 6.2 14.4 8.2 5.8 6.4 0.7 7.0 11.0 20.4 6.4 6.2 15.7 24.0 24.5 23.1 16.2 20.9 25.7 23.7 14.3 24.9 25.2 22.0 36.4 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 13.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.2 0.5 0.0 0.0 0.0 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 84.5;pituitary gland: 26.0;retina: 92.6" "Cell type enhanced" "Detected in some" "Astrocytes: 91.1;Excitatory neurons: 336.6;Inhibitory neurons: 296.9;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 89.0" "Cancer enhanced" "Detected in some" "glioma: 2.5;prostate cancer: 2.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 25 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.8" "Group enriched" "Detected in some" 10 "GAMG: 7.4;SCLC-21H: 23.7;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA 28000 "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 0.1 7.9 30.0 1.0 56.8 0.0 0.6 66.2 84.5 1.0 0.0 1.0 0.3 0.8 0.1 0.1 0.7 1.0 0.5 47.7 45.3 0.1 0.0 0.3 3.0 41.6 20.7 47.5 2.1 1.5 1.1 26.0 0.5 48.0 3.1 0.6 92.6 0.5 0.6 0.2 0.1 0.8 0.7 5.8 1.4 0.9 12.3 36.1 0.4 0.9 1.5 1.9 0.4 0.4 80.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 7.4 0.3 1.0 0.0 0.0 0.4 1.4 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.2 0.3 23.7 14.7 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 30.0 56.8 66.2 84.5 47.7 45.3 41.6 20.7 47.5 48.0 5.8 36.1 80.8 0.0 0.0 0.0 91.1 0.0 0.0 0.0 0.0 0.0 49.8 0.1 0.0 1.3 0.0 0.0 0.0 62.6 1.5 0.1 0.1 0.0 0.0 23.9 0.2 1.4 0.3 0.0 0.0 336.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.0 296.9 0.0 0.0 0.0 0.0 12.8 0.9 0.0 0.0 31.9 0.0 10.9 0.0 209.1 89.0 0.4 0.0 1.2 0.0 0.5 0.0 0.0 0.0 59.8 0.0 0.0 0.1 29.6 4.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 SLK "KIAA0204, se20-9, STK2" ENSG00000065613 "STE20 like kinase" Q9H2G2 10 103967140-104029233 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015757 Approved Approved "Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" "HPA015757: AB_1857236" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (8.67e-2)" "unprognostic (6.85e-2)" "unprognostic (1.01e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.95e-1)" "prognostic favorable (3.95e-5)" "unprognostic (8.48e-2)" "unprognostic (3.95e-1)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" 20.7 15.3 12.3 15.3 21.0 29.2 21.9 21.6 15.4 16.5 15.3 19.2 13.4 21.5 16.4 57.0 14.2 21.4 22.6 12.4 15.7 20.8 18.0 24.2 11.9 12.6 12.3 10.3 24.2 16.9 26.5 9.6 26.0 12.8 17.8 21.0 15.2 22.0 17.9 23.3 26.5 14.8 20.8 11.4 15.0 24.3 15.4 12.4 15.3 22.6 25.4 17.7 30.8 28.8 19.6 50.5 28.9 33.7 24.3 36.6 50.1 14.2 30.6 40.7 22.5 20.9 18.4 53.7 26.6 18.6 31.8 19.1 53.7 18.0 39.5 33.5 21.3 24.7 27.0 23.5 15.6 26.6 32.7 22.4 25.5 49.5 30.9 87.6 31.7 40.9 16.9 34.6 17.9 29.8 18.6 23.0 18.0 8.4 32.4 18.2 22.2 41.4 13.8 29.0 60.3 8.0 13.8 26.6 25.7 25.8 17.2 13.8 23.4 63.4 16.6 16.9 30.6 36.3 21.6 28.0 16.7 24.2 43.1 10.7 0.6 0.5 1.7 1.4 0.5 1.5 0.4 0.8 1.0 0.5 0.6 0.6 1.0 2.7 0.5 0.4 0.9 0.8 0.3 12.3 21.0 21.6 15.4 12.4 15.7 12.6 12.3 10.3 12.8 11.4 12.4 19.6 73.5 179.5 129.5 38.5 19.9 57.0 87.1 30.9 26.7 32.2 32.0 35.1 110.4 30.0 100.9 44.1 25.0 37.4 40.1 70.0 3.9 34.0 8.4 43.3 77.1 80.2 18.5 25.5 35.3 54.0 13.6 52.6 44.9 90.3 35.3 54.6 50.7 25.3 19.9 25.2 39.3 37.2 18.3 24.5 36.9 16.6 46.6 37.5 8.8 34.7 43.9 25.7 27.8 34.2 63.9 85.5 81.6 63.2 22.3 67.8 21.9 11.5 57.9 25.4 6.6 68.1 49.3 46.3 35.3 61.4 68.5 52.4 44.2 71.7 37.4 201.0 CYB5R4 "b5+b5R, dJ676J13.1, NCB5OR" ENSG00000065615 "Cytochrome b5 reductase 4" Q7L1T6 6 83859656-83967423 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 179.2;Late spermatids: 364.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 199.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 75.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018992 Approved NA NA "HPA018992: AB_1847371" "unprognostic (4.86e-3)" "unprognostic (1.16e-1)" "unprognostic (1.80e-3)" "unprognostic (1.21e-2)" "unprognostic (1.72e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-2)" "unprognostic (7.94e-2)" "unprognostic (4.77e-1)" "unprognostic (6.77e-2)" "unprognostic (1.39e-2)" "unprognostic (5.44e-1)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.15e-1)" "unprognostic (8.15e-2)" 5.2 3.1 4.1 12.1 5.2 17.1 3.7 10.3 6.1 2.4 1.6 7.2 6.5 3.0 3.2 4.5 2.3 3.2 4.3 4.2 3.5 4.0 4.0 5.1 9.9 4.5 3.9 4.1 2.6 5.6 2.6 1.9 3.4 5.5 3.0 5.0 5.4 3.6 2.5 6.4 3.2 7.4 3.5 2.5 8.9 7.1 12.2 4.1 6.7 2.3 4.4 7.2 5.3 3.2 8.7 10.6 9.2 6.5 8.1 3.4 4.6 12.0 7.0 10.9 10.4 14.8 12.7 6.8 19.9 10.8 4.7 27.7 8.8 6.1 10.1 7.5 75.1 14.2 47.0 5.2 7.0 6.4 28.5 40.0 6.1 2.8 7.3 7.1 4.2 5.8 17.2 17.1 14.1 7.7 4.5 7.4 9.6 3.6 8.5 8.9 12.3 23.3 6.9 5.6 10.9 17.4 9.6 8.7 8.2 9.5 3.9 5.0 16.3 7.2 10.2 8.5 21.2 22.4 16.4 27.0 10.7 11.8 19.2 11.7 104.0 59.0 177.3 16.6 50.4 13.6 27.4 14.6 15.0 46.6 26.9 9.4 14.7 199.1 14.2 58.1 19.7 23.9 29.3 4.1 5.2 10.3 6.1 4.2 3.5 4.5 3.9 4.1 5.5 2.5 4.1 8.7 9.9 6.4 13.9 31.3 46.5 11.1 14.4 17.5 8.0 15.5 8.5 5.8 15.4 11.5 18.3 7.3 16.7 5.9 31.3 22.0 11.7 25.7 179.2 8.4 9.2 9.7 16.2 10.1 46.6 25.1 20.5 9.2 21.9 13.5 25.3 6.0 4.2 11.3 45.1 13.5 51.0 14.8 28.5 56.6 49.7 364.5 8.4 59.4 16.0 37.5 74.4 5.8 47.4 48.7 85.8 28.4 17.3 7.5 27.1 13.6 15.7 21.6 14.8 18.7 6.6 16.9 13.1 25.7 27.3 12.5 14.8 11.5 28.2 8.3 13.3 23.6 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104085880 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 584.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 227.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in many" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA 32000 "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 1.1 0.4 0.9 6.7 1.2 12.4 37.7 1.1 1.4 25.5 0.8 37.3 10.8 0.6 6.7 117.5 1.1 0.3 0.5 0.6 0.7 0.3 0.3 0.9 0.1 0.7 0.9 0.6 0.2 0.4 0.0 1.2 35.7 0.8 18.0 27.5 0.0 82.9 9.7 0.5 584.9 37.5 1.0 0.7 2.3 20.0 25.6 0.9 43.1 5.2 0.0 20.0 10.0 102.8 0.9 26.3 0.4 1.5 0.2 0.1 0.0 80.6 0.5 0.3 0.1 0.2 0.3 204.3 0.0 5.1 0.3 3.9 463.8 0.7 745.8 0.7 0.0 0.7 0.0 0.3 0.2 0.1 0.0 0.4 0.7 914.1 0.5 783.7 0.2 3.5 0.1 0.1 0.9 0.0 0.0 0.0 0.3 1.7 5.1 2.6 0.0 0.0 0.3 35.9 26.4 0.2 0.3 0.0 0.2 0.9 4.0 0.2 0.0 1.5 0.5 5.0 0.3 5.5 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 1.2 1.1 1.4 0.6 0.7 0.7 0.9 0.6 0.8 0.7 0.9 0.9 1.0 0.0 1.1 0.7 0.3 585.7 17.7 136.0 299.9 0.6 1.7 85.5 1.1 0.0 16.5 0.0 0.0 10.2 0.3 211.5 0.0 0.8 14.2 23.7 2.3 3.7 2.4 0.0 0.1 0.9 18.9 2.4 23.0 8.1 0.0 0.1 0.0 0.0 1.3 0.0 0.2 5.7 6.1 0.0 28.9 3.6 0.3 0.7 33.8 0.0 0.0 0.4 0.0 0.0 0.4 78.8 35.7 0.7 1.4 16.6 108.5 0.1 5.9 0.4 0.0 0.4 3.0 22.7 1.5 31.9 139.4 5.6 1.3 0.1 21.6 10.7 GSTO2 ENSG00000065621 "Glutathione S-transferase omega 2" Q9H4Y5 10 104268873-104304950 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 133.1;Early spermatids: 314.6;Late spermatids: 442.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 16.9;CAPAN-2: 17.1;hTCEpi: 16.2;hTERT-HME1: 18.3;OE19: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA048141 Approved NA NA "HPA048141: AB_2680281" "unprognostic (5.77e-2)" "unprognostic (6.69e-2)" "unprognostic (7.15e-2)" "unprognostic (1.80e-1)" "unprognostic (2.48e-1)" "unprognostic (3.11e-2)" "unprognostic (3.12e-1)" "unprognostic (2.15e-1)" "unprognostic (7.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.10e-7)" "unprognostic (4.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.75e-2)" "unprognostic (3.47e-1)" 0.5 3.5 3.9 0.3 5.2 2.0 5.3 3.3 5.1 3.5 0.2 2.9 2.9 2.2 5.0 11.9 4.4 1.2 0.6 3.9 2.8 10.4 2.8 2.5 0.3 2.5 2.5 4.6 5.4 16.8 5.0 14.7 1.0 2.9 8.4 3.2 6.1 7.6 3.3 1.4 13.8 3.5 1.2 1.0 0.5 11.0 36.2 3.1 2.2 7.1 1.3 0.7 3.8 7.6 5.2 10.2 1.4 0.5 0.6 0.6 1.3 1.4 9.6 16.9 4.7 4.9 0.6 17.1 1.6 4.0 0.8 0.5 10.7 0.5 5.3 1.2 1.1 3.2 0.5 3.1 2.4 2.1 0.7 0.7 1.7 16.2 0.3 18.3 1.3 0.8 1.7 1.5 2.9 1.3 12.3 0.1 0.5 1.7 22.1 1.1 0.5 0.7 0.3 4.6 6.5 0.6 1.1 3.3 2.4 2.9 0.8 12.6 0.3 2.4 1.5 5.1 0.6 0.5 2.8 6.4 0.4 1.5 0.8 0.5 0.2 0.1 0.7 0.5 0.2 0.3 0.3 0.5 0.3 0.0 0.5 0.7 0.4 1.7 1.0 0.1 0.3 1.2 0.2 3.9 5.2 3.3 5.1 3.9 2.8 2.5 2.5 4.6 2.9 1.0 3.1 5.2 3.6 3.2 21.0 13.1 1.3 34.2 62.1 94.5 50.1 19.0 61.7 78.2 3.0 21.5 46.4 40.5 16.7 14.4 3.8 12.8 133.1 30.6 314.6 26.9 7.6 5.4 54.2 3.6 33.9 63.3 9.9 4.7 31.6 37.6 2.5 3.3 15.7 3.6 1.8 0.0 28.7 34.0 50.8 1.6 3.7 442.8 2.8 2.7 17.8 1.9 2.1 11.1 1.0 24.1 20.1 31.6 29.1 9.8 0.9 25.6 27.1 43.8 31.2 23.0 6.6 3.1 7.4 22.0 8.9 46.0 47.3 6.7 4.3 11.6 40.7 58.0 SEC61A2 FLJ10578 ENSG00000065665 "SEC61 translocon subunit alpha 2" Q9H9S3 10 12129637-12169961 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 41.2;Horizontal cells: 35.3;Inhibitory neurons: 42.4;Late spermatids: 31.1;Oligodendrocytes: 44.2;Spermatocytes: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.83e-2)" "unprognostic (2.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.01e-3)" "unprognostic (4.18e-2)" "unprognostic (1.84e-2)" "unprognostic (1.28e-3)" "unprognostic (1.55e-2)" "unprognostic (2.97e-1)" "unprognostic (3.95e-2)" "prognostic favorable (1.08e-5)" "unprognostic (3.14e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (6.41e-2)" "unprognostic (4.95e-2)" "unprognostic (6.18e-2)" "prognostic favorable (8.75e-4)" 4.1 4.8 21.0 4.9 23.0 15.2 4.5 18.4 27.0 8.0 7.0 6.1 3.4 6.9 7.9 4.1 6.6 4.5 9.9 22.3 23.3 5.0 12.7 5.2 5.7 21.9 21.8 24.6 7.1 4.2 3.8 13.2 4.0 22.5 7.6 5.1 19.0 4.6 5.1 7.8 8.3 5.9 5.0 17.1 7.3 5.0 15.4 23.0 6.2 6.0 7.1 5.5 6.2 6.5 30.9 8.4 13.2 19.2 12.0 7.3 5.0 6.3 8.6 4.6 15.4 16.1 13.3 5.7 3.4 4.4 12.3 20.1 7.2 24.9 10.4 13.2 9.7 10.2 4.0 19.7 9.7 7.6 2.5 9.1 7.2 6.4 27.2 4.5 7.2 4.1 18.7 4.7 9.1 12.9 7.2 8.1 4.2 18.4 6.9 4.4 8.7 7.2 2.0 9.8 8.8 8.6 13.2 11.7 6.3 6.1 14.3 12.3 4.1 7.9 13.5 15.3 17.8 5.9 8.4 12.4 5.2 10.6 3.2 4.1 0.0 0.1 0.1 0.8 0.0 0.7 0.2 0.5 0.5 0.3 0.5 1.0 0.7 1.7 0.9 0.2 2.5 0.7 0.1 21.0 23.0 18.4 27.0 22.3 23.3 21.9 21.8 24.6 22.5 17.1 23.0 30.9 2.4 3.2 2.8 19.2 6.3 1.8 2.6 2.5 2.2 14.6 2.8 1.9 7.3 1.5 3.3 9.2 8.4 3.4 7.5 3.7 0.0 2.8 19.8 6.2 5.8 2.6 1.2 3.6 41.2 2.3 2.3 4.9 3.1 4.2 2.5 5.6 3.9 14.1 2.9 35.3 42.4 2.2 6.1 1.9 2.3 31.1 6.8 2.6 5.4 15.0 1.4 5.8 2.1 26.2 44.2 2.0 2.8 4.5 5.0 3.0 1.3 1.4 4.2 15.9 0.0 2.7 4.8 35.2 14.3 1.7 1.4 3.4 4.9 2.8 1.0 2.0 PRKCQ ENSG00000065675 "Protein kinase C theta" Q04759 10 6427143-6580301 "Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 33.9;skeletal muscle: 125.7;tongue: 113.6" "Cell type enhanced" "Detected in many" "Astrocytes: 22.9;dendritic cells: 22.4;NK-cells: 32.0;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 75.2;T-cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7" "Group enriched" "Detected in many" 11 "NK-cells: 13.3;T-cells: 39.7" "Cell line enhanced" "Detected in many" "HEL: 57.8;JURKAT: 40.0;MOLT-4: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065279, HPA073098" Enhanced "Centriolar satellite" NA NA "Centriolar satellite" "HPA065279: AB_2685453, HPA073098: AB_2686571" "unprognostic (6.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.69e-3)" "unprognostic (2.46e-1)" "unprognostic (8.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.17e-1)" "unprognostic (3.22e-1)" "unprognostic (5.26e-2)" "unprognostic (7.74e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (3.51e-2)" 0.6 0.7 4.7 5.2 7.7 5.8 0.9 5.8 6.9 1.6 10.7 1.4 1.5 2.6 8.4 2.2 3.9 1.5 0.3 5.0 7.7 7.0 1.0 5.4 12.4 7.8 7.9 3.8 1.3 3.4 0.7 0.8 0.2 9.0 1.8 1.7 1.5 1.5 1.1 125.7 0.3 3.3 0.8 4.6 5.0 2.1 1.2 7.1 33.9 15.0 113.6 9.5 2.2 0.6 9.8 0.1 5.3 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.2 0.4 3.4 0.3 0.0 0.0 0.0 0.0 3.3 6.0 0.0 0.0 3.9 57.8 0.0 0.4 0.7 2.8 0.6 0.3 3.5 0.1 0.2 0.0 0.5 40.0 12.8 0.1 0.0 0.0 43.9 8.0 5.8 0.5 0.0 8.5 1.3 0.0 11.6 2.9 0.4 2.1 0.0 0.0 0.0 3.4 0.0 5.8 0.0 0.0 5.6 0.0 0.0 0.1 0.0 0.0 0.0 7.1 0.0 2.4 0.1 0.3 23.0 0.4 18.0 0.1 24.5 24.5 0.2 0.0 19.1 17.9 1.6 13.3 0.0 0.0 39.7 10.5 4.7 7.7 5.8 6.9 5.0 7.7 7.8 7.9 3.8 9.0 4.6 7.1 9.8 0.2 3.2 7.0 22.9 0.8 0.0 0.3 0.3 0.6 1.6 0.3 0.3 0.4 0.0 0.7 1.8 0.0 0.0 22.4 0.0 7.9 0.3 2.1 0.5 1.2 0.2 1.8 8.0 13.7 0.8 0.1 0.7 1.5 3.0 1.3 8.2 1.1 0.0 0.5 0.0 14.7 0.5 0.0 1.3 0.5 5.6 0.0 1.7 0.0 7.5 0.8 1.2 32.0 24.6 75.2 0.1 0.1 0.0 10.2 0.2 0.0 0.3 0.9 0.4 0.0 4.2 0.4 1.0 2.2 0.5 0.0 0.0 31.7 0.3 0.4 0.1 TLE2 "ESG, ESG2, FLJ41188, GRG2" ENSG00000065717 "TLE family member 2, transcriptional corepressor" Q04725 19 2997639-3047635 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.7" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 44.4;RT4: 35.2;T-47d: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049103 Enhanced Supported "Nuclear bodies,Focal adhesion sites" NA NA "Nuclear bodies" "Focal adhesion sites" "HPA049103: AB_2680631" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (2.89e-1)" "prognostic favorable (2.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.87e-3)" "unprognostic (6.40e-3)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "prognostic favorable (2.39e-6)" "unprognostic (2.12e-1)" "prognostic favorable (9.49e-6)" "unprognostic (2.66e-1)" "unprognostic (5.99e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.88e-4)" 34.8 31.8 18.3 5.2 18.4 1.6 34.5 61.2 21.4 41.1 9.8 44.3 12.7 63.1 5.2 13.6 62.7 9.1 63.7 13.1 18.0 49.2 17.2 42.9 5.5 21.5 20.5 13.0 29.5 37.0 20.5 26.2 9.3 35.2 56.0 6.7 8.8 86.3 28.3 67.0 21.2 18.6 11.2 17.4 47.3 30.5 23.2 24.7 4.9 73.1 31.2 2.2 68.0 25.9 22.5 0.5 2.8 0.2 44.4 6.7 1.1 9.5 0.4 0.0 2.1 1.1 14.0 5.1 0.2 5.9 3.2 1.3 7.6 7.7 2.7 0.5 1.2 2.1 0.0 3.4 0.6 8.6 0.0 0.4 9.6 1.2 4.9 0.1 2.6 18.0 12.6 16.2 0.2 0.3 15.0 0.4 0.2 0.1 1.3 2.9 3.9 2.2 4.4 5.5 35.2 2.3 11.1 3.0 22.0 1.1 0.9 25.1 0.1 11.7 14.0 14.4 0.8 0.5 0.5 0.5 3.0 0.3 3.3 2.8 0.0 0.0 0.1 1.1 0.0 0.9 1.7 0.7 0.4 0.0 0.1 1.2 0.7 0.0 0.0 0.0 0.0 0.2 0.3 18.3 18.4 61.2 21.4 13.1 18.0 21.5 20.5 13.0 35.2 17.4 24.7 22.5 27.1 19.2 17.6 1.6 0.7 3.6 34.2 8.3 11.4 36.9 27.0 16.5 24.9 12.8 7.0 36.8 2.1 1.8 2.8 21.7 1.9 11.3 6.5 1.8 9.6 10.3 13.8 0.4 10.3 2.7 4.4 14.8 8.2 6.0 0.0 7.2 16.1 4.0 0.7 1.7 29.3 14.9 8.2 0.3 3.1 18.8 11.8 1.1 5.4 3.7 0.1 19.2 2.1 10.6 14.6 2.7 9.8 15.1 0.3 28.2 1.3 1.1 10.0 4.4 0.0 1.5 11.2 1.2 5.8 4.6 2.3 6.7 2.3 0.7 26.5 32.5 ASB1 ASB-1 ENSG00000065802 "Ankyrin repeat and SOCS box containing 1" Q9Y576 2 238426742-238452250 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003508 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003508: AB_1845065" "unprognostic (1.02e-1)" "unprognostic (5.30e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.49e-2)" "unprognostic (5.81e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.56e-4)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.19e-1)" 6.7 5.6 21.5 7.4 20.1 2.9 5.3 16.4 18.7 8.6 11.1 9.0 3.9 10.8 3.7 5.1 8.6 5.3 16.4 18.5 19.2 6.2 6.4 6.5 8.1 20.1 21.3 16.6 10.3 6.0 8.5 7.6 3.3 21.6 7.5 4.8 5.5 5.5 8.0 21.3 5.8 8.4 8.2 20.6 7.8 8.0 10.8 21.2 6.8 5.8 23.5 8.5 8.1 6.6 19.0 11.1 15.7 21.2 17.0 13.3 14.0 17.1 29.9 19.8 17.7 19.8 7.7 7.7 9.6 4.0 28.2 39.3 12.0 21.1 47.7 27.7 24.3 17.2 12.1 15.2 19.3 31.1 16.8 15.5 15.0 21.7 51.7 69.7 27.8 7.7 16.7 25.9 6.3 32.9 7.6 9.2 17.8 22.6 9.7 13.2 13.3 43.1 6.4 12.9 15.1 17.1 23.2 9.4 6.9 15.7 12.7 5.2 17.9 16.6 31.8 20.6 25.1 59.9 22.8 15.2 16.5 50.2 5.3 16.2 0.0 0.5 1.0 4.2 0.7 2.2 4.3 3.0 4.1 0.6 2.1 2.5 3.0 0.2 2.1 0.4 2.8 4.1 1.3 21.5 20.1 16.4 18.7 18.5 19.2 20.1 21.3 16.6 21.6 20.6 21.2 19.0 2.3 9.6 3.7 7.8 12.2 7.9 27.5 16.4 7.4 10.0 7.4 7.1 45.3 15.7 11.3 9.2 4.2 12.3 12.8 5.2 1.9 15.8 35.2 9.8 8.1 4.0 12.7 19.1 6.1 21.0 28.6 15.0 14.8 4.6 15.9 7.6 5.0 12.5 23.7 10.1 6.1 6.6 10.2 9.5 4.3 19.5 7.8 10.4 7.2 3.7 12.3 9.8 11.3 6.6 8.5 30.4 16.3 14.7 18.5 20.1 8.4 11.3 18.4 6.5 26.3 10.6 16.0 52.1 37.4 7.2 6.8 5.7 13.9 9.9 7.1 15.4 FAM107B "C10orf45, FLJ45505, HITS, MGC11034" ENSG00000065809 "Family with sequence similarity 107 member B" Q9H098 10 14518557-14774897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 526.5;Proximal tubular cells: 359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2" "Cell line enhanced" "Detected in all" "Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4" "Low region specificity" "Detected in all" "HPA039661, HPA058814, HPA073195" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 15000 Nucleoplasm "Golgi apparatus" "HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221" "unprognostic (1.24e-1)" "unprognostic (1.91e-2)" "unprognostic (1.15e-1)" "unprognostic (1.80e-2)" "unprognostic (8.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.67e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.82e-2)" "unprognostic (5.60e-2)" "unprognostic (4.63e-1)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (6.93e-2)" "unprognostic (7.01e-2)" "unprognostic (3.53e-2)" 48.8 45.1 93.9 91.0 147.2 173.0 44.7 117.5 109.1 42.6 105.4 64.8 33.0 48.7 11.5 23.0 20.8 66.7 10.3 89.0 109.3 120.7 148.6 65.4 153.5 131.3 135.2 69.1 7.3 71.2 70.6 21.5 22.3 146.5 27.8 42.9 15.3 69.2 114.8 3.5 22.4 56.4 31.7 114.4 51.1 124.0 37.6 124.2 48.5 12.7 9.4 135.1 67.3 17.2 233.1 60.8 129.1 50.3 3.4 7.6 1.7 21.3 59.7 85.8 35.9 25.6 79.9 49.9 373.0 52.8 27.5 13.4 18.6 16.1 36.4 63.5 449.6 13.9 10.3 55.6 95.0 26.7 136.6 23.3 4.2 28.0 14.9 7.2 42.4 154.6 72.5 1.1 309.6 28.2 15.6 33.6 39.5 12.5 72.7 28.2 240.8 39.1 140.2 81.9 39.0 18.7 53.5 23.6 12.4 39.0 44.7 46.0 294.4 50.8 37.0 31.2 118.3 20.3 136.2 131.7 241.3 6.5 117.5 10.1 52.3 6.0 63.8 100.2 7.1 97.7 12.4 79.4 85.0 5.2 12.6 105.7 106.2 25.2 53.8 14.9 3.5 78.0 74.8 93.9 147.2 117.5 109.1 89.0 109.3 131.3 135.2 69.1 146.5 114.4 124.2 233.1 12.8 105.8 44.4 7.2 203.6 89.7 147.1 25.4 16.5 4.8 94.6 30.4 4.1 134.4 52.5 286.9 2.1 18.1 194.7 65.9 223.0 44.3 27.0 234.9 98.7 37.8 14.3 22.7 1.6 106.8 38.2 49.7 175.3 268.2 119.2 32.7 72.8 177.4 37.1 201.9 7.3 110.5 36.7 53.9 120.9 53.2 2.5 110.7 51.6 15.0 68.8 13.6 198.8 11.1 526.5 90.3 44.3 4.9 176.6 139.6 25.9 359.9 85.3 15.0 0.0 5.4 64.6 56.2 35.7 8.3 82.3 62.5 237.7 3.8 39.9 240.2 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210402-83431051 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "MAIT T-cell: 16.0" "Lineage enriched" "Detected in many" 10 "T-cells: 16.0" "Cell line enhanced" "Detected in many" "CACO-2: 139.4;OE19: 158.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 41.8 44.8 14.2 5.3 15.2 0.4 30.2 15.1 18.2 5.2 9.4 7.7 21.9 4.2 6.6 28.8 4.3 15.7 15.6 13.6 17.5 3.6 9.9 8.9 4.2 15.8 19.0 13.7 10.9 3.4 20.1 12.6 2.9 17.1 8.4 11.1 30.3 10.3 17.4 35.1 12.7 10.5 7.8 13.6 7.4 24.0 16.2 16.4 5.6 6.8 30.8 4.6 15.5 12.1 16.5 29.0 59.1 1.4 0.0 48.0 44.4 0.1 18.4 47.0 19.2 37.1 139.4 24.9 0.0 46.8 43.4 38.2 29.8 43.4 16.4 20.9 0.0 24.4 0.0 33.8 0.0 61.4 14.3 50.3 49.0 32.3 38.7 26.3 32.1 30.4 0.0 20.4 0.1 26.4 32.7 0.0 16.2 0.0 158.3 23.0 0.0 48.5 27.9 56.8 13.7 5.8 14.9 31.2 45.7 1.0 25.0 0.0 34.5 32.4 11.9 14.1 3.9 0.1 10.9 13.3 0.1 0.0 0.0 35.9 0.0 1.6 0.0 0.8 0.3 16.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 14.2 15.2 15.1 18.2 13.6 17.5 15.8 19.0 13.7 17.1 13.6 16.4 16.5 0.9 19.2 12.1 71.8 0.6 1.9 5.1 12.5 6.8 17.1 2.5 0.9 41.0 7.2 12.7 5.5 2.1 0.6 0.5 12.7 1.9 12.3 5.5 0.7 6.8 2.3 0.0 0.0 117.1 9.5 0.9 8.5 62.7 0.2 0.0 11.2 4.2 12.1 7.1 13.5 70.6 4.1 8.2 74.4 25.6 6.5 25.7 16.7 0.0 23.4 5.5 100.6 0.0 123.6 38.6 15.0 4.5 37.2 0.5 5.2 15.2 3.1 7.2 7.5 0.0 4.5 8.3 7.5 2.3 22.3 3.4 0.8 1.8 33.6 8.9 3.3 TBC1D1 "KIAA1108, TBC, TBC1" ENSG00000065882 "TBC1 domain family member 1" Q86TI0 4 37891084-38139175 "Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 310.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041816, HPA058158" Approved Approved Nucleoli NA NA Nucleoli "HPA041816: AB_10796784, HPA058158: " "unprognostic (3.77e-2)" "unprognostic (3.44e-1)" "unprognostic (1.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "prognostic favorable (1.47e-8)" "unprognostic (1.49e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.21e-1)" 30.5 11.0 20.8 38.6 18.9 64.8 23.2 14.0 19.0 45.5 40.7 92.0 31.0 141.0 46.8 23.1 61.6 45.0 56.6 26.2 14.1 83.6 26.4 32.7 54.2 18.0 12.6 14.9 25.0 28.6 135.3 16.9 41.7 13.7 22.9 28.6 9.7 20.7 40.5 111.1 11.2 35.6 92.0 14.2 40.1 34.6 48.5 11.4 59.5 57.2 151.2 41.7 52.1 24.0 16.0 23.2 26.1 46.7 50.5 16.4 45.3 40.2 61.9 103.6 57.3 58.0 15.0 73.8 118.6 15.0 41.5 72.1 1.0 35.8 45.0 87.6 9.4 20.2 45.9 17.1 31.6 26.2 85.7 50.0 55.4 8.9 35.3 24.4 47.7 89.4 81.6 57.0 19.8 60.3 17.7 119.5 80.5 26.3 3.6 23.6 104.9 75.8 34.7 47.3 42.4 40.7 36.5 23.0 21.1 25.6 104.9 20.5 65.4 61.4 75.1 84.3 19.0 91.4 48.1 63.7 310.4 32.8 76.9 68.2 2.9 7.6 23.2 3.8 25.2 6.2 7.1 3.7 3.1 7.4 9.0 3.3 4.2 20.5 9.7 28.2 6.2 3.3 3.9 20.8 18.9 14.0 19.0 26.2 14.1 18.0 12.6 14.9 13.7 14.2 11.4 16.0 38.3 12.8 6.7 50.9 42.0 7.9 14.0 5.0 4.6 12.4 15.1 9.8 73.9 22.8 8.3 27.6 0.0 20.1 30.7 26.0 76.3 13.8 27.6 19.4 27.6 39.9 44.3 11.6 75.9 40.8 27.6 15.5 7.1 25.8 2.5 24.3 27.8 19.8 31.0 10.1 37.7 11.9 36.7 68.6 21.4 50.2 23.3 52.2 10.6 91.8 51.0 9.8 25.7 45.8 9.2 38.7 17.6 19.9 40.7 37.3 13.1 77.3 14.8 1.1 39.5 17.4 79.5 13.0 19.4 3.4 8.7 29.1 32.0 7.4 11.9 35.9 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39950121-40099580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 11.5 10.2 10.5 14.7 12.0 28.4 11.2 20.3 11.3 12.9 8.2 12.1 10.6 13.8 14.4 14.9 15.1 12.8 10.5 9.7 10.2 12.9 16.0 12.2 21.8 11.8 9.9 9.8 20.3 12.9 17.3 8.0 13.7 12.7 11.3 13.8 19.8 13.1 11.9 11.3 12.1 12.1 12.1 9.7 16.8 12.4 19.2 10.6 19.8 20.8 14.1 20.4 13.5 10.1 16.6 28.4 16.6 28.2 27.0 24.9 24.1 19.3 22.1 23.8 19.8 24.6 17.8 19.1 51.0 12.6 23.4 34.8 33.6 23.4 19.4 29.0 25.3 17.3 22.8 20.0 16.0 23.7 34.8 23.5 14.3 25.5 22.6 30.0 22.6 23.6 23.1 39.0 34.3 20.7 14.7 28.0 24.9 40.8 20.0 19.1 30.5 18.5 20.5 18.5 28.1 20.0 28.8 27.6 59.8 19.9 36.7 24.6 43.0 28.3 27.0 26.0 17.6 30.5 28.3 26.0 41.2 19.8 30.9 35.4 7.8 2.2 4.0 4.1 1.9 2.8 6.4 3.8 3.0 1.3 10.5 3.8 3.9 5.9 4.3 3.1 3.3 3.9 1.3 10.5 12.0 20.3 11.3 9.7 10.2 11.8 9.9 9.8 12.7 9.7 10.6 16.6 47.6 44.8 72.0 131.6 49.7 21.4 18.5 15.9 29.0 47.8 36.7 27.7 30.9 25.8 37.1 31.3 70.9 13.7 91.0 23.1 7.9 20.4 13.9 54.3 51.4 30.9 18.7 5.9 179.0 15.4 9.1 31.7 30.1 72.6 17.1 95.5 19.2 23.7 13.2 37.0 166.2 17.6 14.2 23.8 17.4 9.2 26.1 31.6 14.2 145.2 27.9 22.4 53.5 171.9 199.6 28.6 12.9 17.7 50.1 21.8 15.2 12.7 32.8 69.4 6.6 38.5 32.0 36.1 33.4 34.7 26.1 12.2 49.7 56.8 20.1 25.0 MTHFD2 ENSG00000065911 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase" P13995 2 74186172-74217565 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 243.6;monocytes: 184.1;Smooth muscle cells: 239.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003684, HPA049657" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB003684: AB_425867, HPA049657: AB_2680842" "unprognostic (1.82e-3)" "unprognostic (4.60e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.07e-5)" "prognostic favorable (1.01e-4)" "unprognostic (3.10e-3)" "unprognostic (2.24e-3)" "unprognostic (4.75e-3)" "unprognostic (2.64e-2)" "unprognostic (3.96e-2)" "unprognostic (3.76e-3)" "unprognostic (3.57e-3)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.66e-2)" "unprognostic (6.52e-2)" "unprognostic (9.07e-2)" "unprognostic (2.34e-3)" 40.3 12.4 12.2 55.0 13.6 26.0 35.2 14.7 14.1 28.8 13.5 30.9 18.8 21.7 14.6 23.2 34.5 20.3 18.1 11.4 17.7 12.9 7.4 23.2 46.0 17.5 16.3 9.8 11.8 66.5 9.9 18.2 17.8 17.8 16.4 34.0 2.9 17.9 16.8 37.1 11.3 16.2 27.5 16.5 19.2 36.4 17.9 15.4 28.7 18.6 55.8 58.3 48.5 20.7 17.5 197.4 107.8 89.2 235.6 90.0 113.9 186.1 286.2 185.2 156.2 216.7 242.8 81.8 391.0 65.4 154.2 167.5 70.7 296.7 142.0 314.9 248.9 100.9 424.6 55.4 181.9 319.8 360.1 234.8 202.9 423.4 188.5 794.4 74.8 99.0 636.5 192.2 548.0 157.5 159.6 209.5 261.0 161.1 293.3 95.8 222.6 266.3 339.4 72.0 80.8 198.2 143.8 97.4 238.3 549.7 56.9 208.5 324.4 52.9 39.1 359.9 97.7 286.5 484.5 257.6 379.2 111.4 304.1 132.5 43.9 24.0 31.1 8.5 56.6 13.0 13.4 15.2 10.1 34.9 12.2 11.5 7.9 3.2 29.3 57.0 13.0 36.8 22.0 12.2 13.6 14.7 14.1 11.4 17.7 17.5 16.3 9.8 17.8 16.5 15.4 17.5 19.7 16.0 20.2 0.3 49.7 89.3 58.8 54.1 27.3 0.0 53.2 38.0 11.5 4.3 28.2 1.8 0.0 31.5 48.2 19.9 3.9 55.7 3.9 9.7 104.7 35.1 19.1 104.1 1.0 107.9 56.9 45.6 68.8 21.7 53.3 8.7 19.2 0.8 66.2 0.0 3.7 64.0 38.7 61.6 243.6 3.8 22.7 100.6 71.2 12.2 184.1 0.0 27.8 6.6 1.1 81.2 7.5 21.1 141.2 95.7 3.3 3.3 8.5 0.0 138.1 126.3 239.0 36.5 54.9 42.0 74.6 14.0 71.4 21.6 34.0 64.2 SLC9A7 NHE7 ENSG00000065923 "Solute carrier family 9 member A7" Q96T83 X 46599251-46759118 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Potassium transport, Sodium transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 39.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048938, HPA075385" Approved Supported Vesicles NA NA Vesicles "HPA048938: AB_2680565, HPA075385: AB_2686747" "unprognostic (2.77e-1)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.58e-4)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.16e-2)" "unprognostic (2.73e-3)" "unprognostic (5.26e-3)" "unprognostic (1.28e-2)" "unprognostic (9.25e-2)" "unprognostic (5.30e-2)" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (7.20e-2)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" 0.5 5.1 7.6 2.4 39.6 3.6 5.9 6.5 13.4 1.2 0.6 0.6 1.3 0.8 2.6 1.9 1.7 1.6 1.0 8.1 13.4 2.3 3.1 1.3 6.4 14.6 8.6 9.0 4.4 3.4 9.0 9.3 1.1 14.5 4.6 0.9 5.0 6.0 2.0 5.7 2.1 2.2 0.7 6.6 3.7 6.4 0.8 12.4 3.2 4.4 2.5 6.3 1.8 1.3 17.6 10.4 7.7 1.1 3.3 1.2 7.4 4.3 9.6 12.0 5.7 4.5 7.9 10.9 22.7 2.9 15.6 11.0 4.6 7.4 10.9 10.3 11.9 3.9 2.3 3.1 3.3 4.6 1.0 17.9 4.6 1.4 16.1 10.6 26.8 8.2 7.7 0.2 0.3 7.9 15.7 2.6 1.2 5.3 5.0 9.2 10.0 0.4 0.2 4.4 11.4 8.2 1.0 4.9 7.3 2.1 9.2 9.7 0.4 0.4 12.0 4.0 1.8 5.7 2.3 0.5 11.2 17.1 0.1 4.0 0.5 0.2 0.1 0.1 0.2 0.1 1.7 0.2 0.1 1.1 1.7 0.1 0.1 0.8 0.5 0.2 2.8 0.3 0.2 7.6 39.6 6.5 13.4 8.1 13.4 14.6 8.6 9.0 14.5 6.6 12.4 17.6 0.5 3.2 8.2 11.4 21.0 0.6 10.1 0.9 1.2 13.0 16.9 8.6 5.7 1.5 2.6 16.5 4.2 7.9 24.4 0.3 0.0 17.6 0.0 1.8 2.0 1.5 2.4 5.5 43.3 14.2 0.7 2.7 13.3 1.7 0.0 4.5 0.7 6.5 6.4 13.5 66.8 2.0 0.0 6.3 8.4 0.6 0.9 9.2 1.8 3.7 8.0 6.1 1.0 69.9 1.6 16.4 0.1 0.4 2.8 21.0 0.1 2.1 0.1 3.5 6.6 12.1 1.9 0.0 1.6 4.2 1.0 7.3 2.9 1.3 0.9 11.5 FOXJ2 FHX ENSG00000065970 "Forkhead box J2" Q9P0K8 12 8032716-8055517 "Predicted intracellular proteins, Transcription factors" "Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008723 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA008723: AB_1078903" "unprognostic (1.68e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-2)" "unprognostic (1.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (9.65e-2)" "unprognostic (3.08e-1)" "unprognostic (2.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (9.01e-2)" "unprognostic (2.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.02e-2)" 12.8 8.4 6.4 8.7 6.6 15.6 12.4 13.5 12.0 15.3 4.9 12.8 7.3 17.8 8.1 8.9 14.5 8.2 14.0 6.7 6.1 7.4 5.9 12.2 8.4 6.5 6.4 6.1 16.9 10.0 15.5 8.6 11.1 7.7 10.6 7.8 9.4 9.6 12.9 25.4 17.3 10.2 14.8 5.2 10.8 11.4 5.9 6.2 10.8 10.0 20.8 9.2 13.6 12.5 6.6 12.4 10.3 11.1 14.0 12.6 13.8 24.3 17.5 17.8 16.7 12.4 14.8 13.3 0.2 3.2 21.3 15.4 13.2 10.0 11.7 17.8 21.6 6.8 16.4 11.8 5.1 15.8 7.4 43.9 12.2 17.2 21.7 31.5 17.4 12.1 13.0 12.2 8.0 13.7 9.6 10.5 6.6 12.6 18.4 6.8 11.2 17.2 6.0 7.0 8.2 4.6 6.3 22.0 15.1 7.6 23.1 3.5 8.8 11.0 20.3 24.8 14.5 10.7 6.4 6.8 8.1 13.1 5.9 12.3 2.5 1.4 2.2 1.5 1.1 1.9 0.8 1.5 1.7 1.8 1.5 1.7 1.5 2.7 2.8 1.5 1.7 1.2 1.2 6.4 6.6 13.5 12.0 6.7 6.1 6.5 6.4 6.1 7.7 5.2 6.2 6.6 14.1 16.0 13.1 6.2 9.1 18.9 4.5 5.5 14.8 10.7 10.4 9.1 19.9 12.8 4.0 0.0 8.4 5.5 7.7 7.1 0.0 5.9 0.4 4.0 14.0 12.8 4.9 13.7 6.1 7.5 3.1 12.0 7.7 7.2 3.8 16.1 18.9 9.5 10.1 8.4 6.4 8.4 4.1 13.2 23.0 0.9 10.5 13.9 7.2 6.5 14.2 4.0 11.3 3.0 5.7 10.3 4.4 17.0 6.7 9.8 5.0 2.4 2.9 7.5 19.7 9.9 8.4 1.4 6.4 14.2 21.5 6.2 12.3 8.1 7.4 5.3 YBX1 "BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1" ENSG00000065978 "Y-box binding protein 1" P67809 1 42682418-42703805 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2058.3" "Cell type enhanced" "Detected in all" "Early spermatids: 8388.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005875, HPA040304, HPA057159" Supported Supported "Endoplasmic reticulum,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1600000 Cytosol "Endoplasmic reticulum, Vesicles, Plasma membrane" "CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355" "unprognostic (8.59e-2)" "unprognostic (5.16e-2)" "unprognostic (9.27e-3)" "unprognostic (2.68e-3)" "unprognostic (7.76e-2)" "unprognostic (8.03e-3)" "prognostic unfavorable (9.87e-10)" "unprognostic (2.80e-2)" "unprognostic (2.31e-2)" "unprognostic (2.79e-3)" "unprognostic (7.51e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (3.59e-7)" "unprognostic (3.66e-2)" "unprognostic (2.44e-1)" "unprognostic (1.94e-2)" "unprognostic (3.25e-1)" 536.8 256.6 143.6 426.2 150.6 871.4 404.5 154.0 159.0 324.8 167.8 527.1 368.2 409.6 213.1 368.0 339.9 211.6 740.6 138.6 181.9 316.7 312.4 399.7 411.2 173.9 151.9 119.5 314.3 268.9 134.9 123.2 244.2 173.8 310.5 381.8 395.2 272.7 221.5 2058.3 291.3 369.2 341.8 163.7 370.3 408.4 789.7 165.6 356.7 284.4 1144.0 385.3 505.7 335.1 202.6 1552.8 761.5 1020.4 1232.7 991.0 908.1 1200.2 971.5 768.9 1116.6 875.8 1034.6 1253.7 1630.6 1157.5 825.2 495.5 870.2 1162.6 1230.5 1103.9 1087.8 1278.0 1596.4 1491.9 1343.8 786.7 2214.4 1320.7 812.6 1092.3 1094.5 1365.7 630.0 950.3 1271.9 1823.0 720.6 1104.0 837.7 2816.5 2464.6 2902.1 755.0 1006.4 1789.6 1972.5 1938.2 1176.7 933.8 1731.6 1298.5 893.7 1294.0 2038.3 1096.8 443.2 5002.2 862.6 945.4 1748.6 1371.1 2209.3 1213.7 1670.6 2004.8 910.4 1750.3 1049.9 15.3 48.4 69.9 42.9 107.1 52.9 69.4 51.8 43.3 77.4 61.2 44.0 45.9 9.0 35.1 124.2 58.6 69.7 34.1 143.6 150.6 154.0 159.0 138.6 181.9 173.9 151.9 119.5 173.8 163.7 165.6 202.6 701.7 173.1 230.9 16.3 818.3 1397.7 1265.9 419.7 747.3 247.8 569.7 564.5 1072.3 441.8 355.5 325.5 150.1 753.9 678.4 620.6 1457.6 1013.6 8388.7 363.5 695.5 755.1 587.8 2244.2 16.2 886.6 1998.9 687.6 461.3 427.0 383.1 489.1 483.3 480.1 1708.7 121.1 27.1 930.2 354.0 1656.0 2342.9 3743.4 751.2 1307.6 905.4 19.7 1171.0 463.8 744.6 23.6 32.7 858.2 975.1 806.1 981.0 1935.1 993.3 1169.8 196.2 602.4 466.8 754.8 1083.7 3245.2 425.5 1113.5 1302.5 481.5 635.6 811.4 1257.7 1697.8 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469630 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Langerhans cells: 190.8;Late spermatids: 197.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 36.5;NB-4: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775" "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 12.7 5.6 5.7 6.0 11.3 5.5 9.8 2.1 30.1 11.8 0.0 10.0 2.8 9.9 1.5 4.1 7.5 6.6 10.4 10.8 5.5 6.3 2.6 13.1 3.2 18.4 6.6 8.7 1.5 12.8 22.4 3.9 6.6 20.1 8.5 4.0 5.3 9.9 4.8 38.2 5.0 6.5 6.2 0.4 8.3 13.0 24.7 13.4 1.6 11.1 17.0 2.7 8.3 8.2 20.6 0.1 2.5 0.5 6.7 18.7 11.1 3.7 5.6 11.1 0.7 1.9 6.0 5.4 2.6 16.1 14.6 0.4 0.6 3.9 0.7 0.4 6.7 5.5 23.7 8.1 6.7 12.3 3.9 36.5 8.3 0.8 6.2 0.0 0.7 5.3 2.1 18.9 5.5 4.0 1.7 2.3 43.3 2.9 6.7 4.7 15.6 3.7 20.3 0.9 1.4 4.2 1.5 0.4 0.2 6.2 1.0 0.8 7.8 11.2 8.3 10.5 5.7 3.7 10.9 0.9 12.4 3.5 0.3 6.7 4.1 1.7 3.4 0.8 2.5 0.4 0.1 0.3 1.1 2.0 0.0 0.0 0.4 0.1 3.0 2.7 0.1 0.7 1.1 5.7 11.3 2.1 30.1 10.8 5.5 18.4 6.6 8.7 20.1 0.4 13.4 20.6 9.4 3.2 11.6 6.2 10.8 10.1 2.6 2.5 1.8 25.6 6.4 4.3 7.7 8.6 5.5 9.2 0.0 0.5 58.9 7.1 0.0 3.1 48.9 2.1 20.7 8.6 0.0 1.7 39.4 12.9 4.8 12.1 7.1 3.6 31.8 0.3 10.4 0.9 10.2 55.5 43.5 5.1 6.1 22.1 190.8 197.0 17.4 53.9 14.2 12.2 15.4 1.2 22.6 12.5 1.5 12.3 3.8 18.0 27.0 3.0 0.1 0.2 6.9 3.6 6.6 9.0 10.2 8.6 8.5 0.5 8.1 0.4 37.0 1.0 6.8 1.3 PPP2R5A "B56A, B56alpha, PR61A" ENSG00000066027 "Protein phosphatase 2 regulatory subunit B'alpha" Q15172 1 212285410-212361853 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 252.7;Late spermatids: 547.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059288, HPA078841" Approved Supported Cytosol NA NA Cytosol "HPA059288: AB_2683966, HPA078841: " "unprognostic (3.56e-1)" "unprognostic (2.71e-1)" "unprognostic (8.48e-2)" "unprognostic (2.54e-1)" "unprognostic (9.21e-2)" "unprognostic (1.01e-1)" "unprognostic (5.01e-2)" "unprognostic (1.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.84e-2)" "unprognostic (3.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.40e-3)" "unprognostic (8.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" 60.7 12.1 35.4 20.2 40.1 87.3 38.7 35.0 35.2 24.5 28.4 34.5 25.9 20.3 18.6 51.8 19.4 27.9 50.9 30.9 35.7 36.0 52.1 58.2 31.2 37.3 40.8 29.0 15.4 37.2 23.7 13.3 36.2 35.9 22.8 37.3 24.1 36.6 22.4 37.0 30.2 33.7 22.4 36.9 49.9 44.9 17.6 40.2 36.6 42.2 57.2 31.6 35.0 30.5 40.3 45.4 19.1 9.5 19.1 102.5 62.2 76.1 19.6 38.3 21.9 20.6 57.1 45.7 31.9 14.5 31.5 22.9 32.0 18.3 27.9 22.8 27.5 23.1 20.7 19.9 20.8 33.1 43.3 30.7 25.7 36.4 20.1 29.0 27.7 53.3 28.0 29.6 33.4 12.1 19.7 17.1 28.5 16.0 40.6 39.5 22.0 15.2 40.6 38.5 20.9 13.6 9.1 27.3 84.7 65.0 40.0 52.7 38.0 11.4 15.3 15.6 24.2 21.2 50.9 42.7 42.1 18.4 32.6 11.5 18.0 2.0 10.1 4.4 2.3 3.0 1.4 3.4 4.0 1.4 2.2 2.0 4.0 9.8 3.3 3.3 1.5 5.2 1.4 35.4 40.1 35.0 35.2 30.9 35.7 37.3 40.8 29.0 35.9 36.9 40.2 40.3 66.7 99.3 104.4 71.5 34.2 68.6 22.1 9.0 40.9 24.6 30.1 18.5 65.8 47.1 17.4 14.7 2.1 10.9 56.2 51.2 97.8 25.9 252.7 25.5 17.7 53.3 16.2 22.9 21.3 34.8 26.9 18.7 43.8 53.5 40.0 6.6 38.6 52.2 22.1 52.2 13.8 33.9 8.2 34.8 20.6 547.2 19.3 34.1 17.8 45.0 35.1 37.4 53.5 32.6 115.2 27.8 32.5 14.3 29.6 31.0 30.8 20.9 21.3 11.1 32.9 14.8 36.5 18.4 10.9 66.2 81.3 8.2 54.1 58.3 30.8 45.7 CTNNA2 "CAP-R, CT114" ENSG00000066032 "Catenin alpha 2" P26232 2 79185231-80648861 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Differentiation" "Developmental protein" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 101.3;epididymis: 67.6;retina: 81.2" "Cell type enhanced" "Detected in some" "Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.9;glioma: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 96 "basophil: 55.3" "Lineage enriched" "Detected in single" 553 "granulocytes: 55.3" "Cell line enhanced" "Detected in some" "AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7" "Low region specificity" "Detected in all" CAB037175 Enhanced NA NA "CAB037175: AB_476883" "unprognostic (9.15e-2)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (4.04e-1)" "unprognostic (3.17e-2)" "unprognostic (5.62e-2)" "unprognostic (7.96e-3)" "unprognostic (8.76e-2)" "unprognostic (2.27e-4)" "unprognostic (7.80e-2)" "unprognostic (8.44e-4)" "unprognostic (1.73e-4)" "unprognostic (2.83e-1)" 0.1 4.8 74.7 0.6 81.2 0.1 0.0 56.2 101.3 0.2 28.9 1.6 0.3 3.3 67.6 0.2 1.9 0.2 0.1 78.8 57.9 0.1 0.1 0.0 0.0 50.0 70.1 70.0 0.1 0.8 0.0 7.2 0.0 49.7 1.0 0.9 81.2 0.2 0.8 0.2 0.1 0.7 0.5 34.0 0.0 1.1 17.6 75.2 0.0 0.0 0.0 0.0 0.1 0.4 68.6 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 3.8 10.7 0.0 0.0 0.5 1.0 0.0 0.6 0.0 0.4 0.7 0.2 0.0 2.3 0.0 0.0 2.7 0.0 2.0 55.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 74.7 81.2 56.2 101.3 78.8 57.9 50.0 70.1 70.0 49.7 34.0 75.2 68.6 0.0 0.0 0.0 3673.8 0.0 0.0 0.0 0.0 0.0 17.2 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 560.8 12.9 7.0 0.5 0.0 0.0 1358.5 0.0 0.0 0.1 0.0 34.3 0.0 4.7 0.0 0.0 0.0 5.0 1056.9 0.0 0.0 0.0 0.0 144.4 2.5 0.5 0.0 187.4 0.0 112.1 0.0 1304.4 230.7 0.3 0.0 3.0 0.0 0.0 0.0 0.2 0.0 5.0 0.0 0.0 0.2 10.3 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 ELAVL1 "Hua, HUR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958573-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 227.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 230000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 27.1 28.0 15.0 33.4 16.1 28.1 25.3 16.5 16.4 29.6 18.4 28.1 25.4 31.9 26.1 30.3 34.6 22.6 34.3 15.6 20.3 24.7 29.3 24.4 40.5 14.5 15.8 15.4 32.1 28.7 37.8 21.6 33.0 14.5 27.2 27.5 19.2 29.9 29.7 38.0 24.8 25.3 36.2 16.4 30.4 24.8 46.4 15.2 53.2 28.2 32.5 44.5 37.7 25.4 16.9 127.5 84.1 137.9 104.5 52.9 52.7 76.5 89.5 78.4 136.9 106.3 122.4 73.2 153.2 125.5 104.0 76.9 86.0 155.2 107.9 114.8 134.9 131.8 135.5 58.9 115.7 77.4 129.9 103.1 65.8 63.6 95.7 57.7 64.8 106.2 115.6 140.7 112.6 95.7 95.8 215.3 103.7 122.1 96.4 101.6 239.0 89.6 100.9 87.5 93.9 98.0 70.8 88.9 89.1 71.7 82.6 101.8 101.4 79.7 127.3 87.3 119.2 161.8 109.8 114.7 161.9 71.3 154.2 112.2 29.9 19.7 37.2 16.4 17.2 17.0 20.8 24.0 26.3 25.0 27.7 21.8 16.6 5.3 33.1 22.1 12.5 20.9 16.3 15.0 16.1 16.5 16.4 15.6 20.3 14.5 15.8 15.4 14.5 16.4 15.2 16.9 45.7 25.6 23.1 18.6 56.0 72.4 79.5 29.0 51.2 47.2 54.9 37.2 31.3 30.0 20.7 47.8 56.3 86.8 48.1 32.9 66.5 37.1 227.7 41.6 46.5 52.2 42.0 95.7 20.3 33.8 102.3 53.1 40.2 47.2 21.0 59.5 47.2 89.2 64.2 60.6 21.5 52.9 18.3 57.5 79.2 164.1 50.4 47.3 51.6 23.4 43.9 43.4 57.7 33.7 26.9 35.3 45.7 56.8 88.7 98.2 38.3 65.8 27.3 55.7 52.6 45.5 71.0 164.7 61.2 72.0 71.0 74.8 50.9 44.7 60.2 84.6 TIE1 "JTK14, TIE" ENSG00000066056 "Tyrosine kinase with immunoglobulin like and EGF like domains 1" P35590 1 43300982-43323108 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 130.8;Endothelial cells: 108.8;Hepatic stellate cells: 128.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 24 "basophil: 2.1;NK-cell: 2.5" "Group enriched" "Detected in many" 24 "granulocytes: 2.1;NK-cells: 2.5" "Group enriched" "Detected in some" 4 "EFO-21: 106.3;HUVEC TERT2: 238.4;TIME: 210.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 87000000 "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (7.60e-3)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-3)" "unprognostic (1.19e-2)" "unprognostic (7.83e-2)" "unprognostic (2.02e-1)" "unprognostic (9.34e-2)" "unprognostic (1.91e-2)" "unprognostic (2.25e-1)" "unprognostic (1.17e-3)" "unprognostic (2.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.29e-2)" "unprognostic (2.35e-2)" 43.5 10.2 17.6 8.2 13.7 0.9 38.1 13.6 17.0 14.1 12.7 10.6 5.2 20.5 5.3 6.6 16.2 13.4 27.7 12.0 13.0 16.4 6.8 35.6 10.1 15.5 15.6 9.7 7.6 4.2 3.3 8.0 49.0 15.1 10.9 3.1 0.4 7.5 6.6 14.1 7.4 11.1 14.2 12.5 20.1 8.9 3.0 17.2 2.1 24.4 20.9 2.9 15.2 11.9 16.4 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 106.3 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 41.9 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.7 238.4 0.0 0.0 0.0 0.0 0.0 0.0 20.4 1.3 0.0 0.1 8.1 16.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.1 210.0 1.2 0.4 0.0 0.2 0.0 0.2 0.4 0.0 0.0 3.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 17.6 13.7 13.6 17.0 12.0 13.0 15.5 15.6 9.7 15.1 12.5 17.2 16.4 130.8 0.0 4.2 0.0 0.4 2.2 0.6 0.0 1.2 0.3 1.0 0.9 4.9 1.5 1.8 0.0 0.0 0.3 0.7 0.9 0.0 0.0 2.0 0.1 0.4 108.8 0.0 2.5 0.4 0.2 0.1 3.1 0.0 0.4 20.3 0.1 128.8 1.3 0.5 0.0 0.2 0.1 0.0 5.6 3.1 2.5 2.1 1.1 1.8 29.0 0.1 0.1 1.0 1.0 1.1 0.0 0.0 0.7 0.1 0.7 0.1 0.9 3.6 0.9 0.0 2.2 2.2 0.9 0.7 0.5 1.4 0.3 2.3 0.5 0.2 0.7 DIP2B "FLJ34278, KIAA1463" ENSG00000066084 "Disco interacting protein 2 homolog B" Q9P265 12 50504985-50748657 "Human disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.1" "Cell type enhanced" "Detected in many" "Microglial cells: 188.3;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 634.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038472, HPA046133, HPA056045" Enhanced Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019" "prognostic unfavorable (2.60e-4)" "unprognostic (2.85e-2)" "unprognostic (3.67e-3)" "unprognostic (2.86e-2)" "unprognostic (9.56e-2)" "unprognostic (2.45e-1)" "unprognostic (1.69e-2)" "unprognostic (3.90e-2)" "unprognostic (1.94e-2)" "unprognostic (2.67e-2)" "unprognostic (9.57e-3)" "unprognostic (3.90e-2)" "unprognostic (4.29e-2)" "unprognostic (7.99e-2)" "unprognostic (1.82e-1)" "unprognostic (1.60e-2)" "unprognostic (1.70e-3)" 6.7 8.8 25.2 9.0 43.0 12.2 10.6 33.6 31.5 6.8 9.1 9.6 6.3 6.2 3.5 14.7 4.4 7.1 5.8 22.7 31.4 6.0 11.4 6.8 10.0 36.5 41.6 17.3 9.4 7.7 11.1 6.1 10.4 41.7 6.6 10.8 16.5 8.6 4.1 5.1 17.4 6.6 7.1 32.1 15.0 7.0 7.6 35.4 13.1 8.3 6.4 11.8 7.3 8.9 62.1 20.0 12.0 17.9 12.6 10.0 9.7 25.0 11.3 13.1 10.6 8.0 21.8 11.0 13.4 13.4 12.4 10.9 20.5 28.8 21.1 12.6 15.9 10.7 21.3 10.1 27.6 15.7 25.7 12.4 11.0 18.1 11.8 17.1 18.6 20.4 12.0 30.3 12.5 9.4 15.7 19.9 12.9 10.2 11.4 22.0 23.4 17.6 6.4 12.0 15.5 16.9 11.8 28.3 16.4 17.3 20.6 23.0 17.7 21.6 8.6 10.1 7.9 9.3 9.0 16.0 15.4 11.9 11.7 12.0 1.0 1.2 2.7 0.4 1.4 0.6 1.4 0.9 0.3 1.4 2.2 1.6 1.3 4.9 0.5 3.9 0.4 1.0 0.7 25.2 43.0 33.6 31.5 22.7 31.4 36.5 41.6 17.3 41.7 32.1 35.4 62.1 15.4 6.4 10.5 74.1 26.3 54.9 30.2 14.7 12.5 31.5 15.0 11.4 9.0 17.2 10.5 9.2 64.6 13.3 9.2 25.2 0.0 10.9 1.4 14.3 12.9 15.5 31.3 13.7 121.1 17.4 17.6 11.2 20.4 15.1 10.8 25.0 15.0 18.2 20.4 11.8 125.3 18.3 10.2 37.4 15.7 3.3 10.2 24.5 16.0 188.3 18.7 14.4 11.3 144.8 634.8 22.0 14.0 10.1 15.4 28.1 8.4 6.7 8.8 31.9 0.0 8.0 10.0 12.4 17.7 34.6 66.9 38.0 13.3 34.3 12.4 24.4 SMARCD1 "BAF60A, CRACD1, Rsc6p" ENSG00000066117 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1" Q96GM5 12 50085200-50100707 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Chromatin regulator" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004101 Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004101: AB_1080026" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (2.53e-8)" "unprognostic (3.62e-2)" "unprognostic (1.44e-1)" "unprognostic (4.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" "unprognostic (2.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" 24.9 28.4 26.3 23.4 28.6 44.4 25.2 25.8 27.4 23.3 22.1 22.2 23.4 28.2 27.3 27.7 24.0 18.1 17.1 27.2 27.2 25.6 19.1 24.1 35.3 26.8 27.1 27.1 26.6 22.7 47.6 19.8 29.1 27.1 23.4 27.4 25.4 24.5 22.0 17.1 24.1 28.0 29.0 26.8 31.5 20.7 24.0 26.9 57.8 27.0 16.2 47.9 23.7 21.9 28.7 28.4 47.6 134.8 75.8 41.1 38.9 68.1 35.1 62.0 100.3 58.2 130.0 42.1 109.4 51.0 67.2 44.4 35.4 112.9 91.5 87.3 84.4 87.0 107.2 49.4 75.8 49.3 95.0 41.1 40.2 60.2 59.8 107.4 66.1 119.5 114.0 93.1 64.8 50.6 67.7 137.6 54.0 166.0 43.2 76.6 165.5 34.9 96.0 57.3 66.1 71.4 121.3 73.1 35.2 139.3 100.4 79.4 78.7 70.4 50.1 56.0 31.7 69.9 91.6 88.2 95.4 40.6 37.7 56.9 3.4 1.2 2.2 2.9 1.2 2.9 3.6 1.6 2.0 1.8 2.7 1.0 3.3 0.5 1.7 1.9 3.5 2.7 1.2 26.3 28.6 25.8 27.4 27.2 27.2 26.8 27.1 27.1 27.1 26.8 26.9 28.7 29.7 0.0 9.6 11.1 42.9 16.6 22.3 17.7 42.7 33.7 33.2 30.2 6.5 15.7 20.5 27.6 20.9 21.1 39.6 21.6 52.8 32.8 4.3 20.0 36.9 30.1 31.1 25.7 9.3 29.0 19.4 17.8 14.8 30.5 16.5 40.0 17.5 15.1 17.3 26.9 10.5 18.2 10.2 14.4 13.1 9.1 16.4 16.8 17.8 7.5 27.1 26.5 29.9 11.1 17.1 36.8 14.8 16.1 28.9 28.8 19.5 47.9 9.4 28.8 32.9 31.6 28.2 28.4 36.5 31.3 19.6 11.1 30.0 26.8 19.1 15.9 KDM4A "JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A" ENSG00000066135 "Lysine demethylase 4A" O75164 1 43650149-43705518 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007610 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA007610: AB_1852006" "unprognostic (7.01e-2)" "unprognostic (1.50e-1)" "unprognostic (3.22e-2)" "unprognostic (6.18e-2)" "unprognostic (3.54e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.88e-3)" "unprognostic (1.13e-1)" "unprognostic (5.47e-1)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.32e-3)" "unprognostic (2.02e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" 10.7 20.8 10.0 12.3 10.9 12.2 13.0 12.4 11.5 15.3 10.7 18.2 28.2 14.4 13.1 14.5 18.2 11.9 10.0 10.2 9.6 12.9 15.0 14.8 15.7 10.5 10.0 10.2 19.9 12.8 19.2 11.0 11.3 11.0 13.8 18.6 19.8 13.5 11.5 11.2 21.9 22.8 15.0 9.3 14.0 14.6 5.8 10.3 21.8 17.5 15.8 18.2 13.8 11.9 11.1 25.1 22.6 36.6 63.6 34.5 32.6 25.3 23.4 26.4 34.7 34.6 26.0 21.7 32.5 23.5 23.4 26.3 25.3 45.1 27.6 35.4 23.2 37.8 46.5 33.7 21.2 32.7 33.4 35.9 35.4 43.2 33.7 42.3 26.6 37.0 27.9 23.5 45.1 25.5 19.6 26.4 28.2 59.9 21.5 23.0 35.0 42.2 23.9 24.3 48.8 32.1 29.1 50.5 34.2 63.3 52.8 20.0 111.5 28.1 20.6 32.8 18.7 31.9 20.7 26.7 29.2 21.3 27.8 39.3 10.2 4.9 9.0 4.4 3.7 4.9 4.3 4.3 3.6 4.1 3.1 2.9 2.6 3.0 4.1 5.2 3.6 4.9 3.5 10.0 10.9 12.4 11.5 10.2 9.6 10.5 10.0 10.2 11.0 9.3 10.3 11.1 5.3 9.6 22.3 12.7 14.0 9.2 5.3 8.3 25.6 20.1 8.9 7.5 7.4 8.6 8.2 1.8 37.5 8.5 10.4 19.3 5.9 8.6 9.7 11.2 9.8 9.2 12.0 16.4 21.3 6.7 6.1 9.8 23.4 6.9 13.3 12.0 7.9 13.1 8.9 32.0 17.8 16.6 10.2 9.7 5.5 6.1 12.5 7.9 1.8 5.6 11.6 10.9 13.4 17.6 23.8 10.7 13.5 14.7 14.3 5.4 17.3 6.9 25.4 23.5 6.6 11.1 7.7 0.6 2.9 21.0 4.7 8.1 9.5 13.6 15.4 6.0 NFYC "CBF-C, NF-YC" ENSG00000066136 "Nuclear transcription factor Y subunit gamma" Q13952 1 40691648-40771603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 347.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055011 Supported Nucleoplasm NA NA Nucleoplasm "HPA055011: AB_2682671" "unprognostic (1.20e-3)" "unprognostic (1.51e-2)" "unprognostic (9.77e-2)" "unprognostic (1.37e-3)" "unprognostic (8.53e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.47e-2)" "unprognostic (5.66e-3)" "unprognostic (3.53e-3)" "unprognostic (2.75e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.25e-2)" "unprognostic (3.63e-1)" "unprognostic (3.12e-1)" "unprognostic (7.75e-3)" 26.9 27.1 29.1 30.0 29.4 40.9 29.8 37.2 33.8 31.1 34.6 31.1 29.2 32.6 24.2 33.8 31.3 23.9 61.4 30.2 27.7 30.4 34.1 24.5 37.4 28.0 29.2 28.4 40.9 33.0 50.6 21.1 30.4 30.1 26.0 23.7 27.9 47.1 24.7 73.6 42.7 29.8 29.1 27.3 40.1 31.4 22.9 31.0 41.5 35.1 64.0 34.1 29.7 30.6 30.5 34.7 46.6 67.3 51.0 26.6 24.1 67.2 28.3 31.5 49.4 46.2 65.4 85.7 83.0 43.2 27.1 43.7 40.8 54.6 42.5 51.5 50.6 57.7 90.1 33.8 59.9 31.6 48.0 73.8 26.8 45.2 48.9 51.4 38.0 32.6 62.4 40.3 51.5 23.7 47.6 86.6 47.3 58.2 41.4 36.0 64.2 71.7 74.9 46.6 41.9 45.8 42.4 33.9 73.4 77.4 77.2 33.3 347.6 29.8 22.9 77.9 40.5 42.4 47.6 84.0 68.9 53.2 61.1 62.8 54.8 61.8 64.7 28.4 69.3 29.2 47.0 37.6 32.2 59.8 43.1 40.3 30.5 103.2 41.3 81.1 46.2 44.2 41.0 29.1 29.4 37.2 33.8 30.2 27.7 28.0 29.2 28.4 30.1 27.3 31.0 30.5 27.3 19.2 21.3 51.6 40.0 29.2 28.1 25.5 31.3 18.6 22.6 24.5 32.6 15.7 20.6 11.0 10.4 74.4 22.6 23.7 37.2 27.6 9.2 14.8 22.0 29.0 16.3 39.5 37.6 37.5 51.9 21.7 25.5 21.7 38.0 25.2 26.0 23.1 51.9 25.2 46.8 21.9 30.5 30.5 31.6 6.2 27.7 33.0 17.8 49.6 44.2 29.3 25.7 39.2 41.9 26.8 18.7 21.4 33.6 19.6 25.2 22.3 10.7 12.6 19.7 24.0 27.5 43.8 39.1 27.3 32.4 76.1 30.2 27.7 27.4 25.1 ZMYND12 DKFZp434N2435 ENSG00000066185 "Zinc finger MYND-type containing 12" Q9H0C1 1 42430329-42456253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.2;testis: 29.0" "Cell type enhanced" "Detected in many" "Early spermatids: 164.2;Late spermatids: 71.4;Respiratory ciliated cells: 40.0;Spermatocytes: 95.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 2.6;SK-MEL-30: 2.2;WM-115: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (4.54e-2)" "unprognostic (1.57e-1)" "unprognostic (2.20e-1)" "unprognostic (6.43e-3)" "unprognostic (2.53e-3)" "unprognostic (8.13e-2)" "unprognostic (4.89e-2)" "unprognostic (2.79e-3)" "unprognostic (7.23e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "unprognostic (1.87e-2)" "prognostic favorable (1.11e-5)" "unprognostic (1.76e-1)" "unprognostic (2.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" 1.0 2.3 4.8 0.2 4.0 0.2 2.2 4.5 5.7 2.1 5.1 1.2 1.0 1.3 9.5 0.3 17.2 1.8 2.3 3.6 5.7 9.4 7.0 1.9 0.4 5.1 4.9 3.5 1.9 3.4 2.3 3.4 0.5 4.9 2.3 1.1 4.1 1.0 2.2 1.8 0.7 0.4 0.9 5.0 0.9 1.6 29.0 4.7 0.6 5.0 2.5 0.3 1.0 0.3 4.6 0.0 0.0 0.2 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.5 2.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.3 4.8 4.0 4.5 5.7 3.6 5.7 5.1 4.9 3.5 4.9 5.0 4.7 4.6 0.4 3.2 2.7 4.6 0.5 0.0 0.8 2.6 0.0 0.9 2.5 1.8 3.7 7.2 4.3 7.3 0.0 1.5 0.3 0.6 15.6 1.0 164.2 26.3 1.0 0.5 0.0 1.3 1.6 0.5 1.3 1.3 4.1 1.8 0.0 1.1 0.4 3.8 2.6 0.0 1.7 1.5 6.1 2.6 0.0 71.4 2.5 3.7 3.6 2.8 0.8 3.5 1.0 1.0 1.6 0.1 0.3 2.2 0.8 0.5 0.9 18.4 40.0 2.8 0.0 1.0 0.5 95.9 5.4 0.8 0.3 0.7 0.4 1.9 0.7 1.1 SLC9A3 NHE3 ENSG00000066230 "Solute carrier family 9 member A3" P48764 5 470456-524449 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 45.8;intestine: 95.1;kidney: 63.1;stomach 1: 50.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7" "Cancer enhanced" "Detected in many" "stomach cancer: 14.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 37.8" "Region enriched" "Detected in single" 14 "cerebellum: 4.1" "Low region specificity" "Detected in many" "HPA036493, HPA036669" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA036493: AB_10673353, HPA036669: AB_10670843" "unprognostic (1.27e-1)" "unprognostic (4.88e-1)" "unprognostic (9.35e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (3.35e-1)" "unprognostic (2.51e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (8.49e-4)" "unprognostic (5.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.69e-2)" "unprognostic (3.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-1)" 2.9 4.4 2.9 10.5 3.1 2.0 3.1 5.5 5.2 3.8 1.4 95.1 46.4 2.9 4.0 8.8 4.9 45.8 3.2 4.9 2.2 63.1 2.4 2.8 3.9 3.4 2.4 3.0 4.3 6.7 6.3 0.7 2.1 3.8 7.3 10.9 1.7 10.0 3.8 6.2 19.1 68.6 3.3 1.6 3.7 50.6 5.9 4.2 3.6 4.9 4.0 3.4 2.5 2.5 3.9 6.7 5.1 10.4 10.5 2.5 3.0 7.8 5.3 3.9 8.0 5.0 11.0 7.4 14.0 7.5 3.0 5.5 10.0 6.1 4.0 3.9 37.8 10.7 6.7 23.4 5.4 3.9 5.5 8.2 4.2 8.1 3.5 5.4 3.9 2.4 6.3 9.6 7.5 2.9 9.0 6.0 24.3 4.0 17.8 8.3 8.6 9.3 8.3 2.8 4.8 11.5 5.0 19.0 5.3 4.2 4.5 12.3 4.2 2.9 8.0 7.2 5.3 3.9 12.4 5.8 8.5 5.2 21.2 5.6 0.0 0.7 0.1 2.6 0.3 2.2 0.9 3.3 2.4 0.9 1.0 3.9 3.1 0.1 2.4 0.2 1.2 2.7 1.8 2.9 3.1 5.5 5.2 4.9 2.2 3.4 2.4 3.0 3.8 1.6 4.2 3.9 3.8 16.0 5.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 7.3 8.9 0.7 0.0 5.6 16.5 0.0 0.0 3.4 0.7 5.9 9.0 0.0 3.8 3.6 2.3 0.0 0.0 0.3 8.8 0.0 2.2 0.0 2.6 2.5 5.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 4.6 0.0 0.0 0.0 0.1 7.7 0.0 0.0 0.7 0.0 1.1 40.7 2.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 2.3 5.4 0.0 0.0 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878701-233013256 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 56.7;brain: 101.2;intestine: 43.1;liver: 35.8;skin 1: 30.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7" "Cancer enhanced" "Detected in many" "testis cancer: 22.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0" HPA008160 Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 1.1 56.7 12.1 2.2 101.2 0.1 1.9 0.0 59.6 3.3 0.0 14.3 43.1 5.1 4.1 10.4 4.9 3.1 1.3 25.5 16.7 7.1 35.8 0.7 0.2 18.9 3.9 23.2 2.1 6.1 12.0 2.8 0.3 38.7 1.8 10.6 1.4 2.1 0.7 0.9 30.5 31.6 6.7 0.0 0.4 10.8 3.8 11.4 0.0 0.9 0.7 0.3 1.8 5.3 35.5 53.9 15.4 0.6 0.2 0.2 8.2 0.9 0.9 0.1 0.4 0.0 0.7 5.2 0.0 15.2 10.9 5.5 6.9 11.6 3.0 0.4 45.3 3.8 0.1 21.6 16.7 0.2 0.0 0.3 0.0 0.2 3.5 0.6 0.2 1.9 0.2 0.2 0.2 0.5 4.0 0.0 0.1 1.3 0.2 57.0 0.0 0.0 0.1 1.0 1.4 1.9 0.4 6.6 3.3 0.1 2.0 32.2 0.4 0.0 0.5 4.5 0.3 1.0 0.5 0.2 0.0 3.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 101.2 0.0 59.6 25.5 16.7 18.9 3.9 23.2 38.7 0.0 11.4 35.5 0.0 0.0 0.0 10.4 0.0 9.9 1.2 1.2 2.8 0.3 2.1 1.4 2.4 4.3 0.5 0.0 0.0 0.1 0.0 38.0 0.0 3.9 0.7 9.1 0.9 0.4 4.9 0.0 105.9 10.5 0.3 0.7 17.3 2.0 0.0 0.3 0.4 20.4 0.1 1.7 12.8 14.6 0.0 0.3 0.6 2.0 0.0 0.3 1.8 6.5 0.0 5.5 0.0 4.5 6.0 12.1 23.5 1.2 0.1 0.5 66.7 9.8 2.5 0.2 0.0 0.2 0.3 1.1 0.8 3.8 7.5 0.0 0.2 0.5 20.2 1.1 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Assembly factor for spindle microtubules" Q8IZT6 1 197084121-197146694 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 10.2;lymphoid tissue: 17.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.2 0.1 0.0 3.0 0.0 10.2 0.4 0.0 0.1 0.2 0.0 1.6 2.1 0.3 0.0 1.5 0.0 0.4 0.1 0.0 0.1 0.0 0.6 0.3 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 1.9 0.0 0.2 0.0 0.0 2.7 1.9 0.7 0.1 0.9 1.1 3.2 0.1 17.1 0.1 0.0 5.2 0.6 0.4 0.3 44.6 22.9 39.1 23.2 1.9 5.5 14.7 35.1 23.2 32.6 25.6 16.7 31.1 45.4 12.5 27.5 13.8 40.2 33.6 12.1 39.1 41.8 25.4 33.1 56.1 12.8 0.4 51.9 20.5 0.6 1.0 26.1 15.2 7.3 31.5 32.9 41.8 50.7 29.0 16.0 40.6 10.3 17.8 24.8 6.4 30.2 55.5 31.7 7.4 11.4 20.4 29.5 50.6 20.6 9.5 20.8 26.9 12.7 28.9 20.9 20.0 34.9 61.2 13.9 21.6 26.8 14.9 11.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.6 0.0 1.1 1.3 5.8 6.1 1.5 4.0 2.2 0.1 2.4 2.4 1.1 0.0 1.3 1.8 0.0 20.0 7.8 7.7 0.0 0.3 3.9 2.9 6.2 4.3 0.0 99.5 2.0 0.0 14.8 9.8 13.3 8.1 1.3 121.1 6.4 2.2 11.6 0.0 4.8 6.8 4.1 6.4 2.4 4.5 0.6 6.4 0.0 0.0 0.9 0.7 4.1 0.0 1.0 0.5 0.2 1.5 44.8 2.0 0.4 0.4 0.8 0.3 0.0 0.6 7.0 43.8 44.7 27.1 3.4 3.7 9.1 5.7 16.9 2.1 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4" "Cell type enhanced" "Detected in many" "granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" NA NA 35000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: AB_2686274" "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 3.4 2.4 1.2 19.6 1.9 8.0 2.7 2.0 4.6 2.9 2.0 3.2 2.4 1.4 0.9 2.2 1.1 6.2 1.4 1.2 4.6 0.8 5.2 7.9 24.4 3.7 2.3 0.4 1.5 2.0 0.9 0.4 7.2 4.6 1.1 4.5 0.2 1.4 3.4 0.5 1.3 4.6 4.0 4.4 15.3 3.6 1.9 3.0 9.9 1.1 0.7 13.3 4.8 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 45.3 0.1 0.0 0.0 13.1 49.7 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.1 0.0 0.0 12.9 9.7 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.8 0.0 2.9 0.0 32.7 9.6 15.0 8.2 8.0 6.5 6.3 7.0 10.1 7.1 6.0 4.0 7.4 1.2 1.4 3.2 4.1 10.5 8.8 1.2 1.9 2.0 4.6 1.2 4.6 3.7 2.3 0.4 4.6 4.4 3.0 5.1 1.3 0.0 6.4 0.0 27.4 2.4 0.7 0.0 0.6 0.2 0.6 1.5 1.2 2.8 1.3 0.0 0.0 0.5 20.5 0.2 0.0 0.1 0.9 0.5 0.2 4.2 0.0 21.5 0.1 0.2 0.5 1.2 2.6 0.2 187.1 0.1 3.3 1.1 91.1 0.0 0.2 0.1 0.0 177.0 42.2 1.5 0.6 90.6 5.4 34.7 76.4 0.0 4.1 0.0 0.1 0.0 0.0 0.0 10.8 0.9 0.3 0.3 0.7 0.2 0.0 1.6 1.5 0.1 0.4 0.5 2.4 1.0 46.8 2.9 0.2 0.6 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363398-43368074 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 74.9 55.1 89.4 40.1 122.3 53.3 67.2 130.0 110.3 48.0 77.4 59.5 52.1 46.9 30.8 178.0 39.2 42.8 43.5 88.6 110.9 60.1 46.2 60.1 40.4 151.7 123.9 80.1 29.2 55.9 46.6 27.4 51.4 144.4 59.2 49.1 8.4 73.2 49.3 24.3 192.3 55.9 51.3 136.6 57.5 71.2 18.7 122.2 22.4 67.3 28.3 56.1 69.1 87.5 177.6 108.0 119.5 22.6 44.8 148.4 138.2 70.2 125.2 154.5 153.5 122.4 105.9 182.5 73.9 94.3 193.6 130.3 119.4 79.7 152.2 93.2 94.6 53.9 96.6 77.3 77.1 128.2 84.2 98.0 106.2 168.2 180.9 198.4 114.8 155.0 27.7 68.1 54.8 178.5 79.5 19.9 69.5 33.5 136.9 120.2 43.6 59.9 89.7 195.5 128.7 27.4 28.8 73.7 258.4 105.8 66.8 121.2 82.4 132.2 129.7 82.5 161.2 161.3 26.6 31.2 35.4 127.8 85.2 120.1 134.9 189.6 172.7 105.1 180.0 93.4 109.0 98.4 103.2 212.8 94.2 63.5 88.0 133.0 114.7 179.6 148.8 113.8 203.1 89.4 122.3 130.0 110.3 88.6 110.9 151.7 123.9 80.1 144.4 136.6 122.2 177.6 44.0 19.2 12.5 7.5 28.1 15.6 25.9 61.1 29.6 5.7 60.3 37.5 4.7 34.3 40.2 40.5 10.4 93.4 36.0 114.0 7.9 91.5 3.4 22.9 26.3 43.6 19.2 67.8 3.8 100.1 127.4 26.1 48.4 45.2 21.0 52.6 24.7 16.7 74.9 3.3 3.4 33.8 46.8 46.3 37.5 4.6 20.2 41.5 12.4 7.5 92.5 13.7 32.0 3.0 66.1 133.3 63.9 25.6 19.0 44.7 66.0 23.3 14.5 9.5 19.7 10.0 39.7 8.4 11.2 70.1 31.0 95.9 31.5 50.8 47.2 49.2 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378547 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "bone marrow: 338.2;lung: 101.8;lymphoid tissue: 174.1" "Group enriched" "Detected in many" 6 "Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 179.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 179.7" "Cell line enhanced" "Detected in some" "HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB004079: AB_10692379, HPA044653: AB_2679036" "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 34.6 19.9 12.0 108.3 15.0 338.2 17.9 14.0 19.6 7.2 20.1 14.5 21.7 7.3 2.1 9.2 19.3 21.5 12.7 10.4 25.1 10.6 15.7 101.8 65.5 22.1 14.4 5.7 5.2 7.8 3.1 7.6 28.3 20.0 10.4 10.3 1.0 14.8 6.2 5.0 13.9 29.5 22.1 24.4 174.1 17.2 3.7 23.0 15.9 8.9 8.3 32.2 30.1 7.7 33.1 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.1 0.0 0.0 72.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 90.1 0.0 0.0 0.0 159.7 282.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.7 0.0 0.0 0.2 267.8 0.2 0.0 0.0 48.7 0.2 47.5 0.0 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.0 206.7 0.3 0.0 0.5 0.5 0.1 0.1 0.3 85.3 0.3 117.5 0.1 14.1 19.2 179.7 0.0 27.4 0.0 3.9 0.0 0.0 16.4 2.4 0.0 0.0 83.8 0.0 34.7 0.9 0.0 7.3 12.0 15.0 14.0 19.6 10.4 25.1 22.1 14.4 5.7 20.0 24.4 23.0 33.1 2.1 3.2 1.1 10.4 72.6 10.5 0.5 0.0 1.2 1.3 2.1 5.0 2.9 4.3 0.6 5.5 0.0 2.3 6.3 0.5 19.6 0.1 7.5 0.1 0.3 5.5 4.2 39.7 3.1 0.4 3.1 2.6 1.1 0.3 33.7 0.2 7.9 3.2 432.9 0.0 3.3 0.3 0.0 411.9 537.6 27.5 1.8 453.3 10.6 36.5 357.5 7.0 8.2 3.5 1.5 0.0 0.1 0.0 21.8 0.4 0.2 2.3 0.7 1.7 13.1 1.5 1.4 5.1 9.3 0.8 9.9 4.2 4.8 1.1 0.4 0.5 POLR1H "A12.2, HTEX-6, hZR14, RPA12, tctex-6, ZNRD1" ENSG00000066379 "RNA polymerase I subunit H" Q9P1U0 6 30058899-30064909 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 14.6;B-cells: 17.6;Cardiomyocytes: 15.2;Cytotrophoblasts: 28.2;dendritic cells: 20.5;Extravillous trophoblasts: 43.0;Hofbauer cells: 35.3;Syncytiotrophoblasts: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055074, HPA077979" Supported Supported "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA055074: AB_2682690, HPA077979: AB_2732366" "unprognostic (4.94e-2)" "unprognostic (2.93e-2)" "unprognostic (2.54e-1)" "unprognostic (3.81e-1)" "unprognostic (3.88e-2)" "unprognostic (8.55e-2)" "unprognostic (5.36e-2)" "unprognostic (2.82e-3)" "unprognostic (1.96e-1)" "unprognostic (9.52e-3)" "unprognostic (5.18e-1)" "unprognostic (3.28e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (2.57e-1)" "unprognostic (1.51e-1)" "unprognostic (9.97e-2)" "prognostic favorable (2.75e-5)" 22.8 26.4 6.1 4.4 6.2 2.6 22.6 5.9 8.2 23.9 6.6 20.8 16.9 22.9 4.7 29.6 21.9 1.1 22.8 6.3 6.8 25.7 24.6 19.8 3.0 6.6 6.4 5.9 25.6 30.2 2.5 18.1 5.9 6.8 21.3 14.3 4.3 17.0 2.7 25.6 23.1 24.9 4.0 6.4 33.4 26.5 30.8 6.5 13.2 17.6 7.8 3.3 23.2 22.3 6.8 17.9 5.4 20.5 40.9 5.7 5.9 6.9 7.2 19.4 19.9 18.7 23.0 9.3 16.2 7.3 8.1 10.4 10.8 37.4 27.7 25.4 2.0 43.1 24.6 13.7 31.0 36.4 33.8 8.1 22.5 13.1 20.4 49.0 6.4 32.3 25.1 60.8 8.3 15.5 29.9 22.9 67.5 0.0 29.9 28.1 18.1 26.5 30.2 11.5 23.7 12.5 20.0 10.0 19.5 10.4 9.8 19.1 30.4 7.3 19.5 8.0 0.0 23.1 9.7 10.7 20.4 3.4 33.1 25.4 22.1 5.3 4.4 6.5 3.9 6.7 4.9 6.0 6.1 6.3 4.3 6.6 5.1 4.0 5.1 3.9 4.9 7.8 4.0 6.1 6.2 5.9 8.2 6.3 6.8 6.6 6.4 5.9 6.8 6.4 6.5 6.8 14.6 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 28.2 20.5 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 43.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 17.6 4.4 0.0 0.0 0.0 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.7;thyroid gland: 24.8" "Cell type enhanced" "Detected in many" "Astrocytes: 155.7;Cone photoreceptor cells: 285.7;Excitatory neurons: 108.1;Horizontal cells: 82.4;Oligodendrocyte precursor cells: 345.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 21.6;HAP1: 12.2;JURKAT: 10.9;RT4: 9.0;SH-SY5Y: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.0 5.2 6.9 0.5 12.8 0.3 4.2 4.3 10.3 24.7 0.7 3.5 0.7 6.4 5.6 0.9 9.0 1.0 3.3 11.8 12.9 9.7 0.4 0.4 0.2 16.4 8.8 7.5 0.5 1.6 3.2 11.1 1.6 11.8 12.7 0.6 16.2 10.4 7.5 5.2 0.7 1.0 3.6 3.6 2.3 1.7 1.7 8.8 3.6 24.8 1.5 0.3 3.3 5.1 9.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 12.2 0.0 0.0 0.0 2.6 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.9 0.0 0.3 3.5 0.1 0.1 0.0 3.4 0.2 0.0 9.0 0.1 6.5 0.0 0.0 3.6 1.3 1.8 0.0 0.1 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.2 0.1 0.4 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.1 6.9 12.8 4.3 10.3 11.8 12.9 16.4 8.8 7.5 11.8 3.6 8.8 9.3 3.1 0.0 2.2 155.7 1.8 1.0 51.7 2.6 2.8 26.7 3.6 5.2 5.2 0.0 1.0 46.0 285.7 0.3 0.5 0.1 25.4 4.2 2.1 35.6 1.5 6.3 0.0 1.3 108.1 0.0 0.2 2.6 0.0 13.8 5.1 12.1 0.7 0.2 4.1 82.4 56.0 0.3 2.0 22.5 3.6 1.6 0.3 2.7 5.4 13.1 0.5 44.0 0.0 345.8 7.9 0.1 0.1 3.4 0.5 19.3 0.0 3.1 3.0 18.5 0.0 1.2 7.1 0.1 2.1 1.5 1.1 0.5 0.8 0.4 0.0 28.4 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "lung: 254.4;stomach 1: 731.4" "Group enriched" "Detected in some" 53 "Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.6;stomach cancer: 186.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "OE19: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.3 0.3 1.0 0.4 0.6 0.1 0.2 1.0 0.4 0.3 1.9 0.5 1.6 0.2 0.5 0.6 0.5 3.4 9.8 0.3 0.5 0.2 0.1 254.4 0.0 0.7 0.7 0.1 0.5 0.8 0.0 0.5 0.3 0.6 0.2 0.2 0.7 0.3 0.4 0.1 1.1 0.9 0.1 1.1 0.5 731.4 1.3 0.4 0.1 0.1 0.0 0.7 0.2 0.3 0.3 0.1 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.5 15.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 1.0 0.4 0.3 0.5 0.7 0.7 0.1 0.6 1.1 0.4 0.3 0.0 1602.5 431.2 1.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 17.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.3 0.2 0.6 0.0 0.0 0.5 11.4 0.0 1.4 1153.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.7 0.0 2.0 0.0 1.9 0.0 0.1 0.0 0.0 0.2 442.5 0.0 0.0 1.3 0.0 0.0 0.1 0.7 1.3 0.0 0.9 0.1 15.3 11.9 0.0 0.0 0.0 1.3 0.0 0.0 0.1 ZBTB11 "ZNF-U69274, ZNF913" ENSG00000066422 "Zinc finger and BTB domain containing 11" O95625 3 101648889-101677132 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015328, HPA024138" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015328: AB_1858938, HPA024138: AB_1858939" "unprognostic (3.25e-3)" "unprognostic (9.62e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.86e-2)" "unprognostic (7.04e-2)" "unprognostic (1.17e-3)" "unprognostic (4.77e-1)" "unprognostic (6.65e-3)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-2)" "unprognostic (5.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-2)" "unprognostic (2.09e-1)" 7.4 7.3 6.6 10.7 7.8 38.3 10.1 12.9 11.4 8.3 7.0 6.8 8.4 9.9 7.3 7.7 6.9 7.4 5.6 7.5 7.0 7.3 9.7 8.3 13.6 7.0 7.2 6.8 10.5 9.7 9.9 5.5 9.2 6.9 8.2 7.7 12.5 9.3 6.8 9.2 12.5 7.2 7.2 7.6 13.2 7.9 10.6 7.3 13.9 8.5 10.1 12.8 8.7 6.9 11.0 14.8 16.5 10.7 14.0 16.7 16.3 18.7 14.4 14.2 13.0 14.3 15.0 10.0 18.1 11.4 11.0 11.6 18.0 16.3 16.4 23.3 18.8 11.3 40.1 15.8 14.1 12.8 28.8 14.2 13.1 20.8 12.1 27.8 11.6 13.0 20.6 23.7 21.2 14.1 18.4 25.5 12.8 10.1 15.7 24.0 20.6 16.7 22.1 12.2 17.4 31.0 11.4 18.7 15.0 19.1 6.5 19.1 15.3 14.7 19.6 14.2 8.2 14.5 24.2 21.7 33.4 12.2 18.6 13.9 6.7 3.7 4.2 3.6 4.6 4.7 2.9 3.1 4.0 4.6 3.8 3.5 3.0 2.4 3.0 7.3 2.7 3.8 2.8 6.6 7.8 12.9 11.4 7.5 7.0 7.0 7.2 6.8 6.9 7.6 7.3 11.0 19.0 32.1 20.8 12.7 28.2 46.4 20.0 8.4 51.8 14.2 21.4 17.4 12.1 10.0 19.3 1.8 33.3 10.2 40.3 14.0 0.0 6.6 3.2 44.7 50.4 20.1 20.2 12.4 32.7 5.5 7.5 19.4 15.8 70.2 8.8 13.7 13.2 10.3 7.9 21.9 28.2 14.5 14.2 23.0 24.4 3.9 8.4 25.9 19.6 12.2 20.3 12.0 21.6 15.1 27.6 7.6 4.4 14.3 32.6 18.3 8.2 6.2 20.1 22.8 6.6 25.0 19.1 25.5 21.8 50.0 49.0 16.8 34.1 14.3 14.2 24.1 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106621 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 9.0 5.9 3.9 5.8 4.2 10.0 6.9 5.0 5.0 6.9 3.7 7.3 3.8 6.4 4.4 10.4 6.1 6.6 5.2 3.8 5.1 5.7 9.7 6.9 7.8 6.2 5.6 3.3 7.2 4.6 6.5 4.0 7.0 6.4 6.0 6.8 3.9 5.8 5.6 3.3 13.0 4.9 8.7 4.4 5.6 5.2 9.4 4.6 8.1 5.9 5.9 9.8 9.1 8.1 5.7 8.6 16.7 14.6 13.6 20.9 20.1 28.4 9.7 15.4 11.9 16.5 12.3 23.2 17.6 18.5 15.8 14.1 14.6 11.6 21.0 26.3 20.0 3.5 7.4 8.0 18.2 17.3 13.5 12.6 16.5 18.1 20.9 21.8 15.9 18.7 19.4 10.1 12.5 18.2 33.1 14.0 11.9 10.4 28.5 13.6 11.0 27.0 9.9 15.3 19.4 5.3 8.8 23.1 9.5 13.3 19.6 18.1 9.1 10.0 11.7 17.0 7.5 5.2 10.8 19.8 16.2 8.3 12.9 6.9 13.5 14.3 10.8 6.1 16.5 7.4 7.7 7.0 6.9 16.2 10.6 7.8 8.8 12.2 8.7 23.0 9.3 8.1 6.3 3.9 4.2 5.0 5.0 3.8 5.1 6.2 5.6 3.3 6.4 4.4 4.6 5.7 55.0 16.0 12.4 33.6 27.6 25.4 28.6 29.8 19.4 35.4 16.9 18.4 19.3 15.7 20.0 42.3 50.1 20.3 31.5 13.8 15.6 25.8 19.8 20.3 34.9 53.0 16.1 30.3 36.1 17.3 29.8 34.6 18.3 22.5 24.6 25.9 49.6 21.1 22.4 26.9 28.6 16.4 12.2 35.1 27.2 26.8 67.7 30.0 23.2 28.1 48.0 20.4 29.9 39.2 51.5 19.6 16.1 65.1 20.1 31.9 16.6 17.7 16.0 46.7 46.0 51.9 38.2 39.1 57.2 21.6 30.3 25.3 28.8 24.8 18.9 28.2 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794305-92839947 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 23.9 23.4 23.0 18.3 25.2 10.5 33.4 23.8 26.2 32.5 25.3 26.6 23.5 22.1 54.7 25.2 19.3 24.3 21.7 22.6 24.2 25.8 54.7 22.6 19.0 24.2 24.1 21.6 20.8 32.5 33.9 23.7 28.4 24.7 31.5 32.8 15.9 32.7 26.0 27.1 22.7 23.1 26.3 24.7 19.2 33.2 34.6 23.9 17.1 33.5 20.1 23.4 24.3 19.7 27.6 32.4 29.4 25.9 23.7 53.1 71.4 44.3 43.9 80.4 41.9 49.2 21.8 43.4 21.0 35.1 70.2 29.2 33.4 23.1 35.9 56.6 25.8 11.2 19.9 14.0 29.3 61.5 23.3 31.8 55.1 63.7 29.5 60.6 46.2 42.0 21.8 17.7 27.3 46.5 60.1 18.1 19.6 16.1 70.2 31.0 13.9 37.9 21.1 42.8 38.9 18.4 26.0 40.0 29.6 45.7 35.7 51.0 25.6 35.0 23.9 15.6 31.3 22.2 33.3 27.6 18.2 54.9 18.2 40.8 10.4 10.0 23.6 10.3 13.0 11.8 9.5 10.4 10.6 9.9 9.5 9.2 8.1 8.8 8.7 11.9 9.1 12.9 6.7 23.0 25.2 23.8 26.2 22.6 24.2 24.2 24.1 21.6 24.7 24.7 23.9 27.6 18.7 28.9 26.3 8.8 15.7 7.8 11.2 17.9 16.5 7.5 16.2 11.9 26.8 8.6 19.6 14.7 12.5 23.7 17.2 23.8 29.4 25.3 31.6 17.6 24.6 16.7 22.3 15.8 17.6 32.7 32.0 21.7 33.1 25.7 9.5 29.7 13.9 33.5 15.4 25.2 15.6 31.6 4.1 14.7 10.3 18.5 23.0 14.6 12.4 15.0 18.2 15.6 16.5 14.6 21.9 28.9 12.0 25.2 29.2 19.4 19.9 24.2 18.7 10.7 26.3 18.0 19.3 34.1 37.0 16.5 11.4 50.3 15.9 15.6 16.5 16.5 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478332-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 302.9;choroid plexus: 202.1" "Group enriched" "Detected in many" 5 "Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 24 "basophil: 13.2;eosinophil: 3.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 13.2" "Cell line enhanced" "Detected in many" "AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 1200000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 3.8 21.5 142.4 8.3 204.7 0.3 23.1 204.2 179.0 19.3 202.1 36.9 10.4 55.1 15.4 25.4 29.8 31.6 3.1 136.0 152.3 26.6 41.4 31.2 2.9 260.1 216.9 117.2 18.1 31.3 61.4 6.9 15.8 225.9 27.7 21.4 1.3 59.6 55.1 0.5 110.2 12.3 43.9 227.3 0.9 22.7 7.6 175.6 10.1 55.1 0.2 9.2 16.7 27.7 302.9 7.2 0.4 30.2 189.0 0.1 0.0 60.9 0.4 0.0 0.0 0.0 49.6 1.1 0.1 12.5 2.8 0.1 55.6 63.7 13.0 0.0 0.1 12.7 0.0 0.2 1.2 1.5 0.2 11.7 0.1 26.2 0.0 0.6 0.0 0.0 0.3 0.2 0.2 0.0 11.7 0.2 0.1 57.8 8.7 0.0 0.1 0.0 7.5 18.0 15.8 0.5 0.5 0.4 33.4 0.0 36.6 49.3 0.0 0.1 0.3 8.5 0.2 0.7 0.1 0.1 0.0 0.3 0.0 0.5 13.2 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 142.4 204.7 204.2 179.0 136.0 152.3 260.1 216.9 117.2 225.9 227.3 175.6 302.9 1.4 19.2 36.0 228.2 0.6 40.1 34.3 18.4 58.6 0.2 8.7 25.4 9.1 213.1 38.4 36.8 0.0 16.5 0.3 7.3 0.0 7.4 4.1 28.1 4.4 1.0 2.4 2.7 14.8 0.2 3.0 9.0 13.3 53.1 0.0 0.1 1.8 5.0 2.3 0.0 31.2 40.8 10.2 0.6 4.4 9.6 1.2 1.1 5.4 10.3 0.6 2.0 1.0 6.0 562.5 0.7 3.0 6.0 0.1 15.0 1.8 13.6 15.3 0.2 0.0 1.6 2.6 0.7 9.9 18.7 27.7 4.0 1.5 0.4 3.8 31.4 LRRC40 FLJ20331 ENSG00000066557 "Leucine rich repeat containing 40" Q9H9A6 1 70144805-70205579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026564 Approved Approved Nucleoli NA NA Nucleoli "HPA026564: AB_2250054" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.54e-4)" "unprognostic (6.42e-2)" "unprognostic (6.65e-3)" "unprognostic (3.94e-2)" "unprognostic (7.69e-3)" "unprognostic (9.90e-2)" "unprognostic (3.40e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-2)" "unprognostic (2.50e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-3)" "unprognostic (1.95e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 9.8 8.5 6.3 9.1 7.8 16.5 11.1 9.5 8.5 7.7 3.9 9.1 14.8 10.4 6.6 9.6 5.5 8.5 11.8 7.8 7.7 14.3 23.8 8.3 13.3 5.8 6.4 7.1 8.4 7.2 6.9 3.5 12.1 6.4 8.7 9.8 10.0 5.7 7.0 7.5 7.7 13.6 11.3 6.0 9.4 6.9 12.0 6.5 14.2 8.3 10.1 12.7 9.9 5.2 7.9 26.4 10.9 42.1 33.3 15.1 16.6 25.4 25.0 18.2 37.0 45.4 16.0 14.5 35.4 21.4 19.6 36.6 19.0 100.0 22.3 50.2 28.5 20.0 26.8 18.6 25.9 19.0 35.4 6.2 13.8 12.7 24.7 24.6 17.1 21.7 22.2 33.6 16.7 31.7 6.8 42.8 27.4 55.5 17.3 22.5 33.8 43.5 22.9 34.1 16.0 21.5 21.7 30.2 29.9 28.6 29.6 14.3 19.8 27.2 26.0 20.8 39.7 28.7 14.0 14.4 57.2 21.0 36.6 27.3 5.4 4.6 5.5 5.5 6.0 7.3 7.2 5.8 5.3 6.0 6.7 6.8 5.8 0.7 7.6 5.8 4.6 7.8 4.5 6.3 7.8 9.5 8.5 7.8 7.7 5.8 6.4 7.1 6.4 6.0 6.5 7.9 13.9 12.8 12.6 22.2 15.1 12.9 7.8 10.5 17.1 16.4 6.9 6.0 10.4 8.6 9.2 14.7 6.2 16.9 23.2 6.9 11.7 12.7 1.3 6.0 12.1 11.3 23.3 17.2 41.1 8.9 13.3 12.7 5.1 10.8 15.2 11.3 13.2 21.4 11.9 15.2 40.1 6.5 20.3 11.7 12.1 3.0 10.2 9.4 5.4 15.9 13.4 7.6 8.2 22.6 30.9 9.2 4.1 10.1 11.7 5.1 13.2 24.1 6.4 12.5 19.7 12.9 12.9 25.1 28.3 11.7 11.1 7.3 15.8 10.4 8.1 5.0 ISOC1 CGI-111 ENSG00000066583 "Isochorismatase domain containing 1" Q96CN7 5 129094749-129114028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070307 Approved "Endoplasmic reticulum,Vesicles" NA NA 1900000 "Endoplasmic reticulum, Vesicles" "HPA070307: AB_2686249" "unprognostic (1.67e-1)" "unprognostic (4.46e-2)" "unprognostic (1.29e-1)" "unprognostic (6.42e-3)" "unprognostic (3.87e-2)" "unprognostic (1.91e-1)" "unprognostic (6.32e-2)" "unprognostic (1.90e-1)" "unprognostic (2.47e-1)" "unprognostic (4.19e-2)" "unprognostic (2.00e-2)" "unprognostic (4.18e-1)" "unprognostic (7.09e-3)" "unprognostic (2.49e-1)" "unprognostic (2.65e-1)" "unprognostic (1.65e-2)" "unprognostic (1.32e-2)" 28.0 28.3 12.8 12.9 12.8 12.7 25.8 12.6 13.9 57.7 11.4 19.8 32.4 103.6 21.2 22.3 27.4 15.8 66.3 11.5 15.4 33.9 101.0 14.1 14.7 16.0 15.4 11.0 17.2 20.0 15.8 20.6 15.4 16.1 19.9 22.0 14.9 28.7 9.0 17.3 23.7 28.5 65.4 14.5 10.1 20.6 11.2 16.0 19.1 13.4 16.5 16.9 21.5 19.4 16.1 27.7 21.4 21.7 33.5 35.0 18.5 95.7 11.7 10.0 13.1 23.1 75.5 38.2 19.6 28.3 6.9 40.0 14.7 46.5 35.2 24.2 107.5 52.8 39.0 20.9 55.7 24.7 15.6 13.6 12.2 10.5 20.5 17.7 9.4 31.6 30.6 43.0 33.2 11.6 110.2 29.2 25.3 33.5 26.4 57.8 41.5 63.2 19.3 32.9 55.4 36.6 156.9 33.7 42.3 21.6 19.7 34.9 13.0 13.4 14.8 28.1 11.9 38.3 27.5 22.9 32.7 16.5 48.4 17.0 64.0 25.2 38.0 54.0 25.0 61.4 47.7 50.3 57.7 31.5 49.4 43.9 51.8 30.9 61.4 25.3 29.0 69.0 48.9 12.8 12.8 12.6 13.9 11.5 15.4 16.0 15.4 11.0 16.1 14.5 16.0 16.1 58.1 12.8 17.2 6.5 18.9 131.8 42.4 28.5 88.2 12.4 33.6 19.8 70.6 34.3 19.3 20.2 10.4 74.7 26.3 19.9 125.2 22.2 1.6 23.5 30.1 16.9 31.8 21.0 1.7 28.1 71.8 33.9 17.3 24.9 18.4 51.0 5.3 84.7 23.9 0.0 5.6 26.6 30.5 8.8 41.0 4.2 13.7 14.3 28.4 4.7 18.9 52.9 18.6 6.0 9.2 16.3 29.8 19.2 36.9 38.5 45.7 96.2 10.6 6.5 0.0 33.7 15.9 6.5 38.1 53.7 84.1 50.9 26.4 79.3 32.8 37.8 EML1 "ELP79, EMAP, EMAPL, HuEMAP" ENSG00000066629 "EMAP like 1" O00423 14 99737693-99942060 "Disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033137, HPA049105" Uncertain NA NA "CAB033137: AB_2098052, HPA049105: AB_2680633" "unprognostic (9.86e-3)" "unprognostic (2.54e-1)" "unprognostic (8.18e-2)" "unprognostic (2.77e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (2.68e-2)" "unprognostic (8.09e-3)" "unprognostic (7.83e-2)" "unprognostic (3.06e-3)" "unprognostic (1.89e-2)" "unprognostic (9.98e-2)" "unprognostic (4.09e-3)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.81e-3)" "unprognostic (7.03e-3)" 13.5 6.5 8.2 9.2 21.3 0.3 9.8 7.6 11.4 13.4 13.4 26.0 6.9 16.2 10.9 24.3 15.3 18.8 17.4 8.8 9.2 8.7 5.6 13.3 3.3 11.3 9.4 7.6 3.8 8.7 28.6 9.3 27.5 13.6 9.7 15.0 50.5 5.0 17.1 48.0 8.8 10.2 31.2 8.5 4.0 15.1 8.1 12.4 1.3 15.0 34.7 4.5 17.2 10.4 23.3 0.0 44.9 36.8 12.9 20.1 39.5 0.3 35.9 67.3 25.2 8.4 5.1 0.9 0.0 22.2 22.6 30.3 0.2 26.7 3.1 11.5 89.5 13.6 0.0 7.9 0.8 4.8 0.1 0.9 11.6 4.9 31.0 11.7 16.0 44.5 0.7 0.1 0.0 10.4 21.3 0.1 0.1 14.5 0.1 17.2 5.4 13.5 0.2 56.2 0.6 14.1 20.9 11.8 1.8 0.0 24.1 13.7 1.2 42.3 22.8 4.1 104.3 14.9 0.5 0.0 0.3 57.3 0.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 21.3 7.6 11.4 8.8 9.2 11.3 9.4 7.6 13.6 8.5 12.4 23.3 22.8 16.0 7.0 17.3 0.3 2.8 1.2 0.4 1.2 9.2 1.0 1.3 15.0 1.5 4.5 3.7 158.4 2.7 0.1 0.1 0.0 4.6 29.1 15.9 14.2 30.1 0.0 0.0 57.5 4.9 0.6 20.6 4.1 4.7 0.0 1.6 40.0 1.3 1.3 1.7 29.9 0.6 0.0 2.5 4.7 61.3 7.2 1.9 7.2 69.3 0.6 8.8 1.0 17.6 61.8 0.8 0.0 6.0 1.2 1.4 0.0 2.5 11.8 113.6 0.0 20.8 8.7 4.8 11.3 0.4 4.0 2.9 0.7 1.2 0.0 0.7 TRMT11 "C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1" ENSG00000066651 "TRNA methyltransferase 11 homolog" Q7Z4G4 6 125986479-126203817 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030473 Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA030473: AB_2673493" "unprognostic (2.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.13e-2)" "unprognostic (7.62e-2)" "unprognostic (9.69e-2)" "unprognostic (2.12e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-2)" "unprognostic (5.73e-2)" "unprognostic (7.35e-2)" "unprognostic (1.06e-2)" "unprognostic (4.74e-3)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (2.06e-1)" 7.8 10.3 7.2 8.1 8.0 2.9 11.8 13.5 10.4 9.4 6.6 8.3 12.9 13.7 10.0 8.1 9.8 9.1 11.0 7.5 7.8 13.4 20.0 8.0 10.6 7.3 8.4 7.4 12.7 6.5 12.7 13.4 9.5 8.4 9.1 9.4 17.0 8.8 8.6 7.6 6.6 10.8 10.8 6.6 6.8 8.9 7.8 7.3 8.8 13.0 8.8 10.5 9.7 8.9 9.5 17.4 11.0 24.2 11.4 12.9 13.7 16.6 13.1 21.7 15.6 24.3 30.8 19.8 26.0 24.2 8.3 29.1 20.7 26.1 14.3 26.4 19.5 37.6 17.8 20.1 46.2 21.9 29.0 5.4 14.3 15.5 15.9 25.6 22.4 7.6 9.1 44.5 5.3 17.7 22.0 15.3 34.6 20.4 15.4 15.1 9.1 16.3 17.6 22.3 9.8 32.4 16.9 13.9 18.0 36.3 18.0 13.1 28.3 5.4 9.7 10.7 27.3 25.8 13.9 1.3 6.6 23.2 24.5 17.7 1.0 1.6 0.0 5.6 1.3 11.0 7.0 7.9 6.5 3.5 6.0 9.5 8.6 0.5 7.7 0.7 4.3 6.0 3.2 7.2 8.0 13.5 10.4 7.5 7.8 7.3 8.4 7.4 8.4 6.6 7.3 9.5 11.0 6.4 22.0 24.8 17.4 13.4 27.8 29.4 23.3 59.5 11.2 13.7 12.2 21.5 26.1 7.3 73.0 18.7 14.9 8.5 19.6 19.2 10.1 13.1 25.5 10.4 9.1 8.4 56.1 16.3 13.7 27.3 27.0 12.3 18.4 20.0 6.8 22.5 7.2 20.2 63.8 11.1 18.3 6.0 3.7 4.7 25.7 7.1 3.6 23.4 11.8 21.1 9.2 31.7 48.5 13.2 15.5 24.5 12.3 22.6 22.6 30.2 24.3 74.7 6.6 21.0 17.2 15.6 9.2 14.3 10.1 14.9 14.7 27.2 13.7 17.9 THUMPD1 "FLJ20274, Tan1" ENSG00000066654 "THUMP domain containing 1" Q9NXG2 16 20702816-20742084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027851 Approved Approved Cytosol NA NA 9300000 Cytosol "HPA027851: AB_10670036" "unprognostic (1.67e-1)" "unprognostic (1.62e-1)" "prognostic favorable (2.99e-4)" "unprognostic (1.48e-1)" "unprognostic (3.69e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "unprognostic (4.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.45e-1)" "prognostic favorable (8.52e-8)" "unprognostic (1.98e-1)" "unprognostic (5.95e-2)" "unprognostic (1.09e-1)" "unprognostic (1.25e-2)" 16.1 16.5 12.0 14.6 12.7 21.4 38.7 13.7 14.2 23.2 13.6 20.8 13.4 25.5 28.5 15.4 22.0 15.8 11.2 12.3 13.1 23.0 17.1 16.7 21.2 11.9 12.1 11.7 23.7 19.0 30.7 13.9 17.7 12.0 33.7 18.7 20.7 19.8 23.0 17.2 15.8 17.8 24.7 12.1 18.4 23.5 16.5 13.3 20.9 20.3 20.4 20.9 20.1 19.4 13.0 22.4 22.8 41.9 23.7 35.7 31.3 25.2 22.0 22.8 20.7 20.4 17.6 23.2 53.9 42.0 25.0 19.5 21.3 27.7 29.6 32.5 32.0 16.0 49.0 20.5 43.3 23.6 79.2 100.2 25.5 40.0 22.5 25.3 23.8 24.1 24.0 95.7 41.5 23.9 25.3 38.7 32.3 35.3 20.5 14.2 51.6 38.0 43.8 24.4 17.9 31.8 21.7 18.2 32.1 23.4 25.5 22.4 28.4 23.1 28.9 17.1 19.8 21.9 42.6 43.2 38.5 21.9 22.7 24.6 13.3 6.4 19.3 15.3 7.4 19.5 10.7 15.6 15.0 6.4 9.7 19.7 17.7 2.9 14.3 8.3 5.5 12.4 9.4 12.0 12.7 13.7 14.2 12.3 13.1 11.9 12.1 11.7 12.0 12.1 13.3 13.0 55.6 41.7 48.5 16.3 66.6 48.4 37.5 27.1 57.5 37.0 62.7 48.8 30.3 42.9 38.2 31.3 20.9 61.0 81.6 35.6 39.2 29.8 5.9 66.2 64.3 47.9 36.5 23.5 25.6 34.4 35.3 45.5 26.5 97.0 72.1 42.7 42.1 45.2 30.0 35.3 24.7 38.3 26.4 34.8 35.2 8.9 41.0 34.3 33.8 20.6 45.5 45.1 55.6 21.1 32.6 27.5 33.8 67.7 41.3 52.0 32.2 49.7 39.8 37.0 46.0 50.9 50.7 44.1 66.3 46.6 55.4 73.1 72.5 25.5 44.9 35.6 MSANTD3 "C9orf30, MGC17337" ENSG00000066697 "Myb/SANT DNA binding domain containing 3" Q96H12 9 100427143-100451734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062662 Approved Nucleoplasm NA NA Nucleoplasm "HPA062662: AB_2684826" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (5.51e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.66e-5)" "prognostic unfavorable (3.23e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.51e-1)" "unprognostic (2.61e-3)" "unprognostic (5.52e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (2.28e-1)" "unprognostic (2.16e-2)" 12.0 11.4 10.0 13.8 8.8 13.3 10.1 11.1 14.9 12.1 4.9 12.1 6.9 14.4 8.4 10.1 8.3 14.2 17.8 9.9 9.0 12.0 13.9 15.3 7.5 9.8 10.8 8.0 8.9 11.4 11.5 10.1 10.6 11.1 10.9 6.7 8.5 9.9 9.3 22.6 8.1 8.3 14.4 7.5 6.4 11.1 5.9 9.5 9.1 13.0 27.8 8.3 16.4 10.6 14.9 54.0 47.3 30.2 34.2 44.3 50.8 38.7 74.8 72.6 66.6 47.1 28.6 48.5 31.4 37.4 65.6 154.1 60.0 19.8 68.6 73.6 47.6 15.3 14.6 34.8 22.3 46.7 21.8 18.4 22.8 28.6 58.5 108.5 60.9 75.9 25.4 26.0 11.6 92.3 35.2 29.5 14.3 49.4 53.7 74.7 34.4 85.4 9.7 63.3 14.0 39.6 46.2 25.4 22.4 63.9 36.6 10.0 24.6 91.3 93.7 115.7 71.6 116.1 17.0 34.2 14.7 130.7 13.6 72.9 8.0 0.4 2.3 2.6 0.2 3.8 2.6 2.3 3.2 1.0 2.7 2.8 2.4 0.3 3.6 0.1 0.6 2.0 1.7 10.0 8.8 11.1 14.9 9.9 9.0 9.8 10.8 8.0 11.1 7.5 9.5 14.9 17.3 16.0 4.2 0.7 4.6 5.9 9.6 9.3 22.2 16.5 7.5 9.1 17.6 8.6 6.7 7.3 2.1 33.3 7.7 1.7 31.3 27.7 1.7 12.5 22.0 16.1 9.6 10.3 4.3 24.5 13.9 16.8 5.6 16.0 3.8 12.9 12.5 10.1 10.6 20.2 4.2 3.7 6.1 2.6 7.7 4.3 7.5 17.8 7.2 1.0 24.5 14.5 7.2 2.5 2.8 49.6 4.6 8.6 5.5 7.6 1.5 9.3 6.3 7.9 6.6 19.1 17.7 2.9 12.8 12.6 4.3 10.8 8.1 7.9 5.7 5.9 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 4.5 2.3 2.1 0.7 1.3 2.0 4.7 0.5 1.5 4.0 3.0 2.6 0.4 2.4 0.2 1.5 2.6 0.4 4.6 0.8 1.4 1.9 0.7 2.2 0.3 1.0 1.1 0.8 4.1 5.7 0.3 2.9 1.8 1.2 0.9 0.4 0.1 1.0 0.8 3.0 2.6 1.9 0.4 0.7 4.2 1.8 2.9 1.8 0.2 1.5 1.0 0.1 2.0 2.1 1.1 0.0 1.7 1.0 3.9 0.0 0.0 6.7 0.3 0.0 0.0 0.0 3.1 0.0 0.0 5.3 0.0 0.7 2.5 3.1 0.0 0.0 0.0 4.9 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 6.7 0.0 0.0 0.0 24.9 0.0 0.0 20.8 0.2 2.0 18.8 7.9 2.0 0.0 0.0 19.2 39.3 4.4 0.6 0.0 2.5 0.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.3 0.5 1.5 0.8 1.4 1.0 1.1 0.8 1.2 0.7 1.8 1.1 22.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.3 0.1 3.2 0.0 0.0 1.8 0.0 1.0 0.0 1.3 1.9 0.7 0.4 0.2 4.4 11.9 7.7 4.8 0.5 0.2 0.8 2.1 0.0 0.2 0.0 0.4 13.9 0.2 2.6 18.5 0.7 2.6 0.0 0.3 1.1 0.1 0.0 0.1 1.8 3.7 0.0 0.2 0.0 0.0 0.1 0.2 1.0 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.7 0.2 8.1 1.2 1.7 0.4 0.1 0.3 2.8 0.0 ATG2B "C14orf103, FLJ10242" ENSG00000066739 "Autophagy related 2B" Q96BY7 14 96279195-96363341 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 84.5;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001427, HPA019665" Approved NA NA "HPA001427: AB_1845551, HPA019665: AB_2274278" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "unprognostic (7.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (3.19e-1)" "unprognostic (9.29e-3)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-3)" "unprognostic (1.45e-2)" "unprognostic (7.60e-3)" "unprognostic (6.66e-2)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (8.49e-2)" 5.9 6.2 5.5 3.9 7.0 6.8 6.5 9.0 8.2 7.2 5.6 6.0 4.4 7.4 5.5 5.2 6.9 4.2 4.8 6.2 6.4 5.7 9.9 6.0 4.7 8.5 6.2 6.2 7.3 12.2 8.3 6.8 4.0 8.6 5.9 4.3 12.2 5.5 4.0 8.7 11.5 7.4 5.0 4.7 6.5 6.5 8.7 6.0 7.0 7.3 7.3 5.0 5.7 6.3 9.4 3.8 4.8 5.8 4.5 9.9 9.1 4.6 5.5 7.8 5.9 6.7 2.6 2.6 8.5 5.1 9.1 3.9 5.1 8.0 5.4 9.5 7.9 4.0 3.7 5.2 2.3 6.5 6.9 3.9 7.6 5.4 8.0 6.3 6.3 7.6 6.3 4.3 7.5 4.8 6.2 6.2 5.9 2.8 4.5 4.8 5.6 13.0 5.7 6.7 4.6 5.6 6.4 8.4 3.4 4.0 5.9 5.3 3.9 10.2 3.3 1.5 8.1 3.5 7.4 6.5 7.7 6.7 4.7 3.2 0.1 0.2 0.4 0.3 0.1 0.5 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.5 0.2 0.3 0.5 0.1 5.5 7.0 9.0 8.2 6.2 6.4 8.5 6.2 6.2 8.6 4.7 6.0 9.4 15.8 12.8 12.3 47.3 11.0 13.8 3.7 4.4 21.6 24.8 12.2 7.7 14.2 12.8 6.3 9.2 27.1 5.8 12.3 9.5 3.9 5.8 41.0 20.8 16.9 12.9 8.3 21.8 84.5 6.1 3.2 14.0 10.7 26.9 7.0 10.9 14.6 27.2 4.2 32.0 66.3 13.3 2.0 12.6 10.7 48.9 12.8 8.9 1.8 36.5 6.4 7.9 6.2 105.6 84.2 5.3 10.7 10.5 27.2 9.0 12.5 8.9 7.0 19.4 6.6 13.8 12.6 17.7 14.9 19.6 28.1 15.7 13.0 8.7 9.4 3.7 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343781 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 11.5 10.4 5.0 14.7 4.4 27.8 13.8 7.5 5.7 14.3 8.2 19.3 17.1 10.6 11.1 15.3 11.9 12.6 9.7 4.4 4.6 23.0 15.3 13.9 15.6 5.6 6.1 3.2 10.4 17.7 28.2 5.4 14.6 6.2 13.1 17.3 36.9 14.9 12.3 12.9 13.8 17.7 10.9 4.5 13.9 19.7 28.5 5.7 22.4 22.6 14.1 17.4 19.9 7.9 6.8 31.8 20.4 19.3 7.3 21.9 29.8 22.5 21.4 24.3 21.7 22.0 12.6 30.0 23.9 8.9 27.6 26.2 22.2 23.5 30.4 26.6 28.3 16.0 40.2 12.0 13.5 18.6 20.9 37.3 18.4 21.6 19.2 31.8 22.3 31.5 24.6 24.5 25.3 25.5 7.2 48.1 9.7 42.5 34.5 18.5 22.4 13.9 4.8 35.8 58.2 7.6 14.9 14.1 33.9 19.5 29.5 58.5 18.3 38.6 14.4 19.3 19.5 16.4 20.4 22.6 17.5 23.6 20.8 14.2 6.1 1.6 4.3 2.8 2.3 3.6 1.2 1.8 2.3 1.6 1.3 3.0 2.6 5.1 2.5 0.9 2.2 3.9 0.9 5.0 4.4 7.5 5.7 4.4 4.6 5.6 6.1 3.2 6.2 4.5 5.7 6.8 38.5 44.8 23.1 73.1 32.7 23.7 34.0 23.8 19.9 36.8 32.7 18.9 33.1 18.6 31.9 38.6 139.7 20.0 47.0 43.2 11.7 29.7 25.4 42.5 34.7 28.5 29.4 16.2 119.0 25.6 15.4 22.9 57.6 53.0 15.2 40.0 23.2 19.6 15.8 43.7 146.3 27.9 14.2 31.3 20.4 36.0 40.0 35.2 17.8 105.9 47.1 22.9 46.4 151.8 126.6 40.1 25.7 30.1 29.8 38.2 30.8 24.7 33.9 100.8 6.6 23.6 26.5 69.4 50.7 26.0 29.5 24.9 42.4 32.1 28.0 60.4 ACSM2B "ACSM2, HXMA, HYST1046" ENSG00000066813 "Acyl-CoA synthetase medium chain family member 2B" Q68CK6 16 20536226-20576427 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 133 "kidney: 418.0;liver: 527.8" "Group enriched" "Detected in some" 20 "Hepatocytes: 1036.1;Proximal tubular cells: 441.9" "Group enriched" "Detected in some" 449 "liver cancer: 30.9;renal cancer: 17.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;Hep G2: 5.5;U-937: 1.9" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.34e-2)" "prognostic favorable (3.31e-4)" "unprognostic (7.13e-2)" "unprognostic (2.29e-1)" "unprognostic (6.67e-2)" "unprognostic (1.24e-1)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" 0.4 0.5 0.3 0.0 0.6 0.2 0.3 2.4 1.6 0.1 0.1 0.9 0.3 0.3 0.3 0.3 0.4 0.5 0.6 0.6 3.5 418.0 527.8 0.4 0.2 0.7 0.5 0.0 0.4 0.2 0.2 0.1 0.1 0.9 0.2 0.0 0.5 0.1 0.0 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.9 0.3 0.1 1.0 0.0 0.1 0.0 0.1 0.8 0.5 0.0 2.9 0.7 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.7 0.5 0.0 1.4 0.0 0.4 0.4 0.0 0.0 0.0 0.5 0.4 0.1 0.7 5.5 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.5 0.0 0.0 0.4 0.3 0.5 0.6 0.7 0.0 0.0 0.6 0.1 0.0 0.1 0.9 0.5 1.4 0.0 0.5 0.1 1.1 0.2 0.0 0.0 0.5 0.0 0.4 0.3 0.2 0.3 0.2 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 2.4 1.6 0.6 3.5 0.7 0.5 0.0 0.9 0.0 0.3 0.8 0.5 0.0 0.0 0.0 6.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 28.6 0.0 7.3 0.0 0.0 0.0 0.2 35.2 0.1 0.8 0.0 0.0 2.2 1.8 24.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.7 1036.1 0.1 0.0 0.0 0.0 0.0 23.2 0.4 0.7 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 441.9 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 2.7 0.1 0.0 0.0 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 31.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.5;dendritic cells: 35.6;Early spermatids: 49.3;Late spermatids: 53.0;Syncytiotrophoblasts: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 24 "plasmacytoid DC: 34.5" "Lineage enriched" "Detected in many" 24 "dendritic cells: 34.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA020989: AB_2670552, HPA063592: AB_2685051" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 2.0 1.4 0.7 2.8 0.9 1.3 2.2 0.5 1.6 1.9 1.4 4.0 2.3 2.5 2.0 2.6 2.0 1.2 2.3 1.0 1.6 9.8 1.6 2.2 3.7 1.3 1.8 1.1 2.2 2.3 2.7 1.5 31.4 1.0 2.2 1.7 2.7 1.8 2.2 7.6 1.9 2.1 2.6 0.5 2.6 1.9 2.3 0.7 3.2 1.6 4.3 2.9 2.9 1.8 0.7 4.1 6.5 2.3 2.9 4.4 4.3 2.1 4.4 3.8 3.9 4.0 4.5 5.2 4.7 3.8 4.6 2.3 3.2 4.7 5.6 5.1 3.9 6.0 8.7 5.7 3.3 3.4 4.9 4.3 3.5 2.8 4.3 5.7 3.6 4.9 1.7 3.4 8.4 3.4 5.6 5.1 0.8 3.2 4.2 3.9 3.1 3.0 2.0 3.8 6.2 2.8 2.1 4.5 3.4 3.7 2.6 2.8 4.6 5.4 2.3 3.4 3.3 5.0 3.0 4.4 4.5 2.8 3.6 4.9 1.1 0.6 1.4 0.4 0.8 0.4 0.9 0.4 0.7 0.5 1.1 0.6 0.4 1.0 0.1 0.5 34.5 0.3 0.9 0.7 0.9 0.5 1.6 1.0 1.6 1.3 1.8 1.1 1.0 0.5 0.7 0.7 3.5 3.2 3.3 14.4 7.0 1.5 1.2 1.0 1.8 5.3 4.0 1.4 2.0 1.5 3.1 1.8 4.2 74.5 35.6 1.5 0.0 2.1 49.3 2.6 5.0 2.8 0.0 0.8 24.4 1.5 17.2 2.7 3.6 3.1 2.5 2.9 0.7 1.4 8.4 1.7 18.9 1.4 0.0 3.8 2.1 53.0 3.4 4.2 8.8 14.0 3.5 2.1 4.1 9.5 12.6 3.3 0.5 2.6 17.0 1.6 1.1 12.2 1.1 6.0 0.0 3.7 2.5 2.9 5.5 1.9 1.7 126.7 3.6 3.2 1.3 1.5 MTFR1 "CHPPR, FAM54A2, KIAA0009" ENSG00000066855 "Mitochondrial fission regulator 1" Q15390 8 65644734-65771261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 365.5;Late spermatids: 792.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "hTERT-HME1: 107.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023152, HPA056120" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA023152: AB_1854176, HPA056120: AB_2683043" "prognostic unfavorable (4.06e-4)" "unprognostic (4.58e-2)" "unprognostic (4.01e-2)" "unprognostic (4.57e-2)" "unprognostic (6.56e-3)" "unprognostic (3.93e-2)" "unprognostic (1.66e-1)" "unprognostic (3.28e-2)" "unprognostic (1.50e-1)" "unprognostic (3.53e-1)" "unprognostic (5.69e-3)" "unprognostic (5.44e-2)" "unprognostic (6.63e-3)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (8.25e-2)" 10.0 15.4 5.2 6.2 6.7 4.9 10.1 5.8 6.2 9.8 5.5 11.4 12.5 8.5 12.1 10.3 6.3 6.6 7.7 5.1 5.7 32.1 35.2 5.9 4.7 6.0 6.4 4.7 6.3 8.9 11.7 3.9 7.7 6.2 7.4 12.1 34.3 8.5 8.6 9.8 8.2 12.6 9.6 5.5 4.1 14.8 19.9 5.8 4.7 11.6 7.4 6.9 9.0 7.7 7.6 34.3 25.1 19.7 22.7 25.7 25.6 15.7 22.3 20.3 26.8 27.9 21.5 34.5 19.0 7.0 21.7 26.6 21.9 44.3 30.0 35.6 6.9 24.0 23.6 16.8 43.1 32.7 6.2 10.9 17.5 31.1 34.7 107.9 15.2 33.1 13.8 32.8 19.0 30.8 30.9 21.1 14.2 20.5 74.9 22.5 10.7 26.9 15.9 32.5 30.2 8.6 12.9 21.9 36.7 29.6 19.6 40.5 13.3 25.8 15.9 22.4 38.8 19.6 18.4 12.9 13.6 19.8 25.0 21.6 1.3 0.8 0.3 0.5 0.6 0.7 0.4 0.7 0.6 0.8 0.3 0.6 0.7 0.2 0.2 0.3 0.5 0.7 0.4 5.2 6.7 5.8 6.2 5.1 5.7 6.0 6.4 4.7 6.2 5.5 5.8 7.6 6.8 19.2 9.8 5.9 6.1 16.8 12.3 13.5 10.2 0.0 9.7 4.8 7.4 18.6 12.2 11.0 0.0 25.0 6.9 11.9 56.7 22.6 365.5 7.5 10.0 10.0 4.8 12.6 13.1 24.1 29.0 10.1 14.3 8.2 5.1 9.2 8.9 39.9 9.7 0.0 16.4 12.6 20.3 6.3 7.0 792.9 16.8 6.5 14.2 11.2 3.8 0.0 4.1 18.6 42.4 20.0 9.6 12.0 10.7 20.6 20.0 112.7 16.1 0.0 6.6 7.5 13.1 93.0 35.9 18.4 19.5 39.1 4.5 20.6 15.7 16.6 STAG3 ENSG00000066923 "Stromal antigen 3" Q9UJ98 7 100177563-100221488 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Chromosome partition, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 55.2" "Cell type enhanced" "Detected in many" "B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 41.7;HMC-1: 54.4;U-698: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA049106, HPA058330" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA049106: AB_2680634, HPA058330: AB_2683681" "unprognostic (6.56e-4)" "prognostic favorable (8.45e-4)" "unprognostic (1.25e-2)" "unprognostic (7.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-3)" "unprognostic (3.59e-2)" "unprognostic (4.62e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-1)" "unprognostic (3.31e-4)" "unprognostic (4.26e-4)" "unprognostic (7.48e-2)" "unprognostic (6.80e-2)" "unprognostic (2.72e-1)" "unprognostic (3.13e-2)" "unprognostic (5.07e-4)" 0.2 0.2 0.0 0.1 0.1 0.8 0.3 0.1 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.3 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.3 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 55.2 0.1 0.6 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 41.7 1.1 0.0 0.1 0.2 0.0 0.0 1.2 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 54.4 0.0 0.1 0.8 0.2 0.0 0.3 1.4 0.2 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 13.1 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 0.1 1.9 0.0 2.7 2.9 56.5 6.8 10.9 1.8 1.2 7.4 1.9 1.8 2.2 10.0 1.7 7.3 2.1 2.0 12.1 1.7 13.7 0.3 29.8 26.1 2.9 4.2 1.2 8.4 6.5 0.2 3.3 4.1 0.5 7.8 1.3 4.9 4.2 29.4 2.2 20.2 6.1 5.7 0.0 2.2 8.6 23.5 4.7 4.6 5.4 5.6 4.2 2.7 13.4 5.0 5.1 0.2 0.5 1.9 2.1 8.2 1.1 6.9 15.1 7.0 0.0 8.0 5.4 152.6 60.0 0.4 8.5 2.9 10.8 2.6 2.0 11.7 FECH ENSG00000066926 Ferrochelatase P22830 18 57544377-57586702 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Distal tubular cells: 156.5;Erythroid cells: 479.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 32.7;K-562: 31.4;U-266/70: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044100, HPA048177" Approved NA NA "HPA044100: AB_2678809, HPA048177: AB_2680300" "unprognostic (2.30e-1)" "unprognostic (3.17e-2)" "unprognostic (4.59e-3)" "unprognostic (6.85e-2)" "unprognostic (7.60e-2)" "unprognostic (1.08e-1)" "unprognostic (3.86e-2)" "unprognostic (3.34e-2)" "unprognostic (2.85e-2)" "unprognostic (2.43e-1)" "unprognostic (1.92e-1)" "unprognostic (2.36e-1)" "prognostic favorable (2.38e-10)" "unprognostic (1.10e-1)" "unprognostic (8.30e-2)" "unprognostic (4.05e-3)" "unprognostic (3.58e-2)" 8.8 14.8 5.0 2.0 6.5 40.0 8.8 4.7 7.5 7.8 5.8 9.7 1.8 9.2 3.0 12.1 7.7 2.6 13.7 5.1 5.5 17.4 22.2 6.6 1.9 7.0 6.1 5.6 8.5 9.2 4.3 9.0 3.2 7.1 9.6 2.5 3.7 9.0 2.4 32.5 8.1 7.2 2.9 4.6 10.1 8.5 4.7 5.6 5.0 9.8 7.5 1.9 9.9 8.5 10.1 5.3 15.1 4.3 8.2 2.6 7.4 4.2 4.5 3.4 2.9 4.0 7.3 3.0 4.8 4.3 6.8 3.9 3.5 4.2 3.8 3.7 6.6 19.0 29.5 12.8 10.5 4.9 17.7 32.7 5.4 4.0 4.0 1.4 4.2 5.3 8.0 31.4 10.9 2.1 10.1 7.8 3.8 4.3 1.9 8.7 6.3 19.7 4.7 8.6 19.1 2.5 8.4 4.8 7.4 3.4 2.5 4.6 2.8 6.8 3.3 1.9 1.4 3.2 33.4 12.4 6.3 3.5 5.6 3.9 3.7 3.8 8.1 4.5 5.0 3.2 2.4 3.0 4.9 6.6 1.0 2.8 3.3 0.6 6.9 5.2 4.3 3.2 3.8 5.0 6.5 4.7 7.5 5.1 5.5 7.0 6.1 5.6 7.1 4.6 5.6 10.1 4.9 6.4 10.6 10.4 5.6 2.5 6.7 8.6 5.2 3.8 7.8 6.1 24.5 15.7 7.2 5.5 4.2 36.6 15.4 6.7 156.5 16.4 0.4 6.6 7.9 7.3 2.4 479.7 20.3 16.3 16.5 10.3 4.6 9.7 16.5 11.8 4.2 26.3 33.4 8.4 14.6 4.1 8.2 10.6 4.9 1.1 9.9 12.7 1.8 12.2 15.4 15.1 9.2 12.1 45.5 12.4 6.4 7.2 12.5 6.5 7.0 18.2 9.8 4.1 0.0 9.0 6.8 4.1 5.5 14.2 3.1 24.2 8.1 19.1 5.7 5.0 MYO9A "FLJ11061, FLJ13244, MGC71859" ENSG00000066933 "Myosin IXA" B2RTY4 15 71822291-72118577 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, GTPase activation, Motor protein, Myosin" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 62.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 225.5;Inhibitory neurons: 192.9;Rod photoreceptor cells: 462.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039812, HPA040071" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039812: AB_10961421, HPA040071: AB_10961117" "unprognostic (7.53e-2)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-3)" "unprognostic (1.63e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (3.56e-2)" "unprognostic (1.26e-1)" "unprognostic (5.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.14e-4)" "unprognostic (3.44e-1)" "unprognostic (4.41e-1)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" 6.5 3.9 11.1 4.8 12.5 4.8 10.8 14.5 12.5 8.8 3.3 6.4 2.1 10.0 7.5 7.8 7.2 5.2 6.8 11.6 10.0 13.8 3.8 8.9 6.4 8.5 8.3 11.2 12.2 3.3 7.4 4.7 7.7 10.6 8.1 6.3 62.2 4.5 7.5 8.1 8.8 4.7 10.3 6.4 7.4 5.3 28.9 10.2 6.8 13.3 15.0 6.4 6.6 6.1 13.7 9.7 14.6 9.6 6.8 14.2 16.5 5.7 9.1 9.8 9.0 9.1 7.1 6.6 43.3 5.4 17.9 11.8 9.0 19.2 10.3 11.9 9.5 11.1 11.1 8.9 3.2 9.0 11.2 8.5 9.5 10.2 10.6 15.2 7.6 11.5 7.7 7.2 10.3 12.2 6.0 6.4 4.5 5.2 3.5 5.9 4.6 18.2 4.3 10.9 14.3 5.4 5.9 12.0 10.0 9.5 11.6 8.0 5.3 15.5 18.0 8.7 29.7 10.4 6.5 17.3 11.3 10.8 9.2 8.1 1.7 1.5 3.7 3.6 1.4 4.9 3.1 3.5 3.0 1.6 4.0 3.6 3.4 0.2 2.8 2.6 6.3 3.1 0.9 11.1 12.5 14.5 12.5 11.6 10.0 8.5 8.3 11.2 10.6 6.4 10.2 13.7 37.0 115.4 77.4 145.6 18.4 20.9 22.2 12.4 20.5 56.3 26.2 25.0 35.5 5.7 24.1 29.5 54.2 11.9 30.2 21.1 17.6 6.1 131.8 27.9 47.3 29.6 12.6 19.6 225.5 8.0 11.3 35.6 15.8 41.2 10.1 53.1 22.1 5.7 9.0 53.8 192.9 9.7 8.2 54.8 10.0 161.9 38.8 17.7 23.2 113.4 13.0 24.0 14.4 177.0 180.2 10.9 15.5 42.9 12.2 25.0 10.4 14.1 28.3 462.1 19.7 54.9 32.6 115.2 41.8 18.4 23.9 12.0 18.5 17.0 12.8 15.7 DDX3Y DBY ENSG00000067048 "DEAD-box helicase 3 Y-linked" O15523 Y 12904108-12920478 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 96.8" "Cell type enhanced" "Detected in many" "Early spermatids: 275.5;Late spermatids: 575.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059583" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: " "unprognostic (3.89e-2)" "unprognostic (1.70e-1)" "prognostic favorable (4.70e-5)" "unprognostic (6.50e-2)" "unprognostic (4.74e-2)" "unprognostic (2.22e-2)" "unprognostic (4.17e-2)" "unprognostic (3.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (7.87e-2)" 25.2 26.3 9.0 15.4 5.6 96.8 20.8 2.2 42.8 0.0 3.3 22.5 12.1 0.0 27.0 18.7 0.0 18.9 17.9 14.9 0.5 20.5 22.2 27.7 9.7 11.2 0.1 0.0 0.1 15.0 12.5 25.3 22.3 12.0 33.9 24.2 23.8 18.6 31.5 20.1 19.0 26.1 0.0 0.4 26.7 20.0 70.7 16.6 0.0 22.2 28.3 23.8 22.2 0.0 48.5 0.7 28.3 0.0 0.0 0.0 0.0 20.0 69.3 49.9 35.9 44.0 0.2 0.0 153.7 0.1 69.5 0.0 0.0 0.0 0.0 63.2 38.8 0.0 156.8 0.0 46.5 34.2 0.1 0.1 37.4 43.4 0.0 0.0 0.0 0.0 15.2 0.2 0.1 43.1 0.2 61.8 0.2 27.1 0.0 0.0 0.0 18.0 28.2 38.2 41.5 44.5 0.1 0.1 0.2 51.4 43.5 0.0 36.5 49.1 55.0 0.3 0.1 45.8 78.7 133.1 112.8 6.9 0.1 0.0 1.5 3.8 3.2 4.4 3.9 4.0 3.2 3.3 3.7 4.9 2.7 3.9 3.5 3.5 3.4 2.4 1.4 3.0 3.2 9.0 5.6 2.2 42.8 14.9 0.5 11.2 0.1 0.0 12.0 0.4 16.6 48.5 0.1 48.1 75.8 10.1 58.0 94.1 92.7 37.5 89.4 53.8 0.0 0.0 26.0 10.0 41.2 9.2 41.7 38.3 13.3 5.6 5.9 13.9 275.5 0.0 0.0 56.5 16.0 24.6 19.7 0.2 18.9 63.4 56.1 0.0 92.9 0.0 42.1 9.1 20.1 42.1 15.7 9.3 10.2 64.1 127.5 575.3 38.8 58.2 26.6 5.6 27.8 53.7 26.8 4.0 5.7 5.0 8.8 39.5 54.7 70.8 10.5 13.9 101.2 49.3 19.7 56.2 39.2 67.2 70.1 43.8 80.4 37.8 66.2 0.0 8.1 75.0 PFKP "PFK-C, PFKF" ENSG00000067057 "Phosphofructokinase, platelet" Q01813 10 3066333-3137718 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 279.5" "Cell type enhanced" "Detected in many" "Early spermatids: 459.8;Late spermatids: 516.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018257, HPA056484" Uncertain Supported Cytosol No No 1900000 Cytosol "HPA018257: AB_10960391, HPA056484: AB_2683147" "unprognostic (1.16e-1)" "unprognostic (2.41e-3)" "unprognostic (5.79e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.55e-4)" "prognostic unfavorable (8.72e-6)" "unprognostic (1.36e-3)" "unprognostic (2.38e-1)" "unprognostic (8.51e-2)" "unprognostic (2.37e-2)" "unprognostic (8.82e-2)" "unprognostic (6.02e-3)" "unprognostic (2.60e-2)" "unprognostic (9.74e-2)" "unprognostic (2.06e-1)" "unprognostic (4.54e-3)" 30.2 11.6 29.6 41.8 35.5 14.6 23.7 11.6 46.5 23.4 46.6 39.4 49.3 56.0 5.7 67.7 35.2 34.4 129.9 61.2 44.3 40.6 4.7 19.2 32.7 29.7 34.5 40.5 19.2 16.0 15.4 30.1 15.6 36.4 35.9 31.0 279.5 40.1 62.6 71.0 37.6 60.1 44.5 7.9 19.3 37.1 142.3 39.3 30.0 38.8 21.2 21.4 65.2 43.1 50.4 314.8 420.2 25.9 0.6 26.8 56.9 336.9 187.2 66.6 186.2 222.8 444.5 320.4 37.0 147.8 134.9 174.9 243.0 141.7 292.3 173.1 102.1 111.0 132.0 189.1 24.2 65.2 53.7 203.4 27.0 61.2 190.0 96.0 273.7 367.8 153.7 37.0 1.3 195.7 239.8 182.5 44.4 42.9 133.9 149.3 138.8 46.9 150.1 185.7 115.9 69.5 64.7 133.7 111.0 172.0 307.8 93.7 80.3 449.2 124.6 65.3 380.5 199.3 195.4 200.1 135.7 331.0 98.0 78.5 30.8 8.5 2.9 26.8 4.2 21.2 13.7 26.2 25.0 14.5 15.3 9.6 15.4 1.3 26.7 1.6 22.5 37.6 16.5 29.6 35.5 11.6 46.5 61.2 44.3 29.7 34.5 40.5 36.4 7.9 39.3 50.4 30.5 3.2 7.0 128.6 14.8 28.7 58.5 96.8 14.8 40.4 10.3 7.7 147.4 8.6 57.9 64.4 54.2 7.8 16.3 72.6 43.0 115.7 459.8 41.2 9.0 36.0 37.2 10.3 49.4 10.8 205.8 25.9 35.7 63.8 55.9 25.8 14.6 0.7 33.9 42.1 25.9 23.1 124.1 7.6 31.4 516.3 7.5 14.3 19.6 15.0 15.4 113.1 16.5 16.1 6.7 116.8 57.2 6.8 14.2 80.9 53.2 5.9 62.6 133.4 13.1 43.2 34.6 149.4 3.5 25.1 22.6 26.5 28.8 11.2 28.9 64.2 IDI1 ENSG00000067064 "Isopentenyl-diphosphate delta isomerase 1" Q13907 10 1039152-1049119 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039169 Approved NA NA 28000 "HPA039169: AB_10674280" "unprognostic (1.61e-2)" "unprognostic (2.59e-2)" "unprognostic (4.58e-2)" "unprognostic (1.97e-1)" "unprognostic (5.72e-3)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.72e-2)" "unprognostic (3.88e-2)" "unprognostic (2.59e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.46e-4)" "unprognostic (9.63e-2)" "unprognostic (2.01e-2)" "unprognostic (2.19e-3)" "unprognostic (2.61e-2)" 32.5 94.4 38.6 37.0 41.0 135.1 153.6 45.6 44.9 18.5 38.1 37.7 67.3 17.2 28.7 50.9 16.9 22.1 21.7 41.4 45.7 34.3 161.6 40.2 39.3 48.2 50.8 38.1 26.9 31.6 26.1 44.2 23.6 52.6 50.6 34.6 37.8 26.5 13.5 106.7 32.4 35.1 17.9 42.6 44.4 37.5 25.5 47.2 26.6 22.0 45.1 40.1 20.2 31.1 58.8 89.5 33.4 173.4 42.0 71.1 154.1 25.2 36.7 41.5 42.4 88.7 89.6 136.8 80.9 23.6 40.8 101.7 75.8 97.8 177.8 38.3 27.9 93.8 78.2 50.1 103.2 83.9 30.4 37.5 99.3 73.2 119.3 15.6 18.1 33.4 75.0 54.5 111.1 72.2 72.4 59.1 51.9 69.0 74.6 19.5 67.2 82.0 89.5 185.7 79.7 26.6 31.6 46.4 96.5 100.7 53.5 99.3 103.8 33.4 22.7 12.9 66.8 27.2 64.3 64.7 151.3 28.2 89.4 20.4 76.0 15.1 37.6 27.6 28.3 27.5 25.8 21.0 22.7 13.9 26.0 15.3 22.6 41.4 24.2 33.5 14.4 24.8 26.6 38.6 41.0 45.6 44.9 41.4 45.7 48.2 50.8 38.1 52.6 42.6 47.2 58.8 119.2 73.7 144.3 53.8 176.2 89.6 80.4 175.7 58.1 77.4 110.0 70.0 79.0 51.5 109.6 40.5 37.5 63.3 233.5 167.5 150.6 62.9 277.8 61.5 28.6 64.6 106.0 31.1 36.2 102.6 53.6 62.8 79.5 108.2 100.7 60.5 67.1 322.8 86.9 63.9 41.0 107.6 156.6 59.1 63.2 101.5 26.4 88.8 133.4 20.6 55.8 130.9 118.4 47.3 65.1 81.9 130.9 29.7 60.2 116.6 70.5 63.5 65.6 70.3 26.3 62.3 73.4 82.5 37.0 79.2 144.6 187.2 154.9 171.1 65.0 121.2 SP100 ENSG00000067066 "SP100 nuclear antigen" P23497 2 230415942-230545606 "Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 191.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 255.0" "Low region specificity" "Detected in all" "HPA016707, HPA017384" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA016707: AB_1857398, HPA017384: AB_1857399" "unprognostic (8.04e-3)" "unprognostic (1.08e-2)" "unprognostic (3.34e-2)" "unprognostic (1.86e-3)" "unprognostic (5.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (6.25e-3)" "unprognostic (5.32e-3)" "unprognostic (1.11e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.96e-2)" "unprognostic (1.48e-2)" "unprognostic (2.33e-2)" "unprognostic (3.25e-2)" 62.9 53.6 11.3 66.1 12.0 191.0 54.2 10.5 18.1 40.5 22.6 42.2 46.5 35.4 31.1 29.7 35.2 56.4 53.4 9.6 14.9 41.1 61.4 73.0 95.0 16.0 12.3 7.8 44.7 41.5 10.6 18.4 54.9 15.7 35.2 36.5 2.6 73.3 33.3 24.5 34.7 60.9 39.0 14.1 79.5 48.4 9.3 15.4 54.7 41.3 32.4 82.2 56.6 37.4 20.1 56.9 16.9 0.8 7.5 80.8 123.2 13.3 70.3 151.0 162.4 255.0 10.6 67.9 22.9 57.0 77.0 103.0 25.9 0.8 66.6 120.7 55.2 1.9 41.8 27.9 24.0 120.0 47.3 51.4 105.6 38.8 79.8 71.4 120.2 125.1 18.9 23.9 37.9 61.7 15.9 32.0 57.6 2.4 25.6 25.6 24.4 40.7 18.2 45.9 45.3 0.4 0.7 30.0 9.5 130.3 2.8 9.1 48.3 140.3 78.7 21.4 49.4 41.8 50.3 16.0 59.8 71.6 54.8 38.1 149.7 84.4 115.8 116.3 74.9 93.9 152.0 113.0 102.4 64.6 160.5 107.5 95.3 284.6 119.8 106.0 67.0 116.0 110.1 11.3 12.0 10.5 18.1 9.6 14.9 16.0 12.3 7.8 15.7 14.1 15.4 20.1 171.9 153.8 56.6 0.3 236.6 70.7 71.2 96.5 49.5 0.6 31.2 36.7 72.3 42.9 74.4 33.1 2.1 32.9 150.6 50.5 43.0 102.9 4.7 61.6 58.3 122.7 9.0 66.9 0.6 105.5 69.4 77.9 46.4 58.9 56.8 39.3 73.5 34.5 81.0 0.0 0.7 32.5 63.1 72.9 70.9 4.8 46.6 104.1 71.2 140.5 114.3 0.2 128.8 4.5 4.8 89.7 56.9 52.6 95.6 74.2 72.8 45.4 68.4 0.8 39.5 61.2 65.9 0.8 1.1 28.4 68.2 16.1 151.5 74.0 25.2 73.7 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 440.7" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 2075.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 213.2 47.4 21.9 123.2 18.1 440.7 130.8 19.0 22.6 96.2 22.0 93.0 55.9 99.1 17.9 167.1 77.9 183.5 46.6 17.4 27.1 64.7 143.0 118.0 65.9 29.0 19.6 16.2 47.7 119.3 32.1 12.1 99.0 23.4 33.0 100.5 18.5 74.4 34.0 85.6 179.1 106.9 209.9 22.5 64.8 73.8 14.7 22.3 57.3 195.7 41.7 45.4 137.6 93.5 29.2 55.0 14.7 27.2 9.0 155.1 154.3 17.1 91.7 46.5 95.9 64.8 38.0 71.4 15.6 20.8 100.0 74.5 32.7 17.0 84.9 79.5 76.6 10.2 2.2 17.5 35.8 66.4 10.3 51.5 51.4 158.2 68.6 129.3 34.2 99.3 10.1 17.5 117.9 123.6 4.0 19.4 15.9 10.2 29.2 26.0 12.6 28.2 55.5 94.1 53.4 12.0 11.5 22.5 64.0 142.8 73.5 32.0 8.6 130.9 128.7 17.8 76.9 43.0 22.6 78.1 28.6 34.7 13.7 40.8 318.8 85.2 234.1 129.8 74.2 115.9 81.1 147.4 131.5 67.6 70.9 44.9 69.0 391.6 72.5 104.6 152.8 120.6 148.7 21.9 18.1 19.0 22.6 17.4 27.1 29.0 19.6 16.2 23.4 22.5 22.3 29.2 511.0 1246.8 489.4 14.0 716.9 585.5 1298.4 625.8 1227.0 39.6 985.9 630.0 63.6 544.7 451.9 138.0 33.3 163.1 518.3 1507.0 21.5 808.6 58.0 1065.6 618.9 469.9 397.3 77.9 18.5 553.0 473.8 545.5 1120.3 1905.9 626.7 195.9 248.4 309.9 583.6 37.0 10.0 746.7 429.3 968.7 885.1 53.2 130.5 992.1 483.8 58.1 609.8 42.9 150.4 7.5 4.3 857.9 949.9 133.9 1172.5 600.2 1009.9 97.4 342.0 90.1 138.1 194.8 441.8 9.0 19.4 2075.6 628.2 195.9 920.5 67.1 542.0 572.5 PLPP1 "LPP1, PAP-2a, PPAP2A" ENSG00000067113 "Phospholipid phosphatase 1" O14494 5 55424854-55534969 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 359.1;Endometrial stromal cells: 206.7;Hepatic stellate cells: 267.0;Leydig cells: 219.3;Prostatic glandular cells: 182.0" "Cancer enhanced" "Detected in all" "prostate cancer: 200.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 445.7;fHDF/TERT166: 142.8;HMC-1: 235.8;HSkMC: 171.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033331, HPA047815" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB033331: AB_2168044, HPA047815: AB_2680164" "unprognostic (1.22e-1)" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.36e-1)" "prognostic favorable (6.06e-4)" "unprognostic (2.81e-1)" "unprognostic (2.20e-1)" "unprognostic (4.05e-3)" "unprognostic (2.43e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.94e-2)" "unprognostic (1.66e-1)" "unprognostic (3.11e-2)" 166.2 78.8 53.0 42.6 60.0 0.9 141.9 64.8 59.5 88.1 61.3 106.4 47.8 120.5 40.1 42.8 74.0 168.9 105.0 50.7 68.3 103.3 68.3 56.7 32.5 63.6 57.8 48.7 29.6 35.9 49.4 28.0 37.9 64.4 256.3 66.4 9.8 33.1 61.9 70.5 55.2 79.7 109.8 67.7 31.4 71.5 21.2 58.7 15.9 113.8 82.3 24.4 129.9 64.4 76.3 9.8 24.4 7.0 14.2 445.7 51.8 9.6 21.8 61.4 11.9 27.9 16.7 17.7 10.2 20.0 142.8 31.9 6.5 25.2 12.6 13.5 6.8 20.1 1.1 9.6 21.3 70.5 2.5 235.8 171.3 25.7 17.6 10.9 23.3 19.9 9.1 0.2 27.0 24.1 6.0 6.8 5.5 15.5 1.1 20.0 2.0 11.7 0.9 46.3 79.8 8.4 5.8 21.5 4.2 13.4 28.8 15.6 1.6 24.0 4.0 6.9 17.8 15.5 16.6 7.4 11.8 15.7 1.3 19.5 0.0 0.4 4.0 1.6 0.5 1.7 6.7 5.3 3.4 2.0 3.3 9.5 7.7 0.3 3.0 0.9 15.0 2.6 1.8 53.0 60.0 64.8 59.5 50.7 68.3 63.6 57.8 48.7 64.4 67.7 58.7 76.3 359.1 6.4 9.4 0.0 9.8 0.0 51.0 0.0 10.2 4.0 8.4 45.7 0.0 21.5 5.6 29.5 2.1 3.3 5.4 61.0 5.9 25.2 44.4 10.7 206.7 112.3 1.2 5.7 0.0 28.5 11.1 115.5 11.2 18.5 27.8 4.0 267.0 48.3 12.8 1.7 0.0 20.2 0.0 12.0 0.0 21.0 219.3 8.1 0.0 0.0 4.5 16.6 1.0 0.0 0.0 30.0 24.6 88.4 13.0 182.0 49.4 29.3 2.2 5.6 59.2 89.7 49.7 54.4 17.7 10.0 0.0 4.9 11.3 3.1 12.1 42.8 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305205 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 390000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 8.1 7.5 28.6 8.9 42.7 1.5 16.9 38.4 34.3 18.4 12.8 46.4 27.5 19.8 10.0 11.6 22.1 19.8 7.8 29.4 30.4 23.6 8.7 16.0 3.9 33.6 38.7 23.5 25.0 17.4 42.1 6.7 1.7 34.6 33.3 55.6 19.6 18.4 36.3 31.2 37.8 26.7 23.5 29.4 5.4 23.1 13.7 37.6 7.2 18.4 25.0 6.2 10.6 9.7 61.2 8.9 42.9 50.1 33.2 29.6 8.6 12.5 3.3 4.1 8.2 1.7 6.4 42.8 2.5 4.9 9.4 30.8 1.9 35.3 19.5 3.5 15.8 26.0 29.0 0.5 6.0 8.6 0.8 0.9 21.3 35.4 1.6 16.2 9.5 0.0 22.3 0.2 53.9 2.0 26.8 10.5 0.7 47.9 6.7 3.6 23.9 26.8 5.8 15.8 23.7 22.7 32.1 40.2 17.6 20.7 39.9 18.6 5.3 0.1 38.0 19.9 12.5 9.3 22.8 45.2 6.2 8.2 8.3 10.9 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 28.6 42.7 38.4 34.3 29.4 30.4 33.6 38.7 23.5 34.6 29.4 37.6 61.2 3.1 9.6 10.4 231.8 2.3 14.1 8.2 20.7 13.6 15.7 14.2 18.2 6.9 21.5 11.4 22.0 14.6 0.5 4.8 55.6 1.9 11.6 3.3 14.4 13.4 3.4 60.1 3.0 124.5 6.4 0.8 14.6 20.9 24.6 0.0 11.8 5.7 8.9 0.9 10.1 72.8 51.2 10.2 1.2 2.7 7.1 31.7 1.2 10.6 62.8 0.1 12.5 2.1 120.1 439.4 9.9 40.0 62.8 2.6 11.5 39.6 15.5 12.7 21.9 6.6 22.2 10.2 11.8 20.3 14.7 25.4 0.3 6.0 3.1 60.5 7.2 TRAM1 "TRAM, TRAMP" ENSG00000067167 "Translocation associated membrane protein 1" Q15629 8 70573218-70608416 "Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Protein transport, Translocation, Transport, Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 670.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023929 Approved NA NA "HPA023929: AB_1858239" "unprognostic (3.85e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (8.34e-3)" "unprognostic (1.31e-1)" "unprognostic (3.52e-2)" "unprognostic (5.93e-2)" "unprognostic (8.94e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (3.39e-3)" "unprognostic (3.61e-2)" "prognostic unfavorable (7.79e-4)" "unprognostic (7.45e-2)" "unprognostic (1.61e-1)" "unprognostic (2.31e-1)" "unprognostic (3.85e-2)" 94.0 83.6 30.1 96.8 31.9 103.2 117.0 31.6 42.5 140.4 49.9 86.2 92.6 94.2 149.8 65.8 79.2 118.7 60.4 28.5 42.2 121.8 191.8 147.6 104.3 36.4 32.4 26.1 74.0 177.0 118.2 39.1 148.0 35.4 88.0 80.5 33.6 195.5 86.8 27.0 49.6 94.4 97.5 34.1 90.8 95.6 61.5 33.1 99.5 172.2 55.4 115.2 121.3 48.1 38.5 171.1 172.5 73.6 45.2 352.6 367.8 105.2 302.9 301.7 231.7 279.1 109.9 275.8 169.1 58.5 259.6 91.3 219.3 67.6 262.1 221.8 112.2 76.1 118.5 54.6 125.7 515.4 91.3 66.3 441.5 249.6 114.2 410.8 238.5 196.7 85.0 77.8 430.3 288.6 47.2 210.4 65.7 48.3 132.3 81.0 100.9 55.3 113.8 610.5 160.4 53.4 54.2 195.0 389.0 180.5 103.1 144.1 102.0 195.3 141.0 117.5 162.4 102.0 338.7 140.1 85.5 160.3 92.9 105.0 150.1 97.3 64.9 120.8 107.7 153.5 107.9 132.1 137.6 114.3 87.9 119.6 125.2 28.2 130.7 113.7 190.4 146.8 232.7 30.1 31.9 31.6 42.5 28.5 42.2 36.4 32.4 26.1 35.4 34.1 33.1 38.5 138.3 275.7 132.0 19.6 166.4 85.5 85.2 214.0 69.4 23.7 114.2 62.4 43.0 131.5 209.3 178.4 14.6 154.3 200.5 69.3 68.4 174.5 142.8 77.9 140.7 134.3 44.2 59.7 27.4 247.7 236.7 177.0 70.8 186.6 72.4 59.0 137.8 202.9 182.7 23.5 26.1 95.5 156.6 134.9 251.0 222.2 127.4 123.7 202.7 29.0 132.1 65.6 128.8 34.2 40.3 290.5 51.0 94.4 670.6 199.6 78.0 147.0 110.2 32.9 124.9 76.4 99.5 134.8 56.8 72.3 88.5 194.3 154.2 78.2 65.5 130.6 PHKA1 PHKA ENSG00000067177 "Phosphorylase kinase regulatory subunit alpha 1" P46020 X 72578814-72714319 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Muscle protein" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "parathyroid gland: 32.2;skeletal muscle: 103.6;tongue: 90.0" "Cell type enriched" "Detected in many" 4 "Astrocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001081, HPA075355" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001081: AB_1079607, HPA075355: " "unprognostic (3.68e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (3.52e-1)" "unprognostic (5.48e-2)" "unprognostic (1.23e-2)" "unprognostic (9.64e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (2.18e-1)" "unprognostic (4.76e-1)" "unprognostic (9.45e-3)" "unprognostic (9.94e-2)" "unprognostic (2.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" 3.2 17.8 7.1 1.0 10.6 0.7 4.9 9.4 6.3 2.4 15.1 3.3 1.1 3.3 6.6 5.7 3.8 3.2 7.6 6.2 11.5 2.7 2.4 2.1 1.1 8.8 10.9 4.5 8.4 7.7 32.2 9.9 1.8 8.5 6.0 3.3 3.9 7.1 6.4 103.6 3.4 2.1 3.4 7.3 3.4 7.0 2.1 9.9 4.0 6.9 90.0 1.4 4.8 3.5 6.8 15.3 21.2 1.2 12.4 7.2 6.8 12.9 2.8 2.6 0.5 0.1 6.2 13.3 0.0 8.2 0.3 15.1 5.9 24.9 10.3 0.8 39.2 25.1 7.0 17.4 5.7 7.5 0.0 0.0 9.1 10.0 2.4 16.7 12.5 14.5 12.7 11.0 0.0 13.6 11.0 11.1 0.7 16.5 25.2 28.0 0.0 0.0 0.0 3.7 7.2 12.9 15.3 13.4 17.3 0.2 15.4 6.2 0.6 7.5 0.0 6.2 2.7 7.3 17.1 17.1 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 10.6 9.4 6.3 6.2 11.5 8.8 10.9 4.5 8.5 7.3 9.9 6.8 5.8 0.0 3.7 85.2 0.5 2.4 6.5 2.3 4.0 2.4 5.2 3.7 6.6 1.5 3.5 11.0 8.4 1.0 0.1 0.8 0.0 1.6 0.4 4.8 1.4 3.5 2.4 4.0 5.3 2.7 1.1 2.5 3.6 2.9 6.3 3.4 5.7 1.9 1.6 3.3 16.0 1.8 4.1 10.4 0.7 0.1 3.1 0.6 1.8 6.5 0.0 1.5 0.0 18.6 0.5 5.4 0.4 8.6 1.3 9.0 0.4 1.6 6.6 3.3 0.0 7.1 1.9 0.4 1.0 5.6 3.4 0.5 0.3 1.9 2.6 8.9 TNFRSF1A "CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60" ENSG00000067182 "TNF receptor superfamily member 1A" P19438 12 6328757-6342114 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Apoptosis, Host-virus interaction" Receptor "Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 507.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004102, CAB010309" Approved "Secreted to blood" NA NA 17700 570000 "CAB010309: AB_2206639, HPA004102: AB_1846232" "unprognostic (2.19e-2)" "unprognostic (3.76e-2)" "unprognostic (8.14e-2)" "prognostic favorable (8.22e-4)" "unprognostic (3.07e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.50e-1)" "unprognostic (1.41e-3)" "unprognostic (1.00e-1)" "unprognostic (8.05e-2)" "unprognostic (4.78e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (2.70e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (5.14e-3)" "unprognostic (1.74e-1)" 146.8 134.4 33.9 77.4 30.8 42.8 121.0 34.3 38.9 104.4 46.0 108.9 102.4 112.7 23.2 106.4 107.6 89.5 76.2 30.0 63.0 95.1 177.9 131.8 38.4 44.3 35.2 25.8 91.4 57.8 54.1 57.7 83.1 40.0 87.6 56.9 3.5 76.6 46.7 91.7 101.2 110.4 98.4 37.1 112.2 85.1 22.8 41.4 39.6 98.2 63.6 36.4 114.2 114.2 49.3 40.2 296.4 40.9 60.2 277.7 282.0 75.7 82.2 143.0 108.2 93.9 34.7 153.6 3.7 28.9 179.3 85.6 107.1 12.9 96.4 74.1 0.8 25.3 20.3 79.2 82.2 245.5 104.4 66.9 291.8 94.4 90.2 131.4 250.4 134.1 42.0 33.7 29.8 126.3 57.1 34.0 100.0 102.1 146.1 87.6 27.9 66.6 32.4 83.7 70.7 0.1 2.1 117.8 60.9 62.5 103.6 16.4 111.4 146.0 84.6 71.7 64.7 78.4 0.1 10.6 12.8 100.5 95.9 107.0 17.1 165.8 93.5 62.2 130.4 60.0 0.5 25.1 51.0 123.7 0.4 22.3 34.0 507.2 9.7 111.5 31.6 26.2 117.3 33.9 30.8 34.3 38.9 30.0 63.0 44.3 35.2 25.8 40.0 37.1 41.4 49.3 102.0 51.3 37.1 15.3 4.8 123.0 115.8 127.3 81.4 0.4 50.1 35.9 9.3 67.2 70.8 27.6 0.0 62.0 35.5 204.0 15.6 98.7 1.2 25.5 66.5 111.8 33.6 30.1 4.6 119.4 120.2 109.3 43.8 42.3 7.6 27.6 159.2 145.0 176.4 0.0 1.3 56.8 32.6 146.7 113.4 5.4 102.2 102.4 71.2 32.8 127.1 15.9 104.0 11.1 0.9 116.6 239.4 65.8 4.2 141.2 227.5 96.9 30.8 0.7 124.9 64.1 89.4 1.3 1.1 57.0 134.7 148.6 31.2 21.5 57.4 140.1 CACNB1 CACNLB1 ENSG00000067191 "Calcium voltage-gated channel auxiliary subunit beta 1" Q02641 17 39173453-39197703 "FDA approved drug targets, Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 331.5;tongue: 217.9" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Excitatory neurons: 14.3;Skeletal myocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023343 Approved NA NA "HPA023343: AB_1845866" "unprognostic (3.44e-2)" "unprognostic (1.89e-2)" "unprognostic (1.69e-3)" "prognostic unfavorable (3.80e-4)" "unprognostic (3.99e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-2)" "unprognostic (2.80e-3)" "unprognostic (4.43e-1)" "unprognostic (1.04e-3)" "unprognostic (5.98e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-11)" "unprognostic (7.62e-2)" "unprognostic (2.30e-1)" "unprognostic (1.34e-2)" "unprognostic (7.44e-3)" 4.9 3.7 11.1 2.7 23.3 1.4 5.6 0.1 31.2 9.5 0.0 6.8 1.5 6.4 5.4 6.9 7.0 2.1 6.7 22.7 10.4 3.3 1.0 9.4 2.5 5.3 7.7 21.7 6.8 2.7 1.6 7.8 1.7 11.5 8.2 2.6 5.5 13.6 5.5 331.5 11.2 4.2 2.9 0.1 4.7 3.7 7.7 4.1 4.4 6.9 217.9 1.8 6.5 6.6 20.0 6.1 2.7 3.3 7.6 3.6 4.4 0.1 3.6 4.4 3.3 4.1 2.0 6.0 10.4 3.6 5.4 4.7 5.6 3.2 5.9 2.4 5.0 3.7 1.5 7.4 0.8 7.4 0.2 0.9 4.9 1.9 6.9 7.8 4.3 2.4 6.4 0.9 8.9 3.5 1.7 7.6 2.8 2.4 0.9 1.9 5.1 10.9 4.6 1.3 1.9 8.3 5.0 2.1 11.2 3.5 1.2 7.9 4.1 3.4 5.9 6.8 4.4 3.7 4.1 1.5 1.7 4.8 0.0 2.4 0.0 0.4 0.0 0.6 0.1 0.9 0.0 0.6 0.8 0.1 0.0 0.2 0.3 0.0 0.6 0.1 1.0 0.1 0.2 11.1 23.3 0.1 31.2 22.7 10.4 5.3 7.7 21.7 11.5 0.1 4.1 20.0 1.4 3.2 3.2 20.9 0.8 2.9 0.7 2.3 2.8 3.1 1.5 1.1 1.7 0.0 2.2 0.0 0.0 0.1 4.0 7.1 0.0 0.6 4.2 1.1 3.3 1.5 0.0 0.4 14.3 0.9 0.1 4.9 2.6 1.7 0.0 2.1 0.4 0.1 1.0 0.0 8.3 1.4 4.1 0.8 5.1 2.4 1.8 1.6 5.4 1.0 0.6 7.2 1.0 2.5 2.1 1.5 1.0 1.2 2.3 2.4 0.0 0.0 0.8 1.4 0.0 13.4 7.0 2.9 0.8 1.1 3.0 0.1 4.6 1.6 1.0 1.1 EVI5 NB4S ENSG00000067208 "Ecotropic viral integration site 5" O60447 1 92508696-92792404 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027339 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027339: AB_1848308" "unprognostic (1.23e-1)" "unprognostic (2.84e-1)" "unprognostic (4.29e-3)" "unprognostic (1.65e-1)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-3)" "unprognostic (7.43e-2)" "unprognostic (1.12e-1)" "unprognostic (9.11e-2)" "unprognostic (9.04e-3)" "unprognostic (2.25e-1)" "unprognostic (6.15e-2)" "unprognostic (8.30e-2)" "unprognostic (5.40e-1)" "unprognostic (6.38e-2)" "unprognostic (2.35e-2)" 5.7 8.1 6.4 4.6 7.8 2.7 4.5 8.9 6.3 6.0 8.1 4.9 4.4 6.5 4.6 4.0 5.2 5.8 7.2 4.0 7.9 5.1 16.6 7.2 3.3 8.2 6.3 2.2 3.8 3.9 7.9 4.0 12.2 6.7 5.3 5.5 4.9 4.6 5.7 3.0 5.0 4.1 7.1 9.3 4.5 6.4 9.6 7.4 1.3 6.6 3.7 3.3 5.5 3.8 11.3 5.4 5.9 9.1 8.9 14.5 18.2 8.6 12.2 18.5 8.2 9.4 10.4 1.4 2.4 16.8 14.0 15.2 6.1 8.6 9.0 14.6 0.2 3.3 4.3 5.6 6.2 14.2 3.1 4.8 11.5 7.2 14.2 8.5 23.9 17.9 0.2 7.7 3.8 13.9 2.7 0.3 3.6 2.6 3.5 4.8 2.2 21.7 3.2 6.3 15.5 3.4 7.0 14.4 7.4 16.6 9.8 3.6 7.1 11.8 9.1 6.6 12.2 8.1 5.5 3.4 3.8 6.0 5.0 7.6 0.9 2.7 2.8 0.1 1.9 0.0 1.2 0.1 0.0 1.3 1.2 0.0 0.0 3.4 0.1 2.9 0.8 0.0 0.4 6.4 7.8 8.9 6.3 4.0 7.9 8.2 6.3 2.2 6.7 9.3 7.4 11.3 27.2 60.9 29.9 91.4 18.7 43.5 29.3 23.0 18.2 24.5 20.5 17.7 51.8 22.8 32.3 16.5 25.0 48.4 7.5 22.9 17.6 27.9 3.0 67.8 39.4 31.2 22.1 11.4 158.4 29.9 26.0 42.5 42.3 26.2 13.3 21.9 43.2 52.4 32.2 30.3 149.3 27.0 14.2 54.0 27.0 5.8 28.3 45.1 26.6 114.3 48.9 28.5 5.2 112.6 199.6 68.4 19.3 54.2 28.8 28.1 21.8 20.1 46.9 25.4 13.1 51.4 56.4 37.4 42.4 21.2 50.0 65.5 5.5 60.9 20.0 32.1 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978926-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.5 17.4 29.4 6.6 31.9 4.5 10.5 19.8 38.0 9.7 15.1 9.8 6.0 9.2 5.7 9.5 7.3 6.4 19.0 32.9 30.9 8.4 13.3 10.3 5.6 33.3 26.6 34.9 8.6 10.2 7.8 16.8 7.5 30.4 9.9 3.6 3.2 8.4 8.9 18.8 9.2 8.0 7.7 23.2 8.0 9.5 13.2 30.2 8.2 13.7 9.0 3.8 11.9 9.2 29.4 5.8 10.8 6.4 8.8 12.7 8.0 5.4 18.3 7.1 9.8 8.3 3.2 31.4 5.8 28.3 14.9 7.3 18.9 6.1 12.9 3.1 19.4 6.6 6.1 10.0 3.6 12.5 4.0 4.6 14.3 9.9 15.4 14.5 8.1 9.3 13.1 14.6 10.9 14.3 8.8 7.6 2.9 3.1 8.9 8.6 4.5 6.5 8.9 20.7 6.3 12.1 7.9 8.4 10.9 11.9 4.0 9.1 4.4 14.3 22.4 7.2 25.8 24.9 10.6 5.8 3.0 20.6 12.1 11.6 1.0 4.1 2.5 5.3 7.7 4.4 4.5 4.3 7.0 6.5 5.6 8.7 9.2 2.1 8.0 18.2 11.5 8.1 5.5 29.4 31.9 19.8 38.0 32.9 30.9 33.3 26.6 34.9 30.4 23.2 30.2 29.4 15.2 0.0 4.1 7.2 5.3 3.2 3.7 7.2 1.8 13.1 7.0 4.8 10.8 2.8 5.8 7.3 6.2 13.0 3.5 8.9 1.9 25.1 1.0 2.8 6.2 7.7 10.2 4.2 6.9 19.0 8.6 11.4 12.8 5.4 4.5 8.5 5.0 5.1 10.8 16.8 8.1 7.3 4.1 3.3 2.2 2.6 9.0 3.3 3.6 2.8 2.5 11.9 2.1 7.5 4.1 20.8 4.9 11.7 3.4 6.8 12.6 4.8 2.7 14.0 6.6 7.5 9.7 20.8 7.8 4.7 2.0 5.6 4.1 13.7 5.6 3.3 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Translation regulation" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 4247.6;tongue: 2926.5" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 2065.2;Late spermatids: 1763.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol No No 310000000 Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (1.30e-4)" "prognostic unfavorable (2.74e-6)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 185.6 605.8 545.3 344.4 547.9 442.9 192.1 588.1 627.5 410.3 673.4 212.9 172.3 204.5 207.5 663.6 242.1 213.9 748.3 528.5 544.1 416.9 32.5 238.9 286.4 607.4 552.7 513.3 170.8 113.6 271.9 225.9 170.0 653.1 254.7 208.2 1277.7 393.0 294.4 4247.6 353.3 219.9 301.6 512.2 241.1 230.5 237.0 653.1 205.4 176.1 2926.5 432.6 584.0 378.0 674.2 1584.6 3937.1 788.9 938.8 914.3 1009.4 638.7 1684.6 3878.2 2619.1 2623.6 1094.4 1931.2 1184.5 1627.3 3157.6 1937.8 2253.9 2480.9 3383.2 2051.7 2134.0 1126.5 727.7 1809.1 929.7 637.1 955.2 1525.1 926.4 1559.2 2025.1 810.9 3403.0 1558.6 587.3 182.8 933.3 4267.0 965.1 359.4 419.6 966.2 2438.6 1433.3 1046.5 2560.0 2301.7 3557.2 1973.8 804.4 871.5 2226.3 1344.7 1755.4 1291.4 932.0 675.7 1247.3 3003.7 1622.0 2928.7 3110.3 1170.0 1762.1 1037.2 3720.5 1534.4 3002.3 131.9 836.3 138.6 192.6 466.7 187.9 205.2 254.1 190.4 685.6 142.9 215.8 162.5 100.7 108.4 380.1 140.5 334.0 1261.7 545.3 547.9 588.1 627.5 528.5 544.1 607.4 552.7 513.3 653.1 512.2 653.1 674.2 95.9 118.6 88.1 107.7 169.6 565.5 708.9 2065.2 307.9 480.7 157.8 174.7 313.2 87.2 759.4 829.4 369.1 566.1 100.2 358.9 802.2 1395.6 315.0 169.2 77.3 207.7 282.2 44.8 90.2 597.0 1416.7 220.1 138.1 188.0 206.7 144.0 73.2 4.3 750.0 1065.0 97.6 166.8 925.7 297.7 532.9 1763.1 157.2 558.8 355.8 38.4 1255.0 784.1 78.2 53.3 33.4 1213.2 264.5 268.1 209.9 431.4 389.1 208.7 396.9 708.6 124.9 160.9 398.2 43.4 98.6 341.6 389.0 575.7 192.7 157.4 380.7 860.7 DHX29 DDX29 ENSG00000067248 "DExH-box helicase 29" Q7Z478 5 55256055-55307694 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Helicase, Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038317, HPA038318" Approved Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA038317: AB_10673169, HPA038318: AB_10672589" "unprognostic (3.43e-2)" "unprognostic (5.09e-1)" "unprognostic (2.21e-2)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.80e-1)" "unprognostic (2.37e-3)" "unprognostic (1.72e-1)" "unprognostic (6.66e-2)" "unprognostic (1.76e-2)" "unprognostic (3.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.57e-3)" "unprognostic (4.01e-1)" "unprognostic (3.85e-1)" "unprognostic (4.78e-3)" "unprognostic (9.40e-2)" 10.2 10.7 6.3 9.8 6.7 6.8 12.2 9.9 6.7 12.6 7.2 10.9 7.3 11.5 6.9 12.8 9.6 8.9 10.8 6.2 6.0 17.1 13.3 9.5 9.6 5.8 6.0 5.6 9.0 11.8 18.8 10.4 11.5 6.5 13.5 9.9 8.8 10.4 12.1 24.4 11.4 8.4 12.7 5.8 8.0 10.5 7.5 5.7 10.1 15.5 14.9 9.8 12.1 10.4 8.0 36.7 25.5 20.9 27.2 32.3 28.2 25.6 38.9 30.9 28.2 28.7 21.3 23.0 20.7 34.9 44.5 35.8 26.0 34.0 37.1 40.5 9.1 19.4 18.8 21.6 14.6 18.3 13.3 19.6 23.8 23.0 29.9 17.2 18.5 37.9 16.5 24.4 15.0 33.4 25.9 21.4 11.1 17.5 10.5 27.1 10.9 31.8 35.7 23.0 25.3 19.6 12.5 37.4 21.3 18.6 20.5 28.7 21.7 32.9 25.9 20.2 22.8 27.4 13.2 24.1 29.0 29.9 23.0 29.1 68.6 22.5 24.3 18.0 24.4 20.4 27.3 22.5 20.0 17.5 26.3 25.0 21.6 20.6 24.5 30.1 36.8 21.9 8.9 6.3 6.7 9.9 6.7 6.2 6.0 5.8 6.0 5.6 6.5 5.8 5.7 8.0 44.5 70.5 42.6 34.0 35.2 37.6 37.5 71.8 39.3 81.6 44.9 49.8 73.6 41.5 69.4 64.4 41.7 68.3 39.5 34.4 54.8 61.4 54.8 37.4 61.5 40.7 38.4 68.4 47.3 61.7 54.6 52.7 35.7 36.5 31.6 39.0 22.9 45.0 41.2 42.1 46.9 36.4 63.1 26.0 26.6 16.6 46.6 41.5 28.4 28.1 50.7 35.7 35.0 42.7 54.9 61.9 27.3 53.0 57.0 53.2 35.2 105.2 35.9 83.6 52.6 52.8 54.2 117.5 108.1 50.1 47.5 81.3 36.1 106.4 39.9 43.3 DNTTIP2 "ERBP, HSU15552, TdIF2" ENSG00000067334 "Deoxynucleotidyltransferase terminal interacting protein 2" Q5QJE6 1 93866284-93879918 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044502, HPA053707" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044502: AB_10960277, HPA053707: AB_2682236" "unprognostic (2.95e-3)" "unprognostic (3.84e-2)" "unprognostic (6.21e-3)" "unprognostic (1.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (7.94e-2)" "unprognostic (5.57e-3)" "unprognostic (2.69e-2)" "unprognostic (2.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (2.59e-1)" "unprognostic (8.41e-2)" "unprognostic (2.25e-1)" "unprognostic (1.06e-2)" 5.0 3.8 5.7 3.6 5.9 15.4 5.0 10.5 7.4 3.5 6.0 3.4 2.8 4.0 6.4 4.4 3.6 4.5 4.5 6.2 6.0 4.2 5.0 3.8 5.5 5.8 5.9 5.0 4.3 3.5 3.8 2.1 4.6 6.0 3.7 3.6 4.2 2.9 3.1 9.0 5.6 2.8 3.7 4.6 4.5 3.6 4.6 5.6 4.4 4.7 5.1 5.3 6.6 2.8 7.5 14.3 6.6 7.2 7.8 6.9 6.2 11.1 9.4 6.6 11.0 9.4 7.3 6.1 18.8 12.2 9.9 13.8 7.7 11.9 11.2 15.6 11.4 6.6 15.4 11.3 11.0 7.2 17.4 5.3 6.8 11.9 11.9 9.8 5.5 7.9 6.0 18.6 6.0 15.1 6.3 12.2 11.3 14.2 6.3 10.6 7.0 15.6 7.2 11.3 10.8 8.7 7.7 9.8 14.4 10.5 9.2 6.2 12.6 7.7 8.8 9.2 10.2 15.9 6.4 9.3 15.3 5.1 13.6 5.9 9.7 5.7 11.6 6.4 8.3 7.7 8.2 5.8 5.8 5.1 8.4 5.3 6.9 8.0 9.6 8.5 3.5 6.4 6.8 5.7 5.9 10.5 7.4 6.2 6.0 5.8 5.9 5.0 6.0 4.6 5.6 7.5 98.9 57.7 78.2 3.6 66.7 54.4 163.0 57.9 43.3 33.9 27.5 38.9 73.0 11.5 91.2 12.9 58.4 52.0 110.2 17.3 21.5 74.3 53.8 85.1 72.0 74.2 8.4 20.6 6.8 60.3 44.4 54.3 38.2 122.4 119.4 36.6 25.7 19.4 38.1 20.2 7.7 14.5 46.8 29.5 72.1 11.0 25.7 75.8 23.2 8.4 52.1 29.2 48.4 3.5 7.2 88.6 20.1 25.9 50.1 96.7 17.2 19.6 85.1 34.4 19.7 90.7 79.0 62.8 65.9 40.0 50.6 55.8 87.7 44.4 23.1 112.0 METTL22 "C16orf68, FLJ12433,MGC2654" ENSG00000067365 "Methyltransferase like 22" Q9BUU2 16 8621683-8649654 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 119.9;Late spermatids: 357.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040803, HPA059882, HPA074173" Uncertain Supported "Nucleoplasm,Nucleoli rim" Yes No "Nucleoli rim" Nucleoplasm "HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672" "unprognostic (1.74e-1)" "unprognostic (6.50e-2)" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (7.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-3)" "unprognostic (3.82e-2)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" "unprognostic (1.15e-2)" "unprognostic (8.90e-2)" 4.2 5.9 9.6 5.8 10.6 7.7 4.6 15.7 13.4 6.6 10.0 5.2 4.9 5.9 6.1 5.3 5.4 4.4 8.2 9.0 9.5 5.1 6.7 4.7 6.1 12.8 10.2 8.9 6.4 6.1 3.1 5.1 5.0 13.8 7.3 4.1 10.5 4.8 5.3 20.3 8.5 4.2 4.8 9.1 4.7 5.2 13.8 11.8 4.0 5.3 6.0 5.0 5.5 5.9 13.6 4.3 8.7 9.7 9.3 3.6 9.1 8.4 7.2 3.8 8.4 9.5 8.5 9.8 6.7 6.3 6.4 3.1 7.9 6.1 11.5 5.5 9.8 8.4 6.9 17.3 24.6 10.8 7.2 5.1 9.2 8.2 9.2 10.1 5.1 6.8 9.2 9.4 6.6 6.5 15.2 7.4 17.0 5.2 1.9 8.5 11.1 7.3 13.9 4.1 4.5 11.9 7.9 6.3 7.3 4.7 5.2 8.0 5.9 5.4 10.0 8.7 8.2 3.3 8.9 5.3 10.4 3.6 9.3 4.7 1.6 2.5 2.0 0.9 1.9 0.9 0.9 0.9 1.0 2.3 0.8 1.1 0.5 9.7 1.6 2.2 1.3 1.2 1.0 9.6 10.6 15.7 13.4 9.0 9.5 12.8 10.2 8.9 13.8 9.1 11.8 13.6 5.1 9.6 5.6 8.5 7.6 3.3 6.9 7.5 8.6 13.8 5.8 6.1 18.3 4.3 6.0 0.0 4.2 12.8 2.7 4.9 11.7 9.3 119.9 3.5 6.5 7.2 7.2 18.5 13.4 9.8 9.8 7.4 9.2 3.5 8.2 11.3 5.7 7.4 29.5 1.7 14.3 7.0 2.0 31.8 9.6 357.8 10.8 27.5 1.8 12.2 17.6 4.9 11.3 12.5 13.3 8.4 6.8 13.9 7.7 11.0 8.3 8.9 3.4 11.8 0.0 9.0 8.5 39.6 15.7 7.5 2.7 13.3 6.6 7.8 6.5 8.1 TP53BP1 "53BP1, p202, TDRD30" ENSG00000067369 "Tumor protein p53 binding protein 1" Q12888 15 43403061-43510728 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004083, HPA008788, HPA022133, CAB079980" Supported Supported "Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles" Yes No "Nuclear bodies" "Nucleoplasm, Mitotic chromosome, Vesicles" "CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382" "unprognostic (2.12e-1)" "unprognostic (7.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.85e-2)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.03e-2)" "unprognostic (3.96e-1)" "unprognostic (2.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.34e-2)" "unprognostic (4.07e-1)" "unprognostic (8.06e-2)" "unprognostic (9.11e-2)" "unprognostic (1.52e-1)" "unprognostic (6.99e-2)" "unprognostic (3.38e-2)" 6.9 11.6 19.9 10.2 17.2 11.7 10.8 19.8 15.0 17.8 18.8 8.6 6.4 16.1 16.1 6.1 14.9 10.8 8.8 14.9 24.1 9.1 4.1 8.3 8.6 14.1 13.8 14.5 16.9 7.5 22.5 24.2 12.3 13.3 12.2 10.3 22.2 10.2 12.9 7.3 9.3 6.4 16.4 9.8 8.7 7.7 21.8 20.0 15.5 18.0 11.1 12.7 11.3 8.8 14.1 13.5 22.3 63.8 40.1 25.8 31.9 15.8 22.8 33.8 31.0 39.1 19.4 15.8 14.5 19.2 39.0 66.9 32.4 46.3 27.5 36.8 38.9 15.8 27.1 40.1 11.7 16.8 30.2 37.4 24.9 19.0 41.8 31.2 51.7 37.4 24.2 26.9 12.3 36.5 9.6 23.7 14.1 41.1 24.2 13.9 25.1 23.9 9.3 22.9 31.8 57.3 26.8 33.8 14.3 8.5 48.6 29.9 16.9 27.5 33.7 22.3 27.0 20.5 9.8 22.4 33.0 27.6 14.6 17.5 1.4 0.5 1.0 1.6 0.7 1.3 1.9 1.6 1.6 1.2 1.8 1.8 1.6 0.6 0.9 0.5 1.3 1.4 0.7 19.9 17.2 19.8 15.0 14.9 24.1 14.1 13.8 14.5 13.3 9.8 20.0 14.1 11.5 22.4 22.3 53.2 17.8 6.4 10.2 10.0 13.6 32.4 17.4 13.2 14.9 5.7 20.8 29.5 47.9 13.4 11.1 7.4 9.8 14.5 38.8 47.0 44.8 16.8 41.9 8.4 66.2 7.1 11.2 23.9 14.8 26.8 26.6 47.0 15.0 3.3 10.8 47.1 81.9 15.7 12.2 3.8 6.9 17.8 23.6 9.3 1.8 17.8 4.0 11.9 7.2 62.8 50.4 7.5 5.8 17.7 17.1 11.0 2.6 8.8 60.7 51.7 13.1 35.2 20.5 33.1 36.2 14.7 5.3 18.5 17.0 29.9 13.4 8.9 TRO "KIAA1114, MAGE-D3, MAGED3" ENSG00000067445 Trophinin Q12816 X 54920462-54931431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 31.4" "Cell type enhanced" "Detected in many" "Astrocytes: 9.4;Excitatory neurons: 14.6;Granulosa cells: 12.3;Inhibitory neurons: 20.0;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 9.4" "Cancer enhanced" "Detected in many" "testis cancer: 11.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 37.1;SH-SY5Y: 33.8;SuSa: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071449 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA071449: " "unprognostic (6.18e-2)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.09e-3)" "unprognostic (2.72e-1)" "unprognostic (5.66e-2)" "unprognostic (1.46e-1)" "unprognostic (4.67e-2)" "unprognostic (3.18e-1)" "prognostic favorable (1.93e-4)" "unprognostic (1.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.67e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (6.86e-2)" 3.7 3.0 10.4 1.3 10.9 1.0 3.8 0.7 23.9 9.3 0.7 2.5 0.9 13.5 6.6 1.6 5.4 4.3 1.9 10.8 11.2 3.9 16.9 2.1 1.6 5.5 3.5 9.1 17.7 7.2 5.3 24.5 4.4 10.9 5.5 2.1 6.2 1.5 5.3 31.4 1.2 1.6 8.7 1.7 1.0 2.0 2.6 8.3 4.7 10.2 1.0 1.6 2.6 5.5 13.6 0.0 0.3 37.1 0.1 7.1 9.8 0.0 2.1 13.1 2.0 0.7 0.0 0.0 0.0 5.3 13.8 3.1 0.2 0.3 0.6 1.0 0.1 23.3 18.0 0.0 1.5 2.7 0.0 0.1 22.8 0.0 12.0 0.0 11.8 0.9 9.1 0.0 0.2 14.0 0.0 0.3 0.1 19.6 0.1 0.0 11.3 16.4 0.1 3.5 0.3 25.3 33.8 0.0 0.5 3.1 74.2 0.0 2.2 0.0 15.7 15.9 0.2 2.2 5.8 0.9 0.0 2.3 0.0 13.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.0 2.2 0.1 0.9 0.0 0.1 10.4 10.9 0.7 23.9 10.8 11.2 5.5 3.5 9.1 10.9 1.7 8.3 13.6 0.4 0.0 0.0 9.4 0.3 0.4 1.4 0.8 5.2 4.2 0.5 1.9 1.8 0.0 1.9 3.7 0.0 0.8 0.2 0.0 0.0 1.7 0.4 0.3 7.9 1.9 0.0 0.0 14.6 0.2 0.6 7.0 0.5 0.5 1.3 12.3 0.4 0.0 0.5 8.4 20.0 0.0 0.0 0.0 0.4 0.6 5.9 0.2 0.0 1.0 0.1 2.2 0.0 17.1 9.4 0.2 0.0 3.8 0.1 0.4 0.0 0.4 0.0 0.9 0.0 1.5 3.3 1.2 1.9 0.1 0.1 0.7 0.7 2.9 0.0 0.3 RRP15 "CGI-115, KIAA0507" ENSG00000067533 "Ribosomal RNA processing 15 homolog" Q9Y3B9 1 218285293-218337983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024639 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria" Yes No "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Mitochondria" "HPA024639: AB_1844368" "unprognostic (2.68e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (5.19e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (3.65e-3)" "unprognostic (2.54e-1)" "unprognostic (2.76e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-1)" "unprognostic (1.11e-2)" "unprognostic (3.23e-2)" 4.1 2.7 1.8 3.3 2.1 4.1 4.8 2.9 2.5 2.9 1.7 2.8 2.2 3.7 2.7 3.0 3.0 2.0 4.9 2.0 2.2 2.8 3.5 2.8 3.7 1.7 2.0 1.8 3.8 2.9 4.5 1.8 3.6 2.0 3.1 2.9 2.2 2.6 2.4 9.7 3.5 2.4 3.4 1.9 2.9 2.7 2.4 2.0 2.6 3.5 7.8 3.6 4.0 2.9 2.3 9.8 7.2 7.9 5.7 5.6 7.8 6.7 9.8 7.3 10.0 7.2 14.1 8.8 14.0 13.1 7.6 6.7 8.7 13.5 13.0 16.6 5.7 10.1 10.9 6.6 7.8 11.6 17.0 5.6 5.4 7.8 13.1 17.4 4.4 6.6 6.5 22.7 4.4 11.4 8.9 11.3 8.3 15.7 7.8 14.8 7.8 4.9 13.8 8.0 8.9 9.0 13.1 8.3 15.3 15.0 9.3 11.0 12.1 9.3 8.0 7.6 14.3 18.3 5.4 8.9 14.4 9.1 8.1 13.1 0.3 0.8 0.1 1.6 1.3 2.3 2.4 2.0 1.4 1.2 2.3 2.6 2.6 0.2 1.6 1.1 1.7 1.3 0.7 1.8 2.1 2.9 2.5 2.0 2.2 1.7 2.0 1.8 2.0 1.9 2.0 2.3 33.7 32.1 28.1 7.5 36.0 65.3 33.6 28.7 24.5 31.1 32.6 31.0 68.4 22.8 25.0 36.8 10.4 38.1 32.7 13.5 27.4 39.7 17.0 22.6 47.3 27.9 12.1 41.0 18.4 52.2 59.1 32.2 19.9 28.5 31.0 18.6 21.8 44.2 33.6 26.9 16.1 20.8 6.1 17.3 18.5 4.6 37.6 17.4 21.4 7.5 20.8 21.2 24.7 7.5 9.0 36.8 9.0 24.8 13.0 34.9 5.2 37.2 11.7 23.6 26.3 72.1 33.0 59.7 69.1 24.3 47.6 18.1 26.4 20.4 32.1 23.0 RHOA "ARH12, ARHA, Rho12, RHOH12" ENSG00000067560 "Ras homolog family member A" P61586 3 49359139-49412998 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Host-virus interaction" Hydrolase "Cancer-related genes, Disease variant, Ectodermal dysplasia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005052 Approved Supported "Plasma membrane,Cytosol" NA NA 1500000 "Plasma membrane, Cytosol" "CAB005052: AB_562216" "unprognostic (1.50e-1)" "unprognostic (3.38e-1)" "prognostic favorable (3.08e-4)" "unprognostic (8.75e-2)" "unprognostic (1.63e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (1.39e-1)" "unprognostic (8.83e-2)" "unprognostic (9.44e-3)" "unprognostic (2.21e-2)" "unprognostic (4.29e-2)" "prognostic favorable (3.21e-6)" "unprognostic (5.14e-2)" "unprognostic (7.50e-2)" "unprognostic (1.57e-1)" "unprognostic (4.52e-2)" 456.4 317.5 245.0 361.2 263.5 477.6 363.1 268.7 276.3 313.0 259.7 355.3 277.1 296.3 301.2 365.9 271.6 269.5 272.1 231.6 296.4 289.5 276.7 434.7 399.6 292.2 256.8 217.4 299.7 227.2 271.6 165.6 400.1 290.8 246.7 372.9 114.3 239.9 318.6 333.7 274.1 283.4 420.5 281.5 332.0 294.8 155.5 264.1 391.3 329.2 301.1 458.6 361.5 275.9 310.4 470.4 406.1 500.9 512.7 569.9 858.9 370.8 930.1 735.7 790.3 722.4 347.6 527.4 721.8 251.6 1404.1 448.8 259.5 560.4 630.6 817.6 505.7 323.3 678.8 488.0 416.0 604.2 647.9 472.8 668.2 437.8 643.2 508.1 799.7 1038.0 391.9 361.1 437.9 967.5 254.3 717.3 739.0 441.4 548.2 497.1 325.5 451.4 610.5 701.9 559.6 167.7 387.3 599.0 464.5 495.4 499.4 301.7 819.6 972.1 558.4 483.2 737.2 725.7 388.0 775.6 754.8 567.9 691.6 678.3 716.9 1105.5 1160.5 480.1 1358.8 423.8 432.7 415.6 479.6 806.9 379.3 314.5 397.1 1282.7 440.9 1398.1 645.5 554.9 1884.8 245.0 263.5 268.7 276.3 231.6 296.4 292.2 256.8 217.4 290.8 281.5 264.1 310.4 502.8 387.8 265.2 20.5 374.6 270.9 260.0 236.1 251.6 47.1 239.4 223.1 141.1 178.7 220.9 180.3 6.2 355.8 373.1 447.2 340.4 339.5 48.2 174.2 243.7 413.8 234.4 319.3 26.1 347.8 709.8 386.2 313.9 201.0 257.3 141.6 312.7 173.2 760.0 82.4 27.0 344.9 191.2 771.9 495.8 55.6 335.2 683.7 327.3 52.5 710.0 219.9 389.3 24.6 51.4 398.0 354.6 407.7 375.7 334.1 341.3 350.8 201.1 40.8 276.1 354.1 450.1 264.4 253.6 390.8 279.6 525.2 359.5 299.1 347.7 371.4 DHX8 "DDX8, Dhr2, HRH1, PRP22, PRPF22" ENSG00000067596 "DEAH-box helicase 8" Q14562 17 43483865-43610338 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049285 Approved Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA049285: AB_2680698" "unprognostic (2.99e-1)" "unprognostic (4.42e-2)" "unprognostic (5.64e-2)" "unprognostic (9.02e-2)" "unprognostic (1.25e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-3)" "unprognostic (9.43e-2)" "unprognostic (2.58e-1)" "unprognostic (3.40e-2)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (4.04e-1)" "unprognostic (5.08e-3)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" 19.5 18.7 28.4 18.2 28.2 55.5 20.7 27.2 37.0 21.3 25.5 21.6 17.4 20.1 26.4 27.1 16.8 16.6 20.1 27.9 27.5 17.7 18.8 20.1 23.9 28.2 28.0 26.9 17.2 17.2 27.7 21.0 21.0 28.1 21.8 24.1 16.9 21.0 20.6 22.8 34.0 20.8 23.8 26.2 26.0 19.6 24.5 28.1 35.4 19.1 19.6 29.8 23.3 21.8 28.1 29.2 81.7 43.3 52.4 42.3 42.5 24.0 30.2 62.0 64.9 61.7 37.4 28.1 40.3 27.0 59.4 46.6 38.0 65.9 53.1 74.8 40.8 51.9 33.8 61.2 56.7 35.8 59.8 49.5 21.1 44.1 53.0 58.4 31.4 57.4 52.1 38.8 35.2 51.2 32.0 75.9 52.7 35.5 35.4 31.0 46.2 82.4 40.2 44.3 60.6 37.3 56.0 33.9 18.6 27.3 50.9 44.1 58.3 40.0 50.3 26.9 36.3 45.8 27.5 36.6 44.7 41.2 36.8 41.2 30.2 17.4 20.4 16.0 25.2 14.7 12.2 12.7 15.5 17.0 11.0 10.6 11.5 21.8 11.0 26.1 10.3 12.8 11.4 28.4 28.2 27.2 37.0 27.9 27.5 28.2 28.0 26.9 28.1 26.2 28.1 28.1 17.1 6.4 15.0 6.5 18.6 11.9 7.1 12.4 12.0 16.9 16.3 13.0 13.2 7.2 19.2 22.0 18.8 9.1 23.6 13.4 13.7 16.2 19.4 18.3 26.2 17.6 26.7 13.7 10.7 17.7 8.8 14.5 14.8 23.9 14.5 15.3 16.1 14.7 11.1 6.7 10.5 15.3 10.2 14.8 11.5 10.6 12.5 18.4 17.8 14.0 24.8 10.6 21.6 9.5 15.8 21.2 16.0 10.9 20.0 9.4 10.1 12.4 13.7 19.8 19.7 20.3 14.4 27.9 16.8 17.2 13.4 21.2 20.9 11.1 10.8 14.3 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050411-2185395 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.7" "Group enriched" "Detected in many" 4 "Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "eosinophil: 16.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "BEWO: 44.5;OE19: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.1 11.2 18.9 4.6 28.8 2.1 5.7 59.7 46.6 4.2 0.0 13.3 29.6 2.2 7.8 16.2 9.6 4.4 9.8 29.5 22.5 16.1 11.1 31.9 8.1 23.4 16.5 28.6 2.8 12.6 14.8 17.8 44.2 26.4 8.5 11.4 14.9 10.9 3.9 0.4 13.7 28.2 1.6 8.6 10.5 9.0 32.1 16.7 3.7 21.9 0.6 7.9 5.9 8.1 31.3 14.7 9.7 3.4 17.2 0.0 0.0 44.5 1.2 0.5 11.1 0.7 23.8 31.0 0.1 27.4 3.9 9.4 25.4 20.5 25.5 7.9 1.0 21.8 0.0 15.2 33.5 3.2 0.1 11.0 0.6 14.9 0.0 8.6 0.0 0.0 4.0 6.6 0.2 0.2 17.9 0.9 0.0 6.4 41.9 22.5 0.0 0.0 5.1 18.6 16.0 24.1 18.7 11.6 27.5 5.2 28.7 17.7 4.0 0.0 0.1 13.1 0.1 0.1 6.8 1.3 0.3 1.2 0.3 16.8 0.3 0.0 16.3 0.5 0.3 2.5 0.3 0.9 0.6 0.0 0.4 0.8 0.3 1.1 0.9 0.0 0.3 0.9 0.3 18.9 28.8 59.7 46.6 29.5 22.5 23.4 16.5 28.6 26.4 8.6 16.7 31.3 0.9 121.8 72.2 2.3 6.5 13.0 11.8 11.0 10.2 27.1 11.3 11.0 1.4 5.7 21.1 7.3 4.2 118.7 7.5 48.9 7.9 12.3 224.4 14.0 4.7 6.3 10.2 6.6 39.5 10.7 66.3 3.1 17.9 11.7 8.2 12.5 10.0 16.5 14.5 62.2 35.2 25.5 10.2 0.8 2.9 708.3 9.6 4.4 7.2 2.8 4.5 19.1 8.2 13.0 41.3 14.2 45.7 8.6 7.4 19.5 78.4 24.7 22.1 25.9 0.0 0.3 4.1 28.3 28.4 13.4 13.4 1107.9 9.8 2.6 31.3 14.3 ZFY ZNF911 ENSG00000067646 "Zinc finger protein Y-linked" P08048 Y 2935281-2982506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 35.7;Late spermatids: 88.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "white matter: 9.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001748, HPA071863" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA071863: AB_2686463" "unprognostic (1.07e-1)" "unprognostic (7.43e-2)" "prognostic favorable (3.58e-5)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-1)" "unprognostic (8.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.91e-1)" "unprognostic (2.54e-2)" 2.6 1.7 1.8 2.6 1.3 8.0 2.2 2.4 5.1 0.0 0.0 2.3 2.7 0.0 3.0 4.6 0.0 3.1 1.8 2.9 0.0 1.4 4.5 1.8 1.3 2.2 0.0 0.0 0.0 2.6 2.0 1.6 3.8 2.0 5.0 5.1 2.3 2.7 4.1 3.5 1.7 4.2 0.0 0.0 2.2 2.5 7.3 3.1 0.0 2.8 7.4 3.7 3.2 0.0 9.4 0.0 5.9 0.0 0.0 0.0 0.0 9.3 13.6 13.5 11.5 10.7 0.0 0.0 10.0 0.0 14.6 0.0 0.0 0.0 0.0 14.7 15.5 0.0 19.2 0.2 7.6 9.6 0.0 0.0 10.6 9.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 12.8 0.0 8.5 0.0 4.9 0.0 0.0 0.0 8.1 5.2 7.6 17.7 9.8 0.0 0.0 0.0 13.4 6.4 0.0 6.5 11.7 11.3 0.0 0.1 7.3 6.7 0.0 17.5 1.8 0.0 0.0 0.0 2.7 2.2 2.3 1.8 3.1 2.0 2.5 1.3 2.8 2.4 2.7 1.4 1.5 2.9 1.5 2.0 1.6 1.8 1.8 1.3 2.4 5.1 2.9 0.0 2.2 0.0 0.0 2.0 0.0 3.1 9.4 0.0 9.6 10.5 7.2 14.7 11.1 10.6 6.8 10.2 12.4 0.0 0.0 7.6 7.2 10.3 1.8 8.4 5.0 8.0 1.0 0.0 4.4 35.7 0.0 0.0 5.8 1.8 11.1 14.1 0.0 2.8 7.8 11.7 0.0 7.0 0.0 10.0 3.7 3.4 13.5 11.3 1.9 2.0 11.3 12.6 88.9 9.9 10.5 3.6 6.5 8.0 12.1 18.6 7.5 6.7 1.3 0.0 10.9 12.2 11.7 1.9 3.3 7.5 8.6 13.1 6.5 5.9 20.3 7.7 12.8 9.5 3.7 12.7 0.1 2.4 12.0 IARS2 FLJ10326 ENSG00000067704 "Isoleucyl-tRNA synthetase 2, mitochondrial" Q9NSE4 1 220094132-220148041 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cataract, Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024212, HPA024594, HPA024596" Enhanced Enhanced Mitochondria NA NA 35000 Mitochondria "HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370" "unprognostic (2.15e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.42e-3)" "unprognostic (3.22e-2)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (1.78e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.24e-5)" "unprognostic (9.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.01e-1)" "unprognostic (2.16e-1)" "unprognostic (8.87e-2)" "unprognostic (6.27e-3)" 56.3 50.2 21.2 33.6 22.1 18.4 42.2 24.7 25.6 35.6 35.4 54.7 43.8 32.1 31.7 48.4 41.7 30.7 60.6 20.7 22.3 66.1 84.5 31.3 39.1 24.8 23.5 20.2 39.3 33.8 81.2 16.2 41.0 26.4 36.4 55.3 35.1 40.3 37.9 93.8 39.3 40.8 39.7 23.0 28.6 39.5 30.3 22.7 32.1 40.0 86.5 43.5 35.9 30.2 24.1 137.2 125.6 70.7 69.9 104.2 104.4 169.6 81.4 86.9 87.9 70.7 121.7 138.8 125.6 107.1 101.4 68.0 129.3 99.0 101.5 100.9 87.5 119.3 62.6 94.6 137.8 64.6 100.4 64.9 76.0 101.3 95.4 97.6 84.7 86.9 79.9 156.9 70.7 116.7 75.9 79.8 72.0 92.1 106.2 82.1 69.5 140.7 202.2 126.2 90.4 38.0 106.6 123.2 188.2 130.3 80.6 218.5 111.9 89.8 86.1 71.6 117.0 138.4 60.0 98.9 90.8 91.3 77.3 97.6 33.8 24.6 22.8 23.0 27.7 30.8 23.6 24.9 30.3 29.2 18.3 27.8 25.6 4.7 28.3 22.3 10.6 29.9 26.7 21.2 22.1 24.7 25.6 20.7 22.3 24.8 23.5 20.2 26.4 23.0 22.7 24.1 66.4 35.3 38.0 15.7 30.7 20.1 28.6 44.1 34.7 28.6 40.1 39.4 144.3 22.8 42.9 29.5 25.0 79.0 31.5 54.2 11.7 47.7 20.0 63.8 48.3 43.7 36.2 29.6 17.3 65.4 55.5 37.0 32.1 44.3 19.6 41.3 37.5 99.6 45.9 20.2 22.7 55.4 28.5 51.0 11.2 6.8 37.3 35.9 19.6 15.0 46.1 34.6 27.8 16.6 31.5 67.4 44.9 42.5 33.1 34.1 38.4 36.1 62.0 35.5 46.0 46.3 39.0 44.6 44.1 63.5 26.6 71.7 31.0 54.4 69.9 27.6 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "brain: 443.1;retina: 199.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 443.1" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.0;naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported NA NA "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 0.5 21.9 73.0 2.2 172.1 0.6 0.7 24.5 443.1 1.4 0.0 3.4 1.5 10.0 0.7 0.7 0.8 1.4 0.2 133.4 92.9 1.9 1.9 0.9 0.3 13.8 31.8 145.4 5.2 0.3 0.0 6.5 2.6 46.3 6.7 2.9 199.4 0.2 5.6 0.2 0.2 3.4 25.4 0.0 2.6 1.3 0.7 21.3 0.5 0.3 0.5 0.3 1.6 2.6 172.5 0.0 19.2 14.2 0.0 1.4 4.0 0.0 1.4 1.7 1.0 1.1 1.0 0.5 0.0 2.8 0.2 5.0 0.6 0.3 2.2 1.6 0.3 0.7 1.0 0.5 0.0 3.6 0.0 0.3 1.1 1.4 5.2 39.4 37.1 13.6 0.7 0.7 2.2 31.9 3.1 1.8 0.0 10.3 2.1 5.3 0.0 14.3 0.0 0.0 5.5 18.8 30.9 0.0 2.4 0.3 9.5 6.8 0.0 5.4 2.0 0.7 0.0 6.2 3.4 8.0 0.1 4.5 0.0 29.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.0 172.1 24.5 443.1 133.4 92.9 13.8 31.8 145.4 46.3 0.0 21.3 172.5 2.2 0.0 0.6 124.7 9.0 0.9 0.1 0.0 0.0 1287.6 0.2 3.4 0.6 0.0 1.3 0.0 894.5 5.6 0.1 0.1 0.0 0.0 1.4 0.6 20.2 10.4 96.9 1.3 3753.2 0.2 2.2 5.9 0.0 0.7 0.0 0.7 1.8 0.1 13.9 62.2 2910.4 0.1 0.0 4.7 7.2 2.9 69.3 1.6 1.8 137.7 0.0 337.7 0.0 126.2 105.1 0.1 7.6 4.5 8.5 11.5 0.1 0.1 0.0 905.8 0.0 0.0 6.7 1.5 5.7 0.2 0.6 5.9 0.4 1.8 0.1 0.3 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213010 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.3;ovary: 18.5" "Group enriched" "Detected in many" 6 "Astrocytes: 882.1;Excitatory neurons: 1473.6;Inhibitory neurons: 753.8;Microglial cells: 534.0;Oligodendrocyte precursor cells: 786.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 47.0;THP-1: 41.8;U-138 MG: 30.8;WM-115: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 3.8 4.9 10.3 1.0 15.4 0.5 4.0 1.3 18.3 1.2 0.0 1.4 0.3 2.0 3.0 1.9 2.2 5.2 1.9 12.9 1.9 0.4 1.0 3.3 0.6 3.4 1.5 12.1 18.5 0.5 0.4 3.2 2.3 4.0 2.2 0.8 5.3 0.9 2.6 1.3 2.3 0.6 2.5 1.1 8.0 0.8 2.8 0.9 1.9 1.2 3.5 0.4 3.4 1.7 12.3 3.5 8.7 0.6 0.2 8.5 18.1 0.3 26.5 20.9 10.7 5.3 1.7 0.6 0.2 1.9 22.0 7.2 2.5 7.8 4.0 19.3 0.1 0.2 0.2 3.9 0.2 6.7 0.1 0.2 6.2 0.2 47.0 11.1 9.3 16.4 0.1 0.0 0.1 26.2 0.5 0.2 12.0 2.7 0.3 2.1 1.0 2.1 0.0 1.7 0.1 0.6 0.0 1.6 0.3 3.5 0.8 0.1 41.8 14.1 30.8 8.1 12.0 18.2 1.2 0.0 0.7 8.8 0.5 38.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 10.3 15.4 1.3 18.3 12.9 1.9 3.4 1.5 12.1 4.0 1.1 0.9 12.3 11.1 19.2 10.0 882.1 0.0 3.6 8.4 0.2 0.0 5.0 3.8 3.8 3.4 0.0 7.5 0.0 0.0 0.1 0.0 0.2 0.0 4.2 10.4 4.2 8.2 5.6 16.4 0.0 1473.6 1.6 0.1 18.7 0.5 10.3 11.4 0.8 3.9 0.0 7.3 50.5 753.8 0.0 0.0 0.0 3.7 4.7 23.9 1.4 12.4 534.0 0.1 18.3 0.0 786.1 144.1 19.2 0.0 7.5 1.2 18.0 0.0 0.3 8.7 2.0 0.0 28.8 5.3 0.3 0.8 0.2 1.4 0.3 1.3 73.7 0.0 2.9 IDH3G ENSG00000067829 "Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No 19000 "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 50.8 67.6 43.2 38.9 47.2 60.9 50.3 44.8 61.8 44.5 42.5 52.3 52.8 51.2 23.7 50.6 45.2 35.3 83.2 50.9 45.0 68.4 49.6 42.4 40.6 46.5 43.2 43.4 49.7 48.7 45.8 48.3 28.5 49.9 44.2 35.0 24.6 52.1 40.3 101.3 52.1 55.2 34.8 39.8 52.2 52.6 32.3 44.8 35.5 48.4 83.7 35.2 44.6 43.5 49.7 94.9 90.0 47.3 65.9 74.4 59.4 62.0 47.3 64.1 80.5 84.3 76.0 66.5 121.4 80.2 74.7 68.2 67.2 72.6 69.2 30.0 38.9 101.7 43.0 118.9 59.0 85.5 61.6 87.5 76.1 48.0 64.4 69.4 50.4 65.3 50.3 24.7 60.4 64.7 138.5 72.0 76.0 21.6 84.2 118.0 62.7 43.3 105.8 94.4 61.1 59.5 42.8 30.2 96.3 48.0 20.8 39.6 51.9 56.0 49.9 34.1 76.8 112.5 89.0 22.6 152.1 81.8 75.8 57.6 178.1 159.3 165.8 71.8 163.9 68.0 68.5 73.2 71.2 163.1 78.9 57.9 63.7 57.8 86.5 169.6 101.3 107.5 140.1 43.2 47.2 44.8 61.8 50.9 45.0 46.5 43.2 43.4 49.9 39.8 44.8 49.7 44.4 35.3 33.8 5.5 49.2 80.9 67.5 103.9 37.5 34.9 48.4 57.9 55.1 50.1 55.0 51.5 29.2 99.8 48.2 145.0 207.4 93.4 132.0 42.2 39.4 44.6 62.3 41.4 5.6 90.5 98.7 48.2 47.9 39.8 93.8 43.6 43.2 35.4 131.0 18.5 6.4 107.0 79.3 98.0 77.0 284.2 53.4 75.6 67.6 3.7 116.4 50.8 64.9 3.0 5.0 73.5 133.8 58.6 49.7 35.6 222.4 253.1 50.7 49.3 52.6 47.4 68.2 15.9 18.3 50.3 77.4 110.8 55.2 103.0 112.7 64.2 ROGDI FLJ22386 ENSG00000067836 "Rogdi atypical leucine zipper" Q9GZN7 16 4796968-4802880 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amelogenesis imperfecta, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.4" "Cell type enhanced" "Detected in all" "Bipolar cells: 179.2;Rod photoreceptor cells: 149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 74.6;intermediate monocyte: 62.7;myeloid DC: 61.5;non-classical monocyte: 61.8;plasmacytoid DC: 34.5" "Group enriched" "Detected in all" 6 "dendritic cells: 61.5;monocytes: 74.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041000 Uncertain NA NA "HPA041000: AB_10794077" "unprognostic (1.74e-3)" "unprognostic (1.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.95e-1)" "unprognostic (3.13e-1)" "unprognostic (3.79e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-1)" "prognostic favorable (9.71e-4)" "unprognostic (5.24e-2)" "prognostic favorable (2.67e-5)" "unprognostic (1.71e-1)" "unprognostic (7.16e-2)" "unprognostic (2.17e-1)" "unprognostic (3.08e-2)" 7.6 24.4 72.2 11.7 71.3 78.7 7.3 69.5 106.4 8.9 51.9 14.8 25.1 7.5 6.6 18.3 14.6 14.5 44.6 80.8 68.8 19.5 19.8 15.6 8.7 78.3 74.2 66.6 5.9 23.1 26.6 18.4 7.9 75.0 19.1 7.7 62.4 25.5 16.8 63.7 6.6 21.6 11.4 67.8 15.7 21.3 8.2 74.9 10.2 4.7 33.2 8.7 11.3 6.5 87.1 13.5 18.8 9.5 42.4 12.2 6.2 36.4 9.4 4.6 8.2 3.6 12.5 15.3 5.9 15.1 19.9 5.3 26.7 9.9 28.7 3.2 4.8 13.3 8.0 28.9 28.1 19.8 10.4 6.5 8.3 11.7 12.4 8.3 21.6 14.5 11.5 5.7 3.5 14.1 74.9 9.4 51.0 15.3 15.4 14.2 30.1 26.1 30.1 19.8 18.1 55.3 24.5 38.6 42.4 9.9 11.9 50.9 40.8 22.3 7.3 17.0 52.5 6.5 14.2 17.0 5.2 8.6 40.0 6.5 10.5 74.6 8.1 2.1 62.7 6.6 2.5 5.4 4.9 61.5 2.8 4.7 5.5 6.7 6.7 61.8 34.5 6.1 38.0 72.2 71.3 69.5 106.4 80.8 68.8 78.3 74.2 66.6 75.0 67.8 74.9 87.1 7.0 19.2 7.8 17.3 6.7 5.1 28.0 84.4 32.5 179.2 23.0 22.5 58.1 21.5 36.7 27.6 110.5 46.9 11.5 23.4 39.2 22.2 30.3 17.6 8.5 12.0 52.0 38.7 33.2 16.0 73.4 15.9 11.7 7.2 5.7 9.8 24.3 19.7 64.8 25.2 19.2 29.7 69.2 28.7 29.0 57.0 6.8 31.0 12.4 10.3 77.0 102.5 6.2 7.5 90.2 13.5 23.7 19.2 4.6 12.7 65.7 80.8 21.3 149.7 6.6 8.2 15.3 6.5 20.7 24.8 5.8 30.6 9.5 64.7 23.1 22.3 PDZD4 "FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L" ENSG00000067840 "PDZ domain containing 4" Q76G19 X 153802166-153830565 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 151.2;choroid plexus: 45.0;pituitary gland: 44.4" "Cell type enhanced" "Detected in many" "Astrocytes: 12.1;Bipolar cells: 18.0;dendritic cells: 14.0;Excitatory neurons: 11.0;NK-cells: 26.8;Rod photoreceptor cells: 14.1" "Group enriched" "Detected in many" 4 "glioma: 20.1;testis cancer: 10.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.4;NTERA-2: 12.4;RH-30: 17.3;SCLC-21H: 29.5;SH-SY5Y: 28.7;U-2 OS: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003878 Enhanced NA NA "HPA003878: AB_2162807" "unprognostic (9.18e-3)" "unprognostic (1.25e-1)" "unprognostic (1.11e-4)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (1.85e-2)" "unprognostic (1.92e-3)" "unprognostic (2.17e-1)" "unprognostic (2.32e-3)" "unprognostic (5.90e-2)" "prognostic favorable (2.96e-5)" "unprognostic (2.27e-1)" "unprognostic (2.54e-4)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.83e-2)" "unprognostic (2.87e-2)" 3.4 5.1 98.4 1.9 102.0 2.1 3.4 76.7 151.2 9.4 45.0 17.2 1.6 12.0 1.3 3.9 14.0 2.0 5.9 134.8 60.8 3.8 2.6 4.9 2.0 61.5 49.8 99.9 2.7 2.3 2.8 44.4 0.1 70.3 10.5 1.3 14.9 4.1 9.9 3.3 4.3 5.9 4.4 36.5 14.2 7.6 6.1 51.3 1.1 3.5 1.3 0.7 10.1 9.3 90.2 0.0 1.6 24.4 6.4 0.0 0.1 0.0 0.7 0.0 0.7 0.8 0.6 0.0 0.0 0.3 0.0 7.9 0.1 4.5 0.0 0.1 0.0 0.8 0.0 1.9 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.3 5.0 0.2 0.9 12.4 0.0 0.3 0.1 17.3 0.0 0.0 0.1 29.5 28.7 1.3 0.0 9.2 8.2 2.8 0.3 0.0 0.0 14.1 0.3 1.8 0.0 0.1 0.0 0.1 0.0 7.9 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 98.4 102.0 76.7 151.2 134.8 60.8 61.5 49.8 99.9 70.3 36.5 51.3 90.2 1.8 0.0 0.0 12.1 0.1 0.3 0.0 0.0 0.6 18.0 0.1 2.4 3.7 0.0 1.3 0.0 6.2 0.0 14.0 0.0 0.0 0.0 0.1 0.2 1.5 3.5 1.8 0.8 11.0 0.2 0.0 0.8 0.5 0.1 1.3 0.2 4.6 0.1 0.0 1.7 8.6 0.0 0.0 1.0 0.0 0.2 0.6 0.1 3.6 4.7 0.2 3.9 26.8 5.5 0.7 0.3 0.0 3.8 3.6 0.2 0.0 0.0 4.4 14.1 0.0 1.7 2.1 0.3 4.1 0.5 0.9 0.0 4.1 0.0 0.0 0.2 ATP2B3 "CFAP39, CLA2, PMCA3, SCAX1" ENSG00000067842 "ATPase plasma membrane Ca2+ transporting 3" Q16720 X 153517676-153582939 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "choroid plexus: 149.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.1;Endometrial ciliated cells: 6.5;Excitatory neurons: 23.7;Extravillous trophoblasts: 10.7;Inhibitory neurons: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 9.9;SH-SY5Y: 2.9;THP-1: 2.5;U-937: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001583 Enhanced Supported NA NA "HPA001583: AB_1079641" "unprognostic (1.35e-1)" "unprognostic (3.07e-2)" "unprognostic (3.28e-1)" "unprognostic (6.82e-2)" "unprognostic (1.30e-1)" "unprognostic (4.32e-2)" "unprognostic (2.67e-1)" "unprognostic (6.34e-2)" "unprognostic (2.68e-2)" "unprognostic (8.58e-2)" "unprognostic (1.38e-3)" "unprognostic (3.44e-1)" "unprognostic (2.71e-12)" "unprognostic (1.44e-3)" "unprognostic (2.04e-1)" "unprognostic (2.42e-2)" 0.0 9.8 3.9 0.0 8.5 0.0 0.0 4.6 34.2 0.0 149.9 0.2 0.0 0.0 0.9 0.0 1.2 0.0 0.0 27.6 4.8 0.1 0.0 0.0 0.0 6.8 1.6 8.3 0.0 0.0 0.1 1.4 0.5 6.0 0.0 0.0 2.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 2.9 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.5 4.6 34.2 27.6 4.8 6.8 1.6 8.3 6.0 0.0 3.6 14.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.5 1.3 0.1 0.0 0.0 23.7 0.0 10.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 30.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.4 0.0 3.5 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.6 4.5 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 ROCK1 p160ROCK ENSG00000067900 "Rho associated coiled-coil containing protein kinase 1" Q13464 18 20946906-21111813 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 406.2;Late spermatids: 505.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004562, HPA007567, HPA045639" Approved NA NA "CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401" "unprognostic (7.86e-2)" "unprognostic (2.86e-2)" "unprognostic (1.22e-1)" "unprognostic (6.63e-2)" "unprognostic (9.90e-2)" "unprognostic (1.17e-1)" "unprognostic (6.74e-2)" "unprognostic (1.00e-1)" "unprognostic (1.63e-1)" "unprognostic (8.89e-3)" "prognostic unfavorable (9.93e-4)" "unprognostic (3.85e-2)" "unprognostic (8.93e-3)" "unprognostic (3.04e-2)" "unprognostic (5.47e-2)" "unprognostic (3.19e-1)" "unprognostic (1.28e-1)" 7.5 4.2 3.7 5.7 4.2 18.4 6.0 4.2 3.6 5.3 4.9 4.9 3.7 6.0 4.7 4.2 6.4 4.3 5.5 2.6 3.7 4.4 4.9 7.7 5.5 5.4 3.8 1.8 5.5 5.2 3.0 2.9 4.4 4.5 4.4 3.3 4.8 4.4 3.4 2.7 3.7 5.2 3.3 4.4 6.3 5.9 2.7 5.2 5.5 4.5 1.9 4.2 6.7 5.5 4.8 6.5 3.9 3.9 3.8 7.2 7.7 6.3 8.9 4.3 3.9 4.2 6.6 2.7 8.0 6.2 10.5 2.1 5.2 3.6 5.2 7.8 11.4 4.1 6.4 7.3 2.9 3.6 17.9 9.6 5.6 4.6 5.8 4.7 3.2 6.0 3.1 3.7 7.9 4.6 4.1 8.5 3.8 3.2 4.3 6.6 11.9 4.5 3.1 3.7 5.9 4.5 3.5 7.1 4.6 3.6 3.4 4.6 6.7 9.9 7.7 6.4 7.1 7.2 10.7 5.3 9.0 5.8 7.5 4.8 3.0 5.0 6.8 5.0 3.2 4.0 3.9 3.6 3.8 4.2 5.0 3.5 3.5 18.0 2.8 4.0 5.5 3.6 2.5 3.7 4.2 4.2 3.6 2.6 3.7 5.4 3.8 1.8 4.5 4.4 5.2 4.8 98.2 96.1 88.7 64.6 112.6 46.3 60.4 30.7 43.9 100.4 32.2 35.6 138.6 28.6 61.4 33.1 131.3 57.5 136.9 36.6 15.6 62.5 406.2 64.8 86.9 94.4 99.0 47.9 81.3 38.0 64.9 78.4 62.7 73.8 72.7 68.5 60.0 47.4 60.3 60.6 74.2 45.8 40.7 135.3 126.7 505.0 97.6 166.2 65.8 106.8 137.1 52.3 204.9 87.0 140.0 70.9 62.8 138.8 83.2 63.2 32.3 21.0 44.6 128.6 170.9 81.4 197.6 107.4 80.9 38.7 36.7 43.0 127.4 70.5 38.9 73.3 CBFB PEBP2B ENSG00000067955 "Core-binding factor subunit beta" Q13951 16 67028984-67101058 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 243.7;U-698: 336.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038852 Uncertain Approved Nucleoplasm,Cytosol NA NA 18000 Cytosol Nucleoplasm "HPA038852: AB_10795358" "unprognostic (1.05e-1)" "unprognostic (1.18e-2)" "unprognostic (1.30e-1)" "unprognostic (3.22e-2)" "unprognostic (4.66e-2)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (1.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-3)" "unprognostic (1.88e-2)" "prognostic unfavorable (2.89e-8)" "unprognostic (1.03e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" 17.9 11.8 5.6 17.4 10.0 11.9 16.7 8.9 5.5 18.4 6.0 11.3 5.5 15.5 2.7 23.5 16.7 5.3 18.0 6.3 9.1 13.3 14.3 18.3 16.4 12.1 8.3 2.2 17.4 14.8 9.8 15.1 7.3 9.8 14.6 3.5 3.8 21.4 4.9 38.9 17.2 14.6 5.0 10.0 18.2 15.2 6.9 8.6 13.6 16.1 10.6 12.2 15.3 20.4 16.7 54.8 43.7 14.8 40.6 8.7 12.2 54.0 76.1 23.6 43.6 30.0 79.1 51.0 106.3 81.2 39.7 16.3 53.7 30.7 22.6 29.2 63.3 48.3 67.2 27.3 38.0 17.8 77.7 171.3 18.2 11.1 51.3 30.4 10.2 25.4 42.2 104.9 28.9 20.8 44.5 115.8 28.9 25.5 16.4 74.1 243.7 92.7 73.4 15.5 43.2 37.9 31.5 166.2 11.0 37.6 10.4 15.4 28.6 87.1 70.8 70.2 34.6 79.6 76.8 147.8 336.8 50.2 50.7 65.0 29.2 7.6 6.3 6.0 9.5 6.5 6.2 5.5 6.4 10.2 7.2 5.0 3.9 4.1 18.2 5.6 2.3 6.0 5.6 5.6 10.0 8.9 5.5 6.3 9.1 12.1 8.3 2.2 9.8 10.0 8.6 16.7 20.1 9.6 20.2 37.2 38.2 56.2 42.2 18.0 27.9 5.8 27.8 14.7 19.8 21.5 18.8 40.5 12.5 15.8 30.0 11.9 27.4 17.6 6.1 23.8 16.0 26.1 19.0 18.5 11.5 28.0 32.1 28.7 16.8 29.8 27.8 34.2 28.5 15.8 37.9 10.1 16.5 12.8 22.4 41.9 66.8 7.6 23.9 39.1 51.6 53.4 25.0 13.2 44.3 97.5 99.8 74.1 6.8 21.1 38.3 50.5 6.9 11.6 20.8 15.3 13.1 21.6 21.0 17.4 19.1 32.2 63.1 17.0 48.6 11.2 11.8 62.0 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465270-24550466 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA046583: AB_2679707, HPA072492: AB_2686526" "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 4.3 2.0 3.4 5.6 6.4 9.0 8.9 1.7 7.3 3.0 2.5 6.0 8.3 2.8 11.0 3.9 5.9 3.2 6.3 12.3 7.2 8.8 4.8 5.0 8.0 2.6 4.2 4.0 4.9 3.0 6.7 5.8 4.1 3.4 4.7 5.3 6.0 11.2 2.9 1.4 6.2 8.3 4.5 0.9 7.8 7.0 11.6 8.5 6.3 2.4 1.8 8.1 4.2 4.1 6.4 11.5 5.2 4.2 8.0 0.2 0.0 5.0 3.4 2.4 4.1 6.9 0.5 13.9 10.4 2.3 0.8 11.6 2.1 12.3 8.4 10.4 9.7 6.0 5.3 6.1 3.3 1.4 4.6 5.8 0.9 3.6 1.1 1.2 0.5 6.8 10.9 0.9 16.5 0.5 20.9 9.4 6.0 8.1 12.2 5.6 5.0 8.0 17.3 4.1 21.4 2.6 4.0 17.9 8.0 5.5 7.3 9.6 1.9 0.1 3.3 3.6 5.8 4.2 11.0 8.9 12.9 8.7 7.7 6.4 13.3 15.4 37.9 11.8 19.6 16.5 7.5 9.1 10.3 12.2 7.3 7.6 8.6 57.6 13.3 18.8 3.5 8.3 12.4 3.4 6.4 1.7 7.3 12.3 7.2 2.6 4.2 4.0 3.4 0.9 8.5 6.4 3.9 3.2 2.0 19.6 15.2 4.6 9.5 13.5 30.1 3.5 11.1 8.1 6.6 1.5 5.2 1.8 0.0 5.5 16.6 4.2 3.9 4.3 71.6 2.1 2.9 3.8 4.2 14.3 92.8 5.1 32.1 4.9 5.6 2.8 5.7 4.9 5.3 5.3 15.0 8.4 78.0 2.9 10.2 19.8 7.4 35.9 3.7 17.4 16.0 35.6 10.3 3.7 25.7 19.6 14.0 2.1 0.3 5.7 19.0 5.9 13.3 14.2 2.4 3.5 0.0 2.0 10.6 10.2 8.3 6.8 4.4 17.8 18.2 9.7 4.1 8.4 HYAL2 "LuCa-2, LUCA2" ENSG00000068001 "Hyaluronidase 2" Q12891 3 50317790-50322782 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 285.1" "Group enriched" "Detected in many" 5 "Adipocytes: 497.6;Endothelial cells: 216.3;Hepatic stellate cells: 253.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "HUVEC TERT2: 363.3;TIME: 502.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036436 Uncertain NA NA "HPA036436: AB_10670104" "unprognostic (9.97e-3)" "unprognostic (2.60e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-3)" "unprognostic (3.44e-1)" "unprognostic (7.41e-2)" "unprognostic (7.93e-2)" "unprognostic (4.70e-1)" "unprognostic (1.44e-1)" "unprognostic (6.76e-2)" "unprognostic (2.36e-1)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (7.36e-2)" "unprognostic (2.72e-1)" "unprognostic (7.02e-3)" "unprognostic (5.62e-2)" 95.0 63.1 24.0 29.3 22.6 3.2 94.7 24.3 28.5 50.7 27.2 30.9 18.1 66.6 10.4 40.1 56.1 48.0 74.7 21.4 24.1 70.0 32.5 188.4 40.3 25.2 24.5 20.1 29.4 28.2 25.9 42.0 88.1 25.7 37.5 11.6 3.4 37.8 22.2 31.2 36.8 39.0 37.8 25.8 285.1 38.9 22.2 27.3 9.6 81.5 36.0 14.8 47.4 46.2 24.1 26.8 38.5 63.0 64.1 38.2 32.9 39.6 29.8 41.2 42.0 32.6 44.6 77.3 7.0 102.4 43.6 82.5 27.4 24.6 58.7 12.0 14.2 19.6 9.7 34.9 69.2 33.0 8.1 24.4 51.9 48.8 42.1 13.8 38.1 363.3 18.2 17.6 8.0 35.4 37.0 17.7 16.6 72.0 23.2 55.7 15.5 12.4 26.1 52.4 24.2 16.6 53.3 30.4 31.2 31.8 21.2 34.4 20.3 502.9 50.0 49.7 33.5 47.5 13.9 24.1 21.6 29.4 25.5 73.0 0.0 9.5 10.7 1.4 14.1 3.0 1.1 1.3 3.8 5.3 1.5 0.4 0.7 9.2 2.8 13.6 4.0 1.9 3.3 24.0 22.6 24.3 28.5 21.4 24.1 25.2 24.5 20.1 25.7 25.8 27.3 24.1 497.6 19.2 9.9 5.2 3.6 13.0 28.6 45.2 11.4 7.8 17.6 16.6 7.3 32.9 30.9 33.1 6.2 33.6 4.1 13.5 11.7 53.0 4.7 8.5 19.8 216.3 7.3 10.1 1.6 38.7 38.4 26.6 16.8 13.8 0.0 31.5 253.1 9.1 46.2 8.4 1.9 13.0 42.7 12.6 9.3 5.0 24.5 9.4 17.8 15.9 7.6 19.7 5.2 4.0 3.4 45.6 13.5 22.2 4.2 45.3 16.1 11.8 11.0 6.1 39.5 11.2 26.0 11.2 56.0 24.9 12.6 32.7 4.1 50.0 16.6 33.3 HDAC4 "BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288" ENSG00000068024 "Histone deacetylase 4" P56524 2 239048168-239401654 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Autism spectrum disorder, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 58.7;tongue: 35.9" "Group enriched" "Detected in many" 4 "Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 32.0;neutrophil: 47.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 47.7" "Cell line enhanced" "Detected in many" "JURKAT: 49.1;MOLT-4: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048723, HPA071448" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA048723: AB_2680501, HPA071448: " "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.39e-3)" "unprognostic (3.06e-4)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.33e-4)" "prognostic favorable (1.13e-4)" "unprognostic (1.40e-1)" "unprognostic (4.82e-3)" "unprognostic (2.40e-1)" "unprognostic (3.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.04e-2)" 4.4 6.3 6.9 5.0 10.4 17.2 3.8 0.6 12.9 7.2 0.1 20.8 2.8 9.1 2.5 8.1 6.8 7.2 4.5 9.1 5.4 2.8 2.5 4.0 3.6 10.3 5.8 6.3 7.6 3.7 2.7 6.5 1.5 11.4 5.6 3.5 2.4 3.3 6.0 58.7 6.0 7.2 6.2 2.3 5.7 7.2 9.3 5.5 9.8 4.2 35.9 2.5 10.0 4.5 10.3 3.2 5.8 4.1 6.1 4.5 3.9 5.9 3.0 2.3 2.3 1.7 2.9 7.5 2.0 1.9 3.4 3.6 3.4 4.0 2.0 1.4 12.8 1.8 3.1 5.1 5.8 3.8 5.5 4.6 4.4 2.6 4.6 3.3 2.3 2.4 49.1 3.7 4.5 2.7 4.7 48.1 10.7 4.0 6.0 2.8 7.6 7.2 4.0 5.3 4.4 4.6 6.4 5.3 2.5 16.2 2.6 1.0 17.9 1.9 5.0 0.4 6.8 4.6 3.3 3.2 3.1 6.9 6.9 7.4 32.0 10.2 2.3 1.0 3.3 1.2 0.2 1.1 1.0 1.0 0.1 0.5 0.5 47.7 3.2 1.7 0.6 1.7 1.1 6.9 10.4 0.6 12.9 9.1 5.4 10.3 5.8 6.3 11.4 2.3 5.5 10.3 8.6 3.2 7.4 62.0 5.2 7.9 2.9 3.0 8.6 12.2 6.2 4.8 13.3 7.2 2.9 11.0 2.1 1.5 12.8 4.1 0.0 2.8 69.9 7.0 15.1 7.1 6.0 6.1 118.1 2.2 1.7 14.0 7.7 7.4 2.5 6.6 11.7 6.7 3.2 16.8 84.9 5.2 2.0 17.2 10.0 59.0 11.8 10.3 5.4 38.4 14.9 8.6 15.5 85.5 124.0 1.9 1.6 12.4 7.0 6.4 5.0 1.6 2.6 7.1 0.0 18.7 6.5 2.8 3.3 11.1 9.7 1.4 12.2 4.9 6.4 2.7 RASSF1 "123F2, NORE2A, RDA32, REH3P21" ENSG00000068028 "Ras association domain family member 1" Q9NS23 3 50329782-50340980 "Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 252.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040735 Approved NA Yes "HPA040735: AB_10671692" "unprognostic (5.02e-2)" "prognostic favorable (2.64e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.00e-3)" "prognostic favorable (2.60e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (3.80e-2)" "unprognostic (2.11e-1)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (4.27e-2)" "unprognostic (2.29e-1)" "unprognostic (1.11e-1)" "unprognostic (9.71e-2)" 50.2 19.0 19.9 23.4 19.9 85.0 46.4 20.1 20.3 41.6 19.0 28.6 15.8 30.0 11.2 26.5 35.7 21.7 44.5 18.6 19.6 28.6 24.9 61.8 39.8 21.4 20.6 17.7 31.5 35.6 7.6 22.4 26.0 21.1 31.9 11.7 6.2 30.4 11.9 28.8 37.4 40.0 18.2 21.1 72.9 32.0 38.8 21.2 16.5 30.0 14.4 25.7 32.6 37.7 22.4 37.4 15.1 11.1 18.5 25.0 33.8 16.2 62.5 40.9 52.6 41.8 34.7 27.3 18.0 9.4 67.3 23.6 19.6 23.3 26.1 28.3 44.6 15.2 61.8 51.9 18.4 28.6 61.2 65.2 26.1 18.1 52.0 18.4 15.4 23.7 21.8 26.2 40.7 24.1 13.1 23.3 81.9 14.7 31.2 44.9 19.0 11.4 41.4 15.7 10.8 13.0 23.9 55.6 37.2 41.5 11.2 22.3 59.2 22.9 36.1 27.2 52.0 31.3 16.5 11.7 39.4 20.3 75.6 66.1 252.6 23.3 79.5 77.0 41.5 48.3 44.3 24.6 55.3 24.9 33.6 15.7 37.7 18.4 64.6 59.1 18.5 27.5 42.0 19.9 19.9 20.1 20.3 18.6 19.6 21.4 20.6 17.7 21.1 21.1 21.2 22.4 76.6 16.0 8.1 4.6 50.7 73.8 36.3 22.6 34.1 11.6 32.7 22.9 14.3 12.8 14.4 1.8 14.6 27.5 116.1 12.2 5.9 23.1 2.4 16.5 16.3 47.4 16.7 33.2 3.8 26.5 28.1 29.1 27.0 17.6 57.1 9.0 26.0 4.3 38.6 3.3 3.8 19.4 22.4 27.7 43.8 10.4 19.0 28.7 90.7 9.4 23.2 6.1 93.7 2.0 6.0 40.9 17.4 14.7 63.8 24.7 12.1 10.2 7.7 10.1 26.3 19.3 50.4 33.1 11.0 19.2 50.2 16.6 67.2 9.0 15.2 21.3 FGFR3 "ACH, CD333, CEK2, JTK4" ENSG00000068078 "Fibroblast growth factor receptor 3" P22607 4 1793293-1808872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 159.4;esophagus: 140.8;skin 1: 273.6" "Cell type enhanced" "Detected in many" "Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004231, HPA067204" Enhanced Supported "Endoplasmic reticulum" "Secreted - unknown location" NA NA 2500000 "Endoplasmic reticulum" "CAB004231: AB_627596, HPA067204: AB_2685804" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (5.90e-2)" "unprognostic (1.24e-3)" "unprognostic (7.22e-2)" "unprognostic (2.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (2.88e-2)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" "unprognostic (1.98e-1)" "unprognostic (4.74e-2)" "unprognostic (1.97e-1)" 1.3 1.6 117.2 1.5 123.2 1.4 5.6 118.7 104.8 12.4 37.3 8.0 19.7 1.5 2.8 140.8 2.3 7.9 4.5 102.2 102.9 26.9 41.0 7.5 0.4 159.4 121.6 83.7 0.5 77.0 0.2 16.2 9.4 157.4 13.9 5.2 0.2 20.3 15.1 1.4 273.6 14.8 0.4 97.4 4.0 7.8 17.7 126.4 1.7 1.5 0.9 11.2 23.3 61.4 78.2 0.0 3.8 19.5 5.6 0.0 0.3 22.1 2.4 0.3 0.8 0.4 48.2 1.0 0.0 17.8 0.7 0.7 34.9 5.5 0.3 0.3 0.2 19.3 14.2 3.9 80.6 0.1 0.0 0.6 0.0 10.9 0.2 0.1 0.1 0.1 2.3 16.7 0.1 0.0 23.9 0.8 0.5 36.1 19.5 0.1 1.2 1.0 0.3 2.8 64.1 5.7 1.6 1.9 4.0 0.0 22.2 20.4 2.5 1.0 0.0 2.1 0.5 1.6 0.1 0.0 0.0 0.2 1.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.2 123.2 118.7 104.8 102.2 102.9 159.4 121.6 83.7 157.4 97.4 126.4 78.2 2.2 0.0 32.5 410.4 1.1 103.8 4.1 29.8 23.9 0.0 4.8 1.5 3.1 91.5 37.6 14.7 0.0 0.5 1.6 36.1 0.0 5.0 7.9 3.0 1.7 3.4 4.2 0.0 0.5 0.7 12.0 3.2 3.6 4.0 0.0 0.1 16.1 30.4 0.6 0.0 1.3 20.7 4.1 1.2 6.5 1.3 0.6 0.6 12.4 14.0 0.6 0.1 0.0 34.2 2.2 0.4 18.0 0.4 0.0 4.2 21.2 9.9 9.8 0.6 0.0 0.7 2.9 0.4 25.9 55.0 88.7 0.8 0.7 0.1 17.0 12.8 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006740-43014456 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 122.4;Paneth cells: 116.7;Proximal enterocytes: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 204.5;BJ hTERT+ SV40 Large T+ RasG12V: 299.2;GAMG: 108.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" "Secreted to blood" NA NA 120000 "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 25.7 41.6 15.3 27.5 16.4 25.1 24.4 14.8 18.4 18.6 15.2 27.1 24.8 17.6 11.8 10.2 20.9 20.3 20.3 13.8 20.3 29.8 30.8 25.8 26.6 19.3 15.2 12.7 24.0 13.7 10.6 14.3 15.1 16.6 28.1 20.6 1.5 29.7 15.3 6.4 11.2 30.4 21.5 15.8 40.2 22.9 5.0 17.8 23.6 21.0 9.3 19.2 21.3 15.5 23.5 12.7 28.8 0.2 1.5 24.2 29.1 6.1 8.2 84.6 204.5 299.2 10.7 46.2 3.9 16.1 24.7 108.0 7.0 1.6 12.9 16.3 33.5 6.1 9.3 10.5 39.5 59.6 10.5 19.3 40.3 4.9 29.0 3.6 18.6 18.8 8.0 5.4 61.2 8.2 12.5 22.7 8.5 0.1 11.6 13.0 18.4 0.1 23.7 25.7 10.9 5.4 0.2 16.4 6.3 88.2 0.6 26.5 20.3 9.3 15.1 0.3 4.8 13.3 54.1 21.8 1.1 27.1 8.2 14.8 60.7 102.7 61.6 44.3 127.8 40.4 37.8 34.0 41.7 62.0 40.0 26.8 33.6 62.1 56.9 122.0 67.0 51.8 80.5 15.3 16.4 14.8 18.4 13.8 20.3 19.3 15.2 12.7 16.6 15.8 17.8 23.5 65.2 16.0 9.7 2.6 28.6 10.5 29.6 31.8 12.5 0.8 16.5 11.3 5.5 11.5 22.7 18.4 2.1 22.7 36.7 83.1 41.1 47.8 9.4 12.3 27.4 32.1 31.7 12.8 0.7 64.0 32.5 32.8 26.5 16.2 7.6 122.4 37.1 31.3 84.8 1.7 0.6 39.4 12.2 36.8 19.2 39.5 28.9 47.8 24.9 5.6 75.5 10.4 64.9 1.0 1.0 41.8 116.7 23.7 54.0 19.1 128.0 93.7 18.0 0.8 6.6 13.2 36.3 0.5 0.4 5.1 9.2 10.4 32.3 25.0 34.6 29.6 HEATR6 "ABC1, FLJ22087" ENSG00000068097 "HEAT repeat containing 6" Q6AI08 17 60041008-60078922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030789, HPA062157" Uncertain Approved Mitochondria NA NA Mitochondria "HPA030789: AB_10601660, HPA062157: AB_2684700" "unprognostic (1.98e-1)" "unprognostic (7.95e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.22e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.02e-6)" "unprognostic (2.24e-1)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (6.81e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" 4.5 7.3 5.4 2.1 6.2 3.1 4.3 6.9 5.9 6.5 4.8 6.5 1.8 7.2 3.2 4.7 6.7 2.0 4.9 5.3 5.4 4.1 3.6 5.1 3.1 6.3 5.8 4.8 7.8 5.2 3.4 7.3 2.7 6.2 5.7 2.3 5.2 5.3 3.6 6.1 5.4 6.2 2.8 5.3 7.2 4.9 4.9 5.6 3.0 4.7 2.4 2.3 6.6 5.2 8.0 4.8 13.0 9.5 7.5 5.1 9.1 6.9 4.5 8.9 8.8 9.7 5.2 3.6 1.8 7.8 8.0 7.1 4.9 5.6 6.0 11.9 4.1 7.2 9.3 8.8 9.7 5.6 7.0 10.1 7.1 8.8 6.4 7.6 9.5 4.7 6.0 5.9 5.1 6.6 64.6 8.9 3.6 5.9 3.9 8.7 3.2 16.9 5.8 5.7 7.1 5.4 13.7 4.6 1.6 6.6 8.2 7.9 5.6 4.5 8.9 15.0 8.2 8.4 6.5 7.1 0.1 7.6 5.1 6.9 2.4 3.4 3.4 3.4 5.4 3.2 8.2 2.5 2.5 6.0 4.3 3.3 2.6 0.5 3.0 5.6 2.9 2.9 2.7 5.4 6.2 6.9 5.9 5.3 5.4 6.3 5.8 4.8 6.2 5.3 5.6 8.0 4.6 12.8 6.3 9.4 8.0 0.9 2.8 6.2 6.2 11.1 3.1 5.0 9.2 2.8 8.1 7.3 10.4 5.7 5.0 1.1 3.9 4.8 1.0 4.8 9.1 5.1 6.7 3.0 13.1 3.3 3.4 7.4 6.6 4.3 11.4 8.8 4.2 2.8 4.6 6.7 13.7 1.5 4.1 5.6 2.6 0.7 3.4 8.5 1.8 15.9 15.3 8.8 7.2 16.6 25.3 2.9 1.0 11.3 3.3 1.7 1.5 3.3 10.5 6.6 6.6 6.5 15.4 5.1 7.7 3.6 2.3 2.1 7.6 10.1 3.1 1.2 COASY "DPCK, NBP, PPAT" ENSG00000068120 "Coenzyme A synthase" Q13057 17 42561467-42566277 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022875, HPA022912, HPA023273" Approved "Intracellular and membrane" NA NA 20000 "HPA022875: AB_1847066, HPA022912: AB_1847067, HPA023273: AB_1847068" "unprognostic (2.83e-1)" "unprognostic (8.35e-2)" "unprognostic (1.81e-1)" "prognostic favorable (2.15e-4)" "unprognostic (1.01e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.54e-5)" "unprognostic (4.06e-2)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (5.55e-1)" "unprognostic (1.62e-1)" "unprognostic (2.16e-1)" 27.1 60.5 22.6 23.3 22.5 29.7 33.1 23.1 28.3 27.0 23.5 32.1 43.7 25.4 17.3 54.8 30.1 17.1 26.0 24.1 21.9 45.8 71.5 30.5 25.2 25.6 23.1 21.7 26.3 59.5 39.3 30.5 25.7 26.4 32.6 24.6 13.4 59.0 28.9 38.9 46.0 37.2 17.3 22.4 36.1 47.6 32.7 24.4 27.8 39.3 25.5 25.4 27.1 31.3 26.5 94.2 149.1 27.2 55.2 55.5 34.8 89.2 38.3 52.9 65.8 46.5 85.7 89.2 52.7 65.6 50.4 69.5 146.9 66.1 81.4 43.7 47.6 122.2 52.5 91.2 140.9 70.2 56.4 73.1 51.5 97.8 62.4 66.6 52.4 63.2 70.5 98.7 70.8 46.6 59.2 71.5 87.2 36.7 125.8 75.1 39.1 93.5 88.1 89.9 66.7 63.3 50.1 34.9 37.3 75.4 52.2 158.0 70.4 41.6 68.3 62.3 52.4 40.1 84.6 127.4 31.0 80.9 55.3 47.5 23.3 29.8 26.8 19.7 31.8 20.5 15.8 15.8 19.1 33.6 15.7 15.7 16.3 19.5 21.0 22.5 23.6 18.1 24.0 22.6 22.5 23.1 28.3 24.1 21.9 25.6 23.1 21.7 26.4 22.4 24.4 26.5 15.4 6.4 23.8 9.8 24.1 15.0 21.7 49.5 25.6 17.8 38.2 22.9 22.9 40.0 33.3 71.7 0.0 89.4 21.2 53.7 33.2 44.8 4.4 31.5 20.6 20.6 17.4 30.3 5.6 52.5 51.6 18.7 40.2 28.0 10.2 101.2 23.9 94.2 40.3 33.7 5.7 36.7 42.7 23.6 16.1 7.7 14.9 19.9 14.2 4.7 36.2 29.4 20.6 3.5 5.9 38.9 32.4 16.6 25.3 31.2 66.3 94.8 36.5 18.0 26.3 15.2 18.6 46.7 31.1 33.4 17.8 77.2 16.9 36.6 45.1 30.7 PLEKHH3 FLJ21019 ENSG00000068137 "Pleckstrin homology, MyTH4 and FERM domain containing H3" Q7Z736 17 42667914-42676994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 45.5;T-47d: 48.7;U-266/84: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046234 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA046234: AB_2679597" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.75e-2)" "unprognostic (5.72e-3)" "unprognostic (1.25e-1)" "unprognostic (3.42e-3)" "unprognostic (5.05e-3)" "unprognostic (5.95e-2)" "unprognostic (6.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.51e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (9.30e-3)" "unprognostic (1.44e-3)" 10.1 11.2 1.8 2.0 1.0 5.3 10.7 3.7 2.4 16.0 0.3 8.8 3.8 15.5 1.6 17.8 17.0 2.8 8.6 1.2 1.6 5.6 7.9 10.1 1.2 2.0 2.3 0.0 15.2 41.7 5.2 9.3 3.5 2.4 11.3 1.1 1.3 9.9 6.5 26.1 11.8 4.8 3.6 1.1 4.4 15.7 7.4 2.8 2.5 8.5 4.9 1.2 12.1 14.6 2.4 13.7 12.2 5.7 9.3 7.0 2.9 10.3 5.2 4.7 3.9 3.7 5.7 7.4 2.0 6.1 5.9 6.6 25.1 4.1 6.7 1.2 12.8 9.0 0.9 26.6 4.9 7.6 0.2 8.7 4.8 11.0 5.1 0.8 3.9 2.7 0.8 15.5 30.1 1.7 24.6 0.7 11.0 2.1 6.9 10.8 2.1 5.6 45.5 1.4 15.1 20.4 22.1 8.1 11.1 12.0 1.3 48.7 11.2 4.0 12.2 11.3 14.2 9.3 36.0 42.9 10.5 8.9 3.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 3.7 2.4 1.2 1.6 2.0 2.3 0.0 2.4 1.1 2.8 2.4 13.4 12.8 13.1 16.3 1.7 15.6 22.9 10.3 41.5 63.2 32.4 29.7 11.3 12.8 9.4 9.2 22.9 11.3 2.1 7.6 0.0 2.7 9.8 15.5 18.4 11.2 7.7 24.4 7.0 7.6 4.4 17.0 30.5 18.3 2.5 2.9 12.8 11.8 2.2 33.7 11.3 5.8 12.2 3.5 11.3 2.7 17.7 2.4 16.0 4.7 1.0 18.0 0.0 6.6 3.9 5.6 1.7 22.6 10.5 12.4 0.7 3.2 7.0 23.1 26.3 16.0 38.0 5.1 16.6 49.4 18.6 6.2 1.8 7.7 6.4 20.0 MEF2A "RSRFC4, RSRFC9" ENSG00000068305 "Myocyte enhancer factor 2A" Q02078 15 99565417-99716466 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 262.8;Microglial cells: 708.3;Oligodendrocytes: 264.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004499, HPA046597" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004499: AB_627921, HPA046597: AB_2679714" "unprognostic (1.89e-1)" "unprognostic (8.82e-2)" "unprognostic (5.91e-2)" "unprognostic (8.04e-2)" "unprognostic (8.68e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.93e-2)" "unprognostic (1.91e-2)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "prognostic favorable (6.93e-4)" "prognostic unfavorable (7.96e-4)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-3)" 28.3 23.1 20.4 20.5 23.5 18.4 22.3 18.0 27.3 27.9 18.4 20.2 12.9 34.9 24.0 21.9 22.0 22.8 90.6 21.4 15.3 25.1 24.7 30.7 25.2 18.9 23.4 17.9 30.4 12.9 37.8 9.8 26.6 16.6 23.2 15.1 24.4 19.7 23.9 62.1 55.3 17.7 36.0 21.3 27.4 18.0 15.1 26.7 23.5 19.9 82.6 23.1 22.7 16.7 23.1 17.9 10.1 16.7 8.5 20.7 26.3 8.2 17.8 40.8 14.4 19.5 10.4 24.4 22.3 24.5 38.6 22.1 19.3 17.1 14.1 18.6 15.3 24.8 45.2 22.3 9.4 35.4 18.1 21.3 17.6 23.2 19.3 39.7 59.6 26.5 18.3 16.3 41.6 27.0 7.4 29.7 26.3 8.9 11.9 14.6 43.3 36.1 18.5 29.5 24.9 10.7 14.8 27.2 11.6 51.0 17.6 11.0 16.4 43.7 39.8 21.9 19.9 21.7 22.6 27.8 48.5 27.8 19.6 38.7 7.7 12.1 14.3 3.9 15.6 3.3 15.8 3.6 3.6 13.3 12.1 5.0 3.9 10.8 6.5 19.3 7.8 2.6 5.6 20.4 23.5 18.0 27.3 21.4 15.3 18.9 23.4 17.9 16.6 21.3 26.7 23.1 152.7 80.1 43.9 113.9 87.2 88.6 31.7 26.9 62.0 52.0 31.6 37.0 175.8 20.0 40.7 29.5 50.1 7.7 32.9 26.5 25.4 18.0 10.4 80.3 60.6 100.6 12.7 24.8 262.8 18.8 3.4 61.5 34.7 130.7 31.0 30.5 50.3 41.0 39.5 30.3 174.9 17.2 12.2 107.5 63.1 7.8 55.9 104.1 35.6 708.3 65.8 25.2 23.7 157.3 264.4 26.8 22.6 64.7 55.6 27.0 18.9 19.7 51.7 44.9 72.3 62.4 69.4 29.9 29.6 29.4 50.4 9.2 27.8 28.8 17.9 26.8 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922024-48958386 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "U-266/70: 1503.3;U-266/84: 407.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 37.5 45.2 38.8 37.3 42.1 57.2 36.9 35.8 45.9 39.9 30.1 43.0 40.0 43.3 30.1 37.8 41.8 24.9 29.4 41.3 40.1 41.5 39.9 39.9 43.8 41.7 40.7 40.4 47.2 38.0 35.9 46.4 26.6 42.8 43.4 21.9 30.5 36.6 32.3 40.0 44.5 47.7 27.2 35.6 61.2 37.8 24.4 40.0 47.5 42.7 25.4 36.0 40.2 37.0 45.0 53.0 77.8 36.0 88.9 59.2 52.3 41.4 45.7 52.9 55.9 59.8 39.7 57.3 58.9 29.2 56.8 49.1 63.3 54.2 45.7 51.7 69.1 65.0 44.5 79.4 45.0 49.3 43.4 48.7 58.1 41.2 58.2 39.5 61.4 44.7 47.8 56.9 90.7 40.0 52.3 67.7 89.2 64.9 19.5 60.4 53.0 52.5 77.4 38.9 46.4 34.7 60.7 60.2 38.7 61.7 82.7 51.6 39.2 64.2 36.5 46.2 97.2 38.1 1503.3 407.1 56.5 56.3 58.9 25.7 5.5 3.3 7.6 6.6 5.2 5.6 8.6 5.1 5.7 4.8 5.3 4.8 7.1 8.5 20.3 5.1 6.2 7.3 3.6 38.8 42.1 35.8 45.9 41.3 40.1 41.7 40.7 40.4 42.8 35.6 40.0 45.0 21.3 9.6 22.3 17.3 33.3 22.2 21.2 13.7 13.1 35.5 23.7 19.7 11.5 15.7 16.3 27.6 27.1 13.3 38.2 28.4 9.8 13.6 1.9 24.5 23.2 19.6 48.2 32.6 15.5 18.3 16.3 18.4 21.4 33.1 7.0 28.5 22.1 24.3 16.7 28.6 15.7 28.5 10.2 22.9 33.9 2.9 20.8 25.7 26.6 15.9 22.6 18.0 30.9 14.1 14.1 21.5 19.0 23.7 38.1 27.5 28.1 21.7 21.6 27.9 13.1 19.9 20.1 10.4 12.6 15.9 25.6 30.8 33.3 28.6 20.1 27.4 TFE3 "bHLHe33, TFEA" ENSG00000068323 "Transcription factor binding to IGHM enhancer 3" P19532 X 49028726-49043410 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.5" "Group enriched" "Detected in many" 4 "granulocytes: 12.5;monocytes: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023881 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023881: AB_1857931" "unprognostic (2.68e-2)" "unprognostic (2.89e-3)" "unprognostic (2.40e-2)" "unprognostic (5.36e-2)" "unprognostic (2.71e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (4.32e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.19e-8)" "unprognostic (1.93e-1)" "unprognostic (8.77e-2)" "unprognostic (4.19e-2)" "unprognostic (6.25e-1)" 31.6 23.8 27.3 17.0 25.3 24.3 23.1 25.0 27.1 24.2 22.0 20.2 10.9 24.9 21.3 15.7 26.4 18.6 15.6 24.0 33.7 15.2 12.7 29.4 11.9 37.3 28.8 22.2 26.0 12.5 25.3 18.5 21.0 26.5 17.4 11.6 15.0 13.5 28.5 17.1 20.6 14.8 24.9 26.0 22.7 17.0 6.0 30.0 10.8 20.2 14.1 13.4 25.2 20.7 33.6 32.8 41.5 14.6 44.6 48.6 45.1 12.5 40.6 55.8 49.7 38.2 23.3 26.8 10.2 18.0 65.7 48.6 25.5 25.4 40.2 44.8 24.4 11.8 8.3 39.6 26.2 69.0 10.0 28.3 38.5 32.3 64.4 50.1 47.8 26.3 8.4 19.8 55.9 49.2 20.6 7.5 17.2 36.3 11.0 34.1 11.9 22.2 26.6 43.1 18.0 12.4 12.4 44.8 19.0 17.9 52.5 27.6 15.0 48.5 47.1 48.7 48.0 27.3 30.1 29.7 8.0 56.1 14.0 33.2 0.0 4.8 1.8 0.6 4.7 1.1 0.5 0.9 0.5 2.2 1.0 0.6 0.5 12.5 0.4 6.3 0.5 1.3 2.6 27.3 25.3 25.0 27.1 24.0 33.7 37.3 28.8 22.2 26.5 26.0 30.0 33.6 13.8 16.0 8.8 13.7 9.8 19.8 19.7 11.2 30.1 6.8 10.9 9.4 8.1 15.7 11.8 20.2 4.2 16.0 4.4 14.3 9.8 17.7 0.7 10.9 15.3 17.5 12.5 5.2 7.5 15.8 9.4 20.2 14.3 14.8 5.7 12.0 10.8 15.0 22.3 18.5 7.2 8.2 0.0 21.7 29.4 2.2 27.4 20.5 8.8 11.2 15.5 12.0 4.1 6.0 7.7 21.4 13.7 24.5 12.9 20.2 10.6 12.1 7.0 5.6 13.1 18.5 14.3 2.2 0.8 18.9 22.0 37.1 8.6 13.9 7.5 19.6 TBC1D25 OATL1 ENSG00000068354 "TBC1 domain family member 25" Q3MII6 X 48539714-48562609 "Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029197 Approved Approved NA NA "HPA029197: AB_2672945" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (5.12e-3)" "unprognostic (1.19e-1)" "unprognostic (9.18e-3)" "unprognostic (1.73e-2)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (7.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.57e-1)" "unprognostic (1.21e-1)" "unprognostic (8.07e-2)" "unprognostic (8.66e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" 7.5 8.3 7.2 4.9 7.9 9.0 7.3 8.8 8.7 7.1 4.4 7.1 4.2 7.2 3.2 7.5 6.9 4.8 10.6 7.9 6.9 5.6 6.9 7.2 6.3 7.4 6.3 7.9 7.4 8.5 7.9 7.7 4.5 7.6 6.8 4.2 5.9 5.9 5.3 9.3 9.6 6.3 6.3 5.5 9.2 6.5 8.2 7.1 7.0 6.7 7.4 5.1 7.2 7.2 7.6 7.6 7.5 2.8 8.6 10.4 10.0 3.9 5.1 9.6 9.0 9.4 4.9 6.8 7.8 3.7 13.0 12.3 6.9 12.8 13.7 8.1 14.6 8.4 4.0 11.7 4.5 11.5 5.2 10.1 10.7 13.7 12.3 14.9 11.3 9.8 8.3 3.1 11.7 11.0 6.6 9.6 9.7 4.3 3.6 13.5 4.9 4.9 10.5 8.3 3.8 7.9 5.4 7.8 7.0 6.8 12.6 7.7 1.7 9.2 5.9 8.7 18.1 5.9 11.5 6.0 5.7 9.8 6.5 5.7 1.6 2.0 5.4 6.6 2.6 5.1 4.3 4.5 5.6 2.2 4.8 4.7 4.9 4.3 4.5 2.1 2.5 4.2 4.5 7.2 7.9 8.8 8.7 7.9 6.9 7.4 6.3 7.9 7.6 5.5 7.1 7.6 5.7 19.2 9.3 6.5 11.2 17.3 9.4 11.1 10.8 9.5 5.7 5.2 7.4 5.7 5.9 1.8 14.6 7.1 13.0 7.5 11.7 6.8 16.2 5.7 4.9 6.1 15.6 4.0 8.1 14.0 7.5 6.2 3.6 8.2 5.7 4.6 8.6 4.5 5.5 13.5 9.0 3.4 10.2 4.4 9.3 36.9 5.6 6.5 7.2 3.7 4.5 4.9 22.6 5.5 8.0 11.6 3.2 4.9 8.6 8.2 4.0 4.9 5.0 7.0 26.3 4.7 6.1 9.5 11.8 8.4 14.9 14.6 13.6 6.0 3.9 8.6 ACSL4 "ACS4, FACL4, LACS4, MRX63, MRX68" ENSG00000068366 "Acyl-CoA synthetase long chain family member 4" O60488 X 109624244-109733403 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 360.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000286, HPA005552" Supported Approved "Golgi apparatus,Mitochondria" NA NA 16000 "Golgi apparatus" Mitochondria "HPA000286: AB_2665966, HPA005552: AB_1078774" "unprognostic (9.13e-2)" "unprognostic (3.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (5.32e-2)" "unprognostic (4.14e-3)" "unprognostic (1.92e-1)" "unprognostic (9.45e-2)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (4.78e-1)" "unprognostic (3.29e-2)" "prognostic favorable (5.73e-4)" 44.6 41.0 11.1 39.1 13.9 16.3 20.0 12.7 15.2 48.6 8.9 12.8 15.5 19.4 17.9 16.0 13.5 29.5 29.7 16.4 19.1 46.8 14.0 39.3 24.8 18.2 18.5 12.3 15.1 12.0 20.0 9.3 21.6 19.7 13.5 13.7 24.9 10.7 15.3 42.9 9.5 13.5 22.2 13.0 22.4 19.5 27.1 16.8 20.5 18.8 17.1 18.6 68.6 10.7 24.0 67.3 21.3 24.2 28.3 97.8 61.6 20.3 94.0 107.6 91.0 97.4 21.1 45.0 46.2 35.4 71.7 100.9 19.4 22.4 92.0 143.0 15.7 23.3 181.4 26.6 223.3 44.8 44.8 360.0 51.4 36.7 103.6 74.0 50.2 71.8 25.5 5.6 54.2 100.7 4.7 40.7 60.7 31.6 15.2 37.2 26.4 45.4 39.6 136.3 20.9 15.2 12.3 109.3 0.4 63.2 49.0 1.9 45.8 128.5 81.1 22.6 129.3 85.9 28.1 31.7 41.2 139.7 97.8 52.2 32.5 10.9 35.0 4.2 15.5 3.2 3.3 3.9 3.5 10.6 3.1 3.0 3.8 29.6 4.0 19.4 4.0 6.7 6.5 11.1 13.9 12.7 15.2 16.4 19.1 18.2 18.5 12.3 19.7 13.0 16.8 24.0 27.9 76.9 184.3 29.0 19.5 22.3 25.7 20.0 81.4 44.2 7.3 8.1 37.2 15.7 40.1 73.5 2.1 7.3 18.3 0.8 50.9 27.7 1.4 79.5 27.0 29.8 7.7 26.1 76.7 25.4 36.9 46.0 7.1 208.8 633.8 151.6 18.2 44.2 23.9 6.7 78.3 5.7 2.0 64.9 59.1 4.9 5.6 67.8 16.0 57.1 70.4 10.9 8.2 71.4 116.4 32.3 3.0 10.1 36.1 19.4 0.7 12.4 12.2 16.7 0.0 20.0 27.9 3.7 5.3 10.1 8.1 31.6 25.2 34.9 2.7 18.4 INPP5A 5PTASE ENSG00000068383 "Inositol polyphosphate-5-phosphatase A" Q14642 10 132537787-132783480 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 6.7" "Lineage enriched" "Detected in single" 28 "granulocytes: 6.7" "Low cell line specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 250.8" "Low region specificity" "Detected in all" HPA012285 Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA012285: AB_1851802" "prognostic unfavorable (7.47e-4)" "unprognostic (2.38e-1)" "unprognostic (2.54e-1)" "unprognostic (1.68e-3)" "unprognostic (1.43e-1)" "unprognostic (3.25e-2)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (5.65e-2)" "unprognostic (4.35e-1)" "unprognostic (4.70e-2)" "unprognostic (1.70e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (8.91e-3)" "unprognostic (8.66e-2)" 21.3 17.0 27.9 12.1 71.3 9.6 17.5 58.2 29.7 28.4 12.7 43.3 19.4 49.9 19.6 29.9 30.9 15.3 75.6 21.8 23.8 13.6 14.8 25.3 8.4 26.1 40.7 24.5 19.7 12.9 12.3 14.8 29.0 36.6 24.8 16.9 17.1 13.6 23.8 76.1 21.7 23.6 42.4 18.2 14.0 27.8 23.1 48.6 6.9 14.2 50.7 7.4 35.8 22.9 27.4 35.4 13.7 22.6 21.9 33.8 23.7 18.4 36.4 27.9 23.3 15.4 32.6 14.0 3.1 13.7 38.8 15.1 19.5 24.8 15.2 27.9 10.8 14.4 5.1 17.3 44.7 24.3 12.9 11.9 16.0 14.9 15.0 28.2 18.6 16.3 6.6 7.6 18.2 12.6 28.3 3.6 40.9 10.5 21.0 24.3 7.6 14.9 5.6 19.4 19.9 5.4 18.5 18.3 26.5 22.6 20.5 17.2 30.4 13.7 14.9 17.2 20.1 21.6 3.6 18.4 11.0 14.4 8.6 6.5 6.7 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.3 27.9 71.3 58.2 29.7 21.8 23.8 26.1 40.7 24.5 36.6 18.2 48.6 27.4 14.7 9.6 19.7 14.7 4.5 5.4 4.4 1.9 0.0 10.5 7.1 5.3 10.1 4.3 6.4 7.3 0.0 3.9 5.0 24.8 0.0 6.5 12.3 2.8 22.8 10.0 6.1 3.2 33.5 9.2 3.7 5.6 6.6 5.9 8.8 8.6 15.0 17.9 2.9 8.4 25.2 9.9 2.0 7.2 12.0 17.0 7.2 6.9 1.8 19.7 4.1 9.6 0.0 18.1 29.2 12.1 11.5 11.7 2.5 6.5 13.8 4.3 2.5 5.2 6.6 6.5 24.3 6.3 7.3 2.8 5.8 2.5 2.7 10.7 13.9 8.6 GPKOW "GPATC5, GPATCH5, Mos2, Spp2, T54" ENSG00000068394 "G-patch domain and KOW motifs" Q92917 X 49113407-49123735 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000287, HPA001894" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000287: AB_1079015, HPA001894: AB_1079014" "unprognostic (3.34e-2)" "unprognostic (9.54e-3)" "unprognostic (8.95e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (2.03e-3)" "unprognostic (1.02e-1)" "unprognostic (9.29e-2)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" "unprognostic (7.08e-2)" "unprognostic (1.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.73e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-2)" 16.6 16.0 20.0 11.8 20.8 16.2 16.5 21.8 22.0 14.4 13.0 16.8 14.5 17.1 11.9 14.8 15.3 10.4 17.7 18.7 23.7 14.3 14.6 13.9 15.1 23.2 22.1 17.7 13.7 12.2 19.2 17.4 13.9 22.2 12.8 12.8 12.0 13.9 16.7 35.1 19.7 14.2 13.9 20.8 15.5 15.6 7.3 23.7 17.9 13.5 25.6 14.5 16.3 14.4 23.2 36.5 38.1 24.9 20.9 21.6 18.6 27.0 23.1 25.9 36.0 38.0 27.9 35.5 15.2 17.4 28.6 36.8 25.2 27.9 27.3 23.4 32.2 29.8 15.8 31.4 19.9 25.8 18.9 32.1 20.4 34.3 28.8 29.2 21.1 27.4 30.0 19.8 23.1 23.8 59.5 26.0 31.5 17.6 19.5 30.0 32.2 27.4 41.5 18.5 45.8 20.8 24.1 26.9 25.2 25.4 26.1 48.5 24.5 30.7 20.7 31.2 30.4 22.1 35.4 26.1 20.7 26.7 31.1 32.7 26.2 22.3 28.9 37.2 31.4 30.3 20.5 28.6 27.8 22.6 34.8 24.3 22.4 17.3 25.0 35.9 20.8 31.1 20.2 20.0 20.8 21.8 22.0 18.7 23.7 23.2 22.1 17.7 22.2 20.8 23.7 23.2 10.9 19.2 11.0 7.2 10.5 8.0 14.1 21.8 4.6 14.8 6.4 5.5 13.1 21.5 19.1 7.3 4.2 28.4 16.3 16.2 15.6 26.2 1.1 15.6 10.0 13.4 7.8 22.5 2.8 25.2 20.5 11.7 14.3 10.6 11.4 10.4 11.7 14.5 16.7 5.0 2.8 12.1 18.3 10.9 9.3 1.7 15.5 8.7 5.4 2.8 13.2 20.9 28.8 2.0 3.9 25.6 23.2 15.1 9.4 9.4 19.5 20.5 12.7 13.4 39.5 12.9 13.0 9.9 18.4 6.1 9.9 43.8 16.7 10.6 11.0 12.8 GRIPAP1 "DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3" ENSG00000068400 "GRIP1 associated protein 1" Q4V328 X 48973720-49002264 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 212.7;Rod photoreceptor cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000282, HPA000615" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA000282: AB_1079022, HPA000615: AB_1079023" "unprognostic (3.34e-1)" "unprognostic (2.86e-3)" "unprognostic (3.24e-3)" "unprognostic (3.93e-3)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" "unprognostic (3.97e-3)" "unprognostic (1.01e-2)" "unprognostic (5.26e-2)" "unprognostic (3.65e-1)" "unprognostic (1.69e-3)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-7)" "unprognostic (4.24e-3)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "prognostic favorable (4.63e-7)" 17.3 24.0 34.3 23.8 35.2 35.6 16.8 30.6 39.5 19.4 23.0 18.8 19.1 17.7 24.9 19.4 19.5 13.4 15.0 35.1 33.4 18.9 22.2 21.5 25.6 32.9 31.4 31.0 20.1 15.6 23.1 33.9 15.8 33.9 19.2 15.6 48.5 16.8 15.6 18.5 24.5 22.1 14.8 26.3 28.3 19.6 19.9 32.8 26.3 21.1 13.1 24.3 18.1 17.7 36.0 27.9 43.6 30.7 64.3 18.1 13.8 27.7 22.4 27.6 28.3 26.7 23.7 24.0 42.1 12.6 22.3 30.4 39.0 38.5 24.5 22.6 49.3 19.7 34.0 59.8 25.2 31.1 36.7 58.3 14.4 34.5 37.7 27.8 26.2 26.1 35.6 25.2 54.3 26.3 51.5 32.2 49.3 36.3 19.8 23.5 35.3 46.1 33.8 28.0 34.1 27.0 30.0 47.6 18.8 28.4 44.4 42.6 72.5 31.3 14.9 23.2 30.7 18.5 33.0 27.6 29.6 25.9 54.9 25.9 32.5 14.6 21.3 10.1 13.3 8.6 11.3 10.4 9.7 12.0 13.6 8.9 9.5 25.9 15.7 13.0 12.4 9.0 9.5 34.3 35.2 30.6 39.5 35.1 33.4 32.9 31.4 31.0 33.9 26.3 32.8 36.0 22.6 9.6 25.1 13.7 28.6 8.2 15.5 25.2 10.8 67.6 11.6 9.1 13.9 22.8 26.7 18.4 212.7 21.2 30.1 25.8 29.4 15.5 9.3 23.8 19.3 21.2 21.7 17.2 32.1 18.4 9.9 14.4 26.0 26.3 43.1 31.2 18.5 18.5 17.2 69.0 32.9 22.4 34.6 27.0 18.7 14.4 17.1 28.5 7.2 10.3 32.7 25.3 33.0 18.1 17.7 18.4 30.6 19.2 22.2 16.9 23.9 19.1 25.5 169.4 19.7 16.9 17.8 11.5 10.1 16.6 14.2 26.1 25.1 35.8 16.5 19.5 FTSJ1 "CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7" ENSG00000068438 "FtsJ RNA 2'-O-methyltransferase 1" Q9UET6 X 48476021-48486364 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 75.7;Pancreatic endocrine cells: 60.1;Plasma cells: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002718 Approved Approved Cytosol NA NA Cytosol "HPA002718: AB_1078914" "unprognostic (2.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.44e-1)" "unprognostic (3.37e-1)" "unprognostic (2.13e-1)" "unprognostic (6.77e-2)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.95e-2)" "unprognostic (2.39e-1)" "unprognostic (3.96e-3)" "unprognostic (2.06e-3)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.24e-10)" "unprognostic (2.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.56e-2)" "unprognostic (1.23e-1)" 14.5 15.3 5.3 14.7 6.5 16.1 14.0 6.3 9.0 16.1 5.2 10.2 8.3 13.9 4.7 15.0 12.2 8.7 11.0 6.3 6.3 9.6 9.9 13.4 16.4 5.7 5.8 5.4 12.8 17.0 12.5 12.3 8.5 5.9 10.4 7.8 5.8 15.5 12.9 14.9 14.0 10.3 12.4 5.5 13.8 13.9 9.9 5.7 14.9 14.5 11.0 13.5 14.4 14.2 6.7 75.9 51.1 19.1 76.4 27.1 27.9 31.3 36.0 34.3 51.4 40.5 30.8 102.6 43.6 26.3 55.4 32.4 49.8 38.3 127.3 23.1 33.4 36.3 27.8 62.5 35.5 75.8 38.5 67.4 26.0 63.0 64.8 63.2 28.5 36.4 49.2 24.1 35.2 67.4 42.6 50.4 27.3 43.2 32.1 86.6 40.4 62.7 91.2 48.3 25.4 26.0 25.5 57.4 31.1 27.5 22.1 35.7 21.7 35.8 40.6 54.9 85.3 44.9 47.6 39.8 31.4 89.6 71.3 43.6 19.5 23.7 19.1 34.6 27.1 43.0 27.2 29.5 35.4 28.3 31.5 26.8 34.5 3.4 30.3 27.8 19.1 30.2 27.8 5.3 6.5 6.3 9.0 6.3 6.3 5.7 5.8 5.4 5.9 5.5 5.7 6.7 15.1 6.4 11.0 3.9 20.6 12.7 11.4 30.7 14.2 4.5 8.5 8.8 6.7 4.3 23.8 7.3 2.1 5.3 19.7 6.6 17.6 21.2 49.5 11.1 11.8 13.4 5.4 14.7 4.4 18.2 28.7 12.4 16.3 15.2 8.8 9.2 6.4 5.9 17.0 3.3 4.3 11.3 10.2 8.4 10.6 75.7 10.8 11.0 5.4 5.6 8.9 5.7 19.6 3.0 5.8 60.1 2.7 8.6 59.5 17.0 4.8 11.3 14.0 6.5 13.1 9.6 16.7 7.5 10.1 15.0 10.9 5.7 17.0 10.7 9.4 26.5 PRR11 FLJ11029 ENSG00000068489 "Proline rich 11" Q96HE9 17 59155732-59206709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.3;lymphoid tissue: 20.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 26.3;Extravillous trophoblasts: 22.3;Granulosa cells: 14.4;Kupffer cells: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA023923, HPA052376" Uncertain Approved "Endoplasmic reticulum" Yes Yes "Endoplasmic reticulum" "HPA023923: AB_1855783, HPA052376: AB_2681803" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.15e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.22e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.80e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.84e-1)" "unprognostic (1.55e-3)" 1.4 0.7 2.0 6.6 1.9 18.3 1.9 4.5 2.7 1.2 1.3 4.7 6.6 1.8 0.5 3.8 1.5 1.4 1.0 1.9 2.2 0.6 1.4 2.3 10.4 1.7 2.1 1.7 1.4 0.5 0.3 0.0 4.3 2.5 0.8 5.6 1.7 0.6 0.8 1.2 3.1 5.1 3.6 1.2 3.3 2.4 1.8 1.7 20.8 1.3 0.4 12.1 2.0 0.6 3.5 105.3 56.9 84.5 24.8 2.4 16.0 31.7 66.7 41.9 69.1 54.2 68.4 78.7 80.2 65.9 52.7 56.2 40.7 67.0 73.9 145.0 99.3 39.1 86.4 58.8 50.3 0.6 88.7 32.5 4.0 5.3 81.9 109.0 17.1 77.2 57.9 48.6 76.7 72.8 95.2 80.7 26.1 31.9 52.0 82.5 67.3 135.7 45.9 20.0 32.4 34.5 45.4 61.7 18.4 29.2 38.0 54.4 34.1 57.8 146.4 157.3 73.5 117.8 48.8 108.2 73.6 34.5 47.4 150.1 1.7 2.1 2.3 0.6 4.0 0.2 1.1 0.5 0.7 2.6 0.6 0.3 0.5 2.1 0.5 9.5 1.1 1.4 0.8 2.0 1.9 4.5 2.7 1.9 2.2 1.7 2.1 1.7 2.5 1.2 1.7 3.5 4.5 0.0 1.7 3.3 3.1 1.9 2.0 1.5 0.0 2.0 0.8 1.5 2.0 1.5 1.6 0.0 0.0 6.2 1.4 2.0 0.0 0.4 0.9 1.4 1.9 3.6 4.9 26.3 1.6 0.5 22.3 2.9 2.6 2.2 2.5 14.4 4.2 0.3 7.8 1.7 1.8 5.0 0.0 18.6 6.3 0.4 0.9 7.8 1.8 2.8 8.4 0.9 4.1 2.0 3.4 0.9 0.7 2.2 9.7 1.1 0.5 0.5 0.6 3.2 0.0 2.9 3.3 2.6 5.1 5.5 1.3 2.1 3.3 1.3 8.4 1.7 REEP1 "C2orf23, FLJ13110, SPG31, Yip2a" ENSG00000068615 "Receptor accessory protein 1" Q9H902 2 86213993-86338083 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;testis: 44.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 86.2;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 39.2" "Cancer enhanced" "Detected in many" "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 68.1;HAP1: 15.0;RPMI-8226: 16.0;SCLC-21H: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058061 Enhanced NA NA "HPA058061: AB_2683591" "unprognostic (1.94e-2)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.29e-2)" "unprognostic (5.10e-2)" "unprognostic (6.63e-2)" "unprognostic (9.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (6.15e-2)" "unprognostic (2.35e-1)" "unprognostic (2.56e-2)" "unprognostic (6.77e-2)" "unprognostic (2.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.07e-3)" 4.1 6.3 16.1 1.8 18.5 0.0 4.9 8.2 33.5 4.0 11.1 30.0 4.4 19.0 3.7 6.3 13.7 3.8 15.8 16.0 26.1 2.0 1.1 3.6 0.5 24.6 38.5 21.5 1.9 10.0 8.0 14.0 2.2 39.0 7.4 5.0 13.1 1.7 13.0 20.0 1.8 9.4 20.9 5.8 2.1 8.9 44.9 27.3 0.3 2.0 14.4 0.6 21.9 5.9 44.0 0.0 0.0 2.2 2.9 0.1 0.0 68.1 0.0 0.0 4.5 0.5 2.5 0.0 0.0 3.2 0.0 3.4 4.9 15.0 0.1 3.9 0.0 8.1 0.0 5.0 0.4 0.0 0.3 0.4 0.7 0.1 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.1 2.7 0.1 0.0 2.6 0.1 0.0 0.1 6.5 16.0 0.3 0.3 32.0 3.1 3.5 1.6 0.2 1.3 5.1 0.9 0.0 0.0 2.3 1.3 6.3 7.2 5.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 18.5 8.2 33.5 16.0 26.1 24.6 38.5 21.5 39.0 5.8 27.3 44.0 1.7 9.6 0.5 14.7 0.2 2.0 0.3 0.3 0.0 10.0 3.6 1.1 23.0 2.8 2.8 0.0 2.1 2.4 0.0 0.4 1.9 3.5 18.0 17.1 0.3 5.7 4.8 0.0 86.2 6.2 26.6 2.4 0.0 0.7 0.0 0.8 12.5 0.2 0.9 3.3 95.5 0.2 8.2 0.8 1.6 14.4 2.5 0.4 1.8 6.5 0.6 13.4 0.0 39.2 6.0 6.5 0.0 3.4 0.0 1.6 0.0 5.1 16.6 15.8 19.7 4.2 13.5 4.0 2.7 0.5 1.1 6.6 0.2 0.0 0.5 0.4 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 9.0 10.5 14.1 8.9 19.4 18.4 6.2 16.3 12.4 13.1 4.8 4.3 10.0 10.2 5.8 7.1 8.8 15.1 21.6 7.5 14.0 12.8 10.2 39.8 5.8 23.5 20.7 4.7 6.5 12.5 23.3 16.4 10.2 21.6 4.3 3.2 15.1 9.1 3.9 13.3 8.6 8.3 9.2 17.8 9.0 5.4 8.9 18.0 8.2 14.0 17.5 6.2 6.6 5.9 39.1 28.0 14.0 17.5 20.5 8.7 11.7 30.9 13.0 7.6 10.9 8.8 44.5 31.5 14.1 15.5 11.0 14.0 23.2 15.8 10.8 10.5 14.2 14.9 16.3 11.9 23.3 13.6 30.8 25.5 7.9 8.2 13.2 8.0 8.8 29.0 12.6 11.4 2.3 7.7 10.5 14.1 19.4 7.5 31.8 9.9 12.2 7.1 8.1 59.3 6.4 27.8 7.7 12.7 16.3 10.7 22.4 6.2 40.4 19.2 0.0 23.3 14.1 9.9 7.4 15.5 5.9 4.8 28.3 12.2 0.0 1.1 1.7 0.4 1.6 0.3 0.6 0.2 0.2 0.6 1.8 0.3 0.2 3.1 0.0 1.5 0.5 0.0 0.3 14.1 19.4 16.3 12.4 7.5 14.0 23.5 20.7 4.7 21.6 17.8 18.0 39.1 25.6 218.0 215.0 22.2 11.3 10.8 3.4 4.9 1.2 42.0 5.2 3.7 42.3 31.5 29.4 16.5 235.6 1.7 7.0 2.4 5.9 32.7 0.9 51.2 24.2 34.2 12.0 3.8 35.0 11.4 32.2 16.5 8.6 176.3 12.0 62.2 27.1 16.5 20.7 13.5 32.5 3.5 14.2 33.6 16.9 1.9 11.1 29.3 10.6 48.7 36.9 11.0 6.2 33.7 138.3 24.3 6.1 4.9 7.7 7.7 10.5 15.7 13.3 44.8 0.0 9.5 12.8 4.0 10.1 6.3 9.7 8.6 8.4 8.7 5.9 3.9 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" No No "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (7.20e-2)" 5.4 5.7 3.5 5.9 3.8 5.0 4.6 2.8 4.5 4.7 3.3 5.0 4.2 8.2 3.1 6.1 5.2 2.9 5.8 3.7 3.3 3.6 5.1 4.0 4.6 3.3 3.5 3.5 5.2 5.3 7.2 5.0 5.1 3.8 4.6 5.1 3.5 3.9 5.1 10.9 5.6 3.9 7.0 2.6 3.8 4.6 6.2 4.1 6.3 4.5 7.5 4.9 5.3 4.3 4.1 18.5 41.1 18.0 34.7 17.2 13.7 25.9 16.6 10.9 23.2 14.4 51.9 14.2 41.9 17.2 17.0 22.7 20.9 46.6 24.4 20.6 17.6 24.0 36.2 18.0 35.1 12.1 34.8 18.7 10.5 15.0 34.6 26.7 8.8 18.2 19.0 48.8 10.3 16.2 16.4 25.8 15.1 32.7 24.4 26.8 30.7 39.5 19.6 10.5 29.7 27.7 14.6 18.3 23.8 12.7 12.3 14.0 12.0 29.3 28.0 22.2 24.3 33.8 14.5 15.3 35.7 14.6 29.3 25.3 0.5 0.4 0.0 0.7 0.6 0.9 0.5 0.3 0.6 0.4 0.6 0.3 0.4 0.1 0.5 0.5 0.7 0.1 0.4 3.5 3.8 2.8 4.5 3.7 3.3 3.3 3.5 3.5 3.8 2.6 4.1 4.1 4.9 3.2 9.1 13.4 8.8 4.2 4.9 5.3 12.0 12.4 6.2 5.5 11.1 8.6 4.7 9.2 16.7 6.3 7.2 5.1 3.9 6.0 3.0 5.4 13.8 6.5 9.6 10.9 19.7 4.9 5.4 7.7 8.2 6.9 6.3 11.0 4.2 8.3 12.5 11.8 18.1 6.7 2.0 3.1 3.5 1.7 6.2 5.5 5.4 6.5 3.3 4.2 6.2 20.1 18.2 6.6 3.0 5.3 10.1 9.1 3.5 3.4 5.2 9.7 0.0 14.3 6.2 5.0 7.2 13.4 2.7 3.8 7.5 12.4 10.4 4.0 LAPTM4A "HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp" ENSG00000068697 "Lysosomal protein transmembrane 4 alpha" Q15012 2 20032650-20051628 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 1393.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031402, HPA031404, HPA068554" Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Plasma membrane" "HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003" "unprognostic (2.01e-1)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (5.73e-1)" "unprognostic (6.04e-2)" "unprognostic (3.00e-2)" "unprognostic (1.53e-3)" "unprognostic (5.37e-2)" "unprognostic (1.27e-1)" "unprognostic (3.65e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (8.70e-2)" "unprognostic (1.05e-2)" "unprognostic (7.78e-3)" "unprognostic (2.18e-2)" "unprognostic (7.98e-3)" "unprognostic (2.36e-1)" 363.7 455.3 117.1 178.7 117.1 201.3 342.0 123.1 148.1 473.8 148.4 258.6 221.6 512.4 342.7 318.3 373.4 387.1 325.5 112.9 148.5 465.1 412.6 310.7 161.5 124.5 122.8 106.3 464.4 293.2 291.6 156.8 400.9 126.0 309.0 236.1 59.6 308.7 617.5 206.4 249.1 229.6 415.7 127.7 192.6 242.6 392.9 122.8 123.9 369.1 236.9 179.9 345.2 250.8 128.4 417.7 228.8 136.4 283.2 1393.4 1031.8 509.1 514.3 651.8 349.3 393.6 180.5 398.4 73.2 116.2 637.9 356.9 400.7 115.0 250.6 317.8 181.2 183.2 112.4 244.3 520.1 534.8 86.7 294.9 691.7 501.2 338.7 386.4 481.9 367.6 62.2 86.6 135.8 527.5 243.3 53.8 114.0 299.2 353.1 207.1 89.3 397.5 139.7 858.6 347.7 214.8 207.3 480.4 390.5 335.9 492.9 169.6 70.1 467.5 575.7 203.8 500.3 336.5 221.7 349.2 118.3 455.3 172.8 234.4 737.8 382.3 289.3 94.6 324.9 116.4 197.4 112.9 106.9 269.2 192.3 126.7 113.7 200.1 124.3 393.4 226.9 119.3 427.0 117.1 117.1 123.1 148.1 112.9 148.5 124.5 122.8 106.3 126.0 127.7 122.8 128.4 351.7 195.5 203.1 39.2 156.5 659.0 601.1 1210.5 339.2 24.4 330.3 306.1 211.7 380.3 727.7 553.6 12.5 224.4 109.8 174.8 162.4 539.4 1235.7 195.7 407.1 384.0 138.1 65.0 15.0 347.6 1035.3 896.8 111.6 286.0 521.9 445.7 331.3 519.4 311.3 20.2 14.3 203.6 767.0 299.3 716.0 1080.9 835.3 254.4 588.7 39.4 278.0 315.3 48.4 34.7 18.7 289.4 246.2 600.7 156.8 331.2 171.5 940.9 506.7 24.7 532.5 389.4 583.0 356.3 173.5 268.2 709.8 302.9 146.4 579.1 224.8 500.9 TTC7A "KIAA1140, TTC7" ENSG00000068724 "Tetratricopeptide repeat domain 7A" Q9ULT0 2 46916157-47076137 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 41.2" "Cell type enhanced" "Detected in many" "Late spermatids: 168.0;Microglial cells: 77.8;Oligodendrocytes: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 90.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036781, HPA036782" Enhanced NA NA "HPA036781: AB_10673665, HPA036782: AB_10671711" "unprognostic (2.51e-1)" "unprognostic (1.43e-1)" "unprognostic (8.56e-2)" "unprognostic (1.67e-2)" "unprognostic (4.01e-2)" "unprognostic (1.03e-3)" "unprognostic (1.51e-3)" "unprognostic (3.60e-1)" "unprognostic (4.36e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (3.19e-3)" "unprognostic (1.15e-1)" "unprognostic (5.06e-3)" "unprognostic (1.30e-1)" "unprognostic (9.62e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-2)" 8.0 16.9 2.0 7.0 3.4 18.6 6.7 3.8 2.3 6.0 8.5 6.2 13.0 4.2 1.9 14.1 5.0 3.8 3.2 2.0 4.1 6.2 5.7 12.6 10.5 6.3 3.3 1.0 4.3 16.2 4.6 4.5 5.8 4.7 5.0 5.8 4.0 13.0 4.4 1.9 12.6 12.6 2.7 3.7 10.7 10.4 41.2 3.8 29.4 10.5 0.8 14.7 4.8 8.9 5.3 39.9 14.6 4.6 1.3 6.9 8.5 19.2 10.7 14.2 6.9 6.4 22.6 23.2 26.5 10.2 19.9 8.0 16.4 6.4 13.5 5.6 51.9 5.3 2.7 11.6 24.1 2.9 10.8 10.4 3.4 15.9 8.6 10.6 8.1 5.6 10.2 10.4 17.5 3.9 14.8 54.5 11.4 5.1 42.5 3.7 90.0 7.8 47.6 6.5 10.0 5.8 5.4 19.8 39.8 3.5 8.5 7.5 22.7 14.1 7.8 6.0 5.9 9.0 10.7 4.3 13.5 5.7 13.0 4.4 0.0 1.5 0.0 0.3 0.8 0.3 1.2 0.9 0.3 0.7 1.1 0.6 0.2 0.3 0.2 0.3 1.6 0.3 0.4 2.0 3.4 3.8 2.3 2.0 4.1 6.3 3.3 1.0 4.7 3.7 3.8 5.3 2.4 22.4 12.4 32.0 22.0 6.5 4.8 5.1 9.1 1.9 4.7 2.7 4.3 11.5 5.4 7.3 0.0 8.0 16.7 29.1 3.9 5.1 52.9 27.9 10.9 5.0 6.7 7.4 24.2 7.5 11.2 8.4 13.3 15.4 8.2 4.7 1.8 9.2 16.4 0.0 18.8 9.4 0.0 29.5 15.7 168.0 4.7 24.6 5.4 77.8 18.6 22.6 1.0 17.6 86.8 22.2 11.8 6.8 22.9 3.1 38.7 4.6 12.4 3.7 0.0 8.0 5.2 6.1 6.8 12.2 5.5 4.0 11.5 2.9 7.6 4.5 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: AB_2732165" "prognostic favorable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favorable (1.83e-4)" 57.6 97.1 53.4 39.9 57.0 131.3 80.8 83.8 59.1 117.5 52.3 83.8 80.6 102.7 109.3 96.1 78.9 48.4 61.3 54.3 56.3 107.0 84.1 55.9 54.1 56.1 53.7 54.6 99.9 91.9 48.4 122.8 45.2 62.0 112.6 88.8 64.3 89.4 42.6 46.2 146.3 89.8 43.5 48.8 79.6 80.2 55.9 55.6 72.8 109.7 31.8 43.8 67.3 114.3 68.0 25.9 49.5 100.6 71.2 55.5 69.3 72.6 48.0 54.0 54.0 62.2 41.1 67.0 45.5 38.7 45.5 67.8 65.3 50.6 72.1 50.0 54.1 44.9 52.2 172.7 89.5 45.0 50.3 48.9 65.7 103.0 73.3 59.7 71.8 76.2 143.8 39.5 55.4 63.9 57.3 107.4 68.3 77.4 50.0 90.4 44.4 33.3 50.0 73.7 121.7 62.4 94.6 103.9 69.5 53.0 79.6 67.7 83.3 54.8 58.3 57.4 37.0 48.7 50.6 65.4 64.2 53.3 57.7 52.4 158.1 50.5 92.7 63.4 50.8 57.6 60.8 55.1 60.4 50.1 60.2 51.1 52.7 80.3 67.5 65.3 52.0 84.2 46.8 53.4 57.0 83.8 59.1 54.3 56.3 56.1 53.7 54.6 62.0 48.8 55.6 68.0 63.3 70.5 52.9 38.5 41.3 83.1 87.2 182.5 174.2 66.5 69.9 77.5 12.9 38.6 109.1 99.3 39.6 114.3 39.4 157.4 76.3 58.7 43.8 50.8 64.8 46.1 110.2 40.1 31.1 47.4 73.9 73.7 64.2 56.9 54.5 60.3 32.5 25.1 41.4 20.2 40.6 108.6 150.5 16.6 33.5 16.4 81.1 24.5 26.6 22.5 30.3 32.4 44.3 50.8 52.6 60.5 105.7 68.4 34.0 59.0 84.7 65.5 68.4 56.0 52.6 31.5 50.6 71.6 57.9 90.3 83.0 124.0 43.3 87.9 89.8 89.3 STON1-GTF2A1L SALF ENSG00000068781 "STON1-GTF2A1L readthrough" 2 48529925-48776517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 13.1" "Cell type enhanced" "Detected in some" "Early spermatids: 8.4;Excitatory neurons: 2.9;Late spermatids: 2.2;Oligodendrocyte precursor cells: 12.1;Spermatocytes: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;ASC TERT1: 2.0;HSkMC: 1.4;hTERT-RPE1: 3.6;SuSa: 7.3" HPA005715 Uncertain NA NA "HPA005715: AB_1080113" "unprognostic (5.66e-3)" "unprognostic (8.85e-2)" "unprognostic (1.18e-3)" "unprognostic (8.26e-2)" "unprognostic (5.08e-2)" "unprognostic (3.53e-1)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (2.81e-1)" "unprognostic (1.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-2)" 2.2 0.3 2.2 0.8 1.7 0.0 0.3 3.0 0.9 1.6 2.0 2.3 0.2 2.1 0.5 1.3 1.3 2.1 0.2 0.3 1.7 0.6 0.0 0.4 0.0 6.7 2.8 0.0 1.8 0.0 0.0 0.1 0.8 6.8 0.8 0.9 2.1 0.0 0.9 0.0 0.0 0.4 2.5 4.8 0.5 1.0 0.5 1.6 0.1 0.1 0.0 0.0 2.6 0.4 13.1 0.0 0.0 0.8 0.0 2.1 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.1 1.4 0.1 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.0 0.9 0.3 1.7 6.7 2.8 0.0 6.8 4.8 1.6 13.1 0.2 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 1.9 0.0 0.4 0.0 12.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 8.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 SRBD1 FLJ10379 ENSG00000068784 "S1 RNA binding domain 1" Q8N5C6 2 45388680-45612165 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030567, HPA030568" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA030567: AB_10611244, HPA030568: AB_10601856" "unprognostic (1.16e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-3)" "unprognostic (2.46e-1)" "unprognostic (8.20e-3)" "unprognostic (4.14e-1)" "unprognostic (8.69e-3)" "unprognostic (9.74e-2)" "unprognostic (7.11e-2)" "unprognostic (9.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.76e-1)" "unprognostic (3.42e-3)" "unprognostic (3.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (2.29e-1)" 6.8 5.6 2.0 7.2 2.5 6.5 7.7 2.3 2.1 9.9 3.5 7.1 5.7 7.2 11.9 4.8 5.4 5.7 5.8 1.8 3.6 7.7 8.8 6.5 7.6 2.7 2.3 1.4 5.5 7.4 12.3 3.7 6.9 2.9 7.4 8.1 3.8 5.2 5.7 3.1 3.9 5.4 6.8 2.6 8.7 8.2 9.1 2.6 11.6 10.3 5.0 7.6 5.3 3.9 3.0 18.7 9.5 19.1 12.9 6.9 15.0 15.1 14.1 12.2 13.2 12.1 8.0 7.8 16.1 10.2 10.1 9.8 8.7 19.0 17.9 24.3 22.1 10.6 21.4 7.4 17.3 8.1 17.9 12.1 9.3 7.2 15.7 18.2 5.8 16.2 5.8 15.6 11.9 19.8 17.0 24.3 13.8 21.9 12.0 10.3 16.5 27.5 14.7 15.0 12.1 16.8 13.7 12.3 13.1 14.0 9.9 8.2 6.4 14.9 18.4 14.7 9.0 12.3 12.5 4.9 9.6 10.4 17.6 13.5 3.9 6.2 13.1 5.4 7.0 4.8 5.3 4.0 6.3 6.1 4.6 5.4 5.0 2.3 8.3 12.3 5.7 4.5 4.3 2.0 2.5 2.3 2.1 1.8 3.6 2.7 2.3 1.4 2.9 2.6 2.6 3.0 10.9 19.2 7.7 28.7 13.0 3.6 3.5 6.2 8.6 7.9 8.7 8.0 8.8 8.6 10.6 3.7 4.2 8.4 15.7 5.9 9.8 8.3 3.5 11.5 20.7 9.3 7.2 15.8 22.0 9.1 7.1 10.9 20.9 9.9 8.2 11.0 7.9 13.8 9.6 13.5 32.7 9.7 0.0 22.5 3.9 2.5 7.5 13.8 7.2 46.9 13.7 12.9 13.4 48.2 51.8 4.6 6.3 6.4 19.8 2.9 5.9 10.8 7.8 14.7 13.1 12.9 10.2 37.5 28.4 9.5 3.8 5.6 12.8 16.6 5.1 2.2 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62391025 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 300000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 12.0 7.8 15.1 23.4 19.5 12.9 10.9 15.5 17.8 19.7 0.7 13.9 11.6 12.1 6.4 12.6 17.8 13.0 6.3 16.6 16.3 8.1 5.4 9.9 33.1 19.0 18.0 10.1 13.0 10.3 12.4 8.6 17.0 18.4 10.0 14.8 43.1 7.0 11.5 4.8 5.9 16.1 13.2 15.0 18.6 9.7 49.5 14.9 44.0 12.7 6.9 29.1 20.4 7.3 28.2 47.3 46.9 81.4 67.3 28.8 39.6 65.2 51.2 38.5 54.6 67.5 53.1 49.6 111.9 53.3 41.9 67.2 29.1 61.3 37.7 72.5 116.8 44.2 113.8 41.2 27.8 34.7 65.3 42.9 30.5 26.6 50.1 47.5 33.1 49.1 66.5 86.6 66.7 46.9 36.1 104.4 33.1 42.6 12.0 31.9 78.3 59.6 65.3 25.4 55.4 68.0 55.9 67.0 27.9 34.7 55.3 37.6 38.5 39.8 31.9 52.2 40.5 51.3 64.8 94.9 114.1 36.4 74.5 39.8 10.4 4.6 4.7 29.2 5.0 35.3 13.5 29.8 32.7 6.2 10.5 26.3 29.0 7.8 23.2 3.3 9.6 42.3 17.7 15.1 19.5 15.5 17.8 16.6 16.3 19.0 18.0 10.1 18.4 15.0 14.9 28.2 30.8 16.0 14.1 54.5 44.1 16.8 41.4 20.1 39.3 45.5 17.9 23.9 9.4 4.3 20.5 20.2 104.3 20.3 73.4 23.1 13.7 37.5 113.8 103.3 47.2 21.4 21.0 42.3 56.7 30.9 22.6 28.2 20.4 43.4 17.7 25.6 19.6 4.4 15.4 52.2 64.5 7.9 14.2 12.9 22.1 130.7 13.1 83.6 12.4 26.2 104.9 28.0 76.2 119.6 156.0 26.6 26.1 13.2 47.8 42.7 13.5 18.7 49.2 92.9 26.3 33.1 25.4 118.9 42.8 34.3 9.5 43.9 77.9 48.9 11.0 56.1 RASGRP2 CALDAG-GEFI ENSG00000068831 "RAS guanyl releasing protein 2" Q7LDG7 11 64726911-64745456 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 148.5;lymphoid tissue: 141.6" "Cell type enhanced" "Detected in many" "B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015635, HPA015667" Approved Supported "Plasma membrane" NA NA 1900000 "Plasma membrane" "HPA015635: , HPA015667: AB_1856090" "unprognostic (5.96e-2)" "unprognostic (3.24e-3)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (3.52e-2)" "unprognostic (4.74e-5)" "unprognostic (1.11e-2)" "unprognostic (7.36e-3)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.91e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.23e-1)" 22.5 10.2 15.2 53.3 29.5 148.5 16.9 9.5 21.5 19.3 7.9 30.8 6.7 28.5 4.6 9.2 29.5 8.8 49.4 12.7 13.5 15.7 10.2 29.7 106.8 13.2 15.4 10.7 9.1 4.1 1.0 5.5 11.0 17.6 23.4 5.4 1.3 4.7 18.8 12.3 5.6 87.1 15.2 8.7 141.6 17.6 12.0 23.0 34.9 10.7 10.3 62.5 26.9 15.6 11.4 0.1 0.1 3.0 0.1 0.0 0.3 8.7 1.3 0.2 1.2 0.8 1.5 0.2 62.8 2.7 0.2 0.8 0.7 5.4 0.9 0.3 0.3 1.7 103.4 0.0 0.4 0.3 192.8 35.9 0.0 0.0 0.5 0.0 0.0 0.1 25.9 4.1 1.1 0.0 1.4 45.4 347.1 2.5 0.4 0.0 105.0 0.2 4.4 0.0 0.0 0.5 2.3 0.1 0.1 0.0 2.2 0.6 108.5 0.6 0.0 2.0 1.5 0.1 0.5 0.1 58.9 0.0 58.2 0.0 64.4 34.1 59.9 70.4 88.0 37.3 170.7 72.9 57.2 34.5 100.2 92.7 83.1 70.9 55.3 105.8 85.9 93.8 67.5 15.2 29.5 9.5 21.5 12.7 13.5 13.2 15.4 10.7 17.6 8.7 23.0 11.4 27.4 3.2 1.8 2.6 125.5 2.3 0.1 0.0 0.0 2.6 1.6 3.7 53.1 2.8 0.0 0.0 0.0 1.7 86.1 0.1 0.0 0.0 6.6 1.9 27.1 13.5 0.0 24.2 6.0 0.0 1.3 6.6 2.6 1.2 3.8 5.7 31.4 1.7 6.1 0.0 12.2 0.1 0.0 77.3 19.7 19.5 18.0 72.2 0.0 6.5 55.8 0.7 98.9 2.5 0.9 0.0 0.0 47.8 28.6 0.1 0.4 0.9 0.7 2.5 131.5 5.4 56.8 18.0 43.9 0.9 1.3 11.8 61.0 0.8 0.3 0.2 PSME4 "KIAA0077, PA200" ENSG00000068878 "Proteasome activator subunit 4" Q14997 2 53864069-53970993 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.3" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 238.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060922 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA060922: AB_2684386" "unprognostic (2.77e-2)" "unprognostic (1.57e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.26e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (4.84e-4)" "unprognostic (4.76e-2)" "unprognostic (6.67e-2)" "unprognostic (5.65e-2)" "unprognostic (3.72e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-3)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-1)" 7.5 8.6 5.1 8.2 8.3 16.3 12.2 5.5 9.7 15.6 10.1 8.8 6.0 16.2 6.3 8.9 8.0 12.0 15.2 5.9 6.6 7.0 16.7 8.1 11.2 6.8 6.7 3.6 6.7 8.0 8.4 6.9 8.5 7.3 10.1 8.5 9.0 14.6 7.4 60.3 7.2 7.2 15.2 5.3 9.6 10.7 33.9 6.8 10.8 14.5 45.6 12.3 13.3 8.2 12.6 28.0 18.3 27.6 8.5 9.1 19.4 18.1 29.1 25.6 29.3 23.6 28.3 10.6 38.7 26.1 29.4 14.1 18.1 32.1 23.5 52.7 29.4 18.8 59.8 18.3 38.5 11.7 32.1 17.1 14.8 14.2 33.1 26.6 12.1 30.4 10.1 48.1 24.0 26.3 10.9 19.5 15.4 26.7 13.7 15.4 22.8 41.9 25.3 15.7 27.1 20.6 23.1 18.2 23.9 14.8 17.4 18.1 12.7 39.6 25.5 21.4 19.7 27.0 17.1 16.6 24.9 20.1 26.4 16.1 0.5 0.1 0.5 0.7 0.3 0.4 0.6 0.4 0.4 0.3 0.9 0.5 0.7 0.4 0.6 0.2 0.4 0.3 0.1 5.1 8.3 5.5 9.7 5.9 6.6 6.8 6.7 3.6 7.3 5.3 6.8 12.6 20.0 16.0 35.0 58.1 33.1 75.8 72.4 37.4 60.9 20.6 40.0 19.6 63.5 20.0 45.4 22.0 45.9 16.1 51.0 20.1 3.9 20.8 99.7 60.0 49.6 27.3 40.6 28.8 100.3 37.1 12.8 27.2 41.3 97.0 28.5 34.9 18.5 34.3 19.5 25.2 83.5 19.5 30.5 28.7 47.7 92.5 21.1 35.1 28.4 71.2 28.0 15.7 36.0 64.3 238.5 43.6 9.3 10.5 61.3 92.5 8.7 10.3 39.0 27.8 13.1 48.9 26.5 36.0 18.0 79.3 66.1 29.7 42.6 14.0 18.8 107.3 IFT80 "FAP167, KIAA1374, WDR56" ENSG00000068885 "Intraflagellar transport 80" Q9P2H3 3 160256986-160399880 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 254.5;Respiratory ciliated cells: 71.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035868 Uncertain NA NA "HPA035868: AB_10959463" "unprognostic (2.71e-2)" "unprognostic (4.47e-3)" "unprognostic (2.13e-1)" "unprognostic (5.29e-2)" "unprognostic (3.03e-1)" "unprognostic (7.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.29e-2)" "unprognostic (5.95e-2)" "unprognostic (6.70e-2)" "unprognostic (8.31e-2)" "unprognostic (4.24e-3)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (5.60e-3)" 7.6 10.1 19.4 8.3 27.4 6.2 11.7 18.9 26.4 13.4 20.9 7.8 6.2 14.8 17.0 8.9 17.5 11.7 10.1 20.2 20.1 15.5 7.6 14.7 12.2 21.8 23.0 17.8 16.6 10.3 27.7 25.9 7.6 23.4 9.9 9.9 25.3 7.3 10.9 4.7 12.4 8.4 10.9 16.6 9.5 11.3 24.3 21.9 18.4 18.4 6.8 11.7 9.0 9.0 43.3 23.9 16.3 36.9 16.9 34.0 59.8 9.1 20.0 29.3 15.1 19.8 13.3 33.9 15.5 25.7 18.9 22.9 20.3 13.1 19.3 33.7 23.1 14.5 20.7 23.4 9.5 33.8 9.9 17.4 33.2 13.0 17.2 18.4 68.1 17.1 19.7 8.9 28.8 23.8 11.5 18.4 11.7 11.6 15.0 9.5 16.3 19.3 26.3 31.5 6.9 22.0 23.2 21.9 20.6 26.1 23.9 34.5 11.3 15.3 15.5 10.5 21.2 19.9 41.7 28.9 28.5 26.7 17.8 15.6 0.9 0.5 0.5 0.6 0.2 0.6 0.8 0.7 0.7 0.7 0.7 1.0 0.7 0.4 0.9 0.5 1.4 1.0 0.6 19.4 27.4 18.9 26.4 20.2 20.1 21.8 23.0 17.8 23.4 16.6 21.9 43.3 6.5 41.7 33.0 42.7 7.0 3.3 5.9 7.5 15.4 16.7 6.4 3.8 7.2 18.6 14.4 23.9 16.7 3.1 7.3 3.8 7.9 5.6 30.5 39.0 19.0 7.0 11.4 11.6 61.7 1.8 2.9 13.8 5.6 9.6 2.5 13.3 6.8 4.0 2.9 1.7 44.9 5.2 2.0 4.1 2.7 9.5 16.4 4.4 1.8 27.2 2.5 8.0 7.2 46.3 254.5 2.6 2.6 21.8 10.9 2.4 1.9 6.7 71.7 18.1 6.6 8.3 8.3 43.2 10.4 8.5 3.8 0.7 8.8 11.6 5.1 3.6 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 304.6;tongue: 220.2" "Cell type enhanced" "Detected in all" "Early spermatids: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 42.7 44.4 111.7 11.6 135.2 17.6 40.0 143.2 123.9 40.2 84.6 42.0 12.8 37.5 10.5 42.8 37.6 15.2 67.7 103.9 116.4 35.7 51.9 38.5 13.8 145.3 134.3 97.0 49.4 33.7 18.3 31.4 10.6 142.9 33.0 10.3 12.0 41.8 15.0 304.6 49.0 32.6 18.5 141.4 40.4 41.7 43.8 127.8 13.2 34.8 220.2 13.1 41.6 38.1 177.8 16.1 9.8 8.4 20.6 46.7 31.8 5.8 11.3 20.2 17.8 22.7 17.1 10.2 5.4 23.7 21.3 13.2 8.3 14.6 25.1 10.9 25.2 15.6 10.1 10.9 10.9 33.0 7.0 22.4 33.5 29.7 14.4 16.9 21.4 31.9 17.7 10.1 42.0 28.2 8.9 15.4 6.2 1.2 27.6 13.6 19.9 22.8 15.3 14.8 14.9 20.7 9.0 12.9 17.8 13.0 7.0 8.0 19.2 28.9 24.0 5.1 37.2 17.0 16.9 8.8 12.6 18.1 19.0 22.0 48.9 54.7 59.8 44.9 69.1 28.5 24.9 21.9 31.0 42.9 28.9 14.3 23.6 42.7 36.5 56.7 44.0 33.1 51.9 111.7 135.2 143.2 123.9 103.9 116.4 145.3 134.3 97.0 142.9 141.4 127.8 177.8 39.5 16.0 19.4 26.1 21.0 51.6 30.3 35.1 35.3 29.7 28.8 29.7 42.1 14.3 27.2 12.9 35.5 36.5 90.8 28.4 37.2 29.0 173.0 24.7 15.4 31.1 17.5 27.1 31.2 17.6 15.2 30.3 44.9 26.5 25.4 29.5 28.5 19.7 66.3 30.3 27.2 24.1 97.6 38.3 51.7 74.8 31.1 37.1 46.2 11.2 20.0 22.6 85.5 76.4 110.8 26.5 23.9 41.0 39.7 14.9 54.0 38.8 30.1 28.2 19.7 113.5 27.9 15.3 7.2 30.1 60.1 42.3 45.8 31.3 18.2 21.5 ERLEC1 "C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB" ENSG00000068912 "Endoplasmic reticulum lectin 1" Q96DZ1 2 53787044-53818819 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 394.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031501, HPA031502, HPA031503" Enhanced "Intracellular and membrane" NA NA "HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425" "unprognostic (1.27e-2)" "unprognostic (3.36e-3)" "unprognostic (3.17e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-2)" "unprognostic (1.86e-1)" "unprognostic (3.27e-3)" "unprognostic (3.79e-1)" "unprognostic (1.29e-1)" "unprognostic (2.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.92e-1)" "unprognostic (4.71e-2)" "unprognostic (1.47e-1)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (3.92e-2)" 38.7 51.5 34.2 31.6 36.6 34.1 49.2 33.7 40.5 66.9 41.5 46.2 38.0 41.3 94.7 26.4 36.5 41.4 45.6 36.5 41.3 38.5 43.7 44.5 32.7 33.9 35.6 34.2 38.3 67.7 57.8 59.9 57.1 35.3 73.5 50.7 55.0 54.5 56.4 32.4 20.0 34.3 38.8 33.0 33.4 55.8 42.8 35.1 28.3 73.2 39.8 41.5 45.1 27.4 39.7 42.1 47.3 44.4 27.4 123.3 111.3 65.5 100.5 109.1 49.0 51.4 31.3 55.7 29.4 94.5 106.3 86.3 29.7 29.2 42.3 62.1 67.0 38.7 36.1 29.1 93.8 84.4 60.2 63.9 70.5 69.4 51.6 83.3 99.4 58.1 28.6 39.0 115.8 73.6 35.3 27.7 48.0 34.1 67.1 30.4 24.9 53.1 82.7 57.7 39.3 26.5 46.3 36.6 79.0 64.6 50.3 38.0 45.9 63.3 53.9 47.2 44.0 60.3 170.1 120.3 16.5 88.2 35.8 64.5 77.0 25.1 30.7 41.4 27.8 45.8 36.8 36.3 39.9 28.0 28.6 33.9 39.0 9.6 45.4 33.3 40.1 36.6 41.5 34.2 36.6 33.7 40.5 36.5 41.3 33.9 35.6 34.2 35.3 33.0 35.1 39.7 57.2 89.8 116.7 22.2 86.3 25.1 42.5 88.0 34.1 77.0 76.3 54.6 83.5 52.9 93.5 66.2 31.3 100.2 60.9 43.4 33.2 76.1 168.4 67.7 77.5 63.8 55.1 23.1 24.0 115.7 105.8 99.7 54.6 101.7 74.1 36.6 68.6 81.8 60.1 95.9 28.5 169.7 107.8 39.7 31.5 117.9 88.3 41.7 80.0 17.8 61.7 79.7 72.1 20.6 25.3 90.2 42.8 84.2 394.0 113.4 32.3 51.4 118.2 68.6 52.6 55.6 109.5 146.1 65.3 40.3 33.4 183.6 57.0 48.3 57.1 67.5 PPP2R5B "B56B, B56beta, FLJ35411, PR61B" ENSG00000068971 "Protein phosphatase 2 regulatory subunit B'beta" Q15173 11 64917553-64934475 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "eosinophil: 8.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036607 Approved NA NA "HPA036607: AB_10670235" "unprognostic (2.20e-2)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (3.24e-5)" "unprognostic (1.98e-1)" "unprognostic (1.68e-1)" "unprognostic (3.33e-2)" "unprognostic (9.37e-3)" "unprognostic (8.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.40e-1)" "unprognostic (2.12e-2)" 15.2 14.5 37.5 9.2 38.7 14.8 14.6 41.1 47.5 13.2 13.3 23.3 7.7 17.0 11.4 11.3 14.5 16.7 23.8 41.5 35.4 21.4 13.8 22.0 9.6 44.9 38.9 39.3 11.7 18.1 12.5 26.2 10.2 47.5 17.8 8.6 22.9 13.4 15.0 20.3 17.1 16.8 14.6 26.0 25.1 16.9 5.7 41.4 6.9 19.2 12.9 8.5 16.8 14.4 43.2 12.2 5.9 7.7 18.0 15.8 11.6 1.2 13.4 12.2 18.7 15.0 4.4 9.1 3.0 9.2 15.9 20.7 8.1 7.4 11.6 10.5 17.7 5.2 3.5 12.0 2.9 15.1 1.4 15.2 7.4 19.5 20.3 22.8 21.3 15.1 10.3 6.9 7.5 14.1 4.8 2.1 5.5 2.4 3.7 16.9 3.6 2.1 7.0 14.0 5.4 20.0 18.7 8.2 6.0 12.6 6.6 6.8 2.9 15.2 23.9 7.9 25.9 5.1 9.0 7.9 2.4 29.8 2.2 11.1 0.9 0.6 8.9 0.6 1.0 0.5 0.7 0.3 0.6 0.4 0.9 0.3 0.4 0.3 0.7 1.3 0.3 0.8 0.2 37.5 38.7 41.1 47.5 41.5 35.4 44.9 38.9 39.3 47.5 26.0 41.4 43.2 17.1 0.0 3.0 17.6 5.9 8.5 6.4 19.2 9.1 35.6 6.4 3.0 3.3 5.7 6.2 1.8 27.1 1.8 7.2 16.4 13.7 9.9 0.9 3.2 4.9 12.4 15.6 44.8 19.3 6.6 4.0 5.7 7.1 6.2 4.5 2.7 15.0 3.3 6.8 28.6 22.5 8.4 10.2 5.5 4.0 1.5 5.9 6.3 7.2 11.2 3.7 15.4 6.2 13.0 20.9 17.0 7.6 8.2 6.1 11.1 6.1 14.4 3.8 19.3 13.1 6.3 8.9 0.7 2.7 3.6 9.7 2.9 5.6 3.9 3.7 18.3 PYGM GSD5 ENSG00000068976 "Glycogen phosphorylase, muscle associated" P11217 11 64746389-64759974 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 65 "skeletal muscle: 8548.8;tongue: 3626.1" "Cell type enhanced" "Detected in many" "Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 8.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.1" "Cell line enhanced" "Detected in some" "HSkMC: 3.7;NB-4: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056003 Enhanced NA NA 10000000 "HPA056003: AB_2683006" "unprognostic (3.33e-1)" "unprognostic (6.03e-3)" "unprognostic (3.87e-4)" "unprognostic (1.95e-3)" "unprognostic (8.71e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (2.92e-1)" "unprognostic (3.88e-1)" "unprognostic (3.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.64e-1)" "unprognostic (6.33e-6)" "unprognostic (3.37e-3)" "unprognostic (1.81e-1)" "unprognostic (1.62e-2)" "unprognostic (5.68e-2)" 15.3 3.0 31.6 2.1 31.1 1.2 7.8 54.8 29.7 5.7 14.1 18.4 1.5 10.5 6.5 93.0 14.7 3.9 52.8 24.8 28.4 2.3 1.2 2.7 2.2 47.8 27.3 15.8 4.0 1.6 0.3 1.7 1.4 35.8 25.8 3.6 3.0 50.4 26.6 8548.8 3.1 7.0 14.8 38.3 3.3 7.0 6.8 43.8 1.3 5.2 3626.1 1.2 16.9 5.3 37.5 0.1 0.0 0.7 0.1 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.6 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.3 0.2 0.0 0.3 0.4 0.1 3.7 0.2 0.2 0.1 0.0 0.0 1.1 0.7 0.6 0.0 1.1 0.7 2.2 0.7 0.1 0.1 0.4 0.7 0.1 0.0 0.1 0.2 0.0 0.2 0.3 0.4 0.4 0.3 0.4 0.3 0.0 0.4 0.1 0.0 1.0 1.4 0.4 0.0 0.1 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.3 0.0 0.2 0.2 0.1 31.6 31.1 54.8 29.7 24.8 28.4 47.8 27.3 15.8 35.8 38.3 43.8 37.5 2.4 0.0 2.3 29.7 3.0 0.8 0.6 0.2 5.2 3.5 2.9 4.7 47.5 0.0 0.8 0.0 4.2 0.6 1.9 1.0 0.0 0.1 11.7 1.6 5.2 2.0 0.0 0.0 0.2 0.0 0.2 5.1 1.1 4.0 0.0 0.8 1.8 0.0 0.5 0.0 0.2 0.9 0.0 0.6 1.3 49.2 16.4 2.3 0.0 1.0 0.5 9.9 4.1 0.5 0.4 0.3 0.2 44.0 0.3 1.3 0.6 0.0 0.1 1.3 6.6 64.3 12.8 1.2 0.9 2.5 0.6 0.1 2.9 0.9 1.1 0.3 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687447-49695984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 151 "testis: 17.3" "Group enriched" "Detected in some" 5 "Spermatocytes: 166.9;Spermatogonia: 206.5" "Group enriched" "Detected in many" 4 "liver cancer: 10.5;melanoma: 5.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 188.0;Karpas-707: 139.8;U-266/84: 230.7" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 139.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.4 0.3 0.2 0.3 1.6 0.6 2.8 230.7 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 166.9 206.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PITX1 "BFT, POTX, PTX1" ENSG00000069011 "Paired like homeodomain 1" P78337 5 135027734-135034813 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 717.3;pituitary gland: 166.0;vagina: 200.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 121.0;Basal squamous epithelial cells: 409.2;Squamous epithelial cells: 1069.0;Urothelial cells: 257.3" "Cancer enhanced" "Detected in many" "cervical cancer: 73.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 141.4;HeLa: 108.9;K-562: 112.1;T-47d: 157.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA008743 Approved Approved Nucleoli Yes No Nucleoli "HPA008743: AB_1855413" "unprognostic (1.84e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (4.62e-2)" "unprognostic (5.08e-2)" "unprognostic (5.26e-3)" "unprognostic (1.03e-2)" "unprognostic (1.66e-2)" "unprognostic (5.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.60e-2)" "unprognostic (2.27e-1)" "unprognostic (5.80e-14)" "unprognostic (6.22e-2)" "unprognostic (1.33e-1)" "unprognostic (5.98e-3)" "unprognostic (4.97e-3)" 1.2 1.9 0.7 7.8 0.6 0.3 0.6 0.8 0.7 40.3 4.0 7.6 12.2 0.8 0.0 717.3 0.5 1.1 0.1 0.9 1.0 0.1 0.3 0.4 0.1 0.8 0.8 0.6 0.6 0.4 0.0 166.0 2.8 0.8 20.2 2.0 0.1 138.6 0.0 14.2 1.9 7.9 0.4 0.6 0.2 42.2 2.2 0.6 0.0 0.2 20.2 12.7 85.7 200.7 0.8 57.5 36.9 0.0 44.7 1.4 0.9 13.4 9.6 14.6 5.1 2.3 141.4 32.5 59.9 17.6 0.9 12.6 17.6 6.4 25.5 0.3 0.7 48.2 13.4 108.9 38.4 15.6 5.8 0.1 1.4 18.4 0.0 4.9 0.3 0.1 10.1 112.1 0.2 1.9 18.4 0.6 12.3 0.1 4.8 31.8 18.5 1.1 1.2 0.6 17.9 20.2 0.1 48.4 24.1 0.0 0.5 157.5 4.2 1.5 6.1 13.4 3.5 17.0 0.1 0.2 40.7 8.1 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.8 0.7 0.9 1.0 0.8 0.8 0.6 0.8 0.6 0.6 0.8 0.1 0.0 0.0 0.0 0.2 1.3 121.0 12.8 409.2 1.0 2.5 2.7 2.3 1.5 8.6 0.0 0.0 0.8 0.0 4.2 0.0 0.2 4.2 0.3 0.6 1.2 0.0 50.8 0.0 0.4 2.1 28.8 0.5 0.2 0.0 2.7 0.0 0.0 0.9 0.0 0.0 2.4 6.1 0.0 0.3 5.7 0.3 1.0 0.0 0.0 0.0 0.4 1.0 0.0 0.1 16.9 3.4 0.0 3.1 101.6 0.3 0.2 6.1 1.8 0.0 2.1 4.5 2.2 5.6 1069.0 6.8 7.7 0.9 0.7 2.5 257.3 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136212745-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB022592, HPA031126" Uncertain NA NA "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.0 0.9 0.6 0.6 0.1 0.7 0.3 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAST4 KIAA0303 ENSG00000069020 "Microtubule associated serine/threonine kinase family member 4" O15021 5 66596361-67169595 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 519.7;Basal prostatic cells: 507.3;Excitatory neurons: 636.6;Inhibitory neurons: 489.6;Suprabasal keratinocytes: 399.2;Urothelial cells: 676.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 29.3" "Immune cell enhanced" "Detected in many" "basophil: 15.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 33.2;HDLM-2: 43.2;HEL: 35.5;RT4: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000544 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000544: AB_1079315" "unprognostic (1.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.80e-1)" "unprognostic (4.99e-3)" "unprognostic (2.83e-2)" "prognostic favorable (5.18e-5)" "unprognostic (9.01e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-2)" "unprognostic (9.47e-2)" "unprognostic (5.03e-2)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (1.37e-2)" "unprognostic (2.63e-1)" "unprognostic (2.63e-1)" "unprognostic (3.08e-2)" 15.0 11.1 4.8 4.5 5.5 1.9 11.2 1.1 29.3 8.3 1.6 5.4 5.2 10.1 5.0 27.2 9.5 8.0 25.8 6.1 4.2 12.1 8.5 11.1 4.4 4.8 6.0 2.5 16.6 4.6 15.4 4.6 8.9 6.0 7.7 4.1 4.8 11.6 6.7 11.2 14.9 4.6 9.4 1.3 5.1 7.1 10.1 3.1 16.9 6.5 7.2 10.1 16.1 21.4 12.5 14.6 7.8 3.8 0.2 12.4 10.9 9.0 3.2 4.9 1.1 1.0 7.3 3.9 1.0 6.5 2.7 2.9 12.8 11.8 33.2 1.3 43.2 3.8 35.5 4.7 3.1 0.9 0.1 11.9 18.4 17.8 7.1 14.2 13.3 26.2 3.2 3.5 3.9 8.9 12.6 5.1 0.2 2.5 1.2 6.3 1.1 3.3 0.7 3.1 42.9 5.5 4.4 4.3 1.7 0.2 2.7 2.8 0.2 25.2 3.0 4.1 4.6 5.4 9.9 4.8 0.2 7.7 0.1 2.4 15.2 0.3 0.8 0.9 0.4 2.5 2.9 4.0 1.0 0.4 2.5 4.2 1.8 3.5 2.3 0.9 1.0 6.9 1.3 4.8 5.5 1.1 29.3 6.1 4.2 4.8 6.0 2.5 6.0 1.3 3.1 12.5 130.2 32.1 53.3 519.7 11.4 368.6 507.3 127.9 114.9 15.9 79.3 38.1 139.1 27.1 78.7 18.4 2.1 40.7 4.9 24.4 37.2 59.0 129.2 35.8 5.3 111.8 32.2 5.5 636.6 115.8 50.0 33.2 28.5 55.3 93.8 19.4 70.6 42.2 5.1 8.4 489.6 18.1 40.7 6.9 33.7 127.4 41.3 9.8 48.0 78.7 2.1 55.2 4.1 165.9 108.4 70.8 27.2 32.7 13.5 355.5 14.8 93.9 57.2 4.5 39.5 15.9 31.1 14.8 9.2 211.7 399.2 137.2 21.0 14.7 16.1 676.4 ADGRF5 "DKFZp564O1923, GPR116, KIAA0758" ENSG00000069122 "Adhesion G protein-coupled receptor F5" Q8IZF2 6 46852522-46954943 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 105.4" "Cell type enhanced" "Detected in many" "Adipocytes: 428.1;Alveolar cells type 1: 291.7;Alveolar cells type 2: 539.9;Endothelial cells: 222.6;Hepatic stellate cells: 251.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 25.0;TIME: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 55000000 "unprognostic (8.45e-2)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (3.26e-1)" "unprognostic (6.51e-2)" "unprognostic (1.89e-2)" "unprognostic (5.76e-2)" "unprognostic (9.00e-3)" "unprognostic (7.80e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.56e-2)" "prognostic favorable (8.84e-5)" "unprognostic (1.43e-2)" "unprognostic (5.91e-2)" "unprognostic (2.82e-2)" "unprognostic (3.78e-2)" 70.4 23.1 18.2 7.0 14.5 0.0 46.4 14.8 18.1 10.2 9.9 9.3 5.7 16.1 7.8 7.1 15.2 17.0 38.8 12.7 14.5 59.4 13.1 105.4 8.6 16.9 15.6 10.6 6.6 6.5 13.3 6.8 51.1 16.9 9.0 5.8 1.8 5.9 9.3 30.7 7.0 8.6 22.0 13.2 40.9 8.5 3.1 19.0 3.7 32.4 70.8 3.2 11.5 10.1 19.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 74.1 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 14.5 14.8 18.1 12.7 14.5 16.9 15.6 10.6 16.9 13.2 19.0 19.0 428.1 291.7 539.9 2.0 2.9 0.0 0.2 0.0 2.2 0.0 1.5 2.9 16.2 8.6 89.7 1.8 0.0 0.2 1.1 0.6 11.7 0.2 10.6 0.8 1.2 222.6 0.0 0.0 8.4 0.0 1.1 9.0 2.6 0.4 12.6 0.0 251.3 4.0 0.2 0.0 1.0 0.5 0.0 13.7 0.0 4.8 3.1 2.7 0.0 104.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.2 0.6 0.5 0.2 48.1 0.7 98.6 9.6 80.1 0.2 0.9 0.6 0.0 0.3 1.8 15.5 0.1 0.8 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644445 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.5;cervix: 5.6;testis: 9.8" "Cell type enhanced" "Detected in many" "Early spermatids: 16.0;Enteroendocrine cells: 14.9;Excitatory neurons: 18.9;Extravillous trophoblasts: 17.1;Horizontal cells: 20.2;Inhibitory neurons: 14.8;Late spermatids: 20.0;Syncytiotrophoblasts: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.8;BEWO: 11.4;RPMI-8226: 4.7;SuSa: 7.2;U-2 OS: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014725 Approved Nucleoplasm NA NA 5300000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.1 0.5 3.8 1.1 2.8 0.6 0.6 1.3 2.4 5.6 0.0 0.6 0.1 1.7 1.3 0.7 2.4 0.6 0.8 5.4 1.9 0.3 0.1 1.1 1.1 5.2 2.0 2.4 0.3 0.1 0.9 1.4 0.3 6.5 1.9 0.3 0.9 0.7 0.8 0.2 0.5 0.8 0.3 2.1 2.7 0.5 9.8 4.5 0.7 1.3 0.3 1.0 0.4 0.7 4.1 0.0 2.0 13.8 3.9 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 3.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.5 0.0 4.7 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 4.2 1.8 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 3.8 2.8 1.3 2.4 5.4 1.9 5.2 2.0 2.4 6.5 2.1 4.5 4.1 0.4 0.0 2.7 6.5 4.4 0.9 4.6 9.9 2.8 6.8 0.8 5.0 2.0 1.5 1.9 0.0 0.0 6.7 0.2 0.2 0.0 0.3 16.0 0.5 3.9 0.8 14.9 0.4 18.9 0.2 17.1 4.6 0.5 1.0 1.3 5.6 0.0 0.0 0.6 20.2 14.8 0.4 0.0 0.0 0.2 20.0 0.6 0.6 1.8 2.8 1.1 9.7 0.0 6.6 6.6 0.0 0.0 0.0 1.3 2.3 0.0 0.3 0.2 0.8 0.0 1.2 0.9 10.7 3.5 0.3 0.1 17.8 0.8 10.4 0.0 1.1 ADAM7 "EAPI, GP-83" ENSG00000069206 "ADAM metallopeptidase domain 7" Q9H2U9 8 24440930-24526970 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 237 "epididymis: 3759.0" "Cell type enriched" "Detected in some" 7 "Early spermatids: 128.3" "Group enriched" "Detected in some" 16 "prostate cancer: 1.0;renal cancer: 0.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "BEWO: 2.4;NB-4: 6.1;RPMI-8226: 1.7;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008879 Enhanced "Intracellular and membrane" NA NA "HPA008879: AB_10601789" "unprognostic (1.03e-3)" "unprognostic (3.96e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3759.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.3 0.1 0.6 0.2 0.0 1.2 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.3 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 16.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUP133 FLJ10814 ENSG00000069248 "Nucleoporin 133" Q8WUM0 1 229440259-229508341 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059767 Approved Supported "Nuclear membrane" NA NA 6300 "Nuclear membrane" "HPA059767: AB_2684123" "unprognostic (2.05e-2)" "unprognostic (3.54e-1)" "unprognostic (5.75e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.17e-1)" "unprognostic (3.02e-2)" "unprognostic (2.20e-2)" "unprognostic (5.72e-2)" "unprognostic (2.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.48e-1)" "unprognostic (8.31e-2)" "unprognostic (2.22e-1)" "unprognostic (7.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.30e-2)" 11.8 10.8 9.7 11.3 11.3 12.7 16.0 13.5 12.0 11.8 8.0 10.6 8.6 14.5 11.3 10.7 14.0 8.7 15.3 9.5 10.0 12.3 10.2 10.9 14.5 9.9 10.1 9.7 16.6 10.1 18.1 9.9 15.3 10.3 11.8 11.5 19.3 10.1 11.9 18.0 13.5 9.7 13.3 10.0 11.7 9.9 13.1 9.7 16.9 13.9 14.4 15.5 11.2 10.5 14.9 30.6 24.3 37.0 19.2 26.0 27.8 71.9 24.8 25.1 36.0 32.4 28.8 29.4 44.1 20.9 24.8 16.1 39.4 51.8 26.3 38.4 26.8 64.2 26.7 23.6 21.8 20.9 54.8 20.8 21.8 19.4 25.9 30.8 25.0 30.5 37.1 61.2 20.6 28.6 13.7 40.8 23.4 55.6 42.7 21.8 39.1 38.5 43.6 20.3 26.6 31.7 39.3 36.9 22.9 27.6 18.0 35.7 42.8 26.8 16.3 19.9 28.5 37.3 19.7 26.1 46.8 18.6 31.2 34.6 5.5 5.7 4.4 5.6 5.7 7.0 5.8 5.9 6.2 7.1 4.4 5.9 6.3 1.9 5.5 10.2 4.0 5.9 5.2 9.7 11.3 13.5 12.0 9.5 10.0 9.9 10.1 9.7 10.3 10.0 9.7 14.9 10.4 9.6 18.9 26.4 19.9 9.1 6.8 10.1 13.6 16.5 9.9 8.5 21.2 14.3 10.7 14.7 8.4 21.4 11.5 4.4 5.9 8.3 1.5 10.9 8.7 10.3 10.2 21.7 48.9 8.5 13.8 13.8 15.8 8.4 7.6 17.1 11.7 12.0 9.8 16.8 44.1 7.5 8.2 13.6 8.6 3.7 12.5 10.8 7.2 25.3 13.4 12.4 5.2 28.1 60.2 7.0 4.9 12.0 19.0 6.7 4.7 7.9 13.1 12.3 0.0 16.3 10.7 12.6 18.2 14.6 10.7 18.3 13.6 11.8 9.0 6.6 NUCKS1 NUCKS ENSG00000069275 "Nuclear casein kinase and cyclin dependent kinase substrate 1" Q9H1E3 1 205712822-205750182 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062351, HPA063843" Supported Supported Nucleoplasm,Nucleoli No No 13000 Nucleoplasm Nucleoli "HPA062351: AB_2684745, HPA063843: AB_2685134" "unprognostic (1.68e-1)" "unprognostic (3.92e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (5.16e-3)" "unprognostic (1.18e-3)" "unprognostic (1.37e-1)" "unprognostic (5.82e-3)" "unprognostic (7.45e-3)" "unprognostic (1.44e-1)" "unprognostic (2.25e-2)" "unprognostic (7.57e-2)" 63.8 57.8 95.1 43.7 103.8 33.7 73.6 92.9 96.9 71.4 62.5 46.9 29.8 84.2 62.5 54.9 72.5 47.1 99.2 89.3 96.9 71.0 105.1 49.1 61.7 98.9 95.7 79.2 109.9 41.6 96.8 39.4 50.0 98.3 72.3 48.5 82.2 47.2 71.8 114.8 51.9 33.5 70.4 103.1 56.9 43.4 26.0 93.2 98.3 99.0 102.5 61.2 48.2 45.6 123.0 223.5 134.6 354.2 140.8 96.0 131.7 166.1 157.3 161.3 215.6 172.6 74.4 250.0 246.1 89.0 154.2 68.2 160.0 272.6 131.9 245.7 118.6 135.8 160.3 113.2 81.8 70.6 255.0 54.9 105.1 116.9 128.6 221.7 115.6 171.4 156.3 261.9 76.7 170.7 258.1 233.2 128.0 363.0 88.9 99.4 239.1 436.4 141.1 121.4 135.4 146.9 270.9 232.2 183.3 127.5 272.4 280.3 189.9 172.8 164.5 144.8 190.0 282.8 69.9 88.0 192.6 112.8 140.5 226.2 5.6 3.2 3.9 9.1 4.9 8.8 5.6 8.3 8.0 4.6 6.9 10.1 10.7 0.6 10.7 4.2 7.3 5.5 3.8 95.1 103.8 92.9 96.9 89.3 96.9 98.9 95.7 79.2 98.3 103.1 93.2 123.0 258.4 214.7 283.4 73.4 179.5 258.1 277.4 212.9 282.9 356.2 221.2 229.7 412.4 318.8 241.8 303.5 73.0 301.5 174.5 125.5 385.4 202.5 61.3 227.0 410.3 254.5 179.0 324.2 85.9 171.5 381.3 356.5 131.0 299.5 215.4 329.0 258.5 668.2 264.1 316.3 88.7 219.2 116.0 216.8 266.4 52.6 512.0 164.0 174.3 71.2 162.1 546.9 195.7 56.8 126.2 117.2 113.2 485.2 128.2 295.3 49.4 384.5 187.8 200.2 315.5 458.0 358.1 70.0 104.1 321.4 243.9 177.2 190.5 443.9 265.1 220.8 VPS35 "FLJ10752, MEM3, PARK17" ENSG00000069329 "VPS35 retromer complex component" Q96QK1 16 46656132-46689518 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040802 Supported Supported Endosomes,Lysosomes NA NA 500000 "Endosomes, Lysosomes" "HPA040802: AB_2677142" "unprognostic (1.11e-2)" "unprognostic (8.70e-2)" "prognostic favorable (7.74e-4)" "unprognostic (4.75e-2)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "prognostic unfavorable (2.10e-6)" "unprognostic (5.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-2)" "unprognostic (3.33e-3)" "unprognostic (2.49e-1)" "prognostic favorable (9.75e-5)" "unprognostic (3.68e-3)" "unprognostic (2.43e-1)" "unprognostic (1.34e-1)" "unprognostic (6.89e-3)" 4.9 4.2 2.7 3.0 3.0 9.6 4.7 2.4 3.1 4.2 2.5 4.2 1.9 4.4 1.9 4.8 4.1 1.5 5.6 2.8 2.3 3.7 1.8 4.2 3.0 2.8 2.3 2.8 4.7 4.5 5.2 3.4 2.1 3.1 3.0 1.9 4.1 4.5 2.4 4.6 6.1 5.0 1.7 2.1 4.2 4.6 2.8 2.5 3.9 2.7 2.8 1.8 4.6 4.2 3.5 3.2 5.0 4.1 2.8 6.5 7.3 2.1 3.8 5.4 6.4 3.7 4.3 2.7 4.2 2.3 6.5 3.3 3.9 7.5 7.5 9.1 1.6 6.4 3.9 3.8 3.0 5.4 5.2 5.8 5.8 5.5 7.3 4.5 6.3 6.6 6.0 3.1 1.8 6.5 2.9 4.0 5.0 1.4 3.0 6.6 5.4 5.4 5.2 5.2 4.4 1.8 2.1 4.1 3.2 1.8 4.5 1.9 2.6 3.9 1.9 1.9 4.3 2.7 2.3 3.2 4.9 3.4 4.0 1.3 1.8 1.3 1.3 0.7 1.7 0.7 0.8 0.7 0.6 1.5 1.0 1.0 0.7 1.5 0.8 2.3 0.6 1.1 1.1 2.7 3.0 2.4 3.1 2.8 2.3 2.8 2.3 2.8 3.1 2.1 2.5 3.5 65.9 51.3 59.4 20.5 84.3 72.5 80.0 98.6 72.8 56.5 77.9 75.9 102.9 57.2 83.4 68.0 60.5 134.5 44.9 65.9 54.8 111.7 111.2 136.4 92.3 63.3 80.8 52.6 43.1 72.5 102.2 70.1 88.7 88.4 72.2 211.1 54.7 40.2 123.4 45.4 42.5 79.7 107.8 108.3 87.9 32.4 77.9 113.6 46.2 30.0 153.0 71.4 45.3 28.6 31.3 101.1 101.9 72.2 41.7 77.0 164.6 103.7 188.9 82.6 46.0 57.5 88.9 207.9 118.0 101.5 87.7 113.1 51.5 95.9 97.6 84.5 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973674 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 67000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: AB_2680883, HPA060538: AB_2684315" "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 20.9 25.4 33.3 14.3 35.6 24.1 19.9 37.0 39.1 18.1 34.3 20.3 20.2 22.2 28.8 21.7 17.5 16.6 36.3 34.5 34.1 28.3 36.3 16.8 19.9 33.2 33.4 34.0 22.2 17.1 29.4 16.5 20.0 34.1 22.0 19.1 29.7 17.2 20.8 37.5 21.1 20.7 17.2 33.9 22.9 19.3 25.2 33.4 20.5 22.4 39.0 21.6 21.8 18.3 37.0 23.1 26.9 26.6 22.8 35.7 34.1 40.3 29.4 35.4 43.4 20.5 23.7 23.6 37.1 23.2 31.9 18.6 35.0 43.0 30.2 49.8 8.8 36.0 27.2 12.8 50.7 42.7 41.7 36.3 36.5 34.6 25.2 23.7 37.9 30.4 14.7 31.7 12.0 37.0 25.4 30.1 57.5 40.6 21.1 39.6 34.3 48.7 44.1 52.7 24.1 36.1 23.1 34.9 52.1 33.4 26.1 20.3 32.2 31.6 25.4 16.0 18.5 25.1 29.3 21.7 49.0 26.9 35.5 21.8 13.1 10.3 13.5 9.8 12.7 12.9 11.3 13.2 11.2 9.4 8.4 12.9 13.1 10.7 12.8 11.3 6.7 17.2 9.7 33.3 35.6 37.0 39.1 34.5 34.1 33.2 33.4 34.0 34.1 33.9 33.4 37.0 64.3 51.3 35.9 11.8 78.4 126.9 75.1 56.4 101.3 38.8 37.5 28.4 100.3 40.0 48.2 40.5 18.8 85.2 76.1 67.6 90.1 73.4 93.3 86.9 76.8 52.2 52.0 49.4 16.6 62.2 72.5 66.2 54.0 72.1 53.9 52.7 31.1 54.9 56.5 37.0 15.3 55.6 52.9 42.5 86.4 56.8 50.1 65.1 72.9 12.2 72.3 60.5 45.3 10.1 11.0 71.2 64.2 59.0 70.7 61.6 83.3 111.4 67.6 43.7 52.6 63.4 99.4 177.7 106.0 111.1 120.5 172.4 89.6 131.4 62.6 87.3 BCL3 "BCL4, D19S37" ENSG00000069399 "BCL3 transcription coactivator" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "hypothalamus: 51.2" "Group enriched" "Detected in many" 4 "eosinophil: 5.5;neutrophil: 19.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 19.8" "Cell line enhanced" "Detected in many" "HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Yes No Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: AB_2680074" "prognostic favorable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 48.3 43.9 6.9 25.3 5.8 54.4 37.5 6.0 7.8 26.6 7.8 39.2 32.5 27.1 1.7 68.1 36.2 13.5 34.6 5.3 51.2 41.0 163.1 88.1 11.7 11.2 7.3 4.8 23.9 37.7 3.2 25.4 8.0 7.8 43.8 9.4 1.3 41.2 9.0 17.9 27.6 44.6 11.8 7.4 59.1 36.2 9.7 8.5 6.6 37.1 4.9 12.8 37.9 38.0 7.8 9.8 33.5 0.7 17.5 6.1 12.6 1.7 5.8 6.3 3.7 5.3 6.9 17.8 9.5 13.4 11.5 18.5 10.5 2.4 9.9 2.3 67.3 0.6 1.1 18.9 9.3 14.6 0.7 28.2 22.5 7.8 8.1 9.9 16.6 10.0 0.0 1.2 54.1 2.2 8.4 0.0 7.4 0.9 15.1 12.8 4.3 6.5 3.4 16.5 19.9 0.0 0.9 69.7 35.7 1.9 1.1 12.7 7.6 16.8 11.8 11.6 18.5 2.2 50.1 21.4 10.1 22.1 1.2 9.2 0.4 2.7 5.5 0.8 1.8 1.1 1.5 1.0 1.3 2.6 1.3 0.5 0.7 19.8 2.3 1.1 3.1 1.7 1.0 6.9 5.8 6.0 7.8 5.3 51.2 11.2 7.3 4.8 7.8 7.4 8.5 7.8 56.3 19.2 51.3 2.6 43.9 46.7 38.8 22.4 172.4 2.3 106.8 62.0 3.0 42.9 28.6 12.9 0.0 0.6 33.4 60.6 9.8 31.8 11.8 49.4 34.2 76.3 21.5 4.2 0.5 68.7 6.8 47.8 128.0 70.0 38.0 1.4 38.9 35.5 16.1 8.4 0.8 56.2 8.2 30.5 110.8 2.7 13.4 86.6 40.9 1.0 28.4 2.2 2.1 0.0 0.1 43.0 40.0 4.5 100.4 58.9 56.6 17.7 20.5 0.6 6.6 43.3 40.1 0.5 2.0 146.0 61.1 1.4 46.2 0.3 34.5 51.2 KCNAB2 "AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B" ENSG00000069424 "Potassium voltage-gated channel subfamily A regulatory beta subunit 2" Q13303 1 5990927-6101193 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 182.5" "Cell type enhanced" "Detected in many" "dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5" "Cancer enriched" "Detected in all" 7 "melanoma: 29.3" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 278.8;JURKAT: 142.7;U-937: 289.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001975 Enhanced NA NA "CAB001975: " "unprognostic (6.60e-2)" "unprognostic (2.33e-2)" "unprognostic (3.97e-3)" "unprognostic (2.30e-2)" "unprognostic (1.76e-2)" "unprognostic (8.18e-3)" "unprognostic (4.30e-2)" "unprognostic (1.05e-1)" "unprognostic (4.85e-2)" "unprognostic (1.58e-2)" "unprognostic (7.71e-3)" "unprognostic (8.83e-3)" "prognostic unfavorable (3.50e-5)" "unprognostic (2.88e-2)" "unprognostic (3.10e-2)" "unprognostic (2.35e-1)" "unprognostic (5.24e-2)" 12.4 7.7 72.0 28.8 95.9 64.3 8.0 9.6 182.5 5.1 0.0 8.4 5.5 7.2 2.4 5.0 8.7 11.3 16.4 147.1 50.7 25.3 10.2 31.4 44.0 76.9 17.5 84.5 5.6 4.0 1.5 20.5 6.0 86.8 6.2 4.7 18.0 6.5 3.5 12.7 12.4 24.1 6.3 0.5 66.3 6.5 5.6 26.0 27.2 6.3 16.0 24.9 8.9 5.2 94.1 11.3 27.0 2.5 4.5 1.5 5.0 10.3 6.3 40.0 6.3 7.8 10.6 4.1 62.0 23.3 6.1 7.7 5.4 2.7 1.0 3.2 84.6 9.6 71.1 25.3 21.1 6.0 278.8 1.9 6.5 1.3 3.4 7.5 6.3 3.6 142.7 2.7 114.2 3.1 9.8 61.9 115.9 1.1 3.9 15.4 13.8 9.7 78.9 0.1 0.2 20.6 6.2 5.3 6.4 101.0 2.7 5.4 117.3 1.1 1.3 9.4 14.4 7.5 84.4 122.4 100.4 12.7 289.2 1.9 4.4 34.3 18.6 29.8 27.2 26.8 7.5 18.2 28.0 31.0 8.7 18.7 20.6 14.4 19.4 25.0 12.7 19.1 43.2 72.0 95.9 9.6 182.5 147.1 50.7 76.9 17.5 84.5 86.8 0.5 26.0 94.1 3.0 0.0 6.6 7.5 23.0 4.8 1.7 1.8 1.8 24.0 1.2 2.3 15.7 7.2 1.5 1.8 6.2 0.5 50.3 0.3 0.0 0.3 5.8 3.4 1.9 3.1 0.0 11.1 67.8 1.4 2.3 3.5 2.0 0.6 8.8 2.9 3.9 1.0 63.6 6.7 49.2 0.5 2.0 86.2 19.0 5.2 3.7 51.3 64.0 5.6 26.6 4.9 51.5 8.5 6.1 0.6 0.1 2.6 23.4 0.4 0.1 40.8 8.7 11.8 0.0 2.1 3.1 3.2 2.9 0.7 2.8 0.8 44.3 2.5 0.3 0.6 ABCC9 "CMD1O, SUR2" ENSG00000069431 "ATP binding cassette subfamily C member 9" O60706 12 21797389-21942529 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" Transport Receptor "Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007279 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007279: AB_1844435" "unprognostic (4.82e-2)" "unprognostic (3.62e-2)" "unprognostic (5.51e-4)" "unprognostic (1.09e-1)" "unprognostic (1.09e-1)" "unprognostic (8.30e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.47e-2)" "unprognostic (8.72e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (3.10e-3)" "unprognostic (8.22e-5)" 27.7 6.0 7.8 3.4 5.9 1.7 9.2 3.6 9.7 7.8 10.2 5.8 4.0 19.3 8.3 6.3 12.4 11.8 28.6 5.8 5.3 6.6 45.6 7.8 3.5 5.4 6.8 5.1 11.0 3.5 1.9 2.2 3.6 4.6 8.0 1.8 3.3 4.6 10.0 42.3 4.2 3.2 21.2 3.8 4.4 8.1 1.2 5.2 1.8 6.3 30.6 1.5 5.3 5.2 7.7 0.9 0.2 11.9 0.3 24.9 11.0 0.3 6.1 14.0 7.0 3.5 20.8 1.0 0.5 1.2 0.6 0.8 0.3 0.0 0.0 7.2 0.3 0.2 0.5 0.8 0.3 0.1 0.5 0.6 27.1 0.0 6.7 2.5 0.4 0.0 0.4 0.3 1.2 0.3 1.4 0.2 0.4 1.4 1.2 0.6 0.5 0.3 0.3 0.0 1.2 0.4 1.7 0.4 0.5 0.2 1.7 1.2 0.3 0.3 27.0 1.9 2.2 8.7 1.1 1.3 0.4 6.7 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 7.8 5.9 3.6 9.7 5.8 5.3 5.4 6.8 5.1 4.6 3.8 5.2 7.7 33.8 35.3 60.3 72.1 0.2 3.4 1.5 5.0 0.6 0.8 0.5 0.8 38.2 0.0 25.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.8 20.6 19.7 0.0 0.0 17.2 0.2 0.1 26.2 1.1 0.6 24.0 0.0 7.1 99.4 0.1 1.7 1.0 0.0 0.0 2.4 5.9 0.1 0.3 2.5 10.6 2.8 0.0 15.9 0.0 1.5 1.4 0.1 0.0 0.4 0.0 0.5 0.0 0.1 20.4 1.2 131.5 11.1 140.7 0.4 1.6 1.1 2.3 0.3 2.5 0.2 0.0 2.2 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 32 "brain: 423.8;pituitary gland: 892.7" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3" "Cancer enhanced" "Detected in many" "testis cancer: 22.2" "Region enriched" "Detected in many" 10 "hypothalamus: 423.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6" "Region enhanced" "Detected in many" "hypothalamus: 82.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 200000 "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 3.0 0.9 3.2 15.0 12.0 0.7 4.4 1.1 5.2 0.6 0.9 14.5 1.8 0.2 0.0 0.8 1.0 0.2 0.6 2.8 423.8 1.5 0.3 0.5 0.1 42.5 5.2 1.3 0.2 2.1 0.1 892.7 0.3 9.6 4.4 4.0 0.0 0.9 0.2 0.4 20.3 4.2 10.0 0.6 0.3 9.8 1.0 12.4 0.7 0.4 0.0 0.0 0.7 3.0 3.0 0.0 11.0 1.1 0.3 0.0 0.0 24.0 36.7 0.0 0.7 0.0 267.2 9.9 0.0 12.7 1.3 0.4 0.1 0.0 0.2 0.0 0.0 119.3 6.4 74.6 0.0 1.3 3.7 0.0 1.7 4.0 0.0 0.1 0.0 6.3 0.0 139.5 0.0 0.2 77.2 0.0 493.5 60.3 2.9 23.7 0.0 0.1 51.1 0.6 0.0 49.8 189.6 25.8 1.5 0.0 26.8 1.5 57.6 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 12.0 1.1 5.2 2.8 423.8 42.5 5.2 1.3 9.6 0.6 12.4 3.0 0.6 0.0 0.0 0.0 0.2 2.0 22.2 0.1 0.0 0.0 3.2 5.8 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.0 38.9 0.1 64.2 50.8 3.4 1.8 4.2 2.1 52.1 48.7 6.6 2.0 26.4 4.5 0.4 0.0 0.0 2.0 0.0 0.2 1.1 4.1 0.0 1.2 0.2 0.0 0.7 1.8 0.0 0.6 0.0 0.0 0.0 0.3 39.5 0.1 0.0 1.0 82.5 0.0 0.4 0.0 0.0 0.0 1.6 6.7 2.2 10.9 1.1 3.4 1.9 0.8 0.0 1.3 24.3 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699553 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.9" "Cell type enhanced" "Detected in many" "B-cells: 128.6;dendritic cells: 112.0;Early spermatids: 95.5;monocytes: 81.6;NK-cells: 131.8;T-cells: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2" "Group enriched" "Detected in all" 11 "B-cells: 127.5;T-cells: 223.0" "Group enriched" "Detected in many" 4 "Daudi: 67.9;HDLM-2: 53.3;Karpas-707: 31.0;U-698: 105.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 5.9 1.9 3.8 16.9 3.7 16.1 5.6 3.5 4.9 5.6 4.1 4.3 3.3 4.5 12.0 3.2 5.4 5.6 4.5 3.4 3.7 3.5 2.9 8.6 53.9 4.2 3.5 3.3 6.1 2.4 0.8 2.3 2.6 3.9 7.4 4.0 2.2 6.6 4.5 3.0 3.6 20.5 2.0 4.1 26.9 5.6 9.6 3.8 31.9 4.5 1.3 42.0 5.8 4.7 4.1 1.2 2.5 3.5 0.3 0.5 1.4 4.0 1.7 2.5 0.6 2.1 1.9 2.1 67.9 0.3 1.8 1.0 0.7 1.2 0.2 1.1 53.3 0.9 2.1 1.6 2.9 5.7 1.7 1.7 2.3 1.7 0.5 2.1 8.0 0.1 1.2 0.5 31.0 1.5 4.5 0.7 5.9 3.2 0.2 0.4 14.9 1.6 2.2 3.4 3.6 0.6 1.3 0.9 2.8 3.0 6.6 0.6 1.8 0.6 1.3 1.8 1.0 1.2 4.4 1.1 105.8 2.8 3.1 2.1 6.8 2.1 1.5 188.1 1.4 114.5 95.0 183.3 208.7 2.3 127.5 192.3 223.0 6.0 16.5 1.3 1.6 175.2 109.8 3.8 3.7 3.5 4.9 3.4 3.7 4.2 3.5 3.3 3.9 4.1 3.8 4.1 8.9 6.4 20.7 11.8 128.6 4.1 39.7 2.1 1.8 1.3 6.5 6.1 9.6 4.3 7.1 1.8 4.2 10.4 112.0 0.8 7.9 3.0 95.5 3.6 6.9 13.0 0.0 21.5 6.3 1.9 6.0 12.2 4.6 6.2 20.2 18.1 12.5 2.3 9.2 5.0 6.8 2.5 0.0 20.9 17.8 28.3 8.4 19.4 1.8 56.2 81.6 3.2 131.8 27.6 4.4 2.8 2.0 9.8 71.5 17.2 0.5 2.1 7.4 2.3 19.7 26.2 8.7 5.7 6.3 1.9 4.8 4.8 215.1 7.4 3.5 24.3 FUNDC1 MGC51029 ENSG00000069509 "FUN14 domain containing 1" Q8IVP5 X 44523639-44542859 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038773 Uncertain NA NA "HPA038773: AB_10670789" "unprognostic (1.04e-1)" "unprognostic (3.91e-2)" "unprognostic (1.91e-1)" "unprognostic (3.11e-2)" "unprognostic (4.93e-1)" "unprognostic (1.72e-2)" "unprognostic (3.40e-3)" "unprognostic (1.88e-3)" "unprognostic (6.40e-2)" "unprognostic (2.85e-3)" "unprognostic (6.63e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-1)" "unprognostic (2.49e-2)" "prognostic favorable (8.35e-4)" "unprognostic (6.67e-3)" "prognostic favorable (2.58e-4)" 11.6 18.6 31.2 9.5 31.7 11.4 20.6 36.0 38.1 14.5 30.3 12.8 12.6 13.5 22.6 13.2 15.5 15.9 38.0 30.5 34.2 25.4 13.1 10.6 18.0 35.5 32.3 29.2 19.1 10.3 28.4 14.9 11.6 35.2 16.5 13.6 34.5 49.6 11.6 18.1 16.3 8.1 12.5 33.1 12.9 30.0 14.5 33.0 20.2 16.9 25.1 16.4 15.7 12.1 33.9 39.4 33.1 36.5 22.4 15.8 21.8 20.8 19.4 29.4 38.2 41.7 41.3 32.2 29.0 19.1 26.6 83.5 21.0 60.4 36.7 46.2 32.2 67.6 32.5 41.5 32.3 23.4 35.3 103.3 22.1 35.3 55.1 27.4 36.6 23.8 30.9 34.9 18.0 45.8 41.6 32.9 42.6 43.3 33.6 38.4 20.3 37.1 21.5 39.1 28.0 20.0 31.6 59.3 32.5 37.7 66.0 65.4 0.1 14.0 23.5 34.1 28.0 21.6 14.0 25.2 34.6 31.1 13.8 31.3 7.5 6.3 10.9 7.3 6.3 9.8 10.8 10.1 11.5 11.6 6.6 11.5 9.0 6.8 11.5 4.6 23.8 10.7 5.5 31.2 31.7 36.0 38.1 30.5 34.2 35.5 32.3 29.2 35.2 33.1 33.0 33.9 15.2 19.2 10.8 5.2 12.5 14.8 20.1 67.3 18.2 21.9 18.6 21.2 41.6 27.1 34.1 25.8 6.2 35.3 13.0 14.0 115.4 33.6 1.7 27.1 20.9 15.8 10.2 12.0 5.3 36.8 29.4 20.2 16.8 23.1 7.6 36.4 20.3 14.8 37.5 21.9 6.4 13.8 42.7 14.5 7.2 5.7 23.0 13.6 14.2 6.5 13.1 62.9 17.5 6.6 6.8 34.6 26.0 21.8 14.3 17.5 14.5 50.7 26.4 16.1 13.1 12.9 19.8 19.9 45.4 20.7 16.3 26.5 12.7 35.5 17.1 26.0 MAOB ENSG00000069535 "Monoamine oxidase B" P27338 X 43766610-43882450 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 320.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 120.6;granulocytes: 137.8;Hepatocytes: 221.1;Peritubular cells: 95.2;Proximal enterocytes: 178.8;Proximal tubular cells: 182.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 41.4;SiHa: 78.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002328, CAB037200" Enhanced NA NA 110000 "CAB037200: AB_1841012, HPA002328: AB_1854062" "unprognostic (1.19e-2)" "unprognostic (1.36e-1)" "unprognostic (5.16e-2)" "unprognostic (1.85e-2)" "unprognostic (4.39e-2)" "unprognostic (2.69e-2)" "unprognostic (5.61e-2)" "unprognostic (4.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (9.74e-2)" "unprognostic (5.35e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (1.90e-3)" 78.7 51.5 110.8 6.5 96.9 0.1 46.1 94.5 118.7 32.6 80.3 35.7 74.1 120.4 55.5 31.7 98.9 17.5 98.8 93.2 143.0 125.4 320.2 33.3 6.1 146.3 122.4 88.1 156.7 11.0 15.7 26.1 11.3 123.2 83.7 16.7 14.0 79.1 156.9 115.7 9.0 79.7 104.2 117.5 2.4 24.0 9.1 144.2 3.8 5.7 65.6 7.1 28.6 25.6 116.6 0.0 1.0 0.1 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 5.4 4.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 8.1 41.4 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.3 3.5 0.0 0.0 0.0 0.0 0.4 4.0 0.0 0.1 1.1 78.2 0.0 0.5 0.6 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 110.8 96.9 94.5 118.7 93.2 143.0 146.3 122.4 88.1 123.2 117.5 144.2 116.6 5.9 0.0 4.1 53.5 0.4 5.5 0.4 1.2 1.8 1.4 3.5 22.4 120.6 52.9 1.9 5.5 4.2 0.4 0.0 10.2 62.6 20.1 0.4 26.4 81.6 10.3 0.0 2.7 36.9 2.8 0.5 17.0 16.3 6.0 137.8 69.6 7.5 221.1 1.5 15.2 7.6 6.4 12.2 4.3 3.6 2.1 46.0 1.8 7.2 9.4 0.0 27.2 0.0 11.6 1.3 7.9 7.8 95.2 0.3 0.6 178.8 182.6 11.8 1.0 13.1 2.6 18.4 0.3 0.4 2.3 4.0 0.4 5.5 0.5 10.5 0.5 RORA "NR1F1, ROR1, ROR2, ROR3, RZRA" ENSG00000069667 "RAR related orphan receptor A" P35398 15 60488284-61229302 "Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 81.2" "Cell type enhanced" "Detected in many" "Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 26.7" "Cell line enhanced" "Detected in many" "Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009861, HPA074448" Approved Supported Nucleoli NA NA Nucleoli "CAB009861: AB_2180141, HPA074448: " "unprognostic (1.57e-1)" "unprognostic (4.76e-2)" "unprognostic (2.22e-1)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (2.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (9.93e-2)" "unprognostic (1.34e-1)" "prognostic favorable (5.42e-6)" "unprognostic (6.94e-2)" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.62e-2)" 8.1 38.4 17.2 6.3 13.0 17.6 13.7 51.1 13.0 9.0 8.5 6.1 2.6 6.0 4.7 17.5 6.9 9.2 6.7 5.1 12.3 12.7 28.9 11.3 6.3 6.8 35.7 1.4 10.0 14.1 10.1 7.7 3.0 18.3 5.7 3.5 38.1 8.6 5.6 41.8 81.2 6.3 5.5 4.1 9.4 6.3 14.0 55.1 4.3 12.9 20.4 7.5 5.2 9.3 4.3 0.1 0.8 2.7 0.0 3.4 1.7 0.9 1.3 1.5 1.2 1.4 1.8 0.5 0.0 0.6 3.4 3.6 0.5 6.1 2.6 2.2 2.9 5.2 0.0 0.4 2.9 1.3 0.0 0.3 7.8 0.6 3.3 0.0 1.1 11.6 11.2 0.2 73.2 5.1 0.2 0.6 0.0 2.1 1.9 1.1 0.1 2.4 1.1 2.4 0.5 1.9 4.4 0.3 0.6 0.1 7.3 0.0 0.0 0.3 10.1 4.5 4.2 0.1 41.7 62.1 0.2 17.0 0.0 1.2 0.2 0.1 0.0 23.2 0.0 26.7 1.4 17.4 16.0 0.0 0.1 5.4 11.5 0.5 6.5 0.1 0.7 16.3 4.7 17.2 13.0 51.1 13.0 5.1 12.3 6.8 35.7 1.4 18.3 4.1 55.1 4.3 32.5 41.7 31.7 2125.3 23.4 185.2 30.1 17.0 55.2 167.5 24.7 16.1 26.3 30.0 23.4 58.8 454.5 0.7 185.3 1.4 13.7 21.4 148.8 26.9 52.9 40.8 18.5 42.5 627.1 12.3 1.9 69.4 11.7 36.1 2.5 7.9 34.2 97.2 0.8 126.2 1056.8 3.3 10.2 9.1 35.8 97.1 46.6 8.3 60.5 757.0 4.7 50.4 250.3 1524.0 114.9 8.2 0.5 87.3 88.7 24.0 0.7 44.6 16.0 160.0 39.5 57.9 32.2 1.9 3.8 73.2 423.4 4.7 237.6 11.5 2.1 61.9 DRD4 ENSG00000069696 "Dopamine receptor D4" P21917 11 637269-640706 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Bipolar cells: 168.8;Cone photoreceptor cells: 87.6;Rod photoreceptor cells: 206.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062682 Uncertain "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA062682: " "unprognostic (8.83e-2)" "unprognostic (2.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.81e-2)" "unprognostic (7.52e-2)" "unprognostic (7.89e-3)" "unprognostic (3.14e-2)" "unprognostic (2.96e-1)" "unprognostic (8.45e-2)" "unprognostic (5.07e-2)" "unprognostic (3.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.05e-4)" "unprognostic (1.26e-2)" "unprognostic (8.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-1)" 0.9 0.8 0.8 0.0 0.5 0.0 0.8 1.3 0.8 2.3 0.1 1.4 0.0 1.6 0.0 1.1 2.6 0.0 0.9 0.7 0.1 1.3 1.5 1.3 0.0 1.6 0.4 0.2 3.5 1.5 0.0 4.2 0.0 1.1 2.3 0.0 0.0 0.5 0.0 1.0 1.4 1.1 0.0 0.8 0.6 0.8 2.6 0.7 0.0 1.8 0.0 0.0 1.7 1.7 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.5 1.3 0.8 0.7 0.1 1.6 0.4 0.2 1.1 0.8 0.7 1.1 0.5 0.0 0.5 4.2 0.2 0.0 0.3 0.2 0.0 168.8 0.3 0.4 1.7 0.0 0.1 1.8 87.6 0.6 8.6 0.8 0.0 0.1 0.7 0.3 0.4 1.5 0.0 0.0 0.8 0.4 0.3 0.5 2.0 0.7 0.0 1.5 0.0 0.1 0.2 6.7 1.2 1.3 0.0 0.3 0.3 0.2 0.6 0.9 0.0 0.0 0.1 26.0 0.0 0.0 2.6 0.4 0.2 0.7 0.1 1.1 8.3 1.9 0.1 206.9 0.0 0.8 0.6 1.2 2.6 0.8 0.4 0.1 0.1 0.5 1.3 0.3 TGFBR3 "betaglycan, BGCAN" ENSG00000069702 "Transforming growth factor beta receptor 3" Q03167 1 91680343-91906335 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 143.9;Hepatic stellate cells: 322.7;Leydig cells: 146.3;Skeletal myocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 35.2" "Group enriched" "Detected in many" 18 "NK-cells: 16.6;T-cells: 35.2" "Cell line enhanced" "Detected in many" "ASC diff: 227.2;ASC TERT1: 108.4;RT4: 57.1;U-2197: 78.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008257, CAB018971" Supported Approved Cytosol "Secreted to blood" NA NA 50000000 Cytosol "CAB018971: , HPA008257: AB_1080258" "unprognostic (7.57e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (9.39e-3)" "prognostic favorable (4.84e-4)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (9.32e-2)" "unprognostic (1.07e-1)" "prognostic favorable (4.99e-4)" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.08e-2)" 66.9 35.5 7.5 9.3 7.3 5.0 62.8 7.9 9.0 57.0 20.2 24.1 8.2 34.3 24.5 28.8 36.9 20.1 13.9 7.1 8.6 28.4 16.7 27.5 7.2 6.0 8.7 5.0 82.3 12.4 5.9 7.1 59.0 9.8 16.5 12.6 1.5 35.3 33.0 12.9 23.5 19.9 27.7 8.0 40.3 18.2 11.1 9.5 7.8 13.3 29.6 4.2 47.7 28.9 8.0 9.9 9.4 14.1 2.4 227.2 108.4 44.6 7.1 35.3 8.1 9.9 4.4 1.4 0.1 1.7 13.0 6.4 1.4 3.6 1.0 6.2 34.1 7.6 0.0 11.1 41.2 5.0 0.3 0.1 26.3 4.7 17.8 4.0 1.3 4.2 0.0 23.6 0.7 2.4 0.2 0.1 0.1 5.9 4.6 3.2 0.5 4.8 2.1 3.2 57.1 0.7 0.0 3.4 0.2 20.4 5.8 1.2 3.7 12.7 13.5 3.5 78.0 1.7 34.8 3.3 0.0 2.8 1.9 1.7 1.2 0.0 0.0 35.2 0.2 19.4 0.0 8.7 19.2 0.0 0.0 2.7 12.7 0.6 16.6 1.4 1.2 4.5 8.1 7.5 7.3 7.9 9.0 7.1 8.6 6.0 8.7 5.0 9.8 8.0 9.5 8.0 77.6 9.6 9.7 58.8 3.1 37.6 10.0 2.3 44.3 0.3 38.2 60.1 20.7 30.0 4.2 31.3 2.1 27.5 66.7 0.5 3.9 2.0 54.3 11.2 32.8 90.5 24.0 10.7 7.7 5.1 12.0 143.9 5.1 8.1 2.5 20.5 322.7 21.0 11.8 0.0 34.0 1.9 8.2 23.2 29.4 29.8 146.3 5.2 35.6 82.4 0.7 1.2 62.8 7.5 0.9 3.3 0.4 74.4 21.3 8.5 1.4 20.9 8.3 0.2 13.1 187.2 36.5 0.8 2.2 17.2 34.1 58.0 36.9 92.2 3.7 8.0 PLA2G10 GXPLA2 ENSG00000069764 "Phospholipase A2 group X" O15496 16 14672548-14694308 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 27.6;pancreas: 10.6;stomach 1: 42.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 280.1;Exocrine glandular cells: 116.3;Gastric mucus-secreting cells: 116.2;Intestinal goblet cells: 137.7;Paneth cells: 225.3" "Cancer enhanced" "Detected in many" "stomach cancer: 6.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.6;CAPAN-2: 6.4;HaCaT: 2.2;MCF7: 2.3;OE19: 5.9;SK-BR-3: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041893 Uncertain "Secreted in other tissues" NA NA "HPA041893: AB_10794495" "unprognostic (8.44e-3)" "unprognostic (2.37e-1)" "unprognostic (6.72e-2)" "prognostic favorable (5.74e-5)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (5.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.77e-2)" "unprognostic (2.72e-1)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.08e-2)" "unprognostic (1.03e-1)" "unprognostic (2.30e-2)" "unprognostic (9.97e-3)" 0.0 0.2 0.1 2.4 0.1 0.1 0.1 0.1 0.2 1.4 0.1 27.6 7.7 0.1 0.0 0.2 4.5 3.5 0.0 0.1 0.1 0.0 0.0 4.8 0.2 0.1 0.1 0.1 0.0 10.6 0.0 0.0 0.3 0.1 0.4 23.8 0.0 0.1 0.0 0.0 0.0 7.0 0.6 0.1 0.0 42.2 2.2 0.1 0.0 0.0 0.0 0.3 4.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.5 6.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 35.3 23.1 0.7 0.3 0.0 0.9 3.7 0.6 0.0 0.7 0.5 0.1 5.7 17.9 1.8 0.0 0.6 0.1 280.1 0.0 2.6 0.3 25.1 3.5 0.2 12.7 0.0 0.5 116.3 56.7 0.1 116.2 45.7 0.0 0.4 0.0 0.0 0.9 0.0 0.3 137.7 24.4 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 20.5 225.3 0.0 0.7 1.3 16.1 0.0 60.1 0.0 0.0 0.0 2.0 1.1 1.2 1.7 0.0 0.5 0.5 0.0 57.3 14.6 HES2 bHLHb40 ENSG00000069812 "Hes family bHLH transcription factor 2" Q9Y543 1 6412418-6424670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 33.9;skin 1: 15.4;vagina: 19.0" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 48.9;Late spermatids: 45.3;Paneth cells: 33.0;Squamous epithelial cells: 58.5;Syncytiotrophoblasts: 99.3" "Cancer enhanced" "Detected in many" "cervical cancer: 17.0;head and neck cancer: 16.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 3.0;neutrophil: 1.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "BEWO: 19.7;HaCaT: 37.6;HBEC3-KT: 32.3;hTCEpi: 18.3;PC-3: 13.4;TIME: 55.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039462 Uncertain NA NA "HPA039462: AB_10673533" "unprognostic (1.96e-1)" "unprognostic (7.00e-2)" "unprognostic (1.66e-1)" "unprognostic (6.82e-3)" "unprognostic (1.13e-2)" "unprognostic (1.89e-1)" "unprognostic (2.56e-4)" "unprognostic (4.74e-2)" "unprognostic (7.41e-2)" "unprognostic (3.20e-2)" "unprognostic (5.63e-3)" "unprognostic (1.38e-1)" "unprognostic (7.67e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-2)" 0.1 0.0 0.3 0.8 0.3 0.4 0.9 0.3 0.4 6.1 0.2 6.1 0.3 0.3 0.6 33.9 2.6 0.1 0.1 0.3 0.5 0.8 0.1 1.1 0.1 0.3 0.2 0.3 0.1 0.0 0.3 0.2 6.8 0.4 1.6 4.6 1.2 3.8 0.1 0.1 15.4 1.3 0.3 0.1 0.1 0.1 2.9 0.3 0.3 0.0 0.1 1.7 0.4 19.0 0.7 1.8 0.6 0.0 0.2 0.3 0.1 19.7 0.0 0.0 0.1 0.0 0.5 0.3 0.1 3.5 0.2 0.2 37.6 1.0 32.3 0.0 0.0 0.4 0.3 0.4 0.3 0.3 0.0 0.2 0.1 18.3 0.1 0.7 0.0 9.8 0.0 0.3 0.3 0.1 2.9 0.1 1.6 0.0 2.0 13.4 0.1 0.0 0.2 0.3 0.5 0.2 0.0 1.9 10.3 0.3 1.9 1.4 0.7 55.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.1 3.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 1.3 0.2 0.1 0.2 0.1 0.1 0.3 0.3 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.4 0.1 0.3 0.7 0.4 9.6 3.9 0.0 0.4 6.5 8.7 10.5 8.0 1.8 2.0 1.5 9.1 0.0 12.7 1.8 4.2 3.6 0.4 17.3 0.0 1.1 19.4 10.3 1.2 1.5 3.0 0.0 0.0 0.0 4.6 1.1 0.0 9.9 1.3 0.2 1.4 0.2 0.9 0.0 0.0 48.9 6.1 0.6 4.8 45.3 0.3 1.2 1.8 0.0 0.1 1.0 1.0 0.0 0.0 0.5 33.0 0.7 0.3 10.9 9.2 6.6 16.8 6.1 0.0 1.4 0.9 5.8 4.8 58.5 19.6 99.3 0.8 0.1 13.1 23.2 ATP1B3 "CD298, FLJ29027" ENSG00000069849 "ATPase Na+/K+ transporting subunit beta 3" P54709 3 141876124-141926549 "CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 982.6;Late spermatids: 930.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020697, HPA048963" Enhanced Supported "Plasma membrane" NA NA 33000 "Plasma membrane" "CAB020697: , HPA048963: AB_2680574" "unprognostic (2.31e-1)" "unprognostic (1.11e-3)" "unprognostic (2.75e-1)" "prognostic favorable (5.19e-5)" "unprognostic (2.60e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (8.11e-3)" "unprognostic (6.99e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.29e-5)" "unprognostic (5.14e-2)" "unprognostic (2.04e-1)" "unprognostic (7.19e-3)" "unprognostic (6.15e-2)" 157.9 352.4 62.0 81.7 64.6 63.6 87.8 78.1 91.3 79.2 97.7 148.1 113.7 76.3 37.9 183.8 97.0 55.9 94.9 64.1 275.7 97.2 24.7 192.7 41.6 73.2 69.9 64.6 181.5 37.0 20.4 170.0 97.5 72.6 102.8 169.6 44.0 86.5 46.7 27.0 261.3 126.1 72.0 70.0 66.2 66.8 76.3 72.1 51.9 76.4 16.1 57.6 101.9 162.5 78.4 280.8 170.1 155.5 145.6 411.7 118.0 354.7 322.2 287.6 224.2 252.1 253.7 136.5 223.3 278.2 243.5 328.4 595.8 157.0 152.2 253.4 120.4 190.0 195.7 161.4 156.8 161.7 164.9 149.1 126.5 355.1 179.1 169.7 162.4 245.7 156.3 135.9 193.7 233.8 114.6 165.6 275.0 213.6 384.5 76.1 225.0 116.4 227.1 191.1 186.7 127.6 86.0 413.2 188.5 455.9 270.7 145.6 197.2 170.7 196.4 76.3 298.8 189.8 138.0 197.6 367.5 259.5 176.5 165.2 69.7 104.1 35.4 70.4 174.3 51.7 39.7 56.3 74.8 103.3 30.4 32.6 59.6 6.7 32.0 260.4 64.8 68.4 103.7 62.0 64.6 78.1 91.3 64.1 275.7 73.2 69.9 64.6 72.6 70.0 72.1 78.4 114.7 57.7 41.9 38.2 143.4 492.8 428.3 535.9 326.7 35.9 53.0 46.4 19.7 17.2 177.6 220.7 25.0 281.3 464.5 982.6 41.1 73.9 465.9 86.0 72.2 199.2 56.1 147.1 107.5 60.6 226.8 164.1 24.5 127.2 130.7 94.3 100.6 9.0 305.9 25.2 91.2 65.2 164.8 148.0 678.3 930.5 84.8 455.3 222.3 37.5 364.8 46.3 75.2 46.3 54.7 70.6 321.1 68.4 153.1 396.5 413.3 41.5 33.3 28.4 124.9 99.5 265.2 69.0 200.2 178.4 414.4 391.4 216.1 122.2 134.9 370.2 NEDD4 "KIAA0093, MGC176705, NEDD4-1, RPF1" ENSG00000069869 "NEDD4 E3 ubiquitin protein ligase" P46934 15 55826922-55993660 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.1;tongue: 58.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001991, HPA039883, CAB072833" Approved Approved Cytosol NA NA 6500 Cytosol "CAB001991: , CAB072833: , HPA039883: AB_10795683" "unprognostic (1.18e-1)" "unprognostic (2.10e-2)" "unprognostic (5.66e-3)" "unprognostic (1.15e-1)" "unprognostic (6.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.18e-3)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (6.38e-3)" "unprognostic (2.98e-1)" "unprognostic (2.22e-1)" "unprognostic (2.35e-2)" 6.2 3.6 1.9 4.1 1.9 6.3 7.0 2.0 2.0 5.5 2.2 4.8 4.2 7.2 2.9 4.4 3.6 5.7 4.6 1.5 3.4 6.8 27.6 5.3 3.1 2.5 2.1 1.1 4.1 1.9 5.4 2.1 15.7 2.5 5.5 4.4 4.5 3.1 7.7 68.1 9.2 8.2 8.0 2.3 4.9 3.4 1.8 2.5 5.6 7.2 58.6 3.1 5.6 4.4 2.6 21.5 32.8 9.0 8.8 11.5 18.5 14.1 40.0 62.9 29.1 28.5 14.5 6.3 4.8 10.4 15.4 70.2 34.6 9.7 26.3 48.2 11.1 5.6 26.1 7.2 7.9 59.0 10.6 2.3 30.8 64.7 35.2 58.9 14.2 24.3 14.9 11.5 0.0 86.4 10.7 15.2 0.1 2.2 10.9 5.1 10.5 67.5 3.1 11.9 42.3 0.7 5.1 17.4 12.5 15.7 15.8 15.2 8.8 84.5 63.9 20.6 13.5 66.0 3.4 8.1 12.3 42.0 24.6 15.7 0.0 0.1 0.0 0.1 0.4 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 1.9 1.9 2.0 2.0 1.5 3.4 2.5 2.1 1.1 2.5 2.3 2.5 2.6 35.9 93.0 116.7 28.4 1.6 12.1 3.4 5.5 8.6 0.7 4.6 8.0 5.7 7.2 44.8 0.0 22.9 23.2 2.0 5.2 1.9 3.3 1.7 1.7 13.3 31.1 0.0 17.5 4.2 5.8 7.5 18.5 5.1 1.6 73.2 4.2 17.5 20.5 4.7 0.0 11.9 4.0 2.0 2.2 2.3 1.6 5.6 8.8 1.8 30.0 1.1 8.6 6.2 69.9 28.7 2.9 0.8 7.2 1.9 4.5 25.8 13.4 75.5 6.7 0.0 11.5 17.7 5.3 7.2 7.1 10.4 13.8 9.4 4.8 5.6 1.9 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 6.5 4.8 2.4 5.8 2.6 9.2 9.1 2.7 2.6 5.6 3.0 7.1 7.6 6.4 11.1 5.7 7.9 6.4 2.8 2.6 2.9 10.4 9.5 6.4 8.2 2.9 2.5 2.2 4.8 5.8 10.7 3.9 4.8 2.5 7.8 7.9 8.0 4.3 6.9 1.5 6.2 5.9 5.7 2.5 6.1 7.6 6.6 2.5 6.4 13.5 1.9 8.7 7.6 3.8 3.1 10.5 12.2 5.8 4.1 6.6 13.2 7.8 9.0 19.9 10.4 17.8 5.1 10.3 10.9 10.4 12.9 15.6 18.3 3.3 9.5 8.6 10.4 6.4 10.9 13.6 6.7 11.9 30.8 8.7 12.5 11.4 7.9 10.7 13.8 13.6 9.2 12.2 6.9 15.0 9.1 3.4 12.8 3.1 7.9 4.8 4.9 5.6 24.1 18.4 12.4 2.5 6.2 8.1 12.2 17.3 5.4 11.7 22.2 9.5 13.6 4.3 3.7 18.6 8.1 15.9 8.6 12.4 34.5 10.2 13.6 7.7 3.3 6.2 9.7 7.0 6.0 6.1 6.9 7.0 3.9 4.8 5.5 14.5 5.3 11.4 5.4 6.5 5.5 2.4 2.6 2.7 2.6 2.6 2.9 2.9 2.5 2.2 2.5 2.5 2.5 3.1 3.5 9.6 9.5 17.6 27.5 4.6 9.5 14.9 4.6 3.3 5.6 4.2 3.4 1.5 14.9 0.0 12.5 12.4 11.2 4.8 1.9 7.4 26.8 4.3 3.2 4.7 6.6 8.2 18.3 10.9 12.0 6.0 6.1 6.4 8.2 4.6 6.8 4.4 8.6 1.7 17.7 4.1 4.1 7.5 6.7 5.1 1.5 8.8 3.6 12.2 8.4 2.7 11.3 17.1 14.6 6.9 4.0 1.5 3.8 3.4 6.4 9.7 7.9 9.4 6.6 4.8 4.2 5.9 3.8 5.7 4.0 6.6 12.5 4.2 4.0 7.4 MAPK6 "ERK3, HsT17250, p97MAPK, PRKM6" ENSG00000069956 "Mitogen-activated protein kinase 6" Q16659 15 51952106-52067375 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 218.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005184, HPA030262, HPA047825" Approved Supported Supported Cytosol NA NA Cytosol "CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: " "unprognostic (6.61e-2)" "unprognostic (1.75e-2)" "unprognostic (5.05e-2)" "unprognostic (3.40e-3)" "unprognostic (2.72e-1)" "unprognostic (5.52e-2)" "unprognostic (6.13e-2)" "unprognostic (2.32e-3)" "unprognostic (3.99e-2)" "unprognostic (8.54e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-2)" "unprognostic (3.27e-3)" "unprognostic (2.03e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.31e-2)" 11.0 7.1 11.6 12.2 12.9 32.7 14.0 16.7 16.4 14.5 9.2 20.4 17.6 16.5 11.0 28.3 8.3 17.7 7.8 12.0 13.5 15.4 35.6 8.9 10.8 12.7 13.1 10.9 6.3 8.4 11.1 8.0 12.7 13.1 10.1 18.9 18.0 15.4 8.8 27.9 21.0 24.7 13.8 11.9 8.3 17.0 29.6 12.9 14.6 14.0 33.2 13.8 27.5 21.4 13.9 27.1 36.0 69.1 26.7 21.1 34.3 50.5 38.0 38.0 34.2 40.1 43.3 15.9 38.9 26.0 48.9 50.0 37.5 53.8 72.4 46.5 24.0 16.8 58.0 20.3 68.9 50.4 43.9 118.6 36.8 130.0 41.5 106.8 36.4 32.7 26.1 76.5 64.3 44.2 61.3 30.8 34.4 24.7 33.6 17.2 26.8 44.5 62.3 32.8 112.3 33.8 31.9 30.7 24.6 56.5 94.9 22.6 64.3 32.9 40.7 43.9 26.8 51.4 33.2 104.4 47.5 50.4 62.9 51.2 1.7 2.5 0.7 1.9 2.3 2.3 2.5 2.8 2.2 2.3 1.3 2.6 1.9 0.3 3.6 1.5 1.0 4.3 1.9 11.6 12.9 16.7 16.4 12.0 13.5 12.7 13.1 10.9 13.1 11.9 12.9 13.9 31.3 28.9 31.5 24.5 24.2 111.9 123.8 50.6 24.5 55.6 39.3 19.3 21.9 25.8 43.1 16.5 16.7 16.9 15.9 110.2 17.6 35.2 147.5 61.3 75.7 28.8 31.0 17.1 29.1 50.1 39.5 39.2 35.7 126.4 137.9 19.3 17.9 59.6 28.0 33.7 31.0 42.9 42.7 41.8 66.6 218.1 22.7 50.5 30.2 17.8 15.7 32.3 11.3 28.6 63.7 69.1 46.5 23.7 35.3 89.0 110.6 60.3 42.9 23.8 19.7 24.7 33.9 72.7 81.0 49.6 110.7 33.1 23.0 13.9 28.6 174.0 GNB5 GB5 ENSG00000069966 "G protein subunit beta 5" O14775 15 52115100-52191392 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 121.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 267.5;Cone photoreceptor cells: 279.4;Muller glia cells: 206.9;Rod photoreceptor cells: 296.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032353, HPA041942, HPA044198" Uncertain Approved "Nuclear speckles,Centrosome,Rods & Rings" NA NA "Nuclear speckles" "Centrosome, Rods & Rings" "CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: AB_2678853" "unprognostic (2.38e-2)" "unprognostic (3.58e-1)" "unprognostic (1.97e-3)" "prognostic favorable (1.47e-6)" "unprognostic (6.15e-2)" "unprognostic (1.37e-2)" "unprognostic (2.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-3)" "unprognostic (2.10e-1)" "prognostic favorable (3.32e-11)" "unprognostic (1.40e-3)" "unprognostic (8.12e-3)" "unprognostic (3.55e-3)" "unprognostic (1.52e-1)" 10.9 14.6 16.3 11.9 21.6 5.5 12.8 27.2 28.4 26.0 8.1 15.1 6.0 28.6 17.4 11.9 27.1 21.0 22.4 19.8 23.4 36.7 18.9 9.0 22.0 21.7 17.9 20.9 49.8 19.1 40.9 26.1 5.8 24.2 16.7 5.6 121.1 11.3 25.8 2.5 8.5 13.2 17.5 8.7 13.6 11.2 15.8 23.9 15.0 21.9 4.8 20.1 21.0 18.3 31.7 18.9 47.6 12.9 23.1 21.5 26.9 12.5 36.1 34.8 31.4 34.0 13.3 13.9 32.6 11.0 29.7 52.9 27.0 23.1 34.3 23.6 25.5 17.5 21.8 60.7 15.6 25.7 11.0 75.8 25.0 28.3 25.2 9.3 33.3 19.9 28.2 1.7 29.9 34.8 33.6 17.6 31.4 12.1 6.3 20.9 23.4 44.9 40.0 22.4 56.7 20.8 18.0 34.6 3.2 28.7 15.8 11.1 33.9 49.5 28.1 30.7 32.2 36.8 18.9 39.0 35.7 58.9 26.6 46.2 10.1 3.8 0.4 21.4 3.8 17.6 41.5 27.2 25.5 10.1 43.8 25.2 21.9 2.2 23.6 3.2 20.6 42.5 18.7 16.3 21.6 27.2 28.4 19.8 23.4 21.7 17.9 20.9 24.2 8.7 23.9 31.7 15.9 22.4 23.8 17.0 79.5 19.2 22.8 15.5 21.1 267.5 20.7 27.9 18.3 34.3 21.8 18.4 279.4 4.8 27.1 2.7 19.6 28.9 1.8 28.3 28.7 17.7 19.7 6.1 72.8 18.5 24.8 23.5 8.6 59.9 29.8 20.1 13.6 10.0 3.8 111.0 67.7 1.7 14.2 6.2 15.2 4.6 39.7 20.5 19.6 8.4 4.0 206.9 15.5 22.1 7.8 19.1 5.1 116.9 18.7 10.9 0.8 36.3 24.6 296.5 46.0 16.6 23.9 2.1 6.2 10.8 16.3 2.9 31.9 20.1 2.8 17.8 RAB27A "GS2, HsT18676, RAB27, RAM" ENSG00000069974 "RAB27A, member RAS oncogene family" P51159 15 55202966-55319113 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Exocytosis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 121.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 261.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001333, CAB034046" Enhanced NA NA "CAB034046: AB_2176724, HPA001333: AB_1079730" "prognostic favorable (2.56e-4)" "unprognostic (9.75e-2)" "unprognostic (2.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (1.79e-1)" "unprognostic (1.73e-1)" "unprognostic (2.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.77e-1)" "unprognostic (6.24e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (4.23e-2)" "unprognostic (4.34e-1)" "unprognostic (7.95e-3)" "unprognostic (4.32e-1)" 16.8 28.0 3.8 40.5 3.8 101.1 14.1 4.3 5.0 13.0 7.4 53.5 30.3 12.9 5.0 20.8 12.4 17.7 6.6 3.2 17.3 10.4 44.0 42.8 46.4 5.9 4.7 2.7 8.0 29.4 11.5 31.7 17.7 5.3 61.7 66.8 4.2 18.4 11.9 3.2 12.9 41.2 26.0 4.9 31.0 121.0 10.0 5.5 19.5 30.7 7.1 46.6 37.9 14.0 7.1 23.0 10.0 9.7 11.3 8.3 38.8 9.5 29.4 32.5 19.2 26.4 7.0 15.6 0.9 22.3 16.0 38.9 16.0 15.7 27.0 18.3 84.9 9.7 5.4 37.6 18.1 56.0 208.7 26.5 34.3 44.2 29.0 71.6 80.7 46.9 26.4 238.0 179.4 20.7 27.7 1.5 57.6 3.6 38.9 14.7 32.4 27.3 50.3 28.7 17.7 14.9 7.1 31.4 15.2 188.3 24.3 13.3 162.2 25.3 52.5 20.3 33.1 33.6 72.0 88.2 6.0 70.2 185.1 19.0 261.3 72.4 99.8 59.2 30.1 58.2 8.0 28.6 61.9 39.0 13.4 13.9 37.4 114.9 34.1 24.0 2.1 36.2 48.9 3.8 3.8 4.3 5.0 3.2 17.3 5.9 4.7 2.7 5.3 4.9 5.5 7.1 27.5 76.9 147.1 12.7 18.6 14.1 25.7 19.2 6.2 3.0 16.3 18.3 7.4 15.7 50.1 11.0 2.1 6.3 81.0 18.5 13.7 24.6 2.8 10.1 15.6 32.1 74.3 12.8 12.5 87.6 18.7 16.9 93.3 16.7 31.7 8.8 41.7 41.7 15.6 0.0 12.2 252.0 12.2 33.3 15.2 2.2 7.5 31.1 71.2 10.3 71.9 2.4 104.0 10.1 7.1 62.9 15.9 13.9 38.6 32.3 14.6 6.7 31.3 4.4 19.7 9.4 15.8 9.3 4.6 7.1 15.5 7.5 81.4 4.6 18.4 23.4 HDHD5 CECR5 ENSG00000069998 "Haloacid dehalogenase like hydrolase domain containing 5" Q9BXW7 22 17137511-17165287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Ductal cells: 35.2;Extravillous trophoblasts: 42.2;Granulosa cells: 37.0;Hofbauer cells: 42.3;Proximal tubular cells: 41.1;Theca cells: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005548 Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA005548: AB_1078497" "unprognostic (4.04e-2)" "unprognostic (5.04e-2)" "unprognostic (4.54e-3)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.04e-3)" "unprognostic (7.35e-2)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (5.76e-2)" "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (7.07e-3)" "unprognostic (1.71e-1)" "unprognostic (1.20e-2)" "unprognostic (7.21e-3)" 17.1 29.9 14.1 13.4 14.4 16.6 17.4 14.7 15.8 12.8 15.3 18.8 26.7 14.8 6.9 21.9 13.8 9.9 35.6 14.6 14.2 19.8 40.9 12.7 14.6 14.7 14.4 13.8 12.3 21.1 17.6 11.7 8.1 14.5 15.6 14.3 5.7 18.8 10.1 47.4 22.9 17.4 11.5 14.1 19.4 20.0 16.0 15.2 13.8 10.2 56.2 12.1 16.6 14.3 14.3 64.0 41.5 30.5 41.5 17.7 10.8 38.8 17.9 19.6 47.1 50.2 61.1 23.3 103.9 29.3 21.6 23.0 44.0 38.7 42.0 21.8 31.6 56.7 0.0 30.7 0.0 29.4 47.6 23.5 26.1 51.1 21.0 23.1 26.4 33.3 67.4 31.0 26.2 24.9 62.1 84.2 97.2 46.6 97.9 36.7 47.4 45.8 26.3 32.2 34.7 61.4 46.5 34.9 49.9 54.3 23.9 50.1 58.5 29.1 39.7 29.4 28.2 31.3 41.3 48.5 77.8 32.0 0.1 34.2 12.3 86.2 4.7 28.4 56.7 35.6 24.6 26.4 25.8 74.5 23.6 34.3 29.3 4.5 30.7 31.4 30.9 29.7 48.0 14.1 14.4 14.7 15.8 14.6 14.2 14.7 14.4 13.8 14.5 14.1 15.2 14.3 21.5 6.4 2.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 23.9 22.4 0.0 0.0 5.0 5.5 0.0 26.5 9.3 0.0 43.0 35.2 0.0 8.4 14.9 9.2 0.0 0.0 0.0 28.2 42.2 7.7 0.0 11.5 5.1 37.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 5.2 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.5 0.0 0.0 41.1 1.5 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 15.7 3.4 55.8 0.0 0.0 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449911-19479202 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 782.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 41.7 40.1 22.8 37.1 25.2 65.4 38.1 26.1 30.1 32.5 26.1 42.9 32.4 47.2 54.8 48.8 31.7 29.6 42.6 23.5 27.8 36.1 52.3 37.5 43.8 27.9 25.5 22.1 32.1 39.6 45.1 32.0 35.6 27.9 32.4 38.8 21.9 38.4 30.3 99.1 41.8 36.0 39.8 27.3 38.9 41.1 53.8 26.3 62.2 35.2 42.9 47.9 40.6 37.3 28.6 187.5 132.4 110.6 168.5 89.0 62.0 86.0 150.2 148.8 202.9 187.1 147.8 78.8 129.2 114.1 126.7 93.3 157.5 131.5 132.1 175.1 239.8 138.0 136.5 88.3 119.4 84.4 218.6 177.7 57.4 133.0 173.2 84.4 59.1 164.7 67.9 782.0 240.5 125.1 268.5 142.0 133.4 79.8 232.2 111.9 170.1 262.0 50.1 126.6 172.5 90.5 102.2 118.2 126.0 123.3 114.2 75.9 103.5 180.9 169.6 230.8 143.2 164.1 102.9 221.7 168.8 142.5 110.3 158.6 150.9 90.6 158.1 107.0 140.3 103.7 87.7 122.5 112.4 81.0 82.6 104.6 102.9 167.1 105.7 140.7 113.1 224.5 129.5 22.8 25.2 26.1 30.1 23.5 27.8 27.9 25.5 22.1 27.9 27.3 26.3 28.6 68.3 25.6 34.5 0.0 16.4 0.0 0.0 0.0 0.0 0.0 39.7 55.2 0.0 0.0 16.7 27.6 0.0 121.1 44.9 0.0 84.1 115.7 0.0 43.1 36.9 32.6 0.0 0.0 0.0 142.2 107.3 25.4 0.0 44.9 27.8 36.0 0.0 0.0 88.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 76.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 7.5 0.0 0.0 81.0 27.7 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 170.3 26.3 61.5 0.0 0.0 LRP6 ADCAD2 ENSG00000070018 "LDL receptor related protein 6" O75581 12 12116025-12267044 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 96.6;Oligodendrocyte precursor cells: 108.0;Oligodendrocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004490, HPA029925" Enhanced NA NA 390000 "CAB004490: AB_627894, HPA029925: AB_10601768" "unprognostic (1.80e-1)" "unprognostic (3.72e-1)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (6.11e-2)" "unprognostic (1.07e-1)" "unprognostic (4.56e-2)" "unprognostic (1.37e-2)" "unprognostic (3.35e-2)" "unprognostic (6.98e-2)" "unprognostic (1.82e-1)" "unprognostic (5.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-2)" "unprognostic (3.16e-1)" "unprognostic (1.23e-2)" "unprognostic (2.47e-1)" 3.6 2.3 1.8 1.2 3.5 0.2 4.6 2.3 2.3 6.0 11.3 4.2 2.8 6.6 1.9 2.0 4.4 2.8 2.9 1.6 1.4 4.5 7.9 4.6 0.8 3.0 2.5 0.6 5.5 4.9 6.2 2.6 8.4 3.2 3.4 2.9 2.8 6.8 3.3 4.5 3.4 2.8 4.2 1.4 0.9 3.5 2.1 2.7 1.2 4.6 4.6 1.0 3.4 5.3 2.7 3.9 13.3 9.9 5.3 6.1 4.0 7.8 5.8 5.4 4.6 5.3 6.5 3.6 0.0 2.8 5.6 3.8 3.7 14.6 3.7 8.7 0.0 3.9 4.1 4.9 3.2 2.1 5.7 2.8 3.2 2.0 6.9 5.4 5.1 4.8 4.1 5.0 0.0 3.0 3.2 4.2 1.1 14.4 2.2 1.7 5.3 9.2 1.0 6.8 7.6 2.0 5.6 7.4 2.5 6.0 11.5 2.0 3.7 6.9 3.6 13.2 2.6 4.9 0.0 0.0 1.9 2.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.5 2.3 2.3 1.6 1.4 3.0 2.5 0.6 3.2 1.4 2.7 2.7 21.6 41.7 49.5 96.6 1.0 15.4 8.6 11.9 9.6 28.2 20.1 19.0 15.4 11.5 16.6 14.7 22.9 3.7 0.5 20.4 1.9 9.0 1.0 18.0 39.0 25.9 10.8 0.4 58.2 13.7 3.2 24.0 25.5 29.1 0.0 32.8 22.1 46.7 2.3 6.7 58.0 12.9 10.2 2.4 6.0 5.1 30.4 1.7 14.2 35.6 0.6 19.9 1.0 108.0 97.0 11.3 20.5 38.7 1.6 14.7 15.1 5.2 6.0 29.0 0.0 21.5 17.3 21.5 26.4 11.0 13.8 3.4 1.9 23.7 14.4 8.1 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696599 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 68.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6" "Region enhanced" "Detected in some" "midbrain: 1.8" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles NA NA Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.5 0.2 0.3 3.4 0.3 0.5 0.0 0.3 0.1 0.0 2.5 37.5 68.8 0.3 0.0 1.9 0.0 0.9 2.2 0.2 0.6 0.4 0.3 0.2 0.4 0.3 0.3 0.0 0.0 2.3 0.0 0.0 0.2 0.3 0.3 41.8 0.1 0.6 0.0 0.7 0.9 67.0 1.4 0.6 0.2 1.9 0.4 0.3 0.0 0.5 0.0 0.3 0.5 0.2 0.5 0.4 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.6 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.3 1.1 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.3 0.1 0.2 0.6 0.3 0.3 0.0 0.3 0.6 0.3 0.5 0.0 0.0 0.0 1.3 6.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.1 0.1 0.0 0.0 176.7 0.0 1.4 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 56.0 0.0 0.3 0.3 0.2 0.0 0.3 0.0 1.0 0.3 0.0 0.0 1.0 0.2 0.4 97.9 0.0 0.1 0.0 81.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 47.6 0.0 SCT ENSG00000070031 Secretin P09683 11 626309-627181 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 44.6" "Cell type enhanced" "Detected in some" "dendritic cells: 92.8;Enteroendocrine cells: 267.8;Intestinal goblet cells: 46.4;Proximal enterocytes: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 138 "plasmacytoid DC: 126.7" "Lineage enriched" "Detected in single" 138 "dendritic cells: 126.7" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050961 Enhanced "Secreted to blood" NA NA 571000 "HPA050961: AB_2681291" "unprognostic (5.28e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.72e-1)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" "unprognostic (2.43e-3)" "unprognostic (4.19e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-2)" "unprognostic (1.88e-1)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (8.37e-2)" "unprognostic (5.45e-1)" "unprognostic (6.09e-2)" "unprognostic (1.13e-1)" 0.0 0.2 0.8 0.1 1.5 0.6 0.0 1.7 1.3 0.3 0.0 0.8 44.6 0.1 0.3 0.3 0.2 0.0 1.1 0.8 0.0 0.4 0.4 2.2 1.3 1.5 1.0 0.0 0.4 0.2 0.0 2.0 0.7 3.4 0.7 0.1 0.2 0.2 0.0 10.4 0.0 8.6 0.0 0.1 3.3 0.7 3.0 0.8 0.4 0.6 1.4 0.7 0.3 0.1 3.9 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.9 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.9 0.0 126.7 0.0 0.4 0.8 1.5 1.7 1.3 0.8 0.0 1.5 1.0 0.0 3.4 0.1 0.8 3.9 0.1 0.0 0.0 0.7 4.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.4 1.5 0.0 0.0 0.0 0.1 92.8 1.6 1.9 0.0 1.7 0.3 0.3 0.1 267.8 0.0 0.0 0.0 0.0 1.9 1.1 0.4 0.0 3.5 0.4 0.0 0.2 0.0 0.1 46.4 0.0 0.0 1.2 1.1 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.2 39.2 0.2 0.0 0.0 0.0 1.6 0.2 0.8 10.2 0.0 0.1 0.0 0.1 0.1 3.2 0.2 PHRF1 "KIAA1542, PPP1R125, RNF221" ENSG00000070047 "PHD and ring finger domains 1" Q9P1Y6 11 576470-612222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "white matter: 10.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 24.2;MOLT-4: 39.0;U-138 MG: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019867, HPA062933" Uncertain NA NA "HPA019867: AB_1852416, HPA062933: AB_2684907" "unprognostic (5.67e-2)" "unprognostic (1.00e-2)" "unprognostic (3.94e-2)" "unprognostic (9.65e-2)" "unprognostic (1.79e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.28e-2)" "unprognostic (2.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (3.50e-2)" "unprognostic (2.33e-1)" "unprognostic (3.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" 14.1 17.7 0.0 1.0 1.5 3.1 14.1 0.0 7.1 13.4 0.0 14.2 0.0 13.3 1.3 18.9 13.6 1.1 13.7 2.3 1.6 12.7 26.7 14.6 0.0 0.0 4.3 0.0 14.7 14.5 0.0 14.0 0.0 3.1 14.6 0.0 0.2 14.0 1.2 18.9 21.9 16.4 1.0 0.0 17.8 14.5 18.0 3.4 0.1 13.6 0.0 2.1 12.7 14.5 10.6 2.6 1.6 0.4 7.9 0.0 0.4 1.5 6.2 0.5 0.6 0.0 0.0 0.2 14.8 14.7 0.3 0.3 3.1 0.2 0.0 0.0 4.6 10.5 0.9 0.0 24.2 0.0 1.7 1.6 3.6 0.0 0.0 3.9 0.0 0.3 13.1 3.5 0.0 0.0 0.8 39.0 0.5 1.9 0.2 7.2 1.4 1.5 0.0 0.0 0.3 11.4 1.8 4.3 12.9 0.1 8.9 0.4 5.1 1.2 21.2 7.4 0.5 1.5 2.7 3.7 1.5 0.5 1.2 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.1 0.4 0.5 0.3 0.4 0.4 0.2 0.5 0.3 0.1 0.4 0.3 0.2 0.0 1.5 0.0 7.1 2.3 1.6 0.0 4.3 0.0 3.1 0.0 3.4 10.6 11.5 6.4 11.1 10.1 14.9 17.6 10.1 7.4 18.2 12.2 11.6 7.9 7.8 11.5 8.2 14.7 8.4 8.0 17.1 24.1 0.0 11.6 2.1 14.0 12.9 11.9 11.4 16.0 5.9 10.6 8.0 11.3 23.4 17.7 5.1 14.7 4.6 17.5 9.5 20.2 6.6 14.2 2.0 10.6 11.7 2.8 11.8 13.1 3.6 10.3 11.3 8.2 23.7 4.5 8.4 18.0 12.2 10.5 17.5 12.4 21.8 7.0 12.5 16.0 13.1 14.1 12.2 26.4 28.0 17.4 17.8 8.9 17.2 13.0 14.9 13.6 ELP1 "DYS, IKAP, IKBKAP, IKI3, TOT1" ENSG00000070061 "Elongator complex protein 1" O95163 9 108866898-108934328 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "basophil: 36.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 36.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021340, HPA049677, HPA050686" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216" "prognostic unfavorable (1.57e-4)" "unprognostic (8.71e-2)" "unprognostic (5.13e-2)" "unprognostic (4.21e-2)" "unprognostic (6.44e-2)" "unprognostic (4.49e-2)" "unprognostic (2.76e-2)" "unprognostic (1.55e-1)" "unprognostic (1.67e-1)" "unprognostic (4.02e-2)" "unprognostic (1.10e-2)" "unprognostic (2.80e-2)" "unprognostic (1.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.57e-1)" "unprognostic (2.27e-2)" "unprognostic (4.98e-2)" 12.9 40.1 5.9 6.5 6.3 6.6 13.7 7.0 8.2 21.7 7.9 16.0 5.9 17.2 9.6 13.1 20.1 6.8 17.9 6.0 7.4 13.8 18.5 15.3 9.7 6.6 6.7 6.0 30.2 17.7 29.6 38.4 6.9 8.0 18.2 8.2 25.1 14.9 8.4 15.8 14.9 16.1 9.0 6.1 18.3 15.6 12.1 6.9 9.6 20.2 11.5 8.9 15.6 18.5 6.4 15.6 26.7 19.7 12.8 21.7 21.1 21.1 23.4 15.1 20.8 16.9 31.5 9.2 31.0 12.0 20.2 27.5 35.7 40.7 29.8 25.8 28.6 26.6 15.2 38.2 63.3 18.6 28.7 13.7 18.7 19.1 34.5 26.7 18.0 20.9 33.6 43.1 17.9 22.9 25.3 21.2 13.6 32.1 41.0 34.4 20.7 31.9 18.3 17.3 16.1 26.6 23.9 27.8 23.3 15.7 22.4 33.3 14.1 15.4 10.4 16.2 26.0 25.1 15.5 47.2 13.8 20.0 20.2 19.1 36.6 1.4 2.8 2.9 2.2 4.4 2.2 3.4 4.6 2.4 1.2 3.1 4.0 0.2 4.5 3.3 1.6 2.6 2.1 5.9 6.3 7.0 8.2 6.0 7.4 6.6 6.7 6.0 8.0 6.1 6.9 6.4 7.3 12.8 18.8 0.0 2.9 0.0 0.0 0.0 0.0 0.0 7.7 7.0 0.0 0.0 3.1 14.7 0.0 6.9 5.8 0.0 0.0 5.8 0.0 9.9 10.6 4.7 0.0 0.0 0.0 21.1 6.2 3.8 0.0 9.6 2.5 11.4 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.6 0.0 0.0 2.7 0.0 0.0 6.3 6.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 5.6 2.8 24.4 0.0 0.0 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" P80303 11 17208153-17349980 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 764.8;salivary gland: 778.2" "Cell type enhanced" "Detected in all" "Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 1867.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 690000 "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 56.7 76.4 25.4 62.7 29.0 625.4 142.6 30.2 32.4 138.4 55.2 69.0 57.9 61.3 462.3 147.7 108.1 61.4 91.8 24.4 34.6 43.6 103.1 50.3 60.7 28.4 26.1 23.3 56.5 764.8 483.0 113.9 91.7 28.3 71.6 69.0 65.1 778.2 192.7 38.8 21.2 41.1 79.1 27.7 42.6 93.8 120.2 28.4 337.3 155.2 30.7 79.2 62.4 45.3 28.4 119.9 49.0 53.7 163.4 118.9 162.3 65.0 260.5 381.0 115.1 203.0 48.7 26.8 182.9 63.5 250.7 107.1 50.1 34.4 66.8 178.7 126.7 76.3 135.8 57.8 85.2 340.5 1867.0 238.6 71.1 86.8 82.9 200.9 284.9 143.3 672.1 120.1 361.1 114.9 105.9 656.2 670.3 12.9 194.0 50.5 239.8 130.4 15.1 51.9 37.5 63.5 35.4 114.6 114.2 61.4 78.0 93.5 498.1 128.1 120.9 110.9 369.1 112.1 70.3 41.3 101.1 140.5 646.1 106.4 210.5 43.5 168.2 94.1 30.5 122.9 22.7 88.5 173.7 40.6 14.5 246.7 271.2 39.3 277.9 25.6 426.0 42.7 119.8 25.4 29.0 30.2 32.4 24.4 34.6 28.4 26.1 23.3 28.3 27.7 28.4 28.4 118.7 44.8 70.4 16.3 54.8 27.5 60.2 156.3 14.8 71.0 152.8 87.0 193.8 55.8 176.5 42.3 54.2 127.1 136.5 17.6 27.4 91.1 690.6 112.4 92.9 94.7 42.4 137.8 21.9 132.6 319.1 148.8 40.2 97.0 67.6 80.0 108.5 141.8 70.7 35.3 23.5 189.0 189.2 29.4 40.0 508.5 149.8 37.6 69.4 18.7 24.1 111.2 95.8 13.6 10.8 75.2 13.2 114.3 256.5 108.7 3.9 28.5 618.8 99.3 46.0 50.8 75.4 174.9 61.3 87.7 30.1 1158.2 92.3 88.3 45.3 61.2 PFN2 ENSG00000070087 "Profilin 2" P35080 3 149964904-150050788 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 461.8;Ionocytes: 231.9;Muller glia cells: 289.3;Proximal tubular cells: 198.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035611, CAB037073" Enhanced NA NA 19000 "CAB037073: AB_1079600, HPA035611: AB_10672870" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.42e-4)" "prognostic unfavorable (2.19e-7)" "unprognostic (4.11e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-2)" "unprognostic (2.96e-3)" "unprognostic (4.86e-3)" "unprognostic (6.82e-2)" "unprognostic (1.25e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.99e-1)" 27.6 39.5 196.0 19.9 229.5 3.1 36.2 170.7 252.8 40.6 178.5 38.8 25.4 61.5 153.1 25.3 97.9 36.1 46.1 280.9 215.2 117.0 25.2 20.4 7.3 185.0 180.9 217.5 61.0 38.1 79.9 62.2 21.6 192.1 66.8 27.7 156.3 49.4 65.3 257.4 13.5 34.7 59.3 182.3 16.4 38.7 27.6 185.4 28.7 100.4 90.7 10.2 52.6 32.7 224.2 556.7 189.8 446.3 184.0 97.5 330.3 119.1 174.0 262.9 268.3 310.1 71.2 435.7 0.1 357.8 383.1 457.2 5.7 187.0 247.5 386.7 17.8 111.3 6.5 94.7 206.0 130.1 31.3 8.8 209.1 205.4 263.9 341.5 285.9 159.3 87.9 1.6 21.3 282.9 206.0 27.3 1.5 195.0 3.7 248.1 31.1 321.7 2.6 200.8 278.6 241.6 248.8 86.4 41.1 239.6 306.6 65.3 4.5 116.1 127.2 177.3 214.1 228.4 28.5 2.3 14.7 275.3 1.8 159.2 1.7 0.2 0.4 2.2 0.1 4.7 2.0 4.8 4.1 0.1 1.0 7.3 4.4 1.2 1.4 0.0 0.2 1.4 2.1 196.0 229.5 170.7 252.8 280.9 215.2 185.0 180.9 217.5 192.1 182.3 185.4 224.2 16.2 6.4 6.9 26.4 4.5 9.8 52.4 106.0 100.2 52.1 54.3 37.0 48.3 32.9 47.3 136.1 18.8 11.9 1.9 12.8 461.8 42.1 57.6 75.5 28.3 22.6 121.2 0.0 65.0 27.3 11.5 54.7 7.7 10.6 8.2 39.5 25.4 12.3 3.2 26.9 33.8 27.9 231.9 1.2 9.3 27.2 74.0 2.9 35.6 15.9 4.8 289.3 1.0 21.6 30.3 14.9 19.4 96.7 3.4 57.9 103.2 198.2 116.4 42.2 13.1 52.7 71.8 28.5 19.2 51.5 7.5 10.3 5.0 55.8 30.5 37.7 PTPN3 PTPH1 ENSG00000070159 "Protein tyrosine phosphatase non-receptor type 3" P26045 9 109375466-109498313 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 64.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 48.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 26.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 29.4;RPTEC TERT1: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038343, HPA046728" Approved NA NA "HPA038343: AB_10671741, HPA046728: AB_2679776" "prognostic unfavorable (6.71e-4)" "unprognostic (3.48e-1)" "unprognostic (3.64e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (3.71e-2)" "unprognostic (5.38e-2)" "unprognostic (6.37e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.22e-15)" "unprognostic (1.64e-2)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (8.21e-2)" 4.0 2.2 7.1 1.7 2.6 0.1 7.6 0.6 2.5 6.7 6.8 9.6 12.5 2.3 17.8 13.3 10.2 2.7 19.0 2.7 4.1 23.2 29.7 5.8 1.1 0.4 15.3 2.2 0.6 15.0 10.8 2.9 7.3 1.4 5.9 10.2 2.5 8.6 5.1 64.0 30.4 13.0 1.5 0.4 0.3 9.8 3.2 26.9 3.6 10.2 47.3 4.4 4.2 7.3 2.9 11.1 13.5 0.5 3.5 0.0 0.0 21.1 2.3 0.0 2.9 3.2 7.2 17.7 0.0 2.4 0.1 7.3 25.8 3.7 15.2 2.9 6.2 8.2 0.0 6.2 7.5 0.1 0.0 0.1 0.2 16.0 3.6 7.7 1.2 0.0 4.5 0.0 0.1 0.2 14.0 19.3 3.3 1.6 29.4 10.0 0.1 4.4 0.3 34.0 21.1 8.6 1.8 5.9 21.8 0.0 7.1 12.5 1.8 0.1 1.0 8.2 1.4 0.0 10.4 18.2 0.0 11.2 0.0 7.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 7.1 2.6 0.6 2.5 2.7 4.1 0.4 15.3 2.2 1.4 0.4 26.9 2.9 0.4 16.0 28.4 0.7 0.5 11.9 25.9 19.3 4.0 13.4 7.8 8.6 48.6 24.3 24.7 31.3 0.0 23.6 0.1 30.0 17.6 14.5 21.5 27.6 3.1 3.3 13.1 0.0 16.1 19.2 23.7 1.8 15.8 38.4 1.3 0.9 4.6 36.3 2.6 0.0 5.2 18.7 8.2 0.0 1.8 18.5 1.2 0.8 3.6 1.0 0.7 0.3 1.0 0.5 0.6 29.1 24.0 1.9 0.2 26.1 27.9 19.2 28.4 2.2 6.6 3.2 6.0 1.6 10.4 7.0 20.6 10.8 0.8 0.4 18.4 29.0 SPTB ENSG00000070182 "Spectrin beta, erythrocytic" P11277 14 64746283-64879907 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 63.1;skeletal muscle: 125.1;tongue: 70.5" "Cell type enhanced" "Detected in some" "Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 39.2;K-562: 47.8;U-937: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003394, HPA003398, CAB015169, CAB016232" Enhanced Approved Cytosol NA NA 7800000 Cytosol "CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074" "unprognostic (2.69e-1)" "unprognostic (4.72e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-3)" "unprognostic (2.66e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-2)" "unprognostic (2.97e-1)" "unprognostic (3.44e-2)" "unprognostic (2.18e-2)" 2.2 1.5 6.5 0.2 10.6 63.1 0.3 28.5 11.6 0.3 22.5 0.2 0.1 0.2 5.3 2.0 0.5 0.4 22.9 11.3 6.4 1.0 0.1 0.4 0.0 24.7 8.6 5.9 0.2 2.6 11.1 5.3 6.7 28.8 1.5 0.1 1.6 2.2 1.1 125.1 0.2 0.2 0.8 4.7 0.8 0.2 0.8 12.1 0.4 0.1 70.5 0.0 0.2 0.2 31.4 0.3 1.5 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.3 2.3 6.3 0.2 0.0 0.4 3.7 39.2 0.3 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 1.4 47.8 0.0 0.0 0.3 0.0 0.3 0.0 0.5 2.1 0.0 0.0 0.2 0.0 0.2 6.1 2.6 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.3 6.7 0.0 0.6 1.5 7.7 0.0 0.1 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.5 10.6 28.5 11.6 11.3 6.4 24.7 8.6 5.9 28.8 4.7 12.1 31.4 0.1 0.0 0.0 0.7 0.0 0.8 0.7 0.6 0.0 10.3 0.5 0.1 6.3 1.5 0.7 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.4 0.4 0.9 0.4 3.0 81.0 16.0 0.2 0.3 0.8 0.0 0.9 2.5 0.2 0.0 0.0 0.2 16.8 32.1 0.3 0.0 0.0 0.4 0.4 0.3 0.3 1.8 1.9 0.0 5.0 1.0 11.1 2.1 0.3 0.0 1.2 0.1 0.7 0.0 0.2 0.0 2.6 6.6 11.6 3.8 0.1 1.1 0.5 0.4 0.1 0.6 0.4 0.1 0.6 DAPP1 BAM32 ENSG00000070190 "Dual adaptor of phosphotyrosine and 3-phosphoinositides 1" Q9UN19 4 99816827-99870190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.5;lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" "B-cells: 92.0;Langerhans cells: 188.5;monocytes: 235.5;Respiratory ciliated cells: 88.6;Urothelial cells: 221.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 61.2;RPMI-8226: 70.2;SK-BR-3: 30.6;U-698: 46.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033822, HPA046074" Approved NA NA 56000 "CAB033822: AB_2245677, HPA046074: AB_2679525" "unprognostic (9.30e-2)" "unprognostic (1.36e-1)" "unprognostic (1.77e-2)" "unprognostic (9.96e-2)" "unprognostic (3.48e-1)" "unprognostic (1.14e-1)" "unprognostic (1.68e-1)" "unprognostic (9.09e-2)" "unprognostic (4.71e-1)" "unprognostic (5.13e-2)" "unprognostic (4.01e-3)" "unprognostic (2.24e-1)" "unprognostic (8.45e-5)" "unprognostic (2.88e-1)" "unprognostic (3.91e-2)" "unprognostic (9.32e-2)" "unprognostic (4.60e-2)" 1.6 1.0 0.5 22.8 0.9 15.7 3.7 0.5 0.9 3.6 0.9 3.1 2.1 8.4 1.0 29.5 5.2 12.0 0.5 0.5 1.0 0.7 1.5 6.4 34.9 1.0 0.7 0.5 0.4 0.4 0.2 0.2 6.8 1.0 2.8 3.3 0.1 8.6 0.8 0.9 13.8 6.3 13.6 1.1 16.7 6.6 0.4 0.7 10.3 0.6 1.3 38.8 15.0 13.0 1.5 22.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 22.5 23.8 0.3 0.0 0.1 12.8 0.0 25.3 0.0 61.2 0.0 24.3 0.0 0.0 0.0 9.4 1.0 0.0 11.3 0.0 7.5 0.0 0.0 1.0 1.2 21.7 0.0 0.2 0.1 6.7 0.0 0.0 0.4 0.1 0.1 70.2 4.6 16.3 0.1 0.0 0.0 30.6 0.0 0.2 0.4 10.1 0.0 0.0 0.4 0.0 0.1 8.3 3.2 46.4 0.1 6.5 0.0 25.0 70.2 71.0 2.3 62.6 2.5 90.9 11.4 4.0 75.9 98.7 12.5 4.5 138.1 17.8 57.3 32.4 25.2 65.3 0.5 0.9 0.5 0.9 0.5 1.0 1.0 0.7 0.5 1.0 1.1 0.7 1.5 0.3 3.2 3.0 0.0 92.0 61.8 30.2 51.4 16.5 0.1 10.1 5.0 0.8 2.8 43.2 9.2 0.0 2.6 13.3 8.4 0.0 6.2 0.3 37.1 0.8 1.2 1.2 9.4 0.4 3.1 14.1 1.4 14.8 9.0 8.2 0.2 0.7 0.7 25.1 0.0 0.1 1.8 22.4 32.0 188.5 0.9 0.0 86.0 12.4 5.6 235.5 0.0 7.2 0.0 0.1 18.9 17.6 0.0 60.2 24.3 0.2 0.1 88.6 0.2 0.0 0.9 4.2 0.2 0.5 40.4 70.3 3.4 17.2 0.1 2.2 221.2 FGF10 ENSG00000070193 "Fibroblast growth factor 10" O15520 5 44300247-44389706 "Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Disease variant, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.4" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 21.6;Fibroblasts: 14.6;Leydig cells: 8.4;Muller glia cells: 4.3;Peritubular cells: 10.5" "Cancer enriched" "Detected in some" 6 "breast cancer: 5.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AF22: 27.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB010315 Uncertain "Secreted in other tissues" NA NA "CAB010315: AB_2262731" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (8.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.54e-2)" "unprognostic (4.06e-3)" "unprognostic (2.72e-2)" "unprognostic (6.73e-2)" "unprognostic (5.59e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.14e-2)" "unprognostic (5.23e-4)" 10.2 1.6 0.3 2.6 1.2 0.0 15.3 0.4 0.6 14.2 1.3 5.2 0.4 2.4 4.5 1.4 8.6 2.8 0.6 0.5 2.1 0.4 0.1 2.7 0.6 1.3 1.2 0.4 17.4 4.9 0.0 2.1 5.6 0.5 4.6 1.5 0.3 5.5 3.0 0.7 0.8 2.9 1.3 1.1 0.0 4.3 0.8 1.3 1.1 5.3 3.9 0.2 5.0 12.1 0.8 0.0 0.0 27.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.4 0.6 0.5 2.1 1.3 1.2 0.4 0.5 1.1 1.3 0.8 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 21.6 0.9 0.0 0.0 3.0 0.5 0.0 14.6 0.0 0.3 0.0 1.6 0.4 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.5 8.4 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.3 0.0 10.5 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 SLC44A1 "CD92, CDW92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 289.4" "Cell type enriched" "Detected in all" 8 "Oligodendrocytes: 2444.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 285.9;ASC TERT1: 224.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064714, HPA074007" Enhanced Supported Nucleoplasm,Mitochondria NA NA 99000 Mitochondria Nucleoplasm "HPA064714: AB_2685334, HPA074007: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favorable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 17.1 13.4 118.0 13.1 196.0 11.5 26.5 170.0 138.6 16.9 83.5 50.7 22.8 16.0 32.7 18.5 15.4 20.4 12.9 117.5 141.3 22.0 38.3 18.6 9.8 197.1 173.5 95.6 14.2 15.3 23.4 5.4 23.5 195.3 11.9 49.5 14.2 9.6 25.3 9.5 21.6 27.2 17.4 177.3 9.6 35.5 3.6 159.7 13.7 44.0 20.4 15.6 22.0 15.7 289.4 29.0 23.8 6.4 7.9 285.9 224.1 20.3 23.9 61.7 15.1 20.2 25.6 74.8 38.4 12.0 90.2 17.1 56.1 19.3 34.4 25.7 34.0 15.7 47.8 15.8 32.0 19.3 9.6 23.7 125.3 27.6 29.0 26.1 38.8 48.6 19.7 1.4 77.1 17.3 40.8 38.8 10.9 35.9 51.1 22.9 8.0 24.7 29.3 20.9 66.6 30.6 12.0 33.4 36.5 33.3 37.8 36.2 28.7 41.9 15.1 13.5 16.5 17.7 59.1 41.7 28.4 29.2 20.6 20.2 1.7 3.3 0.7 0.7 1.2 0.4 1.1 0.7 0.4 2.2 2.0 0.8 0.3 0.5 5.3 0.7 0.8 0.8 0.9 118.0 196.0 170.0 138.6 117.5 141.3 197.1 173.5 95.6 195.3 177.3 159.7 289.4 48.6 35.3 26.5 83.2 22.2 70.6 36.0 28.3 75.1 10.3 76.9 27.2 10.1 67.2 19.9 106.7 235.6 53.3 7.6 296.5 3.9 17.5 2.9 59.2 40.3 45.2 157.2 20.4 174.2 36.5 12.1 64.0 84.1 175.2 100.1 16.7 48.9 170.0 21.3 6.7 108.1 160.0 14.2 46.5 46.5 6.1 110.0 48.6 74.7 81.5 91.0 9.0 13.4 257.3 2444.2 36.9 161.2 79.7 162.9 23.8 95.4 27.1 31.4 53.3 39.5 43.8 34.9 2.3 4.4 86.9 74.3 70.6 20.3 12.1 199.1 34.8 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 40.1" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Excitatory neurons: 66.7;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 4.7 4.4 4.3 4.0 5.3 2.1 5.5 4.6 5.4 40.1 10.9 5.8 5.3 6.3 7.9 3.4 7.5 5.9 2.5 4.2 4.4 6.9 5.6 4.5 4.8 4.3 4.3 4.5 9.4 4.6 7.3 3.7 5.7 4.3 5.3 5.8 7.0 3.8 4.5 2.2 5.7 5.8 3.9 4.1 4.1 5.6 5.2 4.5 5.8 8.5 2.2 3.9 4.8 3.7 7.1 8.0 5.5 4.2 8.9 14.5 11.9 8.2 8.4 9.2 5.4 6.4 2.6 5.8 6.5 8.0 6.2 6.1 9.1 9.7 6.1 8.4 8.1 4.9 4.2 2.7 3.6 10.2 5.9 9.6 14.6 10.7 3.0 10.3 9.8 7.1 4.9 5.2 6.8 7.1 5.3 3.1 2.2 3.9 13.0 8.6 4.3 6.7 2.2 9.0 11.7 8.8 4.3 9.4 6.7 5.5 7.8 8.6 9.0 10.0 10.9 4.1 8.2 4.2 4.1 3.5 3.8 6.8 4.3 5.5 0.0 1.1 1.2 1.3 0.8 0.9 0.7 0.8 0.7 0.9 0.7 1.2 0.8 0.5 2.5 0.7 1.9 1.3 0.8 4.3 5.3 4.6 5.4 4.2 4.4 4.3 4.3 4.5 4.3 4.1 4.5 7.1 12.2 19.2 17.2 39.8 13.0 5.4 7.1 5.9 5.7 14.6 8.0 7.7 3.7 2.8 8.5 22.0 4.2 10.2 9.8 9.4 1.9 8.1 88.5 22.8 17.6 8.3 18.0 7.6 66.7 3.8 7.7 10.4 9.2 29.1 12.0 20.0 8.9 13.3 6.5 6.7 62.8 10.0 6.1 12.8 5.0 31.5 15.2 8.7 1.8 39.4 11.1 5.2 14.4 69.9 106.0 5.6 7.6 10.9 9.3 9.3 9.5 4.8 14.2 16.4 0.0 7.0 8.0 9.3 11.0 10.0 5.5 11.1 8.9 14.5 12.1 8.0 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6 nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303785 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 11.2 13.1 14.8 12.5 14.2 13.8 10.6 16.4 14.7 15.2 11.9 10.9 9.4 26.9 11.2 16.6 21.9 17.3 13.8 13.5 17.5 11.3 7.5 12.0 12.4 20.3 14.7 12.5 37.9 7.5 14.5 13.4 10.6 15.3 14.0 9.5 19.3 10.5 12.9 13.0 16.1 10.9 19.1 11.4 9.9 9.7 19.7 16.1 23.3 11.8 9.2 11.0 13.2 12.1 16.5 14.9 22.5 31.7 20.6 33.6 27.0 16.3 23.6 25.9 26.3 22.2 27.6 7.3 15.7 8.3 34.8 12.0 21.3 23.5 20.1 27.4 15.7 14.7 15.3 11.8 13.5 19.2 8.2 10.5 38.5 14.5 21.2 18.6 42.6 24.3 15.3 12.8 18.5 19.9 11.7 20.8 6.6 10.2 8.9 11.7 21.4 20.2 6.2 15.2 13.5 5.3 16.1 24.6 7.1 10.2 22.2 11.1 6.0 32.2 24.0 13.1 25.6 25.1 16.0 10.5 7.2 19.1 9.1 14.0 3.0 0.7 0.8 1.3 0.3 1.3 0.5 1.1 1.3 0.4 0.7 1.5 1.1 0.5 2.0 1.6 1.3 0.6 0.6 14.8 14.2 16.4 14.7 13.5 17.5 20.3 14.7 12.5 15.3 11.4 16.1 16.5 17.2 22.4 18.4 41.4 13.2 7.9 13.8 13.1 10.2 35.6 13.8 14.5 8.0 7.2 11.8 14.7 75.0 16.5 17.7 17.9 5.9 13.8 22.5 19.4 37.1 20.3 4.2 12.8 57.1 12.4 10.7 21.0 18.3 21.3 10.8 20.3 17.9 9.1 10.3 47.1 61.7 14.4 16.2 8.7 6.8 36.9 16.8 10.6 8.8 81.5 15.9 24.8 21.6 44.7 64.3 17.2 15.2 19.9 14.6 14.7 10.1 7.6 17.9 50.5 26.3 27.1 20.4 63.7 59.0 15.1 8.7 17.4 24.9 22.4 13.5 14.2 EXOC5 "SEC10, SEC10L1, SEC10P" ENSG00000070367 "Exocyst complex component 5" O00471 14 57200507-57268905 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060837 Approved NA NA "HPA060837: AB_2684375" "unprognostic (2.95e-2)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (6.84e-2)" "unprognostic (5.05e-2)" "unprognostic (3.38e-1)" "unprognostic (9.47e-3)" "unprognostic (2.82e-2)" "unprognostic (9.14e-2)" "unprognostic (4.42e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.38e-1)" "unprognostic (7.92e-2)" "unprognostic (2.98e-2)" 9.0 6.4 5.8 6.7 6.6 5.1 5.1 6.9 7.0 4.5 7.2 4.8 5.7 4.8 5.0 6.6 4.5 4.8 5.3 5.6 6.5 7.7 8.5 6.7 7.2 6.8 6.9 3.9 4.7 3.7 6.9 3.4 7.7 7.9 5.7 4.5 9.9 5.5 4.9 5.8 5.6 5.9 6.4 6.1 8.0 5.8 11.2 6.5 8.8 7.5 6.0 6.7 5.8 3.8 9.0 21.7 13.4 26.3 13.4 17.4 17.1 20.1 33.1 15.6 12.3 14.3 12.6 13.4 31.9 19.6 17.9 12.5 17.3 16.3 13.5 19.1 37.7 9.6 20.4 9.9 9.6 16.1 25.2 25.7 10.3 14.0 12.1 13.5 16.2 22.6 22.4 19.9 23.5 25.0 9.8 34.2 5.7 14.2 12.4 23.8 23.9 38.7 11.8 15.4 17.7 20.4 17.5 26.8 10.7 16.4 22.1 19.9 12.2 24.9 26.7 29.9 17.1 16.5 12.0 15.9 26.7 24.5 14.1 17.5 6.8 5.1 6.1 4.8 5.5 5.9 5.6 4.9 5.2 6.3 5.8 5.4 4.7 2.8 6.3 5.2 3.2 6.3 6.8 5.8 6.6 6.9 7.0 5.6 6.5 6.8 6.9 3.9 7.9 6.1 6.5 9.0 32.1 25.6 18.6 34.3 26.7 22.6 23.1 18.8 22.2 32.2 23.4 13.2 28.3 21.5 24.2 14.7 29.2 17.4 24.2 17.1 17.6 18.6 130.7 29.4 32.5 35.7 34.6 34.7 56.2 17.3 19.4 27.5 21.9 23.2 34.9 20.6 45.0 38.6 21.6 63.9 56.5 17.0 32.6 31.5 34.1 108.6 23.6 31.4 21.4 38.4 34.3 28.6 23.7 49.3 71.9 25.2 10.8 35.7 27.7 24.7 11.1 41.1 29.4 30.2 19.7 31.1 33.9 128.6 53.2 32.8 30.0 18.7 26.0 34.6 15.3 20.1 CLTCL1 "CHC22, CLH22, CLTCL, CLTD" ENSG00000070371 "Clathrin heavy chain like 1" P53675 22 19179473-19291719 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 188.9;testis: 47.6;tongue: 61.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 2.1;neutrophil: 5.2" "Group enriched" "Detected in many" 20 "granulocytes: 5.2;monocytes: 2.1" "Cell line enhanced" "Detected in many" "HMC-1: 64.8;K-562: 31.8" "HPA075327, HPA075795" Enhanced Approved Vesicles NA NA 2300000 Vesicles "HPA075327: , HPA075795: AB_2686764" "unprognostic (1.29e-2)" "unprognostic (3.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.16e-3)" "unprognostic (8.20e-2)" "unprognostic (6.93e-3)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (4.42e-2)" "unprognostic (2.93e-3)" "unprognostic (3.14e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "unprognostic (8.71e-4)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" "unprognostic (1.06e-1)" 6.0 16.2 5.1 0.8 5.5 15.8 4.9 5.9 5.7 4.4 4.5 2.4 0.5 3.2 1.6 3.6 3.9 1.2 12.0 4.8 6.3 3.2 6.6 3.0 0.8 7.1 7.7 4.4 3.7 2.5 2.1 13.5 1.5 7.5 5.3 1.0 2.0 3.9 0.8 188.9 3.9 1.8 1.7 5.1 3.5 2.8 47.6 8.4 4.0 8.0 61.9 0.5 2.8 3.7 6.5 4.5 4.6 3.0 4.9 10.8 5.9 1.4 3.1 3.3 4.2 6.3 1.7 1.4 1.9 0.4 7.0 3.3 1.5 4.7 8.5 3.5 0.3 4.6 0.2 4.4 5.3 5.5 6.5 64.8 25.0 7.0 7.8 10.9 12.5 2.7 2.4 31.8 1.7 10.0 3.6 0.6 22.4 3.8 18.1 2.8 2.4 24.2 0.1 3.4 1.8 6.9 1.2 6.6 4.1 0.4 3.6 8.9 27.1 0.8 7.6 15.5 4.2 5.2 3.1 8.4 0.8 4.5 17.4 1.6 0.0 2.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.4 5.1 5.5 5.9 5.7 4.8 6.3 7.1 7.7 4.4 7.5 5.1 8.4 6.5 1.4 3.2 0.5 9.4 0.1 0.6 0.5 1.0 1.2 2.4 0.7 0.3 11.3 1.5 1.8 0.0 14.6 0.4 0.2 1.2 0.0 0.8 19.3 1.2 1.9 0.9 0.0 0.8 4.5 0.0 0.2 1.4 1.5 1.4 0.0 3.5 1.1 2.4 0.3 0.0 8.9 1.3 6.1 1.0 0.7 17.0 2.5 0.5 0.0 4.7 1.3 1.5 0.0 12.5 12.5 1.2 0.8 4.1 0.1 1.3 0.2 1.3 1.0 2.0 0.0 2.6 4.5 14.5 4.7 1.0 0.9 1.1 0.1 6.2 0.9 0.0 FGF22 ENSG00000070388 "Fibroblast growth factor 22" Q9HCT0 19 639879-644371 "Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;skin 1: 12.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.4;Horizontal cells: 13.5;Muller glia cells: 4.7;Rod photoreceptor cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-3)" "unprognostic (1.04e-2)" "unprognostic (1.17e-1)" "unprognostic (5.25e-4)" "unprognostic (1.16e-1)" "unprognostic (3.66e-3)" "unprognostic (2.85e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-4)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (3.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (8.36e-2)" 0.4 0.3 2.4 0.0 2.4 0.0 0.6 2.2 5.0 0.7 1.1 0.5 0.2 0.6 0.0 0.5 1.0 0.0 0.2 2.3 1.9 0.3 0.2 0.3 0.0 2.4 2.4 2.4 2.9 0.2 0.0 0.6 0.0 2.6 1.1 0.0 0.1 0.6 0.1 0.7 12.6 0.4 0.0 1.5 0.2 0.6 1.1 2.5 0.0 0.2 0.0 0.0 0.9 0.9 2.7 0.2 0.3 0.1 1.9 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.7 0.0 0.0 0.3 0.1 0.2 0.4 0.7 0.5 0.0 0.1 0.0 0.3 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.2 0.1 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.4 2.2 5.0 2.3 1.9 2.4 2.4 2.4 2.6 1.5 2.5 2.7 0.6 3.2 0.0 1.0 0.6 0.8 1.3 0.0 0.0 8.4 0.5 0.6 1.4 1.5 0.1 0.0 0.0 0.4 1.2 0.6 0.0 0.1 0.6 0.6 0.6 0.5 0.0 0.4 1.6 0.0 0.4 1.1 0.0 1.0 0.0 0.5 0.7 0.4 0.2 13.5 0.9 0.5 0.0 0.0 1.0 0.2 0.3 0.1 1.8 0.0 0.2 4.7 0.0 0.0 1.6 0.4 0.1 0.0 0.7 1.5 0.8 0.5 0.2 6.4 0.0 1.9 0.9 1.1 2.0 0.0 1.0 3.4 1.6 0.2 0.5 0.6 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676392-683392 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 3647.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 164.7;hTCEpi: 181.2;SiHa: 341.5;U-2197: 173.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Supported Nucleoplasm "Secreted in other tissues" NA Yes 7000000 Nucleoplasm "CAB024899: , HPA045378: AB_2679300" "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 80.9 164.6 15.2 24.4 14.2 13.5 62.9 12.4 20.0 74.8 15.3 64.3 7.7 62.5 6.1 22.1 70.8 16.6 125.1 15.1 18.6 45.8 26.4 133.9 5.5 21.0 14.0 12.5 64.3 49.7 3.2 29.1 180.8 18.0 75.5 6.0 2.4 21.3 22.3 11.7 31.1 36.8 42.8 15.6 22.8 43.5 75.8 15.9 2.3 38.2 4.9 1.6 71.1 63.7 17.1 9.5 74.0 5.1 3.7 22.3 56.4 164.7 126.1 18.5 30.7 11.3 27.1 14.4 4.1 49.4 84.7 17.6 65.2 4.1 106.4 10.1 7.8 8.7 3.5 110.2 22.4 95.6 6.7 12.0 70.7 181.2 34.0 140.2 79.3 5.5 3.9 8.2 5.3 46.7 33.1 2.4 4.0 6.2 62.0 26.2 7.2 3.4 8.7 43.1 1.7 3.3 5.7 341.5 6.9 4.3 6.4 6.2 3.5 75.5 30.6 106.6 173.4 46.9 8.5 4.4 2.3 4.7 20.0 14.2 0.0 1.9 0.0 0.4 1.8 0.0 0.1 0.6 0.4 0.9 0.3 1.0 0.6 0.0 0.2 1.4 0.3 0.0 0.9 15.2 14.2 12.4 20.0 15.1 18.6 21.0 14.0 12.5 18.0 15.6 15.9 17.1 4.6 19.2 1.9 40.5 1.5 14.5 31.0 11.7 1.8 1.3 11.3 7.9 16.7 32.9 4.4 9.2 0.0 53.9 1.0 1.1 7.9 86.1 8.8 6.4 14.8 8.7 1.2 1.7 9.8 64.3 3647.6 59.6 2.0 18.3 0.0 5.7 16.4 1.9 77.1 3.3 8.4 1.0 0.0 3.7 4.8 7.6 61.2 7.4 5.4 2.8 10.6 6.6 1.0 6.0 5.5 306.5 0.2 26.7 1.0 78.0 1.2 17.7 3.1 1.1 46.0 22.4 57.0 4.6 5.6 4.3 7.7 792.0 2.0 3.6 2.5 30.7 DGCR2 "DGS-C, IDD, KIAA0163, LAN, SEZ-12" ENSG00000070413 "DiGeorge syndrome critical region gene 2" P98153 22 19036282-19122454 "Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000873 Uncertain NA NA 84000 "HPA000873: AB_1847632" "unprognostic (1.68e-1)" "unprognostic (4.27e-2)" "unprognostic (4.03e-2)" "unprognostic (1.33e-2)" "unprognostic (6.28e-2)" "unprognostic (8.51e-2)" "unprognostic (1.05e-1)" "unprognostic (6.86e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.72e-7)" "unprognostic (3.63e-2)" "unprognostic (2.29e-1)" "unprognostic (6.27e-2)" "unprognostic (6.28e-3)" 23.4 28.8 43.4 15.1 38.1 7.5 26.7 32.1 47.5 29.5 22.3 32.8 26.5 33.2 13.0 46.9 28.0 19.2 29.4 42.4 40.4 31.3 30.9 28.9 17.0 43.5 42.6 40.5 36.2 45.0 26.6 33.3 16.5 41.8 35.0 16.2 9.2 34.0 23.7 27.5 61.1 29.1 15.8 34.9 25.7 30.5 25.5 45.1 16.8 40.1 19.7 12.6 31.4 32.3 36.6 43.2 26.5 32.6 58.3 57.9 23.2 31.8 28.3 34.8 27.2 26.8 45.7 47.9 22.7 38.7 30.7 19.4 79.7 24.2 27.2 11.4 19.4 44.4 15.3 16.0 37.0 35.1 28.8 33.4 33.3 61.6 21.1 24.3 23.4 30.3 14.2 115.6 19.3 14.0 45.0 15.2 31.0 27.3 67.8 19.1 26.5 34.4 8.9 46.2 46.8 44.4 32.8 52.1 36.0 32.6 17.6 33.5 25.9 27.0 50.0 25.6 26.3 23.1 21.5 8.5 14.9 23.7 16.5 38.9 9.5 10.3 16.5 6.1 5.3 5.3 4.3 6.5 6.1 6.8 4.7 7.8 6.4 23.5 4.6 3.9 4.0 9.5 11.3 43.4 38.1 32.1 47.5 42.4 40.4 43.5 42.6 40.5 41.8 34.9 45.1 36.6 16.4 19.2 27.0 34.3 10.0 9.7 10.8 17.1 17.6 30.1 23.4 20.6 18.0 30.0 23.3 27.6 14.6 17.2 9.5 59.7 0.0 24.9 13.7 9.6 11.2 13.7 19.9 4.2 35.7 21.9 19.0 13.5 27.0 16.9 8.2 24.5 21.4 27.3 12.1 37.0 43.7 30.3 18.3 18.5 4.7 22.2 17.1 10.4 8.8 22.5 16.4 18.5 11.3 54.8 32.6 30.9 24.0 22.6 11.1 18.8 27.7 10.6 14.0 23.0 13.1 14.4 15.1 12.6 12.9 22.1 12.4 10.8 11.8 17.7 28.4 16.8 RNF126 FLJ20552 ENSG00000070423 "Ring finger protein 126" Q9BV68 19 647526-663233 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043050 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043050: AB_10794768" "unprognostic (2.24e-1)" "unprognostic (1.64e-1)" "unprognostic (1.97e-1)" "unprognostic (2.48e-3)" "unprognostic (1.90e-1)" "unprognostic (2.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (9.96e-3)" "unprognostic (7.04e-3)" "unprognostic (3.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 21.1 23.6 8.0 16.2 9.0 22.0 21.9 6.6 17.2 17.6 0.9 25.6 21.8 20.9 2.7 42.6 19.3 4.6 24.3 9.7 6.9 20.7 40.6 19.4 14.2 9.5 7.8 8.8 16.9 23.2 6.9 20.3 8.8 9.7 20.4 4.9 4.4 21.2 7.0 62.1 45.1 27.4 4.9 5.8 30.8 24.5 49.8 8.0 10.1 14.8 12.9 5.9 21.8 24.2 12.7 79.7 26.5 21.0 30.6 4.8 6.7 38.5 40.6 15.0 22.5 21.2 52.1 26.9 64.2 25.9 16.5 8.9 51.7 12.6 30.0 6.2 43.8 98.8 32.7 24.5 47.0 18.2 64.9 46.0 11.3 22.9 18.5 14.3 9.0 20.6 51.8 68.5 63.4 12.0 62.9 67.7 35.0 62.4 22.5 50.6 48.9 18.1 102.0 17.0 43.6 52.0 42.1 30.1 39.8 42.4 7.2 25.3 51.5 28.6 40.6 30.6 62.1 71.1 112.3 59.5 77.6 52.1 39.2 43.0 3.7 14.7 12.3 25.1 18.4 21.1 23.9 23.1 24.7 19.0 25.5 17.7 16.6 3.7 27.7 22.6 21.5 28.3 14.8 8.0 9.0 6.6 17.2 9.7 6.9 9.5 7.8 8.8 9.7 5.8 8.0 12.7 34.2 12.8 7.4 9.1 66.9 137.9 61.2 44.3 45.5 31.4 35.7 39.6 27.6 27.1 23.2 9.2 16.7 72.8 74.8 60.9 54.8 60.6 146.4 20.2 17.8 31.0 21.7 37.8 11.9 75.6 139.2 29.3 40.2 22.7 14.7 23.1 22.9 22.9 43.2 32.0 9.9 39.3 26.4 26.7 58.9 36.8 21.5 32.9 42.7 3.7 47.5 32.7 112.3 7.1 15.7 136.2 70.0 19.5 76.5 98.2 68.1 40.8 14.8 24.6 59.2 22.0 40.5 153.6 65.3 74.4 144.8 88.1 60.7 43.2 58.1 87.0 MNT "bHLHd3, lncRNA-HAL, MAD6, MXD6, ROX" ENSG00000070444 "MAX network transcriptional repressor" Q99583 17 2384073-2401104 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Urothelial cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059532, HPA067578" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059532: AB_2684053, HPA067578: AB_2685864" "unprognostic (3.72e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (5.30e-3)" "unprognostic (1.31e-2)" "unprognostic (4.49e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-2)" "unprognostic (3.47e-3)" "unprognostic (2.27e-3)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "unprognostic (5.09e-1)" "unprognostic (9.32e-2)" "unprognostic (1.98e-2)" 11.0 11.2 9.7 7.1 6.9 15.5 9.8 0.9 9.9 11.8 0.1 13.6 6.5 13.5 4.0 16.8 13.5 5.2 7.4 9.8 3.6 9.2 7.2 10.1 5.1 4.5 3.9 6.7 13.9 7.9 6.9 15.5 4.8 6.3 11.2 3.3 4.0 8.7 6.9 5.9 13.9 10.2 5.3 1.8 11.4 10.7 13.8 5.3 4.6 10.8 2.9 3.3 12.9 11.8 6.7 8.9 10.4 8.8 11.2 10.8 12.1 8.3 6.2 7.5 3.1 3.4 7.5 8.1 12.4 6.0 8.5 6.8 13.4 6.4 12.2 2.3 6.8 10.4 8.6 19.3 6.1 7.4 3.5 15.4 19.6 11.4 6.6 9.0 9.8 5.4 9.2 7.7 10.4 3.5 6.1 8.7 6.3 4.1 6.3 7.9 9.6 4.4 7.8 5.7 12.7 9.5 13.7 6.8 6.4 15.2 4.5 5.2 6.8 10.3 7.6 5.4 12.3 4.7 9.4 5.0 4.7 15.2 7.8 5.2 0.4 0.4 0.9 0.1 0.5 0.3 0.3 0.2 0.3 0.1 0.1 0.2 0.2 1.3 0.2 0.4 0.3 0.0 0.2 9.7 6.9 0.9 9.9 9.8 3.6 4.5 3.9 6.7 6.3 1.8 5.3 6.7 9.6 6.4 19.1 11.4 10.3 18.6 20.2 15.8 13.1 16.1 11.6 9.7 6.6 14.3 20.3 14.7 22.9 6.8 16.4 25.7 1.9 10.2 8.3 33.5 24.7 13.5 19.8 5.0 9.4 10.2 9.8 12.8 19.9 51.8 13.9 12.4 14.6 9.9 14.3 26.9 6.7 25.1 14.2 26.0 9.5 20.7 11.1 17.2 10.6 7.5 13.9 13.0 13.4 1.0 4.7 12.3 18.7 13.2 8.2 25.4 18.2 2.7 14.7 12.1 6.6 15.5 14.2 34.6 26.4 19.4 25.7 9.3 10.9 10.3 28.4 65.5 ZXDC "FLJ13861, MGC11349" ENSG00000070476 "ZXD family zinc finger C" Q2QGD7 3 126437601-126475891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.7" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.4" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;granulocytes: 1.7;monocytes: 4.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049593 Approved Nucleoli Yes No Nucleoli "HPA049593: AB_2680828" "unprognostic (3.06e-1)" "unprognostic (2.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.06e-2)" "unprognostic (5.97e-2)" "unprognostic (4.34e-2)" "unprognostic (3.37e-2)" "unprognostic (2.67e-2)" "unprognostic (1.06e-1)" "unprognostic (8.13e-2)" "unprognostic (2.98e-1)" "unprognostic (4.66e-2)" "unprognostic (1.12e-3)" 6.7 5.3 7.1 6.2 8.4 39.7 6.4 8.1 8.7 8.2 7.5 5.4 5.1 7.9 5.2 7.4 8.9 6.0 5.7 5.9 6.3 6.3 7.7 7.1 7.9 9.0 7.2 6.0 10.8 15.0 10.2 4.0 7.5 8.6 7.2 5.4 7.7 8.1 6.7 16.3 9.3 6.0 6.6 7.0 8.9 6.8 6.5 7.2 10.1 8.6 9.9 6.0 6.1 5.7 14.2 15.2 7.6 9.4 8.9 10.1 7.8 16.7 6.7 7.4 9.7 8.6 11.6 6.4 11.2 11.2 6.1 8.9 12.3 12.6 7.9 7.6 6.0 10.8 8.8 9.2 7.7 10.7 13.6 13.7 6.2 15.1 6.0 10.6 9.6 10.0 13.0 9.6 14.6 8.2 8.9 13.1 7.5 13.4 10.0 7.6 14.1 6.4 14.3 6.8 10.9 17.1 9.5 13.0 9.5 18.2 6.2 12.9 11.9 10.2 8.9 11.4 13.4 8.3 12.1 6.1 14.6 9.7 10.5 10.0 1.7 0.4 0.8 0.5 0.2 0.2 0.1 0.3 0.4 0.7 0.4 0.5 0.4 1.2 0.3 4.4 1.1 0.2 0.2 7.1 8.4 8.1 8.7 5.9 6.3 9.0 7.2 6.0 8.6 7.0 7.2 14.2 10.1 25.6 15.6 84.5 11.9 6.2 8.3 4.5 10.8 30.1 6.8 6.5 5.5 12.8 7.9 5.5 45.9 7.2 10.0 8.6 7.9 4.8 1.7 8.1 7.9 7.7 3.6 12.0 51.3 6.1 2.6 7.8 9.2 12.2 2.5 16.8 7.9 14.3 5.7 13.5 44.3 6.9 0.0 5.4 4.4 0.8 7.5 9.0 1.8 47.8 7.3 23.0 7.2 67.8 99.2 4.4 5.2 7.5 12.9 6.0 8.4 9.5 7.7 30.4 0.0 13.5 8.9 3.3 9.0 9.0 4.3 6.3 11.1 10.5 6.6 6.3 JMJD6 "KIAA0585, PTDSR, PTDSR1" ENSG00000070495 "Jumonji domain containing 6, arginine demethylase and lysine hydroxylase" Q6NYC1 17 76712832-76726799 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 122.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004548, HPA059156" Supported Supported Nucleoplasm No No Nucleoplasm "CAB004548: AB_628185, HPA059156: AB_2683934" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (8.06e-2)" "unprognostic (9.46e-2)" "unprognostic (5.95e-2)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.75e-6)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-2)" "prognostic favorable (5.71e-4)" "unprognostic (5.66e-2)" "prognostic unfavorable (7.59e-7)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (8.86e-2)" "unprognostic (3.82e-1)" 24.5 27.2 17.7 17.1 16.0 122.8 19.8 18.9 24.2 19.2 14.9 27.7 15.5 19.6 7.5 18.9 22.6 18.9 37.7 17.7 17.1 18.3 18.6 27.1 15.8 17.5 15.3 12.6 27.8 18.2 11.1 22.6 16.3 19.0 20.1 10.4 29.8 15.3 10.8 38.6 15.0 18.6 16.2 15.8 21.2 24.6 18.0 18.1 13.5 16.8 28.3 12.9 24.1 20.6 22.9 39.0 53.3 18.0 23.5 22.6 19.4 17.6 34.7 26.8 49.6 47.6 53.6 18.7 25.3 14.9 37.6 72.6 28.8 57.3 17.3 47.2 18.6 45.9 37.3 37.5 54.4 36.8 19.7 55.0 23.9 26.8 54.2 18.2 31.6 41.6 13.8 57.1 45.2 37.0 24.4 34.7 28.4 15.9 37.3 62.4 27.1 33.6 39.2 16.6 12.1 31.1 31.1 30.2 43.7 43.7 30.4 39.5 28.6 27.7 56.7 33.3 29.9 65.8 50.6 28.8 23.4 55.7 17.4 32.5 50.8 28.6 40.2 24.7 37.8 24.0 20.5 28.4 28.2 25.9 13.0 23.3 22.2 23.3 14.6 39.4 22.4 31.0 20.1 17.7 16.0 18.9 24.2 17.7 17.1 17.5 15.3 12.6 19.0 15.8 18.1 22.9 44.1 25.6 22.9 9.1 29.3 83.2 79.9 46.1 67.2 16.5 30.8 42.8 30.5 14.3 29.2 9.2 50.1 29.0 96.5 33.1 17.6 28.1 30.3 39.1 29.6 36.0 39.4 13.0 6.6 27.4 52.9 37.9 33.1 58.6 65.2 18.6 28.2 10.2 32.7 6.7 7.4 32.0 24.4 19.5 79.2 12.5 16.1 52.4 58.7 3.7 26.9 11.8 21.6 7.1 7.9 29.6 32.1 17.7 50.0 38.5 40.8 7.9 20.5 35.4 13.1 32.7 69.2 59.6 27.2 48.8 73.6 30.5 80.4 29.9 31.3 60.2 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 254.5;Late spermatids: 133.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 280.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011616, HPA049104, HPA069013" Enhanced Uncertain Vesicles NA NA Vesicles "CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: " "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.65e-4)" 12.3 17.7 27.6 13.6 28.4 51.7 27.7 83.7 35.8 15.7 27.6 12.4 10.9 13.1 19.9 26.7 13.3 17.5 26.4 28.6 29.9 15.3 34.2 14.3 20.4 28.2 30.8 27.5 20.6 17.0 18.9 26.9 11.2 39.3 25.0 13.3 18.1 30.6 11.4 86.2 23.2 10.9 10.7 29.1 17.4 14.2 53.6 30.8 25.0 14.4 70.7 22.4 31.1 19.1 30.0 40.2 23.5 40.6 80.4 21.8 20.7 33.8 25.2 29.3 41.5 37.7 33.1 46.0 36.4 31.1 16.5 43.4 20.0 34.1 29.5 50.3 23.8 36.7 26.5 18.2 45.3 34.1 18.6 280.6 18.8 34.4 30.1 35.4 51.8 32.1 77.2 58.4 22.4 40.3 23.6 78.0 52.6 54.4 48.4 26.7 44.2 40.8 31.4 78.4 32.1 22.7 41.8 29.9 19.9 79.0 41.4 52.5 31.5 17.8 19.1 27.0 48.8 24.6 32.5 58.4 52.2 19.3 39.4 52.2 47.6 15.1 48.1 12.0 18.8 13.3 12.2 12.5 13.0 15.7 11.1 14.1 13.3 63.6 22.2 26.3 84.9 19.3 11.5 27.6 28.4 83.7 35.8 28.6 29.9 28.2 30.8 27.5 39.3 29.1 30.8 30.0 13.9 3.2 13.6 6.8 20.2 16.8 30.1 14.2 31.3 2.9 14.3 15.1 21.6 7.2 20.7 7.3 8.4 7.5 51.9 3.1 5.9 11.7 254.5 13.8 7.7 12.5 6.0 7.6 15.8 9.6 7.0 9.7 10.2 9.9 23.4 12.7 8.6 12.7 7.4 6.7 20.3 5.4 4.1 5.7 9.9 133.9 7.2 18.2 7.2 19.7 11.2 8.3 13.4 12.5 16.7 33.6 5.8 3.8 21.9 41.6 4.3 6.8 16.4 4.4 0.0 6.6 12.3 19.4 15.4 27.3 20.0 11.1 16.2 7.8 6.6 31.6 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643786 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 61.6;intestine: 197.8;stomach 1: 65.5" "Cell type enriched" "Detected in many" 5 "Intestinal goblet cells: 801.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 32 "T-cells: 8.9" "Group enriched" "Detected in some" 4 "K-562: 65.5;OE19: 107.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 3500000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.7 0.1 5.1 12.7 5.0 2.8 2.1 5.0 7.4 61.6 4.2 156.8 63.0 5.1 3.9 24.6 3.8 18.4 2.2 4.8 5.3 0.4 0.1 5.7 1.2 5.8 5.3 4.3 0.8 0.7 0.1 0.0 2.1 5.5 7.0 197.8 1.0 26.5 0.5 1.4 1.0 76.4 5.4 5.1 14.8 65.5 3.1 5.7 0.2 0.3 0.9 2.4 3.1 4.5 4.9 0.2 2.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.2 11.9 0.0 0.0 12.4 0.0 2.9 0.0 0.0 0.0 19.5 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 65.5 0.0 0.0 0.0 0.2 0.2 0.0 107.5 0.4 0.0 0.0 0.4 0.1 0.7 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.1 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 1.3 0.9 5.1 5.0 5.0 7.4 4.8 5.3 5.8 5.3 4.3 5.5 5.1 5.7 4.9 8.6 16.0 7.5 0.7 0.3 0.1 5.7 90.2 12.0 0.1 0.1 0.0 2.0 17.2 143.4 0.0 0.0 0.3 0.0 133.3 0.0 1.4 0.3 85.1 7.6 27.2 33.0 6.7 0.4 18.2 0.1 1.3 65.7 77.6 0.0 0.3 8.6 0.0 0.3 0.0 0.3 801.0 50.8 0.0 0.0 0.9 1.5 1.1 0.0 18.7 0.0 0.0 0.0 1.5 0.3 42.8 76.1 0.0 0.0 2.4 51.6 0.0 117.4 1.2 0.0 0.3 5.3 0.4 0.1 12.8 0.1 0.1 1.8 63.3 123.1 24.5 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 128.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 114.1;eosinophil: 223.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 223.6" "Cell line enhanced" "Detected in many" "ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favorable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 29.1 19.0 11.4 14.2 11.7 26.8 30.7 12.6 15.3 33.4 17.9 36.8 12.9 15.5 14.6 14.9 12.7 23.5 79.1 10.7 13.3 33.6 18.8 26.4 8.8 12.6 12.4 9.7 11.3 30.1 25.4 18.0 62.9 12.7 17.5 38.9 8.3 55.5 18.4 128.4 20.6 15.0 18.9 11.5 12.6 29.5 9.7 13.9 5.9 21.3 98.4 16.9 22.2 14.5 12.0 4.9 9.8 8.6 12.5 224.3 167.2 49.0 36.3 163.5 13.7 43.6 7.2 7.3 3.0 16.0 74.2 47.9 3.7 3.3 22.1 23.9 4.4 4.6 34.7 3.2 42.6 216.7 2.4 48.5 180.8 39.5 54.2 72.0 44.2 61.3 5.3 2.5 82.0 41.1 29.9 0.5 7.1 1.8 12.7 15.0 0.4 30.3 35.7 20.2 16.7 2.4 11.4 7.7 103.8 183.4 44.4 54.8 9.5 61.2 65.4 10.1 31.0 8.6 78.2 92.0 10.5 98.9 16.5 29.7 114.1 18.4 223.6 11.9 22.7 5.3 4.4 3.1 11.7 9.0 1.4 0.2 5.6 39.0 10.7 24.7 6.3 2.7 15.0 11.4 11.7 12.6 15.3 10.7 13.3 12.6 12.4 9.7 12.7 11.5 13.9 12.0 26.2 9.6 11.5 12.7 13.3 7.8 11.9 45.6 0.6 15.0 24.1 8.9 7.3 28.6 48.5 16.5 2.1 44.0 18.3 30.2 31.3 31.2 6.3 26.3 19.9 17.2 12.0 56.6 9.4 57.2 165.7 41.2 25.5 40.0 7.0 12.3 33.9 11.7 35.6 10.1 8.2 67.6 44.7 18.2 14.5 5.2 46.3 37.1 42.7 20.6 34.2 10.6 20.6 6.0 12.2 28.8 20.1 42.2 83.3 55.3 8.5 71.8 49.6 15.7 26.3 10.1 24.1 5.0 5.1 3.3 6.8 125.1 13.6 27.8 28.2 36.7 FRMPD1 "FRMD2, KIAA0967" ENSG00000070601 "FERM and PDZ domain containing 1" Q5SYB0 9 37650954-37746904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 69.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 47.8;Cone photoreceptor cells: 152.2;Inhibitory neurons: 24.3;Rod photoreceptor cells: 79.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 4 "granulocytes: 3.2;NK-cells: 1.3" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042934 Uncertain NA NA "HPA042934: AB_10960422" "unprognostic (6.41e-2)" "unprognostic (6.74e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (4.04e-1)" "unprognostic (7.26e-2)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.53e-3)" "unprognostic (2.63e-3)" "unprognostic (3.94e-2)" "unprognostic (1.12e-3)" "unprognostic (7.80e-2)" "unprognostic (4.41e-2)" "unprognostic (2.13e-2)" "unprognostic (5.91e-2)" 0.4 0.5 3.4 0.8 3.7 3.0 0.9 2.9 4.4 0.4 0.6 0.5 0.8 1.0 0.7 1.6 0.8 1.6 0.7 2.8 2.8 0.5 0.5 0.7 1.3 3.2 4.2 3.0 0.3 0.9 0.8 0.8 0.4 2.6 0.5 0.5 69.5 4.1 0.5 4.3 6.4 1.1 0.4 2.2 0.4 0.6 9.4 5.0 0.2 1.0 1.2 1.1 0.5 0.1 4.8 0.2 0.3 1.2 0.1 0.0 0.0 1.5 0.5 0.0 0.1 0.1 0.6 0.5 0.3 0.2 0.3 0.5 0.9 0.9 0.5 0.3 0.4 0.3 0.1 0.5 0.3 0.0 0.0 0.2 0.6 0.0 0.5 0.2 0.6 0.0 0.9 0.5 0.2 0.2 0.3 0.1 0.2 0.7 0.1 0.6 0.6 1.0 0.1 0.0 0.9 2.5 1.7 0.0 1.6 0.8 0.4 0.8 0.3 0.0 0.3 0.5 0.5 0.4 0.4 0.7 0.6 0.4 0.3 0.4 3.2 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.1 0.5 0.3 0.3 1.0 1.3 0.4 0.3 0.2 0.1 3.4 3.7 2.9 4.4 2.8 2.8 3.2 4.2 3.0 2.6 2.2 5.0 4.8 0.2 3.2 10.5 11.1 0.3 0.1 0.3 0.0 0.0 47.8 0.5 0.3 1.1 4.3 1.8 0.0 152.2 0.2 0.0 0.4 0.0 0.1 4.8 0.2 0.1 1.4 0.0 0.0 3.7 0.2 0.5 0.8 0.0 0.4 5.1 0.2 0.7 0.8 0.1 1.7 24.3 0.3 0.0 1.3 2.1 1.3 0.9 0.8 0.0 1.0 0.3 9.0 0.0 13.6 6.7 0.1 0.1 0.4 0.1 0.2 0.0 0.0 1.5 79.8 0.0 0.8 0.2 0.4 1.7 0.0 0.4 0.7 1.0 0.1 0.1 0.3 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favorable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favorable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favorable (6.60e-4)" 39.6 46.0 49.7 23.4 46.8 16.4 40.2 51.9 53.3 45.3 57.9 77.8 54.7 45.0 27.1 36.6 44.6 26.6 81.7 46.8 52.8 84.9 66.4 54.6 24.8 52.3 55.5 45.9 40.2 54.6 37.5 66.0 24.9 55.7 60.8 41.4 71.7 50.4 27.9 76.5 38.5 90.5 23.1 43.8 59.0 64.4 31.0 58.4 18.5 62.2 44.0 21.8 53.5 41.3 52.7 18.1 29.3 39.6 38.4 18.8 11.4 40.0 24.1 18.8 23.9 25.0 32.8 14.1 19.3 17.1 14.7 51.5 18.4 38.2 16.2 12.0 27.5 26.2 20.8 87.8 35.6 20.8 31.2 49.4 19.8 29.8 20.3 21.1 57.9 63.4 18.9 20.7 36.0 22.6 18.0 8.5 32.0 41.2 36.6 45.7 15.5 16.0 16.3 33.3 41.9 32.2 43.0 13.5 33.3 24.5 48.1 22.8 27.8 44.6 25.8 30.9 22.4 29.9 24.2 16.5 16.0 32.3 11.3 20.5 11.1 2.9 2.0 3.8 3.9 2.5 3.7 3.7 4.7 2.8 4.7 2.2 1.9 3.2 2.4 2.5 4.4 2.8 2.2 49.7 46.8 51.9 53.3 46.8 52.8 52.3 55.5 45.9 55.7 43.8 58.4 52.7 12.7 12.8 8.0 45.1 11.2 7.4 18.2 9.4 6.2 77.5 15.0 10.8 13.7 17.2 14.5 27.6 114.7 11.1 16.6 71.7 21.5 10.5 14.1 10.0 8.1 16.0 35.8 17.2 23.5 12.0 10.2 8.0 46.4 13.8 14.0 18.7 30.7 20.1 9.2 52.2 26.4 35.8 16.2 12.8 10.7 24.3 12.5 10.7 12.4 8.4 13.3 16.2 12.3 18.1 20.2 15.1 57.6 9.8 11.7 15.8 87.4 17.8 17.9 102.9 13.1 12.2 12.2 9.2 5.7 8.8 9.9 22.2 9.4 11.3 41.4 26.3 NDST1 "HSST, NST1" ENSG00000070614 "N-deacetylase and N-sulfotransferase 1" P52848 5 150485818-150558211 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Multifunctional enzyme, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 1.4;classical monocyte: 5.5;eosinophil: 3.6;intermediate monocyte: 1.7;myeloid DC: 4.2;neutrophil: 5.4;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 10 "dendritic cells: 4.2;granulocytes: 5.4;monocytes: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060532 Approved NA NA 1400000 "HPA060532: AB_2684310" "unprognostic (1.36e-1)" "unprognostic (5.54e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.77e-1)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.97e-3)" "unprognostic (6.92e-2)" "unprognostic (7.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.08e-2)" 37.6 22.9 37.6 14.2 39.3 7.7 28.8 41.3 33.4 15.8 2.3 16.5 12.6 17.5 7.9 39.1 14.8 15.3 27.1 28.8 27.4 14.5 43.0 34.6 7.4 59.9 47.1 23.2 23.2 40.0 20.7 6.8 12.3 52.9 14.6 9.6 14.0 37.7 17.0 23.8 34.5 17.5 19.4 48.7 43.8 16.1 14.7 46.0 4.3 23.1 13.1 10.0 14.2 18.9 59.3 32.4 28.3 46.1 56.4 45.3 44.9 46.3 58.1 75.9 56.8 84.8 84.1 33.3 22.0 57.6 116.8 91.0 54.4 25.1 118.0 37.6 2.6 38.9 26.0 18.5 13.2 33.5 19.5 45.5 61.6 48.1 68.7 31.0 56.9 78.3 12.9 25.3 7.8 56.3 27.5 2.3 6.2 21.6 9.1 33.0 37.6 38.4 9.8 33.4 32.5 13.8 48.3 35.2 108.5 46.3 32.7 58.3 4.8 38.8 96.4 86.2 42.3 48.3 17.1 4.7 8.1 79.2 30.1 38.0 1.4 5.5 3.6 0.1 1.7 0.0 0.4 0.0 0.4 4.2 0.1 0.0 0.2 5.4 0.0 4.7 0.3 0.0 2.8 37.6 39.3 41.3 33.4 28.8 27.4 59.9 47.1 23.2 52.9 48.7 46.0 59.3 29.8 38.5 8.7 23.8 1.9 5.7 3.5 14.4 6.2 11.6 29.9 15.4 11.5 17.2 9.6 16.5 8.4 8.6 0.5 20.9 1.9 10.4 0.7 5.5 7.7 35.5 1.2 3.2 12.0 10.5 11.3 11.0 2.0 6.8 1.3 20.4 31.8 47.5 7.7 13.5 11.7 5.3 8.2 14.4 7.6 1.9 12.5 8.7 10.6 16.9 7.4 12.1 0.0 12.1 39.7 18.8 6.6 32.0 3.7 7.9 17.8 8.8 3.8 11.3 0.0 8.7 11.5 0.7 1.6 17.4 12.4 4.5 1.2 11.8 5.8 5.3 ASNS ENSG00000070669 "Asparagine synthetase (glutamine-hydrolyzing)" P08243 7 97851677-97872542 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" Ligase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.4" "Cell type enhanced" "Detected in all" "Early spermatids: 233.9;Late spermatids: 217.0;Smooth muscle cells: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 8.9;T-cells: 14.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004924, HPA029318, HPA064737" Approved Enhanced Cytosol No No 47000 Cytosol "HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341" "unprognostic (3.93e-2)" "unprognostic (2.51e-1)" "unprognostic (6.70e-2)" "prognostic unfavorable (4.24e-4)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.79e-5)" "prognostic unfavorable (9.42e-6)" "unprognostic (2.28e-2)" "unprognostic (9.08e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-3)" "prognostic unfavorable (6.21e-7)" "unprognostic (5.33e-1)" "unprognostic (2.15e-1)" "unprognostic (6.21e-2)" "unprognostic (1.33e-1)" 15.6 18.2 57.1 19.7 58.5 13.8 18.0 58.8 64.0 19.3 35.4 23.9 9.8 19.2 31.7 27.2 20.2 11.3 18.4 62.2 64.5 18.7 9.4 25.9 29.0 63.4 50.6 58.3 21.0 122.4 26.5 44.5 4.7 64.7 21.7 20.1 35.6 41.9 14.6 8.1 23.1 22.8 18.2 50.1 30.5 46.3 33.6 56.6 13.5 27.7 8.7 25.9 21.9 18.8 69.5 124.6 46.6 51.6 415.9 35.3 57.9 109.1 85.7 62.5 41.6 134.8 64.2 49.3 101.7 45.3 189.8 92.3 57.4 118.2 151.2 102.2 122.4 85.3 31.0 24.6 50.8 347.8 207.1 89.9 106.2 508.8 55.8 361.2 23.5 41.4 94.4 177.1 365.2 76.3 286.5 6.4 54.4 68.1 308.4 125.4 14.0 10.0 282.7 28.4 22.3 218.1 156.7 23.2 136.7 499.0 60.6 57.1 139.1 7.6 21.6 138.5 56.7 40.7 412.6 239.7 401.1 288.7 90.3 220.8 1.9 0.3 0.4 3.6 1.1 4.3 8.9 7.2 3.4 1.5 6.0 10.1 5.5 1.8 2.0 1.0 0.2 14.2 3.3 57.1 58.5 58.8 64.0 62.2 64.5 63.4 50.6 58.3 64.7 50.1 56.6 69.5 5.8 9.6 7.2 11.1 14.4 12.4 26.1 20.9 6.2 20.3 9.7 11.2 7.6 7.2 12.3 9.2 25.0 3.1 6.7 10.5 7.9 30.9 233.9 2.9 8.6 6.7 24.4 46.1 51.8 61.6 7.8 8.9 14.3 4.5 8.2 8.8 2.9 1.3 1.1 25.2 48.6 19.6 32.6 1.3 3.2 217.0 9.6 2.1 8.8 5.6 7.3 9.2 5.2 16.1 16.9 36.6 14.7 9.4 19.9 26.1 1.1 3.9 4.5 24.9 6.6 10.2 112.3 3.4 20.2 5.5 10.9 5.6 11.2 6.0 9.9 14.9 AP3M2 "AP47B, CLA20" ENSG00000070718 "Adaptor related protein complex 3 subunit mu 2" P53677 8 42152946-42171673 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014876, HPA045591, HPA048380" Approved NA NA "CAB014876: , HPA045591: AB_2679377, HPA048380: AB_2680379" "unprognostic (5.53e-2)" "unprognostic (2.26e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (2.02e-2)" "unprognostic (8.20e-2)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-1)" "unprognostic (4.80e-2)" "unprognostic (3.61e-2)" "unprognostic (2.69e-1)" "unprognostic (4.32e-1)" "unprognostic (8.04e-2)" "prognostic favorable (2.38e-4)" 8.5 11.4 25.1 8.1 28.3 11.3 8.9 19.6 27.7 8.9 14.7 8.2 7.3 10.6 13.1 7.1 16.5 10.6 14.3 26.8 29.6 12.5 4.6 12.8 12.5 23.0 22.6 25.9 9.6 6.5 22.9 13.4 20.7 25.9 10.3 8.8 42.3 6.2 11.6 8.9 12.7 7.9 10.0 20.0 10.5 7.0 23.9 26.5 8.4 13.6 10.7 10.5 10.0 8.1 27.2 20.6 20.8 18.2 21.4 16.2 15.9 4.0 23.5 23.3 22.0 25.7 11.7 24.4 12.3 14.7 13.5 24.8 23.9 28.6 14.8 28.4 17.0 26.9 23.4 17.8 8.1 14.7 10.1 13.4 14.5 25.1 24.0 13.6 30.5 15.0 35.1 28.5 11.3 20.2 9.7 30.0 11.9 20.4 25.0 14.5 28.6 34.7 13.2 16.8 24.0 25.9 18.6 14.4 7.2 26.1 18.8 21.2 6.4 9.6 13.4 19.2 20.0 10.9 9.6 19.5 11.2 18.8 1.4 37.8 2.9 1.9 1.5 7.5 2.7 9.7 4.7 15.5 8.1 4.2 3.0 14.4 5.7 2.3 7.7 2.8 6.8 5.9 5.0 25.1 28.3 19.6 27.7 26.8 29.6 23.0 22.6 25.9 25.9 20.0 26.5 27.2 16.2 12.8 3.3 16.6 13.6 17.5 20.3 8.0 9.1 35.9 6.9 7.4 17.0 1.5 9.3 14.7 39.6 7.0 21.3 2.6 5.9 12.9 59.8 15.7 11.6 18.1 3.0 10.8 26.2 7.4 4.8 11.5 6.6 11.1 3.8 12.1 18.5 4.3 6.6 35.3 33.6 3.0 16.2 2.1 10.1 70.1 5.3 6.5 37.4 14.0 13.5 19.6 11.3 15.1 16.0 16.3 1.8 9.1 17.1 8.9 0.9 6.8 18.8 37.1 19.7 8.1 15.0 26.8 45.0 6.6 19.7 2.9 41.5 11.0 4.3 15.4 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel subunit beta 1" Q14028 16 57882340-57971128 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "retina: 605.5" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4" "Region enhanced" "Detected in some" "hypothalamus: 4.5" "HPA039159, HPA060355" Approved Vesicles,Cytosol No NA Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.1 2.6 17.6 1.2 15.1 0.2 0.0 0.0 23.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.1 0.3 0.0 27.3 18.4 0.0 0.1 0.1 0.2 3.2 4.8 12.5 0.0 0.5 0.0 0.2 0.4 4.7 0.0 0.4 605.5 0.0 0.1 0.0 0.2 0.6 0.1 0.9 0.1 0.0 0.4 24.4 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.3 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.5 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.6 5.0 0.0 2.9 1.4 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.6 15.1 0.0 23.0 27.3 18.4 3.2 4.8 12.5 4.7 0.9 24.4 5.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.0 61.6 0.3 0.0 1.1 0.0 0.1 0.0 331.5 6.9 0.0 0.0 0.0 0.4 1.6 0.9 0.1 4.2 0.0 0.0 3.2 0.4 0.9 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.4 25.2 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 89.5 0.0 1.0 0.1 0.2 1.1 0.0 0.0 0.2 0.0 0.3 0.0 1111.1 0.0 0.1 0.2 0.5 0.7 0.0 0.0 1.4 0.1 0.1 0.0 0.2 ST6GALNAC2 "SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM" ENSG00000070731 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2" Q9UJ37 17 76565377-76586956 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 501.1;Late spermatids: 1763.3" "Cancer enhanced" "Detected in all" "melanoma: 22.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 9 "neutrophil: 47.0" "Lineage enriched" "Detected in many" 16 "granulocytes: 47.0" "Cell line enhanced" "Detected in some" "BEWO: 25.4;HaCaT: 33.8;HBEC3-KT: 28.5;hTCEpi: 73.1;MCF7: 36.4;SK-MEL-30: 112.5;T-47d: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (8.93e-3)" "unprognostic (5.86e-3)" "unprognostic (1.67e-2)" "unprognostic (5.18e-3)" "unprognostic (3.37e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.95e-1)" "unprognostic (5.37e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.57e-1)" "unprognostic (5.17e-3)" "unprognostic (3.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 4.6 2.9 1.7 1.9 1.6 1.0 12.3 2.6 1.4 15.1 27.6 10.6 1.0 4.9 10.4 16.6 50.9 1.9 3.8 2.3 7.1 9.7 1.2 17.6 0.6 5.4 3.9 0.7 1.2 6.4 7.5 2.1 6.0 3.9 11.2 6.0 53.3 11.4 10.3 18.5 52.1 4.8 2.3 5.1 3.7 7.2 34.1 2.9 1.5 25.5 18.7 4.9 9.6 14.6 3.0 2.6 0.0 0.0 0.0 0.5 0.0 25.4 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.5 1.7 0.1 33.8 0.3 28.5 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.0 73.1 0.1 9.0 3.8 0.1 0.0 0.0 0.0 0.4 36.4 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 9.8 0.5 0.0 4.1 0.1 112.5 1.3 23.4 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 2.9 5.2 0.0 1.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 47.0 0.2 0.4 0.0 0.0 0.4 1.7 1.6 2.6 1.4 2.3 7.1 5.4 3.9 0.7 3.9 5.1 2.9 3.0 0.2 0.0 1.5 2.6 0.8 32.9 44.0 104.2 23.9 7.9 0.4 1.5 5.1 7.2 21.0 0.0 27.1 12.5 0.0 2.4 0.0 0.3 501.1 4.5 1.1 3.9 0.0 0.0 0.5 0.0 21.1 2.0 4.6 0.6 1.3 0.0 7.9 1.5 3.0 0.0 1.3 4.8 8.2 5.0 6.9 1763.3 7.5 3.8 65.8 1.0 2.7 84.9 0.0 0.0 0.2 0.1 0.5 7.2 0.2 15.2 0.7 0.5 39.3 79.7 19.7 7.3 3.4 7.6 4.6 28.8 30.3 10.5 2.2 0.0 1.6 37.6 CHAT ENSG00000070748 "Choline O-acetyltransferase" P28329 10 49609095-49667942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Acyltransferase, Transferase" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 9.4;placenta: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "NB-4: 20.9" "Region enhanced" "Detected in many" "basal ganglia: 20.6" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0" "CAB002313, HPA048547, CAB079053" Supported Supported NA NA "CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437" "unprognostic (2.34e-2)" "unprognostic (6.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (2.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.5 0.2 2.1 0.0 0.0 0.2 9.4 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.0 7.2 3.5 0.9 0.0 0.3 0.0 0.0 5.5 8.3 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.8 20.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.1 0.2 9.4 0.1 4.0 7.2 3.5 0.9 8.3 1.2 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PABPC1 "PAB1, PABP1, PABPC2, PABPL1" ENSG00000070756 "Poly(A) binding protein cytoplasmic 1" P11940 8 100685816-100722809 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011536, HPA045423, HPA067156" Supported Supported Cytosol NA NA 3900000 Cytosol "CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (5.00e-2)" "unprognostic (2.64e-2)" "unprognostic (3.18e-1)" "unprognostic (4.50e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.93e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (2.51e-3)" "unprognostic (5.70e-2)" "unprognostic (1.50e-2)" "unprognostic (3.21e-3)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.70e-12)" "unprognostic (6.22e-2)" "unprognostic (2.55e-1)" "unprognostic (6.98e-3)" "unprognostic (1.40e-2)" 623.0 344.3 53.1 495.2 66.5 367.1 580.6 44.2 49.2 579.6 86.7 523.2 454.2 457.2 68.9 1364.2 440.8 229.1 219.2 30.8 104.5 295.4 350.5 494.6 546.8 109.5 57.9 16.6 730.1 734.1 127.8 169.1 216.3 85.0 477.9 272.9 80.9 1298.5 174.3 199.3 714.1 506.1 228.6 56.5 487.0 529.0 511.9 83.4 424.9 305.9 76.5 536.7 635.9 860.4 150.1 2069.1 644.4 372.2 842.0 585.0 1050.0 793.4 504.4 593.5 451.8 468.7 791.5 1107.8 3230.4 1609.1 809.5 291.3 792.4 554.6 1092.3 459.5 758.2 555.4 1713.1 302.2 562.6 835.7 673.3 891.0 1338.6 1050.2 554.8 2126.1 950.7 690.8 1071.8 1339.4 1120.1 477.5 857.3 2617.8 949.5 882.3 1487.3 929.6 967.5 541.7 1074.2 301.8 953.1 629.2 650.1 415.8 548.6 1200.7 513.2 1031.7 949.5 1005.1 512.4 809.4 723.9 897.9 753.6 606.1 1523.2 609.7 1378.1 538.8 122.8 401.3 131.2 159.3 405.2 348.9 297.4 333.0 264.3 421.4 263.0 437.4 370.4 112.5 306.9 468.5 277.2 301.5 568.0 53.1 66.5 44.2 49.2 30.8 104.5 109.5 57.9 16.6 85.0 56.5 83.4 150.1 348.4 371.8 939.1 28.7 1089.1 787.4 1075.3 735.0 1067.7 66.5 1036.1 641.2 139.7 459.0 1020.8 110.3 50.1 454.2 872.8 457.0 264.1 467.0 1727.8 352.1 628.4 523.0 477.1 999.1 42.4 769.0 860.8 458.8 530.1 436.1 1054.1 357.3 570.8 308.3 615.5 72.3 34.1 853.8 360.1 1520.8 1162.9 306.0 498.9 1144.3 370.0 53.4 1583.7 167.7 679.7 29.7 41.1 626.9 698.0 424.3 674.4 655.3 446.1 388.4 473.5 88.4 499.6 530.4 876.7 1433.1 476.0 929.6 765.3 777.9 1041.1 408.3 1061.2 1296.9 TESK2 ENSG00000070759 "Testis associated actin remodelling kinase 2" Q96S53 1 45343883-45491163 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 222.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 14.6;RT4: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027257, HPA063869" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027257: AB_10602477, HPA063869: AB_2685137" "unprognostic (2.95e-1)" "prognostic favorable (2.22e-4)" "unprognostic (3.90e-2)" "unprognostic (5.04e-3)" "unprognostic (6.03e-2)" "unprognostic (1.87e-3)" "unprognostic (3.22e-2)" "unprognostic (1.43e-2)" "unprognostic (5.15e-2)" "unprognostic (2.96e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (4.36e-2)" "unprognostic (2.49e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (2.01e-1)" 3.3 2.2 6.8 2.8 10.3 10.3 6.7 10.0 8.8 5.0 5.2 5.4 8.6 3.2 3.8 7.1 3.0 2.6 2.0 7.0 7.7 2.3 7.0 3.9 4.0 11.7 10.0 5.7 9.9 3.6 3.4 2.4 3.5 10.6 15.6 7.1 2.9 8.5 2.7 8.3 12.6 10.9 2.9 9.4 5.3 4.5 9.7 9.2 4.3 3.4 4.8 5.2 4.7 7.5 15.1 1.9 0.0 0.9 0.1 3.5 1.8 14.6 0.7 4.9 2.1 3.6 4.3 1.7 6.2 0.6 1.8 5.4 2.3 3.9 3.1 1.6 4.4 4.9 4.2 2.0 3.2 1.9 1.4 11.1 1.9 3.2 2.4 3.4 3.2 1.7 8.1 0.8 12.4 1.4 0.7 3.6 2.9 3.8 1.8 1.8 5.2 0.1 1.5 1.9 14.7 0.4 1.6 3.8 7.3 14.1 8.6 11.3 1.8 0.0 0.2 2.1 1.3 1.3 8.0 5.0 1.2 1.1 0.0 1.0 12.8 4.6 13.3 2.7 3.4 1.9 8.0 2.5 1.8 2.4 6.6 4.1 2.3 19.0 1.5 8.0 1.3 1.9 3.4 6.8 10.3 10.0 8.8 7.0 7.7 11.7 10.0 5.7 10.6 9.4 9.2 15.1 3.9 0.0 2.8 54.2 10.7 7.8 7.1 2.8 14.2 2.4 11.9 9.4 1.3 4.3 3.4 0.0 14.6 8.3 4.2 13.9 0.0 1.3 23.7 4.6 1.8 3.2 4.2 5.0 10.2 2.7 2.8 3.7 7.7 8.9 7.0 2.4 2.2 6.3 6.8 0.0 6.7 6.9 4.1 5.5 4.4 7.8 2.8 6.0 3.6 15.9 4.6 1.1 4.1 18.6 222.9 1.1 7.3 1.9 9.8 10.6 14.9 1.2 2.0 3.1 6.6 2.6 6.1 22.0 13.6 12.6 8.5 14.8 4.7 1.8 4.9 8.0 CFAP20 "C16orf80, fSAP23, GTL3" ENSG00000070761 "Cilia and flagella associated protein 20" Q9Y6A4 16 58113592-58129381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 336.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018195 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA018195: AB_1850408" "unprognostic (9.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.80e-1)" "unprognostic (7.45e-2)" "unprognostic (2.27e-1)" "unprognostic (7.14e-3)" "unprognostic (9.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-1)" "unprognostic (2.86e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-2)" "unprognostic (9.72e-2)" "unprognostic (9.71e-2)" "unprognostic (7.58e-3)" "unprognostic (1.47e-1)" 19.3 24.0 34.3 15.8 36.1 26.3 21.2 34.8 37.5 20.9 31.9 17.0 17.5 20.3 23.4 19.1 36.6 18.1 43.5 34.6 36.3 20.8 34.1 20.6 25.8 34.1 34.0 35.6 31.6 14.7 35.0 31.1 30.5 34.1 18.7 16.3 28.8 17.6 17.9 12.2 20.8 16.7 17.7 36.3 18.3 16.6 31.0 34.4 39.6 26.8 20.2 22.0 18.2 18.0 36.8 58.1 45.6 75.5 40.9 27.6 22.0 59.2 53.7 37.4 83.3 53.7 73.3 61.4 60.1 75.5 36.4 37.8 58.0 70.7 53.3 82.2 34.5 75.0 34.1 25.3 97.7 32.1 51.7 64.9 24.9 36.3 53.1 47.9 31.8 51.6 92.5 57.2 28.0 66.3 43.7 147.4 104.2 69.5 39.7 91.6 141.5 94.3 56.7 46.8 35.6 68.7 61.2 95.7 36.9 54.0 51.8 32.0 63.3 36.1 51.0 67.0 56.3 62.1 33.7 33.5 115.1 33.3 53.5 70.0 88.6 29.6 52.9 46.4 30.2 45.5 55.0 48.1 49.6 33.9 49.7 64.0 54.3 24.8 66.6 31.1 56.8 94.9 52.5 34.3 36.1 34.8 37.5 34.6 36.3 34.1 34.0 35.6 34.1 36.3 34.4 36.8 70.9 12.8 20.3 10.4 21.8 0.0 38.5 0.0 60.3 28.7 28.7 50.9 51.7 30.0 16.1 20.2 33.3 101.9 29.3 7.4 56.7 36.7 336.7 60.1 29.2 58.7 24.3 19.1 7.3 16.5 75.3 40.8 18.8 22.0 12.6 22.5 30.4 35.7 35.1 18.5 7.7 19.6 0.0 11.4 0.0 137.7 33.8 17.4 0.0 3.7 17.4 32.3 23.7 16.6 21.0 22.6 17.2 31.2 19.1 30.8 23.5 34.7 33.5 38.8 19.7 60.9 30.3 109.7 30.3 35.6 0.0 65.9 31.6 38.5 17.2 19.5 CSNK2A2 "CK2alpha', CSNK2A1" ENSG00000070770 "Casein kinase 2 alpha 2" P19784 16 58157907-58198106 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 113.6" "Group enriched" "Detected in all" 5 "Early spermatids: 227.4;Late spermatids: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 92000 "unprognostic (9.49e-2)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.40e-5)" "prognostic unfavorable (1.80e-4)" "unprognostic (6.84e-3)" "unprognostic (2.93e-3)" "unprognostic (2.40e-1)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (2.06e-3)" "unprognostic (7.07e-2)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" 20.9 14.3 19.8 9.1 19.9 6.4 19.2 19.3 22.3 21.7 23.6 25.8 10.0 21.2 29.3 15.9 20.4 14.3 21.1 20.2 20.3 17.4 16.1 16.3 14.4 19.3 20.5 19.2 32.7 34.5 24.1 15.8 15.6 19.3 15.6 12.6 13.6 17.1 16.8 41.4 60.8 14.4 22.1 20.0 12.7 28.1 113.6 20.4 18.4 18.1 27.0 17.4 24.4 19.8 20.2 28.1 35.3 24.5 19.1 46.2 62.5 27.6 24.7 41.8 47.7 30.7 64.0 23.2 44.2 38.8 29.6 18.9 29.2 41.6 37.2 53.4 16.9 28.3 23.4 18.0 56.1 66.5 32.6 20.5 66.9 88.9 33.8 65.9 62.0 45.4 43.6 53.4 15.1 31.0 15.8 41.2 21.9 23.4 16.6 45.7 48.4 38.7 25.7 33.1 28.7 20.5 18.4 39.7 20.3 63.6 41.9 13.9 24.6 33.6 27.8 33.7 23.3 25.7 36.2 30.2 63.2 24.3 21.8 24.4 1.1 0.2 0.3 0.7 0.1 0.4 0.6 1.1 0.4 0.2 0.6 1.8 1.3 0.0 0.7 0.1 1.9 0.0 0.1 19.8 19.9 19.3 22.3 20.2 20.3 19.3 20.5 19.2 19.3 20.0 20.4 20.2 30.6 12.8 22.5 19.2 16.7 29.6 10.9 13.0 8.6 24.0 19.3 19.9 24.4 12.8 7.6 9.2 4.2 15.9 28.3 16.4 7.9 14.5 227.4 24.7 37.8 25.8 16.8 10.3 27.7 17.2 26.1 17.7 8.6 29.5 8.2 37.0 19.6 17.0 16.9 18.5 19.1 11.9 4.1 25.5 23.0 281.0 14.3 23.1 12.4 20.6 14.2 25.3 18.6 20.6 26.1 25.0 11.5 19.5 9.2 18.1 16.0 16.3 13.4 21.7 13.1 29.2 23.2 48.1 36.8 12.6 29.0 24.5 20.3 35.6 17.5 23.0 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase non-receptor type 21" Q16825 14 88465778-88555007 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "CAB011468: AB_442979, HPA073999: AB_2732247" "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favorable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.0 5.5 7.1 4.2 6.9 0.0 9.3 6.7 6.7 10.9 9.6 11.2 6.0 12.1 6.0 10.4 10.2 8.8 21.5 6.3 9.6 7.8 7.7 18.1 2.2 9.9 7.9 6.0 17.7 9.4 8.4 4.6 10.4 7.0 9.3 7.7 9.2 7.5 9.6 11.9 29.3 8.3 10.5 8.2 4.1 9.1 20.4 7.6 1.1 18.8 9.9 1.9 10.2 9.9 7.7 5.8 4.6 11.8 4.6 12.3 10.6 12.1 15.2 11.6 8.8 12.2 8.1 10.2 0.0 3.6 19.6 7.9 5.4 1.7 5.4 12.9 0.3 2.7 0.0 5.6 3.4 13.6 0.1 0.2 7.1 10.4 7.4 8.8 11.4 7.2 0.0 1.8 0.2 22.9 4.7 0.0 0.3 3.5 6.2 8.7 0.1 35.3 0.1 7.7 4.1 0.8 13.6 8.7 21.6 5.2 10.0 10.7 2.3 14.5 16.3 12.8 6.7 10.6 0.5 1.9 0.0 6.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 6.9 6.7 6.7 6.3 9.6 9.9 7.9 6.0 7.0 8.2 7.6 7.7 7.2 57.7 6.0 14.4 0.0 10.5 6.3 4.0 4.0 7.2 7.1 5.8 34.9 5.7 7.1 7.3 35.5 10.3 0.1 18.1 0.0 5.0 19.1 10.2 11.4 6.0 4.8 8.0 12.8 8.4 5.4 12.0 7.1 7.1 2.5 9.2 6.1 9.7 1.9 1.7 14.4 15.0 8.2 1.3 3.9 5.3 17.1 0.4 0.0 13.1 0.0 4.7 1.0 28.1 20.3 10.7 6.1 27.1 0.0 8.8 6.7 3.5 10.3 9.4 0.0 12.7 10.5 20.2 6.6 3.5 11.9 101.9 0.6 7.4 6.2 4.7 EIF2B3 "EIF-2B, EIF2Bgamma" ENSG00000070785 "Eukaryotic translation initiation factor 2B subunit gamma" Q9NR50 1 44850522-44986722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024213, HPA024218, HPA024219" Supported Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069" "unprognostic (2.12e-2)" "unprognostic (7.49e-2)" "unprognostic (4.37e-3)" "unprognostic (5.14e-2)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (4.55e-2)" "unprognostic (1.14e-2)" "unprognostic (7.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (5.38e-2)" "unprognostic (6.98e-2)" "unprognostic (7.80e-2)" "unprognostic (5.69e-3)" "unprognostic (2.73e-2)" 22.6 27.4 12.0 11.7 11.7 11.0 22.1 13.9 15.7 18.2 10.7 15.5 8.7 17.1 12.6 17.5 16.4 9.7 35.2 11.8 12.3 15.5 24.9 13.6 14.4 12.5 12.7 12.3 18.3 17.0 30.2 16.0 9.8 13.0 15.1 13.5 19.1 25.3 13.8 77.8 17.3 10.8 19.6 11.5 15.0 14.3 19.5 12.2 13.4 12.7 48.4 14.6 17.9 17.3 14.7 35.4 26.9 30.9 25.5 36.3 43.1 36.2 56.1 42.2 56.5 52.9 39.0 20.7 90.6 39.9 43.2 45.0 20.6 65.3 48.6 69.5 32.5 58.1 44.3 29.3 38.4 46.2 71.2 24.3 29.3 25.8 61.0 69.9 26.5 52.8 30.1 106.1 31.6 62.3 23.1 69.7 30.2 42.0 38.8 52.7 54.7 51.3 65.7 28.7 15.7 53.2 20.5 55.1 63.8 37.4 40.7 24.7 32.8 28.3 35.9 42.9 53.4 73.7 31.6 37.9 68.9 27.9 59.5 43.1 1.6 23.4 3.9 18.6 37.2 22.8 14.8 18.3 21.1 37.0 18.9 22.9 23.6 2.1 25.5 33.1 25.3 17.6 21.4 12.0 11.7 13.9 15.7 11.8 12.3 12.5 12.7 12.3 13.0 11.5 12.2 14.7 13.9 6.4 22.0 24.8 15.8 13.8 19.0 33.0 10.8 15.1 15.8 16.8 79.2 15.7 24.9 5.5 20.9 25.1 12.1 4.5 29.4 18.9 26.1 17.0 23.0 14.4 3.6 15.3 39.9 15.8 22.6 22.6 13.7 11.5 25.9 21.1 3.9 22.6 24.8 21.9 44.5 7.0 20.3 10.7 11.2 11.3 26.4 15.4 17.8 26.2 30.1 21.7 10.3 29.1 35.7 13.7 6.9 25.2 22.6 17.1 5.7 23.1 34.2 21.8 26.3 19.7 45.4 45.5 23.6 17.1 14.9 14.9 13.5 40.4 9.4 13.9 CAMK2A "CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 697.8" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 245.8" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Region enhanced" "Detected in many" "cerebral cortex: 697.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 1071.1" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 66000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 0.2 0.9 166.6 0.2 233.1 0.1 0.1 0.0 697.8 1.2 0.0 0.8 0.1 2.8 0.3 1.3 1.5 0.3 4.9 492.9 76.7 0.7 0.2 0.9 0.0 15.2 8.0 257.3 0.4 0.1 0.0 3.6 0.3 107.2 0.8 0.2 1.9 0.7 0.4 95.9 0.7 0.4 2.4 0.0 0.3 0.5 0.1 9.0 0.0 0.1 35.0 0.0 2.0 0.7 131.4 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.9 0.0 0.7 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.6 233.1 0.0 697.8 492.9 76.7 15.2 8.0 257.3 107.2 0.0 9.0 131.4 0.0 0.0 0.0 12.1 0.0 3.4 0.0 0.0 0.0 5.1 0.0 0.0 14.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.0 0.0 245.8 0.0 0.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 55.5 0.0 0.0 0.0 0.8 0.3 0.0 0.0 3.6 9.4 0.0 0.4 0.0 8.5 8.1 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 3.6 1.8 0.0 0.3 0.0 1.4 0.3 0.2 0.0 0.0 0.0 TCOF1 "TCS, treacle" ENSG00000070814 "Treacle ribosome biogenesis factor 1" Q13428 5 150357629-150400308 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 105.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033199, HPA038237, HPA038238" Enhanced Enhanced "Nucleoli fibrillar center" NA NA 18000 "Nucleoli fibrillar center" "CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524" "unprognostic (7.23e-2)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (3.18e-3)" "unprognostic (9.40e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.26e-8)" "unprognostic (1.71e-2)" "unprognostic (1.11e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.62e-5)" "unprognostic (1.21e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (2.41e-1)" 12.9 10.9 43.2 14.6 42.2 14.0 13.6 42.4 105.6 15.4 38.9 17.5 7.4 16.9 7.4 16.8 14.9 6.5 13.6 42.3 40.5 12.0 9.6 12.6 18.5 43.7 41.8 40.6 15.8 14.9 10.0 11.1 10.4 45.0 15.9 8.8 9.7 12.2 10.9 21.6 16.7 15.4 11.8 39.9 18.9 14.4 14.6 43.9 20.7 12.7 9.8 16.4 19.9 14.2 47.9 78.3 85.0 42.7 80.3 16.2 21.4 115.1 59.4 24.5 81.1 80.9 211.5 59.3 113.1 53.2 21.9 92.6 88.2 93.0 107.4 57.4 59.9 100.8 54.9 55.6 80.8 17.4 91.5 40.7 18.0 24.8 94.1 71.4 20.1 36.1 59.2 80.2 32.8 27.7 70.7 100.4 67.4 128.8 35.3 80.4 91.4 67.4 64.8 19.5 54.3 58.0 59.7 68.5 111.0 55.2 66.8 49.7 36.1 35.0 59.3 73.5 71.8 113.4 40.6 55.6 123.4 46.6 78.2 54.1 1.6 2.2 1.1 3.8 2.0 4.8 4.6 3.6 3.8 2.1 4.2 3.1 3.4 1.4 8.3 2.1 2.2 2.4 3.2 43.2 42.2 42.4 105.6 42.3 40.5 43.7 41.8 40.6 45.0 39.9 43.9 47.9 18.5 9.6 22.4 7.8 41.7 40.0 21.1 14.5 15.9 25.4 13.6 12.7 17.9 11.5 10.4 11.0 41.7 21.7 29.7 24.0 5.9 19.6 8.4 13.2 17.3 24.4 18.7 23.3 7.4 23.4 41.0 20.1 18.3 17.6 23.5 29.1 12.8 10.0 28.8 21.9 6.4 18.8 16.2 27.9 53.3 6.8 19.0 40.0 12.4 2.8 27.8 9.7 33.0 3.0 8.9 15.2 8.4 15.8 26.1 37.8 15.1 6.3 10.1 25.6 26.3 20.3 17.7 27.6 34.1 22.7 39.1 8.9 26.3 20.1 32.0 19.3 CDC42 "CDC42Hs, G25K" ENSG00000070831 "Cell division cycle 42" P60953 1 22025511-22101360 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004360, HPA069590" Approved Supported "Microtubules,Cytokinetic bridge" Yes No 2700000 "Microtubules, Cytokinetic bridge" "CAB004360: AB_627233, HPA069590: AB_2732138" "unprognostic (9.40e-2)" "unprognostic (1.37e-1)" "unprognostic (9.45e-3)" "unprognostic (5.11e-2)" "unprognostic (1.73e-1)" "unprognostic (9.72e-2)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.09e-1)" "unprognostic (7.92e-3)" "unprognostic (1.86e-2)" "unprognostic (3.90e-2)" "unprognostic (9.41e-2)" "unprognostic (9.72e-3)" "unprognostic (2.71e-1)" "unprognostic (3.88e-2)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" 179.0 117.2 100.1 161.7 102.2 406.5 144.2 106.1 114.7 129.7 111.9 200.0 143.6 132.5 100.7 163.7 125.9 132.9 118.1 102.0 121.1 160.3 154.8 155.4 169.2 123.0 108.2 101.4 106.9 83.2 129.5 60.1 171.8 115.6 109.3 187.2 96.7 104.7 108.5 121.1 129.5 158.2 176.5 116.1 158.9 161.4 64.8 105.6 159.2 111.6 122.0 218.6 196.6 115.9 132.0 341.9 146.4 272.2 222.0 295.0 306.4 274.2 347.3 318.8 365.5 336.2 178.0 374.5 253.1 272.8 416.7 136.2 210.7 241.1 369.3 431.1 332.4 180.1 438.1 184.5 225.4 259.1 388.5 350.5 285.6 396.6 341.0 195.2 234.7 535.6 157.8 250.8 273.4 430.2 135.6 242.9 307.5 170.2 242.9 179.3 199.6 297.6 243.3 316.2 301.3 183.4 175.8 293.4 228.7 263.4 296.3 242.3 219.1 466.3 265.3 265.2 349.3 207.8 148.6 355.9 305.8 234.5 419.3 277.6 244.3 200.6 255.1 142.4 282.3 144.3 108.0 152.0 146.7 162.3 103.4 109.5 143.5 308.3 145.0 352.2 107.2 157.4 244.8 100.1 102.2 106.1 114.7 102.0 121.1 123.0 108.2 101.4 115.6 116.1 105.6 132.0 502.1 60.9 51.8 20.9 301.0 450.6 385.5 266.0 136.1 119.1 281.1 179.6 86.9 231.6 168.0 312.6 18.8 349.6 470.1 434.9 375.6 441.3 38.0 350.5 356.5 307.7 300.4 243.0 58.5 441.9 499.6 225.2 152.4 425.8 163.6 138.2 277.0 230.9 439.2 106.0 71.0 315.4 187.2 585.4 875.2 41.3 157.8 443.4 423.4 53.4 654.9 102.5 286.3 41.7 72.9 570.5 369.7 177.1 192.9 323.1 283.1 578.2 176.2 65.2 236.7 174.2 308.3 155.3 116.2 176.6 556.6 551.6 379.2 178.6 286.7 469.6 OSBPL3 "KIAA0704, ORP-3, ORP3, OSBP3" ENSG00000070882 "Oxysterol binding protein like 3" Q9H4L5 7 24796540-24981634 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000691, HPA048401" Enhanced Supported Nucleoli,Cytosol NA Yes Cytosol Nucleoli "HPA000691: AB_1854814, HPA048401: AB_2680386" "unprognostic (3.57e-1)" "unprognostic (1.14e-1)" "unprognostic (6.11e-3)" "unprognostic (3.89e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.57e-3)" "unprognostic (4.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (2.34e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" 2.6 1.2 4.7 6.9 4.9 4.2 3.9 3.7 8.7 10.2 4.5 6.0 9.4 2.3 0.8 7.7 5.2 5.1 2.5 6.2 4.2 10.4 1.2 8.7 11.4 4.0 4.3 3.1 5.3 1.9 14.2 2.0 3.9 4.1 2.3 6.1 1.3 3.7 2.5 3.4 10.4 7.7 3.7 4.1 6.8 8.6 2.9 4.3 8.3 9.9 2.1 14.5 13.4 6.5 6.0 40.2 10.7 7.8 14.4 17.3 34.5 17.5 44.5 49.3 20.4 32.1 27.0 52.0 22.2 6.2 47.8 26.9 34.6 23.6 33.4 31.4 13.5 9.8 5.3 16.4 20.4 24.5 15.3 113.8 17.0 27.2 26.7 31.8 26.0 31.0 19.0 28.4 30.1 34.9 0.0 9.4 18.7 15.3 38.1 13.7 7.5 21.6 9.1 20.4 28.2 1.6 16.1 30.3 21.5 6.7 23.0 11.1 1.5 37.1 9.1 17.9 49.4 33.7 20.7 32.8 55.6 19.5 24.7 102.0 5.8 1.9 1.5 8.5 1.7 7.3 3.3 5.3 5.6 3.3 1.6 1.8 3.5 0.4 7.7 1.2 2.3 9.5 2.5 4.7 4.9 3.7 8.7 6.2 4.2 4.0 4.3 3.1 4.1 4.1 4.3 6.0 2.2 0.0 26.1 123.1 18.3 12.1 8.0 8.8 21.6 0.3 3.8 4.4 5.5 5.7 22.2 25.8 0.0 8.4 13.2 3.8 3.9 3.5 0.3 24.6 2.3 3.6 1.8 11.1 176.1 3.9 2.1 3.1 19.4 31.9 0.0 0.4 3.6 0.5 10.8 0.0 272.2 1.7 20.3 12.7 9.3 0.3 0.6 13.2 16.0 94.6 7.8 4.8 14.4 44.2 3.6 24.4 4.5 0.0 91.7 5.2 3.3 0.5 53.1 0.2 0.0 3.4 4.6 0.5 5.0 16.5 8.0 4.0 18.5 20.3 4.5 16.5 EPHA8 "EEK, Hek3" ENSG00000070886 "EPH receptor A8" P29322 1 22563489-22603595 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "choroid plexus: 23.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.2;Cone photoreceptor cells: 2.1;Early spermatids: 2.8;Horizontal cells: 3.3;Late spermatids: 5.8;Rod photoreceptor cells: 8.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 59.6" "Region enhanced" "Detected in many" "cerebellum: 13.0" "Region enriched" "Detected in many" 4 "cerebellum: 11.7" "CAB009660, HPA031433" Uncertain "Intracellular and membrane" NA NA "CAB009660: AB_2099696, HPA031433: AB_10601371" "unprognostic (8.58e-2)" "unprognostic (8.59e-2)" "unprognostic (3.72e-1)" "unprognostic (1.15e-2)" "unprognostic (4.69e-4)" "unprognostic (3.58e-1)" "unprognostic (7.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.75e-2)" "unprognostic (9.80e-2)" "unprognostic (2.10e-1)" "unprognostic (9.84e-14)" "unprognostic (2.14e-3)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (8.68e-2)" 0.0 3.6 1.8 0.0 2.4 0.0 0.0 1.4 1.8 0.0 23.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.8 0.0 0.0 0.0 0.0 1.7 2.9 2.2 0.0 3.3 0.0 1.5 0.0 1.6 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 4.6 0.0 2.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.6 4.8 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 1.4 1.8 5.0 4.8 1.7 2.9 2.2 1.6 1.0 3.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 8.8 0.0 0.0 0.1 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A3 NCCT ENSG00000070915 "Solute carrier family 12 member 3" P55017 16 56865207-56915850 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 100 "kidney: 101.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 20 "plasmacytoid DC: 14.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 14.9" "Group enriched" "Detected in some" 11 "BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA028748 Enhanced NA NA "HPA028748: AB_10603886" "unprognostic (1.54e-3)" "unprognostic (7.09e-5)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.38e-4)" "unprognostic (1.81e-1)" "unprognostic (9.70e-2)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.84e-2)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.3 0.4 0.5 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 101.7 0.0 0.1 0.8 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.3 0.4 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 4.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.1 0.3 0.5 0.0 1.0 0.6 0.0 0.6 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.7 0.0 0.0 4.2 0.0 5.9 0.0 0.4 2.1 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 4.2 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RAD18 RNF73 ENSG00000070950 "RAD18 E3 ubiquitin protein ligase" Q9NS91 3 8775402-8963773 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006716, HPA006724, HPA008752" Supported Approved Enhanced "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-3)" "unprognostic (2.73e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.01e-1)" "unprognostic (9.76e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.73e-4)" "prognostic unfavorable (3.65e-5)" "unprognostic (1.97e-2)" "unprognostic (1.51e-1)" "unprognostic (7.92e-2)" "unprognostic (1.89e-2)" 2.5 2.3 1.4 3.4 1.7 5.3 5.4 1.6 2.0 3.0 0.6 3.8 10.2 2.8 2.0 3.5 2.3 3.1 1.7 1.7 1.7 1.6 2.8 2.8 4.7 2.2 1.3 1.5 2.8 1.7 2.1 1.3 3.0 1.9 3.3 5.0 2.6 3.2 1.6 1.4 4.6 6.5 2.8 1.3 3.5 2.2 2.9 1.4 5.8 3.7 1.0 4.5 2.5 3.0 2.5 16.2 15.2 12.3 7.4 3.0 6.4 14.9 25.0 8.5 23.5 16.1 13.7 10.1 19.8 4.7 14.2 13.8 5.6 13.1 13.0 23.8 12.2 17.2 16.9 16.1 8.2 1.9 22.7 13.9 2.4 4.6 23.3 15.7 6.3 7.7 17.1 18.2 19.0 20.9 18.6 22.9 15.9 17.2 12.7 28.5 18.0 13.6 15.6 6.9 12.2 5.1 11.5 11.2 10.5 8.2 9.7 11.0 9.8 6.4 19.4 10.5 16.8 21.7 9.6 16.1 43.7 14.3 24.5 14.6 6.4 1.6 5.1 1.5 1.7 2.8 1.9 2.1 2.7 2.0 1.9 2.2 1.6 0.7 2.8 1.1 3.6 3.0 0.8 1.4 1.7 1.6 2.0 1.7 1.7 2.2 1.3 1.5 1.9 1.3 1.4 2.5 5.7 16.0 9.8 6.2 7.7 11.1 7.5 6.4 5.7 4.6 7.3 11.7 2.2 4.3 7.5 3.7 2.1 9.0 8.6 5.2 1.9 9.6 4.2 4.0 5.8 4.6 1.8 7.2 20.9 8.2 12.4 6.8 3.6 4.9 13.9 14.8 6.1 3.1 7.1 3.3 15.7 6.5 2.0 5.2 5.6 3.0 4.1 4.6 3.6 14.0 7.1 3.2 8.2 16.1 14.3 10.2 4.3 2.6 8.7 6.4 4.0 3.1 4.1 2.3 6.6 4.3 6.9 26.2 14.0 6.0 11.8 6.7 7.5 9.3 6.3 3.6 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 781.6;Langerhans cells: 435.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 314.6;LHCN-M2: 501.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 18.6 11.4 19.0 25.8 67.1 107.8 19.8 17.8 56.4 19.0 0.0 33.4 41.2 18.4 12.2 14.8 18.8 25.4 11.1 44.5 27.1 16.5 22.9 21.4 29.4 14.4 18.6 41.7 13.2 17.2 21.7 11.1 27.5 26.7 14.0 32.6 71.8 11.6 15.0 24.6 26.2 30.4 19.9 0.0 31.0 29.3 23.3 12.1 18.6 14.5 24.3 29.0 37.4 10.7 40.0 24.0 117.8 45.5 22.1 64.5 102.2 20.9 71.2 232.6 67.5 106.8 47.7 21.6 46.8 4.9 99.3 77.6 21.0 40.3 19.7 187.5 16.2 46.9 16.6 39.8 41.9 209.6 70.7 26.6 85.0 36.9 210.8 314.6 78.9 17.5 17.6 27.9 16.6 501.1 37.6 22.1 30.1 35.6 32.9 55.6 31.1 146.4 19.7 64.4 108.5 42.9 23.4 82.6 22.9 20.2 91.7 33.9 7.8 12.5 181.8 29.4 67.6 78.9 12.7 21.2 49.1 82.6 19.6 41.0 9.4 39.4 22.3 20.9 42.5 26.4 84.5 36.3 26.8 51.3 84.4 13.2 16.8 127.1 27.0 86.1 9.0 53.7 21.8 19.0 67.1 17.8 56.4 44.5 27.1 14.4 18.6 41.7 26.7 0.0 12.1 40.0 46.0 44.8 46.0 90.8 226.4 201.6 71.0 29.3 76.2 370.9 30.9 109.7 20.3 45.8 30.0 53.3 154.3 176.8 139.8 181.5 1.9 27.6 2.3 29.3 61.0 63.6 91.6 31.5 781.6 28.5 42.1 91.6 44.9 59.4 31.6 45.5 49.6 39.5 193.5 302.9 279.1 30.7 16.2 116.0 435.1 9.6 29.2 285.4 55.2 126.5 157.1 96.4 50.4 193.5 91.9 25.5 80.6 32.0 133.9 54.7 75.0 22.1 20.6 113.3 32.9 97.0 69.5 44.5 130.7 30.4 204.7 228.8 125.1 76.0 65.9 90.2 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;intestine: 3.3;pancreas: 2.4;seminal vesicle: 1.8" "Cell type enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 9.7" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.1 2.9 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.1 0.3 0.6 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.1 NCK2 NCKbeta ENSG00000071051 "NCK adaptor protein 2" O43639 2 105744912-105894274 "Plasma proteins, Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 184.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016116, HPA031004" Approved NA NA 87000 "CAB016116: AB_2150588, HPA031004: AB_10795571" "unprognostic (2.39e-1)" "unprognostic (3.48e-1)" "unprognostic (6.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (5.85e-3)" "unprognostic (4.04e-2)" "unprognostic (4.88e-2)" "unprognostic (1.22e-1)" "unprognostic (9.62e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.24e-2)" "unprognostic (2.14e-2)" "unprognostic (7.21e-3)" "unprognostic (4.22e-2)" 35.1 19.9 18.9 20.7 19.6 17.7 33.9 26.6 29.2 30.9 18.6 37.7 55.2 30.0 19.0 69.4 25.6 19.2 28.9 28.0 20.9 26.5 11.2 37.4 27.8 21.7 22.8 19.1 25.3 40.2 13.7 19.8 37.1 22.7 24.9 16.5 10.4 47.2 18.9 54.0 33.4 52.2 18.0 21.4 52.4 40.6 27.5 23.1 18.8 28.6 27.4 19.3 35.9 50.8 23.2 25.8 20.2 51.6 23.9 15.0 10.7 73.3 19.0 25.0 21.6 12.5 58.8 20.9 11.2 23.4 24.2 31.0 25.1 21.9 47.7 14.6 79.5 24.5 5.0 9.4 37.8 39.2 28.1 9.8 21.4 34.0 23.5 30.0 18.7 22.0 27.3 7.7 38.5 17.9 21.7 29.3 48.2 28.8 21.6 23.0 23.4 36.2 41.7 28.1 51.2 32.9 45.4 14.4 37.2 184.4 30.4 13.6 70.3 25.0 37.9 55.2 1.0 27.2 28.8 19.6 3.8 16.7 24.5 61.6 26.2 1.0 12.5 7.0 1.0 9.2 7.7 13.1 11.8 1.2 11.1 13.6 12.5 9.3 11.9 1.0 1.8 24.5 5.0 18.9 19.6 26.6 29.2 28.0 20.9 21.7 22.8 19.1 22.7 21.4 23.1 23.2 41.8 16.0 7.9 28.1 32.8 17.6 13.9 14.2 7.4 13.5 27.1 35.9 21.3 71.4 9.6 16.5 12.5 39.0 30.3 31.2 7.9 28.1 15.5 18.0 21.8 23.7 19.2 2.5 60.0 18.8 15.2 16.2 13.3 19.9 5.7 33.0 18.2 2.3 26.0 82.4 48.4 23.1 18.3 14.2 13.9 9.2 23.6 18.7 10.6 77.8 10.5 61.4 18.6 24.6 18.3 29.9 29.2 28.2 15.8 17.7 51.3 8.4 18.9 4.6 32.9 33.1 54.4 4.2 9.6 10.7 16.8 29.7 52.4 18.1 31.2 30.0 MAP4K4 "FLH21957, HGK, NIK" ENSG00000071054 "Mitogen-activated protein kinase kinase kinase kinase 4" O95819 2 101696850-101894689 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 433.8" "Cell type enhanced" "Detected in many" "Microglial cells: 337.3;Oligodendrocytes: 1134.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008476 Uncertain NA NA "HPA008476: AB_1079362" "unprognostic (6.40e-2)" "unprognostic (1.09e-2)" "unprognostic (4.01e-1)" "unprognostic (1.89e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-2)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (4.29e-2)" "unprognostic (9.79e-2)" "unprognostic (2.22e-3)" "unprognostic (8.65e-2)" "prognostic unfavorable (3.62e-6)" "unprognostic (6.67e-3)" "unprognostic (8.98e-2)" "unprognostic (3.15e-1)" "unprognostic (7.14e-3)" 54.6 9.2 340.1 43.3 321.6 73.2 32.4 238.1 273.3 23.3 129.6 18.2 10.7 27.7 12.3 35.5 19.9 34.8 45.2 240.5 275.9 13.0 33.1 29.5 54.5 342.1 310.6 186.3 23.3 16.3 15.1 10.1 49.9 421.1 14.0 18.0 22.9 19.5 10.3 37.7 20.1 17.9 28.9 283.0 24.4 22.2 40.5 330.0 44.7 15.9 30.9 60.6 33.4 25.8 433.8 112.7 83.8 175.2 84.3 162.4 288.6 219.5 139.8 114.3 122.2 100.1 139.5 145.6 163.1 118.3 210.3 36.0 45.5 56.0 123.2 121.1 219.8 38.0 122.4 62.5 367.7 136.7 59.1 5.5 261.3 55.3 301.9 133.5 122.1 322.5 90.3 80.9 0.4 325.4 61.3 137.8 36.5 89.2 42.5 131.5 164.1 120.0 0.6 81.2 38.8 68.5 113.6 96.5 0.4 104.0 160.8 22.4 105.1 409.1 240.5 102.9 70.6 168.6 0.3 0.4 96.7 155.2 73.2 180.1 8.8 3.2 0.0 2.3 3.2 1.6 3.4 2.9 1.5 1.1 5.0 2.2 2.5 13.5 1.1 3.1 6.0 3.7 1.5 340.1 321.6 238.1 273.3 240.5 275.9 342.1 310.6 186.3 421.1 283.0 330.0 433.8 104.3 19.2 23.9 283.0 64.5 30.0 41.9 17.4 12.5 109.1 14.3 17.4 71.0 28.6 29.6 18.4 50.1 13.1 38.4 12.0 0.0 57.4 31.5 67.2 77.1 84.2 17.4 48.0 197.5 53.2 23.4 49.7 26.5 101.0 24.0 151.8 67.1 39.2 38.8 35.3 122.4 13.6 14.2 26.9 245.9 46.0 55.0 54.7 19.6 337.3 88.0 49.2 10.3 228.7 1134.5 128.1 12.0 17.3 18.0 72.1 5.3 6.3 22.9 10.4 52.6 65.2 73.3 29.0 82.1 24.3 24.6 7.8 38.4 17.2 14.4 40.4 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A" Q9UM21 2 98619106-98731132 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 96.8" "Cell type enhanced" "Detected in many" "Microglial cells: 175.2;Proximal enterocytes: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 11.3 7.8 13.8 21.0 19.7 96.8 12.6 27.4 16.6 9.0 17.6 24.7 29.7 5.9 3.7 6.4 7.0 12.8 7.0 14.3 19.6 27.8 9.7 17.0 21.2 15.6 16.7 14.0 3.2 39.1 28.2 9.9 19.8 17.9 7.6 25.7 5.4 26.1 6.4 3.8 3.9 44.2 11.6 21.2 8.1 11.4 6.3 16.1 20.7 8.7 4.7 18.4 13.3 4.7 21.3 8.8 1.7 3.4 7.3 0.0 0.0 127.2 0.0 0.1 0.9 0.0 21.0 10.6 0.0 18.9 0.0 2.4 0.4 7.2 1.0 0.2 10.6 7.9 0.5 0.0 36.7 0.2 17.8 6.4 0.0 4.7 0.0 0.7 0.3 48.3 86.5 1.6 9.2 0.0 17.3 39.3 30.9 1.1 7.6 1.4 9.8 0.0 10.5 24.8 17.6 10.4 3.3 2.5 32.2 4.8 9.2 7.6 23.8 78.8 0.0 4.0 0.1 2.6 3.2 7.6 2.2 0.0 26.7 0.6 7.0 5.1 12.7 20.8 1.0 27.5 3.6 25.2 23.7 3.8 2.5 32.6 27.2 14.0 15.3 2.5 17.1 16.0 12.5 13.8 19.7 27.4 16.6 14.3 19.6 15.6 16.7 14.0 17.9 21.2 16.1 21.3 80.8 54.5 25.7 19.2 22.7 9.9 21.1 6.1 11.4 19.8 28.2 15.6 13.4 11.5 17.6 22.0 4.2 6.2 116.9 92.4 21.5 20.8 12.7 14.2 3.8 39.8 53.0 6.3 58.0 29.8 77.9 7.2 19.4 35.1 13.3 5.1 18.9 10.4 57.2 48.8 48.6 41.3 34.6 33.9 18.3 17.5 2.5 54.5 10.6 175.2 21.0 13.4 89.6 36.7 42.0 21.6 58.2 2.2 31.4 17.8 132.4 27.3 7.1 4.8 6.6 6.8 4.9 2.5 7.7 8.6 10.5 14.9 112.2 0.7 40.9 30.2 RPL31 L31 ENSG00000071082 "Ribosomal protein L31" P62899 2 101002229-101024032 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072263 Approved NA NA 110000 "HPA072263: AB_2686502" "unprognostic (4.82e-3)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (1.86e-2)" "unprognostic (9.36e-2)" "unprognostic (3.32e-2)" "unprognostic (3.94e-2)" "unprognostic (8.43e-2)" "unprognostic (2.24e-2)" "unprognostic (5.69e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.08e-6)" "unprognostic (1.81e-1)" "unprognostic (4.92e-2)" "unprognostic (2.35e-2)" "unprognostic (2.51e-2)" 2758.6 1950.2 1800.1 1398.8 1809.8 4292.4 3111.4 1719.7 2524.2 3395.2 1808.8 2353.2 1197.4 2455.8 1727.5 2942.1 2811.6 934.4 1953.3 1759.4 1786.0 2130.7 1666.7 1881.5 2392.5 1780.4 1763.6 1739.4 5983.3 3708.2 1206.4 2133.8 1320.9 1793.2 2454.8 1384.6 641.5 2280.4 966.1 2641.5 3046.3 2071.9 1041.8 1839.6 2201.2 2300.9 772.8 1806.7 2256.1 1969.0 1412.2 2259.3 2609.6 3064.8 1828.7 2131.8 1223.9 2161.3 3354.1 4081.4 5576.9 4033.6 3365.3 2630.1 2057.6 1635.4 3869.0 2441.5 5448.6 2542.4 2168.0 2092.3 2298.5 2112.3 3408.0 2154.0 1942.4 3326.5 3222.5 3926.9 4547.4 3203.0 5735.5 2507.1 4590.2 5268.6 1810.4 4133.3 4419.6 2364.2 2877.4 3081.2 1252.2 2394.2 2822.0 4274.2 7185.2 4047.5 2859.0 1460.9 2363.2 3273.8 4437.9 3238.0 3345.3 2666.9 2906.1 1424.2 4883.1 6312.3 1954.6 2369.4 7643.6 3601.4 1663.1 2960.9 1965.0 2671.1 2618.3 3840.8 3720.7 2310.8 5301.1 1651.1 1913.5 3911.6 860.5 4359.8 2983.4 7228.7 8467.2 7801.4 6122.4 5140.0 7039.0 10632.6 8774.1 567.2 5348.4 2507.4 5182.9 5414.0 14433.2 1800.1 1809.8 1719.7 2524.2 1759.4 1786.0 1780.4 1763.6 1739.4 1793.2 1839.6 1806.7 1828.7 371.3 1352.6 2182.1 17.3 2271.0 3559.8 3859.2 3734.6 1044.3 69.1 2577.6 1284.6 809.5 1870.1 2378.5 1259.8 33.3 4002.6 1393.0 1267.4 3644.9 2181.4 1237.0 750.6 1149.8 1613.1 1770.7 1556.4 23.5 4152.0 4687.5 1518.2 498.9 849.8 2176.4 458.5 2626.5 2193.9 2563.9 48.8 19.5 3731.2 1055.9 2680.9 4079.7 2108.6 4234.0 1331.1 2459.9 16.9 3560.2 409.0 3318.3 21.6 16.7 3288.7 2799.4 2097.7 609.8 3081.4 2175.4 4409.4 1292.7 99.5 1255.6 2624.5 1366.9 600.1 397.6 1504.9 4376.2 3853.0 2405.7 543.9 3818.3 3606.7 WDR1 ENSG00000071127 "WD repeat domain 1" O75083 4 10074339-10116949 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1232.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020804, HPA036434, HPA070293" Approved Supported "Plasma membrane,Cell Junctions" NA NA 63000000 "Plasma membrane, Cell Junctions" "CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152" "unprognostic (1.35e-1)" "unprognostic (6.64e-2)" "unprognostic (5.31e-2)" "unprognostic (1.32e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (2.63e-3)" "unprognostic (6.83e-3)" "unprognostic (1.69e-1)" "unprognostic (9.00e-3)" "unprognostic (2.52e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.73e-5)" "unprognostic (1.11e-1)" "unprognostic (3.56e-1)" "unprognostic (3.46e-2)" "unprognostic (4.83e-3)" 125.5 78.3 58.8 196.2 57.2 152.2 108.7 56.2 64.1 144.1 99.3 191.7 150.4 263.3 91.8 166.7 181.1 118.4 130.4 65.3 77.6 120.0 84.9 144.0 176.0 67.0 61.0 51.3 121.5 64.2 90.3 58.9 106.2 62.7 125.5 142.8 93.8 125.9 175.3 95.7 104.9 149.5 216.5 63.2 110.9 132.8 133.0 61.7 189.7 110.7 90.3 150.8 204.7 140.5 66.9 249.5 246.9 213.2 179.4 160.1 265.9 336.9 612.9 561.7 542.9 423.1 296.4 303.3 173.6 193.3 744.4 579.3 158.8 237.3 451.0 582.4 270.7 82.8 494.1 244.6 213.8 377.9 159.4 538.6 256.7 228.4 552.9 276.3 418.7 599.3 301.6 151.6 273.3 540.7 142.8 700.1 229.0 253.4 200.7 250.4 327.8 197.7 146.7 344.9 394.7 72.4 80.5 265.6 141.3 257.3 282.9 120.1 173.9 909.9 415.7 174.6 345.7 548.0 173.4 296.4 225.5 439.7 240.4 522.9 177.4 115.7 213.6 172.3 195.9 134.4 81.6 143.8 173.0 141.4 61.1 145.6 156.9 201.5 129.0 246.9 154.5 214.9 298.4 58.8 57.2 56.2 64.1 65.3 77.6 67.0 61.0 51.3 62.7 63.2 61.7 66.9 66.5 35.3 52.9 10.1 77.0 145.3 204.6 103.5 46.7 22.0 65.9 68.7 62.9 52.9 87.4 104.8 41.7 172.5 126.7 347.1 86.1 282.5 500.8 72.2 63.8 103.6 109.2 56.8 4.7 211.3 302.4 68.7 118.3 111.7 82.4 78.7 84.3 71.8 249.2 33.7 8.4 152.6 138.4 159.4 135.8 1232.1 46.9 174.9 80.0 15.0 303.7 82.6 147.2 11.6 9.6 322.8 244.4 92.2 78.3 150.7 169.0 113.1 73.5 28.0 98.6 46.1 168.1 81.6 64.3 74.9 137.0 231.6 132.2 77.2 172.8 193.6 SNX13 "KIAA0713, RGS-PX1" ENSG00000071189 "Sorting nexin 13" Q9Y5W8 7 17790761-17940501 "Predicted membrane proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 274.3;Late spermatids: 211.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.26e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (9.02e-2)" "unprognostic (3.25e-1)" "unprognostic (2.52e-1)" "unprognostic (4.39e-1)" "unprognostic (1.23e-1)" "unprognostic (2.21e-1)" "unprognostic (7.85e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.98e-6)" "unprognostic (8.12e-2)" "unprognostic (6.96e-2)" "unprognostic (4.07e-1)" "unprognostic (1.46e-1)" 12.9 12.9 9.9 8.0 10.5 4.9 12.9 11.7 11.2 11.8 9.2 13.2 10.0 13.8 13.1 8.1 9.5 9.3 12.8 10.1 10.7 13.8 9.1 9.5 8.9 10.4 10.9 9.0 13.8 9.8 21.1 8.6 14.3 10.3 13.3 13.9 11.3 12.6 9.8 14.3 10.3 9.7 10.2 9.6 10.6 11.7 7.9 10.5 8.4 17.5 17.5 7.3 9.3 10.1 10.7 8.6 4.0 7.5 9.9 19.7 19.0 8.9 8.4 13.3 6.7 8.0 3.5 8.6 9.4 5.6 9.6 14.3 9.1 5.9 7.9 10.9 1.7 6.8 3.3 8.2 4.7 12.4 8.3 6.0 13.7 14.5 6.3 10.7 13.4 9.7 6.6 7.3 7.7 12.1 4.1 6.0 10.5 7.0 11.1 7.1 4.4 7.8 5.1 14.5 13.2 6.5 6.7 7.9 18.0 7.7 14.8 9.6 14.2 9.0 10.3 4.9 13.8 10.1 15.4 6.1 7.3 14.6 5.6 15.1 0.9 0.9 1.2 0.7 1.5 1.1 0.9 0.6 0.5 0.8 0.6 0.8 0.7 2.0 0.9 1.2 0.5 0.4 0.4 9.9 10.5 11.7 11.2 10.1 10.7 10.4 10.9 9.0 10.3 9.6 10.5 10.7 29.9 22.4 32.1 65.6 24.6 10.6 14.0 15.6 21.1 19.4 18.4 14.2 41.3 12.8 28.3 12.9 43.8 34.1 20.7 30.1 13.7 13.2 274.3 22.7 30.2 22.9 19.8 24.8 89.7 12.9 14.2 25.6 22.4 17.3 19.6 24.8 35.7 15.4 23.7 16.8 96.0 16.1 22.4 31.4 22.8 211.1 23.6 31.5 5.4 126.5 23.4 18.8 16.5 107.5 94.3 12.3 27.7 17.7 21.2 19.9 18.8 17.3 31.3 25.0 26.3 28.6 24.5 34.2 21.5 20.1 11.9 51.3 18.5 25.7 16.3 24.5 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "intestine: 256.7" "Cell type enriched" "Detected in some" 4 "Distal enterocytes: 1139.3" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.2 0.0 0.0 11.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 236.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 256.7 0.0 0.0 0.5 0.0 0.0 0.3 4.8 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1139.3 0.0 0.0 0.4 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.6 0.1 27.8 0.0 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072776 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 16.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 80.2" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 30.2 11.4 5.0 7.0 6.2 3.3 22.8 2.6 6.7 30.9 9.8 35.4 5.0 17.0 9.9 36.0 35.4 13.1 33.8 6.3 3.1 9.7 7.9 15.3 5.8 3.6 5.0 3.1 33.7 9.3 16.2 6.3 10.8 4.0 26.2 8.1 14.5 11.2 20.1 38.9 21.5 16.8 13.4 4.1 9.9 26.5 11.9 6.3 11.4 17.1 33.4 6.8 44.6 31.1 4.3 21.0 8.3 4.4 9.2 33.2 45.1 46.0 28.3 23.5 17.9 13.8 21.6 11.8 0.0 4.7 24.4 15.0 10.1 16.4 23.4 21.5 11.4 10.9 7.2 6.2 0.7 51.2 7.1 8.0 23.4 17.9 22.3 19.0 22.7 22.0 6.0 1.0 38.3 32.3 25.5 4.5 0.0 4.1 13.9 4.0 8.1 12.7 24.5 12.3 19.0 10.7 5.1 7.4 29.6 7.9 19.0 3.7 0.6 21.9 16.8 12.9 10.3 13.8 14.2 1.8 0.1 25.5 0.9 15.1 0.0 1.7 16.7 5.3 0.1 10.5 0.0 4.1 6.2 3.0 0.0 1.2 6.0 0.2 5.3 0.1 0.1 5.4 2.4 5.0 6.2 2.6 6.7 6.3 3.1 3.6 5.0 3.1 4.0 4.1 6.3 4.3 18.5 3.2 4.1 5.5 1.5 14.4 7.9 7.0 16.5 7.1 13.0 15.4 64.8 5.7 3.5 1.8 43.8 29.0 11.1 0.2 0.0 5.8 13.6 16.3 83.5 11.8 0.0 1.3 63.3 16.0 48.2 45.6 11.2 31.8 1.3 21.7 4.2 13.0 20.9 3.3 26.7 0.4 0.0 6.2 33.7 10.2 137.6 24.2 5.4 46.9 58.4 8.2 8.2 124.7 2.1 14.0 0.1 121.1 3.2 4.5 0.8 15.0 1.3 132.9 144.7 22.7 107.3 4.7 13.3 15.7 10.2 12.7 16.0 9.1 1.1 3.1 RPS6KA2 "HU-2, RSK3" ENSG00000071242 "Ribosomal protein S6 kinase A2" Q15349 6 166409364-166906451 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 26.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "eosinophil: 22.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 22.4" "Cell line enhanced" "Detected in many" "ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026243, HPA045061, HPA054237, CAB069428" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425" "unprognostic (8.71e-2)" "unprognostic (3.14e-3)" "unprognostic (7.29e-2)" "unprognostic (1.72e-1)" "unprognostic (3.80e-1)" "unprognostic (2.45e-1)" "unprognostic (6.44e-3)" "unprognostic (8.63e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.63e-5)" "unprognostic (8.68e-2)" "unprognostic (4.11e-2)" "prognostic favorable (2.86e-5)" "unprognostic (3.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (2.01e-1)" 30.0 9.1 41.1 8.1 39.3 10.6 28.0 35.2 36.5 18.3 12.2 15.2 6.2 26.2 7.2 20.3 18.9 18.4 62.4 38.8 39.5 13.8 6.7 45.4 7.6 46.7 42.1 31.1 29.4 19.6 50.0 27.4 18.1 45.4 15.0 10.4 29.2 14.8 14.4 24.3 15.2 16.6 22.9 40.6 26.3 21.6 7.7 44.6 6.0 36.6 30.8 7.4 24.7 15.0 51.9 9.1 0.0 17.9 26.0 214.5 156.1 0.4 19.3 37.4 10.6 14.6 0.0 5.8 1.1 6.2 68.2 8.4 8.2 9.4 41.8 9.4 4.2 2.3 0.1 40.2 0.4 158.5 0.6 7.2 141.4 29.4 56.6 173.0 316.2 58.0 19.2 0.2 0.2 43.6 1.9 0.8 2.1 4.5 9.1 10.5 3.0 9.2 27.3 11.1 10.1 9.8 68.8 6.7 17.9 24.8 4.4 0.5 14.3 21.7 37.3 3.7 103.8 5.6 5.2 8.4 2.6 24.8 1.2 36.0 0.2 0.6 22.4 0.6 0.8 0.3 0.3 0.6 0.3 0.8 0.5 0.7 0.3 0.5 4.4 2.2 4.7 0.5 0.4 41.1 39.3 35.2 36.5 38.8 39.5 46.7 42.1 31.1 45.4 40.6 44.6 51.9 60.9 22.4 46.2 399.6 2.7 4.7 5.4 4.6 3.4 37.1 7.1 5.0 60.0 15.7 11.6 36.8 8.4 0.2 8.0 1.9 11.7 15.2 14.8 20.6 4.6 58.2 5.4 0.0 204.1 24.0 0.3 16.3 16.8 20.3 2.5 10.5 45.3 11.9 7.2 287.7 552.3 5.3 2.0 6.0 6.7 69.3 5.3 8.0 19.6 144.3 3.5 10.1 1.0 244.8 97.7 26.8 1.7 4.5 2.4 9.9 0.3 7.0 9.4 17.1 13.1 10.0 14.5 3.5 2.3 1.2 3.4 0.3 2.0 9.5 1.4 6.6 ING3 "Eaf4, FLJ20089, MEAF4, p47ING3" ENSG00000071243 "Inhibitor of growth family member 3" Q9NXR8 7 120950763-120977216 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 81.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004762, HPA067388, HPA067575" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863" "unprognostic (1.35e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.78e-1)" "unprognostic (3.03e-1)" "unprognostic (1.39e-2)" "unprognostic (4.26e-2)" "unprognostic (7.09e-3)" "unprognostic (4.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.04e-3)" "unprognostic (2.86e-1)" "unprognostic (6.90e-2)" "unprognostic (3.96e-2)" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (5.64e-2)" 9.4 7.8 4.1 10.0 4.7 81.2 10.2 11.6 5.6 8.4 4.1 9.2 8.3 10.9 10.6 7.5 9.7 8.6 8.6 4.0 4.9 9.8 9.3 11.0 15.0 4.5 5.5 3.8 9.0 8.6 7.8 6.1 15.2 6.1 8.1 11.9 7.7 8.6 7.7 4.7 4.7 7.7 13.1 4.6 15.7 9.8 8.2 4.7 18.8 11.6 8.4 13.6 8.6 5.0 6.0 19.3 5.6 24.8 14.0 9.2 7.3 8.3 12.9 10.1 18.1 21.1 7.3 21.6 31.3 5.7 11.3 19.0 9.2 24.1 9.9 20.7 22.1 42.2 22.5 21.2 4.3 12.6 43.8 25.5 5.4 5.0 16.0 11.3 8.7 28.7 19.1 51.0 48.4 17.5 6.7 36.0 26.0 29.9 10.9 10.4 17.6 17.7 25.7 18.4 19.4 22.4 24.1 13.3 26.9 14.0 15.3 6.1 17.0 10.4 18.5 6.8 40.0 23.7 22.2 15.1 46.0 9.3 28.9 15.6 44.0 28.0 26.4 20.1 30.8 19.9 21.7 20.3 18.7 23.4 24.3 20.4 18.6 50.7 30.6 32.3 17.7 27.1 14.8 4.1 4.7 11.6 5.6 4.0 4.9 4.5 5.5 3.8 6.1 4.6 4.7 6.0 27.1 19.2 18.4 24.5 37.7 7.6 20.4 17.6 9.1 23.3 16.3 14.4 14.2 11.5 14.0 7.3 4.2 38.8 31.7 19.6 21.5 12.6 7.2 21.5 20.1 24.7 12.0 27.0 14.5 18.0 22.0 19.5 16.8 28.3 33.7 21.8 21.4 14.3 17.9 26.9 21.5 18.7 22.4 35.8 16.6 4.3 13.7 23.4 16.0 18.7 24.3 17.6 27.8 22.6 24.3 15.5 17.7 9.8 26.8 14.0 17.7 12.8 13.5 19.8 19.7 26.9 25.9 16.6 15.3 12.0 11.2 45.7 28.6 25.7 15.4 18.7 VASH1 KIAA1036 ENSG00000071246 "Vasohibin 1" Q7L8A9 14 76761468-76783015 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Growth arrest" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 68.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 139.7;Early spermatids: 72.8;Late spermatids: 95.3;Microglial cells: 53.4;Rod photoreceptor cells: 98.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 46.1;HEL: 35.1;HUVEC TERT2: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000653 Uncertain "Secreted to blood" NA NA "HPA000653: AB_1080551" "unprognostic (1.47e-1)" "unprognostic (9.13e-2)" "unprognostic (2.56e-2)" "unprognostic (7.29e-2)" "unprognostic (1.93e-1)" "unprognostic (2.53e-3)" "unprognostic (2.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.23e-2)" "unprognostic (6.94e-2)" "prognostic favorable (6.56e-6)" "unprognostic (8.84e-2)" "unprognostic (6.44e-3)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (5.06e-2)" "unprognostic (1.73e-1)" 12.2 18.7 38.3 12.4 34.5 3.0 7.5 33.6 36.2 8.3 24.8 7.1 5.6 12.0 4.2 4.4 8.8 9.0 26.6 30.4 32.4 7.0 3.8 16.2 7.8 41.3 38.8 26.1 13.6 5.7 4.0 13.8 20.1 48.3 6.6 5.2 68.2 5.6 4.6 7.6 4.7 8.3 11.6 39.4 18.5 5.2 13.3 37.1 3.3 6.1 7.0 6.6 8.5 6.6 39.7 1.1 5.6 46.1 13.8 11.6 8.4 2.3 4.0 1.3 3.4 1.4 1.5 3.1 2.1 2.8 3.2 4.2 1.3 7.3 1.5 1.0 25.0 5.3 35.1 3.4 1.5 6.9 1.5 3.5 4.5 0.3 1.3 0.2 10.4 85.0 6.2 1.6 0.4 1.1 7.1 1.3 3.0 4.7 1.4 2.8 1.3 4.6 1.0 0.9 2.6 19.1 14.8 4.6 1.8 2.2 9.1 7.8 7.4 24.2 4.3 9.6 5.2 2.0 2.0 1.1 1.2 6.1 11.2 8.3 0.0 0.8 0.0 0.6 2.0 0.5 0.1 0.3 0.3 1.3 0.3 0.2 0.3 0.0 0.2 2.7 2.4 0.1 0.5 38.3 34.5 33.6 36.2 30.4 32.4 41.3 38.8 26.1 48.3 39.4 37.1 39.7 17.3 0.0 2.3 7.2 2.7 0.6 0.0 0.3 0.0 9.4 0.9 2.4 10.9 1.5 0.7 1.8 139.7 0.4 11.1 0.0 0.0 0.9 72.8 0.8 7.7 27.5 6.7 0.0 13.4 0.0 0.3 7.6 1.5 0.6 12.0 18.1 31.8 1.2 14.8 0.0 11.9 0.4 2.0 14.2 9.3 95.3 1.8 23.6 1.8 53.4 7.6 15.2 3.1 21.6 21.8 0.3 0.0 3.0 0.4 0.0 0.0 0.2 0.0 98.8 13.1 5.5 10.0 0.8 2.3 0.4 0.1 0.3 1.8 5.7 0.2 0.1 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501807-8574668 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 578.8" "Cell type enhanced" "Detected in many" "Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "T-reg: 20.5" "Lineage enriched" "Detected in many" 6 "T-cells: 20.5" "Cell line enhanced" "Detected in many" "HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" No No 6600 "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 125.4 14.4 9.8 46.0 8.7 0.2 98.3 13.1 11.0 27.4 35.3 17.0 9.1 91.0 18.5 36.4 58.4 67.8 81.2 13.6 25.8 25.4 9.8 132.9 17.4 13.1 10.8 6.8 66.4 38.0 30.2 8.8 55.0 11.8 35.1 7.1 15.3 42.6 17.0 578.8 26.9 20.3 63.9 13.6 56.1 46.8 11.4 10.6 4.8 18.7 263.2 10.2 111.5 31.8 14.6 9.4 52.0 8.6 6.6 62.0 34.6 8.9 37.9 19.4 20.5 50.0 38.8 11.5 0.0 4.2 44.2 8.8 0.8 4.9 9.9 8.4 16.0 3.6 11.6 3.5 7.6 88.9 0.0 1.1 124.9 0.2 93.8 0.7 11.9 10.1 0.0 0.0 0.0 26.8 6.7 0.0 0.1 16.8 12.0 2.3 0.2 28.2 0.1 19.1 3.6 0.3 21.3 6.4 31.1 20.6 23.9 40.7 0.1 5.0 20.4 40.3 83.0 25.9 5.1 6.2 2.6 4.1 2.9 27.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 2.9 0.6 3.3 0.3 0.0 0.1 0.0 0.0 0.0 1.0 20.5 0.3 9.8 8.7 13.1 11.0 13.6 25.8 13.1 10.8 6.8 11.8 13.6 10.6 14.6 287.6 9.6 10.7 2.0 2.1 31.6 42.1 7.4 9.6 13.0 20.4 17.0 14.7 14.3 13.5 5.5 10.4 3.9 1.7 1.4 3.9 122.0 1.1 9.6 77.7 161.9 12.1 0.0 0.8 48.5 4.2 64.5 7.1 4.8 10.2 44.2 30.7 12.6 3.4 97.6 1.2 2.4 4.1 0.8 47.0 2.3 11.5 3.2 53.4 29.0 9.0 38.9 1.0 4.0 8.7 114.1 0.9 32.4 8.0 8.4 0.3 45.5 12.0 8.0 0.0 57.0 112.9 6.4 9.1 29.0 27.1 4.4 5.3 21.5 4.7 7.5 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23 rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 712.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 40.2 49.6 36.1 40.4 38.4 59.2 43.9 38.2 40.9 36.0 41.6 49.1 47.4 38.9 72.9 42.1 59.4 34.8 88.7 39.3 39.3 43.3 47.6 38.8 53.0 38.8 37.4 37.1 38.1 71.4 49.6 45.5 31.0 38.0 38.2 48.2 20.5 56.4 42.6 129.1 43.4 40.6 41.7 37.7 42.4 45.3 131.0 38.1 45.1 57.0 79.1 52.1 52.4 33.1 40.1 142.1 151.8 53.6 429.2 72.0 64.2 91.1 95.1 83.3 118.5 96.1 211.4 182.6 163.6 48.9 99.5 204.0 97.0 124.8 91.0 108.4 116.6 147.1 72.0 174.8 86.7 91.2 200.3 98.8 57.3 102.2 103.2 93.9 59.7 77.4 130.3 285.4 288.9 103.7 219.6 128.0 277.8 130.2 317.8 172.2 110.5 106.8 712.0 132.5 100.2 163.4 124.4 126.3 329.2 146.5 53.0 207.9 159.0 85.2 101.8 130.3 130.0 208.3 99.5 192.6 275.5 232.3 155.6 218.0 54.8 64.9 60.6 112.0 74.2 124.9 175.3 127.1 122.5 122.9 153.5 132.8 121.5 11.9 125.4 68.0 190.9 150.6 132.6 36.1 38.4 38.2 40.9 39.3 39.3 38.8 37.4 37.1 38.0 37.7 38.1 40.1 67.0 44.8 64.5 0.0 26.5 0.0 0.0 0.0 0.0 0.0 75.4 85.7 0.0 0.0 42.7 46.0 0.0 75.7 64.1 0.0 97.8 119.9 0.0 133.6 51.2 28.6 0.0 0.0 0.0 140.8 82.7 24.5 0.0 79.6 46.7 49.2 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 21.2 0.0 0.0 0.0 0.0 126.0 0.0 0.0 16.5 0.0 0.0 103.5 78.7 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 106.7 28.1 73.0 0.0 0.0 SEL1L "Hrd3, IBD2, SEL1L1" ENSG00000071537 "SEL1L adaptor subunit of ERAD E3 ubiquitin ligase" Q9UBV2 14 81471547-81533853 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 406.9" "Cell type enhanced" "Detected in all" "Plasma cells: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 339.5;U-266/84: 313.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024267 Enhanced "Intracellular and membrane" NA NA "HPA024267: AB_1856659" "unprognostic (4.94e-1)" "unprognostic (8.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.91e-1)" "unprognostic (5.93e-2)" "unprognostic (1.16e-1)" "unprognostic (3.29e-1)" "unprognostic (2.78e-1)" "unprognostic (9.97e-2)" "unprognostic (2.58e-2)" "unprognostic (2.76e-3)" "unprognostic (4.86e-1)" "unprognostic (3.31e-2)" "unprognostic (1.30e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-2)" "unprognostic (1.25e-2)" 30.9 19.3 14.8 31.4 18.5 17.9 25.4 17.6 17.1 21.6 13.0 36.1 37.1 24.4 18.2 17.0 17.2 22.2 23.0 15.4 19.0 29.0 67.2 27.9 21.8 20.0 17.8 14.2 17.3 406.9 30.1 8.8 38.7 19.6 31.9 32.1 15.8 19.7 23.0 22.3 15.6 32.7 28.3 19.2 30.9 35.4 11.3 18.0 18.0 54.7 21.3 29.6 29.2 12.2 26.9 35.3 69.3 27.4 35.5 60.2 58.6 48.5 54.6 52.3 31.2 33.0 26.6 53.7 36.0 58.8 63.2 38.1 32.8 19.2 30.6 56.1 56.0 13.6 26.3 21.7 33.2 86.0 53.6 60.3 47.8 72.0 31.4 68.0 45.9 51.7 29.5 16.2 195.2 38.6 42.7 30.6 15.1 8.7 58.7 29.6 21.2 38.9 28.4 24.0 54.1 15.5 25.7 42.7 39.4 44.9 23.5 68.5 35.5 86.8 87.7 49.0 49.2 34.1 339.5 313.1 35.4 96.5 24.1 34.4 31.5 19.7 24.8 16.8 25.6 13.7 14.2 12.9 13.4 18.9 13.1 12.0 12.9 45.7 16.7 22.5 13.7 14.0 14.5 14.8 18.5 17.6 17.1 15.4 19.0 20.0 17.8 14.2 19.6 19.2 18.0 26.9 51.6 12.8 35.2 27.1 44.8 26.8 19.0 27.1 15.9 23.5 31.5 18.9 67.0 32.9 24.9 27.6 31.3 23.5 44.1 48.8 5.9 24.1 3.5 21.1 48.9 40.0 21.6 15.4 35.9 45.6 21.9 44.7 37.8 28.0 34.2 32.0 38.9 125.7 31.9 30.3 35.2 38.9 50.8 58.1 40.4 5.4 23.6 47.6 53.4 29.0 39.7 18.3 30.9 42.3 70.7 40.1 33.1 28.2 238.9 40.0 34.8 20.2 27.8 18.3 46.0 28.5 51.8 14.0 18.8 16.0 26.1 41.9 32.9 38.9 32.0 33.9 TRIP13 16E1BP ENSG00000071539 "Thyroid hormone receptor interactor 13" Q15645 5 892884-919357 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.2" "Cell type enhanced" "Detected in many" "Early spermatids: 115.4;Late spermatids: 206.9;Respiratory ciliated cells: 79.9;Spermatocytes: 86.4;Spermatogonia: 70.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005727, HPA053093" Enhanced Approved Nucleoplasm NA NA 78000 Nucleoplasm "HPA005727: AB_10603220, HPA053093: AB_2682042" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.93e-4)" "unprognostic (2.34e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.44e-3)" "unprognostic (1.73e-3)" "prognostic favorable (1.39e-4)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.99e-1)" "unprognostic (1.31e-1)" "unprognostic (3.34e-1)" 1.4 0.7 1.9 4.5 2.2 6.1 2.7 1.0 1.8 1.2 1.1 3.9 3.6 1.8 0.6 4.7 6.8 0.7 0.4 1.7 1.8 1.1 0.8 1.3 7.2 1.4 1.6 1.6 2.0 1.3 0.2 1.6 3.3 1.4 0.8 5.8 0.5 1.0 0.4 0.6 2.3 3.6 3.6 1.4 1.9 1.7 30.2 1.8 9.3 0.5 0.3 8.5 1.9 1.7 1.5 67.5 73.9 46.6 69.6 4.3 10.1 51.8 68.6 33.1 103.4 96.7 72.2 43.4 59.1 48.7 39.5 90.1 48.7 100.3 47.6 129.1 91.0 83.7 40.6 136.4 52.3 1.1 67.3 23.9 4.7 3.6 87.0 37.3 10.7 51.5 45.9 61.7 50.2 71.7 45.7 67.6 60.6 53.0 37.7 69.4 38.8 87.3 113.0 29.3 34.2 47.9 49.0 103.1 38.2 20.8 40.2 71.3 32.0 26.4 55.6 70.4 46.5 79.0 31.9 68.9 64.6 34.2 79.3 63.1 0.0 0.0 0.0 0.4 0.0 0.2 1.1 0.6 0.7 0.1 1.2 0.2 0.1 0.0 1.6 0.1 1.0 2.1 0.4 1.9 2.2 1.0 1.8 1.7 1.8 1.4 1.6 1.6 1.4 1.4 1.8 1.5 0.7 0.0 1.1 0.3 4.3 3.4 3.5 7.3 4.0 0.9 2.2 1.8 0.3 0.0 5.0 0.0 0.0 8.6 0.7 2.2 0.0 3.0 115.4 29.3 2.1 2.5 4.2 14.3 1.3 2.0 25.2 3.4 1.5 3.8 5.7 9.8 2.2 0.4 7.3 3.3 0.5 3.0 4.1 1.3 4.2 206.9 2.1 1.7 0.0 0.0 1.1 0.7 0.0 0.0 0.4 2.2 1.8 2.2 18.1 2.8 0.5 1.2 79.9 0.9 6.6 2.5 5.2 86.4 70.1 7.6 1.4 3.4 3.2 2.7 5.1 3.3 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428633-154436516 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain NA NA 700000 "CAB015218: " "prognostic unfavorable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favorable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 56.6 94.3 106.3 43.5 116.9 59.7 57.2 105.2 119.5 59.0 119.9 60.0 48.8 54.6 146.4 85.9 60.5 46.4 85.7 117.8 119.8 104.6 51.8 97.6 47.3 118.2 105.8 118.3 63.8 87.4 177.5 111.2 78.6 129.6 85.8 57.6 74.6 88.1 55.3 54.2 82.7 57.9 49.5 110.9 95.4 71.0 47.9 119.0 41.3 82.6 54.9 42.9 64.3 61.4 149.4 110.1 101.6 88.2 146.2 145.7 77.4 162.2 78.5 116.6 122.5 176.1 93.4 135.1 64.7 337.8 177.1 216.5 112.3 133.8 71.9 76.6 58.6 135.1 37.5 113.7 100.0 170.6 60.9 260.2 98.1 126.7 112.4 68.2 139.5 177.0 47.8 45.6 176.4 84.7 158.1 43.6 96.8 32.1 171.0 100.8 66.6 59.1 170.7 139.9 87.3 84.6 89.7 72.6 289.7 159.3 87.3 123.1 157.8 135.5 87.4 79.0 151.1 135.6 256.3 311.8 77.0 104.4 132.8 90.2 246.6 295.1 363.9 147.3 313.8 148.6 91.7 118.4 127.8 376.7 113.6 107.1 117.8 326.9 140.3 255.6 215.9 155.2 216.9 106.3 116.9 105.2 119.5 117.8 119.8 118.2 105.8 118.3 129.6 110.9 119.0 149.4 39.4 38.5 57.5 17.0 32.3 30.2 42.7 122.4 25.6 105.8 58.5 42.2 37.7 54.3 102.1 97.5 47.9 145.1 40.1 84.3 19.6 65.4 3.1 52.5 33.7 50.1 89.0 35.8 17.0 52.5 104.5 48.8 36.7 57.4 77.3 51.8 54.3 46.6 246.3 129.5 24.2 59.0 160.7 143.6 88.2 5.5 41.3 130.3 72.9 15.0 79.9 68.4 27.8 22.1 26.4 42.4 67.5 42.5 61.7 34.1 63.7 49.1 112.5 69.2 65.7 35.7 45.5 64.4 10.7 31.6 32.8 196.5 36.3 74.1 54.6 47.2 TCF3 "bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR" ENSG00000071564 "Transcription factor 3" P15923 19 1609290-1652615 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 467.3;U-698: 597.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018351, HPA049808, HPA062476" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (1.26e-2)" "unprognostic (1.25e-1)" "unprognostic (1.91e-2)" "unprognostic (8.25e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.07e-2)" "unprognostic (7.99e-2)" "unprognostic (2.35e-1)" "unprognostic (2.42e-1)" "unprognostic (9.29e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (4.87e-3)" "unprognostic (1.88e-1)" "unprognostic (3.07e-1)" "unprognostic (8.05e-2)" 23.3 18.1 19.1 49.7 18.5 73.5 26.3 16.8 22.9 31.8 19.9 30.2 35.8 29.9 16.3 28.4 25.7 20.0 20.7 17.5 17.5 25.7 19.0 26.1 87.3 20.9 17.7 15.8 35.4 28.7 10.3 26.4 18.1 18.0 27.6 18.9 11.1 26.6 12.1 19.7 32.8 48.4 14.6 16.9 63.0 27.5 75.4 17.8 69.0 31.8 12.6 61.5 27.6 27.7 19.6 83.6 48.6 146.4 139.8 18.6 49.6 50.4 51.9 48.0 67.8 60.6 89.8 68.7 421.7 53.5 50.1 12.7 98.4 87.9 69.2 42.8 253.7 52.4 43.2 71.2 115.2 44.8 105.7 56.8 34.0 75.1 52.4 39.2 64.0 82.5 176.1 163.8 146.6 46.0 158.2 301.1 107.8 187.1 65.1 49.2 467.3 61.7 104.3 46.5 78.5 119.3 175.7 50.1 55.9 70.8 53.0 63.8 191.7 103.2 87.1 90.5 116.0 94.1 353.5 173.5 597.2 63.1 140.3 80.1 3.3 1.2 1.0 3.6 1.5 3.6 10.0 2.1 3.1 2.8 10.6 2.8 4.3 0.4 2.8 3.2 12.9 2.2 1.7 19.1 18.5 16.8 22.9 17.5 17.5 20.9 17.7 15.8 18.0 16.9 17.8 19.6 17.3 6.4 9.1 14.7 33.9 13.9 5.3 10.0 4.6 12.3 16.6 16.1 10.7 4.3 10.8 1.8 27.1 4.3 26.5 14.7 1.9 11.4 8.6 9.9 20.4 13.5 16.2 32.2 3.9 6.9 8.9 12.3 14.8 16.6 7.0 27.8 9.7 4.8 7.7 5.0 5.6 16.5 16.2 8.9 12.3 5.2 13.7 9.4 10.6 6.5 8.1 9.2 10.3 3.0 7.3 17.6 13.3 10.1 31.1 13.0 16.4 6.3 2.9 13.8 19.7 8.2 16.9 5.5 46.2 9.0 13.2 2.9 12.5 10.4 20.1 8.5 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 104.3;Muller glia cells: 100.3" "Cancer enhanced" "Detected in all" "melanoma: 74.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 48.8" "Group enriched" "Detected in many" 8 "B-cells: 12.2;NK-cells: 19.3;T-cells: 48.8" "Cell line enhanced" "Detected in many" "AN3-CA: 183.5;HEL: 185.7;K-562: 258.0;SK-MEL-30: 189.3;WM-115: 246.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 40.5 63.6 31.1 39.2 31.4 17.0 38.7 37.8 35.5 19.2 31.8 23.3 18.0 44.8 43.7 15.6 23.6 29.0 45.1 33.1 38.2 52.1 21.2 40.1 73.3 33.1 32.0 30.2 98.7 26.4 18.1 20.2 47.0 31.2 33.3 13.5 139.0 20.5 25.8 14.4 15.9 25.4 34.5 31.6 80.4 42.2 28.8 33.3 39.6 24.1 19.7 70.2 48.8 19.6 30.6 0.2 0.4 138.8 183.5 48.9 44.7 0.2 7.9 7.5 4.9 7.9 0.9 15.3 16.3 5.5 16.9 0.8 2.3 10.3 16.1 4.2 18.3 28.9 185.7 0.4 2.7 60.7 10.7 68.0 41.7 16.0 20.3 5.6 48.9 22.1 23.8 258.0 0.3 7.9 1.7 24.4 44.8 66.1 7.0 18.0 0.0 46.2 6.7 31.9 23.4 118.9 56.6 1.1 7.4 189.3 41.4 0.2 1.1 13.9 65.3 32.0 0.6 17.8 0.1 0.2 22.9 35.2 36.3 246.7 1.7 0.2 3.2 12.7 0.0 15.8 9.6 26.1 13.8 1.2 12.2 15.0 9.2 0.5 19.3 0.2 0.1 48.8 8.9 31.1 31.4 37.8 35.5 33.1 38.2 33.1 32.0 30.2 31.2 31.6 33.3 30.6 52.2 3.2 8.3 25.5 12.5 6.1 9.1 26.9 19.4 55.0 7.9 8.6 17.1 12.8 15.6 16.5 31.3 2.6 17.5 0.7 7.9 17.2 4.3 9.7 11.6 43.9 0.0 22.1 13.5 104.3 0.2 11.3 20.9 15.9 34.2 77.3 59.6 6.7 5.8 20.2 6.9 0.4 28.5 5.1 8.2 14.3 77.3 3.8 30.2 13.1 3.0 100.3 26.8 59.8 2.7 45.3 0.2 74.4 21.0 11.6 0.3 1.0 17.9 66.7 52.6 9.9 41.2 1.0 6.0 5.7 5.4 0.8 27.1 30.5 0.8 32.5 DAZAP1 MGC19907 ENSG00000071626 "DAZ associated protein 1" Q96EP5 19 1407569-1435687 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004201, HPA004631" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 1600000 Nucleoplasm Cytosol "HPA004201: AB_1078627, HPA004631: AB_1078626" "unprognostic (1.50e-1)" "unprognostic (3.19e-2)" "unprognostic (7.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.31e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (6.13e-2)" "unprognostic (1.09e-1)" "unprognostic (8.11e-3)" "unprognostic (2.72e-3)" "unprognostic (2.40e-3)" "unprognostic (8.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.21e-3)" 40.3 34.9 19.5 56.4 20.3 69.9 37.5 21.0 23.7 30.4 21.2 44.8 45.8 33.8 10.6 65.2 32.4 13.4 49.1 18.7 21.2 38.2 51.7 37.3 50.2 23.0 20.4 16.7 32.6 48.4 20.5 22.7 22.4 23.0 33.3 23.9 20.2 32.6 17.3 65.8 41.2 47.3 19.7 18.0 49.7 39.3 78.2 21.6 48.1 32.4 21.6 34.6 42.6 37.0 25.9 275.7 98.0 64.3 117.9 27.8 33.5 183.9 120.7 59.6 95.7 78.2 98.0 132.3 320.8 72.1 58.7 47.4 151.2 84.9 114.5 80.7 225.9 135.2 165.4 95.2 101.3 64.3 203.1 136.1 33.7 73.8 65.4 119.0 41.1 85.0 133.7 251.5 164.1 60.6 111.9 357.5 178.3 198.7 99.6 97.1 254.3 102.4 199.3 72.9 91.7 127.3 114.2 79.9 124.0 149.3 83.1 113.1 266.8 93.7 79.0 107.5 139.7 267.9 192.9 212.2 256.0 95.6 194.4 123.8 1.5 2.3 1.9 2.7 3.4 2.9 3.1 2.4 2.9 2.2 2.1 2.4 2.6 1.0 3.0 2.4 2.7 2.7 1.3 19.5 20.3 21.0 23.7 18.7 21.2 23.0 20.4 16.7 23.0 18.0 21.6 25.9 57.1 9.6 27.6 29.7 50.3 69.3 90.9 37.6 34.1 55.7 46.9 33.3 40.0 38.6 28.8 25.8 35.5 43.5 68.7 60.0 23.5 44.4 49.8 26.3 37.0 45.0 33.0 96.6 17.1 55.1 108.6 39.7 46.9 34.0 26.6 58.0 36.0 41.6 47.7 26.9 16.8 71.6 28.5 49.2 54.9 65.7 28.0 50.3 40.9 16.9 36.0 35.1 34.0 18.6 45.2 63.5 49.4 23.7 73.6 110.3 50.4 48.2 23.5 45.4 26.3 50.5 58.9 111.6 41.0 67.0 74.9 69.0 53.0 41.8 81.5 107.9 MBD3 ENSG00000071655 "Methyl-CpG binding domain protein 3" O95983 19 1573596-1592865 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013265 Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB013265: " "unprognostic (1.41e-1)" "unprognostic (2.12e-2)" "unprognostic (3.44e-2)" "prognostic favorable (5.08e-4)" "unprognostic (1.85e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (2.50e-1)" "unprognostic (3.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (4.42e-2)" "unprognostic (5.89e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" 39.3 46.5 14.9 7.1 12.6 12.9 36.5 17.5 16.6 40.6 7.9 40.7 7.7 46.6 7.7 42.7 40.9 6.6 54.3 14.4 10.0 43.4 59.7 38.6 9.7 13.4 12.8 11.1 49.3 33.0 7.5 50.4 9.1 16.0 55.3 6.4 4.1 30.6 7.0 74.6 40.4 34.9 7.5 11.3 50.2 39.3 43.7 13.2 9.1 45.6 4.8 9.2 41.4 34.1 14.6 26.4 56.3 22.5 34.9 21.6 15.0 20.8 20.9 13.5 21.5 19.5 44.9 15.6 49.9 12.1 26.7 7.5 35.8 37.8 23.7 13.0 41.2 36.8 24.6 77.4 27.9 17.6 28.2 24.5 20.3 23.1 35.6 17.4 14.2 25.2 25.7 55.8 34.2 17.6 56.6 32.7 30.5 29.4 12.6 25.5 31.1 23.3 21.2 14.1 50.0 64.5 36.8 25.2 18.3 12.6 12.2 23.5 21.1 20.0 28.9 15.5 65.5 42.1 31.8 39.8 38.6 21.2 37.0 27.7 0.7 0.4 0.1 0.3 0.4 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.3 0.5 0.3 0.2 0.5 0.1 0.2 14.9 12.6 17.5 16.6 14.4 10.0 13.4 12.8 11.1 16.0 11.3 13.2 14.6 21.6 12.8 24.3 14.4 10.6 10.8 8.9 9.4 5.2 22.6 23.8 20.6 20.8 12.8 11.0 11.0 14.6 46.4 17.4 48.1 5.9 15.0 3.1 9.8 20.5 19.8 14.9 14.9 8.4 26.2 42.7 20.0 18.3 16.1 3.8 48.4 24.7 42.6 27.2 18.5 9.2 26.4 14.2 32.0 10.3 8.1 22.4 16.9 5.4 15.9 17.5 40.5 14.4 10.6 12.3 19.3 16.8 25.6 9.7 14.9 20.8 19.1 4.8 11.3 39.5 21.6 18.7 9.2 10.3 11.0 12.8 121.5 10.8 36.0 40.6 8.8 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 22.2" "Cell type enhanced" "Detected in single" "Endometrial ciliated cells: 1.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Region enhanced" "Detected in some" "medulla oblongata: 22.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.3;MCF7: 1.8;RPMI-8226: 1.4" "Group enriched" "Detected in some" 58 "hypothalamus: 11.3;pons and medulla: 21.5" "Region enriched" "Detected in single" 14 "medulla oblongata: 5.5" HPA014976 Uncertain "Secreted in brain" NA NA "HPA014976: AB_2732413" "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.8 0.0 0.0 0.1 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 8.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.8 22.2 0.0 0.0 0.4 4.5 0.6 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLTF "HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3" ENSG00000071794 "Helicase like transcription factor" Q14527 3 149030127-149086554 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 143.4;Spermatogonia: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015284, HPA049001" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015284: AB_1857263, HPA049001: AB_2680594" "unprognostic (3.21e-2)" "unprognostic (3.46e-2)" "unprognostic (6.81e-2)" "unprognostic (1.95e-3)" "unprognostic (4.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (3.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.27e-1)" "unprognostic (4.78e-2)" "unprognostic (9.00e-3)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (3.42e-1)" "unprognostic (2.83e-2)" "unprognostic (1.07e-2)" 12.3 23.8 10.8 7.5 12.4 11.6 14.0 21.1 12.4 11.2 16.5 8.0 5.3 13.7 10.3 7.6 11.6 9.4 19.2 10.8 16.3 17.1 18.7 7.9 12.0 14.4 14.1 9.8 19.0 13.7 17.4 12.5 8.3 14.5 15.8 7.6 27.9 11.1 11.7 11.7 5.6 6.8 12.2 13.6 8.8 10.0 45.1 12.6 15.9 21.2 11.5 11.2 8.3 6.0 17.4 66.7 31.8 44.3 34.6 29.0 37.3 4.3 44.1 26.2 32.0 37.0 25.8 45.1 42.7 52.3 20.6 62.3 1.9 60.1 17.5 52.9 23.7 29.1 102.6 23.6 10.5 18.1 27.2 40.7 23.7 9.3 23.9 13.9 48.4 18.7 68.1 36.5 26.9 44.2 33.5 56.4 40.9 33.5 33.3 39.3 64.2 49.8 6.6 26.2 21.1 43.5 25.6 66.9 30.4 60.8 23.3 91.5 25.9 13.2 37.1 22.4 53.1 48.5 39.3 23.5 55.4 36.2 36.3 14.6 8.2 1.0 3.5 4.3 1.7 8.0 6.9 3.8 5.8 3.4 4.9 5.6 5.7 0.0 4.7 1.9 7.8 3.9 2.8 10.8 12.4 21.1 12.4 10.8 16.3 14.4 14.1 9.8 14.5 13.6 12.6 17.4 19.5 25.6 20.4 56.8 15.6 5.6 8.5 12.9 10.8 99.3 20.1 16.5 46.4 18.6 18.5 31.3 41.7 10.2 29.9 1.9 35.2 10.1 9.9 36.7 31.1 14.3 4.9 71.5 67.5 8.4 10.1 27.6 12.8 11.7 55.7 55.8 13.2 17.2 8.7 47.1 88.7 6.9 18.3 4.6 3.1 12.3 33.8 11.9 5.4 28.1 5.2 35.4 12.3 66.4 68.7 7.4 3.6 32.4 19.3 8.2 2.0 19.2 26.2 76.2 13.1 37.5 23.8 143.4 113.2 11.5 4.3 1.6 22.1 100.6 7.5 6.6 FAM50A "9F, DXS9928E, HXC-26, XAP5" ENSG00000071859 "Family with sequence similarity 50 member A" Q14320 X 154444141-154450654 "Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003585 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003585: AB_1080603" "unprognostic (1.95e-1)" "prognostic favorable (2.05e-4)" "prognostic unfavorable (9.52e-5)" "unprognostic (5.39e-2)" "unprognostic (4.73e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (2.56e-1)" "unprognostic (4.62e-2)" "unprognostic (1.40e-1)" "unprognostic (3.64e-3)" "unprognostic (6.35e-2)" "unprognostic (3.28e-2)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-2)" "unprognostic (4.14e-1)" 63.8 60.1 62.2 35.0 63.2 35.9 55.1 62.8 66.7 46.8 60.2 60.6 35.7 47.3 51.0 36.4 40.3 24.4 67.0 60.5 60.7 58.5 51.4 53.6 26.9 67.1 63.1 58.1 36.3 50.8 46.1 60.6 36.2 67.5 54.8 27.6 26.7 45.2 34.9 103.2 38.2 46.9 37.2 62.3 51.7 54.0 17.2 63.6 31.8 52.1 57.8 24.9 59.4 41.8 68.4 120.7 145.9 48.0 68.8 174.2 124.7 94.7 152.6 136.0 145.2 219.8 134.2 54.9 6.2 154.6 161.6 211.5 46.2 113.4 106.0 111.8 87.5 72.7 38.6 178.6 86.0 253.4 35.1 109.0 143.2 75.0 224.6 114.4 104.9 120.7 44.5 50.4 94.6 142.9 81.8 41.8 46.0 32.3 105.1 90.7 60.2 120.2 86.4 92.8 119.2 85.6 61.1 55.8 88.4 190.1 81.8 77.0 67.4 149.4 99.8 81.5 165.6 191.3 218.0 134.6 43.0 134.9 120.7 113.6 34.5 54.4 42.1 43.8 72.1 59.3 34.4 45.8 42.2 50.7 30.1 24.8 34.3 30.0 41.7 79.4 38.7 53.5 33.5 62.2 63.2 62.8 66.7 60.5 60.7 67.1 63.1 58.1 67.5 62.3 63.6 68.4 60.0 35.3 54.4 14.4 38.2 26.0 42.8 17.9 23.3 65.6 33.5 36.1 88.1 52.9 19.0 29.5 27.1 70.5 50.5 96.0 56.7 53.2 1.8 50.0 71.0 48.7 63.3 56.4 7.3 68.1 109.8 61.0 69.3 68.8 47.0 40.3 41.0 42.6 145.1 47.1 7.4 87.7 18.3 62.3 69.1 5.5 77.9 81.3 32.0 8.4 70.6 80.0 62.8 3.5 17.2 69.8 95.1 79.7 51.6 52.1 123.1 112.1 18.5 68.2 32.9 50.5 76.4 8.3 17.8 29.7 25.9 121.6 62.2 65.0 59.7 45.3 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "FAM3 metabolism regulating signaling molecule A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 109.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted to blood" Yes No 15000 "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 27.7 37.6 40.9 11.4 43.3 11.4 27.8 45.1 51.7 43.7 33.7 34.3 28.3 36.3 7.7 41.6 39.3 8.5 54.7 35.3 40.3 38.6 63.6 27.0 9.4 47.3 43.0 33.0 51.9 52.5 14.9 41.2 10.2 47.3 39.5 6.8 6.1 28.7 12.8 37.1 30.2 34.0 7.4 43.7 28.4 36.4 10.0 42.5 12.3 40.2 13.8 5.5 36.1 35.6 53.5 44.4 41.1 10.3 34.5 30.3 15.4 28.8 22.3 15.1 14.8 17.6 19.1 26.2 28.5 109.2 36.8 29.0 31.6 16.2 19.3 3.6 23.4 21.7 11.2 36.9 13.8 47.2 7.6 17.6 19.0 17.5 30.7 21.4 17.7 10.5 18.1 21.6 20.5 17.3 46.3 14.2 32.7 4.6 47.8 52.4 17.3 10.4 79.6 16.6 18.0 20.4 15.6 10.3 24.4 37.3 7.4 18.7 11.8 12.0 19.9 12.0 54.7 30.6 77.6 46.5 36.0 36.4 19.6 20.8 23.4 10.8 15.2 13.4 12.7 13.2 6.1 8.6 9.6 11.0 8.7 10.0 12.0 5.8 10.6 11.3 14.6 9.1 10.1 40.9 43.3 45.1 51.7 35.3 40.3 47.3 43.0 33.0 47.3 43.7 42.5 53.5 23.5 12.8 16.7 13.1 16.9 16.3 23.4 29.2 22.8 25.4 21.9 24.9 21.9 22.8 16.3 22.0 14.6 47.0 19.3 60.2 27.4 27.6 1.0 13.4 18.3 18.3 17.5 29.9 7.1 42.5 50.0 28.4 50.0 15.0 5.7 34.8 23.6 30.3 29.8 21.9 9.4 58.9 18.3 16.4 15.3 2.8 33.5 18.0 33.8 6.5 17.6 28.9 24.7 11.1 14.3 28.2 57.5 29.3 32.5 28.7 116.2 33.1 12.7 20.4 6.6 26.7 24.5 5.2 10.1 32.1 21.2 71.3 19.3 23.7 39.7 22.9 CPSF1 CPSF160 ENSG00000071894 "Cleavage and polyadenylation specific factor 1" Q10570 8 144393229-144409335 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065167, HPA068906" Enhanced Nucleoplasm No No Nucleoplasm "HPA065167: AB_2685426, HPA068906: AB_2686055" "unprognostic (6.37e-2)" "unprognostic (7.72e-2)" "unprognostic (2.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.93e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (1.05e-1)" "unprognostic (2.00e-3)" "unprognostic (6.45e-2)" "unprognostic (7.54e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.54e-5)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (7.90e-2)" "unprognostic (9.66e-3)" 39.1 52.4 13.3 11.1 13.5 20.6 45.9 12.7 23.5 51.3 13.1 50.6 27.6 49.2 3.9 49.6 49.6 9.1 40.5 13.1 12.1 52.5 76.9 43.7 12.4 13.8 12.7 13.3 57.1 89.3 6.2 78.6 6.9 14.3 62.2 4.3 5.3 50.0 7.7 41.4 53.3 68.6 5.7 11.6 71.1 69.5 133.0 12.6 15.1 53.4 5.3 6.9 41.5 44.3 13.9 21.4 29.4 26.3 27.7 13.8 11.0 25.7 19.6 12.4 15.8 16.3 29.8 27.0 24.6 18.7 14.8 10.7 19.1 14.9 16.7 4.4 22.2 43.0 48.3 37.4 48.6 11.7 18.6 28.8 12.1 6.9 14.5 8.5 9.5 21.2 40.1 41.1 20.4 8.0 90.7 48.8 38.6 15.9 17.9 41.0 34.7 10.6 19.9 17.0 31.1 21.3 21.1 25.4 15.7 14.8 7.4 27.9 20.5 18.4 10.8 41.3 23.9 22.3 12.1 10.2 23.3 14.6 31.0 13.1 3.8 5.1 3.3 4.8 6.1 5.1 4.0 5.2 5.1 5.7 4.8 4.5 4.3 0.9 4.0 6.2 2.6 6.7 4.2 13.3 13.5 12.7 23.5 13.1 12.1 13.8 12.7 13.3 14.3 11.6 12.6 13.9 10.1 16.0 22.5 10.1 9.5 10.1 4.0 6.6 6.2 9.6 15.1 16.9 8.3 20.0 10.7 9.2 12.5 10.1 14.5 26.4 1.9 9.5 19.5 9.6 7.8 11.7 13.1 15.8 9.4 11.5 11.5 10.7 21.9 11.8 14.0 20.7 8.9 8.1 15.1 8.4 6.9 28.6 8.2 12.4 12.4 40.4 14.0 11.7 14.2 3.7 11.9 5.0 10.3 5.5 6.5 10.5 8.8 16.1 17.9 4.1 24.0 6.2 11.7 14.4 6.6 7.7 9.0 36.5 23.1 12.2 12.4 7.3 11.5 7.6 30.3 4.3 MYO3B ENSG00000071909 "Myosin IIIB" Q8WXR4 2 170178145-170655171 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 14.2;kidney: 5.3;parathyroid gland: 8.9;retina: 5.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 85.5;Early spermatids: 34.2;Inhibitory neurons: 18.3;Late spermatids: 29.6;Rod photoreceptor cells: 51.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HDLM-2: 11.2;HEL: 8.8;RT4: 11.7" "Region enriched" "Detected in some" 5 "basal ganglia: 5.2" "Not detected" "Not detected" HPA045483 Approved NA NA "HPA045483: AB_2679344" "unprognostic (1.65e-1)" "unprognostic (7.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" "unprognostic (7.15e-3)" "unprognostic (5.07e-2)" "unprognostic (2.61e-2)" "unprognostic (5.84e-3)" "unprognostic (2.12e-1)" "unprognostic (7.99e-3)" "unprognostic (2.59e-1)" "unprognostic (4.25e-5)" "unprognostic (2.34e-1)" "unprognostic (8.12e-3)" "unprognostic (1.18e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 14.2 0.4 0.6 0.1 0.0 0.0 0.2 5.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 8.9 0.3 0.0 0.0 0.0 0.0 5.9 0.1 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.4 1.3 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 11.2 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.1 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.3 0.6 0.5 0.3 0.0 3.1 0.2 0.3 0.7 0.0 0.5 3.7 85.5 0.0 0.6 0.1 13.7 0.3 34.2 5.3 0.4 0.3 1.8 0.0 1.8 0.0 0.0 0.8 0.0 1.7 0.0 0.1 0.0 0.2 0.0 0.0 18.3 0.6 0.0 0.3 1.1 29.6 0.3 0.2 0.0 1.9 0.0 3.0 0.0 5.5 2.9 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.2 51.0 0.0 1.7 0.5 1.5 0.8 0.3 0.4 0.1 0.3 0.3 0.0 0.1 CYBRD1 "CYB561A2, DCYTB, FLJ23462, FRRS3" ENSG00000071967 "Cytochrome b reductase 1" Q53TN4 2 171522247-171558129 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport" "Oxidoreductase, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 221.2;Fibroblasts: 243.4;Leydig cells: 202.0;Peritubular cells: 221.5;Proximal enterocytes: 689.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.4;intermediate monocyte: 17.7;myeloid DC: 16.8;neutrophil: 9.8;non-classical monocyte: 13.7" "Group enriched" "Detected in many" 4 "dendritic cells: 16.8;granulocytes: 9.8;monocytes: 17.7" "Cell line enhanced" "Detected in many" "ASC diff: 1064.0;ASC TERT1: 453.8;BJ hTERT+: 408.2;HSkMC: 327.3;hTERT-RPE1: 276.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014757 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014757: AB_1847374" "unprognostic (1.35e-1)" "unprognostic (1.57e-1)" "unprognostic (2.89e-2)" "unprognostic (4.87e-2)" "unprognostic (2.97e-2)" "unprognostic (3.11e-2)" "unprognostic (2.86e-1)" "unprognostic (5.44e-3)" "unprognostic (8.90e-3)" "unprognostic (3.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (1.02e-3)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-2)" 154.7 98.5 31.7 24.6 36.1 18.5 150.2 34.8 34.4 141.2 39.2 61.9 199.5 101.2 50.2 71.3 89.0 155.0 88.4 27.8 60.4 32.3 21.8 131.0 34.1 45.1 34.2 22.5 182.5 21.8 12.1 26.3 38.4 41.7 71.2 39.4 22.4 64.2 77.4 23.5 85.7 235.4 88.6 34.4 30.9 53.8 24.0 39.0 28.2 233.2 83.6 30.4 85.1 91.2 43.2 24.8 18.1 10.1 19.2 1064.0 453.8 1.3 88.3 408.2 45.0 56.4 1.1 33.8 0.0 14.8 214.2 46.2 12.2 8.4 7.2 53.2 18.9 2.2 20.7 26.1 0.4 222.7 22.0 1.9 327.3 68.8 70.5 13.7 276.3 29.6 12.4 7.0 0.2 128.3 0.0 7.1 20.4 5.1 0.0 4.6 2.5 125.3 1.5 7.0 1.4 1.3 4.7 104.2 0.2 56.5 3.6 35.8 13.5 59.5 101.0 14.4 96.1 38.3 0.3 0.4 0.2 49.5 18.3 55.6 0.0 17.4 0.8 1.6 17.7 0.3 0.0 0.3 0.2 16.8 0.0 0.0 0.0 9.8 3.6 13.7 0.7 0.0 7.5 31.7 36.1 34.8 34.4 27.8 60.4 45.1 34.2 22.5 41.7 34.4 39.0 43.2 37.6 221.2 109.0 45.1 0.9 121.2 47.3 20.3 38.7 0.0 54.7 48.0 18.4 37.1 34.7 25.8 0.0 1.9 3.4 16.1 0.0 1.0 1.5 4.2 35.6 33.9 0.0 85.0 0.9 6.4 2.3 243.4 13.3 8.3 2.5 1.6 73.5 2.4 48.5 0.0 1.5 22.2 2.0 60.7 92.0 6.1 202.0 28.4 44.4 36.5 29.3 27.9 4.1 12.1 54.2 1.8 16.2 221.5 2.2 22.5 689.4 0.3 6.9 1.5 19.7 89.6 49.9 1.2 1.2 7.0 60.1 1.4 5.9 2.8 27.6 18.2 CDH19 CDH7 ENSG00000071991 "Cadherin 19" Q9H159 18 66501083-66604138 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.3;heart muscle: 27.2" "Cell type enhanced" "Detected in some" "Fibroblasts: 60.1;Melanocytes: 44.4;Oligodendrocyte precursor cells: 57.8;Oligodendrocytes: 192.6" "Cancer enriched" "Detected in some" 21 "melanoma: 16.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SK-MEL-30: 35.9;WM-115: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056332 Uncertain NA NA 320000 "HPA056332: AB_2683102" "unprognostic (1.63e-2)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (3.14e-2)" "unprognostic (1.93e-1)" "unprognostic (3.79e-1)" "unprognostic (1.02e-1)" "unprognostic (4.39e-2)" "unprognostic (9.33e-2)" "unprognostic (2.25e-2)" "unprognostic (4.58e-3)" "unprognostic (8.16e-3)" "unprognostic (8.21e-2)" "unprognostic (1.56e-5)" 2.4 4.3 2.6 3.2 9.7 0.1 1.3 3.7 8.1 5.9 0.1 14.3 2.2 0.9 1.6 3.1 1.9 2.6 27.2 4.3 8.0 0.4 4.2 1.2 0.1 8.1 7.2 2.4 1.1 1.2 0.1 0.4 2.9 8.0 4.3 2.8 0.1 3.4 4.1 4.3 1.9 5.4 1.7 2.6 2.2 4.9 0.8 6.1 0.1 1.0 1.2 0.0 5.2 5.9 18.3 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 35.9 0.1 1.5 0.0 0.0 0.1 0.3 0.2 0.1 4.0 0.2 0.0 0.1 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 9.7 3.7 8.1 4.3 8.0 8.1 7.2 2.4 8.0 2.6 6.1 18.3 0.0 0.0 0.0 1.0 0.0 1.1 0.3 0.2 2.8 0.0 1.1 0.3 9.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 2.8 0.0 0.0 60.1 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 0.5 0.0 2.0 0.6 1.0 0.2 5.3 0.1 44.4 0.0 0.0 0.0 0.0 57.8 192.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 3.6 2.7 0.9 0.3 0.3 0.0 0.1 0.0 0.0 0.4 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Approved Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: AB_2686754" "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 24.7 25.9 19.7 30.3 20.2 35.7 43.4 21.1 23.9 27.3 19.2 31.4 32.7 26.1 40.2 32.8 34.0 23.6 22.1 20.2 20.5 33.5 33.0 23.6 43.6 20.0 20.4 18.6 30.1 45.8 29.8 17.0 28.7 20.2 26.1 38.7 17.8 32.0 30.5 36.7 26.1 26.1 28.9 19.9 27.8 30.8 20.1 20.5 42.7 35.0 27.2 51.0 33.1 21.8 20.3 50.5 36.2 53.8 126.7 75.8 82.6 59.3 58.6 66.7 67.9 75.3 65.2 43.1 90.6 46.6 64.8 90.8 70.5 116.5 97.1 98.9 74.7 127.2 128.6 46.2 119.3 91.9 161.6 83.3 75.6 93.4 86.2 138.7 71.2 95.8 123.9 260.3 57.7 84.1 109.5 113.0 116.6 77.5 161.6 54.9 79.4 41.5 117.8 103.7 29.3 98.4 102.4 66.7 107.8 71.6 58.1 54.8 162.8 73.0 33.3 71.4 80.1 105.1 76.5 96.4 97.9 62.1 154.9 87.0 4.1 12.4 11.5 14.1 12.0 16.5 14.2 15.9 14.9 17.3 13.8 15.5 14.8 5.3 18.8 15.2 15.9 20.3 12.0 19.7 20.2 21.1 23.9 20.2 20.5 20.0 20.4 18.6 20.2 19.9 20.5 20.3 47.2 12.8 15.3 9.4 54.1 49.5 76.4 14.6 40.5 36.9 58.0 59.7 27.4 52.9 14.0 29.5 12.5 63.9 82.2 29.2 78.2 55.3 17.0 36.1 38.5 38.8 47.2 64.1 13.2 74.1 71.6 32.2 32.1 33.5 15.9 59.8 44.6 28.2 49.2 16.8 12.7 44.0 22.4 41.9 33.2 15.0 49.0 40.9 35.6 8.4 62.8 34.7 84.5 8.0 12.4 58.6 36.4 40.6 58.0 103.9 47.8 83.6 16.0 35.3 19.7 43.8 55.5 33.0 85.8 58.7 46.0 46.7 60.7 60.8 68.0 84.1 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859491-84913629 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.6;retina: 15.9" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 42.1;Bipolar cells: 19.7;Excitatory neurons: 63.9;Inhibitory neurons: 57.4;Melanocytes: 32.0;Oligodendrocytes: 46.9" "Group enriched" "Detected in some" 4 "head and neck cancer: 2.2;melanoma: 7.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 93.5;ASC TERT1: 55.4;hTERT-HME1: 135.3;SCLC-21H: 91.7;SK-MEL-30: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 0.4 1.4 6.0 0.2 8.4 0.0 0.4 4.3 13.5 0.7 0.0 0.4 0.1 0.5 0.0 2.8 0.2 0.0 0.0 6.2 11.3 0.1 0.0 0.1 0.0 7.2 13.4 6.8 0.3 0.0 0.0 5.5 3.8 13.2 0.2 0.2 15.9 0.8 0.1 0.0 1.4 0.4 0.3 0.3 0.0 0.1 0.4 8.1 0.1 0.3 1.6 0.2 0.2 1.3 22.6 0.0 2.5 10.3 0.0 93.5 55.4 0.1 0.1 21.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 12.0 1.2 0.0 23.7 0.1 0.0 25.1 0.0 4.1 0.0 33.5 0.0 0.2 31.4 48.2 11.9 135.3 25.3 0.3 0.0 0.0 0.0 25.9 0.0 0.1 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 91.7 22.6 0.1 31.1 71.0 0.2 0.0 0.0 0.0 12.7 6.5 0.1 0.0 0.0 0.0 0.1 23.1 0.0 27.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 8.4 4.3 13.5 6.2 11.3 7.2 13.4 6.8 13.2 0.3 8.1 22.6 0.0 0.0 0.0 4.2 0.1 2.7 0.0 3.1 42.1 19.7 0.1 0.1 0.5 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 63.9 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 57.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 32.0 1.9 0.0 1.1 0.0 4.0 46.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 11.1 0.0 0.5 1.0 0.4 0.5 5.8 0.6 0.3 0.0 0.0 0.0 0.0 RDH11 "ARSDR1, MDT1, SDR7C1" ENSG00000072042 "Retinol dehydrogenase 11" Q8TC12 14 67676800-67695793 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cataract, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 587.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 241.8;Muller glia cells: 299.7;Prostatic glandular cells: 285.7" "Cancer enriched" "Detected in all" 13 "prostate cancer: 286.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046011 Enhanced "Intracellular and membrane" NA NA 340000 "CAB046011: AB_11129613" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (1.77e-1)" "prognostic favorable (2.62e-4)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (9.29e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.58e-2)" "unprognostic (2.91e-2)" "unprognostic (1.27e-1)" "prognostic favorable (1.30e-7)" "unprognostic (1.65e-1)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (4.74e-2)" 23.8 60.0 41.8 24.7 44.5 14.0 29.0 51.1 54.8 32.9 37.8 29.4 34.4 33.5 86.7 34.9 23.7 43.1 17.4 43.6 48.4 106.9 154.4 35.2 20.6 50.7 49.1 40.5 29.2 42.9 80.4 23.6 22.1 51.1 587.2 31.7 74.6 44.6 34.7 8.4 28.6 24.1 44.0 49.5 22.4 32.2 28.6 48.4 31.0 62.3 13.6 26.4 34.6 30.6 60.9 183.7 81.9 71.3 82.0 111.5 100.4 59.3 68.0 134.2 83.7 150.9 68.6 216.7 31.7 51.2 64.6 104.8 142.5 104.0 150.8 113.7 63.0 42.6 65.1 40.7 69.0 106.9 24.3 46.0 94.4 98.0 109.3 92.0 63.9 97.4 87.0 52.1 101.1 77.2 97.5 72.2 38.8 40.4 49.7 92.8 53.6 87.4 45.8 194.1 93.0 73.8 62.0 71.2 89.7 99.1 58.2 100.7 38.3 74.2 89.5 101.1 38.9 49.5 47.5 40.0 40.7 115.8 66.0 74.3 282.4 71.1 104.0 62.3 57.7 68.2 39.0 67.7 61.5 51.3 45.5 67.3 64.8 11.0 56.3 65.4 59.1 65.1 115.8 41.8 44.5 51.1 54.8 43.6 48.4 50.7 49.1 40.5 51.1 49.5 48.4 60.9 27.0 25.6 66.0 38.2 29.2 11.5 40.0 77.9 16.5 53.5 45.4 24.5 20.4 68.6 59.9 47.8 50.1 24.9 32.4 26.8 7.9 92.5 2.5 21.9 50.9 39.3 43.3 29.2 33.3 84.0 38.1 37.5 19.9 38.2 29.2 46.3 47.8 241.8 35.8 79.1 37.6 28.9 89.5 42.4 15.4 6.1 43.2 35.9 35.6 17.8 39.8 299.7 37.0 70.4 43.4 61.2 36.7 56.1 27.3 285.7 17.5 56.0 23.9 97.0 46.0 29.7 38.7 25.8 24.0 20.2 19.2 63.5 29.8 66.7 25.3 46.1 PRKACA PKACa ENSG00000072062 "Protein kinase cAMP-activated catalytic subunit alpha" P17612 19 14091688-14118084 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 313.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 116.8;Theca cells: 100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010361, HPA071185" Approved Approved "Cytokinetic bridge,Cytosol" Yes NA 170000 Cytosol "Cytokinetic bridge" "CAB010361: AB_2268772, HPA071185: AB_2686356" "unprognostic (1.08e-1)" "prognostic favorable (6.28e-6)" "unprognostic (2.09e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (1.38e-2)" "unprognostic (2.95e-1)" "unprognostic (1.64e-1)" "unprognostic (9.36e-3)" "unprognostic (7.01e-2)" "unprognostic (3.41e-1)" "prognostic favorable (6.47e-4)" "unprognostic (2.86e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.66e-2)" "unprognostic (6.14e-3)" 61.8 127.5 43.0 27.8 47.2 19.1 54.4 39.6 64.7 53.1 29.2 51.5 21.1 57.4 28.7 42.1 54.2 14.3 190.3 47.0 48.8 35.6 79.1 46.5 16.1 52.2 48.7 45.7 94.9 34.2 21.8 71.7 17.5 57.1 41.6 13.1 25.4 42.7 21.0 313.4 40.8 36.7 22.0 38.3 72.1 40.5 57.6 49.9 18.4 39.9 123.2 13.5 51.0 44.5 60.0 37.5 16.3 40.3 74.4 36.2 30.8 9.9 30.5 23.6 32.7 27.5 21.6 15.0 13.8 26.2 49.2 22.9 25.4 26.7 26.6 32.3 23.1 17.7 27.7 20.6 24.4 36.8 21.9 33.5 33.8 18.1 30.0 11.1 26.6 29.7 19.0 29.1 47.3 36.7 48.1 46.3 31.9 21.5 38.7 45.0 38.0 47.8 36.7 41.7 13.5 36.5 24.2 34.2 31.3 23.8 18.1 37.2 26.5 37.7 71.7 20.3 100.7 39.6 31.9 24.9 23.6 49.6 28.0 32.7 0.1 1.5 0.2 0.8 2.7 0.3 0.8 0.3 0.5 1.1 0.5 0.5 0.7 3.2 0.4 2.5 0.6 0.3 0.6 43.0 47.2 39.6 64.7 47.0 48.8 52.2 48.7 45.7 57.1 38.3 49.9 60.0 39.5 6.4 3.4 9.4 7.0 8.8 6.8 6.4 2.2 42.2 19.2 19.0 116.8 22.8 4.7 14.7 27.1 6.9 9.0 24.6 7.9 12.4 32.4 11.7 22.9 26.7 17.5 2.5 16.9 19.1 5.7 22.6 8.6 12.9 0.0 15.9 26.4 39.7 34.5 3.3 21.6 11.8 2.0 49.4 50.8 15.7 49.0 37.1 14.2 9.4 37.8 26.1 9.2 10.1 10.7 15.6 11.6 51.9 3.3 6.4 20.7 11.8 7.0 23.9 19.7 23.3 23.5 26.4 6.9 10.1 11.2 8.1 10.0 100.6 14.4 6.6 ADGRL1 "CIRL1, KIAA0821, LEC2, LPHN1" ENSG00000072071 "Adhesion G protein-coupled receptor L1" O94910 19 14147743-14206187 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.2;Excitatory neurons: 52.8;Horizontal cells: 35.3;Inhibitory neurons: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 35.8;HMC-1: 25.6;SCLC-21H: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037974 Uncertain NA NA 180000 "HPA037974: AB_10675623" "unprognostic (5.52e-2)" "unprognostic (3.89e-1)" "unprognostic (1.04e-1)" "unprognostic (5.52e-3)" "unprognostic (6.29e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (5.39e-2)" "unprognostic (2.73e-1)" "unprognostic (5.68e-2)" "prognostic favorable (1.14e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.45e-4)" "unprognostic (7.65e-3)" "unprognostic (1.32e-1)" "unprognostic (3.06e-2)" "unprognostic (2.18e-1)" 10.5 5.4 18.0 2.4 15.8 1.3 11.2 7.0 26.6 17.1 0.0 17.6 3.9 22.9 2.5 8.6 15.7 2.6 11.7 20.4 4.6 9.3 1.3 9.9 1.8 6.8 6.8 18.0 9.4 9.2 8.9 26.3 2.3 9.1 11.7 2.3 6.7 9.7 4.6 1.6 12.1 11.8 4.9 0.3 6.4 14.5 10.1 10.2 3.0 16.2 0.6 1.1 12.2 10.1 13.8 11.7 4.4 10.0 35.8 2.6 0.7 3.5 0.8 1.2 1.1 0.7 3.9 4.0 0.9 11.9 1.3 2.3 0.7 12.1 3.4 0.3 1.7 10.3 2.1 2.0 0.6 5.9 0.7 25.6 2.1 3.1 0.3 0.5 1.8 1.0 11.3 10.4 1.1 0.1 19.7 1.0 1.1 14.9 6.3 8.6 5.7 1.2 13.0 1.9 3.6 27.4 7.0 2.1 14.3 5.0 3.5 14.2 5.4 1.4 9.2 14.0 2.5 3.3 2.8 2.5 15.9 2.7 13.5 3.4 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.1 0.2 0.1 0.0 18.0 15.8 7.0 26.6 20.4 4.6 6.8 6.8 18.0 9.1 0.3 10.2 13.8 6.7 0.0 4.5 29.4 0.7 0.0 3.0 0.0 9.1 64.2 13.0 9.4 8.8 1.5 1.8 7.3 10.4 0.4 4.9 4.9 0.0 3.2 0.9 4.1 10.0 7.6 7.3 6.6 52.8 3.2 0.4 6.6 8.6 4.9 5.1 5.9 8.2 0.2 0.9 35.3 46.2 4.3 0.0 1.9 0.0 2.6 9.3 1.2 0.0 6.5 1.1 31.8 11.3 33.7 22.7 2.1 9.1 16.1 1.6 4.5 7.2 0.8 0.0 23.2 19.7 1.2 5.4 2.3 19.1 6.2 0.0 0.3 3.1 6.2 6.5 1.6 SPP2 SPP24 ENSG00000072080 "Secreted phosphoprotein 2" Q13103 2 234050679-234077134 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4368 "liver: 523.3" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 258.7" "Cancer enriched" "Detected in some" 112 "liver cancer: 65.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 480000000 "prognostic favorable (2.33e-6)" "unprognostic (7.02e-3)" "unprognostic (9.62e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 523.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.3 0.3 0.6 0.0 0.7 0.0 0.1 5.1 0.0 5.0 258.7 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 ACTN1 ENSG00000072110 "Actinin alpha 1" P12814 14 68874128-68979440 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 529.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 351.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 364.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004303, HPA006035" Approved Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 210000000 "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB004303: AB_626633, HPA006035: AB_1078095" "unprognostic (4.40e-2)" "unprognostic (1.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (6.19e-3)" "prognostic unfavorable (7.63e-5)" "unprognostic (3.62e-1)" "unprognostic (3.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.08e-10)" "unprognostic (2.87e-2)" "unprognostic (2.00e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (8.00e-4)" 118.4 41.1 28.3 150.9 46.3 150.7 104.4 0.7 32.1 109.2 29.4 329.4 50.2 315.7 60.8 155.8 153.4 145.2 111.6 27.7 42.2 36.0 62.3 100.9 47.9 27.3 12.1 28.5 62.3 47.2 9.2 27.5 96.9 14.2 175.9 110.0 28.4 117.4 297.9 21.8 59.0 107.8 529.2 5.1 56.4 173.1 21.4 29.2 32.9 35.3 13.4 51.1 308.4 84.0 29.8 871.9 262.3 158.6 121.4 275.2 180.5 592.4 749.3 712.0 770.0 571.1 211.8 196.6 0.7 256.5 744.7 310.4 370.9 126.8 790.3 965.2 4.6 38.5 118.2 133.5 179.0 494.0 85.4 14.3 231.7 152.1 479.8 540.3 551.6 428.6 48.2 56.9 1.4 612.0 246.9 10.1 181.1 124.7 217.9 198.1 59.3 294.1 32.6 292.0 225.6 57.0 68.7 649.9 96.8 177.1 474.8 146.0 170.9 546.0 1085.2 432.8 126.9 662.5 113.8 47.8 3.9 314.4 115.7 584.4 64.6 67.5 137.1 5.7 28.8 7.1 0.1 22.7 12.4 45.5 0.2 103.9 92.2 364.2 4.5 8.9 2.0 9.6 89.2 28.3 46.3 0.7 32.1 27.7 42.2 27.3 12.1 28.5 14.2 5.1 29.2 29.8 44.7 38.5 25.1 19.6 4.0 119.3 154.9 137.4 82.0 74.7 88.6 157.6 60.3 51.5 36.0 42.3 246.0 155.3 3.0 17.2 3.9 186.8 34.0 65.8 112.8 135.5 38.5 21.9 102.7 144.9 351.8 88.9 34.1 90.2 7.6 15.9 129.5 96.6 79.5 18.5 29.7 57.3 59.0 100.9 82.1 10.7 35.8 96.4 30.2 34.7 105.1 6.0 4.1 9.0 4.3 203.7 28.0 245.6 0.6 132.6 2.4 15.3 47.8 80.8 177.5 30.0 270.6 19.4 18.4 51.8 59.8 66.9 22.7 20.9 47.0 67.1 ZFYVE26 "KIAA0321, SPG15" ENSG00000072121 "Zinc finger FYVE-type containing 26" Q68DK2 14 67727374-67816590 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 50.1;Rod photoreceptor cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 11 "dendritic cells: 4.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055500 Approved NA NA "HPA055500: AB_2682837" "unprognostic (3.14e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (2.84e-6)" "unprognostic (6.87e-2)" "unprognostic (8.18e-2)" "unprognostic (2.97e-2)" "unprognostic (8.29e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.54e-6)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (6.69e-2)" "unprognostic (5.34e-2)" 5.1 6.5 4.7 5.4 5.8 6.0 5.4 5.6 6.1 5.4 6.3 5.5 4.1 5.7 4.1 5.6 4.5 4.4 4.7 4.3 6.4 4.9 4.5 6.7 7.1 6.0 6.0 4.0 6.7 5.0 7.4 5.5 5.9 6.3 4.8 4.8 6.4 4.8 4.6 8.8 7.2 5.9 6.0 4.8 7.4 5.2 2.7 6.9 6.9 5.2 9.7 6.7 5.2 4.8 7.0 12.1 6.9 7.3 7.8 15.2 6.8 10.7 5.8 9.1 13.0 14.9 7.2 7.3 6.7 3.0 7.4 10.8 7.2 10.1 6.9 10.6 6.9 5.6 5.1 8.4 6.7 8.4 3.1 8.3 8.3 9.1 10.1 8.1 6.4 14.6 7.4 7.6 5.3 8.9 9.2 5.1 4.6 3.8 4.8 7.8 4.5 12.1 3.5 5.6 12.2 7.3 4.7 9.0 6.8 8.0 7.1 9.8 4.0 12.9 11.3 9.2 6.9 4.7 4.5 3.3 8.2 9.3 5.6 5.5 0.0 0.2 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.0 0.3 0.0 4.8 0.4 0.2 4.7 5.8 5.6 6.1 4.3 6.4 6.0 6.0 4.0 6.3 4.8 6.9 7.0 4.4 0.0 9.0 19.9 4.6 2.8 1.8 3.1 6.8 11.6 4.6 3.6 5.8 7.2 4.1 3.7 50.1 2.8 9.6 6.1 0.0 3.9 2.0 4.2 3.7 5.0 3.5 3.8 20.5 2.8 2.4 4.0 5.1 5.2 0.0 6.5 7.1 4.9 9.7 16.8 19.0 3.4 2.0 6.3 6.1 3.1 2.8 8.0 3.6 8.4 7.5 6.9 7.2 16.6 22.1 4.0 6.2 2.2 7.3 2.5 5.0 2.7 4.1 126.3 6.6 7.5 4.0 1.2 1.6 6.9 7.2 4.0 3.8 3.6 3.4 1.9 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84188199 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.3;Inhibitory neurons: 70.7;Oligodendrocyte precursor cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.1;PC-3: 7.9;RH-30: 9.9;SH-SY5Y: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.4 2.0 2.3 0.5 3.2 0.1 1.7 3.3 3.0 2.0 2.3 2.9 1.2 1.7 3.2 0.8 2.3 1.1 0.4 2.6 3.1 5.7 0.6 0.6 0.2 2.8 2.5 2.8 2.7 0.9 7.1 5.8 0.3 2.1 2.9 2.3 7.1 1.7 2.7 1.7 2.0 1.3 1.0 1.4 0.4 1.7 1.5 2.2 1.0 8.2 0.4 0.3 1.3 1.4 2.7 0.0 2.4 2.6 0.0 2.4 2.2 0.0 5.2 2.7 2.3 1.9 1.9 2.0 0.0 0.0 2.6 0.0 0.1 6.4 4.6 5.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 1.4 0.0 0.0 2.4 3.0 0.6 0.0 0.0 0.1 2.0 0.0 1.1 0.1 8.1 0.0 7.9 0.0 9.9 0.0 0.5 5.4 0.0 9.4 0.0 3.4 0.0 3.8 1.4 0.0 0.0 0.1 2.4 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.6 0.0 2.3 3.2 3.3 3.0 2.6 3.1 2.8 2.5 2.8 2.1 1.4 2.2 2.7 0.3 9.6 2.7 6.2 0.7 0.3 5.3 0.3 3.4 21.1 3.6 3.4 2.6 12.8 1.9 18.4 25.0 2.6 0.1 6.7 1.9 0.5 0.7 1.9 1.2 1.2 25.0 2.7 75.3 1.2 0.7 2.2 2.0 0.9 0.0 21.8 1.1 1.3 0.2 1.7 70.7 3.6 0.0 0.0 0.0 0.4 4.4 0.5 0.0 3.7 0.1 2.1 1.0 31.2 5.8 1.3 3.4 6.0 0.0 9.2 1.8 4.3 3.7 18.2 0.0 4.9 1.5 8.4 6.2 2.5 0.4 2.3 0.9 2.0 6.5 5.2 EPN2 "EHB21, KIAA1065" ENSG00000072134 "Epsin 2" O95208 17 19215615-19336715 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Oligodendrocyte precursor cells: 868.6;Oligodendrocytes: 258.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 10.9;eosinophil: 29.0;neutrophil: 9.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.0" "Cell line enhanced" "Detected in many" "SuSa: 127.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049809, HPA053360" Approved Supported Vesicles NA NA Vesicles "HPA049809: AB_2680893, HPA053360: AB_2682126" "unprognostic (1.38e-2)" "unprognostic (2.54e-2)" "unprognostic (2.58e-2)" "unprognostic (2.09e-1)" "unprognostic (1.94e-1)" "unprognostic (8.12e-3)" "unprognostic (6.73e-3)" "unprognostic (1.43e-1)" "unprognostic (8.89e-2)" "unprognostic (4.58e-3)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.32e-1)" "unprognostic (9.40e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (8.15e-5)" 19.1 14.1 62.6 9.8 63.7 11.6 16.9 51.0 63.3 32.8 30.9 23.7 9.7 29.8 11.6 40.6 26.9 14.7 32.6 61.2 49.2 17.0 9.3 18.8 6.5 63.0 63.7 49.8 22.7 14.7 15.4 18.3 21.8 66.7 23.8 9.6 19.2 18.1 23.6 22.6 49.2 13.5 22.7 49.1 14.4 16.1 19.9 61.4 4.8 17.9 17.2 8.5 27.2 34.1 92.9 31.3 30.4 43.9 19.2 22.8 36.3 34.5 29.4 18.9 17.9 15.3 20.2 9.2 4.9 28.2 29.5 16.8 29.0 19.8 22.1 21.9 23.6 21.2 3.2 20.3 9.2 23.7 1.4 13.1 20.5 19.5 28.3 22.7 23.2 38.8 6.6 8.6 3.9 15.8 22.5 1.3 2.1 11.1 41.3 19.8 7.1 18.8 8.1 21.0 8.6 13.0 28.8 20.9 13.9 14.7 127.9 21.0 4.0 35.6 19.7 22.3 30.9 12.9 6.7 4.3 3.9 54.0 0.5 31.1 10.9 1.3 29.0 1.6 0.8 1.2 3.0 1.1 1.3 0.5 3.4 1.3 1.2 9.0 0.7 1.0 0.6 1.0 0.7 62.6 63.7 51.0 63.3 61.2 49.2 63.0 63.7 49.8 66.7 49.1 61.4 92.9 60.0 54.5 29.3 74.4 13.7 24.1 36.6 21.2 43.9 68.3 32.8 33.4 44.5 25.8 25.0 38.6 47.9 27.6 3.3 7.2 27.4 22.5 36.8 69.2 35.0 42.5 6.0 13.5 51.3 8.4 39.8 36.1 15.8 40.6 14.0 37.3 15.0 10.4 8.4 35.3 45.0 16.8 10.2 5.1 6.2 72.7 46.6 5.9 5.4 54.4 1.6 38.3 2.1 868.6 258.3 23.3 14.9 39.5 14.4 32.0 7.0 14.2 43.2 82.3 26.3 50.5 63.7 45.8 38.3 63.9 48.9 21.9 7.4 35.0 7.8 40.1 PTPN18 BDP1 ENSG00000072135 "Protein tyrosine phosphatase non-receptor type 18" Q99952 2 130356045-130375405 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 143.4;NK-cells: 148.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 63.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012174, HPA053367" Uncertain Approved "Intermediate filaments" NA NA 270000 "Intermediate filaments" "CAB012174: AB_2173224, HPA053367: AB_2732579" "unprognostic (3.11e-3)" "unprognostic (2.89e-3)" "unprognostic (1.67e-3)" "unprognostic (1.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-3)" "unprognostic (2.49e-2)" "unprognostic (1.28e-2)" "unprognostic (4.65e-1)" "unprognostic (2.10e-2)" "unprognostic (7.33e-2)" "unprognostic (5.65e-2)" "unprognostic (4.52e-2)" "unprognostic (1.00e-2)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.85e-3)" 22.2 12.4 19.0 23.4 19.1 28.5 21.7 20.7 21.5 20.1 18.4 27.5 21.9 15.8 6.1 18.0 19.7 14.9 14.1 18.4 19.5 25.5 38.2 22.2 43.1 19.9 18.8 18.4 12.7 34.9 9.6 19.2 12.3 20.1 33.6 24.9 6.4 32.2 13.4 7.6 12.7 39.7 13.5 17.9 64.3 27.2 4.6 19.6 11.3 20.2 7.6 49.0 18.9 19.1 19.2 12.4 8.3 3.2 16.2 19.7 13.5 32.9 6.2 5.6 7.9 8.8 16.4 18.5 46.4 6.2 15.2 3.7 13.8 14.3 14.1 7.6 21.1 8.0 16.9 9.8 19.5 10.2 16.6 44.5 16.0 11.4 8.7 12.0 1.7 15.2 10.1 16.1 34.2 15.4 24.3 3.1 28.4 3.3 26.6 8.6 28.4 9.5 63.0 15.9 7.5 20.6 5.4 10.9 38.6 18.7 3.1 13.2 24.1 14.4 11.2 12.6 6.2 5.9 5.6 1.6 44.5 17.1 14.9 12.4 8.4 7.8 6.7 6.4 11.2 4.0 7.3 4.2 6.1 6.9 5.1 2.6 5.1 4.8 3.1 19.4 7.5 6.0 10.7 19.0 19.1 20.7 21.5 18.4 19.5 19.9 18.8 18.4 20.1 17.9 19.6 19.2 37.2 28.9 23.9 12.1 43.6 6.5 28.8 15.9 12.0 13.4 52.0 53.5 9.0 18.6 17.5 36.8 4.2 15.6 85.6 75.9 54.8 19.0 0.9 20.6 14.0 30.7 48.6 32.4 18.2 45.4 30.5 16.3 65.2 24.0 35.5 12.2 25.7 21.1 92.4 10.1 18.6 52.5 30.5 113.6 35.9 1.6 19.0 143.4 33.8 35.6 65.2 18.4 148.3 5.5 6.1 29.0 66.9 11.3 23.5 37.9 41.3 37.3 20.5 11.6 19.7 15.1 21.5 2.6 6.0 19.4 5.8 11.5 39.3 16.2 47.5 28.9 LIMS2 "PINCH-2, PINCH2" ENSG00000072163 "LIM zinc finger domain containing 2" Q7Z4I7 2 127638381-127681786 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 357.7" "Cell type enhanced" "Detected in many" "Adipocytes: 109.4;Cardiomyocytes: 91.7;Endothelial cells: 105.1;Granulosa cells: 134.1;Hepatic stellate cells: 134.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 22.5" "Group enriched" "Detected in many" 13 "B-cells: 22.5;T-cells: 10.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 27.0;fHDF/TERT166: 31.2;HHSteC: 32.7;MOLT-4: 40.2;TIME: 83.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058340 Enhanced Supported "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058340: AB_2683683" "unprognostic (2.51e-2)" "unprognostic (1.25e-1)" "unprognostic (5.82e-3)" "unprognostic (4.51e-2)" "unprognostic (9.25e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.53e-7)" "unprognostic (3.98e-2)" "unprognostic (3.73e-1)" "unprognostic (2.29e-1)" "unprognostic (3.78e-2)" "unprognostic (8.86e-2)" "unprognostic (3.33e-1)" "unprognostic (4.60e-3)" "unprognostic (3.64e-2)" "unprognostic (1.77e-1)" "unprognostic (4.00e-2)" 100.2 21.8 25.1 18.1 22.0 0.4 94.7 20.7 32.5 102.0 25.9 357.7 15.9 263.6 17.1 42.5 140.7 26.0 225.9 21.2 19.5 72.1 46.9 115.3 13.0 24.2 22.7 17.6 29.2 14.2 6.5 15.7 28.0 24.0 133.2 15.3 0.6 27.3 99.8 33.7 31.1 96.5 82.6 19.2 122.8 124.1 12.1 26.6 13.3 52.0 27.0 5.4 222.3 85.8 22.1 0.8 1.6 0.5 0.0 4.6 1.0 0.3 19.1 27.0 20.2 18.1 4.7 0.1 0.1 10.3 31.2 1.1 0.1 0.3 0.0 4.2 0.0 0.8 0.0 11.9 3.6 32.7 0.0 0.0 0.2 0.0 7.0 0.2 10.7 12.9 15.3 0.0 0.0 10.0 0.0 40.2 1.0 1.3 0.0 2.4 9.0 1.7 1.0 1.3 0.0 0.1 0.2 3.0 1.7 0.7 6.7 0.7 0.0 83.7 0.1 12.9 15.2 0.1 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.3 0.0 15.2 5.3 1.1 0.2 22.5 10.7 4.4 0.3 0.0 0.2 1.2 8.0 2.5 25.1 22.0 20.7 32.5 21.2 19.5 24.2 22.7 17.6 24.0 19.2 26.6 22.1 109.4 22.4 6.1 0.3 10.1 9.4 0.3 0.2 1.2 0.2 1.9 17.1 91.7 4.3 1.3 0.0 0.0 0.6 0.8 0.1 0.0 1.2 1.3 2.9 5.3 105.1 0.0 5.7 0.4 0.2 12.4 22.5 1.1 0.9 2.5 134.1 134.6 16.3 1.0 0.0 0.3 0.0 0.0 6.5 13.0 3.1 19.9 1.7 10.6 30.9 0.0 0.3 0.0 4.0 0.3 0.5 0.0 49.7 1.7 0.3 0.0 0.5 0.8 0.9 26.3 4.2 35.4 0.8 2.1 0.6 6.7 1.0 2.3 1.8 0.0 0.3 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 10.3;pituitary gland: 22.2;retina: 6.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 223.4;Cone photoreceptor cells: 173.0" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 21.2;HMC-1: 6.2;K-562: 12.1;SH-SY5Y: 5.2" "Region enhanced" "Detected in many" "basal ganglia: 73.2" "Low region specificity" "Detected in many" HPA036042 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036042: AB_10672998" "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.1 1.1 6.4 0.0 3.9 0.0 0.0 3.8 6.9 0.3 1.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 3.8 4.5 0.0 0.0 0.1 0.0 4.9 8.4 4.0 0.0 0.0 0.0 22.2 0.0 3.7 0.1 0.0 6.5 0.0 0.1 0.0 0.1 0.0 0.0 4.4 0.0 0.0 1.3 10.3 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.9 3.8 6.9 3.8 4.5 4.9 8.4 4.0 3.7 4.4 10.3 3.6 0.1 0.0 0.0 0.3 0.0 0.1 1.6 0.1 0.0 223.4 0.9 1.0 1.1 0.0 0.0 0.0 173.0 2.5 0.0 0.7 0.0 0.0 6.1 0.0 0.9 0.4 0.0 0.0 0.3 0.4 1.0 0.9 0.0 0.3 17.8 0.4 0.0 0.0 0.1 0.0 11.6 0.6 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 39.2 0.4 0.0 2.5 0.4 0.1 1.1 1.3 0.2 0.0 12.8 0.0 3.1 0.6 0.3 0.6 0.0 0.3 2.9 0.4 0.5 0.9 0.3 SPEG "APEG1, BPEG, KIAA1297, MGC12676, MYLK6, SPEGalpha, SPEGbeta" ENSG00000072195 "Striated muscle enriched protein kinase" Q15772 2 219434843-219493629 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 120.1;skeletal muscle: 119.1" "Cell type enhanced" "Detected in many" "Astrocytes: 45.7;Cardiomyocytes: 61.5;Late spermatids: 39.6;Sertoli cells: 46.0;Smooth muscle cells: 32.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 45.9;U-87 MG: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018904 Enhanced Approved Vesicles NA NA Vesicles "HPA018904: AB_1844924" "unprognostic (3.70e-1)" "unprognostic (1.23e-2)" "unprognostic (5.05e-3)" "unprognostic (2.45e-4)" "unprognostic (2.04e-2)" "unprognostic (4.65e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (8.92e-3)" "unprognostic (2.29e-2)" "unprognostic (8.66e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-9)" "unprognostic (1.14e-1)" "unprognostic (7.01e-2)" "unprognostic (5.95e-4)" "unprognostic (1.28e-3)" 15.7 6.9 16.7 7.8 17.4 0.0 15.4 15.3 20.9 71.8 10.3 120.1 5.3 90.2 6.3 15.7 70.6 7.4 43.5 19.9 14.6 4.2 1.3 8.8 0.6 15.9 15.9 15.3 22.0 3.5 4.4 34.6 4.5 15.2 59.3 3.8 1.0 10.0 25.8 119.1 7.0 32.2 23.3 14.8 2.4 48.5 5.4 15.2 0.5 6.0 21.9 0.2 88.4 42.5 15.6 6.1 0.5 3.1 4.9 1.6 4.7 1.8 13.1 8.5 8.6 6.4 4.5 1.9 0.0 4.5 9.7 4.3 7.2 2.5 3.1 3.4 0.0 1.7 0.0 6.1 0.3 2.1 0.0 0.5 13.2 4.6 7.8 1.9 45.9 0.0 3.2 3.5 0.0 6.1 1.6 0.1 18.8 6.5 0.0 2.4 2.8 7.0 1.1 8.5 0.0 3.4 15.1 0.6 0.0 0.3 14.3 0.3 0.2 0.0 20.6 21.3 2.4 21.1 0.4 0.0 0.2 23.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.4 15.3 20.9 19.9 14.6 15.9 15.9 15.3 15.2 14.8 15.2 15.6 2.4 0.0 2.2 45.7 0.4 3.2 6.0 1.3 2.8 5.3 10.3 14.6 61.5 4.3 0.1 1.8 2.1 0.6 1.4 4.1 0.0 1.5 21.8 0.9 3.6 2.2 6.7 2.7 20.5 1.2 0.9 10.0 3.6 1.3 0.0 1.0 5.7 3.1 1.1 5.0 20.9 4.1 0.0 5.6 1.9 39.6 10.5 1.6 3.6 4.7 1.4 8.4 0.0 5.0 1.0 0.2 3.2 18.8 0.9 6.5 8.5 4.3 0.1 0.9 46.0 17.1 32.4 11.6 3.7 0.2 1.4 1.4 1.2 0.4 3.5 5.3 LNX1 "LNX, MPDZ, PDZRN2" ENSG00000072201 "Ligand of numb-protein X 1" Q8TBB1 4 53459301-53701405 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002235, HPA071091" Approved Supported "Cell Junctions,Cytosol" "Intracellular and membrane" NA NA "Cell Junctions" Cytosol "HPA002235: AB_1079261, HPA071091: AB_2686344" "unprognostic (4.95e-2)" "unprognostic (1.74e-2)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (2.79e-1)" "unprognostic (2.31e-1)" "unprognostic (1.31e-1)" "unprognostic (5.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.67e-1)" "unprognostic (5.49e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" 22.1 2.5 2.5 2.1 7.2 1.0 14.4 0.3 11.4 6.0 0.0 6.7 9.5 4.2 0.7 24.6 6.5 5.6 8.2 7.5 4.7 10.7 4.5 2.7 2.2 1.3 1.1 7.6 2.1 16.4 12.0 4.3 24.8 1.6 6.0 6.9 3.9 25.3 7.3 6.0 11.9 9.1 3.0 0.0 0.9 9.5 4.5 1.5 3.4 18.1 12.1 4.1 4.3 8.0 4.9 1.4 0.5 1.6 0.9 2.7 5.8 8.0 1.2 0.6 0.0 0.0 2.9 8.9 1.7 1.1 4.3 0.4 1.4 0.0 0.2 0.0 0.4 4.6 2.2 1.5 1.5 1.3 2.4 0.7 4.4 0.2 0.3 0.0 1.9 2.7 0.8 1.9 0.8 6.4 4.5 2.2 1.7 4.3 17.7 0.7 1.2 0.6 0.7 5.6 8.2 2.2 2.1 0.6 10.8 0.9 9.1 5.7 1.1 7.8 10.0 2.6 3.1 1.6 3.6 0.5 1.1 8.7 2.0 1.5 0.3 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.0 0.7 0.4 0.2 0.2 0.0 2.5 7.2 0.3 11.4 7.5 4.7 1.3 1.1 7.6 1.6 0.0 1.5 4.9 77.5 0.0 3.9 4.9 1.7 8.2 18.0 14.5 24.5 7.5 13.3 7.1 1.6 12.8 15.5 7.3 6.2 30.6 1.5 18.5 19.6 13.7 171.7 37.7 7.6 16.0 13.8 3.6 123.8 11.7 22.1 4.8 14.3 83.0 2.5 1.5 2.9 6.2 2.5 42.1 42.2 13.4 14.2 0.3 2.1 47.9 4.4 1.3 5.4 11.2 0.4 2.2 2.1 43.7 4.0 12.3 26.5 8.6 0.9 8.5 14.5 2.9 17.9 5.8 0.0 10.0 2.2 0.9 2.6 32.2 11.9 14.9 1.9 1.4 14.2 15.2 ALDH3A2 "ALDH10, FALDH, SLS" ENSG00000072210 "Aldehyde dehydrogenase 3 family member A2" P51648 17 19648136-19685760 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 291.0" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 285.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014769, CAB020692" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 32000 "Endoplasmic reticulum, Cytosol" "CAB020692: , HPA014769: AB_1844728" "unprognostic (1.42e-1)" "unprognostic (7.62e-2)" "unprognostic (7.77e-2)" "unprognostic (2.49e-2)" "unprognostic (4.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-2)" "unprognostic (2.23e-1)" "unprognostic (3.93e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "prognostic favorable (3.85e-8)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-2)" "unprognostic (1.26e-1)" 75.9 204.9 25.6 15.3 31.7 9.3 35.2 27.1 29.7 49.8 63.5 50.1 68.8 29.6 42.1 132.5 38.7 71.1 45.1 30.8 43.7 174.6 291.0 59.7 15.1 25.8 28.2 24.2 32.6 52.7 41.0 22.0 11.9 24.9 75.6 36.9 41.1 62.2 41.8 53.5 209.3 72.4 30.4 26.4 19.5 82.2 27.2 27.9 23.3 75.8 101.7 36.7 24.4 40.9 33.7 27.7 147.0 29.2 58.5 88.7 89.4 19.1 12.3 29.9 24.4 27.6 63.2 52.5 12.3 35.9 50.5 29.3 99.0 59.8 125.2 19.9 36.2 42.5 5.3 120.9 142.8 12.2 30.6 5.4 42.9 137.6 22.9 12.2 49.7 49.2 25.5 2.2 0.6 37.3 45.3 0.7 25.2 32.3 285.4 78.5 38.6 64.1 25.3 17.5 132.3 46.3 30.4 98.9 38.4 35.3 152.2 78.1 35.0 46.7 10.1 28.7 68.8 45.6 11.3 28.6 15.5 47.4 0.3 48.3 0.8 21.1 17.5 6.3 18.3 9.9 5.2 6.0 6.1 20.7 4.9 6.8 6.3 2.2 15.0 20.6 1.3 11.3 11.0 25.6 31.7 27.1 29.7 30.8 43.7 25.8 28.2 24.2 24.9 26.4 27.9 33.7 22.1 176.3 86.5 14.7 13.3 57.1 143.9 85.1 287.4 15.3 13.6 24.0 54.1 105.8 86.5 33.1 12.5 12.5 8.2 48.9 43.0 97.5 79.6 47.5 13.4 19.5 16.2 8.2 30.5 52.0 4.6 39.9 87.7 36.9 29.7 34.6 13.6 116.7 24.6 6.7 20.1 27.7 26.4 21.7 15.1 19.5 55.9 23.5 7.2 13.1 25.7 105.9 8.2 19.6 29.1 43.9 28.7 80.5 28.6 104.2 90.6 119.2 59.2 21.4 13.1 70.1 22.1 15.5 24.0 232.6 90.2 1.4 13.2 29.1 46.0 51.4 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082096 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 256.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 860.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" NA NA 1310000000 38000000 "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.62e-2)" 45.0 28.9 23.6 63.9 20.6 256.7 20.4 20.7 29.0 31.6 18.0 77.9 36.2 24.0 11.2 36.3 26.1 25.1 29.6 23.1 29.9 26.6 28.0 78.7 23.2 25.0 22.4 18.9 94.7 16.0 45.1 13.2 104.0 28.1 13.3 56.2 47.7 15.8 13.5 76.9 20.7 32.4 31.8 22.0 15.7 21.6 21.8 24.4 22.2 20.3 69.3 28.3 69.1 17.5 28.4 175.3 155.0 69.8 142.1 151.7 87.3 438.7 242.5 183.7 168.1 276.3 384.6 156.6 178.5 446.3 91.0 363.5 261.8 243.3 81.1 204.2 860.4 82.4 677.4 120.2 179.2 119.4 561.8 130.4 99.1 78.6 144.5 129.0 47.8 56.9 95.6 287.3 164.1 132.8 161.7 185.8 116.8 214.9 228.6 314.0 97.3 103.9 214.1 148.3 435.3 159.3 65.9 234.4 613.9 55.2 115.9 595.0 115.8 72.5 198.4 159.7 175.3 369.7 46.3 387.8 276.7 232.3 149.2 122.3 0.0 1.6 2.2 2.2 7.3 1.4 5.1 2.4 1.5 3.5 3.1 2.1 1.7 0.2 1.9 13.2 7.1 6.4 2.1 23.6 20.6 20.7 29.0 23.1 29.9 25.0 22.4 18.9 28.1 22.0 24.4 28.4 25.4 44.8 32.1 43.1 46.6 60.3 37.2 33.6 21.1 53.1 37.1 34.9 103.0 41.5 38.8 20.2 148.0 122.5 53.2 156.6 0.0 49.4 3.5 35.3 20.3 23.6 56.1 556.4 24.7 41.8 25.3 32.4 77.5 56.1 23.4 40.2 8.6 93.2 73.4 13.5 28.3 67.8 22.4 37.1 77.6 5.3 11.5 161.7 17.8 44.0 49.4 22.0 9.2 11.6 8.2 52.0 50.8 8.6 42.1 25.6 48.3 13.1 32.1 44.4 26.3 36.3 29.3 23.8 18.2 51.3 35.8 502.7 42.6 16.6 103.5 23.7 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837011 "Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 221.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "RPMI-8226: 202.5;SK-BR-3: 178.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710" "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favorable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favorable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 42.6 221.0 21.4 7.9 32.2 20.3 46.9 15.9 24.7 44.0 4.4 36.2 28.9 23.6 9.0 69.2 43.0 14.2 21.8 13.4 16.0 22.7 129.6 26.7 9.1 34.6 25.5 9.4 41.8 17.2 8.5 37.3 7.8 67.4 37.6 6.8 3.9 90.3 16.8 34.8 47.9 34.3 5.7 16.4 17.3 25.4 35.6 31.8 14.5 27.2 2.9 6.3 32.8 49.2 29.7 54.1 122.5 12.0 85.2 24.9 55.8 23.5 18.5 60.0 16.4 39.2 23.3 104.2 33.5 17.2 14.8 14.5 144.0 16.7 47.2 4.0 21.1 7.2 16.8 86.4 19.1 36.1 2.5 29.6 42.0 19.6 21.8 12.5 12.2 17.6 64.9 36.8 105.8 2.5 118.7 46.9 26.1 17.8 38.3 23.1 32.6 10.8 202.5 9.0 23.1 16.3 70.5 24.4 178.7 48.0 8.9 62.0 32.6 21.5 8.2 40.5 19.5 12.5 32.2 3.1 15.5 48.9 24.6 45.2 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.4 0.6 1.3 0.1 0.1 0.1 0.0 0.2 21.4 32.2 15.9 24.7 13.4 16.0 34.6 25.5 9.4 67.4 16.4 31.8 29.7 6.1 6.4 26.0 66.9 11.9 9.3 12.0 29.2 14.8 24.5 58.0 30.6 9.4 18.6 29.7 20.2 29.2 4.5 11.4 44.5 1.9 16.5 2.7 30.9 37.2 10.5 29.9 24.8 12.8 23.5 15.7 24.7 31.1 31.9 14.7 13.2 12.8 72.2 12.1 58.9 11.3 30.8 24.4 14.0 13.3 4.9 29.8 15.1 8.8 15.0 11.0 51.7 1.0 10.6 56.7 16.7 20.8 10.9 8.4 19.0 33.2 6.6 32.1 31.6 13.1 15.6 12.9 11.4 4.9 40.2 18.3 19.8 13.4 27.5 41.1 25.2 TRPC5 PPP1R159 ENSG00000072315 "Transient receptor potential cation channel subfamily C member 5" Q9UL62 X 111768011-112082776 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "brain: 3.7" "Group enriched" "Detected in some" 11 "Excitatory neurons: 46.3;Inhibitory neurons: 78.5;Oligodendrocytes: 38.3" "Group enriched" "Detected in some" 23 "testis cancer: 0.8;thyroid cancer: 2.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NTERA-2: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (7.32e-2)" "unprognostic (2.60e-3)" "unprognostic (3.68e-2)" "unprognostic (5.69e-2)" "unprognostic (5.09e-2)" "unprognostic (2.78e-2)" 0.0 0.1 1.1 0.0 2.1 0.1 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.1 0.8 0.0 0.0 1.9 3.7 1.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 0.9 1.3 1.2 1.8 1.9 3.7 1.4 1.9 0.3 1.8 3.3 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 78.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 38.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 AFF4 "AF5Q31, MCEF" ENSG00000072364 "AF4/FMR2 family member 4" Q9UHB7 5 132875395-132963634 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Disease variant, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023690, HPA029634" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA023690: AB_1844633, HPA029634: AB_2673129" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.17e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (2.56e-2)" "unprognostic (7.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.13e-2)" "unprognostic (4.94e-2)" "unprognostic (3.52e-1)" "unprognostic (1.16e-2)" "unprognostic (2.77e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (1.69e-1)" 21.6 28.5 11.0 17.1 13.2 43.8 23.0 20.0 15.4 20.5 10.1 18.6 14.6 26.9 18.3 27.0 16.6 26.2 16.6 10.6 33.8 24.5 21.3 19.9 15.6 13.3 10.3 7.7 29.2 25.1 36.6 19.7 20.7 12.0 25.3 17.8 47.8 19.2 21.5 25.6 18.1 15.1 23.8 6.8 17.0 25.3 18.1 15.9 19.2 33.4 25.8 17.2 23.3 19.5 15.9 42.5 33.5 45.2 50.3 34.1 40.9 35.3 44.8 47.9 40.4 51.2 49.8 27.2 21.5 51.7 59.2 49.0 20.8 36.8 55.5 67.3 15.4 23.7 26.6 44.6 17.8 43.6 9.4 26.5 48.2 36.2 70.2 70.7 43.5 39.4 19.2 19.4 17.7 51.2 16.0 26.1 10.0 17.4 12.6 13.6 17.3 44.1 8.1 35.0 58.8 35.2 37.0 50.9 12.3 50.4 62.0 26.2 15.0 55.9 48.3 40.8 43.0 48.2 24.3 45.3 19.3 45.2 17.2 33.7 13.0 1.8 3.2 4.0 1.5 3.0 6.2 3.7 2.8 2.2 6.3 3.8 3.3 4.1 3.0 4.1 4.1 1.9 1.3 11.0 13.2 20.0 15.4 10.6 33.8 13.3 10.3 7.7 12.0 6.8 15.9 15.9 134.3 80.1 43.9 62.3 98.7 79.7 79.8 52.0 140.0 74.8 94.1 76.7 65.2 57.2 70.8 58.8 158.4 36.4 75.9 69.9 7.9 51.1 244.1 136.4 147.8 79.3 97.6 29.2 99.5 46.2 47.8 98.0 197.2 229.0 43.1 222.1 54.3 25.2 41.9 79.1 85.1 59.1 50.8 62.3 123.7 200.5 69.3 100.9 69.4 60.9 41.6 61.9 39.1 73.9 106.0 75.8 65.5 67.4 93.0 97.3 56.1 35.7 53.2 135.1 78.9 126.5 103.8 34.2 21.5 130.6 86.5 69.9 68.9 89.6 47.2 120.0 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334979-58370751 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 140.0;tongue: 65.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 112.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 13.1 12.0 6.2 16.9 6.6 32.7 7.8 7.3 8.1 9.0 5.5 11.5 7.1 12.8 7.5 11.7 7.1 9.6 33.6 6.9 6.6 8.2 8.4 8.9 13.9 7.3 7.0 5.5 8.5 5.6 9.0 4.0 9.0 7.1 9.5 12.1 5.4 5.6 6.8 140.0 6.0 8.3 13.7 6.9 13.5 6.5 4.6 7.1 7.8 8.4 65.9 11.5 15.3 5.6 7.7 19.1 10.2 18.8 24.4 37.5 30.0 12.1 12.4 21.2 13.9 20.3 20.9 16.4 0.0 19.0 18.6 10.3 17.1 36.6 18.0 19.5 19.8 21.2 4.9 3.7 12.2 24.4 15.3 11.8 34.8 19.9 14.4 26.8 18.7 28.1 13.1 10.0 7.8 19.1 6.1 16.5 17.1 23.0 11.7 15.7 13.8 16.9 10.6 21.2 11.2 14.0 18.8 24.2 40.3 20.6 28.5 14.8 10.2 22.8 5.3 18.6 18.2 13.7 19.7 16.4 16.8 16.7 31.3 6.2 10.1 38.5 17.8 6.2 27.1 7.2 8.9 7.3 7.9 20.0 9.8 7.5 6.2 112.3 8.2 23.4 8.3 9.8 23.4 6.2 6.6 7.3 8.1 6.9 6.6 7.3 7.0 5.5 7.1 6.9 7.1 7.7 41.6 12.8 11.2 5.5 54.3 194.4 94.1 60.6 46.1 23.7 45.6 45.5 92.4 17.2 39.0 27.6 18.8 29.9 41.7 27.4 76.3 62.3 5.0 32.6 46.9 42.5 41.7 12.0 18.5 42.0 50.4 51.9 38.7 51.2 22.9 19.6 27.5 15.6 73.7 16.8 17.1 40.1 69.2 90.6 104.0 3.0 33.2 147.7 53.4 4.7 94.6 17.9 22.6 12.5 21.2 81.2 52.7 32.4 26.4 108.4 16.1 54.3 33.6 16.1 6.6 51.4 59.1 33.5 19.9 47.1 190.2 149.0 42.8 14.9 28.5 118.2 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67240713-67336061 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 156.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.5 8.8 15.2 6.4 21.7 5.6 10.7 19.3 16.8 8.9 24.7 12.9 20.6 6.4 21.3 13.7 7.3 8.0 7.4 13.6 19.3 31.7 19.8 12.4 4.8 19.7 19.7 11.9 6.1 8.8 19.7 7.2 9.9 20.7 16.4 12.1 17.4 18.5 12.8 18.2 8.5 20.9 7.2 20.4 6.6 9.5 8.9 19.1 10.4 25.4 13.7 6.2 9.1 8.4 29.3 156.4 24.4 24.1 18.5 13.3 12.3 20.6 46.4 23.6 33.2 21.6 23.8 45.9 12.7 21.5 37.8 11.0 31.0 13.9 26.1 50.2 5.5 9.5 11.8 23.6 16.8 15.5 4.5 8.5 13.1 10.0 17.9 23.7 24.2 19.0 13.5 12.6 4.7 53.9 20.4 14.4 5.0 7.7 22.2 16.2 12.2 37.1 15.2 30.1 36.8 13.2 9.4 28.2 27.0 15.5 21.1 28.6 9.2 29.2 41.4 87.2 13.8 19.9 7.8 7.6 19.3 27.2 10.1 14.7 0.1 0.5 0.8 0.4 1.0 0.3 1.1 0.5 0.6 0.8 0.4 1.1 0.6 0.0 2.2 0.7 0.6 0.3 0.4 15.2 21.7 19.3 16.8 13.6 19.3 19.7 19.7 11.9 20.7 20.4 19.1 29.3 13.2 64.1 28.9 37.2 8.8 21.0 26.0 14.6 22.2 8.5 22.4 12.8 24.7 11.5 21.1 22.0 43.8 23.1 5.2 47.2 13.7 21.7 5.9 29.5 15.0 17.7 5.4 6.7 24.8 26.9 11.3 17.3 18.3 46.2 5.1 15.8 17.2 20.7 17.6 3.3 34.7 21.2 12.2 11.9 13.4 4.5 8.1 9.2 3.6 22.5 6.6 23.4 3.1 41.2 129.8 26.7 32.5 11.3 13.1 30.1 54.3 33.5 14.9 34.3 6.6 17.7 22.2 22.4 36.1 29.2 17.3 17.5 7.7 7.5 22.4 38.7 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 145.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.7 14.0 6.2 4.1 7.0 0.9 7.1 6.1 7.6 15.9 6.3 7.2 6.7 14.6 2.4 3.0 11.0 11.6 13.7 5.3 5.4 31.1 6.8 10.7 2.8 6.9 6.7 4.7 10.3 9.2 8.7 3.2 37.4 8.8 7.8 4.8 24.5 2.1 10.0 145.6 3.6 5.7 12.3 6.3 15.0 20.9 15.2 7.3 1.9 3.4 19.8 1.2 7.5 7.6 8.5 0.2 12.0 17.8 0.0 8.3 7.3 0.0 5.3 4.8 4.3 6.4 0.6 0.2 0.0 21.9 28.0 2.0 0.3 5.3 1.6 5.0 0.0 4.8 1.1 8.8 67.3 9.0 1.4 0.4 10.6 3.0 2.6 2.7 16.5 20.6 3.8 10.2 0.0 19.1 0.4 5.2 0.0 7.7 0.2 7.9 4.5 24.9 6.4 14.1 0.7 4.9 19.0 6.3 6.9 6.9 11.1 1.4 2.4 18.5 8.2 21.1 0.2 5.9 0.0 0.0 0.0 4.1 3.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 6.2 7.0 6.1 7.6 5.3 5.4 6.9 6.7 4.7 8.8 6.3 7.3 8.5 13.7 16.0 8.7 3.6 1.0 1.8 1.0 0.5 0.6 3.4 3.7 2.5 29.5 1.5 2.3 1.8 135.5 66.1 0.2 0.7 1.9 3.8 75.2 11.0 14.7 13.6 8.3 3.8 74.3 16.0 3.4 8.6 34.1 4.5 0.0 59.0 17.9 9.6 11.3 334.8 23.1 7.7 4.1 21.5 1.4 35.3 8.1 14.1 1.8 57.1 0.4 16.0 0.0 14.1 155.5 16.4 2.5 4.9 0.1 1.2 1.5 36.4 10.2 25.1 6.6 16.7 11.8 2.8 1.4 0.6 1.4 302.4 0.8 15.2 4.3 0.4 SMC1A "DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb" ENSG00000072501 "Structural maintenance of chromosomes 1A" Q14683 X 53374149-53422728 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005499, CAB025404" Supported Enhanced Nucleoplasm NA NA 33000 Nucleoplasm "CAB025404: , HPA005499: AB_1080028" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (5.76e-2)" "unprognostic (1.04e-1)" "unprognostic (9.89e-2)" "unprognostic (1.29e-3)" "unprognostic (1.89e-1)" "unprognostic (9.80e-3)" "unprognostic (9.49e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-2)" "unprognostic (2.58e-1)" "unprognostic (4.18e-3)" "unprognostic (6.28e-2)" "unprognostic (2.89e-1)" "unprognostic (9.39e-2)" 16.8 11.9 9.3 28.7 11.6 30.6 17.4 15.1 10.8 13.6 10.0 20.2 18.8 21.2 8.1 17.3 16.9 11.6 15.7 8.6 12.0 16.4 18.9 16.1 34.7 10.8 11.3 6.8 19.3 14.6 26.0 6.4 18.3 12.0 14.1 18.5 21.2 15.3 13.1 18.1 18.2 16.0 23.1 9.9 20.3 15.8 7.9 11.9 58.6 17.0 19.0 30.1 15.7 12.5 14.6 110.0 115.1 92.4 76.1 32.4 35.4 51.5 68.0 37.0 76.4 59.4 71.6 60.5 115.8 54.1 40.7 105.2 78.9 162.9 92.6 85.1 91.7 176.0 94.3 133.9 51.1 15.4 134.9 120.9 20.6 23.3 86.0 52.8 19.4 67.5 68.7 144.7 64.7 58.6 69.2 122.0 40.8 139.9 47.8 55.6 117.2 165.5 100.1 34.4 69.4 92.8 83.5 176.9 84.4 33.5 122.8 87.9 54.0 45.7 63.3 68.0 65.1 62.2 45.8 77.9 91.9 39.1 152.1 64.1 2.7 6.8 4.5 7.3 8.5 7.6 5.4 5.8 6.7 8.4 5.8 5.2 6.3 2.7 4.6 12.4 4.6 5.7 6.7 9.3 11.6 15.1 10.8 8.6 12.0 10.8 11.3 6.8 12.0 9.9 11.9 14.6 40.7 44.8 39.9 16.0 45.6 24.1 37.0 27.7 28.5 46.6 30.7 27.4 63.5 27.1 47.4 20.2 27.1 43.2 57.7 49.6 7.9 31.6 10.5 46.5 62.6 41.7 19.9 70.7 12.0 27.1 61.4 37.2 29.0 44.0 35.4 42.7 18.9 54.1 47.6 60.6 14.2 43.5 22.4 41.1 27.6 7.6 37.9 51.5 23.2 24.4 55.2 38.1 59.8 16.6 30.2 33.1 23.6 36.1 61.2 40.7 29.0 24.6 47.1 48.4 39.5 49.5 71.0 54.5 51.2 39.8 24.4 48.4 47.9 34.0 51.4 32.0 HSD17B10 "17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1" ENSG00000072506 "Hydroxysteroid 17-beta dehydrogenase 10" Q99714 X 53431258-53434370 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, tRNA processing" Oxidoreductase "Disease variant, FDA approved drug targets, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 444.0;Proximal tubular cells: 427.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001432 Approved NA NA 290000 "HPA001432: AB_1078740" "unprognostic (1.27e-1)" "prognostic favorable (2.80e-4)" "unprognostic (2.60e-1)" "unprognostic (2.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (5.24e-2)" "unprognostic (1.02e-1)" "unprognostic (8.64e-3)" "unprognostic (4.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.95e-2)" "unprognostic (8.38e-2)" "unprognostic (3.07e-3)" "unprognostic (2.92e-1)" "unprognostic (9.51e-2)" 71.7 111.6 58.1 52.9 61.9 65.4 63.2 65.6 65.2 56.0 59.0 61.9 58.5 62.5 56.7 112.5 55.8 33.7 99.3 56.4 69.0 99.5 263.5 48.8 59.8 65.2 61.4 54.5 67.6 75.4 74.1 66.6 37.6 62.7 51.1 63.5 12.8 55.4 46.4 91.2 88.7 50.7 62.5 61.7 52.4 66.9 21.7 62.4 60.7 66.9 82.4 76.9 56.8 60.3 64.2 121.9 203.1 97.2 181.3 93.4 41.0 146.5 73.7 72.9 192.0 125.3 210.3 101.8 205.8 65.6 84.9 124.2 124.5 316.1 148.7 104.3 164.1 177.7 97.1 283.6 177.0 156.3 185.1 145.5 87.6 138.9 148.7 82.8 41.6 142.2 181.2 141.6 158.1 90.3 426.7 165.3 277.0 269.9 163.0 259.5 166.2 179.2 364.9 149.3 132.2 171.1 225.1 211.7 250.2 138.6 123.0 263.3 169.8 64.2 81.7 129.7 171.9 113.4 128.3 194.1 256.5 113.4 384.9 123.2 54.2 127.8 40.4 84.8 125.1 87.2 98.8 78.0 84.1 176.7 111.4 64.4 67.9 10.5 98.7 94.5 96.5 114.8 126.6 58.1 61.9 65.6 65.2 56.4 69.0 65.2 61.4 54.5 62.7 61.7 62.4 64.2 42.8 48.1 37.3 4.9 61.8 86.4 90.2 150.8 44.9 11.8 72.5 74.9 62.0 107.2 70.2 101.2 4.2 173.2 55.0 73.8 283.7 131.5 1.6 26.1 64.7 58.3 104.6 71.3 2.5 135.4 228.1 72.0 28.1 51.9 56.5 75.3 56.4 444.0 136.8 13.5 3.3 78.2 99.7 73.9 98.6 5.7 78.3 65.4 96.0 3.7 118.7 61.3 89.6 6.6 6.2 101.9 54.1 94.8 83.3 74.6 78.5 427.8 31.5 13.2 78.9 63.1 117.9 23.6 56.3 91.3 116.2 151.6 62.4 104.1 103.0 83.7 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911020 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: AB_2686722" "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 11.0 13.9 11.7 21.3 14.3 24.2 16.9 7.2 16.4 15.6 8.3 26.1 26.3 14.7 7.7 52.3 16.7 14.2 18.9 14.1 7.6 14.0 13.2 17.1 21.7 11.0 8.8 12.7 12.1 22.6 19.6 20.0 15.0 11.8 20.7 22.6 8.9 27.3 13.2 21.0 40.5 25.3 16.5 6.1 24.3 21.1 10.7 8.5 23.4 19.7 13.8 24.2 19.5 25.2 17.0 52.0 34.1 26.6 28.6 14.6 18.6 35.2 20.8 20.0 29.5 22.3 34.1 49.5 37.8 35.6 20.8 32.0 57.5 26.9 28.7 24.6 26.7 20.9 40.7 23.9 20.3 17.0 45.9 51.4 10.9 36.8 27.0 21.4 13.5 24.7 33.6 35.7 36.5 19.5 64.4 49.3 29.9 31.7 36.0 24.2 39.9 20.4 39.7 19.1 39.8 37.9 25.4 34.7 90.2 24.3 28.9 65.1 26.4 22.7 30.3 19.1 39.6 23.4 24.5 28.8 36.7 20.1 23.2 25.3 1.4 0.7 2.1 1.3 0.7 2.1 0.9 1.0 1.3 1.0 1.6 0.8 0.9 3.6 1.6 1.1 0.9 0.6 0.7 11.7 14.3 7.2 16.4 14.1 7.6 11.0 8.8 12.7 11.8 6.1 8.5 17.0 17.3 6.4 6.8 29.7 18.5 25.2 21.1 9.1 19.4 26.8 30.0 18.2 12.8 27.1 11.9 20.2 8.4 26.0 33.4 90.3 1.9 20.2 0.6 29.5 15.8 14.7 29.9 14.7 43.6 21.4 20.6 11.7 27.0 41.0 17.2 21.1 13.6 13.0 17.9 20.2 30.3 39.9 10.2 26.7 18.5 0.9 12.8 25.0 3.6 29.0 17.0 18.8 36.0 31.7 51.8 27.3 39.4 10.9 15.6 30.4 33.4 8.1 14.5 18.1 19.7 19.6 13.1 9.1 18.4 39.9 34.4 65.0 23.6 16.0 33.6 44.3 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491941 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.8;lymphoid tissue: 27.5;testis: 27.7" "Cell type enhanced" "Detected in many" "Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 0.8 0.7 0.3 10.2 0.3 20.8 2.1 0.4 0.4 0.6 0.1 6.6 7.5 0.8 0.2 4.0 0.5 0.9 0.8 0.2 0.5 0.7 1.8 1.0 18.2 0.4 0.4 0.2 0.2 0.3 0.9 0.2 6.2 0.3 0.5 8.9 0.8 0.8 0.2 1.2 4.3 6.6 2.9 0.3 2.9 3.6 27.7 0.5 27.5 0.7 0.4 17.9 2.2 1.4 0.6 77.0 47.2 94.5 50.8 5.0 9.0 70.3 71.4 34.9 88.0 78.9 96.8 145.1 127.5 66.0 22.2 118.5 86.3 112.4 69.0 148.6 116.1 34.4 76.7 32.3 48.4 1.4 68.7 67.3 2.4 4.1 82.8 64.0 14.7 50.6 85.7 73.2 101.0 93.2 28.5 72.3 38.8 81.9 51.2 51.6 78.0 126.3 63.9 34.8 20.4 78.8 43.8 106.3 32.8 38.6 45.1 97.3 54.5 32.9 63.2 52.4 50.6 97.2 53.7 96.3 102.4 41.4 104.2 61.1 0.2 0.2 0.0 0.1 0.1 0.3 0.3 0.3 0.1 0.2 0.2 0.1 0.2 0.1 0.5 0.0 0.6 1.5 0.2 0.3 0.3 0.4 0.4 0.2 0.5 0.4 0.4 0.2 0.3 0.3 0.5 0.6 0.4 0.0 1.1 1.3 6.0 2.5 1.8 4.5 2.8 0.6 3.2 3.7 2.5 4.3 3.2 0.0 0.0 37.3 2.3 5.3 0.0 0.8 86.2 3.8 3.1 3.1 1.2 133.3 0.6 0.2 55.1 4.6 11.7 5.7 0.0 21.6 5.3 3.8 22.2 0.0 0.4 7.8 6.1 8.8 2.7 60.9 2.1 7.6 0.0 0.0 2.3 0.1 1.0 0.5 1.2 0.2 0.3 0.7 22.9 1.5 1.3 2.6 2.8 1.0 6.6 0.6 3.8 100.9 23.3 14.1 1.4 4.5 5.2 1.6 15.6 3.0 CHFR "FLJ10796, RNF196" ENSG00000072609 "Checkpoint with forkhead and ring finger domains" Q96EP1 12 132822187-132956304 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;Late spermatids: 89.1;Rod photoreceptor cells: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045768, HPA073826" Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Nuclear bodies, Microtubules" "HPA045768: , HPA073826: AB_2732242" "unprognostic (1.46e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-1)" "unprognostic (2.14e-3)" "unprognostic (6.56e-4)" "unprognostic (1.94e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.00e-2)" "unprognostic (3.98e-3)" "prognostic unfavorable (4.21e-9)" "unprognostic (5.03e-1)" "unprognostic (8.46e-2)" "unprognostic (6.71e-2)" "unprognostic (1.11e-2)" 9.9 8.1 7.5 15.7 7.2 22.2 9.2 6.7 9.2 9.3 5.7 12.5 16.0 10.7 3.4 15.7 8.8 10.0 10.8 6.5 7.3 8.7 9.1 12.3 21.1 7.4 6.5 7.1 6.2 12.0 7.7 9.5 17.8 8.2 10.0 8.6 6.4 9.4 9.7 8.0 12.3 15.2 12.7 5.7 17.6 13.1 15.5 8.3 25.4 9.2 9.3 13.9 14.5 10.9 8.3 11.0 24.1 19.3 1.6 16.8 21.3 41.0 23.4 17.9 23.7 22.7 20.6 8.7 0.2 21.6 25.3 16.7 18.6 2.1 21.5 12.2 1.3 21.0 36.5 16.7 24.4 42.0 1.2 67.5 32.4 20.0 19.6 13.5 15.5 30.1 2.8 15.9 0.0 16.7 40.4 24.5 25.3 27.4 20.9 19.8 2.9 2.5 11.4 15.3 49.4 20.8 28.2 18.2 20.0 17.8 22.5 34.4 36.2 33.3 1.2 4.7 11.8 7.7 37.0 0.1 4.2 0.0 6.8 21.7 38.3 25.5 35.5 16.7 29.6 15.8 10.5 13.2 17.8 20.7 6.4 12.0 13.3 34.8 23.2 31.5 10.6 21.5 19.3 7.5 7.2 6.7 9.2 6.5 7.3 7.4 6.5 7.1 8.2 5.7 8.3 8.3 11.2 12.8 19.5 20.5 17.2 6.1 7.9 6.0 4.6 22.1 8.2 5.7 9.9 4.3 15.3 7.3 93.8 12.3 29.4 17.9 9.8 10.2 53.0 11.1 14.3 13.1 21.1 13.0 33.4 13.8 15.7 10.8 28.1 12.2 66.4 14.4 11.4 7.7 19.4 21.9 32.0 10.2 14.2 21.7 9.3 89.1 7.5 22.0 10.6 24.4 29.4 8.8 40.2 18.1 31.3 16.9 11.4 8.6 24.2 11.2 11.7 4.4 10.8 117.9 19.7 9.2 10.7 19.0 24.6 11.1 9.7 23.7 24.2 16.1 8.6 13.8 TRHDE "PAP-II, PGPEP2, TRH-DE" ENSG00000072657 "Thyrotropin releasing hormone degrading enzyme" Q9UKU6 12 72087266-72670758 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5;pancreas: 10.4" "Group enriched" "Detected in some" 4 "Excitatory neurons: 216.9;Inhibitory neurons: 292.7" "Cancer enhanced" "Detected in some" "renal cancer: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 30.3;BJ hTERT+: 29.1;EFO-21: 15.3;HBF TERT88: 10.3;hTERT-RPE1: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 7300000 "unprognostic (3.56e-2)" "unprognostic (4.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.44e-6)" "unprognostic (1.77e-1)" "unprognostic (6.37e-2)" "unprognostic (7.79e-2)" "unprognostic (6.96e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (5.14e-4)" "unprognostic (2.40e-1)" "prognostic favorable (1.53e-7)" "unprognostic (2.55e-2)" "unprognostic (2.48e-1)" "unprognostic (8.91e-3)" "unprognostic (2.94e-2)" 3.7 0.9 0.2 0.3 3.8 0.4 0.8 4.6 2.5 3.2 0.0 1.1 2.4 1.2 0.6 0.2 1.1 0.8 0.4 7.5 0.2 5.1 0.6 1.4 0.1 1.3 1.2 1.5 3.2 10.4 0.0 0.1 0.1 0.8 1.3 0.5 0.8 0.8 2.8 0.2 0.1 2.1 0.4 0.0 2.5 0.3 0.7 0.1 0.1 0.1 0.4 0.3 1.2 2.3 0.9 3.6 0.0 0.6 0.0 1.6 0.0 9.5 30.3 29.1 2.9 1.9 0.0 0.0 0.0 15.3 4.3 3.0 0.4 5.4 0.0 10.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 2.3 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 8.7 0.0 0.0 0.0 9.5 6.7 2.9 0.1 0.0 0.0 0.0 0.5 0.0 5.7 0.0 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 4.6 2.5 7.5 0.2 1.3 1.2 1.5 0.8 0.0 0.1 0.9 0.2 0.0 0.5 2.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.9 1.5 0.0 1.8 0.0 0.1 0.0 7.1 3.9 0.0 35.9 0.1 0.4 0.2 0.0 0.0 216.9 2.6 0.4 4.7 0.0 0.3 0.0 0.1 0.4 1.4 0.2 0.0 292.7 3.5 0.0 0.0 0.0 62.8 29.5 0.7 0.0 2.8 0.0 0.4 0.0 38.2 4.0 2.2 3.9 13.5 0.0 0.2 15.8 9.1 0.7 0.6 0.0 37.4 0.6 0.2 0.7 0.0 0.0 0.1 0.1 0.2 1.6 0.1 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132190147-132295315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 324.2;U-87 MG: 323.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No 13000 "Endoplasmic reticulum, Vesicles" "CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.12e-4)" 16.2 11.8 19.8 16.2 13.6 2.4 12.4 12.9 25.4 29.7 36.4 29.0 22.8 31.4 77.4 19.8 29.8 20.1 38.4 20.7 17.1 80.8 10.6 31.7 2.5 15.9 12.9 13.0 8.7 71.3 10.9 20.1 35.4 17.0 10.9 33.1 7.9 32.7 17.3 13.1 16.8 27.1 53.0 13.5 8.8 20.6 9.8 18.6 11.4 20.9 23.1 8.4 23.1 22.4 30.9 57.0 34.9 11.2 57.2 149.2 173.7 61.1 261.9 223.7 108.9 265.0 78.9 50.3 1.5 71.8 283.3 120.5 70.2 33.2 136.5 172.7 41.5 11.9 0.6 48.1 49.0 324.2 0.0 33.9 104.6 193.1 128.8 117.4 162.7 59.1 0.1 21.2 3.6 134.0 23.2 0.2 0.5 3.0 53.7 27.2 0.9 3.6 9.8 31.1 11.0 5.4 15.8 67.7 22.3 47.9 84.1 28.4 3.7 88.9 171.7 63.5 51.0 57.1 24.4 28.1 11.8 323.4 0.4 48.3 0.0 0.4 0.0 0.8 0.3 0.7 0.0 0.4 0.1 0.2 0.0 0.0 0.1 1.0 0.9 0.0 0.3 0.0 0.2 19.8 13.6 12.9 25.4 20.7 17.1 15.9 12.9 13.0 17.0 13.5 18.6 30.9 13.0 35.3 10.3 7.5 1.1 16.8 43.6 115.6 23.9 11.6 9.5 9.5 13.3 8.6 36.9 11.0 22.9 2.6 0.3 43.2 5.9 68.3 1.4 26.7 96.9 12.2 15.0 0.0 7.7 71.8 70.2 61.6 12.8 28.0 5.7 11.1 9.3 7.8 7.6 0.0 7.7 18.6 32.6 1.3 5.5 2.0 8.1 4.4 30.2 2.8 2.6 6.8 0.0 1.5 1.2 81.9 41.0 5.3 3.0 19.6 41.4 44.6 71.9 5.2 26.3 109.4 47.6 23.0 29.1 6.8 9.8 7.5 4.8 10.4 13.8 15.3 FCGR2B "CD32, CD32B, FCG2, FCGR2" ENSG00000072694 "Fc fragment of IgG receptor IIb" P31994 1 161663147-161678654 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "IgG-binding protein, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "placenta: 401.5" "Cell type enhanced" "Detected in many" "B-cells: 75.0;Hepatic stellate cells: 333.8;Langerhans cells: 244.0;Macrophages: 145.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 327.2;memory B-cell: 202.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 24.9;HMC-1: 31.2;NB-4: 7.3;RPMI-8226: 11.7" "CAB007796, HPA014730" Enhanced NA NA "CAB007796: AB_562288, HPA014730: AB_2669074" "unprognostic (1.58e-1)" "unprognostic (5.14e-2)" "unprognostic (3.32e-3)" "unprognostic (3.12e-2)" "unprognostic (6.79e-3)" "unprognostic (4.05e-3)" "unprognostic (1.27e-1)" "unprognostic (4.65e-3)" "unprognostic (1.91e-1)" "unprognostic (4.72e-2)" "unprognostic (2.89e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.51e-2)" "unprognostic (6.36e-2)" "unprognostic (4.31e-1)" "unprognostic (3.37e-1)" 30.7 7.5 1.3 12.3 2.2 1.7 15.6 1.4 6.5 9.8 6.0 10.4 3.0 2.6 2.8 11.5 4.4 13.1 8.0 0.7 1.5 4.1 42.7 21.9 15.9 3.7 1.2 0.7 4.8 4.7 2.8 1.4 401.5 2.0 1.8 11.1 1.1 7.1 2.9 2.2 4.8 16.2 16.7 2.3 25.7 5.0 2.5 1.5 7.4 4.3 13.8 29.8 18.9 3.1 5.5 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.1 0.1 0.0 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 2.8 0.0 327.2 8.5 26.4 1.4 9.7 0.6 202.8 0.7 1.1 72.4 160.4 0.1 1.4 53.6 0.7 9.5 0.1 0.1 13.0 1.3 2.2 1.4 6.5 0.7 1.5 3.7 1.2 0.7 2.0 2.3 1.5 5.5 2.2 0.0 3.9 0.0 75.0 5.4 0.1 0.0 0.0 0.0 0.3 0.9 2.1 2.8 1.3 0.0 0.0 0.2 5.6 0.0 0.0 0.0 4.8 0.0 0.0 49.8 0.0 3.2 0.0 0.0 0.2 1.7 1.1 0.0 2.5 0.2 333.8 8.2 7.6 0.0 0.0 0.0 0.0 47.4 244.0 4.2 0.6 145.5 23.2 0.0 9.5 0.0 5.2 0.0 0.1 0.0 0.0 0.0 45.4 0.0 0.0 0.3 0.0 0.0 0.0 1.7 2.5 0.3 0.2 0.7 3.1 0.4 5.8 0.1 0.1 0.0 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 105.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050665: AB_2681210" "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 10.6 6.6 11.6 12.1 12.2 23.2 11.4 14.0 12.6 11.5 12.9 9.3 11.9 10.1 9.2 10.8 10.7 8.5 7.3 10.0 10.4 11.1 19.9 17.8 23.5 11.4 11.7 8.0 11.8 11.7 23.2 5.1 11.3 12.0 10.4 10.3 10.5 10.7 9.9 28.8 22.8 11.8 11.5 11.0 17.8 9.2 27.5 12.8 103.0 14.2 22.4 22.9 9.5 7.0 14.0 12.8 15.5 24.6 26.3 20.9 13.6 21.4 8.3 10.7 23.6 19.9 21.4 11.0 43.0 12.4 14.1 7.7 18.7 29.0 14.4 22.1 8.6 18.9 44.0 15.2 48.3 13.6 37.1 105.0 10.2 17.4 23.5 12.6 12.1 20.0 35.4 54.5 12.7 17.3 25.5 60.5 51.0 15.0 19.4 7.7 34.3 23.0 44.7 9.9 14.4 17.7 18.5 62.6 15.0 8.1 14.3 20.7 28.4 11.9 12.0 12.5 14.2 12.5 16.2 30.7 77.7 9.3 34.9 16.6 17.7 3.5 7.7 20.4 5.3 19.3 7.3 11.6 20.5 4.1 8.2 11.6 18.3 4.7 20.4 11.2 4.4 8.5 15.0 11.6 12.2 14.0 12.6 10.0 10.4 11.4 11.7 8.0 12.0 11.0 12.8 14.0 26.4 35.3 49.5 50.3 41.8 78.4 41.7 39.4 33.0 28.8 64.0 36.4 1.5 78.6 32.5 58.8 33.3 53.1 64.9 20.8 23.5 27.2 155.3 33.8 17.0 27.2 26.0 34.0 46.2 21.9 16.0 19.7 7.1 37.4 49.4 24.3 37.1 117.0 23.7 37.0 53.8 37.3 34.6 51.0 28.9 99.9 21.8 29.5 23.2 91.8 40.6 9.1 129.8 45.8 73.5 33.1 33.1 26.7 28.6 75.3 57.6 53.5 31.3 27.3 19.7 27.9 18.0 68.6 61.7 25.9 143.2 85.0 59.4 19.7 39.1 58.1 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126933-3150879 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Yes No Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 8.9 10.1 7.1 9.0 7.7 3.5 8.5 8.3 8.3 7.8 7.2 8.1 4.4 8.8 5.5 9.5 7.6 8.4 8.4 7.8 8.4 12.3 10.1 8.4 9.7 7.5 7.7 7.5 8.4 8.4 8.4 10.4 10.6 7.4 11.4 7.6 4.1 7.8 6.4 9.4 6.5 8.0 8.3 7.8 10.8 9.2 6.6 7.9 9.9 11.4 7.7 11.0 13.2 8.0 8.2 20.0 29.6 18.2 9.8 24.1 21.5 20.5 19.9 17.4 21.6 20.9 25.0 20.9 35.6 12.8 22.4 32.0 12.6 24.6 18.6 26.5 24.6 13.3 28.7 25.3 24.9 31.4 32.2 20.8 17.9 25.0 20.2 6.8 15.0 21.0 24.1 25.1 9.8 35.9 37.2 22.0 21.4 15.2 29.2 19.0 20.5 28.1 32.5 26.1 25.8 10.8 15.9 31.6 20.6 18.5 26.3 18.7 16.3 14.8 22.8 18.7 23.6 25.7 12.6 31.4 43.4 17.2 27.6 25.0 49.4 12.4 36.4 16.4 18.1 16.0 25.8 20.8 18.1 16.8 15.7 22.7 20.1 16.6 19.8 19.0 15.6 18.6 11.2 7.1 7.7 8.3 8.3 7.8 8.4 7.5 7.7 7.5 7.4 7.8 7.9 8.2 20.7 16.0 13.4 15.3 30.2 14.8 29.0 19.9 24.5 13.5 12.1 11.0 14.3 2.8 16.3 18.4 14.6 25.8 23.5 10.6 45.0 19.1 2.3 15.8 19.0 21.1 8.4 16.6 23.8 9.9 17.8 19.9 23.4 12.0 22.8 20.7 12.5 9.2 13.3 10.1 27.0 10.7 16.2 11.0 13.3 2.9 10.8 13.3 7.2 23.4 20.3 17.1 18.6 23.6 34.7 10.6 9.2 8.6 30.7 30.9 11.0 32.7 11.4 15.7 0.0 14.9 17.4 20.8 17.9 23.4 13.1 28.3 22.0 24.7 13.5 23.9 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225266 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 858.4;tongue: 824.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 98000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 199.6 408.5 112.4 79.4 120.1 104.4 144.1 123.4 127.7 103.5 154.4 157.7 309.0 99.4 44.8 182.5 94.8 93.5 436.3 111.7 122.3 206.1 521.7 107.6 52.5 119.5 117.7 103.6 81.6 238.4 160.9 191.1 113.0 119.9 134.3 132.9 35.2 159.9 115.0 858.4 126.3 272.8 111.6 110.3 133.2 187.9 76.5 126.1 84.2 160.6 824.3 83.6 138.2 116.2 115.8 193.7 162.5 65.8 92.4 271.2 99.2 135.9 156.5 169.0 136.9 84.5 67.2 155.3 90.4 109.0 260.0 49.7 147.9 43.8 135.5 119.6 295.9 47.1 50.6 120.9 101.1 131.2 49.0 129.5 112.5 122.0 114.7 178.5 212.6 124.8 111.3 73.3 110.2 222.7 65.3 49.6 68.4 34.3 178.4 91.9 70.4 78.3 227.2 305.1 155.0 19.1 47.3 206.8 224.8 110.8 60.6 102.8 74.9 151.5 127.5 101.6 75.9 149.9 104.5 59.1 5.2 230.7 85.7 94.9 24.2 96.1 121.3 39.1 57.8 35.7 25.2 32.5 43.8 99.9 24.6 23.7 29.1 20.2 37.8 39.3 80.4 31.8 79.4 112.4 120.1 123.4 127.7 111.7 122.3 119.5 117.7 103.6 119.9 110.3 126.1 115.8 109.9 60.9 81.9 143.3 72.3 87.3 336.0 322.4 91.6 42.0 157.7 104.5 451.4 138.7 206.7 202.3 62.6 482.9 87.7 484.2 185.9 310.8 133.0 87.2 52.7 77.4 179.3 65.2 40.9 77.0 197.8 118.6 406.7 88.5 88.4 121.1 53.6 365.4 182.4 33.7 33.4 251.8 233.9 67.9 94.6 249.9 124.5 101.5 81.8 34.7 274.9 40.7 73.2 23.1 24.5 106.1 388.9 132.8 172.3 369.0 489.8 345.8 144.1 41.3 105.2 88.3 147.4 114.3 47.8 113.8 87.5 663.3 75.5 169.2 316.8 367.5 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042079-172188224 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.2;lymphoid tissue: 45.6" "Cell type enhanced" "Detected in all" "dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 143.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 16000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: AB_2669151" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favorable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 5.8 3.8 37.5 3.5 77.2 11.5 15.7 4.8 4.5 4.1 8.6 8.5 5.0 1.7 5.7 4.8 13.3 6.9 2.7 5.4 5.6 6.3 18.5 44.5 5.0 4.1 1.6 2.5 7.2 3.1 4.1 17.4 8.1 4.4 7.0 1.2 4.7 3.5 5.1 14.3 16.1 7.9 5.0 45.6 11.2 14.1 5.3 20.8 5.4 5.6 25.2 15.1 5.2 7.2 22.2 20.2 12.7 18.8 14.7 18.1 31.5 28.4 24.0 20.2 18.9 10.6 28.6 26.8 14.6 35.6 42.3 25.4 5.7 35.1 13.5 35.0 9.3 32.1 8.2 6.1 20.2 32.7 36.4 17.4 7.5 27.4 23.1 7.5 18.3 10.4 3.0 36.2 14.7 35.7 23.5 73.4 5.0 11.3 16.1 38.2 9.9 17.7 8.2 27.6 8.3 10.2 16.4 22.5 77.9 15.6 8.2 68.7 24.8 22.3 11.3 15.8 15.5 30.2 48.4 17.1 29.4 49.8 143.3 16.7 26.5 23.4 36.5 46.3 26.9 10.0 19.3 26.3 22.5 8.1 11.0 20.0 48.9 16.9 71.8 7.1 26.7 44.0 3.8 3.5 15.7 4.8 2.7 5.4 5.0 4.1 1.6 8.1 5.0 5.3 7.2 35.8 3.2 11.2 1.6 40.5 6.6 8.4 7.2 5.7 4.3 3.3 3.7 3.8 5.7 6.1 1.8 6.2 4.1 107.7 11.8 1.9 4.5 2.5 3.5 4.6 23.9 12.0 11.8 8.5 6.2 27.2 9.3 20.9 7.1 28.4 3.6 18.2 2.3 36.3 47.1 7.9 19.9 2.0 91.4 43.8 3.2 2.8 61.3 8.8 32.8 49.8 2.1 171.0 10.1 14.4 10.7 11.8 1.5 42.8 11.7 6.5 2.0 6.1 2.2 13.1 5.1 10.2 5.3 7.8 2.6 4.1 5.1 81.4 11.4 5.3 10.7 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072204 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA072204: AB_2686493" "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 19.7 20.6 36.0 13.8 40.3 8.3 17.2 37.1 40.3 20.0 29.2 14.0 12.7 23.1 12.5 24.5 27.2 17.7 36.5 41.1 38.7 23.2 20.9 17.8 16.9 37.1 37.2 34.4 25.9 29.4 33.4 14.3 14.0 35.8 19.1 16.1 37.5 13.6 20.5 34.8 13.8 13.3 26.3 38.9 18.3 20.2 14.4 39.9 17.5 21.3 35.9 22.2 19.4 16.0 45.0 35.4 35.6 52.0 45.2 39.9 40.2 26.4 37.1 51.7 45.0 54.9 36.7 23.1 32.5 44.3 46.4 72.0 22.8 37.6 56.3 74.6 42.7 37.3 26.2 35.0 28.5 35.4 29.8 36.0 28.5 38.2 36.8 59.8 48.5 38.6 27.3 16.6 31.7 55.7 26.5 20.7 15.3 19.8 20.8 39.5 30.1 43.7 22.0 34.8 29.2 21.6 37.2 32.9 27.3 70.8 38.7 34.2 31.0 33.8 44.3 22.0 27.4 37.2 31.8 38.9 22.2 31.3 27.8 34.6 25.4 7.3 7.2 5.8 5.1 6.1 8.5 4.8 5.7 7.3 8.4 4.3 5.7 7.1 14.1 5.7 8.6 5.7 6.6 36.0 40.3 37.1 40.3 41.1 38.7 37.1 37.2 34.4 35.8 38.9 39.9 45.0 35.4 25.6 21.2 75.4 52.7 19.1 15.6 21.8 32.5 43.5 26.4 22.1 59.1 42.9 20.8 27.6 8.4 8.5 49.8 25.1 43.0 33.7 32.9 42.0 47.9 26.3 28.8 27.4 86.5 36.9 7.8 24.7 38.2 51.0 20.8 25.8 29.3 43.1 12.8 35.3 85.3 21.6 20.3 29.6 25.3 34.3 29.5 26.6 12.4 62.8 24.6 63.6 16.5 75.9 94.4 54.1 14.9 28.6 36.5 30.2 21.5 52.4 17.1 34.3 46.0 28.2 33.5 34.5 16.0 28.7 23.7 12.0 28.8 17.2 15.0 32.9 ACAP1 "CENTB1, KIAA0050" ENSG00000072818 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 1" Q15027 17 7336529-7351477 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.4;intestine: 43.7;lymphoid tissue: 96.8" "Cell type enriched" "Detected in many" 6 "Late spermatids: 3430.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075570 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA075570: AB_2732295" "unprognostic (1.20e-2)" "prognostic favorable (3.66e-4)" "unprognostic (2.49e-1)" "prognostic favorable (2.97e-5)" "unprognostic (4.43e-4)" "prognostic favorable (4.17e-5)" "unprognostic (5.66e-3)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (2.48e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.14e-1)" "unprognostic (5.58e-2)" "unprognostic (2.90e-1)" "unprognostic (8.61e-3)" 4.1 1.1 0.5 19.1 0.5 41.4 2.1 0.5 0.6 2.2 0.7 4.8 4.2 1.5 0.3 4.2 4.0 3.6 1.8 0.3 0.5 4.5 5.2 16.2 39.9 0.6 0.5 0.3 0.9 1.2 0.1 1.3 0.5 0.5 3.8 2.1 0.2 3.6 0.4 0.9 2.2 43.7 0.9 0.6 96.8 5.1 0.8 0.7 26.0 5.2 0.8 22.8 4.3 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 23.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 8.8 0.1 0.0 0.1 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 29.4 0.0 0.0 14.5 37.9 0.4 0.0 0.0 15.1 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.1 0.0 0.0 9.1 8.2 10.9 0.1 24.9 0.0 28.8 7.9 30.8 29.6 2.4 33.3 20.2 31.5 32.1 13.7 21.3 26.7 27.5 22.6 32.5 0.4 17.3 39.0 22.3 0.5 0.5 0.5 0.6 0.3 0.5 0.6 0.5 0.3 0.5 0.6 0.7 0.6 3.8 9.6 5.5 1.6 150.9 8.3 7.6 25.1 2.8 15.8 7.0 8.1 32.9 7.2 12.3 5.5 18.8 3.9 160.7 2.0 7.9 3.9 498.1 8.3 5.4 5.0 3.6 22.9 0.3 3.7 3.2 8.0 5.6 3.4 40.5 1.8 7.1 5.3 7.5 0.0 1.9 2.7 8.2 26.2 39.5 3430.7 20.2 27.9 24.9 2.8 38.3 11.7 332.7 0.5 1.0 5.5 0.0 15.4 68.0 4.6 1.3 3.8 44.6 20.4 19.7 7.5 8.1 15.6 10.5 1.5 7.4 4.4 268.3 0.9 1.6 3.5 CRMP1 "DPYSL1, DRP-1" ENSG00000072832 "Collapsin response mediator protein 1" Q14194 4 5748084-5893086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.0;pituitary gland: 67.8;retina: 58.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 148.9;Excitatory neurons: 40.8;Horizontal cells: 210.3;Inhibitory neurons: 44.5;Muller glia cells: 78.4" "Cancer enhanced" "Detected in all" "glioma: 37.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 81.0;HAP1: 117.2;NTERA-2: 84.3;REH: 229.4;RH-30: 129.6;SCLC-21H: 167.2;SH-SY5Y: 105.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035640, CAB037313" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "CAB037313: AB_1078571, HPA035640: AB_10670838" "unprognostic (1.56e-1)" "unprognostic (7.22e-2)" "unprognostic (5.14e-2)" "unprognostic (8.08e-3)" "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (1.84e-2)" "unprognostic (1.20e-1)" "unprognostic (2.79e-1)" "unprognostic (9.71e-2)" "prognostic favorable (4.54e-4)" "unprognostic (2.26e-1)" "unprognostic (8.52e-3)" "unprognostic (1.21e-2)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.60e-3)" 1.8 9.9 43.0 2.8 52.6 0.1 0.9 42.6 56.0 8.1 8.7 3.8 1.3 22.1 0.1 2.7 4.9 5.1 2.9 54.1 46.4 2.1 0.3 5.7 1.9 27.5 32.7 52.1 8.0 5.8 0.7 67.8 5.5 34.4 3.2 1.6 58.1 2.7 3.1 0.5 3.7 2.9 14.6 22.7 1.1 3.7 3.1 39.0 1.2 2.4 1.1 1.0 2.6 2.9 38.9 1.3 2.7 81.0 2.8 0.1 0.0 0.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 27.2 1.9 117.2 0.0 0.0 2.2 0.9 0.0 4.0 0.6 1.4 0.1 0.7 1.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.3 1.3 0.0 0.4 0.0 84.3 0.0 2.6 229.4 129.6 20.2 0.0 0.2 167.2 105.8 0.0 0.6 1.4 54.2 0.8 0.1 6.8 3.8 27.3 2.3 2.6 14.8 2.2 0.1 9.8 0.9 69.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.0 52.6 42.6 56.0 54.1 46.4 27.5 32.7 52.1 34.4 22.7 39.0 38.9 1.0 0.0 1.1 23.8 0.0 0.4 0.0 1.5 0.0 148.9 0.0 0.0 1.5 0.0 0.0 0.0 18.8 0.1 0.0 0.0 0.0 0.1 2.2 0.4 13.6 6.3 2.4 1.3 40.8 0.0 0.2 3.5 3.1 0.5 0.0 2.4 0.0 0.0 0.5 210.3 44.5 0.0 0.0 0.0 0.0 5.5 0.6 0.2 1.8 6.5 0.0 78.4 0.0 33.2 2.9 0.4 0.0 0.4 0.0 0.4 0.0 0.0 0.0 22.8 6.6 0.4 6.2 1.0 12.4 1.1 0.1 0.3 0.2 1.5 0.0 0.1 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711201-5814305 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 26.4;Microglial cells: 10.3;Skeletal myocytes: 10.5" "Cancer enhanced" "Detected in all" "renal cancer: 16.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 62.3;hTERT-HME1: 60.7;hTERT-RPE1: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain NA NA "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favorable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavorable (9.47e-5)" 6.7 3.3 2.3 3.0 2.0 0.1 5.4 1.7 1.6 10.4 4.4 6.5 1.9 13.8 8.3 8.2 14.0 14.2 7.2 1.7 3.4 26.2 2.8 8.4 2.8 3.7 2.4 0.6 33.8 9.3 18.9 1.9 3.7 1.7 11.5 3.4 1.7 9.7 9.9 1.4 7.9 3.0 11.9 2.4 3.0 4.6 3.6 2.3 4.2 9.5 3.3 2.8 7.1 6.1 1.3 7.5 9.4 5.1 13.4 32.6 46.7 1.8 16.3 62.3 18.6 23.9 0.0 0.0 0.0 5.1 26.2 31.0 8.7 5.4 13.5 15.2 12.4 3.7 0.0 5.6 2.5 24.1 0.0 1.4 23.2 19.4 24.8 60.7 53.0 13.1 0.0 0.1 0.1 43.6 0.0 0.0 0.0 5.6 0.0 8.6 11.4 14.1 0.2 6.4 1.3 2.9 8.7 0.0 0.0 6.4 4.9 3.4 0.6 22.9 15.8 3.0 11.3 14.5 9.9 8.6 0.8 45.2 0.0 15.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 1.7 1.6 1.7 3.4 3.7 2.4 0.6 1.7 2.4 2.3 1.3 0.5 3.2 2.3 26.4 0.1 3.4 1.9 3.6 2.2 0.5 0.5 1.1 2.0 1.5 2.2 3.7 0.0 0.1 0.0 0.0 1.9 0.6 0.5 0.8 6.6 0.7 0.0 0.4 1.2 0.0 0.0 6.5 1.5 4.5 0.0 1.5 0.7 0.8 0.0 0.0 1.1 0.0 2.0 0.0 1.0 0.2 0.9 0.2 5.4 10.3 0.0 2.0 0.0 2.0 0.1 0.3 0.0 0.7 0.4 0.9 0.0 1.5 1.5 0.1 0.0 10.5 2.6 0.0 0.0 2.0 2.8 0.1 0.9 2.4 0.0 1.2 DERL2 "CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa" ENSG00000072849 "Derlin 2" Q9GZP9 17 5471254-5486811 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 259.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037287, HPA048957, HPA056551" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171" "unprognostic (2.54e-1)" "unprognostic (5.30e-2)" "unprognostic (5.83e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.51e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.63e-1)" "unprognostic (2.17e-1)" "unprognostic (1.12e-3)" "unprognostic (1.73e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (3.73e-1)" "unprognostic (2.91e-2)" 13.7 19.0 6.2 16.6 6.4 34.2 13.1 6.8 7.7 13.2 7.3 13.0 15.0 12.9 29.9 15.4 14.1 17.5 10.3 5.8 8.1 14.1 28.2 11.4 18.3 6.9 6.5 6.0 12.9 28.8 14.8 12.2 13.5 7.1 14.1 12.5 8.2 28.6 11.5 10.6 10.1 17.7 12.5 6.6 15.3 15.6 24.6 6.7 10.9 24.8 5.0 15.5 15.1 11.2 8.1 32.0 40.4 18.8 31.7 31.5 23.6 24.0 44.5 36.1 30.0 36.4 27.8 27.9 22.0 39.2 28.5 33.6 35.0 13.2 25.7 29.9 29.3 27.6 10.8 25.8 30.0 43.4 8.1 25.2 22.0 21.0 40.6 34.9 26.4 31.4 22.4 12.0 37.5 40.9 16.5 17.3 12.3 18.2 20.7 16.0 20.8 26.6 16.3 32.5 16.2 7.9 23.2 27.1 18.5 47.6 20.6 24.8 11.8 23.9 35.4 23.9 21.8 43.3 26.0 31.4 20.0 37.0 20.1 28.4 71.9 62.6 77.0 64.6 70.4 67.2 66.5 61.2 68.7 48.2 65.5 48.3 59.3 59.9 60.4 56.4 69.2 81.0 117.5 6.2 6.4 6.8 7.7 5.8 8.1 6.9 6.5 6.0 7.1 6.6 6.7 8.1 36.1 12.8 23.9 12.4 46.4 34.3 50.5 157.7 27.9 17.7 48.4 48.5 31.3 35.8 82.7 44.1 22.9 70.6 70.5 28.1 15.6 79.9 259.2 32.5 41.7 35.7 18.5 35.3 8.1 89.7 103.6 51.3 22.4 41.6 49.4 38.8 30.4 57.5 74.5 11.8 9.0 37.2 89.5 33.6 44.8 63.4 43.8 37.8 46.2 6.5 64.7 35.1 48.4 6.6 16.2 86.7 25.2 35.3 119.9 68.7 37.1 50.4 55.6 24.8 59.2 33.9 54.3 126.4 45.4 26.2 31.1 96.2 47.7 45.8 30.4 62.8 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532555-113629575 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 10.3;salivary gland: 10.9" "Cell type enhanced" "Detected in many" "B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 33.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035862 Approved NA NA "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.2 2.8 4.2 5.2 6.1 3.4 5.4 5.3 6.5 3.1 0.0 6.2 2.0 0.7 0.2 1.4 1.9 3.7 0.4 6.0 4.0 0.8 0.6 1.8 8.8 3.9 4.2 6.4 0.2 0.7 0.5 5.5 1.0 2.1 5.1 10.3 0.4 10.9 1.5 0.3 0.5 5.5 0.7 3.7 7.2 3.5 0.9 3.8 5.3 0.4 0.4 8.9 4.5 0.9 5.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 1.5 0.0 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 4.2 0.0 15.4 4.2 0.2 0.0 16.2 21.0 6.2 0.0 0.5 0.0 14.9 0.2 0.1 0.0 4.2 0.2 0.0 13.8 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 7.0 0.1 7.1 7.5 4.7 5.8 1.5 6.6 5.9 5.1 0.3 9.1 0.0 33.7 3.9 3.4 4.2 6.1 5.3 6.5 6.0 4.0 3.9 4.2 6.4 2.1 3.7 3.8 5.1 1.6 6.4 3.3 7.2 47.4 0.4 1.4 1.9 0.0 1.4 9.7 4.7 1.1 4.3 4.2 1.8 0.0 0.0 34.5 17.2 0.0 0.4 5.0 3.1 0.7 1.0 10.2 0.8 117.8 1.1 0.2 0.4 8.2 6.3 3.8 0.0 0.4 0.5 11.2 0.0 86.8 23.3 2.0 3.5 1.8 1.5 0.0 10.1 5.4 23.4 2.6 0.1 21.6 4.5 4.0 0.8 3.9 0.0 14.5 3.9 2.2 0.1 9.3 0.2 0.0 0.7 0.7 0.2 0.1 0.9 0.3 0.1 16.4 0.3 7.0 1.9 NDE1 "FLJ20101, NDE, nudE" ENSG00000072864 "NudE neurodevelopment protein 1" Q9NXR1 16 15643267-15734691 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein" Lissencephaly "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "granulocytes: 21.8;monocytes: 11.7;NK-cells: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024075 Approved NA Yes "HPA024075: AB_1854336" "unprognostic (1.09e-1)" "unprognostic (1.66e-1)" "unprognostic (3.26e-1)" "unprognostic (1.47e-1)" "unprognostic (3.84e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.43e-2)" "unprognostic (1.59e-1)" "unprognostic (4.55e-2)" "unprognostic (3.70e-3)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.19e-4)" "unprognostic (1.29e-1)" "unprognostic (3.28e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" 9.2 5.9 12.6 13.1 21.3 25.9 9.5 21.0 14.8 12.9 7.1 19.9 7.6 11.7 2.7 17.9 11.2 9.9 10.3 9.6 14.9 6.0 4.2 11.2 20.6 25.0 23.6 6.8 7.5 4.0 4.1 3.1 10.1 24.9 14.3 7.4 2.0 12.3 5.1 7.4 27.4 13.0 10.8 19.6 12.6 10.2 11.2 19.1 23.6 6.4 8.0 21.0 15.4 20.0 42.1 37.0 33.0 34.2 39.9 11.4 18.6 10.4 15.4 21.0 30.4 34.5 18.3 58.3 21.9 24.0 23.2 16.7 34.5 25.3 47.3 20.8 33.7 16.0 24.6 35.3 51.7 16.3 33.3 37.2 6.6 28.9 28.8 52.0 16.9 40.6 27.9 20.5 80.5 26.6 43.9 43.0 30.5 30.5 26.5 14.3 64.8 32.3 34.8 11.6 24.1 17.0 21.0 27.5 40.7 27.6 25.9 42.8 34.3 12.5 26.9 17.6 43.2 36.1 17.4 13.1 38.1 27.5 43.0 55.0 5.1 4.7 15.0 3.0 3.8 1.7 3.3 3.0 1.3 3.4 1.9 1.8 2.0 21.8 8.5 11.7 3.1 3.3 3.9 12.6 21.3 21.0 14.8 9.6 14.9 25.0 23.6 6.8 24.9 19.6 19.1 42.1 11.7 3.2 4.4 11.1 36.1 26.0 32.7 19.0 24.5 7.0 9.5 10.4 2.0 4.3 8.9 5.5 6.2 3.9 25.0 9.6 0.0 4.5 46.9 17.1 23.1 11.6 4.2 49.0 2.1 5.3 5.3 11.8 19.4 15.0 10.8 15.5 8.6 1.7 10.1 3.3 2.4 7.4 2.0 15.8 11.0 58.5 15.8 19.3 12.4 22.5 53.0 7.4 50.4 9.5 105.5 7.1 4.2 6.0 16.6 26.3 4.6 1.9 13.3 6.5 6.6 6.9 9.5 13.8 10.0 18.8 30.7 2.5 28.3 9.8 10.2 21.6 IRAG1 "IRAG, JAW1L, MRVI1" ENSG00000072952 "Inositol 1,4,5-triphosphate receptor associated 1" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 24.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.0" "Cell line enhanced" "Detected in some" "ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8" "Region enriched" "Detected in many" 5 "thalamus: 7.6" "Low region specificity" "Detected in all" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" NA NA 220000 Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favorable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 23.5 8.1 65.0 18.4 73.8 1.5 16.3 50.8 53.6 50.7 19.9 51.0 8.6 61.3 16.2 37.8 46.0 33.4 9.4 54.3 49.0 9.3 2.1 13.4 3.7 63.5 65.2 39.9 20.4 2.9 2.8 3.8 11.9 61.1 38.2 17.4 1.8 4.1 39.9 6.8 7.9 22.2 69.7 50.8 7.1 34.0 8.3 80.3 2.3 10.3 8.2 1.8 44.2 22.1 48.2 0.1 0.0 4.2 0.0 20.8 4.1 0.2 15.3 17.6 0.0 0.0 0.4 1.7 0.0 0.1 6.9 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.0 0.2 4.8 0.4 0.0 0.1 0.0 1.2 0.0 0.6 0.1 0.3 0.0 0.1 0.3 0.5 0.0 0.1 6.8 0.0 0.3 0.0 0.0 0.0 3.1 0.0 2.6 0.0 4.4 0.0 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 6.0 0.0 0.7 2.2 1.7 0.0 3.9 0.0 0.8 0.0 0.0 0.6 0.9 0.0 0.0 24.0 0.0 5.7 0.1 0.0 0.7 65.0 73.8 50.8 53.6 54.3 49.0 63.5 65.2 39.9 61.1 50.8 80.3 48.2 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661139-16690023 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 586.9;tongue: 262.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.7;Cone photoreceptor cells: 85.5;Excitatory neurons: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 36.9;eosinophil: 12.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.9" "Cell line enhanced" "Detected in many" "Daudi: 16.1;OE19: 15.2;U-266/70: 15.6;U-698: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 2.2 4.1 13.4 1.3 16.9 5.8 2.3 15.9 17.6 1.9 44.5 2.8 1.9 1.3 18.2 9.3 3.5 0.9 16.6 12.8 17.1 5.7 7.6 4.5 1.5 12.9 16.2 12.4 2.4 2.1 4.5 7.4 0.6 16.1 7.1 2.7 10.1 9.3 5.1 586.9 1.6 2.1 1.4 11.3 1.6 14.9 3.9 17.6 2.9 2.5 262.3 2.4 1.7 1.4 13.9 4.1 0.8 1.0 6.1 3.3 0.3 0.5 1.4 0.8 0.9 1.9 1.3 5.8 16.1 2.4 0.3 5.3 3.3 8.1 1.7 0.9 1.1 2.4 0.0 2.5 1.3 0.9 0.1 0.2 1.4 6.2 1.1 0.7 4.6 0.4 2.9 0.1 1.5 0.6 6.3 0.2 1.7 1.5 15.2 9.4 8.5 1.4 4.4 5.8 3.0 9.9 6.9 4.4 0.5 2.1 0.5 3.0 1.3 0.0 1.2 2.8 3.7 0.7 15.6 12.2 27.1 1.4 9.6 1.2 36.9 4.2 12.3 0.0 1.6 0.0 4.6 0.5 0.1 0.4 6.0 0.1 0.1 2.4 3.5 1.0 0.8 0.8 1.0 13.4 16.9 15.9 17.6 12.8 17.1 12.9 16.2 12.4 16.1 11.3 17.6 13.9 2.8 3.2 1.5 18.3 2.3 1.1 3.5 6.7 3.4 30.7 3.9 2.2 25.9 1.5 3.0 0.0 85.5 0.1 0.6 1.7 1.9 3.6 0.1 1.4 0.6 4.5 4.2 0.0 31.0 2.5 0.1 3.0 17.3 1.4 0.0 2.2 9.7 9.2 0.4 13.5 24.0 7.6 14.2 4.3 1.2 0.9 10.5 0.9 3.6 3.7 0.9 13.9 0.0 7.5 3.1 10.8 1.1 22.6 2.9 3.4 0.4 1.2 1.8 9.5 0.0 25.4 3.9 0.9 1.3 3.3 0.3 0.1 0.6 2.1 2.7 1.3 AP1M1 "AP47, CLAPM2" ENSG00000072958 "Adaptor related protein complex 1 subunit mu 1" Q9BXS5 19 16197854-16245906 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 92.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045256 Uncertain NA NA "HPA045256: AB_10960697" "unprognostic (5.10e-2)" "unprognostic (3.71e-2)" "unprognostic (4.70e-3)" "unprognostic (2.85e-1)" "unprognostic (5.19e-2)" "unprognostic (2.05e-2)" "unprognostic (3.10e-2)" "unprognostic (3.52e-2)" "unprognostic (2.08e-1)" "unprognostic (2.15e-1)" "unprognostic (1.37e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (1.02e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (1.56e-1)" 47.6 47.6 25.4 30.9 29.2 59.0 38.2 20.3 36.6 32.3 18.2 32.4 32.4 39.2 9.3 29.8 30.0 21.6 37.9 29.4 27.9 39.2 81.7 32.2 37.1 25.0 26.0 30.6 32.0 18.9 20.2 24.2 27.7 29.0 25.5 12.7 17.4 21.8 25.0 44.8 29.8 31.2 35.7 19.5 37.9 27.5 61.3 25.0 38.1 23.9 29.2 28.4 38.7 29.4 29.2 63.3 70.2 69.3 65.3 82.7 80.9 39.1 69.6 74.1 99.5 103.3 83.9 48.6 49.8 78.7 76.6 64.4 35.1 54.2 56.9 111.3 85.5 122.3 80.9 63.4 114.6 67.1 91.5 96.9 83.5 42.2 89.2 59.8 65.4 95.6 69.8 40.3 98.0 109.5 75.8 131.2 55.4 56.9 22.3 162.7 87.9 56.7 67.3 54.9 45.2 44.4 99.4 56.8 34.4 64.0 36.9 41.0 73.1 83.1 111.8 45.6 151.7 134.3 104.6 141.6 54.9 125.5 112.8 88.7 89.4 142.3 243.9 104.8 180.7 105.6 99.8 103.4 111.2 121.6 92.3 115.1 147.0 101.8 133.1 235.7 131.2 161.8 174.3 25.4 29.2 20.3 36.6 29.4 27.9 25.0 26.0 30.6 29.0 19.5 25.0 29.2 17.4 41.7 31.2 12.7 30.6 4.6 7.4 13.2 11.4 35.4 11.3 10.9 17.9 14.3 15.2 12.9 20.9 32.1 30.5 8.3 15.6 21.1 32.5 10.6 27.2 22.7 19.8 21.7 11.8 18.2 40.4 28.1 8.6 14.8 27.1 19.0 21.8 41.9 42.6 42.1 11.7 7.3 6.1 36.0 13.3 92.1 23.0 30.2 10.6 5.6 34.9 18.3 38.1 4.5 12.8 31.2 5.9 19.9 24.5 6.2 25.1 23.6 13.9 40.2 0.0 26.1 22.8 61.9 23.3 12.6 7.1 17.5 32.9 17.7 9.0 4.6 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "PVR cell adhesion molecule" P15151 19 44643798-44666162 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;monocytes: 5.5" "Cell line enhanced" "Detected in many" "TIME: 175.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012568, HPA064739" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" NA NA 720000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248, HPA064739: " "unprognostic (2.90e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavorable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavorable (2.75e-4)" 11.2 17.6 9.4 7.1 9.3 5.2 9.6 8.5 10.2 8.6 9.0 9.9 12.6 14.1 5.3 8.5 11.9 6.3 24.7 9.3 13.5 12.4 31.0 19.6 2.8 9.8 9.1 9.5 12.6 14.1 10.4 17.4 12.6 11.1 9.8 8.9 5.4 10.0 6.5 19.1 7.1 11.1 10.6 7.1 4.6 12.4 5.8 13.4 2.5 10.7 6.2 2.9 9.2 8.5 10.4 58.8 52.1 5.6 25.0 8.6 9.7 7.4 96.7 38.8 40.7 45.8 31.9 28.2 0.1 50.6 43.7 60.2 44.4 24.3 51.1 31.7 7.8 27.1 8.8 40.3 23.3 43.7 4.1 22.2 10.6 28.0 40.9 82.5 49.7 50.7 6.6 4.3 0.5 23.4 7.8 4.2 5.8 12.5 30.1 31.7 0.1 23.2 5.0 111.8 25.5 21.2 22.9 66.3 54.3 14.7 7.2 22.8 12.5 175.3 39.0 52.8 33.7 78.2 0.3 6.3 0.2 35.3 23.4 24.6 0.2 4.5 0.0 0.1 4.5 0.0 0.0 0.0 0.2 3.8 0.0 0.2 0.1 1.1 0.7 5.5 0.5 0.0 1.7 9.4 9.3 8.5 10.2 9.3 13.5 9.8 9.1 9.5 11.1 7.1 13.4 10.4 11.1 16.0 25.2 2.3 1.6 3.6 16.0 6.9 4.0 5.7 4.7 3.4 14.4 14.3 12.2 1.8 2.1 2.9 0.2 18.5 3.9 37.9 10.5 5.4 6.3 20.4 13.1 2.1 11.4 35.3 34.8 7.7 13.7 11.6 1.3 6.5 7.9 41.1 8.4 1.7 13.7 11.3 2.0 8.9 7.5 14.3 5.6 6.8 1.8 5.6 17.2 1.8 2.1 6.0 4.6 69.6 18.0 15.8 0.2 14.4 10.8 5.7 2.8 3.4 0.0 23.8 10.4 10.4 1.5 5.8 5.5 1.0 0.9 10.8 12.7 7.4 XRCC1 RCC ENSG00000073050 "X-ray repair cross complementing 1" P18887 19 43543311-43580473 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005427, HPA006717" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005427: AB_2215661, HPA006717: AB_1858896" "unprognostic (1.10e-2)" "unprognostic (3.51e-3)" "unprognostic (4.59e-1)" "unprognostic (2.81e-2)" "unprognostic (4.08e-1)" "unprognostic (2.68e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.07e-2)" "unprognostic (3.12e-1)" "unprognostic (7.51e-2)" "unprognostic (3.00e-2)" "unprognostic (9.54e-2)" "unprognostic (1.07e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-3)" "unprognostic (2.20e-2)" "unprognostic (5.69e-2)" 16.9 16.5 14.9 18.2 14.9 24.6 18.0 18.0 17.3 23.6 12.8 18.5 14.7 23.7 16.3 16.3 23.4 14.6 15.6 14.2 14.5 15.7 10.8 16.3 23.1 15.2 14.8 14.1 32.3 19.8 17.7 32.5 16.7 14.7 16.4 11.5 16.9 16.4 15.7 19.7 20.5 15.8 17.4 13.0 20.3 18.6 24.1 14.7 29.2 20.8 15.9 21.1 18.8 18.2 15.2 57.4 51.4 54.4 48.2 23.6 24.6 27.0 28.4 36.0 42.5 46.3 32.0 40.4 44.1 39.1 28.9 39.1 30.0 33.2 36.8 24.7 46.4 33.9 57.5 49.4 36.1 23.2 34.5 42.9 27.3 24.8 53.5 26.4 48.8 37.2 49.1 35.9 42.5 37.3 48.9 57.5 52.5 18.5 44.2 21.3 57.0 35.4 25.8 34.3 44.1 44.5 26.5 41.6 35.3 20.7 26.8 33.9 67.4 23.3 55.7 40.4 16.3 39.9 44.2 44.2 32.0 42.8 28.0 58.7 18.6 13.1 15.6 10.8 11.9 12.3 11.7 13.8 14.6 11.6 10.5 11.3 10.9 15.1 10.4 7.9 9.1 14.5 11.7 14.9 14.9 18.0 17.3 14.2 14.5 15.2 14.8 14.1 14.7 13.0 14.7 15.2 10.2 16.0 9.8 5.9 13.4 6.1 7.1 17.5 12.5 12.6 10.2 9.0 7.6 7.2 14.7 7.3 6.2 29.8 12.5 9.1 19.6 15.4 32.2 18.7 13.3 12.2 13.7 15.4 8.2 11.6 19.2 13.3 8.2 13.7 19.7 22.0 11.4 7.1 21.0 5.0 9.2 15.3 10.2 18.0 10.1 19.5 10.2 12.6 14.2 3.7 14.3 8.6 8.2 4.5 8.1 12.2 9.7 12.8 17.7 4.1 9.2 16.9 39.0 12.7 6.6 9.6 17.7 21.4 14.1 10.8 7.1 20.0 14.6 16.4 13.7 4.7 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "adrenal gland: 1003.9" "Cell type enhanced" "Detected in many" "Adipocytes: 133.9;Granulosa cells: 114.6;Hepatocytes: 159.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 6.2;myeloid DC: 8.9;plasmacytoid DC: 21.0" "Group enriched" "Detected in many" 6 "dendritic cells: 21.0;monocytes: 6.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 148.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved "Vesicles,Lysosomes,Rods & Rings" NA NA Vesicles "Lysosomes, Rods & Rings" "CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201" "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavorable (1.83e-5)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 55.7 1003.9 11.0 4.0 18.7 1.3 55.8 5.4 13.3 12.7 17.7 11.6 12.6 13.8 1.0 9.2 13.2 13.1 9.3 10.6 6.7 6.7 237.6 15.5 6.3 9.0 8.2 3.9 55.2 9.7 4.0 15.3 112.4 12.5 13.1 9.2 12.1 21.4 2.3 9.9 24.9 15.0 7.9 5.2 12.8 8.9 19.3 11.4 2.9 11.8 5.1 10.5 12.4 12.9 9.3 30.1 50.0 22.2 51.4 12.3 23.1 0.0 24.2 20.0 21.4 12.1 56.7 61.7 91.6 66.4 12.4 31.1 39.2 58.0 109.3 13.2 45.5 51.4 18.5 53.1 68.3 33.2 35.9 17.2 39.5 19.7 41.0 32.5 36.7 57.2 9.1 41.5 21.5 4.3 27.7 12.9 23.5 22.8 30.7 66.0 51.0 18.8 148.7 0.8 32.9 38.8 12.1 126.5 95.9 70.2 13.3 55.8 29.9 4.6 2.6 23.8 14.3 29.8 10.1 3.8 15.7 11.3 29.0 23.9 0.0 6.2 0.0 0.2 3.0 0.1 2.3 0.0 0.2 8.9 0.9 0.0 0.0 0.8 0.0 0.6 21.0 0.0 3.8 11.0 18.7 5.4 13.3 10.6 6.7 9.0 8.2 3.9 12.5 5.2 11.4 9.3 133.9 3.2 2.7 25.8 8.6 5.6 3.6 9.0 6.8 6.1 14.8 17.0 6.5 8.6 5.3 3.7 29.2 10.7 10.5 46.7 3.9 5.4 18.1 1.0 5.3 44.2 10.7 8.2 21.0 7.4 13.8 7.9 11.7 3.4 1.3 114.6 21.4 159.4 51.6 16.8 24.8 13.1 8.2 14.8 11.4 12.6 9.0 16.7 48.0 74.9 5.9 52.9 0.0 23.1 27.3 5.8 12.9 5.3 8.0 9.9 10.0 2.9 4.7 7.5 0.0 3.1 5.0 25.0 1.6 6.5 3.1 43.4 1.8 60.0 9.4 4.4 CYP2W1 "FLJ20359, MGC34287" ENSG00000073067 "Cytochrome P450 family 2 subfamily W member 1" Q8TAV3 7 983181-989640 "Predicted intracellular proteins" "Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 19.2;intestine: 6.2;skin 1: 9.2" "Cell type enriched" "Detected in some" 7 "Enteroendocrine cells: 98.5" "Group enriched" "Detected in many" 5 "colorectal cancer: 25.3;stomach cancer: 15.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 13.5;Hep G2: 49.8" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (7.09e-3)" "unprognostic (1.94e-2)" "unprognostic (2.75e-2)" "unprognostic (1.51e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (6.26e-2)" "unprognostic (2.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.34e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.85e-4)" 0.1 19.2 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.0 0.9 6.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.3 1.0 0.1 2.1 0.5 0.2 0.3 0.2 0.0 9.2 1.0 0.0 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 2.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 4.0 2.3 1.5 0.0 0.6 0.0 0.0 0.5 0.0 2.6 0.0 0.0 1.1 0.0 3.7 0.0 0.1 0.1 0.1 0.0 0.3 98.5 0.0 0.0 0.9 0.6 10.2 0.0 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 13.6 0.0 0.0 0.9 0.0 1.8 0.3 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.1 3.3 0.0 0.1 1.2 1.1 0.0 3.3 0.6 0.0 0.8 0.3 0.2 0.1 0.0 4.4 1.9 0.2 4.4 11.4 3.7 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598410-127622436 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 68.2;lymphoid tissue: 37.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 120000 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 3.1 3.4 1.6 16.6 1.7 68.2 6.3 2.4 1.8 4.4 0.6 9.3 8.1 5.0 2.4 11.1 7.7 2.5 6.5 1.9 1.9 2.7 6.3 3.4 27.0 2.1 1.9 1.6 6.4 3.1 3.8 2.4 17.1 2.5 5.1 10.3 3.5 4.8 2.8 9.5 10.6 8.6 5.3 1.9 9.7 5.7 12.4 1.8 37.9 4.8 5.8 26.2 4.2 5.4 2.4 133.6 110.3 122.4 102.1 7.0 14.4 110.5 65.2 42.3 129.9 146.9 177.7 84.7 136.0 65.2 32.3 113.6 105.6 204.8 76.1 79.1 127.2 127.1 227.4 134.8 131.1 4.4 214.3 102.4 8.2 8.4 86.1 13.1 15.3 40.6 160.7 116.0 123.7 47.4 169.0 229.0 156.2 172.5 108.3 90.7 242.4 165.1 203.3 26.9 97.9 143.0 106.8 175.8 48.9 16.7 45.7 111.9 165.3 20.3 104.2 87.9 128.4 91.7 127.1 163.5 362.6 73.2 159.7 41.0 0.0 0.6 0.3 4.4 1.4 5.5 9.7 3.9 5.4 2.9 8.1 3.6 4.7 0.9 6.5 0.4 3.7 11.2 3.5 1.6 1.7 2.4 1.8 1.9 1.9 2.1 1.9 1.6 2.5 1.9 1.8 2.4 1.2 3.2 2.0 0.7 8.5 4.6 2.6 4.6 2.2 2.5 4.1 5.3 8.3 0.0 3.9 0.0 0.0 63.3 1.8 4.8 0.0 5.3 0.9 5.2 3.5 2.9 3.6 65.6 0.3 1.9 28.8 4.2 6.6 4.8 1.3 18.8 1.4 1.7 18.2 0.0 0.4 8.2 0.0 1.6 3.2 0.7 1.8 2.7 1.8 0.0 9.2 2.1 0.0 0.0 0.7 2.1 1.7 1.5 20.5 0.8 1.1 0.8 7.4 2.1 0.0 2.6 4.1 8.1 25.9 7.1 3.0 33.5 6.3 3.8 13.8 2.3 MOV10L1 "CHAMP, DJ402G11.8, DKFZp434B0717" ENSG00000073146 "Mov10 like RISC complex RNA helicase 1" Q9BXT6 22 50089879-50161690 "Enzymes, Predicted intracellular proteins" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 43.0" "Cell type enhanced" "Detected in some" "Early spermatids: 118.9;Late spermatids: 310.8;Spermatocytes: 80.3;Spermatogonia: 46.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.5;HUVEC TERT2: 12.5;TIME: 5.8" "Not detected" "Not detected" HPA019034 Approved NA NA "HPA019034: AB_1854070" "unprognostic (1.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.88e-2)" "unprognostic (7.91e-2)" "unprognostic (4.29e-2)" "unprognostic (4.05e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (9.43e-2)" "unprognostic (7.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.03e-1)" "unprognostic (8.02e-3)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" 0.4 0.1 1.1 0.2 1.3 0.2 0.4 3.8 1.6 3.0 0.4 1.4 0.1 4.4 1.7 0.6 2.1 1.0 0.5 1.3 0.9 0.4 0.8 0.6 0.2 1.2 1.2 1.4 3.0 0.2 0.0 1.0 0.6 2.0 2.1 0.2 1.3 0.5 0.1 0.0 0.3 1.1 1.6 0.3 0.0 0.2 43.0 1.0 0.0 0.5 0.0 0.2 0.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.4 0.7 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.0 1.1 0.1 0.0 0.0 0.0 0.1 12.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 3.8 1.6 1.3 0.9 1.2 1.2 1.4 2.0 0.3 1.0 1.8 0.3 0.0 0.0 1.3 0.0 0.3 0.1 0.1 0.0 3.1 0.1 0.3 1.6 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 118.9 0.3 5.2 0.8 0.0 0.0 5.5 0.4 0.1 0.6 0.0 0.5 0.0 0.7 0.4 0.1 1.7 5.0 3.2 0.0 0.0 0.0 0.0 310.8 1.5 0.2 0.0 8.4 0.0 2.3 0.0 1.5 1.1 0.0 0.0 3.0 0.0 0.1 0.0 1.7 0.0 3.7 13.1 0.2 0.3 80.3 46.7 0.1 0.0 0.1 0.1 0.3 0.0 0.1 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180295 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 11.4;Excitatory neurons: 13.3;Hepatocytes: 10.7;Inhibitory neurons: 15.8;Muller glia cells: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.9" "Lineage enhanced" "Detected in single" "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 10.3;HDLM-2: 16.7;Hep G2: 19.6;MCF7: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 0.6 0.8 7.5 0.5 4.2 1.6 1.0 7.0 37.1 1.4 0.0 0.3 0.0 1.3 0.5 5.2 2.2 0.4 0.4 8.3 9.7 3.0 9.7 2.2 0.0 41.8 13.0 1.1 3.5 1.4 0.3 7.9 0.1 45.9 4.0 0.0 1.6 5.0 1.4 0.7 1.0 0.2 0.0 6.0 2.0 0.4 1.7 13.2 0.0 7.3 0.1 0.1 1.4 2.0 38.4 0.9 2.1 0.4 2.3 0.0 0.2 4.9 2.6 2.5 0.5 0.4 0.5 8.0 0.0 10.3 0.3 1.4 0.5 1.3 1.0 0.1 16.7 1.4 0.4 3.5 19.6 0.7 0.1 1.2 0.2 1.0 0.7 0.0 1.1 0.6 0.0 1.4 0.0 0.2 10.8 0.0 1.0 3.9 0.0 4.2 1.0 0.0 4.0 0.0 1.6 9.8 0.9 1.6 0.2 6.5 0.5 0.7 0.8 4.5 0.5 4.1 6.7 4.9 1.8 0.1 0.6 0.3 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 7.5 4.2 7.0 37.1 8.3 9.7 41.8 13.0 1.1 45.9 6.0 13.2 38.4 0.0 0.0 1.1 7.2 0.3 0.5 3.1 0.6 0.0 11.4 2.5 2.4 0.8 1.5 2.6 0.0 0.0 0.0 1.5 0.0 5.9 2.3 0.3 5.9 1.5 0.7 0.0 0.4 13.3 2.8 0.2 0.8 0.0 7.0 0.0 2.1 0.0 10.7 0.1 0.0 15.8 0.0 0.0 0.9 1.5 0.2 0.0 1.1 0.0 1.9 1.8 29.7 0.0 6.6 1.2 1.8 0.0 1.2 0.5 6.0 0.0 3.0 3.0 3.6 0.0 0.1 0.9 0.0 1.8 0.3 0.3 0.0 0.2 0.1 0.0 4.5 SELENOO SELO ENSG00000073169 "Selenoprotein O" Q9BVL4 22 50200979-50217616 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 28.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 21.1;Granulosa cells: 34.7;Proximal tubular cells: 41.7;Theca cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071795, HPA079100" Approved Supported "Mitotic chromosome,Mitochondria" "Intracellular and membrane" Yes NA Mitochondria "Mitotic chromosome" "HPA071795: , HPA079100: " "unprognostic (1.79e-1)" "unprognostic (2.07e-3)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" "unprognostic (3.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.85e-2)" "unprognostic (5.91e-2)" "unprognostic (1.51e-1)" "unprognostic (5.62e-2)" "unprognostic (8.20e-3)" "unprognostic (8.91e-2)" "unprognostic (1.81e-2)" "unprognostic (7.31e-2)" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "prognostic favorable (8.32e-4)" 6.8 6.8 1.7 4.6 2.5 14.1 4.9 11.1 6.3 5.2 1.8 5.2 8.1 5.9 2.9 8.3 5.8 4.2 5.2 2.6 1.6 6.5 28.1 4.7 6.5 4.2 2.0 3.3 5.0 13.2 3.0 4.1 3.1 5.8 5.7 2.0 2.9 7.8 4.1 12.4 8.2 6.5 2.5 1.7 6.6 7.1 3.7 1.9 4.4 5.1 4.1 3.9 5.2 6.2 5.5 12.0 7.7 4.2 4.7 5.6 4.1 8.6 11.8 5.6 7.0 5.5 10.6 7.5 7.9 9.2 4.7 3.9 26.2 6.5 10.7 1.4 2.3 29.9 5.7 17.4 6.4 2.8 10.6 6.9 5.4 7.2 4.5 3.5 4.5 5.8 5.3 7.8 5.6 2.9 18.6 5.7 16.4 3.7 2.8 15.6 17.6 5.9 11.8 4.3 15.3 8.4 9.3 12.8 11.3 7.5 2.1 8.7 7.5 9.5 6.0 8.3 6.5 7.1 13.8 3.6 4.7 6.8 6.9 3.5 0.0 1.1 1.3 0.2 0.4 0.5 0.0 0.2 0.5 1.1 0.2 0.1 0.4 0.5 0.0 0.4 0.4 0.2 0.3 1.7 2.5 11.1 6.3 2.6 1.6 4.2 2.0 3.3 5.8 1.7 1.9 5.5 11.8 0.0 21.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 13.3 13.2 0.0 0.0 5.6 9.2 0.0 3.1 12.2 0.0 15.6 3.6 0.0 11.8 10.9 3.0 0.0 0.0 0.0 4.6 2.4 6.0 0.0 15.2 3.8 34.7 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 4.5 0.0 0.0 41.7 3.6 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 1.9 5.5 29.6 0.0 0.0 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631389-189897276 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.2;skin 1: 138.4;vagina: 54.8" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 0.3 0.3 0.3 0.6 0.4 0.5 18.2 0.8 0.6 12.0 0.6 0.2 0.1 0.3 10.6 70.2 1.0 0.3 0.6 0.5 0.6 0.3 0.4 1.9 1.0 0.3 0.4 0.3 0.1 0.3 0.0 0.5 10.9 0.5 17.6 0.2 0.0 21.0 18.2 42.7 138.4 0.2 0.3 0.2 0.3 0.4 3.4 0.6 23.3 0.3 12.5 17.9 18.8 54.8 0.4 2.3 4.6 0.0 0.1 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 16.6 0.6 0.1 0.2 87.1 0.0 167.3 0.0 1.4 0.0 1.9 1.3 0.4 0.0 0.0 0.3 0.2 124.0 0.2 117.3 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.3 0.2 0.0 1.0 0.3 0.0 0.2 185.1 0.2 0.1 0.2 0.0 0.0 2.5 0.9 0.2 0.3 0.2 0.1 0.2 0.0 25.3 0.3 1.1 0.5 0.1 0.8 0.6 0.0 0.2 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.3 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.0 0.3 0.4 0.8 0.6 0.5 0.6 0.3 0.4 0.3 0.5 0.2 0.6 0.4 0.2 0.0 5.3 1.0 0.9 275.4 26.8 61.9 335.2 0.0 0.9 30.1 0.7 0.0 8.5 0.0 0.0 24.9 0.1 0.1 0.0 0.2 1.8 0.0 0.1 1.1 0.0 0.0 1.3 0.2 2.8 1.4 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.0 4.8 0.0 2.0 0.0 11.9 0.4 0.3 0.7 8.8 14.0 0.6 0.0 0.0 0.5 1.4 1.6 0.0 1.2 1.6 5.6 0.0 0.0 2.8 0.0 0.0 5.3 0.9 0.5 2.4 173.4 283.1 8.9 0.6 0.2 0.0 15.2 ALPK1 "FLJ22670, KIAA1527, Lak" ENSG00000073331 "Alpha kinase 1" Q96QP1 4 112285509-112442621 "Enzymes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 18.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA027435, HPA027443" Approved Approved Centrosome NA NA Centrosome "HPA027435: AB_10599614, HPA027443: AB_10599421" "unprognostic (6.24e-2)" "unprognostic (1.92e-1)" "unprognostic (9.30e-2)" "unprognostic (1.69e-2)" "unprognostic (7.40e-2)" "unprognostic (5.45e-2)" "unprognostic (2.55e-2)" "unprognostic (7.47e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (7.14e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.82e-7)" "unprognostic (1.60e-1)" "unprognostic (4.17e-2)" "unprognostic (2.81e-1)" "prognostic favorable (1.17e-4)" 4.8 5.3 1.9 4.4 2.3 10.8 5.1 2.0 2.9 4.9 3.1 4.1 2.5 3.8 3.7 4.4 5.3 4.3 2.7 4.0 2.0 4.8 4.5 5.2 5.5 1.5 1.2 1.6 5.4 3.5 4.2 2.6 3.7 2.0 5.0 4.3 2.1 5.4 3.1 1.8 6.9 5.0 4.2 0.6 8.8 4.1 2.1 1.4 5.2 4.2 2.3 6.1 6.1 4.4 2.5 1.6 5.0 1.5 0.3 6.4 10.1 2.1 1.7 3.6 2.6 3.3 0.5 7.8 5.3 3.3 3.3 5.2 1.0 1.7 3.2 3.7 6.7 1.9 3.6 2.0 0.4 10.1 2.2 2.0 12.8 8.3 3.7 7.8 5.7 0.9 2.7 0.9 9.1 5.0 3.1 1.3 2.0 0.3 3.7 1.2 0.6 1.1 1.6 3.9 1.8 0.5 0.8 1.7 6.4 2.8 0.2 2.9 4.1 1.8 2.3 2.0 3.8 1.3 2.2 0.7 4.5 5.8 5.3 2.1 1.6 3.7 1.7 0.2 4.7 0.6 0.9 0.6 0.1 3.7 0.9 0.8 0.6 18.7 0.4 2.2 0.5 0.0 1.4 1.9 2.3 2.0 2.9 4.0 2.0 1.5 1.2 1.6 2.0 0.6 1.4 2.5 10.8 12.8 26.8 11.4 7.3 2.9 10.9 11.5 12.5 0.5 8.7 10.7 4.0 4.3 15.5 5.5 0.0 4.9 2.9 10.0 0.0 8.0 11.1 12.0 13.7 8.2 1.2 5.0 5.9 6.7 3.0 9.6 16.3 10.9 6.3 10.9 7.1 7.4 10.1 0.0 1.2 8.6 8.2 13.5 4.6 2.6 3.7 18.7 7.2 73.1 16.1 10.7 1.0 0.5 0.7 7.1 9.0 7.5 2.4 8.8 8.0 5.3 25.7 0.2 6.6 8.4 10.8 0.9 0.7 10.3 4.5 7.3 4.0 7.0 6.4 12.4 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL scribble cell polarity complex component 2" Q6P1M3 17 75525080-75575209 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favorable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 3.5 7.9 2.4 14.3 5.0 4.6 9.0 5.8 3.6 16.4 7.8 60.2 55.0 4.2 24.2 55.9 15.0 21.5 2.9 1.6 3.4 56.6 27.1 27.9 5.1 5.3 5.4 1.0 4.9 75.1 17.4 11.3 6.3 5.7 14.8 28.7 10.5 43.8 12.6 1.4 33.9 55.9 1.9 4.3 24.7 64.8 7.0 3.6 2.3 17.9 1.0 5.7 9.7 26.1 9.4 60.1 54.7 0.3 10.4 0.0 0.0 22.7 0.4 0.6 1.1 0.6 92.6 134.2 4.0 13.6 0.2 5.0 73.7 10.1 10.1 0.2 5.1 18.1 4.0 16.1 35.1 0.6 0.6 8.5 0.0 13.6 0.2 2.1 1.3 2.0 5.8 7.9 5.4 0.0 132.1 3.5 7.1 7.4 101.6 21.2 6.9 0.2 14.9 28.4 92.9 22.1 4.5 11.8 127.5 4.0 12.2 96.6 9.4 0.5 0.2 0.6 0.2 1.0 6.4 9.3 1.8 0.4 0.3 2.7 0.0 0.1 0.1 3.1 0.3 0.7 0.3 0.7 2.1 0.1 0.3 0.1 1.2 0.1 2.1 0.1 1.1 0.5 0.4 2.4 5.0 5.8 3.6 1.6 3.4 5.3 5.4 1.0 5.7 4.3 3.6 9.4 7.7 89.8 51.6 3.6 9.0 10.6 34.7 17.3 12.0 15.5 28.8 20.1 3.8 74.4 40.5 90.1 166.8 3.7 44.7 297.5 31.3 84.1 0.6 88.7 7.2 9.0 95.1 0.8 1.1 138.9 8.5 3.5 158.5 87.7 22.2 7.2 4.6 25.0 6.0 8.4 0.8 113.0 32.6 3.8 6.0 1.0 4.7 4.7 3.6 5.6 5.5 28.1 50.4 0.5 49.9 249.4 159.8 4.1 16.1 37.6 84.5 47.0 53.9 117.5 6.6 1.3 6.4 1.5 18.9 27.5 21.7 4.4 21.8 7.5 136.1 89.7 PDE8A HsT19550 ENSG00000073417 "Phosphodiesterase 8A" O60658 15 84980440-85139145 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Oligodendrocytes: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RT4: 89.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007722 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA007722: AB_1855130" "unprognostic (1.68e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (4.97e-2)" "unprognostic (6.25e-2)" "unprognostic (3.47e-2)" "unprognostic (2.97e-2)" "unprognostic (3.94e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (8.99e-3)" "unprognostic (2.75e-2)" "unprognostic (3.42e-1)" "unprognostic (3.72e-1)" "unprognostic (4.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.94e-2)" 16.9 16.8 21.9 8.6 30.3 3.3 10.6 21.9 21.1 11.7 15.5 24.2 15.4 9.2 7.3 6.4 9.1 15.9 8.1 17.2 22.1 24.5 30.2 10.9 5.6 24.8 29.0 13.4 12.8 14.7 17.0 6.8 11.5 39.2 7.0 22.1 14.6 6.4 9.6 5.9 6.3 13.7 10.7 22.1 6.3 11.1 11.1 27.5 4.6 12.4 6.5 5.1 17.9 7.1 45.8 29.0 48.4 7.9 5.4 32.7 17.2 9.6 19.4 21.1 16.6 18.9 10.9 16.9 5.8 14.6 25.9 19.7 20.2 33.8 14.9 22.0 10.8 20.2 7.7 30.3 15.6 23.5 4.5 11.3 17.4 9.1 19.6 18.6 14.3 21.6 6.4 15.6 18.3 15.2 24.5 2.6 4.5 3.8 9.5 8.6 3.6 6.5 8.1 13.2 89.0 18.3 14.1 18.9 20.3 55.5 8.7 6.7 8.7 17.1 38.4 13.6 13.9 31.6 8.9 16.7 6.2 26.1 18.1 11.0 0.0 0.9 0.6 0.3 0.7 0.6 0.2 0.5 0.6 0.5 0.3 0.7 0.3 0.0 0.2 1.6 0.0 1.1 0.2 21.9 30.3 21.9 21.1 17.2 22.1 24.8 29.0 13.4 39.2 22.1 27.5 45.8 30.7 6.4 26.5 83.9 14.8 11.3 11.1 13.9 18.2 13.0 6.6 5.2 6.8 41.5 15.4 7.3 12.5 8.0 5.5 58.7 7.9 11.3 6.4 12.5 21.6 24.3 14.5 0.8 60.8 9.6 7.1 16.2 26.5 20.6 22.1 17.9 14.3 23.3 10.8 10.1 126.2 19.0 4.1 12.3 18.9 5.6 10.8 19.2 10.6 85.3 9.0 2.6 10.3 119.1 968.6 11.5 31.8 11.3 7.2 25.4 22.1 21.1 10.5 31.2 39.5 17.8 24.5 25.6 17.3 7.5 10.4 4.5 10.8 25.3 28.5 26.4 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156975-10237660 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;retina: 38.2;skeletal muscle: 45.3;tongue: 34.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.0;Cone photoreceptor cells: 102.2;Excitatory neurons: 45.7;Horizontal cells: 52.2;Inhibitory neurons: 54.0;Oligodendrocytes: 76.5;Rod photoreceptor cells: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.6;neutrophil: 2.2" "Group enriched" "Detected in many" 6 "B-cells: 2.6;granulocytes: 2.2" "Cell line enhanced" "Detected in many" "GAMG: 25.3;HEL: 24.3;SCLC-21H: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Approved Vesicles NA NA Vesicles "HPA031313: AB_10601358, HPA063637: AB_2685069" "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favorable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 2.6 2.7 20.0 1.5 26.2 1.8 1.1 27.1 25.1 1.3 4.1 0.9 0.8 0.6 22.8 1.8 2.9 2.2 12.4 20.7 21.0 2.9 3.2 3.0 2.8 27.5 25.5 16.6 1.7 2.2 10.9 5.3 1.1 24.5 1.5 0.7 38.2 2.2 1.1 45.3 0.9 0.7 0.7 25.0 2.6 1.5 1.9 25.5 2.6 6.6 34.5 1.8 1.2 0.7 33.2 5.9 4.6 2.7 0.0 1.5 2.5 0.1 0.2 0.0 0.0 0.0 9.1 4.6 5.0 13.0 1.5 25.3 1.4 1.4 2.9 0.2 0.1 5.7 24.3 2.2 3.5 7.3 0.0 0.1 12.9 3.4 7.0 1.5 4.7 9.4 0.0 1.5 0.1 3.3 1.1 0.0 0.2 4.0 7.1 15.3 0.0 4.5 0.0 2.1 0.8 24.1 8.7 8.6 1.1 0.0 2.7 1.7 2.7 7.4 3.1 5.8 15.3 0.6 0.5 12.1 1.8 10.5 0.0 4.5 1.6 0.3 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.4 2.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.3 20.0 26.2 27.1 25.1 20.7 21.0 27.5 25.5 16.6 24.5 25.0 25.5 33.2 1.0 9.6 3.1 11.8 4.9 0.5 0.6 2.0 0.0 85.0 1.1 0.4 31.1 8.6 2.2 7.3 102.2 0.2 0.0 0.1 0.0 2.5 0.1 2.6 1.3 3.0 15.0 9.4 45.7 3.6 0.1 4.0 1.1 3.1 1.3 0.7 13.6 5.1 3.1 52.2 54.0 0.6 4.1 4.8 2.3 0.0 0.9 3.4 0.0 15.9 1.0 15.4 0.0 24.6 76.5 4.1 0.1 3.8 0.4 0.8 0.0 2.9 5.3 42.6 0.0 8.7 6.0 0.0 0.5 0.2 0.1 0.3 0.1 2.6 0.3 1.3 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128730-35142304 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 7.1 7.5 4.3 5.9 4.9 6.2 8.9 5.1 5.4 6.9 3.1 5.5 4.1 6.8 3.0 8.5 7.4 3.2 4.2 4.9 4.6 5.0 7.3 4.7 6.8 4.7 4.0 5.0 12.1 23.9 3.9 4.3 5.0 4.3 6.1 4.0 2.6 7.6 4.7 8.0 6.8 5.1 4.1 3.4 6.3 7.7 4.5 4.7 6.6 5.1 3.5 5.5 7.4 5.8 4.5 15.9 36.8 12.5 22.7 6.9 11.4 19.6 14.0 12.7 24.4 19.3 26.1 14.8 34.9 18.6 12.0 18.0 21.0 26.8 35.6 15.1 5.6 44.2 14.9 18.2 33.2 10.3 29.9 12.0 12.9 19.0 25.6 38.3 10.7 15.5 33.9 42.4 12.7 14.6 22.1 47.1 25.5 23.6 13.5 16.6 37.6 20.9 38.5 14.3 14.8 25.6 14.8 13.1 13.4 17.1 11.1 32.4 22.4 14.5 13.3 18.3 13.0 47.4 9.8 7.8 29.1 9.3 24.9 25.8 0.1 2.2 0.0 4.0 2.4 6.2 3.4 3.8 4.2 3.4 4.6 5.2 3.5 0.3 1.8 1.2 0.8 2.1 2.2 4.3 4.9 5.1 5.4 4.9 4.6 4.7 4.0 5.0 4.3 3.4 4.7 4.5 4.7 3.2 1.1 0.3 8.6 8.7 8.6 7.4 9.6 4.7 12.3 14.0 2.6 10.0 3.7 3.7 2.1 12.1 2.4 3.9 0.0 8.9 1.0 2.1 5.4 5.0 4.9 8.8 1.3 15.4 20.9 7.4 6.6 2.8 3.8 9.4 5.3 6.6 7.6 1.7 1.5 8.1 2.0 4.6 2.6 5.4 4.1 2.8 1.8 1.0 3.8 1.9 2.1 1.0 0.7 8.5 3.6 4.9 5.1 8.6 3.4 7.1 2.8 3.1 0.0 6.5 7.2 4.2 6.5 12.5 10.1 4.9 4.1 9.2 13.4 5.5 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-257082 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 455.9;skeletal muscle: 483.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria No No 360000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavorable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favorable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 70.2 149.2 65.1 29.9 63.5 38.7 66.3 80.8 71.8 50.1 64.3 108.3 150.3 53.6 27.6 67.7 50.8 34.2 455.9 63.8 73.9 139.3 279.0 54.8 43.5 75.7 66.7 61.6 66.4 72.1 124.0 45.2 29.0 79.2 46.7 82.9 43.1 67.4 36.0 483.5 59.4 117.7 36.5 65.5 67.0 116.5 56.9 71.7 42.2 50.1 226.8 36.8 63.8 56.7 69.9 88.4 154.2 54.8 95.0 96.9 68.5 154.1 63.3 81.8 107.2 108.4 163.9 115.9 108.3 218.6 70.2 92.1 111.8 102.4 129.7 66.3 241.9 98.9 50.1 390.8 224.1 60.0 69.5 70.7 70.6 84.3 83.6 33.7 93.6 123.9 83.5 84.6 83.1 48.7 155.8 93.9 206.9 19.3 101.4 193.5 119.0 84.6 223.2 245.4 122.7 62.3 35.4 332.5 205.5 90.7 36.1 115.0 93.2 91.1 80.3 82.1 48.2 52.5 93.0 40.9 79.8 81.6 99.9 52.5 66.6 70.8 88.1 95.2 85.7 86.8 79.5 92.5 94.5 93.3 73.3 89.2 85.0 14.1 85.5 74.7 59.5 149.3 111.3 65.1 63.5 80.8 71.8 63.8 73.9 75.7 66.7 61.6 79.2 65.5 71.7 69.9 29.4 35.3 71.1 20.2 50.9 61.2 81.4 105.8 31.3 51.0 24.6 17.0 272.6 64.3 78.5 75.4 102.2 109.6 39.3 169.7 142.8 94.7 58.7 39.1 30.1 39.1 47.5 56.8 34.4 44.9 102.8 49.4 47.9 48.5 43.7 64.8 47.5 167.0 67.5 101.0 39.9 96.3 105.8 41.0 55.0 28.8 68.3 38.8 90.7 12.2 60.2 50.7 52.5 19.1 37.9 54.2 100.1 55.7 67.5 37.0 274.4 190.7 75.2 87.2 78.9 33.2 51.7 96.9 54.3 40.9 35.9 154.7 56.7 85.0 160.1 88.2 SMARCE1 BAF57 ENSG00000073584 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1" Q969G3 17 40624962-40648654 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" Neurogenesis "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003916, CAB037318" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB037318: AB_476780, HPA003916: AB_1857279" "unprognostic (7.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.09e-2)" "unprognostic (8.06e-3)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (4.48e-1)" "unprognostic (1.25e-2)" "unprognostic (2.20e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-2)" "unprognostic (2.04e-1)" "unprognostic (9.80e-2)" "unprognostic (5.93e-2)" "unprognostic (7.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-2)" 39.8 22.3 10.4 38.2 11.6 43.6 35.9 11.1 13.4 46.3 15.2 40.6 39.2 56.8 28.5 44.0 39.3 41.8 40.5 9.1 12.5 31.5 31.8 36.4 50.0 13.4 10.9 7.2 59.1 35.7 38.6 13.4 48.8 12.9 34.5 38.8 17.6 33.9 42.5 42.8 27.2 39.6 57.9 11.9 40.8 31.1 31.8 10.6 76.8 41.2 45.1 54.6 47.3 26.4 16.5 86.5 139.6 169.1 126.5 87.7 125.5 82.8 105.9 145.4 122.1 91.0 92.7 72.7 135.9 149.6 145.3 81.0 114.5 106.1 112.3 145.1 128.3 138.0 97.2 73.4 165.2 87.8 179.8 94.5 109.3 87.6 97.7 140.6 122.1 133.4 106.5 144.2 52.2 118.2 96.5 331.6 37.1 95.4 70.8 68.6 183.3 190.2 103.7 147.5 144.9 134.6 130.0 94.5 269.4 86.6 181.5 161.5 111.4 109.7 98.1 107.6 89.7 132.6 97.7 122.8 204.5 100.0 80.9 154.9 106.3 64.4 88.2 91.7 67.8 95.0 99.8 82.4 96.1 77.9 112.3 68.3 79.3 26.5 124.7 82.2 80.3 114.7 112.2 10.4 11.6 11.1 13.4 9.1 12.5 13.4 10.9 7.2 12.9 11.9 10.6 16.5 41.4 48.1 45.1 13.1 67.5 38.1 43.0 69.5 65.4 75.8 19.7 20.2 53.0 38.6 61.5 20.2 16.7 101.8 68.7 38.7 15.6 41.5 27.1 34.9 47.0 60.4 96.5 84.1 17.1 32.3 75.7 72.4 44.9 32.1 74.0 41.3 62.8 44.0 51.6 82.4 18.8 53.5 65.1 42.9 39.6 11.8 90.4 30.9 24.9 19.7 63.2 63.3 105.0 26.7 32.7 35.7 46.7 82.4 44.2 36.5 52.8 30.5 59.3 37.1 39.5 62.7 57.0 49.7 50.9 63.3 40.1 114.8 53.8 35.3 62.5 34.3 FNDC8 DKFZp434H2215 ENSG00000073598 "Fibronectin type III domain containing 8" Q8TC99 17 35121615-35130732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 473 "testis: 89.7" "Group enriched" "Detected in some" 73 "Early spermatids: 592.7;Late spermatids: 2294.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;JURKAT: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026521, HPA059803" Supported Approved Cytosol NA NA Cytosol "HPA026521: AB_2106163, HPA059803: " "unprognostic (1.45e-1)" "unprognostic (6.58e-2)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.25e-2)" "unprognostic (2.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-1)" "unprognostic (8.43e-2)" "unprognostic (3.48e-3)" "unprognostic (9.02e-2)" "unprognostic (6.41e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 89.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 0.0 0.1 0.5 0.3 0.1 0.0 0.1 0.7 0.3 0.7 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.7 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 592.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2294.8 7.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 19.7 0.0 0.0 7.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" "Cytolysis, Necrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.8;liver: 53.3;stomach 1: 47.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 45.7;Gastric mucus-secreting cells: 62.2;Intestinal goblet cells: 30.7;Paneth cells: 54.2;Proximal enterocytes: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 8 "SK-BR-3: 458.1" "Not detected" "Not detected" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819" "unprognostic (5.78e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favorable (5.91e-9)" 10.7 1.4 13.3 13.2 13.4 5.1 9.4 13.9 22.7 5.5 12.7 45.5 67.5 3.4 5.1 4.8 6.3 12.6 4.1 13.5 12.6 6.0 53.3 8.0 11.1 12.9 12.8 13.2 6.4 8.3 0.3 4.0 2.9 13.2 11.0 57.5 5.4 4.7 4.4 1.5 8.4 76.8 5.0 12.3 15.1 47.8 4.3 12.6 10.9 9.0 0.5 8.5 20.3 5.7 14.2 2.0 1.5 2.9 0.8 6.7 4.3 2.6 1.8 1.1 0.6 1.8 1.7 55.2 2.8 2.5 1.7 0.9 7.6 1.6 1.6 4.0 11.7 1.8 1.1 0.8 0.8 2.0 0.3 0.7 2.9 9.2 2.4 3.3 4.6 1.2 9.0 1.3 3.5 0.7 0.6 3.3 6.2 0.8 18.2 2.0 3.1 1.1 4.5 0.2 1.8 1.1 1.4 0.6 458.1 1.9 13.2 2.4 1.9 1.7 2.0 3.0 5.1 1.0 9.9 9.2 2.8 0.7 1.9 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 13.3 13.4 13.9 22.7 13.5 12.6 12.9 12.8 13.2 13.2 12.3 12.6 14.2 1.5 3.2 12.0 9.1 3.9 1.9 1.4 4.9 4.0 2.8 3.3 2.9 2.5 8.6 8.1 5.5 4.2 1.6 3.5 45.7 0.0 1.7 5.5 1.5 1.8 1.8 6.1 0.0 20.1 7.8 0.6 1.2 62.2 1.8 1.3 3.0 0.4 8.1 0.3 1.7 9.2 30.7 0.0 1.3 2.0 5.4 1.2 1.1 3.6 3.7 1.5 1.3 2.1 7.1 5.1 8.9 54.2 1.9 5.6 1.4 108.2 0.3 14.1 2.3 0.0 1.4 2.2 0.4 1.4 1.8 3.4 0.3 4.8 3.0 23.7 6.7 KDM5A "JARID1A, RBBP2" ENSG00000073614 "Lysine demethylase 5A" P29375 12 280057-389320 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006201 Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA006201: AB_1079160" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (4.46e-2)" "unprognostic (1.60e-1)" "unprognostic (3.53e-3)" "unprognostic (1.81e-2)" "unprognostic (5.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.77e-3)" "unprognostic (6.11e-2)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (2.60e-2)" "unprognostic (7.69e-2)" 8.1 8.8 6.9 11.5 8.6 45.9 11.2 11.9 9.3 8.7 10.6 8.3 7.3 9.8 7.1 8.9 7.7 8.1 5.2 6.2 7.0 7.9 10.0 8.8 15.4 7.1 6.6 5.5 11.1 9.4 10.2 4.3 11.9 7.8 8.7 10.0 9.7 6.7 7.4 5.6 12.6 7.3 9.5 6.6 13.6 8.9 21.3 6.7 21.8 9.2 7.6 14.6 8.8 7.2 15.4 14.4 25.3 18.3 14.2 16.1 15.2 20.3 12.5 16.5 18.4 19.8 15.2 17.0 24.0 3.9 21.0 16.0 13.3 19.2 14.2 21.9 37.9 15.9 29.3 26.5 9.0 13.0 38.6 22.1 16.6 13.1 22.6 29.9 18.8 18.8 21.0 17.9 32.7 15.7 9.7 27.9 11.0 28.4 12.3 7.9 25.7 47.5 11.4 8.8 32.6 7.0 20.5 24.5 11.0 13.0 25.0 11.9 24.0 26.0 12.0 17.0 13.6 21.1 11.5 13.6 53.7 15.5 16.5 18.0 64.5 21.8 44.4 31.4 25.0 32.3 27.1 24.6 25.9 22.8 32.0 26.3 22.8 63.0 35.8 28.9 32.0 20.9 22.5 6.9 8.6 11.9 9.3 6.2 7.0 7.1 6.6 5.5 7.8 6.6 6.7 15.4 53.1 64.1 61.6 61.7 80.6 33.0 22.2 30.1 48.9 69.0 35.3 27.9 38.2 31.5 39.0 35.0 116.7 48.8 103.3 51.3 3.9 37.4 96.8 60.2 72.8 51.6 69.7 51.3 71.7 31.6 34.7 47.2 39.8 99.8 54.4 106.9 42.8 30.9 30.2 87.5 59.1 40.0 40.7 52.5 37.5 32.5 48.4 63.9 26.6 57.1 82.9 48.3 105.0 68.3 85.9 38.7 37.0 55.7 73.1 32.4 33.6 11.8 40.2 71.9 59.2 64.0 59.9 137.1 104.8 50.1 47.6 71.1 80.1 67.5 40.1 42.0 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44758988-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 35.8;heart muscle: 9.9" "Cell type enhanced" "Detected in some" "Astrocytes: 10.7;Bipolar cells: 11.8;Cardiomyocytes: 18.0;Excitatory neurons: 47.1;Horizontal cells: 23.5;Inhibitory neurons: 23.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEK 293: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced NA NA 23000 "HPA074550: AB_2732259" "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 0.5 0.2 7.4 0.0 16.8 0.2 0.6 21.5 35.8 1.6 0.0 1.9 0.1 3.3 0.3 0.5 1.6 0.5 9.9 19.3 5.3 0.3 0.2 0.3 0.1 9.4 7.7 14.7 1.4 0.2 0.0 1.9 0.0 10.9 1.4 0.0 2.8 0.3 0.8 0.2 1.0 0.6 1.0 0.5 0.2 0.8 4.1 16.8 0.3 0.3 0.0 0.0 0.9 0.9 17.7 0.0 1.3 0.5 4.4 0.2 0.0 0.3 0.1 0.0 1.2 0.3 0.7 0.2 0.1 0.3 0.0 1.9 0.0 3.3 0.0 0.4 1.4 19.7 0.1 0.4 0.3 0.1 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.4 0.3 0.1 4.2 0.0 2.3 0.7 1.5 1.2 2.7 0.0 0.3 0.0 0.1 3.2 1.7 0.0 0.1 1.0 0.3 1.3 0.7 0.0 0.5 1.4 1.5 0.4 0.7 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.4 16.8 21.5 35.8 19.3 5.3 9.4 7.7 14.7 10.9 0.5 16.8 17.7 0.2 0.0 0.0 10.7 0.1 0.0 0.2 0.2 0.0 11.8 0.3 0.3 18.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.5 0.2 1.4 0.4 0.0 0.0 47.1 0.0 0.0 1.9 0.0 0.2 0.0 0.6 0.0 0.2 0.1 23.5 23.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 4.7 0.0 2.2 1.0 3.0 4.2 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.1 3.5 0.0 0.3 1.3 0.7 0.6 0.0 0.0 0.1 0.1 0.4 0.0 0.0 PPP2R3A "PPP2R3, PR130, PR72" ENSG00000073711 "Protein phosphatase 2 regulatory subunit B''alpha" Q06190 3 135965728-136147894 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 51.7;skeletal muscle: 182.2;tongue: 118.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3;Oligodendrocytes: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 37.4;BJ hTERT+: 35.3;RPTEC TERT1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035829, HPA035830, HPA065338" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475" "unprognostic (3.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.71e-1)" "unprognostic (4.04e-1)" "unprognostic (1.44e-4)" "unprognostic (9.43e-2)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (8.92e-2)" "prognostic favorable (1.15e-5)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.91e-4)" 3.1 3.4 3.3 2.3 6.9 0.2 7.2 4.0 6.1 5.2 3.6 6.6 2.0 7.8 5.2 8.4 4.1 5.1 51.7 4.2 4.8 22.2 1.1 4.0 0.6 5.4 5.6 3.1 5.6 3.4 11.8 1.9 2.8 6.5 5.9 5.5 2.6 8.9 6.5 182.2 19.0 2.4 9.7 4.2 1.1 7.4 7.2 5.0 0.6 3.1 118.6 1.2 4.6 4.0 13.9 37.4 2.0 10.3 5.0 8.1 10.2 11.9 28.5 35.3 13.2 16.3 2.4 2.4 0.1 10.7 29.3 9.5 4.7 4.3 10.0 28.3 0.1 1.4 1.6 1.0 0.1 5.8 0.0 1.4 9.3 8.5 16.8 7.8 13.3 12.8 1.0 1.0 0.1 19.2 6.2 0.3 0.2 7.2 0.4 6.9 0.1 15.1 0.1 46.2 1.4 0.7 5.7 4.7 5.7 10.9 9.2 9.1 0.5 8.4 13.7 7.5 18.8 12.7 0.4 1.0 0.1 10.1 0.8 4.9 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 3.3 6.9 4.0 6.1 4.2 4.8 5.4 5.6 3.1 6.5 4.2 5.0 13.9 7.9 28.9 27.6 51.6 2.8 26.4 19.5 7.1 19.4 5.7 19.9 15.5 115.3 8.6 10.0 55.2 0.0 10.9 6.7 25.3 21.5 20.6 8.4 9.9 19.0 11.4 13.1 0.4 35.2 9.9 15.4 14.8 21.9 16.1 3.8 15.7 8.6 2.9 2.5 3.3 47.2 6.9 6.1 2.4 9.8 10.7 24.5 3.2 28.4 13.1 9.6 8.9 2.1 72.4 201.1 17.2 10.6 18.4 1.5 17.8 21.7 40.1 8.1 2.6 6.6 29.0 14.0 10.1 18.6 15.3 33.2 10.4 3.4 6.7 8.9 15.6 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040505, HPA072965" Uncertain Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 230000 "Focal adhesion sites" "Nucleoplasm, Cytosol" "HPA040505: AB_10673300, HPA072965: " "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 149.7 21.4 27.8 39.2 29.7 0.5 58.1 28.0 37.6 45.1 19.9 78.5 13.2 106.1 26.5 47.2 56.2 66.3 67.5 28.4 31.5 55.9 109.2 48.3 15.4 34.2 27.8 25.4 44.0 20.8 18.5 13.2 117.4 31.3 69.7 33.6 29.8 22.8 119.0 49.3 11.8 29.5 156.9 29.6 37.9 46.8 15.6 28.1 7.0 36.2 70.2 6.7 78.5 29.3 37.4 22.8 18.9 101.6 46.8 163.7 133.7 84.6 148.4 95.2 172.3 107.9 34.1 17.6 0.1 49.4 153.1 33.8 9.6 80.1 11.1 128.3 0.2 22.6 31.9 83.1 40.3 209.6 0.4 12.6 129.4 23.5 95.3 125.4 78.5 91.2 16.8 0.6 153.4 131.7 28.0 7.7 0.5 64.3 0.2 51.3 3.9 103.8 0.4 60.9 20.6 6.2 130.5 157.8 35.0 37.7 103.3 30.1 1.1 115.2 134.5 92.4 108.2 56.0 22.6 29.4 0.6 30.9 0.2 33.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 29.7 28.0 37.6 28.4 31.5 34.2 27.8 25.4 31.3 29.6 28.1 37.4 152.7 76.9 42.0 116.5 1.0 18.6 150.6 15.5 13.6 39.5 33.8 41.4 65.8 24.3 25.6 40.5 37.5 74.8 2.3 0.2 31.3 48.5 68.2 20.1 141.7 110.4 0.0 2.7 13.7 33.2 178.1 103.9 3.6 40.2 58.3 31.6 110.3 82.3 10.4 15.2 16.1 0.5 4.1 8.9 19.5 27.9 74.9 4.4 46.2 29.0 4.8 52.3 1.0 41.2 92.0 27.6 0.1 174.9 4.5 40.0 0.0 44.7 10.1 56.0 151.2 83.4 174.1 4.1 16.2 2.2 8.1 102.6 7.9 12.3 0.4 37.0 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168915498-169031324 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 81.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.6;RT4: 1.6;TIME: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.0 0.0 0.3 0.1 0.3 0.0 0.6 0.3 0.5 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 81.5 0.0 0.1 0.9 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.0 6.3 0.2 0.0 0.0 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.4 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.2 0.2 0.9 0.5 0.2 0.3 0.3 0.2 0.2 0.0 41.7 44.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 19.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 16.5 0.1 0.0 1.8 0.0 2.7 0.8 0.0 0.0 6.6 0.0 0.0 24.0 0.0 0.0 20.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 9.1 0.0 3.8 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.6 0.2 0.0 0.6 DHRS9 "3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4" ENSG00000073737 "Dehydrogenase/reductase 9" Q9BPW9 2 169064789-169096167 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.1" "Cell type enhanced" "Detected in many" "Club cells: 229.3;Distal enterocytes: 261.2;Early spermatids: 153.2;Paneth cells: 299.9;Respiratory ciliated cells: 155.9;Syncytiotrophoblasts: 267.5;Urothelial cells: 249.2" "Cancer enhanced" "Detected in many" "pancreatic cancer: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 258.3;eosinophil: 99.2;neutrophil: 77.3" "Lineage enriched" "Detected in many" 10 "granulocytes: 258.3" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 22.8;HUVEC TERT2: 21.5;NB-4: 33.7;THP-1: 98.0;TIME: 49.9;U-2197: 31.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036491, HPA036667" Approved "Intracellular and membrane" NA NA "HPA036491: AB_10673498, HPA036667: AB_10670237" "unprognostic (1.15e-1)" "unprognostic (3.82e-3)" "unprognostic (1.15e-1)" "unprognostic (1.85e-1)" "unprognostic (4.80e-2)" "unprognostic (2.35e-1)" "unprognostic (3.24e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (3.62e-4)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.72e-1)" "unprognostic (3.23e-1)" "unprognostic (1.85e-2)" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.41e-1)" 6.7 0.2 2.0 12.6 2.8 8.6 5.1 3.0 2.8 4.3 2.4 71.1 2.0 1.2 0.9 28.4 1.0 5.8 30.5 2.5 2.4 0.3 3.1 7.1 20.4 3.6 3.0 1.9 0.7 0.4 0.2 0.4 2.8 4.4 0.9 46.7 1.3 6.1 0.5 0.3 2.5 5.8 4.3 4.9 7.7 10.9 11.4 2.7 2.2 0.3 0.8 27.0 17.7 10.2 4.5 0.0 0.7 0.0 0.0 2.5 10.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.0 6.5 1.7 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 8.9 1.0 0.4 0.5 1.3 6.1 22.8 21.5 0.0 1.0 0.0 0.0 0.0 0.1 33.7 0.0 0.3 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 98.0 49.9 0.1 0.2 31.4 0.2 0.1 0.0 0.0 0.8 18.9 0.0 258.3 21.0 99.2 0.0 25.0 0.6 6.5 0.0 0.0 21.6 5.0 0.1 0.0 77.3 0.4 5.1 1.6 0.0 5.9 2.0 2.8 3.0 2.8 2.5 2.4 3.6 3.0 1.9 4.4 4.9 2.7 4.5 0.3 0.0 1.3 0.0 1.4 1.7 19.3 72.4 0.0 0.0 0.1 0.4 24.4 0.0 229.3 0.0 0.0 2.5 0.0 261.2 0.0 4.6 153.2 0.5 0.0 0.6 1.8 0.8 0.2 25.3 1.3 1.5 7.7 0.1 91.0 0.0 0.0 0.6 25.0 0.0 0.2 51.6 36.7 10.2 38.8 45.5 1.2 16.6 0.0 19.7 3.5 3.9 0.0 0.0 0.2 68.6 299.9 0.4 6.4 6.5 1.5 0.1 155.9 0.1 6.6 0.2 10.9 1.1 0.6 0.3 1.4 267.5 3.8 0.0 8.2 249.2 CD5L "API6, Spalpha" ENSG00000073754 "CD5 molecule like" O43866 1 157830911-157898256 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 578.0" "Group enriched" "Detected in some" 36 "Hofbauer cells: 279.0;Kupffer cells: 567.0" "Cancer enriched" "Detected in some" 5 "liver cancer: 4.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA065686, HPA068384" Enhanced "Secreted to blood" NA NA 4030000000 4300000000 "HPA065686: AB_2685532, HPA068384: AB_2685979" "unprognostic (2.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "prognostic favorable (8.88e-5)" "unprognostic (1.73e-2)" "unprognostic (4.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.56e-1)" "unprognostic (5.95e-3)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" "unprognostic (3.63e-1)" 1.4 0.0 0.0 1.5 0.0 17.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 105.6 1.6 9.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 578.0 0.5 0.1 0.1 6.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 6.1 6.1 279.0 0.0 0.0 0.0 0.0 567.0 0.0 1.3 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.3 0.0 0.0 0.0 PTGS2 COX2 ENSG00000073756 "Prostaglandin-endoperoxide synthase 2" P35354 1 186671791-186680922 "Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 117.8;seminal vesicle: 128.6;urinary bladder: 164.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 16 "neutrophil: 11.7" "Lineage enriched" "Detected in single" 16 "granulocytes: 11.7" "Cell line enriched" "Detected in many" 4 "BJ hTERT+: 405.5" "Region enhanced" "Detected in many" "hippocampal formation: 15.1" "Low region specificity" "Detected in many" "CAB000113, HPA001335" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Vesicles" "CAB000113: , HPA001335: AB_1079712" "unprognostic (1.36e-3)" "unprognostic (9.97e-3)" "unprognostic (3.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (5.96e-2)" "unprognostic (9.50e-2)" "unprognostic (9.03e-3)" "unprognostic (2.81e-1)" "unprognostic (3.24e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (8.04e-3)" "unprognostic (4.38e-2)" "unprognostic (8.89e-2)" "unprognostic (3.74e-2)" 17.2 8.0 2.0 14.0 2.4 117.8 3.0 1.4 11.1 62.8 3.7 10.8 2.6 9.0 0.7 7.0 5.1 31.8 6.7 2.1 1.8 5.9 8.0 34.6 8.9 2.3 1.7 1.9 2.6 2.2 5.6 3.1 8.5 1.9 25.2 10.0 0.3 1.2 128.6 0.4 1.5 3.6 12.3 2.2 2.8 14.9 0.2 2.3 5.2 3.2 6.5 0.7 164.1 2.2 4.3 0.0 21.8 0.1 0.0 2.5 2.1 0.0 93.4 405.5 0.6 3.6 15.0 17.2 0.0 0.0 0.1 2.5 12.2 0.0 7.6 1.3 0.0 0.0 0.8 2.2 0.0 13.2 0.0 0.2 0.8 2.7 11.3 28.7 1.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 5.5 1.5 0.0 1.0 0.0 0.9 2.7 0.0 0.1 1.5 19.3 0.6 13.5 0.6 0.2 0.0 0.0 27.7 0.4 2.3 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 11.7 0.0 0.4 0.0 0.0 0.0 2.0 2.4 1.4 11.1 2.1 1.8 2.3 1.7 1.9 1.9 2.2 2.3 4.3 5.2 342.9 77.7 0.0 7.4 118.8 59.1 72.8 12.5 0.0 2.6 12.8 2.5 0.0 79.7 0.0 0.0 0.2 4.2 0.3 0.0 0.8 0.2 50.0 9.9 31.1 1.2 3.6 3.8 0.2 0.3 270.7 2.0 98.9 347.6 3.8 13.6 0.2 12.1 0.0 1.0 1.0 8.2 21.0 305.6 0.0 0.0 173.1 35.6 3.7 3.4 0.1 0.0 0.0 0.1 4.9 0.1 0.0 2.0 122.6 0.2 0.3 13.1 0.3 0.0 1.8 12.8 0.1 0.4 3.3 28.4 0.5 10.8 3.7 1.2 151.6 IGF2BP2 IMP-2 ENSG00000073792 "Insulin like growth factor 2 mRNA binding protein 2" Q9Y6M1 3 185643130-185825042 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 126.6;Glandular and luminal cells: 117.7;Rod photoreceptor cells: 176.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 263.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017126, HPA035145" Enhanced Enhanced Cytosol NA NA Cytosol "CAB017126: , HPA035145: AB_2674491" "unprognostic (7.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.12e-5)" "unprognostic (2.46e-3)" "unprognostic (8.25e-3)" "unprognostic (4.17e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (9.45e-2)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.94e-3)" 7.5 9.1 1.1 4.1 1.1 12.0 5.3 5.7 1.6 7.2 1.5 12.8 15.1 5.0 0.7 3.3 11.3 7.5 9.0 0.9 2.6 8.3 1.7 11.8 1.3 2.2 2.1 0.6 6.6 4.9 6.4 1.4 15.2 1.8 1.9 15.1 22.5 9.4 1.1 2.0 4.3 16.1 4.6 1.8 4.4 13.3 6.1 1.6 2.2 7.4 3.5 1.9 3.9 5.5 1.8 129.4 11.0 124.2 22.5 64.8 102.5 73.2 68.5 94.2 102.2 121.6 94.1 36.2 0.0 98.2 56.9 130.1 57.7 58.4 97.3 163.9 0.2 58.2 37.7 0.6 64.1 140.2 1.2 0.2 75.0 50.4 67.6 263.9 53.2 95.3 10.1 37.6 0.1 75.2 1.1 0.3 27.8 87.3 22.1 45.7 13.5 48.1 38.8 63.7 0.4 7.7 1.2 5.0 0.2 113.5 120.5 10.1 82.1 144.8 34.8 74.8 44.6 78.2 0.4 0.2 0.3 34.7 0.1 50.3 0.4 1.4 0.2 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.7 1.7 0.4 0.0 0.6 1.1 1.1 5.7 1.6 0.9 2.6 2.2 2.1 0.6 1.8 1.8 1.6 1.8 6.2 12.8 11.6 2.3 0.6 19.8 20.1 48.1 1.2 5.2 18.4 6.2 15.7 44.3 49.2 25.8 16.7 2.8 0.9 82.0 3.9 38.9 126.6 86.4 13.8 18.9 35.6 46.9 0.7 25.4 18.0 25.3 20.9 117.7 2.5 64.5 39.7 0.5 16.4 1.7 1.1 44.7 46.8 8.8 16.9 81.7 5.3 10.5 14.2 13.1 11.3 21.2 6.2 4.5 0.2 61.1 80.1 0.4 1.5 63.0 68.8 11.4 74.8 176.7 0.0 2.0 18.8 4.7 14.4 1.2 14.6 6.3 1.1 0.8 45.9 77.8 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489094 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favorable (1.11e-4)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 13.0 34.3 20.0 13.1 21.1 15.9 21.2 24.5 26.0 17.1 19.8 24.8 24.5 18.1 57.3 19.9 20.4 18.3 9.6 21.3 21.1 31.1 29.8 17.7 11.8 22.0 22.1 20.1 22.4 26.1 34.9 20.8 13.2 22.2 19.9 26.5 36.5 26.5 15.0 4.7 14.1 25.2 17.2 23.4 13.2 24.1 19.0 24.4 11.2 26.0 6.9 15.1 23.4 16.0 23.9 73.9 14.5 27.4 0.7 24.4 29.9 16.1 16.5 11.2 26.2 31.5 27.9 27.0 0.6 55.1 30.4 43.7 41.1 0.8 38.4 46.5 82.1 36.8 0.3 18.9 23.3 26.5 39.2 20.1 27.2 32.8 22.6 28.1 27.1 29.6 0.7 0.9 57.5 23.8 23.0 4.6 18.2 31.5 56.5 33.4 0.6 32.8 40.5 46.9 18.8 44.7 29.8 28.0 41.5 59.9 29.8 62.8 21.5 19.7 21.5 27.8 39.4 36.5 29.3 40.8 24.4 31.4 19.5 36.1 14.0 21.6 9.4 16.6 22.1 25.7 42.8 19.6 21.0 37.4 34.9 27.2 26.6 35.9 20.8 15.9 16.4 8.6 12.4 20.0 21.1 24.5 26.0 21.3 21.1 22.0 22.1 20.1 22.2 23.4 24.4 23.9 69.5 54.5 82.7 80.0 41.8 141.6 219.1 196.7 100.7 117.9 144.0 115.1 25.2 144.4 131.6 79.1 91.8 139.5 22.9 96.1 287.6 106.6 134.8 76.5 50.7 65.9 106.4 43.8 170.7 127.5 38.9 49.0 72.4 73.1 29.8 96.6 93.5 99.4 64.9 45.4 184.5 130.9 138.4 53.2 193.0 213.0 43.2 52.7 85.4 28.1 283.9 137.5 22.6 102.1 89.8 137.5 95.1 54.2 40.6 322.2 111.6 283.9 125.7 88.8 46.0 38.5 62.7 119.5 39.1 94.6 145.6 203.4 32.2 50.0 109.3 279.4 ST6GAL1 SIAT1 ENSG00000073849 "ST6 beta-galactoside alpha-2,6-sialyltransferase 1" P15907 3 186930325-187078553 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 500.0;lymphoid tissue: 149.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 237.3;Hepatic stellate cells: 258.5;Hepatocytes: 608.7;Microglial cells: 602.4" "Cancer enhanced" "Detected in all" "liver cancer: 70.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 250.6;U-266/70: 628.0;U-266/84: 887.9;U-698: 334.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015018, CAB016122" Supported "Secreted to blood" NA NA 15000000 3300000 "CAB015018: AB_629203, CAB016122: AB_627178" "unprognostic (5.85e-3)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.62e-1)" "unprognostic (2.64e-1)" "unprognostic (2.44e-2)" "unprognostic (1.38e-3)" "unprognostic (3.43e-2)" "unprognostic (3.17e-1)" "unprognostic (2.20e-1)" "unprognostic (3.99e-1)" "unprognostic (1.43e-1)" "unprognostic (1.91e-2)" "unprognostic (7.30e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-2)" 24.8 12.6 29.7 50.7 25.2 15.4 32.8 30.4 26.8 61.9 32.5 38.5 14.0 16.2 6.0 13.6 27.2 18.0 36.4 24.4 31.8 60.6 500.0 30.3 102.5 41.0 33.2 17.1 10.2 8.1 45.8 9.9 18.7 46.7 49.2 45.8 2.7 39.7 14.7 13.0 8.3 29.4 19.1 40.2 68.1 29.0 3.6 39.9 67.2 65.4 20.3 149.3 28.2 9.0 47.6 4.3 5.0 20.6 17.1 1.1 0.0 36.3 1.6 3.0 1.4 2.0 1.9 2.0 250.6 19.5 0.1 8.8 10.1 132.7 15.4 1.6 11.3 7.4 10.1 0.8 119.0 1.3 22.8 75.0 1.7 28.3 0.0 11.5 19.9 77.5 24.2 52.2 20.3 5.2 8.7 17.0 14.7 49.9 11.3 7.6 38.2 0.4 8.1 9.9 0.5 36.4 4.1 1.5 26.6 64.6 29.1 38.9 16.8 32.6 0.2 3.3 0.6 2.1 628.0 887.9 334.0 0.5 45.4 84.7 22.6 8.9 3.6 46.9 16.2 42.9 87.9 51.3 39.7 14.2 83.3 80.4 58.4 4.2 26.9 29.3 11.9 43.8 58.7 29.7 25.2 30.4 26.8 24.4 31.8 41.0 33.2 17.1 46.7 40.2 39.9 47.6 34.6 44.8 27.4 13.4 110.0 4.0 13.8 68.0 4.6 0.3 5.1 4.1 26.2 75.8 55.9 237.3 0.0 0.3 26.3 20.7 0.0 17.1 0.5 8.9 5.0 56.0 94.1 24.8 47.2 0.9 3.5 3.7 7.7 16.1 10.8 7.3 258.5 608.7 20.3 0.0 31.5 10.9 34.6 61.3 16.4 1.1 0.3 18.2 7.2 602.4 17.2 0.1 26.8 145.3 2.8 6.0 17.8 0.7 124.3 103.6 0.6 0.5 39.8 1.1 0.0 2.2 6.8 0.0 0.5 0.8 1.6 0.7 28.4 0.3 37.3 39.0 TBX21 "T-bet, TBLYM" ENSG00000073861 "T-box transcription factor 21" Q9UL17 17 47733236-47746122 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 11.2;lung: 3.3;lymphoid tissue: 11.8" "Cell type enhanced" "Detected in some" "dendritic cells: 92.8;NK-cells: 119.4;Plasma cells: 22.8;T-cells: 45.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 15.7;NK-cell: 14.3" "Group enriched" "Detected in many" 7 "NK-cells: 14.3;T-cells: 15.7" "Cell line enriched" "Detected in single" 113 "HDLM-2: 16.3" "Region enriched" "Detected in single" 27 "olfactory bulb: 22.1" "Region enriched" "Detected in single" 4 "olfactory bulb: 4.2" "CAB009524, CAB030043" Enhanced NA NA "CAB009524: AB_2200557, CAB030043: AB_1595503" "unprognostic (3.31e-3)" "unprognostic (3.17e-3)" "unprognostic (1.17e-2)" "unprognostic (5.35e-6)" "unprognostic (3.93e-1)" "unprognostic (2.56e-4)" "unprognostic (5.86e-4)" "unprognostic (6.90e-2)" "unprognostic (3.63e-3)" "unprognostic (6.26e-4)" "unprognostic (1.43e-1)" "unprognostic (1.93e-2)" "unprognostic (3.04e-4)" "unprognostic (7.92e-2)" "unprognostic (2.67e-1)" "unprognostic (9.19e-3)" "unprognostic (4.43e-3)" 0.7 0.4 0.3 1.9 0.3 11.2 0.4 0.3 0.4 0.4 0.5 0.5 1.0 0.3 0.4 0.3 0.4 0.8 0.3 0.2 0.3 0.5 1.2 3.3 7.5 0.4 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.4 0.5 0.0 0.6 0.2 0.5 0.2 1.6 0.4 0.3 11.8 1.2 0.4 0.5 1.0 0.7 0.2 2.2 0.7 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 3.6 2.0 3.1 8.9 0.0 0.5 0.4 7.8 0.2 14.3 0.0 0.1 0.1 2.4 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.3 0.2 0.3 0.3 0.5 0.4 1.1 0.0 0.6 0.0 7.6 0.0 0.0 0.0 0.6 0.0 0.6 0.9 1.3 1.5 0.0 0.0 0.0 0.1 92.8 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 1.3 0.1 0.0 0.0 0.2 1.1 0.2 2.5 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 1.9 0.0 1.9 0.8 0.0 119.4 0.0 0.1 0.0 0.0 0.0 22.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.8 0.1 0.1 0.0 45.6 0.0 0.0 0.0 FRY "13CDNA73, bA37E23.1, C13orf14, CG003" ENSG00000073910 "FRY microtubule binding protein" Q5TBA9 13 31846713-32299125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 26.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 185.6;Excitatory neurons: 259.2;Inhibitory neurons: 272.7;Oligodendrocyte precursor cells: 229.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;eosinophil: 11.8;neutrophil: 8.3" "Lineage enriched" "Detected in many" 10 "granulocytes: 11.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 12.3;RT4: 25.1;THP-1: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041635 Approved NA NA "HPA041635: AB_2677588" "unprognostic (4.09e-1)" "unprognostic (2.76e-1)" "unprognostic (2.95e-1)" "unprognostic (1.27e-1)" "unprognostic (5.19e-3)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-1)" "unprognostic (4.24e-2)" "unprognostic (5.07e-2)" "unprognostic (4.00e-2)" "prognostic favorable (9.60e-4)" "unprognostic (2.47e-2)" "unprognostic (2.89e-2)" "unprognostic (8.33e-3)" "unprognostic (2.25e-2)" 6.4 1.9 5.2 2.1 8.3 7.4 4.8 17.9 8.4 3.7 0.0 4.8 1.4 3.6 2.7 1.9 5.2 6.2 26.3 7.9 7.1 5.6 4.4 6.7 2.3 3.9 5.4 8.5 2.4 7.7 2.8 5.5 2.7 6.1 4.6 2.2 11.3 2.0 5.9 13.7 5.4 2.5 5.8 1.0 3.1 4.7 2.8 4.8 3.1 3.3 19.9 1.1 7.1 2.8 9.0 0.0 0.0 0.7 0.5 1.4 1.4 0.0 2.1 7.6 0.7 0.8 7.0 0.0 1.3 0.2 2.3 2.3 0.6 1.0 0.0 0.7 3.2 0.4 0.9 1.6 2.3 6.7 1.8 0.7 0.3 0.3 1.0 0.7 0.0 12.3 1.3 0.0 4.0 1.1 0.1 0.1 4.3 1.7 0.8 0.6 0.0 1.0 3.0 0.5 25.1 1.8 1.4 3.6 2.2 0.2 0.8 0.3 15.8 2.9 0.7 0.3 0.5 0.3 2.3 2.6 0.1 1.1 2.3 1.1 7.6 1.1 11.8 0.3 0.5 0.3 0.0 0.4 0.2 0.8 0.0 0.2 0.1 8.3 0.3 1.2 0.0 0.1 0.2 5.2 8.3 17.9 8.4 7.9 7.1 3.9 5.4 8.5 6.1 1.0 4.8 9.0 53.9 16.0 29.5 17.3 3.0 4.2 9.6 2.1 6.8 47.1 12.7 7.2 73.4 27.1 14.3 14.7 185.6 0.3 7.1 0.7 1.9 6.0 1.9 7.7 3.1 54.3 2.4 6.1 259.2 5.1 0.2 9.6 21.4 3.7 6.3 3.5 36.0 19.9 1.2 37.0 272.7 8.1 10.2 8.1 8.3 4.4 5.9 14.0 17.8 66.5 16.9 8.1 5.2 229.2 20.6 4.2 2.7 25.6 3.1 4.0 0.8 0.7 11.0 6.8 19.7 17.3 49.3 3.7 5.7 0.6 4.3 0.1 3.0 4.5 0.8 8.4 PICALM "CALM, CLTH" ENSG00000073921 "Phosphatidylinositol binding clathrin assembly protein" Q13492 11 85957175-86069882 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 500.3;Oligodendrocytes: 709.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 40.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019053, HPA019061" Enhanced Enhanced Vesicles NA NA 40000 Vesicles "HPA019053: AB_1855361, HPA019061: AB_1855362" "unprognostic (9.27e-3)" "unprognostic (7.29e-2)" "unprognostic (3.51e-1)" "unprognostic (6.83e-2)" "unprognostic (5.13e-2)" "unprognostic (1.93e-1)" "unprognostic (5.36e-3)" "unprognostic (9.02e-3)" "unprognostic (9.80e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.31e-1)" "prognostic favorable (2.02e-6)" "unprognostic (1.26e-2)" "unprognostic (5.21e-3)" "unprognostic (2.52e-1)" "unprognostic (1.02e-1)" 185.2 63.1 111.8 121.5 152.1 112.4 112.4 116.5 116.4 87.1 53.5 87.1 107.3 79.9 52.9 110.1 66.7 128.1 88.8 90.1 110.3 170.1 148.2 100.2 83.3 122.4 132.6 61.7 95.2 81.3 121.5 36.8 158.5 137.4 73.8 83.9 72.1 62.8 94.5 76.5 74.8 116.4 136.5 118.8 127.6 73.7 65.5 115.9 94.0 76.4 102.8 97.5 140.8 74.1 196.9 167.0 78.4 121.1 85.9 185.5 188.8 228.5 211.7 274.7 164.4 143.0 310.7 222.4 126.0 210.8 342.6 171.1 134.6 129.4 154.2 232.8 38.6 45.0 364.9 101.5 98.9 185.6 87.2 158.3 166.6 161.7 308.7 253.3 275.1 178.7 85.9 239.1 103.0 305.2 98.2 103.9 76.8 66.9 269.0 42.7 69.8 182.2 91.1 312.5 139.2 72.9 58.7 258.4 85.4 68.7 156.5 115.6 67.0 196.9 298.6 104.1 355.0 170.2 36.7 107.1 118.4 70.8 64.6 206.6 6.4 13.5 7.5 5.7 11.7 4.9 3.1 4.2 8.0 11.4 2.1 4.2 4.0 40.6 7.1 12.5 3.9 6.4 5.3 111.8 152.1 116.5 116.4 90.1 110.3 122.4 132.6 61.7 137.4 118.8 115.9 196.9 147.1 35.3 58.9 134.5 33.3 116.0 44.4 33.0 30.1 20.8 34.8 28.6 46.4 42.9 34.3 71.7 12.5 42.9 43.9 64.2 31.3 57.7 59.3 32.3 32.8 98.7 25.1 88.8 144.7 37.6 127.1 44.6 34.1 50.9 48.2 23.2 71.4 52.3 85.0 40.4 140.7 30.1 30.5 142.8 229.2 95.4 35.8 127.4 60.5 500.3 92.1 22.6 32.0 188.0 709.3 90.2 55.3 43.6 39.1 49.5 71.4 84.0 41.0 16.3 78.9 36.4 92.7 17.3 14.1 34.4 96.5 41.3 38.9 23.6 30.6 77.7 NSF "SEC18, SKD2" ENSG00000073969 "N-ethylmaleimide sensitive factor, vesicle fusing ATPase" P46459 17 46590669-46757464 "Enzymes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 276.3;Inhibitory neurons: 284.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003154, CAB009324, HPA071089" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 59000 Cytosol "Golgi apparatus" "CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343" "unprognostic (5.70e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.95e-2)" "unprognostic (5.48e-2)" "unprognostic (2.37e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (3.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.74e-1)" 13.2 20.4 22.5 8.1 33.9 5.8 12.6 10.8 62.0 12.4 0.0 15.5 4.9 11.9 7.3 21.8 9.8 8.0 11.3 38.0 34.5 12.0 13.8 11.7 9.7 39.4 18.8 36.1 7.1 23.1 15.4 43.4 7.7 43.9 12.5 14.0 63.6 18.5 5.9 39.2 16.4 16.2 6.4 4.2 15.0 15.7 16.8 31.4 8.0 12.0 13.6 10.0 13.3 14.4 97.4 11.7 25.4 16.6 1.2 9.6 13.4 13.5 15.6 18.2 14.7 14.3 17.5 0.1 28.5 27.3 34.8 15.3 2.0 18.9 5.8 23.9 10.1 24.6 1.0 17.4 24.2 14.3 0.8 6.1 12.3 7.8 29.8 12.3 7.8 23.4 7.0 19.4 15.0 32.9 22.8 19.4 7.5 9.4 36.0 29.9 13.7 16.1 26.7 16.7 24.0 15.2 17.2 23.1 0.1 11.1 17.5 28.5 35.1 19.3 41.2 14.4 22.0 23.7 32.0 19.9 16.4 11.5 15.2 29.7 9.3 11.5 6.6 6.1 9.8 6.7 5.4 6.2 8.1 12.6 6.1 5.1 6.1 4.8 5.9 10.8 5.0 9.4 7.5 22.5 33.9 10.8 62.0 38.0 34.5 39.4 18.8 36.1 43.9 4.2 31.4 97.4 16.3 9.6 11.3 54.9 28.2 4.0 3.6 6.7 6.2 106.6 14.0 10.0 8.1 7.2 10.9 22.0 87.6 13.0 18.8 32.3 11.7 12.4 45.2 8.3 19.7 11.5 30.5 8.6 276.3 16.2 14.4 10.9 13.7 11.2 9.5 8.2 11.0 19.3 18.8 43.7 284.7 26.3 24.4 29.9 10.9 45.8 5.9 20.5 10.6 69.3 35.4 24.5 8.2 98.5 71.8 13.7 17.4 8.6 21.7 9.0 18.5 14.7 8.7 89.9 0.0 10.6 12.9 40.6 31.4 9.5 5.7 18.5 14.8 18.3 20.6 8.6 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.0" "Cell type enhanced" "Detected in some" "Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: AB_2686677" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 1.5 1.0 2.1 0.9 1.6 0.0 1.4 1.4 1.2 4.0 0.5 2.8 0.4 4.8 1.2 0.8 2.9 2.1 1.7 0.9 1.5 0.9 0.4 2.1 0.3 2.3 1.6 0.9 11.0 0.3 0.1 1.8 0.8 1.7 3.0 0.6 0.0 1.4 1.1 0.9 2.6 1.6 1.9 1.5 0.8 1.6 2.4 1.9 1.3 1.0 0.4 0.3 3.1 2.5 1.0 0.0 10.3 20.1 5.5 3.2 4.0 0.0 5.8 1.8 2.4 2.4 0.0 0.5 0.0 0.9 5.2 0.9 0.3 4.3 0.2 1.9 0.0 2.1 0.4 6.1 0.2 3.8 0.0 1.2 2.3 0.0 13.1 0.0 2.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 1.6 4.3 0.1 2.2 3.5 0.0 0.0 2.0 2.1 3.8 0.0 0.2 4.3 0.1 0.0 5.1 0.0 17.9 2.5 0.0 0.0 0.1 0.0 7.4 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.6 1.4 1.2 0.9 1.5 2.3 1.6 0.9 1.7 1.5 1.9 1.0 0.3 0.0 0.0 39.5 0.0 2.0 0.1 0.5 0.6 0.0 0.1 0.9 1.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.3 6.1 0.5 0.0 0.0 0.7 0.2 0.1 10.4 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.5 2.1 25.1 0.1 0.0 2.8 0.0 0.0 1.0 3.0 0.3 1.0 0.0 30.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.0 3.4 0.1 3.6 0.1 1.7 0.0 0.0 7.9 0.0 0.1 CLASP1 "KIAA0622, MAST1" ENSG00000074054 "Cytoplasmic linker associated protein 1" Q7Z460 2 121337776-121649476 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 197.9;Excitatory neurons: 248.4;Inhibitory neurons: 212.5;Oligodendrocyte precursor cells: 233.2;Oligodendrocytes: 283.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065219 Uncertain NA NA "HPA065219: AB_2685436" "unprognostic (6.21e-2)" "unprognostic (6.26e-2)" "unprognostic (2.45e-1)" "unprognostic (2.06e-3)" "unprognostic (4.06e-2)" "unprognostic (3.94e-1)" "unprognostic (7.87e-2)" "unprognostic (1.59e-1)" "unprognostic (3.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.00e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.50e-4)" "unprognostic (1.02e-1)" "unprognostic (2.04e-1)" "unprognostic (5.41e-2)" "unprognostic (1.14e-1)" 12.7 12.7 16.8 8.2 17.9 17.4 12.0 27.2 20.7 11.9 12.6 11.5 6.3 12.0 11.8 11.3 11.4 9.0 20.6 17.8 18.7 10.0 11.7 9.9 10.4 16.7 13.3 15.7 16.0 10.2 11.3 11.6 9.1 16.9 11.2 7.0 44.2 9.3 11.5 43.0 15.1 9.8 10.8 10.7 11.5 9.6 18.9 16.7 13.3 13.4 27.8 9.7 11.8 12.0 17.1 15.6 14.1 36.2 21.4 26.0 25.6 11.0 16.9 20.6 16.7 19.4 22.0 10.1 24.3 13.1 18.1 17.1 13.1 26.1 32.2 20.4 30.4 9.6 45.1 18.3 24.9 21.0 20.9 21.7 23.7 24.5 22.7 54.1 18.3 18.9 14.4 29.2 26.9 24.6 13.9 23.8 20.4 21.7 5.8 14.1 30.7 18.3 17.6 19.2 21.9 21.0 26.9 19.6 10.1 17.5 22.3 6.4 14.9 21.3 21.7 21.5 12.6 12.1 15.7 16.5 24.1 17.2 18.9 33.8 1.7 0.8 0.9 1.9 0.8 1.5 0.8 1.0 1.1 0.8 0.8 1.1 1.1 0.9 5.7 1.1 1.0 0.9 0.9 16.8 17.9 27.2 20.7 17.8 18.7 16.7 13.3 15.7 16.9 10.7 16.7 17.1 21.8 22.4 12.8 197.9 12.1 10.7 10.0 14.0 22.2 35.0 12.7 10.4 43.6 11.5 13.1 12.9 45.9 6.6 27.1 7.3 5.9 11.8 31.4 19.6 14.7 17.5 9.0 20.6 248.4 6.0 4.4 13.8 9.7 22.6 14.5 22.1 42.1 21.9 7.7 62.2 212.5 6.2 14.2 14.1 6.9 47.6 28.6 12.0 8.8 131.2 12.9 29.4 46.4 233.2 283.4 11.9 7.4 56.8 21.9 8.1 5.6 7.9 17.6 57.0 6.6 20.6 15.2 14.3 23.4 16.3 11.8 3.7 17.6 10.3 6.6 9.6 MRPS34 "MGC2616, MRP-S12" ENSG00000074071 "Mitochondrial ribosomal protein S34" P82930 16 1771890-1773150 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 354.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042112 Supported Supported Mitochondria NA NA Mitochondria "HPA042112: AB_10796899" "unprognostic (2.02e-1)" "unprognostic (4.83e-2)" "unprognostic (6.79e-2)" "unprognostic (3.42e-2)" "unprognostic (2.27e-1)" "unprognostic (9.59e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (3.52e-1)" "unprognostic (1.37e-2)" "unprognostic (6.60e-2)" "unprognostic (3.18e-1)" "unprognostic (5.44e-2)" 38.3 85.1 12.6 8.3 12.2 15.0 39.2 16.0 30.4 37.5 5.8 52.7 17.7 41.7 1.8 74.8 38.4 3.9 57.7 12.1 12.2 53.6 84.5 33.3 9.6 17.4 13.2 12.1 32.8 86.1 7.6 43.6 6.1 16.1 44.6 3.0 1.5 52.3 9.8 88.9 61.0 49.3 3.0 15.8 59.9 56.4 22.5 14.3 6.7 35.5 6.3 4.4 44.3 44.0 17.9 72.4 77.1 10.6 26.9 9.1 10.7 86.5 75.8 14.9 26.2 20.2 51.7 40.7 89.1 120.7 9.6 14.9 82.3 15.7 37.3 4.0 63.2 354.6 63.9 68.2 56.3 19.9 116.7 63.3 9.8 17.5 16.1 7.1 11.8 20.4 45.1 105.7 18.6 7.5 113.3 63.1 209.4 101.5 19.1 229.5 137.9 51.9 201.0 10.2 19.4 132.2 100.6 85.8 42.4 82.5 2.9 54.9 46.5 51.9 28.2 88.9 37.1 62.8 154.8 116.9 141.9 22.1 65.3 36.1 68.6 185.4 108.3 144.9 172.6 153.3 189.3 160.0 154.2 205.6 224.2 150.2 135.6 40.6 165.1 153.9 192.1 204.7 189.6 12.6 12.2 16.0 30.4 12.1 12.2 17.4 13.2 12.1 16.1 15.8 14.3 17.9 72.0 38.5 31.7 13.1 92.5 100.3 60.8 132.6 103.6 45.6 108.8 127.9 59.9 101.5 77.3 97.5 10.4 181.3 87.9 170.1 250.5 116.1 5.9 65.3 82.8 59.6 91.1 90.6 10.1 182.5 181.9 66.2 105.0 66.2 36.1 75.6 65.3 168.1 173.3 55.5 12.0 174.0 109.9 96.1 66.2 11.6 72.7 74.8 81.8 8.4 108.8 87.8 110.2 11.6 17.1 155.4 153.4 70.0 183.8 94.0 265.6 261.8 43.1 38.2 19.7 48.2 73.7 30.9 49.2 192.3 120.6 68.4 83.2 140.7 232.3 75.7 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch receptor 3" Q9UM47 19 15159038-15200995 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 46000000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: AB_2678926" "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 68.6 5.4 14.2 10.5 14.3 0.2 50.9 10.0 21.5 45.6 9.7 14.9 5.6 40.2 17.1 74.9 36.1 23.7 34.4 8.3 10.4 17.6 3.2 38.6 9.2 14.8 14.0 5.6 19.1 10.8 12.8 10.4 60.3 16.6 22.2 4.3 0.5 24.6 16.7 30.0 81.1 14.4 17.0 6.9 15.1 11.7 3.8 13.8 34.4 32.6 25.4 10.5 26.5 55.6 14.5 13.0 8.1 66.3 30.3 9.2 7.3 29.8 10.2 0.4 0.4 0.3 15.6 13.4 0.4 7.7 18.9 0.1 15.1 12.1 0.2 0.6 0.1 3.1 0.4 12.4 3.5 4.5 0.0 1.2 8.4 7.3 15.5 1.6 0.6 0.8 4.6 0.5 0.6 1.2 66.9 15.9 0.1 38.8 11.2 0.0 0.1 3.7 0.3 0.0 41.2 1.9 21.4 0.1 37.8 0.0 19.6 40.3 0.1 0.0 1.9 21.0 0.3 0.1 0.1 0.7 0.0 45.7 0.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 14.2 14.3 10.0 21.5 8.3 10.4 14.8 14.0 5.6 16.6 6.9 13.8 14.5 39.6 9.6 1.5 5.9 0.4 24.1 7.8 17.8 4.6 0.4 41.5 30.7 60.7 0.0 28.5 16.5 0.0 20.2 1.0 0.0 5.9 14.8 0.5 4.8 13.5 32.0 0.0 0.0 0.6 0.0 3.9 24.2 2.0 11.8 0.0 5.9 4.2 0.0 2.8 0.0 0.3 0.3 6.1 10.4 12.3 0.1 9.0 4.1 17.8 13.1 0.7 0.8 0.0 0.0 0.2 0.9 0.1 11.7 0.0 13.0 0.1 0.0 4.2 0.8 414.2 131.6 317.0 0.9 1.2 72.1 72.2 31.5 2.0 1.2 0.2 36.0 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637794 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No 17000 Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 51.0 89.5 87.1 63.6 92.1 72.9 80.8 90.7 93.4 62.7 82.8 73.4 50.1 64.1 100.5 86.0 75.4 53.6 77.1 81.3 92.4 60.1 106.5 46.1 100.3 89.2 87.3 78.4 104.3 90.8 60.6 54.4 66.1 90.0 61.8 78.3 97.9 58.7 58.0 99.2 51.9 54.0 57.3 93.1 62.4 66.3 46.1 88.9 103.8 79.7 101.6 106.3 75.3 61.5 96.6 138.4 134.7 216.6 160.7 157.1 224.8 86.8 119.1 181.3 189.0 168.9 326.5 190.0 308.6 194.5 144.6 148.1 162.8 263.0 245.6 227.2 178.6 160.1 301.9 161.7 188.8 132.5 451.8 134.1 182.9 278.9 165.9 311.7 185.5 217.4 187.1 404.8 91.9 186.6 205.0 299.2 364.5 205.7 458.8 243.9 161.5 419.8 332.7 136.7 191.9 219.0 250.1 158.2 177.7 112.1 155.2 241.8 195.8 144.4 138.7 171.2 274.4 116.8 184.3 276.6 330.1 55.0 166.9 114.4 48.1 100.6 39.1 61.1 107.1 68.9 96.5 76.1 66.3 138.7 99.5 91.1 77.8 7.1 101.2 93.6 85.3 72.8 105.7 87.1 92.1 90.7 93.4 81.3 92.4 89.2 87.3 78.4 90.0 93.1 88.9 96.6 47.9 16.0 20.3 14.7 91.6 82.7 107.0 248.2 116.7 67.2 75.4 78.6 71.6 71.4 102.6 58.8 50.1 132.9 70.0 27.4 84.1 76.4 17.0 45.1 57.4 53.1 31.8 123.6 21.7 87.5 145.9 72.5 43.8 34.5 78.0 117.0 57.5 62.2 91.1 58.9 24.3 65.3 87.5 108.7 99.3 13.6 87.7 74.9 76.5 10.3 153.8 221.9 57.7 17.6 24.9 65.4 54.3 68.4 64.8 108.2 79.3 97.6 71.6 60.3 52.6 61.8 54.5 116.0 109.4 128.0 86.1 80.6 69.2 126.7 112.5 103.9 PPP2R2C "B55gamma, IMYPNO, MGC33570, PR52, PR55G" ENSG00000074211 "Protein phosphatase 2 regulatory subunit Bgamma" Q9Y2T4 4 6320578-6563600 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.3" "Group enriched" "Detected in many" 5 "Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, HPA060473" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291" "unprognostic (9.39e-2)" "unprognostic (7.10e-2)" "unprognostic (9.12e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (5.91e-2)" "unprognostic (2.70e-4)" "prognostic unfavorable (4.94e-4)" "unprognostic (1.77e-1)" "unprognostic (3.90e-1)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (1.36e-13)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.66e-3)" "unprognostic (9.90e-3)" 0.7 6.2 80.6 0.6 81.4 0.0 1.4 49.1 110.3 17.3 1.4 0.9 0.8 27.2 7.4 36.2 9.9 0.4 2.2 88.2 59.5 0.3 0.1 0.1 0.3 65.2 63.6 71.7 0.6 0.7 1.5 22.8 0.1 83.6 5.0 0.3 11.0 5.4 14.6 0.8 34.3 1.3 12.0 70.6 0.3 0.8 7.4 68.1 2.7 0.2 0.9 3.1 0.9 11.6 97.7 31.4 46.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 19.0 0.0 68.4 13.7 20.0 0.7 0.0 0.0 2.4 0.0 3.2 3.7 0.7 0.0 0.1 6.6 11.4 0.0 0.0 0.0 0.1 4.2 0.0 0.1 6.6 36.2 0.0 0.1 2.2 0.6 38.9 0.0 0.0 1.2 0.0 0.1 39.1 7.5 1.5 0.1 0.0 1.1 18.9 0.1 0.0 0.2 22.7 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.6 81.4 49.1 110.3 88.2 59.5 65.2 63.6 71.7 83.6 70.6 68.1 97.7 0.2 0.0 0.0 61.0 0.0 14.7 0.4 0.8 4.6 11.0 1.9 0.4 4.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 67.4 0.8 5.7 0.6 0.0 0.0 203.3 0.2 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.1 3.3 82.8 0.0 0.0 0.0 1.1 182.5 6.8 0.0 0.0 4.7 0.0 6.5 0.0 14.1 94.6 2.4 0.0 4.5 0.0 1.3 0.0 0.2 0.0 3.1 0.0 0.0 2.5 2.3 1.6 6.5 22.0 0.0 0.2 0.1 0.0 0.2 TEAD2 "ETF, TEF-4, TEF4" ENSG00000074219 "TEA domain transcription factor 2" Q15562 19 49340595-49362457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 51.1;Early spermatids: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "memory B-cell: 1.7;naive B-cell: 2.7" "Lineage enriched" "Detected in single" 27 "B-cells: 2.7" "Cell line enhanced" "Detected in many" "AF22: 135.3;AN3-CA: 147.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066292, HPA069963" Supported Nucleoplasm NA NA Nucleoplasm "HPA066292: AB_2685651, HPA069963: AB_2686222" "unprognostic (2.69e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (8.66e-4)" "unprognostic (2.91e-1)" "unprognostic (4.47e-3)" "unprognostic (1.11e-1)" "unprognostic (3.96e-3)" "unprognostic (1.24e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" 30.0 17.9 7.0 15.5 6.5 0.2 31.8 6.4 7.9 40.1 14.8 39.3 7.7 40.0 12.5 11.1 34.5 15.6 48.7 7.1 12.9 24.4 12.0 36.0 9.0 8.6 7.6 6.0 33.7 27.0 19.6 9.3 17.8 7.1 26.7 11.4 3.4 18.6 22.9 13.0 10.4 18.6 38.7 7.2 14.9 31.6 26.8 8.3 3.1 17.0 22.3 7.4 27.5 24.6 7.1 12.5 28.6 135.3 147.6 14.2 20.8 24.3 22.8 23.9 25.6 29.7 2.3 6.8 1.2 29.6 38.5 13.1 13.9 37.5 7.7 14.1 0.1 17.5 0.0 27.2 19.3 24.6 0.1 0.3 24.8 17.8 17.4 8.4 50.6 92.1 0.1 22.0 0.0 36.1 15.3 0.0 0.2 45.4 35.2 36.2 0.0 40.8 0.2 23.3 0.2 0.2 82.0 38.1 5.6 10.1 46.1 40.5 3.5 55.0 45.9 28.1 9.9 1.8 0.1 0.1 4.8 1.7 0.6 18.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 6.5 6.4 7.9 7.1 12.9 8.6 7.6 6.0 7.1 7.2 8.3 7.1 26.1 3.2 3.2 0.0 3.8 3.3 6.9 5.9 8.6 0.4 21.1 9.5 1.0 8.6 3.4 12.9 0.0 0.6 0.4 1.3 1.9 51.1 76.6 7.3 20.7 29.5 7.1 3.2 0.1 26.2 23.7 15.0 9.7 6.5 0.0 14.7 21.4 2.8 0.6 0.0 0.1 6.6 8.2 0.9 3.6 29.6 15.2 0.7 5.4 1.9 0.0 15.9 0.0 0.0 0.1 22.7 4.9 22.2 0.1 7.2 0.1 0.2 1.2 0.4 32.9 7.6 28.7 2.1 2.4 2.0 1.6 1.2 0.5 4.4 6.8 2.8 EED "HEED, WAIT-1" ENSG00000074266 "Embryonic ectoderm development" O75530 11 86244753-86278813 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012211, HPA060089, HPA061140" Supported Supported Nucleoplasm NA Yes Nucleoplasm "CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437" "unprognostic (7.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (1.80e-5)" "unprognostic (2.90e-1)" "unprognostic (1.32e-2)" "unprognostic (2.39e-1)" "unprognostic (2.31e-1)" "unprognostic (9.19e-3)" "prognostic unfavorable (1.36e-7)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic favorable (2.27e-5)" 9.3 9.0 13.9 16.5 14.0 9.3 11.6 15.9 15.3 13.1 13.7 12.3 12.2 11.6 15.3 12.8 10.7 9.4 8.6 13.8 13.7 10.2 12.0 8.5 29.1 13.8 13.8 13.1 12.2 10.6 9.1 9.5 14.6 14.0 11.8 12.0 16.6 10.4 10.7 10.6 12.2 11.7 10.3 13.8 14.6 11.0 10.4 13.8 18.0 10.8 11.2 32.3 13.1 12.2 14.7 34.2 37.8 40.9 16.8 22.6 20.2 47.0 49.2 22.6 46.3 46.8 121.0 64.4 79.8 50.6 15.8 44.2 41.4 48.7 26.8 43.2 79.7 22.7 51.4 38.7 36.3 19.8 54.2 33.4 12.4 18.0 46.8 20.1 17.5 20.9 34.7 58.8 16.2 39.0 55.2 51.5 55.4 30.4 107.8 18.4 56.2 49.1 38.8 29.1 55.4 27.5 22.4 63.5 29.6 14.5 29.1 49.2 22.6 19.0 48.1 44.1 70.0 43.2 9.2 32.1 63.9 13.7 46.6 36.8 31.0 9.1 15.0 25.4 15.3 22.1 45.0 33.2 32.0 13.9 47.3 26.4 29.6 3.9 19.3 16.8 9.2 58.6 19.1 13.9 14.0 15.9 15.3 13.8 13.7 13.8 13.8 13.1 14.0 13.8 13.8 14.7 15.4 6.4 9.3 28.1 32.7 25.6 11.6 27.5 25.0 26.4 13.3 11.8 9.5 11.5 15.4 7.3 18.8 45.2 31.0 16.1 19.6 14.5 7.7 17.6 17.1 16.6 7.2 15.8 35.0 10.2 36.8 14.8 16.3 15.5 15.9 15.0 13.2 11.4 16.9 32.0 45.6 12.8 12.2 14.5 32.5 3.6 22.7 15.2 19.6 37.5 30.4 11.5 25.7 31.2 38.9 11.9 11.1 17.3 17.6 11.9 11.7 8.6 21.3 18.3 6.6 14.3 24.5 18.7 20.0 16.9 16.8 24.9 31.6 17.5 15.0 20.9 CDHR2 "FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC" ENSG00000074276 "Cadherin related family member 2" Q9BYE9 5 176542511-176595974 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 278.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4" "Group enriched" "Detected in many" 14 "colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "Hep G2: 22.2" "Region enriched" "Detected in single" 6 "hypothalamus: 2.1" "Low region specificity" "Detected in all" "HPA012569, HPA017053" Enhanced NA NA 8800000 "HPA012569: AB_1845298, HPA017053: AB_1845297" "unprognostic (1.34e-2)" "unprognostic (8.90e-4)" "unprognostic (3.82e-2)" "unprognostic (8.51e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (6.66e-2)" "unprognostic (2.06e-3)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (7.66e-3)" "unprognostic (1.75e-1)" "prognostic favorable (9.29e-4)" "unprognostic (6.58e-2)" "unprognostic (3.55e-1)" "unprognostic (2.30e-2)" "unprognostic (1.42e-1)" 0.0 0.1 1.0 4.5 0.6 0.2 0.0 0.2 0.7 0.0 0.0 23.4 278.3 0.1 0.0 0.1 0.6 5.1 0.0 1.4 0.4 10.2 30.5 0.0 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.2 0.0 12.7 0.3 0.0 0.0 0.0 0.1 240.3 1.1 0.0 0.1 12.5 4.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.2 0.5 0.0 0.2 0.0 0.1 0.0 1.3 0.0 0.0 0.3 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.2 0.7 1.4 0.4 0.0 0.0 0.7 0.2 0.0 0.6 0.2 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 8.6 0.0 1.8 0.0 0.0 0.3 167.0 0.0 4.0 182.4 3.2 0.1 0.2 33.6 0.0 3.9 1.0 0.0 0.0 55.0 0.1 0.0 0.0 0.0 15.3 0.0 0.0 4.2 42.7 0.0 0.6 0.0 680.0 1.5 0.5 0.0 1.0 0.0 1.6 0.0 1.5 0.5 15.3 215.0 2.2 0.1 0.0 611.4 13.7 0.7 0.3 0.0 0.0 0.1 3.8 2.0 0.0 0.0 0.1 0.7 3.5 19.8 0.0 SNCB ENSG00000074317 "Synuclein beta" Q16143 5 176620082-176630556 "Human disease related genes, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "brain: 450.8;retina: 183.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 105.1;Excitatory neurons: 36.8;Horizontal cells: 50.5;Inhibitory neurons: 32.6;Rod photoreceptor cells: 49.7" "Cancer enriched" "Detected in some" 8 "glioma: 11.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 54.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002681, HPA035876" Enhanced Supported NA NA "CAB002681: , HPA035876: AB_10670592" "unprognostic (3.55e-2)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (3.41e-1)" "unprognostic (2.39e-1)" "unprognostic (2.29e-3)" "unprognostic (3.31e-1)" "unprognostic (5.41e-5)" "unprognostic (1.31e-3)" "unprognostic (8.57e-2)" "unprognostic (2.81e-1)" "unprognostic (8.42e-3)" 0.1 3.2 73.2 0.1 170.6 0.0 0.1 90.4 450.8 0.1 0.0 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.9 132.7 99.7 0.1 0.2 0.2 0.2 118.5 47.0 164.0 0.3 0.8 0.0 17.2 0.0 130.9 0.1 0.0 183.8 0.1 0.0 1.9 0.3 0.4 0.0 2.3 0.2 0.3 0.6 108.2 0.0 0.2 2.8 0.0 0.1 0.1 268.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.7 0.0 6.0 0.3 2.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 1.8 1.0 0.0 0.0 3.9 0.0 2.3 0.0 0.0 0.3 0.0 0.0 54.6 2.0 0.0 0.2 5.4 0.1 2.5 0.3 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 170.6 90.4 450.8 132.7 99.7 118.5 47.0 164.0 130.9 2.3 108.2 268.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 105.1 0.0 0.0 1.5 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 50.5 32.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.5 0.0 10.3 0.0 3.5 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18526951 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 296.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavorable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favorable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 40.4 56.1 42.8 32.5 43.6 61.3 57.2 44.7 51.2 45.2 47.4 49.9 43.1 40.6 56.8 57.2 49.7 36.8 68.8 43.3 45.6 70.8 62.9 44.2 43.2 44.1 44.1 43.4 45.0 45.8 61.9 36.8 61.9 43.9 43.5 59.5 43.9 46.8 41.5 77.7 46.6 43.8 43.3 45.0 34.2 45.8 56.0 43.5 46.3 52.9 83.7 57.9 47.4 42.5 48.1 51.3 79.1 73.7 51.1 82.2 85.4 63.7 77.1 103.0 92.2 90.3 54.3 27.5 65.5 49.2 86.4 103.7 77.0 74.0 70.3 102.0 95.4 87.7 41.1 38.6 79.7 106.3 64.6 69.8 75.0 139.9 48.6 131.6 102.2 76.8 68.4 66.9 55.2 112.7 85.7 45.7 66.8 45.1 115.6 81.5 37.0 72.5 54.7 63.6 68.8 52.2 88.6 75.7 61.6 101.1 77.1 59.7 64.8 43.1 63.0 38.0 126.4 59.4 37.2 76.0 56.9 64.5 34.2 80.5 187.8 69.8 155.7 50.4 81.6 52.4 78.5 48.0 54.0 66.1 69.2 51.5 54.9 123.6 57.9 114.3 54.5 84.4 91.1 42.8 43.6 44.7 51.2 43.3 45.6 44.1 44.1 43.4 43.9 45.0 43.5 48.1 63.0 64.1 57.5 22.9 44.4 42.6 81.5 159.2 26.7 41.0 39.2 42.2 68.0 42.9 90.4 44.1 25.0 191.9 34.2 85.5 125.2 112.4 48.0 58.4 36.0 54.4 61.6 74.5 29.1 101.3 107.7 48.6 32.6 48.9 44.9 46.2 47.2 36.0 79.6 37.0 28.4 65.0 156.6 45.2 33.6 21.2 56.2 51.6 56.9 26.2 82.3 86.1 54.6 32.2 32.8 132.7 76.2 43.2 47.0 103.0 72.2 126.8 113.4 43.3 46.0 44.7 81.2 177.6 153.7 32.8 48.4 296.1 38.1 91.5 47.8 97.4 NCBP3 "C17orf85, ELG, HSA277841" ENSG00000074356 "Nuclear cap binding subunit 3" Q53F19 17 3802158-3846246 "Predicted intracellular proteins" "Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008959, HPA013195" Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA008959: AB_2668184, HPA013195: AB_2668800" "unprognostic (1.39e-1)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (3.49e-3)" "unprognostic (1.97e-2)" "unprognostic (5.47e-2)" "unprognostic (2.53e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.23e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.90e-4)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-1)" "unprognostic (5.68e-2)" "unprognostic (5.36e-2)" 9.0 8.3 8.2 8.0 10.2 17.3 8.8 9.3 9.7 11.2 8.1 10.0 8.5 8.3 3.5 9.7 10.8 5.0 8.7 8.4 9.4 7.2 7.0 8.1 6.6 9.2 9.9 7.3 10.9 12.1 5.9 6.8 7.1 10.4 8.6 5.9 10.5 9.4 4.3 8.9 11.8 10.4 5.9 9.0 10.9 9.5 17.0 9.2 14.0 8.5 3.3 5.4 9.5 9.5 15.5 12.4 15.8 14.3 10.6 7.3 5.3 7.0 8.3 5.6 11.4 7.2 6.3 4.7 10.9 7.3 8.8 5.4 22.2 10.8 10.9 14.5 13.6 14.9 8.9 7.7 7.0 6.1 5.4 12.6 8.2 4.6 10.9 11.5 9.1 9.6 16.0 11.2 11.1 8.5 4.1 19.7 9.6 13.1 5.6 5.9 33.8 11.3 7.1 5.9 6.3 5.2 11.2 17.4 5.9 11.9 11.6 9.1 11.2 9.8 6.5 8.9 10.3 18.2 5.9 6.0 9.3 8.3 9.6 10.3 0.9 2.0 2.6 2.2 1.3 1.9 1.7 1.8 3.0 1.3 1.1 3.0 2.5 2.8 1.4 0.8 2.1 3.2 1.2 8.2 10.2 9.3 9.7 8.4 9.4 9.2 9.9 7.3 10.4 9.0 9.2 15.5 45.1 51.3 41.2 0.0 31.2 0.0 26.8 0.0 26.2 44.8 32.2 27.3 0.0 22.8 24.1 25.8 35.5 93.6 59.5 13.1 13.7 24.8 13.5 49.8 63.2 27.8 10.9 21.7 0.0 23.5 21.0 31.1 29.6 48.2 24.0 56.7 29.6 21.5 23.3 33.7 0.0 16.6 0.0 29.9 0.0 17.0 24.8 28.3 0.0 0.0 36.7 20.9 46.4 0.0 0.0 26.8 16.9 18.8 37.7 28.6 20.3 18.2 35.0 45.4 32.9 42.4 27.8 48.0 50.6 30.9 0.0 99.3 34.3 34.1 19.4 28.4 ATP2A3 SERCA3 ENSG00000074370 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3" Q93084 17 3923870-3964464 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 102.4;salivary gland: 186.9" "Cell type enhanced" "Detected in many" "B-cells: 82.5;Distal enterocytes: 120.7;Enteroendocrine cells: 97.8;Gastric mucus-secreting cells: 153.4;Intestinal goblet cells: 128.4;Plasma cells: 96.0;Undifferentiated cells: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 186.8;HMC-1: 266.1;JURKAT: 152.1;MOLT-4: 253.2;SK-BR-3: 195.2" "Region enriched" "Detected in all" 15 "cerebellum: 67.2" "Low region specificity" "Detected in all" "HPA007180, CAB010882" Approved NA NA 5400000 "CAB010882: AB_258368, HPA007180: AB_1845177" "unprognostic (4.14e-2)" "prognostic favorable (4.69e-5)" "unprognostic (1.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.02e-2)" "prognostic favorable (2.51e-4)" "unprognostic (8.83e-3)" "unprognostic (2.30e-1)" "unprognostic (8.29e-2)" "unprognostic (3.67e-3)" "unprognostic (3.95e-3)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (1.60e-1)" "unprognostic (3.25e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-3)" 6.8 13.8 6.0 62.8 7.2 99.1 7.8 19.8 5.1 5.9 15.5 55.5 31.0 9.1 1.6 9.8 6.1 13.9 7.8 2.8 3.9 8.7 4.7 22.6 102.4 2.4 11.8 1.2 3.1 64.6 2.2 2.5 2.8 8.4 20.5 33.3 0.2 186.9 19.8 3.4 25.4 75.9 6.4 1.7 99.0 93.6 2.1 11.4 98.4 11.8 3.3 59.2 17.1 7.3 2.4 0.3 7.6 0.3 6.8 0.0 0.0 0.3 0.4 0.9 0.2 0.6 2.5 1.7 186.8 11.0 0.6 0.1 0.8 3.1 0.0 0.0 23.5 2.1 98.0 6.0 0.1 1.7 108.0 266.1 0.2 0.0 0.7 0.0 0.1 0.3 152.1 20.1 117.1 0.1 116.8 253.2 115.5 1.2 53.1 1.6 27.5 0.2 43.3 0.0 3.3 11.5 3.4 1.5 195.2 0.2 1.1 12.2 26.3 0.5 0.0 2.1 0.4 0.1 43.4 14.2 66.0 2.5 75.6 0.1 16.0 1.4 33.7 10.8 0.9 8.3 9.8 6.7 10.3 1.6 11.4 4.8 6.0 13.1 3.8 0.5 15.8 6.4 6.7 6.0 7.2 19.8 5.1 2.8 3.9 2.4 11.8 1.2 8.4 1.7 11.4 2.4 7.1 0.0 1.9 0.7 82.5 0.9 0.4 0.7 1.2 0.0 4.7 1.7 3.8 2.8 2.7 23.9 0.0 0.2 59.2 120.7 0.0 1.3 0.1 0.3 0.4 7.8 97.8 22.5 0.5 12.1 0.3 1.9 153.4 0.3 33.0 0.2 8.9 1.0 2.8 0.0 0.6 128.4 36.7 3.1 2.5 0.2 0.0 17.8 12.4 5.6 5.0 0.2 28.8 0.0 0.3 25.2 50.3 0.7 96.0 4.2 14.0 0.4 2.7 0.2 0.0 1.0 3.4 0.0 1.5 0.4 0.3 0.0 38.4 0.4 65.6 4.6 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63381846 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" Lyase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 292.9;skin 1: 143.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 174.6;Distal enterocytes: 422.6;Paneth cells: 160.8;Squamous epithelial cells: 185.3;Suprabasal keratinocytes: 252.2;Undifferentiated cells: 138.8" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 213.0;ASC TERT1: 213.0;RT4: 226.2;SK-BR-3: 177.9;T-47d: 286.8;U-138 MG: 300.5;U-87 MG: 361.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008773, CAB025181, CAB062549, CAB068179, HPA073203" Enhanced NA NA 52000 "CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394, HPA073203: AB_2686580" "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 8.0 0.2 6.3 18.8 34.5 0.1 43.3 5.1 5.9 41.4 109.1 105.0 0.4 28.6 4.1 76.0 25.3 7.8 1.8 7.2 19.9 292.9 0.7 3.0 0.3 9.6 9.0 2.2 0.6 70.8 0.3 10.8 2.3 14.5 5.6 95.1 1.9 26.5 8.7 0.6 143.3 8.3 56.7 0.4 0.8 8.0 0.6 16.9 0.1 4.6 0.2 8.8 27.6 49.4 2.6 0.0 213.0 3.5 0.5 27.3 213.0 11.2 15.7 13.7 2.5 4.1 1.6 0.5 0.0 51.4 12.6 81.7 1.1 0.0 10.4 6.2 0.3 7.7 0.0 13.9 0.4 0.6 0.0 0.3 81.3 11.4 63.6 20.4 0.1 2.7 0.1 0.0 0.3 2.8 125.2 0.3 0.2 3.4 0.0 33.4 0.1 0.0 0.1 0.2 226.2 1.8 0.2 0.9 177.9 0.0 2.1 286.8 0.1 0.4 300.5 16.0 10.1 0.2 0.0 0.0 0.1 361.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 34.5 5.1 5.9 7.2 19.9 9.6 9.0 2.2 14.5 0.4 16.9 2.6 0.7 0.0 6.9 11.4 1.1 174.6 20.0 87.7 93.4 0.1 93.5 50.4 1.3 1.5 30.3 40.5 0.0 0.4 1.6 422.6 54.8 17.2 12.1 28.4 6.2 2.1 8.4 0.0 1.3 58.4 2.0 14.6 8.2 75.0 1.3 0.3 0.0 0.2 0.6 0.0 0.8 111.4 20.3 0.3 11.9 3.9 0.0 4.0 23.2 0.0 0.0 2.7 0.0 1.0 0.1 10.2 160.8 0.0 0.0 19.8 15.6 73.9 6.9 0.2 0.0 0.2 4.1 0.0 0.0 185.3 252.2 1.8 2.8 0.1 138.8 17.4 MGLL "HU-K5, MAGL, MGL" ENSG00000074416 "Monoglyceride lipase" Q99685 3 127689062-128052190 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 84.7;plasmacytoid DC: 89.8" "Group enriched" "Detected in all" 14 "dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7" "Cell line enhanced" "Detected in many" "BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011348, HPA011993, HPA011994" Enhanced Enhanced Nucleoplasm NA NA 100000 Nucleoplasm "HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (2.14e-1)" "unprognostic (8.19e-2)" "unprognostic (1.15e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (3.61e-2)" "unprognostic (1.45e-1)" "unprognostic (8.83e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (2.51e-1)" "unprognostic (2.11e-3)" 176.4 16.2 83.2 23.1 80.4 19.1 92.8 74.5 124.4 27.0 42.1 82.6 37.2 17.9 10.0 141.2 34.6 45.2 82.2 86.0 64.6 71.4 107.8 72.6 13.6 68.6 78.6 74.2 6.2 7.8 3.7 12.6 41.9 75.0 26.0 60.9 6.3 102.9 27.8 66.6 34.7 50.7 28.1 54.3 45.3 38.6 6.3 91.9 10.1 19.1 65.5 21.5 42.8 39.7 78.5 52.4 46.2 0.1 0.5 76.8 90.0 6.2 209.1 238.6 45.3 72.2 1.2 21.0 14.0 56.9 71.3 13.7 2.1 0.4 27.9 25.2 23.5 0.9 1.6 31.4 0.4 27.7 0.3 1.7 34.2 16.1 85.0 92.4 25.6 97.5 1.0 0.3 3.0 191.3 5.6 0.5 0.9 0.5 33.6 71.5 0.2 24.6 109.4 170.4 5.9 26.5 2.1 36.3 70.4 12.6 2.0 3.5 2.1 125.9 49.5 14.8 121.0 29.1 0.5 0.4 43.4 102.4 3.4 156.6 20.6 8.3 36.0 0.5 84.7 2.8 4.9 0.5 1.1 9.2 0.5 0.2 0.2 1.5 2.0 57.2 89.8 0.0 17.1 83.2 80.4 74.5 124.4 86.0 64.6 68.6 78.6 74.2 75.0 54.3 91.9 78.5 565.4 195.5 108.6 83.2 8.5 22.8 11.9 14.1 5.7 22.8 25.2 19.9 53.7 118.7 32.2 42.3 0.0 84.6 16.1 398.7 168.3 99.4 4.1 100.0 36.4 207.7 88.6 30.7 39.0 160.7 154.6 71.5 47.9 132.1 8.8 0.1 17.2 148.7 123.9 0.0 48.9 239.1 63.1 32.8 86.3 5.8 32.6 77.8 21.4 52.5 235.2 54.5 2.1 43.2 5.8 535.2 201.0 69.6 36.2 18.5 134.2 102.0 48.0 7.8 85.5 22.3 141.4 0.7 1.7 64.7 22.3 72.7 9.3 1.1 74.0 6.0 NTN4 ENSG00000074527 "Netrin 4" Q9HB63 12 95657807-95791189 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 183.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 198.6;Hepatic stellate cells: 369.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 513.8;hTERT-HME1: 205.8;PC-3: 189.6;TIME: 289.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049832 Approved "Secreted to extracellular matrix" NA NA "HPA049832: AB_2680905" "unprognostic (3.08e-1)" "unprognostic (2.17e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (2.85e-1)" "prognostic favorable (8.12e-9)" "unprognostic (3.52e-2)" "unprognostic (7.08e-2)" "unprognostic (1.93e-1)" "prognostic favorable (6.67e-5)" 22.2 17.5 7.2 5.7 7.6 0.1 73.7 5.2 10.7 26.7 13.5 16.7 12.1 12.8 15.4 15.8 34.7 22.6 67.5 8.8 7.9 108.6 26.9 70.9 2.9 6.4 9.4 7.3 86.9 63.1 13.4 7.6 12.0 6.6 42.7 18.3 0.6 32.8 59.7 12.7 8.5 17.6 15.2 6.6 183.1 49.2 12.2 5.8 6.3 14.6 20.0 6.5 49.9 14.5 9.2 26.7 71.3 2.0 0.1 28.5 45.0 3.0 49.7 513.8 67.1 78.2 56.1 48.8 0.0 3.5 105.3 88.1 42.2 0.6 15.3 34.0 0.0 4.3 2.3 12.7 11.1 1.7 0.0 0.1 1.1 43.5 75.0 205.8 72.9 133.3 0.4 0.0 0.1 25.4 20.0 0.2 0.3 1.1 7.9 189.6 0.2 0.6 0.1 64.8 133.4 0.3 0.6 60.5 77.1 1.3 2.3 22.2 0.1 289.3 25.9 9.5 101.3 5.2 0.1 0.1 0.0 5.9 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 7.6 5.2 10.7 8.8 7.9 6.4 9.4 7.3 6.6 6.6 5.8 9.2 31.9 41.7 123.2 6.2 3.8 4.7 120.5 15.2 39.3 1.8 77.6 55.4 44.8 44.3 30.8 198.6 0.0 6.2 1.3 4.4 5.9 36.7 10.3 36.4 3.2 35.5 0.0 2.7 28.1 28.0 3.6 33.7 23.0 28.1 1.3 25.9 369.5 10.2 0.4 0.0 70.6 37.2 4.1 26.3 3.7 3.8 2.1 2.6 7.2 20.6 0.6 0.3 0.0 112.6 1.8 36.7 4.0 3.4 0.9 108.9 1.5 84.3 38.0 0.2 26.3 119.0 73.9 1.9 0.6 5.9 2.3 1.6 3.3 1.4 6.4 127.0 BCS1L "BCS, BJS, h-BCS, Hs.6719" ENSG00000074582 "BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone" Q9Y276 2 218658764-218663443 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Deafness, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037700, HPA037701" Supported NA NA "HPA037700: AB_10794619, HPA037701: AB_10805235" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (6.28e-2)" "unprognostic (4.99e-2)" "unprognostic (6.44e-2)" "unprognostic (4.31e-1)" "unprognostic (4.25e-2)" "unprognostic (2.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.83e-2)" "unprognostic (1.21e-2)" "unprognostic (6.02e-2)" "unprognostic (3.47e-3)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" "unprognostic (8.38e-2)" "prognostic favorable (3.31e-4)" 19.8 29.5 24.8 11.6 25.7 12.5 21.5 25.8 26.1 24.8 24.4 21.9 16.1 21.8 14.4 28.4 20.5 10.9 34.7 25.0 26.0 30.6 40.2 16.4 15.6 26.1 26.1 24.5 25.4 41.5 18.0 17.5 11.9 26.8 27.4 16.6 13.7 20.9 17.6 32.3 22.7 21.1 17.0 25.2 24.4 26.0 10.2 25.6 9.9 22.3 22.7 14.5 25.8 23.7 27.4 17.1 34.3 19.3 26.8 42.8 28.6 28.9 28.4 15.7 44.9 32.9 92.1 28.0 25.2 40.4 29.1 30.3 46.2 63.0 73.1 25.4 37.2 67.9 40.4 45.5 76.0 49.4 35.6 24.4 36.6 55.0 61.1 79.5 18.4 46.0 35.3 58.3 35.6 41.1 57.7 26.6 48.2 23.7 39.9 43.5 38.3 23.8 40.0 37.6 31.1 41.1 17.9 20.1 48.2 36.9 30.4 25.4 34.9 26.7 33.3 27.7 22.3 39.5 28.1 23.2 43.2 21.1 54.2 32.6 20.1 12.2 10.5 10.3 7.7 11.7 13.5 8.1 9.7 24.6 12.8 9.9 11.9 1.4 7.7 1.1 13.7 13.4 10.2 24.8 25.7 25.8 26.1 25.0 26.0 26.1 26.1 24.5 26.8 25.2 25.6 27.4 16.0 9.6 7.5 6.5 6.4 10.6 15.2 29.9 8.6 13.3 13.0 16.0 32.7 20.0 18.3 5.5 6.2 31.4 5.4 9.2 21.5 18.1 1.3 9.2 15.4 13.7 6.1 7.8 3.8 10.1 18.0 13.8 11.2 10.8 11.4 14.6 10.4 11.8 17.4 6.7 3.9 11.0 20.3 5.0 9.0 2.2 9.0 6.6 14.2 2.8 9.2 12.1 11.3 8.0 6.9 11.4 12.7 15.4 9.8 11.6 13.1 22.2 10.7 15.9 6.6 14.7 19.4 5.5 11.6 16.6 9.9 14.5 6.4 18.8 17.0 12.9 NUAK1 "ARK5, KIAA0537" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063345-106138954 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 58.0;EFO-21: 55.1;RH-30: 77.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" Yes No "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: AB_2683349" "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavorable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 15.4 3.7 8.5 2.4 19.4 0.6 12.2 11.2 25.7 9.5 3.6 4.1 2.2 9.5 3.1 3.6 9.0 5.0 18.9 16.7 9.2 4.2 4.0 9.4 3.2 8.4 8.1 15.1 6.1 3.2 17.7 2.7 4.5 12.4 6.0 4.0 5.4 3.4 6.0 20.8 21.0 4.3 10.3 6.0 0.8 3.8 2.7 7.2 3.3 4.3 17.4 2.3 4.8 8.2 33.4 13.0 8.3 58.0 0.6 23.7 2.5 27.0 14.2 9.5 9.9 8.0 4.3 2.1 0.0 55.1 27.4 5.0 11.9 12.6 11.2 4.8 0.2 3.4 0.0 9.7 4.7 5.0 0.1 0.1 11.0 8.1 6.0 1.7 19.2 21.2 0.1 0.0 40.3 7.8 1.3 0.2 0.6 11.1 0.2 3.3 0.1 77.7 10.5 6.6 13.3 6.8 0.4 6.9 1.9 0.5 37.2 2.9 0.4 16.6 9.4 29.7 3.3 17.0 0.0 0.0 0.7 2.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.5 19.4 11.2 25.7 16.7 9.2 8.4 8.1 15.1 12.4 6.0 7.2 33.4 56.4 0.0 2.4 15.7 0.6 13.5 32.9 29.8 10.2 32.3 2.1 4.2 48.9 10.0 7.2 7.3 0.0 0.8 13.5 0.9 3.9 6.2 0.4 5.1 6.6 111.7 0.0 5.3 150.5 9.6 5.2 17.9 2.0 3.8 0.0 2.9 136.3 12.1 8.0 40.4 55.4 2.3 12.2 8.4 8.8 2.6 4.1 1.3 10.6 93.7 0.6 1.9 1.0 15.6 73.5 18.4 0.5 3.0 3.2 10.6 0.2 1.8 2.2 2.9 0.0 7.1 26.4 1.0 5.5 2.5 15.9 0.3 2.7 0.4 0.8 5.2 DPP8 "DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141" ENSG00000074603 "Dipeptidyl peptidase 8" Q6V1X1 15 65442463-65517704 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008706 Approved Supported Cytosol NA NA Cytosol "HPA008706: AB_1078665" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-2)" "unprognostic (2.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (4.09e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (7.58e-2)" "unprognostic (8.56e-2)" "unprognostic (2.59e-1)" 12.8 10.3 8.2 12.2 8.8 15.1 12.0 9.6 11.4 11.9 5.6 11.5 14.6 11.8 9.8 10.1 8.4 9.8 15.0 7.9 9.0 12.8 8.0 11.2 13.0 9.1 9.0 7.2 10.9 7.4 15.3 5.7 11.3 8.2 10.9 13.0 15.5 9.6 11.6 27.8 9.8 13.7 13.2 7.6 14.9 11.1 26.3 9.9 13.9 14.2 30.8 11.4 11.3 8.3 10.3 14.1 24.4 15.7 15.8 17.4 25.2 12.8 22.5 28.4 21.1 20.3 10.6 12.6 25.1 16.3 30.3 14.5 25.9 30.6 17.6 26.0 20.9 17.2 24.2 18.1 10.4 17.9 34.3 23.8 18.6 18.3 17.0 16.0 18.5 23.2 19.2 16.4 24.1 26.5 12.5 17.1 12.0 9.9 15.7 11.1 22.6 27.9 24.7 19.8 32.7 10.5 17.0 14.3 15.8 25.3 15.6 14.4 22.5 28.6 28.2 19.2 12.7 25.5 26.9 42.2 25.8 21.3 32.8 20.4 30.5 11.7 15.1 12.1 11.7 12.6 11.8 10.0 11.2 10.9 12.2 9.5 10.6 20.9 8.2 15.8 8.6 11.3 7.2 8.2 8.8 9.6 11.4 7.9 9.0 9.1 9.0 7.2 8.2 7.6 9.9 10.3 39.1 35.3 27.9 65.6 30.0 13.4 15.0 20.4 15.9 24.1 21.1 14.2 43.4 21.5 25.4 14.7 37.5 20.4 35.3 25.8 23.5 22.7 57.4 17.3 19.3 39.5 25.9 17.9 50.1 30.0 15.2 22.3 31.1 17.5 27.8 24.7 46.1 18.2 21.5 28.6 58.6 27.0 16.2 36.0 15.1 59.7 29.2 31.9 23.2 38.4 47.6 32.3 45.3 36.2 57.1 38.4 25.8 29.3 24.7 19.3 24.2 27.5 25.9 28.1 19.7 29.9 22.1 69.3 24.4 21.9 20.2 17.6 28.5 46.5 26.7 23.6 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 35 "retina: 195.2" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 338.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039370 Enhanced Approved Microtubules NA NA Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favorable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 4.0 3.1 2.1 2.0 2.4 1.9 4.9 5.5 2.6 4.9 2.6 2.6 2.3 3.8 4.7 2.4 5.2 3.8 1.5 2.2 2.5 3.8 2.9 3.1 3.3 2.4 2.1 1.9 5.4 3.0 3.8 2.7 3.6 2.8 3.3 2.5 195.2 2.7 3.1 1.0 5.1 3.0 2.9 2.4 4.0 2.6 4.2 2.2 2.4 5.2 1.3 1.9 3.0 3.2 2.6 1.5 3.0 3.2 2.9 4.7 7.9 4.0 3.7 4.2 3.7 2.4 1.4 6.5 2.1 12.4 3.7 1.3 4.1 3.9 4.2 2.1 2.2 2.8 4.6 2.5 6.8 6.8 3.1 6.0 6.7 5.9 2.1 12.3 5.1 6.4 4.8 5.0 7.0 6.0 6.4 2.0 2.8 4.1 13.5 1.2 2.0 1.0 1.4 5.6 6.0 1.5 2.1 1.0 2.8 8.0 4.4 6.0 4.2 9.3 3.7 3.7 1.4 2.6 2.8 5.5 2.4 3.9 6.4 3.1 2.6 0.4 0.7 0.4 0.4 0.5 0.4 0.4 0.4 0.3 1.0 0.3 0.4 0.6 0.8 0.2 0.8 0.1 0.1 2.1 2.4 5.5 2.6 2.2 2.5 2.4 2.1 1.9 2.8 2.4 2.2 2.6 4.0 6.4 5.1 5.2 3.4 1.5 1.4 1.2 1.8 29.8 3.5 2.8 2.3 0.0 3.8 0.0 27.1 4.2 1.6 2.9 0.0 1.5 1.6 6.3 5.4 15.6 1.8 1.7 2.2 1.3 2.7 2.6 4.1 7.9 2.5 4.7 3.6 1.4 1.9 20.2 2.0 2.5 2.0 3.1 1.6 2.5 3.1 2.7 1.8 4.7 1.2 26.1 2.1 3.0 1.4 2.6 0.5 2.2 3.3 1.4 2.6 0.7 4.1 338.3 0.0 3.4 2.5 20.3 10.1 2.9 1.0 2.5 2.5 8.3 2.6 0.9 ZNF532 FLJ10697 ENSG00000074657 "Zinc finger protein 532" Q9HCE3 18 58862600-58986480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 90.1;Excitatory neurons: 86.9;Inhibitory neurons: 90.9;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 178.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015322 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015322: AB_2304947" "unprognostic (3.43e-1)" "unprognostic (4.36e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.46e-5)" "unprognostic (4.24e-1)" "unprognostic (5.84e-2)" "unprognostic (1.50e-3)" "unprognostic (7.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.09e-3)" "unprognostic (1.90e-1)" "unprognostic (7.60e-3)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (5.76e-4)" 24.2 12.7 35.1 15.8 48.2 1.4 18.1 69.1 38.1 29.5 12.2 20.7 7.2 65.7 20.2 22.5 26.5 24.7 36.3 31.6 56.0 12.6 4.2 20.1 14.4 54.5 43.6 24.3 53.3 6.8 16.4 15.8 26.6 55.9 48.4 13.4 25.9 16.0 34.5 61.6 16.7 12.1 41.8 38.7 17.2 12.9 24.5 43.2 12.0 25.0 50.3 17.6 23.2 21.5 84.6 21.3 30.0 118.8 63.4 18.5 42.2 5.8 37.6 35.2 26.0 23.4 10.2 23.0 26.5 28.3 47.2 12.9 34.1 1.0 29.7 26.7 19.5 25.0 0.0 51.8 0.6 24.5 0.2 0.2 33.1 54.5 27.2 49.5 34.4 28.8 0.0 0.3 31.9 30.8 0.0 0.2 0.3 63.0 1.0 19.9 0.6 31.6 4.2 18.1 2.8 27.1 70.3 24.2 2.6 40.8 78.8 30.3 17.3 22.0 70.7 50.1 0.5 30.7 0.4 21.7 7.3 24.0 0.0 55.2 0.0 0.3 0.0 0.4 1.1 0.1 3.7 0.2 0.2 0.7 1.6 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.4 35.1 48.2 69.1 38.1 31.6 56.0 54.5 43.6 24.3 55.9 38.7 43.2 84.6 16.6 12.8 12.2 90.1 13.2 10.6 12.5 8.0 12.0 28.8 9.3 8.8 17.0 5.7 10.1 1.8 27.1 2.0 1.4 0.3 0.0 4.9 4.9 8.3 48.3 24.2 4.2 0.0 86.9 0.5 2.7 17.9 3.1 10.0 0.0 15.8 14.6 0.1 4.4 35.3 90.9 0.2 4.1 9.1 14.3 3.5 11.5 9.2 8.8 53.4 5.2 22.1 0.0 130.2 178.2 6.0 1.4 18.0 8.6 33.5 0.0 1.6 8.8 9.7 13.1 15.5 24.2 5.5 17.2 8.9 9.2 3.4 4.3 5.0 0.3 11.9 SCARF1 "KIAA0149, SREC, SREC1" ENSG00000074660 "Scavenger receptor class F member 1" Q14162 17 1633858-1645744 "Predicted intracellular proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.8" "Cell type enhanced" "Detected in many" "Adipocytes: 65.9;Endothelial cells: 51.3;Hepatic stellate cells: 62.4;Langerhans cells: 37.7;Microglial cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 12.1;REH: 11.5;TIME: 37.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035108, HPA072936" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 2000000 "Golgi apparatus" "HPA035108: AB_10670289, HPA072936: AB_2686559" "unprognostic (1.94e-1)" "unprognostic (2.84e-1)" "unprognostic (2.53e-3)" "unprognostic (2.88e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (3.76e-1)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.22e-2)" "unprognostic (1.38e-1)" "unprognostic (6.39e-2)" 14.9 5.1 1.9 3.2 2.1 0.4 12.8 1.7 3.5 5.6 1.7 4.5 0.0 6.1 0.9 2.7 6.6 2.2 9.5 1.9 1.9 7.5 7.6 16.5 2.1 3.1 2.0 1.8 2.6 3.1 0.1 3.9 4.4 2.5 4.6 1.2 0.2 4.2 0.0 5.3 3.1 5.4 1.2 2.0 25.8 4.3 1.6 2.2 0.5 18.9 1.9 1.0 5.6 4.7 3.1 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.3 12.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 11.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.3 37.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.9 2.1 1.7 3.5 1.9 1.9 3.1 2.0 1.8 2.5 2.0 2.2 3.1 65.9 22.4 17.6 6.5 0.6 3.4 0.4 0.7 1.2 1.2 0.8 0.9 3.5 0.0 2.9 3.7 4.2 0.4 2.0 4.9 1.9 0.4 0.3 0.5 0.9 51.3 0.0 3.4 5.4 0.2 0.2 2.5 4.1 1.1 3.8 0.3 62.4 2.3 9.0 0.0 3.5 4.4 0.0 15.7 37.7 0.4 1.2 10.1 3.6 26.2 4.8 0.7 0.0 0.5 1.1 0.3 1.2 1.2 0.0 0.7 3.0 0.2 3.0 2.0 0.0 2.1 3.0 0.5 0.6 0.3 2.7 1.2 1.0 1.3 2.2 0.8 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359265 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 502.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Supported "Endoplasmic reticulum,Vesicles" NA NA 18000000 Vesicles "Endoplasmic reticulum" "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 36.3 43.7 16.2 39.7 17.6 21.9 44.3 18.5 19.6 66.5 21.5 34.4 46.1 46.6 53.3 31.4 49.2 32.2 43.0 15.3 26.9 65.1 182.6 33.9 28.6 18.9 17.8 13.7 43.7 53.6 74.9 32.9 55.2 18.6 59.0 39.7 40.3 69.6 44.1 33.7 20.5 49.5 38.0 17.9 27.6 59.9 21.4 17.6 32.4 87.3 41.5 35.1 40.5 21.4 22.1 90.6 52.7 55.1 46.4 125.6 215.6 110.7 159.6 227.9 105.7 140.5 52.7 85.2 16.0 110.7 191.0 75.7 108.1 79.0 90.5 191.0 61.7 50.4 52.5 65.4 109.5 148.9 183.6 77.0 144.7 106.8 102.5 208.1 198.1 108.1 54.3 89.7 173.6 104.2 24.5 53.5 37.9 37.8 45.8 64.5 60.0 100.1 176.0 58.9 67.6 37.5 40.9 80.6 78.0 91.6 76.8 57.8 70.8 89.8 170.5 59.9 55.2 94.0 131.6 71.3 76.2 179.1 96.0 142.6 6.0 2.5 0.7 7.3 3.7 10.0 7.1 7.9 7.7 3.5 5.1 7.5 7.7 0.3 10.0 2.1 8.8 9.6 4.0 16.2 17.6 18.5 19.6 15.3 26.9 18.9 17.8 13.7 18.6 17.9 17.6 22.1 120.0 102.5 97.1 15.0 104.0 69.8 120.3 213.5 84.8 39.2 104.5 97.2 134.6 71.4 171.2 80.9 106.3 149.3 86.7 32.8 21.5 130.6 28.1 117.5 203.7 97.7 51.6 49.6 17.2 84.6 304.8 162.4 106.0 200.7 33.6 96.9 75.0 394.0 80.2 58.9 22.1 181.4 107.8 41.9 40.1 10.3 110.6 52.5 67.6 22.5 53.5 76.8 54.6 20.1 33.5 71.6 45.5 85.4 502.1 214.1 95.5 75.6 164.7 66.7 65.7 95.4 142.3 47.2 65.1 80.7 57.0 231.2 69.5 149.6 89.7 129.5 HACD3 "B-ind1, HSPC121, PTPLAD1" ENSG00000074696 "3-hydroxyacyl-CoA dehydratase 3" Q9P035 15 65530418-65578349 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014837, HPA060347" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA014837: AB_1855914, HPA060347: AB_2684260" "unprognostic (1.51e-2)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.52e-1)" "unprognostic (1.92e-2)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (3.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.57e-1)" "prognostic favorable (3.09e-5)" "unprognostic (3.44e-2)" "unprognostic (5.33e-2)" "unprognostic (1.10e-2)" "unprognostic (2.04e-2)" 23.3 84.9 59.4 18.7 56.6 17.5 75.2 65.0 68.1 40.5 65.4 30.3 29.2 30.1 43.4 19.4 32.7 34.4 11.9 53.5 79.5 80.3 120.1 30.5 19.0 68.1 73.3 52.5 48.2 30.1 62.0 44.5 37.5 77.7 41.9 34.6 54.5 28.8 34.7 6.9 27.9 29.5 28.3 64.0 21.3 69.4 34.9 82.1 29.2 71.4 7.8 20.5 43.4 18.0 75.9 88.9 194.4 211.3 106.2 130.3 78.0 99.8 95.9 82.4 106.6 119.6 149.9 129.1 110.8 81.8 104.7 132.6 237.9 344.4 80.1 94.8 61.9 191.8 88.1 88.7 165.3 65.9 110.6 64.9 80.3 58.7 73.3 52.5 102.7 105.5 65.1 117.5 40.8 174.3 105.6 82.5 86.0 180.6 235.3 65.4 91.8 178.9 125.0 152.1 151.2 126.8 111.9 103.6 114.9 110.5 197.5 117.1 57.9 84.2 134.4 117.6 66.9 134.9 79.1 251.2 154.5 89.7 105.8 82.6 8.5 7.5 2.5 31.7 11.2 36.1 23.7 28.6 30.2 13.2 22.2 33.0 32.9 1.0 23.2 12.7 17.4 24.6 22.7 59.4 56.6 65.0 68.1 53.5 79.5 68.1 73.3 52.5 77.7 64.0 82.1 75.9 63.6 64.1 64.8 84.5 18.7 0.0 60.5 0.0 76.2 121.3 94.8 64.5 9.9 62.9 27.9 176.6 100.1 189.1 23.8 6.1 25.4 71.3 107.2 62.8 76.2 51.8 43.7 67.3 57.5 46.3 124.4 62.7 73.4 39.8 16.4 127.0 42.1 165.2 51.2 139.7 97.1 26.3 0.0 23.1 0.0 32.5 87.3 22.2 0.0 29.0 5.2 89.8 16.5 57.8 66.7 32.1 18.2 88.4 28.9 71.5 28.3 56.2 36.5 83.7 78.9 40.9 41.9 156.9 110.3 54.3 0.0 113.1 22.3 136.2 45.1 78.7 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 17.9;brain: 13.8;lymphoid tissue: 13.6;thyroid gland: 39.5" "Cell type enhanced" "Detected in many" "dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 71.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 19.8;THP-1: 10.5;U-937: 11.0" "Low region specificity" "Detected in all" "HPA028708, HPA028710" Supported Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" NA NA "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: AB_2732442" "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 0.7 0.2 5.3 7.9 5.1 17.9 1.5 4.5 13.8 2.7 0.0 1.3 0.7 1.2 1.4 1.4 2.1 2.9 0.6 4.7 7.6 2.8 2.1 1.5 13.6 0.0 8.8 3.7 0.6 0.7 0.1 0.6 1.6 3.4 0.8 1.2 0.2 1.2 0.4 0.2 0.5 2.3 0.9 0.7 6.9 2.4 1.0 11.5 10.7 39.5 0.2 12.9 2.1 0.5 10.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 19.8 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 3.1 1.2 0.8 0.0 0.5 0.1 0.1 0.3 0.7 2.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.0 0.0 3.2 14.5 71.6 13.0 6.5 27.6 0.0 16.3 12.5 16.2 0.1 27.9 16.8 42.7 14.3 8.5 0.4 22.6 12.6 5.3 5.1 4.5 13.8 4.7 7.6 0.0 8.8 3.7 3.4 0.7 11.5 10.3 1.1 0.0 1.7 7.8 3.5 0.6 0.5 0.4 12.0 0.6 1.8 1.0 1.1 1.5 1.7 1.8 0.0 1.7 46.1 0.0 7.9 2.1 1.3 2.0 1.2 2.3 0.0 3.2 120.0 0.0 0.1 1.0 3.1 2.5 0.0 0.1 3.3 1.1 2.8 3.3 9.8 0.5 2.0 23.4 15.2 0.3 0.3 15.2 0.0 252.9 17.9 0.2 27.8 9.0 14.6 0.0 0.1 0.4 20.7 0.6 0.1 2.0 1.3 0.2 0.0 3.4 0.4 0.2 1.1 4.0 0.6 2.7 65.5 2.0 0.3 1.3 ZZEF1 "FLJ10821, KIAA0399, ZZZ4" ENSG00000074755 "Zinc finger ZZ-type and EF-hand domain containing 1" O43149 17 4004445-4143030 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 115.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031778, HPA031790" Uncertain Approved Nucleoplasm,Mitochondria NA NA 1100000 Nucleoplasm Mitochondria "HPA031778: AB_10599831, HPA031790: AB_10600999" "unprognostic (4.48e-2)" "unprognostic (7.59e-2)" "unprognostic (6.75e-2)" "unprognostic (2.39e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.80e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (2.21e-2)" "prognostic favorable (6.08e-4)" "unprognostic (1.54e-1)" "unprognostic (1.38e-3)" "unprognostic (6.09e-3)" "unprognostic (1.80e-1)" "unprognostic (9.43e-2)" "unprognostic (6.46e-2)" 9.5 10.7 5.6 10.2 6.1 21.0 9.8 6.7 6.6 8.4 15.3 16.4 15.6 10.0 5.8 11.2 9.2 6.5 10.4 6.5 5.5 7.6 9.0 11.4 10.1 7.2 6.5 4.8 10.2 14.3 12.2 11.3 6.1 9.1 10.2 14.7 11.3 9.2 7.5 22.4 12.2 27.7 8.8 5.4 14.3 12.1 8.1 7.5 15.2 10.8 13.4 9.8 11.0 8.2 6.9 13.1 20.1 7.1 9.7 17.4 9.8 8.5 11.1 13.9 12.7 12.3 10.0 4.5 12.4 7.3 15.0 8.4 14.6 14.4 7.6 12.9 14.5 15.0 12.0 16.4 6.5 11.8 10.2 22.6 12.6 10.0 12.5 14.7 6.6 16.6 12.3 8.8 12.2 8.0 8.9 12.7 6.0 4.3 12.5 7.6 14.0 8.6 5.4 7.1 13.2 5.6 8.2 12.6 7.7 10.8 7.0 7.6 7.7 19.7 11.1 5.6 14.1 14.7 5.4 3.0 6.3 11.1 8.9 10.5 0.7 0.6 0.6 0.8 0.9 1.0 0.4 0.5 0.5 0.5 0.3 0.3 0.6 1.0 0.2 1.0 0.4 0.4 0.4 5.6 6.1 6.7 6.6 6.5 5.5 7.2 6.5 4.8 9.1 5.4 7.5 6.9 19.3 57.7 54.8 39.8 23.5 7.1 5.4 6.6 13.1 30.6 12.6 10.3 22.8 18.6 30.0 9.2 98.0 8.3 23.7 93.4 0.0 7.3 48.9 18.8 17.4 19.2 13.2 12.4 50.3 11.2 6.4 21.6 46.4 25.6 26.5 21.8 23.2 15.2 11.9 40.4 55.3 38.5 12.2 30.5 10.6 26.8 14.9 29.0 12.4 22.5 20.4 15.8 19.6 35.2 53.6 14.9 34.3 9.8 27.8 9.5 115.2 4.8 22.7 50.3 6.6 23.7 15.2 12.0 11.8 16.4 10.1 8.9 31.1 18.0 28.6 9.3 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395368-155455839 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "MCF7: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles NA NA Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENO1 "ENO1L1, MBP-1, MPB1, PPH" ENSG00000074800 "Enolase 1" P06733 1 8861000-8879190 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Plasminogen activation, Transcription, Transcription regulation" "DNA-binding, Lyase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018614, HPA068284, HPA068721, CAB069394, CAB080034" Supported Enhanced "Plasma membrane,Cytosol" NA NA 310000000 "Plasma membrane, Cytosol" "CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119" "unprognostic (6.51e-3)" "unprognostic (9.50e-3)" "unprognostic (3.56e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.71e-4)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (2.37e-2)" "unprognostic (5.58e-2)" "unprognostic (9.72e-2)" "unprognostic (1.67e-2)" "unprognostic (1.46e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.36e-3)" 455.7 421.8 523.2 558.3 551.3 799.8 413.2 645.4 755.8 303.3 527.6 367.8 404.9 324.4 126.8 1057.8 284.0 304.7 285.9 579.1 676.1 763.4 617.2 457.1 496.5 583.2 557.5 532.2 297.5 222.7 350.0 247.6 365.7 559.5 281.6 361.7 747.9 586.1 357.5 232.9 551.2 385.5 475.6 559.8 398.1 324.2 219.4 536.0 459.8 273.7 147.8 701.1 490.5 524.0 553.1 3637.0 3088.4 1461.8 1258.6 1194.2 1323.8 1316.6 1919.1 2110.9 4044.1 3767.4 1986.9 2041.5 2586.5 2496.8 2328.5 1651.8 1736.8 2511.5 5127.7 4081.0 1780.5 2645.9 2191.3 2848.0 2511.0 1789.6 4421.6 1290.1 1377.4 1526.1 3208.9 4825.9 3045.2 2630.1 1294.6 2444.4 982.3 2664.2 1784.1 1685.2 2354.5 1600.3 1290.4 3063.4 1712.4 2172.9 4259.0 4815.0 843.6 1961.4 1211.1 2251.0 3232.5 2407.8 1748.4 1621.8 1302.1 2424.7 2774.5 2444.5 2402.3 3328.3 2771.0 2120.4 3906.9 4313.8 3556.1 2388.6 195.9 1198.7 232.3 528.4 822.7 597.3 411.2 552.5 543.2 1216.4 386.1 443.4 466.0 230.6 635.3 830.6 336.1 700.0 2171.2 523.2 551.3 645.4 755.8 579.1 676.1 583.2 557.5 532.2 559.5 559.8 536.0 553.1 140.0 278.9 499.1 99.6 222.3 416.5 570.9 1939.8 348.8 178.2 242.7 324.6 69.6 283.1 657.4 606.9 70.9 1045.4 194.0 455.9 925.4 2259.3 281.3 205.3 227.7 314.3 189.0 145.4 32.0 1399.1 2078.5 303.5 144.8 248.4 297.2 408.6 133.5 351.7 1147.4 482.9 33.2 297.3 787.3 356.4 524.5 699.6 171.5 454.2 448.2 30.9 1558.2 2624.9 279.1 28.6 26.9 1433.6 366.9 135.1 211.0 555.7 742.2 1005.4 245.7 216.6 151.2 156.1 402.5 215.1 154.3 468.1 349.6 1001.8 285.6 609.8 528.4 444.2 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 878 "kidney: 712.0" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 209.4" "Cancer enriched" "Detected in single" 4 "renal cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 25.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.1 0.0 0.2 0.1 0.2 0.2 0.1 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 712.0 0.4 0.0 0.0 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.2 0.5 0.5 0.5 0.2 0.4 0.2 0.2 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 38.6 0.0 0.0 0.0 0.0 209.4 0.0 13.5 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.2 0.3 0.1 0.0 1.0 0.0 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYDGF "C19orf10, IL-25, IL-27, IL25, IL27, IL27w, R33729_1, SF20" ENSG00000074842 "Myeloid derived growth factor" Q969H8 19 4641374-4670362 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 768.1;Plasma cells: 857.6;Syncytiotrophoblasts: 581.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 1043.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041872, HPA046744" Approved "Secreted to blood" NA NA 285000 2100000 "HPA041872: AB_2677718, HPA046744: AB_2679783" "unprognostic (3.14e-1)" "unprognostic (1.32e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.50e-7)" "unprognostic (4.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.08e-2)" "unprognostic (1.71e-1)" "unprognostic (5.11e-2)" "unprognostic (4.56e-2)" "unprognostic (8.19e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (4.99e-12)" "unprognostic (4.42e-1)" "unprognostic (3.24e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" 75.2 95.0 41.7 84.6 41.5 92.8 73.8 43.0 49.1 79.8 45.6 82.1 76.4 75.7 115.6 68.1 71.6 44.5 65.3 42.1 46.6 71.2 261.6 92.5 62.5 44.7 42.4 40.1 72.7 211.7 42.1 127.1 76.7 44.4 84.9 66.1 13.1 136.7 53.3 24.9 59.7 71.6 53.4 45.0 124.0 95.3 55.0 44.1 31.1 76.0 15.2 45.9 75.0 63.8 47.4 250.5 118.7 74.6 189.8 228.0 190.2 133.0 449.6 378.1 210.8 263.8 194.9 155.8 145.0 206.5 455.4 171.9 122.7 88.6 157.7 121.8 137.7 152.0 87.6 212.7 250.0 353.9 310.9 201.6 159.0 187.8 154.6 292.3 263.0 233.0 78.8 155.4 1043.7 194.9 134.4 83.9 174.1 94.5 235.3 417.1 80.0 126.3 701.0 169.1 114.2 114.1 117.0 151.0 189.1 227.5 64.2 111.4 366.6 268.9 162.8 135.1 449.2 325.9 505.8 229.6 122.2 401.8 405.8 260.1 156.8 216.6 82.6 148.7 232.2 151.6 123.6 118.7 121.1 264.0 101.0 99.8 107.0 13.8 151.5 209.0 426.0 96.3 225.2 41.7 41.5 43.0 49.1 42.1 46.6 44.7 42.4 40.1 44.4 45.0 44.1 47.4 134.4 44.8 68.1 4.6 185.1 0.0 160.1 0.0 46.1 31.0 153.8 133.9 6.6 110.1 18.6 77.3 4.2 284.0 135.6 39.8 43.0 355.9 8.7 65.9 168.2 131.9 31.5 55.3 7.3 351.1 768.1 177.0 92.8 158.8 16.4 135.8 126.7 207.3 415.6 26.9 9.6 96.2 0.0 118.8 0.0 12.8 140.5 155.4 0.0 9.4 250.8 51.3 116.4 8.0 10.6 401.8 71.3 91.0 857.6 342.0 182.9 86.8 9.5 32.7 92.1 92.7 157.1 183.2 125.1 64.4 0.0 581.6 84.9 145.5 101.0 260.7 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 73.1;Inhibitory neurons: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049206 Uncertain NA NA "HPA049206: AB_2680675" "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 6.0 21.2 9.5 4.7 8.4 2.6 6.7 9.3 14.7 4.9 1.7 4.6 4.4 3.8 1.1 11.7 5.0 5.4 4.9 9.0 7.9 7.2 7.2 6.5 4.4 12.1 10.6 7.6 3.8 7.0 6.7 4.6 3.4 12.4 4.9 2.3 4.1 7.8 2.7 8.4 17.8 4.8 2.8 9.2 5.5 8.3 3.2 10.4 5.3 6.1 4.9 2.8 3.6 6.4 10.4 6.3 5.5 14.8 16.8 4.4 3.1 24.5 6.3 3.6 3.2 3.6 2.4 13.2 0.5 6.5 6.2 4.5 5.7 3.1 5.1 1.9 27.8 7.6 4.2 18.0 3.7 2.2 0.9 6.9 3.5 4.7 4.2 3.0 8.2 2.4 9.9 3.1 6.2 2.1 4.8 5.6 1.6 8.4 7.1 21.9 9.2 3.1 7.5 5.3 10.3 5.4 17.8 6.8 6.4 5.2 5.4 9.2 2.8 2.5 7.4 4.1 22.9 6.9 10.7 9.2 1.0 11.7 7.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 9.5 8.4 9.3 14.7 9.0 7.9 12.1 10.6 7.6 12.4 9.2 10.4 10.4 4.4 6.4 1.7 73.1 1.0 0.9 0.4 0.7 2.2 5.2 10.3 9.9 2.4 1.5 1.1 0.0 4.2 3.9 3.4 2.1 0.0 1.8 0.2 2.3 1.6 1.4 0.0 0.4 12.6 1.6 8.7 1.6 10.2 4.6 5.7 5.9 1.1 3.5 1.7 1.7 19.3 2.4 2.0 1.9 1.4 0.3 2.1 2.2 0.0 9.4 0.8 2.5 0.0 12.5 7.8 1.8 0.3 0.7 3.0 0.8 2.3 0.9 0.7 2.7 0.0 1.5 2.4 0.3 0.8 2.1 1.4 2.6 2.2 4.7 2.2 0.8 TUBE1 "dJ142L7.2, FLJ22589, TUBE" ENSG00000074935 "Tubulin epsilon 1" Q9UJT0 6 112070663-112087529 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 199.6;Spermatocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 48.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032073, HPA032074" Approved NA NA "HPA032073: AB_10601773, HPA032074: AB_10601216" "unprognostic (4.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-2)" "unprognostic (7.36e-2)" "unprognostic (1.22e-1)" "unprognostic (8.36e-3)" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (4.99e-3)" "unprognostic (1.70e-1)" "unprognostic (5.15e-3)" "unprognostic (1.64e-1)" "unprognostic (7.68e-2)" "unprognostic (2.50e-1)" "unprognostic (1.59e-3)" 10.8 9.0 11.9 5.1 12.1 4.1 11.1 13.6 16.9 15.1 11.8 10.0 5.1 17.2 8.3 6.9 16.6 8.9 16.7 11.5 12.0 9.5 40.4 8.0 7.4 12.3 12.5 11.5 15.3 11.0 7.6 14.5 9.2 12.5 11.1 6.3 10.2 6.7 8.5 5.9 11.4 7.6 10.4 12.0 6.9 11.8 27.3 12.0 4.8 10.7 4.8 5.5 12.8 10.5 13.3 2.1 2.8 7.6 24.0 17.5 9.2 6.3 8.6 13.7 5.9 11.6 4.2 4.2 8.0 5.4 3.6 9.2 6.4 8.7 3.8 12.2 4.1 7.8 2.8 2.0 6.1 25.0 15.4 10.1 10.0 25.1 8.1 20.9 8.5 7.4 22.8 15.6 10.8 4.8 1.7 8.8 20.5 7.6 12.1 5.2 10.3 4.7 5.2 9.0 2.0 11.5 10.1 7.0 6.0 26.4 6.6 4.8 36.5 4.3 5.3 4.9 48.2 9.2 3.2 1.1 8.7 7.7 18.2 13.8 0.0 0.4 1.1 1.1 0.5 3.3 1.5 2.4 1.5 0.8 1.1 3.2 2.7 0.3 1.8 0.8 0.6 2.5 0.9 11.9 12.1 13.6 16.9 11.5 12.0 12.3 12.5 11.5 12.5 12.0 12.0 13.3 27.6 6.4 16.7 25.8 13.4 24.6 17.8 12.3 15.4 23.0 15.0 13.3 17.5 11.5 13.5 22.0 35.5 4.1 9.8 6.8 15.6 12.5 199.6 12.1 12.0 16.7 6.1 19.1 58.2 18.0 12.3 18.8 7.7 7.7 16.5 11.5 18.5 71.9 7.2 13.5 68.3 11.4 4.1 6.7 10.2 49.8 15.5 6.2 7.2 21.5 4.6 11.8 9.2 31.7 82.0 12.6 9.0 19.9 10.9 13.2 12.7 25.6 14.6 28.0 19.7 13.3 13.4 97.0 27.0 12.7 12.5 3.3 14.8 35.0 8.0 14.8 ARHGEF10L "FLJ10521, KIAA1626" ENSG00000074964 "Rho guanine nucleotide exchange factor 10 like" Q9HCE6 1 17539698-17697874 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 88.2" "Cell type enhanced" "Detected in many" "Astrocytes: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 41 "classical monocyte: 18.8;intermediate monocyte: 18.0;myeloid DC: 13.4;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 48 "dendritic cells: 13.4;monocytes: 18.8" "Cell line enhanced" "Detected in many" "Hep G2: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026426, HPA026440, HPA028115" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285" "unprognostic (4.34e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "prognostic favorable (8.13e-5)" "unprognostic (3.61e-2)" "unprognostic (7.90e-2)" "unprognostic (2.10e-2)" "unprognostic (1.75e-3)" "unprognostic (1.94e-3)" "unprognostic (5.83e-2)" "prognostic favorable (5.65e-4)" "unprognostic (4.11e-2)" "unprognostic (1.66e-1)" "unprognostic (8.17e-2)" "unprognostic (5.21e-3)" 18.4 10.6 11.2 11.5 9.6 1.7 16.7 36.4 11.5 21.5 14.1 25.0 16.0 16.4 4.6 28.3 16.1 12.0 28.7 9.3 11.2 32.8 88.2 13.1 4.6 16.0 17.7 6.7 10.5 44.3 17.2 8.0 6.0 18.5 18.5 13.1 4.0 26.1 19.7 66.9 38.4 21.9 8.8 10.6 9.8 20.9 3.8 16.9 1.6 18.1 35.8 4.3 24.8 21.9 16.9 8.0 9.1 11.3 3.9 19.1 6.3 7.6 5.4 10.6 6.3 5.3 9.5 23.6 0.0 9.8 10.2 8.8 6.0 1.6 2.9 1.2 0.2 2.9 0.0 9.5 26.9 4.2 0.0 0.0 8.5 5.5 3.9 1.1 12.7 1.2 0.0 0.0 0.2 17.8 7.7 0.0 0.2 4.9 12.2 0.0 0.0 4.5 3.0 13.4 16.4 16.5 12.2 4.2 2.9 12.3 3.2 11.0 9.5 0.0 5.5 6.5 6.5 2.3 0.0 2.5 0.0 8.5 0.2 3.0 0.0 18.8 0.0 0.0 18.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.3 0.0 4.8 0.0 0.0 7.6 11.2 9.6 36.4 11.5 9.3 11.2 16.0 17.7 6.7 18.5 10.6 16.9 16.9 1.3 3.2 7.4 82.6 1.0 5.7 5.3 7.2 5.2 16.1 13.7 12.3 36.4 20.0 13.9 31.3 2.1 0.7 0.1 41.6 9.8 19.8 15.9 3.4 4.2 2.1 37.8 2.7 16.7 20.3 0.6 8.5 17.9 6.5 0.0 3.9 2.5 43.7 26.0 10.1 23.8 45.5 8.2 8.6 26.4 8.9 5.0 18.6 3.6 19.7 9.6 14.6 0.0 24.6 7.1 11.7 24.9 6.8 0.2 5.9 13.6 18.3 9.4 5.4 13.1 10.8 18.3 11.9 1.6 8.0 8.7 1.0 0.6 0.3 46.1 12.1 TXK "BTKL, PSCTK5, PTK4, RLK, TKL" ENSG00000074966 "TXK tyrosine kinase" P42681 4 48066393-48134250 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 12.5;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" "dendritic cells: 84.1;NK-cells: 288.4;T-cells: 52.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "NK-cell: 152.3" "Group enriched" "Detected in many" 19 "NK-cells: 152.3;T-cells: 54.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HMC-1: 14.0;U-266/70: 6.8;U-266/84: 9.2;WM-115: 32.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062482 Approved Vesicles NA NA Vesicles "HPA062482: AB_2684778" "unprognostic (1.04e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (9.24e-3)" "unprognostic (1.09e-2)" "unprognostic (2.58e-4)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (1.50e-1)" "unprognostic (6.39e-3)" "unprognostic (8.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (2.59e-1)" "unprognostic (2.04e-2)" 0.9 1.0 0.1 7.9 0.1 5.6 0.9 0.0 0.6 0.8 0.8 1.5 1.8 1.1 12.5 1.5 2.0 2.2 0.6 0.1 0.3 1.1 2.1 2.8 15.9 1.0 0.4 0.0 0.2 0.8 0.4 0.7 2.0 1.6 0.5 1.4 2.1 1.4 0.5 0.6 2.2 5.6 0.4 0.2 10.7 1.1 1.1 0.7 5.7 1.2 0.0 10.9 2.3 0.9 1.5 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.1 6.1 0.0 1.8 0.0 0.2 0.3 0.0 0.1 0.6 0.3 0.1 3.1 0.0 0.0 0.0 0.4 14.0 0.0 0.0 0.1 0.0 0.9 0.2 0.6 0.2 0.1 0.8 0.0 0.0 2.8 0.0 0.8 1.0 0.4 0.0 0.0 1.7 1.6 0.0 0.3 0.0 0.0 1.6 0.1 0.0 0.2 0.5 0.0 0.0 0.4 0.1 6.8 9.2 0.6 0.0 0.5 32.0 5.4 0.1 1.0 42.0 0.2 54.8 0.2 21.1 20.2 0.2 0.1 53.2 37.0 2.4 152.3 0.3 0.6 17.6 36.3 0.1 0.1 0.0 0.6 0.1 0.3 1.0 0.4 0.0 1.6 0.2 0.7 1.5 0.7 0.0 1.8 0.3 3.2 0.4 0.6 0.0 0.6 0.5 0.8 0.4 1.1 1.5 0.0 0.0 4.2 0.4 84.1 0.2 1.9 1.5 10.1 2.0 0.4 0.9 0.0 10.7 21.5 0.0 0.1 0.6 0.0 5.5 1.3 0.1 3.6 1.5 1.6 0.0 3.3 0.2 0.0 6.9 0.4 2.8 0.3 1.9 1.8 3.7 1.6 1.4 288.4 0.5 0.5 0.1 0.1 0.0 8.9 0.6 0.4 0.5 0.0 0.4 0.0 1.2 0.1 1.0 0.8 0.8 1.1 0.5 52.3 0.1 0.4 0.8 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129288-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.4;thyroid gland: 17.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "RT4: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 0.9 0.7 6.9 0.1 11.9 0.0 0.8 38.4 14.8 3.5 1.0 2.6 0.3 10.2 2.1 1.0 2.6 0.1 0.3 16.9 7.1 1.0 0.0 0.3 0.2 4.4 4.4 9.7 0.3 1.4 0.0 1.4 0.2 14.0 4.3 0.3 12.0 0.3 13.6 0.2 0.6 0.7 6.8 2.5 0.1 1.9 0.2 7.9 0.0 17.0 0.4 0.1 2.5 1.3 7.9 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.4 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.9 11.9 38.4 14.8 16.9 7.1 4.4 4.4 9.7 14.0 2.5 7.9 7.9 0.8 0.0 0.0 5.9 0.6 0.1 0.0 0.1 0.0 43.7 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 30.1 0.0 0.0 1.6 3.1 0.0 0.0 0.0 0.7 0.0 0.0 21.9 27.7 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 2.8 0.0 0.3 0.0 9.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400208-63472677 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 102.8" "Cell type enhanced" "Detected in some" "Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: AB_2683339" "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 0.0 6.2 62.3 0.1 43.1 0.0 0.0 25.8 102.8 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.3 0.3 0.1 74.7 12.5 0.1 0.0 0.0 0.0 18.0 0.9 54.2 0.0 1.2 0.0 19.2 0.0 32.2 1.6 0.0 2.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 10.7 13.3 0.0 0.0 0.0 0.0 0.0 0.1 24.3 0.0 0.0 21.2 35.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.6 0.0 8.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 19.3 0.5 0.2 0.0 0.0 0.1 0.0 0.0 67.8 119.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 62.3 43.1 25.8 102.8 74.7 12.5 18.0 0.9 54.2 32.2 0.0 13.3 24.3 0.6 0.0 0.0 7.2 0.1 0.1 0.0 0.0 0.0 5.7 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 16.5 0.0 0.1 1.0 0.0 0.0 61.7 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.5 37.5 0.2 0.0 0.0 0.0 8.1 0.6 0.1 0.0 1.0 0.0 0.9 0.0 50.8 2.1 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.0 0.1 0.1 7.4 28.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416918 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 127.2;stomach 1: 38.2" "Cell type enhanced" "Detected in some" "Horizontal cells: 6.7;Kupffer cells: 2.4;Leydig cells: 2.8" "Cancer enriched" "Detected in many" 4 "stomach cancer: 6.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 4.2;U-87 MG: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA076573: AB_2732313" "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 0.8 0.3 1.4 2.5 1.3 0.4 0.8 1.7 1.8 8.5 0.2 127.2 5.0 25.5 0.2 14.9 20.6 0.5 3.2 1.9 0.4 0.3 0.5 0.7 0.3 0.4 0.2 1.0 1.8 0.3 0.0 0.3 0.2 0.8 6.2 9.1 4.1 0.5 1.1 2.8 1.1 31.6 33.4 0.0 0.3 38.2 0.7 0.2 0.1 0.4 0.2 0.1 32.6 8.6 1.0 0.9 0.6 0.2 0.3 1.4 0.1 0.1 0.2 0.1 0.2 0.3 0.3 0.1 0.1 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.8 0.3 0.8 0.1 0.0 1.4 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.2 1.2 0.0 0.3 0.0 0.2 0.2 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.6 1.2 4.2 0.1 0.5 0.1 0.3 1.4 0.2 0.6 0.5 0.5 0.6 0.1 2.3 0.1 0.8 0.2 0.4 0.0 0.1 1.3 0.1 0.3 0.2 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.4 1.3 1.7 1.8 1.9 0.4 0.4 0.2 1.0 0.8 0.0 0.2 1.0 0.5 0.0 0.5 0.3 0.1 0.6 0.2 0.2 0.0 0.2 1.1 1.4 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.3 0.6 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.6 0.0 0.2 1.4 0.1 1.2 6.7 0.1 0.3 0.0 2.4 0.4 0.1 2.8 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.4 0.1 1.5 0.2 0.0 1.1 0.7 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.4 ACTR6 "ARP6, FLJ13433" ENSG00000075089 "Actin related protein 6" Q9GZN1 12 100199122-100241865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038587, HPA038588" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA038587: AB_10670781, HPA038588: AB_10672719" "unprognostic (1.24e-2)" "unprognostic (8.43e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (7.70e-9)" "unprognostic (4.11e-2)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (6.98e-2)" "unprognostic (3.99e-1)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "unprognostic (3.22e-1)" "unprognostic (6.67e-3)" "unprognostic (3.40e-2)" 15.2 16.8 20.0 12.9 20.4 7.5 29.2 20.7 24.4 14.0 20.1 14.7 15.4 15.3 18.3 13.9 14.3 10.4 17.6 20.8 22.0 22.3 19.7 12.3 21.0 20.7 21.1 19.2 18.0 5.0 20.9 4.5 17.1 21.7 17.0 15.5 20.8 15.4 16.1 14.4 13.7 14.5 14.5 20.6 16.2 10.7 21.5 20.4 20.6 16.4 15.9 19.4 17.2 4.6 23.3 60.2 23.5 27.1 35.9 22.4 28.3 63.3 26.0 22.6 25.0 18.2 15.2 17.8 32.9 24.7 19.5 18.8 23.0 36.5 22.5 34.3 48.9 33.8 22.8 22.2 17.7 23.6 33.7 17.7 17.4 27.7 20.2 25.8 38.5 28.9 38.0 36.9 10.5 29.2 15.5 33.7 50.8 31.6 22.5 34.2 27.0 27.3 41.4 27.3 35.8 24.8 47.0 35.3 62.5 36.5 22.4 40.6 39.5 18.8 18.4 12.3 20.5 23.7 23.6 55.6 42.8 12.1 21.2 21.7 5.7 6.4 10.0 15.2 11.5 19.3 12.6 17.9 20.3 8.2 12.1 19.4 19.6 3.0 19.4 13.2 12.0 20.5 12.1 20.0 20.4 20.7 24.4 20.8 22.0 20.7 21.1 19.2 21.7 20.6 20.4 23.3 33.5 16.0 17.7 6.5 25.8 22.9 36.2 72.4 29.6 32.7 26.5 23.9 34.8 8.6 38.1 23.9 18.8 55.6 36.9 9.9 46.9 21.4 135.2 56.8 27.7 20.7 12.5 21.7 20.9 12.0 68.4 25.0 12.2 28.9 33.0 19.1 16.1 16.4 23.7 33.7 23.2 11.3 73.2 19.1 13.4 34.3 20.2 17.5 32.0 13.1 19.5 27.0 25.7 17.1 17.4 13.2 10.0 22.6 19.7 24.7 11.7 67.9 67.9 32.8 32.9 27.8 36.8 80.8 19.9 23.8 19.7 96.0 36.6 23.8 13.3 33.8 TIPIN FLJ20516 ENSG00000075131 "TIMELESS interacting protein" Q9BVW5 15 66336191-66386746 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 98.0;Langerhans cells: 93.7;Spermatocytes: 120.6;Suprabasal keratinocytes: 108.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039704, HPA058799" Enhanced NA Yes "HPA039704: AB_10795258, HPA058799: AB_2683824" "unprognostic (3.47e-1)" "prognostic favorable (4.15e-4)" "unprognostic (3.49e-3)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (2.47e-4)" "unprognostic (3.75e-1)" "unprognostic (1.32e-3)" "unprognostic (1.42e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.18e-3)" "unprognostic (9.47e-2)" "unprognostic (1.09e-1)" "unprognostic (4.91e-1)" "unprognostic (2.89e-3)" 4.2 4.5 3.8 7.1 3.7 12.8 5.9 5.7 4.6 4.0 2.3 4.8 2.8 4.8 1.8 5.0 5.5 2.6 3.2 3.5 3.6 4.1 5.0 3.5 9.5 3.7 3.6 3.6 6.4 4.7 5.2 3.2 3.8 3.8 3.5 5.3 8.1 3.3 3.2 4.1 4.0 3.1 4.5 3.3 3.7 3.8 20.7 3.7 7.9 4.5 4.8 10.9 3.6 3.3 4.0 28.6 33.9 36.9 17.7 6.4 13.6 30.2 39.1 16.0 54.8 48.0 49.9 32.1 58.5 27.8 14.9 31.9 44.8 94.2 34.1 51.7 39.0 52.4 51.7 33.0 28.0 12.9 54.4 17.1 17.5 11.1 51.2 41.2 7.8 23.0 47.6 43.6 27.4 47.8 32.7 50.3 35.2 37.7 66.7 26.7 50.1 54.9 58.0 19.0 32.5 35.0 21.9 27.5 17.4 25.3 26.8 26.6 32.9 15.3 38.9 42.6 33.7 73.4 16.4 91.2 92.7 26.0 98.8 40.3 0.4 2.1 1.4 2.7 4.3 3.2 2.3 2.0 2.4 3.8 4.3 3.0 3.4 0.4 4.5 2.7 2.9 1.9 1.9 3.8 3.7 5.7 4.6 3.5 3.6 3.7 3.6 3.6 3.8 3.3 3.7 4.0 7.8 6.4 7.0 14.0 15.7 98.0 72.4 24.3 5.7 11.8 7.1 9.0 2.7 28.6 11.5 9.2 10.4 35.9 7.8 5.4 86.1 11.8 63.3 8.3 8.6 18.4 4.8 15.6 7.8 8.6 41.2 16.5 5.1 4.8 8.2 11.8 14.6 13.7 21.4 8.4 11.1 7.1 14.2 27.4 93.7 31.4 19.0 13.2 56.9 1.0 12.3 9.2 15.5 10.1 9.6 7.3 7.0 18.0 8.7 41.2 3.8 63.5 6.8 14.7 32.9 51.9 29.0 120.6 62.5 6.6 108.8 19.4 21.0 9.3 10.1 34.1 SRI ENSG00000075142 Sorcin P30626 7 88205115-88226993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 571.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 1172.0;Extravillous trophoblasts: 1475.3;Paneth cells: 1606.5;Proximal enterocytes: 1342.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019004, HPA073666" Enhanced Approved Nucleoplasm,Cytosol No No 1100000 "Nucleoplasm, Cytosol" "HPA019004: AB_2670006, HPA073666: AB_2686623" "unprognostic (1.86e-2)" "unprognostic (2.31e-3)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-3)" "unprognostic (1.24e-3)" "prognostic favorable (3.08e-4)" "unprognostic (9.87e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.36e-1)" "unprognostic (2.10e-2)" "unprognostic (1.29e-2)" "unprognostic (9.87e-2)" "unprognostic (8.44e-2)" "unprognostic (3.14e-3)" 97.5 90.2 140.6 96.7 147.5 85.9 96.7 151.3 178.6 86.3 115.7 571.3 179.6 71.0 123.5 68.8 149.1 52.7 78.9 134.3 168.6 86.7 42.6 84.9 69.8 147.3 146.2 135.7 83.9 76.5 57.2 75.8 65.0 153.9 70.5 451.5 50.8 75.0 65.2 37.9 49.1 254.3 95.0 154.0 60.7 66.8 39.2 141.0 55.1 71.1 53.4 78.8 138.1 82.0 165.8 181.7 59.5 188.5 193.8 295.0 247.0 89.3 106.5 177.5 121.5 143.3 56.2 414.0 198.9 108.3 168.0 296.6 182.8 237.6 244.5 160.2 155.9 92.2 103.4 177.6 0.1 173.8 139.0 108.5 250.5 221.2 127.0 185.1 218.2 365.4 123.7 87.8 175.8 170.4 106.3 211.7 94.5 159.4 261.2 119.3 86.1 256.8 110.9 229.2 179.0 131.5 151.5 323.0 188.0 154.7 179.7 88.0 61.4 218.1 223.4 185.6 201.5 192.9 159.6 79.2 222.4 220.7 130.5 387.8 620.5 151.3 580.6 169.8 217.3 202.4 173.0 185.9 194.9 201.0 151.9 137.7 158.5 93.3 224.3 262.2 161.1 210.4 216.7 140.6 147.5 151.3 178.6 134.3 168.6 147.3 146.2 135.7 153.9 154.0 141.0 165.8 258.8 86.6 123.7 63.6 84.4 95.1 389.6 494.2 75.1 34.9 117.2 129.5 107.1 35.8 402.0 156.3 12.5 166.0 104.7 1172.0 442.2 223.0 89.7 307.3 148.6 135.6 94.3 198.6 29.4 418.5 1475.3 175.7 80.0 172.7 135.6 131.3 106.7 40.5 147.6 47.1 22.9 471.7 276.7 79.5 117.9 34.0 172.1 103.2 104.9 15.9 172.5 195.6 113.3 40.2 34.9 380.9 1606.5 141.4 75.2 422.9 1342.4 182.2 660.4 25.9 111.7 111.9 183.9 80.8 106.3 86.9 108.3 197.4 117.9 126.8 536.9 488.1 EIF4G3 eIF4GII ENSG00000075151 "Eukaryotic translation initiation factor 4 gamma 3" O43432 1 20806292-21176888 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 515.2;Inhibitory neurons: 464.4;Microglial cells: 255.8;Oligodendrocyte precursor cells: 425.8;Oligodendrocytes: 483.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025031, HPA025039, HPA025041" Enhanced Approved Cytosol NA NA 68000 Cytosol "HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104" "unprognostic (1.29e-1)" "unprognostic (8.38e-2)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (9.60e-7)" "unprognostic (1.02e-1)" "unprognostic (6.95e-3)" "unprognostic (8.36e-2)" "unprognostic (4.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.21e-2)" "unprognostic (5.07e-2)" "unprognostic (1.14e-1)" 21.4 20.8 4.2 20.7 4.0 32.6 18.1 1.5 20.1 18.7 45.7 22.1 15.1 21.3 17.3 19.9 18.9 20.1 17.4 5.8 4.9 15.8 15.0 16.6 17.6 4.5 3.5 0.0 17.4 12.2 39.8 26.7 15.7 10.3 17.5 24.7 26.6 12.7 20.8 42.5 18.7 17.6 27.7 0.0 17.2 17.4 75.0 2.2 17.3 36.0 23.6 20.0 22.9 16.9 14.7 31.8 25.2 78.3 32.0 80.1 77.9 16.4 66.8 70.4 46.5 46.1 27.2 33.4 60.7 41.1 73.2 42.6 34.5 48.4 53.9 64.3 50.4 48.2 31.6 47.7 18.9 38.5 53.1 56.5 86.4 39.9 47.8 61.2 69.0 59.2 22.3 23.9 42.0 66.3 25.1 16.6 19.2 23.3 36.7 21.3 31.7 29.8 21.4 40.8 16.4 46.1 35.4 70.0 29.6 35.9 46.3 20.7 58.0 60.7 51.4 19.1 73.5 30.2 18.8 22.5 0.3 63.5 78.7 48.4 0.5 0.5 0.9 0.7 0.0 0.3 0.6 0.3 0.3 1.0 0.8 0.2 0.3 1.2 0.4 0.3 0.6 0.5 0.5 4.2 4.0 1.5 20.1 5.8 4.9 4.5 3.5 0.0 10.3 0.0 2.2 14.7 50.9 19.2 30.5 181.5 29.5 20.6 19.9 15.0 17.1 52.0 19.2 17.4 44.5 14.3 28.2 16.5 66.7 4.6 51.1 51.3 0.0 20.6 173.9 66.6 81.2 42.7 16.3 26.1 515.2 19.4 8.8 33.8 46.4 46.8 26.6 44.9 46.1 14.7 23.1 50.5 464.4 21.6 4.1 31.5 11.3 121.8 44.7 39.3 14.2 255.8 18.0 18.6 28.8 425.8 483.4 24.8 32.1 44.8 27.3 21.0 15.7 10.3 51.1 40.5 32.9 36.6 31.3 100.6 51.2 33.8 26.3 3.4 23.7 68.4 29.6 28.0 NUP37 "FLJ22618, MGC5585" ENSG00000075188 "Nucleoporin 37" Q8NFH4 12 102073103-102120120 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056300, HPA073708" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA056300: AB_2683092, HPA073708: AB_2686629" "unprognostic (1.42e-3)" "unprognostic (5.39e-2)" "unprognostic (3.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.72e-4)" "prognostic unfavorable (7.70e-6)" "unprognostic (2.48e-3)" "unprognostic (2.37e-3)" "unprognostic (7.77e-2)" "unprognostic (2.90e-3)" "unprognostic (1.67e-2)" "unprognostic (7.47e-2)" "unprognostic (5.55e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-1)" 11.4 14.3 3.6 17.3 4.1 22.9 19.7 5.0 7.8 12.9 2.0 20.3 13.1 12.0 21.7 19.0 19.2 11.0 17.8 4.5 3.7 15.3 13.2 11.7 28.4 3.3 3.1 4.0 12.2 8.7 17.6 5.9 17.0 3.8 13.8 24.1 11.0 11.8 13.9 17.7 13.5 15.0 17.9 2.1 12.1 13.0 15.3 3.3 26.0 16.6 15.6 33.7 17.8 9.7 6.0 105.5 74.5 64.2 29.6 51.7 68.4 144.6 64.8 61.0 99.8 68.0 97.4 55.5 70.1 45.4 50.9 68.9 76.2 113.5 101.2 124.4 98.5 65.2 75.6 37.2 86.4 66.0 107.5 22.8 53.4 43.5 78.3 57.3 66.7 83.3 91.2 135.5 25.8 93.9 71.6 79.9 87.9 63.4 96.8 117.2 51.9 92.0 52.8 79.0 76.1 33.6 24.0 49.8 52.7 50.3 72.1 90.7 61.7 27.2 35.7 39.4 51.0 91.1 38.5 78.9 119.4 41.9 86.1 61.8 67.8 24.0 28.3 21.4 29.3 23.2 31.2 25.7 21.9 30.2 28.2 23.0 26.1 7.0 23.9 24.9 25.3 45.4 22.5 3.6 4.1 5.0 7.8 4.5 3.7 3.3 3.1 4.0 3.8 2.1 3.3 6.0 12.3 6.4 14.3 8.8 22.6 11.3 20.9 63.8 17.1 8.0 10.5 11.7 9.5 14.3 28.2 16.5 8.4 68.1 17.7 9.1 25.4 24.0 2.9 21.6 17.6 17.2 6.0 38.7 5.8 20.0 92.3 19.9 12.2 11.8 7.6 21.2 13.6 10.0 35.6 3.3 7.3 16.0 22.4 15.2 8.4 6.3 19.6 13.5 7.2 5.6 20.5 18.9 13.4 11.1 12.6 17.2 10.6 18.8 34.1 10.7 11.5 24.6 39.3 20.1 19.7 8.6 18.3 49.0 42.4 25.5 9.5 40.2 18.8 31.9 26.5 16.8 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.8" "Cell type enhanced" "Detected in many" "Astrocytes: 58.4;Cone photoreceptor cells: 45.9;Excitatory neurons: 89.7;Rod photoreceptor cells: 66.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 1.5" "Lineage enriched" "Detected in single" 16 "monocytes: 1.5" "Cell line enhanced" "Detected in many" "AF22: 129.3;BJ: 102.9;fHDF/TERT166: 112.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA 1600000 Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: AB_2681770" "unprognostic (1.20e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 6.9 0.2 2.3 3.8 5.6 0.1 1.5 0.5 3.3 4.4 0.0 7.0 1.5 1.0 2.2 5.9 1.6 5.7 2.6 1.8 1.3 0.4 0.4 2.3 3.3 3.1 1.8 1.0 0.5 0.4 0.5 2.1 10.5 4.9 2.9 5.8 22.8 0.4 0.4 0.1 1.1 2.5 4.8 1.3 3.9 2.0 1.2 0.3 0.5 1.8 0.5 1.7 5.5 0.6 4.3 11.8 32.8 129.3 0.1 3.8 3.1 8.4 102.9 60.0 8.5 5.3 11.4 30.7 0.0 4.8 112.0 1.1 57.0 0.3 24.6 11.8 0.0 4.2 0.0 6.0 0.0 3.3 2.6 0.0 3.9 0.0 18.1 4.4 26.2 32.1 0.1 0.1 0.2 3.4 0.6 0.0 0.0 48.6 0.5 11.6 2.3 55.3 3.4 18.5 0.8 9.8 5.2 0.8 0.2 1.1 20.7 0.6 1.1 18.3 11.2 11.6 32.6 15.1 7.6 5.5 0.0 11.5 4.5 22.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.3 5.6 0.5 3.3 1.8 1.3 3.1 1.8 1.0 4.9 1.3 0.3 4.3 1.0 3.2 1.7 58.4 0.0 0.9 0.0 15.4 0.0 15.1 0.2 0.3 6.0 0.0 22.4 0.0 45.9 0.4 0.3 0.1 0.0 0.1 0.2 2.0 0.7 7.3 0.0 0.0 89.7 2.0 0.2 9.3 0.0 9.0 1.3 3.5 1.8 0.1 1.0 3.3 10.0 0.0 2.0 0.3 2.7 0.2 2.5 0.5 1.8 7.5 0.0 19.6 0.0 9.5 5.8 5.5 0.0 0.0 0.0 0.3 0.0 0.0 15.6 66.3 0.0 1.5 2.1 1.7 1.9 0.4 1.3 0.3 1.1 18.6 0.0 0.2 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296870-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.2;lymphoid tissue: 19.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 0.6 0.6 0.1 5.1 0.2 11.2 0.5 0.4 0.2 0.4 0.2 2.4 4.1 0.8 0.0 3.6 0.2 0.5 0.3 0.1 0.4 0.3 0.4 0.6 9.3 0.3 0.4 0.0 0.2 0.2 0.1 0.1 2.6 0.4 0.2 2.6 0.1 0.7 0.1 0.1 2.5 2.9 1.2 0.2 2.5 1.9 7.2 0.4 19.8 0.2 0.2 8.8 1.0 1.2 1.0 59.5 27.6 53.2 42.2 1.1 3.0 25.5 50.3 23.5 71.7 58.8 29.3 21.9 55.7 13.0 19.4 32.8 30.3 48.0 12.7 45.7 33.7 52.0 37.4 38.9 22.8 0.1 67.5 43.8 0.6 1.0 30.9 15.6 7.5 31.2 39.7 29.0 67.8 43.4 33.1 60.9 33.0 37.2 24.2 30.7 59.6 59.7 36.3 11.7 10.7 27.5 37.5 48.1 30.7 21.5 23.8 26.2 25.8 25.1 40.6 75.8 33.4 53.7 38.6 19.7 56.3 25.8 32.2 60.5 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.4 0.3 0.2 0.1 0.2 0.4 0.2 0.1 0.4 0.3 0.4 0.0 0.4 0.2 0.4 1.0 1.1 0.0 0.0 0.7 7.0 2.8 1.1 2.1 0.6 0.7 2.8 3.4 1.6 0.0 0.5 0.0 0.0 19.2 6.8 7.6 0.0 0.9 5.6 2.1 4.7 3.9 1.2 52.2 0.3 0.2 31.2 5.1 16.8 4.3 0.0 27.1 6.4 1.2 19.9 0.0 0.5 9.4 2.0 7.5 4.0 3.9 0.3 4.7 0.0 0.0 0.1 0.4 0.0 0.5 0.1 0.8 0.2 0.7 19.1 1.8 0.5 0.5 0.2 0.3 6.6 2.6 5.4 73.6 27.8 11.7 2.6 1.5 5.0 1.2 13.8 1.6 SEMA3C "SEMAE, SemE" ENSG00000075223 "Semaphorin 3C" Q99985 7 80742538-80922359 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 92.2;Breast myoepithelial cells: 93.5;Fibroblasts: 109.6;Ionocytes: 91.6;Oligodendrocytes: 223.7;Respiratory ciliated cells: 103.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "basophil: 49.6" "Lineage enriched" "Detected in many" 9 "granulocytes: 49.6" "Cell line enhanced" "Detected in many" "GAMG: 252.7;RT4: 238.3;T-47d: 267.0;U-2197: 349.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042418 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 13000 "Golgi apparatus, Cytosol" "Plasma membrane" "HPA042418: AB_10797389" "unprognostic (1.93e-2)" "unprognostic (2.54e-3)" "unprognostic (4.94e-1)" "unprognostic (9.86e-2)" "unprognostic (6.74e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (9.28e-3)" "unprognostic (1.91e-3)" "unprognostic (1.39e-2)" "unprognostic (9.01e-2)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.07e-2)" "unprognostic (1.55e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-2)" 54.3 9.6 3.8 12.8 7.5 0.8 57.9 7.6 5.5 53.4 5.1 29.8 10.7 43.1 23.3 20.7 15.6 30.2 22.3 11.3 11.7 10.1 1.3 18.6 1.1 12.9 9.6 3.5 48.9 2.7 0.8 3.7 6.1 17.0 67.2 31.6 1.0 27.6 42.7 19.5 18.0 14.2 44.8 7.7 22.4 20.8 13.0 6.1 1.4 1.8 34.7 1.1 70.5 14.5 18.4 6.6 77.0 156.4 0.6 35.2 82.5 0.3 51.8 59.7 25.9 32.5 12.4 144.7 0.0 2.1 17.7 252.7 31.2 0.7 47.0 42.4 0.1 15.8 9.9 63.6 0.7 41.3 0.7 0.2 36.1 32.3 63.6 62.0 220.2 0.5 0.0 0.5 0.1 46.4 113.7 0.2 0.3 1.4 22.2 12.2 0.1 75.5 1.2 142.9 238.3 0.8 82.4 145.7 38.9 9.5 66.3 267.0 0.2 125.2 140.1 64.2 349.2 93.9 1.2 0.0 0.1 52.8 0.0 142.3 49.6 5.7 0.9 0.0 2.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 2.6 0.0 1.9 3.3 0.0 1.7 3.8 7.5 7.6 5.5 11.3 11.7 12.9 9.6 3.5 17.0 7.7 6.1 18.4 7.4 9.6 8.9 3.3 0.3 26.4 41.8 92.2 10.8 0.3 15.8 93.5 38.2 1.5 39.8 7.3 6.2 0.5 1.7 56.1 1.9 3.8 0.5 20.3 11.9 7.7 6.0 4.6 41.7 6.6 1.3 109.6 17.9 34.4 5.1 13.2 1.1 0.0 8.8 0.0 16.7 15.7 91.6 3.1 14.9 2.3 7.8 9.0 55.2 20.6 8.3 1.5 1.0 3.0 223.7 68.2 12.4 52.3 0.0 53.7 12.5 0.4 103.0 0.6 0.0 38.8 17.3 0.7 2.7 3.0 18.9 0.3 1.5 9.9 30.4 70.0 TTC38 FLJ20699 ENSG00000075234 "Tetratricopeptide repeat domain 38" Q5R3I4 22 46267961-46294008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 235.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 134.2;NK-cells: 182.3;Proximal enterocytes: 144.5;Proximal tubular cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 90.5" "Group enriched" "Detected in all" 4 "granulocytes: 29.9;NK-cells: 38.0;T-cells: 90.5" "Cell line enhanced" "Detected in many" "Hep G2: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029302, HPA075893" Approved Approved Cytosol NA NA 170000 Cytosol "HPA029302: AB_10601704, HPA075893: " "unprognostic (7.78e-2)" "unprognostic (5.85e-2)" "unprognostic (4.92e-3)" "prognostic favorable (3.21e-6)" "unprognostic (8.34e-2)" "unprognostic (6.38e-2)" "unprognostic (8.72e-2)" "unprognostic (3.62e-2)" "unprognostic (9.45e-2)" "unprognostic (7.22e-2)" "unprognostic (1.12e-1)" "unprognostic (5.66e-2)" "unprognostic (7.34e-3)" "unprognostic (9.02e-2)" "unprognostic (4.12e-1)" "unprognostic (4.97e-1)" "unprognostic (8.33e-2)" 24.9 23.8 9.4 10.3 10.4 47.4 25.9 9.8 10.8 16.3 11.6 38.9 80.1 14.0 6.5 12.6 17.4 15.6 21.9 8.5 11.5 65.0 235.5 15.7 10.8 12.7 10.5 7.4 26.2 35.8 7.7 13.3 7.9 11.1 23.8 32.2 4.8 27.3 7.3 20.7 11.4 81.6 10.4 9.5 22.9 29.4 6.9 11.1 2.5 15.4 12.4 5.9 17.0 13.6 14.6 12.0 13.2 16.4 34.5 15.2 13.1 15.7 17.2 11.5 18.7 14.6 21.8 8.5 0.1 10.8 17.9 7.4 10.8 16.8 13.9 6.8 27.0 36.9 15.6 28.4 76.0 21.0 9.0 59.8 22.6 7.3 8.5 9.7 12.9 15.9 0.2 11.9 19.4 12.2 12.1 0.3 28.2 12.5 22.6 13.1 0.0 8.0 8.0 12.6 13.8 2.9 22.8 23.7 16.3 13.3 7.5 26.1 18.0 18.5 13.0 14.1 10.3 11.0 14.7 9.2 1.7 8.8 13.7 13.8 29.9 11.9 22.5 90.5 11.4 9.7 2.3 8.5 41.0 10.8 1.7 3.5 36.9 7.6 38.0 8.7 4.3 4.5 42.5 9.4 10.4 9.8 10.8 8.5 11.5 12.7 10.5 7.4 11.1 9.5 11.1 14.6 9.2 0.0 7.5 13.7 6.5 3.3 5.9 4.3 3.4 2.6 10.2 6.7 9.2 38.6 4.3 9.2 6.2 10.4 69.1 69.0 23.5 10.4 0.3 7.4 9.6 8.9 20.9 10.5 0.3 10.2 9.3 7.5 11.7 6.9 17.2 13.3 9.7 134.2 13.4 5.0 1.8 37.8 4.1 14.9 4.3 0.9 7.5 9.6 5.4 9.4 12.8 9.3 182.3 5.5 5.6 9.7 51.6 13.9 16.2 8.6 144.5 149.6 5.3 5.4 6.6 7.4 5.9 1.8 3.7 5.3 8.2 6.4 29.2 22.7 51.7 4.6 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108116695-108147603 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 628.5;liver: 977.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 420.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria NA NA 1400000 Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 136.6 152.7 45.2 24.5 45.6 38.8 57.4 47.1 60.6 41.4 83.0 97.2 104.8 44.3 34.4 45.4 39.4 25.9 292.1 42.4 52.4 628.5 977.5 44.1 28.4 44.7 45.1 41.1 65.3 111.5 96.7 31.2 24.9 44.8 46.0 86.5 26.4 105.0 60.8 465.4 43.0 53.6 57.6 46.3 29.5 82.6 66.9 46.2 19.3 66.1 414.4 29.9 44.5 34.9 47.7 76.9 57.7 48.2 139.3 155.9 138.7 25.1 71.7 78.8 77.7 91.7 168.1 77.3 41.3 116.8 83.6 119.7 78.1 142.3 70.3 83.3 84.9 114.6 117.4 64.6 163.9 107.6 112.9 64.9 124.6 77.1 69.2 127.4 91.5 85.0 92.3 172.1 61.8 128.6 45.8 57.4 122.4 48.2 103.1 135.0 88.1 96.9 420.4 114.7 50.4 75.7 88.1 111.6 152.7 83.0 37.0 132.2 97.6 87.4 83.2 44.5 73.5 88.8 18.9 57.8 77.7 37.6 233.1 59.6 1.4 17.1 4.7 25.3 25.5 29.9 29.2 28.8 30.0 33.5 13.8 25.5 22.4 1.8 13.4 27.8 11.3 35.7 23.4 45.2 45.6 47.1 60.6 42.4 52.4 44.7 45.1 41.1 44.8 46.3 46.2 47.7 50.5 54.5 91.8 17.9 37.2 43.1 52.2 48.9 23.9 30.1 34.6 29.6 508.4 78.6 33.5 104.8 27.1 39.9 29.2 125.0 698.5 43.1 345.7 62.2 42.1 62.5 30.0 74.7 35.1 60.5 41.5 57.1 29.0 25.7 27.8 48.6 99.2 663.4 97.9 38.7 37.8 38.5 97.6 73.6 27.8 65.3 66.5 39.1 58.7 30.0 50.1 39.1 25.7 22.6 26.5 33.8 93.8 82.4 52.7 27.8 51.4 1484.0 101.8 28.8 65.7 54.2 69.2 172.7 27.2 39.2 48.4 25.2 38.1 61.6 84.5 24.4 GRAMD4 "DIP, KIAA0767" ENSG00000075240 "GRAM domain containing 4" Q6IC98 22 46576012-46679790 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 169.6" "Cell type enhanced" "Detected in many" "Astrocytes: 45.1;Distal enterocytes: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 96.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.67e-3)" "unprognostic (1.78e-3)" "unprognostic (2.19e-2)" "unprognostic (8.11e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.04e-4)" "unprognostic (1.08e-1)" "unprognostic (7.07e-2)" "unprognostic (5.72e-2)" "unprognostic (1.44e-3)" "unprognostic (1.54e-2)" "unprognostic (4.11e-1)" "unprognostic (1.61e-2)" "unprognostic (2.73e-2)" "unprognostic (2.08e-1)" "unprognostic (5.38e-2)" "unprognostic (8.69e-2)" 15.3 52.5 13.7 17.6 14.9 22.8 12.0 9.8 20.9 11.3 8.9 41.0 34.9 7.6 10.0 24.4 16.3 20.6 37.7 14.3 12.3 12.8 169.6 19.7 17.7 10.3 10.2 15.2 10.9 17.8 10.1 24.3 10.5 9.0 14.2 26.9 9.1 17.9 7.1 24.0 45.7 36.3 9.2 10.5 16.1 28.2 7.4 9.8 23.7 20.4 12.0 26.9 9.4 13.4 12.9 12.6 14.2 16.3 20.9 21.4 12.5 16.8 9.5 5.9 3.8 4.8 5.1 19.6 45.9 15.9 10.7 11.1 26.2 10.0 5.2 5.8 12.2 11.3 15.4 10.9 12.2 17.4 96.9 60.0 8.4 12.2 3.0 6.8 13.4 5.3 34.6 29.4 30.3 5.4 22.0 56.4 51.0 8.9 28.2 6.6 25.3 2.5 30.2 7.4 14.6 11.6 32.3 10.2 20.3 37.1 18.7 19.8 33.8 8.3 4.9 9.7 6.6 6.3 6.2 21.5 24.3 10.9 37.4 43.1 1.2 1.4 1.0 0.6 0.9 0.3 1.0 0.5 0.4 2.0 0.3 0.4 0.2 0.5 3.9 0.4 2.4 1.9 0.8 13.7 14.9 9.8 20.9 14.3 12.3 10.3 10.2 15.2 9.0 10.5 9.8 12.9 17.7 16.0 18.4 45.1 5.9 8.2 3.6 7.6 6.8 5.0 7.1 10.8 19.3 8.6 4.1 3.7 0.0 3.7 9.5 56.1 0.0 4.7 0.3 13.4 7.2 7.5 20.8 3.8 21.6 6.7 2.2 4.7 8.2 10.6 7.0 5.4 2.5 23.0 14.0 3.3 18.2 20.7 6.1 10.1 14.7 1.1 4.7 12.0 7.2 11.2 10.9 12.2 3.1 13.6 5.9 7.9 18.9 5.7 8.6 5.0 34.5 3.0 5.1 1.7 0.0 3.4 5.3 1.2 3.8 8.2 10.4 3.4 7.0 5.9 22.8 3.7 CELSR1 "ADGRC1, CDHF9, FMI2, HFMI2, ME2" ENSG00000075275 "Cadherin EGF LAG seven-pass G-type receptor 1" Q9NYQ6 22 46360834-46537620 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 31.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 41.7;Basal respiratory cells: 28.1;Club cells: 31.1;Endometrial ciliated cells: 31.8;Glandular and luminal cells: 42.6;Respiratory ciliated cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory B-cell: 2.2;naive B-cell: 1.9" "Lineage enriched" "Detected in single" 6 "B-cells: 2.2" "Cell line enhanced" "Detected in many" "A549: 68.4;RPTEC TERT1: 48.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052976, HPA060521" Enhanced "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 280000 "Plasma membrane" Nucleoplasm "HPA052976: AB_2682004, HPA060521: AB_2684303" "unprognostic (5.62e-2)" "unprognostic (4.93e-2)" "unprognostic (4.22e-2)" "unprognostic (1.54e-3)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.66e-1)" "unprognostic (3.36e-1)" "unprognostic (5.31e-2)" "unprognostic (1.05e-2)" "unprognostic (1.18e-2)" "unprognostic (8.59e-2)" "unprognostic (2.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.67e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" 0.7 0.8 2.3 3.2 1.3 0.8 7.9 1.6 0.5 10.0 0.8 1.6 0.9 3.7 10.3 11.6 15.6 1.4 3.5 1.0 3.6 17.2 5.3 12.6 5.9 1.8 2.8 0.2 0.2 2.6 6.4 2.4 1.0 1.1 5.0 1.8 0.5 12.1 3.9 0.2 31.8 1.6 1.1 2.1 3.3 5.5 1.3 1.8 2.4 3.7 0.1 7.9 3.9 3.7 0.9 22.3 68.4 11.3 10.6 0.0 0.0 6.5 2.3 3.4 2.3 1.3 21.7 21.9 0.2 32.1 1.3 22.0 35.0 7.5 28.7 2.0 0.0 10.2 0.0 25.6 2.0 1.0 3.2 1.8 0.0 43.5 0.0 26.2 31.6 0.4 1.7 0.3 0.4 0.0 38.4 0.1 11.9 4.5 12.1 8.1 0.1 0.1 8.1 48.7 13.5 0.7 0.9 16.1 17.3 3.7 7.9 39.7 16.7 0.9 0.1 0.3 0.0 0.4 10.6 1.1 10.5 15.2 0.1 12.9 0.0 0.0 0.0 0.2 0.1 0.2 2.2 0.1 0.1 0.0 1.9 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.1 2.3 1.3 1.6 0.5 1.0 3.6 1.8 2.8 0.2 1.1 2.1 1.8 0.9 0.5 41.7 23.5 0.0 5.8 17.1 4.1 28.1 8.0 0.2 14.2 5.2 12.7 2.8 31.1 5.5 0.0 1.9 2.3 0.8 0.0 1.8 2.3 31.8 5.0 5.6 1.2 0.0 1.2 0.7 1.9 1.0 2.6 42.6 0.0 0.6 1.8 1.5 2.4 0.0 1.2 2.8 6.1 0.0 4.1 10.3 0.0 1.1 5.4 1.0 1.1 1.1 0.0 0.5 0.7 4.0 0.3 0.0 1.1 4.3 0.0 8.2 60.3 0.3 0.0 0.1 2.8 0.4 0.6 12.6 15.6 0.8 1.1 0.0 1.7 5.1 WNT8B ENSG00000075290 "Wnt family member 8B" Q93098 10 100463009-100483744 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 1.2;retina: 1.0" "Cell type enhanced" "Detected in single" "Oligodendrocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;JURKAT: 3.1;RPMI-8226: 1.0;SCLC-21H: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036570 Uncertain "Secreted to extracellular matrix" NA NA "HPA036570: AB_10670113" "unprognostic (6.92e-2)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (6.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.90e-1)" "unprognostic (2.64e-1)" "unprognostic (9.16e-4)" "unprognostic (1.95e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (7.83e-2)" "unprognostic (2.42e-3)" "unprognostic (5.02e-2)" "unprognostic (1.63e-1)" "unprognostic (2.68e-2)" "unprognostic (1.24e-2)" 0.0 0.8 0.1 0.0 0.4 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.4 1.2 0.1 0.0 0.2 0.2 0.0 1.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.2 0.0 0.6 0.8 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.0 0.7 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.5 0.3 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: AB_2683426" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.73e-5)" 20.7 22.3 35.0 21.8 48.3 28.4 24.9 77.7 52.7 23.2 37.3 20.6 15.7 29.4 18.6 19.9 22.3 19.3 34.0 35.7 37.4 24.4 31.1 21.4 25.2 38.3 39.7 32.9 37.6 22.0 28.1 25.1 23.4 46.0 22.4 19.7 49.0 21.1 19.7 52.0 16.4 19.1 23.1 31.9 23.3 22.0 30.0 36.0 31.2 30.1 34.0 22.8 21.5 17.3 83.5 36.2 51.0 77.0 36.1 44.4 48.3 59.2 40.4 46.6 33.6 30.0 49.2 34.6 59.2 36.6 37.1 52.3 29.9 72.1 41.4 48.7 60.5 40.1 77.8 54.8 45.4 38.3 72.0 50.6 30.8 39.5 36.1 66.7 47.8 52.5 39.2 79.4 33.8 49.6 36.1 50.9 52.9 66.7 54.1 32.4 43.0 116.5 41.7 36.0 54.3 59.0 38.7 49.8 34.7 52.8 76.3 32.3 43.7 54.3 41.4 60.0 31.1 41.2 27.6 45.7 57.4 34.8 46.3 45.8 64.1 17.0 33.5 18.1 16.3 17.2 25.4 17.1 17.2 14.0 26.0 22.5 16.7 29.1 21.5 24.1 17.7 16.0 10.8 35.0 48.3 77.7 52.7 35.7 37.4 38.3 39.7 32.9 46.0 31.9 36.0 83.5 63.1 67.3 112.4 227.9 63.9 31.7 56.8 40.8 46.1 111.5 36.8 35.4 107.0 27.1 59.0 40.5 123.0 42.5 46.7 39.2 19.6 43.0 15.7 54.2 63.7 65.9 38.4 57.2 286.9 40.9 29.0 83.5 50.0 59.2 79.1 112.8 38.6 48.6 32.5 67.3 268.4 34.2 32.6 41.9 33.3 15.8 75.2 49.6 23.2 225.8 71.6 56.4 56.7 342.3 619.5 39.6 35.7 63.9 50.5 60.0 38.1 21.6 74.7 104.0 32.9 98.3 73.1 110.1 78.3 37.4 30.3 50.2 56.1 74.0 36.8 58.9 SLC25A40 MCFP ENSG00000075303 "Solute carrier family 25 member 40" Q8TBP6 7 87833568-87876360 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055197 Uncertain NA NA "HPA055197: AB_2682735" "unprognostic (4.19e-2)" "unprognostic (1.01e-1)" "unprognostic (7.30e-2)" "unprognostic (2.15e-1)" "unprognostic (8.80e-2)" "unprognostic (4.03e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.73e-1)" "unprognostic (3.51e-2)" "unprognostic (3.45e-2)" "unprognostic (1.83e-1)" "unprognostic (5.78e-2)" "prognostic favorable (1.52e-5)" "unprognostic (8.42e-2)" "unprognostic (2.45e-1)" "unprognostic (2.88e-2)" "unprognostic (4.85e-2)" 4.9 7.1 4.6 8.5 5.2 7.7 8.1 7.2 7.1 5.9 3.4 7.9 6.6 6.8 6.2 5.9 6.2 5.5 9.8 5.1 5.6 8.2 6.7 5.9 10.7 5.3 5.9 4.6 8.7 4.3 9.5 3.6 3.8 6.0 8.7 9.7 8.8 6.1 5.1 6.4 8.1 7.2 5.3 3.6 9.0 7.2 4.8 7.5 9.7 7.1 5.2 10.0 5.2 4.2 7.5 20.3 5.3 16.3 6.3 6.5 10.4 4.8 14.3 12.6 10.1 14.7 4.6 28.2 23.8 9.1 7.1 16.3 8.7 8.0 8.2 14.5 15.1 4.0 12.6 12.3 5.7 6.2 30.8 16.2 6.3 5.8 9.2 7.2 8.5 11.0 18.9 13.9 34.0 17.5 8.6 35.7 25.6 7.6 16.6 5.9 17.6 20.6 21.0 14.7 10.8 8.0 19.2 18.4 17.8 14.1 13.1 8.7 24.0 7.7 17.3 12.8 27.2 13.8 18.7 21.6 30.6 12.0 37.0 36.1 9.1 3.5 5.0 1.1 3.7 1.8 1.5 1.6 1.6 3.9 1.7 1.7 1.6 1.9 4.0 4.0 1.0 1.9 1.5 4.6 5.2 7.2 7.1 5.1 5.6 5.3 5.9 4.6 6.0 3.6 7.5 7.5 5.8 3.2 5.3 33.0 12.3 7.5 6.1 4.0 12.0 5.7 8.3 5.2 16.6 12.8 7.7 7.3 10.4 8.6 10.5 9.6 15.6 3.8 10.0 5.7 5.0 5.9 3.0 17.9 35.2 3.9 8.4 5.7 9.2 6.4 5.1 9.1 6.1 8.1 11.1 3.3 37.0 8.9 6.1 28.6 4.1 3.9 7.8 19.4 21.4 19.7 17.5 4.5 5.2 32.2 30.8 6.5 13.8 10.9 18.8 3.5 7.2 8.6 5.2 4.9 13.1 4.6 4.4 9.0 5.0 10.4 8.0 3.7 9.4 9.1 10.0 5.5 TIMM21 "C18orf55, HSPC154, TIM21" ENSG00000075336 "Translocase of inner mitochondrial membrane 21" Q9BVV7 18 74148523-74160531 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010587, HPA051543" Uncertain NA NA "HPA010587: AB_1851244, HPA051543: AB_2681528" "unprognostic (4.88e-1)" "unprognostic (2.20e-2)" "unprognostic (1.16e-1)" "unprognostic (8.61e-2)" "unprognostic (3.81e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (9.22e-5)" "unprognostic (1.42e-1)" "unprognostic (1.59e-2)" "unprognostic (1.93e-2)" "unprognostic (4.79e-3)" "unprognostic (1.55e-3)" "prognostic favorable (1.38e-9)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.31e-1)" "unprognostic (6.66e-2)" 13.9 14.7 24.9 10.1 25.5 8.1 10.6 27.9 29.1 9.5 24.5 15.4 12.3 10.5 12.0 13.4 9.6 5.7 42.5 24.8 25.1 19.5 22.5 7.5 9.9 24.6 24.6 24.2 12.0 9.6 18.1 11.4 10.0 25.4 12.3 13.7 14.9 10.2 10.0 51.3 11.2 11.6 9.6 24.7 13.9 12.5 7.1 25.5 7.8 12.5 48.3 10.2 12.7 10.3 26.5 25.6 26.6 24.4 30.2 19.7 17.4 35.9 38.5 12.8 22.8 19.2 19.5 18.3 34.2 12.1 15.0 19.1 41.6 34.0 32.8 38.1 21.7 19.6 14.7 46.2 53.9 10.0 55.6 23.7 16.2 19.4 29.0 19.9 18.6 17.5 19.0 30.2 23.2 27.9 25.6 29.6 45.6 23.5 15.3 48.6 27.5 28.2 42.6 30.2 35.5 25.9 14.2 14.5 35.9 23.8 19.1 24.9 28.6 12.6 53.3 37.9 17.5 40.3 7.3 60.3 37.2 26.0 59.7 38.0 8.7 9.8 6.3 12.7 15.6 15.2 16.0 12.2 10.7 13.2 12.3 15.3 17.6 1.2 17.1 18.2 15.7 10.0 8.8 24.9 25.5 27.9 29.1 24.8 25.1 24.6 24.6 24.2 25.4 24.7 25.5 26.5 8.0 12.8 17.8 8.1 12.1 8.0 9.3 30.2 21.6 17.1 9.0 12.6 165.5 14.3 16.7 5.5 6.2 29.4 10.2 9.4 54.8 13.2 3.1 7.3 13.5 13.1 14.4 16.2 8.6 9.4 28.3 19.0 14.8 6.7 9.5 12.6 11.7 20.2 18.8 16.8 11.1 11.5 8.2 11.7 3.5 1.5 11.5 8.5 1.8 6.5 13.4 20.0 9.2 8.5 9.2 9.1 6.2 12.4 25.7 10.5 12.5 34.5 15.0 20.1 6.6 15.0 16.5 12.8 12.7 20.2 8.0 16.4 7.5 12.9 18.2 7.7 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 67.1;brain: 50.5" "Cell type enhanced" "Detected in many" "Early spermatids: 31.7;Erythroid cells: 74.1;Excitatory neurons: 70.1;Horizontal cells: 139.7;Inhibitory neurons: 51.8;Late spermatids: 62.4" "Group enriched" "Detected in many" 5 "glioma: 5.2;testis cancer: 11.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.2;non-classical monocyte: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 33.9;JURKAT: 33.1;K-562: 46.5;NTERA-2: 86.7;RPMI-8226: 41.7;SCLC-21H: 42.8;U-251 MG: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 18000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202" "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.1 1.7 10.4 2.0 19.3 67.1 0.9 15.4 50.5 0.5 0.0 0.7 0.1 0.5 0.3 1.4 0.7 0.3 0.6 15.4 20.0 0.1 0.2 1.0 2.5 15.6 7.8 22.5 0.2 1.7 0.2 4.1 0.7 12.9 0.5 0.3 16.2 0.2 0.2 0.8 0.3 0.9 1.1 0.0 1.3 0.3 2.8 6.7 0.7 1.4 1.0 2.2 0.5 0.6 37.4 17.6 20.5 0.8 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 2.7 12.3 0.0 33.9 0.0 0.0 0.1 20.1 1.7 0.2 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 8.0 0.0 33.1 46.5 0.0 0.0 0.1 0.2 1.6 86.7 0.0 0.4 0.0 0.5 41.7 5.7 0.0 42.8 19.3 21.6 0.1 0.1 9.4 0.1 10.7 0.8 0.2 0.9 0.0 47.1 14.1 17.0 0.0 0.7 7.1 7.9 0.0 0.0 0.0 0.0 1.2 0.0 2.2 0.0 0.0 0.0 1.7 0.8 0.4 0.0 0.0 2.3 0.0 0.0 0.3 10.4 19.3 15.4 50.5 15.4 20.0 15.6 7.8 22.5 12.9 0.0 6.7 37.4 2.8 0.0 0.5 1.0 4.2 0.1 0.3 0.0 0.0 23.3 0.2 0.0 2.5 0.0 0.0 0.0 2.1 0.1 0.0 0.1 0.0 0.1 31.7 0.1 0.2 3.9 0.0 74.1 70.1 1.1 0.2 1.0 1.1 0.1 0.0 0.0 2.9 0.0 0.2 139.7 51.8 0.0 0.0 1.0 0.4 62.4 0.9 0.6 1.8 2.8 0.8 0.8 0.0 17.6 1.8 0.3 0.0 0.7 0.1 0.6 0.0 0.0 0.0 8.7 0.0 0.6 0.3 3.5 6.8 0.0 0.1 0.3 0.5 1.5 0.0 1.3 FGF4 "HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF" ENSG00000075388 "Fibroblast growth factor 4" P08620 11 69771022-69775341 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.1;Early spermatids: 3.1;Late spermatids: 1.4;Spermatocytes: 1.5" "Cancer enriched" "Detected in some" 5 "testis cancer: 13.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "NTERA-2: 16.1;SuSa: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA011209 Uncertain "Secreted in other tissues" NA NA 326000 "HPA011209: AB_1848527" "unprognostic (1.47e-2)" "unprognostic (6.22e-2)" "unprognostic (7.77e-2)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RASAL2 nGAP ENSG00000075391 "RAS protein activator like 2" Q9UJF2 1 178094104-178484147 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 29.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 505.8;Inhibitory neurons: 398.4;Microglial cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018805, HPA020453" Enhanced Approved "Plasma membrane,Focal adhesion sites" NA Yes "Plasma membrane, Focal adhesion sites" "HPA018805: AB_1856085, HPA020453: AB_1856086" "unprognostic (5.55e-3)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (6.33e-2)" "unprognostic (3.40e-2)" "unprognostic (5.59e-2)" "unprognostic (5.91e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (2.92e-2)" "unprognostic (3.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-2)" "unprognostic (4.98e-2)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.05e-4)" 9.6 3.7 1.1 2.8 3.4 0.6 8.1 0.0 7.2 5.7 0.1 4.0 2.7 6.2 3.7 17.2 5.6 7.6 13.7 4.0 2.5 5.8 3.0 9.5 1.8 0.1 1.4 3.0 3.7 4.7 4.6 5.9 9.5 1.4 5.0 4.5 29.2 6.7 4.5 4.6 7.1 3.4 6.6 0.0 3.3 3.7 9.0 2.8 1.8 5.3 10.1 2.9 5.0 10.5 2.3 30.9 8.9 12.1 4.2 8.6 11.6 17.3 13.2 13.6 11.7 8.5 14.8 15.6 0.0 23.0 13.2 19.7 25.2 10.2 23.0 10.7 0.0 5.0 0.0 9.8 7.1 10.0 4.7 0.5 35.1 5.2 13.4 54.1 13.7 10.3 0.0 1.0 0.0 16.5 3.2 0.0 4.2 10.1 6.4 1.8 0.1 5.2 0.0 7.2 3.6 8.8 4.4 10.9 9.5 9.0 10.8 10.4 5.5 18.9 15.1 15.7 17.2 21.0 6.5 0.1 0.1 13.3 2.4 11.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 3.4 0.0 7.2 4.0 2.5 0.1 1.4 3.0 1.4 0.0 2.8 2.3 99.8 76.9 12.9 47.3 1.0 15.9 10.0 15.7 8.0 50.7 17.8 11.7 37.4 17.2 18.2 16.5 152.2 15.0 1.0 9.0 5.9 21.8 17.4 33.6 43.0 66.2 34.1 0.0 505.8 12.5 16.4 18.4 17.9 27.6 7.6 19.0 35.3 6.7 16.8 84.1 398.4 15.7 6.1 4.5 21.6 7.3 19.6 16.5 3.6 271.7 8.5 24.7 0.0 154.3 101.3 33.6 5.2 23.0 2.9 32.6 4.9 6.6 34.7 175.5 65.7 22.7 56.9 40.5 34.5 17.8 24.2 41.9 2.3 8.3 12.6 38.2 VPS9D1 "ATP-BL, C16orf7" ENSG00000075399 "VPS9 domain containing 1" Q9Y2B5 16 89707134-89720898 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.2;Inhibitory neurons: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "neutrophil: 18.0" "Lineage enriched" "Detected in single" 26 "granulocytes: 18.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007847, HPA023620" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA007847: AB_1845582, HPA023620: AB_1845583" "unprognostic (7.08e-2)" "unprognostic (8.63e-2)" "unprognostic (6.26e-3)" "unprognostic (1.63e-3)" "unprognostic (5.67e-2)" "unprognostic (2.29e-3)" "unprognostic (5.03e-2)" "unprognostic (8.72e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (8.23e-3)" "unprognostic (1.37e-1)" "prognostic favorable (2.91e-5)" "unprognostic (4.06e-2)" "unprognostic (3.55e-1)" "unprognostic (2.25e-1)" "unprognostic (3.13e-3)" 11.5 27.1 21.6 16.4 22.9 13.3 10.5 13.6 39.5 13.3 13.0 13.2 13.6 11.1 4.5 33.6 12.1 7.4 15.5 23.2 17.6 22.8 30.6 16.2 9.4 23.0 18.8 23.0 10.9 12.7 12.6 31.8 5.5 24.1 15.4 3.8 5.8 15.4 6.2 11.7 12.5 17.3 5.0 12.4 29.4 13.0 19.0 18.9 3.5 17.4 5.5 5.1 11.3 16.0 21.3 6.2 9.3 10.2 10.8 10.2 9.9 8.5 11.3 11.7 9.6 4.7 8.0 13.6 6.3 7.1 12.6 5.4 14.1 0.9 6.4 2.7 5.7 15.0 4.5 8.7 10.0 7.7 2.6 10.5 10.9 5.8 11.6 2.7 15.5 6.7 5.8 11.5 3.8 6.5 28.1 4.8 10.0 3.8 4.9 10.4 11.8 8.5 3.8 7.7 9.8 8.4 8.8 14.5 5.3 11.6 3.1 24.0 11.0 10.5 12.4 15.5 10.2 6.9 17.4 5.9 5.4 18.0 6.8 10.6 2.2 0.6 0.3 0.3 0.5 0.1 0.2 0.1 0.1 0.3 0.4 0.4 0.2 18.0 0.2 0.3 0.0 0.2 0.2 21.6 22.9 13.6 39.5 23.2 17.6 23.0 18.8 23.0 24.1 12.4 18.9 21.3 3.5 6.4 5.1 30.0 3.6 2.0 2.0 5.4 5.7 13.3 6.5 5.5 8.8 2.8 6.4 9.2 10.4 3.0 6.1 11.6 7.9 4.9 13.5 5.8 6.8 3.1 10.8 1.7 43.2 7.8 2.3 5.3 8.2 9.3 4.5 8.7 9.7 9.6 4.8 8.4 41.9 3.9 2.0 8.5 8.3 21.7 6.2 12.6 3.6 4.7 3.7 6.6 3.1 16.1 17.5 6.2 5.1 6.0 3.9 1.8 13.5 6.1 4.6 12.8 0.0 5.2 5.8 12.3 4.7 7.5 3.8 3.0 4.5 8.6 7.2 2.8 ZNF37A "KOX21, ZNF37" ENSG00000075407 "Zinc finger protein 37A" P17032 10 38094334-38150293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003172 Approved Approved Vesicles NA NA Vesicles "HPA003172: AB_1080709" "unprognostic (8.64e-2)" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" "unprognostic (6.87e-2)" "unprognostic (1.17e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.83e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (4.39e-2)" "unprognostic (1.29e-1)" "unprognostic (3.43e-2)" "unprognostic (3.09e-2)" 5.0 5.7 5.9 6.3 6.4 3.1 5.8 11.5 8.1 6.4 4.1 4.9 4.8 7.3 5.9 3.7 5.3 4.5 4.4 6.5 5.9 5.8 4.9 4.9 5.9 6.2 6.4 5.1 7.5 8.8 9.8 8.6 4.9 7.1 5.7 4.9 16.8 7.6 5.7 3.7 6.3 4.6 5.6 3.6 6.1 5.6 2.4 6.2 5.9 8.2 5.2 6.0 4.4 4.2 9.0 15.8 7.9 7.0 13.2 10.5 10.2 7.6 11.9 4.5 5.4 7.2 6.4 4.5 23.1 3.5 6.6 7.4 6.3 13.2 10.0 8.4 14.9 12.5 23.3 9.7 9.1 9.0 24.7 14.4 7.8 16.4 9.3 7.7 10.8 7.2 10.8 15.4 15.9 11.7 3.7 14.0 3.7 6.1 5.5 13.0 10.0 19.0 4.6 5.7 6.1 5.6 9.6 8.2 6.6 6.7 7.4 12.1 7.6 12.4 10.1 10.9 9.8 11.6 17.8 20.5 8.9 6.7 17.3 6.5 1.3 1.0 1.0 1.5 0.8 2.0 1.5 1.8 1.6 1.0 2.6 2.1 1.8 0.7 2.7 2.3 1.2 1.1 0.7 5.9 6.4 11.5 8.1 6.5 5.9 6.2 6.4 5.1 7.1 3.6 6.2 9.0 21.8 25.6 43.6 31.6 26.0 8.2 14.7 11.0 18.8 66.1 14.4 16.4 29.6 15.7 18.8 11.0 54.2 10.2 23.2 7.6 1.9 18.1 3.7 15.0 30.0 26.3 41.9 26.3 46.7 11.8 6.8 27.0 16.3 14.9 40.5 56.9 22.9 10.4 7.1 42.1 57.7 10.4 10.2 11.3 6.4 1.4 28.3 13.8 5.4 40.3 16.6 27.4 30.9 64.3 85.5 11.9 8.3 28.2 34.4 17.0 12.6 7.3 12.6 55.1 13.1 53.5 25.7 22.2 15.2 14.7 6.0 3.8 18.5 48.5 12.5 9.3 MARK3 "CTAK1, KP78, PAR-1A" ENSG00000075413 "Microtubule affinity regulating kinase 3" P27448 14 103385377-103503831 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 32 "eosinophil: 101.5" "Lineage enriched" "Detected in all" 32 "granulocytes: 101.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024652 Approved NA NA "HPA024652: AB_1853582" "unprognostic (6.86e-2)" "unprognostic (2.93e-1)" "unprognostic (7.70e-2)" "unprognostic (3.48e-2)" "unprognostic (8.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.29e-3)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (1.60e-1)" 31.5 53.0 15.7 23.2 16.3 53.7 27.7 16.9 22.3 29.8 15.6 32.7 20.6 31.6 26.9 40.1 37.1 21.0 59.6 15.8 15.2 35.5 31.0 38.7 25.1 16.5 15.9 14.9 33.9 47.1 34.1 32.3 23.0 17.2 30.8 21.6 23.4 29.5 24.4 71.6 25.9 32.1 31.0 15.8 42.9 46.9 38.7 15.5 31.2 33.5 43.1 26.4 32.4 28.7 16.6 28.1 33.3 52.8 34.7 64.3 43.6 40.9 54.9 56.8 66.3 62.4 23.3 46.2 36.3 31.9 52.5 27.0 51.5 58.3 56.6 81.2 39.4 28.0 46.8 34.9 30.8 123.5 53.4 27.2 56.1 51.5 53.1 105.0 51.9 61.0 33.0 45.4 77.1 51.2 61.6 34.9 38.4 42.0 57.7 56.0 44.9 56.2 30.1 54.1 52.3 44.5 43.1 59.0 36.6 52.1 58.7 50.8 47.1 50.2 34.8 23.4 62.1 48.4 44.4 67.0 42.1 41.5 40.8 48.0 0.3 1.5 101.5 1.4 1.1 0.9 1.5 2.2 2.8 1.8 0.6 2.4 1.6 2.3 1.4 1.1 1.2 3.1 0.7 15.7 16.3 16.9 22.3 15.8 15.2 16.5 15.9 14.9 17.2 15.8 15.5 16.6 38.0 57.7 79.1 154.1 43.6 44.2 57.2 28.7 33.0 78.7 26.3 21.7 74.6 47.1 45.2 38.6 162.6 33.3 47.9 36.6 11.7 46.8 38.0 47.5 63.7 50.9 31.2 187.1 153.5 42.0 31.0 47.3 52.0 62.1 48.2 128.7 63.9 30.1 30.2 58.9 145.0 32.3 30.5 40.4 63.0 52.4 60.9 42.6 37.4 70.3 57.5 34.4 61.8 138.2 172.3 60.4 34.0 59.0 55.9 67.4 34.6 21.5 36.8 86.7 32.9 38.9 44.1 74.6 72.4 36.1 52.1 49.1 54.8 98.9 33.7 114.6 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1552.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1748.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria NA NA 83000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favorable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 299.9 555.2 137.2 186.3 132.7 211.0 269.8 160.3 144.9 223.7 195.4 419.6 400.0 285.8 228.1 441.2 251.1 137.4 998.1 134.0 158.2 423.6 373.1 257.9 203.4 149.5 150.6 124.0 292.7 395.5 503.9 218.6 194.0 155.8 211.7 350.9 168.6 305.2 223.0 1552.0 272.3 323.8 259.6 148.6 237.0 427.0 91.5 149.5 207.6 227.0 1244.1 315.4 297.2 266.8 148.6 731.4 447.1 620.0 509.6 534.1 891.5 1005.3 622.8 724.1 704.3 573.4 787.6 316.4 1003.2 376.9 633.0 320.3 573.7 616.9 741.3 680.6 402.9 651.8 589.5 297.4 563.3 683.0 665.7 416.6 857.3 616.8 494.2 681.2 994.3 990.8 488.8 654.9 240.5 782.7 436.5 642.5 724.2 605.4 540.6 988.5 703.0 730.3 1075.0 858.8 559.6 355.5 506.1 740.1 565.5 1009.8 504.4 771.0 676.3 782.0 371.2 390.0 442.8 603.4 486.5 648.5 678.1 295.6 368.3 494.9 184.7 408.9 223.2 244.7 520.2 285.6 298.5 270.8 271.4 534.7 222.6 281.3 269.8 166.6 288.5 545.2 321.7 377.4 637.0 137.2 132.7 160.3 144.9 134.0 158.2 149.5 150.6 124.0 155.8 148.6 149.5 148.6 319.2 214.7 294.8 46.0 392.2 376.0 590.6 751.4 495.1 223.1 442.5 549.3 1748.6 370.3 384.5 215.2 79.2 785.9 480.8 727.5 874.6 512.1 41.7 217.9 275.3 328.6 312.4 413.5 44.9 879.5 946.2 393.1 390.4 288.7 210.4 477.9 278.1 416.3 589.4 292.7 49.7 470.7 370.2 467.9 280.7 29.0 255.1 449.1 437.6 34.7 593.5 317.3 294.5 32.2 42.2 632.9 602.7 256.5 442.7 652.4 945.5 1029.4 201.1 230.2 302.4 470.5 733.5 126.1 169.9 796.6 362.4 814.7 356.3 536.0 729.1 769.9 FNDC3B "DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421" ENSG00000075420 "Fibronectin type III domain containing 3B" Q53EP0 3 172039578-172401669 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 283.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 26.8;hypothalamus: 12.8;pons: 7.4;thalamus: 12.5;white matter: 13.3" "Immune cell enhanced" "Detected in many" "neutrophil: 37.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007859 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA007859: AB_1078900" "unprognostic (7.18e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (6.03e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (3.25e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (2.17e-3)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (3.50e-2)" "prognostic unfavorable (5.65e-7)" "unprognostic (4.35e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-2)" 34.8 25.7 2.0 26.5 2.4 37.4 16.7 0.6 26.8 26.2 12.7 20.0 13.1 22.1 18.4 9.2 12.6 19.6 24.6 3.6 12.8 17.7 28.8 22.0 9.0 3.3 2.4 0.0 23.0 28.6 15.1 8.6 53.2 7.4 13.0 19.7 4.4 21.4 15.8 21.4 6.7 11.5 25.6 1.5 14.8 20.8 9.4 12.5 6.9 32.7 18.6 11.1 38.9 9.6 13.3 47.4 55.9 36.0 43.5 107.6 73.6 87.6 68.3 73.1 43.3 58.3 30.5 100.5 4.2 178.9 99.0 85.6 27.4 12.4 53.2 74.9 27.5 9.2 6.0 34.8 78.6 109.2 62.1 100.1 75.5 24.9 80.8 75.9 102.8 116.7 8.1 10.9 32.6 44.3 14.8 2.4 24.9 20.8 18.0 22.0 5.4 37.5 21.9 44.8 42.1 2.2 10.8 62.2 30.6 53.9 49.3 31.1 28.5 182.6 60.5 28.5 78.9 52.2 67.3 84.0 9.3 63.5 32.7 61.0 13.5 8.3 20.4 4.2 5.3 1.8 1.1 1.3 2.3 4.7 0.1 1.4 2.5 37.5 4.6 2.7 0.7 1.2 3.4 2.0 2.4 0.6 26.8 3.6 12.8 3.3 2.4 0.0 7.4 1.5 12.5 13.3 54.8 86.6 49.0 115.2 19.2 63.9 51.4 61.1 39.3 7.5 27.4 31.9 51.0 41.5 47.9 46.0 12.5 41.4 29.2 53.1 15.6 69.8 16.2 73.7 73.4 61.5 16.8 16.4 37.9 45.6 99.6 103.7 32.6 179.5 15.2 95.2 58.2 68.9 47.1 0.0 43.9 30.7 12.2 59.2 53.3 9.3 57.5 65.1 69.4 155.5 52.2 17.4 39.1 115.6 31.4 78.5 44.8 54.5 283.6 67.8 16.1 35.7 33.6 11.5 52.6 89.4 69.1 2.3 3.2 18.6 33.5 34.8 23.1 26.0 26.2 88.4 FOSL2 "FLJ23306, FRA2" ENSG00000075426 "FOS like 2, AP-1 transcription factor subunit" P15408 2 28392448-28417317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 287.6;Langerhans cells: 319.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 36.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 152.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004817, CAB013460, HPA061417" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (1.21e-1)" "unprognostic (8.55e-2)" "unprognostic (1.28e-3)" "unprognostic (3.41e-2)" "unprognostic (7.24e-2)" "unprognostic (3.78e-3)" "unprognostic (1.08e-1)" "unprognostic (7.73e-3)" "unprognostic (1.40e-2)" "unprognostic (2.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.38e-1)" "unprognostic (1.72e-2)" "unprognostic (1.99e-2)" "unprognostic (2.79e-2)" 118.8 171.3 27.7 68.2 18.9 234.2 79.3 18.3 37.0 76.9 24.0 62.8 30.5 78.5 7.0 130.6 86.4 80.3 64.7 33.9 100.0 55.8 31.2 84.1 9.2 38.4 16.7 13.4 134.6 37.5 7.6 47.0 47.3 22.5 54.2 40.6 10.8 47.7 26.9 102.5 102.9 52.7 82.1 18.0 32.9 77.3 7.3 23.0 17.3 35.5 34.2 16.7 83.0 113.0 46.7 45.0 30.2 2.0 23.2 23.9 41.6 62.0 37.7 38.0 58.8 51.1 35.9 34.6 0.2 53.9 48.6 59.6 42.0 2.5 49.7 52.6 10.6 3.1 4.6 59.3 6.3 37.3 7.9 18.9 66.9 123.3 69.0 60.5 49.5 31.2 1.5 0.6 12.5 39.7 7.3 0.7 24.3 3.6 45.2 14.8 1.8 57.4 4.3 94.3 152.5 15.7 2.3 61.0 35.2 10.9 16.8 3.8 35.5 93.8 122.8 81.9 72.3 55.2 19.1 7.6 0.2 81.5 43.3 21.6 17.2 9.9 8.7 7.7 7.3 7.4 0.0 1.6 3.8 3.9 0.0 0.4 2.5 36.6 4.6 6.4 1.3 1.2 5.1 27.7 18.9 18.3 37.0 33.9 100.0 38.4 16.7 13.4 22.5 18.0 23.0 46.7 183.1 32.1 50.9 4.6 20.2 143.1 86.3 85.8 90.0 0.8 76.4 41.7 27.9 70.1 59.7 167.3 0.0 27.4 287.6 140.6 19.6 58.5 1.3 115.7 88.0 111.0 28.1 4.4 11.9 59.8 148.3 79.7 115.7 193.6 108.3 68.1 56.7 16.5 37.4 0.0 8.1 65.2 40.7 58.0 319.8 4.3 22.4 181.2 85.4 15.0 62.8 2.3 53.5 0.5 0.6 54.1 91.5 24.5 67.0 82.2 124.8 35.1 38.2 1.4 26.3 93.8 122.3 1.6 2.5 157.6 150.7 50.2 142.4 23.6 57.6 152.8 CACNG5 ENSG00000075429 "Calcium voltage-gated channel auxiliary subunit gamma 5" Q9UF02 17 66835117-66894751 "FDA approved drug targets, Predicted membrane proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "brain: 12.5;retina: 15.9" "Cell type enriched" "Detected in some" 14 "Oligodendrocyte precursor cells: 74.9" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "olfactory bulb: 124.3" "Low region specificity" "Detected in many" HPA050115 Uncertain NA NA "HPA050115: AB_2681022" "unprognostic (1.85e-3)" "unprognostic (3.84e-2)" "unprognostic (1.44e-1)" "unprognostic (2.46e-6)" "unprognostic (4.52e-2)" "unprognostic (1.29e-1)" 0.0 0.0 4.6 0.0 3.1 0.1 0.0 1.0 5.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.3 0.1 0.0 0.0 0.4 3.3 6.4 2.4 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 15.9 0.0 0.0 0.1 0.1 0.0 0.0 3.7 0.2 0.0 0.1 12.5 0.1 0.0 0.0 0.3 0.0 0.0 3.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.1 1.0 5.3 1.9 3.3 3.3 6.4 2.4 1.9 3.7 12.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964707-67033398 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.4;prostate: 11.8" "Cell type enriched" "Detected in some" 6 "Oligodendrocyte precursor cells: 145.3" "Group enriched" "Detected in many" 5 "breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 387.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 118.1" "HPA005803, HPA065370" Enhanced Approved Vesicles NA NA Vesicles "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.2 0.8 26.4 0.1 33.4 0.0 5.4 6.0 22.6 0.4 3.3 0.5 0.2 0.5 0.1 0.2 4.2 0.4 0.1 13.0 15.4 0.1 0.0 5.8 0.0 15.7 15.1 15.8 0.1 0.4 1.2 0.3 0.7 21.4 11.8 0.1 0.8 1.7 1.3 0.1 0.4 0.1 1.1 10.0 0.0 1.5 0.2 21.1 0.0 0.1 0.0 0.0 0.4 0.7 10.6 6.4 4.1 15.6 0.0 0.0 0.0 4.4 0.0 0.0 1.4 0.0 4.6 0.2 0.0 0.2 0.0 41.2 64.1 0.1 0.0 0.0 0.0 0.3 0.0 1.8 3.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 34.5 0.1 0.3 15.7 7.3 0.0 0.0 0.4 8.7 0.0 11.1 15.8 387.4 3.6 10.4 0.0 38.1 38.5 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 33.4 6.0 22.6 13.0 15.4 15.7 15.1 15.8 21.4 10.0 21.1 10.6 0.0 3.2 1.3 0.0 0.0 0.0 1.1 0.3 0.0 0.2 6.4 3.4 1.3 0.0 1.4 0.0 0.0 0.3 0.1 0.6 0.0 0.1 2.6 1.0 0.2 0.1 7.7 0.0 1.8 0.2 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.0 3.4 0.0 145.3 0.3 0.7 0.2 0.0 0.0 2.6 0.0 0.0 1.9 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 FRYL "AF4p12, DKFZp686E205, KIAA0826, MOR2" ENSG00000075539 "FRY like transcription coactivator" O94915 4 48497357-48780322 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.8" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 1148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 13.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 13.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031106, HPA031107" Supported Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA031106: AB_10600660, HPA031107: AB_10600536" "unprognostic (7.50e-2)" "unprognostic (9.72e-3)" "unprognostic (6.68e-3)" "unprognostic (3.22e-2)" "unprognostic (5.37e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (4.80e-2)" "unprognostic (4.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.62e-2)" "unprognostic (3.32e-2)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" 8.9 5.4 9.9 13.4 37.3 15.2 8.0 22.9 26.4 8.5 2.3 38.3 10.4 8.5 3.7 6.7 6.2 8.3 8.7 9.6 19.2 8.5 5.8 9.7 13.5 28.1 21.8 5.7 7.9 5.6 20.5 2.7 10.6 28.3 6.6 37.1 29.5 6.8 6.7 4.5 10.2 12.9 9.3 23.4 10.9 10.8 6.4 25.2 16.9 8.0 12.1 13.2 10.3 3.4 79.8 19.7 11.6 26.8 16.4 11.3 16.1 14.5 18.1 17.4 17.6 21.2 9.4 14.7 25.0 14.3 19.3 32.9 11.8 17.8 28.1 37.9 14.3 6.1 45.6 11.3 4.3 7.0 31.6 16.8 11.6 10.5 24.0 24.9 16.4 26.4 21.3 14.8 9.2 22.9 9.6 34.5 10.9 4.6 8.9 9.8 25.4 35.0 4.7 15.7 20.8 23.1 9.9 17.7 5.2 9.9 12.8 6.8 19.6 40.3 19.8 25.5 10.1 35.3 12.4 17.5 22.1 16.6 20.6 19.8 13.5 0.9 1.8 2.0 1.4 1.6 1.5 1.8 1.7 1.0 1.2 2.0 1.9 2.8 2.7 1.0 1.7 1.3 0.7 9.9 37.3 22.9 26.4 9.6 19.2 28.1 21.8 5.7 28.3 23.4 25.2 79.8 87.1 38.5 33.1 92.1 50.1 47.3 24.3 32.0 38.7 45.3 23.7 17.0 33.5 18.6 28.9 16.5 135.5 23.6 59.9 122.8 3.9 13.8 11.6 48.2 29.0 74.8 79.5 80.6 110.1 11.6 21.5 23.7 128.4 56.8 46.9 25.6 48.9 15.2 19.4 47.1 172.5 195.1 38.7 30.1 34.0 3.9 17.1 40.1 26.6 214.5 35.1 32.8 63.8 146.8 1148.7 28.8 87.3 18.4 38.6 43.4 50.4 8.4 21.0 105.6 19.7 31.2 37.3 12.8 10.9 37.3 49.3 10.8 54.4 15.6 93.9 53.3 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995948 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" NA NA "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 12.2 12.3 7.0 20.9 7.3 17.7 10.7 7.1 7.7 19.0 9.2 26.0 18.7 16.5 8.6 14.4 15.4 16.0 13.1 7.1 6.5 12.2 13.6 12.5 25.6 6.1 7.4 6.8 16.5 19.2 27.7 11.2 18.4 5.9 16.7 23.4 11.5 13.5 11.6 24.6 24.3 19.5 16.7 6.0 18.6 26.4 14.8 9.7 18.6 12.9 22.5 23.3 14.2 10.5 8.4 26.1 15.7 28.8 21.0 29.6 35.8 31.4 37.8 36.5 18.9 22.7 20.3 36.8 41.3 20.4 39.3 32.2 18.4 30.5 50.5 28.0 29.4 19.8 30.0 10.6 29.3 33.4 28.2 38.6 34.4 20.2 33.7 34.7 32.0 23.5 19.8 18.1 42.8 58.2 15.7 20.6 17.9 15.8 20.2 33.4 29.7 18.3 18.3 19.3 30.7 32.3 15.7 24.4 16.7 23.2 30.7 14.0 25.8 28.1 49.1 22.4 23.9 14.7 18.1 26.8 20.6 38.5 24.3 33.9 3.7 1.3 3.6 1.7 1.6 1.9 2.1 1.5 1.7 1.7 1.9 1.7 2.3 0.9 2.5 1.6 2.4 1.0 1.0 7.0 7.3 7.1 7.7 7.1 6.5 6.1 7.4 6.8 5.9 6.0 9.7 8.4 29.4 16.0 27.9 90.1 41.2 19.8 17.7 16.3 24.5 28.3 17.3 16.0 34.7 15.7 23.4 20.2 22.9 15.4 33.1 62.2 3.9 9.7 14.4 88.9 33.9 19.3 30.1 23.5 113.1 24.0 12.7 23.5 60.1 86.8 23.5 21.3 22.9 26.0 24.5 25.2 99.7 45.6 10.2 29.2 18.5 20.1 20.8 35.8 12.4 87.1 47.0 14.1 9.2 92.5 129.8 18.1 40.1 19.2 36.3 17.9 27.4 7.0 38.2 19.3 13.1 31.9 24.9 21.2 26.0 25.0 25.6 13.5 22.4 28.0 36.6 16.0 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592816-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 256.5;Hofbauer cells: 274.2;monocytes: 1028.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 600.3;Hep G2: 464.9;K-562: 533.6;NB-4: 600.9;PC-3: 508.2;SH-SY5Y: 482.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4300000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 27.1 40.0 23.4 31.4 45.1 8.4 25.1 15.2 37.7 27.7 6.2 12.2 4.4 19.9 0.7 70.0 15.8 7.7 15.3 30.0 37.7 15.0 8.4 27.8 14.6 38.6 33.9 22.9 48.1 5.6 2.3 20.4 28.2 46.0 10.4 1.7 3.4 24.0 2.5 7.4 54.2 12.7 5.8 11.8 56.1 9.4 42.9 43.2 9.1 25.8 2.1 8.4 20.5 41.9 46.7 62.3 139.3 91.2 326.3 34.8 65.4 600.3 144.2 62.4 24.2 26.1 98.5 15.6 1.3 172.0 63.5 24.3 231.3 52.2 229.9 2.1 70.6 28.7 4.8 142.0 464.9 18.0 0.2 13.9 40.8 66.6 46.1 37.2 40.4 118.3 0.7 533.6 0.9 31.6 6.9 2.0 600.9 238.4 4.2 508.2 140.0 22.3 2.3 34.9 5.9 73.1 482.4 121.0 2.6 5.3 58.5 3.9 38.4 246.4 167.4 289.3 99.1 151.0 0.9 0.8 0.7 107.8 0.6 317.2 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 23.4 45.1 15.2 37.7 30.0 37.7 38.6 33.9 22.9 46.0 11.8 43.2 46.7 90.0 3.2 4.1 1.6 8.3 181.2 26.7 75.1 189.5 9.4 32.3 44.3 10.4 1.5 13.4 1.8 0.0 6.7 10.8 3.9 0.0 12.8 14.3 8.0 37.8 120.6 42.1 28.0 12.1 5.1 110.8 48.9 10.7 10.1 16.5 256.5 84.6 0.8 274.2 0.0 10.9 5.4 8.2 28.0 136.1 12.3 25.4 27.4 51.6 23.4 1028.2 73.5 0.0 4.5 43.2 15.5 1.1 9.1 4.2 7.5 0.4 0.4 2.9 2.6 0.0 29.7 46.3 5.7 8.0 121.2 147.2 14.6 12.2 8.3 2.6 28.0 ACTB ENSG00000075624 "Actin beta" P60709 7 5526409-5563902 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 22882.9;Pancreatic endocrine cells: 14370.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002621, HPA041264, HPA041271" Supported NA NA 5800000000 "CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (1.66e-1)" "unprognostic (1.15e-1)" "unprognostic (4.20e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (4.51e-4)" "unprognostic (9.80e-3)" "unprognostic (1.57e-3)" "unprognostic (1.73e-1)" "unprognostic (5.99e-2)" "unprognostic (3.33e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (3.78e-5)" "unprognostic (2.68e-2)" "unprognostic (3.20e-1)" "unprognostic (1.50e-1)" "unprognostic (4.88e-3)" 2581.5 1246.0 2348.5 4288.9 2493.1 3630.4 2027.0 2556.1 2733.4 2153.1 2449.6 5279.2 1674.1 5076.2 1644.6 2956.0 2969.6 1787.7 796.9 2538.4 2873.0 1318.7 1774.5 2900.9 4430.0 2821.3 2441.8 2296.6 1725.9 768.4 845.5 737.1 1832.3 2686.4 2044.2 2360.8 492.5 1482.2 2970.8 469.6 1486.1 2849.6 5788.3 2708.1 3035.8 2893.7 563.4 2542.5 3308.6 1329.7 528.7 4639.9 3752.1 2242.1 3100.7 7791.1 5198.8 5604.1 4658.2 2321.1 3120.3 6654.3 6049.6 4853.2 6209.7 4619.4 8249.5 4361.9 4522.7 4557.0 9445.4 4904.8 4820.3 3279.5 9453.9 4507.4 5324.6 1668.7 3974.3 4579.6 4520.6 3538.8 4733.2 9853.8 4098.5 2786.7 6863.0 1738.0 4128.6 5073.2 3561.3 2189.7 3513.0 6603.4 7531.9 4055.1 13162.1 6813.7 2468.5 3490.8 5658.6 3351.4 3419.7 5904.6 3175.8 1633.1 2746.9 5754.7 5822.1 2400.3 5088.3 5859.7 5314.8 7975.3 10437.4 7019.9 7000.1 8802.8 1902.3 2442.5 5082.1 5772.0 6622.6 12412.7 14674.1 18104.2 29636.6 10647.1 19648.6 8327.7 5139.6 7639.4 9512.9 19292.5 4844.1 5592.0 7894.3 18040.6 6233.1 22870.8 7122.2 11463.2 37406.8 2348.5 2493.1 2556.1 2733.4 2538.4 2873.0 2821.3 2441.8 2296.6 2686.4 2708.1 2542.5 3100.7 2775.4 1150.6 680.4 142.4 4118.9 5737.0 9776.6 5792.0 3110.2 146.7 1564.0 2047.2 145.3 1080.9 2763.3 2144.5 85.5 3647.7 3989.3 3419.3 2277.4 6508.8 101.3 1422.1 2344.0 2768.4 1451.5 3170.9 129.3 6365.4 12480.2 2958.5 3136.1 2041.6 1539.9 2372.0 2163.5 2590.6 13977.7 269.2 101.3 2006.7 3694.5 7392.0 11420.0 199.7 1766.7 8486.4 2995.4 259.5 22882.9 1654.4 5237.9 116.1 302.2 14370.0 2899.8 2680.3 3040.4 4764.9 4968.2 2149.2 1453.8 146.7 3287.0 1398.2 5423.9 133.8 381.9 4376.1 4722.2 3257.7 5961.7 1688.9 1966.6 6941.4 MOCOS "FLJ20733, HMCS, MOS" ENSG00000075643 "Molybdenum cofactor sulfurase" Q96EN8 18 36187497-36272157 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 10.3;liver: 16.1" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 18.8;Hepatocytes: 39.4;Proximal enterocytes: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 40.7;hTERT-HME1: 49.7;SiHa: 54.9;SK-MEL-30: 38.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039412, HPA047958" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039412: AB_2676496, HPA047958: AB_2680225" "unprognostic (3.07e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (3.18e-3)" "unprognostic (2.55e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.84e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.91e-2)" "prognostic unfavorable (3.03e-12)" "unprognostic (8.98e-2)" "unprognostic (2.37e-1)" "unprognostic (4.09e-1)" "unprognostic (6.35e-2)" 1.9 10.3 0.3 0.9 0.3 0.3 2.6 0.5 0.5 0.9 0.5 1.6 6.1 0.8 1.9 3.8 1.7 1.4 0.2 0.4 0.4 1.1 16.1 1.6 0.2 1.0 0.3 0.3 6.4 0.8 2.3 2.0 1.1 1.3 1.3 1.6 0.7 1.9 3.3 0.6 2.0 6.5 0.6 0.2 0.3 1.6 0.9 0.4 0.1 1.2 0.4 1.2 2.7 0.7 0.8 14.3 4.8 0.2 0.1 4.3 5.5 2.9 8.2 4.6 3.9 10.0 3.1 4.4 0.1 2.5 13.4 1.0 8.6 2.9 12.9 5.4 2.4 2.3 0.2 13.5 11.8 14.6 0.1 3.8 8.7 40.7 15.2 49.7 0.5 0.6 0.1 4.9 0.1 6.2 3.6 0.0 0.1 0.8 3.4 4.1 0.0 0.1 0.0 5.5 18.5 0.1 1.2 54.9 3.3 38.8 0.9 2.5 0.2 2.7 3.0 3.7 6.7 1.4 0.1 0.1 0.1 7.8 0.1 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.5 0.4 0.4 1.0 0.3 0.3 1.3 0.2 0.4 0.8 0.9 12.8 5.0 0.3 0.9 0.6 1.4 3.7 1.8 0.3 4.5 1.9 1.0 4.3 6.4 0.0 2.1 0.5 0.2 2.2 0.0 3.1 7.2 5.9 3.4 0.8 3.0 0.0 0.9 12.4 4.3 2.4 1.5 18.8 0.0 2.0 0.4 39.4 0.6 0.0 1.1 3.1 6.1 0.6 2.6 3.2 1.8 1.0 3.6 4.7 11.9 6.6 0.0 1.0 0.3 4.6 2.3 9.1 0.9 2.3 22.4 0.2 4.5 0.5 0.0 6.5 1.2 0.1 0.3 5.1 1.3 2.3 0.5 2.7 4.5 2.2 PLD1 ENSG00000075651 "Phospholipase D1" Q13393 3 171600404-171810950 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 87.6" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 519.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004527, HPA042396, HPA066938" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: " "unprognostic (3.23e-1)" "unprognostic (3.27e-1)" "unprognostic (5.82e-2)" "unprognostic (5.13e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.46e-1)" "unprognostic (6.23e-2)" "unprognostic (8.02e-2)" "unprognostic (2.06e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.76e-6)" 7.9 26.6 11.1 6.7 21.7 7.8 7.6 17.2 13.2 7.9 5.5 14.7 47.3 6.3 2.9 33.3 6.4 87.6 24.6 9.6 16.9 12.1 33.9 4.8 9.2 22.7 21.2 4.8 24.4 21.4 1.6 2.3 10.8 22.6 3.4 14.8 0.5 14.0 6.0 2.5 29.5 44.3 4.8 17.9 15.8 8.2 5.1 18.5 4.1 3.7 6.8 10.8 5.1 12.5 41.3 4.5 7.2 3.7 1.4 11.2 12.6 7.7 2.3 9.9 3.5 4.3 1.1 6.4 0.0 17.0 0.9 24.0 15.2 0.6 2.0 5.7 3.6 3.2 4.2 11.5 26.1 4.9 7.3 18.9 4.9 10.9 4.2 2.0 10.0 57.5 1.2 2.8 0.0 0.9 1.3 0.0 6.4 0.8 11.9 5.1 0.2 1.5 0.1 8.9 1.8 0.1 0.1 7.9 4.7 31.1 5.1 9.0 9.7 50.7 1.5 5.7 4.0 2.5 9.6 8.2 0.1 6.7 8.6 1.9 8.3 1.8 2.3 0.3 1.1 2.6 0.0 0.2 0.6 0.6 0.0 0.0 0.1 1.0 2.2 0.4 0.0 0.8 0.6 11.1 21.7 17.2 13.2 9.6 16.9 22.7 21.2 4.8 22.6 17.9 18.5 41.3 7.7 0.0 4.7 2.0 0.9 7.1 3.4 11.0 10.8 0.4 4.9 5.6 33.6 57.2 11.1 1.8 0.0 3.0 1.9 37.5 3.9 8.4 13.1 1.0 4.8 7.4 4.2 6.3 8.9 3.4 3.7 15.7 27.0 1.3 27.9 10.4 6.4 15.9 20.0 0.0 12.1 23.6 6.1 13.2 2.4 9.5 10.5 10.2 12.4 98.4 5.4 0.0 1.0 12.5 519.6 2.4 18.3 4.5 3.4 0.7 38.3 48.0 9.9 0.1 19.7 3.8 8.4 6.1 5.3 93.5 34.9 2.3 2.3 12.1 17.8 4.7 ATP12A "ATP1AL1, H-K-ATPase, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680408-24712472 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 11.3;kidney: 5.5;lymphoid tissue: 14.9;placenta: 5.6;skin 1: 5.8" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 75.6;Club cells: 49.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SuSa: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments" Cytosol "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 5.6 0.0 0.2 2.0 0.0 0.1 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 14.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 0.0 75.6 0.0 0.0 0.2 0.3 0.4 0.0 49.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.2 8.2 0.0 0.0 0.1 0.3 0.1 0.0 1.0 0.0 0.0 0.0 1.0 0.6 0.1 1.2 0.0 0.0 0.2 0.0 0.1 13.6 0.0 0.0 0.0 1.8 1.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 1.3 WDR62 "C19orf14, DKFZP434J046, FLJ33298, MCPH2" ENSG00000075702 "WD repeat domain 62" O43379 19 36054649-36105108 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 111.3;testis: 64.2;tongue: 63.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6" "Cancer enhanced" "Detected in many" "testis cancer: 10.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.7" "Lineage enriched" "Detected in single" 4 "monocytes: 2.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043255, HPA043639" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA043255: AB_2678393, HPA043639: AB_2678593" "unprognostic (1.77e-1)" "unprognostic (2.79e-3)" "unprognostic (3.16e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-1)" "unprognostic (4.22e-3)" "unprognostic (1.78e-4)" "unprognostic (2.00e-1)" "unprognostic (4.00e-2)" "unprognostic (5.82e-3)" "unprognostic (4.72e-2)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.73e-3)" "unprognostic (2.72e-1)" "unprognostic (1.50e-1)" "unprognostic (2.67e-1)" 0.4 0.4 0.3 2.1 0.4 5.4 0.4 0.8 0.7 0.7 0.1 0.6 1.1 0.6 0.2 3.7 0.7 0.3 22.4 0.4 0.3 0.4 0.7 0.7 2.9 0.5 0.3 0.2 0.4 0.2 0.1 0.4 0.5 0.4 0.7 0.5 6.8 1.3 0.2 111.3 2.7 1.2 0.7 0.1 2.0 0.9 64.2 0.3 5.0 0.4 63.6 1.8 0.3 1.4 0.8 19.9 37.8 12.3 12.6 1.1 0.3 7.8 18.0 7.6 24.1 20.8 20.0 6.7 24.7 10.9 9.3 11.3 6.1 18.6 6.8 13.5 16.1 8.8 16.9 20.5 13.5 0.8 16.8 19.6 0.3 0.7 17.7 5.2 1.7 6.0 17.3 21.7 26.8 11.3 20.6 33.1 9.0 7.3 16.0 7.4 23.3 12.5 11.7 3.3 7.5 15.3 8.6 12.1 16.7 2.8 7.6 9.6 14.3 4.1 20.8 19.9 16.7 29.6 14.0 22.1 32.0 9.1 13.0 24.6 0.5 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.6 0.2 2.7 0.1 0.5 0.1 0.3 0.4 0.8 0.7 0.4 0.3 0.5 0.3 0.2 0.4 0.1 0.3 0.8 1.8 0.0 5.5 0.3 1.0 2.2 1.3 0.5 0.6 1.6 0.9 0.6 43.4 0.0 0.8 0.0 85.5 1.9 1.2 2.5 1.9 0.4 42.5 0.8 0.8 2.0 0.0 11.0 1.4 0.9 1.9 1.8 5.6 0.8 0.0 4.3 1.1 0.8 2.2 3.3 1.0 2.2 2.0 1.3 1.6 46.2 1.2 1.9 1.8 1.0 0.8 2.1 0.0 1.0 1.0 0.5 0.2 0.4 7.1 0.8 0.3 0.3 0.2 41.7 6.6 2.8 1.9 67.6 15.4 2.0 3.7 0.3 2.2 1.2 3.0 0.7 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299330 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 422.9;Oligodendrocytes: 1542.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 20.9 14.6 29.4 14.8 57.7 16.3 18.6 37.7 39.5 24.0 17.1 24.4 24.2 19.9 11.7 37.9 16.2 17.2 19.6 27.8 29.7 27.8 26.1 18.2 14.9 41.0 46.6 20.3 23.5 17.3 32.0 14.5 21.4 54.6 16.0 26.6 39.1 20.4 18.8 25.4 18.3 25.6 21.4 27.8 13.1 23.1 15.6 43.2 27.4 43.6 28.4 20.7 20.5 20.7 75.0 128.0 20.0 40.3 75.7 34.2 36.2 40.7 52.2 46.2 49.2 59.0 60.4 59.8 41.5 127.1 47.7 95.7 86.4 39.3 76.4 97.7 10.9 22.5 35.2 31.1 40.5 35.2 35.0 33.3 27.8 43.3 49.1 101.3 163.1 64.8 32.2 26.7 51.4 125.6 41.5 51.3 12.9 35.3 71.1 35.4 26.7 51.6 26.8 51.9 55.3 19.7 32.3 72.9 49.5 49.4 46.7 108.8 26.0 62.5 127.5 33.5 36.1 79.9 76.0 50.6 50.6 50.3 51.8 40.0 2.5 0.7 1.2 0.8 0.7 1.3 1.6 1.3 0.9 0.8 1.2 1.3 1.3 2.4 1.1 0.4 1.1 1.0 0.8 29.4 57.7 37.7 39.5 27.8 29.7 41.0 46.6 20.3 54.6 27.8 43.2 75.0 24.0 25.6 25.7 113.3 28.5 53.3 52.3 45.5 40.5 42.0 29.6 23.0 25.6 35.8 44.6 49.7 95.9 48.9 25.2 72.4 5.9 22.8 12.9 51.8 37.4 28.1 28.9 17.5 422.9 20.2 19.5 27.7 51.5 68.5 12.0 29.9 27.8 54.6 14.9 37.0 117.8 34.4 28.5 26.4 26.0 19.2 28.6 19.2 37.4 165.8 18.3 71.9 43.3 257.3 1542.2 30.3 48.0 25.6 34.1 52.3 50.6 20.8 66.3 101.7 13.1 40.5 25.5 31.2 37.9 66.7 70.8 25.0 30.6 29.3 38.8 106.8 RAB7A "CMT2B, RAB7" ENSG00000075785 "RAB7A, member RAS oncogene family" P51149 3 128693669-128825942 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport" Hydrolase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006964, CAB037131" Supported Supported Lysosomes NA NA 5700000 Lysosomes "CAB037131: AB_477460, HPA006964: AB_1856015" "unprognostic (1.99e-2)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.45e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (9.89e-6)" "unprognostic (2.15e-2)" "unprognostic (2.38e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (4.69e-1)" "unprognostic (6.73e-3)" "unprognostic (1.88e-1)" "unprognostic (1.97e-1)" "unprognostic (3.03e-3)" "unprognostic (5.64e-3)" 170.0 158.4 113.7 102.3 130.3 100.8 150.8 126.9 152.9 127.4 116.6 128.5 109.2 138.6 144.3 189.7 111.1 110.7 188.5 128.8 131.2 133.1 146.5 154.2 109.7 133.1 133.1 112.5 123.7 89.3 157.2 102.3 118.5 137.4 102.2 127.2 104.7 134.4 64.5 335.5 163.7 117.7 125.1 131.0 124.0 115.9 61.9 131.8 125.8 123.5 251.9 137.7 145.8 144.6 166.8 280.2 95.5 146.0 78.3 300.6 94.0 126.0 252.8 183.9 164.4 158.8 170.1 179.2 134.2 163.2 236.2 289.9 163.4 175.2 248.6 99.2 149.4 111.7 294.3 83.6 165.8 303.0 269.4 182.5 243.7 104.0 176.7 204.4 220.7 89.2 114.4 143.4 148.0 108.1 213.1 176.8 294.6 121.4 294.8 144.8 140.2 130.7 170.4 85.7 205.4 105.8 138.5 142.1 194.7 405.4 174.9 180.3 254.8 202.9 192.7 98.0 325.7 125.9 184.4 187.0 192.0 312.7 212.1 235.5 194.9 176.8 213.6 92.1 192.3 92.3 93.2 97.4 94.5 200.0 85.8 94.8 93.6 374.2 128.8 204.0 81.8 120.7 201.3 113.7 130.3 126.9 152.9 128.8 131.2 133.1 133.1 112.5 137.4 131.0 131.8 166.8 154.4 89.8 81.8 66.9 109.9 296.7 331.2 218.1 104.7 66.0 112.8 73.0 110.7 90.1 129.4 132.4 18.8 230.0 92.3 222.1 240.7 259.6 11.2 90.8 90.8 165.3 96.9 111.3 83.9 198.9 283.4 172.5 79.0 142.4 146.2 46.5 142.8 127.9 403.9 74.0 82.5 122.8 219.7 208.6 379.9 19.6 133.6 242.8 339.7 99.3 220.9 154.6 121.5 80.9 111.4 303.7 185.0 157.2 79.9 279.2 172.7 332.3 118.7 37.6 138.1 107.7 160.5 116.4 100.4 122.8 308.0 497.9 107.7 109.6 103.5 324.6 BCAP29 "BAP29, DKFZp686M2086" ENSG00000075790 "B cell receptor associated protein 29" Q9UHQ4 7 107580246-107629170 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029215, HPA049694" Supported Approved Cytosol NA NA Cytosol "HPA029215: AB_10602331, HPA049694: AB_2680854" "unprognostic (3.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.82e-2)" "unprognostic (1.05e-2)" "unprognostic (5.42e-3)" "unprognostic (4.71e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.43e-2)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (2.31e-2)" "unprognostic (7.36e-2)" "unprognostic (8.34e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-2)" "unprognostic (5.28e-3)" "unprognostic (1.81e-1)" 47.5 25.9 21.5 22.7 26.1 16.8 28.2 20.1 27.3 49.1 16.2 32.9 16.2 43.0 18.7 34.7 21.9 23.2 61.6 25.3 21.0 20.3 33.6 26.3 16.9 20.3 21.2 23.0 21.6 19.0 34.8 12.3 26.9 21.1 32.2 31.5 9.6 18.5 25.3 39.0 22.2 18.9 38.5 21.7 18.2 22.6 70.7 21.5 12.9 86.2 31.8 15.9 31.2 32.8 23.6 71.7 22.8 26.4 13.8 65.2 81.6 22.6 80.6 68.2 32.9 39.7 23.2 72.1 13.4 54.5 58.1 75.1 35.8 13.7 38.6 52.5 50.1 17.3 27.1 35.6 26.2 63.3 33.6 41.2 48.9 31.8 46.7 38.0 95.4 116.9 25.3 58.3 33.4 75.4 67.2 23.2 34.3 15.4 29.7 30.0 18.6 34.1 34.6 60.6 49.1 10.2 37.7 68.2 54.9 58.2 39.3 25.6 37.5 113.9 102.5 52.1 94.6 104.7 31.7 67.9 27.5 66.5 30.5 77.2 47.5 10.5 25.5 9.5 13.6 9.3 12.8 7.5 9.5 10.0 8.5 4.3 8.5 3.9 9.9 21.7 10.1 13.6 8.1 21.5 26.1 20.1 27.3 25.3 21.0 20.3 21.2 23.0 21.1 21.7 21.5 23.6 169.8 67.3 57.2 35.6 33.9 38.5 80.7 99.0 25.0 35.2 40.4 34.2 117.8 27.1 77.7 23.9 10.4 30.2 31.4 38.1 15.6 46.4 227.1 54.6 93.3 99.0 22.3 73.2 81.1 73.6 50.8 72.9 32.6 102.0 58.3 14.8 73.2 40.7 52.6 8.4 71.3 35.8 69.2 36.6 35.6 95.8 61.2 49.6 37.4 44.0 41.6 28.3 22.6 50.8 49.7 71.2 32.5 89.1 17.7 110.4 15.6 19.5 55.9 26.7 78.9 62.9 91.3 202.2 35.0 46.5 38.8 70.7 33.5 32.0 45.4 83.5 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486646-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 28.7;Bipolar cells: 32.2;Cone photoreceptor cells: 39.6;Excitatory neurons: 38.1;Horizontal cells: 40.4;Inhibitory neurons: 40.7;Oligodendrocyte precursor cells: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.1;JURKAT: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavorable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.1 1.5 1.6 1.1 1.7 2.5 2.0 1.9 2.6 2.4 0.9 2.3 0.3 2.1 1.1 0.8 2.7 0.8 2.8 1.5 1.4 2.2 2.0 1.7 1.6 1.6 1.4 1.8 2.8 0.6 1.7 3.7 0.8 1.7 2.3 0.8 1.5 1.6 0.8 6.0 1.3 2.4 0.8 1.1 3.0 1.7 2.8 1.5 3.0 2.0 8.3 1.3 1.8 1.5 1.7 0.1 0.0 2.0 0.5 0.6 1.0 0.1 0.4 0.9 0.2 0.6 0.1 0.0 0.4 0.6 0.0 0.1 0.0 1.1 0.2 0.5 2.5 0.5 1.0 1.5 0.2 0.9 0.8 0.8 1.8 1.0 0.1 1.2 9.1 0.3 8.9 0.1 1.3 0.0 0.0 1.4 2.3 0.0 0.2 0.4 2.0 0.0 0.9 0.6 0.0 0.1 0.7 0.2 0.0 0.4 1.5 0.4 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.6 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 1.9 2.6 1.5 1.4 1.6 1.4 1.8 1.7 1.1 1.5 1.7 2.5 6.4 4.5 28.7 2.4 1.1 0.9 1.7 1.2 32.2 2.9 2.0 8.0 4.3 2.3 11.0 39.6 1.2 4.5 3.8 0.0 0.4 2.3 1.3 3.4 2.6 5.4 0.4 38.1 0.2 0.3 2.4 3.1 1.6 1.3 7.7 2.9 6.1 2.2 40.4 40.7 3.3 0.0 4.8 1.7 1.7 3.4 3.5 1.8 7.5 5.2 3.6 1.0 32.6 21.5 0.2 2.0 4.1 2.5 1.2 2.4 1.0 2.2 5.8 0.0 1.9 2.2 7.7 3.2 1.8 1.1 0.8 4.6 4.7 4.0 1.1 SART3 "KIAA0156, p110, RP11-13G14, TIP110" ENSG00000075856 "Spliceosome associated factor 3, U4/U6 recycling protein" Q15020 12 108522214-108561400 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028840, HPA044322" Approved Supported Nucleoplasm No No Nucleoplasm "HPA028840: , HPA044322: AB_2678895" "unprognostic (1.72e-1)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (2.74e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.38e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (7.91e-2)" "unprognostic (1.61e-1)" "unprognostic (6.36e-2)" 14.4 15.2 14.2 18.6 14.8 25.8 14.9 18.3 15.8 18.7 13.0 16.1 12.7 19.5 13.9 19.3 17.6 12.0 14.0 14.3 15.3 12.7 16.2 14.7 26.5 13.4 14.0 13.7 24.0 13.3 18.4 19.1 15.5 14.7 16.6 15.3 20.4 14.2 14.7 17.9 19.1 17.3 14.0 13.7 19.9 15.2 16.9 14.4 25.9 19.0 15.2 23.4 15.6 16.1 17.4 34.5 61.5 45.4 53.8 24.2 18.9 43.6 29.3 35.8 50.1 37.2 51.5 23.4 51.3 20.1 26.4 32.2 32.0 68.2 33.9 44.1 61.8 43.0 74.1 40.9 47.9 39.2 74.0 44.4 26.4 31.4 31.9 46.8 38.1 30.8 42.1 85.7 33.7 30.9 34.6 69.9 57.5 90.2 27.6 59.9 67.3 44.7 59.3 26.1 57.5 56.8 40.3 45.0 17.0 30.7 38.7 49.0 51.1 26.0 39.0 21.0 30.1 30.7 42.6 68.3 75.6 34.1 42.2 46.2 6.9 6.2 6.4 8.3 5.1 9.9 7.7 6.3 8.3 9.0 7.1 9.4 6.0 1.6 8.6 7.6 6.1 10.5 7.9 14.2 14.8 18.3 15.8 14.3 15.3 13.4 14.0 13.7 14.7 13.7 14.4 17.4 14.7 19.2 24.5 16.0 25.9 14.7 16.3 15.4 16.5 42.0 11.5 11.4 19.9 10.0 23.4 18.4 35.5 21.4 21.1 12.0 7.9 14.7 53.6 15.1 21.6 20.0 12.5 23.1 22.1 12.7 14.0 17.1 15.3 15.9 17.7 21.9 11.7 12.5 13.2 35.3 22.2 9.3 24.4 14.1 13.8 30.8 10.2 17.0 16.0 16.9 18.6 23.4 14.4 19.1 24.9 13.5 7.7 17.7 29.6 16.1 9.5 8.2 27.4 39.1 32.9 22.0 18.0 27.2 31.1 19.6 18.0 23.7 24.2 19.1 14.0 17.0 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 80.5;lymphoid tissue: 75.9" "Cell type enhanced" "Detected in many" "B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA 38000 "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 6.6 5.9 1.5 27.4 1.6 80.5 7.7 2.3 2.3 4.2 2.5 7.4 6.8 2.6 9.8 4.0 2.8 11.5 4.8 1.2 2.1 4.4 10.3 9.9 59.8 2.5 1.8 0.7 1.9 1.3 1.7 1.0 4.1 2.5 4.3 7.7 1.3 4.2 5.2 1.2 2.0 15.2 3.9 2.6 45.3 7.6 7.4 1.9 75.9 4.5 2.2 46.7 11.5 4.3 3.5 0.3 0.1 4.9 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 59.4 0.2 0.1 0.1 0.1 0.2 0.1 0.3 14.6 0.0 75.8 0.5 0.1 0.0 124.3 1.2 0.0 0.0 0.2 0.2 0.1 0.0 47.0 0.3 4.4 0.0 0.1 82.0 100.4 0.3 0.0 0.1 44.7 0.6 22.7 0.0 0.1 0.2 0.4 0.3 0.2 1.0 0.1 4.5 131.0 0.6 0.4 1.2 0.1 0.2 1.0 0.3 89.5 0.7 63.9 3.9 181.8 32.0 140.1 97.7 34.3 161.6 94.3 172.8 125.7 56.3 86.2 119.0 101.7 207.2 121.4 40.5 54.3 147.7 99.9 1.5 1.6 2.3 2.3 1.2 2.1 2.5 1.8 0.7 2.5 2.6 1.9 3.5 8.2 0.0 9.6 2.0 126.3 5.6 0.1 0.0 0.0 0.3 1.8 2.0 3.9 1.5 2.5 0.0 0.0 0.2 78.9 0.3 0.0 0.1 132.3 1.8 2.3 4.3 0.0 26.3 12.2 0.0 0.3 9.7 8.6 3.5 88.5 0.0 8.6 0.8 21.3 1.7 6.8 0.0 0.0 39.9 30.9 17.5 14.9 43.0 8.8 250.1 34.9 0.4 89.6 20.6 3.2 0.0 0.0 3.4 65.8 0.2 0.0 0.7 2.2 0.3 46.0 2.7 31.6 68.4 1.2 0.4 4.5 0.3 149.2 0.1 0.2 0.2 TUBA3D H2-ALPHA ENSG00000075886 "Tubulin alpha 3d" P0DPH8 2 131476119-131482934 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 221.9" "Cell type enhanced" "Detected in some" "Early spermatids: 358.9;Late spermatids: 119.6;Spermatocytes: 667.9;Spermatogonia: 326.1" "Cancer enhanced" "Detected in many" "testis cancer: 7.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "CAB004972, HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA NA Microtubules "CAB004972: AB_425727, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic favorable (4.65e-4)" "unprognostic (6.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-3)" "unprognostic (1.82e-1)" "unprognostic (1.50e-3)" "unprognostic (2.17e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (2.89e-1)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (4.75e-9)" "unprognostic (4.60e-2)" "unprognostic (2.28e-1)" "unprognostic (9.96e-4)" "unprognostic (2.28e-1)" 0.1 0.1 0.4 0.2 0.2 0.4 0.6 1.5 0.4 2.0 0.0 0.1 0.1 4.9 6.9 0.2 4.1 0.2 47.7 0.7 0.1 0.1 0.4 0.1 0.4 0.3 0.0 0.2 0.5 0.2 0.0 0.1 0.0 0.7 10.2 0.0 0.3 0.3 0.4 0.1 0.6 0.2 0.3 0.1 0.2 0.2 221.9 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.5 0.2 0.2 0.9 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.8 0.3 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.7 0.1 0.6 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.5 0.5 1.1 0.7 0.0 0.3 0.4 0.0 0.2 0.0 0.2 0.5 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.4 0.5 0.3 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.4 0.7 0.1 0.3 0.0 0.2 0.7 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.4 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.9 0.4 1.1 1.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 1.1 0.0 0.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 119.6 12.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 4.8 0.0 0.0 0.0 0.0 52.6 0.0 0.1 667.9 326.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735396-100829944 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 29.8;kidney: 85.9" "Cell type enhanced" "Detected in some" "Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0" "Group enriched" "Detected in some" 9 "cerebellum: 1.3;pons and medulla: 3.4" "Group enriched" "Detected in some" 7 "cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.0 0.0 1.7 0.0 1.2 0.0 0.0 2.1 0.6 2.9 0.2 0.0 0.0 1.8 29.8 0.0 8.5 0.0 0.0 0.4 2.9 85.9 0.1 0.0 0.0 6.1 0.6 0.1 0.2 0.4 5.9 0.8 0.0 3.2 0.2 0.0 1.2 0.0 11.6 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 1.4 0.1 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 14.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.6 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 16.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.2 2.1 0.6 0.4 2.9 6.1 0.6 0.1 3.2 4.7 1.4 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 5.9 0.0 0.0 145.3 0.0 0.0 0.0 0.0 49.0 0.0 9.4 129.5 14.8 0.6 0.0 0.0 0.5 0.2 0.0 0.2 0.0 246.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.0 1.1 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.5 0.0 0.0 0.6 1.1 1.2 0.0 0.0 0.0 1.2 0.0 0.1 0.0 EXOSC7 "EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p" ENSG00000075914 "Exosome component 7" Q15024 3 44975241-45036066 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036182, HPA057980" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA036182: AB_10673346, HPA057980: AB_2683571" "unprognostic (1.69e-2)" "unprognostic (3.92e-3)" "unprognostic (1.84e-3)" "unprognostic (4.97e-2)" "unprognostic (3.00e-3)" "unprognostic (2.16e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-2)" "unprognostic (2.96e-1)" "unprognostic (7.85e-2)" "unprognostic (1.20e-1)" "unprognostic (7.67e-3)" "prognostic favorable (2.69e-4)" "unprognostic (4.33e-1)" "unprognostic (7.30e-2)" "unprognostic (2.94e-1)" "unprognostic (1.20e-1)" 16.4 44.5 10.3 12.6 10.1 17.3 18.6 10.6 11.0 21.9 11.0 14.9 11.7 20.6 7.1 27.5 17.1 9.1 27.1 10.0 11.3 22.2 18.3 15.1 19.7 11.1 10.3 9.9 19.2 18.8 20.2 17.4 15.6 10.7 16.0 10.9 5.9 17.7 16.1 44.1 44.8 13.3 11.3 10.3 15.4 20.2 23.4 10.6 20.4 20.1 36.7 16.9 23.0 22.4 10.6 61.5 55.7 44.9 37.3 45.9 50.0 40.5 26.2 42.2 56.0 57.7 93.3 47.8 77.4 40.3 45.6 42.6 33.9 55.9 72.2 46.0 52.3 49.2 67.5 64.5 91.5 88.7 95.3 26.5 44.1 45.6 61.2 123.6 36.5 54.8 84.9 107.4 37.8 40.3 63.2 68.6 167.9 54.3 55.2 78.4 33.8 41.7 117.7 51.0 85.5 20.9 31.4 37.0 31.6 39.7 38.4 46.7 77.9 39.3 28.8 43.0 48.3 71.7 47.1 47.5 92.6 42.4 131.6 26.2 6.8 41.3 7.6 38.8 41.5 43.6 71.3 44.6 40.2 66.0 59.7 51.8 41.4 2.1 58.3 31.5 40.2 47.7 45.4 10.3 10.1 10.6 11.0 10.0 11.3 11.1 10.3 9.9 10.7 10.3 10.6 10.6 25.0 35.3 30.1 16.0 23.2 61.8 68.8 97.2 47.3 29.5 23.9 43.2 39.0 21.5 46.5 35.0 18.8 67.8 22.1 8.6 135.0 51.7 3.9 23.7 34.8 24.0 13.1 19.6 19.9 46.7 62.4 32.7 23.0 21.7 15.2 33.0 18.2 28.6 46.5 20.2 22.5 19.3 79.3 14.2 22.6 8.3 47.8 17.4 26.6 8.4 20.6 37.6 33.0 10.6 14.0 41.7 10.3 41.0 19.4 74.8 17.7 47.4 34.3 23.4 13.1 25.7 53.9 53.7 66.3 35.5 74.2 63.1 26.2 52.2 24.3 56.3 KIFAP3 "FLA3, KAP-1, KAP3, SMAP" ENSG00000075945 "Kinesin associated protein 3" Q92845 1 169921326-170085208 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 193.9;Excitatory neurons: 190.5;Inhibitory neurons: 192.4;Late spermatids: 200.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023738, HPA023742" Supported Approved Microtubules NA NA Microtubules "HPA023738: AB_1857285, HPA023742: AB_1857286" "unprognostic (5.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (6.05e-2)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (7.17e-3)" "unprognostic (7.74e-2)" "unprognostic (1.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-3)" "unprognostic (4.39e-3)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (2.22e-2)" 17.2 35.1 44.8 12.0 53.6 7.0 16.5 40.9 63.0 18.9 30.4 20.1 11.7 17.4 23.5 12.7 19.5 15.5 51.5 54.1 56.9 23.7 16.7 15.5 13.3 51.8 47.3 49.2 19.3 14.2 27.3 29.3 14.6 54.2 14.5 16.0 56.9 13.1 16.4 22.6 13.8 14.6 15.8 40.9 10.8 10.1 35.4 49.3 19.0 16.8 23.3 14.1 13.6 18.3 65.0 13.0 11.8 17.6 19.0 41.0 43.2 9.9 16.1 19.9 19.7 24.2 5.8 20.5 23.2 23.1 33.3 9.1 27.6 37.7 22.6 18.5 49.3 19.9 56.3 13.8 5.3 20.4 16.6 9.4 30.5 30.3 34.7 30.1 23.3 22.6 29.5 47.7 17.1 24.9 3.5 31.2 9.8 3.8 33.7 10.7 12.3 15.5 14.8 37.2 4.8 20.8 32.0 22.1 17.9 25.1 40.5 16.7 10.4 24.1 42.0 9.7 26.7 19.5 33.0 23.9 21.2 19.6 6.0 27.3 16.8 3.8 14.8 13.0 10.6 15.0 7.5 13.2 14.9 8.8 7.6 14.9 15.3 1.4 22.3 19.3 7.6 18.6 8.4 44.8 53.6 40.9 63.0 54.1 56.9 51.8 47.3 49.2 54.2 40.9 49.3 65.0 33.2 32.1 27.8 64.6 14.4 9.1 11.9 12.3 12.0 56.5 13.8 18.2 37.3 28.6 27.6 29.5 43.8 14.2 22.8 14.5 9.8 25.9 193.9 51.5 35.4 20.9 32.2 25.9 190.5 8.2 16.0 32.4 9.2 25.5 31.0 15.5 12.8 13.6 9.8 48.8 192.4 12.5 24.4 13.4 5.9 200.7 38.5 17.1 10.6 51.5 8.6 42.7 29.9 84.4 65.0 12.0 9.4 21.8 27.8 4.9 13.2 37.3 64.3 70.7 0.0 34.5 31.1 77.8 64.0 14.6 10.7 8.8 20.3 17.4 17.0 9.9 MKRN2 "HSPC070, RNF62" ENSG00000075975 "Makorin ring finger protein 2" Q9H000 3 12557057-12586208 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 10 "Early spermatids: 572.9;Late spermatids: 774.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037559, HPA037560" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037559: AB_10672460, HPA037560: AB_10696936" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-2)" "unprognostic (5.99e-2)" "unprognostic (3.89e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (4.38e-1)" "unprognostic (8.49e-2)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (2.56e-3)" "prognostic favorable (6.04e-4)" "unprognostic (3.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-2)" "unprognostic (3.32e-2)" 15.3 11.6 15.6 11.0 15.1 3.5 13.9 16.8 17.8 15.9 13.5 15.0 13.1 16.7 12.1 18.1 14.9 11.7 32.8 14.7 16.6 16.2 15.2 13.6 14.7 15.5 16.0 14.2 21.9 24.3 24.1 12.9 16.8 16.1 12.6 13.6 11.5 14.2 14.1 32.2 14.1 12.3 19.0 16.7 10.8 13.8 56.8 16.7 21.6 21.3 24.7 17.4 15.5 14.4 17.8 20.6 18.8 24.5 17.4 45.2 44.3 40.6 30.0 35.5 41.7 34.1 19.2 18.8 26.7 16.9 37.7 18.8 10.9 38.4 33.1 37.1 30.9 29.2 40.3 19.1 31.1 51.9 38.8 14.4 46.8 30.6 47.6 30.2 34.8 34.9 39.1 39.7 30.8 37.7 25.9 51.4 17.8 16.5 21.7 40.4 45.9 26.0 32.2 30.4 24.8 14.8 26.4 28.4 12.8 30.4 17.3 29.7 38.0 31.1 23.0 23.0 28.5 43.0 26.6 62.8 60.8 28.8 49.5 41.1 20.9 17.9 32.9 20.7 16.4 26.4 21.3 21.4 22.0 19.8 16.5 22.8 20.8 13.2 27.8 23.3 15.9 24.5 20.2 15.6 15.1 16.8 17.8 14.7 16.6 15.5 16.0 14.2 16.1 16.7 16.7 17.8 15.4 19.2 9.6 9.8 13.8 9.6 9.9 13.5 10.2 13.8 8.5 8.9 14.7 1.5 14.2 5.5 4.2 19.7 20.8 7.6 19.6 16.1 572.9 9.7 13.8 14.1 2.4 5.0 15.9 16.8 19.6 11.4 5.1 10.1 19.0 17.3 7.9 5.8 15.5 11.8 15.5 10.0 6.1 7.2 9.1 774.2 20.5 9.6 16.0 6.5 20.1 19.1 20.6 14.1 11.1 16.0 10.8 20.7 14.7 9.5 12.0 11.6 14.2 13.2 13.1 11.3 17.4 66.5 38.4 8.1 9.2 16.1 15.7 23.6 10.1 9.8 MCM6 Mis5 ENSG00000076003 "Minichromosome maintenance complex component 6" Q14566 2 135839626-135876443 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004818, CAB009577" Enhanced Enhanced Nucleoplasm NA Yes 33000 Nucleoplasm "CAB009577: AB_2266309, HPA004818: AB_1079339" "unprognostic (6.73e-2)" "unprognostic (6.68e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-3)" "unprognostic (8.98e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (5.70e-7)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.36e-2)" "unprognostic (1.36e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (8.29e-12)" "unprognostic (2.84e-1)" "unprognostic (9.02e-2)" "unprognostic (7.42e-2)" "unprognostic (1.68e-1)" 9.4 5.4 4.9 20.9 5.3 35.9 11.8 6.6 6.5 9.6 4.4 12.9 11.8 10.1 5.1 11.2 8.0 6.8 5.0 5.1 5.4 6.4 9.6 7.9 34.7 4.6 5.5 4.7 11.4 3.9 4.6 3.0 12.7 5.2 6.9 15.7 3.2 6.1 8.4 8.2 10.6 13.4 11.9 5.0 10.0 8.3 14.7 5.2 48.9 4.5 7.6 38.3 9.6 9.0 5.7 104.4 62.8 133.8 85.7 28.2 36.5 52.3 73.9 55.8 84.3 93.0 129.3 77.7 181.0 52.9 54.0 36.9 60.4 136.7 67.6 89.5 93.6 94.4 179.9 85.0 40.9 13.1 218.4 76.9 21.7 8.6 61.7 18.9 16.8 58.1 139.8 130.8 147.9 62.6 106.3 268.6 159.6 120.9 91.3 62.1 131.1 159.9 165.7 42.3 90.3 83.7 71.3 97.6 45.9 47.0 95.2 53.1 135.4 29.0 58.3 48.0 63.4 56.8 87.8 153.7 234.2 81.4 163.5 70.9 9.2 1.6 1.1 8.1 4.7 7.6 6.1 11.1 9.9 5.2 4.7 9.9 12.4 0.9 9.1 4.5 10.6 16.1 6.3 4.9 5.3 6.6 6.5 5.1 5.4 4.6 5.5 4.7 5.2 5.0 5.2 5.7 6.4 0.0 2.7 3.9 10.3 6.6 4.1 5.4 7.4 3.3 4.2 5.8 4.6 2.8 5.4 3.7 0.0 40.1 28.2 3.0 0.0 7.2 3.2 2.5 8.9 8.3 2.4 50.5 3.5 6.6 28.0 13.3 9.7 7.1 9.5 27.2 8.9 3.0 24.4 3.3 3.4 11.7 0.0 4.7 3.5 2.1 9.3 9.6 5.4 3.7 3.2 2.4 4.1 2.0 2.8 3.9 4.9 17.0 27.6 1.6 2.4 0.9 3.0 0.5 0.0 7.2 10.0 26.6 40.4 10.2 4.1 10.7 22.0 9.6 15.4 2.7 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439435-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" NA NA 340000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favorable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavorable (6.70e-4)" 51.6 57.7 24.1 40.6 25.4 55.5 57.7 25.9 31.8 71.6 28.3 65.5 24.5 72.1 46.9 66.4 38.4 48.2 141.6 23.5 29.1 103.4 50.7 42.3 32.8 30.1 26.8 22.9 69.6 45.9 155.7 32.8 57.4 29.9 73.1 47.6 9.3 116.3 58.5 41.2 50.9 33.4 107.6 26.5 45.2 65.9 54.0 25.9 30.7 36.8 40.9 37.4 68.9 65.0 28.5 159.3 92.7 32.1 88.4 254.6 268.7 81.9 266.3 192.9 122.6 155.4 244.9 261.2 88.8 258.2 220.8 185.4 97.4 74.1 219.5 201.5 86.9 61.3 98.1 136.0 144.7 339.2 72.3 29.5 190.8 206.0 157.4 163.7 214.1 223.1 84.7 183.9 48.6 278.5 38.7 49.4 84.0 102.3 119.1 160.3 45.7 112.1 317.1 177.0 126.9 59.8 38.5 122.7 86.7 110.8 134.8 184.9 35.6 231.4 162.5 194.2 124.0 161.6 39.7 52.4 146.3 111.3 165.2 89.7 64.3 14.0 21.3 32.2 19.2 37.2 37.6 47.9 41.1 18.8 29.2 43.0 35.1 3.5 45.2 20.6 70.1 75.3 29.1 24.1 25.4 25.9 31.8 23.5 29.1 30.1 26.8 22.9 29.9 26.5 25.9 28.5 82.9 105.8 56.4 20.9 42.3 138.9 146.5 189.1 88.2 14.9 99.2 100.6 370.0 47.1 126.5 95.6 2.1 171.6 55.3 27.2 277.8 126.6 83.6 75.3 110.8 98.4 80.9 315.2 20.0 70.7 188.5 176.8 48.4 85.2 31.8 40.1 89.6 80.0 98.2 5.0 17.4 82.9 89.5 21.0 56.7 48.1 210.6 33.9 241.9 15.9 41.9 36.5 29.9 25.1 33.5 110.0 33.7 176.8 103.8 199.6 26.7 371.4 126.5 8.3 52.6 90.6 177.0 237.3 82.1 119.9 162.7 269.1 47.5 120.6 72.4 130.4 RBM7 ENSG00000076053 "RNA binding motif protein 7" Q9Y580 11 114400030-114414203 "Predicted intracellular proteins" Meiosis RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 196.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013993, HPA048003" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013993: AB_1856137, HPA048003: AB_2680231" "unprognostic (2.90e-3)" "unprognostic (8.21e-3)" "prognostic favorable (6.14e-4)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-2)" "unprognostic (1.93e-2)" "unprognostic (2.89e-1)" "unprognostic (9.38e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.05e-1)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" 17.7 9.2 3.1 6.6 4.7 40.2 15.4 7.0 7.9 12.5 3.7 13.2 6.2 14.0 4.9 13.4 14.0 10.6 9.7 3.7 6.9 9.6 18.1 13.8 6.9 6.1 4.4 2.7 16.6 10.1 9.7 7.2 11.4 5.7 10.2 11.3 6.9 12.8 8.8 12.3 10.7 11.4 11.0 4.4 10.1 12.2 11.6 4.1 15.4 10.5 14.7 9.4 12.7 13.3 6.2 13.1 13.4 17.0 11.5 21.9 27.6 11.3 31.1 43.5 34.6 37.8 30.7 28.1 24.2 34.5 28.0 26.0 11.0 19.7 23.6 40.4 15.3 8.4 27.5 14.5 27.3 36.7 18.9 15.3 32.2 25.0 31.2 41.7 32.6 30.1 17.1 19.8 2.9 20.8 6.4 23.0 9.5 13.9 13.1 19.7 14.5 29.5 18.2 26.1 22.2 13.1 12.5 18.8 10.4 8.9 27.5 6.8 5.0 26.6 9.1 17.2 10.2 22.8 10.8 12.4 18.8 7.3 22.7 14.9 53.0 15.3 17.8 11.5 13.7 15.2 11.9 11.6 10.5 15.2 9.7 14.8 11.6 14.0 17.3 16.5 14.0 14.7 10.6 3.1 4.7 7.0 7.9 3.7 6.9 6.1 4.4 2.7 5.7 4.4 4.1 6.2 49.4 16.0 25.7 2.0 44.0 67.4 78.4 48.4 41.5 11.5 47.4 31.9 15.1 30.0 34.2 29.5 12.5 51.0 52.4 30.8 66.5 49.8 196.4 37.6 38.8 45.0 47.4 26.1 5.4 35.1 78.0 51.7 26.0 51.3 40.0 20.1 37.9 27.5 29.8 8.4 5.6 30.9 40.7 27.4 55.3 29.5 31.4 30.8 42.7 7.5 32.2 24.5 28.8 8.5 10.2 39.0 37.6 17.0 18.0 71.2 38.1 46.5 27.8 13.0 0.0 49.1 47.6 35.3 16.9 32.8 68.6 92.5 46.6 18.7 38.4 82.6 RBMS2 SCR3 ENSG00000076067 "RNA binding motif single stranded interacting protein 2" Q15434 12 56521820-56596193 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 78.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039225, HPA058784" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA039225: AB_10963056, HPA058784: AB_2683819" "unprognostic (1.35e-1)" "unprognostic (5.31e-2)" "unprognostic (2.61e-1)" "unprognostic (5.29e-2)" "unprognostic (9.09e-2)" "unprognostic (3.19e-3)" "unprognostic (4.78e-2)" "unprognostic (1.89e-2)" "unprognostic (7.01e-2)" "unprognostic (2.80e-1)" "unprognostic (2.86e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.22e-4)" "unprognostic (2.67e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (2.63e-2)" 19.0 7.2 13.2 5.8 10.0 3.6 17.5 9.3 13.2 14.4 15.7 11.9 4.7 13.8 9.4 8.2 13.8 9.6 14.0 9.0 10.0 12.9 3.5 37.6 3.2 14.1 11.7 5.7 12.8 7.1 8.7 6.2 23.7 11.8 11.3 8.9 6.1 10.1 8.8 8.4 8.1 9.1 12.2 8.5 10.6 8.6 4.3 17.7 3.5 18.4 10.9 4.0 10.4 14.0 15.4 28.8 24.3 10.5 14.9 23.7 22.7 9.3 34.8 37.0 26.9 23.9 18.7 50.2 0.2 42.1 36.6 11.1 20.4 7.8 57.8 30.1 8.3 6.7 3.7 19.0 4.8 15.4 3.8 6.5 20.9 13.9 28.1 33.5 31.4 51.1 6.1 1.8 6.5 47.0 3.7 4.1 4.9 6.2 0.0 7.5 2.4 11.5 0.3 34.1 6.4 0.8 6.9 39.6 14.9 5.1 22.2 16.0 6.3 78.2 16.7 35.8 9.5 8.4 6.1 2.5 1.7 6.1 0.9 23.6 0.6 4.7 1.6 0.8 1.3 0.9 0.3 0.3 1.2 2.7 0.5 0.9 0.6 1.6 1.0 0.3 0.6 0.5 0.8 13.2 10.0 9.3 13.2 9.0 10.0 14.1 11.7 5.7 11.8 8.5 17.7 15.4 74.4 41.7 20.5 34.6 1.5 3.7 9.7 6.8 11.4 4.2 11.4 9.4 7.9 12.8 14.2 12.9 10.4 19.8 7.0 19.7 1.9 23.6 12.6 16.4 16.9 47.9 5.4 3.2 7.2 16.9 38.5 16.9 6.1 21.8 8.2 10.4 52.1 1.0 10.5 8.4 10.0 5.9 4.1 22.7 5.5 24.2 17.4 11.2 0.0 53.4 6.2 5.4 4.1 30.7 9.6 37.8 11.5 24.8 0.8 13.4 1.6 13.4 6.8 1.7 26.3 11.2 15.5 0.9 1.8 5.4 2.0 23.7 2.5 8.7 7.0 17.3 BAZ2A "KIAA0314, TIP5, WALp3" ENSG00000076108 "Bromodomain adjacent to zinc finger domain 2A" Q9UIF9 12 56595596-56636816 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005782, HPA063806" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA005782: AB_10601089, HPA063806: AB_2685128" "unprognostic (1.70e-1)" "unprognostic (1.75e-2)" "unprognostic (5.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.72e-2)" "unprognostic (3.10e-1)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (3.00e-2)" "unprognostic (3.77e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (3.43e-1)" 27.5 24.1 14.5 31.1 12.4 66.6 27.5 21.0 18.8 28.8 19.2 27.3 25.7 25.6 23.1 31.2 25.1 21.1 20.9 10.9 12.4 19.8 21.8 36.2 33.7 17.8 13.4 4.5 36.6 31.1 33.7 27.9 35.7 20.0 23.5 26.8 49.2 25.9 21.2 28.4 29.7 31.4 23.3 6.1 35.6 26.4 47.8 16.5 51.1 27.6 32.3 30.8 25.0 30.9 38.8 50.3 45.6 61.9 52.5 35.3 35.4 66.5 32.6 44.2 46.9 34.1 56.2 59.3 69.2 49.2 38.6 44.3 41.5 70.6 46.3 40.6 48.1 37.1 80.8 35.5 28.8 38.5 47.1 60.2 31.0 43.8 40.2 55.7 50.8 46.3 28.4 87.7 94.1 26.3 30.7 40.2 30.9 54.9 32.7 34.6 33.9 45.0 48.3 32.6 48.8 41.0 33.8 54.8 57.0 30.0 66.0 65.6 41.7 65.2 24.3 49.1 30.0 23.0 46.0 48.4 65.1 22.5 33.4 34.6 12.1 7.6 5.6 4.8 6.2 4.2 6.8 3.8 3.7 3.0 6.0 3.1 2.7 28.6 17.2 15.5 11.7 3.6 3.0 14.5 12.4 21.0 18.8 10.9 12.4 17.8 13.4 4.5 20.0 6.1 16.5 38.8 47.6 67.3 61.3 29.4 74.7 50.9 43.2 35.3 60.3 70.5 43.3 26.7 26.4 30.0 36.9 25.8 137.6 48.0 62.8 71.6 7.9 32.0 66.8 29.4 33.7 50.1 44.8 53.4 29.3 28.7 37.2 35.6 34.1 41.7 43.6 34.8 53.9 32.5 24.3 32.0 27.4 39.6 26.4 62.1 65.6 73.7 60.6 38.5 39.2 40.3 80.1 24.4 116.4 25.6 33.2 34.8 39.4 57.6 78.0 65.1 44.7 12.6 34.4 67.3 85.5 44.9 44.0 134.1 131.2 59.5 61.8 95.6 58.0 41.6 34.8 67.6 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase non-receptor type 23" Q9H3S7 3 47381011-47413435 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 17.2 19.3 5.7 12.7 8.2 14.8 17.5 5.0 10.6 23.4 4.2 16.3 14.4 21.1 7.6 19.2 19.4 8.5 13.0 6.6 6.3 17.4 14.1 18.9 9.2 8.9 6.5 5.4 23.7 20.4 23.7 31.2 11.7 8.8 18.9 6.6 8.5 20.2 11.5 30.3 26.3 18.6 8.8 5.7 20.2 16.2 15.8 6.6 8.1 27.3 9.0 7.4 18.7 20.5 13.7 21.5 29.9 16.4 21.4 21.0 16.0 15.8 19.2 18.9 17.5 14.8 25.0 20.7 15.1 17.2 21.9 31.2 19.0 14.3 20.8 8.5 14.3 15.1 21.0 22.2 24.0 23.0 12.3 27.5 21.4 20.9 22.9 23.2 12.4 21.7 12.5 15.9 20.3 19.0 30.2 11.5 10.4 17.5 14.9 20.1 7.2 7.9 18.5 13.2 40.9 8.6 20.6 17.1 35.6 13.6 9.8 20.3 12.0 22.4 26.7 22.2 37.7 27.5 28.8 20.4 8.7 29.0 11.6 19.5 0.8 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.3 0.3 5.7 8.2 5.0 10.6 6.6 6.3 8.9 6.5 5.4 8.8 5.7 6.6 13.7 11.1 9.6 7.0 17.0 8.2 8.0 5.2 6.9 13.6 11.7 9.5 8.0 8.7 8.6 9.5 5.5 14.6 10.6 11.0 15.7 1.9 10.5 2.1 10.3 13.7 12.4 7.3 2.5 9.8 8.9 7.9 9.1 26.5 21.1 2.5 14.9 11.4 12.7 13.9 16.8 12.0 16.3 20.3 10.4 5.5 3.1 19.3 9.5 12.4 7.5 8.7 8.8 6.2 9.5 14.3 13.5 10.4 13.5 15.4 9.3 14.6 9.4 12.6 14.2 6.6 10.2 8.8 13.6 13.3 13.2 10.9 9.3 8.9 9.4 12.8 8.2 MLH1 "COCA2, FCC2, HNPCC, HNPCC2" ENSG00000076242 "MutL homolog 1" P40692 3 36993350-37050846 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013294, HPA052707, HPA060714, CAB070868" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348" "unprognostic (1.26e-2)" "unprognostic (3.88e-3)" "unprognostic (2.36e-2)" "unprognostic (1.82e-1)" "unprognostic (3.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (8.24e-5)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (8.54e-2)" "unprognostic (8.63e-3)" "unprognostic (2.10e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (8.86e-2)" 15.5 18.1 7.0 17.6 7.5 22.3 15.6 6.9 9.1 16.7 7.4 16.5 12.1 16.4 14.1 14.4 15.1 11.2 32.2 6.6 8.0 16.2 19.3 15.9 22.0 7.6 7.5 6.5 15.2 16.7 22.6 22.9 14.9 8.6 16.4 14.7 9.7 12.2 14.1 49.6 13.3 13.5 19.4 7.1 18.9 15.6 25.6 7.7 28.6 19.3 42.6 24.5 17.3 14.1 9.5 37.1 56.7 66.7 0.2 25.9 34.5 30.7 54.7 44.4 64.1 62.3 43.4 40.1 92.2 25.0 44.1 33.6 24.7 65.2 45.8 68.5 42.2 32.1 68.1 42.3 54.9 23.2 81.9 40.5 28.4 29.0 54.8 57.8 21.9 37.6 55.0 86.0 32.0 66.2 27.6 81.0 22.2 49.4 38.4 31.6 4.6 90.6 40.2 35.1 39.3 14.2 36.1 52.1 56.9 32.7 33.3 79.9 55.6 28.8 46.0 50.5 44.0 65.9 29.1 93.7 88.1 37.8 71.9 45.7 12.6 12.5 15.1 12.7 22.6 9.8 11.3 7.7 11.4 14.3 9.7 8.4 9.6 2.6 7.8 29.2 5.9 15.0 11.0 7.0 7.5 6.9 9.1 6.6 8.0 7.6 7.5 6.5 8.6 7.1 7.7 9.5 10.8 25.6 15.8 22.9 18.5 7.1 12.4 18.7 7.4 18.5 9.6 9.7 41.8 12.8 15.8 11.0 10.4 33.4 16.0 6.1 19.6 14.6 31.3 12.5 11.3 10.7 5.4 19.0 18.5 14.7 26.9 14.4 12.2 9.5 7.6 13.0 13.6 14.9 20.1 3.3 21.6 8.6 16.2 16.3 8.9 13.2 11.1 13.8 8.8 10.3 18.2 15.9 11.3 27.2 31.3 9.3 7.4 13.9 22.1 6.4 5.3 12.9 16.5 18.1 13.1 10.0 14.0 58.6 29.3 9.3 5.5 20.0 15.9 14.8 8.4 6.5 UNG "DGU, HIGM4, UDG, UNG1, UNG2" ENSG00000076248 "Uracil DNA glycosylase" P13051 12 109097597-109110992 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 64.9;Spermatogonia: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011605 Uncertain Approved Cytosol NA Yes Cytosol "CAB011605: AB_778737" "unprognostic (4.38e-2)" "unprognostic (3.82e-3)" "unprognostic (1.03e-2)" "unprognostic (1.33e-2)" "unprognostic (4.64e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.68e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.66e-2)" "unprognostic (8.78e-3)" "unprognostic (1.91e-1)" "unprognostic (1.35e-3)" "unprognostic (2.57e-2)" "unprognostic (4.50e-1)" "unprognostic (1.40e-2)" "unprognostic (6.89e-2)" 19.4 57.2 30.5 14.8 29.2 16.1 23.3 28.8 35.0 15.3 25.7 28.2 17.3 14.6 12.8 30.0 15.7 10.5 21.3 27.6 37.9 27.7 32.5 9.7 18.2 31.1 29.2 27.0 15.8 12.5 33.4 11.0 17.9 35.8 13.8 29.6 6.8 17.9 17.7 43.3 32.7 18.9 14.7 29.6 16.2 17.8 24.5 31.2 23.0 22.4 33.8 27.2 13.6 20.3 29.1 77.1 77.5 72.8 66.6 118.6 33.8 69.5 44.4 30.1 68.6 52.3 61.7 51.6 100.3 65.1 40.2 35.9 47.6 81.4 46.0 66.4 85.6 150.9 98.1 41.1 105.5 17.7 147.6 58.2 30.7 41.6 33.0 18.3 54.6 50.4 117.8 80.9 32.5 47.0 96.2 136.8 173.6 130.0 124.2 117.7 123.9 109.8 85.9 43.4 95.6 103.3 57.4 79.6 67.8 39.5 94.2 126.2 68.2 26.0 59.1 52.7 39.3 62.5 62.6 145.0 190.5 44.8 97.7 73.8 12.9 2.7 5.0 22.4 5.3 31.6 16.0 25.5 25.6 6.8 17.2 16.4 18.4 0.0 16.5 5.5 4.9 25.5 14.4 30.5 29.2 28.8 35.0 27.6 37.9 31.1 29.2 27.0 35.8 29.6 31.2 29.1 26.6 0.0 4.8 16.0 9.2 18.0 11.0 13.2 25.0 2.6 21.7 14.1 12.4 7.2 5.0 42.3 4.2 64.9 12.5 14.7 19.6 14.4 3.4 7.6 15.0 17.7 8.4 32.4 7.0 6.2 38.1 12.6 14.3 9.9 7.6 24.8 20.3 20.8 18.3 5.0 6.2 21.4 10.2 3.8 5.4 4.2 14.0 5.5 14.2 6.5 3.8 15.8 7.2 6.6 4.0 5.0 10.3 14.7 16.7 6.8 9.3 20.2 3.2 3.5 6.6 10.2 11.5 21.9 74.6 37.8 20.9 20.4 15.3 25.7 40.4 9.7 FMO4 FMO2 ENSG00000076258 "Flavin containing dimethylaniline monoxygenase 4" P31512 1 171314183-171342084 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 49.0;liver: 61.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Hepatocytes: 22.1;Oligodendrocytes: 18.5;Proximal enterocytes: 16.5;Proximal tubular cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 5.7;HSkMC: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA049100: AB_2680629, HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favorable (1.09e-4)" "prognostic favorable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 3.7 2.6 2.1 1.9 2.9 0.9 4.1 2.8 3.0 3.0 3.1 5.1 5.4 2.8 6.4 2.4 3.5 4.9 5.3 2.1 3.2 49.0 61.8 3.2 2.9 3.0 2.8 1.8 3.9 2.5 4.7 1.9 2.3 3.2 3.2 4.8 0.7 2.0 2.2 1.0 3.5 9.3 2.0 2.7 3.1 5.1 1.7 2.8 3.7 3.3 2.2 3.4 2.4 3.0 3.5 0.1 0.1 0.3 0.4 4.1 3.4 0.2 0.8 3.7 1.1 1.2 0.6 5.3 3.7 5.7 0.1 2.0 0.2 0.7 1.0 1.6 1.6 0.8 0.0 0.0 0.0 0.6 0.7 0.8 6.6 2.4 0.4 1.0 0.4 0.2 1.7 0.2 2.3 0.5 0.7 1.6 1.3 0.4 0.9 1.2 0.4 0.4 2.1 2.6 0.0 0.1 0.0 1.2 1.0 2.4 4.1 2.2 1.0 0.1 0.9 0.3 1.0 0.7 2.9 1.0 2.2 1.8 1.1 0.8 0.2 1.0 0.3 0.9 1.6 0.7 1.2 0.8 1.3 0.9 1.8 1.2 0.9 0.1 1.7 1.1 1.2 2.1 0.8 2.1 2.9 2.8 3.0 2.1 3.2 3.0 2.8 1.8 3.2 2.7 2.8 3.5 2.2 0.0 2.6 7.2 3.2 2.8 4.6 5.0 2.8 0.0 2.3 2.0 3.7 2.8 3.7 9.2 0.0 2.8 0.6 7.1 29.4 2.3 5.7 3.8 1.7 1.4 1.2 0.0 0.1 1.4 1.2 6.6 8.2 1.7 1.3 1.5 2.9 22.1 3.7 0.0 0.1 3.2 2.0 5.9 1.3 1.3 1.5 2.7 5.4 2.8 1.6 1.8 1.0 0.0 18.5 1.1 0.7 0.4 1.1 0.9 16.5 49.5 7.3 0.0 0.0 1.8 2.1 0.3 0.5 1.9 1.6 1.9 1.7 2.0 2.8 1.8 KLHL20 "KHLHX, KLEIP" ENSG00000076321 "Kelch like family member 20" Q9Y2M5 1 173714941-173786692 "Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025034, HPA053704" Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA025034: AB_1852578, HPA053704: AB_2682234" "unprognostic (2.97e-3)" "unprognostic (3.11e-2)" "unprognostic (8.27e-2)" "unprognostic (6.48e-3)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (8.66e-2)" "unprognostic (3.02e-1)" "unprognostic (1.90e-1)" "unprognostic (2.62e-2)" 13.9 10.3 6.3 7.7 7.5 5.9 8.8 7.6 6.8 11.9 5.4 8.6 6.7 13.7 7.0 9.9 8.2 9.4 10.9 6.7 7.0 10.9 16.3 10.1 9.8 7.7 7.0 5.1 12.1 6.0 8.0 5.3 11.5 7.4 13.2 9.0 9.1 6.2 9.4 12.6 9.6 7.9 13.6 7.3 10.4 7.6 16.1 6.9 12.4 8.5 14.0 9.2 10.1 8.3 7.3 12.8 8.0 12.5 13.1 28.7 26.4 10.2 19.7 19.2 14.9 15.6 5.8 8.7 9.0 16.4 21.3 7.9 12.5 11.2 14.2 17.4 11.0 6.0 8.2 10.8 6.9 18.4 15.5 9.3 22.6 16.1 13.8 18.4 17.3 22.2 9.0 18.5 10.0 27.6 4.7 9.1 8.0 13.3 11.3 36.1 9.7 15.4 9.8 11.4 8.1 5.3 14.7 18.0 12.1 12.3 16.9 10.8 18.0 22.2 14.3 8.6 17.6 15.7 13.3 7.4 13.5 9.4 11.0 16.2 7.0 2.9 4.3 4.5 3.2 4.0 3.6 4.4 5.5 2.8 3.5 5.6 5.7 1.6 3.2 2.4 4.6 5.6 2.3 6.3 7.5 7.6 6.8 6.7 7.0 7.7 7.0 5.1 7.4 7.3 6.9 7.3 21.8 16.0 25.9 36.2 17.3 11.1 8.1 13.5 8.0 13.3 8.0 8.0 12.8 17.2 12.8 12.9 37.5 13.1 18.1 13.5 1.9 9.9 132.4 4.4 14.0 23.4 9.6 11.1 28.1 12.1 10.1 18.2 16.3 5.6 7.6 14.9 42.1 21.0 11.2 11.8 37.3 9.1 10.2 18.5 9.1 30.2 22.4 10.0 3.6 18.7 9.4 16.4 20.6 33.7 35.2 11.4 8.9 28.6 12.3 8.8 16.3 14.1 8.2 20.7 0.0 20.9 16.4 55.8 35.6 11.3 10.5 9.9 16.9 24.1 9.7 7.8 RGS11 ENSG00000076344 "Regulator of G protein signaling 11" O94810 16 268301-275980 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.5;pituitary gland: 56.8" "Cell type enhanced" "Detected in many" "Astrocytes: 31.0;Bipolar cells: 69.7;Cone photoreceptor cells: 120.9;Excitatory neurons: 31.9;Inhibitory neurons: 33.6;Oligodendrocytes: 28.0;Rod photoreceptor cells: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;ASC TERT1: 2.2;fHDF/TERT166: 2.0;HHSteC: 3.1;hTERT-RPE1: 2.4;SCLC-21H: 3.0;SH-SY5Y: 2.3;T-47d: 2.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041692, HPA043039" Uncertain NA NA "HPA041692: AB_2677619, HPA043039: AB_2678282" "unprognostic (8.39e-2)" "unprognostic (1.97e-1)" "unprognostic (5.46e-2)" "unprognostic (4.55e-3)" "unprognostic (1.46e-1)" "unprognostic (8.50e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (2.93e-1)" "unprognostic (6.56e-2)" "prognostic favorable (1.24e-4)" "unprognostic (1.70e-1)" "unprognostic (1.48e-3)" "unprognostic (6.91e-3)" "unprognostic (2.27e-1)" "unprognostic (1.20e-1)" "unprognostic (1.04e-1)" 10.6 4.6 11.0 1.0 12.0 0.0 8.5 17.6 40.5 8.4 5.1 16.7 7.2 4.2 0.3 7.4 4.6 0.9 18.9 10.6 8.4 5.3 2.4 9.1 0.4 14.5 11.1 11.5 0.8 17.0 4.4 56.8 2.7 13.5 19.4 0.7 9.0 3.8 2.7 2.2 2.2 7.0 1.1 7.8 3.4 15.1 0.8 10.9 0.0 4.3 1.1 0.0 9.3 8.9 11.8 0.0 0.0 0.0 0.0 2.1 2.2 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.0 0.2 0.0 0.0 3.0 2.3 1.2 0.0 0.5 0.0 2.5 0.0 1.6 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 12.0 17.6 40.5 10.6 8.4 14.5 11.1 11.5 13.5 7.8 10.9 11.8 1.8 0.0 0.0 31.0 0.1 0.1 0.2 0.1 0.6 69.7 1.0 0.6 7.5 1.5 0.0 0.0 120.9 0.1 0.3 0.9 0.0 0.1 0.0 1.9 5.2 1.8 10.3 0.0 31.9 1.0 0.2 8.6 3.1 3.3 0.0 0.4 6.1 0.0 0.2 10.1 33.6 0.4 2.0 0.0 1.1 0.0 0.9 0.2 1.8 4.7 0.6 3.3 0.0 18.1 28.0 0.4 7.1 1.9 0.0 0.5 5.8 0.0 0.0 67.5 0.0 1.5 7.2 0.5 1.5 0.3 0.6 0.8 0.3 0.1 1.4 0.1 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394642-28407197 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 94.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 26.6;Hepatocytes: 27.8;Hofbauer cells: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "CACO-2: 205.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 6.7 25.0 8.0 5.8 9.8 3.4 5.7 14.1 8.3 5.6 22.6 5.7 94.7 4.7 8.6 2.4 13.5 4.6 4.6 7.8 10.1 7.6 27.6 6.9 5.5 10.4 9.3 6.7 8.8 11.3 15.1 15.6 8.3 9.9 7.5 5.6 8.8 12.6 9.0 3.6 2.3 40.8 5.6 9.9 11.2 5.6 3.1 9.4 23.6 6.5 2.8 2.1 5.0 2.6 12.0 5.4 22.5 7.4 12.2 5.9 1.3 22.9 6.3 4.6 5.1 5.7 205.4 6.4 0.4 3.6 3.4 14.8 17.3 8.4 14.1 4.3 13.1 19.6 0.2 14.0 17.6 2.1 0.1 10.1 2.8 25.3 5.3 15.8 7.1 0.4 1.8 8.9 1.2 0.9 7.2 0.1 0.6 4.4 5.2 2.9 0.3 6.0 2.7 4.0 11.8 19.4 10.2 43.6 20.1 2.4 10.1 15.6 3.4 0.6 0.8 8.6 1.2 6.6 9.0 11.1 0.3 1.2 1.3 4.7 5.2 0.9 0.6 0.4 3.0 0.7 1.6 0.4 0.3 1.4 0.8 0.5 0.8 1.0 1.6 2.6 0.5 0.9 0.5 8.0 9.8 14.1 8.3 7.8 10.1 10.4 9.3 6.7 9.9 9.9 9.4 12.0 1.2 12.8 5.3 7.5 1.0 0.4 1.9 2.8 4.0 26.6 5.1 6.1 2.3 17.2 2.2 7.3 4.2 20.8 0.2 3.7 0.0 3.5 3.6 18.2 1.8 1.9 1.2 0.4 2.8 4.6 9.7 3.6 3.1 1.5 1.3 4.2 1.8 27.8 25.7 20.2 4.6 2.4 0.0 21.5 1.0 19.5 4.1 8.0 0.0 5.6 2.0 2.2 0.0 8.0 6.9 3.8 3.6 3.4 3.0 2.6 3.9 4.6 4.3 6.0 6.6 3.7 1.4 0.3 0.3 1.2 0.3 4.4 0.6 5.8 1.3 1.6 PLXNA2 "FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2" ENSG00000076356 "Plexin A2" O75051 1 208022242-208244384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 35.3" "Cell type enhanced" "Detected in many" "Astrocytes: 100.6;Excitatory neurons: 134.7;Horizontal cells: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 52.8;HaCaT: 55.4;HUVEC TERT2: 70.3;TIME: 162.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009763 Approved NA NA 1400000 "CAB009763: AB_2166388" "unprognostic (8.25e-2)" "unprognostic (3.91e-2)" "unprognostic (8.85e-2)" "unprognostic (2.77e-2)" "unprognostic (8.66e-2)" "unprognostic (2.07e-1)" "unprognostic (1.97e-2)" "unprognostic (4.84e-2)" "unprognostic (6.88e-3)" "unprognostic (7.06e-2)" "unprognostic (2.61e-1)" "unprognostic (8.41e-2)" "unprognostic (4.49e-3)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (1.27e-2)" "unprognostic (2.40e-1)" 6.9 1.5 5.6 2.1 8.8 0.4 4.9 11.0 11.2 3.1 16.6 9.1 6.9 6.1 2.0 15.5 5.2 4.0 7.7 9.8 3.4 3.1 2.5 14.5 1.0 3.9 5.3 6.8 13.9 35.3 1.3 3.0 8.6 5.0 4.1 7.2 3.7 4.2 3.1 9.7 9.3 7.7 5.9 1.6 1.3 9.1 0.6 2.1 4.4 6.8 9.5 2.4 9.5 6.4 7.8 6.4 3.7 6.9 1.0 7.6 14.7 52.8 5.0 3.1 3.0 0.5 0.2 0.1 0.0 9.8 3.9 1.3 55.4 0.1 31.4 0.9 1.9 1.1 0.0 6.9 3.7 3.2 0.0 0.2 3.9 10.0 2.4 14.2 2.0 70.3 0.0 0.0 0.0 30.7 0.7 0.1 0.1 1.1 11.2 9.4 0.0 7.0 4.7 5.7 4.0 2.0 12.5 5.9 4.5 5.5 13.3 0.5 0.0 162.9 1.1 1.7 5.9 10.4 0.3 0.0 0.0 6.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 8.8 11.0 11.2 9.8 3.4 3.9 5.3 6.8 5.0 1.6 2.1 7.8 50.7 28.9 28.6 100.6 1.7 4.8 16.2 12.9 30.1 12.7 2.9 2.2 5.8 7.2 25.6 0.0 2.1 5.3 0.8 64.6 1.9 4.2 0.9 13.8 0.9 48.1 9.1 0.0 134.7 15.3 2.5 9.6 44.4 9.5 6.3 1.1 36.8 5.9 3.3 249.0 62.9 29.0 8.2 5.5 6.0 0.6 9.9 4.4 5.4 54.4 1.4 0.4 1.0 44.7 3.1 23.3 52.2 6.8 1.7 8.2 33.6 2.2 8.5 2.7 6.6 26.3 8.1 1.9 1.0 41.1 10.5 1.9 1.1 1.4 26.5 22.7 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599025 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.2;kidney: 36.8;testis: 74.6" "Cell type enhanced" "Detected in many" "Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 11.7;T-reg: 4.9" "Group enriched" "Detected in many" 6 "granulocytes: 11.7;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" Yes Yes "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.2 3.3 7.2 7.9 7.9 38.2 2.5 6.0 9.5 2.1 5.6 8.4 8.0 2.0 2.4 8.3 1.8 1.8 1.4 7.8 7.2 36.8 15.0 3.4 14.6 6.9 6.9 7.7 2.8 1.6 1.1 4.4 5.7 7.8 2.2 10.8 10.9 2.5 0.8 1.0 5.5 9.2 3.5 5.6 7.5 3.6 74.6 7.4 22.6 8.8 0.7 17.4 2.6 3.6 7.7 84.7 87.7 103.3 78.4 5.2 8.6 42.4 65.9 42.4 98.1 78.3 69.2 25.5 59.8 34.2 46.8 91.7 70.2 114.5 42.7 103.8 108.6 72.9 62.9 87.9 80.2 0.6 83.1 76.1 2.9 3.8 78.6 40.4 14.5 52.1 90.6 69.7 101.5 80.7 52.6 109.4 92.9 54.2 68.3 44.5 72.1 144.4 70.9 29.0 43.0 78.6 45.8 96.4 114.9 31.6 84.9 82.2 70.6 25.7 56.4 91.3 46.6 114.6 46.7 72.9 87.3 37.8 60.6 91.8 11.7 0.0 0.0 0.4 0.4 0.7 0.6 1.2 0.9 0.1 1.4 1.1 0.9 0.2 0.8 0.3 0.3 4.9 0.9 7.2 7.9 6.0 9.5 7.8 7.2 6.9 6.9 7.7 7.8 5.6 7.4 7.7 0.5 3.2 1.7 0.7 3.3 2.0 0.9 1.3 1.2 5.0 1.1 1.0 0.7 0.0 1.9 0.0 0.0 9.0 1.3 4.7 1.9 0.5 126.0 6.0 1.1 1.5 13.1 37.2 5.2 0.4 12.2 2.6 5.1 1.8 1.3 12.6 3.3 6.3 6.5 3.3 6.0 4.6 4.1 2.7 4.0 25.2 0.9 6.1 0.0 1.9 0.9 0.7 0.0 2.0 1.7 0.4 4.7 0.0 13.1 0.8 8.1 12.5 7.7 3.9 6.6 2.0 2.2 72.6 21.0 5.2 1.0 3.8 2.8 0.9 5.1 1.1 ANKRD13A "ANKRD13, NY-REN-25" ENSG00000076513 "Ankyrin repeat domain 13A" Q8IZ07 12 109999186-110039763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 160.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 205.4;HBF TERT88: 200.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039488, HPA043218" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA039488: AB_10673612, HPA043218: AB_2678367" "unprognostic (1.54e-1)" "unprognostic (3.94e-3)" "unprognostic (5.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "prognostic favorable (7.70e-6)" "unprognostic (5.68e-2)" "unprognostic (1.31e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (9.71e-3)" "unprognostic (1.67e-1)" "unprognostic (2.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.13e-2)" "unprognostic (1.08e-1)" "unprognostic (5.29e-2)" 13.3 11.0 5.5 36.8 9.4 36.4 16.6 8.2 7.6 14.2 5.8 22.0 14.4 12.1 6.6 32.0 12.4 23.1 10.8 6.3 7.2 17.7 15.5 27.2 54.4 8.3 8.2 4.4 16.5 12.4 17.6 4.7 24.6 8.9 18.1 22.6 8.8 27.7 24.8 6.9 21.9 17.8 24.6 6.8 33.1 17.2 61.4 8.2 28.1 28.4 8.8 67.2 26.1 13.3 14.7 163.7 7.3 16.9 15.6 25.4 25.1 20.8 160.9 150.5 149.8 79.3 21.2 10.3 107.8 12.4 205.4 18.7 19.0 21.7 24.0 200.3 122.3 19.2 39.9 15.6 17.4 22.2 46.8 46.2 21.9 24.9 63.8 36.5 37.3 23.0 24.9 31.6 17.2 66.5 5.8 41.3 19.5 9.3 11.7 34.1 35.8 47.3 42.7 21.2 20.7 34.7 16.5 29.6 57.0 19.5 11.4 26.0 38.5 29.2 111.6 20.0 62.2 87.4 36.8 23.3 144.1 54.3 31.7 16.5 1.5 1.2 5.6 0.5 2.5 1.5 2.0 1.3 0.6 1.5 1.2 0.7 1.0 3.5 0.9 1.1 1.0 0.6 0.7 5.5 9.4 8.2 7.6 6.3 7.2 8.3 8.2 4.4 8.9 6.8 8.2 14.7 15.7 48.1 32.5 13.4 75.5 29.3 18.7 11.0 15.4 24.4 23.1 16.9 13.0 28.6 30.5 57.0 14.6 16.9 31.2 30.3 21.5 29.2 104.7 22.0 12.3 14.9 18.7 19.4 15.9 17.6 21.0 15.5 16.3 29.5 13.3 18.5 15.7 17.3 15.4 25.2 26.9 9.4 4.1 37.1 26.9 160.4 11.8 33.7 14.2 16.9 34.2 9.7 21.6 17.6 46.0 20.8 12.5 21.8 33.0 16.2 16.0 9.8 37.6 14.2 32.9 50.3 18.0 71.1 15.0 23.9 37.8 37.6 31.8 16.9 17.0 25.7 TPD52 "D52, hD52, N8L" ENSG00000076554 "Tumor protein D52" P55327 8 80034745-80231232 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 189.2" "Cell type enhanced" "Detected in many" "Ionocytes: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 50.5" "Group enriched" "Detected in many" 5 "B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0" "Cell line enhanced" "Detected in many" "Karpas-707: 252.6;SK-BR-3: 572.5" "HPA028427, HPA062167" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 310000 Cytosol "Golgi apparatus" "HPA028427: AB_10610561, HPA062167: AB_2684704" "prognostic unfavorable (1.11e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-2)" "unprognostic (3.77e-3)" "unprognostic (8.24e-2)" "unprognostic (3.75e-1)" "unprognostic (7.99e-3)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.77e-6)" "unprognostic (2.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (1.70e-2)" 5.3 9.3 44.8 28.7 48.9 9.0 76.6 43.2 64.9 19.8 41.9 118.8 99.8 10.0 56.7 35.2 15.5 31.4 11.8 53.2 45.7 47.0 30.9 20.0 44.3 42.4 48.0 47.6 2.4 42.2 27.6 34.6 23.1 45.7 105.7 130.9 189.2 81.4 18.5 8.6 47.3 101.2 10.5 39.6 16.2 84.8 5.2 56.6 15.6 65.1 9.9 56.7 21.1 20.3 57.1 131.8 34.9 1.6 23.0 0.0 0.0 51.7 8.6 12.9 34.7 17.1 18.0 37.4 189.9 45.2 0.8 25.5 52.5 52.7 36.3 24.6 23.8 44.2 26.8 46.9 29.4 0.2 8.6 0.7 0.0 25.2 0.1 12.2 21.6 2.0 128.9 0.4 252.6 0.1 43.6 42.6 39.4 11.7 148.8 86.0 0.3 0.7 122.0 60.7 31.6 64.9 44.1 40.1 572.5 110.7 51.0 55.9 34.2 2.1 0.0 35.2 0.6 30.8 94.1 87.1 155.2 22.5 0.2 2.6 0.6 0.1 5.5 12.7 0.1 22.0 50.5 12.4 11.1 2.5 44.7 8.1 9.3 0.5 15.1 0.1 5.2 9.1 8.3 44.8 48.9 43.2 64.9 53.2 45.7 42.4 48.0 47.6 45.7 39.6 56.6 57.1 17.3 44.8 67.8 10.4 133.6 80.7 89.6 83.4 51.2 171.1 105.6 54.2 22.2 82.9 78.1 66.2 118.9 98.9 28.6 230.9 170.2 112.8 20.6 25.2 8.4 26.2 169.9 11.6 85.4 79.6 116.9 6.7 97.3 72.8 1.3 15.3 25.7 40.6 13.1 32.0 53.9 331.9 476.0 14.6 24.2 13.0 1.2 10.8 104.9 37.5 91.2 50.3 60.8 69.9 181.0 79.7 317.5 1.5 270.5 214.4 132.3 135.3 21.4 232.2 0.0 49.6 8.3 1.6 18.2 91.4 124.6 231.2 51.3 0.3 247.1 135.4 ACACB "ACC2, ACCB, HACC275" ENSG00000076555 "Acetyl-CoA carboxylase beta" O00763 12 109116595-109268226 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 185.0;skeletal muscle: 174.6" "Cell type enhanced" "Detected in many" "Adipocytes: 128.7;Astrocytes: 136.8;Hepatocytes: 216.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 17.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.5" "Cell line enriched" "Detected in many" 18 "ASC diff: 222.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA006554 Enhanced "Intracellular and membrane" NA NA "HPA006554: AB_1844495" "unprognostic (2.24e-1)" "unprognostic (4.66e-1)" "unprognostic (3.97e-2)" "unprognostic (4.54e-6)" "unprognostic (2.82e-1)" "unprognostic (1.59e-2)" "unprognostic (8.62e-3)" "unprognostic (5.81e-2)" "unprognostic (2.86e-1)" "unprognostic (1.63e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.63e-2)" "prognostic favorable (1.15e-5)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.21e-3)" "unprognostic (2.58e-2)" 185.0 20.0 20.1 3.4 19.7 3.6 101.4 8.1 11.7 11.9 24.2 28.9 8.5 12.1 3.6 10.7 12.2 11.0 30.1 8.8 15.2 12.6 54.8 6.7 3.8 18.0 15.5 6.2 14.4 19.4 18.1 11.3 2.6 15.7 11.9 8.3 1.7 12.6 11.8 174.6 9.2 15.6 9.5 5.9 7.9 18.8 4.9 19.9 4.5 18.3 62.0 3.0 23.1 11.6 12.1 0.9 5.7 3.6 6.9 222.6 1.7 2.6 0.9 1.5 1.0 0.6 4.1 1.1 2.9 1.6 1.2 2.4 4.8 3.0 1.5 0.6 3.8 5.3 6.6 6.2 4.3 1.0 5.7 1.6 2.6 1.5 2.3 0.6 1.7 0.5 4.9 0.7 0.3 0.7 1.7 4.1 5.3 3.9 0.4 12.4 2.2 4.8 1.5 1.8 2.0 2.3 5.4 5.9 2.8 3.4 1.5 2.6 5.9 0.4 2.2 1.3 2.5 1.9 8.8 5.3 4.0 5.3 4.5 1.7 4.6 0.4 17.5 1.1 0.1 0.6 2.2 1.0 0.3 0.2 3.0 1.8 0.9 0.7 0.1 0.2 0.3 0.6 0.1 20.1 19.7 8.1 11.7 8.8 15.2 18.0 15.5 6.2 15.7 5.9 19.9 12.1 128.7 6.4 1.1 136.8 3.7 2.3 2.6 1.0 3.4 3.1 32.5 5.0 35.3 25.8 1.7 23.9 0.0 0.6 2.4 13.9 1.9 2.1 34.3 3.3 3.4 26.0 10.2 25.7 5.1 4.0 0.5 16.0 18.3 1.3 1.3 20.0 41.4 216.5 1.7 23.5 6.4 9.6 0.0 12.6 2.4 36.4 29.2 3.7 5.4 28.1 1.2 5.2 2.1 29.7 25.8 2.7 7.3 50.4 2.5 0.9 17.9 6.5 2.3 4.1 6.6 29.3 12.0 2.3 3.0 2.5 1.6 0.1 3.5 21.8 11.8 1.1 TRAF4 "CART1, MLN62, RNF83" ENSG00000076604 "TNF receptor associated factor 4" Q9BUZ4 17 28744005-28750956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Urothelial cells: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 54.0" "Lineage enriched" "Detected in all" 6 "dendritic cells: 54.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009055, HPA021904, HPA052377" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804" "unprognostic (1.77e-1)" "unprognostic (9.05e-2)" "unprognostic (1.31e-2)" "unprognostic (2.51e-3)" "unprognostic (1.76e-1)" "unprognostic (7.38e-3)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (7.55e-2)" "unprognostic (1.74e-3)" "unprognostic (6.98e-2)" "unprognostic (9.26e-2)" "unprognostic (2.77e-2)" "unprognostic (5.58e-3)" 7.4 19.6 15.9 11.3 17.9 31.5 19.5 16.3 19.2 10.3 18.0 25.1 47.5 9.2 4.1 28.8 14.5 20.5 4.8 15.3 17.6 39.1 60.6 22.9 18.9 19.3 18.2 14.4 12.3 32.3 4.0 14.6 16.5 19.2 31.7 22.4 3.6 47.2 7.0 1.8 14.2 39.0 5.1 17.3 19.2 36.2 15.2 16.9 13.8 29.3 0.8 20.2 37.1 11.9 24.5 41.2 62.7 85.3 41.6 12.0 13.9 131.2 27.3 22.8 28.2 37.2 50.2 50.0 62.5 38.8 29.9 19.0 61.0 39.1 61.5 11.6 20.3 58.5 22.5 111.7 58.3 45.9 10.9 25.0 26.5 59.2 33.2 39.7 25.5 22.2 29.1 60.1 5.4 26.1 67.3 34.6 22.7 65.9 80.2 14.4 52.1 38.8 30.6 80.8 115.7 53.2 61.3 42.0 181.7 84.3 73.4 69.5 17.2 15.0 17.8 37.4 20.3 39.2 8.2 21.3 80.1 14.0 17.8 81.9 5.7 0.5 1.9 1.0 1.1 2.6 9.7 1.8 1.9 2.9 9.3 1.3 1.3 0.2 1.8 0.9 54.0 1.0 1.8 15.9 17.9 16.3 19.2 15.3 17.6 19.3 18.2 14.4 19.2 17.3 16.9 24.5 9.3 22.4 28.3 28.4 59.2 137.5 185.0 58.2 122.3 3.4 134.8 100.1 0.4 44.3 66.7 20.2 6.2 107.9 88.3 121.3 43.0 78.5 53.4 102.8 22.8 20.7 84.1 4.8 0.9 109.2 136.8 20.4 83.1 133.7 7.0 10.1 8.9 38.1 13.9 8.4 1.6 81.6 61.1 2.2 71.9 12.1 3.7 16.0 39.2 3.7 7.3 23.0 5.2 37.7 19.8 128.0 125.7 1.5 36.6 219.0 155.7 33.8 68.7 2.3 0.0 9.8 34.9 5.8 22.6 57.7 78.6 124.4 31.5 14.5 93.5 346.4 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 169.6;granulocytes: 124.5;Melanocytes: 140.5;Microglial cells: 166.8;Sertoli cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 35.4;HMC-1: 45.5;SK-MEL-30: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: AB_2685685" "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 3.8 3.1 4.0 9.1 3.7 12.4 2.0 14.7 4.1 1.6 4.5 9.3 7.7 1.9 2.3 1.7 1.8 7.2 3.7 3.1 3.6 1.7 4.7 15.0 14.7 4.5 5.1 2.3 1.2 15.0 0.9 2.0 16.1 7.2 2.6 8.8 5.0 3.7 2.1 1.3 4.4 9.1 3.0 6.4 9.2 4.5 0.7 4.9 10.5 1.9 2.1 14.1 4.8 2.7 5.9 0.1 0.1 4.8 0.2 8.9 8.5 0.1 2.0 15.5 1.0 1.9 0.3 0.1 35.4 0.2 0.5 7.6 1.5 0.1 1.8 0.9 0.9 4.5 20.8 0.3 0.0 9.1 3.4 45.5 4.1 1.2 8.9 8.2 0.9 0.0 6.2 0.2 0.1 14.8 0.3 12.6 0.3 0.4 8.1 1.4 9.5 2.4 0.1 1.6 7.6 1.0 1.7 0.0 0.3 36.1 0.8 1.2 3.5 0.3 1.1 0.6 0.0 1.2 5.7 1.6 12.3 9.7 11.7 8.5 13.1 1.4 2.0 2.5 6.4 6.1 2.0 6.2 4.4 1.9 1.6 4.9 3.8 2.3 1.7 14.6 4.1 7.2 2.7 4.0 3.7 14.7 4.1 3.1 3.6 4.5 5.1 2.3 7.2 6.4 4.9 5.9 6.2 0.0 12.4 40.8 37.0 31.5 3.9 5.2 0.6 39.7 2.2 2.2 15.4 10.0 14.0 3.7 0.0 0.8 39.0 169.6 0.0 4.0 3.5 0.6 4.4 10.9 3.6 3.8 57.5 6.5 26.2 24.3 8.2 1.1 124.5 97.0 12.5 10.3 27.1 63.9 60.0 23.2 6.1 73.6 26.2 2.1 2.5 79.1 140.5 166.8 40.8 34.9 19.6 82.4 75.3 2.0 62.1 7.9 38.4 7.7 109.3 0.4 0.8 3.2 124.9 32.3 37.1 0.2 3.0 3.8 22.6 2.3 78.1 11.8 27.4 13.7 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080899-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604, HPA074327" Approved Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Golgi apparatus, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499, HPA074327: " "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 3.5 3.1 2.8 3.5 3.1 3.8 4.5 5.1 4.0 4.1 2.0 4.8 5.4 4.5 4.4 4.3 3.9 2.8 3.8 3.0 2.9 4.4 3.5 3.4 5.0 2.9 3.1 2.9 7.2 3.9 6.4 2.6 4.2 3.3 4.3 4.5 3.9 4.7 3.4 4.2 5.6 4.6 4.5 2.6 4.3 5.0 4.4 3.1 6.0 4.7 3.3 5.1 3.7 3.7 3.4 8.8 18.2 8.4 9.1 5.5 6.2 7.1 7.8 5.4 11.6 9.7 12.9 7.9 12.3 9.7 6.2 5.5 7.7 10.6 6.4 10.1 21.4 6.6 11.7 6.8 9.8 7.2 20.3 7.6 5.3 7.4 7.9 7.2 5.6 6.6 9.6 12.5 7.7 5.8 11.2 11.8 7.1 5.9 11.5 7.5 11.9 10.6 5.5 5.4 5.4 9.3 6.2 12.3 7.6 4.6 7.2 6.4 14.5 7.5 10.2 7.6 5.6 11.3 6.4 11.1 10.6 6.3 10.3 9.5 23.1 6.4 7.4 6.0 6.6 4.1 6.2 5.6 7.7 6.0 7.0 9.6 6.0 4.7 3.5 3.7 5.3 9.2 5.0 2.8 3.1 5.1 4.0 3.0 2.9 2.9 3.1 2.9 3.3 2.6 3.1 3.4 6.5 9.6 7.9 5.9 9.1 6.1 5.0 6.0 10.8 9.7 5.2 4.6 11.8 1.5 9.8 7.3 14.6 10.5 10.7 12.0 15.6 6.8 3.2 5.2 9.4 6.4 4.2 4.2 7.2 4.5 5.2 7.5 10.2 6.8 16.5 10.1 7.9 4.6 4.1 3.3 7.0 7.7 8.2 6.0 5.2 2.1 10.2 5.8 8.8 2.8 5.8 7.1 16.5 5.5 7.0 9.0 8.7 8.2 5.5 3.3 6.8 6.6 10.3 11.9 0.0 8.0 7.3 19.5 14.8 6.5 3.7 5.5 9.1 7.0 6.5 3.4 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339661 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 208.4;liver: 73.8;lymphoid tissue: 86.5" "Cell type enhanced" "Detected in many" "B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1948.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 1948.5" "Cell line enhanced" "Detected in many" "Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0" "Not detected" "Not detected" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 390000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 16.9 7.5 4.4 50.8 4.4 208.4 10.1 4.3 6.0 4.9 5.5 16.2 15.3 3.6 2.9 7.7 6.3 9.0 15.0 4.2 4.2 11.8 73.8 16.2 72.8 4.7 4.6 3.8 2.9 15.3 3.0 1.0 4.6 4.7 6.8 11.1 0.9 15.3 3.0 18.1 4.3 28.3 4.5 4.7 86.5 19.7 2.1 4.6 49.1 6.8 12.0 51.0 14.2 4.5 4.3 12.4 5.8 4.2 13.1 6.8 5.3 7.3 7.5 5.1 5.9 5.2 5.3 8.1 0.2 24.9 6.2 0.1 5.4 0.2 5.5 2.0 106.2 3.7 23.8 5.4 22.6 3.4 96.7 102.1 4.8 4.4 7.0 2.6 6.4 2.9 57.1 13.0 324.6 6.9 24.0 13.9 222.3 3.2 31.7 38.3 11.1 2.7 257.6 6.2 11.2 1.3 5.6 6.5 20.4 17.3 1.9 17.7 23.9 4.6 28.0 3.0 31.2 7.6 20.7 188.8 37.3 20.2 179.0 22.1 193.6 395.4 872.4 362.7 287.8 436.2 280.1 343.0 331.7 327.5 271.7 301.5 283.9 1948.5 380.1 417.4 52.9 436.3 614.5 4.4 4.4 4.3 6.0 4.2 4.2 4.7 4.6 3.8 4.7 4.7 4.6 4.3 22.6 3.2 29.7 0.7 151.9 8.2 6.5 7.0 10.2 0.3 23.1 20.6 0.1 21.5 9.8 5.5 0.0 12.0 164.6 49.1 62.6 16.9 7.7 10.7 9.4 19.2 5.4 37.4 0.2 35.4 24.7 10.2 16.8 9.9 30.4 5.5 31.1 168.8 24.0 1.7 0.1 33.2 4.1 70.0 50.4 10.0 6.2 52.9 55.2 1.0 127.7 6.4 313.1 0.0 0.1 23.2 43.8 4.1 137.2 12.3 79.9 54.4 9.0 1.2 0.0 7.3 10.7 5.7 0.7 8.3 8.4 4.7 183.3 5.4 36.4 10.2 NT5C2 "cN-II, GMP, NT5B, PNT5, SPG45, SPG65" ENSG00000076685 "5'-nucleotidase, cytosolic II" P49902 10 103087185-103277605 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Allosteric enzyme, Hydrolase" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003751 Approved NA NA "HPA003751: AB_1854664" "unprognostic (8.18e-2)" "unprognostic (1.98e-1)" "unprognostic (2.55e-2)" "unprognostic (2.46e-1)" "unprognostic (5.54e-2)" "unprognostic (4.87e-3)" "unprognostic (2.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.41e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-3)" "unprognostic (6.20e-2)" "unprognostic (3.26e-2)" "unprognostic (3.70e-2)" "unprognostic (6.40e-2)" "unprognostic (3.43e-1)" "unprognostic (1.50e-1)" 23.0 27.3 25.7 19.2 27.8 30.0 23.2 27.5 28.7 32.2 35.6 27.6 10.0 19.0 17.5 67.6 26.7 16.6 25.1 25.5 31.6 28.0 28.0 31.1 18.4 28.8 29.1 25.7 32.7 22.2 21.9 34.2 18.1 27.6 32.6 16.9 47.7 46.8 18.6 52.0 19.7 20.6 13.5 27.1 33.1 22.4 31.0 27.8 28.9 55.9 18.3 24.7 33.7 43.1 29.4 148.4 52.5 32.6 67.5 27.2 33.2 18.2 66.0 64.7 29.9 32.4 34.6 91.7 49.2 47.7 45.6 27.6 62.8 23.4 33.8 38.3 40.3 21.6 38.7 21.1 39.6 48.5 64.2 21.0 50.4 34.1 28.0 24.8 57.5 25.6 19.4 29.4 36.4 54.5 73.8 53.7 64.6 34.6 43.2 68.6 102.6 30.0 19.6 43.3 72.5 10.0 24.9 35.8 25.9 50.3 33.7 39.2 38.1 30.5 20.5 24.8 39.7 51.7 32.9 71.6 85.5 23.9 64.6 7.8 29.5 16.5 31.3 10.0 18.8 10.3 8.9 8.4 8.7 14.7 5.2 6.7 8.0 27.4 14.4 23.0 9.6 9.3 10.5 25.7 27.8 27.5 28.7 25.5 31.6 28.8 29.1 25.7 27.6 27.1 27.8 29.4 16.2 83.3 34.9 141.7 17.2 7.4 29.0 26.9 5.7 24.4 13.9 13.6 2.6 18.6 60.4 27.6 45.9 19.4 23.3 48.7 11.7 28.5 103.7 29.5 17.1 19.8 11.5 12.4 79.8 26.0 11.7 17.5 25.5 46.2 8.8 18.2 13.9 17.4 19.9 47.1 83.6 17.6 18.3 29.8 14.2 61.9 24.8 27.1 26.6 78.7 25.9 85.5 16.5 70.4 107.5 57.9 23.1 13.5 21.0 35.7 11.7 15.3 44.1 59.1 32.9 22.9 21.7 25.3 20.5 22.9 7.5 35.0 16.6 15.8 18.0 80.5 MCAM "CD146, HEMCAM, MelCAM, METCAM, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6" "Cancer enhanced" "Detected in all" "melanoma: 83.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" NA NA 1900000000 "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 335.7 30.3 38.2 69.0 49.1 1.2 182.1 47.3 46.3 94.9 44.6 134.8 29.4 177.3 47.4 90.0 137.6 67.4 119.1 36.2 43.3 28.5 10.6 117.4 19.8 57.3 46.4 32.5 61.4 22.2 94.5 18.0 169.4 75.5 78.7 32.5 12.3 39.8 149.4 41.1 42.1 73.6 162.4 37.9 35.7 98.5 9.8 47.5 15.6 59.2 37.8 15.6 176.0 80.5 45.2 0.7 5.1 4.7 0.3 21.5 0.3 23.2 3.2 0.3 29.9 13.3 17.9 0.9 1.2 94.5 10.7 44.7 3.2 38.3 8.1 15.0 56.9 14.5 1.2 102.4 19.8 51.0 0.1 0.4 15.2 0.3 40.8 18.7 1.1 1121.0 7.1 38.7 1.5 6.1 0.0 1.2 9.3 19.9 0.2 4.4 0.9 147.8 32.9 27.1 0.0 12.5 3.9 87.1 2.1 249.2 46.2 4.3 0.9 1107.4 3.1 156.7 0.2 89.1 2.4 2.3 0.6 43.1 0.1 869.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 38.2 49.1 47.3 46.3 36.2 43.3 57.3 46.4 32.5 75.5 37.9 47.5 45.2 128.5 0.0 2.3 1.3 1.4 4.7 0.6 11.1 8.0 1.2 9.9 19.7 65.8 18.6 1.1 0.0 22.9 0.5 2.5 0.1 0.0 17.3 1.7 7.8 14.0 153.5 0.0 0.0 1.4 0.4 38.7 14.1 1.5 10.3 0.0 18.2 60.0 0.6 0.8 0.0 3.5 0.0 0.0 1.3 7.0 0.7 0.9 2.4 21.4 14.0 0.6 89.8 1.0 18.6 45.2 1.6 0.0 25.2 3.1 1.7 0.0 0.9 1.3 4.0 322.1 9.9 384.6 2.1 1.6 1.7 3.3 0.4 9.3 4.9 0.1 1.8 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415489 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 190000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favorable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favorable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 9.4 9.9 6.0 5.0 6.6 0.1 5.6 5.7 5.8 12.1 4.8 18.8 10.7 10.9 16.5 7.5 11.3 9.1 6.5 5.9 6.4 20.8 1.8 17.5 2.5 7.3 6.0 5.5 12.4 10.9 5.7 16.7 29.2 5.9 8.1 11.0 1.2 13.1 11.5 24.5 3.5 10.9 17.9 6.7 5.8 17.0 7.8 4.8 8.5 5.9 20.2 2.0 10.4 5.2 8.7 0.0 0.0 209.7 8.3 8.9 1.3 26.0 1.6 0.0 0.0 0.0 0.1 0.5 0.3 71.7 1.2 0.0 0.1 121.8 0.1 0.0 0.0 11.5 0.0 0.0 0.0 0.2 0.0 0.0 37.3 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 6.0 0.1 0.1 110.3 0.0 3.2 0.6 19.2 0.0 276.6 8.4 0.1 1.5 0.8 0.1 0.1 242.0 3.2 3.2 0.0 21.3 24.8 0.0 13.6 0.0 0.0 0.1 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 6.6 5.7 5.8 5.9 6.4 7.3 6.0 5.5 5.9 6.7 4.8 8.7 1.7 51.3 29.2 54.5 0.2 1.5 3.7 14.7 14.2 0.0 2.9 2.0 4.4 5.7 8.7 23.9 0.0 0.5 0.2 2.5 3.9 7.0 0.6 5.9 1.7 1.2 2.4 0.0 4.7 12.7 36.2 14.4 6.6 10.0 0.0 30.6 0.0 0.0 2.5 0.0 1.4 11.1 4.1 0.6 3.9 2.1 2.1 2.0 1.8 14.0 1.1 1.0 0.0 4.5 4.3 16.5 4.3 0.4 0.1 1.4 4.6 30.3 12.8 0.1 0.0 6.3 13.6 2.4 23.6 2.3 0.4 3.1 1.0 1.4 11.3 0.6 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.8;placenta: 172.2" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1" "Cancer enhanced" "Detected in all" "liver cancer: 13.8" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 123.8;Hep G2: 171.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.9 11.8 1.1 8.8 2.0 14.9 4.8 1.8 2.7 3.7 6.3 11.8 10.0 4.9 24.5 11.0 9.5 5.8 6.1 0.9 3.2 8.0 59.8 6.0 13.9 3.5 3.0 0.4 4.8 10.1 4.3 1.6 172.2 2.8 4.1 11.6 0.1 6.7 11.2 0.6 12.7 9.9 4.0 1.9 11.4 13.1 43.2 1.5 14.4 8.3 3.5 15.3 8.6 2.8 3.7 7.2 0.0 8.6 1.4 1.6 3.6 15.7 0.5 3.2 1.1 0.0 123.8 22.7 32.6 0.7 1.3 1.1 7.7 19.8 8.2 0.8 3.3 7.6 29.1 25.9 171.5 1.5 32.9 10.2 1.5 7.1 0.0 3.6 0.1 1.1 20.4 2.6 9.2 1.6 19.2 56.3 12.5 1.3 27.5 1.6 53.2 10.7 18.6 5.7 18.6 3.1 10.5 14.8 8.6 4.3 15.1 3.1 8.4 3.9 6.3 1.2 8.2 6.7 18.2 13.0 47.0 1.2 21.8 20.2 11.9 7.9 5.5 16.6 9.9 14.4 20.6 9.8 11.6 8.8 25.5 10.0 11.2 1.2 18.7 21.7 17.0 2.2 9.1 1.1 2.0 1.8 2.7 0.9 3.2 3.5 3.0 0.4 2.8 1.9 1.5 3.7 4.1 3.2 6.8 16.0 16.9 8.8 2.2 2.1 5.2 0.7 3.5 3.6 14.7 41.5 5.0 11.0 0.0 328.3 9.5 12.8 3.9 1.5 5.8 12.6 1.3 3.6 6.7 55.8 0.9 5.4 56.6 7.5 15.3 6.6 8.8 6.8 6.4 119.6 29.3 0.0 0.9 9.8 0.0 27.2 6.5 9.4 23.0 9.6 7.2 30.0 10.6 0.2 9.2 0.0 20.6 1.3 3.6 50.8 12.2 1.4 6.4 9.7 4.5 1.9 0.0 3.1 2.7 2.1 1.7 13.6 8.5 344.1 10.3 5.7 10.3 3.3 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595863-7618304 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 62.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: AB_2684698" "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favorable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.3 3.3 2.0 0.8 3.8 0.0 5.3 2.0 8.5 4.6 0.0 5.9 15.0 0.5 2.3 25.0 3.1 1.6 0.3 3.9 1.7 11.9 24.5 4.7 0.2 2.6 1.1 4.3 0.5 20.8 2.7 8.3 0.5 2.0 10.3 2.4 3.2 18.2 4.5 0.2 62.7 11.6 0.1 0.0 0.6 15.7 13.1 0.6 0.5 11.2 0.0 1.1 3.6 13.5 1.9 11.2 1.8 0.3 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 26.7 5.8 3.1 4.5 0.0 1.2 9.7 4.3 2.8 0.0 2.0 10.1 0.0 0.5 15.6 0.0 0.0 4.4 0.0 5.5 0.0 0.4 0.4 0.0 4.5 0.9 0.0 0.0 13.0 0.2 0.2 6.6 8.4 4.7 0.7 0.0 3.7 1.9 6.0 8.2 8.7 1.3 12.5 0.0 1.6 10.4 1.7 0.0 0.0 2.0 0.0 0.4 5.0 1.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.8 2.0 8.5 3.9 1.7 2.6 1.1 4.3 2.0 0.0 0.6 1.9 0.2 9.6 19.2 3.3 1.1 9.8 2.7 2.4 3.4 22.7 19.3 12.1 1.5 20.0 5.3 9.2 0.0 0.5 0.2 40.0 3.9 5.7 4.4 9.6 1.4 1.5 13.1 0.0 9.1 11.8 0.7 0.2 38.7 13.5 5.7 8.6 0.4 24.8 0.2 10.1 10.1 22.4 0.0 1.9 1.2 2.9 1.5 1.0 0.0 1.9 0.0 1.5 0.0 4.5 0.6 13.1 28.4 0.0 0.6 6.2 29.2 15.6 2.9 13.4 0.0 0.0 1.1 0.4 2.8 9.8 18.9 0.5 0.9 1.5 18.4 8.0 RAP1GAP "KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII" ENSG00000076864 "RAP1 GTPase activating protein" P47736 1 21596215-21669363 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 164.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 46.3;OE19: 162.8;SCLC-21H: 52.1" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 231.1" "HPA001922, CAB003851" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB003851: AB_562338, HPA001922: AB_1079743" "unprognostic (1.17e-2)" "unprognostic (4.33e-2)" "unprognostic (7.84e-2)" "unprognostic (2.45e-2)" "unprognostic (4.52e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (8.33e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (3.43e-2)" "unprognostic (1.35e-2)" "prognostic favorable (1.12e-6)" "unprognostic (1.11e-1)" "unprognostic (9.85e-3)" "unprognostic (4.86e-3)" "unprognostic (3.64e-2)" 0.5 81.5 60.9 2.6 101.8 0.8 4.5 21.9 92.6 7.5 0.1 19.8 12.5 1.9 1.9 7.6 4.3 25.1 6.3 75.0 37.5 84.4 36.4 14.3 1.0 34.9 22.4 75.0 1.6 107.1 57.7 38.2 2.1 40.7 12.9 17.4 27.5 89.5 0.8 0.2 3.2 21.9 0.7 8.2 1.2 111.7 3.7 28.6 0.5 164.2 0.3 0.9 4.0 3.4 66.5 6.2 46.3 0.5 3.6 0.0 0.0 0.8 0.0 0.1 0.1 0.0 4.3 6.4 0.1 4.6 0.2 30.2 7.9 4.4 0.3 0.1 1.0 2.3 2.2 4.3 22.1 0.7 0.0 6.6 0.3 3.1 0.0 0.0 0.0 0.0 22.1 29.6 1.1 0.0 15.6 7.7 0.7 2.8 162.8 7.0 4.3 1.2 1.1 10.2 3.4 52.1 9.3 7.7 27.4 8.9 1.8 2.7 5.2 0.1 0.0 3.1 0.0 0.1 0.6 0.1 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.9 101.8 21.9 92.6 75.0 37.5 34.9 22.4 75.0 40.7 8.2 28.6 66.5 0.0 9.6 29.3 10.4 0.5 1.3 1.1 1.1 0.6 64.1 8.5 5.6 5.1 25.8 4.5 14.7 0.0 0.2 0.1 4.3 72.4 25.1 0.8 3.1 0.6 0.4 6.7 4.0 82.0 28.8 1.4 1.0 17.3 8.0 0.0 6.2 0.4 8.5 0.3 92.5 45.8 112.6 6.1 0.6 0.3 0.3 0.0 0.6 16.0 3.7 0.6 11.5 0.0 51.8 18.6 15.3 17.2 0.0 0.2 5.0 6.0 13.5 1.2 7.3 0.0 0.0 0.7 1.0 3.6 0.5 1.1 1.5 0.3 2.5 7.7 2.6 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629545 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048751: AB_2680512" "unprognostic (1.13e-1)" "prognostic favorable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 27.2 23.8 15.0 15.3 16.7 44.9 30.8 16.8 25.0 35.9 14.1 26.7 17.6 34.1 7.0 25.6 32.3 11.9 23.5 15.1 16.3 27.8 28.0 27.4 20.9 17.1 16.0 15.3 46.2 36.2 13.5 27.3 15.5 17.0 33.0 5.4 9.0 31.3 17.7 35.8 38.3 27.8 9.3 15.3 34.8 31.1 38.0 15.3 21.3 35.0 13.4 10.7 29.3 29.9 22.7 39.8 35.7 21.2 27.9 21.9 16.3 41.2 22.8 26.5 39.6 40.0 46.4 25.4 26.7 44.1 21.3 28.9 34.2 30.2 33.2 10.0 47.1 39.0 35.5 30.2 41.3 28.3 47.5 30.8 28.8 27.0 28.0 20.2 21.3 24.2 56.4 32.4 69.0 12.4 44.0 44.9 73.8 48.3 24.8 69.6 49.3 26.8 47.0 15.8 30.7 30.2 34.4 25.9 25.1 23.2 13.8 32.0 41.6 24.1 18.1 29.5 41.3 39.0 117.7 75.0 39.0 31.0 40.1 27.4 8.8 10.0 9.3 11.8 10.2 11.3 10.1 11.0 9.1 8.0 12.2 13.1 10.0 6.4 8.3 13.9 6.9 14.2 12.1 15.0 16.7 16.8 25.0 15.1 16.3 17.1 16.0 15.3 17.0 15.3 15.3 22.7 18.3 0.0 1.8 3.9 22.9 19.6 16.2 28.1 14.2 14.1 89.4 54.4 1.4 25.8 20.1 47.8 12.5 46.0 24.8 28.3 35.2 19.8 39.9 24.7 13.3 16.4 18.6 14.1 2.3 34.4 26.4 16.7 33.6 32.3 19.7 27.7 17.5 46.4 19.8 3.3 2.5 21.2 24.4 19.2 11.0 19.1 28.3 18.3 26.6 3.7 26.5 13.9 23.7 1.0 3.7 15.1 12.4 21.8 19.4 12.2 28.9 159.5 13.4 14.2 39.5 15.9 21.6 36.1 57.3 14.6 17.8 65.9 20.6 17.8 23.9 14.3 ARHGEF1 "LBCL2, P115-RHOGEF, SUB1.5" ENSG00000076928 "Rho guanine nucleotide exchange factor 1" Q92888 19 41883173-41930150 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 169.7" "Cell type enhanced" "Detected in all" "dendritic cells: 156.2;NK-cells: 187.4;T-cells: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009502, HPA012924, HPA060784" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363" "prognostic favorable (5.92e-4)" "unprognostic (2.09e-1)" "unprognostic (8.29e-3)" "unprognostic (8.10e-3)" "unprognostic (7.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.99e-2)" "unprognostic (7.28e-2)" "unprognostic (5.88e-2)" "unprognostic (1.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.29e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (3.54e-1)" "unprognostic (1.95e-1)" "unprognostic (8.00e-2)" "unprognostic (4.65e-2)" 47.4 21.1 13.8 79.8 17.9 114.5 40.2 16.5 22.1 36.2 16.4 34.6 27.0 33.7 3.6 34.3 36.7 23.7 26.4 13.1 17.8 31.9 30.2 68.3 128.6 20.9 17.1 11.2 33.1 27.7 12.7 26.1 18.4 20.1 32.4 10.5 5.6 29.0 11.9 15.6 37.7 87.8 13.6 16.5 169.7 35.2 11.0 16.8 97.4 37.0 9.0 49.3 34.2 33.4 25.2 58.8 69.9 15.8 19.9 21.9 22.9 18.4 30.1 45.7 37.4 32.8 21.5 49.2 77.9 54.6 27.8 19.8 33.8 20.3 46.9 11.8 74.1 23.6 63.1 30.6 28.4 31.9 68.4 100.8 27.8 30.5 36.3 23.5 19.9 36.2 68.2 25.5 46.7 21.8 40.4 48.0 52.9 17.9 46.4 54.0 71.8 29.7 46.3 23.2 31.8 10.3 43.8 42.3 18.7 36.0 8.1 21.9 114.4 49.6 49.7 33.2 26.8 47.7 63.0 43.2 68.4 40.5 107.6 80.2 10.4 20.5 29.2 47.0 39.5 37.2 20.1 35.6 49.4 21.5 19.5 36.1 39.4 27.4 32.1 57.5 11.3 38.7 36.4 13.8 17.9 16.5 22.1 13.1 17.8 20.9 17.1 11.2 20.1 16.5 16.8 25.2 46.6 6.4 22.0 35.3 97.3 14.5 13.9 15.0 20.5 18.7 13.1 12.4 4.2 8.6 8.8 7.3 27.1 13.3 156.2 21.7 3.9 23.6 1.4 12.2 16.7 29.0 21.7 23.8 8.0 24.9 22.8 17.7 56.6 16.8 31.7 19.3 26.7 9.3 38.2 11.8 7.9 29.2 16.2 52.5 31.9 1.8 19.3 58.9 19.6 18.7 39.0 8.8 187.4 13.6 27.6 55.9 22.7 16.6 66.4 15.7 10.1 7.3 6.3 19.1 26.3 17.6 17.3 7.3 10.1 17.3 14.8 10.1 159.0 20.4 26.4 11.1 STXBP2 "Hunc18b, UNC18B" ENSG00000076944 "Syntaxin binding protein 2" Q15833 19 7636881-7647873 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 196.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 262.5;Macrophages: 249.1;monocytes: 368.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 248.6;classical monocyte: 471.0;eosinophil: 295.6;intermediate monocyte: 604.8;myeloid DC: 239.7;neutrophil: 356.2;non-classical monocyte: 893.3" "Group enriched" "Detected in all" 6 "dendritic cells: 239.7;granulocytes: 356.2;monocytes: 893.3" "Cell line enhanced" "Detected in many" "HMC-1: 244.8;U-937: 224.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015564, HPA063868" Approved Enhanced Cytosol No No 870000 Cytosol "HPA015564: AB_1857626, HPA063868: AB_2685136" "unprognostic (1.20e-2)" "unprognostic (6.17e-3)" "unprognostic (2.85e-2)" "prognostic favorable (2.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (4.65e-4)" "unprognostic (4.22e-3)" "unprognostic (2.35e-1)" "unprognostic (6.25e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (1.51e-1)" "unprognostic (4.62e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.68e-4)" "prognostic favorable (5.13e-6)" 17.8 23.0 4.9 66.4 6.3 196.0 24.6 4.7 10.0 22.4 9.4 46.2 68.0 8.5 33.5 73.7 27.9 28.7 7.1 4.9 8.0 62.5 49.4 90.4 51.5 7.7 5.4 5.0 5.4 87.5 36.4 29.6 36.6 7.8 52.6 37.4 4.3 80.1 23.0 2.9 49.5 64.4 14.7 7.6 163.5 72.5 75.5 7.7 86.1 52.4 3.0 34.8 34.9 35.0 10.9 113.0 39.1 0.9 0.5 0.0 0.9 75.6 14.2 1.5 2.7 7.4 92.5 69.6 29.6 55.4 11.3 49.5 75.5 4.1 67.5 2.7 124.1 46.9 127.8 49.7 55.8 63.6 83.2 244.8 4.4 67.4 13.4 38.0 0.3 58.5 74.7 81.4 98.5 0.0 70.9 41.2 193.2 28.7 72.7 68.0 41.8 0.3 114.7 55.0 128.1 11.5 0.6 34.0 49.6 2.2 35.6 61.9 212.7 61.7 0.4 21.8 1.5 0.8 108.4 58.6 38.8 1.2 224.8 2.7 248.6 471.0 295.6 69.9 604.8 56.7 47.3 52.7 63.8 239.7 52.2 36.6 44.3 356.2 74.7 893.3 91.5 78.9 306.9 4.9 6.3 4.7 10.0 4.9 8.0 7.7 5.4 5.0 7.8 7.6 7.7 10.9 2.1 0.0 7.7 0.7 44.1 23.6 48.2 105.1 18.8 6.0 38.0 22.9 0.9 31.5 68.5 35.0 2.1 97.7 56.2 181.4 33.2 100.3 99.9 32.5 5.4 6.7 59.8 38.3 0.6 118.8 123.2 5.7 150.3 47.6 71.8 34.6 16.4 19.6 168.4 0.0 0.4 108.2 105.8 262.5 46.6 233.5 1.8 249.1 14.2 1.0 368.2 0.9 72.1 0.0 0.0 132.8 152.6 1.9 54.7 49.1 171.7 75.9 42.5 4.0 6.6 1.0 8.6 45.7 20.2 35.3 21.3 153.0 47.7 6.0 79.3 68.7 MAP2K7 "Jnkk2, MKK7, PRKMK7" ENSG00000076984 "Mitogen-activated protein kinase kinase 7" O14733 19 7903843-7914478 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001633, CAB004262, HPA064711" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331" "unprognostic (1.77e-1)" "unprognostic (5.04e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (4.24e-2)" "prognostic favorable (8.54e-5)" "unprognostic (1.80e-3)" "unprognostic (2.55e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-2)" "unprognostic (1.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.54e-2)" "unprognostic (3.71e-2)" "unprognostic (6.05e-2)" "unprognostic (1.73e-2)" "prognostic favorable (1.56e-4)" 18.1 17.1 16.5 11.8 16.3 19.5 19.7 14.9 19.2 24.6 9.2 22.5 13.2 26.3 3.8 20.3 20.7 5.9 19.6 13.6 13.8 18.9 24.9 17.3 11.8 16.5 16.2 11.6 23.4 21.8 9.7 23.6 9.2 19.7 21.2 4.6 5.6 19.3 8.0 52.9 28.0 20.3 6.3 14.2 24.7 18.9 17.6 16.7 11.0 19.2 16.6 6.1 22.2 22.5 17.0 25.8 14.4 12.2 20.2 9.7 9.3 22.8 16.5 8.0 11.0 11.3 20.9 15.2 30.5 25.9 8.8 10.7 22.9 10.7 12.8 4.3 24.7 53.3 21.4 20.9 15.6 12.4 20.1 26.0 10.8 16.1 8.7 9.8 14.5 10.0 21.9 31.9 38.5 6.5 13.4 28.8 48.6 21.7 13.6 32.0 28.5 13.4 31.0 9.8 21.0 22.4 22.5 11.3 19.4 23.9 7.3 21.0 22.7 15.3 33.2 19.0 23.7 22.7 55.5 27.7 28.8 16.6 29.2 13.6 0.0 0.8 0.6 0.6 0.8 0.4 0.7 0.5 0.6 0.4 1.0 0.5 0.7 1.5 1.0 0.5 0.8 0.2 0.4 16.5 16.3 14.9 19.2 13.6 13.8 16.5 16.2 11.6 19.7 14.2 16.7 17.0 15.4 25.6 18.1 11.1 27.0 38.6 37.2 22.7 22.2 52.9 23.5 16.5 14.4 24.3 14.5 20.2 77.2 28.3 27.8 31.1 13.7 22.8 4.8 16.2 20.3 19.5 36.5 23.6 9.9 19.0 31.1 18.5 16.3 24.8 10.8 33.3 21.4 22.2 18.6 57.2 11.0 24.0 32.6 22.2 17.1 11.7 28.9 20.5 32.0 6.5 25.3 23.9 46.4 9.0 15.0 25.7 20.8 12.4 30.4 39.8 38.7 18.4 15.3 65.7 32.9 30.2 22.1 17.7 36.4 22.7 42.6 49.3 30.3 30.3 27.6 33.2 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 111 "heart muscle: 1317.2;skeletal muscle: 640.8;tongue: 728.5" "Cell type enriched" "Detected in some" 36 "Cardiomyocytes: 995.1" "Cancer enhanced" "Detected in some" "renal cancer: 32.8;testis cancer: 13.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 29.2;NTERA-2: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522" "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.6 1.7 0.4 0.0 0.2 0.0 0.8 0.3 0.9 0.1 0.1 0.4 0.0 0.4 0.1 5.8 0.6 0.0 1317.2 0.6 0.3 1.8 0.3 2.1 0.0 0.5 0.3 0.0 0.5 0.6 0.0 1.7 0.1 0.5 2.6 0.1 0.0 8.0 0.9 640.8 0.5 0.5 0.0 0.3 0.1 0.6 0.5 0.2 0.0 0.6 728.5 0.0 0.4 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.9 0.6 0.3 0.5 0.3 0.0 0.5 0.3 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 995.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.4 0.0 0.0 0.2 0.0 0.6 26.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 24.6 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 DGKD "DGKdelta, KIAA0145" ENSG00000077044 "Diacylglycerol kinase delta" Q16760 2 233354494-233472104 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 30.6" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 143.2;Inhibitory neurons: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.3;HeLa: 21.8;U-698: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027530, HPA049101" Approved Supported Cytosol NA NA Cytosol "HPA027530: AB_2672320, HPA049101: AB_2680630" "unprognostic (1.84e-1)" "unprognostic (2.19e-2)" "unprognostic (7.76e-3)" "unprognostic (1.92e-2)" "unprognostic (5.69e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (1.69e-5)" "unprognostic (2.25e-1)" "unprognostic (1.17e-3)" "unprognostic (6.03e-2)" "unprognostic (5.76e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.07e-8)" "unprognostic (1.78e-1)" "unprognostic (7.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.94e-3)" 4.9 3.4 4.3 2.0 5.5 12.1 5.9 19.7 5.1 3.9 3.9 8.4 1.6 5.9 1.6 2.2 5.8 1.0 7.3 5.5 13.0 2.5 3.6 10.7 4.4 6.3 4.1 2.8 9.0 2.7 0.4 3.7 2.9 10.2 5.7 2.3 5.5 5.9 0.5 30.6 2.9 13.0 0.7 3.9 11.5 25.4 9.7 4.4 1.0 8.4 0.9 4.5 5.3 2.7 8.7 1.7 8.5 2.1 1.5 1.5 1.4 3.0 2.4 1.0 0.6 0.5 9.7 1.9 10.3 1.1 2.4 4.5 2.0 2.4 1.0 3.2 17.3 11.3 4.7 21.8 5.8 0.9 11.7 7.2 2.3 2.2 1.1 2.1 1.8 0.8 2.1 7.8 1.8 1.6 3.1 9.2 3.3 1.6 2.8 6.9 14.5 5.7 1.6 0.9 3.3 2.1 2.2 1.4 2.3 1.0 1.8 0.6 5.2 1.0 1.2 3.0 1.2 1.7 7.1 6.2 22.7 0.8 5.6 0.6 1.7 1.6 5.6 2.1 0.6 1.1 4.8 0.5 1.5 0.4 5.0 1.7 2.4 1.2 0.6 1.0 0.4 0.2 1.7 4.3 5.5 19.7 5.1 5.5 13.0 6.3 4.1 2.8 10.2 3.9 4.4 8.7 18.9 32.1 46.2 27.1 61.1 8.9 6.4 5.6 4.6 33.8 19.6 11.6 21.0 0.0 13.8 0.0 62.6 14.6 62.0 40.6 0.0 3.6 14.9 23.4 12.5 19.1 2.4 5.0 11.1 4.4 1.2 9.7 143.2 38.1 5.7 13.1 4.6 7.0 6.8 8.4 137.9 32.8 8.2 10.4 13.8 38.7 6.5 28.7 8.8 11.2 17.5 13.9 49.4 43.2 81.5 26.0 13.5 4.5 34.7 17.6 29.6 2.6 4.8 44.3 19.7 49.4 21.2 14.4 29.3 4.5 3.7 2.5 32.5 7.6 20.1 9.9 CTTNBP2 "C7orf8, CORTBP2, KIAA1758, Orf4" ENSG00000077063 "Cortactin binding protein 2" Q8WZ74 7 117710651-117874139 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "non-classical monocyte: 7.7" "Lineage enriched" "Detected in single" 26 "monocytes: 7.7" "Group enriched" "Detected in some" 6 "HEL: 57.6;HMC-1: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009151, HPA044654" Enhanced Approved "Midbody ring,Cytosol" Yes No "Midbody ring, Cytosol" "CAB009151: AB_2088281, HPA044654: AB_2679037" "unprognostic (6.28e-2)" "unprognostic (2.90e-1)" "unprognostic (5.11e-2)" "unprognostic (1.81e-3)" "unprognostic (1.21e-1)" "unprognostic (3.64e-1)" "unprognostic (7.38e-2)" "unprognostic (3.28e-4)" "unprognostic (3.83e-1)" "unprognostic (7.98e-2)" "unprognostic (7.93e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.71e-5)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.45e-3)" 7.0 1.8 13.3 0.7 18.7 0.0 3.8 14.0 16.0 5.8 8.9 2.3 1.7 10.7 4.9 12.2 6.0 3.5 1.3 14.0 15.8 6.4 1.8 1.8 0.2 17.2 17.4 10.9 3.1 7.9 9.4 2.9 1.7 18.0 3.4 2.4 8.0 3.4 1.8 0.6 1.6 2.4 5.2 13.4 2.2 1.4 1.0 16.6 0.7 5.5 0.9 0.9 4.3 4.2 28.3 0.0 0.9 1.6 0.0 0.0 0.0 1.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.1 8.3 0.0 0.0 0.0 2.5 57.6 0.5 0.0 0.2 0.0 74.1 0.3 0.4 0.0 0.0 1.0 1.6 0.0 0.0 0.1 1.1 0.0 0.0 0.0 10.6 0.0 0.3 0.0 0.0 0.2 10.6 0.0 6.1 0.0 0.0 0.0 0.2 4.6 0.0 0.0 0.0 2.6 1.0 0.1 0.0 0.7 0.0 0.2 5.0 0.0 1.3 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 13.3 18.7 14.0 16.0 14.0 15.8 17.2 17.4 10.9 18.0 13.4 16.6 28.3 15.6 3.2 4.8 10.1 0.0 1.9 3.4 3.7 15.9 33.6 1.9 6.7 3.6 10.0 5.6 7.3 56.3 2.8 0.3 1.8 1.9 6.3 1.8 5.1 32.5 10.2 1.8 0.0 128.8 4.2 2.1 9.1 1.1 7.4 139.9 3.8 20.0 1.1 9.2 74.0 194.9 1.1 24.4 10.1 12.3 3.3 0.9 8.0 7.2 75.9 1.3 97.2 0.0 428.8 444.2 0.6 2.1 1.2 0.3 2.1 0.3 24.3 1.4 6.6 0.0 3.3 9.6 0.6 2.1 38.8 0.3 1.1 2.7 0.2 6.8 1.4 ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656448 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 22.9;pituitary gland: 15.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 76 "SCLC-21H: 28.5;SH-SY5Y: 28.7" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoli rim, Mitotic chromosome" "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 0.0 1.8 10.6 0.0 16.9 0.0 0.0 12.1 22.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.7 12.2 0.0 0.0 0.0 0.0 6.9 5.0 15.5 0.0 0.8 0.1 15.4 0.0 9.8 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.5 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 16.9 12.1 22.9 15.7 12.2 6.9 5.0 15.5 9.8 2.0 6.2 14.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.1 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 19.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.0 0.0 1.2 0.0 3.5 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 41.4;Excitatory neurons: 66.8;Inhibitory neurons: 92.6;Microglial cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.7;HEK 293: 16.0;hTERT-RPE1: 82.3;WM-115: 36.5" "Region enriched" "Detected in all" 9 "basal ganglia: 109.2" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 4.1 7.1 2.9 2.6 14.4 0.0 7.0 2.6 6.3 9.4 6.8 4.5 1.7 7.4 6.8 8.0 6.1 5.3 14.1 3.8 4.3 15.2 6.5 5.3 6.8 4.9 2.2 4.0 11.6 1.3 6.1 7.6 14.5 4.9 12.6 2.2 13.7 13.2 11.3 2.5 1.1 2.0 5.9 2.1 5.0 3.9 0.6 3.4 1.2 9.2 5.4 4.3 7.3 6.2 4.3 0.0 1.9 1.2 6.4 13.7 3.6 0.0 1.6 0.8 0.0 0.6 0.3 0.1 0.1 0.2 2.5 0.3 0.4 0.0 0.3 0.0 0.1 16.0 0.1 0.1 1.1 0.3 0.2 0.1 7.1 0.0 0.0 0.0 82.3 13.4 0.1 0.1 5.6 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.6 8.3 0.0 0.2 0.1 9.1 0.0 0.1 0.0 1.1 0.1 2.1 7.0 0.2 0.0 0.1 5.6 0.2 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 14.4 2.6 6.3 3.8 4.3 4.9 2.2 4.0 4.9 2.1 3.4 4.3 2.4 0.0 0.5 41.4 0.3 0.1 18.0 6.4 1.8 4.5 1.7 7.5 12.0 12.8 14.9 11.0 25.0 0.2 0.8 0.0 0.0 1.6 1.5 8.3 4.2 10.5 0.0 0.0 66.8 0.9 0.1 6.8 7.7 3.0 0.0 0.1 22.1 2.1 0.4 5.0 92.6 0.0 2.0 1.9 0.4 1.2 0.0 0.3 0.0 29.0 0.0 24.8 0.0 19.6 2.9 1.4 0.0 0.0 0.2 10.2 0.6 0.6 9.2 6.3 0.0 2.9 9.7 0.2 1.0 6.6 0.1 0.3 0.5 0.2 0.2 9.7 TOP2B ENSG00000077097 "DNA topoisomerase II beta" Q02880 3 25597905-25664907 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Autism spectrum disorder, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004601, HPA024120, HPA050441" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127" "unprognostic (2.90e-2)" "unprognostic (5.17e-2)" "unprognostic (7.21e-3)" "unprognostic (2.42e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (7.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" "unprognostic (1.49e-1)" "unprognostic (7.93e-2)" 27.4 25.8 15.3 39.3 17.4 49.6 35.0 25.2 16.4 36.6 11.1 30.4 29.0 43.3 25.7 34.4 30.0 26.4 38.9 14.3 17.5 32.4 27.9 28.2 50.8 13.1 16.9 11.6 41.0 29.1 53.6 11.7 34.7 14.3 39.0 33.6 113.3 27.3 34.5 30.1 32.7 28.8 34.5 15.0 36.7 32.4 19.7 14.0 83.3 46.2 37.0 47.0 44.1 18.7 24.7 57.6 58.6 125.9 155.3 41.1 51.7 50.1 54.4 69.6 49.4 53.9 30.1 44.6 176.9 37.1 79.2 30.5 47.7 105.6 60.5 82.5 85.5 56.7 268.5 71.2 50.6 28.9 212.8 137.4 37.1 29.7 55.3 48.2 49.8 81.7 118.6 92.0 84.3 64.4 64.0 138.5 52.5 95.9 38.5 44.1 569.9 71.0 82.6 43.9 199.5 63.2 109.7 81.1 57.4 49.9 72.2 59.7 187.1 78.7 68.3 52.6 55.2 58.9 129.6 78.6 185.1 44.9 155.6 46.5 3.2 1.4 2.8 3.0 1.7 3.3 2.0 2.9 3.1 2.2 2.5 3.3 3.0 1.0 3.9 2.6 2.8 2.3 1.1 15.3 17.4 25.2 16.4 14.3 17.5 13.1 16.9 11.6 14.3 15.0 14.0 24.7 36.4 64.1 62.7 65.3 47.3 39.1 47.9 30.9 31.3 62.4 44.4 31.9 121.5 34.3 36.1 25.8 56.3 47.8 65.8 29.9 13.7 34.3 3.6 48.0 58.8 36.6 59.3 65.6 77.8 33.4 24.5 40.2 28.5 45.1 34.1 71.4 25.0 35.1 26.2 60.6 89.8 32.3 20.3 40.7 50.1 6.0 39.1 45.3 23.2 43.1 49.8 51.3 68.0 76.4 113.0 35.5 22.2 33.4 46.0 56.2 20.6 25.6 39.2 95.7 32.9 56.5 51.0 94.9 44.0 57.9 37.6 46.7 53.7 48.4 39.2 64.3 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518110-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" NA NA 240000 Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 57.5 53.9 31.8 55.1 35.2 37.0 58.9 36.3 35.1 65.9 39.4 112.8 118.0 63.1 69.8 58.0 46.4 90.7 40.1 30.8 40.8 68.6 75.6 43.6 42.4 37.0 35.0 27.3 63.5 74.0 70.6 22.7 68.3 37.6 92.5 95.4 43.8 83.9 56.9 26.8 38.8 113.4 51.2 39.4 42.1 185.2 35.0 33.4 45.2 88.2 41.4 45.2 73.5 35.1 46.8 146.8 97.2 106.5 149.3 151.4 112.4 127.7 197.8 146.7 84.0 67.5 116.4 281.6 107.3 107.0 175.8 105.5 135.3 97.6 108.1 156.8 121.3 83.6 95.3 81.8 92.0 114.5 197.7 107.2 105.0 108.6 118.6 203.7 253.2 94.7 96.4 97.0 119.9 132.2 66.4 77.1 76.2 68.9 237.9 59.6 94.6 134.4 84.8 120.1 106.8 49.6 110.3 104.1 98.6 103.0 126.2 171.0 73.7 165.3 103.5 87.1 104.6 183.1 123.7 152.3 98.4 140.9 134.9 73.5 5.7 2.2 3.8 3.5 2.3 4.0 2.1 3.6 3.9 2.7 1.5 2.7 3.6 2.4 3.9 2.4 7.1 4.0 1.3 31.8 35.2 36.3 35.1 30.8 40.8 37.0 35.0 27.3 37.6 39.4 33.4 46.8 115.7 51.3 43.0 43.1 53.2 116.8 118.8 63.2 51.8 57.8 103.1 73.0 65.0 121.5 88.2 141.6 56.3 77.5 89.5 238.7 21.5 80.7 27.6 93.0 162.0 99.8 123.9 68.8 59.9 146.1 97.6 98.7 212.0 192.2 40.6 75.0 78.9 126.9 60.0 58.9 64.0 368.3 69.2 85.6 125.3 12.8 93.2 73.5 103.2 49.6 56.8 58.1 54.6 69.9 79.2 132.1 140.6 82.4 88.9 196.1 141.5 59.3 65.9 54.7 65.7 89.2 121.0 45.8 38.4 73.2 120.6 140.9 63.0 74.5 246.7 156.2 NFKB2 "LYT-10, NF-kB2, p105, p49/p100, p52" ENSG00000077150 "Nuclear factor kappa B subunit 2" Q00653 10 102394110-102402524 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 168.0;Karpas-707: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008422, CAB022098, HPA023900" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435" "unprognostic (1.10e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.53e-2)" "unprognostic (8.08e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-3)" "unprognostic (3.98e-2)" "prognostic favorable (8.45e-5)" "unprognostic (4.04e-1)" "unprognostic (8.34e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.69e-12)" "unprognostic (2.37e-3)" "unprognostic (1.63e-1)" "unprognostic (4.90e-2)" "unprognostic (1.56e-1)" 22.8 21.1 8.2 44.8 6.6 70.0 19.8 6.2 9.3 21.5 7.7 31.9 15.7 21.8 2.4 17.8 20.6 18.7 19.4 8.1 8.8 29.9 28.4 41.4 41.0 7.7 6.3 5.3 21.5 24.3 6.2 10.9 14.8 7.4 29.3 6.8 1.1 21.4 9.2 18.6 19.4 26.7 12.3 7.1 51.0 22.9 10.1 7.0 17.0 20.3 7.7 25.9 37.3 19.3 12.7 67.9 48.6 7.7 31.7 11.1 16.6 19.3 18.5 61.0 19.6 25.9 28.6 55.2 32.9 43.5 11.9 48.8 40.9 20.5 28.2 6.8 168.0 11.2 7.0 11.7 15.9 30.1 5.1 45.5 22.0 14.6 34.1 32.3 26.5 7.8 16.1 7.6 157.8 7.4 26.4 7.1 22.7 10.3 15.7 16.6 16.8 24.5 27.0 34.3 22.1 1.7 8.2 16.2 36.7 26.3 7.2 29.3 16.4 21.2 19.0 28.9 25.4 47.0 113.1 105.0 32.6 31.1 14.8 10.9 0.0 1.3 0.0 0.7 0.9 0.7 2.6 0.8 0.7 0.7 2.1 0.8 0.8 5.6 0.8 2.1 0.6 1.1 0.5 8.2 6.6 6.2 9.3 8.1 8.8 7.7 6.3 5.3 7.4 7.1 7.0 12.7 20.8 9.6 8.8 3.3 88.3 43.5 59.3 41.2 34.7 2.2 17.1 14.5 3.1 25.8 29.9 18.4 16.7 6.3 39.0 33.3 5.9 33.2 1.1 33.7 14.4 26.1 16.3 0.4 0.1 21.0 15.8 26.0 80.0 52.0 71.8 5.5 11.7 3.7 20.9 0.0 0.1 30.4 22.4 19.4 122.9 1.7 7.5 52.5 30.2 1.9 75.1 3.9 12.3 1.5 0.7 44.9 37.4 4.9 49.1 49.3 33.2 8.6 19.9 5.3 0.0 36.4 43.6 4.7 11.1 17.5 44.6 23.1 54.6 8.8 17.9 45.6 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 2.3 3.7 7.7 10.5 8.1 29.0 4.5 7.3 11.7 3.3 6.6 13.2 8.8 4.5 4.5 10.7 3.4 2.6 9.8 8.2 8.6 3.6 3.2 3.0 19.1 7.9 8.1 7.7 1.0 0.7 4.5 3.0 10.2 8.1 2.1 15.6 2.5 2.7 3.1 17.4 5.4 8.3 9.5 7.4 6.3 4.8 19.4 8.3 47.5 3.0 13.2 18.8 6.4 5.0 8.8 123.3 111.6 167.1 79.8 15.4 27.9 94.2 130.2 72.8 146.0 102.6 79.9 147.1 140.4 50.0 47.0 108.4 98.6 154.1 76.7 131.2 128.1 87.2 85.6 54.0 93.8 6.9 105.2 102.0 9.8 18.1 114.0 47.2 34.3 85.8 157.4 111.0 114.0 116.4 113.3 190.8 135.1 65.4 126.9 57.4 145.0 176.2 122.9 57.1 58.1 131.3 132.8 90.2 112.1 44.8 49.8 117.1 64.6 41.8 65.7 104.6 116.1 159.6 57.8 120.1 182.9 64.5 107.0 139.1 0.0 0.7 1.7 3.3 2.3 2.5 8.5 4.5 3.3 1.7 6.6 6.4 7.1 0.0 1.2 8.9 3.4 10.8 2.4 7.7 8.1 7.3 11.7 8.2 8.6 7.9 8.1 7.7 8.1 7.4 8.3 8.8 1.9 0.0 2.2 1.3 13.3 14.3 10.4 29.9 2.8 6.4 6.3 8.6 12.8 0.0 12.1 5.5 0.0 74.5 5.4 10.1 5.9 10.9 24.4 15.7 7.6 5.3 1.2 134.3 8.3 7.5 103.4 11.8 10.7 6.7 8.8 32.2 3.9 2.4 27.7 10.1 6.1 14.4 32.6 1.9 5.4 8.2 3.1 5.8 3.6 1.9 2.6 1.6 0.0 1.0 1.4 10.3 2.9 4.1 32.1 5.2 3.3 12.2 16.2 1.2 6.6 0.8 11.3 114.1 113.1 15.5 10.9 22.4 9.3 12.1 30.5 11.3 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 360.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 16.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 40.4 11.2 6.5 36.3 11.9 8.4 18.0 9.8 11.7 52.3 17.5 108.9 24.3 224.1 30.8 151.5 53.1 73.1 360.1 5.8 5.9 14.5 8.5 25.0 18.7 15.4 12.8 3.7 38.6 7.2 6.3 5.1 34.7 15.5 144.1 65.4 7.6 20.2 200.5 84.9 9.7 31.1 248.6 15.9 31.1 41.8 7.2 9.2 7.8 11.0 81.2 15.3 87.6 23.2 27.3 2.2 4.4 3.3 3.2 4.6 3.3 5.4 1.7 1.7 1.8 1.7 1.9 3.9 2.5 0.8 3.2 4.3 7.0 5.0 2.7 1.9 3.3 3.1 2.5 7.1 1.2 1.1 5.4 2.8 2.6 3.0 2.5 2.6 9.1 1.5 2.8 3.9 2.9 3.1 1.7 4.1 3.4 2.3 2.4 0.9 2.6 8.5 3.7 1.4 8.1 4.0 3.1 3.3 3.9 1.9 4.4 3.4 2.4 1.9 2.5 1.5 1.9 1.5 4.2 4.3 2.7 2.4 4.4 10.2 2.4 1.7 1.5 1.6 1.0 1.4 2.0 1.1 1.0 1.5 2.1 1.3 1.0 16.2 0.7 1.5 1.7 1.7 0.5 6.5 11.9 9.8 11.7 5.8 5.9 15.4 12.8 3.7 15.5 15.9 9.2 27.3 12.5 12.8 19.8 181.5 6.0 17.3 49.0 35.6 8.6 59.3 11.1 20.6 836.8 11.5 23.0 12.9 75.0 18.1 8.6 52.9 11.7 10.1 39.2 19.3 16.1 15.2 24.0 5.2 225.7 12.9 8.4 51.4 17.3 7.6 18.9 438.3 16.4 9.6 9.4 26.9 205.0 17.2 63.1 23.5 10.9 13.1 12.2 8.2 8.8 102.1 7.8 10.2 5.2 102.5 647.4 6.3 21.1 51.1 9.6 24.3 12.8 7.1 27.4 30.4 32.9 38.6 162.7 19.3 13.9 7.1 10.9 25.4 10.7 14.2 33.9 28.4 DNAJC10 "ERdj5, PDIA19" ENSG00000077232 "DnaJ heat shock protein family (Hsp40) member C10" Q8IXB1 2 182716255-182794464 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 114.9" "Cell type enhanced" "Detected in all" "Early spermatids: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031111 Approved NA NA "HPA031111: AB_10601211" "unprognostic (3.29e-2)" "unprognostic (5.20e-3)" "unprognostic (3.10e-3)" "prognostic favorable (6.42e-5)" "unprognostic (1.89e-1)" "unprognostic (1.18e-1)" "unprognostic (4.34e-3)" "unprognostic (1.82e-2)" "unprognostic (1.54e-2)" "unprognostic (4.34e-2)" "unprognostic (2.29e-1)" "unprognostic (9.76e-2)" "prognostic unfavorable (2.19e-7)" "unprognostic (2.91e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.87e-2)" 21.4 15.1 5.8 30.4 6.1 8.5 22.8 5.9 6.2 29.2 8.2 20.7 19.6 40.7 114.9 13.8 30.4 27.6 18.3 5.9 10.4 19.9 15.1 18.7 32.6 8.0 7.0 4.9 24.8 33.2 28.7 20.4 24.8 7.0 24.2 28.3 15.7 24.3 29.1 9.3 8.4 20.5 28.2 7.3 26.3 35.5 39.2 6.5 18.9 37.3 10.9 40.4 22.8 12.4 9.3 25.6 29.0 42.8 28.5 60.2 72.7 45.4 49.6 85.5 34.9 49.4 43.6 65.9 126.0 50.0 58.0 53.1 29.4 26.5 47.4 64.4 44.5 22.4 23.5 35.1 43.9 55.6 68.0 51.4 41.3 57.3 47.3 109.0 70.1 87.7 23.9 32.3 52.4 41.1 16.4 21.0 10.8 48.5 46.3 46.0 28.6 31.7 114.9 48.2 38.4 30.6 33.1 35.1 42.6 28.5 69.9 21.0 21.9 79.6 70.8 44.9 36.0 39.8 32.5 51.0 45.2 83.0 43.7 58.5 1.7 12.3 0.9 5.5 10.6 7.2 22.4 5.8 6.5 15.7 16.7 4.7 5.7 0.9 7.2 9.8 5.9 4.8 9.3 5.8 6.1 5.9 6.2 5.9 10.4 8.0 7.0 4.9 7.0 7.3 6.5 9.3 49.6 44.8 22.0 34.3 79.9 17.2 21.1 18.8 18.2 36.0 38.6 27.8 44.1 34.3 39.5 57.0 18.8 11.7 22.9 12.5 5.9 45.3 219.8 103.0 61.5 51.9 32.4 23.4 46.2 61.9 41.5 49.4 43.8 115.5 30.9 46.0 34.6 23.4 38.7 23.5 38.3 117.3 40.7 29.3 29.1 55.1 36.4 40.6 19.6 48.7 41.2 22.8 27.8 37.7 47.2 44.0 19.9 44.4 67.9 38.8 6.8 19.4 132.0 30.5 46.0 40.2 53.8 112.6 41.7 20.6 14.8 10.8 28.8 32.8 21.5 18.6 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;dendritic cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 31.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 17.2 29.0 20.1 10.0 19.7 16.8 16.8 16.8 32.9 28.3 31.3 20.6 8.9 26.9 7.9 65.7 24.8 11.6 35.2 20.7 16.4 25.4 21.9 20.4 12.3 16.6 17.4 18.2 24.6 35.6 18.8 48.2 11.1 15.2 40.8 9.7 18.5 25.1 12.8 50.6 49.4 18.7 15.7 12.4 21.4 24.9 26.8 17.4 18.7 34.9 21.0 11.3 19.9 35.4 17.5 27.8 60.1 43.3 50.7 37.8 30.4 24.6 29.5 33.0 40.2 34.0 45.0 25.6 30.5 42.3 36.4 30.6 30.3 55.4 37.6 32.9 13.7 53.1 25.2 49.8 63.8 21.3 29.1 32.2 37.5 28.0 49.5 21.8 26.9 40.2 34.6 31.7 24.2 32.0 67.6 32.5 34.8 58.4 15.1 28.3 59.7 53.4 31.4 25.2 28.7 54.4 36.5 29.8 24.9 18.6 34.4 44.8 21.8 43.2 40.2 24.0 25.6 30.7 25.6 24.8 30.2 16.6 31.7 30.2 2.6 3.4 3.5 31.9 3.2 23.0 3.1 3.6 15.8 4.3 2.2 3.7 10.0 2.5 12.2 3.3 6.6 4.0 6.9 20.1 19.7 16.8 32.9 20.7 16.4 16.6 17.4 18.2 15.2 12.4 17.4 17.5 16.9 19.2 23.9 29.7 10.8 18.4 7.3 14.3 23.3 45.5 10.6 11.9 27.4 10.0 17.2 12.9 93.8 7.8 86.2 18.4 5.9 11.8 2.8 40.4 37.3 18.0 30.0 7.2 30.2 11.5 4.3 22.5 19.9 22.3 19.0 26.1 13.9 13.7 10.9 26.9 33.9 17.6 18.3 10.3 7.7 4.5 19.3 12.9 3.6 14.0 10.0 15.0 52.5 17.1 23.4 15.8 9.3 15.8 29.6 13.9 10.2 9.0 30.8 35.1 13.1 16.4 15.1 17.2 18.2 34.8 20.6 4.2 32.7 25.7 12.2 6.7 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 92.0;granulocytes: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive B-cell: 78.1" "Group enriched" "Detected in all" 5 "B-cells: 78.1;granulocytes: 31.1" "Cell line enhanced" "Detected in many" "Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 38500 110000 "Nucleoplasm, Plasma membrane" "Centriolar satellite" "CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favorable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 43.8 45.6 20.7 83.1 19.0 104.4 34.4 18.4 22.2 37.1 23.0 82.8 27.5 36.1 6.0 71.4 42.7 41.5 30.2 17.1 40.6 42.4 117.0 120.3 118.0 27.8 21.4 15.2 14.5 30.0 32.0 15.0 39.7 22.8 50.3 35.9 2.4 20.6 25.9 9.4 24.5 56.1 37.6 23.3 90.7 55.5 15.6 27.4 22.5 24.4 6.7 90.4 63.7 45.8 23.3 39.9 10.1 6.4 13.1 3.1 14.1 14.3 24.7 27.3 9.3 7.7 20.4 105.2 124.2 30.1 38.5 18.3 39.7 7.3 115.0 8.2 110.6 4.0 22.6 6.6 31.6 40.8 6.1 61.7 23.5 45.0 44.2 26.5 48.7 50.7 6.8 10.5 9.8 15.0 17.3 0.7 18.8 8.0 34.2 9.1 0.4 47.5 10.2 42.9 43.2 1.9 0.6 3.7 24.7 5.0 15.6 8.2 23.5 81.0 21.0 9.8 19.0 17.6 6.1 2.1 119.7 2.1 21.1 0.3 1.4 7.2 13.0 4.2 3.1 3.4 25.8 6.9 4.4 4.1 78.1 10.0 5.0 31.1 8.2 1.8 4.8 5.3 5.8 20.7 19.0 18.4 22.2 17.1 40.6 27.8 21.4 15.2 22.8 23.3 27.4 23.3 30.5 28.9 49.2 0.7 92.0 13.3 43.3 34.9 26.2 0.3 9.4 14.2 2.4 34.3 33.4 1.8 0.0 17.6 29.8 60.0 0.0 39.5 0.3 6.6 2.2 39.0 23.4 5.2 1.7 32.3 3.8 17.2 32.1 17.2 110.8 0.7 62.8 45.9 27.2 0.0 0.6 35.5 8.2 30.6 29.9 0.8 0.3 34.3 14.2 38.4 39.3 0.0 7.2 0.5 0.7 49.3 28.7 0.0 13.4 37.7 24.0 1.2 28.5 0.2 39.5 16.4 20.0 0.8 3.3 23.8 14.9 24.9 38.3 0.2 16.7 46.9 USP33 "KIAA1097, VDU1" ENSG00000077254 "Ubiquitin specific peptidase 33" Q8TEY7 1 77695987-77759852 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005719 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA005719: AB_10601708" "unprognostic (2.31e-3)" "unprognostic (2.73e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (9.19e-3)" "unprognostic (1.88e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.59e-1)" "unprognostic (5.36e-3)" "unprognostic (4.89e-2)" "unprognostic (5.76e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" 41.1 31.5 35.0 24.8 45.4 34.8 34.7 57.0 53.4 24.4 39.9 24.6 25.6 28.3 27.1 21.8 22.7 26.5 21.9 39.9 41.3 31.4 25.6 26.4 28.4 34.8 33.6 38.5 29.6 19.6 35.3 21.1 28.2 37.3 29.0 25.5 49.5 25.4 23.1 18.1 24.5 27.1 24.3 26.3 26.3 24.6 25.6 32.9 27.4 30.6 20.9 26.2 23.2 20.2 59.2 42.4 18.8 64.1 44.2 90.0 78.3 54.8 45.3 42.9 54.0 60.1 25.4 35.5 31.4 41.2 44.3 88.2 32.1 47.4 31.1 65.7 28.8 36.6 111.1 44.6 22.2 56.0 37.8 26.8 58.3 23.9 52.4 37.9 51.9 48.7 28.0 43.9 26.3 41.2 16.1 34.9 38.0 62.2 32.6 37.2 33.0 67.7 22.2 51.0 41.1 53.8 41.2 31.9 41.5 64.2 54.3 23.1 41.2 41.2 49.4 34.4 50.1 43.2 21.0 28.4 30.4 37.3 44.5 25.4 67.3 22.5 31.8 21.0 22.6 21.7 20.5 20.6 21.7 17.5 22.3 24.5 21.9 30.5 19.2 30.1 18.4 20.7 16.7 35.0 45.4 57.0 53.4 39.9 41.3 34.8 33.6 38.5 37.3 26.3 32.9 59.2 40.2 44.8 40.9 66.3 35.1 17.2 18.8 21.2 32.5 56.7 25.7 22.1 39.9 22.8 25.5 35.0 58.4 25.1 48.8 35.9 9.8 20.8 4.3 54.8 37.8 31.8 35.5 50.9 149.3 15.4 19.0 39.6 43.3 54.6 23.4 43.1 28.2 23.1 19.0 62.2 159.0 28.6 22.4 30.8 20.7 5.5 35.8 35.1 23.2 75.9 38.7 31.4 37.0 98.0 138.5 19.6 27.8 32.0 42.4 22.9 33.2 25.6 37.3 44.5 19.7 34.9 35.6 39.8 30.1 28.4 16.3 11.9 41.0 39.2 24.8 21.8 PAK3 "bPAK, hPAK3, MRX30, MRX47" ENSG00000077264 "P21 (RAC1) activated kinase 3" O75914 X 110944285-111227361 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;pancreas: 43.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 104.1;Excitatory neurons: 364.0;Inhibitory neurons: 323.5;Oligodendrocyte precursor cells: 165.9;Peritubular cells: 81.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "EFO-21: 10.8;HAP1: 9.9;HDLM-2: 12.4;NTERA-2: 9.7;SCLC-21H: 12.4;SH-SY5Y: 7.7;U-2197: 7.6;U-251 MG: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044791, HPA060219" Approved Approved Vesicles NA NA Vesicles "HPA044791: , HPA060219: AB_2684223" "unprognostic (1.80e-2)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "unprognostic (3.27e-4)" "unprognostic (2.46e-1)" "unprognostic (5.63e-3)" "unprognostic (7.29e-2)" "unprognostic (3.23e-2)" "unprognostic (1.27e-2)" "unprognostic (3.01e-1)" "unprognostic (6.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.89e-4)" "unprognostic (5.71e-3)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" 1.0 5.2 10.7 1.7 18.5 0.1 5.3 0.0 19.2 2.3 0.0 0.7 0.2 5.5 5.9 0.7 2.5 1.6 0.3 16.5 22.0 0.7 0.3 0.9 1.7 2.3 8.8 15.9 6.3 43.1 0.1 13.8 0.6 4.9 3.4 0.7 7.1 2.2 4.9 1.7 1.2 0.5 4.7 0.0 2.0 2.1 2.6 8.9 0.6 6.2 0.4 0.8 0.9 0.7 12.3 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.3 0.4 1.1 0.0 0.0 0.0 0.0 10.8 1.2 1.6 0.0 9.9 0.6 1.3 12.4 0.4 0.0 1.3 0.0 0.0 0.0 0.4 0.3 0.0 0.1 2.2 5.7 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.2 9.7 0.0 2.2 0.1 4.3 0.0 0.8 0.0 12.4 7.7 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.7 4.7 7.6 13.6 0.1 0.1 0.1 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.7 18.5 0.0 19.2 16.5 22.0 2.3 8.8 15.9 4.9 0.0 8.9 12.3 0.9 3.2 1.1 16.0 0.6 0.3 13.3 0.2 0.0 104.1 6.9 10.4 1.0 20.0 0.7 0.0 0.0 0.3 0.2 0.2 0.0 4.7 4.4 1.0 10.8 2.3 3.6 0.0 364.0 13.1 0.4 10.3 10.2 1.7 1.3 21.9 1.4 0.2 0.2 6.7 323.5 0.3 0.0 0.3 5.7 7.0 34.2 1.1 0.0 17.8 0.7 27.5 1.0 165.9 12.0 5.3 0.0 81.3 1.0 1.7 0.0 0.6 0.0 6.0 0.0 1.6 7.8 1.4 1.4 0.3 1.1 6.7 2.4 29.2 0.3 0.9 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245099-111270483 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 214.5;placenta: 83.8;seminal vesicle: 73.1" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 198.5;Syncytiotrophoblasts: 140.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 10.8;NTERA-2: 16.3;SuSa: 14.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 9.6" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 2.1 0.0 0.0 7.3 0.0 0.0 12.8 0.0 0.0 12.0 0.0 5.6 1.9 22.7 214.5 2.3 3.2 8.4 0.3 0.0 0.0 6.5 0.3 0.5 2.8 0.0 0.0 0.0 2.6 7.5 0.1 0.2 83.8 0.0 10.7 8.7 0.0 14.3 73.1 3.0 0.9 1.7 8.3 0.0 1.7 13.0 2.0 0.0 1.9 1.5 9.1 4.7 3.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 16.3 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.3 0.4 0.3 0.0 14.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.1 0.0 1.2 0.0 0.6 2.0 0.3 7.2 0.0 7.3 0.0 39.9 0.1 0.1 3.9 8.3 0.0 18.0 4.3 0.4 0.0 0.0 0.0 0.7 198.5 12.9 6.6 40.1 0.0 0.0 0.0 0.0 7.6 0.0 0.1 1.2 0.0 0.0 0.3 0.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 22.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 1.0 0.5 0.1 0.1 0.9 0.0 140.5 0.3 0.9 0.5 0.3 DCX "DBCN, DC, LISX, SCLH, XLIS" ENSG00000077279 Doublecortin O43602 X 111293779-111412429 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;endometrium 1: 1.4;retina: 2.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 39.1;Inhibitory neurons: 90.2;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 21.8" "Cancer enriched" "Detected in some" 5 "glioma: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 52.5;SH-SY5Y: 22.1" "Region enriched" "Detected in many" 9 "olfactory bulb: 74.0" "Region enriched" "Detected in all" 4 "olfactory bulb: 68.6" HPA036121 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA036121: AB_2674950" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (7.36e-2)" "unprognostic (4.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.00e-2)" "unprognostic (7.18e-2)" "unprognostic (3.24e-2)" "unprognostic (2.33e-3)" "unprognostic (3.67e-1)" "unprognostic (4.90e-4)" "unprognostic (5.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" 0.1 0.2 1.3 0.0 2.3 0.0 1.3 0.0 2.5 0.1 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.0 1.1 1.9 0.0 0.0 0.0 0.0 0.4 1.0 2.2 0.0 0.1 0.0 0.3 0.0 0.9 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 52.5 22.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.3 0.0 2.5 1.1 1.9 0.4 1.0 2.2 0.9 0.0 1.8 0.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.5 1.6 2.2 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 39.1 0.0 0.2 6.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 90.2 0.2 0.0 0.0 0.4 0.5 0.0 0.0 1.8 1.9 0.0 1.6 0.0 49.8 2.3 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 10.2 0.0 0.0 SNRPA "Mud1, U1-A, U1A" ENSG00000077312 "Small nuclear ribonucleoprotein polypeptide A" P09012 19 40750637-40765389 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004652, HPA046440, HPA054834" Supported Supported Nucleoplasm NA NA 35000 Nucleoplasm "CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619" "unprognostic (3.53e-2)" "prognostic favorable (2.50e-4)" "unprognostic (3.78e-2)" "unprognostic (2.10e-1)" "unprognostic (3.30e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.03e-1)" "unprognostic (8.04e-2)" "unprognostic (9.08e-3)" "unprognostic (1.81e-1)" "unprognostic (3.38e-2)" "prognostic unfavorable (2.96e-9)" "unprognostic (2.52e-2)" "unprognostic (1.05e-1)" "unprognostic (4.80e-2)" "unprognostic (7.01e-3)" 45.3 42.5 31.3 41.2 33.7 60.5 47.4 31.8 39.9 61.7 34.1 54.3 36.7 55.2 43.0 55.6 58.9 18.4 38.8 30.7 36.5 44.3 45.3 48.9 57.6 33.2 32.5 30.4 69.8 38.3 20.6 48.1 29.0 32.8 55.5 34.2 10.9 41.4 33.3 51.4 41.3 53.2 30.4 32.6 65.7 46.3 36.8 33.7 64.1 56.6 27.9 48.6 54.3 52.2 35.4 143.4 134.6 157.2 129.4 44.2 56.8 125.9 53.8 76.8 145.5 151.9 119.4 129.8 197.2 70.1 75.6 76.2 114.2 162.0 149.6 126.7 96.7 191.5 137.0 115.2 150.0 64.9 159.8 90.0 56.1 36.6 101.4 164.6 78.2 131.7 180.1 167.5 101.2 98.5 145.4 273.7 285.1 164.1 133.1 134.8 251.6 102.0 154.5 100.8 88.4 117.8 113.4 102.4 113.4 90.6 84.3 110.1 150.8 73.8 77.4 127.8 77.5 131.2 107.4 121.6 252.9 78.0 179.3 100.0 3.2 28.0 7.5 27.6 32.2 29.2 28.1 29.2 32.4 56.5 26.4 29.6 27.9 2.5 28.0 16.2 34.7 31.8 23.0 31.3 33.7 31.8 39.9 30.7 36.5 33.2 32.5 30.4 32.8 32.6 33.7 35.4 39.3 12.8 15.2 4.9 53.0 35.9 51.6 63.7 63.7 7.2 49.8 67.2 7.2 15.7 27.0 25.8 2.1 87.1 39.6 34.9 43.0 41.6 32.7 22.7 31.1 34.2 33.0 65.4 5.4 49.4 127.0 43.7 51.0 37.6 32.4 67.0 31.4 21.9 60.1 5.0 6.5 44.9 48.8 29.9 35.0 14.6 37.3 37.5 23.2 3.7 50.4 17.8 29.9 6.0 9.5 44.6 29.4 28.2 56.6 38.9 34.6 35.2 17.5 5.1 19.7 28.2 75.7 60.7 66.2 85.1 33.1 66.4 50.9 44.3 61.2 47.7 SPAG6 "CFAP194, CT141, FAP194, PF16, Repro-SA-1" ENSG00000077327 "Sperm associated antigen 6" O75602 10 22345445-22454224 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.6;choroid plexus: 51.7;fallopian tube: 49.4;testis: 97.1" "Cell type enhanced" "Detected in some" "Early spermatids: 228.6;Endometrial ciliated cells: 73.2;Respiratory ciliated cells: 266.4;Spermatocytes: 372.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "U-937: 105.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 11.1" HPA038440 Enhanced NA NA "HPA038440: AB_10671742" "unprognostic (5.02e-2)" "unprognostic (9.52e-2)" "unprognostic (8.94e-6)" "unprognostic (2.21e-1)" "unprognostic (2.51e-2)" "unprognostic (4.91e-3)" "unprognostic (1.68e-1)" "unprognostic (2.38e-1)" "unprognostic (8.68e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-3)" "unprognostic (3.10e-2)" "unprognostic (2.78e-4)" 0.0 0.0 17.0 0.0 4.2 0.4 1.7 5.5 2.2 1.3 51.7 0.0 0.0 0.2 0.4 0.0 49.4 0.0 0.1 2.6 31.6 0.3 0.1 7.1 0.1 15.0 14.2 0.3 0.1 0.3 1.8 14.7 0.0 9.9 1.0 0.0 5.8 0.0 0.0 0.0 0.2 0.0 0.0 22.2 0.0 0.0 97.1 6.6 0.4 0.1 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.9 2.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.1 1.7 0.8 0.2 0.0 105.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 17.0 4.2 5.5 2.2 2.6 31.6 15.0 14.2 0.3 9.9 22.2 6.6 11.0 0.0 0.0 4.8 0.0 0.1 0.1 0.1 14.0 0.0 0.2 0.5 0.3 0.6 0.0 24.5 0.0 0.0 0.1 0.2 0.1 1.9 0.3 228.6 73.2 0.4 0.2 0.0 0.0 7.1 0.0 0.0 0.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 16.2 0.0 0.2 51.4 5.0 0.5 1.8 4.7 0.0 0.3 0.0 0.5 6.0 0.4 0.0 4.9 0.3 1.8 0.0 1.4 266.4 1.2 0.0 0.0 3.7 372.6 4.8 0.0 0.1 0.0 0.5 0.1 0.0 0.1 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397359 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA053150: AB_2682058, HPA055677: AB_2682882" "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 12.7 19.6 15.7 14.3 17.3 17.5 14.1 16.1 26.3 11.9 12.5 13.4 11.6 11.4 4.2 21.6 15.2 6.6 14.2 16.1 15.9 10.0 21.9 7.4 22.2 18.2 16.1 16.0 14.5 28.8 5.9 7.2 7.5 16.6 11.1 7.2 2.4 16.6 8.5 42.0 23.1 10.9 7.3 16.7 14.5 13.8 11.4 16.0 14.9 11.7 23.3 11.9 14.9 14.0 19.4 58.2 123.5 15.1 48.8 10.7 13.5 39.4 24.5 13.1 44.6 37.0 72.5 47.5 92.9 64.8 12.9 22.8 25.1 33.1 31.3 12.2 66.7 117.3 42.7 45.5 55.7 32.1 76.7 41.8 16.3 69.0 35.6 33.8 12.1 21.1 57.7 57.5 70.2 14.2 88.1 70.2 58.6 56.6 85.2 59.9 66.9 40.9 94.8 17.6 43.1 64.4 47.8 34.6 62.4 68.2 10.5 31.1 95.6 16.2 45.9 37.4 30.1 76.9 109.6 138.5 106.3 34.9 116.0 39.0 15.2 68.2 1.9 41.3 77.7 47.9 66.0 43.3 40.9 110.1 74.0 63.2 55.4 5.0 62.1 48.6 118.7 37.0 48.6 15.7 17.3 16.1 26.3 16.1 15.9 18.2 16.1 16.0 16.6 16.7 16.0 19.4 16.1 3.2 4.8 2.3 21.3 30.5 29.0 29.6 44.9 5.5 30.1 44.2 8.4 22.8 16.9 18.4 4.2 28.4 23.5 12.7 37.2 21.7 9.1 5.5 16.7 11.1 8.5 28.0 5.0 21.4 124.0 13.1 16.3 9.1 5.1 24.7 7.1 20.3 28.8 6.7 4.8 18.4 20.3 11.8 13.3 8.5 16.8 18.9 14.2 2.8 18.9 7.0 18.6 4.0 4.3 17.2 15.3 12.4 21.3 28.0 6.6 34.9 12.7 4.1 6.6 17.8 16.0 17.0 33.1 47.4 33.2 21.2 17.0 31.5 34.2 23.8 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171750158 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" NA NA 82000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favorable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 65.7 59.1 98.7 44.8 127.9 23.3 65.9 128.8 187.4 62.8 84.2 62.9 54.8 75.2 51.4 68.9 47.5 59.2 66.5 98.8 112.9 80.8 41.6 52.2 39.1 134.2 127.9 93.2 72.4 39.1 68.7 29.6 76.8 136.6 60.4 65.3 64.1 47.1 60.9 51.4 49.2 51.4 81.1 121.2 41.7 49.8 56.4 122.9 60.5 56.8 58.2 47.8 73.0 53.7 165.4 87.5 55.0 167.0 61.9 151.2 144.0 94.2 149.2 115.7 122.9 133.7 96.5 84.4 79.2 127.7 178.8 168.0 86.2 132.5 143.5 159.8 30.1 59.7 69.3 65.7 109.6 75.5 80.0 71.7 113.0 133.4 152.3 97.3 171.7 219.1 76.5 112.1 21.3 246.1 54.4 68.9 65.7 77.0 127.0 55.5 68.7 149.8 58.3 163.3 138.0 105.8 116.6 82.7 65.6 90.6 126.0 64.1 77.3 238.3 185.9 91.9 75.2 90.9 26.3 54.0 64.5 126.8 64.2 139.2 209.6 93.9 49.2 50.7 98.0 54.3 77.2 58.1 59.4 68.7 71.1 51.7 49.5 5.8 64.4 100.1 111.8 66.2 39.6 98.7 127.9 128.8 187.4 98.8 112.9 134.2 127.9 93.2 136.6 121.2 122.9 165.4 146.2 198.7 60.6 30.3 49.2 50.6 59.2 138.5 19.9 73.1 101.7 87.1 75.4 158.7 124.8 169.2 64.6 101.9 46.3 169.5 131.0 207.6 129.5 118.2 147.3 117.1 84.3 95.2 102.4 161.5 107.5 91.2 42.8 172.6 102.3 69.3 174.9 150.7 101.1 80.8 104.9 140.0 116.0 148.1 39.8 48.0 128.6 75.9 35.6 45.9 156.2 91.3 70.0 35.7 182.4 189.2 126.9 138.0 22.7 44.7 139.2 270.3 108.0 128.9 111.7 61.4 111.0 248.4 95.2 43.2 60.0 115.6 46.7 60.6 123.9 58.5 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438341-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 146.7" "Cell type enhanced" "Detected in many" "B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 182.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" No NA "Plasma membrane, Cytosol" "HPA017009: AB_2669505, HPA063903: AB_2685147" "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favorable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 31.0 4.7 6.1 48.2 8.6 45.9 14.6 10.7 8.3 3.5 7.5 6.2 7.1 2.2 1.6 3.4 5.9 11.7 4.3 6.9 15.2 5.0 38.6 15.6 50.4 16.2 10.7 3.6 1.5 4.3 1.7 2.8 8.9 16.4 2.6 6.8 0.6 5.2 2.1 1.4 3.1 18.0 7.6 19.6 57.0 9.3 0.8 12.6 146.7 3.6 2.7 44.6 10.6 3.7 18.4 0.1 1.8 0.0 0.0 12.8 21.2 11.3 37.0 7.2 20.8 19.8 0.0 0.0 101.0 0.5 24.9 22.2 0.1 0.0 0.0 28.6 0.0 0.0 73.3 0.2 0.0 0.0 13.9 0.1 30.3 0.0 0.7 0.0 2.6 0.0 40.5 0.1 62.0 0.0 0.0 87.7 19.5 0.1 7.9 0.0 195.4 0.1 72.4 5.8 0.0 0.1 0.0 3.4 0.3 0.1 0.3 0.1 47.6 0.1 0.0 0.5 6.8 0.1 16.8 0.0 204.7 16.9 71.0 0.0 81.5 23.8 58.5 30.2 23.6 24.9 32.6 25.8 25.9 15.4 39.5 29.3 28.8 182.9 19.1 38.9 50.3 27.2 13.4 6.1 8.6 10.7 8.3 6.9 15.2 16.2 10.7 3.6 16.4 19.6 12.6 18.4 3.2 0.0 25.3 1.6 88.2 1.1 0.1 0.1 0.6 0.1 1.6 3.2 1.0 8.6 2.6 3.7 0.0 2.2 149.1 0.1 0.0 3.9 0.4 0.7 12.8 4.7 0.0 28.2 1.1 0.0 20.7 15.0 3.6 0.4 23.4 0.1 6.8 28.9 59.9 0.0 2.9 0.2 0.0 117.7 18.4 0.3 0.0 93.4 3.6 381.3 65.2 0.0 134.9 4.0 1.5 0.1 0.1 0.0 41.7 0.1 0.0 5.1 3.7 0.2 0.0 0.9 11.3 0.1 1.1 0.4 0.1 1.4 125.9 0.4 0.1 0.1 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586129 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 205.8;Syncytiotrophoblasts: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 79.6;NB-4: 174.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 26.8 37.8 12.6 25.5 14.9 49.6 27.1 13.8 26.3 31.0 14.3 29.2 19.3 28.5 5.1 36.1 34.0 8.5 26.5 11.8 13.5 35.7 31.2 52.5 33.8 17.4 13.7 9.9 55.7 33.8 12.8 51.6 11.0 17.6 36.4 5.5 21.6 36.6 8.9 41.7 30.5 72.2 5.4 13.1 131.1 31.5 113.2 15.3 27.4 48.2 7.3 14.8 24.5 30.1 19.9 15.2 9.8 8.5 9.2 6.5 4.3 17.3 14.5 7.3 9.0 7.1 16.6 24.7 9.9 17.0 3.6 10.7 15.9 5.5 7.0 3.0 10.5 12.2 9.8 12.0 8.1 18.4 18.0 79.6 8.0 7.5 7.6 5.5 7.6 10.3 27.6 18.5 18.7 6.6 32.2 21.2 174.5 11.5 20.5 11.2 25.6 7.1 13.9 10.3 4.2 12.5 18.6 7.8 25.6 20.2 16.2 13.6 40.5 14.4 12.2 23.6 15.2 9.1 23.3 9.9 9.9 9.1 51.6 22.3 22.5 10.6 14.6 5.8 8.4 5.5 6.1 5.9 6.8 7.0 6.6 7.9 6.9 30.6 1.6 5.9 7.7 6.3 3.7 12.6 14.9 13.8 26.3 11.8 13.5 17.4 13.7 9.9 17.6 13.1 15.3 19.9 7.5 9.6 12.7 7.5 29.4 12.0 15.4 13.0 5.7 15.9 14.8 8.4 0.8 27.1 15.1 22.0 41.7 39.4 42.9 27.2 15.6 32.7 205.8 11.9 7.7 9.9 6.1 12.2 7.3 24.7 13.9 9.1 14.8 13.5 19.6 12.7 15.4 13.8 32.8 13.5 7.9 11.8 20.3 65.9 33.6 32.3 24.8 40.5 14.2 3.7 66.1 13.6 46.4 4.5 5.2 28.9 13.1 10.1 15.7 12.8 41.9 6.9 12.1 33.5 19.7 9.8 13.3 58.3 33.9 9.0 11.5 103.3 33.7 12.0 10.0 16.4 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768953-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.8" "Group enriched" "Detected in many" 7 "Early spermatids: 261.6;Late spermatids: 372.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA036608: AB_2675215" "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favorable (2.72e-4)" 5.8 5.1 1.2 12.6 1.6 39.8 5.3 3.9 2.3 4.2 1.8 4.9 9.2 6.9 1.6 4.1 3.9 5.3 4.0 1.3 1.7 3.1 8.3 5.1 17.2 1.9 2.4 0.9 5.6 6.2 3.8 2.3 6.7 1.7 4.8 5.2 5.4 4.7 3.4 4.0 5.8 6.4 4.5 1.6 8.5 6.0 17.9 1.8 14.3 5.5 3.8 17.7 4.9 3.8 3.1 8.0 6.0 22.1 12.0 3.6 3.6 18.4 13.4 6.4 9.6 11.0 22.4 15.3 29.8 16.5 6.4 12.5 15.0 13.1 4.5 10.1 16.1 9.5 35.0 10.9 11.8 9.2 25.0 19.3 4.7 7.3 11.1 9.9 6.3 9.3 17.5 21.1 16.1 5.5 5.8 28.0 29.9 12.3 8.5 5.4 30.0 16.5 17.7 7.3 8.8 9.3 26.3 16.3 9.1 10.1 7.4 12.1 10.9 9.5 13.4 14.1 15.8 12.3 8.8 19.7 45.5 3.2 23.8 19.2 0.1 1.9 3.5 3.3 2.0 2.7 1.8 3.0 3.4 1.3 1.5 2.7 4.1 5.7 3.3 1.9 4.8 5.2 1.8 1.2 1.6 3.9 2.3 1.3 1.7 1.9 2.4 0.9 1.7 1.6 1.8 3.1 27.9 6.4 16.5 14.7 41.5 13.8 12.5 8.4 22.8 16.1 17.0 16.4 12.9 8.6 14.0 5.5 27.1 8.5 28.9 10.5 0.0 7.7 261.6 23.2 23.4 19.2 20.4 34.1 18.7 7.5 10.1 14.9 15.3 18.3 10.8 21.0 15.4 19.8 8.3 11.8 15.9 14.0 4.1 18.0 18.0 372.1 17.1 20.0 16.0 13.1 17.7 12.4 19.6 16.6 30.1 9.1 16.0 15.4 16.2 12.5 10.3 2.4 12.3 15.1 26.3 17.6 21.3 31.8 20.9 14.4 16.1 7.7 26.4 15.0 10.8 10.7 SIRT6 ENSG00000077463 "Sirtuin 6" Q8N6T7 19 4174109-4182566 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Distal enterocytes: 199.2;Paneth cells: 129.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049729, HPA071776" Supported Supported Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA049729: AB_2680865, HPA071776: AB_2686445" "unprognostic (4.58e-1)" "unprognostic (3.41e-3)" "unprognostic (1.36e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (2.93e-3)" "unprognostic (8.32e-2)" "unprognostic (1.86e-1)" "unprognostic (6.13e-2)" "unprognostic (7.27e-3)" "unprognostic (4.42e-2)" "unprognostic (5.84e-2)" "prognostic favorable (9.13e-4)" "unprognostic (5.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (2.58e-4)" 8.2 12.1 9.7 7.8 9.7 10.5 8.7 9.6 15.2 10.4 8.3 16.8 10.1 10.7 2.4 12.4 9.2 3.6 9.6 9.9 9.3 12.3 11.1 9.0 7.2 10.4 9.8 9.1 7.6 14.2 5.2 13.4 4.4 10.5 12.8 7.6 2.0 9.4 5.1 8.1 11.8 14.3 2.6 9.4 15.5 9.9 6.1 10.6 4.9 10.2 2.8 4.0 10.0 9.8 10.9 25.7 16.8 8.3 10.4 6.5 6.2 12.9 12.0 8.9 10.1 8.8 11.2 9.5 16.0 12.9 8.1 9.1 15.9 4.6 12.9 1.6 30.8 10.0 6.8 9.7 10.3 14.3 17.4 25.2 7.9 10.4 10.3 6.4 7.7 8.7 15.0 15.2 35.3 5.4 19.2 23.9 18.3 14.5 9.3 15.2 18.9 7.7 18.8 9.7 11.4 11.0 18.1 11.0 10.2 24.1 3.2 10.2 23.0 12.2 10.4 10.5 36.9 17.4 45.6 25.7 18.4 20.8 28.1 12.7 5.3 13.1 12.2 10.8 16.3 6.4 9.6 7.5 8.7 14.3 10.1 6.4 6.1 11.8 5.6 13.5 11.9 12.6 8.5 9.7 9.7 9.6 15.2 9.9 9.3 10.4 9.8 9.1 10.5 9.4 10.6 10.9 9.2 12.8 7.3 5.9 13.8 10.3 10.3 32.3 9.6 12.6 6.6 6.3 3.2 7.2 18.4 5.5 18.8 24.1 7.1 199.2 13.7 32.2 1.9 6.2 7.9 11.8 26.4 9.5 8.9 26.7 24.2 9.3 19.9 9.2 5.7 5.6 13.6 6.8 24.0 13.5 10.4 29.1 18.3 11.7 10.1 2.6 11.5 15.0 5.4 1.9 27.0 15.2 14.4 3.5 6.3 32.5 129.7 8.2 10.3 9.7 28.2 14.3 11.0 13.8 0.0 7.2 11.3 7.4 9.6 13.3 12.6 25.6 10.6 7.9 30.9 11.9 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177875-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease variant, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "skin 1: 31.8" "Cell type enriched" "Detected in some" 5 "Melanocytes: 184.9" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 995 "SK-MEL-30: 426.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles NA NA Vesicles "CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 426.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.3 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.5 5.2 0.3 0.0 184.9 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 2.0 0.0 0.1 0.0 0.0 0.0 POLD3 "KIAA0039, P66, P68, PPP1R128" ENSG00000077514 "DNA polymerase delta 3, accessory subunit" Q15054 11 74493851-74669117 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA058846 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA058846: AB_2683833" "unprognostic (3.68e-1)" "unprognostic (3.22e-2)" "unprognostic (2.05e-3)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.99e-3)" "unprognostic (1.54e-3)" "unprognostic (9.21e-3)" "prognostic unfavorable (7.90e-6)" "unprognostic (7.92e-3)" "unprognostic (2.65e-1)" "unprognostic (9.11e-2)" "unprognostic (1.23e-1)" 8.0 6.3 6.9 14.7 6.5 10.2 11.2 6.5 7.3 10.6 7.6 17.3 15.9 16.6 12.1 13.0 16.4 15.0 8.9 6.2 6.6 45.0 7.2 11.6 14.6 5.4 5.8 5.4 16.2 11.5 7.9 4.7 11.6 6.0 8.4 18.1 15.1 6.9 10.2 7.7 11.7 14.6 15.4 5.7 11.5 15.6 19.8 5.6 15.8 15.1 12.6 15.4 12.8 7.5 7.8 32.2 28.6 43.6 29.8 13.2 22.5 30.9 42.7 23.9 43.7 37.0 37.8 40.8 45.7 30.9 20.5 25.3 41.2 36.3 28.0 54.6 34.5 23.3 29.1 44.3 12.8 9.5 56.4 25.3 10.0 17.3 51.1 27.3 13.8 17.1 39.8 26.7 35.5 25.6 25.3 63.4 25.3 26.4 95.3 29.1 60.0 109.4 37.9 20.2 30.6 29.0 19.5 50.7 25.3 49.7 26.2 29.5 35.7 16.4 42.9 30.8 48.8 34.2 24.8 56.6 102.4 24.5 35.1 33.2 7.3 22.6 15.9 9.2 18.5 9.1 10.1 11.7 8.2 17.7 8.0 11.6 9.6 19.4 10.8 19.0 5.2 13.7 13.0 6.9 6.5 6.5 7.3 6.2 6.6 5.4 5.8 5.4 6.0 5.7 5.6 7.8 14.8 12.8 20.0 13.1 9.7 5.9 7.0 11.4 12.5 12.3 10.5 12.8 7.8 7.2 17.7 9.2 8.4 19.7 11.1 17.9 5.9 17.2 28.3 24.8 17.1 14.2 5.4 24.2 20.1 32.1 26.7 13.1 16.8 14.4 19.0 20.9 8.2 4.9 15.6 23.5 15.3 12.7 12.2 12.9 7.2 23.1 12.5 16.9 3.6 15.0 25.3 15.3 9.2 6.6 18.7 17.4 13.4 8.6 11.4 11.4 10.7 39.1 45.2 19.1 6.6 13.7 12.4 60.3 37.7 11.2 5.4 13.0 11.8 10.0 19.9 10.5 ACTN2 ENSG00000077522 "Actinin alpha 2" P35609 1 236664141-236764631 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 51 "heart muscle: 780.0;skeletal muscle: 2155.0;tongue: 1273.4" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 1762.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7" "Region enhanced" "Detected in many" "basal ganglia: 66.6" "Region enhanced" "Detected in all" "basal ganglia: 44.5" "HPA006035, HPA008315" Enhanced Uncertain "Actin filaments" NA NA 25000000 "Actin filaments" "HPA006035: AB_1078095, HPA008315: AB_1844543" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (2.41e-2)" "unprognostic (1.69e-3)" "unprognostic (2.91e-1)" "unprognostic (4.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.80e-1)" "unprognostic (2.97e-1)" "unprognostic (2.66e-1)" "unprognostic (2.71e-11)" "unprognostic (1.30e-2)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" 0.7 0.2 11.8 0.0 27.7 0.1 0.9 8.8 19.3 0.3 11.0 0.4 0.0 0.5 0.0 22.0 0.5 0.7 780.0 13.6 13.9 0.4 0.3 3.9 0.2 13.1 10.9 13.8 1.1 1.7 0.1 0.5 0.1 13.1 16.2 0.0 1.4 18.5 0.1 2155.0 0.9 0.5 1.8 9.3 0.2 3.9 4.3 12.1 0.5 0.7 1273.4 0.1 3.5 0.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.2 0.0 0.0 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 27.7 8.8 19.3 13.6 13.9 13.1 10.9 13.8 13.1 9.3 12.1 15.3 0.3 0.0 0.6 18.6 0.0 0.3 0.4 0.0 1.2 2.6 0.4 0.5 1762.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 8.6 0.5 1.2 10.4 0.0 0.0 40.9 0.7 0.0 43.7 3.6 1.4 0.0 0.1 1.8 0.2 0.1 0.0 11.3 0.0 0.0 0.0 0.3 24.6 0.6 1.2 0.0 11.2 0.0 0.0 0.0 24.6 156.9 0.2 0.0 0.4 0.0 0.2 0.0 1.4 0.0 1.2 0.0 66.3 12.4 3.1 2.0 1.2 0.1 0.0 0.4 0.4 0.0 0.2 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line subunit beta" P47756 1 19338775-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1188.8;Late spermatids: 3669.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol No No 6600000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 208.5 194.6 126.0 198.4 125.6 155.6 190.8 127.9 134.4 221.2 131.3 273.3 150.4 256.6 147.1 267.3 201.7 145.5 199.3 135.9 138.4 162.2 128.8 219.8 225.6 131.7 126.9 125.0 206.8 94.9 129.7 122.4 180.2 130.7 202.6 216.3 124.9 153.8 179.6 304.2 193.8 222.4 243.5 126.4 217.7 194.2 217.9 129.3 239.3 156.5 216.1 274.0 232.3 224.0 139.4 263.9 146.4 260.0 179.3 355.6 467.0 187.9 435.9 430.0 364.0 377.5 189.6 338.1 179.7 186.4 533.5 218.7 212.0 224.0 297.9 424.3 280.0 160.5 340.1 170.6 298.3 355.0 236.5 533.6 424.0 243.4 314.9 292.6 300.5 338.6 204.5 132.1 229.7 393.9 185.1 270.5 307.0 200.5 343.8 155.3 223.4 184.6 225.2 507.6 133.0 158.0 123.4 255.2 200.6 299.3 229.5 222.2 199.6 351.5 237.9 207.0 409.4 208.7 156.0 188.8 217.4 314.1 306.8 261.5 456.1 358.2 1077.5 304.0 542.3 265.0 266.1 318.5 329.4 362.3 203.7 263.5 293.7 576.3 196.7 703.0 199.1 404.2 597.6 126.0 125.6 127.9 134.4 135.9 138.4 131.7 126.9 125.0 130.7 126.4 129.3 139.4 197.7 99.3 68.9 52.9 160.3 156.3 282.8 263.0 103.6 93.9 106.9 117.7 87.6 112.9 143.5 101.2 41.7 338.0 247.5 301.7 297.4 322.1 1188.8 86.7 122.2 182.4 141.2 89.4 49.8 256.5 396.4 178.9 101.9 96.8 147.5 164.6 156.0 98.7 800.9 77.4 67.5 278.7 215.7 302.6 276.7 3669.8 232.7 311.2 144.1 124.6 561.5 151.1 338.8 42.7 64.9 349.6 295.2 302.4 103.4 206.8 235.6 251.2 122.6 93.2 243.3 97.8 262.6 119.0 81.5 150.3 182.7 342.2 268.2 197.9 193.8 280.5 GPR137B TM7SF1 ENSG00000077585 "G protein-coupled receptor 137B" O60478 1 236142505-236221865 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 136.8" "Cell type enhanced" "Detected in many" "Langerhans cells: 139.0;Muller glia cells: 226.0;Proximal tubular cells: 115.1;Rod photoreceptor cells: 171.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 17.6" "Group enriched" "Detected in many" 5 "granulocytes: 17.6;monocytes: 7.3" "Cell line enhanced" "Detected in many" "ASC diff: 82.8;SK-MEL-30: 220.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026422 Approved NA NA "HPA026422: AB_1849338" "unprognostic (1.59e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (6.49e-2)" "unprognostic (2.42e-1)" "unprognostic (1.96e-1)" "unprognostic (5.54e-2)" "unprognostic (1.41e-1)" "unprognostic (5.06e-2)" "unprognostic (2.73e-2)" "unprognostic (5.53e-2)" "unprognostic (4.77e-2)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (7.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 15.9 6.9 32.8 15.6 38.2 6.4 13.8 35.8 40.1 22.7 19.7 10.7 9.8 19.2 40.3 9.2 6.1 20.5 22.4 31.9 35.0 68.7 22.3 16.8 18.6 39.5 35.5 28.8 12.4 3.8 13.2 3.3 30.2 35.7 10.5 10.9 136.8 6.2 14.8 1.4 19.0 8.7 16.0 35.2 16.5 11.1 3.5 34.6 6.3 15.2 5.0 17.1 28.9 13.3 39.3 5.6 7.8 6.4 5.7 82.8 46.6 2.0 12.3 27.5 7.4 10.3 1.8 6.7 0.9 19.1 13.0 16.7 4.3 8.4 7.6 7.2 5.4 15.8 3.2 1.0 1.4 11.7 4.3 29.7 30.5 25.4 5.7 2.8 23.3 12.0 7.6 0.5 0.1 12.6 6.7 3.6 1.7 3.1 2.4 2.9 6.1 10.0 2.4 10.8 20.1 4.6 9.3 4.2 16.9 220.5 4.9 22.1 7.5 10.7 11.2 7.8 26.2 12.1 1.0 7.2 0.8 6.7 3.1 17.3 17.6 0.9 9.6 0.9 4.1 0.4 0.5 0.6 2.7 1.1 0.3 0.3 0.8 0.1 0.1 7.3 0.3 1.7 0.4 32.8 38.2 35.8 40.1 31.9 35.0 39.5 35.5 28.8 35.7 35.2 34.6 39.3 7.3 0.0 1.7 17.6 10.3 25.7 22.2 8.0 14.2 31.9 8.2 4.8 23.0 7.2 5.1 12.9 35.5 46.7 9.7 1.1 17.6 14.4 0.1 1.9 10.2 7.1 8.5 4.0 14.8 10.4 9.9 19.3 6.6 2.1 20.3 2.8 11.7 4.1 88.0 52.2 15.4 2.7 0.0 81.4 139.0 0.9 9.0 55.0 69.4 8.4 83.8 226.0 4.1 30.2 14.9 11.1 2.7 6.0 8.4 21.4 2.2 115.1 6.1 171.2 0.0 7.1 10.5 0.1 1.1 9.4 19.9 40.8 19.9 3.5 2.7 29.8 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.0;testis: 14.0" "Group enriched" "Detected in many" 4 "Early spermatids: 39.7;Excitatory neurons: 109.3;Horizontal cells: 70.7;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 153.8;Oligodendrocytes: 83.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 19.2;SH-SY5Y: 6.1;SuSa: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060820: AB_2684373, HPA065419: AB_2685487" "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 3.3 10.1 2.9 0.4 3.4 0.1 3.3 1.8 5.2 10.1 0.9 1.7 0.2 4.2 1.9 0.8 3.4 1.2 1.9 3.2 3.1 1.5 0.9 2.1 0.4 4.0 3.6 2.6 7.5 0.7 0.1 20.0 3.6 4.4 3.2 0.6 3.5 1.1 1.2 1.1 0.7 1.3 1.1 2.1 2.7 1.2 14.0 3.2 0.1 1.4 0.7 0.2 2.2 4.0 4.4 0.1 0.2 1.8 0.1 0.5 0.1 2.2 0.1 0.1 0.1 0.0 19.2 0.7 0.3 0.2 0.0 0.3 0.3 1.3 0.0 0.0 0.0 0.3 1.9 0.4 1.7 0.2 0.1 0.1 1.9 0.0 0.0 0.0 0.5 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.3 1.8 0.5 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.1 0.0 0.2 0.0 4.3 0.2 0.4 2.4 0.1 1.4 0.3 0.3 1.0 0.3 0.3 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.9 3.4 1.8 5.2 3.2 3.1 4.0 3.6 2.6 4.4 2.1 3.2 4.4 2.6 0.0 0.0 3.3 0.1 0.3 0.1 0.0 0.0 17.3 0.0 0.0 2.4 1.5 0.6 0.0 0.0 1.2 0.1 0.0 0.0 0.1 39.7 0.8 13.7 1.2 0.0 0.0 109.3 0.0 0.6 7.5 1.1 0.6 0.0 1.7 0.7 0.2 0.3 70.7 110.2 0.0 0.0 7.2 0.4 17.7 11.1 0.5 0.0 12.2 0.0 8.4 0.0 153.8 83.7 0.0 0.0 14.7 0.4 0.4 0.0 0.1 0.0 2.4 0.0 6.4 4.6 0.6 11.3 0.4 0.0 0.8 0.2 19.4 0.2 0.1 JADE1 "JADE-1, PHF17" ENSG00000077684 "Jade family PHD finger 1" Q6IE81 4 128809700-128875224 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020016 Approved Approved Mitochondria NA NA Mitochondria "HPA020016: AB_1855292" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (1.63e-2)" "unprognostic (3.19e-1)" "unprognostic (2.09e-2)" "unprognostic (7.59e-2)" "unprognostic (6.96e-3)" "unprognostic (6.93e-2)" "unprognostic (8.16e-2)" "unprognostic (9.39e-2)" "unprognostic (8.38e-3)" "prognostic favorable (8.22e-6)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (9.92e-2)" "unprognostic (1.68e-1)" 25.5 21.8 13.3 10.4 13.3 46.6 20.3 21.8 12.7 16.2 11.4 13.3 8.6 12.4 8.8 12.3 18.7 12.7 17.0 10.7 27.6 24.9 11.8 16.0 15.3 14.3 14.6 12.2 28.2 71.4 16.6 15.1 11.3 15.1 18.2 6.3 20.5 19.0 17.4 15.0 13.0 12.4 12.8 12.6 15.5 19.2 9.8 15.1 18.0 31.7 11.6 12.4 19.7 13.0 12.3 13.5 25.8 25.2 18.6 33.7 23.7 32.9 21.0 12.5 22.4 20.4 22.8 22.9 40.8 24.3 12.1 9.8 4.5 29.8 7.4 24.9 31.9 13.5 22.8 35.9 20.9 57.9 37.5 17.6 26.5 11.5 27.3 20.2 18.5 24.5 26.1 36.7 54.3 17.5 16.2 47.8 28.0 67.8 13.5 13.1 35.0 17.3 22.0 35.7 6.5 32.7 23.7 20.1 16.2 16.5 35.0 13.1 20.9 17.1 21.9 36.3 16.9 24.8 35.9 32.0 46.0 23.7 36.8 18.3 31.4 10.7 35.9 17.2 17.2 21.1 13.4 18.3 19.2 10.4 18.6 25.5 19.9 13.8 31.1 23.6 4.9 14.6 16.3 13.3 13.3 21.8 12.7 10.7 27.6 14.3 14.6 12.2 15.1 12.6 15.1 12.3 24.5 38.5 25.4 17.6 35.4 14.9 16.1 4.3 32.5 40.3 25.8 32.3 33.9 42.9 13.7 49.7 50.1 25.2 42.0 3.1 19.6 30.1 3.6 45.5 21.7 21.7 10.2 48.8 24.5 48.7 16.5 36.7 25.5 37.0 17.7 34.3 18.2 37.3 10.1 28.6 31.8 8.3 46.8 28.5 14.3 4.2 36.1 16.3 21.4 12.2 27.5 26.7 107.1 17.1 19.2 44.0 7.8 48.2 41.2 12.6 12.6 34.7 29.7 28.4 85.5 33.0 59.0 6.6 21.9 20.9 13.4 4.0 40.9 8.9 10.8 5.9 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399336-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035188, HPA078530" Uncertain Approved Cytosol NA NA Cytosol "HPA035188: AB_10602400, HPA078530: " "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 10.7 2.6 3.5 7.4 3.4 1.8 9.4 3.5 4.2 6.8 5.3 14.1 14.4 5.1 3.4 21.6 5.4 4.3 4.2 3.4 4.5 7.7 10.7 10.3 5.5 4.5 3.5 3.1 6.1 6.0 7.0 1.9 8.3 3.9 4.7 15.6 0.5 10.9 4.7 1.6 16.4 12.9 8.8 3.7 4.9 9.0 2.1 3.8 3.7 4.2 4.6 11.4 7.9 11.4 5.8 32.4 23.3 1.9 9.2 30.0 44.5 12.2 17.9 21.7 13.8 13.2 12.4 16.0 4.0 10.2 47.4 41.1 23.2 18.2 16.0 12.4 28.5 5.4 11.3 7.4 16.4 19.3 10.6 11.7 18.8 28.3 22.5 19.8 18.9 16.6 6.1 2.3 17.1 15.7 58.9 0.1 15.9 10.3 16.6 35.1 3.2 0.0 4.6 22.3 10.9 1.5 0.0 23.0 47.8 29.1 7.3 8.5 11.0 24.2 22.2 7.1 25.0 28.0 0.4 14.2 8.3 22.3 17.8 19.7 0.0 3.5 0.2 0.9 4.9 1.7 4.4 1.8 2.9 6.0 3.7 0.9 1.8 0.1 6.4 11.2 1.6 1.5 1.6 3.5 3.4 3.5 4.2 3.4 4.5 4.5 3.5 3.1 3.9 3.7 3.8 5.8 8.3 6.4 9.7 30.7 8.0 7.8 7.3 8.9 9.6 0.2 6.1 6.6 1.6 2.8 5.6 3.7 0.0 11.9 9.1 21.8 9.8 4.5 0.0 0.9 7.6 6.9 7.3 3.4 10.3 8.9 7.1 11.8 9.7 1.8 8.2 2.1 6.4 5.8 10.3 0.0 6.2 9.6 4.1 7.1 13.6 0.4 8.1 7.5 10.6 1.0 11.9 0.2 9.2 36.7 1.4 13.9 11.4 5.7 2.8 5.4 19.8 9.6 2.0 0.4 0.0 7.8 9.2 0.5 2.3 19.8 13.9 6.8 6.8 1.0 12.2 5.8 UBE2A "HHR6A, HR6A, RAD6A, UBC2" ENSG00000077721 "Ubiquitin conjugating enzyme E2 A" P49459 X 119574536-119591083 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 508.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (2.27e-3)" "prognostic favorable (2.16e-4)" "unprognostic (1.12e-1)" "unprognostic (9.09e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.07e-4)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (6.54e-2)" "unprognostic (2.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (2.20e-6)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.21e-1)" "unprognostic (7.92e-2)" 40.4 27.6 31.9 39.5 33.7 30.1 29.7 35.6 39.2 34.4 29.8 52.8 37.8 32.3 38.5 53.8 27.6 32.9 63.8 31.8 33.8 40.3 30.4 33.1 47.3 36.3 32.7 29.4 20.3 29.5 39.5 19.0 57.3 35.7 31.3 45.4 27.4 31.2 33.3 72.6 30.3 39.4 43.4 35.0 27.0 30.8 17.8 34.8 46.6 30.8 55.5 50.8 47.4 33.0 37.0 129.5 104.1 60.8 54.1 103.0 125.6 63.9 122.6 106.3 141.8 130.3 50.8 84.0 96.4 126.4 133.9 240.6 86.4 86.3 65.7 128.6 142.3 60.6 42.7 71.9 47.1 96.6 105.9 72.1 86.9 90.1 134.0 58.3 98.1 99.4 86.5 57.0 83.6 160.1 134.5 166.6 99.9 106.3 125.7 126.9 84.2 64.0 91.6 113.1 76.6 48.9 51.3 171.2 75.0 93.7 73.2 65.8 92.6 101.5 92.4 42.0 184.3 142.5 83.6 147.1 92.4 99.1 136.3 74.6 46.8 58.5 92.5 43.0 92.1 34.8 52.6 37.9 38.5 74.6 48.7 23.7 33.9 78.0 35.0 101.1 58.5 56.8 51.1 31.9 33.7 35.6 39.2 31.8 33.8 36.3 32.7 29.4 35.7 35.0 34.8 37.0 67.5 102.5 40.9 12.7 79.1 124.8 91.6 129.4 51.8 17.2 60.7 43.9 66.7 44.3 80.7 40.5 31.3 179.8 93.0 168.6 101.8 95.4 51.7 75.6 55.3 62.9 45.5 70.4 9.9 102.1 176.2 67.7 37.8 63.0 57.0 35.7 46.4 35.5 131.3 8.4 9.4 49.7 103.7 59.1 183.9 15.3 37.0 97.3 83.6 15.9 129.0 49.8 41.2 14.6 18.0 137.6 132.5 40.6 92.2 98.2 85.6 125.2 107.7 35.0 46.0 56.3 101.1 44.1 32.1 74.6 127.9 508.5 94.8 36.6 54.5 120.3 FGFR1 "BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM" ENSG00000077782 "Fibroblast growth factor receptor 1" P11362 8 38400215-38468834 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Transcription, Transcription regulation" "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 176.7;Leydig cells: 192.0;Oligodendrocyte precursor cells: 166.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 508.7;BJ hTERT+: 278.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033614, HPA056402" Approved NA NA 78000000 "CAB033614: AB_783377, HPA056402: AB_2683118" "unprognostic (9.53e-2)" "unprognostic (7.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.35e-2)" "unprognostic (4.23e-3)" "unprognostic (7.02e-2)" "unprognostic (6.59e-2)" "unprognostic (2.77e-1)" "unprognostic (1.81e-1)" "unprognostic (3.99e-2)" "unprognostic (7.97e-3)" "unprognostic (4.59e-2)" "unprognostic (7.69e-2)" "unprognostic (6.87e-3)" "unprognostic (5.60e-2)" "unprognostic (4.59e-3)" "unprognostic (1.05e-3)" 95.4 12.9 29.8 16.1 24.2 14.2 87.8 43.2 23.3 74.2 33.8 76.6 8.9 74.8 16.0 36.1 86.6 57.6 81.4 28.3 42.1 32.5 9.2 56.2 16.8 35.0 34.0 17.0 109.1 99.4 20.5 57.5 51.7 50.2 61.0 18.1 15.9 31.7 54.1 25.0 33.9 42.1 57.6 31.4 10.0 40.7 20.5 34.3 17.2 34.0 23.5 16.2 80.0 64.5 34.4 12.9 42.0 198.0 508.7 120.1 91.2 142.9 136.7 278.8 90.0 95.8 27.3 6.5 1.8 38.3 127.7 103.9 0.2 90.0 6.8 104.3 39.2 24.1 0.0 7.7 27.8 69.7 31.1 0.6 80.5 0.7 70.9 13.3 45.6 86.9 6.0 11.9 0.4 40.5 12.5 91.5 9.2 145.9 1.6 21.6 86.3 21.1 0.4 35.6 0.3 7.9 19.4 23.4 1.0 5.1 93.4 9.3 5.4 51.4 49.2 28.9 149.6 29.7 2.4 4.1 0.5 60.3 1.7 27.1 0.2 0.3 0.1 1.7 0.1 1.1 0.3 0.7 1.2 0.0 0.6 0.5 1.5 0.6 0.4 0.2 0.2 1.0 0.1 29.8 24.2 43.2 23.3 28.3 42.1 35.0 34.0 17.0 50.2 31.4 34.3 34.4 101.0 3.2 15.8 55.8 1.8 31.5 95.9 1.1 37.0 4.4 28.7 77.7 52.5 24.3 5.1 9.2 4.2 8.3 6.3 0.4 0.0 27.3 15.3 48.2 40.6 75.5 25.0 3.6 25.4 65.2 80.5 176.7 3.1 75.3 8.2 40.4 47.5 0.8 25.3 21.9 21.1 0.6 4.1 5.6 75.2 15.0 192.0 11.7 33.8 19.7 1.7 88.1 6.2 166.4 14.2 21.6 0.3 99.6 6.4 94.7 0.1 7.9 1.0 3.3 13.1 118.9 59.9 1.6 14.1 4.8 19.7 10.4 14.1 2.1 0.7 11.7 FKBP6 "FKBP36, PPIase" ENSG00000077800 "FKBP prolyl isomerase 6" O75344 7 73328161-73358637 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 221 "testis: 58.9" "Group enriched" "Detected in some" 6 "Early spermatids: 68.5;Late spermatids: 92.4;Spermatocytes: 142.0;Spermatogonia: 37.2" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA061109, HPA077010" Enhanced Approved Cytosol NA NA Cytosol "HPA061109: AB_2684430, HPA077010: " "unprognostic (5.07e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-1)" "unprognostic (1.91e-1)" "unprognostic (1.05e-1)" "unprognostic (3.98e-2)" "unprognostic (8.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-1)" "unprognostic (4.29e-2)" "unprognostic (1.48e-1)" "unprognostic (6.20e-2)" "unprognostic (9.15e-2)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 58.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.2 0.6 0.0 0.6 0.0 0.3 0.5 1.5 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 68.5 5.2 0.3 0.2 0.0 0.0 0.3 0.2 0.0 0.2 0.0 1.0 0.0 0.2 0.4 0.2 0.3 0.0 0.3 0.0 2.0 1.3 0.0 92.4 3.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 1.2 0.0 0.0 0.0 0.1 12.6 0.5 0.0 0.3 0.1 142.0 37.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 31.3" "Group enriched" "Detected in some" 6 "Spermatocytes: 897.6;Spermatogonia: 448.5" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA001500 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 31.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.1 0.0 18.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 75.6 0.5 0.2 0.8 0.0 0.0 1.4 0.0 0.9 0.3 0.0 0.2 0.0 0.7 0.4 0.1 0.1 0.0 1.1 0.0 0.0 0.3 0.0 36.9 5.6 0.5 0.0 1.0 0.0 0.3 0.0 1.0 1.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.2 1.0 98.6 0.4 0.2 897.6 448.5 0.0 0.0 0.8 0.1 0.0 0.0 0.2 FBLN1 FBLN ENSG00000077942 "Fibulin 1" P23142 22 45502238-45601135 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9" "Cancer enhanced" "Detected in all" "endometrial cancer: 199.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001612, HPA001613, CAB004393, CAB068187" Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 21000000000 "Endoplasmic reticulum" "CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824" "unprognostic (6.62e-2)" "unprognostic (2.47e-2)" "unprognostic (1.64e-1)" "prognostic favorable (9.28e-4)" "unprognostic (1.26e-3)" "unprognostic (4.82e-2)" "unprognostic (9.79e-3)" "unprognostic (2.49e-1)" "unprognostic (6.30e-2)" "unprognostic (3.86e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.02e-10)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.29e-2)" "unprognostic (3.64e-2)" 290.4 124.1 19.2 73.0 23.5 1.7 320.9 26.9 31.4 1103.1 680.7 193.6 76.2 414.1 127.1 308.6 502.0 682.1 458.5 47.1 21.9 61.7 15.8 418.5 16.3 20.8 25.4 14.2 215.9 107.3 218.6 91.0 510.0 30.9 470.8 84.4 3.2 122.2 160.0 36.3 286.3 176.0 181.9 14.9 25.1 271.4 22.1 23.8 20.7 197.0 47.9 13.1 710.5 948.5 13.9 17.7 41.6 122.9 258.0 1839.4 809.8 559.8 1029.3 1615.9 89.8 33.8 179.2 5.2 0.4 42.8 38.6 2.5 90.9 78.0 2.7 10.8 0.9 21.0 0.4 209.4 121.5 243.2 1.0 1.0 1345.8 15.8 89.6 32.7 1.8 0.2 1.4 0.9 2.1 63.3 2.4 0.8 3.2 173.8 3.7 15.4 1.4 0.9 2.1 41.1 1485.2 8.7 162.7 127.5 589.6 0.6 344.3 3.7 5.4 8.0 17.4 109.3 465.8 1.0 1.6 0.8 1.4 1.2 1.0 43.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.2 0.0 2.4 1.2 0.0 0.1 19.2 23.5 26.9 31.4 47.1 21.9 20.8 25.4 14.2 30.9 14.9 23.8 13.9 34.4 6.4 1.3 34.3 1.2 170.9 113.4 54.8 21.1 0.1 5.3 11.6 20.1 10.0 28.3 1.8 0.0 666.3 1.6 0.1 0.0 1.3 10.5 61.5 628.2 34.5 0.0 0.0 0.5 0.2 651.6 1506.5 38.7 256.5 1.3 29.0 22.1 0.6 82.4 0.0 0.8 0.3 6.1 0.0 222.9 25.4 92.2 11.4 170.7 41.2 0.0 0.1 0.0 0.0 0.4 1.0 0.1 30.5 4.5 47.4 0.0 0.3 10.2 0.6 118.3 37.1 81.5 42.2 68.7 23.8 130.3 1215.9 18.2 2.3 0.4 86.9 ITGA8 ENSG00000077943 "Integrin subunit alpha 8" P53708 10 15513954-15719922 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, Integrin, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 37.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6" "Cancer enhanced" "Detected in many" "prostate cancer: 6.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 14.1" HPA003432 Approved Approved "Plasma membrane" NA NA 200000 "Plasma membrane" "HPA003432: AB_1851825" "unprognostic (2.15e-1)" "unprognostic (1.22e-3)" "unprognostic (1.05e-2)" "unprognostic (2.03e-1)" "unprognostic (1.25e-2)" "unprognostic (8.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "unprognostic (6.82e-2)" "unprognostic (3.80e-1)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (4.10e-3)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.03e-2)" 8.7 10.6 1.5 2.1 2.0 0.1 2.7 1.7 5.0 24.0 8.5 6.1 6.8 9.8 5.6 9.9 8.9 6.7 7.8 6.9 1.0 10.1 0.7 20.9 3.2 1.4 2.6 1.6 5.7 0.8 4.8 3.3 0.2 1.0 37.7 6.2 1.7 1.8 31.1 3.0 2.8 6.9 9.2 1.4 20.1 19.5 0.6 1.3 1.0 5.6 6.9 4.4 15.8 9.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 8.4 2.5 0.0 0.0 0.0 0.0 19.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 9.7 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 1.7 5.0 6.9 1.0 1.4 2.6 1.6 1.0 1.4 1.3 2.2 1.2 0.0 1.3 0.7 2.4 1.0 1.9 0.0 0.6 6.3 0.1 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.0 11.4 0.0 0.0 82.8 0.0 0.0 10.1 0.0 0.2 0.0 0.0 4.2 0.0 0.1 0.0 56.1 0.0 0.0 0.0 1.8 0.1 0.9 0.5 1.8 34.7 0.0 13.6 0.0 64.8 4.0 0.0 0.0 0.0 25.5 1.5 0.0 0.0 0.0 0.3 52.6 11.3 57.6 0.0 0.2 0.4 1.1 0.0 1.2 0.1 0.1 1.4 CST7 ENSG00000077984 "Cystatin F" O76096 20 24949269-24959928 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 1105.3" "Group enriched" "Detected in many" 9 "dendritic cells: 1094.4;Langerhans cells: 541.7;monocytes: 659.7;NK-cells: 1385.2;T-cells: 544.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "gdT-cell: 1287.0" "Group enriched" "Detected in all" 27 "granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0" "Cell line enhanced" "Detected in some" "HL-60: 77.8;HMC-1: 204.6;NB-4: 212.1;U-937: 380.4" "Region enhanced" "Detected in single" "olfactory bulb: 1.9" "Low region specificity" "Detected in all" HPA040442 Enhanced "Secreted to blood" NA NA 26000 "HPA040442: AB_2676988" "prognostic favorable (6.55e-4)" "prognostic favorable (7.90e-4)" "unprognostic (9.37e-2)" "prognostic favorable (9.17e-6)" "unprognostic (2.38e-2)" "prognostic favorable (5.85e-5)" "unprognostic (1.00e-2)" "unprognostic (8.66e-2)" "unprognostic (2.84e-3)" "unprognostic (7.93e-2)" "unprognostic (5.05e-2)" "unprognostic (7.42e-2)" "prognostic unfavorable (4.37e-6)" "unprognostic (7.64e-2)" "unprognostic (3.38e-1)" "unprognostic (4.45e-1)" "unprognostic (7.62e-2)" 13.4 3.7 1.3 24.4 1.5 1105.3 5.7 2.8 4.5 4.6 3.3 5.8 5.9 4.6 4.8 5.5 10.5 17.8 5.3 1.5 1.4 5.4 12.8 49.7 74.1 2.7 1.8 0.8 2.6 3.9 1.0 2.2 4.4 2.0 4.4 5.2 0.2 6.6 2.1 1.9 4.4 14.0 5.0 1.5 149.3 8.8 1.7 2.1 17.4 5.6 4.4 16.5 19.4 5.3 1.8 0.3 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.3 1.7 0.0 0.4 0.0 77.8 204.6 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 2.8 0.0 0.2 2.0 212.1 0.1 0.0 0.2 0.5 7.7 0.1 0.0 0.1 0.3 0.2 0.0 0.1 1.0 0.1 0.0 13.3 0.2 0.1 0.8 0.2 0.5 0.1 0.1 0.2 0.1 380.4 0.1 74.3 3.0 10.4 1287.0 3.4 720.2 3.7 186.8 904.7 28.4 3.9 38.8 531.2 342.2 655.3 3.5 7.2 123.0 600.8 1.3 1.5 2.8 4.5 1.5 1.4 2.7 1.8 0.8 2.0 1.5 2.1 1.8 8.1 9.6 14.1 0.0 14.5 22.8 0.3 0.0 0.0 0.0 2.5 2.4 1.4 4.3 0.6 0.0 0.0 0.2 1094.4 0.3 0.0 1.3 0.0 1.3 0.7 3.2 0.0 46.7 0.0 3.7 0.1 5.2 11.2 1.2 60.0 0.0 11.0 3.8 1.4 0.0 0.0 0.1 0.0 16.2 541.7 0.0 0.0 61.9 24.9 1.9 659.7 0.0 1385.2 0.0 0.1 0.2 0.1 0.0 90.9 0.1 0.4 2.3 2.2 0.0 0.0 2.2 3.6 0.0 0.2 0.5 23.9 1.1 544.5 0.0 0.6 0.6 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 243.5;retina: 414.6" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5" "Group enriched" "Detected in many" 4 "glioma: 30.4;thyroid cancer: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012558, HPA012828" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 5.6 11.7 80.9 1.2 110.0 0.3 5.6 2.3 243.5 4.4 0.0 2.5 0.9 2.3 4.0 6.6 2.5 7.7 8.5 120.9 136.4 3.7 3.9 13.6 1.8 36.5 76.5 113.4 7.5 10.7 15.6 34.1 0.9 48.8 7.7 1.7 414.6 7.8 4.9 1.7 17.1 1.6 2.8 4.5 1.7 3.3 6.6 77.3 3.5 16.9 4.7 2.4 1.6 5.3 172.3 2.6 0.6 296.9 0.0 3.9 2.2 0.1 1.9 2.1 0.7 2.2 0.0 16.1 0.0 1.7 3.8 14.0 4.1 23.4 1.8 1.0 0.1 1.4 1.2 8.9 0.1 36.7 0.3 0.2 3.1 9.6 0.1 5.8 17.3 7.8 0.1 0.0 3.1 0.3 1.1 0.1 0.0 106.7 0.5 0.5 0.0 0.6 0.3 3.8 0.1 148.6 82.7 6.3 0.9 3.7 34.8 8.2 0.0 0.2 0.3 1.7 0.1 4.1 1.9 0.0 0.0 15.5 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 80.9 110.0 2.3 243.5 120.9 136.4 36.5 76.5 113.4 48.8 4.5 77.3 172.3 16.8 96.1 3.2 127.3 1.8 5.9 3.3 12.0 4.6 144.7 6.2 8.0 4.9 27.1 3.7 5.5 875.7 0.4 0.1 0.0 3.9 26.8 22.1 2.2 1.1 15.7 32.4 2.7 883.3 11.0 0.1 5.3 3.6 4.4 1.3 1.6 18.5 0.4 0.5 33.7 823.6 0.2 6.1 1.4 1.5 10.7 28.6 1.4 19.6 74.0 0.0 129.7 0.0 688.6 53.8 10.0 0.0 15.4 0.1 12.3 0.0 0.4 3.4 514.5 32.9 5.1 26.1 6.6 22.7 2.3 6.5 0.3 0.3 6.6 0.0 0.7 PIAS2 "ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4" ENSG00000078043 "Protein inhibitor of activated STAT 2" O75928 18 46803218-46920160 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.9" "Cell type enhanced" "Detected in all" "Early spermatids: 521.4;Late spermatids: 519.5;Spermatocytes: 238.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068792 Enhanced Supported Nucleoplasm Yes No Nucleoplasm "HPA068792: AB_2686037" "unprognostic (9.59e-3)" "unprognostic (2.14e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.25e-1)" "unprognostic (6.39e-2)" "unprognostic (1.05e-3)" "unprognostic (3.67e-2)" "unprognostic (1.05e-1)" "unprognostic (3.71e-3)" "unprognostic (1.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.58e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.71e-1)" 4.6 5.4 6.8 4.1 8.9 7.4 5.1 17.7 10.5 4.7 6.8 4.9 2.9 5.1 7.5 3.7 4.6 4.6 6.9 8.2 8.2 6.5 6.0 4.4 6.2 5.8 8.2 7.3 5.0 4.2 11.9 5.7 4.0 8.9 6.6 7.1 11.0 5.6 4.5 16.3 7.7 4.2 4.8 4.1 6.0 4.6 67.9 7.2 4.6 8.3 10.3 5.2 4.1 4.4 8.6 13.7 5.5 6.1 8.7 6.0 7.5 2.9 7.0 5.6 6.0 5.5 6.5 5.1 13.7 3.7 5.3 6.1 4.5 12.3 7.5 8.5 6.6 4.6 8.5 5.4 7.7 5.9 14.3 5.8 7.7 4.5 5.3 5.6 9.7 5.5 11.9 6.4 3.5 12.0 7.4 8.2 8.3 6.7 2.5 3.5 15.0 13.1 0.1 5.5 10.4 11.7 9.0 6.4 4.1 4.7 6.8 6.1 6.3 6.9 12.8 5.5 4.5 5.3 10.1 5.4 17.7 9.5 15.1 12.8 0.7 1.7 1.2 2.0 1.3 1.3 1.6 1.8 2.4 2.0 3.0 2.5 2.1 1.0 1.9 1.3 2.1 1.9 0.8 6.8 8.9 17.7 10.5 8.2 8.2 5.8 8.2 7.3 8.9 4.1 7.2 8.6 26.3 19.2 21.9 60.4 25.0 20.6 19.9 15.2 23.9 57.7 21.8 13.2 30.7 12.8 12.6 25.8 89.6 2.6 32.8 18.1 19.6 13.5 521.4 16.6 25.4 26.0 28.5 16.6 137.9 8.9 2.3 20.6 19.4 15.9 14.5 48.4 34.2 22.3 28.1 32.0 134.9 18.0 16.2 50.3 15.7 519.5 33.5 24.2 12.4 73.1 34.7 21.9 40.2 133.7 94.0 7.9 17.1 35.0 30.3 28.4 11.8 23.1 13.9 36.0 6.6 42.5 18.2 238.7 72.4 24.7 15.3 1.4 19.2 35.6 25.5 18.0 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631420 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.1;pituitary gland: 21.4;retina: 66.5" "Group enriched" "Detected in many" 5 "Bipolar cells: 72.2;Cone photoreceptor cells: 87.6;Excitatory neurons: 228.2;Inhibitory neurons: 198.4;Oligodendrocyte precursor cells: 96.5;Rod photoreceptor cells: 59.4" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 64.6;ASC TERT1: 37.8;BJ hTERT+ SV40 Large T+: 25.4;BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 44.8;HBF TERT88: 23.1;U-138 MG: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favorable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 6.5 1.3 14.4 1.5 27.4 0.0 6.0 11.3 54.1 5.9 0.0 3.1 0.5 4.0 3.4 3.3 4.8 3.0 5.4 28.2 21.5 2.5 0.4 1.0 0.4 15.3 4.3 26.3 0.9 1.8 0.3 21.4 0.0 16.2 1.5 1.4 66.5 2.6 2.9 3.7 1.3 1.8 3.8 4.1 1.9 2.8 2.5 9.8 0.7 1.7 9.7 0.2 2.4 2.9 38.7 0.0 0.0 16.7 0.0 64.6 37.8 0.0 2.4 0.0 25.4 29.9 0.0 0.0 0.0 0.0 4.8 44.8 0.0 0.0 0.0 23.1 0.0 2.0 0.2 0.0 0.0 0.0 0.3 0.1 22.4 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.5 0.1 0.3 0.0 0.3 8.5 0.0 0.0 0.0 0.0 1.9 0.0 0.1 4.9 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 24.6 17.1 8.8 9.8 0.1 0.3 0.0 16.8 0.3 22.6 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.4 0.0 0.0 14.4 27.4 11.3 54.1 28.2 21.5 15.3 4.3 26.3 16.2 4.1 9.8 38.7 0.8 0.0 0.0 22.5 0.6 0.3 0.1 0.0 0.0 72.2 3.1 2.2 7.9 0.0 0.0 0.0 87.6 0.0 0.3 0.0 1.9 0.3 9.9 0.4 3.2 1.1 0.0 0.0 228.2 0.0 0.0 8.6 0.0 0.3 0.0 0.2 3.9 0.1 0.1 1.7 198.4 0.0 0.0 13.0 1.1 15.0 2.8 0.7 0.0 22.5 0.5 7.6 3.1 96.5 5.5 0.1 0.0 4.9 0.1 0.0 0.0 0.0 0.0 59.4 6.6 8.3 8.4 4.7 2.8 0.0 0.3 0.0 0.6 2.0 0.0 0.0 ARAF ARAF1 ENSG00000078061 "A-Raf proto-oncogene, serine/threonine kinase" P10398 X 47561205-47571908 "Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066326 Approved NA NA "HPA066326: AB_2685659" "unprognostic (1.21e-1)" "unprognostic (5.69e-3)" "unprognostic (2.47e-2)" "unprognostic (2.10e-2)" "unprognostic (7.63e-2)" "unprognostic (9.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "unprognostic (6.75e-2)" "unprognostic (8.65e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.97e-1)" "unprognostic (2.01e-1)" "unprognostic (6.37e-2)" "unprognostic (4.71e-2)" 37.6 42.1 15.8 37.2 18.5 103.2 36.5 17.4 21.3 34.5 21.0 38.9 38.1 36.9 21.4 32.5 35.3 32.8 45.1 14.9 19.0 44.5 56.1 39.7 40.7 21.5 18.7 13.9 39.9 59.6 52.2 28.0 31.6 18.1 41.3 33.6 15.5 45.5 35.0 137.6 36.3 40.1 31.5 16.9 46.5 47.1 12.1 18.1 38.3 39.7 86.4 31.7 36.4 31.0 18.7 49.1 69.5 29.2 46.9 43.5 34.2 39.0 40.3 42.3 58.6 54.1 57.2 58.6 29.0 32.4 54.6 49.2 67.3 51.8 56.3 34.3 53.5 61.9 29.4 74.4 30.6 61.4 58.3 85.1 45.0 56.0 56.2 49.6 39.2 45.9 36.0 55.2 55.7 40.5 83.3 42.6 64.0 41.8 41.2 77.8 39.2 38.0 65.5 34.4 46.7 32.8 25.0 43.7 39.7 24.5 47.0 74.9 43.3 44.2 38.0 42.5 76.2 41.4 71.1 49.2 22.5 50.8 65.3 31.1 48.3 47.8 61.3 44.1 57.8 40.3 32.6 38.4 40.9 55.2 37.3 33.5 40.5 37.8 38.7 67.9 40.4 41.6 50.8 15.8 18.5 17.4 21.3 14.9 19.0 21.5 18.7 13.9 18.1 16.9 18.1 18.7 13.3 16.0 29.2 7.5 25.8 15.7 25.0 29.0 18.2 5.3 15.0 9.8 25.1 34.3 22.0 18.4 10.4 33.0 26.3 43.8 23.5 29.3 1.3 11.4 10.8 17.5 31.8 22.3 5.0 34.3 30.4 16.9 39.3 15.6 16.5 13.6 24.3 42.6 28.0 13.5 5.5 35.9 40.7 26.4 21.6 4.3 17.4 25.8 33.8 4.7 43.7 18.4 32.0 8.5 8.9 26.2 41.5 17.7 27.9 20.3 44.6 27.1 11.5 9.0 19.7 15.9 18.0 8.2 10.5 17.7 16.2 44.6 26.5 12.5 32.3 24.6 MCCC1 MCCA ENSG00000078070 "Methylcrotonoyl-CoA carboxylase 1" Q96RQ3 3 183015218-183116075 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 153.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008310 Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA008310: AB_1853620" "unprognostic (4.01e-2)" "unprognostic (1.83e-3)" "unprognostic (2.05e-2)" "unprognostic (2.59e-3)" "unprognostic (3.46e-2)" "unprognostic (4.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-3)" "unprognostic (2.57e-3)" "unprognostic (9.82e-2)" "unprognostic (9.74e-2)" "unprognostic (7.65e-2)" "prognostic favorable (3.68e-4)" "unprognostic (4.73e-1)" "unprognostic (2.21e-1)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" 38.2 22.8 8.1 9.6 9.8 14.0 33.6 9.0 13.5 12.4 11.6 17.5 16.2 10.2 14.7 17.7 12.3 12.0 34.5 8.5 8.3 59.3 59.8 18.1 11.8 8.5 9.0 8.8 17.3 31.5 18.8 8.5 6.4 9.8 15.3 18.8 10.9 18.2 13.5 22.1 12.2 14.0 10.7 7.6 11.9 21.9 9.2 9.2 16.2 19.1 26.5 15.6 26.8 9.5 12.5 43.1 16.5 10.3 10.6 42.6 19.1 20.4 19.5 26.4 21.1 23.5 22.9 17.1 47.6 31.0 17.2 35.8 22.0 15.4 12.9 26.4 16.6 17.0 40.0 18.3 23.9 28.7 27.5 22.0 21.6 14.5 10.0 23.3 14.0 28.6 40.7 22.7 24.7 23.6 35.4 27.1 15.9 11.2 66.3 17.9 22.4 22.6 60.1 32.2 67.2 22.0 16.4 75.3 100.1 21.1 10.7 153.9 37.8 14.0 15.8 12.5 12.8 28.6 24.3 48.8 48.2 16.8 38.4 15.2 14.4 13.3 25.0 10.7 15.6 12.3 17.9 14.1 11.8 26.6 15.4 14.7 13.1 2.1 25.4 16.8 17.3 9.6 10.7 8.1 9.8 9.0 13.5 8.5 8.3 8.5 9.0 8.8 9.8 7.6 9.2 12.5 6.2 9.6 53.9 44.7 14.6 7.0 20.1 17.9 15.9 13.0 10.6 9.5 32.8 31.5 20.2 27.6 10.4 35.4 6.3 7.2 33.2 25.3 5.4 11.0 10.2 6.6 6.0 10.9 66.6 17.2 5.4 10.3 21.4 21.9 7.6 19.0 6.1 36.5 16.5 8.4 56.9 13.6 16.2 11.1 8.6 5.5 8.7 10.5 7.2 44.0 10.5 12.0 4.1 47.7 61.6 13.4 15.8 10.5 12.5 10.4 13.5 40.6 21.4 11.2 6.6 11.6 9.6 8.1 4.4 22.3 5.8 28.3 10.1 24.3 20.5 21.7 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122215-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lung: 221.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 486.7;monocytes: 339.6" "Cancer enhanced" "Detected in many" "lung cancer: 27.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 5.6" "Group enriched" "Detected in many" 8 "granulocytes: 5.6;T-cells: 4.8" "Group enriched" "Detected in many" 4 "EFO-21: 169.5;HDLM-2: 46.6;HHSteC: 60.4;hTCEpi: 59.1;JURKAT: 52.7" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 59000 Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.7 0.6 0.2 33.4 0.5 0.8 1.3 0.3 0.3 1.4 0.0 3.3 2.7 0.7 2.7 4.5 1.1 3.9 0.3 0.3 0.2 0.6 0.9 221.6 16.2 0.2 0.2 0.1 0.3 7.8 1.9 0.5 1.9 0.2 2.7 6.8 0.6 27.4 2.5 0.2 7.0 3.1 4.4 0.0 9.1 4.1 22.9 0.3 28.3 7.6 0.2 21.7 11.3 0.9 0.2 10.7 0.3 0.2 1.7 0.1 0.1 8.7 0.2 2.8 1.8 0.5 2.8 5.3 0.1 169.5 0.9 18.9 1.5 3.7 6.4 0.2 46.6 5.9 0.0 0.3 0.4 60.4 0.0 1.4 0.9 59.1 0.1 7.4 0.0 7.6 52.7 0.4 9.9 0.2 0.2 2.5 0.4 0.3 0.9 2.7 0.0 0.0 0.8 0.2 3.4 0.7 0.4 0.8 0.3 5.0 2.1 3.4 0.4 8.3 0.0 3.0 0.4 0.2 3.5 13.2 0.5 0.0 0.1 0.1 0.3 0.0 5.6 0.2 0.0 2.4 0.1 1.8 1.1 0.0 0.2 2.3 1.3 1.3 0.6 0.0 0.0 4.8 0.7 0.2 0.5 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.2 0.0 0.3 0.2 0.2 64.1 486.7 0.0 2.0 6.0 2.9 2.4 8.6 0.0 0.3 0.6 1.2 1.5 9.5 1.8 0.0 2.9 0.1 0.1 0.0 0.6 34.3 1.3 0.2 0.5 0.0 0.4 0.7 6.1 0.4 1.0 1.5 0.8 18.9 0.4 0.0 0.0 1.3 0.0 0.6 0.2 0.0 0.0 41.1 84.9 0.6 4.8 1.8 0.0 339.6 0.0 0.0 0.0 0.1 0.6 0.0 0.0 4.1 1.6 0.1 0.0 11.5 0.0 0.0 0.4 0.3 14.0 0.5 4.0 5.7 1.2 2.3 0.0 0.5 2.2 FAP DPPIV ENSG00000078098 "Fibroblast activation protein alpha" Q12884 2 162170684-162245151 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.7;smooth muscle: 26.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 67.6;Fibroblasts: 43.4;Microglial cells: 17.8;Muller glia cells: 57.5;Smooth muscle cells: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 192.2;ASC TERT1: 202.3;BJ hTERT+: 167.8;hTERT-RPE1: 209.1;U-138 MG: 167.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.1;hippocampal formation: 2.4" HPA059739 Uncertain "Secreted to blood" NA NA 108000000 56000000 "HPA059739: AB_2684117" "unprognostic (7.48e-3)" "unprognostic (7.87e-3)" "unprognostic (4.10e-2)" "unprognostic (5.04e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.30e-2)" "unprognostic (4.89e-2)" "unprognostic (4.59e-2)" "unprognostic (3.52e-1)" "unprognostic (7.32e-11)" "unprognostic (1.72e-3)" "unprognostic (9.84e-3)" "unprognostic (7.97e-2)" "unprognostic (4.49e-3)" 5.5 0.2 1.0 5.3 0.7 0.0 10.3 0.5 1.3 15.3 0.5 2.7 0.5 31.7 8.6 3.6 4.8 22.4 4.9 0.3 1.3 0.7 0.2 4.1 1.5 0.7 0.5 0.2 3.0 2.6 0.7 0.5 23.3 0.5 2.0 2.5 6.5 4.8 5.9 4.5 2.8 0.9 26.6 0.2 0.4 1.0 1.6 0.8 0.5 2.9 7.6 1.5 15.6 3.6 0.7 0.0 0.0 0.0 0.0 192.2 202.3 0.4 82.8 167.8 16.6 25.4 0.0 0.0 0.0 0.6 31.3 0.0 0.1 0.0 5.1 8.0 0.0 0.0 0.1 1.2 0.0 19.5 0.0 0.0 66.2 1.2 28.1 5.2 209.1 0.1 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.5 0.0 9.0 0.2 0.1 0.0 84.3 167.3 3.1 41.4 0.4 0.0 0.1 0.0 37.5 0.1 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.5 1.3 0.3 1.3 0.7 0.5 0.2 0.5 0.2 0.8 0.7 3.9 0.0 0.0 5.5 0.2 4.5 0.1 7.0 0.0 1.8 0.3 0.5 0.4 0.0 0.3 0.0 0.0 0.9 0.1 0.0 0.0 0.2 6.7 3.4 67.6 6.4 4.9 0.0 13.3 0.2 1.9 43.4 0.0 6.2 0.0 0.0 1.4 0.0 0.9 1.7 0.3 1.4 0.0 0.0 2.6 4.1 8.4 0.8 3.6 17.8 0.0 57.5 0.0 0.5 4.2 1.0 0.0 0.0 0.3 0.0 0.0 1.2 0.2 2.0 0.0 4.7 25.2 2.3 0.4 0.4 4.3 1.8 0.8 1.3 0.2 0.0 NEBL "bA165O3.1, C10orf113, LASP2, LNEBL" ENSG00000078114 Nebulette O76041 10 20779973-21293011 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "heart muscle: 314.9" "Cell type enhanced" "Detected in many" "Astrocytes: 951.0;Cardiomyocytes: 2413.0;Excitatory neurons: 359.0;Inhibitory neurons: 436.6;Oligodendrocyte precursor cells: 352.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;SCLC-21H: 31.0;SH-SY5Y: 7.2;SK-BR-3: 8.0;TIME: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013994, HPA013995" Approved NA NA "HPA013994: AB_1854359, HPA013995: AB_1854360" "unprognostic (3.79e-2)" "unprognostic (1.92e-3)" "unprognostic (3.44e-2)" "unprognostic (3.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.25e-2)" "unprognostic (1.05e-1)" "unprognostic (6.20e-3)" "unprognostic (2.36e-2)" "unprognostic (8.42e-2)" "prognostic favorable (2.77e-8)" "unprognostic (3.51e-1)" "unprognostic (8.11e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.56e-4)" 1.8 2.7 26.9 0.2 22.4 0.0 6.2 34.9 23.9 3.3 1.0 1.2 0.0 0.6 0.1 16.2 0.6 0.4 314.9 27.1 45.7 11.3 1.2 16.3 0.2 32.2 31.7 15.0 1.1 7.0 1.2 22.2 3.7 36.9 8.8 1.0 2.6 18.2 3.0 0.6 13.9 1.3 0.4 27.6 0.2 3.2 2.8 35.0 0.6 21.7 0.4 1.2 2.1 13.0 26.8 0.4 3.5 3.8 0.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.9 0.5 0.5 5.5 0.0 0.1 2.5 0.2 0.0 0.0 0.0 3.5 0.0 1.8 0.0 2.9 0.0 0.0 3.3 3.6 0.0 0.6 0.0 0.0 0.2 0.3 0.5 0.0 3.5 0.1 0.0 1.0 0.7 1.9 0.0 0.0 0.1 0.3 0.6 31.0 7.2 1.5 8.0 0.0 0.2 4.7 0.0 6.6 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 22.4 34.9 23.9 27.1 45.7 32.2 31.7 15.0 36.9 27.6 35.0 26.8 17.2 218.0 67.2 951.0 0.0 18.4 12.6 6.1 0.0 91.4 51.6 24.8 2413.0 15.7 19.9 33.1 39.6 15.3 1.0 7.5 29.4 2.9 331.4 17.4 3.9 20.8 18.0 0.0 359.0 7.1 11.1 61.0 8.6 47.3 0.0 1.0 0.7 0.2 2.1 146.4 436.6 19.5 14.2 0.6 2.3 61.7 3.7 1.2 12.4 206.1 5.9 4.0 0.0 352.3 9.0 12.9 25.7 4.9 0.0 17.3 5.5 7.7 39.1 10.3 0.0 0.8 14.8 2.8 1.1 33.8 46.2 36.8 1.8 4.5 13.7 33.9 ACER3 "APHC, FLJ11238, PHCA" ENSG00000078124 "Alkaline ceramidase 3" Q9NUN7 11 76860859-77026797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 335.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070087 Approved NA NA "HPA070087: AB_2732147" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (9.54e-3)" "unprognostic (1.37e-1)" "unprognostic (4.06e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (7.13e-2)" "unprognostic (2.35e-3)" "unprognostic (8.45e-3)" "unprognostic (1.30e-1)" "unprognostic (3.68e-3)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.24e-2)" "unprognostic (3.37e-1)" "unprognostic (9.88e-2)" "unprognostic (7.97e-2)" 11.0 3.0 7.2 4.8 9.1 3.0 5.4 9.3 9.0 5.0 5.2 6.4 6.3 4.2 3.1 6.9 4.1 3.2 3.4 7.3 9.3 4.7 2.5 8.0 4.2 9.7 8.5 6.5 2.3 2.9 3.6 2.1 6.3 10.2 4.1 5.6 2.3 4.2 2.3 1.6 2.9 4.6 3.9 9.0 5.6 3.5 6.1 8.4 2.3 3.4 1.2 3.8 4.6 4.5 13.1 7.3 7.7 6.4 7.6 29.2 14.0 5.7 11.2 10.7 8.2 9.2 6.0 7.3 6.4 8.4 8.0 10.3 12.9 10.9 10.6 10.0 8.6 4.3 9.0 4.8 3.6 8.1 9.3 15.0 6.3 5.0 11.8 10.9 4.8 16.8 5.8 6.1 4.2 9.9 5.9 0.7 6.2 3.6 19.3 8.8 4.3 22.8 5.0 6.8 7.2 2.2 5.5 13.9 12.6 3.5 4.9 10.7 5.1 22.2 8.2 6.4 23.3 8.3 3.1 7.1 8.6 5.1 4.7 8.9 0.1 4.3 2.5 0.7 3.1 0.8 1.2 0.5 0.9 4.6 0.4 0.3 0.4 0.9 0.2 2.4 1.5 1.2 1.6 7.2 9.1 9.3 9.0 7.3 9.3 9.7 8.5 6.5 10.2 9.0 8.4 13.1 32.4 41.7 35.0 52.9 11.5 31.9 21.4 17.0 33.0 18.8 11.3 11.0 7.5 11.5 27.6 9.2 10.4 13.6 11.3 54.6 7.9 15.5 66.8 6.3 29.0 29.4 2.4 13.5 65.0 17.6 7.5 17.0 26.0 11.5 83.5 30.9 27.8 10.0 44.4 43.7 71.9 30.5 18.3 64.1 67.1 31.7 20.2 64.0 17.8 61.8 40.0 11.3 12.3 159.3 335.1 18.6 37.9 25.9 8.6 15.6 20.0 15.3 12.3 10.0 6.6 17.0 21.0 69.8 25.9 26.3 16.8 26.8 15.2 7.2 20.1 24.1 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698109-39782792 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Approved "Plasma membrane,Cytosol" NA NA 390000 Cytosol "Plasma membrane" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 30.2 19.6 14.4 23.6 20.2 21.5 21.9 23.6 24.2 16.1 11.3 36.1 31.5 18.0 17.9 26.4 12.8 13.1 18.6 19.4 18.0 26.9 45.8 16.5 20.2 14.5 16.8 14.5 13.7 13.3 20.6 16.0 24.6 17.2 20.0 24.4 21.2 17.0 15.0 37.6 22.7 25.0 17.4 11.0 18.2 32.1 16.7 15.2 22.6 24.1 25.8 18.2 20.4 17.3 20.4 91.3 90.7 49.3 45.6 29.8 28.7 82.8 122.8 26.4 32.8 34.0 138.0 91.1 114.3 105.2 35.0 79.8 39.0 95.4 54.7 51.9 76.1 70.0 145.7 88.9 121.6 38.4 159.0 79.6 27.1 60.2 46.0 49.0 35.2 43.3 49.3 152.9 39.6 33.9 86.6 111.5 89.9 67.7 54.4 69.8 66.3 144.0 44.2 46.0 123.9 103.9 47.4 91.7 34.5 58.9 54.1 44.4 58.2 116.9 49.9 105.7 60.0 114.5 55.3 174.0 121.4 26.9 101.4 59.5 19.6 18.1 24.8 14.4 16.9 13.4 20.7 15.0 13.8 19.7 14.7 11.2 12.6 15.1 14.0 25.4 27.6 16.0 10.5 14.4 20.2 23.6 24.2 19.4 18.0 14.5 16.8 14.5 17.2 11.0 15.2 20.4 63.2 57.7 63.1 69.2 53.0 122.9 65.5 74.3 59.7 62.2 65.3 52.5 72.3 52.9 66.7 49.7 29.2 84.5 76.5 143.7 66.5 83.5 144.9 72.0 82.3 65.6 59.7 85.8 115.9 89.4 168.7 59.2 68.3 90.9 34.8 40.1 63.5 113.6 80.2 104.3 113.8 74.5 65.1 77.1 91.8 202.4 65.3 76.5 56.9 89.0 104.0 87.1 56.7 87.0 118.2 139.6 94.3 56.4 55.5 111.4 75.3 98.0 60.7 42.9 39.5 61.8 121.1 145.2 55.1 74.3 137.9 147.5 61.3 54.8 74.1 107.0 PIK3C3 Vps34 ENSG00000078142 "Phosphatidylinositol 3-kinase catalytic subunit type 3" Q8NEB9 18 41955234-42087830 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 114.9;Inhibitory neurons: 104.1;Oligodendrocytes: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040718 Approved NA NA "HPA040718: AB_10793862" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" "unprognostic (3.55e-3)" "unprognostic (6.15e-2)" "unprognostic (3.61e-2)" "unprognostic (6.00e-3)" "unprognostic (1.91e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.86e-2)" "unprognostic (6.41e-2)" "prognostic favorable (4.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-3)" 10.9 16.3 6.2 12.1 9.9 16.0 16.5 18.2 11.6 13.4 11.5 11.8 9.0 15.1 16.8 11.9 12.3 12.3 11.7 7.8 7.9 16.4 14.4 11.8 14.2 8.2 7.9 6.0 17.1 9.1 18.7 8.0 17.3 9.9 12.9 13.8 16.8 11.0 12.6 12.3 11.3 10.7 14.0 7.7 13.4 11.6 18.1 7.4 18.7 15.4 16.4 15.9 15.3 9.9 12.8 16.2 11.3 27.8 21.3 31.6 33.8 17.1 31.4 39.8 24.7 33.2 5.4 8.0 10.0 17.6 31.8 19.4 26.0 22.1 17.5 34.2 16.3 15.5 20.8 15.4 21.7 26.3 30.9 22.1 37.3 25.8 23.2 29.9 37.9 25.6 19.9 20.9 12.2 34.3 5.3 13.6 19.8 20.4 6.0 8.1 81.9 21.0 26.1 28.3 17.1 24.2 28.1 10.2 7.3 22.2 30.8 10.8 24.8 33.7 33.3 9.7 7.4 14.6 33.3 42.2 11.3 27.5 41.4 18.0 20.5 9.9 21.2 9.2 11.0 10.3 11.4 9.3 11.5 10.2 10.1 11.8 8.9 19.2 12.1 12.5 5.8 17.0 8.2 6.2 9.9 18.2 11.6 7.8 7.9 8.2 7.9 6.0 9.9 7.7 7.4 12.8 22.4 22.4 36.9 70.2 21.1 11.5 10.8 15.3 15.4 28.2 11.5 11.0 23.5 4.3 27.3 14.7 20.9 20.6 26.8 13.8 7.9 14.4 28.6 16.9 22.4 19.9 4.9 19.1 114.9 10.3 13.3 22.4 13.7 18.3 17.1 25.4 17.2 13.4 15.6 55.5 104.1 11.5 16.2 17.9 10.1 13.2 14.6 20.9 7.2 58.1 21.5 26.2 13.4 83.4 115.6 14.3 10.0 24.0 18.2 14.5 12.9 12.3 22.4 22.5 19.7 25.4 18.9 20.0 18.6 14.3 11.4 27.4 23.8 24.7 10.6 15.9 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056850-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.4" "Cell type enhanced" "Detected in many" "Horizontal cells: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 0.9 0.7 1.9 2.5 1.4 4.2 2.9 2.0 1.2 2.5 1.9 2.2 2.4 3.4 1.9 1.8 1.8 1.6 1.1 0.9 3.1 1.5 5.9 1.6 3.6 1.8 1.5 0.8 3.1 4.2 1.4 1.2 3.6 0.9 2.4 2.2 2.2 3.5 0.9 0.7 1.9 2.3 0.8 1.1 1.9 1.9 1.8 2.8 11.4 3.5 1.0 4.1 2.1 1.4 0.8 2.0 2.0 12.0 1.9 0.8 3.8 9.5 2.2 2.5 1.3 2.7 3.9 4.0 10.7 4.3 2.1 2.2 1.5 7.7 2.4 3.0 3.4 2.3 4.8 1.5 1.8 1.9 13.0 11.2 4.3 3.3 2.1 4.6 0.4 3.3 10.0 10.8 4.5 2.5 1.9 26.8 6.4 6.0 1.6 1.7 15.4 14.1 2.5 1.0 4.7 4.7 8.3 2.2 1.6 2.1 7.8 1.5 3.8 4.5 1.5 7.3 0.9 1.7 7.4 8.0 7.3 1.4 4.8 3.0 5.1 0.8 0.4 1.7 0.9 1.8 1.2 2.3 1.3 1.4 1.7 3.4 1.9 0.2 8.2 0.9 6.5 1.1 0.9 1.9 1.4 2.0 1.2 0.9 3.1 1.8 1.5 0.8 0.9 1.1 2.8 0.8 9.6 22.4 24.4 19.2 18.2 12.0 14.3 5.1 18.8 33.0 12.3 11.2 12.3 11.5 13.2 22.0 27.1 44.2 36.7 9.0 0.0 6.0 4.7 17.6 15.1 11.4 19.3 22.5 16.5 12.6 12.9 15.5 12.2 20.7 5.1 36.1 6.8 20.7 12.4 72.3 47.2 17.1 10.2 16.3 24.6 4.3 9.9 24.0 7.2 36.5 17.9 12.4 27.8 44.2 3.1 11.4 10.8 3.8 36.0 12.4 7.3 3.6 8.7 22.6 13.1 17.9 6.3 22.0 24.3 13.0 13.1 27.0 28.4 30.4 8.5 9.2 TIGAR C12orf5 ENSG00000078237 "TP53 induced glycolysis regulatory phosphatase" Q9NQ88 12 4307763-4360028 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Autophagy" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hofbauer cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034010, HPA040354, HPA044111" Approved Supported Cytosol NA NA Cytosol "CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814" "unprognostic (1.76e-1)" "unprognostic (6.33e-2)" "unprognostic (4.08e-1)" "unprognostic (2.60e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (5.41e-2)" "unprognostic (2.11e-1)" "unprognostic (9.37e-2)" "unprognostic (1.85e-1)" "unprognostic (5.21e-2)" "unprognostic (2.03e-2)" "unprognostic (2.02e-3)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (1.05e-1)" 3.5 5.5 1.7 1.9 1.8 1.9 2.9 2.1 3.1 1.7 2.0 3.6 0.7 2.8 1.2 3.8 2.3 1.4 4.2 2.6 1.7 2.7 3.2 3.7 2.1 2.2 2.2 1.7 1.1 2.0 0.9 5.3 1.4 2.5 2.8 1.7 2.3 3.0 1.8 5.8 2.5 3.6 2.2 2.6 5.3 3.3 3.5 2.1 1.7 2.3 2.0 1.9 3.6 2.5 2.6 4.1 9.9 4.8 7.7 10.9 6.3 47.3 9.3 8.0 5.3 7.3 5.7 3.8 4.1 0.7 5.8 5.2 5.7 5.8 7.6 7.0 3.8 2.9 0.1 4.7 7.8 14.3 2.1 0.5 8.1 12.9 5.9 6.8 3.2 14.5 3.4 0.3 2.2 9.2 7.7 2.2 0.8 8.6 5.5 1.7 3.0 6.4 1.0 6.7 5.0 0.2 2.8 7.9 3.2 10.1 22.0 0.8 1.6 10.5 8.2 5.9 5.6 3.8 1.4 2.1 6.9 5.4 0.8 5.7 0.5 1.7 0.2 0.7 3.5 0.5 0.9 0.7 0.8 1.9 1.3 0.6 0.7 1.5 0.8 3.4 1.6 1.4 0.6 1.7 1.8 2.1 3.1 2.6 1.7 2.2 2.2 1.7 2.5 2.6 2.1 2.6 10.7 0.0 1.7 0.0 14.7 0.0 13.8 0.0 5.7 4.2 6.2 7.5 10.5 1.5 0.0 5.5 18.8 27.4 16.9 5.0 15.6 15.6 28.0 4.7 5.9 9.4 7.3 1.3 0.0 13.9 28.5 6.6 11.7 4.8 0.0 4.5 5.0 5.6 59.3 1.7 0.0 1.5 0.0 20.4 0.0 27.8 3.7 30.6 0.0 0.0 34.9 11.5 7.2 0.0 0.0 17.5 2.6 4.5 16.3 9.5 2.9 11.7 0.0 3.3 6.6 5.7 8.3 19.9 22.3 8.1 0.0 34.3 11.8 10.8 2.3 15.6 TULP3 TUBL3 ENSG00000078246 "TUB like protein 3" O75386 12 2877223-2941138 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: AB_2669889" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 19.0 17.2 12.3 7.6 13.2 2.7 18.4 17.2 16.3 33.3 14.6 17.6 5.5 23.4 11.8 18.0 24.5 12.2 13.0 12.5 14.6 17.3 9.1 13.6 6.1 15.9 13.1 11.3 38.1 9.7 13.4 12.4 13.9 13.8 15.5 8.2 12.8 13.1 14.1 10.5 25.0 10.6 18.4 13.3 9.5 15.7 13.1 13.0 9.4 15.6 9.8 8.2 16.9 24.3 16.3 22.6 18.8 35.0 29.1 34.3 51.0 32.9 34.5 57.5 36.4 40.2 24.0 20.4 16.7 5.1 51.2 31.2 18.5 21.1 22.2 42.0 21.7 15.4 10.0 23.4 15.5 44.3 10.8 11.1 30.1 25.7 55.3 74.9 44.6 28.6 20.8 9.7 15.1 31.0 20.3 16.1 9.4 47.4 17.8 13.7 16.8 34.2 6.3 22.9 18.7 8.8 23.4 30.1 17.8 19.9 63.4 22.2 10.5 23.0 26.6 32.0 54.7 33.9 4.7 6.0 14.3 26.9 5.9 41.5 0.0 0.9 0.3 2.1 0.8 3.5 1.6 1.7 2.2 0.7 1.8 2.0 2.8 0.4 2.7 0.5 1.6 3.3 1.0 12.3 13.2 17.2 16.3 12.5 14.6 15.9 13.1 11.3 13.8 13.3 13.0 16.3 12.9 6.4 10.5 70.5 6.2 20.3 16.9 14.8 26.2 6.1 9.9 12.2 8.0 18.6 15.9 1.8 2.1 9.4 6.0 4.6 23.5 17.3 5.8 35.1 33.5 15.2 3.6 6.1 6.0 7.3 10.6 31.7 6.6 14.6 0.0 11.5 24.3 5.5 5.3 40.4 10.8 4.0 14.2 2.5 8.6 3.6 40.7 5.4 19.6 14.0 6.7 50.7 12.3 10.1 34.9 11.1 2.4 24.8 8.3 23.3 3.2 21.9 47.4 10.0 39.5 22.3 26.3 38.0 50.8 22.2 20.2 11.6 6.5 13.3 6.4 13.2 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981863-158099176 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 116.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 133.4;TIME: 109.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavorable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 4.0 5.8 29.8 6.3 64.4 20.2 8.1 57.7 49.2 4.6 5.5 10.7 7.1 7.7 10.6 7.8 5.6 9.5 10.8 24.2 41.2 4.7 4.9 4.6 5.9 83.3 79.0 22.2 3.7 8.1 1.5 4.2 3.5 92.3 6.9 10.5 2.3 16.6 5.9 7.3 4.3 6.9 7.8 74.7 4.2 8.6 9.5 61.2 6.5 5.3 9.6 6.6 11.1 4.7 116.7 16.4 56.6 4.5 7.3 3.4 11.2 24.2 29.8 60.4 35.0 41.1 28.7 13.5 0.5 19.8 57.9 133.4 15.4 10.1 18.5 40.1 22.9 9.3 31.8 29.8 30.9 6.5 10.9 32.6 5.9 9.9 53.3 12.4 47.1 61.7 16.4 24.7 6.5 16.1 7.6 14.0 12.2 5.1 51.4 31.2 6.0 19.1 13.4 11.8 18.8 34.8 2.0 22.7 14.2 5.9 17.2 10.9 7.1 109.7 25.8 26.8 61.4 36.5 2.5 7.8 0.4 49.2 17.5 18.4 3.0 0.6 0.5 0.9 0.3 1.9 1.0 1.3 0.8 0.6 2.0 1.1 0.8 4.3 1.0 0.4 0.5 1.2 0.5 29.8 64.4 57.7 49.2 24.2 41.2 83.3 79.0 22.2 92.3 74.7 61.2 116.7 17.2 3.2 3.3 5.2 15.4 21.7 19.9 7.5 14.2 2.4 25.4 18.4 13.9 21.5 8.6 18.4 0.0 7.7 12.8 20.0 3.9 59.0 35.5 48.5 13.7 26.4 17.4 5.5 102.1 35.2 5.0 16.6 34.1 114.2 5.1 37.7 7.9 5.2 2.0 0.0 10.1 14.8 10.2 2.2 17.6 56.5 1.2 12.5 10.6 7.5 6.9 1.6 16.5 8.5 502.1 140.2 7.1 6.4 13.5 50.6 13.1 1.7 14.4 0.6 0.0 7.3 18.9 0.9 1.1 11.5 17.2 15.9 17.1 2.2 15.7 36.2 ADCY2 "AC2, HBAC2, KIAA1060" ENSG00000078295 "Adenylate cyclase 2" Q08462 5 7396138-7830081 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 45.9;skeletal muscle: 68.9;tongue: 31.0" "Group enriched" "Detected in many" 5 "Astrocytes: 647.1;Excitatory neurons: 406.6;Horizontal cells: 201.9;Inhibitory neurons: 423.9;Oligodendrocyte precursor cells: 181.5" "Cancer enhanced" "Detected in some" "glioma: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 5.6;NTERA-2: 4.3;SK-MEL-30: 4.6;SuSa: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031482, HPA038015, HPA038483" Approved NA NA "CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799" "unprognostic (6.48e-2)" "unprognostic (2.60e-2)" "unprognostic (1.49e-1)" "unprognostic (5.65e-2)" "unprognostic (3.77e-1)" "unprognostic (4.03e-4)" "unprognostic (1.94e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (7.68e-2)" "unprognostic (1.09e-5)" "unprognostic (1.05e-1)" "unprognostic (7.33e-3)" "unprognostic (4.90e-2)" "unprognostic (3.92e-3)" 1.1 2.2 31.6 0.3 37.4 0.1 1.8 26.7 40.2 3.7 8.0 2.5 0.9 3.2 0.6 3.1 3.0 1.1 0.3 35.8 34.6 0.2 0.0 0.3 0.0 42.2 42.4 33.0 4.0 0.8 0.4 6.3 0.8 31.6 5.2 0.5 7.1 1.8 3.9 68.9 5.5 1.1 3.3 45.9 0.2 1.7 2.7 28.8 0.2 0.4 31.0 0.1 1.9 3.1 37.7 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 3.8 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 31.6 37.4 26.7 40.2 35.8 34.6 42.2 42.4 33.0 31.6 45.9 28.8 37.7 0.3 3.2 2.7 647.1 0.1 5.9 0.7 0.1 0.0 26.8 1.5 1.5 2.2 1.5 2.6 0.0 68.8 0.6 0.2 0.2 0.0 0.6 3.2 0.2 1.6 1.3 12.6 0.0 406.6 0.5 0.3 3.5 0.0 0.2 1.3 3.2 0.4 0.2 0.2 201.9 423.9 1.2 0.0 0.0 5.0 4.9 4.4 0.9 40.9 20.6 0.0 2.0 0.0 181.5 10.6 3.6 7.6 1.9 0.0 8.0 0.2 0.2 5.3 4.9 0.0 11.9 0.9 1.2 1.7 0.0 4.7 0.8 0.7 0.3 0.4 1.4 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 525.3;T-cells: 323.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 55.2 58.9 75.7 78.3 78.5 130.3 62.6 70.3 81.5 59.7 59.1 71.3 52.9 54.3 64.1 74.5 49.6 58.2 113.7 90.2 75.6 59.1 90.0 67.4 138.0 77.3 73.8 74.3 61.7 60.1 64.7 43.5 46.0 75.6 51.0 75.1 56.7 69.8 56.4 80.0 67.8 57.8 61.3 77.8 72.7 54.3 67.1 75.6 115.5 67.1 73.7 125.7 67.9 44.5 78.4 100.6 67.4 111.8 108.6 99.5 138.8 107.9 92.7 121.5 113.5 107.9 68.2 169.8 272.1 86.9 120.8 79.7 102.7 103.6 98.2 146.6 123.2 48.3 79.0 74.8 66.7 73.3 122.7 162.4 91.9 124.4 78.2 72.1 100.7 103.3 145.3 167.5 111.7 109.7 153.2 124.1 135.1 65.0 200.7 111.2 103.7 125.8 67.8 109.3 112.1 87.2 163.3 125.6 82.2 161.1 78.0 150.2 92.9 103.0 71.1 67.3 276.4 93.0 154.8 249.3 449.4 106.6 89.5 81.0 97.5 72.7 72.6 217.2 94.3 140.0 74.8 139.8 172.3 65.4 68.8 98.4 153.5 133.7 68.2 104.6 95.8 156.2 91.3 75.7 78.5 70.3 81.5 90.2 75.6 77.3 73.8 74.3 75.6 77.8 75.6 78.4 51.0 83.3 93.9 61.4 94.4 58.6 45.7 35.0 26.2 30.8 51.7 35.8 133.9 47.1 52.4 36.8 58.4 49.8 525.3 69.3 46.9 38.3 79.6 104.2 39.2 45.9 47.4 45.3 124.6 46.9 46.6 43.4 33.6 54.9 69.6 38.7 59.3 78.5 73.2 26.9 92.2 78.9 38.7 122.9 84.5 69.5 52.5 78.4 85.4 84.3 128.2 49.9 280.2 71.4 89.8 50.6 69.7 45.5 193.9 48.9 51.0 62.8 76.5 43.3 39.5 34.3 54.1 47.1 27.5 36.2 70.3 52.4 323.4 42.7 62.6 71.6 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713340 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.8;skeletal muscle: 96.1;tongue: 45.7" "Group enriched" "Detected in some" 8 "Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 0.2 1.5 8.4 0.4 28.6 0.5 0.1 3.8 75.8 0.6 0.0 0.8 0.2 0.2 3.1 1.1 1.1 0.1 23.1 30.1 28.5 0.3 0.1 0.1 0.1 8.9 1.2 21.5 0.3 0.2 0.0 1.1 0.1 14.0 1.7 0.5 5.7 2.2 4.1 96.1 0.4 0.2 0.0 1.5 0.0 0.2 1.1 4.5 0.2 0.1 45.7 0.0 0.4 0.4 26.2 0.1 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.7 0.0 0.0 0.1 1.6 0.0 0.0 0.0 25.9 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.0 0.7 0.1 0.4 0.2 0.0 0.1 0.2 0.2 0.2 0.0 0.3 0.3 0.2 0.7 0.2 0.1 0.1 0.2 0.0 8.4 28.6 3.8 75.8 30.1 28.5 8.9 1.2 21.5 14.0 1.5 4.5 26.2 0.0 0.0 0.5 97.9 0.0 0.0 0.0 0.0 0.0 10.9 0.4 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 6.6 0.3 1.8 0.9 0.0 0.0 5800.8 0.2 0.0 3.5 0.0 0.1 0.0 47.8 0.0 0.0 0.1 0.0 5921.8 0.5 0.0 0.0 0.3 4.9 1.2 0.5 1.8 132.1 0.6 6.6 0.0 597.6 689.4 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 2.8 0.0 17.0 1.2 0.6 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "retina: 2652.0" "Cell type enriched" "Detected in all" 5 "Rod photoreceptor cells: 1373.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" NA NA 1900000 "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavorable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 179.7 125.0 162.0 181.5 210.6 149.0 120.8 149.3 232.6 125.3 95.1 167.3 175.2 128.1 91.6 127.8 115.4 111.9 120.7 210.7 187.4 126.2 104.1 147.9 161.3 155.8 164.2 191.2 131.4 106.8 149.4 107.6 142.3 176.5 119.4 124.2 2652.0 121.6 120.0 67.4 112.7 209.9 157.5 136.4 143.9 130.8 99.9 168.3 168.8 114.6 97.9 146.8 154.0 103.6 202.4 373.2 344.2 400.2 280.4 222.4 242.4 154.4 515.4 339.9 456.2 355.2 282.8 361.8 385.5 369.3 522.5 258.6 192.0 405.5 373.5 411.4 595.9 199.2 375.0 308.2 325.6 279.1 227.7 394.4 216.4 256.6 437.2 402.9 306.1 376.8 298.8 236.8 337.8 440.0 230.3 501.9 177.4 230.8 190.0 275.0 482.9 308.7 306.4 310.8 227.5 489.9 556.5 477.1 306.6 420.5 272.8 214.8 305.9 579.4 399.3 267.5 314.8 379.1 227.1 432.8 888.7 341.4 470.1 230.5 11.4 13.3 21.9 9.9 16.4 9.1 9.0 9.9 11.2 13.3 9.6 6.7 7.2 22.1 12.8 17.5 22.7 12.5 8.2 162.0 210.6 149.3 232.6 210.7 187.4 155.8 164.2 191.2 176.5 136.4 168.3 202.4 172.0 70.5 42.6 57.5 67.9 86.3 51.6 47.4 33.0 149.8 65.3 57.8 60.6 52.9 42.4 75.4 175.2 44.2 124.4 140.9 46.9 88.0 29.1 93.3 112.9 131.6 122.9 40.3 102.4 100.5 99.4 77.8 52.0 121.6 53.8 101.9 95.3 60.3 100.8 180.0 101.9 95.5 40.7 152.7 114.6 33.8 76.1 128.0 53.4 115.2 119.5 250.3 73.2 70.9 110.1 175.4 91.0 88.0 75.3 100.5 167.6 67.4 41.1 1373.7 78.9 71.0 105.9 68.8 67.1 51.6 101.7 36.4 74.5 83.7 83.0 94.1 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162438-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5" "Cell line enhanced" "Detected in many" "HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3" "Not detected" "Not detected" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.1 6.0 0.0 2.8 0.0 2.5 6.9 0.0 0.2 12.1 0.0 19.5 0.0 17.1 5.7 1.0 19.8 0.0 0.0 0.0 0.0 28.4 0.0 0.4 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.1 14.2 3.9 0.0 0.0 4.5 16.3 23.5 15.0 1.9 0.2 0.9 0.2 0.0 0.0 1.9 0.1 0.0 0.0 17.0 14.0 0.2 37.7 0.0 0.0 18.4 6.0 4.4 0.0 14.6 11.7 1.2 1.2 2.4 1.4 0.3 1.4 7.9 0.0 34.7 23.5 0.0 1.2 0.0 124.4 0.3 1.1 0.0 0.6 0.0 0.5 6.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 43.9 8.1 0.0 0.0 42.0 0.7 113.4 0.0 15.6 0.0 0.3 0.6 0.0 31.3 1.4 0.0 11.4 14.0 0.2 0.0 0.0 0.0 0.0 42.3 0.0 6.7 0.8 0.0 1.3 0.2 0.2 0.1 0.0 0.1 5.6 0.9 0.2 0.0 0.8 11.5 0.3 1.8 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 6.2 0.0 0.0 0.0 2.0 25.1 14.9 0.0 3.4 0.0 12.2 14.7 0.5 0.0 0.0 18.4 0.0 0.2 2.9 10.5 54.8 0.0 0.0 1.0 31.1 4.3 39.4 16.6 0.0 0.0 0.3 4.8 0.0 0.6 0.0 0.0 0.7 0.0 0.3 0.0 0.0 21.7 0.0 3.4 4.2 0.0 0.0 1.9 5.4 0.0 0.8 0.0 2.1 0.0 0.0 0.0 20.2 0.0 0.9 19.4 13.3 75.1 0.0 0.0 0.0 3.0 4.6 0.0 1.0 2.6 27.6 0.3 2.2 0.3 21.4 14.2 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290361-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "non-classical monocyte: 4.9" "Lineage enriched" "Detected in single" 6 "monocytes: 4.9" "Cell line enhanced" "Detected in many" "EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 32.4 1.9 15.3 7.4 13.7 4.7 23.8 14.1 15.8 5.4 14.9 10.7 10.5 7.1 6.4 12.2 9.5 13.6 7.5 13.1 12.8 7.6 3.2 36.9 5.7 17.0 14.1 11.3 2.6 9.6 1.4 1.1 18.7 16.0 5.5 14.6 1.0 12.2 9.0 7.6 11.8 9.8 11.4 13.2 12.4 10.5 4.7 15.1 1.7 3.4 6.4 2.4 10.0 6.0 15.0 10.3 57.6 1.1 0.1 0.3 0.2 0.2 18.2 16.0 15.0 12.4 74.6 8.6 0.0 660.4 7.2 9.2 5.4 0.0 10.6 11.0 0.8 0.0 0.0 2.1 2.3 0.8 0.0 0.0 0.4 6.2 3.0 2.1 4.7 446.8 0.0 0.0 0.0 56.8 1.6 0.2 0.3 0.6 10.4 0.7 0.2 5.1 0.1 35.3 9.4 0.6 0.0 1.8 53.1 0.1 117.2 137.5 0.8 334.3 37.1 30.1 0.7 23.5 0.3 0.4 1.3 0.3 0.0 1.6 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 4.9 0.1 0.0 0.0 15.3 13.7 14.1 15.8 13.1 12.8 17.0 14.1 11.3 16.0 13.2 15.1 15.0 190.7 173.1 23.8 2.9 0.8 189.9 749.7 99.9 151.4 0.2 68.7 26.8 2.2 8.6 110.6 38.6 0.0 1.8 0.8 189.7 3.9 316.3 13.3 187.2 16.3 236.8 15.6 2.7 3.6 218.9 0.4 9.0 22.4 289.7 1.3 0.8 169.2 1.8 1.8 1.7 3.0 43.8 12.2 5.0 6.7 19.8 5.6 5.3 8.8 6.5 10.9 0.3 0.0 3.5 0.6 268.5 145.7 0.4 0.4 185.8 119.6 8.3 27.4 0.4 6.6 1.8 21.8 1.0 0.6 53.7 64.5 0.8 9.7 0.1 196.6 141.8 MLLT10 AF10 ENSG00000078403 "MLLT10 histone lysine methyltransferase DOT1L cofactor" P55197 10 21524646-21743630 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 201.3;Spermatocytes: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005736, HPA005747, HPA072790" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005736: , HPA005747: AB_1079393, HPA072790: " "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 15.4 13.1 12.5 12.1 14.5 30.7 14.6 22.0 16.1 17.7 16.2 17.7 9.2 18.9 16.1 16.3 17.5 11.5 15.8 12.6 15.6 15.2 15.7 14.8 15.4 14.4 14.0 11.8 25.0 13.7 18.7 12.7 16.6 14.9 13.2 12.9 20.8 13.8 11.9 15.8 25.6 13.3 17.0 12.7 12.9 12.4 93.8 13.5 23.4 22.0 14.3 14.7 19.3 16.6 19.4 32.1 29.6 38.3 22.2 23.3 25.0 44.1 19.6 10.6 21.7 21.6 29.5 31.3 34.9 10.8 20.7 21.1 24.1 43.3 25.1 22.2 25.0 21.9 59.2 24.5 44.5 29.6 1.6 33.4 21.3 28.6 17.7 19.2 21.8 30.1 34.3 65.4 26.5 19.3 28.1 44.1 28.5 17.3 17.5 9.2 36.6 23.5 31.7 23.2 12.6 13.8 39.6 24.7 29.0 45.8 30.7 13.3 37.1 29.8 14.7 24.6 26.7 18.9 23.5 32.2 43.4 15.4 21.5 9.9 10.3 6.5 13.5 5.0 4.1 4.6 5.3 6.1 6.1 5.1 4.3 6.6 6.0 4.8 4.6 4.7 7.5 5.5 2.5 12.5 14.5 22.0 16.1 12.6 15.6 14.4 14.0 11.8 14.9 12.7 13.5 19.4 33.3 28.9 40.4 155.7 25.1 37.7 17.4 22.4 44.3 38.4 19.9 20.7 31.5 18.6 19.6 18.4 43.8 34.0 24.9 13.3 13.7 14.6 66.1 16.1 26.6 28.7 3.5 30.9 201.3 12.8 58.6 26.6 21.9 21.3 25.2 28.6 26.0 22.7 28.9 30.3 169.6 16.3 26.4 36.1 23.0 109.0 39.4 28.6 48.0 107.7 29.7 17.8 21.6 148.3 160.0 13.2 14.6 48.2 23.5 22.7 18.8 23.1 18.7 53.7 39.5 31.4 35.7 233.8 57.4 48.5 43.9 50.2 29.5 24.2 18.0 13.5 ZCWPW1 "DKFZp434N0510, FLJ10057, ZCW1" ENSG00000078487 "Zinc finger CW-type and PWWP domain containing 1" Q9H0M4 7 100400826-100428992 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 42.8" "Group enriched" "Detected in many" 12 "Spermatocytes: 996.6;Spermatogonia: 361.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.6;hTERT-HME1: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020911 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA020911: AB_1858990" "unprognostic (1.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.92e-3)" "unprognostic (6.74e-2)" "unprognostic (2.58e-2)" "unprognostic (8.46e-3)" "unprognostic (1.99e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.93e-4)" "unprognostic (2.43e-3)" "unprognostic (1.72e-2)" "unprognostic (2.84e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-2)" "prognostic favorable (5.26e-4)" 3.7 2.6 6.6 2.6 7.7 2.9 4.4 9.3 9.1 2.7 5.5 2.8 1.2 4.0 4.5 2.4 5.1 2.9 4.0 6.6 6.8 3.5 6.1 2.6 3.8 8.0 7.4 5.8 6.3 2.2 4.4 2.1 1.9 8.3 3.2 1.9 3.2 2.1 3.8 4.0 4.5 2.6 2.9 7.4 4.1 2.5 42.8 7.3 2.8 5.2 4.6 3.7 3.8 2.3 8.6 5.8 2.6 1.3 2.2 7.2 5.7 0.8 2.9 3.3 2.4 3.1 1.0 1.8 15.6 11.5 2.2 5.5 1.5 1.3 0.9 3.8 1.2 1.1 4.8 0.6 0.8 2.3 2.0 2.9 3.2 6.1 1.9 13.8 1.2 0.2 3.1 3.4 4.6 2.3 5.4 1.6 4.4 0.5 2.9 0.7 3.6 1.0 1.0 2.1 1.3 4.2 1.8 7.4 2.0 4.7 1.1 3.0 3.2 0.3 6.3 2.5 5.4 1.0 1.6 2.1 7.0 2.4 5.2 5.5 3.6 1.6 15.9 2.1 3.2 3.4 14.6 2.7 3.0 1.9 12.8 4.5 3.3 5.5 3.3 9.6 3.6 1.6 2.1 6.6 7.7 9.3 9.1 6.6 6.8 8.0 7.4 5.8 8.3 7.4 7.3 8.6 7.5 0.0 7.4 14.4 13.1 8.0 10.3 5.2 12.5 10.9 9.3 11.8 7.3 0.0 8.5 5.5 2.1 1.3 7.5 2.1 11.7 5.8 36.1 11.3 5.2 5.3 2.4 1.7 6.7 3.6 0.7 7.6 12.8 4.0 21.0 8.6 5.7 9.7 3.4 5.0 9.1 3.3 0.0 9.5 7.6 52.5 16.4 5.8 1.8 2.8 4.0 13.6 8.2 5.0 20.7 3.8 4.6 7.9 2.9 5.5 4.6 12.5 23.0 5.2 46.0 11.0 4.6 996.6 361.4 4.2 4.5 1.4 6.4 5.4 3.9 5.9 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052308-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 128.2" "Group enriched" "Detected in some" 4 "Astrocytes: 57.1;Inhibitory neurons: 45.7" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.7;NTERA-2: 4.8;SCLC-21H: 4.1;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles NA NA Vesicles "HPA030739: AB_2732461, HPA049877: AB_2680928" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favorable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 5.8 11.5 93.4 2.3 79.4 0.0 4.1 59.1 58.4 13.2 3.8 5.2 0.8 5.4 1.6 2.9 29.8 1.3 2.8 70.4 123.2 0.0 0.2 0.8 0.1 96.7 101.5 59.3 1.8 1.6 1.6 9.9 0.1 88.5 1.8 1.3 2.7 2.2 3.2 1.3 1.1 2.2 3.7 60.7 0.5 3.5 1.6 128.2 0.8 2.1 8.1 0.8 1.8 4.3 54.8 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 7.4 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.6 0.8 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.4 79.4 59.1 58.4 70.4 123.2 96.7 101.5 59.3 88.5 60.7 128.2 54.8 4.2 0.0 0.0 57.1 0.0 0.5 0.0 0.0 0.0 1.7 0.2 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.7 0.0 0.0 10.8 0.0 0.0 4.6 0.0 6.3 0.0 1.2 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.7 0.9 11.5 0.0 1.8 2.8 0.0 0.0 0.0 11.6 1.5 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 5.8 0.3 1.5 0.0 0.3 0.0 0.2 0.1 0.0 0.1 FGF20 ENSG00000078579 "Fibroblast growth factor 20" Q9NP95 8 16992181-17002345 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5" "Cell type enriched" "Detected in some" 7 "Microglial cells: 8.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;CAPAN-2: 5.3;OE19: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.8" "Secreted in other tissues" NA NA "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (5.57e-3)" "unprognostic (3.95e-2)" "unprognostic (1.59e-3)" "unprognostic (1.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.65e-2)" "unprognostic (9.32e-2)" "unprognostic (9.95e-2)" "unprognostic (3.92e-1)" "unprognostic (4.08e-2)" 0.1 0.6 0.8 0.0 0.9 0.0 0.2 2.5 1.3 1.0 0.5 0.0 0.1 0.0 0.6 0.0 0.2 0.3 0.1 0.8 1.1 0.0 0.0 0.1 0.1 1.0 1.2 0.6 0.6 0.1 0.0 0.4 0.1 1.2 0.2 0.0 0.1 1.1 0.1 0.0 0.0 0.1 0.0 1.2 1.0 0.6 0.2 1.1 0.2 0.2 0.0 0.4 0.1 0.1 1.6 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.6 1.6 0.2 0.8 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 2.5 1.3 0.8 1.1 1.0 1.2 0.6 1.2 1.2 1.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 8.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 P2RY10 P2Y10 ENSG00000078589 "P2Y receptor family member 10" O00398 X 78945332-78963727 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.7" "Cell type enhanced" "Detected in some" "B-cells: 79.3;granulocytes: 29.2;Langerhans cells: 38.5;monocytes: 32.5;Plasma cells: 32.6;T-cells: 55.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 256.1" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "Karpas-707: 121.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036757, HPA065766" Enhanced NA NA "HPA036757: AB_10696786, HPA065766: AB_2685556" "unprognostic (3.02e-3)" "unprognostic (1.47e-3)" "unprognostic (1.50e-6)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.13e-4)" "unprognostic (3.33e-2)" "unprognostic (8.30e-2)" "unprognostic (1.13e-2)" "unprognostic (4.13e-3)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (2.23e-1)" "unprognostic (6.54e-2)" "unprognostic (3.85e-2)" "unprognostic (3.99e-2)" 0.8 0.5 0.3 14.7 0.7 8.2 0.9 1.6 1.2 1.0 0.0 2.8 3.1 0.8 0.3 1.1 0.4 3.3 0.4 0.5 0.1 0.4 1.6 2.4 27.7 0.2 0.1 0.4 0.4 1.5 0.0 0.1 0.3 0.6 1.3 3.6 0.6 1.2 0.2 0.2 0.6 6.4 0.7 0.0 16.7 4.0 0.3 0.1 10.3 0.6 0.1 26.0 5.5 0.4 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 121.8 0.0 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 9.9 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.1 0.0 26.5 0.1 1.4 0.2 0.3 0.1 256.1 0.2 158.1 12.6 0.9 11.4 73.1 28.0 25.5 4.0 74.1 25.7 19.5 27.9 18.1 10.9 2.8 41.7 13.2 0.3 0.7 1.6 1.2 0.5 0.1 0.2 0.1 0.4 0.6 0.0 0.1 0.8 0.7 0.0 1.7 0.0 79.3 1.8 0.0 0.0 0.0 0.0 0.3 0.3 1.2 0.0 0.6 0.0 0.0 0.0 15.0 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.4 0.0 0.8 0.5 0.1 29.2 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.6 38.5 0.0 0.0 3.6 8.8 0.0 32.5 0.0 9.2 0.0 0.0 0.0 0.0 0.0 32.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 2.0 0.0 55.1 0.0 0.0 0.3 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 325.9" "Cell type enhanced" "Detected in many" "Adipocytes: 390.0;Endothelial cells: 368.4;Fibroblasts: 302.1;granulocytes: 194.6;Leydig cells: 335.5;Muller glia cells: 188.9;T-cells: 239.2" "Cancer enhanced" "Detected in all" "glioma: 51.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 172.6;eosinophil: 88.5;gdT-cell: 107.1;MAIT T-cell: 79.3;memory CD4 T-cell: 204.7;memory CD8 T-cell: 170.5;naive CD4 T-cell: 216.7;naive CD8 T-cell: 101.6;NK-cell: 130.3;T-reg: 168.1" "Group enriched" "Detected in all" 7 "granulocytes: 172.6;NK-cells: 130.3;T-cells: 216.7" "Cell line enriched" "Detected in some" 5 "MOLT-4: 1749.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favorable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 81.0 10.9 100.0 27.0 93.0 46.1 75.2 98.9 155.4 55.8 82.2 30.8 15.2 44.8 19.0 40.4 43.2 29.0 116.4 92.6 101.4 20.8 6.4 52.7 87.9 103.0 102.4 78.3 183.0 10.1 15.0 21.2 29.9 110.0 23.0 32.5 12.0 75.5 22.6 41.6 24.7 22.3 57.0 93.2 24.7 24.4 16.1 105.1 325.9 83.9 75.9 47.3 42.7 26.2 97.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 216.6 2.5 0.0 4.4 0.0 69.9 0.0 0.0 0.0 113.1 124.2 19.5 0.0 0.0 0.0 0.1 0.0 333.3 80.2 0.0 0.0 0.0 1749.0 77.6 25.0 0.0 0.0 0.7 0.1 0.3 64.6 0.0 0.2 19.0 0.0 0.9 0.0 17.6 2.2 2.5 3.0 0.0 1.8 0.4 1.1 208.1 0.0 0.0 0.2 0.0 8.7 172.6 0.8 88.5 107.1 1.3 79.3 23.4 204.7 170.5 0.8 23.5 216.7 101.6 3.9 130.3 1.1 6.1 168.1 115.3 100.0 93.0 98.9 155.4 92.6 101.4 103.0 102.4 78.3 110.0 93.2 105.1 97.6 390.0 3.2 14.8 1.0 28.0 67.4 13.2 2.1 50.1 3.1 21.1 81.9 29.3 2.8 4.4 1.8 0.0 0.4 64.8 2.1 5.9 0.4 3.1 0.4 2.6 368.4 2.4 42.7 3.5 50.9 0.2 302.1 29.6 0.6 194.6 1.4 135.0 1.0 1.3 1.7 2.3 85.6 0.0 9.5 39.5 7.1 335.5 8.6 62.2 114.3 3.2 188.9 65.9 18.1 60.2 1.0 1.4 117.8 81.8 12.3 0.2 1.4 0.7 12.1 0.0 31.8 22.5 0.5 2.6 24.3 47.0 0.3 239.2 2.0 2.9 2.5 NRDC "hNRD1, hNRD2, NRD1" ENSG00000078618 "Nardilysin convertase" O43847 1 51789191-51878937 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 269.5" "Group enriched" "Detected in many" 9 "Early spermatids: 597.7;Late spermatids: 1672.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053661 Approved Nucleoplasm NA NA 58000 Nucleoplasm "HPA053661: AB_2682221" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (2.14e-2)" "unprognostic (5.62e-2)" "unprognostic (2.61e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (5.49e-6)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (1.67e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.12e-9)" "unprognostic (2.75e-1)" "unprognostic (2.35e-2)" "unprognostic (9.54e-2)" "unprognostic (5.53e-3)" 48.6 37.1 33.3 48.7 34.5 48.9 34.5 33.7 42.6 31.4 38.0 32.8 32.6 31.3 20.4 40.8 30.0 31.3 52.9 34.5 35.3 26.8 56.2 34.6 44.1 36.4 34.9 33.7 32.9 40.4 61.4 33.0 40.6 37.7 38.9 35.6 48.5 28.9 30.8 269.5 48.4 31.6 38.7 33.7 41.2 35.5 96.5 36.4 55.4 33.4 183.6 47.1 36.9 28.7 38.1 166.8 91.0 94.2 133.4 98.9 145.5 106.8 165.6 143.9 116.6 123.5 65.6 65.3 108.3 84.7 128.4 157.6 95.1 136.5 127.9 156.2 127.7 66.1 129.5 125.4 62.9 97.9 114.4 95.4 117.2 102.1 169.7 160.0 105.0 125.7 113.1 174.7 71.7 153.4 62.9 105.0 45.2 161.5 71.8 97.4 101.6 106.4 122.6 92.8 94.7 86.5 65.2 148.0 124.8 94.5 185.7 79.3 152.5 102.4 103.8 94.2 114.2 146.0 103.9 168.4 100.1 120.8 146.6 120.1 44.5 33.8 50.0 23.2 35.1 23.3 23.2 21.5 26.0 33.7 15.6 20.9 22.7 67.8 29.8 28.3 27.5 26.9 33.1 33.3 34.5 33.7 42.6 34.5 35.3 36.4 34.9 33.7 37.7 33.7 36.4 38.1 43.5 35.3 69.0 0.0 58.9 0.0 46.3 0.0 38.7 73.3 38.2 31.0 0.0 28.6 34.7 27.6 81.3 56.8 94.3 11.1 31.3 48.1 597.7 63.1 78.8 39.4 18.2 85.8 0.0 64.0 45.5 40.1 56.6 55.4 35.3 74.6 30.4 59.9 44.3 62.2 0.0 19.5 0.0 44.6 0.0 1672.1 66.2 72.5 0.0 0.0 70.3 45.9 55.6 0.0 0.0 57.6 13.7 59.0 126.1 41.9 30.1 19.6 59.0 71.8 59.2 64.5 38.2 39.0 28.1 57.7 0.0 82.5 52.8 65.9 21.6 42.3 VDAC3 HD-VDAC3 ENSG00000078668 "Voltage dependent anion channel 3" Q9Y277 8 42391624-42405937 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 388.8;skeletal muscle: 923.0;tongue: 951.1" "Cell type enhanced" "Detected in all" "Spermatocytes: 403.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026864 Uncertain Supported Mitochondria NA NA 1200000 Mitochondria "HPA026864: AB_1858733" "unprognostic (2.55e-2)" "unprognostic (1.96e-2)" "unprognostic (9.88e-3)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-1)" "unprognostic (4.98e-2)" "unprognostic (2.25e-2)" "unprognostic (1.40e-2)" "unprognostic (5.76e-2)" "unprognostic (3.74e-1)" "unprognostic (1.19e-2)" "unprognostic (6.16e-3)" "unprognostic (2.96e-2)" "unprognostic (1.76e-1)" "unprognostic (8.78e-3)" "unprognostic (6.94e-3)" 68.1 76.8 122.8 59.6 130.1 92.9 71.0 127.3 151.9 53.4 124.6 101.8 80.5 64.1 69.2 100.8 86.5 56.5 388.8 128.4 138.7 109.8 93.7 52.4 66.8 132.1 131.2 126.7 62.2 65.2 93.2 59.3 64.5 143.0 70.1 107.5 124.2 62.1 82.1 923.0 54.6 73.6 93.6 122.4 67.8 72.7 115.6 128.6 80.8 84.0 951.1 79.9 79.6 60.3 155.6 226.3 225.7 174.5 185.9 146.3 126.6 84.8 180.0 151.1 225.4 205.2 173.4 190.4 235.8 165.0 153.7 196.3 142.5 238.4 194.1 244.7 117.2 196.6 352.9 138.4 250.2 105.2 172.0 190.1 98.6 143.3 171.6 80.9 149.6 279.8 201.3 284.4 158.6 235.7 126.4 373.3 197.1 205.2 285.6 144.5 193.6 322.1 165.3 245.7 198.8 156.8 133.3 112.1 132.8 116.1 126.4 279.9 129.9 149.8 86.6 150.0 217.7 174.0 145.2 264.1 266.9 117.5 238.0 150.9 142.8 165.3 183.4 145.8 167.2 148.7 126.5 155.6 146.5 222.7 96.6 152.7 147.7 82.8 125.8 155.6 163.0 202.5 360.5 122.8 130.1 127.3 151.9 128.4 138.7 132.1 131.2 126.7 143.0 122.4 128.6 155.6 78.1 44.8 24.4 50.6 59.8 64.5 81.1 197.8 58.1 85.9 53.0 73.9 321.2 55.8 82.8 66.2 35.5 145.5 91.9 65.7 307.2 116.3 151.1 112.8 56.7 70.5 47.8 186.4 63.2 90.0 112.1 81.5 41.3 47.1 55.2 100.6 68.2 60.4 139.7 138.0 78.9 86.1 177.0 58.5 77.8 146.4 69.3 107.7 72.9 26.2 130.1 72.9 83.4 38.2 34.7 84.9 86.7 97.4 75.9 48.9 125.3 177.5 142.1 94.5 65.7 146.4 123.8 403.7 156.3 82.3 70.8 58.3 79.7 94.2 124.8 70.4 PCM1 PTC4 ENSG00000078674 "Pericentriolar material 1" Q15154 8 17922840-18027975 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 528.5;Spermatocytes: 569.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023370, HPA023374, CAB058695" Enhanced Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073" "unprognostic (1.52e-2)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (3.35e-2)" "unprognostic (9.52e-2)" "unprognostic (1.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.74e-3)" "unprognostic (1.09e-1)" "unprognostic (2.26e-1)" "unprognostic (2.84e-1)" "unprognostic (2.83e-1)" "unprognostic (1.76e-2)" "unprognostic (2.16e-1)" "unprognostic (4.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.45e-1)" 29.8 31.6 33.6 28.4 42.3 52.6 43.5 44.6 37.2 39.6 40.1 33.2 22.0 39.6 42.0 28.4 44.5 31.0 36.7 32.9 37.9 32.2 39.6 33.9 41.8 36.2 35.1 27.2 47.4 40.2 53.0 31.3 35.5 37.4 33.8 27.7 77.3 35.4 32.5 106.1 30.6 29.8 30.9 35.9 33.7 28.2 155.6 34.0 57.4 49.4 85.6 37.6 31.3 26.4 48.6 64.0 66.8 100.5 133.4 55.2 57.0 51.7 52.6 64.4 54.9 61.3 45.4 37.0 83.0 35.3 52.8 47.2 45.0 64.8 48.3 93.0 27.6 25.1 142.7 46.2 93.1 61.6 63.7 35.1 50.3 50.6 63.9 70.3 47.9 64.1 84.9 98.4 62.6 67.9 32.0 136.8 103.3 82.7 52.8 19.1 81.0 90.1 30.0 45.3 87.1 76.6 57.6 56.5 30.5 82.1 42.8 48.2 91.0 57.8 49.6 40.5 61.3 45.0 26.6 62.9 72.5 41.8 68.3 52.0 31.5 7.2 18.7 13.0 4.6 13.5 13.0 11.6 15.1 7.3 13.1 12.9 13.2 7.6 13.9 10.0 17.8 13.1 5.6 33.6 42.3 44.6 37.2 32.9 37.9 36.2 35.1 27.2 37.4 35.9 34.0 48.6 91.6 128.2 154.9 187.7 109.3 33.8 66.3 44.4 75.7 196.1 74.1 72.0 249.4 62.9 117.2 86.5 350.3 50.9 145.9 33.6 29.4 73.0 528.5 275.2 130.4 86.5 71.2 115.5 219.9 59.0 33.6 100.4 55.0 132.5 142.1 103.9 64.6 50.8 43.3 129.5 211.8 45.7 61.1 61.3 39.7 301.3 92.2 83.6 55.2 162.1 82.8 145.8 132.8 208.6 243.1 58.9 36.0 97.8 84.7 45.8 45.6 25.9 282.1 234.9 124.9 173.8 92.7 569.3 177.1 65.4 38.2 60.5 122.5 92.1 50.6 47.2 TNRC6C "FLJ20015, KIAA1582" ENSG00000078687 "Trinucleotide repeat containing adaptor 6C" Q9HCJ0 17 77959240-78108835 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 25.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 237.7;Oligodendrocyte precursor cells: 175.4;Oligodendrocytes: 144.9;Rod photoreceptor cells: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "basophil: 15.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.9" "Cell line enhanced" "Detected in many" "MOLT-4: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022007, HPA062051" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022007: AB_2670877, HPA062051: AB_2684670" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-3)" "unprognostic (2.66e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (2.89e-3)" "unprognostic (2.59e-1)" "unprognostic (7.83e-2)" "prognostic favorable (6.56e-5)" "unprognostic (1.36e-1)" "unprognostic (1.17e-2)" "unprognostic (1.07e-1)" "unprognostic (1.84e-1)" "unprognostic (3.04e-1)" "unprognostic (5.70e-2)" 5.0 3.1 9.7 4.6 10.7 3.2 5.2 17.0 11.8 5.0 0.0 4.0 2.0 5.9 4.3 2.8 5.7 4.2 6.2 10.4 5.1 2.9 3.5 3.7 5.9 8.4 7.5 8.4 7.4 4.0 3.8 7.5 1.9 9.7 5.2 2.7 25.2 5.7 4.0 10.9 3.0 4.0 4.8 3.1 5.1 3.7 8.4 6.9 17.9 4.4 7.6 5.0 4.6 4.2 18.9 4.2 4.0 7.1 7.7 3.0 2.2 0.0 6.3 5.3 4.4 3.6 4.2 1.2 0.0 2.6 4.9 3.1 0.3 5.2 0.2 2.7 3.4 5.5 15.0 1.5 4.7 2.7 3.6 7.3 1.9 2.0 1.7 4.1 2.0 9.4 14.6 2.5 7.4 4.6 5.8 34.5 1.7 3.7 1.8 3.0 4.5 14.2 2.8 1.0 6.0 8.7 16.0 7.6 9.2 3.0 3.4 6.9 5.1 7.0 9.8 3.2 5.1 7.9 5.5 0.9 4.3 2.8 5.3 7.2 15.9 0.2 1.2 1.5 0.1 1.6 0.9 1.6 1.6 0.1 0.9 1.8 2.1 0.9 2.4 0.0 0.6 0.8 0.4 9.7 10.7 17.0 11.8 10.4 5.1 8.4 7.5 8.4 9.7 3.1 6.9 18.9 43.9 28.9 27.8 63.6 24.7 22.0 9.5 4.7 26.7 123.2 28.4 17.5 30.1 30.0 7.6 9.2 237.7 0.1 36.2 8.8 1.9 7.5 9.7 12.6 26.3 25.3 39.8 21.0 125.8 6.0 0.7 36.5 8.6 13.6 22.8 13.0 40.7 21.3 2.1 74.0 112.6 8.7 8.2 10.5 14.8 7.9 51.3 6.6 16.0 33.7 7.3 33.1 41.2 175.4 144.9 9.0 5.3 42.9 15.8 11.8 6.5 5.2 5.9 138.1 0.0 35.9 27.4 36.7 20.1 12.2 14.2 0.3 47.9 14.4 7.9 5.1 CBFA2T2 "MTGR1, ZMYND3" ENSG00000078699 "CBFA2/RUNX1 partner transcriptional co-repressor 2" O43439 20 33490075-33650036 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 128.3;Excitatory neurons: 114.7;Inhibitory neurons: 116.6;Oligodendrocytes: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 45.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060523, HPA072433" Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA060523: AB_2684305, HPA072433: AB_2686520" "unprognostic (6.51e-3)" "unprognostic (3.29e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-3)" "unprognostic (1.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.85e-3)" "unprognostic (3.90e-2)" "unprognostic (3.08e-1)" "unprognostic (3.89e-2)" "prognostic favorable (6.93e-6)" "unprognostic (7.83e-2)" "unprognostic (1.39e-3)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.12e-2)" 6.3 4.9 11.4 5.9 11.6 5.6 6.6 9.2 14.0 10.9 4.9 12.0 7.6 7.5 5.0 9.3 8.5 4.1 7.2 12.9 9.8 7.5 7.6 8.6 6.6 10.6 10.9 10.1 11.7 7.1 9.2 9.8 4.6 11.4 16.9 9.2 15.5 8.3 5.9 9.7 12.2 10.7 5.9 7.1 9.0 8.9 11.2 10.7 9.0 10.8 5.7 6.4 9.6 10.7 17.9 6.8 6.5 9.3 6.8 9.2 7.0 9.5 4.1 4.9 5.5 4.6 13.8 6.3 7.9 8.4 5.7 12.3 9.0 5.4 6.8 4.8 3.3 4.1 10.9 6.5 8.3 5.8 4.5 9.0 5.9 8.9 5.7 7.9 6.8 4.9 8.1 6.2 5.1 4.8 6.1 9.6 7.6 3.2 8.3 7.1 7.5 10.3 8.3 6.3 9.7 30.1 45.1 20.7 8.0 6.7 9.4 7.5 6.9 5.3 13.1 5.9 8.9 5.0 9.3 11.0 4.5 6.7 4.1 4.2 4.2 1.1 1.2 2.1 1.0 1.9 2.7 2.2 2.7 0.5 2.7 1.3 1.8 2.2 1.2 0.7 1.5 1.9 0.7 11.4 11.6 9.2 14.0 12.9 9.8 10.6 10.9 10.1 11.4 7.1 10.7 17.9 9.9 12.8 21.7 128.3 17.8 19.1 12.9 9.3 26.2 29.9 15.9 11.3 11.4 7.2 11.1 12.9 45.9 12.8 12.7 17.1 1.9 8.5 12.0 14.4 11.6 11.8 90.4 11.6 114.7 6.4 11.4 14.1 19.4 17.1 1.3 16.3 11.4 8.1 9.4 13.5 116.6 50.1 14.2 11.0 13.7 14.9 14.0 8.4 17.8 59.0 12.1 10.9 17.5 74.4 166.9 9.4 15.6 12.8 19.1 21.8 14.4 5.4 11.4 38.5 13.1 12.5 11.9 24.1 18.1 20.4 15.3 8.9 19.5 7.5 18.9 15.2 BRINP1 "DBC1, DBCCR1, FAM5A" ENSG00000078725 "BMP/retinoic acid inducible neural specific 1" O60477 9 119153458-119369435 "Predicted intracellular proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 37.9" "Group enriched" "Detected in some" 8 "Astrocytes: 178.9;Excitatory neurons: 285.7;Inhibitory neurons: 163.4;Oligodendrocyte precursor cells: 204.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 8.6;NTERA-2: 17.0;SCLC-21H: 7.4;SH-SY5Y: 3.2;SuSa: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038828 Approved Uncertain Microtubules "Intracellular and membrane" NA NA Microtubules "HPA038828: AB_10670909" "unprognostic (8.60e-5)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (5.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.14e-2)" "unprognostic (1.37e-1)" "unprognostic (2.98e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (2.28e-4)" "unprognostic (1.51e-2)" "unprognostic (5.06e-3)" "unprognostic (1.39e-3)" "unprognostic (1.56e-1)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" 0.1 3.8 27.5 0.0 21.8 0.0 2.4 19.0 37.9 0.5 0.6 0.2 0.2 0.7 5.0 0.6 0.0 1.5 1.9 34.4 17.0 1.7 0.6 1.9 0.0 9.1 22.7 23.0 0.1 0.0 0.0 1.7 0.0 13.6 1.6 0.1 5.3 0.8 5.2 0.3 0.1 0.6 0.1 13.4 0.3 0.2 0.5 26.1 0.8 0.3 0.1 0.0 0.3 0.2 19.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 17.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 7.4 3.2 0.0 0.0 0.0 6.0 0.6 0.0 0.0 1.1 1.8 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 21.8 19.0 37.9 34.4 17.0 9.1 22.7 23.0 13.6 13.4 26.1 19.3 0.1 0.0 0.0 178.9 0.0 0.0 0.5 0.5 0.0 8.7 8.1 4.2 0.9 0.0 0.1 0.0 25.0 0.1 0.0 0.3 0.0 0.0 2.1 0.5 15.9 0.5 2.4 0.0 285.7 0.0 0.0 0.4 0.0 0.4 0.0 0.2 2.9 0.0 0.3 1.7 163.4 0.0 0.0 0.3 0.0 1.0 0.0 0.3 0.0 8.4 0.0 1.6 0.0 204.6 4.9 0.1 0.0 0.4 0.0 0.4 0.0 23.9 0.0 2.6 0.0 0.0 0.4 1.0 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.3 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363241-34540748 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 139.7;Oligodendrocytes: 260.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607" "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 19.6 16.3 12.8 18.3 25.5 27.6 20.2 18.7 20.1 24.7 16.7 21.8 20.4 19.6 16.7 43.1 15.9 17.2 20.4 14.7 16.0 23.6 56.0 18.9 21.6 18.5 20.6 10.7 19.0 16.7 23.3 7.9 25.8 19.9 19.8 23.7 25.8 18.9 20.1 17.4 14.1 21.0 21.7 19.0 20.5 21.1 38.8 18.8 23.4 26.6 21.9 25.9 30.9 15.0 45.7 55.5 34.6 35.2 25.9 38.3 57.4 42.7 43.5 52.0 56.2 54.0 101.5 83.8 26.7 42.1 55.6 73.9 66.2 54.9 92.3 66.2 20.8 17.9 78.3 28.2 59.3 43.9 32.6 34.4 31.7 46.2 44.4 72.2 49.8 41.7 40.6 45.5 45.7 46.2 26.5 49.2 18.8 16.9 35.6 44.2 40.9 76.3 63.6 34.7 91.2 21.4 16.4 82.0 32.7 51.0 33.9 38.3 31.1 39.5 61.5 36.0 42.8 33.3 36.2 40.5 40.0 41.0 21.6 38.0 4.6 6.7 7.0 12.0 7.0 12.5 9.2 4.2 6.1 4.9 7.8 3.7 5.7 20.2 7.6 4.9 14.3 5.8 4.3 12.8 25.5 18.7 20.1 14.7 16.0 18.5 20.6 10.7 19.9 19.0 18.8 45.7 26.1 12.8 21.8 56.5 33.1 15.0 23.9 11.7 25.6 19.5 15.1 8.5 25.0 12.8 25.6 31.3 25.0 17.5 46.1 28.8 5.9 12.8 59.0 26.5 34.6 20.7 12.0 26.5 85.0 16.3 21.2 24.2 33.1 36.1 19.0 17.9 18.2 53.0 15.8 15.2 72.3 16.9 10.2 24.3 26.7 139.7 22.4 31.4 26.6 68.4 30.0 38.2 43.3 79.4 260.0 22.6 23.7 15.4 50.3 25.8 21.1 26.8 23.5 26.0 13.1 21.4 22.0 40.6 25.5 30.4 16.2 46.9 30.8 12.3 11.9 40.6 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.2" "Group enriched" "Detected in many" 5 "Early spermatids: 42.7;Spermatocytes: 52.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 2.2;Karpas-707: 2.6;U-266/70: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.4 0.9 1.2 0.5 1.9 1.5 0.2 2.9 1.2 0.1 0.2 0.1 0.3 0.3 0.7 0.4 0.3 0.4 1.2 0.9 0.9 0.2 0.1 0.2 0.9 0.6 0.6 0.9 0.3 0.8 0.1 0.3 0.2 1.3 0.4 0.2 1.1 0.5 0.0 2.3 0.5 0.2 0.1 0.2 0.7 0.4 8.2 1.2 0.1 0.7 0.8 0.2 0.1 0.2 3.2 0.7 0.5 0.1 0.0 0.1 0.2 0.7 0.2 0.0 0.0 0.0 0.0 1.4 1.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.4 0.6 2.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.2 1.4 0.7 2.6 0.0 0.2 0.5 1.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.4 0.4 0.6 0.1 0.4 0.3 0.2 0.2 0.2 0.4 0.7 0.2 0.5 2.0 1.6 0.1 1.0 0.2 0.8 5.3 0.9 1.8 1.0 0.6 0.5 1.5 0.8 0.7 0.5 1.9 1.0 0.9 4.1 1.0 0.6 2.0 0.6 0.6 1.2 1.9 2.9 1.2 0.9 0.9 0.6 0.6 0.9 1.3 0.2 1.2 3.2 0.6 3.2 2.2 4.6 4.7 2.2 1.8 0.6 7.4 2.4 0.5 0.4 1.7 0.0 0.9 0.0 0.0 0.4 1.6 0.6 0.0 0.1 42.7 1.5 1.3 1.3 0.0 0.8 5.0 0.0 0.2 1.5 0.5 1.8 1.3 0.5 1.4 0.4 0.3 3.3 5.6 0.0 2.0 0.6 1.9 8.2 0.6 1.3 3.6 1.9 0.1 0.9 1.0 3.5 6.1 0.1 0.0 0.4 1.7 1.5 0.1 0.3 0.0 4.1 0.0 3.2 1.1 52.3 3.1 2.6 1.1 0.1 3.1 0.8 0.2 0.8 TP53INP2 "C20orf110, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH" ENSG00000078804 "Tumor protein p53 inducible nuclear protein 2" Q8IXH6 20 34704339-34713439 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 702.0;choroid plexus: 209.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 143.5;Early spermatids: 208.6;Late spermatids: 353.7;Paneth cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.7" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 219.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.33e-2)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (3.08e-2)" "unprognostic (2.07e-1)" "unprognostic (1.86e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-1)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (1.52e-2)" "unprognostic (2.57e-2)" "prognostic favorable (1.26e-8)" "unprognostic (8.03e-2)" "unprognostic (1.68e-1)" "unprognostic (1.93e-2)" "unprognostic (6.17e-2)" 19.8 28.3 478.2 11.2 442.2 90.5 13.9 386.8 350.4 16.4 209.2 40.5 20.1 26.6 15.9 65.3 19.5 24.1 79.6 282.1 406.8 28.1 46.0 19.8 5.7 556.3 481.2 230.7 15.6 16.7 35.4 22.1 10.6 504.9 37.2 38.8 46.3 27.8 31.5 53.6 12.4 23.7 35.1 479.6 6.7 24.6 40.2 430.8 2.9 31.9 94.8 17.4 33.3 24.0 702.0 2.5 3.0 9.8 12.6 22.1 18.1 4.2 9.8 30.9 12.8 10.6 17.3 1.2 7.7 6.6 19.6 25.1 1.9 20.8 4.7 14.0 2.3 2.6 14.0 8.2 16.9 28.6 2.2 10.9 52.3 7.0 10.1 1.4 16.0 20.2 6.9 5.8 24.8 14.5 3.4 1.6 4.8 1.3 2.1 7.4 7.4 6.4 12.4 16.1 8.8 21.4 24.1 8.7 219.0 15.2 11.6 15.8 10.3 15.3 35.0 12.0 4.6 4.1 9.8 12.5 6.2 22.2 31.2 12.5 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 478.2 442.2 386.8 350.4 282.1 406.8 556.3 481.2 230.7 504.9 479.6 430.8 702.0 9.5 3.2 10.6 5.5 8.1 3.7 17.0 11.7 5.7 20.4 17.4 12.3 75.4 15.7 16.7 3.7 52.1 1.7 12.8 143.5 5.9 16.5 208.6 19.6 10.1 10.4 52.4 0.4 4.3 23.9 1.1 9.6 46.9 24.2 7.0 7.5 11.0 28.7 5.3 32.0 6.1 59.5 32.6 10.2 3.6 353.7 7.5 15.5 5.4 2.8 2.6 10.9 0.0 1.0 17.7 24.3 116.1 13.2 7.4 15.3 34.0 8.9 25.1 55.8 19.7 35.9 27.4 4.0 2.7 4.5 3.0 28.5 8.4 9.1 23.9 24.4 SDF4 Cab45 ENSG00000078808 "Stromal cell derived factor 4" Q9BRK5 1 1216909-1232067 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 406.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011249, HPA011895, CAB015227" Supported Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 2600000 "Golgi apparatus" "CAB015227: , HPA011249: AB_2668468, HPA011895: " "unprognostic (1.98e-1)" "prognostic unfavorable (5.89e-4)" "unprognostic (3.63e-1)" "unprognostic (2.38e-3)" "unprognostic (5.88e-2)" "unprognostic (7.95e-3)" "unprognostic (3.73e-3)" "unprognostic (1.06e-1)" "unprognostic (2.01e-1)" "unprognostic (8.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.04e-2)" 87.0 92.5 41.2 79.5 41.7 56.7 80.9 42.2 65.8 84.0 62.9 90.8 118.2 92.6 44.3 66.8 75.2 66.8 125.5 40.8 45.4 89.6 162.0 82.7 53.8 48.3 41.6 35.5 86.2 105.4 62.0 79.1 74.0 45.1 77.6 60.9 25.9 84.2 52.7 79.6 73.3 117.7 58.7 39.4 78.6 94.3 72.2 44.0 35.0 82.5 48.1 39.9 82.9 72.2 45.7 139.7 123.7 67.1 214.0 320.0 160.4 80.5 266.1 241.4 191.2 159.4 147.0 236.2 87.8 201.8 258.0 137.4 140.4 77.5 117.1 58.2 147.9 133.0 153.6 185.7 207.8 147.4 156.7 199.2 199.0 59.5 144.6 81.2 186.5 155.9 57.3 129.2 225.0 95.7 101.1 77.8 158.9 61.7 158.0 167.1 85.8 86.5 234.4 127.2 66.4 243.3 86.7 177.2 208.2 182.8 59.0 108.0 176.7 198.8 196.2 107.0 149.5 154.2 138.9 141.2 144.6 222.9 289.7 87.1 14.4 21.5 30.8 19.3 14.6 14.6 13.5 27.6 28.4 21.9 16.8 16.0 14.1 16.9 26.8 23.2 14.0 25.1 11.8 41.2 41.7 42.2 65.8 40.8 45.4 48.3 41.6 35.5 45.1 39.4 44.0 45.7 92.9 22.4 19.2 18.6 62.5 119.8 74.0 24.6 46.7 34.5 51.2 47.6 35.7 68.6 28.9 49.7 18.8 124.1 68.4 240.0 11.7 79.0 39.1 49.0 76.2 77.8 65.5 32.8 21.1 71.4 284.4 117.1 81.1 60.8 36.2 61.4 76.4 117.1 122.4 38.7 23.5 174.9 30.5 73.7 154.8 36.8 95.4 62.8 167.2 13.1 50.8 64.9 111.2 13.6 17.5 73.0 213.5 76.0 202.5 101.5 406.2 57.7 18.4 40.0 59.2 69.8 75.1 101.7 63.5 53.2 114.2 168.0 73.4 88.7 181.0 71.1 MYH7B "dJ756N5.1, KIAA1512, MHC14, MYH14" ENSG00000078814 "Myosin heavy chain 7B" A7E2Y1 20 34955810-35002437 "Predicted intracellular proteins" "Actin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 251.4;skeletal muscle: 158.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 86.6;Early spermatids: 34.0;Late spermatids: 67.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;U-138 MG: 1.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (4.05e-4)" "unprognostic (1.64e-1)" "unprognostic (1.66e-2)" "unprognostic (2.71e-1)" "unprognostic (5.36e-2)" "unprognostic (1.46e-2)" "unprognostic (3.89e-2)" "unprognostic (5.44e-2)" "unprognostic (4.87e-1)" "unprognostic (4.72e-2)" "unprognostic (4.41e-3)" "unprognostic (1.92e-1)" "unprognostic (1.02e-4)" "unprognostic (8.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.44e-5)" 1.3 1.0 14.1 0.3 16.3 0.5 1.4 10.6 15.5 3.4 6.1 1.7 1.2 1.9 1.3 1.7 2.5 0.6 251.4 10.0 11.3 2.4 2.3 1.4 0.5 14.9 14.5 8.8 4.5 1.1 0.0 3.6 0.2 21.3 4.9 0.1 2.2 2.8 0.4 158.6 1.2 1.4 0.2 10.8 1.4 0.9 29.3 19.5 0.2 3.4 26.9 0.1 1.2 1.7 23.8 0.9 0.3 0.2 0.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 1.6 0.5 0.2 0.6 0.0 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.5 0.6 0.7 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.6 0.0 0.7 0.2 0.5 0.1 0.4 0.1 0.9 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.4 0.1 0.2 0.2 0.2 1.3 0.3 0.4 1.5 0.7 0.2 0.2 0.9 0.1 0.3 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 14.1 16.3 10.6 15.5 10.0 11.3 14.9 14.5 8.8 21.3 10.8 19.5 23.8 0.6 0.0 5.6 7.5 1.1 3.6 1.6 0.1 1.2 16.5 1.2 1.0 86.6 1.5 0.7 5.5 8.4 1.3 0.3 0.5 0.0 0.5 34.0 0.7 1.0 2.1 0.0 0.0 3.4 0.6 0.6 2.2 0.0 1.0 1.3 2.0 1.8 0.2 0.4 10.1 3.8 0.5 0.0 1.6 2.1 67.9 2.1 1.2 0.0 2.8 0.5 4.3 0.0 1.5 17.3 0.6 0.1 3.4 0.6 1.1 0.6 0.6 0.3 14.1 6.6 9.4 2.5 11.0 6.3 0.3 5.4 0.8 0.9 1.5 1.0 0.9 BPIFB2 "BPIL1, C20orf184, dJ726C3.2, LPLUNC2" ENSG00000078898 "BPI fold containing family B member 2" Q8N4F0 20 33007704-33023703 "Plasma proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "salivary gland: 2313.3" "Group enriched" "Detected in some" 4 "Breast glandular cells: 6.1;Breast myoepithelial cells: 9.1;Early spermatids: 4.8;Late spermatids: 9.3;Prostatic glandular cells: 7.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 20.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 582 "Hep G2: 232.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049491, HPA060121" Enhanced Approved Vesicles "Secreted in other tissues" NA NA 36000 Vesicles "HPA049491: AB_2680792, HPA060121: AB_2684207" "unprognostic (1.94e-1)" "prognostic favorable (1.97e-5)" "unprognostic (2.24e-4)" "unprognostic (9.48e-2)" "unprognostic (9.81e-2)" "unprognostic (2.02e-3)" "unprognostic (1.72e-2)" "unprognostic (2.71e-1)" "unprognostic (9.28e-2)" "unprognostic (5.35e-1)" "unprognostic (8.19e-2)" 0.4 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 100.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 1.8 0.0 0.0 2313.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.1 9.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652516-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 6.4;fallopian tube: 6.8;skin 1: 6.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.0 0.0 1.8 0.7 0.8 0.5 0.8 3.9 0.5 1.0 6.4 0.2 0.0 0.1 0.1 3.7 6.8 0.0 0.1 0.8 0.7 0.1 0.2 0.9 1.1 1.8 1.8 0.1 0.1 0.8 0.1 0.3 0.0 1.4 2.7 0.1 0.2 3.0 0.3 0.2 6.6 0.2 0.0 1.6 0.7 0.3 0.7 1.0 1.6 0.2 0.0 1.5 0.1 2.9 1.0 2.6 0.1 0.3 7.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.9 4.0 2.6 2.0 0.0 0.9 4.3 2.7 0.9 0.0 0.8 8.7 0.2 3.9 2.6 0.0 0.0 2.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.8 1.9 15.0 2.0 0.5 0.0 0.1 0.0 11.6 0.1 0.3 3.8 18.0 8.4 0.4 0.0 0.8 0.0 10.9 9.2 0.0 2.9 7.5 0.0 5.8 3.3 0.7 18.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.8 3.9 0.5 0.8 0.7 1.8 1.8 0.1 1.4 1.6 1.0 1.0 0.0 0.0 1.5 0.0 1.2 3.1 3.8 13.0 16.5 0.5 0.2 2.5 1.5 0.0 7.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 21.8 31.0 0.3 0.3 2.4 3.2 0.1 0.2 0.4 0.4 0.0 0.7 0.0 0.1 0.4 0.2 0.3 0.0 0.1 0.5 2.0 0.0 1.3 15.7 0.6 0.1 1.8 0.0 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 6.8 0.2 0.0 0.1 35.8 0.1 0.0 0.0 2.6 0.1 0.4 1.6 2.3 0.3 0.4 0.1 0.3 0.2 TOLLIP IL-1RAcPIP ENSG00000078902 "Toll interacting protein" Q9H0E2 11 1274371-1309654 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 498.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038621, HPA038622" Enhanced Approved Cytosol NA NA 140000 Cytosol "HPA038621: AB_10673177, HPA038622: AB_10675946" "unprognostic (8.39e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (8.89e-2)" "unprognostic (2.51e-1)" "unprognostic (8.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-2)" 27.0 35.7 52.8 12.5 68.0 13.7 26.0 26.6 74.6 28.7 16.2 25.8 25.8 23.7 11.6 94.2 22.6 18.6 30.4 75.3 45.5 43.0 114.2 26.8 14.3 39.7 41.4 70.3 24.8 58.7 19.1 54.6 12.2 46.6 31.6 8.3 11.5 31.9 20.7 76.8 73.6 23.6 11.2 30.6 29.0 32.2 73.9 39.8 13.4 24.9 22.9 14.3 33.8 49.2 57.5 31.4 32.6 16.3 18.6 34.0 21.2 14.2 27.2 24.5 31.3 27.7 35.4 19.5 14.6 25.6 25.3 47.9 27.7 14.7 33.4 8.5 30.1 30.1 11.9 6.9 54.2 48.4 22.8 29.0 32.1 38.5 18.6 17.9 17.1 19.7 21.7 19.9 38.5 26.1 26.3 29.1 27.9 20.0 33.9 42.1 21.8 16.6 14.6 20.9 41.3 43.5 25.5 24.4 29.4 30.7 8.3 23.3 25.7 36.0 33.8 14.4 14.4 16.0 38.8 37.8 18.3 53.2 14.9 27.0 45.4 126.6 139.6 33.4 114.0 27.8 38.8 35.3 31.5 99.9 50.0 27.4 26.1 179.1 44.5 108.8 52.4 48.8 77.3 52.8 68.0 26.6 74.6 75.3 45.5 39.7 41.4 70.3 46.6 30.6 39.8 57.5 19.5 9.6 19.3 15.0 27.8 66.9 43.9 71.7 23.3 42.6 30.3 24.6 22.8 58.6 30.9 23.9 8.4 49.2 28.0 50.8 70.5 66.3 173.6 11.7 14.8 24.9 51.6 45.0 35.1 69.2 41.1 27.6 19.4 15.8 38.1 20.7 37.9 112.2 92.1 74.0 17.0 30.8 48.8 38.4 33.1 498.2 21.8 48.3 71.2 16.9 50.6 38.1 19.6 10.6 15.0 76.3 53.7 30.9 33.4 55.7 66.6 110.1 15.4 20.6 6.6 18.5 24.5 100.7 39.6 76.3 98.9 104.4 22.0 27.4 29.3 74.0 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926436-43956136 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 32.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 30.2" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 5.3 8.4 12.3 2.4 12.6 2.3 5.0 14.7 17.8 4.5 10.3 5.4 2.5 4.5 5.7 5.3 4.5 3.4 9.8 12.9 11.7 7.0 10.8 4.4 2.7 12.7 12.3 11.7 5.1 10.1 4.6 5.1 2.8 13.1 5.8 2.9 7.0 5.7 4.5 32.8 5.0 4.0 4.4 12.7 4.7 4.6 3.0 12.0 2.7 5.0 28.1 2.8 5.3 5.2 13.2 4.9 4.0 2.4 11.0 11.0 4.5 1.8 2.3 5.8 2.9 3.7 2.1 5.6 4.6 6.3 6.3 8.1 5.3 3.1 2.5 4.4 10.5 5.4 5.0 5.8 5.4 4.1 10.9 9.8 3.4 5.2 3.3 5.0 4.2 3.6 5.5 5.6 9.2 4.0 3.0 6.5 6.1 5.4 5.9 5.1 4.0 3.3 7.1 6.2 5.9 8.8 30.2 5.0 9.7 3.8 4.4 4.9 3.3 3.2 1.9 6.0 4.1 6.9 13.5 10.8 2.2 5.7 14.2 10.9 10.2 14.5 17.5 11.1 23.8 11.4 12.8 13.5 12.5 15.1 12.7 16.2 13.4 1.4 9.9 28.7 13.0 12.6 8.8 12.3 12.6 14.7 17.8 12.9 11.7 12.7 12.3 11.7 13.1 12.7 12.0 13.2 14.9 0.0 6.5 8.8 10.4 6.2 9.1 9.4 4.0 9.6 24.3 24.3 24.6 14.3 10.0 16.5 2.1 11.9 11.9 8.4 54.8 18.7 6.2 8.9 7.2 12.9 18.7 9.9 14.2 28.4 20.3 14.9 8.2 8.7 4.5 11.1 12.5 25.4 27.4 11.8 13.5 8.0 8.2 11.6 14.1 10.7 12.2 12.5 16.0 8.4 18.4 18.8 5.2 20.1 12.1 14.1 7.6 21.8 11.2 12.1 15.5 52.0 5.5 11.6 6.6 23.0 10.5 15.6 9.6 10.8 11.2 7.7 8.8 16.5 8.4 12.3 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 35 "retina: 300.5" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 407.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 34.3" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA 11000 "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.2 1.0 2.2 0.5 5.0 3.9 2.3 1.3 4.3 1.5 5.7 0.9 0.5 1.4 0.5 1.2 1.8 2.0 0.3 2.5 2.4 5.4 0.5 1.4 0.8 4.1 2.8 1.7 4.9 1.3 3.7 3.9 0.6 4.4 8.6 0.1 300.5 2.4 1.1 0.2 0.7 1.4 0.1 1.7 0.1 3.2 2.7 3.4 1.8 6.9 0.0 0.1 0.8 0.2 8.3 3.6 5.4 10.1 6.8 0.0 0.0 6.1 3.9 0.3 0.0 0.0 4.2 2.1 4.3 1.0 0.0 3.6 1.5 0.0 0.6 0.0 3.6 9.3 7.3 2.9 34.3 0.0 2.5 1.3 0.3 0.0 0.0 0.0 1.7 0.4 10.5 10.5 12.3 0.0 1.2 4.4 7.8 0.7 4.4 2.4 8.8 4.8 15.5 1.1 1.1 8.8 6.2 4.0 2.5 3.4 8.0 3.3 1.0 0.8 4.0 5.7 2.8 2.0 6.9 13.3 9.7 3.2 4.7 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.3 0.0 2.2 5.0 1.3 4.3 2.5 2.4 4.1 2.8 1.7 4.4 1.7 3.4 8.3 0.1 0.0 2.6 0.3 0.1 0.0 3.8 1.5 2.8 29.6 2.8 5.0 0.2 0.0 1.7 0.0 20.9 0.8 0.0 0.1 1.9 0.4 0.7 2.5 0.3 2.0 0.0 0.0 5.2 0.2 0.1 0.4 0.0 3.2 0.0 3.5 0.0 0.0 0.2 16.8 3.8 0.0 0.0 0.0 0.3 0.8 0.9 0.2 0.0 1.0 0.0 58.1 0.0 0.0 4.9 0.0 0.0 1.2 0.0 5.5 0.0 0.5 2.4 407.5 6.6 0.0 0.3 10.6 8.6 0.2 0.1 0.4 0.1 17.3 0.1 1.6 RUNX1T1 "AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2" ENSG00000079102 "RUNX1 partner transcriptional co-repressor 1" Q06455 8 91954967-92103286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 93.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 142.1;Excitatory neurons: 196.9;Hepatic stellate cells: 124.2;Inhibitory neurons: 326.3;Oligodendrocyte precursor cells: 262.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 4 "cerebellum: 93.3;pons: 29.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 19.6;fHDF/TERT166: 16.5;HEL: 35.9;HSkMC: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049852, HPA070951" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049852: AB_2680914, HPA070951: AB_2686326" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (3.37e-4)" "unprognostic (2.29e-4)" "unprognostic (5.56e-3)" "unprognostic (1.24e-2)" "unprognostic (1.62e-2)" "unprognostic (2.11e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-4)" "unprognostic (8.98e-3)" "unprognostic (6.78e-2)" "unprognostic (1.51e-1)" "unprognostic (7.80e-3)" 6.5 2.8 5.0 2.1 13.6 0.2 5.1 93.3 9.5 8.4 0.8 5.1 1.2 7.5 3.6 2.5 4.7 5.1 8.2 13.6 5.4 1.4 0.7 3.9 1.3 1.6 15.3 5.9 4.7 1.0 1.0 3.0 5.8 29.6 2.5 2.5 5.2 3.1 2.4 3.9 2.3 2.5 6.5 2.1 1.9 2.8 3.7 3.4 0.5 3.7 4.8 1.1 3.8 3.9 4.0 0.0 0.0 0.4 1.9 5.0 7.2 0.0 7.6 11.6 5.0 7.6 0.0 0.0 19.6 0.0 16.5 0.0 0.0 4.0 0.5 3.3 0.0 3.2 35.9 0.0 0.0 1.9 0.0 0.0 13.6 0.0 8.4 0.4 0.0 10.8 0.0 0.1 0.0 1.3 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 11.1 6.0 0.0 0.0 0.0 7.8 0.0 0.0 1.2 0.4 0.0 0.9 0.0 3.8 0.0 6.3 0.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.6 93.3 9.5 13.6 5.4 1.6 15.3 5.9 29.6 2.1 3.4 4.0 44.9 0.0 1.1 90.8 0.1 6.2 0.2 0.0 0.6 142.1 1.2 5.1 46.0 0.0 0.6 0.0 16.7 1.1 0.5 0.2 1.9 0.0 2.6 1.1 65.8 64.3 47.7 2.7 196.9 0.2 0.3 77.7 0.5 1.1 1.3 2.1 124.2 1.5 1.9 35.3 326.3 0.6 0.0 4.1 9.4 7.5 96.3 1.2 10.6 103.0 0.0 3.9 0.0 262.4 17.3 0.2 0.0 98.9 0.0 0.3 0.0 0.1 0.0 7.2 65.7 24.4 43.1 3.3 16.8 0.9 4.8 1.1 1.1 20.7 0.0 0.1 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127162-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 317.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "neutrophil: 16.0" "Lineage enriched" "Detected in single" 17 "granulocytes: 16.0" "Cell line enhanced" "Detected in some" "CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 7500000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.9 0.2 0.7 29.1 0.5 2.7 0.5 0.9 0.8 0.1 1.6 263.3 317.1 1.4 0.8 1.7 0.3 3.1 0.6 0.5 0.2 0.8 0.3 0.2 1.5 0.4 0.3 0.5 0.5 1.7 0.0 0.0 0.2 0.4 1.2 249.0 0.5 0.9 1.6 0.5 0.6 272.9 9.4 0.2 5.5 2.6 0.6 0.2 0.3 0.7 0.1 1.8 0.8 0.1 1.2 0.2 18.5 0.2 0.4 0.0 0.4 1.6 0.2 0.3 0.2 0.3 98.8 3.5 0.3 0.3 0.0 0.1 1.0 0.3 0.3 0.3 0.2 1.1 0.1 0.8 0.6 0.3 0.2 4.3 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.4 1.5 0.1 0.7 0.5 1.3 0.3 430.1 0.5 0.3 0.0 2.8 0.3 0.2 1.3 1.2 0.4 0.4 0.5 0.4 0.7 0.9 0.0 0.6 0.7 1.2 0.5 157.2 0.3 0.2 0.3 0.3 0.6 2.9 0.9 1.4 0.2 0.8 0.1 0.3 0.2 0.1 0.5 0.8 0.2 0.3 16.0 0.7 0.5 0.4 0.2 0.2 0.7 0.5 0.9 0.8 0.5 0.2 0.4 0.3 0.5 0.4 0.2 0.2 1.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 569.4 0.0 0.3 1.0 0.0 0.0 0.0 108.4 0.0 0.5 0.0 0.0 0.1 2.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 183.7 0.0 0.0 0.5 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 408.6 0.0 0.2 0.0 336.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 2.1 0.0 241.6 0.1 THOC1 "HPR1, P84" ENSG00000079134 "THO complex 1" Q96FV9 18 214520-268050 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019096, HPA019687" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA019096: AB_1857979, HPA019687: AB_1857980" "prognostic favorable (8.43e-4)" "unprognostic (2.06e-3)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" "unprognostic (8.75e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (6.74e-3)" "unprognostic (2.49e-3)" "prognostic favorable (2.89e-5)" "unprognostic (3.60e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.03e-1)" "unprognostic (2.24e-1)" "unprognostic (3.42e-1)" "prognostic favorable (9.62e-4)" 6.0 5.2 9.0 8.1 10.0 7.6 5.8 10.3 12.3 5.6 9.9 6.7 6.3 4.7 4.5 6.6 4.1 4.6 4.4 9.1 9.5 6.7 10.0 4.6 12.4 9.7 9.3 8.6 4.8 3.9 6.7 3.7 6.4 10.1 5.1 5.5 5.9 7.0 4.2 6.2 6.3 6.0 5.8 9.4 6.4 5.3 16.9 9.3 13.0 4.7 6.2 11.7 9.6 3.8 10.9 27.0 15.8 32.4 26.1 20.8 15.4 40.2 15.4 14.5 29.8 31.1 30.8 16.1 37.2 11.9 20.0 46.0 17.1 43.0 24.4 36.9 12.3 19.1 22.2 18.4 21.0 16.0 50.5 20.2 10.6 14.4 33.3 21.8 13.6 33.3 34.5 52.3 17.4 27.3 20.5 38.1 29.6 31.5 34.2 21.1 53.3 30.3 33.4 17.2 26.1 21.2 16.6 39.0 19.9 25.3 36.7 14.0 37.1 16.6 26.6 29.9 21.8 48.3 15.9 26.4 54.7 22.2 36.0 22.8 13.4 7.3 6.4 9.8 10.7 14.8 13.3 11.7 12.4 11.9 11.5 13.5 13.4 0.7 11.2 9.4 7.2 12.8 6.6 9.0 10.0 10.3 12.3 9.1 9.5 9.7 9.3 8.6 10.1 9.4 9.3 10.9 20.4 19.2 11.7 48.3 21.0 12.9 15.6 16.8 23.9 30.8 13.1 14.1 9.6 2.8 17.9 11.0 20.9 24.7 23.2 6.0 15.6 16.5 67.1 15.0 23.6 16.7 9.5 21.0 45.3 8.2 16.7 19.9 9.2 21.9 27.3 32.4 8.2 10.3 16.1 28.6 51.6 8.7 10.2 6.9 11.1 11.6 19.3 15.0 3.6 32.8 14.3 12.9 10.3 41.7 74.6 12.7 7.0 17.0 15.6 16.7 9.2 10.2 10.5 27.6 6.6 21.6 22.9 73.4 30.5 13.8 9.1 18.7 22.3 17.7 13.4 12.9 FKBP7 FKBP23 ENSG00000079150 "FKBP prolyl isomerase 7" Q9Y680 2 178463664-178478600 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.4" "Cell type enhanced" "Detected in many" "Early spermatids: 149.1;Endometrial stromal cells: 54.8;Fibroblasts: 67.6;Leydig cells: 64.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 155.0;ASC TERT1: 96.7;fHDF/TERT166: 60.9;HSkMC: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008707 Approved Supported Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA008707: AB_1848624" "unprognostic (1.33e-1)" "unprognostic (1.89e-2)" "unprognostic (1.43e-1)" "unprognostic (1.67e-1)" "unprognostic (5.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.34e-2)" "unprognostic (1.83e-2)" "unprognostic (6.05e-2)" "unprognostic (8.96e-3)" "prognostic unfavorable (4.61e-6)" "unprognostic (3.50e-3)" "unprognostic (1.34e-2)" "unprognostic (4.19e-3)" "unprognostic (1.10e-1)" 9.1 5.4 1.5 3.9 1.6 1.4 12.0 2.7 2.9 23.3 1.7 7.2 2.8 28.0 11.4 6.0 15.2 15.5 10.9 1.6 1.4 5.2 8.3 7.9 2.9 1.7 1.5 1.4 50.4 2.8 2.8 5.1 13.1 1.7 9.4 6.3 2.1 5.1 13.5 3.8 3.8 4.4 19.4 1.1 3.1 5.5 4.5 1.4 2.6 6.7 6.5 2.8 11.7 10.3 2.1 0.2 1.9 18.5 27.8 155.0 96.7 1.7 33.3 55.0 5.9 19.0 0.3 1.9 5.4 7.3 60.9 5.5 0.3 7.1 2.8 10.3 4.5 3.9 5.7 7.3 5.5 23.7 3.5 3.8 64.7 1.4 24.0 3.4 44.2 19.8 6.6 2.5 3.4 25.2 0.3 6.1 6.0 3.6 3.5 2.9 7.8 31.9 7.7 8.4 0.6 9.7 32.0 7.0 0.2 6.2 12.7 0.5 6.8 18.2 11.0 6.8 12.8 3.2 6.3 7.2 2.6 19.9 8.7 24.3 0.0 0.4 0.0 1.0 0.7 1.2 1.1 0.9 0.7 2.6 0.7 0.9 1.0 0.0 0.6 0.0 2.1 1.1 0.4 1.5 1.6 2.7 2.9 1.6 1.4 1.7 1.5 1.4 1.7 1.1 1.4 2.1 16.2 6.4 4.1 2.9 5.4 7.0 9.3 19.6 7.4 4.2 6.7 13.6 16.1 2.8 5.2 7.3 0.0 7.6 2.7 0.7 1.9 10.9 149.1 3.4 54.8 19.3 1.2 4.2 1.6 8.4 22.4 67.6 4.1 3.5 14.0 19.0 15.7 11.9 5.8 5.0 3.7 5.6 14.2 4.4 13.6 27.1 64.0 3.8 17.8 4.7 1.6 4.2 1.0 7.1 4.2 3.9 0.7 48.5 10.3 3.4 0.4 3.7 2.1 3.6 6.6 31.1 37.7 8.5 5.1 3.7 5.8 5.1 5.5 30.4 3.1 4.1 OSBPL6 ORP6 ENSG00000079156 "Oxysterol binding protein like 6" Q9BZF3 2 178194481-178402893 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 34.0;tongue: 20.5" "Cell type enhanced" "Detected in many" "Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2" "Cancer enhanced" "Detected in many" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.8;hTERT-HME1: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032131 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA032131: AB_10670963" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "unprognostic (2.47e-1)" "unprognostic (5.95e-3)" "unprognostic (5.26e-2)" "unprognostic (1.40e-2)" "unprognostic (7.55e-2)" "unprognostic (4.81e-2)" "unprognostic (3.32e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.49e-2)" "unprognostic (1.15e-5)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (3.73e-4)" "unprognostic (4.44e-6)" 1.3 1.5 4.1 1.0 6.1 0.2 1.7 4.6 16.5 0.8 0.0 0.9 0.7 0.8 0.7 2.4 1.0 1.1 3.9 6.2 7.6 2.7 5.6 4.0 1.1 5.6 6.0 4.3 1.4 1.2 0.8 6.7 0.6 7.5 3.1 1.0 8.5 2.2 1.5 34.0 8.8 3.6 1.4 1.1 1.0 0.8 1.3 7.4 1.6 2.4 20.5 0.8 1.0 1.5 8.5 0.0 1.1 8.3 16.9 6.8 7.5 6.3 13.9 7.2 12.0 14.6 1.4 0.2 0.0 0.5 12.9 6.6 0.3 19.6 11.4 20.2 0.2 10.2 48.8 2.9 0.0 4.4 8.0 0.3 5.0 17.6 26.4 50.8 4.3 5.8 6.2 0.9 5.8 15.9 7.0 0.1 0.0 10.0 0.0 10.2 0.0 16.9 3.2 0.9 0.0 6.3 3.8 6.2 1.8 13.7 9.2 2.4 0.1 11.4 13.7 8.5 9.3 16.3 31.8 13.4 0.0 16.3 0.0 6.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.1 6.1 4.6 16.5 6.2 7.6 5.6 6.0 4.3 7.5 1.1 7.4 8.5 0.7 0.0 7.2 281.4 0.0 13.3 2.1 1.3 7.4 59.4 2.1 1.7 15.2 4.3 6.5 0.0 25.0 0.2 0.0 0.1 1.9 0.6 1.0 4.4 1.0 1.7 1.8 0.0 314.2 0.8 4.9 4.3 0.0 0.4 7.0 2.0 0.0 6.2 3.9 1.7 404.2 6.0 4.1 3.5 1.0 1.1 0.0 0.7 5.4 62.8 0.0 10.6 0.0 134.2 10.3 0.2 0.0 1.5 1.5 2.2 9.5 6.2 78.2 6.9 0.0 25.4 5.8 0.1 2.1 6.4 20.9 0.1 0.9 14.5 1.4 0.5 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36596588-36688334 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 15 "brain: 783.1;choroid plexus: 407.5;retina: 223.0" "Cell type enhanced" "Detected in many" "Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6" "Group enriched" "Detected in many" 16 "dendritic cells: 1.6;monocytes: 1.5" "Cell line enhanced" "Detected in many" "AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 30.3 16.6 511.7 7.4 515.4 3.4 17.9 554.6 783.1 8.8 407.5 3.0 0.5 1.6 1.1 10.6 6.1 8.0 30.4 518.7 531.4 2.2 3.8 10.3 17.5 493.6 485.6 505.6 12.7 5.1 2.2 18.3 20.5 489.6 3.2 1.1 223.0 4.7 4.7 14.2 6.1 3.2 4.1 500.0 9.4 2.3 1.2 509.2 3.6 3.4 9.3 5.4 7.0 5.3 504.5 1.3 0.2 50.0 5.3 5.9 14.3 37.7 0.3 0.0 2.4 4.9 112.6 5.6 0.0 27.8 2.3 1.0 71.4 16.9 9.1 2.2 1.8 33.0 0.0 0.5 0.0 2.5 1.3 0.6 26.9 34.5 14.4 5.3 1.8 0.0 1.1 0.0 0.2 8.7 0.2 0.1 0.1 6.0 0.1 5.9 0.0 0.5 0.0 0.1 3.1 4.7 0.0 5.1 14.6 2.1 24.4 0.2 3.1 0.0 6.2 10.3 0.1 20.7 0.0 0.0 0.3 21.7 37.7 12.6 0.0 1.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 511.7 515.4 554.6 783.1 518.7 531.4 493.6 485.6 505.6 489.6 500.0 509.2 504.5 1.1 3.2 0.5 1735.2 0.7 10.7 14.3 19.0 83.1 7.1 3.7 3.4 36.0 0.0 3.1 0.0 2.1 32.9 0.1 0.0 0.0 0.8 0.7 16.3 1.2 8.9 0.0 0.8 2.6 0.0 15.9 7.8 2.0 11.7 0.0 0.2 1.1 0.5 41.2 3.3 4.7 0.0 0.0 77.6 5.9 4.1 4.4 59.6 7.2 332.6 3.3 472.6 0.0 237.7 249.0 0.3 0.0 0.0 0.7 5.2 0.0 0.0 5.3 19.1 6.6 2.6 3.1 0.3 0.3 32.7 7.1 9.2 1.0 20.7 0.0 3.6 XRCC5 "KARP-1, KU80, Ku86, KUB2" ENSG00000079246 "X-ray repair cross complementing 5" P13010 2 216107464-216206303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004468, HPA025813, HPA064685" Supported Enhanced Nucleoplasm NA NA 940000 Nucleoplasm "CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322" "unprognostic (4.23e-2)" "unprognostic (1.75e-1)" "unprognostic (9.07e-3)" "unprognostic (3.44e-3)" "unprognostic (2.44e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.10e-7)" "unprognostic (4.42e-3)" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (3.38e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-1)" "unprognostic (2.88e-2)" "unprognostic (3.58e-2)" "unprognostic (6.01e-2)" 80.3 74.7 55.7 103.3 62.9 113.0 115.8 60.2 70.5 97.2 44.2 91.8 82.9 104.3 86.0 97.7 96.7 83.9 77.8 60.4 60.8 101.2 141.7 77.3 128.8 56.3 57.0 55.8 104.9 72.4 119.4 61.8 87.8 57.6 85.4 107.7 102.9 72.3 92.1 103.9 92.4 83.0 101.0 58.1 84.6 77.7 70.1 55.0 178.4 130.4 93.5 142.0 133.0 73.3 69.0 234.4 194.9 427.0 230.5 185.5 210.9 256.6 269.9 279.2 307.1 328.5 421.0 225.7 225.6 214.8 239.1 269.2 203.5 425.2 329.5 469.7 215.0 291.0 488.5 282.9 398.0 229.2 437.1 230.0 193.5 172.1 361.2 156.6 218.4 368.0 272.1 314.4 199.7 405.9 225.9 496.7 221.7 498.0 236.0 170.6 429.8 376.7 186.5 331.9 262.6 372.6 314.6 217.8 159.9 201.1 428.5 196.7 325.8 264.2 287.3 241.5 190.6 312.3 240.0 311.4 493.6 223.4 339.5 290.0 253.2 172.7 175.0 153.6 177.1 165.3 121.2 148.1 157.0 168.0 121.6 147.6 149.1 192.7 172.9 217.4 102.1 167.5 330.4 55.7 62.9 60.2 70.5 60.4 60.8 56.3 57.0 55.8 57.6 58.1 55.0 69.0 129.0 105.8 126.3 65.6 131.0 113.7 174.0 242.4 90.5 136.7 93.6 87.1 163.0 105.8 190.0 101.2 45.9 210.5 141.6 79.8 97.8 304.3 103.0 147.4 175.4 142.4 133.3 159.4 73.9 235.8 238.8 134.1 74.5 159.1 146.7 140.2 82.8 222.5 157.3 89.2 82.4 90.7 173.0 100.5 85.3 30.0 101.5 130.7 69.4 108.7 310.9 142.0 138.0 93.0 111.4 247.9 70.3 129.4 132.5 137.4 82.8 139.9 160.1 114.0 111.7 142.9 161.3 252.2 179.2 114.7 120.3 165.5 149.7 165.3 112.0 161.2 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672648 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 98.6" "Cell type enhanced" "Detected in many" "granulocytes: 123.0;Respiratory ciliated cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "hTERT-RPE1: 1196.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Enhanced Approved Nucleoplasm,Cytosol No NA 4700000 "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 34.6 47.4 3.4 21.7 5.8 27.4 22.6 6.6 4.5 20.5 12.5 42.4 30.6 13.8 23.9 10.0 34.6 40.9 15.3 4.1 5.4 18.0 5.6 26.6 18.8 4.1 3.8 3.0 50.2 14.2 14.1 16.1 22.2 4.1 37.2 44.4 3.7 42.8 18.1 5.5 12.5 26.3 23.1 3.2 10.3 15.1 4.5 5.3 13.9 18.5 7.9 14.4 98.6 14.6 4.0 0.1 40.7 3.1 0.5 17.0 58.2 3.4 31.3 80.4 7.6 15.2 0.1 91.3 0.3 28.2 8.7 0.2 14.1 8.1 12.7 11.2 0.1 40.2 19.6 33.0 0.4 19.5 5.0 0.5 131.5 2.3 14.5 2.4 1196.4 296.5 0.1 0.3 0.9 0.0 167.0 2.1 0.0 3.6 7.3 10.5 5.5 0.0 40.0 27.6 113.4 5.1 0.1 0.0 42.5 10.4 9.4 0.3 0.1 42.8 0.3 0.3 42.3 0.1 0.6 0.0 0.2 14.8 1.6 0.5 28.8 5.8 8.6 5.6 5.8 5.8 10.3 11.7 9.3 7.3 6.9 12.9 7.2 36.7 9.8 3.6 7.6 29.8 6.5 3.4 5.8 6.6 4.5 4.1 5.4 4.1 3.8 3.0 4.1 3.2 5.3 4.0 71.0 16.0 9.2 0.3 4.4 5.6 84.1 27.0 4.6 0.3 17.3 21.2 3.8 11.5 38.7 16.5 4.2 13.4 5.5 34.1 15.6 18.5 3.9 20.7 16.5 88.5 35.2 86.3 0.5 26.4 16.2 28.8 6.1 7.6 123.0 3.6 77.8 0.8 22.9 0.0 0.3 73.1 22.4 6.3 18.1 7.9 8.4 8.0 19.6 4.7 17.7 8.9 6.2 0.0 0.3 15.1 58.4 2.6 2.8 49.8 48.6 15.5 120.3 1.2 13.1 1.3 29.4 0.9 10.8 8.6 8.2 4.0 6.5 5.9 30.8 77.0 SP140 "LYSP100-A, LYSP100-B" ENSG00000079263 "SP140 nuclear body protein" Q13342 2 230203110-230313215 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 15.7;lymphoid tissue: 56.3" "Cell type enhanced" "Detected in many" "B-cells: 149.9;dendritic cells: 37.4;NK-cells: 50.4;Plasma cells: 77.2;T-cells: 62.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory B-cell: 97.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 31.1;HDLM-2: 52.4;Karpas-707: 25.2;RPMI-8226: 16.3" "Low region specificity" "Detected in all" "HPA006162, HPA067493" Enhanced Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" Mitochondria "HPA006162: AB_1857403, HPA067493: AB_2685851" "unprognostic (8.15e-3)" "unprognostic (2.25e-3)" "unprognostic (3.90e-3)" "unprognostic (5.72e-4)" "unprognostic (5.66e-2)" "unprognostic (3.33e-4)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (6.05e-2)" "unprognostic (1.12e-3)" "unprognostic (3.89e-2)" "unprognostic (2.88e-1)" "unprognostic (1.20e-9)" "unprognostic (9.12e-2)" "unprognostic (8.50e-2)" "unprognostic (3.66e-1)" "unprognostic (9.30e-3)" 1.3 0.8 0.8 25.2 1.0 6.7 1.2 0.9 1.6 0.6 1.1 3.5 3.0 0.9 0.8 0.9 0.7 2.9 0.6 0.8 1.4 0.9 1.6 4.5 55.1 1.5 1.1 0.5 0.4 0.3 0.2 0.7 1.2 1.6 0.9 3.9 1.0 2.7 0.5 0.2 1.6 15.7 1.0 1.3 28.1 5.2 1.5 1.8 6.9 1.3 0.1 56.3 4.3 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 2.4 0.0 0.3 31.1 0.0 0.0 5.2 0.0 0.0 0.1 1.8 52.4 0.0 0.0 0.0 0.6 0.2 4.4 0.1 0.5 0.0 0.5 0.6 0.4 0.0 0.3 0.0 25.2 0.6 0.0 0.0 1.5 1.3 0.0 0.0 0.1 2.8 16.3 8.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.1 0.3 1.3 0.0 0.0 9.2 4.0 1.1 2.2 0.7 0.0 0.1 3.5 12.0 23.1 7.3 25.6 97.5 22.8 25.3 8.3 71.0 11.5 15.0 33.4 15.1 10.6 0.5 22.5 10.6 0.8 1.0 0.9 1.6 0.8 1.4 1.5 1.1 0.5 1.6 1.3 1.8 1.9 1.6 0.0 2.3 3.9 149.9 0.9 0.0 0.2 0.0 0.7 0.3 0.5 0.5 0.0 0.8 0.0 8.4 0.1 37.4 0.1 0.0 0.0 17.2 0.5 0.2 1.1 0.0 9.7 5.0 0.0 0.2 0.8 1.5 0.1 0.0 0.2 2.2 0.9 11.4 0.0 5.0 0.1 0.0 8.4 8.6 4.8 0.0 13.2 7.2 26.2 13.7 0.5 50.4 2.5 2.8 0.1 0.1 1.2 77.2 0.1 0.0 0.4 2.4 1.7 0.0 0.2 1.0 1.2 0.4 0.7 1.1 0.3 62.1 0.3 0.2 0.2 MKNK1 MNK1 ENSG00000079277 "MAPK interacting serine/threonine kinase 1" Q9BUB5 1 46557407-46616843 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 129.6" "Cell type enhanced" "Detected in all" "Hofbauer cells: 142.8;Microglial cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB027355, CAB037310, HPA071293" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382" "unprognostic (4.05e-3)" "prognostic favorable (7.05e-4)" "unprognostic (5.28e-2)" "unprognostic (3.47e-2)" "unprognostic (1.64e-1)" "unprognostic (7.38e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.50e-2)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (7.02e-2)" "unprognostic (3.19e-2)" "unprognostic (4.67e-1)" "unprognostic (5.67e-3)" 29.7 22.0 14.6 23.7 13.4 30.6 23.3 17.2 18.1 21.7 15.7 26.2 15.7 18.6 12.1 23.7 21.6 16.3 21.4 14.1 14.5 17.6 22.0 31.8 17.1 13.4 12.5 13.2 19.2 129.6 12.1 18.5 22.3 14.5 19.6 17.9 3.9 16.8 8.6 24.1 18.0 25.1 18.5 13.1 48.5 23.2 12.5 13.1 22.8 16.3 24.2 14.0 20.3 20.9 14.8 34.1 21.7 13.5 15.7 12.0 17.9 18.0 16.7 16.4 20.7 27.1 26.4 13.5 23.1 20.2 17.8 23.0 38.5 23.8 27.5 23.1 37.7 21.4 47.8 28.3 21.7 17.3 25.4 34.8 22.0 17.7 25.2 13.4 10.8 24.1 26.2 24.7 16.6 12.2 21.5 18.3 21.8 9.9 19.6 24.8 16.7 30.5 22.1 20.2 35.2 10.4 9.0 32.3 27.9 25.6 26.5 21.5 28.6 18.5 7.6 1.4 22.2 19.9 12.6 23.7 21.2 14.6 31.9 13.4 9.7 26.3 36.1 15.3 25.7 44.7 9.9 12.9 14.2 13.1 11.6 9.2 13.9 69.7 11.2 20.6 9.7 10.6 14.5 14.6 13.4 17.2 18.1 14.1 14.5 13.4 12.5 13.2 14.5 13.1 13.1 14.8 20.3 12.8 21.5 41.4 15.3 13.9 17.8 15.2 9.1 19.4 17.8 12.3 19.2 15.7 17.8 22.0 2.1 21.6 23.7 27.9 7.9 18.9 15.5 12.5 12.8 18.3 16.8 21.9 42.2 37.1 34.2 20.5 11.7 13.3 12.0 22.8 18.2 22.7 142.8 18.5 52.7 12.0 4.1 84.5 61.0 23.8 21.5 49.9 10.6 100.2 26.7 5.2 21.6 21.6 8.5 32.3 17.7 36.5 13.3 19.5 27.8 15.7 11.1 5.0 6.6 31.2 15.0 15.3 17.2 22.6 11.1 18.5 25.2 35.1 15.0 29.6 TNS1 "DKFZp586K0617, MXRA6, PPP1R155, TNS" ENSG00000079308 "Tensin 1" Q9HBL0 2 217799588-218033982 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 173.1;Cardiomyocytes: 339.0;Leydig cells: 169.6;Peritubular cells: 504.0;Sertoli cells: 368.1;Smooth muscle cells: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 135.1;ASC TERT1: 74.1;fHDF/TERT166: 66.6;REH: 75.4;TIME: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018774, HPA036089, HPA036090" Approved Enhanced "Focal adhesion sites" NA NA 47000 "Focal adhesion sites" "CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.13e-2)" "unprognostic (5.46e-2)" "unprognostic (2.63e-2)" "unprognostic (1.20e-3)" "unprognostic (7.34e-2)" "unprognostic (2.55e-2)" "unprognostic (1.28e-3)" "unprognostic (5.57e-2)" "unprognostic (9.74e-2)" "unprognostic (4.71e-3)" "unprognostic (5.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.49e-2)" "prognostic unfavorable (5.19e-4)" 250.5 60.8 60.1 43.3 82.7 42.7 101.8 71.0 36.6 99.2 52.0 266.0 23.6 255.8 44.7 118.9 137.4 81.1 154.8 33.3 50.1 75.3 39.9 118.2 11.6 79.6 75.4 11.6 111.4 55.7 33.5 15.5 55.0 151.8 127.2 42.1 7.7 53.3 227.2 173.0 40.1 79.6 179.5 73.4 70.7 116.1 23.7 70.2 21.7 66.4 209.0 7.5 230.3 83.3 80.8 0.3 0.4 8.9 0.1 135.1 74.1 0.8 22.9 7.8 1.3 0.9 10.0 0.1 0.0 13.1 66.6 1.5 1.7 1.4 1.3 0.7 9.4 0.8 19.8 5.7 2.6 9.8 0.1 2.3 35.2 0.0 24.4 0.2 43.6 32.2 0.1 0.6 2.6 18.8 4.4 0.1 1.4 0.9 0.2 0.4 75.4 16.8 1.0 4.8 0.2 2.1 10.1 3.9 9.7 2.0 6.1 3.1 8.5 63.2 16.6 29.5 17.5 4.9 1.1 0.1 0.1 9.8 2.7 1.2 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.8 60.1 82.7 71.0 36.6 33.3 50.1 79.6 75.4 11.6 151.8 73.4 70.2 80.8 93.3 173.1 85.9 29.7 1.1 16.2 48.6 29.5 42.1 4.8 7.2 21.2 339.0 38.6 27.5 14.7 0.0 8.7 0.5 0.1 7.9 36.1 2.2 3.0 29.5 76.6 0.0 143.1 3.9 19.1 1.5 52.4 1.1 3.8 30.4 8.8 71.7 38.5 13.0 42.1 5.3 0.0 6.1 15.3 19.3 11.9 169.6 16.7 10.6 32.8 1.3 14.1 0.0 15.6 52.0 17.0 0.0 504.0 0.4 12.1 0.0 26.1 22.3 1.3 368.1 29.7 183.5 1.1 1.9 5.7 11.8 1.9 4.1 20.7 0.2 17.3 REXO1 "EloA-BP1, KIAA1138, TCEB3BP1" ENSG00000079313 "RNA exonuclease 1 homolog" Q8N1G1 19 1815248-1848483 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 161.2;Late spermatids: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042155, HPA042552" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA042155: AB_10806233, HPA042552: AB_10794280" "unprognostic (1.36e-1)" "unprognostic (3.86e-3)" "unprognostic (7.52e-2)" "unprognostic (3.70e-3)" "unprognostic (4.21e-2)" "unprognostic (2.38e-3)" "unprognostic (7.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-3)" "unprognostic (3.75e-2)" "unprognostic (2.87e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-2)" 12.8 28.0 14.4 10.4 16.9 19.1 12.8 1.4 18.0 10.6 0.0 14.1 10.0 14.1 2.6 12.9 11.8 6.3 11.5 15.7 1.9 12.2 16.5 12.6 13.2 4.3 2.2 10.6 13.6 13.5 5.7 9.6 10.1 7.5 11.8 4.3 4.8 10.6 5.2 16.4 18.3 14.1 4.5 0.6 23.8 12.3 30.3 4.7 9.3 11.5 6.3 5.7 12.5 11.0 7.8 20.8 13.1 11.8 18.4 4.6 6.0 23.7 14.7 7.8 10.5 9.4 17.1 11.2 17.6 9.7 10.3 6.8 17.9 9.0 16.5 4.6 28.2 13.8 18.6 15.3 10.1 10.4 16.5 29.3 10.6 9.3 13.9 9.2 6.0 9.7 24.8 28.4 29.8 5.5 13.0 27.5 18.6 26.6 8.3 12.8 24.3 9.8 16.7 7.0 11.6 17.3 19.0 9.2 15.3 19.3 7.8 13.4 24.1 16.9 16.6 14.3 27.9 24.8 47.9 24.8 15.1 13.3 19.7 21.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 14.4 16.9 1.4 18.0 15.7 1.9 4.3 2.2 10.6 7.5 0.6 4.7 7.8 17.1 0.0 5.9 7.2 12.6 15.9 8.0 6.9 14.2 19.5 11.3 9.1 1.3 5.7 7.3 18.4 8.4 21.9 20.8 27.9 1.9 7.3 161.2 14.2 13.8 13.2 18.4 10.8 7.9 8.5 10.6 9.7 23.4 23.8 5.7 20.1 13.2 14.2 11.0 47.1 6.2 16.4 2.0 8.8 10.5 214.3 7.5 12.7 7.2 10.3 7.3 7.3 11.3 6.6 6.9 14.0 17.2 7.5 15.9 11.8 11.4 8.7 3.9 20.0 0.0 15.1 10.2 14.8 18.3 17.9 16.8 20.5 14.6 33.7 18.9 12.0 SAR1A "SAR1, Sara, SARA1" ENSG00000079332 "Secretion associated Ras related GTPase 1A" Q9NR31 10 70147289-70170523 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006923, CAB022545, HPA048368" Supported Supported "Endoplasmic reticulum" NA NA 660000 "Endoplasmic reticulum" "CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373" "unprognostic (3.77e-2)" "unprognostic (7.13e-2)" "unprognostic (3.08e-3)" "unprognostic (3.13e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (7.00e-5)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.60e-2)" "unprognostic (1.00e-1)" "unprognostic (1.02e-2)" "unprognostic (4.06e-2)" "unprognostic (2.06e-1)" "unprognostic (2.38e-3)" "unprognostic (1.76e-1)" "unprognostic (4.80e-2)" "unprognostic (1.10e-2)" "unprognostic (7.13e-2)" 77.8 53.3 43.4 38.7 44.6 164.7 48.5 46.6 46.9 43.5 54.0 37.5 26.8 41.3 47.4 41.7 37.7 35.3 44.2 44.3 51.2 43.7 70.8 51.8 37.0 44.9 46.8 41.5 41.3 34.1 44.5 38.2 76.6 44.8 39.2 35.8 42.3 40.2 39.3 51.5 38.0 34.8 50.1 49.2 41.0 38.2 23.7 46.9 33.5 40.2 56.8 38.7 46.3 36.5 53.5 85.8 56.3 75.7 131.9 246.1 143.1 61.1 128.3 154.4 115.6 140.0 169.7 78.2 74.4 67.1 153.7 52.8 96.6 94.5 75.9 111.6 103.9 44.3 54.1 65.8 82.5 112.4 86.7 56.6 155.9 68.4 76.4 133.2 119.0 63.8 55.9 68.7 105.9 110.0 60.0 73.8 72.6 65.2 55.6 141.3 70.8 84.4 42.5 88.7 69.7 42.6 73.8 98.0 134.6 72.2 66.8 65.8 59.7 88.6 63.7 94.3 92.2 91.3 72.3 141.3 114.0 84.9 111.7 48.7 75.5 63.5 74.0 88.0 80.9 94.8 47.7 68.5 85.9 58.5 38.6 65.7 88.7 67.9 103.3 72.9 44.8 53.2 95.9 43.4 44.6 46.6 46.9 44.3 51.2 44.9 46.8 41.5 44.8 49.2 46.9 53.5 88.4 128.2 110.2 6.8 53.5 235.7 138.0 120.2 25.0 38.6 99.2 62.4 74.7 57.2 105.3 49.7 33.3 120.6 109.8 51.6 54.8 78.4 3.0 52.3 85.8 85.2 42.7 46.1 21.2 77.3 199.0 127.8 23.9 89.7 53.2 46.3 69.7 114.1 101.0 26.9 22.2 72.1 65.1 51.2 208.9 5.6 54.7 68.1 113.8 21.5 58.4 61.9 75.2 16.1 26.4 78.8 56.2 58.6 97.7 141.4 59.1 95.9 67.1 33.4 78.9 73.7 158.8 64.1 51.8 37.2 248.8 238.9 86.3 45.2 53.2 175.2 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520277 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.4" "Cell type enhanced" "Detected in many" "Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 3.7 1.5 3.9 4.7 3.2 15.6 11.4 3.0 4.2 5.4 5.0 6.0 7.4 5.3 2.7 2.3 13.1 3.3 2.2 4.0 10.0 6.3 1.8 6.0 7.2 4.4 4.1 2.2 4.7 2.0 6.0 3.6 5.1 3.3 7.6 6.1 5.5 3.4 3.0 2.6 3.6 10.8 4.7 3.6 6.8 5.9 28.4 3.8 6.5 5.9 2.8 4.4 4.4 3.3 3.4 3.3 2.6 8.1 9.3 2.9 2.1 5.7 4.1 2.7 3.9 3.1 8.9 2.7 1.6 3.0 2.4 3.2 2.5 5.6 2.3 4.0 3.4 13.7 5.8 2.3 2.9 1.1 7.8 9.8 1.8 0.6 4.3 1.4 2.0 7.0 3.3 44.7 4.8 5.8 1.4 6.3 8.7 5.1 2.1 3.3 6.8 10.6 1.7 2.8 7.2 1.5 2.7 4.3 4.1 5.6 3.9 1.9 10.0 3.1 2.2 4.9 3.8 2.5 2.4 0.9 2.5 2.7 7.3 1.3 12.2 3.6 9.0 6.9 3.3 12.5 4.5 10.9 8.2 3.5 2.9 10.2 5.5 5.4 4.4 2.3 6.2 6.0 4.1 3.9 3.2 3.0 4.2 4.0 10.0 4.4 4.1 2.2 3.3 3.6 3.8 3.4 14.1 3.2 5.5 145.9 10.6 3.7 4.5 1.7 4.6 0.4 15.8 11.0 6.6 0.0 4.4 1.8 4.2 2.7 23.2 18.4 0.0 3.0 171.5 48.3 11.8 13.5 4.8 3.8 4.3 1.9 1.0 7.0 6.6 51.1 15.2 4.8 7.1 1.0 2.8 0.0 1.4 4.0 2.0 5.5 7.3 191.7 5.0 11.1 5.4 51.5 9.3 11.4 6.2 53.8 3.6 3.1 11.2 0.7 13.5 5.2 22.9 2.5 22.5 3.8 0.0 6.2 6.0 2.3 3.6 4.9 2.4 2.2 44.1 3.0 3.7 4.1 RAPGEF3 "bcm910, cAMP-GEFI, EPAC" ENSG00000079337 "Rap guanine nucleotide exchange factor 3" O95398 12 47734363-47771040 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004386, HPA040365, HPA043518" Approved Uncertain "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524" "unprognostic (2.12e-1)" "unprognostic (2.88e-2)" "unprognostic (2.99e-2)" "unprognostic (1.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-4)" "unprognostic (9.35e-2)" "unprognostic (1.25e-2)" "unprognostic (5.32e-3)" "unprognostic (4.67e-2)" "unprognostic (4.37e-2)" "prognostic favorable (6.67e-7)" "unprognostic (9.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.61e-3)" "unprognostic (3.38e-2)" 41.9 2.8 27.2 2.6 32.2 1.4 44.4 28.9 29.4 25.5 12.0 9.2 4.1 16.5 6.9 13.3 24.3 13.3 16.7 27.9 21.4 40.0 1.9 12.0 4.5 32.5 28.3 20.3 38.5 4.8 5.9 6.5 9.0 33.6 13.6 2.5 0.9 21.4 11.1 11.5 9.5 8.9 5.2 21.9 16.3 11.6 3.6 28.5 1.6 32.6 9.0 2.1 15.1 21.4 39.1 2.3 0.6 0.7 2.4 0.3 2.3 0.9 1.7 1.5 0.7 0.4 0.3 6.1 0.1 26.9 3.0 1.1 2.4 0.8 4.5 0.3 3.0 0.4 0.2 2.6 0.2 0.2 0.4 0.3 0.9 0.3 1.3 0.8 3.4 12.1 0.6 0.1 2.9 0.5 1.5 0.0 14.3 0.6 1.0 3.7 0.4 0.1 1.0 13.3 2.5 0.2 0.3 0.2 1.7 0.4 0.8 6.7 0.6 12.0 6.6 1.1 1.5 0.6 1.0 0.4 0.2 4.1 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 32.2 28.9 29.4 27.9 21.4 32.5 28.3 20.3 33.6 21.9 28.5 39.1 130.6 0.0 11.7 143.0 0.7 2.7 5.8 2.6 13.1 0.5 4.5 4.8 15.7 2.8 3.6 69.9 0.0 0.2 1.4 1.7 7.9 1.1 1.6 11.8 2.4 53.0 0.0 0.0 1.5 0.7 0.4 6.3 18.3 21.2 3.8 1.5 20.7 0.2 0.9 0.0 2.9 6.6 4.1 0.6 2.6 3.7 24.2 1.5 5.4 12.2 0.0 1.5 2.1 10.6 45.7 5.8 6.3 8.6 4.4 11.6 0.8 41.3 1.9 0.5 6.6 2.7 5.1 1.2 1.6 1.4 3.3 0.3 1.3 6.6 0.8 17.2 CEACAM1 "BGP, BGP1, CD66a" ENSG00000079385 "CEA cell adhesion molecule 1" P13688 19 42507304-42561234 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 248.6" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 335.2;Distal enterocytes: 731.7;Paneth cells: 585.4;Prostatic glandular cells: 244.9;Urothelial cells: 618.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 43.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "eosinophil: 43.6;neutrophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 43.6" "Group enriched" "Detected in many" 5 "CAPAN-2: 30.6;Hep G2: 101.0;OE19: 80.9;RT4: 59.2;SK-MEL-30: 67.4" "CAB002146, HPA011041" Enhanced "Intracellular and membrane" NA NA 130000000 "CAB002146: AB_563614, HPA011041: AB_1078481" "unprognostic (7.13e-3)" "unprognostic (2.15e-1)" "unprognostic (2.67e-2)" "prognostic favorable (6.32e-7)" "unprognostic (3.04e-1)" "unprognostic (1.80e-3)" "unprognostic (1.21e-1)" "unprognostic (4.45e-2)" "unprognostic (4.43e-1)" "unprognostic (5.46e-3)" "unprognostic (4.87e-2)" "unprognostic (4.03e-1)" "unprognostic (1.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.06e-1)" "unprognostic (7.55e-2)" "unprognostic (5.52e-3)" 7.7 10.6 1.4 31.4 1.0 75.2 13.4 3.1 1.8 10.3 0.0 248.6 53.8 11.2 3.9 65.4 6.0 7.5 3.1 2.2 0.0 31.9 61.0 6.8 4.3 0.4 0.2 0.3 1.1 2.5 1.8 3.8 33.4 1.5 20.4 142.6 0.6 59.4 10.4 2.8 3.1 51.4 13.2 0.0 8.0 20.1 3.8 0.2 2.4 3.1 3.2 21.7 37.4 29.4 0.6 0.6 5.6 0.3 0.3 0.0 0.0 14.4 0.0 0.2 1.0 0.5 2.3 30.6 1.7 12.2 0.0 3.2 0.8 0.0 7.9 0.4 0.1 0.5 0.3 0.2 101.0 1.7 0.2 13.3 0.0 0.1 0.1 0.1 0.0 0.7 1.4 0.0 5.0 0.0 3.2 0.3 0.2 0.9 80.9 1.7 2.6 0.0 1.3 0.6 59.2 0.5 0.2 0.0 0.2 67.4 7.3 0.3 0.0 2.1 0.3 1.2 1.4 0.5 1.8 0.0 3.7 0.2 0.4 1.0 0.8 0.0 43.6 0.1 1.7 0.3 3.3 0.9 0.4 0.2 0.8 0.6 0.2 26.3 0.1 3.3 0.1 2.7 0.6 1.4 1.0 3.1 1.8 2.2 0.0 0.4 0.2 0.3 1.5 0.0 0.2 0.6 16.7 6.4 8.2 1.0 6.0 1.3 335.2 10.4 2.8 6.0 16.3 12.7 1.8 7.2 14.7 0.0 4.2 2.0 0.7 731.7 0.0 21.3 3.5 5.0 5.2 22.3 17.3 0.4 1.7 16.1 9.4 2.9 12.8 28.7 8.9 4.6 41.4 37.7 1.4 5.0 1.4 46.1 4.1 5.9 3.1 0.2 0.0 2.6 7.2 0.0 0.9 1.3 2.1 0.5 0.6 58.7 585.4 0.7 0.2 244.9 97.5 11.1 3.9 6.4 0.0 2.7 3.1 4.3 3.9 9.2 1.0 0.7 5.5 2.2 33.2 618.9 SENP1 ENSG00000079387 "SUMO specific peptidase 1" Q9P0U3 12 48042897-48106079 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 32.8;testis: 62.4" "Cell type enhanced" "Detected in many" "Spermatocytes: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011765, HPA046491" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA011765: AB_1079907, HPA046491: AB_2679672" "unprognostic (2.66e-2)" "unprognostic (6.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.69e-2)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.72e-5)" "unprognostic (6.48e-2)" "unprognostic (2.44e-3)" "unprognostic (8.20e-3)" "unprognostic (2.57e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (7.61e-2)" "unprognostic (3.02e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-1)" 5.0 3.7 2.8 9.2 3.6 14.6 5.7 8.3 3.7 6.2 2.1 5.0 4.9 7.6 5.1 7.5 4.8 5.6 3.9 2.6 4.2 3.8 3.8 4.6 12.1 3.2 3.5 2.0 5.5 4.4 6.4 3.3 6.6 3.6 4.8 6.8 6.6 32.8 4.8 3.7 6.9 4.8 7.0 2.2 6.3 4.8 62.4 3.2 12.3 5.9 4.3 13.0 6.1 4.0 4.9 13.8 17.7 22.4 16.3 6.4 9.8 15.7 14.9 17.1 25.8 20.7 22.2 22.3 38.0 12.8 13.9 9.9 13.0 28.0 13.0 25.7 34.6 11.4 33.9 17.9 10.9 10.1 32.2 22.4 7.4 10.4 22.7 20.1 11.4 13.7 25.2 30.2 15.9 13.4 12.0 40.1 11.2 20.0 9.5 12.8 36.6 23.6 19.1 7.2 17.3 22.8 15.4 21.9 13.2 8.8 12.7 20.6 14.4 12.2 21.1 18.4 12.5 16.4 18.4 32.5 36.7 13.3 71.4 10.0 0.8 0.8 2.9 1.6 1.1 2.1 1.0 1.6 1.6 1.4 1.8 1.4 1.5 1.6 1.6 0.8 1.5 1.9 1.0 2.8 3.6 8.3 3.7 2.6 4.2 3.2 3.5 2.0 3.6 2.2 3.2 4.9 11.2 9.6 8.9 18.9 14.3 3.7 4.7 4.7 6.8 7.9 6.7 4.7 3.2 4.3 7.6 3.7 4.2 4.0 9.1 3.6 3.9 3.9 16.7 5.6 11.6 9.1 3.5 11.1 14.0 6.5 3.4 7.3 7.7 5.0 6.3 9.8 6.8 6.6 4.5 15.2 15.9 4.2 8.2 9.5 4.2 6.0 6.2 7.7 1.8 15.0 7.2 5.2 5.2 17.6 17.8 5.8 1.9 6.8 13.5 4.4 2.8 3.7 4.6 8.7 0.0 9.8 8.3 86.5 31.0 8.5 6.1 2.7 12.2 7.4 4.2 3.8 DUSP13 "BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP" ENSG00000079393 "Dual specificity phosphatase 13" "Q6B8I1, Q9UII6" 10 75094432-75109221 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 249.5;testis: 54.2;tongue: 123.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 428.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 4.3;EFO-21: 5.0;Hep G2: 11.0;K-562: 4.3;LHCN-M2: 9.5;RH-30: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.79e-1)" "unprognostic (2.39e-2)" "unprognostic (2.39e-1)" "unprognostic (7.07e-2)" "unprognostic (1.66e-3)" "unprognostic (2.47e-3)" "unprognostic (8.63e-2)" "unprognostic (1.97e-1)" "unprognostic (2.63e-2)" "unprognostic (1.27e-1)" "unprognostic (3.92e-1)" "unprognostic (2.22e-7)" "unprognostic (1.93e-2)" "unprognostic (1.54e-1)" "unprognostic (4.81e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.1 0.0 0.1 5.9 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.3 3.8 0.1 0.0 16.8 0.1 0.2 0.1 0.1 0.3 0.0 0.1 0.6 0.1 0.0 0.0 0.2 0.1 0.0 0.8 1.0 0.0 0.0 3.5 0.0 249.5 0.5 0.0 0.0 0.1 0.5 0.0 54.2 0.2 0.2 0.1 123.6 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 4.3 0.0 9.5 0.5 0.0 0.0 0.6 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.6 0.1 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 1.1 3.4 0.0 0.0 0.1 12.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 428.1 0.0 0.0 0.6 0.0 0.0 0.1 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 94.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.1 0.1 0.0 0.0 0.2 0.0 0.0 21.7 0.6 10.4 3.3 6.3 2.0 3.0 0.1 0.0 0.0 0.2 CIC KIAA0306 ENSG00000079432 "Capicua transcriptional repressor" Q96RK0 19 42268537-42295797 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026388, HPA044341, HPA064725" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB026388: , HPA044341: AB_2678901, HPA064725: AB_2685335" "unprognostic (2.02e-2)" "unprognostic (4.08e-1)" "unprognostic (1.41e-2)" "unprognostic (3.54e-3)" "unprognostic (3.67e-1)" "unprognostic (4.17e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" "unprognostic (4.87e-1)" "unprognostic (1.85e-2)" "unprognostic (1.72e-3)" "unprognostic (3.10e-1)" "unprognostic (4.23e-2)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (1.88e-2)" "unprognostic (1.56e-1)" 38.6 41.8 39.0 23.6 30.4 32.1 43.1 34.7 47.8 51.5 1.8 39.5 15.7 62.8 8.8 34.6 49.6 16.3 34.1 32.2 18.8 42.0 45.0 41.2 24.4 34.8 23.4 27.1 70.7 39.7 12.3 59.2 12.7 32.1 40.9 5.8 13.6 35.7 18.9 45.6 46.1 37.2 16.1 11.2 47.3 38.9 75.1 24.0 21.2 44.7 15.4 13.6 39.9 37.8 28.2 31.8 56.7 26.4 34.4 16.6 30.7 10.7 22.8 22.5 22.9 20.9 18.5 21.4 26.7 20.8 21.8 19.6 16.6 14.6 38.9 7.6 61.9 19.6 22.2 44.7 23.0 20.1 11.8 50.9 36.7 25.5 24.4 15.5 24.8 19.2 15.9 21.8 52.5 13.3 31.9 25.1 25.6 16.2 12.6 5.8 21.5 21.2 14.3 20.5 25.3 33.6 27.1 23.7 15.7 21.6 8.3 18.3 25.8 27.5 52.0 43.7 15.9 33.2 41.0 29.8 18.1 37.9 19.4 32.6 0.0 0.5 0.1 0.7 0.8 0.5 0.5 0.3 0.5 0.5 0.6 0.2 0.4 1.1 0.2 0.6 0.6 0.1 0.6 39.0 30.4 34.7 47.8 32.2 18.8 34.8 23.4 27.1 32.1 11.2 24.0 28.2 27.8 0.0 3.0 15.7 13.7 25.9 12.8 16.2 27.9 38.3 20.7 16.9 7.8 21.5 7.1 9.2 20.9 6.9 9.1 14.2 3.9 13.4 5.1 14.6 14.9 20.3 14.8 8.4 8.0 15.3 5.1 11.2 17.9 22.3 12.0 11.1 13.9 19.2 11.9 42.1 9.0 10.1 10.2 18.0 23.6 3.3 21.8 15.3 24.9 7.5 13.0 18.4 8.2 4.0 10.3 16.9 11.2 18.0 10.4 11.3 10.6 6.2 8.0 18.8 26.3 19.9 17.6 19.4 20.2 16.5 19.5 13.0 13.2 14.2 10.6 11.9 LIPE HSL ENSG00000079435 "Lipase E, hormone sensitive type" Q05469 19 42401514-42427388 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism" Hydrolase "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 841.9;breast: 529.1" "Cell type enhanced" "Detected in many" "Adipocytes: 76.1;Early spermatids: 127.8;Late spermatids: 236.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "ASC diff: 136.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006567, CAB017700" Enhanced Supported Cytosol NA NA Cytosol "CAB017700: AB_2135504, HPA006567: AB_2667618" "unprognostic (4.24e-2)" "unprognostic (2.46e-2)" "unprognostic (8.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.77e-1)" "unprognostic (3.38e-3)" "unprognostic (5.68e-2)" "unprognostic (2.84e-1)" "unprognostic (3.11e-1)" "unprognostic (9.44e-2)" "prognostic favorable (1.15e-4)" "unprognostic (1.52e-1)" "unprognostic (3.63e-10)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-2)" "unprognostic (2.34e-3)" 841.9 45.5 20.2 7.8 61.1 5.0 529.1 67.4 41.2 4.6 0.0 8.9 5.3 6.5 1.3 8.7 5.9 3.7 25.0 18.0 42.4 7.2 1.5 3.7 7.3 86.3 70.1 9.2 4.9 6.3 4.7 6.9 2.9 81.8 7.2 1.5 2.0 17.3 2.6 19.9 20.0 24.6 2.7 48.8 14.5 8.5 69.2 48.4 7.0 9.7 23.5 3.7 14.4 7.8 112.7 12.7 9.6 6.0 2.3 136.8 1.3 0.1 5.8 3.1 9.2 8.5 2.3 4.6 20.6 6.3 1.8 4.5 5.6 3.7 11.5 1.0 4.0 6.1 5.8 5.3 0.2 2.7 0.1 13.9 1.2 10.7 1.5 2.1 1.3 2.6 8.5 2.7 12.8 1.2 0.1 14.8 0.5 0.8 9.7 2.7 12.2 1.1 6.9 2.6 13.1 8.5 8.8 5.1 5.7 5.6 0.3 1.5 7.5 4.7 2.5 7.8 1.1 5.3 9.7 8.5 15.6 6.3 0.7 8.7 11.0 8.6 3.8 2.5 4.7 2.3 3.4 3.2 3.7 3.6 4.5 2.8 2.5 1.5 3.6 2.7 2.9 3.0 3.1 20.2 61.1 67.4 41.2 18.0 42.4 86.3 70.1 9.2 81.8 48.8 48.4 112.7 76.1 0.0 3.3 4.2 8.1 4.1 12.1 2.4 4.6 11.0 4.8 2.9 2.5 0.0 2.0 1.8 10.4 0.1 4.8 1.3 1.9 8.0 127.8 0.9 3.4 10.2 0.0 5.3 4.6 2.7 0.1 2.0 3.6 1.5 0.0 6.6 17.9 0.0 0.6 8.4 6.7 2.0 6.1 2.2 2.4 236.5 3.1 0.8 5.4 4.7 0.9 4.0 6.2 6.0 37.9 1.8 0.7 1.5 3.0 6.7 18.4 1.5 0.8 13.9 0.0 7.2 2.1 39.4 13.1 2.5 2.4 0.0 5.1 5.2 2.9 10.7 FDFT1 SQS ENSG00000079459 "Farnesyl-diphosphate farnesyltransferase 1" P37268 8 11795573-11839304 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 479.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Daudi: 133.1;RPMI-8226: 361.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008874 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA008874: AB_1078844" "unprognostic (2.33e-1)" "unprognostic (2.60e-1)" "prognostic favorable (4.92e-5)" "unprognostic (1.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.71e-1)" "unprognostic (8.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (2.45e-1)" "unprognostic (2.31e-3)" "unprognostic (2.57e-1)" "prognostic favorable (6.59e-9)" "unprognostic (2.28e-1)" "unprognostic (4.06e-2)" "unprognostic (3.86e-1)" "unprognostic (2.06e-1)" 65.0 127.7 8.1 6.8 14.3 15.1 70.0 11.9 11.7 78.4 5.0 88.8 6.8 80.8 2.9 167.0 59.9 3.2 62.8 9.1 12.1 64.2 119.3 88.7 6.1 25.9 12.8 6.0 67.4 59.0 2.1 51.6 4.3 18.8 65.1 5.9 5.5 142.9 3.1 161.6 123.3 93.0 4.9 15.0 50.8 114.1 119.6 13.3 3.2 46.2 7.0 4.5 71.0 108.7 30.6 19.1 8.1 28.8 19.4 3.8 5.7 10.9 19.2 10.6 7.4 8.6 8.1 14.1 133.1 3.9 3.2 34.6 17.8 10.6 24.7 8.2 13.1 17.2 9.6 11.1 21.7 7.4 5.5 13.0 11.2 6.0 13.2 4.7 5.3 2.1 24.5 12.1 60.0 4.6 11.1 16.7 12.9 27.1 9.0 5.3 14.9 11.3 361.0 11.9 61.5 9.6 11.2 4.3 11.2 35.9 12.3 11.6 6.8 11.3 5.1 21.6 3.1 5.8 17.0 30.2 26.3 7.5 18.7 19.7 52.1 19.5 25.5 23.1 23.6 20.7 60.5 25.3 24.5 29.1 45.6 25.7 23.3 22.3 26.7 15.1 27.9 45.7 43.9 8.1 14.3 11.9 11.7 9.1 12.1 25.9 12.8 6.0 18.8 15.0 13.3 30.6 31.1 54.5 164.1 67.6 78.0 52.5 94.0 479.6 87.6 17.7 79.6 49.8 78.5 101.5 325.8 79.1 14.6 266.2 49.4 134.8 88.0 165.6 294.4 55.0 20.9 45.2 79.1 113.2 29.3 284.4 153.3 37.1 64.2 68.1 57.0 86.2 22.1 221.8 94.1 11.8 25.6 117.4 284.8 41.9 32.2 228.8 77.0 54.3 101.4 38.4 97.1 61.9 55.6 30.2 95.6 163.6 108.4 53.4 50.0 101.3 87.0 74.9 142.6 21.0 52.6 13.8 74.4 215.5 76.1 112.5 88.8 175.0 55.7 131.4 100.4 167.2 PAFAH1B3 ENSG00000079462 "Platelet activating factor acetylhydrolase 1b catalytic subunit 3" Q15102 19 42297033-42303546 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035639 Uncertain Approved "Intermediate filaments" NA NA 290000 "Intermediate filaments" "HPA035639: AB_10670163" "unprognostic (3.19e-1)" "unprognostic (5.38e-3)" "unprognostic (1.13e-1)" "unprognostic (5.99e-2)" "unprognostic (1.83e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" "unprognostic (6.36e-2)" "unprognostic (2.37e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.68e-1)" "unprognostic (3.21e-2)" "unprognostic (4.56e-2)" "unprognostic (6.80e-3)" 7.2 23.7 32.1 12.5 33.4 28.2 13.8 34.5 44.4 18.5 28.1 16.9 12.5 13.9 13.0 28.3 14.9 10.9 4.5 32.4 35.2 18.8 8.0 9.3 17.2 30.1 30.0 32.5 18.5 18.2 13.9 21.4 6.0 31.1 15.3 12.2 13.1 17.2 6.4 13.7 12.4 14.8 7.5 29.4 16.1 16.1 23.9 38.8 37.9 9.3 5.2 18.4 14.2 16.8 31.6 111.9 200.2 127.5 135.8 2.6 6.7 38.1 27.9 39.2 91.9 94.4 67.7 94.7 70.0 34.8 35.0 63.7 37.1 58.9 75.2 38.3 105.7 77.0 85.8 52.7 91.8 19.3 54.4 90.3 19.9 33.9 56.5 26.3 50.7 41.3 152.5 58.5 81.9 67.9 162.5 124.2 42.4 70.3 138.3 0.2 90.0 47.9 62.0 76.4 117.7 144.8 109.9 44.6 89.4 47.0 40.4 111.4 62.1 22.3 74.8 98.5 6.7 77.3 38.0 84.9 60.6 41.3 87.4 65.8 23.2 27.5 15.7 23.4 22.3 31.2 38.3 32.8 26.7 51.1 48.2 43.3 30.6 3.4 18.2 12.0 27.8 58.1 21.0 32.1 33.4 34.5 44.4 32.4 35.2 30.1 30.0 32.5 31.1 29.4 38.8 31.6 18.8 16.0 11.2 3.6 26.1 28.2 45.7 82.7 46.1 26.5 67.9 83.2 2.3 30.0 41.6 33.1 14.6 38.6 13.2 39.1 80.3 112.9 16.7 30.4 12.4 24.4 58.9 53.0 3.0 55.3 44.9 21.7 38.7 33.1 27.9 71.4 17.9 10.3 62.7 11.8 5.4 54.0 87.5 28.2 33.5 27.0 13.7 21.8 46.2 1.0 18.2 33.7 11.3 3.0 3.6 81.5 36.1 9.1 37.3 31.0 30.9 63.7 35.0 19.8 0.0 3.6 52.6 5.6 188.8 59.0 17.8 13.5 24.6 46.2 74.3 58.9 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 67949349-68433913 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.9" "Group enriched" "Detected in many" 5 "Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 4.1 5.2 21.9 1.9 19.6 3.9 4.6 15.0 20.6 6.0 1.0 3.4 2.5 5.6 3.8 3.8 3.2 2.7 3.1 19.0 12.3 4.4 1.3 4.5 1.9 10.1 9.9 17.6 4.6 3.2 3.6 2.7 5.7 12.5 10.2 3.5 11.6 5.5 5.1 6.6 6.4 2.9 4.0 4.3 2.3 3.9 2.6 11.6 1.2 4.7 4.9 1.4 2.3 3.8 18.5 23.6 5.1 3.2 7.3 7.1 6.8 5.0 4.2 5.6 8.3 10.1 3.3 4.5 1.5 13.7 4.9 3.4 5.7 3.1 2.9 12.6 0.9 2.1 5.2 6.9 3.7 2.4 2.1 5.2 4.6 4.8 6.9 6.4 10.6 5.6 1.1 3.2 3.1 4.3 10.1 0.8 1.8 7.5 10.0 4.8 0.9 7.3 1.3 8.5 7.6 1.7 2.8 7.2 9.1 13.7 7.1 6.2 1.6 6.0 5.0 7.3 18.1 4.5 2.9 3.4 1.0 4.0 2.8 3.5 1.0 1.0 0.4 0.5 0.4 0.4 0.5 0.4 0.3 0.4 0.8 0.4 0.5 4.6 0.5 0.6 1.6 0.3 0.2 21.9 19.6 15.0 20.6 19.0 12.3 10.1 9.9 17.6 12.5 4.3 11.6 18.5 13.8 16.0 19.3 383.9 0.0 3.2 5.4 2.0 10.2 5.4 6.7 5.0 3.3 2.8 6.4 18.4 6.2 23.0 2.3 3.9 0.0 1.2 2.0 7.2 4.3 8.1 4.2 1.3 84.6 0.8 11.7 18.0 14.8 12.9 8.8 36.3 5.0 0.2 4.6 0.0 78.8 3.0 2.0 2.1 9.5 1.7 21.1 5.9 8.8 54.4 1.2 16.0 3.1 600.2 41.7 1.3 2.4 12.0 0.1 8.5 3.8 1.8 10.9 5.1 0.0 24.1 5.4 0.3 1.9 8.9 5.1 66.9 1.4 4.2 4.1 4.2 AFM "ALB2, ALBA" ENSG00000079557 Afamin P43652 4 73481745-73504001 "Plasma proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 969.5" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 300.4" "Cancer enriched" "Detected in single" 167 "liver cancer: 62.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "CACO-2: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017006, HPA052437" Enhanced "Secreted to blood" NA NA 54900000000 8700000000 "HPA017006: AB_1844635, HPA052437: AB_2732575" "prognostic favorable (1.80e-4)" "unprognostic (5.73e-2)" "unprognostic (4.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 80.4 969.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.3 0.2 4.3 0.0 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 300.4 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 KIF22 "Kid, KNSL4, OBP-1, OBP-2" ENSG00000079616 "Kinesin family member 22" Q14807 16 29790719-29805384 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 89.3;lymphoid tissue: 73.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 288.7;Hepatocytes: 565.5;Proximal tubular cells: 194.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048213, HPA075670" Enhanced Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA048213: AB_2680316, HPA075670: " "unprognostic (3.71e-2)" "prognostic favorable (3.87e-8)" "unprognostic (1.86e-1)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (6.06e-3)" "unprognostic (5.06e-3)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (4.73e-2)" "unprognostic (7.84e-2)" "unprognostic (2.10e-2)" "unprognostic (2.21e-2)" "unprognostic (3.67e-2)" "unprognostic (2.62e-1)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" 7.9 7.1 9.1 19.8 9.6 89.3 13.5 7.8 10.5 9.2 6.7 22.8 16.8 8.3 8.7 22.5 12.4 6.5 10.9 9.3 8.7 11.3 8.3 8.6 34.4 8.5 8.2 9.0 8.3 7.3 34.1 9.2 15.9 8.4 25.1 20.8 9.0 10.6 12.1 8.5 33.1 17.1 8.1 8.1 18.8 12.0 28.5 8.8 73.7 26.2 11.1 35.0 10.1 13.4 9.2 89.3 103.9 120.6 87.6 8.0 11.9 104.8 65.8 52.1 123.1 113.9 97.9 103.3 130.6 60.4 34.4 61.2 90.0 118.9 67.5 57.4 84.8 100.4 72.4 115.1 119.0 2.7 79.1 76.0 6.7 17.7 68.5 51.3 17.1 67.2 144.7 109.4 104.1 65.5 186.5 173.1 196.1 101.8 65.7 59.6 237.9 110.6 122.4 44.9 45.0 99.8 65.4 48.5 94.7 33.1 39.4 84.8 105.2 29.8 63.8 66.6 57.7 72.6 96.6 105.3 141.4 41.9 129.0 83.3 58.7 14.1 39.5 49.7 21.1 37.3 30.4 50.0 53.1 14.7 27.3 40.0 38.4 6.2 31.5 18.3 9.6 56.5 40.5 9.1 9.6 7.8 10.5 9.3 8.7 8.5 8.2 9.0 8.4 8.1 8.8 9.2 13.9 32.1 115.4 5.5 23.0 30.8 25.8 56.7 52.9 27.5 56.5 56.4 288.7 57.2 38.5 69.9 25.0 81.7 20.1 44.2 62.6 16.6 9.9 29.5 18.9 29.2 41.4 85.2 4.8 50.1 85.4 50.1 25.0 31.1 43.6 29.5 49.2 565.5 46.3 6.7 6.1 39.5 34.6 47.7 40.4 8.5 15.5 36.7 35.6 4.7 38.6 69.8 29.9 4.0 5.3 17.3 44.0 12.8 49.9 26.1 18.0 194.0 29.7 20.5 13.1 23.7 34.2 50.9 61.6 41.4 27.6 76.9 34.2 12.2 42.3 22.5 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;intestine: 19.4;pancreas: 67.6;pituitary gland: 38.8;stomach 1: 19.0" "Cell type enriched" "Detected in some" 5 "Enteroendocrine cells: 600.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2;renal cancer: 22.6" "Region enhanced" "Detected in many" "hypothalamus: 34.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7" "Region enriched" "Detected in many" 16 "olfactory bulb: 82.0" "Region enriched" "Detected in some" 9 "olfactory bulb: 137.1" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 3.4 3.5 2.8 3.4 1.3 0.2 3.3 20.7 3.2 0.1 0.3 17.0 12.5 0.0 0.0 0.2 0.1 0.9 8.0 13.9 34.7 1.4 4.2 0.8 0.1 1.6 6.5 0.6 0.3 67.6 0.1 38.8 3.3 6.0 2.0 19.4 1.0 2.5 0.1 0.0 0.6 11.6 1.2 1.1 0.0 19.0 0.6 7.5 0.4 1.9 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 24.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 20.7 3.2 13.9 34.7 1.6 6.5 0.6 6.0 1.1 7.5 1.4 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.6 0.5 107.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.1 0.0 0.0 2.2 600.1 0.0 0.2 0.4 0.2 0.3 9.2 0.0 0.0 0.9 3.3 0.5 0.1 0.0 1.8 14.3 4.1 0.0 0.0 0.2 0.6 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 4.8 3.7 0.0 0.0 3.7 1.1 3.1 0.0 0.0 13.1 0.0 9.1 0.2 1.1 0.0 0.0 0.0 0.1 0.5 2.2 0.3 CARMIL1 "CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A" ENSG00000079691 "Capping protein regulator and myosin 1 linker 1" Q5VZK9 6 25279078-25620530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 27.9;Collecting duct cells: 35.0;Distal tubular cells: 46.9;Endometrial ciliated cells: 37.3;Glandular and luminal cells: 39.3;Granulosa cells: 31.8;Proximal tubular cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 36.0;RPTEC TERT1: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029038, HPA029039" Enhanced Supported Cytosol NA NA Cytosol "HPA029038: AB_10601668, HPA029039: AB_10611382" "unprognostic (2.34e-2)" "unprognostic (9.45e-2)" "unprognostic (2.07e-2)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" "unprognostic (2.22e-1)" "unprognostic (1.66e-3)" "unprognostic (3.82e-1)" "unprognostic (4.02e-1)" "unprognostic (7.15e-3)" "unprognostic (8.25e-3)" "unprognostic (5.86e-2)" "unprognostic (1.28e-3)" "unprognostic (3.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-1)" 4.4 3.9 3.0 2.9 4.3 0.7 6.5 6.8 6.4 5.3 0.0 10.8 15.4 2.5 7.2 4.4 5.6 5.8 2.8 2.7 2.1 8.6 2.1 8.1 3.6 1.2 2.6 2.2 4.3 4.5 5.1 1.2 4.7 2.8 3.3 10.1 1.0 5.4 2.7 0.4 5.9 15.9 2.7 1.1 2.8 7.5 11.5 2.0 7.7 5.3 2.0 3.8 5.3 3.7 1.8 12.9 12.7 3.5 4.5 3.2 1.6 12.1 4.3 9.7 4.5 7.9 13.7 9.4 4.4 13.8 6.9 13.2 13.7 13.6 12.2 3.3 11.1 7.2 10.7 14.0 1.7 8.9 0.5 1.6 1.7 8.2 8.7 13.3 5.6 0.2 1.6 0.3 3.5 2.9 10.0 0.7 0.0 4.8 22.7 5.2 1.5 2.1 36.0 34.7 11.5 9.0 1.9 19.1 32.4 12.4 10.1 7.8 0.3 0.2 3.3 5.8 15.8 4.4 0.5 0.2 7.0 5.2 3.9 12.6 0.0 0.4 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.4 1.3 1.0 0.1 0.0 0.6 1.3 0.9 0.0 0.1 3.0 4.3 6.8 6.4 2.7 2.1 1.2 2.6 2.2 2.8 1.1 2.0 1.8 3.2 19.2 27.9 0.0 7.7 0.0 0.0 0.0 0.0 0.0 17.5 11.6 0.0 0.0 4.3 35.0 0.0 20.8 0.4 0.0 46.9 16.7 0.0 37.3 7.0 4.0 0.0 0.0 0.0 15.6 7.9 12.8 0.0 39.3 8.8 31.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 17.6 0.0 0.0 7.6 0.0 0.0 58.8 3.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 10.9 1.6 14.9 0.0 0.0 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593411-63660245 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 1574.0;tongue: 795.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Supported Cytosol NA NA 21000000 Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625" "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 114.7 71.3 30.9 20.9 32.1 21.7 57.9 33.7 38.7 34.2 47.6 59.5 61.4 23.1 19.4 49.8 17.2 30.5 150.7 30.7 33.0 52.6 282.0 43.0 14.9 41.5 32.4 28.5 51.4 113.2 65.8 32.1 27.1 31.8 47.0 50.4 22.8 42.1 50.2 1574.0 30.2 55.5 41.7 31.1 14.8 30.9 11.2 33.7 14.5 27.8 795.0 19.5 38.8 22.3 29.6 113.4 47.0 17.3 57.0 111.0 81.4 138.6 45.7 61.8 48.9 79.0 38.8 51.3 35.8 93.2 71.2 107.4 26.5 24.0 96.3 55.9 44.0 32.1 75.3 72.6 40.3 91.6 66.8 4.3 103.4 60.7 57.1 88.5 129.8 29.6 36.3 0.1 46.3 78.8 6.9 19.6 36.7 78.3 3.4 73.9 26.8 80.0 11.8 70.0 35.3 10.4 66.7 100.0 103.0 157.4 78.6 32.4 25.2 3.1 71.6 36.0 64.0 39.4 29.1 45.5 57.8 117.0 58.0 31.5 46.0 33.2 49.2 40.5 22.4 32.7 22.4 23.5 31.0 48.4 11.8 21.0 24.7 38.7 43.9 21.2 13.9 20.4 35.4 30.9 32.1 33.7 38.7 30.7 33.0 41.5 32.4 28.5 31.8 31.1 33.7 29.6 8.4 93.0 29.4 48.3 16.9 17.8 29.0 58.8 47.8 9.2 33.8 21.8 139.2 48.6 24.2 16.5 10.4 76.6 14.2 81.8 88.0 55.9 32.0 8.2 12.1 12.7 13.1 5.7 17.9 238.4 185.9 37.0 27.0 13.5 5.1 134.3 15.0 214.4 24.6 0.0 26.3 47.5 20.3 17.0 10.8 8.5 22.1 13.5 26.6 4.7 32.8 75.8 29.9 32.2 9.8 70.5 31.6 38.0 40.4 29.2 90.2 74.8 17.0 11.4 13.1 53.4 25.5 5.6 10.1 57.3 18.2 58.8 19.0 20.2 81.5 19.0 DDX1 DBP-RB ENSG00000079785 "DEAD-box helicase 1" Q92499 2 15591178-15634346 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing" "Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 362.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012280, HPA034502, HPA034503" Enhanced Supported Nucleoplasm,Cytosol NA NA 86000 Nucleoplasm Cytosol "CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025" "unprognostic (9.94e-2)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (8.36e-3)" "unprognostic (9.28e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (2.55e-1)" "unprognostic (2.05e-1)" "unprognostic (4.81e-3)" "unprognostic (3.89e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.69e-4)" "unprognostic (3.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.94e-2)" "unprognostic (1.20e-3)" 53.3 53.9 37.9 39.3 38.0 38.1 62.4 40.3 44.6 50.3 41.4 54.3 45.4 45.8 48.5 57.0 42.8 32.0 88.4 37.3 41.0 77.4 62.5 39.2 35.5 40.9 39.2 35.2 46.1 59.5 90.2 47.1 51.3 40.1 45.0 58.6 56.0 53.4 48.3 159.3 50.2 46.3 57.0 39.1 34.0 50.9 42.9 39.7 47.4 62.8 135.3 47.2 48.8 41.3 44.8 84.1 127.1 172.3 126.2 148.1 125.5 193.3 176.8 142.6 165.1 135.9 203.0 80.7 221.8 80.4 202.8 120.9 118.8 245.5 166.8 170.7 94.6 154.3 244.5 150.6 241.8 110.2 204.5 102.3 101.2 105.9 140.6 129.6 100.8 151.0 98.4 253.4 61.8 161.9 112.2 110.3 126.7 221.0 205.6 104.4 125.0 276.8 152.6 178.9 161.9 136.6 169.3 124.3 118.0 154.8 123.2 83.6 77.5 133.7 132.1 139.8 84.2 197.2 84.5 169.3 296.2 120.5 153.7 128.4 32.4 34.5 20.3 31.0 42.0 33.2 28.6 35.8 37.0 38.8 30.5 39.9 35.8 3.0 38.5 42.0 30.1 38.1 34.1 37.9 38.0 40.3 44.6 37.3 41.0 40.9 39.2 35.2 40.1 39.1 39.7 44.8 41.3 80.1 57.6 25.8 34.9 40.3 57.2 96.4 31.9 58.9 50.3 41.5 362.7 67.2 78.6 90.1 52.1 112.1 29.0 43.7 142.8 112.3 23.1 49.2 69.6 57.2 52.1 64.2 52.1 120.3 108.5 67.0 28.5 51.2 57.0 49.3 47.5 123.0 53.4 45.4 48.6 69.8 83.4 30.3 19.7 19.5 72.7 28.1 49.8 29.0 41.2 60.1 55.6 45.8 49.0 107.2 52.4 78.2 32.8 31.3 74.5 170.2 80.6 75.9 59.2 51.3 94.6 174.0 76.8 30.0 42.3 80.2 30.7 73.5 74.1 36.6 DNM2 "CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII" ENSG00000079805 "Dynamin 2" P50570 19 10718079-10833488 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Phagocytosis" "Hydrolase, Motor protein" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 242.8;Paneth cells: 177.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054246 Supported Approved "Golgi apparatus,Cytosol" NA NA 230000 "Golgi apparatus, Cytosol" "HPA054246: AB_2682427" "unprognostic (2.30e-1)" "unprognostic (5.23e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "prognostic favorable (8.91e-4)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.03e-1)" "unprognostic (3.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.75e-2)" "unprognostic (5.35e-2)" "unprognostic (5.47e-2)" "unprognostic (5.40e-3)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" 51.1 70.5 47.5 63.8 66.7 126.8 46.5 65.3 64.6 46.0 33.6 106.8 66.5 42.6 25.5 68.1 42.8 40.8 82.2 42.4 51.5 73.3 57.6 87.8 62.9 70.7 71.9 33.5 36.9 68.8 39.3 42.2 51.7 77.5 47.8 84.7 31.0 55.4 56.3 109.0 90.6 100.4 35.4 56.2 81.6 99.4 55.5 62.5 59.1 48.0 83.6 65.9 65.2 54.9 95.0 116.4 92.8 67.6 54.6 67.6 65.4 86.5 75.1 70.5 108.8 91.7 94.2 74.7 83.2 132.2 81.5 52.5 99.4 92.6 82.1 90.8 103.1 72.4 160.1 81.7 107.1 82.9 87.8 146.5 67.8 62.4 83.5 77.9 66.2 107.3 84.9 131.5 139.1 68.0 140.1 126.3 85.7 76.6 138.3 109.7 125.6 72.6 95.7 71.3 171.1 97.1 63.8 86.6 73.6 54.2 74.9 58.8 106.2 99.6 120.7 40.5 172.0 102.7 112.7 127.3 77.9 89.9 134.0 61.0 3.5 3.5 7.0 4.0 6.2 3.8 2.5 3.0 4.4 4.2 2.1 1.7 3.0 6.5 8.9 8.4 8.4 3.8 4.1 47.5 66.7 65.3 64.6 42.4 51.5 70.7 71.9 33.5 77.5 56.2 62.5 95.0 37.8 32.1 22.3 24.8 48.8 23.2 17.1 13.8 22.2 28.8 19.7 16.3 30.3 14.3 25.7 51.5 22.9 25.7 57.2 242.8 50.9 35.2 48.4 32.2 17.9 33.1 21.6 38.1 29.2 32.0 106.9 19.5 168.7 39.7 19.0 36.8 20.3 22.8 49.1 43.7 31.1 106.9 14.2 28.0 39.6 98.0 16.8 55.2 19.6 60.9 43.4 17.2 39.1 23.1 90.9 45.2 177.3 27.8 92.2 20.2 90.7 38.8 18.0 26.3 26.3 18.7 27.6 15.0 12.3 26.6 31.5 31.7 46.4 40.7 82.5 22.8 EPB41L2 "4.1-G, 4.1G" ENSG00000079819 "Erythrocyte membrane protein band 4.1 like 2" O43491 6 130839347-131063322 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 371.7" "Cell type enhanced" "Detected in many" "Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005730, HPA006642" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 54000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA005730: AB_1848195, HPA006642: AB_1848194" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (8.34e-3)" "unprognostic (3.40e-3)" "unprognostic (1.41e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (1.25e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (3.24e-1)" "unprognostic (1.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.64e-2)" "unprognostic (3.82e-1)" "unprognostic (3.48e-2)" "unprognostic (9.19e-2)" 122.1 35.3 67.3 41.3 115.6 10.1 50.5 73.5 84.0 41.7 26.3 52.3 27.8 49.6 24.4 28.8 55.6 40.0 50.4 68.5 79.0 24.5 26.9 59.2 38.0 100.3 74.9 51.6 93.4 20.4 14.9 18.1 59.3 106.2 23.8 50.2 371.7 23.5 33.2 39.0 14.8 48.2 43.5 84.7 60.2 26.8 75.1 83.0 31.0 34.0 68.4 26.6 36.3 35.1 131.4 34.0 35.6 78.0 109.5 53.4 85.7 23.9 56.4 72.2 57.9 79.9 67.5 47.7 41.7 102.9 79.6 46.6 17.1 30.6 53.2 114.2 178.4 70.9 74.0 42.5 38.5 31.5 0.1 87.4 42.3 1.1 101.7 38.8 91.8 89.3 62.5 206.1 115.8 37.2 8.5 59.4 13.1 72.6 146.3 38.5 90.9 94.4 4.0 96.5 31.9 8.4 0.3 23.7 0.7 45.4 80.1 12.2 78.3 108.9 66.9 125.0 113.6 172.1 95.6 1.7 38.5 45.8 0.5 103.8 0.1 2.9 0.5 0.9 8.0 0.8 2.5 0.9 1.1 8.2 8.4 1.4 0.6 0.0 1.1 3.2 2.2 2.6 1.2 67.3 115.6 73.5 84.0 68.5 79.0 100.3 74.9 51.6 106.2 84.7 83.0 131.4 132.5 6.4 12.0 150.5 17.0 15.4 13.3 5.3 24.5 63.1 10.2 19.9 16.5 21.5 16.0 1.8 225.2 4.4 4.8 54.7 0.0 32.7 332.6 72.3 83.3 92.9 10.2 5.9 300.9 16.6 5.7 120.5 9.7 113.2 44.3 100.3 43.9 5.4 33.5 28.6 144.0 41.9 0.0 166.7 63.3 332.1 73.0 50.8 10.6 433.8 14.0 472.5 2.1 119.1 288.8 57.9 25.0 46.3 10.2 6.2 28.0 10.4 11.2 1272.4 118.3 149.6 89.2 102.8 97.6 12.1 10.2 2.5 9.4 82.8 39.3 7.2 RIMS1 "CORD7, KIAA0340, RAB3IP2, RIM, RIM1" ENSG00000079841 "Regulating synaptic membrane exocytosis 1" Q86UR5 6 71886703-72403143 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "brain: 367.0" "Group enriched" "Detected in many" 4 "Excitatory neurons: 653.2;Inhibitory neurons: 572.7;Oligodendrocyte precursor cells: 323.2" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Region enriched" "Detected in many" 5 "cerebellum: 367.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.2;EFO-21: 8.8;LHCN-M2: 10.0;RPTEC TERT1: 15.0;SH-SY5Y: 10.7;TIME: 5.4;U-138 MG: 5.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 352.9" HPA076565 Enhanced NA NA "HPA076565: " "unprognostic (1.34e-3)" "unprognostic (3.47e-1)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (6.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.73e-2)" "unprognostic (8.57e-2)" "unprognostic (2.85e-1)" "unprognostic (7.76e-4)" "unprognostic (2.42e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (5.74e-2)" "unprognostic (1.07e-2)" 0.2 1.2 7.2 0.8 13.5 0.0 0.5 367.0 24.4 0.3 0.0 0.2 0.7 0.2 0.0 2.1 0.0 3.9 0.1 15.9 8.5 0.0 0.0 0.2 0.0 3.2 26.2 6.0 0.0 0.5 1.6 2.4 0.0 76.6 3.0 0.1 7.5 1.1 0.3 0.2 0.1 0.4 0.7 0.0 0.0 1.4 4.2 6.7 0.0 0.0 0.9 0.0 0.1 0.0 15.2 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.2 1.4 0.0 0.2 0.0 0.0 5.2 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 1.6 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.5 15.0 0.0 0.4 10.7 0.0 0.0 0.0 0.3 0.7 0.0 5.4 5.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 13.5 367.0 24.4 15.9 8.5 3.2 26.2 6.0 76.6 0.0 6.7 15.2 0.2 0.0 0.5 120.2 0.0 0.0 0.2 2.1 0.0 69.1 3.0 3.2 1.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.2 0.0 0.9 2.5 0.0 0.0 653.2 0.8 0.0 1.8 0.0 0.0 1.3 0.3 3.6 0.0 0.0 62.2 572.7 0.0 2.0 0.0 0.0 10.2 0.3 0.3 3.6 16.9 0.0 109.7 0.0 323.2 76.5 0.5 0.0 1.5 0.0 1.0 0.0 0.4 3.6 9.9 0.0 1.3 2.7 21.3 13.6 0.0 0.1 0.0 0.1 0.3 0.0 0.5 MOXD1 "dJ248E1.1, DKFZP564G202, MOX" ENSG00000079931 "Monooxygenase DBH like 1" Q6UVY6 6 132296055-132401475 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 64.8;smooth muscle: 79.2" "Cell type enhanced" "Detected in many" "Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 33 "memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1" "Group enriched" "Detected in many" 41 "B-cells: 3.1;dendritic cells: 5.1" "Cell line enhanced" "Detected in many" "ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035740 Approved Approved Cytosol NA NA Cytosol "HPA035740: AB_10610141" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (8.05e-2)" "unprognostic (9.87e-3)" "unprognostic (5.62e-2)" "prognostic favorable (7.09e-5)" "unprognostic (5.77e-2)" "unprognostic (2.48e-1)" "unprognostic (6.55e-2)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (2.92e-2)" "unprognostic (6.24e-2)" "unprognostic (1.73e-2)" 2.3 36.8 18.8 5.8 9.2 0.1 2.5 4.0 12.3 25.9 4.5 11.6 5.2 64.8 11.1 23.7 3.5 29.0 5.5 10.8 46.8 32.4 1.8 25.5 6.2 6.4 5.3 10.6 0.8 2.2 0.5 4.5 1.4 5.8 32.3 8.9 5.0 12.3 40.0 0.3 14.6 7.6 79.2 4.4 4.7 5.2 1.8 6.2 2.1 1.9 0.5 15.7 19.3 12.9 11.3 0.1 0.9 4.1 0.0 164.8 131.7 0.2 106.1 71.0 37.7 65.8 0.2 1.2 0.4 0.1 196.5 30.9 0.1 1.4 0.5 120.6 0.0 19.3 0.0 0.1 0.0 1.5 0.1 0.1 31.8 0.0 76.6 2.5 46.6 0.0 0.0 0.0 7.8 22.4 0.0 0.1 0.2 3.5 0.0 0.7 1.1 0.4 0.2 46.3 0.4 2.8 0.2 0.0 0.4 2.4 9.6 0.1 5.9 0.5 17.4 15.9 310.0 56.1 4.1 0.0 0.0 43.9 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 18.8 9.2 4.0 12.3 10.8 46.8 6.4 5.3 10.6 5.8 4.4 6.2 11.3 0.4 0.0 1.3 92.7 5.4 28.0 0.4 0.1 153.1 0.3 0.4 0.6 0.7 0.0 2.5 1.8 0.0 0.9 2.7 0.0 0.0 0.6 70.2 1.0 57.8 0.6 0.0 0.0 36.0 0.0 1.5 23.9 0.5 1.2 3.8 0.0 0.0 0.0 0.4 0.0 8.6 0.0 0.0 0.3 4.7 11.8 0.3 0.3 7.2 4.7 0.0 16.4 0.0 33.7 1.1 0.4 0.0 0.4 9.5 1.5 0.0 0.3 0.0 0.8 0.0 6.2 3.3 0.5 0.8 14.6 6.8 0.0 0.5 0.1 0.1 0.0 STX7 ENSG00000079950 "Syntaxin 7" O15400 6 132445867-132513198 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 53.6;classical monocyte: 51.6;eosinophil: 49.1;intermediate monocyte: 58.1;memory B-cell: 85.9;myeloid DC: 61.6;naive B-cell: 106.8;neutrophil: 83.2;non-classical monocyte: 61.6;plasmacytoid DC: 73.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001467, CAB062564" Enhanced Supported Lysosomes NA NA 380000 Lysosomes "CAB062564: AB_2665605, HPA001467: AB_1857623" "unprognostic (1.91e-3)" "unprognostic (1.06e-3)" "unprognostic (2.67e-2)" "unprognostic (7.95e-3)" "unprognostic (1.21e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (4.52e-2)" "unprognostic (4.46e-1)" "unprognostic (4.19e-2)" "unprognostic (2.84e-1)" "unprognostic (2.79e-1)" "unprognostic (1.65e-3)" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "unprognostic (1.67e-1)" "unprognostic (8.42e-2)" 35.4 17.8 17.2 41.9 19.0 21.8 21.4 19.4 21.3 22.7 15.0 25.4 37.6 27.4 12.2 34.1 22.3 33.8 36.3 18.2 19.3 51.6 18.5 31.8 77.0 22.2 21.1 14.4 31.2 14.4 20.7 7.4 43.3 21.4 19.7 29.4 16.1 20.8 26.1 23.4 20.5 38.3 29.5 21.8 45.9 28.6 8.3 17.8 17.8 31.1 22.9 72.4 26.5 16.7 28.3 17.5 17.5 28.7 20.6 56.4 49.9 22.6 33.9 34.7 34.4 49.3 30.9 28.9 87.6 32.7 41.1 51.0 22.8 25.5 31.2 46.6 30.2 30.4 33.1 14.6 33.0 44.6 22.8 24.2 28.6 28.5 35.3 31.6 46.5 37.8 19.2 36.1 30.7 39.8 24.8 10.4 18.2 11.0 25.4 20.2 24.6 22.5 25.5 57.9 20.4 23.5 7.1 15.3 24.9 91.9 42.2 17.0 21.2 66.4 20.1 20.5 44.1 36.6 29.1 18.2 37.2 28.3 17.9 23.2 53.6 51.6 49.1 10.8 58.1 4.4 85.9 8.0 7.7 61.6 106.8 5.7 6.8 83.2 9.5 61.6 73.9 12.8 31.3 17.2 19.0 19.4 21.3 18.2 19.3 22.2 21.1 14.4 21.4 21.8 17.8 28.3 37.7 70.5 36.5 34.0 151.6 42.1 23.5 33.8 26.7 26.8 26.7 22.2 51.0 85.8 33.1 42.3 2.1 85.7 111.5 50.8 64.6 56.9 1.2 27.9 33.4 38.3 13.2 57.9 61.3 30.9 54.5 34.1 42.3 28.0 40.6 25.9 43.5 19.4 177.6 37.0 60.6 39.8 38.7 99.4 78.7 2.1 30.7 109.6 133.4 109.6 110.7 25.7 54.6 44.2 77.9 57.6 63.1 46.3 37.3 24.7 113.5 155.0 43.9 16.5 39.5 30.2 38.6 2.7 17.6 36.2 41.2 55.4 24.4 17.9 28.4 24.9 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783662 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 91.1" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 99.4;Respiratory ciliated cells: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 13.2 13.0 30.6 18.8 20.6 14.5 16.0 19.6 23.3 22.5 62.1 15.8 12.6 21.9 91.1 13.4 67.2 14.6 9.2 25.1 21.3 17.8 12.3 22.0 23.3 22.9 27.5 20.3 22.7 16.4 14.7 26.9 11.7 19.9 16.4 16.9 30.4 16.9 17.1 8.8 22.3 15.7 15.7 26.1 19.5 14.6 23.3 18.0 21.8 28.4 4.6 20.5 17.1 15.8 19.7 23.0 20.4 34.1 26.7 37.3 29.6 25.0 16.7 18.5 13.2 18.1 5.8 19.7 14.7 14.7 24.1 21.6 29.5 15.8 19.6 14.2 13.3 23.2 12.8 40.2 15.1 15.4 36.1 13.0 25.3 26.2 17.5 21.9 39.2 15.0 26.0 9.9 17.9 26.7 28.8 18.2 15.9 13.2 14.0 15.0 30.1 19.8 16.1 25.9 22.4 14.6 26.5 20.5 17.8 13.4 23.4 17.7 11.2 23.2 12.6 25.1 10.9 11.4 15.2 7.4 7.2 23.8 8.8 18.1 1.8 14.4 13.1 21.4 23.5 15.5 15.2 16.4 17.3 15.7 19.2 18.7 18.3 5.4 15.9 28.4 18.0 18.6 14.7 30.6 20.6 19.6 23.3 25.1 21.3 22.9 27.5 20.3 19.9 26.1 18.0 19.7 6.2 12.8 13.4 14.4 16.8 5.4 13.4 13.3 15.9 15.2 13.3 11.8 5.1 12.8 24.1 22.0 31.3 12.1 16.2 10.6 13.7 21.3 25.7 99.4 11.2 7.2 5.4 9.9 25.7 10.8 11.1 11.4 9.7 8.6 3.8 22.1 5.3 8.9 12.0 16.8 18.9 8.0 22.4 10.1 6.9 24.2 14.0 8.4 17.8 4.7 14.4 13.9 36.0 7.1 15.1 10.4 4.9 10.9 8.0 7.3 8.6 16.3 188.6 40.0 6.6 15.0 14.8 38.8 27.0 8.8 5.7 6.7 16.0 11.9 10.7 6.5 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486125-10503558 "Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 179.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 31.0 41.5 58.0 20.7 62.9 20.6 30.5 63.5 61.4 32.3 51.2 35.5 26.7 31.5 22.4 55.8 29.2 24.5 49.9 55.1 61.5 32.6 61.4 25.5 23.4 63.5 62.4 54.1 25.5 33.1 24.5 30.2 17.1 62.2 37.1 16.7 16.6 35.0 25.1 179.7 38.9 27.7 18.8 63.5 32.4 33.5 20.7 60.5 23.2 35.9 76.4 18.7 41.7 36.6 70.5 58.0 102.8 27.2 35.1 55.8 45.4 30.3 48.1 35.9 46.6 41.6 73.7 54.2 82.9 122.9 53.3 34.8 49.7 55.6 36.9 23.7 78.3 61.7 126.3 29.9 87.9 54.5 65.4 63.9 50.0 51.0 53.5 25.1 39.1 46.3 23.7 79.1 135.4 41.6 79.9 46.1 177.8 80.8 54.2 88.6 84.6 34.8 95.1 30.4 67.4 75.3 40.4 66.8 42.4 42.1 23.9 37.8 82.3 56.5 72.9 41.0 86.0 57.0 86.8 113.0 81.1 58.0 78.5 56.0 36.4 37.9 41.4 55.3 33.8 53.1 26.3 38.5 52.0 45.4 11.7 23.6 33.7 20.9 42.5 34.6 31.4 50.2 41.8 58.0 62.9 63.5 61.4 55.1 61.5 63.5 62.4 54.1 62.2 63.5 60.5 70.5 18.3 28.9 20.8 5.5 13.8 21.9 24.4 40.3 27.9 21.5 15.7 11.4 24.0 21.5 25.4 11.0 8.4 27.3 11.6 33.2 13.7 32.8 27.5 13.4 17.1 27.8 26.9 45.2 5.3 36.3 25.2 23.5 18.8 13.3 12.0 22.8 35.3 34.4 29.0 26.9 5.9 21.4 40.7 15.1 13.4 43.9 29.2 16.1 10.6 3.7 41.8 43.0 7.2 11.6 18.3 29.8 27.1 25.9 26.6 33.3 36.8 24.9 17.2 13.9 13.1 17.7 22.4 21.2 16.6 34.7 22.0 26.8 20.1 29.6 31.5 24.8 DDX43 "CT13, DKFZp434H2114, HAGE" ENSG00000080007 "DEAD-box helicase 43" Q9NXZ2 6 73394828-73417566 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "placenta: 4.9;testis: 19.7" "Group enriched" "Detected in many" 6 "Spermatocytes: 50.6;Spermatogonia: 41.5" "Cancer enriched" "Detected in many" 15 "testis cancer: 13.0" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.0;CAPAN-2: 13.8;HHSteC: 3.7;MCF7: 2.6;U-2 OS: 8.7" HPA031381 Enhanced NA NA "HPA031381: AB_10601885" "unprognostic (4.03e-3)" "unprognostic (8.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (3.59e-4)" "unprognostic (1.64e-2)" "unprognostic (3.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (3.08e-1)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (2.68e-1)" "unprognostic (1.58e-1)" "unprognostic (8.78e-2)" 1.0 0.4 0.4 0.5 0.4 0.7 0.9 0.4 0.7 0.5 0.6 0.8 1.2 0.8 0.0 0.9 0.4 1.2 0.5 0.3 0.6 0.4 0.3 1.0 0.8 0.7 0.7 0.1 1.1 1.3 0.0 0.4 4.9 0.8 1.4 0.5 0.4 1.8 1.8 0.2 1.2 0.8 0.8 0.5 0.9 1.7 19.7 0.7 0.2 1.4 0.3 0.6 1.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.5 0.0 0.0 0.0 0.1 13.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.0 0.3 0.7 0.8 0.7 0.9 0.2 1.0 0.4 0.1 0.2 0.6 0.2 0.0 0.4 0.2 0.4 0.4 0.4 0.7 0.3 0.6 0.7 0.7 0.1 0.8 0.5 0.7 0.9 2.1 3.2 5.4 0.3 1.0 2.7 0.9 3.4 0.0 0.3 0.8 0.9 0.8 1.5 2.5 0.0 0.0 7.2 2.6 0.5 0.0 0.4 5.1 2.1 0.5 2.4 0.0 0.0 0.3 1.0 3.2 1.7 0.0 2.4 0.0 0.1 0.4 0.1 2.7 0.0 0.3 0.3 4.1 0.8 1.5 5.0 2.1 1.5 3.6 0.0 0.6 0.5 6.2 0.0 2.0 1.5 0.0 1.2 0.7 0.3 0.3 1.5 1.4 1.1 0.0 1.7 1.3 50.6 41.5 0.0 1.4 6.0 2.1 0.2 0.3 0.8 PTPRH SAP-1 ENSG00000080031 "Protein tyrosine phosphatase receptor type H" Q9HD43 19 55181247-55209506 "Enzymes, Metabolic proteins, Predicted membrane proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 24.5;intestine: 69.2;stomach 1: 23.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 123.6;Gastric mucus-secreting cells: 60.1;Paneth cells: 94.9;Proximal enterocytes: 113.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 11.8;K-562: 15.0;OE19: 30.9;SK-MEL-30: 22.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042300 Approved Mitochondria NA NA Mitochondria "HPA042300: AB_10796900" "unprognostic (1.87e-1)" "unprognostic (1.10e-1)" "unprognostic (2.59e-1)" "unprognostic (7.57e-3)" "unprognostic (5.01e-3)" "unprognostic (8.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.96e-3)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-11)" "unprognostic (4.08e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-2)" "unprognostic (1.57e-1)" 0.8 17.0 2.7 3.6 4.7 0.0 0.7 5.4 3.5 0.7 1.4 28.1 68.4 0.7 0.1 0.3 0.5 24.5 0.9 2.1 3.9 0.1 13.4 0.1 0.1 6.9 5.3 1.7 0.4 4.7 0.1 5.1 0.1 5.7 0.2 21.4 1.3 0.1 0.0 0.0 0.1 69.2 2.1 5.4 22.4 23.8 0.9 4.7 0.0 0.1 0.0 0.1 5.7 0.6 7.7 6.9 4.2 0.0 1.6 1.3 3.6 0.1 0.1 3.6 0.7 1.4 1.8 9.5 0.0 0.3 0.6 8.2 0.0 0.0 0.0 0.8 0.1 0.1 0.5 0.1 4.9 11.8 0.0 4.8 1.0 2.9 2.3 3.6 0.4 0.2 0.0 15.0 0.6 0.0 0.0 0.0 0.3 0.0 30.9 9.8 0.0 0.0 0.5 0.0 0.0 0.4 1.0 0.0 4.2 22.4 0.0 0.0 1.9 0.0 1.0 1.4 0.5 0.1 0.0 3.7 0.0 1.1 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 4.7 5.4 3.5 2.1 3.9 6.9 5.3 1.7 5.7 5.4 4.7 7.7 0.3 0.0 0.0 0.0 0.4 1.8 2.8 1.9 0.0 0.1 0.2 0.3 0.6 21.5 3.8 1.8 0.0 0.0 0.0 123.6 0.0 15.5 0.0 1.2 1.0 0.5 4.8 0.0 0.8 25.8 0.1 1.1 60.1 0.5 0.0 4.1 0.7 5.7 0.2 16.8 0.7 20.8 0.0 0.0 1.1 0.3 0.0 0.4 0.0 1.0 0.6 0.2 1.0 0.0 5.8 26.9 94.9 0.0 0.4 3.4 113.1 0.0 4.5 0.5 0.0 3.1 1.8 0.3 0.2 0.0 1.1 0.1 0.5 3.6 18.7 19.7 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436811-94479682 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "skin 1: 108.2" "Cell type enriched" "Detected in some" 23 "Melanocytes: 3552.1" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 272 "SK-MEL-30: 257.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.4 0.4 0.6 0.0 0.9 0.1 3.0 0.5 0.7 0.2 0.2 0.2 0.0 0.3 0.9 0.0 0.9 0.1 0.1 0.6 0.7 0.2 0.2 0.1 0.0 0.5 0.6 0.6 0.4 0.4 0.0 1.6 0.0 0.5 0.3 0.0 0.9 1.5 0.3 0.4 108.2 0.1 0.1 0.5 0.1 0.1 0.6 0.5 0.5 0.2 0.1 0.0 0.2 0.3 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 257.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.5 0.7 0.6 0.7 0.5 0.6 0.6 0.5 0.5 0.5 0.5 0.0 0.0 0.0 23.5 0.0 152.3 0.1 0.0 0.0 1.0 0.3 0.5 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.5 0.1 1.2 0.0 0.0 16.1 0.2 0.0 1.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 25.5 23.8 0.9 0.0 3552.1 1.9 0.0 3.5 0.0 6.6 2.4 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.5 1.0 0.5 0.8 0.0 33.4 0.0 0.9 0.1 0.0 0.0 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027011: AB_2672082" "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 22.4 36.6 21.7 17.3 20.8 27.4 23.4 20.1 25.4 26.2 20.4 22.3 21.5 23.3 17.5 32.1 23.4 18.4 16.7 20.4 19.3 27.8 38.6 23.0 24.2 21.4 21.6 19.3 25.8 35.2 15.0 20.5 18.4 20.9 31.5 10.2 11.4 30.5 14.1 18.4 32.8 26.6 10.5 19.7 33.9 27.9 25.2 21.6 14.5 29.4 8.3 13.5 22.6 25.8 21.4 35.9 45.1 17.5 15.0 23.9 23.2 36.3 17.6 33.7 19.7 22.6 60.9 54.6 22.5 63.2 19.9 24.7 49.0 9.3 40.5 6.7 19.6 32.5 20.2 29.5 49.0 46.6 27.6 23.6 33.6 51.0 27.4 29.8 20.8 15.2 23.7 33.3 41.5 14.2 85.0 19.8 40.7 24.3 34.1 36.7 18.9 19.7 45.3 25.8 35.1 28.1 39.6 16.4 87.1 60.9 10.4 56.0 47.8 15.7 53.2 33.7 27.5 32.0 55.6 51.5 25.2 58.0 29.7 23.9 42.7 37.9 48.0 37.5 39.9 35.4 29.7 39.0 38.8 42.4 27.9 44.5 40.3 33.5 33.4 30.8 72.9 41.1 44.1 21.7 20.8 20.1 25.4 20.4 19.3 21.4 21.6 19.3 20.9 19.7 21.6 21.4 17.0 16.0 19.1 24.5 27.6 14.4 29.0 35.5 29.0 41.3 32.4 25.4 6.7 21.5 29.2 27.6 41.7 89.5 32.6 26.9 13.7 41.3 5.9 12.8 13.0 18.4 21.0 12.4 13.6 61.8 49.2 24.0 26.0 13.9 14.7 20.3 31.8 27.5 38.7 18.5 13.6 35.1 26.4 22.8 8.2 6.7 19.3 23.6 21.4 14.0 36.4 23.4 34.0 11.1 14.2 35.0 26.9 19.2 28.8 50.0 34.8 18.3 18.7 33.6 19.7 20.1 19.0 16.1 23.6 24.8 16.6 79.2 25.9 24.8 30.2 33.1 CRYBG3 DKFZp667G2110 ENSG00000080200 "Crystallin beta-gamma domain containing 3" Q68DQ2 3 97822011-97944984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 122.6;Bipolar cells: 123.6;Early spermatids: 121.4;Late spermatids: 131.8;Oligodendrocytes: 128.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 8 "dendritic cells: 3.6;granulocytes: 1.5;monocytes: 1.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075635 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075635: " "unprognostic (1.88e-1)" "unprognostic (7.62e-3)" "unprognostic (2.54e-1)" "unprognostic (4.56e-2)" "unprognostic (7.60e-2)" "unprognostic (2.70e-2)" "unprognostic (2.45e-2)" "unprognostic (7.10e-2)" "unprognostic (3.41e-3)" "unprognostic (6.59e-2)" "unprognostic (2.80e-2)" "unprognostic (7.86e-2)" "prognostic favorable (7.07e-4)" "unprognostic (1.78e-2)" "unprognostic (1.58e-1)" "unprognostic (1.14e-2)" "unprognostic (6.38e-3)" 10.7 2.9 5.4 5.6 12.9 0.8 7.8 9.1 7.0 8.1 4.5 7.1 3.6 6.6 2.8 9.0 5.6 5.4 6.6 5.0 10.2 5.0 3.2 5.8 3.4 15.1 10.1 3.4 3.6 5.4 3.8 1.2 10.8 14.9 5.0 7.7 7.9 6.4 4.1 7.6 13.0 4.5 6.5 12.6 4.1 5.4 14.1 10.6 2.8 26.9 9.9 4.5 7.6 4.6 17.7 16.5 6.1 3.5 4.2 11.1 11.8 6.2 5.8 5.3 4.2 6.3 0.4 5.4 0.1 1.9 10.1 6.2 10.5 7.0 4.9 8.0 20.4 3.8 4.1 2.7 2.1 5.8 6.1 1.0 7.7 4.9 5.3 5.8 6.9 8.2 1.3 0.3 3.0 7.4 0.2 2.2 0.7 3.0 4.5 5.5 0.0 12.3 2.1 6.1 10.9 39.2 3.0 12.2 4.8 3.9 2.2 4.2 6.8 10.9 8.9 6.9 5.2 7.1 5.0 0.1 3.7 9.3 3.5 5.8 1.5 1.4 0.0 0.1 0.9 0.2 0.1 0.2 0.2 1.4 0.2 0.1 0.1 0.0 0.0 1.0 3.6 0.0 0.3 5.4 12.9 9.1 7.0 5.0 10.2 15.1 10.1 3.4 14.9 12.6 10.6 17.7 122.6 32.1 19.6 48.0 4.2 5.1 7.0 3.7 23.9 123.6 13.7 9.3 37.6 1.5 16.9 18.4 6.2 4.0 13.8 6.0 1.9 8.8 121.4 32.6 48.9 52.1 12.7 2.5 37.5 13.1 11.3 38.0 18.3 22.7 0.0 68.0 15.0 5.1 6.6 13.5 23.0 8.3 2.0 17.4 3.0 131.8 8.4 18.9 8.8 37.5 22.1 29.4 1.0 10.6 128.3 13.2 8.7 4.5 12.0 7.1 2.5 2.8 21.3 9.6 39.5 29.2 18.2 49.6 9.5 24.5 6.1 2.3 3.0 14.0 5.2 7.0 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 26.2;testis: 8.5" "Cell type enhanced" "Detected in some" "Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 9.3;U-266/70: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.2 0.0 7.5 0.0 11.2 0.0 0.2 26.2 11.4 0.8 0.0 2.0 0.1 0.9 0.3 0.8 1.9 0.9 0.3 11.9 5.3 0.4 0.0 0.1 0.0 2.9 1.7 10.9 6.4 0.5 0.1 0.1 0.0 13.2 1.0 0.7 1.1 0.1 0.6 0.0 0.0 0.3 1.4 0.0 0.0 0.6 8.5 3.3 0.2 2.0 0.1 0.1 1.4 0.6 4.4 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 9.3 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.4 0.0 0.9 28.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 11.2 26.2 11.4 11.9 5.3 2.9 1.7 10.9 13.2 0.0 3.3 4.4 0.0 0.0 0.0 421.5 0.1 0.3 0.3 0.0 5.2 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.8 0.1 1.4 0.1 0.0 0.0 423.8 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 879.2 0.0 0.0 0.0 0.0 208.7 3.1 0.2 0.0 30.0 0.0 1.0 0.0 31.2 9.0 0.1 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.3 0.0 0.2 0.1 14.7 2.7 6.0 0.0 0.1 0.0 0.4 0.0 0.1 SCTR ENSG00000080293 "Secretin receptor" P47872 2 119439843-119525301 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 26.8;pancreas: 68.7" "Group enriched" "Detected in some" 6 "Alveolar cells type 2: 54.4;Ductal cells: 92.0;Exocrine glandular cells: 93.8;Pancreatic endocrine cells: 41.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.3" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "basophil: 1.5" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.5" "Cell line enriched" "Detected in single" 5 "Karpas-707: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA007269 Uncertain NA NA "HPA007269: AB_1856640" "unprognostic (1.51e-1)" "unprognostic (2.22e-1)" "unprognostic (4.99e-2)" "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (9.08e-2)" "unprognostic (7.35e-2)" "unprognostic (2.38e-2)" "unprognostic (6.11e-3)" "unprognostic (1.65e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (4.38e-2)" 0.3 0.4 0.3 0.2 0.3 0.3 0.0 0.6 1.2 0.0 0.3 0.1 26.8 0.2 0.2 0.3 0.4 0.4 0.2 0.4 0.3 4.2 0.4 8.7 0.1 0.3 0.3 0.2 0.4 68.7 0.1 0.2 0.1 0.4 0.0 0.0 2.4 0.0 0.0 0.2 0.2 3.8 0.0 0.2 0.3 4.5 0.5 0.4 0.1 0.9 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.6 1.2 0.4 0.3 0.3 0.3 0.2 0.4 0.2 0.4 0.4 0.0 0.0 54.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.8 5.5 0.0 0.0 0.0 0.1 11.7 92.0 4.5 0.0 0.2 0.1 2.4 0.0 3.0 93.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.7 5.0 4.1 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 1.0 1.6 0.3 0.0 0.0 0.7 41.9 0.0 0.0 0.0 0.1 0.1 0.5 0.0 1.9 0.0 0.0 0.6 0.3 0.9 0.0 0.0 0.3 0.4 0.0 0.1 0.0 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;choroid plexus: 34.0" "Cell type enhanced" "Detected in many" "Astrocytes: 394.4;Early spermatids: 182.8;Excitatory neurons: 333.6;Inhibitory neurons: 208.8;Microglial cells: 188.3;Oligodendrocyte precursor cells: 256.9;Oligodendrocytes: 179.6;Respiratory ciliated cells: 150.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 26.4;HDLM-2: 16.2;SCLC-21H: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favorable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 3.0 1.9 15.8 2.0 16.3 6.3 3.4 24.3 33.4 4.3 34.0 2.4 2.2 3.2 2.8 1.4 11.6 2.2 1.7 29.4 14.2 2.1 1.6 4.3 3.5 13.5 15.1 14.3 3.8 2.4 3.3 4.5 2.7 8.3 3.1 2.4 9.0 2.2 1.8 3.3 2.2 2.8 1.6 21.4 3.0 3.1 21.4 8.8 6.4 2.7 1.5 3.7 2.2 2.9 13.2 2.5 3.3 26.4 6.4 1.0 1.1 2.6 1.0 2.9 2.3 1.7 1.0 3.1 3.9 1.1 1.4 1.8 1.4 6.5 2.8 3.9 16.2 1.8 7.3 3.6 2.2 1.3 1.5 1.0 1.6 1.3 2.7 4.4 4.4 4.0 5.0 1.4 3.9 2.4 1.9 4.7 5.4 7.0 2.1 1.4 4.9 1.8 1.0 3.6 1.9 14.1 6.2 1.5 0.8 2.4 5.1 1.3 3.9 2.5 1.7 3.8 0.9 1.6 1.3 0.6 7.8 1.8 1.7 1.8 2.4 2.2 4.7 5.9 3.3 3.6 4.1 5.3 4.7 2.2 5.1 3.6 4.5 6.1 4.0 1.0 3.2 7.2 2.7 15.8 16.3 24.3 33.4 29.4 14.2 13.5 15.1 14.3 8.3 21.4 8.8 13.2 15.7 6.4 7.7 394.4 20.9 5.0 8.0 6.4 6.2 24.7 7.7 6.2 6.9 2.8 23.2 3.7 25.0 2.0 11.3 2.4 0.0 3.9 182.8 89.4 16.1 18.5 141.1 7.4 333.6 2.5 2.7 7.3 7.1 11.2 6.3 8.4 15.0 1.0 3.1 38.7 208.8 9.4 6.1 7.3 5.7 120.8 7.2 8.6 1.8 188.3 5.4 14.5 5.2 256.9 179.6 4.2 4.9 7.5 8.1 6.1 2.9 2.2 150.3 24.7 0.0 22.8 11.4 8.9 5.2 4.9 6.3 1.4 12.2 5.9 6.0 3.9 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 6.2 5.1 4.9 7.4 8.6 21.9 10.1 14.3 7.8 6.6 3.3 5.7 4.3 8.3 4.0 5.7 5.7 5.6 3.6 5.3 5.4 5.5 6.7 5.1 8.5 5.0 5.6 4.2 11.3 7.1 6.8 3.5 8.1 6.1 6.0 6.2 8.3 7.8 5.1 7.6 7.3 4.7 6.3 4.6 6.5 6.1 11.1 5.3 10.8 9.1 9.6 8.0 7.4 4.7 14.3 20.8 17.4 26.8 20.5 10.7 13.8 25.9 24.8 18.0 21.6 25.5 28.9 16.4 39.2 21.7 17.3 17.9 21.3 41.2 17.1 36.1 27.8 19.8 63.4 21.4 21.0 11.2 64.7 20.2 10.3 11.3 38.8 28.7 12.3 21.3 23.5 52.2 32.6 22.1 13.8 38.3 22.9 43.2 11.2 22.9 38.4 42.1 26.1 11.6 24.9 24.2 18.8 32.0 14.6 16.5 18.8 12.9 23.1 27.0 32.9 22.8 20.3 26.7 16.0 29.6 55.4 15.3 25.5 22.5 6.3 2.5 3.0 4.3 1.7 4.9 4.0 3.6 3.2 1.8 3.1 4.8 3.7 2.8 7.7 3.5 1.6 2.8 1.7 4.9 8.6 14.3 7.8 5.3 5.4 5.0 5.6 4.2 6.1 4.6 5.3 14.3 53.1 96.1 49.7 41.1 43.5 49.3 47.5 21.9 33.0 48.2 30.4 29.8 38.2 28.6 38.0 14.7 31.3 39.2 40.3 19.6 1.9 38.5 22.6 38.0 61.7 48.0 25.0 84.3 68.5 21.9 35.9 51.3 34.7 65.0 34.1 88.6 27.1 19.7 23.0 47.1 72.4 30.9 14.2 26.4 27.0 14.0 43.8 37.6 30.2 48.7 44.1 35.8 32.0 73.9 126.3 29.9 23.5 34.3 45.1 53.2 14.9 12.9 21.3 42.8 85.5 106.5 51.2 122.8 113.1 28.9 41.6 40.9 45.3 58.9 34.6 45.4 RAB21 KIAA0118 ENSG00000080371 "RAB21, member RAS oncogene family" Q9UL25 12 71754863-71800286 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 497.9;Late spermatids: 807.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016988, CAB037048" Approved NA NA 13000 "CAB037048: AB_1841130, HPA016988: AB_1855998" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" "unprognostic (8.57e-2)" "unprognostic (3.03e-1)" "unprognostic (6.28e-2)" "unprognostic (1.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (2.43e-2)" "unprognostic (5.68e-2)" "prognostic favorable (5.39e-8)" "unprognostic (1.75e-1)" "unprognostic (1.81e-1)" "unprognostic (1.91e-2)" "unprognostic (6.31e-2)" 6.1 7.4 6.8 3.8 7.9 8.1 5.1 7.4 7.3 4.8 5.7 4.8 3.8 4.9 4.0 5.8 4.4 4.5 11.6 6.3 7.6 8.4 6.2 6.5 4.5 8.1 7.8 6.0 5.2 3.9 6.6 5.4 5.4 7.7 5.1 3.5 3.5 4.2 4.4 14.3 6.3 4.0 4.4 8.1 4.7 4.3 2.5 7.5 4.7 5.9 7.7 4.3 5.4 5.4 9.0 6.0 4.6 4.7 3.8 7.5 4.8 8.1 8.3 4.9 5.6 3.8 5.6 2.8 9.3 9.5 7.4 3.3 5.1 8.5 5.8 8.8 7.5 3.9 8.6 3.3 6.2 7.7 9.5 5.0 5.6 8.9 6.2 9.6 8.6 3.9 5.1 6.0 5.3 8.6 5.5 7.7 6.3 7.0 3.4 6.9 7.4 5.2 6.7 8.4 8.3 4.7 3.8 10.4 9.8 6.2 5.8 7.7 6.1 6.1 7.3 2.9 11.7 6.2 6.8 7.0 7.1 3.8 5.4 5.3 0.8 0.3 0.5 0.4 0.3 0.4 0.4 0.4 0.3 0.2 0.4 0.4 0.4 1.2 0.4 0.3 0.5 0.3 0.1 6.8 7.9 7.4 7.3 6.3 7.6 8.1 7.8 6.0 7.7 8.1 7.5 9.0 93.7 28.9 56.5 17.9 60.7 119.6 78.4 29.6 32.5 45.4 66.1 45.1 179.9 48.6 31.6 47.8 79.2 39.4 96.5 60.4 13.7 22.5 497.9 48.0 56.6 73.1 49.6 21.0 24.9 20.8 38.0 66.6 30.1 109.0 24.1 22.1 48.5 62.3 42.7 52.2 31.9 35.8 20.3 55.7 168.9 807.6 36.1 88.9 55.2 17.8 41.5 41.9 36.0 33.7 47.5 34.2 40.7 41.8 47.8 97.7 44.4 62.5 20.0 37.3 26.3 90.9 81.2 19.2 16.6 56.1 160.1 83.5 59.8 35.5 41.2 117.7 SLC4A4 "hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5" ENSG00000080493 "Solute carrier family 4 member 4" Q9Y6R1 4 71062667-71572087 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 120.6;pancreas: 262.5" "Cell type enhanced" "Detected in many" "Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0" "Group enriched" "Detected in many" 5 "glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022493, HPA035628, HPA035629, HPA079220" Enhanced NA NA "CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: " "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "prognostic favorable (7.69e-4)" "unprognostic (5.32e-2)" "unprognostic (1.01e-1)" "unprognostic (5.09e-2)" "unprognostic (4.24e-2)" "unprognostic (7.49e-2)" "unprognostic (1.46e-1)" "unprognostic (9.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.18e-4)" "unprognostic (7.00e-2)" "unprognostic (2.92e-1)" "unprognostic (2.05e-3)" "unprognostic (2.04e-1)" 5.2 0.7 31.9 2.2 40.2 0.5 1.0 48.9 33.8 11.6 1.1 41.4 54.8 0.4 0.3 1.2 1.0 29.6 6.3 23.6 61.5 120.6 21.9 7.0 0.2 37.9 28.6 21.9 0.8 262.5 17.3 5.9 2.7 30.2 35.0 41.6 5.1 2.5 1.1 2.3 0.1 14.7 1.7 34.8 0.8 18.8 0.5 29.6 3.5 22.2 3.5 0.0 4.6 0.4 34.0 0.0 3.5 1.0 0.0 0.0 0.0 0.1 13.0 1.9 2.2 1.6 0.0 0.1 0.0 0.1 6.1 0.5 0.0 0.2 0.0 5.7 0.0 1.7 0.9 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 6.0 0.0 0.7 0.0 0.5 1.2 0.0 4.8 0.2 0.1 0.2 0.0 0.0 0.0 0.9 15.4 4.1 0.9 0.1 0.0 0.0 0.2 1.3 0.0 0.0 0.0 7.7 0.7 5.5 0.6 0.0 0.0 0.0 5.1 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 31.9 40.2 48.9 33.8 23.6 61.5 37.9 28.6 21.9 30.2 34.8 29.6 34.0 1.5 3.2 37.1 819.1 2.2 0.0 4.3 3.2 0.6 3.2 0.9 0.3 24.0 133.0 31.1 25.8 0.0 0.3 7.2 282.9 15.6 129.2 11.5 2.8 0.5 1.3 8.5 4.0 51.4 24.2 0.1 4.9 33.1 5.8 1.3 0.6 3.9 35.8 0.2 0.0 93.4 65.6 2.0 0.6 0.2 1.5 0.0 2.3 1.8 34.7 1.0 3.9 1.0 29.1 3.7 16.2 60.8 0.0 1.7 40.8 31.8 211.0 10.4 1.5 6.6 1.0 6.2 0.1 1.0 5.5 0.0 0.3 6.8 2.4 68.1 12.3 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease variant, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 246.5;Inhibitory neurons: 263.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 1486.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA 19000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favorable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 52.4 56.4 86.2 36.5 86.7 96.5 62.7 93.5 92.3 42.4 43.6 31.3 20.3 53.7 57.8 42.0 57.9 46.5 44.2 97.1 74.0 46.3 58.8 40.6 51.3 62.3 66.8 82.3 167.5 37.1 171.6 32.9 48.6 103.7 42.9 32.0 64.2 51.1 53.7 98.7 48.6 27.9 44.6 50.7 52.8 32.3 56.8 80.6 42.6 56.2 60.6 48.2 32.1 29.0 74.5 45.7 32.9 23.7 33.8 47.2 56.6 71.7 59.4 44.6 24.9 19.5 0.5 17.7 76.2 22.0 50.7 13.5 18.8 12.9 46.5 17.6 1486.7 20.2 208.3 88.2 16.2 18.7 88.3 118.1 37.6 17.5 24.9 46.4 44.9 40.3 35.4 7.3 255.1 43.0 19.1 22.2 72.3 23.4 26.4 12.6 97.6 30.5 69.4 57.6 40.9 15.3 14.0 36.2 8.3 14.9 34.1 16.3 55.8 49.1 40.6 19.8 25.8 27.3 22.9 31.8 33.6 43.5 32.5 11.4 26.1 5.2 15.8 10.8 7.2 10.4 12.3 10.5 11.2 6.4 9.4 13.1 10.3 14.6 9.9 10.3 12.5 12.6 5.0 86.2 86.7 93.5 92.3 97.1 74.0 62.3 66.8 82.3 103.7 50.7 80.6 74.5 83.9 73.7 70.6 246.5 57.2 58.6 18.3 55.0 82.6 57.6 103.7 74.3 95.2 31.5 54.1 106.7 37.5 99.3 102.8 32.0 31.3 30.6 38.0 44.1 61.6 69.0 37.2 41.2 216.2 22.4 24.5 65.7 19.4 45.2 48.0 27.9 36.8 62.0 31.5 35.3 263.2 31.2 48.8 54.9 34.7 22.6 76.7 57.5 49.8 142.4 45.2 53.4 43.3 120.6 100.8 18.7 15.1 86.9 71.4 13.9 26.9 18.5 88.3 37.4 13.1 58.7 40.3 42.9 14.6 66.2 52.7 88.7 74.8 56.1 28.2 12.7 RDH8 "PRRDH, SDR28C2" ENSG00000080511 "Retinol dehydrogenase 8" Q9NYR8 19 10013249-10022279 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 115.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 39.3;Cone photoreceptor cells: 54.2;Early spermatids: 72.6;Muller glia cells: 22.1;Rod photoreceptor cells: 203.4" "Cancer enriched" "Detected in some" 4 "melanoma: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064473 Approved "Nucleoplasm,Midbody ring,Cytosol" Yes NA Nucleoplasm "Midbody ring, Cytosol" "HPA064473: " "unprognostic (4.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (9.98e-3)" "unprognostic (4.58e-3)" "unprognostic (2.66e-1)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (3.86e-1)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 115.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.2 0.0 0.0 0.0 54.2 0.0 0.0 0.0 0.0 0.0 72.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 203.4 0.0 0.0 0.2 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SESN1 "PA26, SEST1" ENSG00000080546 "Sestrin 1" Q9Y6P5 6 108986437-109094819 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 137.2;Excitatory neurons: 134.9;Inhibitory neurons: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 48.0;NK-cells: 58.9;T-cells: 74.6" "Cell line enhanced" "Detected in all" "BEWO: 80.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073659 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA073659: AB_2686622" "unprognostic (2.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (3.52e-2)" "unprognostic (1.17e-1)" "prognostic favorable (6.47e-5)" "unprognostic (2.68e-1)" "unprognostic (6.91e-2)" "unprognostic (1.01e-1)" "unprognostic (8.33e-2)" "unprognostic (1.83e-3)" "prognostic favorable (2.07e-4)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (7.95e-2)" 30.9 26.9 33.9 23.4 35.3 50.7 42.8 33.9 35.7 28.2 34.4 29.4 20.4 32.0 26.9 22.9 32.8 18.7 34.3 34.3 36.6 16.9 29.5 25.9 34.1 31.2 31.9 32.5 63.2 31.9 50.7 26.0 53.9 33.0 25.3 24.1 25.3 18.4 23.9 152.6 40.4 38.4 33.2 32.6 37.3 31.2 42.4 33.3 22.1 32.3 141.2 34.1 28.6 28.5 34.4 3.5 5.7 25.7 12.2 32.1 40.6 80.5 13.8 15.7 4.7 9.0 10.9 3.6 29.3 11.4 10.2 3.7 4.1 7.0 27.6 5.8 2.6 34.7 13.0 6.9 40.9 19.7 5.1 12.7 44.2 43.0 8.5 13.7 20.5 24.7 8.3 9.7 20.5 23.3 6.9 11.3 16.4 10.6 5.7 3.6 9.0 7.3 13.7 10.1 17.4 6.3 12.7 7.5 4.7 5.7 41.3 4.5 33.5 15.3 3.6 7.1 3.3 4.5 20.5 12.5 12.0 7.9 12.8 7.9 11.9 2.7 3.4 34.4 6.3 74.6 13.3 32.4 27.3 2.7 48.0 39.6 20.8 10.0 58.9 8.7 5.4 15.1 20.3 33.9 35.3 33.9 35.7 34.3 36.6 31.2 31.9 32.5 33.0 32.6 33.3 34.4 13.9 64.1 22.4 79.0 37.3 6.5 4.9 7.4 25.0 23.8 14.2 14.5 30.0 17.2 15.2 14.7 45.9 57.8 22.9 12.7 9.8 4.3 137.2 10.3 15.2 9.8 15.5 24.2 134.9 5.3 13.7 21.9 28.5 8.2 3.8 17.4 10.8 14.7 44.9 26.9 127.7 10.0 2.0 43.1 11.3 104.8 34.5 56.5 16.0 71.2 9.4 39.1 25.7 64.3 119.1 3.1 11.9 35.3 26.2 9.4 7.8 9.3 26.4 44.3 26.3 43.9 15.9 18.4 16.2 25.4 8.4 44.6 41.8 102.9 13.6 4.3 MID2 "FXY2, MRX101, RNF60, TRIM1" ENSG00000080561 "Midline 2" Q9UJV3 X 107825755-107931637 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 14.5;Inhibitory neurons: 21.5;Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Lineage enriched" "Detected in single" 6 "T-cells: 1.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 41.5;Karpas-707: 35.5;MCF7: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.28e-2)" "unprognostic (8.51e-2)" "unprognostic (3.69e-4)" "unprognostic (6.40e-3)" "unprognostic (1.16e-1)" "unprognostic (7.50e-2)" "unprognostic (3.87e-1)" "unprognostic (7.20e-2)" "unprognostic (1.09e-2)" "unprognostic (4.87e-2)" "unprognostic (2.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.19e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (3.77e-1)" "unprognostic (5.97e-3)" 11.3 9.3 5.3 3.9 6.0 0.4 7.3 4.6 3.7 8.3 4.1 4.6 1.8 9.5 8.0 13.7 8.9 7.8 3.1 3.6 9.7 6.1 5.5 6.5 4.5 7.6 7.5 2.1 9.3 9.7 13.0 3.2 4.5 7.8 10.4 3.6 15.0 11.2 9.7 13.0 9.2 2.7 15.9 5.9 3.8 4.5 2.1 7.5 2.3 13.4 18.7 5.3 10.7 7.6 7.5 8.4 7.1 0.2 11.2 8.8 12.3 0.1 5.9 15.0 5.0 3.6 0.6 1.5 0.0 7.5 11.7 8.3 5.2 4.1 12.1 1.1 0.0 5.5 0.0 4.2 0.0 13.5 0.0 0.0 8.0 13.3 0.1 14.5 9.1 41.5 0.5 0.0 35.5 5.6 26.8 0.1 0.0 1.2 0.3 13.0 0.0 3.2 0.0 6.3 7.5 0.6 0.0 12.6 0.5 18.6 3.9 4.6 0.5 8.2 0.0 2.1 9.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.8 1.4 0.0 0.2 1.6 1.1 0.0 0.0 0.0 0.0 0.1 0.4 5.3 6.0 4.6 3.7 3.6 9.7 7.6 7.5 2.1 7.8 5.9 7.5 7.5 3.1 3.2 0.0 8.1 0.4 3.1 3.3 0.9 4.0 1.9 2.3 1.8 0.6 1.5 1.1 0.0 0.0 0.0 0.3 0.3 1.9 1.8 1.1 1.0 1.7 2.6 0.0 0.0 14.5 1.5 0.0 1.5 1.1 1.5 0.0 0.3 2.2 1.8 0.1 0.0 21.5 0.2 0.0 0.0 0.0 1.4 0.0 0.2 3.6 7.5 0.0 0.8 0.0 8.0 7.4 1.1 0.0 0.7 1.1 4.2 0.5 0.8 2.3 3.9 0.0 1.9 2.1 0.2 0.4 3.9 3.7 0.0 1.7 0.8 0.4 11.4 DNAAF6 "CXorf41, MGC35261, NYSAR97, PIH1D3, TWISTER" ENSG00000080572 "Dynein axonemal assembly factor 6" Q9NQM4 X 107206611-107244247 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 12.2;testis: 12.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "midbrain: 3.0" HPA072496 Enhanced NA NA "HPA072496: AB_2732202" "unprognostic (8.66e-2)" "unprognostic (2.75e-3)" "unprognostic (7.73e-4)" "unprognostic (3.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.3 0.2 0.2 0.8 0.0 0.0 0.1 0.6 0.0 12.2 0.0 0.0 0.2 0.9 0.1 0.0 1.5 0.0 1.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 12.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.3 0.2 0.2 0.9 1.4 0.8 0.1 0.7 1.0 0.3 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COL5A3 ENSG00000080573 "Collagen type V alpha 3 chain" P25940 19 9959561-10010504 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Astrocytes: 510.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 38.9;BJ: 23.6;BJ hTERT+: 26.2;BJ hTERT+ SV40 Large T+: 14.4;HSkMC: 28.2;WM-115: 26.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA041695, HPA048256" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 330000 "Plasma membrane" "HPA041695: , HPA048256: AB_2680330" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" "unprognostic (4.63e-2)" "unprognostic (3.24e-2)" "unprognostic (6.84e-3)" "unprognostic (3.01e-1)" "unprognostic (7.47e-2)" "unprognostic (1.79e-2)" "unprognostic (2.36e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.17e-8)" "unprognostic (3.25e-2)" "unprognostic (7.31e-3)" "unprognostic (6.00e-2)" "prognostic unfavorable (6.87e-5)" 42.8 5.1 31.0 9.9 31.5 0.1 32.6 29.7 46.2 43.9 37.9 15.8 3.8 27.5 1.9 9.1 23.0 4.2 27.8 31.2 23.5 3.3 13.5 14.3 3.2 34.4 26.4 26.1 6.3 5.2 3.0 3.5 33.1 29.0 16.8 2.0 21.3 7.4 9.0 15.4 21.9 11.8 10.4 28.5 1.7 10.0 4.7 28.9 4.6 12.8 6.1 3.9 12.7 26.6 26.9 0.0 0.0 0.5 0.0 12.4 38.9 0.0 23.6 26.2 14.4 5.7 0.0 0.0 0.0 0.2 4.4 0.3 2.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 28.2 0.6 5.2 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.1 0.0 0.0 0.0 11.6 5.5 0.5 0.0 0.0 0.0 0.0 1.5 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 31.5 29.7 46.2 31.2 23.5 34.4 26.4 26.1 29.0 28.5 28.9 26.9 13.7 0.0 0.0 510.3 0.0 4.2 0.1 0.2 2.2 65.1 0.3 0.9 6.4 0.0 0.1 0.0 6.2 0.1 0.3 1.3 0.0 0.2 6.9 0.4 12.0 8.1 0.0 0.0 15.6 0.0 0.2 17.5 0.5 0.4 0.0 0.0 3.9 22.9 0.6 3.3 3.4 0.0 0.0 0.0 3.2 2.1 17.4 0.4 14.2 36.5 0.1 2.6 0.0 73.9 2.5 0.3 0.1 8.2 0.0 0.3 0.2 0.1 0.9 28.3 92.1 8.5 58.0 0.3 0.3 3.2 7.1 0.1 1.9 0.9 0.0 0.3 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 15.5 12.0 2.6 19.1 2.8 30.4 10.2 4.9 4.3 12.9 1.0 13.3 15.8 15.6 6.4 13.6 14.4 11.0 12.2 2.3 0.8 9.7 7.2 11.7 15.5 5.5 3.0 0.0 17.1 19.6 20.4 9.5 12.7 10.2 12.7 11.3 12.6 18.1 13.2 24.8 16.4 16.2 15.2 0.6 18.8 16.1 20.8 3.7 20.4 14.1 19.6 13.7 11.4 10.0 5.1 29.5 60.1 36.9 35.9 28.3 19.5 37.7 24.0 21.1 26.2 20.7 27.8 21.9 65.9 29.7 30.5 16.9 27.8 37.7 27.5 21.9 42.2 88.1 42.5 56.2 24.3 11.4 49.8 48.0 20.8 13.2 40.3 29.0 12.8 27.8 21.7 65.4 36.5 19.7 34.5 42.2 17.4 37.6 10.8 27.7 57.7 28.7 36.4 7.5 34.2 34.5 36.5 26.6 31.0 8.4 12.2 35.4 26.0 44.1 37.0 26.5 21.0 31.6 39.8 36.7 45.9 29.7 23.2 28.9 0.3 0.7 2.9 0.8 1.2 0.6 0.7 0.4 0.9 0.5 1.0 0.5 0.4 2.2 0.6 0.3 0.9 0.9 0.7 2.6 2.8 4.9 4.3 2.3 0.8 5.5 3.0 0.0 10.2 0.6 3.7 5.1 3.0 3.2 3.7 8.8 9.8 24.6 1.9 186.4 13.1 7.5 3.3 1.8 2.4 4.3 145.6 1.8 8.4 2.3 5.3 54.3 0.0 1.4 1.2 4.6 3.0 3.4 11.3 7.6 8.6 3.1 1.4 4.2 19.9 4.7 2.5 3.0 2.2 3.0 2.3 8.4 8.6 17.7 179.0 1.9 14.3 0.9 2.8 3.4 10.6 8.4 3.0 1.7 6.2 4.5 10.6 1.9 39.1 1.2 11.1 3.1 3.1 0.6 118.3 5.8 0.0 5.0 14.3 5.6 6.0 7.8 58.2 2.5 8.9 2.0 25.6 3.1 PUM3 "HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5" ENSG00000080608 "Pumilio RNA binding family member 3" Q15397 9 2720469-2844095 "Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 338.4;HEL: 327.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002353 Approved Supported Nucleoli NA NA Nucleoli "HPA002353: AB_1852266" "unprognostic (1.39e-2)" "unprognostic (1.32e-2)" "unprognostic (7.54e-2)" "unprognostic (2.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (4.89e-5)" "unprognostic (2.02e-1)" "unprognostic (6.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.44e-3)" "unprognostic (8.44e-2)" "unprognostic (1.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.43e-2)" 16.8 16.9 6.6 22.5 6.4 19.2 24.9 8.2 5.7 13.9 5.0 16.0 12.9 14.8 9.9 25.0 13.7 11.8 11.7 5.8 5.6 18.1 15.3 15.5 23.4 5.1 4.9 5.4 18.4 14.9 12.3 10.1 18.2 5.6 12.6 18.8 7.5 17.0 10.7 11.2 16.8 11.8 13.7 4.6 14.8 13.3 15.5 5.1 17.2 12.0 9.5 22.2 31.0 16.1 7.0 78.9 56.7 47.0 48.2 38.6 40.8 53.5 71.7 37.6 72.3 67.3 43.6 36.0 86.4 16.1 49.5 43.2 38.8 85.8 62.0 93.5 338.4 30.7 327.8 59.3 52.9 51.0 146.2 58.7 33.3 26.8 58.8 83.5 33.0 54.3 55.6 35.0 38.1 63.8 36.0 74.6 119.9 120.4 59.9 25.1 86.7 36.8 37.3 48.8 52.7 48.4 46.4 43.2 39.8 40.3 52.0 25.2 78.4 52.1 48.6 40.2 46.8 97.1 17.7 31.0 120.5 36.8 52.4 36.1 7.7 13.7 4.1 18.8 19.9 26.3 23.4 19.3 18.9 18.5 22.4 21.2 20.7 1.9 25.2 17.1 20.8 15.7 11.8 6.6 6.4 8.2 5.7 5.8 5.6 5.1 4.9 5.4 5.6 4.6 5.1 7.0 27.7 48.1 41.4 0.0 35.8 0.0 59.6 0.0 62.6 28.0 27.5 26.7 0.0 14.3 41.5 23.9 10.4 34.7 25.5 1.9 46.9 41.2 4.8 36.7 79.1 28.3 8.5 23.8 0.0 26.5 45.4 30.9 35.2 54.9 17.7 39.8 20.0 22.1 21.6 26.9 0.0 9.2 0.0 15.8 0.0 4.9 47.2 20.6 0.0 0.0 29.4 14.2 25.7 0.0 0.0 29.1 8.0 23.0 29.2 57.7 7.6 108.3 32.1 24.0 0.0 50.2 26.8 43.7 45.3 54.3 0.0 35.0 26.5 44.5 12.7 38.2 CPB2 "CPU, PCPB, TAFI" ENSG00000080618 "Carboxypeptidase B2" Q96IY4 13 46053186-46105033 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 84 "liver: 1496.4" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 1332.7" "Cancer enriched" "Detected in some" 112 "liver cancer: 268.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 86 "Hep G2: 173.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA004146 Approved "Secreted to blood" NA NA 8500000000 "HPA004146: AB_1078397" "unprognostic (3.44e-2)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.89e-2)" "unprognostic (7.69e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.89e-1)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.83e-2)" "unprognostic (3.20e-3)" "unprognostic (1.34e-1)" "unprognostic (7.10e-2)" "unprognostic (3.34e-2)" "unprognostic (9.61e-2)" 0.0 0.0 0.3 0.1 2.6 0.7 0.1 0.7 2.4 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 4.9 0.0 0.4 1.3 0.4 1496.4 17.7 0.1 2.6 1.8 0.3 0.0 0.5 0.0 0.0 0.0 2.5 0.1 0.0 0.4 0.1 0.2 0.2 0.1 0.1 0.0 0.5 0.4 0.1 0.2 1.6 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.3 173.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.1 0.0 2.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.5 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 2.6 0.7 2.4 0.4 1.3 2.6 1.8 0.3 2.5 0.5 1.6 4.9 0.0 3.2 27.0 3.9 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 190.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.0 0.0 10.7 4.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 15.7 1332.7 0.1 0.0 5.3 0.0 0.0 22.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 13.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 CHRNA3 ENSG00000080644 "Cholinergic receptor nicotinic alpha 3 subunit" P32297 15 78593052-78621295 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 39.6;lymphoid tissue: 66.4;retina: 53.9" "Cell type enriched" "Detected in some" 19 "Cone photoreceptor cells: 164.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 356.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029430 Enhanced Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA029430: AB_10603785" "unprognostic (2.28e-1)" "unprognostic (3.45e-1)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.16e-3)" "unprognostic (1.97e-1)" "unprognostic (4.28e-2)" "unprognostic (7.20e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-4)" "unprognostic (2.65e-3)" "unprognostic (2.76e-1)" "unprognostic (1.53e-1)" "unprognostic (4.48e-1)" 0.4 39.6 3.9 5.2 2.0 0.0 0.1 6.2 2.3 0.6 0.7 6.5 1.5 0.5 0.0 0.1 0.0 0.3 0.3 0.8 2.0 0.0 0.0 0.2 0.3 3.0 6.7 0.5 0.1 0.2 0.0 1.2 0.1 6.6 0.2 4.1 53.9 0.1 0.0 0.1 0.5 3.0 3.8 0.3 0.1 2.8 1.0 9.1 66.4 0.2 0.0 0.9 0.2 0.7 1.1 0.1 0.3 0.7 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 8.8 0.0 0.0 0.3 1.4 0.5 0.4 0.1 0.0 0.1 4.0 0.0 0.3 0.0 0.0 0.0 0.0 22.6 0.2 0.0 0.0 0.3 7.1 0.0 1.6 0.1 0.2 0.4 0.3 0.1 0.0 0.4 67.7 356.1 0.3 0.1 0.1 0.5 0.4 0.0 0.0 0.1 1.7 0.1 0.4 0.2 0.7 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.0 6.2 2.3 0.8 2.0 3.0 6.7 0.5 6.6 0.3 9.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 164.7 0.0 0.0 0.2 1.9 0.0 3.7 0.1 1.2 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.4 3.6 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.1 0.1 0.3 2.1 0.0 0.0 0.0 0.0 2.6 0.1 0.1 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114055926-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 28.0;brain: 21.0;liver: 31.6" "Cell type enhanced" "Detected in some" "Astrocytes: 36.2;Excitatory neurons: 149.9;Inhibitory neurons: 97.0;Oligodendrocyte precursor cells: 63.3" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 17.5;NTERA-2: 6.4;SK-MEL-30: 12.9;THP-1: 21.8;U-937: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.3 28.0 9.0 0.2 12.0 0.0 0.5 12.5 15.1 1.8 2.5 0.9 0.3 2.9 0.3 0.2 0.4 0.4 6.8 21.0 9.9 4.0 31.6 2.3 0.4 11.1 7.5 7.3 0.8 4.5 0.4 7.7 0.0 7.6 9.7 0.7 2.5 0.5 4.3 9.6 1.3 0.3 2.0 9.7 0.5 0.7 3.1 7.0 0.2 0.3 6.7 0.2 2.4 1.0 12.4 0.1 0.0 0.0 0.0 0.0 0.0 2.1 17.5 2.7 0.3 0.0 0.0 0.2 0.0 0.5 0.0 2.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.0 0.2 0.0 0.3 0.0 1.4 6.4 0.0 0.0 0.0 0.0 0.8 0.2 0.1 2.1 0.0 0.0 0.2 12.9 0.4 0.3 21.8 0.3 0.0 0.5 1.8 0.0 0.1 0.0 0.1 2.0 7.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 12.0 12.5 15.1 21.0 9.9 11.1 7.5 7.3 7.6 9.7 7.0 12.4 1.4 0.0 1.1 36.2 0.0 0.3 0.3 0.0 0.0 7.9 0.6 1.3 15.1 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.6 0.6 0.5 0.0 8.2 0.0 0.0 149.9 0.9 0.0 0.8 0.0 1.3 0.0 0.8 5.0 18.3 0.0 0.0 97.0 1.0 0.0 1.0 0.3 0.5 0.0 0.1 21.4 6.5 0.0 0.4 0.0 63.3 9.2 1.0 0.1 0.0 1.2 4.7 0.0 0.7 0.0 7.8 0.0 0.1 0.3 0.3 6.5 0.3 0.3 0.0 0.0 0.2 0.5 0.6 CNOT4 "CLONE243, NOT4, NOT4H" ENSG00000080802 "CCR4-NOT transcription complex subunit 4" O95628 7 135361795-135510127 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005737 Approved NA NA "HPA005737: AB_1078544" "unprognostic (9.11e-2)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "unprognostic (5.47e-2)" "unprognostic (3.61e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.82e-2)" "unprognostic (4.18e-2)" "prognostic favorable (1.61e-4)" "unprognostic (9.08e-2)" "unprognostic (1.00e-2)" "prognostic favorable (7.67e-6)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.33e-2)" 9.3 9.0 10.7 8.3 11.4 8.0 8.4 16.1 14.1 11.4 6.7 7.8 7.4 11.2 9.2 10.2 10.5 8.9 12.7 11.5 10.7 10.1 10.5 8.7 10.2 10.8 9.8 8.7 15.5 9.2 13.6 6.6 10.8 10.9 9.6 8.5 15.6 11.5 9.5 21.8 10.3 7.7 11.1 7.9 9.6 8.2 17.8 9.5 12.0 13.7 22.4 11.6 9.0 8.7 11.4 15.4 14.3 14.3 19.3 23.3 18.4 10.3 16.9 18.3 14.1 17.4 12.4 15.4 15.2 14.3 15.6 20.0 14.2 18.3 12.8 20.0 17.3 14.1 12.6 11.9 11.0 12.9 14.4 14.5 14.2 16.0 18.1 11.1 16.2 14.7 10.7 22.4 11.8 21.0 19.2 19.8 21.2 18.9 14.1 11.9 12.7 14.1 16.6 16.6 14.0 15.1 17.7 19.7 21.7 11.6 13.2 13.5 15.8 20.0 17.0 10.0 15.9 18.5 18.1 18.2 21.5 17.2 16.4 23.2 23.7 10.5 14.6 12.4 10.8 13.6 9.8 10.4 10.4 9.4 10.7 11.1 10.5 9.4 15.8 13.1 7.5 9.7 9.2 10.7 11.4 16.1 14.1 11.5 10.7 10.8 9.8 8.7 10.9 7.9 9.5 11.4 53.9 22.4 43.0 83.9 63.0 67.7 76.3 54.0 45.5 50.6 49.7 58.2 42.7 31.5 44.3 36.8 106.3 31.5 60.9 30.0 70.5 32.9 30.7 31.3 56.7 48.3 40.7 50.9 103.7 20.7 22.5 58.4 35.2 45.1 62.6 46.1 40.0 25.0 25.5 55.5 94.0 30.2 30.5 28.1 61.0 20.7 65.3 33.4 42.7 88.1 61.0 69.1 68.0 119.6 102.8 32.4 31.2 69.2 58.9 73.0 32.0 56.2 35.4 72.4 19.7 83.8 75.3 113.4 75.7 42.1 75.7 44.6 61.6 45.9 29.3 89.4 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 25.3 22.8 49.7 26.7 77.1 40.0 28.5 62.9 58.5 28.4 48.0 50.0 50.7 25.5 27.2 35.5 23.1 32.0 18.1 47.6 57.0 35.8 32.2 32.4 22.6 69.0 66.0 39.9 22.2 23.1 35.4 11.7 43.4 70.6 24.5 46.7 23.6 23.1 23.6 18.5 38.5 49.4 27.3 64.3 22.8 31.3 32.8 64.6 26.4 37.2 23.5 31.0 35.3 19.4 122.3 37.1 55.9 50.6 20.0 68.9 49.9 46.7 52.5 60.1 52.6 66.7 69.9 88.9 23.7 34.1 50.5 43.0 94.9 43.2 40.1 57.3 54.6 26.7 27.1 35.1 34.4 63.8 27.7 50.7 50.4 71.9 44.3 54.4 48.5 43.2 26.2 31.0 46.6 50.0 72.8 21.0 35.7 22.0 64.5 40.4 26.4 42.7 30.2 73.7 76.5 28.1 38.3 57.4 53.0 47.1 45.4 66.3 60.7 45.7 53.1 43.5 44.1 25.3 30.3 47.9 23.7 44.9 32.8 33.3 126.8 94.5 96.3 23.1 106.0 22.6 23.1 22.3 19.0 83.4 31.8 20.7 20.1 129.3 42.8 125.0 43.6 37.0 70.3 49.7 77.1 62.9 58.5 47.6 57.0 69.0 66.0 39.9 70.6 64.3 64.6 122.3 22.2 28.9 30.5 35.9 25.8 28.6 24.6 24.7 12.0 17.1 25.0 17.7 12.5 15.7 30.2 23.9 39.6 27.1 30.7 79.1 5.9 27.1 22.9 26.3 26.4 22.3 16.2 12.0 38.9 26.7 29.2 23.7 32.1 47.4 18.3 29.6 15.7 24.6 30.5 13.5 40.2 39.5 24.4 50.5 40.8 12.9 16.4 52.3 16.0 39.4 51.8 13.8 14.4 48.7 395.8 38.2 58.8 15.4 23.6 38.8 76.2 13.0 29.0 28.0 26.3 20.0 19.0 40.2 14.4 20.4 33.0 49.9 21.6 18.6 41.3 51.5 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98579446-98593648 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 352.8;Extravillous trophoblasts: 75.9;Oligodendrocytes: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEL: 166.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Supported Mitochondria No No 170000 Mitochondria "HPA015736: AB_1847194, HPA054448: AB_2682490" "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 8.2 10.1 24.3 11.6 30.2 44.5 7.3 26.6 31.9 8.7 17.6 10.1 21.4 10.2 7.2 16.3 7.5 8.2 8.7 22.7 26.7 6.6 35.6 7.6 12.4 34.3 28.5 21.7 10.8 7.3 9.6 5.4 18.1 32.2 8.5 12.1 4.5 7.7 8.0 11.3 13.2 15.4 9.1 29.6 9.5 9.5 4.8 28.7 12.9 7.2 9.9 12.4 8.2 11.0 45.3 47.9 22.9 19.9 35.4 36.5 26.9 56.6 30.0 21.7 30.7 34.7 38.2 14.7 5.0 33.1 16.2 33.6 34.1 24.9 32.8 51.9 15.4 21.6 166.4 12.9 49.9 18.5 35.7 37.8 21.2 27.0 29.0 12.0 35.9 29.6 20.2 32.2 20.9 29.1 14.8 36.2 30.4 23.4 26.6 41.0 25.4 45.0 22.1 26.2 19.8 13.1 13.0 32.0 10.9 96.2 22.1 16.7 22.5 24.9 45.1 44.0 26.1 22.4 31.6 26.8 26.7 44.6 38.3 33.7 0.0 0.6 0.0 0.3 0.3 0.7 0.5 0.6 0.8 0.5 0.5 0.2 0.8 0.0 0.6 0.2 0.3 0.3 0.2 24.3 30.2 26.6 31.9 22.7 26.7 34.3 28.5 21.7 32.2 29.6 28.7 45.3 6.4 3.2 8.7 9.1 5.6 7.4 3.9 7.3 11.4 4.3 6.0 4.6 8.0 7.2 4.2 3.7 8.4 23.9 6.5 7.9 1.9 3.7 0.1 5.2 8.6 7.4 8.4 352.8 17.7 1.7 75.9 9.4 10.2 5.0 1.3 7.0 11.7 36.4 12.7 0.0 12.3 9.1 4.1 11.3 10.0 0.2 7.5 11.4 12.4 11.2 12.7 5.8 3.1 13.0 99.1 3.2 4.1 7.9 10.4 5.2 9.4 6.3 5.0 5.0 13.1 6.4 7.2 0.3 6.1 12.2 10.2 10.7 12.7 9.7 9.9 4.2 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "brain: 1181.4;choroid plexus: 423.4" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 575.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 54.1 43.1 584.3 41.1 810.2 49.5 49.3 768.6 745.6 52.4 423.4 50.7 36.8 59.3 43.5 78.5 47.1 51.0 58.1 568.2 672.6 39.6 50.5 47.3 55.1 885.4 769.5 508.4 64.5 23.8 32.8 28.5 74.4 886.0 49.9 47.4 46.9 30.1 52.4 43.9 63.9 42.5 64.0 826.8 44.3 37.7 107.5 741.9 45.2 40.9 69.5 55.3 64.6 66.3 1181.4 67.3 26.2 83.2 50.7 96.0 75.0 44.6 52.0 69.8 71.0 97.8 52.7 66.9 33.7 69.1 49.4 134.3 90.4 61.6 39.9 124.3 79.3 27.5 68.3 18.6 48.1 76.2 62.7 67.3 88.4 207.6 54.0 58.7 77.6 79.1 64.7 35.4 100.6 102.9 33.4 47.8 42.8 75.1 28.7 55.9 31.9 110.6 43.4 67.7 30.0 30.1 82.6 74.6 24.4 108.5 110.5 24.5 52.8 75.1 94.6 86.2 65.3 69.3 130.8 59.8 53.9 154.9 61.0 125.2 179.8 91.0 103.9 102.1 55.4 193.5 101.5 190.3 187.1 98.9 99.3 76.6 78.1 70.2 274.0 56.7 63.9 399.7 155.1 584.3 810.2 768.6 745.6 568.2 672.6 885.4 769.5 508.4 886.0 826.8 741.9 1181.4 83.3 35.3 36.6 17.9 72.1 144.0 131.7 122.3 87.0 20.1 43.6 45.3 53.8 17.2 71.4 27.6 25.0 52.0 72.8 16.9 29.4 21.2 105.3 21.1 47.7 70.8 28.7 65.4 25.1 16.2 160.6 86.6 30.1 41.7 36.8 25.2 61.4 19.4 35.6 15.2 23.6 19.6 89.5 29.2 168.1 76.7 51.6 46.9 113.8 20.6 42.3 28.1 38.1 30.7 575.2 30.3 16.8 46.6 131.7 98.1 34.6 23.3 27.5 35.0 52.6 53.2 128.4 182.4 55.3 90.1 196.5 95.8 147.1 22.8 17.5 121.9 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305190 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 126.9;testis: 54.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 185.6;Early spermatids: 212.8;Late spermatids: 185.8;Respiratory ciliated cells: 156.9;Rod photoreceptor cells: 465.7" "Cancer enriched" "Detected in many" 4 "melanoma: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 149.0;hTEC/SVTERT24-B: 383.5;NB-4: 499.1;U-138 MG: 200.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027292 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 7.2 11.3 16.2 1.8 14.9 3.0 6.8 13.5 18.7 7.6 23.1 4.8 3.4 7.8 7.4 4.3 21.4 4.7 12.7 16.1 15.0 11.9 5.9 5.3 1.7 14.7 15.6 14.2 13.0 9.7 7.2 18.7 2.4 14.6 7.7 1.8 126.9 6.3 3.6 2.3 6.8 3.1 3.9 14.2 4.7 9.4 54.4 14.4 1.7 14.9 0.7 1.3 8.4 5.6 14.4 18.9 16.5 2.2 9.5 3.8 13.1 4.2 37.7 11.0 53.4 63.7 1.5 45.4 14.5 3.1 7.2 11.5 4.1 3.3 19.4 149.0 16.2 14.1 3.4 2.3 12.7 15.9 1.6 17.9 11.1 4.9 383.5 35.3 41.3 2.0 2.9 3.4 1.0 35.3 12.5 1.2 499.1 0.7 8.3 39.4 2.2 1.0 0.3 21.9 0.8 6.0 3.9 6.8 2.6 109.4 0.8 11.2 1.5 1.4 200.4 10.4 7.7 12.1 1.3 2.4 1.2 40.2 1.2 93.1 0.0 0.7 0.0 0.5 0.6 0.8 0.0 0.4 1.4 3.0 0.5 0.7 1.7 0.5 8.0 0.1 0.0 0.0 0.9 16.2 14.9 13.5 18.7 16.1 15.0 14.7 15.6 14.2 14.6 14.2 14.4 14.4 5.8 19.2 17.5 68.6 1.0 10.7 6.3 12.0 7.4 40.9 19.1 17.3 12.3 10.0 27.5 12.9 185.6 1.4 2.4 6.1 5.9 8.3 212.8 122.1 16.9 7.2 4.8 3.6 54.7 16.0 2.6 17.6 12.2 10.7 3.8 12.2 8.6 2.0 2.1 16.8 37.5 2.4 6.1 1.3 5.3 185.8 30.4 2.5 80.0 7.5 0.5 59.5 1.0 16.1 6.8 6.5 1.2 16.1 1.1 2.7 3.5 11.1 156.9 465.7 26.3 22.4 13.4 121.4 32.0 5.4 5.8 1.2 4.2 13.4 4.2 3.8 HSP90AA1 "FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA" ENSG00000080824 "Heat shock protein 90 alpha family class A member 1" P07900 14 102080742-102139699 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 2035.0" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 12150.7;Urothelial cells: 5781.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002058 Approved Supported Cytosol NA NA 71000000 Cytosol "CAB002058: " "prognostic unfavorable (5.59e-4)" "unprognostic (3.77e-2)" "unprognostic (1.78e-2)" "unprognostic (9.25e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (7.79e-3)" "unprognostic (5.71e-2)" "unprognostic (7.81e-3)" "unprognostic (3.68e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.18e-5)" "unprognostic (1.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" 308.8 443.1 1369.4 302.1 1227.8 463.1 443.0 1280.4 2035.0 284.4 1319.4 292.5 193.0 241.9 321.4 264.2 565.2 366.9 451.6 1396.6 1272.1 456.6 383.7 379.4 324.5 1383.6 1274.1 1135.5 353.4 275.8 425.1 358.3 424.1 1394.3 351.5 314.1 1137.6 374.3 322.5 409.6 220.8 246.3 308.9 1390.3 219.5 300.0 546.7 1478.5 408.6 225.3 438.7 379.8 410.3 234.7 1774.9 1348.6 1832.2 1142.0 794.2 678.0 567.7 1512.1 1466.0 709.0 1779.5 994.1 1123.6 1245.6 1671.5 1323.1 960.7 1164.7 1471.2 3319.0 1452.5 3215.8 1227.4 1091.9 1291.8 1029.3 1444.3 334.9 1936.9 950.0 539.4 604.6 1140.3 416.2 1107.1 998.6 1764.9 1818.9 838.8 1634.1 1850.8 2087.7 891.1 1191.0 2500.5 1709.3 1968.2 1550.2 715.1 1030.3 1738.2 1497.0 1077.2 1860.4 1389.6 848.2 1903.9 1790.2 765.2 708.2 1234.6 786.5 1860.0 2826.4 783.5 2534.1 2402.7 1167.3 1182.5 1521.0 184.4 87.6 112.1 195.4 128.5 254.9 128.4 162.4 202.2 104.9 127.8 119.2 174.8 57.5 252.6 124.9 208.0 177.8 113.5 1369.4 1227.8 1280.4 2035.0 1396.6 1272.1 1383.6 1274.1 1135.5 1394.3 1390.3 1478.5 1774.9 1571.4 1137.8 696.7 255.6 934.0 1340.7 12150.7 814.1 748.4 1185.6 1215.2 1173.1 2257.3 684.9 1020.6 513.1 2103.8 1415.1 1091.2 905.8 342.4 1210.5 662.9 2972.0 1350.8 1163.8 947.3 1502.3 158.9 867.6 1909.7 1632.5 788.5 2209.5 916.4 1026.8 341.3 554.4 1348.0 723.5 216.2 992.2 703.9 618.8 3110.7 442.6 732.0 2305.3 1300.2 267.0 773.6 1548.1 356.3 96.5 435.3 779.9 1021.6 722.9 1227.4 3791.1 552.2 896.4 2827.3 3623.6 618.0 1112.4 1974.9 3800.9 2142.4 830.1 1113.7 2050.2 3196.2 972.6 1028.8 5781.1 RBL1 "cp107, p107, PRB1" ENSG00000080839 "RB transcriptional corepressor like 1" P28749 20 36996349-37095997 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.3;Inhibitory neurons: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054962, HPA056525" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054962: AB_2682652, HPA056525: AB_2683165" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" "unprognostic (1.30e-2)" "unprognostic (3.70e-3)" "unprognostic (2.13e-1)" "unprognostic (1.51e-1)" "unprognostic (6.25e-5)" "unprognostic (6.91e-2)" "unprognostic (7.19e-3)" "unprognostic (1.20e-1)" "unprognostic (4.49e-3)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (3.15e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-2)" "unprognostic (1.26e-1)" 2.0 1.6 1.5 4.9 2.5 14.6 2.8 8.5 1.8 2.1 0.9 2.8 2.4 2.9 1.3 2.9 1.9 2.0 1.8 1.1 1.6 1.6 1.4 2.2 7.4 1.8 2.2 0.6 4.4 2.4 2.6 1.1 3.5 3.2 2.0 3.5 4.1 1.5 1.4 7.0 3.2 2.5 2.8 1.8 3.4 2.7 3.1 2.0 8.9 2.7 8.0 6.7 2.0 2.2 3.2 24.8 15.8 19.4 13.1 4.9 6.4 12.4 28.2 12.6 23.9 24.6 16.8 13.5 27.5 7.9 11.8 14.0 23.8 17.5 18.2 39.7 9.7 9.4 27.2 18.1 14.3 3.0 35.3 18.2 3.0 2.5 31.6 11.1 4.0 13.6 17.9 20.1 25.8 13.7 10.5 33.1 11.7 5.7 12.5 15.3 21.3 57.7 20.9 5.5 12.2 4.6 11.5 30.8 17.6 8.2 6.2 11.3 25.3 9.1 42.0 15.9 38.9 24.8 8.6 16.4 27.7 30.2 24.4 21.1 0.9 0.7 1.4 2.7 0.8 2.3 3.0 3.0 2.5 1.3 2.1 3.2 2.7 0.3 2.2 1.2 3.0 4.5 0.9 1.5 2.5 8.5 1.8 1.1 1.6 1.8 2.2 0.6 3.2 1.8 2.0 3.2 3.5 6.4 11.0 10.4 8.7 2.4 1.5 1.7 4.0 5.9 2.5 1.7 2.9 1.5 6.1 0.0 2.1 5.9 6.5 1.8 0.0 1.8 1.5 2.2 4.3 3.3 1.2 23.3 14.7 1.1 5.1 4.6 2.6 2.9 8.8 9.0 2.2 1.4 4.5 3.3 22.8 1.9 0.0 3.0 3.2 0.6 2.1 6.8 1.8 6.5 4.7 3.1 7.2 19.6 18.5 0.9 3.6 3.0 14.1 0.8 1.0 0.7 0.9 12.2 6.6 8.5 4.1 17.5 8.7 5.3 1.3 3.8 11.7 6.4 3.5 0.9 DLGAP4 "DAP4, KIAA0964, SAPAP4" ENSG00000080845 "DLG associated protein 4" Q9Y2H0 20 36306336-36528637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 213.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 212.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054105, HPA056378" Approved Approved "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA054105: AB_2682381, HPA056378: " "unprognostic (1.11e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.73e-6)" "unprognostic (1.23e-1)" "prognostic favorable (9.88e-5)" "unprognostic (1.28e-1)" "unprognostic (2.18e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" 49.8 47.9 37.4 23.7 29.7 7.5 40.6 2.7 46.3 51.1 3.9 57.7 21.4 65.1 12.6 32.0 45.6 26.6 56.7 38.2 12.5 34.5 37.6 61.0 16.7 10.9 16.9 30.1 48.8 48.2 13.9 36.7 26.7 14.8 45.1 15.2 25.7 38.1 30.9 131.9 82.0 37.5 42.9 1.8 33.1 36.8 29.6 30.3 14.9 43.6 46.3 14.9 56.7 47.0 19.1 49.9 44.2 53.0 44.1 49.0 79.9 53.2 73.2 66.5 70.0 48.2 67.4 30.9 14.0 38.5 103.3 61.9 46.7 14.3 75.1 51.8 22.5 5.2 31.8 22.7 46.2 70.9 12.9 26.5 52.9 57.0 83.1 57.6 54.2 69.7 19.5 22.5 37.2 53.6 37.0 26.3 49.0 23.2 36.2 93.4 26.1 14.0 19.4 33.0 24.3 34.8 47.9 48.0 96.0 60.0 53.7 55.3 22.3 71.2 212.1 64.6 92.6 40.9 12.7 9.8 15.1 84.9 16.2 85.4 2.7 16.5 26.9 15.0 17.3 11.9 19.5 13.5 10.7 14.5 20.8 10.1 8.1 23.6 9.6 17.9 17.4 11.9 12.6 37.4 29.7 2.7 46.3 38.2 12.5 10.9 16.9 30.1 14.8 1.8 30.3 19.1 30.4 16.0 20.5 34.0 25.2 66.4 53.8 30.6 9.1 34.9 30.2 21.0 27.9 22.8 22.9 12.9 8.4 23.1 23.7 27.2 7.9 53.0 69.9 25.9 47.7 36.6 63.3 4.4 77.9 55.7 52.3 40.1 23.4 29.4 12.6 35.7 27.8 17.5 27.2 74.0 93.4 35.0 20.3 22.4 54.4 213.4 29.8 23.9 10.6 37.5 47.5 38.7 21.6 81.4 13.2 84.4 25.0 26.4 8.9 72.9 25.8 20.4 28.3 29.5 72.3 28.8 51.0 13.7 30.3 13.2 71.7 55.1 20.7 29.8 20.6 52.3 IGSF9B "KIAA1030, LINC00947, LOC283174, MIR4697HG" ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133896438-133956968 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;choroid plexus: 18.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Inhibitory neurons: 11.6;Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 10.0;SCLC-21H: 17.7;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010802 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Golgi apparatus, Cell Junctions" "HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 1.0 1.4 11.4 1.4 4.7 0.2 0.8 41.4 34.2 1.8 18.3 3.4 0.5 4.9 3.1 2.8 4.6 1.3 6.7 9.1 0.7 0.3 0.0 0.8 0.7 1.5 3.3 8.5 1.0 0.9 0.7 2.7 0.6 15.5 2.7 1.3 9.4 0.8 4.1 4.8 2.3 1.3 4.5 0.0 1.0 1.9 3.3 1.0 0.5 2.6 3.5 0.7 2.6 1.6 4.4 0.0 0.6 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.1 2.6 1.6 0.7 0.6 0.3 3.7 3.9 0.0 0.1 2.8 3.1 0.0 0.0 0.0 0.1 1.0 5.1 0.1 0.0 0.0 0.5 0.5 0.0 4.7 0.0 0.0 0.0 1.9 0.5 0.4 2.5 10.0 0.0 0.0 0.0 0.0 0.9 0.0 17.7 11.1 0.1 0.2 0.0 3.7 1.8 0.0 0.0 1.2 1.3 1.0 0.9 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.4 4.7 41.4 34.2 9.1 0.7 1.5 3.3 8.5 15.5 0.0 1.0 4.4 0.4 0.0 0.0 1.3 0.0 3.4 0.1 0.2 0.0 2.9 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.4 0.0 0.0 0.9 0.0 0.0 25.2 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 30.7 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.2 0.6 0.0 0.3 0.1 4.8 0.0 0.6 0.1 0.2 0.1 CFHR2 "CFHL2, FHR2, HFL3" ENSG00000080910 "Complement factor H related 2" P36980 1 196943738-196959622 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2749 "liver: 1322.7" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 38.5" "Cancer enriched" "Detected in single" 175 "liver cancer: 8.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA040726, HPA049813" Supported "Secreted to blood" NA NA 4800000000 "HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895" "unprognostic (1.25e-2)" 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1322.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 38.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80 kinetochore complex component" O14777 18 2571557-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 29.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 63.4;Spermatocytes: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 7.2;granulocytes: 8.3;T-cells: 11.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA066330 Supported Nucleoplasm,Centrosome NA Yes Nucleoplasm Centrosome "HPA066330: AB_2685661" "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavorable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 1.8 0.9 1.7 9.7 1.4 31.5 2.5 2.4 2.0 2.2 0.2 7.0 6.0 4.4 2.1 5.7 1.2 2.5 1.2 1.2 0.9 1.2 1.6 1.5 20.7 1.9 1.4 1.6 0.8 0.9 0.5 0.1 10.5 3.1 5.4 9.9 0.7 1.2 14.1 0.9 7.9 6.3 5.0 0.6 5.6 3.8 15.3 1.4 29.5 1.6 0.7 19.5 3.3 4.6 3.1 80.3 17.7 86.5 38.6 4.5 9.8 44.5 91.7 49.1 117.7 99.7 49.2 44.0 86.6 40.4 35.9 49.7 47.9 98.2 39.9 123.6 32.2 24.6 68.8 49.5 38.1 1.5 133.2 55.1 5.1 3.7 67.8 47.8 12.0 54.3 52.8 56.8 107.1 104.0 36.2 65.1 57.2 44.9 51.6 25.3 71.0 88.6 69.7 31.0 38.0 69.3 31.4 84.4 21.7 32.7 34.0 36.7 52.4 33.2 75.7 168.1 60.7 123.2 46.5 78.6 116.0 33.5 60.8 65.8 3.5 0.6 2.5 1.8 0.4 1.7 7.2 3.2 3.8 0.2 5.3 2.0 2.0 8.3 1.7 0.5 1.3 11.3 1.3 1.7 1.4 2.4 2.0 1.2 0.9 1.9 1.4 1.6 3.1 0.6 1.4 3.1 2.8 0.0 0.6 0.3 5.8 2.3 0.7 3.8 0.6 0.0 0.6 0.9 15.8 0.0 2.4 0.0 0.0 15.5 4.8 2.1 0.0 0.9 22.0 1.3 3.7 1.9 0.0 63.4 0.6 0.4 21.7 6.8 2.6 2.1 0.0 20.8 5.7 0.5 11.5 0.0 0.5 2.8 8.2 3.2 2.4 7.6 7.5 1.7 0.0 1.0 0.4 0.0 7.2 0.5 0.5 0.3 0.1 23.3 14.1 0.4 0.4 0.2 1.4 0.0 19.7 0.6 6.8 82.8 21.1 4.2 0.6 2.1 8.7 9.8 6.2 1.5 AP4E1 "AP-4-EPSILON, SPG51" ENSG00000081014 "Adaptor related protein complex 4 subunit epsilon 1" Q9UPM8 15 50908672-51005895 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041749, HPA041891" Approved NA NA "HPA041749: AB_10794490, HPA041891: AB_10796462" "unprognostic (1.72e-2)" "unprognostic (3.44e-1)" "unprognostic (9.21e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (9.46e-2)" "unprognostic (6.83e-3)" "unprognostic (1.06e-2)" "unprognostic (2.37e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (6.84e-2)" "unprognostic (3.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" "unprognostic (2.03e-2)" 3.4 3.0 2.5 4.5 3.0 3.1 3.1 3.4 2.9 3.4 3.1 3.3 3.0 4.3 2.1 4.7 3.2 2.6 3.9 2.5 2.8 2.9 3.0 3.1 5.5 2.9 3.0 2.2 2.9 2.2 5.2 2.5 4.7 2.9 2.7 3.4 3.9 3.3 2.6 8.3 5.3 3.2 4.5 2.8 4.6 2.9 3.9 3.0 6.6 3.8 6.3 4.8 4.0 4.1 3.6 11.5 8.7 6.0 7.1 7.9 12.0 11.7 11.1 8.9 10.7 11.1 10.7 1.8 11.2 4.3 12.5 10.8 13.7 9.0 9.6 12.4 12.3 4.6 9.8 14.5 4.3 11.1 12.1 8.2 12.2 11.6 13.4 21.0 6.6 7.2 8.8 9.1 6.3 14.7 15.4 7.1 6.9 3.9 5.2 4.4 9.7 8.5 6.9 7.9 10.4 4.1 6.7 11.8 8.4 8.7 10.7 7.6 11.7 10.0 15.7 5.8 9.5 15.9 9.6 11.7 14.1 12.3 26.1 7.3 2.7 0.6 0.3 0.8 0.9 0.5 0.5 0.6 0.7 0.6 0.3 0.4 0.9 0.1 0.5 0.5 0.4 0.3 0.4 2.5 3.0 3.4 2.9 2.5 2.8 2.9 3.0 2.2 2.9 2.8 3.0 3.6 6.6 6.4 6.1 17.6 8.7 5.7 1.5 3.8 4.0 9.8 4.9 3.7 10.4 2.8 8.4 5.5 18.8 7.3 7.7 7.9 0.0 4.9 2.0 5.9 10.0 7.8 3.0 6.9 26.7 4.8 5.7 4.7 7.1 6.2 10.2 7.2 6.8 8.1 7.2 8.4 27.0 5.3 2.0 17.0 4.1 1.4 5.9 10.2 1.8 25.3 6.5 3.9 8.2 19.1 36.0 10.6 2.4 4.1 9.6 2.2 6.2 3.6 4.8 11.2 6.6 7.1 6.6 10.2 7.7 6.6 7.0 7.3 9.6 4.8 5.5 2.4 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: AB_2680787" "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 6.0 6.1 5.1 7.8 5.0 34.7 8.3 13.4 6.1 8.0 3.7 8.4 6.2 10.4 6.6 7.4 8.0 6.4 5.2 4.7 5.3 8.1 6.4 7.5 10.6 3.9 4.8 4.7 14.3 11.1 11.1 5.1 6.7 6.0 8.0 8.7 13.8 6.9 7.0 8.1 7.5 7.5 7.1 4.0 9.2 6.8 10.8 4.8 12.4 9.1 8.0 10.6 6.5 5.6 5.1 14.6 4.1 13.7 8.2 8.0 9.2 6.6 5.1 10.9 10.1 10.5 4.9 4.3 12.7 7.9 6.3 4.6 6.2 9.8 6.2 16.4 12.3 7.1 9.6 4.4 5.6 6.0 18.1 9.9 7.0 6.7 8.6 8.2 8.6 8.1 14.0 14.7 7.7 7.5 14.9 14.7 10.8 11.6 4.6 6.9 26.3 13.4 6.6 6.0 6.2 13.8 11.0 9.7 9.4 8.7 6.8 4.5 12.1 9.7 9.0 9.7 13.5 8.3 10.3 8.2 15.9 9.3 10.9 15.4 53.3 14.5 25.6 29.1 11.7 29.3 32.2 31.2 27.2 12.8 33.1 31.9 26.2 29.0 25.4 13.4 27.3 30.6 12.6 5.1 5.0 13.4 6.1 4.7 5.3 3.9 4.8 4.7 6.0 4.0 4.8 5.1 37.4 35.3 20.1 16.0 52.7 74.7 39.2 26.9 45.5 90.0 35.0 46.7 21.5 24.3 29.6 25.8 66.7 26.3 68.0 55.5 19.6 22.3 25.6 26.2 39.4 38.9 49.4 37.5 34.3 26.0 24.1 41.5 17.9 28.8 36.1 23.4 32.5 18.7 19.2 97.6 34.2 58.5 28.5 26.3 37.7 9.0 50.4 25.7 40.9 30.9 35.0 56.7 62.8 33.7 34.6 21.2 54.0 49.7 34.7 44.3 40.2 17.2 27.8 106.5 39.5 43.8 54.9 96.8 37.0 34.3 65.1 31.5 84.8 24.2 52.7 37.8 MAGI3 MAGI-3 ENSG00000081026 "Membrane associated guanylate kinase, WW and PDZ domain containing 3" Q5TCQ9 1 113390515-113685923 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 266.0;Excitatory neurons: 206.7;Oligodendrocyte precursor cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008444 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA008444: AB_2668069" "unprognostic (4.07e-1)" "unprognostic (3.59e-2)" "unprognostic (1.54e-3)" "unprognostic (2.32e-2)" "unprognostic (2.31e-2)" "unprognostic (5.21e-3)" "unprognostic (2.23e-1)" "unprognostic (7.06e-2)" "unprognostic (2.80e-2)" "prognostic favorable (4.29e-4)" "unprognostic (1.09e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.60e-8)" "unprognostic (1.71e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-2)" 2.9 3.4 4.9 2.3 7.4 0.2 7.7 3.4 9.0 3.5 3.7 9.2 5.9 4.9 6.6 7.6 3.7 3.9 3.3 5.4 6.4 7.1 6.3 13.4 1.3 4.6 7.3 6.5 6.0 10.8 3.9 4.7 7.4 6.1 4.2 8.2 35.1 4.4 2.7 1.5 1.8 7.6 4.6 2.5 2.3 11.7 4.1 5.2 2.4 11.0 2.4 3.9 2.7 4.1 6.2 8.8 10.8 10.0 4.5 4.4 6.4 2.7 6.1 3.0 4.8 5.3 9.5 2.6 0.4 4.5 5.7 4.1 3.9 9.1 4.7 5.9 9.5 8.6 4.0 9.6 4.3 1.0 3.3 5.6 3.4 2.3 5.1 11.0 5.7 6.7 4.2 4.7 8.4 6.6 5.9 5.2 0.9 3.5 15.3 6.3 7.3 16.1 1.0 5.5 4.0 8.9 9.0 7.4 12.1 2.2 12.3 6.3 1.7 11.6 7.8 9.8 7.1 8.7 3.1 2.8 0.0 4.1 1.5 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.9 7.4 3.4 9.0 5.4 6.4 4.6 7.3 6.5 6.1 2.5 5.2 6.2 14.0 266.0 103.2 106.7 1.3 10.8 9.1 9.2 21.1 97.1 27.1 16.0 9.2 14.3 60.7 12.9 50.1 16.0 1.0 51.8 7.9 10.9 39.4 11.2 19.7 11.9 13.8 3.2 206.7 10.7 2.4 14.9 37.8 15.9 6.3 12.1 12.1 14.4 4.1 40.4 100.1 23.6 4.1 2.2 6.9 28.4 10.2 2.6 12.4 92.8 0.5 35.6 0.0 128.7 17.7 13.5 40.2 11.3 8.8 9.5 32.6 5.3 17.5 45.6 13.1 13.4 10.7 23.8 9.6 23.4 7.5 5.5 4.1 8.7 28.9 10.5 CXCL2 "CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2" ENSG00000081041 "C-X-C motif chemokine ligand 2" P19875 4 74097040-74099196 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 514.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 1668.3;Basal respiratory cells: 3166.0;Basal squamous epithelial cells: 1671.5;Langerhans cells: 2390.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 1.1;non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 10 "monocytes: 1.1" "Cell line enriched" "Detected in many" 8 "GAMG: 430.9" "Secreted to blood" NA NA "prognostic favorable (5.93e-5)" "prognostic unfavorable (1.41e-4)" "unprognostic (5.28e-3)" "unprognostic (1.36e-1)" "unprognostic (2.64e-3)" "unprognostic (1.27e-1)" "unprognostic (7.14e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.07e-6)" "unprognostic (1.05e-2)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" 72.8 12.6 4.5 28.5 3.7 89.5 40.1 3.3 6.1 61.6 7.4 9.5 3.5 15.3 0.3 12.3 17.6 52.7 49.8 4.1 15.3 14.6 514.0 88.4 12.7 5.6 4.5 3.3 9.2 89.1 2.8 7.3 3.8 4.0 13.5 21.3 1.7 20.9 10.1 21.7 3.2 11.0 14.9 4.2 7.8 26.9 1.4 8.6 3.8 6.7 35.9 1.3 83.0 3.5 5.2 1.3 3.8 0.2 0.0 1.3 4.4 0.1 4.2 52.9 2.1 6.2 0.3 8.0 0.0 7.0 0.3 430.9 0.1 0.3 11.2 8.4 0.1 0.2 3.3 5.0 0.0 35.6 1.4 0.0 4.0 38.5 27.2 37.0 1.4 4.6 0.1 0.1 0.0 1.1 0.0 0.5 0.5 0.0 4.6 1.1 0.0 0.0 0.0 26.2 0.0 0.0 0.1 2.5 0.4 1.1 0.4 0.1 0.1 7.1 1.9 0.7 7.7 4.0 0.1 0.1 0.1 30.8 8.9 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 4.5 3.7 3.3 6.1 4.1 15.3 5.6 4.5 3.3 4.0 4.2 8.6 5.2 620.7 477.5 1668.3 1.0 15.0 415.5 336.3 3166.0 1671.5 0.0 762.9 283.3 22.9 469.0 957.6 9.2 0.0 3.3 17.9 91.4 0.0 858.1 1.1 489.8 149.1 677.8 132.1 34.7 0.0 603.6 3.1 488.7 206.9 1223.1 85.2 0.1 365.1 325.8 117.3 0.0 0.0 131.6 498.5 291.4 2390.3 0.8 15.8 926.0 277.5 0.0 50.7 0.6 0.0 0.0 0.0 282.5 14.6 0.0 35.3 342.6 57.8 1.1 194.1 0.3 72.3 131.8 288.7 1.1 5.0 440.3 227.7 2.2 36.3 0.6 128.5 119.1 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "liver: 3.7" "Group enriched" "Detected in some" 10 "Hepatocytes: 107.5;Proximal tubular cells: 101.6" "Cancer enriched" "Detected in some" 4 "liver cancer: 208.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 192 "Hep G2: 2165.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 150000000 "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2165.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 9.7 5.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 2.7 2.8 0.3 0.0 0.1 0.0 0.1 2.5 107.5 2.3 0.0 0.1 0.1 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 101.6 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 1.5 0.2 0.1 0.2 0.0 COL4A4 CA44 ENSG00000081052 "Collagen type IV alpha 4 chain" P53420 2 227002714-227164453 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Collecting duct cells: 46.0;Cone photoreceptor cells: 56.3;Granulosa cells: 62.6;Muller glia cells: 78.6;Oligodendrocyte precursor cells: 55.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.1" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Cell line enhanced" "Detected in some" "HeLa: 34.3;hTERT-RPE1: 27.2;Karpas-707: 8.9;RPTEC TERT1: 14.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (7.31e-2)" "unprognostic (7.56e-2)" "unprognostic (6.65e-2)" "unprognostic (4.88e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (8.50e-3)" "unprognostic (5.14e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "prognostic favorable (2.30e-13)" "unprognostic (1.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.30e-1)" "unprognostic (4.15e-2)" 0.7 7.0 1.6 2.2 1.4 0.1 0.7 0.9 1.2 0.4 12.3 0.9 0.9 2.1 7.3 1.1 2.2 4.4 7.2 1.0 1.5 13.9 1.6 8.4 2.8 3.0 2.2 0.2 2.0 5.6 0.6 10.3 0.3 2.7 4.5 0.9 8.5 0.7 8.4 7.0 0.2 2.4 1.7 1.4 2.0 1.2 1.3 5.6 0.9 9.9 5.8 4.5 3.0 0.9 2.3 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.1 0.6 0.0 0.7 0.0 1.7 0.0 0.7 0.1 3.1 1.1 0.2 0.0 3.4 0.0 34.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 27.2 0.0 1.1 0.0 8.9 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 14.5 5.6 0.8 0.0 2.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 2.7 0.0 0.3 6.7 5.3 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 1.4 0.9 1.2 1.0 1.5 3.0 2.2 0.2 2.7 1.4 5.6 2.3 2.0 73.7 24.1 3.6 11.1 0.5 0.4 0.2 0.0 29.1 0.5 1.3 3.5 8.6 6.2 46.0 56.3 0.0 1.4 0.1 1.9 0.3 0.8 0.3 1.8 5.2 1.2 0.0 2.5 3.8 0.0 8.1 1.5 0.9 0.0 62.6 2.5 0.7 0.1 0.0 10.4 0.1 2.0 0.3 1.5 4.3 25.1 0.8 0.0 12.2 0.0 78.6 0.0 55.3 3.4 4.1 0.1 27.1 14.9 0.2 0.0 3.6 0.0 8.5 0.0 16.8 8.6 0.1 0.6 0.2 0.0 0.0 1.4 0.9 0.3 0.1 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114681-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "lymphoid tissue: 609.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 73.0;T-cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 28.8;memory CD4 T-cell: 49.7;memory CD8 T-cell: 29.0;naive CD4 T-cell: 97.2;naive CD8 T-cell: 62.3;NK-cell: 43.0" "Group enriched" "Detected in many" 20 "NK-cells: 43.0;T-cells: 97.2" "Cell line enriched" "Detected in many" 6 "MOLT-4: 1324.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275" "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 4.1 5.4 2.5 56.9 2.5 16.5 4.0 1.9 1.9 3.2 17.4 5.8 16.1 3.9 41.9 3.6 43.5 6.2 2.4 3.3 7.6 3.0 5.9 5.6 95.2 5.0 2.1 1.0 1.8 9.5 2.1 6.5 3.5 2.1 5.1 6.8 1.5 8.1 3.6 1.4 4.3 20.6 1.8 4.3 35.0 11.1 3.4 2.4 609.9 6.4 1.0 70.6 9.9 2.1 2.8 0.2 7.8 8.2 29.2 3.9 16.2 11.4 2.2 4.4 0.7 0.8 61.6 19.3 0.4 14.0 13.4 32.3 1.0 13.1 3.1 0.6 3.0 12.2 0.2 7.4 46.4 0.4 0.4 1.6 1.1 0.1 12.6 0.7 5.7 1.8 218.2 7.9 0.3 1.3 0.7 1324.2 1.4 9.0 19.2 10.4 1.6 0.0 1.4 3.0 1.4 3.4 25.1 6.0 1.8 1.6 6.4 1.6 7.3 1.9 81.2 0.5 37.0 2.8 1.3 0.1 0.4 42.7 0.5 4.1 2.2 0.3 3.2 12.3 0.2 28.8 3.5 49.7 29.0 0.2 1.4 97.2 62.3 1.9 43.0 0.2 0.5 6.5 21.8 2.5 2.5 1.9 1.9 3.3 7.6 5.0 2.1 1.0 2.1 4.3 2.4 2.8 6.0 3.2 1.9 4.6 27.3 15.7 27.9 6.9 2.8 28.6 14.5 14.9 3.1 10.0 2.9 3.7 73.0 21.6 47.4 18.4 0.0 6.1 3.8 57.6 30.4 9.6 12.6 5.3 2.4 9.9 30.5 11.7 6.6 35.8 20.3 12.1 6.8 3.0 7.1 10.1 2.0 17.0 6.1 9.7 20.0 2.3 6.2 8.7 10.6 1.0 17.1 12.4 41.2 3.5 4.1 23.6 18.5 4.5 9.3 24.6 50.8 1.4 2.5 58.4 0.0 61.4 16.1 4.0 11.0 3.3 11.4 30.0 108.3 8.6 24.1 14.9 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteoclastogenesis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Melanocytes: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No 210000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavorable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavorable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.34e-6)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.4 19.3 4.5 18.0 5.4 5.8 9.9 4.7 6.5 10.5 27.6 12.0 8.0 13.8 9.1 12.8 9.5 12.6 19.4 5.0 8.5 15.7 13.2 16.4 14.8 5.9 5.8 3.9 7.6 5.9 15.5 8.4 14.2 6.5 13.9 11.2 17.7 8.9 16.8 11.9 9.9 9.1 23.5 5.4 18.4 8.5 10.2 6.9 13.8 10.8 11.6 13.6 17.0 7.1 7.7 6.0 17.2 20.1 29.4 59.0 19.0 28.6 42.8 42.7 30.7 50.4 10.0 9.8 13.7 34.4 30.0 82.5 11.1 20.2 14.6 47.0 31.6 15.7 28.9 10.9 12.8 45.6 32.1 64.6 28.1 35.7 37.7 30.0 28.2 15.8 15.2 23.3 48.7 50.3 8.4 7.1 7.3 8.0 7.1 13.0 11.4 29.1 7.5 22.0 15.7 2.2 11.8 34.7 8.7 79.9 26.6 10.0 45.8 19.3 26.7 9.8 59.7 61.4 18.6 34.4 11.9 78.9 21.3 60.3 31.4 20.2 22.8 20.3 29.4 21.5 14.7 16.9 22.3 17.8 8.6 15.6 19.8 29.8 22.0 43.5 12.9 22.6 27.0 4.5 5.4 4.7 6.5 5.0 8.5 5.9 5.8 3.9 6.5 5.4 6.9 7.7 28.5 9.6 19.0 26.4 26.0 46.7 19.8 11.7 21.6 28.3 10.0 7.0 24.8 12.8 9.4 12.9 10.4 21.7 32.3 21.9 1.9 12.4 12.0 7.5 15.7 20.7 4.2 4.6 36.6 22.9 33.9 24.4 15.8 9.6 24.1 6.9 26.7 13.2 52.8 28.6 40.1 5.8 6.1 46.5 29.5 5.4 14.3 43.1 151.2 20.6 25.6 23.7 40.2 21.1 36.6 16.8 17.0 28.6 25.0 17.9 7.6 25.5 9.8 17.5 26.3 18.5 29.6 28.0 18.7 12.4 31.1 61.2 29.5 23.7 3.3 16.0 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890337 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 45.7;Inhibitory neurons: 111.4;Muller glia cells: 39.3" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.2;HEK 293: 2.9;Karpas-707: 5.6;RH-30: 7.3;U-87 MG: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061419 Supported NA NA "HPA061419: AB_2684511" "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.0 0.1 0.9 0.0 3.2 0.0 0.0 11.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.2 0.0 0.0 0.0 0.0 13.8 5.0 0.9 0.3 0.0 0.0 0.4 0.0 16.9 0.8 0.0 3.7 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.4 5.5 0.4 0.0 0.1 0.0 0.0 0.0 14.8 0.0 0.2 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 7.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.7 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 3.2 11.6 3.9 0.6 3.2 13.8 5.0 0.9 16.9 0.4 5.5 14.8 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 14.9 0.1 0.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.1 0.6 3.5 0.0 45.7 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 111.4 0.0 0.0 0.0 0.0 3.2 0.6 0.1 0.0 1.0 0.0 39.3 0.0 11.1 1.4 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 4.1 6.6 0.1 0.2 1.4 4.4 0.0 0.0 0.0 0.1 1.1 0.0 0.2 IMPG2 "IPM200, RP56, SPACRCAN" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320575 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Heparin-binding, Receptor" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "retina: 308.1" "Group enriched" "Detected in some" 18 "Cone photoreceptor cells: 517.1;Rod photoreceptor cells: 329.1" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Region enriched" "Detected in some" 8 "midbrain: 8.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008779, HPA015907" Enhanced "Secreted in other tissues" NA NA "HPA008779: AB_2668138, HPA015907: AB_2669323" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.3 0.1 1.4 0.1 0.0 0.1 0.2 0.0 9.7 0.1 0.1 0.2 0.6 0.1 0.0 0.0 0.2 0.8 8.4 0.1 0.1 0.1 0.0 0.1 0.0 1.1 0.1 0.1 308.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.2 0.6 0.8 8.4 0.1 1.1 0.2 0.4 0.6 0.3 0.0 0.0 5.9 0.4 0.1 0.0 0.1 0.0 22.8 0.1 0.5 0.6 0.0 0.1 0.0 517.1 0.0 0.3 0.0 1.9 0.1 0.3 0.7 0.5 2.4 0.0 0.0 7.5 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.1 13.5 14.0 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.0 4.7 1.2 23.4 0.0 8.5 2.6 0.1 0.0 0.7 0.6 0.1 0.0 0.0 0.5 329.1 0.0 0.6 0.3 0.1 0.3 0.0 0.3 0.0 0.2 1.2 0.0 0.0 PCNP ENSG00000081154 "PEST proteolytic signal containing nuclear protein" Q8WW12 3 101574180-101594465 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035011, HPA063861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No 38000 Nucleoplasm "Nuclear bodies" "HPA035011: AB_10601386, HPA063861: " "unprognostic (4.34e-2)" "unprognostic (9.65e-2)" "unprognostic (6.74e-2)" "unprognostic (2.08e-3)" "unprognostic (7.67e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.91e-1)" "unprognostic (3.44e-3)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (4.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (8.32e-2)" "unprognostic (2.05e-1)" 47.5 48.0 52.5 43.9 55.4 59.2 54.0 58.7 69.7 48.7 62.1 41.6 39.1 54.3 53.1 48.5 44.2 41.4 58.2 52.9 61.0 52.4 50.0 41.4 57.8 54.0 56.8 52.9 70.3 33.6 50.4 39.6 51.0 54.4 48.0 45.6 58.8 42.9 49.5 67.1 39.3 36.4 53.9 55.9 40.1 35.1 28.7 56.3 58.6 50.2 67.0 58.0 51.2 40.3 60.0 135.0 71.1 105.2 82.9 96.1 136.8 113.4 90.0 126.3 94.1 105.1 85.8 73.1 139.4 66.5 100.0 92.8 71.4 138.0 119.6 196.9 102.6 76.6 151.1 84.9 103.4 73.6 141.1 72.1 82.4 115.5 78.0 109.6 134.8 129.6 64.1 143.7 82.6 117.2 55.8 123.8 120.2 162.4 110.8 113.9 71.8 93.2 110.0 123.7 76.7 136.1 108.0 83.4 82.0 132.6 119.3 76.7 105.4 81.5 86.5 113.8 44.1 97.1 62.1 100.2 174.0 84.1 150.9 107.4 58.3 22.4 38.6 22.1 27.0 29.1 29.8 28.9 26.9 23.9 24.1 29.1 27.3 20.2 36.4 36.0 18.9 35.9 40.9 52.5 55.4 58.7 69.7 52.9 61.0 54.0 56.8 52.9 54.4 55.9 56.3 60.0 94.9 60.9 101.4 25.5 124.2 232.6 235.2 171.7 126.9 89.5 90.3 65.8 111.5 75.8 106.2 64.4 39.6 120.3 75.0 46.6 266.1 130.3 30.1 89.1 80.4 111.0 81.9 195.9 50.4 95.0 205.7 126.9 55.5 114.6 102.6 53.8 90.3 51.7 90.3 97.6 51.3 70.8 187.2 87.3 242.1 15.0 130.8 105.0 250.8 39.4 131.0 128.4 102.0 36.2 49.1 111.2 51.6 134.6 77.8 207.5 72.2 182.6 85.8 90.5 131.5 110.8 170.3 105.7 70.1 100.6 238.5 235.9 125.1 60.9 78.8 196.3 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 6.9 16.4 5.1 17.7 2.5 9.8 16.9 19.0 13.7 14.5 9.2 6.9 9.6 12.2 10.5 13.2 8.2 8.7 15.9 16.1 10.5 6.0 8.6 4.2 17.4 16.6 16.0 11.1 18.2 16.1 10.1 7.6 17.0 10.3 9.3 13.1 15.5 10.6 11.1 6.7 6.6 10.2 17.3 5.9 9.8 20.1 16.5 7.3 11.6 9.8 4.5 8.5 7.4 19.2 29.6 13.6 10.3 15.3 6.2 7.4 13.0 14.4 12.1 13.1 17.3 11.6 20.3 0.0 10.4 15.1 8.0 16.4 11.5 14.5 14.7 7.4 13.7 8.6 5.2 6.8 24.2 6.4 7.9 15.1 23.5 13.4 8.7 8.1 18.9 7.4 5.5 11.0 12.7 14.8 3.6 9.6 11.2 15.8 13.5 0.0 9.9 10.4 19.5 10.8 20.0 17.8 10.8 22.2 10.6 11.0 29.8 5.5 15.0 12.2 8.5 9.9 7.5 8.3 12.0 0.1 0.1 6.9 9.3 12.2 2.5 2.2 2.2 1.4 4.2 2.9 2.3 2.3 5.4 1.5 2.8 4.1 0.3 2.9 1.4 4.2 1.8 2.3 16.4 17.7 16.9 19.0 15.9 16.1 17.4 16.6 16.0 17.0 17.3 16.5 19.2 7.2 12.8 10.9 15.7 4.3 3.2 4.9 6.2 14.2 9.9 9.9 7.2 12.1 7.2 9.0 0.0 8.4 8.5 2.5 4.7 5.9 10.7 3.2 7.7 8.4 6.0 6.1 7.8 27.4 8.8 4.4 6.5 8.2 11.1 1.3 9.6 10.8 5.4 6.8 10.1 22.6 8.4 8.2 6.3 2.2 2.3 6.2 3.3 3.6 11.2 6.8 7.5 2.1 21.6 19.1 8.8 6.2 12.0 5.6 5.6 3.6 4.8 11.0 9.3 0.0 7.2 7.4 36.1 8.1 12.6 4.3 2.9 2.6 6.1 7.9 4.3 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619920-67651708 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 221.9;prostate: 109.5;thyroid gland: 105.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 190.1;Collecting duct cells: 165.5;Glandular and luminal cells: 145.2;Proximal tubular cells: 220.9;Syncytiotrophoblasts: 601.3;Urothelial cells: 165.2" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 58.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria NA NA Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 2.3 7.4 6.8 2.9 7.4 0.5 4.8 8.1 11.4 17.2 8.5 2.5 3.7 7.0 3.7 16.4 1.8 9.3 2.1 7.4 18.5 64.6 3.8 3.8 0.5 7.6 7.7 6.8 18.9 5.1 221.9 45.9 8.9 9.2 109.5 1.4 22.5 17.2 5.8 36.0 1.9 15.4 3.8 6.8 0.9 3.3 3.4 9.1 3.0 105.8 53.0 1.7 17.9 9.9 8.9 8.9 1.5 14.4 9.4 2.1 0.1 20.1 6.7 17.4 20.6 34.5 36.3 4.5 14.6 1.9 4.3 9.4 2.1 58.2 26.8 24.9 0.7 14.6 6.7 2.6 41.9 6.2 1.8 37.8 1.1 33.6 10.2 49.7 1.6 35.4 37.7 19.4 0.1 1.4 4.4 2.5 1.4 27.2 4.0 0.5 0.8 2.0 16.8 16.8 14.3 31.5 12.2 4.2 4.2 6.4 32.9 15.1 1.2 7.3 6.4 15.9 0.7 5.0 1.3 2.4 4.9 12.8 7.5 10.9 0.1 0.4 0.7 0.3 0.1 0.1 0.2 0.1 0.3 0.5 0.7 0.2 0.2 0.6 0.1 0.4 0.0 0.9 1.0 6.8 7.4 8.1 11.4 7.4 18.5 7.6 7.7 6.8 9.2 6.8 9.1 8.9 3.9 0.0 5.8 5.5 8.4 8.8 190.1 17.0 7.4 5.2 41.6 28.7 6.3 4.3 20.3 165.5 10.4 86.5 14.6 9.0 37.2 8.4 16.5 75.1 18.7 5.9 36.8 8.8 20.3 3.3 6.2 5.6 37.8 145.2 7.0 23.9 2.9 1.3 14.7 10.1 41.8 24.5 12.2 0.6 3.6 3.2 0.3 9.3 10.6 7.5 0.9 40.5 1.0 9.0 9.2 5.0 5.0 0.4 5.7 95.4 72.8 220.9 3.0 17.6 6.6 6.2 8.9 8.4 3.4 9.7 5.4 601.3 15.1 2.2 8.7 165.2 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 560.6;tongue: 249.0" "Cell type enhanced" "Detected in many" "B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3" "Group enriched" "Detected in many" 5 "B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6" "Cell line enhanced" "Detected in many" "Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 29.1 27.0 18.5 39.6 67.2 11.2 17.7 0.0 73.2 19.0 0.0 16.1 7.0 26.1 7.4 13.7 17.4 28.8 35.5 50.3 28.2 10.5 10.6 21.5 63.4 2.5 6.4 38.6 35.3 5.6 9.4 6.3 45.9 13.1 20.2 15.6 34.5 9.1 17.9 560.6 4.4 11.3 31.7 0.0 44.2 12.8 9.5 0.0 12.9 21.9 249.0 78.3 21.5 7.6 15.9 1.6 0.0 7.1 0.0 7.7 4.6 0.2 2.2 4.5 0.3 1.0 0.2 1.0 103.6 0.6 12.0 2.5 3.1 9.6 9.1 0.2 31.7 12.5 229.3 12.3 0.0 2.8 10.4 0.6 21.6 0.0 0.3 0.0 1.4 35.1 0.0 12.3 121.6 9.0 0.0 0.3 0.1 2.2 0.1 8.4 261.8 63.1 50.5 0.0 1.2 0.0 8.3 0.0 0.7 29.5 3.9 0.3 58.0 40.4 5.6 1.0 0.6 5.4 92.0 11.5 62.0 1.5 70.1 145.2 0.6 72.0 0.2 0.2 82.6 0.1 141.6 0.2 0.1 95.2 187.9 0.2 0.2 24.3 16.7 71.5 100.3 0.5 34.4 18.5 67.2 0.0 73.2 50.3 28.2 2.5 6.4 38.6 13.1 0.0 0.0 15.9 367.4 32.1 52.0 117.5 471.5 10.7 4.2 0.0 7.4 22.6 5.2 26.5 86.4 10.0 21.7 1.8 214.8 0.8 138.6 9.2 27.4 0.8 11.0 0.8 13.4 197.5 1.2 59.1 735.7 12.7 1.2 26.8 2.0 1.0 5.1 107.5 283.4 3.4 171.1 5.0 759.5 1.5 0.0 205.8 127.5 8.6 29.8 205.1 67.6 730.7 202.7 61.8 8.2 119.6 18.7 0.4 3.0 71.8 314.7 2.1 0.2 0.8 3.7 202.9 335.2 72.7 257.6 4.0 29.5 2.5 8.4 1.6 12.2 58.6 6.3 2.3 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase receptor type C" P08575 1 198638457-198757476 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Hydrolase, Protein phosphatase" "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 210.6;lymphoid tissue: 332.6" "Cell type enhanced" "Detected in many" "B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 24000000 "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 33.1 11.7 3.7 250.7 5.0 210.6 14.0 5.6 5.5 15.0 8.5 26.6 27.7 11.4 5.7 15.3 8.5 46.1 7.3 3.4 8.9 7.0 29.8 69.2 332.6 13.3 6.5 2.1 5.8 5.7 4.0 2.9 23.7 11.0 11.7 30.8 2.1 13.9 6.7 4.7 5.7 43.2 25.6 10.1 204.2 38.3 5.5 7.4 309.7 7.0 7.7 253.2 62.6 5.3 12.1 0.4 0.0 0.2 0.2 0.0 0.0 0.8 0.3 0.3 0.1 0.0 0.0 0.1 209.9 0.3 0.7 0.2 0.3 0.0 0.2 0.4 0.6 0.0 118.0 0.2 0.1 0.0 108.1 0.7 0.0 0.0 0.3 0.0 0.4 0.5 266.4 2.4 3.3 0.3 0.1 161.1 65.0 0.5 0.2 0.2 4.6 0.4 0.3 0.1 0.1 1.2 1.8 0.1 0.4 0.5 0.2 0.3 87.0 1.3 0.0 0.8 0.8 0.4 93.7 91.2 123.4 0.1 94.5 0.4 226.1 480.0 521.4 634.4 885.8 541.8 249.0 437.0 618.1 385.8 245.8 489.8 494.1 844.3 506.9 1015.8 57.4 508.6 1340.6 3.7 5.0 5.6 5.5 3.4 8.9 13.3 6.5 2.1 11.0 10.1 7.4 12.1 12.6 44.8 62.3 0.7 525.2 15.8 0.9 0.0 4.0 0.3 6.0 9.3 4.6 5.7 14.2 1.8 0.0 0.6 1026.4 1.0 0.0 0.7 2.4 2.3 2.3 15.1 1.2 58.8 0.7 0.0 0.9 17.2 46.9 2.7 246.5 0.1 14.6 6.9 96.0 0.0 1.7 0.4 0.0 334.9 214.5 3.5 1.2 534.1 21.4 201.4 554.9 0.1 769.3 2.5 0.7 0.1 0.8 0.0 474.2 1.1 0.1 2.5 11.7 0.2 6.6 7.4 6.7 0.3 0.6 1.8 15.2 0.8 1049.1 5.4 0.9 0.8 CACNA1S "CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5" ENSG00000081248 "Calcium voltage-gated channel subunit alpha1 S" Q13698 1 201039512-201112451 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 86 "skeletal muscle: 257.3;tongue: 194.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Cone photoreceptor cells: 6.2;Late spermatids: 5.9;Skeletal myocytes: 6.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "BEWO: 1.1;HSkMC: 1.8" "Region enhanced" "Detected in single" "olfactory bulb: 1.8" "Region enriched" "Detected in single" 8 "olfactory bulb: 2.6" "CAB009507, HPA048892, HPA056815" Enhanced NA NA "CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242" "unprognostic (2.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.52e-3)" "unprognostic (4.53e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-3)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (7.36e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.9 1.5 0.0 257.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.0 194.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.5 0.3 0.8 0.0 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 6.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "esophagus: 420.0;skin 1: 705.5;vagina: 202.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 139.7;Squamous epithelial cells: 234.5;Suprabasal keratinocytes: 409.0" "Group enriched" "Detected in many" 4 "cervical cancer: 125.5;head and neck cancer: 295.4;lung cancer: 79.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 234.6;HBEC3-KT: 144.2;hTCEpi: 501.4;hTERT-HME1: 132.5;PC-3: 192.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 2500000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 9.8 0.2 0.2 0.2 0.3 0.2 32.1 0.0 0.9 49.4 0.0 0.3 0.2 0.2 3.3 420.0 1.0 0.1 0.5 0.1 0.1 0.4 0.3 5.0 0.2 0.0 0.3 0.3 0.2 0.5 0.0 0.6 5.6 0.3 32.6 0.2 32.7 61.0 9.2 6.7 705.5 0.7 0.0 0.0 0.1 0.4 0.2 0.1 23.9 0.5 2.9 48.4 3.2 202.1 0.3 49.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 1.1 0.0 0.2 0.1 0.0 234.6 0.0 144.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 501.4 5.6 132.5 0.0 0.0 0.1 0.0 0.2 0.0 38.4 0.0 0.1 0.0 0.0 192.6 0.0 0.4 0.0 0.0 1.1 0.0 0.0 18.3 4.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.9 0.1 0.1 0.0 0.3 0.3 0.3 0.0 0.1 0.3 39.9 0.0 0.0 0.3 0.0 139.7 58.2 57.1 63.7 34.7 7.7 17.9 1.9 0.0 20.0 0.0 2.1 0.1 0.1 0.1 0.0 2.5 0.1 0.2 0.1 4.1 0.0 0.0 0.6 1.1 0.1 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.0 0.1 1.6 4.1 0.0 16.5 0.8 0.0 0.4 16.0 0.0 0.0 5.2 0.0 0.0 0.1 16.1 0.1 0.0 0.0 25.7 0.2 0.1 2.8 37.4 0.0 6.1 2.0 0.0 0.1 234.5 409.0 0.1 1.1 0.0 0.1 47.5 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132679794 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 418.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017235, HPA076042" Supported Enhanced Vesicles,Cytosol NA NA 43000 Cytosol Vesicles "HPA017235: AB_1858507, HPA076042: " "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 18.5 29.4 16.4 18.7 18.7 21.7 23.3 16.3 17.4 18.2 27.8 21.7 24.2 17.3 30.6 17.3 16.7 17.0 24.0 16.9 17.7 31.6 32.1 17.8 22.6 14.0 14.6 16.0 17.1 52.6 31.2 22.5 26.0 14.2 25.1 22.8 25.4 48.4 20.4 31.7 22.2 25.1 17.9 14.1 21.3 26.9 17.2 14.6 19.9 32.1 24.6 25.1 17.3 11.9 17.0 67.2 24.4 42.1 35.3 28.4 31.9 44.5 57.1 57.2 34.4 39.6 44.9 24.2 52.1 41.1 40.8 23.3 39.6 41.6 43.6 49.5 51.3 18.1 63.6 39.6 50.1 27.9 79.6 36.7 28.0 24.8 32.8 48.7 31.8 38.6 28.6 41.0 76.2 38.0 59.4 44.1 29.2 38.6 56.3 22.9 38.6 37.0 99.8 31.0 50.9 40.2 35.8 33.5 32.0 51.3 37.8 40.0 39.5 35.9 36.7 36.2 17.8 29.8 71.7 51.8 98.3 40.9 28.1 33.5 8.3 7.1 7.0 12.4 8.2 14.6 15.1 13.8 19.1 15.9 10.2 16.1 16.3 1.6 26.0 9.5 19.2 15.5 10.5 16.4 18.7 16.3 17.4 16.9 17.7 14.0 14.6 16.0 14.2 14.1 14.6 17.0 23.1 35.3 25.9 37.2 24.0 17.2 18.9 26.4 21.1 22.1 26.1 13.1 36.9 22.8 24.4 7.3 14.6 63.0 28.4 8.3 68.4 30.3 124.8 17.7 22.2 20.5 21.6 10.9 37.6 44.9 48.0 24.8 28.5 17.4 24.1 16.8 13.2 22.8 22.6 21.9 35.6 22.6 34.6 10.3 11.4 418.2 16.8 13.9 17.8 16.9 21.6 26.1 16.5 37.7 28.4 23.2 16.7 27.1 85.4 23.1 35.4 43.1 20.8 23.6 32.9 23.5 28.2 49.4 23.1 15.9 18.5 99.7 20.4 29.7 18.3 18.1 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133583-196176503 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 379.8;lymphoid tissue: 114.2" "Cell type enhanced" "Detected in many" "B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1" "Region enriched" "Detected in all" 5 "cerebellum: 63.4" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 28.4 9.0 2.4 67.7 3.2 379.8 21.7 3.9 5.5 24.4 4.4 19.3 28.1 5.4 1.8 12.0 5.8 20.6 4.0 4.1 4.6 6.5 8.5 23.8 114.2 3.3 2.2 2.3 2.2 12.9 2.1 3.1 16.8 3.3 10.6 17.6 0.4 17.2 5.7 2.4 10.8 40.5 16.9 2.6 57.4 20.3 9.5 3.4 61.5 7.2 3.6 112.0 24.6 5.3 3.1 11.0 7.5 11.2 4.2 47.7 18.1 12.4 25.7 38.4 27.7 28.5 22.8 3.9 122.3 23.1 14.8 7.3 7.4 4.7 11.1 33.4 21.8 12.7 11.6 9.1 2.2 14.2 47.0 118.9 23.1 10.9 34.3 17.7 39.2 11.5 28.5 9.1 111.6 69.4 5.9 61.6 106.0 6.3 19.9 17.2 10.1 67.5 37.4 16.3 25.6 4.2 4.2 6.6 6.4 5.4 17.2 4.3 24.3 14.0 26.8 13.1 19.3 14.7 45.5 78.9 132.1 20.2 15.9 12.1 165.1 74.3 163.1 43.7 81.3 55.4 49.2 77.0 52.8 53.0 58.6 98.6 82.4 236.7 40.8 113.1 37.7 73.8 89.3 2.4 3.2 3.9 5.5 4.1 4.6 3.3 2.2 2.3 3.3 2.6 3.4 3.1 23.3 89.8 74.0 48.3 229.3 59.9 27.1 15.1 10.8 0.9 28.9 15.2 2.6 12.8 42.5 11.0 0.0 7.9 267.7 54.0 3.9 6.6 6.8 15.3 14.1 11.3 3.0 68.8 3.4 2.8 24.0 27.2 38.2 26.5 195.1 47.4 5.3 2.4 26.1 0.0 3.1 13.9 18.3 151.1 201.3 3.6 5.6 198.9 58.7 11.2 158.0 0.6 118.4 17.6 0.7 10.9 41.6 4.5 191.8 34.3 80.7 2.5 26.9 0.3 6.6 49.7 19.7 41.1 26.3 16.4 63.4 5.1 342.5 22.6 13.2 53.8 CDC14B "Cdc14B1, Cdc14B2, CDC14B3, hCDC14B" ENSG00000081377 "Cell division cycle 14B" O60729 9 96490241-96619843 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8" "Cell type enhanced" "Detected in many" "Astrocytes: 86.5;Excitatory neurons: 83.5;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 156.9;Oligodendrocytes: 273.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 10.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064747 Supported Nucleoplasm NA NA Nucleoplasm "HPA064747: AB_2732719" "unprognostic (5.69e-2)" "unprognostic (9.09e-2)" "unprognostic (3.50e-2)" "unprognostic (8.08e-3)" "unprognostic (4.24e-1)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (4.49e-2)" "unprognostic (1.63e-2)" "unprognostic (2.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-1)" "prognostic favorable (2.97e-10)" "unprognostic (2.01e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (7.40e-2)" 4.3 2.4 11.1 1.1 13.3 3.1 3.0 5.1 11.0 2.9 1.0 3.1 2.9 1.3 2.1 1.4 4.3 2.9 5.1 4.0 7.2 5.6 10.4 3.0 0.9 9.9 11.2 2.1 3.4 4.7 6.9 1.1 2.0 15.3 3.3 3.3 1.8 1.8 4.1 0.7 0.8 3.3 1.8 9.8 0.8 6.1 9.3 10.1 2.9 8.6 1.4 1.2 4.1 0.9 26.8 7.4 4.1 4.2 4.4 20.2 30.1 11.6 5.3 7.0 3.5 5.6 14.0 11.6 0.0 5.0 11.3 8.4 8.1 6.1 4.0 4.1 1.9 5.8 1.1 1.5 11.2 3.3 0.0 0.2 12.4 2.1 3.7 3.4 4.0 0.7 0.0 4.4 0.8 4.8 3.5 0.0 1.2 7.9 8.4 3.6 0.0 2.6 0.2 5.4 11.3 1.3 6.6 3.7 1.1 2.0 14.2 0.9 2.3 2.2 3.5 4.1 9.0 3.9 0.1 0.0 0.0 3.7 0.0 8.3 10.4 0.0 2.2 2.0 0.0 1.0 1.1 0.8 1.5 0.0 0.4 1.4 0.9 0.0 0.1 0.0 0.0 1.1 0.6 11.1 13.3 5.1 11.0 4.0 7.2 9.9 11.2 2.1 15.3 9.8 10.1 26.8 4.0 6.4 8.8 86.5 3.7 9.1 8.9 4.4 9.1 7.2 8.4 6.1 17.9 11.5 11.4 9.2 8.4 6.4 2.3 7.1 7.9 5.5 36.9 27.4 7.5 6.2 2.4 0.4 83.5 6.5 3.0 17.3 21.4 33.9 14.5 2.9 6.8 31.2 11.3 8.4 110.2 9.0 8.2 1.6 6.7 33.3 9.0 5.5 8.8 56.2 2.4 12.8 2.1 156.9 273.9 8.6 7.3 11.7 8.3 10.8 16.9 17.0 15.7 12.4 26.3 18.6 15.7 10.8 7.3 4.7 7.7 3.4 4.4 1.2 8.6 13.2 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96754553-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 21.5;Inhibitory neurons: 22.7;Oligodendrocytes: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 3.6 3.8 4.6 3.3 5.0 2.3 4.8 8.6 6.3 5.2 2.7 3.4 2.6 4.7 3.5 2.7 4.0 2.7 3.6 4.8 4.9 3.9 3.8 3.3 4.4 4.2 4.8 4.6 5.7 5.2 5.0 4.6 3.1 5.0 4.3 3.3 11.8 3.3 4.3 4.4 3.4 2.9 4.1 3.9 4.2 3.4 3.4 4.8 5.6 4.7 4.8 4.8 3.7 3.3 5.4 4.2 4.3 8.1 7.2 6.7 6.3 4.0 3.7 6.5 6.1 6.4 3.7 2.7 5.7 2.2 3.7 5.8 8.7 3.2 3.3 5.8 6.5 3.7 6.0 7.0 2.5 3.5 3.5 5.2 4.3 5.8 4.5 6.9 6.5 5.3 8.2 6.8 4.5 7.8 3.9 9.3 5.2 6.6 5.9 3.6 5.6 14.4 2.4 4.3 3.2 9.9 7.8 7.0 3.9 3.8 5.4 3.1 6.2 4.1 4.4 4.5 5.6 5.9 8.8 9.8 3.5 2.7 2.0 4.6 0.4 0.2 0.6 0.7 0.3 1.2 0.9 1.2 0.9 0.2 1.0 1.3 0.9 0.1 1.4 0.8 0.3 0.8 0.4 4.6 5.0 8.6 6.3 4.8 4.9 4.2 4.8 4.6 5.0 3.9 4.8 5.4 5.5 3.2 3.2 13.4 4.5 1.7 1.6 1.7 0.6 11.0 2.6 2.5 5.1 1.5 2.9 3.7 2.1 2.2 3.2 1.4 1.9 2.2 5.7 3.5 6.3 4.2 1.2 4.0 21.5 2.6 1.4 5.7 2.0 4.0 1.3 5.7 3.6 1.3 2.0 16.8 22.7 2.1 2.0 2.5 0.5 6.9 5.9 2.2 5.4 10.3 2.0 4.5 8.2 18.1 20.5 1.8 2.8 4.1 3.1 2.0 1.0 1.9 3.2 6.5 6.6 4.6 3.3 3.6 5.6 1.8 1.4 0.8 4.6 4.3 1.5 1.1 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362534 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 68.9;kidney: 35.1;parathyroid gland: 45.0;retina: 29.5;thyroid gland: 17.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9" "Cancer enhanced" "Detected in many" "renal cancer: 29.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 39.4;CACO-2: 64.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria No NA 74000 "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: AB_2685353" "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 0.6 0.0 4.5 0.0 19.8 0.1 9.7 16.2 16.5 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 5.9 16.2 35.1 0.3 1.2 0.0 27.4 17.0 2.4 0.0 0.0 45.0 0.1 7.6 28.2 0.0 0.0 29.5 1.0 0.0 0.1 0.1 0.0 0.0 16.9 0.0 0.0 0.2 16.7 0.0 17.5 0.0 0.0 0.0 0.0 68.9 0.0 0.0 39.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 19.8 16.2 16.5 5.9 16.2 27.4 17.0 2.4 28.2 16.9 16.7 68.9 0.2 6.4 43.7 1.0 3.0 0.3 0.2 0.0 0.0 2.8 22.9 15.1 2.1 2.8 2.5 3.7 87.6 63.2 0.2 0.0 17.6 0.0 3.1 0.1 0.1 0.5 0.0 0.0 1.8 0.0 2.2 1.8 0.0 0.1 2.5 0.0 0.0 0.8 5.1 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 2.5 0.0 1.9 0.0 33.1 0.0 1.5 300.1 0.0 0.0 0.0 0.0 0.0 0.0 283.9 2.2 19.5 0.0 0.0 0.3 0.1 0.8 0.0 0.0 23.1 1.7 0.0 0.0 0.2 ZNF506 DKFZp761G1812 ENSG00000081665 "Zinc finger protein 506" Q5JVG8 19 19785839-19821751 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.88e-3)" "unprognostic (4.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" "unprognostic (6.26e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (3.68e-3)" "unprognostic (4.74e-3)" "unprognostic (7.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (4.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.28e-2)" "unprognostic (2.51e-3)" 9.9 6.1 9.5 7.4 11.6 9.1 10.5 14.1 13.8 9.7 9.6 8.4 7.9 8.7 11.7 7.9 8.7 8.3 10.0 9.3 10.4 10.9 4.3 7.0 11.3 10.1 10.0 9.5 12.8 10.8 10.8 6.0 7.8 10.1 9.6 8.6 12.1 7.2 7.7 7.8 14.2 9.0 6.6 7.7 11.5 9.9 5.8 9.9 9.9 16.9 5.7 13.0 10.6 3.6 16.3 1.3 0.8 7.6 1.2 6.9 9.3 11.9 4.5 2.6 4.2 2.8 3.5 8.9 13.1 10.4 4.2 7.8 8.0 6.2 0.4 5.8 1.9 8.7 1.7 2.8 1.5 9.6 2.2 1.6 7.0 7.1 4.5 0.5 3.5 0.8 7.0 1.2 2.4 6.4 1.2 22.6 4.7 11.2 2.3 1.9 7.1 12.5 6.2 11.1 4.8 12.6 8.5 9.2 4.8 4.9 9.4 9.3 13.3 3.5 5.3 0.8 10.9 5.0 4.3 2.4 7.2 0.5 6.2 7.1 7.7 4.2 9.4 6.4 4.7 7.5 10.6 6.7 6.1 3.3 12.5 12.5 10.7 8.2 7.3 6.7 11.9 7.1 4.2 9.5 11.6 14.1 13.8 9.3 10.4 10.1 10.0 9.5 10.1 7.7 9.9 16.3 18.1 16.0 12.6 19.6 30.3 6.2 10.0 7.5 10.2 18.1 12.6 11.9 10.0 15.7 11.7 36.8 27.1 10.3 34.4 11.4 35.2 10.0 35.7 19.3 14.6 14.0 10.3 1.7 24.4 11.6 6.5 14.6 11.2 22.9 9.5 20.0 13.9 2.8 8.1 26.9 29.5 11.2 12.2 8.7 11.4 7.4 12.2 9.2 8.8 25.3 8.0 14.2 35.0 33.7 42.0 13.3 9.0 9.8 17.2 14.3 11.4 37.0 12.1 19.8 6.6 11.6 14.4 7.5 5.3 7.6 8.5 14.6 25.2 14.3 9.8 12.1 JMJD4 FLJ12517 ENSG00000081692 "Jumonji domain containing 4" Q9H9V9 1 227730425-227735411 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 74.0;Late spermatids: 204.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027260, HPA052861" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA027260: AB_10602608, HPA052861: AB_2681975" "unprognostic (1.80e-1)" "unprognostic (1.37e-1)" "unprognostic (4.86e-2)" "unprognostic (2.29e-1)" "unprognostic (1.43e-1)" "unprognostic (2.86e-1)" "unprognostic (1.23e-1)" "unprognostic (6.19e-2)" "unprognostic (1.74e-2)" "unprognostic (4.31e-2)" "unprognostic (8.69e-3)" "unprognostic (8.68e-3)" "prognostic unfavorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (2.82e-1)" "unprognostic (2.05e-1)" "unprognostic (4.68e-1)" 6.5 12.9 7.9 4.8 7.3 3.6 7.2 7.1 9.5 5.3 7.2 6.0 4.3 8.2 4.9 6.9 7.1 4.1 6.6 7.9 7.3 6.5 12.0 5.2 7.0 8.4 8.5 7.7 7.9 9.7 5.8 10.1 4.0 8.0 9.8 2.4 1.6 8.8 5.7 10.2 6.0 6.2 4.3 7.6 9.1 6.0 14.9 8.1 6.6 6.4 4.7 4.5 6.9 4.6 8.1 18.4 26.4 8.4 9.3 9.0 5.1 31.0 11.3 11.6 17.0 10.4 22.6 15.2 24.3 16.8 10.7 9.1 18.1 5.8 17.9 2.0 13.2 29.4 14.9 13.3 17.8 15.8 15.7 7.1 9.0 11.1 16.2 11.8 6.7 8.8 17.5 19.7 7.8 8.3 15.4 19.5 8.3 14.6 13.9 42.2 17.8 10.3 21.9 10.1 16.7 16.4 11.1 10.8 37.4 14.5 4.3 30.2 16.9 7.7 8.6 8.8 10.6 21.0 14.5 5.0 9.3 8.6 7.6 24.1 3.2 7.2 2.8 11.1 7.4 12.2 8.7 8.4 7.7 6.6 8.6 13.1 11.4 0.7 14.3 4.1 13.2 10.2 8.0 7.9 7.3 7.1 9.5 7.9 7.3 8.4 8.5 7.7 8.0 7.6 8.1 8.1 7.0 6.4 7.2 4.6 7.9 4.1 8.0 8.6 1.8 14.0 16.6 13.2 3.7 4.3 7.4 7.3 0.0 13.1 7.2 8.8 5.9 21.7 74.0 5.2 11.0 6.9 9.0 13.9 4.4 28.9 14.0 9.7 10.7 4.9 7.0 12.7 6.8 14.5 16.9 11.8 3.3 6.9 2.0 7.6 2.1 204.9 11.5 6.1 12.4 2.8 11.0 12.2 13.4 3.0 2.1 23.7 5.6 4.1 14.7 11.0 12.9 12.5 7.7 14.7 6.6 6.7 8.2 36.1 7.5 7.4 4.7 9.6 7.3 13.3 7.3 7.5 DUSP12 "DUSP1, YVH1" ENSG00000081721 "Dual specificity phosphatase 12" Q9UNI6 1 161749758-161757238 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008840 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008840: AB_1847884" "unprognostic (3.51e-2)" "unprognostic (2.62e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-2)" "unprognostic (2.11e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.25e-3)" "unprognostic (9.52e-2)" "unprognostic (2.42e-3)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.17e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-1)" 13.0 9.7 12.7 9.1 13.0 31.2 14.2 15.0 14.7 13.4 12.9 12.5 7.7 14.4 9.0 10.3 12.6 6.8 9.1 12.7 13.1 11.5 9.5 11.5 13.9 12.9 12.9 12.3 13.7 13.7 8.3 9.6 11.2 13.0 11.1 10.6 13.3 11.0 9.6 7.5 10.7 12.5 11.1 13.0 14.2 11.6 6.8 12.9 11.8 12.2 7.4 13.1 13.2 11.6 13.9 32.6 28.2 33.1 21.7 17.2 18.5 30.4 25.9 33.7 39.2 29.9 42.1 28.2 19.9 25.7 31.9 24.4 22.7 26.0 32.0 38.0 25.5 22.0 17.8 27.7 28.4 36.4 38.6 17.1 25.4 34.6 34.1 61.0 22.2 27.6 27.2 31.7 20.9 28.3 30.0 22.7 43.2 52.1 35.2 43.1 32.2 32.0 32.9 22.2 39.3 20.6 43.6 21.9 36.2 44.1 36.2 31.3 43.6 19.3 33.3 30.8 26.3 55.6 35.3 31.0 47.0 20.3 38.1 33.3 32.0 16.9 13.7 18.4 19.5 22.9 19.2 20.8 17.8 22.0 20.0 19.6 21.8 6.8 28.4 12.2 10.0 19.5 12.9 12.7 13.0 15.0 14.7 12.7 13.1 12.9 12.9 12.3 13.0 13.0 12.9 13.9 22.9 19.2 12.8 8.1 25.5 13.6 14.4 25.9 25.6 15.9 13.4 16.1 5.0 8.6 15.6 7.3 8.4 21.7 26.4 4.8 21.5 22.2 4.2 7.4 13.7 18.4 11.3 16.2 11.9 24.3 22.7 17.3 11.7 7.2 18.3 18.7 18.5 8.2 20.5 10.1 14.8 9.8 8.2 20.6 16.2 1.2 8.7 15.4 10.6 10.3 22.1 15.8 33.0 12.1 14.4 21.2 6.5 17.7 27.5 17.1 8.6 18.5 7.0 19.6 0.0 13.2 24.5 13.9 12.6 18.2 13.1 17.6 23.5 16.4 12.1 12.0 AACS "ACSF1, FLJ12389, SUR-5" ENSG00000081760 "Acetoacetyl-CoA synthetase" Q86V21 12 125065434-125143333 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 67.1;Excitatory neurons: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058815 Approved Approved Vesicles NA NA Vesicles "HPA058815: AB_2683826" "unprognostic (1.28e-1)" "unprognostic (9.78e-2)" "unprognostic (1.86e-1)" "unprognostic (1.06e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-3)" "unprognostic (6.60e-6)" "unprognostic (3.03e-2)" "unprognostic (3.32e-2)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (7.71e-2)" "unprognostic (6.80e-2)" 32.0 7.9 4.9 5.7 8.6 3.7 43.8 3.3 11.3 14.7 3.3 12.8 18.1 6.3 8.7 31.1 8.6 7.7 7.1 9.1 5.1 8.3 3.9 6.3 5.8 6.5 4.2 7.3 6.0 12.9 9.7 8.6 6.1 6.9 8.7 11.4 6.3 48.6 7.6 5.6 38.6 10.5 5.9 2.7 5.2 17.1 13.6 4.9 10.5 10.1 7.6 10.2 6.2 14.4 8.0 26.8 26.2 11.2 15.3 40.3 26.1 18.7 21.2 20.1 24.6 21.8 34.0 17.4 16.5 21.3 25.7 10.6 28.4 21.0 22.8 13.2 17.8 19.2 13.1 16.9 26.2 33.5 9.4 12.8 29.1 18.2 21.0 21.0 30.8 18.1 9.5 9.4 9.9 15.9 49.1 10.8 12.7 14.2 28.0 30.4 2.1 28.2 23.0 25.0 40.2 29.7 8.6 22.4 35.0 16.6 10.8 26.2 20.7 17.4 11.8 18.7 13.4 16.4 22.0 13.6 18.0 14.8 15.4 13.2 7.7 2.1 5.9 3.3 0.6 4.4 2.4 3.1 2.5 2.4 1.2 4.4 3.0 0.3 5.4 0.7 9.9 2.1 3.4 4.9 8.6 3.3 11.3 9.1 5.1 6.5 4.2 7.3 6.9 2.7 4.9 8.0 4.2 6.4 17.3 16.3 4.5 16.6 5.6 14.1 9.1 20.9 23.6 16.9 9.4 17.2 12.0 5.5 27.1 2.1 6.5 14.0 7.9 11.0 67.1 6.3 15.3 6.5 25.2 0.8 59.4 10.7 8.7 11.8 13.3 12.3 2.5 13.1 2.2 4.2 4.8 6.7 28.6 22.0 16.2 4.1 9.0 22.5 9.3 3.9 5.4 5.6 5.4 5.6 5.2 12.1 12.5 9.9 7.4 5.3 12.1 8.2 10.7 6.5 5.7 21.8 0.0 8.6 7.7 22.0 5.3 25.3 28.1 2.5 8.1 20.8 15.8 5.6 DELE1 "DELE, KIAA0141" ENSG00000081791 "DAP3 binding cell death enhancer 1" Q14154 5 141923855-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 42.2 54.6 26.3 22.7 28.0 40.1 42.3 29.6 33.1 43.3 31.9 42.8 30.5 41.5 14.8 35.7 39.1 25.1 79.6 26.6 26.9 43.3 53.9 46.6 30.4 29.6 28.5 25.0 38.3 43.2 38.5 34.3 29.7 29.1 41.7 31.5 14.1 33.4 24.7 71.6 32.4 40.0 30.4 28.1 66.3 42.8 15.7 30.2 19.5 40.6 50.2 27.3 43.8 39.0 29.3 23.6 31.5 44.7 65.9 34.7 45.5 29.7 29.8 48.8 51.6 56.8 46.0 54.0 55.1 33.2 32.9 29.9 35.1 27.2 62.8 28.4 31.7 24.0 33.4 37.9 34.5 43.8 48.3 63.3 55.8 31.3 45.4 37.0 46.0 54.5 11.5 21.4 72.9 26.9 30.8 13.0 26.8 17.2 28.6 49.9 43.5 29.7 61.8 37.2 33.7 25.0 31.8 35.2 54.0 72.6 28.8 70.3 42.6 44.1 38.9 23.8 20.7 27.0 20.1 23.3 34.0 32.0 38.1 43.4 21.2 43.0 14.8 21.2 56.7 19.7 20.6 16.5 20.7 56.1 19.1 13.8 18.2 18.2 24.7 66.9 22.2 27.2 25.3 26.3 28.0 29.6 33.1 26.6 26.9 29.6 28.5 25.0 29.1 28.1 30.2 29.3 31.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 16.0 17.0 0.0 0.0 0.0 11.0 0.0 26.2 13.7 0.0 13.7 12.4 0.0 12.0 13.7 10.9 0.0 0.0 0.0 24.3 13.8 6.3 0.0 12.1 0.0 24.4 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 17.2 0.0 0.0 5.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 25.7 4.8 34.5 0.0 0.0 SLC13A1 "NAS1, NaSi-1" ENSG00000081800 "Solute carrier family 13 member 1" Q9BZW2 7 123113531-123199972 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sulfate transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 82.6" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 452.1" "Cancer enriched" "Detected in single" 219 "renal cancer: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA053615, HPA062714" Enhanced NA NA "HPA053615: AB_2682207, HPA062714: AB_2684846" "unprognostic (1.86e-1)" "prognostic favorable (8.95e-5)" "unprognostic (1.71e-1)" "unprognostic (3.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 82.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 7.3 0.0 0.0 0.0 0.1 27.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 75.3 452.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.1 0.0 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318411-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 682.7;Microglial cells: 180.8;Oligodendrocyte precursor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 43.5;Karpas-707: 56.3;OE19: 63.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 159.9" HPA056398 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056398: AB_2683117" "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 9.8 21.3 11.4 4.6 16.3 0.1 18.5 99.9 31.5 30.0 9.6 10.8 12.7 35.3 30.6 4.5 11.1 15.8 9.5 16.5 15.6 38.7 13.3 18.2 3.5 9.3 46.3 10.5 10.0 26.2 12.0 13.9 6.0 33.8 19.6 10.8 7.3 48.7 18.7 2.5 3.7 10.1 21.9 7.8 6.8 20.2 4.1 19.1 5.0 18.5 7.9 3.9 9.3 8.6 21.5 0.0 0.1 3.4 0.0 5.1 5.2 0.3 0.5 13.5 2.9 13.4 0.1 12.6 0.0 0.0 6.4 0.4 0.1 0.4 1.9 1.3 0.0 11.1 4.4 0.1 25.1 16.9 0.0 0.2 5.5 2.4 2.3 1.7 11.8 43.5 0.0 0.0 56.3 0.2 30.9 0.0 0.1 12.6 63.6 21.4 0.0 0.0 23.2 0.6 14.3 20.5 0.0 0.6 24.4 1.2 3.2 9.5 0.1 12.5 4.7 3.1 0.1 8.9 16.8 0.7 0.0 18.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 16.3 99.9 31.5 16.5 15.6 9.3 46.3 10.5 33.8 7.8 19.1 21.5 29.3 9.6 43.9 85.2 3.1 2.2 7.9 7.3 10.2 0.6 36.7 22.4 12.9 11.5 14.4 40.5 0.0 0.4 0.5 4.3 17.6 4.4 8.5 4.8 13.5 24.7 4.8 0.0 682.7 11.1 0.5 13.0 42.3 11.2 1.3 10.1 14.3 12.5 0.4 3.3 14.2 13.2 10.2 3.1 1.4 6.8 9.6 0.6 3.6 180.8 0.0 27.2 0.0 111.1 11.0 4.8 3.7 10.1 15.7 13.4 5.7 7.9 9.4 1.5 0.0 6.9 6.2 0.7 4.2 6.2 1.4 0.3 0.7 11.3 8.0 8.5 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121818-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.7;Endometrial stromal cells: 8.2;Fibroblasts: 9.5;Horizontal cells: 8.4;Peritubular cells: 6.4;Skeletal myocytes: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 8.7;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 3.2 2.2 3.0 0.7 3.3 0.0 3.4 3.7 3.8 3.4 0.6 1.7 0.6 5.5 3.8 1.5 4.0 2.4 1.9 3.3 7.6 1.5 0.3 2.1 0.4 5.1 4.1 2.7 4.2 8.6 1.4 2.8 0.1 5.3 2.5 0.9 1.6 2.1 2.0 1.7 1.2 1.0 3.4 4.9 0.7 1.3 0.5 3.3 0.4 1.5 2.1 0.2 2.1 2.1 7.0 0.0 0.0 0.3 1.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.7 5.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 3.3 3.7 3.8 3.3 7.6 5.1 4.1 2.7 5.3 4.9 3.3 7.0 9.7 0.0 0.5 0.0 0.0 1.1 0.4 0.2 0.6 4.9 2.6 3.8 1.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 8.2 4.3 0.0 0.0 0.0 1.7 0.0 9.5 0.0 0.3 0.0 0.1 3.6 0.0 0.1 8.4 0.0 0.0 2.0 0.0 1.1 0.0 1.5 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.7 0.0 0.0 2.5 0.6 0.0 8.7 4.0 1.4 0.5 0.0 2.0 0.0 0.0 0.5 0.0 0.4 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.0;EFO-21: 8.4;hTERT-RPE1: 2.2;U-2 OS: 3.4;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA059326, HPA078110" Enhanced Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 0.2 0.3 0.5 0.1 1.0 0.0 0.3 4.2 0.9 0.4 0.0 0.1 0.2 0.6 0.3 0.0 0.3 0.3 0.0 0.9 0.8 0.4 0.0 0.2 0.1 0.5 0.7 1.0 0.4 1.0 1.5 1.5 0.0 1.1 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.1 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 1.0 0.1 0.4 0.0 1.3 0.0 3.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 4.2 0.9 0.9 0.8 0.5 0.7 1.0 1.1 0.3 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512975 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 2.2 1.7 2.0 0.7 1.6 0.0 1.9 3.0 2.2 3.0 0.8 1.1 0.1 2.9 1.9 0.8 3.1 1.4 4.9 2.7 3.0 1.1 0.7 2.0 0.2 3.8 2.8 1.2 6.4 1.8 3.8 2.6 0.7 2.5 2.0 0.3 2.3 1.3 2.3 1.0 1.0 0.6 2.1 3.4 0.6 0.9 2.3 2.6 0.8 1.6 1.1 0.2 1.4 1.7 2.5 0.0 0.7 0.3 0.2 2.8 6.4 0.0 3.9 1.3 0.3 0.5 0.0 0.0 0.1 0.4 4.4 0.5 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.4 0.1 0.0 0.2 3.9 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.5 0.0 0.2 0.5 0.0 2.3 0.1 0.3 0.4 0.0 2.3 0.6 0.3 0.2 0.0 0.0 0.3 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 3.0 2.2 2.7 3.0 3.8 2.8 1.2 2.5 3.4 2.6 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 3.2 0.3 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 1.1 0.9 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.5 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 HSPB11 "C1orf41, FAP232, HSPCO34, IFT25, PP25" ENSG00000081870 "Heat shock protein family B (small) member 11" Q9Y547 1 53916574-53945699 "Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Stress response, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 412.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030140 Uncertain Approved Nucleoplasm,Cytosol NA NA 38000 Nucleoplasm Cytosol "HPA030140: AB_10600713" "unprognostic (5.73e-2)" "unprognostic (6.37e-3)" "unprognostic (8.81e-2)" "unprognostic (2.99e-3)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (9.58e-7)" "unprognostic (5.12e-1)" "unprognostic (6.70e-3)" "unprognostic (8.31e-3)" "unprognostic (2.22e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.84e-2)" "unprognostic (2.74e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-2)" 26.1 36.8 37.5 34.4 38.8 61.8 46.9 37.8 50.3 34.2 46.3 32.2 25.2 43.0 71.1 30.4 80.3 27.1 26.8 39.5 38.8 35.6 55.5 30.0 63.1 37.1 37.3 37.9 42.2 26.6 31.1 23.2 41.9 37.2 35.2 34.8 30.1 24.2 37.0 11.6 37.6 26.2 37.2 37.8 35.1 37.1 31.0 37.1 56.3 97.7 19.8 62.8 39.8 19.4 39.7 115.4 50.3 141.8 31.2 51.1 67.7 59.4 95.8 91.4 142.5 163.8 122.2 60.5 134.7 77.1 69.6 251.8 88.9 62.2 99.5 168.7 114.6 91.6 166.6 108.1 163.7 58.2 83.7 108.0 70.0 76.7 135.5 37.0 88.4 77.4 82.5 102.3 30.6 184.4 24.9 184.8 132.4 59.5 96.1 111.5 125.5 184.3 72.5 118.3 128.7 74.2 59.8 140.7 64.8 95.4 142.7 396.4 118.5 52.7 92.4 115.1 104.9 107.8 54.6 97.3 141.7 148.5 78.1 81.5 171.2 47.4 130.6 87.0 65.9 78.8 95.6 85.6 104.7 56.8 76.9 67.1 84.9 33.5 109.4 71.8 121.8 122.0 58.3 37.5 38.8 37.8 50.3 39.5 38.8 37.1 37.3 37.9 37.2 37.8 37.1 39.7 37.8 32.1 31.4 14.7 54.3 106.4 79.6 244.6 68.9 22.4 67.5 73.2 42.7 42.9 134.6 51.5 8.4 181.9 72.0 42.4 117.4 60.4 55.7 249.2 60.0 40.7 77.3 48.6 18.2 65.7 101.3 59.0 27.5 60.3 61.5 59.3 31.8 64.9 115.0 13.5 16.9 42.2 217.7 46.5 74.8 15.7 61.5 57.2 78.2 11.2 80.5 87.8 70.0 13.0 22.9 79.6 52.0 63.6 80.8 70.5 54.7 119.2 412.1 19.8 39.5 32.6 93.0 130.0 97.9 66.4 82.8 116.8 73.7 120.3 39.7 118.0 PHLPP1 "KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP" ENSG00000081913 "PH domain and leucine rich repeat protein phosphatase 1" O60346 18 62715541-62980433 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 106.7" "Group enriched" "Detected in many" 10 "Astrocytes: 423.7;Oligodendrocyte precursor cells: 538.3;Oligodendrocytes: 1663.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 4.0;T-reg: 1.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.0;T-cells: 1.3" "Cell line enhanced" "Detected in all" "REH: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020200 Approved "Intracellular and membrane" NA NA "HPA020200: AB_2670383" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" "unprognostic (2.26e-1)" "unprognostic (1.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.07e-2)" "unprognostic (5.57e-2)" "unprognostic (5.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.10e-1)" "unprognostic (2.95e-1)" "unprognostic (6.03e-2)" "prognostic favorable (5.35e-8)" "unprognostic (1.52e-1)" "unprognostic (3.49e-2)" "unprognostic (8.13e-2)" "unprognostic (8.25e-2)" 5.5 14.8 41.5 1.9 67.2 7.4 6.5 46.8 49.9 4.1 14.7 5.3 5.5 4.6 1.9 7.6 3.4 4.1 2.8 40.8 44.7 3.2 16.8 3.5 2.7 66.8 56.5 33.6 4.5 7.1 5.7 7.6 5.6 67.1 4.1 5.7 16.3 10.9 3.5 4.2 12.3 5.0 3.3 45.1 1.9 4.9 10.9 54.8 4.4 4.7 3.7 3.6 5.5 4.8 106.7 13.7 5.0 20.2 6.8 3.4 2.9 15.8 4.0 3.6 7.8 8.0 11.1 8.0 9.1 2.4 6.1 3.1 16.3 10.5 6.4 10.0 28.4 8.8 3.1 5.4 20.6 4.8 4.7 1.5 3.0 4.1 8.4 7.6 6.4 5.6 4.9 8.0 17.9 7.6 3.0 3.5 4.1 8.2 2.7 4.9 32.7 11.5 11.1 4.5 17.5 9.3 3.7 4.4 9.9 8.2 11.8 4.4 13.3 7.2 6.4 3.0 3.9 9.4 2.0 1.1 10.6 3.8 5.4 5.0 0.0 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.2 0.0 4.0 0.3 0.1 0.2 1.3 0.1 41.5 67.2 46.8 49.9 40.8 44.7 66.8 56.5 33.6 67.1 45.1 54.8 106.7 10.1 3.2 1.5 423.7 1.9 16.8 5.0 2.9 8.0 21.2 12.1 11.3 4.1 11.5 6.3 0.0 29.2 12.9 3.3 8.4 1.9 3.8 33.5 13.7 6.0 8.1 12.1 3.8 80.1 4.1 5.8 7.0 10.2 26.6 2.5 9.6 5.3 21.5 2.4 26.9 64.7 8.5 2.0 2.5 9.8 36.4 5.9 5.8 24.9 79.6 2.6 83.6 2.1 538.3 1663.2 4.5 8.0 3.8 1.0 7.5 7.4 1.9 10.0 17.4 0.0 13.5 5.3 8.0 15.4 13.2 18.6 26.1 2.7 8.3 11.1 11.0 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 90.2;RT4: 168.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 7.6 5.4 1.4 8.5 1.8 1.2 9.6 3.4 3.1 16.4 2.8 76.9 30.6 6.0 3.5 14.9 10.7 18.2 4.5 1.6 1.3 6.7 7.8 8.4 2.2 2.2 1.7 1.2 2.1 23.5 9.8 2.7 7.0 2.0 17.7 62.2 0.6 20.8 11.6 1.9 8.2 38.6 8.4 1.0 4.6 46.5 0.6 1.6 1.5 22.2 1.8 3.6 30.3 13.1 3.0 32.0 10.7 0.1 0.6 10.5 19.2 11.9 62.6 63.6 67.4 40.4 8.0 24.3 1.5 19.3 90.2 22.3 44.9 0.2 13.9 64.3 0.2 1.1 0.2 2.6 2.5 2.2 0.4 0.6 2.9 12.6 20.8 34.0 39.5 33.0 0.3 0.3 0.7 34.1 15.6 0.1 0.3 0.3 35.5 3.3 0.3 0.2 0.0 7.9 168.1 0.8 0.7 1.3 32.5 0.1 0.5 10.3 0.6 35.3 48.3 2.0 7.7 14.2 0.4 0.4 0.5 1.1 0.4 2.8 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.0 0.2 0.1 0.0 0.0 1.4 1.8 3.4 3.1 1.6 1.3 2.2 1.7 1.2 2.0 1.0 1.6 3.0 25.9 19.2 27.0 11.1 4.1 7.8 66.7 20.6 10.2 0.7 28.4 10.4 5.4 27.1 48.9 40.5 0.0 25.6 0.6 279.7 0.0 27.0 2.8 26.3 4.0 30.8 68.4 0.4 61.2 53.1 2.7 7.1 98.4 40.1 4.5 0.9 33.2 19.1 2.4 6.7 11.7 180.5 22.4 2.8 4.0 0.4 0.3 1.0 7.2 37.5 0.9 0.1 0.0 20.6 10.7 38.5 116.7 0.0 0.9 70.8 58.2 0.2 44.7 1.2 13.1 2.8 20.7 0.3 1.5 28.0 16.3 10.9 1.7 2.3 185.7 119.2 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67398724 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6;placenta: 7.0" "Cell type enhanced" "Detected in some" "dendritic cells: 8.4;Excitatory neurons: 22.5;Inhibitory neurons: 16.6;T-cells: 12.8" "Group enriched" "Detected in many" 4 "cervical cancer: 1.8;head and neck cancer: 2.5;melanoma: 5.6;renal cancer: 1.7" "Region enhanced" "Detected in many" "hippocampal formation: 4.6" "Immune cell enhanced" "Detected in many" "NK-cell: 21.3" "Group enriched" "Detected in many" 35 "NK-cells: 21.3;T-cells: 6.0" "Group enriched" "Detected in some" 9 "HMC-1: 4.6;SCLC-21H: 6.8;SK-MEL-30: 18.4;THP-1: 13.4" "Region enhanced" "Detected in single" "olfactory bulb: 1.4" "Low region specificity" "Detected in all" HPA024168 Uncertain Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 1.9 0.3 0.7 1.2 1.8 0.8 0.4 0.0 2.5 0.6 1.5 0.4 0.3 0.2 0.3 0.8 0.1 0.5 0.2 4.6 0.6 0.3 0.8 0.4 1.8 0.2 1.0 1.2 0.2 2.6 0.8 0.0 7.0 0.5 0.1 0.4 0.1 1.3 0.7 3.6 1.4 0.4 0.4 0.0 1.4 0.3 1.0 0.3 1.0 0.1 0.7 0.9 0.7 0.2 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.1 18.4 0.0 0.0 13.4 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 6.0 0.0 3.2 0.0 1.6 1.0 0.0 0.0 0.0 0.1 0.3 21.3 0.0 0.0 3.9 1.2 0.7 1.8 0.0 2.5 4.6 0.6 0.2 1.0 1.2 0.5 0.0 0.3 1.1 0.2 0.0 2.3 1.0 0.6 0.5 0.2 0.1 0.6 0.0 0.1 0.3 0.7 0.0 0.7 0.0 0.0 0.0 8.4 0.0 0.0 0.0 1.5 0.3 0.3 0.1 0.0 0.8 22.5 0.0 0.0 0.9 2.6 0.7 0.0 1.5 0.0 0.0 3.8 0.0 16.6 0.0 0.0 0.8 0.9 0.9 0.0 0.5 1.8 2.8 0.0 0.0 4.1 1.0 1.6 0.2 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.0 0.6 0.0 12.8 0.0 0.0 0.1 SMARCD3 "BAF60C, CRACD3, Rsc6p" ENSG00000082014 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3" Q6STE5 7 151238764-151277896 "Metabolic proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 127.3;skeletal muscle: 130.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7" "Cancer enhanced" "Detected in all" "glioma: 28.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 5.5" "Group enriched" "Detected in many" 6 "dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5" "Cell line enhanced" "Detected in many" "AN3-CA: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063955, HPA065517" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063955: AB_2685159, HPA065517: AB_2685500" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.38e-3)" "unprognostic (4.67e-1)" "unprognostic (1.41e-3)" "unprognostic (2.24e-2)" "unprognostic (3.52e-2)" "unprognostic (1.63e-1)" "unprognostic (3.50e-1)" "unprognostic (2.08e-3)" "unprognostic (9.18e-2)" "unprognostic (1.02e-1)" "unprognostic (2.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.35e-3)" "unprognostic (1.29e-1)" 20.3 40.6 90.3 5.1 96.9 7.1 22.3 65.4 127.3 24.7 55.4 20.0 3.1 23.0 14.8 8.5 30.8 14.7 66.0 100.6 86.3 18.7 2.8 18.9 4.7 75.4 85.5 97.2 37.9 14.4 27.5 42.6 5.8 77.6 27.9 3.8 10.1 14.4 23.4 130.3 11.5 11.0 13.5 64.3 9.2 18.5 17.5 86.9 1.9 18.3 70.0 2.5 22.9 18.4 81.6 0.8 6.1 19.6 69.3 30.0 13.3 1.6 13.3 13.0 7.5 4.3 4.5 4.2 7.7 4.7 20.4 3.0 1.3 15.7 1.3 3.0 2.4 10.2 0.0 4.5 1.4 25.9 0.4 12.5 31.8 1.8 2.4 0.2 32.7 1.5 19.5 16.4 2.5 39.5 8.3 1.3 10.3 6.1 2.0 2.5 0.5 31.7 0.3 6.6 0.0 11.2 22.6 12.4 2.1 9.5 3.1 2.0 19.7 2.6 6.1 7.7 15.7 4.9 16.1 0.0 6.5 14.2 17.6 21.6 0.4 5.5 0.0 0.1 1.3 0.1 0.1 0.5 0.0 1.6 0.0 0.3 0.5 1.9 0.0 0.2 0.0 0.4 1.3 90.3 96.9 65.4 127.3 100.6 86.3 75.4 85.5 97.2 77.6 64.3 86.9 81.6 7.5 6.4 21.7 33.6 0.7 10.7 38.3 3.1 47.8 15.2 28.5 29.6 67.5 21.5 4.6 11.0 4.2 0.4 1.2 0.2 31.3 24.8 2.5 3.9 24.4 5.2 3.5 1.3 16.7 2.6 0.5 28.0 1.5 3.4 2.5 44.3 2.9 0.5 3.6 11.8 23.9 0.3 0.0 17.0 5.7 14.0 50.7 16.0 7.2 8.4 19.7 23.7 0.0 16.1 7.4 2.8 0.1 88.4 0.1 14.6 0.0 2.1 4.7 5.7 65.7 40.9 56.9 1.7 20.0 1.5 4.7 1.1 4.7 22.8 0.2 9.0 WDR70 FLJ10233 ENSG00000082068 "WD repeat domain 70" Q9NW82 5 37379285-37753435 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 177.2;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 168.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043064, HPA048149" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA043064: , HPA048149: AB_2680287" "unprognostic (2.55e-2)" "unprognostic (3.39e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (4.40e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (6.34e-2)" "unprognostic (8.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "unprognostic (8.11e-2)" 9.3 6.3 3.4 7.5 4.3 12.8 10.6 8.0 5.0 9.4 4.9 8.9 7.2 11.6 8.7 8.1 9.0 6.9 7.8 3.5 4.2 7.4 8.0 8.3 10.4 5.3 5.2 2.8 10.9 8.5 9.5 4.0 9.6 5.8 8.5 9.4 5.3 7.6 8.9 15.5 8.8 8.3 10.7 3.4 9.6 7.9 8.9 4.4 12.0 8.9 11.2 10.9 8.7 7.9 6.2 17.8 11.5 22.7 28.9 22.8 22.4 31.2 21.6 21.9 26.3 21.6 19.5 17.9 28.7 12.7 21.6 19.8 16.4 19.4 21.7 27.9 27.5 24.5 21.5 34.3 13.9 17.6 37.4 18.5 21.8 15.8 19.9 26.9 19.8 21.5 21.7 27.2 11.5 16.7 12.2 23.8 18.6 15.4 14.7 21.4 27.2 56.1 29.9 13.3 21.0 19.5 18.3 73.6 16.3 16.6 17.0 21.0 23.3 23.8 22.7 21.6 22.2 17.8 15.3 24.1 32.9 15.1 33.3 19.2 8.1 16.5 15.0 9.7 20.7 10.5 13.4 11.2 10.6 17.9 14.8 11.0 10.5 3.7 14.0 19.5 18.4 12.0 8.3 3.4 4.3 8.0 5.0 3.5 4.2 5.3 5.2 2.8 5.8 3.4 4.4 6.2 23.7 32.1 29.1 103.2 25.1 9.2 13.7 15.4 12.5 37.2 23.3 17.5 18.6 17.2 14.4 9.2 37.5 27.1 33.6 18.3 19.6 18.3 20.1 16.9 36.4 17.7 13.8 17.7 177.2 20.7 26.7 17.9 15.8 20.1 19.7 22.8 22.5 25.7 18.9 25.2 166.2 21.5 14.2 25.8 6.4 7.0 29.5 21.2 12.4 113.4 31.3 16.4 30.9 153.3 168.6 16.1 17.0 22.6 21.5 6.9 16.1 21.2 20.8 52.2 13.1 20.0 21.7 42.7 25.2 11.9 7.7 22.2 20.2 17.3 22.1 8.7 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105252-39274528 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.5;lymphoid tissue: 113.8" "Cell type enhanced" "Detected in many" "dendritic cells: 142.9;Extravillous trophoblasts: 88.7;Hofbauer cells: 157.0;Macrophages: 104.2;T-cells: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1670.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HEL: 61.5;JURKAT: 211.9;MOLT-4: 212.9;REH: 61.3;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6200000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 10.3 5.9 5.1 83.2 6.9 53.5 5.2 6.7 9.5 6.7 11.2 10.1 9.2 3.9 10.6 5.8 3.7 16.9 2.4 5.3 20.6 5.1 13.7 17.7 86.5 17.5 12.9 3.2 2.7 1.8 2.1 1.5 18.1 13.8 4.3 11.1 0.5 7.5 3.0 1.3 2.0 15.1 11.8 10.2 73.7 12.3 3.3 12.9 113.8 2.7 2.8 63.5 17.3 1.8 36.0 0.2 4.2 0.0 0.0 0.5 0.0 21.1 0.1 1.2 0.3 0.4 0.4 0.3 0.3 0.0 0.0 8.0 16.4 0.0 0.3 0.1 0.3 0.0 61.5 0.0 0.1 0.0 23.3 18.6 0.3 0.4 0.0 0.4 0.1 0.0 211.9 0.0 0.0 0.0 0.0 212.9 13.5 0.2 0.1 0.1 61.3 0.0 0.3 1.0 3.5 0.1 0.0 0.1 0.5 6.5 1.4 0.0 5.2 0.0 0.0 0.2 0.2 0.2 0.4 0.0 4.5 0.0 81.4 0.2 151.3 359.0 354.6 76.3 406.5 52.9 1.8 216.7 134.5 127.6 1.3 271.7 169.8 1670.8 89.9 483.9 30.8 231.5 400.1 5.1 6.9 6.7 9.5 5.3 20.6 17.5 12.9 3.2 13.8 10.2 12.9 36.0 4.4 16.0 24.7 0.0 6.2 0.0 0.0 0.0 0.0 0.0 3.2 7.6 0.0 0.0 5.6 14.7 0.0 28.8 142.9 0.0 9.8 0.4 0.0 0.7 1.1 4.3 0.0 0.0 0.0 0.0 88.7 3.8 0.0 1.0 15.2 0.1 0.0 0.0 157.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 35.9 3.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 40.2 119.3 0.1 0.0 0.0 MPP4 DLG6 ENSG00000082126 "Membrane palmitoylated protein 4" Q96JB8 2 201644870-201698694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 194 "retina: 288.7" "Group enriched" "Detected in some" 36 "Cone photoreceptor cells: 1586.7;Rod photoreceptor cells: 808.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 22.2;hTEC/SVTERT24-B: 21.0;LHCN-M2: 85.8;TIME: 16.4;U-87 MG: 21.3" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 2.7" HPA057393 Supported "Actin filaments,Cytosol" No No Cytosol "Actin filaments" "HPA057393: AB_2732612" "unprognostic (1.42e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-1)" "unprognostic (2.50e-2)" "unprognostic (2.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.09e-2)" "unprognostic (9.42e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (9.20e-2)" "unprognostic (3.33e-16)" "unprognostic (1.82e-2)" "unprognostic (8.23e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" 0.1 0.5 0.2 0.1 0.4 0.0 0.2 1.3 0.4 0.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.1 0.0 0.0 0.3 0.1 0.6 0.1 0.0 288.7 0.0 0.1 0.1 0.8 0.0 0.0 0.2 1.4 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.1 6.6 0.0 11.2 2.7 6.6 6.7 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.8 22.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.7 0.0 21.0 0.1 3.2 12.3 0.1 0.0 0.0 85.8 0.0 0.0 0.0 0.6 0.0 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 16.4 8.4 2.6 2.0 7.8 0.0 0.0 0.0 21.3 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.3 0.4 0.4 0.3 0.5 0.3 0.3 0.6 0.2 0.2 0.4 0.7 3.2 8.6 0.3 0.0 0.4 0.0 0.2 0.0 20.0 0.4 0.0 0.2 1.5 6.2 1.8 1586.7 0.1 0.2 0.0 0.0 0.2 2.8 0.4 0.4 2.6 0.0 0.0 7.3 0.2 0.1 0.6 0.0 0.1 3.8 0.1 0.0 0.1 0.1 18.5 2.8 0.0 0.0 0.3 0.9 2.5 0.0 0.4 1.8 0.0 0.1 33.0 1.0 2.0 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.1 6.7 808.3 0.0 1.4 1.1 0.1 0.4 0.0 0.4 0.0 0.3 0.1 0.2 0.0 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20 related adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 412.8;Proximal enterocytes: 124.0;Proximal tubular cells: 217.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 188.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Uncertain Aggresome,Cytosol NA NA Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favorable (4.45e-4)" "unprognostic (4.93e-2)" 30.2 53.6 28.3 9.0 29.7 81.5 16.9 29.7 31.1 10.3 26.6 27.9 37.4 13.3 17.5 17.1 10.5 14.4 32.1 28.9 30.3 74.0 105.8 10.7 14.7 31.4 29.6 27.4 14.2 17.7 6.2 17.5 19.8 30.5 11.2 30.6 40.8 14.0 7.7 110.1 8.4 43.3 10.3 30.9 13.8 9.2 16.0 29.7 11.5 18.1 70.2 11.7 9.8 9.4 34.1 12.6 21.5 36.2 47.0 58.5 73.8 25.6 25.6 43.4 34.9 51.6 29.6 11.9 0.1 16.0 40.7 42.4 12.6 35.8 23.9 62.7 14.9 30.1 15.2 9.6 62.9 43.9 18.4 16.7 62.5 21.6 43.7 39.0 63.5 26.5 28.5 33.4 5.3 188.5 6.8 17.2 31.1 49.2 11.7 22.6 22.8 14.5 9.6 29.2 9.9 6.0 29.3 17.6 13.1 76.8 66.0 6.7 34.4 25.7 20.6 16.1 26.6 19.3 21.1 39.0 5.8 35.8 8.2 20.5 5.5 12.9 16.3 9.2 14.4 8.3 28.8 12.2 13.4 17.2 35.8 15.5 15.6 2.6 29.0 13.1 7.7 16.4 15.8 28.3 29.7 29.7 31.1 28.9 30.3 31.4 29.6 27.4 30.5 30.9 29.7 34.1 5.0 9.6 4.2 17.0 20.2 2.2 6.8 6.5 11.4 13.8 24.9 10.8 27.8 28.6 6.1 14.7 83.4 51.0 6.3 40.9 39.2 12.4 3.9 7.5 7.4 5.6 16.9 412.8 20.8 15.4 27.6 13.6 6.6 10.2 5.7 12.0 7.9 94.6 19.2 11.8 19.8 22.6 8.2 16.9 5.2 8.1 10.8 13.5 16.0 15.0 14.8 19.6 7.2 26.7 26.0 9.0 35.2 3.8 10.9 10.2 124.0 217.8 5.3 19.1 6.6 21.7 6.6 45.0 46.7 15.2 1.4 27.9 8.9 26.8 25.0 9.1 BZW1 "BZAP45, KIAA0005" ENSG00000082153 "Basic leucine zipper and W2 domains 1" Q7L1Q6 2 200810594-200827338 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 3845.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047288, HPA053272" Uncertain Approved Vesicles NA NA 34000 Vesicles "HPA047288: , HPA053272: " "unprognostic (2.45e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.08e-3)" "unprognostic (1.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.31e-3)" "unprognostic (3.98e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.49e-3)" "unprognostic (7.93e-3)" "unprognostic (1.08e-3)" "unprognostic (8.97e-3)" "unprognostic (4.38e-2)" "unprognostic (3.04e-1)" "unprognostic (7.61e-2)" "unprognostic (8.03e-2)" "unprognostic (1.24e-1)" 131.8 130.4 32.1 98.4 35.2 221.6 89.6 39.4 40.8 66.1 51.9 99.3 65.2 67.2 58.9 121.9 53.8 93.9 53.0 35.0 51.3 89.3 228.9 74.2 98.7 38.4 38.6 28.8 62.8 63.1 73.0 31.0 106.1 37.5 100.5 91.5 46.2 61.7 62.3 102.5 48.3 72.0 80.8 42.8 63.3 69.7 172.5 39.1 124.2 75.0 75.9 110.3 166.2 62.0 47.0 296.6 230.1 309.4 187.1 305.2 353.3 221.6 425.2 501.8 281.2 244.5 360.7 195.3 142.5 144.7 339.7 186.1 159.8 284.9 512.6 521.8 154.6 151.3 370.8 453.9 280.1 244.5 420.9 199.6 205.3 233.5 373.2 398.9 244.6 495.4 132.3 328.5 234.0 379.3 236.6 387.9 201.3 392.4 120.1 575.4 293.1 333.4 148.6 256.1 435.2 188.9 218.7 325.5 120.9 226.1 255.5 126.6 216.7 555.0 416.8 242.9 255.2 276.6 286.1 428.6 377.8 341.2 209.3 312.1 236.7 140.7 168.5 177.9 173.4 207.2 102.0 126.0 167.5 162.6 87.1 112.4 156.7 117.0 218.5 195.1 75.5 171.5 294.6 32.1 35.2 39.4 40.8 35.0 51.3 38.4 38.6 28.8 37.5 42.8 39.1 47.0 207.3 86.6 108.1 31.3 148.5 198.5 318.5 310.7 125.7 37.1 159.0 89.8 18.1 82.9 290.3 90.1 18.8 115.4 263.2 127.5 138.9 250.2 927.0 108.3 145.3 149.0 96.7 72.8 28.7 233.1 164.3 181.2 72.4 150.0 196.9 72.7 99.2 262.4 114.1 58.9 32.1 113.3 183.1 88.6 194.0 3845.6 102.2 169.1 124.5 15.0 308.1 119.6 170.0 24.6 36.6 464.4 106.5 95.9 132.7 242.3 68.2 163.3 121.7 33.4 98.6 159.4 179.8 175.2 169.2 133.2 196.1 195.2 200.3 103.3 106.1 370.9 PGR "NR3C3, PR" ENSG00000082175 "Progesterone receptor" P06401 11 101029624-101129813 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 64.4;endometrium 1: 104.4;fallopian tube: 34.6;smooth muscle: 79.0" "Cell type enhanced" "Detected in many" "Early spermatids: 64.0;Endometrial ciliated cells: 90.1;Endometrial stromal cells: 177.1;Glandular and luminal cells: 76.3;Late spermatids: 40.9" "Group enriched" "Detected in some" 13 "breast cancer: 10.1;endometrial cancer: 11.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 338 "T-47d: 170.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000068, HPA004751, HPA008428, HPA017176, CAB055100" Enhanced NA NA "CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728" "unprognostic (2.59e-2)" "unprognostic (9.80e-3)" "unprognostic (5.23e-3)" "prognostic favorable (5.76e-8)" "unprognostic (2.81e-2)" "unprognostic (1.56e-1)" "unprognostic (4.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.08e-1)" "unprognostic (2.50e-1)" "unprognostic (3.29e-2)" "unprognostic (1.77e-1)" "unprognostic (7.71e-3)" "unprognostic (1.90e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (5.44e-3)" 1.1 1.7 2.0 0.3 1.1 0.0 7.0 1.0 1.0 64.4 1.0 1.8 0.5 104.4 0.8 0.7 34.6 0.9 3.7 0.8 6.4 1.1 0.3 1.4 0.2 1.6 1.5 0.5 16.4 0.6 0.3 1.1 1.8 1.6 3.7 0.7 0.1 3.9 9.1 0.6 0.4 0.7 79.0 1.7 1.8 0.6 3.5 6.2 0.2 1.3 1.8 0.2 1.7 10.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 170.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.1 1.0 1.0 0.8 6.4 1.6 1.5 0.5 1.6 1.7 6.2 1.3 1.3 3.2 0.0 0.3 0.7 0.1 1.1 0.0 0.0 1.3 35.9 19.8 18.7 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 64.0 90.1 177.1 3.5 0.0 0.0 0.1 0.0 0.1 12.5 0.0 76.3 0.0 34.7 2.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 40.9 14.6 1.9 0.0 22.5 0.0 0.0 0.0 1.0 0.3 0.1 0.0 10.5 0.0 0.3 0.0 0.0 0.0 0.2 6.6 1.4 14.9 3.9 2.3 0.0 0.6 0.0 2.3 15.1 0.0 1.0 C1QTNF3 "2310005P21Rik, Corcs, Cors, Cors-26, CTRP3" ENSG00000082196 "C1q and TNF related 3" Q9BXJ4 5 34017858-34043213 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.7;salivary gland: 52.4" "Cell type enhanced" "Detected in many" "Early spermatids: 161.6;Fibroblasts: 61.5;Late spermatids: 387.6;Muller glia cells: 227.2;Skeletal myocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 211 "U-266/84: 810.2" "HPA064996, HPA066011" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 44100000 24000000 "Golgi apparatus" "HPA064996: AB_2685399, HPA066011: AB_2685597" "unprognostic (7.71e-2)" "unprognostic (2.81e-3)" "unprognostic (5.83e-2)" "unprognostic (6.58e-2)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-3)" "unprognostic (5.18e-2)" "unprognostic (1.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.89e-3)" "unprognostic (1.80e-1)" "unprognostic (9.38e-3)" "unprognostic (2.35e-1)" 7.4 0.5 3.7 1.7 4.3 0.6 6.8 6.5 4.1 2.9 2.4 10.4 3.5 2.8 1.0 33.7 3.0 5.9 0.7 3.5 6.0 3.6 1.1 4.2 0.8 4.9 3.9 2.9 1.4 1.7 0.3 1.3 0.6 4.5 2.2 10.1 23.9 52.4 5.0 2.2 2.4 8.9 23.6 6.1 0.7 10.8 11.5 4.2 1.1 1.6 10.0 0.4 13.4 3.7 4.9 0.7 0.1 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.9 0.2 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.2 0.7 0.8 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.8 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.2 0.2 1.6 0.0 0.1 0.6 0.1 0.0 3.8 0.6 0.1 1.0 0.0 1.0 0.9 810.2 1.3 0.0 0.8 3.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.7 4.3 6.5 4.1 3.5 6.0 4.9 3.9 2.9 4.5 6.1 4.2 4.9 2.3 3.2 2.0 0.0 2.0 5.7 0.6 0.4 1.8 5.1 3.0 2.3 1.0 8.6 0.8 3.7 0.0 0.9 1.5 0.7 1.9 1.2 161.6 2.6 1.0 7.2 1.8 1.3 0.0 1.4 0.5 61.5 1.5 2.6 0.0 1.8 0.4 1.3 1.3 8.4 0.0 1.4 2.0 0.6 9.6 387.6 1.8 1.1 7.2 0.0 0.3 227.2 1.0 0.0 0.0 0.5 1.5 2.6 0.2 0.8 0.8 2.1 1.2 11.9 0.0 77.5 4.5 6.2 2.0 1.1 5.8 0.4 1.3 1.0 2.0 0.5 ME2 ENSG00000082212 "Malic enzyme 2" P23368 18 50879080-50954257 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 176.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008247, HPA008880" Enhanced Supported Mitochondria NA NA 84000 Mitochondria "HPA008247: AB_1853704, HPA008880: AB_1853702" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (9.57e-3)" "unprognostic (2.22e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.29e-8)" "unprognostic (1.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-2)" "unprognostic (4.75e-2)" "unprognostic (1.43e-2)" "unprognostic (4.27e-3)" "unprognostic (2.30e-1)" "unprognostic (2.47e-1)" "unprognostic (4.09e-1)" 12.2 15.9 13.8 22.1 14.5 15.8 9.4 14.8 17.0 9.0 48.2 30.9 38.7 9.1 8.9 12.9 8.6 12.8 45.4 15.7 17.1 12.7 15.2 11.7 26.0 15.8 15.8 13.4 8.0 21.1 32.5 10.1 13.2 16.3 13.9 32.7 14.7 7.3 20.1 26.4 8.8 32.6 18.2 15.0 27.4 26.8 18.9 16.2 21.6 11.0 23.1 22.8 16.9 3.4 16.4 40.5 39.9 52.0 61.0 23.2 25.6 24.2 33.2 24.7 42.2 35.5 18.4 21.8 143.3 12.8 29.7 38.5 32.6 78.1 33.3 48.2 60.0 11.6 36.5 22.8 21.5 68.1 123.9 42.5 16.0 40.3 53.1 85.8 27.8 55.0 83.5 39.9 34.1 29.1 8.4 90.4 12.3 34.8 29.0 15.9 58.0 25.8 41.1 45.9 8.6 63.9 34.0 31.0 18.7 33.0 31.0 14.4 59.0 34.6 30.0 32.7 15.8 44.7 62.9 27.1 70.6 30.2 86.5 32.5 7.5 16.4 20.7 6.5 19.0 5.1 7.1 4.2 7.9 13.3 7.2 3.6 4.5 18.1 9.8 25.7 4.4 4.4 7.4 13.8 14.5 14.8 17.0 15.7 17.1 15.8 15.8 13.4 16.3 15.0 16.2 16.4 20.9 9.6 11.9 40.1 32.8 15.2 20.2 13.6 12.5 17.0 10.9 10.0 103.6 11.5 22.6 14.7 14.6 16.7 37.9 39.0 39.2 31.9 18.0 18.5 22.6 18.7 12.0 16.6 35.6 38.6 16.3 19.1 43.3 19.1 16.4 176.4 24.3 9.1 89.7 8.4 45.9 27.3 18.3 93.8 15.1 6.7 11.5 54.5 12.4 47.8 48.3 18.0 48.4 52.3 32.5 35.6 22.3 16.6 61.5 25.0 72.4 17.1 10.6 55.0 6.6 23.0 23.2 59.8 30.6 13.2 10.7 8.6 28.1 22.4 36.5 17.4 C5orf22 FLJ11193 ENSG00000082213 "Chromosome 5 open reading frame 22" Q49AR2 5 31532287-31555053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 28.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 28.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043062 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA043062: AB_10795766" "unprognostic (2.58e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.50e-1)" "unprognostic (2.91e-1)" "unprognostic (8.73e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.65e-1)" "unprognostic (7.30e-2)" "unprognostic (8.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (4.44e-2)" "unprognostic (1.08e-1)" "unprognostic (3.22e-1)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" 4.4 3.8 2.1 5.6 3.1 5.8 6.6 2.6 3.1 6.0 1.9 6.8 4.6 6.0 3.5 6.6 5.9 5.7 10.3 2.5 3.0 7.7 7.1 6.7 7.4 2.5 2.7 2.0 4.1 11.1 8.3 1.4 5.7 3.1 5.9 7.7 4.8 5.4 5.3 13.8 3.9 5.9 8.3 2.2 5.2 5.3 3.6 3.0 7.2 6.7 15.2 8.8 7.0 2.8 3.5 10.0 7.2 18.4 25.3 13.0 10.7 20.9 16.2 12.2 18.1 13.4 8.7 10.7 8.2 23.4 14.7 15.7 7.3 22.2 13.4 19.2 11.8 11.9 15.7 23.9 12.6 20.9 24.3 51.8 14.6 16.6 12.2 18.9 7.4 15.4 11.5 21.2 12.9 19.6 10.3 13.1 6.1 11.0 10.1 10.7 12.2 30.7 11.7 12.7 15.5 12.3 17.1 45.1 19.9 32.9 11.6 15.9 16.4 13.0 13.6 15.5 16.7 16.4 8.7 18.7 15.0 7.9 42.5 20.7 28.0 2.5 2.4 2.6 2.9 2.8 2.9 3.4 2.8 2.4 2.4 3.2 3.4 0.9 3.8 5.2 1.4 2.1 1.5 2.1 3.1 2.6 3.1 2.5 3.0 2.5 2.7 2.0 3.1 2.2 3.0 3.5 6.0 3.2 5.3 10.1 9.6 4.5 3.3 4.0 10.8 4.1 5.6 2.8 23.5 4.3 4.9 12.9 0.0 5.3 9.2 8.8 1.9 4.3 2.9 6.9 7.3 6.2 6.7 7.2 16.5 6.0 6.2 6.4 10.2 7.6 7.6 5.5 6.1 10.2 6.4 6.7 17.7 9.2 12.2 10.7 2.5 1.7 4.7 7.7 8.8 8.4 10.7 4.8 2.1 15.1 15.5 6.8 5.7 3.4 12.8 5.1 5.9 7.9 7.9 4.9 6.6 3.9 5.6 6.1 6.5 10.3 4.0 5.3 9.5 6.3 6.9 4.3 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.44e-4)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favorable (3.28e-4)" 12.9 12.2 11.5 12.3 11.7 29.2 15.7 15.1 12.7 15.6 12.0 12.9 13.6 13.7 15.0 12.9 14.1 9.5 11.4 11.0 12.1 10.1 18.4 15.0 15.6 12.3 13.2 10.6 17.5 20.0 15.2 15.2 12.1 12.2 13.6 12.2 19.2 13.1 10.8 10.4 15.5 14.5 8.6 12.2 15.7 14.9 12.4 12.0 14.5 14.6 9.7 14.2 15.2 16.4 15.8 9.0 4.4 28.0 10.5 13.6 13.7 21.3 12.2 9.9 11.2 13.9 11.9 10.1 14.6 8.9 10.0 5.4 11.4 17.0 9.1 16.3 7.9 11.5 15.8 11.9 16.9 13.3 14.3 13.4 12.6 17.6 11.1 13.5 14.4 16.8 10.8 13.4 14.6 13.2 6.1 16.0 21.2 22.8 7.4 9.0 15.2 10.0 11.7 17.4 24.4 19.1 15.8 8.9 10.3 14.2 20.3 10.8 17.3 15.3 14.4 15.9 6.2 9.0 10.2 6.7 15.1 9.0 11.2 12.5 3.8 1.6 2.0 1.7 2.0 2.1 1.6 1.9 2.1 2.1 1.2 3.3 2.6 2.1 2.8 1.0 1.9 2.6 1.3 11.5 11.7 15.1 12.7 11.0 12.1 12.3 13.2 10.6 12.2 12.2 12.0 15.8 27.1 25.6 26.0 49.6 38.0 15.0 28.8 17.9 26.7 34.7 21.6 15.4 23.5 14.3 21.8 14.7 33.3 11.9 35.3 22.4 7.9 16.2 5.5 20.2 30.2 21.5 18.5 20.0 73.6 14.9 9.6 23.7 46.9 33.1 11.4 31.1 18.9 20.9 10.1 42.1 70.1 16.4 6.1 15.7 22.1 14.6 14.0 25.2 8.8 52.5 23.6 12.9 19.6 76.9 81.8 14.2 19.0 22.2 26.5 35.4 19.1 7.0 12.4 34.5 19.7 17.7 24.2 17.7 23.6 25.3 18.2 13.7 29.0 25.2 17.1 50.5 FAM135A "FLJ20176, KIAA1411" ENSG00000082269 "Family with sequence similarity 135 member A" Q9P2D6 6 70412941-70561174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.1" "Cell type enhanced" "Detected in all" "Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031743, HPA031744" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031743: AB_10600767, HPA031744: AB_10601101" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "prognostic favorable (8.00e-4)" "unprognostic (1.59e-1)" "unprognostic (1.66e-2)" "unprognostic (1.08e-1)" "unprognostic (6.69e-4)" "unprognostic (4.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "prognostic favorable (3.46e-4)" "unprognostic (3.99e-1)" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "unprognostic (2.65e-2)" 2.7 2.8 2.5 4.8 3.6 1.3 2.5 8.2 3.3 4.6 0.5 10.8 13.8 6.4 2.6 30.1 4.1 7.1 4.1 2.7 5.0 4.9 2.5 4.2 3.8 2.4 2.3 2.2 6.4 6.0 9.7 1.9 4.0 2.3 16.2 11.2 8.2 4.6 3.5 2.6 9.7 11.6 3.8 1.3 3.5 10.8 10.2 2.0 2.9 3.9 6.5 6.5 4.9 7.2 3.8 7.9 4.8 9.5 6.1 4.5 3.2 8.9 2.5 5.0 2.6 4.3 8.9 6.2 14.3 18.1 1.9 12.6 7.3 9.6 5.6 4.6 6.8 8.2 6.2 4.6 8.0 5.5 12.3 6.4 2.9 13.8 5.0 13.4 3.1 7.2 4.4 10.6 6.8 3.1 0.8 2.2 5.5 6.4 9.2 3.9 6.8 31.3 6.8 9.8 4.0 10.1 3.1 2.9 2.6 3.0 6.3 1.8 5.2 3.6 2.2 5.7 2.2 5.8 8.5 10.3 5.5 1.6 10.4 4.2 1.8 2.3 0.1 0.8 2.0 0.9 1.6 0.7 0.3 3.5 2.0 1.1 0.7 0.6 2.7 3.3 0.5 0.9 0.9 2.5 3.6 8.2 3.3 2.7 5.0 2.4 2.3 2.2 2.3 1.3 2.0 3.8 12.0 28.9 12.5 85.8 10.8 15.9 12.9 8.3 31.3 20.8 4.5 4.1 11.5 17.2 8.9 20.2 29.2 2.9 4.7 49.9 5.9 6.7 30.4 13.9 15.6 13.0 23.4 1.7 170.1 12.4 1.5 10.2 45.9 21.4 8.8 13.5 9.7 6.5 5.6 238.9 172.8 29.2 16.2 10.6 15.5 23.8 15.5 11.9 5.4 132.1 11.9 13.8 4.1 219.2 121.3 18.4 31.7 13.2 6.4 35.4 24.0 10.0 9.9 26.4 6.6 11.6 9.3 33.2 10.5 71.4 33.5 8.2 4.6 10.9 25.5 15.8 COL19A1 ENSG00000082293 "Collagen type XIX alpha 1 chain" Q14993 6 69866556-70212468 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.4;lymphoid tissue: 3.2" "Cell type enhanced" "Detected in some" "B-cells: 33.5;Excitatory neurons: 66.6;Inhibitory neurons: 164.2;Oligodendrocyte precursor cells: 39.7" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Region enhanced" "Detected in many" "cerebellum: 9.4" "Group enriched" "Detected in some" 218 "memory B-cell: 14.6;naive B-cell: 31.9" "Lineage enriched" "Detected in single" 299 "B-cells: 31.9" "Cell line enhanced" "Detected in some" "HDLM-2: 5.3;RH-30: 11.4;SCLC-21H: 3.7;SH-SY5Y: 2.9;SK-MEL-30: 9.6;WM-115: 9.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042422 Uncertain "Secreted to extracellular matrix" NA NA "HPA042422: AB_10794798" "unprognostic (2.65e-2)" "unprognostic (2.55e-1)" "unprognostic (2.71e-1)" "unprognostic (9.24e-2)" "unprognostic (2.26e-2)" "unprognostic (6.20e-2)" "unprognostic (3.17e-1)" "unprognostic (1.10e-3)" "unprognostic (3.41e-1)" "unprognostic (1.28e-1)" "unprognostic (2.76e-1)" "unprognostic (1.62e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.20e-1)" "unprognostic (3.35e-1)" "unprognostic (8.91e-2)" 0.0 0.1 0.7 1.6 1.7 0.3 0.0 9.4 2.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 0.1 0.7 2.5 0.7 1.5 0.1 0.0 2.6 0.3 0.3 1.4 0.0 0.2 0.0 0.6 0.0 4.1 0.7 0.7 0.7 0.1 0.0 0.7 0.0 0.7 0.0 0.0 1.6 1.1 0.4 0.1 1.1 0.0 0.2 3.2 2.2 0.2 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 5.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.4 0.0 0.0 0.0 3.7 2.9 0.0 0.0 9.6 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 31.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.7 9.4 2.1 2.5 0.7 0.3 0.3 1.4 4.1 0.0 0.1 2.2 0.0 0.0 0.0 11.1 33.5 0.1 0.2 0.0 0.0 4.4 0.1 0.0 2.5 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 66.6 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.7 0.1 0.0 0.0 164.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 8.4 0.3 0.1 1.0 39.7 10.6 0.0 0.0 0.0 0.9 0.0 0.0 3.8 0.7 0.1 0.0 11.2 0.4 1.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 171.9;Excitatory neurons: 306.8;Inhibitory neurons: 237.4;Late spermatids: 291.6;Oligodendrocytes: 159.2;Syncytiotrophoblasts: 214.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 12.4" "Lineage enriched" "Detected in many" 5 "monocytes: 12.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 62.8;HUVEC TERT2: 59.5;SCLC-21H: 65.5;TIME: 164.8;U-2 OS: 57.7;U-2197: 57.1;U-251 MG: 71.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 100000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 27.8 28.4 6.7 27.7 3.2 4.2 11.8 13.3 40.9 6.4 0.0 17.9 50.1 7.9 5.7 10.8 13.8 9.4 4.7 5.8 9.9 34.2 4.9 14.0 8.0 43.8 14.2 0.9 11.5 7.0 60.1 10.5 21.3 52.8 5.9 13.3 46.2 4.1 7.4 6.1 3.6 48.1 13.6 8.1 12.3 3.2 62.9 31.9 6.6 4.6 10.8 4.0 10.4 5.7 50.3 0.3 0.9 3.9 0.0 54.5 62.8 43.7 12.8 0.0 0.0 0.0 0.7 0.1 0.1 0.1 39.8 23.2 0.2 38.6 0.0 0.0 0.0 34.2 0.1 0.4 0.0 0.2 0.1 4.6 33.3 0.0 12.3 0.1 16.2 59.5 0.0 0.4 0.4 0.1 0.0 0.5 0.7 7.9 0.2 12.5 0.3 0.0 0.2 0.4 4.8 65.5 0.5 0.1 0.5 25.9 31.2 0.7 4.8 164.8 0.3 57.7 57.1 71.6 0.1 0.1 0.0 0.2 5.4 6.8 0.0 4.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.7 0.0 12.4 0.0 0.0 0.7 6.7 3.2 13.3 40.9 5.8 9.9 43.8 14.2 0.9 52.8 8.1 31.9 50.3 18.2 19.2 6.4 28.7 1.3 15.9 4.1 0.0 3.4 75.6 5.3 1.7 3.5 2.8 1.9 7.3 77.2 98.6 0.2 44.0 15.6 0.4 171.9 2.2 10.1 21.9 9.1 3.2 306.8 0.7 44.2 27.7 0.0 2.1 0.0 0.0 7.1 0.8 58.8 3.3 237.4 10.0 0.0 82.2 66.7 291.6 22.4 81.9 10.6 103.0 50.9 3.3 2.1 44.2 159.2 0.8 8.3 7.9 1.6 3.8 91.2 68.4 1.6 14.7 0.0 3.0 13.1 2.7 11.5 2.3 8.4 214.0 2.6 0.2 12.3 1.7 COBLL1 KIAA0977 ENSG00000082438 "Cordon-bleu WH2 repeat protein like 1" Q53SF7 2 164653624-164843679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 108.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 218.8;Cone photoreceptor cells: 250.2;Microglial cells: 351.3;Syncytiotrophoblasts: 331.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 15.0;naive B-cell: 9.4;plasmacytoid DC: 8.1" "Group enriched" "Detected in many" 13 "B-cells: 15.0;dendritic cells: 8.1" "Cell line enhanced" "Detected in many" "Karpas-707: 62.6;RPTEC TERT1: 63.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044933, HPA053344" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA044933: AB_2679148, HPA053344: AB_2682123" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.38e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-1)" "unprognostic (4.49e-3)" "unprognostic (1.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.27e-13)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (2.47e-1)" "unprognostic (1.42e-1)" 35.4 51.9 11.2 7.4 7.7 4.1 14.0 6.7 9.4 10.2 27.2 8.1 10.8 4.6 15.7 32.9 4.9 12.4 7.3 6.8 6.7 69.4 108.5 18.3 12.9 9.3 7.9 3.8 12.7 44.0 11.0 5.0 51.3 8.8 27.6 7.9 57.3 18.1 28.2 3.3 17.1 7.9 7.5 6.2 10.0 30.3 2.0 11.1 4.9 18.6 7.2 16.4 22.8 16.5 9.2 10.7 2.2 5.9 0.0 7.1 1.3 11.9 34.0 13.3 4.7 5.6 8.9 4.3 1.0 6.9 3.2 5.0 38.4 26.2 21.3 5.6 2.9 10.7 10.5 9.5 36.3 10.2 0.0 0.0 1.8 19.8 1.0 27.6 5.8 21.1 1.3 0.0 62.6 7.5 12.5 0.3 0.1 2.9 25.9 12.8 1.3 22.4 10.4 63.1 36.0 14.4 5.8 16.1 14.7 4.6 11.4 10.7 0.0 9.5 11.3 9.7 3.8 8.3 24.3 10.0 3.6 4.7 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.8 0.0 8.1 0.0 0.4 11.2 7.7 6.7 9.4 6.8 6.7 9.3 7.9 3.8 8.8 6.2 11.1 9.2 56.4 70.5 66.5 7.5 102.5 97.3 54.3 14.5 30.7 21.6 22.4 22.4 9.3 30.0 26.0 218.8 250.2 52.1 40.8 11.3 62.6 25.5 0.1 24.6 12.2 47.1 22.2 22.5 23.7 33.8 71.3 35.0 53.5 19.5 34.1 9.0 6.1 127.9 8.7 3.3 30.9 11.0 24.4 3.9 9.0 1.3 14.6 3.7 19.6 351.3 0.7 144.5 0.0 5.0 1.6 29.8 4.9 7.9 154.8 46.0 12.6 28.6 12.4 190.2 46.0 8.6 71.2 0.6 2.7 69.0 70.3 331.4 8.3 8.0 10.0 75.6 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444835-70505490 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: AB_2686879" "prognostic unfavorable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favorable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 3.6 3.7 12.5 5.0 16.3 0.7 11.9 8.6 19.5 10.4 8.7 18.6 13.5 8.4 25.7 20.5 19.3 10.8 7.1 20.1 12.0 10.9 1.7 8.9 3.6 6.9 10.2 15.3 12.0 35.5 36.6 11.7 6.0 8.2 11.5 19.1 10.6 23.4 10.9 1.2 11.6 16.2 9.0 5.6 20.2 17.5 1.8 10.5 4.7 15.5 2.1 7.5 10.4 12.3 12.8 6.9 3.1 18.9 8.1 4.8 5.8 13.2 4.0 4.5 2.2 2.2 19.4 15.8 0.0 9.1 4.0 1.6 14.5 37.1 8.8 1.4 8.1 11.3 0.0 17.4 10.7 9.4 0.2 2.6 6.1 5.7 2.8 6.1 19.4 0.8 12.9 3.7 26.5 2.1 24.1 15.8 0.1 31.9 55.5 22.3 14.7 9.3 3.0 12.8 20.7 8.9 0.5 3.2 36.9 7.3 15.6 19.4 0.0 1.5 2.5 2.5 2.4 3.0 17.3 13.9 8.4 3.7 0.1 3.7 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.0 0.7 0.1 12.5 16.3 8.6 19.5 20.1 12.0 6.9 10.2 15.3 8.2 5.6 10.5 12.8 2.2 19.2 22.5 4.6 1.7 0.8 5.5 10.8 7.4 20.2 16.8 10.4 17.2 22.8 17.5 9.2 0.0 6.3 7.0 36.7 11.7 15.0 0.0 27.7 5.7 1.8 25.7 0.8 24.8 24.9 2.6 7.4 17.9 15.8 1.3 6.4 3.6 0.3 0.6 5.0 24.5 23.7 4.1 0.3 1.2 0.3 1.5 1.3 1.8 7.5 1.8 11.6 3.1 20.1 5.4 21.6 19.3 6.4 5.7 13.9 26.1 6.0 31.5 6.3 6.6 4.0 11.1 2.9 2.9 13.1 2.0 1.6 8.1 2.5 21.4 10.5 KCNK2 "K2p2.1, TREK-1" ENSG00000082482 "Potassium two pore domain channel subfamily K member 2" O95069 1 215005775-215237090 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "adrenal gland: 53.6" "Group enriched" "Detected in some" 10 "Excitatory neurons: 19.7;Inhibitory neurons: 53.9;Microglial cells: 30.0;Oligodendrocyte precursor cells: 45.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 79.7;fHDF/TERT166: 76.3;hTERT-RPE1: 49.2;T-47d: 108.5;U-2197: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (3.81e-4)" "unprognostic (2.58e-1)" "unprognostic (3.58e-2)" "unprognostic (3.48e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (1.82e-1)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-6)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "unprognostic (7.69e-3)" "unprognostic (7.46e-3)" 1.2 53.6 3.3 0.9 6.5 0.0 6.6 0.1 5.9 2.0 1.4 0.8 0.3 0.4 0.7 0.9 1.2 1.4 0.1 5.2 5.0 0.7 0.0 0.3 0.0 2.0 2.7 2.8 3.4 0.5 0.0 0.5 0.0 3.2 0.8 1.3 0.2 0.8 3.6 0.9 3.4 2.2 1.2 1.2 0.0 4.3 0.5 4.4 0.7 9.7 1.3 0.0 2.7 1.2 3.1 0.0 0.0 2.2 0.1 20.3 79.7 0.1 29.8 19.7 9.3 21.6 0.0 1.1 0.0 0.0 76.3 0.1 0.0 13.2 0.1 15.8 0.0 0.1 0.0 0.8 0.0 1.0 0.0 0.0 21.0 0.2 22.7 2.2 49.2 0.0 0.0 0.0 0.1 10.8 0.0 0.4 0.0 2.3 4.1 0.6 0.1 0.0 0.0 0.1 0.0 7.0 0.1 5.1 0.5 0.4 0.2 108.5 0.0 0.0 15.6 0.6 39.2 1.3 1.6 4.1 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 0.1 5.9 5.2 5.0 2.0 2.7 2.8 3.2 1.2 4.4 3.1 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.3 0.0 0.0 19.7 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 53.9 0.0 0.0 0.0 0.8 0.1 0.0 0.0 3.6 30.0 0.0 0.0 0.0 45.8 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.1 0.3 0.0 1.4 0.0 0.1 0.0 0.0 0.0 SERTAD4 DJ667H12.2 ENSG00000082497 "SERTA domain containing 4" Q9NUC0 1 210232796-210246631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4" "Cancer enhanced" "Detected in many" "breast cancer: 10.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027344, HPA028514" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA027344: AB_10601770, HPA028514: AB_10611391" "unprognostic (1.75e-2)" "unprognostic (3.92e-2)" "unprognostic (3.83e-2)" "unprognostic (9.74e-2)" "unprognostic (1.98e-2)" "unprognostic (1.27e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-1)" "unprognostic (7.74e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-2)" "unprognostic (5.98e-2)" "unprognostic (6.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.85e-2)" "unprognostic (6.55e-2)" "unprognostic (4.24e-1)" 1.0 0.3 0.7 0.3 1.7 0.0 3.7 1.0 1.2 2.0 0.4 3.6 0.4 3.8 0.6 4.3 1.7 0.7 2.4 0.7 1.3 1.0 0.0 1.5 0.1 0.9 1.4 0.6 1.0 0.1 0.6 1.0 1.0 1.1 1.8 1.4 0.1 5.9 1.4 0.2 3.2 0.8 2.7 1.1 0.1 1.4 0.2 1.1 0.6 1.4 0.7 0.7 0.6 1.9 1.2 7.5 0.1 1.6 0.0 0.8 0.7 7.4 1.8 1.8 1.4 2.4 0.3 0.8 0.0 0.2 0.4 1.1 3.6 0.2 0.6 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 1.7 0.2 0.0 0.0 0.0 0.3 1.8 0.0 0.0 5.2 6.0 0.3 0.0 2.4 0.0 1.2 1.3 7.4 6.3 1.2 8.5 0.1 2.9 10.5 0.0 2.3 2.0 8.7 0.1 5.6 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 1.0 1.2 0.7 1.3 0.9 1.4 0.6 1.1 1.1 1.1 1.2 5.0 6.4 3.9 1.6 0.0 16.7 9.6 16.0 28.5 2.5 23.1 9.3 0.7 1.5 10.9 9.2 0.0 14.2 0.0 1.5 7.9 2.1 0.5 4.8 1.2 5.2 1.2 0.0 10.1 3.9 54.9 7.5 2.6 5.8 0.0 9.3 2.5 0.0 1.4 0.0 3.7 5.6 24.4 0.0 5.0 0.6 0.6 0.3 10.6 3.7 0.0 0.5 0.0 1.0 9.4 8.1 1.3 1.5 0.0 2.5 0.0 0.4 13.9 0.3 0.0 1.8 3.7 0.1 1.7 27.4 4.7 4.4 0.3 0.1 6.5 3.4 TRAF5 RNF84 ENSG00000082512 "TNF receptor associated factor 5" O00463 1 211326615-211374946 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 75.9;Early spermatids: 55.0;Late spermatids: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008052, CAB010277" Enhanced Supported Centrosome,Cytosol NA NA Cytosol Centrosome "CAB010277: AB_2287961, HPA008052: AB_1858230" "unprognostic (6.44e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.39e-2)" "unprognostic (6.44e-3)" "unprognostic (7.94e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.94e-10)" "unprognostic (3.72e-1)" "unprognostic (1.34e-1)" "unprognostic (1.71e-2)" "prognostic favorable (7.29e-5)" 7.9 3.3 3.8 17.2 3.9 4.2 6.1 1.9 3.3 9.8 22.5 12.3 5.1 17.5 7.5 5.7 18.0 8.2 3.3 3.9 2.8 5.1 1.8 5.8 29.9 3.2 3.0 3.0 6.2 21.4 1.7 3.0 5.4 2.9 9.1 9.6 0.7 7.6 10.9 1.5 2.6 17.6 20.2 2.4 16.8 9.4 7.0 3.3 13.6 3.1 2.7 27.4 13.6 6.6 2.8 6.2 4.5 7.9 7.1 6.8 4.9 2.8 8.6 10.3 12.2 10.8 2.2 11.9 18.8 4.8 13.6 6.2 1.2 15.1 1.4 6.1 36.3 5.4 0.9 7.1 0.0 9.9 3.0 13.3 5.8 2.7 6.6 2.0 18.4 8.6 16.3 7.6 8.7 3.4 4.8 8.3 3.4 9.5 9.7 3.8 12.6 11.0 17.6 9.3 4.3 14.0 14.6 6.4 0.3 18.3 29.2 4.4 0.3 5.4 7.9 6.1 2.7 9.8 2.4 3.8 20.0 2.1 0.0 3.0 13.8 0.3 0.4 9.2 0.3 17.3 22.2 11.6 12.5 1.5 19.6 10.2 10.2 0.7 21.3 0.5 1.1 17.7 7.4 3.8 3.9 1.9 3.3 3.9 2.8 3.2 3.0 3.0 2.9 2.4 3.3 2.8 15.2 12.8 7.2 3.3 75.9 3.7 4.0 2.7 9.6 2.5 13.9 13.7 2.5 0.0 6.8 11.0 0.0 9.5 31.0 3.6 0.0 0.9 55.0 5.3 23.6 9.0 14.8 4.6 13.4 9.8 2.2 16.9 16.8 8.1 15.2 5.3 6.1 0.3 10.0 0.0 14.1 11.4 4.1 4.8 12.6 47.9 14.3 17.3 8.8 20.6 16.3 1.0 32.0 7.5 2.8 7.1 11.4 27.4 11.3 3.4 1.8 0.8 8.6 0.7 13.1 7.3 29.1 3.8 2.7 4.4 4.0 1.4 41.6 5.0 14.3 2.6 MRPL22 "HSPC158, MRP-L25, RPML25" ENSG00000082515 "Mitochondrial ribosomal protein L22" Q9NWU5 5 154941073-154969411 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047063 Uncertain Approved Mitochondria NA NA Mitochondria "HPA047063: AB_2679919" "unprognostic (9.17e-2)" "unprognostic (1.18e-2)" "unprognostic (2.16e-2)" "unprognostic (2.56e-2)" "unprognostic (5.42e-2)" "unprognostic (6.65e-2)" "unprognostic (1.80e-2)" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (3.01e-3)" "unprognostic (3.40e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (3.54e-1)" "unprognostic (2.69e-1)" "unprognostic (4.09e-2)" "unprognostic (4.29e-2)" 23.5 38.8 20.0 20.5 20.1 41.2 26.5 21.7 28.1 20.3 19.3 28.7 26.3 20.7 26.2 31.0 19.1 15.5 39.5 20.2 20.7 37.6 49.8 19.7 28.7 21.0 20.4 19.8 18.3 30.5 31.5 24.0 24.4 21.4 19.6 28.2 17.1 25.0 19.5 38.8 23.3 23.1 20.2 20.2 26.4 27.3 29.6 20.6 28.4 23.6 34.8 27.3 24.9 21.8 21.3 68.5 65.8 57.1 79.7 43.7 55.0 67.9 47.6 55.9 93.9 118.3 191.5 82.8 93.7 82.9 40.1 100.0 61.2 83.2 90.0 99.8 32.2 94.3 36.1 64.1 110.1 57.1 81.5 47.2 36.5 59.4 63.4 76.9 41.8 161.8 84.6 55.2 81.9 58.8 100.8 74.1 78.3 43.5 74.0 50.6 67.4 49.6 97.9 93.1 50.9 65.4 24.3 62.5 89.1 104.9 41.0 130.2 71.3 47.5 57.7 57.5 51.1 89.3 43.4 57.5 104.4 57.9 99.7 55.4 35.9 49.0 44.1 47.5 59.7 48.7 72.3 51.5 51.3 66.6 61.5 47.7 54.6 19.8 64.0 60.4 51.9 75.1 62.4 20.0 20.1 21.7 28.1 20.2 20.7 21.0 20.4 19.8 21.4 20.2 20.6 21.3 55.2 25.6 28.1 11.1 52.2 63.9 54.4 191.6 43.9 28.1 45.9 67.9 213.2 64.3 95.6 60.7 27.1 144.6 37.9 46.6 223.0 114.9 56.2 49.6 44.4 69.2 49.6 64.0 13.0 127.1 132.6 64.7 27.0 41.3 45.0 56.2 51.4 85.2 99.3 32.0 11.8 65.6 79.3 33.2 57.1 29.3 66.2 35.7 51.6 2.8 61.3 35.9 56.7 11.1 20.1 113.9 83.4 75.2 71.1 47.2 68.1 203.7 89.0 27.1 32.9 48.5 86.7 167.7 67.0 50.3 65.8 78.5 48.4 122.2 78.5 54.6 GEMIN5 ENSG00000082516 "Gem nuclear organelle associated protein 5" Q8TEQ6 5 154887411-154938211 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037392, HPA037393" Uncertain Enhanced "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA037392: AB_2675453, HPA037393: AB_10672489" "unprognostic (1.14e-2)" "unprognostic (2.81e-3)" "unprognostic (5.41e-3)" "prognostic unfavorable (6.23e-5)" "unprognostic (5.44e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (9.91e-2)" "unprognostic (8.70e-2)" "unprognostic (3.61e-2)" "unprognostic (9.38e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (9.40e-3)" "unprognostic (5.01e-2)" 7.2 4.5 5.2 5.0 6.0 3.4 8.3 5.5 5.6 5.8 5.0 4.9 3.3 6.3 4.6 5.3 6.1 3.5 6.2 5.2 5.6 4.8 6.0 4.4 6.5 5.5 5.4 5.1 8.5 5.5 6.5 4.5 4.8 5.7 5.8 4.7 4.1 4.6 6.0 12.5 6.7 4.0 6.9 5.5 5.6 4.3 6.0 5.5 7.5 5.3 10.3 7.4 6.8 5.0 7.1 17.2 25.0 15.9 37.0 16.8 14.2 20.4 16.4 9.9 28.0 20.6 41.6 15.0 45.0 20.2 15.7 28.8 17.8 47.7 29.8 38.0 9.0 22.3 27.3 15.6 25.2 9.3 48.0 15.2 10.7 13.6 38.9 23.2 10.1 23.2 10.7 43.9 10.7 21.2 23.6 26.0 19.2 22.3 13.4 19.4 33.3 31.2 37.4 11.6 11.6 20.9 14.4 18.9 20.7 13.3 15.7 24.6 11.0 14.2 25.1 18.0 19.1 37.2 10.7 17.5 34.5 10.7 38.8 22.6 0.0 1.9 1.7 2.4 2.3 3.9 3.4 2.2 2.2 2.6 2.7 3.2 3.5 0.1 2.8 2.2 1.9 2.2 2.1 5.2 6.0 5.5 5.6 5.2 5.6 5.5 5.4 5.1 5.7 5.5 5.5 7.1 6.7 0.0 6.4 6.8 8.4 10.3 6.7 5.3 10.2 6.3 5.2 5.0 15.0 1.5 12.3 3.7 0.0 4.4 5.0 1.9 0.0 5.7 3.4 4.3 9.5 8.4 1.2 8.8 19.1 4.2 4.4 11.1 5.1 4.8 1.3 15.6 4.6 9.2 4.5 16.8 20.5 3.9 0.0 14.4 2.6 4.1 10.8 4.5 7.2 11.2 6.0 7.0 5.2 15.1 19.3 3.4 1.1 13.2 4.5 7.0 2.6 4.5 2.5 4.3 0.0 11.5 8.6 11.7 16.1 8.2 15.9 2.1 5.6 15.6 4.7 4.9 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225724-53251637 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 10.9" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.1 0.1 7.6 0.0 10.9 0.0 0.0 1.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 3.5 0.0 0.0 0.1 0.0 4.4 2.0 7.9 0.0 0.0 0.0 0.0 0.2 5.4 1.6 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.7 0.1 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 21.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 10.9 1.4 4.0 3.4 3.5 4.4 2.0 7.9 5.4 0.0 5.7 5.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 4.5 0.6 0.1 0.0 0.0 6.7 0.0 8.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061545 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 434.8;skeletal muscle: 1370.6;tongue: 866.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA063384: AB_2684998, HPA065424: AB_2685488" "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favorable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 155.6 131.8 109.7 75.7 99.3 31.4 91.9 111.7 99.3 104.4 195.8 108.6 106.9 150.8 89.0 127.1 131.8 98.2 434.8 112.7 124.9 161.1 104.9 84.0 64.4 131.0 125.0 84.6 150.1 65.8 116.2 83.1 101.5 139.4 96.5 80.9 67.7 92.9 124.7 1370.6 122.1 114.2 142.2 122.1 114.0 79.7 69.9 137.2 62.9 133.7 866.0 59.7 90.5 87.0 142.0 122.2 265.4 172.0 147.4 349.8 168.2 128.6 193.7 269.2 135.1 149.8 327.6 137.6 139.8 379.2 244.6 175.2 245.5 122.5 154.5 144.7 239.9 104.1 78.8 181.0 111.1 418.6 178.0 122.1 232.6 380.7 246.7 267.2 228.7 214.6 93.5 142.5 377.4 169.4 103.3 115.5 56.0 113.0 110.0 101.4 80.1 241.8 136.4 150.0 181.0 105.8 160.2 132.4 89.0 272.4 222.5 175.7 120.5 291.2 324.2 141.4 112.3 197.4 626.6 460.1 134.1 310.4 73.6 191.3 14.2 11.8 4.0 3.4 6.5 2.0 5.2 3.1 3.5 2.6 4.9 2.4 2.7 26.1 3.0 8.7 12.9 1.2 1.3 109.7 99.3 111.7 99.3 112.7 124.9 131.0 125.0 84.6 139.4 122.1 137.2 142.0 60.1 57.7 49.4 25.1 15.8 55.7 19.3 45.0 34.1 68.8 39.2 33.8 303.1 50.1 34.4 77.3 35.5 22.7 14.7 150.7 25.4 41.3 8.1 57.9 92.0 66.3 30.1 11.6 24.5 36.2 21.5 47.9 27.5 58.8 28.4 89.3 80.3 126.7 36.0 72.3 28.0 51.5 38.7 32.8 18.9 10.6 102.2 23.8 21.4 20.6 31.5 25.4 15.5 9.0 14.4 51.8 64.8 83.8 17.4 33.8 100.3 39.1 49.5 34.8 59.2 39.3 53.8 30.0 35.5 25.9 48.4 22.3 14.2 44.6 49.4 24.4 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909082-123028605 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Excitatory neurons: 30.8;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 45.2;Smooth muscle cells: 14.3" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 79.7;NTERA-2: 15.7;SH-SY5Y: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.6 1.5 13.7 0.4 13.5 0.0 1.4 9.3 15.6 1.5 8.7 1.1 0.9 1.4 2.8 0.7 3.6 2.5 7.7 18.2 11.7 7.5 0.9 1.2 0.6 10.4 10.5 15.4 1.4 1.7 0.6 2.7 2.6 11.9 1.4 0.8 7.2 0.5 1.4 0.9 1.2 1.5 1.9 9.7 0.2 0.6 0.7 9.8 0.2 2.6 0.5 0.7 1.6 1.6 12.6 0.0 0.0 79.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 21.3 0.0 0.2 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 13.5 9.3 15.6 18.2 11.7 10.4 10.5 15.4 11.9 9.7 9.8 12.6 1.2 0.0 1.1 9.4 0.0 0.0 0.0 0.1 0.0 7.2 0.1 0.0 3.5 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.8 0.0 0.0 30.8 0.0 0.3 0.7 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.6 7.3 0.0 45.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 14.3 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GSK3B ENSG00000082701 "Glycogen synthase kinase 3 beta" P49841 3 119821321-120094994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016263, HPA028017" Approved Supported Nucleoplasm No No Nucleoplasm "CAB016263: AB_2279451, HPA028017: AB_10600708" "unprognostic (1.09e-2)" "unprognostic (2.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (3.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.05e-3)" "unprognostic (6.79e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.39e-1)" "unprognostic (2.58e-1)" "unprognostic (1.28e-2)" "unprognostic (1.16e-1)" 11.1 13.7 7.4 11.8 8.5 15.2 11.4 15.8 17.0 10.1 0.0 11.8 12.4 10.4 11.2 13.9 10.2 11.2 18.4 9.4 9.9 12.1 14.9 14.0 10.5 15.4 11.1 5.8 9.4 10.8 17.4 7.2 16.5 22.2 10.1 12.5 23.8 13.3 9.4 17.7 15.8 15.4 13.4 4.6 13.0 12.7 23.3 10.3 20.2 15.2 18.1 11.8 12.1 9.6 16.1 59.3 22.7 46.8 25.5 31.9 29.5 50.3 36.6 57.6 28.3 29.3 25.9 23.8 24.1 19.1 43.0 33.8 46.0 22.2 59.1 45.8 15.5 6.6 42.2 18.4 16.6 35.6 31.6 49.9 34.3 39.5 27.0 56.8 27.3 31.5 29.3 13.6 34.6 40.5 25.1 44.0 10.7 25.2 23.3 28.3 16.9 41.0 22.2 25.1 45.3 37.1 22.6 38.5 29.0 44.1 41.1 30.9 27.0 40.0 45.5 55.1 12.7 20.6 31.9 35.2 44.8 29.4 22.0 33.9 1.0 1.8 6.3 0.7 1.6 1.2 0.5 1.0 1.7 1.4 0.7 0.9 0.8 6.6 0.5 2.1 1.1 1.2 0.8 7.4 8.5 15.8 17.0 9.4 9.9 15.4 11.1 5.8 22.2 4.6 10.3 16.1 39.3 32.1 26.7 113.6 28.3 50.9 37.8 22.2 46.1 63.2 21.9 17.0 39.7 20.0 21.4 18.4 60.5 27.0 29.0 37.3 11.7 26.9 138.2 25.2 31.6 31.5 26.9 15.4 218.7 32.0 49.3 25.1 46.4 32.5 17.2 18.1 25.0 22.9 21.5 143.0 246.3 22.3 20.3 27.3 29.2 48.1 13.1 33.4 35.6 197.7 35.5 31.6 22.6 241.8 202.5 49.0 23.4 19.9 29.0 28.7 35.8 17.3 16.3 42.4 13.1 24.4 38.2 38.8 29.3 50.8 41.1 43.0 36.4 32.7 25.9 41.6 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 64000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 96.1 32.9 25.0 26.3 29.8 3.4 71.9 32.5 21.5 69.2 63.9 43.2 33.4 76.6 16.5 55.4 33.5 72.3 67.1 23.3 33.1 48.6 51.9 54.4 6.0 35.9 28.7 14.7 28.3 23.3 22.0 20.7 83.0 31.4 37.6 25.1 14.4 50.0 47.4 30.2 81.2 32.8 60.6 31.9 41.3 29.9 13.6 31.6 12.3 34.6 34.0 10.0 40.6 70.6 37.1 189.1 459.9 32.4 82.7 296.6 84.2 166.3 197.5 120.0 35.9 57.6 92.6 240.3 0.8 93.5 336.3 177.0 148.0 29.5 102.7 31.2 2.0 20.1 66.3 69.5 98.0 51.0 0.4 116.8 51.2 23.2 91.1 46.9 508.7 121.2 0.2 60.7 98.1 122.7 190.0 0.8 1.1 145.8 105.1 50.4 0.4 52.2 71.8 98.8 41.2 0.9 67.5 146.6 214.5 165.7 56.4 121.9 4.2 318.2 134.9 200.7 118.5 103.7 16.6 18.4 1.3 141.3 0.8 477.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 2.5 25.0 29.8 32.5 21.5 23.3 33.1 35.9 28.7 14.7 31.4 31.9 31.6 37.1 50.4 6.4 6.7 55.5 1.0 17.2 23.1 18.8 6.2 8.1 20.6 27.2 28.9 42.9 10.0 29.5 4.2 68.5 0.6 34.9 11.7 38.3 10.7 22.0 21.4 27.5 3.5 2.7 0.9 18.8 7.4 52.1 11.2 13.4 0.0 135.9 31.1 39.1 72.3 35.3 18.1 12.9 2.0 36.8 17.5 4.1 20.2 28.5 10.6 60.9 0.4 50.2 0.0 16.6 12.5 70.4 27.0 16.6 0.6 24.9 21.0 10.7 6.2 14.9 39.5 31.3 52.1 2.6 7.0 15.6 22.3 55.1 1.7 1.0 16.3 14.8 ERC1 "CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2" ENSG00000082805 "ELKS/RAB6-interacting/CAST family member 1" Q8IUD2 12 990509-1495933 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 292.3;Horizontal cells: 185.1;Inhibitory neurons: 487.0;Microglial cells: 213.6;Oligodendrocyte precursor cells: 230.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019513, HPA019523, HPA024130" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014" "unprognostic (2.41e-1)" "unprognostic (4.00e-2)" "unprognostic (2.14e-1)" "unprognostic (5.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (5.50e-2)" "unprognostic (8.49e-2)" "unprognostic (2.53e-1)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (6.79e-2)" "unprognostic (3.75e-3)" "unprognostic (4.19e-2)" "unprognostic (3.01e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (7.01e-4)" 10.5 9.8 12.2 6.9 14.4 7.3 8.1 38.4 11.3 8.9 8.3 9.8 3.5 9.1 4.8 11.9 8.2 7.6 14.0 13.9 16.7 9.3 6.5 7.3 4.8 13.5 14.7 9.2 10.6 7.6 15.5 8.1 11.9 18.7 9.6 6.3 7.1 8.5 12.2 9.5 9.2 5.9 13.0 11.7 5.8 7.3 7.6 15.8 7.9 13.5 9.0 5.4 13.5 9.1 12.7 8.2 20.1 10.3 7.1 27.8 22.2 14.2 25.0 20.0 17.0 15.3 17.7 10.0 12.5 3.4 33.2 16.8 13.3 22.1 19.7 23.1 25.9 11.6 30.3 20.1 9.3 21.1 16.1 6.9 18.7 17.0 30.0 55.6 20.7 22.3 7.9 9.6 23.9 12.9 9.2 5.2 3.5 16.8 8.1 9.7 9.9 38.9 3.8 16.9 14.2 6.3 12.3 38.8 9.3 13.9 37.6 9.3 7.0 39.6 29.6 29.0 21.6 24.0 6.4 13.1 18.1 19.2 9.4 12.9 1.5 3.1 2.3 1.7 1.2 2.4 12.7 2.7 2.7 2.7 5.6 3.8 2.7 2.4 1.4 4.8 3.4 2.8 0.7 12.2 14.4 38.4 11.3 13.9 16.7 13.5 14.7 9.2 18.7 11.7 15.8 12.7 36.9 25.6 25.1 155.4 21.2 21.0 25.6 9.4 29.0 39.2 13.2 14.1 56.4 17.2 17.4 20.2 47.9 34.1 12.6 12.7 1.9 20.3 34.3 31.2 43.4 34.6 30.0 7.6 292.3 13.4 18.0 32.3 23.9 53.9 14.5 59.2 24.3 17.3 12.4 185.1 487.0 11.9 2.0 12.6 16.5 35.2 24.8 17.0 14.2 213.6 18.4 34.8 6.2 230.7 171.1 18.5 10.3 30.9 39.1 30.8 6.1 4.1 13.2 33.4 19.7 35.5 33.1 18.5 28.8 33.8 27.4 78.7 15.8 18.7 10.3 29.4 XPO1 "CRM-1, CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61476032-61538741 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 410000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 33.5 30.1 33.8 49.1 32.1 26.0 39.6 36.9 39.0 38.2 32.7 35.2 25.0 53.0 37.3 35.4 46.3 32.3 36.3 34.1 36.4 31.1 42.1 32.1 65.8 34.2 32.6 28.0 59.4 26.4 38.8 22.2 52.5 33.5 34.5 42.4 52.5 20.0 35.2 37.9 34.4 33.5 49.0 35.1 43.8 32.2 55.0 38.3 74.2 39.2 47.6 61.4 39.0 22.6 58.9 169.1 152.9 194.1 135.8 91.4 107.9 145.5 166.6 109.2 192.9 151.8 217.3 114.7 256.0 117.4 127.1 186.3 125.0 307.9 126.5 268.6 151.6 110.7 242.8 136.2 148.4 55.4 234.6 145.4 62.9 103.8 149.4 145.9 126.0 149.5 108.7 285.5 127.7 164.9 97.8 212.6 100.4 213.1 189.9 111.5 175.6 208.0 148.1 103.0 124.9 152.8 77.5 174.2 142.8 87.1 185.6 108.6 110.8 98.9 153.7 178.7 137.2 175.0 102.8 203.2 347.0 96.8 214.0 151.0 3.3 1.4 2.2 1.8 2.2 1.9 1.1 1.0 1.8 2.1 0.7 1.0 1.0 0.6 2.7 1.2 1.6 1.2 1.2 33.8 32.1 36.9 39.0 34.1 36.4 34.2 32.6 28.0 33.5 35.1 38.3 58.9 42.0 41.7 43.2 114.3 55.3 52.1 32.1 45.5 78.6 67.5 40.2 38.6 64.5 38.6 38.7 31.3 95.9 54.1 56.6 27.3 13.7 29.7 4.2 58.6 79.7 47.7 45.1 73.2 87.9 26.1 49.3 49.9 42.3 68.6 41.8 100.4 41.4 55.8 57.2 72.3 101.3 34.2 40.7 55.3 58.4 11.9 33.5 63.9 37.4 68.4 64.2 33.4 61.8 83.4 102.5 32.3 20.9 30.9 57.2 55.6 21.0 22.2 56.9 101.7 19.7 50.5 55.7 65.9 91.6 83.3 56.8 30.1 54.5 54.4 46.2 47.7 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812770-149962139 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 591.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 462.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA064784: AB_2685350" "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favorable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 48.6 41.5 65.1 40.7 98.9 20.1 54.4 95.1 90.6 33.9 71.5 35.4 29.1 33.6 57.7 32.9 30.5 41.0 34.7 64.1 83.5 68.5 74.5 64.7 38.3 102.0 93.4 57.4 35.9 36.5 52.7 18.5 64.6 104.4 47.0 37.5 40.8 76.2 39.7 36.8 32.6 30.8 37.2 98.3 53.5 34.6 25.4 86.3 32.3 64.6 43.0 33.4 42.7 29.2 140.0 60.6 39.4 24.4 29.0 92.2 55.2 40.3 32.2 86.2 32.3 47.4 33.4 84.4 26.6 48.7 42.0 58.7 58.0 37.5 41.5 42.9 34.1 24.6 35.8 17.3 31.2 61.5 35.0 41.8 59.9 73.1 26.5 71.8 37.3 37.0 24.9 10.1 49.7 28.0 34.5 26.2 18.8 16.8 58.6 29.1 19.0 26.7 108.5 54.2 29.6 12.6 37.6 28.5 39.9 110.3 19.2 79.2 34.0 37.8 40.8 16.5 45.6 23.4 89.9 61.9 51.5 35.9 30.1 23.6 98.2 130.1 106.5 37.4 153.8 48.8 51.9 41.5 44.8 93.1 48.4 38.0 42.4 462.3 46.3 207.8 68.3 48.7 104.5 65.1 98.9 95.1 90.6 64.1 83.5 102.0 93.4 57.4 104.4 98.3 86.3 140.0 100.9 109.0 72.3 78.7 55.3 73.5 68.2 84.3 74.0 44.5 54.5 51.1 27.3 48.6 68.1 47.8 29.2 101.2 61.9 30.2 43.0 63.0 2.5 32.5 34.5 69.4 20.3 32.4 122.1 70.6 83.5 84.8 31.6 39.7 60.8 14.6 80.3 53.7 201.2 21.9 98.8 27.7 67.1 183.9 173.7 6.7 76.1 177.6 103.2 92.8 93.5 98.5 38.1 115.6 591.2 58.7 33.6 88.0 62.4 71.9 38.5 71.5 40.4 37.2 92.1 76.3 55.5 23.6 32.5 52.3 72.5 52.5 49.8 38.2 27.7 55.8 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529060-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "choroid plexus: 672.3" "Cell type enhanced" "Detected in many" "Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HAP1: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles NA NA Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.5 0.6 20.2 0.1 25.9 0.2 0.1 41.0 11.9 1.0 672.3 0.1 0.8 1.1 1.4 0.1 0.4 0.4 0.5 42.4 24.5 16.7 0.2 0.1 0.1 32.7 44.5 2.7 3.6 0.5 0.0 2.9 0.1 26.8 0.5 0.1 23.2 0.1 2.5 0.3 0.1 0.0 0.2 20.0 0.3 0.6 5.1 41.5 0.2 0.9 0.1 0.0 0.2 0.4 17.4 0.0 0.0 0.9 0.0 1.1 2.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 17.2 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.2 0.0 0.0 1.0 4.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.0 0.9 0.0 1.1 0.0 0.2 0.0 0.3 0.2 0.0 0.0 3.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.2 25.9 41.0 11.9 42.4 24.5 32.7 44.5 2.7 26.8 20.0 41.5 17.4 0.3 3.2 3.0 905.0 0.5 0.4 0.9 0.0 0.6 16.4 0.3 0.5 5.3 5.7 2.5 16.5 66.7 0.1 0.2 0.1 5.9 0.1 4.8 1.4 1.0 1.3 15.4 0.0 390.3 0.2 0.1 3.0 0.0 3.2 0.0 1.4 0.7 0.3 0.2 1.7 186.9 0.1 0.0 0.9 1.4 2.3 5.6 0.8 0.0 56.2 0.2 184.5 1.0 105.6 8.3 0.1 0.1 9.1 0.0 0.5 0.1 33.3 0.8 10.1 0.0 3.5 1.3 1.3 0.6 0.0 0.9 0.3 0.9 0.6 0.0 0.3 PALB2 "FANCN, FLJ21816" ENSG00000083093 "Partner and localizer of BRCA2" Q86YC2 16 23603160-23641310 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB014895, HPA057000" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB014895: , HPA057000: AB_2683307" "unprognostic (1.11e-1)" "unprognostic (5.67e-3)" "prognostic favorable (2.83e-5)" "unprognostic (1.43e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (2.00e-3)" "unprognostic (5.18e-2)" "unprognostic (2.46e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.05e-2)" "unprognostic (1.04e-2)" "unprognostic (2.72e-1)" "unprognostic (1.25e-1)" "unprognostic (7.20e-2)" "unprognostic (3.21e-1)" 5.5 5.6 7.3 4.5 7.7 3.5 6.5 11.0 10.7 6.3 7.4 6.1 6.5 5.7 5.6 10.2 5.4 3.3 4.3 7.4 7.5 6.2 10.0 4.8 6.4 7.4 7.6 7.3 6.3 6.1 5.8 5.1 3.8 8.3 5.4 5.3 8.7 6.0 4.0 5.4 8.9 7.0 4.0 7.1 7.8 5.8 9.9 7.7 6.4 5.3 4.9 7.0 6.7 7.3 8.2 17.3 13.1 15.4 10.8 12.6 9.4 13.9 12.0 18.4 19.7 23.6 11.2 17.3 18.2 8.7 8.6 15.0 15.2 13.9 19.8 23.4 10.8 8.1 11.2 18.2 31.8 11.7 20.5 17.3 11.2 20.3 18.7 20.7 10.9 10.6 17.1 23.4 9.4 17.2 17.4 21.2 21.3 34.3 12.5 7.6 24.2 18.9 24.7 15.2 15.2 11.2 11.3 12.5 13.5 16.7 13.4 12.9 13.9 7.7 23.1 8.7 11.2 13.2 11.2 19.0 18.3 15.4 14.8 14.3 6.4 1.8 1.8 2.1 2.3 2.6 1.8 2.4 2.7 2.0 1.4 2.6 2.1 0.1 2.1 4.5 1.5 1.7 1.1 7.3 7.7 11.0 10.7 7.4 7.5 7.4 7.6 7.3 8.3 7.1 7.7 8.2 4.7 12.8 4.2 8.5 5.1 0.9 3.5 5.4 2.2 4.8 4.0 3.7 4.8 2.8 8.2 3.7 4.2 2.9 3.8 2.4 3.9 5.8 6.8 2.3 5.1 4.8 1.2 4.6 7.4 5.0 2.0 4.4 4.1 2.6 5.1 7.7 3.3 4.7 3.7 1.7 8.0 3.4 2.0 5.0 1.5 3.6 4.7 5.1 1.8 5.6 8.4 4.8 5.2 7.1 5.9 8.6 2.5 6.4 4.2 5.3 4.6 5.4 8.3 7.5 6.6 4.7 3.0 30.0 17.7 5.4 2.7 1.2 3.7 6.9 4.8 4.1 DOP1A "dJ202D23.2, DOPEY1, KIAA1117" ENSG00000083097 "DOP1 leucine zipper like protein A" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.7;Cardiomyocytes: 9.8;Cytotrophoblasts: 4.8;dendritic cells: 5.9;Hofbauer cells: 4.1;Plasma cells: 3.8;Syncytiotrophoblasts: 3.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favorable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 5.3 5.0 3.6 6.3 5.4 4.9 11.0 8.4 5.8 9.0 2.6 8.0 7.9 10.5 7.4 7.2 9.5 7.3 9.1 4.3 4.5 7.0 6.3 6.8 7.3 4.0 3.5 5.5 13.9 9.1 11.7 7.7 6.0 4.9 9.6 8.9 24.2 9.6 10.8 6.4 13.7 8.9 7.6 3.2 8.3 7.3 12.8 4.0 10.7 13.7 9.4 7.6 6.3 5.1 10.7 4.2 3.0 9.8 8.9 8.7 9.1 4.6 7.0 5.9 4.7 6.8 6.4 1.0 8.2 4.9 7.7 5.9 5.5 10.0 7.6 5.9 7.2 11.3 6.8 4.2 2.4 4.7 10.1 6.9 7.3 10.4 6.6 17.0 6.2 7.0 12.6 14.4 5.9 5.1 3.9 3.0 4.5 2.0 3.1 6.1 8.2 7.4 3.0 6.1 11.7 17.6 3.2 5.2 3.3 1.3 7.0 5.3 5.7 11.8 5.9 2.1 6.0 5.5 7.3 5.7 4.6 3.2 4.6 4.7 0.0 0.3 0.4 0.5 0.4 0.4 0.6 0.4 1.1 0.7 0.4 0.8 0.4 0.0 0.4 0.3 0.3 0.4 0.4 3.6 5.4 8.4 5.8 4.3 4.5 4.0 3.5 5.5 4.9 3.2 4.0 10.7 5.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 4.8 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 3.4 0.8 0.0 0.0 0.0 LYRM2 DJ122O8.2 ENSG00000083099 "LYR motif containing 2" Q9NU23 6 89568144-89638749 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063932 Uncertain Approved Cytosol NA NA Cytosol "HPA063932: AB_2685155" "unprognostic (3.23e-2)" "unprognostic (1.47e-1)" "unprognostic (8.52e-3)" "unprognostic (8.49e-2)" "unprognostic (4.27e-2)" "unprognostic (6.26e-2)" "prognostic unfavorable (2.58e-8)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "unprognostic (3.29e-3)" "unprognostic (8.07e-3)" "unprognostic (3.63e-2)" "unprognostic (7.98e-2)" "unprognostic (3.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.23e-2)" "unprognostic (5.64e-2)" 10.8 16.1 12.3 10.4 12.9 15.0 14.3 11.9 12.4 9.5 9.1 13.8 8.7 11.2 14.5 12.4 13.5 10.3 17.5 12.7 12.7 17.6 12.5 10.2 13.0 11.7 12.1 12.5 10.0 10.6 22.7 10.8 14.0 11.8 13.3 16.3 9.1 9.9 8.6 21.5 6.3 9.6 12.0 13.0 9.1 13.1 8.8 12.1 9.3 25.4 17.1 11.0 10.8 6.6 13.5 18.4 9.6 32.1 19.7 16.0 24.0 12.8 31.3 22.2 24.0 23.8 8.6 9.6 25.1 29.5 29.6 35.7 16.5 20.6 29.7 30.8 32.0 36.5 39.8 9.9 7.3 24.0 42.6 29.7 29.7 28.2 27.2 36.5 19.4 18.8 27.0 41.8 32.0 27.9 16.5 10.0 15.3 7.6 14.9 12.5 20.7 40.1 18.9 27.2 18.1 35.7 24.2 18.3 11.1 31.1 14.6 15.8 43.0 30.2 15.0 13.2 27.4 44.0 22.9 35.1 13.0 31.6 30.3 28.9 16.4 21.0 14.3 21.5 24.8 23.1 32.6 24.0 28.4 19.7 30.9 26.8 25.1 6.0 27.3 33.9 26.1 24.2 14.8 12.3 12.9 11.9 12.4 12.7 12.7 11.7 12.1 12.5 11.8 13.0 12.1 13.5 37.1 41.7 50.3 11.8 47.6 11.9 29.0 43.1 29.0 27.0 37.6 45.7 87.5 27.1 48.3 27.6 16.7 87.6 33.9 31.3 93.9 40.1 66.0 86.2 56.6 30.7 40.7 35.3 17.6 49.4 32.9 35.6 37.2 55.8 32.9 33.9 24.7 27.1 57.8 25.2 19.7 43.4 44.7 35.1 12.9 18.7 30.7 39.9 30.2 15.9 44.8 100.6 44.3 13.0 26.4 40.1 32.8 27.1 30.9 25.9 29.3 68.8 70.6 45.3 52.6 39.2 41.1 57.0 31.6 43.3 16.2 72.4 37.5 81.8 39.8 26.2 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 79.0" "Cell type enhanced" "Detected in all" "Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoplasm,Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria "Nucleoplasm, Nucleoli" "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 19.9 10.8 6.9 7.7 8.1 8.3 22.5 12.1 8.6 11.8 10.2 22.7 11.6 9.2 7.2 10.4 11.6 7.9 18.9 8.6 6.4 32.1 79.0 7.4 8.9 10.7 8.8 5.6 14.7 13.0 19.9 7.2 4.9 12.4 16.1 20.9 7.9 26.8 11.5 11.0 8.3 12.5 9.5 10.7 6.4 17.7 13.2 8.6 9.1 15.6 15.4 9.1 11.3 7.6 15.6 13.8 5.1 18.8 25.3 18.6 16.1 14.9 9.7 19.8 15.4 21.0 8.3 18.5 38.9 10.1 23.1 18.0 13.6 10.6 12.7 21.5 48.8 15.6 19.4 12.6 11.3 20.7 27.7 8.3 15.6 12.8 10.7 13.3 13.8 18.6 29.8 16.6 33.8 35.0 7.6 10.3 16.3 14.0 30.1 6.5 25.5 58.3 33.8 43.2 20.7 12.6 17.8 16.2 13.4 9.9 20.6 17.3 21.1 8.0 9.2 6.3 8.5 13.0 24.0 25.2 12.9 11.3 20.4 14.2 3.4 4.2 1.0 10.1 5.1 13.3 10.6 8.3 8.5 8.3 12.7 11.0 11.6 0.8 17.4 5.9 12.9 20.3 6.1 6.9 8.1 12.1 8.6 8.6 6.4 10.7 8.8 5.6 12.4 10.7 8.6 15.6 8.4 9.6 21.0 296.5 11.5 8.5 12.5 21.1 15.9 7.8 19.6 14.7 29.3 8.6 18.0 5.5 2.1 17.0 9.1 17.5 27.4 8.2 110.9 8.3 10.3 8.0 12.0 10.3 72.0 10.4 8.3 13.7 15.3 17.6 16.5 19.2 11.0 66.5 12.2 3.3 94.9 31.3 10.2 9.1 9.0 13.7 8.7 5.4 16.0 59.0 7.3 15.5 10.3 98.5 101.7 5.4 10.4 8.6 8.4 6.2 11.5 33.1 13.5 8.7 6.6 11.1 9.4 15.2 5.6 20.1 12.4 10.4 9.9 15.5 17.4 10.9 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051994 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Supported "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 14.5 7.2 9.4 15.6 12.8 38.5 12.4 19.9 11.3 13.8 11.3 10.3 9.7 15.7 8.7 13.5 12.1 11.3 9.2 9.4 11.1 9.2 10.1 16.9 16.9 14.1 13.0 6.1 21.7 11.8 18.1 6.8 15.0 12.6 11.1 10.7 18.3 9.7 9.8 13.3 16.7 12.2 13.6 9.7 15.9 11.4 11.5 10.8 27.2 14.3 16.1 17.3 12.1 10.8 17.5 19.6 23.2 34.8 21.8 17.8 20.3 9.8 15.4 20.6 17.9 14.2 16.3 11.5 33.4 13.4 19.0 19.5 17.3 27.3 18.6 23.2 16.1 14.4 60.4 14.2 10.3 14.8 27.3 23.6 17.1 19.1 20.4 24.8 14.5 18.8 29.7 36.6 24.2 16.0 10.4 59.9 9.4 12.8 20.4 8.1 37.7 39.1 9.9 11.0 27.1 17.6 16.7 15.8 12.4 13.8 15.8 26.3 12.9 25.5 21.6 15.3 21.1 15.5 16.8 22.1 33.8 12.6 14.1 17.3 2.5 0.8 1.8 1.6 0.9 1.6 1.4 1.6 2.1 0.6 1.6 1.9 1.8 5.1 1.9 0.9 1.1 1.9 1.2 9.4 12.8 19.9 11.3 9.4 11.1 14.1 13.0 6.1 12.6 9.7 10.8 17.5 87.5 35.3 34.9 64.0 54.0 50.3 24.2 15.5 18.2 54.8 31.7 25.5 23.7 18.6 25.3 12.9 54.2 14.4 61.5 23.2 3.9 14.2 2.6 30.3 47.5 56.7 24.7 31.2 62.8 11.8 17.0 32.4 21.4 44.8 35.4 31.9 43.5 25.3 17.0 58.9 76.6 24.9 10.2 44.2 34.5 4.8 28.3 43.7 23.2 120.9 30.3 27.9 61.8 93.5 129.2 15.7 20.2 23.0 38.7 30.7 22.9 10.6 22.8 44.9 19.7 49.3 34.6 37.8 37.0 23.0 61.2 21.1 61.4 19.7 19.3 27.2 TUT7 "FLJ13409, KIAA1711, PAPD6, TENT3B, ZCCHC6" ENSG00000083223 "Terminal uridylyl transferase 7" Q5VYS8 9 86287733-86354454 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 80.3;Endometrial stromal cells: 61.1;Glandular and luminal cells: 206.7;Syncytiotrophoblasts: 92.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 114.6" "Group enriched" "Detected in all" 5 "granulocytes: 114.6;monocytes: 47.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020615, HPA020620" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020615: AB_1858983, HPA020620: AB_1858984" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (3.66e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-2)" "unprognostic (2.49e-2)" "unprognostic (4.43e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (1.40e-1)" 11.9 9.5 5.6 16.1 7.1 22.8 18.9 6.7 10.5 11.2 11.7 12.3 11.1 9.1 9.0 24.9 8.9 11.4 8.2 6.2 7.9 7.3 38.7 16.6 19.2 8.1 6.3 3.3 8.8 13.2 8.8 8.2 14.4 8.2 21.0 12.0 7.8 14.4 7.2 13.7 33.0 12.4 7.9 6.3 20.7 13.7 11.7 8.4 15.3 8.7 9.3 19.4 13.5 16.1 10.1 16.2 17.2 9.8 14.3 22.4 36.0 12.2 21.6 20.5 9.1 10.6 7.8 13.7 22.8 18.9 14.0 9.5 27.3 11.8 12.0 13.5 27.1 6.0 16.5 18.4 13.7 19.3 19.1 21.8 23.5 22.7 14.5 16.2 13.7 15.0 12.3 15.9 24.0 24.6 14.9 16.0 11.0 7.5 25.1 11.1 8.0 17.5 10.1 15.3 31.4 7.2 5.7 13.1 15.5 7.4 11.6 6.4 7.8 24.8 8.7 10.5 15.7 14.8 27.4 23.3 16.5 20.7 10.8 11.8 35.4 19.4 20.5 15.0 24.7 12.5 11.6 8.2 10.7 11.9 12.2 9.5 10.1 114.6 12.8 47.8 5.5 8.8 8.9 5.6 7.1 6.7 10.5 6.2 7.9 8.1 6.3 3.3 8.2 6.3 8.4 10.1 28.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 34.2 16.4 0.0 0.0 0.0 9.2 0.0 22.4 36.6 0.0 5.9 29.6 0.0 80.3 61.1 7.2 0.0 0.0 0.0 17.9 17.4 5.6 0.0 206.7 0.0 36.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 12.4 0.0 0.0 0.0 0.0 27.8 0.0 0.0 13.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 92.5 14.8 30.9 0.0 0.0 ULK2 "ATG1B, KIAA0623, Unc51.2" ENSG00000083290 "Unc-51 like autophagy activating kinase 2" Q8IYT8 17 19770829-19867936 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 62.0;Inhibitory neurons: 76.9;Late spermatids: 70.1;Oligodendrocytes: 94.6;Spermatocytes: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.0;non-classical monocyte: 3.4" "Lineage enriched" "Detected in single" 5 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "SuSa: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037021 Approved NA NA "CAB037021: AB_1841237" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (2.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.11e-3)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (3.44e-1)" "unprognostic (2.69e-1)" "unprognostic (3.23e-1)" "unprognostic (1.38e-2)" 10.6 7.0 14.7 4.7 19.2 3.0 7.9 17.2 15.3 10.1 9.1 8.6 3.0 9.4 6.5 6.4 10.9 7.5 8.4 15.2 13.3 6.5 3.5 8.5 4.9 21.9 19.3 14.4 11.6 7.6 13.4 5.3 8.2 19.7 8.1 4.3 9.5 5.9 9.9 15.4 7.2 4.7 9.6 20.9 7.2 7.5 34.1 18.0 3.9 6.5 14.8 3.8 9.1 8.6 26.9 12.7 13.1 18.0 2.4 10.2 19.3 0.0 10.3 12.8 10.6 9.8 0.2 2.6 0.0 5.4 13.4 12.0 5.8 0.0 2.1 9.9 10.6 13.2 0.3 5.2 0.0 13.1 0.0 6.3 12.5 15.6 5.4 4.4 9.3 7.6 0.0 0.0 0.0 8.1 3.4 0.0 0.5 2.7 0.2 3.3 0.8 0.0 0.0 7.3 5.3 4.6 18.7 16.4 2.0 5.2 43.7 12.6 4.5 12.0 0.0 1.5 3.7 6.3 0.0 0.0 0.0 1.6 0.0 3.8 0.0 0.9 0.2 0.2 4.0 0.1 0.0 0.5 0.5 0.8 0.0 0.8 0.5 0.2 0.2 3.4 0.0 0.1 0.3 14.7 19.2 17.2 15.3 15.2 13.3 21.9 19.3 14.4 19.7 20.9 18.0 26.9 8.9 19.2 14.1 32.3 1.8 7.4 4.7 3.2 6.8 16.1 9.5 8.1 10.9 4.3 6.1 7.3 8.4 7.7 4.4 1.4 3.9 3.1 34.2 19.6 15.3 5.3 2.4 6.7 62.0 3.4 2.8 12.0 6.6 11.3 0.0 18.0 3.6 1.7 8.5 15.2 76.9 3.9 4.1 20.5 5.1 70.1 14.0 9.1 8.8 41.2 12.3 6.1 7.2 35.2 94.6 2.5 2.4 12.4 2.1 7.5 1.0 5.4 10.0 12.7 13.1 11.5 12.7 58.2 22.1 8.6 9.7 2.9 4.7 6.6 2.9 3.8 GRHL2 "BOM, DFNA28, FLJ13782, TFCP2L3" ENSG00000083307 "Grainyhead like transcription factor 2" Q6ISB3 8 101492439-101669726 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004820, HPA062839" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004820: AB_1857928, HPA062839: AB_2684878" "prognostic unfavorable (6.43e-4)" "unprognostic (2.54e-2)" "unprognostic (4.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.68e-1)" "unprognostic (4.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (2.61e-2)" "unprognostic (8.29e-4)" "unprognostic (4.54e-3)" "unprognostic (2.64e-1)" "unprognostic (1.08e-1)" "unprognostic (1.03e-2)" 0.1 0.0 0.0 1.0 0.0 0.0 12.4 0.0 0.3 6.9 0.0 8.1 4.1 1.7 16.2 20.6 8.6 3.3 0.0 0.1 0.0 4.1 0.4 5.6 0.0 0.0 0.0 0.0 0.0 11.2 9.4 0.8 6.7 0.0 23.4 9.3 0.0 14.9 7.3 0.0 28.8 4.4 0.4 0.0 0.1 9.9 0.3 0.0 3.0 10.3 0.0 4.6 7.8 10.5 0.2 39.3 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 28.0 18.9 0.0 0.0 0.1 0.0 46.3 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.3 0.2 37.9 0.0 0.0 0.0 0.1 0.0 68.9 1.9 0.0 0.0 15.0 0.0 4.4 79.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 32.1 13.0 0.3 0.0 24.3 10.5 7.6 20.5 0.0 14.4 6.1 0.7 17.2 20.8 11.0 0.0 14.0 0.2 10.3 5.9 7.5 2.4 20.0 1.5 0.8 1.2 0.0 0.8 5.5 7.1 0.8 15.3 20.7 0.0 0.0 0.0 0.0 1.4 0.0 1.3 9.8 2.0 0.0 1.1 9.3 0.0 0.3 1.8 0.0 0.6 0.0 0.0 2.0 0.5 8.8 8.5 0.0 1.3 9.3 5.7 0.1 28.8 0.0 0.0 0.5 1.0 0.1 0.0 27.1 26.0 19.8 0.3 0.1 11.0 6.3 TNPO1 "IPO2, KPNB2, MIP, MIP1, TRN" ENSG00000083312 "Transportin 1" Q92973 5 72816312-72916733 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016325 Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 130000 Nucleoplasm "Cytosol, Cytoplasmic bodies" "CAB016325: AB_675691" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-3)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (6.55e-5)" "unprognostic (8.93e-3)" "unprognostic (9.03e-2)" "unprognostic (3.40e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "unprognostic (1.27e-2)" "unprognostic (2.49e-2)" 23.7 23.2 10.1 29.1 13.5 32.0 25.3 14.2 10.1 20.3 20.6 24.7 20.6 24.2 34.1 23.3 20.8 28.0 21.0 10.3 19.5 30.8 28.7 17.5 30.1 18.0 14.5 7.7 22.6 31.8 40.1 15.7 37.1 15.6 23.6 30.2 65.6 21.1 28.4 25.2 11.7 21.0 28.5 16.2 20.8 31.0 37.6 13.2 35.9 37.1 27.2 32.5 33.6 14.1 21.4 94.8 123.7 154.5 104.8 133.3 144.5 110.4 112.3 145.6 112.2 113.6 111.4 87.1 117.5 78.5 173.0 140.4 71.6 126.3 108.8 160.8 66.6 71.9 76.2 144.8 55.9 103.9 78.4 55.1 110.8 80.2 151.0 184.8 78.2 248.6 52.9 113.4 54.8 298.1 50.3 87.2 37.3 99.3 39.8 90.9 83.1 150.5 74.1 73.4 109.5 87.5 73.6 160.6 60.3 135.8 99.8 71.2 61.9 225.1 79.5 113.8 116.8 136.7 53.2 95.8 155.8 69.9 91.3 154.4 8.2 8.2 6.9 11.9 11.0 16.5 10.3 10.9 9.3 10.3 10.8 11.6 11.9 8.4 14.1 14.0 5.0 8.3 10.5 10.1 13.5 14.2 10.1 10.3 19.5 18.0 14.5 7.7 15.6 16.2 13.2 21.4 42.3 12.8 25.0 45.7 49.0 59.1 40.9 29.7 60.3 105.0 38.7 24.0 53.8 30.0 28.7 27.6 98.0 81.9 44.9 39.8 17.6 39.0 105.4 38.6 46.1 64.8 53.2 27.1 142.2 41.5 50.0 52.8 53.0 46.7 22.1 62.8 50.7 38.1 42.7 89.2 77.8 46.3 28.5 40.0 42.2 60.9 46.6 42.1 24.9 50.6 47.4 143.1 26.8 79.9 84.7 58.9 24.9 60.2 42.9 57.0 33.9 36.1 27.6 187.9 26.3 72.5 48.8 58.5 76.3 42.0 53.3 131.3 36.9 40.2 37.2 60.2 PLOD1 "LH1, LLH, PLOD" ENSG00000083444 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" Q02809 1 11934205-11975538 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 236.8;Sertoli cells: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049137, HPA055799" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 3600000 Vesicles Nucleoplasm "HPA049137: AB_2680649, HPA055799: AB_2682924" "unprognostic (1.00e-1)" "unprognostic (2.69e-3)" "unprognostic (9.21e-3)" "unprognostic (5.43e-2)" "unprognostic (7.53e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.13e-3)" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (4.15e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.91e-12)" "unprognostic (2.79e-1)" "unprognostic (7.12e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.43e-4)" 58.6 34.9 58.4 35.5 48.4 16.3 41.6 47.3 57.1 66.0 45.3 40.6 38.1 65.6 30.7 21.5 51.5 42.4 67.0 50.4 46.2 44.9 78.7 44.8 15.5 52.3 46.8 39.4 54.9 39.3 37.2 29.9 84.5 54.4 35.0 23.4 10.7 76.5 41.0 40.9 27.0 35.9 79.1 47.0 31.7 35.8 11.7 59.7 7.9 35.2 41.9 13.0 42.7 36.3 76.1 112.5 91.4 51.3 239.7 343.4 190.6 39.0 330.4 436.1 170.4 287.1 105.2 71.5 63.1 339.5 367.3 125.9 93.4 75.6 115.6 115.6 66.2 78.3 34.0 136.6 137.3 212.5 21.9 162.7 234.0 59.7 206.2 81.9 573.3 305.0 14.8 97.6 30.9 180.2 71.1 5.7 58.6 22.9 115.4 131.6 25.8 100.0 141.0 98.7 24.3 19.2 77.7 137.3 97.4 164.8 80.4 48.3 55.9 298.7 190.1 141.6 236.3 161.9 71.4 123.7 38.7 425.1 75.5 316.8 0.0 40.3 2.0 17.3 34.4 3.1 1.7 3.0 8.4 32.7 3.4 1.2 6.4 35.5 5.4 32.3 4.9 2.0 22.6 58.4 48.4 47.3 57.1 50.4 46.2 52.3 46.8 39.4 54.4 47.0 59.7 76.1 19.4 0.0 7.9 9.4 3.7 7.0 8.0 22.8 8.0 5.7 17.9 17.5 18.3 8.6 8.6 11.0 2.1 39.7 8.7 14.8 3.9 30.3 1.0 11.0 62.2 33.9 8.4 3.0 4.2 9.8 236.8 47.5 17.3 24.8 0.0 20.4 36.8 37.1 46.3 6.7 5.8 12.5 4.1 26.5 8.3 2.4 44.4 16.3 10.6 15.9 17.9 7.9 15.5 3.0 9.8 22.4 15.4 24.5 19.4 8.0 41.5 16.7 4.5 3.1 105.2 77.2 47.3 0.5 3.3 7.4 5.1 33.7 5.5 37.1 16.6 3.9 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696240 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.9;lymphoid tissue: 78.9" "Group enriched" "Detected in some" 4 "B-cells: 94.6;Plasma cells: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "memory B-cell: 76.4;naive B-cell: 84.8" "Lineage enriched" "Detected in many" 20 "B-cells: 84.8" "Cell line enhanced" "Detected in many" "Daudi: 53.2;Karpas-707: 32.7;RPMI-8226: 59.5;U-698: 47.1" "HPA021948, HPA067827" Supported Supported Cytosol NA NA Cytosol "HPA021948: AB_1854878, HPA067827: AB_2685908" "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.8 0.3 1.7 30.7 2.9 9.5 0.8 0.6 3.1 0.3 0.0 2.5 1.6 0.1 0.0 0.7 0.3 1.3 7.8 2.4 2.2 0.7 0.5 1.4 78.9 1.2 1.0 3.1 0.0 0.2 0.2 1.2 0.2 1.9 0.5 1.9 0.4 1.8 0.0 17.6 0.0 24.9 0.5 0.4 54.9 3.4 0.7 1.5 12.2 0.9 4.0 54.3 2.7 0.3 2.2 8.3 6.7 0.0 0.0 0.2 1.3 0.0 8.4 3.9 0.9 2.6 5.5 9.8 53.2 4.9 4.2 2.9 4.3 18.8 0.0 1.7 0.9 3.2 2.7 17.5 6.3 1.2 3.6 4.2 2.1 1.8 0.2 12.4 6.5 0.0 12.2 0.5 32.7 18.2 0.0 23.4 8.1 4.9 4.4 20.5 0.8 0.0 59.5 0.2 6.3 4.3 0.0 7.5 2.5 3.9 0.0 2.0 3.3 0.1 0.0 4.5 0.2 1.5 11.0 25.2 47.1 0.0 5.1 0.5 0.0 0.1 2.0 3.1 0.0 4.2 76.4 2.8 2.2 0.4 84.8 0.3 0.3 0.0 0.0 0.0 0.1 1.9 4.5 1.7 2.9 0.6 3.1 2.4 2.2 1.2 1.0 3.1 1.9 0.4 1.5 2.2 0.1 0.0 0.6 0.0 94.6 0.4 0.1 0.0 0.0 0.8 0.1 0.1 2.7 0.0 0.0 1.8 0.0 0.0 13.4 0.0 0.0 0.2 4.8 0.2 0.2 0.7 0.0 11.1 0.0 0.2 0.0 0.3 0.5 0.3 4.5 0.0 1.4 0.4 0.2 0.0 0.0 0.1 0.0 1.2 0.0 3.1 1.5 1.6 3.6 0.0 1.1 0.0 2.1 0.0 0.0 1.5 0.0 0.0 29.7 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.9 1.0 0.8 0.0 0.0 0.0 11.0 0.0 0.1 0.1 ITGAE "CD103, HUMINAE" ENSG00000083457 "Integrin subunit alpha E" P38570 17 3714628-3801188 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.5;intestine: 5.9;lung: 6.7;lymphoid tissue: 4.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 6 "T-cells: 3.7" "Cell line enriched" "Detected in single" 22 "MOLT-4: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036313, HPA052147" Enhanced NA NA 38000 "HPA036313: AB_10795355, HPA052147: " "unprognostic (9.81e-2)" "unprognostic (1.78e-3)" "unprognostic (7.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-1)" "unprognostic (8.02e-2)" "unprognostic (2.92e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.34e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (8.40e-3)" "unprognostic (1.15e-1)" "unprognostic (1.82e-2)" "prognostic favorable (3.56e-4)" 0.1 0.0 0.1 1.1 0.4 6.5 0.7 0.0 0.4 0.3 0.1 1.7 3.6 0.2 0.2 0.8 0.5 1.7 0.0 0.1 0.1 0.0 0.1 6.7 0.5 0.2 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.3 1.5 0.0 1.2 0.4 0.0 0.4 5.9 0.2 0.1 0.8 2.8 0.8 0.2 4.3 0.3 0.0 1.5 0.9 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.5 12.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.6 1.6 0.1 0.5 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.5 0.1 0.4 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 32.7 6.4 25.7 10.4 65.4 30.0 38.9 74.2 33.0 15.8 45.0 58.5 59.6 38.6 33.9 14.7 8.4 27.6 62.5 25.1 92.0 35.6 54.5 39.8 35.3 34.0 28.2 36.2 8.9 65.6 58.5 42.4 18.8 47.0 67.4 22.8 42.8 53.2 53.0 6.7 7.8 25.1 67.1 42.3 44.9 40.3 26.8 50.8 58.7 1.9 54.1 61.1 53.5 9.0 15.7 56.8 21.3 29.7 61.1 48.8 40.3 81.5 31.3 19.6 26.3 21.3 43.7 107.3 33.3 53.8 41.3 13.1 68.0 35.0 39.3 38.5 DIS3 "dis3p, EXOSC11, KIAA1008, RRP44" ENSG00000083520 "DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease" Q9Y2L1 13 72752169-72782096 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 169.2;Late spermatids: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039281, HPA058762" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039281: AB_10795583, HPA058762: AB_2683810" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" "unprognostic (8.97e-2)" "unprognostic (8.14e-2)" "unprognostic (1.51e-2)" "unprognostic (1.49e-1)" "unprognostic (2.84e-1)" "unprognostic (6.38e-2)" "unprognostic (8.68e-2)" "unprognostic (1.32e-3)" "unprognostic (3.35e-3)" "unprognostic (1.02e-1)" "unprognostic (2.37e-2)" "unprognostic (3.69e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-1)" 14.0 10.0 6.1 12.5 6.7 20.6 16.0 10.1 7.1 11.4 7.7 10.1 8.6 11.3 11.6 12.5 10.0 10.5 11.7 6.0 6.7 12.9 16.8 11.5 17.7 6.5 6.8 5.8 13.5 9.0 12.0 9.0 12.1 6.8 12.4 11.0 12.2 9.4 10.6 10.3 11.2 10.0 11.1 6.3 12.3 10.0 21.4 7.1 14.2 15.1 10.4 17.4 14.2 10.9 7.7 29.5 13.4 25.9 21.9 26.9 31.9 17.0 25.5 31.0 25.6 31.1 20.7 23.8 35.6 21.6 26.3 16.2 23.8 35.7 29.4 40.9 29.3 26.3 41.8 27.8 18.7 33.4 71.4 23.2 33.4 20.1 29.0 37.9 25.5 27.8 26.6 28.3 14.4 31.4 10.3 30.5 34.8 24.3 44.7 15.7 24.2 19.7 16.2 25.4 23.2 23.3 30.8 20.9 17.3 25.4 26.8 16.7 32.1 26.1 15.4 12.5 17.5 27.4 27.6 33.2 28.0 42.9 33.2 22.7 8.4 3.6 5.2 4.0 6.3 5.6 4.2 5.0 4.5 4.3 3.7 4.9 4.5 2.1 6.9 5.2 2.7 6.7 3.2 6.1 6.7 10.1 7.1 6.0 6.7 6.5 6.8 5.8 6.8 6.3 7.1 7.7 51.6 35.3 37.2 12.4 35.3 25.5 36.5 24.5 18.2 38.8 27.6 26.4 27.6 21.5 40.2 9.2 29.2 23.8 45.0 19.0 23.5 21.7 169.2 26.2 37.6 41.2 30.5 18.7 21.5 20.1 23.5 33.3 19.9 45.6 33.6 26.3 26.7 23.7 14.4 32.0 24.0 17.2 18.3 19.2 13.8 135.5 28.9 21.4 12.4 24.4 38.2 23.6 25.7 17.6 24.2 25.4 8.1 28.2 30.2 27.4 16.3 17.2 35.4 41.6 6.6 58.3 27.0 28.9 37.7 31.4 31.3 22.6 33.7 29.1 21.2 53.9 PIBF1 "C13orf24, CEP90" ENSG00000083535 "Progesterone immunomodulatory binding factor 1" Q8WXW3 13 72782133-73016461 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Immunity "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 334.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052269, HPA066120" Approved Supported "Centriolar satellite" "Secreted to blood" NA NA "Centriolar satellite" "HPA052269: AB_2681779, HPA066120: AB_2685621" "unprognostic (1.54e-1)" "unprognostic (4.17e-1)" "unprognostic (6.73e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.80e-2)" "unprognostic (3.79e-2)" "unprognostic (3.87e-2)" "unprognostic (4.08e-2)" "unprognostic (2.62e-2)" "unprognostic (2.26e-3)" "unprognostic (1.39e-1)" "unprognostic (6.85e-3)" "unprognostic (8.31e-2)" "unprognostic (2.78e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-1)" 7.5 9.2 5.4 6.8 5.8 10.2 12.3 7.9 7.4 11.6 9.7 7.5 7.1 11.6 10.8 7.2 11.1 8.5 7.6 5.1 5.4 8.4 9.9 8.7 10.0 5.9 5.5 4.5 12.7 5.5 8.5 7.5 9.7 5.5 9.8 8.9 10.3 7.5 8.2 6.7 8.6 7.0 8.6 5.3 8.5 8.8 14.4 5.5 13.1 15.6 7.5 8.4 10.2 8.1 6.6 13.1 4.2 16.8 9.8 14.4 25.3 6.5 11.9 15.9 11.8 14.4 5.8 22.1 12.0 13.7 13.2 6.2 11.1 9.1 12.0 18.9 12.2 8.7 8.2 10.9 6.7 18.4 31.0 7.5 16.4 9.4 12.7 30.7 15.1 15.5 8.2 11.7 6.1 15.9 3.7 15.2 18.6 8.9 23.3 3.9 12.0 12.4 12.4 24.5 7.0 9.6 15.4 9.2 6.3 16.3 13.5 10.6 21.8 11.8 6.0 6.3 9.5 7.2 9.7 7.5 6.0 18.0 17.3 13.3 8.4 3.4 6.1 6.0 3.7 6.4 5.9 6.4 6.5 3.0 5.6 8.7 7.3 3.3 8.6 3.6 5.1 5.3 2.5 5.4 5.8 7.9 7.4 5.1 5.4 5.9 5.5 4.5 5.5 5.3 5.5 6.6 33.8 32.1 30.8 101.2 21.6 10.3 16.3 10.5 16.5 17.1 15.5 17.8 28.1 14.3 27.7 5.5 16.7 9.4 19.3 6.6 13.7 11.6 334.5 41.5 33.6 20.0 7.2 15.2 115.1 11.1 10.2 20.4 21.4 18.5 24.1 21.8 9.7 5.6 7.1 18.5 119.3 9.7 12.2 8.6 3.5 50.4 19.3 10.3 8.8 92.8 9.8 11.9 17.5 143.7 138.6 12.0 8.5 15.4 11.6 11.8 7.1 6.5 46.3 31.3 13.1 28.9 17.9 59.4 39.2 11.8 8.9 6.0 23.1 25.6 10.0 13.7 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: AB_2732759" "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 8.8 8.3 15.4 6.8 19.3 5.8 12.1 20.1 17.8 10.2 14.6 10.0 9.6 10.9 10.0 10.5 9.9 9.3 10.8 13.6 16.2 11.5 9.5 12.6 9.2 18.0 17.2 12.1 14.1 14.2 11.0 7.7 6.0 18.5 8.1 11.2 11.0 9.4 7.5 16.9 11.4 8.8 9.3 18.9 8.8 11.3 12.4 17.4 12.1 12.1 18.6 9.3 8.1 7.7 23.2 6.7 7.3 15.3 36.7 5.9 13.3 9.5 7.6 8.4 8.7 5.6 4.9 10.9 16.0 3.0 11.1 7.4 8.9 12.6 11.0 9.4 12.5 10.1 30.4 13.7 9.4 12.0 21.3 15.4 8.9 15.4 5.1 15.1 17.9 12.0 13.3 6.7 9.7 9.5 7.4 19.5 11.4 11.7 24.4 5.5 10.1 7.5 11.0 12.0 8.8 13.8 16.4 10.9 13.2 27.9 10.9 6.8 9.3 10.2 5.4 5.6 6.1 8.5 18.8 17.7 13.7 5.0 11.0 16.7 0.3 1.4 1.6 3.2 2.2 2.3 2.2 3.7 3.7 2.1 1.4 3.0 3.8 0.1 2.1 1.7 4.6 4.5 1.3 15.4 19.3 20.1 17.8 13.6 16.2 18.0 17.2 12.1 18.5 18.9 17.4 23.2 24.5 22.4 30.0 169.1 13.8 7.9 9.6 9.3 14.8 30.9 10.8 10.2 44.4 11.5 18.2 11.0 54.2 8.8 18.7 11.5 21.5 13.4 20.9 18.8 24.4 15.9 17.4 7.2 101.1 17.8 10.6 18.5 18.3 15.7 152.3 26.1 11.7 8.8 6.9 20.2 128.9 12.8 12.2 9.5 7.8 24.4 19.0 22.2 19.6 69.3 12.2 12.7 20.6 142.7 168.7 10.6 19.2 18.4 14.6 7.1 12.4 12.3 22.8 30.6 6.6 32.9 12.9 38.9 21.6 14.1 6.7 6.7 20.9 30.6 14.0 8.0 NUFIP1 "NUFIP, Rsa1" ENSG00000083635 "Nuclear FMR1 interacting protein 1" Q9UHK0 13 44939249-44989471 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 3.3 3.8 3.3 2.8 3.7 8.0 4.6 3.3 4.6 3.6 2.4 2.5 2.8 4.5 5.5 3.3 3.5 2.4 2.5 3.6 3.4 4.0 4.2 2.4 3.7 3.1 3.1 3.4 4.3 3.8 4.0 1.8 3.1 3.2 3.4 3.0 2.6 3.3 3.2 4.8 3.4 2.4 4.0 2.9 3.1 2.8 5.6 3.3 3.6 3.9 4.0 3.8 4.3 2.6 4.2 7.4 5.7 9.5 7.9 6.4 6.6 11.3 8.6 7.4 15.6 9.9 15.6 11.5 21.5 7.0 8.0 9.4 11.3 17.9 12.2 20.2 6.6 14.0 16.4 3.7 14.0 10.5 21.3 6.4 6.9 11.0 10.5 15.8 6.0 7.9 10.9 13.3 3.5 11.1 8.5 17.8 13.4 22.5 19.5 9.3 17.3 9.0 13.1 9.5 6.3 5.2 11.5 7.3 9.9 9.6 8.9 7.5 11.8 6.0 7.9 6.8 10.3 11.9 4.8 7.9 26.7 8.9 14.8 11.4 0.0 2.6 0.8 2.5 2.6 4.7 4.0 2.9 2.8 3.4 4.1 4.5 3.4 0.2 5.9 1.8 4.5 1.7 1.8 3.3 3.7 3.3 4.6 3.6 3.4 3.1 3.1 3.4 3.2 2.9 3.3 4.2 11.3 6.4 12.2 6.2 10.5 15.4 11.8 16.7 23.9 7.8 9.8 16.3 4.5 4.3 15.4 5.5 12.5 15.7 11.7 4.2 17.6 14.0 37.2 14.0 21.7 10.9 5.4 14.5 19.2 16.7 15.9 11.9 7.7 18.6 17.7 14.1 7.1 9.7 10.8 8.4 16.9 5.3 12.2 3.4 5.5 63.2 10.8 7.9 8.8 7.5 6.9 9.7 7.2 16.6 14.4 10.8 1.6 11.3 5.0 8.6 3.2 14.8 6.6 6.8 6.6 20.3 15.6 27.1 31.6 14.3 16.6 8.8 9.9 15.7 8.4 7.1 PDS5B "APRIN, AS3, CG008, FLJ23236, KIAA0979" ENSG00000083642 "PDS5 cohesin associated factor B" Q9NTI5 13 32586452-32778019 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 185.5;Inhibitory neurons: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039513, HPA040015" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039513: AB_10671999, HPA040015: AB_10671047" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (4.25e-2)" "unprognostic (6.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.30e-1)" "unprognostic (8.98e-2)" "unprognostic (3.29e-1)" "unprognostic (4.17e-2)" "unprognostic (1.28e-2)" "unprognostic (3.96e-2)" "unprognostic (6.29e-2)" "unprognostic (5.47e-2)" "unprognostic (9.62e-3)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.91e-2)" 10.4 8.2 3.5 9.5 7.1 23.5 12.7 8.3 15.5 17.7 0.2 12.0 6.2 19.1 13.3 7.2 12.9 7.9 7.4 7.4 3.8 9.9 9.7 11.0 13.4 1.0 1.2 2.1 16.0 7.5 9.4 9.9 10.2 3.7 12.9 8.3 11.2 8.6 9.9 11.5 10.4 10.7 11.8 0.2 13.5 9.8 12.2 1.3 21.0 10.5 8.0 10.8 10.3 11.5 11.7 12.4 7.3 32.7 17.6 15.3 11.0 9.2 20.5 13.7 17.1 17.1 10.1 20.2 45.0 7.2 10.1 17.2 16.1 23.9 12.9 20.2 36.1 9.0 40.7 13.1 14.2 9.0 37.6 24.0 8.6 6.4 14.3 12.8 11.2 13.1 17.8 14.4 29.6 15.8 15.9 45.3 28.2 24.2 25.9 8.9 45.7 45.2 15.5 11.0 10.2 8.5 20.4 23.6 23.0 9.2 19.7 22.2 24.8 26.0 16.3 15.7 11.8 12.4 9.0 10.7 37.4 7.0 25.1 24.1 3.0 2.7 4.0 3.0 2.4 3.5 3.4 3.5 3.2 3.5 4.5 3.4 3.3 3.3 2.8 3.3 2.3 2.8 1.6 3.5 7.1 8.3 15.5 7.4 3.8 1.0 1.2 2.1 3.7 0.2 1.3 11.7 50.3 16.0 30.2 86.8 33.9 28.9 23.8 14.6 34.1 42.3 24.3 17.0 26.7 21.5 24.6 27.6 25.0 24.9 35.9 17.4 5.9 14.8 14.5 24.2 79.7 42.2 31.8 22.9 185.5 16.0 18.5 46.4 19.4 19.9 23.5 55.3 23.9 28.0 18.5 47.1 222.6 21.8 16.2 39.0 38.1 13.7 67.1 31.3 35.6 131.2 39.4 15.8 34.0 154.8 155.1 14.7 17.9 62.4 43.8 23.4 15.9 12.9 31.3 20.8 72.3 46.9 51.4 49.5 60.6 17.0 29.3 6.2 37.1 41.8 21.1 17.0 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870425 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 248.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 243.7;Distal tubular cells: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 238.7;SiHa: 319.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA 440000 Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favorable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 53.2 16.0 26.7 16.8 37.1 13.5 18.7 26.0 33.5 12.3 17.2 17.9 8.4 15.0 17.7 27.1 12.6 15.4 248.2 35.2 29.4 53.5 1.3 8.1 21.8 20.9 24.1 29.8 13.9 5.4 49.0 14.8 5.1 22.6 25.7 21.3 23.8 19.1 30.1 28.7 23.2 12.9 36.9 20.2 11.1 34.6 13.3 26.4 77.5 27.5 43.0 26.1 15.2 13.9 28.4 35.3 1.6 27.9 33.6 84.7 45.0 0.1 62.1 38.9 50.3 30.4 5.7 23.5 91.2 15.0 47.5 25.8 20.5 77.5 55.9 58.5 78.5 9.1 63.9 238.7 11.9 36.8 125.8 20.9 42.7 15.3 49.3 82.2 24.6 46.4 81.6 13.3 114.0 58.1 4.5 105.5 6.1 6.4 0.0 24.5 82.8 78.9 68.7 41.7 2.9 27.9 28.8 319.5 0.3 38.3 2.5 0.4 27.4 28.3 39.7 51.9 68.6 50.6 18.6 16.5 3.6 59.9 90.9 30.9 1.4 1.4 4.7 11.6 1.5 13.8 10.0 11.5 12.7 6.3 7.5 13.6 10.9 0.4 11.3 2.5 2.4 21.5 6.6 26.7 37.1 26.0 33.5 35.2 29.4 20.9 24.1 29.8 22.6 20.2 26.4 28.4 8.4 6.4 9.2 37.5 19.2 14.8 11.7 12.4 17.6 14.1 18.8 14.2 243.7 7.2 14.3 11.0 2.1 7.0 18.3 5.0 187.9 5.4 19.1 11.7 18.8 9.8 13.2 23.1 71.5 0.7 11.9 21.3 20.4 31.2 9.5 8.7 6.8 0.3 38.2 13.5 84.2 18.6 12.2 1.3 7.0 8.6 6.2 5.2 16.0 26.2 4.4 11.8 10.3 66.4 46.8 4.8 5.3 7.5 31.3 12.1 2.9 27.4 5.6 21.6 13.1 9.7 24.6 35.6 19.7 27.6 21.6 6.8 26.6 8.6 18.1 9.0 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717749-55758774 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favorable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 12.8 14.9 13.5 7.2 14.2 8.2 14.8 11.7 12.8 14.1 11.1 10.7 7.0 18.7 35.0 9.0 20.7 13.1 15.3 13.9 15.2 16.4 8.1 11.2 8.4 12.4 13.6 13.2 22.4 8.0 23.3 15.0 11.5 13.1 16.5 9.7 17.2 8.9 18.2 12.2 12.2 8.9 17.4 12.0 11.4 9.7 9.3 14.6 10.3 23.2 16.1 8.7 12.1 10.0 14.2 11.9 8.9 10.0 7.6 34.7 32.2 2.6 10.3 19.0 9.1 12.2 5.2 7.7 3.5 72.6 14.4 7.6 7.5 9.1 5.8 8.4 6.5 12.7 5.2 12.1 10.5 24.6 8.4 8.0 38.4 21.9 6.8 8.8 36.8 12.3 9.3 7.3 8.1 15.3 8.8 4.5 11.7 10.4 3.2 14.4 17.0 11.1 10.0 13.9 15.3 10.0 8.9 14.2 4.4 15.6 25.4 12.9 8.8 6.8 11.2 5.2 10.4 5.6 11.1 16.4 6.7 8.5 18.2 5.0 7.1 4.7 4.1 5.0 6.7 7.5 6.8 6.5 6.9 7.3 10.4 7.4 7.5 1.4 6.5 3.9 4.6 7.5 4.0 13.5 14.2 11.7 12.8 13.9 15.2 12.4 13.6 13.2 13.1 12.0 14.6 14.2 14.5 12.8 17.4 22.9 16.0 8.7 15.3 16.1 19.4 20.4 9.7 10.2 16.4 4.3 10.4 18.4 14.6 7.4 6.8 4.9 27.4 9.8 1.8 14.3 16.1 12.7 4.2 11.1 32.4 5.0 5.5 15.6 10.7 11.9 17.1 16.7 5.7 2.6 7.3 20.2 29.6 5.1 8.2 5.4 7.8 2.9 9.9 7.9 5.4 23.4 7.8 27.0 2.1 28.6 38.2 4.3 10.8 15.4 6.4 9.0 7.3 19.3 10.4 25.6 0.0 17.9 16.6 7.7 14.6 11.2 7.7 4.8 11.8 26.9 6.9 6.9 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963682-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "placenta: 6.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "breast cancer: 2.4;ovarian cancer: 7.7;pancreatic cancer: 4.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 3.0" "Region enhanced" "Detected in single" "midbrain: 1.4" "Group enriched" "Detected in some" 5 "amygdala: 1.7;basal ganglia: 2.9;cerebral cortex: 2.7;hippocampal formation: 2.2" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" NA NA "HPA038212: AB_10672739, HPA045455: AB_2679330" "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CYLD "CYLD1, KIAA0849, USPL2" ENSG00000083799 "CYLD lysine 63 deubiquitinase" Q9NQC7 16 50742050-50801935 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 95.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 136.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011713, HPA050095" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No "Centriolar satellite" Nucleoplasm "CAB011713: AB_731794, HPA050095: AB_2681013" "unprognostic (9.83e-2)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" "unprognostic (2.83e-2)" "unprognostic (3.84e-1)" "unprognostic (5.06e-2)" "unprognostic (3.87e-2)" "unprognostic (3.24e-2)" "unprognostic (9.46e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (3.43e-2)" "unprognostic (6.83e-2)" "unprognostic (8.42e-2)" 14.4 22.2 24.6 39.2 24.2 95.2 13.7 18.3 20.3 13.1 23.7 16.4 16.2 15.2 12.2 23.5 11.1 20.7 20.3 17.7 22.6 14.3 21.2 21.7 53.8 22.3 28.1 16.4 15.5 15.3 23.2 15.5 15.6 22.9 16.4 19.5 22.2 19.1 16.2 34.6 15.4 16.3 17.0 22.8 39.4 20.1 38.7 31.6 35.9 25.1 20.7 48.8 24.3 13.0 26.4 26.9 8.3 9.4 10.6 14.3 21.0 8.7 39.1 56.7 39.9 23.4 6.9 12.5 30.7 13.7 38.3 43.4 10.3 11.3 23.7 58.7 136.6 16.6 15.5 15.3 5.8 29.1 15.4 69.5 23.0 18.6 48.1 50.1 37.7 16.3 21.3 6.6 26.1 56.4 4.0 14.4 22.3 10.1 8.5 13.3 13.4 18.8 29.4 12.9 9.1 12.0 9.2 33.1 11.2 9.8 14.3 11.0 18.9 18.6 67.2 15.4 23.4 15.9 68.0 68.4 33.2 49.3 16.7 14.7 64.6 15.2 38.3 18.1 17.7 21.8 17.2 27.1 24.5 18.3 11.1 24.4 19.4 32.3 25.7 18.8 11.0 37.3 19.5 24.6 24.2 18.3 20.3 17.7 22.6 22.3 28.1 16.4 22.9 22.8 31.6 26.4 28.8 44.8 31.8 31.6 87.7 120.1 59.5 32.2 40.9 89.2 35.5 26.0 34.4 21.5 32.9 18.4 93.8 6.8 84.1 28.3 5.9 20.0 48.2 22.5 24.9 36.0 31.1 26.1 51.9 19.1 4.4 37.3 22.4 47.1 80.5 21.4 27.8 25.5 21.5 67.3 54.7 10.7 30.5 40.0 127.6 31.3 25.4 66.4 74.7 57.1 63.7 23.3 70.0 51.8 119.2 18.0 22.4 21.1 79.7 66.4 15.4 13.9 23.3 48.3 6.6 54.2 30.5 59.2 15.2 64.3 155.6 4.1 119.5 21.3 14.8 66.7 SLC27A5 "ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2" ENSG00000083807 "Solute carrier family 27 member 5" Q9Y2P5 19 58479512-58512413 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Ligase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 21 "liver: 1031.9" "Group enriched" "Detected in many" 4 "Early spermatids: 144.4;Hepatocytes: 439.9;Late spermatids: 464.4" "Cancer enriched" "Detected in all" 26 "liver cancer: 49.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA007292, CAB056160, CAB068239" Enhanced NA NA "CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064" "unprognostic (5.97e-2)" "unprognostic (9.12e-2)" "unprognostic (9.95e-2)" "unprognostic (6.36e-3)" "unprognostic (2.52e-1)" "unprognostic (7.46e-2)" "prognostic favorable (1.57e-4)" "unprognostic (1.04e-1)" "unprognostic (1.85e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.66e-4)" "unprognostic (2.27e-1)" "unprognostic (3.33e-2)" "unprognostic (7.80e-2)" "unprognostic (2.16e-1)" 5.1 10.0 34.2 3.3 34.0 3.8 6.5 33.0 50.3 7.1 30.9 6.4 2.5 5.4 2.9 5.4 9.2 2.9 6.1 33.8 34.0 11.0 1031.9 4.1 4.4 33.8 33.9 32.8 6.8 10.7 7.1 10.9 1.7 33.7 8.1 1.7 3.0 10.0 4.5 4.9 5.6 4.0 4.5 33.9 5.3 7.3 20.8 35.9 6.2 6.6 4.4 4.6 8.3 6.3 33.8 41.2 55.0 9.6 10.2 9.0 9.3 6.1 2.3 5.3 7.5 10.3 4.4 8.7 52.9 6.5 2.8 1.4 8.4 11.0 35.3 3.2 24.8 37.0 35.8 58.3 46.7 13.5 18.9 12.2 10.9 5.9 1.2 20.5 12.9 3.9 39.4 33.5 0.0 9.1 33.4 47.2 39.8 5.8 34.4 31.9 23.4 0.2 72.6 25.0 19.3 13.1 17.8 0.1 53.5 12.1 2.7 15.8 16.3 3.1 0.0 6.8 0.0 4.7 33.5 41.0 22.7 10.9 35.0 2.0 0.1 4.0 3.8 13.5 5.3 29.6 24.3 17.5 18.0 10.8 15.8 21.3 21.7 0.5 18.1 4.0 18.2 23.3 13.9 34.2 34.0 33.0 50.3 33.8 34.0 33.8 33.9 32.8 33.7 33.9 35.9 33.8 12.5 0.0 7.3 3.3 9.8 9.1 15.5 16.0 14.2 11.8 50.1 73.2 8.3 20.0 9.9 5.5 0.0 7.3 6.9 4.6 39.2 9.6 144.4 12.4 10.1 11.3 10.1 25.0 4.3 15.4 3.3 8.9 8.6 8.0 5.1 20.2 16.8 439.9 10.5 10.1 5.3 4.7 6.1 16.7 9.6 464.4 10.8 6.7 16.0 1.9 3.4 12.0 12.3 5.0 7.4 8.0 1.2 9.4 8.9 32.2 1.8 57.6 11.5 8.5 6.6 7.4 18.4 50.9 12.7 15.5 14.1 3.4 11.3 26.7 6.1 15.0 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 37.0;Horizontal cells: 33.7;Rod photoreceptor cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 54.2" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" No No "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favorable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (3.56e-1)" 3.4 3.9 4.7 3.4 4.9 6.8 3.7 6.1 5.6 4.3 2.5 4.0 4.3 5.0 3.2 5.9 5.2 2.9 3.4 5.2 4.0 3.0 5.8 3.2 3.1 4.8 3.8 5.7 5.8 7.0 4.4 6.7 2.9 5.0 4.6 2.2 3.0 4.7 4.2 3.1 6.5 3.9 3.3 2.9 4.0 4.4 4.4 3.5 6.9 4.8 2.6 2.9 4.4 3.9 5.3 7.8 8.9 5.0 10.1 5.3 5.0 7.2 6.3 6.4 5.6 5.0 8.5 4.2 11.2 5.9 4.3 7.6 9.3 6.4 6.6 2.1 10.5 54.2 6.9 6.7 3.6 4.5 12.3 9.2 3.9 8.5 7.1 3.3 5.1 3.7 7.9 11.4 7.1 6.0 6.0 12.5 6.6 5.4 6.4 12.9 13.9 6.5 7.3 3.8 15.5 11.8 9.5 6.5 10.8 3.8 3.6 4.9 10.1 6.4 17.6 3.9 6.4 11.2 10.4 12.0 5.8 9.5 6.7 6.5 2.3 5.3 8.9 10.5 5.9 11.5 5.8 8.0 11.6 3.8 6.2 12.1 9.7 15.6 7.3 4.5 7.0 8.8 4.2 4.7 4.9 6.1 5.6 5.2 4.0 4.8 3.8 5.7 5.0 2.9 3.5 5.3 4.8 0.0 1.7 5.2 8.4 9.1 5.5 3.1 2.2 37.0 10.3 7.5 7.5 2.8 3.8 0.0 25.0 4.8 6.9 9.9 0.0 4.9 1.2 6.3 6.3 5.5 7.8 6.5 5.6 4.1 3.8 6.0 6.6 3.6 1.3 11.3 7.5 3.6 2.9 33.7 6.3 7.9 6.1 2.4 3.7 1.6 12.8 3.2 3.6 7.5 4.1 15.8 7.2 4.5 6.7 4.2 12.4 14.7 5.6 8.0 9.0 2.3 5.8 57.2 6.6 11.7 8.5 19.4 15.8 4.8 13.4 6.7 7.6 11.2 6.3 3.8 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favorable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 2.5 6.8 6.7 3.7 6.8 4.5 4.3 10.9 7.8 3.4 6.8 5.3 1.8 2.5 5.4 2.0 4.5 2.8 5.8 6.5 7.2 6.0 2.8 4.1 8.0 6.8 7.0 6.2 3.3 3.5 9.5 9.7 4.0 7.6 5.8 2.3 8.4 3.8 5.9 7.7 2.1 6.5 2.7 6.7 13.6 2.8 6.5 7.2 13.8 8.4 6.9 8.6 4.9 2.0 7.1 0.1 0.2 2.2 0.0 0.4 0.1 0.0 2.5 1.4 4.8 1.7 0.3 0.4 5.2 0.8 3.6 1.5 0.1 1.9 2.1 5.6 5.7 3.6 0.1 0.8 0.0 4.2 0.0 7.3 6.2 1.5 3.0 1.7 5.6 0.7 5.4 0.8 2.5 4.4 0.1 10.1 0.1 3.2 0.0 5.1 3.9 6.8 3.2 1.8 0.2 0.2 0.0 0.0 0.1 3.5 5.4 1.4 7.3 0.0 0.5 2.6 0.0 1.9 4.5 0.1 2.8 0.5 1.2 1.6 19.4 10.5 19.3 8.0 9.5 21.4 22.7 17.0 14.1 14.9 30.4 24.2 19.7 7.3 20.9 15.1 13.7 18.9 15.0 6.7 6.8 10.9 7.8 6.5 7.2 6.8 7.0 6.2 7.6 6.7 7.2 7.1 1.1 0.0 0.6 5.9 5.2 0.6 0.7 0.9 0.0 5.8 1.3 1.0 5.4 4.3 1.2 3.7 0.0 2.3 2.0 0.0 1.9 3.7 0.2 0.8 0.4 1.7 0.0 3.4 3.4 0.0 1.1 0.7 0.0 0.7 2.5 2.9 1.1 1.2 3.8 6.7 4.1 0.2 6.1 2.7 0.8 0.7 0.0 2.3 1.8 2.8 1.9 8.4 6.2 4.0 2.8 0.3 0.1 0.4 3.8 0.5 0.9 1.6 0.9 7.8 0.0 0.2 1.6 7.0 5.0 0.4 0.4 0.8 4.1 0.6 0.5 0.1 ZNF416 FLJ20557 ENSG00000083817 "Zinc finger protein 416" Q9BWM5 19 57571566-57578911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063318 Approved "Nuclear bodies,Cytosol" No No Cytosol "Nuclear bodies" "HPA063318: AB_2684983" "unprognostic (1.40e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.14e-2)" "unprognostic (7.57e-3)" "unprognostic (3.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" "unprognostic (6.62e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.20e-5)" "unprognostic (1.31e-1)" "unprognostic (2.62e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-1)" 2.1 2.3 2.5 1.6 2.9 2.6 3.8 4.4 3.7 2.8 2.2 2.0 1.4 2.4 3.9 3.2 3.4 1.9 2.7 2.6 2.5 2.6 2.1 2.5 2.8 2.1 2.4 2.5 4.5 1.4 4.4 2.0 2.9 2.7 2.7 2.1 3.8 2.2 3.1 2.6 4.9 1.7 2.8 2.1 2.8 2.1 4.3 2.6 4.0 3.6 3.0 4.1 2.4 2.5 2.8 3.2 3.1 6.5 5.2 3.9 5.6 4.3 3.2 5.8 6.2 4.0 2.2 1.7 2.2 2.3 4.1 4.5 1.2 3.8 5.5 7.6 3.5 15.5 5.3 3.5 1.8 7.0 4.7 3.3 5.6 5.6 3.9 8.2 4.9 4.3 5.3 0.7 1.7 8.4 1.3 9.9 2.2 7.7 3.8 5.7 4.9 9.7 4.8 4.3 6.8 4.7 5.3 5.8 3.0 2.9 7.3 2.7 5.6 3.2 6.7 3.2 2.2 4.8 5.4 9.5 5.9 1.5 3.1 4.1 1.1 2.6 1.9 4.3 1.9 7.7 6.6 5.9 6.3 4.1 10.4 8.0 5.8 0.8 9.0 1.7 3.7 2.9 3.7 2.5 2.9 4.4 3.7 2.6 2.5 2.1 2.4 2.5 2.7 2.1 2.6 2.8 1.1 0.0 0.5 1.3 2.9 1.7 1.6 1.6 1.2 3.5 1.6 1.8 1.8 1.5 1.6 0.0 0.0 2.1 1.0 0.6 3.9 2.8 5.0 0.9 0.9 1.8 0.0 3.6 1.5 0.9 0.8 1.1 1.5 1.1 2.5 2.6 0.7 1.2 1.7 8.4 1.4 1.1 0.0 1.0 0.6 2.0 0.9 0.6 0.0 1.0 0.5 3.2 3.1 3.0 0.2 1.4 1.2 0.7 0.8 1.3 1.1 1.3 0.6 2.8 6.6 1.5 1.2 3.1 4.1 1.3 2.4 1.9 1.3 2.4 0.9 2.2 ZNF586 FLJ20070 ENSG00000083828 "Zinc finger protein 586" Q9NXT0 19 57769655-57819939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA030306, HPA060782" Approved Approved "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" Vesicles "HPA030306: AB_2673423, HPA060782: AB_2684362" "prognostic favorable (9.83e-5)" "unprognostic (1.60e-2)" "unprognostic (2.93e-1)" "unprognostic (1.72e-3)" "unprognostic (2.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.10e-2)" "unprognostic (1.02e-3)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (1.88e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (6.01e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.36e-4)" 4.7 4.3 3.7 6.3 3.6 25.6 7.0 16.0 4.4 5.9 5.0 5.5 5.9 5.9 5.1 6.6 5.9 5.0 6.0 3.7 2.5 5.4 4.8 5.8 11.9 2.9 2.3 2.4 9.1 6.5 4.3 4.8 6.9 6.1 8.4 5.9 9.4 9.0 4.1 9.8 8.4 6.6 5.9 0.4 10.5 7.3 5.1 2.7 13.6 6.2 7.2 9.9 6.6 7.2 4.5 7.2 6.0 8.6 9.6 4.1 3.7 14.4 5.0 5.3 7.0 3.8 2.8 7.2 16.1 0.4 4.6 6.6 4.7 1.6 7.2 13.1 2.4 30.9 12.2 15.1 1.6 7.5 12.0 10.4 6.4 7.5 5.2 7.6 7.9 8.5 15.6 8.0 0.7 8.3 1.7 12.3 8.2 12.8 4.8 17.3 11.9 3.2 20.2 8.3 17.8 11.9 5.9 2.3 7.4 5.8 7.4 7.1 7.6 4.6 9.2 5.1 0.3 8.8 15.4 23.0 17.1 5.0 1.3 6.6 8.0 9.6 31.5 8.4 8.0 8.2 7.0 10.8 8.9 8.9 9.7 13.3 12.2 29.5 10.1 5.4 6.6 15.1 7.3 3.7 3.6 16.0 4.4 3.7 2.5 2.9 2.3 2.4 6.1 0.4 2.7 4.5 3.9 0.0 1.5 3.6 13.6 12.1 7.9 6.6 9.6 3.6 4.9 4.2 4.8 0.0 3.3 3.7 0.0 7.1 8.5 2.1 9.8 3.4 0.9 4.3 2.8 4.5 3.0 4.4 4.0 2.0 6.9 3.4 2.6 5.7 3.8 8.6 5.0 3.5 5.5 6.7 4.7 4.0 8.2 8.2 6.8 1.1 0.9 5.6 3.6 1.9 7.1 3.1 6.2 3.0 3.4 2.1 1.7 2.6 9.2 3.6 4.4 5.9 2.2 5.2 6.6 2.6 3.8 10.4 8.7 7.0 11.4 10.0 9.2 4.5 4.0 8.5 ZNF446 "FLJ20626, ZKSCAN20, ZSCAN52" ENSG00000083838 "Zinc finger protein 446" Q9NWS9 19 58474017-58481230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052786, HPA078262" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052786: , HPA078262: " "unprognostic (1.52e-2)" "unprognostic (8.71e-3)" "unprognostic (2.72e-1)" "unprognostic (5.04e-3)" "unprognostic (3.28e-2)" "unprognostic (1.78e-2)" "unprognostic (5.15e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-1)" "unprognostic (3.94e-1)" "prognostic favorable (1.32e-4)" "unprognostic (3.94e-1)" "unprognostic (9.24e-2)" "unprognostic (2.43e-1)" "unprognostic (9.96e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 5.4 7.3 7.9 3.4 7.9 3.1 6.8 9.2 8.6 8.8 7.0 7.9 3.3 9.5 4.7 6.0 10.0 3.2 6.0 7.9 7.7 8.2 10.9 4.8 4.1 8.6 7.8 7.7 11.6 9.4 7.8 12.6 2.3 8.2 11.0 2.2 3.7 6.2 5.5 6.5 8.9 6.6 3.3 7.2 6.7 8.0 13.3 7.5 4.9 9.5 3.1 2.5 8.7 6.5 8.7 4.4 8.8 6.0 6.2 5.8 10.1 5.6 2.6 7.9 2.4 2.8 4.3 4.1 4.0 3.8 3.8 10.2 6.4 2.6 3.5 0.9 5.9 27.7 4.8 6.7 3.9 8.6 2.6 6.9 9.4 6.3 4.0 4.0 8.7 5.2 7.0 2.9 2.8 3.5 5.2 7.0 3.0 2.2 4.1 5.5 6.1 4.2 5.5 4.8 8.0 7.4 6.8 4.9 7.3 4.5 3.3 5.3 3.6 3.7 11.4 3.8 2.4 5.7 9.6 13.2 2.6 5.7 1.4 4.9 2.9 2.1 2.3 2.8 3.1 1.8 2.3 3.3 1.8 3.0 2.8 2.2 2.9 2.6 1.7 5.2 1.9 2.8 1.9 7.9 7.9 9.2 8.6 7.9 7.7 8.6 7.8 7.7 8.2 7.2 7.5 8.7 4.8 3.2 3.2 7.8 4.6 2.0 2.3 7.0 4.0 8.9 7.3 8.3 1.0 14.3 5.6 5.5 8.4 5.6 2.2 8.3 3.9 7.9 5.5 14.4 5.7 4.2 10.7 5.7 7.8 5.1 3.8 4.5 6.1 5.8 8.2 6.7 2.2 3.1 4.5 8.4 9.7 6.6 10.2 3.3 2.3 5.2 7.2 2.4 3.6 3.7 2.1 10.8 7.2 5.5 9.5 4.9 4.8 5.3 3.4 1.9 6.8 6.3 11.8 8.5 0.0 6.8 4.8 40.0 21.1 4.1 3.7 3.4 3.4 8.8 5.3 1.5 ZNF264 KIAA0412 ENSG00000083844 "Zinc finger protein 264" O43296 19 57191500-57222846 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046330 Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: " "unprognostic (2.19e-1)" "unprognostic (2.33e-1)" "unprognostic (9.26e-2)" "unprognostic (1.08e-3)" "unprognostic (3.60e-1)" "unprognostic (1.25e-2)" "unprognostic (1.23e-1)" "unprognostic (2.75e-1)" "unprognostic (9.92e-2)" "unprognostic (2.70e-1)" "unprognostic (2.19e-3)" "unprognostic (5.96e-2)" "unprognostic (2.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.04e-1)" "unprognostic (3.36e-1)" "unprognostic (1.65e-2)" 6.2 4.3 6.2 6.5 6.7 8.2 6.0 8.5 6.3 5.6 9.6 4.0 4.8 6.0 5.0 4.8 6.0 4.1 3.0 5.2 6.1 5.0 5.3 5.3 7.1 12.0 6.7 4.2 8.9 8.1 6.5 4.9 6.8 8.0 5.3 4.5 8.8 5.2 5.1 3.9 6.8 5.4 5.2 6.3 8.3 7.4 10.0 9.1 8.0 7.4 4.0 7.1 4.5 4.4 12.8 9.9 6.9 7.8 6.2 5.4 7.5 3.2 5.7 8.8 7.6 13.6 4.8 7.8 3.2 3.9 7.9 6.4 10.3 0.0 7.8 10.9 0.1 27.7 13.3 11.9 3.8 6.3 2.6 12.0 7.9 4.2 9.5 21.7 6.4 7.4 7.6 0.2 0.2 7.0 0.1 11.1 3.3 5.1 2.8 17.2 4.1 10.0 10.5 5.7 13.6 8.6 5.9 11.5 3.5 4.4 6.5 6.3 6.3 10.6 10.1 8.7 3.1 8.2 13.8 17.6 10.1 7.5 0.1 4.3 0.9 1.0 4.3 1.8 1.5 1.2 4.2 2.7 1.8 1.3 1.8 3.4 3.2 0.9 2.4 1.5 1.8 2.1 1.1 6.2 6.7 8.5 6.3 5.2 6.1 12.0 6.7 4.2 8.0 6.3 9.1 12.8 17.2 16.0 18.4 15.7 18.4 1.5 10.9 1.3 9.1 22.1 19.7 12.1 8.8 31.5 7.5 16.5 31.3 7.3 17.5 11.2 7.9 10.1 33.3 29.5 12.5 22.1 16.2 11.4 20.5 15.8 9.2 14.2 7.7 17.5 8.2 13.1 24.3 15.1 13.3 32.0 18.5 11.4 4.1 22.9 0.9 19.0 9.9 14.1 0.0 18.7 13.2 10.9 21.6 15.1 27.1 14.6 5.4 15.8 15.1 16.6 9.3 10.2 6.3 21.0 26.3 17.9 13.3 22.8 18.8 13.4 1.3 4.9 16.7 11.6 10.0 16.7 RPS5 S5 ENSG00000083845 "Ribosomal protein S5" P46782 19 58386400-58394806 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 11301.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055878, HPA061979" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA 880000 "Endoplasmic reticulum, Cytosol" "HPA055878: AB_2682954, HPA061979: AB_2684650" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" "unprognostic (3.06e-1)" "unprognostic (1.53e-1)" "unprognostic (2.37e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (4.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.77e-1)" "unprognostic (1.81e-1)" "unprognostic (5.06e-1)" "prognostic unfavorable (4.75e-4)" "unprognostic (2.79e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (1.01e-1)" 1054.7 1087.8 572.0 610.0 574.3 1623.0 1286.0 557.2 788.0 1393.0 547.4 1038.4 595.7 1062.6 382.0 1590.1 1231.9 508.8 809.7 531.8 569.0 802.1 1005.7 796.1 1279.6 581.6 564.8 523.4 2458.0 2910.3 525.1 674.3 524.4 573.6 1235.8 581.0 184.1 1073.2 488.7 1468.9 2037.8 913.1 576.2 611.0 1041.8 1084.4 334.0 587.2 1017.2 837.0 828.6 1010.3 1107.8 1315.4 586.8 1779.4 2543.8 953.2 1524.9 1812.8 2328.6 1485.9 967.6 1590.9 1162.4 737.1 1909.7 1270.7 3655.5 1185.5 1379.5 1134.2 1126.2 1529.9 2381.7 478.7 1000.1 11301.4 1451.3 1247.3 2444.6 2241.6 2459.7 1183.1 2980.8 3882.4 1210.7 2740.2 1288.9 1539.0 1662.6 1880.1 1897.8 1260.5 1432.8 2399.9 1683.0 1589.7 2782.4 3399.7 2289.6 1364.6 3236.9 1296.9 2199.0 1424.2 1776.2 677.7 1916.6 2066.3 556.4 1109.2 2923.7 980.7 1743.4 1276.4 705.7 2149.8 2527.3 4650.9 2768.7 1092.1 1817.9 980.8 322.0 652.6 131.2 739.4 621.6 1360.4 2219.4 1272.0 962.1 1196.9 2071.6 1829.6 1435.3 92.8 1022.1 467.6 1253.3 1128.4 2583.3 572.0 574.3 557.2 788.0 531.8 569.0 581.6 564.8 523.4 573.6 611.0 587.2 586.8 1118.4 679.5 1091.0 10.1 3747.2 5916.6 5060.2 3028.2 3999.8 242.5 5685.5 7711.0 243.7 1499.9 1654.2 526.0 123.0 3220.8 1739.2 1023.0 1823.4 1792.4 490.1 640.6 1967.1 1631.2 1236.3 2005.8 10.6 4571.3 4191.9 1629.9 1014.8 915.6 1003.0 2412.5 1452.8 1468.4 1973.5 163.2 15.2 2390.3 958.2 1800.2 3567.2 1482.6 2160.0 1414.9 2431.5 12.2 1874.2 700.7 1618.0 12.1 25.1 2022.9 1856.1 945.2 2346.5 4934.9 1734.6 2607.0 711.5 456.9 696.8 2096.0 3046.0 489.6 758.2 4308.1 7256.9 3174.7 2382.2 2244.1 2922.0 4637.7 FAT1 "CDHF7, CDHR8, FAT" ENSG00000083857 "FAT atypical cadherin 1" Q14517 4 186587794-186726722 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 95.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 285.7;LHCN-M2: 206.7" "Low region specificity" "Detected in all" "HPA001869, HPA023882" Enhanced "Intracellular and membrane" NA NA 4600000 "HPA001869: AB_1078818, HPA023882: AB_1848429" "unprognostic (1.98e-1)" "unprognostic (4.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.86e-1)" "unprognostic (1.53e-2)" "unprognostic (5.82e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.15e-3)" "unprognostic (6.80e-2)" "unprognostic (3.57e-2)" "unprognostic (8.03e-3)" "unprognostic (9.41e-2)" "unprognostic (6.25e-3)" "unprognostic (4.27e-2)" 20.2 1.3 16.3 7.3 16.6 0.8 22.1 30.0 12.2 20.1 95.3 35.3 26.1 23.6 16.1 13.4 9.9 23.7 22.2 13.3 64.7 22.3 10.1 13.0 2.4 34.4 24.5 3.9 10.5 12.7 11.5 9.8 17.1 24.2 21.6 31.7 3.5 18.9 24.4 3.5 17.7 24.4 25.9 20.6 2.2 17.0 9.8 21.7 6.0 14.7 3.9 4.5 32.3 11.0 20.5 22.2 83.5 80.9 0.3 79.1 94.5 19.9 110.9 181.9 52.8 33.5 50.0 49.0 0.0 26.0 285.7 34.1 40.4 32.0 136.7 71.6 0.2 13.2 0.0 30.5 50.8 39.4 37.3 29.2 34.5 48.4 98.7 63.5 72.4 1.1 44.8 0.6 0.0 206.7 27.1 66.2 0.1 18.1 42.2 13.9 0.3 22.3 1.8 79.2 79.0 8.6 32.3 19.2 32.2 12.7 54.9 0.3 13.3 23.8 149.8 57.9 2.0 69.8 0.4 0.2 0.5 34.1 0.1 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 16.6 30.0 12.2 13.3 64.7 34.4 24.5 3.9 24.2 20.6 21.7 20.5 6.1 16.0 6.7 55.2 0.3 85.0 27.2 115.4 27.3 5.2 26.5 27.6 27.6 38.6 40.7 53.3 0.0 1.6 0.2 71.2 5.9 25.2 0.7 25.7 17.2 5.0 14.5 0.0 5.8 26.5 3.6 28.8 54.0 29.6 16.5 75.0 1.1 26.1 0.4 0.0 30.3 56.4 18.3 0.8 7.3 0.9 14.6 1.7 12.4 5.6 0.0 4.5 0.0 14.1 12.4 30.3 30.0 37.2 0.2 55.8 78.2 26.7 37.0 0.4 39.5 23.1 65.1 1.5 10.4 10.2 46.9 1.6 1.9 11.7 45.1 38.9 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350090 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favorable (7.29e-5)" 41.2 27.3 24.6 19.7 27.8 117.7 44.2 33.7 24.3 50.1 21.4 38.4 15.8 44.0 22.9 48.4 42.7 15.4 33.6 22.5 25.0 32.6 33.4 40.9 28.6 24.8 25.4 19.3 69.1 44.9 20.4 41.6 24.0 26.0 38.2 19.8 38.9 42.5 17.8 47.6 51.0 40.9 17.3 26.0 42.2 36.6 31.5 24.9 30.6 42.5 16.9 26.9 37.6 51.0 34.7 31.8 18.4 37.1 22.2 21.7 18.8 30.4 33.8 21.3 20.6 21.5 22.9 27.9 50.8 27.0 17.2 16.7 23.3 35.1 29.4 33.1 38.2 21.3 38.8 27.3 25.6 22.1 41.5 29.0 17.8 31.3 18.5 44.0 26.6 22.6 24.7 37.5 29.0 30.7 23.9 48.9 37.1 27.6 30.4 18.0 42.4 41.6 22.8 32.6 35.6 31.9 24.8 29.5 31.5 25.9 34.3 24.6 28.8 24.1 23.5 24.9 16.4 22.5 30.1 21.8 53.7 15.9 26.6 22.0 69.3 20.3 40.4 24.1 12.7 19.0 36.1 19.6 19.8 12.2 44.8 26.9 22.9 105.4 20.8 27.0 39.3 20.3 9.7 24.6 27.8 33.7 24.3 22.5 25.0 24.8 25.4 19.3 26.0 26.0 24.9 34.7 104.6 112.2 129.5 54.9 104.7 119.9 103.6 76.2 88.8 105.8 112.8 107.2 92.6 85.8 125.1 73.5 70.9 73.6 136.8 58.1 52.8 70.2 98.5 131.9 135.3 92.2 85.8 74.7 43.8 57.2 124.8 81.3 54.0 254.8 94.7 86.2 63.5 85.6 43.2 90.9 49.4 77.9 63.1 61.0 75.9 22.0 74.6 84.5 64.0 56.2 67.0 99.2 96.8 59.3 110.1 81.6 56.0 67.7 103.2 121.6 42.0 44.0 113.2 138.4 52.6 122.0 98.8 139.2 95.9 127.1 134.5 119.0 122.0 59.5 66.9 119.8 CHMP2B "CHMP2.5, DKFZP564O123, VPS2B" ENSG00000083937 "Charged multivesicular body protein 2B" Q9UQN3 3 87227271-87255556 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 445.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035069, HPA052754" Uncertain Approved Cytosol NA NA Cytosol "HPA035069: AB_10602798, HPA052754: AB_2681936" "unprognostic (7.83e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "unprognostic (9.78e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (5.76e-2)" "prognostic favorable (1.74e-6)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (6.41e-3)" "unprognostic (1.21e-1)" 26.3 24.4 17.7 23.0 21.3 43.1 26.5 24.0 22.4 27.3 18.2 42.0 38.8 29.8 22.7 35.5 22.8 29.0 27.3 17.4 21.2 29.9 34.8 23.1 22.0 26.9 22.3 15.9 25.1 29.5 24.5 30.7 25.2 25.1 35.2 37.9 15.4 25.1 28.0 35.6 26.5 41.1 29.8 27.3 22.3 31.4 16.2 21.8 17.4 43.5 28.2 21.8 42.7 30.0 34.3 68.4 71.6 25.4 17.4 45.0 38.4 29.7 52.8 71.2 45.1 57.1 57.0 115.0 25.3 36.7 60.1 38.6 35.0 31.6 37.6 56.0 41.7 34.7 29.5 24.6 25.4 39.2 44.9 42.5 29.3 63.2 42.9 58.3 42.6 35.8 29.6 17.3 36.7 50.2 53.2 41.1 18.3 32.4 91.1 65.5 21.4 31.0 26.1 36.0 71.3 9.7 10.8 54.2 45.6 91.4 28.8 40.6 13.7 30.6 42.9 36.5 445.0 37.7 37.7 56.3 41.6 47.6 24.8 30.9 124.7 50.7 136.7 27.3 65.2 37.3 49.6 34.6 34.8 55.1 53.4 32.0 32.4 96.8 31.4 67.8 31.3 52.4 37.8 17.7 21.3 24.0 22.4 17.4 21.2 26.9 22.3 15.9 25.1 27.3 21.8 34.3 56.2 83.3 68.7 11.4 58.7 132.0 254.5 90.0 53.5 19.9 59.8 52.1 68.8 62.9 85.0 49.7 4.2 75.4 45.7 268.7 138.9 170.6 6.8 86.7 45.2 54.4 46.7 36.2 14.1 261.2 187.0 68.9 48.4 86.9 74.1 27.1 48.5 60.8 86.9 37.0 15.1 80.3 73.2 61.9 87.6 7.5 66.2 72.6 40.9 9.4 62.0 213.9 42.2 10.6 36.0 237.4 241.3 96.3 30.0 226.0 101.7 145.8 90.5 16.3 72.3 58.5 57.5 78.7 76.7 62.8 145.6 180.9 52.9 38.1 81.3 330.3 SMAP2 SMAP1L ENSG00000084070 "Small ArfGAP2" Q8WU79 1 40344850-40423326 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 218.0" "Cell type enhanced" "Detected in all" "B-cells: 338.4;dendritic cells: 258.0;Kupffer cells: 284.4;Macrophages: 256.8;monocytes: 291.7;Plasma cells: 224.4;T-cells: 199.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 177.1;THP-1: 302.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021466, HPA024424" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021466: AB_2239737, HPA024424: AB_1857259" "unprognostic (1.65e-1)" "prognostic favorable (6.55e-4)" "unprognostic (7.17e-2)" "unprognostic (1.40e-3)" "unprognostic (4.32e-1)" "prognostic favorable (5.34e-5)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.05e-2)" "unprognostic (2.27e-1)" "unprognostic (2.24e-1)" "unprognostic (4.00e-3)" "unprognostic (2.65e-1)" "unprognostic (1.02e-2)" "unprognostic (1.88e-2)" "unprognostic (5.45e-2)" "unprognostic (6.23e-2)" "unprognostic (1.24e-1)" 65.8 24.2 45.8 138.0 54.5 81.7 33.7 39.8 62.3 44.3 39.4 33.8 17.7 18.0 14.2 26.4 31.0 46.7 17.3 54.5 47.2 19.0 74.2 58.9 207.5 45.7 45.1 52.5 17.2 24.0 27.6 44.2 38.3 46.7 20.2 32.4 48.9 29.8 19.1 30.2 32.5 100.0 40.5 43.8 218.0 42.2 17.1 48.3 159.7 19.4 21.4 201.2 52.7 19.5 58.3 25.1 9.3 22.0 22.2 31.4 60.0 12.2 38.4 34.7 38.9 37.9 11.7 16.8 93.1 18.4 34.4 16.0 10.2 41.1 29.4 53.3 177.1 34.8 51.7 14.2 25.5 28.1 54.3 153.7 51.7 24.3 50.4 21.6 19.1 22.4 71.6 94.9 95.2 47.0 16.8 79.3 51.2 13.4 24.7 84.7 30.3 20.4 96.3 18.9 28.9 37.1 17.1 18.1 46.1 29.9 16.8 14.8 302.3 12.4 42.8 17.6 40.2 29.9 31.3 37.1 75.9 38.8 53.1 28.2 12.4 87.7 102.0 14.5 153.8 18.2 43.7 23.3 22.1 49.3 58.6 32.4 30.1 195.4 31.6 195.8 9.3 35.5 52.1 45.8 54.5 39.8 62.3 54.5 47.2 45.7 45.1 52.5 46.7 43.8 48.3 58.3 12.8 25.6 28.4 10.1 338.4 18.0 11.4 8.5 4.0 34.7 17.5 13.6 15.3 30.0 24.5 7.3 22.9 5.5 258.0 11.0 5.9 12.6 12.7 78.2 15.8 18.7 9.5 66.7 75.7 18.7 9.6 17.1 26.0 25.0 28.4 10.4 38.6 66.3 43.5 26.9 52.4 9.8 12.2 284.4 140.1 19.5 5.3 256.8 28.4 89.9 291.7 15.0 129.8 54.8 33.6 17.1 8.9 4.9 224.4 9.6 10.0 9.1 70.2 25.6 32.9 12.8 27.9 15.9 11.6 12.7 17.8 4.1 199.9 14.6 9.5 14.6 PPIE "CyP-33, MGC111222, MGC3736" ENSG00000084072 "Peptidylprolyl isomerase E" Q9UNP9 1 39692182-39763914 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA019357, HPA020131" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA019357: AB_2670131, HPA020131: AB_1847405" "unprognostic (2.94e-1)" "unprognostic (4.32e-2)" "unprognostic (6.34e-2)" "unprognostic (6.97e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.52e-2)" "unprognostic (2.69e-1)" "unprognostic (3.88e-3)" "unprognostic (1.25e-1)" "unprognostic (9.29e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (5.86e-2)" "unprognostic (3.95e-1)" "unprognostic (9.06e-2)" "unprognostic (1.00e-1)" 25.7 28.1 22.3 16.2 22.8 18.6 27.0 22.8 26.7 31.1 20.4 37.0 18.5 34.0 25.1 32.1 35.3 18.2 32.5 22.2 21.9 30.8 34.0 23.5 27.4 22.3 21.7 21.7 37.0 40.5 24.0 27.9 20.9 22.6 32.6 22.7 21.0 26.4 23.8 43.5 28.9 29.4 25.6 23.8 32.9 31.9 42.2 21.9 20.8 29.4 30.6 28.4 36.7 29.7 24.5 24.5 34.4 37.2 25.7 40.9 36.9 14.3 40.8 42.7 58.7 56.4 32.8 64.8 68.4 52.2 47.9 34.5 32.8 57.1 52.3 68.8 41.1 38.4 75.6 37.4 9.7 50.9 68.4 36.3 32.8 47.2 53.9 21.0 42.0 54.5 52.8 74.8 39.5 46.6 24.7 34.2 42.1 39.9 49.7 31.5 41.4 28.4 38.4 37.8 37.2 47.7 42.3 43.8 31.5 28.4 49.7 40.9 155.8 35.8 36.3 35.3 48.4 57.1 55.8 66.4 52.5 27.0 86.4 52.3 38.3 62.8 32.6 83.9 64.8 82.8 107.5 89.4 83.8 74.1 109.2 103.5 82.4 6.0 123.2 70.0 63.8 101.3 122.5 22.3 22.8 22.8 26.7 22.2 21.9 22.3 21.7 21.7 22.6 23.8 21.9 24.5 28.2 32.1 36.7 10.7 37.0 24.9 43.1 69.8 23.9 25.9 30.3 47.5 31.8 21.5 62.1 33.1 14.6 62.5 39.3 22.8 66.5 57.5 29.2 34.6 27.7 28.7 28.8 38.3 7.7 48.4 59.3 34.0 16.3 23.4 55.2 44.1 37.9 31.1 56.1 23.5 8.8 32.9 40.7 33.4 26.9 76.3 29.8 30.0 39.2 8.4 46.8 34.0 58.7 8.0 13.6 40.0 24.1 45.1 31.7 32.0 39.3 69.8 63.4 29.7 59.2 23.3 40.1 76.1 51.4 24.5 26.3 34.8 36.6 36.3 35.9 32.9 ZMPSTE24 "FACE-1, HGPS, PRO1, STE24, Ste24p" ENSG00000084073 "Zinc metallopeptidase STE24" O75844 1 40258041-40294180 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006988 Approved NA NA 50000 "HPA006988: AB_1080659" "unprognostic (6.32e-2)" "unprognostic (1.63e-2)" "unprognostic (3.75e-3)" "unprognostic (4.63e-2)" "unprognostic (4.16e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.73e-6)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (1.84e-3)" "unprognostic (4.78e-2)" "unprognostic (7.96e-2)" "unprognostic (5.06e-2)" "unprognostic (3.65e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (2.71e-2)" 20.7 24.8 17.9 20.0 18.2 5.6 25.8 19.9 23.1 26.5 22.4 28.7 22.4 26.9 27.7 22.0 19.0 25.9 20.8 17.5 23.3 46.4 38.7 21.9 16.9 19.6 19.1 16.0 14.4 17.6 53.8 10.2 22.3 19.9 26.6 33.4 11.0 19.7 24.0 16.4 16.4 23.6 32.5 20.6 13.8 21.5 11.1 19.6 15.6 27.7 18.3 23.2 29.6 16.3 20.4 69.3 38.4 35.6 26.1 90.3 71.3 67.0 64.0 60.6 81.7 73.9 35.4 118.8 62.7 41.1 92.1 29.9 71.0 78.4 67.9 97.9 54.4 39.8 59.9 36.0 44.5 45.4 99.3 68.8 45.5 67.4 64.7 28.4 45.4 58.3 27.3 63.0 60.6 80.1 30.2 60.7 28.3 70.0 47.2 42.2 52.2 60.2 77.6 75.2 58.0 38.0 44.6 60.9 155.6 85.9 56.3 55.2 249.1 46.4 68.6 52.5 56.0 78.0 37.1 106.2 49.6 75.6 64.6 79.1 18.9 21.4 14.0 17.6 27.2 22.5 15.0 19.4 19.4 29.4 11.4 16.7 22.9 8.5 29.6 24.3 18.4 24.6 22.7 17.9 18.2 19.9 23.1 17.5 23.3 19.6 19.1 16.0 19.9 20.6 19.6 20.4 28.9 38.5 24.1 19.2 20.1 32.0 24.2 41.4 33.0 6.6 35.9 19.0 25.5 54.3 43.0 73.5 0.0 41.4 22.1 44.3 31.3 58.9 3.5 30.7 32.6 31.2 27.6 18.1 16.6 36.9 38.3 36.0 21.9 40.0 21.0 16.6 27.5 64.4 34.0 10.1 13.9 31.0 54.9 33.9 24.5 2.2 28.6 28.6 24.9 11.2 30.5 29.3 19.6 17.6 20.2 44.0 29.3 32.7 31.1 37.7 31.7 42.6 64.2 7.7 0.0 26.8 41.2 7.8 6.4 31.5 27.1 39.0 23.1 28.9 35.6 24.5 STARD7 GTT1 ENSG00000084090 "StAR related lipid transfer domain containing 7" Q9NQZ5 2 96184859-96208827 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033965, HPA064958, HPA064978" Supported Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.56e-5)" "prognostic favorable (3.89e-6)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.72e-3)" "unprognostic (2.38e-1)" "unprognostic (2.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.38e-6)" "unprognostic (1.02e-1)" "unprognostic (2.04e-1)" "unprognostic (2.64e-2)" "unprognostic (2.42e-2)" 45.1 54.8 55.1 47.1 58.0 34.6 44.3 60.7 53.7 34.2 54.3 58.2 56.2 30.0 30.7 37.1 44.4 29.3 92.3 48.0 72.9 81.1 63.4 61.6 71.2 54.9 53.6 43.0 29.7 42.6 70.3 23.8 29.6 51.3 39.3 56.7 54.9 65.8 46.1 204.4 34.3 45.8 38.0 62.8 53.5 45.0 21.3 59.6 56.8 57.1 175.5 87.6 42.5 27.2 72.0 128.8 79.1 102.3 106.2 134.9 66.9 150.1 122.6 107.0 121.2 129.6 188.8 117.7 228.7 129.0 98.6 95.8 102.3 183.3 106.4 157.3 147.2 131.9 204.1 74.3 218.3 62.2 158.1 106.9 65.4 77.9 101.0 99.1 77.2 123.2 92.6 211.1 89.2 108.8 113.0 175.9 161.0 173.3 110.3 115.2 171.6 156.4 227.1 73.2 162.2 191.6 90.5 62.5 201.8 115.8 126.0 60.5 171.6 103.8 100.1 100.4 112.0 125.8 113.9 114.0 201.7 92.8 174.9 112.6 35.6 25.4 22.7 25.6 30.2 26.1 42.6 21.5 26.6 36.2 37.8 23.6 23.4 3.0 30.8 19.9 42.2 41.5 26.0 55.1 58.0 60.7 53.7 48.0 72.9 54.9 53.6 43.0 51.3 62.8 59.6 72.0 32.0 134.6 44.2 21.5 71.2 63.7 43.2 34.3 101.9 39.5 58.1 50.2 176.9 55.8 47.1 46.0 108.4 35.8 83.8 63.3 74.3 32.4 2.5 34.5 43.2 49.9 44.4 48.6 25.6 38.0 40.3 31.3 37.8 48.6 15.8 45.4 41.7 114.7 71.0 40.4 23.8 58.4 24.4 122.4 102.3 6.9 23.3 54.4 42.7 20.6 95.8 38.4 30.9 19.1 42.6 35.8 26.6 25.2 120.6 68.4 50.1 65.7 31.8 58.1 26.3 43.5 43.0 22.7 35.1 75.4 57.4 35.4 62.9 36.8 81.9 38.8 NOA1 "C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3" ENSG00000084092 "Nitric oxide associated 1" Q8NC60 4 56963350-56977606 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035838, HPA035839" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035838: AB_10669531, HPA035839: AB_10669658" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (1.65e-3)" "unprognostic (5.19e-2)" "unprognostic (9.06e-2)" "unprognostic (1.49e-2)" "unprognostic (2.04e-2)" "unprognostic (1.29e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.38e-4)" "unprognostic (8.97e-2)" "unprognostic (6.87e-2)" "unprognostic (1.79e-2)" "unprognostic (4.27e-2)" 10.5 8.9 6.6 10.4 7.4 17.6 15.7 8.0 7.6 12.4 7.6 15.9 19.7 11.2 11.4 11.4 16.9 9.7 11.0 7.1 6.9 11.2 8.7 9.2 16.8 7.3 6.7 7.0 15.2 23.1 11.0 4.2 8.3 7.7 11.4 14.4 7.0 16.2 10.8 22.0 17.9 14.9 10.3 6.9 11.7 13.4 6.7 6.6 17.8 12.1 16.2 17.7 11.5 8.6 8.3 18.9 17.2 12.3 21.9 22.7 40.5 33.9 14.6 26.5 16.7 16.8 30.3 34.4 67.8 24.5 12.5 13.1 19.7 24.2 26.2 15.8 12.4 30.8 16.8 14.2 33.0 17.7 30.8 17.4 37.7 31.4 15.4 26.7 34.9 28.5 28.6 28.9 22.0 22.8 27.9 44.3 41.2 16.2 36.0 26.4 30.5 13.2 25.4 24.1 28.1 28.5 24.3 15.1 60.2 22.5 15.8 26.9 21.6 18.4 13.0 31.2 15.8 27.3 29.5 13.2 34.5 13.2 19.4 17.1 14.2 33.1 16.7 26.2 31.3 40.8 45.6 40.1 33.8 39.4 35.7 48.3 40.6 8.0 48.1 28.3 30.3 52.0 35.8 6.6 7.4 8.0 7.6 7.1 6.9 7.3 6.7 7.0 7.7 6.9 6.6 8.3 10.3 3.2 5.8 5.2 21.3 25.4 20.9 31.4 35.9 6.6 24.7 20.6 16.2 17.2 18.4 7.3 4.2 31.5 19.8 10.6 19.6 19.0 27.0 30.9 14.3 13.2 17.5 27.3 6.8 22.8 32.7 15.6 15.3 15.2 8.2 19.1 10.4 5.1 17.8 1.7 6.8 20.6 16.2 20.3 16.2 12.5 16.1 14.2 12.4 1.9 26.9 10.0 25.7 5.0 8.0 16.9 20.3 23.3 14.7 16.7 31.4 14.8 25.0 9.4 13.1 15.5 19.8 13.0 8.9 24.4 24.7 27.9 18.2 30.8 34.5 20.6 REST "DFNA27, NRSF, XBR" ENSG00000084093 "RE1 silencing transcription factor" Q13127 4 56907876-56966808 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006079, CAB068222" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB068222: AB_2665651, HPA006079: AB_1079801" "unprognostic (7.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (1.39e-1)" "unprognostic (7.47e-3)" "unprognostic (2.30e-1)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.32e-3)" "unprognostic (1.73e-1)" "prognostic favorable (9.50e-5)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" 7.0 5.6 5.6 9.5 6.2 25.1 9.9 6.7 6.8 8.9 9.5 7.0 6.4 9.4 9.0 8.2 7.9 8.0 7.7 5.1 6.7 11.0 11.6 8.1 13.5 8.1 6.6 3.7 11.3 7.8 13.9 0.5 10.0 7.3 10.1 7.1 7.5 7.9 8.2 5.2 9.0 6.3 8.0 7.1 10.8 8.2 12.4 7.3 18.3 11.0 6.6 13.7 8.8 2.1 8.4 10.8 13.0 17.4 18.2 13.2 16.0 22.7 15.6 13.8 16.0 14.7 11.5 16.5 24.5 23.5 16.8 10.7 9.8 13.2 16.3 24.4 12.6 8.1 22.0 9.4 12.5 16.2 29.0 13.5 16.5 14.6 15.1 16.0 20.5 20.1 19.0 14.3 26.3 19.0 17.3 31.5 21.3 15.2 12.3 8.9 30.0 14.5 8.1 19.0 18.3 0.3 8.1 17.8 18.8 14.6 24.8 19.3 20.3 28.7 20.4 18.1 12.4 14.2 10.8 7.8 15.1 13.2 16.7 10.8 7.4 2.5 7.2 6.2 3.9 6.2 11.6 6.9 5.9 5.2 21.1 10.8 4.4 2.8 6.1 7.9 6.0 9.4 2.5 5.6 6.2 6.7 6.8 5.1 6.7 8.1 6.6 3.7 7.3 7.1 7.3 8.4 38.1 70.5 60.2 18.6 51.1 57.1 51.9 33.3 99.6 1.6 42.6 35.2 50.2 42.9 43.3 29.5 81.3 58.0 65.2 21.4 23.5 58.4 9.7 67.3 64.3 50.5 3.6 54.7 0.1 38.2 57.1 40.8 23.9 63.4 51.4 56.3 47.2 31.0 32.2 0.0 0.2 23.5 44.7 36.2 37.9 11.9 39.4 44.0 21.4 12.2 78.0 45.1 71.1 11.1 21.1 45.8 29.0 36.9 44.3 44.3 22.1 24.4 43.3 36.1 32.9 56.5 56.0 58.3 53.8 55.0 45.7 66.4 66.6 62.3 26.1 48.7 HAL HIS ENSG00000084110 "Histidine ammonia-lyase" P42357 12 95972662-95996365 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 199.8;skin 1: 61.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 129.6" "Cancer enriched" "Detected in some" 11 "liver cancer: 23.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 56.9;neutrophil: 73.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 73.3" "Cell line enhanced" "Detected in some" "BEWO: 2.2;NB-4: 2.8;THP-1: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038547, HPA038548" Enhanced Approved Cytosol NA NA 280000 Cytosol "HPA038547: AB_10669541, HPA038548: AB_10673175" "unprognostic (3.39e-1)" "unprognostic (4.46e-2)" "unprognostic (1.53e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (5.05e-2)" "unprognostic (2.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-3)" "unprognostic (1.89e-2)" "unprognostic (3.74e-1)" "unprognostic (4.03e-2)" "unprognostic (2.87e-2)" 1.4 0.3 0.1 3.0 0.1 11.6 2.2 0.2 0.4 0.8 0.3 0.4 0.6 0.4 0.0 1.0 0.7 0.6 0.3 0.1 0.1 0.3 199.8 2.3 0.5 0.1 0.1 0.0 0.2 0.9 0.1 3.0 0.4 0.1 0.2 0.4 0.0 0.6 0.1 0.2 61.6 0.8 0.5 0.1 7.7 0.4 0.1 0.1 0.5 0.2 0.6 1.4 0.5 1.4 0.1 0.4 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.4 0.4 0.0 0.6 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.0 0.1 2.8 0.9 0.1 0.4 0.2 0.1 0.0 0.1 0.6 0.1 0.3 0.3 0.0 0.0 0.0 0.0 11.4 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.0 1.7 0.0 56.9 15.1 2.4 0.0 5.7 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 73.3 0.7 13.6 0.3 0.2 4.4 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 1.1 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.7 2.8 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 3.2 2.0 0.4 0.0 9.7 0.2 0.2 0.7 0.1 0.5 15.0 0.0 0.1 2.5 129.6 0.3 0.0 0.1 0.1 0.0 7.7 0.8 0.0 0.0 3.5 0.0 0.0 6.3 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.4 0.2 1.2 0.7 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 2.8 0.0 0.6 0.0 0.3 0.1 SSH1 "KIAA1298, SSH1L" ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778191-108857590 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 63.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 6.0 5.2 5.1 5.1 5.1 8.0 5.1 8.5 5.5 5.6 6.7 6.4 3.0 6.0 4.1 5.5 5.4 5.3 7.6 5.7 9.9 5.2 5.6 11.9 4.1 5.7 5.5 4.8 5.0 4.4 5.4 5.3 5.2 6.6 5.2 4.2 5.7 3.9 4.9 12.0 4.6 5.1 5.6 4.7 7.6 4.9 3.5 5.5 3.7 5.3 6.5 4.2 6.1 5.3 7.6 9.9 12.7 8.2 6.4 15.1 12.8 7.2 12.8 26.1 11.0 9.7 6.4 4.6 4.9 8.7 29.0 18.8 9.8 4.9 20.7 8.9 9.9 4.8 11.3 6.0 4.0 8.1 5.8 28.4 17.7 7.0 10.0 22.0 27.1 10.3 5.6 2.5 3.6 29.1 5.4 6.6 8.0 5.8 3.8 10.3 4.6 9.8 6.1 4.5 17.1 6.1 8.1 11.0 2.8 24.2 11.2 3.9 4.8 8.1 19.6 8.4 11.9 7.1 7.3 7.0 5.6 10.3 4.5 63.1 1.8 0.9 2.0 1.0 1.5 0.9 0.6 0.5 0.9 0.6 0.6 0.4 0.5 2.1 0.7 1.2 0.7 0.6 0.5 5.1 5.1 8.5 5.5 5.7 9.9 5.7 5.5 4.8 6.6 4.7 5.5 7.6 34.5 9.6 16.1 26.1 6.3 9.4 20.8 23.6 19.4 12.9 6.9 6.6 25.1 11.5 12.7 14.7 16.7 6.0 18.5 8.2 5.9 8.4 2.2 10.8 17.1 52.2 5.4 7.8 27.3 8.2 4.4 14.0 13.7 16.9 20.8 12.0 29.3 15.2 12.3 11.8 35.4 5.4 0.0 23.0 20.3 5.0 6.5 21.1 12.4 55.3 33.7 7.8 14.4 14.1 14.8 12.3 2.4 12.8 13.1 21.8 4.0 6.7 9.0 19.1 6.6 17.8 18.1 1.4 7.7 13.2 8.9 2.3 17.9 7.6 7.8 13.9 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583742-67586656 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 2104.7" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 4033.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 4998.3;OE19: 7810.3" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol No No 69000000 "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 285.7 278.4 294.5 234.2 312.5 606.5 291.2 315.9 429.0 485.1 580.5 332.7 398.1 334.7 282.7 2104.7 653.2 439.7 359.7 291.0 405.5 461.2 45.5 472.3 324.5 330.7 316.4 269.9 309.5 343.7 743.5 322.7 329.7 321.8 294.2 199.0 139.1 545.6 787.5 357.9 704.8 324.4 216.1 317.4 259.3 540.2 46.1 340.6 299.7 583.7 315.3 384.0 531.5 954.1 329.0 1202.5 1599.4 763.7 1198.9 577.8 645.2 705.3 511.3 678.1 761.2 589.3 2956.3 1225.0 3.3 1144.7 813.5 683.7 1707.8 2073.9 2248.5 214.4 848.0 765.3 59.9 1107.6 0.5 852.2 400.3 667.6 807.2 4998.3 609.9 583.3 560.9 1160.2 847.2 1318.2 321.8 605.7 4.3 918.2 1100.6 1475.2 7810.3 681.3 844.8 129.6 3.8 1236.8 3.6 260.6 754.3 719.1 230.9 2394.0 598.2 3.6 656.3 634.5 351.6 883.8 740.6 378.6 200.0 1353.9 447.1 400.0 652.4 747.8 56.0 3145.4 246.6 720.0 2470.8 271.9 509.2 322.4 597.7 3582.7 476.3 267.8 466.5 130.5 1443.8 1608.5 1435.1 363.3 3948.4 294.5 312.5 315.9 429.0 291.0 405.5 330.7 316.4 269.9 321.8 317.4 340.6 329.0 466.7 1153.8 872.3 25.5 296.8 865.6 1914.8 3813.8 767.2 170.0 628.7 838.3 297.3 987.9 2763.5 1230.4 33.3 2116.8 372.4 655.0 1805.9 1811.9 4.9 1381.0 589.0 431.4 368.2 166.3 6.8 1444.4 1703.9 710.5 781.9 1020.9 269.9 795.0 382.3 10.5 861.2 70.7 10.1 992.4 1930.7 597.9 1090.3 25.5 572.3 703.5 1531.5 27.2 2166.5 558.5 459.3 17.6 38.4 1412.1 948.9 400.2 591.6 2266.2 844.4 3495.5 3715.4 274.4 361.6 401.3 941.7 4.8 54.9 4033.7 1061.7 1645.5 342.5 527.8 1118.5 3418.6 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130068147-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 249.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles NA NA 1500000 Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favorable (2.90e-4)" "unprognostic (4.42e-2)" 219.1 131.4 134.7 145.3 129.6 198.3 194.2 169.0 159.2 171.8 236.0 211.9 274.8 178.0 139.8 135.4 169.1 203.6 274.2 130.6 146.8 363.2 337.5 394.9 78.1 134.8 143.7 126.9 182.4 137.2 293.7 87.8 327.5 134.6 290.2 178.4 545.5 136.4 293.7 66.4 109.9 228.5 213.4 140.8 96.5 151.1 55.4 152.4 82.2 613.3 86.0 57.3 201.0 130.7 151.4 216.7 170.3 307.1 281.2 1259.7 847.8 393.7 598.6 741.1 294.2 251.8 1300.5 1541.3 107.9 1515.3 1422.2 322.4 540.4 229.1 567.6 168.0 165.6 206.4 180.9 116.7 502.9 191.9 556.7 363.8 566.4 367.8 244.5 469.5 1520.2 912.7 34.1 180.7 228.9 495.2 205.7 26.9 245.3 182.8 256.8 301.1 70.0 69.8 105.5 758.9 589.6 109.9 239.0 706.9 368.0 92.0 535.8 582.2 489.5 1567.6 314.1 211.7 496.8 281.9 33.8 50.6 245.5 347.0 487.7 221.0 55.1 249.3 65.3 17.9 122.2 13.5 16.3 12.7 17.0 110.1 44.8 9.4 12.6 160.8 15.6 94.6 10.5 20.0 149.5 134.7 129.6 169.0 159.2 130.6 146.8 134.8 143.7 126.9 134.6 140.8 152.4 151.4 239.6 942.3 550.3 37.9 74.4 106.7 175.4 497.0 78.6 967.9 252.9 183.1 262.0 254.5 460.6 404.6 706.8 798.1 72.0 354.2 52.8 305.5 13.6 211.0 191.3 220.3 92.8 156.3 99.0 107.1 130.3 253.5 86.6 432.8 103.5 109.6 127.1 498.2 652.4 240.6 133.5 159.8 463.9 287.6 214.3 13.8 167.4 405.5 96.0 54.4 293.1 396.1 56.7 45.8 31.6 276.5 220.7 214.4 45.5 190.1 352.0 244.9 258.3 729.0 190.7 148.9 207.7 182.8 240.4 81.6 109.4 927.3 58.8 165.9 161.5 215.4 FAM234B KIAA1467 ENSG00000084444 "Family with sequence similarity 234 member B" A2RU67 12 13044381-13142521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 23.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 29.8;Breast glandular cells: 16.8;Collecting duct cells: 18.4;Erythroid cells: 13.2;Spermatogonia: 13.7" "Cancer enhanced" "Detected in all" "breast cancer: 16.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010803, HPA010850" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010803: AB_1079200, HPA010850: AB_2732402" "unprognostic (1.85e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-3)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (8.03e-3)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (9.55e-2)" "unprognostic (3.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "unprognostic (1.85e-3)" "unprognostic (5.22e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (7.62e-2)" 3.4 2.6 11.3 1.6 15.7 3.0 16.6 10.3 23.9 2.3 4.4 1.3 1.8 2.5 3.2 2.0 2.9 1.6 1.7 16.6 17.0 5.5 2.2 2.7 1.6 10.5 13.0 14.3 2.5 2.7 3.3 5.2 5.7 15.1 6.3 1.2 17.8 2.7 2.4 2.3 12.8 1.8 2.4 6.9 2.2 1.6 5.7 12.6 2.3 8.7 1.7 1.6 2.5 2.7 15.8 3.6 3.6 10.9 7.7 8.3 8.0 8.4 2.4 2.8 5.3 10.4 3.8 5.3 14.7 2.9 2.9 9.4 5.4 13.9 2.6 11.0 1.7 7.7 8.7 4.1 3.0 4.4 7.6 4.7 6.3 5.5 7.8 5.9 8.0 7.2 10.2 2.2 5.1 5.8 12.2 6.5 4.8 14.3 2.8 2.0 8.5 14.0 1.6 3.3 8.9 15.0 4.9 5.3 3.5 4.3 18.5 4.4 4.2 3.5 3.5 5.8 6.5 2.6 2.8 3.9 9.4 11.1 3.4 4.4 0.2 1.4 1.1 1.3 2.6 1.8 2.4 1.5 1.3 1.2 3.4 2.1 2.3 0.3 1.5 4.2 2.3 1.2 0.7 11.3 15.7 10.3 23.9 16.6 17.0 10.5 13.0 14.3 15.1 6.9 12.6 15.8 5.4 3.2 3.3 0.0 2.2 0.0 2.1 0.0 1.2 29.8 16.8 3.6 0.0 2.8 0.0 18.4 2.1 9.6 1.0 0.0 1.9 2.0 9.3 1.1 1.0 3.2 12.2 13.2 0.0 1.3 3.4 1.9 0.5 1.5 0.0 2.0 5.0 2.3 3.6 3.3 0.0 0.8 0.0 1.6 0.0 3.6 5.6 1.5 0.0 0.0 2.3 4.2 1.0 0.0 0.0 1.1 1.2 5.3 1.9 3.3 2.6 1.2 0.0 3.3 0.0 1.6 1.3 9.2 13.7 2.2 0.0 3.6 1.3 1.2 0.9 1.5 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 88.2;choroid plexus: 35.1" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 487.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.0 0.1 54.4 0.1 69.4 0.1 4.0 49.7 64.5 0.0 35.1 0.1 0.0 0.1 0.2 0.1 0.3 0.2 0.9 46.8 53.0 1.2 11.6 2.8 0.7 66.1 59.7 39.2 0.2 2.4 0.2 0.4 1.2 63.4 0.7 0.0 0.6 15.9 0.0 0.4 0.5 0.1 0.0 52.5 0.5 0.4 1.9 56.8 0.6 0.2 0.0 0.4 0.2 0.0 88.2 2.1 0.6 0.8 0.1 0.0 0.0 3.4 0.0 0.0 0.1 0.0 3.8 1.4 0.1 2.1 0.2 0.0 0.3 0.3 0.2 0.5 0.7 0.9 0.0 0.5 1.5 0.0 0.4 0.3 0.0 1.7 0.2 0.2 1.5 0.1 0.4 4.0 1.2 0.0 2.6 0.4 0.1 16.7 2.0 0.2 0.2 0.2 12.0 0.0 2.2 1.9 2.9 0.0 0.2 0.2 16.1 3.2 0.9 0.0 0.1 1.7 0.8 0.4 23.1 9.8 0.2 0.1 0.3 0.0 0.2 0.1 0.1 0.4 0.1 0.6 0.4 0.6 0.4 0.0 0.2 0.6 0.4 1.3 0.3 0.0 0.2 0.5 0.1 54.4 69.4 49.7 64.5 46.8 53.0 66.1 59.7 39.2 63.4 52.5 56.8 88.2 0.0 35.3 3.1 5.9 0.0 0.0 0.0 0.0 0.0 0.2 3.5 2.8 0.5 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.8 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 102.1 0.0 0.1 0.0 2.5 487.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 WBP11 "BUG13, CFAP90, FAP90, NPWBP, PPP1R165, SIPP1" ENSG00000084463 "WW domain binding protein 11" Q9Y2W2 12 14784582-14803486 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039710, HPA040037, HPA046403, HPA049126" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644" "unprognostic (4.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.16e-2)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (5.67e-3)" "unprognostic (3.30e-2)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.68e-1)" "unprognostic (2.96e-3)" "unprognostic (6.11e-2)" "unprognostic (3.07e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" 22.5 23.6 14.3 22.6 15.7 66.3 21.0 14.7 17.5 18.0 14.2 19.6 16.3 22.6 17.6 20.0 24.3 18.4 31.4 15.2 16.2 20.2 23.3 20.6 27.6 14.8 14.9 13.6 25.0 21.2 25.3 13.4 25.3 15.2 22.0 22.4 21.5 21.4 18.2 39.1 23.5 18.9 22.4 13.6 23.1 18.9 39.3 16.0 26.3 24.5 33.2 29.8 21.7 16.9 15.2 52.1 45.3 53.0 102.4 34.7 32.9 95.6 41.8 35.0 62.3 62.3 83.9 63.2 64.1 26.7 38.0 53.0 42.4 82.3 55.3 76.5 114.6 54.5 94.3 48.1 52.0 34.8 89.6 50.1 32.2 43.7 69.8 52.0 33.6 50.2 59.5 61.3 33.7 50.1 50.1 84.0 48.7 171.9 35.4 29.0 70.7 84.3 40.6 45.3 70.8 28.3 57.6 55.8 46.3 44.9 123.8 24.6 58.2 37.8 43.7 66.1 38.9 72.8 29.2 43.8 116.6 45.7 43.6 59.3 12.3 14.0 12.7 18.8 19.4 20.8 18.3 18.1 19.1 13.2 16.9 20.9 19.6 8.7 19.2 20.6 9.6 21.3 13.7 14.3 15.7 14.7 17.5 15.2 16.2 14.8 14.9 13.6 15.2 13.6 16.0 15.2 56.8 57.7 61.0 10.1 79.3 54.9 86.9 49.7 41.5 43.7 53.5 40.6 108.6 54.3 60.7 36.8 47.9 57.8 87.2 36.6 43.0 62.5 98.5 70.1 66.8 52.5 39.5 72.6 17.5 59.5 93.3 62.2 32.6 56.7 106.3 41.0 45.0 48.6 46.6 43.7 16.2 37.8 32.6 44.3 42.1 58.4 45.4 56.7 35.6 9.4 104.6 49.6 74.2 13.0 23.0 52.8 22.3 32.7 64.0 64.1 34.0 53.8 78.7 54.1 59.2 79.3 81.3 207.5 140.4 43.5 55.7 75.9 84.8 42.9 42.6 68.1 EIF3I "eIF3-beta, eIF3-p36, EIF3S2, TRIP-1" ENSG00000084623 "Eukaryotic translation initiation factor 3 subunit I" Q13347 1 32221077-32245397 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA029939, HPA029940" Enhanced Approved Cytosol NA NA 70000 Cytosol "HPA029939: AB_10611109, HPA029940: AB_10600878" "unprognostic (4.48e-2)" "unprognostic (1.01e-1)" "unprognostic (7.82e-2)" "prognostic favorable (2.14e-4)" "unprognostic (3.86e-2)" "unprognostic (2.32e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (9.26e-2)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.81e-6)" "unprognostic (1.80e-1)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (8.47e-2)" 117.1 147.8 70.6 110.3 70.9 104.4 166.2 77.6 88.0 127.5 77.6 138.5 97.3 105.2 163.7 156.1 142.9 94.6 117.5 69.9 78.2 124.9 154.0 100.5 135.1 75.2 71.3 68.0 155.5 136.0 143.1 78.9 117.2 73.4 114.2 165.1 53.0 128.3 121.6 249.3 120.6 91.8 146.1 74.2 85.4 119.8 49.3 72.2 166.0 133.0 222.4 188.6 159.6 108.0 79.1 404.3 293.3 207.4 463.5 326.9 427.2 209.3 301.3 514.2 517.2 401.5 317.1 418.3 533.0 320.7 514.0 315.9 265.9 498.6 549.9 667.0 234.4 348.1 288.9 245.8 362.7 352.5 559.1 295.4 413.1 471.2 528.0 569.5 363.4 478.8 363.8 699.1 223.4 502.4 276.3 469.3 370.2 624.2 445.4 339.4 344.1 356.3 509.0 515.9 300.9 325.6 343.4 276.6 351.7 562.1 366.6 282.9 270.7 286.4 333.2 360.3 523.8 653.5 377.7 495.7 487.4 365.2 419.6 440.2 113.8 196.6 93.7 164.4 206.7 180.4 182.1 171.8 160.5 235.8 164.9 148.4 140.5 15.2 183.0 162.0 177.0 219.6 299.8 70.6 70.9 77.6 88.0 69.9 78.2 75.2 71.3 68.0 73.4 74.2 72.2 79.1 136.9 51.3 76.7 6.8 114.5 136.6 227.6 275.6 84.8 38.0 123.6 114.7 41.9 87.2 136.4 51.5 10.4 300.8 118.2 90.1 133.1 295.4 60.8 79.2 114.2 163.5 138.6 69.0 6.8 272.8 341.4 125.6 71.9 85.1 115.3 120.3 89.6 77.1 224.1 13.5 8.2 184.0 148.5 108.1 131.5 29.5 172.4 108.8 144.1 5.6 190.8 69.9 112.3 7.1 10.7 284.4 115.6 139.2 107.5 173.9 125.9 216.2 99.2 41.8 92.1 108.0 338.3 76.5 76.6 121.8 141.4 342.3 115.1 192.3 213.5 219.9 NKAIN1 "FAM77C, FLJ12650" ENSG00000084628 "Sodium/potassium transporting ATPase interacting 1" Q4KMZ8 1 31179745-31239887 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "adrenal gland: 24.4;brain: 18.6;skeletal muscle: 19.6;tongue: 12.0" "Cell type enriched" "Detected in some" 12 "Oligodendrocytes: 43.9" "Group enriched" "Detected in many" 5 "breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006873 Uncertain NA NA "HPA006873: AB_1848410" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (8.54e-2)" "unprognostic (6.11e-5)" "unprognostic (6.59e-2)" "unprognostic (1.24e-1)" "unprognostic (4.30e-4)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (2.78e-2)" "unprognostic (2.01e-2)" "unprognostic (8.07e-2)" "unprognostic (6.31e-9)" "unprognostic (1.00e-2)" "unprognostic (8.83e-3)" "unprognostic (1.62e-4)" "unprognostic (5.50e-2)" 0.1 24.4 8.6 0.2 14.2 0.0 0.4 16.5 10.8 0.2 3.2 0.2 0.1 0.6 3.5 0.6 0.1 0.0 0.0 11.7 11.5 0.2 0.0 0.0 0.0 17.7 16.4 7.4 0.1 0.2 0.6 2.2 0.3 18.6 1.0 0.1 1.5 0.4 0.3 19.6 1.7 0.1 0.2 5.8 0.0 0.1 0.3 12.1 0.2 0.0 12.0 0.0 0.0 0.5 13.7 0.0 0.4 21.2 35.8 0.2 0.0 0.3 0.1 0.0 0.4 0.1 0.4 0.2 0.0 0.7 0.4 0.4 0.0 5.3 0.0 0.1 0.0 1.5 0.0 0.3 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.3 0.8 92.7 0.0 0.9 0.0 0.3 0.1 0.1 3.6 27.3 43.9 1.0 0.3 2.5 2.4 9.6 0.4 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 14.2 16.5 10.8 11.7 11.5 17.7 16.4 7.4 18.6 5.8 12.1 13.7 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.2 0.0 0.5 0.5 0.1 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.9 0.2 0.0 0.1 1.1 0.0 0.0 0.0 3.6 0.0 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 3.3 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 43.9 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.1 0.5 0.0 0.3 0.3 0.8 1.2 0.3 1.4 0.4 0.0 0.1 0.0 0.2 COL16A1 ENSG00000084636 "Collagen type XVI alpha 1 chain" Q07092 1 31652263-31704319 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 109.0;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 122.0;Peritubular cells: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 133.1;ASC TERT1: 102.9;BJ hTERT+: 115.9;fHDF/TERT166: 106.5;HSkMC: 98.7;U-2197: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027237 Uncertain "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 960000 Cytosol "Plasma membrane" "HPA027237: AB_10600699" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (5.64e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.00e-1)" "unprognostic (3.99e-2)" "unprognostic (2.04e-1)" "unprognostic (4.48e-3)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (4.00e-9)" "unprognostic (9.62e-2)" "unprognostic (6.13e-2)" "unprognostic (4.60e-2)" "unprognostic (2.15e-2)" 29.6 17.5 23.0 14.6 37.8 0.3 41.4 34.1 26.3 155.0 6.1 61.8 14.9 94.4 23.9 22.6 37.7 39.8 23.3 14.5 27.4 11.5 3.3 31.3 8.6 51.6 39.4 9.9 179.4 7.8 3.5 28.8 21.3 66.8 103.7 11.0 8.9 35.8 92.2 8.4 69.9 36.1 56.7 35.3 10.0 42.4 41.2 37.6 5.7 47.2 7.4 4.2 107.8 87.5 55.8 0.1 2.0 0.0 0.1 133.1 102.9 14.6 60.5 115.9 15.1 16.1 0.4 11.0 0.0 1.9 106.5 2.3 48.3 0.0 65.8 3.5 0.0 0.2 0.0 8.1 21.3 45.1 0.0 0.3 98.7 44.6 43.2 22.7 3.8 0.1 0.3 0.0 0.2 2.1 0.0 0.1 0.5 0.1 0.4 0.2 0.2 1.3 0.4 0.0 0.4 1.5 2.7 7.3 1.2 9.6 0.5 1.2 0.0 0.2 52.3 52.5 92.1 1.3 0.1 0.2 0.0 36.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 37.8 34.1 26.3 14.5 27.4 51.6 39.4 9.9 66.8 35.3 37.6 55.8 4.3 9.6 3.9 109.0 0.1 30.7 14.8 37.5 15.9 2.4 7.9 21.3 8.4 0.0 9.8 18.4 2.1 1.9 0.6 2.0 0.0 4.6 13.6 2.6 11.5 2.8 27.6 0.4 23.9 0.7 3.8 54.3 8.2 2.4 7.0 0.2 5.0 0.0 1.3 0.0 8.2 30.9 8.2 0.6 11.4 26.8 43.8 0.7 14.2 10.3 0.0 31.3 0.0 62.4 122.0 1.2 4.7 91.4 0.3 9.3 16.8 2.1 15.0 2.5 0.0 5.4 25.0 14.9 3.8 1.9 21.2 2.2 2.2 0.5 6.8 15.3 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179675-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: AB_2686525" "prognostic favorable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favorable (5.53e-4)" "prognostic unfavorable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favorable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.9 36.1 21.3 20.9 21.8 16.7 20.4 20.6 20.9 29.4 26.5 29.6 17.0 35.7 22.9 30.9 30.7 18.9 21.4 20.4 25.0 24.6 45.9 23.3 22.2 25.3 23.5 18.5 29.3 29.5 32.8 31.9 16.8 24.2 30.3 18.0 12.7 23.4 21.9 22.0 31.6 24.6 28.0 21.3 28.7 26.7 29.6 25.7 19.5 27.2 14.6 27.3 28.8 24.6 24.7 45.1 37.7 38.5 43.5 48.8 63.8 31.1 62.7 49.6 59.3 56.6 42.4 47.4 51.1 24.9 61.2 19.5 49.5 53.0 41.2 53.7 58.8 41.0 80.8 57.6 55.8 51.7 59.4 61.4 64.3 54.2 62.8 29.6 43.6 47.6 60.8 33.5 51.3 49.2 25.0 43.8 38.1 56.1 32.0 34.3 50.8 58.3 45.1 40.6 56.4 40.1 41.3 65.1 40.8 68.5 46.9 37.8 35.6 49.9 62.3 53.5 83.3 81.1 75.8 63.0 45.7 64.5 79.5 58.9 11.0 8.8 4.6 12.9 9.8 11.0 6.8 8.8 9.7 6.9 7.4 7.6 8.3 1.4 14.2 13.3 14.3 7.0 10.6 21.3 21.8 20.6 20.9 20.4 25.0 25.3 23.5 18.5 24.2 21.3 25.7 24.7 26.2 22.4 21.4 13.4 13.4 8.8 11.3 14.1 17.1 16.0 26.4 24.6 9.5 11.5 16.8 14.7 39.6 10.8 18.9 15.0 1.9 17.4 14.4 26.9 44.7 23.6 26.3 12.4 9.7 16.4 14.3 27.7 23.9 27.4 13.3 20.2 16.1 32.2 18.2 26.9 9.6 18.1 12.2 11.0 10.0 16.8 23.9 15.9 5.4 7.5 20.9 13.3 10.3 9.5 12.9 22.4 7.2 20.7 19.8 12.4 8.3 12.7 24.1 26.1 13.1 33.6 25.8 34.3 23.8 21.2 12.1 6.8 15.5 23.2 14.7 7.7 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 171 "intestine: 306.9;liver: 1200.8" "Group enriched" "Detected in some" 8 "Hepatocytes: 2967.4;Proximal enterocytes: 1585.9" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "Hep G2: 1079.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" NA NA 1490000000000 100000000000 "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: AB_2680885" "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 2.7 0.0 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.7 0.2 0.4 183.0 0.2 0.0 0.1 0.1 0.5 4.4 0.1 0.3 0.3 1200.8 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.4 306.9 0.2 0.2 0.5 0.3 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 35.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1079.8 0.0 0.6 0.1 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.6 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 277.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 1.6 3.5 0.0 104.2 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 52.8 2967.4 0.1 0.0 0.2 30.8 0.0 69.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.5 1.5 0.0 0.0 1585.9 0.6 0.0 0.0 0.0 1.1 0.2 0.5 0.3 0.0 0.0 0.0 3.9 0.9 14.5 0.0 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 81.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276" "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 16.7 15.2 23.1 13.4 24.8 17.4 17.5 23.9 27.3 18.7 13.3 13.9 21.1 19.2 12.9 17.7 15.8 14.1 15.4 27.9 19.5 19.1 15.1 16.1 15.4 17.9 18.0 20.1 26.8 17.5 30.2 16.7 17.3 16.3 15.3 16.7 47.7 16.1 20.3 33.7 15.5 19.1 19.2 15.4 16.4 12.6 20.1 20.5 26.3 11.9 36.5 16.4 15.1 15.6 21.5 14.1 10.3 17.7 9.2 19.2 17.3 26.9 7.4 14.7 9.1 8.1 9.6 5.9 10.2 3.1 13.5 17.4 3.4 10.7 6.3 9.8 48.6 15.5 36.5 4.1 4.1 12.0 16.9 29.1 27.9 9.4 8.8 7.1 11.3 9.4 12.9 22.6 16.5 14.0 9.4 15.1 6.0 8.5 8.2 6.8 11.8 81.5 5.1 9.9 18.9 16.2 12.8 17.1 10.2 7.4 9.3 12.3 8.6 10.2 15.2 11.9 10.5 7.5 18.8 17.5 17.2 8.6 10.5 7.7 10.6 3.3 7.0 3.4 2.6 3.8 1.6 3.0 3.8 2.5 2.4 2.9 3.5 13.8 3.5 2.9 5.2 3.7 2.0 23.1 24.8 23.9 27.3 27.9 19.5 17.9 18.0 20.1 16.3 15.4 20.5 21.5 41.0 38.5 31.5 467.5 16.7 30.5 11.6 7.8 14.2 96.5 32.3 26.7 41.9 17.2 22.8 14.7 52.1 13.1 47.0 39.0 7.9 16.5 29.7 14.6 37.6 34.9 25.2 29.9 313.0 26.6 18.1 39.8 19.9 28.4 20.2 52.9 36.8 22.8 17.9 62.2 421.8 20.7 20.3 29.8 30.3 7.4 47.2 37.7 19.6 341.9 34.7 66.7 78.2 459.4 305.8 20.1 33.5 43.2 14.3 15.7 30.4 12.5 16.9 71.6 39.5 116.9 34.4 37.7 37.6 16.6 31.0 5.3 33.4 27.2 24.1 21.7 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "parathyroid gland: 50.4;testis: 194.6" "Group enriched" "Detected in many" 6 "Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 8.9 16.9 8.5 8.1 7.4 13.7 12.5 7.1 8.2 14.5 7.7 13.5 8.9 14.1 26.3 18.5 21.0 14.4 12.8 7.4 8.3 22.7 7.3 11.3 10.8 8.7 8.3 6.4 14.5 15.1 50.4 12.6 11.3 9.3 15.4 11.6 16.4 21.4 16.6 7.2 20.7 10.0 14.7 5.5 8.6 11.9 194.6 7.7 15.7 28.8 6.6 8.7 15.0 7.4 7.8 55.0 34.7 55.4 37.2 11.6 23.0 62.9 10.9 23.5 30.9 31.9 30.2 40.5 30.3 34.0 18.9 43.4 24.6 44.8 49.4 33.9 25.9 66.8 44.5 42.0 65.7 23.6 21.6 14.4 24.4 36.7 27.1 22.0 46.9 32.8 43.5 38.9 23.8 30.3 21.5 63.2 32.3 39.4 39.4 23.7 64.5 62.9 48.0 31.9 13.6 37.1 53.6 21.5 16.7 35.0 53.9 24.9 16.3 16.4 28.6 39.2 13.8 23.9 47.7 27.2 62.4 31.8 24.4 26.1 8.8 1.8 4.5 3.3 1.1 2.5 4.6 4.1 4.6 4.1 2.3 3.6 2.2 1.1 8.5 0.7 2.3 2.8 3.8 8.5 7.4 7.1 8.2 7.4 8.3 8.7 8.3 6.4 9.3 5.5 7.7 7.8 3.6 0.0 10.1 5.2 6.3 3.3 8.3 7.2 13.6 5.7 8.6 6.7 6.7 10.0 6.8 9.2 0.0 14.7 1.8 5.9 19.6 8.3 302.7 13.0 3.9 4.9 2.4 11.6 7.9 6.0 7.9 6.4 5.6 5.8 1.3 14.1 6.4 4.1 5.2 0.0 9.1 8.4 6.1 3.1 3.5 338.0 10.5 8.0 7.2 6.5 4.9 6.8 0.0 10.1 10.1 5.0 7.6 11.3 17.1 6.0 6.3 25.0 10.7 10.0 0.0 4.2 7.0 156.8 41.2 16.3 2.7 8.3 5.0 9.4 8.6 10.5 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042076-25159135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.4;skeletal muscle: 20.2" "Cell type enhanced" "Detected in many" "Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 0.8 1.7 24.2 0.6 44.8 0.3 0.5 23.2 30.7 0.5 0.0 0.9 0.4 0.7 5.1 0.3 0.6 0.5 4.6 46.3 24.7 0.5 0.2 2.5 0.3 41.1 25.5 22.3 0.8 0.4 3.9 9.4 1.7 49.4 0.5 0.6 11.1 0.3 0.8 20.2 0.6 0.5 1.2 10.9 3.4 0.9 2.6 28.4 0.3 3.4 3.8 0.2 0.5 0.4 40.8 0.2 8.3 9.5 10.3 0.5 0.1 12.0 1.0 0.2 0.5 0.1 6.7 0.4 0.1 0.6 1.4 3.3 0.6 7.5 0.0 0.1 1.6 1.8 1.6 0.3 0.6 0.0 0.1 0.8 0.1 0.0 2.3 0.1 0.7 0.3 0.2 0.1 0.4 0.2 0.9 0.2 0.5 1.9 0.1 6.6 0.8 9.1 0.3 0.1 0.3 4.0 10.7 1.2 18.0 5.9 5.3 0.9 0.1 0.5 0.5 2.7 4.1 2.0 0.7 0.9 0.1 7.3 0.1 1.9 1.3 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 24.2 44.8 23.2 30.7 46.3 24.7 41.1 25.5 22.3 49.4 10.9 28.4 40.8 3.1 28.9 1.1 127.0 0.0 0.0 0.8 0.0 0.0 9.9 0.3 1.0 9.7 0.0 0.0 9.2 22.9 0.1 0.1 0.7 0.0 0.3 20.6 1.3 0.3 6.7 3.6 0.0 58.5 0.8 0.2 1.0 0.0 0.3 0.0 1.1 2.9 0.0 0.9 5.0 110.7 0.1 0.0 0.0 0.3 46.0 1.2 0.1 0.0 54.4 0.0 22.0 0.0 19.6 51.2 0.7 0.0 2.6 0.1 0.6 0.5 0.1 0.0 10.7 0.0 1.6 1.4 2.4 2.2 0.0 0.1 0.1 0.1 0.2 0.3 0.4 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926598-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 81.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 53.5;Horizontal cells: 42.1;Inhibitory neurons: 45.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" NA NA "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favorable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 2.9 6.8 27.5 2.3 44.7 1.5 2.9 9.8 81.2 3.8 0.0 4.3 1.3 3.6 1.7 2.2 2.7 3.6 2.4 47.3 27.5 1.6 0.7 2.0 1.2 41.3 17.5 47.0 6.8 1.4 3.8 11.8 2.1 46.5 3.0 1.7 19.7 2.2 3.8 1.8 2.3 2.5 4.3 0.0 1.6 2.4 2.4 30.8 2.6 3.0 2.5 1.1 2.8 3.7 53.0 25.7 38.1 19.9 15.4 11.4 13.1 15.9 13.1 6.4 7.7 8.7 6.8 3.8 0.0 10.6 11.9 24.1 2.7 15.2 7.8 5.2 4.5 7.3 9.3 2.6 14.0 6.7 2.3 7.7 9.6 2.3 24.2 4.8 29.6 25.8 7.3 3.3 3.2 8.3 1.8 6.7 3.2 20.5 0.7 11.1 10.4 9.9 1.7 17.7 6.2 24.2 54.4 5.2 2.2 27.3 16.4 0.8 3.1 20.6 13.4 13.7 6.1 12.9 0.8 4.6 3.1 30.4 12.5 11.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.0 0.4 0.3 27.5 44.7 9.8 81.2 47.3 27.5 41.3 17.5 47.0 46.5 0.0 30.8 53.0 1.9 0.0 0.0 9.4 0.2 0.5 1.6 1.5 1.2 16.7 2.0 2.4 3.5 2.8 1.1 0.0 6.2 0.6 2.1 0.1 0.0 8.4 3.4 1.0 2.1 5.6 3.0 0.0 53.5 1.4 4.2 2.6 0.5 1.4 7.0 8.8 7.9 0.1 3.5 42.1 45.9 0.3 2.0 4.6 1.1 4.8 1.8 2.6 3.6 12.2 2.0 7.0 0.0 27.6 13.7 10.1 0.0 4.5 1.5 1.0 0.0 1.2 1.3 9.6 6.6 2.8 3.1 0.3 1.6 1.0 0.3 1.2 1.7 5.1 0.2 1.0 RAB10 ENSG00000084733 "RAB10, member RAS oncogene family" P61026 2 26034084-26137454 "Enzymes, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 488.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045611 Approved NA Yes 4300000 "HPA045611: AB_10961124" "unprognostic (7.73e-3)" "unprognostic (2.45e-2)" "unprognostic (8.21e-3)" "prognostic unfavorable (7.40e-4)" "unprognostic (8.22e-3)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (9.22e-3)" "unprognostic (6.14e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.06e-2)" "unprognostic (8.69e-3)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.99e-2)" 47.8 52.0 47.9 44.6 53.2 17.8 45.5 53.5 57.3 42.7 36.4 59.3 41.7 39.3 40.7 174.3 39.9 42.3 50.3 46.0 51.8 57.3 49.0 40.3 43.1 56.4 53.6 44.0 37.4 38.0 66.9 21.7 41.2 58.2 43.0 58.5 29.3 52.1 42.0 215.9 71.6 46.7 48.5 56.4 44.8 59.3 24.2 51.5 44.2 54.7 115.0 65.1 79.3 78.8 68.2 117.1 139.7 63.8 53.1 131.2 108.2 61.9 90.3 76.8 69.7 61.6 83.2 83.8 77.9 83.4 96.7 79.5 62.0 77.3 84.4 73.9 82.3 56.0 135.1 54.4 134.8 122.6 112.2 73.5 89.0 135.9 85.9 100.3 109.6 89.0 48.9 114.1 76.7 95.1 52.0 69.1 87.1 65.2 139.5 81.7 65.2 133.4 132.8 141.6 111.8 90.1 83.7 75.2 135.1 94.9 70.5 59.5 80.1 110.2 107.1 56.2 75.7 97.2 50.5 84.2 124.4 107.9 132.6 83.5 58.0 75.5 35.5 31.5 135.2 38.6 33.4 36.9 34.1 69.9 32.0 31.1 35.2 54.6 50.6 152.6 24.3 44.6 81.0 47.9 53.2 53.5 57.3 46.0 51.8 56.4 53.6 44.0 58.2 56.4 51.5 68.2 70.8 80.1 49.7 37.9 56.2 341.8 195.5 156.4 122.3 23.8 85.2 64.6 76.4 85.8 134.7 92.0 8.4 121.0 48.7 168.8 115.4 188.3 35.5 67.8 76.7 78.4 65.2 101.0 43.6 96.0 204.4 80.7 97.3 98.3 50.7 44.0 53.2 66.8 159.7 26.9 36.0 94.1 107.8 157.2 285.1 29.6 62.7 151.6 88.9 36.5 246.8 104.9 38.1 47.7 78.1 136.8 123.8 70.0 63.6 199.7 85.9 135.2 107.4 32.7 85.5 94.1 159.5 85.3 73.4 255.9 488.0 128.3 59.3 65.6 117.7 334.3 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496839-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "liver: 137.5" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 96.5" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA045855, HPA052227" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "CAB034098: AB_2247323, HPA045855: , HPA052227: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.6 7.2 1.0 0.2 1.4 0.9 0.6 4.0 1.6 0.4 1.2 0.1 0.7 0.5 0.6 1.5 0.2 2.3 0.4 1.1 1.4 0.3 137.5 0.2 0.6 1.8 1.1 1.3 5.9 1.8 0.2 0.4 0.2 2.3 0.5 0.3 0.9 0.4 0.2 0.3 0.8 0.2 0.3 0.5 1.6 6.6 2.7 0.9 0.2 0.1 0.1 0.3 0.3 0.4 1.8 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 13.4 0.7 20.7 0.8 0.0 0.4 0.3 1.0 0.5 0.1 2.2 6.4 0.1 0.0 0.2 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.5 0.2 4.2 0.1 0.3 0.6 0.2 0.4 0.1 0.2 1.2 0.1 0.2 0.8 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.4 0.3 0.0 0.1 0.0 0.2 1.0 1.4 4.0 1.6 1.1 1.4 1.8 1.1 1.3 2.3 0.5 0.9 1.8 0.3 0.0 0.0 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 7.9 0.1 0.6 0.6 0.0 0.0 2.0 10.4 0.0 0.2 18.3 0.1 0.0 0.1 0.7 96.5 0.1 0.0 1.6 0.0 0.0 2.1 0.0 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 13.7 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.2 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HADHA "GBP, LCEH, LCHAD, MTPA" ENSG00000084754 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" P40939 2 26190635-26244672 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 506.6" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 527.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015536, HPA056070" Approved Enhanced Mitochondria NA NA 470000 Mitochondria "HPA015536: AB_1850473, HPA056070: AB_2683026" "unprognostic (2.02e-1)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (3.43e-1)" "unprognostic (2.67e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.16e-2)" "unprognostic (3.45e-1)" "unprognostic (3.81e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.68e-5)" "unprognostic (7.97e-2)" "unprognostic (1.71e-1)" "unprognostic (2.87e-3)" "unprognostic (2.64e-2)" 103.8 126.3 57.1 31.4 59.3 46.7 95.7 64.7 70.1 69.0 57.5 97.3 116.0 62.3 31.0 90.8 60.6 32.6 266.0 52.9 58.5 99.1 158.0 67.5 35.6 65.4 59.8 48.7 78.4 102.3 95.8 57.9 39.5 62.7 60.7 76.9 15.0 78.5 33.7 506.6 94.8 107.1 57.9 62.6 69.0 94.5 49.4 61.7 47.1 60.0 303.3 59.0 79.8 74.2 66.7 105.7 88.1 58.4 90.8 221.1 139.9 51.5 80.6 84.7 78.5 67.7 114.7 104.1 71.7 50.2 138.4 78.6 66.8 103.4 152.6 72.5 139.1 103.6 103.3 86.2 197.9 73.3 132.2 69.2 142.7 101.6 112.4 109.3 82.8 127.7 70.4 140.2 133.2 101.1 128.2 63.4 137.7 50.1 77.5 134.1 52.9 128.5 143.7 90.3 125.3 41.9 85.1 94.6 104.6 102.4 44.5 52.2 125.8 127.1 48.8 70.7 69.9 58.0 44.8 86.5 113.4 77.6 150.2 56.2 22.5 84.0 33.5 31.8 92.3 39.1 40.5 36.8 38.7 80.8 31.2 42.6 40.1 20.9 38.8 86.1 31.3 50.9 89.9 57.1 59.3 64.7 70.1 52.9 58.5 65.4 59.8 48.7 62.7 62.6 61.7 66.7 122.4 89.8 99.0 47.0 101.2 89.0 137.5 139.9 97.3 35.6 89.7 96.4 349.9 82.9 128.0 77.3 52.1 182.0 95.1 242.1 131.0 120.8 39.2 73.3 121.1 99.1 91.4 155.9 22.8 108.5 94.7 96.1 100.4 85.5 139.9 140.3 84.3 185.1 163.0 20.2 28.2 156.5 89.5 136.8 106.0 74.3 92.6 145.0 81.8 12.2 170.7 65.4 93.7 30.7 37.4 90.0 195.6 84.2 90.4 76.2 527.4 182.5 84.8 62.3 52.6 129.9 109.6 147.9 54.9 136.5 103.3 129.2 100.5 154.7 216.7 104.4 MAPRE3 "EB3, RP3" ENSG00000084764 "Microtubule associated protein RP/EB family member 3" Q9UPY8 2 26970637-27027219 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 147.8" "Group enriched" "Detected in many" 5 "Early spermatids: 428.2;Late spermatids: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009263 Uncertain NA NA "HPA009263: AB_1078716" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (8.31e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-2)" "unprognostic (3.40e-2)" "unprognostic (2.22e-2)" "unprognostic (1.35e-3)" "unprognostic (1.75e-2)" "unprognostic (3.49e-1)" "unprognostic (4.77e-3)" "unprognostic (2.37e-1)" "unprognostic (1.22e-2)" "unprognostic (3.84e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" 23.9 23.3 93.1 7.4 105.9 1.3 23.8 77.2 134.3 25.2 50.6 23.8 7.3 25.0 10.5 12.3 42.6 12.7 43.0 105.2 105.0 30.3 38.0 18.0 5.9 90.6 85.8 110.8 46.5 14.8 37.1 102.5 10.9 95.7 26.3 9.9 71.1 18.5 15.1 147.8 41.2 10.6 13.0 65.7 15.9 23.3 56.8 99.2 7.7 24.6 57.3 6.5 22.2 19.2 114.4 19.8 15.2 13.6 24.0 24.4 13.5 3.9 15.3 12.2 12.7 12.9 5.7 25.8 0.0 14.4 19.1 33.5 10.1 7.6 16.3 7.5 16.5 18.7 2.9 8.1 1.3 22.4 2.3 36.5 11.1 28.5 6.4 11.9 34.6 3.1 1.7 19.4 15.1 7.7 9.0 0.1 1.0 6.0 69.2 23.9 0.1 0.3 2.0 8.8 13.0 34.4 17.0 10.6 7.5 11.0 8.9 8.0 1.4 3.3 11.1 11.4 16.0 13.7 11.5 4.4 0.1 39.9 1.5 22.6 0.2 1.3 0.3 0.7 1.4 0.4 0.6 0.3 0.2 0.8 0.3 0.5 0.1 3.5 0.5 1.7 0.0 0.1 0.7 93.1 105.9 77.2 134.3 105.2 105.0 90.6 85.8 110.8 95.7 65.7 99.2 114.4 13.7 3.2 2.8 25.8 2.6 8.8 21.8 15.2 11.4 44.0 6.4 8.8 8.3 5.7 6.6 3.7 25.0 1.4 1.6 32.3 17.6 11.5 428.2 64.7 11.2 5.5 25.1 2.5 43.7 4.6 4.6 11.2 11.2 4.1 38.1 13.8 14.3 8.6 2.1 58.9 45.0 1.9 18.3 2.8 4.5 311.4 12.8 4.6 7.2 5.6 0.8 69.3 4.1 26.2 27.4 12.0 8.4 11.7 2.7 9.6 0.2 6.8 48.8 44.6 32.9 10.2 14.0 21.0 14.4 6.5 13.8 18.9 3.4 38.6 3.0 15.0 CAD GATD4 ENSG00000084774 "Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase" P27708 2 27217369-27243943 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007781, HPA065158, HPA069341" Supported Supported Cytosol NA No 260000 Cytosol "CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125" "unprognostic (1.69e-1)" "unprognostic (7.34e-2)" "unprognostic (1.49e-1)" "unprognostic (4.71e-3)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.72e-11)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.94e-2)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.93e-3)" 14.4 13.6 11.5 12.5 12.5 9.1 15.0 11.2 15.6 19.4 10.7 16.1 8.6 24.0 10.0 19.4 19.5 7.8 11.6 10.7 11.1 15.6 28.0 12.4 15.0 13.0 11.9 10.2 22.4 22.5 5.9 18.8 7.5 12.8 15.4 7.9 5.1 12.4 8.8 10.4 18.9 16.3 12.0 11.2 20.3 14.1 22.3 12.5 11.7 16.0 5.9 10.6 17.0 16.0 13.7 75.2 66.4 28.9 58.4 46.1 37.6 22.9 31.0 21.4 38.3 27.0 75.7 29.2 66.4 27.4 28.5 29.6 41.4 85.7 41.1 28.5 43.8 69.2 95.2 55.0 40.0 23.0 75.7 46.2 28.8 33.1 55.7 63.0 17.8 41.6 60.6 68.3 36.0 34.2 74.8 48.7 112.0 69.7 31.3 49.7 84.0 86.5 69.5 28.6 37.6 57.9 29.1 43.3 30.5 37.4 21.3 23.9 31.3 37.7 57.7 47.5 45.5 63.5 74.0 51.8 135.2 23.3 71.7 51.0 0.0 0.8 0.4 3.1 1.5 2.5 3.4 4.4 5.2 1.9 3.1 2.8 2.8 0.5 2.7 0.9 3.4 5.9 2.0 11.5 12.5 11.2 15.6 10.7 11.1 13.0 11.9 10.2 12.8 11.2 12.5 13.7 4.2 3.2 3.9 12.7 5.3 3.7 4.3 5.0 5.7 10.6 7.1 8.6 8.3 10.0 4.7 1.8 16.7 5.9 3.9 3.9 0.0 6.1 1.5 2.9 7.9 5.1 6.6 9.7 5.6 3.7 6.6 7.0 6.1 4.3 4.5 16.9 3.3 6.6 7.7 6.7 5.7 5.8 0.0 3.0 1.9 1.9 6.2 3.6 3.6 6.5 4.7 4.1 5.2 8.5 7.4 5.9 1.9 9.8 7.3 8.0 2.5 2.0 3.5 6.8 0.0 8.2 5.2 5.6 12.1 6.2 3.4 2.2 5.1 9.7 7.5 2.2 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736479 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 3747.5;U-2197: 3049.9" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 58000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 498.5 250.6 277.3 211.5 301.8 200.5 561.6 321.0 368.1 308.1 493.2 245.3 121.8 293.4 980.2 483.3 371.3 479.5 564.7 276.5 388.7 582.7 342.7 558.3 150.1 317.1 313.3 264.6 230.5 356.6 712.1 252.3 489.7 324.3 259.1 274.1 131.8 699.3 447.4 534.3 269.3 169.3 383.4 321.1 133.0 426.5 128.8 318.9 169.3 310.7 923.1 291.0 555.7 328.2 321.0 297.2 278.4 77.6 212.0 1697.1 1314.9 46.8 1765.7 1778.5 408.9 451.9 129.7 822.1 23.9 291.5 1802.5 475.5 314.0 141.0 1589.9 561.1 475.5 218.2 31.3 846.7 193.1 483.2 183.4 94.8 631.8 387.2 343.3 1550.6 1104.9 2475.5 109.3 207.9 585.9 2575.4 282.7 79.9 70.3 43.5 541.8 1421.8 30.1 232.1 227.8 1304.4 510.0 54.3 79.5 576.2 243.7 298.2 218.0 187.5 18.1 3747.5 838.6 235.5 3049.9 595.9 273.8 558.8 30.4 734.2 1.3 1556.9 164.9 22.3 209.6 50.9 7.9 64.8 63.9 104.9 56.6 95.4 59.6 68.2 41.4 134.3 92.5 4.8 49.9 298.2 53.5 277.3 301.8 321.0 368.1 276.5 388.7 317.1 313.3 264.6 324.3 321.1 318.9 321.0 728.0 272.4 247.2 32.3 39.1 286.0 1103.2 951.4 82.0 51.3 434.9 270.0 315.5 444.7 569.7 242.8 33.3 553.5 29.2 344.6 164.4 1445.2 129.4 94.3 91.6 792.6 166.6 206.0 25.1 618.3 407.2 303.5 109.6 115.6 139.4 88.2 585.0 185.7 486.7 47.1 29.9 112.8 722.2 139.4 374.2 61.6 237.3 88.2 1270.0 54.4 161.7 198.3 26.8 32.6 22.2 1195.7 392.2 204.7 149.7 1678.0 41.7 208.2 1042.5 56.2 276.1 159.1 410.7 130.6 31.2 83.7 284.4 836.6 52.4 139.5 104.9 1531.0 CD82 "IA4, KAI1, R2, ST6, TSPAN27" ENSG00000085117 "CD82 molecule" P27701 11 44564427-44620358 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 280.3;Proximal enterocytes: 220.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 536.4" "Group enriched" "Detected in all" 6 "B-cells: 310.1;granulocytes: 536.4;T-cells: 173.1" "Cell line enhanced" "Detected in many" "HMC-1: 463.8;U-87 MG: 323.3" "Region enhanced" "Detected in all" "white matter: 210.9" "Low region specificity" "Detected in all" "CAB002508, HPA028900, HPA061418" Supported Approved Vesicles NA NA Vesicles "CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510" "unprognostic (5.31e-2)" "unprognostic (4.62e-1)" "unprognostic (2.38e-2)" "unprognostic (1.33e-1)" "unprognostic (2.79e-1)" "unprognostic (1.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.29e-2)" "unprognostic (3.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.58e-2)" "unprognostic (1.58e-1)" "unprognostic (3.48e-3)" "unprognostic (1.86e-3)" "unprognostic (2.33e-2)" "unprognostic (2.88e-2)" "unprognostic (6.30e-2)" 39.6 9.2 46.5 57.9 67.3 142.2 36.9 41.9 42.3 35.5 39.6 24.9 74.7 9.2 32.2 131.9 54.5 39.9 18.4 35.4 66.0 17.7 37.2 88.1 69.1 54.6 69.7 26.3 15.0 31.6 7.9 7.5 41.4 53.9 27.8 17.3 4.2 81.8 72.8 23.2 80.7 82.3 16.7 35.3 47.7 63.3 4.6 65.4 45.4 22.6 20.2 83.2 48.0 66.7 60.7 30.0 5.2 35.1 7.2 24.0 98.4 1.2 16.9 132.9 29.4 78.5 2.0 19.6 30.9 20.8 8.1 61.1 118.8 4.6 88.4 59.6 145.4 2.7 220.9 9.3 0.6 21.3 58.8 463.8 142.1 99.2 128.3 62.1 68.4 49.7 26.9 1.6 9.4 247.3 25.0 46.7 97.7 1.1 103.2 2.4 1.5 190.0 43.9 16.8 36.1 1.2 2.0 13.0 162.6 23.0 4.2 161.2 51.3 33.9 94.4 12.5 1.8 179.0 3.6 0.4 0.9 323.3 32.5 56.0 369.9 59.3 110.7 29.9 33.0 51.4 310.1 150.7 70.3 14.9 211.9 51.1 23.1 536.4 50.1 25.0 44.5 173.1 65.9 46.5 67.3 41.9 42.3 35.4 66.0 54.6 69.7 26.3 53.9 35.3 65.4 60.7 43.6 48.1 38.8 9.4 112.8 55.1 108.1 149.0 107.6 2.4 68.1 54.7 7.7 58.6 143.8 158.2 2.1 1.3 14.9 17.4 11.7 79.7 2.0 23.1 5.0 41.0 13.2 92.9 0.3 66.7 1.1 29.1 58.6 25.2 280.3 0.7 59.6 32.5 64.3 1.7 0.6 36.8 63.1 26.6 18.2 2.0 40.4 52.3 64.0 3.7 11.0 35.7 0.0 54.3 22.4 86.7 50.3 8.2 16.0 59.1 220.6 2.5 73.0 2.7 13.1 109.0 46.0 2.1 5.9 161.3 67.2 1.4 46.3 0.6 43.1 142.8 BCORL1 "CXorf10, FLJ11362" ENSG00000085185 "BCL6 corepressor like 1" Q5H9F3 X 129981107-130058071 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Syncytiotrophoblasts: 93.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.6;HAP1: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031775, HPA031777, HPA068568" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007" "unprognostic (8.07e-2)" "unprognostic (2.78e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (4.58e-1)" "unprognostic (1.68e-3)" "unprognostic (1.96e-3)" "unprognostic (5.56e-3)" "unprognostic (2.39e-1)" "unprognostic (8.02e-2)" "unprognostic (4.46e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (9.18e-2)" "unprognostic (2.60e-2)" "unprognostic (3.09e-1)" "unprognostic (1.41e-2)" 3.5 3.1 2.3 2.7 2.2 5.6 2.2 4.0 2.6 3.5 0.4 2.6 2.6 4.5 2.2 2.6 4.3 2.0 2.8 2.3 4.4 2.6 2.0 2.9 1.7 2.8 2.1 1.4 5.6 4.6 5.9 2.6 11.4 2.3 3.3 2.1 2.0 3.4 3.8 3.3 2.9 2.9 4.4 1.3 2.8 2.2 6.6 1.9 2.3 4.5 3.3 1.7 2.7 2.6 1.9 3.4 8.0 18.7 29.6 10.6 8.0 5.3 4.5 5.2 5.7 6.5 9.6 2.2 1.5 9.9 8.8 5.5 2.0 44.2 1.8 5.2 3.4 6.7 16.2 3.9 3.1 5.2 3.8 4.8 4.9 3.6 11.0 0.6 8.3 6.8 5.2 7.7 16.4 3.6 1.9 6.0 11.3 5.2 2.6 5.9 12.6 7.5 2.2 3.0 0.4 3.2 10.9 2.3 0.7 3.0 9.4 6.7 5.9 5.9 4.5 6.0 5.7 4.5 5.1 10.1 2.5 2.9 7.8 2.2 0.0 0.3 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.7 0.2 0.1 0.1 0.0 0.2 2.3 2.2 4.0 2.6 2.3 4.4 2.8 2.1 1.4 2.3 1.3 1.9 1.9 5.4 0.0 2.8 6.8 2.9 11.9 2.8 2.2 10.8 1.7 12.5 7.5 7.1 4.3 1.9 7.3 0.0 14.1 6.1 3.7 0.0 3.0 0.5 3.7 7.0 7.9 12.0 2.5 4.6 1.1 4.8 6.9 2.6 4.7 7.0 4.3 4.6 2.8 3.2 8.4 4.4 2.4 2.0 2.2 5.9 1.2 4.7 2.7 7.2 5.6 3.0 2.3 4.1 4.5 8.5 2.6 1.9 3.8 3.2 3.8 4.2 2.3 2.9 1.3 6.6 8.0 6.1 3.4 6.9 9.2 11.5 93.4 4.9 0.9 3.6 2.8 ATRX "JMS, MRX52, RAD54, XH2, XNP" ENSG00000085224 "ATRX chromatin remodeler" P46100 X 77504880-77786233 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001906, CAB009372, HPA064684, CAB068176" Supported Supported "Nuclear bodies" NA NA "Nuclear bodies" "CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321" "unprognostic (1.77e-2)" "unprognostic (1.55e-1)" "unprognostic (6.65e-2)" "unprognostic (4.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.15e-2)" "unprognostic (6.04e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (5.80e-2)" "unprognostic (5.14e-3)" "unprognostic (1.50e-1)" "unprognostic (6.19e-2)" "unprognostic (1.76e-2)" "unprognostic (2.24e-1)" 18.2 16.1 20.1 17.8 23.0 30.1 18.3 35.7 22.1 18.2 23.6 12.8 11.3 21.4 14.9 13.4 11.9 14.8 15.6 20.9 21.8 17.1 13.3 13.5 22.8 18.6 23.2 16.8 25.1 13.5 23.4 8.6 16.7 18.4 19.3 13.6 27.0 14.2 15.0 19.3 15.8 11.0 15.8 18.5 23.0 16.7 6.7 21.8 26.0 20.2 27.2 18.8 14.2 10.0 22.1 36.0 55.1 60.1 45.0 31.8 38.1 21.2 29.4 27.3 21.8 25.9 19.6 30.7 48.5 29.9 32.5 39.9 30.0 44.6 18.1 37.5 27.3 30.8 29.3 67.2 16.2 16.1 38.4 10.2 25.5 20.2 32.2 30.4 29.4 41.9 30.3 34.9 53.3 29.3 27.6 30.2 25.0 42.0 17.6 42.5 48.6 76.3 26.0 25.6 46.4 33.1 55.5 60.5 23.1 21.9 37.2 18.6 20.8 55.8 32.8 76.1 34.4 21.0 16.3 52.9 42.1 23.0 30.9 27.8 44.0 10.5 22.7 26.0 13.3 25.2 31.2 24.0 20.9 8.1 32.4 24.6 20.1 33.2 23.2 20.0 20.7 22.2 9.7 20.1 23.0 35.7 22.1 20.9 21.8 18.6 23.2 16.8 18.4 18.5 21.8 22.1 201.0 160.3 230.1 157.4 176.6 92.4 112.2 71.3 114.9 220.1 87.8 86.7 277.8 60.1 101.5 71.7 212.7 72.2 176.9 49.0 23.5 91.8 4.7 103.1 195.5 162.8 126.8 105.8 197.8 83.1 51.0 134.3 114.2 137.3 113.1 261.4 97.8 56.7 70.9 158.2 246.9 78.0 69.2 87.0 101.6 12.7 162.4 113.1 62.2 195.8 149.0 112.3 183.4 202.5 237.1 92.0 47.6 208.0 183.9 120.8 49.2 37.2 102.6 245.4 92.1 174.7 160.0 19.8 52.8 78.7 84.4 59.8 158.0 312.4 73.3 112.0 AK6 CINAP ENSG00000085231 "Adenylate kinase 6" Q9Y3D8 5 69350984-69370013 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 185.9;Late spermatids: 275.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005361, HPA070217" Supported Supported "Nuclear speckles,Centrosome,Cytosol" No No "Nuclear speckles" "Centrosome, Cytosol" "CAB005361: AB_2302969, HPA070217: " "unprognostic (5.47e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (8.58e-2)" "unprognostic (8.73e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-2)" "unprognostic (1.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" 42.7 58.4 19.3 12.6 20.0 11.7 40.3 21.0 27.3 26.2 20.4 38.9 15.3 32.7 21.8 29.9 29.8 7.8 43.4 20.0 20.1 45.4 47.0 29.7 13.1 20.3 19.9 19.1 32.8 36.1 11.7 28.9 12.2 20.0 33.2 12.7 23.4 31.2 8.4 80.5 19.5 30.3 9.6 20.1 28.2 36.7 43.7 20.0 13.4 33.3 23.6 12.6 35.8 28.2 21.3 40.3 18.8 28.0 42.6 43.6 26.3 51.1 59.3 18.6 23.8 30.7 56.0 35.5 82.1 54.9 23.4 62.2 14.0 37.2 23.3 40.0 33.1 15.7 40.7 47.8 44.9 33.0 49.5 17.1 14.0 33.3 23.0 37.0 25.0 14.8 45.8 36.6 29.3 28.6 42.1 50.2 31.4 25.0 17.9 10.5 55.8 34.5 44.5 40.3 31.3 14.4 13.3 28.2 26.4 44.6 21.3 25.1 54.7 29.5 20.4 34.6 41.4 47.6 33.1 74.4 75.3 29.8 69.3 28.9 25.2 16.8 20.1 19.2 22.1 20.3 29.8 22.8 24.9 24.8 26.1 24.5 26.3 2.7 24.1 21.0 29.9 25.8 13.3 19.3 20.0 21.0 27.3 20.0 20.1 20.3 19.9 19.1 20.0 20.1 20.0 21.3 51.5 22.4 30.0 14.0 33.9 0.0 95.7 0.0 33.6 19.8 57.3 86.6 55.6 18.6 16.7 23.9 10.4 86.7 27.2 16.8 185.9 75.6 174.9 36.4 34.6 38.6 9.7 29.2 14.8 78.5 95.1 47.3 16.8 30.2 21.5 31.7 30.7 42.5 71.3 20.2 15.4 21.3 0.0 30.6 0.0 275.9 33.5 32.2 0.0 6.5 42.4 58.7 34.0 13.0 17.0 59.1 25.5 32.0 29.4 116.6 48.6 149.8 18.2 29.3 52.6 40.9 50.0 56.5 37.9 24.3 0.0 66.2 27.6 44.7 32.9 88.1 FCN1 FCNM ENSG00000085265 "Ficolin 1" O00602 9 134903232-134917912 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 160.4;lung: 46.6;lymphoid tissue: 97.1" "Group enriched" "Detected in many" 10 "Kupffer cells: 504.4;Macrophages: 542.4;monocytes: 1017.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in all" "classical monocyte: 1699.8;intermediate monocyte: 1195.1" "Lineage enhanced" "Detected in all" "monocytes: 1699.8" "Group enriched" "Detected in some" 5 "NB-4: 4.7;U-937: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000685, HPA001295, CAB016760" Enhanced "Secreted to blood" NA NA 1060000000 36000000 "CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842" "unprognostic (1.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.14e-3)" "unprognostic (1.34e-1)" "unprognostic (9.91e-2)" "unprognostic (1.62e-3)" "unprognostic (3.66e-3)" "unprognostic (2.21e-1)" "unprognostic (1.14e-1)" "unprognostic (5.59e-2)" "unprognostic (2.49e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.73e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.28e-1)" 11.6 1.4 0.5 48.2 0.5 160.4 5.1 0.7 0.7 1.5 0.7 3.0 0.5 1.5 0.0 1.7 6.4 3.9 4.7 0.5 0.3 3.7 7.3 46.6 3.2 0.5 0.6 0.3 1.0 2.5 0.1 1.1 2.4 0.6 2.4 1.6 0.1 2.8 0.5 1.7 1.2 2.9 12.2 0.2 97.1 3.7 0.7 0.6 2.5 2.2 1.1 1.4 10.2 2.3 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.0 0.1 0.0 7.2 0.1 9.3 1699.8 18.0 2.9 1195.1 3.5 5.9 1.4 1.6 492.6 1.5 1.7 1.6 277.1 2.8 582.2 13.0 2.1 1796.8 0.5 0.5 0.7 0.7 0.5 0.3 0.5 0.6 0.3 0.6 0.2 0.6 1.3 2.1 6.4 17.1 0.0 6.6 1.9 0.2 0.0 0.0 0.0 0.3 0.0 2.6 1.5 5.0 1.8 0.0 0.8 6.0 0.1 0.0 0.0 0.1 0.2 0.2 2.7 0.0 5.2 0.0 0.0 1.5 3.6 1.5 0.1 12.6 0.1 3.9 2.6 68.4 0.0 0.0 0.0 0.0 504.4 68.3 0.0 0.0 542.4 0.0 0.0 1017.8 0.0 27.8 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 2.1 0.7 0.0 0.0 1.0 0.5 0.0 0.1 0.2 0.4 1.1 6.1 0.3 0.0 0.2 MYNN "SBBIZ1, ZBTB31, ZNF902" ENSG00000085274 Myoneurin Q9NPC7 3 169773396-169789716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045149 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045149: AB_10960839" "unprognostic (7.13e-2)" "unprognostic (2.28e-2)" "unprognostic (3.67e-2)" "unprognostic (2.19e-2)" "unprognostic (1.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.09e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.77e-1)" "unprognostic (8.25e-3)" "unprognostic (1.25e-3)" "unprognostic (1.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.36e-3)" 6.1 5.4 3.9 6.5 4.6 14.9 9.8 7.7 4.9 8.0 4.7 5.7 5.1 10.4 6.3 7.2 6.9 6.2 5.8 3.5 4.1 6.9 7.9 6.5 8.8 3.5 4.4 3.5 10.1 7.3 8.5 3.6 7.2 4.4 7.3 7.0 15.5 6.4 6.3 8.0 7.8 6.8 8.5 3.9 8.0 7.1 10.0 3.8 7.7 8.6 10.9 9.9 7.5 5.5 5.7 13.1 6.0 6.9 13.6 14.2 12.2 8.7 8.6 12.4 13.0 14.3 7.3 13.1 19.7 15.3 9.4 10.3 10.2 12.5 10.9 17.2 17.7 9.8 18.4 9.1 7.2 12.0 17.1 12.9 10.8 13.9 7.9 22.8 10.5 11.7 8.6 7.9 18.9 13.0 11.0 10.1 8.8 10.4 16.1 6.6 11.1 9.7 21.4 8.6 22.1 9.6 11.3 10.4 23.5 14.8 9.0 29.0 12.5 8.7 11.9 5.4 11.1 16.6 21.6 16.4 26.8 9.5 10.6 11.7 22.2 4.8 11.2 7.3 5.2 10.0 8.1 8.4 7.1 5.5 7.9 10.0 7.7 6.7 10.8 4.5 5.5 9.1 7.7 3.9 4.6 7.7 4.9 3.5 4.1 3.5 4.4 3.5 4.4 3.9 3.8 5.7 25.8 28.9 21.6 10.7 25.2 41.3 31.1 21.4 46.7 9.0 14.9 12.1 14.7 14.3 20.3 11.0 22.9 14.6 20.1 9.8 13.7 10.4 46.3 15.8 14.8 20.3 14.3 14.5 15.6 9.4 17.0 16.6 19.4 20.3 7.6 12.7 11.4 7.3 8.2 10.1 15.0 8.4 20.3 7.5 14.0 12.6 17.1 12.3 16.0 13.1 12.7 13.3 19.6 12.5 14.0 9.9 9.4 18.8 31.6 18.1 12.2 12.3 18.3 31.7 6.6 15.7 14.7 34.9 18.8 27.3 38.4 20.8 25.5 12.0 9.6 25.7 MECOM "EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3" ENSG00000085276 "MDS1 and EVI1 complex locus" Q03112 3 169083499-169663775 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 74.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046537 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA046537: AB_2679689" "unprognostic (4.09e-2)" "unprognostic (1.96e-1)" "unprognostic (3.24e-3)" "unprognostic (7.29e-2)" "unprognostic (2.87e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-3)" "unprognostic (1.53e-2)" "unprognostic (3.27e-3)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.87e-1)" "unprognostic (2.60e-3)" "unprognostic (6.54e-2)" "unprognostic (1.03e-1)" "unprognostic (2.81e-2)" "unprognostic (3.37e-3)" 14.9 0.9 9.4 7.3 6.9 1.4 12.4 7.9 7.7 21.5 4.9 25.1 20.0 17.5 4.4 13.6 23.6 8.3 13.1 5.4 4.2 41.7 1.5 25.8 1.5 8.4 6.7 2.9 2.3 23.5 1.8 4.2 17.6 7.7 7.0 30.2 1.8 8.9 8.1 4.3 2.4 10.3 8.1 3.6 6.2 74.0 3.0 7.9 2.0 5.7 12.1 5.3 30.7 7.5 11.8 25.8 0.7 0.9 0.2 3.7 2.7 1.1 3.7 4.2 1.1 2.2 10.7 26.1 0.9 39.1 0.6 5.5 13.4 10.2 15.7 3.1 1.4 16.6 16.7 7.6 1.1 0.4 0.3 5.1 5.7 2.2 1.0 12.1 12.0 55.5 1.4 13.0 1.8 10.3 9.8 0.9 0.4 1.7 13.5 6.6 9.8 13.1 0.3 71.2 119.6 1.0 3.1 1.3 6.7 0.3 1.5 7.1 1.1 53.4 9.7 6.6 2.5 16.9 1.4 0.7 0.9 4.8 1.0 1.6 0.9 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.4 0.5 1.6 0.1 0.0 9.4 6.9 7.9 7.7 5.4 4.2 8.4 6.7 2.9 7.7 3.6 7.9 11.8 80.2 60.9 184.8 16.0 0.6 2.2 33.3 29.4 10.2 0.0 1.2 0.9 11.4 2.8 69.6 125.0 0.0 1.1 0.1 25.5 52.8 1.6 10.4 71.9 5.8 70.5 19.9 7.4 10.3 75.4 0.2 4.8 111.1 107.7 9.5 0.8 69.3 0.2 0.0 0.0 9.1 29.0 20.3 0.6 1.9 3.2 0.3 2.6 1.8 346.6 1.0 0.0 0.0 6.0 13.8 49.8 19.3 0.0 0.3 13.9 6.2 0.7 53.2 0.1 0.0 1.4 5.7 3.0 1.2 39.4 1.4 0.4 1.3 0.5 53.9 45.4 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360611-78480739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Uncertain "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Vesicles" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 18.1 22.6 22.4 12.8 24.8 8.5 28.5 28.8 27.2 24.1 25.0 19.8 16.2 25.3 23.4 24.9 29.8 20.4 24.9 23.5 28.5 28.9 18.0 17.9 12.2 23.1 26.8 21.7 23.0 25.4 47.4 15.9 23.6 23.4 34.6 22.5 40.6 31.7 30.0 10.7 17.8 15.7 26.8 21.5 13.8 28.2 14.2 27.8 14.7 40.2 16.4 13.5 25.2 11.5 28.9 32.7 23.9 23.4 76.1 35.5 45.5 40.8 30.0 46.1 26.5 56.1 9.3 61.1 48.1 31.4 45.5 65.7 26.2 34.9 57.0 45.9 17.4 32.5 20.5 17.8 20.1 22.7 13.6 16.5 28.6 54.5 27.3 41.2 62.5 41.3 25.0 8.4 33.6 50.9 39.2 25.2 26.7 19.9 14.3 26.0 29.5 38.3 55.3 43.5 38.6 70.9 40.6 27.6 38.5 26.7 24.9 52.5 26.1 36.6 26.3 19.3 30.0 24.2 20.9 29.4 27.6 50.1 50.4 22.6 20.3 11.4 13.2 7.5 12.7 9.3 7.6 8.7 9.2 14.8 6.5 7.1 6.3 6.8 10.3 16.6 4.5 9.1 8.0 22.4 24.8 28.8 27.2 23.5 28.5 23.1 26.8 21.7 23.4 21.5 27.8 28.9 59.5 25.6 22.4 45.7 20.3 39.1 31.5 33.6 38.7 72.1 33.4 22.7 36.1 21.5 30.4 40.5 70.9 13.8 21.7 19.1 13.7 24.2 42.2 34.9 30.2 31.4 35.4 12.0 80.0 30.5 24.8 34.3 36.7 34.1 12.0 41.7 27.1 15.7 19.2 32.0 100.1 34.2 20.3 33.7 33.1 15.3 20.2 25.1 30.2 45.0 19.1 47.4 19.6 76.4 60.3 29.8 14.9 28.6 23.9 44.6 14.2 24.7 65.4 68.2 13.1 33.5 25.4 25.6 23.1 30.8 45.3 10.5 21.2 30.8 18.8 33.7 PREP ENSG00000085377 "Prolyl endopeptidase" P48147 6 105273218-105454062 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025414, HPA031388, HPA031389, HPA031390" Supported Supported Cytosol NA NA 1700000 Cytosol "CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857" "unprognostic (3.05e-2)" "unprognostic (9.09e-3)" "unprognostic (2.85e-2)" "unprognostic (5.46e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.63e-3)" "unprognostic (2.39e-1)" "unprognostic (6.78e-2)" "unprognostic (5.81e-2)" "unprognostic (2.66e-2)" "unprognostic (1.15e-1)" "unprognostic (4.47e-3)" "unprognostic (2.74e-2)" "unprognostic (8.98e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" 17.2 17.6 8.3 14.7 8.6 14.4 17.9 7.8 11.9 15.3 8.3 32.4 23.9 15.9 12.2 21.2 13.1 8.8 20.9 8.9 8.2 10.6 19.1 16.3 13.7 7.3 8.3 7.9 16.1 19.4 20.7 13.1 18.0 8.3 11.6 37.9 15.6 18.7 9.1 85.5 33.4 25.8 15.4 7.2 14.4 18.8 21.6 9.8 16.6 12.4 47.4 16.3 21.6 17.7 9.8 22.3 26.9 27.9 32.1 63.1 37.1 27.7 28.6 27.0 37.2 39.0 35.9 14.2 28.5 26.8 33.9 35.0 33.3 41.8 86.5 42.7 41.8 37.4 38.1 21.7 40.0 25.3 40.5 26.2 35.8 53.4 27.6 71.7 28.0 35.4 50.1 67.4 49.8 45.5 38.8 25.8 41.4 27.9 44.2 25.0 41.1 48.4 18.3 28.2 53.8 36.0 51.8 25.3 42.0 21.7 35.3 17.9 61.9 36.1 17.3 23.9 21.6 36.2 14.2 9.7 38.5 30.4 42.6 56.6 5.5 15.2 8.4 16.3 16.8 16.8 9.3 14.2 17.1 16.5 6.9 12.9 15.5 0.8 19.9 22.7 7.0 13.6 13.5 8.3 8.6 7.8 11.9 8.9 8.2 7.3 8.3 7.9 8.3 7.2 9.8 9.8 6.3 3.2 6.7 22.9 10.1 10.8 6.8 12.0 5.7 5.1 6.0 5.5 14.8 7.2 13.6 7.3 14.6 28.2 14.5 19.3 5.9 10.4 1.4 6.6 15.1 10.1 19.3 11.2 79.7 11.7 35.9 10.6 24.5 11.6 13.4 11.2 7.5 15.1 15.0 13.5 48.3 29.4 10.2 14.2 10.8 3.2 10.8 13.3 5.4 27.2 19.1 3.3 5.2 28.6 18.7 18.0 29.1 9.1 11.0 5.3 18.5 8.8 4.8 10.4 0.0 8.3 10.3 3.9 18.8 12.9 8.5 67.9 16.1 14.4 38.2 8.5 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728094-104859919 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Excitatory neurons: 118.8;Inhibitory neurons: 84.2;Microglial cells: 45.9;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: AB_2679524" "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.75e-1)" 3.7 3.2 2.4 2.2 3.8 3.0 3.1 5.2 5.2 3.9 0.3 2.2 2.1 4.0 1.1 5.3 3.3 3.1 3.3 2.9 2.9 6.2 1.6 3.6 2.2 2.2 2.9 2.7 3.9 1.9 7.2 1.5 30.9 2.8 3.8 1.8 11.6 3.0 4.2 2.2 2.5 2.2 4.0 1.9 2.5 2.4 10.5 4.1 4.0 4.6 4.2 2.4 3.3 3.0 6.0 3.9 2.7 11.3 14.3 6.6 8.8 13.3 7.7 11.9 4.8 7.2 2.5 2.3 2.2 3.4 5.9 8.1 2.6 2.8 5.3 10.0 9.1 7.2 7.7 2.5 3.4 6.6 6.8 2.5 5.9 4.7 6.2 5.2 6.3 8.0 9.2 7.6 2.4 9.6 2.8 5.1 4.1 5.0 2.9 2.6 8.0 12.8 0.9 3.8 6.6 6.1 9.1 4.2 4.3 2.3 7.3 2.7 9.2 8.5 3.9 3.2 10.5 7.4 3.5 4.1 7.6 4.0 6.4 7.1 0.0 0.6 0.7 1.2 1.0 1.3 0.9 1.1 1.1 0.6 0.8 1.2 0.9 0.1 0.8 0.5 0.8 0.4 0.5 2.4 3.8 5.2 5.2 2.9 2.9 2.2 2.9 2.7 2.8 1.9 4.1 6.0 11.6 3.2 1.1 42.4 5.1 4.7 2.3 2.3 5.2 11.6 5.3 3.7 6.7 1.5 3.9 5.5 45.9 10.6 4.1 1.5 1.9 1.6 6.2 2.7 6.2 12.9 1.8 3.0 118.8 1.5 5.4 7.1 5.6 3.4 1.3 7.1 4.2 2.6 5.7 16.8 84.2 2.0 0.0 4.1 2.4 4.6 6.2 3.5 1.8 45.9 4.3 6.1 8.2 64.3 74.6 1.4 2.9 3.8 3.7 1.6 3.8 5.7 2.6 31.7 6.6 6.4 6.6 13.2 3.5 5.3 4.7 6.3 6.2 2.9 1.9 1.9 SEH1L "SEC13L, Seh1, SEH1A, SEH1B" ENSG00000085415 "SEH1 like nucleoporin" Q96EE3 18 12947133-12987536 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039964 Uncertain NA NA "HPA039964: AB_10795241" "unprognostic (5.14e-2)" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" "unprognostic (1.14e-2)" "unprognostic (7.97e-2)" "unprognostic (1.87e-2)" "unprognostic (1.13e-3)" "unprognostic (7.14e-2)" "unprognostic (1.93e-2)" "unprognostic (1.45e-3)" "unprognostic (7.12e-2)" "unprognostic (8.06e-2)" "unprognostic (3.81e-3)" "unprognostic (5.91e-2)" "unprognostic (3.01e-1)" "unprognostic (2.67e-1)" "unprognostic (7.05e-2)" 16.1 12.1 15.7 16.7 19.6 12.9 14.7 17.4 22.5 11.8 14.8 15.1 11.7 13.8 12.3 19.9 12.2 9.8 14.5 22.9 19.2 15.0 22.6 12.5 19.9 14.8 15.3 18.1 12.2 15.2 10.8 14.3 12.7 16.0 11.2 14.0 6.6 12.0 9.2 37.6 15.2 12.1 13.5 15.7 13.3 12.1 15.2 18.5 24.0 12.6 27.1 21.7 19.4 13.3 19.9 53.6 40.6 30.9 49.2 21.2 31.5 45.1 45.5 46.3 52.3 59.8 104.7 27.5 114.8 54.0 53.1 46.8 26.6 72.8 52.0 67.5 31.9 46.8 71.6 38.4 62.3 47.7 197.0 45.4 22.5 40.1 60.6 88.8 21.8 27.7 51.6 98.1 41.5 42.9 57.9 106.3 84.4 39.2 215.5 41.9 70.6 71.8 74.6 40.6 53.4 59.8 35.7 58.2 43.7 47.9 22.3 27.3 64.7 22.4 53.5 123.6 81.4 80.7 30.6 48.1 122.1 35.1 70.1 35.0 4.1 23.5 5.6 14.0 31.6 18.5 23.7 16.3 17.0 37.8 23.9 20.9 18.0 2.6 23.6 26.4 20.6 12.2 22.6 15.7 19.6 17.4 22.5 22.9 19.2 14.8 15.3 18.1 16.0 15.7 18.5 19.9 13.1 6.4 20.2 8.5 26.5 54.7 47.0 24.6 40.9 8.0 16.3 12.8 14.0 14.3 18.3 12.9 12.5 23.6 16.1 12.9 9.8 15.0 9.2 18.5 19.2 19.3 19.2 26.1 15.3 13.3 31.8 17.9 15.8 27.6 7.6 17.8 13.2 21.6 21.3 3.3 10.1 20.3 14.2 13.2 20.4 11.4 9.3 19.7 16.0 12.2 16.9 5.8 7.2 6.0 13.3 16.0 15.3 10.9 23.9 46.7 11.5 16.5 8.5 10.1 13.1 26.8 22.3 16.9 14.0 41.6 59.8 23.7 16.0 19.6 24.9 43.0 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 93.6;Suprabasal keratinocytes: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favorable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.7 7.2 17.8 5.5 29.6 12.3 6.4 16.9 27.4 7.7 3.0 6.8 3.7 9.4 5.7 14.5 8.5 7.4 8.2 27.0 23.5 7.7 3.5 7.1 5.7 15.5 14.9 25.1 7.6 5.9 9.3 5.3 6.6 17.5 7.4 5.4 37.3 5.9 7.1 17.2 22.7 4.6 10.3 11.1 5.7 6.0 22.9 18.4 7.8 6.2 15.4 7.6 7.6 9.0 24.1 15.6 4.7 8.8 10.9 17.0 14.8 4.7 17.4 10.7 11.4 12.7 4.6 2.3 7.0 9.0 16.7 8.4 17.1 12.5 7.6 15.0 13.1 7.0 5.8 9.9 5.3 9.7 9.2 8.3 9.2 12.4 17.9 8.5 13.8 13.7 8.1 3.5 9.5 19.4 9.3 8.9 7.2 3.7 5.0 9.1 12.5 22.3 3.9 19.0 13.3 15.3 14.0 15.2 8.1 12.5 9.4 3.7 9.3 23.5 15.1 7.0 26.7 14.5 6.1 5.4 5.5 17.6 9.0 23.0 18.0 5.4 7.1 3.3 5.7 3.1 2.4 3.1 3.5 5.8 3.4 2.8 2.5 22.0 2.7 5.9 6.3 5.5 2.6 17.8 29.6 16.9 27.4 27.0 23.5 15.5 14.9 25.1 17.5 11.1 18.4 24.1 16.5 12.8 6.5 33.3 13.8 93.6 5.1 7.7 62.0 15.3 11.1 12.6 18.9 10.0 8.0 7.3 45.9 2.4 25.1 2.7 5.9 3.5 33.2 20.5 9.3 12.1 3.0 1.7 46.2 0.9 2.1 10.7 8.2 10.4 2.5 5.6 7.1 2.0 4.4 11.8 39.1 1.0 4.1 5.5 28.4 41.4 8.4 13.9 24.9 19.7 6.3 13.2 8.2 15.1 26.5 3.9 0.9 15.1 14.9 2.4 2.4 5.5 18.9 32.3 6.6 13.5 16.5 32.2 28.9 52.1 104.4 4.9 18.9 3.3 2.1 4.1 WDFY1 "FENS-1, KIAA1435, WDF1, ZFYVE17" ENSG00000085449 "WD repeat and FYVE domain containing 1" Q8IWB7 2 223855716-223945357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050603, HPA079597" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA050603: AB_2681188, HPA079597: " "unprognostic (2.49e-1)" "unprognostic (1.24e-1)" "unprognostic (2.94e-1)" "unprognostic (7.62e-2)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (2.63e-2)" "unprognostic (7.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.29e-2)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (3.81e-3)" "unprognostic (3.94e-1)" "unprognostic (2.98e-1)" "unprognostic (3.04e-1)" "unprognostic (7.55e-2)" 17.7 13.3 10.4 18.1 10.3 48.9 14.6 10.0 12.1 20.6 12.2 20.6 15.8 22.8 19.9 14.6 20.7 17.7 10.8 10.1 12.8 15.0 18.1 18.6 23.5 11.7 11.1 9.4 20.3 14.3 20.0 8.7 27.7 12.1 16.3 20.3 16.0 13.7 12.9 11.5 13.6 16.0 19.7 10.4 21.3 20.0 11.0 11.1 16.0 22.3 12.8 19.1 18.0 13.8 11.9 27.9 19.3 34.9 27.2 46.4 44.0 43.7 34.7 48.3 37.5 30.4 81.4 25.0 7.7 30.8 60.6 47.3 19.2 18.7 52.3 40.4 15.6 15.8 19.2 31.9 59.2 36.4 15.2 15.8 39.0 37.9 46.3 71.0 62.4 63.9 16.2 34.3 23.4 44.4 26.8 6.5 11.1 34.5 20.7 16.6 25.3 44.8 8.6 28.4 47.7 29.6 15.7 20.7 19.2 90.9 41.6 12.5 38.1 70.9 74.9 25.7 13.5 18.0 28.8 4.6 21.4 36.3 32.9 26.2 4.4 21.5 8.1 13.7 29.0 16.6 14.1 9.7 13.5 14.8 11.7 10.0 9.5 10.3 24.0 25.7 3.0 9.7 17.6 10.4 10.3 10.0 12.1 10.1 12.8 11.7 11.1 9.4 12.1 10.4 11.1 11.9 40.0 16.0 9.3 22.5 22.0 12.5 14.5 19.9 17.1 14.0 11.8 7.6 7.7 12.8 24.4 16.5 8.4 22.6 25.5 36.4 9.8 12.9 0.8 23.2 30.7 34.1 10.3 11.2 28.7 17.2 11.2 21.4 29.6 36.5 17.7 12.5 16.8 25.7 17.9 28.6 28.1 15.2 8.2 26.3 17.2 2.4 14.6 24.4 35.6 27.2 25.6 13.9 24.7 33.7 39.8 18.0 24.4 23.7 21.8 16.6 16.0 14.4 29.9 10.9 6.6 13.1 26.7 3.8 8.8 24.4 15.5 19.0 21.1 15.0 21.8 28.7 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414319-111427735 "Plasma proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 134 "fallopian tube: 2089.3" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0" "Region enhanced" "Detected in many" "cerebellum: 5.9" "Not detected" "Not detected" "HPA031666, HPA062205" Enhanced Supported Vesicles,Microtubules "Secreted in female reproductive system" NA NA Vesicles Microtubules "HPA031666: , HPA062205: AB_2684710" "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favorable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favorable (3.93e-5)" 3.4 1.6 7.7 1.1 8.2 1.9 3.6 8.5 10.9 3.8 6.4 3.3 1.1 15.5 5.2 3.0 2089.3 1.1 2.2 8.2 7.8 4.9 8.1 3.9 2.2 8.0 7.5 8.2 6.8 1.5 6.9 2.4 2.0 8.1 5.6 2.2 4.3 4.3 1.5 2.6 7.0 5.3 1.5 6.9 4.6 2.8 9.3 7.2 1.2 2.4 1.0 2.1 4.7 3.8 8.7 0.4 0.4 0.9 0.5 1.8 2.0 1.7 0.2 1.4 0.3 0.7 0.6 0.0 0.8 1.7 0.6 0.0 0.5 0.3 0.3 0.5 2.0 4.9 0.3 0.8 2.4 0.6 0.9 2.2 1.8 2.9 0.0 1.0 1.4 0.4 3.2 0.3 1.5 0.1 0.5 0.6 1.2 0.2 6.4 1.7 0.6 0.2 0.7 1.4 3.7 0.6 0.6 0.1 5.0 0.7 2.4 0.3 0.8 0.8 0.1 0.2 2.5 0.7 1.8 0.5 0.4 0.2 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.7 8.2 8.5 10.9 8.2 7.8 8.0 7.5 8.2 8.1 6.9 7.2 8.7 1.2 0.0 1.1 3.3 0.6 3.1 1.1 0.3 0.0 2.1 1.7 1.9 0.6 0.0 0.5 0.0 0.0 5.6 0.2 1.1 1.9 0.2 4.0 9.7 0.7 1.6 0.0 0.0 10.4 0.0 2.6 0.6 0.0 12.0 0.0 1.0 1.4 2.9 0.6 0.0 8.5 1.5 2.0 0.6 1.4 6.1 1.5 0.5 0.0 3.7 0.0 0.4 0.0 1.5 2.4 0.2 0.5 1.9 0.1 1.6 0.6 2.8 1.3 0.6 0.0 0.7 1.1 3.8 0.7 1.0 3.1 17.4 0.8 0.2 1.6 1.6 SLC25A24 "APC1, DKFZp586G0123" ENSG00000085491 "Solute carrier family 25 member 24" Q6NUK1 1 108134043-108200849 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Distal enterocytes: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028519, HPA063636" Enhanced Enhanced Mitochondria NA NA 19000 Mitochondria "HPA028519: AB_10603890, HPA063636: AB_2685068" "unprognostic (1.94e-2)" "unprognostic (7.30e-3)" "prognostic favorable (1.01e-4)" "unprognostic (7.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.91e-1)" "unprognostic (8.54e-4)" "unprognostic (1.51e-2)" "unprognostic (7.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-3)" "unprognostic (6.18e-2)" "unprognostic (6.76e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 9.2 6.2 0.7 5.4 0.6 3.8 8.3 0.6 1.3 12.6 0.7 13.6 11.5 6.6 3.2 6.1 6.7 6.8 4.7 0.7 0.7 6.4 1.6 9.1 5.1 0.8 0.7 0.7 6.0 4.3 8.3 2.8 9.5 0.9 4.1 16.2 6.7 6.7 4.7 3.8 4.3 12.4 8.7 0.5 5.8 7.0 3.2 0.8 5.0 7.2 4.6 5.0 10.2 7.0 0.9 38.2 8.9 28.8 8.6 17.9 23.4 11.4 13.0 17.0 25.1 27.4 11.3 12.9 0.0 10.3 28.7 10.9 14.1 7.9 24.0 35.1 7.9 4.4 2.4 13.4 5.2 14.9 6.1 4.9 17.6 17.0 15.0 18.5 16.8 19.6 5.7 6.2 13.0 32.2 28.7 3.7 1.4 14.3 17.3 8.1 5.7 33.9 12.6 16.9 22.8 5.0 8.7 17.4 14.9 17.5 27.5 13.3 10.7 10.5 13.8 6.2 23.2 15.0 3.0 2.3 0.0 5.0 11.8 8.2 0.4 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.2 0.4 0.4 0.1 0.3 0.1 0.2 0.7 0.3 0.4 0.1 0.7 0.6 0.6 1.3 0.7 0.7 0.8 0.7 0.7 0.9 0.5 0.8 0.9 33.9 54.5 27.8 5.5 24.2 15.6 20.4 20.6 17.1 14.7 25.5 16.8 15.5 17.2 33.5 18.4 8.4 7.1 16.3 126.7 21.5 31.2 3.2 62.0 46.7 28.6 18.1 6.7 18.0 36.9 60.2 23.2 40.2 61.7 22.2 20.9 29.6 1.2 54.1 10.1 14.9 43.2 18.3 51.8 32.8 2.9 19.6 50.0 23.2 16.9 44.7 12.7 11.3 14.6 20.8 67.6 51.2 18.0 9.7 14.3 54.4 24.9 55.2 33.9 52.6 27.2 26.5 6.2 2.4 24.8 14.9 6.2 23.9 41.8 59.1 33.8 MAP3K4 "KIAA0213, MAPKKK4, MEKK4, MTK1" ENSG00000085511 "Mitogen-activated protein kinase kinase kinase 4" Q9Y6R4 6 160991727-161117385 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 31.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007625 Uncertain Approved Cytosol NA NA Cytosol "HPA007625: AB_1853770" "unprognostic (3.05e-3)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-1)" "unprognostic (7.65e-2)" "unprognostic (1.35e-3)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-3)" "unprognostic (2.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.93e-1)" "unprognostic (6.84e-2)" 5.0 4.0 5.4 6.4 4.9 5.8 6.1 10.0 7.6 7.8 0.3 5.7 5.3 9.4 3.7 8.6 7.2 4.5 5.5 6.2 6.9 5.1 4.5 6.2 7.4 3.2 2.4 5.3 8.7 6.5 8.1 3.9 7.1 3.1 7.4 5.3 4.1 7.4 6.3 11.2 8.6 5.5 7.6 2.8 6.4 5.8 7.6 3.5 9.7 5.5 10.3 9.9 7.2 6.8 7.3 8.1 9.0 16.8 14.7 9.9 11.9 11.1 9.0 7.9 10.2 10.7 12.6 5.8 16.7 6.4 23.2 14.6 19.7 17.4 18.0 12.4 12.4 14.3 21.8 8.5 12.9 7.9 22.9 10.1 7.6 20.5 10.7 9.6 15.8 13.5 12.4 56.1 18.8 11.0 8.3 15.6 11.9 10.3 5.8 13.8 16.9 15.6 13.3 9.0 5.8 9.7 8.5 17.0 17.8 1.5 14.7 7.4 27.6 13.0 12.4 15.9 11.7 43.3 10.8 9.3 15.3 14.6 23.2 13.2 31.5 4.0 2.7 5.2 3.2 9.3 6.7 7.5 4.8 4.9 9.1 5.2 5.2 0.2 4.1 1.9 6.1 5.7 3.0 5.4 4.9 10.0 7.6 6.2 6.9 3.2 2.4 5.3 3.1 2.8 3.5 7.3 19.9 19.2 12.2 32.7 20.8 9.8 10.5 9.7 30.7 18.5 13.3 16.8 20.9 10.0 14.9 14.7 22.9 20.6 17.0 7.1 3.9 9.7 5.5 35.3 55.4 14.5 15.4 12.8 66.1 7.5 11.5 16.1 15.8 39.4 3.8 35.3 6.1 8.3 7.3 23.5 64.5 9.3 6.1 8.2 6.4 4.4 11.5 15.3 0.0 45.9 18.8 14.9 10.3 87.4 57.1 12.5 8.1 12.4 18.2 13.6 9.3 6.9 10.6 29.8 6.6 21.8 19.4 14.7 25.7 28.1 11.8 33.1 25.2 8.1 11.7 16.7 PILRA FDF03 ENSG00000085514 "Paired immunoglobin like type 2 receptor alpha" Q9UKJ1 7 100367530-100400096 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 80.8;Kupffer cells: 100.7;Langerhans cells: 65.9;Leydig cells: 52.5;Macrophages: 144.7;monocytes: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 1659.8;non-classical monocyte: 1146.1" "Group enriched" "Detected in all" 5 "granulocytes: 1659.8;monocytes: 1146.1" "Cell line enhanced" "Detected in some" "ASC diff: 27.9;HMC-1: 25.5;NB-4: 20.4" HPA056132 Approved "Secreted to blood" NA NA 1500000 "HPA056132: AB_2683048" "unprognostic (5.53e-2)" "prognostic favorable (2.99e-4)" "unprognostic (7.61e-2)" "unprognostic (2.88e-1)" "unprognostic (2.20e-1)" "unprognostic (5.88e-2)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-3)" "unprognostic (9.95e-2)" "unprognostic (8.57e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.47e-2)" "unprognostic (3.17e-2)" "unprognostic (1.99e-1)" "unprognostic (4.80e-2)" 13.3 9.3 6.6 38.9 7.7 26.3 9.0 12.8 9.0 8.0 8.6 7.5 4.1 8.3 4.8 3.7 14.3 9.4 5.2 6.6 10.7 12.5 9.8 30.7 9.2 11.6 8.3 5.8 9.6 5.4 3.6 15.6 11.4 10.9 11.4 5.3 3.8 5.7 4.1 5.3 5.1 8.0 9.9 10.0 31.4 5.9 10.9 8.3 5.1 9.5 2.9 3.5 17.9 6.8 12.3 0.3 0.4 0.6 0.7 27.9 1.8 0.2 0.2 1.4 0.1 0.5 0.0 0.5 0.6 1.7 0.4 0.3 0.8 0.2 0.1 0.0 1.4 1.0 0.6 1.3 0.1 0.3 1.1 25.5 2.0 0.4 0.2 0.6 0.1 0.3 2.5 0.2 1.8 0.2 0.9 2.0 20.4 0.6 0.4 0.3 0.5 0.0 0.4 1.1 0.6 0.8 0.3 0.0 6.9 0.7 0.1 0.1 6.0 0.6 1.2 1.2 0.8 0.2 2.5 2.0 0.6 0.3 2.3 0.4 316.9 584.3 18.5 2.5 863.0 2.1 2.3 0.9 1.0 288.0 1.1 1.0 1.8 1659.8 6.4 1146.1 5.4 2.2 354.1 6.6 7.7 12.8 9.0 6.6 10.7 11.6 8.3 5.8 10.9 10.0 8.3 12.3 1.0 3.2 12.4 8.8 2.7 1.8 0.3 0.9 0.0 3.6 2.1 3.0 0.6 2.8 3.9 1.8 4.2 0.6 2.1 0.6 27.4 0.2 0.7 3.9 13.1 4.1 0.0 2.7 15.9 0.4 0.6 2.8 0.5 5.8 10.1 0.8 1.8 1.8 80.8 1.7 14.8 1.3 0.0 100.7 65.9 1.9 52.5 144.7 1.8 28.1 72.3 1.4 3.1 2.0 10.3 0.3 0.1 21.4 0.4 0.5 0.1 0.7 3.1 2.4 0.0 1.0 0.7 1.6 2.6 0.2 0.9 0.8 2.0 0.4 0.9 0.3 IGSF9 "IGSF9A, KIAA1355, Nrt1" ENSG00000085552 "Immunoglobulin superfamily member 9" Q9P2J2 1 159927039-159945613 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.1;retina: 35.1;skin 1: 23.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 93.8;Distal enterocytes: 83.5;Gastric mucus-secreting cells: 37.8;Rod photoreceptor cells: 145.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 24.9;HaCaT: 37.0;NTERA-2: 18.9;SCLC-21H: 32.9;SH-SY5Y: 16.8;T-47d: 18.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 2.9;cerebellum: 5.5" HPA037753 Uncertain "Intracellular and membrane" NA NA 140000 "HPA037753: AB_10672915" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (3.30e-2)" "unprognostic (6.06e-3)" "unprognostic (8.93e-3)" "unprognostic (1.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.04e-2)" "unprognostic (2.15e-2)" "unprognostic (6.03e-3)" "unprognostic (2.87e-1)" "unprognostic (8.60e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" 2.0 0.0 0.1 0.6 0.3 0.2 2.1 0.1 0.3 2.7 0.0 7.8 7.5 0.8 2.0 10.1 4.6 0.4 0.5 0.2 0.3 0.6 33.1 0.5 0.0 0.4 0.1 0.0 0.7 1.7 1.6 0.6 0.3 0.3 6.0 4.3 35.1 5.8 3.5 0.0 23.5 9.6 0.3 0.0 0.2 12.9 5.1 0.3 1.8 1.4 0.0 0.7 1.8 6.3 0.3 8.6 0.0 3.3 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 12.1 4.2 0.0 0.3 0.1 0.0 37.0 1.8 5.1 0.0 0.0 0.1 0.6 0.6 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.5 0.0 0.0 1.5 0.4 0.0 0.0 15.9 0.3 0.0 18.9 14.4 4.0 0.0 0.0 1.5 0.0 11.6 32.9 16.8 1.1 14.3 0.0 3.3 18.6 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.0 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.1 13.4 3.7 8.2 6.8 11.6 5.6 6.2 1.8 10.0 3.4 0.0 93.8 1.3 0.0 83.5 0.0 4.5 19.8 7.8 0.9 1.3 8.3 0.0 0.0 33.8 3.2 1.2 37.8 13.7 0.0 1.9 0.4 19.6 0.2 1.7 0.0 7.9 4.1 0.3 2.8 3.4 0.3 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.1 29.0 12.5 0.0 0.1 2.1 24.1 0.1 3.4 145.8 0.0 0.2 0.4 0.6 1.8 6.4 12.5 0.7 0.2 0.7 7.4 1.7 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503017-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 102.7;intestine: 71.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 27.2;NK-cell: 17.9" "Group enriched" "Detected in many" 9 "NK-cells: 17.9;T-cells: 27.2" "Cell line enhanced" "Detected in some" "CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 12.2" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.2 102.7 16.0 3.9 12.6 1.9 3.6 13.0 17.0 6.4 6.8 16.8 26.7 11.1 3.6 3.1 5.0 15.7 1.5 14.8 14.4 34.1 28.2 6.4 3.2 17.1 13.7 8.4 2.3 2.0 1.4 0.6 2.3 17.5 4.3 18.4 2.2 1.2 3.1 0.2 1.5 71.3 9.9 13.8 4.2 2.1 1.0 17.1 2.7 1.9 1.4 3.5 3.6 1.8 16.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.1 4.3 0.0 0.0 67.3 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 20.4 37.7 4.2 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 24.2 0.2 0.9 78.9 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 4.0 0.0 0.9 7.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 11.1 0.0 27.2 0.8 2.7 6.8 0.0 2.5 1.7 6.6 0.2 17.9 0.0 0.1 0.0 2.5 16.0 12.6 13.0 17.0 14.8 14.4 17.1 13.7 8.4 17.5 13.8 17.1 16.0 17.1 0.0 3.0 3.9 9.9 0.8 0.1 0.0 1.2 1.9 0.4 3.9 3.0 95.8 0.6 49.7 0.0 5.8 24.7 109.9 5.9 13.8 27.3 0.6 0.6 52.9 0.0 7.8 16.1 1.9 0.2 3.7 0.0 0.7 3.8 0.3 2.5 38.4 0.4 0.0 11.4 15.8 0.0 0.6 1.2 3.8 0.9 1.6 0.0 570.6 0.2 0.2 32.0 6.0 3.2 8.1 106.2 0.0 4.6 0.2 204.6 57.7 0.7 1.1 0.0 0.4 1.3 0.4 0.9 0.2 0.6 9.9 24.5 0.1 19.9 0.3 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142804 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 22.7;Late spermatids: 58.3;Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: AB_2683225" "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 4.0 6.7 4.6 3.7 3.9 4.0 4.7 4.9 6.2 5.2 0.3 5.6 5.5 6.5 1.7 6.9 5.2 3.2 5.4 4.3 3.0 4.0 2.5 3.6 5.8 6.3 4.1 4.3 6.5 7.3 4.9 6.8 2.1 5.3 5.8 1.3 4.4 10.5 3.1 11.6 10.1 6.9 2.3 3.0 5.0 5.8 18.1 4.2 2.5 5.3 1.2 0.9 5.7 5.2 4.7 3.6 11.1 4.9 11.3 4.7 3.8 6.0 6.4 2.6 3.3 3.9 3.6 7.2 4.3 6.2 4.2 4.9 8.4 2.2 7.1 1.3 9.2 8.3 2.4 13.4 7.0 8.8 7.5 7.8 3.7 8.7 4.4 1.8 2.5 2.5 8.2 8.0 9.4 2.2 15.1 7.0 9.1 8.3 3.8 8.4 9.4 5.7 8.1 2.6 2.4 10.0 8.5 9.7 5.7 4.7 3.1 7.5 12.8 6.3 6.8 6.2 7.7 4.5 5.2 5.4 6.4 2.7 9.9 5.3 0.0 0.5 1.3 1.2 0.9 1.1 0.9 1.2 0.8 0.5 1.5 1.5 1.1 1.3 1.6 0.7 1.2 0.7 0.8 4.6 3.9 4.9 6.2 4.3 3.0 6.3 4.1 4.3 5.3 3.0 4.2 4.7 4.1 0.0 1.1 3.6 1.9 1.9 1.5 2.1 2.8 5.3 4.8 4.2 4.4 1.5 1.7 0.0 2.1 1.8 3.4 10.2 1.9 4.0 22.7 3.0 3.1 3.4 2.4 2.1 3.2 4.9 2.0 3.9 4.6 4.4 4.5 4.8 4.6 1.4 3.2 8.4 3.5 6.0 0.0 5.1 1.7 58.3 6.5 3.6 0.0 1.0 4.4 5.6 5.2 0.5 4.6 5.2 4.2 7.2 1.3 2.1 14.6 2.5 1.5 5.2 19.7 3.9 4.1 9.5 4.5 4.8 2.0 1.4 2.3 3.5 6.6 1.8 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442356-134459284 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "adrenal gland: 3064.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 649.2;Cytotrophoblasts: 1105.1;Extravillous trophoblasts: 1284.9;Ionocytes: 697.8;Syncytiotrophoblasts: 2022.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 1667.3;BJ hTERT+: 3096.2;RPTEC TERT1: 1447.8;U-87 MG: 1343.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol No No 1500000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935" "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.00e-4)" 63.5 3064.1 86.5 38.8 92.7 22.1 52.7 94.5 98.1 40.2 82.7 39.9 20.7 42.8 44.4 28.5 39.1 40.5 200.0 86.0 93.8 124.7 19.5 55.5 75.2 100.7 97.2 82.9 61.0 34.7 112.1 77.1 205.4 105.0 34.7 31.2 36.8 42.3 335.8 333.1 24.6 51.2 40.0 95.4 63.3 51.8 45.3 92.6 55.5 44.7 400.4 63.0 67.9 35.3 101.5 184.2 1667.3 186.5 261.4 785.9 212.3 494.6 177.2 3096.2 259.3 335.0 75.8 170.6 0.0 79.2 301.5 1143.3 78.6 204.0 175.3 206.6 65.2 168.2 93.4 225.0 230.1 1117.9 0.1 0.8 196.9 133.4 367.6 98.3 252.8 370.3 181.1 0.1 62.4 292.4 3.5 283.3 131.0 309.2 13.9 1.8 292.9 116.5 138.8 1447.8 915.5 137.1 301.6 1261.5 1.5 134.3 121.3 0.6 140.6 289.6 254.5 116.0 22.7 195.6 168.2 196.9 470.0 1343.5 0.7 153.0 125.7 106.4 5.6 147.6 72.3 135.2 133.0 124.7 144.5 145.3 121.7 162.9 156.7 8.5 119.7 39.2 20.4 94.9 230.2 86.5 92.7 94.5 98.1 86.0 93.8 100.7 97.2 82.9 105.0 95.4 92.6 101.5 34.1 12.8 19.4 9.1 50.3 20.6 55.3 66.1 20.5 36.2 11.7 27.9 202.4 25.8 26.4 649.2 8.4 1105.1 35.1 2.3 164.4 112.7 5.0 6.1 20.9 50.9 31.0 20.2 10.5 41.5 1284.9 100.3 20.4 5.9 53.8 59.8 82.1 2.6 394.1 72.3 18.7 15.1 697.8 172.8 53.9 14.5 79.2 127.7 30.2 14.0 76.3 49.3 66.9 5.5 12.4 51.0 4.5 77.5 72.6 25.6 0.3 60.2 24.9 24.1 59.2 98.9 54.5 22.6 100.2 10.5 11.6 2022.4 49.9 70.5 6.7 54.2 CPNE3 ENSG00000085719 "Copine 3" O75131 8 86514435-86561498 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 249.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029552 Uncertain Supported Nucleoplasm,Cytosol NA NA 71000 "Nucleoplasm, Cytosol" "HPA029552: AB_10600703" "unprognostic (5.63e-3)" "unprognostic (1.47e-1)" "unprognostic (2.95e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (6.58e-2)" "unprognostic (8.40e-2)" "unprognostic (4.76e-2)" "unprognostic (3.50e-1)" "unprognostic (1.19e-1)" "unprognostic (8.64e-3)" "unprognostic (2.77e-1)" "prognostic favorable (5.07e-4)" "unprognostic (1.15e-1)" "unprognostic (4.33e-1)" "unprognostic (1.65e-3)" "unprognostic (1.13e-2)" 35.8 29.6 14.8 22.6 18.0 77.3 42.7 23.3 15.5 41.0 23.3 35.4 32.4 33.5 21.6 74.3 32.3 30.3 52.8 14.8 23.9 52.0 46.6 34.1 39.8 15.2 17.2 14.5 39.6 30.0 52.6 11.9 25.7 16.3 41.6 34.6 18.4 37.5 30.2 17.7 36.6 31.0 32.0 16.2 28.6 30.4 8.4 16.0 38.9 61.5 26.6 46.9 35.2 25.7 22.2 135.1 46.8 30.9 40.9 116.9 92.1 24.6 63.3 93.3 51.9 58.2 30.4 44.5 36.7 40.6 77.6 31.6 101.2 68.7 67.5 92.5 39.5 52.1 6.0 27.2 34.7 41.0 2.3 1.5 63.0 71.2 57.6 76.0 83.1 64.6 17.6 33.2 68.4 65.0 51.6 65.9 1.8 10.5 110.6 64.4 30.7 28.9 174.4 67.4 92.2 66.2 51.5 55.4 249.3 39.6 35.7 95.0 10.3 69.3 44.5 44.1 61.3 49.4 47.0 63.3 9.9 66.0 12.6 42.9 28.6 32.6 54.3 33.2 38.1 26.2 26.4 27.5 23.8 63.1 26.9 23.8 26.1 46.5 27.6 52.5 62.2 20.9 32.0 14.8 18.0 23.3 15.5 14.8 23.9 15.2 17.2 14.5 16.3 16.2 16.0 22.2 84.1 137.8 103.9 23.2 52.0 81.8 110.6 111.8 96.2 16.2 80.2 73.9 120.2 75.8 89.3 69.9 14.6 73.0 85.4 49.4 99.7 77.9 1.6 66.9 73.5 66.3 50.2 28.4 37.0 83.7 55.1 92.6 48.9 83.5 8.2 44.7 66.4 103.9 50.4 45.4 39.9 55.3 81.4 71.0 93.8 4.5 85.7 64.0 53.4 13.1 75.0 75.6 36.0 58.3 24.5 59.3 51.7 87.6 49.4 112.5 53.3 126.1 78.8 17.4 59.2 102.1 77.4 3.2 8.8 183.2 91.1 78.0 55.2 71.4 75.1 91.8 RRN3 "DKFZp566E104, TIF-IA" ENSG00000085721 "RRN3 homolog, RNA polymerase I transcription factor" Q9NYV6 16 15060033-15094311 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049837 Supported Supported "Nucleoli rim" NA No "Nucleoli rim" "HPA049837: AB_2680906" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" "unprognostic (5.74e-3)" "unprognostic (3.67e-2)" "unprognostic (4.50e-2)" "unprognostic (7.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.25e-3)" "unprognostic (1.17e-2)" "unprognostic (7.71e-2)" "unprognostic (2.76e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" 21.7 17.2 9.3 11.3 9.1 28.4 20.2 11.7 13.6 15.1 8.9 15.8 7.1 16.8 11.2 13.5 16.1 12.1 15.8 9.2 13.1 15.3 31.4 12.9 15.7 9.2 10.2 8.8 20.8 20.2 20.9 15.6 12.3 10.0 17.0 18.4 24.1 13.1 13.5 41.7 15.6 14.9 13.7 9.4 16.4 15.2 13.8 10.1 19.2 16.6 39.5 18.3 18.4 14.1 10.3 17.3 8.5 25.6 22.8 20.2 24.2 7.6 19.4 19.9 28.5 29.9 5.6 31.6 39.2 28.9 27.8 27.7 18.0 40.5 26.3 46.9 20.4 21.9 95.6 17.3 52.4 44.5 17.9 103.4 19.9 41.4 38.2 41.0 25.2 20.9 13.6 18.6 32.0 44.9 26.3 17.0 44.1 25.5 23.3 4.6 61.7 26.4 41.0 26.6 18.4 42.3 33.8 30.5 38.2 24.7 16.4 43.3 25.4 19.4 34.5 14.2 19.8 26.8 27.7 32.8 56.1 20.4 30.2 43.7 8.4 3.4 3.9 3.8 2.3 5.3 4.7 2.8 3.4 3.6 2.2 4.1 3.0 0.4 6.8 2.7 1.8 3.1 4.6 9.3 9.1 11.7 13.6 9.2 13.1 9.2 10.2 8.8 10.0 9.4 10.1 10.3 31.6 9.6 13.7 13.1 28.1 17.8 10.3 8.6 28.5 14.4 16.5 12.8 22.3 8.6 10.2 16.5 20.9 11.7 21.4 14.3 5.9 10.1 18.1 9.6 22.3 20.2 7.2 22.5 13.7 8.0 10.9 19.9 20.9 15.0 10.1 22.4 15.4 18.2 15.1 11.8 16.4 17.0 12.2 14.1 15.0 7.7 14.6 21.2 16.0 14.0 15.9 19.0 18.6 13.6 12.7 11.0 13.7 18.0 23.2 12.2 12.8 15.1 5.9 18.9 0.0 14.9 19.1 15.5 21.3 27.9 21.9 6.7 27.6 19.4 14.9 11.0 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.2;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "A-431: 450.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA 11000000 "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: AB_2683379" "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (2.19e-6)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 87.2 143.6 28.5 15.7 30.1 4.9 83.7 30.2 32.5 111.3 28.3 85.1 28.7 118.8 18.9 132.7 85.7 35.4 89.6 28.4 31.1 109.9 67.5 75.5 9.1 33.7 31.7 27.6 113.8 80.2 18.3 94.8 24.1 31.4 102.4 24.1 8.5 93.7 27.3 66.3 104.1 71.5 32.0 31.0 53.7 92.9 62.5 30.2 8.8 90.2 14.6 12.8 88.9 102.0 33.5 450.2 97.2 32.0 37.2 53.2 81.9 52.5 93.8 92.5 80.7 63.4 129.5 110.3 17.5 90.6 121.1 86.3 97.3 38.6 98.7 58.7 35.5 39.1 1.7 73.6 61.1 113.9 0.4 22.6 116.6 68.0 89.4 50.2 84.4 68.8 0.5 51.3 3.3 80.9 122.9 0.9 6.4 35.0 163.4 58.6 0.2 39.3 14.3 90.5 143.7 26.3 44.9 68.3 93.2 158.0 57.2 75.8 1.9 86.8 70.8 45.3 111.2 63.6 7.4 5.2 1.0 141.1 0.4 98.9 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.1 0.4 0.0 6.8 28.5 30.1 30.2 32.5 28.4 31.1 33.7 31.7 27.6 31.4 31.0 30.2 33.5 95.3 44.8 51.8 61.7 4.0 151.9 102.8 85.8 46.1 39.4 81.0 57.9 64.1 80.1 95.4 134.3 18.8 83.8 1.6 224.4 64.6 146.5 12.4 86.4 84.8 89.9 74.4 18.9 93.4 221.5 95.6 89.1 76.0 116.1 6.3 117.7 78.9 44.1 10.4 38.7 65.4 123.8 57.0 8.9 34.1 26.1 103.2 38.6 122.7 28.1 5.9 42.5 0.0 40.2 145.8 260.6 177.8 98.9 3.1 153.5 108.4 164.3 89.4 32.5 59.2 61.0 87.5 32.0 47.0 76.7 174.9 106.3 5.4 91.4 111.9 258.1 WNT11 ENSG00000085741 "Wnt family member 11" O96014 11 76186325-76210736 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.2" "Group enriched" "Detected in some" 5 "Adipocytes: 41.5;Fibroblasts: 23.2;Theca cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 36.2;CACO-2: 12.1;CAPAN-2: 17.8;EFO-21: 57.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA050101 Uncertain "Secreted to extracellular matrix" NA NA "HPA050101: AB_2681015" "prognostic favorable (5.97e-4)" "unprognostic (9.27e-2)" "unprognostic (2.01e-2)" "unprognostic (2.52e-1)" "unprognostic (1.87e-2)" "unprognostic (8.43e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (2.88e-2)" "unprognostic (4.36e-2)" "unprognostic (3.10e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (3.16e-3)" "unprognostic (1.09e-3)" 35.2 21.0 4.5 0.4 3.2 0.9 23.9 4.1 2.5 4.8 11.6 3.4 2.6 2.7 1.3 1.3 6.7 2.1 7.9 3.7 3.1 1.2 8.1 6.3 1.1 6.5 2.5 1.3 4.5 9.6 1.2 3.1 4.1 6.8 4.3 1.1 0.3 4.4 1.1 12.4 8.0 3.3 0.6 2.8 3.5 1.5 0.9 3.5 0.9 17.4 7.1 0.2 4.0 3.9 5.8 0.0 0.0 0.0 0.0 2.9 0.2 36.2 0.0 0.0 0.1 0.2 12.1 17.8 0.0 57.0 0.1 0.2 5.5 1.1 0.0 0.0 5.5 2.1 2.9 1.4 2.2 0.0 0.0 0.4 0.1 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 1.4 0.3 0.0 0.4 0.9 0.0 2.9 0.4 0.0 2.1 0.2 0.0 2.5 0.1 1.4 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.2 4.5 3.2 4.1 2.5 3.7 3.1 6.5 2.5 1.3 6.8 2.8 3.5 5.8 41.5 0.0 0.0 0.3 0.5 1.3 0.5 0.0 1.2 0.0 0.9 1.9 4.7 0.0 0.0 0.0 0.0 0.9 2.3 2.2 0.0 0.0 0.0 5.0 2.9 1.8 0.0 0.0 0.2 0.2 3.3 23.2 0.0 1.1 0.0 0.4 0.7 2.5 0.1 0.0 0.5 0.5 0.0 0.3 2.3 0.0 0.0 0.7 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.6 0.7 0.7 0.1 3.8 0.0 0.0 0.0 0.0 1.8 5.7 0.4 0.5 0.1 0.9 1.4 0.9 24.3 1.5 0.1 MTIF2 IF-2mt ENSG00000085760 "Mitochondrial translational initiation factor 2" P46199 2 55236595-55269347 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006021, HPA061422" Approved Enhanced Mitochondria NA NA Mitochondria "HPA006021: AB_2147687, HPA061422: AB_2684514" "unprognostic (2.91e-2)" "unprognostic (9.58e-2)" "unprognostic (1.52e-2)" "unprognostic (1.87e-3)" "unprognostic (8.86e-2)" "unprognostic (5.57e-2)" "unprognostic (9.76e-3)" "unprognostic (1.88e-1)" "unprognostic (6.85e-3)" "unprognostic (3.01e-2)" "unprognostic (6.58e-3)" "unprognostic (1.76e-1)" "unprognostic (3.98e-2)" "unprognostic (2.54e-2)" "unprognostic (1.66e-1)" "unprognostic (9.45e-3)" "unprognostic (1.33e-1)" 17.7 18.3 16.8 16.8 17.5 14.3 19.8 18.0 18.1 14.5 19.6 28.0 27.4 10.9 18.0 18.9 13.1 11.7 32.2 16.1 17.8 25.0 33.3 12.4 20.8 17.9 17.0 14.3 11.5 26.9 24.4 11.0 13.6 17.8 14.6 31.8 15.6 18.7 14.1 44.6 16.2 22.1 12.5 18.1 17.5 20.9 12.3 17.3 16.9 20.7 49.2 20.5 15.2 13.3 18.7 42.4 39.8 23.2 40.2 27.8 37.7 53.1 37.8 29.9 35.5 30.9 48.0 39.8 69.1 69.6 34.5 39.7 36.7 55.2 54.5 58.3 77.1 42.6 63.3 30.9 89.4 53.4 101.6 36.4 41.7 54.9 49.1 101.9 31.4 29.1 37.8 114.4 38.4 37.0 35.2 31.5 68.2 49.3 52.2 48.5 32.7 74.3 67.1 34.4 36.8 41.3 26.2 33.7 54.8 71.0 27.8 28.9 33.6 28.5 37.0 42.5 44.6 62.8 71.3 68.3 18.8 39.3 74.3 29.7 5.6 10.3 9.7 9.0 12.7 11.7 7.5 9.2 8.6 13.5 9.5 11.2 11.5 4.0 16.7 10.8 6.6 12.2 6.8 16.8 17.5 18.0 18.1 16.1 17.8 17.9 17.0 14.3 17.8 18.1 17.3 18.7 10.9 22.4 23.6 9.8 16.6 7.6 19.1 18.8 13.6 0.0 15.5 14.2 80.7 22.8 16.9 7.3 0.0 32.1 22.2 18.7 29.4 33.6 16.9 24.0 17.6 13.5 19.2 22.1 8.9 33.5 31.1 14.0 17.3 15.6 21.5 26.7 10.4 29.9 23.8 0.0 9.7 19.3 18.3 25.1 7.0 18.2 9.0 19.0 8.8 12.2 35.5 0.0 21.6 8.5 13.6 29.8 15.3 10.5 21.5 11.8 26.3 25.7 22.5 0.0 6.6 14.0 20.6 30.1 17.8 20.3 7.4 16.3 13.3 29.0 33.3 15.1 DDHD2 "KIAA0725, SAMWD1, SPG54" ENSG00000085788 "DDHD domain containing 2" O94830 8 38225218-38275558 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015202, HPA023143, HPA023147" Supported Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535" "unprognostic (1.49e-3)" "unprognostic (2.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (7.72e-4)" "unprognostic (4.54e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.49e-2)" "unprognostic (3.01e-3)" "unprognostic (3.21e-2)" "unprognostic (2.46e-1)" "unprognostic (7.88e-2)" "unprognostic (1.49e-1)" 29.1 18.3 29.8 14.5 33.6 15.0 19.5 36.9 40.4 22.2 23.8 17.7 19.8 21.1 23.5 21.1 19.3 17.7 28.0 31.6 31.9 21.8 12.2 17.1 19.9 34.3 32.4 27.7 29.2 22.4 21.2 18.5 15.4 38.3 22.8 16.9 32.0 18.5 29.6 32.3 16.9 22.4 18.4 33.6 17.4 15.2 22.9 33.5 19.7 18.8 36.1 22.5 17.8 17.8 41.2 57.7 26.1 58.3 28.3 21.8 30.6 18.4 18.1 33.0 42.5 38.4 30.8 22.6 22.8 24.1 32.8 26.3 22.7 33.9 34.1 64.9 19.8 22.6 83.0 36.0 29.9 19.6 9.6 12.8 16.0 26.4 26.4 26.8 27.0 51.5 31.2 59.6 24.5 27.3 12.3 66.6 14.7 13.2 9.5 15.1 34.0 50.1 16.5 22.5 34.8 21.2 32.0 44.4 21.9 22.2 18.2 26.3 26.1 46.6 24.8 31.1 24.3 28.4 25.7 25.8 54.0 39.5 18.4 35.3 2.5 3.9 4.7 10.6 4.9 11.8 9.8 9.6 11.9 6.5 15.2 10.2 7.5 0.3 16.5 3.5 3.8 15.6 7.3 29.8 33.6 36.9 40.4 31.6 31.9 34.3 32.4 27.7 38.3 33.6 33.5 41.2 15.4 22.4 7.0 20.5 17.3 13.8 10.6 8.2 14.2 27.9 12.7 7.4 23.9 8.6 8.4 20.2 18.8 12.1 16.2 7.2 23.5 11.6 4.5 9.7 13.4 13.8 15.7 25.2 51.3 11.0 11.5 13.6 12.8 12.4 21.0 22.8 12.5 5.5 7.4 53.8 51.2 9.3 6.1 8.4 11.2 10.8 20.2 7.7 19.6 21.5 13.0 19.9 16.5 35.7 46.9 16.2 6.2 20.7 24.0 10.2 23.8 10.0 5.4 5.9 6.6 17.6 13.6 30.9 35.3 8.7 10.7 6.4 17.9 13.4 8.9 7.7 TTC39A "C1orf34, DEME-6, KIAA0452" ENSG00000085831 "Tetratricopeptide repeat domain 39A" Q5SRH9 1 51287258-51345116 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 60.0" "Group enriched" "Detected in many" 9 "Early spermatids: 425.0;Late spermatids: 616.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 42 "plasmacytoid DC: 31.7" "Lineage enriched" "Detected in single" 42 "dendritic cells: 31.7" "Cell line enhanced" "Detected in many" "HDLM-2: 70.6;MCF7: 52.4;SK-BR-3: 153.7;T-47d: 111.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028098, HPA043440" Uncertain Enhanced Centrosome NA NA Centrosome "HPA028098: AB_10601705, HPA043440: AB_2678483" "unprognostic (5.05e-2)" "unprognostic (1.95e-1)" "unprognostic (3.35e-2)" "unprognostic (7.60e-2)" "unprognostic (8.53e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (8.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.89e-2)" "unprognostic (1.73e-3)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 2.2 8.2 3.9 3.3 3.3 1.7 36.3 3.3 9.8 14.2 0.0 29.8 6.2 1.0 16.0 18.6 7.6 15.0 15.5 1.2 6.9 26.7 2.8 9.2 1.4 7.7 6.3 2.5 0.3 13.6 13.6 11.1 0.3 10.4 20.7 35.6 4.7 11.6 4.2 4.2 10.6 8.1 1.6 2.4 0.4 29.7 60.0 9.8 0.5 10.2 1.7 2.1 8.0 9.5 10.2 6.4 3.4 0.7 0.3 0.4 0.7 28.2 0.3 0.2 0.2 0.2 18.2 2.8 0.1 9.6 0.4 0.4 0.2 3.8 0.2 0.1 70.6 9.7 0.5 1.8 3.2 1.1 0.0 0.7 0.1 1.6 0.1 0.0 0.8 1.4 0.2 0.4 0.1 0.2 52.4 0.6 0.2 4.8 33.8 0.6 0.1 0.2 4.3 28.6 9.1 22.1 1.6 0.5 153.7 1.8 2.0 111.7 0.8 0.8 0.4 2.5 0.5 0.5 5.4 7.1 0.2 2.1 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 31.7 0.0 0.3 3.9 3.3 3.3 9.8 1.2 6.9 7.7 6.3 2.5 10.4 2.4 9.8 10.2 0.4 3.2 25.2 1.3 1.1 1.5 5.3 1.7 0.0 2.5 30.8 15.1 13.0 5.7 6.4 9.2 0.0 0.5 15.3 29.3 11.7 38.9 425.0 5.4 3.0 1.9 41.4 9.7 9.7 52.7 4.8 0.9 21.9 9.5 3.8 0.5 0.4 0.6 2.0 0.0 10.2 56.0 6.1 0.3 1.3 616.8 2.5 0.9 0.0 1.0 2.6 1.7 0.0 0.0 0.9 30.5 13.7 2.6 0.4 12.0 2.7 24.4 9.3 7.3 6.6 1.8 1.3 22.8 6.5 4.8 6.5 3.4 1.7 0.5 20.7 14.6 EPS15 "AF-1P, MLLT5" ENSG00000085832 "Epidermal growth factor receptor pathway substrate 15" P42566 1 51354263-51519266 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Host-virus interaction, Protein transport, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 314.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008451, CAB010164, HPA061431" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" NA NA 65000 "Vesicles, Cytosol" "CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662" "unprognostic (1.45e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (1.05e-2)" "unprognostic (7.72e-3)" "unprognostic (3.99e-1)" "unprognostic (1.42e-1)" "unprognostic (4.96e-3)" "unprognostic (9.26e-2)" "unprognostic (4.13e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.41e-1)" "unprognostic (5.36e-2)" "unprognostic (8.73e-3)" "unprognostic (2.13e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" 32.2 35.4 46.1 25.7 51.3 20.9 25.9 44.1 53.3 24.1 33.5 19.3 16.0 23.0 17.8 21.1 18.5 26.3 26.7 49.7 43.4 24.7 26.7 27.2 46.4 45.2 49.9 37.8 29.1 14.8 29.2 15.7 31.8 46.0 26.9 20.7 23.6 16.8 21.1 48.1 24.4 17.9 24.5 47.7 34.4 21.5 47.3 48.5 27.9 25.5 40.9 46.0 23.0 21.1 63.0 35.4 10.4 22.0 20.8 49.6 49.2 54.5 24.2 37.9 19.4 28.4 14.4 19.2 71.8 24.3 38.1 39.5 32.7 28.7 23.1 29.1 81.8 18.0 64.1 16.9 17.1 46.7 36.9 56.4 40.3 21.0 34.0 45.7 33.5 36.5 25.2 40.4 31.7 29.8 17.5 29.9 19.8 30.2 24.6 16.7 24.1 33.3 15.9 25.5 43.2 15.0 20.9 28.8 50.4 42.1 60.2 20.5 25.7 51.1 18.0 19.1 36.3 20.5 37.6 41.0 47.6 26.6 41.0 16.1 18.8 10.4 12.1 9.4 10.7 14.2 15.6 11.2 14.9 10.8 9.0 6.6 9.6 7.8 10.8 13.0 7.1 19.0 8.7 46.1 51.3 44.1 53.3 49.7 43.4 45.2 49.9 37.8 46.0 47.7 48.5 63.0 51.5 35.3 41.0 142.4 78.3 43.0 32.1 16.4 30.1 18.1 28.2 15.6 59.8 24.3 22.7 44.1 31.3 22.8 65.0 28.5 19.6 15.2 27.0 22.1 50.1 43.3 28.8 81.0 77.1 19.0 18.9 52.5 41.3 35.6 24.6 36.0 61.4 37.7 83.4 28.6 60.6 30.7 12.2 80.9 61.9 61.7 65.9 67.0 103.2 110.5 57.6 38.4 27.8 29.7 314.1 23.3 19.8 48.2 78.4 62.1 20.7 28.1 31.9 26.6 39.5 45.1 38.0 74.4 44.5 33.8 51.0 28.5 74.3 28.5 21.4 50.8 ORC1 "HSORC1, ORC1L, PARC1" ENSG00000085840 "Origin recognition complex subunit 1" Q13415 1 52372829-52404423 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 29.3;lymphoid tissue: 11.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.5;Early spermatids: 5.6;Erythroid cells: 14.1;Extravillous trophoblasts: 9.9;Plasma cells: 6.3;Spermatogonia: 6.5" "Cancer enhanced" "Detected in many" "testis cancer: 15.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "NK-cell: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027439, HPA027450" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA027439: , HPA027450: AB_10602041" "unprognostic (3.28e-1)" "unprognostic (4.42e-3)" "prognostic favorable (1.74e-5)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (3.77e-3)" "prognostic unfavorable (3.69e-4)" "unprognostic (3.86e-2)" "unprognostic (2.70e-3)" "unprognostic (8.39e-2)" "unprognostic (1.25e-10)" "unprognostic (4.56e-3)" "unprognostic (1.05e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" 0.4 0.7 0.1 3.6 0.1 29.3 1.1 0.5 0.2 0.5 0.0 3.4 1.7 0.6 0.1 2.8 0.3 0.4 0.2 0.1 0.1 0.5 0.6 0.6 6.7 0.2 0.1 0.1 0.5 0.3 0.3 0.3 1.9 0.2 0.4 4.1 1.0 0.6 0.1 0.5 2.0 2.4 0.9 0.0 2.0 1.0 5.2 0.2 11.7 0.3 0.1 7.7 0.9 1.0 0.2 19.3 20.8 33.0 21.7 0.8 2.7 31.8 13.5 12.2 38.9 40.0 25.8 10.7 44.2 11.6 8.5 17.8 25.9 48.9 16.9 33.8 19.0 28.1 53.2 30.2 25.8 0.2 71.9 29.2 1.4 0.8 38.1 4.3 2.7 11.7 27.6 63.0 20.9 12.8 14.4 56.9 34.0 73.1 11.7 29.5 60.2 51.3 43.1 6.8 25.0 18.5 15.6 31.0 18.8 10.3 30.5 10.2 28.7 5.4 15.8 22.5 24.9 34.0 10.9 31.1 54.4 15.6 52.6 19.5 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.4 0.4 0.6 0.8 0.1 0.3 0.4 3.4 0.2 0.0 1.2 0.3 0.1 0.1 0.5 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.2 0.2 0.6 0.0 0.0 0.3 1.7 0.9 0.3 0.4 1.2 0.7 0.7 1.1 0.5 0.0 0.1 0.0 0.0 5.5 0.7 1.2 0.0 0.3 5.6 0.5 0.6 0.5 0.0 14.1 0.7 0.2 9.9 0.7 0.5 0.6 0.0 2.8 0.0 0.2 2.9 0.0 0.7 1.3 0.0 0.3 0.4 3.8 0.6 0.6 0.0 1.0 0.3 0.2 0.0 0.5 0.5 0.2 0.8 0.4 6.3 0.2 0.2 3.9 0.1 0.9 0.0 0.6 0.7 4.1 6.5 2.5 1.1 1.8 1.1 0.9 3.7 0.4 MGST2 MGST-II ENSG00000085871 "Microsomal glutathione S-transferase 2" Q99735 4 139665768-139740745 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid metabolism" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 396.4" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 441.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 194.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 276.3;OE19: 558.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010690, HPA010707" Enhanced Uncertain "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA010690: , HPA010707: AB_1853922" "unprognostic (9.35e-2)" "unprognostic (6.13e-2)" "unprognostic (4.33e-2)" "prognostic favorable (5.26e-5)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (4.38e-2)" "unprognostic (2.77e-2)" "unprognostic (8.78e-2)" "unprognostic (6.41e-2)" "prognostic favorable (3.22e-9)" "unprognostic (4.10e-1)" "unprognostic (9.91e-2)" "unprognostic (1.77e-2)" "unprognostic (1.01e-2)" 57.8 93.4 38.8 30.7 39.1 43.0 67.3 40.9 61.1 64.1 49.9 113.6 133.7 39.6 82.8 179.0 71.4 88.4 119.4 38.5 43.4 100.1 396.4 49.4 36.3 42.6 41.3 36.2 26.6 66.8 102.8 45.0 76.3 42.3 75.6 122.3 7.8 91.4 50.4 105.2 97.9 144.7 57.9 42.5 61.0 73.1 51.1 43.2 35.5 46.2 119.5 65.1 87.5 79.1 43.8 40.8 58.5 28.7 0.3 4.8 15.4 17.7 7.2 66.1 3.2 10.7 62.3 276.3 0.1 158.2 17.5 13.6 74.8 52.7 81.2 4.9 22.3 47.7 174.9 57.3 251.5 13.3 152.7 130.0 53.0 197.2 2.1 12.5 63.9 166.3 0.3 75.9 25.7 23.3 33.9 0.2 24.7 6.5 558.9 59.4 12.7 33.4 54.0 153.0 87.4 71.9 21.6 53.2 83.2 64.8 2.0 52.9 202.2 104.9 5.6 27.3 7.8 6.4 29.7 22.5 9.7 3.8 254.8 12.6 43.8 103.8 30.4 4.1 64.8 2.9 1.3 7.6 3.5 147.0 2.4 2.3 2.6 17.7 26.4 22.2 194.6 37.7 39.4 38.8 39.1 40.9 61.1 38.5 43.4 42.6 41.3 36.2 42.3 42.5 43.2 43.8 327.9 25.6 36.6 5.5 7.7 61.1 295.9 316.7 75.7 7.8 99.1 57.3 100.5 205.9 185.5 95.6 25.0 85.3 71.0 168.3 90.1 121.0 6.3 132.5 27.1 238.4 121.8 60.2 19.4 138.6 62.8 31.8 90.2 172.9 43.2 56.9 203.1 419.3 378.1 6.7 24.2 215.1 170.9 107.8 77.8 12.8 44.4 85.3 39.2 49.6 83.6 14.1 27.8 11.6 4.7 121.8 213.1 33.4 7.1 94.6 441.1 277.2 126.6 3.5 13.1 44.6 49.6 4.6 15.1 264.0 124.9 67.2 15.2 43.6 258.2 344.9 CHERP "DAN16, ERPROT213-21" ENSG00000085872 "Calcium homeostasis endoplasmic reticulum protein" Q8IWX8 19 16517894-16542437 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (8.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-3)" "unprognostic (2.40e-1)" "unprognostic (2.05e-2)" "unprognostic (9.09e-2)" "unprognostic (3.35e-1)" "unprognostic (3.72e-3)" "unprognostic (4.05e-1)" "unprognostic (7.38e-2)" "unprognostic (6.39e-3)" "unprognostic (9.86e-2)" "unprognostic (1.74e-2)" "unprognostic (4.72e-2)" "unprognostic (6.26e-2)" "unprognostic (9.62e-2)" 15.8 17.5 10.9 12.8 10.5 16.7 17.1 10.6 18.4 18.1 5.7 18.5 13.5 20.1 4.6 18.5 18.9 7.3 15.4 12.1 7.8 15.1 26.0 14.0 14.9 9.3 8.2 10.4 22.6 17.7 9.7 17.5 9.3 8.7 18.9 4.7 6.8 17.8 8.3 30.9 19.3 18.4 6.4 5.9 19.8 17.1 20.6 8.2 11.1 17.9 9.0 8.2 19.5 16.7 9.8 47.3 29.8 26.8 26.4 13.4 10.0 75.0 22.7 12.1 20.3 18.0 46.3 41.0 56.6 41.8 12.9 14.5 37.6 30.1 27.4 9.4 46.7 71.4 49.1 28.8 36.4 17.8 49.4 42.3 16.6 20.0 20.4 17.6 10.7 16.1 33.5 72.8 32.3 12.5 61.7 64.9 56.4 84.9 36.5 50.8 69.6 28.4 48.0 18.2 42.4 50.3 52.9 24.1 37.7 30.2 12.3 29.5 39.9 25.2 31.8 26.9 46.0 50.4 56.2 51.6 61.6 28.3 59.6 38.7 1.6 3.3 1.9 4.5 3.9 4.2 3.8 3.5 4.4 3.3 4.0 3.4 3.8 4.5 3.0 2.8 4.4 2.6 4.0 10.9 10.5 10.6 18.4 12.1 7.8 9.3 8.2 10.4 8.7 5.9 8.2 9.8 18.1 9.6 12.9 12.4 26.4 21.4 25.3 12.7 17.6 22.3 21.5 22.4 6.3 10.0 11.0 7.3 29.2 22.2 21.5 20.6 1.9 11.1 3.2 21.0 21.3 15.9 20.9 28.6 9.3 12.1 18.4 13.8 16.3 31.9 9.5 22.4 14.3 26.7 14.7 16.8 10.7 20.9 12.2 11.3 9.1 6.8 21.1 14.4 12.4 10.3 13.5 15.3 13.4 6.0 11.5 13.6 19.0 17.0 22.5 27.4 14.7 9.8 10.1 27.9 13.1 19.4 12.7 16.0 22.5 19.7 24.0 20.5 21.7 18.8 21.9 27.6 ATG16L1 "APG16L, ATG16A, ATG16L, FLJ10035, WDR30" ENSG00000085978 "Autophagy related 16 like 1" Q676U5 2 233210051-233295674 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012577, HPA063900" Supported Approved Cytosol NA NA Cytosol "HPA012577: AB_1845155, HPA063900: AB_2685146" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (3.57e-2)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" "unprognostic (4.49e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.51e-1)" "unprognostic (1.80e-1)" "unprognostic (1.85e-2)" "unprognostic (6.66e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.93e-2)" "unprognostic (1.41e-1)" "unprognostic (2.41e-1)" "unprognostic (2.08e-1)" 7.5 7.9 6.7 3.9 7.4 14.4 8.9 8.0 8.4 8.1 11.4 11.2 5.1 9.7 5.5 11.7 7.2 3.4 9.5 7.4 6.7 9.2 15.2 7.7 5.9 6.8 6.6 7.3 8.5 8.6 5.4 5.6 4.0 7.0 12.2 5.3 5.6 11.6 4.4 20.1 16.5 11.2 5.2 6.6 11.6 11.2 13.6 6.7 5.9 11.3 6.2 5.3 11.6 8.3 7.7 13.3 12.2 4.9 8.5 12.4 8.0 14.0 11.4 9.3 9.6 8.9 8.9 9.7 3.1 3.7 8.9 14.3 7.7 9.8 6.4 9.8 6.2 7.7 7.1 9.1 14.6 9.1 5.6 9.0 5.3 9.1 11.5 8.7 7.2 9.0 4.7 7.6 2.9 10.2 9.3 6.7 11.2 19.1 14.1 17.6 4.8 10.3 2.6 9.9 8.4 8.8 6.5 7.8 8.5 8.5 7.4 5.3 7.1 10.7 6.2 5.4 9.6 10.3 6.5 3.9 6.1 10.5 5.7 10.2 0.0 1.7 2.9 4.8 1.4 3.7 2.0 3.1 4.4 1.4 2.2 3.5 3.5 1.2 4.1 4.7 0.7 3.8 2.1 6.7 7.4 8.0 8.4 7.4 6.7 6.8 6.6 7.3 7.0 6.6 6.7 7.7 6.1 6.4 8.2 5.2 7.4 9.1 4.6 5.2 3.4 8.4 12.0 6.6 5.6 7.2 11.6 5.5 4.2 4.6 20.9 13.9 5.9 8.3 1.2 16.4 10.9 6.4 9.0 3.8 31.0 6.7 6.2 5.2 8.2 31.8 9.5 6.4 6.1 10.2 5.6 1.7 25.6 5.1 6.1 6.3 5.7 1.7 4.1 5.1 10.6 8.4 6.6 7.1 4.1 11.6 21.4 16.8 8.0 3.8 8.1 7.1 9.2 5.6 11.5 19.5 6.6 5.8 6.9 11.0 17.6 7.3 13.2 3.7 19.2 5.1 8.4 6.0 USP40 FLJ10785 ENSG00000085982 "Ubiquitin specific peptidase 40" Q9NVE5 2 233475520-233566782 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 79.3;Oligodendrocytes: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005821 Uncertain Approved "Vesicles,Focal adhesion sites" NA NA Vesicles "Focal adhesion sites" "HPA005821: AB_1080526" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" "unprognostic (3.70e-1)" "unprognostic (2.15e-1)" "unprognostic (5.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.45e-1)" "unprognostic (4.09e-2)" "unprognostic (1.90e-2)" "unprognostic (2.53e-2)" 11.9 12.1 10.4 7.6 15.5 3.4 14.0 12.6 10.7 10.1 15.0 9.5 10.6 10.7 24.3 10.5 11.6 11.7 8.3 9.2 12.9 14.3 13.3 12.6 7.3 18.8 13.7 6.0 16.1 14.2 16.9 8.6 12.5 17.1 13.6 9.6 14.3 13.0 10.5 9.7 19.9 10.2 8.6 12.3 10.0 13.3 14.8 13.2 10.2 16.5 7.7 7.9 9.7 7.6 25.3 17.3 19.9 17.6 12.0 25.2 23.0 15.7 16.4 12.4 14.7 16.0 14.3 20.2 0.4 4.7 26.4 38.6 30.3 13.3 29.7 20.6 0.0 9.0 13.3 17.4 24.3 22.3 5.8 8.9 22.2 21.1 22.2 30.9 26.2 17.3 8.1 22.0 3.2 21.4 14.0 6.2 8.5 7.9 17.8 16.0 0.0 36.3 8.1 17.9 27.6 9.6 10.3 13.5 13.5 16.9 12.9 15.4 12.9 17.3 20.9 13.1 8.9 20.6 6.0 4.9 0.8 27.1 10.2 18.6 0.0 1.0 0.0 0.5 1.1 0.2 0.4 0.5 0.4 1.5 0.7 0.7 0.7 0.1 0.5 0.9 1.9 0.8 0.5 10.4 15.5 12.6 10.7 9.2 12.9 18.8 13.7 6.0 17.1 12.3 13.2 25.3 11.8 32.1 35.5 79.3 7.9 7.4 9.1 13.6 15.4 18.1 17.0 14.7 10.7 10.0 19.9 16.5 25.0 21.2 6.7 9.9 7.9 9.4 8.4 19.8 18.3 11.1 15.0 5.7 25.9 12.6 10.6 11.9 21.4 21.3 9.5 23.4 12.8 25.4 8.2 23.5 38.2 10.9 4.1 11.6 3.6 10.7 6.8 9.1 3.6 40.3 5.9 11.9 4.1 48.2 127.7 10.5 12.6 8.2 10.9 12.9 13.9 14.6 21.0 19.4 13.1 17.5 10.6 30.2 20.9 17.2 10.5 15.7 5.5 21.1 12.1 10.0 POMGNT1 "FLJ20277, LGMD2O, MEB, MGAT1.2" ENSG00000085998 "Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)" Q8WZA1 1 46188682-46220305 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044518 Approved NA NA 17000000 "HPA044518: AB_10795985" "unprognostic (4.59e-3)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (3.20e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.82e-1)" "unprognostic (5.74e-2)" "unprognostic (5.37e-2)" "prognostic favorable (4.27e-4)" "unprognostic (5.86e-2)" "unprognostic (4.39e-2)" "unprognostic (4.99e-3)" "unprognostic (1.72e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" 22.7 40.8 48.3 15.0 53.2 5.5 24.0 54.3 50.9 26.0 45.4 21.7 21.7 24.3 31.4 18.8 26.4 18.0 78.8 48.1 52.1 36.6 41.0 24.2 13.7 56.4 56.0 47.3 22.1 29.7 88.2 47.7 21.0 55.8 38.2 18.0 22.0 25.0 27.7 74.5 23.4 19.8 28.1 56.1 24.8 30.5 37.5 53.1 19.0 38.2 48.6 16.3 28.1 21.1 63.3 37.7 39.6 47.3 46.0 51.0 55.3 60.9 49.3 82.7 65.9 51.5 22.6 30.5 34.6 79.7 82.3 112.3 21.1 34.2 70.5 39.3 45.4 38.6 27.3 34.2 34.3 44.6 21.3 25.8 56.2 90.5 73.7 68.2 118.0 68.0 46.6 32.9 21.9 108.9 26.2 37.8 15.3 39.2 21.5 54.7 27.2 48.4 32.7 58.2 45.9 17.9 64.1 45.7 52.1 70.7 67.4 34.8 29.8 50.0 49.2 43.5 56.4 96.4 54.7 65.3 16.1 75.1 20.8 53.5 0.0 1.1 1.2 3.3 2.1 2.2 1.4 2.2 2.6 1.6 2.6 4.1 3.2 0.0 6.2 4.1 4.6 2.5 1.4 48.3 53.2 54.3 50.9 48.1 52.1 56.4 56.0 47.3 55.8 56.1 53.1 63.3 12.0 12.8 40.4 15.0 11.7 8.4 40.4 31.0 13.6 38.9 18.5 14.9 44.5 21.5 30.1 35.0 50.1 25.2 17.5 13.9 13.7 39.3 47.6 15.3 13.7 17.5 27.0 9.0 19.4 39.9 27.4 14.8 7.1 27.1 27.1 25.2 14.6 20.5 15.6 26.9 20.6 12.6 16.2 14.6 6.4 15.6 20.2 10.6 24.9 8.4 18.0 21.9 19.6 19.6 33.7 38.7 14.5 13.2 16.9 44.4 19.0 22.8 21.2 36.4 13.1 16.4 16.4 11.2 12.9 12.7 7.5 23.4 13.6 19.0 17.4 33.0 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46246461-46278480 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.5;testis: 15.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 0.5 0.7 2.8 4.1 3.7 8.7 1.0 4.6 4.0 0.8 2.1 3.3 2.0 0.7 0.1 5.4 0.4 0.5 0.6 3.0 2.6 1.3 0.5 1.2 5.5 3.8 3.1 2.9 0.5 0.5 0.3 0.4 3.5 3.9 1.0 4.7 0.4 0.9 0.4 1.2 2.3 2.8 1.8 3.2 2.8 1.5 15.8 3.0 15.5 1.9 0.0 8.4 0.8 1.9 3.9 22.2 16.1 46.8 29.1 3.3 2.4 43.9 25.8 11.3 42.8 43.3 33.3 14.2 42.5 19.1 11.0 38.5 22.2 44.6 14.5 36.8 23.7 43.0 53.0 49.7 32.1 0.1 54.0 29.3 1.6 1.2 42.1 12.5 6.9 13.5 49.7 38.2 41.7 23.1 20.4 68.9 60.0 42.5 19.4 25.2 52.8 26.8 19.0 9.4 17.5 22.4 16.3 18.4 25.2 5.7 38.0 9.1 37.7 5.7 43.9 26.1 23.6 43.7 17.6 10.6 46.9 11.5 35.1 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.2 2.8 3.7 4.6 4.0 3.0 2.6 3.8 3.1 2.9 3.9 3.2 3.0 3.9 0.0 0.0 0.0 1.0 0.7 0.3 0.7 0.5 1.8 0.0 0.5 0.5 0.8 0.0 0.1 0.0 0.0 4.3 0.4 1.8 0.0 0.3 2.7 2.3 0.8 0.5 0.0 7.2 2.8 0.0 9.4 1.1 0.5 8.0 4.5 5.6 0.4 0.0 2.6 0.0 1.1 1.3 0.0 0.3 0.3 0.7 0.0 0.4 0.0 0.0 0.0 0.0 1.0 1.0 2.9 0.3 0.1 0.0 4.7 0.4 0.4 0.0 0.1 0.0 0.0 0.4 4.0 12.4 5.6 3.1 0.3 1.6 1.1 0.2 2.9 1.0 MAST2 "KIAA0807, MAST205" ENSG00000086015 "Microtubule associated serine/threonine kinase 2" Q6P0Q8 1 45786987-46036122 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 66.9;Inhibitory neurons: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039722, HPA040155" Approved Approved Cytosol NA NA Cytosol "HPA039722: AB_10795294, HPA040155: AB_10793957" "unprognostic (7.80e-2)" "unprognostic (3.02e-2)" "unprognostic (5.77e-2)" "unprognostic (1.52e-1)" "unprognostic (3.82e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (4.31e-8)" "unprognostic (8.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (6.85e-13)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (4.90e-1)" 16.3 11.9 16.2 11.1 14.8 8.1 18.8 14.3 17.4 54.0 7.2 37.7 22.1 43.9 12.9 14.8 31.5 19.1 59.0 14.3 16.2 12.2 19.1 18.0 9.0 19.0 25.7 14.5 52.4 9.3 14.0 27.3 8.7 22.1 40.4 25.5 24.2 18.5 15.6 172.0 14.6 30.9 26.6 14.3 7.2 24.2 56.8 17.3 5.9 13.3 73.8 11.2 47.2 29.0 18.7 31.7 25.1 24.7 19.2 30.7 41.4 27.6 32.2 22.8 29.4 32.6 29.4 10.1 48.8 15.2 38.6 59.9 15.7 30.1 18.8 30.4 23.7 16.4 22.2 29.2 27.4 28.4 12.0 27.3 34.1 23.7 49.8 37.0 35.2 27.5 12.5 17.3 14.6 34.2 21.9 17.7 12.5 20.4 21.2 28.2 25.6 40.7 9.4 16.1 16.8 34.0 20.6 38.0 50.4 16.3 26.9 22.8 11.9 27.9 55.7 36.8 30.1 33.0 19.5 18.9 17.5 38.0 16.0 24.2 0.0 0.3 0.4 0.3 0.2 0.4 0.0 0.2 0.4 0.6 0.1 0.1 0.2 0.0 0.5 1.5 0.0 0.0 0.2 16.2 14.8 14.3 17.4 14.3 16.2 19.0 25.7 14.5 22.1 14.3 17.3 18.7 5.5 0.0 2.0 32.0 2.3 4.2 4.1 3.0 8.0 15.8 8.2 6.7 46.5 4.3 5.5 3.7 54.2 6.1 2.4 66.9 1.9 4.6 38.0 4.4 17.0 7.3 12.1 6.5 45.4 6.3 4.8 12.0 12.8 7.8 0.0 13.0 3.6 6.6 6.2 5.0 86.6 24.6 0.0 2.8 7.8 57.7 9.0 5.3 7.2 30.9 2.5 3.7 7.2 52.3 52.5 8.3 33.9 10.1 5.5 10.7 50.2 5.7 3.1 12.8 6.6 11.7 9.0 28.0 13.2 6.3 2.7 5.5 3.5 12.4 22.4 7.4 DNAJA1 "dj-2, hdj-2, HSJ2, HSPF4, NEDD7" ENSG00000086061 "DnaJ heat shock protein family (Hsp40) member A1" P31689 9 33025273-33039907 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001306, CAB033665" Approved Supported Microtubules,Cytosol NA Yes 160000 Cytosol Microtubules "CAB033665: AB_2094242, HPA001306: AB_1079043" "unprognostic (3.11e-2)" "unprognostic (5.05e-2)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (3.17e-2)" "unprognostic (2.88e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.39e-4)" "unprognostic (1.69e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.40e-4)" "unprognostic (3.27e-1)" "unprognostic (2.65e-1)" "unprognostic (1.25e-1)" "unprognostic (4.70e-2)" 79.5 136.0 172.6 84.7 167.8 150.0 66.5 160.1 333.6 84.4 161.0 60.4 44.9 81.8 81.1 52.1 103.6 84.3 71.1 187.8 171.0 107.9 218.7 95.3 81.3 174.4 166.4 154.3 84.2 60.2 106.1 81.3 109.2 181.4 86.6 64.1 78.9 61.5 65.3 47.6 39.4 50.5 87.9 172.3 72.7 68.2 136.2 183.4 96.6 66.6 62.1 89.8 131.9 57.8 221.0 255.6 447.5 353.7 123.6 240.2 155.1 202.4 256.5 205.9 451.2 348.2 299.2 115.0 259.5 191.6 175.4 254.9 113.1 515.7 154.7 386.1 368.2 150.2 208.3 537.3 382.7 115.1 242.5 234.2 96.1 156.1 170.4 53.9 218.4 273.6 110.9 330.5 109.7 262.0 208.6 407.7 530.3 345.3 254.2 308.2 294.7 126.6 132.9 254.1 148.8 223.8 243.5 345.4 220.6 120.0 262.5 103.5 231.5 236.1 160.0 273.1 184.6 346.2 69.9 233.3 271.7 209.9 208.3 140.9 154.1 140.8 160.9 93.3 202.0 111.1 127.5 116.8 105.7 127.8 119.7 119.6 113.4 176.2 117.8 268.3 213.4 110.4 209.9 172.6 167.8 160.1 333.6 187.8 171.0 174.4 166.4 154.3 181.4 172.3 183.4 221.0 1110.8 214.7 154.9 7.8 368.7 264.6 942.8 245.3 327.8 209.3 307.8 513.5 187.7 95.8 257.7 82.8 208.5 274.0 619.1 287.9 172.1 247.7 536.4 549.2 348.2 427.8 391.1 198.9 16.2 181.1 341.6 392.8 188.6 526.1 424.7 127.6 133.2 129.6 231.1 121.1 16.7 327.3 213.6 156.0 497.4 222.2 99.1 402.3 284.6 22.5 243.7 150.5 91.6 8.0 22.5 189.8 334.7 94.8 195.8 393.8 134.7 178.1 417.8 161.7 105.2 391.1 476.0 492.7 209.4 238.5 265.4 464.9 678.9 179.2 273.3 636.8 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 215.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 346.6;SiHa: 635.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 97000000 "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favorable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 50.2 39.5 6.0 44.3 5.7 80.9 92.1 7.1 6.5 65.4 17.2 38.3 22.1 36.0 36.0 50.1 49.8 48.2 49.3 5.3 16.9 42.5 90.1 50.6 33.6 8.5 6.2 4.1 78.1 44.3 77.7 21.3 53.3 7.3 39.1 34.6 26.5 70.9 34.4 31.2 35.0 28.3 55.7 7.8 40.0 52.5 38.6 8.3 27.0 61.3 16.8 41.5 80.2 45.3 8.3 99.1 71.8 13.1 18.1 64.9 113.7 235.9 100.6 125.7 59.5 58.8 44.0 112.1 37.8 62.4 147.3 77.2 51.9 13.7 124.5 59.4 346.6 13.6 21.6 277.6 34.1 127.4 17.9 35.0 128.0 218.1 68.0 82.2 127.6 64.0 11.5 24.9 45.5 57.0 86.1 16.3 35.4 8.1 54.1 21.8 21.0 12.2 25.1 177.0 84.6 9.8 12.7 635.5 122.2 25.8 40.4 154.8 32.3 59.9 42.2 49.4 137.2 39.8 7.6 17.9 23.3 131.0 24.2 15.8 30.6 33.2 20.3 45.2 30.5 59.2 87.1 30.4 40.7 23.3 69.9 17.9 23.3 96.5 72.4 24.8 215.3 22.0 24.0 6.0 5.7 7.1 6.5 5.3 16.9 8.5 6.2 4.1 7.3 7.8 8.3 8.3 104.4 86.6 71.9 3.3 112.0 141.9 53.0 59.2 75.7 3.8 215.8 66.7 37.2 88.6 59.5 167.3 20.9 94.9 206.2 146.1 15.6 78.2 21.9 108.6 39.7 60.6 8.4 12.8 4.1 125.9 155.8 99.9 80.0 163.7 36.8 19.6 91.1 195.4 53.9 0.0 4.5 64.0 24.4 82.3 333.3 11.1 50.7 129.0 96.0 33.7 31.3 7.7 39.1 3.0 1.0 157.8 57.4 44.4 116.4 89.0 23.9 57.7 33.8 40.1 52.6 80.0 50.8 6.4 13.8 86.1 108.4 173.9 92.7 33.9 41.6 93.2 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282070 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No 22000 "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 54.0 55.0 52.3 37.0 53.1 30.8 50.0 53.6 64.3 49.5 54.5 56.2 55.7 41.6 48.5 65.1 44.2 42.4 50.5 52.2 54.1 78.6 56.8 54.0 41.9 54.7 53.6 50.4 43.2 32.9 64.5 50.1 64.4 54.2 55.3 56.5 54.2 44.0 39.7 48.6 45.5 59.7 34.2 54.4 43.8 55.1 36.5 53.1 45.3 56.3 44.7 38.4 50.1 57.0 60.6 92.2 66.5 67.0 43.5 99.0 89.0 61.9 90.1 99.7 138.3 152.6 50.9 56.9 49.0 96.3 84.3 95.9 39.2 70.5 72.8 111.1 102.5 49.3 41.5 129.7 55.8 85.9 53.4 78.8 95.6 131.3 93.6 86.4 114.5 73.3 68.3 44.9 63.6 110.5 41.3 56.1 164.1 61.8 70.1 80.6 34.0 59.2 32.9 115.2 48.7 32.7 83.6 91.0 53.4 87.2 77.8 54.2 82.7 74.4 69.5 73.0 60.2 80.8 42.3 87.6 57.0 100.5 36.0 45.6 98.6 50.3 106.3 25.3 56.5 27.6 31.0 33.7 33.8 46.5 26.4 30.6 29.4 129.4 47.4 67.3 71.2 43.4 51.3 52.3 53.1 53.6 64.3 52.2 54.1 54.7 53.6 50.4 54.2 54.4 53.1 60.6 182.7 89.8 59.0 14.0 52.9 188.1 156.2 372.5 71.7 63.7 85.2 75.1 64.7 94.4 228.6 110.3 27.1 172.0 77.4 241.0 285.7 141.7 245.2 228.0 90.6 133.8 80.2 90.1 19.6 86.1 186.1 104.4 56.1 167.0 58.4 66.5 97.5 70.5 154.9 26.9 19.0 137.9 246.2 100.9 103.2 35.9 93.2 95.3 117.4 15.0 166.3 156.2 38.1 14.6 26.8 151.9 247.9 104.6 45.2 182.4 226.3 355.2 328.9 68.2 85.5 97.0 130.0 99.5 68.7 70.1 236.3 259.0 68.5 71.4 78.5 246.0 NFX1 "MGC20369, NFX2, TEG-42, Tex42" ENSG00000086102 "Nuclear transcription factor, X-box binding 1" Q12986 9 33290512-33371157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056310, HPA061382, HPA073519" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614" "unprognostic (3.90e-2)" "unprognostic (6.01e-2)" "unprognostic (1.19e-2)" "unprognostic (1.40e-1)" "unprognostic (3.07e-2)" "unprognostic (2.02e-2)" "unprognostic (9.11e-2)" "unprognostic (1.81e-2)" "unprognostic (8.71e-2)" "prognostic favorable (3.75e-4)" "unprognostic (3.40e-2)" "unprognostic (1.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.36e-2)" "unprognostic (1.14e-2)" "unprognostic (9.62e-2)" "unprognostic (3.20e-2)" 15.6 17.0 14.4 15.7 15.8 22.1 20.8 21.2 17.7 15.5 15.6 17.2 17.0 17.5 15.8 18.4 15.5 12.5 23.6 14.7 14.8 14.8 27.9 16.2 22.5 14.0 13.9 14.5 22.1 16.0 23.6 13.6 13.6 15.5 16.7 19.3 19.6 18.1 16.2 38.0 25.5 17.6 15.8 11.9 18.4 15.9 12.3 14.5 26.5 23.1 26.7 25.4 16.9 15.8 18.9 29.8 24.0 21.4 20.3 31.3 35.1 21.5 27.6 27.4 30.6 30.5 21.7 11.9 46.0 17.0 32.0 20.5 16.3 38.8 29.8 28.4 33.9 18.9 24.1 58.2 24.5 38.1 43.3 25.6 32.7 48.9 26.1 65.4 27.3 18.9 25.6 37.6 38.3 32.2 20.9 28.3 40.7 34.7 21.9 26.8 30.0 23.3 25.2 20.7 28.1 29.3 20.6 27.5 29.3 15.9 25.1 17.0 42.7 23.8 24.8 20.6 18.1 30.4 20.4 19.9 44.6 27.3 21.5 14.4 35.9 5.5 10.4 9.8 8.9 10.5 13.0 10.7 10.8 9.0 10.3 11.8 11.9 3.5 9.3 7.4 15.4 7.6 6.7 14.4 15.8 21.2 17.7 14.7 14.8 14.0 13.9 14.5 15.5 11.9 14.5 18.9 16.0 60.9 42.5 35.3 41.9 8.4 24.6 12.5 21.6 29.3 13.2 13.5 36.9 22.8 35.4 27.6 54.2 12.5 17.2 20.6 7.9 16.1 65.9 16.7 19.0 14.9 9.1 25.2 59.7 13.2 11.8 18.5 26.5 19.8 18.9 15.7 17.5 32.4 15.0 21.9 59.0 23.9 12.2 19.4 10.2 17.0 18.3 19.0 3.6 47.8 16.4 13.7 16.5 37.7 55.0 12.4 21.6 23.0 47.1 25.3 23.3 8.2 43.7 32.2 13.1 27.3 17.5 16.1 14.8 20.9 11.2 18.1 20.9 19.2 16.7 21.0 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 52.3" "Cell type enhanced" "Detected in some" "Astrocytes: 4.2;Cardiomyocytes: 8.3;Collecting duct cells: 5.5;Ionocytes: 2.0" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.4" "Region enriched" "Detected in some" 7 "cerebellum: 21.0" "Not detected" "Not detected" HPA015278 Enhanced NA NA "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 2.7 0.1 3.9 0.0 0.1 5.5 2.6 0.2 1.7 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.1 2.6 2.5 52.3 0.3 0.1 0.0 4.6 4.8 1.8 0.0 0.1 0.2 0.2 0.0 4.9 0.2 0.0 0.2 1.0 0.2 0.0 0.3 0.2 0.1 3.2 0.1 0.4 2.4 5.5 0.0 0.0 0.0 0.0 0.1 0.1 3.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 1.4 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.9 5.5 2.6 2.6 2.5 4.6 4.8 1.8 4.9 3.2 5.5 3.3 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.6 0.0 0.1 0.4 0.3 8.3 0.0 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 1.6 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.6 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIMT1 rRNA methyltransferase and ribosome maturation factor" Q9UNQ2 5 62347284-62403943 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.4 13.7 8.2 13.4 8.2 9.1 19.9 8.4 9.4 17.4 8.1 10.2 8.5 14.7 14.0 17.7 14.6 14.3 17.8 8.3 8.5 10.7 15.5 9.9 16.0 8.4 8.3 8.1 15.6 19.5 13.4 10.4 17.4 8.4 16.0 12.1 3.0 15.3 16.3 9.8 8.4 8.9 21.2 8.3 13.5 8.5 8.3 8.3 15.1 13.5 12.9 16.9 26.3 11.5 8.4 33.1 19.9 24.2 44.1 37.7 57.4 35.0 57.3 33.7 57.3 55.8 45.1 36.3 61.4 48.4 61.9 45.4 20.2 38.7 35.8 61.3 46.4 34.0 27.2 15.0 33.8 48.1 32.4 34.7 46.7 31.1 54.1 57.3 28.1 46.1 37.0 49.3 27.9 47.3 43.5 50.1 58.6 36.1 18.9 49.7 28.2 33.3 119.2 45.8 29.9 31.5 19.8 38.5 32.2 35.5 19.6 27.0 29.2 40.3 21.0 29.5 33.7 71.2 27.4 46.7 62.6 27.0 61.6 45.1 7.9 5.3 2.7 6.7 9.1 12.7 10.4 11.2 9.1 9.3 6.1 11.6 9.7 0.1 7.7 6.8 12.1 7.8 6.3 8.2 8.2 8.4 9.4 8.3 8.5 8.4 8.3 8.1 8.4 8.3 8.3 8.4 25.3 3.2 9.5 6.5 37.8 50.9 90.3 54.8 69.4 6.2 29.9 20.2 35.3 17.2 36.3 14.7 10.4 45.3 21.9 5.0 21.5 28.6 10.1 23.8 28.3 32.0 4.8 20.4 11.1 22.5 48.1 35.6 13.7 23.2 13.3 13.3 17.5 13.4 33.1 0.0 10.5 12.1 32.6 16.4 22.8 4.4 28.9 18.5 28.4 2.8 19.7 7.4 13.4 8.0 12.9 19.8 7.5 20.3 29.3 104.3 4.0 32.5 24.0 4.7 6.6 51.8 49.8 16.5 20.4 58.7 37.8 35.7 31.1 28.6 18.3 76.6 IPO11 RanBP11 ENSG00000086200 "Importin 11" Q9UI26 5 62403972-62628582 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "NK-cell: 22.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065346, HPA067097" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065346: , HPA067097: AB_2685776" "unprognostic (9.29e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.35e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (4.28e-5)" "unprognostic (4.26e-2)" "unprognostic (6.45e-2)" "unprognostic (1.26e-3)" "unprognostic (9.63e-2)" "unprognostic (5.09e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.24e-2)" 15.6 9.2 13.6 9.7 13.9 6.6 14.6 13.8 14.7 10.7 16.4 8.8 7.0 9.5 8.5 12.2 10.3 10.8 13.6 14.5 13.4 12.0 11.5 7.8 10.5 13.6 14.0 13.7 9.5 8.7 13.5 6.0 16.6 13.8 9.1 8.7 6.4 8.5 8.5 12.7 8.9 7.9 11.1 13.2 13.5 8.6 21.6 14.8 10.1 14.1 14.5 10.2 13.5 10.0 15.9 27.1 25.4 22.3 34.6 17.0 23.4 30.9 28.4 20.5 29.1 31.9 27.5 20.2 45.3 22.2 28.9 35.5 21.4 47.3 32.0 45.6 17.5 24.6 21.6 24.5 24.4 12.8 23.7 11.6 16.7 17.7 34.3 35.7 13.7 113.8 22.4 41.5 14.5 27.9 26.0 26.1 32.2 28.0 15.4 14.5 31.6 33.7 41.6 17.7 26.4 24.1 13.9 24.8 19.3 21.0 21.9 24.9 17.0 51.8 17.4 19.3 19.8 26.4 11.3 20.0 31.3 21.2 33.4 21.3 16.5 2.4 2.2 3.8 3.8 4.5 3.3 3.9 3.9 4.0 4.8 5.5 4.0 2.5 22.7 7.0 2.4 2.8 3.6 13.6 13.9 13.8 14.7 14.5 13.4 13.6 14.0 13.7 13.8 13.2 14.8 15.9 39.6 9.6 3.7 35.9 11.8 8.5 4.2 3.3 13.6 4.2 6.2 4.8 13.2 5.7 4.5 7.3 2.1 7.6 7.9 2.7 3.9 4.2 42.2 8.4 7.0 40.0 3.0 21.7 68.4 5.5 6.7 7.6 6.1 5.6 13.3 9.6 65.0 6.2 5.2 5.0 55.0 4.4 2.0 6.5 6.4 25.3 5.6 7.4 3.6 20.6 2.6 3.9 10.3 28.1 48.3 3.3 1.7 4.1 10.7 5.2 2.6 3.6 25.6 4.9 6.6 9.7 8.7 14.6 16.2 10.9 8.8 5.1 8.8 4.6 5.7 4.8 FOLH1 "FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA" ENSG00000086205 "Folate hydrolase 1" Q04609 11 49145092-49208638 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 268.8;prostate: 76.7" "Cell type enriched" "Detected in some" 8 "Oligodendrocytes: 367.6" "Cancer enriched" "Detected in many" 27 "prostate cancer: 142.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001451, HPA010593" Enhanced NA NA "CAB001451: AB_563979, HPA010593: AB_1079685" "unprognostic (1.33e-1)" "unprognostic (1.19e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.24e-5)" "unprognostic (2.55e-1)" "unprognostic (8.31e-2)" "prognostic favorable (4.25e-4)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (2.67e-3)" "unprognostic (2.13e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.81e-2)" "unprognostic (7.27e-2)" "unprognostic (4.74e-3)" "unprognostic (4.04e-1)" 1.9 1.2 18.9 0.9 34.0 0.7 4.8 25.8 24.0 1.9 7.5 0.7 268.8 1.7 0.9 1.5 3.6 10.3 0.5 17.5 24.7 13.6 35.8 1.3 0.9 32.5 28.6 13.0 1.0 0.4 0.2 0.0 0.3 31.5 76.7 0.5 4.0 53.3 0.6 0.2 1.7 83.6 1.0 26.4 2.4 1.1 0.8 27.2 0.1 1.0 0.2 0.6 1.4 0.3 60.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 2.3 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.2 0.7 0.0 1.8 0.3 0.2 0.3 0.0 1.3 0.1 0.9 0.2 0.1 0.0 0.2 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.9 34.0 25.8 24.0 17.5 24.7 32.5 28.6 13.0 31.5 26.4 27.2 60.0 0.5 0.0 0.6 0.0 0.0 0.3 0.7 0.1 0.6 0.0 8.2 7.0 0.3 0.0 1.9 0.0 0.0 0.0 0.5 0.0 7.9 0.0 5.2 2.1 0.5 5.0 0.0 0.0 0.5 0.0 0.0 2.2 0.0 2.8 0.0 0.0 2.9 25.9 0.1 0.0 1.0 1.1 0.0 0.3 0.0 1.4 1.5 0.2 3.6 1.0 0.0 17.4 0.0 0.0 367.6 0.0 1.2 0.4 0.0 43.0 0.8 32.4 0.1 0.6 0.0 0.0 0.4 1.1 1.5 1.5 0.9 0.0 0.2 0.5 0.2 0.6 EIF2AK1 "HRI, KIAA1369" ENSG00000086232 "Eukaryotic translation initiation factor 2 alpha kinase 1" Q9BQI3 7 6022247-6059175 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Cytotrophoblasts: 219.1;Erythroid cells: 422.0;Syncytiotrophoblasts: 371.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016496, CAB022082, HPA061675" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022082: , HPA016496: AB_1848057, HPA061675: AB_2684583" "unprognostic (7.15e-3)" "unprognostic (2.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.91e-1)" "unprognostic (6.70e-2)" "unprognostic (9.69e-3)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.36e-1)" "unprognostic (2.54e-1)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (1.99e-1)" "unprognostic (5.45e-2)" "unprognostic (9.02e-2)" "unprognostic (1.06e-2)" 27.5 39.7 28.3 27.9 29.5 106.8 36.3 30.8 36.4 29.3 33.7 49.3 37.4 25.2 37.7 30.7 31.3 24.0 34.1 28.3 30.7 44.2 65.7 30.6 35.5 30.7 29.4 27.4 29.5 44.7 78.6 26.1 52.8 32.0 35.3 47.8 29.2 47.2 24.4 38.6 33.5 37.5 24.0 29.9 26.9 49.5 19.7 29.7 44.0 39.7 34.7 40.8 27.4 22.6 34.1 144.5 90.5 71.2 108.8 66.4 59.6 92.4 73.0 66.8 64.2 80.8 83.7 96.2 112.5 77.4 81.3 115.5 100.4 93.1 67.1 82.2 69.8 140.3 115.9 91.6 127.3 54.3 100.8 102.0 48.1 82.8 60.7 64.9 67.7 69.4 88.1 189.0 106.8 61.4 146.5 55.6 128.6 88.5 84.6 99.7 120.0 74.6 134.0 82.3 70.3 87.3 156.5 139.3 186.6 63.8 98.6 141.0 122.4 65.9 37.0 134.2 65.3 78.2 106.5 114.8 115.6 73.9 129.8 108.7 11.1 6.9 17.3 8.2 5.5 5.6 12.3 6.5 9.3 6.9 9.5 7.5 6.6 3.7 10.2 6.2 6.0 8.9 4.8 28.3 29.5 30.8 36.4 28.3 30.7 30.7 29.4 27.4 32.0 29.9 29.7 34.1 23.1 38.5 43.7 14.4 42.8 23.8 34.9 34.3 41.5 29.7 52.5 34.9 49.6 45.8 37.7 44.1 16.7 219.1 52.5 57.1 66.5 55.0 8.8 59.5 42.3 27.5 38.5 422.0 21.8 44.8 82.1 29.7 64.7 48.1 20.8 44.9 21.0 63.2 53.8 32.0 21.9 68.7 54.9 39.0 29.9 16.1 34.5 65.2 24.9 13.1 62.8 46.4 70.0 19.1 26.9 53.0 47.0 37.6 60.1 43.3 47.5 66.1 48.3 26.5 13.1 32.0 26.0 33.7 34.5 45.5 22.4 371.0 38.0 57.1 52.7 32.3 NME8 "CILD6, NM23-H8, SPTRX2, TXNDC3" ENSG00000086288 "NME/NM23 family member 8" Q8N427 7 37848597-37900397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "bone marrow: 12.4;testis: 10.5" "Cell type enhanced" "Detected in some" "dendritic cells: 22.8;Early spermatids: 46.3;Late spermatids: 23.4;NK-cells: 17.5;Oligodendrocytes: 9.8;Spermatocytes: 26.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;NB-4: 2.0;NTERA-2: 1.7;THP-1: 1.7;U-937: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016416, HPA019259, HPA029572" Enhanced Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB016416: , HPA019259: AB_1858475, HPA029572: " "unprognostic (7.44e-3)" "unprognostic (2.32e-2)" "unprognostic (9.11e-2)" "unprognostic (2.97e-2)" "unprognostic (6.05e-2)" "unprognostic (1.20e-2)" "unprognostic (6.56e-2)" "unprognostic (4.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (2.34e-2)" "unprognostic (8.13e-8)" "unprognostic (5.90e-2)" "unprognostic (3.36e-1)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" 0.1 0.1 0.5 0.6 0.8 12.4 0.1 0.6 0.7 0.1 0.6 0.3 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.4 0.7 0.0 0.1 0.4 0.5 1.0 0.7 0.3 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.8 1.0 0.2 10.5 0.9 0.3 0.0 0.0 0.3 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.1 0.9 0.3 0.2 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.3 2.1 0.1 0.0 4.6 0.0 0.4 0.5 0.8 0.6 0.7 0.4 0.7 1.0 0.7 0.3 1.0 0.8 0.9 1.1 0.1 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 22.8 0.0 0.0 0.0 46.3 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 1.9 5.1 23.4 0.0 3.3 0.0 0.0 2.6 0.0 17.5 0.0 9.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.5 0.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 EPDR1 "EPDR, MERP-1, MERP1, UCC1" ENSG00000086289 "Ependymin related 1" Q9UM22 7 37683843-37951936 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 116.5;skeletal muscle: 124.1" "Cell type enhanced" "Detected in many" "Granulosa cells: 95.5;Peritubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-937: 122.2;WM-115: 114.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026298, HPA072321" Enhanced "Secreted in other tissues" NA NA "CAB026298: AB_425991, HPA072321: " "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (4.44e-3)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic unfavorable (6.97e-4)" "unprognostic (2.53e-2)" "unprognostic (2.75e-1)" "unprognostic (3.13e-1)" "unprognostic (7.23e-2)" "unprognostic (1.85e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (4.13e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.00e-4)" 23.3 40.6 51.1 4.2 46.0 4.6 11.4 42.4 85.0 38.9 29.8 10.1 13.5 42.1 13.7 8.5 28.4 10.2 27.6 54.6 63.3 16.5 11.0 27.4 5.0 79.1 53.5 51.0 34.3 9.5 8.0 9.5 4.9 90.1 34.8 8.5 14.4 13.9 41.4 124.1 2.9 13.3 30.2 49.5 17.3 5.8 13.2 59.1 11.5 31.3 72.8 3.0 8.8 17.1 116.5 0.2 77.9 6.4 0.1 57.9 20.8 0.1 5.9 0.0 3.0 9.1 7.7 5.1 0.0 84.2 86.0 88.7 0.2 1.8 0.7 0.0 0.1 9.8 34.9 10.2 49.5 0.5 29.1 0.2 35.1 0.0 21.1 0.4 20.0 0.0 34.3 0.0 25.2 51.6 5.1 11.3 25.1 24.0 0.0 11.6 35.2 22.3 30.6 47.3 19.3 8.4 29.3 0.0 3.8 28.2 15.3 0.1 20.4 0.0 16.6 27.8 46.6 36.7 33.8 15.4 0.5 75.5 122.2 114.7 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.8 0.0 2.2 0.0 0.1 51.1 46.0 42.4 85.0 54.6 63.3 79.1 53.5 51.0 90.1 49.5 59.1 116.5 6.4 32.1 46.2 12.7 1.4 1.3 7.8 3.5 1.2 5.7 1.1 10.5 20.7 7.2 12.7 1.8 0.0 0.5 6.8 5.1 17.6 10.0 0.3 5.5 31.8 2.4 3.6 25.6 36.9 8.0 0.2 15.0 1.5 5.9 2.5 95.5 7.5 10.7 3.1 11.8 39.3 5.1 0.0 1.6 2.0 2.1 28.3 3.1 28.4 14.0 14.2 13.3 2.1 24.6 13.0 19.7 6.9 98.9 0.2 14.6 19.3 14.8 5.7 7.2 6.6 46.4 23.9 0.3 1.8 0.5 0.3 0.1 1.2 28.7 6.4 2.6 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291862-26374383 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 285.7;Hofbauer cells: 148.7;Kupffer cells: 215.5;Macrophages: 166.5;monocytes: 152.3;Muller glia cells: 310.5;Proximal tubular cells: 204.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 336.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 103.1;U-937: 87.3;WM-115: 297.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 23.9 14.7 28.2 35.0 35.1 42.5 11.1 24.3 42.3 4.5 15.2 5.6 4.2 9.1 1.1 2.9 3.0 8.8 1.8 34.6 43.6 38.1 69.7 41.5 37.2 34.0 39.5 35.0 1.1 7.9 1.3 4.8 11.0 41.1 3.5 6.5 47.5 1.7 2.1 1.0 1.4 6.2 9.6 28.8 42.4 3.9 5.2 42.0 15.9 2.9 2.7 25.1 11.0 1.6 55.9 55.8 5.0 0.2 10.1 0.1 0.0 57.8 0.0 3.9 0.1 0.0 0.5 18.4 24.0 41.4 0.0 36.2 1.7 13.5 3.6 0.0 33.3 12.4 2.5 0.4 36.3 0.1 52.2 8.9 0.6 5.4 0.0 4.2 0.1 0.8 30.7 1.5 0.3 0.0 9.7 22.2 54.3 15.3 0.9 5.1 0.1 0.1 1.3 103.1 12.0 22.5 7.1 11.7 8.5 62.7 18.1 15.2 72.6 0.3 0.1 12.2 0.2 13.7 17.9 15.5 16.4 0.5 87.3 297.4 55.9 144.7 3.7 18.6 158.5 18.2 82.3 13.2 16.4 101.2 71.7 6.9 12.0 336.7 47.7 162.5 37.0 29.6 70.0 28.2 35.1 24.3 42.3 34.6 43.6 34.0 39.5 35.0 41.1 28.8 42.0 55.9 3.3 3.2 14.7 6.8 63.4 5.4 1.2 0.7 1.8 20.3 17.6 9.5 1.8 34.3 4.4 23.9 2.1 14.9 18.6 2.5 285.7 66.0 1.3 2.1 40.7 7.6 9.5 19.1 63.1 27.1 111.8 3.4 0.0 2.3 31.1 2.9 2.2 109.8 148.7 35.3 53.4 3.3 0.0 215.5 130.3 2.1 1.2 166.5 8.8 19.7 152.3 310.5 33.0 7.1 8.5 14.1 1.5 0.0 8.0 4.4 4.5 204.9 0.8 23.2 0.0 0.7 4.7 7.1 29.5 0.8 3.0 28.7 31.6 0.9 8.7 1.3 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317428-13348298 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA 21000 Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 28.1 28.8 23.4 23.8 23.4 25.6 33.9 25.6 22.5 25.8 26.9 31.5 23.4 32.6 36.2 24.9 35.6 24.0 31.1 21.8 26.6 57.0 49.0 24.5 29.6 27.4 27.9 19.5 36.0 33.8 48.5 23.6 28.0 24.2 26.6 33.0 25.2 27.2 25.0 33.6 21.1 24.8 33.5 26.2 22.0 25.8 22.3 25.5 64.9 55.9 36.9 34.6 25.0 17.6 25.1 127.7 90.8 182.4 176.3 59.4 45.1 85.8 55.4 42.6 115.6 97.9 103.5 116.4 123.1 67.2 65.0 55.9 79.6 195.2 91.4 120.5 186.7 80.9 67.4 66.8 132.9 61.4 92.0 41.4 39.6 64.6 67.7 39.5 53.9 95.0 255.9 90.7 97.5 83.2 168.1 228.8 39.3 301.8 119.8 40.9 176.3 88.8 73.7 62.2 51.0 64.5 119.5 169.6 74.1 75.7 157.7 93.8 96.1 64.1 51.1 96.3 67.6 117.6 71.3 143.4 228.1 41.2 67.6 41.9 10.2 11.6 8.8 7.7 17.1 9.5 9.5 7.8 8.9 13.6 6.4 10.0 9.4 1.7 15.4 24.8 15.4 13.3 8.3 23.4 23.4 25.6 22.5 21.8 26.6 27.4 27.9 19.5 24.2 26.2 25.5 25.1 24.1 12.8 13.1 8.1 12.3 17.2 16.5 19.3 9.6 17.1 23.8 19.4 14.1 20.0 18.0 22.0 0.0 31.6 27.1 17.6 33.2 26.4 13.5 16.9 15.4 26.1 16.7 19.3 8.2 30.1 45.2 18.0 11.7 16.1 15.8 27.7 19.6 32.7 21.1 21.9 8.3 13.7 20.3 10.1 11.7 14.1 14.9 13.1 16.0 4.7 8.0 35.2 9.2 4.0 12.9 34.1 15.3 18.4 18.7 17.5 16.4 44.6 13.4 15.6 6.6 14.2 26.1 17.6 21.2 15.0 16.9 25.6 13.2 25.9 18.0 15.1 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 366969-371289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria NA NA Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 43.1 63.7 37.6 26.0 42.4 44.1 44.0 37.2 56.3 40.7 34.5 47.6 31.7 47.4 20.7 58.4 39.7 23.5 87.5 42.7 38.9 75.5 80.5 39.0 30.6 37.1 37.7 39.9 36.7 32.5 46.9 44.4 21.2 37.7 45.6 18.3 20.5 38.2 24.1 88.3 46.1 43.4 26.0 35.6 52.6 44.1 85.9 38.0 37.1 44.6 59.8 27.4 43.5 42.6 39.6 72.8 135.8 68.3 82.9 37.9 48.6 90.1 82.6 107.3 147.2 143.2 175.4 95.9 105.5 88.6 85.0 75.3 87.6 107.8 172.6 78.2 95.4 211.8 78.7 110.0 149.2 123.9 98.1 96.1 73.8 84.6 136.3 110.5 69.0 109.5 99.5 143.8 75.6 93.0 249.0 152.9 98.2 109.1 72.3 82.5 181.7 85.2 149.1 121.4 41.3 115.2 102.4 102.5 100.3 84.6 66.4 131.1 92.4 85.5 86.0 118.6 70.8 92.4 111.1 100.3 143.0 60.0 68.4 140.8 95.4 105.7 122.1 71.0 107.2 59.1 93.3 62.0 68.9 96.6 105.0 43.0 54.7 120.5 79.3 115.1 119.0 125.8 97.9 37.6 42.4 37.2 56.3 42.7 38.9 37.1 37.7 39.9 37.7 35.6 38.0 39.6 44.2 38.5 34.1 8.5 43.6 34.7 50.4 134.5 25.6 34.8 35.6 36.4 55.4 40.0 69.0 69.9 8.4 87.0 46.8 70.2 193.7 112.5 97.7 35.3 30.0 44.9 64.1 51.3 5.8 111.9 108.0 41.2 37.2 31.2 26.6 57.2 47.2 66.6 99.7 28.6 5.0 54.6 77.3 66.5 36.1 232.6 38.2 47.8 71.2 2.8 136.1 56.1 45.3 3.0 5.4 107.0 76.5 38.4 47.2 46.7 106.3 180.0 55.4 42.5 39.5 31.0 61.9 122.2 50.5 38.9 32.4 45.8 37.1 86.6 65.8 52.9 HBQ1 HBQ ENSG00000086506 "Hemoglobin subunit theta 1" P09105 16 180459-181179 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 25.8" "Cell type enriched" "Detected in some" 9 "Erythroid cells: 399.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "granulocytes: 1.3;T-cells: 1.3" "Group enriched" "Detected in some" 8 "HEL: 22.4;Hep G2: 15.8;K-562: 56.5" "Low region specificity" "Detected in all" HPA062473 Enhanced Approved "Lipid droplets" NA NA 160000 "Lipid droplets" "HPA062473: AB_2684774" "unprognostic (4.24e-1)" "unprognostic (3.38e-1)" "unprognostic (2.11e-2)" "unprognostic (2.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.33e-1)" "unprognostic (8.92e-2)" "unprognostic (2.02e-3)" "unprognostic (8.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (5.55e-1)" 0.2 0.1 3.0 0.0 2.5 25.8 0.1 0.7 4.7 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.5 2.4 1.8 0.5 0.4 0.9 0.0 0.8 0.8 2.4 0.1 0.0 0.0 0.7 0.8 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 3.7 0.1 1.9 2.0 0.0 0.2 0.0 0.0 0.0 0.2 2.0 0.0 1.3 0.4 4.1 0.0 0.0 0.7 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 22.4 1.0 15.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.3 56.5 0.0 0.0 0.2 2.5 0.0 2.9 0.0 0.2 0.2 0.0 0.4 0.8 0.0 0.5 2.9 0.0 0.0 0.7 0.0 0.1 0.9 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.2 0.4 0.9 0.0 0.0 0.2 0.6 1.3 0.0 0.0 0.1 0.0 4.3 3.0 2.5 0.7 4.7 2.4 1.8 0.8 0.8 2.4 1.5 0.4 2.0 2.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 399.8 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 4.1 0.3 7.6 3.6 0.0 0.6 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 6.0 36.1 0.0 0.1 0.3 0.6 1.2 0.3 0.0 ITPKC "IP3-3KC, IP3KC" ENSG00000086544 "Inositol-trisphosphate 3-kinase C" Q96DU7 19 40717112-40740860 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 97.5" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "hypothalamus: 71.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050760, HPA053003" Approved Supported "Nuclear speckles" No No "Nuclear speckles" "HPA050760: AB_2681227, HPA053003: AB_2682011" "unprognostic (4.27e-2)" "unprognostic (3.73e-2)" "unprognostic (8.31e-2)" "unprognostic (9.12e-3)" "unprognostic (1.10e-2)" "unprognostic (9.81e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (4.91e-4)" "unprognostic (1.48e-1)" "unprognostic (1.54e-3)" "unprognostic (1.84e-3)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.70e-1)" "unprognostic (2.86e-2)" "unprognostic (3.45e-2)" "unprognostic (3.32e-1)" 37.1 14.0 10.8 10.9 8.9 3.6 29.7 9.0 11.6 25.4 10.9 16.7 11.8 18.7 4.7 97.5 25.2 23.2 18.7 9.3 71.4 18.8 17.8 42.2 6.1 14.3 10.8 8.7 13.0 23.0 10.4 22.2 10.4 11.6 27.4 6.8 5.6 31.3 10.6 18.6 50.0 17.0 16.4 10.1 14.6 26.5 6.0 13.2 8.7 17.4 9.0 14.0 22.6 42.4 13.1 12.9 12.0 7.3 11.5 32.2 27.8 11.6 7.5 15.7 7.6 6.7 17.3 13.1 3.5 8.5 9.7 5.7 13.3 7.3 32.6 3.1 6.7 7.5 2.7 4.5 12.3 31.8 3.0 3.6 38.8 46.4 7.2 26.5 10.3 18.9 5.0 10.6 6.1 7.5 15.7 4.4 4.5 3.7 29.4 5.4 4.7 3.6 4.9 12.0 21.5 5.2 6.5 7.6 30.5 7.2 8.4 14.1 7.6 12.2 4.9 7.3 3.3 5.1 3.5 0.9 3.7 7.6 3.1 5.4 0.9 0.7 0.4 0.8 0.3 0.3 0.3 0.6 0.4 0.3 0.7 0.4 0.5 0.3 0.2 0.5 0.5 0.6 0.4 10.8 8.9 9.0 11.6 9.3 71.4 14.3 10.8 8.7 11.6 10.1 13.2 13.1 75.4 86.6 35.2 6.5 2.7 60.4 72.4 17.4 39.9 10.0 88.4 44.4 4.1 7.2 29.7 3.7 0.0 7.7 2.8 57.7 1.9 13.9 2.1 67.5 23.2 26.4 16.7 3.2 7.4 12.3 5.5 20.1 151.4 139.3 3.8 4.3 25.7 6.8 2.9 5.0 6.0 27.2 2.0 7.8 9.6 2.2 11.8 6.8 19.6 6.5 3.1 3.7 3.1 9.0 3.5 23.2 50.8 7.5 1.2 65.3 28.7 4.4 29.4 6.2 0.0 7.1 10.1 1.9 2.0 160.8 53.4 16.8 5.2 4.6 18.0 98.6 CEACAM6 "CD66c, NCA" ENSG00000086548 "CEA cell adhesion molecule 6" P40199 19 41750977-41772211 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 183.1;esophagus: 196.8;intestine: 222.5;lung: 289.2;salivary gland: 179.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 942.3;Club cells: 322.1;Distal enterocytes: 640.1;Paneth cells: 391.1;Urothelial cells: 182.3" "Group enriched" "Detected in many" 4 "cervical cancer: 139.4;colorectal cancer: 500.8;lung cancer: 344.1;pancreatic cancer: 437.5;stomach cancer: 231.8" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "OE19: 1799.0" "CAB008370, HPA011041" Enhanced NA NA 86000000 "CAB008370: AB_592067, HPA011041: AB_1078481" "unprognostic (1.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.62e-2)" "unprognostic (8.22e-2)" "unprognostic (1.39e-1)" "unprognostic (9.06e-3)" "unprognostic (2.32e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "unprognostic (5.22e-2)" "unprognostic (3.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.42e-4)" "unprognostic (4.08e-1)" "unprognostic (8.71e-3)" "unprognostic (2.85e-1)" "unprognostic (7.68e-2)" 2.1 0.4 0.3 30.0 1.0 183.1 2.7 0.5 0.6 19.2 0.0 196.9 33.3 0.6 1.8 196.8 8.3 131.3 0.2 0.2 0.0 0.3 0.7 289.2 0.3 0.3 0.1 0.1 0.4 5.3 0.1 0.3 0.5 0.2 2.4 222.5 0.0 179.1 1.4 0.1 6.2 24.6 6.7 0.0 2.4 15.7 0.4 0.2 2.2 0.3 0.0 32.7 9.7 79.7 0.5 0.1 162.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 5.5 4.6 0.0 0.2 0.0 0.5 19.4 0.0 0.0 0.1 0.3 0.2 0.0 0.5 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.1 11.2 0.1 0.2 0.2 1799.0 4.5 0.1 0.0 0.1 1.0 0.7 1.8 0.1 0.0 4.2 0.0 0.2 0.6 1.9 0.4 0.2 0.3 0.5 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.5 0.1 0.0 3.1 0.3 1.0 0.5 0.6 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.5 0.0 942.3 84.5 0.0 2.3 0.0 4.9 17.9 0.0 0.0 3.5 2.0 0.2 75.8 322.1 0.0 0.0 0.0 0.0 640.1 0.0 77.0 0.2 0.4 0.1 1.3 5.4 0.0 0.1 16.3 0.0 1.3 1.5 0.8 7.0 0.0 0.4 0.3 0.0 0.0 0.1 102.3 14.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.7 391.1 0.0 0.0 24.2 5.7 0.0 71.8 0.0 0.0 0.0 9.9 0.0 0.1 15.6 0.0 0.0 1.2 0.0 31.7 182.3 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 104.8;esophagus: 51.3;skin 1: 56.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 18.0;Basal respiratory cells: 31.6;Basal squamous epithelial cells: 27.9;Early spermatids: 16.0;Extravillous trophoblasts: 20.6;Squamous epithelial cells: 53.2;Suprabasal keratinocytes: 19.6" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Group enriched" "Detected in many" 6 "cerebellum: 104.8;pons: 32.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 35.1;EFO-21: 21.0;HaCaT: 51.7;HBEC3-KT: 23.6;hTCEpi: 70.5" "Region enriched" "Detected in some" 18 "cerebellum: 32.0" "Region enriched" "Detected in many" 56 "cerebellum: 224.4" CAB033680 Enhanced NA NA 300000 "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.3 0.2 0.2 0.0 3.6 0.1 3.7 104.8 3.6 6.2 0.0 0.1 0.1 0.1 1.7 51.3 1.0 0.0 0.1 0.5 1.0 0.2 0.1 0.2 0.0 11.7 6.4 0.1 0.1 0.2 0.2 0.5 0.9 32.7 5.3 0.0 0.1 9.0 4.8 0.2 56.4 0.2 0.0 0.3 0.1 0.1 13.3 1.2 2.2 0.1 0.0 3.5 2.9 24.6 6.6 1.7 0.0 0.0 0.1 0.0 0.0 35.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 21.0 0.0 0.2 51.7 0.0 23.6 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 70.5 0.0 3.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.7 0.1 0.0 0.1 1.1 0.2 0.5 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 104.8 3.6 0.5 1.0 11.7 6.4 0.1 32.7 0.3 1.2 6.6 0.1 0.0 0.0 0.7 0.0 18.0 5.8 31.6 27.9 0.0 3.4 12.8 1.9 0.0 11.1 1.8 0.0 0.4 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.3 0.0 0.0 5.0 0.0 20.6 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 2.9 0.0 0.0 0.0 1.5 7.8 0.0 0.0 7.2 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.1 3.0 0.0 0.0 0.0 0.4 0.5 0.1 53.2 19.6 1.0 0.1 0.0 0.0 13.0 RBM22 "Cwc2, FLJ10290, fSAP47, ZC3H16" ENSG00000086589 "RNA binding motif protein 22" Q9NW64 5 150690792-150701077 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001634 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA001634: AB_1079746" "unprognostic (1.94e-1)" "unprognostic (1.17e-3)" "unprognostic (6.86e-3)" "unprognostic (1.00e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-2)" "prognostic unfavorable (5.50e-6)" "unprognostic (7.08e-2)" "unprognostic (2.51e-1)" "unprognostic (4.58e-2)" "unprognostic (8.71e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (7.29e-2)" "unprognostic (2.37e-1)" "unprognostic (7.82e-2)" "unprognostic (9.87e-3)" 20.5 16.0 18.7 19.4 20.8 65.0 22.5 21.8 28.7 21.5 18.2 22.7 19.8 23.7 20.0 17.0 25.6 22.9 21.1 18.8 19.6 22.0 21.5 22.9 29.4 20.6 19.2 16.8 31.0 18.3 24.1 11.0 22.8 20.5 17.9 23.6 23.8 16.6 19.8 27.5 18.7 19.2 21.5 19.4 26.9 19.3 11.7 19.5 42.0 22.4 34.6 32.6 26.3 16.1 26.0 34.9 37.3 56.0 66.2 37.2 34.3 79.4 35.0 39.1 68.4 75.7 61.3 50.7 51.7 54.5 33.6 65.1 36.1 73.0 63.3 71.0 57.6 55.6 41.4 35.1 26.3 35.4 74.4 47.0 29.1 50.1 56.5 37.0 30.2 48.9 41.7 44.3 50.7 43.2 41.3 68.4 50.6 33.8 42.2 37.6 69.8 46.4 45.9 34.0 35.6 52.4 39.1 39.3 64.4 65.2 33.4 67.2 64.9 33.0 55.5 43.7 24.3 64.4 46.8 56.0 74.2 44.0 66.3 42.6 27.0 30.6 51.8 33.9 36.7 38.2 37.9 31.4 32.5 36.5 35.9 33.2 31.8 52.8 43.8 46.9 19.7 37.4 33.4 18.7 20.8 21.8 28.7 18.8 19.6 20.6 19.2 16.8 20.5 19.4 19.5 26.0 69.4 28.9 28.2 8.5 51.3 26.0 52.9 33.9 42.1 33.3 29.3 25.9 28.2 27.1 35.9 16.5 25.0 54.9 56.6 34.2 25.4 36.3 8.4 48.4 44.1 50.5 25.9 34.9 7.4 34.3 43.6 39.3 24.5 101.6 63.4 37.3 27.8 16.6 44.3 30.3 7.6 33.2 44.7 31.1 30.3 3.6 43.2 45.8 23.2 6.5 48.5 35.9 58.7 7.5 13.7 29.1 37.1 45.5 32.1 25.6 29.4 22.5 23.1 19.0 32.9 40.2 37.6 32.0 28.5 22.8 21.7 72.7 56.9 34.4 33.4 39.4 TMED2 "P24A, p24b1, p24beta1, RNP24" ENSG00000086598 "Transmembrane p24 trafficking protein 2" Q15363 12 123584533-123598582 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014060 Approved Supported Vesicles NA NA 82000 Vesicles "HPA014060: AB_1856389" "unprognostic (6.36e-2)" "unprognostic (3.38e-3)" "unprognostic (5.41e-3)" "unprognostic (1.75e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.57e-3)" "unprognostic (2.20e-2)" "unprognostic (4.31e-2)" "unprognostic (9.76e-3)" "unprognostic (1.03e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.35e-7)" "unprognostic (2.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (9.87e-2)" 107.0 98.0 41.8 93.4 44.0 123.2 137.4 45.2 51.2 156.9 58.6 133.8 124.8 103.5 205.1 112.9 103.2 96.9 117.6 41.8 49.4 103.7 273.3 86.1 73.3 48.3 45.5 39.3 102.4 231.1 100.1 65.5 126.4 48.2 141.7 142.1 57.4 229.6 103.1 132.2 75.4 111.5 102.9 48.9 63.7 135.0 59.0 44.5 69.8 199.3 113.1 95.9 119.7 72.0 51.8 237.7 204.9 133.4 232.2 295.7 260.2 317.5 401.2 318.5 246.8 194.2 209.9 198.9 199.3 210.7 398.7 169.4 228.1 181.8 214.5 257.3 155.2 169.3 217.3 114.0 267.6 559.5 296.9 178.1 220.5 349.2 212.6 286.0 352.7 234.7 133.5 223.1 132.9 255.6 175.1 159.8 242.7 192.9 201.0 206.6 164.8 216.8 235.7 303.9 349.1 166.5 143.1 267.3 263.6 273.7 160.0 450.2 237.2 226.2 210.1 132.4 204.9 227.5 292.3 290.7 167.6 248.3 192.9 254.2 249.7 143.2 145.9 157.0 147.5 198.8 111.8 137.0 148.4 158.6 102.5 110.3 129.4 111.1 148.5 141.3 242.5 140.1 142.2 41.8 44.0 45.2 51.2 41.8 49.4 48.3 45.5 39.3 48.2 48.9 44.5 51.8 97.1 48.1 71.5 9.1 148.8 417.4 290.3 348.5 207.1 50.1 258.8 98.0 167.2 213.1 233.2 154.5 20.9 281.5 166.9 169.6 117.4 325.1 12.2 89.2 136.5 142.0 170.7 76.3 20.0 249.6 678.6 242.7 156.5 136.8 92.6 88.4 143.5 538.8 215.8 48.8 20.3 352.4 321.4 141.7 414.3 13.9 181.4 128.5 378.8 17.8 129.8 124.1 195.7 19.6 27.5 224.9 158.5 153.4 521.0 486.3 178.1 163.0 142.1 54.7 164.3 112.6 193.5 165.9 150.6 289.8 498.8 451.9 154.3 125.0 263.9 389.2 ERO1B "ERO1-L(beta), Ero1beta, ERO1LB" ENSG00000086619 "Endoplasmic reticulum oxidoreductase 1 beta" Q86YB8 1 236215101-236281958 "Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 155.2" "Cell type enhanced" "Detected in many" "dendritic cells: 72.8;Early spermatids: 133.4;Spermatocytes: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.4" "Group enriched" "Detected in all" 5 "dendritic cells: 6.0;granulocytes: 15.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028085 Enhanced "Intracellular and membrane" NA NA "HPA028085: AB_10601214" "unprognostic (1.16e-1)" "unprognostic (1.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (2.49e-2)" "prognostic favorable (7.53e-5)" "unprognostic (1.73e-2)" "unprognostic (2.85e-2)" "unprognostic (4.65e-2)" "unprognostic (5.90e-2)" "unprognostic (8.26e-3)" "unprognostic (7.87e-2)" "unprognostic (3.37e-1)" "unprognostic (2.22e-3)" "unprognostic (8.09e-3)" 5.9 5.6 3.8 5.6 4.3 7.3 7.7 9.0 5.1 5.0 4.4 4.6 10.2 5.2 21.5 2.8 4.9 9.2 4.8 4.9 4.4 8.4 18.9 5.3 7.1 3.8 3.9 3.6 6.5 155.2 14.9 9.8 5.2 4.9 5.9 3.2 17.4 8.1 5.4 3.3 3.3 5.4 5.1 3.2 8.3 47.2 28.6 3.7 5.7 27.5 4.0 6.3 4.8 4.0 5.5 2.0 2.3 3.9 3.4 3.0 1.8 4.5 3.1 2.9 2.2 1.7 0.7 2.2 5.5 8.2 4.8 8.3 1.0 1.8 2.8 3.0 5.8 11.1 1.6 0.3 2.1 7.9 2.1 0.9 3.5 5.6 3.8 7.3 4.5 2.6 5.0 0.8 14.2 2.7 1.1 0.9 0.9 1.5 0.3 0.7 11.3 2.6 1.5 4.0 4.7 7.8 4.6 10.2 3.3 8.7 2.0 7.9 9.5 2.5 3.2 2.8 3.2 4.2 9.3 0.6 3.4 4.3 3.1 5.0 15.4 1.5 3.0 2.2 1.6 1.9 1.5 1.2 1.5 1.6 2.1 1.7 1.7 3.1 1.1 0.7 6.0 1.2 0.8 3.8 4.3 9.0 5.1 4.9 4.4 3.8 3.9 3.6 4.9 3.2 3.7 5.5 33.4 9.6 9.4 0.0 47.8 0.0 17.9 0.0 45.5 20.7 27.9 23.7 0.0 27.1 3.1 16.5 14.6 12.7 72.8 0.2 1.9 5.3 133.4 1.7 13.2 12.8 14.6 5.5 0.0 16.9 5.1 16.9 32.1 3.9 5.1 9.6 17.5 26.4 6.9 25.2 0.0 5.3 0.0 21.5 0.0 25.6 19.3 34.5 0.0 0.0 11.9 12.2 29.9 0.0 0.0 9.9 0.2 11.3 69.5 18.4 2.7 7.7 1.5 55.4 0.0 36.0 15.1 94.3 14.9 13.6 0.0 22.6 43.8 2.8 1.8 11.0 ZFAND6 "AWP1, ZA20D3, ZFAND5B" ENSG00000086666 "Zinc finger AN1-type containing 6" Q6FIF0 15 80059568-80138393 "Predicted intracellular proteins" "Apoptosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 496.7;Late spermatids: 598.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034845, HPA052746, HPA077824" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA034845: AB_10671234, HPA052746: , HPA077824: " "unprognostic (2.04e-1)" "unprognostic (2.25e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-2)" "unprognostic (4.26e-2)" "unprognostic (1.03e-1)" "unprognostic (4.91e-2)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (6.48e-3)" "unprognostic (4.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-1)" "unprognostic (1.55e-1)" "prognostic favorable (8.20e-4)" 63.7 70.7 44.3 48.8 45.8 80.6 66.1 58.1 49.2 48.2 52.2 62.1 55.3 58.7 66.8 55.4 55.4 50.3 91.3 44.6 67.6 77.0 124.6 56.2 73.8 55.6 47.7 37.4 41.1 42.4 61.1 41.5 51.0 50.9 56.8 61.6 74.9 53.3 51.0 129.6 43.3 54.4 60.3 53.6 61.4 60.2 137.1 49.1 51.4 101.8 110.8 76.1 55.7 43.5 61.1 78.9 161.0 116.9 67.3 118.0 93.4 110.3 91.7 127.2 78.7 107.0 56.6 133.6 87.5 115.7 94.3 76.6 63.1 125.9 92.3 83.8 52.8 107.2 207.1 72.7 78.5 138.2 74.7 131.9 83.3 117.8 87.3 117.7 108.3 120.0 74.4 84.5 66.8 87.3 83.3 59.5 74.0 73.6 70.3 53.4 48.1 102.6 200.8 196.3 129.4 23.9 68.8 79.2 91.0 238.4 144.5 89.1 106.7 111.5 82.1 66.5 53.2 89.8 88.9 189.1 102.6 85.0 127.1 58.6 505.1 90.0 290.1 93.6 118.9 82.5 226.4 84.7 91.2 103.1 174.4 88.2 98.4 216.3 85.0 167.1 89.5 91.2 135.7 44.3 45.8 58.1 49.2 44.6 67.6 55.6 47.7 37.4 50.9 53.6 49.1 61.1 60.5 54.5 86.8 76.0 122.5 149.5 141.3 236.1 46.7 40.3 96.2 60.1 92.7 85.8 147.8 75.4 41.7 125.3 101.1 95.9 199.6 103.7 496.7 102.0 57.0 75.0 82.6 97.2 18.1 98.3 130.8 75.0 69.8 135.3 105.1 57.0 72.8 154.6 144.2 32.0 27.7 88.6 203.4 96.1 173.5 598.2 53.1 109.8 124.5 78.7 167.2 101.3 91.6 61.9 73.9 126.5 107.6 62.8 92.7 174.1 64.8 278.8 168.3 89.9 92.1 70.0 98.6 230.6 173.3 62.8 169.3 392.8 87.0 67.6 67.3 183.4 HSD17B2 "HSD17, SDR9C2" ENSG00000086696 "Hydroxysteroid 17-beta dehydrogenase 2" P37059 16 82035004-82098534 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 432.9;liver: 219.6;placenta: 384.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7" "Group enriched" "Detected in many" 4 "liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0" "Group enriched" "Detected in some" 5 "midbrain: 2.2;pons and medulla: 3.4" "Not detected" "Not detected" "HPA021826, HPA050235" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021826: AB_10961148, HPA050235: AB_2681059" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.48e-2)" "unprognostic (2.58e-1)" "unprognostic (1.77e-1)" "unprognostic (4.29e-2)" "unprognostic (2.60e-1)" "unprognostic (7.35e-2)" "unprognostic (6.05e-3)" "unprognostic (4.98e-2)" "unprognostic (7.35e-2)" "unprognostic (6.31e-4)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.83e-4)" 0.9 0.0 0.4 4.3 0.3 0.7 26.6 0.9 0.5 4.3 0.2 75.5 432.9 1.2 0.1 9.7 0.1 21.3 0.2 0.3 0.2 5.0 219.6 2.3 0.3 0.1 0.1 0.2 0.3 23.4 0.0 1.2 384.9 0.5 2.0 57.4 17.5 22.3 0.2 0.1 3.1 190.1 2.4 0.0 0.2 20.3 0.3 0.1 0.4 0.1 0.0 3.4 79.3 1.4 0.5 0.4 0.1 0.4 0.0 0.0 0.7 0.7 0.2 57.9 0.0 0.0 10.9 1.7 0.1 11.4 0.0 0.1 0.4 0.0 2.4 0.0 0.1 0.1 0.3 0.3 47.5 0.4 0.3 0.3 0.0 3.1 0.0 27.1 0.6 0.9 0.1 0.1 0.4 8.6 0.1 0.0 0.9 0.2 87.1 21.4 0.1 0.2 1.3 1.0 96.8 0.4 1.5 0.0 2.7 0.2 0.0 0.1 0.1 54.0 0.6 0.5 0.3 0.0 0.2 0.2 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.1 0.2 0.0 0.0 0.4 0.3 0.9 0.5 0.3 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.5 1.0 3.2 3.9 0.3 0.7 0.4 2.7 16.4 2.2 0.5 45.7 12.3 0.6 155.8 21.4 0.0 0.0 2.7 0.3 203.4 0.0 73.6 0.5 5.9 5.4 21.3 3.0 2.7 0.1 6.0 1.8 38.3 15.3 41.3 0.0 0.0 2.5 121.9 3.5 0.0 0.1 26.3 6.1 3.1 0.0 0.9 0.0 0.4 1.8 0.0 0.0 45.1 0.0 0.0 0.1 20.1 284.2 0.0 0.1 2.7 390.7 1.4 5.6 0.7 0.0 0.4 2.0 0.0 0.1 0.8 1.1 6.4 0.7 0.0 47.1 14.8 TXLNG "CXorf15, FIAT, FLJ11209, LSR5, MGC126621, MGC126625, TXLNGX" ENSG00000086712 "Taxilin gamma" Q9NUQ3 X 16786432-16844519 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000297, HPA000841" Approved Approved Cytosol NA NA Cytosol "HPA000297: AB_1078590, HPA000841: AB_1078589" "unprognostic (2.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-3)" "unprognostic (4.78e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.61e-2)" "unprognostic (5.27e-3)" "unprognostic (6.96e-2)" "unprognostic (3.61e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-3)" "unprognostic (2.04e-2)" "unprognostic (2.22e-1)" "unprognostic (8.62e-2)" "unprognostic (6.00e-3)" 14.6 16.1 5.0 8.1 5.3 14.1 10.2 8.1 6.4 6.9 6.3 6.4 8.4 9.9 6.6 6.2 9.2 6.4 5.7 4.4 7.6 7.6 8.0 7.8 12.7 4.5 5.3 4.3 16.7 8.5 11.6 6.9 5.9 5.6 6.5 6.1 14.8 7.1 8.7 6.0 6.2 6.5 7.6 3.7 7.8 6.8 6.1 4.7 9.3 10.5 6.1 11.6 8.0 4.6 6.7 27.7 16.9 15.9 28.3 28.4 15.5 8.4 10.8 10.4 12.1 11.8 23.7 16.1 57.6 26.7 6.1 34.8 17.5 54.9 35.4 21.6 17.7 66.7 20.7 23.5 15.3 12.1 31.1 14.2 9.2 17.1 28.2 50.6 16.4 15.5 23.4 40.3 16.6 9.5 16.5 28.6 17.9 47.6 18.3 19.4 19.5 21.7 47.7 9.7 13.6 25.8 18.7 25.0 23.6 19.8 27.1 28.7 12.7 7.6 7.6 10.0 26.9 18.9 17.4 28.4 57.6 9.6 20.1 7.8 0.6 1.9 1.0 3.1 1.5 4.0 3.7 3.4 3.7 2.1 4.0 4.0 4.4 0.7 2.9 1.7 2.1 3.8 2.1 5.0 5.3 8.1 6.4 4.4 7.6 4.5 5.3 4.3 5.6 3.7 4.7 6.7 26.3 16.0 24.8 17.6 32.0 41.0 60.2 13.6 23.3 35.9 27.0 29.1 13.3 17.2 23.3 9.2 6.2 14.2 37.7 9.0 21.5 19.3 4.4 33.5 27.3 15.6 14.4 19.8 32.5 16.7 13.2 35.8 9.7 27.2 13.3 13.1 13.2 16.1 9.0 28.6 39.7 15.0 8.2 7.7 11.1 2.2 27.1 12.2 17.8 11.2 9.0 17.7 12.3 16.1 28.3 15.6 7.7 21.1 17.0 43.6 12.3 20.5 16.3 23.0 6.6 42.3 25.8 17.1 37.7 19.1 34.8 21.9 32.9 16.3 16.2 33.0 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 5.8;testis: 14.7" "Group enriched" "Detected in some" 9 "Early spermatids: 64.0;Late spermatids: 139.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.1;HeLa: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.2 1.5 0.0 2.3 1.0 2.4 2.1 2.6 0.1 1.2 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.2 1.8 1.7 0.2 0.1 0.3 0.1 3.5 2.0 1.8 0.2 0.1 0.0 0.5 0.6 2.7 0.4 0.0 1.4 0.1 0.3 0.1 0.4 0.1 0.0 2.3 0.2 0.1 14.7 2.0 0.1 0.2 0.0 0.1 0.2 0.1 5.8 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.3 2.1 2.6 1.8 1.7 3.5 2.0 1.8 2.7 2.3 2.0 5.8 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.0 0.0 0.0 0.1 0.0 0.0 11.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 4.7 0.0 0.0 0.0 0.3 139.0 0.6 0.0 3.6 1.0 0.1 0.6 0.0 0.5 2.2 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 1.2 1.2 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 LAT2 "HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5" ENSG00000086730 "Linker for activation of T cells family member 2" Q9GZY6 7 74199652-74229834 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.8;lymphoid tissue: 57.1" "Cell type enhanced" "Detected in many" "B-cells: 90.6;granulocytes: 171.6;Hofbauer cells: 82.7;Kupffer cells: 71.1;Langerhans cells: 81.9;Macrophages: 89.1;monocytes: 89.6;NK-cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 871.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 192.2;REH: 205.7;RPMI-8226: 73.3;THP-1: 186.5;U-937: 177.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003462 Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA003462: AB_1079238" "unprognostic (1.24e-2)" "unprognostic (1.14e-2)" "unprognostic (1.32e-2)" "unprognostic (3.55e-3)" "unprognostic (1.09e-1)" "unprognostic (3.30e-3)" "unprognostic (2.79e-2)" "unprognostic (1.33e-1)" "unprognostic (9.27e-2)" "unprognostic (1.19e-1)" "unprognostic (6.34e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" 6.9 5.5 10.4 38.1 11.4 61.8 3.9 12.1 13.1 3.8 10.6 6.6 6.4 2.9 2.5 3.6 4.2 9.1 2.3 11.0 15.4 2.7 4.8 19.4 52.1 15.9 12.6 8.0 1.7 3.0 2.3 3.0 7.4 17.0 7.2 7.8 1.2 4.6 3.5 3.4 3.0 13.7 8.8 19.0 47.4 6.6 2.0 14.8 12.3 2.8 2.4 57.1 10.2 2.5 18.7 1.7 1.1 1.1 3.1 0.3 0.0 1.1 1.4 1.2 0.6 0.7 2.3 28.9 19.6 0.4 0.5 6.1 1.2 0.4 1.1 0.6 31.4 1.2 8.6 1.8 1.8 0.1 56.1 55.6 0.4 0.8 2.1 0.6 1.2 0.3 1.1 1.6 9.3 0.5 1.7 1.3 192.2 0.9 5.5 2.0 205.7 1.1 73.3 0.2 1.7 0.9 0.8 0.6 1.2 1.2 0.9 1.1 186.5 2.1 2.1 19.9 0.8 1.8 0.9 6.2 32.2 9.4 177.6 1.5 871.6 276.6 46.0 8.8 159.0 0.9 169.3 2.3 1.4 225.2 191.1 1.0 2.9 491.0 73.9 93.9 8.9 4.9 214.7 10.4 11.4 12.1 13.1 11.0 15.4 15.9 12.6 8.0 17.0 19.0 14.8 18.7 1.3 3.2 16.2 0.7 90.6 3.4 0.7 0.0 0.6 0.3 1.0 1.9 1.1 5.7 3.1 3.7 0.0 0.6 47.8 0.2 0.0 0.3 2.4 1.3 0.6 3.9 7.8 16.6 1.7 0.2 1.1 1.7 1.1 2.1 171.6 0.4 3.9 4.5 82.7 0.0 1.4 0.8 0.0 71.1 81.9 3.4 0.0 89.1 1.8 20.6 89.6 0.2 70.0 0.5 0.9 0.6 0.1 0.7 18.7 1.2 0.1 0.2 5.9 1.3 0.0 1.9 0.9 0.4 1.4 0.1 2.6 1.2 27.7 0.3 0.8 0.4 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1" Q7Z6Z7 X 53532096-53686728 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Granulosa cells: 507.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol NA NA 73000 "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 37.5 46.5 57.8 21.2 59.8 26.9 37.7 59.1 70.5 39.6 40.2 45.2 17.8 46.0 53.0 48.8 41.1 18.7 51.4 61.1 57.8 40.0 42.1 36.5 26.8 58.1 67.7 54.3 54.4 46.3 43.6 54.6 24.2 67.2 38.7 22.9 40.4 39.2 28.9 101.8 59.7 40.6 29.0 49.3 42.8 45.9 43.4 62.3 41.6 43.2 58.6 30.6 45.0 40.6 58.1 166.8 100.4 64.0 45.4 109.2 64.8 78.5 48.8 62.6 50.2 52.3 77.0 52.2 86.6 32.3 89.4 90.4 77.8 145.6 81.8 68.3 125.6 64.6 69.1 91.9 60.5 100.2 104.5 40.6 62.4 59.8 120.8 137.6 49.7 88.3 66.4 70.3 54.5 66.3 102.4 57.0 58.2 87.7 45.4 71.3 52.0 87.9 52.8 84.0 113.3 53.1 38.4 137.7 60.5 44.1 118.7 87.0 50.1 113.8 46.0 65.8 66.5 62.9 47.3 50.2 73.1 49.2 100.1 67.6 2.8 2.3 4.3 3.3 1.9 4.0 2.4 3.1 3.5 3.3 2.4 2.2 2.2 1.9 3.5 3.8 3.5 2.9 1.9 57.8 59.8 59.1 70.5 61.1 57.8 58.1 67.7 54.3 67.2 49.3 62.3 58.1 41.4 51.3 46.1 70.2 41.9 30.1 32.6 30.4 44.9 57.8 37.0 35.6 110.4 37.1 35.4 40.5 50.1 31.0 40.0 29.2 1.9 42.8 28.6 45.6 59.8 38.3 47.6 47.7 94.4 35.4 34.8 38.6 57.1 69.6 22.1 507.7 32.9 48.1 24.8 82.4 85.8 28.1 18.3 31.4 30.8 32.8 28.3 34.1 26.6 59.0 43.7 22.6 35.0 83.9 95.3 49.3 20.5 39.1 50.9 44.1 27.1 14.7 35.7 33.3 13.1 69.6 56.4 34.5 44.6 53.3 41.6 37.9 46.7 114.1 31.7 42.0 ZW10 KNTC1AP ENSG00000086827 "Zw10 kinetochore protein" O43264 11 113733187-113773735 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011565, HPA051253, HPA055410" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809" "unprognostic (4.33e-3)" "unprognostic (6.65e-2)" "prognostic favorable (2.70e-4)" "unprognostic (3.12e-1)" "unprognostic (5.51e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (7.44e-2)" "unprognostic (8.01e-3)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.57e-3)" "unprognostic (6.00e-2)" "unprognostic (8.73e-2)" "unprognostic (2.95e-1)" "unprognostic (1.17e-3)" 7.0 6.0 3.3 8.1 3.9 9.3 11.1 4.9 4.9 8.2 3.7 8.4 7.2 7.7 7.4 9.7 6.2 6.0 5.6 3.7 3.8 8.9 13.1 6.4 9.5 4.1 4.5 3.3 7.0 9.2 7.3 5.1 7.8 4.3 8.0 10.1 6.9 8.4 7.4 13.5 13.8 7.2 8.7 3.7 7.0 7.3 13.6 3.8 12.2 6.8 12.1 12.1 8.6 7.6 5.5 25.0 14.4 30.2 22.1 18.4 20.0 17.4 26.1 21.4 32.2 32.5 38.1 46.1 29.0 34.5 25.8 28.1 34.2 36.7 31.6 46.0 19.1 15.1 30.9 12.0 23.5 20.6 31.7 18.8 16.5 20.8 34.1 27.4 14.2 33.5 31.7 36.3 11.8 33.8 12.2 29.3 20.9 21.7 29.8 29.0 27.0 34.4 32.7 21.2 22.2 13.3 15.7 29.1 24.2 11.8 24.2 44.9 17.4 21.1 28.8 44.2 14.4 28.8 6.1 10.6 30.6 9.9 38.1 33.0 8.5 7.4 7.4 6.3 10.4 8.5 5.9 5.9 5.6 9.5 5.1 5.4 6.8 1.9 6.2 9.2 3.0 5.6 5.6 3.3 3.9 4.9 4.9 3.7 3.8 4.1 4.5 3.3 4.3 3.7 3.8 5.5 5.6 0.0 4.8 11.1 5.8 12.1 7.6 7.5 8.0 2.9 5.9 5.0 6.8 7.2 7.3 0.0 0.0 9.2 3.9 3.9 9.8 10.1 10.7 7.7 7.1 6.9 3.6 10.7 12.5 11.8 10.0 6.5 8.2 12.7 3.8 7.8 3.9 8.1 9.2 3.3 11.1 4.6 4.1 6.0 5.4 7.3 5.0 6.1 3.6 10.3 8.0 7.6 3.1 12.1 18.7 8.4 3.8 5.7 10.4 5.6 5.3 7.2 4.8 4.9 19.7 7.0 7.0 44.4 17.5 9.4 12.5 10.5 5.9 6.9 6.4 5.8 ALG9 DIBD1 ENSG00000086848 "ALG9 alpha-1,2-mannosyltransferase" Q9H6U8 11 111782195-111871581 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 26.6;Inhibitory neurons: 31.8;Oligodendrocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038575 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038575: AB_10672718" "unprognostic (1.48e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (5.34e-3)" "unprognostic (8.72e-2)" "unprognostic (2.90e-1)" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (7.07e-3)" "unprognostic (5.11e-2)" "unprognostic (8.75e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (9.15e-2)" "unprognostic (7.76e-2)" "unprognostic (4.20e-2)" "unprognostic (1.10e-2)" 13.6 9.8 6.3 8.7 7.4 7.9 12.5 8.7 7.9 12.3 6.4 10.3 12.2 11.6 11.0 11.5 9.3 8.0 9.2 6.5 7.1 9.6 13.5 9.6 6.7 6.9 6.6 6.5 12.7 19.9 12.8 10.0 9.7 7.4 9.7 10.4 12.2 17.7 11.4 9.1 15.1 10.3 11.2 6.2 8.5 12.1 13.7 6.7 9.9 12.4 8.4 9.3 11.4 11.2 6.9 16.6 16.5 30.7 31.1 19.0 18.0 23.7 20.5 16.5 16.4 17.9 28.7 27.4 27.1 28.7 23.8 21.4 29.8 16.6 25.4 23.4 20.2 12.2 19.7 8.6 21.2 22.0 22.2 13.6 15.5 17.2 17.7 17.8 24.2 16.2 20.2 20.3 41.0 28.4 12.5 22.2 20.3 10.7 23.3 15.9 20.4 26.9 51.5 18.5 13.7 15.0 25.4 18.0 28.0 11.4 21.6 29.0 9.3 16.9 35.0 25.2 17.1 22.6 13.3 10.2 24.4 15.1 27.4 24.7 4.5 3.1 3.8 4.0 4.5 4.7 4.0 4.1 4.6 5.2 3.1 5.8 3.6 1.1 4.2 4.0 5.6 4.5 3.3 6.3 7.4 8.7 7.9 6.5 7.1 6.9 6.6 6.5 7.4 6.2 6.7 6.9 3.2 0.0 4.4 21.5 5.9 2.0 1.5 3.2 9.6 8.9 3.8 3.4 5.6 1.5 3.9 7.3 8.4 3.5 4.6 3.2 3.9 7.5 5.1 2.0 5.2 4.1 4.2 6.3 26.6 7.1 12.6 4.7 4.6 3.8 0.0 5.5 2.2 6.8 3.2 15.2 31.8 4.0 4.1 1.9 1.9 4.3 4.7 3.5 0.0 12.2 3.1 4.9 3.1 21.1 31.8 6.5 2.9 3.8 22.8 1.3 4.6 2.3 2.2 9.7 6.6 3.5 5.4 4.2 5.7 8.6 1.6 9.0 5.8 2.5 4.4 0.8 MYBPC2 "fsMyBP-C, MGC163408, MYBPCF" ENSG00000086967 "Myosin binding protein C2" Q14324 19 50432892-50466321 "Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 4380.5;tongue: 1209.8" "Cell type enriched" "Detected in some" 29 "Skeletal myocytes: 56.9" "Cancer enriched" "Detected in some" 9 "head and neck cancer: 9.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HDLM-2: 58.7;Karpas-707: 143.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042991 Enhanced NA NA 420000 "HPA042991: AB_2678257" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" "unprognostic (6.25e-2)" "unprognostic (3.26e-3)" "unprognostic (1.91e-3)" "unprognostic (2.15e-2)" "unprognostic (6.22e-3)" "unprognostic (2.46e-1)" "unprognostic (5.38e-2)" "unprognostic (9.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (2.19e-8)" "unprognostic (1.85e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-3)" "unprognostic (2.73e-1)" 0.2 0.0 0.2 1.1 0.2 0.3 0.4 0.2 0.4 0.0 0.1 0.4 0.0 0.0 0.0 4.2 0.1 0.0 0.2 0.2 0.3 0.3 0.1 0.2 1.1 0.3 0.4 0.2 0.1 0.3 213.9 0.2 0.0 0.4 6.7 0.2 0.0 12.6 0.0 4380.5 0.5 0.4 0.0 0.2 0.3 0.2 0.3 0.3 1.4 1.0 1209.8 1.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.3 0.3 0.4 0.2 0.4 0.2 0.3 1.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 56.9 0.5 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324353-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "kidney: 139.3" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 164.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 14.3;HUVEC TERT2: 27.7;TIME: 70.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 6.0 0.7 0.7 0.7 1.1 0.2 3.8 0.9 1.9 1.5 1.4 1.0 0.2 4.9 0.4 0.4 1.3 2.4 5.5 0.5 0.8 139.3 0.3 1.5 0.2 1.3 0.8 0.4 0.8 0.3 3.6 0.9 3.1 0.9 1.0 0.3 17.3 3.0 1.3 1.7 1.1 0.6 3.5 1.3 0.4 0.5 0.3 0.8 0.1 2.1 3.6 0.5 1.4 1.1 1.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.5 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.1 14.3 27.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.1 0.0 0.0 0.3 7.1 0.4 0.0 70.6 0.2 5.0 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 1.1 0.9 1.9 0.5 0.8 1.3 0.8 0.4 0.9 1.3 0.8 1.9 4.4 0.0 0.0 2.9 1.0 0.6 0.1 0.4 0.0 7.5 0.2 0.3 1.0 0.0 0.0 11.0 6.2 2.2 0.2 0.1 15.6 0.0 0.8 1.0 1.4 5.9 0.0 0.0 30.0 0.0 0.8 9.2 0.0 3.0 0.0 0.6 2.5 0.1 0.2 0.0 21.1 0.0 0.0 0.0 0.5 0.7 0.3 1.3 0.0 6.5 0.1 4.5 0.0 7.1 28.4 0.1 0.0 1.2 0.3 0.1 0.0 164.0 0.0 27.1 0.0 1.2 1.0 0.6 0.7 0.1 0.3 2.5 1.1 0.1 0.0 0.1 ACOX3 ENSG00000087008 "Acyl-CoA oxidase 3, pristanoyl" O15254 4 8366282-8440723 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035840, HPA035841" Uncertain Supported Peroxisomes NA NA Peroxisomes "HPA035840: AB_10696514, HPA035841: AB_10671940" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.12e-1)" "prognostic favorable (2.16e-4)" "unprognostic (5.52e-2)" "unprognostic (1.81e-3)" "unprognostic (2.21e-1)" "unprognostic (3.37e-2)" "unprognostic (2.27e-1)" "unprognostic (4.43e-2)" "unprognostic (4.81e-1)" "unprognostic (1.39e-1)" "unprognostic (1.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.65e-1)" 7.8 8.9 5.7 6.4 5.2 4.5 12.3 3.9 6.2 7.2 5.7 8.3 9.0 5.7 4.3 26.8 6.6 6.0 13.5 5.2 4.8 6.5 15.0 7.3 6.7 5.9 4.6 5.8 7.5 12.1 7.2 4.6 8.5 5.1 10.6 6.3 3.8 15.5 8.5 6.4 12.5 8.9 11.5 4.7 5.4 10.2 2.9 4.6 4.6 8.6 5.7 8.6 10.1 13.8 7.2 8.9 9.6 10.5 14.1 11.0 18.7 17.2 11.1 15.1 18.5 16.1 4.8 11.7 11.9 11.7 22.8 25.0 5.4 4.6 14.4 14.3 4.1 4.5 5.2 8.2 14.8 18.3 10.7 9.4 18.9 12.1 16.7 6.5 13.3 22.1 13.1 7.0 10.6 16.1 8.2 11.4 15.6 5.9 11.3 16.4 11.8 17.3 14.3 11.2 12.4 5.1 11.7 14.2 7.2 7.3 8.6 7.2 14.9 21.7 18.2 5.9 7.5 11.8 7.9 5.6 5.4 23.2 13.1 11.8 0.1 13.2 3.3 6.1 15.2 6.3 5.4 7.1 7.8 17.8 4.9 6.5 6.7 3.1 9.5 14.4 21.4 10.4 9.4 5.7 5.2 3.9 6.2 5.2 4.8 5.9 4.6 5.8 5.1 4.7 4.6 7.2 6.2 6.4 5.9 14.7 4.8 4.5 7.6 12.3 8.6 8.2 11.6 7.6 9.4 10.0 9.8 11.0 33.3 23.9 7.7 10.9 3.9 17.3 4.4 13.1 4.2 5.6 1.8 3.0 13.2 13.7 9.3 6.6 10.2 10.0 0.0 21.7 4.6 14.2 10.2 1.7 14.2 4.9 14.2 4.1 4.4 3.3 6.8 5.3 5.4 6.5 7.6 3.8 2.1 12.5 14.5 16.9 7.4 11.3 5.6 9.1 18.3 8.2 11.2 18.6 0.0 3.8 6.9 2.4 2.3 14.1 5.8 74.6 6.0 6.0 7.5 11.4 MTMR2 "CMT4B, KIAA1073" ENSG00000087053 "Myotubularin related protein 2" Q13614 11 95821766-95925315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 120.1;Oligodendrocytes: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049831 Approved Supported Vesicles NA NA Vesicles "HPA049831: AB_2680904" "unprognostic (1.71e-2)" "unprognostic (2.55e-3)" "unprognostic (7.81e-3)" "unprognostic (4.16e-1)" "unprognostic (4.18e-3)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.61e-8)" "unprognostic (3.23e-3)" "unprognostic (3.42e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.60e-4)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (8.03e-3)" 14.7 9.4 13.1 11.3 17.7 4.4 11.9 17.4 18.1 12.3 14.3 13.1 7.1 12.4 6.3 14.8 12.5 14.5 13.7 12.4 15.3 16.6 4.3 12.4 9.6 16.6 16.2 11.4 11.6 7.9 12.8 6.4 24.8 17.5 16.2 14.1 18.8 20.7 11.5 6.3 8.3 8.3 18.1 17.3 8.6 13.1 31.3 15.5 15.2 10.0 9.0 12.2 15.3 10.5 23.9 24.1 25.3 54.1 39.2 19.2 29.0 47.5 43.3 37.9 42.4 37.8 57.3 47.1 16.2 50.3 45.5 35.9 30.9 47.7 48.2 38.9 30.8 21.3 31.5 55.0 33.0 42.8 59.3 26.7 24.0 31.2 56.6 54.5 41.8 64.4 35.4 44.7 14.2 39.6 17.9 29.0 27.2 46.6 59.0 34.9 23.2 32.2 16.8 43.9 125.0 35.6 40.6 43.6 36.4 19.2 35.1 27.6 26.5 64.4 47.7 45.1 34.4 41.1 13.1 42.4 14.3 20.4 15.6 50.6 9.8 3.9 1.7 12.4 4.7 13.4 5.8 7.9 15.7 7.6 4.9 4.0 11.3 0.9 14.1 7.2 3.7 8.1 7.8 13.1 17.7 17.4 18.1 12.4 15.3 16.6 16.2 11.4 17.5 17.3 15.5 23.9 19.6 3.2 8.6 28.7 9.6 10.3 15.0 9.0 8.6 0.0 8.0 6.7 17.3 0.0 11.6 9.2 0.0 9.0 8.8 9.1 9.8 17.8 74.8 18.1 14.1 20.2 16.2 12.8 69.8 16.9 34.3 17.0 9.7 8.7 19.0 49.1 11.0 1.0 12.5 0.0 37.5 9.8 24.4 10.3 8.2 120.1 11.1 8.3 3.6 40.3 6.8 0.0 14.4 63.8 226.6 17.7 4.7 12.0 7.0 15.1 6.0 29.3 17.0 0.0 32.9 7.9 29.0 46.8 19.2 15.4 6.0 9.0 8.8 12.9 10.6 15.6 PPP1R15A GADD34 ENSG00000087074 "Protein phosphatase 1 regulatory subunit 15A" O75807 19 48872421-48876058 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 580.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 340.1" "Group enriched" "Detected in all" 5 "dendritic cells: 114.6;granulocytes: 340.1" "Cell line enhanced" "Detected in all" "HHSteC: 282.8;hTERT-HME1: 493.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018395, HPA020240" Approved Uncertain Vesicles NA NA Vesicles "CAB018395: AB_2237473, HPA020240: AB_1849404" "unprognostic (2.43e-3)" "unprognostic (3.21e-1)" "unprognostic (7.75e-2)" "unprognostic (1.17e-3)" "unprognostic (2.22e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.22e-1)" "unprognostic (6.43e-3)" "unprognostic (1.49e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" 152.0 85.5 49.4 50.0 34.1 580.7 98.6 42.8 94.2 84.8 64.8 73.6 36.3 70.8 11.4 99.1 148.7 82.7 172.2 46.0 35.6 90.7 85.8 228.7 33.4 45.9 35.0 28.0 102.1 33.6 23.3 65.5 75.4 36.5 61.0 45.9 11.0 41.9 38.9 89.2 160.4 59.3 102.6 30.9 69.6 91.5 23.5 39.8 52.5 70.0 61.2 20.4 111.6 109.3 82.7 55.8 23.7 24.9 20.5 71.2 40.4 39.3 95.1 148.0 106.5 95.9 36.5 27.6 19.1 25.0 69.0 145.5 39.4 9.3 49.7 79.8 10.7 14.4 86.4 14.4 18.1 282.8 20.2 119.2 55.1 135.5 147.0 493.7 48.0 56.3 21.5 118.2 155.6 69.5 6.1 11.1 27.9 6.2 100.3 42.3 12.6 23.1 6.5 22.3 63.8 14.2 24.3 49.2 33.2 230.2 26.0 11.9 36.1 60.6 126.3 31.8 89.3 58.5 82.8 72.1 17.9 46.2 13.7 154.8 161.8 49.4 91.3 22.5 31.1 19.6 36.7 22.2 18.7 35.9 29.7 12.3 11.0 340.1 13.8 37.6 114.6 31.5 36.9 49.4 34.1 42.8 94.2 46.0 35.6 45.9 35.0 28.0 36.5 30.9 39.8 82.7 499.1 288.4 225.1 2.3 387.2 482.2 989.5 232.0 730.1 25.0 294.3 220.7 173.3 127.2 204.3 12.9 35.5 104.8 290.3 435.6 3.9 224.0 4.6 619.6 427.4 370.4 170.9 213.5 4.1 94.5 219.0 466.3 430.7 1063.2 708.1 53.3 150.0 14.4 195.0 35.3 4.1 354.1 140.4 146.7 904.4 5.1 58.7 615.3 396.6 9.4 105.1 50.5 20.6 1.0 2.0 233.4 421.8 23.0 477.1 731.5 348.7 9.0 246.2 27.7 85.5 483.5 612.1 7.0 9.5 573.1 431.0 288.4 427.9 102.8 321.8 733.9 HSD17B14 "DHRS10, retSDR3, SDR47C1" ENSG00000087076 "Hydroxysteroid 17-beta dehydrogenase 14" Q9BPX1 19 48813018-48836510 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 78.2;Hofbauer cells: 149.9;Proximal tubular cells: 434.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 3.7;NK-cells: 4.7;T-cells: 3.1" "Cell line enhanced" "Detected in many" "GAMG: 53.9;HHSteC: 49.5;hTERT-RPE1: 37.9;Karpas-707: 50.7;RT4: 40.5" "Not detected" "Not detected" HPA021467 Approved NA NA "HPA021467: AB_1847652" "unprognostic (2.03e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (4.39e-5)" "unprognostic (4.32e-2)" "unprognostic (8.03e-2)" "unprognostic (1.47e-1)" "unprognostic (7.54e-2)" "unprognostic (7.76e-3)" "unprognostic (2.71e-1)" "unprognostic (4.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (4.56e-1)" "unprognostic (5.50e-3)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (5.51e-2)" "unprognostic (1.81e-2)" 8.7 39.8 34.1 3.2 32.2 1.2 11.3 36.9 48.1 33.2 61.3 9.3 3.3 31.9 5.7 4.3 22.9 11.7 5.9 33.6 43.6 58.8 79.5 13.2 8.1 32.3 36.8 27.7 56.7 6.2 47.1 24.3 7.4 31.8 15.2 2.0 10.1 6.4 9.3 1.3 7.5 8.3 8.5 32.9 8.8 8.6 4.9 39.9 9.7 25.5 2.2 3.8 15.9 14.7 33.2 0.1 14.0 14.1 2.4 15.8 2.6 0.3 2.6 19.9 1.1 1.2 13.4 0.2 8.0 14.2 0.6 53.9 0.1 1.3 0.1 1.3 0.5 1.0 4.1 0.3 1.8 49.5 0.0 20.9 19.0 0.5 1.2 0.5 37.9 18.1 4.8 0.1 50.7 0.1 0.5 1.1 0.4 1.2 8.2 9.3 7.9 0.1 1.5 0.0 40.5 3.5 9.0 0.0 1.8 10.9 6.0 0.4 0.5 0.0 0.3 5.2 0.5 0.1 8.9 18.9 0.6 11.9 1.2 0.1 0.0 0.0 0.0 0.9 0.0 1.5 3.7 1.5 0.7 0.0 2.5 3.1 2.3 0.0 4.7 0.0 0.5 0.5 0.8 34.1 32.2 36.9 48.1 33.6 43.6 32.3 36.8 27.7 31.8 32.9 39.9 33.2 3.3 3.2 11.5 21.5 6.0 2.5 3.6 1.7 0.0 5.5 1.3 5.0 2.0 1.5 4.4 7.3 0.0 1.4 0.3 0.0 78.2 1.9 0.4 0.3 3.5 8.2 13.2 5.3 5.0 1.1 3.0 14.1 2.0 0.7 7.0 7.4 28.5 32.0 149.9 11.8 5.0 0.3 8.2 13.4 9.5 1.4 4.1 17.3 21.4 6.5 8.0 53.5 1.0 4.5 0.8 2.6 0.0 7.2 0.1 3.8 2.2 434.5 0.7 1.6 0.0 2.4 2.9 5.6 15.7 0.3 1.8 2.2 2.8 7.5 0.2 2.9 TRIP6 "MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1" ENSG00000087077 "Thyroid hormone receptor interactor 6" Q15654 7 100867387-100873454 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046454, CAB046460, HPA052813" Approved Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 21000 "Plasma membrane, Focal adhesion sites, Cytosol" "CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961" "unprognostic (7.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.84e-3)" "unprognostic (3.52e-2)" "unprognostic (2.92e-2)" "unprognostic (3.18e-2)" "unprognostic (4.61e-3)" "unprognostic (8.48e-2)" "unprognostic (4.18e-2)" "unprognostic (5.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.25e-2)" "unprognostic (5.07e-2)" "unprognostic (9.71e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" 41.7 43.3 29.4 15.9 32.7 15.8 43.0 32.5 42.0 58.8 34.8 39.0 9.8 75.2 16.3 64.2 49.9 37.4 31.2 28.2 42.8 56.0 41.5 34.1 14.7 36.0 30.9 24.6 51.1 40.1 46.8 16.9 27.7 31.7 43.3 8.5 5.4 47.2 57.2 10.3 55.3 21.7 27.7 32.4 20.2 27.8 18.5 32.8 16.7 50.9 5.8 12.2 47.6 53.0 32.9 128.1 63.4 26.8 126.1 37.8 44.9 131.2 82.3 79.8 101.2 94.8 55.8 143.9 5.5 81.3 87.7 128.3 94.2 38.0 149.2 27.3 19.1 58.5 0.5 117.9 0.8 99.3 66.5 7.1 81.1 94.0 67.8 108.2 64.2 52.8 19.1 83.3 1.0 90.5 286.9 1.3 99.5 92.4 52.3 50.4 47.9 27.0 12.7 65.5 42.8 9.7 1.7 67.5 192.3 78.1 43.8 20.3 77.5 86.5 149.5 145.8 167.5 186.7 1.0 2.1 0.8 92.9 7.8 230.5 0.0 1.2 0.2 0.1 2.1 0.4 2.5 0.9 0.7 1.9 2.4 1.1 0.6 0.0 0.0 3.8 5.2 0.9 0.4 29.4 32.7 32.5 42.0 28.2 42.8 36.0 30.9 24.6 31.7 32.4 32.8 32.9 24.5 48.1 38.8 14.4 8.0 131.9 151.5 144.1 78.0 0.9 48.3 55.8 13.9 38.6 87.0 60.7 0.0 113.0 12.0 9.5 80.3 106.9 1.1 22.7 46.1 26.3 4.9 6.7 0.3 84.3 90.4 54.6 40.8 44.8 8.2 55.3 23.9 28.8 44.0 1.7 0.4 12.8 34.6 8.0 59.3 2.8 65.9 17.5 37.4 5.6 20.3 94.8 0.0 4.0 6.5 95.0 13.1 72.6 16.0 72.9 3.6 130.0 34.3 4.6 72.3 50.9 104.0 4.7 4.5 68.2 98.3 132.8 7.1 58.3 18.8 155.6 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 96.3;skeletal muscle: 164.7;tongue: 48.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 990000 "Golgi apparatus" Vesicles "HPA027098: AB_2672111" "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavorable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.7 23.9 2.3 14.2 8.0 2.0 35.7 31.8 4.6 0.0 7.0 5.0 2.7 0.2 2.4 3.2 1.3 7.5 13.3 68.3 3.4 4.2 4.5 3.5 66.9 53.3 13.0 4.6 4.3 4.7 8.4 0.7 59.0 8.2 1.8 5.7 7.2 1.6 164.7 1.3 9.1 0.5 23.1 3.5 2.4 3.9 51.3 3.6 2.3 48.4 1.5 1.4 3.7 96.3 0.0 0.2 0.2 0.2 0.3 0.0 7.9 0.3 0.0 0.1 0.2 13.0 0.1 0.0 0.6 0.0 1.2 0.6 2.0 0.1 0.0 4.6 0.5 0.2 0.1 0.2 0.1 0.0 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.1 13.9 19.7 0.1 4.3 0.0 0.2 1.1 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.8 1.5 0.1 0.8 0.0 2.9 0.0 0.0 0.2 0.5 6.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 14.2 35.7 31.8 13.3 68.3 66.9 53.3 13.0 59.0 23.1 51.3 96.3 0.5 0.0 0.0 3.3 0.5 0.8 20.9 0.9 6.2 13.5 2.9 1.1 6.4 5.7 0.4 0.0 0.0 8.2 0.9 86.2 0.0 10.5 0.0 0.5 1.5 2.1 3.5 37.7 4.7 39.7 2.6 3.0 1.5 2.4 0.0 7.4 2.2 0.4 0.8 55.5 9.7 12.0 0.0 0.3 6.6 0.4 0.6 1.7 1.8 1.0 4.6 11.4 0.0 8.5 0.8 20.1 118.3 0.7 1.8 20.4 45.6 1.1 0.1 6.8 0.0 13.5 4.9 4.1 8.0 1.7 1.0 7.1 0.6 1.4 4.6 15.2 FTL "MGC71996, NBIA3" ENSG00000087086 "Ferritin light chain" P02792 19 48965309-48966879 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Iron storage" "Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 14541.0" "Cell type enhanced" "Detected in all" "Hofbauer cells: 74983.4;Kupffer cells: 70127.1;Macrophages: 34584.5;Proximal tubular cells: 58047.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 125209.0;monocytes: 102128.9" "Cell line enhanced" "Detected in all" "HHSteC: 24796.9;HSkMC: 20811.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020769, HPA041602" Enhanced Approved Cytosol NA NA 170000000 Cytosol "CAB020769: , HPA041602: AB_2677575" "unprognostic (2.95e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-1)" "unprognostic (1.56e-3)" "unprognostic (7.48e-2)" "unprognostic (5.28e-2)" "unprognostic (2.16e-3)" "unprognostic (6.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" 6386.0 3288.9 7506.8 2374.0 7299.6 4251.2 4261.8 6913.6 10133.5 2050.8 6648.1 2362.8 2449.0 1536.1 1019.7 1316.7 2189.1 4336.6 2142.7 6595.7 7699.4 8670.2 14541.0 7323.8 3381.6 7530.6 7063.8 6500.3 2476.0 2184.6 939.6 1743.9 3451.5 7305.4 1963.2 1817.3 690.8 1677.1 1403.4 1357.0 1376.7 2830.1 1859.4 7322.6 6805.9 3231.0 460.0 7437.3 1179.7 3025.1 1081.5 1345.6 4275.8 1820.1 10890.0 869.7 12906.5 949.6 1457.0 16013.9 16478.6 1693.1 2194.1 12820.0 3090.7 6903.8 2852.3 3413.2 656.4 4104.3 13203.9 6755.6 505.8 788.2 1301.8 2765.6 8895.0 507.6 1740.0 3222.8 18949.7 24796.9 4133.3 5591.2 20811.1 1735.9 5272.5 2301.6 4590.4 4549.8 774.6 3284.9 1328.2 6198.4 213.0 1152.1 2402.8 1729.8 15140.6 1306.9 947.6 643.0 6763.9 1989.7 545.0 1209.9 701.5 5761.7 313.4 1239.5 5104.1 183.2 8493.4 3438.3 3353.4 1740.1 4364.3 3083.1 5690.2 13742.1 625.1 3563.9 4334.7 6017.7 64938.4 71067.8 77353.0 6560.6 102128.9 7527.7 17097.3 7247.4 7054.3 25176.6 15607.2 8656.4 7466.9 125209.0 4978.3 91398.0 10579.6 9634.4 94147.5 7506.8 7299.6 6913.6 10133.5 6595.7 7699.4 7530.6 7063.8 6500.3 7305.4 7322.6 7437.3 10890.0 2757.2 1125.0 3379.9 88.5 3311.5 2793.9 6799.5 2785.4 2159.8 474.7 2597.9 3977.3 777.8 4398.0 2550.4 2021.2 177.2 941.5 2199.4 2314.2 10704.0 4251.2 290.2 504.9 1413.1 4867.0 1613.4 4331.2 60.6 6134.8 1447.8 5703.3 1715.1 617.4 2365.7 942.2 4598.0 23702.0 74983.4 533.3 113.8 2368.8 3039.4 70127.1 16939.0 1601.8 4175.9 34584.5 5085.3 129.3 22965.8 3161.9 2020.6 55.8 309.7 6905.5 5604.7 2010.8 4884.7 9790.5 21474.5 58047.8 1908.0 682.6 1341.1 1643.8 3455.6 82.1 311.2 1985.5 2226.7 1502.7 2590.4 1492.0 2816.8 13083.6 SRRT "ARS2, Asr2, serrate" ENSG00000087087 "Serrate, RNA effector molecule" Q9BXP5 7 100875103-100888664 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 251.1;Late spermatids: 329.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042858, HPA058379" Supported Enhanced Nucleoplasm NA NA 32000 Nucleoplasm "HPA042858: AB_2678201, HPA058379: AB_2683697" "unprognostic (5.83e-2)" "unprognostic (3.72e-3)" "unprognostic (5.89e-2)" "unprognostic (1.77e-1)" "unprognostic (1.45e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (4.36e-2)" "unprognostic (4.99e-3)" "unprognostic (2.35e-2)" "unprognostic (4.25e-3)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (6.30e-3)" "unprognostic (2.77e-2)" "unprognostic (9.98e-2)" "unprognostic (1.10e-3)" 48.1 65.2 39.2 47.6 42.2 116.2 52.8 43.6 44.2 69.7 40.2 54.2 38.1 57.3 30.6 63.9 57.0 29.0 46.2 39.3 44.1 57.8 75.4 49.8 62.8 43.5 40.5 36.5 71.8 63.5 33.3 64.6 33.5 42.2 74.2 25.4 31.0 59.8 30.9 51.5 70.2 60.9 27.0 38.9 75.6 55.7 161.1 40.8 51.4 64.7 23.8 40.9 50.1 60.5 44.7 104.3 122.5 123.6 121.2 51.6 36.8 115.2 112.9 56.6 113.0 96.7 161.3 114.5 172.7 75.6 82.0 84.6 96.1 149.6 101.0 56.0 154.0 128.3 163.3 150.3 134.7 46.4 213.6 270.4 55.2 39.0 100.8 28.8 51.3 62.1 103.8 147.1 135.6 79.4 180.9 198.7 235.6 127.5 89.0 107.4 183.1 94.9 103.4 73.6 113.0 97.6 94.4 111.0 136.5 75.4 62.9 85.9 130.7 95.2 127.1 122.7 109.4 154.8 85.5 132.8 185.2 70.6 141.4 122.6 7.7 14.6 22.2 28.3 23.0 18.3 12.2 18.7 38.8 15.7 15.5 16.0 23.0 10.9 10.4 18.1 14.2 9.7 20.9 39.2 42.2 43.6 44.2 39.3 44.1 43.5 40.5 36.5 42.2 38.9 40.8 44.7 22.7 25.6 49.2 17.3 37.6 38.5 27.8 24.1 63.7 23.3 22.4 21.8 21.5 14.3 39.2 16.5 14.6 42.7 43.2 24.4 7.9 31.7 251.1 25.6 36.2 25.9 32.9 51.9 8.6 32.0 50.4 29.2 51.5 41.7 27.1 31.3 12.8 13.1 26.5 26.9 8.5 29.1 18.3 15.0 35.9 329.5 33.8 28.4 16.0 9.4 25.1 29.4 26.8 12.5 12.7 26.3 17.9 27.8 67.2 22.8 16.0 12.2 30.5 46.0 19.7 31.7 41.7 133.3 65.8 52.4 43.5 54.2 62.8 33.9 32.3 21.4 BAX BCL2L4 ENSG00000087088 "BCL2 associated X, apoptosis regulator" Q07812 19 48954815-48961798 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004206, HPA027878" Approved NA NA 1100000 "CAB004206: AB_626729, HPA027878: AB_10601687" "unprognostic (4.11e-2)" "unprognostic (4.70e-2)" "unprognostic (1.50e-1)" "unprognostic (6.23e-2)" "unprognostic (1.70e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (1.63e-5)" "unprognostic (4.92e-2)" "unprognostic (1.09e-1)" "unprognostic (4.71e-2)" "unprognostic (3.66e-2)" "unprognostic (8.10e-2)" "unprognostic (1.19e-2)" "unprognostic (7.83e-2)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (6.22e-2)" 28.7 30.7 24.8 59.7 26.5 66.3 27.4 26.0 29.6 27.8 25.0 78.8 68.8 30.1 23.4 36.1 33.5 38.0 21.8 24.8 28.0 31.0 33.6 46.4 60.0 26.7 25.7 24.3 19.8 32.9 26.4 16.0 43.7 26.7 25.9 59.3 7.2 26.8 27.3 18.2 29.8 65.2 36.6 26.4 60.5 44.2 12.5 26.8 83.9 23.6 12.0 45.1 47.1 26.3 28.1 177.4 286.0 170.1 150.4 165.4 161.7 280.2 117.8 233.4 151.7 210.6 76.4 168.6 214.6 53.9 181.2 141.3 93.8 78.0 229.0 125.7 166.6 181.0 91.9 56.6 288.0 265.7 96.3 280.9 222.3 161.7 126.1 75.5 183.3 354.6 83.4 91.4 86.0 264.8 123.1 157.6 150.3 132.8 171.3 82.5 109.2 113.1 82.4 161.0 168.4 97.4 114.7 99.2 69.8 57.4 240.6 56.2 171.2 210.2 194.0 212.1 120.1 165.1 97.9 136.6 145.0 118.1 129.2 275.1 5.2 12.1 13.4 6.5 18.4 4.6 7.3 3.7 7.1 12.2 5.9 2.4 6.0 13.1 12.2 20.9 12.5 7.5 8.4 24.8 26.5 26.0 29.6 24.8 28.0 26.7 25.7 24.3 26.7 26.4 26.8 28.1 83.2 3.2 4.8 8.1 164.6 54.8 63.8 160.8 101.3 19.3 64.1 67.4 8.4 78.6 98.7 60.7 10.4 126.0 130.2 152.9 74.3 122.7 1.1 43.4 65.7 83.7 114.0 79.3 7.9 96.2 157.9 57.0 114.2 46.0 43.9 151.7 59.3 28.1 263.6 30.3 8.3 102.7 209.5 121.8 143.0 4.0 48.1 148.3 83.6 3.7 295.3 43.9 140.1 7.5 13.8 139.4 177.0 38.4 96.2 126.6 229.8 227.4 66.4 15.9 46.0 35.8 259.4 20.3 38.1 92.0 56.4 101.9 149.4 175.5 149.7 86.7 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 79.3" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 45 "basophil: 29.9" "Lineage enriched" "Detected in single" 45 "granulocytes: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: AB_2683160" "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 8.3 37.0 19.6 8.7 26.1 10.0 9.5 9.1 41.6 7.9 6.1 9.0 10.3 7.1 11.3 5.6 6.5 8.8 11.6 29.2 14.4 16.7 11.2 9.2 16.5 17.7 16.7 25.2 5.0 14.4 28.4 11.2 12.3 20.0 8.3 9.2 79.3 7.5 10.9 6.6 5.9 10.3 6.0 11.2 12.3 9.0 22.2 13.7 13.3 16.9 6.8 15.5 10.2 4.5 31.3 9.5 11.6 28.4 9.7 6.1 7.6 12.1 9.6 10.9 16.9 13.1 59.4 9.1 13.6 13.8 8.4 20.2 8.6 19.6 18.7 19.3 29.7 12.2 52.2 11.2 9.9 10.3 11.6 51.0 9.6 11.9 10.4 12.5 16.0 20.4 36.3 20.1 15.9 16.4 11.6 28.8 13.4 10.4 20.1 5.5 23.8 17.2 10.0 32.0 12.2 19.6 7.2 14.4 14.4 62.4 32.2 22.0 18.2 19.2 11.7 14.1 9.0 19.5 17.6 17.9 13.1 11.6 12.6 13.0 29.9 0.3 0.3 0.5 0.4 0.2 0.6 0.5 0.6 0.3 0.3 0.3 0.6 0.2 0.2 0.5 0.5 0.5 0.3 19.6 26.1 9.1 41.6 29.2 14.4 17.7 16.7 25.2 20.0 11.2 13.7 31.3 17.8 22.4 6.0 57.8 7.8 5.4 3.8 3.0 5.7 94.4 8.7 5.0 27.4 5.7 5.3 33.1 154.3 3.7 4.3 11.4 1.9 3.9 261.1 8.9 5.8 15.0 28.2 11.8 315.5 6.4 3.5 4.8 5.1 11.9 24.1 17.6 9.3 9.4 8.8 37.0 98.2 10.0 2.0 16.9 6.0 355.3 5.6 11.3 16.0 103.0 7.9 11.2 6.2 104.5 366.6 5.7 8.1 2.6 6.4 5.4 5.1 8.4 9.5 89.9 13.1 5.0 6.9 37.1 11.8 4.1 4.8 6.4 5.5 6.7 10.3 6.6 PIGS ENSG00000087111 "Phosphatidylinositol glycan anchor biosynthesis class S" Q96S52 17 28553383-28571794 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018149 Approved NA NA "HPA018149: AB_1855373" "unprognostic (2.29e-2)" "unprognostic (1.37e-2)" "unprognostic (3.89e-1)" "unprognostic (2.52e-1)" "unprognostic (6.61e-2)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.65e-1)" "unprognostic (9.09e-2)" "unprognostic (2.25e-3)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (2.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.06e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (5.31e-4)" 25.2 15.6 7.0 15.7 6.9 25.5 11.5 6.6 8.5 13.0 14.7 25.8 31.2 12.1 3.4 23.7 20.3 15.7 25.6 9.0 6.9 16.8 4.9 20.4 19.0 7.4 8.8 6.8 13.4 17.0 28.7 3.3 17.5 7.5 17.9 15.9 3.4 14.9 16.4 31.7 18.7 32.4 16.2 5.8 18.4 27.1 13.5 6.7 17.6 24.5 19.9 13.8 17.9 5.3 7.9 34.7 57.4 26.5 67.9 51.1 38.2 40.1 42.3 34.5 44.4 58.1 60.4 33.8 22.3 62.9 57.8 43.1 64.5 32.4 48.2 16.6 65.8 92.5 30.1 45.3 26.2 47.8 58.5 73.8 46.7 33.6 27.8 37.8 44.5 60.3 37.8 89.3 34.1 38.5 42.6 36.9 40.2 13.2 77.9 17.6 31.2 87.8 73.6 30.6 36.9 54.3 37.7 60.3 115.4 32.8 26.4 105.4 69.5 52.2 31.5 32.5 27.1 35.0 56.5 84.0 17.0 56.6 56.8 45.1 86.2 60.4 78.9 34.3 55.0 31.0 23.5 27.5 32.5 64.9 22.3 28.8 24.0 29.4 43.0 39.6 49.8 45.2 46.3 7.0 6.9 6.6 8.5 9.0 6.9 7.4 8.8 6.8 7.5 5.8 6.7 7.9 15.7 44.8 21.4 10.7 15.9 8.3 11.3 21.1 13.6 20.5 20.5 17.1 40.7 20.0 18.8 46.0 64.6 35.0 31.6 48.5 11.7 43.5 9.5 15.3 15.7 18.7 40.7 17.9 10.9 26.3 53.4 14.9 18.3 21.5 3.8 17.1 26.4 7.9 31.1 52.2 12.6 28.3 24.4 28.1 8.0 13.1 23.9 22.9 7.2 1.9 66.1 17.5 93.7 9.0 11.7 22.5 21.6 22.6 16.8 15.0 49.0 19.1 14.4 56.1 6.6 12.3 15.9 74.2 62.0 19.3 12.5 36.4 21.8 25.0 27.6 12.4 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110853-179345461 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA 2000000 "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 37.1 11.0 0.5 2.4 3.3 0.3 22.8 0.6 3.3 20.1 1.1 10.2 1.4 21.9 0.5 5.5 15.6 6.2 15.7 0.3 0.9 7.4 15.9 29.8 1.8 3.7 2.9 1.1 12.2 5.8 0.4 15.3 9.8 4.1 9.1 1.4 0.2 5.4 1.9 2.9 8.0 11.7 9.2 0.1 38.7 9.4 3.9 2.5 0.4 6.8 0.8 0.6 15.1 16.8 3.1 0.0 0.0 0.1 0.7 36.0 35.8 0.0 31.4 5.4 11.5 12.4 0.1 0.0 0.0 0.2 39.3 0.7 0.1 1.8 0.0 5.1 0.0 1.5 0.0 0.1 2.3 115.5 0.0 0.0 94.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.1 0.8 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.9 1.2 0.1 0.0 0.4 1.9 0.0 10.7 0.0 19.1 3.0 24.5 0.0 0.3 0.0 0.0 0.9 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.5 3.3 0.6 3.3 0.3 0.9 3.7 2.9 1.1 4.1 0.1 2.5 3.1 3.3 0.0 1.1 1.6 0.1 2.2 0.4 0.0 2.2 0.3 0.2 5.2 1.5 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.9 32.2 1.4 0.0 0.0 17.9 0.0 0.3 30.7 0.0 0.8 1.3 6.5 17.2 0.5 5.1 0.0 8.5 0.0 0.0 71.4 4.4 3.4 5.0 10.4 0.0 4.7 0.3 0.1 0.0 3.0 2.4 0.5 0.0 12.8 0.1 0.4 0.0 0.2 0.0 0.0 26.3 4.7 20.4 2.1 4.8 0.2 2.7 0.0 0.4 0.6 0.0 0.1 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447463-68497604 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 221.9;vagina: 157.6" "Cell type enriched" "Detected in some" 14 "Ionocytes: 476.0" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;OE19: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043816, HPA051062" Enhanced Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA043816: , HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 42.8 0.0 0.0 0.0 0.0 18.4 221.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.2 0.0 0.0 57.1 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 24.7 6.5 157.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 12.9 0.7 0.0 0.0 0.5 0.3 0.3 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 476.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.2 6.6 0.3 1.1 0.7 0.0 0.0 32.6 ATXN7L3 DKFZp761G2113 ENSG00000087152 "Ataxin 7 like 3" Q14CW9 17 44191805-44200113 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064316 Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA064316: AB_2685243" "unprognostic (2.37e-2)" "unprognostic (8.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.86e-3)" "unprognostic (6.74e-3)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.21e-3)" "unprognostic (9.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.40e-1)" 23.3 24.8 53.5 32.9 60.2 45.4 21.5 31.0 77.4 28.3 17.5 27.1 31.5 28.5 26.2 40.4 26.7 24.3 23.0 58.1 47.9 26.2 28.2 25.4 37.5 58.2 46.3 61.9 25.8 24.4 24.7 35.4 30.9 64.2 27.1 24.5 21.6 28.2 27.9 25.5 31.4 29.9 26.0 33.2 36.6 28.5 37.2 53.9 42.5 29.4 22.8 35.8 28.9 28.3 59.9 40.9 67.7 73.3 47.8 50.1 49.5 39.8 49.1 54.3 61.4 57.7 52.0 45.1 71.3 38.6 55.5 56.6 43.9 57.7 46.1 51.2 83.6 57.2 48.5 58.9 58.5 49.3 76.3 94.3 56.1 69.0 51.7 54.1 65.0 60.3 54.2 66.1 43.5 40.8 30.7 92.3 58.0 55.1 36.7 52.5 62.8 70.9 54.1 49.8 57.9 46.5 59.0 29.0 25.4 50.5 101.4 62.0 67.1 52.2 61.5 63.8 32.3 46.5 52.1 73.8 86.4 40.6 32.6 36.8 0.4 1.2 1.5 1.7 0.7 1.0 1.4 1.4 1.1 1.0 2.4 1.0 1.3 2.5 0.5 0.9 1.6 0.8 1.1 53.5 60.2 31.0 77.4 58.1 47.9 58.2 46.3 61.9 64.2 33.2 53.9 59.9 14.3 3.2 3.7 5.5 9.4 7.1 5.6 8.0 8.6 17.4 13.7 9.1 6.2 5.7 6.6 18.4 16.7 6.3 11.3 22.2 3.9 7.1 14.7 14.0 16.9 10.5 14.4 4.0 9.1 13.1 6.7 7.2 8.6 20.7 2.5 9.9 10.4 8.1 8.4 28.6 8.6 11.0 4.1 11.1 10.9 40.0 9.0 10.0 5.4 8.4 12.7 8.6 5.2 3.0 5.3 15.0 13.6 5.7 5.5 8.6 14.1 4.6 7.6 13.9 6.6 6.7 9.3 6.3 8.5 11.0 10.5 13.7 10.0 10.4 11.2 9.1 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378649-78425114 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved NA NA "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favorable (7.33e-5)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 15.9 10.1 14.0 18.0 13.9 40.0 15.5 13.1 23.6 13.7 17.1 12.9 11.8 15.0 6.0 10.9 14.1 13.3 11.2 12.4 14.9 12.5 7.0 23.7 17.1 17.1 15.0 11.9 14.0 11.0 11.6 11.6 19.9 15.6 12.5 7.9 6.6 12.0 10.9 13.6 11.3 14.8 10.4 13.5 20.0 11.5 8.9 18.1 14.1 16.6 7.7 11.7 14.6 12.1 17.0 19.9 16.7 17.8 13.5 14.6 23.0 18.8 18.3 17.2 19.3 21.2 17.8 15.8 20.2 10.8 10.8 19.4 15.5 19.8 12.5 15.1 30.3 24.1 22.2 25.0 17.5 15.2 17.7 16.9 23.6 16.1 14.6 12.6 19.1 37.8 15.9 26.0 14.2 13.2 10.8 39.5 19.5 17.4 8.5 15.9 19.4 29.6 16.8 21.0 19.5 21.4 33.2 15.4 16.4 18.5 17.8 17.4 23.8 22.8 24.9 16.6 13.5 15.4 16.0 9.5 15.2 19.1 19.0 18.7 2.1 17.7 19.3 11.0 15.0 13.6 10.3 11.6 11.7 20.6 11.9 14.5 10.6 33.9 11.2 7.2 9.4 15.1 12.0 14.0 13.9 13.1 23.6 12.4 14.9 17.1 15.0 11.9 15.6 13.5 18.1 17.0 25.9 12.8 16.8 10.1 11.6 4.5 12.0 16.3 7.4 13.0 6.4 8.8 5.8 4.3 12.0 12.9 2.1 20.2 11.2 7.7 3.9 5.8 20.0 9.0 8.7 21.5 4.2 5.5 14.8 7.0 8.1 9.7 12.2 6.7 7.6 13.3 15.0 3.9 15.4 20.2 15.0 6.1 6.1 13.9 8.3 10.8 10.5 19.2 5.4 17.8 12.1 11.0 10.3 11.6 20.4 7.2 15.6 8.6 9.4 9.2 8.0 5.2 14.4 11.4 32.9 6.8 10.8 17.9 18.4 5.8 3.8 19.3 10.8 14.7 8.5 10.9 PSMC5 "p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1" ENSG00000087191 "Proteasome 26S subunit, ATPase 5" P62195 17 63827152-63832026 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 596.6;Late spermatids: 1350.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017871, HPA064293" Enhanced Supported "Plasma membrane,Cytosol" NA NA 120000 "Plasma membrane, Cytosol" "HPA017871: AB_1857638, HPA064293: AB_2685234" "unprognostic (9.65e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-1)" "unprognostic (2.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.35e-1)" "unprognostic (8.29e-3)" "unprognostic (1.24e-2)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" "unprognostic (2.17e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (9.54e-2)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" 91.2 99.8 146.3 81.6 147.0 83.1 81.4 151.5 160.3 78.5 141.2 93.4 68.7 80.8 113.3 105.9 83.9 59.9 108.5 145.3 149.5 122.0 113.6 68.7 93.8 151.1 150.5 142.9 63.9 71.6 162.4 83.1 76.1 151.3 82.1 85.2 86.0 74.0 87.5 238.1 122.5 71.2 91.1 148.4 83.0 85.2 73.9 150.2 94.2 87.2 170.2 108.9 94.2 80.2 151.3 240.1 369.1 233.9 172.9 171.4 174.7 202.8 225.3 197.0 327.1 243.8 390.3 154.7 158.7 154.7 241.6 246.0 182.8 239.1 228.5 383.5 136.8 289.7 330.3 288.9 362.4 180.1 336.0 230.4 177.5 171.4 291.9 266.6 139.1 263.7 180.9 258.4 210.2 284.9 450.7 279.4 237.4 215.6 266.3 330.0 248.9 445.5 244.3 249.0 270.9 203.2 274.1 158.6 313.9 152.3 254.4 306.8 197.8 238.8 360.3 329.9 161.5 482.6 220.5 335.2 250.4 225.8 255.7 241.5 105.1 120.4 149.4 164.1 176.3 222.8 142.7 191.6 179.3 140.0 122.0 161.3 183.1 37.7 167.4 206.3 108.6 272.1 216.1 146.3 147.0 151.5 160.3 145.3 149.5 151.1 150.5 142.9 151.3 148.4 150.2 151.3 97.9 51.3 78.6 8.5 82.7 94.6 145.0 206.3 71.7 84.9 71.1 79.1 156.0 110.1 139.6 68.0 18.8 250.4 85.1 98.8 246.5 195.2 596.6 75.4 69.4 104.7 90.9 107.7 7.9 214.5 187.2 101.4 69.3 68.1 90.2 53.3 86.4 130.9 162.9 72.3 7.9 92.7 197.4 89.8 85.0 1350.2 133.0 93.4 99.6 5.6 148.0 221.4 109.2 7.5 10.5 167.5 96.3 153.4 88.0 125.6 163.7 330.3 95.1 108.4 111.7 113.0 228.7 151.6 150.2 95.0 102.9 369.0 102.9 124.7 97.9 137.9 UIMC1 RAP80 ENSG00000087206 "Ubiquitin interaction motif containing 1" Q96RL1 5 176905005-177022633 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 64.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 64.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037503, HPA037504" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA037503: AB_10671373, HPA037504: AB_10671760" "unprognostic (2.96e-1)" "unprognostic (9.57e-2)" "unprognostic (2.48e-3)" "unprognostic (4.40e-2)" "unprognostic (1.69e-1)" "unprognostic (9.88e-3)" "prognostic unfavorable (7.67e-6)" "unprognostic (1.85e-1)" "unprognostic (1.12e-2)" "unprognostic (6.62e-2)" "unprognostic (1.30e-1)" "unprognostic (5.91e-2)" "unprognostic (1.33e-3)" "unprognostic (8.51e-2)" "unprognostic (5.52e-1)" "unprognostic (7.23e-2)" "unprognostic (1.44e-1)" 27.0 24.8 16.8 14.2 16.6 60.8 27.5 23.0 19.3 30.2 19.5 27.9 9.6 29.6 11.3 18.9 26.8 10.9 25.8 16.2 15.5 19.0 18.7 26.6 23.0 14.8 15.7 15.4 36.1 27.4 9.2 19.8 12.8 16.3 23.2 12.5 15.1 17.3 13.4 32.9 23.9 23.5 19.1 14.1 31.6 22.6 62.8 15.6 27.8 23.7 12.1 22.2 29.4 24.0 18.5 27.6 26.6 26.9 33.1 25.8 22.7 38.3 28.1 31.4 35.5 37.0 30.6 30.7 79.1 33.8 23.3 37.8 21.1 27.9 62.7 41.8 91.4 25.4 35.4 30.9 25.7 28.5 43.8 22.7 15.9 29.0 27.0 74.0 26.9 41.6 47.1 30.9 26.1 26.6 25.7 43.1 29.4 19.6 22.2 16.2 39.5 38.8 46.1 38.0 17.4 29.1 23.2 62.3 20.1 30.4 28.3 17.5 24.2 31.6 20.1 20.3 17.7 37.6 39.1 49.8 50.8 19.6 43.2 22.1 15.8 11.8 33.0 9.0 7.0 9.4 11.8 10.3 8.9 7.4 13.9 10.0 8.3 64.5 14.5 4.5 9.5 14.7 6.5 16.8 16.6 23.0 19.3 16.2 15.5 14.8 15.7 15.4 16.3 14.1 15.6 18.5 24.8 12.8 21.0 36.9 31.3 10.5 18.0 11.8 23.3 19.3 10.9 11.8 20.6 8.6 17.3 9.2 14.6 13.9 22.5 7.8 7.9 13.7 27.4 19.4 23.1 17.0 13.1 47.8 59.5 12.9 12.7 17.1 12.2 22.8 18.3 20.6 13.2 8.8 9.9 16.8 53.3 7.9 8.2 14.8 14.1 13.2 15.5 19.8 1.8 44.0 18.0 8.9 19.6 43.7 51.1 17.0 9.1 12.4 24.2 12.9 8.1 8.9 19.2 33.7 13.1 17.7 18.8 132.1 73.8 13.2 11.9 6.8 23.0 35.4 8.7 13.9 CETP BPIFF ENSG00000087237 "Cholesteryl ester transfer protein" P11597 16 56961923-56983845 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Atherosclerosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 33.8;liver: 43.4;lymphoid tissue: 60.1;placenta: 36.6" "Group enriched" "Detected in some" 6 "Adipocytes: 48.6;Hepatic stellate cells: 75.0;Kupffer cells: 142.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.3;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 2.3;HUVEC TERT2: 4.7;TIME: 2.8" "Secreted to blood" NA NA 2470000000 360000000 "unprognostic (6.52e-2)" "unprognostic (4.17e-3)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (4.01e-3)" "unprognostic (4.03e-3)" "unprognostic (3.56e-2)" "unprognostic (1.41e-1)" "unprognostic (3.05e-3)" "unprognostic (4.92e-3)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" "unprognostic (7.62e-2)" "unprognostic (2.20e-2)" "unprognostic (4.08e-2)" "unprognostic (7.34e-2)" "unprognostic (9.97e-2)" 33.8 2.0 0.9 3.8 0.8 5.8 6.7 0.7 1.5 0.3 0.8 0.6 0.9 0.7 0.0 0.3 0.4 4.1 0.7 0.6 0.9 3.7 43.4 2.8 43.7 1.1 0.8 0.5 0.3 0.5 1.8 3.1 36.6 0.9 0.3 0.6 0.0 0.7 0.5 0.3 0.4 1.9 0.9 0.8 60.1 0.4 0.3 1.0 2.4 5.3 0.3 7.6 1.5 0.1 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.1 0.0 0.0 0.1 1.8 2.3 3.2 0.0 1.2 0.9 0.8 0.7 1.5 0.6 0.9 1.1 0.8 0.5 0.9 0.8 1.0 1.2 48.6 0.0 1.8 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 13.4 0.0 5.3 0.1 0.9 0.4 0.2 0.0 0.1 0.0 0.0 75.0 1.3 3.1 0.0 0.1 0.2 0.0 142.0 1.2 0.7 0.0 2.1 0.0 0.0 1.4 0.0 1.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.1 0.6 0.0 0.4 0.0 0.4 1.3 0.0 0.0 MMP2 "CLG4, CLG4A, TBE-1" ENSG00000087245 "Matrix metallopeptidase 2" P08253 16 55389700-55506691 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 1072.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001939, CAB002788" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 1600000000 220000000 Vesicles "CAB002788: , HPA001939: AB_1079395" "unprognostic (7.26e-2)" "unprognostic (1.36e-3)" "unprognostic (1.66e-1)" "unprognostic (2.14e-3)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (9.36e-3)" "unprognostic (4.81e-3)" "unprognostic (3.79e-2)" "unprognostic (4.59e-3)" "unprognostic (6.12e-2)" "unprognostic (1.28e-3)" "unprognostic (1.59e-2)" "unprognostic (8.00e-2)" "unprognostic (8.98e-2)" "unprognostic (4.63e-2)" 423.5 68.9 3.6 136.3 4.9 1.2 331.7 4.9 12.4 475.0 16.4 156.7 58.0 457.3 194.3 122.6 192.3 1072.1 182.7 3.4 6.9 43.5 15.7 282.2 28.3 5.4 4.5 2.2 273.4 43.2 14.0 14.8 226.9 5.5 117.8 173.0 11.5 125.1 138.8 61.3 366.2 178.8 472.5 7.2 58.7 135.1 50.0 5.9 19.9 114.5 66.7 30.6 667.0 240.1 7.8 6.5 3.9 192.0 2.4 5619.3 1623.2 312.7 501.4 1146.1 99.4 79.0 0.2 2.1 0.5 391.7 891.0 37.0 54.2 1.2 4.6 57.0 0.7 0.9 0.7 12.9 3.0 530.6 0.4 14.8 1396.8 1.7 512.4 4.4 6400.4 651.1 0.5 0.7 2.4 334.7 0.0 0.4 8.2 152.4 0.5 1.6 0.4 46.1 0.9 16.1 7.6 3.2 345.0 93.3 0.8 2.1 849.0 1.6 36.0 924.6 1546.0 144.9 300.5 66.9 1.0 0.6 2.2 1812.3 28.3 289.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.9 4.9 12.4 3.4 6.9 5.4 4.5 2.2 5.5 7.2 5.9 7.8 38.4 0.0 0.5 0.0 0.0 122.1 14.1 48.8 9.1 30.5 3.1 16.8 4.4 0.0 3.1 11.0 0.0 5.6 0.5 0.1 0.0 2.5 12.5 7.7 222.4 46.9 28.2 0.0 0.0 0.4 467.9 815.9 12.2 5.4 0.0 0.0 13.2 0.1 28.2 1.7 0.2 0.1 2.0 1.6 180.7 40.2 340.2 11.8 128.1 27.2 0.0 7.7 0.0 5.0 0.0 9.3 0.0 419.0 2.8 5.6 0.0 0.2 1.1 2.5 13.1 80.0 65.3 1.2 2.8 6.6 102.3 17.2 10.3 35.2 0.0 4.4 MT3 GIF ENSG00000087250 "Metallothionein 3" P25713 16 56589074-56591088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 53 "brain: 6495.8;choroid plexus: 3367.6" "Cell type enriched" "Detected in many" 5 "Astrocytes: 228.8" "Cancer enriched" "Detected in many" 58 "glioma: 392.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "naive CD8 T-cell: 5.0" "Lineage enriched" "Detected in single" 51 "T-cells: 5.0" "Cell line enhanced" "Detected in some" "JURKAT: 3.4;RPMI-8226: 6.2;SCLC-21H: 11.0;U-87 MG: 18.3" "Low region specificity" "Detected in all" "HPA004011, CAB017779" Enhanced NA NA "CAB017779: , HPA004011: AB_1854158" "unprognostic (6.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (8.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "unprognostic (2.45e-2)" "unprognostic (7.99e-2)" "unprognostic (1.66e-1)" "unprognostic (8.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.55e-1)" "unprognostic (2.03e-1)" "unprognostic (9.26e-2)" 3.8 92.5 4021.7 0.9 4018.6 0.1 2.9 4000.2 6495.8 4.6 3367.6 12.4 0.2 0.5 0.0 3.0 3.8 0.4 11.7 3909.4 3807.5 6.0 2.2 1.6 0.7 3902.4 3868.2 3892.5 4.7 1.9 2.2 40.7 1.5 3827.6 7.2 2.5 63.8 44.4 0.7 4.3 3.4 4.9 0.3 3699.1 0.9 6.5 10.1 4121.2 1.9 2.1 5.7 12.9 3.8 9.7 3970.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 6.2 0.0 0.0 11.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.4 0.0 0.0 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.5 4021.7 4018.6 4000.2 6495.8 3909.4 3807.5 3902.4 3868.2 3892.5 3827.6 3699.1 4121.2 3970.8 0.4 0.0 0.5 228.8 0.0 0.3 0.1 10.7 0.0 0.0 0.0 0.5 29.6 0.0 4.0 0.0 0.0 0.0 0.0 9.9 45.0 1.7 8.0 8.3 0.1 0.5 10.3 0.0 14.3 0.0 0.1 2.9 0.0 1.8 0.0 3.9 0.7 0.2 0.3 0.0 10.0 12.3 4.1 0.0 0.0 9.7 1.2 0.3 0.0 16.9 0.0 0.0 1.0 43.7 28.2 0.0 3.2 0.4 0.0 0.3 0.3 0.7 18.4 0.0 0.0 3.8 0.7 4.0 2.5 0.0 0.0 0.0 1.5 20.4 8.3 0.1 LPCAT2 "AGPAT11, AYTL1, FLJ20481, LysoPAFAT" ENSG00000087253 "Lysophosphatidylcholine acyltransferase 2" Q7L5N7 16 55509072-55586666 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 89.2;thyroid gland: 87.1" "Cell type enhanced" "Detected in many" "granulocytes: 173.3;Microglial cells: 224.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 151.4;eosinophil: 199.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 199.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 115.9;HaCaT: 89.2;HL-60: 103.0;HMC-1: 161.7;hTERT-RPE1: 162.9;WM-115: 117.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007891, HPA008433" Enhanced Supported Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA007891: AB_1845223, HPA008433: " "unprognostic (1.43e-1)" "unprognostic (2.44e-2)" "prognostic favorable (3.43e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.91e-1)" "unprognostic (9.65e-3)" "unprognostic (8.12e-3)" "unprognostic (3.26e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (3.18e-3)" "unprognostic (9.16e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" 8.7 9.1 5.6 14.5 8.0 89.2 12.3 11.2 6.1 14.1 12.4 9.1 7.4 18.6 37.0 7.9 8.9 10.5 5.7 5.2 9.7 11.0 4.0 10.5 5.1 14.2 9.3 3.4 15.9 5.5 13.7 1.0 16.1 15.3 7.1 9.4 7.8 8.5 28.9 2.2 12.1 9.2 15.2 15.4 11.9 9.1 4.2 9.1 3.6 87.1 5.9 4.1 9.6 7.6 20.2 33.5 4.2 3.5 0.3 10.8 4.1 5.6 14.1 13.5 6.8 6.9 7.5 115.9 0.0 46.6 19.9 5.5 89.2 2.2 19.4 10.9 9.1 9.6 34.2 10.2 17.3 4.1 103.0 161.7 2.1 19.2 7.5 6.3 162.9 53.5 1.8 1.5 0.4 11.6 2.1 0.0 41.8 5.1 9.5 0.4 10.4 3.8 5.1 6.8 12.9 2.2 25.3 27.1 10.8 19.9 15.8 4.6 25.8 60.3 0.3 0.1 6.9 9.6 0.6 0.2 0.2 0.5 49.4 117.8 151.4 17.5 199.2 0.0 27.4 0.0 0.0 0.0 0.0 21.0 0.1 0.0 0.0 47.0 0.0 39.1 0.7 0.0 6.5 5.6 8.0 11.2 6.1 5.2 9.7 14.2 9.3 3.4 15.3 15.4 9.1 20.2 68.6 6.4 25.7 2.9 1.1 15.4 37.2 68.3 17.1 5.5 8.8 33.9 2.2 4.3 22.3 68.0 10.4 0.7 3.3 7.0 1.9 8.3 1.7 6.4 4.8 41.0 1.2 9.7 8.1 9.7 7.5 20.7 10.2 13.9 173.3 0.4 12.1 2.0 36.5 0.0 11.7 12.2 18.3 71.9 57.7 3.1 16.4 74.4 17.8 224.9 40.6 24.0 0.0 4.5 66.5 32.8 23.0 12.8 1.0 9.0 3.4 3.5 8.1 5.3 0.0 20.0 4.2 49.6 24.0 14.2 15.3 1.9 5.6 7.0 11.6 17.6 GNAO1 G-ALPHA-o ENSG00000087258 "G protein subunit alpha o1" P09471 16 56191390-56357444 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transducer "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 132.9;retina: 52.9" "Cell type enhanced" "Detected in many" "Astrocytes: 135.8;Bipolar cells: 189.2;Excitatory neurons: 138.7;Inhibitory neurons: 132.2;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 368.3" "Cancer enriched" "Detected in many" 5 "glioma: 11.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 30.7;BJ hTERT+ SV40 Large T+: 20.0;SCLC-21H: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008387, HPA040878" Enhanced NA NA 510000 "CAB008387: AB_591430, HPA040878: AB_2677184" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (8.12e-2)" "unprognostic (1.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (6.87e-2)" "unprognostic (1.68e-4)" "unprognostic (3.08e-1)" "unprognostic (1.74e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (6.86e-3)" "unprognostic (6.28e-2)" "unprognostic (1.21e-1)" "unprognostic (6.00e-1)" "unprognostic (9.70e-5)" 3.0 8.0 97.1 3.4 132.9 0.1 1.1 49.7 123.1 1.9 0.0 25.0 3.2 7.8 3.1 2.9 2.9 2.6 20.2 98.3 77.1 1.1 10.2 0.9 1.1 109.0 87.6 95.0 1.7 3.9 1.5 28.7 0.5 103.8 5.2 5.2 52.9 2.3 16.7 2.0 1.3 7.4 10.2 40.0 1.3 11.0 13.9 97.8 1.2 1.9 0.6 1.1 8.0 2.5 104.8 7.3 0.0 0.6 0.1 0.0 0.1 0.9 7.6 30.7 20.0 9.5 0.4 0.0 0.0 0.2 0.0 7.3 0.6 4.9 0.0 13.7 0.2 0.9 0.0 2.0 0.0 0.0 0.0 2.7 0.1 0.2 0.0 0.0 0.0 0.0 6.1 0.0 0.2 0.0 0.8 0.0 0.1 11.1 0.3 0.1 0.1 7.1 0.1 0.0 0.0 61.2 12.2 12.5 0.2 0.7 3.1 0.2 0.0 0.0 0.2 6.8 0.0 3.6 0.8 0.0 0.1 0.3 0.5 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 97.1 132.9 49.7 123.1 98.3 77.1 109.0 87.6 95.0 103.8 40.0 97.8 104.8 0.6 0.0 0.5 135.8 0.8 0.8 0.3 0.2 0.0 189.2 1.4 0.6 43.3 1.5 0.1 0.0 6.2 0.4 4.9 0.1 0.0 0.0 26.8 0.7 4.4 1.5 23.3 0.8 138.7 0.0 0.2 6.8 1.5 1.2 0.0 0.2 0.7 10.4 0.1 79.1 132.2 1.0 0.0 0.8 2.1 53.6 34.8 1.7 3.6 13.1 0.0 20.5 1.0 87.9 368.3 0.3 0.0 44.4 2.1 0.4 0.1 0.3 0.1 13.1 0.0 8.2 5.6 15.4 8.8 0.3 0.4 0.1 7.2 0.1 0.3 0.2 OGFOD1 "FLJ10826, KIAA1612, TPA1" ENSG00000087263 "2-oxoglutarate and iron dependent oxygenase domain containing 1" Q8N543 16 56451521-56479104 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003215, HPA003722" Approved Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003215: AB_1078881, HPA003722: " "unprognostic (1.13e-1)" "unprognostic (4.52e-2)" "unprognostic (3.80e-3)" "unprognostic (2.86e-2)" "unprognostic (2.48e-3)" "prognostic unfavorable (6.65e-4)" "prognostic unfavorable (7.02e-4)" "unprognostic (5.51e-2)" "unprognostic (6.87e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-2)" "unprognostic (4.59e-2)" "unprognostic (7.49e-2)" "unprognostic (7.20e-2)" "unprognostic (6.11e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-2)" 9.7 12.5 5.6 8.9 6.8 4.0 9.6 5.6 7.4 10.5 4.1 7.8 8.9 9.9 7.7 19.6 10.7 6.7 14.7 5.6 7.2 9.3 9.1 8.0 8.9 6.7 6.2 5.3 8.2 5.7 12.1 6.1 9.2 6.8 8.4 9.7 9.7 6.4 9.6 31.8 6.2 5.2 16.9 5.1 7.6 6.2 9.5 6.7 10.6 10.3 23.7 14.6 9.2 5.7 9.2 25.4 27.4 25.7 32.5 28.6 34.5 26.0 39.1 29.9 52.4 38.5 34.5 16.5 44.7 19.0 29.3 21.7 34.9 57.2 25.5 57.3 14.1 29.6 32.4 21.6 32.8 21.4 34.9 36.2 23.2 29.0 38.7 31.2 23.1 45.3 29.3 44.3 8.2 46.2 15.6 27.4 19.2 45.0 19.8 47.2 51.2 41.0 51.9 22.9 16.7 20.4 24.1 46.3 29.0 25.2 26.9 26.4 30.1 28.9 28.1 23.2 22.9 36.7 18.0 37.1 67.5 22.9 26.5 22.7 13.4 4.6 4.5 7.7 6.4 10.1 7.1 9.5 9.4 6.4 5.6 10.7 8.4 1.5 8.5 8.6 6.8 9.0 5.9 5.6 6.8 5.6 7.4 5.6 7.2 6.7 6.2 5.3 6.8 5.1 6.7 9.2 8.9 3.2 16.0 9.8 14.1 17.7 13.8 11.2 17.6 11.3 13.1 10.7 21.4 20.0 15.0 9.2 10.4 18.3 11.7 5.8 25.4 13.7 22.2 11.6 20.0 12.2 2.4 19.6 14.4 14.1 20.5 22.3 12.2 19.1 45.7 13.0 9.7 17.6 12.0 13.5 16.6 7.9 4.1 6.9 10.2 15.6 12.2 10.9 10.6 4.7 16.1 13.6 10.3 9.0 14.5 17.4 5.5 15.8 16.1 11.0 4.6 13.8 8.0 15.2 13.1 16.7 19.0 26.0 29.6 21.2 18.9 11.6 18.4 19.1 10.6 9.0 SH3BP2 "CRBM, RES4-23" ENSG00000087266 "SH3 domain binding protein 2" P78314 4 2793071-2841098 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036789, HPA036790" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036789: , HPA036790: AB_10671712" "unprognostic (7.86e-2)" "unprognostic (3.45e-1)" "unprognostic (9.83e-2)" "prognostic unfavorable (5.42e-6)" "prognostic unfavorable (9.52e-4)" "prognostic favorable (1.57e-5)" "unprognostic (6.58e-2)" "unprognostic (3.16e-2)" "unprognostic (3.17e-2)" "unprognostic (6.41e-3)" "unprognostic (3.35e-2)" "unprognostic (3.30e-2)" "unprognostic (3.24e-3)" "unprognostic (1.78e-2)" "unprognostic (5.32e-1)" "unprognostic (1.78e-1)" "prognostic favorable (2.67e-4)" 15.5 6.9 15.9 30.3 17.4 48.6 7.9 19.7 13.4 6.0 7.6 12.4 11.5 6.9 9.9 7.1 9.0 8.8 6.8 12.7 20.7 13.2 12.2 17.1 23.4 32.5 26.8 7.0 5.8 9.7 4.8 5.1 12.9 25.3 5.3 9.2 5.2 10.5 8.4 17.0 39.7 16.2 10.6 17.9 44.3 16.9 5.2 31.1 8.5 4.8 4.8 13.5 12.4 9.7 20.8 11.2 5.2 7.4 8.7 4.6 14.6 7.2 16.8 13.0 11.1 10.9 6.9 31.6 18.0 20.5 14.2 9.7 5.6 0.3 10.5 7.5 12.2 6.8 41.4 15.2 6.1 17.1 15.4 29.1 27.7 10.5 7.1 5.9 11.8 25.7 13.7 2.5 37.2 15.0 9.6 2.7 24.3 13.3 21.6 13.3 0.6 7.4 9.9 20.1 16.1 25.4 16.4 12.8 10.7 10.3 6.8 15.7 30.8 35.4 12.1 8.9 4.2 13.8 19.5 10.6 4.3 14.1 40.2 14.4 4.1 21.0 13.6 13.8 36.5 8.2 3.0 3.8 8.8 15.9 6.9 1.9 5.0 33.8 8.3 44.6 6.7 6.9 12.1 15.9 17.4 19.7 13.4 12.7 20.7 32.5 26.8 7.0 25.3 17.9 31.1 20.8 27.6 3.2 5.8 40.5 19.5 38.1 10.0 35.3 8.6 0.8 19.8 10.0 8.3 7.2 25.3 40.5 0.0 1.3 43.7 42.5 3.9 6.3 8.5 9.7 11.0 31.3 10.2 14.9 0.4 22.0 1.2 11.3 18.3 22.0 9.5 11.6 33.9 59.0 49.3 0.0 2.7 14.2 30.5 81.5 63.3 10.8 13.7 71.9 19.6 18.7 48.9 23.7 57.7 2.5 0.5 25.3 27.1 10.1 18.1 16.1 23.7 43.7 12.3 6.4 39.5 5.2 16.0 1.9 3.7 18.6 83.4 4.2 22.0 25.5 15.4 20.1 NOP14 "C4orf9, NOL14, RES4-25, UTP2" ENSG00000087269 "NOP14 nucleolar protein" P78316 4 2937933-2963406 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039596, HPA055652" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA039596: AB_2676590, HPA055652: AB_2682876" "unprognostic (4.70e-2)" "unprognostic (6.47e-2)" "prognostic favorable (3.93e-5)" "unprognostic (7.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (2.41e-2)" "unprognostic (8.62e-2)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (2.55e-3)" "unprognostic (1.16e-1)" "unprognostic (1.27e-3)" "unprognostic (1.44e-1)" "unprognostic (7.15e-2)" "unprognostic (4.77e-2)" 17.3 15.9 4.7 18.5 5.8 23.1 16.7 10.8 5.1 12.5 6.2 13.7 12.5 13.3 6.0 18.5 12.3 9.4 13.0 4.2 5.0 10.6 19.1 12.5 23.6 5.3 5.4 3.5 19.3 24.8 11.2 11.1 12.2 6.9 11.7 12.8 7.1 14.0 9.1 42.0 22.3 13.7 11.6 4.9 15.3 15.5 7.8 5.7 15.9 15.7 14.7 19.8 20.0 14.7 6.9 52.7 43.8 25.6 52.9 33.6 37.9 44.6 47.4 33.5 48.2 39.6 57.5 54.1 148.0 32.8 38.7 35.1 35.5 71.1 61.5 51.6 28.4 67.8 117.8 40.5 52.6 44.3 129.3 49.2 38.6 54.2 54.7 49.5 23.9 41.3 44.6 108.7 50.9 37.0 37.7 137.4 94.4 66.6 48.0 70.7 87.8 38.7 49.3 24.1 83.2 52.6 30.9 39.4 28.8 37.9 23.0 55.0 50.3 51.7 40.3 23.3 49.6 88.3 37.9 65.8 124.8 41.9 93.6 42.6 1.0 2.1 0.4 2.8 2.4 4.9 2.1 3.4 4.3 2.5 3.5 4.1 3.1 0.2 3.2 1.6 3.1 2.5 2.1 4.7 5.8 10.8 5.1 4.2 5.0 5.3 5.4 3.5 6.9 4.9 5.7 6.9 13.3 19.2 30.5 3.6 22.2 25.9 23.4 11.6 27.9 9.6 12.2 12.2 20.2 12.8 23.9 1.8 14.6 16.8 21.0 11.8 11.7 19.5 2.6 13.6 27.8 16.5 9.0 22.3 4.7 24.0 18.4 16.3 20.9 16.4 20.8 25.9 8.6 24.3 11.0 20.2 5.7 11.6 4.1 7.0 12.1 2.6 12.5 14.6 0.0 3.7 15.3 6.3 10.3 3.0 4.7 21.3 6.5 9.8 28.1 27.1 5.1 14.1 12.0 7.7 13.1 23.3 19.7 11.8 19.1 32.5 32.5 11.5 24.1 38.5 17.0 21.4 ADD1 ENSG00000087274 "Adducin 1" P35611 4 2843857-2930076 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009794, HPA035873, HPA035874" Enhanced Enhanced "Nucleoplasm,Plasma membrane" NA NA 360000 "Plasma membrane" Nucleoplasm "CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (5.40e-3)" "unprognostic (1.90e-1)" "unprognostic (2.66e-2)" "unprognostic (5.07e-3)" "unprognostic (1.68e-2)" "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "prognostic favorable (3.94e-4)" "unprognostic (5.22e-2)" "prognostic favorable (1.29e-7)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-3)" 99.4 70.6 86.2 61.3 102.2 66.4 89.9 75.9 117.8 96.0 42.2 113.4 66.1 122.4 58.4 72.5 97.2 69.7 101.8 89.0 78.2 74.8 54.2 94.3 65.8 91.6 91.0 77.3 130.7 56.9 68.0 70.7 66.5 109.4 86.9 63.3 271.4 62.4 108.3 167.9 68.3 93.1 111.2 63.5 89.7 85.0 53.6 95.2 76.7 72.3 116.1 62.6 116.3 83.6 107.3 74.7 61.2 142.0 73.8 205.8 152.6 53.2 123.2 146.9 125.6 105.3 90.5 91.8 38.7 63.0 212.3 146.6 46.6 107.5 103.4 104.3 49.9 49.4 109.5 50.4 87.9 100.4 65.8 74.7 151.6 95.2 110.4 44.0 130.1 158.5 71.9 116.0 90.8 145.1 43.7 203.7 91.6 80.0 67.9 85.7 89.1 78.6 45.7 91.2 162.2 84.8 110.0 88.9 35.8 76.9 107.0 84.2 61.7 193.4 102.1 52.4 84.7 103.0 72.5 63.3 48.9 98.2 80.4 100.9 20.1 7.6 35.5 19.1 7.3 17.6 23.8 10.6 16.3 12.0 31.2 9.8 11.8 10.5 27.2 11.4 25.4 14.8 16.0 86.2 102.2 75.9 117.8 89.0 78.2 91.6 91.0 77.3 109.4 63.5 95.2 107.3 89.3 70.5 45.4 141.3 66.5 26.9 29.8 33.0 27.9 99.5 41.2 41.5 78.0 40.0 46.3 60.7 402.4 35.5 84.0 51.3 15.6 37.3 48.5 43.9 61.2 89.4 57.7 57.9 85.7 45.8 32.5 72.9 39.8 58.1 37.3 53.0 84.3 41.8 41.8 111.0 83.2 39.3 28.5 51.6 42.2 35.9 77.6 47.4 35.6 72.1 58.3 233.8 120.5 68.9 178.6 53.2 39.4 121.9 49.7 35.8 48.6 44.6 40.4 624.3 98.6 58.4 73.1 45.3 33.2 30.5 36.7 36.5 55.6 80.7 45.1 33.0 L2HGDH "C14orf160, FLJ12618" ENSG00000087299 "L-2-hydroxyglutarate dehydrogenase" Q9H9P8 14 50237563-50312229 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065409, HPA069708" Approved Enhanced Mitochondria NA NA Mitochondria "HPA065409: AB_2685485, HPA069708: AB_2686179" "unprognostic (1.74e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-3)" "unprognostic (1.04e-2)" "unprognostic (4.33e-2)" "unprognostic (8.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (9.91e-2)" "unprognostic (2.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (9.75e-10)" "unprognostic (1.24e-2)" "unprognostic (5.88e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" 4.6 2.6 2.2 2.2 3.1 2.7 3.8 6.2 5.7 2.3 1.2 4.3 4.8 2.4 3.0 5.1 3.1 2.0 5.2 2.9 2.5 19.8 12.7 1.8 2.6 1.5 2.4 3.1 2.5 3.9 6.2 2.4 1.7 3.5 3.3 5.1 11.5 2.8 3.2 15.7 5.1 3.7 2.5 0.5 1.3 4.4 3.9 2.1 3.0 4.8 14.8 3.4 2.4 2.3 4.2 24.3 16.6 6.8 6.6 3.3 2.2 19.1 7.9 4.4 12.2 14.3 26.8 10.8 19.0 9.0 3.2 9.7 17.4 20.6 8.2 13.5 15.2 11.9 41.1 10.9 3.7 3.1 14.7 13.7 2.0 5.2 8.1 7.0 3.1 5.3 19.3 14.7 11.6 3.2 29.0 16.7 6.7 9.9 20.6 17.6 15.6 22.0 14.8 11.4 28.0 13.8 9.9 23.3 17.5 10.4 9.0 22.9 4.0 5.0 7.7 21.5 9.0 10.6 10.5 25.6 26.3 4.3 7.3 8.8 8.6 0.4 0.9 0.9 0.1 2.2 0.8 1.1 1.0 0.6 0.6 1.3 1.7 0.5 1.7 0.1 1.0 1.6 0.5 2.2 3.1 6.2 5.7 2.9 2.5 1.5 2.4 3.1 3.5 0.5 2.1 4.2 1.9 41.7 19.2 16.6 5.1 3.7 2.7 2.1 8.6 15.5 3.9 2.2 14.7 2.8 20.4 12.9 56.3 6.4 6.1 4.8 15.6 3.8 35.1 5.2 2.8 4.6 7.8 7.4 60.5 4.2 6.6 5.3 7.7 5.6 18.9 6.0 2.9 14.2 2.1 11.8 61.4 4.3 0.0 2.7 0.6 8.8 2.5 3.3 1.8 13.1 2.4 6.1 7.2 20.6 18.9 2.5 3.6 4.5 3.3 2.7 6.0 21.7 18.4 40.3 0.0 5.8 3.9 14.3 12.6 10.5 6.3 4.9 5.0 4.6 7.6 2.1 TXNDC16 KIAA1344 ENSG00000087301 "Thioredoxin domain containing 16" Q9P2K2 14 52430596-52552522 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 69.8;Glandular and luminal cells: 124.9;Inhibitory neurons: 88.8" "Cancer enhanced" "Detected in all" "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002543 Approved Approved Mitochondria "Secreted to blood" NA NA Mitochondria "HPA002543: AB_1079199" "unprognostic (1.37e-1)" "unprognostic (7.79e-3)" "unprognostic (5.95e-3)" "unprognostic (2.36e-1)" "unprognostic (5.95e-3)" "unprognostic (9.73e-2)" "unprognostic (2.50e-1)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-2)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (3.55e-3)" "unprognostic (2.04e-1)" 6.2 4.0 4.5 3.5 5.1 5.1 7.0 10.7 6.0 9.3 1.4 5.9 4.1 7.0 14.8 3.7 4.1 5.3 3.8 5.0 5.0 5.0 7.4 4.5 4.5 4.3 5.5 4.5 10.3 6.5 7.1 3.9 5.9 5.7 27.0 6.0 9.2 4.0 13.1 2.0 4.7 4.8 4.3 4.8 10.3 6.3 7.1 4.5 5.9 4.0 4.0 3.9 3.4 3.9 6.9 8.3 0.8 8.9 5.0 6.5 4.7 7.0 2.7 3.6 4.5 8.7 3.0 6.6 13.5 8.9 2.2 2.8 7.7 10.3 3.7 6.9 5.7 13.5 6.2 6.2 2.8 4.7 7.4 2.9 8.8 3.4 5.8 4.2 4.0 5.1 5.8 8.0 20.4 3.9 4.0 9.3 5.1 9.9 5.5 4.9 18.4 16.9 12.4 5.7 8.4 29.0 10.0 13.2 13.5 3.9 7.5 8.6 5.4 2.7 6.0 3.0 6.9 4.6 5.6 8.0 13.5 1.7 7.7 3.5 1.3 3.0 1.2 1.3 2.4 1.3 0.5 1.3 0.9 2.6 0.3 0.6 0.6 1.7 0.6 2.9 1.0 2.4 1.0 4.5 5.1 10.7 6.0 5.0 5.0 4.3 5.5 4.5 5.7 4.8 4.5 6.9 9.1 9.6 6.4 23.2 6.1 6.6 6.0 2.5 9.6 42.3 26.6 19.0 10.1 8.6 5.0 7.3 8.4 2.3 15.1 8.8 1.9 5.2 4.0 69.8 9.6 7.4 18.5 21.8 61.0 3.9 1.6 7.2 13.3 124.9 2.5 13.9 15.4 14.1 3.3 10.1 88.8 17.9 0.0 18.8 8.6 4.2 27.7 13.0 1.8 24.4 5.9 7.3 7.2 45.8 51.5 1.3 8.5 52.3 11.3 19.0 5.9 2.8 4.4 44.8 0.0 11.1 11.2 12.0 9.5 8.1 8.4 1.1 7.7 5.7 10.9 4.5 RTRAF "C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1" ENSG00000087302 "RNA transcription, translation and transport factor" Q9Y224 14 51989514-52010694 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 316.0;Distal tubular cells: 309.1;Exocrine glandular cells: 289.7;Extravillous trophoblasts: 349.6;Proximal tubular cells: 303.7;Syncytiotrophoblasts: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039824 Supported Supported Nucleoplasm NA NA 48000 Nucleoplasm "HPA039824: AB_10793922" "unprognostic (2.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.89e-2)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (6.08e-2)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (2.23e-2)" "unprognostic (6.50e-2)" "unprognostic (2.80e-1)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (3.34e-1)" "unprognostic (5.03e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-1)" 90.0 93.5 47.4 74.4 48.7 140.1 88.0 50.6 60.8 68.1 52.9 89.0 61.9 71.7 87.8 79.8 65.1 68.4 139.9 46.6 54.2 78.0 79.5 64.5 106.3 50.6 49.0 45.8 97.4 115.0 74.7 66.2 68.8 49.6 67.2 89.6 56.8 77.5 59.3 157.1 79.4 67.8 77.6 51.6 61.7 99.7 143.5 48.8 108.0 81.9 103.1 106.2 88.7 63.3 54.8 214.6 142.1 239.8 233.7 157.7 208.3 228.8 166.9 183.6 180.9 203.1 153.2 184.0 290.8 174.0 139.5 142.2 167.1 226.2 152.6 234.7 158.0 126.5 113.3 287.8 206.7 252.1 243.8 125.0 158.5 155.6 136.6 223.5 210.1 207.2 269.6 118.8 135.1 177.3 237.6 310.8 306.3 187.1 247.8 238.1 278.6 228.0 138.0 176.1 245.2 169.0 171.6 211.0 376.7 274.7 301.3 252.8 190.4 146.0 196.6 216.4 167.2 212.7 50.5 76.2 295.7 96.9 189.3 228.7 54.8 93.3 58.7 73.5 104.7 91.1 108.8 102.0 88.6 117.6 90.9 93.2 95.2 19.2 96.1 112.5 107.9 144.0 126.6 47.4 48.7 50.6 60.8 46.6 54.2 50.6 49.0 45.8 49.6 51.6 48.8 54.8 168.6 44.8 67.2 0.0 39.2 0.0 0.0 0.0 0.0 0.0 181.7 232.8 0.0 0.0 39.0 73.5 0.0 316.0 83.1 0.0 309.1 226.6 0.0 164.3 108.1 77.5 0.0 0.0 0.0 289.7 349.6 77.4 0.0 103.6 61.8 242.8 0.0 0.0 240.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.0 154.5 0.0 0.0 0.0 0.0 232.4 0.0 0.0 13.0 0.0 0.0 303.7 49.6 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 261.6 53.6 233.9 0.0 0.0 NID2 ENSG00000087303 "Nidogen 2" Q14112 14 52004803-52069228 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.3" "Cell type enhanced" "Detected in many" "Adipocytes: 31.0;Endothelial cells: 19.7;Fibroblasts: 46.0;Microglial cells: 19.7;Smooth muscle cells: 22.6;Theca cells: 19.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 15.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 285.4;ASC TERT1: 113.0;BJ: 152.1;BJ hTERT+: 131.8;HHSteC: 158.1;HSkMC: 591.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052460, HPA058772" Enhanced Enhanced "Plasma membrane" "Secreted to extracellular matrix" NA NA 6300000 "Plasma membrane" "HPA052460: AB_2681840, HPA058772: AB_2683815" "unprognostic (6.51e-2)" "unprognostic (3.55e-3)" "unprognostic (3.73e-2)" "unprognostic (3.25e-2)" "unprognostic (2.04e-1)" "unprognostic (1.94e-1)" "unprognostic (5.37e-2)" "unprognostic (3.05e-3)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (4.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.48e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (4.58e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.78e-4)" 28.5 5.3 0.7 9.2 0.8 0.7 9.7 0.5 2.4 7.4 37.5 7.4 2.3 17.5 5.9 5.4 6.7 19.1 15.7 1.3 0.5 4.9 6.0 6.2 3.6 1.8 0.9 0.2 19.1 3.5 13.3 2.5 61.3 0.5 8.5 6.9 0.1 3.7 10.5 4.4 1.6 3.6 11.5 1.0 1.9 6.9 1.4 0.7 2.1 31.9 5.6 1.4 15.5 5.4 1.7 0.0 3.4 76.6 0.0 285.4 113.0 0.2 152.1 131.8 14.5 15.0 0.4 0.0 0.0 22.2 17.3 0.0 10.7 9.9 0.1 3.9 0.1 2.0 0.0 3.0 0.0 158.1 0.0 0.0 591.5 0.0 59.6 0.1 82.5 8.1 0.1 0.0 0.0 8.6 0.0 0.0 0.4 3.3 0.0 5.1 23.5 0.2 0.1 19.9 0.0 0.0 1.8 0.0 0.1 0.0 10.0 0.0 0.0 0.9 54.4 0.6 33.0 0.0 0.0 0.0 0.1 17.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 2.4 1.3 0.5 1.8 0.9 0.2 0.5 1.0 0.7 1.7 31.0 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.6 1.4 0.2 0.3 2.1 0.0 0.0 1.8 0.0 0.7 0.7 3.7 0.0 0.1 14.0 1.5 11.3 19.7 0.0 0.0 0.8 0.0 1.1 46.0 1.1 0.4 1.3 0.4 8.6 0.0 1.6 0.0 1.7 2.0 0.0 0.3 1.2 4.4 6.2 0.3 3.6 19.7 1.0 0.0 0.0 2.0 4.8 0.2 1.3 8.6 0.1 0.2 1.7 0.4 0.0 0.8 6.6 6.1 22.6 0.2 0.1 0.1 1.0 0.8 0.4 19.1 3.0 0.2 GMCL1 "BTBD13, FLJ13057, GCL1, SPATA29" ENSG00000087338 "Germ cell-less 1, spermatogenesis associated" Q96IK5 2 69829660-69881384 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 264.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 93.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039579 Approved NA NA "HPA039579: AB_10805480" "unprognostic (1.89e-2)" "unprognostic (4.95e-2)" "unprognostic (2.53e-2)" "unprognostic (1.79e-2)" "unprognostic (4.09e-2)" "unprognostic (1.96e-1)" "unprognostic (5.20e-2)" "unprognostic (2.60e-3)" "unprognostic (1.27e-1)" "unprognostic (8.80e-2)" "unprognostic (3.04e-1)" "unprognostic (5.94e-2)" "unprognostic (2.48e-3)" "unprognostic (1.10e-2)" "unprognostic (1.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" 9.5 6.5 5.2 8.1 5.4 13.8 10.7 6.2 6.5 8.7 10.9 10.8 16.1 7.8 8.9 8.3 8.0 8.6 4.9 5.9 5.5 11.6 10.8 7.8 12.1 5.3 5.6 5.1 8.6 9.2 19.3 6.5 9.4 5.1 11.2 12.3 6.2 9.5 8.8 4.2 8.9 13.2 6.4 5.4 9.2 8.6 16.5 5.1 18.7 9.2 5.4 12.3 8.4 6.3 6.1 14.7 10.3 17.2 18.4 15.0 13.1 18.4 12.1 8.0 8.1 13.7 9.9 13.5 30.7 9.7 8.0 9.5 14.2 20.3 10.5 14.1 14.2 21.2 48.0 11.3 22.8 9.9 36.1 32.4 7.2 11.3 6.4 14.9 10.5 14.5 23.2 19.5 21.8 12.9 12.6 37.1 33.7 18.4 24.9 9.6 26.1 22.6 23.6 11.9 22.2 27.0 22.5 13.2 19.1 14.8 13.4 12.6 22.2 9.0 12.4 15.5 19.4 14.7 22.1 28.6 18.9 12.8 29.5 13.0 93.5 8.0 40.1 11.1 6.3 19.1 8.8 10.9 13.7 7.5 8.3 15.6 15.5 26.8 26.8 10.3 7.9 15.5 9.4 5.2 5.4 6.2 6.5 5.9 5.5 5.3 5.6 5.1 5.1 5.4 5.1 6.1 17.9 28.9 27.4 22.9 25.9 26.8 21.4 19.5 27.3 22.5 28.3 20.4 7.6 74.4 22.0 18.4 27.1 38.3 42.5 40.0 41.1 36.1 264.8 26.7 21.8 19.5 23.4 29.0 68.1 17.5 51.9 19.4 16.3 18.4 22.2 24.2 26.4 25.4 15.9 21.9 63.8 37.0 44.7 23.8 13.1 50.8 15.8 15.0 16.0 11.2 22.8 44.2 50.4 42.7 45.6 15.2 21.7 22.6 28.2 33.0 42.1 23.2 38.4 37.0 13.1 26.0 21.1 44.2 45.1 38.4 27.7 81.5 36.7 17.5 30.6 25.7 SF3B2 "Cus1, SAP145, SF3b1, SF3b145" ENSG00000087365 "Splicing factor 3b subunit 2" Q13435 11 66050729-66069308 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045028 Supported Enhanced "Nuclear speckles" NA NA 130000 "Nuclear speckles" "HPA045028: AB_10965174" "unprognostic (1.48e-1)" "unprognostic (1.51e-1)" "unprognostic (6.45e-2)" "unprognostic (3.29e-1)" "unprognostic (9.86e-2)" "unprognostic (7.10e-2)" "prognostic unfavorable (6.43e-5)" "unprognostic (8.43e-2)" "unprognostic (4.69e-1)" "unprognostic (2.79e-1)" "unprognostic (3.15e-2)" "unprognostic (1.44e-1)" "prognostic favorable (3.51e-5)" "unprognostic (4.03e-2)" "unprognostic (3.56e-1)" "unprognostic (5.14e-2)" "unprognostic (2.60e-2)" 111.7 96.8 120.4 81.2 129.3 145.9 109.9 123.2 140.6 122.6 126.1 96.4 71.4 112.5 96.3 97.4 113.3 55.7 94.5 123.9 123.6 107.5 112.9 105.2 99.8 126.0 123.5 117.1 137.3 138.6 89.6 138.2 81.2 124.4 100.1 77.7 97.4 92.0 74.5 109.0 116.4 99.3 80.7 122.8 114.8 103.8 146.4 127.1 110.5 116.2 55.1 114.9 109.2 105.6 140.4 226.9 177.3 189.0 178.9 184.3 163.5 153.1 168.4 210.5 234.9 176.8 149.8 188.9 212.5 185.7 186.7 249.5 202.9 263.2 177.8 208.8 170.2 143.5 223.3 164.2 245.5 187.8 229.7 171.5 137.9 174.0 242.5 287.8 171.3 172.7 180.5 215.2 348.7 191.4 309.8 257.5 343.2 196.1 166.2 163.9 235.6 162.9 299.0 192.3 186.0 147.8 218.0 165.9 175.9 257.0 136.3 217.2 147.1 156.7 206.9 178.0 229.0 194.3 267.5 337.0 270.8 229.6 151.6 191.9 152.1 96.2 167.9 135.3 117.2 131.1 106.8 120.3 128.2 98.5 110.2 116.7 116.8 130.2 116.3 160.1 78.8 131.8 147.5 120.4 129.3 123.2 140.6 123.9 123.6 126.0 123.5 117.1 124.4 122.8 127.1 140.4 86.5 128.2 131.0 18.6 144.3 111.3 148.9 165.9 129.1 94.9 69.1 65.0 68.5 98.7 141.5 66.2 89.6 195.9 131.8 114.3 92.0 172.2 278.2 119.5 103.2 104.4 82.5 113.6 19.2 214.8 183.7 117.6 95.8 92.0 120.8 119.0 80.7 72.4 124.9 107.7 19.3 112.4 130.2 103.6 115.0 78.5 120.2 103.8 65.8 10.3 195.6 122.1 155.5 12.1 28.9 158.9 96.3 130.1 198.3 136.6 101.1 108.1 214.7 109.4 78.9 106.1 153.7 220.1 172.0 103.2 99.0 186.6 145.5 118.7 122.3 130.8 KLHL42 "Ctb9, KIAA1340, KLHDC5" ENSG00000087448 "Kelch like family member 42" Q9P2K6 12 27780048-27803040 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Peritubular cells: 172.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020979 Uncertain NA NA "HPA020979: AB_1852559" "unprognostic (4.68e-2)" "unprognostic (1.00e-1)" "unprognostic (3.30e-1)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (5.46e-2)" "unprognostic (7.38e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (4.92e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.22e-1)" "unprognostic (1.36e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" 8.7 7.4 9.6 11.7 12.5 4.6 9.5 7.9 13.1 11.4 2.1 18.5 8.6 19.2 9.7 13.3 13.5 11.8 5.9 12.7 11.9 7.6 6.4 9.2 9.4 9.3 10.1 10.5 8.2 21.5 12.4 9.9 14.3 9.9 14.9 12.2 14.0 6.2 19.0 2.7 9.7 10.1 23.3 8.3 8.8 12.3 10.3 11.2 6.6 10.3 2.6 8.1 21.8 9.8 16.4 11.8 14.9 24.2 22.2 25.9 15.9 23.9 22.5 17.0 16.4 17.6 10.5 16.0 14.6 9.5 14.9 12.6 23.8 11.9 15.6 16.4 19.5 14.5 19.4 29.3 6.9 12.0 17.1 15.2 15.7 12.9 14.3 20.4 21.1 18.7 12.0 6.3 8.0 13.3 10.6 11.9 17.1 34.6 7.6 20.6 13.0 22.1 2.8 9.8 19.2 8.4 24.3 16.6 13.2 17.9 33.8 20.0 15.6 30.2 22.8 13.7 27.7 25.1 9.9 5.5 25.5 14.6 11.2 16.2 0.0 0.5 0.2 1.0 0.4 1.0 0.1 1.1 0.7 0.3 0.5 0.8 1.1 0.0 0.8 0.7 0.7 1.8 0.3 9.6 12.5 7.9 13.1 12.7 11.9 9.3 10.1 10.5 9.9 8.3 11.2 16.4 16.2 19.2 16.8 33.0 9.3 23.1 12.3 14.9 29.0 49.8 17.0 25.1 9.1 10.0 12.6 7.3 22.9 69.5 13.9 14.6 3.9 8.9 1.7 9.3 28.8 18.8 27.7 16.8 61.5 20.2 19.8 26.2 15.3 23.9 11.4 25.5 19.2 24.7 13.2 35.3 78.9 12.8 12.2 8.8 11.7 6.0 35.1 8.6 28.4 17.8 16.7 73.9 32.0 63.8 95.5 11.2 7.2 172.3 7.6 14.0 8.0 8.8 7.6 25.2 65.7 33.8 34.6 5.0 12.3 13.1 20.5 20.5 14.7 27.9 11.0 7.4 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 791.8 1226.9 1570.9 517.3 1529.3 895.1 584.8 1418.9 1759.0 835.5 1386.1 663.4 496.9 617.2 1264.7 891.2 749.4 678.6 2009.2 1536.4 2404.0 630.8 656.4 645.9 775.4 1715.1 1755.9 1475.5 773.4 1934.1 1813.3 1162.6 891.9 1816.4 582.4 613.2 737.6 2970.5 600.0 2423.2 531.1 531.7 789.1 1611.7 611.9 592.4 361.1 1818.3 862.3 3461.5 2838.0 806.6 693.6 241.3 1861.6 215.6 897.3 1501.9 663.3 2691.8 1822.3 1200.1 1219.1 1635.0 1937.3 1201.8 2480.5 1446.7 911.9 1670.3 2314.3 1305.6 976.1 1499.0 2195.3 1540.9 401.4 784.6 984.9 1651.7 2232.7 1420.7 641.6 483.0 1566.4 1113.6 875.1 1399.1 1561.0 1669.7 1100.6 692.0 1294.6 1319.1 4131.0 1759.5 1452.8 487.9 214.0 894.4 1436.7 1287.3 1589.4 2165.5 1315.8 1818.3 3853.2 2157.6 2117.1 1354.2 1921.8 1570.0 1581.7 1343.3 2210.2 1477.0 688.5 1452.3 1314.0 993.3 1583.2 900.0 473.7 1107.1 217.9 96.7 114.2 68.9 127.3 80.0 103.2 73.4 74.8 129.2 93.6 65.8 82.6 103.4 95.6 150.3 174.9 92.7 100.9 1570.9 1529.3 1418.9 1759.0 1536.4 2404.0 1715.1 1755.9 1475.5 1816.4 1611.7 1818.3 1861.6 982.6 221.2 258.8 192.0 310.8 130.4 182.0 130.0 205.5 397.8 465.6 684.4 1025.3 237.4 212.2 261.1 56.3 832.6 390.8 357.3 444.1 233.9 734.9 487.7 515.7 518.3 463.1 252.1 232.5 228.9 342.0 380.9 196.3 685.0 138.6 542.3 380.1 256.4 379.1 1886.1 439.7 327.2 181.0 380.4 405.7 1756.9 265.3 437.1 222.3 236.1 204.0 1367.2 137.0 194.5 166.6 339.9 300.0 197.1 309.7 268.1 273.7 153.6 218.0 222.0 210.4 1998.0 560.4 226.0 73.6 240.5 117.8 1211.7 301.8 860.9 304.4 316.5 DNM1L "DRP1, DVLP, DYMPLE, HDYNIV, VPS1" ENSG00000087470 "Dynamin 1 like" O00429 12 32679200-32745650 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Biological rhythms, Endocytosis, Necrosis" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009952, HPA039324" Approved Enhanced Vesicles,Cytosol NA NA 2000000 Cytosol Vesicles "CAB009952: AB_2093533, HPA039324: AB_2676443" "unprognostic (2.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (5.09e-1)" "unprognostic (4.06e-2)" "prognostic unfavorable (6.27e-6)" "unprognostic (8.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.04e-2)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (7.48e-2)" "unprognostic (1.57e-2)" 23.4 23.4 24.9 23.7 30.8 40.4 21.3 31.1 33.2 18.1 19.1 21.9 18.7 23.8 24.1 28.9 20.0 17.7 39.2 30.0 29.3 28.1 14.3 16.8 21.1 25.7 26.7 28.1 20.1 13.6 40.8 25.5 24.1 26.2 27.3 22.9 45.3 16.1 28.9 44.2 18.5 16.9 32.3 23.2 18.9 17.4 36.4 25.5 21.6 22.6 57.7 25.0 30.2 18.6 30.3 66.8 62.3 64.3 68.3 51.2 52.7 123.2 72.0 55.4 67.2 61.7 80.6 48.0 87.3 50.0 65.8 66.9 57.8 69.2 80.3 79.3 46.6 57.6 102.3 57.2 48.2 41.7 72.5 50.1 48.6 37.4 70.7 66.1 63.5 81.1 41.4 74.4 37.5 75.3 21.7 29.1 61.7 138.2 41.0 30.8 48.6 125.0 61.5 56.5 79.1 57.1 59.3 76.3 51.8 56.7 129.4 59.7 49.0 74.0 57.3 54.4 135.3 68.2 26.1 75.8 86.3 55.6 47.0 43.5 7.4 10.0 3.2 5.6 15.6 6.9 7.0 6.2 6.1 18.8 6.0 7.3 8.4 1.8 8.1 15.6 5.6 7.3 7.9 24.9 30.8 31.1 33.2 30.0 29.3 25.7 26.7 28.1 26.2 23.2 25.5 30.3 42.5 38.5 38.4 82.6 36.0 30.0 34.7 28.0 44.3 80.9 32.5 29.2 82.8 20.0 33.3 25.8 131.3 30.0 53.8 26.7 31.3 34.8 63.9 38.8 55.8 42.0 30.5 28.4 139.4 25.1 63.7 41.0 23.9 59.4 50.7 48.8 26.4 16.0 30.8 126.2 150.0 24.9 34.6 27.5 30.7 78.0 26.8 43.3 14.2 44.0 45.6 59.0 34.0 99.5 121.7 45.7 14.4 30.5 48.5 42.8 11.4 23.3 22.8 164.8 19.7 55.0 55.5 79.3 52.3 39.6 27.6 36.0 42.2 26.0 31.5 36.4 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972733 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 23.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 254.0;Basal squamous epithelial cells: 93.9;Breast glandular cells: 105.4;Breast myoepithelial cells: 56.3;Club cells: 77.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HaCaT: 291.3;HBEC3-KT: 359.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 3.1 0.9 3.1 1.2 2.6 0.0 20.3 1.2 3.2 11.7 8.7 2.6 2.3 10.8 1.1 16.4 1.5 7.5 2.8 4.4 3.2 0.4 0.2 1.2 1.1 3.7 8.0 2.2 1.8 1.7 23.0 2.9 3.0 1.1 5.3 1.7 0.2 8.6 2.4 0.7 1.8 1.6 3.0 0.2 3.7 1.8 1.3 10.9 0.4 1.8 1.7 1.0 9.3 15.3 2.9 1.7 9.9 0.0 0.0 2.9 2.8 0.1 0.3 1.0 0.5 1.3 0.3 7.9 0.0 0.5 2.6 9.1 291.3 1.3 359.8 0.1 7.4 1.7 0.5 1.8 0.1 0.8 0.1 0.4 0.2 19.7 9.1 34.4 0.9 11.2 0.1 0.0 0.4 0.2 0.1 0.1 0.0 1.4 0.4 16.7 0.1 1.5 0.6 34.3 0.3 0.2 0.1 16.4 0.1 2.1 11.5 0.5 0.1 5.6 1.6 8.9 5.1 77.8 4.7 0.1 12.1 7.5 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.1 2.6 1.2 3.2 4.4 3.2 3.7 8.0 2.2 1.1 0.2 10.9 2.9 1.4 0.0 0.0 0.7 0.4 4.6 1.9 254.0 93.9 0.3 105.4 56.3 0.4 0.0 77.5 0.0 0.0 0.0 0.5 0.0 0.0 3.5 5.9 0.9 4.7 4.5 0.0 0.0 0.6 8.9 0.0 13.6 0.0 0.8 0.0 2.6 0.4 0.2 0.0 0.0 11.2 0.0 4.1 0.3 1.3 2.7 0.9 0.6 23.2 1.0 0.6 1.8 0.0 0.0 0.2 8.6 0.0 0.0 6.2 0.5 0.0 0.3 14.8 0.5 6.6 8.0 6.7 3.6 0.2 7.9 1.4 0.0 0.5 0.2 0.0 0.2 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 105.0;choroid plexus: 44.2" "Cell type enhanced" "Detected in many" "Astrocytes: 205.7;Excitatory neurons: 100.4;Inhibitory neurons: 88.7;Oligodendrocyte precursor cells: 218.1;Oligodendrocytes: 241.1" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 85.4;HBEC3-KT: 64.6;PC-3: 113.2;THP-1: 131.3;U-937: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051834: AB_2681629, HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 0.7 1.2 93.5 0.5 95.2 0.5 0.4 86.0 93.9 0.3 44.2 0.8 0.7 1.0 0.7 1.1 8.7 1.9 4.0 89.0 75.8 2.3 0.6 6.0 0.1 89.6 89.0 79.6 6.2 0.2 0.0 1.7 0.6 97.8 0.1 0.8 3.4 0.1 0.0 0.2 1.1 1.0 0.3 80.8 5.6 0.5 0.5 91.4 1.9 0.1 1.0 0.1 0.5 0.1 105.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 85.4 0.0 6.2 1.3 0.0 0.2 0.3 64.6 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 1.4 0.1 10.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 17.9 0.3 0.4 113.2 0.0 0.0 0.7 25.1 1.4 2.1 6.5 0.5 0.0 0.1 0.0 0.5 131.3 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 93.5 95.2 86.0 93.9 89.0 75.8 89.6 89.0 79.6 97.8 80.8 91.4 105.0 0.3 12.8 0.5 205.7 0.3 0.6 1.3 2.1 0.0 13.8 0.2 0.0 8.9 10.0 8.4 3.7 0.0 0.0 0.0 0.0 1.9 1.1 1.0 7.1 3.7 0.3 1.2 0.0 100.4 0.0 0.0 4.2 0.0 2.1 0.0 0.5 3.3 0.0 0.2 5.0 88.7 0.9 44.7 0.3 1.1 0.9 0.0 3.7 0.0 7.5 0.0 0.8 0.0 218.1 241.1 2.9 0.1 0.0 0.9 2.9 4.3 0.1 1.3 1.9 0.0 2.9 0.9 0.3 1.0 0.1 0.4 0.0 0.1 0.9 4.5 3.2 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli rim,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "Nucleoli rim" "HPA049695: AB_2680855" "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favorable (8.18e-4)" "prognostic unfavorable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 38.9 32.8 22.6 38.1 24.5 10.5 46.5 24.4 29.3 34.7 21.9 37.4 34.7 34.7 50.5 46.4 24.4 33.4 52.9 23.4 28.0 30.9 48.0 26.5 34.1 25.1 23.9 22.3 27.1 40.5 47.6 20.9 53.5 24.5 39.9 34.0 29.7 49.7 34.8 34.1 19.4 35.2 39.6 25.6 27.0 32.9 58.3 24.8 35.3 45.5 47.4 43.9 50.6 22.2 34.3 96.7 87.0 69.1 46.8 94.8 111.5 170.1 153.1 123.4 92.7 98.3 115.7 157.6 51.3 149.1 120.7 168.7 98.7 66.0 98.3 146.4 112.6 69.4 84.0 114.6 68.3 55.7 121.2 70.0 79.1 75.9 115.8 116.7 169.3 71.8 69.8 70.5 144.6 122.6 52.3 60.3 126.2 98.9 101.3 235.0 54.9 189.9 107.6 75.5 140.1 26.5 43.2 77.2 86.5 91.5 145.9 168.0 96.7 81.8 124.1 108.1 169.1 167.6 106.4 145.5 106.0 103.7 87.3 105.3 92.3 50.2 70.6 84.7 79.9 102.9 83.2 107.6 101.2 55.1 71.0 106.6 90.3 181.1 72.1 101.1 120.9 130.8 90.1 22.6 24.5 24.4 29.3 23.4 28.0 25.1 23.9 22.3 24.5 25.6 24.8 34.3 54.6 28.9 28.6 20.9 74.3 57.9 68.9 144.1 39.9 54.8 57.2 55.1 61.7 38.6 99.0 53.3 54.2 119.2 60.8 19.4 49.0 72.7 383.0 48.7 66.5 43.7 41.8 44.8 39.2 62.8 120.6 73.0 25.5 54.6 55.8 44.2 34.6 50.2 56.4 48.8 37.8 33.5 87.5 25.5 40.2 51.9 52.5 37.1 62.2 14.0 41.6 69.5 52.5 32.2 48.3 58.1 20.5 59.8 154.0 85.7 32.4 49.5 64.6 60.0 32.9 58.5 105.7 75.0 36.3 49.4 66.3 156.2 68.0 54.0 34.7 78.8 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629306-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.3;skin 1: 53.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7" "Region enriched" "Detected in single" 13 "olfactory bulb: 2.4" "Region enhanced" "Detected in single" "olfactory bulb: 1.4" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.1 0.3 1.3 0.2 0.6 0.1 26.3 0.4 1.5 18.3 0.5 3.2 0.2 6.3 5.3 29.3 2.7 1.0 0.3 1.7 5.1 0.9 0.0 2.7 0.1 0.9 0.8 0.8 0.3 1.0 2.7 0.8 17.1 1.1 7.1 1.2 2.7 20.9 4.5 2.1 53.7 0.3 1.1 0.5 0.1 0.7 1.0 0.6 0.7 2.4 0.1 3.0 4.0 19.4 1.2 12.8 15.8 0.1 0.2 0.0 0.0 190.6 20.1 36.4 25.0 4.5 3.2 0.3 0.0 1.3 13.3 13.3 42.7 27.3 5.5 17.0 0.1 2.8 0.0 1.7 0.0 0.0 0.0 1.7 0.3 21.4 7.4 7.2 0.0 0.0 8.1 0.2 3.2 0.0 169.2 20.8 1.2 9.5 9.9 20.7 0.1 0.0 7.0 0.0 10.1 5.1 0.1 13.6 308.9 21.8 28.3 86.8 4.6 0.2 16.2 0.4 8.6 15.4 0.1 0.0 0.1 4.0 0.1 114.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.4 1.5 1.7 5.1 0.9 0.8 0.8 1.1 0.5 0.6 1.2 0.7 0.0 9.5 3.9 0.3 132.4 29.9 2.4 120.1 4.1 66.1 79.6 1.0 0.0 5.6 9.2 0.0 91.7 1.5 1.7 0.0 0.3 0.3 7.8 18.7 2.0 3.0 0.0 0.0 0.0 59.7 7.4 1.5 16.0 0.0 0.0 0.7 0.0 7.8 0.0 0.0 1.7 10.2 0.3 8.2 0.0 0.0 1.6 21.4 3.7 0.0 0.3 0.0 0.0 0.0 1.0 0.6 0.0 3.8 18.6 0.0 0.0 5.2 0.0 0.0 0.5 2.1 0.0 1.8 81.0 149.3 105.6 1.3 0.0 1.0 18.5 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.3;testis: 31.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved "Nucleoplasm,Mitotic spindle,Centrosome,Cytosol" Yes Yes "Nucleoplasm, Centrosome" "Mitotic spindle, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 1.3 2.3 2.0 10.5 1.7 15.4 2.2 2.4 1.5 1.0 0.8 10.9 11.8 1.5 0.8 7.6 1.2 2.1 5.3 1.1 1.1 2.3 5.0 2.2 21.1 1.5 1.3 0.4 8.5 2.1 1.8 0.6 8.1 1.3 1.1 13.0 3.0 1.9 1.3 8.8 3.5 9.4 5.0 1.5 5.3 4.9 31.1 1.5 20.4 1.4 8.3 22.3 3.0 2.6 2.8 179.9 127.2 84.5 61.2 4.9 10.8 106.3 145.2 66.8 339.7 142.9 361.4 124.8 58.4 96.2 59.2 176.2 142.2 152.4 96.4 360.0 52.4 57.5 102.6 128.9 229.8 2.8 140.4 140.4 5.1 10.1 117.3 104.5 26.7 80.7 93.2 121.8 45.3 146.9 182.1 85.3 108.9 78.3 145.6 129.8 62.9 163.4 65.9 56.0 46.8 73.9 39.6 200.5 228.8 94.2 77.3 137.9 86.1 47.1 149.7 145.3 83.0 208.6 62.3 78.9 100.5 80.5 80.9 127.0 0.2 3.5 4.3 1.2 5.9 1.8 2.5 2.0 1.1 3.7 0.8 0.9 0.9 2.3 1.4 3.4 0.8 4.7 1.7 2.0 1.7 2.4 1.5 1.1 1.1 1.5 1.3 0.4 1.3 1.5 1.5 2.8 2.5 0.0 2.8 0.3 7.4 1.1 1.2 5.6 0.6 1.0 4.3 6.2 5.6 1.5 2.3 3.7 2.1 34.5 8.3 8.3 1.9 4.0 33.9 2.0 2.3 3.1 6.0 81.6 1.1 4.9 67.1 7.0 13.7 3.4 54.1 12.3 3.6 2.6 17.5 1.7 1.5 10.8 2.0 3.5 7.6 16.3 1.5 11.7 0.0 1.0 12.0 3.7 3.1 1.0 2.0 5.2 2.8 0.4 10.1 2.0 5.1 4.2 1.5 2.7 6.6 2.2 7.7 168.2 30.8 8.3 1.1 8.2 8.0 8.7 15.5 1.5 CASS4 "C20orf32, HEFL, HEPL" ENSG00000087589 "Cas scaffold protein family member 4" Q9NQ75 20 56412112-56460387 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 12.3;lymphoid tissue: 9.7" "Cell type enhanced" "Detected in some" "granulocytes: 14.0;Kupffer cells: 8.2;Langerhans cells: 7.1;Macrophages: 12.1;Microglial cells: 29.0;T-cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 23.1;neutrophil: 68.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 68.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.5;HEL: 13.7;HMC-1: 38.9;K-562: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB034217 Approved NA NA 680000 "CAB034217: AB_2071598" "unprognostic (9.55e-3)" "unprognostic (2.53e-2)" "unprognostic (2.44e-2)" "unprognostic (8.51e-2)" "unprognostic (3.04e-1)" "unprognostic (1.56e-3)" "unprognostic (2.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-1)" "unprognostic (4.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.19e-2)" "unprognostic (7.27e-4)" "unprognostic (5.33e-2)" "unprognostic (3.65e-2)" "unprognostic (6.50e-2)" "unprognostic (8.16e-2)" 1.8 0.9 2.0 9.7 1.7 2.8 0.9 1.4 1.9 1.0 1.6 1.0 1.5 0.5 0.2 0.9 0.6 2.4 0.6 1.5 2.4 0.7 1.7 12.3 3.9 2.4 1.5 1.0 1.4 0.4 0.4 0.3 4.6 1.9 0.5 1.0 0.4 0.6 0.4 0.3 0.7 2.1 1.3 1.4 5.7 1.0 0.3 1.9 1.9 0.3 0.5 2.5 2.0 0.4 3.6 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.7 0.2 0.1 0.3 0.2 2.5 0.2 0.1 7.5 0.2 0.2 0.1 0.0 0.5 0.2 0.2 13.7 0.1 0.9 0.2 0.5 38.9 0.8 0.3 0.2 0.0 0.4 0.0 0.2 16.1 0.2 0.5 0.2 0.3 5.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.0 1.7 0.3 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.1 1.5 0.2 0.7 4.0 23.1 1.3 0.9 2.0 0.1 2.2 2.4 6.9 0.1 4.2 3.8 68.9 2.8 0.1 2.4 1.4 2.6 2.0 1.7 1.4 1.9 1.5 2.4 2.4 1.5 1.0 1.9 1.4 1.9 3.6 0.4 0.0 1.1 1.6 0.9 0.1 0.0 0.0 0.6 0.0 0.3 0.3 0.5 0.0 1.8 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 1.8 0.0 0.0 1.8 1.5 0.0 14.0 0.0 0.4 1.1 2.2 0.0 1.4 0.0 0.0 8.2 7.1 0.1 0.0 12.1 0.0 29.0 6.5 0.0 5.2 1.5 1.0 0.0 0.0 0.0 4.3 0.1 0.0 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.1 0.3 13.1 0.1 0.0 0.0 PIR ENSG00000087842 Pirin O00625 X 15384799-15493564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 96.1;Syncytiotrophoblasts: 85.6" "Cancer enhanced" "Detected in all" "melanoma: 48.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 292.4;HUVEC TERT2: 683.9;SK-MEL-30: 267.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000697 Approved Supported Cytosol NA NA 35000 Cytosol "HPA000697: AB_1079621" "unprognostic (3.46e-3)" "prognostic favorable (2.78e-4)" "unprognostic (4.26e-2)" "unprognostic (5.62e-3)" "unprognostic (4.16e-3)" "unprognostic (2.09e-2)" "unprognostic (6.70e-3)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic favorable (4.94e-4)" "unprognostic (3.78e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (6.11e-7)" "unprognostic (1.99e-2)" "unprognostic (8.90e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" 19.3 20.0 19.5 5.2 23.2 5.8 15.6 23.2 24.5 10.8 20.7 9.8 6.5 11.8 15.4 29.8 13.4 11.5 15.3 18.4 24.6 11.4 21.2 15.5 2.7 23.6 24.4 18.2 13.2 3.3 5.0 11.4 10.6 22.6 10.2 6.8 8.0 10.4 14.3 14.8 12.0 8.7 10.5 22.8 20.3 12.0 6.2 22.0 6.3 15.8 6.5 7.1 30.7 17.6 25.6 14.3 76.6 45.0 66.3 26.1 29.0 14.4 4.2 26.5 11.0 24.5 21.5 118.9 0.0 147.2 12.3 292.4 96.7 52.8 21.3 4.0 0.0 11.6 8.4 80.7 63.9 33.4 4.4 29.8 8.3 72.3 41.9 14.4 19.2 683.9 0.0 6.4 19.2 9.4 29.8 3.3 4.1 48.4 62.1 47.7 0.0 8.9 37.9 22.2 136.0 17.2 47.5 36.7 20.5 267.9 76.8 42.4 26.7 43.2 5.9 11.0 28.5 8.7 9.1 39.6 0.3 28.6 15.8 59.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.5 23.2 23.2 24.5 18.4 24.6 23.6 24.4 18.2 22.6 22.8 22.0 25.6 24.5 0.0 4.1 0.0 1.1 8.7 24.3 48.4 10.8 2.8 4.2 4.8 5.8 10.0 19.4 1.8 0.0 96.1 0.0 4.8 9.8 5.9 0.6 59.6 3.8 40.3 11.3 11.6 0.2 2.5 12.8 15.6 15.8 20.0 0.0 21.7 22.9 24.0 22.0 20.2 0.2 3.4 38.7 6.4 3.4 4.0 37.6 4.1 40.9 0.0 11.9 30.8 0.0 0.0 0.0 3.4 1.7 28.6 3.6 18.1 5.9 12.0 38.0 4.8 13.1 8.4 11.3 0.6 3.5 34.5 12.6 85.6 0.6 56.2 4.3 50.9 AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 662.9" "Cell type enhanced" "Detected in all" "Theca cells: 385.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 143.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 280.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 76.5 182.4 32.1 13.1 37.7 21.2 63.0 37.0 43.0 48.8 33.7 56.5 37.8 41.7 28.1 24.8 47.9 23.6 162.1 32.1 33.2 52.4 58.4 47.3 13.9 38.3 36.7 31.2 57.2 34.7 27.6 28.8 21.9 37.2 46.3 29.5 20.3 36.9 34.9 662.9 51.7 47.9 40.6 34.6 31.9 62.9 42.5 36.0 23.9 42.5 174.5 13.7 48.5 43.0 44.8 30.3 24.3 37.2 26.5 106.0 73.3 10.0 49.2 33.4 43.8 54.1 280.1 44.6 20.3 46.5 83.0 43.2 16.9 56.4 32.9 51.9 47.1 45.3 19.5 43.5 52.4 52.2 11.2 17.1 98.3 22.2 46.0 24.2 40.2 131.3 27.0 23.1 32.0 93.2 35.6 23.8 44.3 17.3 84.5 41.4 22.3 63.6 19.6 58.2 18.1 13.1 49.2 62.4 26.7 36.0 55.1 41.2 21.1 138.2 45.5 24.7 87.5 16.5 34.2 58.4 37.8 17.7 18.0 26.2 143.1 28.9 33.3 14.6 17.7 18.8 18.3 28.4 24.2 32.6 25.2 24.8 18.4 16.9 35.9 17.5 33.8 47.3 16.3 32.1 37.7 37.0 43.0 32.1 33.2 38.3 36.7 31.2 37.2 34.6 36.0 44.8 68.4 83.3 25.4 19.6 10.0 64.2 82.7 51.0 24.5 10.0 58.7 67.2 114.1 62.9 42.5 79.1 4.2 29.1 11.8 70.2 144.8 60.0 100.1 37.7 27.8 55.7 22.7 19.1 6.9 73.1 43.1 64.5 39.3 35.8 41.2 53.4 93.9 122.2 46.9 11.8 8.9 48.7 44.7 29.9 35.9 36.3 68.3 22.5 83.6 8.4 56.2 101.3 16.5 18.1 24.8 70.2 132.2 64.3 10.2 46.6 160.3 200.8 50.1 13.9 46.0 53.5 65.8 154.0 85.4 29.2 100.7 15.7 14.8 385.5 61.0 71.2 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 57.4" "Cell type enhanced" "Detected in many" "Astrocytes: 84.2;Early spermatids: 163.7;Late spermatids: 196.2;Respiratory ciliated cells: 103.8;Spermatocytes: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "neutrophil: 23.6" "Lineage enriched" "Detected in many" 9 "granulocytes: 23.6" "Cell line enhanced" "Detected in many" "HMC-1: 19.4;SCLC-21H: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favorable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 7.7 2.0 12.4 2.2 7.0 9.5 6.9 14.0 6.2 5.7 28.4 14.5 3.4 16.3 1.3 8.0 21.0 5.1 6.5 9.9 16.6 2.2 1.7 10.6 1.5 14.7 14.1 4.1 6.7 4.5 1.8 10.4 0.9 11.5 6.0 1.8 1.3 3.3 2.3 2.0 9.8 8.8 5.3 16.9 2.9 7.1 57.4 11.7 4.3 3.5 0.6 1.6 9.6 6.4 11.2 5.3 3.9 6.2 12.3 3.2 1.9 3.9 3.3 4.3 2.6 4.1 1.8 6.0 5.7 3.4 4.1 5.7 7.6 1.6 6.2 3.6 1.4 0.9 8.8 4.0 1.8 3.6 4.1 19.4 2.2 5.3 5.8 3.0 3.1 4.0 7.7 6.0 0.2 2.6 2.6 7.7 5.5 1.7 6.8 2.6 2.1 3.9 0.6 3.3 9.5 24.2 3.4 3.0 2.4 1.7 0.6 4.2 4.3 6.1 1.1 5.6 4.3 3.3 8.2 2.9 3.3 3.2 14.4 2.3 0.0 2.7 1.1 0.1 0.5 0.0 0.4 0.5 0.3 2.1 0.2 0.5 0.6 23.6 0.7 1.6 0.0 0.1 0.8 12.4 7.0 14.0 6.2 9.9 16.6 14.7 14.1 4.1 11.5 16.9 11.7 11.2 12.0 25.6 31.6 84.2 2.6 26.4 33.7 11.5 12.5 3.6 8.5 10.9 7.6 15.7 26.0 3.7 2.1 5.9 2.0 4.1 3.9 5.6 163.7 69.0 9.5 13.2 13.8 6.5 5.2 1.8 8.8 23.0 2.6 4.7 46.2 14.7 12.1 2.8 7.0 0.0 5.5 4.4 2.0 6.2 17.3 196.2 8.1 13.0 7.2 8.4 5.1 5.7 5.2 3.0 1.8 3.5 1.6 4.1 2.4 7.9 4.6 2.1 103.8 3.5 26.3 49.2 11.4 113.2 13.5 6.3 22.0 5.6 5.6 2.6 5.1 22.0 METTL2A "FLJ12760, METTL2" ENSG00000087995 "Methyltransferase like 2A" Q96IZ6 17 62423875-62453385 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.15e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-3)" "unprognostic (8.32e-2)" "unprognostic (1.52e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.26e-1)" "unprognostic (1.59e-1)" "unprognostic (3.35e-2)" "unprognostic (1.52e-1)" "unprognostic (6.51e-3)" "unprognostic (2.14e-1)" "unprognostic (2.33e-3)" "unprognostic (6.86e-2)" "unprognostic (9.77e-2)" "unprognostic (2.00e-1)" 2.6 3.5 2.7 2.3 2.6 1.9 2.7 3.0 3.0 1.8 2.8 2.7 1.8 2.5 2.4 3.1 2.6 1.7 3.3 2.8 2.7 2.5 3.0 2.3 2.5 2.7 2.5 2.8 2.7 3.7 2.6 1.8 2.1 2.7 2.2 2.6 2.8 2.8 1.2 6.4 3.9 2.4 2.0 2.6 2.5 2.9 1.7 2.7 1.9 3.2 2.8 2.4 2.1 2.1 3.0 3.9 3.8 5.3 8.5 2.9 3.7 4.2 4.2 2.6 4.2 2.7 2.6 3.7 4.6 2.2 2.9 1.7 4.2 9.2 4.3 5.7 4.4 7.6 9.2 3.1 3.0 4.8 11.2 4.0 3.4 5.2 2.8 5.4 3.6 2.4 5.9 9.5 4.3 3.8 4.9 11.9 5.1 7.1 5.0 5.1 7.8 15.5 4.4 3.6 4.4 5.4 12.2 2.4 4.9 6.3 2.3 9.9 6.6 5.3 4.5 5.8 4.2 6.8 5.2 6.4 5.7 7.8 6.1 5.7 1.8 1.0 0.9 1.9 1.0 1.6 1.4 1.5 1.5 0.6 1.9 1.4 1.8 2.1 2.4 1.1 1.7 1.5 0.8 2.7 2.6 3.0 3.0 2.8 2.7 2.7 2.5 2.8 2.7 2.6 2.7 3.0 10.9 25.6 12.1 4.2 9.2 9.2 17.0 21.5 7.4 17.0 9.1 9.1 11.1 12.8 20.3 12.9 18.8 21.8 9.2 11.1 23.5 19.3 9.7 10.8 11.6 9.0 7.2 9.4 6.8 14.5 14.3 10.3 10.7 11.4 3.8 14.9 7.1 10.8 13.0 5.0 7.1 9.8 10.2 4.4 8.1 5.3 5.0 5.4 3.6 0.0 6.9 14.5 12.3 4.5 5.7 16.0 15.6 13.2 17.7 20.9 8.5 15.0 19.7 16.4 13.1 13.4 11.6 23.3 11.8 11.9 14.2 15.7 8.9 17.2 15.3 24.0 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552172-48599425 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 288.3;skin 1: 181.4;vagina: 147.1" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041724, HPA043539, HPA076510" Enhanced Enhanced Vesicles,Cytosol NA NA Vesicles Cytosol "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.2 0.2 0.5 0.4 0.4 0.1 11.7 0.5 0.8 37.7 0.4 0.8 9.4 0.5 6.8 288.3 1.2 2.7 0.2 0.5 0.4 3.1 0.3 9.4 0.0 0.5 0.7 0.3 0.1 0.8 8.0 0.4 1.5 0.5 22.8 0.2 0.0 54.0 3.7 0.4 181.4 18.4 0.1 0.3 0.1 3.5 0.5 0.8 0.4 1.9 0.0 28.5 0.7 147.1 0.5 12.6 15.8 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.9 74.2 0.1 0.1 0.0 0.7 3.9 0.1 0.3 0.0 0.5 0.4 0.0 0.5 0.5 0.0 0.0 7.2 0.2 2.1 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 46.8 0.0 0.5 0.0 122.9 0.0 0.1 0.0 0.1 0.0 3.5 0.2 0.1 0.0 6.2 0.3 0.0 36.7 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.5 0.1 0.0 0.3 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.5 0.4 0.5 0.8 0.5 0.4 0.5 0.7 0.3 0.5 0.3 0.8 0.5 0.4 19.2 0.5 1.0 0.0 24.1 30.5 11.6 0.0 0.0 16.8 12.4 0.6 5.7 40.2 9.2 0.0 3.2 0.0 4.4 0.0 12.2 0.0 15.7 1.4 0.9 4.8 0.0 1.0 1.2 3.1 1.2 2.6 17.5 0.0 0.1 0.0 0.3 0.7 0.0 0.9 12.6 24.4 0.0 4.8 0.9 0.3 0.4 12.4 1.0 0.0 1.6 0.0 0.5 0.8 18.5 7.9 0.0 0.0 62.3 75.9 1.3 6.7 0.6 0.0 0.1 2.2 0.2 11.1 56.0 137.4 1.9 0.6 2.0 9.2 114.6 ALG6 ENSG00000088035 "ALG6 alpha-1,3-glucosyltransferase" Q9Y672 1 63367575-63438553 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062536, HPA076130" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA062536: AB_2684792, HPA076130: " "unprognostic (1.21e-1)" "unprognostic (5.60e-3)" "prognostic favorable (4.86e-4)" "unprognostic (1.59e-1)" "unprognostic (3.45e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (2.07e-1)" "unprognostic (9.81e-3)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (1.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (3.41e-1)" 3.4 4.5 1.2 1.1 1.4 1.4 3.5 2.0 1.5 3.6 1.2 3.2 1.1 2.9 1.4 6.2 3.0 0.8 2.1 1.3 1.3 2.7 4.6 2.7 1.9 1.3 1.3 1.2 3.3 3.3 1.4 2.0 1.0 1.5 3.1 1.2 1.3 4.4 0.6 2.9 5.1 4.5 0.6 1.2 5.3 3.2 2.2 1.2 2.0 3.1 0.1 1.6 3.1 4.3 1.6 0.5 1.3 1.3 1.2 1.8 1.3 2.6 0.9 0.2 0.3 0.3 2.0 0.6 2.7 1.4 0.7 1.5 1.0 2.0 1.0 1.4 2.4 4.2 2.2 1.5 2.4 0.6 2.8 2.4 0.9 0.6 0.9 0.6 0.7 2.0 2.3 2.2 1.3 1.0 2.5 1.7 2.4 7.6 1.3 2.3 1.8 1.6 2.1 1.6 2.2 1.5 0.8 2.3 3.2 2.3 2.9 0.9 2.1 0.9 0.6 0.6 1.8 1.5 1.7 1.7 1.7 1.2 3.3 2.4 1.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.6 0.5 0.1 0.4 0.3 0.2 0.3 0.2 1.2 1.4 2.0 1.5 1.3 1.3 1.3 1.3 1.2 1.5 1.2 1.2 1.6 9.8 9.6 4.8 9.8 12.1 11.0 8.5 24.6 15.4 6.3 8.5 5.5 3.1 12.8 22.1 3.7 4.2 42.1 10.2 6.1 1.9 12.4 2.4 11.2 7.0 8.7 4.2 9.0 19.1 8.9 28.5 8.6 11.2 10.0 8.9 12.2 8.2 11.5 15.5 6.7 19.4 7.8 22.4 7.1 8.8 2.0 6.8 9.1 16.0 4.7 4.8 5.5 13.4 19.1 16.8 6.0 3.6 4.9 11.4 4.9 8.2 7.3 11.7 5.4 6.6 4.5 6.6 16.2 15.3 18.3 11.1 26.8 15.1 10.0 11.5 7.4 CNOT3 "KIAA0691, LENG2, NOT3, NOT3H" ENSG00000088038 "CCR4-NOT transcription complex subunit 3" O75175 19 54137749-54155681 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 213.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006408 Approved Approved Cytosol NA NA 39000 Cytosol "HPA006408: AB_1078543" "unprognostic (1.23e-1)" "unprognostic (2.54e-1)" "unprognostic (1.75e-2)" "unprognostic (1.40e-1)" "unprognostic (4.86e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (9.06e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (9.30e-3)" "unprognostic (4.08e-3)" "prognostic unfavorable (2.77e-4)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" 21.3 29.2 10.8 17.7 10.5 19.7 23.1 13.1 14.2 27.0 6.5 26.2 17.0 27.6 19.7 27.0 27.7 12.7 19.1 10.4 9.0 24.8 25.5 21.4 20.5 12.7 9.2 7.8 30.8 28.6 17.6 34.2 19.4 11.5 27.9 13.4 18.1 26.3 18.8 24.3 30.0 25.3 17.0 6.6 30.1 26.8 35.4 9.4 23.8 30.2 11.1 18.2 25.8 25.7 11.5 45.5 69.1 69.7 40.8 25.4 25.2 48.0 39.2 68.4 52.2 45.9 44.2 36.2 53.1 24.8 46.1 41.8 44.1 77.3 39.2 53.1 55.5 213.4 81.7 44.5 39.1 43.3 47.7 54.9 32.1 35.8 46.7 77.3 37.1 41.5 39.0 61.8 47.9 38.3 53.3 63.8 27.9 43.1 87.7 52.4 57.8 52.4 35.7 33.7 85.4 44.9 37.2 75.1 54.6 25.8 50.6 31.3 50.2 37.8 47.3 50.3 23.4 54.4 46.3 54.1 71.2 38.7 37.1 48.0 0.9 1.6 3.1 1.6 1.0 1.2 1.3 1.1 1.5 1.4 1.4 1.2 1.3 4.2 0.8 1.4 3.4 1.2 2.0 10.8 10.5 13.1 14.2 10.4 9.0 12.7 9.2 7.8 11.5 6.6 9.4 11.5 14.2 12.8 7.4 10.7 17.4 9.9 17.2 15.7 18.8 17.5 14.0 13.8 2.0 12.8 14.4 7.3 16.7 28.8 20.5 17.8 9.8 14.8 19.9 20.9 19.6 13.2 14.4 13.3 6.1 14.5 28.5 13.6 20.9 21.4 3.8 22.7 12.5 8.5 16.2 16.8 7.0 17.1 18.3 9.7 6.9 6.6 17.1 13.1 5.4 4.7 15.6 12.0 16.5 5.0 8.0 15.1 23.9 9.4 20.8 21.4 14.9 9.0 14.3 18.5 6.6 17.3 17.9 49.2 47.9 16.6 9.9 50.1 15.4 21.6 13.2 17.3 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 6.2;Early spermatids: 14.3;Excitatory neurons: 9.9;Inhibitory neurons: 10.2;Late spermatids: 8.7;Macrophages: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "HEL: 9.4;K-562: 4.1;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047611, HPA066482" Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA 44000000 "Plasma membrane" "HPA047611: , HPA066482: AB_2685674" "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.1 0.0 0.1 0.0 0.1 0.9 0.2 0.7 0.6 0.4 0.0 0.2 0.0 0.2 0.0 1.4 0.4 0.0 0.7 0.1 0.0 0.3 0.2 0.9 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.3 0.1 0.2 0.4 0.0 0.2 0.4 0.1 0.1 1.1 0.2 0.0 0.0 0.9 0.2 2.7 0.0 0.0 0.4 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.3 9.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 2.5 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.1 0.1 0.7 0.6 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.3 0.0 0.0 3.6 0.0 0.0 0.3 0.3 0.0 2.0 0.3 0.4 0.7 1.5 0.3 0.0 6.2 0.1 0.4 0.7 0.0 0.1 14.3 1.4 0.4 1.2 0.0 0.0 9.9 0.4 0.3 0.6 0.0 2.2 1.3 0.8 3.3 0.2 0.1 3.3 10.2 0.0 0.0 0.8 0.2 8.7 0.3 10.3 0.0 1.0 0.3 0.4 2.1 1.5 1.5 0.2 0.1 0.0 0.0 0.4 0.1 0.0 1.9 2.6 0.0 0.4 0.2 1.4 1.2 0.0 0.1 0.5 0.4 0.0 0.3 0.7 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase non-receptor type 4" P29074 2 119759922-119984899 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 38.7" "Group enriched" "Detected in many" 4 "gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0" "Group enriched" "Detected in many" 16 "NK-cells: 24.4;T-cells: 35.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favorable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 4.5 3.9 6.8 3.6 5.9 5.2 4.7 38.7 10.2 5.7 0.0 3.5 5.1 4.2 4.2 4.2 5.6 3.7 5.8 5.3 3.5 7.5 4.2 5.2 5.4 0.5 11.8 4.2 5.2 2.9 6.4 3.5 2.5 9.6 3.6 2.5 12.2 4.2 2.5 8.1 3.0 2.8 2.9 0.0 6.0 5.8 4.9 13.8 8.1 14.1 12.9 4.3 3.2 2.6 7.4 7.4 4.3 5.0 7.3 4.8 5.0 9.1 3.2 9.3 1.8 4.9 6.2 10.9 4.1 7.6 3.5 5.2 5.3 4.4 5.1 4.8 12.6 3.6 3.7 3.5 6.1 3.2 3.9 2.6 4.5 9.6 8.5 3.7 6.0 8.2 4.8 5.7 4.8 5.0 5.0 5.2 4.4 7.3 4.0 6.9 3.4 9.6 6.9 6.7 10.0 6.8 8.5 4.2 5.8 4.0 4.0 2.8 2.4 10.7 0.0 6.1 1.9 4.0 8.9 13.7 6.6 4.7 0.1 3.0 0.3 0.2 1.8 35.0 0.5 28.1 0.6 16.9 27.9 0.5 0.6 5.2 19.2 0.6 24.4 0.7 0.3 11.0 10.4 6.8 5.9 38.7 10.2 5.3 3.5 0.5 11.8 4.2 9.6 0.0 13.8 7.4 20.5 3.2 14.6 128.9 24.4 8.2 15.5 8.5 27.3 55.7 13.9 11.2 17.9 10.0 8.3 16.5 104.3 10.5 95.5 7.3 7.9 8.0 5.4 18.2 15.7 15.0 9.1 35.4 224.3 7.3 11.8 11.3 16.8 15.8 11.4 47.9 15.0 11.0 4.0 161.5 187.5 9.9 12.2 8.6 7.6 8.8 17.4 9.0 8.8 38.4 11.8 24.9 247.2 200.6 113.6 6.3 9.6 14.3 30.1 12.7 10.6 13.6 8.8 79.8 0.0 25.5 9.0 31.4 26.4 12.8 6.7 3.7 79.4 23.3 11.5 9.5 DDX18 "Has1, MrDb" ENSG00000088205 "DEAD-box helicase 18" Q9NVP1 2 117814691-117832377 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 376.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035400, HPA041056" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 17000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA035400: AB_10672091, HPA041056: AB_2677277" "unprognostic (1.44e-1)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (2.06e-1)" "unprognostic (1.77e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (8.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (1.42e-2)" "unprognostic (4.94e-2)" "unprognostic (8.51e-2)" "unprognostic (1.45e-1)" "unprognostic (1.53e-1)" "unprognostic (7.28e-2)" "unprognostic (5.65e-2)" 25.5 21.6 15.8 30.5 16.7 22.0 33.0 16.8 18.2 23.6 16.4 28.6 22.7 30.3 23.1 25.0 23.8 22.4 21.4 15.0 17.4 27.2 35.5 25.0 41.5 16.8 16.5 14.8 25.7 21.3 21.6 10.9 26.4 17.0 23.4 31.3 19.6 19.5 23.2 18.8 23.1 23.6 26.5 17.9 32.5 23.0 20.8 16.1 34.8 30.4 18.5 42.0 33.5 17.5 19.9 94.0 41.9 61.3 55.5 35.5 31.9 101.0 54.7 43.0 73.7 64.6 104.2 60.6 137.8 85.9 45.6 68.0 71.1 120.3 70.7 108.0 70.6 83.9 132.0 36.9 105.1 49.5 178.4 66.0 33.4 63.9 93.7 94.3 37.6 44.9 70.3 146.5 58.4 57.1 58.6 98.2 92.6 154.4 79.1 62.3 84.4 95.8 121.3 48.8 55.2 58.8 99.3 62.7 69.2 73.4 62.1 43.9 96.7 34.9 65.6 96.5 46.8 99.5 66.3 87.9 376.0 48.2 82.9 30.1 11.7 23.0 16.3 24.9 28.9 32.0 37.4 29.8 28.9 20.7 30.3 35.6 31.7 5.8 29.7 33.1 33.7 25.7 32.1 15.8 16.7 16.8 18.2 15.0 17.4 16.8 16.5 14.8 17.0 17.9 16.1 19.9 144.4 96.1 62.5 24.8 153.9 192.7 114.4 149.4 100.2 150.5 82.8 94.5 50.4 101.5 103.8 121.4 83.4 110.3 140.6 69.0 117.4 125.4 17.1 92.2 125.1 109.1 56.9 76.4 24.3 115.2 120.9 98.2 63.2 102.8 110.3 71.8 107.1 195.6 87.9 82.4 28.0 108.0 109.9 104.8 100.8 17.7 106.6 100.6 92.5 20.6 117.1 70.3 135.9 26.7 39.1 130.0 68.8 103.8 103.3 118.1 53.3 186.5 90.6 132.9 65.7 158.7 110.1 138.6 129.9 81.4 160.5 88.8 143.2 67.4 114.6 65.3 KHSRP "FBP2, FUBP2, KSRP" ENSG00000088247 "KH-type splicing regulatory protein" Q92945 19 6413102-6424811 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034739, HPA056518" Supported Enhanced Nucleoplasm NA NA 710000 Nucleoplasm "HPA034739: AB_10601582, HPA056518: AB_2683162" "unprognostic (2.16e-1)" "unprognostic (3.98e-2)" "unprognostic (2.41e-1)" "unprognostic (4.27e-1)" "unprognostic (4.57e-2)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.25e-1)" "unprognostic (7.12e-2)" "unprognostic (1.74e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.38e-2)" "unprognostic (2.84e-2)" 75.5 91.7 35.5 45.2 34.0 64.5 74.3 32.7 45.0 110.1 12.5 90.7 54.3 122.7 17.2 112.2 106.3 27.7 62.4 36.8 30.0 66.1 90.7 74.1 52.5 33.7 32.3 33.4 121.7 90.3 25.0 78.1 44.3 32.6 76.4 34.5 41.3 75.7 33.4 101.3 92.3 89.1 36.6 30.3 80.2 82.5 107.4 32.9 54.3 84.1 26.3 46.1 95.3 92.3 41.7 302.1 128.6 148.0 139.2 62.0 67.0 216.8 103.7 84.0 147.2 148.3 259.2 77.2 286.8 187.3 76.7 82.8 162.6 203.5 104.5 162.2 2.6 240.3 209.2 94.9 158.2 86.0 204.9 186.2 74.9 47.6 108.3 117.0 65.8 124.0 138.6 328.7 142.5 95.7 146.9 290.7 182.3 264.3 78.9 187.9 284.3 124.5 206.5 73.0 143.9 152.5 160.7 133.8 119.7 144.3 121.7 118.5 222.4 111.4 108.0 160.9 230.4 230.9 257.1 306.8 279.8 107.3 298.1 130.9 1.6 2.7 2.1 2.2 3.1 2.5 2.4 2.6 2.9 2.9 3.2 1.5 1.6 1.9 1.3 2.8 4.8 1.9 1.7 35.5 34.0 32.7 45.0 36.8 30.0 33.7 32.3 33.4 32.6 30.3 32.9 41.7 39.8 9.6 17.5 9.1 27.9 58.8 23.6 18.7 33.6 44.6 50.9 49.7 12.8 41.5 23.5 31.3 50.1 41.8 35.7 46.5 5.9 28.0 84.2 38.5 52.4 32.7 57.6 41.8 12.3 30.9 47.5 33.8 21.9 51.9 18.4 41.8 41.4 44.0 38.9 50.5 12.9 50.5 10.2 42.9 44.2 24.4 50.7 32.0 26.6 12.2 26.7 37.9 15.5 11.1 19.1 32.9 34.9 46.3 33.8 36.9 36.0 23.0 17.4 57.4 26.3 39.7 29.9 92.1 57.3 48.8 72.5 40.0 22.9 34.6 60.4 32.1 GNA11 "FBH, FBH2, FHH2, HHC2" ENSG00000088256 "G protein subunit alpha 11" P29992 19 3094362-3123999 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 330.6;Proximal enterocytes: 323.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048886 Approved NA NA "HPA048886: AB_2680544" "unprognostic (4.64e-3)" "unprognostic (2.21e-1)" "unprognostic (3.12e-1)" "unprognostic (2.23e-2)" "unprognostic (1.30e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.56e-2)" "unprognostic (1.40e-1)" "unprognostic (6.26e-2)" "unprognostic (7.85e-3)" "unprognostic (2.43e-1)" "prognostic favorable (1.48e-11)" "unprognostic (1.05e-2)" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (3.02e-1)" 32.3 32.7 32.0 16.3 27.5 8.4 32.8 47.4 35.0 31.1 17.5 57.4 118.6 42.8 12.8 29.0 44.9 20.1 49.1 30.8 25.6 40.3 26.4 35.0 7.6 28.0 27.7 29.9 32.7 34.2 26.6 30.0 22.5 32.8 40.8 39.0 11.1 33.6 47.5 54.7 34.0 140.5 28.9 24.1 21.6 35.2 51.0 29.6 8.6 33.2 39.5 7.1 39.2 27.3 28.5 56.1 31.2 27.9 48.5 41.7 28.4 30.9 53.8 53.7 71.8 57.8 41.7 27.3 12.0 29.2 76.4 43.6 39.0 37.8 42.7 44.3 30.1 21.9 3.3 35.7 23.6 42.2 3.8 11.8 36.9 36.8 48.4 29.2 36.9 57.8 3.4 27.8 1.9 49.1 25.8 3.0 14.4 20.5 38.4 29.4 23.2 26.4 11.9 33.8 40.8 66.0 40.7 38.3 45.2 27.2 18.9 33.3 7.9 50.0 45.7 33.3 85.4 73.5 1.3 3.9 7.9 33.0 2.9 52.3 2.5 1.4 0.3 0.7 0.7 0.8 0.9 0.5 0.6 0.2 1.1 1.2 0.9 5.1 0.5 1.5 2.3 0.1 0.3 32.0 27.5 47.4 35.0 30.8 25.6 28.0 27.7 29.9 32.8 24.1 29.6 28.5 62.3 32.1 24.1 5.2 3.5 32.6 9.5 15.4 13.6 22.7 43.2 47.9 17.8 35.8 12.6 27.6 37.5 13.2 2.4 330.6 7.9 21.4 45.2 26.9 23.0 33.9 54.6 5.2 8.8 25.4 13.5 25.3 29.6 26.1 4.5 24.1 58.2 28.5 9.0 45.4 11.3 84.1 26.4 9.1 16.4 20.0 50.1 5.1 23.2 11.2 1.1 29.0 0.0 7.1 14.1 36.1 96.0 80.5 1.2 16.0 323.0 18.9 35.4 15.8 19.7 28.5 30.5 23.7 8.9 20.6 41.2 20.4 2.0 22.1 94.9 13.4 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 35.9;Extravillous trophoblasts: 43.3;Granulosa cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 31.8;ASC TERT1: 29.9;HSkMC: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA020537: AB_2670467, HPA020546: AB_2670470" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favorable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favorable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 23.6 39.5 11.6 3.2 11.1 0.1 22.1 12.6 12.5 31.6 9.7 17.5 1.6 18.7 4.2 32.6 24.5 5.2 28.4 10.4 12.2 21.4 20.0 16.1 1.6 14.3 12.0 9.7 58.8 22.4 11.8 18.7 8.1 13.8 31.3 5.3 3.0 38.3 8.1 43.2 52.2 11.1 6.0 12.6 5.1 25.7 18.3 12.9 1.1 29.2 11.8 4.3 21.5 33.7 13.7 1.8 1.8 17.6 11.6 31.8 29.9 21.6 3.2 3.8 4.9 6.3 1.3 0.1 9.2 3.7 6.3 2.9 8.4 12.2 2.9 2.8 0.4 1.6 0.5 4.8 11.8 17.1 0.0 0.9 38.4 4.4 7.9 7.1 14.6 3.9 1.3 6.4 0.0 3.1 3.9 1.3 0.1 3.0 5.0 4.2 4.9 1.9 0.0 3.4 3.7 0.6 6.0 14.1 3.5 3.5 8.7 13.2 0.1 1.4 2.1 5.2 5.9 0.2 3.9 4.2 1.1 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.6 11.1 12.6 12.5 10.4 12.2 14.3 12.0 9.7 13.8 12.6 12.9 13.7 4.5 9.6 6.7 35.9 0.3 2.0 1.5 2.0 2.8 1.1 6.3 3.7 15.5 0.0 4.1 3.7 0.0 2.1 0.0 6.7 3.9 5.8 5.1 2.4 7.3 6.6 1.2 0.0 7.6 6.1 43.3 12.2 10.2 4.4 1.3 28.3 3.9 4.0 1.8 0.0 4.9 8.5 2.0 0.0 1.3 8.1 12.5 0.4 0.0 7.5 0.1 8.3 0.0 18.1 4.2 2.5 2.1 13.5 0.2 2.4 0.8 5.4 4.3 0.6 0.0 2.0 3.4 8.2 11.8 3.7 4.3 1.4 0.2 15.9 5.2 2.1 EDEM2 "bA4204.1, C20orf31, C20orf49, FLJ10783" ENSG00000088298 "ER degradation enhancing alpha-mannosidase like protein 2" Q9BV94 20 35115364-35147336 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 137.9;Plasma cells: 89.0;Syncytiotrophoblasts: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037238, HPA048353" Approved "Intracellular and membrane" NA NA "CAB037238: AB_1840826, HPA048353: AB_2680369" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.05e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (9.87e-2)" "unprognostic (1.46e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (4.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.50e-3)" "unprognostic (2.29e-2)" 19.8 27.1 11.1 16.4 12.4 28.0 18.0 16.8 12.9 18.6 14.3 19.7 20.2 11.7 45.3 14.6 16.3 14.9 15.1 10.4 14.8 19.2 39.2 26.9 20.2 14.3 12.3 10.1 10.5 32.7 13.3 24.7 28.3 14.6 16.1 22.0 10.8 19.3 15.6 7.6 13.9 19.6 15.6 12.0 32.7 16.5 6.7 14.4 16.9 15.4 6.0 21.9 16.6 12.3 13.6 18.6 54.4 8.6 34.0 98.0 33.9 49.2 20.8 70.5 24.4 34.4 61.3 47.7 16.0 61.3 40.9 77.0 37.6 31.5 43.3 19.6 12.3 8.8 31.6 11.8 58.7 54.1 23.2 117.6 41.3 59.4 23.5 58.2 60.2 91.9 30.3 14.9 66.5 33.9 20.6 18.6 28.9 9.7 52.8 35.0 15.5 29.5 33.6 54.6 16.0 7.1 11.1 21.8 55.8 53.9 36.3 26.2 38.5 41.0 36.9 22.0 21.9 25.6 34.5 23.2 9.7 64.7 29.2 31.4 35.9 96.9 75.3 39.9 72.4 78.4 42.3 36.4 39.6 101.4 42.0 26.0 32.9 67.2 42.9 72.9 59.1 47.7 79.9 11.1 12.4 16.8 12.9 10.4 14.8 14.3 12.3 10.1 14.6 12.0 14.4 13.6 16.7 16.0 17.4 6.8 27.5 4.0 14.6 34.7 6.2 3.7 12.0 9.3 4.6 24.3 18.9 12.9 2.1 72.9 27.4 14.7 11.7 35.5 2.5 11.4 13.8 16.4 4.8 13.3 5.2 29.1 137.9 14.1 7.7 16.6 55.1 13.6 13.9 23.3 72.2 0.0 6.5 13.8 32.6 21.3 7.9 1.2 7.8 28.3 12.4 9.4 26.8 7.9 14.4 1.5 6.9 28.9 16.1 5.3 89.0 12.8 43.6 18.9 15.3 6.5 13.1 7.9 19.0 8.7 11.2 8.9 4.7 94.7 18.7 15.7 17.3 12.7 DNMT3B ENSG00000088305 "DNA methyltransferase 3 beta" Q9UBC3 20 32762385-32809356 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 5.3;Extravillous trophoblasts: 5.2;Horizontal cells: 5.0;Inhibitory neurons: 6.8;Sertoli cells: 6.6" "Cancer enriched" "Detected in all" 25 "testis cancer: 111.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 245.7;CACO-2: 95.8;HEL: 100.7;K-562: 98.6;NTERA-2: 333.9;SuSa: 174.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001595, HPA001803, CAB069896" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: " "unprognostic (7.65e-3)" "unprognostic (3.52e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (3.42e-1)" "unprognostic (7.27e-2)" "unprognostic (4.39e-4)" "unprognostic (4.18e-3)" "unprognostic (8.60e-3)" "unprognostic (8.48e-2)" "unprognostic (6.79e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (6.62e-2)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (6.55e-2)" 0.7 0.6 1.3 0.8 1.5 3.7 1.4 2.4 1.6 1.1 1.0 0.7 0.8 1.0 3.1 0.8 0.8 0.8 0.9 1.2 1.4 1.7 1.3 0.7 0.9 1.4 1.3 1.2 0.8 6.0 1.1 0.6 2.1 1.8 0.8 0.8 3.0 1.2 0.6 0.5 3.8 0.8 0.9 0.9 1.0 0.9 5.9 1.3 3.7 1.7 0.2 0.9 1.3 1.1 1.6 3.9 5.3 27.0 6.2 0.5 2.1 245.7 3.5 2.4 3.6 3.8 95.8 4.3 10.0 9.7 1.7 4.3 2.2 17.6 1.7 3.0 1.2 14.0 100.7 3.3 18.5 0.9 4.6 9.7 2.3 1.9 5.5 1.1 1.8 6.6 6.2 98.6 2.7 1.4 15.7 15.6 86.1 333.9 8.8 3.2 15.4 4.5 2.3 9.1 4.2 8.6 5.7 5.9 8.5 2.5 174.4 5.8 5.5 1.6 5.5 12.3 2.8 2.6 5.9 2.8 3.8 2.6 27.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.5 2.4 1.6 1.2 1.4 1.4 1.3 1.2 1.8 0.9 1.3 1.6 1.6 0.0 1.5 3.9 0.1 0.9 0.2 0.3 0.6 2.1 1.5 1.3 1.3 0.0 0.8 0.0 2.1 5.3 0.3 0.2 0.0 1.3 0.1 0.8 0.9 1.6 0.0 4.6 1.1 0.6 5.2 1.2 0.5 2.2 0.0 1.3 0.7 0.6 0.8 5.0 6.8 0.3 0.0 0.3 0.3 1.0 0.0 0.7 0.0 1.9 0.1 0.8 0.0 1.5 1.3 1.0 0.1 0.4 1.3 0.3 0.1 1.3 0.1 2.5 6.6 0.3 0.9 0.1 2.6 0.9 1.3 4.8 0.3 0.8 0.6 0.1 REM1 "GES, REM" ENSG00000088320 "RRAD and GEM like GTPase 1" O75628 20 31475288-31484895 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 18.9" "Cell type enhanced" "Detected in some" "Adipocytes: 7.7;Peritubular cells: 11.7;Sertoli cells: 59.2;Smooth muscle cells: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "WM-115: 22.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.6" HPA049821 Approved NA NA "HPA049821: AB_2680898" "unprognostic (6.16e-2)" "unprognostic (3.17e-3)" "unprognostic (2.62e-1)" "unprognostic (9.65e-2)" "unprognostic (6.03e-3)" "unprognostic (1.84e-2)" "unprognostic (4.39e-1)" "unprognostic (2.15e-1)" "unprognostic (2.48e-1)" "unprognostic (3.88e-2)" "unprognostic (4.77e-3)" "unprognostic (8.03e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (7.79e-2)" "unprognostic (4.88e-2)" "unprognostic (1.57e-1)" "unprognostic (3.06e-2)" 11.4 2.2 1.4 1.7 1.4 0.0 7.6 1.1 1.8 18.9 1.5 5.3 1.3 10.6 7.2 2.1 10.1 2.3 5.9 1.2 1.2 2.2 0.8 4.6 3.0 1.3 1.3 1.1 3.9 1.1 1.2 2.7 2.2 1.5 5.6 1.0 0.0 1.6 4.9 3.4 2.7 3.7 3.2 1.1 2.5 2.4 1.4 1.4 0.7 4.9 2.4 1.5 4.9 9.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 1.1 1.8 1.2 1.2 1.3 1.3 1.1 1.5 1.1 1.4 1.3 7.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 7.1 2.3 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.2 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 5.6 0.3 3.6 1.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.8 0.0 59.2 0.6 28.1 0.0 0.2 0.1 0.9 0.0 0.1 1.5 0.0 0.0 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2 microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.4;lymphoid tissue: 71.0;testis: 31.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 8.1" "Group enriched" "Detected in many" 5 "granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.9 1.4 0.7 13.1 0.9 48.4 2.7 0.8 1.0 1.5 0.5 11.8 9.5 2.4 0.3 13.3 0.9 1.8 0.7 1.0 1.0 0.7 4.3 2.0 26.8 0.6 0.9 0.8 0.5 0.4 0.4 0.2 8.3 0.8 0.7 14.4 0.5 2.1 0.5 1.4 9.9 9.5 6.8 0.6 5.3 6.2 31.0 1.1 71.0 1.0 0.8 32.6 3.4 4.1 2.6 455.1 149.1 176.4 139.1 13.8 25.2 169.8 186.1 104.5 264.0 197.7 319.1 190.4 212.4 106.7 104.5 196.8 232.7 203.7 169.0 298.8 92.3 78.8 416.3 139.7 219.6 4.2 161.9 102.8 8.7 9.1 166.0 120.0 37.9 144.6 157.1 313.8 187.8 209.7 186.2 272.2 125.3 197.1 174.0 159.3 152.5 475.5 128.2 71.2 72.8 127.5 85.7 284.6 106.3 82.0 120.9 185.1 97.3 98.3 294.1 179.7 136.5 290.0 74.4 138.6 187.3 92.2 565.1 195.8 5.1 0.0 0.4 0.4 0.0 0.2 0.6 1.4 1.7 0.5 0.2 0.3 0.5 0.2 3.6 0.1 1.0 8.1 1.0 0.7 0.9 0.8 1.0 1.0 1.0 0.6 0.9 0.8 0.8 0.6 1.1 2.6 1.0 0.0 4.2 0.0 5.9 6.9 1.5 4.3 1.2 0.9 3.0 3.4 0.9 4.3 3.8 0.0 0.0 23.3 3.8 6.4 0.0 1.2 9.3 7.3 6.6 3.9 1.2 90.7 2.9 0.4 68.5 9.2 16.3 8.4 0.0 46.6 8.9 3.0 19.5 1.7 0.9 9.8 10.2 8.0 5.5 13.1 0.9 7.6 0.0 1.0 2.1 0.4 3.1 0.5 0.5 1.8 1.4 0.0 30.8 2.5 0.9 0.0 0.7 0.4 0.0 1.1 15.4 114.5 63.1 31.2 6.1 4.7 8.2 4.2 18.4 2.9 PDRG1 "C20orf126, dJ310O13.3" ENSG00000088356 "P53 and DNA damage regulated 1" Q9NUG6 20 31944337-31952046 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 55.9" "Cell type enhanced" "Detected in all" "Spermatocytes: 86.8;Theca cells: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047084, HPA063542" Approved Approved "Actin filaments" NA NA "Actin filaments" "HPA047084: AB_2679925, HPA063542: AB_2685035" "unprognostic (2.17e-1)" "unprognostic (9.77e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (8.51e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.62e-5)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.59e-1)" "unprognostic (3.82e-3)" "unprognostic (2.44e-2)" "unprognostic (1.30e-1)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.00e-2)" 8.9 12.8 18.4 7.8 18.2 17.2 11.1 20.7 19.3 10.0 18.5 10.4 8.3 8.9 12.9 13.9 10.1 5.8 11.0 18.2 18.3 13.9 14.4 8.2 11.9 19.6 18.8 18.0 9.6 9.9 55.9 11.4 11.2 20.1 11.7 7.0 9.7 8.8 15.2 15.3 11.4 8.9 7.6 19.2 13.3 9.8 38.3 18.4 12.4 10.4 16.0 12.6 10.1 10.2 20.3 36.6 29.2 17.8 19.7 10.0 7.4 32.9 28.8 16.1 42.3 23.8 107.7 17.9 36.4 21.6 13.6 31.1 23.2 37.8 28.9 34.1 13.4 25.2 50.8 21.7 37.8 25.3 29.3 20.2 9.1 20.9 29.8 30.5 17.9 17.8 37.9 51.7 18.2 17.8 44.3 38.3 34.3 36.7 37.6 61.0 29.6 53.6 19.2 27.8 19.5 42.1 20.2 87.2 27.8 53.6 18.3 48.5 35.5 16.3 34.2 40.3 31.7 36.8 13.3 14.9 40.0 22.9 103.4 22.9 13.4 10.4 16.7 19.0 14.9 18.4 35.4 20.2 20.8 15.8 36.2 27.0 23.6 4.3 28.7 21.6 29.9 21.2 18.2 18.4 18.2 20.7 19.3 18.2 18.3 19.6 18.8 18.0 20.1 19.2 18.4 20.3 22.9 19.2 9.7 4.2 23.4 25.5 16.1 14.0 23.9 21.2 26.7 22.7 17.6 14.3 9.1 11.0 14.6 45.8 29.4 9.6 33.2 24.8 11.8 16.7 20.2 22.9 22.0 13.9 6.3 21.2 26.7 22.3 6.6 18.8 33.0 27.7 12.5 7.9 26.2 16.8 5.9 12.6 10.2 9.1 17.8 17.4 16.1 12.4 12.4 5.6 37.4 23.2 13.4 4.0 5.9 23.8 15.0 17.0 14.8 17.8 13.9 19.3 10.0 21.2 26.3 17.2 22.7 86.8 38.1 18.0 28.6 20.4 18.4 170.9 13.4 14.7 EPB41L1 "4.1N, KIAA0338" ENSG00000088367 "Erythrocyte membrane protein band 4.1 like 1" Q9H4G0 20 36091504-36232799 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 156.4;Inhibitory neurons: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "A549: 163.5;HaCaT: 237.9;OE19: 192.9;SK-BR-3: 185.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054104, HPA056817" Enhanced Supported "Plasma membrane" NA NA 33000 "Plasma membrane" "HPA054104: AB_2682380, HPA056817: AB_2683244" "unprognostic (2.01e-2)" "unprognostic (7.77e-2)" "unprognostic (1.76e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" "unprognostic (3.87e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.30e-4)" "unprognostic (1.78e-1)" "prognostic favorable (4.39e-10)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.26e-2)" 55.6 123.2 70.4 8.2 66.9 0.5 25.9 67.7 99.7 38.0 0.0 31.5 13.9 28.2 31.3 46.7 45.7 40.7 21.5 69.8 72.6 65.3 9.0 30.3 4.4 96.4 82.9 65.7 42.1 29.5 37.3 21.3 22.0 99.7 27.2 21.1 39.8 57.1 42.9 12.1 14.3 16.8 27.4 49.5 8.2 64.8 18.4 77.1 4.6 25.0 15.6 14.1 41.1 32.0 91.6 53.5 163.5 57.7 21.5 36.8 22.8 53.8 16.8 37.7 35.1 27.9 108.7 93.7 3.0 26.4 52.7 71.7 237.9 26.7 19.6 26.2 0.5 14.9 0.4 52.7 107.6 11.3 0.2 19.4 19.9 9.4 32.9 2.7 44.7 8.6 13.0 2.7 41.5 30.5 34.2 1.8 0.9 21.4 192.9 49.9 2.6 16.0 66.3 30.5 84.6 20.1 24.5 74.9 185.6 6.4 43.9 45.8 2.4 7.3 40.9 43.0 20.8 3.7 50.3 19.0 0.6 71.2 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 70.4 66.9 67.7 99.7 69.8 72.6 96.4 82.9 65.7 99.7 49.5 77.1 91.6 14.5 16.0 22.1 27.7 0.4 2.9 5.0 11.1 30.7 31.9 12.8 9.4 8.5 28.6 16.5 47.8 156.4 1.5 0.8 23.8 19.6 22.2 2.9 10.6 8.7 9.2 15.5 0.0 56.8 10.8 0.5 11.0 50.4 7.5 52.5 13.3 10.0 3.7 6.9 32.0 75.7 6.0 4.1 1.3 2.2 2.7 15.8 6.0 3.6 3.7 0.0 22.7 0.0 24.6 73.1 31.6 15.7 42.2 2.1 5.1 8.0 37.1 21.9 8.7 32.9 6.8 35.1 4.6 7.1 43.2 1.7 1.1 0.8 7.1 13.2 18.0 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752672 "Metabolic proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 204.7" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 414.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 55.5;SK-BR-3: 54.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.0 0.4 0.4 0.3 0.5 1.1 0.6 0.4 2.4 1.3 2.7 153.0 5.6 5.9 2.1 0.1 43.5 0.0 0.3 0.4 6.0 18.4 0.1 0.3 0.3 0.6 0.3 0.1 8.3 20.8 0.3 0.1 0.6 1.5 2.7 0.0 0.5 0.5 0.7 23.4 204.7 0.4 0.2 0.1 1.2 0.2 1.0 0.2 0.3 0.0 0.6 2.6 3.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.2 55.5 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.5 12.8 0.0 0.1 0.1 3.3 3.2 1.2 0.1 0.6 0.1 54.7 0.0 2.6 0.2 0.0 0.0 0.4 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.3 0.6 0.4 0.3 0.4 0.3 0.6 0.3 0.6 0.2 1.0 0.6 0.6 3.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.5 50.1 2.4 1.8 0.0 0.0 0.0 33.0 1.9 10.7 0.0 8.2 9.9 0.4 3.6 0.0 0.3 0.9 0.0 0.2 0.0 77.6 0.0 7.2 0.4 32.4 0.1 0.0 0.2 12.0 0.0 0.8 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.5 0.3 2.2 13.8 0.0 0.0 0.6 414.1 10.4 1.7 0.0 0.0 1.3 0.8 0.0 0.3 0.0 0.9 0.1 0.4 0.0 5.8 0.5 DOCK9 "KIAA1058, ZIZ1" ENSG00000088387 "Dedicator of cytokinesis 9" Q9BZ29 13 98793429-99086625 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 217.1" "Cell type enhanced" "Detected in many" "Adipocytes: 158.7;Excitatory neurons: 150.6;Inhibitory neurons: 202.2;Microglial cells: 148.0;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 402.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 20.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 2.0;MAIT T-cell: 4.8;memory CD4 T-cell: 5.2;memory CD8 T-cell: 2.1;naive CD4 T-cell: 6.0;naive CD8 T-cell: 4.0;NK-cell: 7.3;T-reg: 2.4" "Group enriched" "Detected in many" 11 "NK-cells: 7.3;T-cells: 6.0" "Cell line enhanced" "Detected in many" "BEWO: 200.8;hTERT-HME1: 435.4;HUVEC TERT2: 180.9;TIME: 179.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034061, CAB034065, HPA043940" Uncertain NA NA "CAB034061: AB_2277513, CAB034065: AB_2094798, HPA043940: AB_2678741" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (8.76e-2)" "unprognostic (4.24e-2)" "unprognostic (1.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.62e-2)" "unprognostic (2.96e-1)" "unprognostic (2.47e-1)" "unprognostic (1.16e-1)" "unprognostic (6.38e-3)" "unprognostic (2.79e-1)" "unprognostic (7.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.36e-2)" "unprognostic (3.31e-2)" 78.3 22.6 86.0 21.6 128.5 6.0 71.7 92.2 93.8 32.8 47.6 40.5 15.9 31.5 35.8 93.8 30.6 36.9 48.1 70.3 92.9 22.1 15.9 93.8 34.1 114.8 113.6 56.0 27.7 20.1 42.1 21.2 99.0 125.6 23.2 21.0 39.8 51.7 21.9 26.2 77.5 35.5 37.2 96.6 17.0 24.9 16.4 115.9 48.3 63.2 64.8 40.7 29.2 50.0 217.1 61.6 19.4 10.6 14.2 10.6 8.3 200.8 17.2 14.2 12.1 10.7 127.4 47.7 51.3 39.8 16.6 21.8 59.5 27.4 54.3 21.8 52.2 15.2 0.0 37.6 2.1 14.0 0.1 2.9 9.0 37.2 12.4 435.4 27.9 180.9 33.0 10.6 11.6 52.1 20.2 35.5 0.3 4.9 84.6 14.2 2.1 39.3 2.7 38.3 50.8 22.4 24.3 26.4 63.4 15.7 85.9 16.9 0.4 179.7 9.7 11.4 6.5 28.5 17.6 14.8 8.6 15.6 0.0 16.0 0.0 0.0 0.0 2.0 0.0 4.8 0.6 5.2 2.1 0.0 0.2 6.0 4.0 0.1 7.3 0.0 0.0 2.4 1.5 86.0 128.5 92.2 93.8 70.3 92.9 114.8 113.6 56.0 125.6 96.6 115.9 217.1 158.7 16.0 39.5 37.5 3.4 15.3 7.1 14.7 10.2 37.9 15.4 6.5 9.4 11.5 12.5 9.2 50.1 35.6 7.0 11.9 1.9 5.4 1.7 10.5 5.3 90.2 6.7 3.6 150.6 6.6 8.3 17.2 2.6 21.4 2.5 18.0 47.8 8.4 5.0 25.2 202.2 6.0 10.2 1.9 7.4 3.3 7.8 1.7 1.8 148.0 0.4 12.9 4.1 238.8 402.2 14.7 5.6 14.7 2.8 10.1 10.6 3.8 7.1 23.9 0.0 122.6 12.4 7.2 5.4 25.6 32.0 17.2 11.0 2.4 5.9 10.5 ANKRD10 FLJ20093 ENSG00000088448 "Ankyrin repeat domain 10" Q9NXR5 13 110878540-110915069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034211, HPA038878, HPA038879" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB034211: AB_2058024, HPA038878: AB_2676252, HPA038879: AB_2676253" "unprognostic (3.29e-2)" "unprognostic (2.38e-1)" "unprognostic (9.26e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" "unprognostic (2.49e-1)" "unprognostic (4.97e-3)" "unprognostic (9.60e-2)" "unprognostic (1.16e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (1.25e-6)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.41e-6)" 78.7 60.8 70.0 42.6 75.7 89.5 76.3 73.7 85.9 102.7 83.5 91.9 44.2 88.1 90.7 37.9 91.4 53.9 73.9 69.4 81.1 91.2 84.8 92.5 63.9 79.0 72.6 68.5 100.4 95.6 25.7 98.2 36.7 79.9 109.1 50.7 78.3 70.8 42.8 178.1 49.3 88.9 49.5 78.3 140.0 75.6 41.1 77.5 52.9 82.8 74.1 50.8 79.8 68.9 87.0 36.1 29.6 66.7 56.2 50.2 48.4 29.6 24.0 50.0 23.5 28.9 31.0 68.8 49.5 51.1 18.2 38.2 81.1 29.2 22.6 31.7 119.1 43.2 59.0 73.3 64.9 20.0 85.9 49.4 46.2 33.7 16.5 24.4 49.1 32.1 48.8 26.4 33.1 64.2 10.8 49.9 95.3 37.0 79.1 18.3 76.0 24.5 49.6 64.9 39.4 53.2 39.7 18.2 31.7 39.9 49.7 22.7 108.0 28.0 27.6 23.0 13.7 24.7 40.8 46.9 28.9 51.7 41.5 44.2 39.0 25.8 22.7 30.4 21.1 26.3 42.9 29.2 25.3 33.8 44.7 30.9 33.7 16.1 31.8 22.3 31.5 39.9 26.8 70.0 75.7 73.7 85.9 69.4 81.1 79.0 72.6 68.5 79.9 78.3 77.5 87.0 77.6 16.0 65.4 83.6 69.3 94.3 39.0 25.9 129.1 33.3 72.2 55.0 32.0 45.8 45.3 38.6 54.2 45.1 54.4 43.4 19.6 52.1 8.5 59.0 79.2 83.3 41.9 30.3 118.7 49.2 51.8 78.3 51.5 105.4 30.4 65.3 40.7 48.8 46.6 32.0 105.8 55.2 57.0 46.5 99.7 7.3 39.1 60.4 72.9 145.2 44.7 28.6 35.0 158.3 203.6 38.7 46.2 51.6 58.5 62.5 40.9 45.1 40.8 55.4 52.6 105.6 88.8 28.0 23.6 44.3 77.7 38.9 58.9 44.9 59.6 53.2 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574054-94596242 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 75.2;U-698: 97.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 10.5 9.5 5.6 8.3 5.8 6.1 12.6 5.9 8.3 10.5 6.5 8.1 10.3 8.1 11.9 7.0 9.2 6.8 5.5 5.2 6.3 11.0 30.3 7.1 13.0 5.9 5.9 5.0 12.3 10.0 8.1 8.4 10.2 6.0 8.0 9.6 7.0 7.8 7.7 4.1 7.6 9.3 6.8 6.0 9.3 9.2 6.1 5.6 14.2 13.4 4.3 11.1 9.1 6.5 7.0 16.7 7.2 11.6 10.6 17.2 13.5 14.1 15.3 14.9 14.2 13.4 18.9 15.9 26.0 14.8 10.9 8.8 10.4 20.1 11.9 14.9 20.3 7.7 20.7 8.1 18.1 21.0 75.2 13.8 14.9 9.5 8.0 22.8 11.1 13.2 18.9 21.3 8.9 13.3 10.8 20.6 38.4 15.2 26.8 8.3 17.1 11.4 15.9 18.3 7.4 15.9 8.9 11.6 24.2 43.5 19.1 10.2 39.8 12.2 5.6 14.5 8.6 12.6 20.0 11.4 97.5 14.9 26.5 15.5 14.7 5.5 10.8 9.6 6.6 14.9 9.5 11.6 10.7 8.7 7.1 16.8 12.5 1.6 12.1 8.3 7.6 13.8 6.9 5.6 5.8 5.9 8.3 5.2 6.3 5.9 5.9 5.0 6.0 6.0 5.6 7.0 7.4 12.8 6.8 8.1 12.8 2.4 9.2 15.9 6.8 4.3 7.8 7.9 5.2 8.6 11.9 7.3 2.1 15.7 12.5 5.8 9.8 11.9 1.2 10.4 8.9 7.0 5.4 3.4 7.7 9.1 17.7 12.9 6.1 6.0 11.4 7.7 7.9 21.4 11.2 1.7 6.7 7.7 8.2 8.8 7.2 1.0 14.3 7.5 8.8 8.4 11.1 7.0 7.2 12.1 10.4 8.9 6.6 8.2 10.7 10.9 10.0 17.6 15.9 4.7 26.3 6.7 8.1 11.9 12.3 8.5 3.7 10.4 11.0 9.2 9.1 9.7 DOCK3 "KIAA0299, MOCA, PBP" ENSG00000088538 "Dedicator of cytokinesis 3" Q8IZD9 3 50674927-51384198 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 12.3" "Group enriched" "Detected in some" 11 "Astrocytes: 223.6;Excitatory neurons: 777.2;Inhibitory neurons: 837.1;Oligodendrocyte precursor cells: 445.4;Oligodendrocytes: 814.7" "Group enriched" "Detected in many" 4 "glioma: 2.7;thyroid cancer: 7.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.1;GAMG: 5.9;HMC-1: 4.9;JURKAT: 5.8;U-87 MG: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037543, HPA037544" Enhanced Supported Enhanced Cytosol NA NA Cytosol "HPA037543: AB_10672495, HPA037544: AB_10670383" "unprognostic (1.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-3)" "unprognostic (6.35e-8)" "unprognostic (2.63e-1)" "unprognostic (3.02e-2)" "unprognostic (4.64e-2)" "unprognostic (3.67e-1)" "unprognostic (1.91e-1)" "unprognostic (7.99e-2)" "unprognostic (2.36e-3)" "unprognostic (1.34e-2)" "unprognostic (1.45e-2)" "unprognostic (5.83e-5)" "unprognostic (7.96e-2)" "unprognostic (6.19e-2)" "unprognostic (1.24e-1)" 0.7 3.3 5.4 0.2 11.8 0.2 0.3 0.8 19.4 0.8 0.0 2.2 0.2 0.7 0.7 2.1 0.9 0.3 2.9 10.6 5.3 0.7 0.1 0.5 0.3 2.3 1.9 12.1 0.4 0.4 5.3 6.4 0.1 4.8 2.0 0.3 10.2 1.5 1.9 1.9 2.0 0.8 1.0 0.0 0.5 1.4 6.0 0.9 0.0 12.3 1.8 0.3 2.0 0.6 15.9 0.1 0.2 0.2 6.1 0.0 0.0 2.6 0.1 0.1 0.3 0.2 0.1 0.4 0.0 0.5 1.9 5.9 0.4 4.1 0.0 0.1 3.7 4.3 0.1 1.2 0.1 0.0 0.1 4.9 0.0 0.1 0.2 0.0 0.3 0.0 5.8 0.0 0.1 0.5 0.2 0.0 0.0 2.0 0.3 1.9 0.0 0.6 0.0 0.3 0.6 3.7 0.0 0.3 3.4 0.0 4.1 0.1 0.0 0.4 0.2 1.6 0.2 2.2 0.3 0.0 0.0 7.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 5.4 11.8 0.8 19.4 10.6 5.3 2.3 1.9 12.1 4.8 0.0 0.9 15.9 0.0 0.0 0.6 223.6 0.0 0.0 0.2 0.0 0.0 22.0 0.3 0.4 7.5 0.0 0.7 0.0 2.1 0.1 0.4 0.1 1.9 0.0 11.4 0.3 0.2 0.4 0.0 0.0 777.2 0.0 0.2 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.5 33.7 837.1 0.0 0.0 0.0 0.0 6.0 0.0 0.4 0.0 52.5 0.0 3.1 1.0 445.4 814.7 0.3 0.0 0.0 0.5 0.1 0.0 0.2 0.1 5.1 0.0 1.1 1.2 6.0 4.1 0.4 0.1 0.0 1.1 0.1 0.0 0.1 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.3;Early spermatids: 54.2;Late spermatids: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;NK-cells: 2.0;T-cells: 6.3" "Cell line enhanced" "Detected in many" "HDLM-2: 48.8" "Group enriched" "Detected in all" 4 "cerebellum: 28.2;olfactory bulb: 27.5" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol No No Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 5.6 8.8 22.5 2.9 22.5 0.9 5.6 29.7 24.2 10.5 24.0 9.2 1.8 10.7 4.4 3.6 9.4 3.6 28.1 21.8 25.1 7.1 5.0 3.7 3.8 23.6 24.6 20.8 12.7 6.7 27.6 12.6 2.1 25.2 9.3 2.6 28.7 7.1 9.9 36.6 2.8 5.4 9.6 21.5 5.3 10.2 19.8 23.7 3.1 9.1 27.0 3.7 9.6 6.5 22.0 1.8 2.7 3.1 0.6 10.1 9.0 1.0 11.1 17.2 9.9 7.2 0.2 2.8 2.3 2.6 15.2 9.3 0.2 0.0 4.3 5.2 48.8 0.3 5.0 6.9 0.8 5.0 0.0 6.0 8.9 0.6 9.6 0.5 7.9 1.9 7.2 1.1 2.2 5.9 0.4 0.4 1.5 3.8 1.9 12.3 1.0 0.3 2.7 0.6 0.4 3.4 16.1 2.9 0.6 0.3 3.5 3.4 1.3 0.6 9.9 7.7 18.1 1.4 2.8 2.5 0.3 14.0 5.1 0.2 0.0 0.4 0.7 5.1 0.1 6.3 2.2 4.3 4.8 0.4 1.4 5.0 6.1 0.0 2.0 0.1 0.8 2.2 2.5 22.5 22.5 29.7 24.2 21.8 25.1 23.6 24.6 20.8 25.2 21.5 23.7 22.0 1.8 0.0 1.1 8.1 2.2 1.1 1.1 0.9 1.2 10.2 1.8 2.0 29.3 0.0 1.4 1.8 8.4 0.4 1.3 0.3 3.9 2.1 54.2 1.1 2.3 2.6 1.8 0.0 5.6 1.8 0.8 4.9 1.5 0.5 0.0 3.1 2.5 2.2 1.6 1.7 8.3 0.7 0.0 1.3 0.3 62.6 4.7 1.1 0.0 3.7 8.9 12.4 3.1 3.0 3.3 0.7 0.1 4.1 1.6 0.5 0.1 3.5 1.2 17.3 13.1 5.6 5.3 2.7 2.5 0.1 0.4 0.1 3.0 2.7 0.3 0.2 COQ9 "C16orf49, DKFZP434K046" ENSG00000088682 "Coenzyme Q9" O75208 16 57447425-57461270 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 257.9;tongue: 243.1" "Cell type enhanced" "Detected in all" "Distal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040918 Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA040918: AB_10794154" "unprognostic (9.18e-2)" "unprognostic (3.60e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-2)" "unprognostic (2.14e-3)" "unprognostic (2.57e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-1)" "unprognostic (2.59e-1)" "unprognostic (9.78e-2)" "unprognostic (2.34e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.03e-11)" "unprognostic (7.40e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.23e-2)" 24.5 45.0 20.7 15.2 20.7 10.7 18.1 22.2 25.2 19.8 33.0 48.4 47.7 16.9 16.8 40.4 24.2 19.6 128.7 19.9 21.1 61.8 53.6 14.5 15.7 20.0 20.6 19.2 16.8 28.2 80.4 15.0 16.9 19.4 26.5 38.5 11.9 44.5 29.1 257.9 25.1 42.1 28.5 19.4 12.3 35.6 24.0 23.4 18.9 29.5 243.1 17.4 38.5 21.8 20.6 33.6 67.2 18.3 45.8 36.0 27.3 21.3 31.9 25.3 44.8 24.9 41.2 43.0 40.3 59.0 28.8 34.3 70.5 52.8 56.6 28.3 21.4 49.3 27.7 44.2 66.1 39.8 36.1 44.4 45.6 73.7 35.9 68.1 29.8 51.1 35.6 54.7 18.1 27.4 48.6 30.5 26.8 29.6 74.4 90.6 60.8 58.7 104.8 71.3 37.4 56.3 56.7 108.4 103.8 54.9 16.1 59.4 39.5 34.4 32.4 38.9 34.8 40.4 42.9 29.5 48.0 44.4 51.2 37.3 21.0 28.2 23.0 19.5 36.6 20.1 18.8 16.6 17.1 34.4 19.1 17.7 26.0 8.9 24.0 38.2 21.5 25.5 21.9 20.7 20.7 22.2 25.2 19.9 21.1 20.0 20.6 19.2 19.4 19.4 23.4 20.6 17.1 12.8 18.9 37.9 15.7 8.4 17.1 55.3 19.9 16.2 21.7 23.1 79.5 45.8 28.7 25.8 16.7 74.7 14.2 68.8 217.2 53.9 37.9 20.4 17.3 17.3 27.6 21.2 21.2 29.3 25.6 20.7 35.7 18.0 7.0 40.7 18.5 53.6 38.8 20.2 24.0 46.6 83.4 16.3 5.4 28.4 21.1 14.1 28.4 7.5 22.7 29.1 14.4 20.6 14.5 27.2 37.0 20.3 15.9 21.5 90.7 114.1 30.0 24.0 13.1 22.6 19.8 66.0 38.8 37.3 11.2 78.7 12.8 91.2 70.2 18.4 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733528-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 221.6;skin 1: 62.5;vagina: 80.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 104.7;Cytotrophoblasts: 128.3;Macrophages: 121.3;Squamous epithelial cells: 116.5;Suprabasal keratinocytes: 201.9;Syncytiotrophoblasts: 656.6;Urothelial cells: 157.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3;urothelial cancer: 12.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 6.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 244.9;hTCEpi: 56.1;hTERT-HME1: 68.0;RT4: 36.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 2500000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.1 0.1 0.2 0.0 0.3 3.4 3.2 0.4 0.5 20.3 0.2 0.0 0.1 0.1 1.3 221.6 3.2 0.1 3.2 0.4 0.2 0.2 0.3 2.1 0.1 0.3 0.3 0.2 0.1 0.1 3.2 0.2 16.0 0.4 3.7 0.0 0.1 27.5 2.5 1.3 62.5 0.0 0.1 0.1 1.8 0.2 0.9 0.3 1.5 0.1 0.7 26.1 15.4 80.8 0.5 26.6 0.1 0.0 0.1 0.0 0.0 22.4 0.2 1.1 1.3 1.4 1.0 4.1 0.1 0.2 0.0 0.6 7.6 0.0 244.9 5.1 0.2 0.0 1.9 0.2 0.8 0.0 0.0 0.0 0.0 56.1 0.0 68.0 0.4 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 0.2 4.3 0.0 1.6 0.0 1.6 36.0 0.2 0.2 0.1 31.3 0.0 4.6 2.8 0.7 0.0 0.0 1.6 0.0 2.1 0.3 0.1 0.4 0.1 0.0 0.0 1.6 0.9 1.1 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.0 0.0 0.0 0.8 0.0 32.9 0.2 0.3 0.4 0.5 0.4 0.2 0.3 0.3 0.2 0.4 0.1 0.3 0.5 0.1 0.0 0.0 0.3 0.3 64.2 104.7 71.7 17.6 0.0 1.5 5.6 4.7 0.0 39.4 1.8 0.0 128.3 0.0 0.1 0.0 0.5 0.8 2.9 0.0 1.8 0.0 0.0 0.3 0.0 14.7 1.8 0.0 0.1 0.0 0.0 2.2 0.7 10.8 0.0 0.3 0.0 12.2 4.8 7.3 2.0 0.3 121.3 10.6 0.0 2.6 0.0 2.1 0.0 0.2 2.2 0.0 0.0 0.0 53.5 0.0 0.0 55.0 0.0 0.0 0.1 3.6 0.7 6.8 116.5 201.9 656.6 1.0 0.2 0.0 157.9 KIF9 MGC104186 ENSG00000088727 "Kinesin family member 9" Q9HAQ2 3 47228395-47283451 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.9" "Cell type enhanced" "Detected in all" "Early spermatids: 690.3;Endometrial ciliated cells: 398.0;Respiratory ciliated cells: 359.0;Spermatocytes: 328.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022031, HPA022033, HPA030429" Approved NA NA "HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921" "unprognostic (1.93e-2)" "unprognostic (6.37e-2)" "prognostic favorable (2.26e-4)" "unprognostic (1.17e-3)" "unprognostic (8.86e-2)" "unprognostic (1.13e-1)" "unprognostic (2.80e-3)" "unprognostic (1.70e-1)" "unprognostic (2.94e-2)" "unprognostic (4.59e-2)" "unprognostic (7.47e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.95e-6)" "unprognostic (4.21e-2)" "unprognostic (2.03e-1)" "unprognostic (9.17e-2)" "unprognostic (1.23e-1)" 6.2 7.5 12.4 3.2 10.1 11.9 10.7 10.1 14.5 7.6 21.0 9.2 6.2 8.0 20.7 5.9 26.5 6.4 13.2 10.5 12.4 21.2 6.0 8.7 2.6 11.7 11.7 9.6 5.1 12.8 10.1 16.5 3.7 11.3 7.8 8.2 18.9 9.0 4.9 9.5 8.1 5.6 4.6 12.1 5.7 9.4 64.9 9.8 2.3 21.2 5.7 3.1 6.8 5.4 9.7 19.4 21.7 7.6 19.1 3.6 8.7 6.2 5.9 6.1 8.8 7.8 8.4 23.0 12.8 7.3 7.6 11.8 12.0 22.6 15.3 8.7 6.6 14.6 11.9 16.5 26.9 3.4 25.3 3.8 4.5 15.3 12.8 9.6 7.4 19.0 13.5 26.5 5.1 6.6 15.5 13.7 37.6 21.7 44.4 30.5 8.6 5.3 18.3 36.7 10.9 10.8 19.9 6.8 13.0 21.8 3.9 8.4 17.6 9.0 5.1 11.0 8.3 13.6 4.4 19.7 16.1 18.9 25.1 11.3 2.5 3.6 2.1 1.5 2.6 3.0 3.5 1.4 2.3 5.7 0.6 1.7 1.9 6.3 3.5 2.3 3.3 1.0 1.3 12.4 10.1 10.1 14.5 10.5 12.4 11.7 11.7 9.6 11.3 12.1 9.8 9.7 34.5 19.2 18.4 4.2 6.7 20.1 53.7 44.3 20.5 7.2 61.4 74.5 28.2 38.6 51.9 64.4 35.5 10.7 7.5 23.8 109.5 45.5 690.3 398.0 17.8 29.3 58.9 20.0 16.6 32.7 11.1 12.1 34.1 38.5 29.1 11.3 17.9 20.7 9.2 5.0 10.3 40.1 52.9 7.2 7.1 160.6 14.0 8.0 16.0 2.8 3.8 17.2 3.1 2.5 3.2 26.0 15.7 13.2 5.7 37.6 15.1 198.1 359.0 44.0 13.1 42.2 16.7 328.8 37.3 17.2 20.2 8.2 7.8 21.8 37.8 37.4 ARHGAP28 "FLJ10312, KIAA1314" ENSG00000088756 "Rho GTPase activating protein 28" Q9P2N2 18 6729716-6915716 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 26.1;testis: 78.1" "Group enriched" "Detected in many" 14 "Early spermatids: 536.8;Late spermatids: 488.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "neutrophil: 3.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "AF22: 30.4;CACO-2: 32.8;SuSa: 22.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA030413, HPA030414, HPA030415" Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598" "unprognostic (8.33e-2)" "unprognostic (8.79e-3)" "unprognostic (3.15e-3)" "unprognostic (6.94e-5)" "unprognostic (1.49e-1)" "unprognostic (2.92e-2)" "unprognostic (1.11e-3)" "unprognostic (1.10e-1)" "unprognostic (7.56e-3)" "unprognostic (9.52e-4)" "unprognostic (1.43e-2)" "unprognostic (3.12e-1)" "unprognostic (4.53e-3)" "unprognostic (3.59e-3)" "unprognostic (6.00e-2)" "unprognostic (3.61e-2)" "unprognostic (2.76e-2)" 4.4 2.0 1.2 1.7 1.4 0.8 2.7 1.9 1.5 8.7 0.9 1.9 1.7 2.9 8.8 1.9 3.1 6.7 2.0 1.3 1.1 8.5 1.0 4.6 1.7 1.0 0.3 1.4 10.5 3.9 3.1 0.8 26.1 0.8 3.9 2.3 1.5 0.8 2.2 5.0 2.1 1.8 1.4 0.1 12.7 2.1 78.1 1.0 3.9 2.9 1.6 0.9 5.5 3.0 1.1 0.2 0.2 30.4 3.1 6.3 10.5 4.9 2.2 5.1 2.5 5.3 32.8 0.2 0.2 1.0 0.4 1.7 1.4 0.1 0.8 3.7 1.0 1.8 0.1 2.9 0.2 1.1 0.1 0.1 12.6 0.6 2.7 0.2 0.3 7.8 0.5 0.8 2.5 4.1 0.5 0.5 0.3 9.6 0.4 1.4 0.1 2.7 0.2 0.0 2.9 2.9 11.9 0.1 2.8 0.5 22.6 0.2 0.1 1.3 0.5 13.1 10.1 0.4 0.2 0.1 0.1 5.0 0.3 1.1 0.7 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 3.0 0.1 0.0 0.2 0.0 0.0 1.2 1.4 1.9 1.5 1.3 1.1 1.0 0.3 1.4 0.8 0.1 1.0 1.1 8.3 0.0 1.9 6.2 0.1 1.9 1.3 0.2 0.0 1.5 0.9 0.5 1.8 0.0 0.7 1.8 20.9 14.9 0.0 0.0 0.0 1.1 536.8 0.5 14.6 7.9 0.0 0.0 7.1 2.7 2.7 16.1 0.0 0.4 0.0 25.8 4.2 0.2 2.1 0.0 34.4 0.1 0.0 0.3 0.4 488.0 18.3 0.5 0.0 12.2 0.0 0.2 0.0 24.6 3.6 0.7 0.0 14.3 0.1 4.7 0.0 3.8 0.0 0.8 0.0 11.0 5.4 14.3 3.7 0.8 1.4 6.6 0.3 23.7 0.0 1.3 CRLS1 "C20orf155, CLS1, dJ967N21.6, GCD10" ENSG00000088766 "Cardiolipin synthase 1" Q9UJA2 20 6006093-6040053 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 170.9" "Cell type enhanced" "Detected in all" "Early spermatids: 264.2;Hepatocytes: 208.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 237.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.88e-1)" "unprognostic (8.56e-2)" "unprognostic (9.64e-3)" "unprognostic (1.89e-1)" "unprognostic (1.41e-2)" "unprognostic (2.65e-2)" "unprognostic (1.42e-1)" "unprognostic (2.00e-1)" "unprognostic (9.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (1.83e-2)" "unprognostic (1.85e-1)" "unprognostic (9.54e-2)" "prognostic favorable (8.02e-4)" 42.2 55.5 15.8 17.0 15.9 28.7 33.5 15.9 18.0 24.2 17.4 32.6 59.7 19.0 20.1 18.7 24.3 20.1 83.5 15.8 16.6 58.4 170.9 27.3 16.6 16.6 17.0 15.2 21.3 37.7 28.5 15.9 18.1 16.7 32.9 33.2 15.6 27.7 26.1 86.7 14.9 41.3 23.9 16.4 14.6 47.0 28.0 17.4 17.0 27.4 80.2 18.4 26.0 17.9 17.0 71.7 46.5 27.9 40.0 83.1 74.9 34.5 43.6 50.9 38.8 46.8 61.5 44.4 75.8 31.4 52.6 73.3 45.0 54.6 70.9 57.6 21.9 39.9 99.5 17.0 237.4 59.6 99.7 32.4 44.6 59.4 41.5 73.5 36.8 57.3 40.3 76.4 31.6 44.2 25.9 63.6 90.1 55.4 154.8 42.4 42.3 44.6 80.7 61.8 22.1 50.3 43.4 44.8 98.7 78.1 27.5 35.8 59.6 39.2 45.9 33.4 48.7 59.0 33.8 79.1 79.9 17.6 79.5 43.9 0.0 1.2 0.6 1.2 0.9 2.2 2.3 0.7 0.8 1.3 1.1 1.4 0.8 0.0 1.7 0.5 1.6 0.8 0.4 15.8 15.9 15.9 18.0 15.8 16.6 16.6 17.0 15.2 16.7 16.4 17.4 17.0 18.8 22.4 47.6 22.2 26.4 33.8 41.4 19.4 31.9 12.9 35.8 27.7 108.0 64.3 16.2 36.8 4.2 45.1 19.5 36.3 64.6 27.9 264.2 29.7 26.2 22.7 28.6 58.0 37.0 28.8 64.1 33.8 52.0 29.7 14.7 31.6 22.5 208.7 34.2 11.8 28.7 50.7 4.1 40.0 24.1 99.5 30.4 31.9 26.6 32.8 28.9 40.5 25.7 39.7 34.3 28.4 49.1 24.5 41.8 117.7 75.7 141.0 15.0 12.9 13.1 29.2 25.6 23.0 18.4 37.7 27.8 36.3 23.3 32.3 82.9 48.6 DEFB127 "bA530N10.2, C20orf73, DEF-27" ENSG00000088782 "Defensin beta 127" Q9H1M4 20 157454-159163 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1157 "epididymis: 1086.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1086.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733195-103847575 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favorable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favorable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.0 4.8 2.5 3.3 4.4 0.7 7.5 7.3 9.0 6.9 3.5 7.8 7.2 7.7 2.1 11.7 9.9 4.7 21.4 8.0 4.2 7.0 5.0 10.0 2.8 1.4 2.6 3.7 11.0 8.4 7.9 6.5 6.0 2.5 10.7 5.7 8.1 10.3 5.4 7.6 11.9 7.7 5.3 0.4 11.4 10.2 19.3 2.8 2.0 23.6 6.3 5.2 8.0 7.1 4.5 4.9 4.2 0.5 5.4 0.9 0.4 1.9 3.2 2.3 4.0 1.8 3.3 4.4 1.1 11.7 2.2 4.9 9.8 5.8 3.7 3.5 2.2 4.0 0.0 1.3 5.7 3.6 0.5 4.4 1.0 4.4 0.3 4.7 1.7 7.9 2.8 0.7 1.7 2.7 20.3 0.0 0.5 1.0 12.3 5.1 11.3 3.2 2.7 7.8 12.7 6.6 16.9 9.9 7.3 2.5 2.6 18.4 0.7 7.1 2.9 4.0 2.4 3.0 4.0 5.8 8.4 1.8 2.9 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 4.4 7.3 9.0 8.0 4.2 1.4 2.6 3.7 2.5 0.4 2.8 4.5 35.1 19.2 39.5 31.0 7.1 13.5 16.6 6.9 18.8 15.8 31.3 20.6 45.4 14.3 11.8 7.3 12.5 2.9 11.9 26.9 3.9 7.9 58.0 37.9 7.9 30.3 15.6 2.7 106.1 6.4 1.0 7.7 37.8 48.5 0.0 83.4 14.3 9.0 2.9 15.2 105.9 14.2 6.1 1.6 5.7 78.4 4.4 3.0 3.6 49.6 0.4 5.8 1.0 31.7 33.2 6.8 18.7 20.3 6.3 13.1 14.6 7.8 8.3 12.9 6.6 10.9 6.7 17.8 15.1 24.1 12.9 2.2 9.0 8.7 15.8 13.7 ATRN "DPPT-L, MGCA" ENSG00000088812 Attractin O75882 20 3471018-3651118 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 101.6;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 89.5;Oligodendrocytes: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008853 Approved Approved Cytosol "Secreted to blood" NA NA 27000000000 Cytosol "HPA008853: AB_1078248" "unprognostic (6.42e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-1)" "unprognostic (5.27e-2)" "unprognostic (1.65e-1)" "unprognostic (3.99e-2)" "unprognostic (4.28e-1)" "unprognostic (3.40e-2)" "unprognostic (4.61e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.19e-6)" "unprognostic (3.71e-2)" "unprognostic (9.49e-2)" "unprognostic (2.77e-1)" "unprognostic (3.91e-2)" 12.9 19.2 9.3 10.4 12.3 8.7 17.3 8.9 13.1 16.6 8.4 11.9 56.3 11.9 15.7 10.5 11.8 14.0 19.3 12.4 11.6 24.1 63.3 14.5 7.6 8.6 9.8 11.4 14.1 20.4 40.4 8.8 22.8 9.3 12.9 12.4 24.4 14.0 13.3 11.6 15.1 33.6 15.0 10.1 13.9 24.2 16.8 10.7 7.9 32.6 14.3 9.7 15.8 9.2 15.7 40.8 37.6 21.9 18.4 37.9 61.5 28.1 26.6 37.5 27.4 23.1 16.3 27.1 0.0 17.5 37.4 33.8 55.6 15.0 58.1 36.4 4.5 12.8 12.7 10.0 35.1 22.8 27.2 8.3 33.1 46.0 29.0 27.8 34.3 36.0 8.7 20.2 19.2 27.0 11.7 11.1 10.4 14.7 13.2 22.3 9.2 50.9 30.8 24.8 28.5 12.9 20.2 26.7 48.9 36.3 21.3 26.2 25.5 44.7 29.0 17.0 30.8 26.6 13.4 20.1 0.1 17.9 17.9 29.6 3.6 3.2 2.0 2.3 2.8 1.0 1.4 1.2 1.4 2.8 1.7 2.0 1.7 0.0 1.5 3.1 2.6 1.8 1.0 9.3 12.3 8.9 13.1 12.4 11.6 8.6 9.8 11.4 9.3 10.1 10.7 15.7 11.1 16.0 10.4 70.2 5.8 6.4 4.3 14.1 6.8 22.5 9.9 8.8 12.6 20.0 10.3 11.0 37.5 7.4 8.0 6.5 1.9 8.2 7.1 9.9 15.1 11.1 9.6 7.4 101.6 14.6 8.4 12.7 20.4 11.8 7.0 39.3 17.9 50.9 10.4 37.0 101.1 10.7 4.1 14.2 6.7 5.4 12.5 11.5 7.2 64.6 10.1 11.8 5.2 89.5 85.7 10.0 14.3 7.9 11.4 7.0 34.6 7.3 10.2 20.1 32.9 14.3 10.9 21.3 21.1 8.5 7.2 5.1 5.8 21.0 12.6 5.2 SMOX "C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO" ENSG00000088826 "Spermine oxidase" Q9NWM0 20 4120980-4187747 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 61.4" "Cell type enhanced" "Detected in many" "Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0" "Cell line enhanced" "Detected in many" "A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047117, HPA060198" Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA047117: AB_2679940, HPA060198: AB_2684220" "unprognostic (1.24e-2)" "unprognostic (6.55e-2)" "unprognostic (7.24e-3)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.33e-6)" "prognostic unfavorable (1.36e-4)" "unprognostic (4.92e-2)" "unprognostic (3.37e-1)" "unprognostic (7.18e-2)" "unprognostic (7.58e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (4.08e-2)" "unprognostic (2.64e-3)" "unprognostic (1.26e-2)" "unprognostic (3.07e-1)" 6.0 4.4 44.6 4.4 50.1 32.5 5.4 50.1 61.4 16.0 26.9 5.0 10.7 10.9 7.2 8.5 7.5 15.3 6.1 41.1 56.4 11.0 8.5 4.9 4.8 49.5 48.0 34.4 12.6 32.8 25.4 13.3 6.3 48.7 12.3 1.2 3.0 12.2 7.9 4.4 11.7 8.2 4.0 46.6 6.5 20.3 5.8 49.0 4.3 6.8 2.9 2.7 8.3 12.5 49.3 11.0 119.6 8.3 6.3 5.5 8.2 14.6 15.6 29.8 11.1 7.4 49.5 29.6 0.0 5.1 14.4 18.0 21.6 6.8 7.5 4.8 0.0 3.5 21.5 4.1 50.6 35.0 4.1 8.3 31.3 13.1 23.1 9.8 13.4 19.8 16.7 4.8 201.7 6.7 3.3 8.1 12.1 10.2 10.7 16.3 7.3 10.3 29.1 91.4 8.3 1.6 7.2 28.9 3.4 54.1 4.2 0.3 5.1 24.0 12.7 12.0 2.3 12.2 9.1 1.7 0.1 10.6 5.4 9.8 0.0 1.0 0.2 0.0 0.4 0.0 0.1 0.2 0.2 2.4 0.0 0.0 0.0 3.6 0.3 0.1 1.1 0.0 16.0 44.6 50.1 50.1 61.4 41.1 56.4 49.5 48.0 34.4 48.7 46.6 49.0 49.3 4.4 0.0 0.5 38.5 3.8 12.6 12.0 14.4 6.8 0.5 6.9 4.6 1.7 12.8 6.3 11.0 0.0 0.4 0.2 1.4 0.0 48.4 4.0 9.2 15.8 11.2 6.0 89.7 1.6 30.5 0.8 11.3 6.6 18.7 5.7 10.4 13.6 2.3 20.6 0.0 3.5 3.0 6.1 3.1 10.2 7.7 14.6 73.3 8.8 5.6 22.6 25.4 1.0 9.0 6.2 131.3 1.5 13.5 7.4 13.1 4.0 3.8 1.2 1.4 0.0 2.7 10.2 19.1 7.8 2.1 10.5 0.3 2.1 1.9 3.7 12.6 SIGLEC1 "CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN" ENSG00000088827 "Sialic acid binding Ig like lectin 1" Q9BZZ2 20 3686970-3712600 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 11 "Hofbauer cells: 78.6;Kupffer cells: 93.4;Macrophages: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Cell line enriched" "Detected in single" 19 "THP-1: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053457 Supported "Intracellular and membrane" NA NA 260000 "HPA053457: AB_2682158" "unprognostic (2.05e-1)" "unprognostic (9.27e-3)" "unprognostic (3.83e-4)" "unprognostic (4.87e-3)" "unprognostic (3.40e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (6.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (8.71e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" 21.5 13.8 2.3 7.8 3.9 12.5 8.7 2.0 6.9 1.6 10.8 9.6 5.2 2.0 1.9 2.3 7.0 8.6 6.2 1.8 7.7 3.8 8.4 16.8 12.8 6.4 3.1 1.7 2.8 1.6 0.5 2.3 18.9 4.0 1.9 6.7 0.3 5.5 1.2 3.8 2.8 11.3 7.8 2.7 19.0 5.2 2.6 9.3 3.6 3.7 2.7 1.9 7.7 3.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 2.3 3.9 2.0 6.9 1.8 7.7 6.4 3.1 1.7 4.0 2.7 9.3 9.6 0.5 3.2 4.4 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 0.3 2.4 0.0 0.6 0.0 2.1 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.3 0.0 0.0 93.4 6.3 0.1 0.0 42.6 0.0 3.7 2.1 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 1.4 1.0 0.0 0.1 0.6 0.6 1.9 0.4 0.0 0.0 0.0 FKBP1A "FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE" ENSG00000088832 "FKBP prolyl isomerase 1A" P62942 20 1368977-1393164 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Paneth cells: 977.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 1749.2;TIME: 1929.6" "CAB004639, HPA051798" Uncertain NA NA 12000000 "CAB004639: AB_425434, HPA051798: AB_2681615" "unprognostic (4.09e-2)" "unprognostic (2.29e-1)" "unprognostic (5.22e-3)" "unprognostic (1.28e-2)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "prognostic unfavorable (3.44e-7)" "unprognostic (7.05e-3)" "unprognostic (2.76e-1)" "unprognostic (8.81e-2)" "unprognostic (5.12e-3)" "unprognostic (6.65e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (1.97e-2)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" 243.5 186.5 129.3 180.4 166.5 168.5 189.8 80.4 164.5 119.9 106.8 160.2 109.9 166.7 151.5 171.2 132.9 105.4 155.7 150.1 103.8 169.4 98.9 237.2 164.0 98.6 89.2 128.2 136.2 115.5 124.1 80.1 220.5 96.8 126.5 190.3 11.9 112.0 120.9 111.3 124.5 118.0 227.1 87.3 187.2 119.3 57.4 103.6 189.9 192.5 151.9 203.9 208.7 127.3 107.6 718.1 299.5 172.9 240.3 654.1 771.3 202.9 423.9 337.1 382.7 354.2 278.4 295.2 272.5 149.3 555.7 656.3 337.7 255.1 1007.2 419.7 68.8 170.5 284.2 113.9 473.3 406.4 390.5 168.0 484.7 332.0 410.3 412.6 513.3 1749.2 401.0 271.0 145.8 443.3 125.8 401.9 453.7 307.1 335.3 276.4 307.0 254.1 351.9 540.0 243.4 248.7 173.8 208.0 479.3 728.8 231.8 177.2 293.0 1929.6 1363.6 201.8 278.1 329.5 76.4 168.1 292.9 248.1 332.3 307.5 316.3 870.8 974.2 112.9 1005.8 104.3 128.1 135.5 133.2 675.2 136.2 140.1 132.6 805.0 160.6 1013.4 312.7 195.0 1153.8 129.3 166.5 80.4 164.5 150.1 103.8 98.6 89.2 128.2 96.8 87.3 103.6 107.6 779.1 86.6 77.2 0.0 160.6 263.1 211.2 393.3 152.0 17.6 175.6 156.5 59.7 170.1 179.5 172.9 0.0 281.8 148.3 456.2 238.7 432.4 47.7 98.7 183.8 814.8 330.6 196.4 0.0 337.5 702.0 212.2 160.0 122.5 143.5 95.3 623.6 113.5 746.7 35.3 0.0 245.9 329.6 541.8 436.5 52.2 200.0 428.8 241.9 0.0 527.4 52.2 152.4 0.0 0.0 483.6 977.5 162.9 214.8 221.1 210.8 332.1 123.0 11.7 138.1 87.4 224.7 169.3 141.8 329.4 299.3 231.5 150.1 347.3 318.0 245.7 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 1900000 Nucleoplasm "Plasma membrane, Cytosol" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 20.5 38.0 36.7 13.6 38.8 28.0 21.7 36.4 46.3 22.3 39.2 21.0 15.0 22.6 27.1 28.7 26.3 13.6 26.6 38.3 37.9 20.7 26.5 18.2 15.3 38.2 36.8 37.6 25.9 15.6 24.1 14.2 21.2 39.6 21.1 18.6 22.8 19.5 26.6 69.5 35.6 17.8 23.1 36.1 20.0 18.1 14.9 37.8 21.2 20.2 43.7 18.8 22.6 21.7 39.1 55.6 64.4 35.9 32.0 30.5 31.4 28.7 21.0 41.8 57.7 41.3 53.9 43.1 31.6 16.6 47.8 47.2 50.4 25.9 70.3 40.8 12.3 25.1 29.8 10.3 61.4 33.8 30.7 16.4 23.5 33.3 55.3 20.3 30.8 46.8 23.4 42.5 26.5 36.2 29.1 31.4 54.7 40.7 42.5 65.4 14.7 41.1 29.8 68.6 37.1 20.5 23.4 29.6 59.8 26.7 18.8 36.5 22.0 37.8 38.7 29.4 23.9 40.2 21.9 41.8 24.7 28.9 43.0 29.3 31.4 21.3 80.3 20.0 26.6 19.7 35.0 21.2 19.5 29.7 36.0 23.4 20.7 69.1 16.7 28.1 23.1 28.2 25.5 36.7 38.8 36.4 46.3 38.3 37.9 38.2 36.8 37.6 39.6 36.1 37.8 39.1 34.6 22.4 23.2 17.3 36.1 89.2 63.5 106.3 44.3 60.2 28.6 26.0 35.4 24.3 57.8 31.3 22.9 150.7 29.7 68.2 56.7 104.7 23.0 51.0 29.6 44.3 43.6 41.0 24.0 94.5 146.0 41.1 30.5 54.9 40.5 49.1 31.1 42.2 81.1 70.7 24.8 42.5 61.1 43.7 43.6 38.8 39.1 43.8 42.7 14.0 52.9 61.7 32.0 17.6 31.2 123.4 65.7 46.3 41.8 76.0 66.4 73.8 43.2 44.5 78.9 44.2 64.7 106.1 103.2 55.1 75.7 151.6 31.6 48.9 44.0 88.5 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 54.5;thyroid gland: 61.4" "Cell type enhanced" "Detected in many" "Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 2.0 6.9 4.2 0.7 2.5 0.4 3.4 2.9 2.8 11.0 4.5 0.3 0.1 0.5 2.6 16.7 1.7 1.1 0.6 2.6 1.9 17.2 0.2 2.0 1.4 1.8 2.3 1.9 0.2 0.6 0.6 4.4 0.2 2.0 5.4 0.3 0.4 54.5 7.1 5.2 12.0 0.6 0.3 0.6 0.7 2.5 6.0 3.5 1.0 61.4 0.1 1.9 3.4 5.8 2.3 11.0 15.5 1.8 7.9 5.1 1.3 21.1 5.4 3.4 2.8 1.6 1.1 14.1 0.0 6.1 1.9 6.6 70.6 8.3 16.8 0.5 0.1 3.2 0.7 7.5 43.0 3.2 4.0 13.6 0.7 6.8 3.4 3.2 2.3 7.0 9.8 1.6 9.7 2.9 7.2 0.5 0.4 12.1 13.6 20.7 2.6 10.3 3.5 16.9 30.7 0.9 4.9 2.7 17.5 0.3 5.4 6.7 7.0 12.1 2.1 7.0 0.5 2.7 0.4 0.6 0.1 0.1 2.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 4.2 2.5 2.9 2.8 2.6 1.9 1.8 2.3 1.9 2.0 0.6 3.5 2.3 0.8 0.0 0.0 1.6 0.0 0.8 2.2 16.3 8.0 0.2 4.9 4.4 1.1 0.0 25.5 112.2 0.0 0.1 0.6 0.8 0.0 0.7 5.8 2.3 0.6 0.7 0.0 0.0 0.3 0.5 0.1 0.3 5.1 4.2 0.0 0.2 1.1 0.0 0.4 0.0 0.1 0.2 79.3 0.3 0.0 2.2 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.3 3.0 1.3 0.4 0.0 3.7 0.0 0.5 48.1 0.2 26.3 0.6 5.8 3.0 4.7 3.3 0.4 0.0 0.2 0.1 0.2 5.7 C20orf194 DKFZp434N061 ENSG00000088854 "Chromosome 20 open reading frame 194" Q5TEA3 20 3249306-3407669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 226.9;Cone photoreceptor cells: 202.3;Excitatory neurons: 205.6;Inhibitory neurons: 163.1;Oligodendrocyte precursor cells: 135.7;Oligodendrocytes: 191.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052103, HPA067418" Approved Approved "Nucleoli fibrillar center,Cytosol" No No "Nucleoli fibrillar center, Cytosol" "HPA052103: AB_2681727, HPA067418: AB_2685835" "unprognostic (9.77e-2)" "unprognostic (8.39e-2)" "unprognostic (5.03e-3)" "unprognostic (1.83e-1)" "unprognostic (1.18e-1)" "unprognostic (4.26e-2)" "unprognostic (1.66e-2)" "unprognostic (7.64e-2)" "unprognostic (6.41e-2)" "unprognostic (1.68e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.97e-1)" "prognostic favorable (7.68e-4)" "unprognostic (9.58e-3)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (7.52e-2)" 11.9 9.6 19.8 5.2 22.1 3.6 8.7 18.5 20.8 10.1 8.0 11.0 4.1 10.5 5.5 8.5 9.9 8.3 15.5 19.4 20.7 11.3 2.6 10.1 4.5 21.2 20.4 19.6 12.4 6.3 4.2 8.9 9.2 20.8 8.6 4.3 16.6 5.8 11.7 32.7 5.5 6.6 13.0 20.5 7.4 9.8 10.5 21.4 3.8 9.7 11.7 2.9 12.7 8.9 26.1 4.0 3.6 9.7 4.7 19.7 21.6 1.1 9.2 10.3 6.0 7.5 0.0 4.3 0.0 2.5 12.3 7.7 4.7 3.7 9.1 8.2 0.9 1.8 1.1 1.4 10.0 9.2 1.2 0.5 17.7 6.9 7.9 6.8 8.6 12.2 3.5 2.0 0.0 8.9 1.8 2.5 6.5 2.9 2.2 2.3 2.9 8.8 0.1 7.8 8.1 1.9 5.7 4.1 7.2 12.0 8.3 6.8 11.3 13.7 7.5 3.2 4.7 4.5 0.1 0.0 0.0 2.4 1.2 5.8 0.4 0.8 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.9 0.4 0.1 0.3 0.0 0.0 0.4 1.0 0.4 0.2 19.8 22.1 18.5 20.8 19.4 20.7 21.2 20.4 19.6 20.8 20.5 21.4 26.1 23.6 28.9 9.2 226.9 3.7 6.9 6.7 10.8 8.6 35.1 10.1 10.8 28.5 15.7 10.3 12.9 202.3 1.8 8.9 0.1 1.9 9.1 31.8 10.6 15.9 20.1 0.0 4.0 205.6 4.7 5.4 13.4 19.4 12.1 14.0 53.3 25.7 2.3 19.6 30.3 163.1 0.5 4.1 34.0 25.5 8.9 19.9 22.4 8.8 89.9 14.1 10.0 3.1 135.7 191.2 9.4 14.8 13.5 1.5 5.4 7.4 8.4 21.8 13.9 13.1 18.4 22.2 28.5 25.0 7.2 5.7 1.8 7.8 16.4 1.4 5.2 ZNF343 MGC10715 ENSG00000088876 "Zinc finger protein 343" Q6P1L6 20 2481817-2524702 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 14.0;Inhibitory neurons: 14.2;Oligodendrocyte precursor cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA030587, HPA052438" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030587: AB_10603246, HPA052438: AB_2681833" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (3.83e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (9.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-1)" "unprognostic (4.88e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.65e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-2)" "unprognostic (9.53e-2)" 6.9 4.4 4.6 5.2 4.4 1.9 8.2 7.0 6.8 6.9 4.5 6.4 4.2 8.0 10.4 5.6 6.6 4.4 4.2 5.2 4.7 5.6 4.8 5.3 5.3 4.0 4.1 5.1 8.0 4.6 8.7 4.7 6.3 5.4 5.9 6.0 6.2 5.5 6.2 8.0 8.1 4.3 7.7 2.9 5.8 4.9 4.4 4.6 5.7 6.5 9.0 6.2 6.8 6.3 6.4 11.7 14.5 8.7 10.5 10.1 10.0 3.4 8.7 9.3 10.2 10.1 8.2 6.8 18.1 3.6 8.3 10.7 12.4 13.8 15.7 13.0 4.4 7.6 9.9 6.9 18.0 9.2 6.8 4.0 10.3 15.0 13.2 20.6 11.2 10.1 11.5 13.9 7.6 10.0 4.7 13.1 5.8 9.0 10.5 13.8 11.1 12.3 10.1 6.3 5.8 10.7 16.6 10.5 17.1 10.6 7.1 6.1 6.1 7.5 13.6 6.7 10.8 10.1 15.4 28.3 8.1 3.2 8.7 8.7 0.5 2.2 2.7 2.9 2.3 3.5 4.0 3.9 2.4 2.3 4.8 4.0 4.7 1.7 1.3 2.1 3.6 3.4 2.1 4.6 4.4 7.0 6.8 5.2 4.7 4.0 4.1 5.1 5.4 2.9 4.6 6.4 2.0 3.2 1.5 6.2 4.0 2.0 1.6 0.9 5.2 4.1 1.8 1.5 1.9 1.5 2.3 1.8 0.0 2.4 2.2 1.6 1.9 2.2 0.9 0.9 3.3 2.2 3.0 0.8 14.0 0.9 1.3 3.6 2.0 1.2 1.3 2.2 1.8 3.6 1.4 8.4 14.2 2.2 4.1 1.3 1.2 0.2 4.1 1.4 1.8 2.8 1.4 2.6 1.0 13.6 8.9 2.5 0.8 3.0 2.3 2.1 1.8 3.4 1.0 2.9 0.0 2.2 3.9 4.2 3.5 4.5 2.3 0.8 1.9 2.0 2.5 1.7 EBF4 "COE4, KIAA1442, O/E-4, RP5-860F19.3" ENSG00000088881 "EBF family member 4" Q9BQW3 20 2692874-2760108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 18.9;Cholangiocytes: 21.5;Endometrial stromal cells: 18.6;Oligodendrocyte precursor cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 7.9;HEK 293: 8.4;SH-SY5Y: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.59e-4)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (7.79e-3)" "unprognostic (3.82e-1)" "prognostic favorable (2.47e-5)" "unprognostic (2.68e-2)" "unprognostic (5.58e-3)" "unprognostic (1.87e-3)" "unprognostic (2.91e-1)" "unprognostic (1.17e-2)" "unprognostic (2.87e-3)" 2.7 3.6 9.2 2.7 10.3 0.3 2.7 7.3 14.1 5.0 1.7 3.2 2.8 19.2 2.2 4.2 6.8 5.8 2.9 9.8 9.0 2.6 1.1 3.7 2.4 11.4 9.2 7.2 13.8 3.9 14.5 2.9 5.7 11.4 12.5 1.9 3.3 5.7 11.2 1.1 2.8 3.8 12.2 8.7 2.3 3.9 1.2 10.6 0.6 18.1 1.5 1.8 3.1 2.0 12.7 0.0 0.7 4.4 4.4 0.1 1.1 0.9 1.2 3.2 2.2 1.1 0.6 0.4 0.0 2.5 0.5 7.9 0.2 1.5 0.2 1.3 6.2 8.4 0.0 0.0 0.2 2.8 0.0 0.0 0.1 1.0 1.0 0.0 0.8 0.3 1.9 0.0 0.0 0.0 0.4 0.1 6.9 0.6 0.0 0.2 6.4 1.2 0.5 0.0 2.7 3.3 21.2 1.2 0.1 1.9 4.2 2.4 0.3 1.7 0.3 1.0 0.2 3.8 1.4 0.2 1.5 0.0 0.9 3.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 9.2 10.3 7.3 14.1 9.8 9.0 11.4 9.2 7.2 11.4 8.7 10.6 12.7 4.1 0.0 1.1 18.9 0.3 3.4 15.6 3.0 6.8 7.7 18.1 11.0 2.2 21.5 5.5 1.8 0.0 0.2 5.1 0.2 0.0 2.0 0.4 1.2 18.6 3.2 0.0 0.0 3.1 0.4 0.1 5.1 1.1 1.1 0.0 1.9 6.4 5.7 0.3 5.0 12.2 0.2 4.1 0.8 1.4 0.8 3.4 0.3 1.8 10.3 0.0 5.5 2.1 52.3 17.9 0.3 1.7 7.2 0.4 11.3 0.0 0.2 4.9 2.3 6.6 3.3 5.1 0.6 1.4 0.6 1.0 0.3 0.7 0.1 0.4 9.3 CPXM1 "CPX-1, CPX1, CPXM" ENSG00000088882 "Carboxypeptidase X, M14 family member 1" Q96SM3 20 2794074-2800627 "Enzymes, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 86.7" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 162.7;Fibroblasts: 60.1;Theca cells: 28.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebral cortex: 7.0" "Immune cell enhanced" "Detected in single" "NK-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 161.7;HSkMC: 85.7;NB-4: 148.1;REH: 150.8;SH-SY5Y: 108.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 8.7" "Secreted in other tissues" NA NA 490000 "unprognostic (7.48e-2)" "unprognostic (3.61e-1)" "unprognostic (6.70e-2)" "unprognostic (1.47e-2)" "unprognostic (3.41e-1)" "unprognostic (5.24e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (9.32e-2)" "unprognostic (7.02e-2)" "unprognostic (3.23e-2)" "prognostic unfavorable (4.62e-10)" "unprognostic (1.30e-1)" "unprognostic (1.49e-1)" "unprognostic (5.55e-3)" "unprognostic (1.27e-2)" 53.6 4.9 1.1 9.8 0.9 19.2 31.5 0.6 7.0 64.5 2.9 3.3 1.4 77.5 8.4 4.3 27.3 86.7 3.8 0.7 1.2 6.5 0.3 5.5 6.6 1.0 0.8 0.7 42.3 3.1 3.9 5.4 51.9 1.3 7.2 1.6 0.0 4.8 2.3 1.2 9.8 3.4 39.1 1.0 0.9 2.2 3.7 1.1 9.7 24.8 0.0 2.8 56.0 29.6 0.9 0.0 0.0 161.7 0.0 0.0 4.9 0.2 0.4 0.7 2.0 0.6 0.0 0.0 0.0 0.5 0.3 0.1 0.0 12.1 0.0 0.5 0.7 8.5 22.1 0.0 0.0 2.2 0.1 3.2 85.7 0.0 7.7 0.0 0.0 0.0 31.1 9.3 0.0 0.1 0.1 0.6 148.1 34.5 0.0 0.0 150.8 0.0 4.2 0.0 0.0 0.2 108.2 0.0 0.2 0.0 25.8 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.2 1.1 0.9 0.6 7.0 0.7 1.2 1.0 0.8 0.7 1.3 1.0 1.1 0.9 3.9 0.0 0.5 0.0 0.3 2.7 5.8 0.7 4.0 0.0 1.1 3.8 0.7 0.0 0.8 3.7 0.0 2.9 1.7 0.5 0.0 3.0 2.3 5.8 162.7 3.1 0.0 7.6 0.0 0.0 3.3 60.1 0.0 4.2 2.5 17.7 0.7 0.0 6.5 0.0 0.0 0.0 0.0 0.0 2.6 2.8 17.4 0.9 1.8 0.0 0.7 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.5 2.5 0.0 0.1 3.1 0.0 0.0 0.4 10.2 0.0 1.5 0.1 2.0 3.3 1.4 28.2 0.6 0.8 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria NA NA 600000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favorable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favorable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 14.3 12.6 12.8 11.6 15.3 10.4 13.1 13.5 12.2 11.2 12.9 17.3 14.9 12.2 8.4 15.0 13.4 6.7 17.5 11.4 12.1 14.5 15.6 13.4 10.0 18.1 15.2 9.5 16.9 17.8 15.5 12.2 9.4 15.1 14.3 15.5 8.2 13.1 10.4 37.8 19.1 17.0 9.7 13.9 14.4 15.5 5.0 13.9 10.5 14.1 29.5 10.9 14.4 11.1 16.4 31.6 36.0 14.3 17.9 38.8 26.2 11.2 18.7 23.8 19.5 14.2 28.4 19.9 13.6 11.1 26.4 55.6 38.7 17.3 28.0 19.9 8.4 8.4 26.3 14.6 45.5 21.4 16.6 10.6 26.7 23.4 33.2 19.6 19.4 20.1 17.6 30.2 10.1 19.3 28.5 25.3 14.1 9.2 15.7 19.6 18.8 19.9 13.7 20.8 31.2 10.7 11.2 21.3 41.0 18.1 20.3 21.9 15.3 30.5 26.5 9.7 31.7 22.1 20.7 26.6 9.4 10.5 20.1 13.7 1.7 2.1 2.0 1.4 1.6 1.0 1.1 1.1 1.1 1.4 1.3 1.2 1.2 1.9 1.8 1.9 1.7 0.9 1.6 12.8 15.3 13.5 12.2 11.4 12.1 18.1 15.2 9.5 15.1 13.9 13.9 16.4 16.6 57.7 48.5 24.8 17.3 2.2 13.9 3.7 19.4 34.0 19.9 13.2 61.0 58.6 21.7 29.5 16.7 33.6 22.5 100.0 13.7 25.9 1.1 16.1 27.5 26.8 34.7 17.1 13.6 30.5 27.5 22.8 25.0 16.6 8.8 36.5 44.3 45.7 25.5 45.4 15.9 32.6 2.0 37.7 2.9 3.2 30.7 20.7 1.8 15.9 32.4 20.7 20.6 12.5 19.9 32.7 29.5 28.2 14.2 18.1 42.8 19.6 16.2 33.7 32.9 26.2 17.5 6.2 4.1 15.6 2.0 18.1 16.7 27.5 57.9 16.6 LZTS3 "KIAA0552, ProSAPiP1" ENSG00000088899 "Leucine zipper tumor suppressor family member 3" O60299 20 3162617-3173592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.6;retina: 54.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Astrocytes: 17.9;Excitatory neurons: 52.5;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031008, HPA031009" Approved Approved Vesicles NA NA Vesicles "HPA031008: AB_10601610, HPA031009: AB_10670162" "unprognostic (4.09e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (1.15e-1)" "unprognostic (6.19e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.98e-4)" "unprognostic (3.31e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (9.69e-3)" "prognostic favorable (5.92e-8)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (8.47e-2)" "unprognostic (1.38e-1)" 3.8 5.9 58.2 1.3 66.0 1.8 5.3 58.3 79.6 12.4 4.5 5.7 9.9 7.6 3.6 3.1 10.1 7.6 12.2 68.9 31.9 23.9 7.1 9.5 1.0 29.2 25.0 62.8 16.2 31.0 9.6 15.2 2.1 41.0 11.3 2.0 54.5 43.8 8.0 11.9 3.9 9.9 2.6 10.9 2.4 21.2 6.2 25.2 1.4 18.7 4.6 0.7 7.7 6.1 57.2 3.5 3.3 4.6 5.2 6.3 1.8 3.2 3.5 7.5 5.8 8.5 19.2 9.9 6.0 1.9 6.9 7.5 1.7 2.6 3.7 4.4 0.1 3.3 0.2 0.7 15.9 14.2 0.3 1.6 2.3 8.1 8.1 3.1 2.1 0.9 5.5 3.5 1.9 2.8 1.6 0.5 0.7 10.4 8.2 3.2 1.6 1.5 6.6 7.4 1.3 18.1 5.6 2.9 4.0 2.8 6.7 9.5 0.2 5.4 6.2 11.7 2.5 1.1 3.7 0.6 1.8 3.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 66.0 58.3 79.6 68.9 31.9 29.2 25.0 62.8 41.0 10.9 25.2 57.2 2.6 19.2 10.3 17.9 1.3 1.5 0.0 3.3 0.0 0.0 7.4 6.3 16.6 0.0 12.9 11.0 0.0 1.6 0.4 0.9 11.7 4.9 0.0 9.7 5.7 1.6 1.8 0.0 52.5 5.1 0.4 3.7 0.0 11.9 0.0 2.2 0.0 0.0 0.3 0.0 27.7 0.0 6.1 0.0 1.1 0.0 0.0 0.5 3.6 3.7 0.0 0.0 0.0 20.6 7.1 8.2 0.0 0.0 0.3 0.0 0.0 11.2 11.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.0 1.6 0.5 1.5 0.6 0.0 F11 FXI ENSG00000088926 "Coagulation factor XI" P03951 4 186266189-186289681 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 245.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 27.6;Hepatocytes: 75.7" "Cancer enriched" "Detected in some" 13 "liver cancer: 16.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "Hep G2: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA039808 Approved Vesicles "Secreted to blood" NA NA 4400000000 Vesicles "HPA039808: AB_2676693" "unprognostic (1.28e-1)" "unprognostic (3.15e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.88e-1)" "unprognostic (2.08e-1)" "unprognostic (2.11e-1)" "unprognostic (1.85e-3)" "unprognostic (2.91e-2)" "unprognostic (7.65e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.2 17.2 0.2 0.1 0.0 0.0 13.2 0.0 0.3 0.0 27.8 245.2 8.4 0.0 0.3 0.3 0.0 0.3 59.4 0.0 0.2 0.0 0.1 0.0 0.1 0.7 0.0 0.2 0.7 0.0 8.8 0.0 0.0 0.1 0.8 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 27.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 2.5 1.8 0.0 0.0 0.2 0.3 11.7 2.3 0.0 0.0 0.0 0.1 0.0 5.3 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.7 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 1.1 5.5 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303331-21389825 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA047118: AB_2679941, HPA050485: AB_2681141" "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 36.4 36.4 14.6 43.0 17.1 74.0 43.3 18.8 16.1 33.6 20.8 30.2 24.5 37.3 31.5 26.2 33.4 36.1 25.0 13.9 21.1 35.1 43.1 34.7 43.6 16.9 15.7 12.8 37.0 33.0 45.6 18.8 37.7 16.9 28.7 32.7 25.0 27.3 33.9 38.5 23.8 25.0 39.7 16.8 36.4 25.1 30.1 16.5 47.2 41.6 26.7 46.2 46.9 23.3 18.6 91.9 106.7 115.1 88.7 84.1 102.7 113.7 82.3 107.1 107.2 124.1 71.8 102.2 89.7 47.8 86.8 146.1 106.0 131.0 138.7 136.6 40.8 66.0 116.0 37.7 136.5 73.9 105.7 96.8 98.0 68.7 118.5 103.1 95.3 93.6 84.5 94.9 74.7 101.0 71.7 156.5 69.6 89.8 88.8 71.1 113.1 195.4 76.9 91.0 95.6 88.9 115.2 96.0 116.6 89.9 88.6 65.5 123.9 87.0 107.0 79.8 24.8 105.4 65.3 90.0 95.0 41.5 48.5 82.5 36.0 68.6 49.2 34.6 54.8 46.4 30.5 37.7 38.1 61.1 30.9 39.8 38.7 69.2 43.9 71.8 26.2 49.2 54.3 14.6 17.1 18.8 16.1 13.9 21.1 16.9 15.7 12.8 16.9 16.8 16.5 18.6 118.6 60.9 112.2 29.7 72.4 63.6 90.8 81.2 64.9 44.9 85.0 75.2 58.7 52.9 94.4 40.5 41.7 106.2 99.1 36.6 27.4 123.8 157.6 119.5 128.5 99.9 59.5 62.6 45.7 120.9 96.8 80.1 39.8 113.7 83.5 92.0 41.0 70.4 105.4 50.5 48.9 52.6 67.1 129.6 57.9 26.8 57.8 111.2 60.5 49.6 165.9 55.1 85.5 46.8 67.6 96.1 53.7 55.7 77.1 91.6 45.1 80.6 102.7 49.7 59.2 120.1 108.1 104.1 116.6 65.6 67.2 105.2 83.5 99.4 68.1 89.7 KIZ "C20orf19, HT013, NCRNA00153, PLK1S1" ENSG00000088970 "Kizuna centrosomal protein" Q2M2Z5 20 21125983-21246622 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 203.0;Late spermatids: 127.3;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 92.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.78e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.45e-4)" "unprognostic (2.05e-2)" "unprognostic (5.71e-2)" "unprognostic (1.90e-1)" "unprognostic (9.71e-3)" "unprognostic (3.68e-2)" "unprognostic (1.44e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (4.82e-2)" "unprognostic (2.20e-1)" "unprognostic (4.94e-2)" "unprognostic (2.12e-1)" 15.4 9.9 27.6 7.3 31.0 10.8 15.6 29.5 29.4 30.8 21.1 50.7 15.2 27.3 11.3 8.0 19.9 12.7 17.6 23.6 26.3 14.5 11.4 9.9 10.7 32.0 31.0 22.2 35.8 24.5 14.7 23.5 8.9 32.9 19.5 13.3 20.4 13.7 24.1 29.6 14.9 17.9 17.3 29.2 13.7 16.4 45.8 30.7 16.7 27.2 14.8 11.2 36.8 23.1 38.8 7.5 5.9 7.9 7.5 27.3 37.3 10.9 10.6 17.9 8.8 10.4 6.4 6.1 14.0 8.9 12.5 9.3 6.2 8.0 22.4 12.2 7.9 9.2 11.3 11.2 92.8 13.8 13.9 9.2 28.2 45.8 8.6 28.2 20.8 8.3 23.3 18.6 18.8 7.6 6.4 14.7 18.0 10.8 13.5 5.9 9.2 22.5 13.7 9.7 13.0 10.7 20.9 21.4 11.4 22.4 17.9 7.3 27.1 7.8 9.2 8.0 7.2 7.7 18.9 13.7 10.5 4.5 15.5 8.4 4.6 5.0 12.5 10.4 5.6 12.2 11.7 10.9 10.5 3.1 11.4 11.5 12.6 16.5 8.4 4.2 7.3 14.3 5.0 27.6 31.0 29.5 29.4 23.6 26.3 32.0 31.0 22.2 32.9 29.2 30.7 38.8 11.0 0.0 10.0 41.1 22.6 0.0 9.2 0.0 9.6 35.4 7.6 10.7 16.6 12.8 5.0 18.4 37.5 7.8 16.6 4.4 7.9 5.0 203.0 24.6 16.0 8.7 11.4 11.6 76.4 7.1 7.6 19.4 6.1 9.8 8.8 18.9 7.5 5.2 4.0 50.5 99.0 9.1 0.0 6.0 0.0 127.3 38.8 6.1 0.0 27.2 7.6 28.1 16.5 198.5 166.8 3.5 5.6 31.6 25.9 4.0 21.7 5.9 10.2 35.1 13.1 20.8 11.4 78.3 37.4 7.7 0.0 4.2 17.8 12.9 9.7 10.9 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 890000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 241.1 264.0 895.7 188.4 962.4 127.9 270.8 892.1 1162.9 289.8 887.6 328.9 164.3 322.1 325.1 725.7 549.0 244.8 237.1 947.5 936.5 325.8 240.4 224.6 243.6 904.0 905.1 919.2 249.1 227.0 230.1 312.1 261.4 894.5 227.8 330.6 182.9 247.4 267.1 86.4 631.8 208.0 393.5 927.8 186.7 246.5 363.2 912.2 309.3 177.6 165.4 360.8 393.6 478.4 991.7 721.6 811.4 779.2 600.8 677.1 713.6 250.8 968.0 451.6 785.6 466.7 770.8 472.3 400.6 510.3 945.1 753.0 629.6 949.3 818.3 781.0 528.3 617.9 390.4 532.9 1062.5 676.2 412.8 620.5 436.2 863.0 584.6 477.5 855.7 831.8 421.5 502.0 446.1 1056.8 960.1 541.4 894.8 642.2 917.7 935.7 543.0 403.0 499.2 1143.1 659.8 535.2 392.0 789.3 677.7 926.6 812.6 673.6 595.3 635.2 592.3 502.1 525.6 852.2 264.0 562.8 404.6 656.8 645.1 776.6 516.6 291.9 384.2 200.6 303.3 155.3 310.4 207.2 211.7 281.8 219.0 132.0 165.7 50.1 282.9 334.8 461.6 373.5 353.0 895.7 962.4 892.1 1162.9 947.5 936.5 904.0 905.1 919.2 894.5 927.8 912.2 991.7 810.1 195.5 101.9 79.3 341.4 922.2 359.1 1275.0 356.8 138.4 800.0 949.4 170.8 303.1 764.6 399.1 83.4 524.6 484.1 689.9 1113.2 691.2 1407.2 1842.5 528.5 541.9 480.8 332.9 111.2 538.9 897.4 538.5 240.5 488.1 316.7 611.9 521.9 499.0 732.1 85.8 62.8 801.6 1121.0 329.4 706.1 4098.6 516.6 466.3 595.9 42.2 701.6 164.0 248.2 47.3 156.4 754.9 798.6 701.8 234.9 304.7 533.4 1125.0 2679.6 193.5 368.1 440.7 1016.3 961.5 721.4 1005.4 1610.1 1006.6 396.6 586.3 498.2 389.6 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 332.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 183.0;Erythroid cells: 222.9;Exocrine glandular cells: 481.2;Gastric mucus-secreting cells: 316.0;Late spermatids: 319.3;Pancreatic endocrine cells: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 261.1" "Lineage enriched" "Detected in all" 5 "monocytes: 261.1" "Cell line enhanced" "Detected in many" "HMC-1: 398.5;NB-4: 675.1;OE19: 288.1;U-937: 221.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053200: AB_2682079" "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 8.2 46.8 17.6 10.3 32.5 119.8 9.0 17.4 25.6 4.4 16.2 3.5 7.3 3.9 122.9 3.3 4.0 36.4 52.0 25.8 24.8 19.0 4.9 10.3 8.1 19.3 16.2 20.2 5.3 103.3 9.5 26.9 10.3 19.2 9.9 2.9 0.5 332.8 19.9 5.1 9.0 7.4 2.8 15.2 12.0 139.7 31.4 17.4 7.5 10.8 8.2 10.3 29.6 5.3 19.5 0.2 97.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 4.3 13.8 4.7 0.0 0.2 0.6 8.1 0.0 0.0 37.5 19.2 115.5 9.8 78.1 0.0 49.2 398.5 0.1 0.0 0.0 0.0 0.0 0.0 18.5 54.0 0.9 0.0 2.2 95.5 675.1 9.0 288.1 0.0 0.4 0.0 52.4 56.5 15.0 17.0 6.1 0.1 0.1 3.6 0.9 0.0 53.9 0.0 0.0 1.7 0.2 0.4 17.0 38.2 0.0 0.1 221.8 0.5 0.0 51.0 51.5 7.0 67.9 0.4 5.5 2.4 9.1 35.8 13.1 0.3 3.8 12.6 11.6 261.1 2.6 3.5 19.0 17.6 32.5 17.4 25.6 25.8 24.8 19.3 16.2 20.2 19.2 15.2 17.4 19.5 35.6 0.0 0.0 5.9 16.2 2.7 0.3 0.4 1.8 0.8 5.5 67.1 58.3 183.0 0.9 12.9 0.0 0.4 21.1 0.2 74.3 159.5 106.5 1.3 0.7 43.6 1.8 222.9 26.1 481.2 0.6 7.9 316.0 3.2 71.1 1.2 1.8 0.5 48.0 0.0 2.0 1.5 0.0 17.9 6.1 319.3 3.1 30.6 72.9 8.4 41.0 0.2 25.7 2.5 1.5 215.6 0.9 3.4 25.8 3.5 0.2 6.1 0.0 1.5 144.7 1.9 68.4 63.0 20.3 0.5 2.0 1.2 28.3 66.7 2.3 1.3 SNX5 ENSG00000089006 "Sorting nexin 5" Q9Y5X3 20 17941597-17968980 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 271.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 639.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020679, HPA051187, HPA076450" Approved Supported Vesicles,Cytosol NA NA 8200 "Vesicles, Cytosol" "CAB020679: , HPA051187: AB_2681379, HPA076450: " "unprognostic (6.00e-2)" "unprognostic (2.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.00e-2)" "unprognostic (4.47e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (2.30e-10)" "unprognostic (1.67e-1)" "unprognostic (6.19e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-2)" "unprognostic (6.50e-2)" "unprognostic (3.48e-2)" "unprognostic (2.99e-1)" 42.4 51.9 11.9 44.1 14.2 58.0 37.9 14.4 13.1 34.8 14.0 37.7 47.5 28.6 49.8 35.5 33.8 25.1 26.9 10.4 16.2 59.8 34.0 36.4 59.5 15.0 13.3 10.0 51.8 32.3 25.0 21.8 29.1 15.3 23.8 40.5 14.3 34.5 17.4 71.4 28.6 40.5 24.6 18.0 57.9 33.4 15.6 13.1 21.4 70.8 22.0 51.6 35.0 32.8 19.8 103.0 108.6 45.3 49.6 29.6 49.8 270.7 84.1 43.3 49.9 55.9 104.8 140.2 169.6 48.6 49.9 69.7 112.2 63.8 124.6 67.2 44.1 57.8 150.1 49.5 639.4 48.0 106.6 173.9 49.2 54.2 54.6 98.3 37.1 72.8 111.3 72.8 109.6 58.6 79.6 94.2 92.6 48.4 87.0 55.3 110.0 115.2 126.1 61.2 116.4 45.0 26.4 76.0 113.7 102.1 34.0 62.4 67.8 57.3 77.8 98.7 49.2 101.5 77.8 129.2 137.2 38.5 37.6 69.6 69.6 58.7 83.6 54.8 81.7 50.0 80.6 49.6 54.6 71.9 75.2 29.7 42.7 4.8 39.0 92.3 37.2 67.3 54.9 11.9 14.2 14.4 13.1 10.4 16.2 15.0 13.3 10.0 15.3 18.0 13.1 19.8 35.6 64.1 113.1 21.5 93.0 31.7 45.7 49.0 48.3 19.1 48.9 44.2 38.5 38.6 59.8 49.7 27.1 101.0 54.9 59.6 160.4 47.8 43.6 51.1 42.3 48.7 31.7 98.4 18.8 44.8 137.7 57.7 52.0 66.9 130.8 47.9 139.9 41.4 151.9 16.8 19.9 54.4 34.6 174.6 47.2 16.0 60.9 88.2 26.6 31.9 68.4 66.3 55.6 24.6 20.3 37.2 58.3 51.6 96.7 49.2 100.0 271.5 52.0 19.8 19.7 50.7 39.6 19.1 44.6 83.5 32.4 78.5 53.0 66.5 100.1 57.4 RPL6 "L6, TAXREB107, TXREB1" ENSG00000089009 "Ribosomal protein L6" Q02878 12 112405189-112418838 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060903, HPA068418" Approved Approved "Microtubules,Cytokinetic bridge" Yes No 620000 "Microtubules, Cytokinetic bridge" "HPA060903: AB_2732653, HPA068418: AB_2685987" "unprognostic (5.95e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (5.49e-2)" "unprognostic (1.10e-2)" "unprognostic (2.50e-1)" "unprognostic (1.02e-2)" "unprognostic (3.74e-1)" "unprognostic (5.63e-2)" "unprognostic (1.07e-2)" "unprognostic (4.19e-3)" "unprognostic (2.52e-2)" "prognostic unfavorable (6.95e-4)" "unprognostic (2.45e-1)" "unprognostic (2.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.90e-2)" 1189.6 1089.6 804.8 945.9 805.4 2407.9 1875.3 793.8 1072.0 1354.6 857.1 1201.8 796.3 1248.4 1584.2 1497.4 1252.2 740.6 853.6 775.8 834.3 988.6 1034.6 810.0 1862.2 825.6 818.5 759.0 2802.6 2001.0 1113.0 1058.0 769.7 818.2 1026.1 1234.1 536.5 1646.3 858.0 1464.7 1610.9 953.9 1027.5 848.4 1023.2 1224.8 281.7 831.7 1832.5 1234.2 1309.5 2222.9 1361.8 1226.3 835.9 1973.8 1887.6 2227.1 2264.4 2725.6 4486.8 2932.4 1843.2 2670.8 2471.8 1408.6 2975.9 1213.3 4225.2 1547.6 2008.9 962.8 1881.4 2395.5 3288.1 2456.2 1682.6 3199.4 2274.7 1590.4 2693.3 2854.8 4103.6 1708.4 4171.2 4542.3 1876.9 4294.7 4571.2 2818.5 2754.1 3060.8 1134.5 2888.4 2727.7 3013.0 6699.3 3096.5 4209.0 2233.7 2731.0 2375.5 4144.9 3118.1 3283.8 2050.1 2651.9 1297.5 3446.9 3342.3 2007.3 3621.2 4189.6 1657.8 1215.8 1484.2 1572.8 2110.7 1542.6 2549.7 3377.6 1573.3 2948.5 1861.4 730.3 2260.1 463.1 2285.0 1851.6 3814.8 3463.8 3465.4 2972.5 2896.3 3116.2 3751.8 3251.5 262.6 2839.0 1688.0 3372.7 3027.9 7777.8 804.8 805.4 793.8 1072.0 775.8 834.3 825.6 818.5 759.0 818.2 848.4 831.7 835.9 1483.8 798.0 1587.2 31.0 3121.1 3145.3 3907.2 3373.8 2996.4 271.4 3790.3 6493.7 262.3 1818.7 1733.0 636.4 137.6 3077.0 2809.4 731.3 3502.2 2270.2 414.6 1133.8 2774.3 1661.9 1388.1 1929.0 42.6 3043.9 4721.2 1695.5 1135.6 1287.6 1290.2 1743.7 1854.3 1727.8 1880.0 121.1 48.2 2036.2 1112.9 2566.7 2790.5 714.3 2849.7 1964.8 1899.7 30.9 3399.6 854.8 2699.3 34.7 48.9 2582.7 1646.1 1589.9 2173.6 3165.2 1095.4 3376.3 776.7 412.3 927.0 2550.9 1835.3 376.5 461.6 3977.5 3650.1 3068.7 2710.6 2783.0 2512.8 3577.6 SIRPG "bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma" ENSG00000089012 "Signal regulatory protein gamma" Q9P1W8 20 1629152-1657779 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 39.4" "Group enriched" "Detected in some" 8 "Early spermatids: 48.9;Late spermatids: 14.1;T-cells: 41.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 369.4" "Lineage enriched" "Detected in many" 6 "T-cells: 369.4" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 4.8;JURKAT: 10.7;NB-4: 13.8;RT4: 3.6;THP-1: 2.3" NA NA "unprognostic (3.35e-3)" "unprognostic (4.09e-3)" "unprognostic (7.32e-3)" "prognostic favorable (1.05e-6)" "unprognostic (4.23e-3)" "prognostic favorable (2.24e-4)" "unprognostic (4.49e-2)" "unprognostic (1.30e-2)" "prognostic favorable (7.36e-7)" "unprognostic (1.62e-2)" "unprognostic (6.90e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.40e-2)" "unprognostic (2.95e-3)" 0.4 0.7 0.0 13.1 0.1 3.0 0.9 0.0 0.2 1.0 0.1 2.5 1.8 0.4 0.2 1.1 0.4 2.3 0.6 0.1 0.0 0.3 1.0 1.5 34.6 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.2 0.1 0.7 3.1 0.0 1.2 0.6 0.0 0.3 5.9 0.8 0.1 9.5 3.1 0.3 0.0 39.4 0.7 0.1 28.3 3.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 4.8 0.0 10.7 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.9 1.5 1.2 67.6 0.7 186.4 0.7 207.6 157.7 0.9 0.7 215.8 176.2 6.0 59.1 1.1 6.7 369.4 101.6 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.0 1.3 1.4 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 48.9 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.2 0.5 0.1 1.3 0.0 0.4 0.2 0.0 0.0 0.4 0.2 0.0 1.0 0.4 14.1 0.3 0.7 0.0 1.0 1.4 0.0 2.1 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 41.3 0.0 0.0 0.0 MAPKAPK5 "MK5, PRAK" ENSG00000089022 "MAPK activated protein kinase 5" Q8IW41 12 111842228-111902222 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 17.6 21.0 12.7 18.0 14.4 27.3 20.6 15.0 15.0 15.3 14.9 28.5 25.7 15.8 20.8 17.3 16.3 12.3 16.9 15.3 12.3 20.5 19.5 17.7 20.9 12.6 12.5 11.9 18.3 20.6 21.6 11.7 20.5 12.9 17.2 31.0 27.4 17.6 15.8 30.7 20.2 28.5 19.1 11.4 15.8 18.2 16.1 13.3 23.4 19.5 25.5 19.5 18.7 14.5 13.8 32.4 42.1 40.0 33.7 28.2 28.4 60.6 31.7 38.1 47.7 32.7 54.8 25.9 48.6 22.9 37.7 28.4 31.6 53.1 33.2 44.4 32.6 29.0 43.4 29.5 44.2 34.1 55.1 29.4 30.2 46.7 45.6 53.7 36.0 35.6 43.4 61.0 18.7 35.3 36.4 55.2 86.6 56.9 79.1 29.4 53.7 29.1 46.9 37.9 46.2 49.0 41.4 36.1 60.5 46.3 36.2 49.1 62.0 31.2 26.8 27.2 27.9 40.4 37.8 50.1 57.4 32.7 39.4 38.9 1.1 3.3 2.3 4.2 2.4 2.2 3.5 2.7 3.0 2.2 3.1 4.2 3.1 1.6 2.9 8.8 2.6 4.8 1.8 12.7 14.4 15.0 15.0 15.3 12.3 12.6 12.5 11.9 12.9 11.4 13.3 13.8 16.9 3.2 23.1 12.1 22.3 20.5 22.3 12.5 21.1 47.0 18.3 14.0 20.1 22.8 15.4 3.7 41.7 29.9 32.4 34.1 13.7 28.2 17.2 14.2 17.3 16.0 36.6 15.8 24.6 29.6 33.3 19.4 20.9 15.2 2.5 22.3 14.6 13.4 19.9 23.5 22.3 47.3 14.2 21.2 17.7 7.3 15.5 15.0 8.8 14.0 27.8 19.6 25.7 15.6 21.8 36.3 27.4 17.7 21.6 37.5 63.6 21.8 12.0 36.4 19.7 22.6 19.8 30.7 40.3 23.6 21.3 30.1 22.2 22.5 32.3 32.3 P2RX7 "MGC20089, P2X7" ENSG00000089041 "Purinergic receptor P2X 7" Q99572 12 121132819-121188032 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 52.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 156.7" "Group enriched" "Detected in all" 5 "glioma: 7.2;melanoma: 19.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.9;gdT-cell: 1.3;intermediate monocyte: 4.5;myeloid DC: 2.6;non-classical monocyte: 3.3;T-reg: 1.4" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 4.5;T-cells: 1.4" "Cell line enhanced" "Detected in many" "Karpas-707: 40.0;RPMI-8226: 24.8;SK-MEL-30: 41.0;U-266/70: 21.7;U-266/84: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034968, HPA042013, HPA044141" Approved NA NA "HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830" "unprognostic (1.05e-1)" "unprognostic (4.90e-2)" "unprognostic (8.87e-2)" "unprognostic (6.54e-3)" "unprognostic (4.49e-2)" "unprognostic (1.55e-2)" "unprognostic (8.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.05e-2)" "unprognostic (1.08e-1)" "unprognostic (2.42e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.91e-1)" "unprognostic (3.59e-2)" "unprognostic (5.55e-2)" "unprognostic (1.65e-1)" 2.6 2.5 23.3 5.2 28.0 3.0 2.1 23.1 28.6 5.3 13.5 2.8 1.5 4.2 1.5 1.4 2.4 3.5 1.3 21.7 22.4 0.7 4.6 6.5 5.9 28.7 25.6 19.1 8.4 1.4 1.7 1.8 3.0 29.2 1.8 2.3 0.5 2.5 1.8 0.6 13.2 1.8 4.3 24.5 6.0 1.6 1.3 24.4 1.7 1.0 1.0 3.6 2.3 4.4 48.4 0.1 0.0 0.0 1.0 1.1 0.4 0.8 0.1 1.9 0.7 1.7 0.0 0.0 0.1 0.1 0.7 4.3 0.2 0.0 0.0 0.5 1.8 0.1 0.7 0.0 0.1 0.8 1.6 11.6 1.0 0.0 2.0 0.0 0.0 1.9 0.4 0.0 40.0 0.0 0.0 0.2 4.4 0.1 0.0 0.4 3.8 8.9 24.8 0.0 0.0 0.5 2.3 0.2 0.0 41.0 0.0 0.6 7.8 0.0 0.6 0.1 0.1 0.2 21.7 20.2 0.1 2.4 11.8 6.1 0.4 2.9 0.0 1.3 4.5 0.5 0.3 0.6 0.6 2.6 0.2 0.5 0.6 0.3 0.6 3.3 0.4 1.4 0.9 23.3 28.0 23.1 28.6 21.7 22.4 28.7 25.6 19.1 29.2 24.5 24.4 48.4 2.0 3.2 4.8 12.1 3.9 6.9 3.0 0.0 1.8 3.9 1.8 2.2 2.4 5.7 3.7 0.0 2.1 3.5 9.0 1.2 0.0 1.2 0.6 0.7 1.6 3.9 0.0 1.7 52.8 0.0 0.9 3.7 0.0 0.3 6.3 2.6 5.3 3.9 23.4 1.7 18.4 0.2 0.0 21.5 35.0 1.5 11.1 34.2 16.0 34.7 21.2 1.3 7.2 87.9 156.7 0.2 0.0 10.5 1.3 1.2 0.1 0.0 3.6 1.0 6.6 3.2 1.9 1.2 0.9 1.0 3.7 4.0 6.6 4.1 0.1 1.0 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784919 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047083: AB_2679924, HPA050396: AB_2681111" "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.2 9.6 12.9 9.7 13.9 7.9 10.9 13.3 12.8 8.6 10.4 8.4 7.6 10.3 10.4 9.2 7.0 8.5 9.6 11.6 13.4 9.8 14.0 6.7 10.9 15.0 13.9 10.3 12.6 6.5 10.1 5.3 11.4 15.6 9.5 9.9 9.1 6.2 7.4 12.7 10.9 6.9 8.9 14.8 10.0 7.9 14.3 13.7 9.8 10.6 12.3 9.8 12.4 7.2 14.7 30.4 24.3 24.1 13.0 18.8 23.3 14.9 28.9 18.5 21.5 19.4 26.0 29.2 38.4 15.1 14.5 40.2 45.9 36.0 30.3 41.4 11.1 18.1 49.5 10.2 64.2 25.4 59.4 13.2 18.7 23.0 33.1 28.2 16.0 17.0 18.7 70.9 17.9 27.1 22.6 46.7 39.8 25.9 27.0 17.1 30.6 61.1 30.4 16.7 22.3 25.9 16.2 23.8 41.8 42.4 22.1 20.5 27.3 23.2 36.2 24.2 25.7 59.1 17.9 43.4 45.7 14.7 27.2 33.2 2.7 8.7 2.7 10.5 11.1 12.3 18.2 12.2 11.6 8.9 17.4 14.9 13.8 0.5 15.1 14.0 19.3 10.0 4.6 12.9 13.9 13.3 12.8 11.6 13.4 15.0 13.9 10.3 15.6 14.8 13.7 14.7 71.5 22.4 45.0 36.6 60.4 61.8 63.8 50.5 44.3 92.8 31.4 53.2 61.7 50.1 47.6 33.1 45.9 47.8 55.3 53.8 33.2 55.0 80.5 35.3 61.4 50.8 48.5 34.5 56.2 42.1 39.2 48.5 32.6 34.0 26.0 55.4 45.0 51.5 45.1 95.9 59.7 49.7 28.5 35.3 22.4 30.2 65.3 35.3 26.6 34.7 57.6 58.0 33.0 53.8 63.6 56.0 48.8 73.7 26.8 62.8 47.6 38.4 34.6 81.9 32.9 117.0 78.0 210.4 175.5 31.5 53.6 41.5 40.8 71.9 61.5 42.2 RBBP9 Bog ENSG00000089050 "RB binding protein 9, serine hydrolase" O75884 20 18486540-18497225 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015830, HPA049005" Approved Supported Nucleoplasm NA NA 40000 Nucleoplasm "HPA015830: AB_1845410, HPA049005: AB_2680597" "unprognostic (1.17e-2)" "unprognostic (2.51e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (4.27e-2)" "unprognostic (1.26e-3)" "unprognostic (2.14e-1)" "unprognostic (7.63e-2)" "unprognostic (1.52e-1)" "unprognostic (4.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.14e-2)" "unprognostic (3.93e-3)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (6.21e-2)" 7.2 10.4 5.5 6.6 6.0 3.3 9.6 6.3 6.0 13.5 7.9 6.4 6.8 7.7 6.7 7.8 5.8 9.5 5.4 4.8 7.8 17.9 25.9 8.5 7.2 5.9 6.3 4.9 7.0 5.4 16.0 5.4 5.5 6.0 8.6 7.5 8.1 8.9 8.9 3.6 11.1 6.6 8.0 5.9 5.6 7.3 3.9 6.7 7.4 24.5 4.0 9.2 8.4 4.7 7.0 12.2 14.1 12.8 18.2 8.9 14.6 13.0 13.7 13.3 17.4 17.7 10.2 10.8 15.2 5.5 9.6 12.1 13.5 10.2 22.5 20.7 4.6 12.5 8.0 4.3 31.4 5.6 11.8 4.7 7.6 8.7 14.3 8.4 8.7 22.2 12.5 5.1 11.6 15.2 6.9 12.2 8.1 8.5 16.9 26.4 11.9 38.0 9.6 15.7 13.2 10.9 18.7 18.2 21.8 9.7 8.7 17.6 3.2 12.8 29.0 9.5 18.5 12.3 13.1 34.5 10.4 11.4 5.5 9.5 9.3 2.0 0.6 1.9 2.5 2.9 2.2 2.3 1.4 2.1 1.7 2.0 1.6 0.3 1.8 2.0 0.4 3.0 2.0 5.5 6.0 6.3 6.0 4.8 7.8 5.9 6.3 4.9 6.0 5.9 6.7 7.0 6.7 22.4 18.3 3.9 5.5 7.4 3.4 7.7 10.2 4.3 7.8 4.6 8.1 4.3 9.3 11.0 0.0 3.3 5.8 5.1 15.6 5.9 5.1 4.9 6.5 6.6 5.4 2.5 3.4 2.8 4.0 5.5 6.6 6.2 0.0 6.2 6.1 17.9 5.7 3.3 4.9 3.6 4.1 6.8 5.2 1.6 5.3 4.4 5.4 1.0 5.9 8.6 3.1 5.0 4.7 4.7 2.5 7.2 4.3 3.3 9.2 21.3 10.5 6.8 0.0 5.7 5.7 1.3 4.1 8.5 6.1 2.5 6.1 7.3 6.4 3.8 ANAPC5 APC5 ENSG00000089053 "Anaphase promoting complex subunit 5" Q9UJX4 12 121308245-121399896 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039457, HPA039801" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA039457: AB_10795676, HPA039801: AB_2676687" "unprognostic (3.41e-1)" "unprognostic (1.16e-3)" "unprognostic (5.37e-2)" "unprognostic (7.24e-3)" "unprognostic (5.35e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.63e-1)" "unprognostic (6.91e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-3)" "unprognostic (4.94e-2)" "prognostic unfavorable (2.01e-9)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (6.87e-2)" "unprognostic (3.28e-1)" 45.3 49.3 32.7 39.0 38.3 55.5 50.1 35.1 40.1 48.5 35.6 43.1 36.6 46.0 41.9 43.9 54.2 33.3 41.3 34.4 36.3 38.4 52.6 34.7 57.3 36.6 35.7 33.1 42.3 77.0 41.8 50.6 36.1 38.9 37.4 47.8 17.7 52.1 37.7 91.3 48.1 42.5 42.5 36.6 51.2 53.1 28.5 35.8 62.5 44.3 61.7 65.3 41.7 39.9 48.7 92.0 123.5 56.4 38.9 98.1 108.1 97.7 86.8 100.2 100.6 89.8 101.9 46.7 124.1 85.0 128.2 40.5 76.7 131.5 86.6 79.8 105.9 139.1 113.7 74.0 114.1 106.5 167.8 108.5 108.3 80.5 101.3 82.6 93.0 129.2 107.0 144.6 74.2 81.4 130.1 141.9 161.6 89.8 91.4 132.1 126.2 82.1 162.6 73.0 92.9 71.1 70.5 127.7 54.2 87.5 63.8 128.9 157.8 80.5 67.1 47.7 43.3 71.5 92.1 97.6 143.1 88.3 123.7 84.0 51.2 67.2 59.9 52.1 71.0 66.2 64.5 60.8 66.3 80.0 52.9 60.1 57.4 15.6 79.0 63.5 52.4 86.1 99.4 32.7 38.3 35.1 40.1 34.4 36.3 36.6 35.7 33.1 38.9 36.6 35.8 48.7 60.3 41.7 64.8 34.6 85.6 65.6 65.0 61.3 68.9 61.7 60.3 55.2 48.0 44.3 68.2 55.2 56.3 90.5 81.4 45.8 70.5 61.0 22.4 72.9 74.8 60.2 85.1 89.6 56.8 88.3 105.2 71.9 58.6 41.5 68.4 76.9 46.8 62.7 55.1 77.4 57.6 55.9 63.1 54.1 50.4 36.6 80.2 78.0 48.0 30.0 94.4 43.2 141.1 45.8 184.3 68.7 42.7 63.6 151.2 53.2 61.3 75.9 93.8 59.7 52.6 59.9 65.0 54.1 89.2 75.5 64.8 82.0 79.6 103.6 71.2 53.3 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 100.1;retina: 108.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA052825: AB_2681965, HPA059314: AB_2683975" "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favorable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favorable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.08e-5)" 9.9 100.1 26.1 8.3 26.7 7.9 9.5 23.6 25.5 12.4 72.0 8.8 6.4 13.0 8.8 6.2 16.1 10.2 7.3 28.4 26.5 7.4 57.5 12.2 10.3 27.1 31.5 24.8 38.8 10.1 17.9 23.4 8.2 28.6 12.6 6.2 108.1 5.9 10.4 3.3 11.5 12.6 10.1 26.8 21.1 9.5 11.5 33.7 8.2 25.3 4.5 10.0 19.0 9.0 32.3 21.2 24.5 32.2 12.2 22.2 12.4 40.9 8.9 12.1 10.3 9.6 12.7 23.6 9.6 9.4 12.4 29.1 20.1 9.1 24.2 19.2 6.0 16.2 13.3 4.3 48.0 12.5 18.9 7.6 10.6 13.8 25.8 15.4 21.5 15.2 15.5 9.3 7.9 13.7 7.9 20.7 10.5 11.4 16.9 14.9 19.0 21.2 14.3 5.6 34.2 10.7 12.0 17.0 17.7 63.3 11.4 9.8 10.9 13.1 23.0 10.7 27.8 17.4 11.2 22.2 25.5 8.1 11.2 36.8 0.0 1.1 0.1 1.1 0.7 1.0 1.8 0.8 0.8 1.5 1.0 0.8 0.8 1.2 0.3 0.9 2.4 0.5 0.9 26.1 26.7 23.6 25.5 28.4 26.5 27.1 31.5 24.8 28.6 26.8 33.7 32.3 9.3 6.4 7.2 50.3 14.5 7.4 4.5 7.0 12.5 236.8 8.3 7.4 7.9 15.7 9.4 14.7 114.7 4.9 12.6 0.8 0.0 5.0 4.6 2.8 10.1 13.0 7.2 8.6 102.8 5.5 6.6 14.2 3.6 1.9 8.2 13.5 17.5 71.3 10.6 85.8 117.4 1.9 0.0 30.2 7.5 9.3 20.2 16.3 16.0 60.0 8.8 24.8 7.2 77.4 78.3 3.4 6.7 29.3 11.9 8.2 0.6 1.3 7.8 71.5 13.1 12.6 12.2 0.6 8.0 5.5 6.1 4.0 8.2 65.6 2.8 14.7 SLC8B1 "FLJ22233, NCKX6, NCLX, SLC24A6" ENSG00000089060 "Solute carrier family 8 member B1" Q6J4K2 12 113298759-113359493 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 76.0" "Cell type enhanced" "Detected in many" "Theca cells: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040668 Approved NA NA "HPA040668: AB_10793861" "prognostic favorable (9.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.27e-1)" "unprognostic (4.30e-1)" "unprognostic (1.93e-2)" "unprognostic (2.80e-3)" "unprognostic (1.90e-1)" "unprognostic (6.52e-2)" "unprognostic (1.84e-1)" "unprognostic (2.68e-2)" "unprognostic (2.60e-1)" "unprognostic (5.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.54e-3)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.02e-4)" 16.1 76.0 7.4 15.0 9.4 17.9 15.2 8.4 9.2 19.3 5.7 12.7 10.7 12.0 8.0 15.9 13.2 11.4 11.0 6.8 9.3 15.3 17.8 20.8 14.0 13.9 9.1 5.9 56.0 18.3 7.5 15.5 8.1 10.4 17.1 9.4 1.4 17.0 9.1 10.1 17.9 17.0 7.0 8.7 29.6 12.2 13.7 10.0 18.2 13.2 5.6 10.0 12.8 15.3 10.2 25.3 5.5 3.2 7.0 15.5 10.9 10.6 8.3 23.8 10.6 10.3 5.4 21.1 6.6 18.5 10.8 9.2 20.1 9.8 5.7 5.1 16.3 3.1 13.3 13.1 6.2 25.8 33.9 28.7 11.1 16.9 12.2 5.2 9.1 24.5 24.0 27.7 3.3 6.0 5.9 10.6 27.5 5.7 8.2 14.2 3.9 4.2 8.3 11.4 34.7 0.2 5.4 22.5 45.1 5.4 4.2 8.0 13.1 54.3 7.5 8.8 22.4 5.0 4.5 10.3 5.0 9.6 19.2 6.0 4.1 16.5 32.8 8.0 24.1 10.2 3.3 14.5 7.9 19.1 4.4 28.8 13.5 10.3 6.1 24.8 14.3 19.4 15.8 7.4 9.4 8.4 9.2 6.8 9.3 13.9 9.1 5.9 10.4 8.7 10.0 10.2 9.3 12.8 12.6 13.7 5.8 4.5 13.2 8.0 4.6 2.4 8.4 6.5 4.3 8.6 10.9 12.9 10.4 7.8 9.2 30.6 5.9 13.0 1.5 6.0 9.4 9.6 4.9 1.7 7.7 17.4 8.6 13.6 14.3 15.5 21.5 32.4 6.4 12.0 21.6 0.0 3.9 13.3 4.1 21.8 22.6 1.5 24.5 32.4 1.8 22.5 17.8 2.8 5.2 4.0 6.2 22.5 20.7 28.2 3.3 19.1 23.6 3.3 4.5 0.8 32.9 9.9 13.3 1.0 3.9 12.2 7.1 10.7 9.8 96.7 13.3 21.3 TMEM230 "C20orf30, HSPC274" ENSG00000089063 "Transmembrane protein 230" Q96A57 20 5068232-5113103 "Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 502.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009078, HPA061421" Uncertain Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA009078: AB_1078345, HPA061421: AB_2684513" "unprognostic (1.39e-1)" "unprognostic (3.61e-1)" "unprognostic (3.73e-1)" "unprognostic (1.28e-1)" "unprognostic (3.71e-2)" "unprognostic (9.67e-3)" "unprognostic (5.85e-3)" "unprognostic (4.34e-3)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (2.74e-1)" "unprognostic (4.07e-2)" "unprognostic (9.70e-2)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.84e-2)" "unprognostic (1.55e-2)" 141.8 121.3 96.2 61.0 103.7 61.0 89.2 107.3 111.6 109.2 115.6 84.7 62.9 89.8 121.4 57.8 87.9 98.5 102.3 94.4 107.0 147.0 199.5 76.5 81.7 105.9 102.3 89.1 98.3 95.9 100.1 90.2 73.1 106.0 106.4 89.6 108.3 79.6 83.9 108.2 34.6 70.8 89.7 105.4 72.4 88.4 50.1 103.5 86.4 136.8 149.6 77.2 94.1 57.1 118.4 157.2 108.1 139.1 105.2 307.1 271.6 105.6 124.0 185.4 119.9 131.4 86.0 152.4 74.8 99.5 180.7 136.6 127.1 104.5 185.2 172.3 83.6 119.6 132.6 31.5 266.3 196.3 154.9 52.8 189.3 202.4 92.2 183.3 167.0 160.1 163.6 126.1 200.3 199.2 44.7 156.9 143.8 106.3 298.8 152.4 100.4 93.2 161.5 182.5 79.4 116.8 141.7 74.6 154.8 270.0 149.0 123.9 145.6 135.7 154.7 90.5 150.1 135.2 133.2 284.3 147.5 62.5 132.2 166.3 128.9 175.4 116.7 136.5 187.1 166.3 170.7 145.8 145.3 163.8 153.1 150.8 148.6 55.7 153.9 180.6 161.2 147.6 349.2 96.2 103.7 107.3 111.6 94.4 107.0 105.9 102.3 89.1 106.0 105.4 103.5 118.4 126.6 57.7 64.6 15.3 123.4 70.4 126.7 148.7 65.4 89.6 151.7 133.7 51.3 111.5 95.1 154.5 64.6 173.4 127.8 55.0 502.9 146.6 200.3 77.1 103.2 109.5 95.8 103.7 20.2 111.2 208.8 141.6 59.1 64.1 114.1 82.8 126.7 147.5 212.8 62.2 27.7 123.1 126.1 162.9 172.9 89.5 212.2 121.9 199.3 14.0 215.6 113.9 151.4 13.0 49.6 100.2 130.0 220.4 161.7 129.6 102.0 363.2 81.9 113.3 85.5 100.4 128.0 99.4 97.5 68.1 60.5 148.0 118.2 184.2 125.6 152.1 DZANK1 "ANKRD64, bA189K21.8, C20orf12, C20orf84, dJ568F9.2, FLJ10600, FLJ30892" ENSG00000089091 "Double zinc ribbon and ankyrin repeat domains 1" Q9NVP4 20 18383367-18467281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 25.8;Endometrial ciliated cells: 35.5;Excitatory neurons: 32.2;Inhibitory neurons: 27.0;Respiratory ciliated cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "THP-1: 25.4;U-266/84: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059478, HPA064255" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA059478: AB_2684033, HPA064255: AB_2685228" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (2.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (3.79e-2)" "unprognostic (2.78e-4)" "unprognostic (2.26e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (3.34e-2)" "unprognostic (2.29e-1)" "unprognostic (1.67e-2)" "unprognostic (5.68e-2)" "unprognostic (2.45e-1)" "unprognostic (6.05e-3)" "unprognostic (8.81e-3)" 1.2 1.3 3.2 0.8 3.2 2.8 2.7 3.1 4.2 1.9 3.1 1.0 0.4 1.0 0.9 1.0 3.5 0.4 0.7 3.2 3.2 2.6 1.0 1.8 1.0 2.9 3.0 3.1 2.1 1.7 1.0 5.7 0.5 3.3 1.7 0.6 3.5 1.2 0.4 0.7 1.6 1.2 0.3 2.6 1.8 1.2 4.9 3.0 0.4 3.8 0.2 0.8 1.2 1.1 4.0 0.3 1.7 1.7 1.5 1.6 1.0 0.3 0.9 0.4 2.4 1.5 6.4 0.8 3.3 0.4 0.8 1.0 0.6 5.5 0.6 1.8 0.4 1.1 1.6 0.9 0.8 1.2 2.6 1.1 0.6 1.0 4.4 0.8 0.6 0.8 1.1 0.1 1.1 0.6 2.7 0.2 1.2 3.6 1.0 0.2 0.8 0.7 0.2 3.4 1.5 1.6 2.2 2.6 1.3 3.1 1.3 1.0 25.4 0.1 2.1 0.4 1.8 1.2 3.6 27.9 3.8 0.7 3.1 0.8 2.6 0.3 0.5 0.1 0.9 0.1 1.1 0.1 0.4 0.3 0.3 0.2 0.2 1.0 0.5 0.7 0.4 0.4 0.2 3.2 3.2 3.1 4.2 3.2 3.2 2.9 3.0 3.1 3.3 2.6 3.0 4.0 1.7 0.0 3.6 12.1 6.1 1.5 1.1 1.6 1.8 4.3 7.7 9.7 1.6 1.5 8.8 3.7 16.7 0.5 2.3 1.5 1.9 2.1 25.8 35.5 5.1 1.5 0.0 0.4 32.2 1.1 0.8 2.3 1.5 5.1 3.8 3.8 1.4 0.3 2.3 6.7 27.0 1.2 8.2 3.8 1.8 19.3 0.3 2.5 5.4 5.6 1.1 4.0 1.0 9.0 16.7 2.5 0.3 1.9 4.0 0.7 0.6 4.1 41.9 18.0 0.0 2.6 2.6 11.6 12.4 0.8 1.4 0.3 2.6 3.2 1.9 0.6 KDM2B "CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2" ENSG00000089094 "Lysine demethylase 2B" Q8NHM5 12 121429096-121581023 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071257 Supported Nucleoplasm NA NA Nucleoplasm "HPA071257: " "unprognostic (7.67e-2)" "unprognostic (3.72e-3)" "unprognostic (2.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.74e-6)" "unprognostic (1.16e-1)" "unprognostic (5.45e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-1)" "prognostic favorable (8.64e-4)" "unprognostic (1.77e-1)" "unprognostic (4.44e-3)" "unprognostic (1.44e-2)" "unprognostic (3.90e-2)" "unprognostic (7.07e-2)" "unprognostic (4.82e-2)" 9.5 8.4 7.7 19.1 9.4 17.0 10.1 13.2 11.4 14.1 7.7 11.6 8.3 11.6 5.5 20.4 12.5 7.1 8.4 8.3 6.8 8.9 15.8 13.2 23.1 9.0 7.5 6.8 15.3 11.7 10.9 9.5 7.3 10.2 9.6 7.6 9.7 12.7 6.1 15.3 28.1 19.0 8.3 7.1 21.6 11.0 14.1 7.1 23.4 11.3 6.2 21.7 12.4 17.0 9.8 15.2 19.1 31.3 9.8 8.7 7.6 34.8 12.4 19.1 17.8 14.9 24.0 7.7 69.3 20.6 11.2 9.9 13.1 34.3 13.7 14.4 29.3 24.0 38.0 15.9 19.4 10.3 44.0 29.5 6.9 7.4 16.9 12.3 19.1 12.7 33.6 31.4 8.8 8.5 20.4 54.5 51.8 55.8 11.0 15.1 61.0 16.4 34.1 9.8 24.5 37.1 21.4 23.8 14.0 14.4 29.5 25.0 49.2 17.3 19.0 15.4 19.2 13.9 23.9 21.3 64.5 17.6 35.2 12.3 4.5 2.8 2.4 6.3 2.3 4.9 9.5 4.9 3.5 3.9 9.3 4.3 5.8 0.4 2.0 1.7 3.5 4.6 3.4 7.7 9.4 13.2 11.4 8.3 6.8 9.0 7.5 6.8 10.2 7.1 7.1 9.8 6.8 0.0 10.6 28.1 36.8 17.0 7.1 4.0 13.6 20.1 10.3 6.7 14.6 14.3 5.4 11.0 12.5 6.7 43.3 3.8 11.7 7.5 57.0 13.0 7.0 8.8 5.4 22.5 36.2 5.8 11.2 8.3 9.2 12.0 14.0 16.5 9.7 15.4 24.4 15.2 41.6 6.1 6.1 21.1 61.0 60.1 7.8 25.5 16.0 26.2 48.0 4.1 24.7 31.2 44.1 5.8 4.7 7.2 34.1 11.2 6.5 4.2 5.7 16.1 19.7 6.5 8.1 11.4 18.3 13.9 15.2 6.6 24.8 6.2 7.4 6.3 CFAP61 "C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156" ENSG00000089101 "Cilia and flagella associated protein 61" Q8NHU2 20 20052514-20360703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 12.9;skeletal muscle: 28.9;testis: 15.6" "Cell type enhanced" "Detected in some" "Early spermatids: 88.7;Excitatory neurons: 20.6;Late spermatids: 73.2;Spermatocytes: 17.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.7;HMC-1: 2.6;SCLC-21H: 5.1;SK-MEL-30: 2.2;U-87 MG: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009079 Approved NA NA "HPA009079: AB_1078344" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (6.73e-2)" "unprognostic (1.38e-3)" "unprognostic (6.20e-3)" "unprognostic (3.67e-3)" "unprognostic (8.58e-4)" "unprognostic (8.24e-2)" "unprognostic (8.29e-2)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.56e-1)" "unprognostic (2.76e-4)" "unprognostic (2.77e-1)" "unprognostic (9.27e-2)" "unprognostic (3.10e-3)" "unprognostic (3.06e-1)" 0.0 0.7 6.0 0.0 2.1 0.0 0.2 2.1 1.3 0.4 12.9 0.1 0.0 0.7 1.0 0.1 12.3 0.1 12.5 2.4 4.1 0.7 0.0 1.3 0.1 4.6 5.2 0.7 0.3 0.3 0.5 3.6 0.0 3.5 0.3 0.0 1.9 0.2 0.2 28.9 0.4 0.0 0.1 5.3 0.0 0.1 15.6 2.5 0.1 0.7 10.3 0.1 0.0 0.1 2.8 0.2 0.5 0.1 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.4 4.7 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.8 0.4 0.0 5.1 0.0 0.1 0.3 2.2 0.0 0.4 0.0 0.4 0.0 0.2 0.3 0.2 0.7 0.3 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 6.0 2.1 2.1 1.3 2.4 4.1 4.6 5.2 0.7 3.5 5.3 2.5 2.8 0.0 0.0 0.5 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 12.7 0.0 2.5 1.8 4.2 0.0 1.4 0.0 0.0 0.0 88.7 12.1 0.3 0.1 0.0 0.0 20.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 12.6 0.0 0.0 0.0 0.0 73.2 0.6 0.2 0.0 1.0 0.0 0.0 0.0 3.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 8.7 0.5 0.0 0.6 0.1 17.3 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462033-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "brain: 4.3;stomach 1: 1.2" "Cell type enhanced" "Detected in single" "Basal respiratory cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.0 1.6 0.0 0.6 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 1.7 0.2 0.0 2.0 4.3 1.6 0.0 1.3 1.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 TASP1 "C20orf13, dJ585I14.2, FLJ20212" ENSG00000089123 "Taspase 1" Q9H6P5 20 13389392-13638932 "Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 136.1;Inhibitory neurons: 131.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030824, HPA030825" Uncertain Approved "Plasma membrane" No No "Plasma membrane" "HPA030824: AB_10600327, HPA030825: AB_10601575" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "unprognostic (6.46e-2)" "unprognostic (3.44e-3)" "unprognostic (9.85e-2)" "unprognostic (9.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.67e-2)" 6.2 4.5 1.2 4.3 1.8 5.0 6.8 1.6 2.9 6.2 3.5 5.2 3.8 6.8 6.0 4.9 8.2 4.6 5.8 1.6 3.1 5.3 4.6 6.0 5.8 1.5 1.5 0.9 5.7 6.0 8.7 7.5 6.6 0.9 5.2 5.8 6.4 6.1 4.7 2.9 5.5 4.6 5.2 0.3 5.6 5.7 6.2 1.4 12.6 7.9 4.4 5.3 5.7 6.2 3.0 13.1 7.7 3.1 3.7 3.6 5.6 6.0 5.3 7.6 6.1 7.1 16.0 13.3 5.9 3.6 7.0 6.7 17.2 4.9 18.4 7.1 3.5 5.8 11.8 4.7 20.3 7.4 16.0 4.1 6.3 12.1 6.2 15.0 3.7 6.1 10.4 10.7 0.2 5.4 15.8 30.7 8.7 4.2 11.7 3.5 4.8 12.7 9.1 8.5 9.8 8.3 5.7 8.2 15.8 10.2 4.4 8.3 5.8 5.9 5.7 4.0 5.9 7.6 11.3 16.7 4.2 3.2 3.6 5.5 2.3 4.5 4.9 12.7 6.5 9.0 12.1 12.8 10.0 5.0 9.8 18.6 14.4 2.5 14.8 6.5 19.5 13.3 7.1 1.2 1.8 1.6 2.9 1.6 3.1 1.5 1.5 0.9 0.9 0.3 1.4 3.0 10.7 6.4 7.7 31.3 19.6 14.1 13.2 11.1 24.5 14.9 10.0 8.8 6.4 17.2 8.8 5.5 10.4 12.0 13.8 3.9 7.9 12.1 20.1 15.7 10.6 6.6 3.6 7.8 136.1 6.0 12.3 15.9 13.3 9.5 15.2 5.2 3.6 6.4 4.7 11.8 131.0 9.9 4.1 3.0 4.7 4.8 3.4 5.8 10.6 35.6 2.9 6.6 11.3 50.3 49.6 8.6 11.4 3.4 13.3 8.0 5.3 12.2 23.5 17.0 6.6 23.7 17.0 29.3 9.3 18.0 12.1 7.0 12.7 10.2 7.7 8.9 OAS1 "IFI-4, OIAS, OIASI" ENSG00000089127 "2'-5'-oligoadenylate synthetase 1" P00973 12 112905856-112933219 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 91.7;urinary bladder: 112.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 151.0;Hofbauer cells: 105.6;Paneth cells: 127.9;Urothelial cells: 171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 572.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 247.1;BJ hTERT+ SV40 Large T+ RasG12V: 336.6;OE19: 307.6;U-266/70: 272.9;U-266/84: 210.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003657, CAB021104" Uncertain Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "CAB021104: AB_10057722, HPA003657: AB_1854747" "unprognostic (1.03e-1)" "unprognostic (6.59e-2)" "unprognostic (8.56e-3)" "unprognostic (2.20e-3)" "unprognostic (2.78e-1)" "unprognostic (1.30e-1)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (6.91e-2)" "unprognostic (3.68e-2)" "unprognostic (5.67e-2)" "prognostic favorable (6.12e-6)" 15.5 11.6 8.4 27.6 9.7 14.5 13.3 7.2 10.2 18.3 7.6 49.5 52.2 8.1 8.2 57.5 10.1 22.7 8.6 7.2 10.8 22.1 38.9 23.3 27.5 13.9 8.0 6.3 8.2 4.4 9.1 8.3 20.6 10.6 9.2 45.5 1.5 91.7 7.4 2.4 10.1 40.1 14.7 9.0 50.9 44.0 4.8 8.9 28.4 7.8 7.5 25.8 112.3 22.9 24.1 4.7 24.4 0.0 0.1 9.4 6.6 1.5 0.1 38.8 247.1 336.6 18.5 34.1 42.3 12.2 0.3 121.8 10.8 0.2 4.2 2.2 21.0 0.0 0.7 35.2 4.6 2.9 0.6 1.4 0.5 7.2 8.0 0.0 3.1 13.5 0.7 0.0 17.4 0.2 0.4 0.6 17.0 0.7 307.6 22.5 5.8 0.2 20.5 11.6 89.4 0.2 0.9 3.7 4.2 85.2 0.4 0.9 5.1 50.4 0.0 0.5 3.2 0.4 272.9 210.3 23.9 2.9 6.6 1.4 6.3 253.6 3.2 26.5 403.9 25.3 108.8 36.3 34.3 153.9 93.1 14.3 18.8 24.4 24.9 572.0 144.5 108.7 217.8 8.4 9.7 7.2 10.2 7.2 10.8 13.9 8.0 6.3 10.6 9.0 8.9 24.1 23.0 3.2 2.2 0.0 21.1 3.4 16.6 24.0 10.8 0.2 6.0 8.1 3.1 14.3 35.4 5.5 0.0 12.6 31.5 151.0 5.9 19.5 0.4 1.9 3.6 17.2 4.2 3.6 0.6 12.0 36.4 11.1 28.5 4.1 5.1 15.4 14.3 11.9 105.6 0.0 1.0 59.3 26.4 36.9 11.4 1.2 7.2 52.9 5.4 13.1 36.2 15.0 18.6 3.5 0.1 19.5 127.9 10.5 24.1 7.4 50.9 25.4 17.5 0.4 6.6 3.0 7.5 0.0 0.5 18.3 2.3 5.7 9.1 12.7 14.6 171.9 GCN1 "GCN1L, GCN1L1, KIAA0219" ENSG00000089154 "GCN1 activator of EIF2AK4" Q92616 12 120127202-120194715 "Plasma proteins, Predicted intracellular proteins" "Stress response, Translation regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018799, HPA019648, HPA024367" Enhanced Enhanced Cytosol NA NA 120000 Cytosol "HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569" "unprognostic (7.36e-2)" "unprognostic (2.10e-3)" "unprognostic (3.17e-1)" "unprognostic (2.60e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" "prognostic unfavorable (1.87e-8)" "unprognostic (5.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.20e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (6.35e-2)" "unprognostic (1.21e-1)" "unprognostic (2.34e-1)" "unprognostic (7.09e-3)" "unprognostic (1.43e-1)" 17.2 16.6 9.1 16.1 10.7 19.3 17.0 9.7 9.1 17.0 11.6 18.5 12.2 20.1 9.6 22.5 17.5 9.6 15.2 8.4 10.0 14.8 18.0 16.2 18.4 10.9 10.2 7.8 20.4 23.1 18.2 21.3 16.6 10.1 15.9 12.5 8.9 18.3 12.8 44.7 22.2 18.2 14.8 9.2 20.7 20.7 18.0 11.0 18.4 19.9 23.1 16.4 18.7 16.5 13.0 51.4 99.3 35.1 39.7 54.4 32.7 122.4 44.9 38.9 45.8 37.2 85.6 34.5 67.8 49.6 64.8 29.0 49.5 82.1 63.5 28.4 45.5 66.9 84.0 65.5 59.8 35.2 78.2 51.5 40.3 36.3 54.3 50.9 40.2 42.5 30.3 100.3 17.0 38.8 51.6 49.7 59.1 62.3 48.8 59.9 59.7 36.0 67.3 31.2 172.8 57.4 57.4 73.8 31.7 26.5 33.1 67.5 43.8 58.6 37.3 41.0 24.7 47.0 66.2 65.4 67.1 35.7 40.5 38.2 0.7 1.8 1.3 3.3 1.7 4.1 2.0 2.6 2.7 2.3 2.1 1.9 2.1 0.0 1.8 4.1 2.7 2.6 1.9 9.1 10.7 9.7 9.1 8.4 10.0 10.9 10.2 7.8 10.1 9.2 11.0 13.0 12.0 9.6 17.9 0.0 11.2 0.0 6.8 0.0 9.6 14.1 11.9 13.6 0.0 12.8 9.3 22.0 10.4 14.2 12.0 8.1 1.9 15.6 1.9 9.0 14.1 10.5 3.6 16.2 0.0 15.9 38.2 10.5 25.5 14.9 5.1 25.7 10.4 24.6 11.2 16.8 0.0 11.4 0.0 9.1 0.0 3.5 14.3 8.9 0.0 0.0 11.1 9.0 7.2 0.0 0.0 18.6 8.6 12.8 17.7 15.7 11.1 9.1 2.9 12.1 6.6 16.4 8.9 8.8 20.8 14.1 0.0 14.6 10.1 14.3 11.7 15.8 RPLP0 "L10E, LP0, P0, PRLP0, RPP0" ENSG00000089157 "Ribosomal protein lateral stalk subunit P0" P05388 12 120196699-120201235 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003512, HPA073501" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA 770000 "Endoplasmic reticulum, Cytosol" "HPA003512: AB_1079844, HPA073501: " "unprognostic (2.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (8.49e-3)" "unprognostic (2.99e-2)" "unprognostic (2.44e-1)" "unprognostic (2.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.67e-1)" "unprognostic (4.82e-2)" "unprognostic (2.34e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (7.66e-12)" "unprognostic (2.74e-1)" "unprognostic (2.39e-1)" "unprognostic (3.06e-1)" "unprognostic (1.47e-1)" 1592.9 1355.7 543.2 1165.8 539.9 3311.5 2747.4 539.8 645.4 1509.4 614.5 1768.9 1568.6 1267.5 996.2 2715.7 2239.8 988.4 990.9 532.9 642.0 881.2 1445.2 1091.2 1850.1 600.7 549.4 509.4 2886.0 3292.8 702.7 759.6 1212.7 573.7 1205.9 1793.6 527.5 1807.2 856.5 2427.3 2547.9 1270.5 1349.4 592.4 1144.3 1621.9 400.3 578.1 1852.8 1165.2 1604.1 2453.7 1795.4 1718.0 601.3 3354.4 3355.3 2339.0 4061.4 4653.6 7635.7 3627.8 2397.9 4274.8 3734.5 2395.4 4364.8 1919.1 7137.6 2541.5 4307.9 945.2 2583.2 4120.3 5060.1 2324.4 2764.8 3209.4 3343.3 2263.6 4630.2 5153.3 4498.4 2490.2 6817.1 8686.1 2619.4 8018.0 6670.0 4528.8 4037.2 4292.7 2014.6 3645.7 5140.3 4443.4 5661.6 4494.0 3290.9 3704.7 3321.6 3175.0 5868.8 3881.1 5170.2 2606.2 3183.0 1722.7 2593.0 5541.7 2631.2 4773.6 6518.2 3016.5 1807.3 2718.5 2322.7 3249.7 4551.6 5143.0 3549.4 3136.7 3560.7 1492.7 337.6 1714.3 136.4 1750.8 1555.9 3999.6 3712.1 3171.7 2361.5 3455.6 3456.2 3255.0 2728.7 123.0 2340.3 927.0 3805.3 2342.6 7075.7 543.2 539.9 539.8 645.4 532.9 642.0 600.7 549.4 509.4 573.7 592.4 578.1 601.3 594.8 586.5 1363.0 12.7 2571.7 3876.3 4947.2 3409.7 5507.4 208.7 3351.1 3986.1 277.8 1312.6 1946.7 562.8 154.3 4464.2 1352.3 967.9 1886.1 2150.7 448.8 811.6 1878.9 1354.0 1217.3 2826.9 12.8 4812.2 7058.4 1577.5 1782.3 1217.8 796.8 1334.4 963.1 1249.9 2014.1 94.2 19.7 2395.8 950.1 1281.9 2122.5 944.5 1740.7 1327.5 1700.4 17.8 1794.6 366.3 1030.9 19.6 28.6 2966.5 1712.5 795.1 4088.9 4142.9 1870.9 2089.5 859.3 486.4 420.7 1701.5 3223.9 309.4 759.2 7221.2 4751.9 4413.0 1892.0 2405.0 3317.6 5180.7 PXN ENSG00000089159 Paxillin P49023 12 120210439-120265771 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 169.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003841, HPA051309" Supported Enhanced "Focal adhesion sites,Centrosome,Cytosol" NA NA "Focal adhesion sites" "Centrosome, Cytosol" "CAB003841: AB_562188, HPA051309: AB_2681436" "unprognostic (4.00e-2)" "unprognostic (1.94e-2)" "unprognostic (3.51e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (1.09e-4)" "prognostic unfavorable (3.72e-5)" "prognostic unfavorable (7.12e-5)" "prognostic unfavorable (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (9.19e-3)" "unprognostic (2.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-2)" "unprognostic (3.35e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.75e-2)" 80.2 61.4 28.4 49.5 28.5 82.2 75.0 27.4 30.8 62.3 32.6 67.6 56.2 56.7 18.9 31.1 73.0 38.5 77.2 27.0 35.4 69.4 29.7 85.3 29.5 36.8 29.2 19.8 28.7 34.8 28.0 29.7 73.9 30.7 59.4 50.4 62.4 49.8 41.0 120.2 43.2 61.6 44.9 29.7 73.1 47.9 26.7 32.9 26.1 58.6 46.5 18.6 76.4 53.7 32.8 182.4 87.5 31.3 30.1 60.4 158.1 206.1 151.8 128.6 118.9 61.5 102.5 108.9 12.2 94.6 154.9 115.1 126.0 21.7 272.0 93.0 9.9 18.6 2.3 63.8 37.9 86.8 2.7 3.6 76.5 176.2 125.3 143.9 139.7 211.6 32.2 32.4 19.5 239.3 119.6 11.1 4.1 43.5 77.1 300.8 26.2 51.0 10.8 121.4 171.9 48.7 14.5 133.2 40.3 81.7 72.1 96.1 14.8 289.9 78.9 86.7 103.6 183.9 20.4 12.3 4.6 228.9 27.0 159.2 40.8 44.2 49.2 84.5 15.7 45.3 1.7 38.4 56.0 26.2 1.1 29.5 40.3 169.6 51.8 0.8 4.1 31.4 60.6 28.4 28.5 27.4 30.8 27.0 35.4 36.8 29.2 19.8 30.7 29.7 32.9 32.8 93.6 57.7 27.9 11.8 3.0 42.3 40.6 32.8 15.4 7.8 20.3 22.9 14.7 22.8 33.3 42.3 33.3 40.8 61.6 83.1 19.6 31.6 2.1 26.0 16.7 71.0 54.6 6.1 5.1 40.2 152.4 29.7 37.2 28.8 18.3 6.2 62.2 17.2 34.2 11.8 7.7 52.7 24.4 42.3 23.7 2.8 24.2 23.5 26.6 19.7 36.8 9.1 99.9 13.0 9.2 84.8 51.6 18.8 14.5 41.7 56.6 14.6 40.0 33.6 6.6 16.7 12.1 3.5 9.1 8.1 19.5 25.0 34.4 11.3 35.8 42.6 SIRT4 SIR2L4 ENSG00000089163 "Sirtuin 4" Q9Y6E7 12 120302316-120313249 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage" Transferase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029691, HPA029692" Enhanced NA NA "HPA029691: AB_10600118, HPA029692: AB_10611520" "unprognostic (2.62e-2)" "unprognostic (7.08e-2)" "unprognostic (4.46e-3)" "unprognostic (1.09e-1)" "unprognostic (1.51e-1)" "unprognostic (2.35e-2)" "unprognostic (2.37e-2)" "unprognostic (4.53e-2)" "unprognostic (1.25e-1)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (1.54e-1)" "prognostic favorable (1.75e-4)" "unprognostic (4.97e-2)" "unprognostic (2.11e-1)" "unprognostic (9.74e-3)" "unprognostic (2.31e-1)" 0.8 3.9 2.9 1.0 2.8 0.3 1.1 3.9 3.3 1.9 3.0 2.3 3.6 2.0 0.9 1.4 1.4 1.2 4.2 2.9 2.8 3.3 3.9 1.6 1.4 3.0 2.8 2.9 2.5 2.0 2.9 0.9 0.9 3.7 1.3 1.0 3.7 3.1 1.5 9.9 3.1 1.6 1.8 2.5 1.5 2.3 6.3 3.1 2.3 1.9 7.2 1.1 1.5 1.3 3.4 0.6 1.4 1.9 0.9 5.9 1.9 0.9 1.4 1.6 1.1 2.9 1.5 0.9 1.0 1.6 0.8 1.5 0.3 1.9 0.7 1.9 2.0 2.5 0.0 0.3 1.2 1.4 1.1 0.5 1.7 1.6 0.6 0.4 3.2 1.5 2.8 2.0 0.1 1.7 0.8 1.9 1.6 1.1 0.4 1.1 2.3 3.5 1.0 1.6 0.1 1.9 1.6 1.0 0.1 0.9 3.2 2.3 0.4 0.2 0.9 1.5 0.8 0.3 2.3 2.1 0.3 0.9 0.6 1.4 6.7 1.4 0.2 3.8 0.6 5.8 2.7 2.5 3.1 0.8 3.5 4.4 3.9 0.0 2.5 0.1 3.8 0.2 1.2 2.9 2.8 3.9 3.3 2.9 2.8 3.0 2.8 2.9 3.7 2.5 3.1 3.4 1.3 6.4 2.0 3.6 2.3 0.4 0.8 0.6 1.2 0.8 1.3 2.4 4.5 0.0 2.4 0.0 2.1 1.2 2.2 0.1 7.9 1.7 29.7 1.2 1.5 0.4 0.0 0.8 5.5 1.1 1.0 1.2 1.1 1.0 0.0 2.8 0.4 1.4 0.7 5.0 7.0 0.9 0.0 0.0 0.6 4.0 1.2 0.4 0.0 1.0 0.0 1.8 0.0 3.5 2.5 0.6 2.9 2.2 0.7 0.4 4.5 6.1 0.4 2.9 0.0 1.1 1.5 6.3 0.9 1.5 1.4 0.8 1.3 6.3 0.9 0.1 RPH3A "exophilin-1, KIAA0985, rabphilin" ENSG00000089169 "Rabphilin 3A" Q9Y2J0 12 112570380-112898881 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 85.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 24.5;Excitatory neurons: 71.6;Inhibitory neurons: 100.6" "Cancer enriched" "Detected in some" 5 "glioma: 4.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 6.3" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 6.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 7.4;SH-SY5Y: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002475 Enhanced NA NA "HPA002475: AB_1079837" "unprognostic (5.50e-2)" "unprognostic (3.19e-1)" "unprognostic (3.72e-3)" "unprognostic (5.90e-2)" "unprognostic (7.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (3.73e-2)" "unprognostic (1.42e-1)" "unprognostic (5.85e-2)" "unprognostic (3.92e-2)" "unprognostic (2.08e-2)" "unprognostic (2.70e-2)" "unprognostic (7.46e-2)" 0.5 3.6 9.9 1.6 22.1 20.9 0.8 21.9 85.4 0.3 0.0 0.8 1.0 1.3 2.4 0.9 0.6 1.9 0.6 18.9 14.6 0.6 0.8 0.6 3.4 26.8 24.5 14.5 0.8 2.4 0.2 0.4 1.3 14.7 0.7 1.2 9.7 0.9 0.4 0.6 2.1 1.1 1.4 5.6 1.8 0.6 1.4 45.8 0.6 1.1 0.4 2.0 0.8 0.2 45.3 0.7 0.3 0.7 1.2 0.3 0.5 2.0 0.0 0.4 0.5 0.1 0.6 1.0 1.1 0.3 0.0 0.6 2.0 0.3 0.5 0.9 0.4 1.4 1.9 3.2 2.1 0.4 1.1 1.8 0.6 0.2 1.3 1.0 0.7 0.0 0.3 0.1 2.7 1.8 0.7 0.6 1.5 1.1 0.2 1.1 0.0 0.9 7.4 0.0 1.5 0.9 16.5 0.2 0.1 0.1 1.6 0.7 0.1 0.1 1.6 1.2 1.5 0.9 1.2 0.3 1.1 1.0 0.8 0.4 1.2 6.3 0.2 0.2 3.0 0.1 0.3 0.1 0.2 0.6 0.8 0.2 0.3 2.3 0.5 4.6 0.2 0.0 1.8 9.9 22.1 21.9 85.4 18.9 14.6 26.8 24.5 14.5 14.7 5.6 45.8 45.3 0.0 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.0 24.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.2 0.0 0.0 71.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 100.6 0.0 0.0 1.2 0.0 7.2 0.0 3.2 0.0 2.8 5.8 1.2 0.0 12.5 3.8 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIF16B "C20orf23, dJ971B4.1, FLJ20135, SNX23" ENSG00000089177 "Kinesin family member 16B" Q96L93 20 16272104-16573448 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 38.1" "Low region specificity" "Detected in all" HPA051198 Approved Uncertain Mitochondria NA NA Mitochondria "HPA051198: AB_2681385" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-1)" "unprognostic (3.92e-2)" "unprognostic (2.44e-1)" "unprognostic (6.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.38e-1)" "unprognostic (5.34e-2)" "unprognostic (3.95e-2)" "unprognostic (5.52e-1)" "prognostic favorable (7.61e-6)" "unprognostic (4.04e-2)" "unprognostic (2.78e-1)" "unprognostic (4.74e-2)" "unprognostic (1.61e-2)" 10.2 27.6 5.9 6.4 6.6 5.9 16.0 5.3 9.1 6.3 4.6 24.7 16.9 6.2 12.6 9.4 5.1 8.3 11.6 4.9 5.2 18.3 11.8 8.9 5.4 6.9 5.9 2.6 12.9 6.6 31.7 5.2 4.9 7.0 7.4 19.3 9.7 7.3 10.9 17.3 12.0 20.9 7.5 4.5 8.3 12.9 5.2 5.9 6.0 11.2 13.2 4.7 7.9 6.2 8.4 7.7 19.3 9.1 8.3 6.8 5.0 8.8 7.4 4.5 4.6 5.0 9.5 18.5 10.7 4.7 8.0 12.7 6.9 10.8 11.0 6.8 5.7 6.2 4.8 4.7 17.6 4.2 0.0 10.5 8.0 21.4 5.5 10.6 7.0 1.8 8.1 8.7 0.0 7.5 12.2 0.1 2.0 2.6 24.9 8.7 8.1 7.2 18.9 7.2 12.2 4.0 7.9 8.0 38.1 23.9 10.7 11.3 6.3 3.7 7.0 5.9 11.4 3.4 0.0 4.9 3.2 6.6 3.2 14.3 0.0 2.1 0.5 2.0 1.7 2.7 2.7 2.2 1.5 3.4 2.6 2.3 1.7 0.2 4.5 1.8 1.6 1.6 1.7 5.9 6.6 5.3 9.1 4.9 5.2 6.9 5.9 2.6 7.0 4.5 5.9 8.4 13.1 19.2 31.7 54.9 9.8 19.1 16.1 11.0 37.5 8.7 30.5 16.0 29.2 4.3 14.8 5.5 18.8 15.7 7.7 60.6 3.9 6.5 12.6 13.2 14.2 13.6 23.4 5.0 67.6 12.3 5.5 15.1 18.3 20.8 9.5 13.6 12.5 15.9 19.1 37.0 84.2 38.9 4.1 12.2 35.7 9.8 11.5 19.8 10.6 59.0 4.9 8.6 10.3 60.3 94.1 13.3 40.9 14.7 6.9 11.1 36.8 21.1 11.6 11.5 6.6 22.7 13.4 12.9 15.0 26.3 22.4 37.5 9.4 12.9 24.8 19.3 TRMT6 "CGI-09, GCD10, Gcd10p, MGC5029" ENSG00000089195 "TRNA methyltransferase 6" Q9UJA5 20 5937228-5950558 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatogonia: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047032, HPA050408" Approved Enhanced "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA047032: AB_2679911, HPA050408: AB_2681117" "unprognostic (1.78e-1)" "unprognostic (4.51e-2)" "unprognostic (1.65e-1)" "unprognostic (4.26e-2)" "unprognostic (2.11e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.70e-12)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.14e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (7.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" 7.4 9.7 5.7 7.4 5.9 14.0 5.9 6.3 6.4 5.8 5.1 5.8 3.4 6.7 6.0 9.2 5.7 3.5 7.3 6.0 5.7 7.0 5.6 5.0 9.4 6.3 5.6 5.2 5.6 7.4 6.8 8.4 5.2 6.3 5.2 5.6 3.7 6.1 10.0 20.4 7.9 5.9 5.7 5.2 6.7 5.8 11.6 5.4 8.9 5.9 7.4 9.1 11.1 6.4 6.1 55.5 27.8 17.1 25.9 10.4 11.8 21.4 24.7 12.5 24.5 20.6 36.5 22.2 62.1 13.1 15.1 33.8 39.9 36.3 41.8 40.3 13.3 25.5 50.6 12.0 32.2 19.8 47.8 13.3 13.6 21.8 44.4 33.4 8.6 10.0 25.6 32.3 18.0 28.8 14.4 50.6 26.2 39.5 36.9 33.9 33.4 33.6 36.1 18.3 31.3 33.9 51.1 29.2 39.3 45.0 16.2 20.2 24.4 8.8 28.5 27.1 26.8 52.1 31.6 64.1 74.6 13.3 37.9 29.3 2.1 7.8 6.3 9.1 9.1 10.9 8.6 9.9 11.5 18.0 8.1 10.1 11.1 0.7 15.6 8.3 7.5 12.5 7.2 5.7 5.9 6.3 6.4 6.0 5.7 6.3 5.6 5.2 6.3 5.2 5.4 6.1 11.7 6.4 20.3 2.0 20.0 21.4 26.1 35.8 25.0 19.8 12.6 14.9 25.9 15.7 31.3 29.5 10.4 26.2 12.4 6.3 35.2 26.3 3.9 18.2 14.8 17.8 13.8 10.7 6.4 30.7 26.8 19.7 12.8 16.2 34.9 25.5 5.0 19.1 17.6 26.9 4.9 8.6 26.4 15.0 47.5 6.5 11.5 35.0 17.8 11.2 13.6 13.2 20.6 4.5 4.0 22.4 7.3 7.2 17.5 33.8 3.8 22.7 30.8 11.0 13.1 26.7 28.7 70.4 103.6 17.4 24.0 29.3 21.0 18.7 12.6 20.6 CHGB "SCG1, SgI" ENSG00000089199 "Chromogranin B" P05060 20 5911510-5925353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adrenal gland: 3499.0;pituitary gland: 1436.4" "Cell type enriched" "Detected in many" 5 "Enteroendocrine cells: 1036.1" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 154.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "SCLC-21H: 355.0;SH-SY5Y: 541.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008759, CAB009403, HPA012602" Enhanced Supported Enhanced Vesicles "Intracellular and membrane" NA NA 6500000 Vesicles "CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706" "unprognostic (1.79e-3)" "unprognostic (7.72e-2)" "unprognostic (3.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (7.96e-3)" "unprognostic (2.86e-1)" "unprognostic (6.18e-3)" "unprognostic (7.93e-2)" "prognostic favorable (9.96e-4)" "unprognostic (8.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "unprognostic (2.73e-1)" "unprognostic (1.01e-2)" 27.8 3499.0 25.1 5.4 19.8 0.8 2.2 137.0 102.7 0.4 0.0 8.0 60.8 1.6 4.2 0.6 13.8 0.4 38.6 113.7 77.4 8.3 0.7 2.4 3.1 72.8 104.5 20.4 26.1 93.6 6.4 1436.4 0.7 138.1 5.4 14.3 57.4 6.2 3.9 11.1 1.7 31.8 1.0 6.4 0.4 134.4 15.0 35.0 4.0 9.9 0.9 1.4 0.4 2.3 218.1 0.0 7.9 0.9 0.0 0.2 0.2 0.4 0.2 0.0 0.1 0.0 1.9 0.0 0.0 4.3 0.0 4.9 0.1 0.0 0.1 0.1 0.6 0.1 2.6 0.0 1.6 0.1 4.2 0.2 1.5 0.0 0.0 2.1 0.1 0.1 0.2 0.4 0.1 1.0 0.0 0.1 0.9 19.7 1.3 0.0 0.1 0.0 0.4 0.5 0.2 355.0 541.8 0.0 0.5 0.4 2.1 0.3 0.4 0.3 0.1 6.4 0.4 3.3 0.0 0.7 2.7 0.5 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 25.1 19.8 137.0 102.7 113.7 77.4 72.8 104.5 20.4 138.1 6.4 35.0 218.1 0.0 3.2 2.4 7.5 0.3 4.2 9.9 0.8 0.0 93.3 0.1 0.3 114.4 0.0 0.7 69.9 20.9 0.1 0.0 1.6 1.9 0.5 7.1 0.2 0.7 3.0 1036.1 0.0 31.6 0.4 0.0 18.9 4.1 0.3 0.0 202.8 0.0 0.3 0.1 75.7 28.8 61.9 65.1 0.3 9.5 8.3 0.9 1.6 7.2 9.4 1.1 13.7 1.0 7.5 5.2 22.9 17.7 0.4 0.0 3.3 3.2 0.3 4.4 75.6 13.1 3.0 1.6 76.6 41.8 0.0 3.7 0.3 1.0 3.0 2.2 4.2 PEBP1 "HCNP, PBP, PEBP, RKIP" ENSG00000089220 "Phosphatidylethanolamine binding protein 1" P30086 12 118136124-118145584 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 2100.2" "Cell type enhanced" "Detected in all" "Distal tubular cells: 3705.6;Hepatocytes: 2242.4;Proximal enterocytes: 2177.7;Proximal tubular cells: 4542.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA008819, CAB009906, CAB013493, HPA063904" Enhanced Approved "Plasma membrane,Cytosol" NA NA 51000000 "Plasma membrane, Cytosol" "CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708" "unprognostic (4.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.28e-2)" "unprognostic (3.39e-3)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-2)" "unprognostic (7.35e-3)" "unprognostic (5.67e-2)" "unprognostic (3.55e-2)" "prognostic favorable (1.52e-4)" "unprognostic (1.63e-1)" "prognostic favorable (2.15e-13)" "unprognostic (2.17e-1)" "unprognostic (7.72e-2)" "unprognostic (7.96e-2)" "unprognostic (8.80e-2)" 219.8 1768.5 994.0 84.8 994.9 122.8 237.9 1025.6 1057.5 260.2 966.0 201.5 606.9 188.2 387.0 221.3 220.3 156.2 468.1 979.3 990.2 1055.8 2100.2 177.9 123.7 1016.5 1018.0 952.3 338.9 360.6 1172.2 294.6 129.9 1019.8 263.9 193.0 339.0 347.5 235.4 585.8 187.5 514.8 169.1 1054.4 122.3 203.4 153.5 1055.2 139.4 746.5 551.7 161.5 202.5 180.5 1134.5 289.2 241.6 340.0 348.8 493.5 250.2 500.0 214.5 262.3 347.7 177.1 151.6 96.4 439.6 221.3 336.2 139.9 194.4 495.0 202.8 257.7 115.1 454.2 220.0 274.7 1021.7 289.2 403.6 94.5 240.8 334.7 203.9 140.0 396.1 162.7 240.9 375.8 169.2 356.4 346.3 226.8 813.7 319.7 243.1 273.9 446.1 235.6 829.7 428.7 277.2 397.5 306.9 439.9 306.2 446.0 200.4 443.6 293.0 168.9 253.7 147.0 254.0 237.3 161.6 315.1 234.1 301.1 303.2 280.9 5.0 67.5 20.0 155.2 76.4 247.0 271.7 258.9 193.1 205.1 210.0 244.6 201.2 8.0 138.1 68.6 231.6 259.7 258.4 994.0 994.9 1025.6 1057.5 979.3 990.2 1016.5 1018.0 952.3 1019.8 1054.4 1055.2 1134.5 193.7 403.8 433.3 101.5 230.9 318.1 449.3 367.6 288.5 539.4 538.4 590.7 697.3 713.4 243.2 783.5 95.9 999.6 144.6 207.1 3705.6 507.9 44.3 499.3 319.0 186.5 320.6 218.1 93.7 244.6 862.3 347.9 169.2 369.8 371.8 419.7 213.8 2242.4 591.6 721.8 99.6 378.8 335.7 201.4 239.0 84.4 543.1 195.3 743.5 53.4 296.8 1792.2 101.0 39.2 199.8 184.2 313.3 731.6 279.3 517.4 2177.7 4542.6 291.6 411.6 368.1 337.5 347.8 330.6 145.7 367.7 325.2 615.5 216.7 921.6 631.3 399.5 TBX5 HOS ENSG00000089225 "T-box transcription factor 5" Q99593 12 114353911-114408442 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 58.2;lung: 21.0;placenta: 28.9" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 104.7" "Cancer enhanced" "Detected in some" "lung cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 18.9;BJ hTERT+: 41.5;BJ hTERT+ SV40 Large T+: 9.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HAP1: 16.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 3.4 0.0 0.1 0.0 0.0 0.0 4.5 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 58.2 0.8 0.0 0.0 0.0 21.0 0.6 0.3 0.1 0.0 0.0 0.0 1.3 0.0 28.9 0.3 3.4 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 5.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 18.9 41.5 9.2 12.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 16.3 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.8 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.2 2.9 0.0 0.6 1.6 0.0 0.1 0.0 0.0 0.0 4.5 0.1 0.1 104.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 BRAP "BRAP2, IMP, RNF52" ENSG00000089234 "BRCA1 associated protein" Q7Z569 12 111642146-111685956 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.7" "Group enriched" "Detected in all" 7 "Early spermatids: 319.6;Late spermatids: 380.1;Spermatocytes: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040357, HPA058820" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA040357: AB_10967924, HPA058820: AB_2683827" "unprognostic (7.02e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.65e-6)" "unprognostic (2.14e-1)" "unprognostic (9.24e-3)" "unprognostic (2.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (3.66e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-2)" "unprognostic (8.08e-2)" 8.9 8.9 8.3 8.0 9.4 33.9 9.3 10.1 9.9 8.0 7.6 9.2 9.2 8.8 7.0 9.6 8.5 7.6 9.8 8.2 8.9 8.6 10.1 8.1 10.6 9.1 9.2 7.7 9.8 8.3 10.6 6.2 10.7 9.1 8.4 9.3 9.2 8.5 8.4 20.0 12.4 8.9 9.5 9.0 9.1 7.8 67.7 8.7 12.9 10.0 14.1 10.9 9.3 8.2 10.9 14.6 21.1 16.9 19.5 17.7 14.8 28.2 20.0 16.7 22.8 17.5 28.6 10.0 28.0 11.7 19.1 12.9 17.6 23.8 16.4 24.2 18.0 15.4 34.8 12.9 19.4 22.2 30.7 22.5 16.9 22.8 19.7 31.8 19.6 20.0 19.0 36.7 8.9 19.0 18.6 25.7 29.6 22.8 15.4 22.1 23.6 18.4 25.1 15.0 30.3 20.9 15.5 23.5 19.8 19.5 19.3 21.7 19.3 18.8 14.6 13.5 13.3 14.4 22.6 30.9 30.4 13.8 16.8 16.3 22.7 16.8 32.3 17.5 17.5 17.3 16.1 18.5 17.9 15.1 16.5 17.1 17.6 32.7 23.1 14.6 10.9 24.7 16.1 8.3 9.4 10.1 9.9 8.2 8.9 9.1 9.2 7.7 9.1 9.0 8.7 10.9 11.6 22.4 11.2 14.7 14.9 11.2 8.9 9.7 12.0 8.9 8.8 7.5 12.7 17.2 10.8 11.0 29.2 13.7 13.7 15.4 5.9 13.5 319.6 11.9 11.6 11.4 9.6 22.9 24.7 7.7 14.9 12.3 15.3 12.4 8.2 13.3 10.4 9.1 10.9 3.3 23.3 12.9 14.2 9.8 11.5 380.1 13.4 11.7 3.6 10.3 19.7 8.6 17.5 13.0 23.3 14.5 12.7 13.5 15.0 13.4 13.5 14.6 13.8 11.8 6.6 11.6 15.1 147.8 38.6 15.4 12.6 22.4 13.5 10.2 11.0 14.5 ERP29 "C12orf8, ERp28, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013348-112023449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 900000 Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 61.0 101.8 57.4 78.6 57.9 204.0 84.8 65.3 62.5 75.7 85.4 95.4 101.6 61.0 110.8 92.3 75.4 64.7 57.9 55.8 66.1 93.7 181.4 79.5 124.8 60.6 60.8 55.2 79.5 176.1 124.6 99.9 73.6 63.5 94.3 92.1 68.9 123.8 88.2 34.7 114.2 96.9 47.5 59.2 119.2 132.5 58.0 61.5 108.6 91.2 34.6 112.1 76.6 71.6 62.6 145.4 137.2 98.8 194.2 367.4 143.7 211.3 139.2 163.7 108.5 139.3 215.2 164.4 152.7 106.4 244.5 117.8 175.4 187.8 181.2 89.3 133.7 104.2 174.3 150.1 239.2 246.8 432.1 164.0 207.5 227.6 178.4 201.6 287.4 156.1 157.9 203.2 277.3 84.7 166.6 140.9 765.7 161.5 513.1 102.5 114.2 120.9 501.2 229.8 213.5 88.6 119.8 173.6 140.1 426.1 187.4 177.1 575.7 116.5 92.6 142.7 88.8 103.3 303.4 379.8 128.0 157.8 268.5 73.2 96.2 241.4 346.2 131.6 178.8 140.4 259.1 170.7 164.1 229.7 264.1 186.5 154.9 47.5 86.5 170.9 455.8 179.6 307.4 57.4 57.9 65.3 62.5 55.8 66.1 60.6 60.8 55.2 63.5 59.2 61.5 62.6 102.6 83.3 183.4 13.7 324.8 141.4 205.5 249.3 132.6 125.3 207.8 199.9 91.6 198.8 178.0 185.8 110.5 497.7 396.6 210.1 93.9 239.5 7.7 142.1 84.9 114.9 197.9 134.4 14.4 211.8 405.3 118.3 131.5 149.9 88.8 164.4 146.3 346.6 373.1 80.8 20.6 280.6 343.8 306.9 192.6 16.6 128.9 230.4 168.9 12.2 269.0 152.8 160.6 11.6 22.8 128.7 288.0 106.8 350.1 195.4 355.5 274.6 187.0 164.9 52.6 79.2 112.2 100.3 195.3 143.1 161.0 441.6 221.7 252.4 285.2 219.8 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 19.7;skeletal muscle: 37.3;tongue: 57.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.1 0.1 12.6 0.5 10.8 0.2 0.1 5.7 7.0 0.2 0.8 1.5 0.1 0.1 0.2 0.8 0.3 0.0 0.0 4.0 11.4 1.3 0.0 0.8 0.1 10.7 11.2 3.0 0.0 1.4 0.0 0.9 0.0 12.4 0.9 0.4 0.3 3.4 0.1 37.3 1.7 0.4 0.3 2.1 0.0 0.2 0.5 19.7 0.0 0.1 57.7 0.1 0.0 0.7 12.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 9.4 0.0 5.8 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 12.6 10.8 5.7 7.0 4.0 11.4 10.7 11.2 3.0 12.4 2.1 19.7 12.5 0.0 0.0 0.0 1.3 0.0 3.8 10.0 2.4 4.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.0 3.0 5.1 0.4 3.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 8.4 0.0 0.0 18.2 0.0 0.0 0.0 32.1 0.2 0.0 0.3 0.7 0.6 0.3 0.2 1.8 1.9 0.0 0.0 0.0 48.2 5.7 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.1 1.8 0.1 0.6 0.0 0.2 0.0 0.0 1.0 FUS "ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS" ENSG00000089280 "FUS RNA binding protein" P35637 16 31180138-31191605 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008784, CAB033036, CAB058691" Supported Supported Nucleoplasm NA NA 480000 Nucleoplasm "CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181" "unprognostic (3.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.86e-2)" "unprognostic (8.68e-2)" "unprognostic (1.44e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.22e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-3)" "unprognostic (1.12e-3)" "unprognostic (1.87e-1)" "unprognostic (5.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 89.4 48.0 46.5 103.9 48.3 99.7 65.7 50.8 59.7 85.0 29.2 73.1 60.1 102.8 41.3 58.9 100.0 39.2 71.0 48.7 47.0 61.6 54.7 65.4 98.7 45.7 46.3 44.2 135.4 57.8 85.7 47.6 58.8 46.9 59.6 63.4 59.9 60.5 71.1 99.6 52.9 63.1 99.0 43.3 69.9 59.9 69.7 45.4 175.7 59.2 86.7 114.1 88.3 63.8 56.4 386.6 337.2 492.6 292.9 128.3 101.7 429.3 504.1 253.1 319.6 238.3 440.7 254.9 579.6 359.3 310.7 349.4 173.0 563.6 421.0 284.3 341.5 304.7 486.6 224.6 445.3 222.7 529.7 348.5 222.4 99.8 437.5 258.9 120.1 295.7 419.6 537.6 204.7 357.0 483.0 446.2 475.5 649.0 307.7 402.0 677.0 535.9 350.1 344.0 265.6 279.1 478.9 344.5 255.7 267.8 314.9 291.8 597.5 276.3 371.5 365.5 242.1 520.5 181.4 350.4 779.0 204.4 364.2 460.9 12.3 38.2 52.8 53.6 67.3 49.9 29.1 36.5 45.9 41.7 35.2 40.3 43.9 35.0 37.3 59.3 50.3 31.0 27.4 46.5 48.3 50.8 59.7 48.7 47.0 45.7 46.3 44.2 46.9 43.3 45.4 56.4 414.6 102.5 121.2 58.1 470.7 144.8 345.7 201.0 507.6 272.6 209.8 223.8 102.1 112.9 156.3 104.8 131.3 299.3 488.8 266.8 68.4 183.6 130.8 201.0 366.1 278.4 212.1 188.2 75.4 154.8 398.5 309.0 222.8 309.7 229.7 445.0 174.2 59.1 208.5 201.9 85.9 229.5 132.2 148.4 270.7 51.2 307.3 282.7 165.4 94.6 185.4 230.8 341.9 117.6 122.2 175.7 219.4 215.5 266.6 245.4 205.4 69.7 115.4 266.3 164.3 584.4 344.2 221.0 237.1 443.6 154.3 295.1 518.2 327.9 232.6 281.2 IGBP1 "α4, IBP1" ENSG00000089289 "Immunoglobulin binding protein 1" P78318 X 70133447-70166324 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "B-cell activation" Chaperone "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 342.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000634, HPA001004, CAB034139" Approved Approved Cytosol NA NA 48000 Cytosol "CAB034139: AB_2295670, HPA000634: AB_1079102, HPA001004: AB_1079104" "unprognostic (3.59e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (5.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.11e-2)" "unprognostic (4.84e-3)" "unprognostic (2.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (1.74e-1)" "unprognostic (3.00e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (1.42e-2)" "unprognostic (4.10e-3)" 54.7 43.6 40.6 30.0 41.6 58.0 55.7 41.9 46.2 67.5 40.6 58.4 58.3 53.8 62.5 47.0 74.2 48.7 53.4 40.1 42.4 58.5 29.6 36.9 59.9 42.6 41.5 39.0 120.1 119.6 39.0 35.9 37.9 42.4 42.6 56.7 30.4 65.0 32.4 118.9 62.5 58.8 42.8 44.9 41.1 70.7 18.9 41.7 68.8 57.9 100.8 70.0 52.8 55.0 44.5 42.7 48.9 30.9 35.9 122.2 163.3 44.5 35.6 99.6 47.9 57.1 45.5 55.7 79.1 58.7 62.0 62.6 57.1 73.8 59.1 60.8 31.4 53.2 25.1 52.7 82.9 83.6 59.4 43.9 158.1 143.1 44.3 63.2 166.6 81.8 57.9 51.4 69.5 52.6 42.7 48.7 100.4 37.5 98.0 73.6 42.3 65.0 79.5 77.8 67.2 35.4 43.4 46.3 40.0 87.0 56.4 21.3 61.1 65.8 25.8 40.2 46.0 27.2 65.0 53.7 40.1 36.4 50.5 31.1 51.4 46.1 41.8 34.1 46.0 40.9 50.9 47.4 45.2 51.1 41.8 53.7 48.9 31.4 39.8 39.0 25.6 75.2 48.0 40.6 41.6 41.9 46.2 40.1 42.4 42.6 41.5 39.0 42.4 44.9 41.7 44.5 50.1 32.1 54.7 12.1 79.3 100.1 114.2 163.9 82.0 21.5 81.4 82.2 75.8 70.1 85.6 27.6 8.4 123.8 45.3 91.3 103.7 80.3 126.3 58.0 61.1 64.1 69.9 38.9 19.3 143.2 129.0 62.2 46.9 57.9 34.8 90.8 85.3 20.9 82.7 6.7 19.5 128.0 69.2 123.1 89.6 121.5 81.4 75.6 49.8 15.0 119.8 48.9 90.6 13.6 27.6 86.4 153.1 61.7 52.9 70.8 342.0 182.0 57.8 23.6 26.3 62.3 63.0 12.2 25.0 76.2 120.3 124.9 81.9 96.1 128.4 130.4 FXYD5 OIT2 ENSG00000089327 "FXYD domain containing ion transport regulator 5" Q96DB9 19 35154730-35169881 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 462.9;Hofbauer cells: 430.3;Langerhans cells: 492.1;Pancreatic endocrine cells: 585.0;T-cells: 459.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010817 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010817: AB_1849214" "unprognostic (3.97e-3)" "unprognostic (5.49e-2)" "unprognostic (6.37e-3)" "unprognostic (3.01e-1)" "unprognostic (2.50e-3)" "unprognostic (4.39e-3)" "unprognostic (4.68e-2)" "unprognostic (1.56e-3)" "unprognostic (3.85e-1)" "unprognostic (5.66e-3)" "unprognostic (4.78e-2)" "unprognostic (4.75e-2)" "prognostic unfavorable (3.71e-9)" "unprognostic (6.07e-2)" "unprognostic (7.88e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" 192.5 39.5 28.0 132.0 29.6 277.7 172.6 29.8 47.6 186.5 42.5 57.5 28.8 76.1 20.3 117.1 104.6 69.4 79.7 27.3 32.4 41.4 40.5 149.8 188.9 38.9 29.9 24.2 28.9 28.3 17.4 40.1 92.5 35.5 69.4 43.7 3.5 70.9 47.0 28.8 84.7 107.5 60.3 33.2 240.3 68.5 9.2 37.3 85.8 59.7 32.8 189.3 105.7 185.3 38.4 932.2 216.7 0.2 0.9 310.5 390.2 213.6 521.7 686.4 362.8 269.3 61.9 263.6 212.9 139.3 632.2 130.3 212.3 132.5 321.3 231.4 265.7 87.9 397.7 111.8 0.5 244.3 228.6 378.0 233.6 141.6 265.3 452.2 213.2 348.5 58.0 380.0 989.0 229.5 1.5 27.4 95.1 66.4 853.4 126.0 127.6 45.0 272.7 134.0 5.2 38.8 0.3 287.1 148.6 316.6 115.0 78.0 180.4 494.8 443.6 170.0 487.7 40.2 1.5 16.2 54.4 675.9 524.8 694.4 644.0 596.4 111.1 451.5 628.4 422.0 602.8 756.5 467.4 718.7 545.6 489.2 405.6 140.1 840.8 636.9 325.0 894.6 934.1 28.0 29.6 29.8 47.6 27.3 32.4 38.9 29.9 24.2 35.5 33.2 37.3 38.4 291.0 3.2 13.4 0.0 330.7 107.1 73.4 106.3 54.1 0.6 80.2 51.2 5.2 32.9 27.8 99.3 0.0 18.9 349.7 2.9 0.0 156.1 1.7 3.4 63.5 276.5 10.7 111.2 2.2 197.3 462.9 93.1 71.9 2.2 361.5 0.3 323.8 6.1 430.3 0.0 0.4 8.2 4.1 385.9 492.1 4.6 6.5 403.9 209.9 10.3 243.7 0.4 260.6 1.0 0.1 585.0 7.8 0.7 302.5 72.2 0.2 4.4 5.5 0.4 65.7 5.7 107.6 1.6 8.1 24.0 69.2 50.9 459.5 0.7 10.0 100.3 ZNF302 "ZNF135L, ZNF140L, ZNF327" ENSG00000089335 "Zinc finger protein 302" Q9NR11 19 34677639-34686397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 204.9;choroid plexus: 121.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059503 Approved "Vesicles,Cytokinetic bridge" Yes No "Vesicles, Cytokinetic bridge" "HPA059503: AB_2684043" "unprognostic (3.52e-1)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.25e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-3)" "unprognostic (1.82e-2)" "unprognostic (4.63e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (2.34e-1)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "prognostic favorable (9.85e-5)" 13.9 18.3 119.9 10.3 122.4 4.6 24.2 123.2 204.9 16.4 121.8 17.8 12.5 19.7 21.8 9.2 18.7 11.2 25.5 119.5 120.5 16.6 19.2 14.7 17.9 121.1 121.8 118.4 28.3 24.6 21.7 16.8 12.0 121.9 18.1 15.5 45.6 13.6 19.0 37.5 12.9 15.8 14.9 121.3 19.5 15.0 15.7 121.2 17.4 19.3 30.7 16.8 18.1 12.2 127.7 10.5 16.0 33.3 13.2 30.8 23.6 11.6 17.8 21.8 16.0 17.3 11.9 9.5 16.3 21.7 13.5 12.0 8.5 16.3 10.4 17.1 1.3 13.6 31.2 18.0 0.3 16.5 0.3 2.4 22.3 15.0 9.9 1.8 20.0 13.8 11.4 0.3 0.9 25.2 5.5 16.9 16.7 15.1 18.9 10.6 12.5 27.0 9.1 16.9 14.0 14.8 24.1 16.2 6.0 21.9 17.7 12.7 24.8 13.6 7.4 17.6 6.8 8.9 18.6 35.1 5.1 6.8 2.4 33.9 28.1 10.1 17.2 14.9 10.0 20.7 23.3 17.0 14.0 8.8 25.0 28.0 22.3 7.5 19.4 13.4 20.3 14.9 9.1 119.9 122.4 123.2 204.9 119.5 120.5 121.1 121.8 118.4 121.9 121.3 121.2 127.7 32.2 28.9 27.6 41.8 33.2 26.8 34.0 16.0 19.9 56.5 24.4 30.9 58.9 25.8 22.1 22.0 52.1 16.8 26.6 10.4 45.0 17.5 31.3 12.7 29.7 34.3 19.9 20.8 41.5 11.4 6.8 41.0 21.4 11.8 29.1 63.0 28.5 11.8 10.1 48.8 42.4 13.4 14.2 14.5 44.9 6.3 59.4 15.7 24.9 29.0 17.8 73.5 42.2 54.8 76.1 10.0 16.4 51.1 14.8 40.1 20.6 14.3 25.6 88.8 52.6 73.5 40.5 67.0 40.2 15.7 21.5 5.5 29.3 44.8 11.6 30.8 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 34.7 37.2 16.3 28.3 14.1 24.1 31.3 14.4 24.7 30.5 16.4 25.8 15.2 32.8 5.4 11.7 36.5 16.6 29.9 14.6 15.7 27.6 21.3 58.6 29.0 19.3 17.5 13.4 38.7 81.5 17.9 29.4 17.0 20.7 32.9 8.5 5.2 56.1 17.2 48.2 13.7 23.5 19.1 14.8 42.5 36.1 16.7 18.0 18.9 25.6 19.1 13.0 36.0 20.3 22.2 17.3 106.0 21.3 41.5 23.9 27.5 19.6 21.6 27.5 21.8 21.6 39.8 11.9 10.8 41.2 25.2 19.3 9.5 22.2 31.9 8.2 48.9 47.3 24.6 25.5 36.8 48.3 21.7 41.1 46.5 19.9 16.1 26.7 36.6 71.5 54.1 31.8 5.7 16.0 13.2 46.5 23.6 38.6 28.4 12.7 47.1 6.9 10.7 24.8 2.5 30.8 64.4 20.0 12.7 33.7 18.4 19.4 20.6 38.9 34.9 22.3 8.0 29.6 8.8 26.3 22.4 23.5 19.6 27.0 23.1 5.7 5.4 3.5 9.6 7.3 0.6 4.6 2.7 5.1 1.2 3.5 5.4 12.7 5.7 19.9 1.7 4.1 3.8 16.3 14.1 14.4 24.7 14.6 15.7 19.3 17.5 13.4 20.7 14.8 18.0 22.2 51.0 22.4 37.3 28.1 23.6 20.8 64.4 15.1 18.2 15.8 22.0 18.7 12.3 0.0 16.1 16.5 16.7 13.1 32.3 3.5 3.9 36.8 1.4 15.3 19.9 63.2 39.4 20.4 8.9 57.8 35.8 25.6 10.7 16.5 9.5 39.5 66.4 5.6 53.8 8.4 12.1 15.0 14.2 39.4 81.6 3.0 25.7 37.7 33.8 15.0 146.0 23.1 19.6 12.5 15.1 41.2 9.6 25.2 40.4 68.6 1.4 15.1 11.5 14.9 13.1 15.4 26.0 1.2 5.7 3.4 15.3 33.1 48.1 50.6 19.7 51.9 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1816.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7" HPA010856 Supported Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 4.5 1.1 6.7 60.1 6.7 1.3 227.5 6.7 8.0 107.7 6.5 1479.8 103.6 13.3 15.4 690.8 105.2 101.5 4.0 6.4 5.9 11.7 2.1 151.5 0.8 7.6 7.2 5.6 1.8 64.9 0.1 24.9 85.6 6.4 516.4 1816.9 45.8 573.8 33.6 2.1 561.6 311.4 36.0 6.3 0.6 577.5 0.6 6.4 18.9 1.5 0.1 164.7 298.3 399.1 7.0 166.3 0.0 0.0 0.4 0.6 0.4 150.5 0.0 0.0 0.0 0.0 6.0 235.3 0.3 0.5 0.0 1.3 896.3 0.1 339.5 0.0 0.1 0.3 1.0 7.7 0.6 0.1 0.1 0.6 0.0 1603.2 0.0 0.7 0.1 0.1 0.1 0.1 1.1 0.0 304.5 0.8 2.2 0.8 3112.0 1.4 0.8 0.4 1.2 0.0 860.2 190.2 2.1 1.0 830.8 61.8 2.3 155.9 0.2 0.0 0.3 0.6 0.9 0.7 0.1 0.4 0.7 1.0 0.3 589.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 6.7 6.7 6.7 8.0 6.4 5.9 7.6 7.2 5.6 6.4 6.3 6.4 7.0 3.1 762.8 262.6 0.3 11.1 576.9 792.9 1870.8 340.4 2.9 557.5 515.7 1.3 201.6 1026.4 134.3 0.0 883.5 8.3 5605.4 1.9 35.6 0.4 180.1 29.5 19.7 974.3 2.7 0.1 708.4 138.1 20.3 356.8 194.1 22.3 0.0 0.0 0.9 81.4 1.7 0.0 2165.8 587.9 0.0 68.3 0.0 0.0 15.6 412.6 0.0 1.6 422.1 0.0 0.0 0.6 556.5 3324.0 0.0 6.5 1041.7 1693.0 0.5 1627.1 13.3 0.0 0.5 66.5 0.2 0.2 541.1 865.5 1512.1 17.9 0.0 1499.3 1509.9 HEPH "CPL, KIAA0698" ENSG00000089472 Hephaestin Q9BQS7 X 66162549-66268867 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 82.7;smooth muscle: 83.4" "Cell type enhanced" "Detected in many" "Astrocytes: 78.0;Distal enterocytes: 211.0;Intestinal goblet cells: 95.6;Paneth cells: 96.9;Proximal enterocytes: 156.2;Undifferentiated cells: 72.4" "Cancer enhanced" "Detected in all" "colorectal cancer: 37.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 28.5;HEL: 25.4;HSkMC: 36.0;K-562: 72.5;LHCN-M2: 28.5;SuSa: 68.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA005824 Approved NA NA 3700000 "HPA005824: AB_1850603" "unprognostic (3.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.25e-2)" "unprognostic (4.25e-2)" "unprognostic (1.29e-3)" "unprognostic (2.25e-1)" "unprognostic (4.94e-2)" "unprognostic (6.17e-2)" "unprognostic (1.40e-2)" "unprognostic (3.35e-1)" "unprognostic (2.40e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (3.08e-2)" "unprognostic (4.46e-2)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" 8.3 19.2 18.5 14.8 23.1 0.0 8.4 21.8 19.3 24.0 10.6 82.7 79.7 35.0 14.5 12.0 14.3 39.0 36.3 16.8 20.0 8.2 3.5 12.4 3.6 23.0 24.3 14.9 22.3 2.3 1.5 3.7 1.4 21.2 24.5 78.4 15.1 7.7 32.1 0.9 4.6 82.3 83.4 18.1 11.2 12.5 3.5 21.6 1.3 5.1 3.2 2.6 19.7 10.1 21.7 0.0 0.0 28.5 2.3 0.0 0.1 0.8 7.3 0.4 0.0 0.0 17.4 0.0 0.0 0.1 15.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 25.4 0.0 0.0 0.3 0.2 0.1 36.0 0.0 0.0 0.0 9.9 0.0 0.0 72.5 0.6 28.5 0.0 0.0 0.6 14.1 4.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 68.6 0.0 0.0 0.7 16.2 1.2 0.1 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 23.1 21.8 19.3 16.8 20.0 23.0 24.3 14.9 21.2 18.1 21.6 21.7 2.5 0.0 0.0 78.0 0.5 0.9 0.0 0.0 0.0 1.0 0.9 6.0 24.1 0.0 0.0 0.0 0.0 0.0 0.1 211.0 0.0 0.3 0.6 1.3 15.1 4.1 40.8 0.0 0.3 1.1 0.0 12.6 0.0 1.2 0.0 1.1 6.4 0.0 0.2 0.0 2.9 95.6 0.0 0.0 1.9 1.5 11.5 0.3 0.0 6.5 0.0 26.1 0.0 3.5 36.2 5.0 96.9 29.7 0.0 0.3 156.2 0.0 0.7 1.3 6.6 4.4 9.8 0.0 0.3 0.3 0.6 0.0 0.5 6.9 72.4 0.2 CDIP1 "C16orf5, CDIP, LITAFL" ENSG00000089486 "Cell death inducing p53 target 1" Q9H305 16 4510669-4538828 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 59.4;RPMI-8226: 68.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049352 Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA049352: AB_2680724" "unprognostic (6.38e-3)" "unprognostic (3.70e-3)" "unprognostic (2.95e-2)" "unprognostic (2.50e-3)" "unprognostic (2.74e-2)" "unprognostic (2.56e-2)" "unprognostic (3.48e-1)" "unprognostic (8.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.14e-5)" "unprognostic (9.05e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.43e-2)" "unprognostic (3.51e-2)" "unprognostic (9.88e-2)" "unprognostic (4.65e-2)" 19.0 43.5 18.1 5.1 21.4 2.1 18.6 12.5 65.6 26.4 0.0 21.9 14.6 30.2 1.0 22.5 24.9 8.0 48.6 17.4 10.6 49.6 44.5 14.6 5.5 14.5 14.3 14.2 34.3 38.2 7.2 65.7 5.3 15.9 25.5 2.6 6.9 14.1 11.0 41.4 17.6 26.2 7.1 4.5 20.2 21.6 28.9 19.9 11.6 24.4 8.5 4.0 20.4 20.2 27.1 10.6 3.6 14.0 3.0 1.7 0.0 0.4 14.9 2.3 11.5 10.6 22.6 2.2 0.7 12.2 10.8 4.6 0.8 12.8 41.9 3.0 27.6 25.8 40.7 12.9 59.4 10.5 20.5 21.0 10.5 44.7 10.2 3.4 3.4 9.6 13.1 1.2 9.1 14.5 1.3 15.0 19.2 19.9 10.6 10.1 50.1 12.8 68.3 3.0 0.5 27.9 13.6 24.2 1.4 16.6 7.2 4.4 13.4 0.8 5.5 16.3 7.7 0.7 27.5 29.1 37.9 0.5 16.7 4.7 4.5 5.8 14.4 11.7 9.0 6.9 6.4 4.1 7.3 5.7 5.7 9.0 6.8 5.0 12.0 17.7 6.6 7.0 5.9 18.1 21.4 12.5 65.6 17.4 10.6 14.5 14.3 14.2 15.9 4.5 19.9 27.1 27.1 16.0 7.0 28.7 19.4 29.6 21.5 25.4 38.1 63.5 7.7 14.4 26.5 7.2 9.0 16.5 12.5 1.8 16.3 12.1 52.8 13.0 90.9 1.5 18.7 20.3 9.6 7.2 23.5 9.2 1.6 15.4 7.7 2.9 22.9 11.3 25.7 18.5 19.6 70.7 26.4 6.1 14.2 12.2 11.7 25.4 18.0 17.5 14.2 8.4 7.1 41.4 45.3 9.5 14.7 8.2 13.2 16.6 24.1 13.3 39.6 65.0 0.9 16.1 6.6 8.4 11.3 21.1 27.7 15.2 14.9 6.7 22.9 13.7 6.7 11.5 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 31.5" "Group enriched" "Detected in some" 4 "Early spermatids: 75.5;Late spermatids: 144.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 8.7;eosinophil: 6.2;neutrophil: 7.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "REH: 19.8" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 1.0 1.1 1.3 2.5 1.2 0.3 0.5 1.0 1.8 1.1 0.1 1.3 2.0 1.5 0.4 0.7 1.1 1.8 0.5 0.7 1.2 0.8 0.5 1.3 1.7 1.7 0.6 0.2 1.9 0.6 1.1 0.8 1.2 1.8 0.7 0.5 0.9 1.0 0.5 0.4 0.9 1.5 0.6 0.8 3.2 1.2 31.5 0.9 2.7 1.0 0.5 1.0 0.9 0.9 3.6 5.1 7.8 1.4 6.4 2.7 2.5 1.4 6.5 3.0 5.1 5.2 1.6 3.3 2.3 3.3 1.9 1.6 3.9 2.2 0.4 2.7 8.8 1.5 0.9 3.7 1.7 1.2 4.7 5.6 2.2 0.6 4.6 0.5 7.7 2.7 4.6 4.2 3.1 2.2 1.9 8.9 4.5 1.1 0.7 2.8 19.8 16.3 5.5 4.5 2.3 3.6 4.8 9.0 0.7 2.2 0.2 2.3 3.3 6.6 8.9 14.1 5.5 2.8 3.1 8.3 8.7 4.3 6.3 10.7 8.7 1.7 6.2 1.4 0.5 1.2 0.1 0.4 0.7 1.6 0.2 0.4 0.4 7.0 1.2 1.1 0.5 0.5 1.0 1.3 1.2 1.0 1.8 0.7 1.2 1.7 0.6 0.2 1.8 0.8 0.9 3.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 75.5 0.0 0.1 0.2 0.0 2.7 0.0 0.2 0.2 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 144.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.1 26.5 0.4 0.0 0.3 0.1 0.4 0.1 0.0 0.1 KCNH4 "elk1, Kv12.3" ENSG00000089558 "Potassium voltage-gated channel subfamily H member 4" Q9UQ05 17 42156891-42181142 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 11.8" "Cell type enhanced" "Detected in some" "Astrocytes: 1.6;Excitatory neurons: 6.8;Inhibitory neurons: 1.5;Ionocytes: 2.0;Microglial cells: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.6;K-562: 4.4;RPMI-8226: 8.1;RT4: 3.0;U-266/70: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.07e-3)" "unprognostic (1.02e-2)" "unprognostic (4.02e-2)" "unprognostic (1.70e-1)" "unprognostic (9.30e-2)" "unprognostic (2.08e-3)" "unprognostic (4.59e-3)" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (9.92e-2)" "unprognostic (4.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.36e-6)" "unprognostic (9.52e-2)" "unprognostic (2.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.72e-3)" 0.3 0.1 0.5 0.5 11.8 0.1 0.3 0.0 3.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.6 2.0 0.0 0.0 0.0 0.2 3.8 0.1 1.7 0.0 0.0 0.0 0.2 0.0 3.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.2 1.7 0.0 0.0 0.1 0.2 1.5 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.6 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.4 0.7 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 8.1 0.0 3.0 1.8 1.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.8 0.0 3.2 0.6 2.0 3.8 0.1 1.7 3.8 0.0 1.7 0.2 0.5 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.5 0.0 2.0 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 GANAB "G2AN, GIIA, GluII, KIAA0088" ENSG00000089597 "Glucosidase II alpha subunit" Q14697 11 62624826-62646726 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026874, HPA061426" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 23000000 "Endoplasmic reticulum" "HPA026874: AB_1849745, HPA061426: AB_2684516" "unprognostic (2.12e-1)" "unprognostic (5.95e-3)" "unprognostic (4.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-2)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (5.80e-3)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.01e-3)" "unprognostic (3.81e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.54e-4)" 94.7 74.5 32.4 89.0 34.1 84.4 93.7 37.3 37.0 113.6 49.5 105.7 96.4 103.1 153.0 67.0 107.9 76.0 68.5 30.5 45.5 99.4 173.1 87.6 82.4 38.7 36.0 29.4 116.6 88.9 131.6 21.9 143.0 37.5 98.4 117.9 80.1 102.7 112.1 39.8 75.3 91.2 127.1 36.2 87.4 86.0 66.7 38.0 106.2 133.8 53.4 95.6 91.5 34.5 43.5 298.2 245.9 318.2 552.0 464.1 389.0 332.9 312.4 480.4 436.2 362.1 222.2 515.9 201.2 616.0 572.5 337.8 376.4 375.2 376.7 443.8 155.8 191.3 202.9 317.8 125.6 389.0 325.7 248.7 397.2 248.4 433.6 475.3 533.0 422.3 199.6 278.5 352.9 398.2 313.6 167.6 193.4 262.3 236.6 237.7 209.5 368.7 513.1 285.7 230.3 168.6 221.2 451.1 308.2 370.8 321.6 380.9 304.8 311.6 430.0 272.2 342.9 309.9 360.8 423.8 152.2 473.9 173.1 421.7 23.9 19.3 19.1 23.8 23.4 23.1 15.9 17.2 20.0 20.8 14.9 20.9 21.3 8.9 29.8 22.2 18.4 17.3 22.6 32.4 34.1 37.3 37.0 30.5 45.5 38.7 36.0 29.4 37.5 36.2 38.0 43.5 42.7 12.8 20.7 17.3 29.8 28.3 29.4 45.8 13.6 31.4 57.4 53.8 7.8 52.9 24.2 68.0 60.5 81.7 33.4 40.1 5.9 47.0 18.5 31.4 59.1 42.2 31.8 25.0 12.6 42.6 137.3 45.9 27.5 46.5 11.4 72.8 48.2 98.0 57.9 35.3 16.0 48.9 34.6 45.8 25.1 16.4 58.4 32.7 35.6 15.9 38.9 36.5 38.1 11.1 16.5 39.5 29.3 68.1 50.4 34.0 47.8 27.0 26.3 41.4 32.9 36.4 34.7 25.3 47.4 21.2 31.3 80.2 25.2 63.1 56.3 32.4 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643657 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.4;lymphoid tissue: 54.7" "Cell type enhanced" "Detected in many" "B-cells: 26.6;Gastric mucus-secreting cells: 24.5;Hofbauer cells: 22.7;Kupffer cells: 33.3;Macrophages: 26.7;monocytes: 27.6;T-cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 92.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 7.1 3.3 2.7 32.3 3.3 51.4 5.4 2.6 5.5 3.7 4.2 8.1 10.5 3.3 1.4 8.6 5.4 6.0 2.8 3.6 6.3 4.3 4.8 17.0 29.6 6.2 3.4 2.1 2.7 6.0 8.9 3.6 4.6 4.3 5.4 6.6 0.4 6.9 2.8 1.2 6.9 22.8 4.3 4.2 54.7 16.9 2.9 5.9 19.3 8.5 2.0 23.1 8.4 5.4 6.9 9.9 4.5 5.9 6.5 6.4 3.3 23.5 6.1 5.2 3.6 3.4 3.6 13.0 24.1 12.1 4.3 4.7 11.5 3.9 6.7 2.3 8.3 6.1 7.6 7.1 4.0 1.9 21.7 92.0 4.2 4.5 3.9 2.0 4.2 8.2 21.1 5.3 8.5 3.9 14.6 13.7 35.8 3.5 12.7 8.1 23.3 2.6 14.0 6.9 23.3 5.1 15.2 8.4 8.7 3.7 4.5 8.0 30.7 15.0 6.6 3.8 7.6 4.6 4.3 1.9 19.8 4.2 28.0 4.6 7.0 19.5 51.9 13.2 23.7 12.3 12.6 8.4 11.9 15.1 12.8 8.9 9.7 71.8 9.7 33.1 13.5 10.0 12.5 2.7 3.3 2.6 5.5 3.6 6.3 6.2 3.4 2.1 4.3 4.2 5.9 6.9 1.7 0.0 10.2 0.3 26.6 1.1 1.7 2.5 1.2 0.0 1.9 1.3 0.9 2.8 3.1 0.0 0.0 0.6 14.9 21.2 0.0 4.1 0.1 1.4 0.9 1.8 0.0 1.3 2.1 4.7 5.3 0.9 24.5 4.0 7.0 3.5 2.5 1.6 22.7 0.0 2.1 6.6 0.0 33.3 6.6 0.4 0.6 26.7 1.8 6.5 27.6 0.4 20.6 0.5 0.2 12.9 20.2 0.7 13.9 2.0 9.3 0.7 1.5 0.1 0.0 0.4 1.6 0.6 1.3 3.5 1.1 0.8 25.8 0.9 6.0 4.1 RBM41 FLJ11016 ENSG00000089682 "RNA binding motif protein 41" Q96IZ5 X 107064420-107118823 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042881 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA042881: AB_10794536" "unprognostic (1.07e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.39e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-2)" "unprognostic (1.98e-2)" "unprognostic (2.19e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "unprognostic (2.80e-2)" "unprognostic (1.92e-1)" 4.6 5.9 3.3 5.0 3.3 3.6 5.7 5.9 3.7 4.2 4.6 5.6 7.8 6.2 6.6 5.7 5.0 4.5 5.6 3.2 2.9 6.9 8.3 4.7 5.9 3.9 3.6 2.5 5.6 4.2 9.4 3.4 5.5 3.5 5.5 6.6 5.9 4.6 5.0 6.4 7.1 7.0 5.7 3.8 5.3 5.0 7.4 3.3 6.7 7.0 8.0 6.2 5.0 4.1 3.9 16.9 13.3 8.4 6.8 5.5 9.5 9.7 9.8 9.6 7.1 9.5 8.9 13.8 9.3 18.0 7.2 12.4 13.7 12.3 9.2 10.8 11.5 18.1 11.3 25.2 11.0 6.2 11.6 8.5 6.7 17.7 8.6 8.6 9.9 10.8 8.5 19.8 12.5 8.7 8.2 9.9 6.6 12.4 9.3 15.1 7.9 7.0 8.0 10.5 10.5 6.9 10.9 12.2 8.7 7.9 11.4 8.0 5.4 10.6 9.8 5.7 11.7 7.8 5.8 11.6 9.9 5.5 5.2 7.6 10.5 5.2 8.3 4.5 2.7 2.7 5.1 3.9 4.6 3.5 4.3 2.9 1.9 0.7 6.6 2.9 3.6 3.9 2.3 3.3 3.3 5.9 3.7 3.2 2.9 3.9 3.6 2.5 3.5 3.8 3.3 3.9 9.6 12.8 17.0 29.0 11.6 5.2 6.6 8.5 12.0 20.3 7.6 6.7 23.2 11.5 8.3 7.3 27.1 8.7 17.4 10.9 1.9 14.8 8.0 27.1 10.1 9.8 7.8 21.0 38.3 7.8 5.3 10.1 8.2 11.6 13.3 19.5 5.3 10.2 6.6 11.8 46.5 8.6 4.1 10.7 4.6 2.3 14.3 12.5 5.4 45.9 11.7 7.4 14.4 50.8 53.4 13.6 11.9 11.7 12.6 5.6 22.0 9.0 13.1 20.2 0.0 14.7 12.4 11.7 8.0 9.0 7.4 4.5 9.7 13.1 11.4 6.2 BIRC5 "API4, EPR-1, survivin" ENSG00000089685 "Baculoviral IAP repeat containing 5" O15392 17 78214186-78225636 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Protease inhibitor, Repressor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.2;lymphoid tissue: 41.3;testis: 19.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 14.1" "Lineage enriched" "Detected in many" 6 "T-cells: 14.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002830, CAB004270" Enhanced Supported "Cytokinetic bridge" Yes Yes "Cytokinetic bridge" "CAB004270: AB_628302, HPA002830: AB_1857672" "unprognostic (8.04e-2)" "unprognostic (3.51e-2)" "unprognostic (4.48e-3)" "unprognostic (2.72e-3)" "unprognostic (3.37e-1)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.28e-6)" "prognostic unfavorable (4.49e-4)" "unprognostic (3.56e-3)" "unprognostic (4.53e-3)" "unprognostic (2.87e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" 0.9 1.1 0.5 8.6 0.6 38.2 5.1 0.6 0.6 1.0 0.4 6.7 7.9 1.6 0.0 12.9 0.6 1.2 0.5 0.4 0.7 0.7 2.1 1.9 16.4 0.6 0.7 0.4 0.4 0.6 0.2 0.2 6.2 0.6 0.6 8.0 0.1 1.8 0.2 1.1 5.9 7.6 4.4 0.5 5.9 3.7 19.7 0.9 41.3 0.5 0.1 16.4 2.6 3.2 1.3 139.1 126.2 111.3 121.5 6.7 11.3 41.0 103.6 57.5 144.0 94.2 104.0 52.9 140.7 41.5 60.5 108.7 71.9 113.6 66.6 125.2 48.2 157.5 93.2 71.4 123.1 0.8 90.8 67.0 3.9 4.5 79.8 59.2 21.0 103.5 104.3 118.8 116.0 112.6 79.7 195.5 86.2 83.4 96.3 218.0 100.5 180.2 108.4 34.5 50.2 136.8 94.8 80.3 88.6 71.7 54.1 117.5 84.8 39.5 173.1 152.6 76.0 150.4 83.3 72.2 163.3 63.3 37.8 154.4 0.0 0.0 0.0 0.7 0.0 0.1 2.4 4.1 2.8 0.8 0.2 0.0 0.4 0.5 2.4 0.0 0.2 14.1 3.1 0.5 0.6 0.6 0.6 0.4 0.7 0.6 0.7 0.4 0.6 0.5 0.9 1.3 1.2 0.0 20.0 0.0 15.9 8.2 3.7 12.2 2.8 0.7 7.7 8.6 2.3 2.8 10.8 0.0 0.0 74.7 3.3 10.7 0.0 2.0 94.1 5.4 5.1 8.8 3.0 166.7 0.4 0.0 162.0 15.1 8.6 6.9 9.5 42.7 12.8 2.7 52.1 0.0 0.2 17.1 10.2 13.7 13.8 68.4 3.1 9.6 1.8 0.0 0.6 0.4 7.2 0.0 0.3 0.4 2.5 0.7 50.2 2.8 3.2 0.1 2.6 0.5 6.6 0.9 15.2 191.1 58.2 31.3 6.5 19.2 10.1 3.4 38.8 6.3 LAG3 CD223 ENSG00000089692 "Lymphocyte activating 3" P18627 12 6772512-6778455 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.8;ovary: 18.8" "Cell type enhanced" "Detected in many" "dendritic cells: 36.7;Leydig cells: 39.1;Peritubular cells: 69.2;T-cells: 63.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 12.6;MAIT T-cell: 10.0;memory CD8 T-cell: 11.0" "Lineage enriched" "Detected in single" 49 "T-cells: 12.6" "Cell line enriched" "Detected in single" 151 "HDLM-2: 147.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002301, HPA013967" Enhanced "Intracellular and membrane" NA NA 13000 "CAB002301: AB_564101, HPA013967: AB_1846277" "unprognostic (9.39e-2)" "prognostic favorable (3.89e-4)" "unprognostic (8.88e-2)" "unprognostic (7.00e-3)" "unprognostic (1.08e-1)" "unprognostic (6.74e-3)" "unprognostic (8.85e-2)" "unprognostic (4.63e-3)" "unprognostic (1.94e-2)" "unprognostic (1.97e-3)" "unprognostic (8.71e-2)" "unprognostic (9.93e-2)" "prognostic unfavorable (4.62e-11)" "unprognostic (3.07e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" "unprognostic (8.19e-3)" 1.1 0.4 0.4 7.4 0.4 1.5 0.9 0.5 0.8 3.1 3.7 3.8 3.4 6.1 2.8 1.3 3.8 1.2 1.0 0.4 0.4 0.6 2.6 2.6 16.3 0.6 0.4 0.3 18.8 0.2 0.1 0.8 0.4 0.5 2.7 2.0 0.8 1.1 7.1 0.2 0.4 6.0 1.9 0.5 23.8 2.2 3.5 0.5 1.7 0.8 0.3 11.0 1.6 3.4 0.9 0.1 0.6 0.8 0.5 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.3 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.1 0.0 147.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.3 0.1 0.2 0.4 0.2 0.5 0.5 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 10.0 0.0 2.4 11.0 0.0 0.0 0.7 4.2 0.0 0.0 0.0 0.2 2.0 1.1 0.4 0.4 0.5 0.8 0.4 0.4 0.6 0.4 0.3 0.5 0.5 0.5 0.9 7.7 0.0 3.3 0.0 1.4 5.1 1.6 0.7 9.6 5.9 12.6 15.5 1.6 0.0 4.3 0.0 10.4 0.3 36.7 2.6 0.0 0.2 0.4 1.2 4.9 4.5 21.7 1.7 0.2 0.0 0.2 7.1 1.5 1.9 0.0 1.0 4.2 3.5 11.5 0.0 0.1 6.3 0.0 4.2 6.2 1.5 39.1 3.3 1.8 0.0 3.4 1.4 2.1 0.0 0.0 0.2 0.8 69.2 10.2 2.4 0.7 0.3 0.3 6.7 6.6 5.9 4.9 0.5 2.4 4.5 3.0 0.1 63.6 0.2 2.9 0.6 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 114.7 200.6 217.7 68.5 230.6 125.0 110.7 211.5 245.6 120.5 211.3 149.1 107.2 149.8 85.9 170.0 121.7 68.8 162.3 232.5 225.5 164.1 301.2 108.0 66.8 212.6 212.2 226.7 117.3 111.9 159.5 146.3 80.1 223.1 143.9 74.8 78.9 132.7 97.2 194.4 143.5 118.7 93.9 209.6 102.3 137.1 98.3 218.7 79.0 115.1 130.3 71.7 136.4 118.5 240.1 222.0 354.3 179.1 294.4 159.3 157.9 283.1 216.6 230.6 318.8 286.9 353.8 195.5 163.1 55.0 265.5 228.1 173.5 220.1 295.3 220.0 274.9 239.3 115.3 174.0 200.7 176.0 128.9 143.0 151.7 240.8 255.2 209.8 257.4 140.7 152.0 152.5 61.8 247.8 320.7 165.7 197.9 554.2 236.1 141.2 102.5 160.2 134.0 310.8 247.7 111.2 224.8 188.8 303.6 203.4 385.8 89.8 186.4 133.7 191.4 279.3 213.5 299.9 80.9 98.2 208.9 259.0 102.2 231.2 259.6 120.3 461.0 82.0 109.9 80.9 85.6 63.7 78.3 134.0 97.6 66.2 75.3 528.0 76.6 129.2 231.6 69.7 115.3 217.7 230.6 211.5 245.6 232.5 225.5 212.6 212.2 226.7 223.1 209.6 218.7 240.1 106.3 38.5 30.9 19.2 77.9 136.5 149.3 230.2 261.2 110.2 157.7 156.3 71.9 92.9 108.7 110.3 41.7 264.3 92.4 120.6 279.7 169.9 12.1 64.6 70.7 86.4 100.7 74.9 36.2 125.9 213.7 100.6 91.7 74.9 84.9 84.1 71.0 168.6 147.7 80.8 32.7 138.6 197.4 57.8 70.6 13.3 114.0 78.9 103.2 13.1 138.9 142.7 39.1 19.1 23.5 153.8 124.7 107.2 108.2 202.6 219.6 324.7 58.6 63.5 52.6 77.1 131.8 96.6 80.8 193.1 125.6 427.6 70.2 138.3 145.0 174.6 OTUB2 "C14orf137, FLJ21916, MGC3102" ENSG00000089723 "OTU deubiquitinase, ubiquitin aldehyde binding 2" Q96DC9 14 94026340-94048930 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 6.4;testis: 14.5" "Group enriched" "Detected in many" 8 "Early spermatids: 641.1;Late spermatids: 1415.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 16.5;Karpas-707: 18.0;OE19: 18.1;RPTEC TERT1: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002329, HPA075090" Enhanced NA NA "HPA002329: AB_1079537, HPA075090: AB_2686734" "unprognostic (6.80e-3)" "unprognostic (1.39e-3)" "unprognostic (3.68e-3)" "unprognostic (4.82e-3)" "unprognostic (1.66e-1)" "unprognostic (2.20e-1)" "unprognostic (2.30e-3)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (3.09e-3)" "unprognostic (2.80e-2)" "unprognostic (1.16e-2)" "unprognostic (6.25e-3)" "unprognostic (1.15e-1)" "unprognostic (2.06e-2)" "unprognostic (1.02e-4)" "unprognostic (3.16e-1)" 0.3 0.6 1.3 0.2 1.2 0.2 0.8 1.4 1.3 1.3 0.2 0.5 0.3 0.8 0.3 3.8 0.6 0.4 0.1 1.0 0.8 0.6 0.8 0.4 0.3 0.3 1.3 1.2 0.7 0.7 1.9 0.2 1.8 0.5 0.6 0.8 0.6 0.7 0.2 0.1 6.4 0.3 0.3 0.2 0.2 0.5 14.5 2.7 0.1 0.2 0.0 0.8 0.9 1.5 0.8 1.3 3.7 2.4 2.3 0.9 0.7 2.6 0.5 0.3 1.4 2.1 0.8 5.9 0.3 2.2 0.6 16.5 0.3 3.2 1.7 1.1 0.9 1.5 0.1 0.4 3.9 1.3 0.0 0.6 0.6 2.1 0.5 0.9 1.8 1.6 3.3 0.1 18.0 0.7 1.3 0.1 0.4 0.7 18.1 3.1 0.1 0.2 1.0 11.2 1.7 1.8 1.3 0.7 0.8 1.9 1.6 6.3 0.8 1.7 0.9 2.8 0.7 1.0 3.0 2.2 0.0 1.7 0.9 1.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.3 1.2 1.4 1.3 1.0 0.8 0.3 1.3 1.2 0.5 0.2 2.7 0.8 0.5 0.0 0.5 0.7 0.2 0.1 0.7 4.0 0.6 1.5 1.1 1.1 0.5 0.0 2.4 0.0 0.0 4.2 0.1 1.9 1.9 4.3 641.1 6.4 2.8 0.9 0.0 2.7 1.9 1.6 1.5 0.6 4.6 24.8 0.0 2.2 0.4 0.9 1.4 0.0 1.3 1.4 2.0 1.2 1.3 1415.3 6.8 2.4 0.0 0.0 0.4 0.5 0.0 0.5 0.6 5.2 1.3 3.4 0.1 0.3 0.5 1.5 1.8 1.4 6.6 0.6 0.6 9.2 4.3 2.0 2.3 117.5 1.0 2.2 1.0 2.4 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048287-94081212 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 80.8 131.6 26.0 4.0 27.3 23.7 75.8 28.6 29.5 79.1 26.5 75.0 3.8 93.9 37.5 49.3 82.1 6.7 112.0 27.2 26.6 56.7 43.8 70.0 10.5 33.7 28.0 27.5 88.0 50.2 7.1 109.8 2.8 28.0 70.5 3.9 8.1 54.3 5.0 124.9 66.7 60.1 4.1 26.7 76.5 66.6 115.2 28.9 8.0 74.1 4.3 9.1 80.9 66.5 30.5 6.5 1.8 11.5 7.5 6.8 8.8 2.7 17.6 14.5 22.4 20.0 2.2 4.0 29.8 6.4 3.9 6.7 4.1 11.9 1.1 24.5 13.0 0.7 15.8 4.3 9.9 5.7 23.0 6.8 1.4 6.6 4.1 3.9 7.5 3.7 5.6 8.5 8.2 9.6 18.2 7.0 19.6 7.6 1.9 0.2 9.3 26.6 3.5 17.0 2.4 9.1 8.4 17.3 4.2 8.5 1.8 6.8 8.1 11.3 6.4 4.4 8.2 5.3 3.4 24.8 31.5 9.2 12.3 5.1 9.5 2.1 1.7 3.0 1.7 0.8 1.7 1.6 1.8 1.2 2.3 3.0 3.0 1.5 3.8 1.8 1.9 2.1 3.0 26.0 27.3 28.6 29.5 27.2 26.6 33.7 28.0 27.5 28.0 26.7 28.9 30.5 164.7 169.9 160.6 45.4 245.9 182.8 186.6 147.4 171.4 184.7 86.6 94.7 228.3 64.3 146.4 147.1 131.3 94.0 332.8 74.1 272.0 147.0 98.2 244.0 248.2 142.2 97.5 75.5 62.9 98.9 72.6 189.0 95.8 201.0 154.9 251.5 109.6 103.4 85.1 232.2 73.6 89.0 118.0 92.1 147.4 67.4 231.5 143.5 99.6 45.0 158.0 133.4 122.6 31.7 56.1 91.0 67.4 244.8 225.6 116.4 70.7 242.3 160.4 200.5 164.3 185.0 198.0 506.5 435.9 127.6 145.6 157.1 342.1 305.9 74.9 123.7 ZBTB25 "C14orf51, KUP, ZNF46" ENSG00000089775 "Zinc finger and BTB domain containing 25" P24278 14 64449106-64505213 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054699 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054699: AB_2682579" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.64e-2)" "unprognostic (1.82e-2)" "unprognostic (1.11e-3)" "unprognostic (5.32e-3)" "unprognostic (4.21e-2)" "unprognostic (2.26e-1)" "unprognostic (7.33e-2)" "unprognostic (1.70e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" "unprognostic (1.04e-1)" 6.7 6.1 7.8 8.3 8.7 7.7 6.2 9.0 8.3 7.3 7.5 6.4 3.6 6.1 8.4 4.1 8.5 5.4 10.3 7.2 7.5 4.8 6.9 6.9 11.2 9.0 7.7 6.4 8.1 6.8 6.2 9.1 4.3 8.0 6.7 5.0 11.2 4.7 4.8 11.3 7.4 7.9 5.6 8.1 8.4 5.2 6.4 8.2 12.9 8.9 8.9 11.2 7.7 6.5 11.5 20.2 8.7 5.6 5.4 8.0 10.0 11.2 3.4 6.1 5.5 7.2 4.0 13.8 14.9 3.9 5.7 6.9 18.1 5.7 5.7 6.7 15.6 1.8 3.4 14.1 1.9 9.2 2.3 7.6 12.8 5.5 5.4 10.7 11.7 5.1 14.0 2.1 23.7 6.6 8.7 8.5 3.5 2.9 7.1 8.9 6.5 6.2 6.4 6.3 9.4 5.5 6.0 7.1 5.3 4.5 5.2 6.8 1.8 5.5 7.5 11.2 3.5 5.2 20.9 5.1 6.7 11.1 3.0 5.7 3.8 2.4 1.6 6.5 1.6 8.6 6.6 9.3 6.4 1.7 3.9 10.7 10.8 2.4 7.0 1.4 2.9 8.9 7.5 7.8 8.7 9.0 8.3 7.2 7.5 9.0 7.7 6.4 8.0 8.1 8.2 11.5 7.2 6.4 13.0 15.3 25.1 7.9 8.4 13.9 12.5 19.4 7.1 7.6 19.2 8.6 7.8 7.3 18.8 7.1 19.3 2.3 9.8 8.5 47.9 15.6 9.4 8.7 3.5 14.1 23.1 6.6 9.8 10.8 6.1 7.6 6.3 11.9 7.1 10.9 10.8 8.4 28.1 2.6 8.2 11.1 19.1 54.1 13.4 12.6 17.8 15.9 10.5 7.5 27.8 26.7 37.0 7.2 3.7 10.9 19.3 6.3 3.8 7.7 15.4 22.4 0.0 12.5 10.2 11.9 11.8 7.7 8.4 4.0 33.2 8.7 4.6 5.9 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097881 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053980: AB_2682331, HPA063300: AB_2684981" "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 10.6 24.0 17.3 11.9 23.7 8.0 13.7 19.2 38.7 15.0 1.0 17.9 15.7 10.3 8.8 12.2 15.7 10.0 12.8 24.7 32.2 16.0 14.6 11.3 8.1 12.6 17.3 26.6 16.3 22.5 27.8 24.9 16.1 15.8 15.9 17.1 42.9 16.0 12.5 8.0 9.4 15.7 11.5 9.7 10.2 16.3 13.7 17.1 14.3 12.7 12.4 10.5 17.0 10.2 47.7 20.4 18.8 12.6 17.6 29.6 22.0 28.2 41.8 26.6 36.1 36.2 40.9 23.1 9.2 7.3 20.9 26.2 14.0 35.2 23.1 31.2 28.2 27.4 11.6 21.2 21.4 26.9 10.7 29.2 28.7 26.3 40.4 48.0 27.7 26.2 15.0 27.3 14.8 38.8 25.8 17.3 2.8 35.1 57.2 15.4 6.8 32.0 9.7 24.6 32.0 20.7 14.3 21.3 29.7 15.9 40.7 10.1 8.9 26.6 16.9 33.3 20.3 30.1 9.4 18.4 19.9 30.6 11.7 26.0 28.8 16.6 36.4 10.9 15.7 12.7 9.8 10.3 11.2 11.9 10.2 12.1 11.0 28.7 10.6 22.7 7.2 16.8 13.0 17.3 23.7 19.2 38.7 24.7 32.2 12.6 17.3 26.6 15.8 9.7 17.1 47.7 18.9 38.5 24.0 11.4 36.1 25.5 22.0 16.0 25.6 49.0 17.5 10.5 10.4 7.2 18.7 23.9 27.1 14.6 32.9 19.8 25.4 15.3 25.4 11.3 20.9 18.1 16.2 17.0 29.4 16.7 14.5 17.9 17.3 16.1 29.2 33.5 15.4 15.2 13.8 28.6 28.4 16.1 12.2 19.8 39.0 13.7 23.3 22.4 28.4 11.2 14.8 30.7 20.6 14.6 21.3 19.0 16.0 14.7 33.7 21.8 23.9 17.8 13.1 46.3 6.6 17.7 21.3 17.4 22.3 21.0 21.3 22.4 35.6 25.2 14.1 22.0 ARHGAP4 "C1, KIAA0131, p115, RhoGAP4, SrGAP4" ENSG00000089820 "Rho GTPase activating protein 4" P98171 X 153907367-153934999 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 120.1;lymphoid tissue: 121.8" "Cell type enhanced" "Detected in many" "B-cells: 65.3;dendritic cells: 70.0;Hofbauer cells: 86.6;Kupffer cells: 77.2;Macrophages: 76.0;NK-cells: 70.0;T-cells: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 103.0;HL-60: 76.7;Karpas-707: 90.8;MOLT-4: 93.0;RPMI-8226: 180.7;THP-1: 83.7;U-698: 90.4;U-937: 79.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA000301, HPA001012, HPA001083" Enhanced Supported Cytosol NA NA Cytosol "HPA000301: , HPA001012: AB_1078201, HPA001083: AB_1078199" "unprognostic (3.54e-2)" "prognostic favorable (3.94e-5)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.79e-2)" "unprognostic (9.42e-2)" "prognostic favorable (3.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.39e-1)" "unprognostic (3.27e-1)" "unprognostic (1.37e-1)" "unprognostic (7.81e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (8.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 18.5 12.6 4.6 52.7 5.2 120.1 13.6 7.0 6.6 9.0 16.6 13.9 14.3 9.8 3.1 7.1 13.0 14.5 9.8 5.2 9.7 17.7 8.7 36.5 74.4 10.1 7.5 3.6 5.4 5.9 1.8 8.6 21.4 7.9 11.2 7.0 1.2 9.2 3.9 4.4 4.9 50.1 6.6 7.2 121.8 12.7 7.3 7.7 43.1 11.0 1.5 34.0 11.7 9.3 9.0 1.5 0.6 1.0 5.9 0.2 0.0 2.5 1.0 0.4 0.1 0.2 0.4 42.8 103.0 5.9 0.1 0.8 1.2 4.6 0.2 0.0 27.8 3.4 44.4 0.5 1.7 3.6 76.7 59.7 0.2 0.4 0.0 0.3 0.5 9.1 22.4 0.5 90.8 0.5 4.6 93.0 1.5 3.7 0.4 0.3 44.6 12.0 180.7 0.4 0.7 8.4 12.1 0.9 2.1 0.9 1.2 19.0 83.7 1.9 0.3 1.3 0.9 0.5 60.1 55.8 90.4 0.7 79.9 0.2 10.9 26.1 35.4 26.2 42.4 18.6 18.0 18.8 21.1 25.5 16.9 17.4 17.4 22.4 16.0 59.4 31.6 23.5 26.1 4.6 5.2 7.0 6.6 5.2 9.7 10.1 7.5 3.6 7.9 7.2 7.7 9.0 16.0 9.6 22.7 2.6 65.3 3.4 0.6 0.2 0.0 13.7 2.4 6.1 48.3 1.5 2.7 18.4 4.2 1.9 70.0 9.5 5.9 0.9 0.1 2.4 1.4 13.0 4.8 11.3 2.1 0.6 1.9 3.5 7.1 1.5 34.2 7.7 4.2 0.5 86.6 3.3 1.4 6.6 0.0 77.2 31.5 0.2 0.9 76.0 10.6 19.7 42.5 1.9 70.0 2.0 0.7 0.2 0.5 0.0 32.9 0.5 3.0 0.8 8.7 4.6 0.0 7.1 2.6 0.7 5.2 1.6 1.7 1.4 69.5 1.1 5.0 0.4 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;liver: 10.7;testis: 14.1" "Cell type enhanced" "Detected in some" "Astrocytes: 12.1;Excitatory neurons: 24.7;Extravillous trophoblasts: 19.1;Inhibitory neurons: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.9;U-266/70: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 0.9 3.7 5.9 0.3 10.7 0.5 0.9 4.3 20.4 1.1 0.3 1.2 0.8 0.8 0.9 0.5 1.4 0.5 0.5 10.8 3.2 2.7 10.7 1.1 0.4 3.2 3.8 9.1 2.0 3.9 0.6 6.5 0.8 5.6 4.2 0.3 2.7 0.9 0.6 1.2 0.5 1.4 0.2 1.2 1.5 1.8 14.1 5.9 0.4 2.8 0.4 0.1 1.0 0.7 10.7 0.1 0.2 0.0 0.1 2.7 0.2 2.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.2 0.1 0.1 0.4 0.0 2.2 0.3 0.0 0.1 0.1 1.5 0.1 0.3 1.5 0.1 0.2 0.7 0.4 0.1 1.7 0.1 4.9 0.0 0.7 0.0 0.1 2.1 0.6 0.6 0.3 0.0 0.4 0.0 0.2 0.8 0.1 0.1 0.1 0.3 0.5 0.6 0.4 0.0 0.1 1.0 0.8 0.0 16.2 1.5 0.1 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 10.7 4.3 20.4 10.8 3.2 3.2 3.8 9.1 5.6 1.2 5.9 10.7 0.1 0.0 1.9 12.1 0.5 0.0 0.2 0.1 0.0 1.2 0.4 0.4 0.9 1.5 1.4 0.0 4.2 0.3 0.0 0.3 0.0 0.1 0.4 0.6 0.2 0.2 3.6 0.0 24.7 0.0 19.1 0.2 1.5 0.4 0.0 0.2 0.7 0.9 0.4 0.0 14.4 0.7 0.0 0.8 0.0 1.7 0.0 0.3 0.0 1.0 0.0 0.9 0.0 3.5 4.4 0.0 0.3 0.0 0.2 0.2 0.5 0.8 0.3 1.2 0.0 0.4 0.2 1.0 2.9 0.2 0.0 1.1 0.2 0.4 0.2 0.2 DHX32 "DDX32, DHLP1, FLJ10694, FLJ10889" ENSG00000089876 "DEAH-box helicase 32 (putative)" Q7L7V1 10 125836337-125896436 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048872 Approved NA NA "HPA048872: AB_2680540" "unprognostic (1.05e-1)" "unprognostic (3.02e-1)" "unprognostic (3.97e-2)" "unprognostic (6.40e-2)" "unprognostic (2.40e-1)" "unprognostic (3.57e-1)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.85e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (9.49e-5)" "prognostic unfavorable (6.34e-4)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (8.62e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" 12.7 18.6 11.7 9.1 12.8 7.3 20.9 13.0 12.9 15.0 21.4 30.9 17.6 11.7 13.8 25.4 12.8 11.0 35.8 10.9 13.2 16.5 15.4 14.7 6.9 12.9 12.6 10.7 25.9 30.7 20.3 10.1 15.5 13.2 18.0 36.4 21.8 24.0 12.0 21.5 25.0 17.9 12.7 13.2 9.5 34.0 33.3 13.1 9.0 14.8 21.5 12.8 17.3 16.5 14.7 70.0 37.8 25.0 51.6 32.4 29.9 44.6 30.3 69.8 27.1 30.2 8.9 67.4 0.3 22.2 35.4 29.9 49.9 11.5 50.9 22.2 35.2 22.5 8.6 18.3 13.6 36.0 17.0 27.4 29.6 52.3 26.6 59.3 48.4 39.9 0.4 24.3 0.3 26.3 31.5 0.3 26.7 19.0 34.2 25.9 0.3 40.6 15.1 39.4 32.1 3.4 18.2 28.1 49.7 42.6 32.5 18.3 14.9 36.0 21.0 12.8 27.0 27.0 26.4 27.5 0.6 37.9 0.4 11.0 0.1 1.7 1.8 1.4 1.8 1.1 4.6 0.6 0.5 1.2 2.0 2.7 1.1 0.0 2.7 0.9 0.7 0.2 0.5 11.7 12.8 13.0 12.9 10.9 13.2 12.9 12.6 10.7 13.2 13.2 13.1 14.7 11.7 16.0 17.2 31.3 6.5 5.0 14.8 10.0 9.6 13.5 12.0 9.9 25.4 12.8 15.3 7.3 22.9 19.4 4.0 41.8 15.6 32.4 101.8 19.7 20.2 13.9 4.2 16.2 20.3 37.7 29.8 9.8 38.2 24.7 11.4 27.1 6.8 10.6 12.1 11.8 27.9 48.2 14.2 6.7 2.4 28.3 10.5 7.4 7.2 9.4 8.2 29.1 2.1 23.6 30.2 54.5 22.2 17.0 9.0 25.0 14.6 13.9 22.1 15.2 13.1 14.4 11.2 51.3 5.9 13.2 7.0 44.2 4.6 22.9 22.5 26.1 RCOR1 "COREST, KIAA0071, RCOR" ENSG00000089902 "REST corepressor 1" Q9UKL0 14 102592649-102730561 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 117.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001956, HPA049327, HPA054241" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (9.96e-3)" "unprognostic (1.72e-2)" "unprognostic (1.87e-2)" "unprognostic (4.98e-2)" "unprognostic (1.46e-2)" "unprognostic (6.05e-3)" "unprognostic (7.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.72e-4)" 11.3 5.9 3.5 11.3 3.3 46.5 9.0 4.6 4.2 11.7 3.8 11.1 12.1 9.6 13.4 33.4 9.5 8.8 6.8 5.2 4.7 6.4 9.5 13.1 12.0 3.5 3.7 3.2 9.0 7.9 10.5 5.2 20.9 3.8 8.9 11.2 6.3 10.3 5.9 11.9 16.0 12.7 8.8 3.8 8.7 13.5 13.8 4.2 14.6 6.4 10.7 14.8 10.3 19.3 4.0 21.3 19.5 17.2 19.0 13.5 18.6 36.1 21.5 15.2 19.7 18.7 18.0 25.2 23.8 17.1 18.7 9.9 32.6 26.2 15.4 29.4 10.1 9.6 44.2 17.4 17.6 18.4 44.3 38.2 13.1 23.6 17.4 26.5 21.1 21.8 22.1 35.7 17.5 20.1 34.6 27.8 29.9 8.5 23.2 33.1 70.4 17.4 10.6 24.1 25.9 22.2 13.8 48.1 21.9 13.9 21.5 30.0 34.6 23.8 13.6 10.2 43.8 14.2 12.9 16.6 25.0 16.3 32.0 14.6 3.1 1.4 2.2 0.2 1.5 0.3 0.3 0.3 0.6 1.5 0.3 0.3 0.3 3.7 0.7 1.8 0.6 0.5 0.5 3.5 3.3 4.6 4.2 5.2 4.7 3.5 3.7 3.2 3.8 3.8 4.2 4.0 15.8 48.1 40.0 32.3 27.3 57.6 27.7 12.0 30.7 8.4 25.6 20.7 16.7 10.0 19.7 3.7 2.1 31.1 39.1 31.5 5.9 6.7 5.1 55.7 36.1 15.9 21.0 32.2 39.3 7.4 20.4 20.2 32.6 58.3 24.1 18.0 11.0 11.7 15.1 10.1 33.8 16.8 10.2 38.8 65.6 4.9 24.2 43.6 24.9 52.5 33.1 9.5 12.3 22.1 23.5 16.7 15.2 21.1 14.8 25.4 18.2 8.0 16.3 5.4 0.0 18.9 19.6 22.5 18.6 46.9 117.6 43.1 26.2 20.3 22.8 72.3 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 9.8 9.0 7.9 12.2 10.2 37.9 9.8 11.1 10.3 8.8 10.9 9.1 8.6 10.6 9.5 11.4 8.1 12.3 10.3 8.0 10.7 9.0 6.9 10.8 12.2 10.0 9.0 7.4 10.5 8.8 9.3 6.9 11.4 9.6 9.9 10.9 15.6 8.3 9.9 12.2 9.1 9.3 12.0 10.9 10.9 9.4 13.9 9.1 11.7 9.8 14.1 12.2 10.6 9.3 12.4 18.7 24.0 19.2 15.3 11.0 17.0 15.7 21.7 15.0 20.7 20.1 16.0 30.8 22.2 12.6 16.8 16.8 22.0 23.4 14.2 36.6 24.7 12.9 19.5 26.1 10.1 14.2 13.7 27.6 17.6 12.6 17.8 23.0 16.2 21.9 18.1 20.6 30.6 18.6 30.6 18.3 17.7 24.2 11.1 17.5 20.3 23.2 11.5 14.7 37.0 15.5 19.2 24.5 21.6 12.0 19.7 25.2 21.2 24.0 26.7 15.3 14.9 16.5 30.7 31.3 29.2 21.4 18.4 28.0 5.3 7.3 7.9 3.5 6.6 3.0 6.3 1.9 5.2 7.2 5.3 4.2 3.0 5.6 5.6 4.8 5.6 4.5 3.7 7.9 10.2 11.1 10.3 8.0 10.7 10.0 9.0 7.4 9.6 10.9 9.1 12.4 35.3 16.0 18.2 48.0 30.2 23.3 37.4 26.0 22.2 100.0 19.9 21.2 46.3 18.6 25.2 18.4 104.3 16.2 36.8 18.8 3.9 20.0 151.4 28.9 46.2 38.2 47.8 17.1 76.0 13.3 12.7 36.6 21.9 54.5 43.7 48.2 29.3 11.6 25.2 158.2 67.0 19.3 24.4 43.0 48.9 138.9 24.8 43.5 23.2 59.0 47.7 42.3 43.3 82.0 75.0 30.4 29.4 37.6 24.6 56.9 40.2 13.5 24.4 122.7 26.3 55.0 41.7 56.6 27.2 18.7 27.3 17.4 31.2 34.9 20.6 42.6 LTBP4 "FLJ46318, FLJ90018, LTBP-4, LTBP-4L" ENSG00000090006 "Latent transforming growth factor beta binding protein 4" Q8N2S1 19 40592883-40629818 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 120.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015194 Approved "Secreted to extracellular matrix" NA NA 9700000 "CAB015194: AB_2139064" "unprognostic (3.29e-2)" "unprognostic (3.91e-1)" "unprognostic (6.09e-2)" "unprognostic (9.94e-2)" "unprognostic (7.86e-3)" "unprognostic (8.41e-3)" "unprognostic (2.67e-2)" "unprognostic (5.94e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.36e-4)" "unprognostic (3.34e-2)" "unprognostic (4.62e-2)" "unprognostic (5.52e-3)" "unprognostic (5.40e-2)" "unprognostic (1.01e-1)" "unprognostic (1.79e-1)" "unprognostic (6.83e-2)" 139.3 48.9 12.8 22.5 10.9 8.3 99.7 2.2 23.5 331.1 35.9 141.2 59.7 312.2 45.1 101.4 248.9 39.7 328.7 10.5 13.5 63.8 37.7 244.7 25.0 14.6 8.7 9.3 317.8 37.5 22.8 76.5 38.7 16.9 255.8 38.5 3.8 83.5 127.5 63.6 72.1 136.5 75.0 9.9 81.2 126.4 79.1 10.5 13.0 174.7 158.1 14.1 190.2 377.7 14.8 19.8 21.3 41.7 56.5 15.1 16.0 6.6 7.7 24.9 7.8 6.4 6.4 43.8 22.4 34.9 13.1 12.4 26.3 10.6 26.8 2.6 61.0 3.3 7.3 53.7 2.4 49.4 3.0 23.1 19.9 21.7 15.6 27.8 41.0 4.9 21.6 46.7 120.3 1.9 19.7 3.1 1.3 4.9 56.1 24.9 51.9 1.1 35.6 3.9 1.7 1.8 17.4 28.3 21.5 7.4 6.4 11.9 11.3 20.4 1.3 81.4 2.6 16.7 26.8 24.9 7.1 35.1 28.5 20.4 0.0 1.5 0.4 8.1 2.4 5.5 3.5 7.7 6.5 2.7 2.0 3.2 3.4 0.3 3.0 1.3 5.0 5.5 2.3 12.8 10.9 2.2 23.5 10.5 13.5 14.6 8.7 9.3 16.9 9.9 10.5 14.8 84.7 6.4 14.1 2.0 11.6 57.6 30.9 62.8 56.3 60.4 13.0 18.2 15.5 17.2 18.5 22.0 0.0 1.5 12.7 38.2 1.9 6.3 11.1 14.8 154.7 29.9 4.2 12.4 8.1 4.7 2.6 327.1 37.2 24.2 10.2 13.5 102.4 3.3 7.5 40.4 11.3 42.2 6.1 6.4 39.6 39.0 972.3 13.9 58.7 15.0 9.5 3.5 16.5 2.0 14.0 6.9 16.6 624.4 16.5 23.6 97.7 0.3 7.1 3.2 59.2 229.2 52.8 50.7 36.3 38.2 29.1 2.6 24.9 10.2 36.4 27.2 BLVRB "FLR, SDR43U1" ENSG00000090013 "Biliverdin reductase B" P30043 19 40447765-40465764 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 630.3" "Cell type enhanced" "Detected in all" "Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 465.2" "Group enriched" "Detected in all" 7 "dendritic cells: 343.3;monocytes: 465.2" "Cell line enhanced" "Detected in many" "A549: 506.6;K-562: 506.8;OE19: 451.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041698, HPA041937" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 370000000 Cytosol "Nucleoplasm, Vesicles, Plasma membrane" "HPA041698: AB_10796781, HPA041937: AB_10794308" "unprognostic (1.86e-1)" "unprognostic (1.14e-2)" "unprognostic (4.23e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (1.20e-2)" "unprognostic (8.56e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" "unprognostic (2.02e-1)" "unprognostic (5.11e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" 103.2 77.4 38.9 48.6 40.4 630.3 94.7 42.2 61.4 73.2 45.6 78.1 75.8 59.5 20.6 190.4 69.9 51.3 113.7 36.8 40.1 102.8 268.4 103.7 59.4 46.3 40.2 36.8 67.2 73.8 46.5 25.4 52.5 51.4 74.9 30.6 5.6 90.2 42.6 212.1 82.4 72.8 32.0 42.1 168.1 139.6 10.3 44.3 27.7 65.0 94.9 25.5 81.7 97.3 45.5 227.9 506.6 7.3 77.7 73.7 70.2 57.3 28.0 88.7 39.3 75.4 103.4 203.8 74.3 212.3 56.3 126.8 73.1 30.4 64.6 10.5 123.8 20.0 114.9 73.4 62.4 169.8 1.6 32.2 69.2 119.4 52.4 34.2 40.1 41.8 27.4 506.8 137.0 51.0 359.2 6.1 7.2 1.9 451.4 133.8 54.0 23.4 120.3 50.9 146.5 0.4 10.5 84.5 224.5 84.4 13.2 221.5 17.6 39.2 99.4 103.9 156.4 15.9 71.7 92.1 28.5 259.1 46.2 39.0 45.5 465.2 18.0 29.2 220.9 27.0 58.2 24.3 24.5 343.3 37.5 24.7 19.3 58.4 27.4 117.7 75.8 37.3 259.4 38.9 40.4 42.2 61.4 36.8 40.1 46.3 40.2 36.8 51.4 42.1 44.3 45.5 74.6 221.2 164.5 9.4 34.4 129.4 348.5 337.9 103.6 11.2 93.8 143.0 130.5 164.5 184.2 97.5 6.2 84.9 39.5 343.6 266.1 234.2 10.0 56.5 46.3 51.1 44.9 3131.8 5.2 267.3 94.7 112.5 280.3 83.1 43.1 31.0 57.1 680.8 1099.2 10.1 5.1 223.5 158.7 627.7 165.4 23.6 124.2 286.7 144.1 13.1 219.8 88.0 32.0 2.0 5.6 260.4 464.0 94.0 25.7 229.7 864.3 488.3 139.1 13.5 32.9 65.4 146.0 2.6 4.0 160.3 130.4 74.7 34.5 34.7 191.0 260.5 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098809-27166981 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 77.2;stomach 1: 66.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" NA NA 21000 "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 9.7 10.8 5.7 10.5 10.8 11.6 9.0 2.6 9.7 10.2 0.0 18.6 29.6 11.0 8.1 11.0 7.7 17.1 13.1 1.7 3.9 5.8 2.4 13.3 7.1 11.5 4.5 1.1 7.1 8.7 20.9 8.2 22.1 11.9 9.0 13.7 4.5 77.2 19.5 4.7 10.3 19.1 10.8 0.1 11.7 66.5 10.2 10.2 6.4 9.6 4.9 6.8 15.2 9.3 9.3 32.3 10.7 9.9 10.1 21.8 15.7 60.8 25.9 38.5 21.7 23.5 13.0 20.0 14.4 21.9 33.4 10.5 38.9 9.8 62.4 13.4 17.4 9.4 21.9 7.1 5.5 66.1 13.1 16.0 19.7 29.5 36.5 50.7 15.8 36.3 9.8 6.3 13.4 32.3 18.7 6.8 6.4 14.0 38.2 21.9 11.8 9.0 6.7 10.9 46.3 11.4 3.7 21.5 28.4 12.6 10.0 13.3 7.9 39.9 23.0 9.4 21.7 14.5 12.6 8.6 4.3 24.6 14.1 13.5 0.0 0.6 0.6 0.7 0.3 1.5 0.1 0.8 0.7 0.2 0.3 0.5 0.6 2.0 0.1 0.6 0.0 0.3 0.8 5.7 10.8 2.6 9.7 1.7 3.9 11.5 4.5 1.1 11.9 0.1 10.2 9.3 13.5 6.4 14.8 6.5 7.9 31.2 17.9 14.6 13.1 7.4 21.7 23.2 13.5 7.2 8.3 11.0 0.0 40.3 11.9 81.5 0.0 9.1 26.5 13.8 15.9 9.7 12.5 0.4 14.1 12.5 19.4 12.7 160.0 26.5 27.3 7.5 6.8 1.2 12.9 20.2 14.1 15.0 4.1 5.7 5.1 14.4 9.3 12.7 7.2 8.4 4.3 8.2 12.3 4.0 4.6 28.1 43.1 13.2 4.8 9.6 38.9 1.2 5.9 3.8 6.6 20.8 9.8 3.6 4.4 15.0 25.1 52.9 9.8 4.8 18.3 18.3 SPTLC1 "hLCB1, HSAN1, HSN1, LCB1, SPTI" ENSG00000090054 "Serine palmitoyltransferase long chain base subunit 1" O15269 9 92000087-92115413 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010860, CAB018747, HPA063907" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.06e-1)" "unprognostic (3.55e-3)" "unprognostic (8.37e-2)" "prognostic favorable (1.36e-6)" "unprognostic (1.13e-1)" "unprognostic (2.41e-2)" "unprognostic (4.28e-1)" "unprognostic (1.49e-1)" 35.9 32.9 27.4 27.6 29.9 23.5 44.6 28.7 34.5 43.5 31.4 42.7 35.1 40.8 41.6 54.8 37.0 34.4 21.7 27.2 29.5 43.2 23.6 33.9 25.9 30.8 29.8 26.8 44.2 26.7 48.4 17.4 42.8 30.9 33.2 44.5 20.0 31.6 28.3 14.3 41.6 38.2 31.7 29.4 26.6 37.4 26.8 28.8 26.2 53.5 18.7 34.7 37.5 35.0 34.7 73.0 48.8 46.8 41.6 120.0 92.0 78.4 74.7 94.2 65.3 66.3 31.5 150.7 38.6 45.1 93.9 78.3 198.4 49.7 68.1 73.0 39.8 36.1 36.7 32.7 51.7 80.5 65.5 49.9 82.6 92.6 68.0 74.8 72.3 62.5 43.5 83.8 46.6 91.1 69.6 34.7 47.6 67.5 97.4 57.9 39.4 58.7 33.3 84.1 37.9 35.0 37.2 104.4 81.1 61.3 62.4 39.2 54.2 72.3 58.8 48.0 73.9 56.8 33.2 44.4 23.9 74.2 39.3 79.4 32.4 33.1 20.2 16.7 36.1 17.0 15.4 18.0 17.4 30.6 15.5 21.4 16.6 33.3 18.5 34.2 18.4 25.7 25.5 27.4 29.9 28.7 34.5 27.2 29.5 30.8 29.8 26.8 30.9 29.4 28.8 34.7 40.7 38.5 38.3 27.7 22.1 10.6 13.6 14.5 26.2 6.9 33.2 20.6 4.1 4.3 25.9 36.8 14.6 12.7 24.4 8.0 9.8 53.4 94.8 34.7 42.5 23.1 2.4 7.2 35.3 56.4 15.6 32.3 13.7 47.4 24.6 26.9 6.1 4.3 11.0 6.7 32.5 7.2 12.2 5.7 10.3 26.1 6.2 24.6 12.4 20.6 22.0 13.7 7.2 36.7 52.1 60.8 7.1 6.0 26.2 9.8 11.7 28.5 28.0 8.7 13.1 12.1 23.5 35.3 25.9 27.6 9.1 21.8 21.9 33.2 6.9 14.5 PAPOLA PAP ENSG00000090060 "Poly(A) polymerase alpha" P51003 14 96501433-96567111 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1036.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001788 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA001788: AB_1079564" "unprognostic (3.18e-1)" "unprognostic (1.30e-1)" "unprognostic (9.69e-2)" "unprognostic (7.26e-2)" "unprognostic (9.10e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.12e-2)" "unprognostic (2.82e-2)" "unprognostic (1.38e-3)" "unprognostic (3.13e-1)" "unprognostic (1.22e-3)" "unprognostic (3.37e-1)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (1.08e-2)" "unprognostic (4.05e-1)" 52.0 61.0 67.6 67.2 68.8 97.8 63.3 76.6 78.7 60.7 73.5 71.2 57.6 69.2 73.1 60.1 58.4 56.6 61.5 69.8 70.2 61.3 82.2 50.5 78.4 69.1 70.1 61.2 76.8 72.2 73.8 53.4 86.0 73.0 54.7 72.5 93.3 64.4 54.5 47.1 58.4 68.2 62.1 68.8 69.9 66.5 76.5 76.7 93.9 69.5 56.9 83.5 67.0 54.0 85.7 126.6 119.4 150.5 152.6 107.2 119.4 331.6 112.9 120.4 132.1 125.8 132.9 125.6 170.9 125.3 134.1 115.2 104.4 50.1 156.9 235.0 141.1 81.1 131.9 88.9 138.5 110.6 166.2 133.4 110.6 134.1 148.0 131.1 127.8 150.5 79.5 128.2 146.5 128.9 184.6 140.5 91.1 102.9 205.0 135.3 146.7 183.5 98.7 132.0 192.7 154.0 102.0 151.4 115.8 111.6 167.9 165.3 158.3 119.0 91.3 72.6 104.1 140.7 114.3 186.7 138.6 144.5 137.5 158.9 73.5 32.0 56.1 23.8 39.3 29.0 38.9 30.2 34.2 38.8 42.7 35.3 33.9 41.3 41.3 37.7 25.1 32.7 36.6 67.6 68.8 76.6 78.7 69.8 70.2 69.1 70.1 61.2 73.0 68.8 76.7 85.7 126.3 80.1 122.4 64.6 171.4 229.7 406.3 196.6 126.9 78.2 140.0 101.6 157.2 88.6 160.1 84.6 95.9 346.2 139.6 124.1 183.9 121.4 634.7 326.1 145.4 150.7 117.2 126.8 87.9 137.0 440.7 129.9 95.3 371.7 136.4 113.8 85.6 112.3 155.6 63.9 111.5 154.9 168.9 141.3 239.4 275.3 96.3 153.2 168.9 104.9 171.8 93.4 135.9 105.1 115.2 129.6 118.9 80.5 197.4 373.0 122.5 136.5 253.1 107.2 105.2 131.6 185.0 256.8 203.0 146.0 247.6 1036.0 167.8 131.2 166.1 540.3 CCNK CPR4 ENSG00000090061 "Cyclin K" O75909 14 99481169-99535044 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Cyclin "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 103.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000645, HPA077073" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000645: AB_1078606, HPA077073: AB_2732331" "unprognostic (8.07e-2)" "unprognostic (9.32e-3)" "unprognostic (9.52e-2)" "unprognostic (1.52e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "unprognostic (9.22e-4)" "unprognostic (1.50e-2)" "unprognostic (2.06e-1)" "unprognostic (1.64e-1)" "unprognostic (4.78e-3)" "unprognostic (8.94e-3)" "unprognostic (7.74e-2)" "unprognostic (3.93e-1)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (6.21e-2)" 20.9 18.2 8.3 26.9 10.0 103.1 17.1 11.3 12.9 18.1 10.3 26.6 25.7 19.1 19.0 25.7 22.3 18.6 18.5 9.5 10.5 16.7 18.0 21.9 28.6 11.6 9.6 7.0 26.0 16.8 13.6 19.9 19.9 10.8 17.1 28.3 16.4 20.8 16.3 39.5 21.8 28.0 20.0 8.5 25.1 25.2 45.8 9.3 33.6 20.2 22.6 34.3 21.7 19.3 12.6 53.9 59.3 59.7 50.2 47.5 49.4 109.3 69.9 62.2 71.4 82.3 86.3 69.7 84.3 47.7 75.9 53.1 59.9 64.3 89.9 99.5 83.0 33.7 78.1 38.6 75.2 62.4 111.1 85.6 53.7 68.2 71.1 81.4 33.8 54.4 82.9 72.1 72.8 62.7 115.1 85.9 44.6 59.0 66.2 52.1 76.5 80.2 44.7 39.8 101.1 49.1 36.5 62.7 31.9 28.6 57.7 87.4 49.6 66.5 25.6 40.7 226.1 63.3 61.7 86.6 101.5 65.5 50.9 53.4 5.3 5.3 12.6 7.2 5.7 6.3 5.4 5.6 6.4 4.7 4.9 6.5 6.0 12.8 5.1 6.2 5.0 6.3 3.4 8.3 10.0 11.3 12.9 9.5 10.5 11.6 9.6 7.0 10.8 8.5 9.3 12.6 29.6 12.8 37.9 13.7 41.8 36.8 48.6 31.3 33.6 16.9 29.5 23.6 11.5 14.3 37.7 22.0 20.9 23.5 52.7 36.0 13.7 20.1 51.5 39.2 39.6 24.1 19.7 39.2 13.7 24.7 29.3 27.6 49.5 56.7 20.3 29.3 25.7 18.7 24.2 18.5 14.0 34.2 30.5 32.7 32.1 22.0 22.4 41.1 17.8 16.9 38.0 13.4 47.4 14.1 18.5 31.8 26.4 18.0 44.9 42.1 26.2 17.2 43.4 28.8 0.0 40.1 23.0 78.9 64.3 35.7 45.3 27.2 46.5 24.9 32.4 70.2 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 394.8" "Group enriched" "Detected in many" 5 "Bipolar cells: 374.5;Cone photoreceptor cells: 654.7;Rod photoreceptor cells: 592.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 22 "B-cells: 5.2;granulocytes: 7.0;T-cells: 12.0" "Cell line enhanced" "Detected in all" "SH-SY5Y: 160.4;SK-MEL-30: 140.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 25.6 27.1 82.0 9.3 102.5 2.6 27.9 95.9 107.6 40.0 69.5 32.9 18.4 39.6 13.5 16.1 32.2 13.2 66.6 83.9 89.4 29.8 20.2 31.4 8.4 117.7 104.8 76.4 34.1 20.3 24.3 49.1 8.7 127.0 56.0 9.4 394.8 24.9 22.3 155.4 21.8 24.3 17.0 94.9 22.5 33.6 24.6 97.1 5.7 35.3 97.1 6.6 38.6 30.7 138.4 35.1 11.8 46.3 67.8 20.6 36.6 7.9 78.7 38.1 46.4 29.8 44.2 12.4 1.1 11.5 62.6 41.0 8.1 43.4 27.5 21.7 55.4 7.0 4.4 41.3 46.1 33.2 4.5 32.7 49.8 50.6 29.6 12.9 57.5 23.5 20.1 2.2 15.2 75.3 16.5 1.9 5.4 22.5 22.2 31.5 24.5 22.4 6.2 16.5 24.7 90.3 160.4 21.5 11.6 140.2 12.2 21.5 17.0 47.2 49.3 92.6 15.7 42.8 10.1 7.0 7.2 57.2 9.9 73.5 7.0 0.1 3.8 11.1 0.0 7.8 5.2 10.6 10.9 0.3 2.6 4.8 3.7 0.0 0.1 0.0 0.1 12.0 3.4 82.0 102.5 95.9 107.6 83.9 89.4 117.7 104.8 76.4 127.0 94.9 97.1 138.4 14.9 3.2 3.2 27.7 3.8 8.7 16.2 14.2 9.1 374.5 12.4 15.7 7.3 1.5 5.6 9.2 654.7 1.5 6.3 7.7 17.6 31.4 49.8 2.2 15.8 17.3 62.0 0.4 15.0 23.4 1.2 13.0 6.6 4.2 1.3 7.8 15.7 3.6 1.1 42.1 20.8 9.4 16.2 1.0 5.1 101.2 22.4 1.5 23.2 5.6 0.9 88.8 9.2 40.7 65.0 42.3 16.6 16.1 5.3 19.8 21.2 10.7 1.5 592.7 6.6 11.6 17.9 1.4 6.0 4.4 11.8 0.5 9.6 3.6 6.1 11.1 RGS1 "1R20, BL34, IER1, IR20" ENSG00000090104 "Regulator of G protein signaling 1" Q08116 1 192575763-192580024 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 25.7;T-reg: 21.9" "Group enriched" "Detected in many" 5 "granulocytes: 25.7;T-cells: 21.9" "Cell line enriched" "Detected in some" 4 "U-266/70: 962.6" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 85.5" HPA074572 Approved NA NA "HPA074572: " "unprognostic (3.68e-3)" "unprognostic (1.14e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-1)" "unprognostic (4.37e-1)" "unprognostic (3.87e-3)" "unprognostic (6.61e-2)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.91e-5)" "prognostic unfavorable (9.57e-4)" "unprognostic (4.01e-2)" "unprognostic (9.90e-2)" "unprognostic (4.56e-2)" 31.7 89.0 20.9 171.8 24.8 152.9 58.5 27.1 67.0 51.1 40.7 64.4 24.9 19.4 5.2 68.9 23.0 113.7 19.3 20.5 54.1 19.8 60.4 79.6 144.0 45.7 24.2 16.3 14.4 19.2 25.8 40.4 22.3 30.4 51.1 113.7 26.8 56.4 13.9 2.9 17.2 73.4 45.3 32.7 75.2 36.9 8.6 29.4 155.6 24.1 5.2 91.4 128.9 39.7 44.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 4.3 0.0 0.0 2.8 4.6 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 220.6 0.0 0.0 0.4 5.6 0.2 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 962.6 4.1 3.5 0.0 0.1 0.2 0.0 0.0 25.7 0.8 0.1 1.9 0.0 5.1 4.5 0.7 0.0 0.4 3.7 0.1 0.7 0.1 4.9 21.9 0.7 20.9 24.8 27.1 67.0 20.5 54.1 45.7 24.2 16.3 30.4 32.7 29.4 44.2 10.8 12.8 103.2 0.0 170.6 49.2 6.9 0.3 5.7 0.7 11.7 18.7 1.2 4.3 13.2 0.0 0.0 2.1 148.8 1.4 0.0 1.4 1.8 1.7 2.0 32.7 4.8 16.4 0.0 2.8 2.8 15.4 47.4 2.5 1398.7 0.0 5.3 3.8 390.4 0.0 0.0 1.6 0.0 211.2 1133.6 7.4 3.1 860.4 250.8 7.5 333.9 0.9 2.1 0.0 0.0 0.2 3.5 0.7 902.4 3.7 1.3 1.2 11.3 1.9 19.7 2.0 8.5 0.4 1.2 3.5 40.2 6.0 748.2 0.2 4.0 8.3 YPEL3 MGC10500 ENSG00000090238 "Yippee like 3" P61236 16 30092314-30096915 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 23.2;eosinophil: 31.0;neutrophil: 47.4" "Lineage enriched" "Detected in all" 8 "granulocytes: 47.4" "Cell line enhanced" "Detected in many" "EFO-21: 74.1;RPMI-8226: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030501, HPA045621" Uncertain NA NA "HPA030501: AB_10602683, HPA045621: " "unprognostic (1.11e-1)" "unprognostic (1.14e-3)" "unprognostic (3.06e-2)" "unprognostic (1.49e-1)" "unprognostic (4.58e-2)" "prognostic favorable (1.09e-4)" "unprognostic (2.06e-1)" "unprognostic (1.47e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-1)" "unprognostic (2.02e-3)" "unprognostic (2.64e-1)" "unprognostic (5.42e-3)" "unprognostic (3.90e-2)" "unprognostic (2.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 94.6 65.4 78.7 34.7 90.0 52.4 96.2 84.1 195.3 83.9 28.9 85.3 32.0 76.5 16.0 98.5 85.8 23.7 95.7 93.5 64.2 84.3 54.9 102.4 41.7 91.3 68.8 92.4 98.7 98.6 35.4 81.0 38.0 100.8 85.4 11.9 25.7 98.1 27.1 192.1 120.4 107.0 14.9 53.7 180.3 77.5 24.6 80.8 39.5 82.2 58.8 31.8 83.9 98.3 95.4 13.5 3.3 8.8 2.9 33.1 32.9 36.6 21.4 13.7 5.1 12.4 1.8 44.9 4.4 74.1 16.2 0.2 7.6 5.1 11.4 2.2 26.6 17.3 5.2 9.6 18.3 24.6 0.0 40.8 54.8 15.6 7.5 2.0 47.0 17.8 0.4 4.4 33.4 7.0 25.7 0.9 4.2 8.1 4.9 2.8 24.4 0.1 102.2 10.3 11.5 18.2 47.7 8.7 10.9 18.7 10.9 15.3 16.3 18.7 1.4 9.0 4.1 0.1 55.9 19.2 7.4 14.7 7.9 4.2 23.2 3.2 31.0 2.4 1.5 2.7 3.3 4.4 3.2 2.0 3.8 4.1 2.3 47.4 5.8 1.3 2.0 4.1 1.4 78.7 90.0 84.1 195.3 93.5 64.2 91.3 68.8 92.4 100.8 53.7 80.8 95.4 128.6 41.7 54.4 44.7 119.0 53.8 87.0 26.7 87.6 90.3 105.3 146.3 56.8 80.1 33.7 71.7 54.2 174.7 149.6 43.2 92.0 80.9 25.1 72.9 35.7 72.9 47.4 232.8 67.3 69.0 126.1 69.7 42.3 61.4 23.5 75.0 127.8 22.0 48.1 55.5 71.5 51.9 26.4 107.7 39.9 33.3 98.5 85.3 32.0 36.5 68.7 139.7 134.9 36.7 61.2 144.7 46.9 63.9 162.7 113.2 68.4 91.3 33.8 103.2 59.2 89.4 75.6 6.4 22.7 55.0 77.0 113.6 111.4 51.7 22.5 152.1 MRPS33 CGI-139 ENSG00000090263 "Mitochondrial ribosomal protein S33" Q9Y291 7 141002610-141015228 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 354.1;Proximal tubular cells: 386.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030425 Uncertain NA NA "HPA030425: AB_10602030" "unprognostic (9.83e-2)" "unprognostic (2.91e-1)" "unprognostic (2.19e-2)" "unprognostic (1.01e-1)" "unprognostic (1.79e-2)" "unprognostic (4.03e-2)" "unprognostic (5.99e-2)" "unprognostic (3.82e-1)" "unprognostic (3.66e-2)" "unprognostic (4.55e-3)" "unprognostic (6.94e-3)" "unprognostic (4.26e-1)" "unprognostic (9.80e-3)" "unprognostic (1.16e-1)" "unprognostic (9.52e-2)" "unprognostic (1.01e-1)" "unprognostic (3.52e-2)" 36.4 64.9 48.8 27.7 51.2 25.2 59.1 51.0 69.3 30.6 51.2 66.0 50.6 25.8 79.8 46.6 35.4 22.6 96.6 49.6 51.3 73.4 84.4 21.0 41.3 51.0 50.0 48.2 35.6 68.2 81.8 49.4 24.6 52.4 36.9 70.4 29.7 50.4 31.5 175.4 34.3 44.9 26.7 51.2 31.2 44.6 45.6 49.8 42.3 52.1 173.0 43.9 37.2 30.5 52.2 79.0 110.5 61.8 65.7 77.1 104.9 67.6 69.5 68.7 65.1 73.2 67.6 104.9 107.7 100.0 67.3 140.9 50.5 69.5 102.6 89.3 96.6 83.1 67.8 20.6 130.8 93.8 98.3 39.2 99.8 103.0 100.8 89.4 73.3 53.9 108.4 113.3 84.0 128.2 124.8 110.1 153.3 129.3 140.0 125.6 28.4 48.5 186.1 114.9 99.8 111.7 88.2 93.7 93.2 145.5 65.3 79.4 90.8 41.8 56.6 38.4 137.5 75.8 128.3 155.7 126.8 125.3 99.8 95.1 13.0 47.6 37.9 48.9 68.7 61.9 85.4 85.5 61.1 79.5 66.8 98.3 83.5 4.9 79.8 60.5 93.8 77.3 61.2 48.8 51.2 51.0 69.3 49.6 51.3 51.0 50.0 48.2 52.4 51.2 49.8 52.2 30.3 38.5 43.6 11.1 54.6 42.6 72.1 207.7 51.2 27.1 101.1 104.6 333.5 82.9 96.5 114.0 31.3 145.4 39.5 96.9 354.1 101.0 136.8 124.2 60.1 42.8 89.7 46.3 8.9 136.8 133.0 55.3 50.0 70.6 48.2 71.4 42.5 221.8 114.1 57.2 9.1 148.3 109.9 59.8 38.1 41.0 57.8 45.7 76.5 8.4 97.4 47.8 51.5 9.0 18.0 95.6 80.6 42.5 88.9 67.1 199.0 386.1 122.5 32.9 19.7 41.0 57.1 157.7 50.8 84.4 45.7 116.8 49.6 82.8 202.3 79.0 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3191.4;Distal tubular cells: 1997.6;Proximal tubular cells: 2437.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 165.6 227.1 340.8 124.5 352.5 144.3 161.6 367.2 445.1 138.5 357.1 242.1 167.5 154.7 173.0 198.5 130.7 143.1 729.4 334.9 360.4 423.1 283.5 141.3 166.2 350.3 349.1 330.5 108.9 160.8 365.7 183.7 106.8 352.7 153.3 184.8 177.5 199.3 153.8 842.7 147.3 162.5 156.2 363.0 156.3 218.2 126.5 360.6 163.8 353.6 921.2 135.1 188.3 146.7 370.0 322.5 497.0 182.1 400.9 291.9 297.5 259.9 227.0 207.6 241.4 229.1 389.7 317.3 243.1 331.7 289.9 441.7 155.4 167.0 333.4 194.1 399.5 556.9 179.1 442.3 461.3 230.0 279.2 231.0 331.6 287.5 227.0 138.2 201.3 368.1 338.8 311.2 289.9 343.2 945.8 448.2 719.4 424.0 670.0 585.0 251.1 174.6 569.4 492.0 634.2 369.0 359.3 310.4 513.8 281.0 205.7 222.9 315.7 295.2 307.0 179.2 365.6 401.5 267.6 567.2 457.2 469.0 447.7 395.8 713.9 1045.5 503.4 779.4 1117.0 673.3 1009.8 755.0 768.2 1161.9 787.8 800.5 793.7 85.6 823.9 1037.9 926.9 772.0 1795.1 340.8 352.5 367.2 445.1 334.9 360.4 350.3 349.1 330.5 352.7 363.0 360.6 370.0 262.7 189.1 238.4 25.5 191.1 226.5 289.3 693.4 128.1 181.9 458.3 514.8 3191.4 351.8 398.1 673.1 98.0 555.4 275.3 776.2 1997.6 373.9 901.2 294.2 298.4 283.6 428.7 143.7 19.9 314.4 466.6 327.2 307.3 366.3 280.6 212.8 205.6 1079.3 710.8 139.7 22.7 576.3 687.7 280.3 337.3 246.9 222.7 336.5 434.0 13.1 356.7 367.2 465.5 19.6 42.3 279.4 647.9 243.8 210.7 440.1 867.3 2437.9 370.2 284.1 197.2 199.2 372.0 77.0 208.6 321.9 280.6 515.0 241.7 288.6 669.6 435.8 NUDC ENSG00000090273 "Nuclear distribution C, dynein complex regulator" Q9Y266 1 26900238-26946871 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 642.2;Respiratory ciliated cells: 635.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027183, HPA028105" Enhanced Enhanced Cytosol NA NA 140000 Cytosol "HPA027183: AB_10600086, HPA028105: AB_10601988" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.61e-2)" "unprognostic (6.52e-3)" "unprognostic (2.30e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-2)" "unprognostic (3.82e-1)" "unprognostic (3.26e-2)" "unprognostic (2.90e-2)" "unprognostic (1.55e-1)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" 62.9 141.2 110.8 38.1 109.0 52.1 64.7 112.7 125.2 69.8 117.0 82.6 36.2 70.7 70.7 60.2 94.7 28.7 103.7 110.6 107.8 72.3 116.9 64.2 42.7 107.7 106.1 103.4 75.1 82.1 53.5 76.0 41.1 110.7 72.7 31.8 49.1 54.9 57.5 127.1 66.8 53.2 42.2 107.0 63.8 86.0 87.4 109.0 47.9 63.7 61.1 42.6 80.7 62.2 128.4 204.2 208.1 106.9 149.2 83.5 74.6 121.2 159.2 97.3 209.4 153.5 192.3 137.8 169.5 137.1 109.6 154.2 156.2 229.5 209.8 160.7 132.1 238.0 210.9 207.7 333.7 147.2 224.9 149.2 80.6 134.5 252.7 161.8 90.9 156.4 194.9 306.1 92.3 143.5 175.9 227.3 289.9 281.2 264.8 266.4 234.7 135.5 172.4 180.1 79.2 177.4 133.1 173.3 109.0 149.1 99.8 106.5 137.0 155.5 148.7 178.1 188.3 207.4 184.0 311.9 202.0 160.4 312.7 170.9 184.4 138.8 141.1 152.7 150.2 154.5 176.7 154.1 145.4 140.7 185.9 150.7 154.9 95.4 147.4 155.1 163.2 163.5 168.0 110.8 109.0 112.7 125.2 110.6 107.8 107.7 106.1 103.4 110.7 107.0 109.0 128.4 111.8 134.6 116.1 12.4 93.6 154.1 329.0 187.2 82.0 93.3 85.1 85.9 166.5 137.2 169.8 110.3 52.1 203.3 89.2 91.3 262.2 285.0 85.6 473.8 105.4 120.6 131.4 99.3 16.1 317.4 206.7 128.9 105.5 113.4 147.6 104.5 95.3 642.2 147.5 111.0 16.5 123.1 128.1 70.2 132.1 132.7 135.8 83.7 151.2 11.2 115.3 181.1 86.5 10.1 19.2 309.7 79.7 153.1 77.5 277.7 76.3 200.1 635.8 105.7 111.7 129.1 174.6 246.4 249.7 70.9 148.5 162.7 128.9 91.1 129.1 200.1 MAEA "EMP, GID9, HLC-10, p44EMLP" ENSG00000090316 "Macrophage erythroblast attacher, E3 ubiquitin ligase" Q7L5Y9 4 1289887-1340147 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 27.7 44.6 19.8 23.7 20.3 18.5 29.0 18.6 24.1 32.7 22.7 36.5 33.8 34.7 11.0 47.1 29.5 17.7 37.8 20.2 25.0 41.2 32.6 24.2 24.5 23.3 20.4 18.6 35.2 35.7 31.0 39.2 17.4 25.3 29.5 14.3 8.9 36.0 21.7 37.4 39.7 36.0 15.0 17.3 40.3 37.4 27.0 22.0 20.9 34.2 19.3 15.9 31.0 33.8 29.0 58.1 66.9 47.6 47.7 31.5 31.1 61.4 57.4 30.6 47.1 42.2 70.5 73.5 52.5 43.6 42.4 85.5 42.0 46.1 72.2 19.1 42.4 52.2 49.2 74.1 68.1 37.1 55.8 50.9 38.8 38.6 37.8 23.6 31.8 38.0 50.4 70.4 41.6 41.3 61.5 84.2 86.5 62.2 63.4 72.9 81.0 38.1 47.8 50.3 68.2 84.7 57.8 51.1 39.3 41.5 26.3 71.5 48.4 52.8 85.9 36.0 39.0 96.1 50.5 83.4 58.1 59.0 51.3 48.2 74.9 49.9 70.9 59.2 52.6 83.5 47.6 47.1 56.4 47.1 38.1 41.4 42.5 117.9 45.5 77.3 33.0 59.8 59.1 19.8 20.3 18.6 24.1 20.2 25.0 23.3 20.4 18.6 25.3 17.3 22.0 29.0 22.0 19.2 25.0 28.4 21.6 18.7 15.7 33.9 8.0 28.1 22.5 25.3 35.5 14.3 24.3 16.5 20.9 48.2 29.7 41.2 46.9 43.4 8.0 21.9 25.2 24.4 20.4 26.3 19.6 30.3 46.4 25.0 25.5 25.0 10.8 30.4 19.6 15.0 39.6 21.9 23.2 33.1 30.5 29.2 15.9 9.8 35.4 23.2 28.4 14.0 46.3 22.3 28.8 22.6 20.0 40.3 31.3 37.2 23.5 22.7 30.4 36.4 17.9 19.1 13.1 24.9 27.9 36.6 44.0 19.3 19.9 95.2 29.7 59.6 38.1 21.8 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10271093-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 221.2;urinary bladder: 217.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA 87900000 2200000000 "Plasma membrane" "Vesicles, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 62.9 23.9 9.1 45.0 8.9 118.2 32.7 7.6 13.2 11.2 11.9 17.7 16.9 24.1 3.6 11.1 26.5 56.9 34.9 8.3 14.5 32.2 67.7 221.2 38.7 12.0 8.0 7.2 13.1 11.2 8.3 9.3 28.0 8.9 22.4 18.3 10.6 18.1 6.3 15.2 17.0 22.8 23.6 9.5 56.3 21.7 5.7 13.0 28.6 31.1 12.9 33.2 217.4 12.6 16.0 46.3 0.5 7.9 0.2 2.0 4.4 9.7 8.6 91.6 21.8 62.0 14.0 49.8 39.6 130.3 3.8 99.3 8.9 1.7 0.4 45.6 123.8 0.1 3.8 1.4 62.0 158.3 1.3 23.9 55.7 4.0 13.7 20.3 2.0 10.7 4.9 15.0 459.7 1.5 3.3 0.5 34.9 3.1 0.5 24.7 1.0 0.2 148.5 36.8 0.3 0.3 1.1 61.2 3.3 94.5 3.7 6.9 2.8 34.3 22.3 1.9 12.3 0.8 137.4 142.7 25.5 35.1 26.3 32.6 5.0 28.3 5.2 5.3 25.8 9.8 3.8 4.0 6.3 24.7 1.5 1.9 3.8 40.8 15.2 17.0 14.1 6.1 20.8 9.1 8.9 7.6 13.2 8.3 14.5 12.0 8.0 7.2 8.9 9.5 13.0 16.0 150.3 612.2 561.6 0.3 31.7 85.3 22.2 62.6 28.5 0.0 50.2 24.9 1.1 21.5 133.5 3.7 0.0 1.1 28.9 2.9 0.0 176.8 2.0 14.1 15.5 240.8 2.4 1.3 0.5 98.7 3.3 136.6 13.7 29.8 139.8 0.1 48.2 12.1 86.7 0.0 0.4 0.7 32.6 53.6 232.6 1.3 4.7 168.3 76.5 7.5 101.9 4.6 5.2 0.5 0.2 113.7 0.3 1.5 57.6 27.1 0.3 15.0 83.2 0.4 6.6 38.2 57.6 0.8 1.6 4.3 69.3 1.2 28.8 0.5 1.6 14.1 STRN4 "PPP2R6C, ZIN" ENSG00000090372 "Striatin 4" Q9NRL3 19 46719511-46746994 "Predicted intracellular proteins, Predicted membrane proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043051, HPA043527, HPA056706" Supported Approved Cytosol NA NA 32000 Cytosol "HPA043051: AB_2678290, HPA043527: AB_10959664, HPA056706: AB_2683214" "unprognostic (3.57e-2)" "unprognostic (7.96e-2)" "unprognostic (2.13e-2)" "unprognostic (7.39e-2)" "unprognostic (1.81e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (6.06e-8)" "unprognostic (8.31e-3)" "unprognostic (5.34e-2)" "prognostic unfavorable (2.98e-4)" "unprognostic (1.56e-1)" "unprognostic (9.41e-3)" "unprognostic (4.86e-3)" "unprognostic (6.74e-2)" "unprognostic (4.06e-2)" "unprognostic (6.04e-2)" "unprognostic (1.84e-1)" 34.0 25.5 22.5 19.6 21.7 37.9 33.1 13.1 31.3 32.9 16.0 36.2 22.9 37.3 8.0 48.5 33.0 19.8 34.1 29.7 17.0 29.4 23.2 34.1 21.4 16.4 16.2 22.2 31.2 36.8 21.4 23.0 20.6 18.3 33.5 12.9 9.7 31.2 20.0 36.4 42.2 30.8 17.9 13.7 43.2 34.1 86.0 19.6 19.5 28.0 15.6 11.7 35.5 34.5 20.2 60.8 79.2 67.5 50.2 19.1 21.1 47.7 51.2 27.4 52.0 45.3 59.7 52.5 30.1 30.2 42.0 42.5 42.2 31.9 49.8 20.3 43.7 66.9 66.3 52.4 51.4 60.8 54.1 69.5 33.8 49.1 33.5 45.5 26.2 46.8 34.9 59.2 38.2 22.1 41.4 60.6 143.4 51.8 63.5 37.1 55.1 41.2 23.3 34.9 107.0 83.5 89.8 71.7 66.1 34.5 29.0 49.7 60.5 64.3 38.8 58.4 26.9 76.4 48.5 74.1 45.0 33.9 33.8 81.9 4.2 6.0 2.8 1.0 9.1 0.3 1.4 0.8 0.7 3.1 2.5 0.4 0.9 9.3 1.4 5.7 2.7 0.3 5.8 22.5 21.7 13.1 31.3 29.7 17.0 16.4 16.2 22.2 18.3 13.7 19.6 20.2 28.4 3.2 7.5 6.2 7.7 17.2 10.7 11.6 6.2 14.7 17.7 15.0 12.1 14.3 8.9 7.3 12.5 14.6 10.4 28.3 1.9 12.6 11.4 15.7 17.9 23.9 17.5 11.6 13.7 15.4 18.1 11.4 15.3 18.2 0.0 22.5 20.3 12.3 14.8 30.3 11.1 23.0 10.2 24.1 14.6 19.6 17.7 22.9 10.6 13.1 16.9 7.9 2.1 5.5 12.1 19.8 17.7 19.9 8.0 18.3 15.4 7.4 9.0 7.9 6.6 13.4 14.3 19.8 44.9 16.8 17.3 20.0 8.5 18.6 18.9 17.8 IRAK3 IRAK-M ENSG00000090376 "Interleukin 1 receptor associated kinase 3" Q9Y616 12 66189195-66254622 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 78.9" "Cell type enhanced" "Detected in many" "Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0" "Group enriched" "Detected in many" 12 "dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043097 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA043097: AB_10795612" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-1)" "unprognostic (7.56e-3)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (8.52e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (5.58e-2)" "unprognostic (4.64e-2)" "unprognostic (3.41e-2)" "unprognostic (3.23e-2)" 17.0 3.8 3.9 12.5 3.6 78.9 11.7 4.1 6.4 9.4 6.8 4.6 1.3 4.1 3.0 3.9 8.0 6.9 7.3 2.9 5.8 3.5 2.9 19.1 4.1 5.5 4.1 1.8 3.2 2.5 0.9 9.0 6.9 6.3 5.3 2.8 0.4 6.2 5.7 2.6 3.4 5.6 5.4 4.5 27.7 7.0 1.8 5.4 2.7 5.1 4.6 4.0 8.5 6.7 8.2 0.0 0.0 0.4 0.0 25.9 21.1 0.0 2.9 0.0 1.5 2.3 0.0 2.2 0.0 1.4 5.3 0.0 0.0 3.2 0.0 1.3 0.0 0.0 22.9 1.4 0.0 13.4 30.8 4.0 13.5 0.1 1.2 0.0 0.0 7.6 0.0 0.0 0.0 1.0 0.0 0.0 25.1 1.3 0.0 0.0 0.0 6.4 0.0 0.1 3.3 0.1 0.0 11.6 0.0 1.2 0.1 0.1 37.3 8.2 0.0 0.0 0.0 0.0 0.9 0.2 2.2 0.0 26.8 0.0 12.7 23.4 4.3 0.0 24.2 0.0 0.1 0.0 0.0 11.5 0.7 0.0 0.0 12.9 1.8 42.0 0.1 0.6 7.3 3.9 3.6 4.1 6.4 2.9 5.8 5.5 4.1 1.8 6.3 4.5 5.4 8.2 83.3 9.6 19.4 1.3 2.3 1.5 4.8 27.5 6.2 0.3 2.5 1.8 2.8 0.0 46.9 3.7 0.0 0.2 14.8 0.5 0.0 0.6 6.4 0.5 7.5 38.5 0.0 9.7 0.4 1.2 0.4 22.3 18.3 0.5 27.3 0.5 36.4 1.2 9.4 0.0 5.6 1.1 36.7 123.0 12.1 5.3 7.2 126.3 5.4 114.3 96.9 0.2 3.1 2.0 0.6 4.9 0.1 11.3 9.1 1.6 0.0 0.2 35.1 0.1 0.0 18.1 10.2 0.8 1.8 1.2 1.3 0.3 3.5 12.5 0.7 2.5 LYZ ENSG00000090382 Lysozyme P61626 12 69348381-69354234 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 10678.5;salivary gland: 21288.2;stomach 1: 9016.5" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5" "Cancer enhanced" "Detected in all" "stomach cancer: 976.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 25266.2;myeloid DC: 14438.7" "Group enriched" "Detected in all" 20 "dendritic cells: 14438.7;monocytes: 25266.2" "Cell line enriched" "Detected in many" 13 "OE19: 12130.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1500000000 1500000000 "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741" "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favorable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 96.7 28.0 3.4 809.3 5.5 10678.5 129.5 3.9 18.7 157.5 17.4 311.9 3637.9 66.3 4.2 107.2 34.2 1063.7 35.1 2.6 19.3 32.6 139.2 1367.2 745.7 7.4 5.9 2.4 20.6 63.7 13.9 7.2 92.1 6.5 40.6 276.4 4.5 21288.2 22.0 34.3 59.2 1333.1 125.1 5.4 626.4 9016.5 22.0 9.2 324.8 28.1 36.7 658.1 432.4 16.3 11.3 0.6 0.1 0.0 0.2 0.0 0.0 4.8 0.0 0.0 0.0 0.3 9.5 6.5 4.2 1.5 0.0 3.6 1.2 0.0 0.0 0.2 1.2 0.1 62.4 1.0 960.4 0.0 110.6 50.5 0.0 0.1 0.0 0.0 0.2 0.0 0.3 7.7 0.3 0.0 0.2 2.6 109.5 2.3 12130.8 0.2 1.6 1.4 16.7 0.3 0.5 0.8 3.6 0.5 0.1 0.5 0.7 0.0 489.0 0.6 0.0 2.6 2.3 0.9 2.6 1.1 1.2 0.1 518.5 0.0 443.4 25266.2 298.2 32.6 4798.4 52.3 100.5 20.1 22.7 14438.7 20.8 20.0 17.8 1007.7 108.1 880.1 301.2 31.1 25392.1 3.4 5.5 3.9 18.7 2.6 19.3 7.4 5.9 2.4 6.5 5.4 9.2 11.3 24.0 86.6 285.8 0.0 80.8 57.2 1.7 1.2 1.2 0.3 1205.7 32.3 0.2 734.9 51.1 27.6 0.0 5.6 39.6 32.1 0.0 55.1 1.9 2.6 1.9 25.1 12.5 264.6 0.2 547.3 9.4 26.8 3106.1 2.9 123.6 0.5 29.6 25.4 887.1 0.0 0.2 112.4 0.0 2841.2 4859.1 17.4 4.1 4870.7 53.4 0.0 7063.0 0.1 176.1 0.0 0.3 3152.5 600.5 2.2 9.0 2.7 41.8 6.6 33.8 1.0 39.5 7.4 9.9 0.7 3.9 1.5 38.2 8.5 50.6 0.3 111.4 38.3 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078496 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 150 "intestine: 550.1" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 1083.9" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA011897 Enhanced NA NA "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 550.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 31.3 0.0 0.0 0.0 0.0 0.0 451.9 0.9 0.0 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 9.7 0.0 0.0 0.1 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 123.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 124.7 0.0 0.0 0.3 1083.9 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 77.8 0.0 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508151 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 16.3 18.3 18.1 12.1 18.5 29.0 16.3 19.7 19.5 15.8 21.8 20.7 14.3 20.6 11.2 21.4 19.8 15.0 31.5 17.7 19.5 19.6 24.8 15.9 13.7 20.1 19.1 17.7 19.3 20.0 36.6 14.7 16.5 19.8 16.1 15.9 7.5 19.5 20.2 35.7 21.6 15.9 20.2 19.1 15.3 18.8 12.3 19.5 12.1 16.4 50.9 15.1 19.3 15.6 20.1 34.1 32.1 18.1 37.9 38.5 21.6 19.6 32.9 39.1 40.1 38.2 19.9 54.8 25.4 35.9 46.8 30.4 50.3 32.9 47.5 28.9 25.4 26.1 19.4 20.4 29.2 45.2 27.0 32.0 35.3 61.6 41.1 42.3 23.4 26.5 22.5 25.8 30.1 44.1 17.3 16.4 18.1 18.7 28.1 30.3 15.8 22.8 32.9 47.1 18.7 18.4 27.3 29.6 31.2 40.5 14.6 22.0 25.6 30.2 38.8 22.3 34.1 29.9 34.9 32.9 27.3 30.4 36.1 36.7 36.2 30.0 38.2 33.1 34.7 34.4 25.3 24.8 33.8 29.6 22.8 28.1 27.6 26.7 32.3 30.7 22.8 37.9 34.0 18.1 18.5 19.7 19.5 17.7 19.5 20.1 19.1 17.7 19.8 19.1 19.5 20.1 14.5 22.4 10.3 10.4 9.8 5.2 9.2 13.9 5.2 13.5 12.3 11.9 16.6 10.0 9.5 18.4 6.2 37.1 13.2 21.6 11.7 26.3 2.2 7.7 9.5 13.1 8.5 8.6 4.9 23.4 22.5 13.9 7.7 9.4 3.8 14.7 13.6 17.6 23.0 13.5 6.8 12.9 16.2 10.0 6.5 4.0 13.1 9.3 19.6 2.8 15.5 16.0 16.5 5.5 6.0 25.6 14.6 15.4 13.1 9.2 13.2 10.6 9.6 11.9 19.7 11.9 14.7 14.6 15.4 7.4 7.1 37.6 9.2 18.0 12.2 10.7 TFAP4 "AP-4, bHLHc41" ENSG00000090447 "Transcription factor AP-4" Q01664 16 4257186-4273075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.1;Proximal enterocytes: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001912 Supported Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA001912: AB_1080251" "unprognostic (1.61e-2)" "unprognostic (1.36e-1)" "unprognostic (5.10e-2)" "unprognostic (4.42e-3)" "unprognostic (8.61e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (8.05e-2)" "unprognostic (8.97e-2)" "unprognostic (4.60e-1)" "unprognostic (5.75e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "unprognostic (1.30e-1)" 5.6 4.2 3.1 7.0 3.5 1.9 5.9 4.7 5.4 9.0 1.2 5.2 6.4 7.9 1.0 8.2 7.0 3.9 2.9 3.0 2.6 3.1 5.4 3.9 6.8 3.4 2.9 2.5 10.1 12.1 3.3 4.3 3.7 3.2 5.8 2.0 0.7 7.6 3.1 7.5 10.4 6.8 2.5 2.9 7.4 5.0 1.7 3.2 8.4 4.7 3.1 3.9 6.4 8.4 3.6 14.9 15.4 12.9 19.2 5.4 14.1 21.7 5.7 14.6 9.6 10.5 8.1 23.0 51.0 14.5 5.5 4.5 22.0 23.6 19.4 3.0 29.8 17.4 15.6 13.0 21.1 7.5 27.8 8.8 13.3 12.2 10.4 29.0 4.5 6.4 16.7 29.1 13.1 3.8 23.9 39.2 46.4 29.8 14.7 20.2 34.3 28.8 53.7 3.7 11.2 27.0 20.0 19.2 19.7 18.9 2.0 10.0 21.9 4.2 13.1 10.4 46.2 15.1 21.3 19.3 43.6 8.8 27.2 9.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.1 3.5 4.7 5.4 3.0 2.6 3.4 2.9 2.5 3.2 2.9 3.2 3.6 7.0 3.2 0.0 2.3 11.6 21.5 9.8 5.7 30.1 4.2 8.1 6.6 2.2 7.2 2.1 27.6 0.0 7.7 5.3 5.3 7.9 4.1 0.1 2.4 9.6 5.4 7.8 22.7 3.0 5.7 11.7 7.6 10.7 3.1 0.0 6.9 3.6 3.4 4.2 0.0 3.9 12.4 8.2 4.0 7.4 0.1 11.8 3.7 3.6 1.0 4.7 2.2 5.2 1.5 3.6 2.9 5.3 5.3 7.2 11.1 40.0 5.7 1.4 3.4 6.6 6.9 7.1 0.9 0.9 22.1 22.3 2.2 7.3 7.5 20.2 4.3 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133808 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 176.1;Cone photoreceptor cells: 221.0;Rod photoreceptor cells: 176.3;Spermatocytes: 164.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA049388: AB_2680741" "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 12.0 12.5 12.9 12.0 13.6 10.1 12.0 17.3 18.3 15.8 11.6 14.0 10.0 16.7 12.8 17.9 13.7 8.5 10.9 14.1 13.1 10.4 12.6 10.3 14.6 14.0 14.1 13.5 17.0 11.3 11.6 11.0 12.0 15.1 13.1 9.4 10.9 10.1 12.1 13.2 11.2 11.4 13.5 11.8 13.5 11.1 19.0 14.0 15.8 12.6 8.8 15.2 14.9 14.1 16.7 18.2 14.9 24.8 25.7 24.4 34.2 15.0 20.4 22.6 24.7 18.8 18.2 19.7 34.9 21.7 16.5 18.5 33.5 63.9 14.7 17.7 21.3 17.0 33.9 12.8 15.9 22.5 46.6 21.8 20.0 22.0 13.6 25.4 23.7 19.8 25.6 44.0 27.6 21.7 13.9 48.7 33.2 30.1 21.1 13.3 42.7 31.8 39.0 15.2 28.5 20.4 24.3 22.8 19.1 31.3 27.0 15.4 37.7 20.0 25.2 24.6 14.8 31.9 49.1 60.4 24.9 22.7 50.5 13.2 2.1 1.4 0.9 2.0 1.2 1.7 2.3 1.9 1.8 1.3 2.4 2.0 1.9 0.3 3.3 1.2 1.8 1.5 0.7 12.9 13.6 17.3 18.3 14.1 13.1 14.0 14.1 13.5 15.1 11.8 14.0 16.7 33.6 0.0 14.3 10.1 46.3 38.0 67.8 6.0 89.4 176.1 33.1 40.9 17.7 21.5 11.1 29.5 221.0 55.3 55.8 17.2 29.4 9.0 5.9 26.8 51.8 36.5 14.4 27.5 31.0 8.2 32.6 38.4 20.4 28.2 19.7 49.0 31.1 19.4 23.6 75.7 32.9 26.9 6.1 23.2 22.8 8.9 58.1 24.7 12.4 9.4 14.5 47.2 45.3 15.1 28.9 7.3 11.6 48.2 37.9 56.8 14.2 22.7 8.5 176.3 46.0 45.5 38.8 164.6 107.3 48.8 39.9 71.4 49.5 60.3 26.1 51.5 SPG21 "ABHD21, ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21 abhydrolase domain containing, maspardin" Q9NZD8 15 64963022-64990310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 181.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA040407: AB_2676965, HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 56.4 62.3 51.3 51.3 56.6 70.0 69.5 55.5 53.3 60.3 66.8 57.0 52.6 60.8 151.4 46.4 74.0 55.2 55.0 51.3 60.4 86.1 114.0 62.4 57.3 55.4 53.4 48.3 55.8 55.2 72.7 47.5 66.8 55.5 50.2 59.9 38.9 46.1 59.5 74.9 58.8 47.0 65.1 56.0 53.0 60.6 35.3 54.4 58.3 83.9 42.8 59.3 61.8 48.2 62.7 87.0 127.0 62.8 119.5 158.7 155.7 78.0 52.8 179.7 103.2 119.8 57.4 131.1 99.1 80.6 124.8 153.1 113.3 182.1 124.5 97.8 41.0 58.5 85.7 81.7 104.0 200.7 82.2 72.7 107.0 139.3 82.1 154.2 100.7 125.6 112.2 72.7 78.3 127.8 124.1 75.8 71.5 69.6 193.9 66.3 78.2 67.3 174.6 107.1 103.6 76.7 68.6 62.7 131.4 124.9 123.3 89.9 140.9 61.5 87.1 90.6 125.4 80.6 55.6 101.8 58.2 112.8 215.1 75.1 9.9 138.2 15.5 14.1 84.2 13.1 39.0 13.8 14.7 76.9 37.6 19.9 10.9 181.4 15.7 69.8 25.1 17.5 52.3 51.3 56.6 55.5 53.3 51.3 60.4 55.4 53.4 48.3 55.5 56.0 54.4 62.7 29.4 9.6 56.3 11.1 67.7 74.9 81.8 70.6 66.6 16.2 62.7 39.4 32.1 61.5 51.5 71.7 37.5 202.9 33.6 42.7 137.0 97.1 6.0 32.9 36.9 56.9 64.8 54.3 13.1 74.1 92.2 67.5 46.9 34.3 28.5 37.5 38.2 121.6 153.9 20.2 13.7 58.2 61.1 158.7 145.4 13.2 86.6 128.5 80.0 16.9 123.2 24.8 64.9 5.5 19.6 62.3 93.5 89.9 66.2 145.2 121.1 202.3 57.9 18.9 39.5 93.4 39.5 35.4 51.3 75.4 82.8 186.5 46.5 35.5 69.5 123.5 FETUB ENSG00000090512 "Fetuin B" Q9UGM5 3 186635969-186653141 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 236.5" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 47.2" "Cancer enriched" "Detected in some" 12 "liver cancer: 44.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035132, HPA035133" Supported Approved Vesicles "Secreted to blood" NA NA 47500000000 3600000000 Vesicles "HPA035132: AB_10601650, HPA035133: " "unprognostic (9.01e-2)" "unprognostic (1.95e-1)" "unprognostic (4.62e-1)" "unprognostic (8.74e-2)" "unprognostic (6.28e-3)" "unprognostic (1.24e-2)" "unprognostic (7.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.73e-2)" "unprognostic (9.18e-2)" "unprognostic (1.79e-1)" "unprognostic (8.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.4 236.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.9 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.9 0.0 5.3 0.2 0.2 0.1 0.0 2.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.7 47.2 0.0 0.0 0.0 0.2 0.0 2.9 0.0 5.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 DNAJB11 "EDJ, ERdj3, HEDJ" ENSG00000090520 "DnaJ heat shock protein family (Hsp40) member B11" Q9UBS4 3 186567403-186585800 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010814, HPA017051" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 100000 "Endoplasmic reticulum" "HPA010814: AB_1078691, HPA017051: AB_1847792" "unprognostic (4.29e-1)" "unprognostic (1.07e-1)" "unprognostic (2.98e-2)" "unprognostic (2.24e-2)" "unprognostic (8.53e-2)" "unprognostic (1.07e-3)" "unprognostic (3.86e-2)" "unprognostic (6.52e-2)" "unprognostic (7.95e-2)" "unprognostic (2.14e-3)" "unprognostic (2.58e-2)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.44e-9)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (1.82e-1)" 31.8 26.5 18.6 52.0 18.3 50.6 28.4 19.9 20.0 30.5 21.3 39.3 35.5 31.7 37.1 33.5 29.0 28.4 39.6 17.8 21.4 31.4 82.4 36.1 34.8 21.4 19.3 15.8 20.7 62.9 31.9 27.2 46.6 20.1 23.5 37.5 16.3 34.6 23.4 23.1 23.9 38.7 31.2 19.5 42.0 38.1 27.3 21.1 31.0 53.6 15.9 36.8 41.0 26.3 24.6 154.5 60.5 87.5 150.5 69.6 53.1 142.4 166.5 98.5 138.6 145.9 187.0 100.5 109.4 326.7 113.3 199.6 139.1 96.0 88.0 135.6 123.7 81.7 97.8 57.0 128.8 150.8 116.8 149.0 46.6 85.5 78.0 130.6 76.4 116.7 59.0 55.8 263.9 93.6 117.4 77.6 85.7 83.1 211.8 76.3 78.1 96.8 187.8 87.7 66.4 73.3 101.3 108.2 181.4 123.2 103.2 209.3 177.6 89.5 76.6 97.1 100.7 244.5 202.9 159.0 175.8 102.3 141.6 169.8 37.4 37.3 39.8 44.0 45.9 37.2 37.2 22.9 36.5 46.2 21.8 21.8 29.2 17.2 50.2 35.4 84.8 33.9 38.4 18.6 18.3 19.9 20.0 17.8 21.4 21.4 19.3 15.8 20.1 19.5 21.1 24.6 42.2 19.2 20.9 12.1 78.1 145.3 212.5 104.3 48.9 22.9 38.3 22.7 152.0 67.2 61.4 14.7 18.8 88.7 75.0 93.5 3.9 109.2 41.5 58.2 44.9 63.6 142.1 37.6 10.8 85.7 173.0 63.3 41.3 77.5 54.7 29.4 61.1 105.0 149.4 23.5 11.6 122.8 67.1 65.3 130.3 10.8 31.4 59.4 103.2 14.0 33.3 48.5 63.8 12.1 24.5 86.9 88.2 25.9 251.1 136.6 74.6 18.9 47.3 28.4 65.7 63.7 61.3 190.6 100.7 51.1 112.2 195.1 61.7 28.4 106.8 155.8 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 22 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 4.8 41.9 4.1 5.0 3.2 1.0 6.5 3.8 3.3 15.4 2.2 19.8 2.8 17.8 18.7 11.0 8.1 4.8 8.9 3.5 16.4 51.8 7.1 29.0 2.4 8.2 4.3 2.9 16.3 3.7 2.3 8.2 9.3 6.5 37.9 10.5 19.4 5.0 26.8 1.3 16.0 6.7 32.7 6.6 55.3 24.1 4.3 4.3 5.2 3.0 1.8 2.0 12.0 20.1 9.0 46.9 18.2 35.1 0.2 0.6 1.4 42.1 48.7 19.3 7.8 12.6 15.0 18.0 0.1 27.1 8.6 120.2 109.9 0.1 65.3 16.3 0.4 6.2 0.1 12.1 0.3 35.4 0.2 0.3 16.9 21.4 15.2 5.4 73.5 1.4 0.1 0.1 0.4 12.3 1.1 0.1 0.4 11.0 31.3 3.7 0.1 7.1 2.8 109.8 77.5 2.5 0.3 66.1 3.7 29.3 51.1 0.1 0.7 24.4 45.9 16.8 0.4 8.9 3.4 0.2 0.5 10.6 0.2 60.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 28.9 0.0 0.2 4.1 3.2 3.8 3.3 3.5 16.4 8.2 4.3 2.9 6.5 6.6 4.3 9.0 5.7 48.1 80.3 19.2 1.0 0.0 7.7 0.0 13.6 2.3 1.6 9.9 1.0 2.8 3.1 44.1 4.2 42.0 9.5 19.8 5.9 4.7 19.6 2.0 27.3 10.5 0.0 2.7 55.6 0.8 14.7 10.3 8.6 1.5 1.3 124.1 32.5 0.8 11.4 10.1 60.4 0.5 0.0 3.2 0.0 14.9 4.7 5.6 0.0 91.8 0.8 44.5 0.0 43.7 4.4 30.6 1.9 0.0 0.2 15.1 0.0 26.2 0.0 1.2 0.0 10.9 45.2 0.5 0.9 13.5 0.0 38.6 0.7 74.3 2.1 3.9 THPO "MGDF, MPLLG, TPO" ENSG00000090534 Thrombopoietin P40225 3 184371935-184381968 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 35.7" "Cell type enhanced" "Detected in some" "Early spermatids: 2.3;Hepatocytes: 12.7;Late spermatids: 4.0;Proximal tubular cells: 9.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 8.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.0;Hep G2: 15.6;K-562: 2.8;RPMI-8226: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1070000 "unprognostic (5.57e-2)" "unprognostic (3.15e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (1.37e-2)" "unprognostic (2.75e-1)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.40e-3)" "unprognostic (4.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.25e-2)" 1.6 2.6 5.1 0.5 3.8 0.0 1.4 4.6 4.8 3.5 2.3 0.7 0.2 3.8 1.3 0.4 2.1 0.4 1.2 4.2 2.8 4.5 35.7 0.8 0.2 3.3 2.7 3.9 2.9 1.7 0.1 0.8 0.5 3.5 1.3 0.3 0.0 0.5 0.5 1.9 0.5 0.7 1.5 2.8 1.3 0.9 4.0 2.7 0.0 0.8 0.9 0.1 1.0 1.9 3.4 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 15.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.3 0.6 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 3.8 4.6 4.8 4.2 2.8 3.3 2.7 3.9 3.5 2.8 2.7 3.4 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 1.6 0.1 0.0 0.0 2.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 12.7 0.6 0.0 1.3 0.0 0.0 0.8 0.0 4.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 1.1 0.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CHRD ENSG00000090539 Chordin Q9H2X0 3 184380073-184390736 "Plasma proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 131.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 31.2;Excitatory neurons: 28.2;Fibroblasts: 16.4;Hepatocytes: 36.4;Inhibitory neurons: 37.5;Skeletal myocytes: 19.1;Smooth muscle cells: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;Hep G2: 11.8;MCF7: 2.5;SuSa: 4.0;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035827 Approved "Secreted in other tissues" NA NA 350000 "HPA035827: AB_10669657" "unprognostic (2.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.63e-2)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.88e-1)" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.12e-2)" "unprognostic (6.55e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (5.53e-3)" "unprognostic (1.85e-1)" "unprognostic (9.84e-2)" "unprognostic (7.99e-3)" 10.3 12.3 12.4 2.1 12.3 0.0 10.0 17.3 21.4 33.3 8.2 6.8 1.6 33.2 3.3 3.4 15.1 2.6 10.2 13.6 9.3 18.8 131.1 7.3 1.5 8.8 9.0 12.5 16.5 17.3 1.1 6.1 2.4 14.0 9.8 0.8 0.0 3.8 5.3 4.4 5.2 6.1 4.7 8.8 9.8 7.8 1.1 8.3 0.3 7.8 2.7 0.3 7.3 15.5 12.1 0.0 0.0 0.3 1.1 0.1 0.1 1.4 0.3 0.0 0.2 0.1 2.8 0.0 0.0 1.1 0.3 1.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 11.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 4.0 1.4 0.0 0.0 0.0 3.8 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 12.3 17.3 21.4 13.6 9.3 8.8 9.0 12.5 14.0 8.8 8.3 12.1 2.6 0.0 0.0 11.8 0.4 2.7 0.0 0.0 0.6 2.9 2.1 1.8 3.1 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 31.2 2.6 0.0 0.0 28.2 3.1 0.0 16.4 1.1 4.5 0.0 0.9 3.3 36.4 0.7 0.0 37.5 0.2 0.0 3.2 3.1 0.0 3.7 0.4 1.8 4.7 0.0 0.0 0.0 7.1 2.5 1.1 0.0 2.2 0.0 0.1 0.0 4.0 0.0 0.5 6.6 19.1 16.4 0.3 0.3 0.3 1.1 0.1 0.7 0.1 0.0 0.3 FLT3LG ENSG00000090554 "Fms related receptor tyrosine kinase 3 ligand" P49771 19 49474207-49486231 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 22.6;T-cells: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 77.8;MAIT T-cell: 144.4;memory CD4 T-cell: 158.2;memory CD8 T-cell: 102.0;naive CD4 T-cell: 169.7;naive CD8 T-cell: 137.8;T-reg: 171.1" "Lineage enriched" "Detected in all" 6 "T-cells: 171.1" "Cell line enhanced" "Detected in many" "HDLM-2: 26.1;U-266/70: 25.0" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (1.29e-3)" "prognostic favorable (2.17e-5)" "unprognostic (2.12e-3)" "unprognostic (9.16e-2)" "unprognostic (3.05e-1)" "unprognostic (3.81e-3)" "unprognostic (2.58e-1)" "unprognostic (1.55e-1)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (1.16e-2)" "unprognostic (2.88e-1)" "unprognostic (7.78e-6)" "unprognostic (2.17e-1)" "unprognostic (5.25e-2)" "unprognostic (8.22e-3)" "unprognostic (5.68e-2)" 18.8 9.6 6.8 18.9 7.0 16.6 18.0 6.0 7.9 25.6 7.2 18.3 9.5 18.4 3.6 11.4 18.1 7.3 11.1 6.2 6.5 11.1 8.1 15.0 24.3 8.5 6.8 5.3 18.7 4.7 2.8 8.7 3.5 7.4 20.7 3.3 2.0 10.2 7.1 8.0 13.6 18.3 5.0 6.3 21.2 12.0 3.2 7.3 22.2 13.2 4.5 10.6 19.0 24.6 7.3 6.1 0.5 0.8 2.2 9.8 16.2 0.6 4.5 9.6 9.7 16.2 0.4 6.3 6.1 2.4 6.8 3.0 6.5 1.6 5.0 2.4 26.1 2.5 4.2 3.3 2.5 16.9 4.0 14.6 11.2 0.7 7.1 1.3 6.4 3.3 8.2 1.9 19.4 2.9 5.0 4.0 6.5 0.2 1.0 1.2 3.2 3.2 6.9 1.4 3.8 0.5 2.0 1.4 1.8 2.8 0.2 2.6 3.2 2.4 12.0 2.4 7.0 6.5 25.0 8.2 2.6 5.7 8.1 3.4 5.8 7.6 24.0 77.8 21.7 144.4 14.1 158.2 102.0 6.2 11.5 169.7 137.8 7.7 29.8 29.5 2.6 171.1 46.2 6.8 7.0 6.0 7.9 6.2 6.5 8.5 6.8 5.3 7.4 6.3 7.3 7.3 10.6 0.0 3.7 3.9 10.5 5.1 6.1 5.7 16.5 1.7 4.3 5.8 0.4 1.5 6.5 3.7 6.2 0.6 17.9 0.4 0.0 1.9 0.4 0.9 5.6 7.9 1.8 2.5 0.5 1.8 0.8 15.5 10.2 0.8 5.7 2.6 8.6 1.4 1.9 8.4 0.7 1.3 0.0 5.1 9.4 0.2 16.4 5.8 8.8 3.7 6.4 5.1 22.6 1.5 1.4 1.5 4.1 7.9 6.5 2.9 0.4 3.7 1.4 2.2 6.6 5.8 9.1 0.8 3.1 7.3 4.7 0.3 73.6 1.5 0.8 5.3 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425649-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 147.9" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 384.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Enhanced Enhanced "Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria" Yes No "Vesicles, Centriolar satellite" "Nucleoplasm, Cytokinetic bridge, Mitochondria" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favorable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favorable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favorable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 23.9 32.6 17.1 5.3 18.0 7.0 19.7 18.2 22.8 27.8 7.6 28.9 9.1 31.6 5.5 12.4 27.8 7.5 31.3 21.0 13.5 147.9 37.6 25.4 5.9 13.6 14.2 17.2 34.1 47.8 16.0 41.8 6.5 15.6 30.1 3.1 6.2 19.5 7.9 52.6 19.1 27.7 7.2 11.4 26.6 22.4 34.8 16.4 5.3 25.0 16.0 3.2 32.0 20.1 18.6 5.9 14.9 14.6 11.9 20.2 13.2 10.0 10.6 11.6 10.7 7.6 11.5 3.0 15.3 11.0 18.7 8.9 5.5 8.9 13.4 3.9 10.8 14.9 7.9 14.8 31.7 20.9 9.5 8.6 12.7 8.8 11.6 9.9 11.7 17.3 10.7 3.5 6.0 14.4 22.5 10.2 15.9 11.7 5.0 6.8 22.8 10.8 4.6 11.3 4.0 13.8 12.0 11.5 13.6 7.5 5.0 7.6 13.9 29.9 14.8 8.8 13.6 7.0 6.9 6.7 18.8 6.5 5.8 11.7 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 17.1 18.0 18.2 22.8 21.0 13.5 13.6 14.2 17.2 15.6 11.4 16.4 18.6 9.4 3.2 1.7 36.9 3.8 3.7 0.7 1.1 2.2 7.7 3.5 4.3 12.4 7.2 4.3 5.5 6.2 1.0 5.7 5.9 27.4 1.6 1.2 6.4 8.7 7.1 3.0 1.7 73.5 1.2 0.2 5.5 2.0 13.1 1.3 8.4 17.9 15.9 0.8 21.9 60.3 3.0 0.0 3.7 1.6 2.6 0.6 4.7 0.0 19.7 0.6 7.2 2.1 46.8 40.7 1.4 3.9 1.9 3.4 0.9 8.1 384.2 3.1 7.6 6.6 5.3 5.4 4.0 2.8 0.3 2.3 0.8 4.4 6.1 5.9 0.3 GNPTG "C16orf27, c316G12.3, CAB56184, GNPTAG" ENSG00000090581 "N-acetylglucosamine-1-phosphate transferase subunit gamma" Q9UJJ9 16 1351931-1364113 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 135.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004055 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 560000000 "Endoplasmic reticulum" Cytosol "HPA004055: AB_1079006" "unprognostic (4.37e-2)" "unprognostic (2.20e-2)" "unprognostic (1.84e-1)" "unprognostic (9.57e-3)" "unprognostic (2.70e-3)" "unprognostic (2.09e-1)" "unprognostic (3.03e-2)" "unprognostic (3.66e-1)" "unprognostic (1.69e-1)" "unprognostic (3.29e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.14e-2)" "unprognostic (2.20e-1)" "unprognostic (2.31e-1)" "unprognostic (4.85e-2)" "unprognostic (2.07e-2)" 34.1 94.8 29.5 19.5 35.8 25.2 34.8 34.1 43.7 30.0 37.0 27.9 17.9 30.0 29.2 23.8 28.7 23.9 28.8 28.7 30.2 36.9 41.2 28.7 28.1 34.9 31.7 26.9 36.0 39.9 40.5 33.2 21.1 34.1 30.2 16.4 15.8 43.3 20.9 34.9 37.5 31.2 15.1 32.9 38.6 35.1 21.6 32.7 13.4 34.2 17.0 14.5 29.1 26.7 40.5 13.3 21.2 15.3 26.9 135.2 50.3 20.1 38.3 49.6 14.9 28.4 19.1 37.0 8.4 43.0 51.8 22.5 24.0 9.2 22.4 7.6 27.0 20.2 11.3 73.9 33.0 57.6 18.2 43.2 67.3 38.4 14.2 20.3 41.6 27.5 15.2 13.7 48.4 24.6 30.7 8.7 18.7 14.4 33.9 11.8 30.5 12.9 38.6 37.3 17.1 12.0 15.5 38.5 39.2 28.7 8.5 36.9 27.3 27.0 29.8 25.5 24.6 19.1 50.6 40.4 17.7 24.4 15.6 20.3 70.5 77.0 49.5 43.3 74.4 39.6 32.1 36.7 40.8 61.5 31.1 33.4 30.8 32.0 32.6 73.9 52.2 46.9 49.7 29.5 35.8 34.1 43.7 28.7 30.2 34.9 31.7 26.9 34.1 32.9 32.7 40.5 39.7 41.7 41.7 17.3 31.9 20.9 26.5 25.4 46.7 15.1 34.0 42.9 9.4 37.1 43.2 20.2 25.0 25.0 34.9 25.8 9.8 27.4 2.6 17.7 29.8 25.6 9.1 9.9 22.7 14.5 20.3 49.7 47.4 23.7 24.6 21.1 30.7 35.2 50.2 8.4 20.5 18.0 14.2 43.4 41.7 4.6 30.1 47.8 33.8 9.4 25.7 31.0 30.9 15.1 32.4 14.8 32.9 17.7 76.1 22.1 32.1 41.7 28.5 24.5 19.7 24.4 22.9 25.4 24.2 48.1 20.3 31.1 30.6 20.5 21.7 24.5 ZNF268 HZF3 ENSG00000090612 "Zinc finger protein 268" Q14587 12 133181409-133214832 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001794 Approved Supported Cytosol NA NA Cytosol "HPA001794: AB_2666437" "unprognostic (7.65e-2)" "unprognostic (2.78e-1)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.94e-1)" "unprognostic (4.91e-3)" "unprognostic (2.21e-1)" "unprognostic (7.63e-3)" "unprognostic (2.57e-2)" "unprognostic (6.59e-3)" "unprognostic (5.69e-2)" "unprognostic (2.30e-1)" "unprognostic (8.79e-2)" "unprognostic (1.53e-3)" 5.7 6.6 3.0 4.0 4.1 3.6 9.6 5.2 4.0 7.5 4.6 5.6 4.4 7.6 7.5 6.5 8.8 4.3 4.4 2.9 4.8 9.4 12.9 5.6 6.2 3.6 3.6 2.8 9.7 5.3 13.2 3.9 9.6 3.5 8.1 5.5 12.1 5.6 7.0 2.4 5.2 5.2 5.9 3.4 6.0 7.2 5.9 3.5 7.4 10.8 4.9 7.1 6.4 3.7 4.5 6.9 10.1 21.4 19.0 9.0 11.5 14.6 10.2 10.8 9.3 7.4 10.6 4.6 5.9 15.5 10.3 9.4 6.3 10.5 12.8 11.8 0.2 8.5 14.6 5.3 13.4 9.6 14.1 12.6 16.9 12.6 11.1 17.4 12.5 10.8 5.6 11.2 7.8 15.9 8.2 5.7 6.4 15.8 8.7 0.6 5.7 6.6 7.3 5.3 15.9 15.3 12.9 20.9 7.0 9.1 18.2 17.0 12.0 11.6 10.6 13.2 3.7 9.3 2.8 4.2 12.9 5.9 7.3 11.3 1.9 5.1 6.0 8.2 5.0 5.5 9.6 9.3 10.4 7.6 7.2 14.2 10.2 1.6 10.8 8.6 6.0 5.2 5.0 3.0 4.1 5.2 4.0 2.9 4.8 3.6 3.6 2.8 3.5 3.4 3.5 4.5 8.0 19.2 22.3 6.8 10.0 1.8 5.6 5.7 5.2 24.3 10.0 8.4 8.4 12.8 13.6 7.3 20.9 14.9 3.2 2.8 5.9 8.8 15.5 7.1 9.0 9.5 3.6 15.8 8.4 6.4 9.4 9.7 4.6 7.5 2.5 19.1 14.6 11.0 9.8 21.9 10.0 6.9 4.1 6.7 3.0 4.3 10.5 7.7 5.4 10.3 5.5 15.8 8.2 11.6 12.9 7.7 7.6 11.3 5.2 6.3 5.5 11.5 7.1 19.1 6.6 17.4 8.8 14.9 17.3 6.4 2.8 8.6 7.5 12.4 6.9 4.4 GOLGA3 "GCP170, golgin-160, MEA-2" ENSG00000090615 "Golgin A3" Q08378 12 132768914-132829078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 110.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039809, HPA040044" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA039809: AB_10962348, HPA040044: AB_10981600" "unprognostic (1.93e-1)" "unprognostic (7.91e-2)" "unprognostic (6.80e-2)" "unprognostic (1.41e-1)" "unprognostic (2.56e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.10e-1)" "unprognostic (7.69e-2)" "unprognostic (1.55e-2)" "prognostic favorable (3.87e-4)" "unprognostic (2.99e-1)" "prognostic unfavorable (6.47e-5)" "unprognostic (1.40e-2)" "unprognostic (1.45e-1)" "unprognostic (2.01e-2)" "unprognostic (1.20e-1)" 12.2 12.4 20.6 12.6 18.6 13.8 11.7 14.9 21.3 15.8 19.7 15.6 8.0 14.8 9.3 16.4 12.9 8.8 13.4 20.0 18.2 9.3 14.2 13.6 12.9 18.9 18.3 19.3 17.2 19.8 7.9 27.1 10.6 23.5 14.9 11.8 26.6 17.4 10.9 14.8 15.2 13.7 12.4 14.1 15.2 15.2 11.7 19.7 17.8 12.6 8.7 11.2 14.6 14.5 25.6 19.7 39.1 13.4 23.2 42.2 28.7 25.9 34.1 23.3 23.8 20.9 40.7 8.7 25.6 16.8 45.4 17.1 19.7 16.3 19.6 14.1 6.4 17.3 27.6 44.6 26.0 25.9 29.5 36.2 23.4 22.8 26.8 26.6 23.4 22.7 19.1 27.1 9.8 21.0 30.2 27.0 26.7 14.0 15.1 24.8 21.8 14.1 10.9 13.4 47.1 16.1 10.5 27.0 22.9 14.6 15.2 31.1 22.2 38.7 23.5 17.6 26.8 21.9 31.0 32.0 40.4 28.8 16.3 28.7 3.2 2.0 2.6 3.4 2.9 3.1 2.5 2.6 3.3 2.3 3.4 2.7 2.9 1.5 3.9 2.3 3.9 3.6 2.0 20.6 18.6 14.9 21.3 20.0 18.2 18.9 18.3 19.3 23.5 14.1 19.7 25.6 22.9 44.8 40.6 25.8 22.0 21.7 12.7 17.0 13.1 26.0 21.2 16.1 35.4 8.6 26.8 14.7 100.1 13.4 20.6 63.0 7.9 15.2 23.8 21.8 46.9 24.8 22.2 16.4 40.2 27.8 24.2 29.0 48.9 47.5 12.0 33.3 14.6 24.1 16.0 18.5 41.1 50.2 10.2 15.1 16.4 34.6 25.7 18.2 17.8 21.5 18.4 20.1 23.7 22.6 33.3 31.5 27.1 22.6 54.2 32.3 17.9 8.6 26.4 110.6 6.6 32.1 27.7 25.1 24.8 19.0 33.1 23.1 21.7 24.6 32.5 29.4 PABPC4 "APP-1, iPABP" ENSG00000090621 "Poly(A) binding protein cytoplasmic 4" Q13310 1 39560709-39576790 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 473.7;skeletal muscle: 562.0" "Cell type enhanced" "Detected in all" "Kupffer cells: 460.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027301, HPA056496" Supported Enhanced Cytosol NA NA 850000 Cytosol "HPA027301: AB_2672208, HPA056496: AB_2683153" "unprognostic (6.81e-2)" "unprognostic (7.01e-3)" "unprognostic (2.93e-2)" "unprognostic (5.45e-2)" "unprognostic (3.63e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.22e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (3.00e-10)" "unprognostic (1.87e-1)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.08e-1)" 94.0 96.7 24.9 51.7 26.8 77.4 76.8 25.5 29.6 69.2 34.4 77.3 37.1 87.9 41.5 72.7 68.3 40.2 149.2 25.8 31.2 52.4 82.7 73.5 65.6 32.9 26.4 21.4 125.8 473.7 28.2 37.6 50.0 34.6 59.8 33.0 22.9 76.1 37.2 562.0 65.1 67.3 46.6 30.5 71.8 154.3 100.2 30.5 33.0 55.4 246.8 65.7 92.7 69.8 32.7 280.8 90.3 75.7 143.3 223.0 441.9 250.7 161.6 135.2 143.5 103.6 175.0 142.2 239.7 150.3 238.5 58.0 131.5 161.2 197.8 175.8 120.6 128.7 200.2 94.1 194.7 234.5 146.5 122.5 392.7 234.3 164.0 252.6 180.0 179.4 174.9 211.3 126.6 231.5 131.5 135.3 132.8 268.9 95.4 98.0 105.4 274.6 194.9 138.4 343.0 63.9 106.9 118.3 106.1 266.1 137.3 115.8 388.9 146.2 118.6 161.8 308.1 201.3 315.1 423.3 202.5 181.7 130.8 78.6 9.8 18.2 4.8 14.2 22.9 13.3 16.0 20.6 13.0 19.0 19.9 25.3 17.6 1.9 11.8 33.0 18.2 14.9 7.9 24.9 26.8 25.5 29.6 25.8 31.2 32.9 26.4 21.4 34.6 30.5 30.5 32.7 55.0 19.2 48.9 8.8 120.6 55.8 80.7 36.5 45.5 25.9 104.4 77.5 145.3 90.1 47.7 47.8 81.3 85.2 82.0 115.5 41.1 44.4 70.7 49.0 95.7 50.5 59.3 75.3 9.4 92.3 154.1 69.1 88.7 78.9 53.2 83.0 69.9 152.7 100.5 33.7 10.3 87.5 26.4 460.9 104.6 25.6 69.0 162.4 56.9 13.1 78.6 29.1 30.9 6.0 13.7 57.0 83.2 46.3 212.5 103.5 96.4 46.5 17.5 110.5 6.6 85.3 75.2 37.4 186.3 77.5 41.8 107.1 66.7 86.2 81.7 114.9 CD209 "CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1" ENSG00000090659 "CD209 molecule" Q9NNX6 19 7739993-7747564 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 34.5;placenta: 23.0" "Group enriched" "Detected in some" 4 "Kupffer cells: 15.6;Langerhans cells: 14.7;Macrophages: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2" "Group enriched" "Detected in many" 4 "dendritic cells: 1.2;monocytes: 1.4" "Cell line enriched" "Detected in single" 14 "THP-1: 3.3" "CAB032436, CAB033831" Supported "Intracellular and membrane" NA NA 3100000 "CAB032436: AB_639039, CAB033831: AB_1121347" "unprognostic (2.76e-1)" "unprognostic (1.15e-2)" "unprognostic (5.36e-3)" "unprognostic (1.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-2)" "unprognostic (3.83e-2)" "unprognostic (2.10e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (6.17e-2)" "unprognostic (1.09e-1)" 34.5 3.9 0.6 8.7 0.6 0.4 4.4 1.4 2.3 4.0 5.7 10.6 14.4 1.4 1.0 4.9 2.5 8.7 4.6 0.3 0.9 1.6 3.4 4.9 18.2 1.0 0.8 0.3 1.0 1.0 0.8 0.7 23.0 0.8 0.8 14.0 0.1 2.1 2.0 0.9 1.3 19.4 10.7 0.8 2.4 4.1 2.1 0.6 5.4 1.4 1.5 2.3 20.4 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 1.4 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.4 0.6 0.6 1.4 2.3 0.3 0.9 1.0 0.8 0.3 0.8 0.8 0.6 1.0 0.3 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 15.6 14.7 0.3 0.0 12.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.9 0.1 0.1 0.0 0.0 0.1 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 71.3;Muller glia cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 55.1;NB-4: 99.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favorable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favorable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favorable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 13.4 13.1 30.6 10.1 35.4 3.4 31.4 25.1 37.3 30.5 16.1 14.2 6.3 21.7 62.0 64.8 21.5 11.3 14.9 33.7 25.7 27.3 58.1 19.5 20.1 35.1 29.7 30.8 22.2 89.8 29.3 22.4 2.0 31.6 33.2 4.0 37.3 55.5 17.7 3.2 44.1 15.3 12.1 29.9 17.8 27.0 11.5 28.6 13.3 52.3 5.3 20.5 18.6 33.0 41.1 0.4 2.1 2.1 25.0 0.8 0.2 1.7 3.1 8.4 3.7 1.7 19.5 1.7 40.0 27.4 0.0 9.6 13.6 16.4 0.4 1.7 35.5 12.4 7.6 0.1 55.1 31.6 0.0 21.3 12.3 20.7 8.8 18.9 10.5 0.3 17.7 5.9 1.2 0.0 0.8 2.6 99.8 25.4 0.2 8.7 49.1 0.8 3.0 6.3 0.0 9.3 12.2 4.3 0.7 14.5 16.7 18.8 8.8 0.2 2.9 7.8 18.6 0.1 24.5 21.1 32.0 0.1 61.9 2.8 12.3 7.1 27.4 7.5 3.9 5.7 19.8 4.3 4.6 4.1 17.7 3.9 3.8 22.4 22.4 2.4 3.9 5.5 5.8 30.6 35.4 25.1 37.3 33.7 25.7 35.1 29.7 30.8 31.6 29.9 28.6 41.1 3.2 6.4 10.7 27.1 31.2 18.0 13.2 12.0 15.4 24.5 47.0 28.8 4.1 22.8 22.2 1.8 18.8 3.4 17.2 0.2 7.9 20.0 1.7 7.9 11.2 8.6 23.9 4.0 38.3 30.5 0.9 15.7 3.1 7.6 12.7 14.4 8.2 71.3 16.4 11.8 24.4 1.3 8.2 7.1 7.2 7.3 14.3 6.7 26.6 16.9 19.6 150.3 27.8 47.7 48.1 9.4 2.5 16.1 12.4 40.6 0.4 44.6 27.8 29.5 6.6 6.9 13.8 1.0 1.6 20.6 25.9 2.9 15.7 2.7 2.5 11.9 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522624-7534009 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 109.4;Kupffer cells: 117.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1" "Group enriched" "Detected in all" 5 "granulocytes: 117.5;monocytes: 105.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favorable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 19.9 37.7 5.8 9.3 5.5 10.5 15.4 6.0 8.5 11.3 7.4 13.5 8.4 11.7 2.7 11.1 12.3 10.1 15.0 6.0 6.4 11.6 14.9 20.5 13.3 7.1 5.9 5.6 10.1 9.9 10.3 21.9 16.1 8.2 8.8 5.7 5.1 12.4 6.1 22.3 20.2 12.2 8.2 6.2 48.6 12.9 5.7 6.6 6.3 8.5 11.8 4.1 15.9 11.0 8.4 11.6 11.7 5.6 19.1 32.0 10.3 16.1 21.2 16.9 25.2 21.6 9.0 10.0 6.5 25.5 14.5 22.2 5.3 9.5 7.3 7.4 12.7 21.1 5.8 11.0 7.3 28.0 6.6 24.5 14.5 16.8 24.1 4.2 7.9 10.7 14.2 10.9 27.9 14.7 3.9 9.1 6.6 12.6 6.1 24.8 12.6 9.4 13.8 9.6 9.9 14.4 17.8 9.1 15.8 26.8 6.1 9.6 11.4 13.5 12.0 6.9 48.8 16.0 21.5 35.5 4.7 19.2 9.2 18.4 117.5 45.2 105.7 7.7 95.5 6.3 4.2 6.5 6.3 19.2 4.1 6.0 6.5 41.1 10.3 105.1 21.1 10.0 17.1 5.8 5.5 6.0 8.5 6.0 6.4 7.1 5.9 5.6 8.2 6.2 6.6 8.4 15.1 3.2 2.6 5.9 8.0 13.4 6.5 16.9 10.2 27.3 15.9 15.0 2.3 15.7 8.1 31.3 22.9 11.6 12.1 32.0 1.9 23.7 4.8 5.0 19.8 14.1 16.8 21.7 10.6 23.1 20.0 16.0 9.7 6.5 1.3 22.2 13.6 13.6 109.4 58.9 8.0 10.0 22.4 117.1 32.2 17.0 16.4 70.6 21.4 7.5 18.0 23.0 16.5 7.5 11.4 23.4 19.3 15.8 8.0 5.6 21.8 12.3 6.5 44.1 6.6 11.2 14.8 10.3 14.7 8.9 17.3 29.6 8.7 17.3 9.4 4.8 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 200.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 23.5 47.9 20.4 26.8 27.4 43.8 26.7 33.3 26.0 26.8 24.0 23.9 21.9 25.6 20.6 23.2 22.5 19.1 21.7 21.0 22.9 18.4 24.0 23.3 35.3 22.8 23.0 20.3 31.4 24.8 25.4 27.1 27.5 24.2 23.7 26.2 57.5 31.5 18.8 23.3 29.7 29.0 23.1 20.7 36.2 32.8 20.8 23.2 27.2 28.9 19.7 34.7 23.3 24.8 38.1 43.9 20.5 47.0 34.0 40.1 49.0 46.4 54.0 36.5 35.3 46.6 19.1 43.2 49.1 35.6 48.8 27.5 39.2 59.0 43.4 53.6 48.3 42.1 104.3 75.7 34.5 35.5 53.0 53.7 39.8 36.6 36.1 39.7 48.1 106.1 36.2 83.8 133.2 44.0 21.9 44.2 68.5 29.7 44.5 36.8 61.3 47.2 57.3 40.7 36.2 57.1 35.6 50.4 45.7 122.7 62.3 23.4 63.0 76.1 37.7 30.9 46.7 31.8 105.6 81.7 48.1 36.3 64.5 56.6 82.1 19.5 35.0 12.2 9.4 13.9 28.6 17.8 17.9 21.1 29.8 20.5 13.1 16.8 12.2 10.9 15.3 21.4 12.6 20.4 27.4 33.3 26.0 21.0 22.9 22.8 23.0 20.3 24.2 20.7 23.2 38.1 37.9 54.5 42.1 32.0 55.4 22.2 25.1 30.3 33.0 86.5 22.2 24.5 65.3 21.5 24.4 20.2 62.6 61.4 48.3 17.8 25.4 28.5 71.4 33.3 48.5 32.5 21.7 88.1 66.4 20.0 56.3 42.0 33.1 41.4 49.9 200.4 27.5 22.1 29.2 50.5 74.2 31.3 32.6 22.6 28.1 47.7 34.8 34.4 58.7 52.5 55.9 30.7 36.0 54.3 112.3 23.8 16.4 51.6 150.1 20.7 24.1 20.2 27.3 69.2 32.9 51.7 39.8 52.7 47.4 35.1 25.7 32.6 41.8 54.8 31.6 21.6 EFNB1 "CFNS, Elk-L, EPLG2, LERK2" ENSG00000090776 "Ephrin B1" P98172 X 68829021-68842160 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.3;Granulosa cells: 134.5;Hepatic stellate cells: 143.5;Suprabasal keratinocytes: 120.5;Theca cells: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 97.0;hTCEpi: 74.1;PC-3: 70.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031489, HPA067188" Uncertain Supported "Plasma membrane" NA NA 1300000 "Plasma membrane" "CAB031489: AB_631414, HPA067188: AB_2685799" "unprognostic (2.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.04e-1)" "unprognostic (2.48e-2)" "unprognostic (8.05e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (1.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.76e-2)" "unprognostic (8.03e-2)" "unprognostic (1.72e-3)" "unprognostic (1.86e-2)" 43.1 23.9 8.4 8.3 8.2 2.3 41.6 7.5 11.9 26.6 7.6 20.8 19.3 19.5 10.8 32.2 19.8 18.4 25.2 8.7 10.3 43.5 11.7 41.9 4.4 8.2 7.6 7.5 14.4 7.6 16.6 10.4 25.6 7.7 20.0 13.4 1.2 11.3 16.3 9.2 49.6 20.8 8.9 7.9 26.3 18.3 6.3 8.4 5.6 19.8 9.6 4.8 26.1 28.1 8.4 10.4 5.3 41.9 15.6 21.7 13.4 21.9 8.7 9.5 3.8 2.8 4.8 19.0 2.5 56.7 3.3 5.0 54.3 40.0 97.0 2.1 4.3 10.2 2.6 2.3 8.5 20.0 1.9 21.3 25.0 74.1 9.4 42.4 3.4 29.3 5.3 2.8 0.2 3.3 8.5 4.2 2.0 29.0 63.5 70.9 18.6 4.4 16.6 15.9 36.1 15.6 7.5 6.7 2.0 2.6 31.7 1.6 3.6 49.7 7.2 8.9 19.6 3.3 0.1 2.3 2.5 3.6 11.3 4.7 0.0 0.6 0.3 0.4 1.7 0.3 0.3 0.4 0.4 3.5 0.2 0.3 0.2 0.1 0.7 1.1 0.5 0.2 0.5 8.4 8.2 7.5 11.9 8.7 10.3 8.2 7.6 7.5 7.7 7.9 8.4 8.4 81.1 3.2 1.1 2.6 3.2 117.3 66.2 60.7 93.4 3.3 3.6 11.2 8.2 20.0 12.8 22.0 0.0 11.4 5.9 59.4 0.0 16.4 0.4 2.6 7.6 42.4 8.4 2.7 1.0 15.6 75.9 20.5 21.4 4.5 4.5 134.5 143.5 4.8 12.4 1.7 1.0 27.6 8.2 9.1 23.8 1.3 27.4 8.6 21.4 2.8 5.9 12.5 2.1 0.5 0.6 46.3 52.6 8.2 2.3 40.2 28.6 5.7 2.8 1.3 13.1 8.7 12.5 2.0 3.8 76.2 120.5 11.2 4.7 116.2 29.8 93.6 PDPR PDP3 ENSG00000090857 "Pyruvate dehydrogenase phosphatase regulatory subunit" Q8NCN5 16 70114332-70162537 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048092, HPA070386" Uncertain Approved Mitochondria NA NA Mitochondria "HPA048092: AB_2680261, HPA070386: AB_2686263" "unprognostic (8.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (9.04e-3)" "unprognostic (6.81e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (2.90e-1)" "prognostic favorable (8.36e-4)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (2.17e-1)" "unprognostic (6.24e-2)" 11.0 12.7 11.0 8.2 13.3 16.0 11.4 14.4 12.1 12.2 9.8 13.4 9.2 14.2 12.0 8.2 13.0 6.8 14.9 11.3 11.0 16.5 8.7 9.6 11.2 13.3 12.9 9.5 13.6 12.4 10.3 10.5 9.0 14.9 11.0 11.9 12.2 10.4 9.7 23.4 12.3 13.8 15.2 10.7 15.5 12.1 19.3 11.8 15.9 13.1 13.8 12.6 13.9 9.9 16.9 6.9 19.4 17.9 33.0 32.6 20.9 12.1 11.1 19.4 17.4 13.1 25.1 13.4 14.4 19.1 35.8 16.1 26.7 26.4 24.1 20.3 3.5 9.1 35.8 12.7 17.6 9.3 39.9 27.9 28.0 22.6 25.1 23.0 25.2 18.7 26.6 24.6 6.6 15.3 20.8 25.3 23.3 27.8 4.9 10.0 49.0 18.5 14.9 13.8 16.3 8.3 12.3 30.2 6.2 8.2 24.2 24.4 12.4 10.9 20.4 27.3 17.6 17.9 15.4 17.9 50.9 9.1 13.8 13.5 1.6 1.5 1.4 1.4 1.5 2.0 0.9 1.1 1.3 1.6 1.5 1.3 1.5 1.1 0.9 1.5 1.5 1.3 1.0 11.0 13.3 14.4 12.1 11.3 11.0 13.3 12.9 9.5 14.9 10.7 11.8 16.9 12.6 22.4 18.2 18.6 13.0 2.8 4.9 3.5 18.2 21.6 14.2 12.1 19.2 17.2 9.1 1.8 31.3 7.7 16.0 12.1 5.9 5.3 54.4 13.7 16.0 17.4 4.9 17.4 18.0 6.7 7.8 16.1 11.7 17.1 18.3 23.9 17.2 11.2 16.4 32.0 20.3 10.0 4.1 17.8 3.5 20.8 10.8 15.7 7.2 10.3 12.2 11.2 15.5 9.5 13.9 6.8 6.1 16.6 11.7 10.3 11.6 4.4 12.7 20.8 19.7 22.7 11.5 10.8 15.4 11.1 1.8 4.9 11.9 12.7 14.5 4.6 AARS1 "AARS, AlaRS, CMT2N" ENSG00000090861 "Alanyl-tRNA synthetase 1" P49588 16 70251983-70289707 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034261, HPA040870, HPA044223" Supported Supported Cytosol NA NA 620000 Cytosol "CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862" "unprognostic (1.98e-2)" "unprognostic (6.87e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (3.58e-1)" "unprognostic (2.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.36e-1)" "unprognostic (1.99e-1)" "unprognostic (1.76e-1)" "unprognostic (8.33e-2)" "unprognostic (2.92e-1)" "unprognostic (3.42e-2)" "unprognostic (3.75e-2)" "unprognostic (2.05e-3)" "unprognostic (8.22e-2)" "unprognostic (3.83e-3)" 43.3 55.2 63.3 33.7 64.7 7.9 41.8 74.1 90.2 41.1 48.9 43.6 26.2 50.2 50.0 29.8 40.7 22.5 46.9 63.2 73.8 44.0 72.6 45.7 30.2 78.6 71.2 57.7 37.6 76.5 75.5 50.5 35.9 86.8 40.3 26.4 59.9 53.7 47.7 62.9 28.6 33.0 48.3 68.0 38.6 52.2 24.0 77.6 36.8 67.2 40.1 35.8 46.3 33.1 95.1 123.7 192.8 52.9 205.7 127.3 115.0 125.7 97.7 135.3 119.7 151.8 162.5 163.2 140.4 127.2 99.3 90.8 137.2 160.5 133.1 170.7 63.2 54.7 135.6 78.0 152.2 348.0 74.4 77.2 133.9 193.8 228.1 508.4 91.4 120.3 209.3 176.0 173.4 91.3 282.0 89.4 85.0 104.3 160.0 108.5 170.4 36.1 317.0 84.7 60.3 67.9 57.3 269.5 62.3 246.1 75.8 197.7 181.3 75.2 85.2 82.9 84.9 78.8 233.8 174.2 258.2 155.4 124.9 175.9 6.5 7.8 2.7 11.9 13.2 13.0 12.8 9.7 11.7 11.9 9.1 11.2 12.2 0.1 22.7 14.1 7.0 8.0 12.6 63.3 64.7 74.1 90.2 63.2 73.8 78.6 71.2 57.7 86.8 68.0 77.6 95.1 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 63.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 29.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 52.0 0.2 0.0 0.0 0.0 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" NA NA 2100000 "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favorable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-4)" 40.9 37.2 25.7 17.5 27.5 9.0 40.6 25.7 26.6 52.2 19.0 41.6 17.4 58.3 22.6 31.1 47.1 20.6 49.3 26.0 27.9 42.5 25.9 38.6 16.4 26.5 31.0 24.8 69.6 58.5 34.6 39.2 25.1 27.5 37.8 18.9 20.5 36.4 25.1 54.3 34.9 36.7 30.2 26.3 35.4 36.6 41.0 29.4 20.2 43.5 16.6 19.0 42.7 41.1 31.2 38.4 52.2 44.7 43.3 113.7 113.2 42.8 45.0 64.2 48.6 68.3 34.4 116.0 22.8 59.8 102.9 35.8 71.1 30.1 62.1 80.1 10.3 26.1 17.9 37.8 54.3 70.5 29.3 12.6 68.0 32.8 63.6 66.3 91.3 100.8 54.8 19.0 24.9 44.2 70.0 14.1 26.0 34.7 81.2 20.6 33.9 32.6 59.5 31.6 17.1 15.8 23.3 87.3 24.9 25.0 47.7 28.2 36.5 79.1 46.1 40.9 48.2 30.3 47.4 51.2 41.1 86.3 22.5 46.6 3.2 16.7 13.3 19.1 15.7 19.2 11.6 23.8 20.9 18.5 10.1 28.2 22.6 7.3 15.4 19.9 18.4 21.0 19.0 25.7 27.5 25.7 26.6 26.0 27.9 26.5 31.0 24.8 27.5 26.3 29.4 31.2 52.8 64.1 50.7 114.3 46.4 27.1 27.2 33.0 55.8 68.5 35.6 35.6 79.5 77.2 39.7 51.5 146.0 78.0 75.6 33.5 7.9 39.9 39.7 49.2 79.3 62.0 38.6 25.0 133.4 42.5 43.6 101.4 38.7 58.0 3.8 91.0 75.3 40.7 50.1 70.7 155.3 31.9 24.4 68.8 42.1 28.1 96.9 44.4 42.7 62.8 64.8 59.6 111.2 97.5 137.3 40.8 28.8 114.3 100.2 33.6 47.8 44.2 44.3 57.9 92.1 84.6 59.9 89.2 87.9 30.5 21.6 75.2 72.4 72.4 32.9 26.4 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290104-70420886 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.3;lymphoid tissue: 12.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.3 0.3 0.6 3.3 0.2 11.3 0.7 0.2 0.3 0.6 0.2 3.8 3.1 0.8 0.0 3.6 1.5 0.5 0.2 0.1 0.5 0.2 0.5 0.5 5.5 0.8 0.6 0.1 0.1 0.1 0.1 0.5 2.3 0.4 0.1 4.6 0.6 0.5 0.1 0.1 2.2 3.4 1.3 0.9 2.4 1.7 1.5 0.4 12.7 0.2 0.0 6.6 0.9 1.1 0.7 60.2 41.1 61.0 30.1 2.9 5.1 24.0 44.7 23.8 59.7 51.6 46.7 34.3 36.7 27.4 22.1 46.2 35.1 66.6 24.2 66.8 42.5 33.4 41.7 50.1 33.4 0.7 46.7 27.8 1.7 1.5 49.6 28.2 7.3 37.0 27.7 53.8 79.1 57.0 38.7 43.0 23.1 61.7 63.8 43.2 47.1 82.2 34.6 14.5 23.4 40.1 33.5 72.9 30.5 18.6 30.6 24.5 18.1 26.0 39.3 50.6 42.6 54.1 22.6 41.7 52.0 20.8 50.4 60.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.3 0.1 0.5 0.8 0.6 0.1 0.4 0.9 0.4 0.7 0.1 0.0 0.5 1.3 1.3 1.8 0.3 1.4 0.6 0.2 1.1 0.8 0.4 1.5 0.2 0.0 0.0 7.0 0.9 2.2 0.0 0.0 0.4 18.6 1.5 1.3 1.2 29.5 1.9 0.0 11.5 2.1 3.1 1.6 0.0 12.2 1.1 0.1 5.3 0.0 1.9 4.6 2.0 1.3 0.7 0.8 0.0 1.4 0.0 0.0 0.2 3.1 0.0 2.0 0.7 0.1 0.1 0.0 8.2 0.4 0.3 0.1 0.4 0.0 0.0 0.2 2.9 8.7 5.4 7.2 0.3 1.8 1.8 1.3 6.6 0.5 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing adaptor 6A" Q8NDV7 16 24610209-24827632 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 15.8 21.2 5.0 6.5 3.3 6.1 15.0 9.3 6.6 17.1 4.7 16.3 5.5 23.7 11.6 11.4 17.8 6.4 11.1 3.4 4.9 10.3 13.1 12.9 7.2 5.7 4.4 2.4 20.8 19.3 13.3 23.0 6.6 6.0 14.7 6.5 7.0 15.0 8.1 14.1 13.2 15.4 8.1 1.3 10.0 15.3 6.6 5.4 8.7 17.9 7.0 7.4 13.1 13.5 7.0 10.1 13.8 16.0 8.7 13.6 17.7 9.1 16.9 13.6 12.0 13.1 10.2 8.2 10.2 7.1 17.0 12.4 11.2 20.1 14.2 18.0 10.4 10.4 10.2 16.7 14.1 11.7 10.5 6.9 18.0 7.3 15.8 10.2 14.8 16.7 6.6 15.7 6.2 15.8 11.9 8.8 6.9 23.1 4.9 6.8 17.1 12.4 9.1 9.1 9.3 7.7 10.8 11.8 7.2 6.6 12.1 8.4 6.8 15.5 15.3 10.5 7.6 12.0 13.7 11.6 16.5 14.3 6.4 11.3 0.5 0.5 0.4 0.5 0.3 0.4 1.1 0.5 0.5 0.2 1.0 0.7 0.5 0.3 0.6 0.3 1.0 0.5 0.3 5.0 3.3 9.3 6.6 3.4 4.9 5.7 4.4 2.4 6.0 1.3 5.4 7.0 51.2 38.5 60.0 289.3 45.5 34.9 17.8 21.9 39.9 97.1 42.8 41.0 75.3 51.5 32.3 46.0 118.9 22.4 49.9 38.3 17.6 23.6 17.2 38.7 65.5 45.5 55.9 34.9 283.8 24.5 15.1 50.5 33.6 42.8 39.3 76.5 60.3 115.3 21.2 176.7 414.6 36.3 22.4 56.2 26.5 11.3 69.0 28.7 30.2 138.7 36.1 42.0 50.4 265.4 234.2 28.5 36.1 81.3 44.7 26.0 42.8 19.2 29.8 81.7 19.7 52.8 60.9 41.2 30.6 38.1 28.7 8.2 39.0 36.5 35.8 17.4 PLEKHG2 "ARHGEF42, CLG, FLJ00018" ENSG00000090924 "Pleckstrin homology and RhoGEF domain containing G2" Q9H7P9 19 39412669-39428415 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant, Leukodystrophy, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 86.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017973, HPA048054" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017973: AB_2669719, HPA048054: AB_2680241" "unprognostic (3.55e-1)" "unprognostic (6.73e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.97e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.24e-2)" "unprognostic (4.48e-2)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (2.10e-1)" "unprognostic (4.99e-1)" "prognostic unfavorable (3.79e-8)" "unprognostic (8.01e-2)" "unprognostic (3.90e-2)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" 27.2 10.8 5.5 23.0 4.9 22.3 20.5 5.2 7.5 26.8 11.8 20.6 8.2 31.5 4.4 10.2 25.1 17.6 25.0 4.9 7.1 16.3 8.1 42.6 20.8 7.6 5.0 3.6 20.2 7.2 5.3 12.3 23.2 6.0 21.1 5.2 4.6 8.5 15.2 6.3 8.4 19.1 18.6 5.2 33.7 15.8 15.8 8.5 21.3 19.2 4.9 18.4 21.1 17.6 6.3 8.5 40.8 73.0 39.9 6.9 9.0 10.6 21.9 17.3 14.9 12.8 26.5 14.9 14.7 15.8 28.8 12.4 2.8 11.1 19.4 7.9 49.3 10.2 19.3 23.5 12.4 11.9 2.2 23.1 20.7 3.3 17.9 8.7 25.8 19.3 41.7 13.2 16.9 24.1 17.0 24.2 7.5 17.3 7.8 3.9 86.1 8.9 4.6 12.7 15.4 2.0 23.6 4.9 1.8 7.0 25.2 21.9 21.8 24.8 38.8 30.0 14.5 14.4 12.6 4.1 21.4 21.6 8.7 22.0 1.3 0.5 0.1 1.4 0.2 0.9 1.2 0.7 0.8 0.3 1.1 1.0 1.2 0.8 0.4 0.7 1.4 1.3 1.1 5.5 4.9 5.2 7.5 4.9 7.1 7.6 5.0 3.6 6.0 5.2 8.5 6.3 30.4 6.4 27.4 1.6 9.7 4.0 5.5 2.9 6.8 0.6 4.6 11.7 6.4 2.8 6.4 0.0 0.0 0.8 8.7 5.0 0.0 5.6 14.2 11.9 20.1 17.7 1.2 1.7 0.5 4.9 2.9 16.9 13.3 30.4 2.5 6.9 8.2 0.8 9.9 0.0 0.8 3.7 0.0 12.8 21.1 19.8 7.2 25.6 5.4 2.8 5.4 1.1 4.1 2.5 0.3 4.2 2.1 8.2 9.1 3.0 2.6 0.2 2.2 2.4 6.6 64.5 26.8 2.5 4.1 6.5 2.8 1.1 12.2 2.4 3.1 1.9 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.7;choroid plexus: 2.1;pituitary gland: 3.5;testis: 1.5" "Group enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.6;naive CD8 T-cell: 1.4" "Group enriched" "Detected in many" 13 "B-cells: 2.6;T-cells: 1.4" "Cell line enriched" "Detected in some" 6 "SK-MEL-30: 83.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024559, HPA056533" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA024559: , HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.0 0.0 4.6 0.1 5.4 0.0 0.0 2.9 5.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.1 0.0 0.0 0.0 0.1 4.7 4.0 4.8 0.2 0.0 0.5 3.5 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.1 0.0 1.5 4.1 0.0 0.1 0.0 0.1 0.0 0.0 5.3 0.1 3.9 0.9 2.0 0.0 0.0 0.6 1.1 0.0 0.7 0.2 0.5 0.9 0.1 3.7 0.0 1.5 0.1 2.3 1.0 0.2 1.2 6.0 0.2 0.1 0.3 0.3 1.0 4.6 0.0 0.0 0.1 0.1 0.1 0.1 4.3 1.1 0.1 0.3 0.0 0.2 0.0 0.7 0.0 6.2 0.6 0.2 0.2 0.2 0.2 13.6 14.1 2.9 0.1 83.7 0.3 0.0 0.2 0.0 0.0 2.6 0.1 1.0 1.4 0.0 0.9 0.1 0.5 2.3 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.1 0.5 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 4.6 5.4 2.9 5.7 4.5 4.1 4.7 4.0 4.8 4.2 4.1 4.1 5.3 0.3 0.0 0.0 0.3 1.1 0.3 0.3 0.4 0.0 0.5 1.3 4.7 0.5 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.7 0.6 0.1 0.7 0.2 3.0 0.0 1.7 0.6 0.6 1.0 0.5 0.3 0.0 1.7 0.0 0.0 0.3 0.0 3.4 0.3 0.0 0.0 0.0 2.2 1.2 0.1 1.8 0.0 0.0 0.9 0.0 24.6 0.5 0.1 0.0 1.5 0.2 0.6 0.0 0.0 0.0 0.7 6.6 0.0 0.6 6.5 39.5 0.2 0.1 0.3 0.5 1.7 0.0 0.1 NAT14 KLP1 ENSG00000090971 "N-acetyltransferase 14 (putative)" Q8WUY8 19 55485188-55487568 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 62.6;Horizontal cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEK 293: 168.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047187 Approved Mitochondria NA NA Mitochondria "HPA047187: AB_2679974" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (5.43e-2)" "unprognostic (1.32e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-2)" "unprognostic (7.01e-2)" "unprognostic (1.94e-1)" "unprognostic (2.97e-1)" "unprognostic (9.12e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (7.00e-2)" "unprognostic (6.74e-2)" "unprognostic (9.85e-2)" "unprognostic (1.58e-1)" 5.1 13.2 34.1 4.6 33.5 3.9 7.6 33.7 38.1 22.5 29.0 15.7 2.5 24.0 7.9 5.2 25.5 4.1 10.0 35.0 33.0 18.6 6.5 10.6 3.9 31.2 34.2 33.9 20.8 8.4 10.8 47.5 6.9 30.3 15.1 2.2 8.5 5.4 7.8 3.0 5.6 8.6 8.9 29.1 7.2 10.2 11.7 37.8 54.1 20.1 1.2 2.9 11.9 10.9 31.0 8.2 27.6 32.1 59.8 12.9 16.3 19.4 29.6 35.5 32.5 46.3 9.7 26.6 3.1 10.3 19.5 16.4 10.6 20.8 18.8 20.0 32.9 168.2 26.1 41.0 21.9 23.3 19.4 25.8 22.7 6.5 22.7 6.2 65.5 24.3 46.9 32.3 9.1 19.7 10.0 33.1 29.7 44.2 16.4 13.1 32.7 19.9 12.6 78.2 15.3 93.4 64.5 11.9 17.8 28.9 12.2 14.5 20.0 28.5 11.8 31.5 1.7 24.5 18.0 7.4 13.7 26.7 3.3 30.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.4 0.1 0.0 0.4 0.0 0.1 34.1 33.5 33.7 38.1 35.0 33.0 31.2 34.2 33.9 30.3 29.1 37.8 31.0 4.0 6.4 3.2 9.1 3.8 2.9 6.7 4.4 4.6 62.6 11.7 13.8 4.1 5.7 2.6 29.5 35.5 13.3 3.8 1.2 15.6 14.5 1.5 41.7 31.7 7.2 12.7 10.3 12.9 1.1 8.3 10.4 3.1 9.7 0.0 11.5 3.9 3.6 2.9 148.0 13.1 2.1 4.1 0.8 2.4 3.1 11.8 1.7 5.4 2.8 2.3 39.6 1.0 7.1 2.8 4.3 0.4 10.5 2.7 4.4 0.7 3.7 18.1 39.9 0.0 13.8 12.1 4.2 3.9 0.7 0.6 6.0 2.6 9.7 1.1 1.9 PITPNM2 "NIR3, RDGB2, RDGBA2" ENSG00000090975 "Phosphatidylinositol transfer protein membrane associated 2" Q9BZ72 12 122983480-123150015 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "lymphoid tissue: 88.1" "Cell type enhanced" "Detected in many" "Astrocytes: 33.6;Cone photoreceptor cells: 54.2;Excitatory neurons: 51.3;Horizontal cells: 40.4;Inhibitory neurons: 41.3;Late spermatids: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 29.5;JURKAT: 35.6;MOLT-4: 55.0;WM-115: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003414, HPA003978" Approved Supported Vesicles NA NA Vesicles "HPA003414: AB_1855410, HPA003978: AB_1855411" "unprognostic (2.43e-1)" "unprognostic (9.29e-2)" "unprognostic (2.00e-1)" "unprognostic (5.39e-2)" "unprognostic (2.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.26e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (9.28e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.19e-2)" "unprognostic (9.99e-2)" 4.7 9.1 10.8 4.6 12.0 5.3 3.8 4.7 15.8 5.9 14.6 5.4 4.7 4.6 3.7 4.8 3.7 2.6 4.9 12.9 5.8 6.7 11.1 6.8 3.3 4.6 3.3 11.6 15.5 3.6 6.7 8.5 3.6 5.0 3.5 2.5 15.3 2.4 3.9 5.0 4.2 4.9 5.8 0.3 4.4 4.6 7.4 4.4 88.1 3.8 3.3 1.9 7.1 4.9 4.4 4.6 8.7 2.8 4.1 1.9 3.7 16.8 0.7 1.1 2.3 1.2 3.8 3.7 0.0 3.7 1.5 4.8 12.8 2.3 2.2 0.8 0.3 2.8 29.5 5.7 10.5 1.3 1.1 6.0 1.8 3.8 3.0 2.3 10.8 4.5 35.6 6.8 0.3 2.9 2.9 55.0 6.1 3.2 1.4 3.9 15.7 0.2 11.4 4.1 4.7 2.5 0.9 6.3 5.2 4.1 1.6 1.1 3.1 13.3 3.3 3.7 5.4 5.1 0.8 1.0 20.4 8.2 2.2 25.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.6 0.0 0.2 0.5 0.4 0.0 1.9 0.0 0.0 0.3 0.7 10.8 12.0 4.7 15.8 12.9 5.8 4.6 3.3 11.6 5.0 0.3 4.4 4.4 16.2 0.0 5.0 33.6 2.8 3.6 0.7 0.7 2.2 19.6 1.5 1.5 7.3 2.8 1.6 9.2 54.2 1.3 6.3 6.3 1.9 3.3 33.0 3.7 3.6 9.3 0.0 1.7 51.3 4.5 6.5 3.8 2.0 5.2 1.3 0.8 6.4 16.3 0.5 40.4 41.3 3.7 0.0 0.6 1.1 87.7 1.8 3.6 1.8 10.3 1.3 3.7 10.3 22.1 1.8 3.9 0.3 4.9 2.2 1.1 6.1 2.6 0.1 15.8 0.0 2.1 2.5 8.2 4.7 3.6 1.6 3.7 4.8 0.4 2.6 0.6 EXOC1 "BM-102, FLJ10893, SEC3, SEC3L1, Sec3p" ENSG00000090989 "Exocyst complex component 1" Q9NV70 4 55853648-55905086 "Predicted intracellular proteins, Transporters" "Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037706, HPA044873" Uncertain Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Plasma membrane" "Microtubules, Cytosol" "HPA037706: AB_10670525, HPA044873: AB_2679125" "unprognostic (7.10e-3)" "unprognostic (4.48e-2)" "unprognostic (8.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.81e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.63e-4)" "unprognostic (2.84e-3)" "unprognostic (4.65e-2)" "unprognostic (2.04e-2)" "unprognostic (4.03e-3)" "unprognostic (1.55e-1)" "unprognostic (1.94e-1)" "unprognostic (3.11e-1)" "unprognostic (2.93e-2)" "unprognostic (6.24e-2)" "prognostic favorable (5.50e-5)" 18.9 16.7 19.2 17.5 21.2 12.8 20.2 21.3 20.4 17.6 20.2 18.2 16.9 16.7 20.6 29.5 16.7 15.6 16.6 19.2 20.6 16.1 10.3 17.5 18.4 22.1 20.5 18.6 15.2 13.0 20.6 14.6 20.9 21.2 14.4 19.3 18.7 17.5 13.0 13.7 28.3 16.4 15.8 20.7 21.0 15.8 17.1 20.4 14.1 16.4 13.6 20.1 16.4 20.3 26.2 21.8 12.4 21.9 25.3 36.9 45.9 14.6 30.2 30.1 24.1 25.1 8.6 37.1 20.9 20.6 32.6 29.1 25.4 18.0 23.9 34.5 11.1 12.4 19.4 14.8 10.1 34.7 21.3 26.4 37.4 32.1 25.1 27.6 31.2 39.9 16.0 28.3 20.1 53.0 13.8 15.6 21.5 13.9 31.2 23.4 18.0 16.4 17.1 26.9 23.6 16.2 28.7 18.0 29.2 25.5 18.5 18.6 22.6 48.5 29.7 24.2 25.8 26.3 23.9 12.7 18.4 38.6 23.4 28.8 21.3 14.6 13.1 6.5 19.0 8.8 8.4 9.2 9.5 14.3 8.3 8.3 6.0 19.5 12.5 23.6 6.4 11.6 7.9 19.2 21.2 21.3 20.4 19.2 20.6 22.1 20.5 18.6 21.2 20.7 20.4 26.2 44.7 41.7 38.0 77.4 24.5 34.8 14.8 34.0 22.2 48.8 26.4 21.2 29.1 17.2 35.6 22.0 31.3 60.8 21.4 38.3 19.6 23.6 45.3 41.0 47.5 39.0 22.2 19.6 72.6 20.0 31.6 28.9 22.4 37.2 36.7 35.5 40.0 12.3 40.9 28.6 86.5 28.8 24.4 37.7 47.4 16.7 21.5 37.8 40.9 56.2 38.7 40.3 22.6 73.4 138.0 36.2 32.4 23.7 19.0 17.4 37.6 21.9 44.7 32.5 32.9 25.9 27.9 47.6 31.6 42.5 39.9 51.2 27.8 44.6 28.7 26.8 RBM27 "ARRS1, KIAA1311, Psc1, ZC3H20" ENSG00000091009 "RNA binding motif protein 27" Q9P2N5 5 146203605-146289223 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (8.18e-2)" "unprognostic (3.17e-1)" "unprognostic (6.04e-2)" "unprognostic (7.03e-2)" "unprognostic (2.75e-2)" "unprognostic (2.04e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (4.73e-2)" "unprognostic (4.59e-2)" "unprognostic (1.65e-2)" "unprognostic (1.19e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-2)" "unprognostic (4.49e-2)" "unprognostic (5.51e-2)" "unprognostic (6.67e-3)" "unprognostic (4.09e-3)" 7.4 5.5 4.5 8.4 4.6 19.7 9.5 7.5 5.0 8.4 4.4 7.9 7.6 9.4 8.1 7.3 7.5 5.9 7.1 4.2 5.1 8.1 10.7 6.7 11.8 4.1 5.0 3.5 11.0 6.0 9.0 3.6 9.3 4.5 7.6 8.3 9.5 6.4 6.4 7.3 7.3 7.3 7.6 4.6 9.5 8.7 10.2 4.8 12.7 11.0 9.3 11.4 9.4 5.9 5.3 15.0 12.1 15.3 24.8 13.1 12.5 17.7 10.9 12.3 15.7 17.2 21.3 18.9 31.7 8.4 12.5 21.5 15.3 23.1 25.2 27.7 24.3 10.2 21.7 12.9 14.9 14.4 34.3 24.1 11.7 13.0 16.9 29.9 12.1 14.2 14.9 24.3 18.7 15.0 13.5 25.0 17.4 21.2 16.5 13.6 22.2 23.7 21.9 16.0 16.6 19.1 13.1 22.5 21.7 17.8 15.6 25.3 18.7 13.5 16.6 17.6 12.5 17.8 17.7 18.1 36.6 12.5 24.7 15.7 1.7 0.8 1.6 1.4 1.3 1.6 1.2 1.4 1.6 1.1 1.4 1.8 1.5 1.2 1.8 1.5 1.3 1.5 0.7 4.5 4.6 7.5 5.0 4.2 5.1 4.1 5.0 3.5 4.5 4.6 4.8 5.3 12.7 16.0 17.6 20.5 13.1 66.2 9.5 52.6 6.2 11.2 13.0 8.6 17.3 5.7 32.3 14.7 10.4 9.2 17.6 10.1 1.9 7.8 32.4 15.1 11.8 15.7 10.8 11.8 32.2 6.8 8.3 17.0 11.2 13.9 22.1 12.2 11.4 12.1 11.2 15.2 31.4 13.8 30.5 20.4 40.6 6.6 11.5 14.1 19.6 28.1 16.9 8.4 12.3 28.6 43.8 11.5 8.7 14.7 7.3 17.4 9.9 7.9 36.8 8.7 0.0 16.5 24.1 31.4 13.2 12.0 62.1 9.7 15.7 9.8 12.5 19.7 POU4F3 "BRN3C, DFNA15, DFNA42, DFNA52" ENSG00000091010 "POU class 4 homeobox 3" Q15319 5 146338839-146341728 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038215 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038215: AB_10697245" "unprognostic (8.41e-3)" "unprognostic (9.46e-2)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.86e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (9.54e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-3)" "unprognostic (1.20e-3)" "unprognostic (1.24e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (7.82e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 24.4 13.6 15.6 24.5 43.3 32.8 21.3 11.8 23.9 22.8 14.8 11.3 9.4 22.5 7.8 24.6 10.6 18.5 14.1 16.5 17.5 36.7 19.3 19.8 31.1 17.8 16.9 20.8 17.6 14.1 13.1 5.6 18.3 17.1 15.1 11.8 14.3 13.6 12.9 10.8 29.0 13.1 19.1 14.7 26.9 16.2 16.8 16.0 34.0 14.4 11.6 32.3 19.3 10.3 17.0 36.5 22.8 49.7 35.5 67.5 94.8 31.6 54.7 76.3 34.2 31.1 33.2 14.6 50.8 30.4 65.3 21.5 14.9 37.2 31.6 51.3 43.6 33.3 136.0 21.0 19.8 41.7 87.2 53.1 50.4 58.7 51.2 63.3 61.8 30.0 29.1 95.0 22.7 57.3 25.0 58.8 41.4 24.3 13.2 22.6 30.4 67.7 29.3 26.4 30.3 27.2 28.4 46.7 16.6 34.0 38.9 13.0 52.4 70.6 55.0 27.5 57.5 29.7 22.7 38.4 54.6 21.0 47.9 32.8 134.8 50.8 74.1 29.2 37.4 27.9 45.3 31.2 24.6 46.9 40.8 27.9 23.2 195.7 36.0 44.5 54.9 41.1 31.8 15.6 43.3 11.8 23.9 16.5 17.5 17.8 16.9 20.8 17.1 14.7 16.0 17.0 63.5 57.7 58.3 54.5 87.8 116.2 65.7 39.6 114.9 49.7 68.4 55.5 42.5 25.8 36.1 51.5 89.6 34.8 111.3 13.6 60.7 53.9 47.4 29.0 102.6 68.7 9.5 63.5 246.3 55.2 28.7 98.0 28.5 44.1 254.8 36.3 52.1 45.9 77.1 42.1 248.6 25.8 40.7 98.0 127.0 22.1 65.9 142.0 35.6 79.6 149.3 50.2 125.7 113.6 92.9 104.0 28.3 82.8 56.8 54.6 23.9 180.2 37.4 37.3 46.0 79.3 83.1 66.2 129.9 89.9 124.5 48.2 105.3 58.4 20.0 62.4 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.4" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 67.7;CAPAN-2: 110.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 9.9 5.0 5.4 12.4 7.0 5.2 10.3 2.9 7.1 13.7 12.3 13.8 10.3 9.3 1.2 54.4 10.6 9.4 6.8 3.3 7.2 5.4 8.8 10.4 11.0 7.6 7.3 1.5 8.2 10.6 8.5 6.7 5.3 8.8 13.8 8.1 4.4 30.7 4.0 12.6 30.7 13.4 4.4 3.0 13.5 14.3 28.3 11.6 9.1 7.9 2.8 10.2 12.2 27.5 10.5 31.8 67.7 9.9 14.7 5.5 5.4 21.2 6.8 5.7 7.2 9.9 19.1 110.9 9.8 4.7 6.8 38.1 23.2 5.3 32.1 4.5 22.1 11.3 5.6 14.4 16.9 7.4 8.2 13.7 9.6 19.1 18.7 10.0 5.6 5.5 17.2 17.3 14.3 8.8 15.3 12.6 28.6 14.4 23.8 10.2 13.8 9.1 17.7 3.4 24.4 3.9 8.2 10.9 18.4 9.3 8.6 18.5 21.6 5.8 40.5 19.0 13.8 27.1 10.7 13.7 11.2 8.8 8.8 21.3 17.7 11.6 17.2 8.6 13.3 6.2 6.6 7.1 8.5 10.1 7.3 7.1 7.9 22.8 4.2 18.8 17.8 11.0 8.4 5.4 7.0 2.9 7.1 3.3 7.2 7.6 7.3 1.5 8.8 3.0 11.6 10.5 7.3 6.4 5.0 5.2 13.1 33.9 19.5 87.2 23.3 2.6 7.1 4.8 2.3 4.3 59.2 7.3 8.4 18.5 12.0 39.1 3.9 19.4 33.0 8.1 3.1 5.9 9.1 3.8 5.7 10.8 13.5 6.5 61.2 10.7 3.8 3.2 7.1 4.3 21.6 3.3 5.2 25.6 22.4 11.0 7.7 10.4 5.6 14.5 7.2 19.7 10.0 5.7 8.2 18.1 10.0 23.1 37.9 4.9 13.9 20.0 21.0 3.2 62.8 9.2 6.6 3.0 7.3 11.0 11.0 27.0 35.4 37.6 9.7 1.9 26.1 62.5 NLRC4 "CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf" ENSG00000091106 "NLR family CARD domain containing 4" Q9NPP4 2 32224453-32265732 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.4;lung: 6.3;lymphoid tissue: 11.5" "Cell type enhanced" "Detected in some" "Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2" "Group enriched" "Detected in many" 32 "dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9" "Cell line enhanced" "Detected in some" "HL-60: 3.1" "Not detected" "Not detected" "HPA006592, HPA075894" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA006592: AB_2667620, HPA075894: " "unprognostic (7.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.25e-2)" "unprognostic (1.97e-1)" "unprognostic (8.88e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (6.33e-2)" "unprognostic (6.33e-2)" "unprognostic (6.03e-6)" "unprognostic (7.42e-2)" "unprognostic (2.06e-3)" "unprognostic (2.02e-2)" "unprognostic (1.63e-1)" 3.4 1.4 0.4 8.8 0.5 8.4 0.7 0.4 0.8 0.6 0.6 0.9 0.9 0.4 0.0 0.6 0.8 1.4 1.0 0.4 0.5 0.5 1.6 6.3 2.3 0.6 0.5 0.5 0.3 0.8 0.1 0.6 2.1 0.6 0.4 0.8 0.6 0.5 0.2 1.1 0.3 1.3 2.3 0.5 11.5 0.6 0.4 0.7 0.7 0.4 0.3 1.2 2.0 0.3 0.7 0.1 0.2 0.3 0.7 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.3 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.3 0.5 0.1 0.4 0.0 3.1 0.5 0.0 0.3 0.0 1.4 0.4 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.4 0.1 0.2 0.2 0.1 0.4 0.5 0.0 0.3 0.3 0.7 0.2 0.2 1.2 0.5 0.1 1.4 0.1 0.3 0.3 0.2 0.4 0.3 0.8 1.2 0.4 1.3 0.4 0.5 49.3 5.8 0.1 56.9 0.4 0.6 0.0 0.0 32.2 1.1 0.0 0.1 24.6 0.3 44.2 0.4 0.2 18.6 0.4 0.5 0.4 0.8 0.4 0.5 0.6 0.5 0.5 0.6 0.5 0.7 0.7 0.2 0.0 1.8 1.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 2.7 4.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 1.1 0.0 11.9 0.0 3.3 0.0 0.0 21.0 1.0 0.0 0.0 14.5 0.0 10.3 18.4 0.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.0 PUS7 FLJ20485 ENSG00000091127 "Pseudouridine synthase 7" Q96PZ0 7 105439661-105522271 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024116 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024116: AB_1848754" "unprognostic (3.07e-1)" "unprognostic (1.52e-3)" "unprognostic (9.03e-2)" "unprognostic (4.94e-2)" "unprognostic (8.91e-2)" "unprognostic (7.95e-2)" "prognostic unfavorable (4.89e-6)" "unprognostic (2.86e-2)" "prognostic unfavorable (7.58e-5)" "unprognostic (1.87e-1)" "unprognostic (5.64e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (1.03e-8)" "unprognostic (2.76e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.28e-4)" "unprognostic (4.90e-2)" 7.0 3.5 3.7 5.5 4.1 3.2 7.5 4.9 4.3 5.5 3.2 5.4 4.0 5.7 3.0 7.8 5.2 3.3 4.4 3.7 3.7 3.7 6.3 4.6 4.3 3.7 3.5 3.6 4.3 6.0 6.5 2.8 5.1 3.9 4.4 5.8 2.3 4.7 3.9 11.1 7.8 3.5 6.5 3.2 2.8 4.3 4.6 3.5 3.0 7.6 4.9 5.3 7.3 6.3 4.3 32.1 18.2 18.0 29.4 13.6 14.9 19.9 14.7 13.0 25.5 20.9 24.5 12.7 17.5 24.7 15.6 22.0 25.0 33.0 17.9 39.6 12.9 26.4 26.2 17.2 25.8 16.1 42.1 9.9 15.2 20.9 21.5 27.9 9.5 27.2 16.2 59.8 14.6 17.9 39.8 48.4 39.4 44.6 39.5 23.6 29.1 26.5 81.5 31.0 23.3 30.2 28.5 29.3 53.0 21.3 20.5 19.2 9.9 16.6 37.4 25.1 49.3 32.5 11.0 24.4 46.9 13.1 35.7 33.1 0.0 0.8 0.2 0.9 2.0 2.1 2.0 1.3 1.0 1.2 1.3 1.1 1.2 0.1 1.4 2.0 0.0 0.9 0.7 3.7 4.1 4.9 4.3 3.7 3.7 3.7 3.5 3.6 3.9 3.2 3.5 4.3 8.5 6.4 9.0 13.1 4.8 13.4 13.9 5.0 13.1 4.0 8.2 6.5 3.8 1.5 6.0 1.8 2.1 5.6 2.8 3.6 1.9 9.5 1.7 7.0 14.3 10.4 7.2 8.4 43.2 7.2 10.2 8.6 8.6 5.5 11.4 4.3 4.2 5.1 4.4 0.0 27.9 4.1 2.0 2.8 6.0 1.8 4.1 3.3 0.0 11.2 4.0 1.5 3.1 8.5 23.8 7.6 3.2 1.9 6.7 18.3 1.0 5.6 4.3 3.2 0.0 14.3 10.4 1.8 9.7 13.7 9.8 3.4 3.9 15.6 8.0 8.2 LAMB4 ENSG00000091128 "Laminin subunit beta 4" A4D0S4 7 108023548-108130361 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 39.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 34.9;Basal squamous epithelial cells: 41.5;Early spermatids: 12.7;Late spermatids: 11.1;Suprabasal keratinocytes: 13.8" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 1.8;HMC-1: 1.1" "Low region specificity" "Detected in all" "HPA020242, HPA024247" Approved "Secreted to extracellular matrix" NA NA "HPA020242: AB_2670388, HPA024247: AB_2671496" "unprognostic (7.41e-2)" "unprognostic (1.79e-1)" "unprognostic (4.85e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (6.29e-4)" "unprognostic (8.90e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.27e-2)" "unprognostic (1.23e-4)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.0 0.1 0.1 0.2 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 39.2 0.2 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.0 34.9 0.0 0.0 41.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 5.9 0.0 12.7 3.8 0.1 0.8 0.0 0.0 2.1 0.2 0.4 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 1.9 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 5.1 0.5 4.2 13.8 1.4 0.0 0.1 0.0 0.1 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 37.7;brain: 37.6;epididymis: 34.7;retina: 38.3" "Group enriched" "Detected in many" 7 "Astrocytes: 612.5;Excitatory neurons: 764.5;Inhibitory neurons: 392.4;Oligodendrocyte precursor cells: 1259.2" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 15 "T-cells: 2.0" "Cell line enhanced" "Detected in many" "A549: 99.6;AF22: 94.8;EFO-21: 175.4;HMC-1: 187.9;SH-SY5Y: 115.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in brain" NA NA 110000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.0 37.7 16.1 1.8 28.7 0.3 1.5 2.1 31.5 5.1 0.0 0.8 0.7 2.1 34.7 0.7 3.6 7.4 0.3 26.1 16.6 6.2 0.4 2.4 0.8 2.2 21.5 25.2 1.5 29.7 7.3 11.4 7.9 3.3 0.8 0.7 38.3 2.0 14.3 0.2 0.8 0.6 0.7 1.2 4.8 1.8 1.7 37.6 2.8 4.2 0.4 2.7 0.5 0.4 15.4 0.1 99.6 94.8 0.0 11.4 2.2 1.8 0.7 0.4 1.0 1.7 40.7 0.0 0.0 175.4 0.7 1.5 0.4 2.2 1.6 1.0 0.1 12.7 0.0 0.7 1.0 0.2 0.9 187.9 15.5 0.0 0.2 0.6 0.2 61.7 0.2 0.2 0.8 1.5 38.2 0.4 0.3 13.1 60.1 0.0 0.0 27.8 33.3 21.4 0.1 18.6 115.9 1.3 0.0 1.9 3.3 0.2 0.1 66.2 4.2 1.0 0.1 16.4 0.2 0.5 0.9 0.7 0.1 55.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.2 16.1 28.7 2.1 31.5 26.1 16.6 2.2 21.5 25.2 3.3 1.2 37.6 15.4 0.2 0.0 0.0 612.5 0.8 0.4 0.1 0.8 1.2 66.2 1.5 0.9 0.7 7.2 0.1 5.5 102.2 3.6 0.0 0.2 3.9 1.6 37.3 10.4 2.4 1.3 0.0 0.0 764.5 12.1 0.2 2.0 3.6 25.0 23.4 4.4 1.4 0.4 0.8 13.5 392.4 0.3 0.0 0.8 0.4 8.3 0.9 0.2 3.6 51.5 0.6 45.1 0.0 1259.2 21.9 3.7 0.0 0.4 2.6 1.2 0.0 3.3 0.1 8.8 0.0 1.0 2.6 1.1 2.7 0.2 0.1 4.4 1.1 34.2 0.0 0.0 LAMB1 CLM ENSG00000091136 "Laminin subunit beta 1" P07942 7 107923799-108003213 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 185.6;Fibroblasts: 99.6;Peritubular cells: 141.8;Theca cells: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 593.0;ASC TERT1: 815.3;HSkMC: 779.6;TIME: 547.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004056, HPA004132, CAB004256" Enhanced "Secreted to extracellular matrix" NA NA 250000000 "CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225" "unprognostic (2.39e-1)" "unprognostic (6.45e-3)" "unprognostic (2.01e-1)" "unprognostic (6.75e-2)" "unprognostic (3.45e-3)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (3.77e-2)" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "unprognostic (3.44e-1)" "unprognostic (5.01e-2)" "unprognostic (2.87e-2)" "unprognostic (4.50e-3)" "unprognostic (1.75e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-1)" 103.1 21.9 1.2 26.7 1.2 0.1 74.8 0.9 4.5 42.2 23.6 75.5 29.6 79.6 3.4 25.5 44.5 53.9 53.9 2.4 0.9 62.3 14.8 105.2 9.5 0.4 0.9 0.6 29.7 48.6 12.2 11.9 155.6 0.3 18.3 40.8 0.7 24.8 29.9 20.5 36.9 68.0 73.9 0.0 42.8 49.9 11.4 1.3 19.9 43.9 40.9 5.3 53.9 31.3 0.4 94.5 148.6 77.3 3.6 593.0 815.3 291.9 103.5 182.5 68.6 72.1 306.7 166.6 0.0 127.7 200.3 90.8 41.9 24.8 143.6 49.9 0.1 24.8 4.8 52.6 87.9 364.3 0.0 2.8 779.6 49.0 175.9 193.4 409.2 450.0 2.8 17.0 0.0 126.5 29.9 0.1 0.5 42.9 54.9 103.6 0.4 51.9 0.3 238.5 96.0 24.3 142.1 75.1 100.9 68.5 180.2 37.6 1.1 547.1 179.9 44.3 60.2 133.1 0.0 0.2 0.4 89.9 0.0 301.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.9 4.5 2.4 0.9 0.4 0.9 0.6 0.3 0.0 1.3 0.4 81.8 0.0 5.6 2.9 2.2 8.9 5.2 16.7 10.8 12.1 2.0 9.5 16.3 15.7 7.6 27.6 4.2 85.5 3.5 10.5 3.9 18.0 2.0 22.6 185.6 57.8 19.2 0.0 51.6 11.2 27.1 99.6 2.6 34.6 2.5 2.9 20.7 3.5 10.1 8.4 23.7 8.0 8.2 2.8 3.8 4.7 71.1 2.4 8.8 11.2 2.0 2.1 5.2 6.0 3.2 21.6 17.0 141.8 0.4 3.6 9.5 11.6 2.9 8.6 52.6 10.2 54.4 5.5 5.1 4.7 6.7 32.6 3.2 174.7 19.2 2.1 SLC26A4 "DFNB4, PDS" ENSG00000091137 "Solute carrier family 26 member 4" O43511 7 107660828-107717809 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "thyroid gland: 266.2" "Cell type enhanced" "Detected in many" "Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9" "Cancer enriched" "Detected in some" 8 "thyroid cancer: 37.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 8 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1" "Region enriched" "Detected in many" 4 "hippocampal formation: 9.7" "Region enhanced" "Detected in some" "hippocampal formation: 4.8" HPA042860 Approved NA NA "HPA042860: AB_10796680" "unprognostic (1.19e-2)" "unprognostic (4.84e-2)" "unprognostic (5.44e-2)" "unprognostic (8.44e-2)" "unprognostic (3.25e-2)" "unprognostic (3.26e-2)" "unprognostic (6.69e-2)" "unprognostic (1.85e-1)" "unprognostic (5.72e-2)" "unprognostic (9.58e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-2)" "unprognostic (1.39e-1)" 0.4 0.1 2.2 0.1 9.8 0.0 0.8 0.0 4.9 1.4 0.0 0.2 0.1 0.5 0.1 0.1 0.3 0.4 0.6 7.7 2.4 6.5 0.1 0.5 0.4 3.5 0.2 11.4 0.3 0.3 3.9 0.3 0.3 1.0 3.8 0.2 0.1 0.4 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.7 0.6 0.0 0.2 266.2 0.1 0.2 1.5 0.3 0.3 0.3 0.1 0.2 0.0 0.3 0.6 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.2 0.0 0.0 1.6 0.4 0.0 0.1 0.1 0.1 0.1 0.5 0.0 0.4 0.2 0.0 3.7 0.0 0.3 0.0 0.1 2.1 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.3 0.2 0.1 1.3 0.3 0.3 0.1 0.3 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 9.8 0.0 4.9 7.7 2.4 3.5 0.2 11.4 1.0 0.0 0.0 0.3 1.8 3.2 7.7 2.6 0.2 1.7 0.7 6.5 0.0 6.6 3.2 1.8 0.6 0.0 19.0 0.0 2.1 0.3 0.4 0.4 0.0 0.2 3.9 0.3 0.5 4.9 7.3 0.0 29.3 0.0 0.1 1.5 0.0 1.8 5.1 0.2 1.1 0.2 0.3 1.7 53.9 0.0 54.9 0.6 2.0 2.7 0.9 0.7 7.2 3.7 0.7 1.2 1.0 1.5 1.6 0.1 0.1 1.2 0.0 17.3 0.0 0.1 15.2 1.8 0.0 2.9 1.6 2.0 0.4 0.1 1.4 0.0 1.7 0.2 0.5 19.9 SLC26A3 "CLD, DRA" ENSG00000091138 "Solute carrier family 26 member 3" P40879 7 107765467-107803225 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 1130.8" "Cell type enriched" "Detected in some" 4 "Distal enterocytes: 2328.4" "Cancer enriched" "Detected in many" 14 "colorectal cancer: 52.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036055 Approved NA NA "HPA036055: AB_10602401" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.69e-1)" "unprognostic (4.02e-1)" "unprognostic (4.09e-2)" "unprognostic (3.05e-3)" "unprognostic (6.31e-2)" "unprognostic (1.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (2.05e-2)" "unprognostic (8.85e-2)" "unprognostic (8.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.54e-2)" "unprognostic (3.58e-3)" 1.1 0.0 0.0 19.9 0.0 0.0 60.1 0.2 0.1 0.2 0.0 1130.8 582.1 0.9 15.4 0.5 0.8 17.9 0.0 0.0 0.0 0.8 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.1 887.2 0.1 0.0 131.1 0.0 0.1 119.5 15.1 0.0 0.0 1.3 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 165.9 4.2 0.0 0.3 0.0 0.0 0.0 51.4 41.7 0.3 34.3 0.0 0.0 0.0 0.0 0.0 2328.4 0.0 0.0 6.4 1.8 0.1 0.3 14.3 0.0 110.2 0.0 0.0 0.1 0.0 0.2 26.7 0.2 0.0 0.1 0.0 0.0 114.3 32.5 0.0 0.0 0.0 0.6 0.3 0.1 0.0 89.9 0.0 0.0 0.0 101.6 182.1 0.0 503.4 0.0 0.0 0.3 388.9 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.2 0.0 86.0 0.1 DLD "DLDH, E3, GCSL, LAD, OGDC-E3" ENSG00000091140 "Dihydrolipoamide dehydrogenase" P09622 7 107891162-107931730 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 360.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 356.2;Distal tubular cells: 226.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044849 Supported Approved Nucleoplasm,Mitochondria NA NA 10000000 Mitochondria Nucleoplasm "HPA044849: AB_2679111" "unprognostic (2.01e-3)" "unprognostic (2.26e-1)" "unprognostic (1.27e-2)" "unprognostic (9.27e-2)" "unprognostic (5.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.48e-1)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (9.43e-2)" "unprognostic (7.35e-2)" "prognostic favorable (7.58e-9)" "unprognostic (4.08e-2)" "unprognostic (1.88e-1)" "unprognostic (4.45e-3)" "unprognostic (1.18e-1)" 109.7 99.7 23.3 42.4 23.8 54.5 49.5 26.7 29.4 36.6 33.2 110.1 82.6 45.7 21.4 95.0 34.6 48.9 266.6 23.2 29.1 154.7 113.8 39.7 50.5 26.3 27.3 21.7 30.3 49.6 137.8 28.0 43.4 26.7 46.1 100.2 35.3 50.6 50.8 297.8 39.2 72.5 68.3 24.9 38.7 81.2 31.6 25.9 43.6 64.8 360.1 68.1 66.8 32.9 24.9 171.4 134.5 74.8 127.9 104.6 91.4 88.4 96.5 80.8 110.6 86.2 159.5 95.5 165.9 159.6 103.0 177.7 110.9 150.2 135.8 166.1 111.1 88.4 116.9 175.6 116.7 80.3 194.7 116.0 104.8 97.6 116.4 63.4 72.3 134.0 137.0 298.5 119.7 121.8 188.1 161.8 138.9 87.4 206.0 98.2 113.1 117.8 225.9 151.8 250.8 92.3 99.9 156.3 262.1 143.9 149.9 100.5 165.8 87.9 120.7 97.3 238.1 149.4 89.3 187.1 114.6 115.0 204.1 130.2 132.7 63.9 136.0 46.9 81.6 49.4 37.8 46.8 46.8 87.2 38.5 47.9 50.5 39.9 68.1 116.9 29.9 49.0 64.2 23.3 23.8 26.7 29.4 23.2 29.1 26.3 27.3 21.7 26.7 24.9 25.9 24.9 26.7 28.9 20.7 14.7 26.3 31.4 42.7 124.7 31.3 47.1 24.0 19.2 356.2 51.5 70.5 79.1 22.9 110.2 27.3 56.1 226.9 69.3 10.2 27.6 26.2 32.2 30.6 53.9 23.9 55.9 62.7 36.3 36.7 28.0 26.6 35.3 26.0 86.8 69.2 21.9 25.3 44.1 114.0 41.0 26.5 7.3 23.3 37.5 37.4 15.9 62.2 36.0 38.1 21.1 16.7 42.6 51.4 42.2 30.7 24.3 60.0 178.9 55.5 45.5 26.3 28.4 44.8 55.2 51.5 48.0 32.4 108.4 29.5 73.7 78.7 39.2 WDR7 "KIAA0541, TRAG" ENSG00000091157 "WD repeat domain 7" Q9Y4E6 18 56651343-57029811 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042074, HPA051057" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042074: AB_2677833, HPA051057: AB_2732563" "unprognostic (1.03e-1)" "unprognostic (1.32e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "unprognostic (7.70e-2)" "unprognostic (9.21e-2)" "unprognostic (2.00e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.13e-5)" "unprognostic (4.80e-2)" "unprognostic (4.52e-3)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" 5.9 7.7 9.8 5.9 14.7 7.3 5.0 6.7 19.8 4.7 2.7 5.5 4.2 4.8 5.4 4.4 4.2 5.3 6.0 18.3 12.4 5.3 7.4 5.1 7.4 14.7 10.2 14.1 4.3 4.3 9.3 8.4 4.8 15.6 7.5 5.0 18.9 4.2 5.7 8.2 4.2 4.3 5.7 5.3 6.2 4.9 4.7 10.3 10.4 9.2 9.7 5.9 5.1 4.5 19.2 4.7 7.7 8.7 4.9 13.5 7.8 2.2 9.2 7.8 7.4 8.8 3.1 2.9 13.0 3.6 8.3 6.3 4.9 8.8 7.2 9.2 15.1 5.4 12.3 5.8 2.8 8.1 18.7 15.0 6.7 5.9 9.9 6.6 6.1 9.3 6.1 6.0 17.5 9.3 4.6 13.0 5.5 3.7 2.4 5.1 5.8 6.7 6.3 5.7 8.4 11.3 5.6 6.5 3.1 4.3 7.4 4.9 5.2 8.3 10.5 5.3 3.2 5.0 17.4 14.2 13.9 8.6 9.3 7.2 4.0 3.0 5.5 3.6 4.4 4.5 2.4 4.0 3.7 3.6 2.2 4.2 3.8 2.6 4.6 5.5 1.7 5.2 2.0 9.8 14.7 6.7 19.8 18.3 12.4 14.7 10.2 14.1 15.6 5.3 10.3 19.2 8.7 3.2 4.8 99.6 7.5 2.9 1.9 2.3 2.8 24.5 3.4 2.4 12.5 5.7 6.8 0.0 31.3 2.0 7.7 5.8 3.9 3.2 21.0 4.4 6.0 6.6 8.4 8.2 268.8 3.6 1.2 6.3 7.7 3.9 10.8 9.0 9.3 8.9 5.8 26.9 223.0 2.7 0.0 16.2 2.8 7.0 5.6 11.3 0.0 111.5 8.8 7.1 10.3 146.3 244.7 2.6 2.6 8.2 10.1 2.6 4.5 3.2 5.7 26.3 6.6 10.7 5.8 2.0 1.7 5.8 2.4 0.7 9.9 9.3 4.1 1.6 TXNL1 "TRP32, Txl, TXNL" ENSG00000091164 "Thioredoxin like 1" O43396 18 56597209-56651600 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002828, HPA002829, CAB016446" Supported Supported Enhanced Cytosol NA Yes 1100000 Cytosol "CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359" "unprognostic (2.05e-1)" "unprognostic (2.97e-1)" "unprognostic (3.38e-3)" "unprognostic (4.54e-2)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (9.62e-6)" "unprognostic (1.83e-1)" "unprognostic (1.03e-2)" "prognostic favorable (6.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-3)" "unprognostic (1.24e-1)" "unprognostic (1.26e-1)" "unprognostic (2.62e-1)" "unprognostic (1.51e-1)" 37.4 56.3 49.7 39.0 52.3 83.8 49.6 53.9 64.1 42.8 46.9 42.1 42.5 38.6 67.4 54.6 35.5 40.4 80.7 53.4 54.3 52.2 81.4 30.8 41.5 51.5 51.8 48.7 47.5 62.7 51.9 38.5 48.5 53.8 40.9 43.8 78.6 49.0 39.7 150.4 36.8 40.9 43.8 52.2 32.5 47.1 42.3 52.5 48.5 199.7 148.1 50.4 52.3 35.4 57.7 77.7 74.8 99.2 102.8 83.2 121.6 70.2 90.2 91.8 113.4 95.4 67.0 74.2 83.4 78.1 98.4 82.3 93.7 94.4 81.3 116.9 85.7 43.1 114.9 58.3 127.1 98.3 168.9 71.7 92.9 82.4 107.4 97.4 118.8 93.0 62.9 85.5 136.0 116.0 74.4 98.1 109.8 71.9 53.5 79.6 78.2 66.8 145.9 133.0 118.6 81.6 74.5 51.3 70.9 88.1 78.3 77.5 89.1 74.3 118.7 62.9 41.9 89.5 130.8 151.1 130.5 77.2 127.0 89.1 98.5 63.1 48.3 26.9 55.8 37.2 38.9 33.0 35.8 54.8 35.4 32.0 32.9 48.3 43.3 54.9 47.0 42.9 61.5 49.7 52.3 53.9 64.1 53.4 54.3 51.5 51.8 48.7 53.8 52.2 52.5 57.7 89.7 57.7 45.9 25.5 80.0 134.3 123.1 177.1 75.7 82.7 89.3 110.4 110.1 67.2 108.3 29.5 139.7 242.3 82.7 72.2 109.5 150.5 246.9 88.0 90.0 84.2 75.9 153.8 43.8 128.3 130.9 86.1 52.0 90.3 53.2 167.5 52.8 78.0 150.1 57.2 43.6 111.6 77.3 97.3 97.0 294.1 77.6 90.5 65.8 15.9 121.8 86.0 78.2 26.2 55.6 139.5 83.7 83.8 88.9 121.2 110.0 144.7 75.1 97.1 65.7 73.0 167.1 204.1 108.0 93.9 126.0 358.6 72.4 171.0 109.7 123.1 IL5RA "CD125, CDw125, IL5R" ENSG00000091181 "Interleukin 5 receptor subunit alpha" Q01344 3 3066324-3126613 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.7;choroid plexus: 7.4;fallopian tube: 10.8" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 28.0;granulocytes: 19.0;Plasma cells: 9.9;Respiratory ciliated cells: 13.9" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 192 "basophil: 178.4;eosinophil: 355.1" "Lineage enriched" "Detected in many" 255 "granulocytes: 355.1" "Cell line enriched" "Detected in some" 28 "HMC-1: 71.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 910000 "unprognostic (1.38e-3)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (6.13e-3)" "unprognostic (2.66e-1)" "unprognostic (1.54e-3)" "unprognostic (7.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.83e-1)" "unprognostic (1.67e-1)" "unprognostic (9.84e-4)" "unprognostic (4.32e-3)" "unprognostic (3.08e-2)" "unprognostic (6.95e-2)" "unprognostic (2.20e-1)" "unprognostic (7.49e-2)" "unprognostic (4.93e-2)" 0.2 0.2 3.4 0.6 1.1 0.6 1.0 1.2 0.5 1.0 7.4 0.7 1.7 0.4 0.2 0.5 10.8 0.8 0.5 0.7 1.3 0.2 0.2 2.8 0.4 4.5 3.1 0.3 0.1 0.4 0.0 1.6 0.1 3.0 1.8 1.1 0.0 0.7 0.1 0.4 0.1 1.6 0.3 5.7 1.8 1.1 1.1 1.6 0.5 0.2 0.0 1.5 1.7 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 2.5 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 178.4 0.1 355.1 0.9 0.1 0.1 0.4 1.0 0.7 0.1 1.3 0.3 0.7 1.0 0.0 0.1 0.1 0.1 0.7 3.4 1.1 1.2 0.5 0.7 1.3 4.5 3.1 0.3 3.0 5.7 1.6 1.0 0.2 0.0 2.5 0.0 4.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 2.3 1.5 1.4 0.0 0.0 0.1 2.8 0.0 0.0 0.0 2.4 28.0 0.3 0.1 0.0 0.8 0.7 0.0 0.0 0.2 0.0 0.5 19.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.3 5.7 0.0 0.1 5.4 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 9.9 0.8 0.0 0.1 13.9 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.1 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16149565-16223522 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 135.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1" "Group enriched" "Detected in many" 5 "liver cancer: 16.7;renal cancer: 5.0" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "classical monocyte: 3.4" "Lineage enriched" "Detected in single" 7 "monocytes: 3.4" "Cell line enriched" "Detected in some" 8 "Hep G2: 68.4" "Not detected" "Not detected" HPA038105 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038105: AB_2675835" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favorable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 5.6 3.6 0.7 0.3 0.7 0.7 3.9 0.7 1.1 1.0 0.8 3.6 13.3 0.3 0.6 0.3 1.6 2.9 1.7 0.6 1.2 26.9 135.3 7.5 0.0 0.8 0.8 0.6 1.0 17.3 2.1 0.9 0.2 0.8 2.9 2.8 0.3 12.8 1.0 4.6 0.4 7.9 0.3 0.8 0.7 6.5 0.4 0.8 0.0 5.7 0.1 0.0 0.4 0.7 0.8 0.0 1.5 0.7 0.0 0.0 0.8 1.8 0.0 0.4 1.0 1.6 7.1 2.3 0.0 0.8 0.0 0.2 0.0 0.7 0.1 0.6 0.0 0.7 1.8 0.2 68.4 0.4 0.0 0.0 2.7 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.2 0.6 0.0 0.0 0.0 0.0 2.3 0.0 0.1 1.0 0.0 0.8 0.1 0.3 8.4 5.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.7 0.7 0.7 1.1 0.6 1.2 0.8 0.8 0.6 0.8 0.8 0.8 0.8 0.3 28.9 31.5 2.9 1.9 0.1 0.5 3.2 0.0 1.0 4.3 3.6 3.3 18.6 8.7 9.2 0.0 0.0 0.0 13.7 45.0 2.2 0.5 4.8 1.0 0.8 3.0 2.7 1.0 7.9 0.0 1.7 13.3 1.0 1.3 1.9 1.8 77.9 1.0 0.0 1.1 10.9 0.0 3.5 0.0 0.7 1.5 1.8 1.8 3.7 3.1 1.5 0.0 1.0 0.4 2.2 8.1 5.7 0.3 2.0 33.7 151.1 25.4 0.6 0.0 0.3 1.2 0.4 0.3 0.2 0.9 0.0 1.4 1.8 11.9 0.7 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32502852 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 815.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Enhanced Approved Vesicles NA NA Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 40.6 26.5 11.6 69.6 11.5 98.1 55.0 12.2 13.6 50.8 23.4 48.2 26.9 46.7 41.3 40.6 178.1 50.8 18.7 11.0 16.3 40.3 133.5 54.8 54.3 14.4 12.9 9.9 18.7 23.7 41.9 9.3 70.7 14.1 49.0 59.0 13.1 33.5 40.2 5.0 49.8 29.7 42.0 14.5 55.9 47.4 40.7 13.9 48.3 62.3 13.7 78.9 79.8 19.1 14.8 107.4 34.2 66.5 50.1 112.1 111.0 292.4 77.5 110.4 79.7 91.5 36.6 174.4 63.5 86.1 104.6 53.8 67.6 47.0 128.9 108.2 285.4 57.3 80.4 22.8 54.5 79.6 135.3 153.0 110.5 81.3 92.0 68.6 128.2 130.3 60.9 39.8 116.0 103.0 33.4 81.9 70.0 59.3 88.6 50.0 68.6 51.7 49.9 111.1 147.9 15.3 44.3 70.5 39.5 76.1 66.9 58.3 133.5 117.8 88.0 57.9 86.7 94.1 59.6 63.9 58.6 61.4 116.8 112.1 176.8 84.4 208.0 29.1 133.4 32.8 54.4 38.1 28.3 72.7 42.2 22.0 24.7 313.4 65.1 210.2 38.6 46.3 108.6 11.6 11.5 12.2 13.6 11.0 16.3 14.4 12.9 9.9 14.1 14.5 13.9 14.8 57.0 35.3 49.9 12.4 243.7 96.0 82.4 159.3 55.2 13.9 233.0 57.5 5.8 60.1 112.0 95.6 12.5 253.6 122.5 88.0 33.2 113.8 12.3 129.1 68.3 70.7 132.1 41.2 14.2 83.0 101.7 74.9 63.2 180.9 126.8 186.5 124.9 305.2 156.5 50.5 19.2 117.6 118.0 310.1 815.8 8.4 39.4 326.0 81.8 30.0 425.8 130.1 71.1 18.1 9.4 136.7 46.1 42.9 104.7 147.1 23.8 63.4 183.0 17.3 39.5 32.9 74.3 36.1 20.2 89.7 126.6 261.7 120.9 50.3 64.6 110.3 ITGA6 CD49f ENSG00000091409 "Integrin subunit alpha 6" P23229 2 172427354-172506459 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 327.2;Basal keratinocytes: 244.7;Urothelial cells: 247.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 144.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 22.9" "Group enriched" "Detected in many" 28 "granulocytes: 22.9;NK-cells: 7.1;T-cells: 12.8" "Cell line enhanced" "Detected in many" "BJ: 326.2;HaCaT: 356.8;HBEC3-KT: 705.8;hTCEpi: 298.9;hTERT-HME1: 301.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009009, HPA012696, HPA027582" Enhanced NA NA 3300000 "CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (2.59e-2)" "unprognostic (5.96e-2)" "unprognostic (4.93e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.19e-1)" "unprognostic (1.61e-3)" "unprognostic (9.34e-2)" "unprognostic (6.01e-2)" "unprognostic (1.85e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.35e-11)" "unprognostic (3.35e-2)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (1.21e-3)" 46.3 8.4 20.2 28.1 18.2 5.9 56.1 17.8 20.5 64.8 38.3 66.0 74.9 43.5 9.6 25.3 25.6 37.6 29.5 17.6 22.2 43.1 8.9 29.5 18.9 22.1 19.2 13.1 5.6 42.4 14.1 6.3 77.4 18.7 24.6 63.0 7.4 81.7 31.1 28.0 47.0 68.0 39.3 19.4 41.5 66.7 26.4 25.4 34.2 21.3 43.0 21.6 55.5 27.0 18.0 77.5 64.8 26.7 49.1 1.4 0.9 146.3 326.2 34.6 32.1 20.0 36.2 141.3 0.7 90.9 86.8 73.8 356.8 17.7 705.8 58.1 0.7 16.6 1.9 64.8 58.7 4.8 21.4 2.4 6.2 298.9 2.0 301.4 32.9 209.6 40.8 0.3 5.5 41.6 3.7 5.9 17.8 48.2 214.2 54.5 1.1 82.3 1.6 48.0 106.6 0.8 3.4 61.2 0.1 69.7 28.0 13.1 1.4 97.9 44.9 41.1 84.2 56.8 4.8 3.6 1.9 1.7 7.2 185.0 4.4 0.2 22.9 5.3 0.0 10.7 0.2 6.7 6.4 0.1 0.5 12.8 5.9 0.7 7.1 0.0 0.0 8.1 4.3 20.2 18.2 17.8 20.5 17.6 22.2 22.1 19.2 13.1 18.7 19.4 25.4 18.0 327.2 9.6 19.5 88.5 8.8 244.7 236.4 43.4 88.8 1.4 55.0 72.8 32.5 22.8 10.5 27.6 56.3 103.8 14.4 139.6 5.9 34.4 31.2 82.5 34.8 196.0 57.4 1.7 4.0 62.1 26.5 20.8 219.7 149.3 8.2 103.4 11.7 21.5 25.5 1.7 6.1 128.8 20.3 3.2 20.8 46.8 4.1 10.0 51.6 119.9 1.7 1.3 29.9 1.5 8.8 127.9 104.2 2.6 109.0 184.8 54.5 52.2 9.2 13.9 0.0 11.8 18.4 7.7 20.2 141.5 84.0 22.3 30.1 44.0 146.3 247.6 RAPGEF4 "cAMP-GEFII, CGEF2" ENSG00000091428 "Rap guanine nucleotide exchange factor 4" Q8WZA2 2 172735274-173052893 "Predicted intracellular proteins" Exocytosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 145.6;choroid plexus: 54.6" "Group enriched" "Detected in many" 7 "Excitatory neurons: 441.1;Inhibitory neurons: 416.6;Microglial cells: 142.4;Oligodendrocyte precursor cells: 303.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 21.5;SCLC-21H: 8.3;U-266/70: 11.0;U-266/84: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004388, HPA028968" Approved Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "CAB004388: AB_670916, HPA028968: AB_2672846" "unprognostic (1.87e-1)" "unprognostic (4.22e-2)" "unprognostic (1.31e-1)" "unprognostic (2.98e-3)" "unprognostic (4.53e-2)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-1)" "unprognostic (3.23e-1)" "prognostic favorable (1.32e-4)" "unprognostic (6.32e-2)" "unprognostic (1.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (5.70e-2)" "unprognostic (2.93e-1)" 4.6 46.0 105.1 1.8 116.3 0.2 6.8 72.3 142.9 6.1 54.6 2.0 2.4 5.7 3.1 2.7 3.4 4.7 7.5 145.5 79.4 5.3 34.9 11.5 2.0 71.0 77.3 112.1 13.2 4.5 4.1 6.2 2.6 76.4 4.2 1.6 19.0 2.4 3.4 1.5 15.0 2.3 5.4 57.6 0.6 7.8 4.7 130.6 2.3 5.6 1.7 2.0 5.3 3.2 145.6 0.1 0.2 3.2 0.5 0.1 0.3 0.1 1.1 0.7 0.1 0.3 0.0 3.7 0.0 0.2 0.0 0.2 0.7 2.8 0.7 0.3 0.2 5.9 0.6 2.8 0.0 0.0 3.2 0.9 0.1 0.9 0.0 0.0 3.2 3.5 1.6 0.0 21.5 0.1 0.1 0.2 0.2 0.4 1.8 0.4 0.1 0.7 0.0 0.0 6.6 8.3 3.0 0.1 0.1 1.1 1.6 0.1 0.1 1.0 0.1 0.3 0.0 0.3 11.0 23.0 0.0 0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.1 116.3 72.3 142.9 145.5 79.4 71.0 77.3 112.1 76.4 57.6 130.6 145.6 14.7 3.2 2.8 23.2 1.9 6.1 1.1 0.1 2.8 3.5 5.5 3.9 6.9 0.0 0.0 0.0 45.9 0.1 0.1 0.0 0.0 1.7 2.5 1.2 0.2 32.4 7.8 0.0 441.1 2.7 0.1 4.8 3.1 0.9 0.0 3.3 23.9 11.8 0.1 1.7 416.6 0.5 0.0 1.2 2.1 1.4 4.4 0.2 3.6 142.4 0.0 1.3 0.0 303.1 28.4 1.5 0.1 1.5 1.6 0.5 0.0 0.0 0.0 9.2 0.0 0.4 1.2 0.7 4.1 1.6 3.8 0.1 0.6 4.2 0.1 0.7 MAP3K20 "MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK" ENSG00000091436 "Mitogen-activated protein kinase kinase kinase 20" Q9NYL2 2 173075435-173268015 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 264.3;tongue: 282.2" "Cell type enhanced" "Detected in many" "Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 15.5" "Group enriched" "Detected in many" 5 "dendritic cells: 15.5;monocytes: 9.4" "Cell line enhanced" "Detected in many" "U-138 MG: 176.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017205 Approved Supported Cytosol NA Yes Cytosol "HPA017205: AB_1858933" "unprognostic (2.90e-2)" "unprognostic (9.99e-3)" "unprognostic (4.63e-3)" "unprognostic (1.98e-1)" "unprognostic (7.63e-2)" "unprognostic (5.02e-2)" "unprognostic (2.34e-2)" "unprognostic (3.89e-3)" "unprognostic (2.83e-2)" "unprognostic (9.27e-2)" "unprognostic (4.54e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.41e-6)" "unprognostic (2.34e-1)" "unprognostic (1.86e-1)" "unprognostic (2.23e-1)" "unprognostic (1.19e-2)" 71.6 11.5 9.0 20.7 9.1 4.7 21.6 10.7 8.6 45.2 15.2 49.2 13.1 77.1 18.8 50.5 48.4 31.7 197.5 8.7 15.8 7.6 25.4 22.7 9.8 13.7 13.2 5.9 70.1 11.8 49.7 3.9 27.8 11.4 44.4 21.1 2.5 12.5 57.6 264.3 14.2 19.4 75.7 10.7 12.6 31.7 10.7 11.5 11.6 16.5 282.2 10.3 56.6 21.4 14.4 34.6 28.6 22.0 29.1 62.7 92.5 13.8 121.9 94.7 55.9 59.6 19.5 22.2 26.5 31.2 122.5 48.8 22.9 33.1 64.6 124.2 52.0 22.0 43.3 30.5 4.1 24.8 39.3 43.8 74.7 27.2 105.2 164.2 46.3 37.5 28.5 19.8 4.9 36.8 14.8 24.8 19.0 12.2 28.9 16.0 36.2 45.0 0.1 13.6 19.6 12.9 12.4 47.0 11.3 19.7 35.6 12.9 20.9 37.9 176.3 71.4 53.1 27.9 0.1 0.1 5.5 126.2 10.6 18.9 0.2 9.4 0.0 1.0 8.3 1.0 1.6 0.8 1.7 15.5 2.5 0.0 0.8 2.6 0.5 8.2 0.3 0.8 3.4 9.0 9.1 10.7 8.6 8.7 15.8 13.7 13.2 5.9 11.4 10.7 11.5 14.4 57.5 38.5 57.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 20.0 44.4 0.0 0.0 7.4 11.0 0.0 52.6 2.3 0.0 1.9 43.9 0.0 36.7 96.7 14.1 0.0 0.0 0.0 27.6 21.9 36.5 0.0 35.6 5.1 100.7 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 15.5 0.0 0.0 0.0 0.0 38.6 0.0 0.0 1.4 0.0 0.0 1.9 13.1 0.0 0.0 0.0 83.2 0.0 0.0 0.0 0.0 21.6 3.6 70.5 0.0 0.0 SMPX "Chisel, Csl, DFN6, DFNX4" ENSG00000091482 "Small muscle protein X-linked" Q9UHP9 X 21705978-21758116 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 51 "heart muscle: 764.5;skeletal muscle: 1194.6;tongue: 1107.3" "Cell type enriched" "Detected in some" 22 "Cardiomyocytes: 807.6" "Group enriched" "Detected in many" 4 "head and neck cancer: 7.2;stomach cancer: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "GAMG: 23.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA077360 Approved "Plasma membrane" NA NA 62000 "Plasma membrane" "HPA077360: AB_2732342" "unprognostic (7.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.39e-2)" "unprognostic (7.46e-2)" "unprognostic (5.27e-1)" "unprognostic (1.96e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (2.82e-1)" "unprognostic (8.38e-2)" 0.2 0.1 2.7 0.5 2.3 0.1 1.1 3.9 3.8 0.3 1.3 17.0 0.7 0.4 0.0 20.2 0.7 0.5 764.5 1.8 3.8 0.1 1.2 0.5 0.2 2.0 3.5 1.8 1.1 0.3 0.0 0.2 0.0 2.0 11.2 3.4 1.7 17.9 0.8 1194.6 0.3 4.1 12.7 1.6 0.1 7.3 0.2 6.1 1.5 0.3 1107.3 0.1 3.2 0.2 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 3.9 3.8 1.8 3.8 2.0 3.5 1.8 2.0 1.6 6.1 2.5 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 807.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 0.0 16.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 35.6 9.5 0.1 0.3 0.0 0.0 0.3 0.1 2.1 0.1 0.0 FH ENSG00000091483 "Fumarate hydratase" P07954 1 241497603-241519755 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Tricarboxylic acid cycle" Lyase "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 278.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017785, HPA025770, HPA025948, HPA027341" Enhanced Supported Enhanced Mitochondria NA NA 1800000 Mitochondria "CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222" "unprognostic (1.03e-2)" "unprognostic (3.82e-2)" "unprognostic (9.46e-3)" "unprognostic (2.18e-1)" "unprognostic (2.10e-1)" "unprognostic (2.07e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-1)" "unprognostic (5.14e-2)" "unprognostic (1.85e-2)" "unprognostic (1.27e-2)" "unprognostic (1.09e-1)" "prognostic favorable (2.76e-7)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (4.41e-2)" "unprognostic (1.24e-2)" 43.8 75.9 31.9 31.3 33.5 31.6 37.7 33.9 42.4 27.8 41.4 67.4 68.8 37.2 26.3 51.5 28.1 23.9 180.7 34.0 33.2 102.8 278.7 26.6 30.2 33.1 31.9 32.0 25.1 38.5 95.8 31.3 32.4 32.7 33.8 69.7 59.4 42.4 38.8 215.4 40.6 59.6 42.4 31.5 30.3 54.1 44.7 32.9 31.6 34.9 231.3 40.7 37.8 34.0 35.3 129.2 105.6 97.9 89.0 93.9 110.0 154.9 155.7 121.1 171.6 107.1 152.2 78.0 81.1 100.3 119.9 75.0 178.4 151.7 115.8 148.4 93.5 48.9 76.3 102.2 131.4 84.1 180.2 66.7 80.2 70.7 96.6 108.0 60.2 107.2 175.8 236.3 101.7 126.9 64.3 156.6 120.1 104.5 186.2 223.6 127.4 107.2 365.7 167.4 107.6 125.4 108.4 131.1 153.3 104.0 67.2 117.1 120.9 106.5 76.6 98.9 137.0 264.0 90.3 103.7 97.3 85.7 203.5 112.6 11.9 22.8 4.9 16.1 33.3 21.0 27.2 18.8 15.1 46.7 25.1 22.3 21.1 1.3 18.3 29.1 23.1 23.8 16.7 31.9 33.5 33.9 42.4 34.0 33.2 33.1 31.9 32.0 32.7 31.5 32.9 35.3 17.1 38.5 30.2 9.4 25.0 20.0 24.6 69.5 17.1 24.7 19.9 17.5 173.5 35.8 40.0 23.9 14.6 101.6 13.7 44.0 78.2 60.4 226.0 25.4 23.5 18.6 18.0 37.7 12.7 45.0 58.7 25.5 26.5 25.4 19.0 24.9 13.6 80.4 50.7 35.3 14.9 40.6 48.8 18.5 14.4 37.4 23.9 23.9 24.9 8.4 27.9 35.0 10.3 8.0 14.4 29.4 35.7 26.7 41.3 19.0 66.1 86.0 29.2 39.1 39.5 27.7 67.9 84.7 47.1 32.1 18.6 166.1 14.9 48.4 74.2 22.8 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747433-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 129.3" "Cell type enhanced" "Detected in many" "B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebellum: 75.6;pons: 23.2" "Group enriched" "Detected in many" 4 "memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2" "Group enriched" "Detected in many" 4 "B-cells: 42.0;dendritic cells: 38.2" "Cell line enhanced" "Detected in many" "Daudi: 287.9;OE19: 217.9;U-698: 187.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 100.4" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 9.4 5.6 5.4 62.1 10.3 13.7 9.4 75.6 11.0 54.5 7.2 72.8 82.7 8.0 69.4 8.8 11.1 54.1 5.3 11.5 4.0 14.6 11.7 41.1 125.8 4.0 7.3 5.9 5.6 48.9 45.9 3.7 37.8 23.2 19.0 69.5 35.5 38.6 4.1 2.9 2.9 73.0 7.9 1.6 63.8 105.8 6.7 6.7 18.9 11.0 2.8 129.3 42.8 2.3 5.7 21.5 23.0 16.7 5.6 2.7 3.3 2.6 10.4 28.3 7.9 25.2 14.6 97.0 287.9 48.9 72.0 66.7 13.3 12.4 45.1 10.6 15.7 7.2 3.3 35.4 19.6 70.0 40.1 2.0 5.7 35.8 27.8 10.9 31.3 105.7 5.8 19.3 0.3 5.6 16.2 0.1 2.8 48.2 217.9 20.1 1.5 91.3 40.6 60.9 71.2 41.0 8.0 69.2 1.0 7.1 23.0 3.3 49.0 46.6 0.5 32.6 0.6 30.6 1.8 0.5 187.9 125.0 16.7 19.3 0.9 0.2 0.0 5.7 0.0 6.8 42.0 7.0 6.4 1.4 41.8 3.0 4.8 0.7 8.0 0.3 38.2 9.6 3.3 5.4 10.3 75.6 11.0 11.5 4.0 4.0 7.3 5.9 23.2 1.6 6.7 5.7 13.2 12.8 36.0 57.1 114.7 0.9 3.4 16.8 1.2 4.0 1.6 0.9 1.8 61.5 51.9 3.7 0.0 30.7 71.0 46.3 0.0 64.9 60.8 6.0 1.5 11.5 11.5 10.5 40.1 33.2 1.3 2.5 71.9 19.3 2.5 3.4 13.6 4.2 4.9 0.0 26.6 92.6 22.4 23.1 4.6 78.3 1.5 14.4 8.8 4.7 14.6 33.2 10.3 128.7 1.4 38.3 22.6 0.4 271.7 13.6 46.9 10.7 24.2 32.8 0.0 0.8 4.7 0.7 2.5 0.7 1.6 16.4 27.8 0.2 36.8 6.1 TF "PRO1557, PRO2086" ENSG00000091513 Transferrin P02787 3 133746040-133796641 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Ion transport, Iron transport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 7587.8;retina: 2454.2" "Group enriched" "Detected in many" 9 "Hepatocytes: 7205.2;Muller glia cells: 12965.3" "Cancer enriched" "Detected in many" 42 "liver cancer: 783.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 48 "Hep G2: 780.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001527, HPA005692, CAB009538" Enhanced "Secreted to blood" NA NA 19800000000000 98000000000 "CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354" "prognostic favorable (4.05e-4)" "unprognostic (2.45e-2)" "unprognostic (1.78e-1)" "unprognostic (1.50e-1)" "unprognostic (8.99e-2)" "unprognostic (5.18e-2)" "unprognostic (6.63e-2)" "unprognostic (8.46e-2)" "unprognostic (2.82e-1)" "unprognostic (3.08e-1)" "unprognostic (1.37e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (2.35e-13)" "unprognostic (2.17e-3)" "unprognostic (5.49e-2)" "unprognostic (3.47e-3)" "unprognostic (9.70e-2)" 81.6 1.2 185.9 1.0 365.1 2.5 13.4 536.0 234.5 2.0 50.7 1.9 0.9 1.7 1.4 11.0 1.5 2.0 12.2 152.7 330.6 3.5 7587.8 1.9 1.3 657.3 377.2 118.2 2.1 4.6 2.3 4.4 1.3 536.4 5.5 1.2 2454.2 56.2 1.8 2.1 3.1 1.6 1.5 523.9 3.0 1.9 14.4 362.7 1.2 2.2 2.7 3.0 1.3 2.8 812.0 1.9 1.4 1.8 1.2 5.5 3.4 0.9 1.9 2.0 1.0 0.8 3.4 1.5 1.7 1.6 1.8 1.2 2.1 1.3 1.8 1.5 1.1 0.7 16.3 2.7 780.9 1.3 4.6 2.7 2.4 3.8 1.0 1.7 1.8 2.2 0.9 6.4 2.1 2.6 1.3 1.1 1.2 1.2 1.2 1.8 1.5 2.9 1.2 1.1 3.1 1.9 1.4 2.4 2.6 7.0 1.3 1.9 1.3 2.9 2.4 1.5 1.6 1.1 1.7 3.0 1.4 2.0 1.5 1.6 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 185.9 365.1 536.0 234.5 152.7 330.6 657.3 377.2 118.2 536.4 523.9 362.7 812.0 0.7 16.0 32.4 36.2 11.4 1.0 5.6 0.6 0.0 101.3 5.3 4.3 2.7 117.2 22.9 0.0 91.8 0.2 0.2 0.1 1.9 0.7 5.4 0.8 1.0 16.7 0.0 56.2 34.2 1.1 0.3 3.9 0.0 0.6 17.7 1.3 87.4 7205.2 0.1 47.1 34.7 0.0 0.0 124.7 0.3 3.8 0.3 4.7 0.0 9.4 0.6 12965.3 0.0 45.2 1077.2 1.1 0.0 0.4 0.0 18.7 0.0 0.5 22.1 400.4 0.0 11.6 0.4 0.5 0.4 3.6 0.0 0.3 7.8 0.5 0.0 3.0 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573686-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 559.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 1103.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 1100000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 118.0 69.2 40.7 114.7 44.2 162.8 73.7 43.3 45.8 59.8 51.2 80.8 58.1 61.1 55.4 79.5 52.1 77.0 73.1 39.3 54.6 65.0 113.9 84.4 160.6 48.7 43.8 34.6 58.5 85.0 86.6 43.4 109.4 48.4 43.6 71.5 49.6 53.1 48.1 252.9 54.8 66.0 76.4 49.1 122.7 89.8 96.6 47.5 196.2 98.2 157.2 166.9 105.3 49.7 50.0 376.2 85.5 147.6 98.0 166.7 203.6 174.5 201.6 261.1 197.6 194.7 213.4 147.0 473.9 298.0 227.4 229.2 158.2 213.5 202.0 366.4 306.1 80.1 282.3 93.2 130.9 258.2 318.7 173.4 194.7 206.7 178.2 473.4 139.6 254.5 137.9 205.7 309.9 289.5 107.1 260.9 180.9 148.9 161.6 108.2 156.8 197.6 382.2 206.9 150.7 116.5 87.8 192.0 140.4 246.0 210.0 456.3 190.8 316.4 209.4 198.5 168.5 202.7 446.9 363.2 1103.9 117.0 187.8 124.7 14.3 10.5 17.6 13.0 12.3 13.5 11.1 12.2 13.2 9.7 7.0 9.7 15.2 9.7 6.4 13.7 15.9 24.0 5.7 40.7 44.2 43.3 45.8 39.3 54.6 48.7 43.8 34.6 48.4 49.1 47.5 50.0 116.3 57.7 69.8 7.2 114.9 145.9 217.3 19.5 63.7 22.6 97.6 77.2 86.2 74.4 34.4 84.6 10.4 51.6 169.7 158.0 37.2 42.1 324.7 174.0 160.5 99.5 47.2 59.5 13.2 87.6 82.0 93.7 88.7 314.4 45.0 63.0 91.1 97.2 118.5 23.5 12.3 102.4 10.2 146.8 117.7 559.5 34.2 145.0 55.2 17.8 100.4 109.5 90.6 8.0 14.5 88.1 101.2 35.7 239.4 320.2 26.9 74.4 27.4 29.9 26.3 120.9 92.5 21.2 30.9 94.0 128.3 35.2 126.5 124.4 90.1 219.5 MYO15A "DFNB3, MYO15" ENSG00000091536 "Myosin XVA" Q9UKN7 17 18108706-18179802 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pituitary gland: 63.4" "Group enriched" "Detected in many" 4 "Early spermatids: 69.9;Late spermatids: 53.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA078501 Enhanced NA NA "HPA078501: AB_2732383" "unprognostic (2.48e-3)" "unprognostic (5.31e-2)" "unprognostic (2.87e-3)" "unprognostic (7.35e-3)" "unprognostic (4.92e-3)" "unprognostic (2.33e-1)" "unprognostic (8.32e-4)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-3)" "unprognostic (8.38e-2)" "unprognostic (4.18e-3)" "unprognostic (5.69e-3)" "unprognostic (9.89e-2)" "unprognostic (1.47e-1)" "unprognostic (2.21e-2)" 0.5 0.4 0.4 0.3 0.4 0.1 0.6 0.5 1.6 1.2 0.0 0.6 0.3 1.1 1.5 0.3 1.5 0.2 0.5 0.1 0.5 0.5 1.9 0.9 0.1 1.7 0.6 0.4 2.2 0.5 0.8 63.4 0.1 2.3 0.9 0.3 0.3 0.7 0.9 0.4 0.3 0.6 0.2 0.3 0.5 0.6 7.3 1.0 0.8 0.9 0.0 0.2 0.7 0.8 1.9 0.0 0.0 0.4 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.5 1.6 0.1 0.5 1.7 0.6 0.4 2.3 0.3 1.0 1.9 0.3 0.0 1.1 0.7 0.8 1.5 2.1 0.2 1.2 2.9 0.9 0.6 4.0 1.5 0.1 0.0 0.0 0.5 0.3 0.7 0.0 0.8 69.9 0.8 0.9 1.0 4.2 0.0 8.5 0.9 0.3 1.4 0.5 1.2 6.3 1.3 0.4 1.7 0.6 10.1 4.5 0.5 0.0 0.8 1.4 53.6 1.2 0.8 3.6 1.0 1.3 2.6 2.1 1.5 0.9 0.6 0.1 1.2 0.1 1.9 0.4 0.3 0.2 2.5 0.0 4.6 1.1 9.2 13.4 0.4 1.3 0.7 0.6 0.7 0.8 1.0 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 238.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 32.9 40.4 25.2 21.6 20.0 32.9 29.5 16.1 20.5 33.0 13.1 43.5 22.5 45.7 5.3 26.1 43.5 21.7 66.1 17.8 18.5 29.8 33.9 29.0 25.3 20.7 20.4 17.6 33.8 36.3 26.8 40.1 17.6 24.2 31.9 10.7 26.7 36.7 25.3 238.8 27.0 31.2 22.2 18.5 27.0 33.9 51.7 28.6 22.4 30.1 99.5 16.0 43.4 29.8 28.4 90.3 86.4 27.8 47.0 37.0 25.0 30.1 41.1 41.8 56.8 51.5 96.1 19.9 53.9 65.4 35.9 29.4 56.2 40.9 33.6 26.8 71.3 74.0 35.4 47.7 41.8 32.5 27.4 53.0 24.3 23.1 41.8 24.7 33.9 31.8 35.3 45.0 20.4 29.8 60.6 60.1 28.6 24.9 28.3 44.4 57.6 56.0 89.0 14.4 31.0 32.5 47.6 44.8 27.2 41.7 90.9 31.4 20.9 38.3 55.8 44.1 87.8 78.0 32.0 25.1 32.2 100.6 38.8 39.0 3.6 7.4 20.4 13.0 7.8 11.9 6.8 13.3 16.1 9.0 10.0 9.5 9.5 4.3 7.2 11.6 5.7 7.4 6.7 25.2 20.0 16.1 20.5 17.8 18.5 20.7 20.4 17.6 24.2 18.5 28.6 28.4 37.2 35.3 33.3 17.9 41.1 64.6 29.0 26.8 19.4 80.3 48.7 40.3 93.5 28.6 24.4 27.6 39.6 33.0 59.0 44.9 84.1 27.4 58.9 53.9 36.5 36.6 60.9 24.0 17.0 31.4 44.8 42.4 18.3 36.7 40.7 25.2 35.7 65.2 33.5 119.5 18.1 45.0 22.4 45.3 56.9 42.5 41.0 36.4 49.8 7.5 36.3 76.3 57.7 9.0 24.0 32.8 38.7 51.9 21.1 35.3 47.6 115.2 46.4 58.9 19.7 39.4 47.3 118.7 117.3 20.3 56.0 31.5 48.3 32.7 39.1 28.6 APOH "B2G1, BG" ENSG00000091583 "Apolipoprotein H" P02749 17 66212033-66256525 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 562 "liver: 18114.5" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 7680.6" "Cancer enriched" "Detected in many" 232 "liver cancer: 2878.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "Hep G2: 1253.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001654, HPA003732, CAB022214" Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 247000000000 41000000000 "Golgi apparatus" "CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.39e-7)" "unprognostic (1.26e-1)" "unprognostic (5.99e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.26e-2)" "unprognostic (5.76e-2)" 0.6 0.3 0.0 0.1 0.1 0.5 0.2 0.1 0.2 0.2 0.3 0.8 2.5 0.1 1.0 0.2 0.8 2.8 0.5 0.1 0.1 32.2 18114.5 5.6 0.3 0.2 0.1 0.2 0.2 11.0 0.0 0.2 0.4 0.4 0.2 0.7 0.2 0.2 0.3 0.2 0.2 1.0 0.0 0.1 4.3 3.8 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 33.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.8 0.0 1.4 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.4 0.0 2.6 1.4 1253.3 0.0 6.4 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.4 0.5 0.2 0.0 0.2 0.1 0.6 31.5 0.0 0.8 6.4 0.1 0.0 0.9 0.4 0.0 3.4 0.1 0.2 0.0 0.0 0.0 1.7 0.2 0.1 0.1 0.0 0.8 0.1 2.9 15.3 2.4 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.1 0.2 0.0 0.0 12.3 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 183.0 0.6 0.0 0.0 0.0 0.0 0.2 3.9 0.8 0.2 0.2 0.0 5.2 0.0 109.7 0.2 2.3 0.6 0.0 0.0 0.1 0.0 0.0 120.0 7680.6 0.5 0.0 0.2 0.4 0.0 182.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.8 0.0 0.0 0.0 0.4 25.6 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 8.8 0.0 0.8 0.0 NLRP1 "CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1" ENSG00000091592 "NLR family pyrin domain containing 1" Q9C000 17 5499427-5619424 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 561.7;Muller glia cells: 151.8" "Cancer enhanced" "Detected in all" "glioma: 20.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 55.4;Karpas-707: 90.9;U-266/70: 45.0" "CAB009189, HPA064431" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009189: , HPA064431: AB_2685262" "unprognostic (4.40e-2)" "unprognostic (1.02e-1)" "unprognostic (3.16e-2)" "unprognostic (3.65e-2)" "unprognostic (4.00e-2)" "unprognostic (1.23e-3)" "unprognostic (4.13e-2)" "unprognostic (1.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "prognostic favorable (7.57e-4)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (6.69e-2)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "unprognostic (1.34e-2)" 26.4 4.0 3.8 28.0 3.3 25.2 22.3 3.3 4.6 20.7 4.6 10.8 5.9 13.9 1.8 16.3 14.5 13.5 15.0 3.0 4.1 9.3 5.3 27.2 38.4 5.0 3.6 2.3 5.8 3.3 1.8 4.1 12.2 5.6 13.3 7.9 0.3 10.9 9.1 7.8 51.2 31.4 9.8 3.5 56.7 7.0 6.1 3.8 15.3 21.9 7.8 32.7 15.9 27.9 4.8 14.2 0.0 0.0 0.0 8.6 10.2 1.8 6.9 6.3 2.6 5.7 0.2 5.5 5.3 20.8 7.6 1.1 6.5 0.0 23.4 4.0 55.4 0.0 1.4 4.8 0.5 7.1 0.0 1.6 6.6 14.5 20.7 13.7 10.4 25.6 1.1 13.0 90.9 11.8 0.0 0.1 4.6 0.0 0.0 0.3 6.0 4.0 23.0 0.0 4.8 0.7 0.0 0.0 0.2 0.4 0.6 0.0 0.5 25.2 5.3 3.0 3.2 1.1 45.0 15.9 4.1 8.7 0.6 0.3 18.3 7.1 5.0 5.9 4.9 6.6 4.4 5.1 6.3 5.0 4.9 5.5 5.2 18.9 4.2 8.6 0.5 7.7 4.6 3.8 3.3 3.3 4.6 3.0 4.1 5.0 3.6 2.3 5.6 3.5 3.8 4.8 46.4 0.0 7.8 1.3 29.0 17.7 7.1 8.0 15.4 60.6 2.7 6.2 4.9 2.8 10.4 7.3 4.2 0.8 30.3 0.3 3.9 0.4 561.7 4.9 18.0 26.9 77.9 3.6 2.9 0.0 1.1 31.6 3.6 1.0 3.8 7.8 44.6 0.6 7.0 85.8 1.5 1.2 0.0 23.0 24.3 93.4 25.4 26.2 7.2 56.2 27.0 151.8 26.8 1.5 0.8 7.0 0.0 28.2 25.9 2.0 0.0 0.4 12.7 11.6 6.6 33.1 17.3 25.0 11.0 10.7 24.9 1.5 37.6 3.6 0.2 8.0 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451263-6556555 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 20.5;Hepatic stellate cells: 27.8;Inhibitory neurons: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 23 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "HaCaT: 17.7;HeLa: 14.8;hTCEpi: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.3 3.2 24.4 1.1 20.8 0.1 1.4 7.8 19.8 2.7 0.0 7.2 1.3 1.9 3.5 18.0 4.4 1.8 0.8 18.2 6.4 2.8 1.4 3.2 0.2 4.0 1.5 23.8 26.8 1.8 0.9 2.0 0.1 7.8 4.5 3.8 8.0 4.7 9.0 0.9 17.2 2.7 4.1 0.0 61.3 6.8 4.2 3.5 0.4 2.7 0.9 1.1 1.7 6.5 14.0 9.0 0.9 0.7 0.3 0.1 0.2 0.7 0.6 0.2 0.8 0.6 0.6 6.3 0.2 3.3 0.2 2.4 17.7 0.3 3.7 0.3 0.3 0.6 0.1 14.8 0.2 0.9 0.4 0.6 0.2 50.4 1.0 2.8 4.1 0.4 0.7 0.1 0.0 0.6 0.8 0.1 0.2 1.0 4.5 2.5 0.3 1.9 0.1 1.2 0.1 0.4 0.5 8.1 3.8 0.2 0.3 1.3 0.0 0.3 0.4 3.2 0.6 2.1 0.5 0.2 0.0 0.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 24.4 20.8 7.8 19.8 18.2 6.4 4.0 1.5 23.8 7.8 0.0 3.5 14.0 1.5 3.2 16.5 3.6 0.2 5.1 2.2 9.6 2.2 13.5 1.3 1.8 2.0 4.3 11.4 1.8 4.2 0.1 0.2 11.1 0.0 2.2 4.1 10.1 1.0 7.8 1.2 0.0 20.5 0.5 0.0 1.6 4.6 10.3 5.7 1.6 27.8 1.6 0.1 5.0 24.2 3.7 4.1 4.1 0.4 1.8 0.6 0.3 0.0 2.8 0.1 0.6 0.0 0.5 1.6 10.0 5.7 0.0 0.2 2.4 0.6 0.3 7.8 11.9 0.0 12.0 1.9 3.4 1.7 11.5 5.8 0.1 0.7 7.1 6.5 5.2 SPAG7 "ACRP, FSA-1, MGC20134" ENSG00000091640 "Sperm associated antigen 7" O75391 17 4959226-4967817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 308.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024032, HPA052394" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024032: AB_1857410, HPA052394: AB_2681810" "unprognostic (7.10e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (2.92e-1)" "unprognostic (8.90e-2)" "unprognostic (9.83e-2)" "unprognostic (8.35e-2)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.79e-5)" "unprognostic (4.66e-3)" "unprognostic (5.51e-2)" "unprognostic (7.07e-3)" "unprognostic (2.72e-2)" 50.8 56.6 53.9 37.9 54.0 46.4 48.7 56.2 64.0 49.8 53.5 60.2 37.5 67.7 41.3 52.5 68.8 38.3 143.7 54.3 54.9 76.2 70.3 46.4 45.0 56.1 53.8 52.4 43.2 45.9 69.9 38.7 52.7 57.4 46.2 38.6 48.0 48.4 40.9 308.2 46.7 45.8 50.7 54.4 52.1 57.1 35.9 55.1 47.7 56.6 217.4 42.0 54.4 48.0 57.6 41.8 90.7 116.9 65.4 79.8 115.5 67.5 80.9 91.8 77.8 59.5 53.7 53.3 52.9 116.6 100.5 54.2 58.6 59.3 123.9 35.1 77.5 52.6 57.6 74.5 75.3 111.3 32.1 82.1 127.4 87.9 66.5 123.9 118.6 99.4 66.9 39.0 53.2 96.2 66.9 58.7 71.2 66.8 58.0 29.0 61.4 74.1 38.3 135.7 52.1 32.8 64.6 68.7 27.3 68.2 59.9 59.2 50.2 96.6 52.4 34.0 26.1 67.2 46.5 40.3 32.5 101.4 45.6 69.1 96.0 88.3 82.6 82.3 72.6 89.7 97.2 77.1 77.9 103.9 81.1 95.5 84.0 23.1 67.3 73.7 105.9 95.0 91.0 53.9 54.0 56.2 64.0 54.3 54.9 56.1 53.8 52.4 57.4 54.4 55.1 57.6 40.6 57.7 52.6 11.1 54.6 55.3 103.0 252.0 52.3 62.0 62.9 66.3 135.8 77.2 125.4 99.3 45.9 183.5 61.1 82.0 324.8 161.6 23.0 63.1 49.1 64.2 57.2 33.7 7.3 144.1 183.5 66.1 40.8 48.1 73.4 68.3 70.6 72.4 139.3 92.5 8.1 73.5 156.6 64.9 88.9 21.9 46.0 65.6 104.9 2.8 221.0 89.7 97.9 7.1 12.0 128.8 82.8 42.2 39.4 98.7 116.4 239.3 127.4 69.7 72.3 53.5 70.1 55.8 50.6 52.8 50.2 230.8 52.2 89.5 74.6 105.2 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.4;lymphoid tissue: 7.5;testis: 9.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 56.7;Spermatocytes: 102.6;Spermatogonia: 108.9;Theca cells: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: AB_2686537" "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavorable (3.53e-4)" "prognostic favorable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.3 0.7 1.8 2.2 1.5 10.4 0.6 1.4 1.8 0.5 1.0 1.7 1.5 0.8 1.1 4.1 0.4 0.6 1.5 1.8 1.6 0.3 0.9 0.6 7.5 1.4 1.7 1.6 0.4 0.3 0.7 0.6 3.3 1.7 0.4 1.9 0.3 0.7 0.2 0.1 1.1 1.5 1.0 1.4 2.4 0.8 9.7 1.6 6.2 0.5 0.3 7.3 1.2 1.3 2.3 28.6 27.4 43.7 33.9 5.4 6.8 31.6 54.2 20.2 59.3 30.9 39.3 18.0 35.6 27.1 10.5 29.1 29.9 57.9 15.1 50.4 17.2 46.4 27.9 13.2 40.1 6.6 46.5 23.7 1.8 2.6 32.4 17.1 9.3 20.0 30.1 36.0 17.4 35.9 26.9 65.6 60.7 48.1 20.7 76.0 78.6 80.6 35.8 14.9 9.8 52.2 30.4 24.5 29.8 18.1 34.9 15.6 37.9 11.6 53.7 34.6 33.6 51.8 12.5 18.9 123.2 22.2 29.5 40.1 0.0 0.3 0.3 0.9 0.7 0.4 0.7 0.5 0.5 0.6 1.4 0.8 0.3 0.0 0.8 0.8 1.0 1.2 0.7 1.8 1.5 1.4 1.8 1.8 1.6 1.4 1.7 1.6 1.7 1.4 1.6 2.3 1.6 3.2 14.5 1.0 8.8 6.6 2.2 3.6 8.6 6.6 4.1 5.8 3.7 1.5 6.3 5.5 4.2 39.3 6.0 9.5 1.9 2.5 13.2 6.5 7.5 4.3 1.8 45.4 6.3 0.7 40.9 8.0 7.1 9.4 1.3 56.7 0.7 9.9 15.7 11.8 2.7 12.4 6.1 3.8 11.9 8.9 2.8 7.7 33.8 2.8 1.2 2.5 2.1 0.0 2.0 2.1 1.4 3.4 18.5 2.6 2.3 1.0 10.7 10.2 0.0 5.1 7.3 102.6 108.9 16.9 6.0 10.9 7.5 47.5 14.4 2.7 ZFHX4 "FLJ20980, ZFH4" ENSG00000091656 "Zinc finger homeobox 4" Q86UP3 8 76681239-76867281 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.9" "Cell type enhanced" "Detected in many" "Astrocytes: 358.5;Bipolar cells: 87.2;Oligodendrocyte precursor cells: 234.2;Oligodendrocytes: 222.6;Skeletal myocytes: 120.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 16.8;TIME: 33.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023837 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA023837: AB_1859013" "unprognostic (2.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.63e-3)" "unprognostic (6.14e-8)" "unprognostic (3.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.79e-2)" "unprognostic (9.15e-4)" "unprognostic (3.18e-2)" "unprognostic (1.17e-3)" "unprognostic (6.20e-7)" "unprognostic (3.50e-3)" "unprognostic (2.51e-1)" "unprognostic (4.50e-4)" "unprognostic (5.89e-4)" 2.5 3.6 7.4 0.5 12.7 0.0 2.1 2.7 7.0 2.2 0.0 2.4 0.0 0.8 3.3 0.3 0.6 0.9 0.3 5.0 13.0 0.3 2.8 0.1 0.3 11.1 19.9 3.4 1.9 0.2 0.2 2.9 0.1 10.1 1.0 0.5 2.2 0.6 5.6 2.9 0.3 0.4 1.1 4.3 0.1 0.8 6.8 12.5 0.6 0.3 3.2 0.1 2.7 2.7 15.6 0.0 2.2 3.8 0.0 7.2 8.7 0.0 3.3 4.6 3.8 3.9 0.0 0.0 0.0 5.8 5.7 1.7 0.4 7.8 1.0 7.6 0.0 10.3 0.1 0.0 0.0 1.9 0.0 0.5 16.8 0.4 9.5 3.0 6.5 0.7 0.0 0.1 0.3 7.0 0.0 0.0 0.0 0.6 0.4 7.1 0.0 6.8 0.0 5.8 0.0 0.0 6.5 0.0 0.8 0.0 0.0 0.9 0.0 33.4 3.7 5.6 10.6 7.4 10.9 1.2 0.0 1.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.7 2.7 7.0 5.0 13.0 11.1 19.9 3.4 10.1 4.3 12.5 15.6 5.4 0.0 1.5 358.5 0.3 0.5 0.1 1.0 2.2 87.2 2.4 2.2 4.0 42.9 0.3 5.5 2.1 0.1 0.2 0.0 0.0 0.1 70.0 0.0 1.1 2.0 0.0 0.0 13.7 0.0 0.0 37.5 0.0 0.0 0.0 0.1 1.1 30.5 0.4 5.0 12.6 0.2 0.0 0.6 1.8 24.3 13.7 0.7 0.0 29.0 0.0 15.0 0.0 234.2 222.6 0.0 0.0 21.4 0.1 0.3 0.0 0.3 0.3 5.8 0.0 120.6 8.1 12.4 2.3 1.2 1.1 0.0 0.6 10.0 0.0 0.9 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338381-22379503 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 51.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 14.4;Rod photoreceptor cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 229 "SCLC-21H: 30.3" "Group enriched" "Detected in all" 5 "basal ganglia: 51.9;hypothalamus: 139.9;midbrain: 172.4;pons and medulla: 86.4;thalamus: 164.9" "Low region specificity" "Detected in many" "CAB037130, HPA039226, CAB078204" Supported Supported NA NA "CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.0 0.0 11.2 0.0 4.6 0.0 0.0 13.9 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 15.0 0.0 0.0 0.0 0.0 32.7 18.5 3.4 0.0 0.2 0.0 3.6 0.0 36.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 51.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 4.6 13.9 10.6 3.9 15.0 32.7 18.5 3.4 36.1 6.3 39.0 51.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPA1 CPA ENSG00000091704 "Carboxypeptidase A1" P15085 7 130380339-130388114 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2324 "pancreas: 239516.8" "Cell type enriched" "Detected in some" 19 "Exocrine glandular cells: 10133.0" "Cancer enriched" "Detected in some" 639 "pancreatic cancer: 1377.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AN3-CA: 11.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA021836, CAB025197, HPA052215" Enhanced "Secreted to digestive system" NA NA 110000000 "CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764" "unprognostic (8.41e-2)" "unprognostic (9.24e-4)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (3.97e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-6)" "unprognostic (4.99e-1)" "unprognostic (1.67e-1)" "unprognostic (2.16e-1)" "unprognostic (4.37e-2)" 23.3 4.8 0.2 5.6 0.2 4.7 13.7 0.1 0.2 7.1 0.9 4.2 33.9 5.0 0.1 7.0 3.7 0.2 43.9 0.2 0.2 4.6 13.0 3.3 8.8 0.1 0.1 0.1 103.0 239516.8 0.0 5.1 18.5 0.2 7.0 0.0 0.2 39.9 0.1 4.7 6.6 21.0 0.4 0.2 7.8 21.5 5.5 0.1 0.1 3.0 0.4 0.0 2.8 4.0 0.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.0 1.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.1 3.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.9 12.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 10133.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.9 1.2 0.0 1.0 44.5 2.1 0.0 0.0 0.0 527.2 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 16.2 2.7 0.9 5.5 0.0 0.0 1.6 0.0 2.5 0.0 0.1 ZC3HC1 NIPA ENSG00000091732 "Zinc finger C3HC-type containing 1" Q86WB0 7 130018287-130051451 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019089, HPA024023" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA019089: AB_1858976, HPA024023: AB_1858977" "unprognostic (7.14e-3)" "unprognostic (4.07e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.89e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (5.11e-2)" "unprognostic (2.60e-2)" "unprognostic (1.53e-1)" 8.4 12.5 10.9 7.4 10.9 4.7 8.5 10.7 11.4 9.0 11.3 8.6 5.4 9.3 8.7 7.5 8.4 5.8 15.3 10.7 11.7 11.9 14.2 6.4 10.7 11.2 11.1 10.7 9.4 7.6 11.7 7.6 8.5 10.8 8.3 7.3 5.8 7.1 7.1 33.0 6.4 7.6 11.6 10.7 12.6 8.7 15.8 11.3 10.5 7.4 29.4 10.7 9.2 7.6 11.2 15.2 24.8 30.3 35.1 17.2 15.5 20.6 19.5 23.5 36.5 36.3 29.7 25.5 34.2 13.7 24.4 48.5 13.4 40.1 29.2 35.0 22.7 34.2 24.1 21.4 29.1 27.7 27.4 22.9 18.4 21.2 38.1 24.2 20.1 39.5 28.9 73.7 11.7 35.5 26.5 33.2 51.9 62.5 26.0 28.0 31.0 23.6 29.5 37.0 10.7 19.3 34.3 27.5 39.4 30.7 42.9 17.3 28.6 17.6 24.2 11.5 20.5 32.8 22.9 36.8 44.7 37.8 34.9 41.2 34.5 24.6 23.8 26.0 29.4 29.5 39.3 26.6 27.5 31.2 37.1 35.2 27.7 2.0 29.5 28.3 18.6 30.8 24.6 10.9 10.9 10.7 11.4 10.7 11.7 11.2 11.1 10.7 10.8 10.7 11.3 11.2 5.2 6.4 2.3 12.4 8.8 1.5 5.4 16.0 11.4 6.1 4.3 5.8 13.5 4.3 7.5 7.3 0.0 19.2 4.8 2.3 17.6 12.8 3.3 3.1 5.5 8.6 3.6 5.2 13.8 9.7 16.9 8.1 4.1 2.6 4.5 12.4 11.4 9.1 9.0 6.7 15.7 4.2 16.2 5.0 3.0 5.2 8.7 4.3 1.8 9.4 11.6 6.9 9.2 11.6 12.4 8.9 7.7 6.4 9.1 2.3 2.6 22.1 8.9 5.9 0.0 7.4 8.3 42.0 22.9 5.0 1.7 7.4 7.0 9.4 4.9 2.2 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 84.5;endometrium 1: 111.9;fallopian tube: 65.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7" "Cancer enhanced" "Detected in many" "breast cancer: 40.2;endometrial cancer: 24.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "MCF7: 46.0;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 4.3 1.9 3.3 1.5 0.9 0.8 29.4 3.1 1.3 84.5 3.3 0.9 0.4 111.9 1.2 0.5 65.5 1.2 1.6 0.7 5.4 2.8 17.0 2.0 1.6 0.5 0.5 0.6 9.1 1.0 0.2 6.7 0.4 0.9 6.2 0.5 3.5 0.9 9.9 5.9 1.0 0.8 50.8 0.4 1.7 0.6 2.3 3.9 1.1 3.4 2.6 2.3 2.2 47.3 0.6 0.6 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.6 0.0 0.0 0.0 1.2 0.1 46.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.7 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.2 57.4 0.0 0.1 0.2 0.2 0.5 0.0 5.2 1.1 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.9 3.1 1.3 0.7 5.4 0.5 0.5 0.6 0.9 0.4 3.9 0.6 0.6 0.0 1.1 1.3 2.3 1.0 1.7 0.0 0.0 3.9 86.6 16.4 4.4 0.0 1.0 0.0 8.4 0.1 0.4 0.1 1.9 0.0 40.1 77.9 79.9 2.7 1.8 0.0 4.5 0.2 0.1 11.3 0.0 98.9 2.5 36.9 5.0 52.1 0.9 62.2 5.4 0.0 0.0 4.0 3.1 10.3 4.1 2.5 1.8 1.0 0.2 2.4 0.0 25.1 0.6 0.1 0.0 2.2 8.5 0.6 0.0 3.7 1.3 4.6 0.0 56.7 11.7 1.8 1.3 0.4 1.7 0.1 2.2 4.8 0.1 6.8 RGS17 "RGS-17, RGSZ2" ENSG00000091844 "Regulator of G protein signaling 17" Q9UGC6 6 153004459-153131282 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 41.9;Excitatory neurons: 54.4;Inhibitory neurons: 57.2;Oligodendrocyte precursor cells: 62.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.9;hTERT-HME1: 7.0;LHCN-M2: 8.7;RH-30: 6.7;U-87 MG: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022276, HPA056493" Approved Approved Vesicles NA NA Vesicles "HPA022276: AB_10794628, HPA056493: AB_2683152" "unprognostic (2.77e-2)" "unprognostic (6.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (3.12e-1)" "unprognostic (3.79e-2)" "unprognostic (7.95e-3)" "unprognostic (1.92e-1)" "unprognostic (5.33e-2)" "unprognostic (5.96e-12)" "unprognostic (2.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 0.8 0.3 2.0 0.5 1.9 1.3 0.7 3.7 2.0 1.4 0.0 0.4 0.5 0.5 0.2 1.6 0.5 1.1 0.2 1.8 2.7 0.3 0.1 0.3 0.5 1.9 3.3 1.6 0.9 1.0 0.0 1.9 0.1 1.8 1.3 0.4 1.7 0.7 0.3 0.1 0.6 0.5 0.2 1.8 0.3 0.9 0.9 2.4 0.6 2.4 0.0 0.1 0.9 0.7 2.0 0.1 2.0 2.2 0.2 1.0 7.9 0.1 0.2 0.7 0.5 1.3 0.0 0.3 0.3 0.4 0.4 4.2 0.3 2.0 1.9 1.0 0.2 0.3 0.4 0.4 0.1 1.9 0.2 1.0 2.3 0.1 3.3 7.0 1.8 3.8 1.1 0.1 0.3 8.7 0.9 0.1 0.3 1.4 0.1 1.4 0.1 6.7 0.1 2.3 0.9 1.7 4.3 0.1 0.0 0.0 0.4 0.1 0.3 1.8 1.4 1.1 1.5 2.5 0.3 0.1 0.1 9.3 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.0 1.9 3.7 2.0 1.8 2.7 1.9 3.3 1.6 1.8 1.8 2.4 2.0 0.3 0.0 0.0 12.7 0.6 0.3 1.2 1.4 0.0 15.9 0.6 0.6 1.0 2.8 7.2 0.0 0.0 0.2 3.7 0.0 0.0 17.1 0.2 0.7 3.5 1.4 41.9 0.4 54.4 0.4 0.2 4.2 4.6 0.8 11.4 0.6 0.0 0.2 0.3 3.3 57.2 0.1 0.0 0.8 3.2 0.6 3.1 0.8 0.0 1.9 0.5 2.7 7.2 62.8 2.2 1.4 1.6 9.1 0.9 6.6 0.0 0.1 3.4 3.5 0.0 3.6 2.4 1.4 9.2 0.1 0.0 0.3 1.7 0.5 0.3 8.7 ANGPT2 Ang2 ENSG00000091879 "Angiopoietin 2" O15123 8 6499632-6563409 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8" "Cell type enhanced" "Detected in many" "Adipocytes: 81.7;Endothelial cells: 182.2;Smooth muscle cells: 79.8" "Cancer enhanced" "Detected in all" "renal cancer: 12.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "HMC-1: 17.9;HSkMC: 39.9;HUVEC TERT2: 62.6;WM-115: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011437, CAB017626" Approved "Secreted to blood" NA NA 3780000 110000 "CAB011437: , CAB017626: AB_1118956" "unprognostic (1.28e-1)" "prognostic unfavorable (7.99e-5)" "unprognostic (1.93e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.36e-5)" "unprognostic (1.66e-3)" "prognostic unfavorable (4.48e-4)" "unprognostic (2.94e-3)" "unprognostic (6.19e-3)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.52e-7)" "prognostic unfavorable (3.87e-4)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (6.44e-2)" 15.5 0.5 5.8 3.8 6.0 0.4 10.0 5.8 8.0 6.2 3.0 2.9 1.2 4.4 1.1 2.2 4.2 4.9 6.8 4.8 6.4 1.9 2.8 4.6 6.9 12.1 7.9 3.1 2.6 0.8 2.4 0.8 11.4 10.5 3.3 1.8 1.6 2.5 2.8 4.0 2.7 2.5 6.9 6.9 0.5 1.8 0.9 9.5 6.4 8.3 2.0 2.8 10.7 3.2 24.8 0.1 0.2 0.3 0.1 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.1 4.7 0.4 0.1 0.9 0.0 17.9 39.9 0.0 0.0 0.0 0.1 62.6 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.8 0.0 0.0 0.1 0.3 0.1 0.1 1.3 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.1 22.7 1.7 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.1 0.1 5.8 6.0 5.8 8.0 4.8 6.4 12.1 7.9 3.1 10.5 6.9 9.5 24.8 81.7 9.6 0.0 5.2 7.8 8.2 2.7 2.5 1.8 9.3 1.5 1.4 2.8 2.8 1.6 0.0 29.2 1.8 3.6 0.6 0.0 1.3 3.2 4.2 5.4 182.2 13.8 1.3 17.0 0.5 1.5 6.3 1.5 5.9 4.5 2.0 30.4 0.9 0.6 38.7 16.1 1.7 0.0 2.5 10.9 5.0 43.5 2.7 16.0 26.2 2.4 2.9 7.2 24.6 11.3 1.3 1.2 3.8 0.9 9.9 2.6 1.0 1.4 12.5 0.0 8.1 79.8 1.6 1.6 0.3 8.0 30.6 5.5 2.9 1.3 4.7 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039739, HPA075651" Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039739: AB_2676657, HPA075651: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favorable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 16.7 20.0 22.5 13.0 26.2 11.6 108.1 22.9 24.2 44.8 23.2 19.8 17.1 64.1 27.9 28.3 38.3 16.0 21.3 21.8 22.3 91.8 24.3 18.8 19.6 23.8 23.6 21.4 22.9 39.5 26.7 15.5 21.8 24.4 24.2 17.0 12.2 30.4 112.9 33.6 28.0 17.5 16.2 23.1 20.5 29.0 23.7 23.5 16.7 23.2 25.1 17.8 20.6 23.2 23.0 23.5 56.0 19.7 16.2 45.7 43.9 19.6 24.1 36.1 46.5 43.8 42.0 59.5 26.1 6.5 24.9 36.0 35.3 22.9 41.5 35.2 28.5 46.1 19.5 45.7 86.2 39.3 31.7 32.8 39.4 46.5 32.8 46.3 41.8 40.8 45.0 40.7 50.1 29.2 31.7 34.6 36.6 9.1 25.4 62.6 29.8 42.8 47.4 39.1 18.7 25.3 20.2 14.6 0.5 59.6 24.9 27.3 59.9 24.7 42.1 28.5 18.8 46.9 52.1 38.0 12.0 44.3 29.7 38.2 20.1 42.8 15.3 31.2 43.4 35.7 37.3 39.6 36.4 44.9 39.8 43.2 35.7 15.9 44.1 32.9 44.0 44.6 31.1 22.5 26.2 22.9 24.2 21.8 22.3 23.8 23.6 21.4 24.4 23.1 23.5 23.0 22.1 19.2 15.4 0.0 22.8 20.6 31.6 72.0 21.6 10.4 64.2 61.2 27.3 24.3 34.5 40.5 6.2 68.5 19.6 18.5 37.2 36.6 13.1 237.2 70.8 28.2 23.4 33.2 0.0 49.8 47.3 21.1 13.7 507.4 22.9 34.4 36.0 20.6 37.6 11.8 0.0 37.3 28.5 32.4 11.8 11.1 13.1 23.8 33.8 0.0 47.7 17.7 29.9 0.0 0.0 41.8 20.7 12.4 29.4 23.4 27.7 30.2 27.1 11.7 6.6 13.2 19.8 45.8 24.7 26.9 22.6 44.6 20.9 25.6 45.7 25.2 CD200 "MOX1, MOX2, MRC, OX-2" ENSG00000091972 "CD200 molecule" P41217 3 112332347-112362812 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endothelial cells: 97.4;Excitatory neurons: 54.5;Inhibitory neurons: 55.7;Syncytiotrophoblasts: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "memory B-cell: 30.7;naive B-cell: 83.6" "Lineage enriched" "Detected in many" 23 "B-cells: 83.6" "Cell line enhanced" "Detected in some" "AF22: 75.9;HHSteC: 27.2;NTERA-2: 47.7;REH: 42.4;SK-MEL-30: 29.8;WM-115: 83.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031149 Approved NA NA 26000 "HPA031149: AB_10600694" "unprognostic (1.84e-1)" "unprognostic (5.08e-2)" "unprognostic (1.79e-1)" "unprognostic (2.03e-3)" "unprognostic (4.97e-1)" "unprognostic (1.21e-2)" "unprognostic (9.29e-2)" "unprognostic (2.25e-2)" "unprognostic (3.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.06e-2)" "unprognostic (2.80e-1)" "unprognostic (4.49e-2)" "unprognostic (1.22e-2)" 14.5 12.2 26.7 15.7 31.5 2.4 11.7 17.0 33.0 20.2 6.5 5.9 3.3 28.7 7.1 9.0 27.0 13.2 6.1 29.2 38.5 8.5 1.0 9.7 26.3 15.9 20.8 28.5 11.7 5.0 10.6 27.0 28.4 19.4 12.2 8.3 15.3 9.1 16.6 1.8 4.1 7.0 18.5 13.7 6.3 5.3 3.0 29.2 23.9 19.0 3.7 25.1 27.8 5.9 27.3 0.0 0.0 75.9 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.1 0.2 4.1 0.0 0.9 0.1 8.2 0.4 0.2 0.2 0.5 0.0 0.3 0.4 27.2 0.0 0.1 0.5 0.2 1.6 0.2 0.2 10.8 0.0 0.1 0.7 0.2 0.0 1.2 0.0 47.7 0.0 0.0 42.4 0.1 0.5 0.6 0.1 19.9 23.0 0.0 0.4 29.8 14.0 0.0 0.3 0.1 0.3 2.6 0.0 0.2 0.1 0.1 0.0 0.6 0.2 83.7 3.6 0.4 0.3 0.3 0.1 3.5 30.7 2.0 0.6 1.3 83.6 2.1 1.3 1.7 1.6 0.3 2.8 1.0 3.4 26.7 31.5 17.0 33.0 29.2 38.5 15.9 20.8 28.5 19.4 13.7 29.2 27.3 15.2 3.2 9.1 10.7 27.8 4.2 12.6 0.3 0.0 26.8 0.7 13.0 0.8 1.5 1.3 1.8 0.0 3.0 1.6 0.8 0.0 0.3 25.1 20.6 4.2 97.4 38.4 0.8 54.5 0.0 12.1 13.0 3.1 41.0 2.5 0.7 1.4 0.0 1.0 3.3 55.7 8.1 0.0 0.3 6.1 30.3 0.3 1.1 8.8 6.5 14.0 7.1 0.0 29.7 38.5 0.2 10.7 0.0 1.9 15.4 0.9 0.3 2.7 2.5 0.0 13.1 2.6 0.6 0.4 0.7 3.3 75.9 2.9 9.3 7.1 21.6 CCDC80 "CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB" ENSG00000091986 "Coiled-coil domain containing 80" Q76M96 3 112596797-112649530 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002266 Approved "Secreted to extracellular matrix" NA NA 510000 "HPA002266: AB_1078423" "unprognostic (1.26e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (3.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.53e-2)" "unprognostic (2.30e-3)" "unprognostic (1.99e-3)" "unprognostic (8.40e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.86e-5)" "unprognostic (5.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.26e-4)" 217.1 15.1 7.0 84.2 7.0 1.1 220.7 10.2 8.7 308.0 23.1 64.3 8.8 279.1 77.5 93.3 82.9 236.0 173.6 6.8 14.9 17.6 6.7 74.6 18.6 12.9 11.4 5.1 62.7 28.9 12.5 10.9 26.2 9.8 68.4 74.2 9.5 35.0 79.4 13.5 72.5 25.3 363.2 10.8 35.1 48.0 43.1 10.5 17.3 88.2 35.2 31.1 196.3 132.9 13.7 26.1 11.0 127.6 5.8 521.4 411.2 6.9 359.0 108.5 118.6 171.8 2.9 2.1 1.2 13.5 1281.3 11.4 33.5 5.3 4.8 123.7 24.3 1.2 0.7 27.7 0.7 109.5 1.0 0.5 409.7 14.4 174.9 11.0 2404.9 27.8 0.6 0.4 1.0 352.7 0.5 0.3 0.7 31.6 0.7 4.2 0.3 14.0 0.6 3.3 0.5 0.4 2.5 53.5 2.3 1.8 23.0 2.1 1.0 141.7 345.6 56.6 66.6 160.1 1.6 0.8 1.2 102.4 0.7 56.8 0.9 0.3 0.2 0.3 0.1 0.3 0.4 0.3 0.3 0.1 0.6 0.4 0.4 0.3 0.3 0.2 0.7 0.2 0.0 7.0 7.0 10.2 8.7 6.8 14.9 12.9 11.4 5.1 9.8 10.8 10.5 13.7 104.5 6.4 15.9 13.1 1.5 60.9 4.2 44.7 26.7 1.1 5.9 59.7 22.5 10.0 62.7 5.5 0.0 57.9 1.0 0.3 1.9 23.7 450.8 95.4 93.2 43.9 0.0 0.0 1.0 1.2 101.5 921.6 16.8 18.4 1.3 44.3 53.6 0.9 9.4 0.0 0.3 0.8 30.5 2.2 121.5 353.6 77.0 9.7 144.1 3.7 2.0 101.4 0.0 0.0 0.0 13.5 0.0 34.6 5.8 3.6 0.0 0.1 112.4 2.5 19.7 177.7 198.4 6.9 4.9 11.9 51.7 27.9 9.0 23.0 0.1 1.9 CMA1 ENSG00000092009 "Chymase 1" P23946 14 24505353-24508265 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 18.7" "Cell type enriched" "Detected in some" 28 "granulocytes: 53.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000363, HPA052634" Enhanced Supported "Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 3000000 "Cytoplasmic bodies" Cytosol "CAB000363: AB_2083616, HPA052634: AB_2681892" "unprognostic (1.37e-1)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" "unprognostic (7.07e-3)" "unprognostic (1.48e-2)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" "unprognostic (8.91e-3)" "unprognostic (4.19e-3)" "unprognostic (1.29e-4)" "unprognostic (2.52e-3)" "unprognostic (7.78e-2)" "unprognostic (7.37e-2)" "unprognostic (4.98e-3)" 6.6 0.0 0.2 3.7 0.1 0.2 18.7 0.1 0.2 4.6 0.2 8.8 0.6 3.2 4.3 10.3 0.9 7.4 1.6 0.1 0.7 0.2 0.5 1.5 1.8 0.4 0.2 0.0 0.1 1.6 0.6 0.2 0.1 0.3 1.0 8.4 0.0 4.7 1.3 0.9 8.1 5.8 2.3 0.3 0.2 1.5 0.9 0.3 3.0 0.4 3.0 2.4 11.2 0.9 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.7 0.4 0.2 0.0 0.3 0.3 0.3 0.3 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 PSME1 "IFI5111, PA28alpha" ENSG00000092010 "Proteasome activator subunit 1" Q06323 14 24136163-24138967 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006632 Approved Approved "Nuclear bodies,Cytosol" NA NA 7500000 Cytosol "Nuclear bodies" "HPA006632: AB_1079686" "prognostic favorable (8.87e-5)" "unprognostic (1.02e-2)" "unprognostic (9.90e-2)" "unprognostic (2.84e-1)" "unprognostic (2.65e-1)" "unprognostic (1.97e-1)" "unprognostic (5.16e-1)" "unprognostic (7.04e-2)" "unprognostic (9.63e-3)" "unprognostic (5.06e-3)" "unprognostic (1.49e-2)" "unprognostic (1.38e-2)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (4.50e-1)" "prognostic favorable (4.60e-4)" "unprognostic (1.62e-3)" 161.1 233.1 36.2 103.1 38.2 121.3 158.4 37.1 47.5 154.2 37.8 177.4 135.1 129.7 85.8 179.0 140.9 68.9 132.0 35.5 41.0 226.1 221.6 185.7 158.1 39.6 37.0 34.4 155.6 132.1 85.3 115.9 73.0 38.7 147.6 121.1 24.8 152.8 86.7 141.9 143.5 213.3 80.5 38.5 274.7 161.8 30.9 38.6 130.3 151.8 67.9 151.9 136.3 158.4 41.5 98.6 79.0 59.8 115.9 127.6 146.0 91.6 61.5 199.0 193.2 274.8 51.9 233.5 252.1 44.8 102.7 101.7 139.1 86.8 127.3 128.7 211.2 52.5 112.9 34.9 289.6 280.0 144.8 137.6 128.2 80.4 87.4 76.3 182.6 147.4 158.1 17.5 218.5 76.3 249.3 376.0 175.1 5.8 162.3 135.9 293.2 123.4 182.9 246.8 259.8 37.7 67.3 78.0 200.7 124.6 35.5 131.9 139.5 85.1 52.8 61.0 60.6 92.7 201.8 224.5 120.9 71.9 128.0 86.6 394.8 441.9 552.3 484.5 570.1 484.8 399.4 448.4 463.2 425.0 370.1 318.6 395.7 653.9 515.6 575.2 408.3 537.9 978.6 36.2 38.2 37.1 47.5 35.5 41.0 39.6 37.0 34.4 38.7 38.5 38.6 41.5 305.5 208.3 172.7 7.5 353.8 156.4 241.6 570.7 199.2 28.2 159.6 169.2 59.6 248.8 296.5 283.3 10.4 393.3 406.7 347.8 318.9 500.0 3.5 171.4 250.5 228.0 189.7 244.9 1.4 549.8 293.2 184.8 138.6 223.9 240.1 124.7 242.4 266.6 313.7 6.7 1.9 397.6 280.8 295.3 294.2 16.5 189.2 275.4 188.5 4.7 930.4 98.3 620.0 3.0 6.6 373.6 461.2 124.8 422.0 280.6 754.3 700.5 236.3 23.5 105.2 121.4 283.6 3.5 24.9 200.0 156.0 304.4 424.6 243.6 406.6 301.3 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 20.1 15.6 25.5 24.1 26.8 43.2 17.3 26.2 41.9 18.2 25.6 18.8 21.2 16.4 16.6 12.6 14.1 18.7 23.1 25.4 28.1 14.5 16.2 17.9 31.3 27.3 26.7 24.8 16.0 10.3 17.1 17.7 18.9 27.3 17.3 20.5 15.6 13.6 14.2 25.1 7.0 22.7 21.2 27.2 24.6 16.4 72.3 26.0 26.7 12.5 25.9 26.1 22.5 10.4 29.5 41.2 21.8 41.7 33.9 32.4 54.5 29.6 33.0 32.0 41.0 48.0 18.1 32.2 47.2 13.4 33.9 15.5 17.6 20.0 13.8 60.5 47.8 19.3 26.2 11.9 65.2 43.3 51.2 51.7 41.9 14.4 29.0 19.7 24.0 55.7 26.2 25.7 46.3 57.4 28.4 46.4 43.1 37.1 27.4 24.3 50.2 27.1 32.8 15.8 24.1 39.9 37.5 41.7 27.6 57.8 19.9 17.9 57.0 47.9 41.3 17.3 36.0 34.9 44.8 52.4 92.8 22.8 47.9 48.1 66.5 41.6 86.9 23.4 52.5 27.0 31.0 24.8 29.5 36.1 33.1 22.0 26.9 76.9 33.1 42.7 16.3 40.8 34.0 25.5 26.8 26.2 41.9 25.4 28.1 27.3 26.7 24.8 27.3 27.2 26.0 29.5 35.5 16.0 24.7 32.7 40.2 11.5 23.3 31.7 9.6 15.9 18.8 14.7 26.3 17.2 25.8 20.2 4.2 19.4 48.1 29.1 33.2 31.2 489.7 23.1 28.1 33.8 31.2 69.7 28.3 36.1 26.2 26.5 19.9 21.7 33.7 31.3 34.6 22.8 61.3 8.4 30.4 26.8 32.6 49.7 36.3 233.5 28.3 42.6 28.4 24.4 71.5 28.7 46.4 36.2 58.8 49.2 22.3 30.5 37.4 24.8 37.8 43.2 25.1 21.5 32.9 24.0 43.1 239.2 58.6 19.6 13.5 34.8 45.2 36.2 24.6 30.5 HAUS4 "C14orf94, FLJ20424" ENSG00000092036 "HAUS augmin like complex subunit 4" Q9H6D7 14 22946228-22957161 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029803 Approved NA NA "HPA029803: AB_10601428" "unprognostic (8.47e-3)" "unprognostic (3.52e-1)" "unprognostic (6.47e-2)" "unprognostic (7.59e-2)" "unprognostic (3.08e-2)" "unprognostic (1.73e-1)" "unprognostic (7.54e-2)" "unprognostic (4.32e-3)" "unprognostic (2.92e-2)" "unprognostic (2.87e-2)" "unprognostic (7.70e-2)" "unprognostic (8.66e-2)" "unprognostic (3.00e-2)" "unprognostic (6.94e-2)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.24e-4)" 29.4 25.0 11.9 29.4 12.9 64.1 40.1 12.3 15.7 33.0 15.2 31.5 28.4 26.4 22.4 30.8 31.2 26.6 24.6 10.8 13.5 26.1 32.5 32.0 41.0 13.8 13.3 9.8 53.3 45.6 27.9 14.6 22.5 13.7 26.3 30.5 10.4 33.5 26.6 19.2 39.6 30.9 24.5 13.3 38.0 32.3 13.0 13.6 31.1 27.9 23.1 37.0 29.3 32.0 15.1 77.0 51.2 55.5 56.9 42.0 50.4 86.6 36.5 48.2 39.3 56.1 37.0 88.5 146.2 17.2 22.3 29.2 75.5 31.2 44.9 34.5 39.8 23.0 48.1 35.8 90.2 37.7 63.3 77.8 35.7 84.7 17.5 50.9 48.2 71.1 82.0 35.8 71.2 41.6 58.1 69.8 56.7 29.9 59.3 50.9 66.3 68.8 57.0 35.2 40.7 22.5 37.1 52.7 54.0 34.0 24.1 47.8 50.2 39.3 36.2 46.3 26.3 33.6 74.6 67.9 67.1 16.7 70.6 20.9 8.7 79.5 17.7 15.7 54.1 20.8 38.2 29.1 22.2 101.3 33.0 40.2 32.0 100.8 23.7 34.7 28.5 43.2 46.0 11.9 12.9 12.3 15.7 10.8 13.5 13.8 13.3 9.8 13.7 13.3 13.6 15.1 4.9 22.4 6.8 16.0 13.4 12.4 5.9 8.7 29.6 1.0 13.7 11.0 1.3 11.5 7.5 1.8 0.0 12.4 3.4 9.6 5.9 17.6 0.6 2.3 3.9 7.5 7.8 42.2 3.7 27.3 13.8 8.3 16.3 3.7 3.8 4.9 8.9 4.4 17.3 0.0 6.1 20.9 2.0 29.1 13.0 0.5 5.6 17.3 5.4 15.9 33.4 6.2 3.1 7.5 8.9 18.4 18.7 4.1 21.5 3.4 26.3 8.0 9.6 0.5 0.0 3.3 6.2 3.1 6.1 32.0 11.1 8.2 10.9 1.2 35.2 5.9 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 134.5;pituitary gland: 67.0" "Group enriched" "Detected in some" 13 "Bipolar cells: 191.4;Horizontal cells: 410.5" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;myeloid DC: 3.2" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 6 "SCLC-21H: 14.2;SH-SY5Y: 35.4;U-2 OS: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045022 Approved Cytosol NA NA Cytosol "HPA045022: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.0 11.8 91.1 1.0 91.5 0.2 1.0 29.0 134.5 6.9 0.0 1.5 0.8 24.5 5.3 0.4 13.8 0.5 0.3 125.3 33.7 2.6 0.3 2.5 1.0 28.1 18.6 113.7 13.7 0.5 1.9 67.0 0.5 43.4 12.4 0.6 12.7 0.3 37.2 0.2 0.8 1.3 13.1 2.3 2.7 0.9 1.4 27.5 0.3 0.4 0.5 0.6 1.6 6.7 66.8 0.0 0.0 0.7 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 14.2 35.4 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 91.1 91.5 29.0 134.5 125.3 33.7 28.1 18.6 113.7 43.4 2.3 27.5 66.8 0.3 0.0 0.6 0.7 0.0 0.0 0.2 0.0 0.0 191.4 0.2 0.1 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.3 0.3 5.7 1.7 1.8 0.0 22.1 0.0 0.0 1.4 0.0 0.1 5.1 1.2 1.8 0.0 2.0 410.5 18.3 0.2 0.0 1.3 9.3 0.2 10.8 0.9 0.0 0.0 0.1 1.6 0.0 15.6 0.4 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 7.7 13.1 0.1 2.3 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 MYH7 "CMD1S, CMH1, MPD1" ENSG00000092054 "Myosin heavy chain 7" P12883 14 23412740-23435660 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 62 "heart muscle: 4312.8;skeletal muscle: 14692.0;tongue: 5426.5" "Cell type enriched" "Detected in some" 127 "Cardiomyocytes: 10295.8" "Group enriched" "Detected in some" 9 "head and neck cancer: 12.2;prostate cancer: 15.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 31 "HSkMC: 11.4" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB015384" Enhanced Uncertain "Focal adhesion sites" NA NA 43000000 "Focal adhesion sites" "CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (6.49e-2)" "unprognostic (8.27e-5)" "unprognostic (1.56e-1)" "unprognostic (3.04e-3)" "unprognostic (4.30e-1)" "unprognostic (7.33e-3)" "unprognostic (8.60e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (1.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.38e-3)" "unprognostic (2.32e-1)" "unprognostic (1.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.28e-2)" 1.7 1.3 2.0 0.0 1.6 0.1 2.6 0.2 1.1 0.3 1.2 1.0 0.5 0.4 0.0 130.3 0.1 1.1 4312.8 1.2 2.1 0.9 1.4 3.2 1.5 1.1 1.4 0.8 0.7 7.8 0.0 1.5 0.0 0.7 77.5 0.0 0.0 37.3 0.0 14692.0 3.2 0.9 0.0 0.7 0.5 0.9 1.4 2.4 0.1 1.9 5426.5 0.1 0.2 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 0.2 1.1 1.2 2.1 1.1 1.4 0.8 0.7 0.7 2.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10295.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 80.9 0.0 0.0 0.2 3.1 0.0 70.5 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 52.2 51.2 0.1 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 CEBPE CRP1 ENSG00000092067 "CCAAT enhancer binding protein epsilon" Q15744 14 23117306-23119255 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 52.2" "Cell type enhanced" "Detected in some" "Hofbauer cells: 6.6;Kupffer cells: 1.4;Macrophages: 2.3;monocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "eosinophil: 750.4" "Lineage enriched" "Detected in many" 250 "granulocytes: 750.4" "Group enriched" "Detected in some" 4 "HL-60: 233.8;NB-4: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.1 0.0 0.1 1.6 0.1 52.2 0.0 0.0 0.2 0.0 0.1 0.2 2.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.6 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 3.2 0.3 0.1 3.4 0.9 0.0 0.2 0.5 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 233.8 39.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.9 122.5 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 26.3 0.0 0.5 3.0 750.4 0.0 0.6 0.1 0.5 1.0 0.4 1.5 0.5 1.8 1.5 3.4 0.0 0.3 1.5 0.0 1.8 0.1 0.1 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.0 1.4 0.6 0.1 0.0 2.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.0 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 333.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 74.1;Kupffer cells: 90.0;Proximal tubular cells: 144.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 9.3;eosinophil: 14.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.0" "Cell line enhanced" "Detected in many" "ASC diff: 68.8;BEWO: 110.6;K-562: 136.9;NTERA-2: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced NA NA "CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340" "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.97e-4)" "prognostic favorable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.52e-4)" 27.8 15.3 1.0 7.0 4.6 1.6 28.0 4.0 6.5 31.0 34.1 12.6 36.6 44.0 4.9 37.8 46.3 18.8 7.9 3.3 4.8 120.4 7.0 15.5 4.5 2.7 3.2 0.4 68.1 20.1 333.5 16.0 16.1 5.0 39.6 13.9 14.0 24.0 35.9 49.8 29.1 24.4 21.1 0.0 18.6 64.0 21.4 5.1 5.0 23.8 15.5 9.0 30.1 37.8 1.6 1.6 0.0 52.9 0.1 68.8 8.5 110.6 6.0 26.3 0.3 2.0 60.4 3.6 0.4 0.8 13.9 5.4 11.7 8.5 3.5 0.3 0.0 5.2 0.6 0.3 0.0 25.5 0.2 35.8 54.1 33.2 0.9 0.9 11.6 5.2 5.4 136.9 0.3 1.5 1.2 0.3 0.8 64.0 12.9 47.4 0.1 0.9 12.5 0.7 21.4 8.2 0.3 0.2 12.0 32.3 60.1 42.8 0.6 0.5 2.3 1.8 0.7 0.0 0.3 15.9 0.2 6.9 0.0 0.4 9.3 0.1 14.0 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.3 0.4 0.0 0.1 0.0 0.5 2.3 1.0 4.6 4.0 6.5 3.3 4.8 2.7 3.2 0.4 5.0 0.0 5.1 1.6 0.5 16.0 15.0 2.3 1.8 3.1 28.8 6.4 29.0 26.4 31.6 15.2 5.7 0.0 9.0 16.5 0.0 18.7 0.5 8.3 5.9 1.9 2.2 13.6 74.1 2.1 33.0 0.0 24.8 2.4 4.4 15.5 53.5 18.4 5.1 27.3 66.4 1.3 59.2 26.9 53.5 33.7 4.1 90.0 3.3 3.1 9.6 15.3 19.6 15.9 0.5 39.3 0.0 4.0 2.6 3.0 6.5 7.9 1.6 26.4 27.3 144.8 1.0 4.4 0.0 2.8 4.7 1.1 1.3 25.3 3.0 41.3 2.9 3.4 18.5 32.3 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446401-20455089 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favorable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 5.6 6.4 6.3 3.8 6.3 6.2 7.1 6.6 7.3 6.6 6.8 7.7 3.8 6.4 8.5 6.0 6.1 6.7 8.2 6.0 6.7 5.8 11.2 6.2 9.3 6.6 6.2 5.9 5.3 5.7 7.5 5.2 6.8 6.5 4.9 7.1 4.2 5.3 8.4 10.6 4.7 6.3 5.7 6.6 8.5 6.4 2.4 6.5 10.0 7.7 10.0 10.1 8.3 4.9 7.0 10.3 17.2 5.6 16.2 9.9 6.6 17.6 8.0 11.3 21.1 20.1 21.5 12.3 21.1 10.3 11.0 9.0 8.6 17.9 17.6 14.1 16.8 19.1 14.8 12.2 32.1 7.4 24.3 19.7 5.3 5.2 26.1 14.0 4.6 14.3 18.8 14.0 12.1 17.6 21.0 25.0 11.8 9.1 31.5 31.8 35.3 10.3 12.4 12.8 11.7 21.3 4.2 15.4 16.0 11.9 3.3 9.7 23.7 6.1 8.7 21.2 11.3 10.7 3.4 18.0 31.7 5.0 36.1 11.0 9.3 29.2 38.5 18.8 27.9 17.4 28.7 19.7 17.2 44.5 38.1 15.9 17.4 13.8 20.9 23.3 16.9 19.2 24.6 6.3 6.3 6.6 7.3 6.0 6.7 6.6 6.2 5.9 6.5 6.6 6.5 7.0 27.1 35.3 34.9 16.3 46.0 11.5 20.9 26.2 14.2 37.8 24.0 25.1 17.2 15.7 29.1 23.9 37.5 66.3 31.8 22.5 35.2 24.7 3.1 19.2 18.3 24.1 26.9 19.6 23.0 29.8 47.0 23.4 28.1 16.3 25.9 24.6 25.7 19.3 65.8 10.1 24.1 24.2 22.4 30.7 32.8 3.0 19.3 34.2 21.4 7.5 28.4 31.0 32.0 16.6 17.0 20.0 30.6 21.4 26.2 10.9 42.2 39.7 25.5 51.5 13.1 24.6 23.9 7.8 16.9 22.0 11.5 46.1 26.8 37.3 31.6 17.4 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 246.8;choroid plexus: 300.6;pituitary gland: 150.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain NA NA "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 6.4 30.4 167.4 3.9 159.4 0.6 11.9 106.9 156.6 24.6 300.6 19.2 4.6 14.9 10.4 4.5 19.2 6.4 14.9 136.9 246.8 16.1 2.5 8.3 3.4 170.1 144.3 146.1 17.2 17.4 11.5 150.3 5.1 131.3 40.1 2.5 26.6 25.6 26.0 1.6 7.6 10.3 7.1 104.0 4.3 13.4 9.0 197.3 1.8 19.3 2.7 1.6 15.4 18.1 159.6 0.0 1.9 20.7 31.4 23.2 11.4 3.4 7.5 11.6 2.5 1.9 0.0 1.9 0.0 2.8 11.0 6.6 0.4 0.7 0.5 0.0 0.0 1.4 4.4 0.0 0.2 13.1 0.0 4.4 16.7 1.2 2.6 0.0 11.3 0.8 9.1 0.0 0.2 3.8 3.2 0.1 0.2 11.3 0.0 0.0 0.0 0.7 0.2 0.0 2.0 19.9 41.5 5.8 0.0 0.0 4.0 3.5 0.6 0.0 2.9 8.9 16.6 0.0 0.1 3.2 0.0 1.9 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 167.4 159.4 106.9 156.6 136.9 246.8 170.1 144.3 146.1 131.3 104.0 197.3 159.6 7.7 0.0 2.7 46.7 2.3 12.6 18.6 2.6 12.5 53.0 23.4 30.1 10.0 2.8 5.5 20.2 43.8 2.4 1.0 0.0 1.9 0.7 0.2 1.8 10.6 12.0 20.8 1.7 71.4 1.3 4.9 21.7 3.6 0.6 4.5 12.0 16.8 0.9 1.0 201.9 111.1 0.0 0.0 0.6 5.1 2.3 21.1 1.2 7.2 19.7 0.7 74.2 0.0 120.6 49.2 1.5 0.0 42.9 9.2 31.3 0.0 16.9 3.2 69.0 0.0 14.1 18.0 1.1 2.3 3.0 10.9 4.8 2.0 4.5 0.3 6.1 RNF31 "FLJ10111, FLJ23501, HOIP, Paul, ZIBRA" ENSG00000092098 "Ring finger protein 31" Q96EP0 14 24146683-24160660 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 16.0;Excitatory neurons: 8.8;Gastric mucus-secreting cells: 7.7;Inhibitory neurons: 8.2;Microglial cells: 10.3;Oligodendrocyte precursor cells: 9.5;Plasma cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "CAB009063, HPA048745" Approved Approved Cytosol NA NA Cytosol "CAB009063: AB_2127706, HPA048745: AB_2680509" "unprognostic (3.58e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (9.05e-2)" "unprognostic (2.52e-1)" "unprognostic (6.24e-2)" "unprognostic (9.09e-3)" "unprognostic (1.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (6.21e-3)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" 13.7 18.7 4.6 9.2 4.4 9.6 14.4 4.1 6.7 16.4 3.2 15.0 7.2 18.3 6.9 16.4 15.0 7.0 17.1 4.3 3.9 17.4 15.9 15.0 10.5 5.0 4.1 3.6 18.0 24.1 10.5 18.8 7.0 5.0 16.8 6.6 4.1 17.1 7.2 41.9 18.9 16.0 9.7 4.0 26.3 18.0 16.5 4.2 11.9 16.6 18.1 9.6 15.2 14.1 4.2 6.1 10.8 10.5 14.8 6.1 6.3 23.2 9.9 15.1 18.2 15.6 10.2 13.5 10.9 6.9 11.8 10.2 7.6 5.4 11.8 9.7 13.2 4.2 11.0 9.5 32.5 12.8 17.5 18.8 12.3 10.4 7.2 12.9 9.6 12.0 7.9 5.9 12.9 7.7 17.3 17.6 8.6 5.3 9.9 12.7 10.1 9.8 6.8 8.9 20.8 9.9 12.7 8.6 25.6 12.5 9.2 7.4 13.3 11.1 12.6 10.2 8.8 8.9 21.4 21.2 11.5 4.4 6.1 13.6 0.0 0.8 0.8 0.6 1.7 1.8 0.4 0.9 0.6 0.5 0.4 0.6 0.4 1.7 1.7 1.0 1.8 1.1 0.4 4.6 4.4 4.1 6.7 4.3 3.9 5.0 4.1 3.6 5.0 4.0 4.2 4.2 0.9 0.0 4.6 16.0 5.2 0.6 0.3 0.0 4.6 0.6 1.0 0.3 0.3 0.0 3.1 0.0 0.0 0.6 1.0 0.8 0.0 0.3 0.1 1.0 1.3 1.3 0.0 3.8 8.8 0.0 0.5 1.3 7.7 0.9 0.0 1.1 0.4 0.8 0.4 0.0 8.2 0.3 2.0 0.6 1.5 0.4 0.3 2.7 0.0 10.3 0.5 0.3 3.1 9.5 7.3 0.2 0.2 0.0 8.7 0.2 0.5 0.2 0.8 0.8 0.0 1.4 1.2 1.6 0.8 5.7 0.9 0.5 4.3 0.8 0.1 0.3 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622291-30737694 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved NA NA 120000 "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 23.4 29.6 12.2 22.5 12.2 10.0 29.5 12.4 12.7 34.3 12.8 27.8 22.4 22.0 41.2 30.0 21.9 19.8 29.9 12.1 12.7 32.8 35.4 22.7 26.4 11.7 12.3 11.9 23.8 46.8 42.2 29.6 28.1 12.1 27.9 30.1 15.0 52.7 24.3 24.8 19.6 24.0 23.1 11.6 19.2 28.3 26.8 11.9 25.9 44.7 29.5 29.3 30.3 21.0 12.1 71.7 26.0 37.8 22.9 64.1 67.0 53.4 57.0 68.4 69.5 83.5 42.2 58.9 36.9 24.2 79.7 38.8 44.5 41.3 46.5 80.0 53.2 22.2 30.7 28.6 149.5 77.9 50.2 32.4 49.1 39.1 48.9 78.1 58.5 45.5 26.5 42.6 68.0 74.7 66.8 30.7 27.8 40.7 83.9 45.1 30.2 42.1 42.2 70.7 45.6 35.9 33.0 58.7 54.4 53.6 42.9 70.5 35.3 48.1 41.9 44.0 43.0 45.3 45.3 40.8 49.4 26.9 36.7 52.9 26.8 17.2 20.2 14.0 23.2 17.8 20.1 16.2 17.3 23.7 14.7 15.2 14.1 3.0 23.1 27.8 16.9 24.4 16.1 12.2 12.2 12.4 12.7 12.1 12.7 11.7 12.3 11.9 12.1 11.6 11.9 12.1 33.0 51.3 31.3 67.9 47.7 25.0 55.2 55.1 18.2 35.0 26.9 27.1 35.3 18.6 50.8 25.8 43.8 61.9 51.3 31.8 64.6 49.2 29.3 34.9 51.6 32.3 47.2 24.2 123.0 50.6 61.0 47.9 20.9 34.2 53.7 32.1 24.3 20.6 44.9 30.3 112.8 44.9 36.7 27.7 33.4 16.6 38.5 35.5 37.4 90.9 66.9 31.1 62.8 112.6 106.6 41.2 23.5 40.3 70.9 42.3 28.8 40.9 52.1 39.9 13.1 53.7 49.0 71.8 53.5 20.5 24.4 83.0 41.4 47.8 30.0 43.5 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559158-30620064 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 42.7" "Group enriched" "Detected in all" 6 "Early spermatids: 722.5;Late spermatids: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Uncertain Approved "Golgi apparatus,Vesicles,Cytosol" NA Yes Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 4.8 3.2 2.5 6.5 6.8 10.1 6.5 11.8 5.6 6.5 0.6 5.7 5.1 6.4 3.7 6.3 4.8 3.9 4.8 3.4 3.3 4.6 5.2 4.6 9.2 4.0 2.2 2.1 6.1 5.3 5.7 2.7 6.4 4.4 5.2 5.4 13.9 5.0 4.6 3.0 5.9 5.0 6.3 1.7 6.3 5.3 42.7 4.3 14.5 6.7 3.9 9.0 4.9 4.0 10.1 37.9 15.6 33.7 16.1 11.2 15.0 30.5 31.9 12.9 20.2 22.9 17.1 20.5 32.9 10.9 18.4 15.9 29.7 36.4 18.8 42.2 25.7 15.7 19.6 17.1 31.0 10.3 34.0 22.5 8.1 7.4 15.1 34.9 18.3 22.9 22.5 21.2 24.2 29.0 21.9 22.6 9.6 31.2 27.5 32.7 21.4 0.0 8.2 10.5 22.3 28.4 19.9 27.7 16.0 7.9 20.5 19.1 12.5 17.3 19.7 21.9 16.9 21.9 14.1 47.7 38.8 5.4 16.6 29.2 20.2 6.5 12.9 7.6 8.5 10.1 9.2 7.4 6.3 5.6 9.9 9.2 7.8 5.9 6.5 11.3 6.8 6.6 4.1 2.5 6.8 11.8 5.6 3.4 3.3 4.0 2.2 2.1 4.4 1.7 4.3 10.1 22.6 19.2 9.0 17.9 32.9 21.9 22.5 11.8 26.7 34.9 13.0 10.8 10.0 12.8 13.6 5.5 25.0 17.8 23.0 9.0 9.8 8.9 722.5 13.9 26.6 17.0 13.8 42.7 45.3 7.1 22.7 20.6 14.3 14.1 17.1 23.3 13.2 7.5 14.2 35.3 38.4 14.7 14.2 13.9 12.4 233.9 16.4 16.5 8.8 24.4 16.2 15.5 32.0 41.7 43.1 10.7 9.4 14.3 14.4 22.5 5.6 12.0 10.9 33.4 52.6 18.0 18.6 69.8 42.7 20.7 25.4 10.0 24.9 11.9 12.4 20.6 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 220.2" "Cell type enhanced" "Detected in all" "Urothelial cells: 302.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: AB_2682496" "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 40.6 49.0 29.4 23.4 35.5 54.5 38.0 60.5 35.1 39.1 33.9 37.2 25.3 37.3 31.0 75.2 34.1 26.9 43.8 28.0 35.6 37.3 74.9 33.2 28.9 31.9 33.3 25.6 38.8 35.0 56.9 34.6 35.8 33.8 31.0 31.5 67.4 43.0 31.3 220.2 51.2 33.9 31.1 31.1 30.7 44.1 43.0 32.2 26.6 51.8 134.8 37.6 40.1 51.9 38.0 95.1 54.6 49.2 30.4 144.0 77.2 44.7 54.8 54.1 47.4 39.7 41.0 47.8 72.1 57.8 97.3 34.0 62.6 63.2 47.7 69.6 44.5 24.9 75.6 44.3 163.9 66.9 81.8 52.7 66.3 64.4 52.2 80.9 63.6 87.5 42.2 54.4 32.1 72.8 72.4 31.8 31.7 36.0 76.6 47.5 53.6 58.0 30.4 71.3 93.2 36.2 40.8 79.8 54.5 49.0 56.3 58.7 49.5 93.4 56.6 42.9 41.9 49.0 34.3 52.9 79.0 28.0 37.3 49.7 9.1 5.7 8.3 4.5 4.8 5.2 4.8 5.2 4.1 6.4 6.3 4.2 4.3 3.0 6.3 3.8 5.3 5.6 2.4 29.4 35.5 60.5 35.1 28.0 35.6 31.9 33.3 25.6 33.8 31.1 32.2 38.0 63.4 48.1 80.8 84.5 60.7 86.7 93.5 61.2 48.3 98.9 40.8 28.6 108.1 25.8 94.8 71.7 98.0 70.2 72.1 40.9 11.7 44.2 3.6 101.6 83.0 60.0 48.7 41.2 89.9 36.1 42.9 59.9 96.8 118.1 32.9 81.6 46.4 84.7 29.0 65.6 101.1 33.0 63.1 43.9 34.5 8.7 69.0 54.0 33.8 90.9 65.1 40.9 78.2 100.0 127.9 52.6 33.9 74.4 71.1 106.3 37.1 22.4 148.4 194.5 46.0 77.4 78.9 50.6 100.0 83.7 114.9 140.0 61.4 97.0 44.5 302.9 HNRNPC HNRPC ENSG00000092199 "Heterogeneous nuclear ribonucleoprotein C" P07910 14 21209136-21269494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005223, HPA051075, CAB075755, CAB075756" Supported Enhanced Nucleoplasm NA NA 1200000 Nucleoplasm "CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335" "unprognostic (1.92e-3)" "unprognostic (1.02e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.42e-2)" "unprognostic (5.21e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (8.66e-3)" "unprognostic (5.96e-3)" "prognostic favorable (1.19e-4)" "unprognostic (3.31e-3)" "unprognostic (5.30e-3)" "prognostic unfavorable (7.29e-5)" "unprognostic (7.36e-2)" "unprognostic (3.73e-3)" "unprognostic (2.28e-3)" "unprognostic (5.42e-2)" 255.0 311.8 287.9 322.4 302.4 545.0 331.8 297.4 335.2 306.0 272.4 269.3 234.4 321.9 314.6 320.9 331.4 248.6 272.0 291.8 322.6 314.9 337.2 254.0 501.8 298.6 306.3 270.2 431.1 239.7 259.9 239.6 344.9 311.0 251.8 293.7 410.9 227.8 250.2 290.6 248.6 257.3 268.2 315.6 308.9 234.2 195.4 299.6 563.0 261.5 246.1 500.0 378.1 280.9 340.9 1076.2 832.7 1277.7 748.5 754.8 704.7 910.2 673.2 764.3 1034.3 900.6 799.4 787.6 1935.6 414.1 772.1 656.8 775.6 1611.4 1035.4 1389.0 1236.1 918.1 992.8 614.2 1241.4 920.6 1495.2 762.6 731.8 854.2 756.5 1781.1 897.8 1078.4 957.7 1483.6 787.1 829.5 1020.0 1713.7 1435.2 1351.4 990.3 770.1 1375.0 1073.9 925.3 1159.7 956.9 699.0 665.5 838.5 760.9 786.4 1057.3 725.2 1332.6 783.1 388.9 698.2 473.8 972.8 708.8 1144.4 1873.6 370.6 1215.3 794.1 480.2 515.1 516.9 419.0 450.9 544.5 531.4 494.0 451.2 716.3 467.0 552.1 478.2 810.8 471.0 439.4 460.5 575.7 1220.5 287.9 302.4 297.4 335.2 291.8 322.6 298.6 306.3 270.2 311.0 315.6 299.6 340.9 172.7 153.8 233.9 69.5 307.2 536.2 583.9 512.2 331.8 169.8 259.9 191.5 137.9 173.0 393.2 275.8 198.1 612.6 309.4 134.0 283.7 315.0 169.0 365.1 352.2 257.5 224.0 389.9 74.3 216.6 746.8 287.1 197.2 555.6 415.9 281.3 174.2 233.9 388.5 116.1 79.2 276.0 260.4 293.8 500.1 76.5 270.0 325.7 208.1 99.3 341.9 157.9 227.6 97.5 112.2 210.7 151.1 230.9 293.6 531.5 135.0 370.8 381.9 296.1 151.2 285.1 282.6 391.5 249.0 315.5 539.9 874.9 339.1 311.8 318.0 590.3 RPGRIP1 "CORD13, LCA6, RGI1, RPGRIP" ENSG00000092200 "RPGR interacting protein 1" Q96KN7 14 21280083-21351301 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Cone-rod dystrophy, Disease variant, Glaucoma, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 80 "retina: 186.9;testis: 60.2" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 231.4;Early spermatids: 177.3;Late spermatids: 108.9;Rod photoreceptor cells: 117.5;Spermatocytes: 51.7" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 8.8" "Group enriched" "Detected in many" 18 "dendritic cells: 3.3;granulocytes: 8.8;monocytes: 3.7" "Cell line enhanced" "Detected in some" "RT4: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042955, HPA060190" Supported Supported NA NA "HPA042955: AB_2678239, HPA060190: AB_2684218" "unprognostic (9.02e-4)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" "unprognostic (1.86e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (2.92e-1)" "unprognostic (1.99e-1)" "unprognostic (3.94e-3)" "unprognostic (2.33e-1)" "unprognostic (7.31e-3)" "unprognostic (2.86e-2)" "unprognostic (2.87e-1)" "unprognostic (3.13e-1)" "unprognostic (1.83e-2)" 0.2 0.1 0.5 0.7 0.4 1.2 0.6 0.9 0.7 0.3 0.5 0.5 0.9 0.2 0.0 0.2 0.1 0.3 0.2 0.5 0.8 0.2 0.8 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.2 0.1 1.3 0.6 0.4 0.6 186.9 0.1 0.1 0.1 0.5 0.8 0.0 0.2 1.5 0.2 60.2 0.5 0.1 0.3 0.2 0.3 0.5 0.1 0.6 0.3 0.8 0.8 0.4 0.0 0.0 1.1 0.3 0.0 0.0 0.4 0.5 0.5 1.1 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.2 0.5 0.4 0.8 0.2 0.0 0.9 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.8 0.7 0.1 0.0 0.3 0.3 0.5 1.2 0.5 0.3 0.4 0.7 0.9 0.0 3.8 0.6 0.5 0.7 0.8 0.2 0.6 0.3 0.5 0.3 0.2 0.2 0.8 0.6 0.9 0.9 1.0 0.4 0.6 0.2 0.7 3.7 0.0 0.0 1.7 0.1 0.0 0.0 0.0 3.3 0.1 0.1 0.0 8.8 0.3 0.0 0.0 0.0 1.0 0.5 0.4 0.9 0.7 0.5 0.8 0.4 0.4 0.3 0.6 0.2 0.5 0.6 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.3 1.0 0.0 0.0 0.0 231.4 0.9 0.0 0.0 0.0 0.0 177.3 0.1 0.1 0.6 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.9 0.0 1.2 0.0 0.0 2.7 0.9 108.9 1.8 0.8 0.0 1.0 0.5 4.8 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 117.5 0.0 0.1 0.1 51.7 2.2 0.0 0.1 1.5 0.1 0.1 0.0 0.1 SUPT16H "CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68" ENSG00000092201 "SPT16 homolog, facilitates chromatin remodeling subunit" Q9Y5B9 14 21351476-21384019 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022551, HPA049787" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 27000 Nucleoplasm "Nucleoli fibrillar center" "CAB022551: , HPA049787: AB_2680881" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (7.12e-2)" "unprognostic (7.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.38e-3)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (4.91e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.48e-3)" "unprognostic (1.02e-1)" "unprognostic (7.58e-3)" "unprognostic (9.05e-2)" "unprognostic (5.87e-3)" 29.6 25.1 9.8 37.0 11.2 42.7 36.3 18.8 14.0 34.5 8.3 30.9 23.3 41.5 19.7 29.2 32.3 24.3 24.4 9.4 14.7 28.9 22.6 26.5 51.6 11.3 11.4 7.9 44.0 22.8 46.6 13.6 32.4 11.9 30.2 35.5 44.8 21.1 32.9 21.9 29.1 26.1 36.9 10.6 33.1 26.5 43.7 11.9 57.4 33.6 24.8 52.2 35.9 20.2 12.3 147.8 136.9 185.5 136.6 85.5 81.7 131.4 130.3 103.2 155.5 145.4 133.9 129.5 311.3 48.5 96.5 99.7 153.9 237.2 118.9 234.0 99.8 100.9 188.7 121.9 195.1 87.0 270.1 134.7 73.4 72.6 131.0 146.3 75.4 107.7 174.2 158.1 129.4 131.3 99.9 253.6 85.8 207.1 136.2 134.1 270.3 210.6 168.0 63.9 160.8 183.8 157.2 209.8 125.3 81.1 118.7 69.2 127.9 91.1 135.0 113.4 85.0 143.3 128.8 230.2 306.7 49.9 158.0 104.9 35.6 18.3 28.2 29.6 23.9 34.7 31.2 27.9 33.2 23.7 27.4 31.3 32.2 15.0 34.0 31.1 22.2 28.4 25.2 9.8 11.2 18.8 14.0 9.4 14.7 11.3 11.4 7.9 11.9 10.6 11.9 12.3 41.5 64.1 55.9 24.2 51.6 35.6 44.3 51.5 45.5 48.9 46.3 49.7 64.2 22.8 50.3 53.3 47.9 65.1 73.6 28.4 25.4 71.0 142.5 52.0 124.3 46.9 23.4 74.6 27.4 61.1 63.9 61.1 29.6 61.7 84.2 73.4 29.3 32.0 41.9 55.5 30.1 31.2 40.7 34.9 25.2 96.1 59.7 40.7 17.8 20.6 90.9 53.3 64.9 16.1 25.2 68.9 15.2 59.8 39.5 46.1 16.5 30.4 40.2 41.1 19.7 78.5 69.5 128.9 152.8 45.1 41.5 45.6 56.3 61.6 43.0 35.7 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favorable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.7 14.7 17.8 14.2 17.8 21.6 16.4 18.0 20.3 18.1 14.9 17.2 12.7 15.6 15.3 21.3 14.8 12.3 20.1 17.4 17.6 13.8 15.8 16.0 15.2 17.3 19.0 16.4 16.0 15.9 20.5 13.7 15.6 17.6 14.8 15.4 16.2 14.9 17.6 56.0 20.8 14.9 19.9 17.2 13.9 17.1 14.4 17.8 26.3 17.3 26.0 21.5 17.5 16.1 19.6 27.1 27.4 22.7 21.5 32.1 30.6 30.3 25.3 49.6 52.7 50.3 27.0 31.6 16.2 17.5 41.5 42.0 31.5 37.4 38.8 66.8 28.6 15.1 18.1 17.7 37.8 41.5 33.6 28.7 40.0 39.8 41.7 39.4 35.9 38.0 30.1 22.6 27.4 37.9 22.8 33.4 19.3 12.8 39.5 43.2 29.7 23.7 18.6 24.5 33.4 20.9 21.5 25.0 26.3 21.3 29.8 24.8 12.6 25.0 27.2 24.9 24.1 22.5 35.1 41.7 36.9 12.8 16.4 28.7 40.9 27.4 40.0 23.1 29.2 25.0 24.0 20.5 22.2 26.0 24.9 21.3 24.4 48.6 29.2 27.5 33.7 31.7 28.9 17.8 17.8 18.0 20.3 17.4 17.6 17.3 19.0 16.4 17.6 17.2 17.8 19.6 60.0 67.3 64.0 0.0 43.3 87.3 63.9 81.3 58.1 75.0 50.4 42.0 51.8 42.9 64.4 46.0 29.2 73.5 69.3 51.0 62.6 47.3 76.1 42.6 46.9 53.4 68.9 48.8 0.0 51.4 64.1 48.4 40.8 50.4 61.4 41.4 37.9 43.1 43.8 42.1 0.0 45.4 52.9 41.3 61.6 36.5 48.7 46.1 39.2 0.0 55.3 40.4 46.4 0.0 0.0 51.4 51.9 44.0 44.4 59.0 91.4 64.0 57.4 54.5 32.9 54.1 58.6 131.9 66.8 50.5 88.8 265.8 62.0 55.5 43.8 70.0 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 45.8;Late spermatids: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 5.9 4.3 7.1 4.6 6.8 10.4 7.9 10.0 8.3 5.7 5.7 6.0 6.8 5.5 7.3 5.8 5.9 4.2 7.8 6.9 4.7 4.6 5.6 4.8 8.9 4.7 4.3 8.0 5.9 4.7 3.8 4.6 5.6 6.5 4.8 6.2 4.8 4.3 4.5 12.2 6.2 4.8 7.7 2.0 5.3 5.1 8.4 5.4 9.2 5.6 8.0 7.9 6.3 5.6 9.0 23.6 34.5 33.3 23.7 11.3 12.6 17.0 11.5 9.0 30.3 30.0 30.7 27.9 36.0 23.4 9.8 11.0 17.5 45.6 18.7 31.5 17.6 26.7 21.5 18.1 76.8 23.9 32.6 12.8 7.3 17.6 18.8 27.5 8.7 26.6 31.4 25.2 25.6 17.3 48.9 36.3 31.2 23.6 29.7 38.3 32.8 36.4 22.6 17.5 15.6 32.2 6.2 24.5 17.7 12.4 18.4 41.5 14.0 11.2 12.7 20.0 13.3 18.6 26.8 44.2 54.1 6.6 34.0 19.6 10.8 12.0 9.9 13.5 13.1 9.8 15.3 12.3 13.5 16.2 15.8 13.5 14.4 3.1 11.9 11.5 16.1 11.8 9.2 7.1 6.8 10.0 8.3 6.9 4.7 4.7 4.3 8.0 6.5 2.0 5.4 9.0 11.6 6.4 3.7 4.9 10.3 8.5 8.1 20.9 8.0 5.9 7.3 12.1 6.0 5.7 11.4 5.5 10.4 12.9 7.0 2.2 11.7 10.8 45.8 11.2 11.3 10.6 3.6 17.2 7.4 6.4 18.9 12.5 2.6 7.5 5.7 11.7 9.7 6.6 11.4 5.0 6.2 7.1 14.2 10.6 7.3 41.1 9.0 6.3 7.2 4.7 9.4 8.1 9.2 4.0 7.4 6.9 2.5 9.8 9.4 8.0 3.1 14.7 15.5 6.9 6.6 8.3 8.1 25.9 15.4 11.3 8.0 3.8 9.1 11.6 9.3 4.8 TGM1 "ICR2, LI, LI1, TGASE, TGK" ENSG00000092295 "Transglutaminase 1" P22735 14 24249114-24264432 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 719.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7" "Group enriched" "Detected in many" 4 "cervical cancer: 30.8;head and neck cancer: 78.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015159, HPA040171, HPA070372" Enhanced Approved "Vesicles,Plasma membrane" NA NA 530000 "Vesicles, Plasma membrane" "CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: " "unprognostic (2.95e-2)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (1.89e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (3.01e-2)" "unprognostic (6.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.94e-7)" "unprognostic (7.11e-2)" "unprognostic (7.38e-2)" "unprognostic (2.22e-3)" "unprognostic (1.86e-2)" 12.4 1.3 0.5 0.9 0.8 0.7 2.2 3.7 2.0 38.5 0.6 1.4 0.9 1.0 1.7 719.2 4.4 0.6 3.2 0.5 0.6 2.5 1.8 5.4 1.5 1.3 1.1 0.4 3.1 3.2 0.2 3.3 1.2 2.1 4.1 0.9 1.7 90.4 4.4 1.1 73.5 1.9 0.5 0.4 2.6 1.8 2.9 0.8 1.3 2.8 0.3 40.7 1.3 145.4 1.2 1.1 2.0 1.1 1.0 0.0 0.8 17.5 0.4 0.2 1.0 1.6 1.2 1.7 1.0 2.3 1.3 0.3 24.2 2.8 2.0 0.6 2.0 3.3 1.4 16.2 5.7 0.8 0.9 1.5 1.5 9.3 0.5 2.0 0.5 0.7 3.4 1.0 1.0 0.7 17.5 0.7 1.9 0.3 1.1 2.2 1.1 0.1 1.1 0.6 2.1 1.2 1.6 0.2 21.7 0.1 1.4 1.5 1.1 0.8 1.1 4.8 2.0 0.9 1.5 1.8 0.3 0.4 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 3.7 2.0 0.5 0.6 1.3 1.1 0.4 2.1 0.4 0.8 1.2 0.2 12.8 1.1 2.0 0.0 0.3 4.6 63.6 4.0 0.9 1.1 0.8 0.8 5.7 18.8 0.0 0.0 1.4 0.3 0.2 29.4 2.0 0.1 0.3 0.2 0.2 0.0 0.0 1.5 0.9 0.8 3.9 0.0 0.6 4.5 0.7 0.0 0.2 0.4 0.0 1.7 0.1 6.1 0.6 0.3 0.0 0.6 0.4 0.0 1.0 0.4 0.2 0.0 1.0 1.0 2.6 0.0 0.4 0.1 7.4 0.1 0.2 2.1 0.6 0.0 0.1 1.0 0.0 0.6 34.7 1.8 1.2 0.6 1.2 0.3 6.2 TINF2 TIN2 ENSG00000092330 "TERF1 interacting nuclear factor 2" Q9BSI4 14 24239643-24242674 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 235.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059061, HPA069807" Enhanced "Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" "HPA059061: AB_2683895, HPA069807: AB_2686203" "prognostic favorable (4.96e-4)" "unprognostic (8.58e-2)" "unprognostic (1.53e-1)" "unprognostic (5.47e-2)" "unprognostic (3.20e-2)" "unprognostic (2.78e-2)" "unprognostic (4.75e-2)" "unprognostic (2.50e-1)" "unprognostic (4.70e-1)" "unprognostic (8.05e-2)" "unprognostic (1.05e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-3)" "unprognostic (2.04e-3)" "unprognostic (2.17e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" 47.2 77.0 18.4 17.5 19.5 20.3 44.4 19.7 23.7 40.9 18.6 38.6 11.6 44.1 21.2 63.7 36.4 12.9 35.7 18.3 20.9 43.6 33.7 44.4 22.9 20.2 19.5 17.6 32.5 44.9 235.2 32.1 14.3 20.1 38.2 15.9 12.9 37.9 16.4 45.5 40.8 38.7 19.6 20.2 56.2 42.1 16.5 19.9 29.5 41.0 16.3 26.8 41.2 41.7 20.8 18.4 16.4 23.2 12.2 25.1 18.5 11.8 18.3 23.1 26.3 24.5 7.1 20.0 26.7 10.3 26.1 19.0 17.5 13.2 16.5 16.5 34.1 6.7 16.8 15.1 28.5 21.6 17.9 23.1 20.5 26.0 21.1 20.0 24.5 28.9 25.0 6.7 33.1 21.5 20.0 27.0 8.8 5.4 19.3 20.1 21.9 14.8 19.5 23.7 25.8 14.2 13.2 19.1 18.0 17.0 15.3 12.9 11.4 23.3 12.2 14.9 21.0 14.6 25.2 19.5 15.1 14.8 9.9 18.6 124.6 47.8 113.7 59.7 51.1 48.1 58.7 46.5 56.2 41.1 65.1 48.3 48.4 60.2 63.5 49.3 34.9 61.5 75.8 18.4 19.5 19.7 23.7 18.3 20.9 20.2 19.5 17.6 20.1 20.2 19.9 20.8 34.6 16.0 23.0 6.2 54.5 16.8 63.8 35.7 26.7 23.0 18.4 17.7 13.5 15.7 29.3 18.4 8.4 31.8 51.1 19.2 35.2 35.1 8.1 12.8 15.7 31.4 13.1 15.8 4.1 47.2 26.5 28.1 16.8 18.7 40.5 10.0 27.8 16.5 35.5 15.2 4.1 16.3 32.6 30.1 19.7 10.7 23.6 29.9 21.4 7.5 43.3 41.8 72.1 3.5 7.5 40.5 23.8 29.7 31.5 38.9 22.0 25.4 9.5 18.8 26.3 25.8 29.9 24.3 26.2 27.4 25.1 42.3 46.5 29.4 15.6 53.0 DAZL "DAZH, DAZL1, DAZLA, MGC26406, SPGYLA" ENSG00000092345 "Deleted in azoospermia like" Q92904 3 16586792-16670306 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "testis: 80.3" "Cell type enhanced" "Detected in some" "Early spermatids: 64.1;Late spermatids: 41.2;Spermatocytes: 257.9;Spermatogonia: 143.1" "Cancer enriched" "Detected in single" 51 "testis cancer: 13.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HAP1: 18.8" "HPA019777, HPA047113" Enhanced NA NA "HPA019777: AB_1847495, HPA047113: AB_2679936" "unprognostic (5.61e-2)" "unprognostic (5.27e-3)" "unprognostic (2.80e-1)" "unprognostic (5.85e-2)" "unprognostic (2.32e-3)" "unprognostic (2.60e-2)" "unprognostic (6.34e-2)" "unprognostic (4.91e-2)" "unprognostic (9.69e-2)" "unprognostic (7.79e-2)" "unprognostic (2.04e-1)" "unprognostic (3.47e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 80.3 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.2 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 257.9 143.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TBL1Y TBL1 ENSG00000092377 "Transducin beta like 1 Y-linked" Q9BQ87 Y 6910686-7101970 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 3.0;thyroid gland: 1.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 3.4;Inhibitory neurons: 2.2;Oligodendrocyte precursor cells: 1.0;Squamous epithelial cells: 5.7;Urothelial cells: 1.1" "Cancer enriched" "Detected in single" 6 "prostate cancer: 1.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-698: 12.3" "HPA050857, HPA060073" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA050857: , HPA060073: AB_2684196" "unprognostic (2.81e-3)" "unprognostic (2.94e-1)" "unprognostic (3.06e-1)" "unprognostic (7.76e-2)" "unprognostic (1.17e-2)" "unprognostic (1.28e-1)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.24e-2)" 0.2 0.0 0.2 0.0 1.1 0.0 0.3 0.1 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.2 0.4 0.6 0.1 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.4 3.0 0.1 0.0 0.8 0.3 0.4 0.2 0.0 0.0 0.4 0.0 0.2 0.3 0.6 0.0 1.6 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 1.9 0.0 2.2 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.1 0.3 0.0 0.2 0.8 0.1 0.0 0.4 0.4 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.2 3.4 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.2 5.7 0.0 0.3 0.0 0.0 0.0 1.1 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443555-116574823 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 60.6;brain: 72.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1" "Cancer enhanced" "Detected in all" "testis cancer: 20.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 620000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 13.5 60.6 21.9 4.9 41.9 3.5 13.2 33.9 34.0 9.0 0.0 20.8 20.1 6.1 2.8 4.5 8.2 13.0 6.3 20.3 30.7 8.6 5.6 18.1 4.6 46.8 39.8 10.8 18.3 11.3 2.0 5.9 32.2 45.9 6.1 17.7 10.5 16.7 2.6 8.3 6.9 25.8 5.8 32.5 11.3 7.1 7.5 38.3 3.6 9.2 6.6 2.2 5.6 8.2 72.4 0.3 0.1 36.9 44.3 0.2 0.0 38.2 0.7 0.4 0.2 0.2 2.2 1.5 1.6 1.7 0.6 0.7 0.4 52.0 0.0 0.1 1.6 7.7 0.7 0.7 13.1 0.5 0.5 2.6 0.7 0.0 0.0 0.0 0.5 0.2 0.3 0.3 0.4 0.2 0.8 0.7 3.9 115.2 0.2 0.3 6.9 24.2 1.8 19.0 33.7 10.3 3.7 0.2 0.7 19.7 221.1 14.4 2.6 0.9 3.6 3.1 0.4 1.5 0.6 0.7 0.8 0.6 1.8 13.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.9 41.9 33.9 34.0 20.3 30.7 46.8 39.8 10.8 45.9 32.5 38.3 72.4 64.7 0.0 0.6 71.8 1.1 6.5 0.7 13.1 34.7 17.9 17.0 8.3 8.6 61.5 3.1 14.7 2.1 128.9 0.3 73.3 0.0 42.9 13.6 12.2 4.8 60.9 28.1 2.7 26.9 1.3 8.1 15.4 1.1 10.6 0.0 9.7 145.6 0.9 12.5 138.0 62.2 30.7 0.0 14.8 4.6 2.4 6.5 1.1 24.9 54.4 0.1 5.8 0.0 138.7 311.3 2.0 46.7 1.9 2.6 1.5 40.7 4.4 0.6 3.5 0.0 36.1 8.1 0.9 1.5 11.3 4.1 348.1 0.8 3.5 40.3 2.2 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 109.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.2;Oligodendrocytes: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 11.7 9.7 5.2 13.5 7.1 21.6 13.8 15.5 7.7 10.4 25.6 13.9 14.5 12.9 14.7 8.7 9.5 11.2 15.7 5.2 4.9 23.1 25.5 11.7 16.8 4.5 4.9 4.6 16.5 12.3 109.8 5.4 13.5 7.1 11.0 14.5 10.6 11.0 10.7 7.9 16.8 13.2 11.5 4.4 12.3 13.8 10.0 5.5 15.7 17.5 9.2 14.6 11.5 8.2 11.0 21.4 21.0 17.2 19.1 48.5 36.2 20.9 26.4 36.7 16.5 21.6 29.1 11.6 46.4 12.7 30.8 42.5 35.1 23.3 19.5 23.4 26.0 13.7 37.1 31.5 15.4 44.0 38.8 27.6 33.9 22.4 18.8 35.0 24.0 13.5 28.8 42.6 34.5 30.4 33.7 25.1 18.8 13.0 29.4 12.8 27.2 23.7 22.7 23.0 49.9 14.2 18.1 18.2 28.7 35.8 30.1 18.0 41.6 20.7 26.1 12.4 122.4 30.8 23.3 54.9 44.0 28.4 77.5 24.8 1.8 1.3 1.6 2.5 1.3 2.9 2.2 1.8 1.7 1.5 2.3 1.6 1.9 1.7 2.4 1.4 1.9 2.0 0.8 5.2 7.1 15.5 7.7 5.2 4.9 4.5 4.9 4.6 7.1 4.4 5.5 11.0 23.9 19.2 31.3 73.1 36.4 31.6 17.2 11.0 44.9 21.9 18.8 11.9 25.9 21.5 8.2 12.9 12.5 23.0 38.4 17.0 3.9 11.7 33.3 21.6 27.1 19.7 18.5 29.6 122.2 12.7 9.4 26.1 37.8 23.1 17.7 26.0 14.6 43.9 14.6 21.9 92.7 19.5 6.1 22.4 19.8 26.0 26.4 26.5 19.6 66.5 24.2 8.5 29.9 80.9 109.1 15.5 13.9 20.3 33.2 24.9 23.4 11.0 19.3 22.6 13.1 30.0 22.0 23.1 23.6 25.7 24.2 16.3 34.5 22.2 20.4 11.1 TYRO3 "Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif" ENSG00000092445 "TYRO3 protein tyrosine kinase" Q06418 15 41557675-41583589 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;ovary: 50.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "BEWO: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071245 Approved NA NA 17000000 "HPA071245: AB_2686371" "unprognostic (1.26e-1)" "unprognostic (6.34e-2)" "unprognostic (1.47e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.56e-3)" "unprognostic (5.41e-2)" "unprognostic (3.72e-1)" "unprognostic (3.21e-1)" "unprognostic (2.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.92e-10)" "unprognostic (7.59e-2)" "unprognostic (5.22e-1)" "unprognostic (4.04e-3)" "unprognostic (1.84e-2)" 21.6 3.5 17.9 1.5 24.2 0.8 5.2 16.2 26.0 2.0 0.0 1.8 1.7 4.6 3.5 13.3 11.6 2.5 1.9 26.9 12.0 11.0 0.9 3.3 1.3 19.5 23.6 24.3 50.1 9.9 0.9 0.9 5.8 18.4 2.6 0.9 2.6 1.9 6.1 0.9 13.9 2.4 4.4 18.1 5.5 3.2 19.0 15.6 0.4 1.1 1.8 3.8 2.1 4.1 31.7 10.3 6.7 20.7 22.7 18.9 12.8 69.2 14.6 9.3 14.2 13.1 37.7 3.4 0.4 18.3 11.9 19.9 23.7 23.3 3.6 6.5 5.8 15.5 3.2 20.2 18.1 13.3 5.2 0.4 4.1 7.3 10.9 3.6 5.8 10.6 9.8 19.1 4.3 7.9 9.8 2.4 1.0 47.7 16.0 6.7 31.9 18.6 3.8 1.2 19.7 24.6 7.0 13.7 21.6 16.3 29.8 17.8 6.0 8.4 28.0 12.2 21.0 22.5 1.7 3.5 3.1 17.2 33.8 17.2 1.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.2 0.2 1.5 0.3 0.1 0.3 0.1 0.1 17.9 24.2 16.2 26.0 26.9 12.0 19.5 23.6 24.3 18.4 18.1 15.6 31.7 3.4 3.2 1.1 17.6 0.9 6.8 8.5 0.4 0.6 2.7 2.2 2.2 2.9 2.8 0.7 3.7 6.2 2.9 1.1 1.3 0.0 3.9 3.6 1.1 13.0 5.4 1.8 0.0 42.4 3.6 10.2 10.5 8.6 1.9 0.0 7.6 9.7 0.4 1.2 0.0 4.6 0.9 0.0 1.9 1.3 5.1 44.4 0.9 8.8 1.0 0.1 8.3 1.0 29.1 46.8 4.6 0.1 47.0 0.3 6.4 1.2 1.2 0.5 4.0 0.0 3.9 4.3 4.0 6.5 4.2 10.9 18.9 0.7 5.8 2.3 5.7 WDR76 FLJ12973 ENSG00000092470 "WD repeat domain 76" Q9H967 15 43826980-43868412 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.3;lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.3;Spermatocytes: 23.5;Spermatogonia: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039804, HPA040626" Uncertain Approved "Nucleoli fibrillar center,Nuclear bodies" NA Yes "Nuclear bodies" "Nucleoli fibrillar center" "HPA039804: AB_10795297, HPA040626: AB_10795527" "unprognostic (2.26e-1)" "unprognostic (7.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.85e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (6.98e-4)" "prognostic unfavorable (8.02e-5)" "unprognostic (4.24e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.91e-2)" "prognostic unfavorable (1.35e-8)" "unprognostic (7.71e-2)" "unprognostic (9.42e-2)" "unprognostic (4.02e-2)" "unprognostic (3.28e-2)" 2.4 1.2 1.0 8.5 1.1 19.3 3.5 4.4 1.7 2.5 0.9 4.9 3.3 3.3 0.9 4.5 1.7 1.9 1.1 0.8 1.6 1.5 2.2 2.4 20.0 1.3 1.5 0.6 2.2 3.1 2.8 1.1 4.0 2.2 1.9 6.1 6.3 2.4 2.0 0.8 4.2 3.3 3.9 1.2 3.6 3.0 5.4 1.3 19.7 2.5 1.3 21.5 2.9 2.8 1.4 35.1 17.5 40.7 31.3 4.5 10.7 11.1 57.3 33.9 61.5 76.8 22.1 17.8 51.4 24.8 26.9 31.0 49.4 42.4 20.5 53.1 80.4 25.2 63.3 52.1 7.3 2.5 65.0 27.0 3.4 3.3 33.8 7.7 8.9 19.9 54.7 48.6 86.9 42.6 12.2 63.4 15.4 14.6 11.0 18.1 66.9 70.1 32.4 11.4 35.5 31.3 30.9 36.1 22.5 7.0 12.6 35.0 31.0 9.1 56.3 26.5 63.5 58.9 42.7 114.6 129.1 40.4 56.7 31.5 0.0 0.6 0.3 3.8 0.5 4.1 1.8 4.6 3.4 1.0 2.2 3.8 2.9 0.0 4.8 0.2 1.2 6.6 2.0 1.0 1.1 4.4 1.7 0.8 1.6 1.3 1.5 0.6 2.2 1.2 1.3 1.4 4.1 3.2 1.3 2.6 8.2 7.4 3.2 2.4 4.6 3.7 3.7 2.8 1.2 1.5 2.3 1.8 10.4 12.8 6.2 3.5 1.9 2.9 1.7 1.8 3.9 4.8 0.0 35.3 2.5 4.2 13.0 3.9 4.6 3.3 5.7 12.2 2.9 0.9 8.9 1.7 3.3 3.7 0.0 3.5 5.3 0.9 1.8 3.9 3.6 2.8 3.3 8.0 10.3 0.5 1.9 1.1 3.1 2.2 16.1 1.5 1.4 0.9 0.4 16.2 6.6 5.8 5.7 23.5 35.9 7.4 5.8 3.6 11.6 1.5 9.0 1.8 CAPN3 "CANP3, LGMD2, LGMD2A, nCL-1, p94" ENSG00000092529 "Calpain 3" P20807 15 42359498-42412949 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 309.6;skeletal muscle: 914.5;tongue: 380.8" "Group enriched" "Detected in many" 5 "Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2" "Cancer enriched" "Detected in some" 10 "melanoma: 9.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 27 "SK-MEL-30: 238.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040052 Enhanced NA NA "HPA040052: AB_2676821" "unprognostic (1.06e-2)" "unprognostic (1.31e-1)" "unprognostic (4.00e-2)" "unprognostic (8.71e-2)" "unprognostic (1.53e-1)" "unprognostic (1.72e-2)" "unprognostic (2.11e-4)" "unprognostic (3.12e-3)" "unprognostic (2.82e-1)" "unprognostic (2.47e-1)" "unprognostic (2.37e-3)" "unprognostic (3.26e-2)" "unprognostic (3.91e-4)" "unprognostic (5.56e-3)" "unprognostic (2.43e-1)" "unprognostic (8.93e-3)" "unprognostic (1.38e-1)" 12.9 8.8 179.2 4.0 227.4 48.1 14.2 221.8 235.5 18.1 146.9 13.1 3.1 11.3 165.2 14.6 13.8 4.5 14.8 173.1 190.3 94.4 37.2 21.7 7.0 238.5 226.8 157.2 15.9 8.7 2.4 11.4 3.0 242.6 16.2 5.3 7.6 18.8 5.2 914.5 55.4 14.1 4.8 200.3 19.3 9.0 31.0 209.1 3.5 10.8 380.8 5.1 11.8 15.6 309.6 0.5 0.3 0.6 1.1 8.8 6.1 0.6 2.6 1.9 0.5 0.8 1.2 0.5 0.2 0.9 1.6 0.4 3.7 0.4 3.5 0.3 0.9 0.8 0.8 0.8 4.1 0.6 1.0 1.5 4.7 3.7 0.8 0.7 1.5 0.1 0.7 0.2 1.8 0.7 0.1 0.2 1.2 0.4 0.2 0.9 1.1 0.4 1.9 1.9 1.3 0.4 0.1 0.2 0.5 238.0 1.0 0.0 5.4 0.9 0.3 0.4 2.6 0.7 1.5 2.1 0.2 0.4 2.4 1.8 0.5 1.0 0.1 0.7 0.2 0.8 0.3 0.1 0.3 0.5 0.5 0.1 0.9 0.9 0.6 0.1 0.5 0.4 0.6 179.2 227.4 221.8 235.5 173.1 190.3 238.5 226.8 157.2 242.6 200.3 209.1 309.6 0.5 12.8 34.5 16.0 2.9 20.1 0.8 2.2 3.4 2.2 0.4 0.3 0.4 1.5 4.4 1.8 2.1 0.7 1.4 2.0 1.9 0.1 512.5 0.5 0.6 2.2 0.0 0.0 4.0 0.0 0.6 1.6 3.6 0.7 1.3 0.4 2.2 8.7 32.7 0.0 5.2 1.8 2.0 4.4 11.6 183.6 5.3 2.9 482.0 13.1 2.5 3.7 2.1 4.5 220.2 0.0 5.4 3.4 0.6 0.9 2.4 59.5 2.6 3.9 0.0 13.8 1.6 15.9 4.7 1.6 8.5 3.3 1.8 1.2 2.3 0.8 SNAP23 "HsT17016, SNAP23A, SNAP23B" ENSG00000092531 "Synaptosome associated protein 23" O00161 15 42491233-42545356 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 675.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001214, CAB037083, CAB037317" Approved Supported "Plasma membrane" NA NA 3900000 "Plasma membrane" "CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.76e-3)" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (9.67e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-1)" "unprognostic (2.93e-1)" "unprognostic (7.31e-2)" "unprognostic (1.36e-1)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.95e-2)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" 44.8 30.6 26.1 63.5 28.5 35.4 38.6 27.8 45.2 37.8 33.5 53.3 50.8 43.6 35.7 32.2 30.1 40.6 45.1 30.0 26.6 42.8 44.8 45.6 85.3 29.4 27.6 20.9 34.9 24.4 36.5 13.0 69.5 33.3 49.6 51.7 12.9 45.6 31.2 44.3 26.7 56.9 48.7 30.0 70.9 40.3 36.4 29.7 38.4 33.4 29.0 79.4 42.9 24.2 39.1 58.3 29.7 55.7 54.7 91.8 70.4 85.1 77.6 61.8 50.8 59.1 93.0 27.8 35.1 91.3 52.3 48.1 52.7 63.2 50.1 70.9 58.4 35.3 149.2 30.5 89.1 66.8 57.4 136.6 59.1 37.9 43.5 70.4 64.7 192.9 69.4 121.6 31.4 67.1 24.1 68.3 69.4 46.0 94.3 22.8 122.4 33.8 55.1 71.8 57.8 9.0 36.3 57.2 51.3 56.4 83.5 76.2 91.6 155.0 46.6 61.2 52.1 80.4 59.1 122.3 153.2 56.3 120.0 62.8 244.8 159.8 675.6 51.4 237.6 60.2 110.2 53.5 50.2 148.2 103.9 68.0 52.4 361.9 70.7 236.0 62.6 66.4 179.4 26.1 28.5 27.8 45.2 30.0 26.6 29.4 27.6 20.9 33.3 30.0 29.7 39.1 58.9 112.2 30.5 30.7 79.0 50.7 107.6 30.8 34.7 7.7 41.9 19.8 19.2 38.6 32.8 20.2 20.9 75.9 45.3 61.3 56.7 71.1 207.6 34.4 38.6 77.1 14.9 25.0 21.2 52.2 109.5 44.3 32.6 41.2 83.5 22.4 77.4 28.0 88.9 5.0 23.6 80.2 52.9 125.4 112.8 326.0 39.1 131.8 44.4 36.5 120.0 14.6 53.5 39.7 54.6 110.8 52.8 60.5 27.9 79.9 55.0 76.2 42.6 18.4 52.6 42.1 40.6 16.7 7.9 29.3 38.5 142.6 48.2 47.8 39.7 64.7 TBX15 TBX14 ENSG00000092607 "T-box transcription factor 15" Q96SF7 1 118883046-118989556 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 47.1;skeletal muscle: 133.3;tongue: 115.7" "Cell type enhanced" "Detected in some" "Early spermatids: 8.2;Fibroblasts: 11.1;Hepatocytes: 15.3;Melanocytes: 7.2;Skeletal myocytes: 13.1;Smooth muscle cells: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 52.6;ASC TERT1: 22.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.4;fHDF/TERT166: 28.2;HSkMC: 37.9;RH-30: 29.1;U-2197: 27.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "spinal cord: 3.3" "HPA052245, HPA053713" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA052245: AB_2681771, HPA053713: " "unprognostic (1.94e-1)" "unprognostic (2.75e-3)" "unprognostic (1.92e-2)" "unprognostic (3.94e-2)" "unprognostic (5.72e-3)" "unprognostic (7.79e-2)" "unprognostic (5.82e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-3)" "unprognostic (1.39e-1)" "unprognostic (3.81e-3)" "unprognostic (5.03e-2)" "prognostic unfavorable (5.57e-8)" "unprognostic (2.63e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-3)" "unprognostic (2.31e-1)" 17.6 0.1 0.7 0.0 0.9 0.0 16.2 0.7 1.4 0.1 2.7 0.1 0.0 0.2 0.1 1.9 0.4 0.5 2.1 0.7 0.6 0.2 47.1 0.6 2.8 0.6 0.7 0.5 0.1 0.1 0.5 1.5 0.1 0.7 1.4 0.0 0.2 7.0 0.0 133.3 7.7 0.1 0.1 0.4 0.0 0.1 0.8 0.8 0.3 2.0 115.7 1.4 0.4 0.3 0.7 1.4 0.0 0.0 0.0 52.6 22.1 0.0 4.7 6.4 12.3 20.4 0.0 0.0 0.0 2.6 28.2 0.0 0.0 0.0 0.0 4.9 0.0 0.3 0.0 1.4 0.0 0.1 0.4 0.0 37.9 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 14.1 0.0 0.0 0.2 2.3 0.0 0.2 0.0 29.1 0.4 3.0 1.4 0.6 0.0 1.6 0.0 0.6 0.6 0.0 0.6 0.0 6.6 4.0 27.3 0.2 0.4 0.2 0.0 13.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.7 1.4 0.7 0.6 0.6 0.7 0.5 0.7 0.4 0.8 0.7 3.2 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 8.2 0.1 0.0 1.2 0.0 0.0 0.3 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.0 15.3 0.1 0.0 0.2 0.0 0.0 0.0 4.0 1.1 0.0 0.1 7.2 1.9 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.1 12.5 0.2 0.4 0.0 2.0 0.0 0.3 0.1 0.0 0.0 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744218 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 135.0;Exocrine glandular cells: 136.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD8 T-cell: 25.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 975.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" No No 1100000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.48e-4)" "prognostic favorable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 51.9 3.0 104.1 9.5 116.0 11.5 30.4 124.4 126.8 36.2 81.0 22.7 7.7 25.6 80.3 57.0 49.8 7.7 16.3 102.6 123.1 36.4 127.1 18.2 15.0 114.9 110.6 90.4 46.5 172.6 104.7 23.9 13.4 117.8 53.0 7.1 7.6 157.5 33.8 2.6 90.5 13.4 15.2 107.8 6.6 42.1 40.7 110.7 34.3 29.7 4.3 13.4 36.1 63.4 147.5 156.8 35.2 148.0 444.6 64.9 82.8 286.1 101.0 209.3 132.9 257.6 195.7 28.6 0.1 58.1 270.5 16.6 205.6 216.8 224.6 83.9 1.1 162.1 29.1 151.3 153.3 135.7 214.3 1.7 147.6 338.6 146.8 142.2 83.0 100.1 519.7 71.4 443.9 66.8 380.9 222.8 90.1 440.0 93.3 274.6 228.0 181.1 24.8 9.6 120.4 160.8 146.0 65.9 63.9 975.9 103.9 164.8 505.7 0.9 38.3 172.1 207.3 134.8 294.0 79.9 246.1 456.9 328.2 302.7 5.3 1.1 0.2 4.7 0.3 0.2 11.1 2.4 8.2 5.3 4.0 13.0 25.2 2.2 1.8 0.3 2.6 4.5 6.3 104.1 116.0 124.4 126.8 102.6 123.1 114.9 110.6 90.4 117.8 107.8 110.7 147.5 5.3 3.2 12.6 31.6 10.0 51.9 118.1 24.2 42.7 0.7 29.7 38.0 2.1 128.7 12.5 20.2 2.1 49.9 2.2 1.6 135.0 60.2 51.2 15.6 3.8 6.9 1.8 5.5 0.3 136.1 54.0 58.7 8.6 12.2 5.7 30.9 3.6 96.1 9.2 0.0 0.6 3.6 18.3 2.2 4.3 116.9 67.7 6.5 56.9 2.8 11.0 82.4 0.0 14.1 32.3 35.6 2.0 127.9 27.4 62.1 0.2 118.4 24.7 3.4 13.1 11.2 48.8 20.0 19.4 57.5 77.1 25.3 5.9 71.4 3.2 56.8 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.2;choroid plexus: 26.6;salivary gland: 23.8;thyroid gland: 25.6" "Cell type enhanced" "Detected in many" "Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" NA NA Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: AB_2683679" "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 1.4 1.5 17.7 0.7 28.9 0.0 2.8 19.2 14.9 2.9 26.6 8.7 0.7 1.2 0.2 1.3 1.7 0.1 4.7 10.7 15.8 1.1 0.6 0.4 0.2 34.3 28.1 5.7 1.7 7.6 0.1 14.1 0.5 40.2 3.2 0.1 1.6 23.8 1.2 0.5 1.8 3.1 0.1 19.7 0.3 2.7 20.8 22.7 0.1 25.6 0.0 0.0 2.8 3.8 37.6 0.2 0.3 0.3 0.2 0.0 0.8 143.4 0.1 0.0 0.1 0.0 1.6 0.2 0.0 13.1 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.9 0.0 8.2 59.6 0.3 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.0 0.0 1.0 0.7 6.4 8.2 0.0 2.5 0.0 1.8 0.0 0.1 0.0 1.5 0.2 0.1 51.1 4.6 0.2 5.4 0.0 0.0 0.7 0.1 1.0 0.2 0.1 0.0 0.2 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 28.9 19.2 14.9 10.7 15.8 34.3 28.1 5.7 40.2 19.7 22.7 37.6 1.6 3.2 0.0 1.0 26.1 3.2 2.2 1.2 1.8 0.9 2.1 2.5 1.6 0.0 0.2 5.5 10.4 5.1 0.4 0.7 1.9 3.6 116.6 2.7 0.4 3.7 4.2 1.3 2.5 0.0 46.4 15.3 6.1 0.7 0.0 0.6 2.5 6.8 2.2 0.0 2.0 3.3 0.0 2.2 0.9 401.9 4.1 1.7 3.6 0.0 0.5 95.8 0.0 84.9 68.9 0.1 7.3 1.5 44.0 1.2 2.3 23.7 2.5 3.7 0.0 0.8 1.0 2.9 7.8 0.9 7.0 4.0 1.4 3.7 2.0 1.0 EZR VIL2 ENSG00000092820 Ezrin P15311 6 158765741-158819368 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004035, HPA021616, CAB047324, CAB075739" Enhanced Enhanced "Plasma membrane" NA NA 42000000 "Plasma membrane" "CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342" "unprognostic (4.79e-3)" "unprognostic (1.48e-1)" "unprognostic (1.97e-2)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.31e-3)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (5.59e-2)" "prognostic favorable (9.56e-8)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-2)" "unprognostic (9.00e-2)" 55.3 188.2 94.1 99.3 86.9 136.4 60.4 86.1 97.6 77.7 194.1 134.7 160.2 35.9 79.1 262.4 115.6 117.1 117.4 91.6 98.2 160.5 58.4 174.8 187.1 92.6 91.7 77.6 45.1 113.6 451.1 43.1 235.0 89.7 82.1 104.6 10.8 90.6 72.9 47.3 182.2 259.2 36.9 95.4 76.3 276.2 56.4 91.5 109.8 127.3 25.7 218.1 221.2 99.4 86.5 668.3 355.4 86.5 125.0 9.3 10.3 502.7 204.7 67.1 225.7 189.2 420.9 357.7 667.1 197.2 235.2 108.5 497.7 172.2 228.0 259.5 235.3 111.2 14.0 204.9 187.5 223.2 167.7 98.9 16.6 172.9 212.9 205.1 191.4 150.2 90.8 134.9 316.7 132.3 175.9 239.3 199.6 144.5 180.6 117.6 176.9 40.7 152.5 462.1 198.6 156.3 127.2 358.5 507.7 37.9 391.5 124.1 218.5 195.3 72.6 233.4 101.1 319.9 216.5 212.8 566.9 45.4 84.9 88.5 177.2 83.4 103.7 195.9 190.8 233.2 466.5 205.6 245.1 181.9 389.7 108.6 146.3 36.2 133.6 202.9 84.5 385.7 298.2 94.1 86.9 86.1 97.6 91.6 98.2 92.6 91.7 77.6 89.7 95.4 91.5 86.5 47.4 951.9 547.8 111.3 799.6 614.7 809.5 202.4 247.0 11.2 240.4 144.4 311.0 154.4 726.2 156.3 0.0 406.1 372.4 806.8 97.8 302.3 10.2 782.9 75.4 71.0 159.9 46.5 0.4 256.1 560.3 213.1 500.5 844.5 119.0 40.8 25.4 37.5 113.3 0.0 0.5 415.3 179.0 79.1 820.5 32.8 135.5 297.5 321.9 12.2 110.5 35.7 62.8 2.0 0.7 618.3 631.2 294.2 564.9 416.7 694.2 238.1 1248.4 5.1 249.8 205.5 136.3 52.5 61.7 430.4 726.5 1243.4 483.8 102.3 312.9 1142.8 MYL6 "ESMLC, MLC1SM, MLC3NM" ENSG00000092841 "Myosin light chain 6" P60660 12 56158346-56163496 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046859, HPA063034" Approved NA NA 60000000 "HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (1.10e-1)" "unprognostic (4.99e-2)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.89e-1)" "unprognostic (3.73e-2)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" "unprognostic (2.04e-1)" "unprognostic (2.86e-2)" "unprognostic (8.33e-3)" "unprognostic (1.71e-1)" "unprognostic (7.90e-2)" "unprognostic (2.01e-1)" 2170.9 1439.3 841.9 1217.8 837.5 1772.0 1994.7 873.5 970.4 1753.3 944.8 4573.1 1037.2 2996.8 1649.3 1792.2 2217.1 913.9 1067.6 819.5 929.4 1731.4 1181.6 1963.6 890.2 911.6 856.0 802.7 1164.9 1041.5 1479.1 753.5 1453.8 882.1 2054.8 2382.6 935.2 1177.2 2939.8 414.5 1092.2 1883.3 4246.4 872.6 1560.3 2145.8 498.5 887.0 1161.8 1327.5 583.9 1416.3 3067.5 1699.2 925.2 1924.9 1739.1 3199.3 958.8 2063.5 2065.5 1755.8 4056.4 4162.8 5469.7 3191.3 2738.5 1720.0 735.0 2274.3 5778.4 1417.7 1222.8 1995.9 2846.0 3556.8 1423.1 666.5 1311.5 2481.7 1536.9 1512.2 913.8 2304.1 2389.9 2013.5 3242.3 1263.1 4706.8 4854.4 867.2 708.1 2121.5 4585.6 2052.1 1291.6 1402.8 1629.5 1071.6 1746.1 1027.3 1265.3 932.9 5125.1 2361.7 1169.2 862.9 4456.0 1380.0 760.4 2312.4 2148.7 2383.0 5212.3 1486.3 1011.6 2077.3 2746.8 635.3 1150.3 867.7 1953.3 1168.9 1578.1 11449.4 4509.8 13302.4 3191.2 5016.0 2404.9 2844.7 2828.6 2994.0 4747.3 2558.5 2020.7 2528.3 8440.7 2233.9 6531.2 5167.0 4209.8 14776.8 841.9 837.5 873.5 970.4 819.5 929.4 911.6 856.0 802.7 882.1 872.6 887.0 925.2 2044.5 1733.9 1161.8 16.0 704.4 2114.0 2470.4 2988.3 746.1 278.4 896.3 1394.8 672.8 946.5 2016.5 1475.0 316.9 1704.4 1144.5 2568.2 2406.5 4126.7 292.4 1134.2 1714.2 1628.1 1017.3 857.4 15.6 4820.4 2604.5 1264.0 871.6 1676.6 994.3 1307.8 1328.6 887.8 3370.3 80.8 19.8 1572.3 1845.3 1148.3 2472.8 910.7 1064.0 1872.2 1469.2 39.4 4426.3 820.8 1195.7 17.6 31.3 6222.1 2715.8 2775.1 892.8 1762.1 3007.9 2956.9 1870.9 763.7 1735.5 685.8 3305.2 76.2 115.0 1139.6 2066.1 1929.9 1191.9 1039.1 1406.1 2558.6 AGO1 "EIF2C1, hAGO1" ENSG00000092847 "Argonaute RISC component 1" Q9UL18 1 35869808-35930532 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067849 Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "HPA067849: " "unprognostic (2.35e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (8.66e-3)" "unprognostic (1.20e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.61e-2)" "unprognostic (6.08e-2)" "unprognostic (1.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.60e-4)" "unprognostic (7.52e-2)" "unprognostic (1.74e-1)" "unprognostic (7.57e-2)" "unprognostic (5.77e-3)" 6.3 6.7 10.2 7.7 9.5 6.5 6.5 7.5 8.7 7.1 6.4 6.6 6.8 7.1 5.1 5.9 6.7 4.8 7.2 9.2 7.3 6.3 4.8 6.5 6.7 10.1 9.2 7.2 8.1 5.8 10.2 5.2 5.1 9.9 8.2 7.1 6.8 6.6 8.7 8.7 11.1 7.5 8.0 9.8 9.0 6.4 5.2 8.6 9.1 6.0 7.9 8.5 5.2 4.5 8.3 14.2 9.4 21.1 18.7 14.4 8.6 23.2 7.3 11.1 12.6 11.9 19.2 9.9 16.0 9.0 14.6 8.7 7.5 30.4 11.7 15.3 14.9 10.0 32.4 15.4 16.8 6.4 19.4 12.5 7.1 5.5 21.3 10.9 8.0 18.2 13.7 24.0 8.9 10.3 10.9 20.4 10.0 47.6 19.1 8.0 15.3 15.9 6.8 5.5 17.8 26.1 11.6 25.6 10.5 8.4 23.7 8.5 7.7 14.9 9.8 21.6 13.7 13.9 9.1 7.9 7.4 10.3 11.6 12.7 1.9 3.8 1.8 1.9 5.1 1.7 1.6 1.4 1.7 1.6 1.4 1.6 1.5 2.4 1.4 4.1 1.6 1.3 4.5 10.2 9.5 7.5 8.7 9.2 7.3 10.1 9.2 7.2 9.9 9.8 8.6 8.3 10.1 3.2 9.3 11.4 11.8 13.9 7.2 6.4 17.6 34.0 13.0 9.9 15.8 12.8 9.1 14.7 39.6 5.2 25.4 12.6 1.9 11.5 5.2 11.6 12.4 13.3 25.9 5.5 15.3 13.2 4.7 10.6 9.7 7.7 16.5 12.5 10.0 13.4 13.3 35.3 15.6 15.5 6.1 30.5 20.0 6.7 14.9 19.2 5.4 4.7 23.9 12.9 20.6 13.6 14.5 11.3 11.1 20.7 7.9 10.6 29.4 10.1 11.4 30.5 13.1 13.1 15.5 12.7 16.8 10.8 14.5 2.3 10.7 14.7 16.2 7.2 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084094-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 63.3;testis: 71.7" "Group enriched" "Detected in some" 4 "Early spermatids: 523.7;Late spermatids: 306.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 8 "NB-4: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027248, HPA027461" Approved Approved Microtubules NA NA Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.1 0.5 5.1 0.1 2.4 1.5 1.0 2.8 2.6 2.2 10.3 0.5 0.1 1.5 0.1 0.2 63.3 0.1 0.1 2.2 3.5 2.3 0.1 6.3 0.1 3.9 4.6 1.7 0.5 2.4 0.7 4.3 0.0 3.5 0.7 0.0 0.2 0.4 0.6 0.0 0.2 0.2 0.4 4.7 0.0 0.4 71.7 2.6 1.1 2.7 0.0 0.0 0.1 0.3 3.3 0.0 0.0 4.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 37.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.1 2.4 2.8 2.6 2.2 3.5 3.9 4.6 1.7 3.5 4.7 2.6 3.3 0.2 0.0 0.0 0.0 0.2 0.1 0.6 9.4 0.0 0.0 0.8 0.6 0.6 0.0 8.0 1.8 0.0 0.2 0.0 0.0 0.0 0.9 523.7 81.2 0.8 0.4 1.8 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 12.2 0.0 0.0 306.1 5.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.1 0.0 3.8 0.0 0.4 0.0 2.5 84.7 0.1 0.0 0.0 2.6 27.6 4.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769978 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.4;lymphoid tissue: 7.9;retina: 6.9;testis: 5.8" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low region specificity" "Detected in many" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 0.5 0.2 0.7 3.2 0.6 11.4 0.5 0.5 1.4 0.2 0.4 1.4 1.0 0.4 0.7 0.9 0.2 0.3 0.1 1.3 0.4 0.2 0.5 0.4 4.9 0.4 0.4 0.6 0.1 0.1 0.2 0.0 1.5 0.6 0.2 2.0 6.9 0.2 0.1 0.6 1.2 1.0 0.9 0.2 1.3 0.9 5.8 0.5 7.9 0.2 0.0 5.3 0.6 0.4 0.8 22.0 17.5 37.8 19.9 2.6 4.8 14.1 43.6 12.0 31.0 41.3 27.9 19.6 45.7 13.9 11.8 22.7 21.4 37.1 14.9 48.1 31.6 16.8 64.5 38.1 12.6 0.1 54.0 36.8 1.0 0.6 53.8 3.7 3.7 16.9 27.1 44.2 30.8 30.3 14.1 56.9 13.1 36.0 14.9 12.2 36.0 57.0 13.8 6.4 35.3 14.0 16.2 37.7 11.6 7.4 25.6 10.0 21.1 12.5 44.6 33.8 27.6 49.3 11.1 29.1 47.1 14.1 37.4 37.0 1.1 0.3 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.2 1.0 0.5 0.2 0.2 0.3 0.3 0.7 0.6 0.5 1.4 1.3 0.4 0.4 0.4 0.6 0.6 0.2 0.5 0.8 2.6 0.0 0.5 0.3 6.5 5.6 5.7 4.4 1.2 9.4 2.9 3.8 1.4 2.8 2.7 0.0 12.5 19.7 4.6 12.8 0.0 1.6 7.9 1.0 3.6 3.6 1.2 55.6 1.6 0.6 41.1 5.2 4.6 3.3 1.3 12.0 2.2 0.4 16.9 1.7 1.5 9.4 2.0 3.0 8.2 6.1 2.5 5.8 3.6 0.0 9.1 9.4 4.1 0.0 0.6 1.4 9.5 0.4 32.5 1.8 0.4 0.2 0.0 101.0 6.6 5.3 8.7 281.1 263.3 5.8 2.0 10.4 7.2 1.2 12.0 3.9 RFFL "CARP-2, CARP2, fring, rififylin, RNF189, RNF34L" ENSG00000092871 "Ring finger and FYVE like domain containing E3 ubiquitin protein ligase" Q8WZ73 17 35005990-35089319 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.8" "Cell type enhanced" "Detected in many" "Late spermatids: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 119.5;Karpas-707: 112.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008096, HPA017910, HPA019492" Approved Approved Vesicles NA NA Vesicles "CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190" "unprognostic (2.59e-1)" "unprognostic (2.87e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.79e-1)" "unprognostic (5.73e-3)" "unprognostic (4.34e-3)" "unprognostic (2.31e-1)" "unprognostic (9.26e-3)" "unprognostic (2.39e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.43e-5)" "unprognostic (1.44e-1)" "unprognostic (1.97e-1)" "unprognostic (8.68e-2)" "unprognostic (1.36e-1)" 10.0 7.2 24.7 17.9 51.9 41.8 12.3 45.4 31.7 10.0 10.0 27.0 28.4 9.7 8.9 36.3 9.4 19.5 8.2 20.8 52.1 17.9 48.7 12.7 17.8 66.9 51.4 13.4 8.6 19.0 12.2 6.9 12.0 62.9 18.5 23.4 21.3 13.3 12.8 16.0 7.5 23.0 13.5 55.2 19.4 23.5 26.9 46.9 26.3 39.3 13.2 29.7 20.5 16.3 92.8 22.9 43.4 10.7 15.0 21.6 28.1 6.1 15.6 25.8 15.5 18.7 15.4 50.5 7.0 19.4 21.4 33.0 32.2 18.4 30.8 22.4 119.5 11.2 40.5 11.0 38.6 18.0 20.2 20.0 19.0 18.8 23.7 46.9 22.6 15.6 21.2 18.2 112.2 16.0 8.7 4.9 19.4 15.2 51.1 24.9 17.3 18.7 43.2 22.8 48.6 12.0 15.8 8.9 10.3 9.1 24.4 15.9 27.7 29.7 8.6 14.9 8.7 24.1 41.4 33.0 9.4 36.4 15.8 7.4 28.6 16.2 33.7 16.8 9.3 20.6 7.8 18.5 16.3 10.8 6.9 16.0 14.5 55.3 14.4 9.9 1.3 29.6 15.5 24.7 51.9 45.4 31.7 20.8 52.1 66.9 51.4 13.4 62.9 55.2 46.9 92.8 6.5 41.7 27.4 0.0 12.6 6.0 11.9 7.4 5.2 10.6 9.9 3.8 1.3 20.0 17.3 0.0 14.6 9.4 12.1 33.7 1.9 8.4 41.0 13.0 6.8 6.6 15.0 23.8 0.0 15.1 1.7 9.3 23.0 18.1 25.3 5.4 9.3 35.2 7.2 6.7 0.0 26.4 6.1 16.3 16.9 109.1 3.1 16.1 1.8 0.0 22.6 20.8 25.7 0.0 0.0 16.8 19.3 4.5 12.9 28.1 16.7 20.4 11.7 34.9 6.6 15.2 5.7 15.9 10.8 16.2 6.1 5.1 23.7 3.1 18.9 39.5 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844552 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 59.4;lymphoid tissue: 66.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7" "Region enriched" "Detected in single" 6 "cerebellum: 5.0" "Low region specificity" "Detected in many" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol NA NA 1500000 Cytosol Vesicles "HPA067117: AB_2685784, HPA073525: AB_2686615" "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 7.7 7.3 5.0 23.7 5.6 59.4 7.9 4.8 7.4 16.9 4.2 10.5 8.1 8.7 2.0 23.8 14.0 6.6 11.9 3.9 6.1 6.2 12.7 38.4 26.1 6.8 5.3 3.3 19.5 8.9 0.5 11.7 9.1 6.0 8.1 4.5 5.6 7.8 5.2 8.6 6.0 18.7 5.0 5.8 66.7 13.9 6.2 6.4 20.9 6.0 1.5 17.8 10.8 19.8 7.7 44.0 18.7 0.4 0.3 0.5 1.0 47.6 0.1 0.0 0.0 0.1 41.4 97.0 3.4 46.4 0.0 7.5 15.4 0.0 2.2 0.0 0.4 0.5 245.7 136.3 24.2 3.9 94.1 245.9 0.6 2.0 0.5 2.1 2.3 17.9 42.5 87.1 1.1 0.0 71.2 100.9 50.8 0.9 69.9 1.7 32.8 1.0 1.5 1.6 17.7 0.3 66.7 19.2 189.7 0.9 0.5 47.1 56.5 48.1 0.8 65.9 0.5 0.5 1.3 5.9 4.0 0.6 31.3 0.2 59.1 16.0 31.2 19.3 16.9 17.4 6.7 11.4 13.6 12.3 3.6 8.8 11.9 40.1 14.7 25.6 7.2 10.8 18.1 5.0 5.6 4.8 7.4 3.9 6.1 6.8 5.3 3.3 6.0 5.8 6.4 7.7 3.8 44.8 8.3 6.8 16.6 1.1 1.7 1.0 0.6 12.0 4.9 2.4 68.3 7.2 4.4 3.7 20.9 4.7 27.0 40.9 0.0 7.2 5.3 1.3 3.3 6.6 6.0 14.9 1.2 6.0 11.6 2.2 2.0 2.3 45.0 9.9 7.9 1.2 58.5 5.0 1.5 3.6 2.0 21.6 8.2 0.5 2.8 22.2 1.8 5.6 22.5 4.5 61.8 3.0 7.9 47.3 30.7 1.5 27.4 1.6 5.5 0.7 1.6 16.2 0.0 4.5 2.6 1.2 1.4 1.5 1.4 25.9 30.9 2.0 6.3 2.3 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 246.0;Early spermatids: 193.4;Late spermatids: 213.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain NA No "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.90e-4)" 14.6 13.9 8.6 13.4 9.6 16.7 15.6 12.0 10.8 14.1 6.1 19.8 16.5 12.7 16.6 18.0 12.0 13.3 19.3 9.2 8.8 12.1 17.0 16.3 12.9 9.8 9.1 9.7 9.8 15.3 22.3 15.6 20.1 10.7 11.6 20.7 38.4 15.5 12.3 28.1 18.5 17.0 15.4 7.6 14.3 20.4 23.2 9.6 14.2 15.9 21.3 14.8 12.2 16.5 12.0 25.0 13.8 16.0 15.1 33.7 20.3 18.8 21.6 20.0 20.4 18.1 28.1 44.5 20.1 17.9 22.2 22.4 23.5 11.5 11.3 21.2 9.3 22.8 19.3 27.1 19.6 16.1 10.6 19.1 24.4 18.0 26.3 11.8 29.5 39.6 26.3 24.5 29.0 26.4 18.6 24.7 17.7 6.7 28.3 8.0 19.2 20.7 41.9 15.9 18.3 15.4 26.1 20.7 29.0 19.3 23.4 51.0 16.3 27.9 36.9 17.8 23.5 18.1 32.1 13.7 29.9 28.6 9.3 25.0 14.5 15.2 13.4 15.9 17.7 6.6 7.6 14.2 16.1 16.7 9.1 8.6 10.6 18.7 7.9 14.7 11.8 21.1 9.4 8.6 9.6 12.0 10.8 9.2 8.8 9.8 9.1 9.7 10.7 7.6 9.6 12.0 15.9 12.8 14.0 45.4 21.3 16.8 16.3 21.1 48.9 39.3 20.5 14.7 18.1 12.8 22.7 14.7 246.0 38.6 19.5 34.3 5.9 15.3 193.4 12.5 14.9 19.5 16.8 30.9 51.9 18.0 78.0 18.9 25.5 14.1 27.3 12.0 17.9 19.4 33.7 40.4 68.2 14.6 20.3 23.9 19.0 213.9 18.3 24.9 19.6 40.3 22.8 24.6 20.6 48.7 63.1 20.9 14.0 13.9 47.3 16.3 23.2 9.9 13.5 103.3 6.6 15.6 15.7 37.8 18.0 33.9 17.2 41.3 27.0 11.5 18.3 15.8 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514031-26658178 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 558.2" "Cell type enhanced" "Detected in all" "Adipocytes: 362.9;Oligodendrocytes: 367.2" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 65.8;intermediate monocyte: 74.5;myeloid DC: 71.2;non-classical monocyte: 48.8;plasmacytoid DC: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 71.2;monocytes: 74.5" "Cell line enhanced" "Detected in many" "ASC diff: 263.7;Karpas-707: 279.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" NA NA 3200000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (5.41e-5)" 57.0 35.1 265.1 22.7 330.7 3.6 48.4 334.6 308.3 24.6 13.2 37.7 10.5 25.1 11.5 18.5 29.9 29.7 54.8 287.4 267.5 18.9 17.8 78.9 17.5 376.5 309.0 256.1 41.1 11.1 7.1 22.3 44.1 399.0 19.8 19.2 64.6 18.6 15.0 19.4 23.6 27.9 33.2 317.7 33.9 21.7 11.3 321.5 19.5 22.7 26.0 20.2 35.9 27.1 558.2 22.0 104.1 100.2 53.9 263.7 120.6 9.8 41.9 97.0 39.2 50.6 41.0 31.0 32.7 29.7 131.7 78.8 20.9 106.6 42.0 37.1 74.2 9.2 37.0 36.9 57.9 168.5 8.0 14.5 150.8 59.5 107.1 61.9 125.5 80.0 24.9 1.1 279.1 39.9 13.9 64.3 8.1 78.8 69.9 20.0 84.3 40.3 21.8 66.2 25.0 45.6 95.8 51.0 0.5 28.6 65.7 7.8 14.8 145.0 88.2 34.8 74.3 18.5 39.1 43.3 24.8 127.7 48.1 46.0 1.3 65.8 0.6 9.1 74.5 3.3 8.5 8.1 6.2 71.2 4.4 4.0 5.2 1.7 11.3 48.8 42.2 13.3 30.3 265.1 330.7 334.6 308.3 287.4 267.5 376.5 309.0 256.1 399.0 317.7 321.5 558.2 362.9 131.4 71.7 193.9 11.5 40.4 1.0 13.2 2.2 111.4 44.4 58.4 105.0 84.4 19.4 22.0 31.3 15.1 64.8 4.5 3.9 21.4 3.1 41.6 154.3 154.6 60.7 22.3 191.9 2.0 9.1 144.9 6.1 33.6 20.8 33.0 211.3 22.8 51.1 141.3 157.0 87.0 4.1 223.5 192.3 10.6 109.0 111.1 120.9 81.5 163.5 165.2 22.6 102.1 367.2 12.6 6.2 89.5 6.5 1.1 4.7 24.4 10.5 38.6 138.1 51.8 110.6 3.8 17.0 1.6 33.8 4.5 14.8 16.8 12.1 1.2 TGFB2 ENSG00000092969 "Transforming growth factor beta 2" P61812 1 218345336-218444619 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Aortic aneurysm, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Astrocytes: 119.1;Muller glia cells: 87.1" "Cancer enhanced" "Detected in all" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 59.6;hTERT-RPE1: 155.6;U-2 OS: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006134 Approved Vesicles "Secreted to blood" NA Yes 4890000 Vesicles "HPA006134: " "unprognostic (7.24e-2)" "unprognostic (7.23e-2)" "unprognostic (6.32e-2)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (3.86e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-2)" "unprognostic (2.35e-1)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (2.43e-2)" "unprognostic (2.64e-3)" "unprognostic (1.23e-1)" "unprognostic (4.90e-2)" "unprognostic (6.04e-2)" 1.5 1.3 10.2 1.1 12.4 0.1 4.0 10.7 15.1 7.1 7.7 1.8 0.6 6.5 4.5 1.8 3.9 2.1 6.5 11.8 22.9 1.4 0.6 7.9 0.6 19.5 13.3 8.6 4.6 1.9 1.1 2.2 13.0 11.4 17.1 0.9 10.6 8.6 11.3 4.9 2.1 0.8 5.1 9.2 2.6 1.3 0.9 10.3 0.4 2.7 2.1 0.8 3.1 3.1 11.5 4.0 20.2 1.8 15.1 4.3 2.1 0.0 2.9 0.4 30.1 21.2 5.5 46.7 0.0 59.6 0.2 25.8 11.1 1.2 2.3 32.0 0.1 0.2 0.0 1.7 0.0 46.7 0.0 0.0 1.9 5.3 4.1 15.8 155.6 8.1 0.0 0.0 0.0 29.6 0.3 0.0 0.0 1.6 0.0 1.8 0.0 8.8 0.0 10.1 0.0 0.3 0.1 34.8 3.9 0.7 39.7 2.9 1.1 38.3 21.3 58.4 17.9 30.7 0.0 0.1 0.1 9.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 12.4 10.7 15.1 11.8 22.9 19.5 13.3 8.6 11.4 9.2 10.3 11.5 2.2 76.9 6.3 119.1 0.5 8.7 8.7 35.3 4.0 9.9 8.4 5.8 4.1 14.3 29.8 5.5 0.0 0.4 0.2 0.0 0.0 40.2 19.3 2.1 6.7 8.1 0.0 0.0 8.6 16.9 13.9 28.8 0.0 6.8 1.3 0.9 4.2 0.0 1.4 1.7 36.0 0.0 8.2 0.6 13.2 28.0 8.1 3.2 12.4 30.0 1.0 87.1 0.0 3.5 1.0 21.5 0.0 13.9 1.2 15.0 0.0 0.8 12.3 3.0 0.0 27.7 19.7 0.3 0.8 0.6 2.8 0.5 0.5 0.8 0.0 2.1 GPATCH2 "CT110, FLJ10252, GPATC2, Pfa1, PPP1R30" ENSG00000092978 "G-patch domain containing 2" Q9NW75 1 217426992-217631090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027181, HPA027322" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA027181: AB_10602601, HPA027322: AB_1848645" "unprognostic (3.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.29e-1)" "unprognostic (2.04e-1)" "unprognostic (3.27e-2)" "unprognostic (5.13e-2)" "unprognostic (6.50e-2)" "unprognostic (1.28e-1)" "unprognostic (6.24e-3)" "unprognostic (2.46e-2)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (9.99e-6)" "unprognostic (3.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" 4.2 4.2 3.9 4.2 4.5 3.2 7.2 3.4 4.8 5.9 6.2 4.4 4.9 6.6 5.9 5.6 5.0 6.2 3.3 4.5 4.8 5.3 4.9 4.2 5.2 3.9 3.6 3.9 4.8 3.9 7.0 4.5 6.3 3.2 7.0 4.6 5.8 3.7 5.3 6.7 4.4 4.9 5.1 3.4 4.9 4.9 6.3 4.4 6.3 6.6 2.9 5.6 6.2 4.2 4.3 8.4 9.4 9.9 7.8 8.6 8.7 8.2 7.7 9.4 10.5 9.9 8.3 10.6 8.9 7.6 6.7 6.5 9.7 11.2 9.1 12.2 6.6 6.4 5.9 7.9 5.3 10.6 9.0 6.7 7.7 13.0 12.3 20.0 9.1 7.3 9.8 14.7 0.1 7.7 7.9 12.2 6.4 18.0 6.7 10.2 5.9 22.7 10.7 7.4 17.9 11.6 16.5 13.7 12.5 10.7 15.5 11.7 8.7 7.5 9.8 6.8 13.9 7.2 9.0 6.8 8.4 7.4 5.9 7.1 4.1 3.1 1.1 2.6 1.9 1.8 2.6 3.0 1.8 3.4 2.8 2.7 2.4 0.4 2.7 2.9 5.0 2.9 1.5 3.9 4.5 3.4 4.8 4.5 4.8 3.9 3.6 3.9 3.2 3.4 4.4 4.3 17.5 12.8 15.9 43.8 19.4 15.6 16.1 13.4 14.8 55.4 27.2 27.9 14.4 21.5 15.3 18.4 171.0 20.8 24.5 22.4 13.7 20.4 62.6 41.3 36.4 20.5 20.8 12.0 113.1 18.0 22.2 23.0 19.4 24.0 9.5 32.9 20.7 12.4 15.7 50.5 60.5 21.5 18.3 9.2 9.2 22.8 19.9 16.6 5.4 39.4 17.2 27.7 28.8 46.3 47.1 15.0 17.2 23.0 24.5 17.5 17.9 18.1 22.3 144.2 19.7 36.8 20.2 53.3 23.8 12.9 19.5 21.6 20.0 41.4 23.1 19.0 NUP50 NPAP60L ENSG00000093000 "Nucleoporin 50" Q9UKX7 22 45163925-45188017 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047162, HPA048328" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA047162: AB_2679963, HPA048328: AB_2680360" "unprognostic (2.64e-1)" "unprognostic (1.21e-2)" "unprognostic (4.96e-2)" "unprognostic (1.22e-1)" "unprognostic (2.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.46e-3)" "unprognostic (5.83e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "unprognostic (7.22e-2)" "unprognostic (5.31e-2)" "unprognostic (1.97e-2)" "prognostic favorable (4.06e-4)" "unprognostic (1.43e-1)" "unprognostic (3.17e-2)" "unprognostic (3.63e-2)" 14.2 14.9 9.0 23.5 10.3 54.9 13.6 12.5 12.3 14.4 11.5 18.9 16.7 10.2 18.9 20.7 18.2 14.5 7.2 10.5 10.6 13.8 23.7 14.7 34.0 8.2 8.6 10.2 14.1 16.0 16.0 6.8 15.7 9.6 12.3 16.9 11.0 11.8 13.6 7.9 19.1 16.5 11.5 8.8 25.7 24.5 30.1 9.3 47.0 15.4 12.8 35.6 19.5 12.4 11.8 75.8 35.5 67.1 43.7 31.0 31.8 70.9 61.9 41.1 46.9 47.1 77.6 32.9 82.7 28.1 41.0 35.1 52.0 83.4 50.5 67.3 44.3 87.4 72.6 54.8 47.7 32.2 193.7 73.7 38.8 34.1 60.1 45.2 22.7 52.4 71.4 76.5 84.3 49.0 50.8 88.2 50.5 50.4 50.0 36.3 91.8 40.7 58.0 37.0 72.5 41.7 40.4 61.5 37.9 74.0 50.9 23.6 50.3 48.3 99.1 88.6 51.6 52.7 58.4 51.3 119.0 37.1 49.2 70.4 55.1 39.1 80.5 20.3 40.2 27.8 19.5 24.5 23.5 25.5 18.1 28.4 19.6 92.7 30.6 24.2 13.9 25.8 34.2 9.0 10.3 12.5 12.3 10.5 10.6 8.2 8.6 10.2 9.6 8.8 9.3 11.8 42.7 9.6 27.9 6.2 32.7 85.5 51.9 26.4 48.3 14.6 26.2 16.3 10.8 22.8 29.6 33.1 12.5 22.6 47.5 34.2 13.7 18.9 46.3 56.3 34.7 29.7 17.4 72.4 16.4 20.9 39.8 21.8 59.1 47.3 34.7 23.9 33.2 38.5 28.1 13.5 15.3 24.4 20.3 47.5 32.8 83.3 14.6 33.4 24.9 11.2 56.9 11.1 42.2 11.6 12.5 29.8 33.5 13.9 49.0 60.8 16.9 22.8 50.0 16.3 26.3 15.9 17.1 45.9 44.3 60.6 89.4 56.6 47.1 23.5 26.3 95.3 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479457-19520612 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.6;lymphoid tissue: 20.6;testis: 23.6" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "K-562: 370.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.5 0.5 1.0 6.3 0.4 25.6 1.5 0.2 0.7 0.6 0.6 4.7 3.5 0.9 0.3 5.3 0.4 0.5 0.3 0.4 0.4 0.3 1.2 0.9 11.4 0.5 0.4 0.0 0.2 0.2 0.2 0.1 3.2 0.4 0.4 6.0 0.1 0.9 0.2 0.2 3.4 3.1 1.8 0.2 2.9 2.6 23.6 1.2 20.6 0.4 0.0 11.9 2.0 1.7 1.2 57.4 42.2 56.4 42.9 2.0 5.6 24.4 65.4 31.6 75.5 75.5 35.8 30.5 62.2 23.2 21.0 28.9 51.9 58.2 45.9 59.5 72.3 96.3 82.8 50.1 41.3 3.1 125.0 43.7 1.3 2.4 57.9 26.0 7.0 38.8 63.0 370.6 73.3 44.8 77.2 98.1 56.5 16.7 106.2 34.4 77.1 95.5 26.5 16.9 49.3 72.1 37.0 38.1 40.0 12.0 21.7 26.2 51.0 15.0 60.0 91.6 46.0 62.8 24.6 46.8 67.5 30.1 58.9 82.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.7 0.1 0.0 0.2 0.1 0.5 0.5 0.1 0.3 0.9 0.6 1.0 0.4 0.2 0.7 0.4 0.4 0.5 0.4 0.0 0.4 0.2 1.2 1.2 0.2 0.0 0.0 0.0 1.9 2.7 1.7 3.7 0.0 0.0 0.7 0.8 0.4 0.0 0.5 0.0 0.0 11.9 1.4 1.9 0.0 0.8 120.5 0.9 0.7 1.2 0.0 29.7 0.1 0.0 19.8 2.3 1.5 1.0 0.0 5.5 3.6 0.0 7.2 0.0 0.1 1.2 4.1 0.6 1.0 14.4 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.7 12.6 0.2 0.4 0.0 0.3 0.0 6.6 1.5 13.9 72.3 50.7 3.3 1.8 4.9 1.2 0.8 5.1 2.5 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941371-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 818.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" NA NA 43000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favorable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favorable (5.67e-4)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 76.0 182.2 81.8 39.9 90.4 72.4 86.2 99.2 141.6 92.0 98.2 75.1 55.5 77.6 48.1 199.6 65.7 60.9 81.3 79.1 97.6 85.2 294.7 94.1 50.2 100.8 85.7 68.7 108.3 74.6 62.1 49.1 117.9 95.9 87.9 20.9 17.4 134.9 71.1 99.4 110.4 64.6 38.6 95.0 64.1 100.7 52.1 93.8 27.1 59.6 50.3 26.2 87.6 125.1 112.0 131.3 131.7 15.0 128.3 141.2 122.5 6.0 143.9 178.8 120.3 133.6 112.1 148.6 51.7 62.7 208.9 48.6 172.9 23.6 152.0 26.2 115.1 163.4 92.5 65.1 267.1 265.1 155.0 35.3 159.2 180.7 104.3 101.3 116.6 113.2 82.0 383.2 109.4 100.6 818.5 63.4 267.9 32.4 361.1 42.9 88.2 127.9 72.8 129.0 404.5 60.4 53.8 47.7 405.7 125.7 7.6 84.0 436.6 137.5 212.7 82.2 71.0 109.6 37.5 18.0 41.2 236.0 211.3 152.5 62.2 312.2 59.6 77.9 218.1 64.0 56.8 52.6 62.6 251.5 57.8 45.5 51.7 12.0 73.5 151.5 291.4 72.6 178.6 81.8 90.4 99.2 141.6 79.1 97.6 100.8 85.7 68.7 95.9 95.0 93.8 112.0 99.1 125.0 88.1 22.9 33.1 102.1 231.9 248.1 188.4 73.4 174.9 218.4 41.9 104.4 162.7 152.6 10.4 885.9 80.1 53.0 320.8 201.0 4.6 59.1 72.2 86.7 84.5 70.0 16.8 193.0 113.5 103.1 46.4 46.9 71.7 95.7 77.1 262.0 311.4 25.2 17.2 97.7 191.2 177.0 107.7 13.3 134.2 137.0 240.1 20.6 137.0 158.7 41.2 25.1 45.7 170.2 108.8 179.8 45.5 132.4 179.9 73.8 135.8 43.2 138.1 143.3 113.1 8.4 5.7 236.4 123.5 648.5 41.8 222.0 122.3 206.6 ADA2 "ADGF, CECR1, IDGFL" ENSG00000093072 "Adenosine deaminase 2" Q9NZK5 22 17178790-17258235 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.6;Glandular and luminal cells: 22.0;Hofbauer cells: 57.6;Macrophages: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.7;EFO-21: 21.4;HUVEC TERT2: 24.0;Karpas-707: 44.9;MOLT-4: 38.9;U-266/70: 23.8;U-937: 39.6" "Low region specificity" "Detected in all" HPA007888 Uncertain "Secreted to blood" NA NA 58000000 "HPA007888: AB_1078495" "unprognostic (1.03e-3)" "unprognostic (2.00e-3)" "unprognostic (6.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.48e-2)" "unprognostic (7.01e-3)" "unprognostic (4.48e-2)" "unprognostic (3.09e-3)" "unprognostic (3.80e-2)" "prognostic favorable (9.26e-4)" "prognostic favorable (8.91e-4)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (4.86e-3)" "unprognostic (1.96e-2)" "unprognostic (4.83e-2)" "unprognostic (2.51e-1)" 13.9 11.4 7.8 39.7 8.7 23.0 17.8 10.5 10.5 22.2 19.4 28.5 18.3 20.1 2.7 12.1 52.0 32.4 40.0 7.5 16.9 14.4 21.3 55.4 47.7 14.8 9.8 5.9 12.2 14.0 5.5 22.7 15.3 13.6 15.5 34.6 11.1 15.7 17.2 3.5 4.7 26.3 23.6 15.2 107.2 19.8 18.6 11.9 54.2 17.1 4.4 61.2 35.0 6.6 19.9 0.0 0.0 6.4 0.0 0.2 0.8 0.3 2.3 0.1 0.0 0.0 0.0 23.7 6.0 21.4 7.2 0.0 0.5 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.1 4.0 0.3 0.3 11.3 0.1 0.0 0.1 0.1 24.0 9.0 0.1 44.9 0.9 0.0 38.9 1.1 17.8 0.0 0.1 1.2 0.0 6.5 0.0 9.3 10.9 0.1 0.1 0.0 0.0 19.1 0.2 9.7 3.0 0.1 0.2 0.0 0.0 23.8 2.3 1.7 0.0 39.6 0.0 17.5 212.9 11.3 34.6 204.9 26.8 25.8 27.4 34.1 139.1 19.7 31.6 32.4 10.5 44.9 176.1 57.4 17.2 170.7 7.8 8.7 10.5 10.5 7.5 16.9 14.8 9.8 5.9 13.6 15.2 11.9 19.9 8.7 0.0 16.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 5.1 4.2 0.0 0.0 11.2 5.5 0.0 0.4 13.7 0.0 7.9 1.7 0.0 27.6 6.6 2.2 0.0 0.0 0.0 5.2 0.9 2.1 0.0 22.0 5.1 12.6 0.0 0.0 57.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 12.4 0.0 0.0 3.1 15.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 8.2 3.1 0.0 0.0 VNN3 HSA238982 ENSG00000093134 "Vanin 3" Q9NY84 6 132722787-132736935 "Enzymes, Metabolic proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 35.2;liver: 35.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 20.7;Club cells: 42.5;Gastric mucus-secreting cells: 15.8;Respiratory ciliated cells: 86.1" "Cancer enriched" "Detected in some" 4 "liver cancer: 3.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 4 "neutrophil: 76.2" "Lineage enriched" "Detected in many" 33 "granulocytes: 76.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 150000000 "unprognostic (3.20e-2)" "unprognostic (2.70e-1)" "unprognostic (7.92e-3)" "unprognostic (1.71e-2)" "unprognostic (3.05e-3)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.01e-1)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (5.84e-8)" "unprognostic (1.25e-2)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" 1.2 0.1 0.1 2.2 0.1 35.2 0.2 0.1 0.4 1.6 0.3 0.1 0.0 0.1 0.0 0.8 1.9 1.0 0.4 0.1 0.1 0.2 35.0 4.5 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 1.3 0.2 0.3 0.0 0.0 1.0 0.1 0.1 0.2 0.2 0.3 0.1 5.5 0.4 0.1 0.1 0.4 0.1 1.1 0.4 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.1 20.7 0.0 0.0 0.2 0.0 0.4 0.0 42.5 0.0 0.0 0.0 0.1 0.2 0.0 3.7 0.2 2.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 15.8 1.7 0.0 0.0 0.4 10.0 0.1 0.0 0.0 0.0 6.1 5.8 0.0 0.2 0.0 3.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.0 0.0 0.1 86.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.3 4.1 ECHDC1 dJ351K20.2 ENSG00000093144 "Ethylmalonyl-CoA decarboxylase 1" Q9NTX5 6 127288712-127343609 "Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035445, HPA035446" Uncertain Approved Vesicles NA NA 56000 Vesicles "HPA035445: AB_10669860, HPA035446: AB_2732468" "unprognostic (9.57e-2)" "unprognostic (1.63e-2)" "unprognostic (2.46e-3)" "unprognostic (1.34e-1)" "unprognostic (4.09e-1)" "unprognostic (3.68e-2)" "unprognostic (5.03e-3)" "unprognostic (4.89e-3)" "unprognostic (4.97e-2)" "unprognostic (1.76e-1)" "unprognostic (3.99e-1)" "unprognostic (9.97e-2)" "unprognostic (8.21e-3)" "unprognostic (6.83e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" 93.7 29.7 24.4 37.1 27.4 16.3 37.7 28.7 28.1 36.7 33.7 58.9 47.2 21.6 23.2 33.8 23.4 27.8 43.0 24.8 29.4 93.4 94.6 57.3 41.7 30.4 27.9 24.1 21.3 28.1 26.4 14.3 36.5 30.4 34.1 54.3 30.2 46.7 28.6 39.7 22.9 41.0 33.7 29.0 28.6 37.4 18.4 27.3 41.4 39.0 52.7 43.0 43.8 23.6 35.0 58.3 45.6 64.0 59.3 92.9 87.7 54.1 92.7 112.1 78.0 99.0 79.7 43.1 87.6 77.8 88.6 88.4 46.9 0.1 69.6 98.3 52.4 43.3 116.9 58.4 128.3 82.6 158.0 63.4 99.6 81.9 73.1 61.6 70.6 71.8 63.2 147.6 51.6 105.7 55.1 105.7 73.5 52.9 29.0 55.8 49.0 78.7 72.3 142.8 70.8 73.3 71.2 52.1 1.8 131.3 48.3 1.8 182.6 75.2 47.8 76.9 121.8 104.8 65.7 141.0 116.3 87.2 136.4 114.7 19.0 71.6 24.0 23.4 57.5 24.7 28.6 19.8 22.9 66.6 29.2 23.7 24.2 28.6 15.3 43.1 50.5 22.1 43.9 24.4 27.4 28.7 28.1 24.8 29.4 30.4 27.9 24.1 30.4 29.0 27.3 35.0 37.0 96.1 114.0 32.3 59.7 26.1 42.3 94.2 35.3 26.4 30.8 28.3 60.8 32.9 102.4 31.3 31.3 106.8 49.3 35.6 127.2 76.1 64.7 47.0 48.3 32.6 13.8 22.9 47.4 79.5 85.6 45.8 38.2 40.2 43.7 32.9 26.0 68.8 85.8 28.6 41.0 35.7 59.0 48.4 38.7 24.4 32.9 55.9 35.6 40.3 55.3 33.5 47.4 55.3 95.0 54.4 41.1 31.2 48.3 31.1 74.4 230.3 47.0 42.3 26.3 55.7 33.0 27.6 28.6 34.7 22.9 65.5 46.3 88.2 56.9 52.7 LRRFIP2 HUFI-2 ENSG00000093167 "LRR binding FLII interacting protein 2" Q9Y608 3 37052626-37183689 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 516.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035956, HPA042023" Uncertain Approved "Plasma membrane,Actin filaments" NA NA 150000 "Plasma membrane, Actin filaments" "HPA035956: AB_10671238, HPA042023: AB_2677802" "unprognostic (2.03e-3)" "prognostic favorable (6.31e-4)" "unprognostic (1.16e-2)" "unprognostic (7.90e-2)" "unprognostic (2.48e-1)" "unprognostic (2.97e-1)" "unprognostic (5.41e-2)" "unprognostic (1.82e-1)" "unprognostic (3.09e-2)" "unprognostic (2.56e-2)" "unprognostic (4.99e-3)" "unprognostic (1.98e-1)" "unprognostic (4.13e-3)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (4.84e-3)" "unprognostic (3.76e-2)" 22.2 24.2 46.0 20.3 47.7 44.7 22.5 46.9 49.1 46.4 36.6 38.6 35.7 32.0 19.9 53.0 26.0 22.1 73.3 41.4 43.9 24.1 48.9 27.3 18.3 46.1 46.8 37.8 27.7 19.4 33.6 18.8 20.9 50.4 41.3 34.5 36.3 28.8 24.5 98.7 36.3 36.5 31.7 44.2 45.3 26.7 72.4 46.5 19.0 27.8 45.7 23.4 24.4 41.3 63.4 56.6 30.8 34.9 27.7 45.5 69.3 30.5 149.9 148.2 82.6 94.3 29.0 25.3 22.2 24.0 145.4 40.8 28.8 25.8 74.2 134.3 49.7 20.2 39.8 44.0 28.6 64.8 31.9 23.3 31.1 52.1 107.8 110.4 45.8 58.2 34.0 32.3 37.8 69.5 14.4 27.2 17.0 23.0 23.0 39.2 13.0 99.2 22.6 58.4 21.7 12.6 19.9 57.9 53.0 49.4 28.0 30.6 32.6 56.5 63.1 42.6 93.4 71.5 29.1 57.1 33.9 37.1 28.1 91.4 20.5 21.4 33.8 8.8 14.9 11.3 9.7 9.3 9.5 14.1 8.5 6.8 8.3 19.2 16.9 26.9 7.9 13.0 11.7 46.0 47.7 46.9 49.1 41.4 43.9 46.1 46.8 37.8 50.4 44.2 46.5 63.4 47.8 28.9 36.5 98.6 29.1 136.1 143.0 41.3 113.8 36.3 64.7 53.2 123.1 38.6 53.7 23.9 29.2 29.2 28.7 117.2 64.6 89.8 516.2 78.9 44.0 59.9 54.0 60.0 169.8 94.3 46.1 57.4 37.8 127.3 52.6 29.4 56.7 58.8 24.9 122.8 197.7 45.6 28.5 35.6 128.3 330.7 42.3 48.2 74.7 62.8 67.7 51.9 30.9 130.7 309.0 109.9 90.1 57.6 45.8 325.6 125.8 46.1 36.2 51.9 39.5 32.4 72.8 159.9 73.4 139.3 170.5 39.3 34.1 90.0 66.0 303.2 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 32.5 23.6 40.5 14.2 44.0 36.8 33.5 42.7 44.2 28.3 36.9 26.3 32.2 30.1 27.6 17.4 27.5 19.1 24.2 37.5 42.1 26.2 16.5 33.4 19.2 44.3 44.1 37.6 29.6 29.9 26.6 26.8 19.5 44.5 37.7 15.7 25.8 23.5 26.2 22.4 18.9 32.9 26.5 43.2 20.6 28.5 27.7 42.8 18.4 24.4 26.4 16.5 25.9 23.3 51.8 24.0 22.2 35.9 30.5 72.4 68.1 7.6 43.8 46.7 46.1 47.9 15.5 37.9 24.5 17.6 50.1 28.2 12.6 24.1 39.8 40.7 32.8 28.5 41.7 40.0 21.0 55.4 19.2 39.5 38.3 53.1 51.4 62.5 46.5 51.1 38.7 37.0 46.5 45.8 16.6 27.1 22.3 19.8 16.0 31.9 11.7 21.4 22.9 40.6 21.1 18.5 27.8 30.9 28.0 34.5 26.5 48.4 20.9 42.9 35.1 27.8 63.8 43.1 36.8 55.6 23.5 41.7 26.6 34.0 11.7 11.5 22.0 13.2 9.0 19.6 11.5 17.6 16.3 10.8 9.4 14.9 13.2 7.1 10.2 9.3 11.3 16.3 10.1 40.5 44.0 42.7 44.2 37.5 42.1 44.3 44.1 37.6 44.5 43.2 42.8 51.8 31.4 25.6 27.6 27.1 23.2 15.0 18.3 25.3 25.0 16.6 31.6 29.6 18.8 24.3 17.2 11.0 29.2 20.5 28.1 1.9 41.1 29.7 61.2 17.5 19.5 30.5 9.0 48.2 18.9 32.9 20.3 31.8 21.9 12.7 49.4 25.1 32.2 14.5 31.3 26.9 18.4 4.9 32.6 19.0 14.4 15.0 32.6 17.6 40.9 21.5 35.5 39.2 24.7 12.5 44.1 28.8 1.0 42.9 23.0 24.0 36.9 29.6 19.4 39.9 39.5 26.6 31.1 96.9 49.8 11.3 10.2 10.5 34.6 20.3 6.6 9.4 XYLB "FLJ10343, FLJ12539" ENSG00000093217 Xylulokinase O75191 3 38346760-38421348 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Xylose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037863, HPA038415" Uncertain Approved "Nuclear speckles" NA NA 12000 "Nuclear speckles" "HPA037863: AB_10672729, HPA038415: AB_10672592" "unprognostic (2.48e-1)" "unprognostic (9.72e-2)" "unprognostic (3.42e-2)" "unprognostic (6.25e-2)" "unprognostic (7.52e-2)" "unprognostic (5.19e-2)" "unprognostic (5.82e-2)" "unprognostic (1.26e-3)" "unprognostic (6.55e-2)" "unprognostic (2.22e-1)" "unprognostic (6.91e-3)" "unprognostic (4.63e-2)" "prognostic favorable (8.57e-4)" "unprognostic (3.26e-1)" "unprognostic (2.06e-1)" "unprognostic (5.78e-2)" "unprognostic (3.37e-2)" 1.4 2.3 1.2 1.5 1.3 2.2 3.0 5.2 2.4 1.7 0.1 4.1 5.8 2.0 0.8 2.0 1.1 1.6 0.5 1.2 0.8 11.5 33.7 0.7 1.0 1.0 0.6 1.3 2.2 2.5 1.1 0.8 1.0 2.4 1.6 4.6 2.1 5.4 0.9 0.6 1.5 6.4 1.4 0.1 1.1 3.5 1.1 0.8 1.7 0.7 0.5 0.8 1.3 1.3 2.1 3.5 6.4 2.8 6.7 4.2 4.3 6.3 5.9 2.0 4.5 4.4 8.2 3.6 3.7 1.4 7.6 5.4 2.5 8.1 2.5 5.6 5.0 6.2 7.5 5.0 24.1 2.2 10.1 7.7 3.0 5.2 5.8 2.7 1.9 4.7 8.5 18.0 6.2 5.0 2.4 8.3 1.4 3.8 8.9 7.9 4.2 5.5 5.0 0.6 6.3 3.6 3.2 3.7 16.0 12.7 2.4 7.2 6.1 2.6 9.0 7.3 15.6 2.5 3.5 6.6 8.5 5.4 9.1 7.2 1.4 0.9 2.0 0.6 1.6 0.5 0.2 0.5 0.3 1.7 0.3 0.6 0.6 1.9 0.5 1.4 0.6 1.5 0.4 1.2 1.3 5.2 2.4 1.2 0.8 1.0 0.6 1.3 2.4 0.1 0.8 2.1 1.0 0.0 1.3 14.0 0.9 0.9 2.1 1.8 6.8 3.2 3.0 3.4 1.1 2.8 1.5 0.0 0.0 4.3 1.7 3.8 1.9 1.0 0.5 0.4 3.5 1.8 0.0 3.4 39.3 3.0 3.8 2.3 8.6 1.0 0.0 1.3 1.1 49.3 4.0 0.0 35.9 5.7 2.0 1.0 3.7 1.0 1.5 2.0 0.0 17.8 1.0 0.4 0.0 17.1 17.7 1.3 5.8 1.9 1.6 1.7 13.0 31.7 1.3 5.1 0.0 2.4 1.4 0.5 2.7 4.1 0.9 1.4 0.8 1.8 5.1 2.1 HDAC6 "FLJ16239, HD6, JM21, KIAA0901, PPP1R90" ENSG00000094631 "Histone deacetylase 6" Q9UBN7 X 48801377-48824982 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Actin-binding, Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003714, CAB004236, HPA026321" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546" "unprognostic (9.53e-2)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (2.42e-2)" "unprognostic (2.82e-2)" "unprognostic (4.11e-3)" "unprognostic (2.17e-2)" "unprognostic (1.16e-1)" "unprognostic (7.68e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-3)" "unprognostic (2.33e-2)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (6.60e-2)" "unprognostic (2.34e-1)" "prognostic favorable (3.34e-4)" 22.0 26.3 29.2 14.4 31.3 23.1 23.8 32.4 54.6 28.4 30.5 26.2 17.9 27.0 10.7 24.6 28.4 11.2 24.8 28.3 33.3 57.5 98.1 25.4 15.7 34.4 33.2 27.5 32.7 26.5 22.5 45.9 13.9 35.5 24.6 16.2 28.1 21.8 12.3 26.3 20.5 28.3 15.4 30.2 29.7 26.8 54.2 32.0 19.0 27.3 16.2 15.2 23.9 23.0 32.5 31.0 25.7 49.6 19.1 20.2 16.6 33.4 14.4 12.4 27.2 26.2 24.9 25.7 29.9 13.8 17.1 34.6 21.3 30.6 15.5 23.2 27.7 19.1 40.7 32.2 26.0 18.3 19.2 60.4 25.7 25.1 21.5 25.3 24.8 23.5 37.4 45.9 31.9 17.7 10.9 27.0 29.3 18.5 14.2 24.5 23.1 53.5 31.3 15.8 13.3 25.9 25.3 29.5 8.7 17.4 63.4 36.1 17.5 19.1 21.5 26.7 29.3 14.2 29.6 31.3 21.3 21.3 24.0 21.5 0.0 5.1 5.8 4.7 8.3 3.4 3.7 3.3 3.4 7.6 5.3 3.1 2.9 2.5 3.6 11.7 8.3 4.0 4.9 29.2 31.3 32.4 54.6 28.3 33.3 34.4 33.2 27.5 35.5 30.2 32.0 32.5 11.4 19.2 25.1 20.9 12.5 7.5 10.2 8.8 6.2 37.6 10.7 10.4 10.6 8.6 17.5 18.4 50.1 11.5 12.6 21.4 19.6 7.9 48.1 10.0 13.0 10.3 14.4 11.4 15.2 7.4 12.3 10.7 21.9 13.2 6.3 22.5 13.6 51.9 11.1 40.4 18.4 15.5 10.2 12.3 9.8 18.4 14.0 13.2 5.4 10.3 12.7 21.9 18.6 17.1 19.0 7.2 13.2 11.3 12.8 7.1 17.8 47.6 12.4 34.0 13.1 15.5 11.1 88.4 41.7 8.6 5.8 9.7 9.7 21.8 16.2 7.2 OR1I1 "OR19-20, OR1I1P, OR1I1Q" ENSG00000094661 "Olfactory receptor family 1 subfamily I member 1" O60431 19 15082211-15092970 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.9;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.3 0.4 0.3 0.3 1.0 0.1 1.4 0.7 0.1 0.1 0.1 0.3 0.2 0.3 0.2 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.2 0.3 0.3 0.1 0.3 0.2 0.4 0.1 0.0 0.3 0.8 0.2 0.1 0.7 0.1 0.1 0.4 0.7 0.2 0.1 0.0 0.3 0.2 0.3 0.2 0.1 0.3 0.0 0.1 0.1 0.0 1.2 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.2 0.8 0.2 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.4 0.1 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.5 0.2 0.2 0.1 0.1 0.0 0.3 0.2 0.1 0.2 0.3 0.2 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.1 1.3 0.3 0.3 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.5 0.3 0.4 1.2 0.8 0.4 0.4 0.3 0.3 0.4 0.3 1.4 0.7 0.5 0.1 0.3 0.1 0.3 0.8 0.0 0.2 1.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor subunit pi" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 153.9;esophagus: 173.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6" "Group enriched" "Detected in many" 4 "breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 11.8" "Group enriched" "Detected in many" 8 "granulocytes: 11.8;monocytes: 5.7" "Cell line enhanced" "Detected in many" "A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 4.5 3.6 13.5 7.3 13.5 10.0 153.9 21.1 19.6 8.7 5.4 4.3 15.5 49.1 19.2 173.1 13.0 27.5 5.4 12.5 12.4 6.1 7.2 14.8 5.7 13.2 9.6 5.5 3.9 24.0 2.0 2.0 9.1 15.5 12.8 5.0 42.5 36.0 16.8 13.8 19.1 16.3 2.7 3.3 7.4 27.6 8.3 14.1 4.7 6.2 2.7 42.6 5.4 29.7 22.3 215.1 9.9 10.1 7.0 0.7 4.3 23.8 3.8 1.5 0.5 0.6 38.1 23.6 3.3 236.8 1.1 2.3 75.7 6.4 0.5 0.6 3.5 7.6 14.1 166.8 5.7 0.8 5.1 11.2 1.6 3.0 2.8 1.8 8.0 1.4 13.4 57.6 26.5 0.4 6.7 9.5 4.7 84.5 3.7 331.3 13.7 6.6 8.2 13.8 11.6 8.2 4.0 76.5 3.9 2.2 418.8 4.2 2.4 8.8 19.1 69.3 15.7 15.7 10.0 6.7 6.3 2.6 13.9 2.9 11.8 1.9 6.1 0.4 1.5 1.1 0.3 0.4 0.3 0.6 0.7 0.5 0.5 4.5 0.2 5.7 0.9 0.6 2.3 13.5 13.5 21.1 19.6 12.5 12.4 13.2 9.6 5.5 15.5 3.3 14.1 22.3 1.1 3.2 0.6 0.0 0.9 0.0 14.9 44.4 0.0 0.0 169.0 113.2 0.7 51.5 83.1 1.8 0.0 5.2 2.3 0.0 0.0 10.4 0.0 146.0 48.8 3.8 0.0 0.0 0.3 13.8 0.6 2.4 2.0 464.0 0.0 0.0 0.0 0.1 2.3 0.0 0.2 0.3 12.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 56.6 0.1 0.0 0.0 24.2 0.1 0.1 34.0 0.0 0.0 0.2 5.9 0.0 0.0 4.5 0.0 5.7 2.7 0.0 0.6 146.6 KRT31 "Ha-1, KRTHA1" ENSG00000094796 "Keratin 31" Q15323 17 41393721-41397608 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "skin 1: 181.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 39.1;Basal squamous epithelial cells: 21.6;Endometrial ciliated cells: 7.2;Glandular and luminal cells: 10.9;Squamous epithelial cells: 16.5;Suprabasal keratinocytes: 7.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049550, HPA055194" Enhanced NA NA 440000000 "HPA049550: AB_2680813, HPA055194: AB_2682733" "unprognostic (3.92e-2)" "unprognostic (3.50e-1)" "unprognostic (3.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.71e-2)" "unprognostic (4.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.84e-1)" "unprognostic (4.07e-1)" "unprognostic (4.26e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.2 0.0 0.2 0.0 0.5 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 4.7 181.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 39.1 0.3 2.9 21.6 0.0 0.2 0.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 10.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 16.5 7.7 0.0 0.1 0.2 0.0 0.0 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287879-40304657 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.4;lymphoid tissue: 17.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 500.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 2.2 1.9 0.7 13.8 1.1 27.4 3.4 0.5 2.1 3.3 0.0 8.5 7.6 2.3 1.1 5.7 1.0 2.8 0.6 1.3 0.7 0.5 3.1 1.4 16.5 0.6 0.2 1.0 0.9 1.9 0.8 0.5 9.4 0.6 1.1 8.7 0.5 1.4 1.2 0.3 2.8 6.7 3.8 0.2 3.7 3.6 10.2 0.4 16.8 1.7 0.5 17.3 4.4 1.8 1.2 155.1 119.0 115.1 86.5 6.7 12.7 118.0 159.9 49.0 149.2 166.5 135.8 64.9 123.9 99.6 35.9 85.9 214.0 112.2 76.2 148.9 64.5 98.4 96.2 122.3 134.6 4.4 133.3 55.1 4.7 8.1 156.4 107.1 14.8 46.9 84.2 183.0 109.0 71.9 95.8 199.3 43.3 101.6 96.9 48.7 145.0 286.8 119.9 30.3 184.8 85.6 76.9 146.9 500.3 55.4 100.3 100.8 120.0 34.7 95.5 146.3 170.8 196.1 46.1 103.6 222.8 84.6 93.9 109.2 0.1 0.1 0.0 0.8 0.0 0.5 0.4 0.6 1.1 0.7 0.3 0.4 1.1 0.1 1.5 0.0 3.6 2.4 0.6 0.7 1.1 0.5 2.1 1.3 0.7 0.6 0.2 1.0 0.6 0.2 0.4 1.2 2.2 0.0 2.0 0.7 4.9 4.2 1.1 3.7 3.4 0.2 2.1 2.2 0.9 1.5 1.3 0.0 0.0 23.2 2.3 7.8 0.0 1.3 2.2 1.3 2.9 2.1 0.0 37.2 2.0 0.6 34.6 5.6 3.6 5.1 0.0 8.1 1.1 0.9 8.3 0.0 0.7 6.1 0.0 1.3 2.1 1.0 2.8 1.5 0.0 0.0 0.0 0.4 2.1 0.0 0.2 1.5 3.0 0.7 31.6 1.3 0.8 0.2 0.2 0.3 13.1 0.6 4.6 69.5 57.2 9.1 1.6 16.7 3.3 1.9 9.3 2.4 UPRT "DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3" ENSG00000094841 "Uracil phosphoribosyltransferase homolog" Q96BW1 X 75156388-75304885 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000805 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000805: AB_1080482" "unprognostic (3.12e-3)" "unprognostic (5.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (1.18e-2)" "unprognostic (4.62e-2)" "unprognostic (1.04e-3)" "unprognostic (9.64e-2)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.14e-4)" "unprognostic (6.09e-2)" "unprognostic (2.54e-2)" "unprognostic (2.74e-1)" "unprognostic (4.53e-3)" 6.2 11.0 8.2 6.4 8.3 13.5 8.0 8.3 8.8 8.1 9.1 7.6 11.0 5.9 9.0 7.9 7.3 6.2 9.4 8.3 9.9 11.5 8.7 7.6 9.0 8.1 8.3 7.5 6.1 6.6 14.1 7.0 5.8 8.8 9.2 8.0 6.5 8.8 6.0 9.0 5.6 8.2 6.6 8.3 7.3 10.4 1.9 8.6 9.0 10.3 10.9 8.3 7.0 4.8 9.1 11.6 7.6 8.9 8.1 9.4 9.9 8.4 8.0 9.2 8.4 9.6 7.2 7.7 16.3 6.6 8.5 15.1 4.8 20.7 6.8 13.9 14.3 8.0 10.2 7.8 9.1 9.0 20.2 20.1 7.5 5.0 11.2 6.1 13.4 15.1 13.1 12.1 15.7 22.6 4.8 22.7 12.4 17.8 8.6 13.0 10.7 22.8 8.1 21.9 6.4 0.6 9.2 11.0 11.4 11.4 15.7 5.3 12.6 12.6 10.6 6.3 19.4 6.8 10.7 36.5 15.8 11.2 21.9 6.9 6.9 7.3 9.2 7.7 10.6 9.0 8.2 7.6 8.0 10.9 7.0 9.4 8.3 1.4 14.4 17.9 5.2 13.5 7.1 8.2 8.3 8.3 8.8 8.3 9.9 8.1 8.3 7.5 8.8 8.3 8.6 9.1 8.5 6.4 5.0 8.1 8.0 6.2 8.7 10.0 3.4 8.5 5.3 3.8 6.6 5.7 11.2 9.2 0.0 8.4 8.1 5.3 27.4 8.8 2.0 4.8 4.1 8.6 6.0 4.6 8.8 6.0 15.1 5.2 5.1 4.1 24.1 5.2 11.7 6.0 11.6 10.1 8.8 5.3 22.4 16.1 8.8 1.8 4.4 10.8 14.2 3.7 7.8 9.4 13.4 13.0 8.4 5.6 3.2 3.4 9.8 5.5 8.4 15.4 6.1 7.2 6.6 4.8 7.1 0.7 2.4 4.2 6.0 12.2 12.1 6.5 7.2 7.4 CDC23 "ANAPC8, APC8, CUT23" ENSG00000094880 "Cell division cycle 23" Q9UJX2 5 138187650-138213343 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039593 Approved "Intracellular and membrane" NA NA "HPA039593: AB_10795146" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (5.26e-3)" "unprognostic (3.46e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.37e-1)" "unprognostic (2.85e-1)" "unprognostic (3.12e-1)" "unprognostic (3.64e-1)" "unprognostic (1.64e-1)" "unprognostic (9.68e-3)" "unprognostic (9.30e-2)" "unprognostic (1.02e-1)" "unprognostic (3.12e-2)" "unprognostic (3.46e-1)" 12.6 11.9 12.5 13.8 13.6 14.2 17.6 15.4 15.9 12.8 10.9 14.1 11.5 15.2 17.4 14.6 12.5 10.7 15.4 13.3 12.7 20.0 18.4 13.4 18.0 12.4 12.9 13.9 14.9 9.6 18.6 10.0 26.4 13.8 15.6 15.8 14.1 11.9 13.7 10.2 16.6 11.0 17.1 12.1 14.5 13.0 15.2 12.6 20.5 16.2 12.3 19.5 14.7 11.8 14.0 42.7 35.8 51.2 62.7 22.2 24.8 59.8 34.8 26.8 70.0 72.3 83.9 46.7 52.0 52.3 32.6 71.9 41.6 67.5 54.0 64.4 40.3 61.9 41.5 30.6 37.7 30.8 33.1 39.4 26.0 36.4 43.9 37.0 29.1 47.3 55.1 43.7 39.1 34.9 28.6 65.6 40.3 32.6 52.6 28.6 58.3 60.8 36.0 38.8 26.9 40.7 36.8 51.8 33.1 61.1 97.3 49.3 41.2 32.6 42.0 27.6 37.1 56.7 43.6 46.7 67.7 28.9 57.2 37.2 41.4 15.1 21.6 18.3 16.5 22.2 16.8 17.9 19.3 14.4 16.2 23.4 20.7 2.9 27.0 12.3 10.4 18.1 16.0 12.5 13.6 15.4 15.9 13.3 12.7 12.4 12.9 13.9 13.8 12.1 12.6 14.0 11.7 19.2 9.5 9.8 9.7 8.0 13.9 18.8 11.4 10.5 11.8 10.5 19.0 5.7 23.3 9.2 25.0 31.9 10.3 8.2 39.2 12.5 0.8 9.1 15.1 13.2 6.1 19.8 14.0 7.2 20.4 11.9 8.6 12.3 9.5 13.5 11.0 20.0 15.7 16.8 12.8 9.0 26.4 13.0 4.7 1.1 8.7 8.8 12.4 5.6 12.6 16.4 9.2 10.6 13.5 9.7 4.6 6.4 11.4 11.3 5.6 26.4 10.4 13.1 6.6 9.7 13.2 14.5 25.3 15.9 10.1 40.8 11.2 13.1 9.8 13.8 AAAS ENSG00000094914 "Aladin WD repeat nucleoporin" Q9NRG9 12 53307456-53324864 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040086 Approved Approved "Nuclear membrane,Centrosome,Cytosol" NA NA "Nuclear membrane" "Centrosome, Cytosol" "HPA040086: AB_10805602" "unprognostic (1.53e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-3)" "unprognostic (1.70e-1)" "unprognostic (4.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.57e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (2.53e-1)" "unprognostic (7.44e-2)" 16.5 36.6 11.9 13.9 14.2 19.3 17.2 13.8 15.7 20.1 13.5 19.0 12.4 19.2 7.3 19.5 20.0 9.5 21.1 12.0 12.4 21.7 24.8 14.2 17.8 13.3 13.3 11.6 19.4 24.1 18.1 25.0 17.6 13.9 18.6 15.3 12.4 18.6 11.8 22.8 16.9 17.8 16.9 12.4 22.3 21.8 27.5 12.7 25.4 19.6 18.7 21.8 17.9 18.1 16.4 26.1 77.3 63.2 38.0 28.6 32.2 38.9 29.8 31.3 72.6 42.1 54.0 56.7 62.2 47.4 37.3 41.9 37.6 106.4 78.8 42.1 41.0 68.1 49.7 29.9 40.7 26.4 45.5 37.9 28.1 39.4 48.9 44.6 40.4 56.6 56.2 67.6 70.6 30.4 72.8 71.2 46.1 40.0 27.7 53.1 72.1 39.3 69.4 38.2 17.5 32.8 41.3 20.2 46.9 21.0 40.2 61.2 38.8 25.5 34.9 51.1 27.4 32.9 32.5 43.5 54.7 25.6 39.6 40.5 1.0 17.7 10.7 18.4 20.2 20.8 20.0 15.9 16.8 18.8 21.8 21.7 21.4 1.1 10.5 22.5 22.6 17.4 15.2 11.9 14.2 13.8 15.7 12.0 12.4 13.3 13.3 11.6 13.9 12.4 12.7 16.4 11.7 12.8 7.8 17.9 15.1 7.4 19.0 26.2 10.2 11.8 13.2 13.0 8.2 17.2 15.4 14.7 16.7 58.4 13.7 9.3 13.7 20.4 12.5 11.9 12.9 11.7 8.4 41.2 7.3 18.3 49.5 14.9 13.3 8.9 8.2 13.1 11.0 12.0 28.5 1.7 6.6 13.1 18.3 12.4 9.3 26.2 17.7 10.6 10.6 5.6 11.6 18.0 15.5 6.6 11.4 8.9 11.0 12.8 20.8 8.1 11.2 18.5 12.6 15.5 19.7 11.0 39.7 34.2 40.5 13.1 7.4 36.5 11.4 14.9 17.2 13.0 CBX5 "HP1, HP1-ALPHA, HP1Hs-alpha" ENSG00000094916 "Chromobox 5" P45973 12 54230942-54280133 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 84.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016699, CAB017548" Enhanced Enhanced Nucleoplasm NA NA 22000 Nucleoplasm "CAB017548: AB_2071368, HPA016699: AB_1850627" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (1.15e-2)" "unprognostic (5.05e-3)" "unprognostic (3.80e-1)" "unprognostic (4.59e-3)" "unprognostic (2.97e-3)" "unprognostic (6.39e-3)" "unprognostic (2.57e-2)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (1.08e-1)" "unprognostic (6.26e-2)" "unprognostic (8.64e-2)" 8.1 14.1 23.7 12.8 23.3 17.3 14.0 15.2 20.0 11.0 84.5 10.6 7.5 9.8 15.1 9.4 16.1 9.0 20.3 19.6 41.0 17.4 8.1 9.6 19.0 21.3 25.8 14.8 18.5 10.0 25.8 19.9 12.4 23.8 11.6 11.0 23.1 8.7 11.9 13.9 17.5 8.8 10.9 25.8 10.8 10.4 25.6 29.3 31.3 24.2 7.8 21.6 7.2 8.5 29.5 33.1 96.3 147.9 68.5 19.3 41.4 34.2 50.1 35.8 41.5 42.8 37.8 102.8 91.0 65.3 49.7 49.4 27.1 106.1 31.2 70.2 144.7 23.1 80.1 108.4 13.5 15.0 42.8 32.8 20.6 20.6 71.0 62.1 46.8 46.4 82.6 92.8 87.4 69.2 57.4 137.2 44.8 118.6 13.9 11.5 133.9 82.7 50.6 43.1 30.0 73.9 113.5 93.6 21.0 10.7 58.0 80.6 71.5 61.4 69.3 59.5 26.6 59.8 22.0 25.9 169.4 44.3 43.0 74.3 1.0 5.4 4.7 6.8 6.0 5.5 11.7 7.3 6.5 9.3 14.3 7.2 6.7 0.8 7.7 8.1 21.8 10.0 4.3 23.7 23.3 15.2 20.0 19.6 41.0 21.3 25.8 14.8 23.8 25.8 29.3 29.5 39.4 38.5 50.5 33.3 46.5 46.3 42.6 46.5 40.9 120.5 59.6 55.4 138.2 55.8 47.0 82.8 45.9 58.2 32.1 25.9 105.7 61.7 117.4 53.9 58.9 49.1 27.0 102.2 28.4 59.7 56.5 69.0 22.4 37.0 30.9 81.3 38.6 37.5 38.7 183.4 38.9 37.6 48.8 22.9 35.8 58.3 64.7 25.9 35.6 23.4 44.5 68.6 36.0 46.3 40.0 45.4 14.1 80.5 49.2 41.4 11.6 63.2 79.3 64.1 32.9 70.2 67.9 221.4 80.1 40.8 32.7 26.1 40.5 83.5 44.1 29.8 FMO2 ENSG00000094963 "Flavin containing dimethylaniline monoxygenase 2" Q99518 1 171185249-171212686 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 70.3;esophagus: 66.5;lung: 94.7" "Cell type enhanced" "Detected in many" "Adipocytes: 187.0;Alveolar cells type 1: 461.6;Club cells: 204.7;Fibroblasts: 98.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "ASC diff: 30.6;ASC TERT1: 13.7;HSkMC: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028261 Approved NA NA "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 70.3 24.2 1.8 1.3 2.0 0.1 48.2 1.4 1.5 6.6 3.3 5.7 1.0 5.1 7.8 66.5 33.6 4.6 43.7 0.8 3.2 10.5 4.3 94.7 11.7 2.3 1.9 0.8 4.3 5.5 5.0 6.3 0.3 2.3 5.6 1.7 0.9 36.8 2.9 17.8 4.1 4.2 4.0 1.6 0.7 6.9 1.1 3.3 8.7 12.1 20.4 11.9 4.6 11.7 1.3 0.0 0.0 0.0 0.0 30.6 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 37.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 1.4 1.5 0.8 3.2 2.3 1.9 0.8 2.3 1.6 3.3 1.3 187.0 461.6 21.7 2.6 0.1 0.4 4.4 36.0 2.8 0.4 14.5 69.1 9.2 0.0 204.7 1.8 0.0 0.0 0.5 0.0 0.0 0.5 5.5 0.1 0.1 69.1 0.0 0.0 0.1 0.0 0.0 98.7 0.0 0.0 3.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.7 2.8 0.9 1.8 0.0 37.5 0.0 0.2 0.0 2.0 0.1 1.3 0.0 0.0 2.5 3.7 0.0 10.2 36.0 0.6 0.0 9.7 48.5 0.3 0.1 7.4 0.0 0.0 1.1 1.6 0.0 1.2 SUCO "C1orf9, CH1, OPT, SLP1" ENSG00000094975 "SUN domain containing ossification factor" Q9UBS9 1 172532349-172611833 "Predicted membrane proteins" Osteogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047251 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA 45000 "Nucleoli fibrillar center, Cytosol" "HPA047251: AB_2679999" "unprognostic (1.28e-2)" "unprognostic (6.38e-3)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (4.57e-2)" "unprognostic (1.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" "unprognostic (7.05e-2)" 8.2 12.0 9.3 9.5 11.1 84.1 14.5 8.9 10.4 13.4 9.9 9.2 10.1 12.2 62.4 8.9 15.8 11.7 9.2 8.5 10.9 12.1 7.0 9.6 9.8 9.3 9.9 8.2 18.0 26.3 27.3 13.2 17.1 9.4 13.6 9.4 35.8 14.8 24.7 3.0 12.2 15.3 9.4 9.8 9.0 13.3 24.8 9.9 14.1 17.8 4.6 10.0 13.0 8.0 12.5 30.2 13.1 37.9 34.0 19.1 18.2 42.8 35.9 20.9 22.3 27.0 23.9 31.5 15.0 21.1 20.6 22.9 46.4 16.3 14.0 38.1 8.4 11.8 11.8 8.2 14.7 22.2 19.1 15.9 16.5 14.1 27.6 22.4 69.0 19.7 17.0 7.7 20.8 33.9 7.2 12.8 12.9 34.5 34.6 30.4 12.5 22.0 9.8 34.6 41.6 20.2 26.1 16.6 28.3 31.9 64.8 27.5 20.5 25.9 20.2 21.2 19.5 36.9 30.9 26.5 26.7 19.2 9.9 32.4 6.5 3.5 6.3 4.3 3.2 4.2 4.5 3.9 3.7 2.9 5.2 4.3 4.4 3.2 5.9 3.9 4.2 3.2 2.4 9.3 11.1 8.9 10.4 8.5 10.9 9.3 9.9 8.2 9.4 9.8 9.9 12.5 20.9 48.1 30.9 40.5 30.4 26.3 32.4 22.6 59.2 43.0 40.5 31.2 30.1 14.3 39.0 27.6 50.1 38.8 35.6 14.2 3.9 15.0 40.7 30.4 29.4 22.2 26.4 48.6 32.3 32.0 27.3 29.1 29.6 56.9 13.9 25.7 15.0 15.2 13.3 47.1 43.8 30.7 18.3 13.1 17.2 55.8 45.7 22.7 26.6 34.7 18.7 63.5 18.6 82.4 66.3 25.0 7.1 28.2 61.9 38.8 34.0 13.2 37.0 53.8 26.3 29.6 23.0 73.6 36.7 28.9 27.0 49.4 37.4 30.0 11.2 34.7 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47403067-47663146 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 46.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles NA Yes 28000 Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 8.2 7.6 9.0 12.9 10.8 15.8 15.9 15.7 11.4 9.8 11.7 12.0 7.9 11.8 14.1 9.5 12.5 5.8 10.2 10.0 11.0 8.3 6.8 8.2 23.9 9.7 9.5 8.7 8.8 6.6 14.9 6.2 11.7 10.4 8.7 15.1 35.2 8.6 7.8 7.1 11.2 9.4 8.9 9.3 10.9 8.2 16.4 9.5 32.9 16.0 7.2 25.2 8.0 6.5 10.3 114.3 35.3 103.3 57.9 7.3 21.2 64.3 62.9 33.3 80.9 76.9 72.3 50.1 141.2 84.6 23.8 56.6 49.8 78.6 37.4 122.3 68.1 55.8 99.3 42.3 65.6 7.7 97.7 34.9 12.3 11.2 68.1 19.0 19.1 45.2 3.9 165.1 34.0 63.1 44.2 119.6 75.4 195.7 69.3 45.1 151.1 182.2 84.4 35.8 57.3 85.9 91.6 58.4 49.2 48.0 83.6 46.9 38.8 18.7 55.5 70.9 57.1 74.6 20.8 63.4 180.1 33.1 72.5 35.4 3.0 1.3 4.9 8.0 4.4 9.3 6.7 7.7 10.3 2.5 7.9 12.6 13.1 1.0 14.2 3.9 3.4 11.8 6.5 9.0 10.8 15.7 11.4 10.0 11.0 9.7 9.5 8.7 10.4 9.3 9.5 10.3 14.7 9.6 11.5 18.6 13.0 8.3 7.9 14.4 8.6 17.4 7.5 7.1 15.6 5.7 12.6 9.2 45.9 19.9 14.2 6.6 3.9 11.5 17.8 21.0 11.3 13.4 3.5 54.1 59.9 8.4 20.7 12.2 7.1 18.8 12.0 28.2 5.0 1.6 11.4 11.8 58.0 12.1 14.2 4.1 4.6 22.8 5.3 5.1 8.8 16.9 5.5 22.6 17.5 35.7 54.7 7.3 5.0 6.4 12.4 2.8 5.4 4.5 23.3 41.1 0.0 9.8 9.0 56.5 50.8 9.3 6.5 5.1 12.8 24.3 13.5 3.8 MAP3K1 "MAPKKK1, MEKK, MEKK1" ENSG00000095015 "Mitogen-activated protein kinase kinase kinase 1" Q13233 5 56815549-56896152 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 210.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 52.5;THP-1: 51.0" "Region enriched" "Detected in all" 6 "olfactory bulb: 18.2" "Low region specificity" "Detected in all" "CAB004500, HPA046509" Approved Approved Cytosol NA NA Cytosol "CAB004500: AB_627926, HPA046509: AB_2679678" "unprognostic (1.77e-1)" "unprognostic (1.71e-2)" "unprognostic (4.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.48e-2)" "unprognostic (5.39e-3)" "unprognostic (5.20e-3)" "unprognostic (2.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.97e-3)" "unprognostic (2.18e-2)" "unprognostic (1.58e-1)" "unprognostic (9.92e-3)" "unprognostic (1.11e-1)" 5.6 3.8 2.9 13.5 2.7 24.2 20.3 4.0 2.1 7.1 5.9 5.4 6.3 7.6 6.7 10.1 9.8 5.7 3.7 2.1 3.1 10.0 6.1 7.6 18.2 3.8 3.2 1.3 7.2 9.8 7.1 1.3 11.5 3.7 5.5 6.3 27.1 18.6 8.4 1.7 19.9 6.6 5.8 3.7 20.6 8.2 8.4 3.8 10.0 16.3 4.5 24.2 6.7 6.4 3.8 13.3 7.9 12.1 8.1 1.9 1.5 20.3 2.5 3.3 7.6 10.6 37.1 9.7 11.9 0.9 3.0 6.5 6.7 10.1 4.6 10.5 4.0 4.4 6.6 3.4 17.5 4.7 10.6 17.6 1.9 4.8 2.4 3.8 2.1 3.3 4.0 5.8 20.7 2.0 5.8 7.4 14.2 5.6 6.8 1.0 11.5 8.6 41.1 13.2 13.6 5.1 52.5 7.6 9.5 21.5 10.7 26.0 51.0 9.8 0.7 6.4 2.9 4.7 15.0 8.2 22.1 1.2 6.1 13.2 6.3 3.1 0.7 0.8 4.5 0.7 4.0 2.4 1.1 1.8 3.3 1.5 0.5 1.7 1.7 4.9 1.0 3.8 1.7 2.9 2.7 4.0 2.1 2.1 3.1 3.8 3.2 1.3 3.7 3.7 3.8 3.8 20.8 6.4 9.8 17.9 102.5 52.4 15.1 17.1 43.9 14.9 73.2 30.6 3.5 48.6 15.9 36.8 47.9 15.1 31.9 7.3 7.9 18.9 2.0 25.0 20.6 24.0 10.2 14.5 11.7 14.8 8.6 10.7 14.3 43.7 7.6 20.0 21.8 15.0 32.3 28.6 31.8 11.4 6.1 76.0 48.4 3.6 5.3 66.5 37.4 69.3 99.1 11.6 9.2 210.1 12.5 12.9 7.7 1.9 41.5 14.8 10.6 20.7 11.0 38.5 6.6 9.3 11.9 8.6 17.9 69.1 54.7 6.7 31.6 15.4 9.7 12.0 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681880 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 28.5 43.6 46.4 24.1 48.5 21.9 29.8 51.9 58.0 35.8 49.3 38.3 28.2 33.5 15.7 29.8 38.9 20.2 35.1 46.5 49.1 34.4 41.3 29.8 33.0 48.4 48.9 47.8 41.0 50.1 47.4 53.2 19.9 50.2 35.1 29.7 69.7 34.4 28.1 93.5 38.8 33.0 29.4 48.0 31.9 44.6 16.2 46.5 45.6 29.0 71.1 35.0 37.0 33.4 57.0 70.8 50.8 80.8 41.5 34.2 57.7 18.6 44.0 64.9 82.8 82.9 35.4 33.8 71.7 49.4 48.2 75.6 41.0 55.7 63.0 57.4 64.2 37.8 48.8 51.4 47.1 43.8 57.2 72.1 47.2 74.8 49.7 85.2 82.9 59.1 141.5 45.1 49.5 61.5 137.0 105.1 83.3 64.2 90.3 85.1 65.8 29.1 106.6 63.5 34.6 106.7 144.4 44.0 64.2 76.0 48.1 59.0 96.5 29.8 94.4 38.2 93.5 69.2 160.0 184.9 49.9 59.7 66.2 94.5 37.0 58.8 82.7 51.0 54.1 53.0 86.2 59.0 52.8 63.4 82.1 77.7 56.8 18.2 64.2 72.8 64.9 77.6 70.0 46.4 48.5 51.9 58.0 46.5 49.1 48.4 48.9 47.8 50.2 48.0 46.5 57.0 40.3 41.7 30.7 10.1 54.8 55.6 79.2 93.0 38.7 75.8 48.3 64.5 8.6 37.1 49.1 33.1 45.9 47.1 52.2 35.2 86.1 53.7 20.9 38.2 24.5 35.0 41.3 26.7 11.9 37.6 55.1 35.0 33.6 27.9 24.1 46.0 30.4 34.6 42.8 42.1 12.5 60.8 79.3 37.6 42.5 27.5 45.1 35.3 49.8 6.5 62.7 115.2 53.5 8.0 14.7 48.7 70.1 34.6 51.1 73.3 87.9 84.1 49.6 129.2 46.0 39.6 53.8 33.3 62.3 39.7 51.0 71.8 51.1 37.4 54.3 71.0 HOOK2 HK2 ENSG00000095066 "Hook microtubule tethering protein 2" Q96ED9 19 12763003-12872740 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 291.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 83.7;RT4: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043519, HPA050351" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043519: AB_2678525, HPA050351: AB_2681102" "unprognostic (4.26e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "unprognostic (1.16e-1)" "unprognostic (4.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.25e-3)" "unprognostic (3.06e-2)" "unprognostic (2.52e-2)" "unprognostic (1.75e-3)" "prognostic unfavorable (7.59e-5)" "prognostic favorable (3.28e-4)" "unprognostic (3.27e-3)" "unprognostic (5.74e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-2)" 38.6 20.8 14.5 10.4 14.0 4.1 46.2 14.6 21.1 30.0 13.1 27.5 52.4 15.2 47.2 56.0 27.2 21.1 42.7 13.8 14.1 52.2 47.2 24.2 7.1 14.2 13.5 14.6 25.1 99.0 38.7 114.7 14.3 15.0 53.5 25.2 13.5 59.8 27.1 71.3 55.1 43.5 10.8 11.3 18.1 42.1 24.9 13.6 7.6 97.0 34.3 13.4 25.3 39.6 14.7 38.5 9.7 11.3 8.0 12.5 11.5 40.5 11.9 5.6 6.5 8.3 33.3 44.2 7.5 20.8 11.5 5.7 48.6 12.0 34.3 6.8 19.7 8.8 7.5 21.1 11.0 5.9 4.2 10.2 14.0 32.4 8.3 13.4 15.0 3.9 14.6 12.6 5.7 13.6 83.7 4.3 7.8 4.8 24.9 10.2 12.1 7.1 18.6 13.4 100.5 28.1 14.5 8.7 25.7 7.3 11.5 35.3 9.1 7.2 12.6 8.5 19.7 4.2 20.6 23.9 4.5 13.4 14.2 9.3 0.2 0.8 0.0 1.4 1.3 0.9 1.7 1.8 0.6 1.3 1.2 3.0 1.9 1.0 1.3 0.8 0.6 0.4 1.1 14.5 14.0 14.6 21.1 13.8 14.1 14.2 13.5 14.6 15.0 11.3 13.6 14.7 14.8 19.2 38.0 25.1 34.4 50.5 99.8 135.0 158.8 117.7 84.4 62.9 29.6 75.8 84.5 82.8 100.1 85.0 11.9 137.2 43.0 77.5 9.2 26.2 21.0 18.6 63.0 11.1 28.9 45.4 40.2 24.2 140.2 39.3 12.6 30.7 22.1 24.4 16.6 63.9 43.3 93.9 118.0 11.1 21.6 9.1 27.1 20.4 28.4 6.5 19.7 26.6 10.3 17.1 10.6 46.7 98.0 26.7 30.1 131.6 291.7 45.4 49.3 84.5 13.1 24.5 25.4 73.9 26.1 82.1 65.5 128.1 27.9 42.1 95.6 87.1 NXPE1 "FAM55A, MGC34290" ENSG00000095110 "Neurexophilin and PC-esterase domain family member 1" Q8N323 11 114521645-114559895 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "intestine: 80.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 27.0;Early spermatids: 73.6;Intestinal goblet cells: 35.1;Late spermatids: 53.5;Paneth cells: 18.1;Undifferentiated cells: 36.2" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049133 Enhanced "Intracellular and membrane" NA NA "HPA049133: AB_2680647" "unprognostic (2.81e-1)" "unprognostic (2.19e-3)" "unprognostic (3.40e-3)" "unprognostic (4.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.2 4.9 0.2 0.0 0.1 0.1 0.4 0.0 0.0 65.5 1.3 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 80.4 0.0 1.2 0.0 0.0 0.0 3.5 2.3 0.1 0.0 0.1 4.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.1 0.3 0.4 0.2 0.0 0.5 0.1 0.2 0.4 0.0 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 73.6 0.0 0.0 0.0 3.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 35.1 0.0 0.0 0.0 53.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 18.1 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 36.2 0.1 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 140000 Vesicles "Golgi apparatus, Cytosol" "HPA037573: AB_10696938, HPA044874: AB_2679126" "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 74.6 68.2 50.1 54.3 52.9 30.7 68.1 54.6 61.0 78.7 62.7 65.6 59.7 69.8 112.1 73.1 61.0 52.0 74.2 50.0 55.4 58.8 92.4 63.1 53.7 53.9 51.7 47.6 66.1 120.7 62.4 89.4 55.1 53.9 69.4 67.8 39.6 80.3 65.1 51.6 60.1 65.4 71.6 52.6 58.4 72.3 46.6 52.9 59.4 65.7 55.5 62.7 67.0 61.5 59.3 90.9 72.6 135.3 98.9 174.0 172.7 66.6 244.8 208.5 102.4 120.7 239.4 116.6 96.4 199.7 275.7 148.0 123.7 160.5 139.5 151.5 128.0 66.3 211.6 56.7 151.4 197.1 140.4 121.8 157.8 117.6 175.0 168.7 149.3 162.2 95.0 106.8 139.2 201.3 157.0 123.2 130.8 85.3 207.7 92.4 107.9 134.2 147.4 137.3 107.0 88.3 86.6 130.2 129.0 70.1 132.5 155.9 111.4 144.0 129.4 65.1 118.4 109.5 79.9 78.5 147.6 74.3 122.6 161.4 118.1 49.8 50.7 52.7 59.8 69.0 39.5 51.7 51.3 54.0 35.4 48.0 44.7 41.5 64.5 64.5 44.9 53.9 55.8 50.1 52.9 54.6 61.0 50.0 55.4 53.9 51.7 47.6 53.9 52.6 52.9 59.3 43.6 35.3 47.9 12.4 32.2 31.6 38.5 31.5 23.9 22.4 39.4 27.9 46.5 24.3 41.9 31.3 4.2 17.2 45.6 68.4 9.8 34.3 11.1 38.4 72.2 43.1 40.2 14.9 15.4 37.8 36.1 44.9 39.3 50.4 39.3 31.9 31.4 55.7 30.3 18.5 17.7 80.2 22.4 36.0 37.6 8.5 48.1 35.3 23.2 11.2 49.0 17.3 26.8 17.1 20.2 46.9 35.8 41.3 68.3 51.5 56.2 30.5 46.2 13.6 19.7 52.7 45.7 44.8 47.6 30.4 34.7 30.2 38.4 43.9 42.6 51.6 EPB41L4B "EHM2, LULU2" ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171974-109321059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 89.6;pancreas: 150.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 21.2 9.8 7.0 4.5 9.8 0.0 15.4 2.9 12.2 4.2 10.6 58.2 48.0 1.2 18.1 1.5 10.9 4.3 7.0 10.1 8.7 6.4 89.6 6.3 0.2 3.7 5.5 11.1 14.0 150.3 11.2 1.6 2.6 4.7 7.6 57.3 3.0 27.2 9.2 6.2 15.5 52.3 1.9 3.7 0.1 30.8 7.6 9.2 0.6 45.1 0.7 1.7 2.2 3.5 7.2 8.7 10.8 0.7 0.8 0.8 0.0 31.7 1.1 0.4 3.7 1.9 18.5 8.5 0.0 2.3 1.0 8.9 13.9 21.5 11.5 3.9 9.2 5.1 0.0 3.4 26.5 2.2 0.4 0.0 0.3 49.8 1.5 17.0 1.1 0.2 8.0 0.3 0.0 5.2 22.3 0.4 0.2 13.8 62.8 15.7 0.0 0.0 0.6 12.9 13.1 13.1 1.4 3.4 22.2 0.0 6.3 5.2 0.1 0.5 7.5 7.6 2.5 3.1 0.1 0.1 0.0 5.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 9.8 2.9 12.2 10.1 8.7 3.7 5.5 11.1 4.7 3.7 9.2 7.2 0.2 6.4 5.1 2.6 0.4 11.5 5.4 6.0 1.2 7.5 22.7 10.4 18.5 20.0 9.6 7.3 0.0 4.1 0.0 134.8 0.0 3.5 11.7 23.8 2.3 0.8 51.6 0.0 79.7 20.8 2.1 2.5 26.0 20.7 0.0 6.2 5.0 125.2 0.6 38.7 58.9 51.4 12.2 1.6 1.5 1.9 13.4 0.4 1.8 3.7 0.0 1.9 0.0 12.1 3.8 10.2 54.4 2.6 0.0 7.2 79.2 0.8 39.2 1.1 0.0 0.8 1.0 1.4 17.2 0.9 24.0 1.9 0.5 6.8 46.5 6.5 TMEM38B "bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B" ENSG00000095209 "Transmembrane protein 38B" Q9NVV0 9 105694541-105776629 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.1;tongue: 62.6" "Cell type enhanced" "Detected in many" "Early spermatids: 267.0;Late spermatids: 488.4;Spermatocytes: 157.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018465 Uncertain NA NA "HPA018465: AB_1858116" "unprognostic (3.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (2.68e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-2)" "unprognostic (3.11e-3)" "unprognostic (1.88e-2)" "unprognostic (3.54e-2)" "unprognostic (5.82e-3)" "unprognostic (5.80e-2)" "prognostic favorable (7.96e-4)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (3.89e-3)" "unprognostic (9.98e-2)" 7.7 14.1 7.7 7.2 11.7 19.3 4.7 20.0 10.5 7.6 6.7 12.6 6.4 8.4 17.4 7.2 7.2 6.9 30.9 7.8 10.0 29.5 15.4 5.8 8.2 8.3 9.2 6.5 18.5 5.0 9.3 5.9 4.7 11.6 8.1 11.9 10.5 4.0 6.9 78.1 6.0 10.8 8.2 5.8 6.3 6.8 28.9 9.5 4.9 29.0 62.6 5.2 5.0 4.1 20.4 16.7 25.6 19.6 30.9 110.5 24.3 40.8 23.4 15.3 22.6 23.3 40.0 22.5 38.4 11.8 8.5 36.4 11.6 28.4 13.5 24.4 29.0 37.8 15.8 16.2 24.7 15.1 48.1 32.7 23.0 11.8 15.5 21.6 7.1 9.1 26.6 84.3 33.2 14.0 46.4 33.6 14.5 15.1 48.7 27.1 22.3 61.4 18.4 10.3 13.2 34.1 8.3 24.2 39.4 17.9 13.0 49.2 33.5 4.9 20.5 20.2 78.9 24.7 40.7 109.8 19.1 38.2 52.2 41.7 15.6 20.2 53.8 13.2 29.6 17.7 56.6 18.3 15.8 23.3 56.6 38.9 24.9 3.1 28.2 26.8 51.7 18.0 24.2 7.7 11.7 20.0 10.5 7.8 10.0 8.3 9.2 6.5 11.6 5.8 9.5 20.4 9.2 0.0 2.7 7.5 27.8 30.3 24.9 6.2 15.9 12.9 8.9 3.9 55.5 15.7 8.4 25.8 29.2 12.0 16.4 19.1 66.5 8.9 267.0 2.2 7.2 9.9 31.8 7.2 12.4 6.9 19.0 24.2 9.2 3.0 15.8 11.3 3.6 24.4 30.9 11.8 28.6 12.9 18.3 7.9 33.2 488.4 85.1 21.4 32.0 6.5 18.3 30.6 3.1 65.4 30.6 6.3 12.2 44.8 20.2 55.1 10.9 47.0 7.6 12.3 118.3 18.2 58.1 157.8 47.6 13.0 32.7 21.2 13.8 39.7 19.0 20.2 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842951 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol No No 250000 Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 15.1 16.7 9.5 13.5 9.4 20.6 23.6 12.5 9.9 16.0 9.2 14.6 12.7 16.5 14.0 16.7 14.2 12.6 9.4 8.9 11.0 13.6 20.7 14.7 16.0 9.6 9.2 8.4 15.3 14.4 10.8 9.9 12.8 10.0 18.2 14.4 11.8 18.0 14.4 9.2 19.9 12.6 18.8 9.8 12.1 14.4 13.9 10.5 14.7 14.4 11.3 19.2 17.3 12.2 13.2 35.0 44.3 20.7 38.6 44.9 44.1 24.4 49.4 38.1 45.3 41.5 38.7 21.7 35.4 22.1 50.2 36.1 50.5 0.0 48.9 52.5 33.1 5.3 29.7 59.2 21.6 33.9 10.2 10.6 37.3 30.6 44.2 47.4 22.7 26.9 37.7 110.2 22.6 42.8 42.9 31.5 21.0 30.6 82.6 31.4 28.0 45.0 28.0 42.1 30.0 28.8 18.3 61.8 50.2 24.7 15.2 60.5 24.5 41.5 0.1 25.0 19.3 45.3 13.0 14.8 38.0 28.6 33.4 41.1 19.3 18.1 15.6 19.8 20.9 21.6 22.2 22.7 23.9 17.7 17.8 21.9 16.9 9.7 18.7 23.7 12.7 32.7 18.1 9.5 9.4 12.5 9.9 8.9 11.0 9.6 9.2 8.4 10.0 9.8 10.5 13.2 14.3 9.6 17.0 20.2 16.7 12.4 11.8 11.7 21.1 11.6 18.9 13.5 8.1 11.5 17.5 9.2 12.5 12.1 15.3 13.6 11.7 12.9 7.7 8.1 20.6 13.7 7.8 17.2 28.4 13.4 11.7 18.4 14.8 11.9 14.5 11.8 17.2 24.9 11.8 5.0 24.5 14.1 8.2 16.1 13.9 4.7 13.1 12.7 14.2 15.0 12.3 9.9 10.3 34.2 29.0 17.1 10.1 16.1 16.0 14.1 10.5 16.8 8.1 10.3 6.6 11.7 16.3 22.4 21.3 27.0 13.5 10.9 17.3 17.7 11.0 9.7 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 153.7;urinary bladder: 176.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 28.9" "Group enriched" "Detected in many" 6 "dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1" "Cell line enhanced" "Detected in many" "ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.35e-4)" 8.1 3.0 2.4 10.6 2.8 9.1 6.8 3.9 6.0 4.1 9.6 72.7 10.9 6.2 2.3 67.9 43.6 9.7 9.0 6.8 4.2 9.4 3.0 11.4 4.6 5.3 4.3 1.1 2.0 1.8 2.1 4.9 2.3 5.9 21.3 24.4 0.7 4.3 6.2 2.1 153.7 17.9 16.3 7.9 8.1 20.7 0.9 4.8 2.2 3.3 4.1 11.7 176.4 16.0 7.3 0.3 0.5 0.4 0.0 113.7 89.5 0.0 115.2 156.0 1.0 1.1 0.0 0.2 4.2 5.4 19.7 0.3 7.1 0.4 10.5 0.9 0.0 0.2 73.6 0.6 0.0 32.9 5.2 298.4 46.1 1.2 5.7 0.3 0.0 42.3 0.1 0.1 0.3 2.3 0.0 0.2 6.6 1.6 0.0 0.5 0.3 1.4 8.6 14.7 0.0 0.5 0.6 0.6 9.5 0.2 0.5 0.3 8.4 1.0 0.7 0.6 1.7 0.1 0.3 0.2 0.0 0.4 31.6 0.3 28.9 12.1 23.3 0.0 13.1 0.0 2.4 0.0 0.0 20.0 3.5 0.1 0.0 5.2 2.8 10.2 1.4 0.2 21.9 2.4 2.8 3.9 6.0 6.8 4.2 5.3 4.3 1.1 5.9 7.9 4.8 7.3 0.9 0.0 6.6 0.0 5.9 9.9 2.6 7.7 0.0 0.1 1.1 1.4 1.6 4.3 2.2 42.3 0.0 0.1 0.2 0.1 0.0 0.6 0.1 109.9 10.4 24.7 1.8 18.7 0.8 0.5 0.3 10.7 2.0 191.9 208.0 0.1 61.8 0.8 26.1 0.0 0.5 0.6 4.1 15.5 20.7 0.3 1.5 55.3 3.6 16.9 11.7 0.0 7.2 1.0 0.1 0.6 0.6 0.0 0.3 2.8 0.0 0.0 0.8 0.1 0.0 1.4 3.6 0.0 0.2 18.2 58.7 0.4 3.4 0.1 1.0 0.8 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Cataract, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Spermatocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 12.9 15.6 9.2 16.3 9.6 21.5 12.0 12.0 9.9 14.4 8.6 13.7 7.5 13.2 8.1 23.9 12.0 9.5 13.4 7.9 12.8 9.0 9.9 16.8 18.2 10.2 10.1 7.1 11.5 12.1 13.2 15.0 11.9 10.3 13.6 11.6 13.8 14.0 9.9 15.9 21.6 13.6 14.0 8.8 16.9 13.8 57.1 9.9 27.6 12.7 10.4 20.6 16.2 15.7 10.8 33.6 62.6 50.8 69.7 37.7 37.2 45.4 45.9 35.9 82.1 54.4 76.3 26.2 58.2 16.7 50.7 52.9 96.6 115.2 56.8 61.0 47.1 55.5 51.9 113.3 60.8 23.9 89.6 50.2 26.0 26.3 86.5 43.8 24.1 47.8 74.1 116.0 40.3 58.8 84.6 77.3 36.5 68.2 63.8 59.4 69.9 109.8 59.2 25.5 37.3 71.2 34.3 118.8 44.7 17.1 37.2 49.3 32.7 39.0 67.7 48.2 69.2 83.5 34.1 67.9 76.9 39.5 56.3 51.2 8.2 4.8 1.7 7.5 8.9 9.7 4.9 6.4 7.4 6.8 4.3 6.4 7.0 0.6 5.4 5.2 2.9 8.3 6.8 9.2 9.6 12.0 9.9 7.9 12.8 10.2 10.1 7.1 10.3 8.8 9.9 10.8 9.6 0.0 12.6 15.7 10.4 6.5 6.6 6.4 5.7 16.2 7.6 7.6 3.5 10.0 5.9 5.5 45.9 8.0 8.6 6.0 1.9 6.1 14.5 7.9 13.2 9.4 9.1 8.6 11.3 6.5 6.5 9.5 9.7 12.2 6.3 24.0 11.0 5.0 8.4 20.2 13.1 7.2 6.1 4.7 6.1 5.7 9.6 8.1 1.8 12.2 5.3 6.8 9.2 12.5 13.0 9.0 2.3 11.7 8.3 10.1 3.3 2.5 6.3 24.4 26.3 18.2 7.1 52.9 37.8 13.6 11.2 8.6 9.4 12.5 7.4 8.2 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094142-129111189 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 229.4;tongue: 203.1" "Cell type enhanced" "Detected in many" "Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 8100 "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favorable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 34.2 51.7 23.1 5.4 21.3 9.1 29.4 22.8 34.0 29.2 21.6 35.4 33.3 25.0 4.0 37.6 23.3 6.6 59.6 21.3 23.4 46.3 152.4 15.3 3.2 24.5 24.3 20.3 23.2 108.0 26.6 12.4 6.6 24.3 42.6 4.3 1.7 33.1 9.0 229.4 23.6 37.5 6.9 21.2 15.3 34.3 147.5 25.4 3.1 21.6 203.1 1.6 31.6 27.7 21.7 0.1 39.3 10.7 21.3 13.4 25.9 17.0 15.0 16.6 18.9 12.0 7.8 14.0 1.5 9.2 25.9 23.2 6.7 2.2 4.9 7.2 23.6 0.3 7.3 19.1 30.4 34.1 0.0 26.1 26.3 0.0 15.7 0.9 15.8 26.2 7.2 3.6 5.7 20.0 9.1 0.5 15.9 2.8 32.0 18.0 16.8 21.8 12.2 18.0 0.6 4.2 12.1 0.0 7.1 4.8 3.4 49.7 5.5 22.6 23.0 1.6 32.1 15.4 25.5 22.6 0.1 28.8 4.2 16.8 1.6 8.4 3.5 3.2 5.5 6.7 1.5 4.4 4.3 8.6 1.3 2.6 3.1 1.1 4.4 5.6 3.9 4.5 6.1 23.1 21.3 22.8 34.0 21.3 23.4 24.5 24.3 20.3 24.3 21.2 25.4 21.7 10.5 6.4 3.7 5.5 4.9 3.2 4.7 10.8 0.6 1.5 9.7 8.1 57.8 21.5 8.2 3.7 2.1 45.9 6.0 64.5 17.6 22.6 181.2 3.5 15.7 12.9 15.5 17.4 5.3 22.4 55.6 19.3 16.8 9.9 7.0 12.9 14.6 65.7 20.7 1.7 6.1 23.6 14.2 13.9 10.5 521.8 22.1 12.4 5.4 6.5 8.3 15.5 6.2 3.5 4.0 11.6 47.6 24.5 9.6 9.3 136.4 52.0 2.8 1.3 6.6 10.5 15.7 123.5 8.6 57.4 4.5 50.3 7.6 20.1 29.3 13.8 SH2D3C NSP3 ENSG00000095370 "SH2 domain containing 3C" Q8N5H7 9 127738317-127778710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 52.6" "Cell type enhanced" "Detected in many" "Adipocytes: 52.6;dendritic cells: 29.7;Endothelial cells: 52.2;Hepatic stellate cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 53.3;HUVEC TERT2: 60.0;REH: 60.7;RPMI-8226: 46.1;TIME: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047586 Enhanced Supported Cytosol NA NA Cytosol "HPA047586: AB_2680093" "unprognostic (8.33e-2)" "unprognostic (4.77e-3)" "unprognostic (3.28e-2)" "prognostic favorable (9.47e-4)" "unprognostic (5.23e-2)" "prognostic favorable (1.98e-4)" "unprognostic (3.75e-2)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (2.58e-3)" "unprognostic (1.61e-1)" "unprognostic (1.88e-3)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (5.28e-2)" 27.3 7.6 10.0 16.0 8.4 11.3 25.1 9.6 13.3 12.0 2.0 7.2 4.5 15.9 1.2 5.8 12.7 9.3 30.5 9.1 7.7 14.6 4.7 52.6 26.0 7.4 6.7 8.7 5.1 4.9 3.9 7.2 15.9 7.8 8.6 1.9 0.8 6.9 3.5 14.7 7.1 15.3 7.3 5.9 47.6 7.4 5.1 7.8 28.0 23.1 11.5 10.6 11.0 9.5 8.3 0.1 0.2 0.9 0.2 0.8 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 19.5 1.1 0.0 1.1 0.7 0.0 0.0 0.0 15.6 0.3 7.3 0.1 0.0 0.3 5.6 53.3 0.3 0.2 0.3 0.1 0.0 60.0 11.6 0.2 20.6 0.0 0.1 5.1 16.8 0.8 0.0 0.0 60.7 0.9 46.1 0.0 0.0 14.5 4.4 0.3 0.1 0.0 1.4 0.1 9.6 50.1 0.0 1.2 0.1 0.1 20.3 22.2 20.3 0.4 4.8 0.0 34.0 29.9 37.8 32.3 94.7 26.4 26.2 18.8 30.4 32.8 29.5 16.6 17.5 82.2 34.6 124.8 59.8 21.6 34.2 10.0 8.4 9.6 13.3 9.1 7.7 7.4 6.7 8.7 7.8 5.9 7.8 8.3 52.6 3.2 5.8 0.7 15.9 1.3 0.3 1.9 0.6 3.2 1.1 1.7 10.5 2.8 0.9 0.0 0.0 0.3 29.7 0.0 0.0 0.5 13.8 2.2 2.8 52.2 4.2 3.6 10.8 0.0 0.2 3.1 2.0 0.8 11.4 0.0 41.7 0.7 6.0 3.3 10.7 0.3 0.0 6.0 3.7 16.3 1.2 10.7 1.8 23.4 13.4 3.6 21.6 3.0 0.7 0.1 0.0 0.7 7.6 0.1 0.0 0.1 0.8 2.4 6.6 1.2 12.5 1.8 1.5 0.9 0.4 0.7 15.5 2.0 0.1 0.2 NANS SAS ENSG00000095380 "N-acetylneuraminate synthase" Q9NR45 9 98056732-98083077 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Intestinal goblet cells: 362.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019223 Approved Enhanced Nucleoplasm No No 410000 Nucleoplasm "HPA019223: AB_1854298" "unprognostic (2.95e-1)" "unprognostic (5.10e-3)" "unprognostic (2.24e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (2.08e-1)" "unprognostic (7.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-2)" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (7.36e-2)" "unprognostic (3.62e-3)" "unprognostic (1.79e-1)" 35.5 29.1 16.2 49.8 15.3 68.4 36.8 14.2 18.4 50.3 28.9 130.3 52.6 28.7 33.8 51.8 29.6 34.5 41.3 15.1 16.1 31.5 67.5 46.3 60.0 16.6 17.1 14.3 26.5 68.2 20.6 42.9 31.9 17.7 107.3 130.4 8.4 121.1 19.9 34.5 28.7 48.2 29.3 14.9 53.8 76.8 27.4 19.2 19.0 27.5 17.5 61.0 48.0 41.9 17.7 387.9 111.8 32.5 94.5 64.0 68.8 70.5 120.9 93.7 96.3 78.3 134.8 53.6 118.1 57.2 133.3 101.9 134.1 61.0 103.6 80.0 95.7 91.0 70.3 128.4 271.9 176.3 80.3 55.3 58.4 69.1 102.9 116.4 111.8 104.3 57.9 129.9 119.8 71.2 265.0 54.1 114.9 56.2 277.5 143.3 103.4 89.0 121.5 78.2 116.6 65.7 34.4 77.8 414.4 107.2 35.8 137.6 85.3 274.2 74.8 72.5 193.4 125.8 110.7 99.3 45.7 88.4 95.9 59.6 30.9 190.9 29.5 34.9 237.6 53.4 55.6 45.5 36.8 194.7 54.9 48.8 33.7 77.4 38.9 217.0 178.8 58.3 91.4 16.2 15.3 14.2 18.4 15.1 16.1 16.6 17.1 14.3 17.7 14.9 19.2 17.7 46.7 28.9 54.9 3.6 57.0 70.1 134.0 183.0 30.7 11.4 61.6 45.5 25.3 42.9 206.3 22.0 18.8 86.7 50.2 234.3 70.5 49.4 42.8 63.4 37.9 63.4 64.9 18.7 6.7 100.7 159.2 50.6 99.4 55.8 43.8 29.5 34.2 33.6 160.0 10.1 7.2 362.7 95.6 67.7 107.6 71.5 32.3 89.8 129.9 6.5 53.1 14.1 14.4 2.0 3.1 70.9 181.0 26.4 141.1 213.6 66.5 68.3 204.5 8.0 13.1 32.9 91.3 10.5 21.9 42.0 61.7 150.8 50.6 44.6 260.1 223.3 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98199011-98255649 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 27.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 77.0;HaCaT: 98.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030871, HPA076521" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Plasma membrane, Cytosol" "HPA030871: AB_10670046, HPA076521: " "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 8.0 5.3 11.4 5.7 14.9 13.2 7.9 11.6 23.2 8.7 9.2 6.9 12.7 4.4 1.5 37.7 5.5 4.1 3.5 9.7 15.1 6.3 20.0 32.3 3.9 14.5 14.4 8.3 2.9 3.0 3.6 4.4 7.3 17.9 12.1 4.5 3.4 14.9 6.2 4.3 24.3 10.2 2.9 12.5 9.5 7.0 3.4 19.4 3.0 8.2 1.4 5.0 11.8 17.5 22.4 77.0 10.8 0.5 2.5 8.2 15.9 24.3 33.2 18.4 23.8 19.6 6.9 32.8 1.3 24.7 19.6 5.2 98.1 0.7 36.8 8.3 2.6 1.4 0.7 38.0 5.4 37.6 1.7 2.9 21.7 59.8 23.6 58.7 41.5 8.6 2.1 2.4 1.0 19.0 9.9 0.4 4.6 1.6 7.4 6.2 1.2 4.8 0.2 36.0 46.7 0.9 1.4 11.3 24.4 3.4 1.7 8.1 2.6 51.7 28.8 8.6 4.8 13.6 1.6 1.5 0.6 29.0 2.9 3.2 2.1 27.5 8.4 2.5 15.3 1.8 1.2 3.8 2.2 10.0 0.8 1.6 1.9 11.9 1.2 12.3 1.3 5.5 10.8 11.4 14.9 11.6 23.2 9.7 15.1 14.5 14.4 8.3 17.9 12.5 19.4 22.4 2.9 57.7 12.5 5.2 2.4 8.3 18.5 30.4 21.6 3.3 2.7 5.6 0.7 4.3 23.3 3.7 0.0 21.5 0.9 16.2 3.9 3.3 1.8 4.6 3.7 5.0 7.7 0.4 4.6 3.2 10.9 2.4 6.1 10.3 0.0 0.6 1.1 6.1 32.0 1.7 5.4 12.6 18.3 16.2 1.8 1.2 1.8 18.3 3.6 4.7 7.5 4.4 3.1 12.1 64.9 14.4 10.7 0.7 1.7 9.2 16.4 3.2 10.8 2.4 0.0 1.8 3.4 2.1 3.0 29.8 10.9 17.4 2.4 0.7 5.7 17.1 WHRN "CIP98, DFNB31, PDZD7B, USH2D" ENSG00000095397 Whirlin Q9P202 9 114402080-114505473 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 105.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 49.5;Endometrial stromal cells: 13.9;Glandular and luminal cells: 39.6;Plasma cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 97.9;U-266/70: 67.8;U-266/84: 89.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.06e-3)" "unprognostic (1.02e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-3)" "unprognostic (4.59e-1)" "unprognostic (7.07e-2)" "unprognostic (3.66e-2)" "unprognostic (7.25e-2)" "unprognostic (6.13e-3)" "unprognostic (3.43e-2)" "prognostic favorable (2.28e-4)" "unprognostic (1.03e-1)" "unprognostic (1.71e-3)" "unprognostic (3.21e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-2)" "unprognostic (3.44e-1)" 4.5 105.5 25.8 2.3 29.9 2.6 6.0 20.7 23.1 15.4 37.0 10.0 3.8 36.7 4.1 5.7 11.6 2.3 4.6 19.1 24.2 8.0 4.8 5.1 2.8 36.0 29.2 12.0 20.7 14.3 7.1 37.0 1.8 34.1 14.0 1.2 12.5 8.8 4.0 0.5 8.8 8.9 6.4 20.3 20.9 7.9 50.5 28.3 8.7 10.2 0.2 0.9 6.5 7.2 57.3 2.0 2.0 2.4 11.3 1.1 0.5 5.2 1.0 1.9 1.5 0.9 1.0 0.9 0.0 3.0 1.2 16.2 5.3 0.6 1.3 0.4 31.0 7.1 0.0 23.4 3.1 0.6 0.2 0.6 1.0 4.9 5.3 0.4 6.9 0.1 2.6 9.6 97.9 1.4 14.7 0.2 0.3 4.7 0.1 18.1 1.6 0.0 32.3 3.8 0.6 14.9 1.1 6.8 10.2 29.7 3.2 8.0 0.3 1.6 3.4 2.2 4.3 5.6 67.8 89.6 0.7 2.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 25.8 29.9 20.7 23.1 19.1 24.2 36.0 29.2 12.0 34.1 20.3 28.3 57.3 1.1 0.0 0.6 0.0 5.2 0.0 0.0 0.0 0.0 0.0 9.2 10.3 0.0 0.0 1.3 0.0 0.0 2.9 10.2 0.0 0.0 1.7 0.0 49.5 13.9 0.7 0.0 0.0 0.0 2.0 2.0 2.0 0.0 39.6 2.5 4.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 14.3 0.0 0.0 1.3 8.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.2 7.8 7.1 0.0 0.0 PDE6C "ACHM5, COD4, PDEA2" ENSG00000095464 "Phosphodiesterase 6C" P51160 10 93612537-93666010 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "retina: 23.3" "Cell type enriched" "Detected in some" 13 "Cone photoreceptor cells: 56.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.61e-2)" "unprognostic (2.24e-1)" "unprognostic (3.17e-2)" "unprognostic (5.23e-3)" "unprognostic (2.46e-3)" "unprognostic (2.81e-3)" "unprognostic (9.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.51e-2)" "unprognostic (2.96e-3)" "unprognostic (2.19e-7)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (1.81e-1)" "unprognostic (1.80e-3)" 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.8 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.0 23.3 0.1 0.0 0.5 0.5 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like cell cycle control factor 1" Q69YN2 10 100232298-100267680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 7.8 7.0 5.6 11.5 6.1 18.9 11.7 7.3 7.7 7.8 5.2 7.3 6.9 8.3 5.7 7.0 8.8 6.7 7.5 5.8 6.2 7.9 8.3 7.5 16.5 5.8 6.4 5.8 10.4 8.1 9.1 6.1 9.0 6.1 6.9 8.7 10.4 8.7 6.6 10.2 11.3 8.2 9.3 6.1 11.9 6.7 14.4 5.9 14.9 8.2 10.3 17.0 8.6 6.6 8.2 29.1 18.8 18.7 29.2 9.1 10.8 20.7 17.2 23.8 37.5 30.6 21.5 22.6 30.5 19.4 16.6 16.3 27.9 42.2 24.9 39.6 19.4 20.8 17.5 15.8 20.6 15.8 44.7 19.6 15.2 10.4 28.0 26.2 14.2 26.6 30.8 20.7 26.8 21.9 18.3 36.2 32.4 14.7 15.0 23.2 12.6 29.2 21.2 15.0 16.5 9.4 16.8 20.6 10.3 26.0 12.6 37.3 19.1 18.6 15.8 21.5 18.3 32.8 23.9 29.6 17.9 20.1 39.1 11.4 10.0 17.0 22.7 12.8 15.9 16.3 14.0 13.3 14.4 14.9 13.0 14.9 15.0 9.6 18.1 14.7 6.8 17.7 13.8 5.6 6.1 7.3 7.7 5.8 6.2 5.8 6.4 5.8 6.1 6.1 5.9 8.2 8.0 19.2 10.8 14.0 16.2 4.5 7.7 6.8 4.6 9.5 4.8 3.9 8.0 5.7 11.3 5.5 4.2 10.4 13.5 4.3 7.9 6.0 23.6 6.8 6.4 8.3 4.2 11.2 26.8 7.7 11.0 6.7 4.6 6.3 17.7 8.3 7.5 5.9 9.5 10.1 24.3 4.2 10.2 13.1 5.7 5.3 6.8 11.3 8.8 14.0 15.5 5.1 19.6 18.6 24.0 7.2 6.7 4.1 11.3 5.3 4.5 6.2 12.5 12.3 0.0 8.4 6.9 18.4 12.2 5.8 7.7 10.9 12.8 6.7 5.3 4.4 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 85.4;liver: 103.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA 1300000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 2.1 12.8 13.0 5.9 10.7 0.4 3.7 17.8 12.4 6.4 11.6 54.1 53.9 3.5 32.4 3.6 5.9 9.1 2.5 10.0 11.2 18.9 103.2 5.8 2.5 10.9 14.3 9.9 19.0 31.6 7.4 10.0 3.9 12.8 20.4 85.4 7.3 8.6 3.0 2.6 16.2 41.5 4.6 8.6 3.2 21.1 3.7 16.4 0.8 15.4 0.8 0.9 4.1 5.1 10.5 0.2 31.7 8.0 3.4 5.0 1.6 6.8 1.2 3.4 1.7 1.7 30.5 5.2 0.5 4.2 1.5 0.6 2.1 8.0 1.4 1.4 0.7 4.9 1.7 3.0 113.8 12.5 1.2 1.0 8.3 1.8 1.6 0.9 22.2 4.4 3.5 3.3 0.4 2.5 2.0 0.5 1.2 1.3 69.1 1.8 3.1 0.7 1.5 7.4 1.0 2.5 12.5 1.1 2.1 3.2 8.7 8.7 1.5 3.0 1.0 3.7 0.8 0.3 1.1 0.6 0.5 0.9 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 10.7 17.8 12.4 10.0 11.2 10.9 14.3 9.9 12.8 8.6 16.4 10.5 0.3 3.2 1.1 3.9 1.2 0.0 0.6 0.7 0.6 3.5 2.5 2.0 1.2 20.0 0.2 0.0 0.0 8.8 0.0 66.4 0.0 2.7 0.2 1.6 0.7 0.6 8.5 0.8 3.0 2.6 1.9 2.0 27.0 0.3 0.0 3.4 2.2 60.5 0.9 11.8 14.1 34.6 2.0 3.3 0.0 0.2 2.1 0.2 1.8 0.0 0.0 0.9 0.0 3.5 5.5 2.4 38.5 1.2 0.2 3.0 47.6 6.4 2.4 1.6 0.0 0.1 0.4 1.1 1.9 0.5 0.1 2.9 0.2 12.7 45.9 0.9 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923770-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA070682: AB_2686294" "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 18.3 13.3 5.4 20.3 7.7 32.4 19.4 8.9 8.8 18.4 6.4 18.7 16.3 20.9 21.3 17.3 23.6 15.3 12.9 6.2 9.3 11.9 15.5 19.3 32.3 6.9 6.3 5.3 25.6 18.3 14.9 13.4 13.8 6.9 16.9 16.1 34.6 19.3 12.9 14.9 50.8 22.2 14.1 5.9 22.1 18.6 18.0 6.0 21.9 17.4 9.2 25.7 20.3 20.1 10.8 28.9 13.8 31.7 38.7 16.5 25.8 15.8 16.5 19.6 16.0 23.7 19.1 17.2 30.8 10.3 16.3 9.9 30.4 21.5 14.6 23.8 21.2 23.2 21.9 35.7 20.0 16.8 33.3 22.0 18.4 18.5 24.3 35.1 34.3 15.6 25.9 18.2 34.5 16.6 12.6 25.8 21.0 14.4 8.3 10.8 20.6 19.7 14.5 14.9 17.5 12.2 14.3 15.8 8.0 20.3 20.8 16.2 21.9 16.9 14.3 11.4 19.5 23.7 39.7 19.6 24.9 22.4 30.1 3.8 4.4 2.7 1.5 2.5 1.9 2.2 2.5 1.9 1.8 2.1 3.1 2.3 1.8 1.9 2.2 3.6 4.9 1.6 1.4 5.4 7.7 8.9 8.8 6.2 9.3 6.9 6.3 5.3 6.9 5.9 6.0 10.8 18.3 19.2 31.5 58.4 29.5 21.7 12.1 7.3 21.6 26.7 16.2 11.9 13.6 7.2 14.6 20.2 45.9 6.6 34.8 7.9 1.9 6.8 12.9 33.3 28.0 15.6 16.2 13.9 78.5 6.6 9.8 17.3 35.2 46.6 24.1 22.4 8.9 8.7 7.1 18.5 66.4 7.1 6.1 9.7 19.8 5.1 11.8 27.1 5.4 67.5 16.4 13.9 14.4 68.3 91.5 6.7 6.3 11.7 52.1 15.7 9.6 3.3 24.9 35.5 6.6 25.7 22.8 24.7 12.2 20.4 29.8 14.6 24.7 11.4 9.3 16.4 IKZF5 "FLJ22973, Pegasus, ZNFN1A5" ENSG00000095574 "IKAROS family zinc finger 5" Q9H5V7 10 122990807-123008812 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015297, HPA051574" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA015297: AB_1855183, HPA051574: AB_2681538" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (2.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.66e-3)" "unprognostic (2.68e-1)" "unprognostic (9.14e-3)" "unprognostic (5.43e-2)" "unprognostic (2.99e-1)" "unprognostic (6.88e-2)" "unprognostic (1.63e-2)" "unprognostic (3.98e-3)" "unprognostic (4.17e-2)" "unprognostic (6.03e-2)" "unprognostic (6.96e-2)" "unprognostic (3.15e-2)" 8.4 8.5 10.3 7.3 12.9 34.4 12.3 12.0 14.8 8.9 8.0 7.2 6.7 9.3 9.8 7.2 8.5 6.2 7.2 10.0 11.9 8.8 12.3 8.3 11.2 12.0 12.4 9.5 14.0 11.2 9.4 10.1 8.2 12.7 8.4 7.1 13.7 8.4 6.1 9.8 10.6 8.6 7.1 11.5 9.3 8.0 10.6 11.6 10.6 10.1 9.5 9.7 7.4 8.5 19.6 7.5 3.7 7.3 12.5 11.5 10.5 7.9 6.2 13.3 8.1 9.8 6.0 8.6 18.8 4.5 7.6 4.4 10.1 13.0 9.3 11.9 10.6 11.5 12.1 6.0 9.0 7.6 14.8 10.6 8.3 12.5 9.7 20.8 11.1 9.0 12.3 16.9 12.2 8.8 5.5 13.6 16.1 6.7 5.6 5.1 10.9 9.1 10.8 6.7 5.1 7.9 7.1 5.1 6.3 12.2 5.8 5.2 9.3 9.3 5.8 4.9 8.6 10.1 11.4 6.6 17.6 7.4 25.5 3.5 6.0 4.1 5.7 5.8 5.3 6.8 4.0 5.3 5.7 4.5 4.7 7.2 8.4 4.0 6.7 5.6 3.1 7.5 4.3 10.3 12.9 12.0 14.8 10.0 11.9 12.0 12.4 9.5 12.7 11.5 11.6 19.6 11.2 12.8 13.1 8.8 16.0 32.2 11.0 7.2 20.5 12.7 23.8 15.0 15.6 8.6 11.3 5.5 14.6 5.8 20.5 7.7 9.8 5.1 8.6 12.0 13.2 11.5 18.0 12.4 10.9 5.3 5.7 15.6 7.7 20.7 17.1 11.3 9.7 15.7 6.5 11.8 13.0 9.2 4.1 10.6 11.4 3.7 13.4 11.0 16.0 17.8 8.9 9.0 17.5 13.0 30.9 4.7 4.9 10.5 14.2 16.1 7.4 11.4 10.9 14.1 13.1 14.3 11.6 22.8 22.3 20.4 32.4 14.4 19.3 7.0 6.7 11.9 BLNK "BASH, bca, BLNK-s, Ly57, SLP-65, SLP65" ENSG00000095585 "B cell linker" Q8WV28 10 96189171-96271587 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 71.1" "Cell type enhanced" "Detected in many" "B-cells: 94.2;dendritic cells: 64.0;Microglial cells: 157.4;Plasma cells: 80.4;Proximal enterocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5" "Group enriched" "Detected in many" 101 "B-cells: 161.2;dendritic cells: 231.5" "Group enriched" "Detected in some" 6 "Daudi: 68.7;REH: 168.4;RPMI-8226: 94.4;U-698: 251.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009333, CAB016291, HPA038309, HPA038310" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946" "unprognostic (4.86e-2)" "unprognostic (6.05e-3)" "unprognostic (1.00e-2)" "unprognostic (2.73e-2)" "unprognostic (2.29e-1)" "unprognostic (1.63e-3)" "unprognostic (1.08e-2)" "unprognostic (5.19e-2)" "unprognostic (2.97e-1)" "unprognostic (1.02e-1)" "unprognostic (8.94e-2)" "unprognostic (3.73e-1)" "unprognostic (1.84e-2)" "unprognostic (5.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.46e-3)" "prognostic favorable (2.67e-6)" 2.2 3.3 3.9 27.8 3.4 10.2 6.3 2.5 4.1 4.1 12.2 17.1 39.3 2.5 30.3 40.2 6.1 10.9 1.0 3.6 4.0 24.8 39.5 6.7 58.1 4.2 3.6 3.1 1.5 12.2 17.5 1.8 6.5 5.0 7.3 18.4 1.4 11.0 13.3 0.5 8.1 34.3 3.1 4.9 54.4 29.5 1.3 4.6 10.7 11.7 1.1 71.1 10.0 16.0 4.5 0.3 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.2 0.2 68.7 0.4 0.0 0.3 0.6 0.1 0.8 0.1 5.5 0.2 0.3 0.3 0.1 0.0 0.1 1.4 0.1 8.7 0.0 0.0 0.1 0.0 0.8 0.3 6.4 0.0 0.7 0.4 0.2 0.2 0.2 0.0 168.4 0.3 94.4 0.9 13.0 0.3 0.3 0.2 15.1 0.1 0.2 23.7 1.1 0.2 0.2 0.8 0.1 0.2 5.4 0.4 251.4 0.1 0.5 0.1 0.3 1.6 0.2 0.3 1.3 0.1 161.2 0.3 0.2 20.6 140.5 0.1 0.1 1.1 1.9 0.1 231.5 0.6 8.1 3.9 3.4 2.5 4.1 3.6 4.0 4.2 3.6 3.1 5.0 4.9 4.6 4.5 0.4 6.4 7.7 0.7 94.2 1.1 21.0 13.1 21.1 0.0 4.1 3.4 1.2 30.0 7.3 40.5 0.0 23.0 64.0 9.2 27.4 14.6 3.1 14.4 1.9 0.3 4.9 5.3 1.0 13.8 17.5 0.7 35.7 22.9 1.3 0.0 2.9 27.8 22.8 0.0 1.3 19.4 30.5 9.0 13.8 1.1 0.3 18.2 1.8 157.4 4.8 0.0 0.0 2.5 0.9 4.4 22.4 0.0 80.4 5.1 64.6 2.3 3.4 0.0 6.6 0.3 0.7 1.6 0.1 34.7 1.4 41.5 3.6 0.5 22.5 23.8 TLL2 ENSG00000095587 "Tolloid like 2" Q9Y6L7 10 96364608-96513926 "Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;heart muscle: 2.0;tongue: 1.9" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 82.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "RPTEC TERT1: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (1.28e-2)" "unprognostic (7.54e-4)" "unprognostic (1.50e-1)" "unprognostic (3.31e-3)" "unprognostic (2.67e-1)" "unprognostic (2.14e-3)" "unprognostic (1.31e-2)" "unprognostic (3.52e-4)" "unprognostic (7.08e-2)" "unprognostic (2.50e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (4.98e-4)" "unprognostic (2.90e-1)" "unprognostic (8.41e-2)" "unprognostic (1.95e-4)" "unprognostic (2.30e-1)" 0.0 0.1 1.3 0.1 1.7 0.2 0.0 0.8 1.7 0.0 0.4 0.1 0.3 0.1 0.1 0.0 0.0 0.3 2.0 1.4 1.8 0.0 0.0 0.0 0.1 2.5 1.4 1.4 0.1 0.2 0.0 0.4 0.1 3.2 0.1 0.1 0.2 0.2 0.0 0.9 0.0 0.4 0.1 1.5 0.1 0.3 0.1 3.8 0.0 0.1 1.9 0.0 0.0 0.0 2.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.1 0.2 0.1 0.2 0.1 0.0 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.6 0.1 0.1 0.4 0.0 20.1 0.0 0.7 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.8 1.7 1.4 1.8 2.5 1.4 1.4 3.2 1.5 3.8 2.1 0.4 0.0 1.1 0.3 0.7 0.1 0.5 1.9 0.0 0.0 0.0 0.0 5.5 1.5 1.0 0.0 0.0 2.4 0.1 0.0 0.0 0.2 6.9 0.2 0.1 1.4 0.0 0.0 1.9 0.6 0.1 2.4 1.5 0.5 0.0 82.4 0.0 0.0 0.3 0.0 5.6 1.7 2.0 0.3 1.4 5.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 18.6 0.7 0.0 0.0 1.4 0.8 1.0 0.2 0.2 0.0 0.0 0.7 0.4 0.2 2.6 0.0 0.4 3.4 0.3 0.1 0.2 0.6 CYP26A1 "CP26, CYP26, P450RAI, P450RAI1" ENSG00000095596 "Cytochrome P450 family 26 subfamily A member 1" O43174 10 93073475-93077885 "Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "liver: 18.1" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 48.0;Endometrial ciliated cells: 46.3;Glandular and luminal cells: 86.7;Muller glia cells: 62.1" "Cancer enhanced" "Detected in many" "testis cancer: 5.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 62.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 6.9" NA NA "unprognostic (2.80e-1)" "unprognostic (4.21e-3)" "unprognostic (5.65e-2)" "unprognostic (2.94e-1)" "unprognostic (2.16e-1)" "unprognostic (4.90e-1)" "unprognostic (4.17e-2)" "unprognostic (6.22e-2)" "unprognostic (3.35e-1)" "unprognostic (4.89e-1)" "unprognostic (1.11e-2)" "unprognostic (6.24e-2)" "unprognostic (2.04e-11)" "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (4.11e-1)" 0.0 0.1 0.3 0.0 0.5 0.0 0.2 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 18.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 62.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.6 0.5 0.4 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 48.0 0.0 1.1 0.4 8.1 0.3 0.0 13.1 0.0 2.1 0.3 0.1 0.0 0.0 0.2 0.2 46.3 10.6 1.0 0.0 0.0 0.9 0.0 1.1 0.2 0.0 86.7 0.0 0.0 0.0 8.2 0.1 0.0 4.9 0.0 6.1 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.0 62.1 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 2.7 0.0 0.0 0.4 2.1 2.6 0.0 0.0 7.7 0.6 1.9 0.0 0.0 TDRD1 CT41.1 ENSG00000095627 "Tudor domain containing 1" Q9BXT4 10 114179270-114232304 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 17.7" "Cell type enhanced" "Detected in some" "Early spermatids: 7.1;Late spermatids: 5.3;Spermatocytes: 25.6;Spermatogonia: 25.5" "Cancer enriched" "Detected in some" 5 "prostate cancer: 4.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 51.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037729 Enhanced NA NA "HPA037729: AB_10670527" "unprognostic (6.77e-2)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (3.15e-2)" "unprognostic (6.13e-2)" "unprognostic (1.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (9.60e-2)" "unprognostic (3.98e-2)" "unprognostic (4.75e-1)" "unprognostic (1.68e-1)" 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.1 0.8 0.1 0.5 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.6 0.2 0.2 2.0 0.2 0.0 0.2 0.3 0.3 0.1 0.4 0.5 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 17.7 0.7 0.3 0.1 0.5 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 0.3 0.1 0.8 0.2 0.2 0.3 0.3 0.1 0.4 0.1 0.7 0.4 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.9 3.5 2.8 0.0 0.0 0.0 0.3 2.7 0.3 0.0 0.2 7.1 0.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.0 0.0 0.3 5.3 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.7 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.5 0.5 25.6 25.5 0.0 0.0 0.1 0.1 0.7 0.1 0.0 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 6.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, CAB032850, HPA043084" Enhanced Supported "Plasma membrane,Focal adhesion sites,Centrosome" NA NA "Focal adhesion sites" "Plasma membrane, Centrosome" "CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favorable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 374.1 21.9 133.4 53.8 163.2 4.8 79.0 119.1 145.3 41.9 54.2 220.5 25.8 170.8 32.4 157.0 100.1 82.0 354.9 133.2 195.4 17.8 49.7 34.7 3.1 178.9 133.3 103.3 19.1 22.2 26.6 11.6 30.5 125.2 141.9 67.6 39.4 24.8 219.5 192.3 22.3 63.2 152.4 146.3 8.1 144.3 14.5 143.5 3.7 14.9 157.3 1.5 237.3 47.5 152.2 1.6 1.2 12.4 3.1 4.2 0.2 2.4 0.4 0.1 0.4 0.1 28.0 10.9 0.0 2.2 0.2 4.2 0.6 2.4 0.6 0.4 3.2 4.5 7.2 0.4 19.5 1.5 0.0 48.3 0.9 0.4 0.5 0.3 0.2 4.9 1.9 11.7 2.3 1.3 0.8 0.1 0.8 5.7 6.2 2.6 1.0 4.0 0.4 15.1 18.3 4.9 3.7 1.8 0.6 45.2 8.9 2.1 0.4 0.3 0.1 4.0 0.1 2.4 1.8 0.5 0.2 4.8 0.5 11.7 6.1 0.1 1.2 0.4 0.6 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.3 0.1 133.4 163.2 119.1 145.3 133.2 195.4 178.9 133.3 103.3 125.2 146.3 143.5 152.2 42.2 22.4 20.9 800.2 0.8 11.6 8.7 0.0 5.2 7.5 6.5 19.3 612.3 12.8 1.3 1.8 2.1 20.2 1.0 4.0 3.9 7.2 70.4 1.4 15.8 25.7 6.0 16.0 401.1 3.1 2.4 21.4 8.6 1.6 16.4 8.2 30.4 50.5 3.1 6.7 295.1 10.9 0.0 3.8 12.0 48.6 7.5 1.1 14.2 163.9 0.7 22.1 1.0 155.3 22.6 2.3 2.8 76.8 1.1 4.7 1.2 6.1 0.1 5.5 0.0 11.8 51.6 3.4 3.7 1.9 12.5 29.6 1.6 0.1 5.1 5.9 CRTAC1 "ASPIC1, CEP-68, FLJ10320" ENSG00000095713 "Cartilage acidic protein 1" Q9NQ79 10 97865000-98030828 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.7;fallopian tube: 38.5;lung: 50.4;seminal vesicle: 33.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 119.5;Club cells: 36.4;Inhibitory neurons: 63.6;Oligodendrocyte precursor cells: 54.8" "Cancer enhanced" "Detected in many" "melanoma: 43.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.0;HMC-1: 2.5;HUVEC TERT2: 7.1;SCLC-21H: 4.7;SK-MEL-30: 7.7;TIME: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008175 Enhanced "Secreted to extracellular matrix" NA NA 550000000 "HPA008175: AB_1847254" "unprognostic (2.55e-1)" "unprognostic (6.41e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.54e-1)" "unprognostic (6.96e-3)" "unprognostic (9.30e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (7.66e-2)" "unprognostic (1.69e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.70e-4)" "unprognostic (1.05e-2)" "unprognostic (3.29e-3)" "prognostic favorable (1.51e-4)" 4.1 0.8 12.9 1.1 20.4 0.0 2.4 11.6 20.3 4.9 9.0 8.0 0.5 1.3 3.8 8.4 38.5 0.3 6.3 10.1 13.5 3.5 0.4 50.4 0.4 41.3 18.2 9.7 0.7 1.3 0.8 5.4 0.0 47.7 2.3 0.4 11.4 3.4 33.9 1.1 3.3 2.3 0.8 11.6 0.1 1.8 4.0 25.0 0.2 4.8 1.5 0.3 30.5 5.0 38.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.7 0.0 3.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 4.7 1.1 0.5 0.0 7.7 0.3 0.0 0.0 9.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 20.4 11.6 20.3 10.1 13.5 41.3 18.2 9.7 47.7 11.6 25.0 38.2 1.9 22.4 119.5 2.9 0.0 1.5 2.7 1.3 5.7 10.1 2.6 2.8 7.1 1.5 36.4 9.2 0.0 0.0 0.1 0.0 0.0 4.6 0.1 0.5 0.1 8.8 1.8 0.0 22.9 0.7 0.0 2.3 0.0 0.6 5.1 0.0 5.7 0.1 0.0 0.0 63.6 0.0 0.0 0.6 0.9 0.6 0.0 0.2 8.8 2.8 0.0 14.1 0.0 54.8 6.2 0.6 0.0 0.4 1.2 1.3 0.0 0.0 0.9 5.3 0.0 3.5 0.3 1.5 1.9 13.1 0.4 0.0 0.4 0.0 0.0 1.7 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677510-28682932 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 82.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" NA NA Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: AB_2668371, HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favorable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 3.2 44.5 13.8 2.3 15.2 6.0 24.0 18.5 17.7 4.9 18.8 3.8 1.6 18.1 3.0 2.2 6.4 5.4 29.7 13.1 16.7 20.0 24.1 12.1 2.0 19.7 15.9 11.5 82.3 7.0 8.3 8.6 39.6 23.6 7.5 4.7 13.5 6.4 16.8 1.8 5.1 2.1 12.3 16.9 18.1 3.8 8.8 14.5 0.4 1.2 1.9 1.4 30.2 5.4 22.4 1.0 41.0 4.2 2.2 4.8 0.1 24.5 9.7 3.5 15.4 10.0 166.7 17.3 0.5 5.7 7.4 8.8 12.2 10.2 1.6 7.2 10.1 21.0 39.5 6.2 63.7 5.9 2.4 51.5 3.7 2.3 10.4 1.6 96.7 2.4 2.1 22.1 18.7 3.1 70.1 0.2 3.3 71.6 34.5 9.9 0.3 7.8 3.6 12.9 40.4 6.8 5.2 13.2 78.5 199.0 357.8 23.2 3.0 0.3 10.4 7.3 17.0 4.7 0.5 15.0 0.0 1.0 8.9 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 15.2 18.5 17.7 13.1 16.7 19.7 15.9 11.5 23.6 16.9 14.5 22.4 6.6 9.6 5.9 15.0 5.7 4.0 7.6 0.6 13.1 14.3 174.7 163.2 34.9 58.6 3.5 11.0 4.2 12.0 9.3 33.8 1.9 20.8 0.1 14.3 15.3 7.3 26.8 0.0 0.5 0.2 22.2 46.1 58.6 21.1 1.3 334.8 14.6 16.0 6.7 6.7 0.2 3.8 0.0 1.6 4.2 1.2 3.4 5.4 16.0 15.9 0.7 50.2 0.0 46.3 21.2 12.1 34.6 2.2 4.3 10.8 1.1 16.1 1.4 5.9 0.0 4.2 42.7 1.9 15.5 13.5 1.3 8.5 7.8 6.2 3.8 14.1 IL11 "AGIF, IL-11" ENSG00000095752 "Interleukin 11" P20809 19 55364382-55370463 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Pancreatic endocrine cells: 64.4;Smooth muscle cells: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 50.9;BJ hTERT+: 60.0;HBF TERT88: 39.0;hTEC/SVTERT24-B: 47.9;U-251 MG: 187.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 34800 "unprognostic (6.60e-3)" "unprognostic (7.23e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (3.32e-3)" "unprognostic (6.33e-2)" "unprognostic (1.04e-2)" "unprognostic (7.84e-5)" "unprognostic (2.47e-1)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (4.83e-2)" "unprognostic (4.07e-8)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.82e-3)" "unprognostic (3.08e-2)" 0.5 0.2 1.4 3.7 1.1 0.9 0.3 2.4 1.4 0.3 0.4 1.0 0.2 2.9 0.3 1.2 0.2 2.8 0.4 0.7 1.9 4.7 0.2 1.2 0.0 3.2 2.4 0.7 0.4 0.4 0.1 4.4 1.1 2.4 2.7 0.1 0.5 0.6 0.6 0.0 1.4 0.5 0.3 1.4 0.3 3.7 1.7 3.0 0.3 0.1 0.0 0.1 2.4 0.5 2.8 2.3 1.4 0.5 0.9 0.0 0.0 0.5 50.9 60.0 26.6 35.2 1.2 1.3 0.7 2.5 5.1 14.4 3.0 0.3 1.4 39.0 2.4 1.7 0.2 4.3 3.8 3.1 0.0 0.3 0.3 1.5 47.9 0.3 12.4 0.0 0.2 0.4 1.8 3.4 1.5 0.1 0.4 1.2 2.1 4.2 0.2 16.9 0.3 0.4 0.5 2.9 2.0 6.8 1.2 1.4 6.8 0.8 0.3 0.7 16.1 20.0 0.2 187.4 1.0 2.5 0.4 33.9 0.4 8.9 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.4 1.1 2.4 1.4 0.7 1.9 3.2 2.4 0.7 2.4 1.4 3.0 2.8 0.3 0.0 0.5 0.3 0.3 3.2 0.6 4.4 1.2 1.7 0.4 1.8 1.1 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 12.7 0.9 3.6 1.8 0.5 0.0 0.0 0.6 2.8 1.2 12.7 0.0 5.6 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.0 0.0 0.3 0.0 0.0 0.6 1.8 0.0 1.0 0.2 0.0 0.0 0.1 64.4 1.2 1.5 0.0 1.3 0.0 0.2 0.4 0.6 0.0 0.4 51.8 0.4 1.6 0.5 0.6 0.3 0.2 0.0 0.3 0.9 MYO3A DFNB30 ENSG00000095777 "Myosin IIIA" Q8NEV4 10 25934229-26212532 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "retina: 15.6;testis: 5.2" "Cell type enhanced" "Detected in some" "Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7" "Cancer enhanced" "Detected in many" "cervical cancer: 1.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3" "Not detected" "Not detected" "HPA051893, HPA075413" Enhanced Supported "Plasma membrane,Actin filaments,Cytoplasmic bodies" No No "Actin filaments, Cytoplasmic bodies" "Plasma membrane" "HPA051893: , HPA075413: " "unprognostic (5.00e-3)" "unprognostic (3.36e-2)" "unprognostic (1.53e-1)" "unprognostic (3.20e-3)" "unprognostic (2.96e-1)" "unprognostic (4.37e-2)" "unprognostic (5.29e-2)" "unprognostic (2.74e-1)" "unprognostic (4.31e-2)" "unprognostic (1.03e-1)" "unprognostic (5.66e-3)" "unprognostic (7.96e-3)" "unprognostic (6.34e-2)" "unprognostic (1.46e-2)" "unprognostic (6.62e-2)" "unprognostic (9.69e-2)" 0.1 0.1 0.7 0.0 1.8 0.1 0.1 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.8 0.3 0.0 0.1 0.0 0.5 0.3 0.2 0.0 0.8 0.0 0.5 0.0 0.4 0.1 0.3 15.6 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.2 5.2 0.4 0.2 0.2 0.1 0.2 0.0 0.3 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.8 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.1 0.6 0.1 0.8 0.5 0.3 0.2 0.4 0.2 0.4 0.3 0.2 0.0 0.5 2.0 0.1 1.8 0.3 0.0 0.0 0.9 0.6 0.3 0.6 0.0 2.5 0.0 0.0 0.0 0.0 0.2 1.9 0.8 156.6 0.6 0.1 0.3 1.8 0.0 2.2 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.4 0.0 0.0 0.0 58.2 1.2 0.1 0.0 1.9 0.0 74.8 0.0 1.0 0.4 0.2 0.0 1.2 0.0 0.3 0.0 1.0 0.0 3.9 0.0 0.0 2.4 31.7 14.2 2.4 1.0 0.0 0.0 0.0 0.4 0.3 WAC "BM-016, FLJ31290, MGC10753, PRO1741, Wwp4" ENSG00000095787 "WW domain containing adaptor with coiled-coil" Q9BTA9 10 28532493-28623112 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036528, HPA042609, HPA074604" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: " "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.80e-1)" "unprognostic (4.53e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.27e-6)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.07e-1)" "unprognostic (2.90e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-2)" "unprognostic (6.63e-2)" "unprognostic (1.36e-1)" 51.8 40.2 18.8 31.1 23.4 52.1 49.3 45.6 22.0 48.5 18.6 57.9 27.6 50.7 16.8 46.3 47.5 23.9 45.0 18.9 19.9 38.3 36.2 50.8 31.9 19.8 22.7 17.7 53.6 39.9 34.3 37.2 31.9 25.5 40.9 23.4 34.8 44.5 25.8 55.6 50.3 47.8 25.2 22.0 46.0 46.2 37.6 21.4 46.3 44.1 34.3 28.6 55.3 47.1 26.3 72.4 45.2 65.5 51.1 40.7 31.4 59.9 58.2 33.1 60.9 50.5 68.7 73.2 71.8 42.8 46.6 44.6 63.1 51.5 46.8 55.1 92.1 54.0 89.0 40.6 41.2 51.2 39.9 66.7 33.0 57.7 65.6 46.7 38.4 44.4 65.8 76.8 69.9 38.4 60.0 87.8 24.6 41.9 48.1 21.4 71.8 109.3 56.2 29.3 36.1 60.1 56.8 50.7 57.4 78.2 40.6 45.8 56.1 47.9 38.5 64.3 40.1 52.8 40.8 44.4 82.6 47.8 70.5 38.8 13.7 10.7 9.2 10.5 15.0 10.5 12.7 8.7 12.7 11.2 12.3 10.3 9.2 13.0 13.4 14.3 7.3 9.2 8.5 18.8 23.4 45.6 22.0 18.9 19.9 19.8 22.7 17.7 25.5 22.0 21.4 26.3 110.8 93.0 75.1 114.6 94.1 176.0 94.6 44.2 105.9 114.5 95.8 78.9 109.6 81.5 52.9 40.5 95.9 59.2 115.7 77.1 31.3 47.0 99.8 92.9 107.4 92.8 69.5 97.8 117.8 47.6 61.5 86.4 58.6 142.4 55.8 94.1 75.3 61.4 53.6 107.7 107.1 86.2 44.7 111.5 154.8 123.6 83.0 107.2 76.5 138.7 92.1 68.4 87.6 142.7 180.9 55.0 68.5 82.8 86.0 128.5 73.2 59.4 45.5 92.4 59.2 113.5 85.1 85.9 59.2 80.5 184.1 99.1 100.4 83.4 71.6 134.5 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 218.3" "Cell type enhanced" "Detected in all" "dendritic cells: 819.1;Early spermatids: 2013.6;Langerhans cells: 1094.0;Late spermatids: 814.3;T-cells: 612.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 103.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 50.0 138.7 35.2 51.4 34.2 22.1 27.3 32.6 39.5 24.5 40.3 21.7 9.0 30.6 11.5 17.8 29.5 44.9 43.1 34.4 99.8 34.7 61.0 30.7 17.8 38.5 34.0 32.1 61.1 16.1 24.7 60.0 101.2 35.6 32.3 13.7 23.7 13.5 23.5 30.3 8.9 16.1 24.8 34.4 25.5 20.8 218.3 38.3 29.6 22.5 31.6 17.1 61.1 19.3 43.6 24.8 39.0 32.3 33.2 22.2 23.0 32.2 31.8 24.8 19.6 27.0 4.6 10.2 42.0 30.2 18.7 21.2 5.6 28.0 20.8 28.5 103.8 20.6 14.9 25.7 18.6 26.5 3.6 15.2 20.4 25.9 38.3 11.7 17.2 55.3 31.1 44.3 16.9 30.4 20.0 26.1 10.8 9.6 9.2 88.6 16.0 16.9 7.8 34.8 9.7 7.5 20.4 15.1 13.1 88.7 36.5 7.2 11.0 74.0 14.9 19.1 41.4 21.3 7.4 10.9 14.6 35.6 33.1 13.0 5.3 3.5 11.5 11.5 5.5 14.6 7.0 12.6 10.4 4.1 6.8 9.0 10.4 9.7 10.2 4.2 12.4 16.2 8.5 35.2 34.2 32.6 39.5 34.4 99.8 38.5 34.0 32.1 35.6 34.4 38.3 43.6 98.7 19.2 47.9 42.7 301.8 143.4 58.0 30.9 18.8 18.3 32.1 32.4 62.3 20.0 33.2 165.5 6.2 98.7 819.1 16.8 97.8 40.6 2013.6 32.6 27.6 118.7 69.0 5.7 50.1 44.4 109.1 140.6 29.0 44.2 347.7 14.5 17.9 37.6 120.6 10.1 34.3 17.9 32.6 61.4 1094.0 814.3 26.1 286.1 247.3 30.0 187.4 39.0 65.9 113.1 34.9 30.6 19.7 32.7 109.4 49.5 15.3 64.2 46.1 19.5 46.0 45.5 232.8 464.7 156.8 15.9 108.4 230.0 612.4 46.4 13.6 52.7 NUBP2 "CFD1, CIAO6" ENSG00000095906 "Nucleotide binding protein 2" Q9Y5Y2 16 1782932-1789186 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041704 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041704: AB_10804006" "unprognostic (1.94e-1)" "unprognostic (5.73e-3)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.02e-2)" "unprognostic (8.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.42e-1)" "unprognostic (1.53e-1)" "unprognostic (8.64e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.63e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.83e-2)" 17.4 34.5 14.2 10.7 15.7 16.7 17.8 15.4 25.7 20.5 20.3 21.5 14.6 18.9 3.9 31.1 17.2 6.0 19.0 14.0 13.1 26.5 53.7 18.1 16.1 17.3 14.5 12.8 17.8 34.4 8.4 18.9 11.0 14.9 25.8 4.2 3.4 22.6 10.5 28.2 25.0 20.7 6.7 15.6 27.0 27.5 10.2 16.0 14.1 19.1 8.3 6.5 21.0 20.3 16.5 28.6 91.4 16.2 49.6 12.1 9.2 50.9 32.2 14.8 20.7 23.3 56.1 41.5 45.0 38.1 7.4 15.2 32.6 10.8 31.6 3.8 39.6 85.7 19.6 67.2 83.0 23.6 30.2 38.2 13.1 26.6 16.9 12.1 13.0 26.2 54.9 49.4 29.6 8.7 109.1 58.8 53.7 44.2 26.4 52.6 80.0 33.4 106.1 16.7 21.1 58.4 70.4 31.9 50.4 38.1 4.2 75.5 35.9 29.8 33.8 42.6 31.9 34.1 65.1 44.9 54.4 20.4 36.0 44.2 72.3 58.1 59.8 64.9 61.6 59.2 48.5 56.5 57.7 62.3 47.6 47.1 45.0 29.7 57.9 60.7 87.5 84.2 67.9 14.2 15.7 15.4 25.7 14.0 13.1 17.3 14.5 12.8 14.9 15.6 16.0 16.5 41.0 16.0 30.9 9.4 38.4 35.8 39.4 75.8 24.5 36.0 52.2 65.9 24.9 42.9 43.7 31.3 20.9 103.9 55.5 40.2 66.5 64.7 33.1 23.1 32.7 35.1 38.2 36.4 6.2 74.3 83.0 38.0 32.6 24.5 20.3 48.6 31.8 65.0 62.2 23.5 7.4 51.7 54.9 39.3 28.8 90.9 36.7 27.9 58.7 7.5 55.1 54.4 68.0 6.0 11.0 63.7 30.4 30.9 38.0 45.0 65.4 67.1 22.2 42.5 46.0 28.2 43.3 34.0 30.6 44.7 41.5 41.3 42.0 49.6 58.2 32.2 TPSD1 ENSG00000095917 "Tryptase delta 1" Q9BZJ3 16 1256059-1259008 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 21.4" "Cell type enriched" "Detected in some" 19 "granulocytes: 202.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 29 "basophil: 2.9" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Group enriched" "Detected in some" 49 "HEL: 28.2;HMC-1: 40.4" "CAB002215, CAB032871, HPA040182, HPA049554" Supported "Intracellular and membrane" NA NA "CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815" "unprognostic (5.99e-2)" "unprognostic (3.00e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "unprognostic (8.97e-3)" "unprognostic (1.15e-4)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" "unprognostic (9.00e-2)" "unprognostic (2.88e-1)" "unprognostic (4.30e-1)" "unprognostic (2.94e-2)" "unprognostic (2.50e-3)" "unprognostic (3.74e-2)" "unprognostic (4.14e-1)" "unprognostic (3.89e-1)" "unprognostic (7.46e-3)" 6.2 0.5 1.3 1.9 1.3 1.6 4.6 1.3 2.7 3.9 1.0 7.9 3.9 8.6 1.9 8.2 3.2 14.0 0.9 1.4 1.2 1.2 0.7 17.9 5.4 1.3 1.3 1.3 0.3 1.5 0.2 0.4 0.1 1.6 5.6 0.9 0.1 4.9 1.2 1.4 8.4 13.6 5.5 1.1 0.4 21.4 1.3 1.3 1.2 0.3 1.1 2.3 13.5 5.1 1.6 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.2 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 1.3 2.7 1.4 1.2 1.3 1.3 1.3 1.6 1.1 1.3 1.6 0.0 3.2 7.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.2 0.0 0.0 202.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480525 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "epididymis: 1594.7;intestine: 760.7;kidney: 852.8" "Group enriched" "Detected in many" 12 "Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.0 4.7 2.7 5.2 92.1 0.8 4.6 6.9 0.6 6.0 30.5 760.7 0.8 1594.7 0.4 2.9 82.8 0.1 5.1 4.7 852.8 36.1 0.4 1.6 5.0 5.1 4.7 0.3 8.1 0.2 3.5 0.1 5.0 1.0 24.7 92.4 0.3 2.3 0.3 1.2 633.4 0.8 4.6 1.2 151.5 2.9 5.0 50.9 0.2 0.1 2.0 0.2 0.2 5.1 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.3 0.0 154.9 0.5 0.2 7.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 74.0 1.0 117.7 0.0 6.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 1.5 0.1 0.1 0.0 113.8 15.8 0.0 185.0 0.3 61.5 0.1 4.3 1.6 0.1 1.4 2.3 0.1 0.1 1.6 0.4 0.0 1.9 0.0 0.0 0.4 1.2 0.1 0.0 0.0 6.5 0.0 87.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.3 0.4 1.0 0.0 5.9 0.0 1.5 1.6 0.8 4.7 5.2 4.6 6.9 5.1 4.7 5.0 5.1 4.7 5.0 4.6 5.0 5.1 0.1 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 14.1 0.1 0.8 0.2 188.8 0.0 58.8 27.1 0.0 0.5 35.1 238.7 4.0 5.1 7.7 0.8 0.3 139.0 22.3 0.7 12.4 0.2 0.3 205.4 13.0 1.3 0.2 0.4 36.3 0.1 0.0 0.1 136.6 0.0 0.6 0.0 15.0 0.3 11.6 0.0 0.0 0.7 4.1 0.0 0.0 0.2 12.4 178.9 0.0 1.7 0.3 4096.4 1884.8 0.0 34.9 0.0 0.2 0.3 0.6 0.7 0.0 0.0 0.0 7.4 0.0 141.3 0.2 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "HIVEP zinc finger 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 7.2 2.3 0.6 8.1 3.4 16.9 5.6 0.7 3.5 7.5 6.0 6.5 5.0 6.0 4.5 7.5 6.2 7.4 3.8 2.5 0.9 4.5 11.8 6.3 8.1 1.5 3.1 0.8 6.5 6.8 10.6 3.4 4.9 2.2 6.9 6.6 5.8 4.9 5.8 2.9 5.7 5.3 6.3 0.0 6.1 4.9 4.8 1.1 9.2 5.0 6.3 8.4 9.4 3.3 2.2 8.1 5.9 7.5 4.2 5.8 7.3 7.2 6.4 5.5 5.2 5.7 3.8 4.2 6.7 13.6 7.8 12.4 7.6 7.4 9.2 7.1 14.6 4.3 3.1 5.6 3.7 4.7 3.7 2.5 5.1 9.0 10.6 16.3 11.0 15.5 4.6 32.9 7.5 11.5 6.0 5.9 3.3 6.4 2.8 2.7 3.2 9.8 10.7 3.1 8.7 7.1 5.2 15.9 12.8 4.3 16.6 7.6 4.7 25.2 13.0 5.8 12.3 7.4 30.0 27.3 12.0 4.0 4.8 5.5 2.4 1.8 2.1 1.2 2.0 0.9 3.1 2.0 0.8 1.2 4.8 3.4 2.1 11.7 3.3 5.2 9.0 4.4 0.7 0.6 3.4 0.7 3.5 2.5 0.9 1.5 3.1 0.8 2.2 0.0 1.1 2.2 40.2 28.9 16.9 74.7 35.6 32.2 25.4 7.4 30.7 20.4 12.3 10.9 10.4 17.2 17.6 7.3 12.5 3.4 18.7 17.5 3.9 5.6 2.5 37.7 16.4 20.3 10.8 6.5 94.6 7.2 1.8 25.2 22.4 51.0 7.6 7.0 6.4 12.3 5.9 21.9 68.3 14.4 4.1 9.6 47.9 1.8 3.7 23.1 19.6 44.0 29.6 13.1 5.2 59.3 25.0 11.5 10.3 4.5 33.6 25.2 6.7 2.5 16.7 9.7 0.0 21.0 17.1 3.9 3.5 18.7 33.4 5.2 18.8 6.6 8.6 23.7 TREM2 "TREM-2, Trem2a, Trem2b, Trem2c" ENSG00000095970 "Triggering receptor expressed on myeloid cells 2" Q9NZC2 6 41158506-41163186 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0;choroid plexus: 33.5;lung: 30.3" "Cell type enriched" "Detected in many" 8 "Hofbauer cells: 1014.1" "Cancer enhanced" "Detected in all" "glioma: 93.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.0" "Lineage enhanced" "Detected in single" "dendritic cells: 2.0" "Group enriched" "Detected in some" 4 "hTCEpi: 74.6;THP-1: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010917, HPA012571" Approved "Secreted in brain" NA NA 50000 "HPA010917: AB_1080365, HPA012571: AB_1858260" "unprognostic (3.89e-1)" "unprognostic (4.44e-3)" "unprognostic (2.77e-2)" "unprognostic (1.80e-2)" "unprognostic (1.29e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (4.83e-2)" "unprognostic (1.07e-1)" "unprognostic (8.57e-3)" "unprognostic (1.33e-1)" "unprognostic (2.09e-1)" "unprognostic (3.58e-3)" "unprognostic (8.04e-2)" "unprognostic (1.04e-2)" "unprognostic (3.16e-3)" "unprognostic (1.85e-2)" 8.2 13.3 30.8 3.6 35.3 0.2 9.9 38.2 62.0 6.6 33.5 3.6 0.9 1.7 2.3 0.6 7.5 9.8 2.0 30.7 41.2 1.1 2.3 30.3 2.6 42.9 36.1 27.4 2.4 4.0 7.4 4.0 10.8 44.3 2.0 4.3 2.0 6.1 3.2 0.4 0.4 1.4 4.6 51.4 0.5 2.5 0.7 41.9 1.8 1.7 0.0 0.4 4.5 0.6 52.6 0.0 0.3 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.2 74.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 42.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 30.8 35.3 38.2 62.0 30.7 41.2 42.9 36.1 27.4 44.3 51.4 41.9 52.6 1.8 6.4 7.5 0.0 0.7 0.8 0.2 79.8 0.0 0.3 1.8 58.8 0.1 1.5 9.6 0.0 0.0 5.0 0.4 0.0 0.0 0.0 0.6 0.0 0.1 10.4 0.0 0.0 0.0 0.0 4.9 1.2 0.0 0.0 2.5 0.0 2.2 0.2 1014.1 0.0 0.0 0.0 2.0 34.7 5.2 1.0 0.6 120.5 0.0 12.2 8.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.3 1.0 6.6 0.1 1.0 0.0 0.0 0.0 0.1 7.3 0.8 0.0 0.0 0.1 KCNK16 "K2p16.1, TALK-1, TALK1" ENSG00000095981 "Potassium two pore domain channel subfamily K member 16" Q96T55 6 39314698-39322968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "pancreas: 23.9;stomach 1: 10.4" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 17 "pancreatic cancer: 13.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "basophil: 2.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.1" "Cell line enriched" "Detected in single" 390 "SCLC-21H: 127.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.29e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 10.4 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRISP3 "Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28" ENSG00000096006 "Cysteine rich secretory protein 3" P54108 6 49727376-49744437 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 1214.1;salivary gland: 2328.9" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 182.2;Glandular and luminal cells: 551.5" "Group enriched" "Detected in many" 7 "breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "neutrophil: 2.5;non-classical monocyte: 1.2" "Group enriched" "Detected in many" 19 "granulocytes: 2.5;monocytes: 1.2" "Group enriched" "Detected in some" 20 "HEL: 12.3;RT4: 4.1;SK-BR-3: 9.3;T-47d: 4.4" "Not detected" "Not detected" HPA054392 Supported "Secreted in other tissues" NA NA 420000000 "HPA054392: AB_2682472" "unprognostic (1.28e-2)" "unprognostic (7.01e-2)" "unprognostic (8.93e-2)" "unprognostic (5.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.22e-4)" "unprognostic (5.30e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (4.34e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-1)" 0.2 0.7 0.0 0.0 0.0 385.4 3.9 0.0 0.0 30.1 0.0 0.1 0.4 1.7 0.1 269.2 1214.1 23.3 0.8 0.0 0.0 0.1 0.9 1.3 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.5 0.6 0.0 2.9 0.0 0.0 2328.9 112.9 0.3 3.5 0.2 0.1 0.0 2.6 0.3 0.2 0.0 0.3 0.2 0.0 4.1 4.7 141.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 9.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 2.1 5.6 0.0 21.5 13.1 3.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 182.2 47.2 0.8 0.0 0.4 0.0 3.7 0.0 0.2 0.0 551.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 26.8 FKBP5 "FKBP51, FKBP54, P54, PPIase, Ptg-10" ENSG00000096060 "FKBP prolyl isomerase 5" Q13451 6 35573585-35728583 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 900.0;tongue: 933.3" "Cell type enhanced" "Detected in many" "Kupffer cells: 384.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009315, HPA031092, HPA031093, HPA031095" Enhanced Enhanced Nucleoplasm No No 39000 Nucleoplasm "CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734" "unprognostic (2.09e-3)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.72e-1)" "unprognostic (6.30e-3)" "unprognostic (3.70e-3)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (7.48e-3)" "unprognostic (2.18e-3)" "unprognostic (8.31e-2)" "unprognostic (4.22e-2)" "unprognostic (6.90e-3)" 403.7 93.2 22.0 70.8 28.7 26.8 162.0 23.7 33.1 76.8 25.6 106.6 11.4 98.3 63.5 131.8 105.5 79.6 90.5 21.4 44.9 109.8 145.7 93.5 168.1 30.1 27.1 17.8 123.2 202.1 229.0 53.3 28.7 29.1 85.8 37.5 25.8 61.5 50.2 900.0 111.1 136.8 82.5 19.7 106.5 130.0 41.8 25.7 231.3 98.0 933.3 81.0 109.8 110.0 33.3 40.0 17.1 73.1 109.7 759.3 468.5 1.2 21.2 1.0 13.6 31.0 29.7 6.9 195.3 19.5 4.1 11.8 0.6 44.1 93.2 32.0 77.7 41.6 84.0 14.1 41.7 593.0 53.3 8.3 718.3 368.6 23.7 220.5 14.8 80.1 38.8 91.3 77.1 144.3 25.3 222.5 99.6 18.9 8.7 12.3 97.7 19.1 95.4 60.2 23.7 27.7 16.8 17.3 19.8 4.2 15.9 108.4 62.2 178.7 19.3 17.3 2.8 29.7 34.9 42.9 243.5 6.6 102.3 7.6 57.6 105.0 70.0 64.4 92.3 78.0 9.7 90.6 68.5 107.5 12.5 133.4 96.7 85.1 45.2 46.8 32.0 37.2 158.5 22.0 28.7 23.7 33.1 21.4 44.9 30.1 27.1 17.8 29.1 19.7 25.7 33.3 180.2 12.8 11.3 23.2 42.9 17.6 59.2 20.1 37.0 1.9 32.0 20.8 131.8 74.4 14.2 5.5 0.0 1.2 102.0 14.3 23.5 0.6 9.8 55.7 76.1 57.9 20.9 102.2 25.9 7.9 0.8 97.5 18.8 79.2 38.5 54.7 117.1 225.6 35.1 0.0 2.8 35.5 34.6 384.2 44.8 22.0 160.9 192.2 7.2 66.5 110.3 4.6 44.3 16.6 26.3 2.9 19.3 218.6 66.4 49.9 157.0 27.4 18.2 22.6 144.7 188.1 106.8 14.9 19.1 37.5 21.3 0.4 128.7 2.8 39.5 22.2 SRPK1 SFRSK1 ENSG00000096063 "SRSF protein kinase 1" Q96SB4 6 35832966-35921342 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 379.9;Late spermatids: 599.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 61.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 61.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016431, HPA056486" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA016431: AB_1857478, HPA056486: AB_2683148" "unprognostic (4.65e-3)" "unprognostic (6.82e-3)" "unprognostic (2.54e-3)" "unprognostic (1.01e-3)" "unprognostic (7.74e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.23e-2)" "unprognostic (2.54e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.53e-5)" "unprognostic (7.28e-2)" "unprognostic (2.21e-3)" "unprognostic (9.24e-2)" "unprognostic (4.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.55e-3)" 8.7 6.1 7.5 18.2 9.2 42.1 14.6 11.0 15.9 12.2 7.6 31.5 25.4 12.8 9.4 24.1 8.7 12.0 8.0 9.2 6.0 16.9 16.1 13.0 19.8 5.3 5.8 8.3 8.8 23.5 14.6 9.1 14.6 6.2 9.6 35.9 26.0 16.2 11.0 20.2 26.9 23.8 14.3 3.7 17.9 18.1 45.1 6.0 20.1 8.8 12.7 24.5 31.3 16.3 12.8 104.1 39.2 54.9 82.4 30.2 39.3 69.0 62.1 60.1 57.3 60.2 109.0 34.1 139.0 51.8 39.1 65.5 51.3 110.3 74.2 100.6 96.2 79.9 73.5 42.6 93.8 26.7 111.3 34.0 25.6 39.3 66.0 84.7 44.6 72.3 76.4 157.7 55.6 48.2 36.8 111.1 80.8 45.9 62.9 42.7 77.8 67.3 84.1 56.8 169.5 117.5 42.9 65.4 59.3 42.5 55.2 33.3 70.3 54.8 52.4 41.3 37.2 78.6 33.1 78.6 128.5 20.9 124.3 48.1 61.0 4.4 30.6 8.5 5.3 12.1 8.6 11.2 11.5 5.9 6.9 9.2 10.0 50.9 11.2 7.6 3.3 14.9 6.3 7.5 9.2 11.0 15.9 9.2 6.0 5.3 5.8 8.3 6.2 3.7 6.0 12.8 26.6 9.6 25.8 18.6 40.0 42.3 119.3 91.0 67.7 36.8 25.8 22.7 28.7 14.3 51.4 22.0 37.5 54.3 33.1 51.6 29.4 55.4 379.9 29.9 40.2 29.2 46.2 46.7 74.2 68.2 53.2 25.1 46.9 54.0 7.6 44.1 13.2 41.8 21.6 10.1 50.0 50.8 32.6 16.3 19.9 599.1 22.1 20.0 16.0 24.4 31.5 16.8 32.0 30.2 29.7 100.4 47.9 24.8 68.0 117.9 50.8 59.4 33.8 92.9 6.6 17.8 48.9 197.3 100.4 126.8 41.8 39.7 43.6 33.7 90.7 162.6 BRPF3 KIAA1286 ENSG00000096070 "Bromodomain and PHD finger containing 3" Q9ULD4 6 36196744-36232790 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022787 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA022787: AB_1845454" "unprognostic (1.44e-1)" "unprognostic (2.24e-1)" "unprognostic (5.52e-2)" "unprognostic (2.15e-2)" "unprognostic (2.98e-1)" "unprognostic (9.51e-2)" "unprognostic (5.33e-2)" "unprognostic (3.78e-1)" "unprognostic (3.02e-2)" "unprognostic (1.07e-1)" "unprognostic (7.98e-2)" "unprognostic (3.74e-1)" "unprognostic (3.59e-2)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.28e-1)" 6.6 12.0 2.2 7.7 3.8 12.2 8.5 8.8 5.5 8.5 1.1 13.3 11.8 12.0 6.2 8.0 8.8 8.7 7.3 5.1 2.5 11.9 6.9 7.5 6.2 2.0 1.7 3.2 12.0 18.2 14.6 4.4 7.5 3.3 9.6 13.0 6.4 15.8 11.0 12.2 12.7 13.9 10.3 0.5 9.0 10.8 20.1 1.7 9.5 12.2 12.3 6.3 7.5 4.7 4.1 10.6 10.0 24.6 19.4 13.3 11.2 21.0 15.6 16.3 21.5 16.9 29.4 9.8 16.3 16.4 15.4 27.0 10.0 21.8 11.2 18.8 15.6 13.5 11.5 9.3 17.6 14.0 9.1 15.5 14.4 9.4 25.6 12.8 15.6 16.3 7.7 24.5 14.6 11.9 15.0 10.4 3.9 12.4 12.9 8.5 29.9 10.1 5.1 6.9 21.4 35.0 11.0 12.7 13.8 12.9 15.1 15.4 24.6 17.2 22.3 18.9 6.1 18.3 12.0 16.8 12.1 3.7 14.1 26.9 0.7 0.0 0.3 0.4 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.1 2.2 3.8 8.8 5.5 5.1 2.5 2.0 1.7 3.2 3.3 0.5 1.7 4.1 5.7 6.4 12.7 8.8 5.6 9.6 7.2 4.6 9.6 9.0 21.1 11.7 13.7 10.0 7.3 5.5 6.2 4.8 9.7 28.1 0.0 6.6 15.3 7.3 10.9 7.2 19.7 5.7 16.6 10.8 4.1 9.8 10.2 12.7 2.5 16.6 9.7 18.2 4.5 0.0 11.4 27.5 6.1 5.7 6.6 14.0 11.1 4.9 7.2 6.5 5.4 6.1 9.2 13.6 11.0 11.2 13.6 9.4 10.5 11.3 21.5 13.5 4.5 7.2 0.0 11.1 8.0 25.7 17.5 7.3 11.4 8.2 6.3 14.2 16.2 10.2 MRPS18A "FLJ10548, MRPS18-3" ENSG00000096080 "Mitochondrial ribosomal protein S18A" Q9NVS2 6 43671202-43687791 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 370.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035450, HPA035451" Approved NA NA "HPA035450: AB_10670701, HPA035451: AB_10602029" "unprognostic (9.85e-2)" "unprognostic (3.08e-1)" "unprognostic (2.04e-1)" "unprognostic (7.35e-3)" "unprognostic (2.00e-1)" "unprognostic (1.15e-2)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (5.16e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (9.15e-2)" "unprognostic (2.14e-2)" "unprognostic (2.42e-1)" "unprognostic (1.96e-1)" "prognostic favorable (4.03e-5)" "unprognostic (9.35e-2)" 33.0 44.5 34.3 21.2 35.1 21.7 33.5 34.8 43.7 29.3 47.2 41.8 36.7 32.6 21.1 58.8 30.4 20.6 54.4 36.4 34.5 47.2 63.8 25.9 22.9 35.5 34.5 33.4 22.1 32.5 39.5 19.7 22.9 35.1 39.9 45.8 15.1 35.4 27.1 150.6 40.8 31.5 27.3 34.8 32.4 56.6 17.6 36.0 26.7 28.7 104.3 33.4 35.1 34.2 35.8 71.0 57.7 45.2 63.9 45.2 30.4 51.4 32.9 50.2 78.6 77.3 118.7 28.4 29.6 55.4 46.0 64.1 56.6 64.3 92.5 40.9 45.6 76.5 55.7 44.3 104.5 78.1 76.1 32.4 41.4 73.5 66.6 100.6 40.2 59.9 73.0 97.9 61.4 47.0 115.2 58.3 63.4 33.6 370.3 46.2 48.8 35.9 95.9 59.1 79.9 72.5 38.9 34.7 64.5 121.8 32.1 65.5 106.7 32.6 49.4 56.4 40.2 60.2 67.1 60.2 110.3 66.2 52.8 134.8 106.6 69.8 76.8 79.1 60.9 74.8 135.4 73.6 76.0 82.3 98.3 73.0 67.9 32.5 93.3 45.2 91.2 86.9 84.1 34.3 35.1 34.8 43.7 36.4 34.5 35.5 34.5 33.4 35.1 34.8 36.0 35.8 27.1 32.1 24.5 5.2 31.8 33.4 44.6 97.7 12.0 13.6 29.1 26.4 1.3 30.0 61.2 33.1 2.1 72.7 15.6 96.0 99.7 78.2 16.5 26.2 26.2 25.3 32.3 23.5 5.1 67.4 64.0 24.6 56.6 43.7 26.6 28.8 30.4 51.8 51.1 8.4 4.5 73.4 73.2 17.5 19.8 35.2 22.7 16.5 40.9 7.5 51.7 23.4 29.9 9.0 5.2 69.3 94.2 21.1 42.9 45.0 73.4 115.4 34.7 15.5 32.9 24.7 25.8 27.3 36.2 31.0 27.3 67.5 19.5 61.7 97.2 77.9 PGC ENSG00000096088 Progastricsin P20142 6 41736711-41754109 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Digestion "Aspartyl protease, Hydrolase, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 45 "stomach 1: 60305.0" "Group enriched" "Detected in some" 10 "Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1" "Cancer enhanced" "Detected in many" "stomach cancer: 1050.3" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Hep G2: 253.1;OE19: 152.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031717, HPA031718" Enhanced Approved Nucleoplasm "Secreted to digestive system" NA NA Nucleoplasm "HPA031717: AB_10670130, HPA031718: AB_10610148" "unprognostic (9.18e-2)" "unprognostic (1.87e-1)" "unprognostic (9.83e-2)" "unprognostic (2.27e-1)" "unprognostic (7.18e-2)" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (8.50e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "unprognostic (8.74e-2)" 10.0 7.1 0.1 0.3 0.1 0.2 6.6 1.1 0.5 5.1 0.0 14.9 1339.4 2.8 0.9 86.2 9.3 2.4 4.3 0.1 0.0 5.0 11.1 382.0 0.3 0.1 0.1 0.0 3.9 137.4 0.0 7.5 2.9 0.6 84.6 0.3 0.1 4.6 441.7 2.5 3.3 3.2 0.0 0.0 7.8 60305.0 4.2 0.0 0.1 2.2 0.0 0.3 3.8 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.6 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 253.1 0.0 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.9 5.7 152.2 0.0 2.9 0.0 6.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 3.7 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.5 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.4 0.0 25.6 335.2 0.0 4.4 0.4 2.8 0.0 0.0 0.0 0.3 0.8 0.3 87.2 5.0 0.0 0.0 1.2 0.0 0.3 0.0 4.6 0.0 0.4 0.0 1.1 0.0 0.0 0.3 131.2 1.5 0.9 5737.5 0.1 10.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 1.7 0.0 0.0 2.0 0.0 0.0 0.0 0.1 1449.1 2.1 0.0 2.4 85.2 0.1 0.2 3.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 4.1 2.6 0.0 0.2 4.2 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671113-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 253.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA072536: AB_2686531" "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 18.3 47.3 56.7 13.7 59.6 10.4 25.1 59.0 72.1 26.0 73.7 25.5 38.7 27.9 36.7 36.5 31.6 25.2 16.7 58.6 66.2 52.0 107.2 18.1 19.8 61.6 59.4 58.5 40.2 36.5 22.4 24.4 16.2 62.9 36.7 26.2 31.7 21.9 21.8 4.5 14.0 35.7 26.6 58.2 13.8 41.1 17.3 60.5 15.6 28.9 8.6 24.1 24.6 26.4 68.2 253.4 37.5 27.3 77.6 73.1 56.0 23.1 50.0 68.0 45.2 69.5 57.8 63.5 30.8 54.2 63.1 94.9 93.9 61.3 83.7 75.3 125.0 50.1 45.6 57.4 95.7 24.0 23.6 54.7 50.5 57.8 49.5 11.1 59.5 61.7 38.9 9.8 85.4 54.1 51.3 46.4 26.9 16.2 165.9 64.7 36.0 38.8 24.5 88.5 48.1 141.4 68.5 55.6 44.2 97.1 33.9 68.0 44.8 45.8 62.0 83.3 24.5 81.3 40.9 37.1 46.6 87.4 14.8 50.7 23.3 0.5 16.4 38.4 0.1 24.8 54.6 48.7 40.4 19.4 36.0 36.9 39.4 2.1 11.0 0.1 35.2 66.5 30.3 56.7 59.6 59.0 72.1 58.6 66.2 61.6 59.4 58.5 62.9 58.2 60.5 68.2 28.6 25.6 17.6 13.1 23.4 48.4 61.9 183.5 56.9 20.4 71.3 72.4 17.4 54.3 90.1 51.5 8.4 56.1 27.5 22.6 64.6 108.1 1.4 31.2 33.3 37.3 33.5 32.8 50.3 140.9 150.8 62.4 50.0 26.3 25.4 46.5 38.6 138.7 47.0 5.0 45.7 53.1 77.3 7.0 56.6 2.5 43.5 10.9 88.9 16.9 4.9 27.1 16.5 15.1 15.5 74.7 25.2 50.0 18.6 48.5 77.4 152.7 85.5 13.2 6.6 38.6 60.7 4.3 41.2 139.5 38.2 15.5 30.9 22.0 51.7 69.3 EFHC1 "EJM, EJM1, FLJ10466, POC9, RIB72" ENSG00000096093 "EF-hand domain containing 1" Q5JVL4 6 52362123-52529886 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 34.9" "Cell type enhanced" "Detected in many" "Early spermatids: 242.0;Endometrial ciliated cells: 227.5;Respiratory ciliated cells: 529.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035307 Approved NA NA "HPA035307: AB_2674561" "unprognostic (2.11e-1)" "unprognostic (5.22e-2)" "unprognostic (3.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-1)" "unprognostic (4.03e-3)" "unprognostic (1.60e-4)" "unprognostic (2.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.33e-4)" "unprognostic (3.04e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (5.83e-2)" "unprognostic (3.14e-1)" "unprognostic (6.53e-2)" "unprognostic (3.27e-1)" 4.2 3.9 9.5 1.9 6.2 3.6 5.4 5.2 5.8 8.3 20.7 4.7 2.1 6.8 6.8 3.3 34.9 3.6 3.5 4.7 5.0 5.6 2.6 6.5 2.4 7.9 7.0 4.3 7.4 4.5 5.6 15.7 3.6 5.5 5.6 3.3 21.9 5.2 3.8 2.1 5.8 3.9 3.4 7.6 3.4 4.3 17.7 5.2 2.1 9.4 1.3 2.0 4.7 5.4 6.9 3.5 3.9 9.3 6.4 9.0 15.3 1.8 4.1 10.6 5.5 8.6 2.4 4.1 1.5 9.0 6.8 10.5 3.6 2.7 7.6 7.1 0.8 3.3 1.4 11.0 3.3 6.2 1.5 1.6 7.3 4.2 7.8 7.2 25.9 11.7 1.7 3.1 2.4 8.4 3.1 1.7 2.3 2.8 2.7 1.5 2.3 5.1 1.9 7.4 1.3 18.5 5.2 1.0 1.8 8.4 11.8 6.5 1.6 3.8 4.0 5.3 1.5 3.2 2.1 2.8 2.7 11.2 0.5 7.3 0.7 0.6 1.5 0.7 0.2 0.3 3.8 0.3 0.6 1.4 3.9 0.3 0.6 2.0 1.5 0.3 6.1 0.2 0.4 9.5 6.2 5.2 5.8 4.7 5.0 7.9 7.0 4.3 5.5 7.6 5.2 6.9 14.5 6.4 14.9 32.7 24.2 18.1 36.0 49.5 53.5 23.1 31.3 19.2 4.5 17.2 44.7 42.3 60.5 12.6 10.2 9.9 0.0 18.8 242.0 227.5 19.0 15.0 25.0 6.5 25.6 8.0 17.8 27.1 14.3 15.3 8.2 22.6 17.5 5.6 7.8 13.5 26.3 14.9 69.2 10.6 14.5 73.8 28.3 6.9 16.0 14.0 8.8 10.9 20.6 22.1 23.8 11.0 15.9 22.2 13.8 17.4 24.8 6.9 529.7 47.5 32.9 29.3 21.3 93.5 22.8 13.2 12.1 4.5 9.0 28.8 10.1 27.8 NCR2 "CD336, LY95, NK-p44" ENSG00000096264 "Natural cytotoxicity triggering receptor 2" O95944 6 41335608-41350889 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "NK-cell: 1.7;plasmacytoid DC: 4.8" "Group enriched" "Detected in many" 17 "dendritic cells: 4.8;NK-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA067249 Uncertain NA NA "HPA067249: AB_2685811" "unprognostic (5.81e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (1.65e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.8 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.1 0.3 0.1 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 HSP90AB1 "HSPC2, HSPCB" ENSG00000096384 "Heat shock protein 90 alpha family class B member 1" P08238 6 44246166-44253888 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 4755.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005230, HPA055729, HPA072606, HPA074351" Enhanced Supported Cytosol "Intracellular and membrane" NA Yes 63000000 Cytosol "CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252" "unprognostic (6.12e-3)" "unprognostic (2.96e-3)" "unprognostic (4.72e-2)" "unprognostic (9.24e-2)" "unprognostic (4.20e-1)" "unprognostic (1.15e-3)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (3.02e-1)" "unprognostic (9.53e-2)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" 505.0 725.4 738.0 372.3 740.3 470.4 512.7 712.6 1201.2 579.8 739.1 407.0 217.8 599.8 544.8 467.5 714.7 335.5 762.7 789.8 832.5 457.7 399.8 531.5 431.2 758.2 757.4 679.9 1215.5 729.0 610.7 579.2 455.7 773.0 475.4 393.6 342.4 413.6 496.5 1390.3 472.6 335.4 531.4 777.5 348.8 543.3 253.6 791.2 365.4 460.9 1007.7 576.1 529.4 513.6 882.1 2393.2 1495.7 1298.1 1606.0 871.2 904.4 1355.3 1049.1 1021.8 1898.3 1325.5 2254.5 708.0 3029.2 1106.3 1099.8 1928.1 1349.9 3197.5 1563.4 2326.7 1010.5 1292.5 2359.3 793.9 2978.8 628.9 2386.2 1563.2 842.6 1034.9 1495.5 1277.7 1658.4 1847.6 1533.9 3210.4 1095.1 1309.8 2404.3 2003.1 1432.6 1519.7 4378.9 1129.7 1900.7 1325.9 1658.7 1287.7 1422.1 1891.1 1154.8 816.3 1164.8 1526.2 1751.5 1518.6 1178.2 1169.0 1124.0 1875.7 931.1 2440.0 1255.6 2125.8 5370.7 1221.7 1720.8 1312.1 65.9 231.7 52.8 343.7 341.0 577.8 544.0 380.3 395.0 375.1 473.1 509.3 494.0 27.3 434.9 349.0 232.1 326.8 678.5 738.0 740.3 712.6 1201.2 789.8 832.5 758.2 757.4 679.9 773.0 777.5 791.2 882.1 1165.2 897.4 678.2 70.5 906.4 1059.3 4755.7 862.6 1331.1 329.3 938.9 1418.3 1407.0 519.0 942.6 366.0 227.2 1104.3 629.3 538.6 729.8 1011.1 185.5 1385.8 1359.6 1070.6 567.4 775.9 103.5 688.9 1107.1 1247.3 616.2 1444.8 1003.4 761.3 360.5 360.3 807.5 339.9 151.0 578.2 518.8 314.5 1262.5 198.4 686.0 896.7 736.4 76.8 573.3 326.1 200.8 69.9 127.4 811.7 504.8 611.2 725.0 1810.6 361.5 664.8 1219.1 262.1 348.4 1512.7 1437.2 266.1 694.1 1232.8 923.5 1123.3 1265.6 1350.0 739.6 2408.7 MLN ENSG00000096395 Motilin P12872 6 33794673-33804003 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 316 "intestine: 257.1" "Cell type enriched" "Detected in single" 11 "Enteroendocrine cells: 3.5" "Cancer enriched" "Detected in some" 6 "testis cancer: 5.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;SuSa: 1.1;TIME: 1.3" "Low region specificity" "Detected in many" "HPA069392, HPA077622" Enhanced "Secreted to blood" NA NA 450000 200000 "HPA069392: AB_2686136, HPA077622: " "unprognostic (7.70e-2)" "unprognostic (6.70e-2)" "unprognostic (4.44e-2)" "unprognostic (3.14e-1)" 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 257.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.3 43.7 0.0 0.3 0.0 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.8 0.3 0.0 0.7 0.3 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDC5L "CDC5, CEF1, hCDC5, PCDC5RP" ENSG00000096401 "Cell division cycle 5 like" Q99459 6 44387706-44450425 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 291.8;Late spermatids: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006302, HPA011361, CAB012275" Supported Supported Nucleoplasm NA NA 22000 Nucleoplasm "CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379" "unprognostic (2.67e-1)" "unprognostic (9.31e-2)" "unprognostic (8.26e-3)" "unprognostic (4.17e-3)" "unprognostic (2.01e-2)" "unprognostic (2.17e-1)" "unprognostic (7.96e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.02e-5)" "unprognostic (1.01e-2)" "unprognostic (6.31e-2)" "unprognostic (1.63e-1)" "unprognostic (4.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" 11.6 12.1 7.4 10.8 7.7 21.5 13.6 10.8 9.4 10.4 7.9 10.6 9.5 12.1 13.3 11.0 9.8 8.8 13.9 8.1 8.1 10.6 18.8 9.6 13.5 7.3 7.6 6.9 14.1 10.2 20.0 5.8 12.1 7.7 11.9 11.4 13.3 9.7 9.5 18.0 8.5 9.5 11.8 7.6 10.6 9.8 13.3 7.5 15.5 10.9 22.7 14.2 12.2 8.1 9.3 43.0 16.5 39.8 32.5 16.0 20.7 22.5 30.6 23.8 37.9 41.5 21.7 14.4 40.8 24.8 24.7 30.8 26.6 41.8 24.2 56.4 34.5 37.6 54.5 15.4 28.1 14.6 41.3 28.2 15.9 20.9 37.0 31.9 21.7 25.0 20.7 42.6 23.3 34.7 29.0 38.4 28.1 28.0 103.5 15.1 29.6 45.7 26.4 21.5 25.2 43.8 38.0 24.7 16.5 33.3 25.4 23.2 39.6 23.0 32.4 32.8 25.5 43.7 19.9 25.8 73.8 20.9 35.3 33.2 20.2 13.1 17.5 10.4 15.7 11.8 9.9 10.0 11.7 13.0 11.3 10.7 10.4 19.9 14.8 18.1 11.2 14.6 8.5 7.4 7.7 10.8 9.4 8.1 8.1 7.3 7.6 6.9 7.7 7.6 7.5 9.3 57.3 73.7 50.3 14.7 48.5 44.2 69.2 58.0 55.8 36.4 26.7 29.5 82.2 30.0 80.5 23.9 31.3 57.5 58.2 26.8 39.2 53.4 291.8 63.7 64.2 51.5 36.1 48.1 20.6 55.2 49.4 52.2 28.5 72.1 71.0 58.8 26.7 44.7 45.3 32.0 34.7 40.7 52.9 38.6 29.8 285.9 61.5 53.1 19.6 18.7 74.3 65.8 45.3 14.1 33.0 47.8 34.5 55.3 37.7 49.0 18.6 28.6 78.6 38.1 65.7 67.9 76.2 48.2 98.7 35.6 38.4 71.7 46.8 59.8 40.8 62.5 ITPR3 IP3R3 ENSG00000096433 "Inositol 1,4,5-trisphosphate receptor type 3" Q14573 6 33620365-33696574 "Human disease related genes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 164.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003915, HPA064704" Approved Uncertain Vesicles No Yes Vesicles "HPA003915: AB_1851845, HPA064704: " "unprognostic (2.57e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.40e-2)" "unprognostic (1.24e-1)" "unprognostic (2.08e-2)" "unprognostic (6.14e-2)" "unprognostic (3.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.14e-3)" "unprognostic (1.88e-1)" "unprognostic (6.44e-3)" "unprognostic (5.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.89e-2)" "unprognostic (2.43e-2)" 16.0 11.5 5.8 17.2 4.2 6.2 14.8 3.4 5.4 15.7 4.4 25.3 29.4 8.6 13.2 18.2 14.1 15.4 13.3 3.4 3.7 14.5 2.2 30.8 20.5 5.3 4.7 2.7 13.6 11.4 2.9 7.5 4.4 4.6 14.0 18.6 0.8 18.6 11.3 4.5 57.9 35.3 4.8 4.1 40.1 41.9 15.5 6.3 14.4 54.4 5.1 21.1 12.2 24.2 5.2 73.7 34.0 6.3 0.3 6.2 19.3 40.9 24.8 62.8 30.5 27.4 46.7 55.9 62.6 26.1 17.9 76.1 70.9 28.6 66.7 15.7 36.8 24.0 0.1 102.6 52.0 14.1 11.3 7.9 14.0 59.2 76.7 164.7 66.5 52.1 24.5 25.0 19.7 33.3 35.0 19.0 6.4 6.2 55.8 49.4 29.0 0.1 37.1 107.6 50.9 57.3 2.1 42.8 61.6 60.2 6.9 21.2 5.9 71.8 41.1 20.1 53.1 55.2 13.5 14.3 29.4 32.8 16.6 24.1 0.8 0.0 0.0 0.8 0.0 0.6 0.4 0.4 0.5 0.0 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.7 0.2 5.8 4.2 3.4 5.4 3.4 3.7 5.3 4.7 2.7 4.6 4.1 6.3 5.2 12.4 48.1 58.9 0.3 13.5 26.5 10.9 27.9 18.2 1.5 9.3 9.9 2.7 12.8 20.2 31.3 0.0 0.3 10.9 52.9 0.0 28.4 123.0 19.1 9.1 18.2 23.9 6.6 1.1 30.2 6.3 9.2 127.4 43.1 0.0 0.2 12.5 0.4 0.5 0.0 1.6 41.6 10.2 0.6 6.9 220.4 23.3 2.6 12.4 23.4 3.2 0.4 4.1 0.5 0.4 89.7 41.6 13.9 18.7 20.5 45.9 0.2 12.1 1.2 6.6 3.9 3.3 1.6 3.2 14.5 25.4 0.5 13.1 5.8 35.6 20.7 ZNF184 ENSG00000096654 "Zinc finger protein 184" Q99676 6 27450743-27473118 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003226, HPA064793" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003226: AB_2218705, HPA064793: AB_2732722" "unprognostic (8.86e-2)" "unprognostic (5.55e-2)" "unprognostic (2.27e-3)" "unprognostic (1.70e-1)" "unprognostic (4.99e-3)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (1.74e-2)" "unprognostic (1.17e-2)" "prognostic favorable (4.41e-5)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (5.79e-3)" 2.9 3.1 2.5 4.3 5.8 8.9 5.5 2.3 9.8 6.1 1.2 4.5 3.4 5.4 4.1 3.8 4.5 4.1 2.9 6.6 2.6 7.0 3.6 4.1 6.4 2.0 1.5 5.5 6.1 2.7 6.0 4.1 3.1 1.8 4.4 4.5 4.4 3.5 4.3 2.9 5.8 3.6 4.3 1.7 4.6 4.4 8.4 1.4 10.3 5.7 5.1 6.6 4.5 3.0 6.0 6.4 2.0 10.8 19.7 7.6 5.6 3.6 6.2 8.3 7.1 10.9 3.6 3.7 11.7 10.3 4.0 4.8 3.9 9.7 4.0 10.3 11.4 6.0 14.0 7.3 5.1 4.0 16.9 9.7 4.1 6.0 5.2 5.4 8.4 7.8 17.8 10.9 21.1 11.9 3.2 27.3 14.3 6.3 3.5 4.5 35.4 15.2 17.5 4.9 5.9 18.4 8.9 7.0 6.0 9.2 5.3 7.0 14.4 5.3 10.8 7.1 4.9 7.2 9.6 17.4 21.8 2.4 19.4 10.9 2.1 2.7 8.0 7.9 3.7 10.9 7.4 8.3 7.7 4.1 6.9 6.3 7.9 1.4 7.0 2.9 2.5 10.4 3.9 2.5 5.8 2.3 9.8 6.6 2.6 2.0 1.5 5.5 1.8 1.7 1.4 6.0 5.4 6.4 8.1 2.0 9.8 4.1 3.8 2.5 6.8 2.5 5.1 5.5 3.5 2.8 6.4 1.8 2.1 4.3 17.5 2.1 7.9 2.7 36.9 7.9 3.7 5.1 7.1 3.4 10.3 3.0 3.0 4.5 2.0 5.0 5.1 7.4 3.9 1.5 2.8 10.1 3.4 5.1 2.0 3.8 3.8 12.6 3.4 3.6 1.8 5.6 3.0 3.3 9.2 4.0 4.2 2.5 2.1 3.8 6.5 4.6 1.6 4.5 6.3 4.8 0.0 5.2 6.8 12.8 5.9 4.3 4.4 2.9 12.5 4.6 4.4 4.5 DSP "DPI, DPII, KPPS2, PPKS2" ENSG00000096696 Desmoplakin P15924 6 7541617-7586714 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 464.4;skin 1: 861.7;vagina: 288.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 314.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1" "Region enriched" "Detected in single" 23 "hippocampal formation: 11.6" "Region enhanced" "Detected in many" "spinal cord: 9.5" "CAB037324, HPA045840, HPA054950" Enhanced Supported "Cell Junctions" NA NA 100000000 "Cell Junctions" "CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645" "unprognostic (1.65e-1)" "unprognostic (3.09e-1)" "unprognostic (6.13e-2)" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.82e-2)" "unprognostic (7.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (5.02e-2)" "unprognostic (2.94e-2)" "prognostic favorable (1.53e-9)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.82e-4)" 4.5 11.7 4.3 7.1 1.5 0.6 66.5 2.6 4.0 74.3 20.1 46.4 52.4 5.5 27.7 464.4 16.5 7.9 70.8 3.5 1.1 22.6 42.2 6.1 3.8 1.8 2.2 1.1 2.1 112.5 55.4 9.1 63.9 1.5 30.2 43.9 21.4 126.1 11.8 3.4 861.7 42.7 3.0 2.3 3.3 48.6 1.5 1.9 37.4 41.9 0.6 79.4 13.3 288.4 1.6 132.2 38.9 0.0 0.1 5.6 8.2 278.0 25.5 21.8 12.4 12.0 110.8 33.5 0.1 35.8 40.9 10.0 302.6 46.1 217.5 2.2 0.1 54.1 0.0 21.5 149.5 0.0 0.6 0.9 1.9 666.3 11.0 121.7 30.0 0.0 0.6 0.2 0.2 22.0 61.4 0.1 1.0 5.6 62.6 19.6 0.1 0.1 32.9 45.3 34.8 12.6 0.3 28.5 59.9 0.2 204.1 71.0 0.3 0.0 4.8 1.2 0.3 0.3 0.1 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.5 2.6 4.0 3.5 1.1 1.8 2.2 1.1 1.5 2.3 1.9 1.6 7.6 51.3 17.0 0.0 7.5 902.0 164.5 157.3 278.3 4.4 184.5 126.4 729.7 97.2 197.5 60.7 14.6 273.0 1.2 357.1 1.9 160.6 1.8 306.5 42.4 46.9 174.6 0.0 0.1 111.9 273.1 51.2 237.0 560.1 3.8 532.2 4.6 186.6 27.5 0.0 0.9 204.7 111.9 1.9 77.8 1.3 0.9 5.9 101.4 3.7 2.6 14.7 0.0 0.0 0.1 167.4 284.2 0.0 5.7 204.0 180.7 12.0 176.6 28.6 0.0 0.4 67.4 1.3 2.7 1657.5 2018.0 385.7 8.1 0.3 247.8 269.9 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884656-67918390 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796" "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 16.6 30.5 9.7 11.1 11.4 19.9 17.7 15.6 11.9 17.2 9.1 11.0 9.3 18.6 12.0 11.0 12.0 14.2 10.7 9.5 10.8 13.6 17.4 12.7 17.9 10.2 10.3 8.5 25.3 12.2 14.1 6.9 12.8 10.7 14.1 12.1 13.6 10.0 11.3 14.7 9.7 9.8 13.8 10.3 14.4 10.4 27.0 10.4 19.4 14.9 18.7 15.2 15.6 9.6 14.0 15.1 16.8 26.2 29.4 24.4 18.7 16.3 20.4 21.0 27.4 24.3 18.7 12.6 31.4 10.8 13.7 17.1 11.7 32.8 6.9 29.3 16.9 19.0 16.7 12.1 14.7 22.3 18.1 12.3 17.3 16.2 16.6 28.3 29.4 11.2 17.6 21.6 16.7 20.3 12.1 17.0 25.0 32.5 9.6 26.6 30.3 20.6 12.4 13.1 9.1 16.8 23.0 37.4 24.4 26.8 22.5 17.7 16.6 9.4 21.2 19.8 19.0 20.1 13.9 17.7 61.8 10.9 27.2 8.9 1.3 0.8 1.1 1.1 1.0 1.6 1.8 1.2 1.5 1.3 1.0 2.2 1.3 1.0 1.2 1.3 1.2 1.0 0.6 9.7 11.4 15.6 11.9 9.5 10.8 10.2 10.3 8.5 10.7 10.3 10.4 14.0 35.7 19.2 7.4 17.0 27.6 39.1 20.9 7.2 22.8 12.5 48.3 33.4 34.8 11.5 8.7 5.5 27.1 7.1 42.5 31.2 5.9 4.3 292.2 38.4 26.2 20.6 42.9 10.3 16.0 5.6 5.4 28.0 23.4 57.1 12.0 14.8 15.4 15.8 9.1 11.8 18.4 21.0 10.2 23.4 28.7 45.6 17.7 34.1 16.0 30.9 14.8 7.1 9.2 18.6 30.7 6.2 20.6 19.5 15.8 26.0 11.2 8.4 4.1 14.0 0.0 43.4 28.8 24.2 16.3 21.1 47.5 12.4 29.1 8.9 18.7 17.2 HNRNPH3 "2H9, HNRPH3" ENSG00000096746 "Heterogeneous nuclear ribonucleoprotein H3" P31942 10 68331174-68343193 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038264 Supported Nucleoplasm NA NA 650000 Nucleoplasm "HPA038264: AB_10697246" "unprognostic (1.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.85e-1)" "unprognostic (7.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (6.17e-2)" "unprognostic (8.29e-2)" "unprognostic (1.75e-1)" "unprognostic (2.32e-1)" "unprognostic (9.81e-3)" "unprognostic (2.75e-3)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-1)" "unprognostic (1.06e-3)" 65.1 65.9 86.4 66.3 87.3 102.6 59.3 86.2 94.0 79.9 75.5 72.0 56.9 93.4 44.8 55.6 72.7 44.5 67.9 80.9 88.9 66.0 57.2 64.1 79.7 94.5 88.2 77.4 110.7 45.1 54.8 55.4 83.9 91.5 60.4 64.3 81.8 48.0 60.8 92.9 63.8 65.1 68.6 92.2 64.4 59.7 69.7 89.0 99.0 75.8 67.5 78.8 69.2 69.8 92.7 233.2 220.5 343.4 107.6 131.8 81.0 221.6 199.1 104.2 183.2 150.0 379.3 200.7 364.7 106.8 132.5 145.2 151.9 280.2 192.8 280.9 226.4 148.2 282.9 194.1 231.7 115.4 326.9 149.4 53.6 172.7 209.0 368.0 151.0 142.8 191.2 356.8 122.7 205.2 323.6 291.3 350.6 229.2 169.0 258.6 239.6 288.2 119.0 148.3 189.7 155.0 168.5 211.9 144.2 221.7 195.4 153.7 164.5 154.6 170.9 284.8 89.8 273.4 147.6 213.7 368.2 94.1 159.0 135.1 22.7 18.6 37.6 17.0 21.2 18.1 16.2 20.4 20.2 21.6 16.2 25.7 21.6 23.8 22.3 26.0 17.6 20.2 13.4 86.4 87.3 86.2 94.0 80.9 88.9 94.5 88.2 77.4 91.5 92.2 89.0 92.7 133.6 102.5 117.3 33.6 111.1 325.8 275.5 99.9 113.3 114.2 83.2 102.6 115.5 64.3 114.5 73.5 95.9 149.6 111.7 71.6 60.7 89.6 29.0 108.2 138.9 125.7 107.7 127.9 39.8 83.8 202.2 143.6 69.3 162.5 141.1 111.5 75.0 39.6 95.5 87.5 41.9 80.2 73.2 69.5 153.2 21.1 96.3 97.1 129.9 50.6 105.7 107.8 75.2 51.8 84.6 76.8 99.7 120.4 97.9 214.3 84.6 72.0 115.2 146.7 131.5 150.0 174.6 277.3 164.5 89.7 266.8 191.8 128.5 90.8 84.4 215.1 IFT74 "CCDC2, CMG-1, CMG1, FLJ22621" ENSG00000096872 "Intraflagellar transport 74" Q96LB3 9 26947039-27066134 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.4" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 93.2;Respiratory ciliated cells: 97.4;Spermatocytes: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020247, HPA026684" Approved NA NA "HPA020247: AB_1846140, HPA026684: AB_1846141" "unprognostic (3.84e-2)" "unprognostic (1.76e-1)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.70e-1)" "unprognostic (1.54e-2)" "unprognostic (1.84e-2)" "unprognostic (1.24e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-1)" "unprognostic (2.65e-1)" "unprognostic (3.62e-2)" "unprognostic (2.93e-1)" "unprognostic (2.43e-1)" 7.4 12.9 5.8 6.5 4.7 6.7 15.1 5.8 5.7 13.5 12.8 9.0 4.6 12.5 22.6 8.4 22.0 6.7 8.4 4.8 6.0 12.3 11.9 7.9 6.2 6.0 5.6 4.3 12.6 8.4 16.8 12.6 9.8 5.3 11.8 9.0 14.8 7.7 13.4 9.2 7.2 6.0 10.5 5.2 8.2 6.8 49.4 5.3 10.1 20.5 9.0 7.5 8.4 7.8 5.5 15.3 26.2 24.3 18.8 17.5 29.4 6.1 16.8 26.8 20.7 17.8 2.9 10.3 6.7 13.9 17.9 21.8 12.8 18.6 23.6 22.8 17.3 8.6 17.0 10.5 12.0 27.8 10.6 16.3 22.9 32.9 24.8 42.6 25.6 13.4 1.4 12.0 22.8 31.4 6.3 12.4 25.9 15.4 11.7 10.7 7.5 9.8 17.0 31.1 9.3 21.0 21.2 11.0 15.2 9.1 14.8 23.2 14.6 9.1 0.0 20.0 5.1 15.6 7.5 24.5 5.4 9.8 12.6 9.5 2.3 6.2 2.0 5.8 7.3 4.7 12.4 6.1 5.8 9.2 12.6 10.3 7.7 0.4 12.1 7.0 7.8 6.1 3.9 5.8 4.7 5.8 5.7 4.8 6.0 6.0 5.6 4.3 5.3 5.2 5.3 5.5 10.1 32.1 27.4 27.4 8.2 7.8 15.8 24.4 10.2 23.9 12.1 16.0 29.1 7.2 28.4 16.5 22.9 23.1 3.4 17.2 21.5 26.5 84.5 93.2 27.6 12.1 13.2 10.7 15.5 22.7 10.6 14.8 7.1 23.1 16.5 19.2 8.9 8.6 15.8 28.6 17.8 13.5 8.2 49.6 4.5 36.1 20.2 9.3 5.4 19.7 8.3 25.2 1.0 23.1 24.2 11.7 10.5 18.0 7.7 6.0 10.2 33.1 97.4 43.5 19.7 18.1 25.4 208.2 29.9 9.7 8.4 10.9 8.3 35.9 17.2 7.3 JAK2 JTK10 ENSG00000096968 "Janus kinase 2" O60674 9 4984390-5129948 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 132.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 132.5" "Group enriched" "Detected in many" 5 "ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013089, HPA040820, HPA043870" Approved Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" No No Nucleoplasm "Plasma membrane, Focal adhesion sites" "CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708" "unprognostic (2.24e-3)" "unprognostic (2.76e-2)" "unprognostic (1.50e-2)" "unprognostic (7.67e-2)" "unprognostic (5.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" "unprognostic (3.85e-1)" "unprognostic (4.53e-2)" "unprognostic (3.43e-2)" "unprognostic (1.96e-1)" "unprognostic (7.37e-3)" 15.7 7.7 3.3 19.4 3.7 21.9 8.9 6.3 7.0 7.9 3.7 6.8 6.6 11.4 8.6 8.9 8.0 10.6 24.7 2.9 3.5 6.9 4.6 11.0 18.3 3.7 1.8 1.0 11.6 3.8 6.5 2.9 11.0 2.6 6.9 6.6 12.9 4.0 6.2 9.9 10.9 7.8 9.6 2.3 17.8 13.5 9.9 2.0 7.5 4.9 9.0 12.8 11.8 9.2 5.0 6.8 3.7 3.7 6.3 42.2 12.4 1.1 9.1 8.6 7.2 4.6 1.2 2.0 0.3 2.1 5.4 5.4 2.3 4.4 5.1 4.9 75.0 1.4 154.7 7.6 1.7 10.0 10.5 7.1 9.5 2.1 2.8 4.5 7.6 6.6 5.1 10.9 17.4 11.6 2.2 2.9 12.8 3.3 3.3 4.3 5.1 8.2 2.2 4.7 3.5 4.2 2.4 2.6 3.5 2.8 3.6 2.0 15.4 13.1 10.2 3.6 10.7 6.4 3.1 6.4 1.5 13.6 4.7 5.3 132.5 20.5 38.2 5.6 20.1 4.5 5.6 4.1 3.1 26.5 4.9 2.2 2.8 19.2 9.6 16.4 9.7 4.5 7.7 3.3 3.7 6.3 7.0 2.9 3.5 3.7 1.8 1.0 2.6 2.3 2.0 5.0 14.3 16.0 7.9 31.6 12.9 9.7 3.3 4.9 10.8 8.0 5.2 3.4 30.0 0.0 6.7 7.3 8.4 1.9 13.9 11.7 1.9 3.3 8.6 5.1 11.2 9.4 3.0 19.8 93.4 3.9 0.9 8.9 38.7 5.6 14.0 11.4 4.6 1.9 14.2 8.4 122.3 4.5 0.0 33.6 28.8 7.1 23.6 38.9 5.4 106.8 49.5 12.6 8.2 69.9 42.3 7.0 20.9 33.4 10.7 3.0 3.9 3.3 7.1 11.2 0.0 9.7 12.5 15.0 5.5 11.6 8.4 3.4 10.4 5.1 4.1 4.5 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.8" "Cell type enhanced" "Detected in some" "dendritic cells: 35.1;Kupffer cells: 13.9;NK-cells: 69.0;Plasma cells: 15.3;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.8;HDLM-2: 35.2;Karpas-707: 57.8;U-698: 15.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA074414: AB_2686687" "unprognostic (7.70e-3)" "prognostic favorable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 2.1 1.2 1.1 15.3 1.8 9.4 0.9 1.0 1.9 1.0 1.9 3.1 4.6 0.7 0.8 1.6 0.8 3.5 0.7 1.1 1.9 0.9 2.2 5.8 24.8 2.4 1.5 1.1 0.6 0.5 1.3 0.5 1.6 2.3 0.9 3.0 0.5 1.7 0.6 0.7 1.6 7.0 1.9 1.2 16.4 4.1 0.8 1.8 6.7 0.7 0.2 14.2 4.1 0.5 3.7 0.3 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.1 0.5 1.0 0.3 2.2 18.8 0.1 0.2 0.7 0.3 0.0 0.0 0.0 35.2 0.2 2.2 0.6 0.3 1.0 0.9 3.1 0.1 0.0 0.5 0.0 0.2 0.1 5.1 0.3 57.8 0.0 0.2 9.7 0.3 0.1 0.1 0.0 6.7 0.1 0.8 0.0 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.4 9.7 0.4 0.5 0.4 0.2 0.2 6.6 11.0 15.2 0.6 12.1 1.1 8.5 12.5 9.2 50.9 34.7 64.0 11.5 34.8 41.7 14.7 9.1 19.3 34.0 14.7 40.9 34.0 8.1 53.0 24.3 1.1 1.8 1.0 1.9 1.1 1.9 2.4 1.5 1.1 2.3 1.2 1.8 3.7 0.5 0.0 3.0 0.3 9.6 0.3 2.1 0.1 0.6 0.0 0.3 0.5 1.0 1.5 0.6 0.0 0.0 0.2 35.1 0.1 0.0 0.0 0.5 0.5 0.2 0.5 0.0 5.2 0.8 0.0 0.8 0.7 3.1 0.7 4.5 0.0 0.4 0.1 6.4 0.0 0.4 0.0 0.0 13.9 4.0 0.0 0.0 11.7 0.0 3.7 11.9 0.0 69.0 0.0 2.6 0.1 0.0 0.0 15.3 0.5 0.4 0.2 0.2 0.0 0.0 0.7 0.3 0.4 0.1 0.0 0.9 0.1 31.5 0.0 0.2 1.3 ABL1 "ABL, c-ABL, JTK7, p150" ENSG00000097007 "ABL proto-oncogene 1, non-receptor tyrosine kinase" P00519 9 130713016-130887675 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 71.2;Oligodendrocytes: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002686, HPA027251, HPA027280, HPA028409" Supported Enhanced "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011" "unprognostic (4.82e-2)" "unprognostic (3.99e-2)" "unprognostic (5.55e-2)" "unprognostic (4.72e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.75e-3)" "unprognostic (1.89e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-2)" "unprognostic (1.09e-2)" "unprognostic (1.48e-1)" "unprognostic (3.96e-3)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 49.7 30.9 26.2 25.5 34.2 23.6 46.1 30.7 27.5 59.2 35.6 79.4 23.3 63.5 11.7 34.1 56.1 36.0 36.1 22.8 45.9 23.2 17.6 37.7 16.4 36.4 35.6 19.9 56.4 25.1 32.8 35.2 26.7 35.7 43.9 26.9 14.3 32.7 34.0 29.6 35.1 45.5 41.5 30.8 23.5 52.1 20.2 30.6 22.6 47.1 31.0 15.5 80.0 43.1 39.1 22.5 48.3 53.6 62.9 76.5 93.3 18.8 38.8 60.4 44.8 38.1 36.4 28.3 32.3 22.3 52.0 47.6 42.5 23.5 36.0 30.7 20.6 16.3 23.7 84.1 33.4 51.8 36.5 32.3 68.8 37.2 80.6 50.0 64.1 61.0 47.9 135.8 26.5 54.9 42.0 49.2 30.5 57.9 34.3 33.8 55.9 67.9 35.9 45.0 25.7 47.9 60.1 66.1 23.5 29.2 31.0 46.2 33.1 71.1 170.7 44.1 66.3 62.6 8.4 20.3 47.9 72.1 27.6 55.1 0.0 0.7 0.3 0.6 0.4 0.8 1.3 0.6 0.6 0.7 0.4 0.6 0.5 0.0 0.8 1.9 1.0 0.3 0.6 26.2 34.2 30.7 27.5 22.8 45.9 36.4 35.6 19.9 35.7 30.8 30.6 39.1 16.2 9.6 13.6 54.9 4.7 9.2 7.3 9.8 5.2 8.2 11.6 10.2 6.2 7.2 7.2 14.7 12.5 13.6 12.1 21.2 1.9 14.4 5.9 8.6 29.7 18.1 22.1 4.6 52.5 11.1 4.3 36.7 5.6 12.4 2.5 22.1 20.3 15.9 16.6 10.1 63.7 17.5 6.1 16.4 11.7 8.8 28.0 10.2 5.4 71.2 6.6 19.2 6.2 66.9 116.0 17.9 18.3 25.6 5.6 8.6 11.6 10.3 7.8 9.1 19.7 29.5 19.8 16.9 16.5 6.6 6.8 15.2 7.9 20.1 21.4 7.2 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6393767 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 157.6" "Cell type enhanced" "Detected in many" "granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "NK-cell: 40.2;plasmacytoid DC: 35.7" "Group enriched" "Detected in many" 5 "dendritic cells: 35.7;NK-cells: 40.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol No No 26000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 11.0 20.6 70.8 18.8 82.2 14.9 10.0 64.6 117.3 15.5 27.9 30.7 55.6 18.3 5.5 35.3 11.1 8.3 14.4 79.2 93.9 48.2 22.2 18.0 22.6 100.3 107.7 85.0 11.3 9.0 3.8 65.6 10.5 121.1 13.0 21.6 24.7 12.0 6.9 5.2 24.6 56.6 23.7 56.2 20.8 19.4 38.4 107.6 28.6 6.2 4.7 19.6 18.1 23.7 157.6 117.6 100.0 96.6 104.6 21.7 35.6 36.4 98.6 50.6 142.7 85.1 347.7 37.0 142.4 70.6 80.4 110.3 113.0 156.9 263.2 53.2 126.0 136.7 75.2 74.4 124.9 88.7 88.8 59.9 32.1 49.6 118.2 139.2 38.1 81.2 174.8 62.3 29.8 76.8 136.6 187.0 94.0 48.5 116.9 228.2 219.9 110.6 95.6 80.9 44.2 52.6 149.1 88.9 134.5 317.9 47.3 47.9 41.2 133.0 129.1 75.4 129.6 158.9 24.9 110.6 202.1 81.8 153.7 80.3 0.0 0.3 0.2 7.3 1.2 1.8 2.1 5.8 6.2 5.4 0.7 2.0 3.9 0.7 40.2 0.9 35.7 8.2 5.3 70.8 82.2 64.6 117.3 79.2 93.9 100.3 107.7 85.0 121.1 56.2 107.6 157.6 3.4 6.4 16.4 9.4 4.9 31.7 16.5 24.2 12.5 46.8 4.1 7.5 9.8 8.6 14.9 9.2 10.4 20.9 14.4 45.4 15.6 22.7 95.5 4.0 6.1 19.1 4.8 26.5 38.6 7.2 29.7 11.5 19.9 7.6 137.2 13.2 8.6 16.8 30.1 47.1 38.9 110.2 36.7 4.8 85.9 160.8 3.7 13.4 39.2 5.6 15.7 12.8 8.2 22.6 21.0 23.2 41.8 7.2 9.3 9.5 179.4 253.7 7.1 24.4 0.0 6.7 17.6 37.8 28.0 26.2 29.5 17.2 21.7 13.7 51.3 19.6 SH3GLB1 "Bif-1, CGI-61, KIAA0491, PPP1R70" ENSG00000097033 "SH3 domain containing GRB2 like, endophilin B1" Q9Y371 1 86704570-86748184 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 634.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 301.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004650, HPA015608, HPA019900" Enhanced Supported Cytosol NA NA 28000 Cytosol "CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356" "unprognostic (1.72e-2)" "unprognostic (1.76e-1)" "unprognostic (5.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (8.34e-2)" "unprognostic (1.75e-1)" "unprognostic (4.29e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (1.56e-1)" "unprognostic (4.04e-3)" "unprognostic (7.70e-2)" "unprognostic (2.65e-1)" "unprognostic (1.88e-2)" "unprognostic (1.69e-1)" 107.5 38.4 20.9 55.8 23.4 66.8 56.6 22.7 25.6 39.6 19.3 54.2 48.9 36.2 31.3 80.1 28.1 47.4 73.5 20.0 28.8 40.8 45.3 49.4 41.3 26.3 21.9 19.0 24.4 64.5 41.6 30.6 58.0 24.8 34.6 58.5 39.3 56.9 36.5 173.4 35.5 47.4 50.7 25.1 46.9 36.6 110.4 21.3 34.4 38.9 99.3 52.3 64.4 42.1 28.4 78.1 28.1 44.2 40.4 180.1 155.1 72.2 115.1 114.5 106.8 112.3 81.4 63.3 39.7 72.0 143.5 132.9 44.5 39.4 75.0 101.2 86.1 28.1 94.7 39.2 87.1 108.7 51.5 92.4 111.8 85.5 118.3 128.7 114.5 171.4 41.7 36.0 108.5 145.1 23.1 46.7 32.7 43.0 56.8 47.6 53.1 184.6 29.7 92.3 132.2 47.9 34.7 64.8 82.4 140.8 65.2 32.7 51.8 151.4 102.2 61.9 129.3 96.5 56.8 56.3 58.6 50.8 52.1 63.5 153.0 59.0 66.5 43.0 64.5 42.4 36.8 40.2 43.8 45.5 35.3 19.1 34.3 301.4 62.4 77.0 43.8 65.4 49.5 20.9 23.4 22.7 25.6 20.0 28.8 26.3 21.9 19.0 24.8 25.1 21.3 28.4 192.0 83.3 65.6 39.2 75.0 89.6 119.5 124.1 44.3 31.2 96.9 69.1 157.0 60.1 104.0 55.2 52.1 84.3 145.7 182.0 86.1 145.2 634.6 86.3 104.5 135.4 86.6 64.4 49.9 169.8 203.4 99.7 45.9 110.0 113.5 61.0 157.1 79.4 143.7 16.8 50.5 130.3 128.1 149.2 99.4 236.9 70.2 116.0 81.8 40.3 163.7 71.9 124.6 46.8 65.2 201.7 173.4 85.0 123.9 103.4 108.8 134.0 90.2 55.4 78.9 146.7 111.7 403.5 86.3 100.6 118.1 101.9 90.4 57.1 87.4 199.8 CDC7 "CDC7L1, HsCdc7, Hsk1, huCdc7" ENSG00000097046 "Cell division cycle 7" O00311 1 91500851-91525764 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.0" "Cell type enhanced" "Detected in many" "Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002669, HPA035831" Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "CAB002669: , HPA035831: AB_2674807" "unprognostic (6.84e-2)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (7.02e-3)" "unprognostic (5.57e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (3.15e-6)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (1.36e-3)" "unprognostic (2.04e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.89e-15)" "unprognostic (9.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.09e-1)" "unprognostic (5.39e-2)" 1.8 2.7 3.3 6.0 4.0 13.9 2.1 6.3 4.8 2.0 2.0 3.1 3.1 1.8 1.7 3.5 1.3 1.7 1.4 3.7 3.8 2.4 1.5 4.2 9.4 3.1 4.0 3.8 2.5 1.6 0.8 4.1 6.0 4.4 1.9 4.7 14.2 1.7 1.4 0.5 5.2 3.7 2.4 2.7 12.2 1.8 17.0 3.8 11.0 1.7 0.5 9.5 2.5 2.4 3.8 32.0 9.4 59.1 17.3 1.4 7.6 18.8 12.0 9.1 22.6 24.3 19.6 10.8 22.5 16.1 7.7 19.8 13.7 39.8 13.5 29.4 36.8 34.3 33.7 27.9 9.5 2.1 37.0 11.9 4.2 4.0 21.0 11.9 4.1 8.9 30.9 44.8 31.4 15.2 11.8 31.5 33.5 48.9 17.2 21.6 38.9 49.5 14.5 10.2 24.0 44.7 18.6 37.5 10.2 21.6 14.3 9.8 18.2 7.3 25.8 22.7 20.6 17.9 11.6 15.6 57.9 9.4 36.0 9.4 0.0 1.0 0.0 3.8 0.7 3.2 0.9 2.8 3.5 2.3 0.9 1.5 3.0 0.1 1.6 0.2 1.4 4.6 1.4 3.3 4.0 6.3 4.8 3.7 3.8 3.1 4.0 3.8 4.4 2.7 3.8 3.8 1.9 0.0 1.1 3.3 3.2 5.9 1.2 2.7 3.4 8.2 14.4 1.4 2.1 0.0 1.3 1.8 0.0 8.2 4.1 0.6 3.9 1.5 37.8 1.1 4.9 4.1 0.0 23.1 18.3 2.6 6.3 3.1 2.6 1.9 4.5 15.4 4.2 0.2 2.7 3.3 19.6 1.8 6.1 2.2 2.9 18.7 0.9 1.6 3.6 5.6 2.1 1.6 6.2 16.6 3.1 1.2 1.7 0.7 7.1 0.9 0.5 0.4 2.0 5.1 6.6 1.5 4.1 30.5 21.4 4.3 3.7 2.2 5.3 7.6 3.6 1.0 SYDE2 FLJ13815 ENSG00000097096 "Synapse defective Rho GTPase homolog 2" Q5VT97 1 85156889-85201016 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Cone photoreceptor cells: 54.2;Rod photoreceptor cells: 145.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.6;SK-BR-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027138, HPA058378" Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus" No No "Nucleoli, Nucleoli rim, Golgi apparatus" "HPA027138: AB_1857686, HPA058378: AB_2683696" "unprognostic (1.68e-1)" "unprognostic (8.90e-2)" "unprognostic (2.34e-2)" "unprognostic (3.43e-3)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (3.84e-3)" "unprognostic (6.47e-3)" "unprognostic (4.39e-2)" "unprognostic (1.85e-1)" "unprognostic (3.88e-2)" "unprognostic (4.05e-1)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (7.51e-2)" "unprognostic (6.69e-2)" 1.1 0.6 0.8 0.9 0.7 0.5 2.0 0.2 1.3 0.8 3.5 3.5 1.5 1.5 0.7 1.1 0.8 2.2 3.2 1.9 1.6 2.5 3.6 3.4 0.3 0.9 0.8 0.6 1.6 1.8 4.3 0.7 2.7 0.4 1.3 1.5 7.7 1.9 1.3 0.4 0.7 1.5 2.2 0.9 0.5 1.8 1.7 0.5 0.4 2.5 1.6 0.3 1.9 0.6 0.5 2.1 0.6 0.6 0.8 2.2 0.6 14.6 2.3 1.4 1.4 2.1 4.0 0.7 0.0 0.8 1.5 2.7 3.9 7.3 1.0 2.1 0.9 2.0 1.9 1.7 1.4 2.6 1.2 0.4 1.0 1.2 1.0 0.9 0.9 0.3 1.3 2.4 0.0 1.0 2.9 1.2 0.2 3.7 1.6 0.9 0.0 3.9 0.5 1.0 5.2 0.1 0.0 1.6 8.0 2.4 3.3 1.8 1.6 0.3 1.7 3.8 0.0 2.3 0.0 0.3 0.8 0.2 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.2 1.3 1.9 1.6 0.9 0.8 0.6 0.4 0.9 0.5 0.5 3.1 51.3 12.4 9.4 1.1 8.3 8.0 1.7 8.0 6.8 10.0 6.5 24.4 4.3 6.9 1.8 54.2 10.8 0.5 2.5 7.9 1.9 3.1 11.0 2.9 2.1 19.2 3.0 12.6 4.7 4.7 7.8 3.6 5.2 1.3 4.4 3.6 8.4 1.5 0.0 5.2 4.1 2.0 0.3 4.0 1.6 2.1 0.7 19.6 1.9 1.7 9.4 1.0 5.5 0.2 3.6 1.3 2.6 0.7 6.9 8.1 5.8 14.0 145.4 0.0 6.3 5.2 16.6 9.0 8.5 4.5 2.6 3.3 6.6 4.5 4.5 PCSK5 "PC5, PC6, SPC6" ENSG00000099139 "Proprotein convertase subtilisin/kexin type 5" Q92824 9 75890644-76362975 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Pregnancy "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Cell type enhanced" "Detected in many" "Astrocytes: 189.7;Inhibitory neurons: 81.9;NK-cells: 82.4;Oligodendrocyte precursor cells: 149.3;Proximal enterocytes: 99.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 2447.1;neutrophil: 626.3" "Lineage enriched" "Detected in all" 18 "granulocytes: 2447.1" "Cell line enhanced" "Detected in many" "BEWO: 32.6;HaCaT: 46.9;RH-30: 30.4;RPTEC TERT1: 42.5;U-2 OS: 66.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031072 Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 290000 "Golgi apparatus" "HPA031072: AB_10602190" "unprognostic (3.28e-2)" "unprognostic (1.44e-1)" "unprognostic (4.13e-4)" "unprognostic (4.08e-2)" "unprognostic (7.43e-3)" "unprognostic (3.17e-1)" "unprognostic (2.07e-3)" "unprognostic (9.39e-2)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (2.81e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (2.99e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-2)" "unprognostic (1.77e-5)" 17.8 4.2 7.1 5.9 5.3 2.3 6.9 20.2 30.4 9.1 4.5 10.3 25.3 7.2 9.7 8.6 7.0 8.6 4.9 5.7 14.4 3.9 1.7 6.1 2.8 21.7 6.3 4.8 13.6 3.1 5.9 2.3 9.5 21.3 3.4 8.5 6.0 3.6 3.0 3.0 3.4 26.7 6.6 18.9 3.4 3.3 6.4 12.2 9.2 4.8 5.5 2.6 5.3 8.9 36.1 2.5 1.8 5.1 3.4 3.2 1.0 32.6 4.7 0.4 0.3 0.0 18.7 2.0 0.8 1.3 0.6 0.1 46.9 2.4 1.4 0.3 0.6 4.1 6.3 4.5 1.6 0.8 1.9 2.8 6.0 0.4 1.0 0.5 0.3 9.6 3.1 7.5 2.4 3.3 11.5 7.4 11.1 22.8 4.3 1.9 1.3 30.4 1.9 42.5 2.9 0.7 0.5 7.1 1.5 0.5 9.5 2.6 8.0 7.6 1.5 66.5 3.8 2.0 0.7 0.3 1.0 5.1 2.7 25.7 2447.1 43.1 192.4 100.0 25.9 85.2 92.3 100.8 93.7 21.8 116.5 98.2 125.2 626.3 135.5 51.6 135.0 96.9 10.1 7.1 5.3 20.2 30.4 5.7 14.4 21.7 6.3 4.8 21.3 18.9 12.2 36.1 41.1 6.4 7.2 189.7 0.1 6.5 3.5 8.6 13.6 4.8 0.7 2.0 5.8 11.5 14.3 5.5 0.0 2.1 9.6 47.3 0.0 8.2 19.0 6.0 35.1 19.5 1.2 0.0 33.5 6.1 34.3 26.6 9.7 10.6 0.0 32.1 15.0 0.9 2.9 55.5 81.9 10.2 6.1 4.1 3.9 39.4 20.5 7.5 1.8 70.3 11.4 30.3 82.4 149.3 5.8 10.1 18.5 25.2 0.4 2.9 99.2 4.2 23.4 1.4 19.7 9.1 11.4 1.0 1.9 6.2 3.0 2.5 6.2 5.6 23.9 0.9 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347233-100364826 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 1244.7;brain: 876.8;liver: 588.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 389.6;Granulosa cells: 187.3;Hepatocytes: 840.3;Oligodendrocytes: 451.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 2534.2;CAPAN-2: 1824.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" No Yes "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: AB_2685154" "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (7.79e-5)" 1244.7 132.2 439.0 25.9 535.2 23.2 263.6 568.2 480.6 25.1 203.6 43.3 94.0 15.6 25.8 108.7 5.0 29.0 47.4 378.1 495.7 18.7 588.5 144.1 17.3 771.7 610.5 345.6 50.1 22.8 80.2 10.3 20.1 674.9 101.0 40.1 18.0 113.4 11.3 6.2 26.3 36.3 16.1 687.9 15.4 25.4 52.3 544.8 18.6 13.1 7.3 21.1 22.7 42.3 876.8 411.2 373.3 777.6 536.4 2534.2 1449.4 158.2 43.4 948.3 101.6 536.6 323.8 1824.4 173.3 33.7 102.2 461.8 716.4 433.7 1549.5 88.9 59.4 179.6 97.5 219.3 653.4 488.4 136.9 100.9 795.5 459.4 395.0 688.9 273.1 196.2 375.3 275.4 513.3 41.7 646.8 155.9 163.3 270.7 120.7 106.3 72.6 287.4 550.4 443.8 455.3 48.9 185.3 85.8 399.7 834.9 224.2 447.7 291.3 79.0 10.0 115.9 9.1 89.8 141.4 81.5 262.9 184.4 416.0 65.9 0.0 0.8 0.0 1.4 1.6 2.3 0.6 0.5 0.7 2.7 0.9 0.4 1.3 0.1 1.4 0.0 1.5 0.0 1.2 439.0 535.2 568.2 480.6 378.1 495.7 771.7 610.5 345.6 674.9 687.9 544.8 876.8 3.8 54.5 389.6 34.0 15.7 3.7 4.5 121.8 0.6 6.5 16.1 6.2 11.2 28.6 66.2 0.0 6.2 3.0 4.7 21.5 0.0 14.6 52.6 13.9 9.0 12.5 25.8 15.8 4.8 67.9 71.7 15.9 25.0 26.9 6.3 187.3 32.9 840.3 34.1 26.9 5.2 16.4 52.9 113.5 4.2 93.0 3.7 21.2 58.7 8.4 10.2 11.9 2.1 18.6 451.5 29.6 2.7 1.5 3.7 31.4 16.2 4.9 31.0 6.2 0.0 3.6 25.7 2.0 1.2 26.7 2.3 17.4 6.6 97.8 38.9 8.2 TMED1 "Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L" ENSG00000099203 "Transmembrane p24 trafficking protein 1" Q13445 19 10832067-10836318 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018507 Uncertain NA NA "HPA018507: AB_1858063" "unprognostic (6.98e-2)" "unprognostic (3.42e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (2.27e-1)" "unprognostic (1.98e-2)" "unprognostic (4.20e-2)" "unprognostic (9.86e-2)" "unprognostic (7.27e-2)" "unprognostic (9.52e-2)" "unprognostic (4.93e-2)" "prognostic favorable (8.66e-5)" "unprognostic (9.49e-2)" "unprognostic (2.56e-1)" "unprognostic (5.16e-2)" "unprognostic (2.45e-2)" 23.6 31.5 12.3 15.6 13.9 21.7 25.3 14.7 17.4 29.5 21.7 18.9 19.1 25.2 16.4 20.1 25.0 18.9 37.4 12.1 17.8 38.0 52.3 19.8 14.4 15.7 13.9 11.0 34.7 34.8 24.7 36.2 21.6 14.1 26.7 8.2 4.5 24.4 14.9 65.0 19.2 17.6 10.7 14.4 22.5 26.5 20.3 14.1 10.3 29.0 35.3 7.0 22.5 21.1 16.9 40.4 63.3 26.7 43.6 26.2 28.5 27.8 63.3 53.0 59.0 82.3 59.2 57.2 29.1 146.5 46.0 30.8 32.2 18.8 33.4 23.6 44.2 38.5 41.5 49.8 48.5 35.4 35.2 91.4 42.2 35.1 34.9 24.9 25.8 37.4 22.3 30.3 80.6 25.3 63.9 25.4 38.0 41.3 23.6 60.5 27.8 22.9 44.6 35.0 33.3 29.5 29.0 37.6 37.0 33.9 11.2 43.8 38.5 41.5 75.1 34.4 80.3 71.6 48.9 56.6 27.8 58.1 63.5 41.6 12.3 94.6 44.3 59.3 94.0 40.9 50.9 39.9 48.6 81.1 42.2 36.6 40.5 35.7 122.8 103.0 59.9 38.9 66.0 12.3 13.9 14.7 17.4 12.1 17.8 15.7 13.9 11.0 14.1 14.4 14.1 16.9 20.2 9.6 15.3 4.6 16.5 18.5 24.4 53.9 12.0 10.2 31.8 32.0 0.2 41.5 33.0 53.3 8.4 111.5 24.5 22.7 41.1 54.4 5.5 30.9 26.7 26.4 23.5 30.7 1.0 44.2 94.0 38.1 15.8 21.7 27.3 43.7 24.3 43.9 52.5 5.0 1.2 21.1 46.8 20.2 16.6 6.3 22.4 20.0 42.7 1.0 25.0 40.3 28.8 4.0 3.2 41.7 35.5 20.3 24.4 35.4 37.7 57.4 42.9 18.0 32.9 28.9 27.1 21.7 30.9 14.8 17.5 146.3 15.1 62.3 28.8 23.3 ABLIM1 "ABLIM, LIMAB1, limatin" ENSG00000099204 "Actin binding LIM protein 1" O14639 10 114431113-114768061 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 875.6;Cardiomyocytes: 592.5;Peritubular cells: 413.0;Squamous epithelial cells: 481.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 139.1" "Group enriched" "Detected in many" 7 "B-cells: 52.2;NK-cells: 63.6;T-cells: 139.1" "Cell line enhanced" "Detected in many" "hTCEpi: 164.1;OE19: 159.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038951, HPA038952" Approved Supported Cytosol NA NA 6000 Cytosol "HPA038951: AB_10673017, HPA038952: AB_10670915" "unprognostic (2.25e-2)" "unprognostic (3.96e-2)" "unprognostic (2.91e-1)" "unprognostic (1.26e-1)" "unprognostic (5.89e-3)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (5.07e-2)" "unprognostic (4.39e-2)" "unprognostic (1.05e-1)" "unprognostic (3.20e-2)" "unprognostic (3.23e-1)" "prognostic favorable (2.72e-5)" "unprognostic (2.77e-2)" "unprognostic (1.92e-1)" "unprognostic (3.22e-1)" "unprognostic (5.87e-2)" 74.0 94.3 68.3 36.0 61.6 13.7 55.2 262.6 62.2 36.2 66.9 47.2 37.6 37.6 26.9 207.5 51.7 33.8 267.9 55.8 73.6 55.2 28.5 54.9 50.4 88.3 66.8 42.8 235.6 32.4 42.7 22.2 31.7 129.7 24.2 58.4 111.1 99.0 26.8 75.8 98.3 34.5 29.5 76.8 20.3 121.8 41.7 65.6 57.3 113.9 112.6 89.9 42.4 90.1 81.9 48.2 34.7 120.2 27.2 1.1 0.4 1.5 9.6 3.2 2.4 6.7 49.0 76.7 61.8 128.7 11.1 18.1 101.4 41.1 66.2 3.1 21.2 35.5 0.5 96.0 128.8 0.5 24.6 0.4 1.5 164.1 18.1 52.1 50.3 47.5 21.4 0.2 93.3 0.5 17.5 5.0 10.8 47.0 159.5 38.4 2.1 29.3 80.3 38.4 105.6 41.7 51.4 40.4 59.2 21.0 60.0 30.7 0.3 32.1 0.1 43.1 1.1 18.3 0.5 0.3 140.0 2.3 54.0 0.9 11.9 0.2 0.8 28.6 0.2 55.5 40.9 53.9 32.8 0.4 52.2 139.1 91.0 2.4 63.6 0.3 0.4 33.7 48.1 68.3 61.6 262.6 62.2 55.8 73.6 88.3 66.8 42.8 129.7 76.8 65.6 81.9 218.9 317.3 36.0 875.6 47.1 86.8 42.2 35.7 306.2 54.5 27.6 29.5 592.5 51.5 97.1 53.3 18.8 1.5 43.2 59.8 35.2 37.8 110.7 88.4 32.7 107.3 16.8 7.4 236.0 54.5 0.8 126.1 225.3 30.9 1.3 119.6 55.6 51.4 0.6 58.9 326.0 101.7 16.2 1.3 18.4 133.7 227.7 9.4 21.4 213.6 4.3 54.7 27.8 50.3 9.2 59.6 34.7 413.0 22.7 49.8 46.7 42.1 79.3 96.7 0.0 155.8 22.0 3.9 4.7 481.0 189.4 0.7 62.8 53.6 51.4 164.0 ERMP1 "FLJ23309, FXNA, KIAA1815" ENSG00000099219 "Endoplasmic reticulum metallopeptidase 1" Q7Z2K6 9 5765076-5833117 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 50.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 76.8;RT4: 154.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055582 Approved NA NA "HPA055582: " "unprognostic (1.93e-2)" "unprognostic (3.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.93e-2)" "unprognostic (2.97e-1)" "unprognostic (8.59e-2)" "unprognostic (4.30e-3)" "unprognostic (2.81e-1)" "unprognostic (5.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.14e-2)" "unprognostic (2.88e-2)" "prognostic favorable (5.83e-10)" "unprognostic (1.41e-1)" "unprognostic (4.00e-1)" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" 4.0 8.0 4.3 3.8 9.4 2.0 6.4 10.3 4.6 10.9 12.1 11.4 4.5 5.7 2.6 15.1 6.5 11.4 10.1 2.9 5.8 25.1 4.6 6.3 3.5 8.3 10.6 1.1 4.5 3.9 50.5 1.5 7.9 10.5 6.1 11.5 2.2 19.3 4.1 7.7 9.3 6.5 3.9 7.8 3.2 13.4 4.8 8.4 4.6 26.8 10.0 6.5 17.2 4.8 12.9 45.1 43.1 1.8 5.2 22.6 20.7 22.6 5.1 11.1 2.3 1.9 10.4 27.2 10.7 19.2 8.4 25.9 32.2 9.6 29.4 3.3 55.6 7.6 56.2 20.0 20.4 4.8 16.0 21.3 10.5 12.9 2.1 13.3 28.6 30.1 4.6 6.9 9.9 2.8 20.7 0.6 6.2 6.6 28.0 8.4 1.7 5.3 14.1 76.8 154.6 9.9 3.3 7.1 52.2 8.1 24.5 33.7 20.5 18.0 1.5 5.0 3.4 16.1 8.9 13.6 5.5 6.7 13.0 4.1 0.2 0.1 0.3 0.4 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.1 0.1 0.1 4.3 9.4 10.3 4.6 2.9 5.8 8.3 10.6 1.1 10.5 7.8 8.4 12.9 3.4 6.4 1.1 24.8 2.2 2.9 18.3 13.3 2.8 4.0 11.1 5.8 13.7 12.8 22.8 73.5 10.4 6.8 5.2 32.1 0.0 4.6 22.3 11.4 10.9 6.3 11.4 6.3 21.0 3.0 7.1 4.6 13.7 13.8 8.9 53.4 2.9 6.1 5.7 3.3 32.8 8.9 10.2 1.6 2.2 41.8 3.1 4.5 1.8 24.4 2.1 3.0 8.2 22.1 88.8 3.5 22.5 4.9 4.1 7.0 9.2 3.3 16.6 2.9 6.6 5.8 4.3 8.8 4.6 17.5 4.5 4.1 5.9 39.8 15.7 66.9 RAB18 ENSG00000099246 "RAB18, member RAS oncogene family" Q9NP72 10 27504174-27542239 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Protein transport, Transport" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025928 Uncertain NA NA "HPA025928: AB_1855997" "unprognostic (9.45e-3)" "unprognostic (7.71e-2)" "unprognostic (2.95e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (1.17e-1)" "unprognostic (3.64e-1)" "unprognostic (1.27e-2)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (1.71e-3)" "unprognostic (9.55e-2)" "unprognostic (1.01e-1)" "unprognostic (1.39e-1)" "unprognostic (8.48e-2)" 41.2 56.0 29.4 29.2 29.9 89.8 51.2 31.7 33.3 32.6 28.7 34.6 33.8 30.8 41.4 44.9 25.6 26.9 48.4 28.9 35.2 48.0 52.7 30.2 26.4 31.6 32.6 26.8 31.1 31.8 53.7 20.5 37.0 33.7 41.5 35.6 71.2 28.2 34.4 51.6 35.7 31.2 37.7 33.3 30.2 32.3 34.6 32.4 35.3 41.4 51.0 33.2 40.1 31.2 36.7 68.1 47.5 56.8 41.0 94.1 53.3 37.9 102.6 47.0 87.6 83.4 46.2 44.6 27.7 42.7 88.8 44.2 44.9 37.4 65.6 72.0 42.3 34.1 39.2 44.2 59.3 68.0 16.9 45.4 70.5 122.2 55.0 31.4 62.3 68.5 25.7 22.6 55.2 75.0 44.1 37.8 11.6 24.8 38.7 22.1 27.3 93.8 33.7 83.5 37.6 30.5 36.9 50.6 57.1 67.5 59.6 115.6 35.0 68.5 40.0 49.9 76.8 60.1 24.0 47.5 34.7 68.6 97.6 22.6 212.9 54.4 137.4 41.7 50.7 91.5 25.6 35.7 45.1 40.6 26.5 30.1 35.9 193.2 45.2 60.9 26.7 42.7 49.8 29.4 29.9 31.7 33.3 28.9 35.2 31.6 32.6 26.8 33.7 33.3 32.4 36.7 50.3 73.7 44.5 37.5 51.4 186.0 105.3 145.9 68.9 74.1 131.7 51.2 131.4 48.6 92.9 90.1 41.7 90.5 64.9 82.3 213.2 105.0 46.7 46.7 55.4 62.1 65.4 41.2 53.9 90.4 114.9 78.7 31.6 51.8 34.9 63.6 62.8 85.1 84.5 48.8 51.2 47.5 152.5 81.0 83.4 33.8 63.0 62.4 99.6 42.2 115.6 117.6 53.5 43.7 54.8 120.5 57.8 69.2 51.3 127.6 73.1 208.6 72.8 91.0 26.3 45.9 76.9 138.7 81.0 80.7 199.0 149.1 60.9 79.1 40.9 132.6 NRP1 "CD304, NRP, VEGF165R" ENSG00000099250 "Neuropilin 1" O14786 10 33177492-33336262 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 366.0;Endothelial cells: 174.4;Hepatic stellate cells: 184.6;Sertoli cells: 282.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 16 "plasmacytoid DC: 39.3" "Lineage enriched" "Detected in many" 16 "dendritic cells: 39.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 444.6;hTERT-RPE1: 371.6;TIME: 369.5;U-87 MG: 425.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004511, HPA030278" Approved "Secreted in other tissues" NA NA 780000000 "CAB004511: AB_2282634, HPA030278: AB_10601976" "unprognostic (3.19e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (1.50e-2)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (6.17e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (6.66e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.87e-4)" "prognostic unfavorable (1.22e-5)" "unprognostic (3.83e-2)" "unprognostic (5.48e-2)" "unprognostic (7.79e-2)" 126.3 42.7 10.5 43.7 10.9 3.8 62.7 0.0 26.4 37.2 17.2 26.9 21.5 52.1 36.0 19.9 34.8 54.6 81.5 44.1 9.6 53.2 53.6 64.3 23.9 3.9 5.1 6.8 43.4 33.3 24.6 9.1 134.8 4.1 21.4 23.8 11.7 19.5 38.8 56.4 22.3 21.1 56.4 4.5 67.3 18.8 13.0 11.2 18.3 50.1 47.0 12.5 35.6 20.2 11.6 57.4 217.8 11.1 1.1 204.8 224.7 1.3 224.4 216.2 109.6 118.2 28.9 132.4 1.1 26.6 444.6 116.8 15.8 13.8 65.2 89.3 0.7 11.2 0.6 24.5 48.7 74.3 20.8 1.6 277.3 11.2 261.7 116.8 371.6 304.0 1.4 0.7 1.4 221.3 96.8 1.4 3.9 5.5 11.9 204.2 9.6 24.8 1.2 109.7 1.3 5.1 2.7 23.0 17.5 0.9 9.2 1.0 3.3 369.5 156.4 36.9 193.0 153.8 0.7 1.1 0.7 425.2 26.4 143.5 0.4 2.5 0.5 0.6 0.4 1.0 0.7 0.7 0.6 2.3 0.6 0.6 0.6 0.4 1.2 0.3 39.3 0.6 0.9 10.5 10.9 0.0 26.4 44.1 9.6 3.9 5.1 6.8 4.1 4.5 11.2 11.6 366.0 0.0 20.2 80.3 4.3 15.7 10.6 5.5 7.4 10.5 4.2 5.5 67.6 28.6 13.0 18.4 4.2 61.5 29.4 0.6 1.9 57.9 1.3 11.3 116.9 174.4 4.2 3.2 105.4 18.9 13.4 58.5 6.6 11.0 7.6 62.3 184.6 12.5 135.4 0.0 14.4 1.8 16.2 62.7 33.3 5.5 42.3 46.0 12.4 78.7 5.8 3.4 0.0 11.6 2.3 15.4 0.0 21.1 1.6 4.1 3.0 59.8 5.4 0.9 282.7 13.1 117.9 0.2 1.3 2.7 10.5 67.2 3.8 61.1 1.5 3.3 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848614-24952606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "NK-cell: 4.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.4" "Cell line enhanced" "Detected in many" "CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2" "Low region specificity" "Detected in all" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 5.5 22.4 22.2 4.5 28.8 0.9 7.7 26.2 27.4 12.4 16.7 10.0 17.9 15.9 7.4 5.5 9.9 14.9 11.0 22.5 30.4 4.8 2.8 4.3 4.2 27.0 24.7 20.4 20.4 4.6 13.5 11.5 3.0 27.3 7.8 11.4 16.7 9.8 8.3 1.3 1.8 17.3 9.8 26.1 3.2 17.6 2.2 24.2 6.8 5.4 2.9 3.2 7.5 6.4 38.4 19.5 41.3 30.2 12.4 4.9 24.4 0.0 20.2 15.1 14.2 19.3 75.9 94.3 0.0 3.1 23.7 1.2 10.7 34.7 0.0 22.0 0.0 1.4 56.2 7.6 0.1 14.6 0.0 0.0 7.1 0.2 7.7 0.0 13.3 22.6 2.2 18.6 10.5 6.8 0.5 8.8 0.1 20.9 3.3 0.7 9.7 0.1 0.2 12.7 0.5 21.5 0.9 19.3 0.1 0.0 0.6 1.1 4.3 12.2 6.3 15.5 23.1 12.2 0.9 0.0 0.0 16.8 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 4.4 0.0 0.1 0.0 0.9 22.2 28.8 26.2 27.4 22.5 30.4 27.0 24.7 20.4 27.3 26.1 24.2 38.4 3.5 0.0 0.5 136.1 0.7 2.7 4.6 5.4 2.8 10.2 1.1 5.8 8.6 7.2 3.9 3.7 2.1 1.0 0.8 3.8 5.9 5.8 1.4 1.5 27.3 2.8 5.4 3.0 38.2 0.5 4.9 20.6 12.2 2.2 0.0 25.1 7.5 0.1 7.2 6.7 43.0 7.3 0.0 0.9 3.1 1.0 12.2 7.8 3.6 24.4 1.5 45.8 0.0 111.6 148.2 2.3 2.1 9.8 1.3 1.1 12.2 0.1 1.1 15.9 0.0 16.4 10.4 3.4 6.3 0.4 2.8 0.8 1.0 22.7 11.6 1.5 PALMD "C1orf11, FLJ20271, PALML" ENSG00000099260 Palmdelphin Q9NP74 1 99646113-99694541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 131.9" "Cell type enhanced" "Detected in many" "Adipocytes: 537.2;Cardiomyocytes: 157.6;Endothelial cells: 219.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 155.2;LHCN-M2: 49.5;TIME: 220.5;U-87 MG: 92.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017959, HPA030549" Supported Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Actin filaments" "Plasma membrane, Focal adhesion sites" "HPA017959: AB_1854949, HPA030549: AB_2673518" "unprognostic (1.48e-2)" "unprognostic (1.15e-2)" "unprognostic (2.05e-2)" "prognostic favorable (9.42e-4)" "unprognostic (7.67e-2)" "prognostic favorable (5.90e-5)" "unprognostic (1.54e-2)" "unprognostic (2.10e-1)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (8.32e-2)" "unprognostic (6.18e-2)" "unprognostic (5.19e-2)" "unprognostic (1.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.70e-1)" "unprognostic (8.08e-2)" 131.9 43.4 14.1 7.2 10.9 0.0 78.2 10.1 15.2 27.6 40.6 8.7 3.4 33.2 6.1 38.5 23.0 14.7 83.0 12.9 23.3 8.5 57.6 28.7 4.0 12.2 10.2 10.1 19.0 4.9 9.3 10.6 43.6 10.6 18.1 6.6 7.5 71.6 8.0 113.5 45.8 8.7 31.7 10.4 6.3 6.1 11.1 12.2 8.1 7.3 66.7 8.7 14.6 16.0 11.5 0.0 0.3 0.4 0.2 7.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 39.2 2.5 0.6 10.8 0.0 0.5 0.1 0.1 0.1 0.0 18.6 26.4 0.0 0.0 0.1 3.9 2.0 0.0 0.0 4.3 155.2 0.0 22.7 0.0 49.5 0.6 0.0 0.0 0.0 1.6 6.8 0.0 38.2 0.1 0.0 8.0 0.9 0.5 0.0 9.9 0.0 1.0 2.3 0.0 220.5 0.0 0.4 16.8 0.0 0.0 0.0 0.1 92.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 10.9 10.1 15.2 12.9 23.3 12.2 10.2 10.1 10.6 10.4 12.2 11.5 537.2 6.4 5.6 0.3 0.5 38.5 11.4 49.6 22.2 2.0 20.0 31.8 157.6 32.9 35.9 3.7 0.0 0.4 1.6 0.1 5.9 8.1 74.9 78.7 71.9 219.4 1.8 2.7 1.4 0.2 0.3 19.2 2.0 17.7 1.3 0.0 96.0 57.3 0.6 3.3 1.8 0.0 14.2 2.2 5.5 12.2 9.3 1.7 24.9 73.1 0.0 55.0 0.0 0.5 0.2 4.1 0.0 24.0 0.0 5.9 0.0 0.4 111.5 3.3 0.0 91.3 12.7 0.5 0.6 27.5 46.5 0.3 1.4 110.1 0.1 3.3 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 62.8 5.3 25.5 15.4 38.7 1.0 61.5 38.8 32.0 13.2 18.6 61.3 39.1 32.9 8.6 10.9 24.8 27.7 14.2 25.9 30.5 22.8 4.7 34.7 8.8 45.1 37.6 22.1 3.4 20.1 3.2 6.7 28.3 40.1 34.8 39.8 3.1 26.9 24.9 18.1 10.0 39.2 31.6 36.0 26.9 76.0 9.6 33.2 3.7 14.6 5.6 7.5 46.4 15.0 65.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 25.5 38.7 38.8 32.0 25.9 30.5 45.1 37.6 22.1 40.1 36.0 33.2 65.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 MACROH2A2 H2AFY2 ENSG00000099284 "MacroH2A.2 histone" Q9P0M6 10 70052544-70112282 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 12.6" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;monocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035865, HPA041189" Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA035865: AB_10672099, HPA041189: AB_2677357" "unprognostic (1.62e-2)" "unprognostic (9.62e-2)" "unprognostic (1.46e-2)" "unprognostic (1.46e-2)" "unprognostic (7.71e-3)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.17e-2)" "unprognostic (7.32e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (3.27e-2)" "unprognostic (4.58e-2)" "unprognostic (8.78e-2)" "unprognostic (4.66e-2)" 3.8 3.2 5.1 5.6 5.0 1.9 10.3 7.3 6.4 14.8 3.6 10.9 9.6 18.5 11.7 17.6 16.6 8.8 13.6 4.5 4.8 10.2 5.3 5.7 5.0 4.2 4.3 4.8 13.4 7.9 15.1 14.1 2.1 4.7 13.2 10.6 3.2 11.0 14.5 6.5 10.5 10.1 15.5 3.6 2.7 8.7 11.9 4.3 7.5 10.3 8.6 7.3 13.3 11.9 4.8 4.7 31.1 173.9 111.5 2.5 5.1 0.1 8.6 0.3 16.2 11.0 0.5 55.8 0.0 23.5 2.8 9.1 27.4 15.3 44.8 5.1 81.1 63.4 0.0 0.2 59.1 11.2 1.9 0.8 8.1 30.4 6.4 8.5 23.4 0.0 6.3 0.1 0.6 15.7 37.5 0.2 0.9 74.8 0.2 44.9 0.4 0.5 0.6 30.7 34.0 137.0 132.4 28.6 0.2 0.0 35.2 41.5 20.3 0.0 0.3 32.3 12.4 6.2 0.4 0.1 0.3 0.0 0.2 0.3 1.6 2.4 0.8 0.6 5.4 1.1 0.3 0.9 0.8 12.6 0.3 0.8 0.9 1.4 1.1 3.0 0.2 0.5 1.6 5.1 5.0 7.3 6.4 4.5 4.8 4.2 4.3 4.8 4.7 3.6 4.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133509 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 23.7 26.1 20.5 22.3 21.6 37.9 24.2 24.4 25.0 24.1 20.0 27.1 25.4 22.7 19.3 20.4 19.9 18.2 59.1 20.9 20.8 23.1 15.7 26.2 29.1 22.2 21.6 19.9 26.9 17.8 23.5 21.7 23.1 22.7 20.8 29.2 20.1 22.1 20.2 22.5 25.2 29.1 21.4 19.6 26.8 21.7 12.6 22.1 24.4 23.5 15.7 27.1 24.0 22.3 27.3 26.1 12.5 21.1 24.3 83.2 46.0 16.9 29.8 64.0 43.7 46.6 28.8 37.8 22.5 18.1 44.8 41.3 28.0 31.2 25.3 43.2 22.2 22.0 15.9 25.6 29.7 58.6 28.0 27.2 47.8 31.2 47.6 30.5 46.2 33.1 19.2 26.6 22.2 53.9 19.1 15.5 48.0 17.1 16.7 58.4 23.1 30.1 13.7 30.5 29.3 7.3 22.4 27.8 25.9 40.9 30.9 31.6 19.2 49.4 22.0 18.5 62.7 25.0 23.4 48.3 19.1 48.9 51.4 9.0 1.0 9.1 9.9 9.1 11.6 10.1 5.1 8.0 8.8 7.3 4.9 7.7 6.0 4.1 8.2 6.9 4.6 9.2 7.9 20.5 21.6 24.4 25.0 20.9 20.8 22.2 21.6 19.9 22.7 19.6 22.1 27.3 16.2 38.5 28.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 10.6 11.0 0.0 0.0 22.9 14.7 0.0 7.4 10.0 0.0 0.0 16.7 0.0 45.7 19.9 7.9 0.0 0.0 0.0 15.6 6.9 8.9 0.0 20.3 15.2 13.5 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.6 0.0 0.0 11.7 41.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.7 7.8 9.4 0.0 0.0 MAST3 KIAA0561 ENSG00000099308 "Microtubule associated serine/threonine kinase 3" O60307 19 18097793-18151692 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 62.6;Oligodendrocytes: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035061, HPA035062" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035061: AB_10670585, HPA035062: AB_10671508" "unprognostic (5.94e-3)" "unprognostic (4.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.02e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (1.93e-1)" "unprognostic (4.63e-2)" "unprognostic (1.43e-1)" "unprognostic (3.21e-1)" "prognostic favorable (7.01e-4)" "unprognostic (2.58e-1)" "unprognostic (1.64e-3)" "unprognostic (1.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.58e-3)" "unprognostic (1.26e-3)" 4.7 4.8 53.0 9.3 52.1 14.5 3.7 0.4 60.5 9.0 0.0 5.9 9.7 5.3 4.8 3.3 7.2 3.1 3.4 64.1 14.2 7.5 14.6 9.2 11.3 13.7 5.9 61.0 7.2 20.3 5.1 15.7 2.6 29.9 5.6 4.4 1.0 4.8 4.0 3.1 7.3 12.5 3.0 0.0 19.3 4.5 3.6 6.9 4.3 4.6 1.6 10.2 3.7 5.0 49.4 3.5 5.1 2.3 10.2 6.7 5.4 5.5 3.5 2.2 2.4 3.4 5.2 4.7 9.0 5.1 3.5 2.6 1.9 3.4 2.0 1.7 7.7 4.2 4.1 5.7 8.3 5.6 2.2 13.2 6.2 5.7 3.6 1.4 3.2 1.1 6.1 4.3 5.8 2.8 6.3 4.7 7.3 2.4 7.7 6.2 12.6 2.0 6.6 1.9 1.5 3.8 6.2 4.9 2.8 2.1 1.6 3.2 5.1 4.0 3.0 3.2 13.1 1.5 6.2 9.0 8.0 6.7 11.6 2.9 0.3 6.2 14.8 11.7 8.0 8.4 5.9 6.3 4.7 3.2 5.9 4.9 8.4 32.9 8.1 14.7 15.4 7.6 6.1 53.0 52.1 0.4 60.5 64.1 14.2 13.7 5.9 61.0 29.9 0.0 6.9 49.4 2.6 6.4 9.4 5.5 13.5 0.5 0.8 2.8 2.8 3.0 2.6 2.8 1.5 7.2 3.6 9.2 2.1 0.5 19.0 30.0 3.9 2.9 9.3 2.8 5.4 3.8 2.4 1.3 62.6 10.5 1.5 3.4 7.7 1.5 2.5 3.0 4.6 16.3 7.7 0.0 6.1 8.5 0.0 21.7 6.3 30.8 4.1 13.3 5.4 19.7 19.6 0.9 32.0 8.0 63.7 7.1 7.9 6.8 5.1 1.2 16.7 8.8 4.2 0.7 0.0 2.1 3.0 0.6 3.9 2.3 2.3 0.4 11.0 5.3 13.0 0.6 MZF1 "MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6" ENSG00000099326 "Myeloid zinc finger 1" P28698 19 58561931-58573575 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 46.0;HeLa: 41.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001757 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA001757: AB_1080718" "unprognostic (8.25e-3)" "unprognostic (2.33e-1)" "unprognostic (5.12e-2)" "unprognostic (5.16e-3)" "unprognostic (7.15e-2)" "unprognostic (4.29e-3)" "unprognostic (1.84e-2)" "unprognostic (4.62e-1)" "unprognostic (8.10e-2)" "unprognostic (7.03e-2)" "prognostic favorable (7.97e-4)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.83e-8)" "unprognostic (1.47e-1)" "unprognostic (1.80e-1)" "unprognostic (4.64e-2)" "prognostic favorable (4.09e-5)" 6.9 13.6 5.0 6.5 4.9 5.9 8.6 5.5 8.6 14.3 10.3 10.5 11.7 12.1 7.0 9.6 17.6 4.4 6.9 4.8 4.5 13.5 11.5 10.1 5.9 7.3 5.2 4.9 16.0 11.5 6.8 17.0 3.6 6.3 15.6 4.1 9.3 10.2 6.0 10.9 9.3 10.4 4.4 4.9 8.3 12.9 6.6 4.6 4.6 19.2 2.4 2.9 10.8 10.7 6.4 8.0 19.9 8.1 5.0 4.5 4.0 10.1 7.2 3.5 1.2 2.4 4.3 9.4 5.7 3.5 1.9 5.9 9.0 2.0 4.7 0.6 10.3 46.0 6.0 41.5 2.6 2.7 4.5 10.0 2.7 12.3 1.8 5.3 7.7 4.1 6.4 5.0 7.0 1.8 8.8 2.7 2.6 3.1 4.6 8.1 7.4 2.0 10.5 4.1 16.9 7.9 11.0 3.7 6.7 4.6 1.6 7.1 6.1 5.1 13.0 4.1 2.3 3.7 12.6 15.3 4.9 10.5 5.0 3.4 0.0 0.9 0.4 2.1 0.6 3.2 2.1 3.6 2.6 1.6 2.7 5.9 3.8 1.7 5.3 0.7 0.4 2.4 2.4 5.0 4.9 5.5 8.6 4.8 4.5 7.3 5.2 4.9 6.3 4.9 4.6 6.4 7.9 12.8 17.0 28.4 15.0 8.0 11.4 11.9 22.2 39.4 22.0 22.4 5.9 10.0 8.0 11.0 33.3 6.0 11.1 20.3 3.9 8.3 22.1 39.1 9.8 7.2 16.8 10.7 23.4 5.4 3.6 8.8 43.3 16.7 4.5 15.8 9.7 10.7 4.9 30.3 20.1 14.5 16.2 5.3 3.3 28.7 10.5 7.6 10.6 7.5 4.2 19.4 15.5 10.6 21.3 6.5 13.4 13.2 9.0 9.6 14.7 10.6 29.8 47.8 19.7 16.6 7.7 10.2 3.8 11.2 8.2 6.4 12.5 16.3 11.9 7.8 OCEL1 FLJ22709 ENSG00000099330 "Occludin/ELL domain containing 1" Q9H607 19 17226213-17229219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 76.1" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 137.0;Proximal tubular cells: 150.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042070, HPA043223" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042070: AB_2677830, HPA043223: " "unprognostic (6.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.13e-1)" "unprognostic (3.00e-3)" "unprognostic (6.40e-2)" "unprognostic (2.06e-2)" "unprognostic (4.33e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (4.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.52e-1)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "unprognostic (1.18e-3)" 16.4 21.8 17.4 4.8 18.3 5.7 16.5 18.6 25.1 14.9 17.4 18.8 19.1 13.6 19.1 9.5 18.3 5.8 15.7 17.0 17.6 37.5 76.1 14.8 7.3 19.1 17.7 16.4 11.3 22.9 7.3 9.2 6.7 19.5 21.3 12.4 9.0 15.1 9.1 14.1 8.4 20.2 7.3 18.6 17.5 22.3 6.8 18.6 6.7 20.6 13.6 9.6 14.0 12.4 19.4 8.2 6.4 3.3 2.9 34.9 13.8 8.5 5.3 14.5 4.1 7.2 4.6 9.8 7.2 19.5 7.8 3.6 3.9 4.5 5.4 3.8 6.0 5.3 6.7 6.8 22.6 11.7 1.4 10.5 11.1 5.6 4.8 8.1 14.2 5.9 8.9 5.8 6.8 7.5 6.7 3.7 4.0 5.6 12.3 11.3 2.7 2.8 18.2 17.7 11.2 1.1 5.6 3.3 10.8 9.4 6.9 16.4 6.8 3.9 2.6 3.0 5.1 2.6 18.5 15.3 5.8 7.7 6.3 1.2 27.7 30.8 15.2 9.9 20.9 9.5 15.7 15.1 11.4 23.3 17.0 16.5 10.8 9.7 16.0 17.1 10.0 19.1 13.4 17.4 18.3 18.6 25.1 17.0 17.6 19.1 17.7 16.4 19.5 18.6 18.6 19.4 14.6 12.8 8.2 3.9 16.4 6.4 26.7 18.8 17.1 11.4 21.4 23.7 7.3 27.1 21.9 20.2 2.1 38.6 23.9 66.8 60.7 21.4 6.3 59.3 12.5 15.6 17.4 9.7 4.7 27.1 46.0 17.2 25.5 20.4 15.9 8.0 25.0 93.5 25.8 25.2 5.2 40.5 10.2 26.1 7.5 14.6 28.3 22.3 16.0 3.7 19.2 29.6 24.7 1.0 4.6 21.0 67.4 23.3 23.2 20.7 137.0 150.5 71.8 9.7 32.9 12.5 25.8 7.8 13.8 8.8 6.7 103.2 16.4 19.9 28.1 21.9 MYO9B CELIAC4 ENSG00000099331 "Myosin IXB" Q13459 19 17075781-17214537 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, GTPase activation, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 204.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037190, HPA042043" Approved Supported Cytosol NA NA 8400 Cytosol "CAB037190: AB_477214, HPA042043: AB_10796897" "unprognostic (1.92e-1)" "unprognostic (1.79e-3)" "unprognostic (4.35e-2)" "unprognostic (6.63e-2)" "unprognostic (1.70e-1)" "unprognostic (1.18e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (5.66e-6)" "unprognostic (1.97e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-2)" "unprognostic (5.53e-2)" 40.9 43.9 43.5 53.1 51.8 99.8 32.6 47.1 57.1 43.3 38.2 45.5 17.6 44.9 12.6 33.2 30.5 20.7 35.4 39.1 51.0 26.9 39.5 78.9 60.8 57.3 54.6 33.9 22.7 26.6 7.0 25.8 21.5 71.1 46.5 14.9 40.5 28.5 13.6 12.8 29.6 62.5 17.6 48.9 159.4 36.5 64.7 55.5 33.4 26.5 5.1 36.2 48.5 41.8 76.8 55.6 25.4 33.2 38.9 23.7 24.7 95.7 51.6 26.4 31.8 27.8 20.5 27.7 51.4 28.0 45.5 28.4 34.3 14.2 25.2 23.9 92.4 29.4 62.1 31.2 19.7 30.2 49.1 95.8 22.8 13.0 44.1 17.1 19.5 33.6 22.5 25.9 34.1 22.2 23.1 66.8 90.8 25.0 17.8 55.4 72.3 24.9 14.8 12.6 46.4 11.3 25.3 32.1 25.2 67.8 17.8 25.0 50.7 65.7 58.9 26.2 92.1 44.1 48.7 33.6 32.8 58.2 63.4 75.0 4.5 3.2 6.1 2.7 4.0 1.7 2.8 2.0 2.2 1.9 2.4 1.3 1.9 12.2 2.6 2.6 3.7 3.5 2.0 43.5 51.8 47.1 57.1 39.1 51.0 57.3 54.6 33.9 71.1 48.9 55.5 76.8 20.5 9.6 23.0 17.0 47.2 19.6 70.3 9.9 10.8 11.9 15.3 13.7 10.3 11.5 10.7 5.5 204.3 17.3 43.5 34.2 1.9 7.8 6.0 14.5 45.3 28.9 7.2 19.8 36.0 7.7 24.8 22.2 35.7 28.1 22.1 24.1 23.2 15.8 74.8 8.4 26.0 14.8 8.2 68.5 91.0 13.6 12.5 103.6 44.4 49.6 65.4 11.1 66.9 40.7 112.8 12.4 18.2 17.0 37.2 40.7 10.9 3.2 9.6 98.8 6.6 16.1 24.6 8.5 14.3 10.5 18.0 14.4 47.0 18.9 17.1 46.9 KCNK6 "K2p6.1, TWIK-2" ENSG00000099337 "Potassium two pore domain channel subfamily K member 6" Q9Y257 19 38319845-38332076 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 151.3;Urothelial cells: 131.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 26.2" "Group enriched" "Detected in many" 6 "dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2" "Cell line enhanced" "Detected in many" "HEL: 37.6;HMC-1: 40.3;T-47d: 22.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022637, HPA040184" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "CAB022637: , HPA040184: AB_2676876" "unprognostic (7.98e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.45e-6)" "unprognostic (3.76e-1)" "unprognostic (6.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.08e-2)" "unprognostic (4.31e-1)" "unprognostic (4.91e-1)" "unprognostic (4.10e-3)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.07e-2)" "unprognostic (3.46e-1)" "unprognostic (5.88e-2)" "unprognostic (4.59e-3)" 3.3 2.4 3.0 7.5 2.8 3.9 5.7 2.8 3.3 27.6 2.8 13.2 4.6 24.2 1.5 30.7 15.8 4.5 5.4 2.8 2.7 3.1 3.1 9.4 5.7 2.8 2.5 2.3 9.5 12.6 0.6 1.9 7.1 3.0 6.3 9.5 0.8 14.6 2.4 1.5 18.9 6.8 14.4 2.3 15.8 9.6 2.1 2.8 2.6 1.4 0.7 7.9 13.4 18.3 3.4 9.2 3.3 0.5 0.5 5.1 3.3 0.7 7.8 3.8 2.0 2.7 2.6 9.8 0.6 3.5 11.2 2.1 11.7 4.2 17.7 1.3 0.4 0.3 37.6 1.9 0.4 4.7 2.7 40.3 0.8 15.6 2.5 4.8 10.5 5.3 5.8 0.5 2.8 5.7 20.2 2.4 2.3 0.4 19.4 2.1 3.9 0.5 2.7 7.1 0.8 0.5 0.8 0.8 0.8 0.3 1.8 22.8 10.5 5.8 0.5 4.4 4.1 0.4 1.0 0.2 1.0 0.6 13.4 0.3 26.2 6.9 15.8 1.4 6.2 1.2 1.4 2.0 1.9 11.4 1.1 1.7 1.2 5.0 0.6 7.2 3.1 2.6 2.3 3.0 2.8 2.8 3.3 2.8 2.7 2.8 2.5 2.3 3.0 2.3 2.8 3.4 8.7 0.0 10.5 0.0 16.0 43.1 50.6 20.6 20.5 3.3 61.2 32.9 12.1 17.2 15.1 7.3 6.2 2.0 18.5 62.4 0.0 19.1 2.8 32.5 58.8 28.3 12.6 17.9 1.1 47.7 4.0 19.2 28.1 84.8 22.2 72.7 151.3 4.3 39.2 0.0 1.7 64.5 2.0 75.7 61.5 1.2 25.7 47.0 5.4 2.8 62.1 1.2 11.3 0.0 0.9 67.2 39.2 20.3 45.6 41.1 37.6 0.4 7.7 5.9 26.3 3.1 9.3 14.8 3.3 48.0 67.2 2.5 14.8 1.5 26.7 131.5 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 31.6" "Cell type enhanced" "Detected in many" "Early spermatids: 29.4;Gastric mucus-secreting cells: 27.0;Late spermatids: 49.2;Proximal enterocytes: 20.7;Spermatocytes: 28.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.4;HMC-1: 1.8;MCF7: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.2 0.1 0.7 0.1 0.9 0.3 0.4 1.0 0.9 0.4 0.4 0.2 0.4 0.2 0.7 0.2 0.5 0.1 0.1 0.6 0.6 0.2 0.2 0.3 0.3 0.9 2.8 0.6 0.4 0.2 0.2 0.2 0.1 1.1 0.4 0.2 0.2 0.4 0.2 0.2 1.0 0.4 0.1 0.5 0.2 0.2 31.6 0.8 0.2 0.5 0.0 0.2 0.1 0.2 1.2 0.0 0.1 0.0 0.6 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.0 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.7 0.1 0.1 0.0 0.7 0.9 1.0 0.9 0.6 0.6 0.9 2.8 0.6 1.1 0.5 0.8 1.2 4.9 0.0 2.7 2.6 3.6 2.5 2.4 1.0 4.6 1.3 4.8 8.0 3.0 1.5 0.6 1.8 0.0 1.7 5.1 10.1 0.0 1.0 29.4 4.9 4.4 2.7 1.8 3.2 4.3 0.7 0.3 3.0 27.0 8.8 1.3 2.0 2.5 0.3 3.2 1.7 3.8 3.9 2.0 1.2 3.1 49.2 1.8 3.3 0.0 1.9 3.9 1.9 10.3 3.0 17.0 0.4 5.6 2.2 2.2 1.9 20.7 0.9 1.3 1.4 0.0 5.3 3.7 28.9 3.7 4.9 1.8 1.4 3.4 1.9 3.5 1.8 PSMD8 "HIP6, HYPF, Nin1p, p31, Rpn12, S14" ENSG00000099341 "Proteasome 26S subunit, non-ATPase 8" P48556 19 38374550-38383824 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 714.7" "Cell type enhanced" "Detected in all" "Late spermatids: 1164.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006702, CAB021101" Supported Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB021101: AB_10061018, HPA006702: AB_1079710" "unprognostic (9.50e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.59e-1)" "unprognostic (5.54e-3)" "unprognostic (1.94e-3)" "unprognostic (5.03e-2)" "unprognostic (2.85e-2)" "unprognostic (1.73e-2)" "unprognostic (4.61e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.08e-2)" "unprognostic (2.58e-3)" "unprognostic (4.84e-2)" 219.9 131.9 103.2 78.7 108.0 119.8 186.5 101.8 115.7 102.2 92.8 111.0 99.0 116.8 120.4 157.9 104.9 69.8 322.4 109.6 108.3 123.3 144.2 115.8 91.6 108.5 103.3 107.4 82.8 118.2 151.5 112.0 102.0 115.1 108.0 99.9 61.1 119.8 85.3 714.7 177.7 107.3 106.1 104.7 100.2 118.6 147.0 114.8 121.5 92.0 364.3 110.8 107.3 111.9 117.0 337.3 522.7 202.2 231.9 322.0 256.9 105.9 238.7 322.9 358.9 372.3 362.0 196.3 234.7 242.8 320.0 220.1 114.1 341.7 296.8 321.6 389.8 225.6 256.1 159.6 226.4 415.1 260.8 217.9 261.2 290.8 309.7 408.8 197.3 286.5 279.9 324.9 255.7 400.6 332.8 247.6 146.1 157.8 492.8 282.7 254.7 324.6 187.4 255.7 275.1 210.8 214.3 247.3 315.7 233.8 187.1 165.3 242.0 212.7 272.1 251.5 289.0 355.8 257.2 322.4 318.0 410.1 264.8 310.1 169.0 239.5 132.6 188.2 265.1 160.0 172.8 162.0 181.0 263.1 173.6 133.0 129.5 89.0 182.7 319.8 183.2 295.2 352.3 103.2 108.0 101.8 115.7 109.6 108.3 108.5 103.3 107.4 115.1 104.7 114.8 117.0 137.4 67.3 67.9 8.1 122.9 206.0 224.5 293.5 80.2 102.6 116.3 141.0 263.8 81.5 158.8 80.9 54.2 367.2 128.2 194.6 348.3 276.0 422.3 137.2 158.2 127.0 146.0 129.2 14.7 267.4 327.5 146.8 71.4 122.5 93.8 146.9 81.4 123.1 296.9 77.4 15.4 183.9 219.7 93.1 169.5 1164.7 118.4 126.9 199.3 10.3 224.0 179.8 143.2 8.0 19.8 296.8 181.2 117.8 178.9 255.0 305.7 332.4 128.5 120.4 151.2 106.6 221.1 305.1 135.4 120.3 212.3 570.3 133.0 201.0 182.5 218.7 FBXL19 "CXXC11, DKFZp434K0410, Fbl19, JHDM1C" ENSG00000099364 "F-box and leucine rich repeat protein 19" Q6PCT2 16 30923055-30948783 "Predicted intracellular proteins" "Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074250 Approved Nucleoplasm NA No Nucleoplasm "HPA074250: " "unprognostic (1.37e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.03e-1)" "unprognostic (3.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.61e-2)" "unprognostic (2.52e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (6.95e-3)" "unprognostic (1.37e-3)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" 5.5 7.7 16.5 9.9 15.0 8.4 5.5 4.7 28.1 8.8 1.7 8.7 10.5 8.6 4.0 16.7 7.4 8.6 5.2 17.3 9.3 9.8 4.4 5.9 9.8 9.9 9.3 16.0 8.5 6.7 7.3 11.5 10.2 18.4 10.0 3.8 8.6 9.0 5.5 4.8 12.3 8.9 4.6 3.9 10.0 8.8 30.2 13.5 10.0 8.0 4.0 5.2 8.6 9.6 14.6 17.5 46.0 44.7 35.6 8.0 8.1 38.6 24.2 12.3 18.3 17.2 24.8 23.9 27.1 27.4 14.4 14.2 24.3 35.9 25.8 14.0 76.3 110.0 30.0 84.0 36.5 9.9 33.5 69.9 8.3 20.4 22.6 16.0 15.9 30.0 37.7 80.0 26.3 10.3 46.9 36.4 46.2 44.4 13.0 15.5 73.1 14.2 27.0 17.7 23.6 29.6 56.3 8.5 53.0 13.7 25.1 32.5 34.8 30.0 20.2 26.1 13.5 17.1 23.1 20.4 16.9 24.7 49.0 29.9 0.0 0.4 0.5 0.3 0.2 0.3 0.5 0.1 0.1 0.2 0.2 0.0 0.3 0.5 0.9 0.0 0.7 0.2 0.1 16.5 15.0 4.7 28.1 17.3 9.3 9.9 9.3 16.0 18.4 3.9 13.5 14.6 3.4 0.0 1.1 4.9 1.5 8.3 2.4 2.5 2.8 6.1 6.8 4.1 1.5 4.3 2.9 3.7 12.5 5.7 4.0 8.9 0.0 6.1 5.6 3.8 4.7 5.0 2.4 1.3 4.5 7.1 5.4 3.1 3.6 6.0 0.0 8.9 3.6 2.3 5.2 1.7 5.0 6.5 2.0 2.8 3.9 6.5 1.5 3.4 0.0 3.7 3.3 2.8 4.1 3.0 2.1 8.6 4.1 2.6 1.7 6.4 3.3 5.1 1.8 6.0 6.6 2.2 3.5 4.7 2.9 5.4 8.9 9.3 2.0 4.9 8.5 6.5 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010638 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 129.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 36.8;Horizontal cells: 38.7;Inhibitory neurons: 31.1;Late spermatids: 13.8" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 11.1;hTERT-RPE1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079008: , HPA069176: AB_2686098" "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.3 1.0 4.5 1.1 9.6 0.4 1.7 18.7 129.0 1.7 0.0 1.9 0.5 3.1 3.3 1.2 1.7 0.4 1.3 11.3 13.0 1.3 6.0 0.5 1.7 44.4 12.4 12.0 1.7 0.9 0.2 6.6 0.2 57.5 1.7 0.4 10.3 1.0 1.9 0.5 3.3 1.8 1.6 0.0 1.8 0.9 4.6 21.0 0.5 0.7 0.1 1.5 0.7 1.3 90.0 0.1 3.0 4.7 0.7 0.5 0.2 0.1 4.2 6.4 5.1 9.0 0.0 3.4 0.7 0.2 5.6 0.1 0.7 2.1 0.6 6.1 2.6 0.4 0.4 2.7 2.4 0.4 0.2 2.9 1.6 0.1 11.1 1.0 20.4 0.0 1.0 0.5 0.2 5.5 1.3 2.0 0.2 2.3 0.0 0.3 7.1 0.2 0.2 0.4 0.0 6.3 4.0 0.5 0.2 0.0 0.7 0.8 0.1 0.8 3.0 2.4 0.4 0.2 0.3 0.2 0.3 3.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 9.6 18.7 129.0 11.3 13.0 44.4 12.4 12.0 57.5 0.0 21.0 90.0 0.4 0.0 0.0 7.2 0.6 0.8 0.1 0.2 0.6 10.7 0.4 0.6 1.2 0.0 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.3 6.9 0.1 0.5 0.8 0.0 0.4 36.8 0.4 0.0 0.7 0.0 0.1 0.0 2.5 1.1 5.9 0.6 38.7 31.1 0.2 0.0 0.6 1.1 13.8 0.3 0.3 0.0 4.7 0.7 1.8 0.0 9.0 5.5 0.2 0.0 1.9 0.0 0.2 0.9 2.1 0.0 3.2 0.0 0.8 0.7 4.6 1.3 0.2 0.6 0.8 0.4 0.1 0.3 0.0 HSD3B7 "C(27)-3BETA-HSD, SDR11E3" ENSG00000099377 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7" Q9H2F3 16 30985207-30989147 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis Oxidoreductase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 137.6" "Cell type enhanced" "Detected in many" "Ductal cells: 42.5;Hepatocytes: 68.9;Hofbauer cells: 53.9;Proximal enterocytes: 45.3;Proximal tubular cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "basophil: 61.8;eosinophil: 27.3" "Lineage enriched" "Detected in many" 38 "granulocytes: 61.8" "Cell line enhanced" "Detected in many" "HDLM-2: 91.0;Hep G2: 66.2;HMC-1: 98.1;U-2197: 96.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015965, HPA050521, HPA060847" Approved Enhanced "Lipid droplets" NA NA "Lipid droplets" "HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379" "unprognostic (5.41e-3)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.62e-2)" "unprognostic (5.06e-3)" "unprognostic (1.47e-2)" "unprognostic (3.52e-2)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.20e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (2.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.79e-1)" 23.5 25.9 5.3 11.0 5.5 4.5 17.2 12.8 8.3 8.5 3.0 15.1 19.6 9.6 2.1 12.3 9.5 11.6 9.9 6.2 6.0 27.5 137.6 11.3 8.5 5.8 5.2 4.9 8.7 25.8 8.1 5.4 4.5 7.4 8.3 5.8 1.6 10.1 4.6 7.0 17.8 18.6 9.9 5.3 16.4 11.2 6.1 6.5 2.8 6.3 4.5 5.6 14.0 8.8 7.3 20.3 23.2 2.4 11.5 7.9 28.5 1.4 24.8 38.7 4.8 10.0 1.7 34.4 1.2 8.1 30.3 0.8 6.1 2.2 3.6 2.4 91.0 5.4 1.6 18.6 66.2 7.4 0.5 98.1 13.7 6.0 23.1 4.6 11.2 2.2 1.2 4.9 1.0 18.3 43.6 0.6 14.4 1.9 8.5 3.2 2.5 7.8 22.3 15.1 1.3 8.4 4.1 3.2 15.9 2.2 1.1 31.1 1.6 11.5 10.0 2.8 96.1 2.7 1.6 15.4 1.1 39.1 2.5 0.8 61.8 1.4 27.3 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.2 0.0 0.1 1.2 0.5 0.0 0.6 0.0 0.7 5.3 5.5 12.8 8.3 6.2 6.0 5.8 5.2 4.9 7.4 5.3 6.5 7.3 7.6 3.2 4.2 3.3 1.2 7.9 2.6 4.1 4.0 0.7 13.6 9.8 1.7 27.1 2.2 14.7 0.0 2.0 0.5 10.8 15.6 42.5 37.5 1.9 7.1 11.1 7.8 4.8 0.2 30.3 3.5 26.0 8.2 4.2 9.5 9.0 6.8 68.9 53.9 1.7 0.4 11.4 6.1 7.3 15.9 2.2 6.5 11.4 14.2 0.0 12.8 2.1 0.0 0.5 1.2 20.7 14.0 5.3 1.9 1.8 45.3 46.7 1.3 0.5 13.1 9.4 6.3 0.8 1.2 4.9 12.6 1.4 1.7 6.5 23.5 2.8 SETD1A "KIAA0339, KMT2F, Set1" ENSG00000099381 "SET domain containing 1A, histone lysine methyltransferase" O15047 16 30957754-30984664 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020646, HPA058376" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA020646: AB_1856752, HPA058376: AB_2683695" "unprognostic (8.62e-2)" "unprognostic (1.93e-2)" "unprognostic (3.96e-2)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (5.01e-2)" "unprognostic (1.54e-1)" "unprognostic (3.18e-1)" "unprognostic (5.77e-2)" "unprognostic (1.72e-1)" "unprognostic (1.55e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" "unprognostic (1.70e-2)" "unprognostic (1.94e-1)" 9.8 10.1 5.2 7.3 4.8 20.2 10.1 7.5 8.4 10.6 2.2 11.3 6.6 13.1 2.8 9.1 10.6 4.1 7.9 4.8 3.7 8.4 10.4 8.3 8.6 5.5 4.7 3.6 12.5 10.7 8.0 12.0 5.1 6.1 10.3 3.3 3.2 9.4 6.2 15.2 12.2 10.5 6.4 3.1 11.9 10.1 21.0 4.6 10.1 11.9 7.1 5.1 10.3 9.4 6.0 13.1 24.4 15.9 19.4 8.7 6.3 18.0 13.6 10.6 11.9 10.1 20.2 12.8 34.2 15.2 13.0 12.0 16.4 15.0 14.6 9.3 18.5 56.1 16.0 47.1 23.2 8.9 26.6 26.2 11.0 11.3 17.1 10.8 9.2 9.3 19.5 32.3 19.0 6.4 27.2 32.3 27.7 23.4 9.0 15.4 48.7 15.9 21.9 7.6 13.9 17.6 18.1 18.7 15.1 10.8 8.7 16.2 22.1 12.8 17.7 17.1 11.6 14.9 28.0 36.2 32.4 14.3 22.9 13.5 0.0 0.1 0.6 0.2 0.3 0.3 0.0 0.2 0.2 0.1 0.5 0.1 0.2 0.0 0.2 0.1 0.6 0.1 0.2 5.2 4.8 7.5 8.4 4.8 3.7 5.5 4.7 3.6 6.1 3.1 4.6 6.0 7.8 3.2 9.2 9.1 8.8 15.7 5.1 3.8 15.4 8.1 9.5 8.3 3.9 5.7 4.0 7.3 6.2 4.6 11.4 6.8 0.0 4.2 3.1 6.1 8.2 9.9 10.3 6.7 6.4 4.2 3.7 7.8 6.1 8.6 3.8 9.5 7.5 9.1 6.5 13.5 6.1 7.9 2.0 4.7 7.1 2.9 9.9 5.5 8.8 6.5 4.7 4.8 7.2 2.5 5.7 5.4 4.8 11.7 7.9 8.3 5.1 2.8 4.0 5.2 6.6 10.8 7.8 17.5 23.3 15.7 12.9 2.9 8.6 10.3 6.9 4.8 BCL7C ENSG00000099385 "BAF chromatin remodeling complex subunit BCL7C" Q8WUZ0 16 30833626-30894302 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 217.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018676, HPA052654" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018676: AB_1845322, HPA052654: AB_2681903" "unprognostic (2.27e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (3.18e-3)" "unprognostic (4.91e-3)" "unprognostic (2.44e-1)" "unprognostic (3.41e-2)" "unprognostic (3.84e-2)" "unprognostic (9.22e-2)" "unprognostic (2.05e-2)" "unprognostic (2.45e-1)" "unprognostic (2.97e-1)" "unprognostic (2.07e-2)" "unprognostic (2.85e-1)" 30.5 18.7 39.1 22.4 38.4 41.0 29.1 38.2 52.6 34.1 34.3 28.2 22.5 27.4 15.0 26.1 28.4 21.6 31.1 34.9 40.5 30.2 19.2 21.0 27.9 42.0 38.9 32.5 40.9 23.4 20.8 21.4 18.2 40.7 27.6 15.7 7.9 33.5 35.3 35.1 32.3 25.2 23.4 37.9 23.8 24.1 24.7 39.4 19.6 24.8 25.7 21.5 30.4 27.5 41.7 84.3 51.4 46.4 132.7 34.5 52.3 32.4 54.8 51.9 65.1 47.2 47.2 54.4 1.8 79.9 69.1 35.7 44.7 22.9 58.0 26.0 53.0 101.2 18.5 37.8 77.0 49.1 34.3 42.5 60.1 58.5 43.3 22.4 27.6 65.9 37.1 46.2 27.5 54.1 120.3 35.9 103.4 26.8 48.7 84.5 74.0 48.7 66.8 38.2 30.1 30.8 52.5 56.2 51.8 42.5 22.7 83.8 53.8 35.4 85.8 81.0 52.0 53.3 28.2 25.9 37.2 57.2 61.1 61.3 8.1 4.6 8.0 7.7 3.1 8.8 9.0 6.7 9.5 4.3 5.8 5.4 6.5 2.9 2.9 3.4 5.7 7.3 2.4 39.1 38.4 38.2 52.6 34.9 40.5 42.0 38.9 32.5 40.7 37.9 39.4 41.7 76.4 12.8 11.4 21.9 31.5 39.6 80.5 21.9 37.5 11.4 67.7 100.5 17.2 47.1 14.0 71.7 6.2 54.3 66.8 45.5 217.2 36.2 21.5 37.2 49.4 52.8 37.3 33.4 7.6 35.5 58.5 67.7 23.9 42.5 2.5 55.9 51.4 26.5 57.1 13.5 20.8 42.8 16.2 38.6 49.1 26.9 55.9 39.5 55.2 16.9 65.6 49.1 64.9 22.1 21.4 48.1 25.2 51.6 17.2 51.4 42.0 78.0 8.8 13.8 19.7 47.3 88.9 5.7 3.5 53.3 42.6 25.0 56.4 49.4 64.3 77.1 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215563-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 29.3" "Group enriched" "Detected in some" 4 "Spermatocytes: 24.7;Spermatogonia: 95.8" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 92.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 77.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 14.8 0.2 0.0 89.9 0.3 0.3 149.7 168.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 24.7 95.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 EFNA2 "ELF-1, EPLG6, LERK6" ENSG00000099617 "Ephrin A2" O43921 19 1285873-1301431 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.4;liver: 13.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.5;Cardiomyocytes: 4.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 5.0;Paneth cells: 2.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.5;stomach cancer: 8.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.3;CACO-2: 6.2;Hep G2: 13.5;NTERA-2: 6.8;OE19: 6.0;REH: 6.8;SH-SY5Y: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067567 Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA067567: AB_2732771" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (2.87e-3)" "unprognostic (1.96e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-1)" "unprognostic (7.19e-2)" "unprognostic (2.34e-3)" "unprognostic (3.58e-2)" "unprognostic (6.82e-2)" "unprognostic (8.48e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-4)" "unprognostic (1.94e-1)" 0.0 0.0 1.5 1.5 1.4 0.0 0.0 1.1 1.1 0.0 0.2 7.6 10.0 0.0 0.0 0.4 0.0 3.5 0.0 1.3 1.8 0.4 13.0 0.0 0.0 1.6 2.8 1.1 0.0 0.1 0.2 0.3 0.2 1.8 0.0 4.5 0.6 0.0 0.0 0.2 0.1 12.4 0.0 1.3 0.0 0.2 0.6 2.9 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.2 10.3 3.1 0.0 0.0 3.7 0.2 0.0 0.0 0.0 6.2 0.1 0.0 1.8 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.4 0.0 0.0 13.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.1 6.8 6.0 0.0 6.8 1.0 0.1 0.0 0.4 0.0 13.3 0.7 0.0 0.2 3.5 0.4 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.5 1.4 1.1 1.1 1.3 1.8 1.6 2.8 1.1 1.8 1.3 2.9 1.3 0.1 0.0 0.0 1.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.0 0.0 2.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.2 0.0 CIRBP CIRP ENSG00000099622 "Cold inducible RNA binding protein" Q14011 19 1259384-1274880 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060537 Supported Nucleoplasm NA NA 240000 Nucleoplasm "HPA060537: AB_2684314" "unprognostic (2.77e-3)" "prognostic favorable (3.63e-4)" "unprognostic (9.80e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.95e-2)" "unprognostic (2.94e-2)" "unprognostic (3.38e-3)" "prognostic favorable (2.50e-4)" "unprognostic (6.43e-2)" "unprognostic (2.29e-2)" "prognostic favorable (2.69e-4)" "unprognostic (1.82e-1)" "prognostic favorable (3.65e-7)" "unprognostic (1.04e-1)" "unprognostic (5.76e-1)" "unprognostic (2.23e-2)" "unprognostic (1.49e-2)" 351.5 371.0 195.1 207.6 189.2 381.2 413.7 194.0 249.0 422.3 166.1 345.1 198.3 476.2 433.4 221.6 501.3 281.8 372.0 181.9 194.1 288.3 202.5 303.5 353.3 289.5 199.5 177.1 860.6 619.9 494.7 500.1 232.7 236.2 380.4 229.2 387.3 370.5 422.0 489.7 405.7 306.5 316.1 184.0 335.4 408.5 185.2 200.2 330.9 424.0 307.0 387.0 347.7 310.4 212.0 285.8 60.4 434.3 220.1 188.0 209.3 112.3 307.3 428.7 235.1 209.9 112.7 108.1 570.7 162.3 318.6 27.9 133.5 182.5 277.5 181.2 255.4 52.3 340.6 68.2 145.9 684.8 532.0 237.9 518.9 244.6 152.3 659.7 324.3 215.0 282.6 228.3 445.6 247.2 202.9 274.7 144.4 172.3 162.4 100.2 337.3 347.2 280.3 267.5 237.3 204.1 369.3 323.9 145.6 251.3 140.9 304.6 148.3 264.6 174.5 105.3 415.1 271.0 581.3 689.3 463.7 148.9 216.4 229.7 208.5 88.3 205.5 212.3 153.5 217.7 248.7 190.0 193.5 97.0 268.0 213.2 205.0 147.4 229.4 237.0 272.5 244.6 196.3 195.1 189.2 194.0 249.0 181.9 194.1 289.5 199.5 177.1 236.2 184.0 200.2 212.0 341.8 205.1 384.3 169.8 541.8 586.6 641.5 585.8 541.8 758.0 682.4 586.5 258.0 427.5 304.2 298.0 329.4 601.9 504.0 175.5 972.4 386.0 78.8 243.9 292.1 388.3 434.2 244.4 51.8 484.2 271.0 493.6 236.0 241.0 404.2 400.6 436.2 149.6 314.4 684.8 69.2 315.5 514.7 372.1 559.7 199.3 649.9 301.0 734.6 60.9 490.2 1307.9 563.4 90.0 157.2 348.7 281.7 499.5 477.5 434.5 399.6 635.6 295.8 712.7 374.7 956.8 488.0 228.5 504.5 327.6 556.8 737.4 482.5 586.9 270.5 378.6 ATP5F1D ATP5D ENSG00000099624 "ATP synthase F1 subunit delta" P30049 19 1241746-1244825 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 812.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1702.2;Exocrine glandular cells: 566.6;Proximal tubular cells: 1831.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002865 Approved NA NA 160000 "HPA002865: AB_1078244" "unprognostic (4.80e-2)" "unprognostic (9.34e-2)" "unprognostic (7.77e-2)" "prognostic favorable (1.23e-4)" "unprognostic (1.64e-2)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (6.75e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-1)" "prognostic favorable (4.60e-4)" "unprognostic (6.95e-2)" "prognostic favorable (3.46e-5)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" 123.6 215.1 67.0 16.4 63.0 32.0 115.0 86.8 110.9 106.2 58.6 194.2 66.2 105.2 8.5 199.8 103.6 11.7 528.5 67.0 69.1 257.4 368.3 88.0 21.8 92.9 67.4 61.3 107.7 254.0 35.0 139.5 14.5 86.9 129.2 17.6 7.0 135.0 29.7 812.9 159.6 144.6 11.4 63.1 114.0 202.1 59.0 86.1 15.9 135.5 124.2 16.1 133.7 121.6 82.0 109.6 58.3 17.9 67.2 20.4 29.9 67.0 73.1 30.4 42.4 30.8 60.6 28.4 109.7 46.2 25.6 10.7 92.8 19.9 76.0 5.5 76.5 196.6 66.5 69.6 81.2 50.4 117.4 95.5 59.5 20.6 17.1 23.6 23.9 45.3 72.2 98.4 85.3 19.9 164.8 127.7 84.9 77.6 69.5 284.8 121.1 47.2 233.1 72.3 70.6 71.3 82.1 48.6 76.5 132.4 7.1 57.2 54.8 66.6 38.4 52.9 93.0 61.4 216.0 118.4 41.7 70.8 54.6 59.3 203.0 283.7 128.0 211.9 287.7 255.9 284.2 267.4 233.8 321.3 287.1 242.4 227.7 99.2 246.5 237.6 349.2 287.1 251.6 67.0 63.0 86.8 110.9 67.0 69.1 92.9 67.4 61.3 86.9 63.1 86.1 82.0 265.3 16.0 25.4 0.0 101.9 0.0 0.0 0.0 0.0 0.0 402.1 533.8 0.0 0.0 9.3 380.7 0.0 393.5 155.1 0.0 1702.2 351.2 0.0 145.6 261.2 80.3 0.0 0.0 0.0 566.6 471.3 109.6 0.0 256.9 5.1 263.9 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.7 0.0 0.0 133.4 0.0 0.0 0.0 0.0 437.8 0.0 0.0 40.7 0.0 0.0 1831.8 5.1 0.0 0.0 0.0 145.9 0.0 0.0 0.0 0.0 341.2 82.8 469.2 0.0 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN subunit beta associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.9;pituitary gland: 22.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 21.8;Early spermatids: 55.9;Late spermatids: 97.4;Spermatocytes: 54.8" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012777 Approved Nucleoplasm NA NA Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 0.8 2.7 6.2 0.1 6.8 0.0 0.4 1.6 15.9 0.5 0.0 0.4 0.1 0.5 0.0 1.4 0.5 0.1 1.4 12.6 13.6 1.9 0.3 1.0 0.0 6.1 1.5 6.2 5.0 0.4 0.0 22.5 0.1 5.6 0.8 0.0 0.3 0.4 0.1 0.4 3.0 0.2 0.0 0.2 0.1 0.4 1.7 2.3 0.0 0.6 0.0 0.0 0.3 0.9 1.5 0.3 0.4 1.1 3.1 0.1 0.5 0.4 2.7 0.8 0.5 0.5 1.1 0.1 0.0 2.7 0.5 0.3 0.9 0.4 0.6 0.1 0.5 0.7 0.1 1.1 0.9 1.4 0.0 1.0 0.6 0.2 0.6 0.1 0.5 0.4 0.5 1.7 0.0 0.3 2.3 0.0 0.6 1.6 0.1 1.2 2.0 0.4 0.2 0.1 0.2 1.4 4.2 0.0 0.0 3.1 0.1 0.4 0.5 1.2 0.7 2.6 2.3 0.7 0.1 0.2 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 6.8 1.6 15.9 12.6 13.6 6.1 1.5 6.2 5.6 0.2 2.3 1.5 1.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 1.2 21.8 1.7 1.8 0.0 1.5 0.0 0.0 2.1 0.0 0.6 0.0 1.9 0.1 55.9 0.9 2.2 0.7 0.0 0.0 0.0 0.2 0.1 1.2 1.1 1.6 0.0 0.9 1.4 0.1 0.3 3.3 0.0 0.0 0.0 0.8 0.0 97.4 1.8 1.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.2 0.0 1.7 0.0 0.7 1.4 54.8 7.0 1.1 0.0 0.0 0.3 0.1 0.0 0.3 PCDH11Y "PCDH22, PCDHY" ENSG00000099715 "Protocadherin 11 Y-linked" Q9BZA8 Y 5000226-5742224 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 5.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 29.1;Excitatory neurons: 52.9;Horizontal cells: 47.1;Inhibitory neurons: 88.1;Oligodendrocyte precursor cells: 54.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.26e-2)" "unprognostic (1.84e-1)" "unprognostic (7.64e-3)" "unprognostic (2.36e-2)" "unprognostic (3.55e-2)" 0.0 0.0 3.1 0.1 3.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.3 0.0 0.0 0.0 0.0 1.1 0.3 0.8 0.0 0.0 0.0 0.0 0.5 4.9 0.1 0.2 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 3.1 3.3 0.0 4.5 4.0 1.3 1.1 0.3 0.8 4.9 0.3 4.5 5.4 0.3 6.4 29.1 1.6 0.5 1.8 1.0 0.0 0.6 3.0 0.3 0.0 0.6 0.0 13.6 14.7 0.0 5.2 0.0 0.1 0.0 0.0 0.3 0.5 0.2 3.9 0.0 0.0 52.9 0.0 0.3 2.7 0.0 0.5 18.9 0.1 3.6 0.0 0.3 47.1 88.1 0.2 2.0 0.0 4.8 0.1 0.3 2.7 0.0 21.5 0.0 0.3 0.0 54.8 4.4 0.1 0.0 0.0 0.4 0.9 0.0 0.7 9.5 3.6 0.0 1.2 0.4 0.3 2.0 0.2 1.6 2.2 2.5 0.0 0.0 1.5 AMELY AMGL ENSG00000099721 "Amelogenin Y-linked" Q99218 Y 6865918-6911774 "Predicted secreted proteins" Biomineralization "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 IGFALS ALS ENSG00000099769 "Insulin like growth factor binding protein acid labile subunit" P35858 16 1790413-1794971 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 117.6" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 85.2" "Cancer enhanced" "Detected in many" "liver cancer: 11.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.9;U-266/70: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040692, HPA040948" Supported "Secreted to blood" NA NA 14700000000 26000000000 "HPA040692: AB_10794067, HPA040948: AB_10794999" "unprognostic (2.74e-3)" "unprognostic (1.95e-1)" "unprognostic (9.13e-2)" "prognostic unfavorable (6.06e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-2)" "prognostic favorable (5.97e-4)" "unprognostic (5.54e-4)" "unprognostic (3.00e-1)" "unprognostic (1.17e-1)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (4.39e-1)" "unprognostic (5.51e-2)" 0.2 0.2 0.6 0.3 0.8 0.4 0.4 1.4 0.7 0.4 0.7 0.6 0.3 0.3 0.1 0.1 0.7 1.6 0.2 0.3 0.3 1.0 117.6 0.8 0.0 0.7 0.6 0.2 0.7 2.5 0.0 0.7 0.0 0.9 0.5 0.1 0.2 0.8 0.1 0.5 0.8 0.6 0.0 0.4 0.3 11.0 2.0 0.4 0.9 0.9 0.0 0.0 0.4 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.5 0.0 0.0 1.7 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.4 0.7 0.3 0.3 0.7 0.6 0.2 0.9 0.4 0.4 1.9 0.1 0.0 0.0 1.6 0.1 0.1 0.2 0.2 0.0 0.5 0.9 0.6 1.6 14.3 0.2 0.0 6.2 0.0 0.0 0.6 0.0 2.7 1.1 0.4 0.0 0.2 0.0 0.0 0.5 0.6 0.0 0.4 8.2 0.1 0.0 0.2 2.9 85.2 0.0 0.0 0.6 14.6 0.0 1.3 0.3 1.7 0.0 0.0 1.8 0.0 0.0 0.3 1.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.2 0.1 0.4 0.4 0.0 0.3 0.0 0.2 0.1 0.7 0.1 HNRNPM "CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1" ENSG00000099783 "Heterogeneous nuclear ribonucleoprotein M" P52272 19 8444767-8489114 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016113, HPA024344" Supported Enhanced Nucleoplasm NA NA 440000 Nucleoplasm "CAB016113: AB_627739, HPA024344: AB_1850879" "unprognostic (2.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.44e-1)" "unprognostic (2.59e-2)" "unprognostic (6.91e-3)" "unprognostic (4.70e-3)" "unprognostic (7.34e-2)" "unprognostic (3.62e-2)" "unprognostic (1.22e-3)" "unprognostic (1.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" 98.1 84.6 57.7 127.4 62.0 232.9 95.2 65.7 62.6 105.2 62.1 109.3 99.3 114.7 57.6 127.4 93.3 54.9 88.4 51.6 60.5 78.1 90.1 91.4 142.5 63.2 59.2 45.7 122.9 84.9 91.2 72.0 88.2 60.3 77.3 92.8 128.8 93.8 76.1 150.0 107.2 101.6 88.8 58.2 111.4 91.6 78.8 62.7 167.8 93.9 62.6 157.3 94.0 102.3 69.8 477.5 315.7 580.8 236.3 131.4 145.2 373.7 279.3 208.5 340.3 256.9 452.4 141.4 697.4 363.4 254.3 242.4 286.3 603.3 349.4 425.1 437.5 501.0 620.1 312.2 439.8 136.3 640.0 317.4 150.5 173.4 289.2 119.9 100.0 309.7 256.3 632.3 193.6 273.3 324.3 617.2 556.8 505.1 258.2 381.1 687.8 508.1 330.5 179.6 452.9 320.7 356.8 469.5 250.4 278.8 276.8 299.0 378.4 362.9 294.5 357.4 313.6 529.2 285.4 560.8 791.4 221.7 511.4 329.1 21.3 78.4 48.0 91.2 93.4 91.7 69.6 79.0 91.6 86.6 61.4 84.3 83.0 20.0 86.0 71.8 86.3 87.6 94.5 57.7 62.0 65.7 62.6 51.6 60.5 63.2 59.2 45.7 60.3 58.2 62.7 69.8 157.1 128.2 189.0 48.6 154.1 166.3 204.8 240.8 105.9 199.6 143.8 125.1 92.1 118.7 240.8 117.7 70.9 272.8 170.3 95.5 97.8 237.4 13.2 150.6 194.7 164.3 190.4 211.5 43.3 273.1 304.4 141.7 76.0 190.2 267.4 136.3 111.4 148.5 174.4 138.0 46.5 154.6 138.4 127.2 139.8 18.3 113.4 137.7 110.3 59.0 212.5 186.1 219.4 60.8 79.8 202.2 102.9 142.1 118.7 92.7 77.8 106.0 193.1 213.6 210.4 194.1 231.2 182.3 150.6 106.3 137.0 262.4 168.7 125.4 183.3 131.3 MARCHF2 "HSPC240, MARCH-II, MARCH2, RNF172" ENSG00000099785 "Membrane associated ring-CH-type finger 2" Q9P0N8 19 8413270-8439017 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014063 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "HPA014063: AB_1853576" "unprognostic (1.15e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.48e-4)" "prognostic favorable (1.05e-5)" "unprognostic (3.00e-1)" "prognostic favorable (8.29e-4)" "unprognostic (3.43e-2)" "unprognostic (6.95e-2)" "unprognostic (3.06e-3)" "unprognostic (2.32e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.01e-1)" "unprognostic (3.52e-1)" "unprognostic (1.01e-1)" "unprognostic (3.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.80e-2)" 61.5 33.2 99.0 20.5 91.9 29.6 50.3 95.2 107.4 23.1 65.1 71.3 15.9 34.7 54.4 32.7 27.4 15.5 91.1 86.3 88.7 35.5 59.6 42.3 19.7 109.5 97.5 80.6 16.0 19.3 15.5 30.7 20.0 103.8 41.2 14.1 9.2 25.7 29.1 90.2 32.4 31.7 30.3 102.9 51.6 33.2 19.1 99.2 14.3 48.3 49.0 14.6 50.2 26.3 96.4 11.4 14.2 6.3 29.5 37.9 12.6 10.7 12.3 14.7 9.5 9.8 7.0 5.5 4.4 34.8 26.7 12.6 8.1 8.2 17.5 7.3 22.7 20.3 34.2 6.6 15.9 20.5 5.0 49.6 14.7 20.1 9.2 8.1 13.9 38.2 17.8 4.9 24.5 7.5 21.5 7.0 16.7 13.3 14.0 34.2 11.0 2.0 11.4 22.4 13.9 3.1 17.7 0.8 12.9 24.2 21.5 10.2 10.8 38.9 13.3 8.4 44.5 10.4 21.7 28.2 5.0 21.6 10.2 10.7 52.6 18.5 31.3 10.6 28.6 10.8 7.2 10.6 8.6 13.1 7.3 7.2 9.6 23.4 7.9 25.7 51.8 14.9 17.4 99.0 91.9 95.2 107.4 86.3 88.7 109.5 97.5 80.6 103.8 102.9 99.2 96.4 23.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 8.1 9.9 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 11.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 5.7 1.5 0.0 0.0 0.0 NDUFB7 "B18, CI-B18, MGC2480" ENSG00000099795 "NADH:ubiquinone oxidoreductase subunit B7" P17568 19 14566078-14572066 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1154.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002817 Enhanced NA NA "HPA002817: AB_1079462" "unprognostic (2.80e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.03e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.95e-1)" "unprognostic (1.45e-3)" "unprognostic (2.07e-1)" "unprognostic (1.87e-2)" "unprognostic (2.02e-2)" "unprognostic (4.14e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (9.25e-3)" 198.4 217.9 169.2 66.7 169.5 104.6 190.4 187.4 328.1 149.1 166.4 249.9 125.7 170.8 51.5 232.6 153.7 58.2 605.3 159.1 175.2 293.6 338.4 128.9 71.0 178.8 176.4 160.7 138.5 215.2 144.4 184.2 62.1 173.2 172.4 56.4 28.8 200.5 94.0 716.2 190.9 164.5 51.1 172.6 151.2 233.8 133.9 184.1 51.1 191.2 269.2 39.9 168.7 162.5 173.1 242.1 237.4 95.0 203.1 80.4 80.5 167.4 110.1 120.6 200.0 189.2 317.9 130.2 109.4 322.0 102.9 87.5 185.0 62.6 241.1 26.7 170.1 320.8 212.2 380.9 334.6 142.1 138.7 141.5 131.7 196.6 105.7 49.6 56.1 161.7 194.9 132.9 194.8 94.2 452.7 227.0 308.0 242.4 228.1 773.2 174.3 112.8 264.6 143.0 253.3 204.4 217.6 114.9 265.6 303.4 24.6 175.0 245.1 122.0 253.5 123.2 324.4 207.0 264.4 295.5 144.1 243.7 267.8 174.5 355.6 414.5 140.4 432.9 395.5 403.8 368.6 291.4 368.9 415.4 327.7 241.3 315.5 119.4 422.4 389.5 460.4 373.3 562.3 169.2 169.5 187.4 328.1 159.1 175.2 178.8 176.4 160.7 173.2 172.6 184.1 173.1 196.4 76.9 95.9 19.9 155.6 133.4 177.9 358.5 126.9 117.4 285.4 363.9 670.4 245.9 214.2 259.3 56.3 359.7 155.5 937.3 1154.3 324.9 81.8 162.8 133.9 163.5 332.1 152.9 7.4 455.3 330.5 185.2 194.7 152.1 102.2 197.4 203.1 589.1 377.5 72.3 11.4 639.3 299.1 237.9 158.0 252.0 207.5 173.9 378.8 10.3 327.3 236.4 365.6 8.5 25.5 367.9 720.8 200.1 197.5 175.4 916.4 1041.9 193.1 152.4 236.7 193.6 330.8 133.7 252.1 235.7 161.2 225.6 138.6 197.5 631.6 220.1 TECR "GPSN2, MRT14, SC2, TER" ENSG00000099797 "Trans-2,3-enoyl-CoA reductase" Q9NZ01 19 14517085-14565980 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1013.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029780, HPA056488" Supported Supported "Endoplasmic reticulum" NA NA 10000 "Endoplasmic reticulum" "HPA029780: AB_10603348, HPA056488: AB_2683149" "unprognostic (9.73e-2)" "unprognostic (3.69e-3)" "unprognostic (1.55e-1)" "unprognostic (8.08e-3)" "unprognostic (1.20e-1)" "unprognostic (3.96e-2)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (9.16e-2)" "unprognostic (1.29e-1)" "unprognostic (5.05e-2)" "unprognostic (3.65e-3)" "unprognostic (2.53e-3)" "unprognostic (2.34e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.60e-4)" 96.3 163.9 175.3 43.5 186.2 74.9 101.3 204.0 239.4 117.0 192.2 72.3 107.0 53.7 104.1 376.2 87.9 50.2 77.3 168.2 184.8 112.0 135.0 68.4 56.2 195.7 184.6 160.5 81.6 106.4 308.6 79.4 68.6 197.5 86.4 59.9 83.5 224.2 84.2 369.8 265.6 96.7 37.1 191.4 76.0 82.4 184.2 190.4 66.4 93.5 211.4 86.0 52.0 187.5 216.6 220.5 162.1 149.5 169.6 214.7 97.2 156.9 62.8 175.2 196.3 242.9 225.3 246.2 113.8 127.4 134.2 152.4 328.8 158.1 254.3 84.0 192.3 165.9 193.7 225.4 254.6 129.7 139.5 143.7 144.9 201.8 174.3 96.1 98.4 93.7 169.2 128.9 391.5 104.0 289.3 170.1 248.3 155.6 556.1 227.6 154.4 96.1 521.1 275.1 115.8 183.2 113.0 103.1 278.4 139.6 77.2 151.3 274.4 55.2 160.5 66.8 141.0 212.6 118.4 119.8 122.7 163.8 212.6 162.2 55.6 72.7 52.5 137.8 106.4 148.8 100.1 180.1 159.1 124.2 99.1 207.1 164.5 32.7 183.7 83.9 137.1 290.1 170.9 175.3 186.2 204.0 239.4 168.2 184.8 195.7 184.6 160.5 197.5 191.4 190.4 216.6 60.4 73.7 71.1 47.7 87.6 169.5 227.5 297.9 125.7 90.8 161.1 155.6 52.9 120.1 221.5 165.5 123.0 509.5 88.1 159.2 56.7 166.2 443.9 102.2 40.1 64.7 100.0 80.1 15.3 225.1 525.5 81.8 89.7 64.2 36.1 90.1 73.2 143.1 188.0 112.7 19.2 144.0 199.4 113.8 99.3 1013.1 72.7 77.8 163.7 18.7 61.6 577.9 103.0 12.5 46.5 104.8 128.2 60.2 206.1 110.2 343.2 202.9 213.1 177.5 65.7 68.4 286.7 215.0 134.2 255.3 239.7 486.2 117.7 116.0 216.2 196.5 TIMM13 "Tim13, TIMM13B" ENSG00000099800 "Translocase of inner mitochondrial membrane 13" Q9Y5L4 19 2425625-2427586 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048985 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA 160000 Mitochondria "Nucleoli fibrillar center" "HPA048985: AB_2680589" "unprognostic (5.47e-2)" "unprognostic (6.63e-2)" "unprognostic (7.15e-2)" "prognostic favorable (4.68e-5)" "unprognostic (8.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.37e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-1)" "unprognostic (1.53e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.91e-2)" "prognostic favorable (3.88e-5)" "unprognostic (4.00e-2)" "unprognostic (3.35e-2)" "unprognostic (4.33e-1)" "unprognostic (2.47e-2)" 50.7 130.1 44.6 26.8 44.3 34.8 50.5 46.7 75.3 43.5 43.5 56.5 51.6 41.3 11.5 106.6 44.2 15.9 84.5 44.0 46.2 97.0 143.9 42.9 26.8 46.4 47.1 40.9 54.4 98.4 32.7 50.2 25.2 46.1 65.3 16.6 6.0 51.5 12.2 88.1 73.3 52.4 11.8 46.4 65.4 68.0 58.8 46.6 31.3 54.6 42.8 15.7 48.5 57.3 45.6 132.4 135.2 48.3 95.8 26.7 26.7 66.3 75.2 26.2 54.3 39.6 196.5 65.2 79.0 26.2 25.1 39.7 95.5 75.2 102.2 15.0 73.2 265.8 66.4 140.2 151.9 76.2 129.1 68.8 62.7 54.3 59.5 40.5 36.9 65.6 102.2 136.4 114.8 22.0 54.7 153.1 176.2 135.5 106.9 196.1 113.8 38.8 212.2 53.5 111.4 178.8 164.4 34.1 137.0 89.6 21.5 91.5 141.0 62.4 63.6 71.3 120.1 152.9 179.5 100.4 85.5 65.4 175.3 98.7 40.2 162.0 51.3 62.5 158.5 77.6 98.8 71.0 65.8 149.5 92.3 87.7 76.3 10.5 99.8 95.8 334.7 78.1 124.3 44.6 44.3 46.7 75.3 44.0 46.2 46.4 47.1 40.9 46.1 46.4 46.6 45.6 75.4 51.3 77.8 9.8 88.9 233.0 146.9 266.3 97.9 40.9 249.6 291.6 147.5 144.4 136.6 130.6 4.2 330.2 118.6 325.8 420.7 251.8 67.5 85.9 146.9 116.9 192.0 103.2 10.1 385.7 435.1 126.9 126.9 101.1 61.6 230.5 99.2 411.8 317.2 26.9 13.5 348.1 189.2 162.7 140.3 121.4 128.6 104.0 225.9 4.7 150.2 91.2 90.6 8.0 15.3 325.5 214.8 98.9 91.0 221.9 359.7 638.8 84.2 43.7 52.6 105.7 156.2 106.0 144.8 195.2 276.2 284.2 60.4 454.8 425.6 189.3 CDC34 "E2-CDC34, UBC3, UBE2R1" ENSG00000099804 "Cell division cycle 34, ubiqiutin conjugating enzyme" P49427 19 531760-542092 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002382, CAB005109, CAB047311, HPA074334" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370, HPA074334: " "unprognostic (4.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (2.84e-1)" "unprognostic (5.73e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (2.20e-1)" "unprognostic (3.11e-1)" "unprognostic (3.83e-2)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (3.02e-2)" "unprognostic (8.87e-3)" "unprognostic (9.68e-2)" "unprognostic (7.82e-3)" "unprognostic (3.33e-2)" 34.1 37.0 48.6 13.4 47.6 34.8 34.5 47.7 63.5 35.8 42.7 51.9 18.0 33.8 14.2 40.8 33.9 10.2 69.3 48.9 45.0 32.3 88.7 32.4 12.6 47.3 47.0 49.3 35.9 59.0 18.8 43.8 29.4 47.2 37.2 11.6 28.4 34.5 19.4 105.9 48.6 27.9 18.7 44.6 31.2 38.9 100.9 48.3 16.5 27.0 63.8 9.7 44.1 34.5 48.4 54.8 54.6 66.4 54.7 29.2 28.4 68.5 47.8 36.1 50.2 51.9 86.1 32.8 29.5 49.3 34.1 30.1 36.9 52.1 40.2 25.0 49.2 146.0 27.8 35.5 94.5 73.6 39.0 32.4 36.4 58.9 42.2 43.6 38.8 60.6 41.2 120.3 57.5 33.8 80.7 53.3 53.6 85.3 39.4 51.7 49.1 35.1 51.2 38.0 32.4 87.2 65.9 41.5 42.1 85.2 53.2 34.0 57.4 50.5 36.5 43.7 86.2 65.2 57.7 47.3 40.1 50.0 55.6 38.8 3.2 2.5 4.7 1.6 2.7 1.1 2.3 2.1 2.9 2.0 1.0 1.6 1.6 8.2 1.2 3.5 1.6 2.5 1.0 48.6 47.6 47.7 63.5 48.9 45.0 47.3 47.0 49.3 47.2 44.6 48.3 48.4 39.4 0.0 5.4 21.9 11.4 46.8 17.5 5.4 16.5 35.5 43.4 47.1 27.7 27.1 3.5 14.7 25.0 44.3 30.9 47.4 13.7 24.9 63.9 29.6 28.3 27.7 13.2 77.7 8.3 20.5 55.4 21.4 16.8 42.3 0.0 28.1 15.7 41.1 27.9 16.8 6.3 34.0 14.2 14.5 38.6 249.4 18.0 20.6 19.6 2.8 15.1 68.9 20.6 6.6 12.9 45.0 27.0 15.1 25.0 34.8 25.9 18.9 5.5 44.3 13.1 22.6 34.9 22.4 54.6 15.2 54.7 63.1 22.0 27.1 23.7 27.9 MTAP "c86fus, MSAP" ENSG00000099810 "Methylthioadenosine phosphorylase" Q13126 9 21802636-21937651 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046915, CAB080036, CAB080037" Approved Supported Nucleoplasm,Cytosol NA NA 3000000 Cytosol Nucleoplasm "CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862" "unprognostic (1.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.21e-1)" "unprognostic (2.58e-3)" "unprognostic (2.78e-1)" "unprognostic (6.16e-2)" "prognostic unfavorable (4.68e-4)" "unprognostic (9.47e-2)" "unprognostic (2.03e-1)" "unprognostic (8.63e-2)" "unprognostic (4.76e-3)" "unprognostic (4.27e-2)" "unprognostic (6.28e-3)" "unprognostic (2.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" 5.9 6.6 4.5 5.5 5.2 5.9 8.6 4.7 6.0 7.9 7.1 6.0 4.8 8.9 7.2 8.9 7.2 4.9 7.1 4.3 4.3 7.0 11.0 5.9 6.4 5.6 4.9 3.8 12.2 6.7 8.5 2.9 9.0 5.4 7.2 8.1 3.9 6.6 7.1 4.6 7.1 5.9 9.1 4.6 7.3 7.2 2.9 5.2 6.8 7.2 5.5 7.4 10.2 7.5 6.3 30.4 1.0 23.0 19.0 19.4 19.0 28.3 42.3 21.0 21.9 24.3 21.7 14.6 15.3 13.4 21.1 16.3 15.2 24.4 59.5 36.8 0.3 19.8 0.3 56.8 28.8 18.6 24.5 26.3 23.5 0.1 38.6 42.6 24.4 22.6 0.5 0.3 20.1 21.9 3.1 26.8 0.7 27.5 14.7 35.2 0.4 18.0 26.0 18.3 0.4 14.4 15.3 14.4 17.1 21.1 17.9 10.9 0.6 23.8 0.3 15.7 0.2 34.4 13.7 25.5 30.0 0.2 24.3 12.0 1.2 5.6 0.2 3.6 4.5 6.1 5.9 5.3 4.2 6.9 8.4 4.6 4.2 0.7 6.7 2.9 6.3 3.2 2.7 4.5 5.2 4.7 6.0 4.3 4.3 5.6 4.9 3.8 5.4 4.6 5.2 6.3 18.8 22.4 19.8 26.1 16.3 14.1 58.4 22.4 16.5 0.0 20.2 23.9 22.4 24.3 27.9 14.7 0.0 52.3 11.4 6.8 15.6 38.6 77.9 28.8 28.5 14.9 9.6 19.1 14.8 28.0 80.0 18.7 15.3 40.6 10.8 30.0 17.5 22.2 27.1 0.0 9.1 14.3 30.5 25.5 11.1 14.8 14.9 15.1 10.6 48.7 15.0 0.0 10.3 40.7 32.9 41.5 6.8 14.7 13.7 45.0 9.2 19.5 19.1 0.0 13.1 20.6 23.1 1.3 13.9 35.1 13.1 22.6 15.1 33.0 20.7 62.9 MISP "C19orf21, Caprice, DKFZp686H18209, MISP1" ENSG00000099812 "Mitotic spindle positioning" Q8IVT2 19 751112-764318 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "intestine: 198.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 133.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049511, HPA062232" Enhanced Enhanced "Plasma membrane,Focal adhesion sites" No No "Plasma membrane, Focal adhesion sites" "HPA049511: AB_2680798, HPA062232: AB_2684719" "unprognostic (7.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" "unprognostic (6.50e-2)" "unprognostic (1.78e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.49e-1)" "unprognostic (2.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.78e-3)" "unprognostic (2.29e-1)" "unprognostic (4.80e-1)" "unprognostic (5.27e-2)" 0.6 0.0 0.3 12.2 0.3 0.0 0.9 0.5 0.4 4.5 0.1 96.4 172.6 0.7 0.0 0.3 9.9 11.4 0.0 0.3 0.2 8.7 0.1 9.4 0.1 0.4 0.4 0.2 0.3 1.7 0.0 8.2 1.2 0.5 5.7 48.9 0.0 1.0 0.5 0.0 0.6 198.2 3.3 0.2 0.0 23.1 0.5 0.2 0.3 0.1 0.0 0.0 9.1 0.6 0.5 30.4 121.4 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 42.1 44.2 10.8 11.5 0.0 0.1 90.2 0.0 37.7 0.0 0.0 0.1 0.0 47.0 13.3 0.0 0.0 1.9 0.0 82.6 0.3 4.5 0.0 0.0 0.0 0.0 0.4 0.2 63.2 0.1 0.7 0.1 76.9 24.6 0.2 0.4 1.0 30.1 33.7 1.4 0.4 42.9 134.3 0.1 0.1 29.3 0.0 0.0 0.0 14.8 1.8 0.2 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.4 0.3 0.2 0.4 0.4 0.2 0.5 0.2 0.2 0.5 0.1 38.5 8.0 0.3 2.9 0.1 4.5 22.5 0.0 0.0 4.7 2.3 0.5 10.0 39.7 11.0 0.0 0.6 0.0 793.4 1.9 39.9 0.6 40.5 1.5 0.8 58.0 0.0 0.2 46.0 6.0 2.4 56.6 14.3 8.9 0.0 0.0 0.0 0.1 0.0 0.3 230.9 28.5 0.0 0.0 0.9 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.2 157.7 646.7 0.0 0.1 41.6 1115.2 27.5 41.3 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.3 2.1 1.6 0.0 220.7 62.1 CEP170B "Cep170R, FAM68C, KIAA0284" ENSG00000099814 "Centrosomal protein 170B" Q9Y4F5 14 104865268-104896770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 229.4;Distal enterocytes: 81.2;Rod photoreceptor cells: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000871, HPA059017" Enhanced Approved Microtubules,Centrosome,Cytosol NA NA Cytosol "Microtubules, Centrosome" "HPA000871: AB_2666124, HPA059017: AB_2683883" "unprognostic (1.09e-1)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.38e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (4.96e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (4.41e-4)" "prognostic favorable (3.26e-4)" "unprognostic (1.62e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (1.17e-2)" 12.7 12.9 13.4 5.0 14.3 0.2 13.3 0.0 28.3 11.6 0.0 23.1 18.1 14.9 2.6 31.5 14.8 6.0 9.9 17.7 6.4 20.7 20.4 15.0 0.8 14.1 8.1 20.4 6.4 28.0 6.2 21.3 2.7 6.3 19.6 5.7 10.3 18.6 7.7 6.5 35.8 21.3 4.2 0.0 4.5 24.5 15.5 4.9 1.0 20.9 1.4 1.9 16.3 16.5 10.8 23.4 19.1 1.4 17.8 7.4 5.3 41.3 18.0 7.0 8.9 5.9 20.3 14.0 0.0 21.5 13.8 6.1 50.7 4.2 21.1 2.3 8.6 8.8 0.0 22.9 13.4 14.9 0.1 18.2 5.2 26.2 9.3 13.5 7.0 9.0 0.1 6.0 0.2 7.7 49.4 0.1 0.3 5.9 33.2 16.3 7.7 0.1 5.6 8.9 39.1 4.8 5.0 26.7 15.5 24.2 3.0 27.1 3.4 20.0 14.0 15.3 39.0 12.3 0.8 0.1 0.1 11.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.3 0.0 28.3 17.7 6.4 14.1 8.1 20.4 6.3 0.0 4.9 10.8 1.7 9.6 15.3 5.2 0.8 23.8 12.6 12.8 10.2 18.0 15.2 11.4 3.7 22.8 10.0 18.4 229.4 3.6 0.2 81.2 1.9 12.2 0.8 16.2 6.3 4.4 22.1 0.0 17.7 24.0 7.6 5.4 48.4 18.2 5.7 5.7 8.6 12.8 1.4 40.4 14.9 41.0 8.2 0.8 5.2 1.7 3.7 1.3 8.8 2.8 1.0 11.1 0.0 5.5 5.9 31.8 42.9 8.6 0.7 30.3 27.5 5.0 20.1 112.6 6.6 6.8 7.8 1.7 5.2 13.9 24.6 6.7 1.9 0.0 35.6 24.5 POLR2E "hRPB25, hsRPB5, RPABC1, RPB5, XAP4" ENSG00000099817 "RNA polymerase II, I and III subunit E" P19388 19 1086574-1095380 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Host-virus interaction, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063030, HPA068992" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA063030: AB_2684926, HPA068992: AB_2686065" "unprognostic (2.52e-1)" "unprognostic (3.73e-2)" "unprognostic (2.49e-1)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (6.42e-2)" "unprognostic (2.59e-3)" "unprognostic (1.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.05e-1)" "unprognostic (2.03e-3)" "unprognostic (3.03e-2)" "prognostic favorable (3.21e-6)" "unprognostic (3.22e-1)" "unprognostic (1.47e-1)" "unprognostic (1.72e-3)" "unprognostic (4.77e-2)" 31.0 16.8 24.5 16.4 21.9 15.6 18.3 21.8 28.6 13.0 15.2 18.8 13.8 12.9 14.6 23.0 17.4 8.0 14.8 24.6 21.8 23.8 41.5 17.1 18.8 25.7 23.6 21.7 14.1 13.3 20.5 12.3 10.3 27.2 12.6 19.7 17.7 14.9 12.2 16.5 16.3 17.1 16.9 22.1 19.5 16.1 13.1 25.0 13.9 17.1 22.8 26.8 14.2 11.3 26.0 33.6 30.8 41.6 33.4 55.6 34.5 19.5 24.2 34.1 39.5 23.1 36.1 11.9 27.5 10.7 72.1 6.1 26.5 79.1 26.9 73.1 29.2 23.9 36.3 36.2 33.9 22.3 54.3 26.4 25.5 17.5 27.7 51.0 40.6 36.7 14.7 42.3 31.0 44.3 27.6 30.0 17.1 33.6 23.9 23.1 31.9 40.7 27.0 39.5 38.3 21.0 23.9 40.2 27.8 17.5 37.2 29.5 24.7 49.9 19.6 21.7 36.0 28.4 47.6 70.9 50.9 32.3 34.6 23.2 24.2 50.2 29.5 25.5 33.7 26.5 18.2 23.2 26.0 44.3 19.6 18.5 18.4 25.2 28.7 38.7 31.2 24.5 38.4 24.5 21.9 21.8 28.6 24.6 21.8 25.7 23.6 21.7 27.2 22.1 25.0 26.0 67.7 32.1 63.0 8.1 80.1 104.3 83.9 152.1 59.7 55.7 80.9 82.9 78.2 60.1 79.9 55.2 41.7 234.3 67.4 103.1 174.1 156.7 21.0 64.0 64.4 77.8 70.6 77.4 13.0 141.1 264.1 95.1 66.3 57.2 71.0 74.9 68.9 96.6 259.7 55.5 13.9 91.8 107.8 93.6 221.7 37.8 69.3 103.7 99.6 6.5 361.7 78.1 103.0 4.5 10.6 162.5 84.6 62.1 93.8 111.7 163.1 188.4 72.3 48.9 26.3 50.5 96.9 125.4 82.5 104.1 109.7 234.6 73.4 110.6 130.5 106.9 POLRMT "APOLMT, h-mtRPOL, MTRNAP, MTRPOL" ENSG00000099821 "RNA polymerase mitochondrial" O00411 19 617221-633537 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 84.0;Spermatogonia: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006366 Uncertain Supported Mitochondria NA NA Mitochondria "HPA006366: AB_1079654" "unprognostic (3.24e-1)" "unprognostic (4.31e-2)" "unprognostic (7.96e-2)" "prognostic favorable (4.50e-4)" "unprognostic (9.46e-2)" "unprognostic (2.94e-2)" "unprognostic (3.04e-2)" "unprognostic (9.41e-2)" "unprognostic (1.45e-1)" "unprognostic (3.48e-1)" "unprognostic (7.64e-3)" "unprognostic (1.81e-2)" "unprognostic (1.62e-1)" "unprognostic (1.28e-3)" "unprognostic (1.66e-1)" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" 16.9 24.1 21.1 9.2 22.1 6.9 18.2 21.8 28.7 18.5 17.9 22.0 14.7 19.9 10.1 21.2 19.4 5.4 31.9 21.7 20.3 26.3 41.6 16.2 9.7 25.9 22.3 21.0 20.9 26.5 11.5 22.8 5.0 23.4 20.9 7.3 5.8 17.3 9.3 69.7 27.7 24.1 6.6 19.9 22.7 22.0 67.1 22.7 11.1 20.3 15.0 7.6 21.6 17.9 26.1 24.5 43.6 9.7 42.1 19.7 11.0 35.7 11.1 12.9 15.7 14.5 44.2 15.9 24.9 22.0 10.2 7.9 24.5 35.5 21.0 11.8 28.3 86.8 19.3 26.4 56.9 20.5 32.6 34.7 10.7 29.3 16.4 19.7 11.3 22.9 34.0 37.3 23.6 14.8 34.3 43.7 44.7 38.4 31.1 30.2 42.0 13.3 42.4 21.4 20.7 30.7 22.1 10.2 26.7 28.4 10.3 15.4 29.9 14.1 17.2 22.0 26.9 33.3 57.4 51.0 38.7 36.9 27.3 21.8 0.0 2.9 2.5 6.2 3.8 5.0 5.6 4.6 4.6 5.5 6.3 3.9 4.5 0.5 6.0 4.2 5.4 3.1 4.6 21.1 22.1 21.8 28.7 21.7 20.3 25.9 22.3 21.0 23.4 19.9 22.7 26.1 10.3 12.8 11.5 2.6 14.2 8.0 6.1 5.8 10.2 18.3 9.1 8.0 18.0 15.7 7.9 16.5 18.8 15.5 13.3 31.5 7.9 6.7 39.8 7.7 6.1 9.7 13.1 9.4 2.7 8.0 8.7 8.9 14.3 8.6 12.7 15.1 8.2 21.9 10.4 11.8 2.7 12.7 4.1 8.3 7.4 84.0 12.5 8.0 10.6 3.7 7.4 8.4 18.6 1.5 4.6 6.5 12.4 13.2 7.8 10.3 26.0 15.1 6.4 18.1 6.6 8.9 10.0 31.6 84.9 10.6 7.2 7.7 12.7 15.6 24.4 6.2 HCN2 "BCNG-2, BCNG2, HAC-1" ENSG00000099822 "Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2" Q9UL51 19 589881-617159 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 129.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 60.4;Horizontal cells: 40.4;Inhibitory neurons: 18.7;Oligodendrocytes: 62.1;Rod photoreceptor cells: 14.9" "Group enriched" "Detected in many" 6 "glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 29.9;HeLa: 15.8;MCF7: 28.4;U-138 MG: 20.2;U-87 MG: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.69e-2)" "unprognostic (3.97e-3)" "unprognostic (3.31e-4)" "unprognostic (1.44e-1)" "unprognostic (2.44e-1)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" "unprognostic (5.32e-2)" "unprognostic (1.19e-3)" "unprognostic (8.00e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.07e-1)" "unprognostic (1.41e-1)" "unprognostic (5.53e-4)" "unprognostic (9.72e-3)" 0.1 4.2 46.5 0.2 41.1 0.4 0.1 74.5 100.5 0.1 0.0 0.5 0.1 0.1 0.2 1.6 0.0 0.1 11.8 27.8 42.9 1.3 0.2 0.2 0.3 78.2 72.5 11.0 0.1 0.3 3.4 12.9 0.1 95.2 0.3 0.0 7.5 0.3 0.1 0.1 0.9 0.4 0.1 41.6 0.4 0.4 3.2 129.3 0.1 0.1 0.0 0.3 0.1 0.5 98.2 0.1 29.9 0.3 1.0 3.1 2.1 1.0 2.1 2.4 0.8 0.2 4.3 0.3 0.0 6.5 2.9 2.1 0.2 0.6 0.1 0.1 5.1 12.6 0.0 15.8 0.4 2.2 0.3 5.6 5.6 0.5 0.2 0.1 0.9 0.1 0.7 1.8 0.2 2.1 28.4 0.1 0.0 1.4 0.7 0.8 0.2 0.1 0.7 0.5 0.9 11.3 5.8 7.3 0.1 2.3 0.5 5.9 1.0 2.8 20.2 3.0 0.4 8.4 0.5 0.4 0.2 41.7 1.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.5 41.1 74.5 100.5 27.8 42.9 78.2 72.5 11.0 95.2 41.6 129.3 98.2 0.5 0.0 0.0 2.0 0.6 0.6 0.0 0.0 1.2 60.4 0.7 0.9 4.1 0.0 0.0 0.0 2.1 0.0 1.6 0.3 0.0 0.1 0.1 0.6 0.4 0.9 1.2 2.7 12.8 0.0 0.3 0.2 0.0 1.2 0.0 0.2 0.7 0.1 0.1 40.4 18.7 0.0 0.0 1.3 0.3 0.4 0.0 1.1 0.0 2.8 0.0 2.7 0.0 5.5 62.1 0.1 0.0 0.7 1.4 0.1 0.0 0.3 0.0 14.9 0.0 0.1 0.5 0.1 1.7 4.5 0.6 0.3 1.2 0.1 0.1 0.1 CDHR5 "FLJ20219, MU-PCDH, MUCDHL, MUPCDH" ENSG00000099834 "Cadherin related family member 5" Q9HBB8 11 616577-626078 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 299.3;liver: 130.9" "Group enriched" "Detected in some" 7 "Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8" "Cancer enhanced" "Detected in many" "liver cancer: 61.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009081, HPA009173, CAB025004" Enhanced "Intracellular and membrane" NA NA 190000000 "CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429" "unprognostic (7.65e-2)" "unprognostic (1.42e-1)" "unprognostic (9.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-3)" "unprognostic (4.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.75e-2)" "unprognostic (6.36e-2)" "unprognostic (7.95e-2)" "unprognostic (5.07e-2)" "unprognostic (5.01e-2)" "unprognostic (3.90e-1)" "unprognostic (8.85e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-2)" 0.1 0.9 0.2 4.0 0.4 0.1 0.4 0.4 0.4 0.1 1.7 58.4 243.3 0.2 0.1 0.3 0.3 3.9 0.0 0.2 0.0 43.7 130.9 0.2 0.2 0.3 0.1 0.1 0.2 1.8 0.0 0.6 0.0 0.7 0.1 52.4 0.1 0.0 0.1 0.1 0.1 299.3 2.7 0.0 0.1 4.3 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 13.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.4 0.2 0.0 0.3 0.1 0.1 0.7 0.0 0.2 0.7 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 11.5 0.0 1.8 0.0 0.0 1.4 811.5 13.7 0.3 2.8 0.1 0.2 0.1 92.8 0.0 0.0 1.3 0.0 0.0 33.6 0.4 13.4 0.0 4.6 126.1 0.1 0.0 0.1 193.2 0.0 4.3 0.0 18.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 732.4 0.0 0.0 0.0 2545.8 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 154.6 0.0 IZUMO4 C19orf36 ENSG00000099840 "IZUMO family member 4" Q1ZYL8 19 2096429-2099593 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "testis: 446.6" "Group enriched" "Detected in many" 51 "Early spermatids: 1750.8;Late spermatids: 2537.9;Spermatocytes: 824.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 8.5;RPMI-8226: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048496 Enhanced "Secreted in male reproductive system" NA NA "HPA048496: AB_2680419" "unprognostic (2.75e-3)" "unprognostic (1.10e-2)" "unprognostic (3.65e-2)" "prognostic favorable (7.08e-4)" "unprognostic (1.40e-1)" "unprognostic (2.18e-5)" "unprognostic (2.67e-2)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (2.48e-1)" "prognostic favorable (1.69e-4)" "unprognostic (2.12e-1)" "unprognostic (6.58e-5)" "unprognostic (6.38e-2)" "unprognostic (2.17e-1)" "unprognostic (5.68e-1)" "unprognostic (7.51e-3)" 2.8 1.9 13.7 1.2 13.7 0.5 3.3 13.8 21.0 2.5 13.2 2.5 0.5 2.7 2.5 2.6 5.1 1.9 2.6 13.2 12.9 4.3 5.4 2.2 1.8 16.0 14.0 12.4 6.5 8.7 0.8 10.2 0.4 14.7 7.5 0.9 2.9 2.4 2.4 2.6 2.4 2.0 0.7 13.2 1.6 3.9 446.6 13.6 1.8 4.6 1.2 2.3 2.5 2.3 14.3 0.6 0.5 0.3 2.7 1.1 1.2 0.3 0.4 0.6 0.4 0.0 0.2 0.5 0.4 0.6 0.6 0.0 0.5 0.0 2.9 0.1 1.2 0.2 0.0 1.1 0.8 3.2 0.0 0.4 0.5 1.1 0.7 0.8 0.9 0.0 1.5 0.0 8.5 1.1 0.1 0.8 0.2 0.3 1.1 0.7 0.7 0.0 10.9 1.2 0.3 0.4 0.7 0.4 0.9 0.4 0.2 0.5 1.0 0.0 0.3 0.1 0.1 0.2 0.9 1.1 0.8 1.4 0.9 0.2 0.0 0.7 0.6 0.6 1.1 1.5 2.7 2.1 1.6 0.9 0.7 1.7 0.7 1.6 0.5 1.6 1.2 2.2 0.9 13.7 13.7 13.8 21.0 13.2 12.9 16.0 14.0 12.4 14.7 13.2 13.6 14.3 1.0 0.0 0.0 31.0 10.3 2.4 4.1 32.8 4.0 3.4 2.5 2.3 1.5 5.7 19.7 9.2 8.4 0.5 2.6 2.0 5.9 2.5 1750.8 4.6 1.9 1.7 7.7 0.4 1.2 5.8 4.5 3.7 1.1 2.3 0.0 2.2 0.7 9.5 1.0 0.0 1.6 1.9 14.2 3.2 8.2 2537.9 28.6 4.3 12.4 0.0 11.3 6.6 1.0 1.5 28.0 1.8 0.7 19.9 8.2 6.8 1.9 11.1 12.1 8.6 6.6 2.6 2.1 824.6 14.3 6.3 1.7 1.6 5.6 2.4 4.4 7.0 RASSF7 "C11orf13, CFAP88, FAP88, HRAS1, HRC1" ENSG00000099849 "Ras association domain family member 7" Q02833 11 560404-564025 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 224.6;Intestinal goblet cells: 179.2;Paneth cells: 194.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.5;HaCaT: 86.4;SK-BR-3: 75.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078015 Supported "Centriolar satellite" NA NA "Centriolar satellite" "HPA078015: AB_2686875" "unprognostic (1.11e-2)" "unprognostic (5.10e-2)" "unprognostic (1.75e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.13e-1)" "unprognostic (2.46e-3)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.60e-1)" "unprognostic (2.55e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.99e-1)" "unprognostic (2.83e-1)" "unprognostic (3.58e-3)" 9.5 5.0 6.1 8.6 7.9 6.6 13.9 9.3 10.5 18.8 5.4 30.0 33.9 6.3 16.0 49.6 51.3 10.9 4.7 6.3 5.9 96.6 93.5 45.0 10.8 7.7 6.0 5.9 6.7 68.0 6.5 27.6 5.1 8.8 43.0 8.6 1.7 42.9 11.6 1.6 53.9 43.8 1.0 5.4 17.9 64.0 13.3 5.7 8.8 23.5 0.6 5.7 18.8 23.9 9.6 51.7 49.9 2.3 12.8 0.0 0.0 35.2 7.7 5.9 8.0 5.9 52.6 85.5 6.6 34.6 4.2 14.0 86.4 7.3 26.5 1.2 8.9 25.6 4.6 28.0 25.9 5.3 10.8 7.4 0.1 25.5 2.7 2.4 11.0 4.8 13.4 11.7 2.5 0.7 51.7 12.2 23.1 7.1 58.2 28.1 19.2 3.7 14.8 39.2 24.8 10.9 8.4 5.4 75.7 6.6 4.0 34.0 6.9 6.6 1.6 23.5 3.1 15.0 8.6 9.9 5.3 12.8 15.1 6.9 5.2 6.0 23.0 17.7 5.2 16.1 13.6 18.3 15.9 10.5 14.8 14.8 13.2 7.3 8.3 5.7 18.7 21.9 8.9 6.1 7.9 9.3 10.5 6.3 5.9 7.7 6.0 5.9 8.8 5.4 5.7 9.6 6.5 86.6 70.0 3.3 19.1 25.4 23.4 118.1 14.2 2.7 39.2 30.6 4.7 92.9 90.4 86.5 0.0 38.9 20.9 224.6 52.8 90.7 17.2 28.8 3.9 8.5 51.0 14.5 5.5 90.5 111.7 5.9 124.4 35.2 15.2 15.5 7.9 73.3 19.9 11.8 2.6 179.2 46.8 11.2 15.7 23.0 2.5 11.5 5.4 1.0 28.7 7.9 21.6 1.5 0.6 148.1 194.4 0.4 12.3 61.8 110.0 44.7 73.4 3.2 0.0 0.3 6.7 4.6 9.7 21.2 25.7 40.5 29.7 4.3 113.1 60.3 GADD45B "DKFZP566B133, GADD45BETA, MYD118" ENSG00000099860 "Growth arrest and DNA damage inducible beta" O75293 19 2476122-2478259 "Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1997.9;Breast myoepithelial cells: 1851.8;Smooth muscle cells: 1753.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 16.3" HPA029816 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029816: AB_10601325" "unprognostic (1.32e-1)" "unprognostic (4.51e-2)" "unprognostic (3.94e-3)" "unprognostic (5.06e-2)" "unprognostic (1.53e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (2.95e-1)" "unprognostic (2.79e-1)" "unprognostic (4.37e-2)" "unprognostic (1.09e-3)" "unprognostic (3.90e-2)" "unprognostic (8.27e-3)" "unprognostic (6.00e-2)" 294.1 76.5 47.3 41.8 46.6 324.3 219.3 46.7 89.7 89.6 56.6 161.0 17.3 84.1 3.3 54.4 191.8 92.3 263.7 39.7 175.3 220.5 412.3 346.3 33.4 52.6 46.2 36.3 160.5 93.4 49.6 175.4 45.4 53.5 91.5 10.0 57.6 73.2 28.8 84.8 136.0 68.5 27.5 49.1 76.5 188.9 17.2 56.8 66.5 211.0 31.1 12.8 104.8 100.9 76.2 62.1 12.2 1.4 8.1 44.1 33.6 3.8 61.7 17.7 47.6 24.4 17.1 23.3 29.1 40.7 30.7 17.1 33.8 3.2 20.5 11.5 22.5 11.0 3.2 13.9 6.6 74.3 6.7 19.7 54.8 13.1 14.3 70.2 51.3 19.0 3.1 1.6 76.9 49.5 19.9 7.7 33.0 7.3 6.2 25.7 28.5 22.0 46.6 21.7 11.0 0.6 0.6 68.7 50.6 20.9 26.2 26.9 49.5 78.8 47.2 43.2 34.0 77.9 34.3 27.9 12.5 11.5 20.0 15.7 32.1 33.5 131.2 58.1 40.8 52.3 21.0 40.7 45.2 32.9 30.2 35.5 47.9 92.5 43.3 33.5 36.9 54.6 35.3 47.3 46.6 46.7 89.7 39.7 175.3 52.6 46.2 36.3 53.5 49.1 56.8 76.2 1997.9 423.1 571.3 24.5 450.9 341.7 805.4 147.3 376.2 11.9 666.3 1851.8 952.6 173.0 226.3 51.5 6.2 93.0 988.3 213.7 191.7 374.3 1.6 614.2 539.7 800.0 85.3 8.6 3.0 209.8 54.0 1143.0 400.1 1122.9 786.6 53.9 138.8 126.1 430.9 13.5 1.5 164.4 282.8 174.8 1169.6 4.7 74.0 863.0 517.6 1.9 157.1 269.8 33.0 0.5 0.9 292.5 309.0 29.3 416.8 823.3 294.3 142.1 211.4 34.2 177.5 818.8 1753.4 1.4 7.8 399.0 308.9 144.2 514.7 128.4 98.8 301.3 PALM "KIAA0270, PALM1" ENSG00000099864 Paralemmin O75781 19 708935-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 259.8" "Cell type enhanced" "Detected in many" "Astrocytes: 85.2;Distal tubular cells: 52.8;Hepatic stellate cells: 63.1;Leydig cells: 48.4;Muller glia cells: 92.8;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 1.9" "Lineage enriched" "Detected in single" 19 "monocytes: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 16.6;EFO-21: 20.7;REH: 34.3;SH-SY5Y: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favorable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 85.1 23.3 139.6 2.0 120.4 0.7 66.5 70.0 259.8 59.9 39.3 40.9 7.5 43.7 3.3 14.5 47.5 2.8 40.7 146.4 91.0 48.0 7.4 30.2 0.6 100.4 85.6 120.0 66.3 5.9 1.2 63.0 6.7 97.9 43.0 0.6 4.6 13.1 8.4 9.6 31.4 21.0 2.5 74.3 23.6 18.1 19.8 90.5 0.6 21.2 1.7 0.2 29.7 42.2 94.3 0.0 7.6 14.6 16.6 0.6 0.2 2.2 0.9 0.0 1.0 0.2 1.9 0.1 0.0 20.7 0.0 0.0 2.7 8.0 0.0 0.4 0.0 14.1 0.0 4.3 9.3 9.4 0.0 0.3 3.0 0.0 0.9 0.0 0.4 0.4 1.6 4.6 0.1 1.1 15.9 1.1 9.4 5.9 1.0 3.2 34.3 0.0 0.2 0.6 0.0 1.7 28.0 7.5 0.1 0.2 4.6 1.8 4.5 0.0 0.0 13.4 16.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 139.6 120.4 70.0 259.8 146.4 91.0 100.4 85.6 120.0 97.9 74.3 90.5 94.3 27.2 0.0 1.7 85.2 2.7 7.1 7.2 6.3 1.8 11.4 5.7 5.3 5.8 1.5 4.9 5.5 12.5 0.9 0.2 1.3 52.8 1.4 1.4 3.8 27.0 25.6 0.0 1.3 26.9 0.2 7.2 37.6 1.1 5.9 0.0 1.4 63.1 0.4 1.0 25.2 15.1 0.1 12.2 2.4 5.4 6.6 48.4 1.1 17.8 10.3 0.1 92.8 0.0 16.6 9.8 0.2 1.4 45.1 0.1 10.1 7.2 57.9 0.5 5.7 0.0 2.3 14.1 0.8 7.3 1.1 7.0 1.9 1.1 0.1 0.4 7.2 MADCAM1 MACAM1 ENSG00000099866 "Mucosal vascular addressin cell adhesion molecule 1" Q13477 19 489176-505343 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 11.8;lymphoid tissue: 14.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 6.8;Endothelial cells: 7.6;Muller glia cells: 5.4;Rod photoreceptor cells: 5.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "neutrophil: 7.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.0" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;Hep G2: 1.8;U-266/70: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB075699, HPA077998" Enhanced NA NA 80000000 "CAB075699: , HPA077998: " "unprognostic (2.30e-1)" "unprognostic (7.81e-2)" "unprognostic (5.52e-2)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (6.26e-4)" "unprognostic (1.68e-2)" "unprognostic (2.17e-4)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (2.54e-4)" "unprognostic (2.42e-1)" "unprognostic (4.95e-3)" "unprognostic (9.80e-2)" "unprognostic (2.07e-2)" 0.8 0.7 2.6 14.0 2.7 0.2 1.1 4.7 4.8 0.5 0.0 4.7 2.8 0.5 0.3 1.5 0.5 2.2 0.4 2.2 1.6 0.6 1.0 0.4 0.4 3.0 3.2 1.6 0.6 3.0 2.2 1.7 0.2 5.2 0.8 2.5 0.8 0.6 0.1 0.6 0.5 11.8 0.1 1.6 8.6 2.9 1.6 1.9 0.0 2.0 0.1 0.2 0.6 0.6 4.0 0.3 0.0 0.0 0.4 0.3 0.0 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.2 0.9 0.0 0.1 0.5 0.0 0.0 0.0 1.1 1.4 0.0 1.1 1.8 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.6 0.1 1.0 0.1 0.5 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 1.8 0.7 0.3 0.0 0.4 0.0 0.0 0.3 0.8 0.3 0.3 0.4 0.3 0.2 0.2 0.0 0.6 0.7 0.7 7.0 0.3 0.2 0.2 0.0 0.1 2.6 2.7 4.7 4.8 2.2 1.6 3.0 3.2 1.6 5.2 1.6 1.9 4.0 1.4 0.0 0.0 1.0 1.5 0.5 0.5 0.2 2.8 6.8 1.0 1.4 0.8 1.5 0.0 3.7 0.0 0.6 2.2 0.3 0.0 0.2 0.3 0.6 0.9 7.6 0.0 0.4 1.6 0.0 0.3 2.8 1.1 0.3 0.0 2.8 1.4 0.3 0.5 1.7 1.7 0.8 0.0 0.6 0.7 0.5 0.9 0.3 0.0 0.0 0.4 5.4 4.1 1.0 0.8 0.1 0.1 0.7 1.0 0.5 0.2 0.8 0.8 5.6 0.0 0.8 0.8 2.1 2.1 0.7 0.4 0.3 1.5 1.1 0.1 0.4 MKNK2 "GPRK7, MNK2" ENSG00000099875 "MAPK interacting serine/threonine kinase 2" Q9HBH9 19 2037465-2051244 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 480.2;tongue: 556.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 367.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021875, CAB037253, HPA070499" Supported Supported "Nuclear bodies" No No "Nuclear bodies" "CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157" "unprognostic (8.76e-2)" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "prognostic favorable (4.86e-5)" "unprognostic (3.08e-1)" "unprognostic (1.59e-2)" "unprognostic (6.42e-3)" "unprognostic (1.35e-1)" "unprognostic (4.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.08e-1)" "unprognostic (6.56e-2)" "unprognostic (4.07e-2)" "prognostic favorable (4.01e-4)" "unprognostic (1.63e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-1)" 88.0 50.6 98.3 51.8 71.7 134.7 39.9 105.0 115.8 34.3 74.2 54.9 47.9 24.9 48.3 115.5 38.5 26.9 45.9 99.6 87.7 27.8 71.7 52.2 67.3 87.8 67.4 52.9 34.8 193.5 34.7 39.9 35.6 91.2 38.9 30.3 36.0 135.0 40.1 480.2 64.3 57.8 22.0 68.8 80.9 55.6 21.8 101.7 34.9 55.1 556.0 59.0 40.3 61.4 123.8 64.9 71.8 30.1 66.3 219.5 79.0 65.1 37.3 27.1 26.5 26.8 45.5 111.8 88.2 50.7 77.4 27.9 78.4 38.4 110.9 12.0 122.1 34.4 36.8 62.1 49.2 367.4 72.3 61.6 84.1 262.0 50.8 107.2 61.9 63.5 59.2 62.0 155.4 18.6 37.7 42.8 59.3 78.6 49.6 78.1 81.8 8.6 113.1 48.1 41.2 39.9 48.2 89.0 125.1 166.4 33.5 52.7 89.5 96.5 9.5 37.5 38.5 46.0 238.9 97.0 85.7 78.2 53.5 17.9 4.4 9.2 9.8 8.1 10.2 7.5 16.9 8.4 9.4 7.7 15.0 5.4 6.6 41.7 9.5 13.6 9.2 12.5 3.6 98.3 71.7 105.0 115.8 99.6 87.7 87.8 67.4 52.9 91.2 68.8 101.7 123.8 102.2 38.5 56.5 9.8 91.4 82.5 105.6 84.5 50.1 55.7 99.0 103.5 54.5 38.6 65.5 36.8 25.0 23.5 106.5 155.3 9.8 27.3 8.7 60.2 28.0 51.9 150.2 80.2 5.6 56.6 47.2 45.0 57.6 76.2 29.2 14.5 82.5 60.3 36.9 42.1 5.9 104.1 46.8 52.5 134.6 13.0 20.2 68.0 56.9 8.4 41.8 63.6 30.9 6.0 5.2 47.2 86.6 20.3 55.4 94.2 98.8 18.6 55.2 47.5 19.7 132.6 48.7 18.1 19.5 97.8 117.2 56.5 69.3 18.1 79.7 114.0 ARVCF ENSG00000099889 "ARVCF delta catenin family member" O00192 22 19969896-20016823 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 24.2;Cone photoreceptor cells: 22.9;Muller glia cells: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 20.1;REH: 10.5;SCLC-21H: 18.0;SH-SY5Y: 13.8;U-2 OS: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.76e-6)" 3.3 3.2 6.2 0.7 4.9 3.2 4.4 17.6 6.3 3.7 0.8 4.9 1.0 4.9 3.2 1.3 3.5 1.3 6.1 5.3 6.7 6.2 6.9 4.5 0.5 6.6 5.2 5.3 3.6 5.1 1.7 9.5 1.0 9.0 5.8 0.3 1.4 7.0 1.7 7.4 4.3 2.8 0.7 4.2 10.9 4.9 4.9 5.3 0.2 15.7 1.2 0.1 2.9 2.8 6.0 4.1 0.4 5.5 7.1 0.1 0.0 5.6 1.0 0.4 0.3 0.6 1.1 0.9 1.7 4.5 0.5 0.5 3.8 0.9 1.8 0.0 0.5 6.8 0.5 0.5 4.4 1.6 0.6 1.3 0.1 0.7 0.3 0.2 0.3 4.5 1.3 20.1 0.6 0.1 3.8 0.3 2.6 5.6 1.3 2.3 10.5 0.3 0.5 0.9 0.9 18.0 13.8 1.1 1.7 2.7 0.9 1.5 0.5 1.7 0.1 15.6 0.7 0.3 2.2 0.7 0.5 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 4.9 17.6 6.3 5.3 6.7 6.6 5.2 5.3 9.0 4.2 5.3 6.0 2.3 3.2 2.6 24.2 0.7 2.0 3.0 4.4 0.6 9.7 6.6 7.9 6.0 5.7 3.2 1.8 22.9 5.6 2.3 1.8 0.0 8.9 2.7 2.4 0.9 3.0 9.0 4.0 4.7 5.5 2.2 2.4 1.5 4.5 0.0 4.7 2.5 4.1 1.4 5.0 6.2 7.0 10.2 1.0 1.2 1.7 4.1 0.8 3.6 5.6 0.0 21.7 7.2 8.0 1.8 10.7 0.6 3.4 0.9 4.7 0.8 5.6 4.9 8.6 0.0 7.7 6.2 2.3 8.4 0.4 1.8 4.4 0.6 1.6 2.1 1.5 TRMT2A HTF9C ENSG00000099899 "TRNA methyltransferase 2 homolog A" Q8IZ69 22 20111875-20117392 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 131.7;Late spermatids: 206.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 84.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001077 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001077: AB_1079092" "unprognostic (5.01e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (9.70e-2)" "unprognostic (1.17e-1)" "unprognostic (8.05e-3)" "unprognostic (2.19e-3)" "unprognostic (5.93e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.99e-8)" "unprognostic (4.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.80e-1)" "unprognostic (1.14e-3)" 15.1 24.2 9.9 7.6 10.1 8.3 17.0 10.0 16.9 16.5 10.0 14.9 8.8 14.8 4.4 16.4 16.1 6.4 12.7 10.0 9.4 16.3 31.7 13.0 13.2 10.9 9.6 9.8 15.6 24.4 5.8 21.9 5.6 10.6 20.8 2.7 2.5 19.3 5.7 15.7 17.1 16.4 3.6 9.8 28.3 17.4 23.0 10.3 10.3 18.9 4.9 5.3 15.4 13.9 11.7 13.8 15.4 6.1 9.9 6.0 4.4 20.9 12.3 6.4 9.7 8.8 18.5 11.7 18.7 10.2 5.9 7.4 21.0 4.5 7.2 1.4 20.3 52.2 22.7 23.3 17.0 15.8 34.9 21.2 8.2 9.0 10.3 3.8 6.7 9.9 15.4 84.5 13.1 6.8 21.7 19.5 21.6 11.2 16.2 19.9 22.8 10.6 7.4 5.7 15.1 16.0 12.2 7.9 18.9 21.5 2.6 13.6 28.7 9.3 11.5 15.4 9.3 10.6 44.3 21.6 14.6 15.2 14.7 11.9 10.2 12.2 7.4 9.8 15.3 14.4 9.7 10.3 11.7 14.3 6.3 11.1 11.1 1.5 10.6 13.5 12.7 8.4 12.3 9.9 10.1 10.0 16.9 10.0 9.4 10.9 9.6 9.8 10.6 9.8 10.3 11.7 10.8 12.8 13.8 13.4 13.4 9.8 10.2 13.9 9.6 12.5 15.9 18.0 7.4 14.3 14.1 11.0 8.4 25.0 18.3 17.0 13.7 12.3 131.7 8.9 9.5 10.9 18.6 14.5 6.9 13.0 18.9 10.8 15.8 6.6 25.4 15.8 8.9 18.6 25.0 15.2 7.4 13.4 14.2 18.9 8.9 206.4 17.7 13.7 7.2 4.7 16.9 22.7 12.3 3.5 9.0 13.0 13.4 14.3 18.1 12.1 14.4 10.5 11.9 12.8 6.6 11.8 11.2 16.4 13.7 10.4 11.2 28.5 16.6 19.2 20.0 9.7 RANBP1 HTF9A ENSG00000099901 "RAN binding protein 1" P43487 22 20115938-20127355 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 754.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 2431.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065868, HPA065931" Supported Enhanced Cytosol NA NA 1400000 Cytosol "HPA065868: AB_2685572, HPA065931: AB_2685580" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.35e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (1.58e-6)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (5.67e-3)" "unprognostic (1.54e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.40e-2)" "unprognostic (3.95e-1)" "unprognostic (4.44e-2)" "unprognostic (7.30e-2)" 60.2 68.6 36.0 63.9 34.6 118.5 61.2 37.2 48.3 62.6 26.8 63.6 53.4 67.3 21.5 95.5 61.7 30.2 46.0 35.7 37.5 55.0 87.4 54.0 95.4 38.9 36.8 33.8 61.6 54.4 36.2 50.7 46.6 39.8 50.2 43.3 35.6 52.2 34.7 55.3 58.7 61.1 36.5 37.5 71.7 55.9 118.7 38.7 104.9 46.9 35.1 73.2 62.4 65.3 42.0 434.6 218.5 479.7 263.2 79.1 93.8 403.7 388.7 169.3 494.6 356.4 401.5 150.8 669.8 169.7 157.8 224.9 394.2 449.4 340.4 269.6 290.1 1071.3 562.6 218.5 426.6 120.3 913.7 294.4 103.9 158.7 393.0 139.2 114.3 227.1 300.2 2431.9 261.1 226.8 339.2 665.5 622.0 547.2 553.8 380.8 667.4 674.7 172.6 171.6 233.9 478.6 354.7 356.6 196.4 236.6 210.3 137.1 378.9 176.4 341.5 668.1 258.7 438.3 260.9 383.6 1066.0 186.9 405.9 292.7 21.1 94.7 75.8 71.3 101.6 78.8 123.1 101.6 91.1 111.5 119.1 101.8 77.0 9.5 90.8 93.6 103.6 115.4 102.5 36.0 34.6 37.2 48.3 35.7 37.5 38.9 36.8 33.8 39.8 37.5 38.7 42.0 133.1 35.3 37.1 14.7 135.0 274.4 195.0 260.6 109.3 44.4 142.3 175.6 47.1 104.4 104.8 90.1 6.2 409.2 103.8 106.4 277.8 188.5 394.2 104.6 131.1 143.5 117.6 259.2 22.2 112.3 754.9 156.7 72.4 86.7 64.7 187.2 93.5 169.5 268.7 37.0 21.4 194.0 209.5 85.5 223.3 236.1 145.1 95.3 177.9 6.5 140.6 103.5 87.6 7.5 23.9 150.0 109.3 136.9 179.6 338.0 107.3 213.7 93.8 39.0 98.6 110.9 289.5 505.1 435.2 220.1 294.9 194.7 119.2 176.5 273.6 218.2 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type palmitoyltransferase 8" Q9ULC8 22 20129456-20148007 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 31.1 31.5 11.1 18.8 11.6 10.8 30.6 7.0 26.6 32.1 0.0 22.9 12.2 31.4 7.6 29.6 27.9 13.1 31.4 11.3 5.5 29.7 36.4 31.3 17.3 9.5 7.8 10.3 34.8 35.9 14.5 41.6 17.0 9.6 28.3 7.0 7.5 27.8 15.6 23.9 32.1 24.9 13.2 4.3 36.0 26.6 15.1 6.5 13.9 37.6 10.4 11.8 25.5 31.2 10.1 30.0 18.7 29.3 38.7 42.0 25.0 26.3 55.1 37.3 36.6 32.6 9.8 15.2 0.1 22.3 46.0 19.8 40.2 15.5 42.2 18.0 43.2 59.4 14.5 57.2 23.0 34.5 0.0 19.5 43.7 27.9 28.2 23.6 22.5 41.4 21.0 101.4 22.8 33.0 14.7 17.8 39.1 14.9 13.2 29.4 37.8 25.6 10.9 15.6 35.9 46.9 23.7 22.4 10.7 26.6 13.1 0.7 20.4 48.0 82.5 59.8 46.8 25.0 32.6 11.5 11.7 24.2 18.7 24.8 1.3 0.4 0.1 0.8 0.5 0.4 0.2 0.2 0.4 0.1 0.5 0.4 0.5 0.0 0.4 0.2 1.3 0.7 0.2 11.1 11.6 7.0 26.6 11.3 5.5 9.5 7.8 10.3 9.6 4.3 6.5 10.1 17.4 3.2 3.1 17.6 3.7 9.1 3.8 3.6 5.7 11.9 8.2 8.1 7.1 4.3 3.5 11.0 14.6 3.6 9.2 4.3 1.9 5.2 0.5 4.3 15.7 11.5 4.2 0.8 16.6 4.5 8.5 9.3 10.2 8.7 5.7 8.7 10.4 9.8 4.9 13.5 9.9 5.9 10.2 5.0 5.0 2.1 10.8 5.7 5.4 9.4 3.7 7.4 1.0 13.0 13.3 7.7 5.4 14.7 2.7 7.6 2.7 2.1 1.5 10.8 6.6 10.5 6.8 1.4 3.8 5.5 9.8 3.4 4.2 8.0 5.0 3.4 KLHL22 "FLJ14360, KELCHL" ENSG00000099910 "Kelch like family member 22" Q53GT1 22 20441519-20495844 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 41.1;Excitatory neurons: 42.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040766 Supported "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No "Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA040766: AB_2732488" "unprognostic (4.15e-1)" "unprognostic (9.34e-3)" "unprognostic (5.37e-2)" "prognostic favorable (4.88e-6)" "unprognostic (1.17e-1)" "unprognostic (2.30e-3)" "unprognostic (1.00e-2)" "unprognostic (1.19e-3)" "unprognostic (2.20e-1)" "unprognostic (8.99e-2)" "prognostic favorable (3.85e-6)" "unprognostic (3.94e-2)" "prognostic favorable (1.34e-8)" "unprognostic (3.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.64e-2)" "unprognostic (1.08e-2)" 12.7 14.4 21.6 10.3 21.8 11.4 12.0 24.8 25.3 19.5 15.4 13.7 7.7 20.6 17.4 8.1 18.0 13.7 14.4 21.8 19.8 15.8 10.9 11.9 17.8 17.0 17.2 22.0 22.5 16.6 23.1 19.8 11.7 19.1 18.9 10.7 15.5 14.1 18.1 22.4 11.8 10.5 21.9 13.0 15.8 12.3 10.2 20.6 8.1 21.0 18.2 20.8 13.5 11.0 20.8 17.1 16.5 37.5 29.9 30.6 35.5 9.0 21.4 37.6 21.0 23.6 8.2 6.4 11.9 7.0 37.3 16.9 21.3 25.6 9.2 18.1 25.9 15.1 12.6 17.4 8.3 30.6 2.6 11.7 26.9 14.2 19.3 12.4 26.8 31.3 9.1 32.7 11.4 20.7 25.9 2.5 15.6 6.3 14.1 11.4 23.5 13.8 0.5 12.3 19.9 19.9 20.3 23.0 16.9 15.8 12.3 15.7 9.3 14.2 25.1 12.2 17.5 8.9 6.4 7.4 7.9 13.5 11.1 16.6 8.9 4.6 19.3 8.1 6.3 6.4 8.3 10.2 7.5 15.5 6.2 7.7 8.3 10.6 16.6 8.3 5.6 19.2 6.5 21.6 21.8 24.8 25.3 21.8 19.8 17.0 17.2 22.0 19.1 13.0 20.6 20.8 4.6 0.0 3.7 41.1 8.2 1.7 2.8 8.4 4.0 11.7 4.3 5.2 4.8 10.0 5.3 9.2 4.2 17.9 5.2 2.9 3.9 8.4 0.8 3.2 7.1 4.8 3.0 1.3 42.9 2.6 6.6 9.2 5.1 3.9 5.1 14.2 4.2 6.3 7.9 13.5 51.1 5.2 12.2 5.7 4.9 1.8 12.2 4.8 1.8 16.9 4.2 13.9 7.2 41.2 26.8 5.6 3.5 19.9 5.4 3.9 3.0 10.9 4.3 6.7 6.6 4.7 5.3 17.3 15.4 2.8 1.4 13.4 7.8 17.7 3.8 1.8 MED15 "Arc105, CAG7A, PCQAP, TIG-1, TNRC7" ENSG00000099917 "Mediator complex subunit 15" Q96RN5 22 20495913-20587632 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 240.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003179 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003179: AB_1079581" "unprognostic (7.98e-2)" "unprognostic (2.26e-1)" "unprognostic (1.70e-1)" "prognostic favorable (7.30e-5)" "unprognostic (2.53e-1)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.73e-2)" "unprognostic (1.12e-3)" "unprognostic (3.46e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.32e-2)" "unprognostic (2.50e-1)" "unprognostic (3.60e-2)" "unprognostic (5.57e-2)" 31.0 32.9 14.4 28.8 17.2 42.5 28.9 24.0 31.6 30.7 11.5 31.1 32.0 40.8 6.2 33.7 26.4 23.3 25.4 15.9 17.1 24.0 15.0 36.2 31.9 13.3 11.0 11.7 26.7 22.6 15.3 20.8 25.2 14.3 26.4 12.0 8.9 26.9 15.0 55.6 34.7 31.2 17.5 7.5 32.1 24.1 20.2 11.4 23.4 23.5 15.9 16.2 34.2 30.9 24.6 73.6 38.5 24.2 29.3 25.0 24.2 44.3 72.9 52.9 56.4 51.9 58.8 32.5 29.6 32.9 51.8 25.4 74.1 22.1 54.2 22.7 42.5 39.5 56.4 42.2 43.2 41.4 51.7 49.6 29.7 41.7 44.7 45.0 31.8 44.3 22.2 240.2 26.8 36.4 49.0 21.7 29.4 26.2 32.2 26.0 37.7 54.7 12.1 34.3 52.7 22.7 39.0 55.0 54.9 77.4 15.7 31.0 28.7 80.4 90.3 67.6 48.7 59.4 35.3 34.3 22.6 65.3 31.5 82.5 6.3 11.8 10.5 24.3 12.4 11.5 5.7 16.9 27.8 10.1 6.3 9.7 16.4 13.0 21.9 23.1 9.0 28.9 15.0 14.4 17.2 24.0 31.6 15.9 17.1 13.3 11.0 11.7 14.3 7.5 11.4 24.6 24.4 51.3 30.9 26.4 19.4 29.8 26.3 25.1 22.8 20.2 18.7 17.5 4.6 12.8 26.5 25.8 18.8 48.9 33.4 46.9 15.6 32.3 34.3 36.3 24.9 25.6 18.0 10.3 31.4 28.6 42.0 21.4 39.8 49.1 20.8 21.3 23.6 9.7 31.4 15.2 32.7 26.0 14.2 24.1 35.1 19.8 14.3 31.1 24.9 34.7 30.7 13.8 47.4 21.6 28.2 67.8 43.4 14.7 24.8 40.2 36.5 11.9 33.1 16.3 46.0 23.2 23.3 22.6 15.4 26.2 27.6 61.8 43.7 24.7 25.4 36.5 SERPIND1 "D22S673, HC-II, HC2, HCF2, HLS2" ENSG00000099937 "Serpin family D member 1" P05546 22 20774113-20787720 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Chemotaxis, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 1263.3" "Cell type enriched" "Detected in some" 25 "Hepatocytes: 283.7" "Cancer enriched" "Detected in many" 80 "liver cancer: 334.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "Hep G2: 208.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB008639, HPA055767" Supported Approved Vesicles "Secreted to blood" NA NA 50000000000 Vesicles "CAB008639: AB_1618010, HPA055767: AB_2682912" "unprognostic (1.68e-1)" "unprognostic (8.27e-2)" "unprognostic (4.40e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.42e-2)" "unprognostic (1.23e-1)" "unprognostic (1.12e-3)" "unprognostic (1.56e-1)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-9)" "unprognostic (2.01e-1)" "unprognostic (4.66e-2)" "unprognostic (8.36e-3)" "unprognostic (1.46e-1)" 0.2 0.2 0.1 0.0 0.9 0.2 0.4 1.6 0.9 0.9 70.3 0.0 0.0 2.0 0.0 0.1 0.9 0.4 0.6 1.8 0.2 0.3 1263.3 2.5 0.0 0.1 0.0 0.2 1.8 0.5 10.2 0.8 1.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.2 0.4 0.1 0.2 0.0 0.7 0.0 0.0 0.8 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 208.2 0.1 0.8 0.5 0.1 0.0 1.6 0.0 0.0 20.4 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 2.4 16.5 0.0 0.7 0.0 0.0 3.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.1 0.0 0.1 0.1 0.0 0.2 7.2 0.2 13.9 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.5 0.2 0.1 0.1 0.3 0.0 0.5 0.1 0.0 0.1 0.9 1.6 0.9 1.8 0.2 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.0 11.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 1.6 0.0 0.1 2.3 0.0 0.0 1.3 0.0 3.9 283.7 0.1 0.0 0.9 0.0 0.0 6.3 0.0 0.0 1.2 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.5 3.4 0.0 0.0 SNAP29 "CEDNIK, SNAP-29" ENSG00000099940 "Synaptosome associated protein 29" O95721 22 20859007-20891214 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" "Ichthyosis, Neuropathy, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 524.1;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 220.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031823, CAB037092, HPA056492" Supported Supported Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151" "unprognostic (1.76e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.72e-3)" "unprognostic (3.26e-2)" "unprognostic (7.83e-3)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (2.05e-2)" "unprognostic (1.34e-2)" "unprognostic (2.60e-2)" "unprognostic (3.68e-2)" "unprognostic (6.85e-2)" "unprognostic (1.22e-1)" "unprognostic (2.52e-1)" "unprognostic (1.45e-1)" "unprognostic (4.51e-3)" "unprognostic (6.08e-2)" 18.2 18.1 11.1 17.3 11.6 19.1 16.1 13.3 18.1 15.4 12.2 20.1 17.5 14.6 11.2 23.3 12.9 13.9 18.5 12.1 11.4 17.0 36.1 14.0 17.2 13.2 11.6 10.4 13.7 17.4 18.8 11.1 19.2 12.6 13.6 18.0 14.6 16.0 14.2 31.5 17.8 16.7 18.2 11.3 17.0 18.7 56.9 11.6 24.3 12.4 27.7 19.9 15.8 15.8 14.7 48.4 19.4 27.1 22.3 30.0 43.5 35.0 44.8 40.3 49.5 49.5 26.8 16.7 30.1 27.9 42.2 50.0 27.8 35.8 30.4 53.2 43.5 27.3 50.0 20.9 29.2 42.7 44.6 38.8 34.6 42.2 51.9 37.2 34.0 35.1 25.5 220.8 41.5 46.2 33.1 40.7 42.9 8.9 55.9 20.2 38.9 60.6 12.1 29.1 25.5 22.0 26.2 48.0 29.9 51.0 33.3 46.8 35.3 30.7 50.1 45.5 34.6 35.6 42.4 74.0 55.3 37.5 29.8 36.7 49.0 43.7 52.4 21.7 61.5 22.7 23.7 21.2 23.7 38.0 22.6 19.3 19.8 49.0 60.0 77.9 43.6 34.5 34.6 11.1 11.6 13.3 18.1 12.1 11.4 13.2 11.6 10.4 12.6 11.3 11.6 14.7 24.4 12.8 29.0 8.8 19.0 16.7 24.5 34.7 17.6 12.4 26.4 22.5 22.5 21.5 22.9 23.9 12.5 80.1 35.9 40.0 43.0 40.3 524.1 26.3 28.2 30.1 22.1 36.4 9.6 50.0 146.0 28.4 26.5 22.3 29.2 25.0 29.6 46.5 74.4 20.2 7.2 27.6 32.6 49.4 23.1 191.7 33.2 46.7 35.6 2.8 51.4 30.6 48.4 10.6 12.1 59.4 21.4 36.5 44.1 26.7 38.8 36.8 37.4 13.2 39.5 21.9 27.9 113.5 81.1 28.2 15.5 98.2 26.5 70.3 25.3 29.7 CRKL ENSG00000099942 "CRK like proto-oncogene, adaptor protein" P46109 22 20917407-20953747 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 344.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000532, HPA001100" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 2100000 Nucleoplasm Cytosol "HPA000532: AB_2666019, HPA001100: AB_1078569" "unprognostic (5.54e-2)" "unprognostic (2.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.92e-2)" "unprognostic (6.51e-2)" "unprognostic (2.35e-2)" "unprognostic (4.60e-1)" "unprognostic (2.71e-1)" "unprognostic (5.99e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (8.40e-2)" "unprognostic (1.43e-1)" "unprognostic (9.52e-2)" "unprognostic (1.61e-2)" 16.8 15.0 35.3 18.6 34.4 54.2 16.4 35.1 36.2 17.6 26.1 18.5 22.2 19.6 13.1 26.8 20.6 14.4 25.3 33.5 34.0 17.3 27.5 20.9 25.7 36.7 37.3 31.3 27.7 23.7 19.2 16.2 26.1 34.2 16.6 19.8 22.6 14.9 19.2 54.7 25.0 19.9 19.7 39.0 22.6 14.8 13.4 35.5 33.6 14.9 43.4 27.8 19.1 18.6 36.8 43.9 25.8 56.7 44.8 37.5 23.9 61.0 29.0 35.5 43.7 49.1 42.8 19.2 56.1 22.9 30.8 30.0 54.8 67.2 46.3 51.7 47.7 65.5 77.7 28.6 47.3 37.4 83.5 38.0 24.3 60.3 38.1 64.6 35.7 39.1 44.3 344.9 44.8 35.7 41.2 49.0 39.0 44.8 45.5 27.7 62.7 89.9 13.5 29.2 37.8 36.5 46.9 48.6 42.4 36.4 67.7 36.4 45.9 31.9 69.0 77.8 26.2 37.2 42.7 44.4 64.1 51.1 34.8 43.3 16.2 15.0 22.1 18.5 13.9 19.3 12.1 16.2 18.4 16.5 11.4 19.7 18.9 15.9 12.9 26.1 8.3 14.4 21.2 35.3 34.4 35.1 36.2 33.5 34.0 36.7 37.3 31.3 34.2 39.0 35.5 36.8 11.8 9.6 17.8 17.3 18.6 54.2 13.5 15.2 29.6 17.8 19.7 14.2 23.1 7.2 12.2 5.5 14.6 19.6 26.4 19.6 1.9 7.7 30.4 19.3 15.3 15.0 20.4 28.6 23.9 8.6 42.4 16.5 10.2 18.4 1.3 15.8 20.7 25.0 17.5 18.5 18.6 19.9 8.2 19.5 20.8 52.5 15.2 15.2 24.9 9.4 19.0 17.5 21.6 16.6 25.0 11.2 11.8 15.4 14.1 19.0 18.5 10.7 14.8 13.2 13.1 15.7 12.1 12.7 11.0 40.2 60.4 27.2 17.8 12.7 18.5 18.6 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982269-20999032 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 18.0 15.3 7.5 8.9 8.3 6.0 17.5 7.9 10.1 19.7 6.1 17.9 10.0 23.5 4.5 12.7 18.7 9.4 13.0 8.1 7.7 15.8 12.1 16.1 7.3 8.9 8.6 8.3 19.7 12.5 11.6 24.9 9.8 9.9 16.4 6.5 3.5 13.1 8.6 14.8 13.2 16.1 11.4 7.9 18.4 14.0 8.2 8.5 6.5 18.9 8.1 5.8 18.2 16.0 9.3 10.3 8.4 12.2 15.0 27.6 18.9 9.6 20.8 14.6 11.6 15.8 4.9 4.2 11.0 7.6 23.4 10.7 13.7 9.3 17.1 4.7 20.5 21.0 11.8 11.8 7.4 14.6 6.4 14.9 17.5 8.5 14.7 10.6 18.4 22.9 10.0 49.8 18.5 13.4 6.3 11.5 6.0 3.8 12.6 9.1 13.4 17.8 4.4 9.2 13.9 11.9 17.9 11.3 19.5 12.4 7.4 9.1 11.7 20.6 27.0 13.3 12.3 11.5 8.0 7.4 3.2 12.2 6.2 13.5 0.0 0.5 0.0 0.7 0.7 0.4 0.4 0.3 0.8 0.4 0.1 0.4 0.3 0.0 0.3 1.0 0.3 0.1 0.5 7.5 8.3 7.9 10.1 8.1 7.7 8.9 8.6 8.3 9.9 7.9 8.5 9.3 12.4 12.8 8.6 20.5 7.9 2.2 1.8 3.7 4.0 9.5 7.5 7.6 11.7 5.7 5.2 9.2 6.2 4.1 11.9 10.7 1.9 7.0 0.9 5.5 12.7 10.1 9.1 2.5 14.2 4.9 4.0 10.9 11.2 8.4 5.7 14.7 12.1 8.5 7.7 3.3 13.2 10.0 6.1 8.8 3.5 1.6 8.7 7.1 7.2 14.0 5.0 5.6 5.2 8.0 17.6 6.1 8.9 9.8 9.2 2.3 7.0 7.6 7.3 9.8 0.0 7.0 11.6 4.5 1.5 5.9 3.7 3.6 7.7 10.1 6.7 1.4 MMP11 STMY3 ENSG00000099953 "Matrix metallopeptidase 11" P24347 22 23768226-23784316 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "cervix: 44.9;endometrium 1: 144.2;placenta: 39.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 84.9;Extravillous trophoblasts: 37.6;Granulosa cells: 61.9;Smooth muscle cells: 35.8" "Cancer enhanced" "Detected in all" "pancreatic cancer: 119.1" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 4.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 38.4;hTERT-RPE1: 19.7;REH: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002593, HPA055204, HPA068864" Approved Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 640000 "Golgi apparatus" Cytosol "CAB002593: , HPA055204: , HPA068864: AB_2686051" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (1.83e-1)" "unprognostic (1.84e-3)" "unprognostic (2.77e-2)" "unprognostic (6.73e-2)" "unprognostic (2.14e-2)" "unprognostic (5.15e-1)" "unprognostic (2.73e-2)" "unprognostic (2.20e-1)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.05e-2)" "unprognostic (6.78e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-2)" 2.9 1.6 0.5 1.4 0.4 0.5 2.2 0.4 1.2 44.9 0.5 3.9 6.9 144.2 0.1 1.0 5.8 6.9 6.1 0.4 0.5 2.5 0.6 1.4 4.0 0.5 0.5 0.4 12.6 1.3 3.3 0.5 39.9 0.5 1.9 3.5 0.0 5.3 1.5 0.9 3.4 6.1 9.5 0.5 1.4 2.6 6.8 0.5 3.2 1.3 0.9 1.7 2.9 3.6 0.5 0.3 0.0 4.8 38.4 5.7 8.3 0.1 0.6 10.4 1.3 0.8 0.4 1.3 1.3 5.1 2.8 1.8 0.2 2.2 0.0 0.4 0.0 0.8 0.0 0.0 2.2 4.2 0.0 0.0 5.4 0.9 1.1 0.1 19.7 6.0 0.4 0.6 0.0 1.4 0.3 0.1 0.1 1.4 1.2 0.2 16.6 0.0 0.4 0.7 0.0 6.0 10.3 3.9 0.6 0.0 5.9 3.6 0.0 2.7 0.6 0.0 1.6 0.1 0.1 0.2 5.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.5 0.4 0.4 1.2 0.4 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.5 1.2 0.0 2.5 0.3 3.4 1.0 0.8 0.8 0.6 0.4 1.9 0.5 6.1 1.5 0.1 0.0 0.0 0.7 1.8 0.4 1.9 8.6 10.3 4.4 84.9 0.9 1.8 0.0 0.2 0.7 37.6 8.4 1.5 4.1 1.3 61.9 1.1 0.0 0.8 0.0 0.4 1.3 2.0 0.0 1.1 10.5 0.6 1.0 1.8 1.0 0.0 0.3 0.0 0.0 0.2 1.4 0.2 0.4 0.2 0.5 0.1 2.2 0.8 0.5 0.0 2.7 35.8 3.1 5.5 0.5 0.6 18.6 2.0 5.7 1.0 0.3 CECR2 KIAA1740 ENSG00000099954 "CECR2 histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;retina: 15.7;skeletal muscle: 22.0" "Cell type enhanced" "Detected in many" "Astrocytes: 109.4;Cone photoreceptor cells: 168.9;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 137.7;Rod photoreceptor cells: 94.1" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.5;HAP1: 14.4;K-562: 8.3;NTERA-2: 22.8;SCLC-21H: 10.1;SuSa: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 0.7 0.4 5.3 0.2 10.7 0.5 1.0 19.0 5.6 1.3 0.7 0.9 0.2 2.3 0.6 0.4 1.7 0.2 3.1 4.6 5.5 1.2 7.7 2.6 0.1 9.7 8.5 1.7 2.9 2.7 0.0 6.4 1.0 12.0 1.0 0.3 15.7 0.9 0.2 22.0 0.7 0.5 0.9 4.6 0.4 0.6 3.5 8.2 0.2 2.2 10.7 0.2 1.3 1.0 12.4 0.2 0.1 15.5 5.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.7 0.1 14.4 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 8.3 0.0 0.0 0.1 0.0 0.5 22.8 0.0 0.0 1.8 1.0 0.1 0.0 5.1 10.1 0.0 0.0 0.2 0.9 9.0 1.6 2.5 0.1 0.1 3.4 0.0 0.0 5.8 1.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 10.7 19.0 5.6 4.6 5.5 9.7 8.5 1.7 12.0 4.6 8.2 12.4 1.9 6.4 10.6 109.4 0.3 0.0 1.1 0.2 0.0 22.1 0.7 0.6 11.8 0.0 0.8 1.8 168.9 10.1 0.0 0.0 0.0 0.1 6.3 6.3 6.2 2.0 0.0 0.0 2.3 0.2 2.5 3.1 0.0 17.2 0.0 3.5 4.2 10.7 0.7 5.0 4.3 0.0 0.0 0.3 0.3 4.0 1.2 1.4 0.0 34.7 0.2 18.3 0.0 120.1 137.7 0.1 0.0 1.2 0.8 1.8 0.0 1.4 0.9 94.1 6.6 33.9 3.2 1.9 15.9 0.1 0.1 33.0 0.2 0.4 0.0 3.6 SMARCB1 "BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1" ENSG00000099956 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1" Q12824 22 23786931-23838009 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009196, HPA018248, HPA019127" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165" "unprognostic (2.15e-1)" "unprognostic (5.62e-2)" "unprognostic (6.60e-3)" "unprognostic (1.63e-2)" "unprognostic (4.01e-3)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.52e-4)" "unprognostic (4.10e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.10e-2)" "unprognostic (4.43e-3)" "prognostic favorable (1.14e-6)" "unprognostic (1.24e-1)" "unprognostic (4.58e-2)" "unprognostic (4.57e-2)" "unprognostic (7.04e-2)" 36.1 46.7 2.4 6.9 1.9 3.4 40.7 3.6 10.1 50.9 2.1 37.5 8.1 51.9 0.4 51.4 40.7 2.2 42.7 1.9 3.6 47.2 37.2 32.6 5.8 4.1 2.3 1.3 63.7 44.2 1.2 48.4 1.2 2.4 36.9 1.1 25.6 44.4 0.6 48.5 50.3 52.1 0.6 2.0 52.2 40.8 68.8 2.0 3.5 41.6 1.8 1.5 37.8 41.3 2.5 2.4 1.6 28.2 2.6 2.7 0.7 5.8 9.2 2.7 2.7 4.3 3.4 2.6 24.2 7.9 1.2 2.9 4.4 6.9 4.6 4.5 4.1 10.5 20.1 3.2 2.1 3.0 21.7 5.6 1.6 3.4 3.2 6.9 1.4 1.4 3.0 5.6 12.9 1.7 6.1 17.6 5.0 8.6 7.2 5.7 11.0 23.1 10.8 2.3 4.5 13.4 10.1 2.2 0.6 17.9 14.8 2.2 3.3 2.2 2.4 9.8 3.8 2.7 13.8 14.3 17.7 1.8 11.3 6.8 7.1 12.8 6.4 4.4 13.4 6.4 24.4 5.5 5.7 12.0 9.2 4.5 3.0 1.1 9.8 16.8 13.3 10.4 8.1 2.4 1.9 3.6 10.1 1.9 3.6 4.1 2.3 1.3 2.4 2.0 2.0 2.5 33.6 6.4 8.6 17.0 120.2 50.2 73.3 85.1 51.2 55.4 42.9 49.1 6.1 47.1 37.4 47.8 20.9 120.6 61.8 36.6 84.1 94.6 42.6 40.9 54.9 37.4 71.8 57.8 14.1 77.1 228.1 46.2 41.8 41.1 34.8 112.2 41.0 20.3 76.1 67.3 18.4 54.6 99.7 23.0 41.7 18.9 35.8 36.5 56.9 15.9 51.2 92.4 45.3 17.1 18.1 74.7 53.1 32.0 139.6 74.4 41.9 86.4 28.5 49.6 19.7 47.7 62.8 138.9 163.3 64.5 53.0 160.1 42.0 96.8 65.4 65.1 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.4;skeletal muscle: 12.5;tongue: 7.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.6;Excitatory neurons: 8.9;Inhibitory neurons: 7.9;Ionocytes: 8.2;Skeletal myocytes: 20.8" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.7;LHCN-M2: 6.7;RH-30: 4.2;U-87 MG: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028776: AB_2672771, HPA028777: AB_2672772" "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.1 0.3 0.3 0.2 0.0 0.1 0.9 2.6 0.1 0.3 0.1 0.0 0.2 0.0 0.2 0.3 0.8 1.3 1.0 1.3 0.2 0.1 0.3 0.2 2.9 1.0 0.3 0.3 0.1 0.0 1.3 0.8 3.4 0.3 0.0 0.3 0.2 0.7 12.5 0.1 0.2 0.1 0.1 1.6 0.2 1.1 0.9 0.0 0.0 7.7 0.0 0.2 0.1 2.8 0.0 0.4 0.7 0.2 0.1 0.0 0.8 0.1 1.7 0.7 1.2 0.0 0.0 0.0 1.1 0.4 2.9 1.3 0.0 0.1 0.1 0.2 0.0 1.9 0.9 0.0 2.8 0.0 2.4 0.3 0.0 1.2 0.0 9.7 0.0 0.0 2.1 0.6 6.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.2 3.1 1.2 0.1 0.5 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.2 0.0 0.0 11.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 2.6 1.0 1.3 2.9 1.0 0.3 3.4 0.1 0.9 2.8 0.2 0.0 0.6 0.3 0.1 0.1 0.8 0.8 0.6 7.6 0.0 0.4 2.4 0.0 0.2 1.8 0.0 0.5 0.0 0.1 0.0 0.0 2.2 1.8 0.5 0.2 3.5 2.7 8.9 0.0 0.4 1.4 0.0 0.7 2.5 0.1 1.8 0.1 0.1 1.7 7.9 0.7 8.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 5.0 3.3 0.0 0.0 0.4 0.1 0.2 0.0 0.3 3.2 1.1 0.0 20.8 0.4 1.6 0.4 0.3 0.1 0.4 0.5 0.1 0.1 0.2 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 62.1;pancreas: 61.3;salivary gland: 51.5" "Cell type enriched" "Detected in many" 6 "Plasma cells: 1428.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "plasmacytoid DC: 187.4" "Lineage enriched" "Detected in many" 14 "dendritic cells: 187.4" "Cell line enhanced" "Detected in some" "Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 1.7 3.2 1.5 4.3 1.6 1.8 5.5 1.4 2.2 4.2 1.8 17.4 10.1 3.7 0.2 4.4 7.1 2.3 5.4 1.3 1.5 5.6 9.2 9.3 9.2 1.5 1.8 1.3 2.1 61.3 0.8 8.2 0.8 1.7 3.4 11.0 0.2 51.5 3.9 2.7 0.8 33.9 0.7 1.8 62.1 29.6 25.0 1.8 1.6 14.7 0.2 17.8 3.7 2.4 1.7 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.5 4.8 0.9 0.0 1.4 0.0 1.1 1.3 0.0 0.5 4.8 0.4 4.6 0.0 0.7 3.2 0.6 0.0 0.2 0.5 0.0 0.1 0.1 0.5 0.8 26.9 0.0 0.0 1.3 2.2 1.0 2.3 0.3 4.2 0.0 23.6 0.9 0.3 0.6 0.1 0.1 0.0 0.2 0.7 0.0 1.5 0.0 0.0 0.0 0.4 0.1 48.5 6.3 8.3 0.8 6.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 13.8 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.0 0.0 187.4 0.0 1.3 1.5 1.6 1.4 2.2 1.3 1.5 1.5 1.8 1.3 1.7 1.8 1.8 1.7 0.5 0.0 1.1 0.3 183.8 1.8 1.5 3.7 0.6 1.1 19.3 1.8 3.5 1.5 4.1 0.0 2.1 0.8 141.7 2.7 0.0 0.5 113.2 33.8 0.9 1.1 1.8 8.2 0.3 5.8 6.2 2.2 7.7 1.7 2.5 15.7 4.6 7.8 3.4 0.0 1.7 7.9 4.1 2.2 2.1 158.2 2.5 5.4 224.1 1.9 0.5 0.8 0.0 1.0 0.5 1.1 0.5 4.1 1428.8 2.5 0.8 0.5 30.3 0.6 0.0 0.8 2.6 67.0 32.9 1.3 2.0 15.5 17.9 2.1 10.7 2.0 SLC7A4 "CAT-4, HCAT3, VH" ENSG00000099960 "Solute carrier family 7 member 4" O43246 22 21028718-21032840 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 21.2;Endometrial ciliated cells: 16.4;Glandular and luminal cells: 32.0;Intestinal goblet cells: 8.9;Ionocytes: 12.2;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "BEWO: 140.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031023 Enhanced NA NA "HPA031023: AB_10669669" "unprognostic (1.02e-3)" "unprognostic (4.34e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.82e-2)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.91e-2)" "unprognostic (3.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (9.69e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" 2.4 2.6 2.6 0.2 2.8 0.0 1.1 4.1 2.3 1.5 3.8 1.1 1.1 1.0 0.3 5.6 1.1 1.3 0.6 2.4 3.3 0.2 0.3 0.8 0.3 2.1 2.7 2.8 0.3 0.2 0.5 4.7 3.3 3.0 2.5 0.9 0.3 2.2 3.2 0.4 1.3 1.2 0.3 0.3 0.6 1.4 15.5 3.7 0.3 0.0 0.0 0.5 1.1 0.7 1.5 0.0 0.0 0.0 0.1 0.0 0.0 140.5 0.0 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 1.3 0.5 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 2.6 2.8 4.1 2.3 2.4 3.3 2.1 2.7 2.8 3.0 0.3 3.7 1.5 0.0 6.4 1.9 0.3 0.0 0.0 0.3 7.4 0.6 0.5 0.7 0.6 0.3 1.5 3.1 0.0 0.0 21.2 0.0 0.5 0.0 0.0 0.3 16.4 2.1 0.3 1.2 0.0 1.4 0.4 7.7 2.0 1.1 32.0 4.5 0.7 1.1 0.0 1.4 0.0 0.8 8.9 12.2 0.0 0.0 1.8 1.8 0.1 0.0 1.0 0.0 2.0 0.0 0.0 0.1 0.8 0.3 0.7 0.0 0.5 0.3 0.0 2.6 0.1 0.0 0.3 0.4 0.3 1.5 1.8 0.0 10.1 0.7 0.0 0.6 0.6 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 180.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria NA NA 100000 Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107" "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favorable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 12.8 13.5 9.0 5.7 10.4 10.9 11.6 8.8 13.4 6.8 2.3 9.9 6.1 8.0 8.9 12.4 7.5 6.8 15.9 9.5 10.2 14.1 16.5 8.4 7.6 12.2 14.0 9.4 7.5 11.9 14.9 7.9 9.3 12.9 8.3 10.4 44.2 10.1 6.9 60.1 13.6 7.8 7.7 9.6 6.5 9.6 10.8 9.9 9.3 9.7 40.8 8.8 10.4 8.7 11.6 16.2 6.1 10.6 11.1 19.6 18.8 17.2 11.4 21.3 17.1 19.8 8.3 11.7 14.6 7.5 15.4 13.9 21.3 12.6 18.4 20.9 12.2 12.3 14.5 7.5 6.1 22.3 21.3 10.0 14.5 21.1 14.0 40.1 24.2 14.7 11.3 34.5 15.2 18.9 11.6 11.7 8.9 10.7 26.8 9.7 10.9 20.7 5.3 20.1 12.4 15.6 11.5 16.4 15.6 31.0 38.0 11.9 18.0 17.2 9.9 5.0 15.3 10.5 11.9 10.5 14.7 14.9 16.1 16.4 5.1 9.5 2.3 2.3 8.0 2.8 3.1 3.1 2.7 5.4 3.2 2.8 2.3 3.6 6.5 6.4 2.9 4.5 4.7 9.0 10.4 8.8 13.4 9.5 10.2 12.2 14.0 9.4 12.9 9.6 9.9 11.6 18.7 22.4 16.7 32.3 21.5 24.6 33.6 22.7 30.1 180.5 21.8 22.4 42.7 12.8 25.3 18.4 12.5 48.5 19.7 31.7 52.8 29.1 34.8 17.7 16.0 17.5 23.4 19.8 41.9 31.6 35.0 20.0 13.3 23.5 8.8 19.7 15.7 36.0 26.0 48.8 38.1 25.4 18.3 30.8 19.8 15.5 14.0 26.3 16.0 27.2 54.7 57.9 12.3 27.6 45.4 36.4 17.8 15.4 15.4 40.3 32.6 44.4 19.6 35.2 0.0 21.3 15.6 33.1 22.6 32.1 27.1 95.9 19.3 22.9 24.0 43.1 DDTL ENSG00000099974 "D-dopachrome tautomerase like" A6NHG4 22 23966888-23972556 "Predicted intracellular proteins" Lyase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 59.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Cardiomyocytes: 11.5;Distal tubular cells: 5.9;Hepatocytes: 6.4;Proximal enterocytes: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 6.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 14.9" HPA074115 Approved NA NA "HPA074115: " "unprognostic (6.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (6.34e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "prognostic favorable (5.98e-4)" "unprognostic (2.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-2)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (3.70e-2)" "unprognostic (3.58e-3)" 4.1 5.5 0.3 3.8 0.7 5.6 4.2 1.6 0.6 4.5 0.5 6.0 6.4 3.7 1.3 6.6 4.1 2.4 6.7 0.4 0.3 11.1 59.0 4.2 5.1 1.1 0.7 0.1 6.4 15.4 1.3 4.3 2.2 1.0 8.5 1.8 5.1 5.2 0.3 4.2 5.2 8.1 0.4 0.1 7.5 9.6 3.6 1.0 0.2 5.8 3.2 0.1 4.5 5.0 2.1 4.6 3.1 3.5 3.8 0.0 0.3 4.4 2.5 0.0 0.0 0.0 6.9 4.5 7.8 1.6 0.0 3.2 11.6 1.2 0.0 0.0 2.9 14.9 4.4 13.6 6.7 1.2 11.1 4.7 0.0 0.0 0.0 0.0 4.7 0.0 2.6 4.5 5.6 0.0 3.5 1.2 6.4 1.3 3.5 2.6 6.5 3.7 1.0 2.1 6.4 3.8 1.9 3.4 6.4 11.4 4.1 5.2 0.8 0.0 6.6 5.1 2.0 1.8 4.2 1.3 2.2 1.5 5.4 2.4 6.8 1.0 1.8 1.4 1.6 1.6 1.4 1.0 2.1 0.9 1.4 0.7 1.2 0.5 2.3 0.3 1.3 1.1 0.8 0.3 0.7 1.6 0.6 0.4 0.3 1.1 0.7 0.1 1.0 0.1 1.0 2.1 0.3 6.4 3.1 0.0 0.6 1.0 1.3 0.1 1.2 0.9 0.9 1.7 11.5 2.8 1.4 0.0 4.2 1.2 0.7 3.0 5.9 1.0 1.6 0.1 0.5 1.3 1.2 0.4 0.3 0.4 1.4 1.7 0.0 0.4 1.3 0.4 2.5 6.4 1.0 0.0 0.4 1.2 0.0 1.2 0.8 0.7 0.6 1.5 0.0 0.0 0.6 0.4 1.0 0.0 0.5 1.2 2.2 1.2 0.7 0.9 7.6 5.1 0.3 0.7 0.0 1.1 1.4 0.2 0.6 1.5 0.9 2.5 1.0 0.0 2.5 0.7 DDT "D-DT, DDCT, MIF-2, MIF2" ENSG00000099977 "D-dopachrome tautomerase" P30046 22 23971365-23979828 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Melanin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 842.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 4869.6;Proximal tubular cells: 1415.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 262.9" "HPA049871, HPA074115" Approved Approved Mitochondria NA NA Mitochondria "HPA049871: AB_2680926, HPA074115: " "unprognostic (1.77e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (8.09e-2)" "unprognostic (4.00e-3)" "unprognostic (2.02e-3)" "unprognostic (6.58e-2)" "unprognostic (4.66e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (7.34e-2)" "unprognostic (3.30e-1)" "unprognostic (3.81e-1)" "unprognostic (2.61e-3)" 107.5 127.8 27.3 15.3 27.2 39.9 99.9 30.0 38.3 65.9 25.6 111.7 44.6 63.1 16.3 120.1 67.9 6.3 158.7 25.7 28.9 217.7 842.8 69.8 13.8 28.9 26.7 24.7 83.7 263.1 24.5 48.0 10.7 28.2 110.0 24.4 12.9 83.3 15.8 130.3 86.2 121.7 8.6 28.3 66.8 177.6 39.6 29.2 12.4 80.7 15.8 12.0 87.5 77.1 31.7 107.6 44.8 15.4 34.9 29.0 24.9 92.6 30.4 20.7 26.1 27.1 39.8 30.6 101.9 27.8 16.1 37.7 86.3 38.3 38.1 17.1 43.6 262.9 60.8 58.9 88.3 28.9 136.2 58.8 25.5 28.5 26.3 23.1 27.9 28.7 16.0 56.8 40.2 26.9 53.0 30.1 123.1 46.2 94.4 134.2 65.3 27.0 148.9 46.4 39.2 51.7 49.2 62.8 117.7 95.9 20.6 30.8 42.3 33.1 26.8 59.9 27.8 32.2 122.6 43.9 65.1 53.1 49.7 52.5 63.5 92.9 72.4 46.0 82.8 47.5 75.3 55.3 49.1 87.8 70.7 49.2 48.9 58.3 61.6 79.1 130.4 74.5 78.8 27.3 27.2 30.0 38.3 25.7 28.9 28.9 26.7 24.7 28.2 28.3 29.2 31.7 116.9 83.3 86.3 11.1 178.3 138.9 220.5 278.8 176.4 58.4 266.6 379.7 21.3 499.0 153.2 242.8 89.6 202.6 134.1 533.1 718.1 237.2 202.1 150.8 126.4 103.4 259.6 230.2 9.1 375.7 288.2 103.9 163.1 260.3 129.4 97.1 154.9 4869.6 281.0 43.7 11.0 402.8 187.2 240.4 162.2 411.0 117.1 172.2 158.3 9.4 235.8 119.6 135.9 6.0 18.8 233.6 395.1 110.6 166.1 257.5 935.1 1415.8 97.6 100.0 78.9 109.5 127.6 117.9 43.8 280.6 188.0 299.8 140.3 212.5 558.7 291.3 OSM MGC20461 ENSG00000099985 "Oncostatin M" P13725 22 30262829-30266851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Cytokine, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 119.3" "Group enriched" "Detected in some" 4 "Hofbauer cells: 74.4;Macrophages: 51.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basophil: 65.2;neutrophil: 34.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 65.2" "Cell line enhanced" "Detected in some" "HDLM-2: 15.7;HL-60: 3.8;HMC-1: 11.1;Karpas-707: 3.5;NB-4: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 39700 "unprognostic (5.15e-2)" "unprognostic (8.80e-3)" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (7.37e-2)" "unprognostic (2.61e-2)" "unprognostic (6.78e-2)" "unprognostic (3.77e-2)" "unprognostic (2.81e-2)" "unprognostic (4.60e-2)" "unprognostic (1.58e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.00e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" 7.3 3.6 0.9 14.5 0.8 119.3 0.8 0.9 4.2 1.2 1.9 1.0 0.5 1.1 0.1 0.8 2.3 6.3 1.1 0.6 6.2 1.3 1.9 7.9 1.6 1.9 1.1 0.4 0.5 1.2 1.0 1.5 5.6 1.3 1.0 0.5 0.1 1.1 0.2 0.2 0.2 0.7 3.1 1.6 5.1 0.9 0.4 4.1 2.6 0.8 3.0 0.8 12.8 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.7 0.0 0.3 0.0 0.0 0.0 3.8 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 3.5 0.0 0.0 0.5 6.6 0.0 0.0 0.0 0.6 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.0 65.2 0.5 2.0 2.0 0.3 6.5 0.0 4.8 2.6 0.8 0.2 0.9 2.4 34.9 4.3 0.1 0.2 1.4 1.6 0.9 0.8 0.9 4.2 0.6 6.2 1.9 1.1 0.4 1.3 1.6 4.1 2.2 0.9 9.6 10.6 0.0 3.2 0.8 0.2 0.0 0.0 0.0 0.7 1.8 0.6 0.0 3.7 0.0 0.0 0.8 13.2 0.0 0.0 0.1 0.1 0.6 0.2 1.9 0.0 1.3 0.1 0.0 0.9 1.4 0.0 1.1 15.2 0.0 0.4 0.0 74.4 0.0 0.1 0.1 0.0 6.1 12.4 0.0 0.0 51.6 0.0 0.0 1.8 0.1 1.0 0.0 0.1 0.1 0.1 0.0 2.5 0.1 0.0 0.1 0.7 0.2 0.0 0.7 0.4 0.0 0.0 0.3 0.3 0.8 14.2 0.1 0.0 0.0 CABIN1 "KIAA0330, PPP3IN" ENSG00000099991 "Calcineurin binding protein 1" Q9Y6J0 22 24011192-24178628 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043296 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043296: AB_10794657" "unprognostic (8.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.74e-2)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" "unprognostic (3.06e-3)" "unprognostic (1.04e-2)" "unprognostic (2.92e-2)" "unprognostic (6.21e-2)" "unprognostic (3.75e-1)" "unprognostic (3.46e-3)" "unprognostic (1.01e-1)" "prognostic favorable (2.94e-4)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-3)" "unprognostic (7.79e-2)" 24.5 29.0 24.8 15.6 25.0 31.1 24.5 27.9 41.2 33.1 25.7 34.6 13.8 32.6 8.8 23.6 36.2 10.2 30.6 24.7 20.4 36.2 28.4 28.7 19.7 23.4 21.8 25.1 27.5 28.3 15.8 46.6 8.3 24.0 34.3 8.5 13.4 22.2 14.2 17.6 24.3 33.4 11.1 19.3 37.5 32.2 34.7 26.5 19.7 50.7 7.1 10.0 29.9 27.3 24.5 24.7 17.7 23.6 20.8 20.9 24.1 33.3 20.4 17.5 16.0 18.1 22.0 11.9 28.6 11.0 20.5 20.8 23.1 28.4 18.5 14.2 48.3 27.8 24.6 21.1 46.8 9.9 57.1 25.6 20.5 11.6 19.6 14.7 19.2 27.1 25.1 52.1 15.2 9.2 32.0 27.1 62.1 14.7 34.5 12.6 26.3 17.3 36.0 14.6 24.8 30.2 25.9 25.2 17.4 26.1 21.3 15.6 25.6 22.3 37.0 28.6 14.3 14.9 26.5 17.1 16.9 17.3 27.3 15.8 7.2 3.9 15.5 5.7 2.7 6.3 2.5 4.3 7.5 2.6 4.1 5.2 4.8 17.4 5.4 1.9 3.0 3.7 2.5 24.8 25.0 27.9 41.2 24.7 20.4 23.4 21.8 25.1 24.0 19.3 26.5 24.5 14.5 22.4 37.5 37.5 22.7 8.3 8.9 11.0 13.1 33.3 14.2 10.8 18.5 4.3 9.1 9.2 89.6 17.4 24.6 19.9 7.9 11.6 16.6 43.6 19.6 15.1 14.8 18.3 54.2 9.7 6.9 16.4 29.6 26.8 17.7 21.1 13.2 9.4 21.7 33.7 39.4 13.0 20.3 12.6 16.2 16.0 21.5 16.1 10.6 20.6 19.2 14.5 44.3 21.1 35.9 10.8 6.6 19.9 24.4 7.1 8.8 7.9 24.4 50.1 19.7 14.6 32.6 60.7 41.6 13.6 9.5 22.4 36.5 18.4 13.8 7.3 TBC1D10A "AC004997.C22.2, EPI64, TBC1D10" ENSG00000099992 "TBC1 domain family member 10A" Q9BXI6 22 30291990-30326947 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007725, HPA008142, HPA076041" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772" "unprognostic (3.37e-2)" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (1.10e-2)" "unprognostic (2.11e-3)" "unprognostic (1.20e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-1)" "unprognostic (6.40e-2)" "unprognostic (1.08e-1)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.05e-2)" "unprognostic (7.52e-2)" 21.5 17.1 6.1 10.3 6.7 8.3 23.9 4.9 10.3 22.8 8.0 18.2 8.7 14.8 4.7 44.4 15.0 12.8 10.8 6.7 10.0 21.2 18.0 23.9 17.4 6.7 7.6 5.4 21.3 10.9 24.7 19.7 17.6 6.2 21.5 5.5 10.9 23.4 13.0 5.6 45.3 17.5 6.8 5.1 24.4 17.4 21.8 7.5 18.5 19.2 7.0 10.5 20.0 40.3 5.6 18.9 7.1 2.9 9.0 8.4 10.8 23.9 10.7 14.9 11.8 18.7 8.4 7.2 9.5 10.2 17.8 16.2 18.3 4.3 9.9 6.2 7.2 12.4 2.6 6.4 6.0 21.9 3.7 12.9 14.0 15.5 23.4 4.0 12.3 5.5 20.5 5.1 8.8 8.9 22.1 26.9 7.9 1.9 33.9 9.5 12.3 12.4 8.8 11.6 17.9 4.9 3.8 11.0 15.7 24.5 7.8 13.8 2.3 10.8 22.9 10.4 13.1 5.8 8.8 4.2 8.3 15.6 5.6 13.1 37.5 14.9 37.9 26.6 30.1 29.3 13.4 30.9 27.2 21.7 20.7 40.7 34.0 10.6 24.3 45.5 37.5 28.8 28.4 6.1 6.7 4.9 10.3 6.7 10.0 6.7 7.6 5.4 6.2 5.1 7.5 5.6 27.8 6.4 3.4 24.8 18.2 49.2 40.2 40.3 32.5 7.8 18.4 12.4 2.7 14.3 23.6 5.5 18.8 57.6 19.5 26.8 23.5 20.1 10.7 8.8 5.4 14.4 10.7 3.0 3.0 10.2 80.6 18.3 19.4 16.4 9.5 20.1 11.0 8.6 27.5 1.7 3.5 14.2 18.3 12.9 46.0 6.9 21.8 15.9 26.6 10.3 78.1 28.1 28.8 2.5 1.0 18.7 18.7 9.1 12.3 24.3 14.9 20.5 6.6 39.3 39.5 7.4 17.1 33.2 13.5 27.6 37.1 116.3 28.0 20.2 11.0 28.3 SUSD2 "BK65A6.2, FLJ22778, W5C5" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181487-24189106 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.7" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 29 "SK-BR-3: 898.7" "Low region specificity" "Detected in all" HPA004117 Enhanced Approved "Plasma membrane" NA NA 6800000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 10.7 9.7 4.7 1.9 2.3 0.2 9.6 1.6 5.1 12.2 3.3 4.6 12.9 9.9 0.5 2.8 15.1 1.9 9.4 1.6 17.2 32.9 2.9 100.7 2.2 16.8 6.3 1.5 5.4 4.4 1.5 7.2 3.6 25.2 5.6 1.0 0.1 4.8 5.6 2.2 27.9 34.9 3.5 6.7 3.6 6.3 3.3 14.1 0.8 17.9 1.5 1.3 5.4 11.1 11.0 5.1 10.4 0.1 0.0 18.8 24.3 0.8 2.4 0.1 0.1 0.0 7.8 0.6 1.4 21.5 0.5 0.4 1.4 0.1 0.5 0.0 0.6 0.3 0.0 0.4 30.6 8.0 0.0 0.3 21.5 0.4 0.1 6.2 0.0 0.1 0.0 0.5 0.3 0.0 9.1 0.3 0.4 0.7 2.5 0.3 0.3 0.0 2.5 0.1 0.2 1.7 13.5 0.7 898.7 0.2 3.6 3.0 0.0 0.0 0.1 0.9 0.7 0.1 1.1 1.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 2.3 1.6 5.1 1.6 17.2 16.8 6.3 1.5 25.2 6.7 14.1 11.0 1.7 250.0 151.5 0.3 0.6 0.3 0.3 2.6 0.0 0.0 3.4 3.4 6.8 0.0 20.9 1.8 0.0 13.8 0.3 0.7 5.9 0.1 0.0 1.3 0.7 1.1 1.8 0.0 0.2 0.0 0.7 6.7 0.5 1.3 3.8 0.1 2.9 0.5 1.1 0.0 0.1 5.5 2.0 0.0 0.3 0.4 0.6 0.8 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.4 154.9 27.8 3.6 0.0 0.0 0.6 22.1 1.7 1.3 0.7 2.7 26.4 1.1 0.0 1.6 0.6 SF3A1 "Prp21, PRPF21, SAP114, SF3a120" ENSG00000099995 "Splicing factor 3a subunit 1" Q15459 22 30331988-30356919 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000690, HPA030083" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA 87000 "Nucleoplasm, Nuclear speckles" "HPA000690: AB_1079933, HPA030083: AB_10602183" "unprognostic (8.61e-2)" "unprognostic (1.60e-1)" "unprognostic (3.21e-2)" "unprognostic (7.54e-2)" "unprognostic (5.06e-3)" "unprognostic (1.79e-1)" "unprognostic (5.54e-3)" "unprognostic (3.30e-1)" "unprognostic (3.83e-1)" "unprognostic (2.59e-1)" "unprognostic (2.58e-1)" "unprognostic (3.26e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.25e-1)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (1.13e-1)" 34.2 29.9 14.0 45.8 18.0 58.6 35.3 18.4 20.6 32.6 12.9 30.9 30.1 36.6 20.7 34.3 32.1 21.5 27.6 15.9 16.3 25.7 27.7 31.3 44.4 17.1 14.9 12.0 46.8 33.2 43.1 24.5 29.2 15.0 29.7 27.3 36.7 33.6 28.3 51.6 39.6 33.1 30.1 11.7 42.4 32.1 49.6 16.6 43.0 31.8 26.0 41.8 33.5 33.0 16.0 86.2 58.9 79.4 77.6 46.4 41.3 94.8 66.5 42.7 71.4 52.8 78.8 55.9 106.4 44.6 47.7 55.9 80.4 101.6 70.8 77.7 97.4 88.4 99.3 69.1 65.3 41.8 202.1 106.3 41.7 49.6 89.5 72.4 40.1 52.1 56.6 112.5 108.0 52.8 49.1 99.4 46.2 132.0 65.7 48.4 139.5 99.4 86.8 40.9 93.6 82.2 74.9 84.4 50.8 78.4 52.5 62.3 65.4 72.9 90.2 80.0 65.1 124.4 83.2 108.2 106.9 69.4 73.8 95.0 6.7 8.9 14.1 10.9 9.8 11.2 10.4 11.0 11.8 9.2 11.0 12.0 11.2 14.1 11.0 13.0 5.6 14.5 8.0 14.0 18.0 18.4 20.6 15.9 16.3 17.1 14.9 12.0 15.0 11.7 16.6 16.0 32.4 57.7 66.5 12.1 60.8 26.1 25.4 19.0 37.0 17.6 25.7 24.4 27.6 34.3 30.5 31.3 16.7 32.5 49.2 30.8 17.6 25.7 106.1 30.5 23.1 32.6 25.1 36.1 7.5 29.4 39.7 29.1 35.2 29.1 52.6 76.3 28.2 28.4 40.6 26.9 9.4 30.7 16.2 37.2 28.3 116.8 35.1 39.8 17.8 5.6 58.5 27.1 46.4 6.0 7.1 28.8 31.3 37.6 45.5 26.4 31.8 17.0 39.4 20.3 46.0 29.0 27.3 64.3 41.6 37.8 27.3 34.6 55.8 26.7 33.9 25.8 GGT5 "GGT-REL, GGTLA1" ENSG00000099998 "Gamma-glutamyltransferase 5" P36269 22 24219654-24245108 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glutathione biosynthesis, Leukotriene biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endothelial cells: 42.8;Fibroblasts: 58.3;Leydig cells: 36.4;Sertoli cells: 184.1;Smooth muscle cells: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.3;eosinophil: 4.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 164.9;ASC TERT1: 124.4;HHSteC: 234.7;HSkMC: 271.7;TIME: 110.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008121, CAB032489" Uncertain Approved "Nucleoli fibrillar center" "Intracellular and membrane" NA NA 22000000 "Nucleoli fibrillar center" "CAB032489: AB_2111010, HPA008121: AB_1078965" "unprognostic (8.14e-2)" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (9.94e-2)" "unprognostic (8.13e-2)" "unprognostic (8.21e-2)" "unprognostic (2.33e-2)" "unprognostic (2.90e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-1)" "unprognostic (8.37e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (6.36e-5)" "prognostic unfavorable (4.06e-4)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.79e-1)" "unprognostic (8.33e-2)" 117.8 61.0 36.0 18.8 36.5 1.5 91.3 34.2 42.0 71.3 34.4 26.6 19.5 54.9 13.0 19.7 71.2 37.5 81.0 31.5 43.5 77.6 55.7 38.0 48.4 48.4 41.5 28.4 26.9 26.0 13.3 41.4 12.0 43.2 49.8 12.1 2.1 37.4 21.1 23.3 35.3 41.1 32.5 37.1 36.4 40.4 9.6 45.0 10.5 111.1 16.8 18.5 45.5 64.7 42.5 0.0 1.8 0.6 0.0 164.9 124.4 1.1 2.9 0.2 0.1 0.0 0.1 0.1 0.2 3.4 0.2 0.3 0.3 0.1 0.1 0.0 2.2 0.9 6.7 1.0 24.1 234.7 3.0 6.4 271.7 0.1 3.4 3.2 0.4 45.8 0.7 0.4 1.2 44.1 0.4 0.0 22.4 3.6 1.1 0.0 0.1 4.0 1.0 6.1 0.0 0.4 5.9 0.1 7.3 0.1 22.7 1.0 1.7 110.8 0.1 2.3 0.1 0.0 0.3 1.5 0.2 3.9 5.7 0.2 2.3 0.5 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.2 36.0 36.5 34.2 42.0 31.5 43.5 48.4 41.5 28.4 43.2 37.1 45.0 42.5 27.2 3.2 16.0 1.0 0.3 7.0 3.3 3.2 0.0 0.0 7.2 4.2 4.4 0.0 17.9 0.0 0.0 0.2 0.4 0.0 0.0 0.6 0.8 0.3 8.3 42.8 0.0 2.7 0.1 0.2 0.2 58.3 1.1 0.4 1.3 0.0 33.5 0.1 2.1 0.0 0.1 0.0 0.0 1.0 12.5 3.3 36.4 1.8 3.6 22.5 3.3 0.3 0.0 0.5 0.0 0.4 0.0 23.7 0.3 2.2 0.0 0.1 2.2 1.0 184.1 33.9 85.6 0.6 0.4 0.3 4.4 0.3 1.1 2.1 0.0 1.4 RNF215 ENSG00000099999 "Ring finger protein 215" Q9Y6U7 22 30368811-30421771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.9;Cone photoreceptor cells: 12.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029427, HPA056498" Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA029427: AB_2732447, HPA056498: AB_2683154" "unprognostic (1.24e-2)" "unprognostic (3.20e-1)" "unprognostic (3.67e-4)" "unprognostic (8.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (1.97e-1)" "unprognostic (5.32e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (6.37e-10)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" 8.4 8.8 19.0 5.7 18.8 7.1 9.3 18.0 22.7 17.1 16.9 10.0 7.9 15.4 9.3 6.8 13.4 6.8 9.0 18.8 19.1 11.7 11.2 8.8 4.7 20.0 19.0 19.9 13.8 13.4 10.8 10.1 6.9 17.5 13.2 3.9 8.6 6.6 8.3 8.0 6.2 7.7 8.0 16.4 11.7 8.9 10.6 19.1 2.8 12.3 2.9 3.9 12.4 10.9 18.0 6.8 14.0 14.4 23.4 13.8 14.3 14.2 11.4 10.1 11.3 6.8 3.8 7.4 2.7 20.1 9.3 21.1 8.4 8.9 13.1 9.0 15.8 10.8 4.5 17.8 5.1 18.9 3.6 18.5 19.4 15.8 19.3 10.3 36.7 13.3 7.0 4.0 12.6 13.6 11.0 2.6 8.5 4.5 9.7 15.4 12.2 8.4 10.8 14.9 10.3 6.3 16.2 11.6 8.3 8.9 13.1 7.6 3.9 18.6 30.2 13.3 8.8 6.7 13.3 3.4 3.7 17.7 2.6 11.9 0.4 0.9 1.5 0.9 0.7 1.0 1.0 1.0 0.8 0.5 1.9 1.8 1.7 0.5 2.5 0.8 1.4 0.5 0.4 19.0 18.8 18.0 22.7 18.8 19.1 20.0 19.0 19.9 17.5 16.4 19.1 18.0 7.1 3.2 3.9 8.8 1.4 0.3 1.2 1.6 2.8 12.9 3.2 3.9 2.2 1.5 2.7 0.0 12.5 1.9 3.7 1.0 0.0 1.5 0.8 3.7 6.4 3.5 0.0 0.4 5.0 1.4 1.5 5.4 6.1 6.6 0.0 8.2 4.6 2.3 1.8 8.4 4.6 0.5 2.0 1.2 0.5 0.4 0.9 1.9 1.8 1.0 2.3 11.7 1.0 2.5 1.1 1.9 0.2 1.2 1.8 1.3 0.7 1.0 0.6 13.7 6.6 4.8 4.8 2.1 0.9 0.6 0.1 1.6 2.0 5.3 0.7 1.2 SEC14L2 "C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1" ENSG00000100003 "SEC14 like lipid binding 2" O76054 22 30396941-30425303 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 86.8;liver: 245.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 146.3;Muller glia cells: 112.6;Pancreatic endocrine cells: 115.2;Proximal enterocytes: 52.8;Rod photoreceptor cells: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 7 "T-cells: 3.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 93.9;hTCEpi: 47.3;hTERT-RPE1: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064466 Approved Supported Nucleoplasm,Cytosol NA NA 580000 Nucleoplasm Cytosol "HPA064466: AB_2685270" "prognostic favorable (3.05e-4)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (5.59e-3)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.63e-6)" "unprognostic (1.25e-3)" "unprognostic (3.76e-3)" "unprognostic (2.23e-1)" "unprognostic (2.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.63e-3)" "unprognostic (1.17e-3)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-3)" "unprognostic (2.01e-1)" 2.3 1.4 32.0 2.6 37.8 4.1 44.8 35.2 34.8 4.7 30.5 2.7 21.8 3.5 86.8 20.8 3.1 7.5 1.9 33.0 47.0 6.4 245.8 2.8 3.1 42.5 37.7 26.4 2.6 2.6 11.1 11.2 1.5 37.6 52.7 1.3 64.8 9.4 13.8 0.7 6.3 24.5 3.5 28.4 1.1 5.9 1.3 39.7 4.2 9.1 0.5 4.5 3.2 7.7 30.5 24.8 5.5 5.0 6.4 6.5 16.8 0.4 18.0 15.5 12.0 13.1 1.6 15.9 0.5 5.6 22.7 20.5 20.0 3.0 93.9 13.8 2.2 4.1 0.4 5.4 8.0 9.2 0.0 7.1 11.5 47.3 11.5 20.8 55.5 29.7 4.2 0.1 0.5 22.2 4.0 3.0 0.5 0.1 13.9 7.6 1.2 8.0 0.6 20.7 7.8 2.8 3.1 13.3 3.2 11.2 0.6 14.7 0.5 41.2 15.8 10.4 6.8 12.7 0.3 0.2 0.8 32.4 0.1 12.6 0.0 0.1 0.2 0.5 0.1 0.2 0.4 1.4 0.3 0.0 0.3 3.7 2.7 0.3 0.0 0.0 0.5 0.7 0.8 32.0 37.8 35.2 34.8 33.0 47.0 42.5 37.7 26.4 37.6 28.4 39.7 30.5 1.1 3.2 5.8 33.6 1.1 4.1 18.0 25.2 6.8 9.2 36.5 21.7 1.2 12.8 10.3 0.0 16.7 4.2 3.2 0.6 5.9 22.9 8.3 2.9 2.3 2.4 1.2 17.2 9.8 18.7 0.3 5.1 5.6 5.8 5.7 0.7 7.1 146.3 0.5 13.5 6.7 2.0 4.1 4.4 0.4 10.7 1.2 2.6 7.2 1.9 0.2 112.6 0.0 21.6 13.2 115.2 0.0 0.7 2.5 15.3 52.8 8.7 3.9 56.0 0.0 2.8 4.0 0.6 1.2 5.6 2.0 3.0 7.4 0.1 2.1 7.8 SEC14L3 TAP2 ENSG00000100012 "SEC14 like lipid binding 3" Q9UDX4 22 30447959-30472017 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;liver: 2.9;retina: 9.1" "Group enriched" "Detected in some" 8 "Muller glia cells: 27.6;Respiratory ciliated cells: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059450 Uncertain NA NA "HPA059450: AB_2684024" "unprognostic (2.42e-1)" "unprognostic (2.56e-1)" "unprognostic (1.42e-1)" "unprognostic (5.35e-2)" "unprognostic (2.00e-4)" "unprognostic (3.62e-3)" "unprognostic (6.68e-2)" "unprognostic (3.19e-1)" "unprognostic (2.41e-10)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (4.10e-1)" 0.0 0.1 0.2 0.1 0.3 3.9 0.0 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.1 0.0 2.9 1.1 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.4 0.2 0.1 0.3 0.1 0.3 0.4 0.1 0.2 0.4 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPECC1L "CYTSA, KIAA0376" ENSG00000100014 "Sperm antigen with calponin homology and coiled-coil domains 1 like" Q69YQ0 22 24270817-24417739 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA070614 Uncertain Supported "Actin filaments" NA NA "Actin filaments" "HPA070614: AB_2686287" "unprognostic (3.54e-1)" "unprognostic (4.93e-3)" "unprognostic (1.62e-1)" "unprognostic (5.88e-2)" "unprognostic (3.74e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (7.82e-3)" "unprognostic (4.98e-2)" "unprognostic (1.72e-3)" "prognostic favorable (7.92e-4)" "unprognostic (3.15e-3)" "unprognostic (6.20e-3)" "unprognostic (1.40e-1)" "unprognostic (3.71e-1)" "unprognostic (5.79e-3)" "unprognostic (1.41e-1)" 13.1 13.2 15.0 12.5 12.6 13.4 14.0 34.2 13.6 16.8 15.9 16.0 7.8 16.0 9.8 17.7 15.6 12.6 18.7 10.8 15.9 13.3 14.5 17.3 12.6 16.9 15.6 8.7 22.1 13.4 17.4 14.7 10.2 19.1 20.3 17.0 10.8 16.4 15.2 12.8 8.8 11.7 19.2 16.0 11.2 11.6 32.1 15.6 14.7 24.2 13.2 13.9 15.0 13.1 18.8 31.1 22.8 42.9 23.7 40.1 39.2 14.5 43.1 34.1 36.8 36.4 25.5 8.4 44.9 10.3 39.5 29.0 27.0 39.2 24.2 43.4 26.1 21.1 28.5 12.9 23.4 26.7 51.2 27.0 33.1 19.2 32.8 34.2 28.8 44.0 18.9 24.5 19.0 39.3 17.3 26.6 18.5 20.7 22.5 17.1 24.0 43.3 16.1 18.4 23.3 37.2 38.3 36.5 27.5 23.8 37.1 18.3 14.4 46.3 77.2 43.7 19.3 29.3 22.7 23.4 20.0 22.6 19.0 29.2 3.9 2.4 4.8 3.3 3.5 2.5 2.8 2.2 1.6 2.3 3.1 2.7 2.9 3.2 1.3 1.6 3.7 1.6 1.9 15.0 12.6 34.2 13.6 10.8 15.9 16.9 15.6 8.7 19.1 16.0 15.6 18.8 11.6 16.0 21.3 0.0 10.4 3.6 2.7 5.0 10.2 8.4 13.8 9.4 13.7 14.3 9.1 12.9 10.4 7.3 7.9 32.8 1.9 6.7 26.9 8.3 14.9 12.0 14.4 7.6 0.0 7.4 3.2 11.4 8.2 9.8 16.5 13.4 15.7 11.4 7.3 10.1 0.0 12.2 14.2 7.3 2.2 93.7 16.1 6.9 14.2 0.0 14.8 6.4 9.2 0.0 0.0 9.0 15.0 13.5 10.7 5.7 8.9 6.1 11.9 8.5 13.1 11.3 12.5 24.1 28.5 9.8 3.1 5.9 9.3 7.6 8.0 3.8 PPIL2 "CYC4, Cyp-60, UBOX7" ENSG00000100023 "Peptidylprolyl isomerase like 2" Q13356 22 21666000-21700015 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "K-562: 190.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035344, HPA055637" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035344: AB_10672863, HPA055637: AB_2682869" "unprognostic (1.97e-3)" "unprognostic (3.61e-2)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (2.90e-3)" "unprognostic (5.16e-3)" "unprognostic (3.77e-2)" "unprognostic (9.46e-2)" "unprognostic (1.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-3)" "unprognostic (5.46e-2)" "unprognostic (5.39e-2)" "unprognostic (5.39e-2)" "unprognostic (1.54e-3)" 9.0 14.3 4.7 12.9 5.6 6.4 9.6 4.0 7.0 11.7 1.8 11.7 8.2 12.1 9.4 16.5 10.8 9.6 14.0 5.3 3.8 12.6 15.1 10.2 16.5 3.3 3.3 4.9 10.8 19.4 16.5 14.4 9.2 3.5 12.5 10.7 9.1 14.8 9.6 19.0 12.4 13.4 10.0 2.3 14.1 14.0 10.2 2.9 16.0 19.0 13.1 16.5 11.8 12.2 4.8 20.4 17.1 18.1 20.1 19.2 17.6 15.8 19.3 17.9 28.0 24.5 21.3 10.3 34.0 12.7 27.2 13.9 22.9 28.6 23.6 16.2 19.2 28.2 26.7 14.2 32.4 14.7 42.5 21.5 17.4 21.2 19.4 14.0 15.1 25.1 18.5 190.3 17.9 19.6 28.6 20.5 13.7 20.2 35.7 14.9 23.7 31.1 5.7 14.2 14.1 30.8 18.4 21.2 32.7 9.7 11.3 27.1 20.3 27.5 15.8 25.1 17.5 12.7 19.2 17.5 24.7 21.6 22.6 24.9 1.5 9.7 5.1 9.6 15.3 12.2 7.2 11.5 12.6 13.7 8.3 10.5 9.4 2.3 14.1 22.6 11.9 15.6 12.1 4.7 5.6 4.0 7.0 5.3 3.8 3.3 3.3 4.9 3.5 2.3 2.9 4.8 9.8 9.6 29.5 15.0 21.5 3.2 7.9 10.9 10.8 26.3 13.4 10.2 5.7 27.1 16.6 14.7 33.3 15.8 39.4 23.9 13.7 12.8 66.8 15.4 14.8 8.0 11.4 17.7 19.9 16.7 13.3 10.3 39.3 19.5 17.1 16.6 10.4 18.9 15.3 18.5 24.2 20.6 14.2 21.0 5.3 90.9 12.2 15.5 1.8 8.4 16.6 11.5 52.5 12.5 17.4 18.5 17.4 13.5 23.8 10.9 14.2 9.1 11.9 31.4 0.0 11.2 9.4 23.6 17.3 12.3 5.7 22.2 24.5 14.8 20.8 12.6 UPB1 BUP1 ENSG00000100024 "Beta-ureidopropionase 1" Q9UBR1 22 24494107-24528390 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 217.7" "Group enriched" "Detected in many" 5 "Hepatocytes: 146.5;Proximal tubular cells: 68.5" "Cancer enriched" "Detected in some" 8 "liver cancer: 25.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 14 "basophil: 2.1;neutrophil: 2.1" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.1" "Cell line enriched" "Detected in single" 7 "CACO-2: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000728, HPA076321" Enhanced NA NA 1400000 "HPA000728: AB_1080471, HPA076321: " "unprognostic (7.27e-2)" "unprognostic (4.57e-3)" "unprognostic (2.27e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (1.09e-4)" "prognostic favorable (2.30e-7)" "unprognostic (8.41e-2)" "unprognostic (1.06e-1)" "unprognostic (2.93e-1)" "unprognostic (4.89e-6)" "unprognostic (3.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (1.99e-1)" "unprognostic (4.63e-3)" 0.2 0.2 0.3 0.2 0.6 2.0 0.1 0.7 1.7 0.2 0.4 0.1 1.2 0.2 0.2 0.1 0.3 0.1 1.9 0.3 0.2 25.8 217.7 0.8 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.4 0.0 0.5 0.3 0.1 1.1 0.1 0.1 0.5 0.6 0.4 0.1 0.0 0.8 0.3 3.1 0.4 0.6 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.4 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.7 1.7 0.3 0.2 0.2 0.2 0.0 0.5 0.0 0.4 0.2 0.8 0.0 2.0 0.3 0.6 0.6 1.3 0.1 0.0 4.0 0.3 0.3 2.4 4.3 0.0 1.8 10.4 0.1 0.1 0.0 11.7 0.1 1.2 0.2 0.6 1.9 2.4 5.3 0.7 0.4 0.1 1.4 0.0 0.5 0.0 0.6 3.6 146.5 0.1 0.0 1.2 0.0 0.0 5.1 2.7 1.4 0.3 1.0 0.0 0.0 21.3 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.7 1.2 0.0 68.5 0.0 1.8 0.0 2.7 3.7 12.8 6.8 0.0 1.1 0.3 0.9 0.2 0.1 1.1 YPEL1 ENSG00000100027 "Yippee like 1" O60688 22 21697536-21735794 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 78.6" "Group enriched" "Detected in many" 9 "Early spermatids: 706.3;Late spermatids: 1354.3;Spermatocytes: 394.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 18.8;JURKAT: 38.0;MOLT-4: 20.4;REH: 22.1;SCLC-21H: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030501, HPA045621" Uncertain NA NA "HPA030501: AB_10602683, HPA045621: " "unprognostic (1.36e-1)" "unprognostic (2.47e-3)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.82e-3)" "unprognostic (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.68e-3)" "unprognostic (2.06e-1)" "unprognostic (1.27e-1)" "unprognostic (6.03e-2)" "unprognostic (1.55e-1)" "unprognostic (2.51e-2)" "unprognostic (5.16e-3)" 3.4 2.4 11.9 2.9 25.4 6.4 3.3 9.5 15.0 1.8 7.7 2.7 2.4 4.1 1.6 2.0 2.7 3.2 7.3 16.3 11.1 2.2 2.6 5.6 5.9 9.3 6.3 16.7 7.7 3.9 3.4 2.6 1.3 11.6 2.7 1.8 3.8 2.7 1.2 15.8 1.7 2.5 2.4 4.2 8.5 3.4 78.6 11.8 14.7 2.7 6.5 4.5 2.1 1.3 11.4 2.1 0.4 18.8 11.6 1.4 0.6 1.0 0.7 0.2 1.3 1.8 0.0 1.0 3.1 2.4 0.3 1.7 0.2 1.1 0.3 1.1 9.6 3.3 0.2 0.3 0.9 1.1 2.1 2.4 1.3 0.3 0.5 0.2 3.3 3.2 38.0 1.2 10.1 1.8 0.5 20.4 5.0 1.1 0.3 2.9 22.1 4.7 1.2 0.4 0.1 19.2 13.6 2.3 2.2 1.5 3.7 1.1 2.7 1.8 0.3 5.0 0.4 0.7 13.9 7.2 10.7 1.1 2.2 3.1 0.2 0.1 0.1 1.9 0.4 1.5 0.3 0.3 1.8 0.2 0.6 0.1 0.9 0.8 2.4 0.1 1.7 0.8 0.5 11.9 25.4 9.5 15.0 16.3 11.1 9.3 6.3 16.7 11.6 4.2 11.8 11.4 6.3 3.2 4.8 13.7 9.1 1.8 2.9 0.5 0.6 6.8 6.4 3.8 4.8 7.2 2.1 3.7 6.2 0.6 62.1 0.6 0.0 7.1 706.3 6.1 3.1 6.4 13.1 10.3 16.7 3.5 0.4 3.6 2.6 3.6 0.0 23.0 10.4 6.7 1.6 6.7 11.6 1.8 0.0 3.2 3.7 1354.3 11.5 4.9 0.0 8.4 2.9 4.7 90.6 9.0 7.6 3.9 0.3 10.9 12.5 3.4 0.2 4.2 2.3 7.5 13.1 8.4 4.3 394.7 12.0 0.5 1.8 1.4 20.6 1.7 2.6 2.4 SNRPD3 "Sm-D3, SMD3" ENSG00000100028 "Small nuclear ribonucleoprotein D3 polypeptide" P62318 22 24555958-24582052 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA001170 Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 290000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA001170: AB_1080042" "unprognostic (3.30e-1)" "unprognostic (1.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.28e-3)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (4.44e-2)" "unprognostic (1.13e-3)" "unprognostic (1.20e-2)" "unprognostic (3.52e-2)" "unprognostic (3.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" 30.8 31.4 21.3 35.5 24.0 39.6 37.8 28.0 35.1 30.0 23.0 51.0 33.5 35.8 35.8 43.9 37.0 20.3 33.6 22.5 24.2 48.5 65.5 27.1 48.1 22.1 22.4 21.5 34.6 23.9 51.7 27.2 24.9 23.8 34.1 41.1 54.6 30.0 32.2 104.6 28.7 36.0 29.8 20.9 34.6 36.8 24.9 23.2 75.1 39.3 87.0 53.8 39.9 32.5 28.9 182.5 45.7 188.6 58.5 70.1 57.7 56.1 173.1 74.8 166.1 148.1 61.4 65.8 158.7 70.1 109.2 83.0 130.7 252.1 219.3 175.5 107.9 188.8 152.4 95.4 113.9 66.2 408.0 95.7 66.5 93.8 186.3 86.6 81.8 120.6 139.8 116.2 60.5 61.5 56.8 187.0 82.6 98.9 237.8 61.9 179.5 190.7 66.6 154.5 130.0 82.2 95.6 83.4 62.7 87.7 162.7 102.3 97.5 135.5 127.0 126.3 74.3 126.2 74.3 168.2 283.7 70.1 127.1 91.4 18.5 42.9 53.9 35.6 50.2 37.6 60.5 38.4 39.2 54.2 50.7 36.6 41.3 18.6 51.1 51.1 49.7 41.1 47.4 21.3 24.0 28.0 35.1 22.5 24.2 22.1 22.4 21.5 23.8 20.9 23.2 28.9 120.0 96.1 81.8 7.5 118.2 108.6 115.3 293.1 133.1 61.1 94.2 138.8 95.9 101.5 162.9 130.6 35.5 239.5 123.1 112.6 291.6 161.9 91.0 176.6 157.7 96.8 111.0 139.4 8.1 114.8 228.8 121.0 92.2 147.9 86.2 145.3 66.0 203.3 176.4 38.7 8.7 134.2 168.9 74.5 84.8 85.1 116.2 98.1 67.6 10.3 151.0 134.3 86.5 8.0 13.4 129.4 118.2 118.5 120.7 96.8 191.7 310.5 135.2 68.9 65.7 102.8 209.6 111.1 131.4 164.9 113.7 180.3 111.9 176.2 139.0 113.3 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 32.4 41.4 25.5 29.4 27.4 35.8 32.5 25.9 30.7 31.7 25.4 29.5 21.9 35.8 21.4 43.9 29.7 20.3 26.6 26.1 25.7 33.7 48.6 26.4 32.5 26.9 26.1 25.1 34.5 57.8 30.3 22.0 21.7 26.7 33.1 19.8 9.3 29.5 21.7 49.2 45.6 28.4 22.7 25.9 34.6 36.0 40.3 27.2 24.0 27.3 20.2 27.5 35.3 32.1 29.3 132.2 146.6 53.0 113.7 59.9 58.4 81.6 84.7 69.6 141.6 110.0 170.6 55.2 177.2 74.4 97.0 110.3 89.4 163.9 153.5 103.1 76.4 159.8 85.9 80.8 149.0 149.3 209.6 86.8 82.7 94.7 148.3 147.3 68.3 93.0 62.4 144.6 69.9 87.7 164.3 102.6 209.8 103.1 128.3 106.7 129.0 91.7 173.3 78.9 88.7 91.4 94.6 84.2 94.6 117.8 42.0 66.8 106.1 74.2 165.9 126.1 85.3 145.1 88.1 81.0 178.6 116.2 94.9 109.0 7.5 24.9 6.4 18.9 29.8 23.2 20.2 17.4 18.1 26.8 20.0 19.4 18.0 0.9 20.0 22.3 23.2 14.3 29.3 25.5 27.4 25.9 30.7 26.1 25.7 26.9 26.1 25.1 26.7 25.9 27.2 29.3 23.6 3.2 18.9 4.9 17.4 22.6 23.4 32.7 22.2 6.5 14.1 12.2 3.8 24.3 22.1 25.8 8.4 34.9 7.8 19.6 25.4 48.0 44.4 11.7 13.8 23.2 23.4 24.6 4.3 43.9 40.0 15.4 22.4 10.6 18.3 24.4 27.8 22.8 38.4 3.3 4.3 22.4 22.4 27.8 12.6 14.3 19.9 21.2 21.4 2.8 29.0 13.5 16.5 6.6 5.1 38.7 16.2 20.3 28.3 26.4 31.3 55.1 24.6 8.9 19.7 23.2 20.7 28.7 20.9 25.9 22.9 28.5 13.5 19.9 29.7 15.1 MAPK1 "ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2" ENSG00000100030 "Mitogen-activated protein kinase 1" P28482 22 21759657-21867680 "Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 341.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 140000 Cytosol "Nuclear speckles" "CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (9.41e-3)" "unprognostic (2.68e-1)" "unprognostic (2.50e-3)" "unprognostic (4.17e-1)" "unprognostic (4.44e-3)" "unprognostic (1.72e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (2.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.58e-1)" "unprognostic (8.43e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-2)" "unprognostic (2.08e-1)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (6.49e-2)" 31.4 33.4 67.1 36.3 87.7 41.6 30.1 40.9 81.0 31.7 34.2 36.4 26.0 29.9 30.4 43.4 29.3 29.1 42.6 85.5 61.3 42.5 34.5 38.8 37.1 34.3 50.2 72.5 29.4 38.4 52.1 12.1 33.4 37.1 33.1 36.5 30.6 29.1 33.0 38.4 45.3 29.7 39.5 40.9 40.9 34.2 44.0 54.6 44.8 46.5 42.3 42.3 35.9 19.0 55.3 78.7 48.0 60.5 37.2 75.9 76.7 25.9 84.7 77.5 73.2 72.0 43.8 40.8 45.8 41.3 112.7 67.5 74.6 73.9 67.9 97.8 180.4 72.1 78.9 43.0 67.7 73.5 113.2 80.5 56.9 60.1 89.4 81.6 58.0 101.7 45.4 341.9 50.5 97.5 36.6 72.0 38.5 24.4 104.5 46.8 79.4 149.6 13.2 55.5 62.9 50.0 28.6 91.5 64.2 57.2 60.4 42.4 47.1 90.1 61.5 79.6 71.9 54.2 47.1 59.4 65.8 60.0 60.0 68.4 1.4 4.9 7.2 15.9 6.0 4.9 2.3 3.6 6.0 4.1 2.6 3.5 6.1 16.5 9.3 6.9 4.0 3.4 4.0 67.1 87.7 40.9 81.0 85.5 61.3 34.3 50.2 72.5 37.1 40.9 54.6 55.3 36.8 48.1 35.8 97.6 44.0 60.2 28.4 25.1 28.5 25.5 32.5 24.5 41.5 42.9 31.2 51.5 54.2 21.8 151.7 74.4 19.6 28.5 49.0 33.5 40.3 39.9 59.6 63.8 109.2 39.2 23.2 38.4 52.0 45.0 92.8 28.8 52.1 63.5 53.2 28.6 91.2 42.2 26.4 89.0 77.1 14.7 32.6 74.9 40.9 68.4 75.0 35.8 143.2 82.4 75.1 45.3 35.2 44.4 37.0 43.8 32.8 46.0 32.2 22.4 32.9 44.6 37.3 74.1 53.4 44.9 61.8 19.2 91.4 43.3 38.6 38.8 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24594811-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis, Lipid metabolism" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 170.6;liver: 116.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9" "Cancer enhanced" "Detected in all" "renal cancer: 37.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles "Intracellular and membrane" NA NA 3600000 Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favorable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 2.8 2.4 6.2 6.5 7.3 12.1 24.9 7.8 7.6 28.9 5.8 17.9 85.5 3.0 72.7 3.3 3.3 47.5 5.0 5.8 7.2 170.6 116.7 43.0 5.4 8.1 7.3 5.2 3.2 63.6 0.2 5.6 2.4 8.4 49.2 11.1 1.7 10.0 21.8 1.9 3.5 81.0 2.2 6.9 13.4 31.6 18.6 7.3 6.6 16.0 0.4 6.2 5.8 4.4 10.0 1.0 79.7 1.0 0.3 0.0 0.5 2.2 0.5 1.7 0.8 1.0 11.7 18.3 1.0 16.2 0.1 14.8 11.0 6.2 0.8 0.5 103.6 12.3 0.6 40.8 64.3 5.5 1.5 33.2 2.1 0.9 2.5 1.7 1.4 0.5 19.0 8.4 165.8 1.0 1.7 1.6 52.4 6.4 169.5 0.7 0.7 6.8 210.3 203.2 2.9 0.5 1.2 0.4 33.3 0.8 22.2 32.4 39.6 6.4 10.6 9.3 46.6 0.9 48.2 18.4 0.7 19.0 58.7 0.5 4.8 12.3 0.2 1.0 6.0 2.9 2.2 5.0 2.4 6.5 0.2 0.6 1.4 15.9 4.9 4.0 0.1 6.5 5.6 6.2 7.3 7.8 7.6 5.8 7.2 8.1 7.3 5.2 8.4 6.9 7.3 10.0 0.2 80.1 22.8 3.3 2.8 0.8 0.1 0.3 4.6 0.5 5.9 2.3 0.7 48.6 4.9 1.8 0.0 1.4 0.7 54.1 1.9 82.6 1.8 1.2 0.6 0.7 1.2 5.3 4.4 8.1 0.4 3.9 15.3 5.1 5.7 0.1 1.8 40.8 4.9 0.0 4.1 4.4 4.1 2.5 1.7 6.7 0.0 2.9 1.8 1.0 5.8 2.5 0.0 1.5 5.7 20.9 20.1 0.4 12.8 2.0 111.7 62.9 1.6 0.1 0.0 0.1 1.0 0.6 0.8 0.4 0.4 0.8 4.0 0.0 6.5 0.1 PRODH "HSPOX2, PIG6, PRODH1, PRODH2, TP53I6" ENSG00000100033 "Proline dehydrogenase 1" O43272 22 18912777-18936553 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 49.6;skin 1: 39.0" "Cell type enriched" "Detected in some" 7 "Astrocytes: 183.1" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "OE19: 91.3;RPTEC TERT1: 35.9" HPA020361 Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" "unprognostic (2.46e-2)" "prognostic favorable (1.54e-4)" "unprognostic (1.40e-1)" "unprognostic (3.70e-2)" "unprognostic (3.80e-2)" "unprognostic (1.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-2)" "unprognostic (2.49e-2)" "unprognostic (6.56e-2)" "unprognostic (3.12e-2)" "unprognostic (1.61e-2)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.34e-2)" "unprognostic (3.94e-2)" 7.1 0.7 5.4 0.4 4.4 0.0 8.6 3.0 9.8 3.8 29.9 3.0 5.7 1.5 0.1 11.7 5.8 0.1 11.4 6.1 3.4 14.3 15.8 20.7 0.2 6.4 3.2 2.8 0.5 1.5 0.0 5.4 0.2 9.8 3.2 0.3 0.6 4.2 0.2 49.6 39.0 32.8 0.0 2.0 0.5 3.5 1.7 4.9 0.3 7.4 6.3 0.9 4.2 8.6 5.0 0.0 0.8 0.0 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.3 0.0 0.0 2.9 3.9 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 4.5 91.3 0.0 0.0 0.0 0.4 35.9 0.9 0.1 0.2 0.8 1.4 0.3 5.2 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 4.4 3.0 9.8 6.1 3.4 6.4 3.2 2.8 9.8 2.0 4.9 5.0 0.1 16.0 25.6 183.1 0.0 5.1 0.3 13.1 0.0 0.0 0.2 0.1 1.8 0.0 11.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.6 1.2 0.2 0.4 3.5 0.0 0.5 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 2.0 0.0 1.5 0.1 0.0 0.1 21.4 17.8 0.0 0.6 0.0 14.1 2.1 0.0 2.3 0.0 0.0 0.0 8.0 0.1 21.0 0.1 0.0 1.1 0.6 0.2 0.4 1.0 15.2 0.0 0.3 0.0 1.6 0.2 PPM1F "CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2" ENSG00000100034 "Protein phosphatase, Mg2+/Mn2+ dependent 1F" P49593 22 21919425-21952848 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endothelial cells: 42.2;Hepatic stellate cells: 56.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 28.6" "Group enriched" "Detected in all" 7 "dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 109.1;K-562: 173.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030989, HPA030990" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 510000 Nucleoplasm "Plasma membrane" "HPA030989: AB_10669549, HPA030990: AB_10601249" "unprognostic (6.26e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.77e-3)" "unprognostic (4.88e-3)" "unprognostic (1.94e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-2)" "unprognostic (1.45e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (6.03e-5)" "unprognostic (6.44e-2)" "unprognostic (3.02e-2)" "unprognostic (3.30e-1)" "unprognostic (4.11e-2)" 24.3 18.2 15.1 21.8 13.0 27.0 17.7 10.8 15.8 18.0 11.2 14.7 9.0 20.0 3.9 22.3 15.2 12.3 16.4 13.1 16.3 15.7 8.0 26.3 15.3 15.6 13.9 12.3 12.6 12.4 6.5 8.5 26.8 16.2 15.9 4.2 3.8 11.0 14.4 17.1 14.9 13.9 12.2 14.2 36.1 12.1 6.4 15.4 7.8 12.5 10.6 7.9 22.2 16.1 15.0 28.9 30.1 19.0 18.6 10.4 18.1 23.9 32.1 18.9 27.7 19.0 13.8 11.3 17.3 39.0 22.7 11.8 33.9 8.3 19.9 9.8 24.7 27.1 66.8 14.5 13.2 17.1 25.0 17.4 17.1 5.9 27.1 12.6 19.6 109.1 16.9 173.4 7.2 35.9 26.2 15.0 19.3 8.0 9.2 32.7 21.9 49.0 5.2 9.4 12.1 7.7 29.6 30.4 10.0 25.7 7.4 12.5 17.2 93.1 33.1 33.4 30.5 31.1 14.1 12.2 19.6 33.5 46.7 64.7 0.0 12.8 5.9 1.7 21.0 1.0 1.1 1.1 0.9 8.9 0.9 1.0 1.3 28.6 3.1 24.4 2.2 2.4 5.4 15.1 13.0 10.8 15.8 13.1 16.3 15.6 13.9 12.3 16.2 14.2 15.4 15.0 32.1 6.4 6.0 11.8 5.5 8.2 5.2 4.9 8.6 8.3 7.4 9.9 11.9 8.6 4.1 1.8 2.1 16.6 5.1 1.4 3.9 5.2 2.0 3.0 9.4 42.2 6.0 5.5 11.6 5.1 10.0 8.4 3.1 3.8 3.8 10.4 56.4 6.5 20.6 8.4 12.7 4.2 6.1 37.0 22.0 1.5 7.2 23.4 7.2 18.7 30.9 4.1 6.2 12.5 6.8 7.4 1.1 6.8 5.0 7.4 2.6 4.4 4.0 6.5 6.6 17.2 8.2 14.2 13.1 8.5 5.7 3.0 6.4 7.1 4.5 6.6 SLC35E4 ENSG00000100036 "Solute carrier family 35 member E4" Q6ICL7 22 30635781-30669016 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.0" "Group enriched" "Detected in many" 4 "Early spermatids: 122.2;Late spermatids: 108.6;Spermatocytes: 55.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 22.8;U-2197: 21.0;U-87 MG: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049558 Approved Approved Cytosol NA NA Cytosol "HPA049558: AB_2680817" "unprognostic (2.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.05e-1)" "unprognostic (1.01e-2)" "unprognostic (4.99e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-4)" "unprognostic (5.71e-2)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (3.45e-7)" "unprognostic (2.77e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (8.05e-3)" 2.4 1.8 3.8 1.4 4.6 1.5 2.2 2.7 6.7 2.5 0.4 3.1 1.0 3.5 1.3 2.9 2.5 1.1 2.9 4.0 3.6 1.6 0.5 2.1 0.8 4.6 4.5 3.7 1.9 1.7 1.7 2.3 0.4 4.9 2.3 1.7 1.6 2.1 1.3 11.2 5.1 1.8 1.4 2.2 1.9 3.5 23.0 4.4 0.4 1.6 2.8 0.5 3.1 2.8 7.3 10.0 4.3 1.6 3.2 4.3 10.9 0.9 6.4 5.6 4.3 4.0 0.3 2.6 0.7 3.4 6.6 6.1 6.2 2.8 3.7 2.2 22.8 3.1 0.1 3.3 0.3 6.1 0.4 2.7 3.5 1.6 17.3 5.4 6.8 14.9 0.8 0.9 2.8 6.8 2.8 0.4 1.9 1.9 2.9 16.2 1.8 3.2 0.3 2.0 0.8 8.7 3.4 6.6 2.8 3.2 0.7 2.0 0.7 20.0 18.2 5.8 21.0 6.2 0.8 0.9 0.3 22.3 0.3 4.9 0.6 0.6 0.1 0.2 0.8 0.4 0.0 0.6 0.9 1.1 0.1 0.5 0.5 0.2 0.6 0.7 0.3 0.7 0.3 3.8 4.6 2.7 6.7 4.0 3.6 4.6 4.5 3.7 4.9 2.2 4.4 7.3 5.7 0.0 1.5 2.6 2.7 14.5 2.5 1.9 8.0 10.6 2.0 3.7 1.9 0.0 1.2 1.8 22.9 0.1 4.8 5.4 0.0 3.4 122.2 6.0 4.9 9.1 2.4 0.8 4.2 2.3 0.5 3.7 2.6 2.0 1.3 4.1 4.2 0.3 1.8 11.8 4.9 4.4 2.0 1.2 7.7 108.6 3.4 8.0 3.6 4.7 2.5 17.2 1.0 2.5 9.2 2.5 11.1 3.8 3.1 1.7 1.2 0.4 5.7 10.5 0.0 3.9 5.0 55.1 3.8 4.2 19.0 0.1 4.9 2.4 5.0 2.1 TOP3B ENSG00000100038 "DNA topoisomerase III beta" O95985 22 21957025-21982813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 112.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072114 Approved Nucleoplasm NA NA Nucleoplasm "HPA072114: " "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (3.37e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (3.93e-1)" "unprognostic (2.15e-2)" "unprognostic (2.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "unprognostic (1.96e-2)" "unprognostic (1.69e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-2)" "unprognostic (1.11e-4)" 10.7 12.1 4.7 10.2 6.1 16.4 11.3 6.6 8.4 17.7 10.2 12.6 11.2 13.7 7.1 15.0 13.6 7.4 11.3 5.2 4.8 14.0 17.1 13.8 12.8 5.1 4.3 4.3 20.4 12.8 7.4 13.0 8.4 5.9 16.8 10.0 7.0 14.0 6.9 10.5 14.8 17.9 9.8 3.3 25.2 13.6 11.2 5.2 13.7 14.5 5.8 13.5 11.5 15.7 7.3 22.1 21.1 40.9 16.8 14.8 12.3 25.7 14.2 17.6 32.1 28.3 22.2 9.3 29.9 10.5 14.9 13.4 39.6 18.6 25.2 25.9 15.3 45.4 23.5 31.4 24.1 20.1 32.3 14.9 6.1 37.5 26.8 12.7 18.6 27.1 17.2 112.5 15.7 15.2 22.3 20.6 25.0 17.0 15.8 19.9 31.6 27.1 4.6 15.8 28.9 26.7 19.3 17.4 15.4 13.7 16.4 11.9 20.7 19.9 13.2 27.6 13.0 17.6 23.2 20.8 28.2 10.2 19.4 14.0 1.9 4.3 1.8 5.5 4.4 3.8 4.5 3.6 3.9 4.7 4.9 3.3 3.5 1.5 4.3 2.6 5.4 4.2 3.7 4.7 6.1 6.6 8.4 5.2 4.8 5.1 4.3 4.3 5.9 3.3 5.2 7.3 7.2 0.0 2.6 12.1 7.2 1.8 2.6 6.2 2.8 4.6 3.7 3.9 0.2 8.6 5.0 3.7 10.4 5.2 7.2 7.0 1.9 4.8 1.3 5.3 6.7 5.7 4.8 2.1 8.9 4.3 3.6 4.3 12.2 5.0 1.3 15.0 7.9 7.1 4.0 1.7 7.7 5.3 4.1 3.4 3.8 1.8 10.5 5.1 5.4 6.5 4.3 3.1 5.2 4.5 9.2 6.4 4.6 7.5 6.1 3.4 4.5 2.8 8.2 6.1 6.6 4.9 9.6 6.6 4.9 3.6 1.6 4.0 5.9 7.6 5.8 2.9 CRYBB3 CRYB3 ENSG00000100053 "Crystallin beta B3" P26998 22 25199858-25207359 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Distal enterocytes: 2.6;Distal tubular cells: 1.9;granulocytes: 4.5;Muller glia cells: 4.3;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;HEK 293: 1.4;HeLa: 1.8;hTERT-HME1: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA055840 Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA055840: AB_2682939" "unprognostic (1.36e-2)" "unprognostic (6.27e-4)" "unprognostic (6.30e-3)" "unprognostic (5.34e-2)" "unprognostic (8.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.45e-2)" "unprognostic (2.07e-2)" "unprognostic (4.15e-2)" "unprognostic (8.28e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-2)" "unprognostic (2.01e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-3)" 0.2 0.5 1.0 0.1 0.8 0.0 0.7 0.0 1.3 0.4 0.0 0.6 0.3 0.3 0.2 0.6 0.4 0.4 0.5 1.1 0.1 2.0 2.0 0.3 0.2 0.2 0.1 0.7 0.1 0.3 0.0 0.3 0.1 0.2 0.8 0.4 0.8 1.0 0.4 0.7 0.9 0.7 0.1 0.0 0.1 0.5 0.2 0.7 0.3 1.3 0.1 0.3 0.1 0.5 0.6 0.6 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.2 1.4 0.8 0.6 0.0 0.0 1.4 0.0 1.8 1.0 0.0 0.0 0.0 0.0 0.7 0.4 1.2 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.5 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 1.3 1.1 0.1 0.2 0.1 0.7 0.2 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.6 0.3 0.4 1.5 0.1 0.0 0.0 0.0 0.0 2.6 1.9 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 4.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.3 10.5 0.4 0.3 0.0 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.1 0.0 0.3 0.1 CYTH4 "CYT4, cytohesin-4, PSCD4" ENSG00000100055 "Cytohesin 4" Q9UIA0 22 37282027-37315341 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 58.8;lymphoid tissue: 67.9" "Cell type enhanced" "Detected in many" "dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004065, HPA071573" Approved Supported "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" Yes NA "Plasma membrane" "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA004065: , HPA071573: AB_2686418" "unprognostic (4.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" "unprognostic (9.28e-3)" "unprognostic (9.25e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (5.84e-2)" "unprognostic (3.30e-3)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (2.41e-8)" "unprognostic (3.70e-2)" "unprognostic (1.92e-2)" "unprognostic (5.56e-2)" "unprognostic (2.07e-1)" 21.7 8.9 4.4 67.9 4.4 58.8 5.1 4.1 8.6 5.3 7.5 10.8 8.6 4.4 1.6 6.2 4.8 16.5 5.7 4.1 10.3 3.8 5.7 19.1 57.5 8.2 4.9 3.8 3.4 2.5 2.1 2.9 28.2 6.8 3.7 10.1 0.3 7.4 4.4 2.2 2.3 15.3 13.0 7.2 59.6 11.6 2.7 6.7 25.8 3.0 5.1 40.6 23.4 2.5 8.6 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.8 9.3 0.3 0.0 2.5 0.1 0.0 0.6 0.0 5.3 0.0 9.8 0.0 0.0 0.0 34.1 141.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 23.2 0.0 0.0 0.5 13.5 0.0 0.1 1.0 1.3 0.2 19.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 95.2 0.3 0.0 0.1 0.1 0.0 28.4 4.0 4.5 18.5 11.5 0.2 15.8 62.6 87.5 55.4 102.5 39.0 30.3 30.5 44.8 47.5 31.8 30.0 38.3 199.1 45.0 129.4 113.8 30.7 76.2 4.4 4.4 4.1 8.6 4.1 10.3 8.2 4.9 3.8 6.8 7.2 6.7 8.6 1.1 3.2 8.4 0.0 37.0 2.4 0.8 0.0 0.6 0.1 0.7 1.5 2.0 0.0 1.8 0.0 0.0 0.5 117.5 0.1 0.0 0.0 0.4 0.1 0.2 2.5 0.0 2.5 0.2 0.2 0.6 1.9 2.0 0.1 57.0 0.0 2.2 1.1 76.8 0.0 0.2 0.2 0.0 71.5 87.5 0.9 0.6 55.0 7.2 24.4 42.7 0.0 120.5 0.5 0.0 0.8 0.0 0.0 25.1 0.3 0.0 0.8 0.0 0.1 0.0 0.9 1.0 0.0 0.2 0.3 2.3 1.0 43.9 0.0 0.2 0.5 ESS2 "bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2" ENSG00000100056 "Ess-2 splicing factor homolog" Q96DF8 22 19130279-19144684 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 4.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 15.7;Distal tubular cells: 13.7;Syncytiotrophoblasts: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 9.4;RH-30: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001221, HPA001222" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA001221: AB_1078645, HPA001222: AB_1078647" "unprognostic (8.31e-2)" "unprognostic (1.81e-3)" "unprognostic (2.26e-1)" "unprognostic (2.83e-1)" "unprognostic (5.75e-3)" "unprognostic (4.70e-2)" "unprognostic (2.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (5.89e-2)" "unprognostic (9.36e-2)" "unprognostic (3.04e-2)" "unprognostic (1.71e-3)" 0.6 0.4 3.4 0.6 3.2 0.2 0.6 4.7 3.3 1.1 1.9 1.7 0.4 1.4 0.5 1.0 0.9 0.5 1.1 3.1 2.9 0.7 0.5 0.5 0.8 3.2 3.2 2.8 1.3 0.7 0.7 1.1 0.5 3.8 1.0 0.4 1.3 0.6 1.2 1.6 1.4 0.9 0.9 2.8 0.9 1.1 2.0 3.1 0.9 0.8 1.6 0.8 1.7 0.9 3.3 1.6 3.0 1.7 1.9 2.7 0.5 0.7 1.5 0.9 2.6 2.1 2.4 0.6 2.3 0.5 0.7 0.6 2.8 5.1 0.8 1.3 3.4 5.8 0.6 2.7 0.4 0.7 2.8 2.0 0.4 3.0 1.8 0.5 0.7 0.5 1.6 9.4 0.3 1.2 1.7 1.7 1.6 1.5 1.8 2.3 2.6 8.3 0.0 0.7 1.2 4.3 0.9 0.7 1.3 1.9 1.1 0.9 1.3 0.4 2.2 3.2 2.2 1.2 1.1 2.5 0.8 0.7 1.7 1.4 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.0 0.2 0.0 0.1 3.4 3.2 4.7 3.3 3.1 2.9 3.2 3.2 2.8 3.8 2.8 3.1 3.3 6.3 6.4 4.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 6.1 6.7 0.0 0.0 1.8 9.2 0.0 15.7 8.3 0.0 13.7 13.2 0.0 7.5 6.9 4.0 0.0 0.0 0.0 10.4 12.4 3.7 0.0 7.5 5.1 10.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 10.3 0.0 0.0 0.0 0.0 13.4 0.0 0.0 2.3 0.0 0.0 12.7 4.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 16.3 4.0 10.2 0.0 0.0 MFNG ENSG00000100060 "MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" O00587 22 37469063-37486393 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.6" "Cell type enhanced" "Detected in many" "Adipocytes: 51.4;dendritic cells: 54.6;Endothelial cells: 37.1;Hepatic stellate cells: 53.2;Kupffer cells: 45.8;monocytes: 40.6;NK-cells: 72.1;T-cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 174.6;HEL: 143.4;HL-60: 220.9;HMC-1: 266.9;HUVEC TERT2: 232.9;TIME: 134.7;U-698: 166.8;U-937: 201.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048936, HPA056479" Approved Approved Vesicles "Intracellular and membrane" NA NA 74000 Vesicles "HPA048936: AB_2680564, HPA056479: " "unprognostic (1.21e-1)" "unprognostic (4.17e-3)" "prognostic unfavorable (5.12e-4)" "prognostic favorable (1.65e-4)" "unprognostic (6.41e-3)" "unprognostic (1.00e-2)" "unprognostic (2.64e-1)" "unprognostic (2.36e-2)" "unprognostic (4.64e-2)" "unprognostic (2.91e-2)" "unprognostic (5.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (2.67e-1)" "unprognostic (4.03e-2)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" 22.4 7.2 8.7 37.3 8.7 40.7 15.0 8.4 10.9 8.3 8.7 10.6 8.6 9.8 2.4 7.6 11.1 14.7 12.4 7.4 9.6 9.3 7.2 26.5 69.6 16.8 11.5 5.8 3.1 3.9 2.6 3.1 30.5 21.4 6.6 7.9 0.7 5.5 5.8 7.6 5.0 24.2 11.6 9.2 59.4 8.7 2.9 12.6 50.9 9.7 8.9 42.9 14.0 6.2 14.3 6.0 2.2 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 7.1 3.0 174.6 0.7 0.0 0.8 10.8 45.1 8.7 0.2 81.6 1.0 143.4 0.6 1.5 0.6 220.9 266.9 0.0 2.6 1.7 3.2 0.9 232.9 69.0 0.7 73.8 0.0 1.5 27.8 3.0 0.4 6.1 1.0 67.0 1.8 128.7 0.4 0.1 94.1 0.9 0.5 0.3 0.3 0.8 1.3 14.1 134.7 0.0 5.8 22.8 0.6 0.4 0.4 166.8 1.1 201.1 2.7 210.3 198.9 386.5 196.1 196.1 214.5 103.0 222.7 206.1 204.1 113.5 243.4 209.9 127.9 217.1 218.7 51.7 284.3 314.0 8.7 8.7 8.4 10.9 7.4 9.6 16.8 11.5 5.8 21.4 9.2 12.6 14.3 51.4 0.0 3.8 0.0 35.4 3.7 0.4 0.2 0.0 6.3 1.0 1.3 1.6 5.7 3.1 0.0 0.0 0.3 54.6 1.1 0.0 2.9 0.2 0.4 0.2 37.1 1.2 30.1 0.1 0.9 0.3 1.1 2.0 1.0 31.6 0.1 53.2 1.5 31.9 0.0 0.1 2.1 0.0 45.8 20.2 0.3 0.0 33.5 3.6 6.5 40.6 0.1 72.1 0.0 0.0 3.7 4.0 0.0 35.0 0.5 2.3 0.3 0.1 0.6 0.0 1.6 1.0 0.1 0.7 0.3 2.4 0.7 51.0 0.1 0.8 0.4 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 35.5;Ductal cells: 25.4;Endothelial cells: 24.8;Pancreatic endocrine cells: 39.4;Paneth cells: 27.6;Proximal enterocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.5;U-2197: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" No No "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: AB_2682861" "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favorable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 9.3 8.5 4.0 5.0 2.7 0.1 10.6 2.5 4.0 6.0 3.0 13.4 34.4 6.1 1.3 8.5 7.5 7.8 10.8 2.7 2.5 14.7 12.5 6.2 2.1 3.9 2.9 1.9 3.1 9.3 2.7 2.1 4.7 4.7 5.5 8.8 0.3 19.2 4.3 8.0 9.5 36.2 4.2 2.8 4.1 10.0 15.1 3.7 0.8 6.8 8.3 1.0 6.2 5.9 4.1 31.3 23.1 4.1 3.0 0.1 8.7 19.6 2.8 6.5 12.8 10.0 14.2 21.8 0.0 10.8 5.4 12.4 43.0 4.9 56.5 3.9 0.1 11.8 0.7 15.6 22.1 5.4 0.5 1.9 2.9 11.5 24.5 31.2 10.2 26.1 0.0 3.3 0.0 9.9 11.0 0.1 2.0 7.2 17.0 13.2 0.0 38.9 3.0 19.1 5.4 1.5 2.4 21.0 9.5 2.1 5.0 10.1 1.7 35.0 9.5 26.9 82.8 16.4 0.1 0.0 0.0 30.2 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.7 2.5 4.0 2.7 2.5 3.9 2.9 1.9 4.7 2.8 3.7 4.1 22.6 0.0 2.0 0.0 0.2 8.5 6.8 3.4 2.2 1.2 3.9 4.3 3.7 10.0 1.6 3.7 0.0 0.4 0.2 35.5 1.9 25.4 7.8 3.3 0.4 24.8 7.7 0.0 0.1 19.6 1.6 1.9 15.8 6.2 0.0 0.4 17.9 4.8 0.1 0.0 0.6 19.8 4.1 0.0 1.2 8.6 0.0 0.4 5.4 3.7 0.0 0.0 0.0 0.0 0.1 39.4 27.6 0.7 0.2 8.6 35.5 12.4 1.2 0.2 0.0 6.2 1.1 0.4 3.4 2.5 3.8 0.0 0.6 1.0 11.3 9.7 SLC25A1 "CTP, SLC20A3" ENSG00000100075 "Solute carrier family 25 member 1" P53007 22 19175581-19178739 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 199.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 221.1;Proximal enterocytes: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 101.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.12e-1)" "unprognostic (3.98e-1)" "unprognostic (8.17e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-2)" "unprognostic (2.61e-2)" "unprognostic (3.11e-2)" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (5.74e-2)" "unprognostic (3.90e-2)" "unprognostic (5.72e-2)" "unprognostic (4.52e-2)" "unprognostic (1.84e-1)" "unprognostic (3.46e-2)" "unprognostic (6.14e-2)" "unprognostic (9.03e-2)" 110.5 77.0 42.3 22.5 42.0 14.3 91.1 45.3 54.5 40.1 41.9 53.1 115.2 40.3 16.4 59.7 35.0 21.7 24.8 37.6 57.0 86.1 199.3 33.9 21.6 56.8 50.4 37.8 44.0 55.3 33.4 39.7 27.7 60.2 54.3 34.2 5.7 39.9 30.3 17.5 48.6 93.2 21.2 47.0 31.7 53.3 36.5 46.8 16.4 46.5 7.8 25.7 44.2 41.1 53.0 111.9 114.3 85.9 73.6 209.1 102.5 91.2 77.5 96.9 65.7 90.4 136.4 77.2 66.9 38.8 110.5 70.5 95.4 82.9 138.1 37.2 59.6 164.1 35.5 97.7 278.4 148.2 67.3 107.5 145.1 81.7 75.7 58.4 73.3 62.8 53.4 184.6 61.9 74.7 288.1 37.0 80.8 57.5 173.5 70.0 70.4 44.6 29.9 196.2 135.8 55.5 71.2 83.1 163.0 48.6 52.6 122.6 171.7 63.6 80.3 69.3 62.0 53.2 78.2 39.9 35.4 82.5 31.5 41.4 11.6 15.7 101.9 16.6 17.9 10.6 33.3 18.7 18.2 13.7 43.5 16.7 14.3 8.1 13.7 23.8 10.5 19.6 10.6 42.3 42.0 45.3 54.5 37.6 57.0 56.8 50.4 37.8 60.2 47.0 46.8 53.0 18.5 9.6 18.9 10.7 35.0 22.0 27.2 21.6 31.9 7.8 44.2 41.9 7.2 38.6 17.0 33.1 2.1 135.6 18.4 178.6 50.9 33.5 30.5 41.4 37.0 16.8 41.0 21.7 5.2 45.6 139.5 27.1 50.4 83.7 2.5 67.5 21.4 221.1 47.5 13.5 6.1 107.3 28.5 30.5 18.2 98.8 28.9 32.6 28.4 2.8 29.6 27.7 16.5 3.0 10.1 39.7 128.1 29.3 38.7 28.7 304.3 127.3 11.1 4.2 13.1 14.5 37.8 15.3 29.5 60.5 30.4 127.7 24.6 55.7 108.3 30.4 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564675-25729294 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 30.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 43.6;JURKAT: 69.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favorable (1.29e-4)" 30.5 5.5 5.7 13.0 9.2 7.9 9.5 2.2 14.1 4.1 0.3 3.0 2.8 5.3 1.3 2.4 8.7 4.7 4.4 17.7 4.0 2.4 3.2 9.4 15.2 4.8 6.5 5.8 2.9 7.1 4.2 3.2 4.4 3.5 7.6 4.0 4.8 3.2 1.6 0.9 3.4 4.8 5.9 2.9 18.9 3.8 15.8 5.4 10.3 4.2 1.2 15.7 6.3 1.5 6.2 0.1 3.9 11.9 3.9 8.1 1.0 17.3 1.3 3.8 3.8 6.5 6.4 6.8 22.5 0.3 0.3 10.5 0.2 11.9 9.1 11.1 43.6 7.6 10.3 1.3 14.3 0.3 33.8 16.8 2.0 6.2 2.6 4.6 0.6 0.7 69.4 1.1 0.1 4.4 5.6 24.4 2.4 8.5 12.1 0.0 10.8 18.9 3.8 0.0 6.6 27.6 37.5 2.2 0.1 9.0 10.9 3.3 13.4 0.3 0.1 23.6 0.2 4.9 2.6 9.1 17.4 15.8 11.8 3.7 0.5 4.1 5.2 0.0 7.2 0.2 4.1 0.0 0.2 3.2 5.0 0.1 0.1 0.2 0.0 6.8 2.7 0.3 1.5 5.7 9.2 2.2 14.1 17.7 4.0 4.8 6.5 5.8 3.5 2.9 5.4 6.2 3.9 16.0 32.2 0.0 10.2 0.0 0.0 0.0 0.0 0.0 11.7 9.5 0.0 0.0 16.7 0.0 0.0 2.0 1.1 0.0 1.9 9.4 0.0 12.7 5.8 2.4 0.0 0.0 0.0 1.8 29.2 4.1 0.0 2.2 18.9 3.7 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 27.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 2.1 0.0 0.0 1.8 6.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 3.3 1.1 5.0 0.0 0.0 PLA2G3 GIII-SPLA2 ENSG00000100078 "Phospholipase A2 group III" Q9NZ20 22 31134807-31140508 "Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 13.9;skin 1: 14.3;vagina: 7.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast glandular cells: 7.5;Suprabasal keratinocytes: 17.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 15.1;AN3-CA: 15.3;NTERA-2: 7.8;SCLC-21H: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021016 Uncertain Uncertain "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA021016: AB_1855443" "unprognostic (1.80e-1)" "unprognostic (4.63e-3)" "unprognostic (1.07e-1)" "unprognostic (1.49e-2)" "unprognostic (9.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (1.74e-2)" "unprognostic (2.30e-1)" "unprognostic (4.25e-2)" "unprognostic (9.55e-3)" "unprognostic (4.41e-1)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.9 0.4 2.9 0.6 0.0 0.3 0.0 0.0 13.9 0.0 0.0 0.0 0.4 0.3 0.5 0.0 2.6 0.0 1.5 0.6 0.0 0.0 0.0 1.0 0.1 0.0 1.7 0.3 0.0 0.0 1.8 0.3 0.2 14.3 0.2 0.0 0.1 0.0 0.6 0.5 0.1 0.1 0.6 0.0 1.7 0.0 7.2 0.6 0.0 0.0 15.1 15.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.4 0.4 0.3 1.5 0.6 0.0 1.7 0.1 0.1 0.6 0.0 0.0 3.6 1.6 0.0 1.3 0.2 0.2 0.0 0.0 7.5 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 17.8 0.0 0.0 0.0 0.0 0.4 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570248-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 338.6;intestine: 199.7;kidney: 154.4;pancreas: 213.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 27 "classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2" "Group enriched" "Detected in all" 50 "dendritic cells: 1207.2;monocytes: 1464.7" "Group enriched" "Detected in many" 4 "CACO-2: 109.4;Hep G2: 62.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.9 1.4 0.3 23.8 1.0 19.3 5.5 0.1 0.6 1.8 0.1 55.5 41.6 3.6 1.1 5.3 4.4 338.6 1.6 0.3 0.3 154.4 5.1 8.7 61.2 1.2 1.0 0.1 0.9 213.3 0.2 0.1 1.8 1.1 2.2 81.9 0.1 2.1 0.7 1.9 9.9 199.7 5.3 0.3 59.7 10.8 0.7 0.8 41.7 1.0 0.7 64.6 8.3 0.5 2.7 2.8 1.5 0.9 1.0 0.0 0.0 1.1 1.7 0.0 0.0 0.0 109.4 0.1 0.4 0.3 0.0 0.3 1.7 0.0 0.0 0.0 0.2 1.1 0.0 0.0 62.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 2.8 0.0 1.0 0.4 21.2 0.3 0.0 0.9 1.3 0.0 0.0 0.0 0.3 1.7 1.9 2.4 0.5 1.6 1.7 6.4 2.0 1.0 4.3 0.8 0.0 0.2 0.3 2.7 0.2 1.3 7.7 1464.7 8.7 1.8 553.8 3.3 9.9 1.8 2.1 1207.2 2.3 2.3 1.9 26.8 2.3 39.7 9.6 3.0 981.5 0.3 1.0 0.1 0.6 0.3 0.3 1.2 1.0 0.1 1.1 0.3 0.8 2.7 1.6 6.4 3.9 0.0 16.4 17.1 0.1 0.5 0.0 0.0 13.2 7.5 0.3 779.2 1.4 29.5 0.0 0.2 7.0 695.4 127.2 26.3 0.1 0.1 0.3 2.3 73.7 4.8 0.1 206.7 0.3 3.2 5.6 0.2 2.5 0.0 0.7 1.9 26.4 0.0 0.1 413.0 0.0 100.8 982.8 0.3 0.6 150.8 24.9 0.0 164.8 0.0 4.1 0.0 0.1 291.6 331.6 0.0 0.9 0.3 2724.7 1764.8 2.1 0.0 0.0 0.3 2.3 0.0 0.4 0.1 12.4 0.3 8.6 0.0 749.3 0.3 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608725-37633564 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 180.7" "Cell type enhanced" "Detected in all" "Late spermatids: 221.2;Spermatocytes: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: AB_2680338, HPA051016: AB_2681312" "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 25.2 49.7 34.5 23.5 36.5 37.5 27.5 36.4 42.6 38.2 37.3 34.5 24.5 32.4 21.7 41.4 37.7 20.6 27.7 33.0 33.0 40.1 42.4 34.0 29.4 38.6 35.2 30.6 46.7 34.8 33.4 53.1 19.2 40.8 40.4 18.0 23.0 35.2 19.8 43.5 35.4 41.0 17.0 35.0 56.1 35.2 180.7 35.9 27.1 45.0 24.8 21.2 31.9 33.7 42.4 37.4 28.3 32.9 31.1 28.0 23.0 35.4 30.8 25.0 27.0 29.6 23.3 21.8 59.9 20.6 22.9 17.0 35.0 29.4 35.6 24.8 51.0 53.6 24.0 52.3 27.3 28.1 56.1 42.6 28.4 31.3 38.9 24.2 45.1 26.5 30.3 48.0 36.8 27.8 37.7 24.8 64.2 26.2 39.2 28.7 28.5 25.8 25.2 28.8 31.0 30.4 54.0 18.7 39.0 48.9 31.3 42.4 42.0 31.0 36.8 35.2 32.1 24.4 81.1 35.3 62.5 39.9 33.6 30.8 8.1 10.7 6.1 18.0 10.2 22.1 8.3 7.2 23.3 6.7 5.0 5.1 16.5 4.5 11.6 7.9 5.8 8.0 11.5 34.5 36.5 36.4 42.6 33.0 33.0 38.6 35.2 30.6 40.8 35.0 35.9 42.4 17.9 25.6 38.5 26.8 50.9 24.2 31.1 36.5 21.1 57.6 26.5 20.8 19.2 20.0 34.5 44.1 83.4 38.8 34.7 67.3 5.9 34.9 148.2 27.6 19.8 32.6 32.4 38.3 18.4 20.1 37.4 18.8 44.4 26.5 49.4 33.3 40.7 20.4 77.1 25.2 19.3 40.4 32.6 66.9 40.3 221.2 26.4 50.5 16.0 20.6 47.9 37.0 73.2 16.6 28.7 36.6 51.6 22.6 24.4 24.7 55.4 13.2 46.7 74.1 26.3 26.9 22.1 193.4 50.4 19.7 28.6 56.8 59.6 44.4 42.8 33.6 HIRA "DGCR1, TUP1, TUPLE1" ENSG00000100084 "Histone cell cycle regulator" P54198 22 19330698-19447450 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 56.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.7;Inhibitory neurons: 51.1;Oligodendrocytes: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 253.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB039243, CAB039244, HPA050714, HPA052902" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984" "unprognostic (1.32e-1)" "unprognostic (1.74e-3)" "unprognostic (2.45e-3)" "unprognostic (1.11e-1)" "unprognostic (4.59e-2)" "unprognostic (2.46e-1)" "unprognostic (2.42e-2)" "unprognostic (2.17e-2)" "unprognostic (2.50e-1)" "prognostic favorable (8.11e-4)" "prognostic favorable (3.97e-4)" "unprognostic (9.05e-2)" "prognostic favorable (5.18e-6)" "unprognostic (4.84e-2)" "unprognostic (8.57e-2)" "unprognostic (6.36e-2)" "unprognostic (1.32e-3)" 11.3 13.0 14.9 10.7 14.7 26.4 10.3 13.8 15.6 9.3 12.4 13.7 14.0 12.4 6.0 12.5 12.3 7.4 11.0 15.3 13.6 13.9 21.9 10.7 14.3 14.6 15.0 14.4 11.3 12.7 22.3 13.3 8.4 13.4 9.4 10.2 7.4 10.0 8.9 23.6 12.6 13.8 9.5 13.0 13.2 14.3 10.2 16.0 20.8 56.6 11.1 11.5 12.3 8.7 14.1 27.0 23.5 32.4 33.7 31.0 20.5 22.5 22.4 25.7 36.1 35.6 53.8 15.4 52.1 10.6 29.0 21.5 30.8 46.4 28.2 23.1 32.1 53.9 48.4 25.5 49.5 33.6 113.1 33.6 24.7 27.1 28.3 27.6 19.4 26.5 51.6 253.1 27.0 20.9 33.7 56.0 40.4 29.6 63.8 23.5 43.7 46.0 15.6 20.9 29.8 47.0 31.2 25.0 25.4 31.7 16.4 16.0 39.0 30.7 24.5 36.0 25.4 26.5 28.4 30.3 53.7 28.7 36.2 20.7 4.8 0.7 3.3 1.3 0.7 1.3 2.4 0.7 1.3 0.9 4.5 0.3 1.0 1.3 2.1 0.4 1.7 0.4 0.8 14.9 14.7 13.8 15.6 15.3 13.6 14.6 15.0 14.4 13.4 13.0 16.0 14.1 7.7 6.4 0.5 29.4 7.4 9.2 2.2 4.4 0.6 7.7 6.4 7.4 2.3 2.8 2.3 5.5 2.1 3.8 12.6 11.7 5.9 5.4 6.2 6.8 8.4 5.6 2.4 19.4 49.7 8.9 3.6 4.7 3.1 7.1 0.0 8.7 7.1 21.1 6.6 16.8 51.1 10.5 4.1 9.1 3.8 2.4 5.0 4.9 10.6 38.4 7.9 5.5 14.4 37.7 45.5 7.9 8.4 6.8 4.5 5.0 8.2 9.9 4.2 4.6 6.6 7.7 6.1 12.9 10.3 4.5 10.5 3.0 6.6 9.2 14.2 2.2 SH3BP1 ARHGAP43 ENSG00000100092 "SH3 domain binding protein 1" Q9Y3L3 22 37634654-37656117 "Metabolic proteins, Predicted intracellular proteins" Phagocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 43.5;HMC-1: 45.4;NB-4: 44.7" "Low region specificity" "Detected in all" HPA000757 Supported Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" "unprognostic (7.81e-3)" "unprognostic (7.91e-3)" "unprognostic (3.42e-1)" "unprognostic (2.62e-2)" "unprognostic (5.38e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.55e-4)" "unprognostic (1.39e-1)" "unprognostic (3.08e-1)" "unprognostic (1.89e-1)" "unprognostic (2.59e-2)" "unprognostic (4.78e-1)" "prognostic unfavorable (3.48e-7)" "prognostic favorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (8.48e-3)" 3.9 3.7 3.0 14.4 3.8 14.5 3.4 3.3 5.9 8.3 2.7 11.7 18.3 3.2 0.7 38.0 4.1 2.1 2.0 3.6 4.8 2.8 2.6 8.9 12.2 4.4 3.4 2.4 3.4 2.9 2.2 2.2 5.1 4.2 7.7 4.6 0.3 9.4 2.0 0.7 25.3 21.0 2.0 5.0 27.2 4.4 5.7 3.9 8.2 2.6 0.5 7.7 10.6 21.2 4.1 20.1 1.0 3.9 3.4 0.9 3.9 28.6 3.8 6.4 6.3 7.0 5.9 2.3 12.6 2.7 2.4 2.0 43.5 2.0 26.0 2.6 36.9 13.7 18.5 0.6 8.6 3.3 25.9 45.4 4.9 6.3 7.9 0.9 5.2 1.0 6.3 6.4 4.8 0.6 12.7 3.0 44.7 7.6 13.7 3.8 15.7 3.2 11.0 0.8 22.2 3.8 10.1 1.0 5.3 17.9 3.9 6.7 22.1 1.3 2.3 10.8 0.5 0.2 29.9 10.2 9.0 3.2 26.4 13.0 1.8 1.4 4.6 1.0 1.8 1.0 0.3 1.1 1.1 0.7 0.1 0.6 1.4 0.9 0.8 3.7 1.2 1.1 0.6 3.0 3.8 3.3 5.9 3.6 4.8 4.4 3.4 2.4 4.2 5.0 3.9 4.1 1.2 0.0 7.2 0.7 23.7 19.1 22.2 42.5 23.3 0.3 3.3 4.1 1.2 4.3 8.0 0.0 2.1 47.5 36.1 55.0 0.0 3.0 0.4 0.6 4.3 1.7 4.2 7.8 5.6 4.7 43.9 6.0 11.2 1.3 14.0 3.4 4.2 0.5 48.3 8.4 0.8 29.9 12.2 33.3 19.0 0.1 5.0 45.6 5.4 2.8 36.0 3.0 53.5 5.0 0.9 2.0 46.8 1.9 20.9 29.6 41.9 0.3 11.4 0.5 0.0 0.9 3.6 3.4 6.0 23.6 15.3 37.5 52.7 5.0 23.6 42.0 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169462-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 64.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 222.1;Inhibitory neurons: 137.7;Oligodendrocyte precursor cells: 586.1" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 5.9;myeloid DC: 5.7;non-classical monocyte: 5.3" "Group enriched" "Detected in many" 58 "dendritic cells: 5.7;monocytes: 5.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 39.9;SH-SY5Y: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles NA NA 6700000 Vesicles "HPA045135: AB_2732518" "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 0.1 10.1 21.3 0.5 39.0 0.2 0.0 9.5 53.0 1.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.1 1.3 64.7 32.8 0.0 0.0 0.2 0.0 23.0 30.6 27.4 0.0 1.5 0.0 5.9 0.0 28.6 0.2 0.2 4.6 0.2 0.1 0.1 0.2 0.4 0.3 3.0 0.2 1.4 0.3 56.1 1.0 0.1 0.0 0.0 0.1 0.1 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 10.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 5.9 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.5 21.3 39.0 9.5 53.0 64.7 32.8 23.0 30.6 27.4 28.6 3.0 56.1 46.8 0.0 0.0 0.0 21.9 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.1 0.2 0.0 0.4 222.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.9 137.7 0.0 0.0 0.0 2.1 2.0 0.6 1.5 0.0 10.3 3.5 0.7 0.0 586.1 5.5 0.6 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 LGALS1 GBP ENSG00000100097 "Galectin 1" P09382 22 37675636-37679802 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 1649.6" "HPA000646, HPA000687, HPA001130, CAB002157" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" No Yes 10000000 20000000 Cytosol Nucleoplasm "CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311" "unprognostic (1.65e-1)" "unprognostic (8.13e-2)" "unprognostic (5.13e-2)" "prognostic favorable (2.36e-5)" "unprognostic (6.38e-2)" "unprognostic (2.67e-3)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.22e-3)" "unprognostic (4.91e-3)" "unprognostic (2.51e-1)" "unprognostic (6.16e-3)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.18e-10)" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.47e-2)" "prognostic unfavorable (5.10e-4)" 1863.0 784.9 478.5 528.5 462.1 327.5 1503.5 565.7 700.7 1801.7 446.6 1234.9 199.5 2289.1 198.5 390.9 1157.1 561.0 1254.3 412.4 596.3 364.9 279.7 928.2 178.2 645.5 504.0 403.7 1452.3 156.8 189.8 256.8 429.6 600.2 910.8 209.1 39.8 400.8 763.4 1184.2 468.5 479.3 1365.4 636.1 464.4 587.6 246.8 531.0 155.3 293.3 698.0 117.8 1068.8 1166.3 792.4 2850.9 1664.3 36.5 1440.9 3314.6 6505.1 32.7 6450.7 7619.4 4761.9 4716.9 189.6 368.3 3.3 649.1 6661.4 1609.2 296.3 58.8 4309.2 1663.3 2917.2 30.9 251.3 1606.3 791.1 2155.3 145.1 3167.7 4031.7 294.2 3785.7 1609.9 4271.1 5325.7 1.7 186.6 1163.4 3771.1 1287.6 5.2 2038.4 14.3 629.6 3914.9 5.4 2388.6 799.7 2000.0 6.4 5.5 843.4 1287.4 224.3 1644.5 66.7 1187.2 1689.0 7122.0 6224.0 3070.2 2788.9 3349.3 701.8 530.6 13.6 7291.9 762.0 2535.9 1086.5 3047.4 110.2 766.5 2320.4 113.6 567.7 694.9 754.2 3653.1 287.5 114.3 478.1 122.2 415.4 2556.7 899.2 1514.7 4667.0 478.5 462.1 565.7 700.7 412.4 596.3 645.5 504.0 403.7 600.2 636.1 531.0 792.4 1505.8 166.7 90.4 12.7 294.3 730.3 144.0 2796.6 49.5 10.0 144.2 477.9 986.3 74.4 213.4 163.7 6.2 88.0 466.5 49.9 17.6 690.2 30.9 183.0 3011.6 1063.6 3.0 74.9 7.5 90.4 1573.3 2540.4 28.1 230.3 540.0 172.2 653.2 614.1 3949.7 8.4 5.4 8.4 339.7 2159.0 4906.5 106.4 975.5 1700.0 2856.6 15.9 7118.4 278.0 588.1 4.0 17.1 233.5 6.1 1300.7 590.9 118.8 0.5 28.7 109.8 45.4 1650.1 1873.6 4703.8 33.8 13.1 18.2 588.0 151.5 767.5 197.2 11.6 57.0 HPS4 "BLOC3S2, KIAA1667, LE" ENSG00000100099 "HPS4 biogenesis of lysosomal organelles complex 3 subunit 2" Q9NQG7 22 26443423-26483837 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 86.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033106, HPA050189" Approved Approved Centrosome NA NA Centrosome "CAB033106: AB_2264349, HPA050189: AB_2681046" "unprognostic (1.55e-2)" "unprognostic (1.02e-1)" "unprognostic (9.82e-2)" "unprognostic (5.30e-3)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (1.83e-3)" "unprognostic (1.59e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (6.46e-2)" 6.7 9.0 9.9 6.6 10.6 10.4 6.8 10.5 10.5 9.1 11.0 6.7 5.5 6.9 7.8 10.0 9.3 6.1 4.2 9.5 10.3 8.7 8.6 6.6 8.5 10.3 10.3 9.2 12.2 12.8 12.2 11.1 5.6 10.7 8.4 5.6 7.7 6.7 7.7 4.7 14.1 7.4 7.2 9.8 9.0 8.2 13.2 10.2 13.1 9.9 5.0 9.7 6.9 8.4 9.9 16.3 7.5 15.5 15.9 11.5 13.6 8.2 9.7 18.8 21.4 19.1 7.9 7.8 15.4 7.5 11.8 12.1 13.2 14.9 21.0 19.3 11.4 15.4 15.6 6.3 13.3 20.5 18.4 17.0 13.3 17.1 19.5 34.5 18.1 14.2 25.5 17.4 19.0 15.7 6.9 31.2 6.2 9.3 15.0 8.0 86.3 18.3 20.4 9.9 10.1 17.6 13.0 9.4 10.6 46.7 11.6 11.5 13.9 8.8 24.8 46.2 12.4 12.2 28.1 23.4 50.5 16.2 11.8 16.3 10.8 3.2 3.1 4.8 2.3 4.5 5.5 3.9 4.1 4.3 4.7 4.5 5.0 1.1 7.2 2.1 5.7 2.8 4.7 9.9 10.6 10.5 10.5 9.5 10.3 10.3 10.3 9.2 10.7 9.8 10.2 9.9 16.6 12.8 32.4 28.7 38.7 12.5 28.3 28.9 17.1 52.6 14.4 12.4 6.3 17.2 25.5 42.3 114.7 21.7 31.7 11.6 17.6 20.4 24.3 16.3 17.2 18.6 26.5 48.1 18.4 27.1 19.4 14.1 28.1 14.1 42.4 40.6 22.5 14.2 24.8 43.7 31.1 20.1 44.7 18.3 12.2 24.3 32.6 19.1 48.0 19.7 14.9 23.7 21.6 32.6 36.4 45.0 13.6 19.9 25.1 29.4 18.0 15.7 28.1 119.3 0.0 16.0 12.2 32.3 46.6 11.1 14.9 20.0 20.6 23.6 21.4 26.9 PIK3IP1 "HGFL, MGC17330, TrIP" ENSG00000100100 "Phosphoinositide-3-kinase interacting protein 1" Q96FE7 22 31281594-31292534 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "T-cells: 143.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive CD4 T-cell: 499.2" "Lineage enriched" "Detected in all" 6 "T-cells: 499.2" "Cell line enhanced" "Detected in many" "RT4: 24.1;SK-BR-3: 26.1;U-698: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes 6800000 "unprognostic (1.02e-1)" "unprognostic (1.97e-3)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-3)" "unprognostic (5.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.99e-1)" "unprognostic (9.95e-3)" "unprognostic (1.28e-2)" "unprognostic (2.65e-3)" "unprognostic (4.42e-2)" "unprognostic (8.68e-2)" "prognostic favorable (3.80e-4)" 41.7 42.1 34.1 59.9 40.9 42.0 39.9 36.9 39.6 20.7 24.5 32.6 17.7 35.1 13.3 21.8 24.3 27.3 35.1 32.2 37.7 27.6 9.4 46.1 110.7 51.8 39.3 31.4 23.0 11.3 17.0 15.3 25.5 45.8 27.3 15.6 11.5 52.8 32.0 21.1 57.5 62.1 23.1 43.4 71.9 25.0 20.5 41.4 68.9 38.0 16.3 80.4 35.0 27.3 54.1 0.5 0.2 0.8 0.1 11.8 20.4 0.9 3.1 9.7 0.2 1.1 0.3 20.4 15.9 11.4 4.9 1.3 13.4 0.1 5.8 0.2 2.6 1.9 0.5 2.3 2.2 4.0 1.1 0.7 20.0 8.3 0.2 0.1 18.9 6.4 2.3 0.9 19.6 1.5 1.3 0.1 2.5 0.9 1.8 0.4 1.2 0.8 11.9 5.1 24.1 1.2 2.6 1.0 26.1 1.2 10.7 2.1 2.3 20.0 0.0 4.5 0.2 0.0 8.9 4.1 34.7 0.5 2.8 0.4 46.0 18.4 16.5 79.7 22.8 95.5 38.2 207.1 113.7 5.9 79.3 499.2 318.3 7.6 59.2 34.2 2.6 257.0 214.7 34.1 40.9 36.9 39.6 32.2 37.7 51.8 39.3 31.4 45.8 43.4 41.4 54.1 26.1 44.8 12.3 17.6 63.7 10.3 19.0 44.6 5.7 29.9 15.5 11.3 11.3 10.0 36.9 31.3 10.4 30.7 89.8 8.3 1.9 50.2 1.6 10.6 10.3 20.9 8.4 12.0 6.5 10.5 3.7 23.8 10.7 24.4 30.4 10.1 32.9 2.0 45.1 6.7 8.6 13.1 32.6 42.5 11.4 3.8 24.5 40.3 12.4 9.4 19.2 82.0 74.2 9.5 25.1 51.7 8.6 30.9 33.1 23.4 19.8 7.9 25.1 9.2 6.6 10.2 14.6 16.5 32.3 4.9 11.5 12.3 143.6 27.4 10.1 60.0 SRRD "HC/HCC, SRR1L" ENSG00000100104 "SRR1 domain containing" Q9UH36 22 26483877-26494658 "Predicted intracellular proteins" "Biological rhythms, Heme biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 49.0;Late spermatids: 54.9;Pancreatic endocrine cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002945 Uncertain Approved Cytosol NA NA Cytosol "HPA002945: AB_1079265" "unprognostic (3.25e-1)" "unprognostic (3.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (9.00e-2)" "unprognostic (8.51e-3)" "unprognostic (2.49e-2)" "unprognostic (4.50e-3)" "unprognostic (3.93e-2)" "unprognostic (2.63e-1)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (1.76e-3)" "unprognostic (2.96e-1)" 5.0 3.6 8.4 4.1 8.8 6.3 6.3 10.4 9.8 5.5 6.4 5.2 3.6 6.4 6.2 5.4 5.5 3.7 7.6 8.6 8.2 6.5 6.9 5.4 5.7 8.1 8.4 8.4 7.1 5.6 6.7 5.1 5.3 8.9 6.9 5.2 5.9 5.0 7.2 19.8 6.1 3.9 7.0 8.0 5.5 4.9 4.9 8.4 5.8 10.6 17.3 7.4 5.6 4.3 8.7 10.7 6.3 10.6 10.9 10.8 6.5 6.1 7.4 10.4 14.7 13.5 6.2 4.6 23.6 5.1 9.7 7.4 9.5 16.6 15.6 14.3 12.2 16.5 10.4 5.5 10.1 7.6 23.1 7.8 6.2 13.4 10.5 16.4 9.7 12.9 13.8 17.2 14.5 9.7 9.2 10.4 7.3 6.6 11.7 7.9 23.3 13.2 17.0 9.7 7.6 11.2 7.6 8.5 7.6 19.7 8.8 9.1 9.0 9.9 11.3 37.2 6.4 13.1 9.5 8.3 19.4 7.7 9.4 15.0 0.3 0.5 0.2 0.7 0.4 1.0 1.1 0.8 1.0 0.5 0.6 1.1 1.2 0.4 0.9 0.4 0.4 0.2 0.3 8.4 8.8 10.4 9.8 8.6 8.2 8.1 8.4 8.4 8.9 8.0 8.4 8.7 12.1 0.0 6.4 3.6 10.6 29.7 16.2 7.5 3.4 13.0 10.0 10.5 3.0 12.8 5.9 1.8 2.1 13.3 5.9 3.7 9.8 24.9 22.4 5.8 10.6 11.2 4.8 46.9 3.1 49.0 22.9 8.9 7.7 8.9 11.4 15.1 11.0 15.4 14.1 13.5 3.0 4.5 2.0 3.8 8.6 54.9 7.2 8.6 8.8 1.0 6.1 9.8 10.3 3.5 1.9 48.9 2.4 9.1 10.4 12.1 3.4 19.9 3.2 9.3 6.6 12.6 10.3 17.8 12.9 7.7 31.8 16.7 9.1 21.7 5.9 14.7 PATZ1 "dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG" ENSG00000100105 "POZ/BTB and AT hook containing zinc finger 1" Q9HBE1 22 31325804-31346346 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047893, HPA048315" Approved Supported Nucleoplasm No No Nucleoplasm "HPA047893: AB_2680201, HPA048315: AB_2680353" "unprognostic (3.25e-1)" "unprognostic (8.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (8.34e-3)" "prognostic favorable (8.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-3)" "unprognostic (1.76e-1)" "prognostic favorable (8.54e-8)" "unprognostic (9.22e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" "prognostic favorable (7.79e-6)" 9.3 10.6 15.1 11.5 17.2 15.9 12.2 16.1 14.8 14.0 10.6 12.8 10.0 18.9 14.3 6.2 22.4 9.3 10.9 13.7 15.5 10.4 11.9 11.3 20.4 17.5 16.0 13.0 27.5 13.6 21.2 10.5 9.3 16.4 13.2 6.9 15.0 18.8 17.2 10.6 7.6 12.8 12.3 16.6 15.9 11.2 8.1 15.4 24.2 19.5 8.6 15.0 15.8 9.8 20.1 19.0 23.3 46.7 27.7 12.1 11.1 24.5 5.7 14.2 22.6 20.6 16.5 17.7 40.1 20.1 10.6 7.9 14.5 32.0 17.3 11.5 23.7 29.5 16.9 16.7 33.8 19.7 57.4 21.9 17.4 20.5 14.4 16.0 17.8 18.0 19.4 7.3 15.7 14.6 57.7 37.1 39.3 31.4 34.4 27.1 61.9 19.9 13.3 15.3 39.4 60.8 48.7 14.2 17.1 31.4 15.4 33.8 36.2 12.8 15.1 28.3 9.5 19.5 20.3 14.4 36.5 6.3 7.5 26.3 0.0 1.0 2.8 1.8 0.6 1.8 2.5 1.3 2.3 1.4 1.8 2.9 2.2 0.4 2.1 0.3 4.0 2.2 1.2 15.1 17.2 16.1 14.8 13.7 15.5 17.5 16.0 13.0 16.4 16.6 15.4 20.1 6.6 3.2 14.9 11.4 12.8 1.7 7.1 7.6 8.0 16.8 22.0 16.0 13.7 17.2 11.7 20.2 8.4 5.2 17.0 3.3 19.6 14.3 0.6 14.9 8.8 7.6 20.4 8.0 2.4 6.2 2.0 6.4 5.6 16.7 6.3 19.3 7.1 16.2 9.4 21.9 5.0 9.7 20.3 8.1 2.6 1.7 9.6 6.6 3.6 7.5 7.7 14.4 12.3 11.1 8.8 6.4 6.0 8.6 5.5 7.4 5.0 7.1 10.5 14.3 6.6 7.1 8.5 0.7 8.1 2.3 1.6 0.8 10.4 8.4 11.8 7.3 TRIOBP "DFNB28, HRIHFB2122, KIAA1662, TAP68, Tara" ENSG00000100106 "TRIO and F-actin binding protein" Q9H2D6 22 37697048-37776556 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003747, HPA019769" Enhanced NA NA "HPA003747: AB_1858328, HPA019769: AB_1858329" "unprognostic (2.94e-1)" "prognostic favorable (4.29e-4)" "unprognostic (2.79e-1)" "unprognostic (4.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.44e-3)" "unprognostic (3.77e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-2)" "unprognostic (5.56e-2)" "unprognostic (2.40e-1)" "unprognostic (1.99e-1)" "unprognostic (4.38e-3)" "unprognostic (1.31e-1)" "unprognostic (2.81e-1)" "unprognostic (3.20e-2)" "unprognostic (1.67e-2)" 55.5 46.9 14.6 27.6 13.8 25.9 51.2 13.1 15.1 72.2 20.0 64.2 24.1 72.4 12.9 79.2 66.7 28.0 70.9 10.4 13.3 37.4 21.8 52.1 17.6 17.3 15.1 8.2 56.1 33.0 31.4 17.0 44.6 18.2 45.7 17.2 4.8 44.7 33.6 24.5 32.1 38.3 31.3 14.6 53.5 54.0 26.3 16.1 16.9 48.6 14.4 12.6 67.0 66.2 17.4 65.9 53.1 33.2 26.4 73.1 118.1 47.5 113.0 111.9 57.7 42.1 11.8 44.8 24.5 30.4 69.6 31.6 52.7 9.2 63.7 18.1 39.6 29.1 6.8 41.6 22.4 75.5 32.1 28.9 47.1 29.8 52.0 24.5 125.3 71.9 20.6 6.4 34.6 45.5 39.3 14.4 23.1 20.2 65.4 63.2 25.1 23.9 17.2 41.0 52.8 16.2 25.4 50.9 46.5 59.7 32.8 25.4 23.0 151.9 87.2 38.6 60.6 27.0 30.4 9.1 15.4 82.7 13.0 104.3 7.7 7.6 12.2 1.8 7.5 0.6 1.3 1.5 1.8 4.1 2.4 1.2 1.8 18.2 1.9 12.5 1.9 2.5 2.0 14.6 13.8 13.1 15.1 10.4 13.3 17.3 15.1 8.2 18.2 14.6 16.1 17.4 102.0 19.2 29.7 17.9 10.7 6.2 48.3 18.3 18.8 22.8 40.1 45.1 65.2 62.9 23.3 58.8 2.1 105.7 14.7 63.8 15.6 42.7 30.3 32.6 107.0 91.6 22.9 28.2 4.7 51.6 34.2 65.5 58.1 34.2 6.3 128.1 124.6 17.1 42.7 16.8 4.6 52.1 6.1 56.0 7.5 10.6 113.1 31.2 14.2 27.2 32.0 29.6 8.2 7.5 14.0 62.8 46.9 92.2 9.5 41.9 24.8 15.8 23.9 7.3 52.6 17.7 31.8 49.8 23.4 57.2 6.1 116.0 12.7 22.5 40.6 57.9 TFIP11 "DKFZP434B194, Spp382, TIP39" ENSG00000100109 "Tuftelin interacting protein 11" Q9UBB9 22 26491225-26512505 "Plasma proteins, Predicted intracellular proteins" "Biomineralization, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027085 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027085: AB_1857964" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (4.87e-2)" "unprognostic (9.14e-2)" "unprognostic (3.24e-2)" "unprognostic (3.86e-2)" "unprognostic (6.28e-2)" "unprognostic (2.63e-1)" "unprognostic (1.76e-1)" "unprognostic (3.01e-1)" "unprognostic (4.38e-2)" "unprognostic (2.34e-1)" "unprognostic (2.96e-3)" "unprognostic (1.46e-2)" "unprognostic (9.24e-2)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" 13.6 13.1 11.7 16.5 12.4 63.4 12.7 14.9 13.3 11.6 11.5 12.8 13.0 12.5 10.5 14.9 13.2 12.7 16.1 12.2 11.7 14.1 19.5 14.1 25.1 11.2 11.5 11.6 12.5 16.8 13.1 10.5 14.6 12.3 12.5 12.7 13.5 11.1 10.7 42.2 20.4 13.6 13.2 10.9 17.9 12.0 26.8 12.1 20.3 16.3 21.7 24.9 14.9 10.9 13.6 22.9 26.4 22.3 24.6 34.7 20.6 21.5 26.4 34.5 41.8 39.1 19.8 16.1 44.4 16.6 33.9 27.6 32.8 32.1 26.3 30.3 32.3 30.4 27.4 16.4 20.2 31.4 63.6 33.2 25.9 34.9 40.0 30.9 22.3 32.6 22.4 37.4 38.9 28.2 28.2 29.2 33.8 21.4 32.2 21.9 43.6 34.6 38.8 24.2 22.4 16.7 24.0 31.9 22.7 32.8 21.4 18.7 27.7 31.6 35.2 56.8 22.4 25.6 29.8 41.8 86.6 27.8 24.6 26.8 68.7 28.4 50.1 37.2 31.3 35.1 37.9 33.0 35.2 26.1 42.9 30.9 28.4 44.9 36.3 44.1 16.4 44.5 33.0 11.7 12.4 14.9 13.3 12.2 11.7 11.2 11.5 11.6 12.3 10.9 12.1 13.6 11.3 9.6 9.7 11.4 17.8 16.8 11.2 13.2 22.2 9.7 7.5 6.3 3.5 17.2 12.3 12.9 8.4 17.9 20.7 14.8 13.7 15.1 67.9 12.2 9.2 13.3 16.2 20.2 7.1 20.7 14.4 7.8 9.2 12.6 8.2 11.9 13.2 10.8 13.3 15.2 7.2 11.2 6.1 6.2 7.8 12.3 11.1 10.4 7.2 4.7 12.3 7.7 19.6 6.0 6.5 25.3 8.4 9.8 18.6 7.6 11.4 9.3 14.1 6.9 0.0 10.1 10.6 43.6 19.4 14.2 16.8 19.4 17.4 11.6 10.7 10.9 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 141.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 6.1 15.9 22.8 3.2 22.1 14.3 6.6 23.3 33.5 6.3 19.1 7.3 5.0 7.9 3.0 17.2 6.1 5.1 31.0 23.4 22.0 13.0 53.7 5.7 2.8 23.2 23.8 22.5 9.1 141.4 6.0 9.8 2.8 24.6 23.0 4.9 2.3 13.4 6.9 19.7 8.1 5.5 4.2 21.3 1.5 13.3 10.4 24.4 4.4 16.2 19.3 3.1 7.2 7.0 22.8 18.7 4.7 11.9 68.2 24.0 19.4 8.4 25.9 26.9 19.2 16.3 10.5 2.1 5.8 11.8 11.7 11.3 10.6 11.9 18.3 4.3 2.6 21.9 12.9 15.0 42.5 39.0 23.0 16.4 22.8 10.9 12.7 27.7 6.2 16.0 23.0 33.2 6.6 9.2 16.2 24.3 42.3 5.0 28.8 19.0 25.2 2.5 34.4 24.6 14.3 24.5 16.7 20.0 32.3 13.9 4.2 25.8 11.1 11.8 19.3 10.6 12.9 9.2 21.9 11.5 12.1 13.3 21.1 20.5 0.1 0.6 0.4 0.7 0.7 0.3 0.1 1.6 0.5 1.3 0.0 3.5 1.4 0.3 1.3 0.4 1.3 1.7 1.4 22.8 22.1 23.3 33.5 23.4 22.0 23.2 23.8 22.5 24.6 21.3 24.4 22.8 3.5 6.4 15.4 9.8 2.8 7.8 18.5 11.2 12.5 8.9 18.6 17.4 54.6 11.5 9.4 11.0 4.2 15.7 0.7 13.1 80.3 7.2 4.1 9.9 8.1 5.5 2.4 22.7 5.0 10.3 19.6 9.8 15.3 16.7 8.9 17.6 5.0 66.1 4.7 8.4 4.7 32.3 8.2 2.9 1.3 7.7 3.7 2.1 21.4 1.0 1.0 25.1 1.0 6.6 4.1 5.4 8.7 9.8 2.0 19.1 8.6 163.8 6.4 2.2 6.6 4.8 30.1 12.6 33.2 19.6 6.0 27.8 3.0 27.8 24.0 14.4 GGTLC2 GGTL4 ENSG00000100121 "Gamma-glutamyltransferase light chain 2" Q14390 22 22644475-22647903 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 18.2" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 22.4;Early spermatids: 24.6;Late spermatids: 28.4;Spermatocytes: 14.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.6;U-2 OS: 3.3" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (2.58e-2)" "unprognostic (2.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.96e-1)" "unprognostic (4.31e-1)" "unprognostic (1.57e-2)" "unprognostic (1.06e-3)" "unprognostic (1.48e-2)" "unprognostic (1.55e-1)" 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.2 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 18.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 3.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.2 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.4 0.0 22.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 24.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYBB1 ENSG00000100122 "Crystallin beta B1" P53674 22 26599278-26618027 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 9.7" "Cell type enriched" "Detected in some" 21 "Hofbauer cells: 82.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 10.3;non-classical monocyte: 7.5" "Lineage enriched" "Detected in many" 7 "monocytes: 10.3" "Group enriched" "Detected in some" 5 "Karpas-707: 43.3;RPMI-8226: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003448, CAB010058" Supported NA NA 89000 "CAB010058: AB_668166, HPA003448: AB_2732396" "unprognostic (1.31e-1)" "unprognostic (5.56e-3)" "unprognostic (1.39e-2)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (7.89e-3)" "unprognostic (1.51e-1)" "unprognostic (9.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-4)" "unprognostic (2.62e-2)" "unprognostic (1.23e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-2)" 1.3 1.6 1.4 0.9 1.5 0.6 0.6 1.5 2.5 0.6 1.3 0.5 0.4 0.3 9.7 0.4 0.4 1.2 0.4 1.5 2.1 0.2 0.4 0.5 1.2 2.0 1.7 1.3 0.2 0.2 0.3 0.5 3.3 2.3 0.2 0.4 0.0 0.4 0.2 0.1 0.1 0.4 0.9 1.8 1.6 0.3 0.3 1.9 0.4 0.2 0.2 0.5 1.1 0.2 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.5 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 43.3 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 0.0 82.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.2 0.5 0.0 0.0 0.7 0.2 1.8 0.0 2.2 0.0 0.0 1.0 0.0 0.0 10.3 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.5 7.5 0.0 0.0 0.6 1.4 1.5 1.5 2.5 1.5 2.1 2.0 1.7 1.3 2.3 1.8 1.9 2.0 0.1 0.0 0.0 0.7 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.1 1.3 0.0 0.0 0.2 82.6 0.0 0.2 0.0 0.0 3.5 0.8 0.6 0.0 2.8 1.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.2 0.0 0.0 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody Yes No "Microtubules, Midbody" Nucleoplasm "HPA071287: AB_2686380" "unprognostic (5.36e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favorable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favorable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 8.5 18.9 22.9 6.0 21.1 7.0 9.2 22.4 23.5 12.5 26.7 14.4 7.2 13.0 7.9 14.2 24.0 6.4 10.5 23.3 25.4 14.6 15.7 8.4 6.5 22.4 23.3 21.6 18.0 18.3 11.8 19.4 5.5 23.1 13.8 6.6 6.3 14.1 11.1 12.7 11.3 8.9 9.5 22.5 9.2 11.0 31.1 24.7 10.5 13.9 8.8 7.3 14.1 11.0 20.8 18.5 18.6 15.4 23.0 19.9 11.3 8.1 24.8 19.2 41.1 25.2 11.8 7.3 17.8 10.1 16.5 13.3 16.4 19.5 14.1 19.9 14.2 39.5 9.3 17.3 28.3 17.7 17.8 20.8 10.1 14.2 22.6 13.3 10.3 25.5 13.1 11.9 12.7 19.1 19.8 17.6 21.1 4.4 24.5 16.5 20.2 18.3 11.3 23.2 6.4 26.4 14.1 20.7 18.8 30.8 7.0 19.3 28.0 15.1 24.5 25.6 12.9 18.6 13.3 11.7 14.3 20.1 15.1 17.9 3.5 4.5 2.2 5.4 5.5 5.4 3.9 5.1 4.0 5.7 5.2 5.3 2.6 2.7 10.2 9.3 5.3 2.4 3.3 22.9 21.1 22.4 23.5 23.3 25.4 22.4 23.3 21.6 23.1 22.5 24.7 20.8 8.4 12.8 14.5 11.8 14.4 15.8 11.0 12.4 12.0 18.3 16.9 15.6 8.1 24.3 12.2 18.4 29.2 20.9 14.0 19.9 39.2 17.1 6.4 47.8 12.6 10.9 9.0 12.8 9.4 14.7 17.7 12.3 12.2 8.5 9.5 23.3 13.6 12.0 13.2 26.9 9.4 14.3 12.2 12.5 10.7 7.7 18.0 8.8 10.6 2.8 9.2 18.5 17.5 13.6 8.6 11.3 15.3 21.4 8.4 11.4 19.2 22.0 48.2 23.2 6.6 13.1 13.4 65.6 42.1 12.7 17.6 16.8 13.3 25.4 20.7 9.9 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli NA NA 72000 Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favorable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 96.9 80.7 26.9 37.4 27.0 87.0 150.9 29.6 33.9 110.6 27.1 97.7 57.4 85.8 42.3 84.6 101.2 21.3 74.8 27.5 26.6 100.6 64.9 57.4 52.5 26.9 27.0 27.5 201.9 260.1 37.0 64.5 53.2 27.4 72.1 64.0 27.1 92.9 79.0 163.4 121.6 74.0 42.6 26.9 58.0 145.0 35.1 27.3 44.7 88.1 43.5 82.8 90.9 87.5 28.2 74.9 44.1 113.7 83.4 107.4 238.0 81.5 69.4 165.4 109.1 147.5 71.6 53.5 253.7 19.2 81.5 38.3 46.1 127.2 96.0 127.1 34.1 211.2 90.0 56.6 33.4 66.9 240.5 73.6 128.8 106.9 81.7 120.7 189.5 138.1 82.4 75.5 67.6 127.4 30.2 65.5 112.0 65.5 90.0 106.7 73.1 156.0 76.0 82.2 44.3 82.4 129.1 68.9 80.1 88.7 127.6 60.7 95.4 67.4 68.3 81.6 42.1 57.1 40.5 68.3 97.0 64.0 103.9 57.1 46.5 162.0 42.4 81.4 148.1 134.2 131.7 116.9 98.2 241.1 113.1 161.8 125.5 22.8 111.3 129.4 116.9 124.2 299.1 26.9 27.0 29.6 33.9 27.5 26.6 26.9 27.0 27.5 27.4 26.9 27.3 28.2 128.9 118.6 210.9 16.6 299.0 397.0 491.6 449.3 278.9 61.3 366.9 299.8 2.5 217.3 238.0 66.2 29.2 699.0 255.0 77.5 416.7 234.3 137.6 94.8 159.4 171.1 197.3 277.2 18.9 461.8 628.9 166.1 101.9 108.3 222.3 318.1 183.1 116.1 256.6 25.2 23.2 236.3 187.2 299.7 418.0 341.2 222.4 229.8 227.7 11.2 447.0 149.1 216.3 11.6 19.3 212.4 211.4 212.1 170.5 306.2 180.7 328.2 90.2 51.1 164.3 278.3 267.4 121.9 128.5 301.9 429.6 703.2 221.6 239.9 378.4 435.0 SNU13 "15.5K, FA-1, NHP2L1, SNRNP15-5, SPAG12, SSFA1" ENSG00000100138 "Small nuclear ribonucleoprotein 13" P55769 22 41673933-41690504 "Predicted intracellular proteins, Ribosomal proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 1057.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA029199 Uncertain NA NA 28000 "HPA029199: AB_10601041" "unprognostic (3.02e-1)" "unprognostic (4.82e-2)" "unprognostic (8.58e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-1)" "unprognostic (4.54e-2)" "unprognostic (1.94e-3)" "unprognostic (2.43e-1)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (3.46e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (6.78e-2)" "unprognostic (1.43e-1)" 65.5 126.8 154.0 75.2 160.7 136.9 81.5 148.4 161.0 82.5 138.3 78.5 65.5 65.2 99.9 66.1 92.0 56.2 146.4 157.3 181.7 76.4 65.7 62.4 98.2 160.6 162.6 155.5 97.5 75.4 114.6 53.1 68.1 169.3 66.4 74.2 86.3 75.4 71.6 188.9 73.9 56.6 72.0 153.6 71.8 66.9 95.7 171.3 99.1 91.0 179.6 109.3 89.6 34.3 189.9 222.8 100.2 151.8 203.7 192.7 173.5 160.1 212.6 181.4 303.0 259.6 215.1 195.0 148.6 165.5 183.6 91.6 160.3 183.6 239.0 205.5 178.1 428.0 163.0 191.1 313.1 249.5 345.3 217.9 157.7 247.0 226.6 330.2 142.1 175.2 161.2 227.3 244.8 200.6 262.7 238.0 369.7 215.6 852.4 240.8 252.7 126.7 505.5 279.6 128.9 135.9 125.0 102.4 249.4 333.7 160.6 116.8 218.1 125.1 152.6 175.3 191.0 166.8 273.7 366.5 353.6 206.9 195.5 218.1 205.5 224.8 210.8 210.5 233.3 225.3 357.4 252.0 226.6 240.3 311.2 266.1 247.4 67.5 205.3 208.5 288.2 346.2 339.9 154.0 160.7 148.4 161.0 157.3 181.7 160.6 162.6 155.5 169.3 153.6 171.3 189.9 217.9 80.1 121.9 0.0 265.1 0.0 390.5 0.0 196.9 160.1 224.4 272.3 0.0 190.1 65.0 185.8 25.0 367.3 205.8 42.1 655.4 310.0 1057.6 223.4 169.0 198.0 70.4 144.7 0.0 302.3 438.5 172.4 125.4 251.9 77.0 162.3 181.3 205.0 293.1 109.4 0.0 118.9 0.0 140.1 0.0 318.4 211.9 162.9 0.0 0.0 186.3 181.8 151.4 0.0 0.0 340.9 127.7 174.2 261.9 630.5 202.2 462.5 68.5 128.4 138.1 169.0 143.0 505.9 279.5 219.8 0.0 460.5 208.0 193.8 139.5 505.0 MICALL1 "KIAA1668, MICAL-L1, MIRAB13" ENSG00000100139 "MICAL like 1" Q8N3F8 22 37905657-37942822 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "hTCEpi: 101.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043480, HPA051956" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions, Centriolar satellite, Cytosol" "HPA043480: AB_10793950, HPA051956: AB_2681671" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (4.94e-2)" "unprognostic (4.90e-1)" "unprognostic (1.57e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.08e-6)" "unprognostic (3.46e-2)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-3)" "unprognostic (6.61e-2)" "unprognostic (8.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" 8.9 5.8 8.3 9.4 13.5 6.2 10.3 14.1 7.3 15.5 6.7 28.9 6.4 28.6 3.2 47.0 13.7 6.5 8.4 7.5 9.9 8.4 7.0 11.8 6.0 17.0 16.0 2.4 4.9 18.7 10.7 4.4 17.5 15.9 17.2 4.6 0.8 18.0 24.2 10.9 35.5 12.6 19.8 14.8 7.2 44.3 10.9 13.6 5.5 10.1 5.3 7.2 25.6 26.3 21.2 25.4 13.7 13.0 15.4 10.4 11.9 59.9 32.3 17.5 34.8 25.3 17.3 13.1 10.8 10.5 22.2 22.7 65.0 9.1 69.9 17.2 21.2 31.3 5.7 11.6 16.7 24.0 11.6 11.8 11.3 101.2 42.5 70.1 10.4 22.1 4.9 8.9 8.1 22.7 10.6 2.9 6.7 5.0 12.9 12.1 16.6 27.4 6.1 8.1 53.0 9.6 8.5 19.3 19.7 20.2 15.4 10.8 10.9 34.3 61.1 47.3 37.8 27.5 9.4 3.7 7.2 55.2 5.8 29.0 0.1 0.2 0.1 0.4 0.2 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.2 0.5 0.5 0.1 0.6 0.1 0.4 8.3 13.5 14.1 7.3 7.5 9.9 17.0 16.0 2.4 15.9 14.8 13.6 21.2 10.9 0.0 7.8 1.3 4.8 7.5 10.1 12.8 23.9 0.7 7.3 7.9 11.9 7.2 9.5 5.5 0.0 31.0 7.8 7.7 1.9 10.5 18.1 11.3 5.4 12.2 3.5 1.3 0.7 10.2 26.3 4.3 27.5 6.8 1.3 5.8 6.4 5.9 8.7 5.0 4.4 3.9 6.1 4.4 3.4 28.8 1.8 4.3 1.8 1.0 7.2 0.7 7.2 2.5 17.8 15.4 2.2 4.1 6.4 13.6 4.4 2.7 6.0 0.7 0.0 3.5 9.4 5.5 2.2 27.2 9.1 39.4 5.2 1.5 3.7 15.2 POLR2F "HRBP14.4, RPB6" ENSG00000100142 "RNA polymerase II, I and III subunit F" P61218 22 37952607-38041915 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in single" 4 "melanoma: 1.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000827, CAB009882" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB009882: AB_2299942, HPA000827: AB_1079834" "unprognostic (8.27e-2)" "unprognostic (7.50e-2)" "unprognostic (1.51e-3)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (2.73e-3)" "unprognostic (2.85e-1)" "unprognostic (5.87e-2)" "unprognostic (4.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.11e-4)" "unprognostic (9.08e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-1)" "unprognostic (7.86e-2)" 49.3 61.6 68.0 34.9 82.3 39.2 51.3 68.9 90.9 59.7 51.4 59.0 38.0 53.7 25.0 59.2 50.7 19.6 82.1 65.1 74.1 58.6 119.6 42.0 31.3 76.8 76.7 57.4 61.4 47.9 77.2 63.1 30.5 86.0 48.1 29.0 16.9 56.6 40.0 112.1 45.6 42.6 29.1 70.0 36.7 58.1 49.1 74.9 37.0 55.1 69.0 26.6 53.6 53.2 117.8 150.7 176.2 120.6 128.7 141.1 81.7 109.4 138.0 81.0 141.4 130.5 210.0 51.8 117.4 99.1 120.3 138.3 106.4 166.9 135.7 67.1 143.0 303.7 107.3 181.3 289.1 125.9 213.6 67.0 112.4 99.8 186.3 72.1 71.2 118.7 130.4 208.9 93.7 101.9 220.2 168.4 258.2 174.3 175.4 134.7 162.3 110.4 134.5 77.4 94.8 180.6 67.2 129.5 88.9 215.3 69.6 62.9 144.3 110.5 119.8 173.9 150.4 158.1 106.0 178.0 247.9 122.4 107.9 138.4 118.9 92.9 140.8 83.8 90.4 78.5 95.8 71.9 81.8 86.3 71.3 63.1 63.7 122.8 113.7 78.5 123.3 103.4 85.3 68.0 82.3 68.9 90.9 65.1 74.1 76.8 76.7 57.4 86.0 70.0 74.9 117.8 82.6 38.5 85.9 9.4 73.2 204.3 113.9 205.4 63.7 26.7 133.8 168.7 0.3 101.5 122.5 121.4 25.0 243.5 70.5 148.7 193.7 160.0 117.0 96.0 117.2 94.8 117.2 109.6 9.9 159.5 303.4 97.4 58.1 82.4 90.0 90.0 98.6 304.4 178.5 28.6 10.7 143.1 116.0 94.2 102.9 42.0 159.7 65.9 225.9 2.8 102.3 99.4 111.2 9.5 99.0 182.4 152.9 151.2 65.7 137.3 196.6 306.5 114.3 33.3 157.8 90.1 197.1 237.0 241.0 106.0 224.3 211.9 82.4 82.7 145.7 121.2 SOX10 "DOM, WS2E, WS4" ENSG00000100146 "SRY-box transcription factor 10" P56693 22 37970686-37987422 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease variant, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 192.4;salivary gland: 115.3" "Group enriched" "Detected in some" 14 "Breast glandular cells: 32.3;Breast myoepithelial cells: 47.8;Melanocytes: 35.6;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 510 "SK-MEL-30: 313.9;WM-115: 432.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003171, HPA068898" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB003171: AB_2195374, HPA068898: AB_2686054" 2.2 2.7 79.5 2.5 118.9 0.1 21.9 94.9 90.4 10.3 22.6 19.5 1.5 0.8 1.3 2.7 2.5 2.2 6.0 73.3 84.8 0.4 0.5 0.1 0.0 117.1 110.2 56.1 1.3 0.8 0.0 1.8 0.0 120.4 6.9 2.6 0.5 115.3 5.9 0.6 17.0 7.1 1.9 93.0 0.3 6.2 2.7 100.7 0.0 0.9 1.6 0.0 8.5 9.5 192.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.9 0.0 0.1 0.4 0.0 0.2 0.2 0.0 0.2 0.0 0.3 0.1 0.7 0.0 432.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.5 118.9 94.9 90.4 73.3 84.8 117.1 110.2 56.1 120.4 93.0 100.7 192.4 0.3 0.0 0.0 0.0 0.1 3.2 0.1 0.0 0.0 0.0 32.3 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.4 0.9 0.1 35.6 0.0 0.0 0.0 0.0 61.3 59.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 CCDC134 FLJ22349 ENSG00000100147 "Coiled-coil domain containing 134" Q9H6E4 22 41800679-41832164 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003936 Approved "Secreted to blood" NA NA "HPA003936: AB_1078419" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-2)" "prognostic favorable (4.09e-4)" "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "prognostic unfavorable (7.42e-7)" "unprognostic (4.35e-1)" "unprognostic (1.69e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.24e-3)" "unprognostic (2.52e-2)" "unprognostic (5.47e-1)" "unprognostic (6.63e-2)" 1.3 10.2 2.0 3.7 2.5 12.7 2.7 8.5 2.3 2.0 1.9 2.7 3.3 1.8 10.6 2.7 3.6 1.3 2.2 1.9 1.6 2.9 2.7 2.4 4.0 2.8 3.0 1.7 2.2 3.7 5.0 1.6 2.7 4.2 2.6 2.8 5.9 4.3 2.6 2.8 4.6 3.6 1.8 1.8 2.9 4.3 6.1 3.2 3.7 2.5 2.3 4.7 1.6 1.5 3.2 8.6 6.4 7.3 11.0 4.4 1.3 5.9 7.1 3.8 9.4 11.2 9.7 5.4 8.6 12.1 5.0 7.2 9.5 7.7 5.6 7.0 7.5 11.2 7.5 19.4 7.1 2.3 10.8 8.7 2.2 2.5 11.6 2.5 4.3 4.4 7.5 4.5 16.1 6.1 5.8 7.0 7.3 4.9 11.5 5.4 12.6 11.6 11.0 7.7 7.1 3.6 3.2 13.8 10.3 5.3 4.1 12.6 5.5 3.6 7.5 11.6 4.5 12.0 18.3 11.9 6.8 7.2 6.6 12.2 1.1 3.3 6.9 4.1 5.1 2.9 3.8 2.6 3.5 1.5 2.5 4.7 3.3 1.9 3.6 5.2 1.6 5.2 2.2 2.0 2.5 8.5 2.3 1.9 1.6 2.8 3.0 1.7 4.2 1.8 3.2 3.2 1.0 3.2 2.0 6.8 2.5 0.3 1.5 2.4 0.6 1.1 2.1 1.5 0.8 2.8 1.5 3.7 2.1 4.0 3.0 3.3 0.0 5.0 0.8 3.5 1.3 1.7 0.0 2.5 6.0 1.9 18.2 1.7 3.6 2.5 0.0 2.1 0.4 1.6 4.3 0.0 6.4 2.0 0.0 1.0 0.7 0.9 0.6 1.7 1.8 10.3 4.1 0.7 2.1 9.0 5.8 2.6 1.9 0.4 7.9 1.8 3.5 1.4 2.6 2.3 0.0 1.7 2.1 3.7 1.3 1.8 0.0 2.9 2.1 3.3 3.1 1.6 DEPDC5 "DEP.5, KIAA0645" ENSG00000100150 "DEP domain containing 5, GATOR1 subcomplex subunit" O75140 22 31753867-31908033 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 31.9;Inhibitory neurons: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 34.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 34.8" "Cell line enhanced" "Detected in all" "U-698: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054969, HPA055619" Uncertain NA NA "HPA054969: AB_2682655, HPA055619: AB_2682864" "unprognostic (5.68e-2)" "unprognostic (1.16e-2)" "unprognostic (8.98e-3)" "unprognostic (8.83e-2)" "unprognostic (5.60e-2)" "unprognostic (7.87e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" "unprognostic (4.59e-3)" "unprognostic (6.64e-2)" "prognostic favorable (2.46e-5)" "unprognostic (5.66e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "prognostic favorable (4.86e-5)" 5.9 7.8 6.4 5.2 6.6 4.4 5.6 8.7 10.9 7.3 5.8 6.9 3.0 6.0 3.5 7.2 6.6 3.5 4.8 6.6 5.9 5.6 9.9 5.3 6.4 6.1 6.1 6.1 11.4 4.2 4.9 6.2 3.7 6.6 5.6 5.3 4.1 6.0 3.1 5.9 6.4 8.6 3.8 5.3 9.5 6.2 7.4 6.1 5.0 5.7 3.9 9.7 6.6 7.1 8.7 5.7 5.0 9.1 5.7 4.5 4.7 7.4 3.9 6.4 5.1 6.8 6.8 3.4 13.0 1.5 5.5 4.1 5.8 6.3 6.3 9.1 6.7 5.8 6.1 6.1 6.7 4.4 20.6 19.0 5.2 3.2 9.6 4.8 4.3 9.3 4.8 4.3 3.9 7.3 5.5 5.8 5.8 4.6 9.9 2.1 11.2 10.0 7.4 6.0 12.0 6.0 6.7 7.8 4.2 5.2 6.6 4.4 11.5 8.0 5.0 6.0 5.2 3.8 5.8 5.7 31.5 5.5 6.0 5.1 34.8 2.9 15.2 2.6 3.4 3.0 6.8 1.9 1.5 2.5 4.2 3.0 3.8 1.8 4.2 3.7 1.8 2.3 1.3 6.4 6.6 8.7 10.9 6.6 5.9 6.1 6.1 6.1 6.6 5.3 6.1 8.7 4.7 0.0 3.9 20.5 12.0 2.7 1.8 3.0 5.2 4.9 4.5 2.9 4.3 2.8 5.5 7.3 2.1 3.8 4.5 10.4 3.9 5.1 1.3 4.2 6.1 5.1 13.2 2.1 31.9 4.9 3.1 4.3 6.6 6.5 5.7 18.2 4.2 4.9 3.5 16.8 29.6 6.2 6.1 3.1 2.2 2.2 1.8 6.9 3.6 24.4 3.9 4.2 5.2 23.1 24.3 4.7 5.6 2.6 4.4 1.6 4.7 2.8 5.2 5.6 6.6 3.1 3.1 4.8 5.2 4.3 2.3 2.3 5.3 11.4 5.0 1.8 PICK1 "dJ1039K5, MGC15204, PRKCABP" ENSG00000100151 "Protein interacting with PRKCA 1" Q9NRD5 22 38056311-38075701 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 116.1;Late spermatids: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000819, HPA072674" Approved Supported Cytosol NA NA Cytosol "HPA000819: , HPA072674: AB_2686547" "unprognostic (1.97e-2)" "unprognostic (4.61e-3)" "unprognostic (7.79e-2)" "unprognostic (9.26e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-1)" "unprognostic (6.04e-2)" "unprognostic (1.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "unprognostic (1.68e-3)" "unprognostic (1.20e-1)" "unprognostic (8.56e-2)" "prognostic favorable (5.26e-5)" "unprognostic (1.36e-1)" "unprognostic (2.74e-1)" "unprognostic (4.61e-3)" 7.8 15.0 12.6 4.8 15.5 5.4 13.6 12.7 20.5 9.5 12.6 12.1 10.2 11.8 13.9 16.0 16.5 9.0 17.0 15.1 15.7 15.2 17.6 10.9 5.4 16.3 14.9 13.6 15.5 18.7 29.5 29.0 6.7 20.9 25.8 12.3 6.0 18.7 12.7 26.6 16.1 11.4 11.4 12.4 10.1 16.3 27.6 14.7 6.0 14.7 16.3 8.3 9.4 12.1 23.4 19.5 13.7 7.6 10.0 5.3 4.1 11.3 10.7 12.8 22.5 22.7 14.6 12.0 8.6 11.6 13.0 17.0 20.8 21.0 43.2 19.3 5.3 33.6 3.1 16.8 17.1 19.3 10.1 20.4 13.3 24.9 14.8 21.9 22.8 8.8 11.1 6.4 6.2 4.7 12.4 6.0 0.9 12.1 44.3 14.9 5.1 0.3 7.8 25.8 31.1 31.5 16.0 12.0 28.8 11.1 11.1 16.8 7.3 2.4 6.4 12.0 8.6 6.4 13.9 3.4 2.7 13.8 3.4 9.4 0.0 0.9 0.0 0.5 0.4 0.2 0.3 0.5 1.0 1.6 1.1 1.0 0.5 0.6 0.4 0.5 0.3 0.7 0.6 12.6 15.5 12.7 20.5 15.1 15.7 16.3 14.9 13.6 20.9 12.4 14.7 23.4 8.1 9.6 10.6 11.1 8.1 8.0 14.2 15.6 12.0 12.7 18.7 16.1 10.2 11.5 12.1 7.3 8.4 26.1 6.0 25.4 11.7 18.8 116.1 15.4 3.6 7.8 10.3 1.7 26.8 15.7 14.8 6.8 29.6 17.3 8.9 36.3 5.7 9.7 15.1 20.2 19.4 20.1 18.3 31.5 13.3 85.5 11.1 16.3 7.2 6.5 16.0 13.6 8.2 8.5 29.0 21.4 18.5 17.0 5.8 22.1 18.3 16.0 12.8 12.5 13.1 6.0 9.5 17.2 6.7 12.0 9.7 38.4 6.8 15.5 18.5 14.7 TTC28 KIAA1043 ENSG00000100154 "Tetratricopeptide repeat domain 28" Q96AY4 22 27978014-28679865 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 291.5;Excitatory neurons: 169.6;Inhibitory neurons: 289.8;Microglial cells: 332.6;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001080 Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Cytosol "HPA001080: " "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "unprognostic (8.55e-3)" "unprognostic (4.83e-2)" "unprognostic (5.20e-2)" "unprognostic (2.25e-1)" "prognostic favorable (4.30e-4)" "unprognostic (3.91e-2)" "unprognostic (1.18e-2)" "unprognostic (5.40e-2)" "unprognostic (5.10e-2)" "prognostic favorable (5.65e-5)" "unprognostic (5.54e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (4.36e-1)" 7.0 4.7 4.6 2.9 3.0 0.8 6.4 0.6 3.4 8.9 3.1 5.7 3.2 10.3 9.9 5.3 8.8 6.5 5.0 4.1 4.0 4.9 3.6 7.2 2.0 2.7 1.9 2.3 17.0 5.1 3.8 3.8 8.9 1.9 5.2 2.9 3.4 6.8 6.9 5.5 2.8 3.8 8.6 1.7 3.5 4.8 8.2 1.7 2.7 6.8 5.1 1.4 6.4 5.1 2.3 0.0 6.8 17.1 7.4 10.0 14.8 0.3 5.1 9.4 7.1 6.1 0.5 0.0 0.1 6.9 14.9 2.3 1.0 11.1 0.3 3.8 0.7 7.5 1.1 8.6 6.5 4.5 0.2 6.8 14.9 0.3 4.6 3.2 4.8 13.0 4.5 4.5 0.6 1.6 2.5 0.1 0.6 3.1 0.0 4.3 7.0 4.3 0.1 3.3 0.2 4.8 10.6 7.1 0.2 4.5 4.7 3.5 0.6 12.2 8.4 4.0 5.5 3.8 2.2 0.2 0.1 3.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.6 3.0 0.6 3.4 4.1 4.0 2.7 1.9 2.3 1.9 1.7 1.7 2.3 29.4 3.2 12.5 291.5 3.2 6.0 5.8 1.7 11.4 34.1 8.7 8.0 9.7 8.6 1.6 12.9 18.8 6.0 2.3 2.1 0.0 6.2 10.8 7.9 28.9 30.9 9.0 7.0 169.6 6.0 1.5 27.3 4.1 12.4 1.3 32.3 36.8 15.3 3.7 28.6 289.8 5.8 0.0 9.4 7.2 9.1 31.4 4.3 10.6 332.6 0.7 11.5 5.2 318.7 116.3 3.9 4.4 45.5 3.1 5.0 4.8 18.6 1.9 24.9 13.1 27.2 19.7 23.8 11.6 6.7 3.8 2.5 3.2 27.4 6.9 4.0 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 8.9" "Cell type enhanced" "Detected in some" "Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075017 Approved Approved "Intermediate filaments,Focal adhesion sites" No NA "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 0.5 0.3 0.6 0.0 2.3 0.2 0.6 0.1 4.2 0.7 0.0 0.2 0.1 0.4 0.0 0.3 0.9 0.1 0.4 0.5 1.9 0.4 0.2 0.3 0.0 3.9 2.0 0.5 0.3 0.4 0.0 1.6 0.0 6.0 1.7 0.0 0.1 1.2 0.0 0.5 0.7 0.2 0.0 0.2 0.3 0.4 0.8 1.8 0.0 0.7 0.0 0.0 0.4 0.7 8.9 0.3 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.4 0.1 2.1 0.0 0.2 0.1 1.3 0.0 0.0 0.0 1.2 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 4.2 0.5 1.9 3.9 2.0 0.5 6.0 0.2 1.8 8.9 0.6 0.0 0.0 0.7 0.0 1.3 0.5 0.6 0.6 0.1 0.6 0.8 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.3 0.1 0.9 0.2 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.4 0.0 1.7 0.7 0.1 1.0 0.0 0.4 0.2 0.0 0.8 1.4 2.5 4.4 0.7 5.4 0.0 0.0 1.4 0.0 0.5 4.0 0.3 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 1.5 2.4 2.1 7.7 0.5 0.9 0.0 0.3 0.6 0.1 0.7 CENPM "C22orf18, CENP-M, MGC861, Pane1" ENSG00000100162 "Centromere protein M" Q9NSP4 22 41938737-41947152 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.2;lymphoid tissue: 25.3" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 116.7;Erythroid cells: 60.0;Plasma cells: 70.8;Respiratory ciliated cells: 102.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 50.8" "Group enriched" "Detected in many" 6 "B-cells: 38.6;T-cells: 50.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042404 Enhanced NA NA "HPA042404: AB_2677981" "unprognostic (3.78e-2)" "prognostic favorable (3.40e-5)" "unprognostic (7.15e-3)" "unprognostic (2.65e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.50e-5)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.99e-7)" "unprognostic (9.54e-3)" "unprognostic (2.44e-1)" "unprognostic (8.73e-2)" "unprognostic (5.61e-2)" 0.9 1.5 0.6 10.0 0.4 29.2 1.9 1.8 1.1 1.8 0.2 10.0 8.4 1.7 0.1 10.0 10.9 2.0 0.6 0.4 0.7 2.3 1.6 3.8 25.3 0.6 0.9 0.4 0.7 0.7 0.3 0.5 3.2 1.2 1.4 5.3 0.1 3.7 0.3 0.9 7.5 8.4 1.9 0.5 10.6 6.2 12.9 0.8 22.8 0.8 0.4 16.5 2.0 4.0 0.8 79.1 79.0 43.5 28.8 3.3 3.3 18.4 37.8 19.4 65.2 66.2 92.3 41.0 101.5 27.8 20.2 42.2 29.5 32.9 38.8 16.2 29.4 137.4 47.8 82.3 64.9 3.2 91.4 51.9 2.7 2.9 42.1 19.3 6.9 24.8 91.5 36.7 95.0 38.8 121.9 91.9 94.8 23.6 47.5 58.1 86.8 43.4 105.6 26.9 46.5 49.3 9.4 58.5 34.5 20.6 7.2 32.8 58.4 12.5 62.8 93.4 42.0 64.1 50.5 38.0 95.2 21.9 75.9 70.0 1.8 0.3 0.0 6.2 0.2 8.8 27.9 18.6 8.4 0.7 38.6 3.5 4.6 1.1 7.4 0.2 0.4 50.8 7.9 0.6 0.4 1.8 1.1 0.4 0.7 0.6 0.9 0.4 1.2 0.5 0.8 0.8 0.4 0.0 3.4 0.3 50.7 2.0 4.8 17.8 1.8 1.9 10.9 10.3 0.6 0.0 7.9 0.0 0.0 39.7 5.4 25.3 17.6 2.1 4.5 116.7 4.2 2.6 7.7 60.0 0.5 0.7 38.9 6.4 10.7 18.0 2.5 15.8 3.6 1.3 43.4 3.3 0.8 34.5 28.5 2.9 3.5 6.7 1.2 5.4 7.2 1.0 1.8 0.1 2.1 1.0 0.2 1.5 8.4 0.4 70.8 2.8 4.0 0.3 102.6 0.6 0.0 0.2 7.0 36.4 29.8 13.3 1.0 8.8 18.5 2.9 36.6 9.0 SEPTIN3 "SEP3, SEPT3" ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 232.2" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 27.9" "Group enriched" "Detected in many" 5 "glioma: 24.6;melanoma: 11.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.6;Daudi: 22.3;SCLC-21H: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Supported Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 0.2 4.6 129.5 0.4 160.6 0.1 1.3 86.3 232.2 0.2 33.7 0.7 0.3 0.2 1.5 0.2 0.1 0.5 0.1 166.8 111.7 0.3 0.1 0.7 0.5 88.6 77.0 154.3 0.2 1.2 18.7 7.8 5.7 100.4 1.3 0.5 28.6 0.4 0.0 0.1 1.6 0.4 0.3 54.9 0.2 0.7 2.1 93.2 0.9 0.8 0.2 0.5 0.3 0.4 150.2 1.5 1.7 26.6 20.1 0.3 0.0 13.3 0.3 0.3 1.8 0.8 0.4 3.1 22.3 0.7 0.2 11.4 0.1 14.0 0.1 0.7 9.2 4.6 0.1 0.5 0.0 0.2 0.0 0.9 0.2 1.0 0.1 0.0 0.0 0.0 12.1 0.0 3.4 0.0 2.4 3.7 0.2 18.2 0.2 0.7 17.9 0.0 1.3 0.0 2.7 71.4 14.8 10.9 0.1 18.2 2.5 2.6 6.7 0.0 0.0 9.2 0.9 1.0 14.1 13.1 0.2 0.3 9.0 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 129.5 160.6 86.3 232.2 166.8 111.7 88.6 77.0 154.3 100.4 54.9 93.2 150.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043261-32113029 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "intestine: 532.9" "Cell type enriched" "Detected in many" 6 "Proximal enterocytes: 768.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "OE19: 34.2" "Region enriched" "Detected in single" 26 "cerebellum: 7.6" "Low region specificity" "Detected in many" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 4.2 0.1 0.0 9.8 0.2 0.2 12.4 0.0 10.1 532.9 0.5 3.5 5.1 1.1 27.1 52.7 0.1 0.1 6.7 1.7 2.2 0.3 0.1 0.0 0.1 0.0 1.7 0.3 1.0 0.0 0.2 3.0 9.8 0.2 19.2 2.4 0.3 13.3 304.9 0.7 0.0 2.9 7.3 2.3 0.4 0.1 0.0 0.0 4.1 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 34.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.3 0.2 0.6 1.7 4.2 0.0 0.0 11.6 6.5 115.2 115.8 8.2 0.0 0.0 0.0 0.2 19.8 0.0 3.0 38.4 2.4 1.4 1.0 25.4 0.0 0.4 1.4 0.0 1.4 5.6 10.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 34.1 0.0 0.0 0.0 71.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 32.6 1.5 0.0 17.6 768.7 6.4 2.0 0.0 0.0 0.0 0.7 10.1 4.2 2.0 5.5 0.0 0.1 0.1 41.2 6.7 SLC5A4 "DJ90G24.4, SAAT1, SGLT3" ENSG00000100191 "Solute carrier family 5 member 4" Q9NY91 22 32218464-32255347 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 19.9" "Group enriched" "Detected in some" 11 "Excitatory neurons: 28.1;Inhibitory neurons: 20.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 9.5" "Cancer enriched" "Detected in some" 10 "melanoma: 7.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "SK-MEL-30: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (1.57e-1)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.85e-3)" "unprognostic (2.97e-2)" "unprognostic (3.80e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-3)" "unprognostic (4.50e-1)" "unprognostic (1.99e-5)" "unprognostic (2.34e-1)" "unprognostic (1.63e-1)" "unprognostic (2.28e-1)" "unprognostic (2.69e-1)" 0.7 0.2 0.1 0.1 0.2 0.1 0.8 0.3 2.9 1.0 0.0 0.1 17.8 0.9 0.3 0.2 0.7 0.6 0.5 0.7 0.5 0.6 0.2 1.5 0.2 1.7 0.2 0.0 0.3 0.4 0.3 0.1 0.0 3.2 0.5 0.1 0.1 0.2 0.3 0.1 0.3 19.9 1.4 0.0 0.3 0.2 0.5 0.8 0.0 1.3 0.0 0.1 0.4 0.7 3.8 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 27.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 2.9 0.7 0.5 1.7 0.2 0.0 3.2 0.0 0.8 3.8 0.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 31.9 0.1 0.0 0.0 9.5 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KDELR3 ENSG00000100196 "KDEL endoplasmic reticulum protein retention receptor 3" O43731 22 38468078-38483447 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 73.2;Fibroblasts: 54.7;Intestinal goblet cells: 70.6;Proximal enterocytes: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 267.0;BJ: 180.5;BJ hTERT+: 182.0;fHDF/TERT166: 289.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043477, HPA076405" Uncertain Supported "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA043477: AB_10962952, HPA076405: AB_2686797" "unprognostic (1.76e-1)" "unprognostic (3.77e-2)" "unprognostic (1.81e-1)" "unprognostic (1.20e-2)" "unprognostic (2.90e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.26e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-1)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.05e-10)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (8.24e-2)" "unprognostic (2.07e-2)" 13.5 4.5 1.1 7.7 1.3 2.1 12.4 2.9 2.1 31.4 7.5 18.2 15.6 7.5 29.8 4.8 7.5 19.8 15.8 1.2 1.6 8.1 12.7 10.3 3.3 1.5 1.2 0.9 3.6 16.0 12.2 14.3 16.2 1.3 19.8 22.8 3.1 34.7 11.0 2.1 3.7 18.6 15.6 1.4 2.5 35.3 4.0 1.2 1.7 6.4 3.7 7.3 12.6 4.4 1.5 35.8 11.1 8.7 37.2 142.7 267.0 6.4 180.5 182.0 42.7 105.3 22.1 45.1 0.3 38.2 289.3 15.2 5.1 8.9 10.7 51.0 0.4 21.8 2.5 8.7 55.2 62.9 0.4 24.1 99.9 8.0 53.9 5.7 60.1 52.4 0.3 9.0 0.1 70.7 56.8 0.1 1.3 2.1 150.2 33.2 0.2 2.4 11.8 51.5 4.8 0.7 4.6 46.7 2.7 22.9 3.6 13.3 2.4 41.5 45.8 29.0 160.3 18.0 1.7 0.6 0.2 73.5 0.1 65.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.0 1.6 0.2 0.1 1.1 1.3 2.9 2.1 1.2 1.6 1.5 1.2 0.9 1.3 1.4 1.2 1.5 14.5 0.0 4.8 0.3 4.5 7.6 5.7 7.5 1.2 1.3 10.0 4.2 2.5 8.6 10.0 14.7 2.1 5.1 0.3 9.1 7.9 19.0 0.2 8.0 19.4 10.2 4.9 0.8 0.7 31.6 73.2 54.7 24.5 11.0 1.3 6.9 14.6 5.3 4.7 0.0 0.5 70.6 0.0 0.9 14.5 0.6 32.6 1.1 16.0 1.9 1.0 6.3 0.0 0.0 0.4 31.5 4.9 16.1 12.8 16.3 40.1 0.8 9.2 1.4 0.0 1.7 20.5 0.5 2.4 1.6 7.1 8.2 2.3 4.2 11.1 7.8 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130865 "Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 322.6" "Group enriched" "Detected in many" 35 "Hepatocytes: 512.8;Proximal enterocytes: 465.2" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.8" "Low region specificity" "Detected in many" HPA045223 Enhanced Approved "Golgi apparatus" No No "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.0 0.2 0.2 0.0 0.3 0.3 0.1 0.7 0.2 0.1 0.2 0.2 3.7 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 322.6 0.1 0.1 0.2 0.1 0.0 0.2 0.8 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.2 11.8 0.0 0.0 0.3 0.1 0.4 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.2 0.2 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.4 0.6 0.0 1.1 5.5 0.7 0.5 0.7 1.3 2.8 7.3 1.1 1.4 0.4 2.8 0.7 1.8 2.1 0.1 0.6 2.9 1.9 0.7 3.1 0.8 0.6 0.6 1.2 0.0 6.5 0.6 0.1 0.3 4.1 1.4 0.0 0.7 5.7 512.8 0.1 11.8 9.4 7.6 0.0 5.6 0.0 13.6 0.0 0.4 0.0 0.0 0.1 0.7 0.0 5.0 4.9 0.7 11.3 1.5 0.4 0.6 465.2 0.5 1.3 2.3 0.0 0.4 2.1 0.8 0.4 0.6 1.1 0.4 1.0 0.1 3.4 0.3 DDX17 P72 ENSG00000100201 "DEAD-box helicase 17" Q92841 22 38483438-38507660 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024908, HPA063142" Supported Supported "Nuclear speckles" "Intracellular and membrane" NA NA 420000 "Nuclear speckles" "CAB024908: , HPA063142: AB_2684949" "unprognostic (1.46e-2)" "unprognostic (5.99e-3)" "unprognostic (4.24e-3)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.06e-4)" "unprognostic (1.17e-1)" "unprognostic (5.51e-1)" "unprognostic (2.52e-2)" "unprognostic (2.73e-2)" "unprognostic (1.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.76e-1)" "unprognostic (4.31e-2)" "unprognostic (3.19e-3)" 175.1 173.8 160.3 125.5 169.4 75.2 200.2 164.6 180.0 246.2 184.3 211.0 108.8 217.9 257.5 151.6 250.3 122.2 167.4 153.3 176.8 212.2 154.0 203.9 187.9 161.8 165.7 147.0 301.3 215.7 145.8 312.3 160.1 162.9 236.4 115.3 345.0 189.9 124.4 186.3 198.6 229.1 120.7 161.7 295.4 193.7 91.8 159.9 217.2 302.5 107.6 159.5 206.1 203.2 207.7 122.0 79.9 237.6 141.8 148.2 166.0 120.7 104.3 85.9 118.3 121.2 89.0 100.5 225.8 65.8 119.5 82.9 133.2 212.5 127.9 145.9 202.5 142.1 140.4 175.8 133.5 153.4 192.9 170.8 122.3 183.7 86.8 142.9 211.7 153.3 109.6 139.7 255.3 116.0 75.6 128.7 164.0 148.0 172.1 51.6 218.0 122.9 137.1 141.2 132.6 134.1 75.3 155.0 125.9 161.2 180.5 110.0 148.4 140.8 125.7 77.6 80.0 79.3 203.7 130.3 183.4 156.7 123.1 154.2 6.7 8.1 9.5 7.6 7.9 8.9 9.0 7.1 7.3 7.0 7.2 5.7 6.8 16.6 5.1 8.7 10.5 9.1 6.0 160.3 169.4 164.6 180.0 153.3 176.8 161.8 165.7 147.0 162.9 161.7 159.9 207.7 252.6 214.7 325.5 483.8 241.9 223.6 206.1 129.3 158.2 448.3 300.7 195.3 147.2 180.1 223.5 283.3 352.3 127.6 297.5 172.8 33.2 111.7 44.4 280.0 293.4 250.4 236.1 177.1 198.9 90.2 99.9 207.5 216.1 234.2 200.7 505.3 233.8 205.3 113.9 321.4 242.1 191.6 146.5 200.6 194.8 49.1 323.7 197.7 154.7 253.9 235.1 223.4 304.9 334.3 553.3 104.7 153.1 278.7 213.1 193.5 154.8 89.8 270.8 559.4 289.3 260.5 213.6 136.4 74.2 120.4 279.9 139.4 218.6 293.7 147.0 255.3 DMC1 LIM15 ENSG00000100206 "DNA meiotic recombinase 1" Q14565 22 38518948-38570204 "Predicted intracellular proteins" "Cell cycle, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 12.4" "Group enriched" "Detected in many" 5 "Spermatocytes: 109.3;Spermatogonia: 36.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 25.5;hTEC/SVTERT24-B: 17.4;U-266/84: 21.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001232, CAB015397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB015397: AB_629406, HPA001232: AB_1078683" "unprognostic (1.29e-2)" "unprognostic (3.11e-3)" "unprognostic (4.48e-3)" "unprognostic (5.71e-2)" "unprognostic (6.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.22e-2)" "unprognostic (2.61e-2)" "unprognostic (4.23e-2)" "unprognostic (3.99e-3)" "unprognostic (7.40e-3)" "unprognostic (1.00e-2)" "unprognostic (2.16e-4)" "unprognostic (3.94e-1)" "unprognostic (2.79e-1)" "unprognostic (7.27e-2)" "unprognostic (2.99e-1)" 0.6 0.2 0.4 1.4 0.4 2.3 0.9 1.2 0.7 0.9 0.3 0.9 0.2 2.5 0.9 0.9 0.8 0.4 2.3 0.4 0.4 0.5 0.3 0.4 2.8 0.4 0.2 0.4 1.2 0.5 0.3 0.4 0.7 0.6 1.2 1.1 0.8 0.3 0.7 1.3 1.6 0.7 0.7 0.1 0.5 0.6 12.4 0.2 3.4 0.3 0.6 3.1 0.6 0.7 0.6 7.1 2.6 5.0 0.1 0.4 2.1 0.2 7.4 1.0 11.7 8.1 0.2 0.8 3.5 0.3 2.0 0.0 1.2 2.0 0.3 13.1 25.5 0.5 13.6 2.0 0.2 0.2 1.2 2.7 0.5 0.0 17.4 0.0 0.1 0.9 11.2 10.5 3.5 4.1 3.9 2.8 10.3 9.0 3.5 0.2 6.2 0.0 5.2 1.5 0.9 9.7 0.5 12.5 1.1 0.1 1.1 2.1 2.9 0.3 0.1 0.8 0.1 0.1 9.8 21.4 6.4 2.0 2.8 0.9 0.4 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.4 0.4 1.2 0.7 0.4 0.4 0.4 0.2 0.4 0.6 0.1 0.2 0.6 0.6 0.0 2.3 3.6 0.7 2.3 1.0 0.4 1.8 0.7 2.7 2.4 2.5 0.0 2.7 3.7 0.0 1.9 0.4 1.3 1.9 0.2 2.9 0.9 0.8 0.8 0.0 11.8 1.1 0.0 1.7 1.4 0.0 1.3 1.3 1.1 0.4 0.1 1.0 0.0 1.4 1.6 0.0 0.0 1.2 3.0 1.5 1.1 0.0 1.9 0.1 4.8 1.0 2.5 0.6 0.1 0.5 1.5 3.8 0.2 0.1 0.4 0.9 0.2 13.1 1.3 0.9 109.3 36.0 0.3 0.6 0.8 0.9 0.3 2.5 0.5 TCF20 "AR1, SPBP" ENSG00000100207 "Transcription factor 20" Q9UGU0 22 42160013-42343616 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 127.0;Inhibitory neurons: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017849, HPA036786" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB017849: , HPA036786: AB_2675313" "unprognostic (2.17e-1)" "unprognostic (2.12e-2)" "prognostic favorable (1.88e-4)" "unprognostic (2.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.89e-4)" "unprognostic (1.77e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-3)" "unprognostic (7.30e-2)" "unprognostic (1.17e-3)" "unprognostic (3.07e-3)" "unprognostic (4.94e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 6.9 6.6 2.4 1.7 3.2 1.6 7.5 0.0 3.0 9.6 0.0 8.7 1.6 9.1 0.2 16.4 6.9 1.0 4.8 3.7 1.5 7.5 7.5 7.2 1.6 1.8 0.7 3.0 7.7 8.3 1.2 7.4 1.2 2.0 6.9 1.3 0.9 10.0 1.0 5.7 14.0 10.0 1.4 0.0 7.4 8.1 15.4 1.0 2.3 9.7 1.3 1.6 7.8 11.1 2.0 6.6 2.3 3.2 2.1 1.0 2.1 5.5 4.2 2.8 2.1 3.5 5.0 2.5 10.9 3.6 1.1 3.1 5.4 3.9 3.3 1.2 8.5 3.9 3.4 2.2 1.6 1.5 6.0 4.7 1.2 2.9 3.0 3.0 0.9 1.0 3.1 4.1 3.9 1.6 3.0 9.4 1.8 3.4 2.2 3.1 4.7 2.0 5.7 0.5 5.2 6.2 2.0 2.7 2.0 2.7 2.0 1.2 4.8 3.9 3.8 8.9 3.9 1.9 7.0 6.2 4.5 2.3 4.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.2 0.0 3.0 3.7 1.5 1.8 0.7 3.0 2.0 0.0 1.0 2.0 10.0 0.0 9.6 23.5 9.1 22.6 11.3 19.4 12.0 25.1 11.5 6.9 7.3 17.2 10.1 9.2 18.8 6.3 11.0 16.6 0.0 10.8 127.0 14.2 9.9 9.3 16.8 9.9 54.0 7.5 5.5 8.1 10.7 22.2 1.3 10.0 8.9 12.6 6.2 10.1 63.5 13.8 12.2 12.4 13.3 36.2 12.5 9.4 7.2 22.5 12.0 5.6 6.2 29.7 55.0 13.3 13.5 6.4 8.7 20.9 13.0 6.0 13.4 12.6 6.6 5.8 8.5 19.1 13.4 19.5 22.9 4.5 13.0 4.3 17.9 14.6 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742039-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: AB_2673919" "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favorable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favorable (8.38e-4)" 8.6 15.4 4.8 6.0 4.7 3.3 9.9 5.1 6.9 12.0 4.6 10.2 8.7 8.1 5.2 8.0 9.3 7.2 7.4 4.5 4.9 11.1 22.1 6.2 11.1 5.4 4.6 4.2 12.1 12.6 5.3 7.3 4.6 5.5 10.8 4.5 1.0 18.9 6.3 11.7 7.5 7.3 4.7 5.0 9.1 11.6 4.1 5.0 4.4 8.0 8.2 4.9 10.8 9.0 5.6 13.8 8.5 3.4 5.5 6.3 16.0 6.5 9.9 13.8 14.2 8.8 3.8 4.8 15.1 4.6 5.6 3.4 9.5 6.9 6.3 6.9 14.6 27.2 5.3 5.8 10.7 13.4 9.7 7.7 10.9 13.8 8.0 12.6 7.5 11.0 4.2 8.2 13.1 5.7 20.1 4.3 8.9 8.4 15.0 20.9 8.6 10.8 17.2 15.9 3.9 11.8 10.8 5.4 20.5 25.9 2.9 8.6 5.9 6.0 19.3 10.2 18.6 9.2 18.2 15.9 13.5 13.5 7.1 13.2 10.1 7.8 4.1 6.1 15.2 7.3 13.0 6.2 7.2 11.5 9.6 6.6 8.3 0.4 11.1 12.0 6.0 4.9 5.9 4.8 4.7 5.1 6.9 4.5 4.9 5.4 4.6 4.2 5.5 5.0 5.0 5.6 21.4 22.4 19.6 14.4 22.8 11.6 22.2 23.3 40.5 5.5 29.4 37.7 7.8 18.6 23.9 20.2 6.2 16.0 16.7 9.0 29.4 25.0 5.5 12.7 23.3 18.4 19.8 12.6 10.0 28.0 13.5 21.4 11.7 21.6 23.4 17.2 20.3 36.3 27.9 5.0 11.2 14.6 16.2 19.0 14.9 4.3 18.6 19.2 14.2 9.4 22.6 17.4 41.2 16.1 14.2 21.2 11.3 11.7 34.1 20.5 20.2 58.1 24.1 8.1 6.6 19.1 21.9 15.1 16.7 19.8 15.6 13.3 15.9 27.1 21.2 17.2 CBY1 "C22orf2, Cby, Chibby, Chibby1, PGEA1, PIGEA-14, PIGEA14" ENSG00000100211 "Chibby family member 1, beta catenin antagonist" Q9Y3M2 22 38656636-38673854 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.06e-1)" "unprognostic (4.60e-3)" "unprognostic (2.42e-1)" "prognostic favorable (5.22e-5)" "unprognostic (3.46e-2)" "unprognostic (1.74e-1)" "unprognostic (4.29e-2)" "unprognostic (4.51e-2)" "unprognostic (9.36e-2)" "unprognostic (9.33e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" "unprognostic (2.35e-1)" "unprognostic (2.16e-1)" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (1.35e-2)" 25.8 46.7 40.8 11.8 39.9 6.4 29.6 40.2 42.8 36.0 39.8 42.7 17.0 33.2 52.0 27.5 59.8 19.8 50.1 39.0 39.3 38.9 28.6 23.7 12.2 40.1 40.0 37.4 40.8 35.1 34.5 33.8 29.5 38.9 40.3 28.1 20.2 29.8 44.1 26.1 27.6 22.4 38.6 39.6 23.0 32.2 25.4 39.8 14.3 32.5 33.8 15.2 37.3 29.9 40.1 31.2 27.8 40.3 56.9 76.4 46.3 19.6 34.3 39.0 34.1 34.6 17.4 28.1 4.3 30.1 39.4 31.1 28.5 32.1 66.7 46.3 13.2 30.0 3.5 22.8 35.2 51.9 10.5 4.6 43.9 52.6 48.8 65.5 62.3 56.1 13.1 19.5 10.6 37.8 51.0 7.2 14.9 22.4 75.7 34.0 6.6 22.9 9.9 88.7 28.1 47.2 12.5 47.2 21.1 43.5 44.6 19.9 9.8 39.3 19.4 24.7 21.8 14.4 11.4 7.4 4.7 28.9 12.3 23.0 4.5 6.3 6.4 10.6 5.0 14.6 6.9 13.4 12.7 6.7 12.0 19.3 13.7 6.3 8.3 6.3 10.6 5.8 6.4 40.8 39.9 40.2 42.8 39.0 39.3 40.1 40.0 37.4 38.9 39.6 39.8 40.1 21.9 12.8 18.5 9.4 5.1 13.8 17.8 57.4 15.9 8.5 32.7 41.0 36.6 28.6 28.9 27.6 6.2 86.1 4.2 13.5 35.2 36.0 60.7 106.3 30.3 24.0 21.6 10.8 12.9 19.5 41.9 34.1 10.2 25.6 8.2 33.6 22.5 10.6 20.1 8.4 13.9 22.0 40.7 6.7 10.4 12.4 49.7 4.2 21.4 5.6 5.5 28.4 2.1 3.5 9.2 24.6 13.2 65.8 5.4 19.9 16.8 51.4 89.0 13.7 26.3 22.8 30.6 20.2 20.2 20.1 16.3 49.5 5.8 84.1 29.4 15.1 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681957-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria NA NA 230000 Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 19.6 21.3 29.5 19.2 29.7 30.6 17.4 30.1 29.9 15.6 30.6 22.8 24.7 15.6 19.4 28.7 20.7 11.6 28.7 29.2 29.8 24.2 28.7 12.8 25.5 30.0 29.6 28.2 19.3 21.3 22.7 10.0 15.8 30.2 15.2 27.9 8.7 21.6 12.6 34.9 21.3 19.6 19.6 29.8 17.1 20.4 17.2 30.4 27.3 17.2 31.3 30.7 24.1 17.9 30.8 61.7 35.5 53.4 56.9 38.6 35.7 57.5 49.7 34.3 71.1 53.1 65.0 35.8 62.0 39.9 48.9 48.7 49.7 81.8 75.2 56.7 53.8 89.9 83.4 25.2 63.0 50.2 223.2 56.7 49.0 52.6 64.1 41.6 37.0 52.9 59.5 64.4 48.2 48.1 47.9 67.7 103.3 82.0 80.8 71.5 73.9 69.2 58.8 47.7 44.3 62.4 41.3 58.1 72.7 59.1 36.1 50.5 73.1 54.3 43.4 81.8 40.1 76.2 65.9 85.7 94.3 54.3 76.0 60.6 12.9 50.9 16.6 35.4 51.1 44.9 48.7 37.8 37.5 66.4 37.8 38.0 41.4 5.0 42.7 43.1 58.0 48.7 72.8 29.5 29.7 30.1 29.9 29.2 29.8 30.0 29.6 28.2 30.2 29.8 30.4 30.8 62.4 25.6 30.4 4.2 123.3 167.0 134.8 158.7 109.8 30.1 79.5 67.7 70.2 82.9 68.0 71.7 16.7 180.0 89.7 74.8 223.0 135.3 139.6 50.5 58.8 77.1 105.1 98.8 7.3 133.2 232.1 70.4 65.7 50.6 74.3 100.3 69.9 101.4 163.9 28.6 8.4 133.5 99.7 120.2 130.7 143.2 55.3 93.3 113.8 4.7 153.2 76.1 105.0 4.5 8.7 116.2 85.2 54.5 130.3 153.4 116.2 245.9 35.2 33.7 72.3 73.3 76.9 130.1 148.2 185.5 210.3 135.6 102.6 100.9 189.7 158.7 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.5;testis: 25.2" "Group enriched" "Detected in many" 6 "Early spermatids: 139.7;Late spermatids: 252.0" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 7.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 7.7" "Cell line enhanced" "Detected in some" "GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.4 2.0 8.0 0.2 9.2 0.2 0.4 7.3 12.2 0.9 8.7 0.5 0.2 0.8 3.5 0.5 12.5 1.3 0.4 9.4 9.9 7.4 0.4 1.5 0.2 8.9 8.5 8.1 4.0 0.9 2.5 3.7 0.1 7.8 0.8 0.2 11.5 0.6 1.7 0.7 1.1 0.3 0.3 8.2 0.5 0.7 25.2 8.0 0.1 2.0 0.1 0.2 0.2 0.4 9.9 0.2 2.5 1.9 2.0 0.0 0.9 0.1 0.0 0.5 0.4 0.4 0.4 0.7 0.5 0.7 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.1 1.0 0.0 0.2 0.4 0.0 1.2 0.0 0.8 0.0 1.0 0.0 0.3 0.3 0.4 0.0 0.6 0.0 0.1 0.0 2.0 4.2 0.0 2.7 0.9 0.0 0.0 0.1 0.1 0.3 0.5 0.0 1.5 0.5 0.1 0.0 4.9 1.9 1.6 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 7.7 0.1 1.8 0.0 0.0 0.6 8.0 9.2 7.3 12.2 9.4 9.9 8.9 8.5 8.1 7.8 8.2 8.0 9.9 1.9 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.0 1.1 0.2 0.5 0.1 1.5 3.7 0.0 4.2 0.0 0.2 0.0 7.9 1.0 139.7 17.8 0.5 0.4 0.0 0.0 3.5 0.2 0.0 0.5 0.0 0.5 0.0 1.2 0.7 0.0 0.1 11.8 2.8 0.1 0.0 0.0 0.0 252.0 2.1 0.3 0.0 0.0 0.0 4.6 0.0 1.0 1.1 0.4 0.0 1.9 0.1 0.2 0.0 17.7 29.2 5.1 0.0 0.8 0.9 29.4 8.3 0.0 0.0 0.0 0.4 2.8 0.1 0.3 XBP1 XBP2 ENSG00000100219 "X-box binding protein 1" P17861 22 28794555-28800597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Angiogenesis, Apoptosis, Autophagy, Differentiation, Lipid biosynthesis, Lipid metabolism, Myogenesis, Protein transport, Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 1168.7" "Cell type enhanced" "Detected in all" "Breast glandular cells: 1756.7;Plasma cells: 2344.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 960.5;SK-BR-3: 870.0;T-47d: 1012.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 100.8 104.7 26.8 151.4 25.4 249.4 727.9 27.5 30.0 372.8 44.2 205.5 165.2 95.1 151.9 86.0 127.6 121.3 73.7 24.9 84.3 76.4 693.0 153.1 139.5 34.6 28.3 21.4 68.1 1168.7 196.7 88.4 108.8 31.9 230.8 198.5 21.2 856.6 153.5 90.8 71.9 141.5 106.4 32.4 214.9 262.0 22.3 36.9 149.6 170.4 49.2 310.4 252.7 52.6 36.4 77.1 50.8 71.4 111.0 132.2 144.2 181.1 130.9 223.2 128.4 168.8 82.5 104.4 290.2 63.0 121.8 75.3 104.5 134.2 64.4 110.4 130.0 84.9 88.3 42.6 356.2 285.9 166.1 80.8 90.7 378.2 85.2 363.7 115.9 104.1 35.0 79.5 355.0 78.6 960.5 23.3 157.0 49.7 594.6 79.0 168.6 78.5 401.5 118.4 105.4 94.7 90.7 79.0 870.0 358.6 94.8 1012.9 188.5 59.8 73.3 69.8 78.5 47.3 598.8 456.8 174.8 98.0 210.0 112.3 185.0 27.1 23.5 73.3 14.1 95.2 38.0 52.4 76.5 23.5 43.8 52.9 43.2 2.1 88.5 10.1 75.0 20.5 38.5 26.8 25.4 27.5 30.0 24.9 84.3 34.6 28.3 21.4 31.9 32.4 36.9 36.4 116.4 86.6 195.6 3.6 379.0 210.6 410.2 192.2 47.3 25.4 1756.7 829.4 46.2 205.9 390.1 138.0 131.3 112.8 298.6 171.2 80.3 240.6 30.2 160.1 147.8 107.0 189.7 68.6 8.5 633.3 335.4 220.0 208.0 293.6 99.7 55.1 93.1 654.5 267.9 15.2 11.4 633.0 225.9 130.0 281.5 22.7 95.7 172.3 355.8 18.7 95.0 18.6 385.2 8.0 7.3 328.4 190.5 64.7 2344.9 381.9 247.0 73.2 168.9 53.2 13.1 144.4 179.3 36.8 32.5 86.2 202.0 349.7 206.1 34.8 260.0 355.3 RTCB "C22orf28, FAAP, HSPC117" ENSG00000100220 "RNA 2',3'-cyclic phosphate and 5'-OH ligase" Q9Y3I0 22 32387582-32412248 "Enzymes, Predicted intracellular proteins" "tRNA processing" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000535, HPA001103" Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 73000 Nucleoplasm "Vesicles, Cytosol" "HPA000535: AB_2666021, HPA001103: AB_1078351" "unprognostic (1.84e-1)" "unprognostic (6.48e-2)" "unprognostic (1.07e-2)" "unprognostic (2.71e-3)" "unprognostic (7.21e-3)" "unprognostic (1.43e-2)" "unprognostic (1.75e-3)" "unprognostic (1.49e-1)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (5.07e-2)" "prognostic favorable (4.25e-5)" "unprognostic (6.91e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" 40.6 44.8 35.1 39.3 36.7 31.7 51.8 38.3 41.1 36.5 36.4 56.7 94.8 44.2 44.1 49.8 46.9 32.8 43.5 34.7 37.9 76.6 75.9 36.7 46.0 37.9 37.8 33.9 46.0 46.1 73.6 40.2 45.8 39.2 46.3 74.5 44.5 47.6 47.9 71.7 77.2 79.7 56.5 38.9 44.1 48.8 32.3 37.4 73.6 41.9 64.1 88.6 54.4 39.5 41.8 116.1 101.9 125.0 94.3 106.8 79.1 99.3 98.8 118.5 154.6 145.9 133.2 45.9 28.5 64.6 116.1 95.2 76.7 144.7 143.5 198.6 144.3 144.8 81.4 83.0 122.1 73.4 192.4 71.2 78.3 93.7 153.3 147.8 85.1 141.3 78.5 98.2 78.7 114.3 96.4 82.5 66.4 71.7 133.4 91.7 126.0 134.7 147.1 106.0 99.0 128.3 71.1 107.2 68.5 129.2 130.6 75.5 73.8 107.3 84.8 124.8 74.7 96.5 54.4 46.6 102.1 87.8 85.6 113.4 112.5 135.3 89.2 93.0 151.3 104.4 143.5 96.6 97.4 161.4 150.4 114.8 99.1 13.2 125.7 118.7 90.4 131.7 156.3 35.1 36.7 38.3 41.1 34.7 37.9 37.9 37.8 33.9 39.2 38.9 37.4 41.8 32.0 32.1 33.4 15.3 40.3 60.5 54.9 84.9 47.8 51.6 35.4 27.6 35.8 47.1 60.6 35.0 20.9 112.6 43.0 74.8 66.5 108.4 4.8 46.3 28.6 45.4 46.7 36.4 22.4 95.6 87.9 35.8 45.9 53.8 42.6 50.5 41.0 58.3 85.4 52.2 19.6 62.2 116.0 47.4 45.9 10.8 35.1 43.2 30.2 25.3 80.0 66.9 34.0 28.6 35.1 106.5 62.1 47.8 36.0 64.3 178.2 146.9 48.2 56.9 26.3 35.4 43.0 67.0 65.1 52.7 76.0 97.8 34.1 59.3 61.3 73.8 JOSD1 KIAA0063 ENSG00000100221 "Josephin domain containing 1" Q15040 22 38685543-38701556 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001168 Uncertain NA NA "HPA001168: AB_1079162" "unprognostic (6.50e-2)" "unprognostic (1.06e-2)" "unprognostic (3.42e-3)" "unprognostic (5.67e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.50e-4)" "unprognostic (1.65e-2)" "unprognostic (5.10e-2)" "unprognostic (1.39e-1)" "unprognostic (3.23e-3)" "unprognostic (2.46e-1)" "unprognostic (1.83e-3)" "unprognostic (1.06e-1)" "unprognostic (4.41e-1)" "unprognostic (2.88e-2)" "unprognostic (4.41e-1)" 30.5 22.2 30.4 25.3 32.5 90.4 25.2 30.2 34.9 24.0 25.2 41.2 27.8 25.9 14.9 23.2 28.3 34.4 24.0 32.4 34.4 20.1 24.0 31.1 21.9 29.9 28.3 32.3 49.3 26.2 16.9 28.0 22.9 31.3 23.3 38.7 21.7 21.4 18.4 24.6 26.8 36.0 28.1 29.5 22.8 25.0 19.4 29.8 28.2 22.5 22.2 24.5 33.4 23.1 32.6 69.6 24.5 35.1 45.7 44.1 53.5 26.6 52.2 62.1 66.5 69.3 40.5 34.4 66.3 26.4 52.6 44.3 43.8 49.2 46.4 53.4 71.4 32.6 35.2 57.3 34.9 74.9 63.8 33.1 46.7 67.8 62.9 107.1 58.3 79.8 41.0 32.0 68.2 49.4 29.4 27.9 25.9 13.3 41.8 27.5 49.5 51.5 27.9 36.1 35.3 32.3 17.4 59.9 29.3 54.7 29.2 29.4 18.2 70.0 39.4 48.1 51.4 32.1 74.9 71.1 54.2 52.4 33.5 37.5 1.0 1.8 1.9 2.6 2.8 1.8 1.6 2.2 3.4 1.3 1.6 2.3 3.7 3.6 2.3 1.6 1.0 3.2 1.4 30.4 32.5 30.2 34.9 32.4 34.4 29.9 28.3 32.3 31.3 29.5 29.8 32.6 45.0 25.6 17.1 12.7 53.1 46.4 75.0 20.2 34.7 28.2 41.0 45.1 17.0 44.3 18.5 36.8 22.9 10.5 94.1 133.1 13.7 34.6 4.9 51.6 38.6 35.3 23.4 21.0 25.2 39.3 15.0 24.2 53.5 114.5 16.5 26.9 23.9 24.8 22.7 18.5 21.7 61.8 12.2 32.6 106.3 4.8 12.8 74.2 16.0 6.5 27.3 27.5 12.3 7.1 24.6 68.0 88.1 13.9 61.5 62.4 64.6 18.1 17.4 23.6 13.1 27.9 27.3 16.2 24.2 35.5 51.6 12.9 75.2 17.8 35.0 102.7 FBXO7 "Fbx, FBX7, PARK15" ENSG00000100225 "F-box protein 7" Q9Y3I1 22 32474676-32498829 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 282.2" "Cell type enhanced" "Detected in all" "Erythroid cells: 680.9;Late spermatids: 620.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032113, HPA032114, CAB034296" Uncertain Supported Nucleoplasm,Cytosol NA NA 550000 "Nucleoplasm, Cytosol" "CAB034296: AB_2102563, HPA032113: AB_2674156, HPA032114: AB_10696202" "unprognostic (3.99e-2)" "unprognostic (1.53e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.36e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.45e-2)" "unprognostic (2.28e-1)" "unprognostic (2.53e-1)" "prognostic favorable (2.66e-10)" "unprognostic (3.33e-2)" "unprognostic (1.65e-1)" "unprognostic (7.02e-2)" "unprognostic (1.79e-3)" 50.3 62.2 76.4 36.2 90.5 282.2 53.4 84.8 84.6 53.9 79.3 50.7 48.1 49.6 69.3 40.5 67.2 44.3 38.9 73.2 81.5 107.5 129.5 60.2 55.0 89.3 89.5 69.2 63.2 41.3 76.6 50.9 72.1 89.4 43.0 54.4 40.4 43.4 54.0 31.3 50.4 48.8 57.6 89.4 66.1 48.8 100.4 86.2 78.6 135.4 48.7 62.3 55.3 44.4 104.3 72.1 52.1 69.3 77.1 105.8 99.5 45.9 64.3 119.6 102.7 121.9 54.4 51.1 71.2 49.6 114.6 87.8 47.6 103.3 84.7 105.1 111.8 80.9 99.1 54.4 83.7 126.8 126.2 82.8 83.8 134.1 90.6 69.2 93.4 112.2 53.1 77.5 88.0 112.7 57.7 65.3 81.2 26.7 102.3 36.1 64.1 72.2 84.0 118.2 81.0 96.6 63.1 81.3 62.4 235.2 98.3 34.0 67.2 76.0 50.6 69.4 48.4 49.5 62.1 69.3 67.6 97.4 65.6 212.3 251.5 59.9 132.1 83.3 70.6 101.5 70.2 75.9 84.9 82.2 63.6 65.6 72.6 22.4 98.3 74.9 55.8 101.3 90.4 76.4 90.5 84.8 84.6 73.2 81.5 89.3 89.5 69.2 89.4 89.4 86.2 104.3 48.8 41.7 25.3 37.9 60.4 46.3 69.4 72.7 48.9 26.0 46.5 32.3 16.1 65.8 48.1 49.7 18.8 90.2 73.6 43.4 97.8 75.3 303.3 41.3 37.8 53.1 67.6 680.9 27.6 77.4 108.9 47.9 40.2 47.2 55.8 63.6 53.9 88.6 71.9 33.7 26.7 42.7 65.1 64.8 53.2 620.8 45.1 55.0 119.2 28.1 125.2 54.1 72.1 101.0 170.6 77.2 58.0 48.9 62.7 68.3 72.2 152.9 34.2 38.1 46.0 35.3 46.2 149.4 136.9 42.3 43.3 71.6 62.3 41.8 47.2 83.7 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705742-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 64000 "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: AB_2685329" "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.4 19.1 14.8 23.6 17.3 106.4 18.6 18.0 38.7 20.0 19.0 20.4 20.7 20.2 12.2 22.6 22.2 17.8 19.7 17.2 23.1 18.5 17.3 29.2 23.2 18.5 15.6 12.3 27.6 22.2 19.4 25.7 16.1 15.7 24.0 17.7 35.0 21.4 15.6 32.0 26.9 23.1 16.8 13.6 28.2 20.6 20.4 15.1 20.2 25.1 20.1 23.2 18.9 19.5 22.9 29.2 10.5 37.4 30.2 12.6 19.7 18.3 27.4 28.7 39.0 33.9 22.0 16.3 27.9 9.8 26.9 17.5 26.6 45.5 28.8 21.6 49.2 32.8 48.7 36.9 16.3 23.9 57.7 24.3 20.3 22.0 31.2 48.7 21.3 24.3 20.2 29.4 56.5 21.8 12.1 32.1 26.1 27.0 16.7 20.8 61.8 38.2 36.7 13.8 23.3 51.0 17.7 33.3 21.0 19.6 16.2 19.0 24.2 26.1 22.3 22.0 16.4 21.2 51.8 18.7 38.5 20.1 29.0 16.9 3.5 3.1 3.9 4.7 4.6 4.2 4.6 3.5 4.9 3.4 3.8 2.5 3.7 7.8 2.3 5.1 1.7 3.3 3.4 14.8 17.3 18.0 38.7 17.2 23.1 18.5 15.6 12.3 15.7 13.6 15.1 22.9 17.8 9.6 8.4 7.8 31.8 27.8 36.0 12.7 15.4 32.6 17.5 15.5 11.2 5.7 12.4 12.9 22.9 7.2 35.9 40.3 5.9 13.2 4.5 22.2 14.3 13.1 16.2 35.3 5.5 19.3 7.9 14.5 23.4 26.4 14.0 17.5 13.6 12.4 8.6 20.2 7.9 24.3 16.2 18.4 43.9 5.4 16.1 19.3 10.6 4.7 26.6 13.2 20.6 5.5 15.2 19.9 21.1 19.2 52.8 47.4 29.8 6.1 16.6 41.0 26.3 19.9 14.5 17.2 7.7 19.2 34.2 19.0 31.9 15.5 13.0 51.0 POLDIP3 "KIAA1649, PDIP3, PDIP46, SKAR" ENSG00000100227 "DNA polymerase delta interacting protein 3" Q9BY77 22 42583721-42614962 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 129.3;Late spermatids: 469.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018419, HPA048790" Approved Enhanced "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA018419: AB_1856928, HPA048790: AB_2680522" "unprognostic (2.00e-1)" "unprognostic (1.55e-1)" "unprognostic (1.32e-1)" "unprognostic (7.05e-3)" "prognostic favorable (7.79e-4)" "unprognostic (2.82e-1)" "unprognostic (1.17e-2)" "unprognostic (5.44e-2)" "unprognostic (8.16e-2)" "unprognostic (4.49e-3)" "unprognostic (2.48e-1)" "unprognostic (5.96e-2)" "prognostic favorable (3.36e-4)" "unprognostic (3.73e-2)" "unprognostic (3.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" 26.1 36.8 49.6 26.5 53.8 68.8 33.6 51.3 55.4 42.0 44.1 35.7 26.1 40.8 35.0 42.9 53.7 24.2 32.8 48.7 53.3 39.0 33.4 36.6 36.5 58.3 52.4 46.1 91.9 36.2 34.7 35.8 32.9 51.7 41.6 29.6 30.4 38.0 33.7 35.2 38.9 32.1 35.7 50.7 38.9 44.8 31.1 51.6 49.0 37.9 34.8 46.7 35.1 34.6 56.8 43.7 43.7 96.3 45.4 42.7 48.7 61.7 49.0 41.1 73.6 54.6 51.6 29.5 73.3 30.8 58.2 34.9 49.5 101.0 55.8 57.1 35.6 74.9 58.4 50.8 53.6 39.5 91.9 57.5 33.8 62.5 54.1 56.0 61.4 52.5 54.1 63.7 47.0 58.8 48.5 76.3 65.3 53.5 56.4 40.5 96.5 87.7 49.5 61.4 27.9 31.5 27.2 59.6 51.1 53.0 56.2 47.4 67.4 48.3 46.7 56.0 31.8 50.1 45.3 59.5 67.1 37.8 56.0 67.4 23.3 36.9 29.8 30.9 34.8 32.0 26.9 27.3 26.3 41.9 26.2 29.7 27.1 21.2 28.6 30.9 21.5 31.0 38.7 49.6 53.8 51.3 55.4 48.7 53.3 58.3 52.4 46.1 51.7 50.7 51.6 56.8 15.8 19.2 15.1 10.4 28.6 19.6 23.7 13.1 22.2 30.1 23.0 20.6 13.3 17.2 16.0 20.2 20.9 36.5 23.1 22.9 21.5 29.1 129.3 22.9 20.7 18.9 19.2 25.6 7.1 24.9 39.7 23.2 21.4 23.4 24.1 18.8 16.1 19.0 22.2 25.2 8.8 15.8 16.2 25.7 17.9 469.0 21.8 19.9 19.6 18.7 40.3 23.6 22.6 11.6 17.4 26.4 21.2 24.8 24.5 37.2 19.2 20.3 19.5 17.1 46.0 19.3 18.5 33.0 34.5 22.9 17.6 52.1 23.0 22.6 19.0 28.6 RAB36 ENSG00000100228 "RAB36, member RAS oncogene family" O95755 22 23145326-23164350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 41.2;Late spermatids: 24.5;Respiratory ciliated cells: 69.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 11.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 11.0" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.5;U-266/84: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059631 Approved Vesicles NA NA Vesicles "HPA059631: " "unprognostic (2.74e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-2)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (6.60e-2)" "unprognostic (1.22e-1)" "unprognostic (3.46e-1)" "unprognostic (2.49e-2)" "unprognostic (7.94e-2)" "unprognostic (2.02e-3)" "unprognostic (5.56e-3)" "prognostic favorable (4.55e-4)" "unprognostic (7.08e-2)" "unprognostic (7.18e-2)" "unprognostic (1.64e-1)" "unprognostic (3.08e-1)" 1.6 5.1 11.9 1.4 8.6 0.7 2.7 4.8 7.9 5.0 17.9 2.4 0.7 4.8 4.5 2.1 33.1 5.3 1.2 9.9 9.4 8.4 0.4 4.9 1.1 7.8 10.3 8.2 6.3 3.4 5.7 17.2 2.9 6.2 3.9 1.1 2.0 3.4 6.6 0.6 1.6 1.2 3.8 8.8 1.6 2.1 6.8 7.9 0.3 17.7 0.4 1.3 2.5 2.1 5.9 8.1 9.4 7.1 10.7 1.6 3.4 2.8 4.5 9.1 9.8 3.7 0.6 0.0 0.0 4.8 6.0 5.4 10.0 0.3 5.2 3.1 0.0 4.3 0.1 0.4 0.9 4.1 0.0 1.2 4.3 1.9 9.1 1.8 6.4 1.4 0.0 0.4 8.1 0.4 6.4 0.1 0.1 0.9 5.3 2.5 0.0 0.0 25.5 12.7 1.5 17.3 7.5 0.4 3.9 2.2 0.5 0.0 0.9 0.8 1.3 2.9 3.4 6.5 17.3 26.2 0.1 8.8 0.0 5.8 0.3 0.6 0.0 0.5 0.2 0.3 0.8 0.1 0.2 0.2 0.2 0.3 0.3 11.0 1.6 0.3 0.0 0.0 0.3 11.9 8.6 4.8 7.9 9.9 9.4 7.8 10.3 8.2 6.2 8.8 7.9 5.9 0.6 0.0 3.2 3.6 1.4 0.5 0.8 4.2 0.0 0.7 1.8 2.8 0.8 4.3 7.0 1.8 6.2 6.0 0.3 0.0 5.9 3.5 10.6 41.2 2.9 0.7 6.7 0.0 2.9 0.2 0.4 2.0 1.5 2.6 1.3 2.4 1.1 0.1 0.4 1.7 1.7 0.7 6.1 0.8 0.3 24.5 3.4 0.3 1.8 1.0 0.5 3.6 1.0 1.5 1.0 0.2 0.2 3.0 0.3 0.4 0.0 9.6 69.6 0.7 0.0 1.0 2.0 3.6 1.6 0.5 0.1 2.9 0.4 4.5 0.3 0.4 TIMP3 SFD ENSG00000100234 "TIMP metallopeptidase inhibitor 3" P35625 22 32801705-32863041 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1663.5;Fibroblasts: 967.5;Leydig cells: 1398.6;Peritubular cells: 1934.1;Sertoli cells: 2327.1;Smooth muscle cells: 1116.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 502.6;BJ: 1173.0;BJ hTERT+: 514.7;fHDF/TERT166: 1073.7;WM-115: 893.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068391 Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 700000 Vesicles "Golgi apparatus" "HPA068391: " "unprognostic (4.98e-2)" "unprognostic (1.77e-3)" "unprognostic (1.60e-1)" "unprognostic (8.53e-4)" "unprognostic (1.67e-2)" "unprognostic (1.05e-2)" "unprognostic (7.01e-2)" "unprognostic (3.22e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (3.92e-1)" "unprognostic (1.95e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.66e-3)" "unprognostic (1.44e-2)" "unprognostic (2.55e-3)" "unprognostic (3.11e-2)" 721.4 291.5 71.9 41.8 71.3 1.1 561.6 71.3 73.2 342.7 210.7 168.8 30.7 396.6 232.4 169.7 377.2 154.9 402.2 65.7 86.1 250.3 92.7 630.6 70.0 83.6 84.8 52.0 117.2 81.8 140.6 140.2 1007.7 88.4 180.3 82.0 32.0 180.1 344.3 129.1 152.7 123.2 382.7 66.6 188.8 153.4 64.6 94.1 41.5 342.9 328.8 29.0 199.1 263.3 69.1 19.6 0.0 16.9 2.7 502.6 280.6 1.0 1173.0 514.7 94.1 110.8 20.5 0.3 0.1 28.1 1073.7 3.6 18.3 3.2 48.4 135.0 0.1 14.3 147.4 23.5 52.4 197.4 0.1 59.7 47.4 120.4 166.9 9.5 3.4 0.0 0.0 0.1 0.9 44.6 1.2 0.4 5.0 2.5 0.0 0.8 0.1 3.4 0.4 2.1 97.0 12.5 16.8 24.1 0.5 322.9 266.6 0.7 1.3 0.0 7.9 25.2 245.9 19.1 0.2 0.4 0.4 232.3 0.2 893.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 71.9 71.3 71.3 73.2 65.7 86.1 83.6 84.8 52.0 88.4 66.6 94.1 69.1 1663.5 365.4 35.9 101.9 5.3 77.4 766.2 49.5 10.2 4.0 31.2 177.2 279.9 14.3 22.2 51.5 4.2 492.2 4.6 0.3 3.9 2.5 14.9 27.9 747.6 677.3 1.8 35.3 26.1 0.7 433.7 967.5 21.4 23.9 89.2 11.4 743.9 102.0 109.2 3.3 15.7 0.0 24.4 39.3 95.0 57.7 1398.6 28.6 76.5 116.2 0.7 146.6 0.0 52.3 0.8 0.9 0.0 1934.1 9.5 159.5 0.0 15.5 8.5 5.5 2327.1 339.2 1116.6 6.2 7.0 14.3 56.4 809.0 21.5 4.8 0.7 163.4 PPP6R2 "dJ579N16.1, KIAA0685, SAP190, SAPS2" ENSG00000100239 "Protein phosphatase 6 regulatory subunit 2" O75170 22 50343304-50445090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030656, CAB034919" Uncertain Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB034919: AB_2183817, HPA030656: AB_10602926" "unprognostic (1.24e-1)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.70e-5)" "unprognostic (2.17e-1)" "unprognostic (3.79e-3)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-2)" "prognostic favorable (7.51e-4)" "unprognostic (6.89e-2)" "unprognostic (1.42e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (7.77e-3)" 21.5 35.9 21.7 21.1 24.0 21.6 23.4 21.5 32.5 23.1 16.2 27.7 24.8 25.6 11.6 28.5 24.0 18.1 33.7 23.5 17.7 29.7 73.0 25.4 27.5 25.0 20.6 22.2 25.0 29.3 21.6 41.4 14.9 28.9 31.6 11.9 12.7 28.1 17.3 66.4 27.8 28.9 14.1 15.4 32.7 30.4 63.2 22.1 26.0 31.0 32.0 16.7 24.1 22.5 21.7 30.9 17.8 27.3 34.8 19.7 21.0 24.4 30.1 31.9 31.5 31.7 15.0 18.7 36.9 14.5 30.0 17.4 24.6 16.9 22.4 11.8 19.3 30.9 19.8 37.7 37.7 25.6 46.9 52.1 31.2 23.8 19.0 10.1 24.8 27.8 30.8 20.5 31.5 23.2 50.0 32.3 33.9 11.3 19.5 21.9 44.8 20.9 24.3 23.1 36.1 17.0 23.1 31.0 47.6 25.0 10.1 17.2 35.2 32.5 29.3 26.4 24.6 20.3 33.6 8.7 32.7 30.6 22.6 41.2 4.0 8.6 5.8 9.0 9.4 10.4 7.9 6.2 9.6 8.8 8.4 5.9 7.9 13.7 5.9 6.8 11.0 13.3 8.5 21.7 24.0 21.5 32.5 23.5 17.7 25.0 20.6 22.2 28.9 15.4 22.1 21.7 28.5 22.4 20.6 79.0 32.0 8.8 14.4 12.9 22.8 43.7 25.5 21.8 19.2 37.1 17.1 27.6 56.3 17.3 39.9 39.8 31.3 19.3 84.0 30.8 39.0 18.1 26.9 19.8 83.0 32.5 11.8 15.3 35.2 34.8 31.8 23.9 18.9 65.1 16.0 65.6 80.8 23.0 16.2 25.3 8.8 48.6 19.6 23.4 10.6 61.8 32.1 25.0 50.4 52.8 59.9 33.3 29.0 19.9 42.0 19.4 27.0 23.6 17.9 43.2 26.3 16.9 18.7 78.5 47.1 17.9 8.5 28.5 28.4 17.8 25.2 17.5 SBF1 "DENND7A, MTMR5" ENSG00000100241 "SET binding factor 1" O95248 22 50445000-50475035 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074004 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA074004: AB_2732249" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (7.39e-2)" "unprognostic (4.87e-2)" "unprognostic (6.11e-2)" "prognostic favorable (3.46e-5)" "unprognostic (2.21e-3)" "unprognostic (1.14e-1)" "unprognostic (2.32e-2)" "unprognostic (3.60e-3)" "unprognostic (1.78e-1)" "unprognostic (1.75e-2)" "unprognostic (2.42e-2)" "unprognostic (3.29e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-2)" "unprognostic (2.05e-1)" 25.6 32.6 45.6 22.5 44.6 20.7 24.4 24.6 73.0 26.1 5.8 32.0 15.0 29.8 3.3 44.2 27.4 10.7 34.3 61.5 30.4 30.5 23.5 27.0 29.1 46.2 34.7 48.0 30.7 48.4 7.2 28.9 8.9 43.4 28.7 4.9 6.6 27.2 11.7 76.3 41.9 38.9 8.8 30.2 35.7 30.4 112.1 35.5 33.0 62.8 14.5 14.9 28.5 27.5 57.8 34.3 28.2 24.0 32.9 24.3 18.6 65.9 23.5 20.1 21.6 17.7 39.0 23.7 78.1 16.7 27.9 23.9 31.4 19.9 28.7 5.3 28.6 76.0 17.6 59.6 50.7 41.7 54.7 26.1 25.0 44.6 28.1 21.0 17.0 14.8 41.6 28.8 20.8 15.0 42.6 54.8 52.4 10.1 26.1 31.7 71.0 45.6 48.3 12.8 27.3 19.1 46.0 36.5 35.5 47.7 10.5 20.7 25.2 25.1 33.9 49.6 24.3 29.7 38.1 13.4 37.6 38.8 22.1 32.7 0.5 1.3 2.1 4.4 1.3 2.4 2.6 3.0 3.5 1.6 1.6 2.2 3.6 1.9 1.9 2.6 5.6 2.6 2.3 45.6 44.6 24.6 73.0 61.5 30.4 46.2 34.7 48.0 43.4 30.2 35.5 57.8 5.7 6.4 11.8 10.7 13.7 13.4 4.6 9.3 6.8 15.5 11.3 9.1 7.6 4.3 9.4 3.7 10.4 4.9 21.4 19.9 1.9 7.2 32.8 10.3 8.9 5.6 3.6 8.6 11.3 12.5 7.9 10.6 24.5 11.4 1.3 20.4 5.7 9.1 6.9 11.8 10.9 13.2 10.2 6.9 10.7 21.4 6.5 9.5 5.4 5.6 10.8 6.9 21.6 11.1 31.7 19.9 8.1 6.0 15.6 11.6 16.0 7.7 11.1 10.0 6.6 12.3 11.6 25.5 23.5 21.3 14.6 11.5 19.8 12.2 12.3 10.1 SUN2 UNC84B ENSG00000100242 "Sad1 and UNC84 domain containing 2" Q9UH99 22 38734725-38794143 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 201.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001209 Supported Supported "Nuclear membrane" NA Yes "Nuclear membrane" "HPA001209: AB_1080465" "unprognostic (9.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" "unprognostic (5.09e-2)" "unprognostic (1.36e-1)" "unprognostic (5.57e-2)" "unprognostic (1.94e-2)" "unprognostic (2.37e-2)" "unprognostic (3.14e-2)" "unprognostic (1.25e-3)" "unprognostic (8.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (8.10e-2)" "unprognostic (2.33e-2)" 124.6 35.5 107.1 74.3 199.2 161.8 112.6 140.6 125.2 91.5 43.1 96.0 48.0 129.3 22.4 84.7 126.4 41.5 84.5 109.7 131.5 52.6 122.9 107.9 104.8 182.9 179.0 83.4 113.9 78.7 18.3 40.6 29.0 179.0 78.9 25.4 12.4 75.5 52.6 146.6 85.8 93.9 46.6 116.1 98.0 95.1 34.9 160.2 75.0 53.6 64.4 60.5 122.8 89.7 252.2 89.8 41.0 40.0 44.7 118.8 29.5 52.0 60.2 69.4 69.7 58.9 36.8 98.7 28.1 71.9 85.9 43.1 65.4 13.4 44.7 28.4 98.0 54.7 18.4 44.7 33.7 71.9 62.3 184.0 25.0 37.3 33.6 31.2 46.9 56.2 55.3 23.5 154.3 38.5 28.7 35.0 53.9 3.9 63.0 26.2 57.6 55.8 85.7 17.4 43.1 35.3 13.2 67.0 73.7 35.1 18.5 49.5 115.3 95.2 50.6 43.3 44.9 79.5 113.1 38.2 30.4 93.8 74.2 86.6 29.0 13.7 18.6 42.3 15.6 27.5 10.8 27.0 34.9 10.7 10.1 27.6 33.6 13.9 24.8 26.9 6.7 19.9 24.8 107.1 199.2 140.6 125.2 109.7 131.5 182.9 179.0 83.4 179.0 116.1 160.2 252.2 55.5 22.4 22.9 20.2 57.0 18.1 28.4 15.1 24.5 9.9 36.5 39.0 6.2 40.0 17.8 33.1 8.4 16.9 141.8 65.6 3.9 34.9 1.8 11.6 15.8 37.4 18.6 31.8 12.5 47.6 65.9 34.0 42.8 32.9 25.4 41.5 52.1 109.6 25.0 21.9 7.7 30.1 8.2 42.4 21.4 4.4 61.2 41.8 17.8 16.9 25.5 21.4 201.8 7.1 132.9 60.0 41.8 65.5 44.7 22.0 42.2 18.9 5.7 13.0 52.6 100.7 37.0 3.8 1.1 32.1 17.2 14.8 133.4 10.9 21.4 21.4 CYB5R3 DIA1 ENSG00000100243 "Cytochrome b5 reductase 3" P00387 22 42617840-42649392 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 830.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001566 Approved Supported "Endoplasmic reticulum" NA NA 1500000 "Endoplasmic reticulum" "HPA001566: AB_1078601" "unprognostic (4.73e-2)" "unprognostic (2.93e-1)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (2.45e-1)" "unprognostic (8.22e-3)" "unprognostic (3.01e-1)" "unprognostic (2.72e-2)" "unprognostic (6.76e-2)" "unprognostic (3.33e-3)" "unprognostic (1.31e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-1)" "unprognostic (5.24e-2)" 354.7 313.1 124.0 88.2 120.5 83.4 274.5 122.2 191.5 229.6 103.1 179.0 95.7 250.5 59.3 153.6 175.5 140.7 356.1 115.0 129.4 182.3 281.7 203.0 76.9 173.5 129.3 100.4 220.1 89.9 62.5 138.4 108.7 148.9 182.9 75.6 27.5 151.0 241.5 204.7 221.4 139.2 202.0 131.5 102.2 183.5 143.8 134.1 54.5 159.1 141.8 72.9 218.5 211.8 140.2 125.5 78.6 126.6 78.6 830.9 654.7 74.4 359.2 330.0 262.2 232.4 104.0 95.6 58.8 156.6 668.8 113.8 112.4 85.3 178.0 133.7 63.9 187.3 83.6 127.3 202.4 211.0 118.4 149.5 397.4 138.1 188.9 124.5 190.8 220.0 74.0 73.5 296.3 361.9 137.9 116.8 108.4 51.0 129.2 142.7 84.9 153.8 131.3 202.0 90.6 56.1 73.2 118.6 113.2 134.0 92.6 90.6 112.0 340.9 282.0 175.3 192.3 137.9 78.3 91.2 72.4 328.8 67.8 237.9 126.3 104.0 300.3 75.9 135.3 76.6 110.1 72.8 83.9 154.0 102.7 50.8 54.0 53.8 63.5 176.7 140.8 95.0 86.4 124.0 120.5 122.2 191.5 115.0 129.4 173.5 129.3 100.4 148.9 131.5 134.1 140.2 238.5 86.6 62.2 17.0 51.7 110.1 95.5 184.8 27.3 16.7 52.3 73.2 106.4 105.8 100.9 60.7 4.2 110.0 37.0 90.5 49.0 216.4 4.8 51.4 82.9 161.5 83.7 113.9 12.3 107.0 199.3 183.4 38.2 65.4 62.8 57.8 180.2 230.4 108.3 16.8 16.1 45.8 142.4 50.6 112.0 17.0 253.9 67.7 176.1 25.3 112.5 91.0 33.0 7.1 26.4 156.8 85.6 280.6 36.7 82.3 116.9 110.8 53.3 18.4 190.7 62.5 202.5 23.8 45.5 57.5 112.7 117.9 43.0 233.1 55.2 96.4 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 124.1;Late spermatids: 210.7;Spermatocytes: 77.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 64.0" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 11.0 18.1 27.5 6.8 31.2 4.5 14.7 19.8 36.8 18.5 21.0 12.8 8.0 12.3 15.1 19.1 35.7 13.0 13.5 27.4 26.9 24.6 11.2 14.0 8.1 21.6 22.0 28.9 17.6 21.5 31.3 31.1 10.0 20.4 18.5 9.7 13.9 18.3 12.2 7.1 17.6 9.9 7.6 20.2 11.5 16.6 66.0 24.3 14.4 25.6 6.3 8.4 14.4 15.7 23.6 17.9 8.9 17.5 15.5 21.8 21.7 0.0 7.5 14.0 11.4 12.2 5.7 20.1 4.5 15.7 10.7 13.1 8.3 11.0 20.5 7.7 11.4 14.8 2.6 2.5 6.6 34.9 14.5 3.7 17.1 64.0 14.9 26.8 29.7 16.6 22.1 5.3 8.5 13.8 21.9 13.6 14.0 6.8 26.3 7.4 12.8 7.5 5.9 23.7 10.8 24.3 13.5 15.4 11.5 30.7 12.1 20.7 13.7 9.8 10.1 10.1 15.5 7.5 5.3 1.8 2.1 29.9 4.9 9.8 15.0 8.5 11.9 11.2 8.9 13.8 7.1 9.3 10.2 8.7 10.6 10.5 9.0 15.0 16.2 11.3 13.2 9.3 7.5 27.5 31.2 19.8 36.8 27.4 26.9 21.6 22.0 28.9 20.4 20.2 24.3 23.6 8.2 6.4 10.5 5.5 5.1 5.6 13.4 18.9 10.2 15.0 20.6 17.8 4.3 14.3 15.2 3.7 2.1 27.6 9.7 10.9 31.3 28.4 124.1 56.4 11.8 8.5 12.6 11.2 11.0 15.5 21.2 10.1 6.1 10.5 15.2 20.3 12.8 3.8 13.7 11.8 10.6 14.7 14.2 4.4 2.8 210.7 11.8 6.5 8.8 4.7 5.7 18.9 8.2 6.6 5.1 18.4 9.1 7.5 1.3 9.8 8.5 20.0 41.0 15.4 6.6 6.6 11.6 77.7 20.0 9.1 10.5 19.8 6.0 20.1 13.2 12.0 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 2.7;parathyroid gland: 3.1;testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 70.0;Late spermatids: 43.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.0 0.3 1.5 0.0 2.1 0.0 0.3 2.0 2.7 0.3 1.2 0.3 0.2 0.3 0.9 0.3 0.3 0.0 0.1 1.7 1.7 0.2 0.0 0.2 0.0 1.4 1.4 1.5 0.6 0.0 3.1 0.4 0.0 1.5 0.2 0.2 0.3 0.4 0.1 0.2 0.4 0.3 0.1 1.1 0.1 0.4 8.7 1.4 1.1 0.2 0.3 0.1 0.3 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.1 2.0 2.7 1.7 1.7 1.4 1.4 1.5 1.5 1.1 1.4 1.6 0.0 0.0 0.0 8.5 0.0 0.1 0.2 0.2 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 70.0 0.3 1.6 0.1 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 43.3 0.9 0.0 1.8 1.0 0.0 3.3 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 3.7 0.2 1.0 0.5 0.2 0.9 0.0 0.1 1.0 0.1 0.1 MIOX ALDRL6 ENSG00000100253 "Myo-inositol oxygenase" Q9UGB7 22 50486784-50490648 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "kidney: 707.3" "Cell type enriched" "Detected in some" 10 "Proximal tubular cells: 4564.6" "Cancer enriched" "Detected in many" 16 "renal cancer: 56.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 24.9;Hep G2: 5.7;Karpas-707: 12.8;U-266/70: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039451, HPA039562" Enhanced NA NA "HPA039451: AB_2676513, HPA039562: AB_2676574" "unprognostic (2.11e-1)" "unprognostic (4.32e-2)" "unprognostic (2.22e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (5.25e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-3)" "unprognostic (2.84e-1)" "unprognostic (4.72e-2)" "unprognostic (1.85e-2)" "unprognostic (9.83e-2)" "prognostic favorable (2.60e-6)" "unprognostic (1.77e-1)" "unprognostic (1.50e-1)" "unprognostic (1.36e-2)" "unprognostic (2.23e-2)" 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.7 0.5 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 5.3 0.0 0.2 0.2 707.3 0.4 0.0 0.7 0.2 0.1 0.2 0.0 1.2 0.0 0.1 0.1 0.3 0.5 0.0 0.1 0.3 0.1 0.0 0.3 0.2 0.0 0.1 0.2 1.1 0.2 0.2 0.2 14.8 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.1 2.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.6 0.4 0.0 0.2 0.2 0.0 0.0 24.9 0.0 0.2 0.4 5.7 2.8 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.1 12.8 0.0 1.2 0.0 0.1 0.2 0.5 0.4 0.1 0.1 0.1 2.6 0.1 0.1 0.3 0.0 0.0 0.6 0.5 0.1 1.4 0.0 0.0 0.5 0.1 0.1 7.8 0.7 0.3 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.7 0.5 0.2 0.2 0.2 0.1 0.2 0.3 0.1 0.2 0.3 0.2 0.0 1.7 0.0 13.0 0.8 0.9 0.1 0.0 0.6 0.7 0.8 0.1 1.5 0.0 99.3 0.0 0.0 0.3 0.3 424.6 0.0 0.0 0.1 0.2 0.2 1.2 0.0 0.0 0.9 0.1 0.3 0.0 0.2 0.0 0.1 0.4 0.3 0.1 0.0 0.0 0.9 0.0 0.0 1.6 0.0 0.0 23.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 4564.6 0.0 0.5 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.3 7.8 0.0 0.1 0.9 LMF2 "TMEM112B, TMEM153" ENSG00000100258 "Lipase maturation factor 2" Q9BU23 22 50502949-50507702 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 182.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062626 Approved Approved Centrosome NA NA Centrosome "HPA062626: AB_2684812" "unprognostic (2.69e-1)" "prognostic favorable (3.47e-4)" "unprognostic (8.67e-2)" "unprognostic (2.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.13e-2)" "unprognostic (1.21e-2)" "unprognostic (2.70e-2)" "unprognostic (5.11e-2)" "unprognostic (2.90e-1)" "unprognostic (2.97e-2)" "unprognostic (3.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.08e-1)" "unprognostic (2.54e-2)" "unprognostic (8.75e-2)" 48.6 44.2 17.6 20.8 18.0 33.9 46.8 17.7 30.2 50.0 27.4 40.6 26.2 44.3 8.4 48.4 42.4 15.4 37.3 17.8 20.1 48.5 57.0 47.2 22.5 21.8 17.9 16.5 48.2 182.4 13.0 63.9 18.2 19.9 51.7 5.7 3.7 49.9 20.2 23.9 36.3 51.8 9.4 18.7 61.0 38.3 42.3 18.1 13.2 57.2 7.6 9.5 45.5 44.9 20.1 48.9 36.0 20.1 38.4 28.6 24.4 46.8 85.4 44.5 53.7 60.0 35.9 24.8 21.4 22.6 45.2 23.9 57.3 6.8 27.0 7.4 17.1 74.7 12.0 69.3 38.4 35.8 22.4 45.1 36.0 24.6 36.7 9.0 23.1 30.1 16.5 14.4 70.0 23.7 35.1 15.9 26.4 12.0 12.4 44.4 35.7 32.3 58.9 22.0 26.1 18.0 26.5 58.2 49.8 40.1 9.7 28.6 15.6 44.3 75.3 42.8 54.6 4.3 26.9 9.4 13.1 54.8 13.6 62.9 16.3 17.9 22.4 26.1 23.5 19.6 13.4 21.6 24.4 18.6 8.6 12.3 13.2 16.5 16.7 20.5 33.8 21.2 18.6 17.6 18.0 17.7 30.2 17.8 20.1 21.8 17.9 16.5 19.9 18.7 18.1 20.1 42.0 12.8 10.8 13.4 26.4 18.6 17.1 37.5 19.9 15.7 23.1 18.7 11.4 28.6 24.5 14.7 22.9 64.4 43.1 55.6 3.9 37.1 9.4 7.6 21.7 25.7 15.0 22.9 14.9 74.9 106.4 39.9 27.5 17.3 15.8 32.7 27.8 33.6 43.1 11.8 11.6 29.4 18.3 21.6 26.7 20.5 29.2 26.1 24.9 13.1 21.5 23.3 40.2 12.5 10.1 30.8 55.7 25.6 49.9 10.8 74.4 19.3 9.4 16.0 19.7 17.9 29.6 12.6 20.1 29.9 17.3 28.5 34.8 32.0 34.2 15.0 RHBDD3 "C22orf3, PTAG" ENSG00000100263 "Rhomboid domain containing 3" Q9Y3P4 22 29259872-29268209 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043979 Approved Approved Microtubules NA NA Microtubules "HPA043979: AB_10960539" "unprognostic (9.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.22e-1)" "prognostic favorable (2.67e-6)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.13e-3)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (8.46e-2)" "unprognostic (4.42e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.11e-3)" "unprognostic (1.84e-1)" "unprognostic (1.03e-1)" "unprognostic (3.42e-3)" 7.0 20.8 5.7 2.4 5.9 2.9 7.0 5.6 10.9 6.8 4.6 7.0 4.9 9.0 1.3 8.7 8.7 1.8 9.9 5.6 5.9 9.4 16.9 6.8 1.9 7.5 6.3 4.8 8.1 11.9 2.7 15.0 2.2 6.0 13.5 0.6 0.9 7.7 4.4 10.1 6.3 7.1 1.6 5.9 10.8 7.2 22.4 6.1 2.3 10.8 0.5 0.9 7.0 6.0 6.4 4.6 7.7 4.2 12.3 1.3 2.2 23.5 2.9 3.8 3.5 4.4 6.9 10.1 12.6 12.4 2.8 2.1 14.2 2.5 2.3 0.4 16.7 19.9 4.6 6.5 8.6 15.0 10.4 11.5 6.6 6.2 1.5 4.2 2.5 4.8 5.1 5.6 8.3 2.6 9.0 6.8 15.8 19.8 2.9 8.6 11.9 7.8 14.6 1.5 4.6 9.2 4.8 9.9 10.6 12.3 1.0 7.0 9.0 7.0 9.5 4.2 4.0 4.4 20.3 6.6 15.1 4.0 4.6 8.1 0.0 4.6 1.9 2.5 4.1 3.1 1.8 2.4 3.7 4.7 0.9 1.8 2.5 1.4 3.6 3.8 11.2 3.9 2.5 5.7 5.9 5.6 10.9 5.6 5.9 7.5 6.3 4.8 6.0 5.9 6.1 6.4 8.4 6.4 7.0 22.2 5.1 6.1 11.7 19.9 5.2 17.2 12.1 9.8 8.4 8.6 16.0 14.7 6.2 44.4 12.8 19.0 0.0 18.6 9.0 19.0 12.8 10.0 8.4 11.2 14.4 19.8 18.7 14.1 21.9 24.6 0.0 21.7 12.8 15.7 25.6 16.8 16.5 15.1 12.2 9.7 5.5 7.4 14.0 7.5 7.2 12.2 7.8 14.5 7.2 11.1 9.9 13.2 16.1 12.0 9.5 16.0 15.9 7.1 12.1 22.9 6.6 9.0 10.2 29.8 26.6 8.6 6.0 38.3 7.4 26.3 17.7 9.6 PACSIN2 SDPII ENSG00000100266 "Protein kinase C and casein kinase substrate in neurons 2" Q9UNF0 22 42835412-43015149 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 95.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049854, HPA056520" Enhanced Supported "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" NA NA 2400000 "Nuclear speckles, Vesicles, Cytosol" "Plasma membrane" "HPA049854: AB_2680915, HPA056520: AB_2683163" "unprognostic (5.62e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-3)" "unprognostic (1.63e-2)" "unprognostic (3.96e-1)" "prognostic unfavorable (7.33e-4)" "unprognostic (4.48e-2)" "unprognostic (3.40e-2)" "unprognostic (2.82e-3)" "unprognostic (3.09e-2)" "unprognostic (1.00e-1)" "prognostic favorable (1.09e-13)" "unprognostic (2.87e-1)" "unprognostic (1.11e-1)" "unprognostic (6.20e-2)" "unprognostic (2.95e-1)" 37.6 74.9 27.1 37.4 28.2 29.6 41.1 34.5 27.5 35.1 32.0 55.5 41.2 39.4 21.4 34.4 35.7 45.7 51.3 27.7 40.9 46.9 41.5 51.4 34.5 38.2 36.1 21.7 31.6 163.8 29.6 40.2 34.4 41.3 47.4 42.0 28.4 43.8 27.7 50.2 37.5 38.4 30.7 30.4 36.2 51.9 19.6 31.0 29.0 44.2 42.8 26.6 36.8 34.8 34.5 76.3 78.3 64.6 41.5 32.6 34.6 52.9 67.8 40.7 59.9 49.7 82.1 43.8 35.2 56.1 50.6 40.8 52.8 42.5 72.1 39.3 36.1 42.4 56.8 39.4 117.8 46.1 40.5 118.1 33.4 69.8 79.1 34.3 48.7 49.9 32.1 49.9 24.9 52.2 49.7 43.1 63.3 35.6 110.4 32.7 52.3 96.5 23.8 68.9 44.4 41.9 18.7 81.1 55.2 155.8 41.5 40.1 53.1 74.3 44.5 56.4 50.0 40.5 18.4 27.2 38.4 42.7 35.4 99.1 26.1 18.5 47.4 6.8 32.2 7.3 11.3 7.8 5.8 21.5 11.6 7.6 5.8 95.7 16.8 33.9 7.9 12.1 14.1 27.1 28.2 34.5 27.5 27.7 40.9 38.2 36.1 21.7 41.3 30.4 31.0 34.5 31.7 70.5 60.6 20.2 20.6 23.2 43.4 23.9 21.1 15.7 37.4 31.1 26.3 24.3 37.2 46.0 39.6 34.4 19.9 142.6 45.0 80.2 3.6 51.6 31.3 28.6 24.7 12.6 22.7 65.4 29.6 20.9 36.7 57.4 71.0 14.7 16.1 22.3 42.7 6.7 41.0 49.5 30.5 38.5 50.0 6.2 21.8 44.9 83.6 54.4 51.3 8.4 7.2 29.1 19.5 70.9 62.3 23.3 13.1 50.6 32.0 55.0 30.7 24.9 92.1 23.5 82.9 22.6 27.6 22.5 16.9 48.2 19.1 13.8 42.2 30.3 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039516-43089419 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.9;Spermatogonia: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria No No Nucleoli Mitochondria "HPA048392: AB_2680384" "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavorable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favorable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 3.7 7.2 9.7 2.7 9.9 2.3 4.6 9.9 12.2 4.9 6.5 4.5 1.8 5.9 8.2 3.9 9.9 3.9 8.5 10.4 9.5 5.2 1.7 3.8 3.8 7.7 8.2 9.3 5.4 3.6 6.0 9.8 2.7 8.2 4.9 3.1 11.4 4.7 3.9 3.4 4.9 3.2 4.0 7.3 3.3 4.1 13.6 9.5 5.6 7.0 3.7 3.4 4.7 4.8 8.7 0.9 0.8 17.5 12.3 18.8 17.1 0.5 5.8 6.5 3.3 5.6 0.0 2.6 1.0 3.5 10.6 1.8 0.6 1.5 1.5 3.4 1.4 2.7 1.7 0.6 1.6 13.3 4.5 2.2 13.5 21.8 2.0 5.4 14.3 10.7 14.2 0.5 10.8 12.3 5.5 4.3 7.4 2.2 4.6 1.2 9.3 9.2 0.2 6.1 1.5 4.0 8.2 4.6 2.4 16.0 9.1 6.3 7.4 10.1 3.4 2.3 7.7 0.8 3.6 0.7 0.5 9.1 8.2 6.2 4.7 5.5 6.7 10.6 5.9 11.2 2.7 9.8 12.3 9.8 4.5 8.4 10.5 1.2 10.5 4.8 6.5 6.4 5.7 9.7 9.9 9.9 12.2 10.4 9.5 7.7 8.2 9.3 8.2 7.3 9.5 8.7 3.8 0.0 2.7 3.9 1.5 2.3 2.4 5.9 2.8 5.1 6.2 7.2 5.0 1.5 5.6 1.8 6.2 2.7 3.4 1.1 15.6 7.3 39.9 12.8 6.6 4.1 0.0 2.1 8.8 4.9 1.3 5.9 3.6 4.1 1.3 9.2 5.7 0.3 4.9 5.0 9.0 3.0 16.2 4.0 2.2 18.2 4.1 2.4 8.8 3.7 4.4 6.4 7.2 4.0 3.8 4.5 6.6 6.0 0.5 2.4 0.6 7.2 20.0 11.5 6.6 5.6 3.7 10.7 32.6 4.8 2.7 0.7 5.9 5.5 1.8 2.2 RASL10A RRP22 ENSG00000100276 "RAS like family 10 member A" Q92737 22 29312933-29319679 "Enzymes, Predicted intracellular proteins" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.3" "Cell type enhanced" "Detected in many" "Astrocytes: 17.9;Breast glandular cells: 35.9;Breast myoepithelial cells: 58.3;Excitatory neurons: 35.1;Rod photoreceptor cells: 19.6" "Group enriched" "Detected in some" 4 "glioma: 2.5;testis cancer: 3.4;urothelial cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.6;NB-4: 2.5;U-2 OS: 1.1;U-266/70: 2.7;U-266/84: 1.0" "Group enriched" "Detected in many" 6 "amygdala: 33.7;basal ganglia: 16.7;cerebral cortex: 36.0;hippocampal formation: 26.3;white matter: 15.3" "Group enriched" "Detected in many" 4 "cerebral cortex: 35.6;hippocampal formation: 27.8" HPA056169 Approved NA NA "HPA056169: AB_2683053" "unprognostic (1.94e-1)" "unprognostic (2.51e-4)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.16e-1)" "unprognostic (7.99e-2)" "unprognostic (9.42e-2)" "unprognostic (1.61e-2)" "unprognostic (5.00e-4)" "unprognostic (2.44e-1)" "unprognostic (7.00e-4)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (3.61e-3)" 0.8 1.4 28.3 0.3 24.7 0.1 2.1 7.6 27.2 0.3 6.8 0.6 0.3 0.6 0.1 0.4 0.6 0.1 2.8 26.1 13.2 1.2 0.9 1.2 0.1 12.6 13.2 26.9 0.2 0.4 0.1 5.1 0.2 17.0 2.0 0.0 2.6 1.0 0.1 0.7 0.7 1.1 0.0 9.6 1.2 0.5 1.8 14.0 0.1 1.1 0.1 0.1 0.5 0.3 19.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.4 0.0 2.5 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.5 0.5 0.2 0.1 0.0 1.1 0.0 0.1 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 24.7 7.6 27.2 26.1 13.2 12.6 13.2 26.9 17.0 9.6 14.0 19.0 3.9 0.0 0.0 17.9 0.4 0.4 0.6 0.0 0.0 6.8 35.9 58.3 1.1 1.5 0.0 0.0 6.2 0.2 1.0 0.7 0.0 0.0 1.3 0.8 0.3 3.1 0.0 0.0 35.1 0.0 4.7 0.5 1.5 1.4 0.0 0.5 7.9 0.5 1.1 0.0 4.4 1.1 0.0 2.6 5.8 0.5 0.3 2.7 0.0 4.7 0.2 3.3 0.0 3.0 3.9 0.1 0.1 0.0 0.3 1.7 0.2 0.1 0.2 19.6 0.0 13.4 0.5 1.5 3.9 0.3 0.6 0.5 0.5 0.6 0.4 0.2 AP1B1 "ADTB1, AP105A, BAM22, CLAPB2" ENSG00000100280 "Adaptor related protein complex 1 subunit beta 1" Q10567 22 29327680-29388583 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065226, HPA068520" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 660000 "Golgi apparatus" "Vesicles, Cytosol" "HPA065226: AB_2685438, HPA068520: AB_2685998" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (2.40e-1)" "unprognostic (2.21e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-3)" "unprognostic (1.60e-1)" "prognostic favorable (7.24e-6)" "unprognostic (1.85e-2)" "unprognostic (3.78e-2)" "unprognostic (2.94e-2)" "unprognostic (3.76e-2)" 31.0 47.1 32.0 47.6 36.1 46.2 26.6 31.1 45.5 21.7 27.9 34.3 43.7 22.9 12.2 63.5 23.7 30.7 23.3 30.2 33.2 34.7 35.1 30.4 58.3 41.3 38.4 27.5 17.6 38.6 67.5 39.5 45.2 44.0 38.6 30.4 35.6 40.6 26.1 24.7 46.9 46.0 27.4 31.5 53.0 41.2 24.9 38.9 34.5 29.9 20.7 54.8 39.8 32.5 43.4 84.6 47.5 49.3 50.2 37.0 27.0 60.0 59.8 65.5 71.2 68.2 74.4 33.2 46.1 37.2 68.4 33.0 74.6 71.5 97.6 45.2 58.2 102.0 79.1 60.8 42.0 38.9 114.1 99.9 38.6 36.0 67.5 55.0 33.0 98.7 17.2 54.6 54.9 48.3 93.7 45.5 36.8 37.3 124.8 53.3 89.0 54.3 119.9 50.2 194.5 75.9 52.2 74.0 82.5 36.4 33.5 66.7 49.5 84.6 79.1 48.8 46.0 62.1 60.4 32.5 84.6 56.1 48.1 46.7 0.0 29.3 5.7 9.2 29.2 9.1 16.2 6.3 7.9 28.7 18.2 4.9 5.2 3.0 7.2 31.7 9.0 8.8 24.2 32.0 36.1 31.1 45.5 30.2 33.2 41.3 38.4 27.5 44.0 31.5 38.9 43.4 17.8 12.8 16.4 27.7 53.0 7.1 9.3 16.7 16.5 26.3 26.2 20.8 16.1 21.5 16.4 22.0 39.6 52.3 15.1 69.6 23.5 41.2 7.5 16.4 11.6 19.8 21.6 40.0 24.1 40.7 30.1 12.1 33.6 30.1 5.1 13.2 35.3 34.3 138.9 45.4 25.6 24.9 18.3 95.5 24.2 13.1 11.8 65.7 12.4 51.5 29.8 28.4 9.2 16.1 14.0 65.9 33.2 12.4 28.5 17.5 51.2 30.1 14.5 42.1 6.6 17.8 12.7 23.5 17.6 33.0 9.1 68.3 17.0 39.6 36.2 18.1 HMGXB4 "HMG2L1, THC211630" ENSG00000100281 "HMG-box containing 4" Q9UGU5 22 35257452-35295807 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000725, HPA076681" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000725: AB_1079073, HPA076681: " "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "prognostic favorable (3.24e-5)" "unprognostic (4.81e-2)" "unprognostic (1.93e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.85e-2)" "unprognostic (8.25e-3)" "unprognostic (6.67e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.62e-1)" "unprognostic (8.71e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.54e-2)" 8.0 4.8 5.2 7.9 6.5 23.7 8.2 6.9 7.3 6.7 4.3 6.7 6.5 11.7 3.7 8.7 7.7 7.1 6.5 5.7 5.7 4.1 5.1 5.6 7.6 6.9 5.8 5.0 14.1 7.1 8.3 2.2 9.0 6.6 7.5 7.5 8.6 6.8 6.3 7.3 6.7 6.7 9.5 5.0 6.3 5.1 7.9 6.6 11.4 6.8 7.3 7.8 8.7 5.4 8.7 22.6 4.9 37.6 17.6 9.3 16.4 9.9 22.3 31.6 22.1 20.1 4.3 8.9 27.5 10.2 23.3 13.4 13.0 14.9 18.3 26.2 23.3 18.6 24.6 6.5 5.3 11.2 56.8 25.1 15.8 14.0 18.5 14.2 13.3 16.8 21.0 19.7 21.6 17.1 11.0 35.1 15.1 15.7 15.6 14.2 25.3 32.5 10.7 13.8 17.5 22.1 23.0 19.6 15.6 16.5 10.6 9.6 16.1 13.3 20.1 41.9 24.1 19.5 26.1 25.5 34.8 17.1 15.9 31.7 34.5 12.5 16.9 13.4 14.8 11.7 10.4 13.1 14.3 9.8 13.3 8.4 9.6 19.0 9.6 13.8 10.8 12.1 5.9 5.2 6.5 6.9 7.3 5.7 5.7 6.9 5.8 5.0 6.6 5.0 6.6 8.7 30.6 12.8 18.5 18.3 30.9 20.9 52.3 33.3 16.5 60.6 26.0 25.1 14.4 34.3 29.7 27.6 35.5 48.0 30.1 31.5 29.4 40.4 14.7 22.2 35.5 32.4 16.9 56.6 17.7 29.3 54.5 34.8 27.5 31.9 52.1 51.9 36.8 24.1 31.8 67.3 20.5 31.9 28.5 26.4 17.6 12.7 53.7 29.1 8.8 7.5 32.1 21.0 34.0 17.1 31.5 35.3 27.4 56.8 21.2 58.1 26.4 21.0 15.6 73.5 39.5 46.4 32.9 67.0 82.9 28.0 22.6 64.7 30.4 33.1 32.3 57.8 TOM1 ENSG00000100284 "Target of myb1 membrane trafficking protein" O60784 22 35299275-35347992 "Cancer-related genes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 215.6" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000818, HPA001749" Approved Approved "Plasma membrane,Centriolar satellite,Cytosol" NA NA 44000 Cytosol "Plasma membrane, Centriolar satellite" "HPA000818: AB_2666101, HPA001749: AB_1080323" "unprognostic (3.75e-1)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.11e-2)" "unprognostic (7.55e-2)" "unprognostic (4.07e-3)" "unprognostic (2.24e-1)" "unprognostic (9.92e-2)" "unprognostic (2.32e-1)" "unprognostic (3.71e-1)" "unprognostic (8.16e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.22e-1)" "unprognostic (1.30e-1)" "unprognostic (7.54e-3)" "unprognostic (3.31e-2)" 32.2 48.2 18.3 17.2 17.1 61.3 32.4 18.0 26.0 36.0 19.6 20.4 29.4 26.8 12.8 77.1 27.0 25.2 42.6 17.3 23.7 32.7 49.4 37.4 15.4 25.9 20.9 17.3 21.7 20.4 48.9 37.7 27.9 30.9 23.4 9.9 6.0 61.1 11.8 215.6 69.4 28.6 10.9 18.1 24.1 21.0 26.1 23.4 13.2 26.7 69.2 12.8 19.6 45.4 24.4 15.8 15.3 8.8 14.3 58.3 34.9 42.3 15.5 43.8 28.4 31.1 21.5 14.3 6.2 28.0 45.4 18.3 7.3 8.6 15.6 9.9 18.7 21.3 5.3 17.1 43.8 58.6 10.8 23.6 49.8 19.2 39.6 13.3 18.5 19.8 11.6 10.3 15.3 14.1 13.8 8.2 27.5 7.0 18.9 8.6 14.9 12.3 13.2 10.9 11.3 14.9 12.1 34.1 34.8 34.5 7.3 18.0 16.7 22.0 34.0 29.4 27.3 7.7 18.0 12.4 16.7 45.7 10.5 11.4 18.6 100.9 44.5 19.3 60.7 15.6 13.6 29.5 18.4 48.0 11.0 22.6 15.7 129.1 15.1 66.2 25.9 48.2 63.3 18.3 17.1 18.0 26.0 17.3 23.7 25.9 20.9 17.3 30.9 18.1 23.4 24.4 10.1 22.4 36.9 8.8 12.7 12.7 10.3 29.5 7.4 11.1 19.1 11.0 23.2 15.7 33.0 12.9 12.5 64.6 13.8 41.6 27.4 40.9 29.9 32.0 17.8 14.2 16.2 9.7 9.3 38.9 57.1 22.6 15.3 48.0 22.8 10.4 16.1 34.0 60.8 11.8 15.2 18.1 50.8 33.5 35.2 21.4 11.5 45.2 19.6 7.5 34.0 19.5 9.2 6.6 13.2 34.2 21.5 12.8 5.7 11.9 55.3 34.9 24.2 8.2 6.6 16.6 15.4 23.5 5.6 17.3 21.9 170.2 18.2 13.4 15.2 10.7 NEFH "NF-H, NFH" ENSG00000100285 "Neurofilament heavy" P12036 22 29480218-29491390 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 527.8;prostate: 248.1" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 20.9;monocytes: 34.6;Prostatic glandular cells: 44.0;Spermatogonia: 29.5;Theca cells: 49.7" "Cancer enriched" "Detected in many" 4 "prostate cancer: 130.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 5 "monocytes: 4.7" "Cell line enriched" "Detected in many" 5 "SiHa: 182.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "spinal cord: 1241.2" "CAB007786, HPA061615" Enhanced NA NA "CAB007786: AB_598179, HPA061615: AB_2684568" "prognostic favorable (2.33e-6)" "unprognostic (6.17e-3)" "unprognostic (9.74e-2)" "unprognostic (3.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.63e-4)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (6.42e-2)" "unprognostic (5.85e-2)" "unprognostic (6.64e-3)" "unprognostic (1.57e-3)" "unprognostic (1.54e-1)" "unprognostic (2.59e-1)" "unprognostic (1.31e-2)" "unprognostic (1.47e-1)" 0.6 21.2 69.2 1.6 20.1 0.6 1.5 141.1 527.8 0.5 0.0 1.2 0.4 0.5 0.7 0.3 0.5 0.4 0.3 25.7 67.9 1.0 0.3 0.4 0.9 352.2 78.4 2.2 20.1 0.3 0.9 15.5 0.6 388.6 248.1 0.5 40.0 0.9 0.6 0.3 0.2 0.9 1.0 59.1 1.2 0.6 7.8 169.3 0.7 0.3 0.3 1.1 0.4 1.2 443.8 0.0 0.0 2.4 0.6 0.1 0.3 1.8 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.9 9.5 0.1 0.0 0.0 0.0 9.0 34.2 0.1 24.2 0.0 1.4 0.2 10.5 3.5 0.0 0.5 0.0 0.0 1.3 0.0 28.0 0.0 11.7 0.0 12.0 1.2 17.4 0.0 0.0 0.1 0.1 1.9 0.0 0.0 1.5 19.5 182.2 0.1 0.0 5.9 0.0 9.9 25.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.0 0.4 2.7 0.8 0.1 0.5 0.4 0.6 0.0 0.1 0.5 0.0 0.2 4.7 0.1 0.2 0.6 69.2 20.1 141.1 527.8 25.7 67.9 352.2 78.4 2.2 388.6 59.1 169.3 443.8 0.7 0.0 0.0 3.9 1.0 0.1 1.0 0.1 2.2 3.2 1.4 5.3 0.9 1.5 0.0 1.8 2.1 1.4 1.6 0.5 0.0 0.2 0.4 0.3 7.7 1.0 0.0 5.9 13.6 0.4 1.1 2.4 0.0 0.8 1.3 8.8 0.0 0.0 5.6 8.4 20.9 0.0 0.0 4.2 2.3 1.0 5.9 5.2 1.8 5.6 34.6 3.6 0.0 2.0 2.6 0.3 0.0 3.0 1.7 44.0 0.2 1.0 0.0 9.9 6.6 1.3 2.0 4.4 29.5 3.0 0.1 0.4 1.7 49.7 0.2 0.7 CHKB "CHETK, CHKL" ENSG00000100288 "Choline kinase beta" Q9Y259 22 50578959-50601455 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Congenital muscular dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 19.1;RPMI-8226: 19.8" HPA018797 Approved Approved Cytosol NA NA Cytosol "HPA018797: AB_1846666" "unprognostic (6.03e-4)" "prognostic favorable (4.66e-4)" "unprognostic (4.31e-2)" "unprognostic (2.63e-2)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (3.25e-3)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (7.84e-2)" "unprognostic (5.23e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.54e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-3)" 14.2 13.1 10.4 0.7 10.1 12.2 13.6 10.6 16.9 10.7 11.7 10.3 3.4 9.6 12.1 11.2 12.1 1.6 11.1 10.0 11.9 13.1 9.5 13.4 4.3 10.4 10.9 10.0 8.7 7.8 17.8 14.4 7.3 10.6 12.1 4.8 1.6 12.0 7.3 8.3 10.9 10.7 5.4 10.6 18.2 11.7 14.6 10.8 9.3 12.7 11.8 9.9 11.8 11.2 10.9 4.2 1.3 0.5 1.6 6.7 5.9 10.8 7.3 16.7 4.7 3.1 1.4 2.1 2.1 4.2 3.8 2.4 0.0 1.5 2.0 1.0 0.3 5.4 3.1 2.2 2.3 19.1 2.5 4.8 2.0 6.5 0.6 8.1 4.5 17.1 5.5 1.8 0.3 12.4 5.3 2.0 8.6 0.7 7.0 1.9 3.5 1.8 19.8 11.5 2.0 2.0 3.2 3.0 7.3 5.9 0.2 1.1 2.8 6.9 0.0 1.7 0.0 2.2 7.4 0.0 3.0 2.3 0.4 3.4 12.0 39.5 27.0 26.4 38.4 25.7 24.0 24.2 27.6 35.7 23.6 22.6 20.8 9.6 37.0 26.1 34.1 33.4 32.6 10.4 10.1 10.6 16.9 10.0 11.9 10.4 10.9 10.0 10.6 10.6 10.8 10.9 16.7 6.4 28.2 0.0 13.6 4.8 2.3 6.9 8.6 4.8 10.0 7.4 7.7 20.0 12.7 7.3 4.2 8.8 14.0 18.4 3.9 30.6 11.6 3.9 3.4 8.0 15.7 9.0 0.0 23.8 14.1 8.6 19.9 3.3 19.0 2.5 10.4 5.4 14.6 8.4 0.0 19.3 12.2 16.6 9.2 30.5 2.5 10.0 3.6 0.0 48.4 3.3 14.4 0.0 0.0 23.5 24.2 3.0 14.6 2.1 29.3 5.5 11.2 6.0 6.6 2.4 6.8 12.6 10.0 14.5 6.3 8.5 11.2 2.8 17.3 2.2 BIK NBK ENSG00000100290 "BCL2 interacting killer" Q13323 22 43110750-43129712 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 17.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 329.3;Club cells: 215.6;Ionocytes: 443.5;Paneth cells: 140.5;Respiratory ciliated cells: 204.1;Urothelial cells: 175.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 72.9;plasmacytoid DC: 58.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 89.9;CAPAN-2: 44.3;Daudi: 44.2;U-698: 172.1" "Not detected" "Not detected" HPA051360 Approved NA NA "HPA051360: AB_2681453" "unprognostic (1.18e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.09e-1)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.86e-3)" "unprognostic (3.27e-1)" "unprognostic (2.71e-2)" "unprognostic (4.36e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.45e-5)" "unprognostic (1.38e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (3.04e-1)" 0.2 2.3 0.2 4.1 0.3 4.1 5.0 0.5 0.3 1.8 0.0 8.0 3.7 0.2 1.2 11.4 3.0 3.1 0.2 0.5 0.0 3.7 0.5 1.4 11.7 0.1 0.0 0.2 0.3 2.5 1.6 1.0 0.1 0.3 11.5 5.2 0.2 17.7 0.5 0.0 3.3 5.3 0.2 0.0 2.9 13.5 2.1 0.0 1.4 1.8 0.1 11.3 2.6 6.5 0.2 89.9 0.7 0.2 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 28.8 44.3 44.2 4.2 0.0 0.9 19.5 4.8 1.9 0.0 0.7 6.7 0.1 0.6 4.9 0.7 21.2 4.1 0.0 8.8 0.0 0.0 0.3 0.2 9.5 0.3 2.0 0.0 22.9 16.9 28.9 6.7 24.2 7.3 0.2 0.1 20.6 0.9 2.6 1.7 0.0 3.1 8.2 6.5 3.1 1.6 28.9 0.8 0.1 2.4 0.2 1.0 10.4 17.1 172.1 0.0 2.2 0.2 1.8 2.9 72.9 2.7 0.7 4.3 17.1 9.5 4.2 10.4 11.7 6.4 3.5 11.3 0.9 0.8 58.6 7.1 6.3 0.2 0.3 0.5 0.3 0.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.6 0.0 4.2 0.0 9.3 12.6 32.7 329.3 3.4 0.0 39.7 24.1 0.7 17.2 215.6 7.3 0.0 1.4 7.9 43.0 7.9 62.2 0.3 17.7 0.8 2.3 50.6 5.7 0.3 16.2 1.2 0.9 90.7 9.1 0.0 0.1 5.3 0.7 0.9 0.0 0.2 52.9 443.5 1.4 4.8 0.4 0.0 4.0 35.6 0.0 6.4 0.0 1.0 0.0 0.1 105.2 140.5 0.7 79.7 53.1 10.2 15.7 204.1 0.0 0.0 0.0 14.9 0.2 11.0 16.1 11.8 1.0 12.9 0.3 53.9 175.3 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 617.2" "Cell type enhanced" "Detected in many" "Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2" "Lineage enriched" "Detected in all" 7 "monocytes: 329.2" "Cell line enhanced" "Detected in many" "BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" NA NA 170000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 151.6 49.3 48.5 65.2 50.0 100.2 20.8 46.7 83.3 17.5 60.0 35.5 107.0 10.5 7.7 48.8 41.1 53.0 14.1 46.0 92.0 94.8 137.6 114.6 57.7 57.9 49.3 41.2 140.2 42.0 7.5 9.7 72.8 65.9 6.7 31.4 1.8 15.2 4.1 108.0 63.7 65.1 39.1 49.1 617.2 20.1 18.0 61.0 25.3 11.4 21.6 49.8 46.6 29.4 113.4 12.2 179.1 1.8 37.7 170.9 49.6 869.1 83.2 57.6 42.9 48.6 82.1 11.3 0.1 18.3 83.3 631.2 10.1 11.4 1.9 16.1 308.6 9.2 4.3 51.5 179.3 218.9 11.5 54.8 146.3 4.2 282.3 19.7 74.6 130.9 0.5 0.0 87.4 152.5 6.9 0.2 4.3 18.1 130.4 20.7 1.2 15.6 28.4 35.2 104.5 2.7 2.4 215.8 19.1 15.5 92.5 8.9 3.0 44.3 506.2 22.1 82.5 82.5 53.5 77.0 9.3 489.4 5.7 8.6 11.3 98.8 7.7 1.1 238.8 0.4 24.8 0.7 1.7 44.6 2.9 0.1 0.5 47.1 5.3 329.2 1.1 1.8 70.9 48.5 50.0 46.7 83.3 46.0 92.0 57.9 49.3 41.2 65.9 49.1 61.0 113.4 19.3 3.2 19.0 0.0 11.5 16.4 27.5 11.0 10.8 0.0 25.0 9.1 2.9 24.3 10.5 5.5 0.0 50.5 3.5 59.1 21.5 13.6 2.1 39.6 12.9 327.1 16.0 5.7 0.2 1.5 285.2 64.1 9.2 74.6 11.4 98.4 23.6 23.6 494.9 0.0 0.4 8.3 18.3 954.1 175.8 4.1 31.1 271.5 35.6 1.9 184.7 0.4 9.2 0.5 1.4 8.3 26.1 5.3 2.5 110.6 61.5 157.9 7.1 0.6 0.0 40.8 52.7 0.9 4.4 5.5 15.6 502.0 6.8 6.9 6.1 118.3 MCAT "fabD, FASN2C, MCT, MCT1, MT, NET62" ENSG00000100294 "Malonyl-CoA-acyl carrier protein transacylase" Q8IVS2 22 43132209-43143398 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003122, HPA035471" Approved Supported Mitochondria NA NA Mitochondria "HPA003122: AB_2666795, HPA035471: AB_10670590" "unprognostic (1.05e-1)" "unprognostic (1.57e-2)" "unprognostic (1.39e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-3)" "unprognostic (4.71e-2)" "unprognostic (5.13e-2)" "unprognostic (2.94e-1)" "unprognostic (1.32e-1)" "unprognostic (9.86e-2)" "prognostic favorable (2.18e-4)" "prognostic favorable (3.89e-4)" "unprognostic (3.67e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-1)" 10.2 21.7 11.7 5.7 12.3 9.0 11.8 11.1 14.5 9.1 14.9 12.4 6.8 11.6 10.0 15.6 14.4 6.7 15.4 13.5 11.8 25.0 22.9 8.8 5.1 11.6 11.2 12.5 11.4 15.1 17.7 16.7 4.7 12.6 13.6 7.2 7.3 13.4 6.6 22.1 14.6 8.7 5.9 10.2 8.2 14.9 17.2 12.3 7.9 13.2 10.2 6.2 10.9 10.4 12.8 14.1 18.2 12.6 22.3 10.4 11.0 12.9 15.4 13.6 20.3 18.8 18.3 14.1 23.6 15.5 11.5 11.5 23.3 24.1 20.4 15.1 8.2 71.3 8.8 21.6 20.6 16.6 42.3 10.3 8.3 19.5 19.9 15.7 11.8 14.7 14.1 21.1 9.4 10.1 26.0 19.9 46.0 12.3 19.8 31.8 26.0 12.4 37.7 25.7 12.1 16.6 8.8 16.6 32.0 24.3 5.7 16.5 27.1 8.9 8.8 17.4 19.2 22.0 16.6 18.4 17.1 19.0 16.0 10.8 0.0 11.4 0.8 8.8 11.1 11.5 9.4 9.7 11.4 16.4 12.4 10.9 7.9 2.9 14.5 6.9 16.2 7.0 7.3 11.7 12.3 11.1 14.5 13.5 11.8 11.6 11.2 12.5 12.6 10.2 12.3 12.8 8.0 6.4 6.8 3.9 6.9 17.8 12.3 19.6 5.7 11.2 13.6 11.4 9.5 31.5 10.6 20.2 0.0 18.7 5.7 12.3 50.9 32.0 23.4 28.5 8.3 9.4 14.5 17.9 3.6 21.8 11.9 8.8 12.2 9.2 3.8 10.8 17.5 22.3 15.5 6.7 3.7 14.7 14.2 6.3 4.3 11.8 7.5 6.1 7.2 0.0 8.2 12.5 4.1 1.5 2.1 23.7 15.2 16.6 5.6 17.3 12.5 94.3 27.7 9.6 19.7 11.2 10.0 30.0 11.7 9.0 21.0 9.2 4.8 30.5 22.4 11.5 THOC5 "C22orf19, Fmip, fSAP79, KIAA0983, PK1.3" ENSG00000100296 "THO complex 5" Q13769 22 29505879-29555216 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048402 Supported Nucleoplasm NA NA Nucleoplasm "HPA048402: AB_2680387" "unprognostic (1.16e-1)" "unprognostic (3.05e-1)" "unprognostic (7.77e-2)" "unprognostic (2.27e-2)" "unprognostic (7.20e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.34e-2)" "unprognostic (5.54e-2)" "unprognostic (2.55e-1)" "unprognostic (2.45e-1)" "unprognostic (8.81e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (9.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.97e-1)" 17.9 11.7 5.6 14.3 7.5 19.2 17.3 9.4 10.2 22.8 3.7 29.7 11.6 32.2 13.7 18.7 20.5 17.3 26.0 6.7 7.4 13.3 13.6 14.8 15.4 8.5 7.6 5.8 21.7 14.7 14.2 9.4 11.3 10.4 18.3 14.0 11.2 12.0 21.1 44.0 13.2 17.6 29.6 5.8 15.1 20.5 20.0 7.5 14.8 11.4 41.3 15.2 29.0 17.8 9.7 43.0 28.7 25.8 77.5 47.7 38.1 32.7 79.3 46.7 68.8 68.0 46.8 18.8 26.4 30.2 63.4 40.9 37.8 36.5 42.4 67.0 30.5 38.5 43.6 40.8 53.0 32.5 100.1 35.8 40.6 39.2 67.8 52.1 56.0 51.2 25.9 50.2 26.3 43.3 47.7 31.2 31.1 53.6 36.7 22.1 45.3 62.1 32.7 25.2 32.4 52.6 84.5 44.1 34.8 49.3 33.9 19.7 35.0 35.5 120.6 69.8 28.7 52.0 41.2 42.7 64.9 40.2 40.9 52.5 6.7 15.6 39.4 14.1 19.5 14.1 12.6 11.6 10.3 17.2 10.1 12.1 11.3 42.8 10.6 24.4 4.1 18.3 13.0 5.6 7.5 9.4 10.2 6.7 7.4 8.5 7.6 5.8 10.4 5.8 7.5 9.7 8.5 22.4 12.6 7.2 11.1 5.4 7.8 9.5 4.0 10.8 10.7 16.3 17.0 4.3 8.9 3.7 20.9 21.3 9.5 8.2 13.7 20.0 43.6 7.0 11.0 10.1 9.0 16.6 9.5 14.7 22.6 12.1 9.7 6.5 11.4 15.9 7.9 8.6 14.2 8.4 11.0 5.6 6.1 11.7 5.7 125.7 12.8 9.6 8.8 2.8 16.9 7.3 18.6 6.6 6.6 17.4 6.4 12.8 10.4 8.9 18.7 17.9 9.2 25.1 0.0 10.9 19.5 39.2 23.5 9.4 6.1 17.4 11.1 17.9 9.4 5.6 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400134-35425431 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 139.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes 44000 Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 13.5 7.2 4.5 49.5 8.4 139.9 14.5 7.1 6.4 13.7 5.2 20.3 19.7 16.4 3.4 25.3 13.8 9.6 8.5 4.5 7.8 8.9 15.0 15.0 70.7 8.8 6.5 3.2 25.9 12.7 10.4 5.3 25.4 8.1 10.3 16.8 2.3 14.0 9.7 13.4 17.8 28.5 12.3 6.8 47.7 18.1 20.8 7.0 59.5 12.2 8.1 54.0 12.8 15.8 11.3 213.0 147.5 115.7 118.8 11.0 22.2 100.6 138.1 71.2 199.4 188.3 98.9 102.4 137.9 78.8 70.5 83.6 103.8 116.0 108.3 64.4 112.7 212.6 198.3 141.5 203.7 3.9 414.0 172.4 12.3 9.7 120.0 32.4 18.4 88.7 124.5 124.0 201.2 76.9 172.7 341.8 137.9 154.9 143.4 86.7 379.6 164.8 173.0 39.4 120.1 88.2 94.8 188.3 75.4 41.8 60.9 78.8 155.6 54.1 201.3 153.1 127.2 145.4 111.9 150.2 265.2 130.9 153.5 157.6 66.5 59.8 43.4 49.5 69.6 35.8 127.5 43.1 53.1 77.8 106.1 34.0 39.0 28.4 65.5 81.2 88.8 96.6 77.1 4.5 8.4 7.1 6.4 4.5 7.8 8.8 6.5 3.2 8.1 6.8 7.0 11.3 8.1 6.4 7.3 1.3 49.5 10.6 13.6 12.1 8.6 1.5 9.2 10.8 3.5 8.6 6.0 7.3 0.0 147.8 30.4 12.0 5.9 19.8 2.8 6.2 4.1 11.8 3.5 96.6 0.3 12.7 77.1 11.2 18.8 9.0 15.2 65.7 13.2 5.3 53.1 1.7 0.4 16.6 4.1 24.0 29.4 5.1 10.8 28.4 7.2 7.5 137.7 5.7 13.4 3.0 6.0 11.0 8.6 6.0 49.3 4.0 6.5 5.7 4.8 3.7 19.7 8.8 14.5 16.1 58.8 14.9 6.3 82.2 19.4 8.5 34.6 9.8 APOBEC3H ARP10 ENSG00000100298 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3H" Q6NTF7 22 39097224-39104067 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 6.6;dendritic cells: 9.6;Hofbauer cells: 4.9;monocytes: 10.5;NK-cells: 6.2;T-cells: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9" "Group enriched" "Detected in many" 13 "NK-cells: 19.7;T-cells: 23.2" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HDLM-2: 2.7;Karpas-707: 6.9;U-266/70: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021492, HPA058565" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021492: AB_10964888, HPA058565: " "unprognostic (7.09e-3)" "prognostic favorable (1.20e-4)" "unprognostic (1.05e-1)" "unprognostic (6.81e-4)" "unprognostic (3.40e-1)" "unprognostic (1.54e-3)" "unprognostic (2.30e-2)" "unprognostic (1.36e-2)" "unprognostic (2.17e-1)" "unprognostic (3.83e-2)" "unprognostic (5.07e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.73e-12)" "unprognostic (1.05e-1)" "unprognostic (1.03e-1)" "unprognostic (6.55e-3)" "prognostic favorable (8.43e-7)" 0.7 0.9 0.2 2.3 0.4 3.7 0.6 0.9 0.7 0.7 0.1 1.8 0.5 0.8 3.7 1.1 1.3 1.7 0.5 0.2 0.3 0.6 0.6 2.4 3.8 0.5 0.3 0.2 0.5 0.4 0.6 0.7 1.0 0.5 0.7 3.3 0.6 0.9 1.5 0.6 0.5 1.2 1.2 0.1 3.1 0.9 1.6 0.4 3.0 0.7 0.0 2.1 1.4 0.6 0.4 0.0 0.5 0.0 0.0 0.0 0.2 2.0 0.0 0.1 0.2 0.0 0.0 0.2 2.8 1.0 0.3 0.0 0.1 0.0 0.6 0.0 2.7 0.3 0.7 0.1 0.0 0.2 0.0 2.0 1.8 1.6 0.2 0.2 0.2 0.0 0.1 0.0 6.9 0.9 0.9 1.4 0.2 0.0 0.0 0.0 1.6 0.0 0.2 0.0 1.3 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 4.8 0.7 0.2 0.2 1.2 0.1 0.1 0.3 0.0 23.2 0.5 9.4 1.4 12.1 19.4 0.2 0.4 0.6 8.9 0.0 19.7 1.6 0.0 11.9 4.7 0.2 0.4 0.9 0.7 0.2 0.3 0.5 0.3 0.2 0.5 0.1 0.4 0.4 0.4 0.0 4.2 0.0 1.6 0.1 0.6 0.9 1.2 0.0 0.2 0.3 0.1 0.0 2.4 0.0 0.0 6.6 9.6 0.1 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.4 0.3 0.0 0.6 0.1 0.5 0.1 3.8 0.1 0.4 0.2 4.9 0.0 0.2 0.0 2.0 1.0 0.6 0.5 0.0 1.0 0.0 0.0 10.5 0.0 6.2 0.0 0.1 0.0 0.0 0.0 2.7 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.9 0.1 0.2 0.2 0.0 1.5 20.8 0.0 0.0 0.5 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 80.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Uncertain "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 5600000 "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favorable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 25.3 25.3 11.4 15.8 14.3 18.6 27.4 14.1 22.0 21.3 22.1 26.1 31.0 22.6 8.7 28.3 25.3 15.8 30.1 11.4 17.4 31.2 43.2 29.3 20.0 16.8 13.0 11.0 11.4 47.1 11.8 35.0 11.0 15.1 29.1 8.2 4.4 39.9 16.3 25.5 16.0 34.1 6.6 13.6 44.8 30.5 54.4 14.4 9.9 32.6 5.1 9.5 24.1 24.9 18.1 8.5 11.0 5.3 10.9 41.8 21.8 13.5 13.0 15.9 5.7 9.3 3.3 12.9 5.3 8.2 22.9 10.8 12.8 1.2 12.3 1.0 2.7 8.0 3.4 14.3 12.5 28.3 5.2 32.7 26.0 24.4 9.5 6.3 19.9 12.8 11.5 3.5 80.4 12.1 9.6 4.6 5.8 1.7 9.0 11.2 4.0 0.4 26.7 9.9 13.5 2.5 8.2 18.2 17.2 10.1 5.1 7.7 6.6 22.1 3.8 15.1 14.9 4.1 18.4 1.9 4.5 11.7 4.3 13.6 10.4 27.7 36.1 17.3 33.3 15.1 10.4 12.4 14.2 22.7 12.5 7.3 10.0 60.4 8.9 43.2 32.1 18.2 16.3 11.4 14.3 14.1 22.0 11.4 17.4 16.8 13.0 11.0 15.1 13.6 14.4 18.1 22.8 6.4 12.9 24.5 22.2 4.7 14.0 23.8 18.8 5.3 18.9 13.1 8.0 27.1 15.5 12.9 4.2 11.5 14.0 85.4 1.9 29.4 62.4 24.4 10.3 13.4 36.7 9.7 9.4 21.3 19.9 19.6 41.3 21.3 6.3 15.3 8.2 28.6 36.8 6.7 8.6 30.6 14.2 29.0 9.5 127.5 10.8 29.2 17.8 10.3 28.7 10.3 8.2 8.0 11.9 24.2 75.2 6.0 132.0 10.8 93.9 22.7 21.2 7.2 0.0 6.6 9.9 48.3 4.1 18.3 5.5 13.3 17.2 7.2 25.0 16.1 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151547-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 695.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1429.2;Pancreatic endocrine cells: 1442.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 516.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 233.8 165.8 35.2 65.9 38.2 492.9 206.1 45.1 61.5 161.0 43.6 141.7 74.3 92.6 8.8 695.7 109.5 39.7 153.1 33.1 57.0 120.9 82.6 183.0 44.7 55.3 40.9 29.5 72.9 94.2 22.6 51.2 30.8 47.7 127.7 34.2 4.2 246.9 29.2 84.7 388.7 117.9 26.8 55.4 208.6 218.7 21.6 47.8 22.4 78.0 27.7 40.3 136.9 358.5 54.4 300.0 143.3 10.2 134.4 54.7 175.3 10.8 216.6 107.0 109.4 115.7 28.8 222.4 0.3 147.8 175.7 52.2 242.2 27.9 171.7 13.9 49.5 111.4 28.9 150.4 10.1 193.4 66.4 145.0 137.5 276.4 65.9 58.2 125.8 262.9 0.2 24.0 53.6 114.2 244.5 1.1 188.5 11.6 154.0 355.7 67.0 0.0 516.2 139.3 173.8 14.0 65.4 103.9 200.4 263.5 0.1 76.3 256.6 269.7 132.6 96.9 135.5 92.9 21.7 4.1 2.7 170.0 218.3 171.4 656.8 1678.5 931.0 314.7 1051.6 247.7 199.2 429.9 309.2 1170.2 266.9 325.9 264.3 1052.3 365.0 713.1 209.0 539.5 1585.6 35.2 38.2 45.1 61.5 33.1 57.0 55.3 40.9 29.5 47.7 55.4 47.8 54.4 225.5 160.3 140.0 3.6 88.9 366.8 392.3 1429.2 554.3 2.8 269.3 360.2 92.1 323.1 555.7 206.0 2.1 10.0 140.3 680.7 369.8 578.5 2.4 170.8 143.6 220.4 194.9 239.9 0.3 586.4 284.9 205.1 440.9 309.5 268.6 124.3 187.1 110.5 758.5 3.3 0.8 636.8 478.1 644.7 524.7 11.7 82.6 611.6 723.9 10.3 776.9 180.5 207.0 6.0 20.1 1442.1 705.9 157.6 76.3 526.2 471.9 180.7 283.2 19.4 105.2 108.2 197.8 2.8 4.5 1067.4 536.0 20.0 180.0 30.5 664.1 786.1 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540831-35553999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 168.8" "Group enriched" "Detected in some" 4 "Intestinal goblet cells: 13.1;Sertoli cells: 46.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 168.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.1;hTERT-RPE1: 9.8;SK-BR-3: 5.6;U-2 OS: 3.1;U-87 MG: 4.0" "Region enriched" "Detected in all" 8 "basal ganglia: 589.6" "Region enriched" "Detected in all" 8 "basal ganglia: 429.3" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavorable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.7 7.4 31.7 2.5 168.8 3.8 2.3 0.1 27.9 2.6 0.0 21.0 2.3 4.7 15.2 1.9 5.7 2.3 5.6 12.2 12.2 1.5 0.4 3.3 0.4 33.7 12.9 13.2 1.2 1.6 1.2 2.1 0.2 69.2 15.3 4.0 0.5 4.0 22.9 15.1 1.5 6.2 7.3 0.3 0.2 3.8 0.7 29.4 0.7 1.2 4.5 1.2 4.4 2.5 9.3 0.1 2.2 0.0 0.4 0.0 0.0 0.0 0.5 0.2 0.8 0.6 0.1 0.4 0.0 0.1 1.9 3.1 0.1 0.1 0.0 0.7 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.0 0.1 2.5 1.6 0.2 9.8 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.2 1.0 0.0 0.7 0.0 0.0 1.5 0.2 1.6 5.6 0.0 0.1 0.4 0.1 0.0 1.3 3.1 0.1 0.7 1.4 0.5 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 168.8 0.1 27.9 12.2 12.2 33.7 12.9 13.2 69.2 0.3 29.4 9.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.6 1.7 2.9 3.3 1.9 0.0 0.2 0.0 0.0 0.0 0.7 3.0 0.0 0.2 0.1 0.1 0.2 2.9 0.0 0.0 3.2 0.2 0.0 3.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.6 13.1 2.0 0.0 0.8 0.2 0.0 0.3 0.0 1.0 0.0 0.0 0.0 1.0 0.7 0.0 2.3 0.7 0.0 0.5 0.1 0.0 0.1 0.2 46.0 0.4 6.9 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.5 0.3 TTLL12 KIAA0153 ENSG00000100304 "Tubulin tyrosine ligase like 12" Q14166 22 43166622-43187134 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 105.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003054, CAB046029" Approved Approved "Plasma membrane,Cytosol" NA NA 140000 Cytosol "Plasma membrane" "CAB046029: AB_11128395, HPA003054: AB_2666770" "unprognostic (2.45e-2)" "unprognostic (3.47e-2)" "unprognostic (7.37e-3)" "unprognostic (5.40e-2)" "unprognostic (2.65e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (5.81e-3)" "unprognostic (2.24e-1)" "unprognostic (6.08e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-3)" "unprognostic (1.40e-1)" "unprognostic (6.66e-2)" "unprognostic (2.81e-2)" 12.8 28.4 7.4 16.8 7.7 26.5 13.2 9.4 14.4 18.2 1.1 36.0 24.6 14.0 3.6 105.3 14.1 18.7 8.8 8.7 8.6 9.0 21.2 9.4 11.3 13.8 8.1 7.2 23.9 19.3 9.5 14.8 7.2 14.8 15.4 19.7 4.7 22.1 6.9 12.7 36.0 23.1 7.2 4.9 10.8 33.7 25.9 7.1 8.0 9.2 8.0 13.0 15.6 37.3 11.7 113.2 46.7 18.5 45.9 27.8 19.0 59.7 36.3 12.8 34.1 17.8 76.2 62.7 107.9 43.0 30.3 16.7 78.8 77.3 66.5 8.7 13.6 123.3 26.5 73.6 66.4 43.5 120.2 26.4 30.2 79.3 40.8 43.4 18.3 36.5 52.1 166.1 24.8 16.1 104.4 84.1 65.2 67.4 78.9 46.1 84.4 63.5 155.6 28.7 36.6 56.2 23.2 77.1 111.2 41.6 8.4 44.0 52.9 35.2 22.7 31.7 44.1 51.4 41.6 55.4 81.0 25.7 60.8 31.4 0.0 2.3 0.3 2.6 1.2 2.5 1.8 2.5 1.9 1.8 1.1 2.4 1.7 0.6 2.3 1.7 1.6 1.8 1.9 7.4 7.7 9.4 14.4 8.7 8.6 13.8 8.1 7.2 14.8 4.9 7.1 11.7 3.7 6.4 6.7 3.6 6.4 11.2 11.4 11.0 17.1 8.5 13.5 9.9 4.5 17.2 7.6 7.3 4.2 8.8 3.2 56.3 5.9 14.2 1.0 5.0 9.5 5.8 9.1 39.1 8.0 8.6 19.0 6.0 34.1 14.7 0.0 14.3 8.2 35.0 9.8 0.0 8.5 30.6 10.2 14.2 2.9 2.6 8.7 7.5 10.6 1.9 7.7 4.2 4.1 3.0 2.2 25.8 56.9 17.0 9.4 28.7 32.1 8.3 5.0 5.6 0.0 5.2 7.2 2.0 12.2 60.2 18.2 4.1 5.9 13.4 39.9 13.7 CBX7 ENSG00000100307 "Chromobox 7" O95931 22 39120167-39152680 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 37.2;U-266/70: 30.7" "Low region specificity" "Detected in all" "CAB011574, HPA048677, HPA056480" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146" "prognostic favorable (6.18e-4)" "prognostic favorable (3.63e-4)" "prognostic unfavorable (3.73e-4)" "unprognostic (9.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.48e-3)" "unprognostic (4.76e-3)" "unprognostic (1.45e-2)" "unprognostic (3.86e-2)" "unprognostic (1.11e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.03e-3)" "prognostic favorable (2.45e-5)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" "unprognostic (3.10e-1)" "unprognostic (1.63e-2)" 33.2 31.5 49.5 16.1 51.6 6.1 32.6 53.1 71.1 52.7 35.8 66.4 17.3 61.7 29.3 24.7 63.2 17.9 53.8 51.2 44.0 32.5 17.9 30.7 27.6 49.1 47.1 52.0 59.0 29.0 41.8 43.1 8.4 51.8 51.3 14.3 34.3 35.6 58.2 68.5 26.9 43.2 27.7 36.1 42.8 48.4 10.9 44.6 14.4 33.6 51.8 21.8 66.8 39.4 52.1 6.9 2.9 1.4 11.0 13.1 5.0 3.6 6.5 8.0 3.5 4.2 1.4 4.7 1.2 7.5 4.9 6.3 2.5 0.9 3.0 2.6 37.2 3.6 0.2 5.5 0.7 4.5 1.7 14.0 2.5 4.4 1.7 0.7 4.5 1.0 5.5 1.7 18.1 2.7 6.7 2.5 0.8 0.8 8.8 4.9 2.8 2.3 10.1 1.8 2.8 3.6 0.9 3.3 4.8 7.6 2.3 5.8 2.7 2.6 5.8 10.9 5.9 2.9 30.7 18.4 4.2 11.8 2.7 2.5 0.4 0.3 2.9 1.9 0.0 2.0 1.5 2.1 2.1 0.0 2.0 2.6 2.5 3.1 1.0 0.5 0.4 2.2 1.0 49.5 51.6 53.1 71.1 51.2 44.0 49.1 47.1 52.0 51.8 36.1 44.6 52.1 17.5 6.4 8.7 16.3 27.9 4.6 11.7 3.7 7.4 57.0 9.6 11.6 74.6 24.3 9.5 14.7 35.5 4.3 10.5 10.5 9.8 4.3 8.2 5.1 4.8 14.4 4.2 20.0 17.0 3.8 1.5 16.2 6.6 3.3 10.8 9.6 28.5 11.8 4.4 60.6 18.8 7.6 8.2 11.7 6.4 18.6 35.1 6.2 19.6 14.0 11.6 16.4 42.2 13.0 28.8 3.4 5.1 27.8 12.0 10.5 18.2 13.6 6.4 62.7 46.0 28.3 24.9 7.0 5.3 3.1 4.8 3.6 22.8 4.1 5.4 7.5 PDGFB "SIS, SSV" ENSG00000100311 "Platelet derived growth factor subunit B" P01127 22 39223359-39244982 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 10.0" "Lineage enriched" "Detected in many" 7 "T-cells: 10.0" "Cell line enhanced" "Detected in many" "A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011604, HPA011972, CAB018341" Supported Approved Vesicles "Secreted to blood" NA NA 4390000 950000 Vesicles "CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134" "unprognostic (4.96e-2)" "unprognostic (8.94e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (9.84e-2)" "unprognostic (4.46e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (8.68e-2)" "unprognostic (1.84e-3)" "unprognostic (5.12e-3)" "unprognostic (7.47e-2)" "unprognostic (6.50e-2)" "unprognostic (1.03e-1)" 32.3 6.5 12.9 7.2 10.7 0.4 24.2 9.3 20.6 7.5 6.0 15.9 5.0 8.9 5.3 6.3 7.3 11.8 25.2 11.5 10.0 15.5 3.7 28.3 7.5 12.5 11.3 8.9 3.8 8.9 9.0 4.1 40.5 15.3 7.6 3.5 0.8 10.7 5.2 18.9 9.7 9.1 9.3 10.2 6.7 7.9 3.4 13.3 2.1 16.2 11.1 1.7 8.5 6.6 11.6 33.8 2.6 8.4 0.0 0.0 0.0 9.9 0.1 0.4 0.2 0.0 13.0 10.3 0.0 69.2 0.0 3.1 12.4 0.5 2.8 0.0 0.1 0.2 0.7 1.1 4.8 4.3 0.0 18.1 0.0 0.3 0.0 0.4 0.9 52.6 0.0 1.3 6.1 1.9 13.7 0.1 0.1 3.2 8.1 3.4 0.0 0.3 22.8 27.7 0.1 0.2 0.0 0.6 53.5 0.2 6.0 24.3 0.1 68.1 0.1 6.4 0.1 7.5 0.1 0.4 0.3 0.1 1.5 31.3 0.0 0.0 0.0 7.3 0.1 10.0 0.0 4.3 5.6 0.0 0.0 3.6 1.9 0.1 0.0 0.4 1.3 2.3 2.1 12.9 10.7 9.3 20.6 11.5 10.0 12.5 11.3 8.9 15.3 10.2 13.3 11.6 75.0 0.0 1.1 0.0 0.6 2.8 1.2 3.8 1.2 0.7 5.1 7.1 3.1 0.0 1.3 7.3 0.0 7.3 4.0 0.1 0.0 20.0 1.3 4.0 0.7 60.6 1.8 0.0 2.8 3.6 6.5 1.6 0.0 5.6 0.0 13.1 16.8 1.4 7.7 0.0 0.9 0.7 4.1 2.6 44.3 0.1 0.6 25.5 1.8 14.0 1.1 0.3 0.0 0.0 0.2 54.7 0.0 0.0 0.0 2.7 0.1 1.9 0.9 0.1 6.6 4.7 9.6 0.3 1.6 1.1 1.4 4.5 2.0 1.2 0.1 0.6 ACR ENSG00000100312 Acrosin P10323 22 50738196-50745339 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "testis: 87.4" "Group enriched" "Detected in some" 33 "Early spermatids: 492.2;Late spermatids: 134.8;Spermatocytes: 216.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA048687 Enhanced "Secreted in male reproductive system" NA NA "HPA048687: AB_2680494" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" "unprognostic (6.27e-3)" "unprognostic (3.58e-2)" "unprognostic (8.04e-2)" "unprognostic (3.30e-3)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (1.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (1.25e-1)" 2.0 0.2 0.3 0.0 0.5 0.0 2.0 0.4 0.5 0.7 2.1 0.5 0.1 1.1 0.7 0.4 1.1 0.2 0.7 0.4 0.4 0.8 0.8 2.0 0.0 0.3 0.3 0.3 0.3 0.2 0.0 0.5 0.1 0.5 0.6 0.0 0.1 0.6 0.2 0.8 0.7 0.5 0.2 0.4 3.0 0.3 87.4 0.4 0.0 0.6 0.0 0.0 0.6 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.5 0.4 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.4 8.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 492.2 0.4 0.1 4.7 3.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 7.5 0.1 0.1 0.0 0.2 0.8 0.0 0.0 0.0 134.8 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.8 2.6 0.0 0.0 1.2 0.4 0.0 0.0 6.6 0.3 0.1 216.9 2.5 0.3 0.0 0.0 0.0 0.1 1.5 0.2 CABP7 MGC57793 ENSG00000100314 "Calcium binding protein 7" Q86V35 22 29720003-29731833 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 35.2" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 28.6" "Group enriched" "Detected in some" 4 "glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1" "Group enriched" "Detected in all" 4 "cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0" "Region enhanced" "Detected in all" "hippocampal formation: 51.0" HPA016439 Uncertain NA NA "HPA016439: AB_2669357" "unprognostic (1.88e-1)" "unprognostic (4.75e-2)" "unprognostic (1.18e-1)" "unprognostic (5.37e-2)" "unprognostic (4.55e-1)" "unprognostic (2.29e-4)" "unprognostic (2.05e-3)" "unprognostic (7.96e-2)" "unprognostic (8.69e-3)" "unprognostic (3.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.22e-1)" "unprognostic (7.44e-7)" "unprognostic (1.25e-4)" "unprognostic (3.60e-2)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" 0.1 5.6 4.6 0.0 4.2 0.2 0.1 18.8 35.2 0.1 0.6 0.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 34.2 3.6 0.1 0.3 0.1 0.1 26.1 10.6 3.4 0.1 3.2 0.0 0.4 0.0 27.0 0.4 0.0 1.0 0.2 0.0 0.1 0.2 1.5 0.0 20.4 0.4 0.3 0.6 4.8 0.0 0.3 0.0 0.0 0.1 0.1 18.5 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 10.3 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.0 0.0 9.7 3.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 3.1 0.1 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.1 4.6 4.2 18.8 35.2 34.2 3.6 26.1 10.6 3.4 27.0 20.4 4.8 18.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 28.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 1.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 RPL3 L3 ENSG00000100316 "Ribosomal protein L3" P39023 22 39312882-39320389 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003365, HPA055361" Uncertain Supported Nucleoli,Cytosol NA NA 470000 "Nucleoli, Cytosol" "HPA003365: AB_1079841, HPA055361: AB_2732594" "unprognostic (9.79e-3)" "unprognostic (2.06e-1)" "unprognostic (2.31e-1)" "unprognostic (1.68e-3)" "unprognostic (5.44e-3)" "unprognostic (1.72e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (3.63e-1)" "unprognostic (5.81e-2)" "unprognostic (5.87e-2)" "unprognostic (7.09e-2)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (6.09e-2)" "unprognostic (2.72e-1)" "unprognostic (4.32e-2)" 2024.7 1950.1 932.1 1497.9 947.0 2990.2 2731.0 919.4 1079.6 2652.1 1019.5 1955.0 1528.8 2024.0 1668.2 2542.6 2445.0 1138.5 1043.7 874.2 955.3 1752.8 1909.6 1433.6 2481.1 962.3 946.0 853.6 4881.6 4552.5 1474.3 1876.0 1109.0 944.4 2198.6 1374.6 816.1 2229.4 1566.3 563.0 3224.9 1737.4 1400.1 1041.4 1838.8 1998.3 758.5 1001.3 2024.3 1724.2 420.8 2339.7 2029.9 2337.0 1001.4 2010.5 1836.9 2035.9 2149.6 2535.3 5394.1 2745.1 1497.8 2703.5 1400.5 1249.7 2327.8 1425.1 8262.2 2062.9 1734.1 873.2 1246.8 2275.3 3060.5 923.2 1448.3 2207.4 2039.5 2153.8 3438.2 3887.7 2932.6 1619.9 5321.2 4063.7 1265.0 4504.5 3956.7 2765.5 2217.6 2407.8 2657.6 2135.0 2597.5 2974.5 4241.1 2054.6 2172.9 1273.8 2369.5 1924.0 4017.5 2609.2 2927.6 1823.4 2180.2 936.2 2925.4 5031.9 1242.2 2226.2 4761.3 2864.1 951.4 1534.4 1027.8 1788.2 2074.0 1741.6 3606.5 2111.3 2564.4 1093.9 638.7 1690.8 351.4 3488.7 1481.6 5383.7 5629.1 4993.5 4037.9 2821.8 5113.1 6376.7 5111.7 215.7 4472.3 1339.8 3182.6 3668.7 11623.3 932.1 947.0 919.4 1079.6 874.2 955.3 962.3 946.0 853.6 944.4 1041.4 1001.3 1001.4 2118.4 984.0 2299.9 16.3 4551.5 10412.0 9836.0 9475.4 2792.1 1065.7 9967.6 10172.3 182.6 4213.6 3849.3 1441.9 425.4 5623.9 4123.0 1288.7 5893.0 2943.4 2097.6 1061.7 2644.4 3666.1 2726.6 2263.9 17.0 6539.7 7508.2 2678.8 1207.4 1390.0 1784.7 4203.6 3429.3 2085.8 3282.5 358.4 18.3 3696.8 2925.6 3062.8 6215.2 4622.8 5581.1 2203.8 5104.8 17.8 3733.3 2455.8 4243.1 9.5 25.1 3814.3 2946.3 3499.2 2308.1 8261.9 3481.6 5422.4 1350.6 1305.5 1577.7 4469.5 4329.1 1074.6 1014.8 3712.4 12290.3 5489.4 4201.1 4673.7 4830.3 9407.7 ZMAT5 "SNRNP20, ZC3H19" ENSG00000100319 "Zinc finger matrin-type 5" Q9UDW3 22 29730956-29767011 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004858 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004858: AB_1080657" "unprognostic (2.14e-1)" "unprognostic (8.03e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-2)" "unprognostic (1.02e-1)" "unprognostic (5.47e-3)" "unprognostic (6.04e-3)" "unprognostic (5.69e-2)" "unprognostic (5.75e-2)" "unprognostic (3.71e-2)" "unprognostic (2.04e-1)" "unprognostic (2.15e-2)" "unprognostic (1.03e-1)" "unprognostic (1.52e-1)" "unprognostic (2.65e-1)" "unprognostic (2.62e-1)" "unprognostic (4.10e-2)" 14.3 26.2 22.4 10.7 22.6 14.3 14.6 22.8 35.2 17.0 21.7 17.4 12.4 18.2 20.0 21.3 20.7 10.1 24.3 21.5 22.1 20.1 27.0 13.8 15.2 23.7 22.8 20.6 16.3 20.5 23.2 10.7 8.5 21.8 19.4 7.3 7.9 18.4 16.8 37.4 17.9 14.5 13.9 22.1 20.0 20.3 10.7 24.0 18.0 19.3 24.7 12.3 19.2 15.9 23.2 17.9 22.1 19.3 37.5 23.7 26.2 8.7 19.4 23.9 28.5 34.7 19.4 11.0 12.2 18.9 20.8 22.0 16.5 16.5 19.9 18.6 39.2 36.3 46.9 10.8 36.3 43.8 21.6 14.8 22.7 30.2 36.5 22.2 24.2 30.4 19.0 12.3 25.9 23.8 26.7 31.0 22.5 7.2 34.7 25.9 37.1 34.2 32.6 22.8 10.9 14.8 27.4 18.1 22.4 27.9 10.9 33.7 30.0 19.4 38.8 19.4 26.4 29.2 24.0 20.5 20.4 29.9 25.6 27.9 48.1 84.6 95.3 46.1 94.6 47.3 61.6 47.7 48.6 73.9 60.3 41.8 49.1 69.5 60.8 94.7 57.6 61.0 65.3 22.4 22.6 22.8 35.2 21.5 22.1 23.7 22.8 20.6 21.8 22.1 24.0 23.2 17.0 16.0 20.8 6.2 14.6 9.6 21.0 32.0 10.2 12.7 16.2 22.6 1.4 17.2 20.4 14.7 18.8 21.5 11.3 16.4 33.2 35.3 0.9 13.8 14.3 15.2 14.4 8.6 3.7 27.3 18.1 15.9 13.3 10.4 33.7 13.0 15.0 17.1 45.1 5.0 5.1 19.4 24.4 21.4 17.9 3.0 15.8 22.1 12.4 3.7 27.7 26.0 34.0 6.0 6.5 31.7 18.1 21.8 14.9 12.4 27.8 40.0 19.3 21.4 32.9 15.1 40.0 11.0 22.8 14.0 11.8 14.1 18.0 18.2 14.4 18.9 RBFOX2 "FOX-2, HNRBP2, HRNBP2, RBM9" ENSG00000100320 "RNA binding fox-1 homolog 2" O43251 22 35738736-36028824 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 378.7;Inhibitory neurons: 418.1;Oligodendrocyte precursor cells: 237.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006240, HPA006455, HPA075862" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006240: AB_1079750, HPA006455: , HPA075862: " "unprognostic (3.17e-1)" "unprognostic (4.80e-2)" "unprognostic (9.30e-2)" "unprognostic (3.21e-3)" "unprognostic (3.42e-1)" "unprognostic (2.74e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-1)" "unprognostic (5.78e-3)" "unprognostic (2.13e-2)" "unprognostic (1.53e-2)" "unprognostic (6.08e-2)" 27.7 22.1 9.2 12.5 22.1 0.2 27.3 40.4 42.2 48.5 0.0 47.4 11.8 68.1 21.7 35.0 40.8 25.5 35.3 21.1 17.7 18.0 26.1 25.8 5.9 8.1 5.6 19.3 63.6 18.9 26.4 27.7 32.8 14.4 31.7 21.6 15.6 23.9 30.0 77.9 23.6 23.6 53.1 0.5 9.9 29.1 25.9 9.2 10.0 28.8 44.7 8.6 43.5 36.9 18.8 46.2 27.4 110.3 64.8 62.4 111.2 36.8 89.9 123.6 67.1 72.0 60.1 21.3 28.2 41.2 108.9 41.9 46.5 40.2 41.7 95.9 19.2 36.6 16.7 26.5 22.3 18.8 4.4 11.6 77.3 53.1 59.6 73.3 64.8 86.8 7.0 13.7 3.9 80.3 14.0 4.5 2.7 40.5 19.7 42.0 7.6 92.0 7.9 50.1 47.5 34.1 106.0 110.3 15.5 31.0 57.0 16.9 6.8 105.5 96.4 54.4 54.7 41.2 2.8 9.4 38.3 42.7 6.8 51.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.2 22.1 40.4 42.2 21.1 17.7 8.1 5.6 19.3 14.4 0.5 9.2 18.8 34.3 67.3 38.5 189.4 1.0 37.1 50.6 57.3 57.5 20.8 31.4 34.5 62.2 31.5 40.4 27.6 0.0 69.9 0.9 17.9 35.2 53.0 24.8 17.8 60.8 45.9 57.0 0.8 378.7 32.1 89.1 67.8 15.8 25.0 2.5 30.6 40.7 26.0 10.5 117.8 418.1 24.7 18.3 1.3 14.7 9.4 79.6 1.8 16.0 183.6 2.6 16.9 0.0 237.2 130.0 77.4 10.7 93.3 1.4 57.4 22.5 18.7 20.9 6.7 52.6 74.5 93.3 42.2 25.6 31.0 33.8 29.0 2.5 48.2 23.8 61.1 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385575 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 122.6" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "melanoma: 19.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 7 "dendritic cells: 44.7;monocytes: 38.9;T-cells: 30.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol NA NA Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favorable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 9.8 24.8 56.0 4.9 84.7 93.7 14.8 64.3 122.6 36.0 20.5 20.3 5.9 22.3 11.7 37.6 23.7 11.4 50.5 84.6 42.1 17.1 5.3 8.7 7.6 36.0 48.5 78.6 73.3 28.2 30.0 15.3 6.6 60.4 29.9 4.4 73.6 45.5 18.2 29.3 52.2 11.9 13.3 3.8 10.7 16.8 19.9 52.1 3.5 11.7 26.6 10.0 25.8 35.2 69.1 5.4 9.6 17.3 31.1 1.7 4.4 7.5 23.2 40.8 29.2 26.9 2.1 0.6 0.2 5.3 6.1 3.3 7.6 11.8 0.5 8.8 0.1 36.6 0.4 0.8 1.0 4.9 1.6 10.5 6.7 1.8 7.9 0.0 20.7 1.4 6.8 11.0 0.7 4.6 12.5 4.8 4.5 3.6 4.8 18.7 14.0 0.0 1.5 0.9 15.0 27.1 5.5 6.1 25.1 23.7 7.1 36.9 27.3 0.5 0.0 19.6 0.3 0.1 6.4 0.2 15.2 0.8 30.2 31.6 0.6 38.9 0.8 30.8 11.8 1.7 5.8 1.1 9.1 44.7 4.2 1.3 15.3 1.7 5.1 0.6 33.1 0.2 18.0 56.0 84.7 64.3 122.6 84.6 42.1 36.0 48.5 78.6 60.4 3.8 52.1 69.1 8.9 9.6 1.1 28.4 21.0 30.3 73.6 33.8 39.3 112.9 61.4 73.0 73.6 75.8 31.4 66.2 27.1 25.0 52.5 0.1 15.6 57.2 40.0 14.3 24.4 9.5 0.0 92.9 57.1 12.3 14.4 44.6 1.5 18.5 2.5 49.0 12.1 5.9 14.2 47.1 47.1 0.3 12.2 20.0 13.8 87.9 133.3 11.7 140.5 20.6 10.1 46.8 91.6 39.7 18.7 21.7 1.1 119.2 23.2 36.4 0.1 9.3 7.5 38.6 19.7 46.8 30.6 62.8 14.7 57.1 37.4 13.1 21.2 131.6 0.4 80.2 TAB1 MAP3K7IP1 ENSG00000100324 "TGF-beta activated kinase 1 (MAP3K7) binding protein 1" Q15750 22 39399778-39437060 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032328, HPA039988, HPA057104" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338" "unprognostic (1.76e-1)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (6.73e-3)" "unprognostic (9.23e-3)" "unprognostic (4.30e-2)" "unprognostic (6.44e-2)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (7.05e-2)" "unprognostic (1.63e-1)" "unprognostic (7.35e-2)" "unprognostic (7.80e-3)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" 12.0 14.9 16.2 9.1 18.5 9.8 13.0 15.6 19.9 18.2 9.3 16.6 10.8 16.6 6.3 13.9 16.0 7.5 15.5 16.2 14.8 12.5 16.8 11.1 11.2 18.2 18.2 14.7 20.7 15.7 10.1 10.6 8.6 20.0 16.8 5.5 12.3 13.9 11.0 20.1 17.2 13.6 8.7 14.2 16.1 14.8 10.3 17.0 12.0 13.4 10.7 7.8 18.1 15.0 19.4 15.0 15.3 15.2 17.5 15.8 13.2 13.5 12.3 15.1 18.4 17.3 14.2 10.6 22.5 9.4 12.0 10.3 18.0 15.5 18.0 7.2 17.6 24.8 9.9 19.0 14.2 13.7 18.8 18.3 13.5 15.7 13.9 15.1 14.0 13.6 13.5 18.4 15.0 9.3 9.7 14.6 15.6 10.6 23.6 15.4 26.0 21.6 22.6 14.4 15.7 13.5 9.9 17.4 21.5 15.4 9.4 17.6 20.4 11.8 12.8 20.2 9.9 10.1 23.6 16.2 16.4 15.1 13.1 12.8 0.8 5.6 4.1 4.3 4.3 3.4 3.3 2.6 3.5 5.0 3.2 4.1 3.9 0.7 3.3 4.5 2.3 2.8 4.3 16.2 18.5 15.6 19.9 16.2 14.8 18.2 18.2 14.7 20.0 14.2 17.0 19.4 6.0 3.2 6.7 17.9 7.0 2.0 2.8 4.0 6.8 55.2 5.9 6.9 7.4 8.6 4.1 3.7 18.8 12.4 4.7 4.9 0.0 6.2 1.6 4.5 7.0 5.4 11.4 6.9 9.1 3.8 7.9 6.2 7.1 4.4 5.1 12.5 2.2 4.7 7.1 28.6 12.6 4.8 0.0 6.0 1.0 3.2 7.8 6.4 5.4 9.4 8.6 12.1 8.2 7.5 18.6 5.4 4.1 9.1 8.4 2.8 7.6 5.4 4.7 18.8 6.6 6.4 7.4 8.2 9.1 5.5 3.3 5.6 8.1 10.3 4.9 1.8 ASCC2 "ASC1p100, DKFZp586O0223, FLJ21588" ENSG00000100325 "Activating signal cointegrator 1 complex subunit 2" Q9H1I8 22 29788609-29838304 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 155.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001439, HPA052879" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" Nucleoplasm "HPA001439: AB_1078229, HPA052879: AB_2732577" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (8.58e-2)" "unprognostic (3.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.45e-3)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (5.39e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.97e-3)" "unprognostic (5.19e-2)" "unprognostic (7.53e-2)" "unprognostic (3.81e-1)" "unprognostic (2.05e-3)" 26.4 31.5 10.9 22.9 12.0 54.2 25.1 11.8 13.8 22.4 15.4 24.7 23.9 21.2 16.3 42.3 20.1 17.3 22.9 10.7 11.7 19.9 36.1 22.3 24.6 12.5 12.2 9.0 20.0 23.7 21.9 26.9 22.0 12.9 27.3 24.9 8.5 30.1 18.2 43.9 30.3 23.3 19.4 11.8 29.6 37.3 24.7 11.9 29.9 28.6 32.6 34.2 27.1 27.7 12.8 46.9 26.8 28.4 38.7 41.6 36.7 40.7 47.6 36.3 48.4 48.1 31.5 24.7 46.5 33.4 46.2 30.7 55.5 36.8 54.0 40.5 59.8 64.3 39.9 33.0 38.0 52.1 72.3 115.6 39.6 48.2 55.0 50.0 28.4 42.9 30.7 41.8 43.7 44.3 57.8 44.5 37.9 20.7 65.6 36.0 53.0 34.9 48.6 29.6 76.1 43.8 38.5 44.3 48.2 35.4 28.8 34.3 37.4 42.8 67.1 11.3 41.2 47.9 51.9 42.8 54.4 39.2 39.9 49.5 44.7 29.8 53.6 32.1 49.2 28.4 18.8 23.6 26.9 37.7 15.0 24.1 24.6 9.2 33.7 43.9 21.7 30.3 20.0 10.9 12.0 11.8 13.8 10.7 11.7 12.5 12.2 9.0 12.9 11.8 11.9 12.8 27.7 19.2 14.7 18.6 35.8 30.0 25.2 38.1 13.1 9.4 23.3 12.3 19.1 31.5 33.3 40.5 4.2 46.3 40.5 38.8 11.7 25.4 110.2 14.0 28.1 20.7 15.5 116.0 13.5 24.9 63.3 22.9 69.8 20.0 34.9 24.3 22.9 25.7 30.6 5.0 13.8 23.2 44.7 29.2 37.3 155.2 31.1 29.1 28.4 11.2 27.9 12.2 56.7 15.6 16.3 27.7 34.0 24.8 32.4 16.2 46.8 18.2 24.4 13.6 19.7 19.6 19.7 48.4 22.5 35.0 39.2 44.3 34.9 27.8 23.9 34.2 MTMR3 "FYVE-DSP1, KIAA0371, ZFYVE10" ENSG00000100330 "Myotubularin related protein 3" Q13615 22 29883169-30030868 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 82.3" "Cell type enhanced" "Detected in many" "Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034515, HPA034516, HPA061399" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: " "unprognostic (4.39e-3)" "unprognostic (7.84e-2)" "unprognostic (2.46e-2)" "unprognostic (1.76e-2)" "unprognostic (5.61e-2)" "unprognostic (4.51e-3)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (3.42e-1)" "unprognostic (4.39e-1)" "unprognostic (8.33e-4)" "unprognostic (1.28e-1)" "unprognostic (5.35e-4)" "unprognostic (7.96e-2)" "unprognostic (7.64e-2)" "unprognostic (2.49e-1)" "unprognostic (8.38e-2)" 16.7 18.6 18.1 13.1 18.0 82.3 17.2 20.5 17.7 17.8 16.5 15.2 11.2 16.2 12.9 22.6 16.6 12.6 13.8 19.5 18.4 11.7 10.9 20.9 11.6 19.1 18.7 15.1 20.6 16.7 18.4 17.1 15.1 16.9 16.1 12.8 21.4 17.3 11.4 37.1 25.1 14.6 15.0 17.4 21.9 15.8 26.4 19.2 16.4 17.4 30.3 14.0 15.2 19.6 16.2 13.4 11.7 17.0 18.3 16.7 12.1 12.8 12.2 17.4 15.7 18.2 10.0 7.9 10.2 7.6 22.1 12.4 16.0 18.5 14.3 16.6 21.0 15.4 18.6 10.6 10.1 15.3 15.9 45.0 12.8 22.9 14.9 26.9 14.7 15.3 10.7 11.6 17.5 10.3 16.2 10.7 11.1 6.5 13.7 7.5 12.5 23.3 10.4 14.1 24.3 19.2 13.1 22.1 19.7 11.7 14.1 11.2 15.3 16.8 25.3 16.7 5.5 8.3 14.7 11.1 9.3 11.0 7.5 11.8 8.3 7.4 11.2 3.2 4.9 4.0 2.3 2.5 3.4 4.1 2.4 3.1 2.7 17.8 4.1 5.4 1.5 2.9 4.3 18.1 18.0 20.5 17.7 19.5 18.4 19.1 18.7 15.1 16.9 17.4 19.2 16.2 15.9 3.2 14.8 111.3 13.3 16.7 9.8 11.5 14.8 0.0 13.7 11.0 4.2 10.0 17.7 12.9 0.0 13.6 10.4 21.5 1.9 9.5 14.0 16.8 14.9 10.6 12.5 21.0 61.2 8.8 7.0 12.6 31.6 24.5 7.6 14.7 13.9 10.1 10.9 0.0 78.3 9.2 46.8 20.6 11.7 16.7 13.7 20.8 14.2 90.9 22.3 0.0 12.3 96.5 73.2 12.3 11.1 11.3 13.0 14.6 12.2 7.3 16.4 0.0 6.6 15.3 11.0 26.8 28.0 18.1 13.8 13.7 13.0 8.9 11.5 21.2 MIEF1 "FLJ20232, L0R8F8, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 266.3;Late spermatids: 377.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 9.6 8.1 10.3 8.0 10.3 12.9 8.5 10.9 10.0 6.3 8.0 9.5 12.1 7.7 6.9 9.4 7.1 5.6 8.2 10.0 9.8 13.2 16.4 7.4 11.3 10.4 11.5 9.5 7.7 9.5 11.0 5.2 8.6 11.9 6.9 9.4 8.4 9.8 8.1 8.5 8.0 10.5 6.8 10.8 9.2 8.2 17.2 11.2 9.6 8.4 9.4 11.8 7.3 6.4 10.2 16.0 15.9 16.5 26.6 15.5 17.0 19.5 15.0 17.4 16.7 15.0 25.9 8.1 44.4 12.2 15.7 10.9 20.0 37.6 20.4 20.1 18.8 36.3 18.1 22.4 26.2 30.1 63.7 23.1 22.3 24.3 14.7 30.7 16.1 17.9 14.5 32.5 23.4 16.7 11.0 20.5 17.8 15.4 32.5 17.2 27.7 23.4 44.6 19.0 18.8 15.3 12.7 16.6 27.6 42.8 17.3 12.3 22.7 17.8 15.7 22.1 14.0 18.6 42.2 47.5 43.9 18.1 28.0 24.7 0.4 5.6 4.7 5.2 6.2 6.4 4.8 5.0 5.1 6.0 4.7 5.4 5.1 0.4 6.8 6.2 3.3 4.7 6.3 10.3 10.3 10.9 10.0 10.0 9.8 10.4 11.5 9.5 11.9 10.8 11.2 10.2 10.9 12.8 18.7 7.5 13.6 19.5 16.0 11.4 10.8 19.0 13.6 12.1 19.3 20.0 8.6 16.5 25.0 19.6 17.0 22.0 25.4 13.1 266.3 5.2 14.3 13.1 9.7 14.7 7.4 13.8 19.8 10.4 8.2 8.9 9.5 14.2 16.8 49.8 15.8 6.7 8.3 11.5 24.4 20.7 20.5 377.2 15.5 12.2 16.0 9.4 19.0 18.7 7.2 2.0 8.9 17.6 7.6 13.9 29.1 23.4 21.9 27.8 8.9 15.2 0.0 14.1 10.2 20.4 28.0 16.2 23.0 13.0 10.8 14.7 20.7 19.1 APOL4 APOLIV ENSG00000100336 "Apolipoprotein L4" Q9BPW4 22 36189124-36204840 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 32.7;Enteroendocrine cells: 14.9;Glandular and luminal cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;monocytes: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 18.7;HDLM-2: 109.9;HSkMC: 16.1;K-562: 23.7;SCLC-21H: 47.9" "HPA049797, HPA055435" Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA049797: AB_2680887, HPA055435: AB_2682816" "unprognostic (2.73e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.51e-1)" "unprognostic (5.31e-1)" "unprognostic (3.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "prognostic favorable (3.45e-4)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.00e-5)" "unprognostic (4.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.18e-2)" "prognostic favorable (2.40e-6)" 10.7 1.0 1.3 6.0 1.1 1.5 14.8 1.2 2.2 4.7 1.1 3.3 4.9 4.0 1.6 4.3 5.9 6.3 5.3 1.2 3.0 4.5 2.0 12.9 4.8 2.3 1.4 1.0 4.0 1.0 0.3 9.5 3.4 2.1 14.9 3.4 0.1 5.9 3.5 1.1 3.9 3.8 2.4 1.2 3.2 5.0 0.7 1.6 3.0 3.2 1.3 1.8 12.2 3.7 1.7 0.0 0.0 0.0 0.0 0.2 2.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 109.9 0.0 5.7 0.0 0.0 0.1 0.0 0.2 16.1 0.0 0.0 0.0 0.0 0.8 0.0 23.7 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.0 47.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 1.3 1.1 1.2 2.2 1.2 3.0 2.3 1.4 1.0 2.1 1.2 1.6 1.7 7.0 0.0 6.7 0.3 0.2 1.3 0.7 1.5 0.0 0.3 4.6 2.2 1.1 1.5 3.4 0.0 0.0 0.5 0.1 0.0 3.9 0.2 0.0 32.7 12.4 6.6 14.9 4.2 0.0 0.7 1.0 10.4 0.0 52.6 2.5 0.0 2.5 0.4 2.3 1.7 0.1 0.8 0.0 6.2 6.5 0.0 2.8 8.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 1.2 0.2 0.3 4.2 0.0 0.0 9.0 1.9 0.0 0.0 0.0 1.1 6.2 1.3 0.5 0.4 1.9 PNPLA5 "dJ388M5.4, GS2L" ENSG00000100341 "Patatin like phospholipase domain containing 5" Q7Z6Z6 22 43879678-43892013 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.9;epididymis: 1.7;skin 1: 2.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.2;Inhibitory neurons: 2.1;Late spermatids: 2.1" "Cancer enriched" "Detected in single" 4 "thyroid cancer: 0.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;RPMI-8226: 2.7" "Not detected" "Not detected" "HPA050409, HPA054211" Uncertain NA NA "HPA050409: AB_2681118, HPA054211: AB_2682418" "unprognostic (6.69e-5)" "unprognostic (3.53e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (3.33e-3)" "unprognostic (1.05e-1)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" 0.0 0.0 0.5 0.1 2.9 0.3 0.3 0.1 2.3 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.1 0.0 1.3 0.4 0.0 1.0 0.0 0.0 1.2 0.5 0.6 0.0 0.0 0.0 0.9 0.0 0.7 0.1 0.0 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.5 2.9 0.1 2.3 1.3 0.4 1.2 0.5 0.6 0.7 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOL1 APOL ENSG00000100342 "Apolipoprotein L1" O14791 22 36253071-36267530 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 222.3" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8" "HPA018885, CAB056156" Supported "Secreted to blood" NA NA 1640000000 9200000000 "CAB056156: AB_2665576, HPA018885: AB_1844953" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (8.98e-3)" "unprognostic (1.67e-1)" "unprognostic (8.28e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (4.41e-2)" "unprognostic (1.58e-1)" "unprognostic (4.07e-3)" "unprognostic (5.15e-2)" "prognostic unfavorable (7.43e-6)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (5.05e-3)" "prognostic favorable (2.01e-5)" 45.3 15.9 8.3 63.1 7.9 4.2 28.7 7.5 9.9 54.2 10.3 29.1 33.0 39.2 17.9 25.9 37.0 69.6 25.7 7.2 9.4 37.4 222.3 60.0 23.3 9.2 8.0 6.5 25.0 9.1 4.9 14.2 53.4 9.2 37.8 27.5 1.0 29.9 52.7 11.9 6.9 29.2 66.0 8.4 57.3 65.4 8.0 9.6 25.1 18.1 13.9 23.8 118.8 30.2 10.5 21.6 5.1 0.1 0.6 46.8 44.6 14.2 2.3 9.0 13.7 38.6 0.6 34.4 7.0 243.9 24.8 31.3 5.3 0.0 19.2 3.6 166.1 0.2 6.1 3.2 41.4 120.3 2.4 20.2 8.3 1.7 38.0 0.8 2.0 27.3 1.3 23.8 85.1 2.4 0.2 8.5 2.1 0.6 0.6 0.2 13.6 2.6 3.2 91.1 146.8 1.9 0.1 10.9 5.8 2.1 0.3 0.8 7.8 24.7 29.5 12.4 3.2 1.5 6.5 4.0 1.6 16.0 12.4 4.6 15.6 6.1 5.5 12.6 6.8 10.7 2.6 8.1 11.2 4.3 1.4 4.6 6.3 16.1 22.4 10.3 0.5 5.4 7.2 8.3 7.9 7.5 9.9 7.2 9.4 9.2 8.0 6.5 9.2 8.4 9.6 10.5 37.4 57.7 34.3 0.3 7.2 1.7 21.4 73.5 2.8 0.5 6.3 3.0 3.6 15.7 67.1 18.4 2.1 11.0 12.6 31.2 0.0 37.8 0.8 106.1 48.8 41.3 7.7 3.8 0.1 20.0 8.2 27.3 45.9 216.2 11.4 4.3 49.6 115.6 9.1 0.0 0.1 17.7 32.6 15.8 5.3 1.4 27.4 10.9 0.0 7.5 19.4 0.1 36.0 0.0 0.0 105.1 19.9 24.0 15.0 31.2 20.5 2.1 60.5 1.3 6.6 5.5 10.6 0.4 0.4 3.4 2.3 6.7 12.9 1.6 4.6 62.5 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923792-43964488 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 31.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 16.7;LHCN-M2: 19.3" "Region enhanced" "Detected in many" "cerebellum: 12.2" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA Nucleoli "Mitochondria, Cytosol" "HPA058058: AB_2683590" "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.2 0.2 0.6 0.5 0.8 0.1 1.6 0.2 1.4 0.6 4.8 0.1 0.8 0.3 0.1 0.2 0.9 0.4 0.2 1.2 0.5 4.6 31.3 0.8 0.3 1.4 1.6 0.7 0.3 0.0 0.2 0.0 0.3 2.1 0.0 0.1 6.4 0.7 0.0 1.7 5.3 0.5 0.0 0.2 0.4 0.2 0.4 1.2 0.1 0.1 0.1 0.2 0.0 0.3 2.2 5.1 1.6 16.7 6.8 4.6 5.2 0.5 3.1 1.8 4.1 8.8 5.0 9.0 0.0 2.5 5.2 2.4 4.3 10.6 5.0 3.4 0.0 0.9 0.3 4.5 9.4 7.5 0.0 0.3 6.0 3.8 13.2 0.6 7.0 0.5 0.2 0.0 0.0 19.3 0.7 0.3 0.0 11.5 0.6 0.0 0.1 8.9 0.2 1.7 0.2 1.5 0.1 3.4 1.4 4.8 2.9 5.3 5.8 0.6 1.6 4.9 0.1 0.1 0.1 0.0 0.0 14.3 0.1 6.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.8 0.2 1.4 1.2 0.5 1.4 1.6 0.7 2.1 0.2 1.2 2.2 0.4 0.0 0.0 4.2 0.2 0.4 0.5 2.4 0.0 35.9 0.5 0.1 1.3 10.0 1.4 0.0 18.8 0.0 0.2 0.2 0.0 0.4 0.0 1.5 0.5 0.4 1.8 0.0 1.9 0.0 0.1 0.5 0.0 3.6 0.0 1.9 0.7 42.3 0.7 0.0 1.2 0.8 0.0 2.8 0.3 0.3 0.3 0.9 1.8 0.0 0.0 1.1 0.0 0.0 0.8 2.6 0.0 0.7 0.0 0.7 0.4 5.0 0.1 37.3 0.0 1.0 0.8 0.6 0.6 0.0 0.1 0.0 0.2 1.6 0.4 0.4 MYH9 "DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA" ENSG00000100345 "Myosin heavy chain 9" P35579 22 36281280-36387967 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 1343.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001644, CAB015386, HPA064783" Enhanced Supported "Nuclear bodies,Plasma membrane,Actin filaments,Cytosol" No No 410000000 "Plasma membrane, Actin filaments" "Nuclear bodies, Cytosol" "CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721" "unprognostic (1.38e-1)" "unprognostic (9.12e-2)" "unprognostic (4.21e-2)" "unprognostic (6.34e-2)" "unprognostic (1.49e-1)" "unprognostic (3.90e-2)" "unprognostic (9.56e-2)" "unprognostic (8.28e-2)" "unprognostic (5.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (9.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.62e-1)" "unprognostic (2.59e-2)" 274.0 96.3 45.0 182.8 42.6 248.1 233.5 38.6 51.5 179.9 74.0 187.2 107.9 359.4 39.7 155.1 183.8 135.7 150.8 48.4 57.7 141.8 102.4 288.7 163.0 52.0 50.1 25.4 122.1 161.6 55.5 53.1 167.9 45.0 132.9 90.7 9.8 178.8 99.3 84.7 155.2 164.9 175.6 45.3 234.4 136.9 38.5 54.3 126.2 142.3 46.7 105.0 170.3 168.2 54.3 612.2 277.0 86.2 74.2 156.8 195.1 437.3 398.4 507.5 554.6 413.2 302.1 170.3 156.9 230.1 666.1 265.0 412.7 125.2 779.4 559.6 356.1 120.9 302.6 294.3 259.9 481.1 346.9 463.8 233.0 234.7 751.9 626.4 540.3 461.8 113.2 67.3 205.8 448.9 161.9 124.4 204.0 51.7 171.1 169.2 233.3 267.3 146.7 314.5 581.5 129.6 53.0 559.7 217.0 251.6 218.5 162.4 177.1 1343.7 1222.6 370.3 237.5 731.5 135.2 114.7 129.0 463.2 172.3 363.1 72.6 25.2 64.7 32.4 19.8 28.4 13.4 23.5 26.4 17.2 11.9 18.3 20.4 41.2 9.0 26.5 8.0 26.3 54.5 45.0 42.6 38.6 51.5 48.4 57.7 52.0 50.1 25.4 45.0 45.3 54.3 54.3 303.9 118.6 87.1 12.7 108.4 144.0 182.4 123.1 72.8 2.6 90.5 89.4 62.6 80.1 89.7 92.0 2.1 87.0 151.7 359.8 7.9 309.4 35.8 89.7 121.6 258.7 73.8 51.9 42.5 245.8 193.1 82.9 123.8 194.7 93.1 117.1 132.8 102.8 100.4 82.4 6.7 131.0 59.0 119.6 124.2 37.4 68.0 168.8 85.4 61.8 196.6 11.9 137.0 7.5 33.3 344.6 186.8 211.4 125.9 184.4 159.8 27.5 51.5 5.3 203.8 39.9 275.2 6.9 10.4 133.6 135.1 46.4 213.2 141.3 139.5 134.3 CACNA1I Cav3.3 ENSG00000100346 "Calcium voltage-gated channel subunit alpha1 I" Q9P0X4 22 39570753-39689735 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.1;thyroid gland: 5.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.9;Excitatory neurons: 16.8;Inhibitory neurons: 12.3" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 2.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-BR-3: 1.9;T-47d: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066992 Uncertain "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA066992: " "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.60e-2)" "unprognostic (3.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-1)" "unprognostic (7.21e-2)" "unprognostic (5.20e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-2)" "unprognostic (6.14e-3)" "unprognostic (1.57e-1)" "unprognostic (3.78e-2)" "unprognostic (8.27e-4)" 0.2 3.4 2.9 0.8 4.4 0.6 0.1 1.5 10.1 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.0 9.4 2.3 0.1 0.0 0.5 1.9 7.3 1.8 3.3 0.1 0.1 0.0 0.3 0.0 8.7 0.1 0.0 2.6 0.1 0.0 0.0 0.1 3.3 0.0 0.2 1.6 0.6 0.8 1.9 0.2 5.3 0.0 0.5 0.4 0.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.9 4.4 1.5 10.1 9.4 2.3 7.3 1.8 3.3 8.7 0.2 1.9 5.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.4 16.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 3.3 12.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 1.0 2.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.1 SAMM50 "CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W" ENSG00000100347 "SAMM50 sorting and assembly machinery component" Q9Y512 22 43955442-44010531 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 242.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034537 Enhanced Supported Mitochondria NA NA Mitochondria "HPA034537: AB_10602794" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-3)" "prognostic favorable (2.63e-7)" "unprognostic (2.43e-3)" "unprognostic (2.28e-1)" "unprognostic (5.28e-3)" "unprognostic (1.70e-3)" "unprognostic (3.37e-2)" "unprognostic (1.95e-1)" "unprognostic (2.42e-1)" "unprognostic (3.52e-1)" "prognostic favorable (4.43e-8)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" "unprognostic (1.60e-1)" 42.1 51.0 25.5 27.2 26.0 32.8 36.1 28.5 30.9 43.8 28.8 36.0 51.2 27.3 29.5 32.0 42.3 29.6 61.0 25.9 27.8 49.2 37.5 22.4 34.9 28.2 27.3 24.7 40.4 33.6 115.3 24.6 20.2 28.9 26.8 35.8 25.8 35.5 25.4 242.7 35.8 38.6 28.0 26.5 24.6 44.2 26.3 26.9 34.7 28.3 178.6 37.3 28.2 24.2 27.0 64.6 59.8 57.1 69.5 72.2 75.9 79.8 61.7 65.7 89.1 76.4 86.1 46.0 105.9 44.3 70.8 51.4 75.6 85.4 82.6 79.7 29.4 105.3 57.5 73.9 102.6 50.4 184.0 83.1 88.3 64.7 77.0 35.5 62.3 93.1 49.9 49.9 34.0 80.9 91.7 72.6 72.0 56.0 77.4 70.9 83.8 61.8 85.9 74.4 81.0 34.1 55.4 68.3 72.2 104.1 60.4 67.7 59.8 57.7 57.3 68.8 53.6 51.2 50.1 74.4 82.1 72.0 66.3 58.7 47.5 39.2 46.9 39.8 39.0 55.4 55.1 36.6 40.5 67.7 51.0 37.8 36.0 6.1 39.1 31.8 26.7 45.7 40.2 25.5 26.0 28.5 30.9 25.9 27.8 28.2 27.3 24.7 28.9 26.5 26.9 27.0 52.9 35.3 18.9 10.4 31.6 20.6 27.0 72.0 30.7 20.1 32.1 40.9 68.6 18.6 39.5 9.2 8.4 41.6 31.7 36.1 60.7 47.2 40.3 47.3 24.9 35.1 18.6 51.4 12.0 55.5 54.1 24.6 42.3 32.7 27.3 43.9 30.0 41.8 51.1 32.0 12.7 35.2 46.8 28.6 20.5 50.1 26.1 25.0 16.0 12.2 41.4 32.8 33.0 9.5 9.1 43.7 34.5 30.5 31.0 16.2 82.4 116.8 39.9 30.1 19.7 23.2 33.4 45.8 31.2 34.3 22.6 20.5 28.5 69.9 59.8 19.3 TXN2 MT-TRX ENSG00000100348 "Thioredoxin 2" Q99757 22 36467046-36481640 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Transport" "Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000994, CAB008681" Approved Enhanced Mitochondria No No 84000 Mitochondria "CAB008681: AB_1623682, HPA000994: AB_1080267" "unprognostic (5.11e-2)" "unprognostic (4.40e-3)" "unprognostic (4.40e-3)" "unprognostic (1.07e-2)" "unprognostic (5.85e-2)" "unprognostic (4.28e-2)" "unprognostic (4.02e-2)" "unprognostic (5.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic favorable (2.04e-4)" "prognostic favorable (1.17e-6)" "unprognostic (1.49e-2)" "unprognostic (2.78e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" 57.6 183.7 87.6 45.9 88.6 65.2 58.6 92.2 99.1 53.6 88.5 65.9 84.7 50.4 52.1 80.5 64.7 49.8 114.0 85.6 88.2 92.1 150.7 45.0 59.7 90.9 88.6 83.5 76.5 59.7 99.9 43.8 47.7 88.5 59.8 64.2 43.4 60.0 52.9 160.9 60.0 64.9 48.7 89.4 66.3 76.7 49.2 92.7 51.4 68.3 181.7 60.4 59.5 54.5 89.3 52.8 80.4 75.4 126.8 115.2 125.0 81.3 70.8 108.1 114.8 128.7 87.9 52.1 133.3 64.2 116.8 54.5 76.1 151.7 127.4 66.1 93.6 131.8 147.7 91.7 125.4 94.6 189.6 125.8 162.3 98.9 101.9 79.3 99.5 118.2 78.4 157.7 104.1 106.1 80.3 87.5 128.2 60.0 170.3 95.3 75.3 79.5 92.6 116.4 84.8 99.9 98.3 70.2 148.1 125.3 61.3 103.6 165.9 83.7 120.5 95.0 69.8 65.9 81.4 64.2 128.6 111.0 109.5 74.1 30.2 173.5 32.3 102.5 194.3 108.9 140.4 101.2 109.0 223.4 133.8 116.4 108.6 59.3 145.4 170.1 167.1 110.9 224.3 87.6 88.6 92.2 99.1 85.6 88.2 90.9 88.6 83.5 88.5 89.4 92.7 89.3 68.9 60.9 53.0 12.1 66.4 83.5 87.7 154.0 108.1 105.6 124.3 137.7 105.4 88.6 82.5 69.9 39.6 213.2 62.8 128.5 303.3 93.0 19.6 45.7 70.6 73.7 89.5 114.0 8.3 106.2 275.8 74.0 75.4 57.2 69.1 148.0 81.0 122.7 173.4 116.1 10.3 132.4 95.6 100.5 80.7 36.8 56.5 80.7 78.2 8.4 91.9 168.9 77.2 9.0 13.5 82.5 104.3 50.8 79.5 52.7 252.2 213.7 49.0 59.4 19.7 61.1 67.1 49.1 42.4 124.5 89.8 207.1 62.4 287.0 179.6 87.1 FOXRED2 "ERFAD, FLJ23322" ENSG00000100350 "FAD dependent oxidoreductase domain containing 2" Q8IWF2 22 36487190-36507043 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in many" 4 "dendritic cells: 5.4" "Cell line enhanced" "Detected in many" "SiHa: 147.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031611, HPA031612" Approved "Intracellular and membrane" NA NA "HPA031611: AB_10599975, HPA031612: AB_10601887" "unprognostic (3.66e-1)" "prognostic favorable (4.86e-5)" "unprognostic (6.73e-2)" "unprognostic (1.26e-1)" "unprognostic (4.66e-1)" "unprognostic (7.58e-2)" "unprognostic (2.24e-3)" "unprognostic (2.00e-2)" "unprognostic (4.31e-1)" "unprognostic (7.15e-3)" "unprognostic (1.67e-2)" "unprognostic (1.48e-2)" "unprognostic (2.15e-2)" "unprognostic (9.56e-3)" "unprognostic (4.49e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (9.42e-2)" 5.5 8.2 12.5 4.9 15.1 3.7 4.6 7.0 16.1 9.5 7.5 4.3 4.9 8.1 10.5 4.5 6.7 5.3 5.0 18.2 9.4 6.9 7.7 3.8 5.3 7.4 10.5 15.7 13.8 3.6 5.3 4.2 6.3 9.4 7.8 4.2 7.5 6.1 5.5 7.1 7.6 3.1 6.0 4.6 11.4 4.4 5.8 9.8 5.2 4.8 6.5 4.9 5.2 3.8 15.4 31.1 32.7 17.1 35.7 10.7 5.1 26.5 16.2 15.7 31.8 26.3 85.8 15.5 42.4 26.4 12.9 2.2 16.5 32.1 8.5 20.4 15.0 50.8 27.6 20.2 38.6 29.2 27.2 88.9 14.8 8.4 21.2 9.3 7.5 10.5 32.7 33.8 0.7 19.5 27.3 29.0 14.2 15.1 25.0 27.5 52.5 38.4 18.8 12.4 21.5 34.8 44.9 147.5 30.3 27.0 6.4 43.4 14.9 11.8 41.1 51.9 30.3 18.6 11.6 19.0 33.2 13.5 23.9 32.8 0.5 0.9 0.1 0.2 1.1 1.2 0.3 0.2 0.3 0.8 0.4 0.6 0.5 0.3 0.2 0.8 5.4 0.2 0.4 12.5 15.1 7.0 16.1 18.2 9.4 7.4 10.5 15.7 9.4 4.6 9.8 15.4 0.9 0.0 4.5 6.8 2.9 2.8 2.6 0.8 3.4 11.6 4.1 3.7 5.5 2.8 0.7 5.5 4.2 11.2 6.1 1.0 1.9 1.9 0.3 2.2 6.2 3.0 0.0 3.4 3.5 1.6 5.4 7.5 1.1 3.9 2.5 7.8 1.8 11.7 10.8 10.1 9.1 1.5 0.0 16.6 3.7 0.9 9.3 4.2 3.6 0.0 1.3 8.6 1.0 6.0 5.5 0.9 0.2 7.5 2.1 1.9 0.4 5.5 1.1 4.0 0.0 12.7 2.3 8.9 22.3 4.7 4.0 3.6 0.9 7.6 3.1 1.4 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2 related adaptor protein 2" O75791 22 39901084-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "lymphoid tissue: 186.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0" "Lineage enriched" "Detected in many" 9 "T-cells: 58.2" "Group enriched" "Detected in some" 4 "HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 290000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.2 0.7 0.2 8.0 0.2 10.4 2.0 0.3 0.4 1.5 0.8 2.2 3.6 0.8 0.5 1.2 0.7 2.6 0.9 0.2 0.3 0.6 1.2 4.4 15.8 0.5 0.6 0.1 0.2 0.4 0.1 0.3 0.6 0.4 1.7 2.4 0.3 1.7 0.7 0.4 1.1 4.5 0.9 0.5 9.4 3.8 2.0 0.6 186.5 0.8 0.5 13.0 3.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 45.7 0.0 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.2 0.3 0.0 175.8 44.8 0.0 0.0 0.0 122.8 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.8 6.3 0.7 0.1 51.4 0.3 38.2 3.1 37.5 56.2 1.2 5.2 31.3 58.2 6.6 5.4 0.3 0.8 35.0 74.9 0.2 0.2 0.3 0.4 0.2 0.3 0.5 0.6 0.1 0.4 0.5 0.6 0.7 1.1 0.0 6.7 0.3 8.2 1.7 0.0 0.0 0.0 0.6 1.1 0.8 1.0 2.8 0.0 0.0 0.0 0.0 18.3 0.1 0.0 0.4 4.8 0.3 0.1 0.8 1.2 32.6 1.3 0.2 0.0 0.6 0.0 0.1 146.9 0.2 2.5 2.3 0.2 0.0 1.2 0.6 0.0 1.9 4.6 2.9 0.3 82.0 1.8 1.0 6.8 0.3 59.8 2.5 1.0 0.0 0.3 0.4 6.3 0.4 0.0 0.4 0.0 0.0 0.0 0.5 0.9 4.4 2.1 0.1 1.1 0.1 57.1 0.0 0.1 0.3 EIF3D "eIF3-p66, eIF3-zeta, EIF3S7" ENSG00000100353 "Eukaryotic translation initiation factor 3 subunit D" O15371 22 36510855-36529184 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045882, HPA063330, HPA066216" Approved Supported Cytosol NA NA 36000 Cytosol "HPA045882: AB_2679482, HPA063330: AB_2684988, HPA066216: AB_2685637" "unprognostic (4.98e-2)" "unprognostic (2.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.50e-3)" "unprognostic (1.39e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.10e-5)" "unprognostic (1.47e-1)" "unprognostic (2.58e-1)" "unprognostic (9.98e-2)" "unprognostic (5.54e-3)" "unprognostic (3.93e-2)" "unprognostic (5.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-1)" "unprognostic (5.22e-2)" "unprognostic (9.78e-2)" 116.7 85.0 45.4 106.2 47.8 178.4 186.4 47.5 48.6 128.7 59.6 119.9 108.3 122.7 124.7 145.6 159.5 85.3 95.9 45.5 51.1 89.2 88.7 88.3 175.6 50.0 46.4 43.0 195.0 229.9 109.0 55.7 110.8 49.3 98.6 136.8 46.0 133.9 103.1 153.3 154.2 101.0 119.7 48.3 139.8 130.3 64.0 48.1 164.1 114.5 93.9 213.5 136.0 117.2 52.5 312.4 171.3 172.2 197.2 237.8 462.3 287.8 235.2 321.2 319.5 313.7 270.7 171.1 395.3 173.4 271.8 202.4 230.9 295.1 374.5 320.7 215.7 313.6 215.4 151.9 209.6 428.2 507.5 214.4 419.6 427.7 357.1 515.0 365.1 347.5 128.0 238.3 195.9 363.6 194.0 180.3 281.0 188.5 484.9 141.6 318.1 278.0 305.0 314.2 214.9 135.9 190.7 153.6 311.3 337.4 180.0 196.7 472.5 243.9 247.9 222.6 188.3 333.6 247.5 171.8 316.9 252.1 318.1 242.7 166.7 383.7 141.3 320.3 353.5 520.4 518.1 461.1 381.1 528.9 509.2 558.2 455.7 95.1 402.3 348.9 303.3 608.7 826.1 45.4 47.8 47.5 48.6 45.5 51.1 50.0 46.4 43.0 49.3 48.3 48.1 52.5 115.6 60.9 92.0 13.7 184.7 212.9 287.1 299.1 134.9 37.3 231.9 216.8 67.9 130.1 167.1 46.0 31.3 224.2 151.5 68.2 150.6 191.7 126.3 108.4 95.3 141.7 112.7 101.4 8.5 207.8 240.4 99.4 78.0 88.1 187.3 128.9 126.7 41.0 219.7 25.2 8.7 149.1 109.9 211.0 176.1 46.4 138.5 121.7 129.9 8.4 275.1 75.6 137.0 10.6 12.5 185.6 134.7 108.3 72.5 230.6 176.5 160.1 119.9 46.2 72.3 147.9 260.8 106.0 83.2 140.3 215.8 246.1 159.8 162.2 219.7 288.0 TNRC6B KIAA1093 ENSG00000100354 "Trinucleotide repeat containing adaptor 6B" Q9UPQ9 22 40044817-40335808 "Metabolic proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 484.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003180 Approved NA NA "HPA003180: AB_1079196" "unprognostic (1.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" "unprognostic (5.88e-2)" "unprognostic (1.92e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-2)" "unprognostic (9.74e-2)" "unprognostic (4.93e-2)" "unprognostic (2.59e-1)" "unprognostic (8.42e-2)" "unprognostic (1.84e-3)" "unprognostic (8.85e-2)" "unprognostic (7.24e-2)" "unprognostic (7.00e-2)" "unprognostic (1.81e-1)" 3.9 3.7 5.0 4.9 6.4 19.6 3.9 20.4 7.4 4.4 11.4 4.1 3.2 4.0 5.8 3.5 3.8 4.4 4.6 4.1 1.5 3.9 5.5 4.9 5.4 3.3 3.2 2.9 4.2 3.9 4.8 5.5 3.6 7.9 3.7 3.5 12.8 4.1 2.8 6.4 5.3 5.2 3.7 1.6 5.6 4.3 15.1 4.2 9.3 5.1 5.1 6.0 3.7 4.3 16.3 6.3 9.3 9.4 9.8 6.1 4.3 5.1 4.2 7.7 6.5 7.9 4.2 4.3 11.9 7.4 5.1 7.6 4.3 11.8 8.6 6.8 13.0 9.3 8.8 9.3 5.3 3.0 10.2 12.5 4.8 4.0 10.2 5.1 3.1 9.0 6.7 7.4 10.8 6.1 6.8 6.3 3.2 12.2 4.8 6.7 7.7 9.0 6.0 6.1 10.6 11.4 2.7 10.2 3.6 5.2 8.5 5.1 3.7 10.3 5.7 20.7 5.8 4.0 8.5 8.2 7.8 3.7 5.1 6.8 228.9 32.8 66.2 48.0 19.2 42.4 100.7 50.5 44.5 16.3 134.6 52.8 53.6 484.5 34.7 29.6 104.9 29.5 12.5 5.0 6.4 20.4 7.4 4.1 1.5 3.3 3.2 2.9 7.9 1.6 4.2 16.3 114.0 38.5 54.9 260.8 178.8 74.8 70.2 60.8 92.8 248.7 103.4 85.9 153.6 125.8 56.0 69.9 458.7 36.4 171.1 77.8 70.5 59.8 82.5 142.2 91.0 104.4 141.0 203.1 334.1 59.3 20.7 108.4 61.2 85.0 65.9 78.1 120.7 109.7 39.0 341.6 371.8 76.7 65.1 115.9 80.1 72.4 111.9 71.4 65.8 235.2 117.2 127.2 168.9 255.9 304.0 54.4 76.4 127.9 117.8 79.8 93.0 69.0 91.3 356.9 52.6 175.5 95.1 87.7 88.3 56.6 82.1 7.5 149.0 82.6 83.7 59.1 SGSM3 "DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3" ENSG00000100359 "Small G protein signaling modulator 3" Q96HU1 22 40370591-40410289 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048980 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA048980: AB_2680585" "unprognostic (4.63e-2)" "unprognostic (7.51e-3)" "unprognostic (3.02e-2)" "prognostic favorable (4.47e-5)" "unprognostic (1.81e-1)" "unprognostic (6.83e-3)" "unprognostic (5.70e-3)" "unprognostic (7.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.67e-2)" "unprognostic (1.71e-3)" "unprognostic (1.93e-1)" "unprognostic (2.97e-1)" "unprognostic (4.08e-3)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.98e-3)" 23.9 42.9 29.9 26.3 32.5 19.5 29.7 24.9 44.0 36.4 28.9 40.9 33.1 32.2 14.6 49.6 37.4 28.9 36.1 30.8 29.5 36.5 37.6 34.0 33.1 34.0 32.3 32.4 31.1 108.6 24.9 55.4 22.0 30.9 63.2 24.6 11.1 70.7 26.1 34.6 35.7 46.5 17.5 25.6 51.9 92.2 40.2 30.3 27.8 49.1 23.6 28.5 33.4 35.9 33.7 37.8 21.1 30.6 34.1 33.2 18.1 43.4 35.0 22.9 26.0 33.7 12.0 30.9 23.3 23.7 37.9 15.6 30.0 29.2 42.9 10.4 58.4 68.8 15.9 56.9 11.3 31.6 23.1 33.1 30.2 29.5 29.1 17.4 29.2 46.0 48.6 19.8 31.4 19.4 60.5 32.1 23.5 20.5 75.8 14.0 59.3 19.3 51.1 26.8 33.0 18.8 24.2 38.6 55.4 27.5 24.2 46.3 38.9 40.2 8.8 31.8 23.4 20.6 47.1 23.2 31.0 37.4 19.0 22.9 1.1 14.6 16.3 18.7 15.7 15.6 17.7 11.5 14.9 18.9 22.3 13.8 11.3 3.3 35.4 11.9 31.6 11.7 15.8 29.9 32.5 24.9 44.0 30.8 29.5 34.0 32.3 32.4 30.9 25.6 30.3 33.7 5.3 3.2 10.3 14.0 32.8 11.5 32.4 33.1 14.8 57.0 12.1 7.1 8.3 27.1 42.1 7.3 18.8 42.8 23.9 46.4 1.9 20.2 17.5 5.1 3.8 14.3 31.3 18.1 27.1 45.3 54.3 14.0 176.4 6.7 15.9 3.1 21.8 24.0 24.2 26.9 34.6 135.3 50.8 17.2 8.3 31.7 22.7 11.8 16.0 13.1 21.6 13.4 30.9 15.6 15.1 21.3 40.6 19.2 30.5 46.1 36.2 4.4 60.2 34.0 39.5 14.4 13.8 83.5 44.4 19.8 10.4 45.6 16.7 3.3 47.7 60.0 IFT27 "BBS19, FAP156, RABL4, RAYL" ENSG00000100360 "Intraflagellar transport 27" Q9BW83 22 36758202-36776256 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 257.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "U-138 MG: 159.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048791 Uncertain NA NA "HPA048791: " "unprognostic (3.04e-2)" "unprognostic (7.25e-3)" "unprognostic (7.06e-2)" "prognostic favorable (1.91e-4)" "unprognostic (9.04e-2)" "unprognostic (6.05e-2)" "unprognostic (6.22e-2)" "unprognostic (1.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.75e-3)" "unprognostic (4.85e-3)" "unprognostic (2.10e-1)" "unprognostic (9.62e-3)" "unprognostic (8.08e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-1)" "prognostic favorable (5.55e-4)" 11.3 21.9 22.5 8.6 22.6 8.9 11.6 25.0 27.2 12.9 27.2 17.2 12.4 13.9 19.5 9.8 36.9 9.5 23.2 22.2 22.0 20.0 18.5 11.3 9.9 23.0 22.4 20.4 15.2 16.4 23.4 39.9 8.1 23.9 15.3 9.8 15.8 14.7 16.7 15.1 11.4 12.6 8.8 23.9 11.9 16.2 23.3 23.4 9.8 18.2 12.0 9.2 15.1 11.2 22.9 17.8 21.9 25.3 28.8 19.9 19.1 15.1 14.1 18.2 18.3 16.1 0.9 15.9 19.3 24.2 13.2 26.3 16.1 13.9 16.0 14.1 37.1 37.4 5.1 4.3 0.0 36.6 6.2 23.3 15.5 25.6 19.4 8.9 14.8 19.6 15.7 9.1 15.5 12.5 32.6 7.7 5.5 13.5 34.4 28.5 36.4 0.0 10.8 18.3 11.4 24.3 26.4 15.0 11.4 37.8 21.3 25.8 11.0 11.6 159.2 9.3 21.3 2.7 36.2 23.6 7.0 25.1 15.5 35.3 14.5 31.8 36.1 24.6 25.0 24.6 22.8 20.4 23.0 39.2 26.0 19.9 19.0 11.7 23.1 30.0 30.5 29.9 21.1 22.5 22.6 25.0 27.2 22.2 22.0 23.0 22.4 20.4 23.9 23.9 23.4 22.9 23.6 6.4 18.4 34.3 18.8 23.3 29.0 50.1 12.5 35.2 29.9 32.1 19.9 20.0 51.6 40.5 29.2 27.2 15.2 19.9 105.7 26.1 66.0 110.5 20.2 23.2 53.3 7.8 8.9 23.0 20.9 27.8 14.3 18.7 33.0 27.6 26.0 18.7 40.7 30.3 12.3 46.9 65.1 13.8 25.0 24.3 27.4 17.8 35.6 5.6 13.2 60.5 21.6 11.6 10.4 19.8 18.3 31.6 29.5 24.7 39.4 57.0 257.2 41.9 13.1 24.2 26.9 78.5 17.9 14.1 33.2 17.5 19.0 21.0 31.6 27.9 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 2148.2" "Group enriched" "Detected in some" 7 "Distal tubular cells: 641.8;Horizontal cells: 1527.7" "Cancer enriched" "Detected in many" 4 "renal cancer: 59.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enriched" "Detected in some" 291 "RPMI-8226: 1561.0" "Region enriched" "Detected in all" 5 "cerebellum: 2120.1" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.4 1.0 73.7 0.7 42.2 0.1 15.2 238.6 76.2 0.0 13.4 0.3 0.2 1.4 0.8 0.1 0.1 0.3 0.2 27.7 88.3 82.9 5.8 2.2 2.4 120.1 94.3 12.3 0.5 0.2 2148.2 1.2 2.4 105.2 0.4 0.3 376.8 2.7 0.7 13.7 0.1 0.3 0.5 51.2 3.2 0.8 1.5 292.9 0.3 5.1 0.4 3.1 3.8 0.2 103.7 0.0 0.0 3.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.1 0.4 1561.0 0.0 5.3 2.3 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 4.6 0.0 0.0 0.9 0.3 15.1 73.7 42.2 238.6 76.2 27.7 88.3 120.1 94.3 12.3 105.2 51.2 292.9 103.7 0.0 0.0 0.0 3.9 0.3 0.0 0.0 0.0 0.0 51.3 2.4 2.0 0.6 0.0 0.0 38.6 10.4 0.3 0.0 0.0 641.8 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.8 0.0 0.3 0.5 0.0 0.0 11.4 0.2 30.0 0.2 53.8 1527.7 29.7 0.0 0.0 2.9 0.0 0.1 0.6 15.7 0.0 2.8 0.1 37.4 0.0 3.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 150.5 0.0 1.0 0.0 0.0 3.6 0.0 0.0 0.4 0.9 0.0 0.0 0.1 KIAA0930 "bK268H5.C22.1, C22orf9" ENSG00000100364 KIAA0930 Q6ICG6 22 45192244-45240894 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 229.0;choroid plexus: 153.4" "Cell type enhanced" "Detected in many" "Astrocytes: 132.2;Excitatory neurons: 139.6;Oligodendrocytes: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 11.0;eosinophil: 8.6;intermediate monocyte: 13.9;myeloid DC: 12.1;non-classical monocyte: 17.3;plasmacytoid DC: 10.0" "Group enriched" "Detected in all" 5 "dendritic cells: 12.1;granulocytes: 8.6;monocytes: 17.3" "Cell line enhanced" "Detected in many" "THP-1: 327.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038091 Uncertain Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nuclear membrane, Mitochondria" Nucleoplasm "HPA038091: AB_10675627" "unprognostic (4.16e-2)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "prognostic favorable (9.22e-5)" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (6.90e-8)" "unprognostic (2.80e-1)" "unprognostic (2.03e-1)" "unprognostic (3.58e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-1)" "prognostic unfavorable (8.95e-7)" "unprognostic (6.89e-3)" "unprognostic (5.32e-2)" "unprognostic (5.58e-2)" "unprognostic (1.15e-1)" 29.9 58.8 219.1 27.9 222.7 24.9 26.1 186.6 215.1 41.3 153.4 26.0 14.8 24.2 40.7 34.8 18.4 16.2 17.0 207.5 199.8 22.4 48.8 25.0 29.3 210.2 214.6 198.2 13.7 20.3 18.6 19.4 12.1 229.0 29.4 11.3 3.5 26.9 25.0 34.1 64.1 21.6 15.4 190.1 39.0 18.8 26.4 217.4 20.6 18.6 13.2 22.4 44.4 35.9 222.4 49.6 31.5 19.1 38.3 64.1 30.2 19.2 26.9 26.8 28.2 24.1 29.5 26.5 33.2 39.2 42.8 22.5 54.5 29.5 118.6 10.7 35.6 46.4 0.1 42.0 34.3 25.7 89.4 19.7 17.1 59.2 27.3 45.3 21.5 26.8 23.9 11.7 53.1 17.4 56.9 40.0 82.8 18.9 35.8 26.5 48.1 12.9 110.7 42.6 29.7 15.9 28.4 42.5 57.6 75.5 36.8 28.1 327.8 36.5 29.0 50.6 39.7 15.7 44.9 32.9 32.1 34.0 133.7 30.3 0.8 11.0 8.6 2.3 13.9 1.6 2.3 0.9 2.6 12.1 1.8 0.9 1.6 2.5 1.9 17.3 10.0 2.0 3.7 219.1 222.7 186.6 215.1 207.5 199.8 210.2 214.6 198.2 229.0 190.1 217.4 222.4 11.4 6.4 8.8 132.2 9.9 52.8 18.6 22.7 6.8 7.3 13.9 13.5 11.5 12.8 11.8 18.4 6.2 2.0 24.9 16.2 0.0 18.6 2.9 11.6 9.3 9.7 10.7 23.1 139.6 20.7 6.5 32.7 4.6 19.5 2.5 3.8 17.5 23.3 67.5 5.0 56.7 10.0 14.2 71.1 50.0 10.8 10.8 59.8 44.4 24.4 68.5 6.5 13.4 16.1 152.9 18.0 13.7 14.7 11.2 25.6 15.7 13.8 9.3 5.9 0.0 10.2 10.9 7.5 4.4 15.2 57.3 2.7 9.3 5.3 12.8 23.1 NCF4 "p40phox, SH3PXD4" ENSG00000100365 "Neutrophil cytosolic factor 4" Q15080 22 36860988-36878017 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 181.9;lymphoid tissue: 163.6" "Cell type enhanced" "Detected in many" "B-cells: 70.9;granulocytes: 74.1;Hofbauer cells: 198.4;Kupffer cells: 85.3;Langerhans cells: 55.8;Macrophages: 85.7;Plasma cells: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 657.3;eosinophil: 750.1;neutrophil: 1235.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 1235.8" "Cell line enhanced" "Detected in some" "HEL: 78.3;HMC-1: 396.0;NB-4: 148.7;REH: 76.5;RPMI-8226: 144.0;THP-1: 137.9;U-937: 76.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010146, HPA036156, HPA057975" Enhanced Enhanced Cytosol NA NA 7800 Cytosol "CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (2.68e-2)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (2.78e-3)" "unprognostic (4.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.03e-2)" "unprognostic (2.70e-1)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (7.06e-8)" "unprognostic (3.60e-1)" "unprognostic (2.23e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" 25.2 14.5 5.0 43.5 5.4 181.9 12.8 5.2 7.6 4.6 8.1 15.2 11.8 4.5 1.0 7.2 14.0 13.1 8.4 5.1 8.0 8.9 10.2 45.5 40.1 7.1 5.6 4.8 3.3 4.2 1.4 5.3 24.5 6.1 7.4 11.9 0.1 10.8 4.6 3.7 5.0 43.0 10.6 6.3 163.6 9.4 1.8 7.9 13.0 8.2 7.2 33.7 18.9 7.2 7.0 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.6 0.0 78.3 0.0 0.0 0.0 12.8 396.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 26.8 0.0 0.8 0.0 148.7 0.0 0.0 0.0 76.5 0.0 144.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 137.9 0.0 0.0 0.2 0.1 0.2 0.5 0.1 23.7 0.1 76.8 0.1 657.3 184.6 750.1 2.3 92.5 9.8 108.2 32.0 6.9 86.1 85.9 1.9 2.1 1235.8 4.4 62.0 100.7 96.3 106.3 5.0 5.4 5.2 7.6 5.1 8.0 7.1 5.6 4.8 6.1 6.3 7.9 7.0 1.5 3.2 18.7 0.0 70.9 2.8 2.2 1.3 0.6 0.0 3.1 2.5 2.1 0.0 5.8 1.8 0.0 3.2 21.1 1.3 0.0 0.6 0.2 0.2 0.1 3.6 0.0 28.8 0.0 3.1 16.0 1.8 2.0 0.4 74.1 0.0 1.4 0.7 198.4 0.0 0.0 0.5 2.0 85.3 55.8 1.0 0.6 85.7 14.2 3.7 38.5 0.0 3.1 0.0 0.1 0.9 22.5 0.0 68.2 0.3 0.2 0.2 0.9 0.3 0.0 0.5 1.6 0.0 0.4 0.5 2.3 13.0 17.5 0.7 1.7 4.3 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor subunit beta" P32927 22 36913628-36940439 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 55.0;lymphoid tissue: 66.1" "Cell type enhanced" "Detected in many" "dendritic cells: 44.8;Extravillous trophoblasts: 37.9;granulocytes: 91.2;Langerhans cells: 68.3;Late spermatids: 41.2;Macrophages: 34.7;monocytes: 42.3;Plasma cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 238.1;neutrophil: 76.0" "Lineage enriched" "Detected in many" 16 "granulocytes: 238.1" "Group enriched" "Detected in some" 5 "HEL: 107.3;HMC-1: 321.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA078677 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 10.2 2.0 1.4 66.1 1.2 55.0 5.5 1.4 4.8 2.5 3.2 10.0 10.4 2.1 0.7 6.6 2.7 9.9 2.3 1.1 3.1 1.4 2.7 15.3 40.4 2.5 1.6 0.5 0.5 2.1 0.9 0.7 31.6 2.7 1.6 8.6 0.1 4.9 1.5 1.0 5.4 11.1 7.1 1.9 23.0 9.4 2.1 2.6 9.9 2.7 4.1 63.1 18.4 2.5 5.6 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.3 0.0 0.0 0.1 16.1 0.0 107.3 0.0 0.0 0.1 1.7 321.1 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.1 12.6 0.0 0.0 0.1 11.2 0.0 0.0 0.0 10.7 0.0 40.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.1 9.6 0.3 1.0 0.1 0.3 0.0 1.6 1.1 6.8 0.2 15.6 0.1 238.1 9.1 23.5 0.0 7.7 0.0 1.6 0.2 0.0 4.8 1.1 0.0 0.0 76.0 0.0 7.0 14.4 2.3 10.3 1.4 1.2 1.4 4.8 1.1 3.1 2.5 1.6 0.5 2.7 1.9 2.6 5.6 4.3 0.0 9.1 1.6 9.1 7.1 0.0 0.0 0.0 0.0 0.2 0.3 1.2 2.8 1.8 0.0 0.0 3.4 44.8 0.0 0.0 0.0 13.4 0.0 0.2 22.0 0.0 32.0 0.1 0.2 37.9 2.8 0.0 0.0 91.2 0.0 4.6 0.0 20.1 0.0 0.1 0.0 0.0 31.9 68.3 41.2 0.0 34.7 12.4 5.6 42.3 0.0 2.1 0.0 0.0 0.0 0.0 0.4 49.5 0.1 0.0 0.1 2.9 0.0 0.0 0.3 0.5 0.0 0.0 0.1 6.3 16.6 2.9 0.1 0.0 0.2 SLC25A17 PMP34 ENSG00000100372 "Solute carrier family 25 member 17" O43808 22 40769630-40819399 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052708, HPA060972" Approved Supported Peroxisomes NA NA Peroxisomes "HPA052708: AB_2681924, HPA060972: AB_2684400" "unprognostic (2.75e-1)" "unprognostic (1.11e-3)" "unprognostic (1.91e-3)" "unprognostic (2.44e-2)" "unprognostic (2.61e-1)" "unprognostic (1.96e-2)" "unprognostic (2.85e-3)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" "unprognostic (1.63e-3)" "unprognostic (8.44e-2)" "unprognostic (2.72e-1)" "unprognostic (5.59e-2)" "unprognostic (8.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" 7.3 12.4 9.8 5.3 9.8 3.3 14.4 10.5 10.5 9.3 11.5 6.4 5.4 13.3 19.7 7.2 11.5 5.8 4.1 9.9 13.0 13.8 17.1 6.7 9.5 10.4 10.1 9.7 20.8 8.9 13.7 9.3 10.1 10.2 10.7 7.3 9.3 9.9 6.0 3.9 9.7 6.1 10.5 10.6 7.3 7.9 10.1 10.5 9.4 12.8 3.6 9.7 8.2 7.2 11.8 23.5 13.5 21.0 18.5 12.8 15.9 16.8 20.7 22.7 32.5 35.7 16.5 8.8 26.7 12.2 20.4 17.7 18.6 30.6 16.6 33.4 27.0 41.3 31.1 18.4 21.1 18.3 35.8 16.2 15.3 22.8 28.6 18.4 14.7 19.4 21.4 46.5 12.9 26.5 19.2 22.0 24.2 17.7 33.2 20.6 23.8 32.4 40.3 27.6 19.7 14.2 12.5 42.8 26.6 26.7 20.3 22.0 10.7 11.8 18.5 24.4 16.1 19.2 13.9 29.6 25.7 19.7 18.4 20.4 7.0 3.3 4.2 4.9 3.9 6.9 8.4 5.8 5.5 4.2 7.6 8.2 6.7 1.5 8.3 3.3 5.4 8.6 4.7 9.8 9.8 10.5 10.5 9.9 13.0 10.4 10.1 9.7 10.2 10.6 10.5 11.8 8.4 19.2 9.5 23.2 10.9 16.6 16.8 29.8 10.8 12.1 13.6 9.3 4.0 7.2 20.7 12.9 8.4 39.8 8.0 5.8 21.5 17.9 9.6 17.9 16.5 10.4 6.1 11.6 17.3 17.7 31.9 15.9 8.2 14.2 5.1 15.5 8.2 24.8 12.9 11.8 21.5 6.5 26.4 7.9 6.0 16.0 27.1 7.4 16.0 7.5 17.6 7.9 10.3 18.1 28.0 18.1 4.4 26.7 11.9 18.1 8.2 21.1 15.0 7.0 32.9 9.3 11.6 51.0 38.0 11.7 17.2 28.6 9.7 16.4 7.5 14.9 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284949-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "prostate: 21.5;skeletal muscle: 35.4;urinary bladder: 48.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "myeloid DC: 86.6" "Group enriched" "Detected in many" 16 "dendritic cells: 86.6;monocytes: 32.0" "Group enriched" "Detected in some" 5 "Hep G2: 29.9;RT4: 48.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.1 0.5 0.1 1.5 0.2 0.1 0.4 0.0 0.3 1.0 0.0 0.1 0.1 0.3 0.3 0.9 0.1 0.1 0.4 0.0 0.0 0.2 0.9 0.3 0.2 0.0 0.1 0.2 5.0 0.7 0.0 0.2 21.5 0.7 0.0 2.8 0.2 35.4 0.0 1.3 0.1 0.2 1.1 0.1 0.1 0.1 0.7 2.3 4.6 0.9 48.4 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 4.6 0.0 0.1 0.0 0.2 0.0 48.9 0.1 0.0 0.2 0.8 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 21.2 0.0 0.0 25.8 0.0 1.2 0.0 0.1 86.6 0.5 0.0 0.0 3.6 0.4 32.0 32.9 0.0 7.4 0.1 0.1 0.1 0.4 0.1 0.4 0.3 0.2 0.0 0.2 0.2 0.1 0.3 0.2 0.0 0.0 0.7 1.2 0.1 15.0 0.1 0.0 0.1 4.6 3.6 0.2 2.8 0.1 0.0 0.0 0.0 4.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.1 3.5 0.0 4.8 8.7 1.7 0.3 6.4 0.0 0.0 22.6 0.8 2.1 0.0 0.0 0.0 9.3 0.0 0.1 54.1 29.8 0.0 0.1 0.0 0.0 1.6 0.5 0.0 0.4 0.0 0.4 0.1 0.2 0.0 4.4 24.5 FAM118A "bK268H5.C22.4, C22orf8, FLJ20635" ENSG00000100376 "Family with sequence similarity 118 member A" Q9NWS6 22 45308968-45341955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 104.0;Early spermatids: 125.0;Syncytiotrophoblasts: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003902 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA003902: AB_1848368" "unprognostic (6.22e-3)" "unprognostic (1.19e-2)" "unprognostic (9.92e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (3.72e-2)" "unprognostic (7.61e-3)" "unprognostic (9.42e-2)" "unprognostic (6.11e-2)" "unprognostic (5.02e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.87e-6)" "unprognostic (9.76e-2)" "unprognostic (1.28e-1)" "unprognostic (4.50e-1)" "unprognostic (1.16e-3)" 14.3 11.9 18.7 23.9 17.4 21.7 23.6 21.7 17.2 18.2 24.7 21.9 20.1 17.9 67.0 18.8 12.3 24.6 20.3 18.3 21.9 15.1 17.3 19.5 49.5 15.3 15.6 14.3 21.9 14.5 38.5 37.9 18.5 19.3 42.0 12.5 9.6 18.5 9.4 30.8 40.0 25.0 10.4 14.2 26.1 21.5 22.9 17.0 13.7 23.9 6.5 27.8 30.0 23.0 17.4 10.9 7.8 11.0 11.9 9.3 8.9 24.0 8.1 13.4 11.5 11.2 25.6 10.1 48.6 6.5 7.5 6.5 40.7 14.3 10.3 11.5 10.6 31.9 26.3 13.2 18.7 12.8 24.8 7.2 9.5 12.3 17.6 10.8 8.0 7.1 14.6 39.5 52.6 5.9 26.1 14.7 51.3 8.2 49.8 10.4 19.0 7.1 17.4 6.6 28.9 21.8 25.6 8.9 19.0 23.9 18.0 8.2 14.4 9.2 8.8 28.8 10.8 10.8 29.0 5.5 24.7 11.9 17.1 16.0 7.1 7.1 2.2 5.8 6.2 4.7 4.3 7.3 7.2 8.8 6.5 11.5 8.6 5.8 5.6 5.0 13.5 10.9 4.4 18.7 17.4 21.7 17.2 18.3 21.9 15.3 15.6 14.3 19.3 14.2 17.0 17.4 12.5 9.6 17.0 23.8 21.2 22.6 36.9 18.8 10.8 18.3 10.9 6.6 11.3 8.6 16.6 7.3 18.8 104.0 83.1 21.4 0.0 7.0 125.0 6.7 15.5 20.7 32.9 14.5 23.1 6.2 8.5 19.2 10.2 7.4 1.3 8.8 23.9 14.5 12.9 6.7 18.3 20.5 12.2 13.0 29.9 75.6 35.8 19.8 1.8 62.8 69.5 16.4 39.1 22.6 21.5 4.8 17.7 23.7 25.8 22.6 13.4 3.9 14.6 22.3 0.0 33.6 14.7 72.5 38.8 8.8 9.9 120.9 55.2 7.3 17.5 35.4 KCTD17 FLJ12242 ENSG00000100379 "Potassium channel tetramerization domain containing 17" Q8N5Z5 22 37051736-37063390 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Ubl conjugation pathway" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 90.8" HPA018459 Uncertain NA NA "HPA018459: AB_1852169" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (1.09e-1)" "unprognostic (1.61e-2)" "unprognostic (5.38e-2)" "unprognostic (3.09e-3)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.89e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-1)" "prognostic favorable (4.22e-5)" "unprognostic (8.62e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.32e-1)" "unprognostic (6.94e-2)" 7.4 15.7 63.2 9.9 97.3 2.4 6.8 47.2 72.2 13.7 41.6 15.1 3.5 15.0 1.8 7.3 10.8 8.6 20.1 67.3 54.1 5.7 3.5 9.4 10.7 51.5 67.7 60.5 13.8 3.7 7.9 43.3 6.5 60.3 11.3 5.2 3.6 3.5 9.1 1.7 20.3 10.5 9.5 42.5 11.2 8.0 46.4 82.2 7.1 7.6 3.0 6.9 17.1 13.1 54.2 15.9 20.5 31.7 23.7 14.9 14.8 1.2 16.2 15.6 25.9 22.3 4.4 4.6 12.2 10.9 20.8 20.3 4.2 10.0 19.0 10.9 23.8 26.8 5.2 5.6 4.9 22.1 0.0 6.1 17.3 9.2 26.6 5.8 17.5 33.6 15.9 1.2 13.2 16.5 12.8 11.0 0.3 20.3 9.4 17.4 19.8 8.4 3.6 6.7 4.1 26.4 32.9 15.0 14.1 7.5 6.6 3.8 4.2 19.6 33.5 31.2 16.0 12.0 17.7 5.5 2.0 29.6 7.3 18.6 0.0 0.8 0.0 0.9 1.0 0.9 1.2 0.6 0.9 0.9 0.4 0.8 0.6 0.0 1.6 0.4 0.2 1.0 0.4 63.2 97.3 47.2 72.2 67.3 54.1 51.5 67.7 60.5 60.3 42.5 82.2 54.2 8.8 0.0 0.5 11.1 5.8 1.5 4.6 2.8 1.2 17.3 1.3 1.5 5.0 4.3 0.8 5.5 2.1 0.4 5.0 17.7 0.0 11.9 24.9 0.7 12.7 9.7 13.1 0.8 22.4 6.1 2.8 9.9 4.1 0.9 4.5 12.0 12.8 0.5 9.2 13.5 11.6 5.3 0.0 9.6 17.0 28.1 10.5 9.8 3.6 1.9 13.0 16.4 8.2 4.5 7.1 3.2 16.0 9.1 4.6 1.2 0.5 2.5 1.5 7.8 0.0 7.8 11.7 19.7 7.1 1.3 4.8 7.5 8.5 10.2 7.0 2.4 ST13 "FAM10A1, HIP, HSPABP1, P48, SNC6" ENSG00000100380 "ST13 Hsp70 interacting protein" P50502 22 40824535-40856639 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1091.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043233, HPA046412, HPA047114, HPA047116" Enhanced Enhanced Cytosol NA NA Cytosol "HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.69e-2)" "unprognostic (7.15e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (2.73e-3)" "unprognostic (1.74e-2)" "unprognostic (3.63e-1)" "unprognostic (2.50e-1)" "unprognostic (1.00e-1)" "unprognostic (9.54e-2)" "prognostic favorable (3.10e-4)" "unprognostic (8.41e-2)" "unprognostic (3.93e-2)" "unprognostic (3.04e-1)" "unprognostic (8.40e-2)" 164.7 159.0 144.5 85.0 149.7 99.8 163.3 154.3 157.0 164.0 149.0 121.4 97.5 199.4 138.4 117.7 182.2 123.9 123.0 133.8 177.3 256.5 299.2 97.8 112.6 159.6 148.1 114.0 547.5 127.2 152.0 93.0 136.4 159.9 146.3 109.1 147.7 112.3 143.9 344.4 98.4 109.2 166.5 163.2 89.8 112.0 108.7 146.5 132.8 178.2 219.8 127.2 132.6 114.4 198.1 249.0 195.1 290.6 255.4 265.7 407.1 263.7 229.0 293.2 279.6 242.3 353.7 144.3 356.8 193.2 232.9 253.7 177.3 387.7 226.3 331.2 228.4 250.3 255.0 379.1 406.4 241.2 374.6 198.5 365.5 235.7 252.6 169.7 351.2 293.6 219.3 313.2 151.2 271.3 187.1 329.5 200.1 166.4 302.0 130.7 375.7 246.4 281.9 284.2 369.8 96.4 97.1 265.0 211.7 337.7 334.1 205.5 233.2 220.8 232.1 223.0 197.0 188.2 173.5 367.9 333.4 317.4 172.0 228.2 108.9 79.5 85.7 84.7 108.7 129.1 146.2 133.0 101.9 107.1 131.6 206.6 160.7 26.3 110.6 146.3 75.5 122.3 162.6 144.5 149.7 154.3 157.0 133.8 177.3 159.6 148.1 114.0 159.9 163.2 146.5 198.1 187.0 141.1 220.5 28.1 217.5 311.6 384.6 267.7 279.4 89.5 364.6 359.2 140.1 334.6 232.5 171.0 16.7 382.8 141.7 192.9 563.4 284.8 513.2 431.6 349.8 204.1 262.0 296.3 37.4 205.1 381.2 239.7 107.0 289.6 207.1 305.0 227.7 539.2 328.6 38.7 41.5 263.7 183.1 270.6 374.5 1010.4 510.4 210.3 211.7 15.0 286.7 265.1 157.6 27.2 53.7 193.7 210.8 413.3 129.0 312.2 369.6 1091.8 281.8 73.0 223.5 212.0 268.7 306.9 191.2 193.5 274.5 500.9 200.6 227.3 333.2 325.8 IL2RB "CD122, IL15RB" ENSG00000100385 "Interleukin 2 receptor subunit beta" P14784 22 37125843-37175054 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.1;lymphoid tissue: 50.7;placenta: 36.6" "Cell type enhanced" "Detected in many" "dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 50.8;NK-cell: 186.4" "Group enriched" "Detected in many" 22 "NK-cells: 186.4;T-cells: 50.8" "Cell line enriched" "Detected in some" 8 "HDLM-2: 525.8" "Region enriched" "Detected in single" 7 "basal ganglia: 1.8" "Low region specificity" "Detected in some" HPA062657 Enhanced NA NA "HPA062657: AB_2684822" "unprognostic (3.38e-3)" "unprognostic (1.21e-2)" "prognostic favorable (6.76e-4)" "prognostic favorable (3.18e-5)" "unprognostic (2.44e-2)" "unprognostic (9.69e-3)" "unprognostic (2.60e-1)" "unprognostic (5.22e-2)" "unprognostic (1.03e-3)" "unprognostic (5.37e-2)" "unprognostic (1.09e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (4.63e-2)" "unprognostic (7.96e-2)" "unprognostic (3.94e-3)" "unprognostic (2.46e-2)" 3.2 1.3 1.9 22.6 1.4 37.1 1.9 0.7 2.2 2.2 2.1 5.2 5.6 7.7 2.9 3.5 3.0 6.8 1.9 2.0 0.6 1.0 8.6 12.5 36.0 2.5 2.4 0.4 1.6 0.8 0.4 0.6 36.6 1.6 2.3 5.3 0.0 4.3 3.2 0.7 9.0 8.4 2.5 1.8 50.7 6.5 1.5 2.2 15.0 1.9 0.7 24.2 8.1 1.0 4.7 0.4 0.0 1.0 0.0 0.0 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 525.8 0.6 1.0 0.0 0.1 0.0 0.0 24.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.0 0.7 0.1 4.2 3.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.2 0.6 2.3 0.0 0.9 0.0 0.0 13.2 0.0 0.6 36.2 66.0 0.1 0.4 0.4 0.5 5.4 0.1 0.5 50.8 0.6 27.4 0.4 11.4 28.6 0.1 1.9 3.6 15.0 1.2 186.4 0.5 0.3 24.4 37.3 1.9 1.4 0.7 2.2 2.0 0.6 2.5 2.4 0.4 1.6 1.8 2.2 4.7 1.5 3.2 6.8 0.0 3.6 3.2 0.7 0.1 5.7 0.0 1.0 0.8 1.7 0.0 0.6 1.8 0.0 0.6 130.1 0.2 0.0 0.3 2.2 0.5 1.2 1.0 0.0 16.8 0.1 0.2 85.5 1.4 5.6 1.2 10.1 0.1 7.1 1.8 2.3 0.0 0.1 0.1 0.0 5.3 1.7 1.6 0.3 3.7 5.4 0.0 2.0 0.0 388.3 0.0 0.1 0.0 0.0 0.0 18.6 0.2 0.1 0.2 0.7 0.0 0.0 0.2 0.9 0.0 0.3 0.5 1.6 1.2 103.6 0.0 0.3 0.1 RBX1 "BA554C12.1, RNF75, ROC1" ENSG00000100387 "Ring-box 1" P62877 22 40951347-40973309 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003038 Supported Nucleoplasm NA NA Nucleoplasm "HPA003038: AB_1079827" "unprognostic (2.34e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.60e-3)" "unprognostic (2.30e-1)" "unprognostic (2.92e-2)" "unprognostic (1.82e-3)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "prognostic favorable (6.63e-4)" "unprognostic (5.01e-3)" "unprognostic (2.19e-1)" "unprognostic (4.99e-3)" "unprognostic (2.22e-2)" "unprognostic (1.34e-1)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" 38.0 47.2 89.9 33.7 91.8 64.0 45.6 94.8 106.0 35.5 87.3 35.5 26.5 34.6 59.7 53.9 31.7 22.5 65.1 89.9 93.9 46.4 39.2 37.8 44.9 94.6 92.3 89.4 27.1 24.9 38.6 34.8 41.3 94.2 33.1 33.1 45.7 33.4 27.1 83.9 42.9 33.4 33.0 97.1 40.1 37.8 25.0 91.5 59.8 36.1 101.4 52.0 36.8 38.1 100.6 111.1 62.2 114.4 57.9 79.9 94.9 64.3 86.6 80.0 128.2 112.9 101.4 52.5 96.7 57.3 86.3 50.8 62.3 110.6 100.2 135.1 113.9 174.7 60.4 84.0 126.1 68.2 148.3 74.8 79.1 79.1 93.0 66.6 73.3 110.5 57.8 72.2 95.6 115.1 136.7 90.2 170.1 63.7 216.3 64.8 116.8 80.0 122.5 149.3 71.0 54.1 34.9 76.5 76.3 82.7 63.8 65.8 99.5 74.8 77.9 81.1 66.4 84.5 80.0 78.9 146.5 98.0 74.7 88.6 151.8 128.1 108.7 79.9 133.9 76.0 114.7 99.2 85.7 129.7 102.4 85.5 93.8 42.3 89.2 154.6 211.1 137.6 250.2 89.9 91.8 94.8 106.0 89.9 93.9 94.6 92.3 89.4 94.2 97.1 91.5 100.6 224.9 230.8 144.8 23.5 173.6 300.9 207.2 567.7 129.1 90.4 189.6 237.9 515.4 171.6 300.0 224.3 25.0 507.3 238.6 181.8 508.7 346.8 41.1 227.4 170.6 222.1 162.1 638.3 29.9 333.6 637.9 211.2 107.6 180.4 129.8 140.0 167.4 254.8 431.3 89.2 29.7 205.1 349.9 236.7 334.2 79.4 185.8 270.7 341.5 15.0 532.3 264.5 228.6 18.6 49.6 377.7 229.8 177.1 180.8 269.5 300.5 586.5 314.3 163.7 118.3 160.0 256.3 220.2 242.9 237.5 370.7 675.9 175.3 185.7 207.1 248.8 EP300 "KAT3B, p300" ENSG00000100393 "E1A binding protein p300" Q09472 22 41092592-41180077 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000146, HPA003128, HPA004112" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746" "unprognostic (7.67e-2)" "unprognostic (5.56e-2)" "unprognostic (2.29e-1)" "unprognostic (2.52e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-1)" "unprognostic (2.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (8.97e-2)" "unprognostic (1.74e-2)" "unprognostic (8.54e-2)" "prognostic favorable (7.45e-5)" "unprognostic (7.97e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" 14.8 13.8 6.6 17.8 8.4 65.7 14.4 19.0 10.8 16.1 5.8 15.8 13.8 17.3 13.6 16.4 16.6 14.3 11.7 7.0 7.2 13.2 15.6 14.8 17.8 10.3 7.6 5.4 24.1 18.2 23.3 13.5 19.4 9.1 15.2 14.6 18.0 15.1 15.7 20.6 18.6 16.1 16.5 4.5 17.1 14.6 19.8 7.5 27.4 20.3 23.6 18.0 15.6 14.9 11.0 31.6 21.7 35.4 23.0 22.2 23.3 32.3 15.0 21.8 21.0 21.0 27.8 12.0 32.7 12.2 28.4 18.7 24.1 48.1 20.8 23.5 30.5 32.2 24.4 25.4 22.3 26.9 59.3 26.5 24.8 22.2 30.0 27.0 19.3 24.9 18.7 26.3 43.9 18.3 12.5 16.2 18.9 27.5 38.3 15.2 33.7 16.7 21.3 20.3 40.4 11.3 11.9 51.1 26.0 25.6 29.5 17.8 33.9 31.3 20.3 24.8 16.3 20.8 28.5 14.1 47.9 16.3 17.4 21.5 3.6 1.7 1.6 1.6 1.9 1.5 2.2 1.7 1.7 2.1 1.4 1.4 1.1 4.9 2.7 1.0 1.6 1.4 1.2 6.6 8.4 19.0 10.8 7.0 7.2 10.3 7.6 5.4 9.1 4.5 7.5 11.0 45.4 67.3 49.2 58.1 53.8 24.6 22.9 11.6 40.9 44.6 35.1 25.8 31.6 38.6 15.8 25.8 35.5 18.4 63.2 37.0 3.9 16.1 15.3 55.1 56.4 36.2 24.7 60.4 71.8 18.7 17.9 32.0 27.5 72.5 25.3 36.1 32.9 29.2 18.4 25.2 73.6 24.2 2.0 60.7 25.7 6.4 28.9 60.5 8.8 45.9 52.0 27.7 40.2 81.4 80.3 25.8 28.9 30.5 51.2 30.8 20.2 10.8 22.8 30.9 26.3 47.6 36.7 22.8 31.2 35.3 25.9 30.2 46.0 36.7 23.7 36.3 L3MBTL2 "dJ756G23.3, DKFZP761I141, H-l(3)mbt-l" ENSG00000100395 "L3MBTL histone methyl-lysine binding protein 2" Q969R5 22 41205282-41231271 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000815 Approved Nucleoplasm NA NA Nucleoplasm "HPA000815: AB_1079220" "unprognostic (2.42e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.98e-2)" "prognostic favorable (4.37e-4)" "unprognostic (3.48e-1)" "unprognostic (1.19e-2)" "unprognostic (4.16e-3)" "unprognostic (1.03e-2)" "unprognostic (2.19e-1)" "unprognostic (2.26e-1)" "unprognostic (7.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" "unprognostic (2.19e-1)" 9.4 14.7 15.4 12.4 16.5 11.1 10.6 14.6 18.2 12.8 12.1 12.4 8.7 13.3 12.2 12.2 19.5 9.6 12.3 15.3 16.3 11.9 16.8 11.9 17.9 16.4 16.5 15.4 14.1 11.1 17.1 16.6 9.6 17.2 14.3 10.3 10.1 13.1 14.0 12.0 13.8 11.7 14.0 14.7 15.6 12.8 15.1 16.6 15.1 12.3 9.1 18.1 14.0 10.5 24.3 21.3 20.8 17.6 35.6 20.9 15.6 20.6 19.8 22.7 37.7 31.1 13.7 15.0 34.6 15.7 26.7 22.6 20.3 40.9 26.3 23.9 42.3 52.8 14.4 35.7 32.9 22.1 65.8 31.4 21.4 10.2 29.6 27.8 16.4 27.2 26.1 24.9 27.5 18.1 37.4 33.4 22.4 23.9 75.6 23.8 34.1 14.3 39.9 19.0 20.9 14.3 10.0 35.5 25.3 21.4 17.0 16.9 36.0 21.6 20.2 19.1 16.2 22.2 22.6 43.1 28.6 23.3 29.7 26.3 10.0 13.4 10.7 21.4 16.6 19.6 15.7 16.7 17.1 17.0 11.0 20.0 18.9 2.1 21.2 18.6 12.9 18.4 21.6 15.4 16.5 14.6 18.2 15.3 16.3 16.4 16.5 15.4 17.2 14.7 16.6 24.3 9.4 16.0 19.6 7.5 12.2 2.7 5.1 8.0 2.8 24.7 9.0 8.9 10.2 15.7 17.1 11.0 16.7 17.7 15.8 9.6 11.7 9.9 13.9 14.8 9.1 9.3 15.0 10.5 9.9 7.9 17.4 9.3 13.7 8.0 11.4 12.0 7.9 14.2 13.0 16.8 10.8 8.7 22.4 11.1 4.6 30.0 7.2 11.6 3.6 3.7 11.2 13.7 12.3 9.5 8.1 7.6 5.8 9.4 13.3 6.9 7.3 8.7 22.6 15.0 6.6 9.4 13.4 21.5 14.4 6.7 3.8 17.1 13.9 17.5 9.4 6.2 CHADL SLRR4B ENSG00000100399 "Chondroadherin like" Q6NUI6 22 41229510-41240931 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 107.8" "Cell type enhanced" "Detected in many" "Muller glia cells: 40.3;Oligodendrocytes: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 11.8;Hep G2: 3.4;hTCEpi: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005696, HPA024654" Uncertain "Secreted to extracellular matrix" NA NA "HPA005696: AB_1079724, HPA024654: AB_1846615" "unprognostic (6.14e-2)" "unprognostic (4.42e-3)" "unprognostic (1.49e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (9.51e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (2.83e-3)" "unprognostic (1.51e-2)" "unprognostic (4.67e-8)" "unprognostic (8.36e-3)" "unprognostic (4.10e-1)" "unprognostic (3.40e-1)" "unprognostic (4.09e-2)" 2.6 4.8 24.3 0.5 53.8 1.0 2.7 53.0 38.6 3.2 4.5 9.0 1.6 1.3 1.5 4.2 2.2 2.7 16.4 21.0 38.7 2.1 3.1 2.2 0.9 61.5 50.8 14.7 2.7 3.6 0.5 4.3 0.6 60.2 6.6 0.3 1.0 11.4 3.8 2.2 5.7 3.4 0.8 49.3 0.7 5.1 3.5 41.8 1.7 4.5 1.6 0.4 2.9 3.7 107.8 0.6 0.2 0.2 0.3 0.1 0.1 11.8 0.4 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.5 0.0 0.6 0.0 0.1 0.2 0.0 0.3 3.4 0.4 0.1 0.1 1.0 3.4 0.3 0.0 0.1 0.4 0.2 0.0 0.5 0.0 0.3 0.2 0.6 0.3 0.3 0.4 0.1 0.5 0.2 0.2 0.3 0.7 0.1 1.3 0.2 0.1 0.0 0.0 1.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 1.6 0.0 0.1 0.4 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.4 0.1 0.2 0.0 0.0 1.2 0.0 0.3 24.3 53.8 53.0 38.6 21.0 38.7 61.5 50.8 14.7 60.2 49.3 41.8 107.8 2.7 6.4 2.2 8.1 0.2 4.0 10.2 1.8 17.6 1.4 7.3 6.5 3.5 2.8 1.7 3.7 0.0 3.0 0.4 0.8 7.9 2.0 18.6 2.5 0.6 1.3 3.0 0.0 2.8 1.2 6.4 5.5 2.6 1.6 0.0 3.2 2.5 2.5 5.1 0.0 2.5 0.8 2.0 0.8 2.1 12.0 3.7 3.4 17.8 1.9 0.4 40.3 0.0 12.5 83.1 0.8 1.0 3.0 0.3 3.7 1.3 5.9 4.1 1.6 0.0 2.5 1.2 0.3 0.8 6.5 3.7 1.5 0.5 0.7 1.4 6.5 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41244779-41286187 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Late spermatids: 1717.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes 75000 "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 26.1 73.5 92.7 26.3 82.4 48.6 29.9 70.1 120.8 28.9 61.4 28.5 18.2 25.1 12.1 80.4 23.8 17.3 38.3 97.8 82.9 43.8 88.7 42.0 30.9 101.8 81.6 81.0 32.7 61.5 12.8 57.8 23.0 112.4 39.6 13.3 33.0 38.3 17.8 43.3 94.5 30.8 17.7 75.7 42.7 39.9 179.5 87.8 40.8 34.7 14.4 32.1 35.0 45.8 111.7 228.0 112.2 75.9 77.3 38.8 31.4 85.9 194.5 103.8 182.8 98.4 135.9 71.9 118.0 154.0 137.4 94.8 203.0 135.5 145.4 125.2 95.7 199.2 103.3 115.0 107.9 46.7 171.6 72.5 30.0 69.5 132.2 123.4 67.6 102.1 45.0 127.7 83.3 111.9 186.1 96.3 130.0 84.5 217.6 127.6 118.8 73.4 126.0 72.5 123.7 66.6 44.1 139.1 117.7 71.7 74.6 72.2 64.4 146.5 141.7 138.5 78.6 154.6 60.1 92.8 124.2 99.3 119.3 82.0 2.7 7.6 6.9 8.1 9.0 9.5 5.9 8.2 7.8 5.6 6.4 7.4 5.9 2.0 5.9 12.9 5.9 9.5 8.2 92.7 82.4 70.1 120.8 97.8 82.9 101.8 81.6 81.0 112.4 75.7 87.8 111.7 10.9 3.2 20.9 8.5 15.0 23.1 22.2 10.9 18.2 16.0 22.4 16.9 19.6 25.8 9.6 9.2 14.6 22.7 20.3 22.9 3.9 33.3 270.7 21.0 14.7 16.1 25.0 16.6 28.3 20.3 35.3 13.3 25.5 25.1 6.3 74.4 8.9 21.8 16.6 15.2 20.8 19.1 16.2 13.9 20.9 1717.0 14.9 16.8 12.4 5.6 8.9 10.1 14.4 6.0 32.2 39.8 5.7 12.0 25.8 37.4 7.1 13.1 11.4 26.4 0.0 6.8 18.2 25.6 17.7 38.8 31.0 23.7 24.3 42.5 24.8 23.3 ZC3H7B "DKFZp434K0920, FLJ13787, KIAA1031, RoXaN" ENSG00000100403 "Zinc finger CCCH-type containing 7B" Q9UGR2 22 41301525-41360147 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001784, HPA076092" Uncertain Supported Cytosol NA NA Cytosol "HPA001784: AB_1080637, HPA076092: " "unprognostic (1.71e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-2)" "unprognostic (3.53e-2)" "unprognostic (3.35e-2)" "unprognostic (5.66e-2)" "unprognostic (3.73e-2)" "unprognostic (7.92e-2)" "unprognostic (7.12e-2)" "unprognostic (7.73e-2)" "unprognostic (1.39e-2)" "unprognostic (3.19e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-1)" 29.7 43.2 37.6 20.4 34.4 16.1 23.1 30.2 42.8 24.4 14.8 24.2 24.5 31.4 13.6 20.4 27.5 17.4 24.0 33.1 36.4 31.5 42.5 27.1 21.5 52.2 38.4 27.2 41.7 31.2 44.9 30.7 18.6 58.0 26.2 13.3 18.0 45.3 26.9 25.2 20.1 26.1 20.9 28.4 25.8 25.0 11.7 35.2 25.4 46.3 19.3 15.3 23.7 19.8 38.7 59.0 32.2 42.0 25.6 37.6 33.9 49.1 65.8 69.6 53.8 42.1 35.3 23.8 33.1 79.1 92.0 30.1 39.1 35.7 61.8 27.4 76.0 58.9 29.6 40.2 45.4 50.4 57.4 24.9 42.7 34.6 46.3 56.4 45.7 58.9 25.7 60.4 17.9 46.0 59.1 45.4 29.7 30.3 44.2 24.1 68.7 26.4 37.8 45.9 41.5 27.1 20.3 60.5 36.6 31.5 29.0 24.1 38.1 119.0 52.5 54.4 16.3 40.8 30.8 18.4 33.2 44.0 28.0 46.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.0 37.6 34.4 30.2 42.8 33.1 36.4 52.2 38.4 27.2 58.0 28.4 35.2 38.7 15.4 12.8 22.2 14.4 13.1 7.1 12.7 13.4 10.2 22.4 18.2 15.6 10.1 20.0 15.7 22.0 18.8 9.0 11.3 13.5 7.9 14.0 0.9 14.2 25.8 17.9 33.6 7.8 20.1 13.3 9.0 16.4 11.2 16.9 8.2 59.0 19.2 44.0 12.0 42.1 20.6 14.6 26.4 12.9 9.8 3.1 33.2 8.2 12.4 13.1 15.2 9.8 20.6 19.1 17.6 18.8 8.1 29.0 7.4 21.2 23.0 18.5 11.7 22.2 19.7 23.1 18.0 2.0 4.9 8.9 5.8 6.2 11.1 46.9 17.1 14.8 PHF5A "bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7" ENSG00000100410 "PHD finger protein 5A" Q7RTV0 22 41459717-41468692 "Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028885 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028885: AB_10602079" "unprognostic (4.38e-2)" "unprognostic (3.58e-1)" "unprognostic (2.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (3.02e-8)" "unprognostic (3.39e-3)" "unprognostic (3.97e-3)" "unprognostic (4.46e-2)" "unprognostic (6.95e-3)" "unprognostic (2.12e-1)" "unprognostic (5.25e-3)" "unprognostic (4.11e-2)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "unprognostic (6.91e-2)" 24.6 21.3 27.5 23.2 30.4 58.7 28.0 31.2 30.1 23.4 29.6 25.4 22.9 23.1 26.3 29.3 23.0 19.7 19.7 27.6 30.2 23.3 31.1 20.3 35.8 30.1 29.8 27.0 20.9 26.4 25.4 21.6 25.8 30.7 19.9 29.1 24.7 21.2 19.3 36.0 26.9 22.6 22.8 30.1 26.6 26.2 18.9 29.5 52.7 19.9 29.3 42.3 30.9 23.9 35.0 80.5 56.8 95.0 62.8 68.7 51.7 65.9 80.1 65.5 102.9 86.4 78.4 46.5 115.4 45.7 60.1 72.1 60.7 130.2 95.3 115.6 71.7 136.5 71.8 86.9 92.2 71.9 190.3 54.9 50.4 72.9 81.3 100.5 41.7 73.8 80.6 97.5 71.8 74.9 107.5 154.8 124.3 96.1 220.8 82.2 115.4 84.9 81.5 68.6 63.1 46.6 38.9 87.9 57.4 90.0 66.6 45.9 96.8 50.7 54.0 95.6 44.1 97.9 58.9 112.3 194.9 52.2 82.6 59.0 32.8 47.0 57.9 36.0 45.2 47.2 47.6 41.1 45.6 49.2 42.6 40.2 39.5 55.6 47.6 44.1 41.7 47.8 59.3 27.5 30.4 31.2 30.1 27.6 30.2 30.1 29.8 27.0 30.7 30.1 29.5 35.0 36.4 22.4 13.9 2.3 52.3 77.2 78.1 81.1 58.1 24.6 35.1 35.4 10.6 41.5 33.5 11.0 4.2 93.0 42.3 27.2 46.9 58.5 14.7 26.6 20.7 43.7 15.0 56.1 3.5 56.2 115.0 36.2 20.4 25.5 33.7 20.9 37.5 24.7 58.7 13.5 3.7 32.1 63.1 38.8 55.9 9.1 42.3 37.3 33.8 2.8 67.5 47.3 59.8 5.5 8.2 64.5 32.5 41.8 41.6 84.4 41.1 42.1 24.3 28.2 98.6 32.3 38.6 63.5 88.1 59.0 91.6 109.2 42.3 20.2 41.9 95.7 ACO2 ACONM ENSG00000100412 "Aconitase 2" Q99798 22 41447830-41529273 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Lyase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 477.5;skeletal muscle: 666.7;tongue: 701.9" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 374.2;Proximal tubular cells: 285.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001097 Enhanced Approved Approved Mitochondria NA NA 2000000 Mitochondria "HPA001097: AB_1078092" "unprognostic (1.95e-1)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (3.06e-2)" "unprognostic (6.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.99e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-2)" "unprognostic (7.32e-2)" "unprognostic (1.64e-2)" "unprognostic (6.07e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.46e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.12e-2)" 89.6 82.2 149.0 39.0 144.9 32.3 52.8 146.4 191.5 39.9 140.0 92.2 164.4 42.3 26.4 60.9 54.1 36.8 477.5 148.1 140.1 140.1 74.5 41.1 40.9 137.3 136.0 135.8 31.1 54.3 235.8 33.9 30.7 140.8 41.6 70.3 47.3 72.6 49.9 666.7 44.4 159.9 44.1 136.6 45.0 111.1 35.4 164.7 38.4 54.2 701.9 43.7 52.9 42.8 146.0 47.2 55.8 56.5 116.3 101.2 69.8 78.7 43.7 60.9 79.0 71.9 81.2 63.5 115.7 72.2 70.6 60.3 109.8 108.8 88.3 42.8 75.8 80.2 51.0 73.7 95.0 86.7 147.8 77.8 120.8 64.4 78.9 83.2 61.7 81.2 61.5 72.9 118.4 65.4 91.7 73.7 47.9 37.0 282.6 115.1 102.3 37.8 162.1 106.8 97.3 37.8 33.9 112.2 128.7 82.0 44.9 74.9 74.7 55.5 60.0 68.7 50.2 45.0 64.7 92.1 80.6 102.0 64.0 66.5 10.3 52.9 18.1 32.0 76.4 29.3 49.4 25.5 34.9 69.0 46.4 29.2 30.8 9.0 39.4 97.1 24.0 41.2 58.6 149.0 144.9 146.4 191.5 148.1 140.1 137.3 136.0 135.8 140.8 136.6 164.7 146.0 26.3 25.6 31.8 45.4 49.4 18.7 54.5 102.7 31.3 60.6 28.0 23.2 9.1 64.3 63.5 60.7 81.3 100.3 33.3 190.8 131.0 58.3 14.5 37.2 17.7 26.1 53.2 30.3 28.8 42.6 60.0 24.0 77.5 37.1 40.6 56.7 20.7 64.6 91.5 53.8 34.0 99.1 89.5 35.5 26.4 8.9 24.2 39.2 35.6 7.5 68.3 73.9 34.0 12.1 20.9 43.9 103.5 27.8 63.2 34.4 374.2 285.7 59.2 73.5 59.2 28.6 38.4 26.4 38.2 35.8 16.1 193.2 30.7 54.4 113.6 64.9 POLR3H "C25, KIAA1665, RPC8" ENSG00000100413 "RNA polymerase III subunit H" Q9Y535 22 41525799-41544606 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046787 Approved Supported Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA046787: AB_2679806" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (9.57e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.05e-2)" "unprognostic (1.33e-2)" "unprognostic (5.43e-2)" "prognostic favorable (5.41e-4)" "unprognostic (6.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (1.49e-1)" "unprognostic (4.00e-2)" "unprognostic (1.70e-1)" 15.4 21.1 38.8 8.6 36.4 5.5 15.2 36.4 49.9 10.3 30.9 11.5 4.8 14.1 9.1 16.5 16.0 8.0 17.2 37.8 37.0 13.5 26.9 14.3 10.1 39.5 39.3 34.7 18.6 12.3 12.0 18.4 6.5 36.3 15.5 5.2 7.0 11.6 10.8 13.9 11.8 9.8 11.8 37.9 11.0 13.5 16.3 38.0 8.1 14.2 9.1 7.8 14.3 9.9 38.0 36.4 23.8 21.4 32.7 23.0 20.9 14.8 30.5 27.3 49.0 39.3 47.9 12.0 30.8 21.9 49.9 27.8 17.8 39.8 48.1 30.6 26.3 50.1 18.4 37.1 23.7 23.9 75.3 30.8 26.3 30.8 64.9 17.4 18.8 23.5 29.3 39.5 19.9 28.0 34.4 19.3 20.1 15.6 49.8 28.1 30.0 16.9 32.6 22.9 21.7 21.2 12.5 37.0 39.7 19.3 13.7 15.6 21.1 22.7 29.8 30.7 49.8 39.8 16.7 28.6 46.6 49.5 26.8 28.9 0.1 12.5 0.2 8.8 18.3 12.6 16.6 8.7 10.4 14.2 13.9 11.6 9.7 0.6 5.4 18.6 13.3 5.8 9.9 38.8 36.4 36.4 49.9 37.8 37.0 39.5 39.3 34.7 36.3 37.9 38.0 38.0 6.1 0.0 32.0 15.7 14.8 17.7 12.0 19.0 13.6 18.8 24.9 23.4 6.4 14.3 19.8 16.5 16.7 32.9 7.9 5.0 46.9 30.4 42.6 12.7 15.4 10.3 14.3 19.1 10.0 29.6 30.9 14.8 13.3 8.9 11.4 13.1 9.7 33.3 30.5 21.9 7.1 4.8 14.2 9.5 11.0 163.9 16.8 10.2 24.9 1.9 19.6 24.1 18.6 2.0 6.7 27.6 6.6 20.3 21.8 16.8 4.1 40.7 12.7 20.9 0.0 17.9 16.8 51.6 50.9 21.2 25.6 17.9 10.3 21.2 9.5 11.8 TRMU "FLJ10140, MTO2, MTU1, TRMT" ENSG00000100416 "TRNA mitochondrial 2-thiouridylase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Mitochondria NA NA Mitochondria "HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415" "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavorable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favorable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavorable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 4.0 7.6 8.1 2.3 7.7 2.9 4.0 8.2 9.7 4.2 8.0 4.4 4.7 3.7 7.5 5.7 3.5 2.7 9.6 7.7 8.4 9.1 8.8 3.6 5.0 8.1 8.5 7.8 4.0 10.3 8.0 5.4 4.2 8.3 4.5 4.2 2.8 5.6 4.7 7.0 4.8 4.1 3.9 8.1 4.3 4.3 2.4 8.3 3.1 4.6 8.5 4.3 4.3 4.2 8.1 17.8 16.0 6.6 15.1 12.2 8.6 16.6 18.1 12.6 24.9 19.2 22.7 4.5 11.5 12.5 16.2 10.9 15.3 28.5 16.0 21.1 7.5 38.4 13.6 25.0 27.1 10.4 26.5 9.0 8.2 17.6 25.8 8.1 10.3 16.2 5.8 19.3 2.7 15.3 19.1 10.4 21.5 25.5 10.6 27.5 12.2 14.4 21.2 12.5 12.1 15.9 19.0 16.0 18.5 31.7 8.2 10.7 10.9 11.9 11.1 19.8 15.8 20.7 6.5 7.8 12.6 15.7 19.1 22.8 0.0 6.2 3.8 9.4 9.0 8.3 5.4 8.2 8.9 7.1 5.5 7.3 6.9 1.3 8.0 9.8 5.8 11.0 5.9 8.1 7.7 8.2 9.7 7.7 8.4 8.1 8.5 7.8 8.3 8.1 8.3 8.1 12.7 9.6 6.1 22.9 13.2 6.2 10.8 16.8 7.4 26.4 10.6 11.8 14.7 10.0 10.7 11.0 16.7 24.9 16.1 14.1 27.4 20.1 1.6 6.3 10.2 14.5 12.5 14.3 19.4 19.6 21.0 11.9 21.9 6.6 9.5 26.8 13.9 16.8 15.9 13.5 18.0 12.3 10.2 9.9 4.0 3.3 15.2 8.8 8.8 5.6 14.9 11.9 20.6 10.1 14.6 19.5 9.9 17.0 13.8 14.2 15.3 27.9 10.2 26.4 6.6 7.6 14.4 18.5 12.9 9.6 9.7 15.3 13.1 21.0 19.3 9.9 PMM1 Sec53 ENSG00000100417 "Phosphomannomutase 1" Q92871 22 41576900-41589871 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 176.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030712, HPA074950" Uncertain Supported Cytosol NA NA Cytosol "HPA030712: AB_10669600, HPA074950: " "unprognostic (2.66e-1)" "prognostic favorable (5.92e-4)" "unprognostic (3.25e-2)" "prognostic favorable (6.09e-6)" "unprognostic (1.25e-1)" "unprognostic (2.85e-2)" "unprognostic (1.01e-2)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "unprognostic (1.78e-1)" "prognostic favorable (2.05e-4)" "unprognostic (6.56e-3)" "unprognostic (5.76e-3)" "unprognostic (2.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.40e-2)" "unprognostic (2.70e-1)" 45.0 52.1 46.1 12.1 46.5 26.4 39.4 43.3 65.5 34.7 37.2 33.4 38.0 27.2 19.4 74.3 35.0 19.0 26.8 45.5 46.5 58.9 64.7 34.1 17.7 45.1 44.0 45.1 48.5 45.4 15.5 19.6 14.3 45.7 26.7 20.5 13.8 23.5 20.4 16.4 32.1 34.1 20.1 42.5 13.8 66.3 32.8 44.2 14.4 13.9 11.5 16.9 32.0 28.2 45.4 16.0 29.0 19.6 42.5 54.3 84.0 23.0 61.7 69.8 56.0 61.0 23.0 15.3 14.9 20.3 74.4 40.0 23.4 25.8 40.0 31.1 31.2 38.6 3.8 34.8 49.2 85.8 22.6 23.8 70.4 38.2 58.3 24.2 61.9 9.3 23.8 16.9 51.9 76.5 42.0 17.1 32.5 6.2 75.1 38.2 13.1 20.7 30.7 24.0 17.1 5.8 11.2 50.5 18.1 75.2 15.2 20.3 24.4 7.5 63.2 34.3 59.4 32.8 33.2 34.0 24.3 70.3 18.8 38.7 21.0 22.0 44.8 27.7 18.5 22.3 17.8 27.6 22.8 23.2 20.5 29.4 21.1 28.8 13.4 22.9 9.2 49.4 18.8 46.1 46.5 43.3 65.5 45.5 46.5 45.1 44.0 45.1 45.7 42.5 44.2 45.4 7.8 35.3 106.4 16.3 15.0 14.8 10.2 22.5 20.5 16.7 22.8 29.3 12.4 82.9 25.8 35.0 6.2 57.1 10.0 104.8 107.6 31.8 17.1 77.7 34.2 6.9 48.7 19.3 14.9 11.0 91.1 33.3 36.2 51.4 3.8 60.9 8.9 83.5 34.5 28.6 10.9 58.1 14.2 14.4 13.5 15.3 28.0 16.3 44.4 3.7 21.9 67.1 16.5 4.0 7.1 10.8 117.0 30.5 17.7 8.5 176.1 138.5 34.8 22.6 39.5 18.9 36.9 72.6 10.9 23.1 14.1 65.3 21.0 37.9 55.3 8.2 DESI1 "D15Wsu75e, DESI-1, FAM152B, POST, PPPDE2" ENSG00000100418 "Desumoylating isopeptidase 1" Q6ICB0 22 41598028-41621043 "Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 761.4;Late spermatids: 415.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053415 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA053415: AB_2682141" "unprognostic (1.07e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-2)" "prognostic favorable (7.70e-4)" "unprognostic (2.31e-2)" "unprognostic (6.16e-3)" "unprognostic (8.75e-3)" "unprognostic (9.27e-2)" "unprognostic (3.97e-2)" "unprognostic (6.27e-2)" "unprognostic (1.80e-2)" "unprognostic (1.42e-1)" "unprognostic (2.31e-3)" "unprognostic (2.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" 11.4 18.6 36.5 10.5 36.5 7.6 11.0 37.9 36.9 10.4 25.0 12.9 11.7 11.3 11.4 26.6 10.3 9.0 33.5 35.4 37.7 17.8 47.7 14.8 11.7 37.2 39.3 34.0 12.5 12.6 13.2 12.3 9.4 38.6 13.1 10.7 13.0 12.1 10.7 16.3 15.5 12.7 11.4 35.7 13.6 16.6 18.9 38.4 8.9 9.3 17.8 13.7 12.8 12.0 36.5 16.7 17.4 17.0 23.4 23.5 28.0 9.6 33.0 21.0 30.0 21.9 23.2 10.4 63.2 22.2 38.2 15.7 23.8 45.7 36.8 31.1 28.6 34.7 14.2 32.5 19.7 28.8 56.4 18.4 24.1 42.2 36.8 34.1 24.3 45.8 21.7 42.0 69.5 24.0 21.2 12.9 17.2 16.8 62.2 26.0 17.3 7.2 65.2 38.0 10.5 12.1 6.3 31.8 34.5 23.0 19.3 11.4 18.3 46.8 22.0 16.0 23.4 16.3 25.4 21.1 29.7 54.4 24.4 29.7 9.1 6.6 7.8 3.3 9.0 4.3 4.1 4.0 3.9 5.2 3.7 3.5 4.3 3.8 2.1 6.2 3.0 5.3 4.2 36.5 36.5 37.9 36.9 35.4 37.7 37.2 39.3 34.0 38.6 35.7 38.4 36.5 21.2 9.6 18.9 10.7 27.1 8.7 36.6 42.1 13.1 19.8 29.7 29.8 55.2 18.6 21.7 9.2 6.2 31.1 15.0 29.0 39.2 50.8 761.4 29.5 24.7 24.1 19.7 11.8 13.9 30.2 39.5 17.6 19.4 55.0 10.8 27.6 19.6 72.9 50.4 21.9 18.1 19.9 22.4 28.1 18.6 415.8 19.0 33.8 14.2 6.5 49.4 18.6 30.9 11.6 13.3 50.0 29.5 10.5 46.5 111.0 80.1 53.7 10.8 11.4 26.3 14.3 24.3 149.4 30.7 43.6 13.2 83.6 22.4 28.9 26.3 72.3 CERK "dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4" ENSG00000100422 "Ceramide kinase" Q8TCT0 22 46684410-46738252 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064699 Approved Vesicles NA NA Vesicles "HPA064699: AB_2685327" "unprognostic (2.93e-2)" "unprognostic (1.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (2.67e-2)" "unprognostic (1.49e-3)" "unprognostic (8.55e-2)" "unprognostic (3.60e-2)" "unprognostic (3.87e-1)" "unprognostic (1.35e-2)" "prognostic favorable (2.35e-4)" "unprognostic (2.26e-1)" "unprognostic (1.50e-3)" "unprognostic (1.27e-1)" "unprognostic (4.78e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.58e-4)" 15.2 23.9 18.8 22.4 16.8 21.3 12.8 32.5 22.1 16.7 15.3 17.3 31.9 17.6 6.0 14.9 18.3 17.5 34.6 18.4 34.6 19.5 19.1 16.8 26.3 28.9 32.3 14.9 26.8 30.5 11.6 49.4 10.1 32.6 11.8 15.0 21.3 17.7 13.6 21.0 15.5 31.5 15.4 19.9 19.5 22.1 6.1 25.3 39.1 21.1 19.4 25.4 13.8 12.5 27.8 25.6 15.1 71.6 22.6 40.3 30.2 6.7 43.7 33.8 24.5 17.2 22.3 8.4 35.3 19.9 46.9 15.1 16.3 30.4 19.8 24.9 12.6 33.0 15.8 36.9 29.0 27.9 49.9 4.0 25.3 25.0 26.7 9.1 39.2 73.5 37.1 12.1 44.5 45.4 1.9 34.0 24.8 32.4 10.3 16.3 62.8 81.2 40.4 14.7 0.5 66.4 60.6 21.5 10.3 47.1 16.5 11.3 37.6 67.4 50.2 26.8 37.5 64.4 45.7 59.5 22.3 53.5 28.0 41.7 0.7 3.0 3.7 10.3 7.0 17.9 2.0 10.7 10.0 5.4 2.1 6.3 5.8 4.2 2.6 8.7 5.7 10.4 4.4 18.8 16.8 32.5 22.1 18.4 34.6 28.9 32.3 14.9 32.6 19.9 25.3 27.8 28.6 9.6 16.6 16.0 17.0 3.4 6.3 6.1 18.2 24.4 6.1 9.8 44.2 10.0 11.0 1.8 6.2 2.4 25.4 23.4 15.6 12.8 7.8 10.3 19.8 27.4 14.4 8.0 11.7 11.8 1.4 14.1 9.2 19.8 10.1 10.2 25.4 22.1 10.8 26.9 21.9 6.6 8.2 24.8 16.9 16.0 9.6 22.1 3.6 15.9 18.6 25.6 22.6 9.5 4.2 10.9 15.2 15.1 43.3 2.1 50.0 16.8 0.7 9.7 0.0 8.3 13.2 4.7 1.7 11.0 4.4 1.8 37.6 5.3 20.0 1.7 BRD1 "BRL, BRPF2" ENSG00000100425 "Bromodomain containing 1" O95696 22 49773283-49827512 "Predicted intracellular proteins" "Erythrocyte maturation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000807, HPA001063" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA000807: AB_1078298, HPA001063: AB_1078297" "unprognostic (1.96e-1)" "unprognostic (2.99e-2)" "unprognostic (1.07e-1)" "unprognostic (5.11e-3)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.18e-2)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.28e-2)" "unprognostic (2.02e-3)" "unprognostic (1.64e-3)" "unprognostic (5.87e-2)" "unprognostic (7.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.26e-1)" "unprognostic (3.95e-3)" 10.7 7.3 3.0 8.2 2.7 15.1 10.9 10.7 3.9 12.4 3.2 13.1 11.8 15.9 2.8 12.9 13.8 7.8 7.5 3.3 2.7 5.4 6.9 10.0 9.4 3.0 2.7 2.8 16.1 13.3 8.6 11.2 8.4 4.9 8.8 5.9 6.1 12.2 8.1 16.8 21.7 12.1 6.8 1.5 12.1 11.6 30.9 2.7 14.1 10.2 9.0 7.7 11.9 12.4 4.4 12.7 12.7 22.8 12.8 9.2 8.2 19.3 13.7 9.3 14.2 11.1 19.3 8.3 13.3 7.9 11.4 5.2 17.9 14.7 9.8 6.1 13.4 26.6 13.2 20.3 11.8 17.8 30.5 18.2 12.2 15.1 8.3 10.5 10.3 10.4 15.9 15.3 14.3 7.3 20.8 23.0 15.9 15.7 9.4 10.1 33.6 19.9 13.9 5.5 18.2 14.6 25.8 17.6 22.7 18.4 10.5 10.6 24.9 12.9 13.1 14.1 9.9 12.7 16.8 4.3 18.9 9.3 10.7 11.8 0.3 0.6 0.7 0.5 0.2 1.0 0.4 0.8 1.0 0.4 0.7 0.8 1.0 0.6 0.8 2.9 0.9 0.3 0.5 3.0 2.7 10.7 3.9 3.3 2.7 3.0 2.7 2.8 4.9 1.5 2.7 4.4 25.9 22.4 27.6 16.3 13.8 15.8 5.7 7.1 8.6 26.6 14.0 14.7 8.4 5.7 12.7 3.7 29.2 6.7 76.8 13.3 0.0 6.7 7.5 32.4 37.1 13.9 16.2 8.2 25.3 9.3 6.6 17.2 14.8 47.7 10.1 28.3 14.3 12.3 6.7 33.7 22.2 13.9 4.1 13.3 14.0 6.7 11.8 15.4 12.4 16.9 11.2 13.8 7.2 19.1 21.9 9.5 8.7 13.9 43.1 9.1 10.6 3.2 11.3 36.1 0.0 25.4 20.1 42.6 19.7 10.7 18.5 10.1 40.6 26.4 11.3 9.0 ZBED4 KIAA0637 ENSG00000100426 "Zinc finger BED-type containing 4" O75132 22 49853844-49890080 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045341 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045341: AB_2679295" "unprognostic (3.82e-2)" "unprognostic (6.39e-2)" "unprognostic (7.22e-3)" "unprognostic (4.43e-2)" "unprognostic (7.90e-2)" "unprognostic (2.42e-1)" "unprognostic (2.48e-3)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (2.43e-2)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.53e-2)" "unprognostic (5.20e-2)" 3.2 2.6 2.2 5.4 2.0 11.1 3.4 5.2 2.4 3.1 1.2 5.8 5.4 3.6 2.7 6.6 3.3 3.6 3.0 2.1 1.8 3.0 4.8 4.2 6.6 1.9 1.9 1.9 3.6 5.4 3.0 3.4 3.9 2.9 3.4 4.9 4.8 3.8 2.2 4.5 5.1 5.4 3.3 1.4 5.2 4.6 3.9 2.0 11.0 3.3 3.2 5.5 4.0 3.6 3.9 14.9 13.1 24.5 19.5 7.4 8.1 15.2 8.6 7.1 9.3 8.6 13.5 6.5 29.3 5.9 9.2 9.7 16.7 17.4 11.1 9.9 11.6 21.2 16.8 13.2 12.8 10.7 36.0 23.2 7.6 16.5 10.2 15.4 9.3 12.6 28.0 18.2 13.7 11.1 11.9 30.0 17.1 13.4 12.9 9.1 35.5 22.1 17.8 9.9 14.9 12.9 25.7 8.5 24.9 17.3 15.2 11.8 20.3 14.7 12.7 19.9 7.5 12.3 13.5 9.0 26.5 7.7 15.9 15.2 0.4 0.4 0.7 0.8 0.6 1.6 0.6 0.8 0.9 1.0 0.4 1.0 0.8 0.2 2.9 0.6 1.0 0.6 0.6 2.2 2.0 5.2 2.4 2.1 1.8 1.9 1.9 1.9 2.9 1.4 2.0 3.9 4.9 0.0 6.5 11.4 7.2 5.1 5.1 5.0 4.0 7.9 6.3 6.1 7.2 7.2 8.6 5.5 14.6 3.6 23.5 8.7 3.9 9.2 4.8 10.0 10.1 6.6 12.6 12.8 14.7 7.1 6.4 5.1 7.7 10.1 0.0 10.1 5.3 6.9 6.8 13.5 14.7 9.5 4.1 12.6 5.2 4.6 3.1 7.3 0.0 16.9 8.5 2.5 16.5 12.1 16.6 13.3 8.5 4.1 12.5 9.2 3.8 2.9 6.2 9.9 6.6 5.8 7.1 4.8 6.4 6.7 3.8 3.3 17.2 7.4 11.0 6.8 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Modulator of VRAC current 1" Q15049 22 50059391-50085426 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 263.9;choroid plexus: 119.2" "Cell type enriched" "Detected in some" 6 "Astrocytes: 115.6" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 20.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced Supported Cytosol NA NA Cytosol "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 0.3 0.1 211.8 0.7 202.2 36.7 0.1 190.1 263.9 1.9 119.2 0.1 0.4 0.3 1.0 0.1 1.8 1.0 0.4 198.6 208.3 0.1 0.4 1.6 0.3 235.6 205.3 171.2 0.3 0.1 0.0 1.1 2.3 192.5 4.9 0.0 4.2 0.1 1.4 0.1 1.0 0.1 0.2 200.2 2.2 0.2 3.8 201.2 0.5 0.1 0.0 0.5 0.4 12.0 188.7 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 68.1 0.0 0.0 0.1 228.2 68.4 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.8 219.8 0.3 0.0 0.1 24.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 401.5 0.0 0.0 0.2 0.1 0.3 131.6 120.2 0.4 0.3 35.7 2.2 0.0 1.1 0.0 3.9 6.8 0.1 0.1 0.3 1.6 0.9 0.0 0.1 1.8 0.1 20.2 9.2 0.2 0.1 4.0 211.8 202.2 190.1 263.9 198.6 208.3 235.6 205.3 171.2 192.5 200.2 201.2 188.7 0.0 0.0 0.5 115.6 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.1 17.2 0.0 0.0 0.0 1.1 0.1 0.4 0.1 0.0 7.8 0.4 0.0 0.1 2.4 0.0 0.1 1.3 4.4 0.4 0.0 3.5 0.0 0.5 0.0 0.0 0.3 0.0 0.7 0.0 0.6 1.8 7.5 0.6 16.3 18.6 0.5 0.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.3 2.7 0.1 0.0 0.0 HDAC10 DKFZP761B039 ENSG00000100429 "Histone deacetylase 10" Q969S8 22 50245183-50251405 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, DNA damage, DNA recombination, DNA repair" Hydrolase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB045977 Supported NA NA "CAB045977: AB_11124034" "unprognostic (1.53e-1)" "prognostic favorable (4.46e-4)" "unprognostic (1.43e-2)" "prognostic favorable (2.45e-5)" "unprognostic (2.71e-2)" "unprognostic (3.70e-2)" "unprognostic (6.15e-3)" "unprognostic (5.48e-2)" "unprognostic (3.28e-1)" "unprognostic (2.56e-2)" "prognostic favorable (9.25e-4)" "unprognostic (4.93e-2)" "prognostic unfavorable (4.74e-11)" "unprognostic (2.21e-2)" "unprognostic (2.52e-2)" "unprognostic (1.43e-2)" "unprognostic (1.38e-3)" 7.4 9.9 3.5 6.0 3.4 9.7 7.2 2.3 10.4 9.3 4.0 7.6 6.6 6.9 1.3 10.8 8.1 3.9 4.6 3.6 2.9 11.4 16.9 8.6 6.7 3.2 2.9 3.0 7.6 11.3 2.2 13.3 3.3 3.1 10.9 1.5 0.2 8.8 2.8 5.2 8.6 12.7 1.9 2.5 17.3 11.5 2.3 3.2 4.3 9.6 0.5 2.9 7.3 8.1 3.3 6.1 3.3 0.9 5.0 4.2 3.3 11.4 4.2 3.4 2.3 1.4 6.4 6.6 4.0 5.7 3.1 2.2 10.2 2.1 5.9 0.5 5.4 5.7 8.5 10.1 10.4 7.5 10.9 27.0 7.0 4.4 2.3 1.3 4.8 4.2 7.8 6.3 6.1 2.0 18.7 5.8 25.9 2.0 6.5 7.4 13.4 3.3 24.6 3.8 10.5 2.7 6.5 4.2 1.4 7.2 1.2 10.8 15.8 7.4 3.9 5.7 6.7 2.5 7.8 2.6 3.6 6.4 6.7 2.8 0.4 1.6 2.5 0.7 1.8 0.6 0.4 0.3 0.5 1.3 0.4 0.3 0.3 0.8 0.5 1.0 1.2 0.6 1.1 3.5 3.4 2.3 10.4 3.6 2.9 3.2 2.9 3.0 3.1 2.5 3.2 3.3 13.9 0.0 3.4 12.1 17.7 8.7 4.8 10.3 9.1 5.7 14.3 13.6 0.6 12.8 6.8 14.7 16.7 11.6 28.6 25.4 7.9 6.3 3.3 9.3 6.9 8.5 20.9 8.4 8.9 3.8 16.2 8.1 32.6 9.0 5.1 16.6 10.0 7.9 21.1 0.0 10.6 17.3 6.1 20.0 13.3 8.3 11.1 19.9 8.8 4.7 18.1 2.9 20.6 3.5 2.4 6.1 17.8 7.9 12.3 3.4 29.2 16.3 14.3 6.5 0.0 3.0 6.3 1.0 2.3 13.1 9.5 10.3 26.0 13.5 18.3 4.4 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.4;intestine: 5.1;stomach 1: 2.6" "Group enriched" "Detected in some" 4 "dendritic cells: 12.5;Excitatory neurons: 43.8;Inhibitory neurons: 17.0;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 11.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 62 "plasmacytoid DC: 10.0" "Lineage enriched" "Detected in single" 100 "dendritic cells: 10.0" "Cell line enhanced" "Detected in some" "OE19: 1.5;REH: 1.7;SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved NA NA "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.0 0.3 2.9 0.4 3.6 0.2 0.0 4.3 4.6 0.1 0.0 1.3 5.1 0.0 0.0 1.1 0.0 0.0 0.0 4.7 5.4 2.4 0.0 0.1 0.1 4.5 3.1 3.6 0.0 1.4 0.0 0.5 0.0 4.2 0.0 0.8 0.1 0.2 0.0 0.0 0.0 2.6 0.1 2.1 0.1 2.6 0.5 3.2 0.0 0.0 0.0 0.4 0.0 0.2 4.4 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.1 1.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.1 2.9 3.6 4.3 4.6 4.7 5.4 4.5 3.1 3.6 4.2 2.1 3.2 4.4 0.0 0.0 0.0 0.7 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.5 2.1 0.0 0.0 0.7 0.0 0.0 0.1 1.8 0.0 43.8 0.6 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.0 1.6 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 37.7 11.9 0.1 0.3 0.0 0.0 0.0 1.5 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.2 0.0 0.0 0.1 0.0 1.6 0.1 ABHD4 FLJ12816 ENSG00000100439 "Abhydrolase domain containing 4, N-acyl phospholipase B" Q8TB40 14 22598237-22613215 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 35.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 35.4" "Cell line enhanced" "Detected in many" "ASC diff: 121.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000600 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000600: AB_1078081" "unprognostic (5.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.68e-3)" "unprognostic (8.17e-2)" "unprognostic (1.17e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-3)" "unprognostic (3.69e-2)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.56e-2)" "unprognostic (5.18e-2)" "unprognostic (1.37e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" 20.8 28.9 20.2 7.4 21.6 12.7 17.7 21.5 22.6 23.8 24.9 17.2 15.1 26.5 27.7 38.6 15.5 24.9 18.5 19.6 25.7 25.3 22.8 17.7 8.1 27.6 22.2 17.5 16.1 14.6 23.0 12.9 18.1 22.1 19.5 13.9 21.9 16.6 34.0 25.7 17.6 18.1 24.7 22.1 14.9 25.1 37.1 23.8 10.2 21.7 27.5 14.9 25.0 26.4 24.9 23.4 38.5 15.5 14.2 121.8 44.0 14.9 10.3 52.2 25.3 46.8 23.5 36.4 2.2 26.7 45.2 27.2 44.5 9.9 26.6 20.6 17.3 3.5 8.7 28.1 77.9 55.6 1.4 30.3 56.1 20.6 33.2 28.2 52.7 26.4 16.0 6.5 41.1 23.5 12.8 0.7 1.3 18.8 94.4 27.7 6.5 13.8 9.8 29.6 24.6 1.0 3.1 69.1 24.3 27.2 30.6 9.5 2.6 18.8 11.0 14.9 18.0 4.1 44.1 25.3 0.8 8.2 1.8 8.9 35.4 6.3 10.2 8.2 4.7 6.8 5.5 5.4 5.5 4.2 3.1 1.7 3.5 25.7 7.3 4.6 0.6 3.4 5.6 20.2 21.6 21.5 22.6 19.6 25.7 27.6 22.2 17.5 22.1 22.1 23.8 24.9 5.0 12.8 5.6 2.6 4.7 3.2 7.0 5.2 7.4 3.5 6.2 6.6 6.7 11.5 3.4 3.7 4.2 6.1 4.8 9.8 9.8 13.3 3.1 8.3 6.0 6.5 6.0 4.4 1.1 11.7 2.3 5.2 16.3 12.5 5.1 5.2 9.3 10.3 7.8 8.4 1.2 6.8 4.1 6.9 1.7 4.7 5.6 4.6 1.8 1.0 9.4 6.9 5.2 4.0 3.7 9.8 9.3 8.2 12.4 9.5 13.3 4.7 2.6 3.2 6.6 3.1 6.0 0.7 0.5 13.2 2.7 26.8 5.0 9.7 3.3 11.7 KHNYN KIAA0323 ENSG00000100441 "KH and NYN domain containing" O15037 14 24429286-24441843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003402 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003402: AB_1079190" "unprognostic (2.95e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.03e-1)" "unprognostic (8.03e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (8.43e-2)" "unprognostic (1.41e-1)" "unprognostic (6.08e-2)" "unprognostic (2.73e-1)" 24.3 24.3 14.5 29.1 16.3 39.5 23.8 20.0 14.1 27.1 15.2 29.1 27.9 25.3 17.4 28.0 28.4 18.4 17.3 12.3 16.8 16.5 19.1 25.4 28.1 19.1 15.7 11.3 41.8 28.6 20.0 18.2 33.2 16.3 25.2 25.8 8.5 24.6 21.4 22.7 26.8 33.7 20.2 15.6 32.6 39.1 9.6 15.2 24.4 22.7 17.9 31.4 27.3 25.4 17.7 28.2 35.1 29.2 23.4 31.2 30.5 29.7 27.3 33.2 30.9 24.2 22.1 48.6 39.3 15.6 25.9 25.3 26.9 25.8 44.4 22.9 63.4 12.0 17.8 33.1 41.1 32.0 26.3 37.1 31.3 100.2 32.0 42.4 42.3 36.4 29.1 24.0 35.7 17.6 36.6 9.6 16.5 7.6 53.7 28.6 15.0 0.3 20.2 19.9 42.1 20.9 21.8 22.4 14.6 36.9 29.0 17.5 30.4 36.2 28.1 24.4 33.9 16.0 66.5 39.9 27.4 15.3 14.4 26.0 0.9 1.3 1.9 1.7 1.6 1.0 1.3 1.4 1.4 0.9 2.3 1.0 1.0 1.7 1.6 1.3 1.5 1.4 1.2 14.5 16.3 20.0 14.1 12.3 16.8 19.1 15.7 11.3 16.3 15.6 15.2 17.7 15.3 12.8 16.3 10.7 15.6 8.9 25.3 15.1 11.4 2.9 13.8 11.9 3.4 17.2 13.0 7.3 2.1 24.7 14.3 32.2 1.9 18.1 0.4 8.6 10.3 15.0 10.8 22.1 2.9 41.8 13.6 11.6 36.7 13.4 14.0 13.5 9.7 9.5 13.6 0.0 1.5 26.1 18.3 12.6 9.3 3.1 14.0 13.3 12.4 6.5 16.6 8.3 16.5 3.5 6.7 41.1 17.3 11.3 8.6 33.7 35.0 3.9 12.9 9.2 13.1 13.6 14.3 1.1 1.6 9.4 12.8 26.8 12.7 14.6 17.6 34.3 FKBP3 "FKBP-25, FKBP25" ENSG00000100442 "FKBP prolyl isomerase 3" Q00688 14 45115599-45135319 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 428.4;tongue: 375.3" "Cell type enhanced" "Detected in all" "Late spermatids: 377.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000864, CAB012232, CAB012520" Supported Supported Cytosol NA NA 1300000 Cytosol "CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873" "unprognostic (7.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (9.72e-2)" "unprognostic (1.25e-1)" "unprognostic (9.82e-3)" "unprognostic (3.58e-3)" "unprognostic (2.28e-1)" "unprognostic (5.04e-3)" "unprognostic (1.22e-3)" "unprognostic (7.47e-2)" "unprognostic (6.92e-3)" "unprognostic (1.00e-1)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" 41.2 47.2 110.4 36.2 111.9 38.7 50.5 120.1 123.0 37.4 102.1 49.9 45.1 31.7 65.4 55.2 31.6 30.1 110.5 110.6 112.0 55.0 70.2 27.9 54.1 111.3 109.5 108.7 35.6 33.1 55.9 57.1 47.3 110.1 58.2 49.6 83.0 37.4 38.2 428.4 38.6 48.2 39.6 109.3 40.3 38.3 53.3 111.6 60.2 40.5 375.3 58.1 43.7 38.9 113.7 161.0 175.3 249.0 132.4 109.0 117.8 98.3 96.2 110.3 149.3 163.5 154.8 134.1 85.1 98.9 110.0 84.1 130.0 188.4 124.8 211.7 123.7 111.0 69.8 138.8 202.6 107.1 122.2 72.8 112.0 127.5 87.2 80.1 136.8 198.0 131.9 102.9 62.1 179.9 196.9 197.5 163.0 126.7 178.3 164.5 187.0 183.7 102.9 242.2 183.7 151.2 59.2 154.8 94.5 156.0 186.4 222.6 89.9 128.7 113.0 195.6 59.9 75.1 104.0 198.8 132.5 68.3 83.0 108.1 23.4 22.4 22.1 18.7 27.3 22.8 29.7 25.0 25.7 33.3 21.8 23.4 26.7 3.6 24.2 29.4 43.0 30.8 20.2 110.4 111.9 120.1 123.0 110.6 112.0 111.3 109.5 108.7 110.1 109.3 111.6 113.7 48.3 41.7 46.6 25.8 45.3 47.8 94.4 205.5 45.5 79.3 39.9 46.7 202.5 48.6 101.4 93.8 10.4 320.9 51.2 56.4 252.4 131.1 212.7 55.0 83.3 58.5 56.1 50.9 49.7 73.0 135.4 70.0 36.7 68.1 53.7 75.6 38.2 91.1 131.1 40.4 44.5 71.2 124.1 39.9 43.0 377.4 80.8 53.7 69.4 17.8 110.7 80.7 50.4 21.1 34.3 88.4 53.7 97.8 58.0 76.4 91.8 220.1 73.5 67.4 105.2 71.3 118.5 154.0 111.2 65.0 47.9 165.0 48.8 84.1 96.1 77.6 SDR39U1 "C14orf124, HCDI" ENSG00000100445 "Short chain dehydrogenase/reductase family 39U member 1" Q9NRG7 14 24439766-24442905 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044294, HPA075356" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044294: AB_10961400, HPA075356: " "unprognostic (2.99e-2)" "unprognostic (1.21e-1)" "unprognostic (4.13e-2)" "unprognostic (2.42e-2)" "unprognostic (2.36e-1)" "unprognostic (6.28e-2)" "unprognostic (2.06e-2)" "unprognostic (1.67e-3)" "unprognostic (4.24e-1)" "unprognostic (2.87e-3)" "prognostic favorable (2.34e-4)" "unprognostic (9.13e-2)" "unprognostic (1.13e-3)" "unprognostic (7.47e-2)" "unprognostic (2.48e-1)" "unprognostic (1.63e-1)" "unprognostic (5.32e-2)" 40.3 74.5 53.4 15.0 54.8 29.1 45.0 57.8 65.6 40.4 50.3 41.4 17.0 33.8 17.9 35.3 36.1 11.7 78.9 51.6 54.8 59.4 58.3 35.4 22.7 55.3 56.0 48.9 47.6 50.6 22.9 58.6 14.6 55.5 47.6 9.4 38.2 38.3 23.4 97.5 40.3 42.4 11.7 55.4 58.2 47.9 35.0 56.2 28.0 39.0 73.2 14.3 41.5 33.7 55.8 20.1 35.4 25.5 30.0 34.8 26.5 24.4 11.5 16.3 26.4 30.2 27.4 26.0 28.4 30.0 13.4 19.6 37.1 22.8 29.2 11.5 38.2 39.5 25.3 26.1 74.1 16.9 23.7 23.4 29.7 34.6 19.0 27.2 26.9 28.5 65.5 23.1 24.5 26.3 36.2 40.2 39.2 24.1 31.3 32.6 50.9 13.2 20.9 47.5 27.1 43.8 36.8 30.3 55.4 28.3 15.1 38.1 34.9 14.2 8.0 25.5 23.7 15.3 38.3 26.9 35.7 21.1 30.6 21.2 39.1 38.3 23.8 40.3 23.7 39.2 49.7 30.7 32.3 43.7 49.7 43.2 45.2 11.4 58.4 20.3 60.7 40.2 33.0 53.4 54.8 57.8 65.6 51.6 54.8 55.3 56.0 48.9 55.5 55.4 56.2 55.8 34.9 28.9 21.7 10.1 35.0 26.5 40.8 40.1 21.6 37.2 44.2 47.2 0.2 45.8 36.5 40.5 12.5 48.4 41.6 19.7 121.3 29.1 16.9 16.9 15.9 27.3 27.6 35.3 12.2 19.9 24.3 24.8 13.3 17.8 36.1 28.4 21.0 38.6 30.2 28.6 12.6 25.8 38.7 19.3 19.6 26.3 32.9 21.6 42.7 12.2 22.9 63.4 37.0 11.1 17.0 15.7 17.7 31.6 34.4 24.9 21.3 71.7 26.8 47.4 0.0 25.5 24.0 67.1 22.6 21.0 27.3 56.1 28.6 27.0 22.5 29.8 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573518-24576250 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 153 "bone marrow: 5399.9" "Cell type enriched" "Detected in some" 16 "granulocytes: 534.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "THP-1: 8681.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" NA NA 330000 "CAB000110: , HPA047737: AB_2680140" "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.91e-4)" 18.3 0.1 0.0 13.6 0.0 5399.9 25.6 0.0 0.1 16.8 0.2 25.7 5.9 9.6 10.3 22.3 2.7 26.1 3.7 0.0 0.0 1.3 3.7 11.7 6.6 0.0 0.0 0.0 0.5 3.5 1.5 1.0 2.9 0.0 3.7 25.8 0.0 11.6 4.9 1.9 24.5 18.3 7.7 0.0 17.1 5.0 3.3 0.0 26.2 0.8 7.7 6.1 35.2 4.2 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 303.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 3.6 41.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.2 0.0 3.6 0.0 0.0 8681.4 0.0 0.0 0.3 0.0 5.3 0.0 0.8 2.8 0.0 1287.5 0.1 0.0 6.0 0.0 1.1 1.0 0.0 0.0 0.9 3.4 5.4 0.0 0.0 1.7 7.3 5.0 0.0 6.5 0.0 19.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.8 33.3 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 534.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 11.1 9.1 0.0 1.5 5.4 0.0 1.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.3 0.3 1.7 0.0 4.0 0.0 5.1 0.0 0.4 0.0 GZMH "CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2" ENSG00000100450 "Granzyme H" P20718 14 24606480-24609699 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.2;lymphoid tissue: 25.4" "Group enriched" "Detected in many" 10 "dendritic cells: 575.2;NK-cells: 492.3;T-cells: 302.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 1678.5;memory CD4 T-cell: 490.7;memory CD8 T-cell: 1389.6;naive CD8 T-cell: 1214.0" "Lineage enriched" "Detected in all" 7 "T-cells: 1678.5" "Cell line enhanced" "Detected in single" "U-266/70: 1.0" "Low region specificity" "Detected in many" HPA029200 Enhanced "Secreted to blood" NA NA "HPA029200: AB_10602908" "unprognostic (3.72e-3)" "unprognostic (1.47e-3)" "unprognostic (5.35e-2)" "prognostic favorable (2.00e-6)" "unprognostic (8.80e-2)" "unprognostic (1.65e-3)" "unprognostic (2.08e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-2)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.80e-1)" "unprognostic (3.35e-2)" "unprognostic (2.77e-3)" 3.4 5.2 1.4 3.1 1.5 34.2 4.6 1.4 2.4 2.7 2.0 2.7 2.4 2.0 5.1 3.7 3.5 7.0 2.5 1.3 1.5 1.2 6.7 16.0 25.4 2.0 1.6 1.2 2.8 0.9 0.7 2.5 1.7 1.6 1.4 2.5 0.0 8.0 2.2 1.9 0.6 2.8 3.4 1.6 24.6 4.8 0.8 1.9 3.9 1.6 0.6 4.6 7.5 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.2 31.6 3.4 1.7 1678.5 3.6 30.2 7.6 490.7 1389.6 3.3 4.6 155.1 1214.0 18.6 250.8 5.4 44.6 4.5 1436.5 1.4 1.5 1.4 2.4 1.3 1.5 2.0 1.6 1.2 1.6 1.6 1.9 2.2 2.9 0.0 4.6 0.0 3.3 1.1 0.1 0.0 0.0 0.0 1.7 1.5 1.4 8.6 0.0 0.0 0.0 0.1 575.2 0.0 0.0 0.1 0.1 0.3 0.3 1.5 0.0 8.6 0.0 0.0 0.0 1.2 1.1 0.4 1.3 0.0 7.5 1.2 0.1 0.0 0.0 0.0 0.0 9.3 3.4 0.2 0.0 4.5 3.6 1.9 3.1 0.0 492.3 0.0 0.1 0.0 0.0 0.0 43.7 0.2 0.0 2.6 0.7 0.0 0.0 1.9 1.3 0.1 0.0 0.4 1.8 0.0 302.2 0.0 0.1 0.1 GZMB "CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT" ENSG00000100453 "Granzyme B" P10144 14 24630954-24634267 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 68.7;lymphoid tissue: 37.4" "Group enriched" "Detected in many" 5 "dendritic cells: 2050.2;NK-cells: 1704.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 6765.2" "Lineage enriched" "Detected in all" 5 "dendritic cells: 6765.2" "Cell line enriched" "Detected in some" 6 "HMC-1: 22.0" "CAB000376, HPA003418" Enhanced "Secreted to blood" NA NA 2170 "CAB000376: AB_323716, HPA003418: AB_1079020" "prognostic favorable (7.27e-4)" "unprognostic (2.82e-3)" "unprognostic (8.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (2.07e-3)" "unprognostic (1.48e-3)" "unprognostic (4.43e-2)" "unprognostic (8.25e-2)" "unprognostic (3.70e-2)" "unprognostic (3.05e-3)" "unprognostic (4.26e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.10e-7)" "unprognostic (1.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-3)" 8.2 1.8 1.5 18.0 1.5 68.7 2.1 1.5 2.9 1.3 1.7 2.5 2.3 7.2 1.6 3.8 1.5 6.6 1.7 1.4 6.3 1.5 4.2 15.5 37.4 1.7 1.8 1.3 0.3 1.1 0.7 0.7 3.3 3.2 1.4 2.3 0.0 2.3 1.4 2.0 0.4 4.4 4.3 1.6 29.2 3.5 0.5 1.8 9.8 1.9 1.5 34.9 18.7 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.7 2.8 9.9 3.0 5.3 1338.5 4.0 16.0 7.0 95.2 641.6 6.3 3.1 29.1 607.5 43.1 507.8 6.0 6765.2 2.7 1607.1 1.5 1.5 1.5 2.9 1.4 6.3 1.7 1.8 1.3 3.2 1.6 1.8 1.6 4.3 6.4 36.0 0.0 15.9 2.8 0.3 0.0 0.0 0.0 0.9 0.8 1.1 4.3 7.4 0.0 0.0 0.4 2050.2 0.6 0.0 1.6 0.0 0.4 0.5 2.7 0.0 11.8 0.0 0.0 0.1 5.1 9.2 0.5 17.7 0.0 4.2 1.2 0.2 0.0 0.0 0.6 0.0 4.8 9.0 0.2 0.0 27.1 42.7 1.0 11.6 0.0 1704.4 0.0 0.1 0.1 2.3 0.0 86.8 0.2 0.6 3.1 4.4 0.0 0.0 1.3 1.3 0.0 0.1 0.4 4.1 0.3 373.8 0.0 0.6 0.1 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893204-22919182 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favorable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 30.5 38.2 38.4 34.4 36.5 53.7 41.1 53.6 42.3 45.8 44.6 38.6 31.0 53.9 39.6 39.9 59.9 39.5 33.9 34.3 40.6 44.6 41.0 42.3 45.1 41.1 36.7 31.7 58.4 39.5 83.8 40.9 47.1 35.8 39.3 42.1 52.6 38.4 40.4 29.3 36.6 37.6 46.3 36.5 45.8 39.6 31.5 39.6 58.4 55.0 41.1 51.0 43.9 38.1 43.5 55.9 86.3 86.6 45.4 46.5 39.6 36.1 59.9 81.3 114.0 88.8 39.6 66.6 93.0 45.8 55.8 54.8 77.3 98.3 50.3 92.2 73.1 81.2 43.7 65.8 2.8 72.9 84.6 68.9 51.0 68.3 65.8 43.4 63.4 64.4 45.5 56.5 58.3 56.6 71.1 93.8 38.0 38.7 84.8 80.3 80.1 71.8 56.6 44.0 78.0 59.5 66.3 89.8 68.8 38.6 56.6 50.8 49.6 59.8 19.3 33.3 47.5 56.1 55.1 77.0 87.6 32.4 48.2 71.7 40.1 47.7 50.7 37.1 37.0 25.1 29.3 26.3 32.2 49.5 34.7 31.5 28.2 136.6 59.7 49.7 24.6 30.0 32.0 38.4 36.5 53.6 42.3 34.3 40.6 41.1 36.7 31.7 35.8 36.5 39.6 43.5 36.8 44.8 48.3 12.1 82.3 18.4 44.7 28.4 27.9 66.4 38.7 35.9 24.3 68.6 42.7 33.1 116.7 53.0 53.8 48.8 45.0 36.3 9.5 55.1 36.8 39.5 65.4 54.1 13.5 33.5 48.0 32.0 36.7 41.4 70.9 27.2 53.2 37.2 31.5 50.5 16.1 39.3 20.3 54.9 33.6 11.9 35.4 40.4 16.0 19.7 70.8 52.4 102.0 18.6 15.3 39.7 55.1 28.2 42.2 29.1 57.3 33.1 64.0 164.2 32.9 47.8 32.1 52.0 64.3 22.0 21.0 101.4 64.0 28.1 42.3 27.8 PRMT5 "HRMT1L5, SKB1, SKB1Hs" ENSG00000100462 "Protein arginine methyltransferase 5" O14744 14 22920525-22929408 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005525, CAB012459, HPA064708" Approved Supported Nucleoplasm,Cytosol NA NA 45000 "Nucleoplasm, Cytosol" "CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330" "unprognostic (8.34e-2)" "unprognostic (5.14e-3)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (1.82e-4)" "prognostic unfavorable (4.77e-5)" "unprognostic (3.64e-2)" "unprognostic (6.80e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.69e-2)" "unprognostic (1.99e-3)" "unprognostic (1.21e-1)" "unprognostic (7.04e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.04e-4)" 27.2 31.2 21.8 28.1 21.0 21.9 35.2 21.2 26.1 32.1 23.1 38.8 24.2 37.2 30.9 49.4 45.0 19.6 33.0 20.8 21.0 37.3 28.6 23.4 26.9 20.6 22.2 20.6 45.7 33.2 47.6 24.7 30.9 22.1 28.1 35.9 31.1 27.9 33.7 66.3 34.7 23.5 35.8 20.5 26.5 29.4 30.6 21.1 33.4 38.2 42.4 34.6 31.7 33.8 22.9 161.7 169.2 114.2 112.9 62.3 67.7 125.6 104.1 91.6 192.7 156.6 159.2 160.1 171.3 83.2 88.5 108.3 135.8 246.4 212.8 213.9 98.5 119.3 104.5 108.3 256.3 111.4 221.7 85.7 69.3 113.2 143.1 264.8 72.7 91.0 128.5 160.0 91.7 108.5 171.4 151.3 102.9 103.1 160.8 221.8 176.0 140.3 122.7 98.8 110.7 126.0 79.8 125.7 132.3 65.5 94.3 91.3 82.6 70.9 75.1 103.1 103.0 145.9 116.6 246.0 207.2 46.1 109.2 116.0 3.0 31.3 0.4 14.2 31.7 22.9 30.6 19.0 23.0 42.8 27.9 24.4 20.4 7.7 19.8 25.1 25.9 17.6 29.1 21.8 21.0 21.2 26.1 20.8 21.0 20.6 22.2 20.6 22.1 20.5 21.1 22.9 8.5 19.2 15.1 5.5 11.4 26.5 26.5 33.8 15.4 10.8 13.9 15.4 1.1 28.6 19.4 7.3 8.4 41.7 8.6 11.1 23.5 32.0 2.3 18.5 21.4 12.3 6.1 24.4 6.1 27.0 33.4 16.7 12.8 12.6 7.0 21.9 10.4 15.1 19.6 16.8 5.8 17.5 20.3 4.4 11.7 3.7 16.4 8.0 26.6 0.0 11.8 18.2 3.1 5.5 4.0 92.8 12.7 21.1 12.4 23.6 7.4 24.6 31.1 11.2 6.6 25.9 19.5 43.1 47.3 20.3 27.8 33.4 8.2 27.5 21.1 17.9 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 506.3" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 63.0;Horizontal cells: 84.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 69.4" "Group enriched" "Detected in some" 12 "memory B-cell: 38.3;naive B-cell: 17.7" "Lineage enriched" "Detected in many" 17 "B-cells: 38.3" "Cell line enhanced" "Detected in many" "HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 50.8" HPA065086 Supported Vesicles "Secreted in other tissues" NA NA 160000 Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 3.2 3.7 6.0 2.8 69.4 4.0 3.4 1.6 18.2 10.7 17.2 3.0 0.8 0.6 2.2 0.9 6.3 2.9 2.0 6.2 13.4 5.2 0.5 0.6 11.1 12.9 7.6 6.0 0.8 506.3 3.4 10.2 1.9 13.0 48.7 2.2 12.2 3.6 74.1 1.3 9.7 2.6 1.1 3.6 2.6 1.7 5.3 10.9 1.3 1.4 5.1 7.8 2.0 23.2 4.8 0.0 35.3 3.1 0.0 0.6 0.1 21.8 0.2 0.0 6.4 17.1 20.9 1.2 0.4 1.7 0.0 1.3 0.1 22.2 0.0 10.6 0.0 95.7 18.1 7.6 63.8 0.0 1.8 7.3 1.3 0.0 0.6 0.0 0.0 0.3 39.9 129.1 5.1 1.6 0.8 9.2 105.5 11.9 0.1 3.7 26.7 0.0 0.9 1.1 3.4 111.8 30.4 2.6 0.6 0.2 12.1 0.0 48.7 0.9 0.0 0.0 0.3 0.1 5.7 15.8 11.2 0.0 0.0 4.7 0.0 0.6 0.0 0.0 0.0 0.0 38.3 0.3 0.0 0.1 17.7 0.0 0.1 0.2 0.0 0.0 0.0 2.2 1.0 6.0 69.4 1.6 18.2 6.2 13.4 12.9 7.6 6.0 13.0 3.6 10.9 4.8 2.0 0.0 0.5 3.6 13.4 19.1 2.3 0.3 0.0 2.7 7.9 1.5 0.8 2.8 0.9 0.0 4.2 6.5 1.3 0.6 1.9 0.5 1.5 2.2 0.8 3.1 17.0 7.4 14.3 63.0 14.3 22.0 1.1 1.0 1.3 1.8 5.0 5.0 3.8 84.1 24.2 0.3 6.1 5.0 25.2 2.0 1.5 2.4 19.6 7.5 2.8 14.5 0.0 6.0 16.5 3.7 4.3 6.0 10.0 3.5 0.2 11.7 0.5 4.0 0.0 2.8 9.0 22.1 20.3 0.1 13.5 6.6 3.3 0.1 0.6 1.7 AP4S1 "AP47B, CLA20, SPG52" ENSG00000100478 "Adaptor related protein complex 4 subunit sigma 1" Q9Y587 14 31025106-31130996 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039963 Approved Supported Vesicles NA NA Vesicles "HPA039963: AB_10795240" "unprognostic (4.03e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (1.03e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.79e-2)" "unprognostic (8.62e-3)" "unprognostic (1.15e-2)" "unprognostic (3.02e-1)" "prognostic favorable (2.87e-6)" "unprognostic (2.20e-3)" "unprognostic (5.44e-2)" "unprognostic (7.75e-2)" "unprognostic (5.59e-2)" 4.8 6.4 9.0 6.7 10.8 6.1 5.7 13.9 12.9 6.1 5.3 6.9 3.9 7.7 7.0 4.9 7.3 5.5 8.8 9.7 9.2 7.5 6.2 5.5 8.2 6.8 7.2 10.5 10.8 8.0 6.6 8.6 6.8 9.0 6.2 4.2 12.0 5.2 6.8 12.7 4.6 4.4 7.9 4.5 8.0 4.4 18.5 8.4 6.6 8.9 7.3 7.8 6.3 4.9 10.9 9.0 12.6 11.0 3.2 4.4 7.9 8.5 6.0 10.4 9.6 9.5 12.2 14.5 10.6 5.5 7.3 7.2 9.7 7.6 9.4 15.9 9.1 4.4 16.4 5.5 19.0 9.5 14.1 9.2 6.3 5.9 9.6 12.0 6.4 11.7 8.0 8.4 7.0 10.3 12.5 9.7 7.8 13.1 10.5 10.9 10.3 9.8 1.4 10.5 12.4 6.1 6.1 10.7 5.1 16.3 7.3 10.8 6.5 8.8 7.3 6.5 5.0 5.2 8.6 17.0 15.9 4.2 4.4 5.7 3.4 1.3 2.4 2.5 3.5 3.7 3.3 3.8 3.0 1.2 3.4 3.7 4.5 2.6 5.8 2.8 3.3 6.6 1.7 9.0 10.8 13.9 12.9 9.7 9.2 6.8 7.2 10.5 9.0 4.5 8.4 10.9 7.1 9.6 7.7 10.7 8.1 3.4 6.5 6.5 1.2 12.1 4.0 4.3 16.5 4.3 3.1 5.5 31.3 9.1 7.6 3.9 5.9 7.6 21.9 5.2 8.8 6.7 6.0 3.8 29.4 4.8 5.3 6.2 7.1 5.8 7.6 7.8 10.8 4.0 7.4 6.7 24.9 3.8 4.1 5.4 4.1 17.0 6.8 6.0 3.6 12.2 7.5 9.3 5.2 25.1 16.4 2.8 6.2 8.6 4.2 4.0 5.0 7.7 8.1 24.4 6.6 8.5 8.1 36.0 8.3 3.0 2.8 11.5 7.3 8.2 4.0 5.2 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 21.0;Spermatogonia: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 0.9 0.9 1.0 5.2 0.5 18.4 3.0 0.7 0.8 1.6 0.0 3.8 2.5 2.6 0.7 3.8 1.0 0.9 0.6 0.4 0.4 0.7 3.2 1.2 5.2 0.5 0.6 0.3 1.0 0.8 0.7 0.5 3.1 0.6 1.4 4.6 3.1 1.0 0.7 0.6 3.6 3.6 2.3 0.7 1.5 2.2 4.1 0.4 5.6 0.9 0.9 6.2 1.4 1.9 0.8 37.2 18.6 34.3 16.3 1.7 9.9 18.2 20.4 10.4 31.9 36.7 19.3 27.5 23.6 11.6 11.6 17.5 22.3 35.3 12.8 36.9 27.4 19.6 35.4 20.6 23.9 0.8 41.2 14.6 2.8 0.8 18.5 2.9 4.1 19.0 30.5 30.9 14.3 31.6 32.7 43.6 28.4 20.2 30.9 42.6 35.9 31.7 21.0 11.6 20.6 24.8 14.3 20.5 11.9 6.7 16.5 24.5 15.8 6.7 5.3 38.5 21.4 16.9 10.7 22.7 52.7 9.8 30.1 20.9 0.0 0.0 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.1 0.2 0.0 0.2 0.0 0.9 0.0 0.2 0.7 0.1 1.0 0.5 0.7 0.8 0.4 0.4 0.5 0.6 0.3 0.6 0.7 0.4 0.8 2.0 3.2 0.5 4.2 2.4 4.8 2.1 1.9 2.2 0.8 1.5 1.1 1.2 1.5 1.3 0.0 0.0 9.1 1.0 2.2 0.0 1.3 1.2 0.8 2.6 1.5 1.2 21.0 9.5 1.5 10.6 2.7 1.1 1.5 0.0 4.3 5.0 5.5 5.5 0.0 11.9 2.8 0.0 1.9 1.6 0.8 1.5 1.1 1.8 7.5 1.0 2.0 4.1 12.1 11.5 0.8 0.5 3.0 5.7 1.9 1.1 1.2 0.9 3.1 0.0 2.1 7.4 5.3 24.4 6.0 3.7 3.4 1.7 1.8 4.7 1.5 VCPKMT "C14orf138, METTL21D, VCP-KMT" ENSG00000100483 "Valosin containing protein lysine methyltransferase" Q9H867 14 50108632-50116600 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001146, HPA076561" Uncertain Supported Cytosol NA NA Cytosol "HPA001146: AB_1845558, HPA076561: AB_2732312" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.05e-2)" "unprognostic (3.86e-1)" "unprognostic (3.54e-1)" "unprognostic (4.74e-2)" "unprognostic (9.97e-2)" "prognostic favorable (2.40e-4)" "unprognostic (8.20e-2)" "unprognostic (1.74e-1)" "unprognostic (4.90e-2)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (6.27e-2)" 2.4 4.1 2.9 3.4 3.3 5.2 2.3 3.7 4.8 3.4 3.9 3.0 1.8 3.0 2.6 4.9 2.9 2.3 2.5 3.8 3.2 2.7 3.9 3.1 4.3 3.3 3.2 3.0 2.6 2.9 1.9 3.3 1.6 3.3 2.7 1.6 1.5 2.2 1.6 2.3 3.4 3.2 1.5 3.2 4.9 3.7 2.1 3.2 4.7 2.6 1.8 4.5 3.0 3.2 4.1 4.2 4.4 4.0 4.9 2.6 3.1 4.4 4.0 4.4 4.4 3.3 2.8 4.8 12.8 2.7 2.8 1.1 7.9 4.9 7.0 4.4 6.4 3.2 2.5 1.7 2.8 3.6 6.4 3.3 2.0 3.9 4.8 4.9 3.0 5.5 4.6 3.0 5.3 3.3 5.5 13.4 6.7 3.9 6.1 7.2 9.0 7.4 3.4 5.6 6.3 6.7 7.9 5.9 1.6 7.1 3.6 4.0 5.7 1.4 7.2 5.6 2.6 4.5 5.1 11.4 5.0 2.5 5.2 3.5 12.1 2.8 0.0 9.3 4.7 10.9 27.1 9.1 11.5 3.8 21.4 11.2 12.4 0.8 11.8 2.2 5.4 7.8 4.8 2.9 3.3 3.7 4.8 3.8 3.2 3.3 3.2 3.0 3.3 3.2 3.2 4.1 11.5 12.8 9.8 7.8 38.0 30.3 17.3 7.7 30.1 6.5 12.8 10.8 3.6 8.6 9.7 7.3 10.4 10.2 25.7 5.6 9.8 5.8 39.4 14.1 9.8 8.3 5.4 9.5 12.6 5.7 8.4 9.3 7.7 17.1 17.7 7.2 6.8 7.7 5.1 1.7 11.0 8.5 12.2 7.5 16.4 10.2 7.5 8.7 10.6 3.7 9.5 3.5 15.5 10.6 17.5 5.3 8.0 4.9 48.2 15.5 7.8 6.7 8.6 8.1 0.0 9.1 9.1 14.4 16.6 24.9 37.4 11.5 22.4 10.2 7.1 17.1 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117130-50231578 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917" "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favorable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 24.0 15.1 17.7 15.5 22.7 39.8 18.1 20.4 18.4 14.4 15.8 17.6 21.7 15.3 22.6 16.5 12.8 13.0 21.7 15.7 18.1 24.7 13.3 16.0 14.5 21.0 20.6 13.2 15.4 16.1 39.6 9.2 17.2 20.6 15.5 17.4 14.2 14.6 18.8 58.1 18.0 24.7 18.1 19.6 18.0 13.9 28.1 19.6 16.7 25.4 64.4 13.7 14.9 10.6 26.0 15.3 11.1 22.1 14.9 16.6 18.0 10.4 13.5 14.8 10.0 12.5 4.9 19.8 16.0 11.9 17.3 17.3 13.8 12.1 10.2 17.7 26.9 4.4 16.1 8.5 8.5 18.3 19.1 16.6 18.8 24.6 9.3 21.6 25.2 21.8 13.1 12.5 39.0 24.2 12.7 15.9 15.1 6.9 11.4 9.6 17.0 30.8 12.1 16.1 14.4 16.0 18.7 15.0 17.5 17.8 15.9 19.4 23.0 24.1 27.3 17.8 12.5 8.9 27.3 31.7 19.6 7.1 10.5 16.4 8.0 1.1 2.8 1.1 0.9 0.9 0.6 0.7 0.8 0.8 0.7 0.8 0.7 4.6 1.7 2.0 1.4 0.0 0.4 17.7 22.7 20.4 18.4 15.7 18.1 21.0 20.6 13.2 20.6 19.6 19.6 26.0 34.1 9.6 26.3 59.4 18.4 35.7 20.9 10.5 10.2 17.2 23.8 15.6 43.7 17.2 18.2 18.4 16.7 8.2 46.3 36.0 7.9 11.3 17.0 18.7 30.4 23.5 20.4 6.3 71.5 10.7 8.0 22.2 12.8 29.8 20.3 37.4 22.9 13.8 8.8 25.2 89.6 18.5 12.2 33.3 17.5 8.6 12.5 29.0 17.8 80.6 29.0 17.6 21.6 100.5 104.8 14.5 24.6 13.5 28.6 27.3 28.6 15.8 14.3 22.5 19.7 43.4 30.8 54.3 12.3 17.7 39.6 13.0 24.2 17.4 14.9 30.6 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50326265-50416461 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA059605: AB_2684080, HPA065919: AB_2685578" "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 13.7 3.6 3.0 4.9 4.1 3.7 3.5 1.3 9.1 14.1 3.1 6.7 13.3 14.0 3.2 5.2 15.5 5.3 2.3 4.6 2.1 19.6 1.6 6.6 6.6 2.5 1.7 3.3 14.0 1.3 1.2 0.6 6.5 3.2 6.0 6.7 20.3 2.8 9.1 7.1 13.6 6.9 8.5 2.8 7.0 5.0 2.0 1.4 1.9 7.9 1.0 2.6 6.9 6.6 7.7 7.7 4.9 3.5 4.3 5.3 6.1 2.3 2.2 3.2 1.9 2.0 4.0 5.9 6.1 2.8 3.2 3.2 5.9 0.8 0.3 1.9 8.9 3.1 12.2 4.6 3.9 6.2 9.7 5.3 1.5 3.0 3.2 8.0 2.4 6.7 10.3 3.3 4.8 1.1 2.5 2.8 4.7 1.9 2.6 3.9 3.3 3.8 3.1 5.3 6.6 4.6 3.4 4.2 18.3 2.1 1.3 2.4 6.2 4.0 6.7 4.1 7.1 5.0 2.4 1.8 2.9 1.7 8.7 7.6 3.2 1.4 2.6 3.5 1.4 3.1 2.6 2.3 3.2 0.8 3.0 1.9 1.9 0.7 2.3 0.2 0.8 2.4 1.3 3.0 4.1 1.3 9.1 4.6 2.1 2.5 1.7 3.3 3.2 2.8 1.4 7.7 3.2 19.2 9.9 6.5 3.0 3.1 4.1 0.2 3.4 0.7 0.4 0.5 0.5 0.0 2.6 11.0 0.0 0.1 2.3 7.2 5.9 1.4 0.4 23.4 9.6 3.3 1.8 6.1 46.2 1.8 0.1 7.6 1.1 4.9 1.3 3.2 6.4 0.3 0.4 0.0 20.6 2.1 2.0 0.9 1.5 1.5 9.0 1.5 0.0 7.5 0.8 0.9 2.1 46.8 25.4 1.9 4.8 3.4 0.2 3.1 4.9 8.0 20.4 0.7 0.0 4.0 4.6 0.0 0.3 4.7 2.7 0.3 4.2 3.6 5.2 2.2 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831162 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 240.5;Muller glia cells: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 31.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome" NA NA "Nucleoli, Nucleoli rim, Centrosome" Nucleoplasm "HPA005939: AB_2667474, HPA070691: AB_2686296" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 11.4 4.5 10.8 20.1 9.3 43.6 8.9 8.7 11.0 7.3 0.0 8.4 4.8 7.8 2.8 13.0 10.6 8.9 18.4 10.0 2.5 6.8 5.8 9.5 26.1 2.8 1.8 7.8 9.8 7.2 9.1 8.9 16.9 3.2 6.9 8.7 19.3 5.4 5.5 6.0 13.0 7.2 10.4 0.0 16.3 9.4 5.2 2.7 20.1 7.8 7.4 23.9 13.7 5.8 8.0 29.1 21.6 42.4 36.8 16.7 26.8 20.4 26.5 22.1 21.4 18.0 14.7 14.6 48.5 17.7 35.5 19.9 32.5 34.2 16.3 45.3 34.7 10.4 25.1 13.2 12.3 9.8 41.6 57.5 18.4 11.4 37.2 14.9 13.3 34.6 25.9 6.6 26.3 31.8 36.8 22.6 14.0 6.4 10.1 23.6 37.1 81.6 5.7 20.1 42.9 18.6 22.2 34.0 9.6 25.1 10.2 21.2 39.3 50.9 55.2 74.3 20.5 29.0 18.6 12.1 34.3 14.4 32.8 30.4 31.9 2.9 24.0 3.9 2.5 3.3 8.9 2.4 6.2 2.0 6.2 5.1 4.7 9.6 2.9 2.1 7.7 2.5 1.4 10.8 9.3 8.7 11.0 10.0 2.5 2.8 1.8 7.8 3.2 0.0 2.7 8.0 34.0 6.4 7.7 100.2 85.6 18.4 9.1 10.2 18.8 13.3 13.3 10.9 68.0 14.3 27.1 11.0 62.6 12.4 102.7 8.7 3.9 7.3 22.2 17.3 28.5 26.7 12.6 29.0 240.5 4.2 11.3 32.9 7.7 14.9 31.6 3.9 21.8 4.4 22.7 6.7 110.4 5.7 20.3 46.8 42.2 10.4 8.4 61.3 23.2 63.7 63.2 150.2 57.7 105.6 75.1 5.2 6.2 9.4 48.1 16.5 3.2 7.3 29.4 21.0 32.9 44.9 24.1 0.2 4.3 20.1 21.0 9.7 56.2 21.8 6.9 15.5 PYGL GSD6 ENSG00000100504 "Glycogen phosphorylase L" P06737 14 50857891-50944483 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 146.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 141.1;neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 279.1;HMC-1: 304.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000962, HPA004119" Enhanced Supported "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane, Cytosol" "HPA000962: AB_1079722, HPA004119: AB_1079723" "unprognostic (2.70e-2)" "unprognostic (8.64e-3)" "unprognostic (1.46e-2)" "unprognostic (8.55e-2)" "unprognostic (9.41e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.66e-1)" "unprognostic (1.34e-2)" "unprognostic (3.34e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (4.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.95e-2)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-3)" 111.1 21.1 6.0 24.3 7.1 109.9 36.7 5.2 8.5 27.8 11.9 19.2 3.7 20.8 6.5 56.3 19.2 13.1 11.4 5.5 15.6 10.2 146.8 26.3 6.4 11.1 16.1 5.7 18.4 5.7 21.3 7.6 49.7 8.3 13.1 24.3 78.9 27.0 29.9 5.2 37.3 8.5 27.0 8.3 49.8 9.7 5.3 8.2 4.9 10.3 5.9 6.8 42.1 38.4 11.0 145.7 40.8 10.1 64.3 47.0 56.2 114.5 28.6 24.1 77.4 117.3 107.4 18.3 0.1 54.4 171.7 91.2 279.1 107.0 144.8 132.0 0.5 46.8 28.0 60.5 82.4 83.8 106.9 304.4 119.4 56.8 104.1 43.6 75.4 69.3 0.8 11.6 0.5 55.4 144.7 0.4 141.7 39.3 12.8 152.0 2.7 36.2 6.1 104.7 95.1 4.5 4.4 131.0 43.3 1.7 38.6 20.6 200.4 3.2 29.7 49.6 56.0 92.9 1.2 0.3 0.5 27.3 107.7 15.9 50.2 55.9 141.1 0.0 24.2 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 153.7 0.6 15.7 1.2 0.2 24.8 6.0 7.1 5.2 8.5 5.5 15.6 11.1 16.1 5.7 8.3 8.3 8.2 11.0 6.7 22.4 6.3 1.3 1.8 30.7 10.5 40.5 6.8 4.6 7.0 3.8 3.4 5.7 35.4 7.3 0.0 28.9 0.2 11.2 3.9 10.9 1.0 35.4 18.9 7.8 1.2 9.0 1.8 2.1 151.2 18.8 6.6 62.6 6.3 9.3 8.2 65.4 177.6 1.7 2.2 7.1 14.2 56.7 7.9 1.5 14.3 54.6 19.6 15.9 52.4 265.1 2.1 14.1 0.6 7.4 5.2 21.8 1.8 9.7 0.0 6.4 24.5 11.9 6.6 15.4 8.8 0.7 1.4 22.4 22.3 21.1 2.3 4.0 14.0 9.2 TRIM9 "RNF91, SPRING" ENSG00000100505 "Tripartite motif containing 9" Q9C026 14 50975262-51096061 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.9;retina: 21.1" "Cell type enhanced" "Detected in some" "Astrocytes: 324.2;Excitatory neurons: 545.6;Inhibitory neurons: 381.1;Oligodendrocyte precursor cells: 582.1;Oligodendrocytes: 143.7" "Cancer enriched" "Detected in some" 8 "glioma: 25.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 32.2;HAP1: 23.0;HDLM-2: 36.5;SCLC-21H: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.22e-1)" "unprognostic (6.37e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-3)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (2.24e-3)" "unprognostic (7.66e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-2)" "unprognostic (2.38e-3)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (9.00e-2)" "unprognostic (7.57e-6)" "unprognostic (1.85e-3)" 0.8 2.2 31.7 1.2 41.6 0.9 1.2 62.9 46.3 3.1 0.0 4.6 0.2 4.6 1.3 0.4 0.8 4.5 1.2 46.0 28.3 0.8 2.3 0.5 0.2 17.1 26.2 41.9 1.3 0.6 0.1 13.6 0.3 35.8 0.8 0.9 21.1 2.2 3.1 0.6 0.9 1.2 3.2 9.7 0.3 1.0 1.0 30.0 0.9 0.5 0.4 0.2 0.7 1.8 42.3 0.0 3.7 5.7 32.2 0.0 0.0 2.1 0.0 0.0 0.4 0.9 2.5 0.3 0.4 0.2 0.5 5.5 0.1 23.0 0.0 0.9 36.5 4.6 1.8 0.1 0.0 0.0 1.3 1.2 0.9 0.0 0.6 0.0 0.1 0.0 3.1 0.0 0.2 0.9 0.1 7.2 0.9 1.9 0.1 4.9 4.2 8.3 0.2 0.1 0.0 32.7 2.6 0.5 0.1 7.3 0.3 0.5 0.9 0.0 2.1 0.9 0.0 1.5 0.6 0.1 0.4 9.6 0.9 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 41.6 62.9 46.3 46.0 28.3 17.1 26.2 41.9 35.8 9.7 30.0 42.3 0.1 0.0 0.0 324.2 0.2 0.5 0.1 0.2 0.6 51.5 0.6 4.3 1.4 1.5 0.0 0.0 33.3 0.4 0.0 2.2 1.9 0.3 0.2 0.3 0.3 0.4 1.2 0.0 545.6 0.0 2.9 1.6 0.0 0.7 0.0 0.8 0.7 0.1 0.2 1.7 381.1 0.0 2.0 0.3 0.3 0.2 2.1 0.0 7.2 28.1 0.0 44.4 0.0 582.1 143.7 0.1 0.1 4.1 1.1 0.2 0.0 0.3 0.0 25.9 0.0 14.8 0.4 0.4 0.8 0.2 0.0 0.3 0.4 0.1 0.2 0.0 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707178-52728590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No 300000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: AB_2678188" "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 43.8 48.8 44.5 47.7 44.7 44.5 58.7 46.1 54.5 44.3 43.3 52.7 50.4 48.1 49.7 65.7 49.6 36.8 79.5 45.3 46.6 66.5 87.8 39.9 55.8 46.7 45.9 42.9 51.4 44.1 60.4 5.5 55.4 47.1 45.7 54.8 60.6 38.3 46.0 119.2 44.9 47.0 57.3 46.9 39.2 47.0 31.6 45.9 56.8 54.8 107.6 67.5 57.7 7.9 49.0 182.0 115.0 135.4 99.0 92.4 95.8 146.0 139.3 133.1 220.8 165.1 142.6 143.5 156.8 169.8 121.6 111.5 134.0 173.9 121.9 230.6 151.2 74.5 115.0 91.3 153.5 111.0 164.9 106.8 71.8 118.4 112.1 111.6 120.1 141.2 77.4 174.2 64.7 161.8 163.2 129.5 111.8 108.7 170.1 153.8 108.4 237.2 70.7 144.6 178.5 96.0 71.2 123.8 76.5 122.3 120.8 156.4 117.0 108.9 121.2 171.0 95.8 145.2 45.6 127.0 175.8 79.1 110.5 112.9 77.5 62.4 67.0 51.2 71.9 59.5 63.4 62.7 56.4 73.9 56.4 59.6 59.0 52.7 55.6 73.0 38.5 85.4 75.4 44.5 44.7 46.1 54.5 45.3 46.6 46.7 45.9 42.9 47.1 46.9 45.9 49.0 81.2 70.5 58.9 23.5 74.2 86.2 141.9 187.1 50.1 65.5 55.3 51.3 76.6 62.9 140.6 57.0 68.8 162.2 69.4 73.5 135.0 131.0 30.4 92.8 75.3 78.2 70.4 85.2 37.4 106.9 139.9 72.1 38.7 96.3 67.7 68.7 50.0 84.4 92.1 62.2 39.0 58.9 109.9 71.3 67.9 19.9 67.1 61.4 80.0 20.6 90.9 64.6 52.5 38.2 46.7 116.2 46.2 65.5 64.0 85.2 72.5 140.2 116.4 107.6 72.3 66.5 130.6 63.4 82.8 48.9 72.0 237.5 65.0 79.7 73.4 116.6 GNPNAT1 "FLJ10607, Gpnat1" ENSG00000100522 "Glucosamine-phosphate N-acetyltransferase 1" Q96EK6 14 52775193-52791668 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 77.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044647 Approved NA NA 72000 "HPA044647: AB_10795986" "unprognostic (4.55e-3)" "unprognostic (1.19e-2)" "unprognostic (4.47e-3)" "unprognostic (5.18e-3)" "unprognostic (4.23e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (3.19e-3)" "unprognostic (1.03e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (8.52e-5)" "unprognostic (5.82e-2)" "unprognostic (3.22e-3)" "unprognostic (2.16e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "unprognostic (4.05e-2)" 21.7 7.4 4.7 11.2 5.9 3.9 16.9 7.3 6.2 14.7 5.2 18.6 15.2 9.3 9.6 8.6 8.5 11.5 5.3 6.0 5.5 13.7 77.8 6.0 7.4 5.3 5.5 5.2 9.4 25.7 8.0 5.8 10.6 5.7 15.6 22.2 5.7 19.4 7.1 11.3 6.8 14.2 10.8 5.3 5.6 19.8 15.5 5.6 5.9 8.5 7.3 8.6 14.0 6.2 6.5 99.8 37.6 30.5 34.7 32.0 73.8 49.9 63.6 41.4 53.5 54.8 43.4 59.1 56.3 34.6 64.2 26.2 40.0 59.2 64.0 92.9 32.4 31.1 38.1 36.2 55.1 46.2 42.7 19.5 29.9 53.1 92.9 99.5 27.7 62.1 35.3 36.7 13.4 70.8 85.6 52.0 21.9 31.8 129.1 67.6 34.7 14.4 33.9 51.2 51.3 30.6 42.8 54.1 70.5 46.6 20.8 83.4 14.6 70.1 55.2 56.9 97.6 50.0 14.0 28.4 24.4 26.1 27.4 32.8 6.4 1.7 0.1 5.0 2.1 6.0 4.6 5.2 4.6 4.0 5.1 5.9 4.7 0.6 5.5 5.0 2.4 6.8 3.1 4.7 5.9 7.3 6.2 6.0 5.5 5.3 5.5 5.2 5.7 5.3 5.6 6.5 14.1 16.0 12.1 5.2 10.7 19.2 33.7 19.1 10.2 9.6 23.6 16.3 3.6 18.6 18.5 12.9 4.2 23.3 10.6 13.4 33.2 40.3 43.8 16.0 25.5 17.7 5.4 13.3 16.5 37.6 74.8 25.8 32.6 39.5 7.0 16.5 12.1 89.4 15.5 3.3 10.8 61.0 10.2 6.0 9.3 11.8 19.6 8.6 7.2 8.4 5.4 5.3 18.6 9.0 9.0 45.9 14.0 18.0 13.8 42.0 8.0 16.1 13.0 6.4 19.7 18.3 24.7 71.2 7.2 22.3 21.3 12.2 10.6 13.7 30.1 38.1 DDHD1 "KIAA1705, PA-PLA1, SPG28" ENSG00000100523 "DDHD domain containing 1" Q8NEL9 14 53036745-53153323 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.0" "Cell type enhanced" "Detected in many" "Early spermatids: 280.9;Excitatory neurons: 140.5;Late spermatids: 146.3;Oligodendrocytes: 177.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049870 Enhanced NA NA "HPA049870: AB_2680925" "unprognostic (2.48e-1)" "unprognostic (1.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (8.14e-3)" "unprognostic (9.40e-2)" "unprognostic (4.91e-3)" "unprognostic (2.25e-2)" "unprognostic (8.07e-2)" "unprognostic (2.63e-1)" "unprognostic (3.24e-3)" "unprognostic (1.78e-1)" "unprognostic (4.67e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" 4.4 3.7 5.0 6.1 6.5 8.8 3.9 9.9 10.1 5.4 1.3 3.8 2.6 5.0 2.2 2.6 3.7 4.6 5.1 6.4 5.4 2.4 2.7 5.3 10.1 7.4 7.0 5.2 5.1 2.9 4.5 5.4 7.6 8.5 3.8 4.7 16.8 2.4 4.1 3.1 3.3 4.7 5.1 4.6 6.2 3.8 31.0 5.8 6.7 3.5 5.3 8.5 5.5 3.4 10.2 8.7 10.2 32.5 12.7 14.0 12.7 6.7 13.0 9.8 9.4 10.3 2.4 1.7 23.3 6.4 9.1 8.7 3.7 15.8 3.6 11.3 12.8 7.0 3.0 8.7 4.7 12.1 10.6 10.3 6.9 4.3 10.0 8.4 6.7 7.1 7.9 5.9 19.6 11.0 9.2 12.6 5.4 6.7 5.6 8.4 9.6 34.0 4.0 5.0 11.3 14.5 9.3 15.2 4.2 4.4 5.7 5.9 6.9 10.5 8.9 13.9 13.4 9.6 9.1 6.3 15.3 4.7 9.6 5.0 1.6 1.4 1.2 4.6 2.2 4.4 3.2 3.7 5.1 1.7 2.6 3.2 3.9 0.8 4.6 3.7 1.5 5.3 1.3 5.0 6.5 9.9 10.1 6.4 5.4 7.4 7.0 5.2 8.5 4.6 5.8 10.2 12.0 6.4 15.4 69.9 40.4 6.1 7.1 3.5 23.9 64.2 9.3 7.0 13.2 7.2 3.6 9.2 87.6 17.6 46.5 3.2 0.0 6.8 280.9 8.7 38.7 19.1 8.4 27.8 140.5 6.7 7.4 25.4 7.7 15.3 7.6 20.0 5.3 5.8 16.2 45.4 120.6 5.0 2.0 18.5 13.3 146.3 13.7 31.5 5.4 38.4 22.1 19.1 49.4 104.0 177.9 5.1 3.4 20.7 42.7 8.2 1.9 4.9 6.7 35.0 19.7 17.1 15.8 57.4 46.6 9.7 6.0 17.4 42.4 24.9 5.6 5.9 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 208.9" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 18.8" "Group enriched" "Detected in all" 6 "NK-cells: 6.4;T-cells: 18.8" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 3.4 1.6 2.8 12.3 3.1 43.7 3.4 5.5 4.4 1.7 3.7 14.1 12.5 2.8 0.4 10.2 1.4 2.9 5.0 3.2 3.7 1.5 2.4 2.1 28.6 2.9 3.3 3.0 1.3 1.1 0.5 1.6 6.7 3.3 1.6 17.1 2.6 3.4 0.7 3.0 6.0 12.7 7.5 2.8 4.9 5.1 208.9 3.7 31.2 1.8 4.2 30.2 5.8 4.1 4.0 276.7 102.5 74.0 78.2 12.5 15.3 46.5 63.1 97.0 135.8 146.9 81.8 136.5 139.9 44.4 96.7 135.9 195.9 114.6 78.3 245.6 169.5 59.3 65.8 69.0 126.8 10.1 86.2 47.6 5.4 4.9 84.3 138.3 44.4 88.4 129.8 36.1 162.2 159.8 186.9 118.1 67.9 27.9 254.7 216.4 72.7 66.6 29.7 70.5 56.9 30.6 42.0 118.7 67.4 52.5 54.6 142.9 69.4 33.0 59.2 195.8 91.7 155.0 38.6 47.4 91.4 98.6 120.4 110.9 0.0 1.3 1.3 1.6 1.7 0.7 2.1 5.5 4.8 1.8 0.9 2.9 2.3 1.0 6.4 1.2 1.5 18.8 3.1 2.8 3.1 5.5 4.4 3.2 3.7 2.9 3.3 3.0 3.3 2.8 3.7 4.0 1.4 0.0 0.0 0.7 10.5 9.3 4.3 9.7 4.6 3.2 6.4 11.6 9.7 0.0 2.4 1.8 2.1 42.6 2.7 7.3 0.0 3.5 2630.9 2.7 3.5 6.8 7.8 125.5 2.5 2.4 35.0 10.2 9.2 3.5 7.0 31.3 6.1 3.1 37.7 5.0 3.9 17.9 4.1 9.8 8.8 659.4 21.5 8.9 1.8 1.0 2.9 1.7 0.0 0.0 0.2 1.9 7.2 10.5 41.0 4.0 3.4 2.8 0.2 2.9 0.0 3.0 20.5 606.9 39.8 22.5 6.5 4.1 8.3 3.9 31.2 5.3 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423561-54441391 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Uncertain Vesicles NA NA Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (8.95e-4)" 73.9 62.2 42.8 51.4 44.6 37.6 74.4 46.1 49.9 60.3 57.6 87.7 100.3 50.0 51.2 73.2 67.6 75.1 85.4 43.2 52.2 80.7 234.8 47.1 61.7 46.8 44.5 39.9 44.4 42.2 60.3 41.5 58.9 45.9 57.8 96.0 60.8 50.1 57.6 59.4 36.3 86.1 68.8 48.8 34.1 45.8 37.4 43.5 56.7 65.5 96.3 79.6 96.0 39.7 52.1 233.4 141.3 113.8 129.2 301.0 380.9 107.8 276.8 348.6 232.0 264.4 86.5 316.4 289.7 180.2 209.2 141.6 226.5 208.3 200.3 287.5 111.9 124.5 112.1 80.9 152.8 303.6 136.5 90.2 314.4 244.3 217.1 304.0 236.8 221.3 117.7 111.5 95.5 262.4 138.4 151.5 102.9 84.2 266.3 281.3 114.8 191.8 97.3 264.2 171.4 95.5 106.3 163.4 127.8 316.7 104.8 197.5 144.9 143.7 194.7 192.9 165.4 167.8 59.7 138.8 141.2 235.9 115.3 176.5 5.3 84.6 10.7 32.5 66.8 54.8 64.3 57.3 47.0 86.0 55.2 75.1 52.1 20.9 44.0 53.7 48.4 65.1 96.6 42.8 44.6 46.1 49.9 43.2 52.2 46.8 44.5 39.9 45.9 48.8 43.5 52.1 41.1 35.3 60.6 14.7 64.9 105.7 86.2 186.1 141.7 41.9 69.2 64.0 85.6 50.1 79.8 46.0 20.9 95.7 48.1 98.8 90.1 89.3 44.4 54.8 57.9 72.3 104.4 65.0 26.9 62.3 123.4 90.3 52.5 32.8 197.3 32.4 70.3 140.0 115.5 67.3 34.8 91.5 99.7 102.8 80.0 17.0 60.0 73.5 83.6 9.4 110.3 59.9 35.0 17.6 22.5 65.6 96.6 65.8 84.0 92.0 149.9 164.7 79.9 45.1 46.0 60.5 68.1 68.7 64.1 144.9 110.0 70.9 69.3 68.4 123.0 91.4 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539292 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 145.4;Spermatocytes: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favorable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 9.8 9.3 20.4 3.9 20.7 8.0 12.1 22.1 26.0 9.2 20.8 10.8 5.4 11.1 13.9 6.0 11.3 5.9 11.8 20.2 21.7 14.7 7.9 7.6 6.1 21.2 21.3 19.7 10.1 13.2 12.9 12.8 7.1 20.7 11.4 6.9 13.7 8.5 11.0 19.4 4.1 8.5 8.7 21.8 8.6 9.8 22.5 20.8 5.7 12.8 12.6 5.3 10.2 7.5 22.2 10.4 8.6 9.7 8.6 16.7 10.6 7.3 9.5 10.2 14.6 15.2 8.7 11.7 5.9 11.9 8.2 15.8 9.1 10.8 8.4 18.5 11.9 8.7 8.3 1.7 10.6 20.1 4.6 4.4 10.9 16.7 11.0 18.1 9.6 10.6 9.3 3.3 7.6 13.6 19.0 4.9 7.2 6.0 9.5 15.3 10.8 12.3 2.9 11.8 13.3 6.4 6.3 8.3 3.9 16.1 8.7 11.3 4.2 9.3 18.2 14.3 7.2 8.7 5.0 6.4 8.5 10.0 5.6 12.0 61.9 12.4 22.6 19.1 15.4 18.7 18.2 19.9 20.2 10.4 19.4 20.0 18.6 12.5 20.3 19.0 9.0 22.3 19.7 20.4 20.7 22.1 26.0 20.2 21.7 21.2 21.3 19.7 20.7 21.8 20.8 22.2 20.3 9.6 11.5 21.5 22.6 7.6 17.4 26.7 16.5 18.6 18.3 18.7 22.1 14.3 17.3 16.5 10.4 14.7 21.8 17.5 23.5 21.6 145.4 13.7 15.1 20.3 10.7 4.2 14.2 16.9 11.5 22.3 5.6 13.1 29.2 12.7 18.9 10.6 17.0 11.8 13.8 9.1 28.5 14.8 10.3 41.5 16.8 24.8 16.0 12.2 15.5 29.4 16.5 17.1 24.3 17.7 13.1 22.6 11.5 16.8 15.6 27.3 22.6 15.9 19.7 17.0 25.0 112.2 36.0 10.0 3.4 12.0 24.0 12.3 11.0 14.0 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Metabolic proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 365.9;Proximal tubular cells: 365.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Yes No 19000 Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favorable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 43.8 117.1 104.7 32.5 113.6 29.1 44.3 101.8 120.7 35.9 107.3 53.4 40.8 34.6 73.1 97.5 48.5 39.1 137.8 113.6 115.9 131.0 52.1 37.9 33.6 105.3 106.5 110.2 26.4 36.5 89.6 66.3 43.8 112.4 56.2 58.0 78.7 45.5 50.2 79.1 39.6 42.0 46.8 104.5 24.5 44.2 42.8 109.5 52.9 90.3 109.5 46.7 55.0 54.5 120.3 242.5 64.7 96.2 62.4 80.2 82.8 73.5 199.1 109.4 145.8 109.1 76.2 85.2 24.8 73.9 155.1 105.3 89.2 72.6 117.9 195.7 82.5 50.8 23.4 74.5 51.0 144.0 24.9 64.8 65.1 77.7 105.4 73.1 131.4 97.6 58.6 50.2 55.3 206.6 78.5 66.5 46.2 60.7 104.6 83.3 48.8 84.2 32.8 171.2 104.3 120.2 49.8 122.9 65.4 145.6 96.2 98.3 53.4 123.8 162.4 121.6 77.6 120.1 55.8 46.1 33.4 150.2 44.1 96.1 106.7 77.5 92.8 48.5 78.8 40.8 39.9 53.2 52.7 83.4 42.0 41.6 41.7 94.0 48.9 83.5 73.9 78.8 65.0 104.7 113.6 101.8 120.7 113.6 115.9 105.3 106.5 110.2 112.4 104.5 109.5 120.3 31.3 54.5 63.0 13.4 27.6 96.2 66.6 112.3 26.2 60.0 44.8 41.8 160.8 55.8 85.0 82.8 54.2 92.3 51.4 91.6 365.9 125.9 190.3 120.8 44.1 40.7 54.4 78.1 22.7 48.9 85.5 51.5 42.3 71.8 41.2 39.8 27.5 45.8 132.0 87.5 21.0 49.4 175.0 44.6 61.0 97.9 32.9 62.2 80.0 6.5 58.5 89.4 47.4 9.5 22.1 121.5 78.7 50.8 21.3 65.9 80.9 365.5 184.1 94.2 13.1 44.5 64.1 100.1 61.5 78.4 138.4 205.9 40.8 71.6 40.6 113.8 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469300-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.7;kidney: 85.4;liver: 37.1;pancreas: 34.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 57.0;Distal tubular cells: 68.4;Proximal tubular cells: 191.8" "Cancer enriched" "Detected in many" 5 "renal cancer: 25.1" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "A549: 11.5;RPTEC TERT1: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.4 0.5 0.6 0.6 0.0 1.1 0.7 0.7 0.0 0.2 1.5 0.5 1.9 0.1 27.7 16.9 0.2 0.4 0.4 85.4 37.1 0.1 0.1 0.9 0.5 0.4 0.1 34.3 0.0 0.0 0.0 1.0 0.1 0.1 0.1 0.0 1.5 0.2 0.6 0.2 0.0 0.4 0.1 0.4 0.1 0.6 0.0 0.2 0.0 0.0 0.2 0.0 1.7 0.0 11.5 0.0 0.0 0.0 0.6 0.2 0.1 0.1 0.0 0.0 1.1 0.9 0.1 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.4 0.3 0.2 0.2 0.0 0.2 0.1 0.0 0.2 34.3 0.4 0.1 0.0 0.1 0.1 0.0 0.3 0.2 0.5 0.3 0.4 0.5 0.1 0.0 0.3 0.3 0.3 1.6 0.4 0.0 1.7 0.3 0.2 0.7 0.1 0.9 0.6 1.4 1.0 0.0 1.2 1.2 1.9 1.5 1.0 0.3 0.5 2.2 1.9 0.4 0.6 1.1 0.7 0.4 0.4 0.9 0.5 0.4 1.0 0.4 0.6 1.7 0.0 3.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.1 0.0 68.4 22.2 0.0 19.7 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.1 0.0 0.0 191.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386984-67412167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1" "Lineage enriched" "Detected in single" 7 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001208 Enhanced Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavorable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 0.6 51.5 0.2 5.5 0.3 12.8 3.9 0.8 0.6 2.2 0.2 25.3 29.8 1.5 32.6 16.6 1.7 3.9 0.3 0.3 0.2 8.6 29.9 1.7 0.2 0.2 0.2 0.1 0.6 8.0 7.0 1.3 1.5 0.3 7.8 28.9 0.1 6.9 4.3 0.3 26.7 32.9 1.3 0.1 0.6 20.8 3.2 0.3 23.1 23.7 0.2 5.5 12.2 8.0 0.5 91.0 13.4 0.0 0.1 0.0 1.0 8.4 17.9 2.7 4.2 5.2 48.8 94.4 0.0 17.3 2.5 0.2 42.4 0.1 177.4 9.6 0.1 0.7 0.0 19.4 0.4 3.8 0.0 0.0 1.9 12.3 4.6 55.4 0.0 14.8 0.0 0.4 0.4 3.0 28.9 0.0 0.2 0.3 57.4 64.1 0.0 0.1 14.0 30.0 2.4 0.7 0.2 17.0 7.9 5.2 0.9 11.6 0.9 69.3 0.0 54.1 0.3 0.4 0.3 0.2 0.3 10.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.4 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.8 0.6 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.3 0.5 0.1 0.0 1.1 1.0 0.6 149.0 29.0 69.9 37.0 0.0 4.9 6.0 0.5 10.0 11.8 5.5 0.0 1.0 0.0 25.0 3.9 42.1 0.1 2.3 0.2 2.0 8.4 16.0 0.8 46.3 5.5 4.2 37.2 2.2 0.0 24.0 0.0 11.5 6.8 0.0 0.6 68.5 26.4 1.3 57.1 0.3 0.3 7.4 21.4 0.0 5.2 0.0 0.0 0.5 0.3 179.8 23.9 0.0 0.0 15.8 47.9 3.2 4.5 0.0 0.0 0.0 4.6 0.4 2.3 21.2 90.6 1.5 1.3 107.7 54.8 25.5 PIGH GPI-H ENSG00000100564 "Phosphatidylinositol glycan anchor biosynthesis class H" Q14442 14 67581955-67600286 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autism spectrum disorder, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Muller glia cells: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031624 Approved NA NA "HPA031624: AB_10601046" "unprognostic (1.59e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (3.47e-2)" "unprognostic (8.25e-3)" "unprognostic (8.69e-3)" "unprognostic (3.26e-3)" "unprognostic (1.19e-1)" "unprognostic (2.73e-1)" "unprognostic (6.17e-3)" "unprognostic (1.39e-1)" "prognostic favorable (2.68e-7)" "unprognostic (7.42e-2)" "unprognostic (1.42e-2)" "unprognostic (7.00e-2)" "unprognostic (3.73e-1)" 15.4 34.5 21.2 8.3 23.7 27.5 19.4 24.5 26.6 26.1 22.4 14.1 12.7 14.1 36.9 14.1 15.6 13.7 14.8 20.5 23.3 35.0 24.1 13.8 12.0 24.3 23.2 20.4 24.0 29.4 67.3 13.7 12.6 24.6 29.2 11.7 48.0 26.4 16.2 32.5 20.0 16.2 11.0 24.2 16.6 19.8 20.8 23.9 12.0 29.0 24.9 13.5 16.6 14.5 28.3 24.5 15.6 14.7 30.3 32.1 12.3 12.4 13.3 16.1 18.2 17.7 25.4 8.3 16.5 12.9 9.1 30.4 17.5 26.3 18.9 20.1 25.4 34.8 17.3 12.4 26.1 25.2 12.8 19.9 17.9 23.8 13.7 21.0 5.6 11.8 28.5 39.7 11.5 13.3 21.4 18.8 21.4 2.7 33.8 41.9 6.3 14.8 9.9 19.6 20.0 18.3 22.1 10.1 19.4 33.8 10.8 22.0 12.5 6.1 18.1 23.2 23.8 15.8 21.9 15.2 11.2 13.9 27.1 25.7 42.0 24.8 52.5 44.9 35.1 58.5 61.8 46.5 41.8 25.4 72.0 48.3 45.0 12.1 51.5 45.7 29.6 48.2 35.0 21.2 23.7 24.5 26.6 20.5 23.3 24.3 23.2 20.4 24.6 24.2 23.9 28.3 14.8 3.2 14.1 5.5 23.6 20.6 20.4 37.1 19.4 35.5 22.8 25.9 4.9 22.8 17.8 22.0 35.5 29.8 28.7 9.5 29.4 22.3 12.1 20.3 10.5 16.1 7.2 13.2 8.0 37.1 28.7 20.8 9.2 10.9 7.0 13.4 13.9 14.6 22.7 26.9 10.4 14.9 26.4 7.6 12.9 9.4 21.5 12.3 35.6 7.5 7.0 96.6 23.7 8.5 10.3 24.3 10.6 21.1 31.2 26.8 29.4 31.3 12.2 45.5 0.0 22.7 18.7 78.8 59.5 17.7 20.9 56.4 20.7 34.6 14.1 18.2 LRRC74A "C14orf166B, LRRC74" ENSG00000100565 "Leucine rich repeat containing 74A" Q0VAA2 14 76826372-76870302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 3.9" "Group enriched" "Detected in some" 84 "Early spermatids: 58.0;Late spermatids: 111.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035094 Uncertain NA NA "HPA035094: AB_10600793" "unprognostic (7.71e-3)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-1)" "unprognostic (5.29e-3)" "unprognostic (3.22e-1)" "unprognostic (1.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.11e-2)" "unprognostic (5.21e-4)" "unprognostic (1.72e-1)" "unprognostic (9.96e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 111.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PSMA3 HC8 ENSG00000100567 "Proteasome 20S subunit alpha 3" P25788 14 58244843-58272012 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000905 Approved NA NA 9700000 "HPA000905: AB_1079702" "unprognostic (3.60e-1)" "unprognostic (4.81e-3)" "unprognostic (1.17e-1)" "unprognostic (2.19e-2)" "unprognostic (4.91e-1)" "unprognostic (5.79e-2)" "unprognostic (1.97e-3)" "unprognostic (1.27e-1)" "unprognostic (7.92e-2)" "unprognostic (7.36e-3)" "unprognostic (1.65e-2)" "unprognostic (7.57e-2)" "unprognostic (1.83e-3)" "unprognostic (2.33e-2)" "unprognostic (6.47e-2)" "prognostic favorable (2.91e-4)" "unprognostic (2.16e-1)" 74.7 89.4 53.4 85.5 56.1 83.6 82.9 57.5 62.4 60.1 57.5 77.5 82.1 55.9 128.7 76.4 58.4 61.3 95.5 53.4 64.3 95.2 163.5 69.6 105.0 56.8 55.5 52.6 40.8 55.9 73.5 46.9 91.6 56.2 61.5 83.7 48.7 55.2 77.1 172.0 53.5 74.9 79.3 57.1 67.1 61.5 41.6 54.7 109.6 75.5 131.6 97.7 103.5 49.1 60.6 359.2 214.3 215.1 179.2 166.4 154.3 277.8 187.2 209.3 257.4 256.8 317.8 294.2 304.1 330.9 171.3 202.4 243.9 249.2 200.9 299.7 262.3 148.9 208.5 150.9 360.8 314.2 340.4 170.0 132.8 142.2 179.2 169.1 151.7 307.2 242.0 201.3 174.6 209.3 400.4 299.7 314.4 144.9 286.8 328.3 249.3 279.6 222.7 377.5 339.7 202.9 100.3 167.5 261.8 189.5 201.6 273.3 244.9 198.3 148.4 287.1 167.6 249.4 68.4 137.3 314.1 215.7 260.2 184.1 95.3 78.9 52.0 71.2 98.9 92.2 85.8 87.1 86.0 91.8 61.9 69.5 80.8 48.2 94.1 85.6 122.4 112.6 95.5 53.4 56.1 57.5 62.4 53.4 64.3 56.8 55.5 52.6 56.2 57.1 54.7 60.6 132.9 118.6 119.2 21.9 93.7 118.7 169.6 418.7 71.2 43.5 69.2 77.6 117.0 71.4 195.7 88.3 35.5 387.5 104.5 83.3 166.3 241.3 24.7 127.6 95.6 137.7 64.4 60.6 27.6 231.1 269.2 108.5 59.1 109.1 95.7 412.6 66.4 145.4 184.0 42.1 29.1 103.8 250.3 59.2 77.5 27.4 109.3 89.4 108.5 26.2 206.0 87.3 84.5 32.6 33.6 192.9 89.0 106.1 118.4 167.5 108.9 297.5 157.4 68.6 98.6 83.7 279.6 109.3 66.9 89.8 106.0 403.5 99.3 104.9 108.4 171.6 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 54.3 27.1 59.2 20.6 60.5 22.5 40.2 58.3 102.9 21.0 54.2 39.6 28.6 18.5 54.0 44.8 18.7 29.0 57.2 59.7 61.2 53.5 41.9 27.1 24.0 59.5 60.2 57.4 21.2 44.3 24.1 17.2 21.5 61.2 22.5 35.5 23.2 30.3 13.8 46.9 29.7 24.3 22.6 59.9 26.7 40.3 31.1 59.8 12.2 34.3 28.5 27.2 33.6 23.6 61.1 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 59.2 60.5 58.3 102.9 59.7 61.2 59.5 60.2 57.4 61.2 59.9 59.8 61.1 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408495-58427531 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria NA NA 78000 Mitochondria "HPA002932: AB_1080287" "prognostic favorable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 42.5 36.1 26.7 18.2 28.4 21.5 40.9 30.9 40.0 37.0 29.3 39.3 23.2 33.9 35.9 30.1 36.4 24.2 34.7 27.4 30.5 39.1 32.1 24.2 28.7 28.0 28.7 27.2 48.7 76.3 21.4 27.9 22.5 28.7 32.4 18.2 28.4 36.1 20.7 66.6 32.6 27.0 27.0 28.3 26.3 37.4 22.6 28.2 19.0 30.4 23.8 25.3 39.5 31.7 32.0 71.0 56.7 45.8 46.6 53.0 99.6 63.0 67.6 38.3 55.0 48.7 60.3 74.3 100.4 73.1 38.8 45.2 48.0 63.9 67.0 76.3 68.0 38.5 53.0 36.2 68.8 129.1 78.5 45.6 77.1 86.5 51.4 100.4 80.2 54.4 47.2 82.0 57.8 53.9 120.3 75.5 101.0 38.2 106.2 98.8 63.3 73.8 58.9 70.3 63.1 60.3 34.3 44.6 109.7 126.7 55.2 78.0 45.1 57.4 63.0 87.0 41.4 73.8 40.4 43.1 91.8 50.0 79.1 76.8 8.8 14.8 4.0 14.3 17.0 26.3 28.5 22.5 21.4 21.4 22.3 28.5 27.3 1.6 27.8 19.2 23.2 25.2 12.5 26.7 28.4 30.9 40.0 27.4 30.5 28.0 28.7 27.2 28.7 28.3 28.2 32.0 26.8 32.1 20.0 12.7 40.5 35.3 46.4 47.6 38.7 15.9 44.2 55.2 20.7 32.9 26.0 14.7 22.9 80.1 30.7 12.2 72.4 39.1 36.7 21.4 38.5 33.6 25.2 35.3 14.2 54.1 92.9 32.2 25.5 21.9 36.8 36.6 39.7 33.0 61.2 5.0 15.4 43.2 24.4 47.9 29.9 32.7 74.3 30.0 33.8 3.7 47.6 31.6 39.1 8.5 12.2 38.2 30.5 51.6 33.8 57.3 35.3 117.7 15.0 24.0 19.7 49.7 32.3 78.8 22.1 39.2 39.6 73.5 29.9 56.9 53.4 42.8 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320996-77331597 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 265.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 373.2;Late spermatids: 398.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 182.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol NA NA 340000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favorable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 13.9 35.0 12.6 9.8 13.9 9.4 23.4 14.9 15.3 12.8 11.7 22.1 22.7 10.8 22.2 27.1 15.1 12.0 10.8 12.0 13.1 23.5 265.2 7.9 13.7 14.8 13.3 12.1 6.5 20.3 26.6 13.4 11.3 15.2 21.2 21.9 5.1 24.3 9.7 47.8 21.6 15.7 8.0 14.1 12.2 19.1 58.2 13.3 14.1 19.7 37.6 17.6 12.1 13.9 15.5 18.8 39.0 27.6 19.9 17.1 23.9 45.8 11.4 11.9 21.6 30.9 13.0 45.2 43.5 14.9 13.6 13.4 24.1 18.9 22.5 20.7 23.2 21.0 20.8 13.3 26.9 26.3 7.8 15.8 22.1 24.0 12.4 20.8 12.0 18.6 24.7 17.5 37.0 14.5 182.1 12.2 16.4 8.2 64.1 30.3 20.2 29.5 34.2 32.5 24.0 30.2 26.2 26.0 49.1 35.6 15.5 81.2 11.1 13.8 17.0 52.5 18.9 8.6 28.2 32.7 35.2 41.9 11.3 20.8 13.4 15.5 9.9 2.6 22.2 2.4 8.2 4.6 3.7 20.7 10.4 3.9 3.1 1.6 5.1 20.1 15.0 7.9 7.4 12.6 13.9 14.9 15.3 12.0 13.1 14.8 13.3 12.1 15.2 14.1 13.3 15.5 6.1 6.4 9.6 6.5 13.5 13.4 19.8 26.2 15.9 7.3 36.1 34.2 13.0 47.1 19.0 9.2 4.2 91.4 7.5 34.9 46.9 45.0 125.8 19.4 15.6 11.1 28.8 30.3 2.9 68.0 62.5 15.0 33.1 27.0 3.8 25.7 15.4 373.2 44.6 16.8 3.3 45.7 20.3 38.1 10.9 398.1 11.8 19.0 17.8 3.7 30.4 26.4 4.1 2.0 9.2 41.8 37.4 6.0 13.2 19.8 72.9 77.8 15.0 11.9 0.0 12.3 13.2 51.3 29.4 38.0 14.1 76.2 6.7 55.8 50.3 30.3 KIAA0586 "JBTS23, Talpid3" ENSG00000100578 KIAA0586 Q9BVV6 14 58427385-58551297 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Early spermatids: 142.0;Late spermatids: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000846, HPA050249" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000846: AB_2234167, HPA050249: " "unprognostic (1.90e-1)" "unprognostic (7.85e-2)" "unprognostic (2.98e-2)" "unprognostic (6.88e-2)" "unprognostic (4.99e-2)" "unprognostic (1.76e-3)" "unprognostic (4.82e-3)" "unprognostic (1.13e-1)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.20e-4)" "unprognostic (8.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.41e-1)" "unprognostic (1.13e-1)" 5.0 5.1 4.5 4.8 4.9 5.5 5.7 6.1 7.2 4.9 4.5 4.9 3.3 4.3 6.2 5.1 4.4 4.9 4.6 4.3 4.8 3.9 6.5 4.2 7.5 5.0 5.0 4.6 6.1 4.1 6.1 7.2 3.8 5.1 5.2 6.1 8.0 4.3 4.6 5.9 5.3 4.5 6.3 4.7 5.5 3.9 16.5 4.9 12.5 4.9 6.1 7.1 5.7 4.8 6.6 21.1 14.0 20.2 9.7 16.4 15.6 8.7 17.3 16.3 15.1 15.7 6.0 11.3 23.4 11.4 14.8 6.2 12.3 19.1 10.9 24.8 16.8 6.9 17.9 11.1 18.2 11.2 27.6 15.3 10.5 4.6 11.2 17.7 7.2 19.9 22.3 18.0 12.4 28.4 13.5 16.9 11.4 8.7 10.7 22.8 20.5 23.5 14.6 10.9 8.8 11.1 8.4 18.4 12.3 8.9 10.8 14.7 14.4 18.8 23.4 18.4 12.9 14.5 7.4 9.5 19.0 16.2 21.8 13.7 13.2 2.0 5.0 7.0 2.1 5.6 6.3 6.6 5.3 2.6 6.8 8.5 6.1 2.0 9.7 3.2 3.3 7.1 2.6 4.5 4.9 6.1 7.2 4.3 4.8 5.0 5.0 4.6 5.1 4.7 4.9 6.6 17.9 12.8 14.5 29.4 20.9 3.2 6.1 6.2 12.5 30.5 10.1 9.8 14.1 7.2 9.3 9.2 81.3 7.5 20.1 5.9 5.9 6.5 142.0 18.5 19.6 13.9 10.7 22.1 52.0 5.2 8.4 14.5 16.8 11.0 21.5 15.2 9.3 4.7 9.5 32.0 56.7 8.5 10.2 7.9 2.8 108.1 10.2 10.8 8.8 27.2 10.6 17.0 14.4 47.3 73.9 5.9 3.0 12.0 20.6 4.3 4.3 7.7 20.0 51.0 0.0 19.7 12.3 61.6 23.9 12.4 4.5 4.8 24.4 15.7 7.3 3.3 TMED8 FAM15B ENSG00000100580 "Transmembrane p24 trafficking protein family member 8" Q6PL24 14 77335029-77377094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 62.7;Cone photoreceptor cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001205 Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA001205: AB_2204460" "unprognostic (1.07e-1)" "unprognostic (4.70e-2)" "unprognostic (4.85e-2)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.23e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (2.77e-1)" 5.6 8.4 8.2 8.7 8.6 7.8 5.7 5.1 8.9 6.0 4.3 4.4 3.4 6.8 5.1 3.6 5.5 4.2 3.5 7.4 14.8 10.5 3.5 4.6 17.6 8.1 9.2 6.9 7.4 5.7 11.2 9.3 4.5 9.1 5.9 4.8 24.4 4.5 6.0 2.3 5.0 5.5 5.7 6.6 8.1 6.2 6.8 11.1 9.9 11.0 2.4 19.6 4.8 3.5 7.5 14.7 12.0 13.9 12.4 8.5 7.6 11.8 9.2 6.0 9.4 10.1 7.5 8.1 58.7 7.5 7.5 7.7 10.0 10.4 10.5 14.6 18.6 6.3 19.6 9.5 7.9 5.9 9.6 51.8 8.0 7.4 12.3 11.0 9.5 13.5 47.7 10.1 15.4 9.5 14.4 15.2 14.2 6.9 10.7 12.0 12.2 12.7 4.7 9.9 9.0 17.2 10.4 15.9 9.4 11.8 10.6 15.2 15.9 9.7 9.7 6.2 17.5 10.7 12.3 25.2 28.9 11.1 17.7 14.3 2.3 0.7 2.2 0.3 0.9 0.4 2.1 0.5 0.4 0.6 2.1 0.3 0.5 1.0 0.5 0.8 1.0 0.7 0.5 8.2 8.6 5.1 8.9 7.4 14.8 8.1 9.2 6.9 9.1 6.6 11.1 7.5 6.6 3.2 7.8 62.7 33.9 6.6 4.9 7.7 2.8 33.4 12.5 8.3 16.8 8.6 5.3 22.0 108.4 10.5 7.9 6.5 5.9 6.4 4.8 9.8 15.5 10.4 44.3 15.4 44.7 4.7 10.0 8.4 7.1 9.0 0.0 9.1 8.9 9.8 7.8 28.6 40.7 6.3 10.2 24.8 7.7 6.9 14.6 19.8 5.4 21.5 16.8 14.9 6.2 39.7 24.2 6.8 3.3 14.3 19.9 7.5 3.2 22.2 20.9 39.3 13.1 7.1 8.4 6.8 15.7 8.2 8.9 4.1 10.3 19.8 6.7 4.3 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 15.4;testis: 17.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 62.6;Early spermatids: 81.8;Endometrial ciliated cells: 38.8;Late spermatids: 111.7;Respiratory ciliated cells: 41.5;Rod photoreceptor cells: 75.7;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.5 0.8 4.9 0.3 2.7 0.6 1.0 0.9 1.7 0.7 6.5 0.2 0.3 1.0 5.4 0.2 4.6 1.1 0.1 2.0 3.0 1.9 0.1 0.8 1.4 2.6 3.1 1.4 0.7 2.0 2.4 2.4 0.3 1.9 0.7 0.3 15.4 0.3 0.7 0.2 0.5 0.2 0.3 1.9 0.2 0.4 17.8 2.1 0.4 4.0 0.0 1.4 0.8 0.2 1.2 2.5 3.4 1.3 2.7 0.3 1.4 1.2 1.0 0.9 2.6 2.3 2.5 2.2 2.8 1.1 1.0 2.3 2.4 0.9 1.4 3.7 0.2 0.5 0.4 1.0 0.6 0.1 0.5 2.9 1.3 0.9 2.3 0.2 1.1 1.8 1.4 0.3 0.7 1.1 7.6 0.6 0.2 0.5 0.6 1.0 1.2 1.2 0.1 4.6 1.4 2.8 1.8 3.5 0.5 0.5 0.5 4.3 0.8 0.7 2.5 1.4 2.6 1.3 0.4 2.4 1.8 3.1 0.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 2.7 0.9 1.7 2.0 3.0 2.6 3.1 1.4 1.9 1.9 2.1 1.2 0.7 0.0 0.0 1.0 0.3 0.3 0.5 0.6 0.0 11.2 0.9 0.9 1.9 2.8 1.8 0.0 62.6 0.3 0.8 0.7 1.9 2.8 81.8 38.8 4.6 0.5 3.6 0.0 1.3 0.6 0.2 1.0 0.0 1.4 0.0 1.3 0.4 0.0 0.1 3.3 0.6 0.5 0.0 0.0 0.0 111.7 1.5 0.3 0.0 0.0 0.1 5.5 0.0 0.5 0.4 0.9 0.1 0.0 0.0 0.2 0.0 3.5 41.5 75.7 0.0 1.0 1.0 59.3 7.3 0.0 0.0 0.3 0.3 6.0 0.1 0.3 AHSA1 "Aha1, C14orf3, hAha1, p38" ENSG00000100591 "Activator of HSP90 ATPase activity 1" O95433 14 77457870-77469472 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000903, CAB006244" Supported Supported Cytosol NA NA 120000 Cytosol "CAB006244: AB_425858, HPA000903: AB_1078112" "unprognostic (3.91e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (3.48e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (5.04e-6)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.88e-1)" "unprognostic (2.63e-2)" "unprognostic (2.16e-2)" "unprognostic (1.33e-1)" "unprognostic (3.06e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-1)" 62.6 99.9 154.8 52.3 146.0 51.4 55.9 150.9 274.8 63.8 147.4 78.4 45.2 80.8 72.9 73.2 121.9 39.7 109.2 158.3 146.8 65.1 72.4 61.3 72.2 155.3 152.8 140.8 70.3 50.7 66.0 67.2 77.2 163.8 65.0 72.5 39.4 57.2 71.0 141.4 59.6 55.4 85.7 155.9 56.2 62.4 100.2 161.7 65.8 47.5 119.4 92.1 77.5 61.7 183.1 185.0 356.7 103.1 131.9 159.1 110.3 175.1 131.2 111.6 223.0 165.3 277.0 163.4 361.3 103.0 145.1 258.4 204.7 386.2 186.5 231.8 131.8 207.5 156.1 181.6 343.3 113.7 102.6 230.8 98.3 244.9 150.7 72.2 133.1 209.9 225.3 205.5 115.6 138.5 522.6 278.6 207.8 170.6 347.7 372.9 210.2 110.3 178.1 178.2 187.1 155.0 161.4 119.2 302.9 115.8 154.4 174.4 152.6 100.3 115.3 162.1 126.2 198.7 103.7 241.6 273.8 169.1 211.3 131.1 82.7 51.5 67.9 66.4 74.0 76.9 81.0 59.8 68.0 67.2 63.7 69.0 70.6 39.8 88.7 92.5 66.4 77.2 52.2 154.8 146.0 150.9 274.8 158.3 146.8 155.3 152.8 140.8 163.8 155.9 161.7 183.1 46.6 35.3 21.6 10.1 59.4 156.0 208.2 82.8 74.0 36.0 49.9 46.6 92.2 42.9 57.0 27.6 85.5 153.4 66.8 60.0 74.3 74.2 40.6 112.6 60.8 54.9 78.3 55.8 14.6 48.8 113.3 68.3 25.5 59.6 76.2 55.2 28.9 41.0 93.5 18.5 14.7 70.5 65.1 26.7 117.5 34.2 67.7 52.6 90.7 12.2 58.5 46.6 61.8 10.1 23.6 67.8 65.6 66.5 54.1 145.4 56.4 87.0 132.2 54.1 98.6 46.9 135.0 92.0 57.3 67.7 140.1 136.7 92.3 86.0 85.2 120.1 DAAM1 KIAA0666 ENSG00000100592 "Dishevelled associated activator of morphogenesis 1" Q9Y4D1 14 59188646-59371405 "Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026605, HPA064789" Uncertain Approved "Plasma membrane,Cytosol" NA NA 9700 "Plasma membrane, Cytosol" "HPA026605: AB_1847464, HPA064789: AB_2685352" "unprognostic (2.81e-1)" "unprognostic (9.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-1)" "unprognostic (1.76e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.01e-2)" "unprognostic (3.29e-1)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" 14.6 6.3 13.6 6.8 14.4 5.4 10.5 13.1 13.8 13.0 19.9 11.1 4.8 13.6 5.6 19.1 7.8 6.0 18.8 12.3 15.3 7.0 12.8 10.6 11.2 8.7 8.4 11.2 8.0 9.4 20.8 5.3 9.2 9.0 12.0 8.6 25.1 9.5 11.1 5.6 31.2 7.3 11.0 8.8 13.2 7.1 7.0 9.4 4.9 7.5 4.7 15.7 9.6 15.2 11.7 18.2 1.9 13.1 3.5 7.8 5.8 17.1 2.5 2.3 4.7 4.8 9.4 16.6 20.4 4.4 5.6 9.6 39.7 11.8 10.0 4.0 9.0 4.1 6.8 4.8 11.8 4.8 7.9 3.8 3.9 10.6 3.9 4.7 10.8 11.3 10.2 11.9 9.9 2.8 17.0 6.9 4.9 7.5 12.9 5.6 6.3 11.1 2.0 6.8 13.5 20.3 4.8 15.8 23.1 16.1 8.7 30.5 2.1 10.8 3.9 7.4 8.4 2.2 2.2 2.7 22.1 5.0 1.5 8.7 7.7 2.0 2.6 2.3 2.4 3.0 10.8 3.0 2.3 2.2 4.6 2.4 2.6 2.8 6.7 3.5 18.3 4.0 1.9 13.6 14.4 13.1 13.8 12.3 15.3 8.7 8.4 11.2 9.0 8.8 9.4 11.7 62.2 35.3 27.0 160.6 37.8 467.3 172.4 128.6 30.7 110.7 56.8 40.6 149.3 38.6 82.3 29.5 308.6 33.0 66.9 47.0 23.5 63.8 40.0 68.4 142.9 71.9 87.7 140.0 143.7 93.1 27.6 67.3 21.9 54.6 26.0 155.2 102.4 47.2 32.8 195.2 202.0 56.7 73.2 16.3 55.8 16.6 60.3 36.1 90.7 66.5 25.2 96.5 16.5 74.9 24.3 191.4 45.1 74.1 30.8 104.2 24.7 12.8 102.4 168.7 32.9 84.6 66.3 51.3 46.3 52.8 332.0 34.2 25.1 25.1 38.1 84.2 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498816 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "placenta: 215.2" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 291.0;Extravillous trophoblasts: 617.2;Syncytiotrophoblasts: 177.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 386.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA 1100000 Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.3 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.6 0.7 0.7 0.2 0.1 1.2 3.7 0.2 0.4 0.1 0.0 0.3 0.6 0.6 0.0 0.0 0.0 0.4 0.4 0.3 0.1 0.6 0.4 0.5 215.2 0.3 1.9 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.6 0.6 0.0 0.2 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 386.3 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.5 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 291.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.4 0.0 617.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 33.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 1.7 0.0 0.0 177.5 0.0 0.0 0.0 0.0 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616637 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favorable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 17.8 12.3 14.8 12.8 25.6 34.0 18.5 23.7 20.1 15.3 10.9 18.7 14.6 10.6 7.6 23.0 14.3 12.0 6.8 15.5 20.4 17.8 7.8 13.2 12.1 28.1 22.4 12.2 10.5 5.7 10.7 6.3 20.6 30.2 8.5 20.0 14.3 13.8 8.8 3.9 12.3 17.5 11.7 27.3 19.8 20.6 5.1 23.3 10.4 11.0 6.1 13.4 15.1 10.9 53.1 28.9 18.5 14.1 15.5 14.3 17.8 23.7 41.7 30.8 28.2 29.3 23.7 62.3 28.8 10.4 42.7 14.5 34.7 38.1 23.7 42.5 12.6 11.0 82.5 13.4 14.3 12.1 8.4 25.8 11.7 11.4 18.4 20.4 16.3 40.6 19.4 16.2 13.5 16.2 24.9 22.2 28.7 9.2 45.4 16.8 23.5 14.3 10.0 32.9 63.4 13.6 17.1 15.0 50.3 15.8 24.7 61.8 15.3 25.9 25.7 18.2 9.6 9.7 7.6 13.4 19.1 17.3 29.4 14.8 18.3 31.3 27.1 6.1 24.2 5.7 6.7 5.1 6.8 31.2 7.9 3.5 5.8 19.1 17.7 31.8 11.1 6.0 13.4 14.8 25.6 23.7 20.1 15.5 20.4 28.1 22.4 12.2 30.2 27.3 23.3 53.1 125.1 28.9 27.3 24.8 27.3 32.4 28.3 27.0 15.4 15.7 24.3 18.4 8.9 15.7 30.7 47.8 35.5 11.9 28.3 37.6 1.9 24.0 1.6 44.1 36.0 53.1 13.2 51.3 31.2 16.1 12.3 18.9 43.3 36.0 51.3 37.2 68.2 7.2 25.1 5.0 29.5 39.3 20.3 75.9 19.8 1.7 14.6 66.2 19.6 83.4 51.3 8.8 32.0 59.3 164.0 35.0 30.4 15.8 11.0 27.0 28.4 8.8 33.5 20.0 32.9 10.5 25.5 7.3 19.0 37.7 29.1 6.6 23.3 14.6 33.0 60.0 RIN3 FLJ22439 ENSG00000100599 "Ras and Rab interactor 3" Q8TB24 14 92513781-92688994 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 46.8" "Cell type enhanced" "Detected in many" "Kupffer cells: 125.1;Macrophages: 78.7;Microglial cells: 100.2;monocytes: 109.8;NK-cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 35.7;classical monocyte: 43.4;eosinophil: 54.1;intermediate monocyte: 40.4;myeloid DC: 41.6;neutrophil: 40.2;NK-cell: 21.5;non-classical monocyte: 50.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "HMC-1: 108.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA079218 Approved NA NA 7400 "HPA079218: " "unprognostic (1.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.93e-1)" "unprognostic (1.87e-1)" "unprognostic (7.18e-2)" "unprognostic (6.40e-2)" "unprognostic (2.44e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (3.07e-3)" "unprognostic (5.69e-3)" "unprognostic (5.13e-2)" "unprognostic (5.90e-3)" "unprognostic (2.88e-2)" "unprognostic (6.95e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" 10.4 13.7 3.4 9.7 3.4 46.8 8.2 3.9 6.4 6.5 3.3 16.0 6.6 15.5 1.6 6.7 8.8 8.1 7.8 3.8 7.2 4.5 12.5 16.4 6.1 9.0 4.7 1.1 6.8 2.2 5.4 2.8 6.5 6.3 7.1 4.9 0.2 5.1 5.1 3.2 4.8 9.8 10.3 6.2 23.0 6.4 5.2 7.7 11.0 5.0 3.0 5.3 10.7 8.6 6.6 10.3 19.8 4.4 1.7 1.7 14.3 15.0 12.9 14.0 12.0 8.0 7.5 17.5 0.0 12.1 19.1 8.2 22.0 3.1 0.1 5.5 10.6 3.9 21.4 1.5 8.1 8.7 6.9 108.1 8.1 7.7 11.5 4.8 4.7 7.1 2.6 3.1 0.5 5.0 6.5 3.3 16.3 2.7 1.1 6.0 2.7 2.1 0.2 4.9 6.9 1.0 0.0 6.2 2.1 9.5 4.3 0.1 2.5 12.5 13.8 10.8 20.1 10.9 3.1 0.0 0.2 13.5 0.3 18.1 35.7 43.4 54.1 10.1 40.4 3.4 7.8 4.7 4.9 41.6 8.5 6.8 7.7 40.2 21.5 50.8 1.8 3.0 24.5 3.4 3.4 3.9 6.4 3.8 7.2 9.0 4.7 1.1 6.3 6.2 7.7 6.6 19.2 0.0 8.9 18.3 28.2 3.8 2.0 3.4 0.6 2.2 3.7 5.5 4.7 1.5 2.2 0.0 0.0 5.1 44.0 9.2 0.0 1.6 10.2 2.2 3.5 15.4 0.0 12.6 6.9 1.4 3.1 4.2 1.1 2.6 51.4 5.4 8.2 14.9 49.3 0.0 5.2 7.3 4.1 125.1 50.8 6.6 5.3 78.7 12.4 100.2 109.8 0.0 114.4 20.6 0.9 10.1 3.8 18.8 9.7 3.8 9.5 6.2 2.5 0.3 13.1 10.1 4.6 19.1 4.0 1.1 2.7 12.7 32.5 1.9 8.9 3.6 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748679 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "plasmacytoid DC: 209.2" "Lineage enriched" "Detected in all" 12 "dendritic cells: 209.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 898.6;U-266/70: 462.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2000000 Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favorable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 175.2 44.8 38.0 82.9 40.8 20.7 70.4 33.8 61.3 53.0 56.3 103.5 111.4 31.1 37.1 65.1 36.9 147.1 79.2 41.2 58.3 207.8 112.0 108.3 178.5 37.2 38.7 38.2 33.3 38.2 249.0 25.1 264.3 36.7 52.3 107.0 19.8 56.9 32.5 50.8 31.6 98.4 65.6 37.6 203.9 108.0 30.0 59.6 53.3 94.1 50.8 55.4 146.1 52.5 50.5 33.2 47.5 30.8 57.4 94.3 76.0 108.4 70.3 67.0 71.7 84.2 36.9 58.6 18.2 101.5 116.5 44.3 81.5 0.0 60.8 33.7 1.6 36.2 1.2 24.4 42.8 27.7 1.0 2.7 54.2 29.1 68.4 39.4 21.3 82.1 33.7 7.4 150.9 5.2 45.2 8.9 1.2 15.1 208.2 32.1 8.4 27.1 898.6 59.2 129.1 33.6 23.2 97.9 59.4 53.0 66.8 43.9 0.6 47.2 35.3 44.8 64.5 21.8 462.5 58.0 25.0 20.0 0.2 69.1 1.9 1.6 0.1 0.8 3.1 1.6 17.0 5.1 1.3 19.3 14.5 15.2 9.0 1.6 3.7 1.0 209.2 9.7 7.0 38.0 40.8 33.8 61.3 41.2 58.3 37.2 38.7 38.2 36.7 37.6 59.6 50.5 34.9 57.7 128.0 8.8 33.9 23.1 37.5 36.0 22.2 10.6 31.2 37.6 29.8 42.9 48.1 31.3 93.8 181.8 24.5 64.2 9.8 61.3 1.3 79.4 23.5 38.3 36.5 22.7 19.2 50.6 140.2 63.8 73.4 177.7 8.8 17.6 276.3 46.4 1448.9 13.5 41.0 31.1 95.6 317.6 89.0 3.3 30.4 346.1 48.0 27.2 37.5 23.6 2.1 10.6 15.2 50.5 57.1 57.9 24.7 44.6 163.4 220.4 20.9 19.8 19.7 40.4 62.1 19.9 17.6 22.3 17.5 416.3 8.2 15.1 48.3 44.7 ALKBH1 "ABH, alkB, ALKBH, hABH" ENSG00000100601 "AlkB homolog 1, histone H2A dioxygenase" Q13686 14 77672404-77708023 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, RNA repair, Translation regulation" "Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044087, HPA060061" Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Intracellular and membrane" NA NA Nucleoplasm "Endoplasmic reticulum" "HPA044087: AB_2678803, HPA060061: " "unprognostic (1.92e-2)" "unprognostic (8.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-3)" "unprognostic (3.41e-2)" "unprognostic (5.03e-2)" "unprognostic (3.74e-3)" "unprognostic (7.45e-3)" "unprognostic (2.68e-2)" "unprognostic (3.95e-2)" "unprognostic (5.05e-3)" "unprognostic (2.16e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.65e-3)" "unprognostic (1.46e-1)" "unprognostic (2.63e-1)" "unprognostic (2.44e-2)" 2.6 2.8 2.8 1.9 3.2 1.2 3.5 3.8 3.6 3.5 2.7 2.8 2.5 2.4 2.1 2.7 2.9 2.2 3.9 2.9 3.3 3.0 3.7 2.3 3.6 2.8 3.0 2.7 2.9 2.7 3.3 1.5 4.0 3.1 3.1 3.4 2.9 2.1 3.1 5.8 2.4 2.2 2.9 2.8 2.3 2.6 3.0 3.1 4.4 3.2 7.5 4.2 3.2 2.2 3.1 5.2 7.5 6.0 4.1 6.3 6.8 7.4 5.3 6.8 11.3 12.7 7.7 3.1 7.9 2.9 4.8 5.3 4.5 13.2 5.7 13.2 5.4 5.1 4.2 4.0 6.4 8.9 4.5 2.6 5.8 9.2 6.6 10.5 5.0 9.4 6.1 6.6 4.4 6.1 8.1 6.0 5.7 6.6 7.7 9.6 6.0 6.0 5.3 6.4 4.5 7.6 5.7 4.3 4.5 5.7 4.9 10.9 4.5 4.3 4.7 4.7 5.2 4.3 5.4 9.4 7.6 3.2 6.3 4.7 10.7 3.0 1.4 2.9 3.5 2.4 3.4 2.7 2.8 3.0 2.7 2.8 2.2 0.8 3.6 2.4 1.6 3.3 2.2 2.8 3.2 3.8 3.6 2.9 3.3 2.8 3.0 2.7 3.1 2.8 3.1 3.1 6.5 0.0 3.9 13.1 7.3 8.4 5.7 6.2 6.8 4.1 5.4 4.4 7.5 1.5 4.5 1.8 2.1 9.9 3.5 4.2 9.8 6.2 4.8 4.4 4.5 5.7 2.4 4.2 15.9 7.0 8.8 5.5 2.6 3.8 9.5 6.1 2.2 3.9 7.6 0.0 15.8 4.9 6.1 5.2 5.0 4.2 6.5 7.7 5.4 5.6 6.6 7.8 4.1 16.1 19.4 6.8 1.5 5.3 4.9 4.5 7.0 6.5 5.5 5.3 6.6 4.2 5.6 21.1 15.9 4.4 5.4 12.2 5.6 5.1 4.8 3.7 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 44.7 33.5 29.0 33.9 30.4 92.0 43.0 32.3 36.3 38.7 30.5 38.3 32.9 39.4 28.6 38.7 38.7 27.0 38.5 28.3 31.1 31.0 33.9 37.4 46.6 30.1 29.8 26.9 41.7 38.9 31.5 30.6 33.2 31.1 32.5 32.4 43.7 34.2 22.1 65.3 51.1 38.8 31.2 30.1 44.9 36.9 48.9 29.7 49.4 34.2 36.2 42.2 39.1 38.3 34.2 91.0 66.6 67.0 70.8 54.5 60.6 76.5 61.3 54.6 66.8 61.2 66.0 81.0 88.3 54.5 46.1 50.8 88.2 81.8 58.9 90.3 71.1 63.5 71.8 59.1 66.7 77.7 50.5 81.0 46.8 76.1 60.0 82.8 71.5 65.8 83.7 103.9 64.7 51.9 93.1 90.7 85.4 74.2 103.1 87.8 97.3 85.5 61.7 61.4 82.6 71.2 76.5 84.7 73.6 87.3 68.1 106.6 95.5 69.9 71.6 81.7 64.9 73.9 62.9 95.5 98.7 65.5 79.8 80.9 94.5 71.0 95.6 57.5 76.9 65.5 59.2 64.5 65.9 72.6 67.0 67.6 63.9 67.8 94.5 92.1 43.2 94.5 76.1 29.0 30.4 32.3 36.3 28.3 31.1 30.1 29.8 26.9 31.1 30.1 29.7 34.2 86.5 93.0 49.3 13.1 64.2 56.5 80.4 89.1 33.6 56.0 40.1 50.0 49.9 47.1 77.9 53.3 35.5 79.4 75.4 38.0 76.3 79.0 43.5 97.2 81.3 69.9 43.6 85.0 17.9 70.1 100.1 64.9 26.5 80.5 92.3 61.5 55.6 33.7 76.4 38.7 18.6 50.8 54.9 53.6 52.0 24.0 77.9 70.7 39.2 30.0 95.6 66.7 65.9 15.6 31.9 71.3 43.8 74.1 46.3 48.9 48.8 57.3 88.1 72.2 65.7 60.9 89.5 300.5 140.7 39.7 54.3 109.0 76.8 54.4 47.9 70.9 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923150-92935285 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 6618.5" "Cell type enriched" "Detected in many" 7 "Enteroendocrine cells: 6553.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Group enriched" "Detected in many" 9 "cerebral cortex: 319.5;white matter: 124.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 151 "SCLC-21H: 489.5;SH-SY5Y: 1339.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 295000000 100000000 Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698" "prognostic favorable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (3.99e-4)" 14.6 1260.4 6.7 9.5 14.2 0.2 0.3 0.6 319.5 8.4 0.0 92.8 244.9 0.4 0.3 1.0 1.1 0.2 0.2 24.3 12.7 1.0 0.4 1.6 0.1 16.6 8.8 8.3 0.2 103.4 6618.5 449.7 0.0 21.1 12.4 106.1 11.1 0.2 0.3 0.1 0.6 181.4 0.9 0.0 0.2 367.5 78.3 6.9 0.6 24.8 0.0 0.0 1.3 1.2 124.7 0.0 0.5 2.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.8 2.7 0.0 0.0 0.2 0.0 1.4 0.0 0.0 489.5 1339.4 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 4.2 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.2 0.6 319.5 24.3 12.7 16.6 8.8 8.3 21.1 0.0 6.9 124.7 0.1 0.0 0.0 11.1 1.0 0.9 0.4 0.0 0.0 17.3 0.2 0.3 2.9 0.0 0.0 0.0 29.2 0.3 0.0 9.8 0.0 0.1 1.3 6.0 2.3 0.8 6553.1 0.0 59.5 0.4 0.1 4.1 195.7 0.5 0.0 0.5 0.0 0.0 1.5 16.8 37.7 820.4 14.2 0.0 0.0 7.9 39.7 0.1 7.2 15.9 2.0 3.7 0.0 10.6 12.8 46.5 137.8 137.3 0.0 6.6 36.7 0.0 0.0 16.2 0.0 0.0 0.2 4.7 2.2 0.0 0.0 0.3 0.2 0.4 25.9 5.1 ITPK1 ENSG00000100605 "Inositol-tetrakisphosphate 1-kinase" Q13572 14 92936914-93116320 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Isomerase, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 106.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 42.9" "Group enriched" "Detected in all" 5 "granulocytes: 42.9;monocytes: 25.9" "Cell line enhanced" "Detected in all" "WM-115: 110.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055230 Approved Approved Mitochondria NA NA Mitochondria "HPA055230: AB_2682748" "unprognostic (1.93e-3)" "unprognostic (2.50e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.56e-4)" "unprognostic (4.27e-1)" "unprognostic (2.04e-2)" "unprognostic (6.97e-2)" "unprognostic (1.32e-1)" "unprognostic (1.24e-2)" "unprognostic (2.86e-2)" "unprognostic (8.14e-2)" "unprognostic (2.27e-1)" "unprognostic (1.37e-3)" "unprognostic (2.39e-1)" "unprognostic (2.02e-1)" "unprognostic (4.20e-1)" "unprognostic (7.25e-3)" 53.8 27.4 85.9 15.6 96.7 17.4 45.7 82.0 93.4 57.1 54.6 57.1 44.8 67.4 11.7 25.0 30.6 19.5 56.7 87.4 76.5 35.5 48.7 31.9 9.0 85.3 92.6 74.9 27.3 31.0 14.9 20.8 6.9 99.1 39.2 16.6 9.4 21.2 21.9 41.3 21.2 58.9 23.6 82.7 38.4 34.5 29.7 94.1 7.0 25.6 16.2 6.6 63.1 35.3 97.4 28.1 56.6 10.3 26.3 22.5 12.6 27.8 11.8 17.5 22.9 13.8 32.8 48.9 17.7 57.4 18.6 8.7 32.5 29.6 50.3 7.2 65.9 13.1 39.2 14.6 28.5 16.8 17.9 41.5 8.2 29.5 11.6 26.3 9.9 22.8 18.0 21.9 19.8 11.3 74.6 15.5 25.5 22.0 36.4 25.5 29.1 15.1 26.3 15.5 46.3 28.0 35.5 29.6 59.0 49.5 7.8 79.5 21.7 18.0 15.9 17.3 27.0 18.9 19.3 19.1 11.4 14.6 13.8 110.8 5.3 9.8 18.2 3.2 15.4 1.9 3.3 2.0 2.1 7.0 1.0 1.2 2.2 42.9 2.4 25.9 3.5 3.0 5.1 85.9 96.7 82.0 93.4 87.4 76.5 85.3 92.6 74.9 99.1 82.7 94.1 97.4 11.8 12.8 11.1 32.0 10.8 7.4 7.5 8.3 2.8 10.2 11.8 7.6 24.3 17.2 5.1 29.5 18.8 9.7 12.9 73.5 13.7 19.2 12.7 18.1 12.5 12.4 28.8 5.9 45.1 27.3 10.0 8.9 13.3 21.2 16.5 9.2 13.9 31.3 19.4 6.7 21.6 24.8 4.1 44.7 11.8 30.3 14.9 30.5 26.6 16.9 23.2 17.2 18.6 31.7 46.5 44.6 38.7 48.2 13.2 15.2 106.6 23.0 3.3 13.7 19.7 7.4 17.8 4.3 14.3 7.0 4.4 6.8 12.7 10.3 34.5 11.0 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144119-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 620.9" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 840.4" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031121, HPA078401" Enhanced Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803, HPA078401: " "prognostic favorable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 57.7 104.3 52.0 44.2 54.1 61.5 59.1 59.6 76.0 49.3 52.2 73.7 109.9 50.3 97.4 44.6 46.3 59.7 47.1 50.7 62.1 101.5 147.6 64.7 45.9 61.0 58.2 52.0 65.4 77.4 228.7 55.1 29.9 63.8 413.6 70.2 112.1 320.2 135.8 620.9 40.0 182.5 51.4 59.8 45.7 184.0 9.9 54.2 39.6 121.4 137.2 49.8 52.2 41.4 65.9 221.3 52.9 41.8 89.3 219.6 74.4 42.8 74.3 186.4 26.5 59.0 37.3 149.8 21.5 41.7 76.8 78.0 92.7 57.2 108.3 34.5 156.1 36.0 53.7 28.7 60.9 110.1 71.8 1.7 63.3 116.7 47.6 153.0 50.8 52.5 66.2 18.2 52.6 61.4 59.2 40.9 67.2 18.6 151.2 55.4 42.7 50.8 24.4 118.3 70.5 83.4 99.8 72.6 118.0 168.2 52.7 72.7 32.5 35.8 126.6 38.7 36.9 44.2 18.3 7.9 45.0 62.6 64.8 93.5 743.5 213.1 519.6 335.7 159.1 340.6 184.4 238.9 298.5 185.0 167.0 134.6 258.5 835.4 294.7 224.0 388.8 215.5 450.2 52.0 54.1 59.6 76.0 50.7 62.1 61.0 58.2 52.0 63.8 59.8 54.2 65.9 109.6 54.5 102.5 16.0 72.2 34.0 70.3 233.2 52.3 25.7 81.2 57.4 27.6 160.2 138.4 86.5 83.4 29.6 210.4 101.3 19.6 222.5 2.1 56.2 55.5 89.7 46.5 20.4 12.2 165.9 88.7 87.9 120.8 120.0 178.5 22.9 48.5 166.4 94.4 42.1 19.0 102.2 386.6 54.5 70.6 3.5 82.3 98.7 108.5 16.9 172.5 94.4 299.7 26.2 20.1 210.6 114.5 84.2 99.0 263.4 840.4 44.1 57.0 70.7 85.5 66.4 73.7 1.6 2.9 47.0 25.4 20.8 152.1 19.7 79.2 47.1 PPM1A "MGC9201, PP2CA, PP2Calpha" ENSG00000100614 "Protein phosphatase, Mg2+/Mn2+ dependent 1A" P35813 14 60245752-60299087 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 144.2" "Cell type enhanced" "Detected in all" "Early spermatids: 446.2;Late spermatids: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029209 Approved Supported "Plasma membrane,Cytosol" NA NA 380000 Cytosol "Plasma membrane" "HPA029209: AB_2672951" "unprognostic (3.14e-1)" "unprognostic (2.14e-1)" "unprognostic (5.64e-2)" "unprognostic (1.85e-1)" "unprognostic (4.00e-2)" "unprognostic (2.30e-2)" "unprognostic (4.50e-2)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.58e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" 22.9 19.4 15.5 22.4 17.9 144.2 23.8 28.5 23.6 22.6 6.2 36.9 37.1 28.2 19.5 26.0 17.5 20.3 37.1 16.8 25.0 42.9 51.6 20.5 24.6 19.0 19.0 14.2 16.4 25.7 37.1 14.5 22.3 21.2 30.2 36.4 51.5 31.8 23.2 79.6 21.7 37.6 26.8 17.6 20.5 23.4 54.9 16.9 31.4 24.6 77.3 26.5 21.6 18.0 24.2 129.7 28.6 24.4 20.9 36.5 33.6 31.1 34.8 40.7 25.3 23.8 16.3 37.2 77.1 32.4 39.6 18.7 28.1 25.5 35.9 44.0 70.1 14.4 47.6 19.5 25.7 30.6 54.7 32.6 28.6 42.1 29.7 40.4 29.5 25.1 38.7 26.9 59.6 31.3 56.5 71.5 12.8 23.0 25.8 23.9 25.3 56.5 25.0 30.4 61.2 41.2 31.0 36.1 41.7 30.1 22.2 42.0 23.5 35.1 52.4 52.0 23.3 25.0 46.1 28.1 89.9 24.0 21.2 27.1 5.4 1.0 3.0 1.8 1.0 1.9 0.9 1.4 1.6 1.5 3.0 1.1 1.0 4.4 2.9 1.2 0.9 2.6 0.9 15.5 17.9 28.5 23.6 16.8 25.0 19.0 19.0 14.2 21.2 17.6 16.9 24.2 25.9 16.0 22.6 43.8 34.2 77.4 41.3 17.6 34.7 42.2 41.6 22.7 95.0 44.3 20.0 38.6 64.6 31.9 49.1 111.2 33.2 24.6 446.2 31.3 34.6 31.5 60.9 93.5 77.8 24.4 24.0 36.6 25.5 38.8 26.6 20.7 22.9 73.3 28.2 58.9 71.6 60.2 22.4 33.5 51.0 565.6 42.3 58.6 60.5 25.3 26.8 40.1 45.3 66.4 53.4 34.6 87.8 52.3 45.4 86.5 128.5 90.0 17.8 66.8 39.5 36.2 35.9 69.8 25.3 32.9 82.3 73.5 40.8 19.4 42.1 69.6 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709539-60724351 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 5.0;parathyroid gland: 15.2;salivary gland: 6.9;skeletal muscle: 14.5;tongue: 15.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Endometrial ciliated cells: 36.1;Glandular and luminal cells: 37.8;Prostatic glandular cells: 23.8;Respiratory ciliated cells: 30.3;Urothelial cells: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 32.1;hTERT-RPE1: 23.3;RH-30: 30.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA031794 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 0.5 0.7 1.8 0.2 1.0 0.1 1.6 2.1 2.7 2.2 5.0 0.2 0.1 0.9 0.7 0.2 2.4 0.6 0.4 2.4 1.6 0.8 0.1 0.7 0.0 2.3 1.6 0.8 1.4 1.5 15.2 2.8 0.9 2.6 2.6 0.0 0.3 6.9 0.6 14.5 0.1 0.1 0.4 1.4 0.0 1.5 0.3 1.8 1.3 1.0 15.8 0.2 1.2 0.4 2.4 32.1 2.1 1.9 7.9 7.2 8.7 14.5 7.1 10.5 2.0 3.0 1.5 10.2 0.0 4.6 3.5 2.0 11.8 8.4 5.8 4.7 2.6 6.4 0.9 3.2 2.1 2.3 3.4 0.3 4.2 2.7 1.7 9.5 23.3 1.8 0.6 6.6 0.0 10.6 7.6 0.0 0.3 5.3 0.2 13.2 2.1 30.2 0.0 3.8 17.3 5.0 0.5 4.3 6.7 1.9 2.8 9.7 0.2 6.4 6.3 14.0 4.2 6.3 2.2 0.1 0.0 2.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 2.1 2.7 2.4 1.6 2.3 1.6 0.8 2.6 1.4 1.8 2.4 0.1 3.2 0.5 0.0 0.1 0.4 13.9 6.9 6.8 0.5 11.9 9.7 3.3 0.0 8.3 1.8 20.9 5.0 0.3 0.1 0.0 0.2 0.1 36.1 2.9 0.9 1.8 0.0 2.6 1.1 4.1 3.2 0.0 37.8 1.3 0.1 0.4 0.3 0.3 0.0 3.2 0.0 2.0 0.0 0.3 0.0 0.3 0.7 1.8 0.0 0.0 1.6 0.0 4.0 0.1 2.9 0.0 1.5 1.3 23.8 0.0 0.3 30.3 0.4 0.0 9.7 2.5 0.4 1.3 2.2 0.6 3.1 0.9 0.1 0.0 17.2 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8;heart muscle: 33.6" "Cell type enhanced" "Detected in many" "Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059136, HPA075325" Approved Approved Vesicles,Cytosol NA NA 370000 "Vesicles, Cytosol" "HPA059136: AB_2683919, HPA075325: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favorable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 12.2 11.7 22.5 2.0 24.5 0.1 12.2 14.6 28.6 5.8 6.6 5.2 2.2 7.4 2.8 3.6 5.6 3.4 33.6 27.5 30.0 7.2 2.0 3.5 3.2 19.6 22.0 21.6 2.1 4.4 2.5 4.7 0.4 17.0 4.0 2.2 1.3 23.7 4.7 4.4 6.7 3.7 8.6 14.4 12.2 3.2 3.5 32.8 2.3 4.9 5.8 1.3 3.1 5.0 21.9 0.0 0.8 8.5 0.3 11.7 5.3 0.0 1.3 0.1 1.5 2.3 0.4 0.0 0.0 0.2 1.4 0.8 0.0 3.0 0.0 0.3 0.1 6.0 0.0 0.2 0.5 0.1 0.0 0.5 0.5 0.0 17.0 0.0 17.2 0.9 0.0 0.0 0.0 2.8 0.5 0.0 0.0 1.7 0.0 0.1 0.0 4.8 0.0 0.5 0.0 8.7 3.0 1.8 0.4 0.0 0.3 0.3 0.0 0.1 1.7 19.9 2.2 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 24.5 14.6 28.6 27.5 30.0 19.6 22.0 21.6 17.0 14.4 32.8 21.9 4.0 0.0 0.0 16.6 0.0 4.1 0.4 0.0 0.0 2.8 3.1 3.0 46.7 0.0 0.0 0.0 2.1 0.1 0.2 0.0 3.9 0.1 9.7 0.2 0.4 1.7 0.0 0.0 27.6 0.0 0.0 24.0 0.5 0.2 0.0 0.3 0.0 0.0 0.2 0.0 23.8 0.1 0.0 0.0 6.1 11.2 0.9 0.3 3.6 5.6 0.0 0.1 0.0 8.0 1.6 0.0 0.0 3.8 0.0 0.5 0.1 0.1 0.0 0.8 6.6 10.1 14.8 0.6 2.1 0.3 3.3 0.0 0.3 11.2 0.6 0.4 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934166-93976739 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 527.2;tongue: 159.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 7 "eosinophil: 50.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 50.8" "Cell line enhanced" "Detected in some" "Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 2.4 0.8 0.5 5.6 2.3 0.5 1.5 0.0 1.9 10.4 0.2 47.6 4.1 31.8 0.3 4.1 26.9 0.5 64.2 0.6 0.9 0.5 0.5 3.0 7.5 0.3 0.1 0.9 3.0 0.3 0.2 0.2 0.2 0.6 14.5 0.5 0.0 6.7 0.9 527.2 1.8 18.4 1.6 0.0 4.3 17.3 0.4 0.5 0.4 1.2 159.0 3.2 30.6 8.5 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.4 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 12.4 0.0 0.2 0.1 0.0 0.0 0.0 5.9 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 42.1 8.6 1.7 0.5 2.6 0.5 0.0 0.2 50.8 1.9 2.7 0.3 1.9 1.7 3.8 4.2 0.4 0.2 0.5 0.1 0.0 7.8 0.4 2.3 1.3 0.5 2.3 0.0 1.9 0.6 0.9 0.3 0.1 0.9 0.6 0.0 0.5 0.8 0.2 0.0 0.0 0.3 3.3 0.4 0.1 8.4 0.0 0.2 0.2 0.9 51.1 0.0 2.9 0.0 0.0 0.1 3.0 0.0 0.0 1.4 26.4 1.7 0.3 0.5 0.0 2.7 4.7 0.0 0.5 1.9 1.1 2.5 0.0 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.3 29.9 0.3 5.3 1.8 1.9 5.8 0.8 2.1 0.0 0.7 0.2 0.0 0.4 10.7 0.1 0.0 0.0 0.4 1.1 0.0 27.6 5.0 0.8 8.4 0.1 0.1 2.9 14.5 0.1 0.1 0.3 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" "Astrocytes: 40.1;Microglial cells: 46.9;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 71.0;Plasma cells: 81.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 7.8" "Group enriched" "Detected in many" 4 "dendritic cells: 6.8;T-cells: 7.8" "Cell line enhanced" "Detected in many" "Karpas-707: 59.9;MOLT-4: 55.7;U-266/70: 110.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001116, HPA018498, HPA077688" Uncertain Supported Centrosome NA NA Centrosome "HPA001116: AB_1078323, HPA018498: AB_1845560, HPA077688: " "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 2.0 0.9 1.6 2.5 2.7 6.2 3.9 4.4 1.9 1.2 1.0 2.0 1.5 2.1 0.6 1.7 2.5 1.0 1.2 1.2 1.4 0.9 0.9 1.5 4.7 2.0 1.4 0.8 1.5 0.6 1.7 0.9 1.0 1.9 1.3 1.7 1.6 1.7 1.0 1.8 2.4 1.0 1.9 1.5 2.4 1.7 5.2 1.5 25.1 1.7 0.9 5.2 2.2 1.3 3.2 14.8 7.9 6.8 5.6 1.6 2.6 3.6 15.5 4.8 9.5 9.3 5.3 8.4 34.5 2.8 4.8 6.2 7.8 7.4 4.9 18.0 19.5 4.7 6.7 9.8 2.7 0.8 6.6 8.6 0.6 1.2 13.6 7.3 1.8 7.3 17.0 8.5 59.9 9.1 9.4 55.7 3.7 5.3 4.0 9.4 9.8 16.8 26.7 2.0 7.7 8.6 4.1 13.1 5.4 2.8 6.5 6.0 5.1 6.7 20.5 11.2 5.7 16.4 110.1 4.8 15.2 5.8 9.1 7.3 0.0 0.6 1.3 2.2 0.2 1.7 1.6 2.3 1.6 2.0 0.6 2.0 0.9 0.1 0.9 0.4 6.8 7.8 0.7 1.6 2.7 4.4 1.9 1.2 1.4 2.0 1.4 0.8 1.9 1.5 1.5 3.2 2.3 3.2 2.8 40.1 7.5 4.0 2.6 1.1 1.2 6.6 3.2 3.0 3.8 2.8 5.7 3.7 2.1 2.4 12.7 0.6 0.0 1.6 8.5 14.8 3.2 2.7 1.2 7.4 27.3 1.2 9.0 3.5 3.1 2.8 2.5 7.8 3.3 0.3 2.5 6.7 25.5 1.0 2.0 0.0 4.6 5.1 1.5 4.8 3.6 46.9 10.3 4.8 1.0 37.7 71.0 1.2 0.3 1.5 81.1 0.9 0.1 0.5 17.2 13.8 6.6 6.6 2.5 16.7 3.8 4.1 1.7 2.3 8.8 2.3 1.5 1.6 ERH DROER ENSG00000100632 "ERH mRNA splicing and mitosis factor" P84090 14 69380128-69398299 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol NA Yes 190000 Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 108.6 114.8 157.5 120.1 159.5 145.6 120.5 158.4 188.3 97.8 160.9 111.6 111.0 113.0 151.6 76.2 113.7 70.7 101.2 157.2 166.9 119.4 143.6 77.0 148.3 158.0 162.5 155.2 107.9 67.2 129.3 58.8 98.9 160.3 87.8 124.1 117.8 110.9 85.1 108.0 58.6 99.9 115.8 163.0 97.3 89.5 92.0 160.1 214.2 98.5 86.5 169.8 118.1 51.6 169.1 972.7 574.9 704.6 409.1 271.8 201.1 356.9 450.7 261.3 401.3 372.0 598.5 403.1 879.9 224.3 305.3 340.3 296.1 563.4 376.9 484.2 437.9 428.3 441.4 366.1 731.8 419.6 389.3 334.6 227.1 203.0 355.9 317.2 239.2 337.8 584.5 454.0 301.6 335.7 1043.2 714.1 750.8 537.2 525.6 686.0 558.9 599.9 320.6 415.4 672.8 449.1 439.8 442.1 464.6 355.6 330.8 539.9 564.4 351.4 425.7 699.7 286.7 480.0 351.7 336.2 1096.1 345.1 417.5 442.4 76.6 101.4 80.9 76.6 98.9 77.5 122.2 100.0 88.0 107.4 94.3 92.7 88.2 45.3 121.5 95.1 122.8 116.5 147.0 157.5 159.5 158.4 188.3 157.2 166.9 158.0 162.5 155.2 160.3 163.0 160.1 169.1 231.2 60.9 54.3 22.2 189.1 273.1 225.0 702.7 180.4 126.4 244.2 314.2 118.9 181.6 282.2 253.8 37.5 455.3 179.4 117.5 673.1 363.8 100.4 238.1 198.9 211.9 188.5 252.6 23.9 275.3 560.3 237.0 120.3 158.7 127.6 186.7 169.6 239.9 341.5 74.0 23.1 244.0 510.6 147.5 215.2 51.3 270.9 162.5 307.7 16.9 302.3 350.3 174.0 19.6 34.6 289.8 183.9 259.2 237.9 288.9 203.9 508.5 278.4 119.8 190.7 177.7 273.8 321.5 230.9 251.0 318.8 279.9 165.3 281.4 265.9 230.6 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 subunit alpha" Q16665 14 61695513-61748259 "Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 452.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 155.0" "Lineage enriched" "Detected in all" 7 "granulocytes: 155.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 941.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 65.5 135.0 25.2 147.9 27.3 452.5 36.6 30.1 28.4 134.1 26.9 43.2 33.9 52.8 75.4 62.7 41.5 146.7 36.9 23.7 44.9 77.9 52.1 76.4 71.9 32.3 31.4 19.5 35.6 36.3 92.5 31.0 78.2 32.8 47.3 42.1 35.8 45.7 67.8 12.2 34.2 37.6 59.6 29.8 73.0 37.9 32.7 36.7 56.3 50.0 17.7 88.9 171.5 43.5 33.3 313.6 123.6 112.7 344.7 185.2 297.1 161.5 253.8 270.1 288.7 258.9 54.1 100.3 75.8 186.2 293.0 73.6 71.8 71.0 416.1 352.5 33.7 41.0 46.5 105.3 93.1 414.8 20.1 49.3 523.4 129.2 216.5 225.6 408.6 198.1 44.4 32.3 0.4 941.4 65.6 59.2 24.3 108.9 49.6 159.7 4.3 269.1 22.8 400.2 204.3 100.3 111.9 472.5 67.0 170.7 148.9 70.6 36.3 119.2 700.2 157.3 235.9 215.2 39.1 61.2 84.1 369.9 38.5 194.7 43.8 22.3 155.0 11.5 18.0 14.4 19.5 15.0 13.3 19.6 19.0 22.6 15.6 56.3 19.7 19.4 9.2 11.0 18.4 25.2 27.3 30.1 28.4 23.7 44.9 32.3 31.4 19.5 32.8 29.8 36.7 33.3 93.3 70.5 116.0 69.2 157.3 106.4 101.8 102.6 97.9 54.1 38.5 30.1 43.5 87.2 69.0 261.1 50.1 24.8 65.1 44.1 103.7 278.5 3.6 95.6 131.3 152.3 66.4 35.3 45.6 251.6 67.1 81.4 49.5 272.3 223.6 339.7 176.0 30.7 136.4 156.5 39.3 39.0 57.0 145.9 111.7 6.2 24.2 240.2 103.2 53.4 87.1 134.0 26.8 78.9 35.8 236.9 21.9 48.5 60.0 59.3 20.2 192.1 37.7 54.8 52.6 75.8 136.9 80.5 44.2 128.7 87.9 25.4 91.6 92.2 51.8 116.0 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715144 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 24.9 19.4 11.9 33.2 12.4 67.8 22.4 26.4 12.8 16.4 13.9 19.4 25.7 13.1 43.4 32.1 21.2 27.8 14.3 13.1 16.4 22.4 12.3 37.5 30.6 24.0 14.4 10.1 13.6 22.3 16.7 14.5 17.2 19.2 18.0 19.2 15.7 29.9 16.9 12.4 27.5 33.0 19.8 16.8 33.8 21.1 10.8 14.3 21.9 22.6 11.6 36.5 21.9 18.3 15.2 19.4 4.9 7.0 6.4 14.0 10.2 12.8 10.7 22.6 6.0 5.8 5.9 16.7 22.6 11.8 13.5 4.8 26.4 4.0 22.1 5.6 38.9 3.0 18.4 4.1 9.8 22.6 3.0 45.6 16.6 21.5 10.1 18.7 6.5 12.4 6.9 5.7 19.6 8.4 9.5 4.5 8.1 1.4 11.3 5.0 7.7 6.2 9.1 11.5 9.8 3.0 4.7 8.8 25.4 4.0 5.1 10.4 8.3 19.4 13.8 8.1 8.8 4.4 13.5 3.2 15.7 8.9 10.3 7.4 16.3 11.6 12.3 5.5 10.2 5.5 5.3 4.8 3.4 7.6 5.0 4.6 3.4 33.0 4.1 13.7 4.3 4.6 8.8 11.9 12.4 26.4 12.8 13.1 16.4 24.0 14.4 10.1 19.2 16.8 14.3 15.2 45.6 12.8 30.0 22.2 24.6 0.0 36.0 0.0 23.3 16.7 44.2 21.5 14.0 21.5 11.2 18.4 20.9 4.3 32.9 44.3 7.9 26.7 1.0 34.7 13.3 32.8 7.3 13.9 34.6 24.6 1.7 13.1 18.8 28.4 8.8 9.7 17.9 15.9 23.5 15.2 21.1 21.9 0.0 67.4 0.0 5.1 5.3 44.3 0.0 107.7 31.6 4.3 16.5 22.1 28.4 38.7 20.4 6.8 15.1 43.0 74.1 15.2 10.9 23.7 26.3 18.3 19.0 8.4 15.4 19.7 0.0 9.2 21.2 7.6 8.5 54.6 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 23000 Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 212.8 189.9 81.7 150.9 79.6 460.9 231.7 70.5 110.5 172.3 119.0 221.6 130.4 224.3 219.9 219.7 243.0 131.2 155.8 87.9 92.2 120.1 185.3 216.7 211.8 115.5 82.0 68.5 221.9 137.8 189.6 217.2 106.0 98.4 174.2 166.3 235.9 237.8 127.9 219.6 275.4 258.7 181.9 77.2 213.7 214.6 104.9 78.5 216.7 226.6 68.9 156.3 190.9 178.9 104.7 456.4 133.5 313.8 141.4 192.7 179.6 177.4 214.6 239.7 177.6 183.7 164.7 283.6 473.1 110.4 301.8 174.7 210.2 242.5 309.2 209.7 407.4 142.3 354.3 386.7 183.6 224.3 334.7 255.7 350.9 201.2 199.7 216.3 260.4 247.0 401.8 255.4 268.3 114.3 382.1 385.1 232.4 182.0 356.6 128.2 324.0 148.5 183.3 237.2 563.1 165.9 236.3 364.3 214.1 296.0 188.5 235.9 292.3 299.7 98.4 264.2 110.9 205.6 261.6 184.5 754.8 232.3 286.1 140.1 137.1 65.8 103.6 93.1 117.9 94.9 109.5 83.1 85.0 70.1 108.7 81.1 79.6 161.9 86.2 129.6 99.8 74.8 77.2 81.7 79.6 70.5 110.5 87.9 92.2 115.5 82.0 68.5 98.4 77.2 78.5 104.7 380.7 253.2 309.1 218.1 392.8 138.0 768.6 610.1 204.9 387.4 248.6 259.1 195.0 240.2 386.6 183.9 239.8 444.3 542.9 471.8 320.8 201.7 190.3 224.2 169.8 293.6 302.9 195.4 199.5 171.8 261.5 288.0 188.6 225.3 480.2 251.3 249.9 225.4 217.7 378.6 177.7 376.6 380.5 236.2 154.3 105.0 345.5 314.7 133.4 104.9 323.4 277.4 428.5 128.2 268.7 226.6 538.5 267.1 212.3 376.7 484.7 228.2 373.4 317.3 276.1 583.7 354.2 201.8 149.8 196.4 145.6 749.2 456.6 201.6 275.5 542.1 SLC10A1 NTCP ENSG00000100652 "Solute carrier family 10 member 1" Q14973 14 69775416-69797241 "Metabolic proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 158 "liver: 430.4" "Cell type enriched" "Detected in some" 25 "Hepatocytes: 147.2" "Cancer enriched" "Detected in some" 79 "liver cancer: 65.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042727 Approved NA NA "HPA042727: AB_10960691" "unprognostic (3.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.51e-2)" "unprognostic (2.11e-2)" "unprognostic (1.93e-2)" "unprognostic (6.51e-3)" "prognostic favorable (9.53e-6)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "unprognostic (2.17e-1)" "unprognostic (5.75e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" 0.0 0.0 0.8 0.1 0.6 0.4 0.0 2.7 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.4 0.1 430.4 0.0 0.0 0.6 0.8 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.8 0.6 2.7 1.6 1.5 0.4 0.6 0.8 0.2 1.0 0.2 0.6 1.5 0.4 0.0 0.0 1.3 0.6 0.1 0.1 0.4 0.0 0.6 0.2 0.1 0.5 5.7 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 1.1 0.1 0.6 0.7 0.0 2.7 4.2 0.0 0.1 0.6 0.5 0.6 0.0 0.1 1.4 147.2 0.1 0.0 2.7 0.0 2.0 3.8 0.0 5.4 0.0 0.3 0.0 2.8 0.0 0.2 0.0 3.0 2.4 0.0 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.2 0.0 3.4 0.7 0.1 0.0 0.2 0.0 0.3 1.7 0.2 0.0 0.1 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 787.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000867, CAB004226" Supported Enhanced Cytosol NA NA 77000 Cytosol "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 91.3 60.9 86.2 55.0 88.3 196.1 72.8 92.4 96.2 49.1 79.2 82.4 80.2 56.8 55.4 75.1 66.8 63.9 86.0 89.9 94.0 93.2 152.6 65.2 62.8 95.1 92.4 81.4 46.0 78.8 82.3 41.1 66.9 94.5 55.4 78.7 50.9 64.1 75.8 165.2 57.2 67.9 71.6 103.6 55.8 65.9 95.7 90.1 62.2 94.3 145.8 80.8 63.4 46.4 104.7 132.9 149.4 174.0 79.1 147.0 129.1 182.3 190.7 205.1 192.5 145.3 223.7 137.3 136.4 117.2 172.4 165.0 173.3 220.9 193.3 325.6 111.9 87.4 121.9 76.3 119.6 152.8 222.1 100.6 139.7 127.0 170.8 230.6 160.2 196.9 98.9 255.8 126.7 161.3 188.7 152.7 73.4 90.5 251.7 285.8 127.4 226.1 85.1 112.8 423.7 153.7 107.7 191.6 141.3 155.9 161.0 135.5 100.8 149.7 152.8 103.3 196.3 201.5 376.2 787.9 287.4 150.5 154.3 182.4 356.8 245.1 323.9 235.1 249.1 265.2 335.0 239.4 224.3 241.5 334.1 283.0 236.8 266.1 315.1 273.0 329.2 221.1 401.0 86.2 88.3 92.4 96.2 89.9 94.0 95.1 92.4 81.4 94.5 103.6 90.1 104.7 282.4 144.2 158.6 56.5 269.5 340.1 346.0 216.0 362.0 196.8 260.5 252.3 307.3 101.5 172.4 73.5 185.6 233.0 298.1 221.9 215.2 243.8 280.6 182.0 162.9 227.9 199.6 408.1 47.3 282.3 212.1 267.6 137.1 252.4 278.7 218.7 134.6 255.5 173.1 176.7 40.9 220.3 187.2 158.4 313.2 683.5 128.0 282.5 152.9 30.9 238.7 167.7 129.8 24.6 60.6 247.8 161.7 173.8 414.4 260.4 233.7 272.3 179.8 212.9 118.3 460.0 372.7 507.8 367.8 323.2 265.2 493.8 281.7 213.1 232.0 254.0 SERPINA4 "KAL, kallistatin, KLST, KST, PI4" ENSG00000100665 "Serpin family A member 4" P29622 14 94561442-94569913 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 554.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1" "Cancer enriched" "Detected in many" 4 "liver cancer: 94.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 28.4" "Not detected" "Not detected" "HPA003607, HPA068939" Approved Uncertain Vesicles "Secreted to blood" NA NA 14500000000 14000000000 Vesicles "HPA003607: AB_1079914, HPA068939: " "unprognostic (1.65e-3)" "unprognostic (4.13e-2)" "prognostic favorable (2.95e-4)" "unprognostic (2.09e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (4.03e-3)" "unprognostic (1.02e-2)" "unprognostic (2.24e-4)" "unprognostic (1.08e-1)" "unprognostic (5.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 2.9 0.4 41.3 0.0 1.5 53.9 0.0 0.0 0.0 7.3 554.4 0.0 0.0 0.0 0.0 0.0 0.0 117.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.3 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 245.9 0.0 3.7 0.0 0.0 0.0 0.0 11.7 30.0 0.0 3.3 0.3 0.3 0.0 2.7 0.0 93.8 0.0 0.0 5.1 4.5 0.0 0.2 5.3 478.5 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SLC8A3 NCX3 ENSG00000100678 "Solute carrier family 8 member A3" P57103 14 70044215-70189070 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 9.6;retina: 9.7;skeletal muscle: 20.7;tongue: 9.5" "Group enriched" "Detected in some" 9 "Bipolar cells: 32.8;Excitatory neurons: 80.5;Inhibitory neurons: 129.4;Oligodendrocyte precursor cells: 107.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.2;LHCN-M2: 7.9;SH-SY5Y: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.65e-1)" "unprognostic (5.53e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.69e-1)" "unprognostic (3.46e-3)" "unprognostic (4.74e-2)" "unprognostic (1.64e-1)" "unprognostic (1.45e-3)" "unprognostic (8.53e-2)" "unprognostic (5.86e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" 0.2 1.2 6.0 0.3 6.3 0.3 0.2 2.0 6.7 0.4 0.0 0.3 0.3 0.2 0.2 0.3 0.1 0.4 0.6 5.1 6.9 0.0 0.1 0.6 0.2 6.5 6.9 6.8 0.0 0.2 0.8 0.9 0.1 7.8 0.3 0.2 9.7 0.3 0.1 20.7 0.3 0.4 0.3 3.5 0.1 0.3 0.1 7.7 0.2 0.0 9.5 0.2 1.2 0.2 9.6 0.0 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 24.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 6.3 2.0 6.7 5.1 6.9 6.5 6.9 6.8 7.8 3.5 7.7 9.6 0.0 0.0 0.6 2.9 0.0 0.1 0.0 0.0 0.0 32.8 0.0 0.0 1.4 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 80.5 0.0 0.4 0.2 0.0 0.0 8.8 0.0 0.0 0.0 0.1 8.4 129.4 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 4.7 0.0 0.8 0.0 107.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 DICER1 "Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1" ENSG00000100697 "Dicer 1, ribonuclease III" Q9UPY3 14 95086228-95158010 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing" "Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 418.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000694, CAB068185" Approved Supported Cytosol NA NA Cytosol "CAB068185: AB_2665650, HPA000694: AB_1078661" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (6.75e-2)" "unprognostic (9.62e-2)" "unprognostic (1.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.21e-1)" "unprognostic (8.52e-3)" "unprognostic (5.73e-2)" "unprognostic (9.22e-2)" "unprognostic (4.22e-2)" "unprognostic (9.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.04e-3)" "unprognostic (3.74e-2)" 14.5 8.0 5.7 14.1 19.5 10.9 15.2 10.7 12.0 13.3 6.4 12.2 7.6 12.8 8.4 15.1 12.5 8.8 9.9 6.0 21.1 10.8 12.9 15.1 11.1 18.6 15.2 3.8 14.4 12.7 11.6 10.7 18.9 18.9 12.6 11.0 19.5 12.5 10.2 19.4 12.7 11.7 11.6 12.8 12.2 10.2 13.3 15.6 8.5 14.8 16.4 12.1 12.8 14.6 39.0 18.6 19.4 40.7 12.0 7.2 14.5 26.4 15.5 10.7 11.3 11.1 25.4 12.5 20.9 16.1 16.0 10.4 21.2 31.6 13.9 20.5 35.9 14.6 36.5 10.1 16.0 6.7 22.6 18.0 12.2 10.1 12.3 20.8 8.0 16.1 15.7 15.7 16.6 16.9 21.8 24.1 6.8 9.3 11.0 10.2 16.0 31.9 12.2 8.2 30.9 31.9 16.4 16.2 13.4 15.2 19.2 18.0 12.4 16.4 8.1 14.4 14.0 16.9 18.9 31.7 31.4 8.0 14.5 13.1 1.4 1.1 0.8 0.3 1.4 0.7 0.7 0.6 0.4 0.8 0.7 0.5 0.3 3.9 0.5 3.2 0.4 0.7 0.4 5.7 19.5 10.7 12.0 6.0 21.1 18.6 15.2 3.8 18.9 12.8 15.6 39.0 69.4 54.5 53.7 88.8 45.7 27.4 49.5 29.9 40.5 98.2 50.7 29.1 36.4 41.5 47.3 46.0 56.3 46.6 36.9 44.0 5.9 33.4 23.3 37.4 54.2 52.0 46.1 33.4 99.7 23.1 22.8 45.6 33.1 50.1 12.0 35.5 42.1 60.1 48.8 107.7 112.2 29.7 24.4 104.2 24.8 15.5 54.3 82.3 23.2 81.5 84.6 33.5 33.0 109.1 418.6 33.2 28.0 52.6 39.2 62.5 27.1 25.9 38.6 73.8 32.9 64.3 41.9 45.5 56.1 63.0 27.6 25.7 31.7 35.9 33.9 62.1 ZFYVE21 "MGC2550, ZF21" ENSG00000100711 "Zinc finger FYVE-type containing 21" Q9BQ24 14 103715730-103733668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055721 Uncertain NA NA "HPA055721: AB_2682896" "unprognostic (1.10e-2)" "unprognostic (3.35e-1)" "unprognostic (8.89e-2)" "unprognostic (7.54e-3)" "unprognostic (1.96e-1)" "unprognostic (8.32e-2)" "unprognostic (4.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.04e-2)" "unprognostic (5.11e-3)" "unprognostic (5.02e-2)" "unprognostic (9.13e-2)" "prognostic favorable (2.58e-6)" "unprognostic (2.30e-3)" "unprognostic (1.71e-1)" "unprognostic (7.18e-2)" "unprognostic (2.06e-1)" 55.9 29.2 108.5 14.3 109.8 12.0 54.5 107.1 144.3 66.6 105.5 47.5 18.4 71.4 50.7 69.0 72.4 28.6 52.1 103.9 107.6 37.1 35.0 31.8 16.7 111.1 105.1 103.3 56.6 26.9 34.4 32.2 30.4 109.0 41.4 25.9 15.3 62.0 53.8 22.2 72.4 31.3 46.0 113.9 28.3 45.3 35.8 108.2 19.5 50.8 30.1 17.6 65.7 68.4 118.8 27.1 34.1 29.1 26.7 76.9 61.6 48.2 49.8 35.2 41.5 36.2 40.2 34.3 6.0 31.5 53.2 29.9 45.4 25.3 59.4 37.3 11.5 30.9 33.5 23.0 55.3 60.8 8.6 21.4 42.1 61.6 18.4 29.8 37.4 51.0 19.6 13.0 11.4 29.9 165.5 23.3 26.8 13.4 41.3 47.9 12.6 21.6 9.2 81.5 95.5 16.6 11.5 35.2 44.3 26.2 32.2 56.6 22.3 44.7 20.1 16.3 68.4 25.6 12.8 13.8 9.2 22.7 18.7 19.5 28.3 36.2 42.1 20.0 57.6 19.8 18.1 18.7 20.1 23.9 24.7 19.4 18.5 29.6 16.3 47.8 19.4 21.7 24.6 108.5 109.8 107.1 144.3 103.9 107.6 111.1 105.1 103.3 109.0 113.9 108.2 118.8 68.0 19.2 23.9 61.7 9.5 45.5 83.5 161.9 59.2 27.8 58.8 68.6 36.0 41.5 83.1 80.9 33.3 115.7 20.9 33.6 121.3 56.4 14.2 25.3 54.7 71.0 19.3 76.2 30.9 54.5 40.0 65.3 12.2 30.3 19.7 22.0 66.4 26.9 55.4 20.2 11.8 34.2 81.4 22.6 29.5 23.0 109.6 28.4 103.2 19.7 32.3 91.6 24.7 11.6 21.8 79.3 51.9 197.1 7.4 87.7 31.5 98.9 47.1 29.6 65.7 57.2 60.7 46.3 78.4 50.9 60.2 101.5 13.4 36.3 32.4 81.9 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" 14 64388031-64463457 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 359.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 142.9;Proximal tubular cells: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 56.9 18.1 9.1 20.1 16.7 27.2 30.0 8.2 12.4 17.0 13.7 23.6 19.9 16.2 10.0 25.3 16.1 13.2 25.8 12.7 8.4 55.8 359.8 15.5 23.8 7.2 7.9 10.4 25.1 24.0 27.7 9.2 13.4 7.5 13.0 27.8 3.6 15.8 14.0 64.7 16.9 19.1 20.2 6.7 14.6 18.1 4.8 8.1 30.5 20.7 62.4 27.9 18.8 16.7 8.9 294.1 164.9 58.5 143.6 70.5 53.4 95.7 106.4 83.3 148.1 147.4 161.2 144.2 103.3 49.6 67.1 68.3 146.0 177.6 111.2 160.4 107.3 117.9 122.2 143.5 131.8 50.6 104.5 81.2 43.0 37.3 124.3 66.4 57.5 93.1 98.1 108.5 98.7 114.7 270.1 179.9 62.3 118.0 186.5 160.4 138.3 201.2 114.4 110.5 160.9 128.7 49.0 183.7 111.4 58.3 54.0 164.4 58.6 51.5 115.1 184.1 102.2 134.2 58.8 65.6 177.9 107.4 125.2 134.8 0.4 11.7 0.1 9.7 19.5 13.0 27.0 10.1 12.3 17.7 15.3 7.8 10.7 0.9 17.8 16.7 4.0 19.5 12.2 9.1 16.7 8.2 12.4 12.7 8.4 7.2 7.9 10.4 7.5 6.7 8.1 8.9 8.1 19.2 23.5 15.0 16.2 13.8 14.2 14.7 13.6 0.0 9.8 8.1 43.9 15.7 19.5 16.5 0.0 30.6 10.8 7.9 41.1 16.9 1.4 6.8 11.7 12.3 3.0 42.3 19.5 10.3 30.9 14.9 15.3 8.7 50.7 27.2 12.8 142.9 25.3 0.0 15.6 14.3 2.0 13.0 11.0 1.5 13.1 12.3 14.2 8.4 13.3 0.0 8.2 14.1 10.9 11.7 6.3 13.2 24.1 10.2 8.2 75.3 11.5 0.0 19.7 13.1 19.3 0.9 8.9 19.5 10.7 9.9 16.6 21.4 24.6 12.7 TCL1A TCL1 ENSG00000100721 "TCL1 family AKT coactivator A" P56279 14 95709947-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 269.7" "Group enriched" "Detected in some" 4 "B-cells: 282.5;dendritic cells: 210.3" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 296 "memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9" "Group enriched" "Detected in all" 350 "B-cells: 2160.3;dendritic cells: 1099.9" "Group enriched" "Detected in some" 142 "Daudi: 459.4;REH: 599.4;U-698: 616.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 1.0 0.1 0.1 34.7 0.2 20.5 0.2 0.1 0.1 0.1 0.0 2.4 0.8 0.8 0.6 0.5 0.1 3.6 0.6 0.1 0.2 0.3 0.4 1.0 269.7 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.8 0.1 0.4 2.0 0.0 4.0 0.0 0.1 0.4 14.3 0.3 0.1 57.2 3.5 7.8 0.1 19.2 1.1 0.0 217.8 2.7 0.1 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 459.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 599.4 0.3 0.8 0.0 0.0 0.2 0.2 0.4 0.7 0.1 0.3 0.1 1.0 1.0 0.2 2.8 0.6 0.2 0.5 3.9 616.2 0.2 0.1 0.1 4.6 1.4 1.8 0.5 0.5 1.3 874.7 0.9 0.4 2.2 2160.3 1.5 0.5 3.3 1.3 1.6 1099.9 1.2 92.4 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 1.3 0.0 282.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 210.3 0.6 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.9 0.6 2.8 0.0 0.0 2.7 0.0 3.1 0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 28.7 60.2 0.0 0.0 0.0 2.7 0.0 0.3 0.0 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562970-88627596 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 175.1" "Cell type enhanced" "Detected in all" "Early spermatids: 1282.6;Late spermatids: 460.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 20.8 21.2 10.7 16.4 12.0 23.8 22.7 28.0 16.3 22.6 33.2 26.3 19.8 25.9 25.4 20.3 28.0 18.9 24.9 10.9 8.5 24.6 43.6 24.4 18.3 8.2 7.7 8.6 26.3 37.8 33.5 24.5 23.2 10.8 23.8 31.5 41.4 31.7 23.8 30.4 21.2 21.4 28.4 6.0 15.8 21.7 175.1 8.5 20.2 32.5 25.3 23.8 22.3 19.7 14.2 39.5 75.4 64.7 54.8 50.8 48.6 68.3 58.6 54.2 85.2 74.7 55.3 63.2 55.1 41.9 61.4 46.3 44.4 46.8 55.7 115.9 43.4 34.7 26.7 51.6 42.5 51.2 57.3 34.3 39.2 65.2 68.2 66.9 53.3 56.7 47.2 54.2 21.0 75.8 86.3 52.8 28.1 39.9 60.8 64.1 46.1 83.9 23.1 54.3 68.2 45.6 37.0 75.2 75.4 37.3 54.3 75.3 36.3 39.2 101.3 65.1 43.1 59.2 29.3 30.0 61.7 49.0 27.1 48.0 19.1 20.7 29.4 18.9 25.3 20.4 16.8 18.0 20.8 22.1 15.4 17.2 16.9 3.8 25.9 29.6 12.5 17.2 17.4 10.7 12.0 28.0 16.3 10.9 8.5 8.2 7.7 8.6 10.8 6.0 8.5 14.2 25.2 121.8 57.0 38.2 18.1 22.7 24.5 25.2 21.1 61.2 27.0 24.9 22.6 28.6 37.6 20.2 77.2 49.2 25.4 28.4 35.2 25.6 1282.6 53.0 46.6 28.7 31.8 17.1 88.8 23.0 27.4 30.5 20.9 34.3 45.6 51.8 24.3 38.1 20.3 65.6 65.5 31.4 34.6 14.9 16.3 460.1 39.4 19.6 5.4 34.7 20.0 33.6 18.6 64.3 62.9 22.0 16.4 47.4 18.6 26.0 27.4 32.4 53.0 78.9 13.1 46.6 35.4 217.9 81.5 23.0 19.7 40.6 20.1 39.2 32.8 16.3 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 12.1 13.3 6.2 7.7 5.8 11.4 13.5 7.6 11.1 15.2 4.1 12.5 8.9 14.2 1.1 14.5 15.2 3.7 12.8 5.7 5.1 11.7 14.9 11.7 8.1 8.9 6.5 5.7 14.5 12.3 4.3 12.6 4.8 6.6 15.9 1.4 1.8 11.5 4.9 17.1 14.4 14.5 2.4 5.1 18.8 12.0 10.1 6.5 5.8 13.4 5.0 3.1 13.7 14.0 7.2 19.7 28.8 8.8 16.8 3.4 3.6 33.9 30.5 5.7 14.4 10.4 37.0 18.3 28.8 25.8 4.9 7.1 20.5 6.3 11.6 2.7 16.9 55.1 16.5 36.7 21.8 5.7 21.0 23.9 7.0 4.3 13.4 2.8 4.9 8.6 24.6 43.2 10.1 5.8 66.3 24.9 56.1 28.2 6.9 23.9 73.5 12.3 29.4 5.4 18.3 36.8 20.6 26.5 24.8 9.8 3.3 23.2 25.3 13.8 31.2 21.7 30.5 25.8 18.2 12.6 53.3 9.9 29.3 26.7 0.0 5.7 2.9 4.1 7.2 3.9 4.1 2.9 3.4 6.9 6.0 3.1 2.5 0.5 3.4 10.7 4.3 2.7 4.7 6.2 5.8 7.6 11.1 5.7 5.1 8.9 6.5 5.7 6.6 5.1 6.5 7.2 15.8 0.0 2.7 18.9 15.2 6.9 7.8 10.4 10.2 13.7 12.7 9.8 1.6 11.5 6.3 9.2 12.5 25.5 9.1 19.4 5.9 8.2 2.0 8.4 11.0 9.6 2.4 10.8 5.3 7.2 20.2 11.4 15.8 9.2 2.5 21.2 8.9 12.3 19.6 18.5 6.4 17.2 8.2 11.8 7.0 1.9 7.5 8.6 8.8 10.3 13.3 17.3 8.2 8.5 7.0 6.9 5.5 14.7 8.7 8.8 13.7 6.3 5.1 20.1 13.1 9.9 11.4 9.8 8.2 10.3 6.5 22.0 9.6 19.0 23.5 5.1 PCNX1 "KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex" ENSG00000100731 "Pecanex 1" Q96RV3 14 70907405-71115382 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 31.5;Alveolar cells type 2: 27.9;dendritic cells: 31.6;Endometrial stromal cells: 35.3;Granulosa cells: 57.2;Theca cells: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048970, HPA053532" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048970: , HPA053532: AB_2682180" "unprognostic (1.96e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-2)" "unprognostic (4.16e-2)" "unprognostic (5.56e-2)" "prognostic favorable (4.05e-5)" "unprognostic (9.01e-3)" "unprognostic (2.90e-1)" "unprognostic (8.11e-2)" "unprognostic (7.37e-2)" 14.2 20.2 8.1 15.4 9.6 17.7 10.8 8.4 9.7 9.6 10.8 10.0 8.0 11.1 5.1 7.9 10.5 10.1 11.6 9.3 8.0 11.9 11.6 12.9 14.5 5.7 7.1 7.9 20.2 7.1 15.9 8.2 9.0 6.2 9.2 7.7 16.7 6.8 8.9 15.3 7.0 11.9 13.3 5.1 13.5 8.3 20.9 8.8 17.0 12.4 22.0 12.6 15.6 7.4 8.9 22.3 15.5 17.4 10.9 28.7 19.3 9.6 23.3 23.2 17.9 24.9 15.4 9.8 15.8 7.8 24.0 14.0 21.9 18.8 18.8 26.8 49.0 7.3 3.0 9.7 17.0 17.4 24.5 8.0 20.0 16.4 17.8 31.9 22.0 18.0 16.1 1.3 22.5 20.9 18.0 11.6 22.0 8.8 9.9 8.4 10.5 20.0 4.7 12.2 16.3 7.2 11.3 17.6 10.5 13.0 17.7 9.5 22.7 21.5 32.7 36.5 10.7 17.1 13.5 7.4 13.4 20.2 19.7 11.6 3.3 1.8 1.7 3.4 1.0 4.6 1.3 5.9 3.6 0.4 2.8 2.5 4.0 9.8 1.9 0.7 3.7 10.3 1.7 8.1 9.6 8.4 9.7 9.3 8.0 5.7 7.1 7.9 6.2 5.1 8.8 8.9 31.5 16.0 27.9 0.0 8.3 0.0 0.0 0.0 0.0 0.0 11.4 19.7 0.0 0.0 6.2 9.2 0.0 5.9 31.6 0.0 1.9 8.2 0.0 14.1 35.3 9.2 0.0 0.0 0.0 5.3 6.9 9.6 0.0 14.1 15.2 57.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 8.4 0.0 0.0 24.3 0.0 0.0 7.5 9.5 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 5.1 24.0 50.0 0.0 0.0 BDKRB1 "B1BKR, BKR1, bradyb1" ENSG00000100739 "Bradykinin receptor B1" P46663 14 96256210-96268967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 14.3;urinary bladder: 23.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 40.8;Basal squamous epithelial cells: 41.5;Fibroblasts: 17.0;Squamous epithelial cells: 22.5;Suprabasal keratinocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.0;fHDF/TERT166: 18.8;HHSteC: 29.2;hTEC/SVTERT24-B: 29.2;U-2197: 27.9;U-87 MG: 90.1" "Low region specificity" "Detected in single" HPA002935 Approved NA NA "HPA002935: AB_1078274" "unprognostic (6.15e-2)" "unprognostic (2.78e-2)" "unprognostic (9.40e-2)" "unprognostic (3.06e-3)" "unprognostic (6.76e-2)" "unprognostic (1.11e-2)" "unprognostic (3.31e-2)" "unprognostic (2.34e-3)" "unprognostic (2.23e-2)" "unprognostic (2.96e-2)" "unprognostic (4.80e-3)" "unprognostic (2.36e-1)" "unprognostic (9.96e-6)" "unprognostic (2.33e-1)" "unprognostic (8.82e-2)" "unprognostic (2.33e-3)" "unprognostic (4.66e-2)" 5.4 0.2 0.4 5.3 0.7 0.0 1.2 1.4 0.9 6.0 0.5 3.7 1.8 0.9 0.6 13.5 5.2 14.3 1.0 0.5 0.5 3.3 0.2 1.3 0.1 0.6 0.5 0.5 0.4 6.5 0.0 0.2 0.7 0.6 1.5 2.7 0.2 1.9 0.2 0.1 3.1 3.6 6.1 0.4 0.1 4.5 2.4 0.5 0.1 1.1 0.5 0.4 23.6 7.4 0.7 0.5 1.4 0.0 1.2 2.9 9.9 0.1 2.3 32.0 3.1 0.5 0.0 0.6 0.0 0.1 18.8 1.4 2.4 0.0 0.4 5.0 0.3 0.1 0.0 2.7 0.0 29.2 0.0 0.1 1.0 2.4 29.2 0.6 0.2 0.0 0.0 0.0 0.1 4.2 0.4 0.0 0.0 0.0 1.7 0.2 0.0 7.2 0.2 0.2 0.1 0.7 0.0 8.2 2.4 0.0 0.3 0.0 0.0 0.0 9.5 0.6 27.9 1.8 4.6 9.3 0.0 90.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 1.4 0.9 0.5 0.5 0.6 0.5 0.5 0.6 0.4 0.5 0.7 1.4 0.0 0.5 0.0 0.0 40.8 2.9 9.0 41.5 1.7 0.0 0.3 0.8 0.0 3.2 0.0 0.0 0.3 0.0 5.5 7.9 2.3 1.1 0.9 3.7 5.0 0.0 0.0 0.4 1.2 1.4 17.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 8.2 0.0 6.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 4.9 0.4 0.0 1.6 2.3 0.1 3.3 0.1 0.0 1.6 2.5 0.9 1.3 22.5 17.2 1.5 0.2 0.0 0.4 2.8 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 11.5 13.2 14.5 17.6 18.8 16.4 13.3 16.6 16.8 10.3 12.8 61.0 48.7 10.7 11.4 41.4 11.0 14.3 11.1 17.5 16.7 16.5 23.4 9.8 19.7 15.5 14.2 16.5 6.7 10.0 9.6 8.2 13.9 15.4 14.0 55.1 68.4 12.2 10.0 12.8 14.5 57.1 16.1 15.8 11.9 23.5 49.0 16.1 11.2 10.4 10.7 22.6 21.3 16.3 17.5 21.9 30.5 33.6 23.1 25.2 29.1 56.6 39.7 30.7 26.2 28.8 22.7 36.6 20.9 23.6 30.4 15.9 23.8 22.1 24.2 37.9 49.9 21.1 8.8 16.1 17.5 23.4 23.1 14.5 23.2 37.7 33.1 32.7 20.1 34.6 23.5 19.2 18.7 33.6 53.5 17.0 18.6 37.3 33.9 38.3 16.7 31.4 19.3 61.5 79.9 11.8 38.4 44.8 41.6 34.9 33.7 31.9 14.3 37.8 12.0 15.1 25.6 12.8 21.7 67.0 17.8 30.6 16.4 19.6 64.4 20.9 47.0 27.7 24.3 42.8 38.3 37.6 32.4 21.2 33.1 37.0 34.5 40.9 37.5 33.6 17.9 66.6 28.6 14.5 18.8 16.6 16.8 17.5 16.7 15.5 14.2 16.5 15.4 15.8 16.1 17.5 12.6 12.8 7.4 5.9 24.8 45.2 24.2 27.6 19.9 26.8 18.4 14.5 18.9 14.3 21.7 20.2 41.7 42.7 17.9 166.1 72.4 34.1 384.9 32.3 11.1 17.4 28.1 24.0 14.3 39.4 43.3 12.1 41.8 32.2 19.7 6.6 17.9 17.3 23.6 23.5 10.8 73.0 52.9 19.8 19.6 321.7 8.1 16.8 19.6 5.6 25.2 22.3 16.5 10.6 17.9 39.9 102.9 7.9 22.6 37.4 81.8 47.4 28.6 104.0 19.7 6.5 16.5 40.0 34.1 35.7 65.9 119.6 24.4 7.9 69.1 43.7 VRK1 ENSG00000100749 "VRK serine/threonine kinase 1" Q99986 14 96797304-96954846 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 50.9;testis: 37.3" "Cell type enhanced" "Detected in all" "Spermatocytes: 198.9;Spermatogonia: 110.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 5.5 5.2 6.3 12.9 7.6 50.9 11.7 6.8 8.0 5.3 5.0 10.9 6.5 6.5 7.0 9.0 9.3 4.5 5.2 6.5 6.1 4.9 5.6 5.0 27.4 6.0 6.3 6.6 6.0 3.2 5.4 3.1 7.7 6.2 5.0 12.5 4.4 4.4 5.0 4.8 7.4 7.2 6.8 5.5 11.4 6.5 37.3 6.3 35.8 6.0 4.6 28.1 7.8 5.5 7.3 52.4 27.0 78.5 30.2 9.2 14.9 44.8 42.8 34.4 67.1 65.4 36.0 54.7 139.2 22.4 24.3 39.2 56.5 75.5 54.4 90.5 73.4 36.4 90.5 18.7 39.3 10.2 168.5 49.2 8.5 9.7 50.4 32.6 12.8 47.0 104.8 76.6 79.0 56.9 65.5 137.1 76.5 47.8 39.9 59.3 124.5 134.2 48.6 32.3 59.3 53.2 28.0 34.2 36.4 30.8 36.0 39.3 66.6 24.4 27.9 22.8 47.7 37.3 37.7 53.5 124.8 44.7 74.6 34.8 42.7 12.3 26.2 21.5 15.5 29.0 31.3 24.9 26.4 15.7 32.7 27.1 27.3 6.5 45.6 15.2 21.4 34.9 19.4 6.3 7.6 6.8 8.0 6.5 6.1 6.0 6.3 6.6 6.2 5.5 6.3 7.3 15.3 3.2 4.6 6.8 30.6 16.8 13.8 23.3 6.2 12.4 9.3 11.3 11.8 12.8 16.7 14.7 8.4 34.8 24.8 6.3 11.7 13.5 21.3 21.1 8.3 12.4 3.0 76.2 42.0 19.4 48.3 11.4 14.8 10.8 28.5 20.0 7.1 3.3 19.2 10.1 36.2 10.4 20.3 11.8 14.9 11.5 5.6 12.0 12.4 19.7 14.2 6.2 27.8 12.1 19.8 10.3 2.2 9.8 25.4 6.1 3.0 11.2 37.6 9.6 19.7 14.3 15.1 198.9 110.9 14.1 13.9 15.1 26.8 9.2 18.1 10.4 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256527-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 310.5" "Cell type enhanced" "Detected in all" "Early spermatids: 593.2;Late spermatids: 549.5;Syncytiotrophoblasts: 469.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 110000 "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 72.1 61.8 52.2 48.4 53.9 87.0 65.6 54.4 63.7 49.8 52.1 67.5 36.0 67.9 72.2 72.0 53.9 37.8 105.1 53.1 55.5 62.7 84.0 55.4 49.9 54.2 54.8 51.0 46.0 53.2 69.8 37.3 70.2 55.4 50.1 61.0 40.5 55.8 58.1 310.5 73.7 54.9 62.0 53.7 58.0 61.7 82.8 53.7 63.1 48.5 143.8 72.8 65.3 54.6 55.7 141.6 131.1 147.5 154.8 126.6 115.4 154.9 133.5 185.7 287.9 215.4 122.3 154.7 119.4 198.4 162.3 132.2 142.8 182.2 155.8 334.2 143.9 80.0 93.8 84.6 105.9 109.1 143.7 120.4 104.3 120.7 187.9 137.1 120.2 176.2 130.3 134.8 69.9 200.6 267.9 108.0 186.7 130.6 180.7 160.4 127.5 190.8 97.6 163.0 144.6 154.6 103.2 109.0 279.6 118.0 121.8 175.9 125.2 134.9 110.1 98.8 119.6 196.3 120.0 204.3 178.3 159.8 129.1 172.1 95.1 101.4 160.1 67.1 93.7 66.4 57.7 68.5 69.0 101.1 56.8 62.5 60.7 109.9 82.0 110.7 70.8 101.2 116.5 52.2 53.9 54.4 63.7 53.1 55.5 54.2 54.8 51.0 55.4 53.7 53.7 55.7 63.1 102.5 80.4 11.4 51.4 65.0 90.3 175.3 30.1 51.3 48.6 45.7 39.2 88.6 136.0 55.2 52.1 304.2 48.2 91.2 119.3 180.8 593.2 68.9 56.1 90.1 57.0 80.6 21.0 197.7 178.9 71.4 30.1 70.1 98.2 82.4 75.7 196.6 150.2 79.1 21.2 68.7 111.9 91.8 82.2 549.5 76.4 74.7 67.6 14.0 146.0 88.1 72.1 10.6 22.3 210.3 71.5 82.0 50.7 75.5 104.2 160.4 123.9 65.8 85.5 67.5 139.5 198.1 48.7 44.1 50.2 469.4 55.4 82.5 74.4 92.7 PAPLN MGC50452 ENSG00000100767 "Papilin, proteoglycan like sulfated glycoprotein" O95428 14 73237497-73274640 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "neutrophil: 2.5;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 7 "dendritic cells: 5.4;granulocytes: 2.5" "Cell line enhanced" "Detected in many" "HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA048682, HPA053453" Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 76000000 Nucleoplasm "HPA048682: AB_2680492, HPA053453: AB_2682155" "unprognostic (1.97e-3)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (3.56e-3)" "unprognostic (7.42e-2)" "unprognostic (7.91e-3)" "unprognostic (2.01e-2)" "unprognostic (2.46e-3)" "unprognostic (9.13e-3)" "unprognostic (3.69e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.89e-2)" "unprognostic (2.14e-2)" "unprognostic (3.05e-3)" "unprognostic (2.69e-2)" "unprognostic (5.58e-2)" 13.6 6.6 16.6 8.5 16.5 2.3 10.8 13.0 19.3 24.6 15.9 11.1 3.0 20.6 15.0 7.1 23.2 5.6 6.0 14.8 30.3 41.9 3.3 13.6 15.4 17.2 13.4 14.5 17.0 4.0 0.4 16.5 4.0 17.0 13.7 4.5 9.6 7.5 7.6 2.1 15.4 18.0 6.4 12.5 29.3 11.4 6.5 13.8 5.1 25.0 1.8 13.7 5.2 9.2 13.4 2.7 2.6 1.0 0.4 1.9 2.3 5.8 0.5 0.0 0.1 0.2 3.4 0.8 0.5 2.7 0.0 0.1 4.3 2.7 2.0 0.3 3.0 3.9 1.2 4.7 0.3 16.1 0.4 2.1 30.6 11.4 0.5 1.7 0.2 0.6 2.5 0.8 0.3 0.0 1.4 0.3 3.0 0.6 0.3 0.8 0.4 0.3 2.8 2.3 0.6 0.3 0.5 6.2 7.0 1.3 7.9 0.2 4.8 0.5 0.7 2.3 0.2 0.3 1.3 0.1 0.3 1.4 1.4 0.6 0.8 0.5 0.3 0.2 0.3 0.1 0.4 0.1 0.2 0.1 0.5 0.2 0.2 2.5 0.3 0.2 5.4 0.3 0.1 16.6 16.5 13.0 19.3 14.8 30.3 17.2 13.4 14.5 17.0 12.5 13.8 13.4 0.4 0.0 2.6 119.8 0.3 2.0 0.7 5.1 0.6 1.2 1.8 1.4 1.9 7.2 4.8 5.5 8.4 0.5 5.7 0.4 0.0 4.0 0.3 11.8 37.9 3.4 0.0 0.0 0.3 0.0 1.1 8.3 0.5 16.1 0.0 0.2 3.3 0.1 1.2 0.0 0.9 0.4 2.0 0.3 1.6 1.7 34.5 1.8 1.8 10.3 1.6 15.7 0.0 3.0 0.3 0.4 0.0 44.0 0.2 1.4 0.2 10.2 3.7 3.0 6.6 1.4 1.8 0.6 0.1 0.8 3.0 0.4 0.7 0.1 1.0 0.4 RPS6KA5 "MSK1, RLPK" ENSG00000100784 "Ribosomal protein S6 kinase A5" O75582 14 90847861-91060641 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 162.0;Oligodendrocytes: 156.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001274, HPA001780, CAB025458" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432" "unprognostic (3.05e-2)" "unprognostic (2.19e-3)" "unprognostic (4.27e-4)" "unprognostic (1.98e-3)" "unprognostic (4.79e-2)" "unprognostic (4.20e-4)" "unprognostic (3.70e-2)" "unprognostic (5.80e-4)" "unprognostic (6.70e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "unprognostic (1.38e-4)" "unprognostic (5.73e-3)" "unprognostic (1.07e-1)" "unprognostic (2.42e-1)" "unprognostic (1.75e-1)" 2.3 0.9 2.0 3.0 6.9 3.3 7.6 14.6 3.6 3.1 0.6 6.2 3.8 5.0 0.3 5.3 4.1 2.8 2.5 1.2 3.4 1.9 1.7 2.8 3.5 3.9 3.9 1.1 4.6 1.5 3.0 2.6 3.4 5.1 3.2 5.1 3.1 5.0 4.3 9.1 3.6 4.9 4.0 3.2 3.1 5.4 2.4 4.1 5.0 4.0 10.0 3.5 5.5 4.1 7.6 1.3 2.1 2.7 1.4 0.0 0.5 9.4 0.9 1.3 2.9 4.1 1.2 2.7 6.7 2.8 2.8 1.8 4.7 2.2 1.8 5.1 1.0 3.5 7.5 1.8 0.4 0.0 7.1 31.8 0.8 4.3 1.7 1.3 0.7 3.2 5.1 0.7 7.1 2.9 3.1 2.0 2.2 0.9 4.6 3.4 3.3 11.2 3.2 3.2 2.9 10.4 3.2 2.7 14.8 8.1 1.8 3.0 1.9 0.6 0.8 1.5 0.6 3.4 2.8 3.5 5.9 1.7 5.0 10.6 16.9 3.0 9.0 3.7 2.5 6.1 4.5 4.6 3.5 2.7 5.8 5.5 3.0 19.8 10.4 3.5 1.2 7.9 2.6 2.0 6.9 14.6 3.6 1.2 3.4 3.9 3.9 1.1 5.1 3.2 4.1 7.6 13.2 19.2 26.5 80.3 53.7 40.4 45.2 20.4 53.5 32.9 41.4 42.9 20.7 14.3 22.7 7.3 16.7 43.7 21.0 36.7 0.0 11.1 9.1 96.2 19.0 21.4 16.3 22.5 65.4 5.1 6.5 21.8 13.3 162.0 92.2 32.5 20.3 6.5 7.1 26.9 32.5 17.3 4.1 17.6 13.4 3.1 14.0 21.8 19.6 53.4 21.2 10.5 23.7 36.7 156.1 3.5 13.0 11.7 26.0 29.3 41.9 3.7 31.3 32.1 13.1 51.9 22.3 21.2 23.7 35.5 46.3 111.8 48.6 7.2 20.8 52.7 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457508-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: AB_2685153" "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.0 13.7 14.9 18.4 15.7 50.5 19.7 18.0 14.9 19.1 17.8 21.4 17.3 20.2 16.1 21.6 20.6 12.4 15.5 13.8 14.5 18.5 23.9 20.4 28.5 15.1 15.4 13.0 22.2 20.0 16.9 15.0 17.7 15.3 18.6 18.7 11.0 21.0 13.2 24.7 25.6 24.6 15.1 14.4 24.3 20.7 22.5 16.5 27.6 17.9 16.9 25.6 19.7 19.5 18.3 24.5 41.4 34.1 27.1 22.5 20.9 60.9 23.2 21.4 24.5 24.6 35.2 32.1 63.1 30.2 19.2 15.0 27.8 36.6 28.9 39.8 52.0 19.7 32.5 25.7 24.5 26.3 59.1 33.1 15.1 50.4 19.7 31.1 20.1 26.7 29.4 33.5 36.2 33.1 52.1 42.8 38.0 31.2 46.5 29.8 54.0 40.6 26.5 30.3 41.5 41.6 25.4 35.3 77.0 32.5 33.6 39.4 37.8 28.0 19.2 20.6 21.1 26.8 36.0 67.0 69.3 25.2 31.8 34.7 6.2 1.9 2.9 4.9 2.6 6.6 4.6 4.5 4.4 2.1 7.4 5.6 4.8 2.5 9.0 3.7 5.0 6.9 2.6 14.9 15.7 18.0 14.9 13.8 14.5 15.1 15.4 13.0 15.3 14.4 16.5 18.3 44.1 32.1 48.3 0.0 83.0 0.0 46.7 0.0 58.1 27.9 35.9 23.5 0.0 32.9 30.3 46.0 20.9 33.9 91.8 21.1 29.4 21.2 13.0 86.9 46.5 33.3 13.3 47.5 0.0 25.1 29.0 27.3 45.3 70.7 20.2 39.8 28.9 51.8 25.8 32.0 0.0 28.2 0.0 48.7 0.0 8.5 37.6 70.7 0.0 0.0 41.8 21.0 44.3 0.0 0.0 27.8 25.7 42.5 75.8 56.6 37.3 23.5 16.8 27.3 26.3 45.9 27.1 91.0 59.9 58.0 0.0 44.3 80.1 33.0 25.8 75.2 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985894-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favorable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 7.4 4.8 6.8 5.8 7.5 12.8 8.3 6.7 7.1 10.8 8.0 8.7 7.5 8.8 11.5 7.5 9.6 9.3 5.6 6.2 6.8 8.4 9.0 6.8 10.2 8.1 7.0 5.1 10.4 9.7 8.4 6.5 5.0 7.4 9.7 9.7 4.4 8.1 5.7 6.8 18.5 8.2 6.8 6.7 10.7 8.4 4.0 6.8 15.9 11.6 8.0 10.6 8.7 8.3 9.6 5.7 10.5 8.8 12.3 13.9 30.8 12.2 6.6 10.2 5.1 6.7 6.6 16.5 16.0 6.1 6.0 7.2 11.8 5.4 16.6 4.7 6.3 3.8 10.1 14.0 15.3 12.1 7.4 8.3 22.4 12.8 7.6 9.6 18.5 9.6 10.1 11.1 3.4 5.3 16.3 9.5 13.6 3.0 12.3 7.3 15.1 8.4 9.8 6.7 8.6 31.8 13.8 8.8 8.4 9.0 9.4 13.0 12.8 5.5 9.6 12.7 4.3 6.7 11.9 3.6 11.0 6.6 9.1 10.0 12.2 7.7 22.9 8.1 7.4 7.2 10.4 6.5 8.5 9.1 10.0 9.8 9.4 11.2 10.4 13.0 6.3 13.4 7.1 6.8 7.5 6.7 7.1 6.2 6.8 8.1 7.0 5.1 7.4 6.7 6.8 9.6 3.1 9.6 1.1 14.7 8.7 3.1 4.1 4.6 10.2 1.4 4.0 4.1 3.3 1.5 2.6 0.0 4.2 4.3 7.8 3.7 7.9 3.9 0.8 3.3 2.6 3.3 15.7 6.5 3.4 3.0 5.7 3.9 7.7 3.0 7.0 4.7 1.4 1.5 3.8 0.0 3.4 6.3 4.1 5.5 2.5 1.5 4.4 3.4 5.4 9.4 1.9 4.1 7.2 7.1 9.9 3.1 7.3 4.1 5.2 1.9 4.6 3.6 4.6 2.0 6.6 3.8 3.7 2.9 8.2 5.3 1.6 3.0 5.2 4.1 5.1 2.5 PSMB5 MB1 ENSG00000100804 "Proteasome 20S subunit beta 5" P28074 14 23016543-23035230 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 1146.8" "Low region specificity" "Detected in all" "HPA049518, HPA061796" Approved Supported Nucleoplasm,Centrosome NA NA 6200000 "Nucleoplasm, Centrosome" "HPA049518: AB_2680802, HPA061796: AB_2684612" "unprognostic (3.03e-1)" "unprognostic (1.99e-2)" "unprognostic (8.35e-2)" "unprognostic (6.13e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.85e-4)" "prognostic unfavorable (2.90e-5)" "unprognostic (2.55e-2)" "unprognostic (9.95e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.19e-1)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.73e-4)" 84.8 117.0 134.6 59.2 137.9 32.3 81.8 145.5 135.4 71.9 142.5 81.5 61.7 71.6 130.6 103.1 94.1 61.5 125.0 139.8 145.9 99.4 120.1 65.2 49.4 143.8 142.3 132.8 62.2 81.6 144.7 80.7 90.9 147.7 77.5 89.6 60.3 74.1 79.4 335.1 75.2 53.5 104.3 149.0 50.7 81.6 58.3 142.2 80.2 73.0 276.5 69.1 93.0 69.0 152.2 181.0 398.9 250.6 245.5 360.4 318.9 261.8 252.0 307.3 446.1 376.1 329.2 282.2 228.0 228.1 352.1 298.4 239.7 428.4 320.2 401.9 139.9 311.4 146.9 260.3 1146.8 287.3 170.2 162.1 354.2 292.0 331.8 264.1 289.7 475.5 190.5 218.6 121.5 376.0 557.2 97.6 218.4 285.7 341.6 631.4 133.8 197.7 150.7 349.9 256.6 336.0 251.0 179.9 354.8 245.4 322.2 175.0 217.7 254.1 212.4 210.1 197.3 247.8 99.7 218.4 158.8 164.9 140.8 274.6 97.8 127.6 58.0 89.4 125.6 103.5 103.8 101.1 85.1 137.6 99.7 135.0 102.5 48.1 67.4 92.7 172.4 91.3 147.8 134.6 137.9 145.5 135.4 139.8 145.9 143.8 142.3 132.8 147.7 149.0 142.2 152.2 94.2 76.9 69.2 16.0 47.3 140.2 174.1 461.5 100.7 61.0 130.4 135.5 157.6 112.9 240.4 95.6 29.2 400.1 40.2 75.0 275.9 277.7 93.0 149.0 109.5 150.0 154.6 82.5 17.6 231.3 435.2 139.9 73.9 88.0 31.0 162.6 89.6 171.6 221.6 70.7 18.0 109.2 329.6 57.5 80.9 106.4 118.7 64.0 115.6 15.9 138.2 170.8 25.7 11.6 29.4 285.7 88.0 122.2 78.2 185.1 81.2 437.8 268.9 71.8 98.6 87.1 355.1 174.4 81.6 144.7 157.1 430.2 43.4 215.7 148.9 215.3 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282788 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 27.4 26.4 21.6 29.2 22.3 56.9 27.3 28.1 24.5 24.8 20.3 31.0 28.2 25.1 34.3 29.1 21.9 22.9 23.0 23.5 21.4 33.3 47.1 24.2 36.3 22.0 21.7 21.4 21.8 24.6 32.8 17.5 34.5 21.8 25.4 29.0 20.3 25.3 23.8 37.1 29.3 29.9 25.0 21.5 32.1 26.4 24.1 21.9 52.8 37.6 27.5 38.5 32.2 21.2 27.0 62.0 30.7 64.2 51.5 51.8 65.9 68.1 60.0 55.1 64.7 66.0 38.6 97.7 94.0 82.3 54.5 37.1 64.0 72.6 64.1 88.3 70.8 60.9 86.8 34.6 50.0 48.4 103.8 73.2 38.7 76.4 45.4 61.4 58.6 63.9 67.3 69.9 61.8 63.7 74.5 113.5 61.8 68.7 98.0 56.0 93.9 88.9 50.7 75.8 58.3 68.2 53.3 79.2 57.8 85.1 54.0 86.6 100.1 57.4 39.4 48.3 97.6 53.8 68.3 72.0 126.6 56.4 68.6 52.5 4.8 5.7 11.9 4.3 4.8 5.6 5.3 5.7 5.9 4.9 8.3 5.4 5.4 9.8 9.5 3.8 5.3 7.7 2.7 21.6 22.3 28.1 24.5 23.5 21.4 22.0 21.7 21.4 21.8 21.5 21.9 27.0 116.0 54.5 66.8 23.8 102.4 238.0 101.1 49.9 211.7 80.5 129.8 98.2 91.5 92.9 50.0 68.0 81.3 118.6 147.4 122.8 72.4 68.7 10.3 118.7 133.8 115.7 110.1 125.4 28.2 82.0 123.6 106.7 58.1 153.6 71.7 99.4 103.5 119.4 81.3 127.9 26.5 108.8 48.8 111.8 225.8 15.7 94.8 121.6 76.5 30.0 117.8 82.0 114.4 20.6 40.7 80.0 95.5 100.8 125.0 168.9 90.0 104.6 47.6 74.9 92.1 106.5 124.3 86.0 67.0 192.1 243.1 175.5 124.8 124.1 118.7 153.5 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 30000 Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 37.7 58.2 59.2 35.4 58.9 67.3 36.9 62.6 65.1 45.4 61.2 42.3 28.8 41.9 30.4 51.3 39.6 24.5 41.1 56.7 61.0 46.8 47.9 34.0 45.6 60.9 59.3 53.9 49.1 45.5 41.7 48.9 37.5 60.8 46.2 33.5 39.3 39.4 28.1 53.4 38.7 46.4 39.3 56.0 66.9 45.6 48.0 60.0 53.3 47.5 36.8 47.8 42.2 41.6 69.8 77.1 77.6 120.0 97.7 73.3 58.5 120.2 83.8 58.8 98.9 80.0 103.8 87.8 141.8 48.4 69.7 65.0 82.6 167.4 95.6 100.7 100.2 74.3 124.5 82.9 144.8 41.8 136.6 106.4 69.0 58.0 101.5 84.8 81.0 87.9 103.4 117.2 55.1 75.7 96.5 156.1 134.6 135.1 84.6 73.3 139.7 93.0 75.8 82.9 133.3 79.7 58.6 111.2 71.7 69.1 86.7 59.2 109.0 90.7 67.3 67.3 64.7 78.5 57.9 70.2 144.0 59.9 101.8 74.8 5.3 4.0 5.1 4.2 3.5 3.2 3.8 2.9 3.2 3.4 5.4 3.8 3.7 10.8 7.5 3.2 5.5 3.5 2.6 59.2 58.9 62.6 65.1 56.7 61.0 60.9 59.3 53.9 60.8 56.0 60.0 69.8 49.8 70.5 123.0 44.4 61.6 37.3 30.2 52.7 64.9 38.1 43.4 40.8 67.9 32.9 67.2 35.0 27.1 58.0 65.0 64.4 17.6 53.4 42.5 70.5 97.6 55.5 58.3 76.2 41.0 49.3 66.8 60.3 85.1 90.1 130.6 79.4 35.0 28.8 47.1 15.2 43.6 50.1 42.7 38.1 40.8 10.9 46.0 52.5 26.6 44.0 53.4 26.1 54.6 45.8 65.6 59.4 49.7 38.4 65.4 43.5 37.7 21.6 82.6 43.3 6.6 52.4 66.9 42.1 39.2 58.5 46.5 69.2 65.2 86.1 55.8 38.4 CCNB1IP1 "C14orf18, HEI10" ENSG00000100814 "Cyclin B1 interacting protein 1" Q9NPC3 14 20311368-20333312 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 381.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.79e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.37e-2)" "unprognostic (5.46e-3)" "unprognostic (2.79e-2)" "unprognostic (8.43e-2)" "unprognostic (5.88e-2)" "unprognostic (1.56e-1)" "unprognostic (1.88e-2)" "unprognostic (4.87e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.18e-6)" "unprognostic (2.12e-1)" "unprognostic (1.54e-2)" "unprognostic (4.43e-1)" "unprognostic (1.52e-1)" 31.3 20.2 32.2 10.6 33.5 35.8 58.7 32.4 44.6 52.3 38.0 32.8 21.5 43.4 48.8 27.6 53.6 21.0 75.4 32.1 35.8 67.0 75.5 37.2 25.5 35.4 33.4 31.6 100.3 45.7 51.8 22.4 31.5 35.6 38.4 30.4 21.4 29.8 24.6 52.6 35.2 24.9 30.1 33.6 20.6 31.2 23.5 32.4 32.3 57.9 64.0 31.0 40.4 42.1 35.0 30.8 24.7 137.5 133.3 68.9 94.1 110.3 37.0 73.6 55.5 72.8 83.2 33.4 106.2 23.9 27.1 55.6 53.8 96.6 69.9 74.3 30.9 82.0 63.1 22.6 79.7 201.7 117.5 56.6 128.8 114.6 39.6 381.3 67.3 42.6 125.7 77.7 82.1 37.0 48.9 68.5 79.3 83.2 66.5 46.6 82.9 67.9 45.5 58.7 44.6 109.0 113.6 25.5 58.5 170.7 75.8 18.7 84.5 18.4 31.6 40.1 38.4 48.8 38.3 51.0 72.6 10.6 97.3 37.1 6.3 4.2 0.1 8.2 1.4 10.9 11.6 9.0 10.3 17.7 9.8 9.2 13.0 0.6 6.0 1.6 18.2 13.3 3.8 32.2 33.5 32.4 44.6 32.1 35.8 35.4 33.4 31.6 35.6 33.6 32.4 35.0 22.2 28.9 27.2 16.3 35.5 58.1 74.0 45.5 113.3 4.2 57.0 71.9 30.9 58.6 21.0 23.9 20.9 41.2 27.7 15.1 103.7 31.8 64.2 13.0 37.6 24.9 41.3 34.7 22.2 38.2 70.6 34.5 23.0 20.2 34.9 76.7 20.0 35.3 17.8 1.7 28.5 40.1 28.5 23.3 26.5 92.8 51.6 22.4 51.6 7.5 17.8 46.9 30.9 15.1 19.7 29.3 18.8 44.0 17.4 63.5 21.0 86.5 5.2 17.6 46.0 36.6 31.6 101.0 77.5 67.0 40.1 34.1 28.7 61.1 44.3 51.3 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: AB_2686295" "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favorable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 10.5 10.6 5.4 8.7 9.2 7.7 10.6 11.4 8.0 11.7 13.0 10.2 10.5 9.8 6.8 12.2 7.8 10.2 10.7 4.3 6.4 13.6 13.0 8.0 9.5 7.9 8.0 2.9 11.1 25.7 19.3 4.8 11.7 7.7 9.7 9.9 10.6 11.1 8.6 11.9 9.0 7.9 10.3 6.6 8.7 15.5 13.7 6.8 11.3 16.8 15.8 11.5 10.5 5.8 11.4 22.8 22.5 14.4 15.2 24.8 38.1 21.8 35.3 27.0 17.1 19.5 13.8 36.0 15.8 25.3 31.3 13.3 29.1 19.1 17.1 37.0 24.1 5.8 17.9 20.4 13.1 18.9 21.2 17.1 14.7 20.4 30.3 25.8 18.9 27.8 8.7 11.9 17.8 27.0 31.7 12.2 5.2 6.6 22.1 16.0 14.8 27.5 8.0 15.3 36.5 10.5 9.5 28.5 16.6 11.0 14.5 36.2 10.5 36.9 19.8 13.8 20.8 16.1 15.7 25.9 14.2 23.2 11.7 25.3 9.3 9.7 20.2 13.9 9.0 13.6 13.0 14.7 13.1 7.9 23.7 14.2 14.9 9.6 14.8 16.1 14.3 14.5 4.3 5.4 9.2 11.4 8.0 4.3 6.4 7.9 8.0 2.9 7.7 6.6 6.8 11.4 66.8 54.5 79.8 57.5 32.5 16.6 30.7 31.7 21.6 61.1 39.9 40.0 115.7 34.3 54.0 38.6 73.0 44.2 41.4 29.8 17.6 72.5 13.6 58.2 81.2 53.9 32.2 30.7 58.1 46.2 32.0 51.7 39.8 56.5 37.9 68.7 32.9 37.5 24.4 43.7 74.7 40.4 32.6 25.7 11.2 14.7 62.1 30.4 7.2 51.5 41.6 56.5 47.4 66.9 92.4 44.7 29.5 54.2 26.3 39.0 31.6 23.4 56.4 70.4 59.2 76.6 50.4 105.0 65.8 19.5 17.0 72.5 30.2 79.8 32.9 35.1 APEX1 "APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1" ENSG00000100823 "Apurinic/apyrimidinic endodeoxyribonuclease 1" P27695 14 20455191-20457772 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000956, HPA002564, CAB004294, CAB047307" Supported Supported Nucleoplasm Yes No 330000 Nucleoplasm "CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174" "unprognostic (2.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.55e-2)" "unprognostic (4.74e-3)" "unprognostic (1.97e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (4.21e-2)" "unprognostic (3.14e-2)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-2)" "unprognostic (2.54e-1)" "unprognostic (7.08e-2)" 83.0 104.4 61.5 83.6 63.3 156.3 104.3 64.1 68.0 81.1 61.7 90.0 108.4 98.0 67.1 81.3 100.0 80.4 77.3 60.9 66.2 83.6 105.4 61.5 113.4 62.8 61.9 58.6 147.6 93.0 89.0 39.7 57.8 63.4 70.0 93.6 53.4 66.6 81.0 103.7 83.9 73.7 96.5 62.8 69.5 86.1 21.7 61.7 126.1 94.1 72.5 122.2 104.8 66.4 67.1 249.3 296.8 267.8 247.2 180.9 259.3 226.5 227.3 245.7 333.3 287.4 216.9 240.7 477.9 198.4 176.4 178.1 262.5 317.5 242.1 304.8 214.7 135.9 195.5 162.8 368.9 189.5 623.1 193.2 270.6 261.6 217.6 212.6 267.2 282.3 193.9 228.4 153.6 270.7 240.0 404.7 264.7 260.3 282.4 269.5 441.5 297.7 200.8 281.7 327.1 315.2 201.8 248.5 305.2 253.1 185.0 186.4 276.7 186.0 175.0 292.8 177.9 216.6 203.1 375.8 327.7 77.8 390.7 224.7 0.9 106.7 7.5 79.6 93.4 108.4 154.8 98.9 95.4 208.6 140.5 133.1 117.7 6.8 97.6 60.1 235.6 65.8 200.3 61.5 63.3 64.1 68.0 60.9 66.2 62.8 61.9 58.6 63.4 62.8 61.7 67.1 63.8 64.1 57.6 11.8 120.3 106.4 101.1 192.9 136.1 57.5 131.3 136.8 50.1 111.5 117.1 68.0 41.7 200.1 114.1 32.4 150.6 152.7 19.9 65.0 161.1 75.6 120.0 135.6 20.6 104.5 212.6 88.7 72.9 82.0 81.6 165.5 42.1 70.8 175.6 28.6 19.5 85.4 138.4 96.7 89.4 5.8 80.5 95.2 64.0 11.2 121.9 77.4 75.2 22.6 19.4 78.2 73.1 64.3 71.1 60.4 66.2 170.1 64.6 51.6 52.6 87.5 174.2 8.5 43.0 106.4 97.0 101.5 75.1 198.4 157.6 76.8 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favorable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 124.7 180.2 212.2 87.1 209.6 138.1 128.8 215.2 242.3 163.5 206.6 172.6 108.6 177.4 131.4 152.2 177.1 63.9 139.0 211.3 210.7 189.1 196.4 131.1 104.8 212.7 207.3 203.6 177.7 140.0 101.9 200.6 80.4 213.8 180.9 102.4 127.7 131.5 86.6 132.6 127.6 169.2 98.2 201.6 175.7 160.6 231.9 209.8 149.0 191.4 95.0 117.4 147.5 145.2 216.1 127.2 133.9 298.3 216.6 125.5 143.1 191.4 120.4 121.6 168.4 157.4 168.0 223.0 229.7 67.0 157.0 180.6 186.4 337.7 169.7 230.7 195.2 116.7 173.5 208.1 435.5 145.2 273.5 220.2 157.1 164.7 125.0 149.1 240.9 188.1 196.0 164.5 174.6 159.8 239.6 296.1 334.5 328.6 151.2 149.3 289.1 114.8 136.2 196.1 256.2 205.6 159.9 161.4 143.2 129.6 196.9 114.2 196.3 153.2 112.1 153.8 110.4 161.8 207.3 153.0 276.5 51.4 221.4 138.7 15.7 7.6 8.5 6.0 5.8 4.9 7.4 6.1 5.5 6.1 9.3 7.5 7.0 10.0 10.1 7.2 13.8 7.6 2.5 212.2 209.6 215.2 242.3 211.3 210.7 212.7 207.3 203.6 213.8 201.6 209.8 216.1 66.3 35.3 49.4 0.0 83.3 157.8 84.4 74.0 158.2 120.1 110.2 89.5 14.3 77.2 51.2 126.9 146.0 70.0 102.5 85.5 13.7 52.6 55.6 71.8 80.8 75.0 161.4 94.2 0.0 57.2 67.4 72.4 68.8 78.6 24.1 169.3 66.0 121.6 63.2 77.4 0.0 107.2 54.9 84.7 119.0 45.9 81.1 85.5 53.4 0.0 104.4 55.8 65.9 0.0 0.0 59.2 91.6 59.8 102.2 88.7 88.9 40.3 49.8 80.2 72.3 57.5 85.0 41.8 33.3 187.4 179.9 62.8 67.3 107.6 108.1 114.6 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356403-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA001581: AB_2666367, HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 18.0 12.7 39.5 5.6 53.8 0.0 22.9 50.8 38.6 45.7 26.2 19.0 3.1 29.4 9.9 44.5 28.9 8.8 11.7 33.0 39.1 7.5 1.8 12.2 3.6 57.3 57.0 26.4 42.3 2.2 22.4 8.4 10.5 65.3 37.1 3.3 10.7 26.4 22.7 3.6 59.5 9.7 12.6 50.0 7.7 12.0 5.5 48.3 3.2 17.6 5.1 4.8 25.5 43.2 76.2 4.7 0.0 73.2 39.5 17.1 20.0 57.7 5.3 11.3 2.0 0.9 0.0 0.0 0.0 0.0 30.3 0.3 27.5 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 11.6 18.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.1 0.0 0.0 0.0 22.6 0.1 0.0 24.1 7.8 66.5 15.1 2.6 0.0 8.7 17.6 0.0 0.0 7.6 0.0 19.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 53.8 50.8 38.6 33.0 39.1 57.3 57.0 26.4 65.3 50.0 48.3 76.2 2.0 0.0 6.7 17.0 0.0 11.6 11.6 5.6 9.6 5.0 20.3 16.3 0.7 0.0 4.1 0.0 6.2 9.3 0.2 0.0 1.9 0.1 0.9 0.6 18.9 1.8 0.0 0.0 0.2 0.0 14.7 15.7 0.0 0.7 0.0 4.4 1.8 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.7 0.8 20.2 0.4 7.2 1.9 0.0 9.0 0.0 22.1 48.9 0.0 0.0 13.9 0.1 7.6 0.0 0.3 1.1 9.3 6.6 12.6 8.9 2.2 0.5 22.7 13.4 18.1 0.5 0.3 0.0 7.0 ARHGAP5 "GFI2, p190-B, p190BRhoGAP, RhoGAP5" ENSG00000100852 "Rho GTPase activating protein 5" Q13017 14 32076114-32159728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 381.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046993, HPA056507" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA046993: AB_2679895, HPA056507: AB_2683158" "unprognostic (1.79e-1)" "unprognostic (2.03e-1)" "unprognostic (2.66e-3)" "unprognostic (6.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (1.55e-2)" "unprognostic (6.23e-2)" "unprognostic (2.88e-1)" "unprognostic (2.18e-1)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.97e-8)" "unprognostic (9.79e-2)" "unprognostic (2.21e-1)" "unprognostic (2.13e-1)" "unprognostic (1.00e-2)" 23.9 27.6 58.4 19.9 61.7 11.0 27.5 74.5 54.1 26.5 21.3 29.7 35.6 28.2 25.0 67.1 23.4 33.0 63.4 54.2 72.6 43.4 32.1 28.3 14.7 56.4 56.7 36.1 47.7 30.0 48.5 10.0 37.4 53.6 30.7 26.5 58.3 60.3 29.5 14.1 31.1 39.2 23.6 54.9 43.3 29.7 46.9 59.3 18.5 69.1 24.9 18.6 33.1 15.8 88.6 61.0 48.5 47.3 69.8 60.7 42.4 27.3 37.1 45.6 22.1 32.9 62.2 58.0 17.9 32.1 47.0 37.2 63.3 46.0 39.9 42.7 18.0 26.6 26.9 30.1 91.2 41.5 16.5 15.5 47.5 78.8 20.7 77.1 54.3 27.4 33.3 24.3 51.8 36.3 31.9 36.4 0.8 23.7 67.1 57.7 38.9 58.2 3.5 48.4 159.5 73.2 28.6 99.6 52.7 74.6 52.5 54.8 1.1 44.6 40.8 60.6 33.9 27.6 19.7 41.5 2.8 20.5 17.5 113.1 2.2 1.4 0.0 3.1 0.7 3.8 6.1 5.5 3.0 5.3 5.3 5.7 3.5 0.5 5.9 1.2 7.6 5.0 2.0 58.4 61.7 74.5 54.1 54.2 72.6 56.4 56.7 36.1 53.6 54.9 59.3 88.6 50.9 192.3 71.9 381.9 40.7 94.2 144.2 52.1 130.9 97.2 52.8 53.3 301.2 58.6 70.2 58.8 114.7 27.5 27.0 85.0 54.8 50.2 42.0 92.1 77.9 42.9 61.8 28.6 81.7 46.1 14.5 65.1 59.7 136.3 5.1 30.0 37.5 51.1 19.0 65.6 140.7 56.8 46.8 19.0 45.4 66.8 104.4 44.2 67.6 65.6 18.6 103.3 14.4 139.7 205.6 75.0 93.5 100.4 35.7 104.2 89.6 60.1 78.4 92.7 59.2 103.1 65.9 128.5 75.6 94.0 70.3 13.4 29.2 77.3 51.1 180.9 CINP MGC849 ENSG00000100865 "Cyclin dependent kinase 2 interacting protein" Q9BW66 14 102341102-102362916 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.47e-1)" "unprognostic (2.84e-1)" "unprognostic (1.50e-2)" "unprognostic (8.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.17e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.61e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-1)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.46e-1)" "unprognostic (2.40e-1)" "unprognostic (2.71e-1)" 20.6 24.1 26.2 13.5 28.8 29.0 20.0 29.8 32.4 14.4 22.7 18.2 13.7 11.6 22.0 25.4 14.4 15.1 26.4 24.6 27.2 22.7 33.8 15.8 20.5 28.3 27.9 22.8 13.8 44.5 19.4 12.7 15.1 29.1 16.1 16.0 4.5 30.1 13.8 32.2 16.2 15.2 17.3 29.8 17.2 23.8 29.4 27.9 19.7 18.5 27.3 17.9 18.4 14.5 32.5 32.1 75.1 29.1 33.3 54.5 71.6 33.4 47.0 61.1 63.3 52.3 50.8 49.6 36.3 45.8 59.4 31.6 52.7 52.0 64.7 57.6 41.6 40.2 26.2 48.0 60.4 46.7 67.2 25.7 54.7 47.5 46.1 52.6 41.9 67.7 34.2 38.5 44.0 57.9 161.2 39.8 36.4 31.2 90.2 74.5 26.2 41.3 47.8 61.5 73.2 30.9 30.2 36.6 60.0 33.6 25.7 71.3 31.5 47.3 36.1 22.0 108.7 42.1 84.9 70.9 63.3 60.4 42.5 41.9 46.1 58.3 55.0 37.5 58.4 34.4 44.1 33.4 35.1 54.3 37.6 31.9 31.5 49.8 38.0 50.8 50.7 41.6 46.4 26.2 28.8 29.8 32.4 24.6 27.2 28.3 27.9 22.8 29.1 29.8 27.9 32.5 27.5 28.9 16.2 3.3 19.1 14.0 26.0 37.5 14.2 18.2 25.2 28.1 39.7 15.7 29.0 20.2 12.5 48.5 18.4 19.1 56.7 39.6 59.4 15.4 24.9 28.8 19.7 29.5 4.1 45.2 53.7 27.8 16.3 16.7 19.6 25.8 28.5 43.9 59.8 15.2 3.6 27.1 18.3 25.5 22.2 111.2 29.8 28.1 17.8 0.0 65.8 25.2 35.0 4.0 10.0 42.6 21.9 20.3 36.5 25.9 43.9 82.2 19.8 20.1 32.9 18.0 21.4 90.1 16.1 33.6 15.8 37.1 20.5 33.9 32.9 25.4 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 339.6;urinary bladder: 395.9" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3" "Region enriched" "Detected in single" 4 "cerebellum: 2.4" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 1.2 1.6 0.3 0.1 0.2 0.0 339.6 0.2 0.4 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.3 0.9 1.6 23.7 0.2 0.0 0.5 0.5 0.2 25.7 10.4 2.1 2.5 3.3 1.2 3.3 0.4 0.4 98.6 3.1 0.0 1.7 0.1 0.2 0.2 19.2 4.8 3.4 0.8 0.0 0.1 0.0 0.0 395.9 13.7 0.5 1.2 2.2 0.2 199.9 0.3 0.3 3.1 0.3 0.2 6.4 0.1 14.4 1.1 0.8 1.9 0.3 10.4 2.0 0.7 1.2 1.4 289.5 21.6 2.8 1.0 719.8 0.0 4.3 25.1 1.7 0.2 2.5 1.7 0.0 0.1 0.4 1.8 0.7 1.4 8.0 2.5 0.3 1.1 6.9 31.7 2.6 6.3 2.7 0.0 828.1 3.5 5.0 5.9 4047.2 4.9 0.7 3.9 1.0 0.0 2.4 1286.3 7.7 4.3 2.0 0.6 11.3 1.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.3 0.9 0.5 0.5 0.2 1.2 0.2 0.8 0.5 0.1 0.0 0.0 0.0 0.4 0.0 2.1 0.2 0.0 0.8 7.4 1.3 0.4 0.0 0.0 0.0 0.0 7.9 0.1 0.1 7.9 0.1 5.0 0.1 0.0 0.2 3.5 0.0 0.1 0.2 15.1 3.5 0.0 0.0 0.0 1.4 0.0 4.9 1.7 0.0 0.1 0.2 0.0 0.3 0.8 3.7 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 4.8 0.2 1.2 0.0 0.3 0.0 0.2 0.0 1.2 6.6 0.0 0.7 0.3 7.4 0.0 0.1 24.8 0.2 12.6 0.7 30.6 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029686 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrolase, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 327.3;Late spermatids: 901.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Approved Cytosol NA NA Cytosol "HPA048977: AB_2680583, HPA062044: AB_2684668" "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 22.9 33.4 18.5 30.5 19.5 17.6 29.0 20.2 22.7 32.8 21.5 28.4 26.1 23.5 36.1 28.7 22.2 23.4 32.4 18.3 22.1 35.6 62.4 25.2 34.9 21.0 20.4 17.3 22.9 55.5 40.0 36.4 29.7 21.6 31.5 29.8 24.4 60.8 29.0 40.1 26.0 27.1 23.7 20.3 28.7 30.7 44.4 20.1 35.8 31.2 34.0 42.9 35.2 23.3 23.7 59.3 66.9 56.7 54.9 62.8 61.3 67.8 83.2 78.3 87.3 107.0 71.3 62.8 75.8 77.5 81.4 75.8 56.1 79.0 66.7 125.6 87.5 37.8 70.9 54.6 184.6 92.7 70.5 65.4 51.5 64.8 63.5 102.3 66.1 88.8 64.9 61.7 82.7 93.1 98.8 81.9 42.4 45.0 96.1 61.3 58.5 72.2 67.4 104.9 89.3 48.9 59.4 59.3 76.7 74.6 71.4 99.4 49.7 66.6 48.7 51.0 62.8 57.1 73.2 108.3 101.1 36.8 45.9 63.5 23.8 27.4 39.2 31.0 35.0 39.6 25.6 31.4 34.0 32.8 25.8 28.7 28.3 27.1 42.1 47.0 21.9 48.2 30.5 18.5 19.5 20.2 22.7 18.3 22.1 21.0 20.4 17.3 21.6 20.3 20.1 23.7 40.8 12.8 49.3 25.5 63.2 40.0 56.0 74.6 37.5 37.5 40.7 29.0 41.0 34.3 81.2 40.5 58.4 67.3 59.6 39.4 64.6 73.2 327.3 53.1 43.9 40.7 44.9 36.2 25.4 79.8 75.6 45.8 38.7 64.3 47.5 37.3 36.4 110.0 49.7 26.9 26.8 48.7 87.5 39.0 43.6 901.8 38.5 47.4 28.4 24.4 56.1 44.3 41.2 27.6 54.6 55.1 34.0 37.6 133.1 60.7 39.0 79.2 93.0 50.1 26.3 38.3 46.1 95.4 76.0 36.0 50.3 94.0 64.7 43.0 31.6 64.5 CPNE6 ENSG00000100884 "Copine 6" O95741 14 24070837-24078100 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 46.3;retina: 16.5" "Cell type enhanced" "Detected in some" "Astrocytes: 15.3;Bipolar cells: 26.3;Horizontal cells: 32.0;Inhibitory neurons: 11.4;Late spermatids: 18.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031636, HPA076665" Enhanced NA NA "HPA031636: AB_10601203, HPA076665: " "unprognostic (1.02e-2)" "unprognostic (3.26e-4)" "unprognostic (1.64e-1)" "unprognostic (5.66e-5)" "unprognostic (3.51e-3)" "unprognostic (2.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.09e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-2)" "unprognostic (2.71e-1)" 0.2 0.2 39.0 0.2 34.7 0.2 0.0 16.2 41.4 0.2 9.1 1.2 2.5 0.2 0.3 1.7 0.3 0.0 0.2 46.3 24.9 6.8 2.2 0.1 0.0 26.9 19.5 33.7 0.1 0.0 0.0 8.1 0.0 29.7 2.9 0.5 16.5 0.0 12.4 0.1 0.3 3.5 0.3 16.1 0.0 0.4 0.5 24.4 0.1 0.2 0.1 0.0 0.7 0.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 34.7 16.2 41.4 46.3 24.9 26.9 19.5 33.7 29.7 16.1 24.4 25.9 0.0 0.0 0.0 15.3 0.0 0.1 0.0 0.0 0.0 26.3 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 6.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 11.4 0.2 0.0 0.0 0.0 18.1 0.6 0.0 0.0 1.0 0.0 1.4 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.3 6.5 2.4 0.0 3.8 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052186: AB_2681754, HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favorable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 12.1 12.0 10.7 13.6 12.0 35.6 15.0 15.8 13.3 12.5 9.5 13.6 9.5 14.9 11.2 15.0 13.0 10.2 11.2 10.5 11.2 10.9 9.7 13.8 18.2 10.9 11.4 10.2 17.2 13.8 22.5 13.2 11.8 11.3 13.3 12.4 14.9 13.7 12.2 15.8 22.3 14.8 14.9 9.8 16.0 14.4 13.0 11.6 25.6 15.0 12.8 17.6 12.9 13.0 13.1 31.2 39.6 43.6 20.7 27.7 23.6 24.9 24.4 28.4 36.5 35.4 35.0 26.3 51.4 14.8 33.1 28.4 37.2 54.9 35.1 46.0 39.3 24.2 46.3 27.6 43.5 25.7 64.6 40.4 32.8 27.2 40.9 29.7 28.6 33.4 40.2 32.4 26.7 28.0 33.9 46.1 26.0 33.4 30.9 34.3 42.0 32.9 17.4 27.3 57.9 30.9 30.7 37.5 29.8 21.8 39.7 20.7 30.5 36.4 29.2 23.0 17.8 29.1 30.3 38.4 50.3 12.1 23.2 29.6 9.1 3.8 9.8 5.5 3.8 6.4 4.2 4.9 5.6 2.7 11.2 5.0 4.4 7.9 7.8 6.7 6.1 4.7 2.7 10.7 12.0 15.8 13.3 10.5 11.2 10.9 11.4 10.2 11.3 9.8 11.6 13.1 27.6 38.5 56.3 27.4 32.2 12.6 11.3 15.9 23.3 33.3 21.9 22.6 19.6 24.3 32.6 33.1 27.1 14.7 40.0 16.8 1.9 21.8 3.4 32.5 37.9 25.5 27.1 27.8 41.0 23.6 12.3 24.0 27.5 39.5 28.4 41.7 13.9 14.9 17.5 23.5 40.2 16.0 8.2 20.1 9.3 4.1 16.1 25.3 10.6 20.6 27.1 18.9 32.0 29.7 33.1 26.5 13.9 17.7 32.4 16.1 12.0 7.4 28.8 24.3 0.0 32.1 26.2 29.2 25.1 24.6 16.6 12.3 31.4 34.1 16.8 12.7 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "intestine: 197.9;kidney: 100.0;liver: 377.2" "Group enriched" "Detected in many" 4 "Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria NA NA 3500000 Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 25.2 10.8 3.3 8.1 3.6 4.5 21.3 3.5 3.2 6.3 3.1 28.1 197.9 5.9 3.1 20.1 6.0 4.6 4.9 2.8 4.5 100.0 377.2 16.6 8.8 4.1 3.8 2.6 3.0 35.0 17.6 8.0 2.8 3.8 9.1 19.4 2.7 18.7 7.2 2.6 12.4 137.5 3.9 3.8 21.9 16.2 19.9 3.7 3.7 19.0 1.2 7.6 10.9 10.1 3.8 17.6 9.8 2.7 18.1 11.0 10.5 46.0 21.5 25.6 17.4 28.4 16.1 19.9 44.6 2.6 33.4 5.6 25.4 18.0 28.1 13.8 22.8 0.8 8.0 5.0 84.2 104.7 15.8 33.4 12.9 104.7 10.6 26.5 5.0 14.0 50.6 23.4 79.3 6.4 74.6 4.0 7.6 3.1 39.4 13.0 8.7 10.5 26.0 5.3 26.7 11.3 18.2 16.5 21.2 103.9 2.6 28.5 24.1 2.7 3.8 19.7 5.6 6.0 53.2 18.6 11.0 10.6 24.5 9.6 0.3 11.6 3.5 4.0 21.6 4.1 11.4 4.5 4.5 15.3 7.3 2.7 2.5 1.3 2.2 22.0 2.5 9.1 6.1 3.3 3.6 3.5 3.2 2.8 4.5 4.1 3.8 2.6 3.8 3.8 3.7 3.8 4.8 12.8 28.5 1.3 17.9 3.3 10.2 12.3 5.7 4.7 8.6 5.2 1.8 18.6 8.0 18.4 0.0 4.7 4.3 91.2 35.2 18.9 60.1 1.6 5.2 5.6 9.1 24.4 0.5 76.3 14.3 7.4 16.8 4.5 1.3 1.6 13.2 309.3 63.8 0.0 0.9 60.8 18.3 25.8 5.7 30.8 3.4 16.4 7.2 1.0 22.9 5.8 7.2 0.0 0.1 29.0 87.8 3.0 13.3 7.6 752.6 237.1 4.8 5.5 0.0 3.4 18.7 19.8 1.0 9.1 4.8 3.0 7.6 6.8 72.0 15.0 PRORP "KIAA0391, MRPP3" ENSG00000100890 "Protein only RNase P catalytic subunit" O15091 14 35121846-35277622 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA020459: AB_2670449" "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 11.4 17.1 11.9 17.1 12.6 12.3 14.0 12.7 16.2 13.7 16.0 20.1 15.4 8.5 16.8 19.4 11.9 10.5 12.3 11.7 13.7 25.3 25.1 12.6 21.4 13.5 12.4 11.2 7.1 10.7 19.5 9.7 11.1 13.1 10.7 21.0 6.2 13.3 9.7 15.2 17.2 14.6 12.0 11.6 13.7 13.8 12.2 12.4 31.4 15.7 17.2 22.7 15.5 12.0 14.9 47.5 34.9 23.6 33.1 25.1 21.0 22.7 31.1 25.3 35.9 26.1 35.8 26.3 53.0 39.0 27.2 9.9 33.9 43.8 47.3 36.5 39.2 12.9 22.6 24.9 77.9 25.2 27.2 23.0 28.3 37.7 33.9 31.6 30.2 50.0 41.3 38.4 13.6 42.5 54.9 46.0 33.3 26.8 30.4 33.4 42.9 40.4 28.1 52.6 44.6 24.0 25.0 40.0 43.3 26.8 29.0 55.4 23.9 44.5 30.7 25.7 22.1 25.8 15.5 40.4 53.9 14.5 32.0 32.5 30.9 10.3 7.2 30.3 9.6 43.9 20.1 47.3 32.8 13.8 14.4 41.6 30.1 14.4 24.7 8.2 20.4 56.1 24.3 11.9 12.6 12.7 16.2 11.7 13.7 13.5 12.4 11.2 13.1 11.6 12.4 14.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 DCAF11 "GL014, PRO2389, WDR23" ENSG00000100897 "DDB1 and CUL4 associated factor 11" Q8TEB1 14 24114195-24125242 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003583, HPA031157" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003583: AB_2667001, HPA031157: AB_10603002" "unprognostic (1.50e-1)" "unprognostic (4.72e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (1.01e-1)" "unprognostic (9.58e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-3)" "unprognostic (3.23e-2)" "unprognostic (4.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.01e-1)" "prognostic favorable (3.50e-13)" "unprognostic (2.58e-1)" "unprognostic (3.48e-1)" "unprognostic (6.80e-2)" "unprognostic (1.68e-1)" 15.4 42.0 21.6 13.5 21.7 39.8 17.3 19.7 23.1 15.3 19.3 20.8 29.5 17.2 23.4 30.1 15.7 13.7 31.5 22.1 20.1 34.0 108.1 17.7 15.8 20.8 20.6 21.6 23.3 60.2 28.4 25.8 9.3 20.9 23.8 16.7 17.8 26.1 17.7 62.8 20.0 37.8 11.8 19.0 29.1 34.6 16.6 21.7 19.2 26.6 50.4 16.2 20.4 16.3 21.1 12.5 18.3 12.3 10.9 10.7 8.8 16.6 9.1 10.7 16.0 19.5 12.0 21.3 19.4 10.3 12.2 13.3 16.1 15.8 9.6 7.4 23.1 9.5 15.6 19.7 67.3 14.3 27.7 31.0 5.3 23.1 6.7 16.7 13.1 12.3 31.6 15.0 23.0 9.7 39.2 23.7 28.5 7.2 35.0 17.0 25.1 16.0 28.2 12.2 28.1 22.1 17.0 5.3 29.9 13.4 12.7 15.4 19.6 5.1 12.5 10.0 13.6 13.2 38.6 36.2 25.3 6.0 17.7 10.9 14.0 13.8 20.5 13.8 15.8 11.7 12.1 12.5 13.5 17.1 11.5 12.2 11.4 11.7 23.0 13.9 8.6 16.7 15.2 21.6 21.7 19.7 23.1 22.1 20.1 20.8 20.6 21.6 20.9 19.0 21.7 21.1 18.2 28.9 45.4 10.4 30.5 8.8 22.2 18.7 31.3 34.1 34.8 20.7 41.2 44.3 23.9 38.6 47.9 34.6 34.2 76.1 46.9 41.6 19.3 22.0 10.8 15.2 28.9 201.2 9.2 46.2 31.5 14.1 29.0 22.5 12.6 26.5 22.1 156.0 37.4 16.8 6.9 40.7 20.3 27.0 12.8 26.6 9.0 24.1 17.8 9.4 39.2 38.8 55.6 7.1 9.7 31.9 34.6 14.7 26.6 25.0 147.9 56.0 22.3 29.4 26.3 15.9 14.5 23.7 12.4 32.6 11.4 50.5 31.2 60.7 49.0 22.7 PSMA6 "IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27" ENSG00000100902 "Proteasome 20S subunit alpha 6" P60900 14 35278633-35317493 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 156.3;Late spermatids: 474.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003049 Approved Supported Nucleoplasm NA NA 18000000 Nucleoplasm "HPA003049: AB_1079703" "unprognostic (9.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.90e-2)" "unprognostic (8.07e-2)" "unprognostic (3.42e-2)" "unprognostic (4.11e-3)" "unprognostic (7.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.27e-4)" "unprognostic (1.29e-3)" "unprognostic (2.63e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.49e-1)" "unprognostic (5.08e-2)" 118.8 142.4 95.4 118.3 98.9 156.8 132.4 94.6 141.9 82.0 94.3 129.8 116.2 83.1 99.6 127.0 84.8 70.3 148.3 96.9 102.9 99.0 174.2 124.7 138.7 99.1 97.0 95.6 71.9 92.7 83.5 83.9 121.7 99.6 75.4 131.3 64.4 88.5 81.8 353.0 107.9 115.8 95.2 97.1 115.4 96.7 249.9 99.8 292.7 83.0 205.7 140.9 133.8 86.4 102.4 502.2 367.2 257.6 264.9 209.8 214.5 523.1 252.2 300.3 368.2 329.0 338.8 341.7 322.9 492.1 244.4 220.4 337.5 306.6 280.0 434.5 337.9 170.1 257.6 233.6 1011.6 235.8 542.0 225.8 166.7 229.4 256.6 324.7 178.2 312.2 548.1 284.2 220.4 298.7 522.9 838.2 458.2 249.3 391.0 407.0 1249.4 261.3 256.9 312.8 634.9 275.1 230.8 285.5 402.2 274.7 211.9 473.8 351.4 267.1 235.8 231.8 245.7 283.6 234.0 576.3 605.9 192.4 335.7 272.0 232.1 364.6 242.2 241.0 344.8 243.0 212.8 230.9 248.9 373.6 171.5 182.5 217.5 131.9 300.6 343.7 385.3 317.0 711.5 95.4 98.9 94.6 141.9 96.9 102.9 99.1 97.0 95.6 99.6 97.1 99.8 102.4 20.8 44.8 40.7 20.2 37.7 33.3 14.9 37.2 69.4 13.7 16.5 15.0 1.4 22.8 45.7 14.7 25.0 32.2 24.8 22.4 21.5 34.2 156.3 21.2 14.9 30.5 18.0 56.8 32.7 36.7 26.0 28.4 46.4 28.2 54.5 10.1 29.6 20.0 22.6 25.2 31.2 18.3 22.4 36.7 89.5 474.9 22.7 62.2 24.9 22.5 34.1 8.6 34.0 20.6 29.4 32.8 19.5 17.3 114.6 15.9 43.1 25.4 59.5 19.4 13.1 17.8 31.3 35.1 20.0 89.8 33.1 41.3 53.7 9.2 22.2 17.1 NFKBIA "IkappaBalpha, IKBA, MAD-3, NFKBI" ENSG00000100906 "NFKB inhibitor alpha" P25963 14 35401513-35404749 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1125.1" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 4056.6;Langerhans cells: 4828.7;Suprabasal keratinocytes: 3420.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 391.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003815, HPA029207" Approved Enhanced Cytosol NA NA Cytosol "CAB003815: AB_344886, HPA029207: AB_10603122" "prognostic favorable (1.33e-5)" "unprognostic (3.39e-1)" "unprognostic (7.29e-2)" "unprognostic (7.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (2.46e-1)" "unprognostic (2.46e-1)" "unprognostic (7.19e-2)" "unprognostic (2.32e-2)" "unprognostic (3.69e-1)" "unprognostic (4.44e-2)" "unprognostic (9.74e-2)" "unprognostic (3.80e-2)" 234.0 172.7 75.1 152.1 77.1 1125.1 172.8 76.1 88.3 124.9 86.0 121.2 61.7 96.3 29.9 153.0 142.4 131.6 135.7 71.3 84.8 104.8 209.9 369.2 123.7 89.5 77.8 67.5 258.0 102.7 69.4 93.1 93.4 81.5 113.5 81.7 18.8 119.2 111.1 140.9 243.0 149.8 93.5 76.8 228.1 131.8 32.0 81.1 124.4 112.8 139.6 182.9 369.8 168.2 80.8 62.5 54.1 20.1 18.2 114.7 75.9 71.1 25.2 240.7 53.3 47.3 16.9 36.5 37.5 66.1 40.2 125.2 79.5 38.3 104.9 76.1 229.2 14.9 18.6 39.9 101.4 68.6 29.9 15.0 83.1 103.5 36.4 92.2 35.5 48.6 18.4 15.9 58.4 38.6 73.0 39.2 71.0 18.6 60.0 33.1 87.8 23.1 31.6 92.8 391.7 17.9 31.2 67.2 115.9 29.7 41.0 66.1 62.2 91.7 72.8 26.5 21.3 41.0 70.9 77.7 64.5 60.8 22.0 15.3 322.0 444.9 301.4 175.3 267.2 264.0 258.4 207.1 182.5 428.9 329.7 178.1 153.0 942.9 285.9 183.7 233.0 154.9 506.4 75.1 77.1 76.1 88.3 71.3 84.8 89.5 77.8 67.5 81.5 76.8 81.1 80.8 802.9 535.2 914.0 14.4 505.6 4056.6 1862.8 2061.4 1729.6 27.0 430.7 414.0 188.6 367.4 719.2 62.5 12.5 196.4 762.2 447.8 195.6 875.0 4.3 703.8 935.6 1079.8 203.5 87.8 7.1 394.8 174.9 1145.1 333.8 1440.1 906.1 68.2 313.4 147.2 791.2 48.8 5.1 453.0 634.7 491.4 4828.7 14.7 153.1 1609.0 1085.1 39.4 428.1 95.2 97.9 6.6 8.6 383.5 511.5 116.2 1039.4 1412.0 1051.6 115.9 298.2 37.4 203.8 956.9 847.2 3.3 26.4 1544.6 3420.6 660.0 838.4 91.8 346.0 1004.6 EMC9 "C14orf122, CGI-112, FAM158A" ENSG00000100908 "ER membrane protein complex subunit 9" Q9Y3B6 14 24138959-24141591 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 155.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 63.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078254 Approved NA NA "HPA078254: " "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.51e-1)" "unprognostic (3.14e-2)" "unprognostic (5.71e-2)" "unprognostic (9.46e-2)" "prognostic favorable (2.43e-4)" "unprognostic (1.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.17e-2)" "unprognostic (1.81e-1)" "unprognostic (3.33e-1)" "unprognostic (1.29e-2)" "unprognostic (1.99e-1)" 10.1 30.4 9.5 2.7 9.7 6.1 10.5 9.9 11.0 11.5 11.3 14.7 10.0 11.1 4.9 14.6 11.6 2.5 17.4 9.7 10.2 20.7 27.0 10.2 4.2 9.9 9.4 9.8 13.4 20.9 5.1 32.2 3.1 10.4 19.7 3.4 12.6 14.5 5.2 40.0 16.3 14.5 3.1 9.2 17.4 13.9 16.4 9.9 6.2 14.5 18.6 3.7 13.3 12.0 10.4 14.1 32.6 9.0 25.0 4.7 2.5 8.3 8.7 7.0 12.5 12.5 14.2 10.5 11.6 7.5 7.0 9.7 12.6 7.4 13.8 7.4 9.3 18.0 2.7 13.2 63.3 5.8 10.3 5.7 3.4 5.6 6.8 11.9 10.0 14.1 16.3 2.7 14.9 9.9 33.0 10.2 8.8 10.4 14.3 23.7 6.4 22.3 12.1 9.8 16.7 15.7 12.7 16.3 28.9 7.7 4.4 16.1 5.2 7.1 5.4 15.0 8.0 14.7 18.7 17.7 13.5 8.4 4.4 8.8 0.8 4.2 3.5 3.7 2.3 4.2 4.6 5.1 5.0 4.3 4.8 2.5 3.4 0.4 3.4 2.1 10.2 7.5 3.5 9.5 9.7 9.9 11.0 9.7 10.2 9.9 9.4 9.8 10.4 9.2 9.9 10.4 14.1 0.0 7.0 3.9 17.3 18.1 10.4 24.7 24.5 46.4 23.3 23.1 19.7 17.2 15.5 23.9 18.8 33.0 17.3 22.1 56.7 17.6 83.3 12.6 12.3 12.3 21.0 32.6 6.1 11.7 24.2 16.6 6.1 12.9 5.1 24.2 8.6 26.1 30.5 11.8 6.6 29.6 24.4 14.0 19.6 155.7 11.5 11.4 16.0 3.7 15.4 21.2 9.2 4.0 3.2 9.7 14.0 21.8 21.6 17.9 75.9 61.0 18.6 54.4 13.1 15.5 18.5 20.9 5.6 18.1 23.9 24.5 13.4 32.0 30.9 10.3 PSME2 PA28beta ENSG00000100911 "Proteasome activator subunit 2" Q9UL46 14 24143362-24147570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 1063.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062661 Approved Nucleoplasm NA NA 5900000 Nucleoplasm "HPA062661: AB_2684825" "prognostic favorable (1.27e-4)" "unprognostic (7.55e-3)" "unprognostic (2.84e-1)" "unprognostic (8.72e-2)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (2.30e-2)" "unprognostic (2.90e-3)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (6.43e-3)" "unprognostic (3.07e-3)" 76.6 206.2 27.8 87.3 28.4 43.2 80.4 27.2 40.4 92.5 30.3 87.0 167.4 69.2 49.1 113.4 75.7 30.9 88.3 27.3 31.3 130.6 230.0 108.8 90.4 30.3 28.1 27.2 72.3 103.0 27.9 124.7 31.0 29.1 94.9 80.0 18.3 84.7 34.1 64.2 69.5 154.1 44.4 28.6 206.3 102.4 57.4 29.7 52.6 92.9 26.9 80.9 74.6 81.2 30.7 95.2 93.2 59.5 140.6 42.8 59.9 85.6 47.7 108.4 145.7 182.4 72.7 183.9 111.0 30.7 59.8 166.5 79.1 32.1 92.0 87.6 198.6 28.9 75.2 45.8 277.1 135.9 103.4 100.1 61.2 26.3 115.1 44.1 65.6 79.3 78.2 37.2 165.2 61.5 188.6 204.2 140.0 19.8 142.3 112.1 189.2 93.2 119.2 108.9 209.4 36.8 47.7 101.6 168.8 70.3 31.0 89.0 110.7 63.4 80.7 75.1 38.2 102.5 143.7 215.1 140.7 52.9 110.0 99.7 110.3 605.5 217.5 421.1 1217.1 431.5 432.6 412.2 415.9 504.7 357.2 305.7 373.8 192.3 543.4 801.7 375.6 447.3 1562.7 27.8 28.4 27.2 40.4 27.3 31.3 30.3 28.1 27.2 29.1 28.6 29.7 30.7 185.3 51.3 113.7 5.2 198.5 154.9 174.3 754.8 126.3 39.7 104.5 120.8 69.5 140.2 287.7 117.7 22.9 296.6 223.6 316.1 299.3 370.5 12.6 113.0 147.3 159.7 98.0 74.2 1.7 567.1 296.6 128.6 132.5 109.9 141.5 83.4 69.7 236.6 332.1 28.6 2.2 288.5 319.4 143.7 224.9 15.5 74.0 237.8 136.9 2.8 763.7 69.8 326.5 2.5 1.3 303.1 324.5 77.8 389.3 282.8 1063.1 373.6 293.7 19.2 46.0 62.0 453.3 54.6 24.8 144.5 139.8 228.2 228.6 229.0 338.5 224.4 BRMS1L "BRMS1, FLJ39177, MGC11296" ENSG00000100916 "BRMS1 like transcriptional repressor" Q5PSV4 14 35826338-35932325 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046623 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA046623: AB_2679724" "prognostic unfavorable (5.78e-4)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.69e-3)" "unprognostic (2.66e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.56e-2)" "unprognostic (2.02e-2)" "unprognostic (8.04e-2)" "unprognostic (6.50e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.55e-5)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (6.87e-6)" 6.2 10.2 8.9 3.8 10.2 2.6 6.2 8.7 11.3 5.9 6.5 4.4 3.2 6.4 5.6 6.4 5.1 4.2 11.7 9.6 9.7 8.9 6.2 4.9 3.0 8.4 9.5 9.0 7.2 3.1 9.9 4.5 7.3 9.2 6.5 3.6 8.3 4.2 6.2 13.7 5.9 3.2 7.1 8.4 3.6 4.3 5.3 9.4 3.5 7.2 13.8 3.9 5.8 5.4 10.1 10.1 10.1 17.1 9.9 15.2 19.1 25.5 10.3 9.9 15.7 15.3 6.5 8.3 8.1 10.3 14.4 7.4 12.6 13.7 18.7 22.3 9.0 16.8 7.4 10.1 28.6 10.7 3.7 5.9 13.4 12.5 12.1 10.2 8.2 11.4 4.7 3.6 6.3 17.7 13.5 4.3 6.0 6.8 14.2 14.8 4.4 19.1 6.2 12.7 11.4 5.1 13.1 12.0 13.7 12.2 13.0 15.7 5.2 7.0 14.9 9.1 8.6 10.2 5.8 8.2 5.0 3.7 8.1 9.2 0.0 0.5 0.3 1.0 1.2 0.8 0.7 1.0 1.3 0.3 0.5 1.4 1.2 0.0 0.4 1.4 0.9 1.4 0.7 8.9 10.2 8.7 11.3 9.6 9.7 8.4 9.5 9.0 9.2 8.4 9.4 10.1 11.6 9.6 13.9 13.7 10.5 18.6 10.2 10.4 19.9 18.5 8.4 7.1 19.2 2.8 10.6 7.3 4.2 19.3 15.7 2.3 7.9 4.9 3.5 6.7 13.0 11.2 4.8 1.3 21.2 6.9 15.4 15.3 6.1 6.3 14.7 6.9 6.8 6.3 5.1 16.8 22.3 3.8 12.2 2.8 9.5 3.2 11.1 3.9 8.8 6.5 6.6 21.4 3.1 20.6 26.2 4.4 3.0 9.8 8.8 14.0 1.7 19.2 6.7 17.5 19.7 17.5 20.0 6.5 16.6 12.6 16.2 22.4 11.4 11.8 3.7 7.1 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 69.4" "Cell type enhanced" "Detected in many" "Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 5.6 6.1 3.4 2.1 3.1 6.7 2.5 4.9 3.9 4.9 4.3 6.7 1.3 7.2 0.1 2.7 15.0 8.9 2.8 3.1 4.6 12.4 3.3 9.6 3.1 7.4 4.2 3.0 3.9 2.7 0.2 69.4 0.6 8.7 7.3 0.4 1.9 4.8 6.3 0.9 1.6 7.4 2.4 2.8 13.7 25.9 30.2 4.5 10.2 3.5 0.3 3.1 4.0 3.8 6.8 0.1 0.2 10.8 0.1 0.4 0.5 0.6 0.4 0.5 1.0 0.8 0.1 1.2 0.2 0.1 0.0 0.6 0.5 0.3 0.0 0.7 1.0 0.2 0.4 0.7 0.0 8.7 0.2 1.5 4.8 0.5 0.4 0.1 4.1 1.9 0.4 0.1 1.4 0.0 0.2 11.7 1.8 3.4 0.0 0.1 0.2 0.0 0.1 0.4 0.4 0.2 47.4 0.0 0.1 0.4 26.0 0.2 0.5 0.4 0.0 0.2 0.3 0.1 1.7 0.5 0.1 0.0 0.2 0.2 2.2 0.1 9.7 4.7 1.1 5.4 1.6 1.7 2.7 3.2 1.7 0.7 2.4 0.1 2.8 5.8 5.2 2.9 1.2 3.4 3.1 4.9 3.9 3.1 4.6 7.4 4.2 3.0 8.7 2.8 4.5 6.8 9.5 12.8 10.8 3.6 6.8 1.9 4.4 15.8 8.6 14.9 2.8 2.0 2.0 25.8 14.8 27.6 0.0 1.4 10.2 5.1 5.9 2.9 150.6 43.5 10.6 4.8 4.8 25.9 3.8 2.7 3.2 10.0 73.9 21.9 3.8 7.9 3.6 2.1 2.3 6.7 5.1 2.5 10.2 5.7 3.9 74.5 4.7 6.6 1.8 2.8 4.0 21.1 2.1 5.5 4.6 5.0 0.7 3.0 11.0 1.5 4.1 24.7 51.4 2.0 0.0 3.7 3.9 8.3 43.4 1.3 2.0 0.4 11.3 33.8 2.4 4.0 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189149-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 25.8 35.5 8.1 10.6 7.8 3.8 25.8 8.8 7.9 28.1 16.6 22.3 12.8 31.4 31.5 25.6 28.1 17.6 20.2 7.7 12.9 25.3 34.9 27.0 7.8 9.0 8.6 7.1 25.0 47.2 36.9 20.1 18.3 8.7 23.6 15.7 5.9 35.9 21.5 19.6 24.0 21.6 18.3 9.1 19.5 29.6 20.4 8.7 8.4 30.9 11.2 12.5 24.0 23.8 8.8 22.0 45.1 17.7 18.0 59.4 40.4 22.4 37.6 55.4 53.7 60.5 19.1 49.0 12.5 25.2 50.3 30.7 50.5 14.9 29.7 39.3 18.4 15.4 9.4 21.3 56.2 41.8 18.5 22.8 41.3 56.1 36.9 50.5 42.3 32.3 7.9 11.2 30.7 43.6 51.2 12.1 15.7 8.4 62.1 39.2 15.6 22.1 24.7 42.5 37.9 16.3 18.6 39.0 44.3 24.5 16.8 28.8 14.1 26.0 47.5 21.2 23.1 28.1 31.0 25.5 7.4 18.1 11.5 39.5 33.4 20.5 25.0 14.1 18.1 15.3 15.0 14.6 12.6 23.4 16.3 13.0 12.9 28.3 23.1 18.5 39.2 17.2 13.5 8.1 7.8 8.8 7.9 7.7 12.9 9.0 8.6 7.1 8.7 9.1 8.7 8.8 5.5 16.0 5.3 8.8 11.2 3.3 6.1 7.3 18.8 4.4 6.1 5.0 1.5 7.2 7.6 1.8 14.6 9.8 5.0 4.0 0.0 8.2 13.9 5.2 7.4 8.7 1.8 5.5 6.6 4.9 10.4 14.9 13.7 6.3 2.5 5.3 5.0 4.8 4.1 0.0 7.1 3.5 6.1 2.5 4.5 6.2 5.3 5.6 1.8 4.7 5.3 5.4 4.1 9.0 7.3 5.3 6.1 4.5 54.3 7.7 3.5 3.0 30.0 7.6 6.6 10.1 7.4 7.0 5.4 19.5 4.7 11.9 9.1 5.7 4.1 3.8 SEC23A ENSG00000100934 "Sec23 homolog A, COPII coat complex component" Q15436 14 39031919-39109646 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 347.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles NA NA 83000 "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: AB_2686223" "unprognostic (2.40e-1)" "prognostic unfavorable (5.75e-4)" "prognostic favorable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.69e-4)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 46.3 32.3 9.8 32.1 14.1 13.2 21.1 18.3 16.7 36.5 30.7 40.4 58.2 43.1 20.1 34.4 21.7 32.4 47.3 14.0 18.7 23.3 81.4 20.4 21.2 13.2 14.1 12.4 34.2 12.1 8.1 10.6 27.3 15.7 34.3 34.5 38.9 10.6 53.1 54.7 12.9 53.1 91.3 6.7 20.7 16.9 23.7 11.0 19.1 18.1 59.0 22.2 41.1 18.0 16.2 52.1 90.8 76.9 74.7 161.3 173.0 25.9 195.1 176.4 135.2 166.8 93.2 44.2 12.6 46.9 279.6 54.9 41.2 99.6 86.3 208.6 39.6 36.9 21.8 67.7 347.3 122.4 35.9 31.3 134.0 48.8 91.6 73.7 114.6 130.8 26.9 15.6 30.1 125.8 47.5 32.9 16.9 18.4 81.7 91.3 44.0 111.8 19.1 84.7 75.6 8.5 20.5 132.8 43.0 51.8 68.6 51.5 12.4 138.4 75.0 57.8 110.8 52.0 27.0 36.6 56.0 50.3 31.4 70.2 70.5 34.3 38.6 26.6 29.3 38.4 23.6 33.1 34.9 31.1 21.1 34.9 28.0 29.5 42.1 27.3 26.7 38.1 31.4 9.8 14.1 18.3 16.7 14.0 18.7 13.2 14.1 12.4 15.7 6.7 11.0 16.2 35.4 16.0 26.9 34.9 30.5 25.9 33.5 15.5 15.4 39.7 11.8 10.3 54.6 15.7 18.8 31.3 68.8 16.0 36.0 87.0 7.9 9.8 13.4 11.3 42.8 41.1 24.5 6.1 48.3 5.6 43.7 55.0 26.5 18.8 27.9 56.9 118.9 133.6 25.6 30.3 51.1 31.6 12.2 36.4 32.3 18.6 74.9 24.3 24.9 48.7 25.6 19.4 32.0 34.2 44.3 17.8 34.1 71.5 38.5 37.5 88.6 32.8 10.1 58.7 39.5 27.6 51.4 18.0 15.5 15.7 24.0 24.8 32.3 31.0 30.2 56.5 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Approved Approved Nucleoplasm,Nucleoli No No 50000 Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032" "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 43.8 92.8 24.4 19.9 25.2 19.5 44.6 26.0 30.4 44.0 27.8 44.0 31.2 38.5 30.2 39.0 45.3 32.3 37.1 24.6 28.5 70.2 56.5 39.1 27.1 26.1 25.4 24.1 51.6 49.4 68.3 48.5 22.9 26.7 42.1 25.7 19.0 42.2 26.5 40.9 34.9 46.2 21.4 25.7 56.3 51.1 22.0 26.2 28.7 58.9 19.9 27.5 43.5 40.6 26.1 27.1 34.2 29.0 26.7 50.9 74.7 40.0 32.1 59.2 47.3 55.7 38.8 24.6 34.7 22.5 49.8 25.5 43.6 42.4 69.2 69.5 19.0 25.5 24.3 25.0 159.1 46.8 53.7 51.4 72.2 54.9 23.6 47.7 61.1 69.7 52.3 12.5 33.3 46.6 51.8 50.1 57.1 34.3 39.5 37.3 33.5 24.2 22.6 69.1 52.7 22.0 36.2 16.9 45.8 52.6 39.5 38.6 41.1 36.2 23.0 15.8 32.0 20.6 59.4 63.1 21.8 16.6 38.9 20.2 24.3 34.2 15.0 19.7 27.5 21.6 13.7 21.5 23.7 35.9 15.9 19.3 20.2 56.0 14.9 27.9 15.8 31.5 26.5 24.4 25.2 26.0 30.4 24.6 28.5 26.1 25.4 24.1 26.7 25.7 26.2 26.1 25.2 25.6 18.7 10.7 23.2 11.0 44.5 49.9 27.3 19.6 24.8 32.9 12.5 38.6 35.7 53.3 4.2 67.2 22.6 35.6 101.8 43.6 18.3 29.6 16.6 26.3 10.3 20.6 7.8 33.0 48.5 18.8 17.9 20.0 31.7 29.7 16.8 24.8 50.0 18.5 8.0 19.8 30.5 46.6 14.6 10.5 28.9 32.5 21.4 9.4 32.1 43.3 25.7 7.5 11.7 33.7 32.1 25.2 21.2 19.0 50.2 123.1 43.2 19.7 26.3 16.0 24.5 19.8 10.3 20.7 10.7 49.3 24.6 51.3 28.4 30.5 PNN memA ENSG00000100941 "Pinin, desmosome associated protein" Q9H307 14 39175183-39183220 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001378 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA001378: AB_1079648" "unprognostic (9.28e-3)" "unprognostic (5.07e-2)" "unprognostic (5.46e-2)" "unprognostic (3.91e-1)" "unprognostic (7.38e-3)" "unprognostic (7.40e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.65e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.51e-3)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.00e-1)" "unprognostic (4.30e-2)" 55.9 61.1 45.7 68.6 48.6 137.1 60.7 53.1 48.5 80.2 74.2 80.4 57.0 82.2 130.6 74.6 77.7 42.1 51.7 45.2 46.9 70.3 125.8 62.0 88.3 51.6 47.7 38.8 85.2 79.2 41.1 91.4 54.2 52.0 84.5 63.7 76.7 66.1 48.9 60.4 64.3 91.2 48.4 47.6 104.4 71.3 59.0 50.3 66.2 89.1 27.2 70.1 69.8 73.9 51.2 152.4 72.0 193.2 94.0 45.5 37.4 141.4 116.6 35.4 82.4 81.2 112.3 232.6 229.1 72.7 53.2 69.7 156.4 153.3 85.5 138.5 105.1 109.0 158.6 243.7 246.0 39.1 201.0 107.6 55.8 73.5 80.1 65.1 115.5 57.3 119.0 149.1 128.2 65.8 122.6 145.5 170.3 126.6 76.2 114.3 188.4 137.0 64.2 65.6 219.3 93.8 50.5 126.2 90.5 69.1 133.2 114.4 117.5 92.7 115.9 90.9 52.7 142.2 102.5 87.8 194.0 59.5 167.3 70.6 9.2 13.7 22.0 17.0 11.4 16.1 22.2 12.1 10.9 11.8 25.5 17.2 16.6 27.6 15.4 16.4 22.1 14.2 6.1 45.7 48.6 53.1 48.5 45.2 46.9 51.6 47.7 38.8 52.0 47.6 50.3 51.2 105.6 192.3 125.0 40.8 170.5 126.2 244.5 84.4 153.1 203.1 77.5 87.5 63.4 61.5 164.8 60.7 56.3 113.2 230.9 129.3 35.2 89.4 59.0 155.0 178.9 127.9 136.2 121.1 33.1 58.3 100.0 117.1 101.9 289.4 142.5 273.5 69.3 67.8 62.3 153.1 35.6 96.6 71.2 69.3 72.5 53.7 156.3 93.9 49.8 25.3 89.2 138.0 193.6 41.2 54.6 76.7 126.3 151.6 116.7 172.1 82.9 28.9 111.7 172.4 151.2 166.2 161.3 212.8 149.3 145.0 112.0 99.6 170.6 211.8 123.7 245.4 RABGGTA PTAR3 ENSG00000100949 "Rab geranylgeranyltransferase subunit alpha" Q92696 14 24265538-24271611 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 59.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043488 Approved NA NA "HPA043488: AB_10794887" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (2.61e-3)" "unprognostic (1.13e-1)" "unprognostic (8.34e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-1)" "unprognostic (5.78e-2)" "unprognostic (3.89e-2)" "unprognostic (7.11e-2)" "unprognostic (3.12e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.51e-4)" "unprognostic (2.01e-1)" 11.2 14.8 6.6 7.8 6.4 10.1 11.4 7.0 9.4 12.1 5.4 10.9 11.1 9.3 10.1 59.6 12.2 9.2 14.0 6.9 7.6 13.7 14.9 14.0 9.9 7.5 6.9 6.2 10.7 17.8 17.0 15.3 7.9 7.9 12.3 8.6 3.1 20.3 8.3 19.3 19.8 13.2 7.0 6.5 17.3 16.5 11.9 7.2 9.1 12.0 12.6 12.5 10.1 19.6 7.8 10.6 13.0 6.8 10.6 8.9 17.4 31.9 15.2 12.8 21.4 19.4 12.2 17.4 13.1 11.8 16.3 9.5 20.4 7.0 33.2 9.2 20.8 14.4 8.6 11.0 45.9 17.9 18.8 36.3 19.9 35.9 11.4 13.5 11.6 19.7 16.4 9.0 16.1 16.3 41.0 12.5 10.1 2.3 14.0 19.2 9.3 6.2 14.5 20.5 15.6 16.9 9.7 10.5 29.9 12.8 9.4 12.5 13.7 14.5 11.2 7.8 6.1 10.5 17.2 13.9 8.7 9.5 11.5 17.6 11.9 25.7 17.1 16.0 46.8 13.3 16.3 15.3 12.4 32.0 10.4 12.8 10.0 7.3 16.9 33.1 5.4 18.1 18.4 6.6 6.4 7.0 9.4 6.9 7.6 7.5 6.9 6.2 7.9 6.5 7.2 7.8 9.3 9.6 11.6 4.6 18.0 17.7 19.6 61.6 35.9 7.7 13.8 14.0 12.4 15.7 28.1 5.5 6.2 38.0 14.4 25.0 15.6 23.4 3.3 9.7 5.8 9.3 13.1 7.8 5.1 27.1 31.1 10.1 23.4 11.9 36.2 8.3 9.7 7.1 26.5 11.8 4.3 14.5 26.4 17.9 10.4 7.7 9.0 18.3 16.0 3.7 18.8 9.0 12.3 4.0 3.7 39.3 23.7 7.2 20.3 15.4 27.7 20.4 15.5 5.3 6.6 5.8 12.0 3.3 34.2 36.9 12.4 57.3 16.8 10.3 18.0 20.9 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" No No "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805" "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 45.1 55.4 8.8 6.0 9.2 0.6 47.6 8.3 10.6 126.1 8.9 56.6 4.5 82.8 13.9 22.4 83.3 17.9 29.6 8.8 15.1 25.2 5.6 30.4 4.9 10.0 8.5 7.6 143.9 13.9 9.1 38.2 18.4 8.9 52.0 5.0 2.9 20.6 16.3 9.1 24.7 30.2 19.0 7.8 17.9 35.8 43.0 9.4 1.7 50.8 2.5 3.6 66.8 66.5 8.1 0.0 0.1 17.8 0.0 25.4 36.8 0.1 17.3 49.5 23.0 20.0 0.0 14.6 14.9 0.5 25.0 1.6 0.0 7.1 0.3 13.9 0.0 0.6 11.3 20.6 0.0 12.3 0.0 0.0 26.8 0.3 13.9 0.1 42.5 18.2 4.7 3.7 0.0 4.5 0.8 0.0 1.7 2.3 1.0 0.1 1.1 1.6 2.0 0.0 0.2 2.9 11.9 0.0 3.3 5.7 8.7 10.3 4.5 10.3 21.3 4.4 20.5 0.0 10.4 1.6 11.0 4.4 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 9.2 8.3 10.6 8.8 15.1 10.0 8.5 7.6 8.9 7.8 9.4 8.1 4.1 3.2 8.1 58.8 1.1 4.5 0.9 1.9 0.6 1.3 3.3 2.8 7.8 0.0 4.8 0.0 0.0 0.6 0.0 0.8 0.0 2.8 4.4 2.5 28.3 4.6 7.7 0.0 0.1 0.2 0.6 22.8 3.6 6.4 0.0 4.1 1.4 0.2 0.6 0.0 0.2 3.4 10.2 0.0 6.8 6.5 17.4 0.4 7.2 13.1 0.0 7.6 0.0 1.0 0.2 0.6 0.3 7.5 0.2 0.8 0.4 0.2 2.1 1.5 26.3 4.3 27.1 12.5 2.9 1.0 3.4 0.5 0.9 6.0 1.6 2.3 PLTP BPIFE ENSG00000100979 "Phospholipid transfer protein" P55058 20 45898621-45912155 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Hofbauer cells: 1640.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 33.1;eosinophil: 29.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032873 Approved "Secreted to blood" NA NA 9720000000 210000000 "CAB032873: AB_2283977" "unprognostic (1.27e-1)" "unprognostic (3.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.72e-2)" "unprognostic (4.19e-2)" "unprognostic (8.30e-2)" "unprognostic (3.19e-2)" "unprognostic (2.65e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (9.52e-8)" "unprognostic (3.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.21e-1)" "unprognostic (9.68e-2)" 441.9 190.4 104.4 81.2 90.4 20.9 123.6 101.4 143.1 156.0 190.6 73.8 42.0 115.9 73.3 62.6 175.1 183.9 103.4 85.7 168.4 194.3 29.7 97.9 61.8 106.4 113.1 73.1 160.9 299.5 22.3 38.8 432.4 98.9 51.1 42.8 4.9 133.2 72.2 24.2 66.9 72.2 183.7 118.0 58.1 90.5 32.6 103.5 232.0 44.8 21.0 21.3 342.9 114.0 155.8 13.8 1.9 94.9 0.1 220.8 66.8 186.8 5.3 16.3 18.5 11.0 78.7 15.9 3.5 151.6 23.6 0.4 154.7 29.2 0.6 8.4 1.8 0.2 28.8 3.3 37.7 233.2 0.0 35.5 302.2 7.7 49.1 0.9 74.1 41.3 3.2 9.5 44.9 6.2 3.9 3.2 123.1 16.9 12.5 74.5 1.3 0.1 1.7 0.5 0.0 10.1 35.4 3.7 110.3 160.9 15.7 1.5 117.2 9.0 46.2 1.1 24.2 0.8 19.7 5.3 5.4 326.4 34.3 7.8 33.1 2.7 29.7 1.6 7.1 1.2 8.7 0.4 1.6 2.5 3.2 0.0 1.0 1.4 4.9 12.6 17.5 0.8 2.7 104.4 90.4 101.4 143.1 85.7 168.4 106.4 113.1 73.1 98.9 118.0 103.5 155.8 21.9 0.0 2.3 30.3 3.8 40.7 34.9 53.0 33.0 0.4 9.5 22.6 1.5 5.7 9.6 27.6 0.0 14.8 3.5 0.5 1.9 3.4 16.3 54.6 36.9 27.9 0.0 9.0 0.8 103.2 97.7 256.8 3.6 5.7 0.0 23.4 121.1 2.8 1640.3 3.3 1.4 1.2 12.2 254.0 40.9 24.9 307.9 71.8 35.6 4.7 3.8 13.8 7.2 0.5 0.2 9.9 0.0 199.0 11.8 15.7 0.0 18.2 70.8 1.1 32.9 16.1 35.6 5.7 7.3 24.0 35.8 31.7 3.3 99.5 0.7 18.4 PCIF1 "bA465L10.1, C20orf67, CAPAM, PPP1R121" ENSG00000100982 "Phosphorylated CTD interacting factor 1" Q9H4Z3 20 45934683-45948023 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049517 Enhanced Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge" "HPA049517: AB_2680801" "unprognostic (5.42e-3)" "unprognostic (7.76e-2)" "unprognostic (7.69e-2)" "prognostic unfavorable (8.86e-4)" "unprognostic (1.39e-2)" "unprognostic (4.20e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.57e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.50e-6)" "unprognostic (1.01e-1)" "unprognostic (4.44e-2)" "unprognostic (9.14e-3)" "unprognostic (1.24e-1)" 26.5 28.3 18.3 18.8 20.4 34.2 29.0 27.6 24.4 36.4 15.8 28.2 16.6 40.0 10.9 24.6 35.6 16.5 30.5 18.4 18.0 23.5 19.7 28.5 27.5 20.4 19.8 17.4 42.1 29.8 23.0 26.2 17.2 21.2 26.4 11.8 16.1 23.8 21.5 42.1 35.6 27.4 21.4 18.7 35.0 25.6 18.2 19.5 34.7 32.3 27.9 19.7 28.9 29.5 22.6 21.2 29.0 22.0 27.2 15.3 18.2 24.2 8.3 25.1 24.9 24.2 49.3 27.7 22.7 27.4 22.6 28.7 23.4 15.8 29.0 10.8 14.1 11.4 29.1 23.1 33.4 28.2 26.4 28.1 25.5 29.9 15.3 24.5 22.3 21.0 37.1 20.8 30.9 17.9 44.6 52.3 48.3 7.8 25.5 24.9 32.2 20.4 28.0 20.1 21.8 30.2 30.0 31.5 29.5 16.1 11.6 31.0 30.7 18.1 30.7 24.1 27.3 16.8 35.4 22.1 21.0 37.7 23.8 18.2 75.5 47.5 80.2 54.5 47.2 43.0 51.6 47.3 50.2 50.3 56.2 48.6 43.0 74.6 74.3 48.0 40.4 54.4 64.0 18.3 20.4 27.6 24.4 18.4 18.0 20.4 19.8 17.4 21.2 18.7 19.5 22.6 19.7 3.2 14.2 4.6 33.7 8.7 26.4 7.9 26.2 9.9 17.0 19.7 21.9 20.0 7.1 11.0 2.1 19.5 32.4 14.6 15.6 21.4 9.6 13.3 10.7 16.1 26.5 25.4 2.5 38.6 22.6 15.4 17.3 13.5 14.5 14.9 9.7 12.4 16.9 13.5 3.6 14.0 4.1 16.0 8.7 8.1 11.5 21.5 17.8 1.0 24.9 12.0 33.0 3.0 3.9 28.3 13.1 12.8 35.5 25.4 14.8 23.2 11.0 13.4 0.0 20.2 19.3 14.4 11.9 23.8 10.7 27.8 30.8 15.1 12.0 38.8 GSS ENSG00000100983 "Glutathione synthetase" P48637 20 34928432-34956027 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 164.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054508, HPA059315" Enhanced Supported Nucleoplasm NA NA 28000000 Nucleoplasm "HPA054508: AB_2682509, HPA059315: AB_2683976" "unprognostic (5.80e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (7.21e-2)" "unprognostic (3.63e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (2.90e-2)" "unprognostic (8.52e-2)" "unprognostic (3.64e-1)" "unprognostic (6.49e-2)" "unprognostic (1.50e-1)" "prognostic favorable (7.31e-6)" "unprognostic (3.35e-3)" "unprognostic (1.96e-1)" "unprognostic (1.42e-3)" "unprognostic (1.52e-1)" 18.9 47.3 24.5 17.8 25.8 27.3 24.0 21.7 24.8 19.5 24.6 41.5 30.6 17.6 68.3 43.7 27.2 18.1 24.7 25.3 24.9 42.9 45.2 21.9 16.1 23.7 25.3 25.7 14.4 15.9 28.0 26.6 19.9 24.7 34.5 41.0 15.8 29.1 18.7 20.6 32.2 28.6 19.3 22.5 23.8 28.7 23.8 25.1 21.7 23.4 17.1 18.7 23.1 26.3 25.6 63.7 75.7 36.2 51.2 41.4 42.8 51.5 52.9 48.7 81.6 67.1 139.9 75.5 44.8 68.6 54.9 78.7 58.7 53.6 134.8 68.5 20.9 30.4 176.1 46.8 140.1 58.1 44.8 59.5 45.3 141.8 77.0 128.8 36.3 58.4 59.5 87.1 35.7 100.6 70.1 72.5 63.5 21.4 83.2 96.0 64.8 72.7 106.9 117.7 63.9 71.0 41.3 93.6 86.5 70.9 19.7 106.5 40.5 46.7 93.1 52.5 61.7 46.5 35.7 35.9 49.1 79.4 48.6 56.7 17.5 36.2 8.7 30.4 39.2 27.6 12.8 24.0 31.4 43.6 8.7 27.7 23.7 8.4 29.3 36.6 23.9 32.6 29.0 24.5 25.8 21.7 24.8 25.3 24.9 23.7 25.3 25.7 24.7 22.5 25.1 25.6 10.6 19.2 10.5 13.4 9.9 26.3 32.5 72.4 38.7 23.0 32.8 20.8 17.1 27.1 38.1 25.8 10.4 79.4 19.1 58.1 25.4 51.6 55.6 14.8 18.2 16.1 23.4 26.9 12.2 47.2 52.5 19.3 37.2 16.4 17.7 80.1 10.0 27.3 59.9 35.3 13.8 50.6 48.8 17.2 17.3 164.1 10.2 26.8 16.0 5.6 31.0 29.6 19.6 10.1 9.9 39.8 40.1 18.4 19.6 21.4 33.8 121.5 18.1 16.9 26.3 12.0 21.0 14.7 18.9 38.1 24.2 49.0 20.6 52.1 77.7 33.0 MMP9 CLG4B ENSG00000100985 "Matrix metallopeptidase 9" P14780 20 46008908-46016561 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "bone marrow: 379.6;lymphoid tissue: 106.2" "Group enriched" "Detected in many" 5 "Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "cerebral cortex: 8.6;thalamus: 3.8" "Immune cell enriched" "Detected in some" 127 "neutrophil: 272.2" "Lineage enriched" "Detected in single" 341 "granulocytes: 272.2" "Cell line enriched" "Detected in some" 13 "NB-4: 360.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201" Enhanced Approved Cytosol "Secreted to blood" NA NA 43300000 61000000 Cytosol "CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150" "unprognostic (4.62e-2)" "unprognostic (1.64e-1)" "unprognostic (2.85e-2)" "prognostic favorable (2.55e-4)" "unprognostic (6.65e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.54e-1)" "unprognostic (8.57e-2)" "unprognostic (3.21e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.05e-5)" "unprognostic (4.65e-1)" "unprognostic (9.85e-3)" "unprognostic (2.48e-2)" "unprognostic (2.17e-3)" 14.5 0.7 0.5 62.5 0.6 379.6 8.2 0.4 8.6 3.0 1.5 5.7 11.7 1.0 0.0 2.2 2.2 3.0 2.6 0.4 1.3 2.5 3.8 21.3 104.1 0.7 0.6 0.3 0.8 1.6 0.1 1.1 2.0 0.7 1.9 3.4 0.6 3.6 0.4 0.7 3.2 12.5 1.9 0.4 106.2 11.4 1.3 3.8 17.1 2.1 0.9 36.8 12.1 1.1 0.6 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.3 28.8 0.0 0.3 0.4 0.0 1.4 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 4.0 0.0 360.6 0.8 0.0 0.2 0.4 0.3 0.1 0.0 0.0 0.6 0.6 0.0 0.6 0.0 3.7 0.3 1.2 0.3 10.3 10.9 0.1 0.3 0.3 0.2 0.2 0.1 0.8 0.2 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 272.2 0.0 0.3 0.0 0.0 0.5 0.5 0.6 0.4 8.6 0.4 1.3 0.7 0.6 0.3 0.7 0.4 3.8 0.6 0.7 0.0 5.5 0.0 3.9 34.3 0.1 61.5 0.0 3.8 0.5 2.0 0.4 1.5 0.9 0.0 8.4 1.5 2.0 0.0 0.0 0.8 0.9 0.0 0.1 7.2 0.0 0.0 0.1 1.8 2.4 2.5 0.0 0.1 1.3 0.2 0.0 0.0 260.1 3.3 0.2 0.5 0.0 1.3 606.0 0.3 0.0 230.6 56.9 0.0 2.3 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.1 0.0 0.3 6.9 5.3 0.0 0.2 45.5 6.7 11.2 0.2 28.1 1.9 3.4 0.3 0.0 0.1 VSX1 "PPCD, PPCD1, PPD" ENSG00000100987 "Visual system homeobox 1" Q9NZR4 20 25070885-25082141 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Developmental protein, DNA-binding" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 14.4;retina: 35.8" "Cell type enriched" "Detected in some" 23 "Bipolar cells: 465.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "Karpas-707: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA079607 Approved Nucleoli NA NA Nucleoli "HPA079607: " "unprognostic (1.93e-1)" "unprognostic (6.63e-2)" "unprognostic (9.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.27e-1)" "unprognostic (1.97e-1)" "unprognostic (4.01e-1)" "unprognostic (8.64e-3)" "unprognostic (2.70e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-9)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "unprognostic (3.07e-4)" "unprognostic (2.38e-1)" 0.0 0.9 3.4 0.0 3.3 0.5 0.1 14.4 2.9 0.1 1.7 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 2.8 3.6 0.0 0.2 0.0 0.1 3.2 3.5 2.6 1.5 0.4 0.7 2.9 0.0 7.6 0.2 0.1 35.8 0.1 0.3 0.5 0.2 0.1 0.0 3.0 0.1 0.1 0.2 3.4 0.7 0.2 0.2 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 3.3 14.4 2.9 2.8 3.6 3.2 3.5 2.6 7.6 3.0 3.4 3.5 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.0 465.9 0.1 0.0 1.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 5.3 0.0 19.6 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TRPC4AP "C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP" ENSG00000100991 "Transient receptor potential cation channel subfamily C member 4 associated protein" Q8TEL6 20 35002404-35092807 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 138.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051197, HPA065061" Uncertain Approved Cytosol NA NA Cytosol "HPA051197: AB_2681384, HPA065061: AB_2685416" "unprognostic (3.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (2.08e-2)" "unprognostic (2.40e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.25e-8)" "unprognostic (1.33e-1)" "unprognostic (5.56e-2)" "unprognostic (2.58e-1)" "unprognostic (1.95e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.19e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" 51.6 61.4 40.5 37.8 47.7 69.9 50.9 41.4 47.7 45.1 40.4 41.7 36.7 42.1 32.4 46.2 41.7 34.4 44.2 39.0 45.9 43.2 62.5 56.3 42.5 48.5 45.4 39.4 40.8 64.8 42.8 62.6 48.2 50.7 47.0 36.5 30.0 48.6 36.4 81.2 45.7 47.3 37.9 43.2 60.8 52.3 36.0 46.0 42.0 47.7 40.0 39.3 42.2 41.7 61.9 53.7 64.4 56.3 58.2 85.2 81.6 86.0 85.2 99.8 95.7 109.6 141.6 78.3 50.0 79.5 99.1 97.4 70.0 51.6 121.5 73.7 26.7 40.2 127.5 54.8 131.0 85.0 74.9 83.8 91.4 75.4 71.7 61.0 100.0 107.9 101.1 61.2 58.3 77.0 40.6 91.1 84.0 44.3 49.2 86.9 56.4 80.9 51.2 82.3 68.9 49.6 50.1 91.9 153.2 59.3 66.6 55.6 59.9 106.7 117.9 53.2 64.8 51.6 52.9 30.6 41.5 128.2 36.6 61.7 30.6 30.5 50.6 24.0 32.4 25.5 17.4 19.9 25.7 40.2 15.3 17.2 18.7 48.5 25.9 38.2 17.4 24.7 27.0 40.5 47.7 41.4 47.7 39.0 45.9 48.5 45.4 39.4 50.7 43.2 46.0 61.9 24.2 19.2 14.1 49.0 29.9 15.2 15.2 20.6 21.6 25.7 24.1 19.9 13.1 12.8 19.1 20.2 79.2 52.6 37.0 34.9 3.9 30.1 14.8 16.0 21.9 25.1 20.4 21.5 44.6 27.3 43.8 23.9 48.4 24.9 19.7 43.4 21.0 23.4 37.2 67.3 56.3 24.6 28.5 25.6 22.2 8.5 25.4 23.7 12.4 40.3 27.9 28.5 23.7 59.3 138.0 36.2 24.1 23.0 45.8 23.6 30.4 11.4 18.0 29.2 39.5 18.3 24.0 23.2 27.3 19.1 15.8 68.4 32.2 30.3 24.0 24.0 PYGB ENSG00000100994 "Glycogen phosphorylase B" P11216 20 25248085-25298012 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 122.8;Distal enterocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 407.8;SK-MEL-30: 528.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031067 Approved Approved Cytosol NA NA 14000000 Cytosol "HPA031067: AB_2673722" "unprognostic (6.13e-2)" "unprognostic (5.98e-2)" "unprognostic (1.21e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.37e-4)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.23e-3)" "unprognostic (8.39e-3)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "unprognostic (3.41e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.43e-4)" 42.0 36.7 75.4 27.9 73.5 14.3 61.7 79.2 83.0 33.0 33.0 124.5 27.2 52.3 21.6 107.6 38.1 39.5 165.4 72.8 70.8 43.8 14.7 32.4 19.3 86.0 76.3 70.2 26.1 25.6 18.3 62.0 11.6 78.5 108.9 73.3 25.6 126.2 107.3 18.8 80.9 45.2 60.3 76.2 22.8 51.8 25.4 73.9 18.6 45.6 10.6 17.5 155.5 53.5 80.6 31.5 220.1 39.1 38.3 97.9 182.7 28.7 62.2 80.9 51.4 43.0 50.1 38.0 37.1 71.8 83.6 96.1 123.9 44.5 165.8 27.9 21.1 27.5 29.5 18.6 86.9 115.7 44.7 40.0 107.1 152.4 130.5 191.3 63.5 66.6 23.0 16.5 91.4 73.0 87.1 45.1 34.6 35.2 38.2 407.8 33.7 71.0 49.8 280.5 56.8 58.4 36.5 42.7 74.0 528.7 31.0 51.9 28.4 147.4 60.3 36.5 65.1 128.7 35.2 58.8 14.4 67.9 34.8 335.3 4.6 14.1 7.1 10.2 19.4 9.9 5.4 8.1 9.2 14.5 4.6 10.3 12.9 3.3 11.2 23.4 7.1 9.6 23.4 75.4 73.5 79.2 83.0 72.8 70.8 86.0 76.3 70.2 78.5 76.2 73.9 80.6 10.0 9.6 34.6 43.1 8.7 11.9 23.1 20.7 22.2 35.8 31.6 43.6 122.8 11.5 14.6 25.8 37.5 7.1 10.7 185.2 11.7 17.6 3.5 12.7 17.2 13.5 28.2 8.6 22.9 16.5 7.2 15.3 40.2 21.6 6.3 16.2 8.9 5.8 10.8 18.5 26.9 47.3 57.0 13.8 10.7 9.2 27.4 18.5 35.6 15.0 16.6 21.3 15.5 11.6 19.1 27.0 68.5 86.5 22.9 17.6 20.9 11.1 11.9 9.3 0.0 13.5 23.1 2.0 8.5 15.3 10.1 4.4 12.9 20.3 72.0 9.7 ABHD12 "ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106" ENSG00000100997 "Abhydrolase domain containing 12, lysophospholipase" Q8N2K0 20 25294742-25390835 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Cataract, Deafness, Disease variant, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 315.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026866 Uncertain NA NA "HPA026866: AB_1844446" "prognostic unfavorable (3.81e-5)" "prognostic favorable (1.30e-5)" "unprognostic (1.32e-1)" "unprognostic (8.74e-2)" "unprognostic (3.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (7.18e-4)" "unprognostic (8.51e-2)" "unprognostic (7.91e-3)" "unprognostic (2.08e-1)" "unprognostic (4.08e-2)" "unprognostic (8.46e-2)" "unprognostic (1.36e-3)" "unprognostic (2.45e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.11e-3)" 27.5 33.3 56.4 27.7 65.2 26.7 27.2 66.8 65.7 29.2 34.1 37.3 47.4 25.5 134.2 50.4 25.0 33.7 30.8 75.3 61.0 40.5 30.1 32.9 31.0 68.5 64.7 53.3 30.8 118.8 55.7 42.4 29.9 69.7 35.9 36.8 31.0 37.2 40.3 13.4 51.0 53.2 23.8 71.3 22.2 55.5 19.4 70.3 23.6 81.5 15.0 41.9 37.6 35.4 95.9 67.2 148.3 41.6 50.9 79.6 47.1 93.3 97.0 84.5 73.7 84.6 90.1 93.0 21.8 53.3 77.0 155.1 116.5 44.4 56.8 62.8 22.7 41.9 33.3 46.8 128.4 59.3 33.3 71.6 58.7 42.0 85.4 44.1 95.7 33.2 37.8 25.8 315.3 72.8 142.5 51.8 31.0 29.4 77.8 96.8 39.2 95.3 195.0 43.4 145.7 46.6 39.7 75.4 198.9 133.8 72.3 67.4 47.6 44.6 98.3 63.0 57.1 54.0 38.8 36.1 33.4 61.8 38.7 57.3 15.8 18.8 17.3 9.9 17.0 7.5 3.8 10.2 13.7 17.9 5.1 8.9 8.9 3.6 15.4 17.7 17.0 10.4 8.6 56.4 65.2 66.8 65.7 75.3 61.0 68.5 64.7 53.3 69.7 71.3 70.3 95.9 20.7 6.4 6.5 19.2 13.8 17.7 32.0 9.8 19.4 34.5 19.6 19.7 16.6 30.0 13.7 27.6 10.4 91.6 22.2 97.0 27.4 33.7 53.0 24.9 18.1 17.5 34.0 14.5 37.7 34.3 95.2 22.9 35.2 28.3 10.2 26.9 15.0 19.5 114.1 42.1 46.0 28.9 20.3 37.8 43.8 107.1 16.1 62.4 33.8 42.2 58.7 44.1 23.7 50.8 67.5 22.9 77.7 20.7 39.3 31.6 126.7 24.6 13.1 23.3 26.3 13.8 19.5 19.9 37.7 27.2 18.3 130.8 18.0 19.6 33.3 35.2 PROCR "CCD41, CD201, EPCR" ENSG00000101000 "Protein C receptor" Q9UNN8 20 35172072-35216240 "Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 95.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 114.2;Fibroblasts: 83.4;granulocytes: 63.1;Hepatic stellate cells: 74.6;Sertoli cells: 170.9;Syncytiotrophoblasts: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 385.0;HUVEC TERT2: 611.1;TIME: 365.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 8.9" HPA039461 Enhanced NA NA 980000000 "HPA039461: AB_10673359" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.69e-2)" "unprognostic (4.69e-2)" "unprognostic (1.84e-1)" "unprognostic (1.52e-1)" "unprognostic (4.76e-2)" "unprognostic (5.22e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.62e-6)" "unprognostic (3.37e-2)" "unprognostic (2.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.19e-2)" 95.1 23.3 6.2 19.8 6.3 8.7 54.4 10.8 9.4 29.5 17.9 22.5 16.5 36.5 13.5 12.1 43.3 21.3 33.2 5.9 17.8 15.2 6.8 20.0 10.0 7.7 6.1 5.4 18.1 12.7 6.1 8.7 31.5 7.8 19.6 21.6 1.8 8.8 17.5 10.2 24.9 21.6 28.6 6.8 27.7 23.4 5.0 7.2 3.0 26.3 10.4 4.0 34.5 28.7 8.1 15.2 88.9 0.2 9.2 93.6 76.1 20.2 20.8 90.4 33.7 65.2 115.2 76.7 2.9 63.3 21.0 93.6 48.5 20.2 131.8 27.8 0.7 27.5 33.2 19.8 4.7 22.8 1.3 385.0 65.1 48.8 159.0 131.1 49.2 611.1 1.1 11.8 4.2 35.3 5.0 1.1 1.6 12.2 18.8 90.4 0.6 16.7 0.4 58.3 5.8 2.7 1.2 11.3 23.9 18.8 11.0 8.1 5.0 365.5 86.0 43.2 32.8 35.4 0.3 1.1 0.9 99.1 33.5 18.6 5.0 1.5 0.8 8.2 1.8 14.8 0.9 2.5 5.2 7.8 1.3 0.6 5.9 4.0 3.3 1.3 1.3 2.2 2.2 6.2 6.3 10.8 9.4 5.9 17.8 7.7 6.1 5.4 7.8 6.8 7.2 8.1 19.9 0.0 12.6 2.3 0.5 13.9 18.5 10.1 10.2 0.5 1.1 4.4 2.4 5.7 4.9 5.5 0.0 12.1 2.0 0.5 1.9 32.2 1.6 1.0 24.0 58.8 6.0 2.7 3.6 16.4 114.2 83.4 1.5 0.9 63.1 15.9 74.6 1.9 21.9 1.7 2.5 0.7 0.0 1.6 8.8 1.0 15.5 13.5 3.6 9.4 2.2 0.3 7.2 0.5 5.6 15.6 0.5 2.6 0.6 9.7 9.8 6.3 1.8 0.6 170.9 4.3 45.9 20.4 19.7 2.8 8.4 69.0 4.4 4.2 2.0 11.9 GINS1 "KIAA0186, PSF1" ENSG00000101003 "GINS complex subunit 1" Q14691 20 25407673-25452628 "Disease related genes, Predicted intracellular proteins" "DNA replication" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.3;testis: 9.1" "Cell type enhanced" "Detected in many" "Early spermatids: 60.2;Erythroid cells: 14.7;Extravillous trophoblasts: 17.9;Late spermatids: 21.9;Spermatocytes: 14.2;Spermatogonia: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051185 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051185: AB_2681378" "unprognostic (6.10e-3)" "unprognostic (2.58e-1)" "unprognostic (5.37e-3)" "unprognostic (1.74e-3)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (5.86e-3)" "unprognostic (1.42e-2)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.42e-11)" "unprognostic (5.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (2.55e-1)" 0.7 0.6 0.9 3.2 0.9 3.4 1.6 1.9 1.1 0.8 0.5 3.2 3.0 1.5 0.7 4.3 0.9 0.8 0.5 0.9 0.7 1.1 1.2 0.6 5.4 0.7 0.7 0.9 0.9 0.5 0.7 0.2 2.9 1.2 0.8 3.9 0.8 0.8 0.4 0.5 3.7 2.9 2.0 0.4 1.5 2.0 9.1 0.7 7.3 0.6 0.0 5.9 1.3 1.6 1.1 43.6 38.8 46.5 30.4 2.6 3.5 46.7 18.9 9.1 35.5 37.2 33.7 42.1 53.3 21.0 7.9 26.4 49.0 40.9 34.4 40.7 14.3 14.2 36.7 13.8 41.3 0.9 48.5 16.2 1.7 2.0 33.8 6.9 4.7 19.1 30.1 36.1 33.9 21.2 47.0 75.1 36.0 31.8 30.0 20.0 53.1 53.6 35.7 13.6 28.8 19.4 20.3 19.3 45.3 16.7 26.0 42.9 24.2 8.7 27.7 29.9 18.2 35.1 13.6 41.1 42.0 7.4 46.8 32.0 0.2 0.2 0.1 0.3 0.2 0.1 0.5 0.2 0.1 0.5 0.3 0.1 0.3 0.2 0.4 0.2 0.5 0.8 0.2 0.9 0.9 1.9 1.1 0.9 0.7 0.7 0.7 0.9 1.2 0.4 0.7 1.1 0.2 0.0 0.6 1.3 1.5 3.2 1.0 1.5 1.8 1.8 1.1 1.3 0.4 0.0 1.6 1.8 0.0 8.2 0.2 1.9 0.0 1.1 60.2 0.5 1.3 1.1 1.2 14.7 6.4 0.7 17.9 2.0 3.6 1.3 1.3 6.8 0.7 0.7 5.9 0.0 3.7 2.5 0.0 1.6 0.8 21.9 0.6 1.2 0.0 1.0 0.0 1.3 0.0 4.0 1.6 0.4 0.6 1.2 8.9 0.6 0.4 2.1 1.7 0.2 0.0 0.5 1.4 14.2 19.7 5.4 1.4 2.5 0.8 2.0 5.5 0.8 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452697-25585531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 37.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000686 Uncertain Uncertain "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Microtubules, Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favorable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 3.5 8.7 5.8 2.0 5.5 0.6 4.1 10.4 6.2 10.1 7.8 7.4 3.3 7.3 7.3 5.8 5.2 3.3 3.9 4.5 6.2 14.5 8.2 4.1 2.3 7.7 7.0 3.2 19.1 5.4 8.3 10.0 1.5 7.7 8.9 2.1 4.7 4.4 3.8 4.5 2.3 3.9 3.6 5.2 5.0 6.3 7.7 6.2 15.9 10.3 1.2 2.2 3.6 8.6 7.0 1.0 10.8 23.0 15.1 2.6 7.5 7.1 3.6 3.1 3.1 4.4 2.8 7.5 0.6 5.0 5.6 7.6 0.8 3.4 0.7 2.6 0.5 4.7 1.6 5.0 37.5 5.4 0.6 0.1 9.2 0.7 3.6 0.0 8.8 6.8 17.8 1.9 0.3 3.8 9.6 21.7 0.7 6.5 0.1 1.1 0.5 17.9 0.8 1.5 1.3 22.7 16.0 8.2 3.0 9.1 18.3 4.9 6.4 0.3 0.1 8.6 0.1 0.2 2.3 4.4 0.1 0.2 0.6 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 10.4 6.2 4.5 6.2 7.7 7.0 3.2 7.7 5.2 6.2 7.0 1.2 0.0 14.6 42.4 0.8 2.0 4.9 2.5 5.7 3.0 2.8 3.3 6.5 12.8 4.8 7.3 25.0 2.8 0.6 0.4 0.0 5.6 0.6 4.2 7.3 2.3 6.1 0.0 7.4 1.2 1.3 8.7 4.6 3.4 0.0 29.6 8.9 8.4 2.3 8.4 32.6 2.3 8.2 0.3 2.0 2.7 13.1 0.8 0.0 12.2 0.0 3.2 2.1 47.3 19.4 2.8 1.5 12.4 0.9 4.5 0.7 8.8 13.7 1.9 6.6 10.8 4.7 2.5 5.0 4.3 0.9 1.5 1.1 21.0 2.5 1.9 CD40 "Bp50, p50, TNFRSF5" ENSG00000101017 "CD40 molecule" P25942 20 46118278-46129863 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 127.5;Basal respiratory cells: 126.0;Langerhans cells: 191.4;monocytes: 242.0;Prostatic glandular cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 139.4;naive B-cell: 157.9" "Group enriched" "Detected in all" 6 "B-cells: 157.9;monocytes: 43.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 76.0;Daudi: 42.1;EFO-21: 131.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002495, HPA031567, HPA031568, CAB072868" Enhanced "Secreted to blood" NA NA 705000 "CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937" "unprognostic (6.41e-2)" "unprognostic (1.55e-2)" "unprognostic (7.08e-3)" "unprognostic (6.21e-2)" "unprognostic (4.23e-3)" "unprognostic (1.25e-1)" "unprognostic (7.64e-3)" "unprognostic (1.34e-1)" "unprognostic (4.15e-2)" "unprognostic (7.16e-2)" "unprognostic (2.48e-2)" "unprognostic (7.04e-2)" "prognostic unfavorable (4.48e-4)" "unprognostic (1.22e-1)" "unprognostic (4.95e-2)" "unprognostic (1.60e-2)" "unprognostic (2.28e-2)" 24.0 8.5 6.3 35.2 6.3 2.8 20.7 6.9 7.8 19.4 8.7 11.5 12.7 14.5 7.7 12.5 19.9 14.4 15.6 6.0 7.9 17.4 18.5 34.7 58.2 7.5 6.4 5.3 24.7 22.1 46.9 10.0 12.5 6.8 23.8 9.7 1.1 24.7 15.6 8.7 17.1 22.0 14.1 7.0 35.4 15.7 3.8 7.0 17.5 20.6 7.2 58.1 33.2 21.2 6.9 26.6 4.1 0.0 12.8 4.7 2.7 5.0 4.9 1.4 3.8 3.6 0.0 76.0 42.1 131.8 0.8 18.7 3.1 2.3 16.2 3.9 29.0 0.0 10.0 0.0 7.5 36.6 0.0 13.0 16.2 6.2 15.3 0.0 0.0 28.3 0.0 3.5 0.0 0.8 0.0 0.0 0.2 1.8 9.3 0.1 1.1 1.0 4.5 32.7 0.3 0.0 0.0 23.1 12.6 0.0 0.0 2.7 14.5 0.0 0.0 41.2 0.0 0.1 0.1 0.1 29.2 9.6 5.0 0.1 4.0 28.0 0.4 4.8 43.3 3.5 139.4 2.6 2.0 16.1 157.9 5.0 3.7 2.8 2.9 32.1 8.3 4.1 20.0 6.3 6.3 6.9 7.8 6.0 7.9 7.5 6.4 5.3 6.8 7.0 7.0 6.9 68.8 12.8 15.0 6.5 127.5 43.6 63.3 126.0 30.1 1.2 3.8 10.0 3.9 30.0 32.9 14.7 0.0 0.4 7.3 1.5 0.0 68.4 9.0 1.3 2.4 61.5 1.2 5.2 0.9 29.7 3.2 37.9 11.7 3.3 3.8 0.6 55.3 17.0 40.5 0.0 0.9 6.2 14.2 13.0 191.4 14.6 25.7 48.1 28.4 12.2 242.0 9.0 6.2 0.5 0.2 37.9 8.8 22.6 25.1 130.2 6.1 4.3 12.2 0.4 32.9 28.0 31.6 1.9 5.7 13.2 34.1 0.4 4.8 2.3 6.8 64.4 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412031 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 64.6;Inhibitory neurons: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 19.6 30.3 22.5 13.9 25.3 4.6 16.7 22.9 27.9 19.6 21.1 24.8 19.1 18.7 23.1 19.0 20.8 12.7 55.9 23.0 25.0 28.8 27.3 15.9 18.0 24.3 24.6 21.7 20.0 16.1 37.5 24.1 15.0 27.5 19.9 26.0 29.8 18.8 18.6 107.8 16.4 19.4 18.6 20.2 19.9 23.2 17.7 23.9 21.4 22.5 106.6 22.1 20.3 18.2 26.6 20.2 28.6 33.5 32.2 34.1 38.4 4.8 38.5 43.3 70.7 48.1 97.7 39.4 66.6 68.5 26.1 60.7 53.5 60.0 70.0 52.6 19.0 24.2 89.2 41.3 80.3 22.7 54.2 25.6 37.6 72.3 37.9 48.8 51.2 24.6 53.5 39.9 23.9 50.0 26.8 58.6 29.2 25.4 42.0 61.5 31.4 50.0 37.9 67.6 26.2 46.4 28.7 32.9 148.9 34.0 28.1 23.9 34.6 23.5 46.2 28.8 25.9 34.6 30.1 37.2 26.5 79.7 31.1 36.8 28.6 10.2 14.2 14.8 14.3 18.3 12.3 13.7 14.7 16.0 15.7 16.7 14.7 0.3 22.3 10.2 14.4 14.2 12.6 22.5 25.3 22.9 27.9 23.0 25.0 24.3 24.6 21.7 27.5 20.2 23.9 26.6 7.0 0.0 7.8 51.6 7.0 6.4 9.3 18.1 6.8 20.7 7.8 5.8 44.0 10.0 11.8 16.5 8.4 22.9 5.3 13.9 60.7 18.2 15.1 10.5 8.5 10.5 12.0 5.2 64.6 13.1 15.7 9.2 7.7 6.9 8.2 17.5 6.1 14.2 11.6 18.5 68.9 9.1 18.3 6.6 3.9 8.6 10.5 5.8 14.2 33.7 13.2 16.7 10.3 44.2 50.3 19.1 6.6 12.0 5.0 8.4 10.9 19.4 14.8 22.8 6.6 9.6 11.9 24.6 18.2 6.2 5.3 17.4 6.2 19.7 13.2 9.6 ZMYND8 "PRKCBP1, RACK7" ENSG00000101040 "Zinc finger MYND-type containing 8" Q9ULU4 20 47209214-47356889 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020949 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA020949: AB_1857223" "prognostic unfavorable (2.56e-4)" "unprognostic (5.09e-2)" "unprognostic (5.84e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.62e-4)" "unprognostic (2.10e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (8.64e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (7.06e-5)" "unprognostic (3.59e-2)" "unprognostic (7.50e-2)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" 12.1 32.9 25.5 10.6 19.2 26.3 14.9 25.8 35.5 11.0 37.9 14.2 11.1 9.8 33.6 16.1 16.1 12.4 11.6 35.8 23.8 12.5 11.0 11.2 12.9 29.5 23.0 18.2 13.8 12.4 11.7 26.1 11.9 38.6 11.9 14.6 20.3 14.7 14.7 15.4 19.7 16.4 8.8 11.2 18.4 20.2 14.3 27.3 14.7 11.1 11.1 12.9 14.6 15.0 40.2 27.6 17.2 90.5 36.6 15.2 21.3 59.4 21.7 17.8 22.3 22.8 107.7 26.0 26.5 34.4 16.3 27.1 18.7 39.4 96.0 33.3 11.4 14.9 110.4 6.3 95.9 55.4 11.9 55.9 20.9 43.4 24.8 94.1 40.4 61.0 9.5 90.6 17.7 41.0 32.1 4.4 45.4 85.9 20.3 24.3 55.8 15.0 22.9 30.4 49.6 38.0 14.3 10.3 32.4 44.4 70.3 17.0 22.6 143.6 23.9 16.6 23.3 20.2 12.5 25.2 23.2 80.8 18.3 80.3 34.8 7.4 10.4 8.7 7.5 8.7 15.3 8.8 9.0 4.7 18.3 11.4 11.8 19.8 16.3 6.8 16.5 9.3 4.3 25.5 19.2 25.8 35.5 35.8 23.8 29.5 23.0 18.2 38.6 11.2 27.3 40.2 48.2 44.8 78.5 94.0 36.6 8.8 32.2 44.6 15.9 108.1 29.3 20.7 23.7 28.6 74.3 90.1 160.6 23.1 36.2 64.0 15.6 36.5 13.6 111.3 29.8 31.7 56.3 112.9 153.8 28.7 42.0 24.2 41.8 124.4 32.2 44.8 30.7 16.1 21.9 85.8 113.5 49.2 42.7 48.8 12.8 21.9 27.7 31.8 10.6 49.6 25.0 24.4 40.2 89.0 138.7 47.1 42.3 26.7 29.7 23.9 56.8 12.0 82.3 50.0 32.9 33.4 27.5 6.3 29.9 19.2 8.4 66.5 34.2 39.3 32.1 24.2 SGK2 ENSG00000101049 "Serum/glucocorticoid regulated kinase 2" Q9HBY8 20 43558968-43588237 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.9;kidney: 41.1;liver: 63.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008859, HPA011387" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008859: AB_2668159, HPA011387: AB_1856744" "unprognostic (1.82e-1)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.98e-4)" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.72e-4)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (2.56e-1)" "unprognostic (3.11e-2)" "prognostic favorable (5.65e-4)" 23.7 1.4 5.2 1.5 13.2 0.5 6.2 12.0 10.1 3.5 1.0 38.0 31.8 1.8 34.1 1.0 3.7 10.1 0.9 5.4 7.7 41.1 63.8 1.0 0.2 16.9 13.4 3.3 6.6 16.4 0.5 3.0 0.8 16.7 2.6 40.9 5.6 1.8 2.9 0.4 6.3 20.3 1.6 13.3 1.1 23.0 1.8 10.6 0.3 1.7 0.4 0.3 4.2 3.0 24.7 0.0 20.5 0.3 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.6 14.2 0.1 8.7 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.4 0.0 18.7 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 0.4 0.2 0.1 0.0 0.1 0.1 0.5 0.1 61.7 0.0 0.1 0.1 0.0 25.4 4.2 0.2 1.0 0.0 1.2 0.1 0.4 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 13.2 12.0 10.1 5.4 7.7 16.9 13.4 3.3 16.7 13.3 10.6 24.7 0.3 0.0 0.0 4.9 0.2 0.1 0.1 0.2 0.0 0.8 0.3 0.8 4.9 8.6 0.0 11.0 0.0 5.1 0.0 76.5 76.3 6.8 0.3 0.9 0.5 0.6 1.8 0.0 0.7 6.3 1.3 0.4 11.2 2.4 0.0 0.7 0.7 32.8 0.7 6.7 1.3 4.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 3.5 20.7 2.5 21.7 0.4 0.0 0.1 23.8 25.5 0.2 0.8 0.0 0.2 0.4 0.1 0.1 0.0 0.1 17.1 0.2 0.0 7.7 0.3 IFT52 "C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5" ENSG00000101052 "Intraflagellar transport 52" Q9Y366 20 43590937-43647299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063367, HPA067423" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA063367: , HPA067423: AB_2685837" "unprognostic (2.88e-1)" "unprognostic (2.44e-2)" "unprognostic (6.82e-2)" "unprognostic (5.18e-3)" "unprognostic (7.39e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.30e-6)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" "unprognostic (2.00e-1)" "unprognostic (2.98e-2)" "unprognostic (2.28e-2)" "unprognostic (3.43e-2)" "unprognostic (7.51e-2)" "prognostic favorable (3.33e-4)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 21.2 15.2 12.1 11.8 12.3 29.4 26.4 12.2 15.4 29.5 13.9 16.5 9.3 27.7 29.2 14.9 38.3 19.2 11.5 12.0 13.4 20.7 7.8 17.1 18.4 12.7 12.5 11.8 39.6 15.9 22.7 16.6 17.6 12.5 17.7 18.0 15.2 13.7 24.0 4.8 14.8 11.3 24.5 12.7 15.8 12.3 32.1 13.3 23.0 31.6 9.1 19.0 19.7 18.1 14.0 33.9 25.4 50.3 35.8 41.9 46.4 23.9 20.8 46.1 53.6 51.6 70.5 33.7 18.8 32.8 42.6 43.4 27.7 21.3 37.3 58.6 15.6 20.0 24.8 16.2 65.9 51.4 33.4 16.4 37.8 40.2 34.9 27.0 39.0 42.7 41.4 21.3 26.1 39.9 34.0 46.4 51.5 28.4 22.2 24.9 48.6 57.5 27.8 41.8 32.9 38.8 45.3 63.6 46.7 52.2 25.3 21.8 45.1 26.9 47.3 35.1 26.3 31.1 25.3 26.9 32.8 56.8 24.0 34.8 8.0 22.0 16.8 18.4 20.9 15.0 17.5 14.7 17.5 28.4 15.3 15.4 16.0 6.3 17.4 26.2 21.5 18.6 17.3 12.1 12.3 12.2 15.4 12.0 13.4 12.7 12.5 11.8 12.5 12.7 13.3 14.0 21.1 6.4 13.1 11.4 13.7 13.0 12.8 22.4 12.0 11.5 14.1 19.2 2.9 11.5 13.2 7.3 0.0 19.9 16.0 14.8 19.6 26.1 78.4 32.1 19.4 18.1 9.5 23.4 20.5 22.2 19.7 25.3 8.2 10.5 14.5 26.7 23.2 2.6 19.4 8.4 22.5 11.0 14.2 18.2 13.9 20.9 28.6 13.3 17.8 12.2 21.3 22.6 18.6 14.6 25.7 14.8 10.1 38.4 13.5 5.9 5.5 18.3 49.0 12.8 13.1 23.9 24.8 57.3 18.5 12.2 14.9 9.6 12.1 30.4 10.3 10.5 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716495 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 92.6;lymphoid tissue: 56.0" "Cell type enhanced" "Detected in many" "B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 34 "plasmacytoid DC: 91.5" "Lineage enriched" "Detected in many" 34 "dendritic cells: 91.5" "Cell line enhanced" "Detected in many" "MCF7: 763.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.6 0.6 0.1 24.5 0.1 92.6 1.6 0.1 0.2 0.6 0.2 8.7 7.1 1.4 0.1 10.1 0.4 1.0 0.3 0.1 0.2 0.6 1.1 1.8 56.0 0.1 0.1 0.0 0.3 11.3 0.1 0.2 5.8 0.1 0.5 7.0 0.0 1.6 0.2 0.1 4.2 7.9 2.1 0.1 28.1 6.1 15.7 0.3 33.6 0.5 0.0 53.9 3.6 2.5 0.4 195.8 121.8 105.4 109.6 1.0 3.5 136.2 87.0 29.0 265.6 194.6 600.2 118.8 393.6 49.2 37.8 55.8 116.1 192.1 59.6 98.8 74.2 124.1 183.2 118.7 164.2 0.2 168.6 121.7 2.4 5.1 101.6 22.9 5.9 72.2 189.6 188.1 470.3 23.8 763.7 346.0 236.3 121.8 155.4 105.4 237.3 216.3 222.1 49.6 39.7 96.7 140.6 255.6 253.3 26.1 110.4 167.2 183.1 34.0 16.3 264.3 118.3 151.5 162.1 363.8 606.5 34.2 142.3 103.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.2 0.0 91.5 1.3 0.8 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.0 0.0 33.0 4.2 0.8 0.8 0.0 0.0 2.5 3.4 2.0 1.5 0.1 0.0 0.0 14.4 32.6 3.4 0.0 0.4 5.9 0.9 1.3 1.8 0.0 82.3 0.4 0.9 32.3 4.8 10.2 2.9 0.0 18.9 0.7 1.4 13.5 0.0 0.3 5.1 0.0 2.4 2.6 14.1 0.0 3.2 1.8 0.0 0.0 0.0 1.0 0.0 0.5 0.7 1.1 0.0 139.6 0.3 0.5 0.0 0.0 0.0 0.0 0.1 3.9 7.0 33.6 8.2 2.4 3.7 3.0 1.2 8.6 2.4 R3HDML dJ881L22.3 ENSG00000101074 "R3H domain containing like" Q9H3Y0 20 44337043-44351238 "Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "intestine: 2.4" "Cell type enriched" "Detected in single" 5 "Microglial cells: 1.0" "Cancer enriched" "Detected in single" 5 "colorectal cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;OE19: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA070264 Enhanced "Secreted - unknown location" NA NA "HPA070264: AB_2686244" "unprognostic (1.89e-1)" "unprognostic (2.23e-1)" "unprognostic (9.86e-2)" "unprognostic (9.12e-2)" "unprognostic (6.06e-3)" "unprognostic (2.64e-1)" "unprognostic (6.32e-2)" "unprognostic (4.95e-3)" 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.7 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 HNF4A "HNF4, MODY, MODY1, NR2A1, TCF14" ENSG00000101076 "Hepatocyte nuclear factor 4 alpha" P41235 20 44355700-44434596 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 103.3;kidney: 43.7;liver: 118.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 48.2;liver cancer: 38.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004712, CAB019417" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB019417: AB_2295208, HPA004712: AB_1079075" "unprognostic (2.47e-1)" "unprognostic (3.08e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-2)" "unprognostic (4.79e-3)" "unprognostic (2.59e-2)" "unprognostic (3.77e-2)" "unprognostic (2.45e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-2)" "unprognostic (8.40e-3)" "unprognostic (2.12e-1)" "unprognostic (2.70e-2)" 0.2 0.1 0.1 6.0 0.2 0.1 0.1 0.3 0.3 0.0 6.8 59.1 103.3 0.1 0.0 0.1 1.0 5.9 0.0 0.4 0.0 43.7 118.0 0.1 0.1 0.1 0.0 0.2 0.0 25.4 0.0 0.0 0.0 0.1 0.0 44.5 0.1 0.0 0.1 0.2 0.0 83.3 1.8 0.0 0.0 22.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 154.4 6.0 0.1 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 114.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 42.2 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.4 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 35.8 0.0 12.9 0.0 0.0 0.0 232.6 15.6 7.8 4.0 2.5 0.1 0.4 35.9 2.7 0.5 22.1 0.0 0.1 38.2 0.1 4.5 0.0 3.6 186.8 0.0 0.0 0.3 69.8 0.0 5.3 0.0 18.7 0.3 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 21.0 120.0 0.4 0.1 0.3 153.9 170.1 0.0 0.0 0.0 0.6 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.8 136.1 0.2 NDRG3 ENSG00000101079 "NDRG family member 3" Q9UGV2 20 36651766-36746090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 115.7" "Group enriched" "Detected in all" 10 "Early spermatids: 962.7;Late spermatids: 356.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017851, HPA018256" Enhanced NA NA "HPA017851: AB_1854340, HPA018256: AB_1854341" "unprognostic (4.59e-2)" "unprognostic (9.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.56e-1)" "unprognostic (1.30e-2)" "unprognostic (5.42e-3)" "unprognostic (2.48e-3)" "unprognostic (3.52e-1)" "unprognostic (9.57e-2)" "unprognostic (2.66e-2)" "unprognostic (3.39e-1)" "unprognostic (3.98e-2)" "unprognostic (1.61e-1)" 15.0 38.5 50.0 14.5 51.9 8.3 18.6 67.9 70.8 22.4 26.7 23.8 19.4 22.7 16.0 18.8 19.0 15.7 30.9 64.4 54.0 18.4 8.1 17.1 18.5 64.6 49.9 51.5 27.5 14.5 40.0 22.4 11.7 71.0 55.0 21.7 115.7 18.6 17.3 21.0 17.4 17.5 24.7 45.4 18.8 15.1 76.1 59.0 21.1 15.6 16.6 21.8 16.5 19.3 81.7 49.3 27.3 34.9 20.8 36.2 39.5 11.5 20.2 24.3 33.8 33.0 52.9 25.0 24.9 23.0 41.4 53.2 44.9 45.5 71.1 38.1 18.8 33.7 69.4 37.0 59.6 19.0 18.2 21.0 37.2 40.3 28.8 8.3 38.5 43.2 43.7 27.6 52.1 30.3 18.4 25.2 25.4 10.5 62.0 47.2 21.9 54.9 18.2 40.0 22.4 31.0 26.6 31.4 136.5 30.7 28.1 63.6 16.0 18.9 32.7 21.2 13.2 25.6 24.3 21.6 15.8 61.2 31.3 17.7 6.7 7.2 14.9 16.9 9.6 17.5 12.9 17.4 16.0 11.1 8.8 14.6 15.5 10.6 27.3 12.0 5.7 18.3 10.2 50.0 51.9 67.9 70.8 64.4 54.0 64.6 49.9 51.5 71.0 45.4 59.0 81.7 12.9 22.4 6.9 22.2 13.4 11.1 15.3 11.4 15.9 49.8 10.3 8.9 24.6 11.5 9.6 7.3 50.1 9.8 10.4 15.0 27.4 14.0 962.7 6.7 11.3 11.5 7.3 5.0 64.6 14.2 12.5 14.0 12.2 7.5 5.7 14.2 11.4 5.2 27.1 21.9 65.3 9.4 18.3 23.4 12.7 356.6 27.7 14.6 12.4 22.5 9.6 25.9 17.5 39.7 29.1 13.2 6.0 27.8 10.8 13.2 13.1 12.0 9.9 65.2 26.3 12.8 16.8 22.4 20.2 25.2 7.7 6.8 17.5 13.8 13.3 8.8 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646196 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.6;lymphoid tissue: 18.4" "Cell type enhanced" "Detected in some" "dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4" "Group enriched" "Detected in many" 8 "dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4" "Group enriched" "Detected in some" 7 "HEL: 91.2;JURKAT: 51.8" "Not detected" "Not detected" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 0.9 0.6 0.4 5.7 0.6 12.6 0.8 1.5 0.8 0.8 0.3 1.7 2.8 1.0 0.5 0.8 0.9 2.5 0.6 0.4 0.3 0.5 1.5 4.1 10.4 0.7 0.5 0.3 0.5 0.4 0.1 0.4 0.6 0.7 0.7 1.7 0.5 1.4 0.5 0.6 0.7 3.1 0.5 0.3 8.0 2.6 0.5 0.5 18.4 0.7 0.3 9.0 2.2 0.6 1.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 91.2 0.6 3.4 0.0 2.5 0.3 0.1 0.1 0.0 0.0 0.0 0.1 51.8 0.1 0.2 0.0 0.2 10.9 7.6 0.1 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.1 7.6 0.1 3.0 0.4 3.8 28.8 0.7 24.1 0.4 23.8 27.1 0.4 0.3 21.8 30.5 4.8 39.2 0.1 48.5 33.4 26.5 0.4 0.6 1.5 0.8 0.4 0.3 0.7 0.5 0.3 0.7 0.3 0.5 1.1 0.6 0.0 3.9 0.0 1.6 0.4 0.1 0.0 0.0 0.3 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.1 97.0 0.6 0.0 0.2 1.1 0.4 0.4 0.4 0.0 8.2 2.2 0.0 0.2 0.5 4.1 0.6 1.3 0.0 0.7 0.1 0.2 0.0 1.7 0.0 0.0 1.6 0.4 0.0 0.3 21.8 0.0 1.9 1.2 0.4 44.3 1.5 1.4 0.3 0.1 0.0 25.8 0.1 0.0 0.1 0.0 0.9 0.0 0.3 0.4 0.0 0.2 0.2 0.1 0.1 59.2 0.0 0.2 0.3 RAB5IF "C20orf24, PNAS-11, RCAF1, RIP5" ENSG00000101084 "RAB5 interacting factor" Q9BUV8 20 36605779-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 218.7" "Cell type enhanced" "Detected in many" "Ductal cells: 215.9;Exocrine glandular cells: 348.7;Hofbauer cells: 242.6;Pancreatic endocrine cells: 442.2;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol NA NA Cytosol "HPA057387: AB_2683425" "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 40.3 49.4 33.5 46.9 33.5 69.6 33.6 36.2 40.7 33.4 35.4 72.3 49.7 29.4 41.2 153.4 27.6 39.0 49.2 33.7 38.3 53.4 116.7 42.2 38.9 37.2 34.4 30.7 22.8 43.1 55.7 20.9 33.7 35.0 30.0 60.5 28.8 56.7 27.9 218.7 38.4 43.5 35.0 37.5 57.4 48.9 37.8 38.2 42.0 28.0 78.9 56.9 50.8 58.6 37.0 224.8 164.4 59.9 75.2 127.2 74.8 142.5 135.8 79.4 132.7 119.5 455.9 279.5 96.6 327.4 122.2 244.8 163.2 123.3 219.3 130.5 73.5 119.1 230.0 233.3 516.7 149.1 247.4 109.3 92.6 225.0 187.7 110.1 70.4 124.5 104.0 158.9 226.4 125.2 156.9 148.6 318.2 98.5 227.1 344.6 114.8 137.2 245.9 119.3 163.5 99.3 76.0 195.3 513.2 187.6 89.3 111.5 206.5 135.1 192.6 132.5 195.3 211.7 138.8 236.0 162.2 204.4 281.3 104.7 22.0 76.9 97.3 17.7 38.9 17.8 35.7 21.2 27.4 47.9 33.6 26.1 19.4 120.6 18.4 46.4 32.8 39.8 28.1 33.5 33.5 36.2 40.7 33.7 38.3 37.2 34.4 30.7 35.0 37.5 38.2 37.0 47.5 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 87.1 64.5 0.0 0.0 0.0 42.3 0.0 83.1 111.1 0.0 76.3 215.9 0.0 43.0 34.8 24.4 0.0 0.0 0.0 348.7 126.8 14.5 0.0 61.6 0.0 24.3 0.0 0.0 242.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 93.0 0.0 0.0 0.0 0.0 442.2 0.0 0.0 11.9 0.0 0.0 147.8 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 135.6 27.0 29.9 0.0 0.0 NFATC2 "NF-ATP, NFAT1, NFATp" ENSG00000101096 "Nuclear factor of activated T cells 2" Q13469 20 51386957-51562831 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.6" "Cell type enhanced" "Detected in many" "Microglial cells: 96.5;NK-cells: 105.0;Skeletal myocytes: 152.0;T-cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 24.5;HMC-1: 26.8;SK-MEL-30: 20.4;WM-115: 41.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008789, CAB018567, HPA024369" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413" "unprognostic (2.69e-3)" "unprognostic (2.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (4.05e-2)" "unprognostic (9.26e-2)" "unprognostic (3.74e-3)" "unprognostic (2.17e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.25e-2)" "unprognostic (1.02e-1)" "unprognostic (1.05e-2)" "unprognostic (6.59e-2)" 7.7 2.1 2.4 7.4 6.1 4.8 4.7 3.3 2.7 3.9 22.6 4.2 8.0 3.9 3.4 3.7 4.3 16.6 2.5 2.1 3.9 1.5 6.2 4.8 16.2 4.5 5.4 0.5 2.1 8.1 3.2 1.5 7.6 4.8 2.4 3.7 0.1 4.9 2.5 3.4 3.8 6.2 2.9 4.0 12.7 10.8 1.6 6.3 5.0 3.5 0.9 13.7 6.6 2.0 5.7 2.7 2.9 0.0 3.6 0.0 0.0 7.5 0.4 1.9 1.2 0.6 14.0 2.5 18.7 2.1 0.9 2.5 0.0 0.9 0.0 1.1 24.5 0.4 8.0 2.1 3.6 0.0 2.2 26.8 0.0 0.0 1.0 0.1 0.2 8.4 6.5 8.0 12.1 0.0 3.1 3.3 13.3 0.3 1.7 6.6 1.4 0.0 8.3 0.4 0.0 0.3 0.0 8.6 2.1 20.4 1.7 3.3 5.3 0.9 1.7 3.0 4.1 0.2 10.2 7.2 18.6 1.7 8.7 41.1 0.4 0.0 3.1 5.3 0.5 2.2 1.3 2.9 4.3 1.2 1.1 1.6 3.0 0.1 5.7 0.2 0.5 1.7 1.3 2.4 6.1 3.3 2.7 2.1 3.9 4.5 5.4 0.5 4.8 4.0 6.3 5.7 16.0 6.4 5.4 14.0 38.1 14.4 16.1 0.9 0.6 0.0 8.7 4.3 3.6 4.3 5.6 0.0 0.0 3.3 42.7 1.9 1.9 3.7 1.6 13.1 12.1 28.0 7.8 18.1 1.7 5.6 0.8 37.2 23.4 12.2 15.2 0.2 30.7 7.5 37.1 0.0 1.0 6.2 0.0 32.5 56.6 0.8 2.1 19.0 62.2 96.5 5.0 0.0 105.0 2.5 5.0 11.4 1.8 0.4 55.8 5.3 1.4 0.3 9.3 0.0 0.0 152.0 15.2 0.4 0.7 3.8 12.9 1.0 65.5 0.0 7.0 6.6 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810546 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell type enhanced" "Detected in some" "Granulosa cells: 110.3;Horizontal cells: 38.7;Inhibitory neurons: 14.4;Sertoli cells: 26.3" "Cancer enhanced" "Detected in many" "breast cancer: 6.6;glioma: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 19.3;MCF7: 13.4;SCLC-21H: 39.9;SH-SY5Y: 20.4;SiHa: 14.0;U-2 OS: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060928: AB_2684387" "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 0.4 1.1 16.0 0.2 23.0 0.0 1.2 7.3 33.0 7.3 1.1 0.6 0.1 1.9 0.4 0.5 8.2 0.6 0.3 23.5 12.6 0.0 0.0 0.9 0.1 17.1 11.3 21.0 6.2 0.0 0.0 12.1 0.0 14.8 2.5 0.5 2.9 1.1 0.9 1.1 0.3 0.4 2.6 5.1 0.0 1.8 10.6 9.2 0.2 5.0 1.7 0.4 0.1 1.5 20.6 0.0 0.5 0.5 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.9 0.1 2.0 0.0 19.3 0.2 0.0 0.0 8.2 0.0 0.8 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 13.4 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 39.9 20.4 14.0 0.0 0.2 0.5 6.1 0.7 0.0 0.0 9.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.0 7.3 33.0 23.5 12.6 17.1 11.3 21.0 14.8 5.1 9.2 20.6 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.1 1.8 0.0 11.3 0.0 0.0 0.4 0.0 0.4 0.0 110.3 0.0 0.0 0.1 38.7 14.4 0.8 0.0 0.0 0.0 2.9 7.2 0.2 0.0 0.0 0.0 1.0 0.0 2.0 0.6 0.1 0.1 13.2 0.0 0.0 0.0 0.0 0.0 1.4 26.3 0.2 1.2 1.2 5.7 0.0 0.1 0.0 0.0 0.5 0.5 0.0 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910060-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 24.6;Collecting duct cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA066650 Approved "Nuclear bodies,Cytosol" NA Yes Cytosol "Nuclear bodies" "HPA066650: AB_2685698" "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavorable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favorable (8.84e-4)" 1.5 2.3 1.7 2.0 1.7 4.1 3.0 1.1 2.1 3.2 2.3 1.6 0.9 1.5 3.5 2.1 3.4 1.4 1.2 1.6 2.4 6.1 5.9 2.9 3.3 1.4 1.3 1.6 6.7 6.1 0.5 6.1 0.6 1.3 5.2 0.7 0.4 2.5 0.9 0.5 2.1 2.9 0.6 1.2 4.4 2.8 1.9 1.9 3.1 8.0 0.1 1.9 1.9 1.9 1.5 2.0 3.4 1.9 4.1 0.4 2.6 8.9 3.7 0.3 1.4 0.4 8.4 3.4 2.2 7.3 0.2 1.2 4.7 0.5 1.3 0.9 1.9 4.0 1.9 8.1 7.2 2.1 1.6 0.5 0.5 6.4 1.2 1.5 1.1 0.0 3.1 3.0 2.2 0.3 8.0 2.8 4.9 1.2 3.0 7.6 3.7 0.6 2.2 0.7 2.6 2.0 3.0 1.6 5.7 6.7 1.8 9.7 1.8 0.2 5.2 5.7 3.4 1.6 5.4 8.8 1.8 1.7 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 1.7 1.1 2.1 1.6 2.4 1.4 1.3 1.6 1.3 1.2 1.9 1.5 1.3 6.4 24.6 11.8 7.0 1.9 3.3 3.3 6.2 0.5 7.6 9.9 1.5 7.2 15.6 20.2 0.0 6.7 4.7 2.8 0.0 3.3 0.6 9.5 6.8 1.5 4.2 1.7 5.3 0.5 4.4 4.2 12.8 11.1 3.8 10.3 0.4 5.7 3.0 0.0 2.3 3.0 2.0 0.8 1.6 0.6 1.8 3.3 0.0 1.9 2.3 1.4 3.1 11.1 3.2 1.8 2.4 1.9 5.1 3.5 1.5 1.5 10.1 1.3 0.0 2.1 2.6 0.9 2.1 4.9 1.7 3.8 7.0 2.1 4.4 2.9 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966479-45080021 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.3" "Cell type enhanced" "Detected in all" "B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 45000 "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 10.1 8.6 7.2 34.1 8.3 58.3 9.2 6.7 10.7 8.0 11.0 11.2 10.3 8.6 7.6 9.2 6.2 11.8 4.2 7.7 8.9 6.0 9.2 16.1 43.4 8.6 7.8 6.1 7.1 6.1 5.9 4.1 10.5 8.9 6.8 13.1 7.4 7.5 8.0 3.4 11.2 13.6 9.4 8.6 30.7 12.8 9.8 8.4 33.4 7.7 4.9 42.0 15.1 7.0 10.3 27.8 18.7 23.3 16.1 13.5 16.9 16.0 23.6 35.7 39.4 35.6 52.7 14.6 66.6 20.4 16.9 33.4 28.5 24.3 31.8 49.7 30.8 13.8 48.6 27.8 36.8 23.8 63.5 66.4 13.8 25.6 36.7 39.6 19.4 14.6 44.6 23.5 37.0 19.9 21.7 47.6 42.3 13.9 17.7 12.5 30.2 25.2 31.2 14.4 18.7 10.9 13.2 35.6 20.0 27.0 17.2 18.3 39.1 18.7 29.2 28.6 34.4 27.8 48.4 41.7 73.2 28.6 29.5 22.0 80.6 19.7 54.8 34.4 19.9 34.3 26.2 32.2 32.0 18.4 26.9 33.1 28.0 101.8 28.5 38.0 10.0 34.3 22.3 7.2 8.3 6.7 10.7 7.7 8.9 8.6 7.8 6.1 8.9 8.6 8.4 10.3 26.2 16.0 24.6 18.9 372.8 55.7 49.3 33.8 28.5 27.3 22.9 17.4 7.6 14.3 25.2 42.3 52.1 24.1 341.8 23.7 9.8 16.3 5.9 19.1 25.1 32.1 25.7 46.3 76.7 17.6 30.3 29.7 34.1 25.1 133.6 114.0 26.0 22.0 61.1 43.7 38.2 20.7 28.5 109.3 606.9 5.0 22.7 154.4 133.4 85.3 367.5 20.2 278.1 34.2 48.1 21.6 27.9 17.0 336.2 32.6 23.2 13.4 26.1 69.9 13.1 25.5 29.2 44.2 42.4 20.9 53.0 19.4 414.5 48.1 19.5 45.5 SALL4 "dJ1112F19.1, ZNF797" ENSG00000101115 "Spalt like transcription factor 4" Q9UJQ4 20 51782331-51802521 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.0;thyroid gland: 5.9" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 26.9" "Cancer enriched" "Detected in many" 11 "testis cancer: 22.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "NK-cell: 2.5" "Lineage enriched" "Detected in single" 9 "NK-cells: 2.5" "Cell line enhanced" "Detected in some" "AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7" "Not detected" "Not detected" "HPA015291, HPA015791" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "HPA015291: AB_1856548, HPA015791: AB_1856547" "unprognostic (1.30e-1)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (7.43e-2)" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (9.23e-2)" "unprognostic (2.50e-2)" "unprognostic (2.39e-2)" "unprognostic (2.42e-8)" "unprognostic (5.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.00e-5)" "unprognostic (7.41e-2)" 0.2 0.3 0.2 0.2 0.2 0.8 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.2 0.0 0.1 0.2 0.3 0.4 1.6 0.2 0.1 0.2 0.2 0.2 0.1 2.1 2.0 0.5 0.2 0.2 2.5 0.2 0.5 0.9 0.2 0.1 0.2 0.4 0.1 0.1 0.6 0.2 4.0 0.2 0.0 5.9 0.0 0.1 0.4 0.1 0.4 0.0 1.7 25.0 17.5 0.0 0.1 33.2 0.0 0.2 0.1 0.3 9.0 0.2 0.0 0.3 0.3 0.3 4.3 0.2 0.1 0.3 0.4 0.0 0.0 7.0 0.4 0.1 0.0 1.9 0.7 0.5 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 1.8 0.0 0.1 60.2 0.2 0.4 2.3 0.0 0.0 0.0 0.5 5.7 3.1 15.6 0.1 1.5 39.7 0.1 1.0 0.0 0.9 3.3 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.4 0.1 0.0 2.0 1.6 0.0 0.0 1.1 0.1 0.0 0.4 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 3.6 0.0 0.2 0.1 0.2 1.2 0.0 4.1 0.2 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.6 0.2 26.9 3.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.2 1.0 2.0 2.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 0.2 0.2 0.7 5.5 0.0 0.0 0.0 0.0 0.1 0.0 1.2 ADNP "ADNP1, KIAA0784" ENSG00000101126 "Activity dependent neuroprotector homeobox" Q9H2P0 20 50888916-50931437 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006371 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA006371: AB_1078105" "unprognostic (3.40e-2)" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.68e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (1.73e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (3.63e-1)" "unprognostic (1.90e-2)" "unprognostic (1.08e-1)" 21.2 22.5 33.9 20.4 34.7 25.5 32.9 39.1 40.3 26.9 32.1 22.6 20.3 31.7 42.4 24.0 29.7 22.5 19.6 33.3 33.5 25.2 25.6 24.2 29.1 32.2 33.5 32.7 39.7 22.0 36.4 20.6 25.5 32.5 28.9 24.4 44.0 22.1 30.2 36.1 28.1 23.0 29.9 32.2 25.2 27.0 36.9 34.6 45.2 29.9 28.6 35.9 27.0 24.1 38.5 51.2 50.9 103.2 53.7 51.3 47.3 38.8 41.2 48.1 79.0 55.8 80.4 42.3 74.0 51.7 52.9 41.9 62.1 86.6 85.1 89.5 32.6 30.8 54.2 58.1 64.0 48.9 87.7 41.2 47.1 101.3 47.8 85.7 61.2 56.7 46.2 66.7 47.2 51.6 61.6 76.4 61.4 45.5 52.7 42.8 76.2 54.4 55.5 50.9 77.2 81.2 61.9 92.7 138.0 73.6 65.8 62.7 82.5 44.7 68.6 69.4 49.0 45.8 36.3 39.2 104.0 42.2 50.5 47.3 38.5 23.8 22.3 40.5 37.4 42.7 26.0 44.6 36.9 28.3 29.8 43.8 58.4 12.3 31.4 52.8 58.2 32.8 22.5 33.9 34.7 39.1 40.3 33.3 33.5 32.2 33.5 32.7 32.5 32.2 34.6 38.5 45.5 9.6 24.4 85.5 31.1 60.0 32.9 22.9 26.7 41.3 46.9 39.2 38.0 38.6 26.4 14.7 25.0 31.4 55.4 25.6 17.6 22.2 26.3 50.0 59.9 33.4 37.1 26.9 75.6 21.9 20.3 32.8 25.0 61.3 17.2 72.5 27.1 29.5 22.5 38.7 93.5 29.3 18.3 27.4 41.0 38.8 31.4 28.9 40.9 77.8 26.7 25.0 20.6 124.1 122.7 28.5 21.1 39.9 27.0 36.1 22.1 23.2 22.0 37.1 39.5 45.9 41.2 27.9 35.2 31.2 52.0 22.2 36.6 42.8 33.7 39.8 PFDN4 "C-1, C1, PFD4" ENSG00000101132 "Prefoldin subunit 4" Q9NQP4 20 54208087-54228052 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024055 Approved NA NA 220000 "HPA024055: AB_1855236" "unprognostic (2.38e-2)" "unprognostic (1.49e-1)" "unprognostic (3.11e-1)" "unprognostic (5.18e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (9.40e-4)" "prognostic unfavorable (7.66e-5)" "unprognostic (7.87e-3)" "unprognostic (3.38e-1)" "unprognostic (2.33e-2)" "unprognostic (7.44e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.47e-10)" "unprognostic (9.43e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-1)" "unprognostic (7.57e-2)" 5.6 6.2 14.2 4.9 14.4 5.4 6.0 14.0 19.2 5.9 12.5 3.5 2.0 8.1 5.8 5.4 4.7 5.9 14.4 14.5 15.1 6.4 4.0 3.9 6.8 14.9 15.6 14.2 7.9 3.7 5.9 2.6 6.7 15.2 5.4 4.3 3.4 4.1 5.2 8.9 4.4 2.8 6.3 14.4 3.2 2.3 7.7 14.9 4.8 6.9 8.3 4.9 5.8 2.7 15.6 9.9 3.4 11.6 3.8 8.1 19.4 11.5 9.2 7.1 21.8 9.6 12.6 9.9 7.2 30.1 10.4 12.6 8.4 13.3 11.9 36.7 7.2 10.0 6.1 13.1 42.6 10.5 12.5 6.8 10.3 16.8 9.4 17.3 11.3 13.8 8.9 11.6 8.2 20.0 38.8 12.8 29.5 14.1 6.2 16.5 9.9 4.1 13.2 18.7 12.7 13.6 14.4 11.2 30.3 31.9 10.5 9.4 25.4 6.9 15.5 18.8 21.8 20.8 5.1 8.1 11.0 15.4 11.0 13.7 3.6 5.4 2.6 4.4 5.8 6.2 6.0 5.9 5.3 7.8 5.2 6.1 5.7 0.8 7.6 5.5 8.6 12.5 5.0 14.2 14.4 14.0 19.2 14.5 15.1 14.9 15.6 14.2 15.2 14.4 14.9 15.6 46.7 28.9 32.9 6.2 47.3 91.1 86.4 190.5 59.7 16.5 67.6 82.2 73.6 52.9 68.7 40.5 0.0 124.4 53.2 45.5 107.6 147.5 196.9 67.6 53.5 65.3 71.2 77.2 14.7 137.9 147.1 66.6 19.9 82.1 43.1 52.1 84.6 71.6 95.3 13.5 14.6 56.7 85.5 104.3 104.8 35.7 78.9 46.8 62.2 8.4 172.5 41.7 52.5 12.1 11.9 145.8 68.5 68.1 35.1 69.0 42.7 135.4 66.6 15.7 105.2 55.5 64.6 181.4 92.8 57.3 88.5 93.4 53.6 48.5 66.5 76.7 DOK5 "C20orf180, dJ805C22.1" ENSG00000101134 "Docking protein 5" Q9P104 20 54475593-54651169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 46.4;tongue: 24.5" "Cell type enhanced" "Detected in many" "Astrocytes: 110.7;Distal tubular cells: 39.2;Excitatory neurons: 49.7;Horizontal cells: 38.7;Inhibitory neurons: 79.6;Muller glia cells: 63.9;Oligodendrocyte precursor cells: 58.3" "Group enriched" "Detected in many" 6 "glioma: 18.0;ovarian cancer: 29.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 32.9;ASC diff: 13.1;ASC TERT1: 11.0;hTEC/SVTERT24-B: 13.7;U-138 MG: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054460, HPA065235" Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA054460: AB_2682495, HPA065235: AB_2685441" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (8.90e-2)" "prognostic unfavorable (8.99e-7)" "unprognostic (1.02e-1)" "unprognostic (1.72e-2)" "unprognostic (5.88e-4)" "unprognostic (5.12e-2)" "unprognostic (4.51e-3)" "unprognostic (2.97e-1)" "unprognostic (2.69e-2)" "unprognostic (1.49e-1)" "unprognostic (6.49e-2)" "unprognostic (4.23e-3)" "unprognostic (3.08e-1)" "unprognostic (4.56e-2)" "unprognostic (1.99e-2)" 2.9 2.0 13.9 1.7 13.7 0.0 1.9 13.6 15.8 1.1 11.9 1.2 0.3 1.8 0.3 1.7 12.3 9.9 18.6 14.7 14.5 2.8 2.3 1.0 0.6 14.3 14.6 12.8 0.9 1.2 0.2 1.2 1.8 15.9 1.0 0.7 11.8 1.5 0.8 46.4 0.5 0.7 2.8 13.2 0.3 0.8 1.7 14.7 0.4 5.2 24.5 0.4 4.7 0.9 13.4 0.0 0.0 32.9 0.0 13.1 11.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 4.3 0.0 13.7 0.0 0.6 1.7 0.0 0.0 4.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 3.6 7.0 0.0 8.6 0.0 0.0 0.1 0.4 1.9 0.0 0.0 0.0 51.3 3.2 1.4 0.0 0.0 0.0 0.1 2.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 13.7 13.6 15.8 14.7 14.5 14.3 14.6 12.8 15.9 13.2 14.7 13.4 4.8 0.0 0.0 110.7 0.3 0.3 2.3 0.0 0.0 12.3 6.7 6.2 7.3 12.8 0.0 11.0 6.2 0.3 0.1 0.0 39.2 17.7 2.3 0.4 1.5 3.3 0.0 0.0 49.7 1.2 0.6 14.4 0.0 10.6 0.0 28.6 17.5 0.0 29.0 38.7 79.6 0.0 0.0 0.6 2.5 4.5 2.5 0.6 0.0 9.4 14.5 63.9 0.0 58.3 2.1 2.2 0.0 1.2 0.1 2.0 0.0 0.2 0.0 8.1 0.0 2.8 5.3 3.7 1.5 0.0 0.4 0.8 0.2 1.6 0.0 0.9 CSTF1 ENSG00000101138 "Cleavage stimulation factor subunit 1" Q05048 20 56392371-56406362 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019270, HPA047275, HPA065000" Supported Enhanced Nucleoplasm NA NA 210000 Nucleoplasm "CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.54e-3)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (8.57e-3)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (4.05e-2)" "unprognostic (3.91e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" 6.3 6.5 4.3 8.2 5.0 5.2 11.2 6.3 5.0 7.4 5.0 7.9 5.4 8.2 8.1 8.9 9.6 7.8 8.1 4.6 4.6 9.6 11.0 8.6 12.5 4.4 4.9 4.4 11.9 10.1 11.5 4.8 9.4 5.0 8.6 8.1 15.0 10.4 7.1 9.5 8.4 5.9 8.9 4.1 7.7 7.9 17.7 5.4 14.4 10.1 14.8 14.6 9.0 5.8 6.4 18.9 17.4 22.1 15.6 22.6 20.2 23.7 25.2 27.8 49.2 36.7 37.6 26.9 39.1 26.7 19.1 31.5 31.2 35.7 43.4 57.8 12.4 12.6 38.1 29.3 23.3 13.4 32.2 23.6 19.4 24.5 27.6 23.8 19.1 30.2 24.3 32.6 18.5 30.2 44.6 36.2 17.0 20.3 37.2 23.2 26.5 47.7 34.6 23.9 19.3 24.5 17.0 34.5 93.1 25.6 25.3 37.1 22.9 17.1 39.9 25.3 16.9 24.9 13.0 21.5 42.0 32.0 21.3 19.4 11.4 16.9 13.6 20.7 14.6 26.0 21.1 25.9 23.4 21.5 24.3 28.4 24.9 13.3 31.2 13.1 23.7 33.3 20.4 4.3 5.0 6.3 5.0 4.6 4.6 4.4 4.9 4.4 5.0 4.1 5.4 6.4 8.4 9.6 13.1 4.2 11.6 9.2 10.8 29.3 12.5 9.2 9.9 8.3 8.9 14.3 16.8 18.4 14.6 30.9 11.5 7.3 19.6 17.9 25.9 7.1 9.4 13.3 4.9 21.0 4.2 14.7 21.1 12.1 9.7 6.0 17.7 12.6 11.7 22.6 15.3 5.0 4.2 9.4 14.2 16.7 7.8 7.5 13.7 8.4 5.4 9.4 18.4 14.2 12.3 5.5 6.7 11.9 11.8 12.8 10.8 12.3 8.5 21.1 12.9 14.7 19.7 11.1 9.9 84.3 30.5 11.3 8.8 21.1 14.9 16.7 9.8 8.8 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168753-57266641 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1;choroid plexus: 37.5;thyroid gland: 46.3" "Cell type enhanced" "Detected in many" "Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.0 6.5 30.9 1.9 31.9 0.0 1.3 37.9 27.7 8.5 37.5 2.4 2.2 1.2 17.3 24.1 9.6 0.4 8.7 33.5 33.0 6.1 0.0 1.6 1.0 39.5 33.3 22.1 0.2 0.5 0.0 2.8 26.0 31.9 5.9 1.7 5.4 3.9 9.3 0.3 21.4 1.9 0.3 32.8 0.6 3.7 0.7 39.9 3.8 46.3 0.0 2.1 6.8 13.1 42.1 0.3 0.7 23.4 5.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 20.0 6.8 172.1 41.3 0.0 8.7 48.3 5.2 0.0 0.0 0.4 17.2 0.1 0.0 0.0 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 202.3 0.0 0.1 12.3 94.4 0.0 0.1 0.1 77.8 0.0 0.2 0.4 17.8 5.5 128.4 0.5 15.2 0.9 0.4 0.4 0.1 10.9 0.0 0.1 0.2 0.3 237.6 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 31.9 37.9 27.7 33.5 33.0 39.5 33.3 22.1 31.9 32.8 39.9 42.1 0.6 6.4 2.2 74.1 0.4 13.8 13.4 12.9 51.8 4.7 0.9 4.6 15.1 0.0 4.2 1.8 0.0 137.4 0.1 0.2 0.0 0.0 5.3 1.7 2.4 1.2 2.4 0.0 0.9 0.0 21.0 13.5 2.0 2.5 21.6 0.1 0.0 0.0 11.0 1.7 4.7 1.5 6.1 0.0 1.9 4.9 0.3 0.4 3.6 2.8 0.1 38.4 0.0 74.4 8.7 0.0 0.3 0.4 2.5 6.6 0.2 2.2 1.9 2.4 0.0 1.3 0.8 1.8 3.4 44.2 9.7 56.9 0.9 0.7 1.5 18.1 RAE1 "Gle2, Mnrp41" ENSG00000101146 "Ribonucleic acid export 1" P78406 20 57351223-57379211 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" "Early spermatids: 113.6;Spermatocytes: 256.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048795 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA048795: AB_2680523" "unprognostic (1.20e-1)" "unprognostic (5.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (3.23e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (1.88e-1)" "unprognostic (8.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.50e-3)" "unprognostic (3.88e-2)" "unprognostic (7.48e-2)" "unprognostic (3.55e-1)" "unprognostic (9.49e-2)" "unprognostic (2.89e-1)" "unprognostic (2.01e-1)" 13.4 14.0 18.4 13.7 20.0 50.9 17.2 19.4 19.2 15.4 18.3 14.4 12.0 16.8 18.3 20.7 17.6 9.0 12.4 19.1 19.4 13.0 16.6 10.1 21.0 16.9 17.9 18.8 16.4 10.9 19.2 13.4 14.7 17.5 12.5 16.4 20.2 12.9 15.2 15.1 22.6 13.7 16.4 17.6 17.1 12.9 103.9 20.9 29.4 12.2 15.9 26.8 14.6 16.1 19.8 43.5 52.6 52.8 29.3 30.1 29.0 46.1 33.9 47.2 172.2 70.3 166.1 33.8 69.2 46.8 52.8 63.8 56.6 101.6 88.3 142.1 20.8 45.2 47.0 46.0 74.9 59.0 57.1 41.3 41.3 74.0 75.8 83.1 29.1 49.9 47.2 84.8 32.5 53.0 114.8 88.3 53.2 32.9 86.3 93.3 47.6 49.4 46.0 37.3 45.5 55.2 47.6 58.4 129.4 61.0 41.2 71.5 54.0 29.7 70.6 63.0 41.7 57.7 34.9 83.9 81.8 48.3 36.1 35.6 21.2 42.0 77.0 27.0 36.8 32.9 31.2 26.0 26.8 32.3 28.1 33.9 30.7 36.2 24.7 37.9 23.8 24.6 40.4 18.4 20.0 19.4 19.2 19.1 19.4 16.9 17.9 18.8 17.5 17.6 20.9 19.8 17.5 19.2 16.7 8.5 21.0 17.2 16.3 42.0 15.9 15.9 12.6 19.3 10.4 11.5 24.1 18.4 14.6 52.8 20.8 11.6 27.4 30.3 113.6 16.5 16.7 17.9 6.6 18.7 10.2 14.3 39.3 18.6 12.2 15.3 38.0 25.6 11.0 13.5 38.3 3.3 9.5 15.2 18.3 59.5 14.5 63.9 21.8 33.5 10.6 14.0 40.0 19.9 27.8 5.5 13.1 22.2 24.3 22.6 15.9 14.0 10.1 20.6 24.1 17.9 19.7 11.6 19.9 256.9 83.1 19.2 21.0 70.5 24.2 34.9 20.1 16.2 TPD52L2 "D54, hD54, TPD54" ENSG00000101150 "TPD52 like 2" O43399 20 63865228-63891545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 187.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047489 Approved Approved Vesicles,Cytosol NA NA 1100000 Vesicles Cytosol "HPA047489: AB_2680067" "unprognostic (1.17e-2)" "unprognostic (2.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.63e-3)" "unprognostic (9.95e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (1.74e-8)" "unprognostic (2.79e-1)" "unprognostic (7.07e-2)" "unprognostic (3.33e-2)" "unprognostic (3.15e-3)" 81.1 85.3 76.2 53.3 73.4 99.7 69.5 73.1 88.8 73.0 74.3 69.5 38.7 73.2 31.7 110.5 68.6 43.0 77.5 73.7 80.6 63.0 51.9 61.3 43.5 77.6 74.2 73.2 61.2 45.9 38.6 59.3 66.4 78.4 66.8 35.6 24.8 50.7 61.4 70.8 67.5 53.1 72.8 76.5 72.0 55.0 40.5 79.0 36.0 50.3 53.9 42.0 84.3 72.1 89.2 175.2 87.9 54.5 66.9 122.4 193.8 80.4 196.7 173.0 343.1 145.0 326.9 194.9 70.0 211.3 200.0 204.2 168.4 111.5 269.0 198.7 39.5 46.4 66.9 112.6 199.6 129.9 85.0 66.3 140.3 296.6 138.5 221.3 121.6 160.1 74.0 140.4 101.0 137.0 96.3 83.5 109.4 78.7 172.6 308.1 114.0 59.5 113.3 135.8 76.0 82.3 92.2 230.9 177.5 165.3 80.3 120.6 171.5 170.1 273.4 79.1 160.9 145.4 63.2 108.6 85.0 256.8 79.0 86.6 66.9 73.0 47.1 29.4 55.1 36.8 33.5 32.3 34.2 47.6 31.4 32.4 29.8 137.3 47.5 48.1 24.0 38.8 74.6 76.2 73.4 73.1 88.8 73.7 80.6 77.6 74.2 73.2 78.4 76.5 79.0 89.2 37.5 16.0 23.4 36.2 26.6 44.1 28.3 58.8 33.0 18.9 28.0 31.1 45.4 20.0 31.3 22.0 6.2 77.2 28.6 27.8 39.2 50.5 7.8 21.7 38.4 36.7 18.6 26.9 19.6 32.1 104.0 37.7 23.9 31.9 38.7 25.8 28.9 14.5 187.3 8.4 21.7 27.2 20.3 47.4 33.0 12.1 42.0 52.3 28.4 7.5 50.6 32.5 27.8 13.6 32.3 74.8 25.1 65.1 29.4 51.7 37.5 36.6 26.5 19.7 46.0 18.9 65.6 13.9 25.6 37.2 42.3 108.8 25.0 42.3 27.9 44.4 DNAJC5 "CLN4, DNAJC5A, FLJ00118, FLJ13070" ENSG00000101152 "DnaJ heat shock protein family (Hsp40) member C5" Q9H3Z4 20 63895126-63936031 "Disease related genes, Human disease related genes, Predicted membrane proteins" Chaperone "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012139, HPA012737, HPA013154" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Vesicles "HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292" "unprognostic (9.96e-3)" "unprognostic (2.75e-1)" "unprognostic (3.91e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (3.04e-2)" "unprognostic (2.73e-1)" "unprognostic (2.65e-2)" "unprognostic (1.78e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.70e-6)" "unprognostic (2.24e-2)" "unprognostic (3.54e-2)" "unprognostic (4.28e-3)" "unprognostic (1.08e-2)" 12.4 22.3 25.3 10.8 30.0 17.0 11.2 7.8 36.6 9.9 1.1 16.8 11.6 12.3 5.8 42.3 11.7 7.4 24.4 32.4 27.4 16.7 12.9 18.1 10.0 23.4 24.1 31.5 8.8 22.9 21.4 28.8 8.5 29.8 16.8 7.0 28.3 16.4 11.7 14.6 18.8 17.6 8.6 8.8 22.4 21.0 10.8 25.7 8.5 17.0 9.6 8.6 13.6 17.1 37.7 25.2 23.7 19.8 18.8 19.4 15.9 14.6 28.6 27.4 49.4 23.8 52.7 30.2 9.8 31.6 28.2 22.7 36.4 15.9 53.6 16.0 8.2 11.3 19.3 17.4 25.8 18.1 19.2 43.5 18.0 39.9 22.9 11.7 19.1 24.2 16.5 19.2 8.9 22.6 17.3 21.1 30.9 7.1 21.0 26.5 21.0 10.9 10.7 16.4 22.6 21.4 13.9 30.8 48.7 17.8 11.6 23.5 75.9 43.7 42.6 14.4 20.4 21.5 11.1 5.6 13.6 42.9 25.3 25.4 0.7 3.2 2.6 3.2 3.7 1.8 1.6 1.8 2.7 2.5 1.4 2.5 2.5 3.1 1.5 3.1 3.9 3.1 2.6 25.3 30.0 7.8 36.6 32.4 27.4 23.4 24.1 31.5 29.8 8.8 25.7 37.7 12.8 6.4 17.8 19.2 10.4 20.8 18.5 25.5 20.5 60.7 17.4 14.1 31.7 14.3 23.2 23.9 62.6 18.5 19.1 71.7 13.7 20.5 48.9 23.9 8.5 18.7 32.4 10.3 37.1 37.6 18.4 12.4 27.0 23.5 1.3 12.1 23.9 27.8 43.5 79.1 38.8 33.3 14.2 51.0 24.8 123.5 7.2 31.4 14.2 25.3 36.9 27.9 22.6 19.1 26.2 59.0 41.1 12.4 17.3 39.5 62.0 22.9 29.4 47.0 13.1 9.0 13.1 13.5 13.2 28.0 22.9 30.2 15.0 13.3 28.4 64.5 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" Q8IXH7 20 58981208-58995133 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262, HPA074936" Enhanced Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 18.5 29.7 20.0 17.8 21.6 24.0 24.7 21.1 23.5 20.4 19.5 18.1 19.5 18.3 16.5 33.2 24.6 16.4 17.0 18.9 22.0 32.0 31.4 14.8 26.6 20.5 20.5 18.2 25.4 21.4 30.9 32.1 25.8 21.4 20.6 18.1 32.2 30.3 17.3 29.6 25.8 19.8 14.2 21.3 20.9 19.4 28.1 21.2 31.8 28.8 20.7 28.2 22.8 22.9 23.7 54.7 57.6 68.5 71.9 22.5 38.9 49.6 42.4 38.8 117.1 66.8 189.6 70.7 68.3 64.0 39.8 60.8 89.1 90.1 98.0 94.8 22.4 64.1 90.5 72.4 150.5 26.7 64.2 60.1 40.9 34.3 44.2 32.8 32.8 68.3 54.0 118.1 51.8 53.3 198.2 135.6 95.4 40.3 151.5 122.9 78.4 56.6 121.1 49.0 76.5 75.9 112.6 126.0 148.3 85.9 38.2 157.5 75.0 30.2 91.6 88.8 36.3 67.7 44.4 80.0 71.1 53.7 57.3 80.6 20.0 44.6 22.9 42.0 51.5 50.0 48.6 39.7 51.2 64.9 44.5 37.7 40.1 5.6 47.1 68.8 33.0 39.7 49.0 20.0 21.6 21.1 23.5 18.9 22.0 20.5 20.5 18.2 21.4 21.3 21.2 23.7 23.0 9.6 27.6 18.3 50.5 30.2 62.6 43.8 40.9 67.3 32.7 34.2 10.9 47.1 24.3 22.0 41.7 133.1 35.5 14.5 50.9 57.0 18.8 26.2 33.3 26.7 23.4 60.0 23.0 31.4 69.2 26.2 26.5 27.4 16.5 50.9 23.2 24.1 36.9 55.5 22.8 21.9 26.4 15.3 24.0 32.1 37.0 24.0 26.6 10.3 48.1 52.9 49.4 21.1 23.6 34.9 14.4 26.4 37.4 37.8 27.8 49.9 15.0 61.5 39.5 31.6 34.2 63.1 94.9 40.5 31.4 103.0 48.5 43.9 36.2 52.8 CTSZ CTSX ENSG00000101160 "Cathepsin Z" Q9UBR2 20 58985686-59008238 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 542.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025114, HPA049876, HPA053504" Supported Supported Vesicles "Intracellular and membrane" NA NA 88000000 Vesicles "CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.07e-2)" "unprognostic (1.11e-3)" "unprognostic (8.25e-3)" "unprognostic (1.15e-1)" "unprognostic (4.12e-2)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.33e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (1.96e-1)" "unprognostic (6.92e-2)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" 174.2 118.8 15.6 210.7 21.9 100.7 138.2 18.4 32.2 92.9 51.3 154.3 217.3 88.1 13.5 53.6 89.7 90.2 152.1 12.8 43.6 125.6 359.3 235.3 273.8 28.4 18.9 9.7 71.6 90.1 92.5 113.4 119.7 24.5 88.5 77.8 4.2 182.5 67.0 59.2 56.1 227.8 98.8 34.8 236.2 89.0 24.8 35.7 57.6 123.3 55.1 92.1 147.7 69.6 37.7 205.4 139.8 1.1 1.1 114.2 124.2 106.5 291.0 225.4 187.4 152.3 231.6 324.6 96.5 213.9 542.1 0.5 160.1 51.4 257.5 30.2 362.1 13.6 80.3 169.0 0.8 137.3 9.0 331.0 130.9 127.8 83.1 62.4 34.8 281.3 1.1 74.0 48.7 90.0 1.1 1.3 70.6 11.5 43.5 158.2 2.9 0.4 135.7 86.3 25.5 2.7 1.7 222.4 258.4 0.8 19.5 131.9 148.4 420.5 1.4 161.8 209.0 2.0 253.7 172.0 18.2 2.8 207.9 0.4 1.2 1.5 1.6 0.6 1.4 0.4 1.1 0.6 0.4 1.1 1.4 0.7 0.8 1.6 0.5 2.9 1.8 0.3 0.7 15.6 21.9 18.4 32.2 12.8 43.6 28.4 18.9 9.7 24.5 34.8 35.7 37.7 132.1 16.0 5.3 5.9 119.8 50.3 64.5 33.8 24.5 6.7 67.4 99.6 21.7 62.9 14.1 71.7 0.0 38.2 104.8 303.6 23.5 176.0 3.5 52.9 47.7 82.2 27.1 63.3 5.3 42.4 104.8 71.5 19.4 71.3 10.8 68.4 62.8 363.0 1078.9 11.8 3.0 56.6 26.4 334.0 983.5 6.0 13.1 652.3 101.4 23.4 723.6 58.6 21.6 2.5 2.5 82.6 217.5 13.9 96.3 50.6 339.8 90.0 18.8 5.0 46.0 67.5 74.5 3.7 4.8 14.5 41.5 41.3 33.4 3.3 99.7 52.7 PRPF6 "ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K" ENSG00000101161 "Pre-mRNA processing factor 6" O94906 20 63981132-64033100 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047106 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA047106: AB_10963084" "unprognostic (1.29e-1)" "unprognostic (9.96e-3)" "unprognostic (7.02e-2)" "unprognostic (9.36e-3)" "unprognostic (1.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-3)" "unprognostic (3.37e-2)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (5.76e-3)" "unprognostic (2.18e-1)" "unprognostic (3.16e-3)" "unprognostic (6.16e-2)" "unprognostic (8.04e-2)" "unprognostic (7.19e-2)" "unprognostic (5.39e-3)" 39.2 32.5 32.7 31.1 35.9 33.5 40.5 43.7 37.4 38.3 33.4 38.2 30.2 43.9 28.1 39.2 49.7 27.4 35.4 31.6 34.4 31.9 30.0 32.4 41.2 36.5 33.6 31.2 51.0 44.6 37.5 37.0 31.1 36.2 34.8 26.2 36.7 38.7 36.7 65.1 57.9 38.5 29.9 33.8 41.2 37.6 41.3 34.3 44.8 36.5 37.4 40.8 40.9 36.5 45.6 72.8 86.5 62.3 66.3 69.5 48.6 81.5 56.1 62.8 167.9 74.6 233.6 86.2 90.9 133.4 74.5 107.1 110.0 101.2 116.1 88.7 44.0 59.0 76.8 112.7 213.3 76.7 105.3 102.3 55.2 81.4 77.5 89.2 59.9 63.3 83.7 76.2 76.6 56.8 89.2 106.8 131.0 55.4 114.4 106.7 116.0 53.0 87.3 64.4 71.9 61.8 72.4 108.6 110.0 74.1 43.2 108.0 135.5 90.1 96.2 55.1 77.4 104.6 63.7 66.5 94.6 70.3 62.5 76.3 90.8 59.7 73.7 67.0 62.7 93.3 67.1 82.3 72.5 58.6 58.4 95.8 80.9 50.3 130.5 77.8 54.5 79.7 92.3 32.7 35.9 43.7 37.4 31.6 34.4 36.5 33.6 31.2 36.2 33.8 34.3 45.6 60.7 60.9 62.6 19.2 69.3 38.4 45.3 50.7 63.2 81.6 54.2 59.8 70.5 34.3 71.6 62.5 37.5 72.5 53.2 43.8 82.2 59.3 49.1 70.3 66.8 55.7 52.7 43.5 12.5 56.7 47.6 51.2 38.7 62.0 91.2 49.0 63.9 55.2 46.3 42.1 14.8 60.6 57.0 44.8 34.1 28.7 58.1 49.9 48.0 5.6 79.7 86.5 57.7 12.5 17.8 65.9 43.9 52.6 67.8 33.5 58.0 65.8 87.7 112.7 59.2 68.2 61.9 120.6 118.9 59.8 46.3 94.5 60.0 32.6 47.7 34.3 TUBB1 dJ543J19.4 ENSG00000101162 "Tubulin beta 1 class VI" Q9H4B7 20 59019429-59026654 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.5;lymphoid tissue: 4.3" "Cell type enriched" "Detected in some" 10 "Macrophages: 191.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 17 "basophil: 63.5;neutrophil: 26.0" "Lineage enriched" "Detected in many" 24 "granulocytes: 63.5" "Cell line enriched" "Detected in some" 19 "HEL: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004286, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 87000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (3.76e-1)" "unprognostic (2.69e-1)" "unprognostic (6.10e-4)" "unprognostic (1.02e-1)" "unprognostic (5.00e-2)" "unprognostic (2.02e-1)" "unprognostic (5.86e-2)" "unprognostic (7.51e-4)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (6.80e-5)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "unprognostic (1.00e-1)" 0.2 0.2 0.2 0.3 0.3 8.5 0.1 0.6 0.6 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.3 2.4 0.2 0.4 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.4 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.2 0.0 0.5 4.3 0.1 0.9 0.3 0.0 0.2 1.5 0.0 0.0 0.0 0.4 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.2 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 29.5 0.8 1.5 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.4 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.2 0.1 0.3 0.0 0.3 0.3 0.2 0.2 0.6 0.1 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.1 0.2 0.3 0.2 0.1 0.2 0.4 63.5 2.4 1.9 0.5 0.6 0.4 0.9 0.2 0.0 1.1 0.5 0.4 0.0 26.0 0.2 0.3 2.6 0.5 281.6 0.2 0.3 0.6 0.6 0.1 0.2 0.4 0.3 0.1 0.4 0.5 0.3 0.4 0.1 0.0 1.1 0.3 1.4 0.0 0.0 0.0 0.0 1.7 0.1 0.1 0.1 0.0 0.6 0.0 4.2 0.0 3.1 0.0 0.0 0.0 16.0 0.3 0.2 1.5 0.0 19.0 0.2 0.0 0.1 0.1 0.0 0.7 1.3 0.0 3.6 0.2 0.3 0.0 0.2 0.0 0.0 2.8 0.0 5.9 0.3 191.2 0.0 0.0 13.8 0.2 13.4 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.1 0.1 0.1 PRELID3B "C20orf45, dJ543J19.5, SLMO2" ENSG00000101166 "PRELI domain containing 3B" Q9Y3B1 20 59033145-59042809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 229.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047721 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047721: AB_2680131" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.37e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.96e-5)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (1.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.20e-3)" "unprognostic (5.84e-2)" "unprognostic (2.64e-1)" "unprognostic (2.61e-2)" "unprognostic (8.96e-2)" 30.2 33.7 19.3 31.1 20.9 37.8 32.6 21.5 24.3 19.2 18.7 69.5 93.3 21.1 18.6 43.5 19.8 22.8 28.7 18.4 23.5 34.6 33.9 23.4 34.8 21.4 21.3 17.1 15.1 26.5 43.7 27.5 28.4 22.1 20.1 65.4 17.8 28.5 13.4 18.9 25.2 84.1 25.1 22.2 25.4 44.8 25.7 21.3 34.7 37.3 39.3 40.4 49.8 20.1 23.8 118.6 54.2 53.5 71.6 36.8 51.0 75.6 87.4 70.2 147.1 77.3 152.4 98.4 187.1 138.2 61.2 115.3 123.5 106.2 127.5 154.3 106.9 68.2 132.1 87.3 33.0 77.7 174.5 114.9 46.4 162.1 85.6 196.3 49.9 47.3 143.0 51.6 77.1 61.6 145.3 186.9 71.0 26.3 187.8 149.6 101.5 125.9 107.8 72.7 98.8 97.2 92.7 139.5 218.5 208.1 37.3 116.2 125.6 64.0 54.8 54.5 101.2 45.4 51.2 77.7 149.5 61.9 81.7 65.1 52.1 22.1 23.3 32.7 30.2 40.6 41.1 40.1 37.7 28.9 30.1 35.4 38.1 19.5 45.6 37.7 24.6 46.5 36.9 19.3 20.9 21.5 24.3 18.4 23.5 21.4 21.3 17.1 22.1 22.2 21.3 23.8 25.5 22.4 36.0 0.0 43.2 0.0 67.0 0.0 52.9 9.8 53.0 32.1 0.0 17.2 15.5 22.0 6.2 64.2 47.1 62.6 68.4 60.8 68.5 43.6 20.6 26.8 27.9 55.2 0.0 56.8 113.2 21.6 45.9 64.7 16.4 26.1 18.5 27.8 54.5 11.8 0.0 46.8 0.0 38.9 0.0 24.7 14.9 37.6 0.0 0.0 49.5 16.6 35.0 0.0 0.0 77.8 45.9 15.8 51.5 113.0 137.5 51.3 22.6 10.6 26.3 31.9 21.5 79.3 39.5 69.5 0.0 124.1 47.0 43.3 59.9 229.4 HRH3 GPCR97 ENSG00000101180 "Histamine receptor H3" Q9Y5N1 20 62214960-62220278 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "brain: 57.7" "Cell type enriched" "Detected in some" 4 "Inhibitory neurons: 23.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.56e-1)" "unprognostic (3.22e-1)" "unprognostic (4.15e-2)" "unprognostic (1.79e-1)" "unprognostic (2.77e-2)" "unprognostic (1.62e-2)" "unprognostic (7.30e-2)" "unprognostic (3.17e-4)" "unprognostic (2.40e-1)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "unprognostic (3.59e-2)" 0.0 0.4 19.7 0.0 39.2 0.0 0.0 9.2 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 22.8 0.0 0.0 0.0 0.0 11.0 23.7 15.4 0.0 0.0 0.0 2.0 0.0 13.8 0.1 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.9 57.7 0.0 0.0 0.0 0.0 0.2 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 15.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 39.2 9.2 22.4 14.8 22.8 11.0 23.7 15.4 13.8 0.8 57.7 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.3 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTG2 "dJ1005F21.2, FLJ10741, GTPBP5, ObgH1" ENSG00000101181 "Mitochondrial ribosome associated GTPase 2" Q9H4K7 20 62183028-62203568 "Predicted intracellular proteins" "Ribosome biogenesis, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047379 Approved NA NA "HPA047379: AB_10965845" "unprognostic (5.52e-2)" "unprognostic (2.93e-2)" "unprognostic (4.17e-1)" "unprognostic (1.25e-3)" "unprognostic (2.76e-1)" "unprognostic (2.33e-2)" "unprognostic (4.16e-1)" "unprognostic (9.04e-2)" "unprognostic (9.68e-2)" "unprognostic (3.56e-1)" "prognostic favorable (6.31e-5)" "unprognostic (2.17e-2)" "unprognostic (6.10e-3)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.00e-1)" "unprognostic (8.30e-2)" 11.9 18.7 4.8 7.8 5.1 8.4 11.4 5.9 6.1 10.6 4.5 11.0 10.7 11.4 3.0 10.5 10.6 6.3 11.7 4.7 5.0 10.8 30.1 9.0 7.4 4.9 5.0 4.5 11.6 12.0 8.6 13.9 6.2 5.2 11.5 4.8 2.9 10.9 4.8 28.3 13.2 10.3 5.6 4.5 12.7 11.5 14.7 5.1 9.3 12.0 10.6 5.8 10.8 10.0 5.0 32.3 19.7 6.1 16.9 11.5 11.0 25.3 14.0 10.3 43.0 17.4 72.0 27.2 34.1 45.0 8.8 20.5 23.9 8.8 19.6 8.3 7.9 10.5 48.7 26.4 18.2 13.0 34.2 10.1 20.3 25.5 25.2 19.2 5.7 12.1 13.8 30.3 14.0 12.3 9.1 18.6 15.9 7.5 31.1 35.7 14.9 31.6 34.6 10.6 16.9 12.9 16.7 47.5 25.5 24.5 3.0 30.3 35.6 10.4 29.2 18.0 15.0 37.6 27.5 36.2 13.4 22.1 11.9 15.8 4.8 4.1 3.9 5.1 4.3 4.3 3.8 3.9 3.9 4.9 3.2 3.8 2.4 9.8 4.8 2.9 3.6 3.5 3.5 4.8 5.1 5.9 6.1 4.7 5.0 4.9 5.0 4.5 5.2 4.5 5.1 5.0 9.5 22.4 11.9 16.0 13.6 9.2 11.1 9.6 10.8 0.0 10.3 9.3 11.4 10.0 12.0 20.2 0.0 15.0 12.8 14.2 9.8 11.5 65.3 11.2 11.1 9.7 9.1 24.2 24.8 14.0 11.8 11.8 13.7 8.1 11.4 23.8 9.3 33.5 13.8 0.0 28.5 11.9 2.0 12.0 8.2 23.7 9.6 11.9 8.8 15.0 19.7 0.0 14.4 21.1 24.8 14.7 12.1 11.7 21.7 14.1 20.3 28.2 17.6 0.0 0.0 9.1 11.3 17.3 19.3 14.1 11.9 17.8 12.5 26.5 12.3 9.7 PSMA7 "C6, HSPC, RC6-1, XAPC7" ENSG00000101182 "Proteasome 20S subunit alpha 7" O14818 20 62136733-62143440 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 760.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046007, CAB046008, HPA047266" Approved NA NA 22000000 "CAB046007: AB_11128404, CAB046008: AB_2171861, HPA047266: AB_2680006" "unprognostic (1.49e-2)" "unprognostic (4.44e-2)" "unprognostic (1.78e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-1)" "unprognostic (6.57e-3)" "prognostic unfavorable (2.54e-5)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (7.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.21e-2)" "unprognostic (6.31e-2)" "unprognostic (1.98e-2)" 224.1 201.7 128.3 149.9 130.1 262.7 199.7 135.3 147.4 132.8 128.6 172.6 133.4 164.8 103.8 192.6 141.7 92.1 235.8 130.6 134.6 169.8 215.7 171.8 166.3 133.6 131.0 127.9 135.5 141.4 115.1 105.0 116.0 135.3 118.8 109.1 55.0 130.2 105.2 760.1 135.7 152.6 118.2 136.5 164.6 154.1 61.8 135.3 189.7 122.9 378.6 156.7 169.7 142.5 140.5 532.8 674.6 390.9 419.4 357.2 277.8 345.0 398.3 343.6 1024.7 428.8 1785.8 504.0 438.2 926.2 421.0 644.1 627.2 371.9 752.5 497.0 261.0 261.1 1009.7 641.9 913.2 454.0 434.3 570.4 297.9 602.0 525.1 454.5 248.8 509.2 436.1 439.2 419.2 441.8 568.6 696.1 673.6 332.5 595.0 859.8 476.9 753.5 482.6 385.3 515.4 526.2 321.6 625.9 777.1 701.9 252.7 468.3 643.3 416.1 898.9 725.4 473.3 631.1 286.9 483.9 531.2 626.7 327.7 536.1 754.4 682.6 801.5 536.5 692.6 458.2 579.3 533.3 531.4 632.2 522.7 415.1 427.3 582.2 421.7 720.3 676.3 723.4 1131.2 128.3 130.1 135.3 147.4 130.6 134.6 133.6 131.0 127.9 135.3 136.5 135.3 140.5 402.9 211.5 180.8 20.9 252.3 374.5 350.6 616.4 167.4 127.5 223.0 296.4 304.9 327.5 369.2 257.5 73.0 666.2 309.5 375.2 498.9 581.9 355.5 290.2 345.4 397.3 232.0 439.4 19.2 727.7 775.7 321.9 132.0 276.5 251.4 304.7 335.5 787.5 807.0 82.4 18.4 325.6 453.7 435.7 453.1 211.0 334.6 414.8 368.2 18.7 598.4 219.3 377.9 15.1 28.9 663.3 386.4 293.8 234.5 639.7 455.1 759.6 288.8 122.5 230.1 237.0 659.7 81.4 126.3 291.9 309.3 852.6 310.4 410.0 386.9 438.7 SLCO4A1 "OATP-E, OATP4A1, SLC21A12" ENSG00000101187 "Solute carrier organic anion transporter family member 4A1" Q96BD0 20 62642503-62685785 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 57.7" "Cell type enhanced" "Detected in many" "Adipocytes: 61.8;Extravillous trophoblasts: 239.4;Melanocytes: 60.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 21.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 197.2;RPTEC TERT1: 193.9" "Region enriched" "Detected in some" 5 "cerebellum: 6.7" "Low region specificity" "Detected in some" "HPA030669, HPA030670" Uncertain Supported "Cell Junctions" NA NA "Cell Junctions" "HPA030669: AB_10601163, HPA030670: AB_10670033" "unprognostic (8.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.41e-1)" "unprognostic (2.46e-3)" "unprognostic (3.34e-2)" "unprognostic (1.12e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.74e-4)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (3.49e-3)" "unprognostic (1.53e-1)" "unprognostic (1.49e-1)" "unprognostic (2.84e-3)" "unprognostic (9.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.25e-1)" 29.0 5.7 24.8 1.8 22.3 1.3 23.6 22.2 36.0 9.3 18.9 8.9 1.2 8.8 0.3 16.8 13.3 1.8 32.0 21.7 23.1 35.9 5.0 57.7 2.4 24.3 22.8 19.8 6.5 4.9 3.8 2.9 4.7 25.0 6.0 1.8 21.7 8.6 1.0 19.0 23.9 9.3 0.8 23.5 6.7 13.6 2.1 28.0 1.1 8.7 5.7 3.2 12.1 16.9 28.6 14.8 19.1 0.8 10.8 2.5 2.1 26.5 4.7 16.6 14.1 5.4 32.0 14.9 17.8 44.2 0.5 9.6 22.0 16.4 1.0 5.4 2.1 9.6 21.7 22.1 23.8 0.1 16.6 6.7 0.0 6.5 0.3 6.2 4.2 2.5 10.7 17.1 4.6 0.0 14.8 17.2 63.9 5.4 74.1 197.2 30.6 1.1 26.2 193.9 14.2 17.4 25.1 4.1 4.4 15.7 6.5 1.0 7.5 2.8 0.4 10.5 7.0 27.2 9.2 15.9 11.1 38.1 24.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.9 0.7 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.2 24.8 22.3 22.2 36.0 21.7 23.1 24.3 22.8 19.8 25.0 23.5 28.0 28.6 61.8 3.2 1.3 1.3 13.1 27.3 1.4 19.8 1.2 14.1 1.2 0.8 4.4 1.5 5.9 25.8 31.3 2.1 3.7 7.5 0.0 5.9 0.3 8.7 3.6 40.3 0.0 2.1 7.9 2.5 239.4 4.3 20.9 35.6 0.0 0.0 14.6 0.6 5.5 0.0 6.6 8.4 2.0 9.7 33.5 0.7 0.3 11.9 60.5 3.7 0.0 6.1 0.0 1.5 0.3 11.8 1.9 0.7 19.1 3.5 0.8 9.6 1.3 43.2 0.0 1.9 2.9 0.2 3.0 1.1 16.1 23.5 5.6 0.1 7.5 11.0 NTSR1 NTR ENSG00000101188 "Neurotensin receptor 1" P30989 20 62708836-62762771 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 9.9;intestine: 8.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.4;Cardiomyocytes: 1.1;Excitatory neurons: 1.6;Inhibitory neurons: 1.3;Kupffer cells: 2.9;Microglial cells: 1.0;monocytes: 1.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Region enriched" "Detected in many" 7 "midbrain: 9.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "PC-3: 57.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050299 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA050299: " "unprognostic (4.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.75e-2)" "unprognostic (8.87e-4)" "unprognostic (9.27e-3)" "unprognostic (1.45e-1)" "unprognostic (4.17e-2)" "unprognostic (2.80e-3)" "unprognostic (7.16e-2)" "unprognostic (3.10e-3)" "unprognostic (3.55e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" 0.0 0.0 0.8 0.0 1.3 0.6 0.0 0.0 0.6 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.5 9.9 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 2.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 2.8 0.2 2.7 0.3 1.1 57.7 1.8 0.0 9.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.6 1.5 0.4 0.5 9.9 1.3 0.2 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 4.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.9 0.3 0.0 0.0 0.5 0.0 1.0 1.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 MRGBP "C20orf20, Eaf7, FLJ10914, MRG15BP" ENSG00000101189 "MRG domain binding protein" Q9NV56 20 62796473-62801729 "Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.4" "Group enriched" "Detected in many" 7 "Early spermatids: 124.0;Late spermatids: 408.9;Spermatocytes: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017012 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA017012: AB_1845679" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (8.56e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.17e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "unprognostic (2.25e-1)" "unprognostic (6.01e-3)" 7.0 7.6 8.5 5.6 8.5 6.7 6.9 9.0 9.9 7.7 7.6 8.4 8.1 6.7 3.2 7.5 6.8 4.7 9.0 8.4 8.4 8.3 13.7 7.1 7.8 8.4 8.6 8.2 10.9 6.8 8.8 7.8 7.3 8.5 7.2 4.1 6.6 7.5 4.4 9.3 7.2 8.9 3.2 7.7 9.8 7.6 48.4 9.1 7.1 7.5 6.7 5.4 7.4 7.5 9.9 32.2 20.0 16.1 24.8 8.7 13.1 15.6 18.2 23.5 69.2 30.0 71.5 25.1 29.3 35.4 14.1 34.3 26.7 18.5 30.7 38.9 9.2 15.8 21.4 22.9 41.8 13.5 25.2 38.7 11.3 22.2 18.9 20.0 14.7 16.6 27.8 29.6 15.7 17.5 48.8 48.0 47.7 13.6 33.5 35.7 42.5 30.5 21.8 10.5 13.1 22.6 18.2 25.9 22.9 33.9 8.9 28.3 36.5 17.4 42.9 44.6 29.4 39.2 20.9 13.7 34.9 42.3 24.8 24.6 0.0 0.6 0.9 0.5 1.0 0.7 0.4 0.6 0.7 0.4 0.4 0.5 1.0 0.7 0.1 0.4 0.5 0.8 0.3 8.5 8.5 9.0 9.9 8.4 8.4 8.4 8.6 8.2 8.5 7.7 9.1 9.9 15.2 0.0 2.2 6.2 17.1 14.7 14.8 9.0 13.1 12.3 14.4 11.9 9.4 18.6 5.3 12.9 8.4 12.6 18.0 9.2 19.6 23.3 124.0 9.3 11.5 12.0 2.4 12.8 7.9 22.2 24.7 13.1 12.8 9.7 1.3 14.5 11.0 14.5 14.3 13.5 7.3 9.6 8.2 11.3 16.5 408.9 12.2 16.1 7.2 2.8 12.4 16.5 8.2 5.0 5.2 24.3 8.0 7.9 18.8 23.5 12.4 18.6 3.2 14.5 0.0 10.2 13.8 113.0 27.8 16.4 13.1 14.6 15.6 19.5 12.0 17.6 TCFL5 "bHLHe82, CHA, E2BP-1, Figlb" ENSG00000101190 "Transcription factor like 5" Q9UL49 20 62841005-62861822 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5;testis: 74.6" "Cell type enhanced" "Detected in many" "Early spermatids: 23.6;Oligodendrocytes: 32.4;Spermatocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055223, HPA076419" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA055223: AB_2682745, HPA076419: " "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.78e-1)" "unprognostic (2.72e-3)" "unprognostic (3.95e-2)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.88e-1)" "unprognostic (1.54e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-1)" "unprognostic (1.33e-3)" "unprognostic (1.01e-2)" 6.8 4.4 59.9 5.0 61.2 4.9 7.5 56.2 64.2 7.3 43.2 6.6 3.7 6.6 7.5 7.0 6.7 5.9 6.6 50.1 53.6 5.6 5.6 4.2 6.2 59.8 62.4 46.7 9.6 5.7 10.0 4.8 5.8 63.1 5.5 4.3 8.9 5.8 7.0 5.8 13.7 4.9 6.4 63.8 5.0 4.8 74.6 58.6 11.9 18.5 7.3 6.2 7.2 5.4 69.5 23.4 6.9 14.9 17.6 31.1 31.3 13.3 14.9 20.1 28.5 15.6 16.9 14.1 11.8 16.7 13.2 15.1 25.0 15.1 16.8 24.7 8.3 12.7 9.9 20.9 25.3 12.2 14.4 11.4 11.6 24.2 8.1 16.4 12.1 12.9 17.9 11.1 4.4 13.3 28.1 63.4 18.0 9.8 19.2 21.7 34.8 25.9 16.8 7.6 6.8 21.3 11.5 26.2 10.4 41.3 10.5 17.9 26.5 14.1 22.4 14.6 19.7 17.7 11.0 8.0 9.9 13.6 17.6 12.7 0.1 0.3 0.6 0.6 0.3 0.4 0.2 0.4 0.4 0.2 0.2 0.4 0.3 0.5 0.2 0.3 0.4 0.4 0.1 59.9 61.2 56.2 64.2 50.1 53.6 59.8 62.4 46.7 63.1 63.8 58.6 69.5 8.9 0.0 1.5 4.9 3.3 10.5 1.6 1.6 0.6 10.2 4.6 5.0 4.7 5.7 1.3 7.3 6.2 0.6 3.7 1.3 1.9 1.4 23.6 2.7 6.9 6.6 2.4 1.7 10.6 1.2 0.9 5.2 1.5 2.7 0.0 7.8 3.3 3.8 1.0 8.4 7.4 2.5 2.0 4.0 6.2 9.4 7.8 2.4 3.6 3.7 2.1 12.8 1.0 10.1 32.4 1.0 1.8 7.2 0.9 1.5 1.2 2.2 1.8 6.9 0.0 4.8 4.1 64.6 8.9 2.1 14.2 0.3 2.5 5.8 2.3 1.3 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: AB_2680944" "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favorable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 27.3 20.3 16.3 21.7 17.4 29.3 31.3 21.4 17.9 33.8 21.7 34.2 19.8 38.5 27.1 27.3 37.1 17.7 26.7 15.5 15.6 24.7 24.9 31.2 31.9 16.5 16.3 14.5 39.8 24.8 28.7 28.3 25.0 17.3 34.3 19.9 20.0 33.5 25.1 32.7 39.2 36.8 21.1 14.5 36.2 29.0 28.1 16.6 31.1 33.3 23.0 27.2 32.9 31.7 22.4 29.6 22.5 36.7 21.0 18.4 22.6 19.6 21.9 18.5 79.4 22.8 96.4 29.9 29.0 29.4 26.9 46.1 45.2 33.8 42.4 51.1 16.1 22.9 41.9 40.2 69.6 23.5 37.8 41.6 23.3 57.0 27.5 15.4 18.1 22.1 54.6 41.7 25.8 20.5 28.7 76.9 33.1 29.4 35.7 32.2 53.7 47.0 18.5 13.1 26.0 45.2 26.7 43.8 41.9 28.9 21.9 41.8 42.7 27.8 64.3 44.8 21.7 31.5 17.1 11.9 38.2 29.3 18.8 23.7 32.6 7.2 20.2 15.0 9.5 15.9 11.7 13.4 14.8 5.1 9.8 17.6 16.5 10.6 13.8 7.6 10.7 11.8 9.6 16.3 17.4 21.4 17.9 15.5 15.6 16.5 16.3 14.5 17.3 14.5 16.6 22.4 24.8 25.6 30.1 37.9 28.4 24.2 35.3 17.8 25.6 25.6 23.1 19.6 27.5 22.8 23.8 25.8 33.3 28.6 49.0 32.3 23.5 18.0 42.8 32.1 26.1 26.2 19.2 21.0 44.9 13.8 15.7 24.2 30.1 34.3 22.8 33.8 20.7 19.6 14.5 38.7 46.0 23.2 14.2 16.8 13.7 13.0 35.1 20.2 21.4 32.8 26.8 16.7 42.2 40.7 47.4 22.2 20.2 33.8 30.0 26.3 25.3 9.6 45.8 23.4 6.6 35.4 23.4 26.1 32.1 26.0 25.6 19.7 32.1 25.6 21.1 34.4 GID8 "bA305P22.1, C20orf11, FLJ20602, TWA1" ENSG00000101193 "GID complex subunit 8 homolog" Q9NWU2 20 62938147-62948475 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049929, HPA055047" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049929: AB_2680957, HPA055047: AB_2682682" "unprognostic (1.35e-1)" "unprognostic (4.06e-2)" "unprognostic (5.90e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.19e-1)" "unprognostic (8.25e-2)" "unprognostic (3.88e-2)" "unprognostic (4.58e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-1)" "unprognostic (2.72e-2)" "unprognostic (1.43e-1)" "prognostic favorable (3.22e-4)" "unprognostic (3.97e-1)" "unprognostic (1.43e-1)" "unprognostic (2.01e-1)" "unprognostic (6.87e-2)" 12.6 13.4 18.3 13.6 17.9 39.5 17.2 18.8 18.3 17.9 16.6 16.7 13.9 16.4 16.9 42.1 20.3 11.2 14.4 18.8 18.4 14.9 24.9 12.8 20.9 17.8 18.4 17.2 26.6 20.5 19.2 16.0 13.1 17.3 16.3 14.4 13.1 17.2 15.0 14.9 29.8 15.6 12.7 18.7 17.0 18.2 13.8 18.5 25.5 18.6 13.3 23.3 15.8 22.7 18.1 39.9 25.0 36.6 33.2 29.5 23.1 35.8 21.8 18.2 61.1 27.5 121.4 37.9 49.9 36.5 28.4 25.1 45.2 33.9 45.3 36.9 13.4 16.6 46.5 32.8 58.6 23.2 54.5 37.7 25.6 49.4 26.4 30.4 22.2 30.1 32.5 36.3 21.0 21.3 56.0 65.3 48.4 37.0 66.1 37.0 51.1 68.8 29.9 22.5 55.4 38.0 31.0 51.5 49.9 32.8 27.0 69.5 51.9 30.6 36.4 45.4 28.8 29.9 21.9 27.0 51.2 24.6 26.2 23.5 5.3 9.5 15.4 9.8 8.3 11.6 7.4 10.4 11.1 8.9 8.2 11.2 12.7 13.5 12.3 7.7 6.7 9.9 8.1 18.3 17.9 18.8 18.3 18.8 18.4 17.8 18.4 17.2 17.3 18.7 18.5 18.1 33.5 19.2 27.4 11.4 42.7 51.6 46.9 76.6 50.1 23.1 56.4 53.0 30.9 52.9 46.5 40.5 6.2 101.7 48.6 57.3 41.1 44.7 19.1 46.4 27.4 37.7 45.0 71.1 17.7 40.4 105.1 35.1 27.0 40.1 26.6 24.4 46.4 77.7 51.8 16.8 15.0 50.1 50.8 47.9 46.4 19.4 32.9 42.9 24.9 11.2 62.1 28.3 51.5 11.6 14.4 40.8 39.2 42.2 44.0 68.2 55.7 42.5 38.8 16.5 13.1 34.1 30.7 49.1 57.9 82.1 79.8 156.9 45.8 21.6 52.1 71.7 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952707-62969585 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.4" "Cell type enhanced" "Detected in many" "B-cells: 18.2;Gastric mucus-secreting cells: 29.0;Hepatocytes: 48.8;Hofbauer cells: 18.0;Intestinal goblet cells: 19.7;Plasma cells: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 35.7;CACO-2: 32.9;Hep G2: 69.5;NB-4: 39.0;RPMI-8226: 36.1;U-937: 43.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047470 Approved Nucleoplasm NA NA Nucleoplasm "HPA047470: AB_2680060" "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 1.3 1.0 0.7 5.8 0.6 11.5 1.3 0.8 1.1 1.7 1.0 3.3 5.5 1.5 0.3 0.8 1.9 1.4 1.0 0.6 0.9 0.9 43.4 3.6 5.3 1.3 0.8 0.1 1.8 1.4 0.0 2.2 1.7 1.2 1.4 3.2 0.0 4.0 0.6 1.0 0.6 4.3 1.4 1.6 11.2 9.6 0.4 1.1 0.7 1.3 0.1 4.2 2.8 1.7 1.4 0.0 0.0 0.0 0.2 0.3 3.1 0.1 35.7 10.0 11.4 18.0 32.9 0.0 25.9 0.0 28.3 0.0 0.0 5.0 0.0 2.8 0.0 0.0 11.5 0.9 69.5 7.7 20.9 0.0 2.5 0.0 13.6 0.0 0.0 7.6 0.1 0.1 14.6 0.0 0.0 0.9 39.0 0.0 12.9 0.2 26.9 0.0 36.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 19.4 2.6 0.0 0.0 1.2 0.0 5.0 0.3 14.2 0.0 43.8 0.0 0.0 0.9 0.0 0.7 1.7 0.5 2.2 0.0 0.4 2.6 1.7 0.0 0.3 0.0 4.9 0.3 0.0 0.1 0.7 0.7 0.6 0.8 1.1 0.6 0.9 1.3 0.8 0.1 1.2 1.6 1.1 1.4 1.1 0.0 1.1 0.0 18.2 0.9 0.2 0.3 0.0 0.4 1.0 1.0 1.3 12.8 1.0 0.0 0.0 0.3 5.5 6.4 0.0 0.3 0.7 2.6 7.3 1.4 3.0 1.7 0.7 0.4 0.9 4.0 29.0 2.5 5.1 2.4 1.4 48.8 18.0 0.0 0.4 19.7 0.0 5.1 12.4 0.6 1.2 7.2 5.4 2.8 1.3 0.1 4.1 1.0 0.1 1.7 3.1 0.7 38.6 0.6 0.2 0.4 0.8 0.1 0.0 1.6 4.2 0.4 1.0 0.0 1.1 0.8 3.6 3.8 9.3 0.6 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240495 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 6.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 12.4;Extravillous trophoblasts: 16.5;Hofbauer cells: 75.8;Melanocytes: 26.6;Muller glia cells: 54.2" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 196.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 0.6 0.9 1.1 0.3 0.5 0.1 0.4 0.4 1.6 1.5 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.7 0.9 0.9 0.3 1.1 1.3 0.8 0.7 0.4 0.1 0.0 0.0 0.3 6.6 1.1 0.1 0.0 0.6 0.2 0.0 0.0 2.4 0.2 0.0 0.9 0.9 0.1 0.1 1.7 0.1 0.2 0.0 0.2 0.3 0.7 1.5 0.3 4.3 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 6.6 1.1 0.0 17.8 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 20.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 196.8 4.4 1.3 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.2 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.4 1.6 0.7 0.9 0.8 0.7 0.4 1.1 0.9 1.7 1.5 0.3 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 1.8 0.0 12.4 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.6 16.5 0.7 0.0 0.0 2.5 0.1 0.0 0.0 75.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.7 26.6 0.0 0.0 54.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 NKAIN4 "bA261N11.2, C20orf58, FAM77A" ENSG00000101198 "Sodium/potassium transporting ATPase interacting 4" Q8IVV8 20 63240784-63272694 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 68.6;kidney: 51.2" "Group enriched" "Detected in some" 5 "Muller glia cells: 80.8;Oligodendrocyte precursor cells: 76.4;Proximal tubular cells: 264.8" "Cancer enriched" "Detected in many" 6 "glioma: 45.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 24.9;MOLT-4: 42.8;SK-MEL-30: 9.3;SuSa: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029876 Approved NA NA "HPA029876: AB_10602038" "unprognostic (1.26e-1)" "unprognostic (4.27e-1)" "unprognostic (6.07e-5)" "prognostic unfavorable (3.14e-4)" "unprognostic (6.65e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-3)" "unprognostic (1.94e-1)" "unprognostic (3.62e-2)" "unprognostic (2.69e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (2.12e-2)" "unprognostic (1.44e-4)" "unprognostic (5.66e-2)" "unprognostic (6.74e-2)" "unprognostic (4.01e-1)" 0.1 0.8 35.7 0.2 34.4 0.1 0.1 22.6 68.6 1.7 14.4 1.2 0.3 0.4 0.4 0.0 0.3 0.1 0.0 39.9 34.3 51.2 0.0 0.1 0.0 32.9 32.4 32.1 0.1 0.1 0.0 2.4 2.8 33.7 0.1 0.1 3.1 0.1 0.1 0.0 0.4 0.4 0.0 28.8 0.1 0.3 2.3 32.3 1.2 0.8 0.1 0.0 0.1 0.6 32.0 0.1 2.0 7.5 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 1.3 0.8 0.0 3.9 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 42.8 0.0 5.2 0.0 0.1 7.8 0.0 0.7 0.3 0.0 0.0 0.0 0.5 0.1 9.3 29.5 0.3 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.5 4.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 34.4 22.6 68.6 39.9 34.3 32.9 32.4 32.1 33.7 28.8 32.3 32.0 0.0 0.0 0.0 23.8 1.9 0.3 0.0 1.7 0.0 2.6 0.0 0.1 0.3 0.0 0.1 11.0 0.0 3.3 0.0 0.0 5.9 0.5 0.7 0.2 0.2 0.2 0.0 0.0 0.1 0.6 3.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.9 5.3 1.5 0.0 1.0 0.0 80.8 0.0 76.4 0.1 4.2 0.0 0.0 0.0 0.0 0.0 264.8 0.1 1.9 0.0 0.0 0.3 0.4 6.0 0.0 0.0 2.3 0.8 0.1 0.0 0.1 ARFGAP1 "ARF1GAP, bA261N11.3, FLJ10767" ENSG00000101199 "ADP ribosylation factor GTPase activating protein 1" Q8N6T3 20 63272785-63289790 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051019, HPA056273" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA051019: AB_2681313, HPA056273: AB_2683084" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-1)" "unprognostic (1.38e-1)" "unprognostic (1.24e-1)" "unprognostic (1.57e-3)" "unprognostic (7.76e-2)" "unprognostic (8.86e-3)" "unprognostic (8.62e-2)" "prognostic favorable (4.57e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (4.34e-2)" "unprognostic (2.86e-1)" 12.6 16.9 10.5 15.6 10.8 12.2 13.1 9.6 20.8 18.1 5.3 18.5 13.2 20.9 8.7 16.0 16.2 17.0 14.2 12.1 8.7 16.0 17.9 16.3 16.3 11.8 9.5 11.5 17.9 28.6 11.9 64.3 15.5 12.2 20.3 9.6 11.8 18.6 13.5 14.2 19.2 18.3 12.6 6.3 20.7 18.7 24.4 9.8 14.3 18.0 7.6 11.4 16.6 15.1 13.3 32.6 60.2 25.6 30.6 30.3 32.5 51.2 46.4 36.5 90.7 45.5 145.2 35.2 24.5 41.7 55.4 41.5 43.2 23.5 73.8 28.5 15.8 26.7 19.4 64.7 128.4 46.2 28.8 38.4 28.5 46.9 44.0 24.9 30.5 32.9 25.5 34.9 27.8 25.1 53.2 52.9 28.0 34.5 34.3 51.9 29.7 36.8 23.6 22.3 38.8 27.3 29.9 55.1 58.7 59.2 20.7 42.8 36.4 42.8 56.0 77.3 35.0 37.6 28.4 20.2 26.5 56.9 20.0 35.3 4.8 5.7 6.4 5.6 7.1 6.4 3.0 3.1 5.3 5.7 4.2 3.0 3.0 2.4 4.7 9.5 4.2 4.1 6.0 10.5 10.8 9.6 20.8 12.1 8.7 11.8 9.5 11.5 12.2 6.3 9.8 13.3 12.6 22.4 30.7 34.9 11.2 10.1 6.0 8.6 4.0 26.6 17.6 14.4 12.4 11.5 14.4 12.9 33.3 12.5 15.4 37.6 9.8 12.2 15.9 11.0 17.1 14.2 24.5 9.5 14.5 15.4 24.9 16.3 50.4 14.9 15.9 30.6 13.6 23.3 14.9 21.9 14.9 40.4 2.0 14.4 11.5 23.3 12.5 13.5 12.4 5.6 12.3 11.8 15.5 18.6 24.8 28.2 18.3 9.8 17.8 11.6 17.4 11.5 18.8 20.1 6.6 11.1 14.9 21.3 7.4 6.7 8.5 15.2 10.3 16.8 24.0 9.2 AVP "ADH, ARVP" ENSG00000101200 "Arginine vasopressin" P01185 20 3082556-3084724 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Hormone, Vasoactive, Vasoconstrictor" "Diabetes insipidus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 860 "brain: 5271.0" "Group enriched" "Detected in some" 6 "Late spermatids: 26.2;Proximal tubular cells: 46.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 12 "hypothalamus: 5271.0" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.7" "Cell line enriched" "Detected in single" 13 "NB-4: 2.3" "Region enriched" "Detected in many" 10 "hypothalamus: 232.9" "Group enriched" "Detected in many" 337 "basal ganglia: 815.6;hypothalamus: 743.3" "CAB025318, HPA071892" Enhanced Supported "Secreted to blood" NA NA 19300 "CAB025318: , HPA071892: AB_2732190" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" 0.3 0.3 79.7 0.0 6.7 0.8 0.2 1.0 44.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.5 5271.0 1.4 0.3 0.1 0.0 0.2 0.8 0.5 0.1 0.1 0.0 6.1 0.0 443.2 0.1 0.0 0.0 0.1 0.0 0.1 1.0 0.1 0.0 0.8 0.0 0.0 1.5 291.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 79.7 6.7 1.0 44.0 1.5 5271.0 0.2 0.8 0.5 443.2 0.8 291.9 0.4 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 5.7 0.0 0.2 0.0 0.0 4.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.0 0.2 0.0 0.0 0.0 0.3 26.2 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 46.6 0.0 0.1 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 COL20A1 KIAA1510 ENSG00000101203 "Collagen type XX alpha 1 chain" Q9P218 20 63293186-63334851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4;testis: 2.5" "Group enriched" "Detected in some" 11 "Oligodendrocyte precursor cells: 72.9;Spermatocytes: 21.8" "Cancer enriched" "Detected in single" 19 "glioma: 8.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA072382 Uncertain "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum" "HPA072382: " "unprognostic (6.34e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "unprognostic (2.01e-1)" "unprognostic (5.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (2.89e-1)" "unprognostic (8.41e-7)" "unprognostic (7.85e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (1.16e-1)" 0.0 0.2 3.0 0.0 3.0 0.0 0.0 2.2 8.4 0.3 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.0 0.1 0.0 0.0 0.0 2.7 2.5 2.7 0.2 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 2.8 0.7 0.0 2.5 2.5 0.0 0.0 0.3 0.0 0.0 0.1 3.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.0 2.2 8.4 2.9 2.0 2.7 2.5 2.7 3.0 2.8 2.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.4 0.0 72.9 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.2 0.1 21.8 4.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 CHRNA4 "BFNC, EBN, EBN1" ENSG00000101204 "Cholinergic receptor nicotinic alpha 4 subunit" P43681 20 63343223-63378401 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 25.5;liver: 58.5;parathyroid gland: 12.8" "Group enriched" "Detected in some" 4 "Hepatocytes: 42.0;Horizontal cells: 139.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "midbrain: 21.8;pons: 20.5;thalamus: 33.5" CAB034064 Uncertain NA NA "CAB034064: AB_2080535" "unprognostic (3.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.87e-2)" "unprognostic (3.98e-1)" "unprognostic (8.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-1)" "unprognostic (2.10e-3)" "unprognostic (5.72e-4)" "unprognostic (9.02e-3)" "unprognostic (9.79e-4)" "unprognostic (6.77e-2)" "unprognostic (1.08e-1)" "unprognostic (3.81e-2)" 0.0 0.2 5.8 0.0 5.2 0.0 0.0 0.6 6.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.4 5.5 3.3 58.5 0.0 0.0 4.5 13.9 4.4 0.1 0.0 12.8 0.8 0.0 5.8 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 1.6 25.5 0.0 0.5 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.2 0.6 6.3 6.4 5.5 4.5 13.9 4.4 5.8 0.4 25.5 6.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 4.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 42.0 0.0 139.7 8.8 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.9 0.0 7.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 2.7 0.0 1.7 0.1 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488013-63499239 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 1653.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Approved Nucleoli,Cytosol NA NA 55000000 Cytosol Nucleoli "CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 0.9 33.0 29.3 1.4 68.5 0.0 1.8 15.0 331.1 1.4 0.0 4.1 0.7 0.3 1.1 9.8 0.4 2.4 291.7 69.9 80.4 1.3 3.0 0.9 0.6 91.7 57.5 92.3 0.5 6.5 16.3 112.3 0.0 77.6 9.7 0.4 37.5 19.7 0.8 1653.6 5.9 1.9 0.8 0.0 0.3 8.6 1.2 69.6 0.2 0.7 323.5 0.1 2.2 1.8 260.1 0.5 71.0 0.8 16.8 0.0 0.6 7.9 10.0 1.3 51.6 16.3 9.8 41.5 0.0 110.4 0.5 13.4 38.8 240.0 0.7 115.9 0.5 13.1 0.0 24.1 4.1 2.9 0.0 13.4 1.4 2.2 0.1 1.0 0.2 0.0 0.0 3.4 0.2 0.5 405.9 1.4 0.5 11.4 95.6 96.5 8.0 0.2 10.2 2.4 3.9 187.0 89.9 90.0 12.6 1.6 2.2 157.2 3.8 0.0 0.3 202.9 0.7 1.8 0.3 0.9 1.4 0.9 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 29.3 68.5 15.0 331.1 69.9 80.4 91.7 57.5 92.3 77.6 0.0 69.6 260.1 0.1 0.0 0.0 9.4 0.7 0.4 0.9 0.0 0.0 130.8 11.8 4.6 125.5 1.5 0.6 0.0 12.5 0.0 1.1 0.4 0.0 1.3 0.2 0.5 0.3 2.2 0.0 0.0 35.5 0.2 0.2 3.6 4.6 1.4 5.7 1.0 1.1 0.1 0.0 269.2 37.2 0.0 0.0 0.3 0.7 0.5 0.0 0.6 0.0 15.0 0.0 11.7 0.0 14.6 12.7 0.3 0.0 0.0 0.3 2.6 0.0 0.5 0.0 50.9 0.0 49.9 3.4 0.0 0.3 0.0 1.8 0.0 1.5 0.0 0.5 1.1 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537376 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.3;skin 1: 52.9;vagina: 43.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.4 0.1 0.8 3.6 1.7 0.8 3.8 2.8 1.2 10.3 0.0 22.8 29.2 0.4 0.1 110.3 0.4 3.5 0.2 0.7 0.8 0.3 5.2 2.6 0.6 1.2 1.0 0.1 0.3 3.6 0.0 0.2 0.3 1.2 3.1 15.8 0.8 19.2 0.6 0.6 52.9 22.4 0.8 1.0 0.8 26.4 0.3 0.8 0.3 0.2 0.0 6.5 9.9 43.5 5.4 22.1 2.6 0.3 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 41.4 0.1 7.2 0.0 0.1 33.9 0.0 0.1 0.0 5.4 0.4 0.0 10.2 0.1 0.1 0.0 6.7 0.0 45.0 0.0 0.2 0.2 0.0 0.1 0.2 2.5 0.2 12.5 0.0 0.2 0.2 57.0 15.5 0.1 1.2 0.5 0.0 26.4 0.3 2.2 2.6 8.1 0.0 0.1 25.2 1.6 0.2 0.3 0.4 0.8 0.3 0.5 0.1 0.1 0.4 0.5 1.1 0.4 0.7 0.1 0.1 0.5 0.5 0.3 0.1 0.0 1.3 0.3 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.3 0.8 1.7 2.8 1.2 0.7 0.8 1.2 1.0 0.1 1.2 1.0 0.8 5.4 0.3 12.8 25.6 0.3 1.4 5.9 2.6 7.7 5.2 2.2 7.0 4.3 0.4 12.8 14.9 0.0 2.1 0.2 0.2 132.1 0.0 1.4 0.2 0.4 0.5 3.2 5.4 0.0 0.1 1.6 0.2 1.4 59.1 1.3 9.5 0.2 0.4 1.7 0.6 0.0 0.1 42.5 2.0 2.2 2.0 0.0 0.3 2.6 0.0 0.0 1.0 1.6 1.0 0.0 0.8 17.6 97.6 0.0 0.1 1.5 80.2 0.2 8.9 3.7 0.0 2.3 1.1 0.2 0.3 48.0 15.5 0.1 2.0 0.2 32.1 15.9 GMEB2 "KIAA1269, P79PIF, PIF79" ENSG00000101216 "Glucocorticoid modulatory element binding protein 2" Q9UKD1 20 63587602-63627101 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009706, HPA067455" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA009706: AB_1078996, HPA067455: AB_2685845" "unprognostic (4.55e-1)" "unprognostic (5.65e-2)" "unprognostic (3.16e-1)" "unprognostic (1.38e-3)" "unprognostic (1.36e-1)" "unprognostic (4.85e-2)" "unprognostic (2.77e-3)" "unprognostic (2.04e-1)" "unprognostic (5.47e-2)" "unprognostic (5.43e-2)" "unprognostic (2.01e-2)" "unprognostic (2.04e-2)" "unprognostic (6.86e-3)" "unprognostic (2.82e-2)" "unprognostic (3.84e-1)" "unprognostic (3.46e-1)" "unprognostic (2.29e-1)" 7.1 8.1 5.7 5.0 5.4 19.5 7.4 5.7 6.7 8.6 4.9 8.4 5.1 9.1 2.5 9.4 10.4 3.1 7.4 5.6 5.6 6.9 9.1 8.3 6.8 5.6 5.3 4.8 9.6 9.9 5.7 8.4 3.7 5.5 9.1 2.4 2.1 8.8 3.5 9.3 9.0 9.3 3.3 4.8 10.8 8.3 13.5 5.8 8.1 15.7 3.4 4.4 8.1 7.1 5.3 13.8 8.3 9.9 8.6 4.7 4.3 13.2 9.3 5.9 14.7 7.7 25.9 10.1 10.9 9.5 8.1 10.6 19.2 7.8 13.7 6.5 5.8 8.8 8.5 12.7 12.6 6.4 8.1 13.6 6.2 12.9 9.5 11.8 6.2 6.5 13.6 12.6 7.7 5.1 14.9 19.8 17.8 7.1 16.3 13.1 21.3 10.1 10.1 6.1 12.1 14.8 12.2 17.0 14.8 10.0 4.5 18.1 13.3 8.3 16.0 8.7 9.7 10.4 14.7 12.8 17.2 9.7 7.5 10.7 0.0 0.8 1.4 1.7 1.0 1.5 0.7 1.5 1.5 0.8 1.0 1.6 1.4 1.7 0.8 2.5 1.0 1.1 1.0 5.7 5.4 5.7 6.7 5.6 5.6 5.6 5.3 4.8 5.5 4.8 5.8 5.3 5.6 3.2 5.6 9.1 7.3 6.0 11.2 3.8 5.2 5.2 6.4 5.6 3.2 4.3 5.0 3.7 0.0 4.1 6.3 9.3 1.9 4.3 29.3 6.9 5.2 6.8 9.6 2.5 5.3 5.4 6.9 4.2 5.6 10.3 2.5 6.0 4.6 6.6 4.5 8.4 4.2 7.6 2.0 3.5 3.8 6.9 4.1 4.5 1.8 4.7 3.2 2.4 4.1 2.5 4.8 6.1 8.2 5.7 7.8 12.0 5.5 3.5 4.2 5.9 6.6 5.0 4.6 22.2 9.5 5.1 5.4 11.5 8.9 3.5 6.1 12.1 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3767781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 178.7;Hofbauer cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 144.6;intermediate monocyte: 249.1;myeloid DC: 199.4;non-classical monocyte: 235.3" "Group enriched" "Detected in all" 5 "dendritic cells: 199.4;monocytes: 249.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol NA NA 140000 "Nucleoplasm, Cytosol" "HPA047483: AB_2680064" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 54.9 24.2 42.6 20.6 106.1 104.5 45.6 39.4 63.8 37.2 28.1 83.3 17.2 42.8 8.8 29.8 52.3 25.7 23.8 39.8 54.2 21.0 25.0 21.0 24.7 65.5 50.8 43.1 66.8 23.8 9.5 23.5 9.0 70.8 24.4 7.8 4.9 15.9 11.0 22.6 26.7 34.2 14.3 36.3 45.9 87.5 22.9 50.9 11.1 23.6 11.6 9.9 74.5 26.5 47.6 172.9 177.7 24.4 106.1 49.5 28.1 42.7 45.5 25.1 70.4 50.3 120.5 61.6 111.1 41.4 48.2 94.7 140.9 65.7 101.9 24.9 26.1 138.3 63.2 35.9 212.6 36.2 88.2 24.7 41.0 41.8 93.3 46.1 24.2 48.2 72.9 114.6 59.8 37.3 240.2 107.6 186.3 114.9 107.0 248.4 86.6 67.9 123.7 43.9 62.0 121.8 56.6 41.2 155.3 85.1 10.4 36.9 96.8 35.9 104.8 73.8 171.6 129.6 50.5 93.2 80.7 31.5 161.2 53.9 1.3 144.6 2.3 28.7 249.1 42.1 38.7 33.6 38.6 199.4 36.2 37.6 37.5 5.4 32.5 235.3 38.7 34.2 87.4 42.6 106.1 39.4 63.8 39.8 54.2 65.5 50.8 43.1 70.8 36.3 50.9 47.6 54.0 0.0 3.3 3.3 26.5 24.2 23.0 26.8 35.3 9.7 28.2 45.7 3.7 8.6 7.4 11.0 2.1 17.5 15.8 10.2 29.4 32.6 21.8 13.8 178.7 28.7 15.7 99.1 6.0 30.0 49.2 27.1 14.3 7.5 22.9 45.0 19.6 17.9 142.9 1.7 9.5 15.9 16.2 119.0 53.1 15.3 32.6 92.2 37.4 5.6 97.4 24.6 15.5 3.5 2.1 34.7 14.6 24.8 20.2 46.6 19.3 32.4 2.7 13.6 65.7 17.1 98.8 27.3 39.1 34.8 32.8 7.3 24.1 69.7 33.0 22.7 SPEF1 "C20orf28, CLAMP, DKFZP434I114, SPEF1A" ENSG00000101222 "Sperm flagellar 1" Q9Y4P9 20 3777504-3781448 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.6;choroid plexus: 12.8;fallopian tube: 11.6;testis: 12.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 104.7;Respiratory ciliated cells: 66.5;Rod photoreceptor cells: 22.4;Spermatocytes: 24.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;hTEC/SVTERT24-B: 1.1;MCF7: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050786 Enhanced NA NA "HPA050786: AB_2681238" "unprognostic (2.41e-2)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (4.91e-3)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.08e-3)" "unprognostic (8.12e-3)" "unprognostic (5.95e-2)" "unprognostic (8.41e-2)" "unprognostic (8.88e-3)" "unprognostic (1.69e-1)" "unprognostic (3.81e-3)" "unprognostic (1.83e-1)" "unprognostic (6.60e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (7.49e-2)" 0.0 0.3 5.4 0.0 7.6 0.0 0.1 3.3 4.5 1.0 12.8 0.1 0.0 0.4 0.5 0.0 11.6 0.0 0.2 4.8 6.5 2.1 0.1 2.8 0.0 6.3 6.0 3.0 0.4 0.6 0.3 2.9 0.0 4.9 0.2 0.0 2.1 0.1 0.1 0.0 0.1 0.0 0.0 7.1 0.0 0.1 12.5 4.1 0.0 1.7 0.0 0.0 0.1 0.0 3.2 0.9 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.4 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.4 0.3 0.0 0.4 0.6 0.0 0.5 0.0 0.0 0.3 0.1 0.4 0.1 0.1 0.0 0.1 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 7.6 3.3 4.5 4.8 6.5 6.3 6.0 3.0 4.9 7.1 4.1 3.2 0.3 0.0 0.0 2.3 0.1 0.4 0.1 3.5 0.0 1.5 1.5 1.1 0.4 0.0 9.9 3.7 16.7 0.1 0.1 0.1 5.9 1.2 5.5 104.7 1.0 0.4 0.0 0.0 16.7 0.2 0.2 0.3 0.0 1.7 0.0 0.2 0.7 0.2 0.2 0.0 6.6 0.0 4.1 0.0 0.0 4.1 0.3 0.3 0.0 1.9 0.0 2.6 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 7.3 66.5 22.4 0.0 0.3 1.5 24.9 2.8 0.0 0.1 0.1 0.3 0.2 0.3 0.1 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Uncertain "Vesicles,Mitotic spindle" Yes Yes Vesicles "Mitotic spindle" "HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 28.3 15.7 30.7 29.1 31.8 29.6 25.4 38.4 33.5 40.5 23.2 35.4 14.6 35.2 9.4 27.3 31.8 18.1 15.7 27.2 32.2 31.4 25.0 79.1 48.0 31.4 29.5 27.6 37.7 12.9 3.9 46.0 31.3 32.8 25.6 11.4 7.8 16.9 9.0 10.5 21.7 41.6 14.4 26.9 56.6 30.4 12.5 32.0 45.1 42.1 6.4 33.1 36.1 30.4 35.2 129.6 273.2 36.5 60.0 43.8 43.0 19.3 63.3 95.3 103.1 75.9 49.2 182.9 91.3 27.5 65.4 253.5 183.5 50.6 105.8 50.2 36.2 54.4 49.4 88.5 59.6 178.4 38.6 25.0 41.1 85.0 95.4 115.7 35.6 58.4 44.2 33.3 232.7 63.1 105.5 119.0 57.7 27.3 90.9 116.9 62.0 102.6 67.5 73.2 12.2 25.8 56.9 148.6 140.8 78.1 31.7 48.1 20.4 48.6 55.1 66.2 101.5 85.0 57.8 97.8 36.8 28.1 38.0 54.6 3.9 2.4 0.0 22.7 3.4 21.3 5.8 22.6 23.3 2.4 7.2 18.6 21.6 0.3 18.1 1.7 1.3 28.2 11.2 30.7 31.8 38.4 33.5 27.2 32.2 31.4 29.5 27.6 32.8 26.9 32.0 35.2 14.0 9.6 21.7 18.6 21.7 11.2 6.0 10.9 7.4 14.4 4.8 5.5 8.6 8.6 4.5 7.3 2.1 11.9 30.6 5.8 0.0 9.9 0.7 2.7 20.6 27.1 7.8 32.6 39.2 4.8 17.7 15.7 17.3 5.4 1.3 11.5 14.3 13.7 30.4 3.3 38.0 10.4 12.2 14.8 9.4 1.1 7.2 12.4 17.8 6.5 8.8 8.3 44.3 22.6 13.2 15.0 4.3 9.1 49.6 6.0 5.5 11.1 3.7 2.6 0.0 26.5 14.0 2.3 12.3 10.3 11.2 3.6 36.4 7.1 10.9 4.4 ISM1 "bA149I18.1, C20orf82" ENSG00000101230 "Isthmin 1" B1AKI9 20 13221274-13300651 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 44.8" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 19.2;Fibroblasts: 18.4;Microglial cells: 8.4;Proximal tubular cells: 5.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 15.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Group enriched" "Detected in some" 5 "ASC diff: 48.9;Hep G2: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA 17000 "unprognostic (7.13e-2)" "unprognostic (3.55e-1)" "unprognostic (4.43e-3)" "unprognostic (5.27e-3)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.06e-1)" "unprognostic (4.48e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.32e-6)" "unprognostic (2.58e-2)" "unprognostic (2.10e-1)" "unprognostic (6.83e-2)" "unprognostic (1.81e-2)" 10.2 2.6 1.3 0.3 1.0 0.0 16.7 0.9 1.3 3.0 0.8 1.6 0.4 3.1 0.3 6.6 4.4 4.8 2.3 1.0 3.0 2.0 6.4 4.5 0.3 1.4 1.4 0.6 0.5 3.8 0.4 2.1 14.5 1.6 1.6 0.2 0.1 15.3 0.7 1.5 17.0 2.6 1.9 1.0 8.2 3.3 0.1 3.2 4.9 44.8 2.1 0.7 1.3 5.6 0.9 0.0 0.5 0.2 0.7 48.9 6.8 0.3 0.4 4.2 0.0 0.0 2.9 0.4 0.0 0.2 0.0 0.4 0.2 0.0 0.1 0.0 0.0 4.1 0.0 0.0 20.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.4 0.0 0.5 0.5 0.0 0.3 1.5 0.0 0.0 0.1 0.0 0.1 4.2 0.0 0.0 1.4 0.2 0.9 0.0 0.0 0.0 2.9 0.4 0.1 0.3 0.0 4.7 0.9 0.0 2.3 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.3 1.0 0.9 1.3 1.0 3.0 1.4 1.4 0.6 1.6 1.0 3.2 0.9 1.9 0.0 0.5 0.0 0.0 4.6 0.4 0.4 0.6 0.8 0.5 19.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.1 0.2 2.0 2.0 0.0 0.0 0.6 0.0 0.3 18.4 0.0 0.2 0.0 3.4 0.0 2.3 0.5 0.0 4.0 0.0 0.0 0.0 3.5 0.0 0.0 0.1 1.8 8.4 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.4 0.1 0.5 0.0 5.2 0.0 0.0 0.0 0.4 1.4 0.0 0.3 0.3 2.8 0.7 0.9 0.0 0.0 0.1 RNF24 G1L ENSG00000101236 "Ring finger protein 24" Q9Y225 20 3927309-4015558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 52.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 112.5;Inhibitory neurons: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 238.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 238.2" "Cell line enhanced" "Detected in all" "ASC TERT1: 81.7" "Low region specificity" "Detected in all" HPA011900 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA011900: AB_10671089" "unprognostic (6.61e-2)" "unprognostic (6.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.17e-2)" "unprognostic (8.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.65e-1)" "unprognostic (5.87e-2)" "unprognostic (2.66e-2)" "unprognostic (5.19e-3)" "unprognostic (3.42e-1)" "prognostic unfavorable (2.67e-7)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (1.24e-1)" 7.7 7.9 9.2 8.1 10.0 52.2 7.1 5.1 10.2 5.9 1.4 5.1 2.5 5.8 15.0 7.6 5.3 6.0 6.3 10.8 8.3 6.8 2.8 14.0 2.3 7.8 7.8 10.5 5.2 4.8 2.5 6.2 3.4 7.9 8.7 3.6 4.7 7.0 6.9 2.1 8.6 4.5 5.4 6.3 12.6 5.8 4.2 8.2 5.5 7.4 3.7 3.9 8.0 6.0 9.1 19.8 9.0 12.9 11.2 48.8 81.7 4.6 16.4 35.4 16.5 23.6 6.0 19.3 4.1 3.5 33.7 25.3 12.9 5.2 18.7 27.4 2.8 3.9 36.4 16.2 4.7 42.1 73.8 13.8 27.6 5.7 43.8 36.8 18.3 15.5 12.6 47.1 9.6 26.9 5.2 11.8 15.1 19.5 18.2 12.6 14.0 10.9 3.3 9.3 10.5 12.1 9.8 44.4 26.3 11.6 18.8 9.6 25.3 23.3 39.8 12.9 27.1 19.7 7.5 7.9 1.4 20.2 24.7 12.7 108.9 23.5 51.3 3.7 8.5 3.0 1.4 7.0 5.4 19.3 4.6 4.2 5.4 238.2 7.5 12.7 0.5 3.4 11.5 9.2 10.0 5.1 10.2 10.8 8.3 7.8 7.8 10.5 7.9 6.3 8.2 9.1 6.2 3.2 19.1 34.0 7.8 48.8 36.9 24.1 26.2 18.1 26.9 19.3 2.7 4.3 18.6 49.7 16.7 1.9 9.1 5.7 7.9 33.6 16.3 17.2 37.4 13.9 13.1 43.3 112.5 25.6 6.7 42.4 9.7 31.4 4.5 12.6 17.2 1.2 5.7 38.7 127.2 6.6 10.2 24.7 71.6 22.6 36.7 30.9 39.2 16.9 25.2 10.4 7.2 74.4 21.1 29.2 5.8 60.2 5.9 73.8 2.2 1.8 6.8 9.6 19.7 12.4 32.3 21.4 22.4 12.8 54.4 2.9 17.0 7.4 4.8 75.1 ARFRP1 "ARL18, ARP, Arp1" ENSG00000101246 "ADP ribosylation factor related protein 1" Q13795 20 63698642-63708025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047028, HPA050634" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA047028: AB_2679908, HPA050634: AB_2681196" "unprognostic (6.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.95e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.70e-2)" "unprognostic (2.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.53e-2)" "unprognostic (5.58e-2)" "unprognostic (3.93e-2)" "unprognostic (1.72e-2)" "unprognostic (5.48e-2)" "unprognostic (3.39e-1)" 24.7 28.0 21.0 14.2 20.7 10.1 25.2 20.4 29.3 31.6 19.9 29.0 19.1 29.6 5.3 36.4 28.2 8.8 38.0 20.4 20.4 32.2 36.8 26.2 18.0 20.7 20.8 19.7 29.5 24.6 12.7 25.2 11.7 21.1 32.7 8.4 5.6 22.6 16.1 32.1 22.0 27.5 10.1 20.0 42.3 24.8 20.3 22.0 17.9 25.8 15.6 11.3 29.8 28.6 21.6 26.5 31.9 10.1 10.6 10.0 10.8 14.6 31.8 21.1 67.7 24.6 60.0 22.4 32.4 21.6 18.8 27.3 35.8 11.0 35.5 11.9 11.3 16.5 23.8 36.1 52.2 34.7 27.3 21.5 15.1 45.2 17.8 21.6 17.9 25.1 30.5 36.0 24.1 16.9 14.9 54.0 37.7 15.8 19.5 46.7 42.3 14.0 33.4 14.5 21.7 16.9 17.3 32.3 46.5 11.4 6.1 20.5 34.8 20.0 39.6 15.9 14.9 32.6 24.9 11.1 25.1 26.5 17.9 22.8 44.3 30.9 23.5 41.5 31.6 34.7 32.6 37.5 39.8 28.3 33.7 46.8 41.5 15.7 37.6 34.7 49.2 32.3 36.5 21.0 20.7 20.4 29.3 20.4 20.4 20.7 20.8 19.7 21.1 20.0 22.0 21.6 40.7 12.8 11.9 12.4 25.9 13.9 25.5 26.1 19.4 44.6 20.8 28.7 34.0 8.6 15.8 25.8 20.9 42.2 28.0 48.9 39.2 31.2 12.8 13.5 27.0 34.3 26.4 25.7 10.6 20.4 25.5 31.6 18.3 10.7 24.7 28.4 24.3 18.4 36.9 37.0 10.6 31.6 18.3 20.7 15.3 10.5 23.9 24.1 24.9 5.6 41.0 40.8 29.9 4.0 11.9 51.6 34.6 29.7 23.4 22.9 52.4 33.4 12.3 42.3 19.7 21.8 35.1 44.5 32.7 22.4 14.2 30.2 30.7 35.7 33.1 17.0 NDUFAF5 "C20orf7, dJ842G6.1" ENSG00000101247 "NADH:ubiquinone oxidoreductase complex assembly factor 5" Q5TEU4 20 13785007-13821580 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Oxidoreductase, Transferase" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 20.7" "Cell type enhanced" "Detected in many" "Early spermatids: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051184 Uncertain NA NA "HPA051184: AB_2681377" "unprognostic (3.81e-1)" "unprognostic (1.27e-2)" "unprognostic (4.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (8.22e-2)" "unprognostic (1.68e-2)" "unprognostic (3.14e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-1)" "unprognostic (1.74e-3)" "unprognostic (2.41e-2)" "prognostic favorable (2.27e-6)" "unprognostic (5.38e-2)" "unprognostic (5.89e-2)" "unprognostic (6.88e-2)" "unprognostic (1.58e-2)" 3.3 3.8 3.6 1.2 4.0 6.0 3.0 4.5 5.0 2.7 3.8 4.6 3.6 3.2 0.9 3.2 2.7 1.5 9.5 4.1 3.7 5.1 4.9 2.6 1.5 3.5 3.8 3.9 2.2 2.5 4.5 3.5 2.1 4.0 3.3 2.6 3.8 2.9 2.0 20.7 3.4 3.1 3.1 3.3 2.4 3.6 4.0 4.0 2.7 2.4 17.2 1.7 3.3 3.0 4.4 6.5 6.3 7.4 5.1 5.7 1.7 3.7 4.6 3.6 6.0 5.0 13.8 4.7 10.8 4.6 4.9 11.3 8.6 13.9 9.1 4.9 5.1 8.0 9.6 3.9 16.8 7.3 8.6 4.7 3.4 6.4 7.3 4.8 2.6 5.2 10.2 7.6 5.2 5.9 8.4 12.3 7.8 2.6 7.3 6.7 8.1 9.1 6.6 6.8 8.5 7.4 7.5 5.0 13.5 15.0 2.4 6.8 6.0 5.6 7.1 3.6 6.0 7.4 5.7 9.2 8.7 3.1 3.6 7.4 1.2 2.1 4.0 2.4 2.7 1.7 2.5 2.0 1.6 3.0 2.2 2.3 2.3 0.5 3.5 1.9 3.6 2.4 1.1 3.6 4.0 4.5 5.0 4.1 3.7 3.5 3.8 3.9 4.0 3.3 4.0 4.4 9.0 0.0 11.2 18.3 8.3 6.2 8.6 15.1 6.8 46.6 6.5 10.4 42.4 4.3 7.4 11.0 27.1 15.9 12.4 8.6 29.4 12.1 68.2 6.5 8.8 8.7 12.5 3.4 27.0 5.6 8.4 10.5 13.3 7.3 7.6 15.9 3.9 11.4 14.0 11.8 29.3 14.1 22.4 8.8 5.9 12.7 6.8 7.7 1.8 12.2 7.9 13.9 13.4 20.6 19.3 9.8 6.2 12.4 8.8 8.9 12.8 33.1 7.4 25.0 0.0 8.8 18.0 35.9 26.7 9.9 7.4 14.6 10.7 18.5 11.7 12.9 SEL1L2 "C20orf50, DKFZp434C1826" ENSG00000101251 "SEL1L2 adaptor subunit of ERAD E3 ligase" Q5TEA6 20 13849247-13996443 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 7.2" "Group enriched" "Detected in some" 7 "Early spermatids: 188.3;Late spermatids: 155.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA059121 Approved NA NA "HPA059121: AB_2683911" "unprognostic (6.70e-2)" "unprognostic (1.64e-2)" "unprognostic (2.72e-3)" "unprognostic (2.19e-1)" "unprognostic (8.51e-2)" "unprognostic (5.33e-2)" "unprognostic (2.13e-2)" "unprognostic (2.54e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "unprognostic (3.12e-2)" 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.3 0.1 0.3 0.1 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.3 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 155.8 1.2 0.1 0.0 1.0 0.0 0.0 0.0 3.5 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.1 24.2 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TRIB3 "C20orf97, dJ1103G7.3, TRB3" ENSG00000101255 "Tribbles pseudokinase 3" Q96RU7 20 362835-397559 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 81.1" "Cell type enhanced" "Detected in many" "Ductal cells: 53.1;Hepatocytes: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 630.3;hTCEpi: 401.9;hTERT-HME1: 461.8;SK-MEL-30: 615.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015272, HPA055442" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015272: AB_1858269, HPA055442: AB_2682818" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.25e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.70e-4)" "prognostic unfavorable (6.75e-5)" "unprognostic (1.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.24e-1)" "unprognostic (7.95e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.07e-13)" "unprognostic (7.62e-2)" "unprognostic (2.79e-2)" "unprognostic (2.31e-1)" "unprognostic (4.05e-3)" 6.9 16.6 6.1 4.1 5.3 16.2 7.9 5.8 6.8 3.6 5.8 3.2 1.3 2.9 3.0 20.6 2.2 2.7 3.9 5.1 5.8 6.1 81.1 15.5 6.6 5.4 5.0 4.9 3.2 17.5 13.4 15.3 8.5 6.6 7.8 2.2 2.7 10.5 3.0 1.8 13.2 5.3 1.8 4.4 12.2 10.3 1.4 6.8 5.7 38.5 0.5 6.0 4.9 5.4 5.6 80.9 41.6 5.1 11.9 13.7 17.9 33.7 23.9 65.8 23.0 47.5 86.7 40.0 35.3 22.2 22.5 102.3 62.6 22.6 107.7 21.4 12.4 16.2 27.5 8.9 144.2 630.3 71.5 12.7 73.3 401.9 43.5 461.8 16.2 45.1 86.1 97.3 155.2 2.3 77.3 4.2 87.0 11.8 122.8 133.0 15.2 7.1 77.1 27.0 33.3 14.7 23.0 5.6 192.2 615.5 7.2 55.7 185.6 24.6 11.7 20.6 0.3 36.2 52.3 73.9 63.5 10.5 61.4 43.6 5.1 6.4 1.4 13.2 4.9 9.4 21.0 12.3 15.3 6.7 13.8 13.7 9.8 4.4 10.2 2.6 2.8 9.7 7.8 6.1 5.3 5.8 6.8 5.1 5.8 5.4 5.0 4.9 6.6 4.4 6.8 5.6 7.9 3.2 1.5 0.3 9.3 6.8 10.9 20.3 3.4 6.8 12.7 8.3 1.6 11.5 8.5 1.8 4.2 14.1 4.0 3.4 0.0 53.1 0.0 0.2 1.6 15.8 1.2 5.7 2.2 22.7 6.4 3.9 0.0 2.6 5.1 0.5 6.8 38.4 6.4 0.0 3.1 8.8 6.1 3.3 4.4 0.0 1.8 3.0 7.2 0.0 4.2 1.0 14.4 1.0 0.6 24.0 1.9 1.5 10.0 12.2 0.0 0.1 2.9 7.0 6.6 6.5 6.9 2.4 3.1 4.0 5.4 7.1 5.7 3.5 2.2 6.7 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823608 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 205.6;retina: 164.2" "Cell type enhanced" "Detected in many" "Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3" "Cancer enriched" "Detected in all" 5 "glioma: 48.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 16.6 9.8 99.8 47.5 135.8 92.1 7.0 162.6 101.4 28.2 56.2 8.5 5.3 25.6 22.7 10.1 22.3 15.8 3.6 79.4 108.5 2.8 5.9 25.6 59.1 205.6 161.2 65.7 7.1 3.1 1.5 5.1 9.1 178.5 7.3 9.7 164.2 3.0 9.4 1.2 4.2 14.7 39.0 164.9 33.0 7.1 20.8 130.7 19.6 4.7 5.0 74.2 20.9 4.9 203.0 0.1 14.5 34.9 56.8 0.4 0.0 59.2 3.5 10.0 0.6 0.2 3.4 0.1 62.7 5.6 3.1 1.4 0.2 5.1 0.0 0.8 22.7 2.1 41.1 0.0 0.7 0.0 74.7 40.1 0.1 0.0 1.3 0.0 1.3 23.4 7.0 0.2 24.0 0.0 0.1 11.0 96.3 7.8 0.0 1.1 17.1 3.9 23.8 0.0 29.0 0.4 2.8 0.0 1.0 1.7 7.4 0.0 47.0 0.7 1.5 7.4 0.7 4.6 0.3 5.9 37.8 0.3 116.8 0.4 85.6 61.5 101.3 7.7 50.1 14.6 24.3 12.0 10.4 46.8 16.4 7.8 6.5 139.5 8.5 59.9 30.7 11.8 42.1 99.8 135.8 162.6 101.4 79.4 108.5 205.6 161.2 65.7 178.5 164.9 130.7 203.0 5.5 0.0 8.7 7.5 49.3 4.7 0.0 0.1 0.0 39.2 4.1 1.7 1.9 1.5 1.9 0.0 27.1 3.0 43.0 0.1 1.9 1.2 6.0 3.2 19.6 18.6 0.0 6.1 1.5 0.9 5.1 10.9 1.1 1.0 54.3 4.5 11.4 1.2 27.1 6.7 1.3 0.7 0.0 87.1 75.8 25.1 33.2 64.6 8.8 26.2 148.5 19.3 7.2 33.7 106.7 0.6 0.0 149.7 14.3 1.2 0.0 0.3 0.1 160.3 0.0 9.4 3.5 0.7 1.0 0.3 2.6 1.4 20.8 0.8 0.0 2.3 CSNK2A1 "Cka1, Cka2" ENSG00000101266 "Casein kinase 2 alpha 1" P68400 20 472498-543835 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020680, HPA059206, HPA061698, CAB069395" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB020680: , CAB069395: AB_1611912, HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (5.44e-2)" "unprognostic (8.28e-3)" "unprognostic (3.62e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (4.11e-6)" "unprognostic (4.08e-2)" "unprognostic (3.89e-1)" "unprognostic (6.88e-2)" "unprognostic (1.94e-2)" "unprognostic (1.16e-1)" "unprognostic (8.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.47e-1)" "unprognostic (9.53e-2)" "unprognostic (7.37e-2)" 36.4 32.9 21.7 39.0 24.1 34.3 36.3 29.4 29.8 36.8 27.6 48.8 39.4 36.1 26.8 50.5 40.2 31.6 54.5 26.7 24.8 41.4 32.1 31.9 41.5 21.8 23.1 24.5 41.9 47.3 59.6 21.3 42.8 23.1 36.1 41.1 33.2 41.5 38.1 111.6 34.2 40.9 39.5 18.6 30.4 49.9 65.7 22.4 52.1 40.0 87.2 46.9 47.9 28.8 28.1 209.5 170.4 152.9 96.0 61.1 103.8 103.5 117.9 116.1 125.8 139.5 178.5 120.0 179.1 74.2 90.1 179.1 147.8 162.1 167.4 187.2 62.6 57.7 247.3 44.7 177.7 102.5 228.1 51.3 99.5 173.3 105.8 316.0 122.2 139.5 146.4 248.9 112.6 123.8 64.2 262.0 73.7 227.4 173.4 97.6 149.8 140.5 140.9 112.9 128.5 163.9 132.3 97.2 184.0 174.8 120.7 120.4 83.9 142.7 136.0 118.4 90.0 178.5 120.6 311.8 174.1 65.8 119.5 138.6 40.5 23.8 28.7 18.2 32.3 22.4 23.0 18.0 17.6 31.5 22.5 17.9 17.4 14.9 25.1 33.5 25.7 20.4 20.8 21.7 24.1 29.4 29.8 26.7 24.8 21.8 23.1 24.5 23.1 18.6 22.4 28.1 50.7 64.1 84.6 51.9 46.1 41.0 40.0 43.8 45.5 49.4 42.1 36.1 59.4 41.5 75.8 44.1 31.3 42.2 50.5 43.5 41.1 68.5 135.5 67.6 77.0 44.5 35.2 59.3 65.6 50.6 54.4 46.3 40.2 75.7 63.8 108.6 27.1 31.1 33.2 60.6 69.3 41.8 46.8 39.2 30.3 140.0 41.0 45.3 14.2 51.5 61.7 38.6 37.0 73.9 73.6 66.6 34.4 36.9 49.6 57.2 43.2 68.8 65.5 27.8 52.6 43.6 56.8 94.2 68.7 52.3 50.2 61.4 38.9 81.2 40.6 59.4 SLC52A3 "bA371L19.1, C20orf54, hRFT2, RFVT3" ENSG00000101276 "Solute carrier family 52 member 3" Q9NQ40 20 760080-776015 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.4;testis: 40.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Cytotrophoblasts: 32.8;Distal enterocytes: 18.8;Glandular and luminal cells: 21.3;Paneth cells: 21.7;Proximal enterocytes: 35.5;Syncytiotrophoblasts: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 42.1;OE19: 31.8;RT4: 12.3;SK-BR-3: 15.4;T-47d: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049391, HPA059078" Approved NA NA "HPA049391: AB_2680743, HPA059078: AB_2732630" "unprognostic (4.53e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (7.84e-2)" "unprognostic (1.29e-1)" "unprognostic (9.03e-3)" "unprognostic (2.12e-3)" "unprognostic (1.43e-3)" "unprognostic (1.15e-2)" "unprognostic (4.36e-2)" "unprognostic (4.39e-3)" "unprognostic (4.82e-2)" "unprognostic (2.04e-3)" "prognostic favorable (5.51e-6)" "unprognostic (3.04e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" 1.5 0.2 11.0 1.5 9.1 0.4 2.6 9.1 11.5 2.3 5.8 11.6 14.5 2.0 2.0 4.9 1.8 2.6 3.5 8.7 10.6 9.4 0.1 1.3 0.4 12.6 9.9 7.0 0.9 1.6 0.2 0.3 4.3 11.5 8.1 7.2 0.6 6.1 4.1 0.6 1.5 19.4 1.7 8.9 0.2 5.6 40.4 11.7 0.1 0.5 0.9 0.8 4.9 2.6 9.4 6.6 2.2 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 4.6 42.1 0.0 7.0 0.0 0.6 6.9 0.0 6.0 0.0 0.0 0.0 0.8 0.7 0.3 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.6 31.8 4.5 0.0 0.0 1.1 0.0 12.3 0.1 0.2 7.2 15.4 0.1 0.8 20.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 2.1 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.1 0.0 0.4 0.2 0.3 0.8 0.5 0.1 0.3 0.1 0.2 11.0 9.1 9.1 11.5 8.7 10.6 12.6 9.9 7.0 11.5 8.9 11.7 9.4 3.8 9.6 3.1 0.0 0.1 0.6 2.2 5.3 1.8 0.4 3.2 2.4 0.7 4.3 5.3 23.9 2.1 32.8 0.0 18.8 1.9 6.6 1.1 8.9 1.1 10.8 0.0 0.0 0.1 2.0 0.9 0.4 4.6 21.3 0.0 5.9 0.0 0.0 2.6 0.0 0.0 6.0 6.1 0.0 1.3 3.2 0.9 0.2 1.8 2.8 0.0 0.0 0.0 0.0 0.0 5.2 21.7 0.4 0.1 4.3 35.5 0.1 2.4 0.1 0.0 0.4 0.6 0.6 0.8 2.3 1.1 52.1 0.2 1.3 10.8 5.8 ANGPT4 ENSG00000101280 "Angiopoietin 4" Q9Y264 20 869900-916334 "Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 5.7;breast: 6.6" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 52.9;Late spermatids: 17.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 41 "ASC diff: 33.7;BEWO: 48.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB013260, CAB013305" Uncertain "Secreted to blood" NA NA "CAB013260: , CAB013305: " "unprognostic (1.77e-1)" "unprognostic (3.25e-1)" "unprognostic (4.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.37e-2)" "unprognostic (3.41e-1)" "unprognostic (5.82e-4)" "unprognostic (1.25e-1)" "unprognostic (7.10e-2)" "unprognostic (3.66e-4)" "unprognostic (9.01e-2)" "unprognostic (1.71e-1)" "unprognostic (5.25e-2)" "unprognostic (1.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.95e-4)" "unprognostic (9.14e-2)" 5.7 0.3 0.3 0.1 0.3 0.0 6.6 0.2 0.2 3.6 0.1 0.2 0.1 3.3 2.1 0.2 3.3 0.3 0.2 0.2 0.3 0.1 0.2 1.2 0.1 0.4 0.4 0.2 3.9 0.1 0.1 0.1 0.0 0.4 0.5 0.1 0.1 0.3 0.4 0.0 1.3 0.3 1.1 0.2 0.0 0.3 0.6 0.4 0.2 1.7 0.6 0.0 1.0 2.2 0.3 0.2 0.0 0.0 0.0 33.7 0.0 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.2 0.3 0.4 0.4 0.2 0.4 0.2 0.4 0.3 0.3 0.0 0.5 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 52.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.3 17.0 1.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.9 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 RSPO4 "C20orf182, dJ824F16.3" ENSG00000101282 "R-spondin 4" Q2I0M5 20 958452-1002311 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.8;lung: 12.7" "Cell type enhanced" "Detected in some" "Astrocytes: 10.7;Early spermatids: 6.6;Late spermatids: 7.3;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 7.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;EFO-21: 2.0;fHDF/TERT166: 2.4;NTERA-2: 6.3;SK-BR-3: 4.3;U-2 OS: 6.9" "Region enhanced" "Detected in single" "basal ganglia: 1.2" "Not detected" "Not detected" HPA048887 Uncertain "Secreted in other tissues" NA NA "HPA048887: AB_2680545" "unprognostic (2.36e-1)" "unprognostic (3.60e-3)" "unprognostic (2.88e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (8.93e-2)" "unprognostic (1.14e-3)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (6.50e-2)" "unprognostic (2.02e-2)" "unprognostic (5.26e-3)" "unprognostic (2.96e-1)" "unprognostic (5.68e-9)" "unprognostic (6.65e-3)" "unprognostic (4.41e-2)" "unprognostic (6.18e-3)" "unprognostic (2.22e-2)" 0.3 0.2 4.9 0.6 4.6 0.0 1.3 2.3 5.4 0.6 1.1 0.2 0.1 0.3 1.4 0.9 1.6 0.5 0.4 3.0 5.8 0.6 0.3 12.7 0.0 11.2 7.4 2.1 0.4 0.3 0.3 2.1 0.2 12.8 0.4 0.0 1.2 0.4 0.2 0.1 2.5 0.3 0.0 3.5 0.2 0.2 3.2 7.4 0.0 3.0 0.0 0.4 0.2 0.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.2 0.0 0.1 0.0 0.0 0.0 0.8 2.0 2.4 0.3 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 6.9 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.6 2.3 5.4 3.0 5.8 11.2 7.4 2.1 12.8 3.5 7.4 9.6 0.0 0.0 0.0 10.7 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.3 0.0 0.0 2.9 0.0 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.8 7.3 0.0 0.0 1.8 1.9 0.0 0.1 0.0 8.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 2.1 0.9 0.0 0.4 0.3 0.0 0.0 0.0 0.0 CDS2 ENSG00000101290 "CDP-diacylglycerol synthase 2" O95674 20 5126879-5197887 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019698 Approved Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA019698: AB_1846464" "unprognostic (4.59e-2)" "unprognostic (1.98e-1)" "unprognostic (2.39e-1)" "unprognostic (3.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.48e-1)" "unprognostic (3.35e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.53e-9)" "unprognostic (8.89e-2)" "unprognostic (3.53e-1)" "unprognostic (1.38e-1)" "unprognostic (2.44e-1)" 14.5 14.0 24.8 9.1 30.7 13.1 10.8 21.4 26.4 10.5 0.8 11.7 5.2 11.6 8.3 9.3 10.8 8.9 25.0 28.7 30.6 14.8 12.9 13.6 8.9 24.3 34.7 24.9 9.4 6.6 17.5 14.6 10.0 31.8 13.5 10.8 31.7 7.6 16.8 9.8 5.7 10.2 18.2 15.4 9.5 10.7 11.8 38.5 13.5 12.6 12.8 12.7 10.9 7.8 34.9 25.4 27.4 28.1 13.7 16.4 14.9 11.7 13.9 28.5 22.7 32.2 17.8 23.8 19.8 6.8 26.4 41.1 36.5 23.1 29.5 23.9 18.4 6.8 23.5 7.9 27.0 15.3 13.9 8.1 12.8 16.1 29.8 11.5 20.3 30.7 26.5 11.6 23.9 21.4 4.6 30.1 5.7 12.1 12.4 7.6 25.0 22.5 9.4 14.5 25.0 11.4 15.5 15.3 26.2 34.6 33.8 16.4 6.7 25.4 15.6 11.6 14.1 14.0 20.8 160.2 15.9 7.4 11.7 8.1 55.3 17.3 21.2 15.2 14.7 16.6 12.1 15.6 17.3 13.8 11.4 12.0 11.8 49.7 12.0 13.4 10.9 19.5 23.7 24.8 30.7 21.4 26.4 28.7 30.6 24.3 34.7 24.9 31.8 15.4 38.5 34.9 43.3 19.2 15.7 36.9 36.2 17.6 30.3 33.0 14.2 60.1 17.7 14.4 55.2 18.6 19.6 33.1 95.9 22.2 29.6 15.3 5.9 33.1 71.6 20.1 14.0 42.3 10.7 14.9 39.3 22.7 40.0 17.9 15.3 21.5 21.0 20.5 27.8 21.7 60.8 43.7 52.0 12.4 12.2 36.6 26.1 33.3 16.1 31.5 32.0 21.5 38.7 21.9 28.8 28.6 56.1 31.7 20.3 24.8 48.9 23.1 15.7 13.2 23.5 65.5 19.7 19.7 52.1 26.8 34.7 14.8 15.3 16.3 36.7 13.0 13.1 29.1 PROKR2 "dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2" ENSG00000101292 "Prokineticin receptor 2" Q8NFJ6 20 5299218-5316954 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;SH-SY5Y: 1.7" "Region enhanced" "Detected in many" "olfactory bulb: 17.0" "Low region specificity" "Detected in all" HPA047281 Uncertain NA NA "HPA047281: AB_10960057" "unprognostic (1.36e-1)" "unprognostic (1.69e-1)" 0.0 0.0 0.7 0.1 1.4 0.8 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.2 0.2 1.0 0.1 0.1 0.4 0.2 0.0 0.7 1.4 0.2 0.9 1.2 0.2 0.0 0.3 0.8 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HM13 "dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1" ENSG00000101294 "Histocompatibility minor 13" Q8TCT9 20 31514410-31577923 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 324.9;Plasma cells: 400.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045089, HPA056062" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045089: AB_10962054, HPA056062: AB_2683022" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (5.03e-2)" "unprognostic (1.59e-1)" "unprognostic (2.82e-1)" "unprognostic (5.87e-3)" "prognostic unfavorable (1.95e-5)" "unprognostic (2.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.10e-2)" "prognostic unfavorable (4.64e-12)" "unprognostic (3.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-1)" "unprognostic (8.17e-2)" 72.8 103.8 11.7 61.4 13.7 62.2 64.0 14.4 15.9 100.8 38.9 51.4 53.1 73.5 112.4 129.6 71.1 47.1 48.7 12.8 22.5 61.6 137.2 84.4 41.0 19.2 14.4 11.0 59.7 243.1 69.3 90.7 65.1 17.4 66.6 44.8 21.0 219.6 81.0 45.0 51.1 52.5 49.6 16.8 70.8 93.3 22.1 20.8 30.8 75.4 14.3 54.6 65.4 72.8 18.0 143.8 147.6 56.6 87.7 260.2 163.5 197.6 239.0 221.3 159.7 162.8 287.3 166.8 90.4 312.8 262.7 209.7 253.8 74.9 162.0 97.7 46.2 112.0 201.3 99.7 179.3 287.0 118.1 78.1 152.5 103.5 133.7 182.7 159.0 124.5 56.0 90.2 364.0 148.8 170.3 100.0 84.0 67.8 234.9 248.5 63.6 272.6 436.5 154.4 75.6 76.3 90.4 243.5 234.9 199.2 56.4 182.0 109.5 153.3 243.1 129.8 246.3 136.2 225.5 145.5 71.7 328.7 413.0 219.4 117.7 380.9 190.8 116.7 372.6 159.7 91.9 108.0 112.9 260.8 74.4 70.6 84.1 282.8 117.5 363.7 271.9 104.1 374.1 11.7 13.7 14.4 15.9 12.8 22.5 19.2 14.4 11.0 17.4 16.8 20.8 18.0 67.4 51.3 55.4 23.8 78.2 33.4 59.0 127.8 31.3 45.4 65.6 49.1 13.6 71.4 102.2 53.3 123.0 154.0 70.7 115.2 13.7 145.6 15.5 55.0 111.5 60.9 61.5 38.9 40.5 169.7 139.0 93.2 80.0 128.4 42.4 55.5 53.2 86.4 324.9 43.7 39.2 134.5 63.1 81.2 83.1 15.9 60.6 106.1 65.8 28.1 77.4 52.2 53.5 33.7 23.8 144.3 81.2 43.6 400.6 92.4 54.8 51.0 49.3 44.8 32.9 49.2 79.2 26.1 26.4 60.0 35.4 213.6 60.1 97.2 70.8 69.3 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266280-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.7" "Cell type enhanced" "Detected in many" "Astrocytes: 45.7;Bipolar cells: 24.3;Excitatory neurons: 60.6;Horizontal cells: 30.3;Inhibitory neurons: 71.7;Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 9 "T-cells: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA049393: AB_2680744" "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favorable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 1.6 3.7 46.6 1.6 48.0 0.6 1.6 6.9 74.7 3.6 0.5 6.4 1.5 6.5 1.9 1.8 6.5 2.6 5.4 54.8 21.2 2.7 0.3 2.4 1.6 36.4 20.7 48.9 2.1 3.6 4.4 12.6 0.6 38.4 6.0 0.8 13.0 6.2 11.2 7.2 1.2 4.6 4.9 4.7 1.7 5.2 3.9 34.3 0.9 5.1 1.6 0.8 4.7 3.0 43.4 2.3 7.6 0.1 6.5 7.6 4.0 0.0 4.1 5.2 4.4 2.0 0.3 0.7 0.4 2.4 4.9 10.9 1.2 1.0 5.7 0.8 1.6 1.8 4.7 1.2 0.1 4.0 0.0 7.1 2.7 2.7 4.5 0.9 4.3 5.6 4.5 0.9 0.2 4.0 0.0 0.4 0.2 2.4 0.0 5.7 0.0 1.5 0.1 5.8 3.4 0.4 2.0 4.1 0.2 5.8 0.6 0.3 0.1 9.6 7.1 5.3 6.4 1.2 0.6 1.4 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.1 0.5 46.6 48.0 6.9 74.7 54.8 21.2 36.4 20.7 48.9 38.4 4.7 34.3 43.4 0.5 0.0 0.0 45.7 0.6 0.1 0.1 2.2 1.2 24.3 2.4 0.9 4.7 4.3 1.2 3.7 6.2 0.0 2.3 0.9 0.0 0.4 10.4 0.2 0.7 1.0 8.4 0.0 60.6 0.6 0.1 1.3 5.6 0.5 0.0 2.1 2.2 0.0 0.3 30.3 71.7 1.0 2.0 0.0 0.3 5.4 1.5 0.2 0.0 9.4 0.2 2.7 1.0 38.2 1.7 1.1 1.0 4.1 0.4 1.6 0.1 1.7 1.2 20.3 6.6 2.6 1.7 1.3 0.5 0.2 0.1 0.0 1.6 1.2 1.8 0.1 MYLK2 "KMLC, MLCK2, skMLCK" ENSG00000101306 "Myosin light chain kinase 2" Q9H1R3 20 31819308-31834689 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skeletal muscle: 739.1" "Cell type enriched" "Detected in some" 5 "Skeletal myocytes: 15.9" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA059704, HPA059890" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA059704: AB_2684108, HPA059890: AB_2684153" "unprognostic (1.74e-2)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (5.27e-2)" "prognostic favorable (4.00e-4)" "unprognostic (5.58e-2)" "unprognostic (1.38e-7)" "unprognostic (2.29e-1)" "unprognostic (2.60e-3)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (7.25e-11)" "unprognostic (2.01e-1)" "unprognostic (3.15e-1)" "unprognostic (2.60e-2)" "unprognostic (2.70e-2)" 0.1 0.0 0.6 0.1 0.5 0.4 0.1 0.5 0.7 0.0 0.4 0.2 0.0 0.1 0.1 4.8 0.1 0.0 0.3 0.6 0.6 0.0 0.0 0.1 0.0 0.6 0.6 0.5 0.1 5.5 0.0 0.1 0.0 0.6 1.1 0.0 0.0 2.5 0.0 739.1 0.3 0.1 0.1 0.6 0.3 0.2 0.2 0.6 0.2 0.2 60.9 0.0 0.0 0.0 0.6 0.3 0.0 0.7 0.6 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.2 0.2 0.5 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 1.3 0.8 0.5 0.1 4.1 0.1 0.6 0.5 0.3 0.5 0.0 0.3 0.6 10.5 8.8 0.0 0.1 0.5 0.5 2.7 0.1 0.0 0.1 0.1 0.1 2.1 0.2 0.7 0.4 2.4 0.0 0.8 0.2 0.1 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.5 0.7 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1561385-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.7;lung: 19.5;lymphoid tissue: 28.8" "Cell type enhanced" "Detected in some" "dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 1594.8" "Group enriched" "Detected in all" 6 "granulocytes: 1594.8;monocytes: 502.2" "Group enriched" "Detected in some" 4 "HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9" HPA047463 Uncertain Uncertain Vesicles,Centrosome NA NA 44000000 Vesicles Centrosome "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 5.4 1.6 1.4 28.8 1.3 52.7 1.9 1.1 3.8 1.2 0.9 2.1 1.5 0.8 0.8 1.3 2.2 11.4 1.5 1.5 0.7 1.2 3.1 19.5 11.1 1.0 0.9 1.0 0.7 1.3 0.3 0.6 2.8 1.4 0.8 1.8 1.3 1.7 0.9 0.8 0.8 2.9 3.2 0.5 24.7 1.5 0.6 1.7 4.5 0.9 1.5 4.3 8.2 0.9 2.2 0.2 0.0 0.2 0.1 0.3 0.5 0.2 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.8 0.4 7.1 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.2 14.9 54.0 0.1 0.2 0.3 0.0 8.0 0.5 1.1 0.0 0.2 0.4 0.1 0.0 76.2 0.2 0.0 3.3 0.2 0.0 0.1 10.8 0.3 0.1 0.2 0.2 0.0 0.5 0.0 0.0 58.9 1.6 0.7 0.1 0.4 0.3 0.1 0.1 0.1 1.1 13.4 0.2 6.1 502.2 868.9 7.3 419.7 10.3 2.8 6.5 5.7 175.2 3.4 8.8 5.5 1594.8 8.2 357.6 165.7 11.8 287.0 1.4 1.3 1.1 3.8 1.5 0.7 1.0 0.9 1.0 1.4 0.5 1.7 2.2 0.6 3.2 5.2 0.3 1.2 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.2 10.9 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.1 0.7 0.0 0.2 7.0 0.0 1.8 0.2 14.7 0.0 0.1 0.0 0.0 29.4 0.0 0.0 0.0 30.9 0.0 0.0 26.7 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 SEC23B "CDA-II, CDAII, CDAN2, HEMPAS" ENSG00000101310 "SEC23 homolog B, COPII coat complex component" Q15437 20 18507520-18561415 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008216, HPA069974" Uncertain Supported Vesicles NA Yes 16000 Vesicles "HPA008216: AB_1079895, HPA069974: AB_2686223" "unprognostic (4.47e-2)" "unprognostic (2.67e-2)" "unprognostic (3.52e-1)" "prognostic favorable (8.25e-4)" "unprognostic (1.24e-1)" "unprognostic (1.33e-1)" "unprognostic (5.44e-3)" "unprognostic (6.01e-2)" "unprognostic (1.39e-1)" "unprognostic (8.75e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-2)" "unprognostic (3.91e-2)" "unprognostic (1.72e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-2)" "unprognostic (8.21e-2)" 19.8 38.6 18.1 32.3 25.6 36.3 38.2 23.6 26.2 36.5 25.5 31.9 24.0 17.3 54.3 28.7 29.8 23.3 8.6 19.7 27.7 37.8 30.8 29.9 30.8 25.9 23.5 16.8 17.1 57.6 51.0 32.9 24.4 25.4 35.1 33.0 41.1 71.5 36.2 4.1 18.3 23.5 18.6 23.4 25.7 38.6 35.1 22.9 27.9 60.0 6.2 38.4 30.7 12.8 38.7 85.0 93.9 49.8 48.7 32.3 36.6 116.0 69.8 45.3 80.0 68.7 84.9 73.8 37.5 44.9 50.4 107.0 88.5 88.5 120.7 86.2 47.5 43.1 64.9 35.6 130.6 70.5 90.2 78.7 28.0 71.8 118.0 151.4 47.6 50.6 34.0 74.8 82.4 55.1 90.7 59.8 49.5 48.0 118.9 101.6 62.4 77.7 122.1 83.0 85.6 78.8 58.0 83.6 188.9 80.6 62.6 82.3 94.4 45.3 53.1 29.8 58.4 87.1 104.2 155.9 60.1 45.3 47.8 74.4 147.9 94.1 106.0 57.2 95.6 78.7 67.2 56.8 61.4 107.9 61.2 51.3 54.0 48.0 78.8 94.9 80.7 75.4 103.7 18.1 25.6 23.6 26.2 19.7 27.7 25.9 23.5 16.8 25.4 23.4 22.9 38.7 8.5 16.0 43.5 15.3 24.7 11.5 21.0 34.3 10.2 21.0 21.5 15.6 3.0 20.0 42.5 31.3 16.7 34.3 36.0 26.2 58.7 36.1 95.6 25.4 12.4 11.3 19.7 7.4 17.9 33.4 30.0 11.7 25.0 31.3 15.9 13.6 11.0 25.6 42.9 13.5 20.5 34.7 26.4 38.7 21.0 11.3 14.3 30.3 23.2 15.0 33.1 23.9 9.2 23.1 27.0 31.8 24.2 10.5 59.0 30.1 11.8 53.2 45.4 20.4 19.7 12.4 12.2 48.7 22.1 15.8 14.2 65.8 21.0 16.0 21.5 28.3 FERMT1 "C20orf42, FLJ20116, KIND1, UNC112A, URP1" ENSG00000101311 "Fermitin family member 1" Q9BQL6 20 6074845-6123030 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 121.3;Oligodendrocyte precursor cells: 229.7;Pancreatic endocrine cells: 384.1;Undifferentiated cells: 95.2" "Cancer enhanced" "Detected in all" "colorectal cancer: 59.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 84.3;HaCaT: 95.4;HBEC3-KT: 100.2;OE19: 75.1;RT4: 54.4" "Region enriched" "Detected in single" 5 "hippocampal formation: 2.0" "Not detected" "Not detected" "HPA039778, HPA041966" Approved NA NA "HPA039778: AB_10805593, HPA041966: AB_10795387" "unprognostic (1.08e-3)" "unprognostic (4.63e-2)" "unprognostic (1.03e-1)" "unprognostic (3.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.82e-1)" "unprognostic (9.49e-2)" "unprognostic (1.53e-3)" "unprognostic (2.13e-1)" "unprognostic (1.83e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (4.38e-2)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.04e-1)" "unprognostic (4.60e-2)" "unprognostic (5.33e-2)" 0.6 11.5 1.8 9.4 2.1 0.3 1.5 1.3 1.5 2.2 0.0 24.8 14.9 2.3 0.8 12.9 3.5 2.6 1.0 1.4 1.7 4.1 0.3 1.0 0.0 3.5 2.3 0.9 4.2 2.7 12.6 0.2 4.8 3.1 5.0 36.1 0.0 1.9 4.4 0.1 17.7 11.1 2.1 2.7 0.4 13.1 0.5 1.8 2.4 3.0 0.3 5.1 6.8 3.4 3.2 53.4 14.4 0.0 0.0 0.4 5.0 18.5 2.8 0.1 1.9 0.8 24.8 84.3 0.0 14.1 2.9 6.3 95.4 36.8 100.2 2.0 0.0 2.6 8.2 10.7 26.8 1.2 0.0 2.5 4.8 43.6 11.5 24.0 0.4 1.2 0.3 0.0 0.2 2.4 1.4 0.0 2.4 11.5 75.1 41.1 0.0 12.5 29.9 9.9 54.4 7.7 0.9 8.8 0.3 0.0 0.7 8.4 2.2 0.4 5.1 3.4 0.7 39.5 0.2 0.1 0.1 3.7 9.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 1.5 1.4 1.7 3.5 2.3 0.9 3.1 2.7 1.8 3.2 0.1 0.0 0.6 0.3 0.0 41.4 51.5 44.8 121.3 0.0 3.4 16.3 1.3 8.6 16.0 0.0 0.0 65.0 0.1 61.2 1.9 34.5 0.1 4.0 31.8 0.6 15.6 8.4 2.3 40.3 31.3 7.5 46.9 2.0 0.0 13.5 0.4 0.4 4.9 0.0 2.2 49.0 2.0 0.0 0.8 1.1 10.8 1.5 1.8 7.5 0.1 0.0 0.0 229.7 0.5 384.1 23.5 3.0 1.4 20.1 13.9 15.8 5.7 0.0 0.0 6.2 2.9 0.2 0.6 80.6 43.0 7.3 1.0 6.2 95.2 44.8 HAO1 "GOX, GOX1" ENSG00000101323 "Hydroxyacid oxidase 1" Q9UJM8 20 7882985-7940458 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 582 "liver: 612.8" "Cell type enriched" "Detected in some" 22 "Hepatocytes: 301.4" "Cancer enriched" "Detected in some" 184 "liver cancer: 93.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049552, HPA072442" Enhanced NA NA 240000 "HPA049552: AB_2680814, HPA072442: " "unprognostic (4.88e-2)" "unprognostic (2.87e-3)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 612.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 13.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 301.4 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PDYN "ADCA, PENKB, SCA23" ENSG00000101327 Prodynorphin P01213 20 1978757-1994285 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 46.1" "Group enriched" "Detected in some" 83 "Early spermatids: 47.8;Late spermatids: 119.0" "Group enriched" "Detected in some" 29 "glioma: 2.6;ovarian cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 152.2;hypothalamus: 60.7" "Region enhanced" "Detected in many" "basal ganglia: 132.2" "HPA053342, CAB079777" Enhanced Supported "Secreted in brain" NA NA "CAB079777: , HPA053342: AB_2682121" "unprognostic (7.00e-2)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" "unprognostic (3.73e-2)" 0.0 0.0 46.1 0.1 33.3 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 33.5 0.0 0.0 0.0 0.0 2.2 6.1 9.6 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 12.6 0.0 0.0 8.3 6.5 0.2 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 33.3 0.0 44.3 41.3 33.5 2.2 6.1 9.6 4.7 12.6 6.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 119.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffold protein" Q9NUG4 20 32010438-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 142.7" "Cell type enriched" "Detected in some" 5 "Theca cells: 248.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 15.6 5.4 7.1 1.6 6.5 0.0 15.1 9.0 6.9 8.3 4.3 4.4 1.3 9.0 0.6 3.7 7.8 2.5 16.5 5.6 5.4 9.5 2.3 11.9 1.5 6.2 6.0 5.5 3.7 2.7 1.4 4.2 7.9 6.6 5.9 1.1 0.4 3.4 1.8 4.8 3.8 5.4 3.3 5.2 142.7 4.3 1.6 6.5 0.8 10.3 4.9 0.9 6.4 6.4 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.0 0.9 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.1 0.0 0.6 3.2 0.1 0.0 0.0 7.7 0.9 0.2 0.0 0.0 1.1 2.5 0.0 4.8 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 6.5 9.0 6.9 5.6 5.4 6.2 6.0 5.5 6.6 5.2 6.5 6.2 45.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.5 0.6 4.6 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.2 32.1 0.0 0.0 2.9 0.2 0.0 1.0 0.0 0.2 0.0 4.3 24.3 0.0 0.0 3.3 2.4 0.0 0.0 0.3 0.3 0.4 0.0 0.2 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 1.8 0.3 0.6 0.1 0.3 0.0 0.1 248.7 0.0 0.1 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5;salivary gland: 57.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA007951: AB_2667944" "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 6.4 7.2 11.8 3.4 3.8 0.5 7.1 54.5 6.3 4.7 28.0 20.6 2.7 8.3 24.6 9.1 15.1 6.0 18.1 2.2 9.6 3.0 0.3 5.5 1.7 12.4 19.2 1.7 2.1 2.1 0.7 8.3 6.6 19.4 9.7 18.0 15.2 57.9 6.2 2.8 4.2 4.3 9.2 3.8 1.3 14.5 2.4 30.5 4.6 33.0 6.8 2.3 8.3 5.3 13.0 0.0 15.1 7.9 0.0 0.0 0.4 0.1 35.8 9.5 10.9 6.1 3.4 2.6 0.0 0.6 91.4 39.0 0.1 2.3 7.6 14.7 0.0 5.3 3.8 5.7 0.0 1.6 0.0 0.0 2.3 3.0 12.7 45.9 18.7 0.1 0.0 4.3 0.4 77.6 5.0 0.0 0.0 8.8 48.2 10.4 0.0 0.0 0.7 96.9 5.8 25.5 18.4 0.0 23.8 15.1 10.5 19.2 0.2 0.5 11.2 0.9 1.2 14.2 0.0 0.0 0.0 1.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 11.8 3.8 54.5 6.3 2.2 9.6 12.4 19.2 1.7 19.4 3.8 30.5 13.0 37.8 6.4 0.5 60.1 0.3 2.4 3.8 1.5 2.2 82.9 5.7 5.3 72.6 0.0 8.9 5.5 0.0 0.0 4.5 17.9 0.0 0.7 1.4 46.2 4.6 40.4 42.0 0.0 105.9 0.2 0.0 9.0 18.8 53.5 0.0 36.6 1.8 0.0 0.1 164.9 113.8 36.4 14.2 0.0 2.1 1.2 1.5 0.8 7.2 183.6 0.6 2.9 0.0 168.9 2.9 7.1 9.7 20.7 0.2 8.5 2.1 1.2 39.5 6.6 13.1 10.5 36.0 1.5 2.0 0.5 1.0 0.1 1.4 4.8 40.4 2.5 MYL9 "LC20, MLC2, MRLC1, MYRL2" ENSG00000101335 "Myosin light chain 9" P24844 20 36541497-36551447 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 5430.9;urinary bladder: 4211.2" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 860.2;Cardiomyocytes: 1856.1;Peritubular cells: 1891.9;Sertoli cells: 2143.1;Smooth muscle cells: 2525.7;Theca cells: 881.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.2;neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 783.3;BJ: 1047.3;fHDF/TERT166: 844.3;hTERT-RPE1: 645.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 76.1" "HPA039262, HPA045244, HPA059197" Supported NA NA 34000000 "HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" "unprognostic (2.67e-3)" "unprognostic (5.38e-2)" "unprognostic (7.17e-2)" "unprognostic (5.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (9.06e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (7.92e-7)" "unprognostic (1.90e-2)" "unprognostic (8.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.92e-2)" 835.9 956.4 54.6 350.2 61.4 5.2 655.0 55.1 133.3 1088.7 121.0 5430.9 272.9 2921.7 240.3 1009.1 1657.7 367.6 2156.9 52.8 56.1 353.3 117.5 623.3 56.9 65.9 57.0 50.9 723.3 82.7 45.7 91.9 161.7 57.9 2367.3 349.0 23.0 202.4 2269.8 165.7 252.5 1298.7 2126.7 53.6 276.5 1962.9 262.8 56.2 27.6 435.3 112.4 23.4 4211.2 951.6 63.0 79.4 1.3 60.3 1.2 783.3 298.6 264.5 1047.3 450.9 541.3 349.9 612.3 9.1 0.2 535.6 844.3 120.6 29.4 0.2 2.4 125.7 0.9 0.2 16.7 114.4 57.3 500.4 0.4 17.7 420.8 54.4 359.9 1.6 645.9 19.2 0.0 2.4 28.0 461.7 0.2 0.3 7.8 24.0 16.1 5.6 0.4 0.0 5.8 4.6 5.8 0.6 4.1 11.1 26.6 0.6 257.5 232.9 15.6 137.0 510.9 220.1 75.5 1.0 0.8 4.0 2.3 194.3 0.8 0.6 0.0 0.1 2.2 0.0 0.0 0.0 0.9 0.0 0.1 0.3 0.2 0.0 0.0 1.9 0.2 0.0 0.4 0.0 7.2 54.6 61.4 55.1 133.3 52.8 56.1 65.9 57.0 50.9 57.9 53.6 56.2 63.0 325.3 394.2 52.3 0.0 6.6 60.7 320.2 167.1 21.6 1.4 36.8 860.2 1856.1 24.3 50.8 90.1 0.0 37.0 6.3 0.1 27.4 310.3 9.3 13.1 419.9 179.7 0.0 5.7 0.2 116.0 78.3 410.4 10.2 9.3 15.2 234.3 169.9 2.7 32.0 1.7 0.1 1.2 14.2 5.0 76.6 55.4 331.8 111.7 72.9 30.9 19.4 230.4 6.2 0.0 0.5 47.9 2.5 1891.9 6.4 156.9 105.5 42.1 31.8 6.1 2143.1 65.9 2525.7 16.3 9.5 6.5 53.4 26.8 14.7 881.1 2.0 61.9 HCK JTK9 ENSG00000101336 "HCK proto-oncogene, Src family tyrosine kinase" P08631 20 32052197-32101856 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 55.7;lymphoid tissue: 113.0" "Cell type enhanced" "Detected in many" "Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7" "Group enriched" "Detected in all" 16 "dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7" "Group enriched" "Detected in some" 9 "THP-1: 69.3;U-937: 199.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB005195, HPA035534, HPA063768" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118" "unprognostic (6.22e-2)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "unprognostic (7.98e-2)" "unprognostic (8.83e-2)" "unprognostic (5.50e-2)" "unprognostic (4.09e-2)" "unprognostic (1.72e-2)" "unprognostic (4.34e-2)" "unprognostic (1.59e-1)" "unprognostic (4.08e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (4.92e-2)" "unprognostic (4.42e-2)" "unprognostic (6.95e-2)" "unprognostic (1.12e-1)" 25.0 9.3 4.5 100.8 5.9 55.7 6.0 5.6 6.5 5.5 13.8 12.9 15.3 3.1 2.6 6.7 7.7 14.5 4.5 4.5 11.7 4.1 14.2 46.4 38.9 10.1 5.6 3.7 2.5 4.5 2.1 3.1 21.1 7.8 4.1 13.7 0.6 5.1 4.8 1.7 5.8 17.9 25.5 8.5 113.0 6.8 2.4 8.5 14.6 2.9 7.0 39.6 33.1 4.1 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 0.1 0.1 1.3 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 15.6 0.0 0.1 0.1 4.9 0.4 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.7 0.0 69.3 0.0 0.0 0.3 0.0 0.1 1.9 0.3 10.3 0.0 199.6 0.0 6.4 575.0 707.8 1.1 1059.1 1.3 48.4 1.1 1.1 336.3 43.0 1.1 0.9 801.3 11.0 1251.7 30.4 1.2 566.4 4.5 5.9 5.6 6.5 4.5 11.7 10.1 5.6 3.7 7.8 8.5 8.5 9.8 0.6 6.4 14.0 0.0 17.1 3.1 4.0 0.2 0.6 0.1 0.4 1.3 2.0 1.5 3.9 7.3 0.0 0.9 12.1 0.2 1.9 0.1 2.5 0.1 0.1 3.7 1.8 1.7 1.2 0.6 0.9 1.3 4.6 0.1 6.3 0.1 1.1 2.3 150.7 0.0 1.0 0.5 22.4 155.5 89.2 0.3 0.0 170.1 1.8 52.5 222.0 0.0 4.1 1.5 0.6 0.0 0.0 0.0 0.7 0.5 0.1 0.3 1.5 0.1 0.0 0.6 0.5 0.2 0.3 0.2 1.1 1.6 3.0 0.2 0.9 3.7 TM9SF4 "dJ836N17.2, KIAA0255" ENSG00000101337 "Transmembrane 9 superfamily member 4" Q92544 20 32109714-32167258 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064099 Approved NA NA "HPA064099: AB_2685190" "unprognostic (3.10e-2)" "unprognostic (9.03e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.37e-6)" "unprognostic (3.85e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.37e-1)" "unprognostic (3.23e-3)" "unprognostic (1.91e-1)" "unprognostic (6.65e-2)" "unprognostic (7.68e-2)" "unprognostic (6.98e-3)" "unprognostic (7.66e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" 23.7 21.2 15.6 23.6 16.7 16.4 22.9 14.5 19.7 26.7 19.2 32.4 29.9 25.2 30.7 30.6 35.1 22.3 24.7 16.9 17.2 26.8 34.0 24.6 19.1 14.9 16.2 16.5 29.0 30.8 53.0 17.1 39.9 15.9 28.3 37.6 17.8 31.0 27.0 23.5 32.3 29.2 32.1 12.7 23.8 30.0 18.1 17.2 21.2 24.9 24.5 24.4 28.1 23.1 15.8 59.0 41.1 46.1 53.2 88.7 71.9 59.1 47.8 71.9 65.6 63.7 122.2 71.1 41.0 88.2 78.2 102.4 94.8 52.4 101.9 56.4 23.5 29.4 94.4 34.6 93.1 78.3 45.9 52.0 76.2 76.3 49.7 79.6 80.3 59.1 48.3 60.4 74.5 51.8 62.5 46.5 36.4 41.2 71.2 50.0 43.9 65.1 51.4 57.2 41.3 39.0 45.7 88.6 57.7 51.4 61.0 72.4 52.0 48.5 119.2 36.7 63.7 59.1 74.9 65.9 38.2 94.4 149.6 54.6 24.0 48.4 9.9 20.0 50.5 24.8 16.5 17.7 22.9 41.8 13.1 19.4 16.4 11.7 18.8 67.8 13.7 19.1 34.6 15.6 16.7 14.5 19.7 16.9 17.2 14.9 16.2 16.5 15.9 12.7 17.2 15.8 16.4 25.6 25.2 33.0 16.2 7.0 17.4 27.1 17.6 12.2 15.7 16.1 16.0 14.3 36.5 9.2 16.7 29.4 11.9 25.2 1.9 19.0 53.5 18.0 25.2 18.4 13.9 12.4 31.2 18.5 21.7 20.4 23.4 24.9 8.2 19.3 16.8 26.2 24.0 8.4 37.1 31.7 20.3 19.1 10.5 57.5 16.8 22.5 7.2 24.4 25.2 14.0 10.3 28.6 34.8 19.8 25.7 10.9 23.1 22.1 29.8 14.0 32.8 12.3 6.6 19.9 25.8 26.5 9.7 21.8 11.4 37.6 16.8 23.4 27.5 21.9 TLDC2 "C20orf118, dJ132F21.2" ENSG00000101342 "TBC/LysM-associated domain containing 2" A0PJX2 20 36876121-36894235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 10.2;granulocytes: 15.2;Intestinal goblet cells: 4.9;Paneth cells: 11.5;Proximal enterocytes: 20.4;Undifferentiated cells: 7.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.4" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "basophil: 4.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.6" "Cell line enriched" "Detected in some" 6 "HMC-1: 34.7" "Region enriched" "Detected in many" 4 "cerebellum: 5.7" "Low region specificity" "Detected in all" HPA047468 Enhanced NA NA "HPA047468: AB_2680059" "unprognostic (9.06e-3)" "unprognostic (3.35e-4)" "unprognostic (4.60e-1)" "unprognostic (1.07e-3)" "unprognostic (1.40e-1)" "unprognostic (6.51e-3)" "unprognostic (1.09e-3)" "unprognostic (5.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.82e-2)" "unprognostic (3.67e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.97e-5)" "unprognostic (7.25e-2)" "unprognostic (6.20e-2)" "unprognostic (5.59e-2)" "unprognostic (4.87e-2)" 8.6 2.6 0.2 4.7 0.5 1.6 6.6 0.0 1.1 5.1 1.9 11.0 18.4 2.7 0.4 3.2 8.0 2.7 4.9 0.2 0.8 5.8 2.4 11.2 2.9 0.8 0.4 0.0 5.1 4.3 0.0 2.8 0.2 0.9 3.8 12.4 1.4 4.2 0.2 2.0 4.3 17.3 0.7 0.5 8.0 3.6 3.1 0.9 0.0 4.1 0.0 0.1 5.5 5.7 1.9 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 1.6 0.5 0.4 0.2 0.7 0.3 0.4 0.0 0.0 0.0 0.1 0.3 1.3 0.6 4.0 0.0 0.4 34.7 0.1 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.0 6.2 1.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.6 0.3 0.2 0.1 0.0 0.0 0.2 0.1 4.6 0.5 0.0 0.2 0.6 0.2 0.1 0.2 0.1 0.8 0.6 0.5 0.1 0.0 0.8 0.7 0.4 0.4 0.5 0.2 0.5 0.0 1.1 0.2 0.8 0.8 0.4 0.0 0.9 0.5 0.9 1.9 0.1 0.0 1.7 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.7 2.8 0.0 0.0 0.0 0.0 0.4 10.2 0.0 0.5 0.3 0.3 0.1 0.1 3.6 0.8 0.3 0.0 0.0 0.5 1.1 0.3 15.2 0.3 0.0 0.0 0.3 0.0 0.3 4.9 0.0 0.0 0.5 0.4 0.0 0.3 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.5 11.5 0.0 0.1 0.0 20.4 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.4 0.1 7.3 0.0 CRNKL1 "CLF, Clf1, CRN, SYF3" ENSG00000101343 "Crooked neck pre-mRNA splicing factor 1" Q9BZJ0 20 20034368-20056046 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.43e-2)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (4.56e-1)" "unprognostic (2.06e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.06e-6)" "unprognostic (1.18e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-1)" "unprognostic (6.09e-2)" "unprognostic (1.43e-3)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" "unprognostic (2.78e-2)" 8.6 8.4 7.3 9.8 9.2 23.9 16.3 12.2 8.1 11.3 7.1 10.3 10.3 13.1 10.4 10.2 9.8 8.1 9.8 7.0 7.9 12.0 11.3 7.9 12.3 7.8 7.9 6.4 14.9 6.8 15.0 5.9 11.6 8.1 14.1 11.5 9.9 8.3 10.7 16.7 9.1 10.0 11.3 8.2 10.6 10.1 11.4 8.0 14.0 13.0 15.4 12.3 9.8 7.1 12.3 21.2 26.0 20.1 24.2 18.7 19.5 26.9 18.9 18.2 23.9 22.9 17.5 19.6 20.7 14.0 20.0 31.4 29.1 24.1 25.3 29.0 10.5 12.2 20.5 8.0 37.1 15.2 24.6 46.5 15.8 14.5 25.9 15.7 16.9 18.8 23.1 22.0 24.9 22.9 32.5 28.2 18.8 18.4 34.3 26.2 23.8 49.8 28.4 14.2 14.7 30.0 22.0 25.8 42.2 27.2 19.2 35.6 18.5 17.0 18.8 15.1 18.3 21.0 33.7 35.4 22.2 9.4 13.6 16.7 37.2 13.8 32.0 13.8 15.3 16.6 14.8 15.9 15.2 10.8 14.4 14.8 13.2 37.7 22.4 23.7 9.8 17.5 11.7 7.3 9.2 12.2 8.1 7.0 7.9 7.8 7.9 6.4 8.1 8.2 8.0 12.3 20.1 22.4 15.1 6.2 23.3 9.3 8.9 11.7 12.5 11.9 19.6 12.7 19.2 18.6 20.5 14.7 12.5 19.8 32.3 17.0 9.8 22.8 11.7 39.7 37.9 16.9 20.4 24.4 8.1 18.5 17.1 18.3 23.0 40.5 35.5 26.5 15.0 19.6 19.4 16.8 7.7 30.2 12.2 18.4 7.6 5.7 20.2 18.3 3.6 5.6 23.3 17.2 19.6 8.0 10.0 19.7 12.7 18.8 30.3 8.3 17.7 18.3 24.8 16.3 26.3 21.7 20.8 62.5 36.9 18.0 8.9 20.1 25.4 22.0 14.9 13.0 POFUT1 "FUT12, KIAA0180, O-Fuc-T, O-FUT" ENSG00000101346 "Protein O-fucosyltransferase 1" Q9H488 20 32207880-32238658 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 20.9" "Lineage enriched" "Detected in all" 5 "monocytes: 20.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054519, HPA059935" Approved Approved Centrosome "Intracellular and membrane" NA NA 60000 Centrosome "HPA054519: AB_2682515, HPA059935: AB_2684171" "unprognostic (6.61e-2)" "unprognostic (4.10e-3)" "unprognostic (8.83e-2)" "unprognostic (5.51e-3)" "unprognostic (6.90e-2)" "unprognostic (1.62e-1)" "unprognostic (4.65e-1)" "unprognostic (8.51e-2)" "unprognostic (1.84e-1)" "unprognostic (5.57e-2)" "unprognostic (3.01e-1)" "unprognostic (2.19e-1)" "unprognostic (6.76e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.03e-2)" "unprognostic (5.86e-3)" 17.8 10.9 7.7 11.8 8.1 10.6 16.6 7.0 7.3 15.3 8.7 20.2 20.6 15.0 14.5 12.5 20.6 11.5 17.6 7.5 9.0 16.3 31.2 12.3 9.2 9.2 8.1 6.6 20.2 13.9 24.0 9.2 16.5 7.8 14.7 19.3 5.9 13.1 18.3 12.9 13.8 24.2 18.3 7.8 9.5 11.2 9.6 7.8 10.6 19.0 14.1 10.1 14.1 11.0 8.1 47.1 37.2 31.5 34.7 52.9 51.4 58.8 47.8 56.2 78.8 51.3 111.9 62.1 31.7 69.8 53.5 87.2 51.2 30.5 59.0 68.0 16.5 19.2 47.1 32.1 51.2 41.2 41.0 28.9 45.4 45.7 59.7 38.8 33.5 44.6 30.0 36.3 17.6 55.6 23.1 28.4 31.4 16.2 45.2 59.4 23.3 83.6 29.5 24.2 30.7 20.6 26.5 109.5 30.0 41.0 24.0 44.7 48.5 38.8 113.4 42.2 71.8 82.4 21.4 29.3 28.7 68.5 139.9 73.0 4.3 5.4 2.6 3.2 15.1 3.6 3.2 2.8 3.0 4.6 2.6 3.6 2.5 1.0 2.0 20.9 3.4 3.3 4.2 7.7 8.1 7.0 7.3 7.5 9.0 9.2 8.1 6.6 7.8 7.8 7.8 8.1 7.8 9.6 9.5 11.1 5.2 2.9 4.7 8.6 5.2 3.1 7.2 7.1 13.4 8.6 7.9 7.3 2.1 15.2 5.7 17.5 1.9 10.0 0.9 7.1 10.8 9.3 12.0 9.2 9.0 10.4 28.2 12.0 9.2 13.6 5.1 13.1 13.9 39.8 10.7 8.4 9.0 13.4 2.0 8.1 3.8 1.7 10.5 6.5 5.4 6.5 9.3 5.2 3.1 11.1 9.6 9.6 11.9 14.3 8.2 6.7 31.7 5.3 7.2 4.3 13.1 11.1 9.4 2.9 7.3 9.7 1.7 7.7 5.0 26.0 19.0 4.1 SAMHD1 "AGS5, HDDC1, Mg11, MOP-5, SBBI88" ENSG00000101347 "SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" Q9Y3Z3 20 36890229-36951843 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity" "Allosteric enzyme, Hydrolase" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047072 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 91000 Nucleoplasm "Plasma membrane" "HPA047072: AB_2679921" "unprognostic (1.09e-1)" "unprognostic (7.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (4.07e-2)" "unprognostic (2.03e-1)" "unprognostic (3.63e-1)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.44e-1)" "unprognostic (9.06e-2)" "unprognostic (3.18e-2)" "unprognostic (2.72e-2)" 79.5 40.3 12.0 95.2 14.5 11.6 66.3 12.8 13.0 37.6 31.4 52.6 29.7 33.2 9.2 46.3 82.5 40.6 43.3 11.1 20.8 12.1 26.3 68.6 78.6 16.7 14.8 8.9 38.3 42.6 14.1 21.9 36.3 17.5 26.5 29.1 5.5 32.9 18.3 24.0 26.9 55.7 44.6 18.7 95.0 45.3 12.7 16.8 29.6 31.9 20.9 51.6 55.8 40.2 24.6 29.9 10.9 3.7 15.6 510.8 101.8 5.5 10.8 37.7 165.8 187.8 39.1 11.2 64.4 19.9 14.4 94.9 21.2 34.7 27.8 30.9 17.4 20.6 5.3 18.8 30.9 39.3 28.2 5.1 96.4 1.0 45.3 1.9 13.3 26.4 0.0 13.7 18.8 5.4 12.0 0.0 19.2 7.9 18.3 25.9 2.8 21.7 35.3 15.7 8.2 23.0 4.2 20.2 10.2 28.2 4.7 20.5 125.4 13.9 11.5 13.5 25.1 28.5 7.3 20.3 21.7 14.5 3.2 7.1 1.4 147.7 4.8 52.2 174.4 47.0 4.5 55.7 53.3 278.6 3.1 55.5 47.6 18.5 56.2 167.0 96.4 95.8 144.3 12.0 14.5 12.8 13.0 11.1 20.8 16.7 14.8 8.9 17.5 18.7 16.8 24.6 48.7 28.9 25.5 4.2 19.4 6.4 2.3 7.8 5.7 5.5 6.9 5.8 17.3 14.3 35.3 1.8 4.2 2.6 214.2 2.6 0.0 10.3 3.3 173.8 12.7 44.3 6.0 30.7 8.6 10.2 3.3 71.4 13.3 40.6 12.6 10.5 42.5 20.1 137.2 6.7 8.5 5.7 8.2 280.2 52.3 4.8 82.3 326.4 5.4 36.5 257.9 25.1 116.4 14.1 3.5 7.5 31.3 96.3 54.8 1.9 1.1 1.9 104.4 2.9 59.2 9.6 31.9 10.2 4.9 12.1 5.8 2.9 102.6 9.7 5.5 4.9 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537370-9839076 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 13.1;retina: 4.7" "Group enriched" "Detected in some" 4 "Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8" "Cancer enhanced" "Detected in single" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 4.6;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.0 1.9 2.6 0.0 5.6 0.0 0.4 13.1 8.4 0.1 0.0 0.0 0.0 0.2 0.6 0.2 0.0 1.2 0.0 5.7 2.5 0.2 0.7 0.0 0.0 1.1 2.7 4.8 0.0 1.3 0.0 1.3 0.0 4.7 0.4 0.0 4.7 0.3 0.4 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.2 2.6 0.4 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.6 13.1 8.4 5.7 2.5 1.1 2.7 4.8 4.7 0.2 2.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277651-32335011 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved NA NA "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 12.3 14.1 25.9 11.2 26.8 8.6 12.2 19.7 26.0 14.6 31.8 18.8 20.0 11.7 17.6 7.8 20.7 15.0 8.2 30.2 24.4 35.7 17.9 13.0 11.6 22.4 23.4 24.4 13.6 23.2 47.1 17.4 8.6 19.6 11.8 19.2 31.1 11.2 11.0 8.5 7.6 24.3 12.2 23.1 10.0 17.8 22.4 26.2 8.2 19.4 5.7 12.0 11.5 8.6 22.3 49.9 33.2 22.6 29.1 29.3 46.3 23.0 24.2 33.7 28.7 22.4 56.9 26.7 26.7 28.4 45.8 40.8 31.4 29.3 35.8 36.3 12.7 13.3 23.1 25.6 28.2 18.6 19.6 16.9 28.6 25.2 49.5 19.5 23.5 23.7 10.7 14.5 10.4 23.4 22.8 9.1 8.9 12.2 26.5 28.8 8.3 37.1 9.7 29.2 36.1 37.0 31.1 63.2 16.7 24.7 18.9 36.8 15.1 28.9 53.4 36.4 31.4 30.2 17.3 26.5 13.5 53.2 33.7 22.2 0.7 1.5 1.9 3.2 2.2 2.6 3.2 2.4 3.0 0.9 3.1 1.4 2.2 1.6 1.4 3.2 1.5 2.0 1.0 25.9 26.8 19.7 26.0 30.2 24.4 22.4 23.4 24.4 19.6 23.1 26.2 22.3 10.6 22.4 23.4 11.1 12.2 6.6 8.5 12.8 13.6 32.4 14.1 10.7 9.2 40.0 15.0 12.9 106.3 8.1 10.8 67.9 3.9 34.4 67.1 48.5 21.3 16.8 39.4 6.3 31.4 39.1 6.3 14.2 20.9 31.3 8.2 13.7 13.9 28.7 8.1 32.0 37.7 26.3 14.2 7.7 5.5 88.2 13.4 9.0 0.0 8.4 10.9 19.2 8.2 10.1 11.4 32.4 33.4 20.3 16.3 12.1 82.4 23.7 59.1 63.6 0.0 21.0 11.7 33.4 7.4 10.7 5.1 6.6 12.4 17.6 27.3 9.3 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 9.8" "Cell type enhanced" "Detected in many" "Adipocytes: 25.4;Breast myoepithelial cells: 33.9;Early spermatids: 33.9;Late spermatids: 31.4;Spermatocytes: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.5" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 0.8 0.6 2.0 0.3 2.3 1.4 0.8 3.1 3.1 0.6 2.5 0.8 0.2 1.0 4.0 0.5 1.0 0.6 1.2 2.2 2.2 0.7 1.4 0.4 0.5 1.9 2.2 2.3 0.9 0.8 0.4 2.6 0.4 2.2 1.0 0.6 4.0 1.1 0.9 2.5 1.9 0.6 0.9 1.5 0.8 0.5 9.8 2.3 0.7 0.7 2.5 1.0 0.6 0.5 2.4 0.6 0.0 0.9 0.3 1.3 0.6 0.6 0.3 0.2 0.3 0.3 1.3 0.7 1.0 0.2 0.0 0.7 0.6 0.5 0.0 0.5 0.0 0.0 0.7 1.3 0.3 0.4 0.2 0.6 0.3 0.1 0.3 0.0 0.8 0.9 0.7 0.6 0.6 0.0 0.0 0.5 1.6 0.3 0.0 0.3 0.7 0.0 0.2 0.5 0.7 0.5 0.5 0.5 0.0 0.4 0.7 0.0 0.1 1.7 1.0 0.3 0.2 0.1 0.9 0.2 1.0 0.9 0.1 0.9 1.3 0.9 0.5 0.3 0.7 0.2 0.7 0.3 0.4 0.3 0.6 0.2 0.2 4.5 0.1 0.6 1.1 0.2 0.3 2.0 2.3 3.1 3.1 2.2 2.2 1.9 2.2 2.3 2.2 1.5 2.3 2.4 25.4 3.2 0.6 17.3 2.0 0.6 1.1 0.5 1.8 6.2 6.6 33.9 3.0 7.2 0.2 0.0 8.4 3.7 0.7 1.6 0.0 0.3 33.9 2.2 6.5 4.0 1.2 3.2 15.0 0.2 1.1 5.3 6.1 2.6 0.0 11.9 1.8 3.9 2.7 0.0 17.5 1.2 0.0 1.6 1.1 31.4 1.5 3.2 1.8 3.7 1.0 5.8 1.0 7.1 8.5 0.1 1.4 3.0 3.5 0.6 4.0 2.6 1.5 4.9 0.0 1.1 11.7 23.6 5.9 1.5 0.4 1.4 1.5 3.4 1.3 0.4 NOP56 "NOL5A, SCA36" ENSG00000101361 "NOP56 ribonucleoprotein" O00567 20 2652593-2658393 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" Ribonucleoprotein "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049918, CAB075757" Supported Enhanced "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "CAB075757: AB_2665763, HPA049918: AB_2680952" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.59e-7)" "unprognostic (2.63e-2)" "prognostic unfavorable (6.77e-4)" "unprognostic (7.11e-2)" "unprognostic (2.59e-2)" "unprognostic (9.87e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.12e-2)" "unprognostic (2.42e-1)" 41.8 31.6 43.3 43.0 42.9 61.0 37.5 41.6 54.7 31.1 38.4 34.1 29.1 40.3 35.0 37.4 51.1 26.5 31.2 45.9 45.4 29.2 30.8 26.1 53.9 44.1 45.0 42.6 50.2 38.9 27.3 31.7 37.7 45.2 31.4 40.3 21.2 27.4 35.9 43.5 38.7 28.4 52.4 42.2 38.0 26.2 28.5 47.1 52.3 33.7 29.5 62.7 52.9 28.7 49.6 152.8 147.3 108.4 108.0 122.8 89.8 184.2 150.4 97.3 198.3 134.9 204.3 122.2 330.5 82.7 104.2 117.7 253.3 287.5 221.4 196.6 93.5 171.4 195.0 76.0 225.3 125.9 179.4 91.3 123.6 137.2 254.8 260.4 78.2 117.4 153.1 215.7 151.2 138.1 103.1 317.8 214.1 233.8 270.9 180.9 257.2 156.2 188.5 120.8 146.7 115.5 101.1 171.0 193.4 302.8 115.7 167.6 152.7 91.6 170.2 115.9 132.6 227.2 91.9 186.0 274.0 45.9 209.4 128.5 5.1 23.2 18.9 33.0 26.4 41.1 35.8 35.9 36.6 23.6 32.4 34.0 34.0 1.8 33.6 19.8 41.1 33.4 24.8 43.3 42.9 41.6 54.7 45.9 45.4 44.1 45.0 42.6 45.2 42.2 47.1 49.6 75.0 44.8 59.8 14.0 89.3 96.4 103.6 76.4 88.2 39.5 62.9 78.6 39.0 42.9 100.1 23.9 62.6 117.5 132.2 71.8 25.4 78.2 8.0 64.6 100.6 73.3 72.3 93.2 24.6 86.5 124.2 87.5 44.4 48.5 79.1 97.5 52.5 40.9 86.9 50.5 24.1 81.2 54.9 46.8 45.9 14.0 57.2 57.5 30.2 12.2 64.9 32.8 80.3 18.1 21.5 75.6 34.6 54.9 79.6 92.0 38.7 53.8 81.2 37.6 26.3 110.0 141.5 50.3 185.9 89.1 81.7 56.5 102.6 99.4 110.0 58.0 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA052348: AB_2681795" "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavorable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favorable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 49.4 71.1 66.0 23.6 65.2 7.4 52.0 64.6 77.0 67.2 64.3 76.3 35.3 86.8 57.6 64.9 72.2 30.9 42.9 66.3 67.8 58.2 42.4 40.9 16.8 66.5 66.1 62.7 67.4 45.8 50.2 58.0 33.4 66.6 78.0 40.5 28.2 46.3 62.4 24.6 57.5 49.1 65.9 64.4 34.5 60.8 43.1 67.2 22.8 55.6 18.1 25.6 81.9 59.0 64.9 66.0 126.5 63.0 63.9 101.0 73.1 54.5 89.9 93.1 85.1 66.6 150.3 87.4 16.9 104.8 109.8 86.7 88.5 60.3 140.2 57.9 12.7 62.5 17.8 51.3 135.3 109.0 19.1 10.8 80.1 97.8 79.3 130.1 85.4 60.2 22.1 29.1 18.1 86.2 77.3 24.0 25.1 50.4 109.6 117.0 14.4 82.7 19.9 81.6 90.3 60.4 68.9 91.1 135.1 76.3 53.7 91.1 30.2 66.6 155.5 58.1 88.6 70.3 24.0 34.9 14.0 111.8 10.4 82.3 12.3 22.8 33.2 14.9 27.0 17.0 24.3 17.9 18.0 21.0 25.6 21.4 20.9 33.8 21.1 21.4 29.2 12.8 16.7 66.0 65.2 64.6 77.0 66.3 67.8 66.5 66.1 62.7 66.6 64.4 67.2 64.9 19.9 25.6 27.1 10.1 9.5 30.1 87.3 84.2 33.0 22.7 41.3 47.9 19.6 35.8 42.1 44.1 4.2 97.0 9.1 24.7 39.2 74.5 6.6 23.8 26.6 28.5 30.5 2.1 8.6 109.3 133.4 42.6 23.9 20.4 7.6 31.5 28.9 22.5 30.3 20.2 10.7 36.7 50.8 15.1 20.6 8.0 46.9 12.3 46.2 6.5 18.0 71.4 18.6 13.0 8.4 103.2 48.4 68.4 16.8 96.0 40.9 61.1 29.9 15.4 19.7 27.4 38.7 26.4 43.8 36.5 30.4 76.9 8.4 40.7 34.8 124.7 IDH3B RP46 ENSG00000101365 "Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta" O43837 20 2658395-2664219 "Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049387, HPA054180" Supported Enhanced Mitochondria NA NA 8300 Mitochondria "HPA049387: AB_2680740, HPA054180: AB_2682407" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.12e-1)" "unprognostic (2.43e-2)" "unprognostic (3.24e-2)" "unprognostic (6.83e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.76e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "unprognostic (1.39e-2)" "prognostic favorable (6.78e-8)" "unprognostic (8.89e-2)" "unprognostic (4.02e-2)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" 55.2 61.8 50.5 33.7 53.2 58.4 55.1 60.1 57.7 55.0 49.6 70.2 74.6 57.7 36.2 62.9 50.2 29.9 156.3 53.0 56.0 71.6 61.0 44.3 42.2 57.0 54.7 51.9 58.2 46.4 75.9 37.1 41.4 60.1 46.1 60.3 46.5 49.5 43.5 206.0 62.0 60.4 45.1 51.3 53.5 64.2 36.8 54.9 60.0 49.8 238.7 57.0 56.0 53.9 62.8 111.6 147.4 66.0 57.9 71.3 55.9 76.0 58.2 74.0 134.5 106.7 191.4 113.4 124.5 52.2 80.4 123.7 152.7 122.9 189.0 122.6 34.7 96.7 151.2 58.4 200.6 69.7 166.5 31.8 74.4 71.5 125.9 65.7 59.2 80.4 105.6 194.9 67.7 83.0 61.1 146.1 190.4 128.3 113.4 137.9 117.7 120.2 140.2 77.7 102.5 118.5 85.5 71.9 235.0 127.3 50.8 118.1 73.0 72.4 104.2 65.4 35.8 136.3 91.2 225.3 129.8 49.1 169.9 101.2 76.0 111.7 72.2 84.9 120.8 64.5 96.3 72.8 77.7 131.9 84.6 84.6 73.1 31.4 84.8 110.9 61.2 108.1 102.1 50.5 53.2 60.1 57.7 53.0 56.0 57.0 54.7 51.9 60.1 51.3 54.9 62.8 50.7 38.5 28.2 10.4 52.1 56.7 60.2 103.8 48.9 37.9 38.5 38.2 186.0 52.9 49.5 23.9 33.3 133.9 71.3 81.7 156.5 88.5 59.3 28.2 36.0 53.7 50.7 41.6 7.0 102.1 86.3 49.2 37.2 35.9 48.2 54.1 41.7 55.4 97.6 13.5 7.6 68.4 71.2 57.7 60.9 115.1 45.1 51.7 69.4 10.3 78.7 49.3 56.7 6.6 8.9 70.8 72.5 47.4 38.1 37.5 121.7 174.9 33.4 33.4 78.9 50.0 64.1 52.8 55.3 48.4 60.0 108.5 49.1 63.4 113.7 54.3 MAPRE1 EB1 ENSG00000101367 "Microtubule associated protein RP/EB family member 1" Q15691 20 32819954-32850405 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003600, CAB009337, CAB019391" Supported Enhanced "Centriolar satellite,Cytosol" NA NA 11000000 "Centriolar satellite, Cytosol" "CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309" "unprognostic (3.74e-1)" "unprognostic (1.89e-1)" "unprognostic (2.68e-1)" "unprognostic (4.48e-3)" "unprognostic (2.98e-3)" "unprognostic (1.10e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.25e-2)" "unprognostic (1.17e-1)" "unprognostic (7.24e-2)" "unprognostic (5.99e-2)" "unprognostic (6.05e-2)" "unprognostic (3.76e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (5.42e-2)" "unprognostic (4.59e-3)" 67.3 45.0 42.5 70.4 46.3 194.4 48.8 48.0 45.9 46.3 44.2 60.4 40.1 61.6 53.3 63.3 45.2 57.9 58.8 39.2 56.0 54.6 30.6 51.0 76.5 49.6 52.5 36.3 38.1 40.7 38.6 24.5 67.3 49.0 56.5 58.6 16.3 33.0 71.3 34.3 35.0 41.6 92.1 50.3 58.2 44.3 54.9 46.6 88.8 74.7 40.0 69.9 83.9 38.2 50.3 179.7 161.4 176.6 102.0 93.5 84.3 250.7 171.3 106.3 261.0 191.0 470.0 161.9 271.2 167.4 154.8 265.6 159.9 213.1 191.6 283.7 92.4 83.1 523.3 105.0 253.2 98.7 190.6 222.8 91.6 94.1 213.8 141.7 89.3 165.0 151.4 240.0 150.6 232.4 111.0 263.0 166.2 127.6 182.7 147.5 174.4 312.8 145.9 143.0 121.8 109.7 115.3 307.2 134.3 179.4 160.6 194.3 140.0 147.5 291.9 157.7 147.3 224.7 131.5 194.5 289.6 154.9 428.3 166.0 256.8 125.8 262.1 100.1 150.8 104.0 75.1 94.1 92.9 97.4 81.8 94.6 104.3 139.7 111.1 170.6 89.5 107.1 185.6 42.5 46.3 48.0 45.9 39.2 56.0 49.6 52.5 36.3 49.0 50.3 46.6 50.3 71.6 19.2 30.2 8.1 67.0 132.8 194.4 48.1 62.0 11.1 54.7 42.3 36.5 25.8 44.5 55.2 8.4 108.0 82.0 67.6 84.1 68.8 90.2 43.5 44.7 64.8 71.5 52.8 7.8 78.3 130.0 61.4 40.8 60.9 115.4 45.7 39.3 14.9 107.0 10.1 8.5 43.6 36.7 94.6 121.2 76.6 35.8 99.5 71.2 12.2 120.5 36.5 92.7 7.5 12.6 75.0 40.5 64.3 71.1 115.3 32.6 74.3 39.4 11.5 65.7 61.5 102.8 72.1 62.1 65.2 110.8 169.2 89.8 76.6 44.4 123.1 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged canonical Notch ligand 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" NA NA 25000000 "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 37.6 10.2 10.0 13.1 8.5 22.0 30.6 8.3 11.6 40.7 12.0 24.0 13.9 27.5 19.7 52.8 27.3 21.8 20.4 12.4 16.9 21.9 6.2 24.1 8.4 11.8 13.2 8.7 20.5 22.2 21.1 8.2 68.4 9.6 26.1 23.2 22.3 16.0 27.0 9.8 57.0 13.8 23.8 9.5 23.5 25.3 4.5 10.7 9.4 20.0 23.0 15.8 28.7 50.4 10.8 4.1 20.6 63.1 78.1 11.8 11.3 2.3 2.4 11.9 3.3 1.8 18.5 11.2 0.7 59.0 2.4 17.7 85.8 9.4 219.2 2.7 0.2 4.5 7.0 2.2 87.9 5.8 28.4 0.5 4.6 63.7 10.6 131.1 12.5 21.1 0.3 0.1 8.8 6.0 0.2 0.0 20.2 18.2 68.7 20.3 5.3 3.9 13.1 29.9 25.6 2.8 2.1 6.3 4.4 26.2 49.8 0.3 3.3 80.5 14.2 9.9 11.8 187.9 3.6 0.6 0.9 9.1 10.3 11.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 10.0 8.5 8.3 11.6 12.4 16.9 11.8 13.2 8.7 9.6 9.5 10.7 10.8 73.0 41.7 15.4 5.9 1.1 104.6 54.9 76.3 211.1 9.7 13.2 29.1 20.6 30.0 34.4 16.5 43.8 16.9 6.8 64.3 1.9 31.6 5.0 197.4 22.2 102.5 5.3 0.0 6.9 30.4 1.0 41.9 76.0 96.4 7.0 2.7 60.0 1.8 4.2 21.9 9.2 12.8 20.3 5.9 33.9 9.6 21.5 9.1 14.2 22.5 2.8 11.9 2.1 24.6 1.3 97.3 18.3 33.8 4.3 24.5 7.8 2.3 30.2 69.1 85.5 46.7 190.1 0.9 3.2 343.9 106.8 2.2 4.3 107.2 39.1 33.7 CDK5RAP1 "C20orf34, C42, CGI-05, HSPC167" ENSG00000101391 "CDK5 regulatory subunit associated protein 1" Q96SZ6 20 33358839-33401561 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 128.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 116.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066301 Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA066301: AB_2685653" "unprognostic (2.86e-1)" "unprognostic (7.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-3)" "unprognostic (2.25e-1)" "unprognostic (6.49e-2)" "unprognostic (7.68e-3)" "unprognostic (2.18e-2)" "unprognostic (5.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-1)" 8.6 8.5 4.5 10.8 5.3 18.8 10.6 4.5 5.3 8.1 5.4 9.1 9.0 9.9 11.6 9.4 9.3 6.2 12.1 5.4 4.1 9.1 11.2 9.0 12.8 4.1 3.9 5.0 8.7 7.7 11.3 7.2 10.4 4.2 8.5 12.3 16.1 10.7 8.8 21.1 12.7 9.6 10.9 3.4 10.4 9.8 9.4 4.2 11.4 12.1 23.0 15.3 8.8 8.0 5.1 27.0 27.6 18.6 17.1 17.4 13.4 40.7 15.8 22.5 45.0 46.9 116.5 23.9 47.3 21.0 17.2 29.0 39.1 31.8 45.1 34.8 8.9 17.3 57.1 30.8 45.1 20.3 36.6 17.4 17.5 18.9 30.2 35.9 11.4 24.9 13.6 36.7 19.3 20.0 26.6 37.8 27.5 14.1 30.2 40.1 27.8 42.4 36.1 24.5 23.6 25.2 14.3 50.5 24.4 33.0 20.9 34.7 17.4 18.4 33.3 27.3 23.1 27.4 16.6 20.1 34.8 19.8 39.3 15.9 4.5 17.3 11.8 18.5 22.3 22.2 21.4 18.3 18.0 19.1 14.1 16.2 14.0 0.9 21.6 18.4 13.4 17.3 15.1 4.5 5.3 4.5 5.3 5.4 4.1 4.1 3.9 5.0 4.2 3.4 4.2 5.1 13.2 16.0 20.0 26.8 18.6 12.1 10.3 21.1 10.8 25.6 9.3 8.9 15.7 11.5 18.6 7.3 27.1 31.4 18.2 7.4 13.7 17.6 2.9 10.1 10.3 11.4 12.6 12.2 36.7 18.3 18.5 10.4 13.3 14.6 29.8 15.6 6.1 15.6 17.5 11.8 25.4 8.6 128.1 10.1 12.6 2.8 13.1 13.5 10.6 10.3 15.2 16.5 19.6 16.1 26.6 13.0 9.0 10.5 19.3 8.3 13.8 15.3 20.9 39.9 19.7 14.8 15.3 32.6 23.6 8.5 10.4 16.0 22.3 16.1 12.6 8.9 SNTA1 "LQT12, SNT1, TACIP1" ENSG00000101400 "Syntrophin alpha 1" Q13424 20 33407957-33443763 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.9;skeletal muscle: 310.8;tongue: 330.8" "Cell type enhanced" "Detected in many" "Astrocytes: 117.2;Cardiomyocytes: 175.1;Muller glia cells: 83.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 10.4" "Group enriched" "Detected in many" 4 "B-cells: 5.7;dendritic cells: 10.4" "Cell line enhanced" "Detected in many" "ASC diff: 66.5" "Low region specificity" "Detected in all" "CAB037059, HPA067154" Approved NA NA "CAB037059: AB_261497, HPA067154: " "unprognostic (2.25e-2)" "unprognostic (1.29e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (5.68e-2)" "unprognostic (6.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.16e-1)" "prognostic favorable (3.72e-4)" "unprognostic (1.99e-1)" "unprognostic (8.09e-2)" "unprognostic (5.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.29e-2)" "unprognostic (7.60e-2)" 32.9 18.8 143.1 4.6 149.8 2.0 25.8 142.6 199.9 21.3 106.4 18.8 6.7 17.0 8.1 22.9 20.6 7.6 170.0 139.0 127.4 22.7 16.7 8.1 5.9 161.4 143.9 124.8 20.7 13.6 21.1 12.5 3.1 142.3 19.7 3.0 15.2 31.5 18.2 310.8 12.9 13.8 9.4 121.9 5.1 24.0 19.5 153.5 3.4 78.5 330.8 5.2 38.9 17.2 122.4 13.0 6.5 2.9 28.2 66.5 13.0 2.8 9.8 13.6 18.3 15.2 16.9 4.3 9.3 11.6 16.8 33.4 16.9 8.4 5.4 3.2 1.9 10.8 0.5 15.7 23.9 18.8 0.9 1.6 12.0 6.7 8.0 3.0 10.1 2.8 8.8 22.8 3.5 9.3 1.6 17.7 2.2 1.6 1.9 37.2 11.1 20.8 10.3 3.8 11.6 12.3 10.6 38.5 11.5 19.4 2.2 17.8 1.6 4.6 9.0 17.5 36.1 9.2 21.2 11.7 5.6 19.5 1.7 1.4 0.0 0.0 0.0 0.9 0.0 1.9 5.7 0.9 0.9 0.0 2.8 0.3 0.7 0.0 0.0 0.0 10.4 1.1 0.3 143.1 149.8 142.6 199.9 139.0 127.4 161.4 143.9 124.8 142.3 121.9 153.5 122.4 4.6 3.2 2.0 117.2 5.1 3.2 4.7 1.3 1.2 5.7 6.2 8.0 175.1 8.6 1.9 1.8 4.2 1.2 4.9 1.3 39.2 2.0 1.0 1.2 3.7 4.4 4.2 5.7 12.7 2.6 1.9 13.4 5.1 4.1 0.0 10.1 3.9 9.1 1.9 0.0 8.3 1.6 8.2 1.9 2.3 2.3 25.1 1.6 5.4 10.3 0.0 83.7 3.1 5.0 6.3 3.3 1.6 28.2 2.3 5.7 5.4 33.5 0.8 36.5 26.3 12.7 36.7 1.8 4.9 3.5 2.8 0.8 9.3 3.2 1.6 5.6 OXT "OT, OT-NPI, OXT-NPI" ENSG00000101405 "Oxytocin/neurophysin I prepropeptide" P01178 20 3071620-3072517 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "brain: 593.3" "Cell type enhanced" "Detected in many" "Early spermatids: 30.0;Hepatocytes: 41.2;Late spermatids: 66.3;Proximal enterocytes: 15.7;Proximal tubular cells: 36.5" "Cancer enriched" "Detected in some" 5 "testis cancer: 12.1" "Region enriched" "Detected in many" 6 "hypothalamus: 593.3" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;HMC-1: 1.1" "Region enriched" "Detected in many" 6 "hypothalamus: 179.3" "Group enriched" "Detected in some" 903 "basal ganglia: 794.6;hypothalamus: 1854.1" HPA071892 Supported Supported "Secreted to blood" NA NA 1500000 "HPA071892: AB_2732190" "unprognostic (7.45e-3)" "unprognostic (1.99e-2)" "unprognostic (2.66e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-1)" "unprognostic (3.82e-2)" "unprognostic (8.22e-2)" "unprognostic (8.36e-2)" "unprognostic (6.02e-2)" "unprognostic (3.05e-2)" "unprognostic (6.65e-2)" "unprognostic (6.18e-1)" "unprognostic (3.81e-1)" "unprognostic (3.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" 2.1 1.7 94.6 0.0 0.7 0.1 1.8 0.5 0.8 0.8 0.7 0.3 1.0 0.4 0.0 0.2 0.3 0.0 0.5 0.2 593.3 3.0 19.5 0.2 0.1 0.2 0.7 0.3 0.3 0.1 0.0 16.1 0.0 15.1 0.7 0.0 0.0 0.5 0.1 0.2 1.6 1.0 0.0 1.1 0.2 0.2 2.6 17.2 0.0 0.6 0.0 0.0 0.4 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.4 0.2 0.5 2.1 0.8 0.5 0.4 1.6 1.4 1.7 0.5 0.2 0.0 0.7 1.3 0.3 94.6 0.7 0.5 0.8 0.2 593.3 0.2 0.7 0.3 15.1 1.1 17.2 0.2 0.6 0.0 1.8 0.3 3.5 0.8 0.7 0.1 1.2 0.0 1.2 1.7 0.2 0.0 1.3 5.5 0.0 0.0 2.3 0.1 1.9 0.1 30.0 0.2 2.4 0.3 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.5 0.0 0.3 0.0 41.2 0.2 0.0 0.1 1.8 0.0 0.3 1.6 66.3 0.9 0.6 3.6 0.0 0.0 0.0 1.0 0.5 0.0 0.2 1.7 1.2 1.2 0.4 15.7 36.5 0.9 0.0 0.0 1.8 0.7 1.1 7.8 0.3 1.0 0.0 1.1 0.0 2.0 0.3 TTI1 "KIAA0406, smg-10" ENSG00000101407 "TELO2 interacting protein 1" O43156 20 37983007-38033461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034230, HPA068338" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB034230: AB_1564322, HPA068338: AB_2685975" "unprognostic (7.14e-3)" "unprognostic (3.15e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "prognostic unfavorable (2.40e-7)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.49e-2)" "unprognostic (2.36e-1)" "unprognostic (9.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.80e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" 6.9 9.6 6.7 9.2 7.2 8.8 9.0 7.2 8.1 8.4 7.2 7.8 6.3 9.8 9.8 7.4 10.1 6.0 8.1 6.8 7.6 8.6 12.1 7.6 11.9 6.8 6.7 6.8 11.9 14.1 11.1 10.1 11.0 7.0 9.5 10.7 10.1 10.2 11.2 16.1 7.9 7.6 10.0 6.6 9.4 8.8 11.1 6.8 13.9 12.3 10.3 12.9 9.1 7.5 9.8 21.7 31.6 34.3 13.1 13.7 19.0 36.7 24.1 14.1 35.2 29.8 74.3 27.5 35.5 24.5 13.8 39.1 33.7 38.8 50.5 34.5 14.3 15.2 48.9 31.3 38.6 15.5 39.4 22.0 14.6 32.6 35.0 21.1 13.5 26.5 37.1 52.3 23.6 26.9 22.3 53.7 27.3 33.7 33.7 32.9 34.7 55.2 41.6 13.4 23.0 31.1 27.7 36.9 64.5 8.6 35.1 36.6 18.8 17.6 47.0 31.2 25.3 24.9 20.4 19.1 39.5 27.5 25.5 24.8 13.8 8.2 15.0 9.3 9.5 10.4 7.9 7.1 9.2 10.8 7.7 10.5 8.5 5.1 9.6 6.1 5.2 9.9 7.9 6.7 7.2 7.2 8.1 6.8 7.6 6.8 6.7 6.8 7.0 6.6 6.8 9.8 6.1 9.6 11.6 16.3 9.2 3.1 3.6 5.1 4.0 8.5 5.0 5.0 12.3 7.2 8.3 3.7 10.4 15.1 5.9 3.4 1.9 5.7 8.9 5.1 6.8 6.9 3.0 9.9 15.9 3.2 10.7 7.0 5.1 5.2 2.5 16.8 3.3 8.4 5.5 8.4 14.6 4.4 4.1 1.6 2.0 3.9 6.5 5.0 3.6 14.0 7.5 5.9 6.2 15.6 25.4 3.9 5.3 6.8 10.5 6.0 3.9 5.0 15.8 9.1 0.0 5.3 5.5 14.5 12.9 4.2 3.0 14.4 8.9 8.2 6.3 4.4 E2F1 "RBBP3, RBP3" ENSG00000101412 "E2F transcription factor 1" Q01094 20 33675477-33686385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.0;Granulosa cells: 11.4;Spermatogonia: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000329, HPA008003, CAB019308, HPA029735" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176" "unprognostic (7.46e-2)" "prognostic favorable (9.22e-6)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.33e-5)" "unprognostic (1.51e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (1.05e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.62e-4)" "unprognostic (1.91e-1)" 1.8 5.5 8.4 5.7 8.0 34.6 1.7 6.4 9.4 1.4 5.1 3.8 3.3 1.2 0.2 5.8 1.3 0.7 1.2 7.3 7.1 0.9 1.8 3.7 8.8 8.8 7.6 6.6 3.5 1.0 1.3 0.6 2.4 10.2 1.9 4.0 0.8 1.9 0.9 1.6 4.7 4.2 2.9 8.0 5.0 3.7 10.5 7.6 10.8 0.8 0.8 7.0 2.5 2.5 8.8 48.1 45.4 52.0 40.5 5.2 3.6 39.3 45.0 21.4 55.9 46.7 81.1 48.0 87.3 44.2 20.2 67.7 35.4 25.3 23.8 24.8 26.4 36.5 71.6 71.9 47.7 0.4 34.0 43.6 2.8 1.4 30.6 5.4 5.7 14.6 54.4 19.3 60.0 34.9 42.3 72.8 71.6 15.6 47.9 64.6 71.4 140.7 36.2 9.6 28.7 76.7 54.1 54.6 37.6 22.7 14.8 47.3 42.4 7.9 65.0 37.7 45.8 64.8 58.1 42.0 72.6 54.1 20.0 39.3 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.4 1.0 0.1 0.1 0.1 8.4 8.0 6.4 9.4 7.3 7.1 8.8 7.6 6.6 10.2 8.0 7.6 8.8 1.1 0.0 1.1 0.7 3.6 2.9 1.7 0.5 0.0 2.3 3.1 4.3 0.4 0.0 1.4 0.0 0.0 5.0 2.9 2.4 0.0 0.9 1.0 0.3 1.0 1.6 0.0 25.0 1.5 0.2 9.6 3.0 7.7 1.2 0.0 11.4 0.7 0.8 4.4 0.0 0.5 4.6 2.0 0.6 2.1 3.1 2.1 3.1 1.8 1.0 0.1 1.5 1.0 1.0 3.4 0.6 0.5 1.2 9.7 0.5 1.4 0.1 0.2 2.3 0.0 1.0 3.0 7.5 32.9 3.7 1.7 1.8 3.3 1.2 7.0 3.5 RPRD1B "C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60" ENSG00000101413 "Regulation of nuclear pre-mRNA domain containing 1B" Q9NQG5 20 38033725-38127780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066290, HPA070590, HPA072645" Enhanced Supported Nucleoplasm NA NA 28000 Nucleoplasm "HPA066290: AB_2685650, HPA070590: , HPA072645: " "unprognostic (3.14e-2)" "unprognostic (3.30e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (2.68e-2)" "unprognostic (4.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.20e-2)" "unprognostic (1.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (5.77e-2)" "unprognostic (1.36e-2)" "unprognostic (3.47e-1)" 12.9 12.5 8.8 12.4 10.4 35.5 14.3 12.0 10.5 14.3 9.6 12.4 10.3 16.4 12.5 14.6 16.6 10.9 23.8 8.0 12.5 14.6 73.1 12.1 21.9 10.3 9.4 6.6 13.8 12.9 17.4 11.0 12.0 10.1 15.2 12.9 18.2 12.3 12.2 35.1 14.5 13.4 12.8 7.9 13.9 12.5 13.4 9.7 16.4 15.1 26.1 30.0 17.7 12.6 14.0 29.6 14.4 28.4 13.0 18.8 25.2 28.3 21.3 20.4 27.9 23.7 70.7 30.8 27.0 27.5 17.0 26.1 34.2 26.3 40.3 33.3 11.1 13.3 44.1 18.6 39.0 22.6 35.0 13.9 20.1 40.0 27.9 34.0 19.0 17.3 28.8 36.9 20.4 21.6 23.0 49.3 27.5 14.1 37.0 29.6 28.3 56.7 26.7 15.0 27.5 28.0 19.7 38.0 60.0 27.8 18.1 29.7 33.7 17.0 46.0 28.8 18.5 24.8 26.8 26.9 48.1 27.8 21.1 15.3 0.6 5.8 5.8 4.6 6.6 5.7 3.4 4.4 4.1 6.0 3.2 5.5 5.1 4.6 3.9 9.0 2.9 2.9 5.0 8.8 10.4 12.0 10.5 8.0 12.5 10.3 9.4 6.6 10.1 7.9 9.7 14.0 13.6 16.0 21.9 20.5 16.2 15.8 12.0 9.8 13.1 16.4 22.7 16.9 49.3 17.2 11.8 18.4 18.8 14.7 12.8 15.7 15.6 7.6 9.4 11.9 17.9 16.2 23.4 17.4 28.6 8.6 12.4 18.0 16.8 14.8 13.3 18.5 24.3 87.9 12.3 18.5 26.3 20.7 4.1 22.7 9.5 10.3 10.5 18.4 10.6 21.5 9.7 10.3 4.1 30.7 41.1 9.8 11.6 13.2 17.4 23.7 17.1 17.4 22.4 19.1 6.6 19.1 14.7 15.2 12.3 19.1 18.6 15.6 14.8 18.3 14.5 19.8 PXMP4 PMP24 ENSG00000101417 "Peroxisomal membrane protein 4" Q9Y6I8 20 33702758-33720319 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 73.6;Late spermatids: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 42.3;SK-BR-3: 75.8;T-47d: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050077 Approved Approved "Nucleoli fibrillar center,Peroxisomes" NA NA Peroxisomes "Nucleoli fibrillar center" "HPA050077: AB_2681006" "unprognostic (3.41e-2)" "unprognostic (1.11e-1)" "unprognostic (2.59e-1)" "unprognostic (1.75e-1)" "unprognostic (5.08e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-1)" "prognostic favorable (3.88e-4)" "unprognostic (3.53e-1)" "unprognostic (4.47e-2)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.03e-10)" "unprognostic (3.84e-2)" "unprognostic (2.20e-1)" "unprognostic (6.08e-2)" "unprognostic (2.20e-1)" 4.2 11.3 5.1 3.1 5.3 3.3 12.0 3.9 5.5 4.8 4.0 6.3 8.2 4.2 5.2 6.3 6.0 3.3 6.4 4.9 4.0 5.0 9.0 14.0 3.7 4.9 4.5 5.4 6.9 6.8 14.9 3.5 3.2 4.4 8.7 5.8 4.4 15.3 6.5 8.1 11.2 7.4 5.2 4.0 4.7 6.9 2.6 4.5 3.5 11.6 7.0 4.0 5.5 5.9 6.5 2.8 12.1 3.3 11.9 5.7 8.3 8.5 8.7 4.7 6.6 2.9 42.3 13.2 0.1 16.2 7.3 16.1 12.5 9.0 10.1 4.7 3.7 3.4 14.0 9.7 0.1 5.3 0.7 10.3 6.4 10.8 9.0 3.0 3.3 4.3 4.4 7.9 8.6 4.7 26.4 12.9 9.8 0.3 21.7 0.0 6.8 16.3 1.7 4.2 9.0 10.7 5.4 24.2 75.8 7.9 1.9 64.0 4.7 8.2 4.7 5.4 11.9 8.2 5.5 13.2 0.2 9.0 4.6 8.1 2.2 11.1 17.5 10.8 22.2 11.3 7.6 10.9 10.9 8.8 9.9 8.3 11.2 2.9 9.1 34.2 5.3 8.5 8.6 5.1 5.3 3.9 5.5 4.9 4.0 4.9 4.5 5.4 4.4 4.0 4.5 6.5 5.2 19.2 73.6 7.2 5.5 1.7 4.3 9.4 4.0 11.1 16.8 12.3 12.6 7.2 17.8 18.4 14.6 12.9 3.5 14.2 9.8 8.2 28.7 6.3 6.1 7.6 4.2 9.9 6.4 9.9 24.3 8.5 6.6 5.7 3.8 6.7 8.9 36.0 15.1 5.0 5.7 10.8 6.1 7.5 1.6 44.0 10.5 6.2 3.6 6.5 7.5 13.6 9.2 9.0 10.8 8.5 10.3 11.3 7.0 4.5 23.0 11.2 7.8 11.4 6.6 8.8 7.8 4.6 9.8 9.5 2.4 4.4 5.8 16.9 13.0 4.0 CHMP4B "C20orf178, dJ553F4.4, Shax1, SNF7-2, VPS32B" ENSG00000101421 "Charged multivesicular body protein 4B" Q9H444 20 33811348-33854366 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041401, HPA051751" Enhanced NA NA 53000 "HPA041401: AB_10965028, HPA051751: AB_2681591" "unprognostic (2.56e-2)" "unprognostic (6.12e-2)" "unprognostic (1.07e-1)" "unprognostic (9.04e-3)" "unprognostic (9.85e-2)" "unprognostic (8.52e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.49e-1)" "unprognostic (4.37e-2)" "unprognostic (1.24e-2)" "unprognostic (6.44e-3)" "unprognostic (1.31e-1)" "unprognostic (6.09e-2)" "unprognostic (2.31e-1)" "unprognostic (5.50e-2)" "unprognostic (1.20e-2)" "unprognostic (3.33e-2)" 102.9 113.3 99.0 76.5 98.3 215.6 103.0 97.1 113.2 107.2 88.6 155.3 103.9 108.6 59.1 160.3 85.2 81.4 129.4 100.6 99.9 98.4 68.2 102.4 71.3 101.1 98.2 94.3 95.7 82.8 75.4 75.2 75.3 100.2 91.1 99.6 53.7 119.1 83.2 233.2 121.0 120.9 77.0 98.6 83.6 118.3 60.6 99.2 83.5 89.2 133.7 71.8 133.1 107.8 102.2 206.4 131.3 72.3 69.3 118.8 95.2 114.5 120.4 159.1 126.1 117.5 279.1 171.2 98.1 183.3 122.3 192.0 160.8 83.2 182.3 99.2 51.0 89.3 174.1 90.4 189.3 137.5 86.1 88.1 137.2 99.4 116.3 106.6 125.2 141.9 113.1 84.2 139.0 97.8 130.2 189.8 246.5 63.4 226.3 179.8 97.7 147.2 120.7 142.7 234.0 56.4 68.6 225.0 192.2 165.8 85.1 149.0 123.9 129.9 216.8 85.0 108.7 117.9 132.4 101.3 117.0 176.5 91.6 65.8 0.0 1.8 0.8 0.7 1.7 0.9 1.6 1.1 0.8 1.0 1.1 0.8 0.7 2.3 0.5 1.4 4.0 1.4 0.5 99.0 98.3 97.1 113.2 100.6 99.9 101.1 98.2 94.3 100.2 98.6 99.2 102.2 66.0 60.9 54.6 17.9 71.5 298.0 224.4 133.8 113.3 22.5 149.1 64.3 95.9 112.9 148.1 110.3 18.8 197.7 77.9 565.8 144.8 360.9 17.8 81.8 76.1 126.0 127.4 81.6 18.7 497.0 151.2 130.1 112.7 130.6 28.5 22.3 71.7 69.8 215.3 18.5 13.8 212.7 154.6 119.3 383.6 18.8 93.8 140.2 220.5 15.0 289.8 73.6 46.4 10.6 17.4 540.2 536.6 120.7 139.0 426.2 482.1 180.0 101.6 20.9 92.1 79.7 120.5 24.5 29.2 291.0 341.3 440.3 62.9 35.7 227.4 413.2 BPI BPIFD1 ENSG00000101425 "Bactericidal permeability increasing protein" P17213 20 38304150-38337505 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "bone marrow: 1516.9" "Group enriched" "Detected in some" 8 "Early spermatids: 201.8;Late spermatids: 220.6;Proximal tubular cells: 99.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "classical monocyte: 14.5;neutrophil: 7.1" "Group enriched" "Detected in many" 17 "granulocytes: 7.1;monocytes: 14.5" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA061284 Enhanced "Secreted to blood" NA NA 7290000 78000 "HPA061284: AB_2684465" "unprognostic (9.30e-4)" "unprognostic (5.49e-2)" "unprognostic (1.97e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.56e-1)" "unprognostic (4.50e-2)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-1)" "unprognostic (8.83e-6)" "unprognostic (2.66e-4)" "unprognostic (9.29e-2)" "unprognostic (2.32e-2)" "unprognostic (9.47e-3)" 0.4 0.2 0.1 0.1 0.2 1516.9 0.7 0.1 0.4 2.5 0.4 0.2 0.0 0.7 1.0 0.1 0.4 0.5 0.5 0.1 0.1 3.4 0.8 3.7 0.3 0.2 0.2 0.1 1.8 0.0 0.0 0.6 0.6 0.2 0.4 0.0 0.0 1.4 1.2 0.1 1.8 0.1 0.2 0.2 13.1 0.1 17.2 0.2 3.8 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.1 0.0 0.6 0.0 0.0 9.8 0.1 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 1.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.0 0.4 3.7 0.0 0.0 0.0 0.0 9.8 0.0 201.8 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 20.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 220.6 17.7 1.3 1.8 0.0 7.1 0.0 1.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 99.7 0.3 0.0 0.0 0.2 0.4 2.1 1.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 CST9L "bA218C14.1, CTES7B" ENSG00000101435 "Cystatin 9 like" Q9H4G1 20 23564732-23568484 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 337 "epididymis: 26.6;testis: 88.7" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Late spermatids: 13.2;Leydig cells: 2.5;Peritubular cells: 1.5;Spermatocytes: 1.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 2.1" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724486-38729372 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 35.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.7;Horizontal cells: 58.9;Inhibitory neurons: 20.7" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 0.0 0.0 11.8 0.0 35.1 0.2 0.0 3.5 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.0 0.0 0.0 0.0 0.0 14.4 5.5 6.8 0.0 0.0 0.0 7.6 0.0 8.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.8 35.1 3.5 18.8 2.3 24.0 14.4 5.5 6.8 8.8 5.0 8.6 3.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 14.7 0.0 0.0 0.4 0.0 0.1 0.0 4.2 0.0 1.3 0.0 0.0 0.0 2.5 0.2 0.0 0.4 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.9 20.7 0.0 0.0 0.0 0.4 0.6 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.0 0.0 0.1 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST3 ENSG00000101439 "Cystatin C" P01034 20 23626706-23638473 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 4252.1" "Cell type enriched" "Detected in all" 4 "Langerhans cells: 18746.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4" "Group enriched" "Detected in all" 9 "dendritic cells: 7959.0;monocytes: 6424.5" "Cell line enhanced" "Detected in many" "ASC diff: 1733.4;ASC TERT1: 1179.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000118, HPA013143" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1040000000 2800000000 "Golgi apparatus, Vesicles" "CAB000118: , HPA013143: AB_1847417" "unprognostic (3.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.53e-2)" "unprognostic (4.06e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.46e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-3)" "unprognostic (3.51e-2)" "unprognostic (1.85e-1)" "unprognostic (1.16e-1)" "unprognostic (2.97e-1)" "unprognostic (5.01e-2)" "prognostic favorable (8.77e-4)" 1020.0 713.4 2674.6 264.7 2597.5 172.2 908.0 2549.1 4252.1 571.0 2576.7 745.5 393.1 714.2 883.6 561.6 809.7 588.3 1151.6 2598.4 2545.6 515.2 840.5 601.0 467.4 2816.0 2595.9 2125.6 580.6 952.1 322.7 675.3 167.3 2567.8 780.5 420.8 47.3 2025.7 445.6 755.1 492.3 807.0 370.8 2560.5 729.6 988.0 767.2 2942.4 422.8 664.3 522.0 209.8 708.9 623.7 2490.1 155.2 328.2 75.4 175.8 1733.4 1179.8 145.3 261.4 350.7 170.3 137.7 625.1 219.7 0.8 241.0 345.2 221.3 496.2 69.6 499.9 51.9 0.9 253.5 157.6 61.1 1082.9 621.2 7.5 251.0 919.0 415.9 226.6 241.5 352.5 268.5 18.5 147.6 4.0 239.5 234.4 1.5 162.2 103.5 461.9 752.2 5.7 96.4 215.2 708.0 328.3 84.7 98.2 191.1 54.6 343.3 107.7 156.5 548.2 702.0 163.4 119.0 231.6 97.7 157.1 6.2 1.8 138.0 339.5 184.0 48.1 4967.5 33.2 66.9 6424.5 25.5 23.1 18.3 45.8 7959.0 13.6 16.9 31.1 809.3 191.4 4297.7 4427.4 13.6 4250.8 2674.6 2597.5 2549.1 4252.1 2598.4 2545.6 2816.0 2595.9 2125.6 2567.8 2560.5 2942.4 2490.1 662.4 115.4 168.8 849.5 93.8 942.9 571.1 568.2 213.9 152.4 660.2 512.1 240.7 1361.2 514.5 641.9 29.2 476.8 603.3 1889.9 414.8 489.9 46.2 441.1 795.0 728.2 882.1 252.1 4.5 783.6 308.7 3026.2 981.7 631.0 359.9 687.0 491.9 2563.0 1816.7 48.8 11.2 1360.6 691.7 4301.1 18746.6 184.3 2132.6 4542.6 1563.5 87.1 2025.6 248.7 99.9 263.9 6.0 1458.5 2342.1 1790.4 67.9 786.0 4301.1 1098.6 364.4 36.3 2195.7 1417.0 846.2 125.5 400.6 461.5 822.0 469.0 117.4 208.1 1039.4 1079.7 ASIP "AGTIL, ASP" ENSG00000101440 "Agouti signaling protein" P42127 20 34194569-34269344 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 14.9;heart muscle: 15.9;ovary: 42.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 27.4;dendritic cells: 44.1;Hofbauer cells: 15.1;Leydig cells: 12.5;Peritubular cells: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 356 "plasmacytoid DC: 134.8" "Lineage enriched" "Detected in single" 356 "dendritic cells: 134.8" "Cell line enhanced" "Detected in some" "CACO-2: 3.2;HSkMC: 2.4;SK-MEL-30: 1.9;U-698: 1.9" "Not detected" "Not detected" HPA048636 Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA048636: AB_2680471" "unprognostic (4.81e-2)" "unprognostic (7.46e-2)" "unprognostic (1.97e-3)" "unprognostic (3.26e-2)" "unprognostic (2.24e-1)" "unprognostic (3.07e-2)" "unprognostic (5.13e-2)" "unprognostic (4.57e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (5.53e-6)" "unprognostic (1.02e-1)" "unprognostic (3.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" 1.1 0.6 0.3 0.0 0.3 0.3 2.4 0.1 0.5 3.4 0.0 0.5 0.0 2.0 14.9 0.1 4.1 0.1 15.9 0.2 0.1 0.9 1.3 0.3 0.4 0.4 0.1 0.1 42.0 0.1 0.0 0.6 0.2 0.6 1.5 0.0 0.3 0.7 0.2 0.9 5.7 0.8 0.0 0.0 0.3 0.3 1.5 0.2 0.2 0.3 1.2 0.5 0.5 1.1 0.4 0.0 1.1 0.4 0.4 0.2 0.7 0.1 0.1 0.0 0.0 0.0 3.2 0.0 1.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.7 0.3 0.5 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.1 0.0 0.7 0.6 0.9 0.0 0.3 0.2 1.7 0.0 0.1 0.6 0.3 0.3 1.4 0.0 0.1 0.2 0.2 0.0 0.2 1.9 0.5 0.3 0.2 0.3 0.5 0.5 0.0 0.3 0.4 0.4 1.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 134.8 0.0 0.6 0.3 0.3 0.1 0.5 0.2 0.1 0.4 0.1 0.1 0.6 0.0 0.2 0.4 0.4 0.0 0.6 1.3 0.8 2.5 0.0 0.0 0.0 0.0 0.3 0.5 27.4 0.0 0.0 0.0 0.0 0.2 44.1 0.0 1.9 0.0 1.1 0.3 9.2 1.2 0.0 0.0 2.1 0.0 0.2 5.6 0.0 0.4 0.0 0.2 2.5 5.8 15.1 0.0 1.8 0.0 0.0 0.8 7.0 1.7 12.5 2.1 1.8 1.0 0.3 0.0 0.0 2.5 2.5 0.1 0.0 10.5 0.0 0.1 0.0 8.3 0.0 0.0 6.6 0.1 0.6 1.7 1.9 0.2 3.1 0.8 0.6 1.0 0.0 0.1 CST4 ENSG00000101441 "Cystatin S" P01036 20 23685640-23689038 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 514 "salivary gland: 29298.9" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 1.7;Collecting duct cells: 9.2;Glandular and luminal cells: 3.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 5.5;RT4: 13.6" "HPA043706, HPA044763" Supported "Secreted to digestive system" NA NA 2800000 "HPA043706: AB_2678627, HPA044763: AB_2679080" "unprognostic (2.80e-1)" "unprognostic (7.88e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (1.00e-2)" "unprognostic (9.52e-2)" "unprognostic (2.11e-2)" "unprognostic (2.31e-1)" "unprognostic (7.95e-2)" "prognostic favorable (2.88e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 56.9 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 30.2 0.0 0.0 3.8 0.0 2.4 0.0 0.0 29298.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 13.6 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ACTR5 "Arp5, FLJ12785, INO80M" ENSG00000101442 "Actin related protein 5" Q9H9F9 20 38748460-38772520 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042676 Approved NA NA "HPA042676: AB_2678110" "unprognostic (1.76e-1)" "unprognostic (4.89e-2)" "unprognostic (6.33e-2)" "unprognostic (8.45e-3)" "unprognostic (1.10e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (2.51e-1)" "unprognostic (2.93e-2)" "unprognostic (1.13e-1)" "unprognostic (5.00e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.83e-2)" "unprognostic (3.15e-1)" "unprognostic (2.01e-1)" "unprognostic (5.95e-2)" 6.1 4.5 5.3 5.5 5.8 10.4 6.6 5.7 6.0 8.1 4.6 5.8 4.9 6.6 3.9 7.5 6.9 3.2 4.6 5.5 5.3 5.3 6.8 5.4 8.0 5.1 5.0 5.9 9.0 6.3 3.7 5.9 3.6 5.3 6.2 4.9 6.0 5.8 3.7 7.2 8.7 7.3 4.6 4.9 8.8 5.4 12.9 5.2 5.4 5.7 2.8 6.6 6.4 7.5 6.9 8.8 12.3 8.4 6.8 4.7 4.6 11.3 4.6 4.6 9.2 6.8 33.5 12.1 18.2 8.2 4.5 17.8 13.9 14.6 13.1 8.9 5.3 7.6 13.7 7.6 19.8 6.4 9.5 11.3 4.2 19.0 9.5 7.3 3.9 9.2 8.5 12.8 13.8 6.0 9.4 19.7 12.9 6.8 20.5 24.1 12.5 15.8 10.7 7.9 5.9 8.4 13.6 17.8 22.3 10.9 8.5 13.8 6.9 5.9 13.7 12.3 12.7 9.7 10.1 12.2 14.7 8.3 9.1 7.8 1.6 7.7 5.0 12.1 10.1 11.4 9.8 9.2 9.0 10.9 9.7 7.2 7.8 1.0 9.4 6.3 6.8 7.7 6.6 5.3 5.8 5.7 6.0 5.5 5.3 5.1 5.0 5.9 5.3 4.9 5.2 6.9 4.9 3.2 6.3 4.6 6.9 3.7 3.3 5.0 8.6 4.2 3.0 3.2 2.2 4.3 4.7 1.8 4.2 4.3 10.8 3.5 1.9 5.5 6.2 2.3 3.7 4.5 7.8 7.0 6.7 5.5 6.1 4.3 4.1 2.6 0.0 4.2 5.7 3.6 4.3 1.7 8.6 4.9 2.0 1.9 3.5 1.4 3.7 3.8 5.4 8.4 3.5 3.2 5.2 6.0 9.5 3.5 3.1 6.0 5.8 2.3 2.3 3.2 2.2 5.1 0.0 3.5 4.8 24.4 15.6 4.5 3.7 1.9 8.6 3.8 4.1 1.6 WFDC2 "dJ461P17.6, EDDM4, HE4, WAP5" ENSG00000101443 "WAP four-disulfide core domain 2" Q14508 20 45469753-45481532 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 5255.3;salivary gland: 2005.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 4507.8;Club cells: 6299.8;Collecting duct cells: 1988.1;Endometrial ciliated cells: 3253.3;Glandular and luminal cells: 4817.5;Respiratory ciliated cells: 2935.3;Urothelial cells: 3783.3" "Group enriched" "Detected in all" 4 "endometrial cancer: 1815.6;ovarian cancer: 1086.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "A-431: 115.8;CAPAN-2: 210.6;EFO-21: 171.3;HaCaT: 151.9;RPTEC TERT1: 165.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042302 Enhanced "Secreted in other tissues" NA NA 1600000 "HPA042302: AB_2677939" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (4.37e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (7.19e-3)" "unprognostic (1.94e-1)" "unprognostic (5.49e-3)" "unprognostic (3.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.42e-1)" "unprognostic (1.40e-1)" "prognostic favorable (4.44e-5)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" "unprognostic (3.20e-2)" 11.8 1.6 6.6 11.1 12.0 0.0 81.9 6.2 9.4 5255.3 18.8 165.2 9.7 242.3 950.2 55.3 682.5 167.6 3.9 6.8 7.2 907.9 23.8 145.9 0.9 7.3 7.4 6.6 10.5 30.7 82.6 153.5 0.7 7.0 223.6 227.0 6.9 2005.6 832.7 2.0 30.9 60.6 29.2 6.4 0.7 44.5 15.0 7.1 12.4 255.9 0.5 8.9 162.5 25.2 6.9 115.8 0.0 0.3 0.4 0.0 0.1 4.7 0.0 0.0 0.0 0.0 4.9 210.6 0.0 171.3 0.0 0.7 151.9 0.0 0.0 0.0 0.8 1.9 0.0 1.2 0.3 0.0 0.2 0.7 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 6.7 0.3 2.7 18.4 0.6 0.0 0.1 0.0 0.0 165.6 1.3 5.0 1.0 10.6 0.0 1.1 2.0 3.1 0.6 0.0 0.3 2.8 0.6 0.5 0.7 0.6 1.6 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 12.0 6.2 9.4 6.8 7.2 7.3 7.4 6.6 7.0 6.4 7.1 6.9 2.8 169.9 273.8 2.6 4.2 8.9 1190.9 4507.8 35.3 30.3 340.4 238.5 2.0 94.4 6299.8 1988.1 22.9 1.0 4.3 239.8 221.1 308.2 1.6 3253.3 359.3 21.7 422.7 0.0 4.7 129.2 0.8 23.4 31.6 4817.5 10.1 12.5 3.9 3.3 1.9 0.0 7.6 1764.7 1328.5 0.6 1.1 5.0 36.1 26.8 10.6 1.9 5.7 31.3 0.0 2.0 3.4 179.0 424.6 0.0 0.8 1169.7 1.7 113.9 2935.3 6.1 6.6 1.1 319.1 12.4 11.9 110.2 14.1 0.7 36.8 0.0 318.2 3783.3 AHCY SAHH ENSG00000101444 Adenosylhomocysteinase P23526 20 34280268-34311802 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 275.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041225, HPA044675" Approved Supported Cytosol NA NA 5000000 Cytosol "HPA041225: AB_2677371, HPA044675: AB_2679041" "unprognostic (3.35e-1)" "unprognostic (2.17e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-2)" "unprognostic (7.74e-2)" "unprognostic (3.15e-2)" "unprognostic (7.34e-3)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (2.61e-1)" "unprognostic (4.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.27e-2)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.88e-1)" "unprognostic (2.93e-3)" 40.4 57.2 39.5 34.6 40.8 59.8 71.7 41.6 40.4 69.8 44.0 62.4 73.4 56.2 66.2 142.0 76.4 31.4 60.5 38.8 42.3 157.0 189.0 41.9 45.8 42.3 42.0 37.0 117.4 162.8 66.0 45.7 39.8 43.3 84.7 58.6 24.8 58.2 50.0 110.2 49.9 55.3 44.0 44.6 40.2 76.4 82.6 42.2 52.2 96.0 64.1 56.4 59.8 67.5 45.4 270.8 345.9 143.6 254.7 163.6 174.8 164.4 108.1 153.9 235.5 186.1 942.0 226.2 417.0 188.0 139.4 152.0 301.2 340.7 606.4 150.3 55.6 207.6 503.9 157.3 612.7 175.5 238.1 158.3 364.1 271.2 146.9 233.8 125.9 162.9 152.0 250.1 102.7 126.8 285.2 313.3 224.2 185.0 343.0 332.7 231.8 364.6 294.1 212.7 188.3 247.8 164.8 216.1 252.6 364.5 112.8 380.3 217.9 104.5 203.3 215.5 104.1 207.6 151.7 239.0 252.3 150.2 144.4 111.3 9.0 32.9 1.0 8.9 60.7 15.0 20.5 13.0 11.5 48.8 19.4 13.8 16.1 2.7 11.6 40.8 55.1 16.4 28.2 39.5 40.8 41.6 40.4 38.8 42.3 42.3 42.0 37.0 43.3 44.6 42.2 45.4 13.2 41.7 23.2 5.5 35.3 36.7 88.2 106.1 68.9 11.7 77.6 82.0 47.8 44.3 43.2 27.6 0.0 109.0 31.4 36.6 58.7 73.5 76.5 30.9 110.6 27.1 21.0 60.8 9.0 82.4 165.3 35.6 83.6 42.8 21.0 42.8 19.6 70.4 115.7 11.8 8.4 73.5 30.5 52.2 32.4 187.4 42.6 34.5 26.6 2.8 26.4 42.4 5.2 5.0 16.4 60.4 41.2 40.6 66.2 95.8 51.4 275.0 17.9 15.2 13.1 27.8 34.6 43.5 45.3 100.8 39.5 91.9 19.8 84.3 117.1 82.6 PPP1R16B "ANKRD4, KIAA0823, TIMAP" ENSG00000101445 "Protein phosphatase 1 regulatory subunit 16B" Q96T49 20 38805697-38923024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;lymphoid tissue: 42.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 119.4;Inhibitory neurons: 46.8;Oligodendrocyte precursor cells: 49.8;Oligodendrocytes: 238.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 57.3;HMC-1: 59.2;HUVEC TERT2: 35.6;U-266/70: 96.7;U-266/84: 41.8;U-698: 38.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049571, HPA079512" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA049571: , HPA079512: " "unprognostic (2.62e-2)" "prognostic favorable (2.11e-4)" "unprognostic (2.67e-3)" "unprognostic (3.35e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.87e-5)" "unprognostic (1.13e-1)" "unprognostic (4.17e-2)" "unprognostic (4.31e-2)" "unprognostic (6.28e-2)" "unprognostic (4.09e-3)" "unprognostic (4.77e-2)" "unprognostic (3.45e-2)" "unprognostic (8.53e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.90e-2)" 13.3 2.9 38.9 19.5 67.7 17.9 8.3 31.0 64.8 3.3 14.2 4.7 3.6 3.4 1.5 3.2 5.9 5.4 5.2 52.7 33.6 28.0 2.4 8.0 38.0 36.7 40.4 49.1 1.1 1.5 0.8 2.2 3.7 41.4 1.6 5.1 3.8 2.0 1.9 3.7 1.5 18.2 7.2 28.3 18.2 5.7 0.7 35.4 18.4 3.4 5.7 42.3 6.0 1.6 56.5 0.1 0.7 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 57.3 0.8 0.0 0.9 0.1 1.0 0.1 0.0 1.4 0.2 4.4 0.0 0.0 0.0 0.2 59.2 0.0 0.1 0.0 0.0 0.0 35.6 7.6 1.0 11.9 0.0 0.0 7.4 9.7 7.9 0.1 0.0 5.0 0.0 0.0 0.0 0.0 17.7 19.7 0.0 0.0 0.0 0.7 0.0 3.1 5.5 0.0 0.9 0.0 0.0 96.7 41.8 38.3 0.0 0.0 0.1 0.0 0.2 2.5 3.4 0.5 1.8 5.3 2.3 3.3 0.7 3.3 1.3 1.8 0.0 2.9 0.9 3.3 2.6 1.1 38.9 67.7 31.0 64.8 52.7 33.6 36.7 40.4 49.1 41.4 28.3 35.4 56.5 29.3 3.2 3.0 1.3 33.6 1.0 0.0 0.8 0.6 2.3 0.5 0.5 23.5 1.5 4.0 0.0 0.0 0.0 34.0 0.3 0.0 0.0 1.9 0.2 0.2 18.7 0.0 2.7 119.4 0.0 0.0 1.6 4.1 0.3 3.8 0.0 38.6 0.3 0.1 37.0 46.8 0.1 0.0 3.1 3.6 1.5 0.0 3.8 8.8 23.4 20.5 0.3 11.3 49.8 238.0 0.0 0.1 0.0 29.3 0.0 0.0 17.4 3.6 0.3 0.0 0.3 1.0 0.0 0.3 0.3 1.3 0.0 37.4 0.0 0.2 0.3 SPINT3 HKIB9 ENSG00000101446 "Serine peptidase inhibitor, Kunitz type 3" P49223 20 45512461-45515622 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "epididymis: 4.8;seminal vesicle: 10.8" "Group enriched" "Detected in some" 4 "Basal prostatic cells: 1.5;Endometrial ciliated cells: 1.4;Glandular and luminal cells: 4.0;Suprabasal keratinocytes: 2.3;Urothelial cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026852 Enhanced "Secreted in male reproductive system" NA NA "HPA026852: AB_2732434" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.4 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 85.3;intestine: 61.7;smooth muscle: 96.2" "Group enriched" "Detected in many" 4 "Basal squamous epithelial cells: 44.9;Erythroid cells: 72.6;Extravillous trophoblasts: 67.5;Squamous epithelial cells: 71.7;Syncytiotrophoblasts: 152.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.1;NK-cells: 1.1;T-cells: 2.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 1.1 1.8 0.7 7.3 1.5 23.5 1.1 1.1 1.5 2.1 0.5 61.7 8.5 1.0 1.6 85.3 1.0 13.7 1.0 1.1 0.7 5.7 3.7 5.2 4.5 0.8 0.7 0.9 0.5 0.4 0.2 0.4 3.4 1.0 16.3 8.7 0.2 7.9 1.7 0.2 10.3 35.0 96.2 0.7 2.0 45.3 5.1 0.7 6.7 1.0 0.2 12.3 27.2 17.3 1.1 112.2 67.3 52.0 44.0 5.8 6.5 93.6 49.3 30.2 94.7 57.4 103.4 49.7 28.3 47.6 32.1 73.4 93.1 71.8 83.9 87.9 9.4 28.6 32.6 50.7 75.2 4.7 14.6 16.5 3.3 4.2 54.6 31.4 11.4 52.7 12.3 29.6 39.5 54.4 59.7 22.7 21.3 43.2 64.4 85.1 21.8 96.0 15.6 27.6 28.0 24.3 40.2 143.0 117.4 20.6 48.1 73.6 14.9 25.4 62.4 76.4 71.6 110.1 12.0 19.6 29.0 28.1 21.2 46.7 0.0 0.0 0.0 0.2 0.1 0.9 0.6 1.0 1.1 0.0 1.1 1.1 1.4 0.0 1.1 0.1 0.0 2.0 0.5 0.7 1.5 1.1 1.5 1.1 0.7 0.8 0.7 0.9 1.0 0.7 0.7 1.1 3.9 0.0 1.3 0.3 2.3 2.3 5.8 7.0 44.9 0.0 2.8 9.0 0.8 1.5 18.0 0.0 0.0 17.3 6.3 6.5 0.0 0.1 0.5 1.1 1.6 2.2 1.8 72.6 3.7 0.0 67.5 2.7 18.3 2.1 0.0 8.2 1.8 5.7 4.8 0.0 1.2 6.0 4.1 1.6 0.5 0.6 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 6.0 0.0 12.5 1.6 1.7 8.3 4.5 0.0 19.7 0.3 4.0 15.7 18.3 71.7 1.8 152.6 5.2 0.3 10.2 4.1 EPPIN "CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7" ENSG00000101448 "Epididymal peptidase inhibitor" O95925 20 45540626-45547752 "Predicted intracellular proteins, Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 75 "epididymis: 330.8;testis: 84.9" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 30.0;Granulosa cells: 13.6;Late spermatids: 29.2;Respiratory ciliated cells: 32.5;Sertoli cells: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8;U-87 MG: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067335 Supported "Secreted in male reproductive system" NA NA "HPA067335: " "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.08e-3)" "unprognostic (1.06e-2)" "unprognostic (3.75e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (2.00e-2)" 0.3 0.3 0.5 0.3 1.3 2.4 0.2 1.9 2.7 0.3 0.1 0.4 0.7 0.7 330.8 0.3 1.3 0.2 0.1 1.2 0.2 0.2 2.3 0.4 0.5 0.5 0.3 0.8 0.2 0.1 0.0 0.0 0.2 1.0 0.2 0.5 1.2 0.3 0.8 0.2 0.8 0.7 0.1 0.0 0.4 0.2 84.9 0.3 0.0 0.7 0.0 0.2 0.1 0.0 2.3 0.8 0.1 0.3 0.3 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.6 0.3 0.1 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.6 1.8 0.0 0.4 0.2 0.7 0.8 0.1 0.2 0.7 0.2 0.5 0.1 0.2 0.3 0.5 0.3 0.1 0.3 0.3 0.4 0.4 0.7 0.7 0.6 0.9 0.5 0.6 0.8 0.3 2.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.9 2.7 1.2 0.2 0.5 0.3 0.8 1.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.1 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 30.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 29.2 4.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 32.5 0.0 13.1 0.0 0.4 5.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" No No "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: AB_2682491, HPA062700: AB_2684838" "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 6.1 4.2 4.5 4.6 4.9 9.9 6.1 4.5 5.2 9.2 3.5 13.3 6.3 11.3 8.1 8.2 8.5 5.6 9.6 4.6 4.2 6.1 4.8 5.3 6.8 4.4 4.4 4.2 8.0 3.7 7.1 3.8 5.3 4.5 8.2 8.7 6.1 5.2 7.3 8.3 7.0 7.9 8.1 4.1 4.8 8.0 6.6 4.4 6.5 5.2 6.3 5.4 12.0 7.1 5.3 10.3 8.4 15.9 6.6 6.0 7.8 11.3 6.0 10.3 13.5 9.9 29.1 9.0 11.4 10.4 11.4 10.4 16.0 11.0 17.5 13.2 2.9 5.2 15.4 14.3 16.7 7.2 18.4 7.7 9.0 11.3 11.7 10.9 8.3 6.1 19.4 16.0 6.5 7.2 8.2 30.0 14.0 9.1 18.5 13.5 14.5 23.2 9.5 5.0 11.8 13.9 11.1 16.4 9.6 15.4 9.9 13.3 14.7 6.0 19.1 10.6 7.8 12.6 6.5 9.2 12.3 10.9 8.2 10.4 0.0 3.0 1.2 2.9 2.7 2.9 2.5 2.4 3.1 4.0 2.9 4.5 2.4 0.6 3.9 2.4 1.4 1.7 2.9 4.5 4.9 4.5 5.2 4.6 4.2 4.4 4.4 4.2 4.5 4.1 4.4 5.3 5.4 0.0 3.7 16.0 3.8 0.5 1.4 2.2 7.4 5.1 2.3 3.0 6.7 4.3 4.8 1.8 4.2 3.7 4.1 4.2 1.9 2.4 3.7 2.5 6.6 3.8 5.4 5.5 23.5 1.1 2.4 3.8 7.7 3.2 8.2 6.1 5.7 7.0 5.0 5.0 21.5 6.3 4.1 4.7 4.0 0.8 6.2 3.3 3.6 14.0 3.6 3.3 6.2 22.6 24.8 2.0 5.8 6.4 4.9 2.7 4.6 2.2 4.3 4.7 0.0 4.7 3.9 1.9 9.4 4.5 2.0 3.0 4.5 4.9 5.4 1.1 DNTTIP1 "C20orf167, dJ447F3.4, Tdif1" ENSG00000101457 "Deoxynucleotidyltransferase terminal interacting protein 1" Q9H147 20 45791954-45811427 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 124.8" "Group enriched" "Detected in all" 6 "dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9" "Cell line enhanced" "Detected in all" "PC-3: 280.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045496 Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA045496: " "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (4.52e-2)" "unprognostic (2.50e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (6.29e-2)" "unprognostic (7.16e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-3)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.18e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" 19.1 19.6 22.6 25.0 22.7 44.5 20.1 22.9 26.3 20.6 23.5 31.9 17.7 27.5 25.2 19.7 24.9 21.9 27.5 22.5 27.8 19.2 19.5 22.5 23.9 22.7 23.7 22.3 20.8 15.9 26.3 21.0 23.3 22.7 22.2 39.1 21.9 19.5 23.0 62.5 27.6 21.2 24.6 23.3 25.5 24.8 30.6 23.4 30.4 19.7 31.2 28.3 34.3 19.4 23.6 79.8 41.6 42.1 40.2 31.7 34.1 43.7 29.2 47.1 92.7 83.4 134.8 126.1 32.8 93.2 42.9 147.1 58.4 37.3 62.8 61.1 18.0 47.2 36.0 45.2 87.2 64.4 70.0 56.7 34.4 58.0 60.8 58.2 42.4 55.1 46.9 33.9 32.6 56.0 107.5 57.9 108.2 28.7 44.8 280.7 46.0 52.3 34.4 47.4 37.9 39.5 35.6 59.7 48.2 65.2 32.7 47.6 111.4 32.6 55.4 41.1 54.0 71.0 35.5 24.8 41.0 120.5 44.8 48.1 16.7 50.9 71.0 4.1 22.0 4.2 12.0 5.5 7.0 43.3 11.1 10.1 4.7 124.8 3.3 13.6 16.6 9.3 13.5 22.6 22.7 22.9 26.3 22.5 27.8 22.7 23.7 22.3 22.7 23.3 23.4 23.6 21.2 16.0 22.9 10.1 22.0 25.5 44.8 43.1 22.2 19.8 20.3 23.0 19.9 21.5 37.1 25.8 4.2 60.7 14.3 37.2 50.9 57.6 37.9 35.1 19.4 22.6 22.2 9.7 11.2 75.4 43.0 25.7 26.5 20.6 6.3 26.4 25.0 16.6 70.8 20.2 9.5 92.7 59.0 26.3 34.7 15.7 28.3 32.4 16.0 11.2 68.3 53.1 15.5 7.5 10.6 105.0 50.5 27.1 21.9 38.2 33.3 44.2 48.0 29.7 0.0 20.8 26.5 92.9 35.4 19.4 27.6 57.7 16.3 32.9 34.8 60.7 MAP1LC3A "ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3" ENSG00000101460 "Microtubule associated protein 1 light chain 3 alpha" Q9H492 20 34546854-34560345 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 178.7" "Cell type enhanced" "Detected in many" "Late spermatids: 674.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 85.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 85.4" "Cell line enhanced" "Detected in many" "HHSteC: 57.5;HSkMC: 71.2;SK-BR-3: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007649, CAB037174, HPA042824, HPA052474, HPA052484" Enhanced Approved Vesicles NA NA Vesicles "CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.02e-1)" "unprognostic (1.99e-2)" "unprognostic (4.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.55e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-2)" "unprognostic (1.98e-1)" "prognostic favorable (5.31e-5)" "unprognostic (2.82e-2)" "unprognostic (1.59e-3)" "unprognostic (3.84e-1)" "unprognostic (1.35e-1)" "unprognostic (7.90e-2)" "unprognostic (2.76e-1)" 48.8 26.8 103.1 13.8 110.8 16.6 41.0 100.8 178.7 46.1 58.6 55.5 30.9 45.3 18.0 22.8 42.1 24.1 75.0 114.6 114.2 54.2 53.6 39.8 28.4 120.4 122.3 112.8 38.7 25.0 23.9 85.5 12.5 136.0 47.0 19.9 31.9 31.2 20.5 55.2 59.0 45.3 19.2 94.8 22.2 36.9 53.2 119.1 6.9 53.4 34.4 30.7 39.4 43.9 144.0 0.0 7.0 4.2 0.0 28.4 37.3 0.2 26.1 21.9 16.3 14.9 0.1 0.5 0.0 0.3 21.3 39.5 4.8 0.1 8.1 3.2 6.2 2.0 0.1 17.2 0.0 57.5 0.0 14.0 71.2 1.4 11.4 4.9 0.1 13.5 0.0 0.0 0.1 17.4 0.0 0.2 0.5 1.6 5.3 5.2 0.0 0.0 0.0 0.0 0.0 41.4 31.9 29.6 62.2 0.0 16.3 0.3 22.7 20.5 45.2 0.4 9.8 11.2 0.0 6.5 0.0 29.4 0.0 16.1 4.0 3.2 11.0 5.1 4.8 3.7 9.4 5.5 5.4 1.0 6.0 1.7 3.4 85.4 3.3 1.7 4.5 12.1 2.9 103.1 110.8 100.8 178.7 114.6 114.2 120.4 122.3 112.8 136.0 94.8 119.1 144.0 107.4 0.0 6.6 19.2 18.3 57.7 123.0 50.5 12.5 127.2 41.9 57.8 25.4 41.5 27.1 46.0 85.5 25.7 26.1 67.3 113.5 42.0 137.3 98.4 78.4 64.4 165.1 3.6 48.4 23.5 15.8 75.4 34.1 90.6 18.4 90.8 75.7 44.6 37.9 70.7 58.8 70.5 136.3 16.1 47.1 674.0 95.1 17.5 62.2 14.0 21.0 98.7 7.2 12.5 54.6 44.7 82.5 108.7 10.1 146.3 149.4 120.0 40.7 127.7 138.1 77.7 119.3 53.0 21.6 5.8 51.4 211.8 26.4 79.8 76.7 98.1 SYNDIG1 "C20orf39, DSPC2, FLJ14220, IFITMD5, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469629-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.0;heart muscle: 27.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 157.4;Microglial cells: 472.2;Oligodendrocytes: 214.3" "Cancer enhanced" "Detected in many" "glioma: 10.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 15.4;RH-30: 43.4;RPMI-8226: 43.6;SCLC-21H: 10.0;U-87 MG: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles NA NA Vesicles "HPA044271: AB_2732515, HPA059267: AB_2683961" "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.16e-6)" "unprognostic (1.40e-3)" 1.8 0.9 24.3 1.5 24.1 0.0 0.5 28.5 28.5 3.2 10.3 0.8 1.2 3.2 0.7 0.2 4.2 8.9 27.2 22.2 20.9 5.0 0.0 0.7 2.0 28.0 24.0 20.2 0.9 0.7 0.2 0.8 0.2 30.6 3.3 0.9 1.8 0.3 12.5 0.1 0.2 2.1 2.2 28.3 0.7 1.7 0.8 22.2 1.6 4.8 0.1 2.5 1.7 2.1 37.0 0.0 0.3 2.6 0.0 0.8 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 15.4 0.0 0.8 0.0 0.0 2.6 0.0 0.0 0.0 43.4 43.6 0.0 0.0 10.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 24.1 28.5 28.5 22.2 20.9 28.0 24.0 20.2 30.6 28.3 22.2 37.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.2 0.7 0.6 1.2 0.0 0.0 157.4 0.0 0.0 2.0 0.0 0.8 0.0 21.9 0.0 0.0 0.1 3.3 69.7 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.0 472.2 0.0 1.9 0.0 41.7 214.3 1.5 0.0 7.2 0.0 0.0 0.0 5.9 0.0 0.5 0.0 0.5 1.4 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041706: AB_2677627, HPA046766: AB_2679794" "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 10.8 15.0 21.3 9.8 25.3 10.6 13.6 24.0 25.5 13.5 18.8 20.2 12.3 16.5 20.0 18.7 25.3 11.5 16.3 21.6 24.1 16.2 13.9 10.4 11.9 25.2 23.8 21.4 21.1 11.6 29.2 14.5 16.0 25.0 12.4 22.5 16.7 12.4 13.6 16.3 13.0 13.4 17.8 23.4 9.7 10.9 19.3 23.6 14.8 13.3 20.7 15.9 14.3 13.9 32.5 30.2 37.2 47.0 34.4 30.0 36.1 46.8 30.0 35.8 50.3 43.9 69.3 61.9 38.4 48.0 30.0 65.1 54.5 43.1 57.0 50.6 16.5 23.2 87.3 22.6 78.9 27.9 53.4 20.0 32.1 36.2 28.9 32.8 23.2 36.7 37.9 44.4 33.4 43.0 33.5 45.6 54.0 23.7 68.8 55.9 32.7 58.5 61.8 44.5 27.4 30.0 28.2 56.6 101.0 38.0 26.0 55.8 37.1 21.7 82.0 29.1 44.8 30.8 22.2 33.3 25.4 49.9 54.8 36.0 14.0 5.6 2.4 16.2 8.4 14.4 10.7 14.5 17.8 13.6 12.6 14.4 14.5 1.0 16.7 6.8 13.2 14.1 8.8 21.3 25.3 24.0 25.5 21.6 24.1 25.2 23.8 21.4 25.0 23.4 23.6 32.5 5.2 9.6 4.8 26.8 6.4 4.5 11.8 32.7 7.4 8.9 4.9 4.7 6.6 8.6 21.6 11.0 16.7 40.1 5.7 15.4 1.9 19.2 17.8 14.4 7.2 9.1 10.2 9.1 30.4 17.6 29.3 10.1 4.6 11.5 8.2 19.5 7.1 8.5 15.8 1.7 39.0 15.3 22.4 6.5 2.2 16.7 5.6 4.7 1.8 16.9 5.7 8.5 5.2 46.3 78.5 10.4 19.0 7.9 7.6 10.6 9.0 9.2 28.5 9.5 19.7 8.3 13.7 34.6 12.8 9.5 5.8 21.2 6.8 9.8 24.3 8.7 TNNC2 "CFAP85, FAP85" ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 109 "skeletal muscle: 30707.5;tongue: 8160.3" "Group enriched" "Detected in many" 4 "Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.2;head and neck cancer: 22.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3" "Region enriched" "Detected in some" 5 "olfactory bulb: 6.1" "Low region specificity" "Detected in some" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles No NA 560000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: AB_2683729" "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 5.6 5.5 5.4 0.4 6.1 1.1 8.4 6.1 7.0 2.1 5.0 5.4 2.6 4.3 1.0 129.6 3.0 2.3 3.9 5.4 5.1 1.7 2.5 3.2 0.5 5.1 5.2 5.3 6.6 2.3 1.2 3.1 0.2 5.5 44.7 2.3 1.3 177.7 1.3 30707.5 8.1 7.8 1.0 4.8 1.8 2.5 4.7 5.2 6.7 5.2 8160.3 0.7 2.5 3.0 6.2 0.1 0.0 0.2 0.4 1.6 1.0 1.7 0.1 0.4 0.0 0.1 0.2 1.1 0.4 1.1 1.0 0.4 0.4 0.0 0.4 0.0 0.0 0.3 0.0 1.0 10.0 0.4 0.3 0.2 14.8 0.2 0.1 0.7 0.3 0.0 1.2 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.4 0.6 0.3 0.6 0.2 0.4 0.1 11.3 0.5 1.6 0.1 0.4 0.5 1.3 0.4 0.5 0.2 0.3 0.9 0.2 1.5 0.4 0.2 1.4 0.1 0.2 0.0 0.6 1.3 0.1 1.1 0.6 5.3 1.3 0.2 0.3 4.6 0.0 0.3 2.0 0.3 0.8 0.8 3.9 8.7 5.4 6.1 6.1 7.0 5.4 5.1 5.1 5.2 5.3 5.5 4.8 5.2 6.2 0.9 3.2 0.6 0.3 3.1 0.8 0.5 2.0 0.0 4.2 3.1 1.7 0.5 2.8 3.6 3.7 0.0 2.4 0.5 171.7 3.9 1.5 6.9 37.1 1.0 3.8 22.9 0.0 1.9 5.1 0.4 7.2 0.5 2.3 0.0 13.9 0.0 1.1 0.3 0.0 0.7 108.2 14.2 0.3 1.1 47.0 1.2 22.4 0.0 0.0 2.1 1.4 1.0 0.0 0.6 3.3 92.9 3.0 0.5 0.7 338.7 1.0 4.3 2.4 0.0 1165.3 9.5 2.5 5.5 0.1 8.4 0.1 4.7 7.2 37.0 0.7 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857405 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria NA NA Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favorable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 7.5 31.9 28.8 8.7 29.4 18.2 7.7 27.5 35.5 8.4 22.8 15.7 21.3 8.5 11.1 17.6 10.8 9.3 25.5 29.1 26.2 21.4 26.3 11.1 12.7 26.6 28.3 27.8 8.0 15.7 15.3 15.5 7.2 28.5 12.8 12.9 9.3 12.9 6.0 28.9 16.8 20.7 6.5 25.2 12.4 21.5 20.4 29.4 13.3 11.5 18.0 9.8 11.1 10.4 29.3 16.8 20.2 6.8 13.4 18.3 11.0 11.7 11.1 9.5 15.1 13.7 29.2 22.7 20.8 48.2 16.3 35.4 32.3 13.0 27.8 6.6 15.5 22.3 21.2 25.1 28.5 16.9 19.9 19.3 12.9 21.3 15.1 10.9 22.6 9.4 23.6 18.8 24.2 11.0 47.4 28.7 27.0 11.8 32.4 52.2 14.0 12.2 37.6 16.5 19.1 23.1 10.8 24.9 61.7 39.5 10.6 34.4 48.8 11.6 37.9 8.5 19.5 18.9 20.7 33.8 14.0 46.3 21.2 20.8 34.3 34.3 43.6 24.8 34.6 21.8 27.5 23.2 21.9 36.7 27.9 20.0 21.6 25.0 16.3 34.2 23.3 31.9 26.7 28.8 29.4 27.5 35.5 29.1 26.2 26.6 28.3 27.8 28.5 25.2 29.4 29.3 8.2 35.3 14.1 5.9 17.9 6.1 12.3 21.9 8.6 19.2 9.8 10.9 9.3 11.5 17.7 12.9 16.7 34.2 11.8 104.2 64.6 21.6 38.5 14.2 10.4 10.9 19.2 17.0 12.3 21.0 20.9 11.4 19.9 14.0 14.0 27.6 11.4 25.5 27.8 8.4 12.0 37.3 10.2 18.6 7.1 90.3 9.9 17.5 10.6 3.7 27.5 17.8 34.0 5.0 9.6 21.6 68.4 8.6 21.3 11.3 105.4 81.5 27.1 22.8 13.1 5.8 12.8 27.0 10.2 16.1 8.0 19.4 13.9 37.6 30.3 16.0 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992751 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 316.6" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 325.4;Hepatocytes: 251.1;Syncytiotrophoblasts: 751.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 680.7;NK-cells: 343.8;T-cells: 367.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Approved Approved "Plasma membrane" NA NA 130000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: AB_2685328" "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 169.5 45.0 57.8 47.7 60.3 189.1 85.4 76.8 66.0 40.4 62.3 47.0 33.0 47.2 107.2 26.9 46.4 43.5 37.8 63.8 70.0 47.8 316.6 53.6 44.4 59.5 63.3 56.6 41.2 45.5 84.1 79.3 80.9 64.5 44.6 43.3 32.2 40.4 48.3 39.8 46.1 35.0 49.6 63.9 67.1 38.8 54.7 67.4 42.8 211.0 24.6 34.4 52.3 29.8 66.3 110.6 191.3 90.0 139.5 175.3 97.5 94.4 141.8 153.4 133.3 137.4 113.7 189.3 45.9 161.1 170.6 232.1 198.1 85.0 165.1 149.1 62.3 69.7 51.2 66.0 226.9 140.9 99.5 115.4 134.3 226.9 154.9 107.0 173.8 192.5 73.4 61.5 195.8 128.6 168.1 68.9 108.2 59.3 166.6 172.1 56.3 312.8 96.3 140.2 98.9 150.6 59.4 146.9 240.5 157.1 92.0 87.6 78.8 173.7 156.9 140.6 134.7 209.5 113.0 134.3 50.9 83.1 148.0 151.9 61.8 99.3 198.9 367.9 98.6 228.8 36.4 100.8 268.2 102.1 37.4 78.6 202.2 680.7 343.8 71.3 50.7 75.0 363.3 57.8 60.3 76.8 66.0 63.8 70.0 59.5 63.3 56.6 64.5 63.9 67.4 66.3 28.5 19.2 32.7 25.8 22.2 24.3 46.7 77.6 17.1 51.4 48.1 32.1 17.5 34.3 39.7 49.7 10.4 325.4 163.2 18.9 17.6 72.0 22.9 18.0 26.3 42.4 18.0 33.6 24.0 45.4 50.6 40.6 15.3 23.8 36.1 68.6 41.4 251.1 95.9 16.8 25.4 19.4 85.5 50.0 94.8 32.5 65.0 59.5 46.2 42.2 105.1 35.0 222.5 19.6 15.9 40.8 25.4 82.0 54.9 34.1 20.8 13.2 24.5 22.5 39.5 36.9 33.2 97.1 90.1 16.7 20.0 751.1 96.7 38.3 28.0 28.1 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243040-37565827 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 123.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 126.4;Excitatory neurons: 197.7;Horizontal cells: 294.4;Inhibitory neurons: 197.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "SCLC-21H: 46.7;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 0.6 11.6 79.3 1.1 105.8 0.3 0.4 59.4 123.2 0.3 12.8 1.5 0.8 0.4 0.6 0.5 0.4 1.2 1.0 91.9 78.4 0.7 0.3 0.6 0.8 60.0 64.8 106.0 1.3 3.9 0.3 28.6 0.9 70.7 0.9 0.4 21.6 1.8 0.2 11.1 1.3 1.3 0.5 26.9 1.1 1.7 3.7 58.2 0.0 1.5 0.2 0.1 0.2 0.5 97.7 0.1 0.1 0.7 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.3 1.0 0.0 0.2 0.6 0.1 0.0 0.0 0.8 0.4 0.0 1.8 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.8 0.0 0.3 0.1 0.5 1.7 0.0 0.3 0.1 0.0 2.1 0.0 0.1 46.7 11.7 1.1 0.3 0.1 0.3 0.2 0.1 0.0 1.4 0.7 0.3 0.2 2.9 0.5 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.3 105.8 59.4 123.2 91.9 78.4 60.0 64.8 106.0 70.7 26.9 58.2 97.7 0.2 0.0 0.0 22.5 0.8 0.4 1.4 0.9 0.0 126.4 0.4 0.5 1.9 0.0 0.3 0.0 41.7 0.3 0.1 0.2 0.0 0.4 46.9 0.7 0.9 4.1 12.7 0.0 197.7 1.1 0.3 1.2 2.0 1.2 0.0 1.8 0.7 0.0 8.6 294.4 197.5 2.5 6.1 0.0 0.0 22.6 0.6 0.3 0.0 14.0 0.0 7.3 0.0 19.1 12.3 2.6 0.2 5.3 0.0 2.7 4.4 6.7 0.3 22.0 0.0 4.3 8.2 12.6 7.6 0.0 0.6 0.3 0.3 1.5 3.5 1.2 ZNF516 "HsT287, KIAA0222" ENSG00000101493 "Zinc finger protein 516" Q92618 18 76357682-76495242 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 75.1;Early spermatids: 77.4;Endometrial stromal cells: 78.9;Langerhans cells: 69.7;Oligodendrocyte precursor cells: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 10.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.2" "Cell line enhanced" "Detected in many" "THP-1: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015792 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA015792: AB_1859314" "prognostic favorable (7.09e-4)" "unprognostic (7.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.22e-3)" "unprognostic (3.33e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.63e-3)" "unprognostic (3.14e-1)" "unprognostic (3.29e-2)" "prognostic favorable (7.96e-4)" "unprognostic (5.87e-2)" "prognostic favorable (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" 5.7 7.7 19.8 4.5 18.3 24.8 6.5 11.5 10.4 28.7 3.1 7.3 6.2 32.5 8.6 9.0 23.8 5.1 5.4 18.7 26.3 4.6 6.3 7.6 3.0 18.1 13.0 11.6 23.0 6.9 9.6 11.4 3.0 12.7 9.8 2.7 16.3 6.4 17.5 14.3 9.8 6.3 11.9 10.9 6.9 6.3 34.6 18.6 4.4 6.4 6.0 2.8 10.3 15.5 20.1 2.4 2.7 18.8 25.0 5.3 8.0 2.4 14.6 12.1 3.1 5.7 5.5 8.9 12.7 3.0 15.5 7.7 5.2 10.4 14.0 2.0 0.0 8.0 1.2 0.0 11.7 13.2 8.5 8.3 15.4 5.9 6.3 6.7 4.2 3.5 5.2 0.0 0.0 3.0 5.2 0.2 14.4 9.5 1.5 0.7 5.7 1.9 6.6 4.7 11.1 18.9 11.3 0.2 0.0 15.3 7.3 3.1 33.2 2.3 7.1 12.4 0.2 1.5 0.1 0.4 9.9 4.2 5.8 18.6 2.5 1.8 2.9 0.0 1.2 0.4 0.0 0.1 0.0 1.2 0.3 0.4 0.2 10.2 0.7 1.4 0.8 0.0 0.4 19.8 18.3 11.5 10.4 18.7 26.3 18.1 13.0 11.6 12.7 10.9 18.6 20.1 9.6 9.6 10.1 75.1 5.0 19.5 17.9 12.7 9.1 15.0 8.6 8.1 8.5 5.7 8.8 1.8 31.3 0.3 6.1 4.2 3.9 5.8 77.4 33.1 78.9 9.8 12.6 3.0 19.8 2.9 0.4 15.6 4.6 47.7 1.3 10.4 7.9 11.4 8.4 3.3 37.3 5.2 6.1 20.0 69.7 43.5 30.4 14.2 12.4 30.0 20.9 8.4 9.2 73.9 0.7 5.5 4.5 35.0 0.6 11.8 7.4 5.4 15.3 30.3 13.1 16.1 15.5 3.7 33.1 7.0 20.2 0.5 2.8 21.5 4.5 20.8 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333430-61555779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 33.4;retina: 11.1;tongue: 24.3" "Group enriched" "Detected in some" 6 "Astrocytes: 1264.4;Oligodendrocyte precursor cells: 742.4;Oligodendrocytes: 1030.7" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "basophil: 2.3" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "AF22: 1.8;ASC diff: 5.7;HHSteC: 2.6;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain NA NA "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 4.8 0.1 20.7 0.0 26.8 0.0 0.9 24.6 19.8 0.2 2.1 0.0 0.0 0.1 0.6 0.8 0.2 0.0 0.1 18.6 18.0 0.1 0.0 0.0 0.0 29.6 27.3 16.2 0.0 0.1 0.0 1.6 0.0 27.2 0.2 0.0 11.1 0.4 0.0 4.8 0.5 0.2 0.0 21.6 0.1 0.1 0.4 22.0 0.0 0.3 24.3 0.0 0.3 0.1 33.4 0.0 0.0 1.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 20.7 26.8 24.6 19.8 18.6 18.0 29.6 27.3 16.2 27.2 21.6 22.0 33.4 0.2 0.0 0.0 1264.4 0.1 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.2 0.0 0.0 146.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 98.7 0.1 0.0 0.3 0.0 2.7 0.0 0.1 0.0 41.2 0.0 11.1 0.0 742.4 1030.7 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 1.1 0.0 1.0 0.2 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ADNP2 "KIAA0863, ZNF508" ENSG00000101544 "ADNP homeobox 2" Q6IQ32 18 80109262-80147523 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007126 Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA007126: AB_1080729" "unprognostic (4.93e-2)" "unprognostic (1.45e-1)" "unprognostic (1.05e-2)" "unprognostic (2.25e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.24e-1)" "unprognostic (6.05e-2)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "prognostic favorable (6.39e-5)" "unprognostic (8.64e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (9.90e-4)" "unprognostic (5.19e-2)" 8.0 6.3 12.6 6.6 12.9 41.6 8.2 7.3 30.7 5.9 7.9 7.3 9.2 7.5 10.9 8.7 6.6 7.5 8.0 11.3 7.9 6.7 8.0 7.6 7.3 16.2 9.8 9.2 8.0 8.3 9.7 7.0 6.7 16.1 6.8 6.7 12.5 6.5 6.4 2.7 12.1 6.7 7.9 11.9 6.5 7.9 22.2 19.4 9.4 8.4 4.5 7.2 7.8 7.0 19.5 23.1 17.8 36.2 27.0 8.1 11.4 27.0 16.3 18.6 19.2 23.8 16.9 11.5 0.2 6.2 13.3 23.6 20.8 35.4 21.1 20.2 21.0 17.8 32.3 12.8 18.5 14.8 47.5 34.5 11.9 19.6 19.7 26.1 12.8 19.4 36.1 31.8 33.3 11.4 16.4 43.8 9.9 24.9 10.3 20.6 16.6 40.5 16.4 11.6 30.3 24.7 31.8 18.4 18.1 13.0 17.6 17.8 36.0 13.3 22.6 56.6 9.5 18.4 11.7 23.1 46.8 15.1 19.8 15.7 0.0 0.4 0.2 1.2 0.7 0.8 0.8 1.5 1.0 0.2 0.3 0.8 1.4 0.6 0.6 1.2 0.8 0.8 0.5 12.6 12.9 7.3 30.7 11.3 7.9 16.2 9.8 9.2 16.1 11.9 19.4 19.5 17.0 19.2 20.9 21.9 10.2 39.5 24.4 11.7 16.5 20.3 17.0 11.9 16.6 10.0 12.6 3.7 27.1 10.1 15.5 17.4 0.0 7.9 9.9 15.8 14.2 14.5 22.2 22.3 22.7 10.9 8.3 15.9 13.3 31.2 12.0 13.6 15.4 19.5 9.9 25.2 25.2 18.9 14.2 10.6 13.8 8.2 7.5 14.6 14.2 11.2 5.5 9.7 3.1 17.1 36.8 11.5 15.9 11.7 9.7 21.7 10.6 7.2 10.2 30.2 0.0 15.6 14.5 45.4 38.3 23.7 43.2 9.7 15.5 17.8 13.6 32.2 RBFA "C18orf22, FLJ21172, HsT169" ENSG00000101546 "Ribosome binding factor A" Q8N0V3 18 80034389-80050651 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040485, HPA041479" Approved Approved Mitochondria NA NA Mitochondria "HPA040485: AB_10795368, HPA041479: AB_10795697" "unprognostic (5.31e-3)" "unprognostic (3.21e-2)" "unprognostic (1.87e-1)" "unprognostic (4.55e-2)" "unprognostic (7.33e-2)" "unprognostic (5.00e-3)" "prognostic unfavorable (2.06e-6)" "unprognostic (2.98e-1)" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (4.28e-2)" "unprognostic (3.76e-2)" "unprognostic (2.43e-1)" "unprognostic (3.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.82e-1)" "unprognostic (5.00e-3)" 18.1 20.1 6.3 9.8 6.3 13.7 18.0 8.0 6.6 12.9 4.8 13.6 12.1 12.5 5.5 17.7 11.1 5.9 15.1 6.3 6.5 14.8 31.5 10.6 8.6 6.0 5.6 6.3 10.2 16.9 9.1 9.0 8.4 6.4 11.7 7.9 5.9 12.8 6.8 22.5 19.4 10.9 10.0 4.9 12.5 12.0 12.2 5.8 10.3 11.1 13.4 10.7 13.5 14.3 6.6 28.4 32.6 20.5 20.0 17.5 20.2 27.7 24.0 11.9 25.8 21.9 19.1 22.1 58.6 8.9 16.5 22.6 26.1 21.8 26.1 20.5 22.1 23.9 35.3 24.6 53.0 14.6 55.7 16.7 18.8 24.9 18.6 26.3 11.3 22.4 35.3 19.1 35.7 15.5 30.0 55.6 38.4 22.4 17.7 30.6 38.0 19.6 72.5 26.8 35.2 35.7 21.3 21.0 23.4 17.3 17.0 17.7 29.5 19.7 37.6 37.2 5.5 27.0 14.1 24.5 48.7 22.1 46.2 22.4 0.0 4.8 0.0 6.4 6.5 10.1 8.9 6.5 6.4 7.6 6.5 7.4 6.8 0.2 7.3 10.3 5.7 5.5 5.3 6.3 6.3 8.0 6.6 6.3 6.5 6.0 5.6 6.3 6.4 4.9 5.8 6.6 25.4 32.1 10.9 14.0 24.1 18.5 24.4 29.8 25.6 13.5 29.2 32.5 12.2 18.6 24.4 27.6 18.8 50.1 14.8 9.9 31.3 28.4 17.7 23.7 39.0 20.3 20.9 29.9 18.3 24.2 49.9 24.7 19.4 20.9 13.3 34.5 15.7 40.8 24.4 32.0 17.5 21.7 14.2 8.2 20.5 17.0 19.0 15.2 33.8 12.2 9.6 8.0 19.6 19.6 14.1 21.3 7.6 18.4 26.2 23.8 13.7 46.4 19.4 21.8 19.7 17.3 26.3 37.7 49.2 38.2 23.4 24.9 16.7 47.5 25.5 20.9 USP14 TGT ENSG00000101557 "Ubiquitin specific peptidase 14" P54578 18 158383-214629 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001308 Approved Supported "Plasma membrane,Cytosol" NA NA 2700000 "Plasma membrane, Cytosol" "HPA001308: AB_1080499" "unprognostic (2.21e-1)" "unprognostic (4.05e-2)" "unprognostic (1.90e-1)" "unprognostic (2.59e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.81e-5)" "prognostic unfavorable (4.30e-5)" "unprognostic (5.14e-2)" "unprognostic (5.00e-2)" "prognostic favorable (7.91e-4)" "unprognostic (1.64e-2)" "unprognostic (2.39e-1)" "unprognostic (1.51e-3)" "unprognostic (2.58e-1)" "unprognostic (1.55e-1)" "unprognostic (2.20e-2)" "unprognostic (3.76e-2)" 26.2 21.7 21.2 22.9 22.8 24.1 17.2 21.3 22.9 15.6 15.7 17.3 14.0 17.2 24.0 24.2 14.7 14.7 25.0 22.2 25.6 23.6 25.5 15.2 21.7 27.0 22.5 22.4 13.4 13.1 21.4 14.4 26.7 26.6 29.9 19.5 15.6 15.3 19.8 56.0 15.0 12.5 24.9 22.8 13.9 15.3 18.1 25.6 22.0 20.6 36.8 31.5 22.8 15.4 26.7 91.6 75.4 62.7 64.5 60.7 60.0 109.6 115.5 64.9 118.9 110.5 98.9 48.7 133.1 86.6 99.1 114.4 50.9 125.1 91.7 134.9 38.7 59.0 72.5 46.0 78.1 60.5 184.1 70.8 48.4 69.1 122.3 69.5 55.0 93.5 65.9 106.2 99.3 119.1 76.2 105.2 52.4 59.4 56.0 83.5 87.8 78.6 98.0 88.7 79.9 71.8 60.1 120.7 59.2 52.5 68.0 58.2 51.5 103.9 138.7 104.3 128.8 170.6 62.3 125.7 130.9 80.0 77.3 88.4 10.7 18.1 13.8 27.9 25.8 33.6 21.1 27.5 29.5 25.6 16.4 26.7 26.2 1.5 39.3 20.5 18.7 28.6 19.4 21.2 22.8 21.3 22.9 22.2 25.6 27.0 22.5 22.4 26.6 22.8 25.6 26.7 40.0 22.4 40.4 27.7 52.7 58.6 53.3 42.0 51.8 58.0 33.4 23.5 44.9 31.5 48.3 44.1 31.3 92.3 58.1 22.5 45.0 60.6 70.9 44.9 56.3 43.1 22.1 102.0 58.8 54.0 71.8 49.0 43.8 80.8 34.8 47.1 28.2 45.4 50.9 116.1 54.4 22.5 46.8 31.5 53.4 21.6 31.7 45.5 35.6 33.7 48.8 39.4 46.4 35.2 74.8 75.8 16.9 45.9 72.7 71.4 15.2 56.0 40.2 50.3 0.0 49.6 51.4 34.1 68.1 57.9 52.4 135.6 55.0 58.9 33.5 51.8 VAPA "hVAP-33, VAP-A" ENSG00000101558 "VAMP associated protein A" Q9P0L0 18 9914016-9960021 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009174 Approved Enhanced "Endoplasmic reticulum" NA NA 580000 "Endoplasmic reticulum" "HPA009174: AB_1080549" "unprognostic (4.03e-2)" "unprognostic (7.47e-2)" "unprognostic (9.36e-2)" "unprognostic (5.20e-2)" "unprognostic (2.00e-1)" "unprognostic (2.99e-2)" "unprognostic (4.79e-3)" "unprognostic (1.80e-1)" "unprognostic (5.39e-2)" "unprognostic (6.80e-3)" "unprognostic (2.99e-2)" "unprognostic (8.11e-2)" "prognostic favorable (5.72e-7)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (5.77e-2)" 31.6 67.6 25.0 24.4 27.8 98.0 29.8 31.7 29.1 26.4 22.7 39.0 31.5 33.2 25.0 47.9 29.5 32.2 37.8 24.6 27.5 32.9 37.0 34.2 25.9 35.1 28.6 22.7 39.4 41.2 36.5 17.8 30.0 35.9 24.7 35.8 20.2 32.9 22.2 70.2 32.2 30.8 27.6 30.7 26.9 39.3 29.4 28.0 30.3 35.5 38.7 26.5 36.8 32.4 36.9 58.1 34.4 40.7 26.7 46.9 50.5 56.8 69.9 57.9 62.3 67.9 46.6 55.9 56.5 63.6 61.5 53.9 39.7 39.8 66.7 70.7 35.6 49.8 92.4 33.8 72.3 110.8 126.3 169.7 47.8 66.3 59.0 69.6 48.7 64.0 45.4 94.6 57.3 55.2 31.2 97.4 72.9 26.2 197.6 54.3 50.4 55.2 77.5 60.9 57.3 57.2 31.2 81.1 48.7 53.2 37.2 45.7 64.2 68.9 100.7 75.3 105.6 86.3 101.9 89.2 66.6 57.0 53.5 70.8 131.3 143.3 251.0 69.8 127.9 82.9 100.0 72.1 75.4 118.1 94.4 78.1 72.1 226.2 90.8 109.5 84.6 98.9 183.9 25.0 27.8 31.7 29.1 24.6 27.5 35.1 28.6 22.7 35.9 30.7 28.0 36.9 173.6 128.2 178.8 63.0 160.0 673.4 358.4 356.5 278.3 113.9 248.2 179.3 218.3 167.3 229.4 207.8 62.6 296.9 148.0 427.2 457.8 291.8 10.5 235.9 182.2 232.4 144.6 188.1 91.4 361.3 321.6 221.4 156.0 255.8 225.2 220.2 211.3 141.1 287.8 136.3 93.2 180.6 390.6 288.2 459.8 21.7 182.0 285.9 279.3 63.7 350.4 124.3 108.1 102.1 150.4 310.2 262.7 216.3 146.6 335.4 255.9 390.4 265.5 79.5 190.7 204.8 371.4 231.3 201.4 267.3 622.5 452.6 190.2 253.6 201.0 390.8 METTL4 "FLJ23017, HsT661" ENSG00000101574 "Methyltransferase like 4" Q8N3J2 18 2537525-2571509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040061, HPA046734" Approved Approved Mitochondria NA Yes Mitochondria "HPA040061: AB_10697713, HPA046734: AB_2732532" "unprognostic (1.85e-2)" "unprognostic (1.27e-1)" "unprognostic (7.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (5.06e-3)" "unprognostic (1.12e-5)" "unprognostic (1.74e-1)" "unprognostic (5.12e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.72e-2)" "unprognostic (3.26e-1)" "unprognostic (4.00e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-3)" 7.5 5.0 6.0 8.0 6.8 5.6 5.9 6.4 7.4 8.0 6.5 5.9 5.7 7.6 5.5 6.2 6.3 5.8 5.3 5.8 6.6 5.5 5.0 6.3 11.6 7.2 6.6 5.0 6.8 4.4 6.4 5.2 5.9 7.3 6.6 6.8 5.1 5.6 7.2 3.5 5.9 8.0 6.8 6.7 10.5 5.9 7.4 6.4 10.5 9.0 5.6 11.1 6.9 7.8 8.5 12.7 5.0 15.1 8.3 5.9 8.7 19.0 19.9 15.7 18.2 16.9 10.8 9.2 24.3 11.5 8.3 16.4 10.7 24.7 9.3 21.2 18.6 9.1 10.6 10.5 7.9 9.0 23.1 12.0 7.1 19.3 19.6 12.0 10.3 17.8 15.9 14.0 33.8 14.3 5.7 16.0 7.4 9.2 10.5 8.2 12.5 13.6 16.7 8.9 7.0 27.6 12.8 16.2 9.3 18.6 11.6 10.8 14.8 11.1 21.9 28.9 19.4 26.3 16.1 47.6 15.7 14.1 15.5 23.8 18.6 2.7 7.3 6.1 2.6 7.0 6.2 7.0 8.5 1.9 7.3 8.5 7.9 10.0 5.9 2.2 3.8 8.8 4.9 6.0 6.8 6.4 7.4 5.8 6.6 7.2 6.6 5.0 7.3 6.7 6.4 8.5 24.3 12.8 8.2 8.5 21.1 4.8 13.6 6.5 10.8 9.6 7.6 7.4 3.8 10.0 10.3 3.7 14.6 7.5 13.7 10.1 0.0 5.9 6.9 7.5 9.1 10.0 2.4 11.0 17.0 7.3 9.4 7.3 12.2 7.4 7.0 10.3 11.4 4.9 6.0 8.4 20.3 7.6 4.1 7.0 6.5 3.3 12.8 7.0 3.6 14.0 4.5 6.6 13.4 18.1 25.8 8.3 4.0 10.9 15.0 10.8 10.1 5.1 12.0 6.5 13.1 8.3 6.8 30.5 21.8 9.0 4.8 10.4 18.3 8.5 6.2 19.4 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013144 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "intestine: 63.4;liver: 167.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 154.4;Granulosa cells: 323.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 7 "granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" Yes No Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519" "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favorable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 9.8 9.4 17.6 21.4 18.5 19.9 9.9 14.9 17.2 9.8 16.7 14.0 63.4 9.9 6.7 10.0 9.6 25.9 7.3 16.0 23.2 26.6 167.1 21.3 24.5 20.9 20.9 15.9 13.3 16.5 13.6 11.0 15.8 24.4 9.1 12.6 10.8 7.4 8.1 2.7 3.5 40.2 9.7 15.7 20.5 28.4 22.2 24.1 19.1 12.2 3.0 19.3 10.0 6.1 22.4 8.7 12.0 17.1 6.6 31.7 27.4 10.5 17.4 22.8 18.9 16.9 16.7 7.1 5.4 10.8 30.2 30.2 0.2 13.8 6.3 13.2 11.2 2.7 13.3 10.0 19.4 27.2 11.2 17.0 27.4 4.6 18.5 17.2 28.2 23.4 14.8 12.8 3.5 28.2 7.2 15.0 12.0 5.7 13.7 13.1 26.7 14.0 23.2 17.6 20.0 14.4 10.2 18.4 9.1 6.8 10.7 0.0 18.0 31.2 25.3 28.7 31.7 14.6 5.0 7.9 12.3 22.1 12.2 8.1 8.7 2.4 7.8 11.8 1.5 12.1 1.0 9.2 7.2 1.0 1.7 9.1 6.3 23.4 12.5 0.8 1.5 9.2 3.2 17.6 18.5 14.9 17.2 16.0 23.2 20.9 20.9 15.9 24.4 15.7 24.1 22.4 17.7 67.3 44.0 55.2 20.4 5.6 9.8 8.5 5.7 35.7 12.1 11.2 11.2 154.4 23.9 38.6 14.6 25.2 41.9 45.3 17.6 11.8 3.3 48.2 33.3 18.9 14.9 138.1 26.3 19.0 11.3 25.4 103.0 64.4 12.6 323.0 19.2 131.1 23.1 116.1 65.6 36.8 16.2 26.8 8.9 11.0 22.7 31.1 8.8 79.6 31.2 16.7 59.8 37.7 21.0 22.2 21.6 31.2 16.1 21.2 92.4 54.9 17.1 16.7 6.6 16.6 20.1 26.5 73.0 0.6 2.0 49.5 58.9 20.3 14.0 14.1 SMCHD1 "FSHD2, KIAA0650" ENSG00000101596 "Structural maintenance of chromosomes flexible hinge domain containing 1" A6NHR9 18 2655726-2805017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Hydrolase" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 363.7;Plasma cells: 391.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 58.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 58.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039441 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039441: AB_10671042" "unprognostic (2.99e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-2)" "unprognostic (9.03e-2)" "unprognostic (8.66e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (1.32e-1)" "unprognostic (4.14e-2)" "unprognostic (3.11e-3)" "unprognostic (3.32e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (8.92e-2)" "unprognostic (2.63e-2)" 13.7 7.0 6.0 24.8 7.3 41.5 12.5 12.0 8.6 15.3 8.4 14.5 13.8 15.0 9.2 8.8 14.2 12.5 9.7 6.0 7.3 6.5 8.5 19.1 34.1 7.7 7.2 5.0 15.6 16.5 12.0 8.0 16.5 8.1 13.5 14.8 16.5 10.2 11.3 11.1 9.1 20.5 12.9 6.3 28.8 12.5 14.3 7.0 25.9 9.7 11.6 22.6 15.2 14.3 9.5 24.1 10.7 35.8 22.6 15.0 21.8 25.7 23.7 16.8 22.0 27.7 20.3 7.7 51.6 10.2 21.2 24.7 13.0 29.1 13.6 34.4 10.7 15.1 32.3 21.7 19.5 16.8 93.9 24.3 14.4 12.2 27.9 22.8 16.8 18.3 25.5 38.3 31.1 21.3 8.6 39.4 23.9 14.4 13.0 12.4 31.7 29.1 22.9 13.6 36.5 29.2 18.4 32.0 10.6 18.8 19.8 7.9 39.3 17.5 27.1 37.4 37.1 44.0 18.8 30.4 46.5 17.4 17.1 24.0 5.1 2.5 6.6 3.6 1.7 2.6 5.8 4.8 4.3 0.9 7.5 5.9 3.8 58.7 2.3 2.3 2.6 5.4 1.3 6.0 7.3 12.0 8.6 6.0 7.3 7.7 7.2 5.0 8.1 6.3 7.0 9.5 96.5 44.8 44.7 71.5 363.7 27.1 35.3 14.5 48.9 112.1 33.3 32.8 53.0 15.7 27.7 18.4 100.1 36.5 232.7 102.7 5.9 23.4 117.2 43.6 83.3 53.0 22.7 69.0 98.4 19.4 22.3 52.8 68.3 75.9 40.4 54.2 30.7 16.4 19.4 99.3 127.2 35.5 10.2 65.4 69.7 38.6 42.0 116.3 30.2 121.8 142.5 32.3 120.5 111.1 130.4 23.6 60.1 38.0 391.1 52.0 46.5 6.1 22.5 88.5 39.5 59.7 69.8 166.7 115.3 41.3 24.9 46.9 257.9 45.9 30.4 57.8 MYOM1 ENSG00000101605 "Myomesin 1" P52179 18 3066807-3219968 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "heart muscle: 416.6;skeletal muscle: 853.6;tongue: 439.4" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 1346.0" "Cancer enhanced" "Detected in many" "liver cancer: 6.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014305, HPA049193" Enhanced NA NA 33000 "HPA014305: AB_1854257, HPA049193: AB_2680670" "unprognostic (2.51e-1)" "unprognostic (2.08e-3)" "unprognostic (2.19e-3)" "unprognostic (8.01e-3)" "unprognostic (8.94e-2)" "unprognostic (4.31e-2)" "unprognostic (9.10e-2)" "unprognostic (1.59e-1)" "unprognostic (9.27e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-1)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (9.15e-2)" "unprognostic (4.90e-2)" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" 15.2 2.3 7.6 1.4 8.7 0.6 4.2 8.6 6.4 2.9 4.3 10.3 1.9 6.4 3.0 14.2 6.9 14.7 416.6 6.3 10.6 1.3 24.9 1.5 1.3 11.5 11.2 4.9 2.9 11.6 0.4 1.6 1.6 11.3 12.5 2.4 2.0 5.4 4.5 853.6 1.3 4.6 12.0 9.2 1.0 3.2 5.8 8.6 0.8 2.8 439.4 0.7 7.7 2.4 9.3 0.0 0.1 0.2 0.0 0.7 0.7 0.3 0.4 0.5 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.0 13.5 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 3.5 6.2 0.3 0.2 0.0 0.3 0.0 0.2 0.0 0.4 0.2 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.2 0.0 0.6 0.0 0.2 7.6 8.7 8.6 6.4 6.3 10.6 11.5 11.2 4.9 11.3 9.2 8.6 9.3 1.2 0.0 0.5 49.0 1.7 1.7 2.3 0.7 0.0 2.1 1.0 0.8 1346.0 27.1 1.2 0.0 2.1 0.9 2.7 7.4 0.0 0.6 11.7 1.1 0.4 12.0 0.0 0.8 3.5 6.3 0.1 27.4 6.6 1.0 0.0 3.4 2.5 19.1 0.3 1.7 7.1 0.7 4.1 1.3 2.1 14.1 2.1 1.3 0.0 7.5 1.5 0.2 2.1 24.6 13.5 1.5 88.9 4.1 0.1 0.8 0.5 0.3 2.1 1.6 6.6 24.6 40.8 4.4 5.4 0.1 1.3 2.2 1.3 1.3 0.6 0.6 MYL12A "MLCB, MRCL3, MRLC3, MYL2B" ENSG00000101608 "Myosin light chain 12A" P19105 18 3247481-3256236 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 4275.0;skeletal muscle: 3098.1;tongue: 2100.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 6094.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004503, HPA039262, HPA045244, HPA059197" Supported NA Yes "CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (2.14e-3)" "unprognostic (5.30e-2)" "unprognostic (1.80e-1)" "unprognostic (5.31e-2)" "unprognostic (3.03e-2)" "unprognostic (7.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.57e-3)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-3)" "unprognostic (2.30e-1)" "unprognostic (9.86e-2)" "unprognostic (1.30e-1)" "unprognostic (4.98e-2)" "unprognostic (4.58e-3)" "unprognostic (7.13e-2)" 490.2 248.5 82.5 361.4 86.3 459.1 427.4 91.0 124.8 313.8 121.0 453.1 318.0 260.6 269.3 414.6 277.1 357.8 4275.0 79.9 112.7 383.5 466.1 569.8 567.4 100.5 86.5 75.4 193.0 230.7 367.3 107.7 449.1 98.9 249.5 491.3 51.1 284.7 248.0 3098.1 271.7 335.4 320.0 96.5 571.2 372.4 107.8 91.3 465.8 317.1 2100.9 606.5 412.1 242.5 96.1 467.6 298.1 580.7 257.3 701.6 691.8 386.7 1045.3 1176.5 827.9 895.4 440.7 543.5 224.6 263.9 1412.9 627.3 192.7 360.9 601.0 736.0 326.9 129.4 236.6 297.2 360.0 1118.3 658.7 401.0 1129.5 803.3 698.0 420.0 799.7 1332.7 272.6 292.6 694.7 1748.4 793.6 282.9 571.7 253.3 496.5 199.3 167.0 341.1 384.7 1827.8 680.1 86.7 211.5 840.9 333.1 674.0 541.8 233.8 918.2 1717.0 212.6 508.4 635.5 828.0 166.9 278.8 351.6 665.5 249.5 798.1 3164.3 1120.8 2382.2 2287.2 1192.8 2280.2 1588.6 2106.9 2315.1 1639.0 1353.6 1901.6 2215.8 1785.1 1629.3 1464.6 2487.8 2068.3 4517.7 82.5 86.3 91.0 124.8 79.9 112.7 100.5 86.5 75.4 98.9 96.5 91.3 96.1 1206.6 737.2 291.0 4.6 530.9 635.9 973.5 1804.3 259.6 29.4 294.8 396.4 6094.3 449.0 949.8 511.3 12.5 748.1 1090.0 1033.5 471.6 1335.5 32.4 570.0 312.1 938.8 105.4 244.9 1.7 1487.7 1168.6 453.0 318.5 662.3 521.0 301.7 870.6 272.5 844.2 57.2 2.9 570.4 889.0 605.3 992.8 32.8 334.6 924.2 442.9 26.2 1616.2 92.6 1388.3 4.0 9.0 2236.5 977.2 396.5 207.4 817.8 758.0 757.7 673.1 42.4 571.9 378.7 757.0 78.9 166.5 262.6 545.1 666.0 1078.8 303.7 429.6 698.2 CEP76 "C18orf9, FLJ12542, HsT1705" ENSG00000101624 "Centrosomal protein 76" Q8TAP6 18 12661833-12702777 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 209.7;Late spermatids: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 60.5" "Region enriched" "Detected in all" 9 "cerebellum: 55.0" "Region enriched" "Detected in all" 5 "cerebellum: 16.3" HPA039395 Approved NA NA "HPA039395: AB_10673357" "unprognostic (3.39e-1)" "unprognostic (2.99e-2)" "unprognostic (2.26e-1)" "unprognostic (9.31e-3)" "unprognostic (1.65e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.00e-4)" "unprognostic (7.88e-3)" "unprognostic (2.45e-1)" "unprognostic (8.70e-2)" "unprognostic (1.67e-2)" "unprognostic (4.39e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-2)" "unprognostic (8.21e-2)" 3.0 3.4 2.6 2.6 2.7 6.2 3.8 8.0 3.3 3.4 2.7 2.9 2.7 3.3 5.1 5.3 2.8 2.6 2.8 2.5 2.7 3.2 4.8 2.7 3.8 2.5 2.6 2.5 3.2 2.4 2.6 2.2 3.4 4.5 2.8 3.9 4.5 2.9 2.8 3.3 4.0 3.1 3.4 2.5 2.6 2.8 8.2 2.6 7.9 3.7 3.5 4.8 3.2 2.8 2.9 7.3 7.2 12.1 5.9 7.1 3.8 11.7 8.4 9.4 16.1 12.5 16.6 8.5 9.7 7.3 5.5 9.4 5.6 12.1 5.3 13.7 6.1 9.8 8.5 8.0 14.1 5.3 20.0 9.5 3.0 5.3 9.5 6.2 4.5 8.5 13.5 14.5 14.3 10.4 5.5 17.5 13.9 8.7 60.5 4.7 12.2 10.5 10.4 8.4 7.1 9.2 8.0 10.5 6.7 6.9 7.9 4.8 11.0 8.0 10.8 21.9 10.6 10.0 8.0 14.8 11.5 5.4 9.7 7.2 0.4 2.3 2.1 2.6 4.4 3.5 1.8 2.9 3.2 2.1 2.3 2.9 3.4 0.7 3.7 1.7 1.2 3.5 2.2 2.6 2.7 8.0 3.3 2.5 2.7 2.5 2.6 2.5 4.5 2.5 2.6 2.9 4.3 6.4 5.9 7.5 7.2 9.7 3.9 3.0 5.2 6.3 4.1 4.6 1.8 1.5 5.4 0.0 12.5 5.9 6.7 3.7 1.9 3.0 209.7 5.5 5.8 5.2 6.0 13.9 16.9 2.5 7.5 4.0 2.0 4.6 5.7 14.0 4.2 4.8 4.1 3.3 16.7 5.5 4.1 3.5 4.1 57.8 3.7 3.4 7.2 3.7 2.5 2.9 6.2 7.5 7.9 3.8 0.6 4.5 10.3 5.1 7.8 2.5 3.5 8.0 6.6 7.1 3.7 27.7 22.1 12.4 8.2 6.2 6.4 11.5 4.8 5.7 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.3;brain: 17.0;parathyroid gland: 6.3" "Group enriched" "Detected in some" 5 "Excitatory neurons: 106.1;Inhibitory neurons: 75.5;Oligodendrocyte precursor cells: 32.2" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" Yes NA 24000 "Plasma membrane, Midbody" "HPA043813: AB_2678683, HPA046771: AB_2679798" "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.1 12.3 2.2 0.0 9.6 0.2 0.0 17.0 10.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 3.1 6.3 1.7 1.0 0.0 0.0 0.0 4.1 0.9 4.8 0.1 0.0 6.3 0.5 0.0 7.3 0.1 0.0 0.7 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 4.2 0.2 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 87.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 9.6 17.0 10.1 6.3 1.7 4.1 0.9 4.8 7.3 0.1 0.4 6.7 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 7.8 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.9 0.0 3.1 0.0 0.1 0.2 0.0 0.0 106.1 0.0 0.0 0.2 0.0 0.0 0.0 12.9 0.0 0.0 0.1 0.0 75.5 0.2 0.0 0.0 0.0 7.3 0.0 0.0 0.0 3.7 0.0 1.1 0.0 32.2 9.1 0.1 0.0 0.4 0.0 0.2 0.0 0.1 0.2 0.6 0.0 0.6 0.2 0.8 0.1 0.0 0.0 0.0 0.0 7.7 0.0 0.1 CEP192 "FLJ10352, KIAA1569, PPP1R62" ENSG00000101639 "Centrosomal protein 192" Q8TEP8 18 12991362-13125052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 67.6;Excitatory neurons: 94.4;Inhibitory neurons: 91.3;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039392, HPA040503" Uncertain Supported Centrosome,Cytosol Yes No "Centrosome, Cytosol" "HPA039392: AB_10697549, HPA040503: AB_10670919" "unprognostic (6.94e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-3)" "unprognostic (6.87e-3)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (9.00e-2)" "unprognostic (6.61e-2)" "unprognostic (1.28e-1)" "unprognostic (7.89e-2)" "unprognostic (2.39e-1)" "unprognostic (4.54e-2)" "unprognostic (1.66e-3)" 2.9 2.2 4.7 4.6 6.7 10.9 4.9 9.6 4.6 4.8 0.0 4.6 4.0 6.5 3.9 3.7 5.0 5.8 3.6 3.8 2.3 2.8 2.9 4.4 6.9 3.9 4.4 0.7 10.0 4.7 4.8 2.6 4.7 4.4 4.0 5.4 6.9 4.1 3.6 1.8 3.6 4.7 4.7 3.1 5.3 4.7 9.4 4.2 11.7 5.5 3.9 5.6 4.1 2.6 7.8 13.5 7.2 19.1 10.1 8.1 12.6 6.1 9.2 12.1 14.3 15.1 9.9 5.8 15.2 6.1 9.4 10.4 6.4 16.7 8.8 16.8 6.0 6.0 13.8 11.3 5.2 4.3 22.2 10.2 8.8 3.2 12.0 10.9 8.2 11.9 10.7 19.3 9.9 11.3 6.8 19.2 9.6 6.1 24.9 4.4 16.3 14.9 7.9 4.9 13.6 13.9 7.8 14.7 7.2 4.4 9.0 5.8 11.3 12.1 11.2 26.2 12.9 12.8 6.6 10.1 17.0 7.2 9.9 11.0 0.4 0.6 0.5 0.9 0.4 0.7 0.5 0.6 0.6 0.3 1.3 0.6 1.0 0.6 0.2 1.7 0.5 0.5 0.3 4.7 6.7 9.6 4.6 3.8 2.3 3.9 4.4 0.7 4.4 3.1 4.2 7.8 13.3 9.6 12.8 67.6 11.4 1.9 3.9 4.3 5.2 13.1 6.4 5.8 28.7 4.3 9.3 7.3 22.9 5.3 13.7 7.6 0.0 4.7 23.3 11.0 11.8 8.5 0.0 18.7 94.4 3.6 3.3 10.5 15.8 12.1 2.5 40.9 8.2 6.5 4.6 11.8 91.3 8.7 4.1 10.1 3.9 14.2 10.2 10.1 1.8 62.8 15.3 6.5 14.4 76.9 90.6 4.8 5.7 13.9 15.0 5.5 4.5 1.2 8.0 17.8 26.3 11.3 8.1 33.5 24.0 8.5 3.1 1.9 12.3 60.6 8.0 7.6 RNMT RG7MT1 ENSG00000101654 "RNA guanine-7 methyltransferase" O43148 18 13726660-13764556 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039409 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA039409: AB_10795289" "unprognostic (3.02e-1)" "unprognostic (1.07e-2)" "unprognostic (3.48e-1)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (3.04e-1)" "unprognostic (6.17e-3)" "unprognostic (1.43e-1)" "unprognostic (3.76e-2)" "unprognostic (1.42e-3)" "unprognostic (9.45e-2)" "unprognostic (9.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.78e-1)" 10.9 9.6 11.1 12.7 12.3 43.7 15.5 12.4 13.0 11.2 15.9 10.7 8.6 14.2 11.6 11.4 11.3 9.1 20.5 12.0 13.6 11.7 11.2 9.5 14.5 13.3 13.6 11.0 17.4 12.2 13.2 14.0 15.3 15.0 11.7 10.5 27.7 12.2 10.6 18.5 13.9 10.6 12.6 10.8 12.2 10.7 16.9 13.8 15.1 17.7 15.7 15.3 11.5 10.8 16.1 24.9 14.4 27.4 20.9 20.0 25.1 19.2 19.9 24.7 20.3 27.4 17.3 11.7 27.7 23.9 20.6 31.6 9.8 32.7 28.6 34.0 15.4 17.6 21.0 14.8 16.4 21.9 54.9 17.1 19.4 30.5 21.4 59.9 26.6 15.9 31.1 31.8 26.9 23.3 15.4 35.2 19.7 21.0 50.1 11.2 22.7 29.0 37.9 18.6 19.2 21.1 31.7 22.5 16.4 38.1 27.8 14.3 22.6 16.5 40.6 56.8 33.3 21.5 53.8 63.6 56.9 29.9 20.8 20.6 45.1 17.6 12.8 16.7 14.6 13.6 23.9 15.8 14.2 11.8 25.7 20.5 16.2 9.8 14.1 17.3 29.5 19.0 5.6 11.1 12.3 12.4 13.0 12.0 13.6 13.3 13.6 11.0 15.0 10.8 13.8 16.1 62.5 73.7 29.9 48.6 148.5 70.4 67.3 97.9 75.1 115.6 50.7 56.1 56.5 35.8 56.5 46.0 123.0 66.3 143.4 46.5 68.4 51.0 75.4 85.2 88.3 43.7 74.8 37.4 75.3 48.0 59.2 71.6 66.3 113.9 34.9 85.6 40.7 38.5 39.8 106.0 83.9 56.3 85.5 59.4 63.6 21.1 72.7 78.8 49.8 45.0 68.0 51.0 60.8 56.8 78.9 56.1 47.0 60.9 99.7 72.3 49.0 64.8 48.0 148.3 39.5 85.6 60.0 111.4 115.1 50.7 68.3 126.4 113.1 48.8 50.0 50.3 SMAD7 "MADH7, MADH8" ENSG00000101665 "SMAD family member 7" O15105 18 48919853-48952052 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 54.5;Distal enterocytes: 56.6;Hepatic stellate cells: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.1;eosinophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026212, HPA028897" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB026212: , HPA028897: AB_10600811" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (5.61e-4)" "unprognostic (8.15e-2)" "unprognostic (5.35e-1)" "unprognostic (2.76e-1)" "unprognostic (6.02e-2)" "unprognostic (2.37e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-2)" "unprognostic (4.44e-1)" 17.5 5.9 8.0 8.7 6.8 17.9 14.6 11.5 7.9 17.5 10.7 12.9 10.4 11.3 2.9 4.9 8.2 10.3 30.7 5.4 5.3 11.7 8.7 22.1 5.8 10.7 8.9 4.0 7.6 5.3 12.4 6.6 19.1 11.0 11.4 12.1 3.2 6.3 8.6 10.8 7.8 15.1 9.3 9.3 5.9 12.6 1.3 7.7 3.8 16.7 6.8 5.3 13.5 12.3 9.2 3.7 2.8 2.8 8.3 14.3 5.0 21.1 18.6 7.1 6.5 3.1 1.0 5.3 0.3 32.2 13.1 6.0 19.2 6.1 5.8 3.6 38.4 9.4 0.3 10.5 6.9 2.1 6.9 18.6 5.1 4.8 7.8 7.8 32.2 1.1 0.6 6.6 25.9 9.1 1.2 0.0 1.9 17.3 27.7 1.1 2.1 2.5 9.0 9.1 4.2 4.8 10.3 8.0 3.5 6.6 21.2 3.3 5.6 17.3 18.5 9.9 5.3 16.5 13.4 7.1 2.0 8.1 4.9 3.1 4.1 0.1 5.6 0.8 0.5 0.6 0.1 0.8 0.7 0.1 0.0 0.2 0.5 0.0 1.7 0.1 0.0 1.2 0.2 8.0 6.8 11.5 7.9 5.4 5.3 10.7 8.9 4.0 11.0 9.3 7.7 9.2 30.4 54.5 9.4 3.9 7.0 12.9 3.5 7.2 14.2 6.1 14.7 10.3 9.7 1.5 11.2 11.0 6.2 9.9 43.7 56.6 9.8 14.4 0.2 43.2 30.5 25.0 12.7 0.0 6.5 13.9 3.3 15.5 8.2 45.9 18.9 4.0 71.4 3.1 8.9 0.0 5.0 19.1 2.0 23.3 8.9 1.1 1.5 14.7 0.0 19.7 8.2 1.4 11.3 5.5 16.3 31.5 17.3 3.4 13.8 3.0 28.7 7.1 3.3 2.5 6.6 11.3 14.1 0.1 0.6 14.2 11.8 12.9 25.2 1.3 12.4 2.6 LIPG EDL ENSG00000101670 "Lipase G, endothelial type" Q9Y5X9 18 49560699-49599185 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 150.6;thyroid gland: 244.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Extravillous trophoblasts: 67.9;Glandular and luminal cells: 49.0;Hepatocytes: 78.2" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 20.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 122.6;HaCaT: 189.8;RPTEC TERT1: 122.4;TIME: 247.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016966 Uncertain "Secreted to blood" NA NA 657000000 810000 "HPA016966: AB_1852893" "unprognostic (2.20e-2)" "unprognostic (3.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.25e-3)" "unprognostic (6.38e-2)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" "unprognostic (4.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.44e-1)" "unprognostic (6.44e-2)" "unprognostic (8.74e-2)" "unprognostic (2.98e-1)" "unprognostic (8.68e-2)" "unprognostic (5.64e-2)" "unprognostic (1.54e-1)" "unprognostic (1.35e-1)" 4.6 0.2 0.6 16.4 0.5 0.3 1.0 4.0 2.6 0.9 1.6 5.9 6.5 1.4 2.9 1.3 0.5 14.1 1.0 2.9 1.8 6.4 35.0 7.2 1.8 2.7 1.8 0.5 0.2 1.9 0.2 0.4 150.6 1.6 1.5 7.3 5.0 0.5 21.1 2.5 1.2 7.2 7.7 1.4 0.4 1.7 7.0 2.2 1.9 244.6 0.1 1.8 14.5 0.6 1.8 2.2 0.3 53.6 122.6 0.5 0.1 0.9 0.6 5.8 0.0 0.1 54.5 19.6 0.2 29.7 0.0 37.2 189.8 8.1 39.0 0.0 0.6 0.3 0.1 0.2 0.3 8.1 0.1 0.8 5.4 43.0 19.1 36.8 0.3 28.0 0.2 0.3 0.3 0.0 0.0 0.0 0.2 8.1 1.4 0.5 0.1 0.0 3.0 122.4 14.8 0.8 0.1 1.0 1.4 0.1 6.9 0.2 0.2 247.4 0.2 0.1 0.1 0.6 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.5 4.0 2.6 2.9 1.8 2.7 1.8 0.5 1.6 1.4 2.2 1.8 0.3 0.0 1.1 0.7 0.3 1.8 5.6 3.3 0.0 0.6 2.8 1.9 1.8 24.3 3.5 14.7 60.5 5.5 0.1 9.3 0.0 3.3 8.4 19.1 8.3 7.9 13.8 0.0 0.2 1.4 67.9 6.0 2.6 49.0 0.0 11.5 5.3 78.2 1.8 0.0 0.3 5.3 2.0 1.9 0.0 8.1 0.3 0.8 1.8 2.8 0.7 1.1 0.0 1.0 0.2 12.8 2.7 0.0 0.3 10.6 10.1 1.3 0.5 2.9 0.0 1.0 2.0 1.4 0.9 0.4 2.6 19.4 1.1 0.1 11.2 11.4 LAMA1 LAMA ENSG00000101680 "Laminin subunit alpha 1" P25391 18 6941742-7117797 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.0" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Distal enterocytes: 173.6;Granulosa cells: 77.3;Intestinal goblet cells: 44.2;Paneth cells: 35.8;Proximal enterocytes: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 56.0;ASC diff: 41.0;BEWO: 199.6;hTEC/SVTERT24-B: 41.7;SK-MEL-30: 38.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" CAB010179 Enhanced "Secreted to extracellular matrix" NA NA "CAB010179: AB_2133741" "unprognostic (2.75e-1)" "unprognostic (3.66e-4)" "unprognostic (2.08e-1)" "unprognostic (3.56e-1)" "unprognostic (4.97e-3)" "unprognostic (3.66e-2)" "unprognostic (1.72e-2)" "unprognostic (7.94e-2)" "unprognostic (2.23e-2)" "unprognostic (3.43e-2)" "unprognostic (3.02e-1)" "unprognostic (6.80e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-2)" "unprognostic (4.85e-1)" "unprognostic (3.47e-2)" "unprognostic (7.34e-3)" 0.5 0.0 2.7 0.2 1.5 0.0 1.6 2.3 1.2 0.8 0.4 0.1 0.0 0.9 1.4 0.1 0.2 0.0 0.1 1.9 2.0 2.0 0.1 0.3 0.0 1.9 2.3 0.7 1.4 1.1 0.0 1.0 0.1 2.0 0.2 0.0 0.4 1.3 0.6 0.0 0.2 0.0 0.3 2.8 0.1 0.0 6.0 2.8 0.1 2.6 0.0 0.0 0.3 0.2 2.9 0.0 0.0 56.0 0.0 41.0 36.5 199.6 2.0 9.8 9.9 21.5 24.4 0.0 0.0 0.5 3.4 8.0 0.1 0.0 7.3 4.1 0.0 3.2 0.0 11.8 0.0 4.8 0.0 0.0 31.1 1.1 41.7 23.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 2.8 0.0 0.0 38.4 11.6 0.0 0.0 0.0 7.5 20.5 4.2 0.1 0.0 0.0 0.0 3.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.5 2.3 1.2 1.9 2.0 1.9 2.3 0.7 2.0 2.8 2.8 2.9 2.6 6.4 0.0 90.8 0.0 0.0 0.8 0.8 0.6 0.5 2.3 7.2 1.9 4.3 0.0 0.0 0.0 4.1 0.0 173.6 0.0 0.0 1.6 4.1 0.6 0.2 1.2 0.0 1.4 0.5 3.1 4.2 0.0 4.3 0.0 77.3 0.0 0.1 0.9 0.0 1.7 44.2 0.0 0.0 0.0 3.7 0.0 0.2 0.0 15.0 0.0 3.4 0.0 4.0 1.8 0.0 35.8 0.0 0.0 1.0 47.5 1.4 0.1 0.3 0.0 0.6 3.4 0.4 2.5 0.3 0.0 4.8 0.2 4.6 16.5 0.3 RNF125 FLJ20456 ENSG00000101695 "Ring finger protein 125" Q96EQ8 18 32018825-32073219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.5" "Cell type enhanced" "Detected in many" "dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8" "Cancer enhanced" "Detected in all" "testis cancer: 8.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041514 Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA041514: AB_10795596" "unprognostic (2.13e-2)" "unprognostic (2.05e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-1)" "unprognostic (5.03e-1)" "unprognostic (4.50e-2)" "unprognostic (2.30e-3)" "unprognostic (6.15e-2)" "unprognostic (4.21e-2)" "unprognostic (3.24e-1)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.99e-1)" "unprognostic (4.12e-1)" "unprognostic (1.82e-1)" "unprognostic (7.07e-3)" 10.3 1.3 2.0 5.3 3.5 18.5 6.3 2.7 2.8 4.0 1.9 5.1 10.6 2.9 0.5 2.5 3.4 3.3 2.0 2.0 2.8 1.0 12.6 4.7 7.0 3.5 3.4 1.7 1.4 3.1 1.7 0.3 3.7 3.6 1.8 6.5 0.3 2.2 1.4 2.3 4.9 11.4 3.4 2.8 5.9 3.5 1.0 2.9 5.4 1.4 3.0 4.1 3.0 1.7 6.4 1.2 0.1 0.2 0.4 0.5 0.8 1.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 1.2 0.1 0.4 0.9 1.6 1.2 0.2 6.6 2.6 0.3 0.4 0.3 0.1 8.9 51.5 1.6 2.4 0.0 2.8 0.3 0.4 2.7 0.1 1.9 0.1 2.0 2.3 8.2 4.2 8.9 1.5 9.2 0.6 0.2 0.5 0.5 0.9 0.3 0.2 0.1 13.2 1.6 1.3 4.2 0.2 0.1 0.7 0.1 0.1 5.9 0.2 0.1 0.6 11.5 6.9 13.3 4.5 4.5 15.0 2.5 9.9 2.5 12.0 12.8 4.2 2.3 9.5 12.3 1.9 15.5 2.8 4.3 13.7 6.9 2.0 3.5 2.7 2.8 2.0 2.8 3.5 3.4 1.7 3.6 2.8 2.9 6.4 62.2 3.2 5.8 3.3 16.3 9.8 3.1 1.0 14.2 0.8 5.3 3.7 2.1 4.3 3.8 12.9 0.0 0.4 169.6 24.6 1.9 1.0 90.7 4.9 2.1 28.4 1.2 15.8 2.7 1.8 0.1 5.3 8.6 13.4 18.9 0.2 12.5 25.1 10.5 0.0 3.0 8.3 0.0 19.2 12.6 17.4 2.8 18.4 1.8 30.9 23.8 0.7 160.6 3.5 64.3 1.1 4.5 0.0 49.9 2.7 41.4 4.5 1.7 0.9 0.0 3.2 3.2 0.5 1.8 5.8 6.8 0.8 114.8 0.2 14.7 2.4 ANKRD12 "FLJ20053, GAC-1, KIAA0874" ENSG00000101745 "Ankyrin repeat domain 12" Q6UB98 18 9136228-9285985 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 106.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040705 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040705: AB_10673301" "unprognostic (2.20e-1)" "unprognostic (1.14e-1)" "unprognostic (3.59e-1)" "unprognostic (1.37e-1)" "unprognostic (1.46e-1)" "unprognostic (3.41e-3)" "unprognostic (7.25e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" "unprognostic (2.39e-2)" "unprognostic (4.62e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.03e-2)" 15.9 9.4 25.0 20.7 23.9 20.7 13.8 62.6 26.9 11.2 5.3 13.1 13.0 11.9 9.5 14.6 6.3 14.7 12.0 15.2 20.8 13.1 13.9 11.6 22.5 15.7 15.1 12.5 14.2 12.0 10.5 6.0 14.3 22.1 12.3 12.1 30.0 12.4 10.7 27.0 20.4 13.5 9.2 15.6 20.1 14.6 27.9 15.0 11.5 16.5 12.5 18.6 13.7 8.1 34.5 10.1 6.7 9.0 6.0 14.2 14.5 7.3 15.3 14.2 5.4 7.4 6.1 7.6 13.9 8.7 10.6 16.4 9.1 6.8 6.0 14.5 14.8 8.1 6.4 4.7 9.0 10.5 15.0 19.7 7.6 13.1 7.7 12.4 12.2 9.2 8.0 14.7 106.4 13.2 5.7 10.1 10.2 3.4 24.7 6.8 9.0 12.6 51.1 7.1 15.8 20.9 7.7 15.0 7.4 11.1 8.0 9.2 12.4 19.9 39.5 18.1 32.1 14.4 30.8 52.0 25.9 19.4 7.9 15.2 102.0 26.4 85.1 42.4 24.1 47.9 63.6 54.9 42.0 19.2 56.2 55.9 43.4 157.3 30.4 37.2 60.6 44.0 18.3 25.0 23.9 62.6 26.9 15.2 20.8 15.7 15.1 12.5 22.1 15.6 15.0 34.5 235.1 278.9 261.5 198.5 246.9 108.2 205.9 83.3 116.7 301.0 87.5 108.5 138.6 94.4 137.7 68.0 523.3 46.3 267.2 163.1 19.6 99.7 204.9 144.3 91.9 136.8 92.7 90.7 172.1 83.5 41.1 126.8 64.2 292.9 187.2 76.3 121.7 74.0 67.8 286.0 218.1 90.4 107.8 99.7 126.2 230.9 134.8 149.3 90.7 161.1 178.2 125.5 244.1 184.5 347.4 93.0 147.1 141.4 210.1 196.8 126.1 37.0 88.5 315.4 111.7 173.2 150.0 239.5 152.8 70.9 96.0 78.1 298.3 63.0 71.0 170.7 NOL4 "CT125, HRIHFB2255, NOLP" ENSG00000101746 "Nucleolar protein 4" O94818 18 33851100-34224952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;pituitary gland: 8.1;retina: 6.4;testis: 12.7" "Cell type enhanced" "Detected in some" "Astrocytes: 133.9;Early spermatids: 268.1;Excitatory neurons: 195.6;Inhibitory neurons: 207.7;Late spermatids: 95.7;Oligodendrocyte precursor cells: 326.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 36.0;SH-SY5Y: 9.5;U-698: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046740 Supported Nucleoplasm No NA Nucleoplasm "HPA046740: AB_10960527" "unprognostic (7.86e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-1)" "unprognostic (5.43e-7)" "unprognostic (5.76e-2)" "unprognostic (1.56e-2)" "unprognostic (7.19e-2)" "unprognostic (3.45e-1)" "unprognostic (1.12e-2)" "unprognostic (4.78e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (7.77e-2)" "unprognostic (7.71e-2)" 0.0 1.8 4.6 0.1 7.5 0.0 0.1 8.1 7.9 0.5 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.1 7.7 8.1 0.7 2.2 0.2 0.2 2.0 4.7 7.5 0.0 1.7 0.0 8.1 0.0 2.9 0.3 0.7 6.4 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.7 12.7 8.3 0.0 1.6 0.0 0.2 0.5 0.0 4.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.2 0.1 0.0 0.0 0.0 36.0 9.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.5 8.1 7.9 7.7 8.1 2.0 4.7 7.5 2.9 1.4 8.3 4.7 0.0 0.0 0.0 133.9 0.0 0.0 0.0 0.0 0.0 17.0 0.5 1.0 0.6 0.0 0.0 0.0 2.1 0.2 0.0 0.4 1.9 0.0 268.1 0.0 0.0 0.5 73.8 0.0 195.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.1 32.0 207.7 0.2 0.0 0.0 0.0 95.7 2.5 0.1 0.0 22.5 0.0 11.6 0.0 326.8 4.5 0.1 0.1 2.2 0.0 0.0 0.0 5.3 0.0 2.1 0.0 0.0 0.0 10.9 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 POLI "RAD30B, RAD3OB" ENSG00000101751 "DNA polymerase iota" Q9UNA4 18 54269517-54321266 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 117.4;Spermatocytes: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012000, HPA064696" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA012000: AB_1847786, HPA064696: AB_2685325" "unprognostic (1.64e-1)" "unprognostic (5.79e-3)" "unprognostic (9.72e-3)" "unprognostic (4.92e-2)" "unprognostic (3.04e-1)" "unprognostic (4.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.04e-3)" "unprognostic (2.22e-2)" "unprognostic (2.07e-3)" "unprognostic (1.30e-3)" "unprognostic (1.55e-1)" "unprognostic (4.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (6.99e-2)" 21.4 9.3 8.0 7.2 10.8 7.1 18.3 8.1 9.3 13.9 5.9 8.0 7.9 15.2 14.6 7.2 11.4 9.7 10.8 6.3 9.0 14.5 7.6 10.1 9.6 9.9 8.5 5.9 16.8 13.5 16.0 11.6 14.9 9.0 14.2 8.7 25.6 8.3 14.7 6.3 7.2 6.6 11.6 10.0 9.5 9.8 38.3 8.4 14.7 31.6 5.6 8.4 9.5 8.8 13.6 12.0 4.3 31.4 19.1 10.3 20.1 10.2 9.7 20.6 10.9 18.0 3.2 11.1 5.6 3.1 14.2 11.1 9.6 7.4 11.1 12.2 13.7 3.7 7.1 5.2 8.3 16.9 11.4 5.5 21.9 16.4 9.5 19.6 24.5 23.4 9.1 4.9 15.6 18.3 9.6 8.2 9.9 10.8 3.0 4.7 5.1 6.4 14.1 12.3 15.9 14.6 14.9 6.9 6.0 10.1 20.2 22.1 5.1 11.3 20.4 5.5 3.1 8.2 12.6 3.0 7.9 14.5 10.0 15.1 4.0 6.3 6.7 4.6 3.5 4.3 5.1 4.8 4.8 6.1 6.5 7.0 4.0 3.9 4.9 3.7 4.8 6.1 3.9 8.0 10.8 8.1 9.3 6.3 9.0 9.9 8.5 5.9 9.0 10.0 8.4 13.6 8.7 25.6 16.4 24.5 5.0 2.5 8.0 9.1 10.8 15.3 12.1 10.0 10.5 2.8 9.6 5.5 10.4 33.5 4.7 1.8 9.8 9.0 117.4 14.4 12.3 8.0 6.1 5.0 16.5 6.2 16.6 11.0 9.2 10.3 13.3 13.9 8.9 6.1 9.2 3.3 20.3 4.7 8.2 5.9 2.5 25.4 19.9 6.2 7.2 26.2 8.2 18.7 7.2 28.6 43.5 6.2 2.6 18.0 3.3 4.7 3.7 15.6 20.6 23.6 32.9 13.9 9.6 80.1 31.4 4.9 2.6 27.9 6.4 11.7 4.3 3.1 MIB1 "DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6" ENSG00000101752 "Mindbomb E3 ubiquitin protein ligase 1" Q86YT6 18 21704957-21870953 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "REH: 121.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019100, CAB037044" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB037044: AB_1841007, HPA019100: AB_1853934" "unprognostic (1.38e-1)" "unprognostic (6.92e-2)" "unprognostic (7.29e-2)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (3.23e-2)" "unprognostic (8.45e-3)" "unprognostic (2.70e-1)" "unprognostic (5.42e-2)" "unprognostic (4.69e-2)" "unprognostic (3.78e-2)" "unprognostic (4.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.91e-3)" "unprognostic (1.73e-1)" "unprognostic (4.86e-2)" "unprognostic (1.85e-2)" 8.2 6.4 10.0 6.1 9.9 4.9 11.3 10.2 9.1 11.1 8.5 7.2 5.2 13.2 9.5 8.1 7.1 8.7 6.1 9.0 9.7 11.2 10.5 7.2 7.7 10.2 10.8 7.6 11.8 8.2 9.9 5.3 11.1 9.8 10.2 7.1 8.3 8.5 8.6 5.8 9.2 5.3 10.3 10.7 7.3 7.6 8.8 10.8 11.6 13.7 7.0 7.9 8.5 8.3 10.5 19.9 7.6 36.4 25.8 19.5 23.0 9.0 15.6 17.2 10.8 15.6 11.3 7.1 16.9 14.1 21.4 11.8 13.2 21.4 21.0 24.4 22.4 10.4 18.8 9.7 15.9 15.8 38.3 7.8 14.8 23.0 12.6 32.0 16.0 27.8 6.6 26.5 47.5 17.2 9.5 18.9 14.7 9.5 12.2 10.2 121.1 30.3 42.5 18.7 16.9 12.1 30.1 26.8 12.4 13.9 18.6 8.8 25.1 23.9 27.8 14.2 11.7 21.1 25.6 9.5 25.4 11.8 24.1 16.9 0.7 0.3 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.1 0.2 0.1 0.3 0.5 0.1 0.2 0.4 0.1 10.0 9.9 10.2 9.1 9.0 9.7 10.2 10.8 7.6 9.8 10.7 10.8 10.5 35.7 48.1 22.7 68.2 11.9 21.9 15.1 19.8 24.5 28.8 24.1 19.7 18.1 25.8 31.8 16.5 25.0 13.3 18.2 20.8 3.9 13.4 7.0 29.0 59.2 30.8 24.0 23.1 106.7 12.9 7.5 33.1 10.2 32.4 14.5 16.8 24.3 30.0 12.9 15.2 92.6 17.1 26.4 17.2 16.2 5.6 20.5 14.2 26.6 67.5 19.4 17.7 15.5 121.2 109.6 18.8 7.0 24.8 18.1 48.5 8.7 15.9 30.6 14.5 0.0 35.4 26.9 26.2 12.0 23.4 24.6 25.3 14.5 21.8 10.4 25.3 RBBP8 "COM1, CtIP, RIM, SCKL2" ENSG00000101773 "RB binding protein 8, endonuclease" Q99708 18 22798261-23026488 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 125.9;Spermatocytes: 116.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 36.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039890, HPA052946" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA039890: AB_10794756, HPA052946: AB_2681996" "unprognostic (1.55e-3)" "unprognostic (4.10e-3)" "unprognostic (7.89e-2)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.28e-2)" "unprognostic (3.60e-3)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (2.29e-2)" "unprognostic (1.58e-3)" "unprognostic (1.04e-2)" "prognostic favorable (1.71e-5)" "unprognostic (3.91e-3)" "unprognostic (2.42e-2)" "unprognostic (1.01e-2)" "unprognostic (4.48e-1)" 8.6 8.8 7.6 10.1 7.5 18.3 29.7 10.0 11.3 21.0 35.7 14.7 9.4 20.3 23.6 22.3 28.3 12.8 6.6 8.2 12.0 42.4 14.6 13.7 14.1 7.1 8.2 7.2 6.5 18.6 22.3 17.6 8.6 7.4 10.9 13.0 6.3 19.6 23.5 2.3 28.8 13.0 16.5 7.2 7.7 13.2 29.0 8.6 32.7 18.3 3.5 17.4 18.5 18.1 8.1 32.9 24.8 36.0 41.9 18.2 19.4 28.2 44.2 31.1 40.3 56.5 45.7 36.3 95.4 19.9 27.9 38.5 67.3 41.2 89.9 78.5 68.3 33.2 41.8 32.0 44.0 22.2 151.5 43.7 13.9 86.0 61.0 105.3 23.6 16.6 65.7 25.0 69.2 41.6 49.1 112.8 50.6 34.2 60.1 41.5 57.6 65.9 58.9 117.4 34.7 84.1 39.8 74.1 22.4 39.0 20.5 129.1 39.4 12.0 107.2 49.3 52.4 78.0 92.9 108.4 105.3 49.1 72.2 58.8 17.0 6.5 3.9 1.2 24.0 0.5 6.6 1.7 2.1 8.2 5.3 0.9 1.5 2.4 7.9 36.7 8.1 4.7 3.8 7.6 7.5 10.0 11.3 8.2 12.0 7.1 8.2 7.2 7.4 7.2 8.6 8.1 13.1 35.3 42.8 10.1 22.9 27.4 44.7 125.9 76.8 4.3 22.6 72.6 10.4 35.8 41.9 29.5 4.2 12.7 25.0 14.5 43.0 30.5 17.7 56.0 19.5 14.2 7.7 37.0 20.3 33.0 9.4 13.2 23.0 67.3 66.1 22.3 5.7 16.4 11.7 1.7 15.5 9.3 16.2 11.4 23.5 14.5 6.5 27.5 23.2 8.4 9.0 2.1 4.1 9.5 2.7 44.9 8.6 5.3 53.8 37.5 17.5 26.1 28.2 7.9 0.0 20.4 14.0 116.6 83.4 36.2 19.7 15.2 13.6 9.8 14.9 45.5 RIOK3 SUDD ENSG00000101782 "RIO kinase 3" O14730 18 23453287-23486603 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 175.9" "Cell type enhanced" "Detected in all" "Distal enterocytes: 338.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001620, HPA024184" Approved Approved "Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus, Centriolar satellite" "HPA001620: AB_1079815, HPA024184: AB_1856289" "unprognostic (7.99e-2)" "unprognostic (1.71e-2)" "unprognostic (2.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.05e-1)" "unprognostic (7.48e-2)" "unprognostic (8.98e-3)" "unprognostic (1.01e-1)" "unprognostic (5.10e-2)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.10e-4)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.90e-2)" "unprognostic (1.46e-1)" "unprognostic (5.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.71e-2)" 23.3 18.7 5.8 20.6 7.1 175.9 19.4 7.8 10.3 15.5 10.1 47.9 52.1 16.8 12.5 66.1 15.0 24.5 33.0 5.9 8.0 29.9 56.0 22.9 23.0 9.5 7.0 4.8 15.8 27.9 23.0 5.5 35.2 9.2 20.2 43.9 19.8 23.4 14.6 53.4 33.6 63.0 19.9 8.0 21.6 38.9 37.0 7.1 21.7 22.4 49.3 30.5 26.1 27.2 10.7 41.9 15.7 17.8 25.0 31.8 37.7 28.5 38.9 29.8 27.6 28.4 17.3 47.5 27.6 52.3 43.7 26.9 57.6 25.9 45.4 38.9 29.5 12.0 25.9 26.9 22.2 71.7 74.7 25.8 39.0 91.2 44.1 66.7 36.7 38.4 19.2 39.8 34.7 45.0 19.4 25.8 15.6 17.6 59.0 31.3 31.3 33.2 41.2 39.3 50.0 39.5 28.9 50.1 28.4 37.4 41.0 21.9 45.0 63.7 48.4 10.9 21.2 28.9 66.1 56.0 38.2 31.0 36.7 38.2 50.1 24.5 14.8 15.0 34.6 10.8 14.0 12.3 12.6 19.1 18.5 9.8 11.2 17.2 15.0 39.0 8.6 19.4 20.7 5.8 7.1 7.8 10.3 5.9 8.0 9.5 7.0 4.8 9.2 8.0 7.1 10.7 49.7 80.1 57.7 23.2 46.4 120.4 92.4 78.6 113.8 44.1 49.3 35.6 69.1 51.5 81.5 25.8 56.3 43.0 74.6 338.1 25.4 51.0 271.5 130.1 85.5 44.1 62.8 259.8 35.5 52.7 64.6 48.8 93.8 267.2 63.3 40.0 29.6 88.5 41.1 28.6 34.2 119.9 50.8 59.9 51.2 305.8 22.4 85.7 42.7 15.9 80.6 18.3 53.5 34.2 49.5 148.4 210.7 30.1 63.4 118.5 199.5 52.5 72.3 46.4 6.6 43.9 51.6 28.4 10.1 164.2 143.6 88.4 57.3 71.1 77.2 244.4 CSTF2 CstF-64 ENSG00000101811 "Cleavage stimulation factor subunit 2" P33240 X 100820359-100841520 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000427, CAB004680" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA 14000 Nucleoplasm "Nuclear bodies" "CAB004680: AB_425385, HPA000427: AB_1078580" "unprognostic (2.02e-2)" "unprognostic (8.70e-3)" "unprognostic (3.50e-1)" "unprognostic (3.43e-1)" "unprognostic (7.00e-2)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.23e-6)" "unprognostic (2.02e-1)" "unprognostic (4.82e-2)" "unprognostic (2.08e-3)" "unprognostic (5.98e-3)" "unprognostic (2.75e-1)" "prognostic favorable (1.12e-4)" "unprognostic (1.75e-2)" "unprognostic (2.90e-2)" "unprognostic (8.75e-2)" "unprognostic (2.89e-1)" 6.3 7.2 5.4 10.0 5.9 10.6 7.7 6.7 6.3 7.0 5.0 12.1 8.7 7.5 8.2 19.3 8.2 6.4 6.2 5.9 6.1 8.0 5.3 6.4 12.6 5.5 5.7 5.2 7.2 4.8 9.0 5.3 7.3 5.6 7.6 13.2 8.6 7.9 8.5 4.6 8.5 8.2 7.7 5.0 7.0 6.6 12.8 6.3 12.2 6.8 5.1 20.1 10.1 8.4 6.3 36.0 41.7 27.5 24.9 14.7 11.4 37.2 29.6 24.0 47.6 68.0 45.4 32.1 35.6 35.2 19.1 61.2 35.1 64.2 35.3 57.2 36.5 39.9 32.8 38.8 29.8 19.4 46.9 33.8 11.3 16.5 49.8 32.6 12.7 29.0 31.3 56.2 33.7 29.2 41.9 38.4 31.8 76.8 55.7 39.9 35.8 46.3 42.3 17.5 34.4 24.1 30.4 49.1 20.5 20.4 27.6 20.5 20.3 25.8 26.2 42.3 38.1 37.8 22.8 52.3 45.9 22.5 48.6 32.4 20.0 16.1 11.1 23.4 18.9 17.9 17.4 21.1 21.8 23.3 16.9 19.0 17.8 2.6 23.9 25.8 16.7 24.2 15.3 5.4 5.9 6.7 6.3 5.9 6.1 5.5 5.7 5.2 5.6 5.0 6.3 6.3 4.1 3.2 1.1 3.9 8.2 4.2 4.6 20.7 9.6 2.2 3.1 3.0 4.9 2.8 12.9 0.0 2.1 16.7 3.6 5.9 5.9 12.5 13.3 6.3 4.9 4.6 4.2 12.8 10.4 8.3 18.4 4.3 6.1 4.3 3.8 5.5 2.5 1.5 10.8 3.3 10.8 3.7 14.2 2.5 3.7 2.4 4.7 4.3 1.8 1.0 5.9 4.5 4.1 7.1 5.7 15.4 6.7 4.1 6.2 2.0 5.4 4.0 9.9 2.9 6.6 2.7 5.7 18.8 25.5 14.4 4.1 7.7 7.1 5.0 6.4 5.0 H2BW2 "H2BFM, H2BM" ENSG00000101812 "H2B.W histone 2" P0C1H6 X 104039949-104042454 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.3;Karpas-707: 3.6" NA NA "unprognostic (1.87e-1)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" 0.4 0.4 2.9 0.3 2.9 0.6 0.6 4.0 4.4 0.4 2.5 0.2 0.3 1.3 0.8 0.2 0.8 0.6 0.1 2.9 2.9 0.2 0.0 0.2 0.9 2.8 2.9 2.9 1.9 0.0 0.3 0.0 0.1 3.1 0.5 0.3 0.8 0.4 0.6 0.2 0.7 0.2 1.1 2.8 0.5 0.3 2.4 2.9 2.0 0.2 0.6 0.7 0.4 0.0 3.0 0.0 0.3 2.8 1.9 0.5 1.0 0.2 0.3 0.2 0.6 0.8 0.6 0.1 0.6 0.2 0.2 0.4 0.0 0.2 0.0 1.2 0.7 1.4 0.4 0.0 0.0 0.6 0.2 0.4 0.1 0.2 0.8 0.2 3.3 0.5 1.4 0.0 3.6 1.2 0.5 1.8 0.0 1.3 0.0 0.2 0.9 1.1 0.3 0.9 0.7 0.5 2.3 0.0 0.0 0.0 0.9 0.0 0.4 0.9 2.0 0.3 0.4 0.7 0.2 0.0 1.2 0.3 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.9 2.9 4.0 4.4 2.9 2.9 2.8 2.9 2.9 3.1 2.8 2.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MXRA5 DKFZp564I1922 ENSG00000101825 "Matrix remodeling associated 5" Q9NR99 X 3308565-3346652 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 35.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 38.5;Collecting duct cells: 31.3;Exocrine glandular cells: 60.7;Fibroblasts: 56.0;Pancreatic endocrine cells: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 31.4;BJ hTERT+: 125.8;fHDF/TERT166: 59.8;HaCaT: 52.4;HSkMC: 24.7" "Low region specificity" "Detected in all" "HPA000508, HPA076518" Uncertain Uncertain Mitochondria "Secreted to extracellular matrix" NA NA 2600000 Mitochondria "HPA000508: AB_2147995, HPA076518: " "unprognostic (7.51e-2)" "unprognostic (6.45e-2)" "unprognostic (8.00e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (7.05e-2)" "unprognostic (7.25e-2)" "unprognostic (1.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-2)" "unprognostic (6.32e-3)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.94e-4)" 12.1 10.4 0.2 9.5 0.4 0.1 13.7 0.1 1.2 35.3 1.1 7.6 4.4 6.9 2.7 9.5 3.0 8.0 11.2 0.2 1.5 5.3 4.5 5.3 1.6 0.4 0.2 0.1 2.9 16.3 1.7 0.9 5.8 0.2 7.4 10.5 0.0 6.2 10.5 1.5 29.8 4.7 16.0 0.5 3.6 10.4 0.1 1.0 5.7 9.9 5.2 3.8 20.1 7.3 0.9 0.0 0.0 0.8 0.0 0.2 31.4 0.0 19.6 125.8 0.2 0.2 0.0 0.6 0.0 1.7 59.8 0.2 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.7 5.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 2.0 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 1.2 0.2 1.5 0.4 0.2 0.1 0.2 0.5 1.0 0.9 10.3 0.0 0.0 0.0 0.0 38.5 7.1 10.5 20.5 0.0 2.0 4.6 1.9 0.0 3.7 31.3 0.0 0.1 0.3 0.9 0.0 2.2 0.0 1.0 8.4 4.6 0.0 0.0 0.7 60.7 0.7 56.0 0.0 1.6 0.0 0.0 10.8 0.1 0.3 0.0 1.1 0.0 0.0 0.3 16.9 0.0 0.0 0.3 17.8 4.7 0.6 0.0 0.0 0.5 0.2 42.8 0.0 1.5 0.1 0.2 0.1 0.1 1.0 0.2 0.0 7.3 9.8 0.0 0.0 5.5 21.7 0.3 1.1 0.9 0.4 2.0 VSIG1 "GPA34, MGC44287" ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 195.3" "Cell type enriched" "Detected in some" 10 "Gastric mucus-secreting cells: 333.8" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 12.0;T-reg: 12.9" "Lineage enriched" "Detected in many" 4 "T-cells: 12.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.5;HUVEC TERT2: 7.4;PC-3: 2.3;TIME: 1.7" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.0 0.1 0.3 1.3 0.4 0.5 0.1 0.2 0.3 0.0 0.3 0.2 1.3 0.1 0.3 0.2 0.0 8.5 0.0 0.2 0.2 0.1 0.1 1.0 1.9 0.1 0.1 0.2 0.0 0.2 0.0 2.6 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.5 0.0 0.1 0.8 195.3 48.1 0.2 0.8 0.1 0.0 1.6 9.0 0.1 0.2 0.1 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.6 0.0 1.1 0.0 7.4 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.6 2.3 0.2 0.0 0.0 0.3 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.7 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 1.0 0.0 3.8 2.8 8.1 3.6 0.0 1.3 12.0 5.8 0.3 0.1 0.1 0.1 12.9 2.6 0.3 0.4 0.2 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 25.6 11.0 1.0 2.4 0.6 0.9 0.7 0.0 0.9 0.2 0.1 0.5 1.5 0.7 0.0 0.0 0.0 0.1 0.4 0.0 2.9 6.1 1.1 0.1 1.0 0.0 0.0 4.1 4.6 0.0 0.6 333.8 0.2 2.5 0.0 0.0 0.0 0.1 0.0 1.4 0.3 0.0 0.0 0.4 10.8 0.6 0.7 0.0 0.0 0.3 0.1 1.0 0.0 0.1 32.9 0.0 0.0 1.0 0.6 0.0 0.0 0.9 0.8 0.0 1.1 0.2 1.0 0.6 0.0 0.0 0.1 4.5 0.2 0.1 3.8 PSMD10 p28 ENSG00000101843 "Proteasome 26S subunit, non-ATPase 10" O75832 X 108084207-108091549 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002920, CAB010434" Approved Supported "Intermediate filaments,Cytosol" NA NA 250000 Cytosol "Intermediate filaments" "CAB010434: AB_640866, HPA002920: AB_1079708" "unprognostic (1.59e-3)" "unprognostic (4.12e-3)" "unprognostic (3.83e-1)" "unprognostic (3.00e-1)" "unprognostic (4.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.85e-3)" "unprognostic (2.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-2)" "unprognostic (4.95e-2)" "unprognostic (7.37e-3)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (2.09e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 28.4 38.9 56.7 26.4 57.7 29.0 35.4 60.3 66.7 34.6 53.4 33.0 25.5 36.8 48.7 34.8 45.3 26.0 26.3 55.2 63.6 34.9 33.7 28.9 35.1 61.9 62.2 54.9 32.0 18.8 41.8 33.3 40.7 65.0 31.9 33.5 45.0 26.4 30.7 25.0 27.0 27.2 36.5 61.8 27.3 28.0 27.8 63.6 42.3 38.5 24.1 39.4 33.7 27.9 65.6 101.3 100.5 68.9 62.6 102.6 77.3 61.8 81.6 69.2 73.9 64.0 60.7 64.4 86.0 119.7 80.2 107.6 54.0 109.8 80.3 113.4 91.3 94.8 50.5 91.0 78.2 51.8 79.2 54.8 58.2 85.9 67.2 82.2 73.2 186.4 83.2 99.9 114.3 94.0 133.0 75.3 70.9 124.1 96.9 138.3 74.2 97.5 92.7 80.7 64.8 44.2 42.1 124.8 52.4 86.0 87.4 56.5 66.9 130.5 58.1 33.1 98.3 61.4 88.5 128.5 90.5 80.4 109.2 69.7 83.6 46.8 72.3 45.9 58.1 49.0 47.9 45.8 49.2 52.2 48.0 45.6 51.4 22.0 58.3 71.4 53.0 57.8 69.9 56.7 57.7 60.3 66.7 55.2 63.6 61.9 62.2 54.9 65.0 61.8 63.6 65.6 14.2 19.2 19.8 3.3 23.4 22.6 25.9 31.8 23.9 15.1 20.4 20.6 11.2 8.6 35.4 11.0 2.1 28.3 12.8 16.5 31.3 19.9 4.1 38.3 26.9 22.8 14.4 35.7 3.4 18.7 35.3 22.6 11.7 21.6 34.1 17.9 22.1 25.6 31.3 13.5 4.5 16.8 16.2 29.5 19.0 4.4 25.7 20.2 17.8 0.0 26.1 18.3 20.6 5.5 9.6 24.5 14.1 21.1 34.7 26.6 14.9 34.8 69.9 7.7 0.0 13.8 32.1 46.2 40.3 32.4 29.1 25.0 20.2 24.6 19.2 33.7 ATG4A "APG4A, AUTL2" ENSG00000101844 "Autophagy related 4A cysteine peptidase" Q8WYN0 X 108091668-108154671 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 84.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036374, HPA064759" Uncertain Approved "Actin filaments,Microtubules" NA NA Microtubules "Actin filaments" "HPA036374: AB_10672354, HPA064759: AB_2685346" "prognostic unfavorable (1.36e-5)" "unprognostic (1.41e-2)" "unprognostic (3.65e-1)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "unprognostic (2.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.14e-1)" "unprognostic (2.62e-2)" "unprognostic (4.09e-1)" "unprognostic (1.03e-3)" "unprognostic (7.53e-2)" "unprognostic (2.98e-1)" "unprognostic (5.02e-3)" "unprognostic (1.20e-2)" 8.2 8.5 4.9 7.9 5.3 9.1 7.8 5.3 6.2 7.7 9.4 12.2 12.9 4.8 11.7 9.0 5.7 7.8 11.9 4.7 7.4 14.2 18.2 9.0 8.3 5.4 5.2 4.1 2.8 17.4 12.5 6.1 8.1 5.4 6.0 13.3 5.8 13.1 7.2 18.7 5.9 11.5 7.8 5.2 7.8 11.3 2.4 5.3 11.3 11.5 18.8 11.2 9.0 5.1 5.7 13.0 6.5 4.1 7.8 38.2 13.2 5.1 17.5 11.2 9.1 10.6 5.3 6.9 14.0 15.7 14.0 14.5 6.0 11.9 13.0 13.5 24.1 12.9 6.0 10.3 3.7 8.4 13.0 18.8 13.4 13.9 11.1 4.8 8.4 84.9 19.5 18.5 43.5 16.6 12.8 12.1 11.9 7.8 23.6 18.4 8.2 6.9 20.3 13.2 11.3 5.9 4.5 11.2 13.9 7.9 12.4 7.0 11.5 24.0 5.7 2.6 19.1 9.8 20.2 24.0 15.1 11.1 14.6 8.1 28.1 7.8 15.1 11.7 11.3 8.4 9.2 8.9 11.4 10.6 9.9 7.1 12.0 2.4 12.3 7.8 5.4 10.3 8.7 4.9 5.3 5.3 6.2 4.7 7.4 5.4 5.2 4.1 5.4 5.2 5.3 5.7 13.6 3.2 10.3 9.1 8.1 5.1 4.9 13.5 2.8 3.2 7.0 4.6 17.4 7.2 12.8 5.5 4.2 6.2 12.4 19.1 27.4 9.6 7.0 10.6 7.4 12.9 6.7 36.7 7.9 17.9 7.5 4.6 8.2 6.0 3.8 3.3 9.7 15.4 9.0 1.7 8.4 9.0 30.5 4.1 3.6 10.0 2.8 7.3 14.2 4.7 6.7 10.3 18.6 7.1 11.6 16.6 8.0 7.5 23.5 5.6 14.7 24.7 17.2 5.0 0.0 4.5 6.9 2.4 3.9 5.9 5.3 10.4 12.0 6.2 5.6 7.3 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7147237-7804358 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 26.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 41.8;Excitatory neurons: 32.2;Inhibitory neurons: 39.3;Syncytiotrophoblasts: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 48.5;RPMI-8226: 69.8;U-266/70: 110.2;U-698: 47.2" "Low region specificity" "Detected in all" HPA002904 Enhanced NA NA "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 18.3 4.7 3.8 4.5 5.0 2.1 5.9 4.2 12.0 5.6 1.3 6.9 2.8 4.3 2.4 3.1 4.9 7.4 6.6 4.3 3.8 4.8 8.7 8.8 4.1 5.8 6.1 4.3 4.8 3.1 2.9 1.2 26.9 6.6 5.3 6.0 6.2 3.2 5.6 5.3 5.0 3.2 6.9 0.9 4.7 12.1 2.4 12.6 4.4 4.0 6.6 3.7 9.5 3.9 7.8 11.5 3.7 7.5 3.0 48.5 24.9 37.5 22.3 7.8 5.8 5.3 19.2 11.2 21.4 5.0 15.5 5.0 3.0 5.4 3.9 5.8 3.3 8.6 1.8 12.7 5.7 2.7 3.8 11.5 8.3 0.7 3.8 2.3 4.0 8.8 2.0 1.4 23.5 15.2 2.9 2.2 3.1 3.3 0.2 4.8 3.9 4.8 69.8 14.2 16.0 5.6 4.8 4.7 8.3 3.0 11.8 3.8 1.6 15.8 22.5 2.2 30.0 4.4 110.2 0.8 47.2 5.9 3.0 6.5 0.9 1.7 0.4 0.4 2.0 0.2 0.4 0.2 0.2 0.9 0.7 0.1 0.3 1.3 0.7 1.3 0.3 0.3 0.6 3.8 5.0 4.2 12.0 4.3 3.8 5.8 6.1 4.3 6.6 0.9 12.6 7.8 10.2 12.8 2.2 10.4 1.8 0.9 1.8 2.9 0.6 3.5 3.3 1.5 7.5 1.5 8.5 1.8 0.0 41.8 1.6 16.7 0.0 8.6 0.3 4.5 4.5 4.2 3.6 3.2 32.2 19.9 18.9 6.1 5.1 5.2 7.0 6.7 3.6 8.2 7.7 1.7 39.3 4.6 10.2 7.5 1.7 0.4 2.8 2.8 1.8 10.3 4.7 2.6 0.0 19.1 12.1 10.2 6.5 6.8 1.9 7.8 4.6 3.0 7.5 0.8 0.0 17.5 5.7 0.5 1.7 0.4 1.0 94.0 1.0 4.0 4.3 8.9 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Congenital hypothyroidism, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 103.8;Oligodendrocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 18.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: AB_2685892" "prognostic unfavorable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favorable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favorable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 9.4 9.2 19.2 8.7 19.2 7.3 9.8 17.0 16.1 17.3 13.6 7.9 2.8 38.7 35.6 10.3 16.7 7.2 7.4 16.0 22.9 16.8 13.7 5.9 9.1 22.8 17.9 14.2 18.1 9.3 24.0 18.9 20.8 18.5 25.6 5.4 16.7 7.4 43.6 4.7 7.3 5.1 26.9 17.9 8.5 8.1 9.7 22.4 18.5 12.1 5.3 10.3 13.7 12.8 19.3 0.1 29.6 18.5 49.2 16.8 17.4 18.4 11.3 25.0 21.3 22.2 22.4 20.2 31.6 0.8 22.7 9.1 6.7 40.7 8.9 30.9 13.0 19.6 20.0 35.6 26.5 23.7 7.2 68.6 15.6 10.1 22.3 11.8 11.7 19.9 17.2 35.8 53.5 12.5 25.6 17.8 27.2 36.7 14.2 31.5 39.3 14.5 39.3 28.9 16.9 23.4 10.6 27.2 6.8 16.9 48.2 13.3 15.6 29.1 7.5 18.3 0.8 4.6 32.6 27.8 25.1 27.2 17.4 7.1 6.3 4.7 5.7 2.2 2.9 1.8 2.2 1.7 2.0 3.5 3.6 3.1 2.9 18.7 0.3 2.0 0.3 2.9 2.1 19.2 19.2 17.0 16.1 16.0 22.9 22.8 17.9 14.2 18.5 17.9 22.4 19.3 12.6 0.0 4.5 103.8 17.3 6.5 13.2 3.8 9.1 11.8 19.1 18.0 10.1 20.0 6.8 31.3 22.9 78.1 20.4 7.9 13.7 10.7 1.0 34.4 80.7 10.3 22.8 3.8 12.5 7.8 6.0 13.1 9.7 51.1 11.4 32.5 11.4 64.3 11.3 6.7 17.1 5.4 2.0 33.0 22.8 3.2 14.3 19.7 5.4 61.8 37.5 46.6 19.6 46.3 109.7 7.5 7.9 28.6 9.5 24.1 0.2 21.8 10.0 24.5 0.0 9.4 27.9 1.4 18.0 16.5 12.4 45.0 18.8 22.3 4.9 23.7 GPR143 OA1 ENSG00000101850 "G protein-coupled receptor 143" P51810 X 9725346-9786297 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8;choroid plexus: 12.3" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 40.6;Melanocytes: 126.3" "Cancer enriched" "Detected in all" 9 "melanoma: 84.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 3.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 159.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA003648 Enhanced NA NA "HPA003648: AB_2667028" "unprognostic (4.60e-2)" "prognostic favorable (8.73e-4)" "unprognostic (7.43e-3)" "unprognostic (5.41e-2)" "unprognostic (4.62e-3)" "unprognostic (2.00e-2)" "unprognostic (3.05e-1)" "unprognostic (2.64e-3)" "unprognostic (3.78e-1)" "unprognostic (5.89e-2)" "unprognostic (8.18e-2)" "unprognostic (8.40e-2)" "prognostic favorable (2.45e-5)" "unprognostic (2.75e-1)" "unprognostic (2.07e-1)" "unprognostic (8.76e-2)" "unprognostic (1.59e-2)" 0.3 1.1 9.8 0.1 11.0 0.0 1.7 11.1 11.6 1.9 12.3 1.4 0.5 3.3 5.3 2.4 2.8 0.9 0.1 9.8 12.8 4.6 1.7 1.0 0.5 11.2 11.6 8.1 3.3 1.2 2.9 2.7 6.1 11.0 2.6 1.4 0.9 3.3 4.5 0.0 9.0 0.5 1.0 10.4 0.0 0.7 0.8 11.5 1.8 3.3 0.0 1.6 1.1 1.1 11.2 1.9 0.4 4.6 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.4 0.1 0.2 1.1 0.1 0.1 0.3 0.0 0.2 0.6 2.3 0.0 3.4 0.1 1.6 0.0 0.0 24.2 6.7 0.0 0.0 0.0 0.0 12.1 0.0 0.1 11.1 0.0 0.1 0.0 0.1 0.1 22.2 3.2 0.9 0.0 0.3 0.0 159.6 10.8 1.9 0.0 4.6 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 3.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 9.8 11.0 11.1 11.6 9.8 12.8 11.2 11.6 8.1 11.0 10.4 11.5 11.2 0.1 0.0 0.0 9.8 0.2 5.5 1.3 1.8 2.2 0.5 2.1 1.7 0.9 0.0 4.9 7.3 0.0 40.6 0.0 0.8 1.9 4.9 0.2 1.7 1.6 1.5 0.0 0.0 0.6 0.6 2.1 1.0 0.0 1.3 0.0 1.8 2.9 0.3 4.8 0.0 0.3 0.8 2.0 0.0 1.6 1.8 1.8 0.1 126.3 1.0 0.0 1.2 0.0 0.5 0.6 1.2 0.2 6.4 0.0 1.8 0.2 5.0 3.2 0.2 0.0 0.0 0.7 0.2 1.3 4.2 0.6 10.1 0.7 1.0 2.0 1.8 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 682.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 520.4;Theca cells: 907.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Supported "Nucleoli,Endoplasmic reticulum" NA NA 1200000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 108.9 172.7 102.3 37.8 112.3 25.3 107.1 90.4 116.4 136.6 102.9 99.1 110.3 155.9 275.7 57.5 150.3 57.4 33.4 111.9 117.6 237.6 682.9 62.6 27.8 104.0 121.1 110.1 94.1 40.6 114.8 59.6 45.3 126.7 128.7 88.1 81.2 72.0 202.3 15.8 48.8 133.0 85.9 105.2 41.8 77.8 46.9 121.8 33.7 89.8 27.2 29.5 78.0 65.6 135.2 165.6 102.4 196.3 227.7 414.2 196.9 127.1 243.0 281.0 126.1 155.7 124.5 196.6 47.3 259.5 253.8 147.3 128.3 216.5 102.1 168.8 50.8 248.7 53.7 88.5 141.0 69.0 88.4 27.5 204.7 56.5 153.8 79.2 93.5 82.6 55.7 57.2 28.8 150.3 176.5 66.9 64.7 515.8 179.4 170.3 78.5 123.1 68.5 168.7 123.9 182.9 81.7 178.1 291.7 98.9 188.2 67.4 56.2 64.2 87.6 127.7 312.6 233.6 29.9 59.2 51.0 238.8 138.6 170.6 21.0 20.1 20.4 8.7 19.9 11.8 5.8 12.0 12.9 17.0 5.5 12.0 10.1 9.1 8.8 18.4 12.0 13.4 50.2 102.3 112.3 90.4 116.4 111.9 117.6 104.0 121.1 110.1 126.7 105.2 121.8 135.2 109.1 125.0 91.4 16.0 19.0 94.1 131.3 67.4 81.4 199.1 110.8 95.1 17.1 120.1 76.7 73.5 68.8 88.2 25.8 170.5 68.4 93.0 4.2 119.7 264.2 81.9 57.7 37.6 36.5 73.0 138.6 153.1 50.4 122.4 40.5 197.0 66.4 520.4 51.8 65.6 58.5 85.0 81.4 35.0 51.2 9.0 172.1 111.1 103.2 15.0 26.5 109.8 18.6 108.6 91.3 68.9 144.7 181.7 22.6 118.8 375.5 295.1 105.4 92.4 105.2 99.2 111.1 68.2 77.2 69.3 87.7 62.1 32.1 907.9 137.6 127.9 POLA1 "NSX, p180, POLA" ENSG00000101868 "DNA polymerase alpha 1, catalytic subunit" P09884 X 24693873-24996986 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA replication, Host-virus interaction" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant, Dwarfism, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Excitatory neurons: 42.3;Inhibitory neurons: 65.7;Microglial cells: 57.1;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 97.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002947, CAB012274" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012274: , HPA002947: AB_1079652" "unprognostic (6.92e-2)" "unprognostic (4.43e-3)" "unprognostic (3.27e-3)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.87e-1)" "unprognostic (9.25e-3)" "unprognostic (2.48e-2)" "unprognostic (8.41e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-2)" "unprognostic (3.08e-1)" 3.8 2.0 1.8 4.8 2.5 7.3 5.1 2.2 1.8 4.1 0.9 4.1 2.4 4.2 1.4 4.0 3.7 2.1 3.3 1.4 1.9 2.9 2.0 3.1 6.9 2.4 2.4 0.9 5.9 2.8 3.5 1.8 5.6 2.6 3.1 5.3 3.7 3.1 3.6 4.9 4.0 3.5 4.9 2.5 3.5 3.7 2.6 2.2 12.1 3.1 3.1 7.7 3.7 3.8 2.9 32.7 24.6 30.3 24.1 5.2 6.5 6.9 23.6 12.7 25.0 28.3 20.4 17.0 41.1 7.7 9.6 23.4 26.0 59.7 18.7 33.6 21.1 24.8 31.0 42.8 13.5 2.4 41.6 15.5 4.1 3.6 31.2 8.4 5.8 13.0 20.8 28.7 20.0 16.8 22.4 45.2 7.2 30.7 20.3 19.1 39.0 81.5 30.7 7.1 21.1 27.9 16.7 28.1 11.2 11.6 33.0 25.7 11.5 10.1 21.3 14.9 42.4 22.6 11.6 18.1 32.7 12.4 18.3 24.9 0.0 0.2 0.2 0.6 1.4 0.8 1.0 0.8 1.0 0.7 0.4 0.4 0.5 0.0 0.8 0.2 0.2 0.9 0.5 1.8 2.5 2.2 1.8 1.4 1.9 2.4 2.4 0.9 2.6 2.5 2.2 2.9 5.8 9.6 6.5 38.5 5.2 2.8 4.6 1.8 5.7 3.9 4.7 4.3 11.8 0.0 7.2 1.8 2.1 6.1 3.2 2.5 3.9 3.2 0.2 3.2 4.7 6.3 4.2 24.2 42.3 3.0 4.9 4.6 4.6 3.8 9.5 8.3 3.3 3.4 4.4 1.7 65.7 4.2 4.1 4.4 1.5 1.7 6.2 4.5 0.0 57.1 3.7 4.8 5.2 59.3 97.7 1.4 1.2 3.4 8.6 2.0 2.3 1.6 6.1 7.4 6.6 9.2 6.0 6.4 4.5 5.5 2.3 2.3 4.9 5.0 4.2 2.4 MID1 "FXY, OS, RNF59, TRIM18" ENSG00000101871 "Midline 1" O15344 X 10445310-10833654 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 129.3;Basal squamous epithelial cells: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 156.1;AF22: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002878, HPA003715" Approved Uncertain "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA002878: , HPA003715: AB_1079384" "unprognostic (1.99e-1)" "unprognostic (2.81e-1)" "unprognostic (4.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.78e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.09e-1)" "unprognostic (2.87e-1)" "unprognostic (9.43e-2)" "unprognostic (1.25e-3)" "unprognostic (9.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.12e-3)" "unprognostic (5.88e-2)" 5.9 2.5 7.1 5.1 7.9 1.7 5.4 17.7 5.3 7.0 6.3 13.4 5.7 8.9 5.0 7.1 6.4 6.8 7.9 6.7 10.0 6.4 4.2 6.5 2.2 4.7 8.1 4.2 4.4 3.6 2.9 4.2 6.2 7.0 10.5 10.7 12.4 4.9 13.0 0.8 2.9 5.9 12.4 2.4 1.0 3.8 3.6 6.9 2.3 4.2 2.2 3.1 11.8 6.3 6.5 33.2 156.1 132.5 16.7 8.1 9.2 14.6 16.2 17.8 19.7 20.7 31.0 9.7 10.6 6.5 21.9 58.4 22.5 11.0 15.1 23.0 1.3 11.0 2.7 24.3 1.1 2.8 0.3 1.2 12.1 7.0 16.1 15.8 20.4 23.1 5.1 2.1 3.2 9.6 8.0 5.3 0.5 32.7 5.1 10.0 3.9 28.9 0.4 18.7 36.2 7.1 3.5 7.4 23.5 10.1 42.7 19.2 0.2 13.7 7.2 1.0 34.1 17.0 2.8 1.2 0.4 13.5 0.3 31.3 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.0 0.1 0.4 0.0 0.1 7.1 7.9 17.7 5.3 6.7 10.0 4.7 8.1 4.2 7.0 2.4 6.9 6.5 16.5 35.3 20.7 129.3 0.7 21.4 31.5 24.7 82.6 10.7 8.5 13.2 4.8 8.6 19.6 23.9 18.8 9.1 1.3 22.6 1.9 13.4 2.2 39.8 8.9 25.4 12.1 2.7 15.5 8.7 26.9 16.2 10.7 38.5 1.3 13.4 69.9 4.0 1.5 69.0 44.3 9.0 2.0 2.5 5.8 7.9 30.1 1.2 3.6 23.4 0.0 37.0 0.0 66.4 59.2 7.3 17.2 41.3 0.2 8.2 11.3 1.5 19.3 2.9 6.6 3.7 3.3 0.3 2.4 36.1 10.1 20.0 0.8 9.7 20.0 49.2 NKAP FLJ22626 ENSG00000101882 "NFKB activating protein" Q8N5F7 X 119920672-119943751 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Repressor "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000916 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000916: AB_1079486" "prognostic unfavorable (4.20e-4)" "unprognostic (4.28e-3)" "unprognostic (9.14e-2)" "unprognostic (1.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.42e-2)" "unprognostic (3.49e-3)" "unprognostic (4.18e-3)" "unprognostic (3.70e-2)" "unprognostic (1.05e-2)" "unprognostic (1.05e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" 9.6 13.2 11.2 9.9 11.7 13.7 10.7 12.0 16.3 9.3 11.3 9.9 10.3 10.7 10.8 7.4 11.1 9.0 11.1 10.7 11.8 11.4 14.6 10.6 14.5 12.1 11.5 10.7 14.2 10.2 14.4 2.8 13.6 11.7 10.5 10.2 9.7 10.0 13.6 18.4 7.4 12.8 10.4 11.5 12.6 9.4 8.6 11.6 12.8 10.2 14.5 13.1 9.8 2.4 13.2 25.0 24.3 17.6 22.3 15.3 24.7 28.9 17.7 20.4 23.4 17.2 15.9 20.9 17.6 29.9 14.6 45.8 18.3 33.7 20.6 27.9 29.6 31.2 11.1 20.6 23.3 25.1 25.2 20.4 17.9 26.4 25.1 24.7 25.3 23.2 23.8 30.6 25.5 18.4 33.8 21.4 47.0 23.6 32.4 32.8 22.8 24.3 32.7 17.5 9.6 19.2 27.2 36.8 19.7 52.3 20.9 16.8 21.1 17.4 14.8 9.0 38.4 27.4 25.4 26.7 30.2 20.4 18.9 26.1 39.7 23.5 55.6 20.8 20.0 21.6 32.2 25.4 21.2 20.6 36.6 25.6 24.3 44.5 22.2 23.1 32.5 26.6 14.3 11.2 11.7 12.0 16.3 10.7 11.8 12.1 11.5 10.7 11.7 11.5 11.6 13.2 39.9 22.4 40.4 5.2 36.1 25.9 36.1 45.5 26.7 34.0 26.2 33.3 30.3 15.7 42.3 20.2 25.0 62.5 36.0 17.5 37.2 36.7 8.8 33.6 37.4 40.3 22.8 20.6 7.2 44.3 132.0 39.1 17.9 26.7 47.4 41.6 41.4 46.3 53.0 55.5 9.0 27.9 22.4 28.0 23.2 8.9 45.1 33.9 35.6 4.7 35.3 56.3 36.0 7.5 11.0 37.5 23.3 55.3 30.6 40.3 25.8 51.3 49.4 38.5 13.1 33.4 45.0 82.7 69.6 19.6 28.7 72.9 41.5 48.3 23.1 33.7 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109051-120115913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 15.2" "Cell type enriched" "Detected in some" 14 "Spermatogonia: 123.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "T-reg: 4.9" "Lineage enriched" "Detected in single" 33 "T-cells: 4.9" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 1.7 1.2 2.5 0.1 2.1 0.1 1.4 3.5 3.5 1.3 2.4 1.3 0.0 0.8 0.0 0.5 2.4 0.2 0.5 2.1 2.6 1.8 0.9 0.5 0.3 2.4 2.6 2.1 3.6 0.3 0.1 1.8 0.0 3.0 1.4 0.0 2.6 0.6 0.2 0.2 1.2 1.0 0.1 2.2 1.3 0.7 15.2 2.4 0.2 1.1 0.0 0.1 1.1 0.8 2.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.9 0.0 2.5 2.1 3.5 3.5 2.1 2.6 2.4 2.6 2.1 3.0 2.2 2.4 2.7 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.0 1.3 0.3 0.5 1.3 0.0 0.0 0.0 4.2 0.1 0.2 0.1 1.9 0.2 1.5 0.2 0.1 0.5 0.0 0.0 0.8 0.4 0.4 0.2 0.0 0.1 0.0 8.3 0.0 0.2 0.1 0.0 1.5 0.3 0.0 0.0 0.0 3.8 0.6 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.1 0.0 0.1 2.4 1.3 0.0 0.0 0.3 3.3 123.8 0.0 0.3 0.0 0.2 0.7 0.2 0.0 NXT2 P15-2 ENSG00000101888 "Nuclear transport factor 2 like export factor 2" Q9NPJ8 X 109535781-109544698 "Predicted intracellular proteins" "mRNA transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 157.3;U-937: 166.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024199, HPA072010" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024199: AB_1854738, HPA072010: AB_2686483" "unprognostic (1.72e-1)" "unprognostic (1.39e-2)" "unprognostic (7.99e-2)" "unprognostic (5.31e-2)" "unprognostic (6.58e-2)" "unprognostic (3.69e-2)" "unprognostic (5.39e-2)" "unprognostic (3.14e-1)" "unprognostic (8.77e-2)" "unprognostic (3.36e-3)" "unprognostic (2.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-3)" "unprognostic (2.59e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (4.90e-2)" 7.7 4.9 5.4 8.0 5.6 17.6 15.3 6.4 6.9 9.2 4.9 7.8 9.3 5.7 7.2 9.0 7.1 6.2 2.8 5.1 6.1 9.3 12.0 8.1 12.4 6.4 5.8 4.4 6.5 4.3 7.3 1.3 8.4 6.6 6.5 8.5 2.2 7.7 4.3 1.9 12.3 7.6 4.6 7.1 7.6 8.8 27.8 5.7 14.9 7.9 3.4 14.2 8.9 4.5 7.2 14.2 12.2 11.6 20.3 17.1 13.5 25.6 8.8 14.9 11.1 14.4 9.6 19.5 18.1 27.1 11.1 30.0 10.5 15.4 13.8 16.9 23.5 9.5 15.1 10.6 15.8 7.0 157.3 60.9 9.9 11.8 10.6 6.6 8.3 10.0 18.7 16.1 72.2 11.0 14.6 23.9 16.6 18.6 19.8 18.0 9.4 16.4 21.6 10.4 13.9 4.6 14.6 37.7 21.2 12.0 10.1 9.0 52.1 7.5 15.9 9.0 21.2 9.3 14.8 19.5 27.7 13.9 166.9 16.6 4.7 7.2 3.6 9.2 9.8 6.0 6.3 6.7 7.5 9.7 6.2 6.6 6.5 1.4 10.8 8.1 5.9 8.4 8.0 5.4 5.6 6.4 6.9 5.1 6.1 6.4 5.8 4.4 6.6 7.1 5.7 7.2 4.8 3.2 6.5 2.0 10.1 19.2 21.0 10.4 9.6 1.4 18.0 11.3 30.0 2.8 12.8 3.7 0.0 15.1 12.9 7.9 21.5 12.5 21.5 9.3 6.0 5.4 1.2 12.4 0.5 14.0 24.8 7.5 7.1 15.0 5.7 6.0 4.6 5.4 11.4 0.0 0.4 4.4 10.2 10.1 20.0 5.9 4.7 9.9 1.8 1.0 31.9 9.2 26.8 1.5 2.5 9.0 7.6 4.5 12.3 20.3 7.6 16.6 10.5 1.4 13.1 5.3 5.2 31.7 33.7 17.0 23.3 29.1 9.4 6.6 6.4 21.3 GUCY2F "CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2" ENSG00000101890 "Guanylate cyclase 2F, retinal" P51841 X 109372906-109482086 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 145 "retina: 42.6" "Cell type enriched" "Detected in some" 26 "Rod photoreceptor cells: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.91e-1)" "unprognostic (4.45e-2)" "unprognostic (2.96e-1)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ATP1B4 ENSG00000101892 "ATPase Na+/K+ transporting family member beta 4" Q9UN42 X 120362085-120383249 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "skeletal muscle: 56.3;tongue: 21.8" "Group enriched" "Detected in some" 32 "Cardiomyocytes: 1.7;Skeletal myocytes: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-2)" "unprognostic (6.02e-4)" "unprognostic (5.78e-1)" "unprognostic (5.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.3 0.0 56.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MCTS2P "MCTS2, psiMCT-1" ENSG00000101898 "MCTS family member 2, pseudogene" 20 31547412-31548081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA001045 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA001045: " "unprognostic (1.71e-2)" "unprognostic (2.07e-2)" "unprognostic (6.17e-3)" "unprognostic (6.04e-3)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (8.10e-2)" "unprognostic (2.97e-2)" "unprognostic (1.52e-1)" "unprognostic (5.49e-2)" "unprognostic (1.41e-1)" "unprognostic (9.81e-2)" "unprognostic (3.90e-4)" "unprognostic (6.59e-2)" "unprognostic (9.97e-2)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" 0.9 0.6 0.1 1.6 0.3 1.5 2.2 0.5 1.3 1.0 0.3 1.6 1.0 1.0 0.5 1.3 1.4 0.6 0.6 0.2 0.3 1.0 0.7 0.8 1.8 0.2 0.2 0.1 2.5 0.7 1.8 1.5 0.4 1.2 1.1 1.4 0.8 0.9 0.7 0.6 0.5 1.4 0.0 0.8 1.3 1.3 0.3 2.4 1.7 0.7 2.7 2.1 0.3 8.8 0.0 7.6 7.2 2.2 5.4 0.0 3.2 5.1 10.3 4.3 0.2 4.1 13.3 0.1 4.4 3.8 11.1 0.1 15.0 12.4 0.2 10.1 20.2 2.4 2.3 3.1 17.4 10.7 3.8 7.2 4.1 7.4 3.3 4.2 8.0 9.7 4.6 3.8 3.2 16.0 2.8 0.2 23.1 7.9 8.4 25.4 4.7 3.4 1.0 10.9 10.4 3.4 9.1 3.0 5.6 4.9 7.2 5.5 5.2 11.4 4.0 8.2 3.4 4.7 10.0 6.2 11.9 6.5 0.0 0.3 0.1 0.3 0.2 0.7 0.4 0.4 0.5 0.8 0.5 0.7 0.6 0.0 0.8 0.1 0.4 0.1 0.3 0.1 0.3 0.5 1.3 0.2 0.3 0.2 0.2 0.1 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG13 "CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W" ENSG00000101901 "ALG13 UDP-N-acetylglucosaminyltransferase subunit" Q9NP73 X 111665811-111760649 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002853, HPA005498" Approved Approved Vesicles,Cytosol NA NA 11000000 Vesicles Cytosol "HPA002853: AB_1078131, HPA005498: " "unprognostic (4.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-2)" "unprognostic (1.51e-1)" "unprognostic (6.97e-2)" "unprognostic (6.14e-2)" "unprognostic (2.74e-1)" "unprognostic (6.55e-3)" "unprognostic (2.26e-2)" "unprognostic (3.39e-3)" "unprognostic (1.73e-2)" "unprognostic (4.62e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.45e-2)" 14.0 18.1 11.9 19.0 13.4 16.8 18.5 13.1 19.1 16.1 14.4 18.4 13.9 16.3 20.7 14.8 15.6 16.5 13.2 11.6 23.0 17.8 24.0 13.9 23.6 13.8 14.2 10.8 16.0 14.8 23.6 18.0 14.2 14.6 17.8 19.6 11.9 15.7 13.5 9.3 19.5 17.5 17.7 13.2 18.7 15.7 17.6 13.2 17.5 18.4 10.0 20.2 21.5 14.8 17.3 22.3 24.4 21.8 13.8 13.8 19.6 12.3 17.7 18.3 22.4 27.5 24.9 23.1 19.5 33.0 24.7 46.5 12.6 26.1 12.5 23.5 14.4 17.6 10.7 26.1 28.4 20.3 19.5 40.5 23.6 22.8 18.0 38.6 23.3 24.8 21.8 23.9 53.5 22.5 55.8 16.4 17.6 19.9 66.3 33.6 12.8 13.9 26.7 36.6 34.0 13.1 19.1 25.2 15.2 16.3 21.7 13.6 18.5 16.7 19.2 9.7 24.9 34.4 25.8 47.1 31.5 20.5 25.5 15.2 39.5 15.8 16.6 9.5 16.3 9.3 10.6 10.6 9.2 18.5 12.1 13.0 10.8 3.0 4.6 12.9 9.5 14.6 9.6 11.9 13.4 13.1 19.1 11.6 23.0 13.8 14.2 10.8 14.6 13.2 13.2 17.3 50.9 16.0 30.8 33.6 127.9 35.2 65.8 53.5 33.6 15.1 33.9 31.6 18.7 22.8 36.0 18.4 10.4 27.3 73.9 39.2 45.0 37.4 21.1 48.2 31.1 37.4 26.5 27.1 64.7 52.1 39.1 34.6 37.2 47.9 109.8 15.7 28.2 28.4 42.5 11.8 57.4 49.0 46.8 39.2 52.3 9.4 21.5 56.1 28.4 83.4 41.8 16.0 29.9 41.7 77.5 58.0 55.6 16.1 60.4 46.9 38.5 55.5 35.3 16.5 26.3 38.7 46.2 32.6 22.4 26.5 35.4 48.7 71.1 28.8 32.8 64.6 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 149.0;parathyroid gland: 183.6" "Group enriched" "Detected in many" 7 "Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051269, HPA067599, CAB070417" Enhanced Approved "Nuclear speckles,Vesicles" NA NA Vesicles "Nuclear speckles" "CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869" "unprognostic (7.50e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 11.1 46.4 5.5 24.8 8.2 24.4 19.9 2.7 11.2 55.0 4.4 30.6 14.2 33.1 26.7 16.2 30.0 28.3 4.3 7.1 6.3 28.2 26.3 13.2 37.1 3.6 7.2 7.1 149.0 63.3 183.6 3.4 6.1 4.1 22.1 31.6 1.3 28.1 84.8 2.2 21.6 15.9 24.5 4.1 15.7 32.8 132.2 8.3 45.0 18.3 4.2 31.7 22.7 21.3 8.0 114.2 63.7 22.1 40.3 26.7 31.8 14.6 54.4 26.8 53.1 51.1 46.3 78.7 34.9 24.2 23.5 45.3 79.9 43.1 53.7 61.5 89.7 108.0 41.7 49.6 43.3 24.7 77.3 38.9 30.5 35.0 39.1 51.7 26.9 22.1 86.8 30.4 39.8 45.2 68.5 117.6 34.7 49.9 81.0 107.3 61.5 102.7 79.5 33.0 81.7 46.1 33.6 64.9 2.1 38.9 30.2 58.8 32.4 24.9 41.8 32.0 162.5 55.5 103.6 41.3 76.8 44.4 39.4 67.4 25.9 20.1 9.4 17.2 19.4 19.9 27.8 25.0 16.4 28.2 30.6 31.7 23.0 8.0 24.3 12.3 19.9 22.6 28.2 5.5 8.2 2.7 11.2 7.1 6.3 3.6 7.2 7.1 4.1 4.1 8.3 8.0 12.2 3.2 8.7 0.7 25.4 64.0 48.5 16.2 41.5 0.6 53.1 15.9 2.0 11.5 12.4 55.2 0.0 1.1 18.5 21.1 72.4 19.3 12.1 24.7 62.5 14.5 21.8 28.4 14.8 39.2 7.3 25.8 31.1 26.4 27.9 16.2 10.4 13.7 24.4 0.0 6.3 27.9 8.2 21.4 44.3 65.8 1431.5 20.7 40.9 3.7 18.2 1.2 18.6 3.5 5.1 24.6 17.4 1995.0 30.7 52.2 6.0 10.4 20.3 0.2 624.5 9.4 19.2 10.3 8.1 29.2 43.8 0.4 27.2 179.2 50.2 36.9 TLR8 CD288 ENSG00000101916 "Toll like receptor 8" Q9NR97 X 12906620-12923169 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 10.8;lymphoid tissue: 16.9" "Group enriched" "Detected in some" 6 "Kupffer cells: 49.8;Macrophages: 21.1;monocytes: 39.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 74 "classical monocyte: 16.7;intermediate monocyte: 14.9;myeloid DC: 8.4;neutrophil: 27.6;non-classical monocyte: 15.6" "Group enriched" "Detected in many" 78 "dendritic cells: 8.4;granulocytes: 27.6;monocytes: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001608 Enhanced NA NA "HPA001608: AB_1080295" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (3.96e-3)" "unprognostic (4.43e-2)" "unprognostic (9.63e-2)" "unprognostic (2.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.72e-2)" "unprognostic (2.73e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" 3.6 0.5 0.2 16.9 0.4 5.7 0.9 0.3 0.5 0.7 0.7 1.7 0.8 0.4 0.1 0.9 0.7 2.5 0.8 0.2 1.4 0.5 2.2 10.8 6.2 1.2 0.5 0.1 0.4 0.6 0.3 0.1 4.3 0.8 0.3 1.9 0.0 0.3 0.2 0.2 0.2 1.5 3.9 0.5 13.4 0.8 0.4 0.4 1.7 0.4 1.3 1.9 3.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 14.9 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.0 27.6 0.0 15.6 0.0 0.0 3.8 0.2 0.4 0.3 0.5 0.2 1.4 1.2 0.5 0.1 0.8 0.5 0.4 1.4 0.0 0.0 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.7 5.3 0.0 0.0 0.0 0.0 49.8 5.1 0.0 0.0 21.1 0.0 0.0 39.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887632-134915257 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 106.9;Endometrial ciliated cells: 80.3;Erythroid cells: 150.1;Late spermatids: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 5.0 14.1 4.7 4.9 4.6 15.5 8.4 5.1 5.5 8.5 11.2 6.8 6.0 16.4 12.9 15.3 27.2 7.2 20.2 4.6 5.0 11.0 7.6 7.6 6.2 5.3 4.8 4.4 11.0 7.8 15.2 3.4 11.9 4.9 8.5 7.5 6.7 9.5 7.8 21.7 10.3 5.7 11.4 5.0 6.5 5.5 10.5 5.0 9.8 9.7 14.3 8.6 10.7 8.8 5.0 19.6 15.1 12.5 8.7 19.5 11.4 27.3 32.2 58.2 30.4 29.4 37.2 7.6 6.5 43.7 20.6 54.9 6.9 19.6 16.7 39.9 21.9 11.5 5.6 36.7 15.1 82.2 15.6 9.1 20.6 20.0 34.2 14.7 34.5 22.6 13.3 7.0 25.9 37.3 27.2 11.2 7.1 12.8 10.2 34.1 8.3 22.2 12.4 13.0 55.3 7.4 9.2 16.3 16.2 56.7 60.6 6.5 9.7 11.3 14.9 9.2 56.0 29.0 20.1 29.0 10.4 20.2 26.4 19.9 4.9 5.4 10.5 5.8 4.3 7.9 4.7 6.9 6.4 6.3 4.1 7.7 7.6 3.5 5.1 5.1 6.7 12.4 4.1 4.7 4.6 5.1 5.5 4.6 5.0 5.3 4.8 4.4 4.9 5.0 5.0 5.0 13.2 6.4 5.8 3.9 11.0 21.3 10.6 13.8 29.6 8.5 10.8 9.4 43.7 4.3 11.8 11.0 2.1 9.0 6.9 7.6 21.5 26.3 106.9 80.3 10.5 12.2 4.2 150.1 7.6 12.4 16.0 10.5 8.6 12.0 5.7 21.5 13.9 6.7 14.9 5.0 8.8 6.9 16.2 11.9 7.7 82.9 6.8 7.5 30.2 4.7 7.4 9.3 11.3 9.0 4.4 20.9 12.7 10.9 14.7 11.8 5.7 27.9 20.0 8.5 6.6 6.8 16.9 3.8 6.6 12.2 20.5 26.1 13.2 15.8 7.1 9.9 AMMECR1 ENSG00000101935 "AMMECR nuclear protein 1" Q9Y4X0 X 110194186-110440318 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000590: AB_2666037, HPA051762: AB_2681596" "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favorable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favorable (8.44e-4)" "unprognostic (7.82e-2)" 2.8 2.9 1.8 3.8 1.9 13.5 3.4 1.9 2.0 2.6 7.2 3.7 3.1 2.3 2.1 7.9 3.4 2.3 1.0 1.6 1.7 3.4 3.3 2.8 4.2 1.4 1.5 1.6 5.6 2.0 2.2 2.0 7.1 1.6 2.2 3.9 14.6 2.8 1.9 1.3 7.4 3.3 3.0 1.2 3.8 3.8 1.6 1.6 4.5 2.5 1.7 5.7 4.9 4.5 1.9 20.3 9.8 7.1 3.4 7.9 11.8 7.8 13.8 12.3 11.1 16.2 15.9 14.4 12.0 6.4 18.4 9.0 9.5 22.7 15.7 11.3 8.4 10.1 16.7 21.7 3.3 19.9 13.5 6.7 6.6 27.3 12.7 22.6 6.0 8.9 5.9 47.1 34.8 8.5 17.2 6.5 4.8 32.6 17.4 19.1 13.7 7.6 21.2 18.8 16.8 11.3 5.3 23.2 22.7 19.9 8.5 5.6 13.3 4.1 7.6 4.6 22.8 12.6 7.1 8.6 18.9 11.6 27.5 25.9 0.6 0.9 0.8 1.6 0.6 2.1 1.6 3.2 2.6 1.5 2.2 2.1 1.9 0.4 0.6 2.7 0.6 2.3 1.0 1.8 1.9 1.9 2.0 1.6 1.7 1.4 1.5 1.6 1.6 1.2 1.6 1.9 4.4 0.0 9.8 17.9 11.5 9.6 3.9 10.5 5.7 35.3 7.5 4.4 4.2 8.6 8.9 3.7 52.1 27.2 9.5 8.9 23.5 9.2 0.5 10.5 7.7 9.6 15.0 83.1 92.8 12.0 9.9 12.8 13.7 13.4 2.5 14.4 19.6 8.4 7.1 1.7 108.7 11.2 12.2 7.6 3.1 2.1 12.8 7.3 3.6 21.5 9.4 7.1 14.4 35.7 19.2 11.5 3.7 17.3 8.0 9.1 10.3 10.2 10.4 87.3 13.1 6.7 8.4 2.2 6.9 17.4 26.7 86.5 13.0 34.7 10.5 15.7 CHRDL1 "CHL, MGC1, NRLN1" ENSG00000101938 "Chordin like 1" Q9BU40 X 110673856-110795819 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Differentiation, Neurogenesis, Osteogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 190.0;seminal vesicle: 226.5" "Group enriched" "Detected in many" 4 "Astrocytes: 50.3;Fibroblasts: 83.8;Leydig cells: 41.0;Muller glia cells: 81.6" "Cancer enhanced" "Detected in many" "prostate cancer: 16.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "ASC diff: 537.8;ASC TERT1: 724.7;hTERT-RPE1: 341.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000226, HPA000250" Approved "Secreted in other tissues" NA NA 610000 "HPA000226: AB_1078522, HPA000250: AB_1078521" "unprognostic (5.13e-2)" "unprognostic (6.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.48e-3)" "unprognostic (1.99e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.42e-2)" "unprognostic (4.89e-2)" "unprognostic (5.54e-2)" "unprognostic (3.43e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (4.75e-3)" "unprognostic (7.91e-2)" "unprognostic (5.01e-2)" "prognostic unfavorable (2.23e-4)" 190.0 7.4 7.8 26.4 11.1 0.9 70.4 8.5 14.2 30.6 7.0 57.2 10.9 149.5 20.3 58.5 54.0 48.3 12.9 9.6 6.6 15.2 1.8 77.0 24.6 4.8 4.6 9.3 7.2 12.6 85.5 6.4 22.1 6.7 142.9 35.8 56.1 23.5 226.5 6.1 14.9 22.3 102.1 4.5 16.2 18.0 6.6 4.7 11.0 38.1 35.2 11.8 28.6 20.1 7.3 0.0 0.1 3.3 0.0 537.8 724.7 0.3 7.6 3.3 18.8 16.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 23.0 0.0 17.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 58.7 0.1 1.6 0.0 341.2 0.0 2.0 0.0 0.0 0.1 0.0 1.0 0.3 21.3 0.0 0.0 0.0 0.0 0.1 3.0 0.0 1.7 5.2 0.0 0.0 0.4 1.4 0.0 0.0 0.0 5.8 4.2 60.4 7.8 0.1 0.1 0.0 5.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.8 11.1 8.5 14.2 9.6 6.6 4.8 4.6 9.3 6.7 4.5 4.7 7.3 8.4 0.0 2.7 50.3 0.1 4.8 0.0 0.0 0.6 1.5 0.3 0.4 2.3 0.0 1.8 1.8 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.0 1.0 13.8 0.0 0.0 4.2 0.0 0.1 83.8 2.0 0.2 1.3 0.3 2.2 0.1 0.2 0.0 9.3 0.0 0.0 0.0 8.1 1.4 41.0 1.1 8.8 1.0 0.0 81.6 0.0 13.6 0.2 0.0 0.0 9.1 1.4 0.3 0.0 4.1 1.5 2.9 0.0 2.7 11.2 0.2 8.2 0.3 4.4 0.1 1.0 0.0 0.0 0.1 WDR13 ENSG00000101940 "WD repeat domain 13" Q9H1Z4 X 48590042-48608869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000913 Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA000913: AB_1858795" "unprognostic (5.03e-2)" "unprognostic (6.53e-3)" "unprognostic (3.65e-3)" "unprognostic (2.10e-3)" "unprognostic (3.50e-1)" "unprognostic (1.54e-3)" "unprognostic (3.54e-2)" "unprognostic (6.76e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-1)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (4.32e-2)" 63.1 77.4 79.3 28.0 76.2 34.9 64.4 63.9 96.0 68.5 76.3 66.4 44.2 72.1 74.4 55.1 67.6 33.7 129.8 80.9 66.5 92.1 107.2 61.3 23.6 68.9 66.0 77.0 93.9 190.8 37.2 80.7 29.7 68.6 68.1 26.5 28.4 76.3 45.7 106.2 56.5 54.8 37.9 64.1 59.1 77.2 23.1 68.8 18.9 65.3 83.7 19.7 60.0 56.7 73.6 41.6 59.4 29.3 90.8 39.3 57.4 22.4 28.1 50.7 31.9 29.0 35.5 64.8 28.7 26.3 57.8 25.7 35.0 14.6 61.6 11.3 34.2 26.2 19.7 72.2 65.3 89.3 17.1 51.4 54.7 86.4 45.3 82.7 55.6 44.4 16.3 19.8 35.5 44.9 59.4 23.7 29.9 21.2 18.0 46.6 22.4 31.0 52.3 56.7 32.6 33.9 41.9 31.8 65.2 66.9 20.4 41.9 32.6 74.0 33.0 48.8 52.8 27.5 41.0 16.6 11.0 48.9 25.3 46.5 75.5 42.4 24.7 20.9 47.4 16.7 32.7 21.8 19.9 39.1 25.0 17.4 19.6 29.9 33.0 57.2 24.6 27.0 31.1 79.3 76.2 63.9 96.0 80.9 66.5 68.9 66.0 77.0 68.6 64.1 68.8 73.6 61.1 44.8 41.7 19.9 22.3 35.1 72.8 69.1 37.5 45.5 39.2 35.8 79.7 68.6 49.9 20.2 54.2 44.2 19.9 75.5 103.7 89.0 6.1 75.9 36.1 54.0 50.4 31.2 7.8 119.2 34.5 50.5 62.2 53.0 30.4 46.2 65.3 50.2 42.6 33.7 6.6 58.3 50.8 35.4 30.6 20.8 51.6 34.9 58.7 15.0 42.1 68.9 22.6 7.1 14.0 96.8 75.0 43.2 28.3 48.3 90.2 140.7 74.3 55.6 46.0 51.2 59.6 11.2 21.0 29.7 29.8 70.7 21.4 56.2 59.8 65.8 SUV39H1 "KMT1A, SUV39H" ENSG00000101945 "Suppressor of variegation 3-9 homolog 1" O43463 X 48695554-48709016 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes "unprognostic (4.92e-2)" "prognostic favorable (8.93e-5)" "unprognostic (9.51e-2)" "unprognostic (4.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.03e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.91e-7)" "unprognostic (2.29e-3)" "unprognostic (6.47e-3)" "unprognostic (2.01e-1)" "unprognostic (5.67e-2)" 3.5 2.2 4.8 4.2 4.6 13.9 3.5 5.1 5.2 2.7 2.3 3.2 3.1 3.2 12.6 5.0 3.3 1.7 3.7 4.6 5.1 2.6 6.6 2.8 7.5 5.5 4.9 4.8 3.8 3.0 2.3 3.0 3.3 5.4 3.1 3.2 3.3 2.6 3.0 5.0 4.4 4.3 2.6 4.1 6.1 3.6 4.9 5.0 9.8 2.6 3.8 7.0 3.4 2.4 4.5 28.7 34.3 13.3 14.0 3.4 4.0 27.0 13.5 10.2 25.8 21.0 21.0 18.7 31.4 8.0 9.9 26.1 19.8 33.0 19.3 15.4 24.2 33.8 12.3 31.8 17.4 2.0 30.7 6.6 3.6 3.7 22.8 11.6 4.2 18.6 20.2 31.9 21.6 14.2 33.1 26.8 32.0 15.7 14.0 32.8 19.3 24.5 33.1 8.6 15.7 17.4 11.4 18.3 17.4 9.8 14.8 26.0 25.5 10.0 15.8 27.0 22.1 23.3 14.6 23.9 26.4 11.8 43.6 17.7 4.9 2.8 6.8 8.5 4.0 6.2 4.6 5.5 9.1 2.2 5.4 6.8 6.6 2.0 10.6 6.5 2.6 11.0 6.5 4.8 4.6 5.1 5.2 4.6 5.1 5.5 4.9 4.8 5.4 4.1 5.0 4.5 1.2 6.4 0.0 0.3 3.5 1.8 0.9 2.0 2.8 5.3 2.2 2.5 2.5 2.8 1.3 1.8 0.0 6.5 6.6 2.1 3.9 2.9 0.2 1.3 0.9 1.7 3.0 6.9 0.7 2.9 28.3 1.9 3.1 1.0 1.3 2.9 1.8 6.7 5.2 0.0 1.0 2.6 0.0 2.9 1.6 0.2 1.2 2.4 5.4 1.0 3.0 0.9 6.2 1.0 0.8 2.3 1.7 1.5 7.1 0.6 1.6 2.4 2.6 3.8 0.0 1.8 2.5 3.7 0.8 2.5 1.1 6.2 3.6 1.7 3.2 0.6 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49834264 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 879.5;placenta: 1031.7" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.1 5.8 0.1 0.3 0.2 0.0 0.0 0.1 0.5 3.9 0.1 0.2 0.4 51.7 879.5 0.0 21.6 0.0 0.4 0.1 0.1 0.9 0.3 0.2 0.0 0.1 0.1 0.0 3.7 2.5 0.0 1.3 1031.7 0.1 173.2 0.0 0.0 0.6 77.9 2.4 0.0 0.3 24.4 0.0 0.3 0.2 5.7 0.1 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.1 11.7 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13314.7 0.0 0.0 0.0 0.0 4.4 1.9 72.5 25.9 0.0 0.0 0.0 0.0 905.4 72.5 0.0 1.9 0.0 0.0 0.0 0.0 1052.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 48.8 20.7 0.0 0.0 8524.1 0.3 0.0 0.0 0.1 SRPX ETX1 ENSG00000101955 "Sushi repeat containing protein X-linked" P78539 X 38149336-38220924 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 182.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 256.9;Granulosa cells: 138.9;Hepatic stellate cells: 418.7;Leydig cells: 110.3;Peritubular cells: 95.2" "Group enriched" "Detected in all" 5 "glioma: 64.2;melanoma: 70.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 49 "plasmacytoid DC: 7.8" "Lineage enriched" "Detected in single" 49 "dendritic cells: 7.8" "Cell line enhanced" "Detected in many" "ASC diff: 3742.4;ASC TERT1: 827.3;HSkMC: 1258.3;HUVEC TERT2: 803.2" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "spinal cord: 12.4" "Secreted - unknown location" NA NA 140000 "unprognostic (2.35e-1)" "unprognostic (1.09e-3)" "unprognostic (1.08e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (6.48e-2)" "unprognostic (3.83e-3)" "unprognostic (3.50e-2)" "unprognostic (2.31e-1)" "unprognostic (4.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (7.80e-13)" "unprognostic (6.94e-3)" "unprognostic (3.90e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (3.36e-4)" 182.3 37.5 8.9 22.6 11.0 0.1 149.2 18.0 7.5 45.1 7.5 70.2 8.0 56.6 39.9 37.0 114.4 58.6 75.7 6.9 25.1 7.3 17.9 47.0 5.0 13.5 13.1 3.5 21.6 24.1 2.8 4.6 89.6 14.8 18.4 25.0 1.6 23.1 15.4 15.7 28.0 53.1 53.4 14.8 1.7 42.9 6.8 13.9 19.4 59.6 13.8 5.3 104.7 43.2 16.5 0.3 5.0 12.1 0.2 3742.4 827.3 0.9 35.3 67.8 11.9 20.2 0.5 3.6 0.1 0.3 74.3 119.9 1.9 2.0 30.8 9.8 0.2 13.8 0.1 1.0 0.4 167.8 3.0 0.4 1258.3 2.6 114.9 58.3 132.8 803.2 1.4 0.1 0.2 130.1 1.7 0.5 0.1 10.2 1.8 26.2 0.0 43.5 6.4 0.8 2.3 2.3 2.3 1.7 0.1 170.1 31.2 0.0 0.4 349.1 82.2 42.3 108.8 103.7 0.0 0.1 0.1 239.0 3.1 106.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.0 0.1 8.9 11.0 18.0 7.5 6.9 25.1 13.5 13.1 3.5 14.8 14.8 13.9 16.5 28.7 3.2 1.3 17.0 0.6 15.3 2.2 2.8 7.4 0.4 2.9 8.6 14.2 0.0 0.2 1.8 0.0 3.6 2.1 2.5 0.0 0.3 0.7 1.1 35.1 67.2 0.0 2.7 1.9 0.4 5.4 256.9 1.5 0.8 0.0 138.9 418.7 2.5 6.1 0.0 2.7 5.8 0.0 11.4 15.2 4.9 110.3 1.6 74.7 1.0 0.0 0.2 0.0 2.5 0.3 0.8 1.8 95.2 0.2 1.6 0.4 0.2 0.0 0.4 26.3 4.8 54.6 0.7 2.3 1.7 7.2 7.1 1.9 21.4 0.5 0.8 GLRA2 GLR ENSG00000101958 "Glycine receptor alpha 2" P23416 X 14529298-14731812 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.4;intestine: 3.8;retina: 5.0" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 74.3" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.6;glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 34 "AN3-CA: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070422 Approved NA NA "CAB070422: AB_11153055" "unprognostic (2.52e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (3.39e-1)" "unprognostic (5.82e-2)" "unprognostic (7.95e-3)" "unprognostic (1.13e-1)" "unprognostic (2.76e-1)" "unprognostic (6.69e-2)" 0.0 0.0 4.7 0.1 3.3 0.1 0.0 8.3 3.1 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.9 18.4 0.0 0.0 0.0 0.0 4.8 12.6 4.3 0.1 0.0 0.0 0.3 0.1 9.0 0.0 3.8 5.0 0.1 0.0 0.0 0.1 0.1 0.1 3.4 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 17.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.3 8.3 3.1 3.9 18.4 4.8 12.6 4.3 9.0 3.4 13.4 4.8 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 2.6 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 7.6 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.0 1.7 74.3 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.0 0.0 0.3 0.0 2.0 12.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.1 0.0 XIAP "API3, BIRC4, hILP, ILP-1" ENSG00000101966 "X-linked inhibitor of apoptosis" P98170 X 123859724-123913976 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway, Wnt signaling pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009203, HPA042428" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009203: AB_2257167, HPA042428: AB_2677993" "prognostic unfavorable (9.21e-4)" "unprognostic (8.43e-2)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.40e-1)" "unprognostic (9.41e-2)" "unprognostic (1.95e-2)" "unprognostic (8.51e-2)" "unprognostic (9.17e-2)" "unprognostic (3.90e-2)" "unprognostic (7.50e-2)" "unprognostic (4.41e-2)" "unprognostic (3.15e-3)" "unprognostic (8.21e-3)" "unprognostic (2.26e-1)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 9.2 7.8 6.7 9.3 7.7 8.4 9.8 7.1 7.1 9.7 11.9 12.6 10.2 8.5 10.1 11.6 7.4 8.7 7.8 6.1 7.8 11.9 12.2 8.6 10.5 7.7 8.7 5.7 7.6 8.4 18.6 6.4 8.7 7.5 8.6 10.2 21.6 8.7 7.5 10.4 8.8 10.2 7.4 8.3 10.5 10.3 4.2 8.4 9.0 15.1 12.0 8.7 9.7 6.2 10.4 15.8 13.2 10.2 8.8 11.8 15.0 13.3 16.9 12.4 8.9 7.7 5.9 17.9 14.7 24.3 14.4 17.1 5.6 15.3 10.5 16.3 15.5 8.3 9.9 11.1 9.2 14.9 18.1 19.7 10.4 16.0 14.9 19.0 10.2 12.7 10.8 15.9 16.4 17.6 16.5 10.2 8.8 8.4 15.6 10.3 10.8 11.9 15.6 13.4 22.6 6.8 10.0 22.9 13.0 13.5 9.0 8.0 8.7 15.7 0.5 6.0 27.0 18.9 13.8 14.9 15.8 18.3 12.7 11.5 9.3 1.8 2.6 3.3 1.5 3.0 3.1 2.4 3.6 1.0 4.0 2.7 1.9 5.6 2.4 2.9 2.9 1.8 1.5 6.7 7.7 7.1 7.1 6.1 7.8 7.7 8.7 5.7 7.5 8.3 8.4 10.4 50.0 80.1 91.6 26.4 42.1 26.6 36.3 35.0 28.5 72.1 29.7 19.9 44.5 44.3 55.2 53.3 95.9 17.9 41.7 122.9 27.4 36.0 2.7 38.4 44.9 55.0 47.4 23.5 30.0 54.0 30.0 38.4 39.8 50.4 60.7 30.9 64.2 85.8 29.0 75.7 34.9 62.2 26.4 43.6 33.0 4.1 42.6 44.2 8.8 29.0 45.8 45.8 55.6 32.6 41.9 65.4 53.5 51.6 39.5 53.0 59.2 59.8 50.6 133.7 65.7 43.6 34.9 15.2 21.0 30.8 35.5 38.0 40.8 30.0 48.0 68.1 STAG2 "SA-2, SA2, SCC3B" ENSG00000101972 "Stromal antigen 2" Q8N3U4 X 123960212-124422664 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002857 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA002857: AB_1079861" "unprognostic (1.62e-1)" "unprognostic (1.01e-2)" "unprognostic (6.75e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.70e-2)" "unprognostic (3.77e-2)" "unprognostic (9.67e-3)" "unprognostic (4.68e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-1)" "unprognostic (3.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.81e-1)" "unprognostic (2.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.97e-1)" 28.1 23.1 22.3 34.5 28.3 73.4 41.9 35.3 24.3 33.6 31.6 29.1 24.0 36.0 28.5 27.0 30.4 25.4 21.7 20.0 29.7 34.0 28.7 28.8 45.3 27.3 25.3 16.9 46.4 31.9 52.3 12.1 36.1 29.3 30.1 28.4 45.8 26.7 29.9 23.5 26.3 26.7 26.0 28.3 37.8 28.8 8.0 24.1 82.2 49.8 36.3 44.7 28.7 17.7 42.5 62.6 56.9 84.5 53.0 34.9 52.3 54.4 58.0 61.8 58.5 73.2 53.8 65.1 115.0 79.6 52.3 65.5 55.6 173.6 48.8 82.5 81.9 74.7 106.6 110.8 35.7 35.6 140.7 80.0 42.2 46.4 69.5 111.4 50.2 49.7 114.2 105.4 118.9 43.1 67.8 180.6 62.9 44.5 55.8 84.4 125.9 112.0 96.1 44.9 117.3 75.7 60.6 131.2 47.7 66.9 59.2 28.9 62.2 61.5 0.3 31.1 69.4 66.6 50.9 82.2 141.6 36.8 84.3 60.3 28.2 15.2 28.0 15.0 18.9 17.8 15.0 15.6 14.6 19.1 19.0 21.3 17.5 44.5 18.8 23.1 16.5 13.5 10.0 22.3 28.3 35.3 24.3 20.0 29.7 27.3 25.3 16.9 29.3 28.3 24.1 42.5 71.1 64.1 56.6 42.4 80.9 56.2 61.5 31.5 72.3 51.0 58.0 48.4 44.9 37.1 50.6 44.1 60.5 32.2 113.4 42.9 21.5 42.3 1.1 65.1 70.4 62.3 58.1 77.0 41.8 38.2 32.7 64.5 39.8 79.3 58.1 53.6 59.3 42.2 36.0 45.4 51.9 35.0 28.5 71.4 65.0 4.2 65.9 89.9 33.8 70.3 91.4 61.2 97.9 69.4 114.0 54.9 29.3 69.2 73.8 81.4 28.0 35.7 51.4 62.9 65.7 104.0 60.3 14.8 15.4 51.0 56.1 71.4 87.2 49.5 38.9 83.6 ATP11C "ATPIG, ATPIQ" ENSG00000101974 "ATPase phospholipid transporting 11C" Q8NB49 X 139726346-139945276 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.2" "Cell type enhanced" "Detected in many" "Spermatocytes: 67.9" "Cancer enhanced" "Detected in all" "testis cancer: 15.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030830 Approved NA NA "HPA030830: AB_10601336" "unprognostic (8.94e-2)" "unprognostic (1.00e-2)" "unprognostic (3.06e-2)" "unprognostic (3.42e-3)" "unprognostic (3.08e-1)" "unprognostic (3.46e-1)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (3.65e-2)" "unprognostic (9.75e-2)" "unprognostic (2.73e-1)" "unprognostic (5.18e-2)" 12.2 7.4 3.8 9.1 4.6 6.1 10.5 3.9 4.7 11.8 9.8 9.0 5.6 12.0 9.4 5.2 10.8 8.5 4.9 3.3 4.9 11.9 50.2 7.3 14.9 5.0 4.9 2.8 12.8 4.9 5.7 3.8 5.4 5.6 9.9 7.2 2.8 6.1 14.7 3.5 5.8 8.7 10.7 4.3 12.3 7.7 9.7 4.7 11.2 6.2 4.4 8.9 13.8 9.4 4.9 16.9 7.1 14.2 23.3 20.7 27.9 18.0 19.7 26.4 15.6 21.5 6.3 13.4 24.0 43.3 28.2 10.3 13.7 34.6 9.0 24.4 22.1 20.2 12.1 15.2 12.3 23.0 21.4 7.4 18.6 5.9 16.9 14.4 17.3 27.3 18.3 14.0 17.9 20.8 9.1 19.7 14.5 24.1 0.1 13.3 19.5 15.3 20.1 13.1 27.6 11.0 18.3 7.8 0.8 10.6 13.3 5.8 11.7 31.0 21.2 6.9 25.9 27.1 5.1 5.4 18.7 9.7 26.3 10.8 2.4 0.4 0.1 0.4 0.3 0.8 0.9 0.4 0.3 0.4 0.9 0.4 0.7 0.9 1.2 0.6 0.7 0.3 0.2 3.8 4.6 3.9 4.7 3.3 4.9 5.0 4.9 2.8 5.6 4.3 4.7 4.9 27.4 16.0 8.4 22.5 14.6 14.5 16.7 6.5 5.7 1.9 8.0 8.9 4.4 2.8 9.2 11.0 0.0 2.3 11.6 7.0 1.9 4.8 13.6 11.5 22.7 32.4 9.1 15.3 1.3 10.1 12.6 17.2 10.7 13.7 9.5 23.6 34.6 46.6 9.4 0.0 26.1 6.4 8.2 37.2 14.4 11.9 14.3 15.3 10.6 45.9 33.9 3.1 7.2 29.1 27.8 7.8 7.2 15.4 13.2 15.8 4.7 7.7 6.8 3.1 0.0 19.3 19.2 67.9 53.1 5.9 13.5 6.7 12.7 11.5 5.2 14.6 MCF2 "ARHGEF21, DBL" ENSG00000101977 "MCF.2 cell line derived transforming sequence" P10911 X 139581770-139708227 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.8;seminal vesicle: 17.1;testis: 18.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 98.0;Excitatory neurons: 27.8;Inhibitory neurons: 36.2;Oligodendrocyte precursor cells: 20.6;Theca cells: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "U-251 MG: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.42e-1)" "unprognostic (2.18e-2)" "unprognostic (1.46e-2)" "unprognostic (5.11e-4)" "unprognostic (8.95e-2)" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (2.33e-3)" "unprognostic (3.68e-2)" "unprognostic (2.92e-2)" "unprognostic (4.62e-4)" "unprognostic (4.02e-2)" 0.2 29.8 6.8 0.4 5.6 0.7 0.1 7.2 9.7 0.0 2.8 0.1 0.0 0.1 12.4 0.0 0.8 0.7 1.0 5.3 7.5 1.6 0.2 0.1 0.6 9.6 8.5 5.2 10.3 0.2 0.0 3.4 0.0 11.1 1.2 0.0 9.3 1.0 17.1 0.1 0.1 0.3 0.0 6.4 1.1 0.2 18.8 12.9 0.5 1.1 0.2 0.1 0.2 0.1 12.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.5 3.1 0.0 0.5 0.6 2.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.6 37.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 5.6 7.2 9.7 5.3 7.5 9.6 8.5 5.2 11.1 6.4 12.9 12.1 0.2 0.0 0.0 3.6 0.3 0.1 0.3 0.2 0.6 2.2 0.6 0.4 1.8 0.0 0.0 0.0 98.0 0.0 0.3 0.1 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.0 27.8 0.0 0.0 0.7 0.0 0.1 0.0 2.2 0.4 0.2 0.1 0.0 36.2 0.0 0.0 0.6 0.3 2.5 1.2 0.2 0.0 4.7 1.4 1.0 4.1 20.6 7.6 0.1 0.0 8.2 0.1 0.4 0.0 0.6 0.0 2.4 0.0 0.1 0.4 0.6 0.8 0.1 0.0 0.0 0.3 22.8 0.0 0.2 F9 FIX ENSG00000101981 "Coagulation factor IX" P00740 X 139530739-139563459 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2470 "liver: 710.7" "Cell type enriched" "Detected in some" 32 "Hepatocytes: 609.1" "Cancer enriched" "Detected in single" 1354 "liver cancer: 67.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 8200000000 "prognostic favorable (6.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 710.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 609.1 0.0 0.0 0.1 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 ABCD1 "adrenoleukodystrophy, ALD, ALDP, AMN" ENSG00000101986 "ATP binding cassette subfamily D member 1" P33897 X 153724856-153744755 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4" "Cancer enhanced" "Detected in all" "melanoma: 36.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035214 Approved NA NA "HPA035214: " "unprognostic (1.90e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-3)" "unprognostic (5.57e-3)" "unprognostic (8.81e-3)" "unprognostic (1.54e-1)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (6.14e-3)" "unprognostic (3.40e-2)" "unprognostic (1.41e-1)" "unprognostic (6.17e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.23e-2)" 13.6 33.5 2.3 5.4 3.5 4.8 12.6 2.7 3.8 7.6 1.9 12.4 10.7 33.5 1.8 3.8 9.3 3.5 10.9 2.1 3.4 7.0 13.4 7.7 4.0 3.4 2.8 1.1 5.4 12.0 2.1 10.0 4.7 5.6 10.0 1.8 0.5 6.2 5.6 20.7 4.4 17.5 4.8 2.3 14.0 7.2 19.1 3.9 4.3 6.1 4.6 1.7 12.0 6.1 3.8 13.2 4.0 2.6 11.2 7.4 3.2 34.3 6.3 6.8 4.2 7.4 2.6 7.1 3.5 69.7 8.6 11.3 1.7 1.6 1.4 0.5 11.8 2.1 10.3 42.1 34.1 9.8 6.4 22.4 6.2 1.7 4.8 0.4 4.4 6.7 4.7 6.0 12.4 5.9 4.7 4.5 6.1 3.3 3.2 50.0 7.8 6.2 5.7 3.2 1.4 2.8 11.5 16.4 49.2 26.4 3.0 3.7 10.8 7.9 5.5 7.4 14.3 7.0 12.2 5.7 8.4 6.9 21.7 7.8 0.4 3.2 2.5 0.8 3.0 4.0 1.0 1.0 1.2 2.7 0.7 1.1 0.8 1.7 0.7 2.8 1.7 0.3 2.5 2.3 3.5 2.7 3.8 2.1 3.4 3.4 2.8 1.1 5.6 2.3 3.9 3.8 5.0 0.0 1.1 3.6 3.8 3.2 1.6 1.6 0.6 2.2 2.7 2.8 2.4 2.8 2.2 3.7 2.1 12.2 4.8 9.5 0.0 3.8 0.7 2.0 3.5 3.4 6.0 3.6 0.5 6.9 19.5 4.5 3.6 4.0 0.0 6.9 5.7 6.8 12.6 8.4 0.9 5.0 2.0 15.9 8.4 2.7 4.1 12.3 1.8 0.0 5.9 2.4 0.0 0.0 1.2 5.0 2.1 5.7 2.4 0.8 39.2 2.8 1.2 0.7 6.6 2.3 2.8 3.8 4.8 0.8 1.3 27.4 4.0 7.8 5.5 1.4 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235470-49250520 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport, Ubl conjugation pathway" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888, HPA075980" Uncertain Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" "HPA000229: , HPA000888: AB_1078420, HPA075980: " "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 10.1 12.4 8.4 10.2 9.0 18.8 10.4 9.1 10.9 11.5 8.0 12.0 10.5 12.3 5.4 14.3 11.4 6.5 12.2 8.6 8.4 12.3 13.0 10.8 15.2 9.9 8.6 8.3 11.3 14.4 8.8 11.3 7.0 9.2 13.6 5.3 4.8 12.4 8.7 17.4 13.9 13.6 6.0 8.8 20.6 13.0 3.8 8.6 13.8 11.1 7.7 8.6 12.0 11.2 9.7 18.8 16.0 9.6 33.5 8.8 8.9 20.4 10.9 7.9 12.0 13.6 16.3 16.0 6.9 15.9 9.7 14.3 15.0 10.6 18.0 4.9 18.1 23.6 7.3 15.6 15.5 14.7 20.8 12.4 8.2 15.2 15.9 8.6 6.1 11.9 13.7 14.7 11.8 8.6 58.3 15.3 24.4 11.2 9.5 23.2 22.0 15.6 30.1 9.4 9.4 11.4 8.8 16.7 19.4 15.0 9.8 30.2 20.2 13.3 15.4 16.5 19.2 11.6 21.2 12.6 12.5 16.8 38.5 12.3 8.6 37.0 23.8 18.3 30.9 20.1 18.9 18.8 21.3 38.2 16.8 16.7 19.6 2.8 10.8 27.1 15.1 21.8 28.0 8.4 9.0 9.1 10.9 8.6 8.4 9.9 8.6 8.3 9.2 8.8 8.6 9.7 8.6 0.0 4.4 3.3 15.0 5.6 9.6 13.0 6.2 11.6 7.4 6.1 2.4 15.7 12.0 11.0 6.2 15.2 11.2 12.5 15.6 13.9 0.3 5.8 4.6 7.8 6.7 8.6 3.7 7.3 14.8 7.6 7.1 6.9 11.4 8.6 11.0 7.2 32.0 1.7 2.9 18.2 8.2 14.4 11.9 0.4 8.1 13.8 7.2 1.9 18.0 9.9 9.2 1.0 4.2 8.6 7.6 7.5 10.2 6.2 15.6 12.1 5.6 8.0 6.6 9.1 9.5 0.1 0.9 8.0 6.7 20.2 13.3 11.0 15.7 8.3 CACNA1F "AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2" ENSG00000102001 "Calcium voltage-gated channel subunit alpha1 F" O60840 X 49205063-49233371 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Sensory transduction, Transport, Vision" "Calcium channel, Ion channel, Voltage-gated channel" "Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "retina: 126.4" "Group enriched" "Detected in some" 13 "Bipolar cells: 66.5;Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 97.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "U-266/70: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA068379 Enhanced NA NA "HPA068379: AB_2732782" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (4.25e-3)" "unprognostic (1.56e-2)" "unprognostic (8.46e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.04e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (6.08e-7)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.77e-3)" 0.2 0.4 0.8 0.4 0.8 1.9 0.7 2.1 1.5 0.1 0.7 0.4 0.8 0.2 1.0 0.2 0.5 0.2 0.2 0.8 0.3 0.2 0.0 0.6 1.3 0.5 0.6 1.2 0.3 0.7 0.0 0.1 0.0 0.7 0.1 0.7 126.4 0.6 0.4 0.0 1.0 1.6 0.2 0.0 0.8 0.6 0.2 0.4 0.8 0.4 0.0 0.5 0.2 0.2 0.9 0.1 0.7 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.8 0.4 0.5 0.4 0.5 0.0 0.0 0.0 0.3 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.2 0.5 0.1 0.3 1.3 0.1 0.0 0.8 0.8 2.1 1.5 0.8 0.3 0.5 0.6 1.2 0.7 0.0 0.4 0.9 0.2 0.0 0.5 0.0 1.1 0.0 0.1 0.1 0.0 66.5 1.1 0.9 1.9 0.0 0.0 1.8 133.5 0.1 2.8 0.2 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.4 0.9 0.2 0.2 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.2 6.7 0.4 2.3 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.1 7.4 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.1 0.4 0.1 0.1 97.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.3 0.1 SYP MRX96 ENSG00000102003 Synaptophysin P08247 X 49187815-49200199 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 285.8;pituitary gland: 107.7;retina: 319.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 529.2;Cone photoreceptor cells: 546.3;Rod photoreceptor cells: 594.4" "Group enriched" "Detected in many" 6 "glioma: 12.8;pancreatic cancer: 5.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 20.3;SCLC-21H: 102.6;SH-SY5Y: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000076, HPA002858, CAB055505, CAB078999, HPA079659" Enhanced Supported NA NA "CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153, HPA079659: " "unprognostic (2.08e-1)" "unprognostic (8.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.37e-3)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (1.87e-1)" "unprognostic (6.46e-5)" "unprognostic (8.52e-3)" "unprognostic (1.62e-1)" "unprognostic (3.44e-3)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.94e-1)" 2.6 40.5 91.5 3.6 155.3 0.8 1.9 43.3 277.2 1.7 0.0 6.9 12.5 1.5 2.0 1.2 1.7 0.8 2.8 145.0 132.3 3.0 0.8 3.1 1.0 106.2 67.8 172.7 1.7 7.7 3.4 107.7 0.8 141.8 1.6 4.0 319.1 1.3 1.1 1.9 1.6 14.0 1.9 10.2 2.0 5.4 1.7 133.3 4.2 2.4 1.4 0.7 1.5 2.3 285.8 0.9 3.9 2.9 5.8 3.2 0.5 0.4 0.2 0.1 0.7 0.8 3.6 2.1 3.2 0.5 0.1 4.4 2.9 3.1 0.4 0.7 6.5 3.5 4.9 1.4 1.1 0.1 0.6 10.5 0.4 0.1 0.5 0.7 0.4 0.3 2.7 20.3 7.6 0.6 1.1 1.7 0.4 9.6 2.5 0.8 0.6 0.6 1.5 0.2 0.4 102.6 36.8 1.1 0.4 1.5 0.9 1.9 1.8 0.6 0.6 3.2 1.0 0.4 0.5 6.7 0.8 1.7 1.3 3.2 0.7 0.2 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.4 0.1 0.1 1.9 0.2 0.1 0.6 0.1 0.0 91.5 155.3 43.3 277.2 145.0 132.3 106.2 67.8 172.7 141.8 10.2 133.3 285.8 7.5 0.0 3.9 24.2 6.3 2.5 2.8 1.0 1.2 529.2 5.8 8.1 1.8 2.8 2.9 9.2 546.3 1.1 1.9 11.3 0.0 0.9 10.3 1.4 3.1 6.5 116.4 0.4 115.1 2.6 0.6 3.7 10.2 3.1 8.8 3.4 6.1 1.2 1.2 122.8 118.4 37.7 10.2 1.9 4.9 12.6 4.1 3.6 3.6 17.8 2.7 54.4 3.1 28.1 33.7 1.2 2.1 3.8 1.5 1.5 16.3 0.9 4.6 594.4 6.6 5.4 7.8 2.4 2.8 3.4 2.6 1.4 3.5 41.3 10.8 1.0 PLP2 "A4, A4-LSB, MGC126187" ENSG00000102007 "Proteolipid protein 2" Q04941 X 49171898-49175235 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 496.5;Exocrine glandular cells: 496.6;Pancreatic endocrine cells: 550.1;Suprabasal keratinocytes: 504.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042415 Approved NA NA 250000 "HPA042415: AB_10796907" "unprognostic (1.40e-1)" "unprognostic (6.67e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (3.32e-5)" "unprognostic (3.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-3)" "unprognostic (4.14e-2)" "unprognostic (2.58e-2)" "unprognostic (9.99e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.55e-10)" "unprognostic (1.66e-1)" "unprognostic (1.25e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 105.2 197.4 17.9 88.4 16.4 361.9 100.6 18.7 21.5 144.1 26.7 159.7 71.7 163.4 43.1 384.8 125.5 53.6 113.6 16.1 35.6 60.6 36.9 119.6 60.3 21.5 19.1 14.6 111.2 252.9 37.8 98.1 61.3 18.9 98.6 131.7 6.3 120.3 105.7 99.8 393.7 97.0 158.0 20.0 79.7 115.6 23.5 19.1 78.7 47.2 53.8 149.2 184.3 266.5 19.5 539.1 312.8 0.4 1.0 131.6 388.9 1.6 278.2 223.5 339.9 255.4 115.2 248.4 193.5 68.1 209.2 340.7 444.1 260.5 517.4 214.5 490.2 104.2 71.4 421.1 3.1 210.0 136.0 304.2 174.7 505.6 443.5 516.5 317.6 260.9 63.0 55.1 239.6 249.2 346.0 14.9 346.2 3.3 263.6 456.2 48.9 300.1 563.8 464.6 355.1 69.4 120.6 394.4 155.6 244.4 2.6 340.6 77.0 293.7 194.4 185.4 344.6 472.4 102.2 100.6 50.9 461.3 359.7 464.4 486.8 287.7 148.7 59.9 99.8 100.7 226.4 214.3 112.8 298.5 144.8 107.8 93.4 320.0 70.5 63.7 694.2 265.8 235.8 17.9 16.4 18.7 21.5 16.1 35.6 21.5 19.1 14.6 18.9 20.0 19.1 19.5 49.3 73.7 38.2 1.0 160.8 439.7 306.0 496.5 167.9 0.4 67.8 115.4 33.3 57.2 101.9 80.9 0.0 2.7 232.0 134.6 21.5 379.6 16.4 71.8 27.8 63.7 111.7 43.1 0.6 496.6 27.2 110.4 71.9 51.1 88.7 15.4 55.3 12.8 157.5 0.0 0.7 254.9 138.4 130.3 210.5 20.3 169.9 133.3 224.1 4.7 146.4 18.9 35.0 0.0 0.6 550.1 200.3 60.9 148.5 219.5 141.8 9.4 92.9 1.1 124.9 76.1 128.7 4.2 1.4 401.0 504.9 6.4 162.7 29.6 285.2 334.1 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "epididymis: 103.5" "Group enriched" "Detected in some" 4 "Endothelial cells: 28.2;Hepatic stellate cells: 93.9" "Cancer enhanced" "Detected in many" "melanoma: 3.2" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 16 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 77 "granulocytes: 7.6" "Cell line enriched" "Detected in some" 119 "HUVEC TERT2: 353.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 6.2 0.3 0.2 1.7 0.3 7.2 5.0 0.3 1.7 1.7 2.5 3.9 4.4 2.3 103.5 2.3 2.6 2.6 5.7 0.3 0.2 0.2 0.7 3.1 1.5 0.4 0.4 0.2 0.9 0.9 0.3 0.2 4.8 0.3 0.9 2.4 0.0 1.1 0.9 1.3 1.4 4.8 2.6 0.3 2.2 1.4 0.2 0.3 0.7 2.0 2.3 0.4 2.7 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 353.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 1.7 0.3 0.2 0.4 0.4 0.2 0.3 0.3 0.3 0.3 14.1 0.0 1.1 1.3 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.2 0.0 28.2 4.2 3.2 1.3 0.2 0.0 1.1 4.6 0.2 0.0 0.1 93.9 0.7 0.1 0.0 1.2 0.1 2.0 0.0 1.1 0.0 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.8 0.0 0.0 0.3 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.4 0.4 LUZP4 "CT-8, CT28, HOM-TES-85" ENSG00000102021 "Leucine zipper protein 4" Q9P127 X 115289715-115307563 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 83 "testis: 8.2" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 35.2" "Cancer enriched" "Detected in some" 9 "testis cancer: 13.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046436, HPA051999" Enhanced NA NA "HPA046436: AB_10964168, HPA051999: AB_2681688" "unprognostic (1.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLS3 T-plastin ENSG00000102024 "Plastin 3" P13797 X 115561174-115650861 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 209.3;Alveolar cells type 1: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "NK-cell: 3.7;plasmacytoid DC: 12.2" "Group enriched" "Detected in many" 6 "dendritic cells: 12.2;NK-cells: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020433, HPA076083" Approved Approved "Plasma membrane,Cytosol" NA NA 120000000 "Plasma membrane, Cytosol" "HPA020433: AB_2670440, HPA076083: AB_2686773" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "unprognostic (6.10e-2)" "unprognostic (4.37e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (6.07e-5)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (5.15e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.72e-4)" "prognostic unfavorable (7.04e-4)" 105.3 32.7 36.7 36.6 44.2 1.4 72.0 47.9 43.9 73.2 34.7 39.1 22.0 121.6 76.9 118.9 68.9 83.8 58.5 34.0 39.7 114.3 203.7 141.0 24.4 44.5 43.5 32.3 102.4 31.7 12.8 11.8 79.0 45.8 44.0 32.2 12.0 47.2 104.1 31.7 120.2 25.2 120.4 42.9 100.7 38.1 22.5 42.5 27.5 176.6 49.2 42.3 76.2 89.2 51.3 206.2 207.1 176.8 51.5 174.3 161.7 269.3 208.2 233.1 194.5 233.9 225.0 167.2 0.8 590.0 171.9 140.6 256.7 190.5 339.1 314.2 2.9 235.8 19.4 234.6 95.0 157.5 0.1 9.6 103.1 159.5 302.7 211.1 315.3 429.5 16.8 0.5 0.3 188.9 59.7 0.4 2.3 234.6 88.0 243.2 0.4 117.8 4.9 233.1 109.1 0.6 36.9 436.8 107.9 89.7 253.7 60.2 3.0 474.3 314.5 53.9 324.6 422.8 7.8 30.5 4.2 137.6 0.8 133.4 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.1 0.0 0.1 3.7 0.0 12.2 1.4 0.2 36.7 44.2 47.9 43.9 34.0 39.7 44.5 43.5 32.3 45.8 42.9 42.5 51.3 209.3 211.5 88.6 26.8 2.0 124.9 121.4 79.6 48.9 0.2 5.6 25.4 17.9 24.3 79.4 99.3 0.0 4.0 1.6 3.5 13.7 59.0 8.4 33.0 39.4 130.5 13.2 4.4 12.3 53.8 105.3 74.3 31.1 64.1 0.0 60.5 64.2 92.1 3.9 0.0 47.6 6.9 38.7 5.0 21.7 8.0 51.9 3.0 56.9 40.3 0.6 26.4 0.0 1.5 97.9 68.6 6.5 82.8 1.6 80.7 2.2 22.0 31.2 1.5 52.6 19.8 132.3 1.2 17.7 65.5 134.1 4.5 3.6 131.1 11.1 100.6 NAA10 "ARD1, ARD1A, DXS707, TE2" ENSG00000102030 "N-alpha-acetyltransferase 10, NatA catalytic subunit" P41227 X 153929225-153935080 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006269, HPA030711" Supported Supported Nucleoli,Cytosol No No Cytosol Nucleoli "CAB006269: AB_425759, HPA030711: AB_2673579" "unprognostic (7.57e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (1.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.04e-1)" "unprognostic (9.01e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (3.29e-8)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (7.48e-3)" 36.3 39.8 17.6 17.3 17.6 13.3 34.9 17.7 27.4 26.4 16.7 31.6 15.4 32.6 15.2 40.9 24.6 10.4 47.9 17.6 18.8 34.3 36.2 26.2 19.9 18.6 18.0 17.2 24.0 46.2 13.9 22.7 12.7 18.6 27.8 10.2 7.3 25.5 12.3 99.2 30.3 25.1 18.3 18.1 29.0 36.2 9.1 19.0 10.3 21.9 25.1 15.4 36.2 27.1 18.1 133.4 136.0 25.8 83.0 36.7 36.9 71.2 46.3 28.6 63.8 57.0 88.5 41.0 102.0 147.6 38.7 79.2 63.0 57.9 56.8 23.9 42.1 255.2 36.8 85.8 91.3 49.1 71.4 76.8 28.8 62.2 57.9 59.1 30.7 72.0 39.2 75.1 41.5 41.6 172.8 115.0 106.4 42.9 124.4 189.0 90.1 65.7 111.5 47.7 59.7 54.0 65.7 18.7 71.0 113.7 23.9 38.4 58.8 41.1 25.6 88.5 89.5 142.0 86.3 107.2 196.0 34.7 91.0 75.5 35.3 53.1 81.3 60.0 65.3 78.1 75.2 63.4 65.6 69.4 77.7 37.4 56.7 49.8 64.7 76.0 75.9 102.9 70.6 17.6 17.6 17.7 27.4 17.6 18.8 18.6 18.0 17.2 18.6 18.1 19.0 18.1 126.9 9.6 30.2 27.1 76.0 70.1 66.1 90.6 68.3 29.5 82.6 113.8 45.1 47.1 52.8 38.6 12.5 125.9 77.0 94.5 95.9 121.1 2.9 46.0 60.7 98.7 58.1 78.9 18.6 149.9 179.0 57.3 76.5 43.4 67.9 64.2 77.8 78.7 123.1 37.0 14.6 92.2 54.9 66.5 96.0 12.5 46.6 66.4 119.2 9.4 84.8 37.9 85.5 14.1 19.1 144.6 75.2 46.6 104.3 136.9 91.5 197.0 40.2 30.4 65.7 56.6 98.3 7.6 33.1 120.7 90.5 108.8 74.8 97.7 110.3 85.9 RENBP "RBP, RNBP" ENSG00000102032 "Renin binding protein" P51606 X 153935269-153944687 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.4;lymphoid tissue: 67.6" "Cell type enhanced" "Detected in many" "granulocytes: 127.7;Hofbauer cells: 183.4;Kupffer cells: 70.7;Proximal tubular cells: 204.2" "Cancer enhanced" "Detected in all" "melanoma: 57.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 4 "granulocytes: 2.7;monocytes: 1.6" "Cell line enhanced" "Detected in many" "EFO-21: 35.5;HMC-1: 121.4;SK-MEL-30: 86.4;U-266/84: 74.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000428, HPA000522" Enhanced NA NA "HPA000428: AB_1079799, HPA000522: AB_1079798" "unprognostic (3.08e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.12e-2)" "unprognostic (3.29e-1)" "unprognostic (8.83e-3)" "unprognostic (1.85e-1)" "unprognostic (5.22e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.47e-3)" "unprognostic (1.99e-1)" "prognostic favorable (3.08e-5)" "unprognostic (2.39e-2)" "unprognostic (6.57e-2)" "unprognostic (4.25e-2)" "unprognostic (8.51e-2)" 18.3 19.4 15.1 13.7 17.5 11.0 11.2 16.0 20.7 4.7 13.5 12.5 8.5 3.9 2.5 3.0 5.6 6.3 10.3 14.2 18.8 43.4 5.3 24.8 16.6 17.8 17.1 12.3 1.7 1.8 2.1 6.1 10.4 19.8 3.8 4.2 2.2 5.9 2.0 2.3 8.6 14.1 4.8 15.6 67.6 5.9 1.2 17.8 6.2 5.5 0.1 6.4 6.3 4.5 19.6 0.0 0.0 3.3 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 35.5 0.0 0.1 0.0 7.1 0.0 0.0 0.0 1.5 28.2 0.0 2.3 20.4 0.0 121.4 0.8 0.0 0.0 0.0 0.0 0.0 1.0 8.2 10.3 0.0 0.6 7.5 0.3 0.4 0.3 0.0 13.6 0.0 0.1 0.0 0.0 0.1 2.0 0.0 0.0 86.4 3.0 0.3 9.9 1.3 0.0 0.8 0.0 0.1 12.5 74.8 5.0 2.5 13.3 9.8 1.7 0.9 2.7 0.1 0.7 0.1 0.4 0.0 0.0 0.1 0.2 0.4 0.2 2.0 0.1 1.6 0.3 0.0 0.5 15.1 17.5 16.0 20.7 14.2 18.8 17.8 17.1 12.3 19.8 15.6 17.8 19.6 1.9 0.0 2.2 7.2 8.0 4.7 1.3 0.3 0.6 2.4 0.4 0.6 1.0 2.8 0.4 9.2 0.0 1.3 2.6 0.4 37.2 1.4 0.1 0.1 0.5 10.7 1.8 3.0 0.2 0.4 6.0 4.5 0.0 0.3 127.7 1.3 52.1 0.8 183.4 15.2 1.7 1.0 0.0 70.7 13.3 0.4 0.3 49.2 28.4 6.5 40.7 10.7 8.2 0.5 6.2 0.5 5.3 0.4 4.0 1.4 12.3 204.2 0.2 0.8 13.1 2.2 4.9 0.1 1.4 0.4 2.0 2.9 7.5 0.7 0.7 0.6 ELF4 "ELFR, MEF" ENSG00000102034 "E74 like ETS transcription factor 4" Q99607 X 130063955-130110716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.6" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 34.3;Granulosa cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058595, HPA060277" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA058595: AB_2683768, HPA060277: AB_2684239" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (3.83e-1)" "unprognostic (2.13e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (4.43e-3)" "unprognostic (7.86e-3)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.29e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (6.49e-6)" "unprognostic (1.43e-1)" "unprognostic (5.46e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.42e-4)" 12.2 3.7 1.8 14.7 1.9 53.6 9.7 2.5 2.4 8.8 3.3 18.3 14.3 10.7 2.1 11.8 12.2 9.4 5.5 1.6 2.4 6.0 2.8 16.0 18.5 2.9 1.9 1.4 17.7 2.7 4.8 4.2 23.9 2.4 6.1 17.9 0.6 5.5 4.2 2.0 10.5 17.2 10.7 1.9 18.3 20.5 2.7 2.6 19.8 3.9 3.7 18.1 19.0 9.2 3.9 56.0 20.7 3.7 0.4 9.1 19.3 52.6 25.3 32.1 30.4 33.4 28.7 38.9 28.6 49.5 34.8 42.3 35.2 20.5 30.0 29.9 31.0 16.8 56.7 27.3 13.6 20.2 49.7 69.3 20.4 32.6 49.1 48.0 19.0 30.0 6.5 22.0 7.7 16.5 32.8 8.2 28.2 2.4 28.4 19.4 17.6 6.5 12.2 18.3 63.9 13.6 6.0 22.8 21.9 6.9 19.1 11.0 46.9 27.6 21.2 16.6 39.5 47.7 4.2 1.8 22.6 24.6 44.8 5.0 1.6 4.0 5.8 7.1 7.6 5.6 2.6 4.2 6.1 4.5 2.7 4.2 4.8 6.9 6.5 5.5 2.7 4.8 4.2 1.8 1.9 2.5 2.4 1.6 2.4 2.9 1.9 1.4 2.4 1.9 2.6 3.9 10.7 9.6 4.4 0.0 8.0 13.6 8.2 2.9 9.1 0.0 2.1 1.5 0.8 0.0 4.4 0.0 0.0 10.6 12.2 24.1 0.0 2.3 0.1 8.9 3.8 8.4 9.0 7.4 0.2 4.0 34.3 6.4 17.9 17.1 1.3 27.5 6.4 1.0 9.7 0.0 0.3 8.3 2.0 12.2 9.2 0.6 1.8 14.8 3.6 5.6 13.1 0.0 16.5 0.0 1.2 9.1 17.4 1.2 2.0 7.5 11.6 0.3 5.4 0.0 6.6 2.6 2.5 0.0 4.0 6.5 10.4 11.2 9.5 5.2 7.1 18.9 SMARCA1 "hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI" ENSG00000102038 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1" P28370 X 129446501-129523500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003335, HPA064712" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003335: AB_1080024, HPA064712: AB_2685332" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (6.21e-2)" "unprognostic (2.16e-2)" "unprognostic (5.44e-2)" "unprognostic (7.15e-2)" "unprognostic (3.41e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.03e-4)" "unprognostic (9.26e-2)" "prognostic favorable (5.09e-4)" "unprognostic (1.87e-3)" "unprognostic (1.28e-1)" "unprognostic (6.14e-2)" "unprognostic (2.33e-2)" 19.1 79.4 18.0 9.1 19.1 0.3 20.9 15.3 19.5 28.2 33.7 16.1 6.8 27.5 35.0 11.4 20.3 21.5 24.7 20.4 28.0 24.1 62.7 16.4 4.6 18.2 18.7 15.7 73.3 15.9 45.0 35.1 38.3 18.5 37.0 7.0 26.9 18.7 35.7 17.5 8.2 8.4 26.1 18.1 9.0 17.5 58.3 23.4 8.0 45.7 19.9 4.3 30.3 14.1 19.1 23.5 53.5 104.8 67.9 76.3 67.1 36.6 46.8 133.2 68.6 76.7 18.3 80.9 0.0 71.8 88.7 81.1 22.1 66.6 27.5 76.4 0.1 12.9 0.2 46.9 100.0 32.6 0.0 0.1 84.2 7.8 49.0 9.3 104.3 50.4 13.1 12.4 5.7 76.1 0.0 0.6 0.2 42.6 9.0 31.0 0.0 56.7 0.2 67.4 28.3 26.0 69.8 6.6 0.9 12.1 73.1 46.9 0.6 35.7 46.0 23.3 30.3 26.4 0.0 0.0 0.2 40.7 0.0 28.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.5 0.0 0.2 0.0 0.1 18.0 19.1 15.3 19.5 20.4 28.0 18.2 18.7 15.7 18.5 18.1 23.4 19.1 23.2 96.1 55.0 24.2 1.5 23.3 35.4 28.3 47.3 26.5 34.8 24.1 80.5 12.8 47.6 40.5 45.9 56.9 1.8 0.1 29.4 30.1 3.7 32.2 80.2 25.6 16.8 3.2 29.3 12.0 15.7 64.3 23.4 42.7 2.5 84.3 22.9 67.0 15.0 92.5 43.4 2.6 14.2 3.2 9.9 18.4 142.9 3.0 28.4 22.5 5.7 47.7 0.0 41.2 17.2 14.0 0.1 125.6 0.1 24.9 0.2 34.9 41.0 13.4 65.7 40.0 49.7 11.4 23.9 17.5 11.8 58.4 2.0 82.9 2.3 29.2 MTMR8 FLJ20126 ENSG00000102043 "Myotubularin related protein 8" Q96EF0 X 64268081-64395452 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Excitatory neurons: 8.6;Inhibitory neurons: 11.3;Microglial cells: 18.7;Oligodendrocyte precursor cells: 16.1;Oligodendrocytes: 12.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.7;JURKAT: 4.7;NTERA-2: 4.2;U-2197: 3.7" "Low region specificity" "Detected in all" NA NA "unprognostic (1.73e-2)" "unprognostic (2.53e-2)" "unprognostic (2.95e-3)" "unprognostic (1.87e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-2)" "unprognostic (3.41e-3)" "unprognostic (1.41e-2)" "unprognostic (2.67e-1)" "unprognostic (2.08e-1)" "unprognostic (8.00e-2)" "unprognostic (2.96e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-1)" "unprognostic (9.22e-2)" "unprognostic (8.20e-2)" 0.3 0.5 0.2 0.6 0.3 0.5 0.4 0.5 0.2 0.8 1.1 1.2 0.5 0.8 0.7 0.9 2.3 0.5 0.2 0.1 0.4 0.6 0.2 0.5 0.9 0.4 0.4 0.1 0.9 0.3 0.6 0.2 0.1 0.4 0.7 1.4 0.9 0.4 1.3 0.2 0.3 0.6 0.7 0.1 0.8 1.2 0.2 0.4 1.0 0.4 0.2 1.1 0.7 0.5 0.2 0.0 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 4.7 0.6 0.0 0.0 0.0 2.6 0.5 1.1 0.0 1.1 1.5 0.2 0.0 0.0 3.3 1.9 0.0 0.6 0.0 0.2 0.0 0.0 4.7 3.4 3.3 0.0 0.2 1.7 0.6 4.2 1.3 0.4 2.6 0.0 1.1 0.2 0.7 0.0 0.4 0.0 0.1 0.0 0.8 0.9 1.6 0.0 0.0 1.0 3.7 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.5 1.1 1.2 1.2 0.8 0.0 1.3 1.5 1.3 0.3 0.3 0.6 0.1 0.7 0.6 0.2 0.3 0.5 0.2 0.1 0.4 0.4 0.4 0.1 0.4 0.1 0.4 0.2 0.7 0.0 0.0 3.6 3.0 0.4 1.2 0.5 3.4 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.0 0.3 1.0 0.6 0.0 1.0 0.0 2.3 0.2 0.6 0.0 0.4 8.6 0.2 0.2 0.5 3.1 0.6 0.0 0.4 0.0 0.0 0.2 0.0 11.3 0.2 2.0 0.3 0.3 0.0 0.6 0.4 0.0 18.7 0.0 0.0 1.0 16.1 12.7 0.2 1.4 0.7 0.4 0.1 0.3 0.4 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.8 0.1 0.3 1.4 0.6 0.8 1.1 ASB9 "DKFZP564L0862, FLJ20636, MGC4954" ENSG00000102048 "Ankyrin repeat and SOCS box containing 9" Q96DX5 X 15235288-15270467 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 16.9;liver: 17.5;lymphoid tissue: 11.8;pancreas: 9.6;testis: 26.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 41.1;Proximal tubular cells: 38.1;Spermatogonia: 126.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "myeloid DC: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.8;EFO-21: 20.1;PC-3: 53.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA003014, HPA003060, CAB004997" Enhanced NA NA "CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225" "unprognostic (8.26e-3)" "unprognostic (1.70e-1)" "unprognostic (8.82e-2)" "unprognostic (2.25e-3)" "unprognostic (1.31e-1)" "unprognostic (2.70e-2)" "unprognostic (6.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.39e-1)" "unprognostic (9.23e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (2.88e-1)" "unprognostic (2.27e-2)" "unprognostic (9.22e-2)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" 2.3 0.8 0.8 0.5 0.6 2.4 1.5 0.9 1.1 2.3 0.8 1.7 1.6 1.3 0.8 1.5 2.2 2.0 2.5 0.7 0.9 16.9 17.5 3.5 0.9 1.0 0.6 0.4 0.6 9.6 0.6 0.5 3.1 0.8 1.0 2.4 0.1 3.8 0.9 0.5 1.8 1.0 2.3 0.6 11.8 4.0 26.1 0.6 4.1 2.2 1.4 1.2 1.4 0.8 0.7 1.5 25.8 0.2 2.4 0.0 1.1 0.7 0.6 2.7 2.9 1.1 5.8 0.1 0.3 20.1 0.9 14.1 7.5 0.0 1.2 1.9 5.4 0.6 6.2 12.6 12.5 0.0 0.0 0.0 6.6 0.2 0.2 0.1 0.3 9.4 1.9 0.1 5.9 1.7 1.8 5.4 0.1 12.2 3.6 53.5 0.1 11.1 5.8 8.0 4.2 2.6 2.6 0.7 1.4 9.0 1.3 0.1 0.7 8.1 0.1 1.8 1.3 3.9 0.4 5.1 0.2 0.8 0.0 14.2 0.5 0.6 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.6 0.1 1.2 0.3 0.2 0.1 0.0 0.0 0.0 0.3 0.8 0.6 0.9 1.1 0.7 0.9 1.0 0.6 0.4 0.8 0.6 0.6 0.7 10.7 0.0 0.0 0.0 1.1 1.9 1.1 0.7 2.2 0.0 0.8 0.9 0.5 12.8 1.0 0.0 0.0 0.1 0.1 0.9 41.1 1.1 2.4 1.2 0.3 11.1 10.7 7.2 0.1 2.0 0.1 1.2 2.6 0.3 1.3 3.4 20.0 12.6 4.7 0.0 0.3 0.3 2.0 4.6 4.4 8.0 1.8 3.3 16.0 1.0 0.3 0.0 0.0 0.0 0.1 0.9 0.5 0.7 0.0 0.6 0.0 38.1 4.8 0.0 0.0 0.0 0.6 1.6 126.5 2.4 3.1 0.1 0.3 5.7 1.6 0.6 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 30 "Astrocytes: 90.4;Excitatory neurons: 232.1;Inhibitory neurons: 219.8;Microglial cells: 128.4;Oligodendrocyte precursor cells: 253.8;Oligodendrocytes: 258.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.5 0.5 2.0 0.4 2.9 0.2 0.5 2.2 2.8 1.3 0.8 1.1 0.6 1.4 0.5 0.3 1.4 0.6 0.4 2.6 2.0 0.7 0.5 0.5 0.5 1.3 1.5 2.5 1.7 0.4 1.6 2.2 0.0 1.6 1.1 0.6 1.9 0.6 1.2 0.2 0.3 0.9 0.9 1.0 0.4 0.8 0.2 1.9 0.9 1.0 0.3 0.3 1.0 0.9 2.4 0.1 0.2 2.1 0.3 0.0 0.0 0.2 0.5 1.1 0.0 0.3 0.2 0.2 0.3 0.1 0.6 0.0 0.3 0.5 0.0 0.0 0.3 1.5 0.7 1.2 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.4 0.0 1.7 0.4 1.7 0.0 0.0 0.9 0.2 0.8 1.2 0.4 1.0 0.1 0.4 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.4 0.7 0.2 0.3 0.4 0.7 1.3 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.0 2.9 2.2 2.8 2.6 2.0 1.3 1.5 2.5 1.6 1.0 1.9 2.4 0.2 6.4 0.5 90.4 1.3 0.0 0.5 0.0 1.2 2.7 0.1 0.6 0.6 0.0 0.0 0.0 2.1 0.0 0.1 0.7 0.0 0.2 0.2 0.7 1.3 0.5 4.2 0.0 232.1 0.2 0.2 1.4 0.0 0.1 0.0 0.6 0.7 0.7 0.1 1.7 219.8 1.3 0.0 0.0 0.3 0.2 2.5 0.0 0.0 128.4 0.1 1.0 0.0 253.8 258.0 0.2 0.6 4.1 0.3 0.3 1.0 0.4 0.0 1.5 0.0 2.1 1.1 0.0 0.1 0.1 0.4 0.0 0.4 0.5 1.0 0.1 RBBP7 RbAp46 ENSG00000102054 "RB binding protein 7, chromatin remodeling factor" Q16576 X 16839283-16870362 "Predicted intracellular proteins" "DNA replication, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037084, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 140000 Nucleoplasm "CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (5.18e-1)" "unprognostic (3.29e-2)" "unprognostic (6.68e-3)" "unprognostic (1.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (3.64e-1)" "unprognostic (1.87e-2)" "unprognostic (3.00e-2)" "unprognostic (7.82e-2)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" 47.4 283.0 28.2 57.5 34.8 100.7 64.5 27.2 40.1 134.2 37.6 70.9 55.5 91.4 296.3 67.7 97.1 50.3 87.3 30.8 31.9 61.5 57.2 43.3 90.6 28.8 26.0 28.5 133.9 47.2 195.7 42.9 97.2 28.0 82.7 73.7 62.0 62.6 168.0 133.9 61.7 57.7 101.8 28.6 48.1 64.9 95.4 27.5 89.5 58.4 90.8 107.4 68.6 52.1 33.6 298.0 219.5 159.5 212.2 99.8 116.6 103.0 143.7 144.7 207.7 233.9 128.6 190.4 328.0 215.2 141.6 236.3 153.1 291.5 214.4 275.2 186.2 400.6 138.9 247.7 153.1 83.8 212.1 160.3 91.3 77.8 240.6 174.9 133.3 211.9 134.6 141.5 167.2 166.9 200.2 236.1 194.0 181.7 141.5 199.5 204.3 295.3 386.7 151.9 197.6 149.3 110.7 271.9 128.3 133.9 225.8 426.8 126.5 99.0 99.5 102.1 265.7 162.8 116.6 178.6 429.3 127.7 140.8 123.3 50.9 45.3 62.3 85.1 79.5 82.6 92.0 70.6 89.4 63.6 80.0 73.3 82.9 18.2 89.2 111.7 74.1 72.1 77.2 28.2 34.8 27.2 40.1 30.8 31.9 28.8 26.0 28.5 28.0 28.6 27.5 33.6 52.0 51.3 65.0 18.6 69.5 74.8 105.7 98.0 33.6 31.4 53.5 51.1 105.1 42.9 80.8 55.2 29.2 440.4 89.8 41.9 78.2 87.3 14.5 55.0 58.0 50.7 60.7 70.2 26.6 74.3 170.8 87.7 44.9 54.8 57.7 101.8 41.4 36.4 109.3 25.2 20.7 57.4 81.4 33.5 39.6 31.2 113.7 43.7 83.6 16.9 60.4 79.4 72.1 46.3 24.7 75.7 39.0 187.3 89.6 75.3 48.6 64.2 63.8 43.6 138.1 73.8 134.3 109.9 121.1 52.5 61.1 532.2 67.8 81.9 79.3 74.2 PPP1R2C "I-4, PPP1R2P9" ENSG00000102055 "PPP1R2C family member C" O14990 X 42777366-42778163 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 181 "testis: 71.6" "Cell type enhanced" "Detected in some" "B-cells: 4.5;dendritic cells: 8.2;T-cells: 22.0" "Cancer enriched" "Detected in single" 38 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971844 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 10.6;NB-4: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 2.8 0.9 2.8 1.5 2.6 2.8 1.8 5.4 2.5 2.6 0.5 1.9 0.8 3.6 1.4 1.1 5.4 2.5 1.7 2.8 3.1 1.7 1.4 2.6 1.4 3.6 2.9 1.6 2.8 1.1 0.4 2.3 1.0 4.4 2.3 0.8 6.1 0.9 2.2 0.5 1.3 2.2 2.5 3.0 3.4 1.8 1.6 2.8 0.7 1.8 0.4 1.4 2.3 2.3 3.8 0.3 1.6 0.7 3.9 5.1 4.1 1.3 0.8 3.3 2.3 1.5 1.1 0.5 1.3 2.8 2.6 0.6 0.5 0.6 0.3 2.2 2.3 2.7 1.2 1.8 0.1 1.9 0.3 2.5 10.6 1.4 4.2 0.4 3.7 0.8 1.9 0.9 3.0 1.7 3.1 0.4 9.2 2.1 0.2 0.6 1.1 0.7 1.3 2.6 1.3 0.4 1.8 0.7 0.0 1.8 7.9 1.7 1.3 2.0 0.5 2.1 0.5 0.2 2.5 3.5 3.2 1.4 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.8 2.6 5.4 2.5 2.8 3.1 3.6 2.9 1.6 4.4 3.0 2.8 3.8 0.9 0.0 1.1 1.0 0.4 0.8 0.0 0.4 0.0 0.2 0.3 0.3 0.8 0.0 0.2 1.8 0.0 0.1 0.4 0.3 1.9 0.2 0.1 0.2 1.0 0.6 3.5 0.0 0.7 0.0 0.1 1.2 0.5 0.5 0.0 1.7 1.1 0.0 0.1 0.0 1.1 0.3 0.0 0.6 0.0 0.2 1.8 0.4 0.0 1.0 0.1 0.4 0.0 2.0 0.1 0.1 0.0 3.8 0.1 0.2 0.2 0.1 0.3 3.0 0.0 0.1 0.6 0.6 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.2 OPN1LW "CBBM, CBP, COD5, RCP" ENSG00000102076 "Opsin 1, long wave sensitive" P04000 X 154144243-154159032 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2590 "retina: 259.0" "Cell type enriched" "Detected in some" 20 "Cone photoreceptor cells: 725.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 259.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 725.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A14 "BMCP1, UCP5" ENSG00000102078 "Solute carrier family 25 member 14" O95258 X 130339888-130373361 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 34.2;Spermatogonia: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060316 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA060316: AB_2684251" "unprognostic (1.65e-2)" "prognostic favorable (1.72e-5)" "unprognostic (1.82e-1)" "unprognostic (2.74e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-1)" "unprognostic (3.36e-3)" "unprognostic (8.92e-3)" "unprognostic (3.52e-2)" "unprognostic (2.95e-3)" "prognostic favorable (1.78e-4)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.52e-6)" "unprognostic (6.05e-2)" "unprognostic (1.12e-1)" "unprognostic (6.92e-2)" "prognostic favorable (1.39e-5)" 2.3 5.7 11.3 2.1 12.6 2.7 3.3 9.2 12.7 3.1 8.0 3.2 1.3 4.1 6.6 2.6 5.9 2.7 4.7 11.8 13.7 3.2 2.5 2.8 2.8 9.7 9.5 12.0 4.1 3.4 4.3 10.9 2.2 10.5 3.0 2.4 10.3 3.2 3.7 3.7 2.9 2.4 4.6 8.3 2.3 3.1 6.7 11.2 4.0 3.4 2.3 3.4 2.6 2.5 13.3 9.0 11.7 8.1 6.1 5.4 5.0 4.4 6.6 8.7 12.3 12.6 4.7 5.3 6.1 22.6 9.0 14.7 4.9 11.9 5.0 12.2 7.6 15.0 2.0 10.7 11.1 7.8 7.7 3.5 4.7 5.9 15.8 4.8 7.4 7.1 8.4 4.9 8.5 20.2 13.8 8.2 10.8 6.7 9.7 18.4 6.9 10.6 12.2 7.5 3.8 10.4 9.2 7.0 7.0 11.7 5.3 4.5 4.3 4.8 6.8 4.5 15.6 13.6 7.8 21.0 5.0 12.3 9.3 6.2 3.2 3.4 2.6 3.0 2.8 3.6 3.9 2.4 2.8 3.7 2.0 1.9 3.1 4.1 3.8 2.7 4.5 4.7 2.4 11.3 12.6 9.2 12.7 11.8 13.7 9.7 9.5 12.0 10.5 8.3 11.2 13.3 4.5 6.4 2.2 5.9 5.6 9.9 8.3 13.3 7.4 10.0 6.6 6.1 4.1 8.6 5.3 3.7 2.1 9.1 4.3 4.5 17.6 10.2 15.8 16.0 5.5 5.1 9.0 3.4 12.7 9.1 8.2 5.4 5.6 4.2 3.8 9.7 7.5 4.3 5.2 6.7 11.9 3.8 12.2 4.7 4.1 7.7 5.0 4.9 8.8 5.6 4.5 8.2 3.1 4.5 5.3 9.0 4.2 8.2 9.0 4.2 4.7 10.7 34.2 13.6 6.6 5.3 9.2 29.1 37.3 7.3 8.4 5.3 5.8 6.5 4.5 6.5 FMR1 "FMRP, FRAXA, MGC87458, POF, POF1" ENSG00000102081 "FMRP translational regulator 1" Q06787 X 147911919-147951125 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Disease variant, Mental retardation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012444, HPA050118, HPA056084" Approved Enhanced Cytosol NA NA Cytosol "CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033" "unprognostic (4.11e-1)" "unprognostic (1.25e-3)" "unprognostic (1.89e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (6.45e-3)" "unprognostic (2.59e-2)" "unprognostic (1.26e-2)" "unprognostic (2.29e-2)" "unprognostic (3.30e-2)" "unprognostic (3.15e-3)" "unprognostic (6.56e-2)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (5.98e-2)" 18.2 16.7 25.5 20.8 26.6 43.9 18.5 32.8 28.0 19.0 20.0 19.3 17.7 27.5 41.4 17.2 23.0 16.0 20.3 24.4 30.4 34.3 39.9 20.2 22.9 24.2 24.4 20.8 28.0 13.4 29.8 13.6 31.4 24.4 16.7 19.1 27.8 14.3 21.6 9.6 23.4 19.8 21.3 25.8 27.9 18.0 19.8 25.3 24.8 30.8 11.7 21.8 16.8 14.8 26.4 44.9 39.6 41.2 27.2 24.4 19.4 31.9 23.8 24.9 37.6 66.4 43.5 42.1 89.5 93.5 29.8 43.3 74.4 65.8 30.2 42.0 34.9 45.2 25.3 71.3 41.4 24.0 28.3 15.1 21.2 16.2 31.6 28.8 22.6 31.8 24.4 15.9 57.7 32.7 59.0 32.0 20.3 18.2 30.9 21.8 34.7 116.8 37.6 43.2 119.3 35.1 23.3 26.8 24.4 35.7 55.4 21.8 24.9 30.4 30.5 25.5 37.7 60.0 61.1 65.5 94.5 27.4 46.9 16.3 2.0 1.3 3.4 2.7 1.6 3.5 2.6 1.8 3.1 1.7 2.4 2.3 2.7 3.5 2.5 1.6 1.3 2.4 1.3 25.5 26.6 32.8 28.0 24.4 30.4 24.2 24.4 20.8 24.4 25.8 25.3 26.4 35.3 57.7 26.6 26.8 22.1 31.4 16.0 12.6 21.1 37.5 20.7 17.4 43.2 14.3 23.9 22.0 12.5 37.2 37.1 27.2 19.6 14.7 1.0 36.4 42.5 27.2 14.9 10.7 33.3 9.8 43.5 27.2 17.9 49.3 19.7 36.8 17.5 37.5 15.4 70.7 32.2 13.8 18.3 25.4 15.7 3.0 30.1 23.7 35.6 29.0 16.8 40.0 11.3 28.6 33.9 13.5 18.1 29.7 20.3 22.7 20.7 42.6 23.4 30.0 6.6 37.2 33.3 14.9 20.9 28.1 32.4 40.8 24.1 39.4 16.9 34.7 PIM2 ENSG00000102096 "Pim-2 proto-oncogene, serine/threonine kinase" Q9P1W9 X 48913182-48919024 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 103.2;intestine: 88.4;lymphoid tissue: 165.2" "Cell type enriched" "Detected in many" 4 "Plasma cells: 738.8" "Cancer enriched" "Detected in all" 6 "testis cancer: 171.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 5 "HDLM-2: 567.6;Karpas-707: 675.0;RPMI-8226: 703.9;U-266/70: 1218.7;U-266/84: 1160.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000285 Approved Cytosol NA NA Cytosol "HPA000285: AB_1079619" "unprognostic (2.34e-3)" "prognostic favorable (4.05e-5)" "unprognostic (8.04e-2)" "unprognostic (7.30e-2)" "unprognostic (6.41e-3)" "unprognostic (2.74e-3)" "unprognostic (2.84e-1)" "unprognostic (5.23e-2)" "unprognostic (2.47e-2)" "unprognostic (4.01e-2)" "unprognostic (1.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.17e-11)" "unprognostic (3.36e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-1)" "unprognostic (4.38e-2)" 8.0 7.1 10.6 86.2 11.7 103.2 8.9 9.9 12.7 5.4 10.9 41.2 88.4 5.2 10.1 8.3 12.0 16.9 5.2 14.6 11.6 9.8 10.5 23.7 115.2 9.7 11.2 11.4 10.4 4.7 3.8 10.2 4.9 10.8 7.4 51.4 5.7 36.7 7.3 2.5 6.1 46.8 7.0 8.9 165.2 45.5 10.1 12.0 45.9 10.2 2.8 105.6 46.0 6.5 12.1 17.5 14.8 8.0 15.4 2.8 2.0 11.7 10.5 13.1 14.8 13.2 13.3 12.9 74.5 4.8 5.3 5.6 10.6 25.1 10.0 14.1 567.6 19.6 90.8 15.0 13.9 6.2 21.7 58.7 5.9 8.4 15.3 9.2 12.1 5.5 9.8 97.8 675.0 8.4 12.6 8.4 45.2 165.2 6.1 22.7 9.9 5.4 703.9 14.9 2.6 5.4 7.8 11.5 8.0 8.3 36.9 19.3 29.8 3.6 3.5 2.5 3.1 10.6 1218.7 1160.5 144.1 14.0 19.0 3.7 279.1 8.2 77.7 60.4 9.7 102.3 124.8 165.9 85.6 13.2 73.5 172.4 113.3 195.5 92.7 17.4 15.2 331.9 79.0 10.6 11.7 9.9 12.7 14.6 11.6 9.7 11.2 11.4 10.8 8.9 12.0 12.1 2.9 12.8 36.0 1.0 161.6 20.3 9.0 7.1 45.5 2.6 16.2 4.7 3.5 2.8 9.9 3.7 2.1 5.8 46.8 5.7 3.9 3.3 1.9 15.6 1.0 5.3 13.1 49.9 2.3 3.5 9.1 5.1 10.7 3.9 23.4 1.3 4.2 6.3 7.2 11.8 2.2 7.5 18.3 7.5 123.1 1.8 1.8 19.8 94.3 0.0 99.5 2.2 38.1 0.5 1.0 2.0 3.7 4.1 738.8 4.6 4.1 6.8 16.3 2.1 0.0 3.8 6.2 2.2 1.6 15.7 13.8 2.5 97.1 8.6 11.8 3.4 SCML2 ENSG00000102098 "Scm polycomb group protein like 2" Q9UQR0 X 18239313-18354688 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.7" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 17.1;Spermatocytes: 26.3;Spermatogonia: 27.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "NTERA-2: 39.7;REH: 37.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001662, HPA064713" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001662: AB_1079879, HPA064713: AB_2685333" "unprognostic (5.15e-2)" "unprognostic (2.57e-2)" "unprognostic (7.93e-2)" "unprognostic (7.26e-5)" "unprognostic (1.24e-1)" "unprognostic (2.24e-2)" "unprognostic (4.95e-5)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (1.18e-1)" "unprognostic (6.15e-4)" "unprognostic (1.83e-1)" "unprognostic (2.35e-4)" "unprognostic (3.30e-1)" "unprognostic (2.54e-1)" "unprognostic (1.97e-2)" "unprognostic (3.31e-3)" 1.4 4.0 1.2 1.2 1.2 6.4 2.0 1.5 1.5 2.2 1.1 1.6 1.1 2.6 1.1 1.0 1.5 0.7 0.7 1.2 1.1 0.7 1.4 0.5 1.1 1.2 1.1 1.0 6.1 1.3 1.7 1.5 1.9 1.3 1.2 1.3 3.5 8.9 1.1 1.3 2.0 0.9 2.5 1.0 1.2 0.6 11.7 1.1 3.4 2.4 1.4 1.2 1.4 1.7 1.5 1.9 6.8 24.7 5.9 1.9 2.5 7.2 4.0 2.9 7.3 8.3 9.2 1.3 0.0 0.9 1.9 5.7 0.1 32.7 0.6 9.4 0.0 26.0 0.0 5.7 4.0 0.9 21.1 5.0 1.5 1.1 5.7 6.9 1.9 0.4 20.2 16.0 0.0 5.1 3.2 33.3 10.0 39.7 0.7 9.0 37.8 11.9 4.5 0.2 0.4 14.0 16.3 7.7 6.5 0.1 26.0 8.2 8.8 1.0 6.8 4.9 15.2 3.6 0.0 20.4 32.0 2.6 13.8 5.4 0.0 0.1 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.5 0.6 0.1 0.0 0.0 0.5 0.0 3.8 0.0 0.2 1.2 1.2 1.5 1.5 1.2 1.1 1.2 1.1 1.0 1.3 1.0 1.1 1.5 0.5 0.0 0.5 3.6 1.7 3.6 1.0 0.0 2.8 2.3 0.8 1.3 1.8 0.0 0.6 0.0 0.0 1.8 1.7 0.4 0.0 0.3 1.3 0.9 2.5 1.2 1.2 4.2 7.7 0.2 0.4 2.4 0.0 0.2 0.0 6.1 0.0 0.9 1.9 6.7 15.3 0.7 0.0 0.0 0.5 1.6 1.8 0.6 0.0 0.0 0.2 1.7 0.0 17.1 10.2 0.2 0.0 1.2 0.3 1.2 0.1 0.8 0.0 3.8 0.0 2.6 0.6 26.3 27.5 1.8 4.1 0.4 0.5 9.8 1.2 0.3 SLC35A2 "UGALT, UGAT, UGT, UGT1, UGT2, UGTL" ENSG00000102100 "Solute carrier family 35 member A2" P78381 X 48903180-48911958 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036087 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA036087: AB_10604093" "prognostic unfavorable (3.16e-4)" "unprognostic (3.34e-1)" "unprognostic (4.88e-3)" "unprognostic (1.11e-1)" "unprognostic (8.15e-3)" "unprognostic (4.25e-3)" "prognostic unfavorable (9.64e-5)" "unprognostic (3.47e-1)" "unprognostic (2.50e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-3)" "unprognostic (9.58e-2)" "unprognostic (3.16e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" 14.9 20.7 13.0 12.8 13.5 16.1 15.0 13.8 14.9 18.8 17.2 29.6 17.5 13.2 28.6 24.9 32.9 15.3 14.8 13.7 15.0 18.1 32.1 18.4 11.5 13.9 13.8 12.8 9.4 30.3 24.9 21.5 20.0 14.7 17.3 28.4 3.1 24.0 14.9 14.1 22.0 18.1 11.8 14.0 14.8 25.3 7.1 14.7 11.9 15.6 7.3 14.8 20.0 15.6 15.4 48.8 55.2 18.8 27.3 36.5 31.6 29.7 49.7 54.1 51.3 59.9 64.0 84.5 18.8 22.2 54.2 64.4 67.0 51.7 40.0 39.7 27.9 34.0 20.5 33.1 49.6 47.8 38.7 40.9 35.7 69.9 48.6 39.8 28.9 30.6 25.9 38.7 29.8 37.6 47.1 20.5 35.0 39.7 55.3 67.7 22.3 35.5 61.1 44.4 39.1 21.8 36.1 52.9 54.5 28.7 35.1 80.8 30.7 28.2 30.3 30.6 55.4 27.5 45.1 32.8 19.6 38.4 34.1 40.3 18.1 22.3 40.0 15.3 23.4 15.8 10.7 12.6 13.9 27.7 9.9 8.3 14.6 24.2 13.8 17.5 27.7 13.1 11.9 13.0 13.5 13.8 14.9 13.7 15.0 13.9 13.8 12.8 14.7 14.0 14.7 15.4 16.2 9.6 17.0 3.3 13.1 14.1 11.7 29.0 2.8 4.5 26.5 10.9 5.2 10.0 23.5 16.5 0.0 31.0 15.6 24.1 3.9 27.4 3.3 24.2 12.0 13.5 12.7 19.0 2.6 32.3 30.6 14.0 18.8 16.8 2.5 8.0 11.0 15.6 23.4 6.7 2.5 31.5 28.5 10.1 14.5 1.3 9.9 12.3 10.6 4.7 21.9 9.4 8.2 4.5 4.4 27.1 19.7 10.9 19.3 18.7 17.8 10.5 50.5 5.7 6.6 9.7 19.4 10.3 6.8 10.9 17.5 48.0 13.8 12.2 21.7 23.4 PQBP1 "MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS" ENSG00000102103 "Polyglutamine binding protein 1" O60828 X 48890197-48903143 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001880 Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA001880: AB_1079671" "unprognostic (7.25e-2)" "prognostic favorable (1.48e-4)" "unprognostic (5.98e-2)" "unprognostic (2.09e-2)" "unprognostic (2.73e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.09e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (4.33e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.68e-7)" "unprognostic (2.68e-1)" "unprognostic (2.52e-3)" "unprognostic (3.97e-2)" "unprognostic (5.70e-3)" 38.5 51.0 36.3 25.9 37.6 46.4 39.6 38.5 44.6 47.8 32.7 46.9 39.5 42.9 22.9 49.0 41.4 24.4 41.1 37.0 39.6 41.7 61.5 35.9 31.4 39.4 38.1 34.8 58.9 63.3 28.4 50.9 18.3 38.6 42.5 20.6 21.7 43.6 28.6 65.5 52.2 42.6 25.6 39.5 45.5 52.5 13.9 41.4 38.9 38.9 32.6 29.2 39.6 43.6 40.7 100.6 124.3 64.5 63.2 58.2 40.8 48.8 57.3 67.1 116.8 70.7 146.3 45.0 91.8 46.2 40.0 88.1 79.9 110.6 42.6 43.5 80.8 95.2 78.1 94.6 109.5 55.9 95.5 69.8 50.7 81.4 96.8 95.5 46.5 67.0 35.9 75.7 169.0 50.1 167.5 41.5 94.3 60.3 69.3 139.6 66.7 63.0 209.4 75.5 66.2 95.7 49.4 75.3 82.6 66.5 48.0 103.5 68.9 58.6 51.1 92.2 65.6 77.4 99.9 106.5 69.5 29.0 88.0 53.8 41.8 81.9 53.1 56.4 79.1 74.7 83.9 78.2 56.2 96.9 70.4 81.5 74.9 23.4 76.1 73.0 86.9 114.3 84.5 36.3 37.6 38.5 44.6 37.0 39.6 39.4 38.1 34.8 38.6 39.5 41.4 40.7 37.0 41.7 65.9 6.2 65.4 111.8 86.1 99.5 85.4 36.7 76.9 97.2 39.0 54.3 68.6 31.3 12.5 58.5 53.4 85.1 49.0 59.9 6.2 37.5 38.6 54.5 70.1 38.7 4.4 95.8 56.1 53.9 39.8 54.3 70.5 36.6 43.5 45.0 70.2 18.5 3.9 68.2 77.3 72.2 113.5 4.9 69.9 56.2 88.9 3.7 96.6 47.4 55.6 3.5 4.8 73.7 123.6 43.6 105.9 54.2 151.1 108.5 51.6 27.7 39.5 64.4 69.8 2.7 17.7 69.5 117.3 54.6 62.9 67.0 67.9 69.3 RS1 "RS, XLRS1" ENSG00000102104 "Retinoschisin 1" O15537 X 18639688-18672108 "Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 207 "retina: 215.5" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 160.6;Rod photoreceptor cells: 162.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059546 Enhanced "Secreted in other tissues" NA NA "HPA059546: AB_2684058" "unprognostic (8.31e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (4.80e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-2)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.77e-3)" "unprognostic (4.14e-1)" "unprognostic (7.03e-2)" "unprognostic (1.06e-1)" "unprognostic (3.06e-2)" "unprognostic (5.12e-2)" "unprognostic (2.04e-4)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 215.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 6.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 1.9 0.0 0.0 0.0 160.6 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 162.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831096-48835610 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 439.9;pituitary gland: 1253.4" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 3045.7;Horizontal cells: 437.4;Paneth cells: 628.8;Proximal tubular cells: 1601.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 2.4;memory CD4 T-cell: 5.0;memory CD8 T-cell: 4.9;naive CD4 T-cell: 2.0;naive CD8 T-cell: 6.4;T-reg: 1.8" "Lineage enriched" "Detected in single" 64 "T-cells: 6.4" "Cell line enhanced" "Detected in many" "HEK 293: 58.9;PC-3: 148.5;SCLC-21H: 58.2;SH-SY5Y: 53.8;SiHa: 52.1;U-266/84: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" NA NA 3300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favorable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 2.3 29.8 163.6 0.5 126.7 0.0 2.0 20.6 199.4 18.1 83.6 16.8 9.7 34.4 2.9 0.9 7.0 0.2 8.5 97.2 439.9 150.7 1.3 2.9 0.1 307.9 222.5 109.9 2.3 54.4 11.2 1253.4 0.2 135.4 14.5 0.5 2.5 6.7 0.8 0.8 8.6 13.8 0.6 87.0 1.1 22.1 19.8 190.0 0.0 3.3 0.0 0.0 1.2 6.6 188.7 0.1 5.4 0.2 14.9 0.6 0.0 0.4 0.0 0.0 0.0 0.0 5.3 0.1 0.0 10.4 0.0 4.2 0.8 0.0 1.1 0.0 0.0 58.9 0.0 0.0 9.3 0.0 0.0 3.7 0.0 0.8 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 7.6 0.0 0.5 7.9 0.0 148.5 0.0 0.0 0.4 1.4 0.2 58.2 53.8 52.1 0.2 4.9 0.7 0.2 0.1 0.1 0.1 22.7 0.2 5.0 13.3 73.6 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.8 0.0 2.4 0.0 5.0 4.9 0.0 0.0 2.0 6.4 0.0 0.0 0.0 0.0 1.8 0.7 163.6 126.7 20.6 199.4 97.2 439.9 307.9 222.5 109.9 135.4 87.0 190.0 188.7 0.8 0.0 0.0 29.0 12.5 15.8 1.3 4.3 0.6 139.6 11.4 14.9 1.4 2.8 4.3 389.9 52.1 1.0 1.0 18.2 277.8 8.6 12.8 44.3 8.7 3.6 3045.7 2.7 64.8 0.7 69.0 17.2 112.1 35.2 0.0 2.5 0.0 0.5 1.7 437.4 118.8 218.9 54.9 0.3 17.2 52.9 3.4 10.5 56.9 22.5 0.4 96.2 1.0 72.9 26.0 23.1 628.8 7.2 4.5 30.4 21.6 1601.1 24.8 148.2 0.0 0.3 12.6 32.5 82.2 0.2 11.5 1.9 20.1 0.2 15.6 3.7 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379273-154381523 "Disease related genes, Human disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 240000 "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 32.8 32.7 25.6 15.5 25.1 26.7 33.5 26.0 32.1 46.2 24.6 38.6 14.9 58.7 16.2 35.3 56.7 11.3 44.2 24.1 34.4 37.1 30.8 33.6 14.0 28.0 26.3 23.3 64.4 51.0 21.5 42.9 15.6 25.9 36.8 11.2 13.0 33.7 22.0 81.0 36.1 27.4 20.1 26.7 27.2 38.8 17.4 28.3 13.1 40.9 29.9 15.6 51.7 36.4 29.6 121.3 42.4 29.0 32.7 26.3 50.6 54.7 58.1 58.2 68.5 72.4 37.9 22.6 99.6 92.2 56.2 143.5 65.5 55.8 67.4 29.5 60.6 116.8 43.7 58.4 22.5 67.9 42.9 46.8 44.1 53.2 60.4 75.0 46.5 48.3 37.5 37.0 39.0 47.9 49.2 74.4 78.1 51.3 66.3 128.9 62.1 45.9 92.4 38.4 21.9 37.9 47.8 29.8 47.6 74.2 27.8 33.6 31.2 43.5 35.7 69.6 80.2 84.2 131.4 100.6 179.3 42.3 70.9 38.1 35.5 29.5 46.4 45.2 37.3 41.8 37.8 43.1 43.6 24.8 37.0 37.7 37.7 31.0 28.7 28.1 54.9 43.3 30.6 25.6 25.1 26.0 32.1 24.1 34.4 28.0 26.3 23.3 25.9 26.7 28.3 29.6 30.3 32.1 39.5 8.1 93.1 71.8 74.8 60.9 84.2 35.1 53.4 60.1 22.3 35.8 40.4 27.6 12.5 60.7 87.4 16.6 70.5 43.5 16.3 46.5 51.8 36.2 23.9 46.7 9.6 55.0 66.4 52.9 53.5 64.4 55.1 40.9 27.1 38.8 52.2 30.3 8.8 37.0 28.5 25.2 93.0 15.4 40.7 69.4 67.6 10.3 50.2 46.9 34.0 5.5 10.8 47.7 31.3 44.8 125.8 86.4 30.9 49.5 27.9 32.6 26.3 49.5 60.1 25.4 36.2 99.3 77.0 125.1 92.7 42.3 30.4 68.3 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411524-154421726 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favorable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 18.4 13.9 35.6 8.6 35.3 41.8 17.4 35.6 44.8 18.2 34.6 17.7 9.8 15.2 7.6 21.9 16.8 8.8 43.9 35.0 34.7 20.1 22.1 21.6 18.0 36.8 35.2 34.3 18.7 21.5 12.2 14.6 6.7 35.8 18.1 11.8 8.4 13.7 10.2 47.4 17.5 23.1 12.4 35.6 39.5 17.5 4.5 35.7 14.2 18.7 66.2 16.1 18.5 18.5 37.5 24.5 28.6 9.3 11.7 18.3 13.4 18.4 6.9 21.0 15.3 17.1 8.5 29.6 28.2 43.6 16.4 36.6 28.4 17.2 16.6 12.3 25.5 19.6 5.5 20.0 16.4 25.8 12.3 11.8 15.4 35.6 11.7 31.7 12.9 25.6 30.9 12.1 34.9 18.1 17.6 29.0 33.2 2.4 24.9 27.9 21.4 16.2 40.1 24.2 9.0 11.8 17.9 5.3 17.9 26.6 11.1 10.5 16.0 15.5 10.4 11.9 25.5 15.2 55.9 30.6 66.2 13.7 36.6 13.3 5.8 11.1 17.5 12.4 10.4 11.5 12.5 16.6 15.5 14.5 18.7 14.1 12.0 9.9 12.7 7.8 7.9 15.4 9.4 35.6 35.3 35.6 44.8 35.0 34.7 36.8 35.2 34.3 35.8 35.6 35.7 37.5 36.2 6.4 11.8 37.2 29.3 10.8 7.9 10.5 14.8 21.6 11.1 15.6 21.1 14.3 13.0 9.2 18.8 5.0 29.7 13.6 5.9 14.7 1.1 6.5 9.6 18.5 6.1 9.7 22.4 16.5 10.1 12.4 23.4 9.6 18.4 19.2 15.0 7.9 24.4 10.1 28.4 15.9 12.2 19.9 16.5 2.0 11.5 20.4 14.2 14.0 21.7 14.2 15.5 23.1 39.7 13.4 12.2 9.1 17.2 8.3 19.6 5.9 8.0 25.6 13.1 12.4 11.3 10.4 3.8 16.8 11.2 2.9 25.6 9.2 15.8 6.7 RAB40AL "RAR2, RLGP" ENSG00000102128 "RAB40A like" P0C0E4 X 102937272-102938300 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.8;Cone photoreceptor cells: 2.1;Enteroendocrine cells: 3.0;Hepatic stellate cells: 2.2;Horizontal cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (1.99e-1)" "unprognostic (3.05e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-1)" "unprognostic (3.49e-1)" "unprognostic (1.83e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" "unprognostic (5.90e-10)" "unprognostic (4.74e-1)" "unprognostic (1.32e-1)" "unprognostic (5.02e-3)" "unprognostic (2.64e-2)" 0.1 0.1 0.5 0.0 0.4 0.0 0.1 0.1 1.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.4 0.1 1.1 0.5 0.2 0.3 0.0 0.3 0.5 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.2 1.8 0.1 0.1 0.1 0.0 0.0 0.0 2.1 0.9 1.3 0.6 0.0 0.0 0.1 0.1 0.2 0.4 3.0 0.4 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.1 2.2 0.9 0.4 1.7 0.0 0.2 0.0 0.8 0.0 1.0 1.5 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 1.5 0.0 0.5 0.4 0.0 0.0 0.6 0.0 1.2 0.1 0.3 0.3 0.1 0.0 0.7 0.0 0.1 0.6 0.3 PGK1 ENSG00000102144 "Phosphoglycerate kinase 1" P00558 X 77910739-78129295 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 1126.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010065, HPA045385, HPA073644, HPA073656" Approved NA NA 170000000 "CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235" "prognostic unfavorable (7.05e-8)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.21e-1)" "unprognostic (8.30e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.65e-6)" "prognostic unfavorable (2.74e-4)" "unprognostic (1.13e-2)" "unprognostic (1.27e-1)" "unprognostic (6.66e-2)" "prognostic unfavorable (8.34e-4)" "unprognostic (5.66e-2)" "unprognostic (2.99e-1)" "unprognostic (8.99e-3)" "unprognostic (3.58e-1)" "unprognostic (2.90e-2)" "unprognostic (6.57e-2)" 121.8 143.1 93.1 150.4 97.2 255.0 90.0 104.0 119.3 101.1 116.0 128.6 124.6 73.0 73.6 155.6 80.0 111.1 249.7 93.1 109.9 235.6 145.0 118.1 140.2 104.1 103.0 92.4 62.5 61.6 190.3 30.2 139.7 111.5 93.7 144.5 301.4 94.0 102.8 456.3 93.3 120.1 117.7 110.5 98.0 86.9 29.5 115.9 159.8 106.6 269.0 191.1 149.8 49.8 133.4 943.0 426.7 139.7 283.8 236.1 190.0 331.3 469.2 324.0 402.9 670.0 390.2 287.7 373.9 473.7 326.5 479.5 397.6 624.8 729.3 800.7 229.8 246.6 290.3 657.8 341.8 258.0 671.8 309.2 238.5 302.2 366.7 192.7 646.1 418.8 361.9 308.5 553.4 557.4 371.2 593.5 506.0 433.3 628.5 800.7 421.8 374.4 1157.0 423.8 385.4 208.0 286.6 486.3 409.0 422.9 352.6 214.8 347.9 340.2 428.1 294.3 433.4 329.0 609.5 1221.7 391.5 1207.0 750.5 286.6 170.6 360.2 321.1 121.9 382.0 135.9 128.4 144.3 132.9 333.7 101.2 130.9 140.7 281.9 140.3 527.0 130.2 168.4 606.0 93.1 97.2 104.0 119.3 93.1 109.9 104.1 103.0 92.4 111.5 110.5 115.9 133.4 166.3 150.6 168.6 20.2 174.8 144.3 272.2 1126.6 122.3 211.3 72.4 67.2 480.4 140.2 436.9 174.7 77.2 298.4 200.6 196.5 471.6 715.8 19.3 123.7 112.4 182.3 102.4 95.9 32.5 236.4 746.4 131.3 95.3 145.1 195.5 98.1 139.6 200.2 499.0 309.6 37.0 164.3 518.8 298.4 188.8 12.1 94.8 310.4 167.2 25.3 499.3 245.7 131.8 20.1 21.9 510.2 149.9 127.2 214.8 118.3 221.5 566.0 235.6 188.8 124.9 84.0 191.8 8.8 57.4 138.4 119.1 349.6 251.9 278.7 203.5 225.8 GATA1 "ERYF1, GATA-1, GF1, NF-E1, NFE1" ENSG00000102145 "GATA binding protein 1" P15976 X 48786562-48794311 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 60.4" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 165.6" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "eosinophil: 471.7" "Lineage enriched" "Detected in single" 1877 "granulocytes: 471.7" "Group enriched" "Detected in some" 9 "HEL: 221.5;HMC-1: 211.9;K-562: 238.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA000232, HPA000233, CAB009195" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951" "unprognostic (1.93e-1)" "unprognostic (7.54e-2)" "unprognostic (8.95e-3)" "unprognostic (3.84e-3)" "unprognostic (2.25e-1)" "unprognostic (3.00e-4)" "unprognostic (4.87e-2)" "unprognostic (3.48e-2)" "unprognostic (4.44e-2)" "unprognostic (1.95e-2)" "unprognostic (6.04e-2)" "unprognostic (7.71e-3)" "unprognostic (4.13e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-1)" "unprognostic (9.10e-2)" "unprognostic (2.71e-2)" 0.2 0.1 0.1 0.1 0.2 60.4 0.1 0.2 0.1 0.2 0.1 0.2 0.6 0.3 0.0 0.2 0.1 0.6 0.1 0.0 0.3 0.2 0.3 2.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.2 1.0 0.3 0.3 0.3 0.4 0.1 0.1 0.0 0.2 0.5 0.3 0.2 2.0 0.5 1.4 0.2 0.1 0.1 0.4 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 221.5 0.0 0.0 0.0 0.2 211.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 238.9 0.4 0.0 0.0 0.1 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 83.6 0.2 471.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.0 0.0 4.4 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.3 0.0 0.3 0.2 0.2 0.6 0.0 0.0 1.3 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 165.6 0.1 0.0 0.5 0.3 0.0 0.0 37.9 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.4 31.5 0.0 9.2 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 1.2 0.2 0.0 0.0 MAGT1 "DKFZp564K142, IAP, MRX95, OST3B, SLC58A1" ENSG00000102158 "Magnesium transporter 1" Q9H0U3 X 77825747-77895593 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 145.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049851 Approved "Intracellular and membrane" NA NA "HPA049851: AB_2680913" "prognostic unfavorable (1.30e-4)" "unprognostic (3.32e-1)" "unprognostic (6.47e-2)" "unprognostic (1.16e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (8.98e-4)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.60e-2)" "unprognostic (5.56e-3)" "unprognostic (1.14e-1)" "unprognostic (6.25e-3)" "unprognostic (1.66e-1)" 25.5 22.8 13.5 24.4 19.4 21.0 36.9 18.1 17.6 39.7 16.9 28.6 25.9 27.8 54.2 25.8 26.2 25.3 37.9 13.3 23.0 42.3 71.7 27.0 22.7 21.5 19.7 11.7 23.9 32.2 38.7 18.6 36.7 21.7 33.8 27.3 5.2 34.9 28.2 17.2 18.5 26.5 24.5 19.2 23.7 29.6 11.4 17.3 21.2 78.7 22.1 23.7 29.4 18.3 28.3 62.5 34.1 41.7 48.8 75.0 49.3 64.8 66.9 67.4 51.7 56.5 45.6 99.5 45.6 90.9 71.7 53.3 56.4 88.4 50.8 80.0 32.3 55.4 30.6 46.2 42.5 66.6 64.9 31.1 45.3 43.5 64.6 56.7 55.1 74.0 31.2 36.5 123.2 64.7 40.4 36.2 23.9 56.1 64.6 41.3 43.3 72.5 84.7 61.9 45.8 14.1 26.3 91.6 64.8 58.0 43.6 43.8 35.3 75.2 45.6 51.1 71.7 33.2 44.8 103.1 58.1 49.7 60.5 61.0 15.3 12.9 13.7 17.2 19.7 18.4 12.5 15.6 16.6 11.1 10.7 14.9 17.7 11.0 18.6 21.0 22.2 12.8 15.7 13.5 19.4 18.1 17.6 13.3 23.0 21.5 19.7 11.7 21.7 19.2 17.3 28.3 50.2 41.7 53.6 9.8 37.3 33.0 55.3 51.6 24.5 5.2 39.1 25.1 53.4 42.9 51.6 40.5 4.2 33.3 43.4 44.8 3.9 35.3 2.2 23.7 38.9 40.7 22.7 33.0 6.1 34.9 59.3 43.7 33.1 58.0 30.4 24.5 43.2 145.6 42.3 1.7 6.3 39.6 32.6 49.8 46.1 2.5 30.7 45.1 33.8 15.9 33.9 17.1 18.6 13.6 28.0 36.2 37.2 27.1 87.4 65.4 31.2 32.0 20.7 5.2 19.7 38.7 31.2 6.6 16.7 36.5 45.6 81.3 36.0 31.2 26.0 69.4 SMS "MRSR, SPMSY, SpS, SRS" ENSG00000102172 "Spermine synthase" P52788 X 21940709-21994837 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Polyamine biosynthesis" Transferase "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029849, HPA029852" Approved Approved "Nuclear bodies,Cytosol" No No 16000 "Nuclear bodies" Cytosol "HPA029849: AB_10602072, HPA029852: AB_10611521" "unprognostic (2.51e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (7.49e-4)" "prognostic unfavorable (7.79e-8)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.18e-3)" "unprognostic (3.95e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (7.85e-5)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (8.50e-2)" 30.0 95.0 51.3 35.0 55.2 51.2 50.1 58.0 62.4 43.0 45.7 50.2 55.4 45.1 64.1 30.9 28.9 40.9 53.5 54.5 51.4 121.0 44.6 36.6 48.2 50.4 49.3 51.6 92.0 24.3 28.2 31.7 115.2 48.8 137.2 50.9 49.9 40.0 42.6 34.9 21.5 51.3 39.9 53.4 41.7 39.6 30.5 56.8 51.2 55.8 32.8 47.7 55.7 32.3 54.7 664.3 161.2 265.3 107.1 71.9 121.4 86.3 174.6 102.6 261.7 249.1 204.0 213.0 239.5 59.8 180.0 722.9 142.2 265.5 318.2 508.2 111.0 128.6 124.4 201.0 145.5 129.4 242.2 103.8 76.8 93.7 266.4 497.2 189.2 254.5 93.6 270.6 32.7 366.7 139.2 181.3 244.1 474.9 149.0 244.3 176.0 188.5 182.9 354.3 90.1 131.4 105.7 143.1 181.8 489.1 687.6 163.9 101.3 232.3 194.4 193.6 405.0 294.5 23.8 52.6 142.2 378.4 107.5 275.6 9.1 57.5 102.5 18.9 59.9 23.7 34.6 29.6 33.3 51.1 22.0 19.1 22.8 55.7 31.4 73.9 10.7 55.4 37.3 51.3 55.2 58.0 62.4 54.5 51.4 50.4 49.3 51.6 48.8 53.4 56.8 54.7 43.4 25.6 21.9 33.6 61.5 65.9 203.0 206.1 42.1 35.7 116.2 66.3 36.1 81.5 115.0 110.3 12.5 644.3 46.7 61.2 608.4 246.3 1.9 126.4 70.4 61.9 58.8 95.2 45.6 152.3 313.1 86.6 57.6 215.9 40.5 249.5 59.6 49.8 364.7 21.9 40.2 103.6 146.5 157.3 200.3 7.1 95.4 153.1 92.5 21.5 250.7 46.8 48.4 22.1 8.1 165.6 63.9 103.4 45.6 276.2 137.0 466.7 78.9 43.2 65.7 76.6 114.2 6.0 181.3 54.1 50.6 869.6 63.7 271.2 119.1 153.1 PHEX "HPDR, HPDR1, HYP, HYP1, PEX, XLH" ENSG00000102174 "Phosphate regulating endopeptidase homolog X-linked" P78562 X 22032325-22251310 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Biomineralization "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 45.3;Granulosa cells: 161.7" "Cancer enriched" "Detected in some" 4 "thyroid cancer: 5.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 37 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 37 "dendritic cells: 4.8" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.7;HUVEC TERT2: 2.8;PC-3: 3.0;TIME: 3.1;U-87 MG: 6.5;WM-115: 2.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" NA NA "unprognostic (2.01e-2)" "unprognostic (2.69e-1)" "unprognostic (2.43e-1)" "unprognostic (1.05e-3)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (2.25e-3)" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-2)" "unprognostic (7.53e-2)" "unprognostic (7.45e-2)" "unprognostic (9.84e-8)" "unprognostic (1.18e-1)" "unprognostic (1.58e-1)" "prognostic favorable (2.51e-4)" "unprognostic (7.68e-2)" 0.0 0.0 1.1 0.5 1.0 0.0 0.7 1.8 0.8 0.8 0.4 0.2 0.5 2.0 0.1 0.2 0.1 0.9 0.0 0.9 2.0 0.1 0.0 2.8 1.5 1.6 1.6 0.7 1.6 0.0 0.0 0.2 0.1 1.7 0.6 0.0 0.3 0.2 0.4 0.0 0.1 0.6 1.5 1.8 0.4 0.1 0.1 1.3 0.3 1.0 0.3 0.9 0.2 0.3 2.2 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.8 0.0 0.1 0.1 0.0 3.7 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 1.3 0.7 0.7 2.1 0.1 2.8 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.6 0.0 0.4 0.1 0.1 0.1 0.2 1.5 0.5 0.4 1.8 0.0 3.1 0.6 0.1 0.4 0.5 0.0 0.0 0.0 6.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 1.1 1.0 1.8 0.8 0.9 2.0 1.6 1.6 0.7 1.7 1.8 1.3 2.2 0.0 0.0 0.0 3.9 0.8 0.0 5.8 2.3 0.0 0.4 3.0 1.8 0.5 0.0 1.6 0.0 0.0 0.2 45.3 0.7 0.0 0.9 0.4 1.3 1.4 0.2 0.0 0.0 2.2 1.2 0.1 2.9 0.0 1.8 0.0 161.7 0.0 0.0 0.0 16.8 1.9 0.5 4.1 0.0 0.4 0.3 1.8 1.2 1.8 0.0 0.0 0.6 0.0 1.5 0.5 0.8 0.0 0.0 0.3 1.8 8.2 0.9 4.5 0.5 0.0 2.1 2.6 0.1 0.4 0.1 0.1 0.8 0.4 18.9 0.4 3.3 UBL4A "DXS254E, GDX, GET5, MDY2, TMA24, UBL4" ENSG00000102178 "Ubiquitin like 4A" P11441 X 154483717-154486615 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003617 Approved Supported Nucleoplasm,Cytosol NA NA 11000 "Nucleoplasm, Cytosol" "HPA003617: AB_1080450" "unprognostic (2.75e-2)" "unprognostic (3.39e-3)" "unprognostic (5.52e-2)" "unprognostic (2.88e-2)" "unprognostic (2.62e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (4.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.24e-2)" "unprognostic (8.26e-3)" "unprognostic (4.50e-1)" "unprognostic (4.41e-2)" "unprognostic (2.74e-2)" "unprognostic (6.01e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-2)" 17.3 29.8 31.4 11.4 32.7 11.3 17.3 29.2 38.2 20.5 25.9 25.2 17.8 19.2 18.1 29.3 18.1 11.5 41.7 32.3 30.3 19.9 28.3 17.9 16.2 31.3 30.0 31.3 15.9 37.2 21.1 16.1 13.6 32.1 21.0 12.5 6.4 28.0 20.4 98.9 24.3 19.6 12.0 30.1 19.0 23.3 4.5 31.9 17.4 16.0 72.7 17.1 26.0 21.7 34.0 84.8 50.9 15.3 42.1 31.3 31.3 51.0 35.0 26.3 37.2 39.5 50.3 32.6 64.1 107.8 33.7 31.5 31.5 76.9 40.4 20.2 42.6 46.5 46.3 46.6 29.6 38.9 55.8 48.1 24.0 45.9 24.8 42.8 36.1 27.0 46.5 51.9 31.4 30.1 66.2 49.9 52.3 17.8 74.4 82.0 44.5 44.5 68.4 31.0 34.2 29.3 44.2 19.4 66.7 59.0 18.2 30.8 40.3 27.3 37.6 42.5 61.1 77.9 60.8 67.8 115.8 39.6 92.4 44.5 94.7 22.0 22.1 33.2 18.9 46.4 20.4 31.2 35.5 21.7 16.3 26.5 30.0 7.1 34.1 16.7 12.7 34.0 41.9 31.4 32.7 29.2 38.2 32.3 30.3 31.3 30.0 31.3 32.1 30.1 31.9 34.0 17.6 3.2 6.7 3.9 12.3 9.6 11.7 13.2 4.0 19.4 16.7 24.5 32.5 15.7 9.2 16.5 4.2 32.5 25.2 21.8 43.0 25.3 0.3 5.7 11.9 14.2 8.5 29.0 8.7 32.2 47.4 14.5 9.2 7.7 9.5 16.8 13.2 18.9 24.2 18.5 6.3 17.2 14.2 13.8 10.2 1.0 12.5 31.7 28.4 1.9 20.3 17.2 38.1 5.5 4.9 30.2 11.4 18.8 19.5 16.7 24.6 25.1 4.7 11.4 0.0 13.2 24.9 0.1 5.7 21.9 12.1 13.0 16.2 7.2 17.4 7.8 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766336-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 180.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.1;Horizontal cells: 52.2;Inhibitory neurons: 57.2;Oligodendrocytes: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" NA NA 1200000 "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660" "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavorable (8.74e-4)" 46.5 28.3 73.2 14.9 71.0 7.4 29.9 71.6 100.4 32.1 29.3 32.4 10.1 40.3 24.7 14.6 30.8 19.3 54.4 69.6 79.4 24.9 47.7 25.4 13.3 102.4 79.3 68.8 39.3 18.9 14.8 24.0 21.6 110.0 26.0 10.7 43.7 14.9 32.9 180.6 12.9 19.3 32.7 75.9 27.1 22.0 11.3 94.9 14.6 17.0 100.1 10.8 29.6 21.2 107.4 8.1 79.8 29.5 36.9 153.3 95.2 8.7 65.2 76.1 32.3 46.3 5.5 10.2 29.3 154.0 114.6 24.2 13.0 40.4 44.4 26.6 68.5 31.9 12.7 17.8 8.2 41.2 21.4 23.3 90.3 14.5 24.0 45.4 50.3 38.6 22.4 8.9 74.9 41.1 17.3 18.9 31.1 12.4 6.9 42.7 18.8 24.2 40.5 31.7 5.4 38.9 19.9 25.8 21.9 29.6 21.6 6.2 36.6 45.8 47.5 14.4 62.2 48.0 62.6 112.3 28.3 59.6 42.3 36.4 7.3 8.6 5.9 6.2 7.6 5.4 4.5 5.8 6.3 8.1 4.8 5.5 6.0 2.1 7.2 12.5 5.8 4.4 7.0 73.2 71.0 71.6 100.4 69.6 79.4 102.4 79.3 68.8 110.0 75.9 94.9 107.4 14.1 16.0 7.8 21.5 8.2 3.1 2.3 3.6 4.6 26.8 3.7 3.2 42.8 11.5 6.4 12.9 18.8 10.1 7.4 2.0 5.9 4.4 0.3 5.6 10.1 13.8 8.4 6.5 49.1 5.3 3.9 15.9 7.1 3.6 7.6 12.6 17.2 26.6 10.2 52.2 57.2 2.9 8.2 16.4 6.8 2.8 20.8 8.6 10.6 23.4 8.1 18.2 2.1 21.6 60.7 3.6 3.1 30.1 12.5 3.4 5.3 11.3 5.0 18.7 0.0 15.9 12.0 2.8 4.9 3.3 1.3 13.5 6.4 11.8 3.3 1.3 EEA1 ZFYVE2 ENSG00000102189 "Early endosome antigen 1" Q15075 12 92770637-92929331 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005861, CAB018782, HPA038158, HPA038159" Supported Supported Vesicles NA NA 20000 Vesicles "CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356" "unprognostic (5.38e-2)" "unprognostic (4.60e-1)" "unprognostic (2.00e-2)" "unprognostic (5.62e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-2)" "unprognostic (6.75e-2)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "unprognostic (5.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-3)" "unprognostic (5.86e-2)" "unprognostic (2.85e-1)" "unprognostic (3.89e-2)" "unprognostic (1.65e-1)" 11.5 6.6 3.2 6.8 3.3 3.7 7.2 6.7 4.6 9.4 0.7 8.2 6.8 8.8 4.1 13.2 4.8 7.4 7.8 3.2 4.5 6.7 9.5 7.2 5.6 5.1 4.9 2.7 8.9 6.1 8.2 2.9 9.5 5.8 7.4 7.0 13.8 7.1 5.8 9.6 10.3 6.7 8.5 3.2 7.3 7.1 5.4 4.0 4.1 8.1 10.5 5.6 8.6 6.9 5.2 14.9 4.9 7.2 5.1 30.1 30.1 16.4 28.8 16.6 15.0 10.6 17.1 4.0 15.2 5.1 20.3 21.3 17.5 16.0 8.1 23.0 10.2 7.8 16.2 5.9 15.7 16.7 11.6 7.3 19.7 11.7 16.1 24.0 16.7 25.3 4.2 12.2 5.0 15.7 6.9 8.4 7.9 7.2 6.0 10.5 9.2 18.2 10.1 7.7 20.4 6.0 4.4 21.2 13.7 12.9 9.9 18.2 10.1 34.4 21.0 8.0 16.8 11.2 5.4 10.1 10.2 7.8 10.1 11.6 0.0 0.6 0.2 0.4 0.4 0.4 0.5 0.4 0.4 0.5 0.4 0.8 0.5 0.5 0.2 0.9 0.5 0.1 0.2 3.2 3.3 6.7 4.6 3.2 4.5 5.1 4.9 2.7 5.8 3.2 4.0 5.2 58.3 99.3 59.8 60.7 36.4 37.9 57.6 25.2 35.9 53.1 26.5 24.9 93.0 17.2 32.8 25.8 37.5 65.5 39.4 35.7 43.0 59.0 15.1 37.1 85.7 58.9 16.8 14.9 58.5 34.7 45.8 81.1 29.0 53.6 32.9 29.8 31.4 37.4 36.4 183.4 76.2 26.6 14.2 38.6 36.8 9.5 61.8 44.5 48.0 68.4 44.0 60.0 28.8 94.5 102.5 40.4 35.9 68.1 19.8 50.0 26.3 35.3 26.4 68.4 46.0 104.4 71.0 131.1 30.0 91.3 50.3 113.6 29.8 35.5 30.7 78.1 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176584-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pituitary gland: 17.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Region enriched" "Detected in single" 4 "hypothalamus: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 5.0;SuSa: 4.0" "Group enriched" "Detected in many" 4 "hypothalamus: 14.4;white matter: 5.0" "Region enriched" "Detected in single" 10 "hypothalamus: 4.8" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA049862: AB_2680920, HPA054678: AB_2682570" "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 17.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 3.4 0.6 0.0 0.0 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RP2 "NM23-H10, NME10, TBCCD2" ENSG00000102218 "RP2 activator of ARL3 GTPase" O75695 X 46837043-46882358 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 50.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 62.8;Langerhans cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000234, HPA000909" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA000234: AB_1079831, HPA000909: AB_2666140" "unprognostic (2.26e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-2)" "unprognostic (2.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (2.58e-2)" "unprognostic (9.76e-3)" "unprognostic (3.10e-2)" "unprognostic (3.79e-3)" "unprognostic (9.75e-2)" "unprognostic (6.15e-3)" "unprognostic (2.96e-2)" "unprognostic (9.66e-2)" "unprognostic (1.61e-1)" "unprognostic (4.28e-3)" 11.0 9.0 2.1 15.7 2.5 50.0 7.3 3.0 2.3 7.9 3.8 10.2 10.7 7.0 4.1 13.0 6.8 12.8 4.9 1.9 4.3 6.7 13.3 11.9 13.0 3.5 2.9 1.8 6.6 4.7 7.5 1.7 25.4 3.5 6.7 10.6 4.3 4.4 5.3 2.0 5.4 11.1 9.0 4.2 13.3 8.2 4.1 2.7 9.9 6.2 3.7 11.3 10.5 4.2 4.9 21.8 10.3 20.4 11.0 15.7 19.4 48.0 27.4 21.5 23.8 23.9 44.6 18.2 25.8 10.7 29.3 20.1 14.0 19.8 20.0 32.1 11.5 11.5 13.9 11.7 10.7 17.9 29.2 46.4 15.1 13.0 18.8 10.1 13.3 30.5 11.4 6.2 13.1 27.0 1.9 18.1 26.8 12.5 14.8 19.5 22.9 27.9 13.8 15.3 22.0 7.4 10.0 24.4 14.9 12.4 36.2 16.8 27.1 27.1 18.3 13.6 29.1 9.8 4.9 6.8 15.4 9.5 20.4 19.5 62.6 22.6 35.5 6.1 30.8 5.0 10.3 4.9 5.3 22.6 9.6 6.0 5.7 43.5 7.6 36.3 7.6 6.1 12.2 2.1 2.5 3.0 2.3 1.9 4.3 3.5 2.9 1.8 3.5 4.2 2.7 4.9 9.6 9.6 7.4 3.9 18.9 15.8 3.2 6.1 15.4 3.1 7.8 6.1 1.7 7.2 5.1 9.2 2.1 23.2 12.0 28.6 0.0 4.7 2.8 15.8 14.5 8.6 3.6 10.3 3.1 5.3 6.4 10.3 12.8 14.9 12.0 4.0 12.5 20.1 24.3 0.0 4.0 9.4 2.0 62.8 72.9 1.7 5.6 44.7 21.4 6.5 36.6 3.6 6.2 12.1 5.9 11.6 13.4 5.7 13.2 8.2 9.8 3.6 14.5 5.5 6.6 7.7 10.5 7.8 4.6 36.4 14.9 38.2 11.4 4.7 10.5 13.6 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 37.2;Oligodendrocytes: 36.8;Spermatocytes: 42.7;Spermatogonia: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.8;naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: AB_2685326" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 3.1 10.8 4.3 3.2 5.0 2.1 6.4 5.5 4.6 5.6 3.3 3.1 2.2 6.1 16.0 3.5 3.9 3.2 3.2 3.6 5.0 3.8 7.7 3.7 4.9 6.8 5.0 3.1 7.2 8.4 3.3 1.1 15.5 6.3 4.3 3.4 2.5 3.5 7.2 1.7 3.2 4.7 5.1 6.5 5.0 4.1 12.3 5.7 7.2 4.2 2.6 6.1 4.7 2.7 9.3 12.1 10.6 17.2 11.9 6.2 4.6 65.7 7.1 5.9 7.8 8.7 12.3 10.3 0.1 4.9 5.2 11.6 4.7 21.1 5.7 11.2 32.6 13.8 9.6 11.9 12.0 10.2 7.3 5.0 3.5 7.8 5.5 17.7 4.8 14.9 18.1 6.7 5.6 6.1 12.5 26.5 8.9 13.6 7.8 9.0 27.0 19.4 16.9 6.6 11.0 14.8 13.1 20.4 18.7 11.3 28.3 12.4 7.6 9.3 8.2 14.2 11.7 4.7 4.3 4.0 22.7 2.3 6.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 4.3 5.0 5.5 4.6 3.6 5.0 6.8 5.0 3.1 6.3 6.5 5.7 9.3 4.1 0.0 7.8 1.0 14.4 4.2 2.3 1.8 2.2 1.5 9.9 4.2 5.4 1.5 1.6 5.5 0.0 9.6 0.1 2.0 0.0 2.4 1.1 3.9 3.9 5.1 8.4 6.5 5.5 3.6 10.3 2.0 2.6 4.4 0.0 9.7 6.1 13.3 1.8 0.0 12.7 2.6 6.1 1.0 5.7 3.7 4.7 1.4 3.6 14.0 2.8 1.2 1.0 37.2 36.8 3.1 1.1 3.8 1.9 4.1 0.5 2.9 1.2 2.3 6.6 1.9 2.8 42.7 35.3 5.8 8.1 14.2 0.7 3.5 2.4 3.7 CDK16 "FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1" ENSG00000102225 "Cyclin dependent kinase 16" Q00536 X 47217860-47229997 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 219.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000974, HPA001366, CAB016535" Approved Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584" "unprognostic (2.37e-3)" "unprognostic (6.93e-2)" "unprognostic (2.96e-2)" "unprognostic (1.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.02e-6)" "unprognostic (2.85e-1)" "unprognostic (5.59e-2)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (1.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.89e-3)" "unprognostic (2.55e-1)" 48.6 61.8 56.2 30.7 53.8 66.2 38.9 60.3 75.5 35.9 31.8 41.2 34.5 37.9 19.9 61.2 37.9 24.0 104.3 60.3 41.3 59.1 35.3 41.9 24.5 51.8 51.2 55.3 45.6 43.5 51.0 42.0 38.2 53.0 37.5 29.9 33.8 44.3 30.7 219.7 39.8 36.6 38.0 35.2 34.3 39.4 55.7 72.7 30.1 50.7 182.0 26.7 34.5 37.2 57.0 177.6 132.5 124.8 185.0 89.5 76.2 124.2 82.4 100.7 122.3 90.5 150.2 83.3 42.1 51.2 148.1 225.7 97.7 134.3 174.7 81.8 50.9 212.6 46.0 193.8 118.8 115.7 48.7 103.0 95.5 109.6 173.8 207.4 101.7 111.0 43.7 69.6 69.7 108.4 153.1 42.7 111.1 97.9 66.3 141.8 44.9 98.8 74.4 91.7 137.7 105.0 79.4 223.2 169.9 86.5 144.4 152.0 59.3 112.9 81.1 131.4 125.4 99.8 54.6 58.2 41.8 71.4 223.0 93.1 2.6 7.8 7.5 3.7 9.3 4.9 3.4 5.0 6.0 9.7 9.8 4.3 4.6 3.2 5.5 8.4 11.3 5.5 6.1 56.2 53.8 60.3 75.5 60.3 41.3 51.8 51.2 55.3 53.0 35.2 72.7 57.0 18.8 0.0 6.1 7.2 20.2 32.5 33.0 30.6 33.6 23.5 38.2 26.8 43.3 21.5 22.1 31.3 4.2 25.7 20.1 67.2 54.8 33.7 26.5 41.2 24.5 21.8 28.1 20.6 12.5 37.0 45.2 24.0 46.4 57.7 5.7 27.8 19.2 16.7 25.3 30.3 15.8 34.3 32.6 19.5 30.8 94.8 17.1 23.5 33.8 2.8 12.6 17.1 9.2 3.5 7.8 48.4 46.1 13.2 31.9 48.3 45.1 34.7 17.9 14.6 0.0 19.1 22.6 27.6 17.5 64.2 34.7 26.0 21.5 30.0 48.6 63.3 USP11 UHX1 ENSG00000102226 "Ubiquitin specific peptidase 11" P51784 X 47232866-47248328 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 203.6;Horizontal cells: 139.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003103, HPA037536" Enhanced Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA003103: AB_10671088, HPA037536: AB_10672904" "unprognostic (1.60e-1)" "unprognostic (2.77e-3)" "unprognostic (5.84e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.08e-2)" "unprognostic (2.02e-1)" "unprognostic (6.11e-3)" "unprognostic (9.21e-2)" "unprognostic (3.18e-2)" "unprognostic (3.52e-1)" "unprognostic (3.29e-3)" "unprognostic (3.74e-2)" "prognostic favorable (4.13e-5)" "unprognostic (3.14e-2)" "unprognostic (9.23e-2)" "unprognostic (9.51e-2)" "unprognostic (7.11e-2)" 25.2 33.1 104.0 23.9 120.9 11.3 27.0 42.1 113.6 48.5 29.5 28.7 11.6 47.3 23.8 18.4 50.3 24.7 42.1 105.8 121.2 31.5 12.8 31.1 30.4 71.3 84.6 110.1 77.0 27.3 36.9 104.5 25.1 80.0 33.7 14.2 85.6 21.5 39.0 32.7 17.9 25.7 36.2 51.3 29.6 25.1 46.6 105.7 43.0 52.7 29.8 29.1 37.2 32.0 92.4 45.6 70.7 117.6 81.0 43.4 28.5 33.0 34.0 52.5 65.6 73.3 67.4 36.7 29.9 26.1 60.5 70.5 53.5 94.7 24.0 56.4 47.1 73.5 34.7 52.9 61.4 50.7 39.2 70.7 42.1 9.8 69.1 29.3 37.3 26.7 68.9 26.6 3.9 51.8 70.0 77.8 43.4 89.2 24.3 62.5 86.1 114.3 25.1 32.4 60.9 66.8 114.4 62.6 12.4 37.7 73.9 26.0 23.0 28.2 56.0 58.0 79.3 39.6 54.3 36.2 51.3 34.3 48.8 50.8 63.9 9.1 19.9 55.4 19.6 48.3 53.1 24.5 54.3 11.9 53.1 36.6 76.3 5.5 56.4 24.3 53.2 35.0 46.0 104.0 120.9 42.1 113.6 105.8 121.2 71.3 84.6 110.1 80.0 51.3 105.7 92.4 13.6 22.4 17.7 25.8 53.5 13.6 42.2 30.9 21.6 203.6 13.0 23.5 24.2 7.2 31.5 33.1 56.3 20.9 52.2 9.4 50.9 18.3 26.4 28.2 26.3 22.5 35.4 18.3 43.3 10.2 15.0 41.3 22.4 28.3 45.7 56.6 22.1 8.2 13.4 139.7 63.7 8.7 28.5 12.0 16.3 41.0 29.5 17.9 28.4 19.7 17.5 96.2 23.7 25.1 24.8 12.5 7.9 42.2 48.1 18.6 4.7 15.2 46.4 63.4 26.3 57.2 40.2 18.3 87.8 11.9 6.5 16.3 44.6 34.2 8.9 26.0 PCYT1B "CCT-beta, CTB" ENSG00000102230 "Phosphate cytidylyltransferase 1, choline, beta" Q9Y5K3 X 24558087-24672677 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 13.1;choroid plexus: 7.0;retina: 12.2;testis: 13.6" "Cell type enhanced" "Detected in some" "Astrocytes: 23.5;Early spermatids: 29.1;Late spermatids: 90.1;Muller glia cells: 30.1;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 41.9" "Cancer enhanced" "Detected in some" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.3;CACO-2: 22.2;HEL: 25.7;Hep G2: 10.2;NTERA-2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006367 Uncertain NA NA "HPA006367: AB_1079585" "unprognostic (4.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.16e-1)" "unprognostic (7.39e-2)" "unprognostic (9.88e-2)" "unprognostic (6.83e-2)" "unprognostic (5.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (5.64e-2)" "unprognostic (2.63e-6)" "unprognostic (2.62e-4)" "unprognostic (4.56e-2)" "unprognostic (1.75e-2)" "unprognostic (1.96e-4)" 0.1 0.8 12.3 0.2 12.3 0.9 0.1 10.9 12.6 0.6 7.0 0.9 0.3 1.6 0.7 0.8 2.3 0.4 1.9 13.1 9.7 0.2 0.0 0.7 0.0 10.6 10.2 11.0 1.4 1.5 0.0 1.3 1.4 10.2 0.8 0.2 12.2 0.1 2.4 0.0 0.1 0.6 2.6 9.3 0.2 0.2 13.6 11.3 0.5 0.0 0.0 0.0 0.3 0.3 13.1 0.0 0.0 10.3 0.1 0.0 0.0 0.1 0.0 0.9 0.3 0.1 22.2 0.0 0.0 5.2 0.0 0.0 1.0 4.2 0.0 0.0 0.0 0.1 25.7 0.0 10.2 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 3.9 0.5 11.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 7.2 5.8 0.0 0.0 0.5 7.1 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 4.4 0.7 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 12.3 12.3 10.9 12.6 13.1 9.7 10.6 10.2 11.0 10.2 9.3 11.3 13.1 0.0 0.0 0.0 23.5 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.5 1.6 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 29.1 10.7 0.2 0.1 1.8 1.3 5.6 0.0 0.0 0.4 0.0 0.2 4.5 5.8 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 90.1 0.3 0.9 0.0 3.7 0.3 30.1 0.0 23.6 41.9 0.2 0.0 2.6 0.1 0.1 0.0 0.5 6.4 1.6 0.0 0.0 1.0 1.8 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 BRS3 "BB3, BB3R, BBR3" ENSG00000102239 "Bombesin receptor subtype 3" P32247 X 136487947-136493780 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "epididymis: 25.9" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "hypothalamus: 6.1" "Low region specificity" "Detected in many" NA NA "unprognostic (1.49e-1)" "unprognostic (1.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (3.73e-6)" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 25.9 0.0 0.8 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTATSF1 TAT-SF1 ENSG00000102241 "HIV-1 Tat specific factor 1" O43719 X 136497079-136512346 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 173.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000504 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000504: AB_10752094" "unprognostic (3.56e-2)" "prognostic favorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.56e-2)" "unprognostic (6.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.32e-3)" "unprognostic (3.27e-1)" "unprognostic (2.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-2)" "unprognostic (3.37e-2)" "prognostic favorable (8.13e-8)" "unprognostic (7.12e-2)" "unprognostic (2.67e-2)" "unprognostic (2.25e-2)" "unprognostic (4.05e-1)" 39.2 100.6 56.4 31.3 57.1 55.2 36.1 60.0 61.0 33.7 49.5 35.1 25.7 39.8 59.7 30.6 35.4 28.8 66.0 54.7 70.5 43.7 31.1 27.2 34.8 63.1 57.7 50.5 60.7 27.9 53.2 145.9 36.7 60.3 35.6 35.7 56.6 28.6 40.0 183.5 35.3 26.2 34.9 60.2 28.8 32.8 41.9 73.3 43.4 48.1 110.2 36.0 35.4 28.0 59.5 151.4 79.3 99.9 70.5 72.1 54.0 87.1 71.5 60.4 57.2 55.5 47.6 66.0 114.1 163.1 68.1 66.3 66.0 120.5 52.3 75.0 86.5 106.9 70.9 99.9 59.2 40.8 138.1 57.7 48.4 66.1 63.2 39.3 40.8 60.3 166.3 67.4 81.0 76.5 114.3 135.7 115.4 58.7 139.4 115.7 104.2 123.7 103.3 62.0 105.9 69.0 106.9 66.7 54.4 56.4 83.9 39.8 96.5 57.4 69.2 52.2 79.5 126.1 47.6 69.1 92.7 44.4 192.4 50.3 48.4 20.6 33.2 41.0 21.5 44.5 33.9 44.4 42.2 28.5 33.3 44.8 40.7 6.7 49.7 35.3 20.6 47.9 27.9 56.4 57.1 60.0 61.0 54.7 70.5 63.1 57.7 50.5 60.3 60.2 73.3 59.5 28.2 51.3 42.9 11.4 36.8 29.6 38.0 28.0 38.7 52.5 25.8 23.5 173.3 20.0 53.1 49.7 10.4 95.3 37.6 26.2 49.0 36.7 6.8 51.0 39.3 29.8 81.2 55.5 10.2 34.3 69.8 42.1 42.3 32.9 34.8 48.4 10.4 22.8 38.2 42.1 12.1 37.8 28.5 19.5 19.2 11.7 45.1 30.3 32.0 7.5 34.4 78.0 25.7 8.0 13.6 32.5 18.5 53.8 54.3 37.2 20.4 32.1 44.4 56.7 46.0 46.9 41.0 29.4 92.2 42.7 26.6 116.8 51.6 45.8 32.6 36.8 VGLL1 "TDU, TONDU" ENSG00000102243 "Vestigial like family member 1" Q99990 X 136532215-136556807 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 205.6" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 1282.0;Extravillous trophoblasts: 582.3;Syncytiotrophoblasts: 1788.6" "Group enriched" "Detected in many" 4 "ovarian cancer: 13.7;urothelial cancer: 47.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 130.7;BEWO: 189.5;CAPAN-2: 72.7;RT4: 328.6;SK-BR-3: 328.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042403, HPA064616" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042403: AB_2677980, HPA064616: AB_2685300" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (5.16e-2)" "unprognostic (1.80e-1)" "unprognostic (4.28e-1)" "unprognostic (6.14e-3)" "unprognostic (1.92e-3)" "unprognostic (1.37e-2)" "unprognostic (5.53e-2)" "unprognostic (3.05e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.4 1.5 1.3 0.6 0.1 0.0 0.0 3.8 0.1 2.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.4 205.6 0.0 1.4 0.0 0.0 5.2 6.7 0.0 0.2 0.2 0.0 0.0 0.1 0.9 0.1 0.0 0.2 0.0 0.0 1.1 22.9 1.6 0.0 130.7 0.0 0.0 0.1 0.0 0.0 189.5 0.0 0.0 0.0 0.0 18.1 72.7 0.0 0.0 0.0 0.0 5.9 0.0 7.5 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.3 0.4 0.1 2.1 0.0 0.1 0.0 0.1 0.0 328.6 0.2 0.2 0.0 328.7 0.3 13.2 5.6 0.4 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 2.3 1.7 0.0 0.0 4.9 1.8 0.2 0.0 16.6 36.8 0.0 1282.0 0.1 0.0 0.0 2.1 0.0 3.3 0.1 2.7 0.0 0.0 0.0 0.2 582.3 5.8 0.0 2.0 1.3 0.0 0.0 0.0 108.2 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.3 0.0 0.1 8.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1788.6 0.0 0.0 0.0 30.5 CD40LG "CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP" ENSG00000102245 "CD40 ligand" P29965 X 136648158-136660390 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 15.6" "Cell type enriched" "Detected in some" 8 "T-cells: 76.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1" "Lineage enriched" "Detected in many" 39 "T-cells: 80.5" "Cell line enriched" "Detected in some" 15 "MOLT-4: 23.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045827, HPA072480" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 776000 20000 "Golgi apparatus, Plasma membrane" "HPA045827: AB_10959606, HPA072480: " "unprognostic (1.94e-5)" "unprognostic (1.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.27e-3)" "unprognostic (4.71e-2)" "unprognostic (3.56e-5)" "unprognostic (3.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.77e-1)" "unprognostic (2.14e-4)" "unprognostic (1.87e-1)" "unprognostic (1.55e-1)" "unprognostic (6.70e-4)" "unprognostic (2.15e-1)" "unprognostic (5.19e-2)" "unprognostic (2.36e-3)" "unprognostic (2.92e-2)" 0.6 0.3 0.1 8.0 0.0 1.9 1.1 0.2 0.2 0.9 0.3 1.9 1.9 0.3 0.2 1.0 0.5 2.1 0.2 0.2 0.1 0.4 1.0 2.4 15.6 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.8 3.1 0.0 0.7 0.3 0.1 0.6 3.9 0.6 0.1 5.0 2.0 0.3 0.1 15.6 0.5 0.2 14.9 2.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.3 26.3 0.1 64.1 0.1 80.5 11.7 0.2 0.0 76.1 0.7 1.3 0.8 0.1 0.1 10.5 13.6 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.0 2.4 0.0 2.4 1.3 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.6 2.6 0.0 1.3 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.6 4.0 8.9 0.0 2.9 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.1 2.0 0.0 76.6 0.0 0.0 0.1 TIMP1 "CLGI, EPO, TIMP" ENSG00000102265 "TIMP metallopeptidase inhibitor 1" P01033 X 47582408-47586789 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 2298.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 2325.3;Hepatic stellate cells: 2681.5;Langerhans cells: 2307.7;Leydig cells: 1776.0;Macrophages: 1705.0;Peritubular cells: 1561.7;Smooth muscle cells: 2043.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 3225.4;ASC TERT1: 4323.2;fHDF/TERT166: 2762.5;HSkMC: 2960.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022360, HPA053417" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 127000000 520000000 "Golgi apparatus" "CAB022360: , HPA053417: AB_2682142" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.68e-2)" "unprognostic (1.81e-2)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" "unprognostic (8.24e-3)" "unprognostic (9.12e-3)" "unprognostic (9.69e-2)" "unprognostic (9.10e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (2.90e-11)" "unprognostic (1.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" 617.2 903.2 96.5 1728.5 100.3 123.2 255.1 100.5 331.9 635.8 182.3 219.4 69.0 345.0 239.5 131.9 575.3 1230.8 721.3 98.9 176.7 391.3 462.4 1231.9 151.6 123.2 102.7 100.5 827.7 171.5 225.7 514.7 594.1 112.2 755.6 206.1 26.1 522.9 416.6 62.3 125.1 181.5 748.1 106.1 241.9 210.7 270.1 234.8 81.1 342.9 79.6 120.7 2298.9 305.9 140.6 194.7 295.9 150.4 1850.9 3225.4 4323.2 36.4 2079.0 1728.4 632.5 514.0 118.9 360.1 1.8 269.6 2762.5 355.3 187.2 82.9 896.0 394.8 387.0 193.8 204.1 191.7 174.9 2097.2 136.6 2440.9 2960.8 227.7 1951.9 410.1 743.6 292.1 0.7 315.8 142.9 1088.6 343.1 2.5 518.0 166.8 229.8 647.9 2.5 318.3 173.8 1038.8 120.4 2.5 8.6 1243.6 8.2 276.9 277.6 15.3 257.6 284.8 943.7 1012.1 1108.3 206.3 58.8 135.0 7.4 2688.9 322.6 634.2 331.9 488.4 8.3 139.4 853.2 137.8 21.9 224.6 122.9 511.4 10.1 73.0 65.4 504.5 88.4 817.9 15.0 104.0 431.4 96.5 100.3 100.5 331.9 98.9 176.7 123.2 102.7 100.5 112.2 106.1 234.8 140.6 145.9 109.0 170.1 6.2 57.5 231.2 591.5 937.3 132.6 25.4 147.8 133.2 22.5 374.6 355.5 132.4 0.0 25.2 59.3 53.6 0.0 538.6 21.6 34.7 511.9 772.1 277.2 102.7 0.4 411.3 280.1 2325.3 53.5 66.7 491.4 163.7 2681.5 345.1 329.7 0.0 0.4 73.0 297.0 741.4 2307.7 86.9 1776.0 1705.0 512.3 6.5 289.0 141.7 73.2 8.5 0.6 802.1 42.4 1561.7 257.4 741.4 1.1 12.9 109.1 8.4 690.2 304.1 2043.5 52.8 10.6 25.8 174.7 45.0 126.5 231.9 50.5 513.7 KLHL4 "DKELCHL, KHL4, KIAA1687" ENSG00000102271 "Kelch like family member 4" Q9C0H6 X 87517409-87670050 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.7;brain: 21.7" "Group enriched" "Detected in some" 4 "Oligodendrocytes: 286.2;Theca cells: 109.4" "Cancer enriched" "Detected in some" 8 "glioma: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.7;GAMG: 18.2;HUVEC TERT2: 32.0;NTERA-2: 24.3;SuSa: 17.8;TIME: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029192 Approved Supported "Microtubules,Centriolar satellite" NA NA Microtubules "Centriolar satellite" "HPA029192: AB_10602341" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (8.74e-2)" "unprognostic (2.84e-3)" "unprognostic (1.48e-2)" "unprognostic (5.90e-2)" "unprognostic (1.71e-2)" "unprognostic (1.89e-2)" "unprognostic (5.21e-2)" "unprognostic (2.63e-1)" "unprognostic (5.98e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (2.40e-4)" "unprognostic (1.05e-1)" "unprognostic (5.87e-2)" "unprognostic (7.25e-4)" 1.3 26.7 5.6 0.4 9.9 0.0 0.9 7.5 7.7 1.2 1.3 0.3 0.1 3.0 0.3 0.5 2.5 1.5 0.8 5.6 7.1 1.1 0.6 0.8 0.4 8.8 8.2 4.7 8.0 0.3 0.0 0.0 0.1 9.3 0.3 0.3 2.4 0.0 1.4 0.3 0.1 0.3 5.1 8.7 1.3 0.3 7.1 7.8 0.1 0.6 0.3 0.1 0.9 0.2 21.7 0.0 3.6 14.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.0 0.1 0.9 0.0 1.4 0.4 0.0 2.6 0.0 11.0 0.2 0.0 1.6 4.7 6.0 1.3 11.6 32.0 0.0 0.2 2.5 8.1 0.0 0.0 0.0 24.3 0.1 5.7 0.0 8.9 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 17.8 0.0 0.1 34.4 0.0 5.6 0.0 0.5 0.2 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.6 9.9 7.5 7.7 5.6 7.1 8.8 8.2 4.7 9.3 8.7 7.8 21.7 1.7 0.0 0.0 2.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 1.5 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.1 15.0 0.0 0.0 44.4 0.0 0.0 4.4 0.0 0.1 0.0 4.5 14.3 0.2 0.1 0.0 6.6 0.0 0.0 0.3 0.3 1.5 0.9 0.1 0.0 4.7 0.0 1.5 0.0 36.2 286.2 0.1 0.0 1.5 0.1 0.0 0.0 3.4 2.2 4.1 0.0 1.2 0.5 0.4 0.4 0.0 0.3 0.0 0.7 109.4 0.0 0.0 GABRE ENSG00000102287 "Gamma-aminobutyric acid type A receptor subunit epsilon" P78334 X 151953124-151974680 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adipose tissue: 9.8;brain: 38.3;heart muscle: 9.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.7;Syncytiotrophoblasts: 61.4;Urothelial cells: 42.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 38.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;EFO-21: 11.6;HeLa: 6.1;SiHa: 5.6" "Region enriched" "Detected in many" 4 "hypothalamus: 18.4" "Region enhanced" "Detected in many" "hypothalamus: 32.3" HPA045918 Uncertain NA NA "HPA045918: AB_10961281" "unprognostic (1.33e-2)" "unprognostic (6.75e-2)" "unprognostic (3.50e-3)" "unprognostic (1.39e-3)" "unprognostic (2.43e-1)" "unprognostic (7.52e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (3.58e-2)" "unprognostic (1.55e-1)" "unprognostic (6.44e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (4.05e-11)" "unprognostic (1.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (5.28e-2)" 9.8 0.4 4.5 0.3 4.4 0.0 4.4 0.1 7.7 1.6 1.6 0.4 0.7 0.6 1.9 1.0 0.7 0.5 9.5 0.8 38.3 0.4 0.1 0.6 0.2 5.3 14.9 2.6 0.8 0.8 0.9 2.2 3.4 17.9 1.8 0.3 0.1 0.8 3.4 0.3 3.2 0.4 0.3 0.3 0.2 0.3 0.1 13.5 0.1 1.0 0.0 0.2 0.6 2.3 4.2 0.2 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.0 0.8 0.4 1.9 0.6 0.0 11.6 2.5 0.0 1.9 0.0 0.6 0.5 0.0 0.4 1.3 6.1 0.7 0.2 0.0 0.1 0.8 0.5 0.9 0.2 1.1 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.7 0.0 0.8 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.4 0.1 7.7 0.8 38.3 5.3 14.9 2.6 17.9 0.3 13.5 4.2 7.7 16.0 9.3 0.7 0.7 17.2 22.9 18.6 30.7 0.0 6.8 4.6 7.3 11.5 25.2 1.8 0.0 25.0 0.5 10.0 0.0 4.1 2.0 7.6 12.8 9.0 1.8 0.0 0.0 0.4 3.5 9.2 0.0 29.2 0.0 0.1 4.2 0.9 3.0 0.0 0.0 2.3 4.1 0.6 4.6 3.5 1.5 0.3 1.8 2.8 0.7 0.6 1.0 0.0 0.0 6.1 7.4 2.2 0.0 19.2 21.6 0.2 5.6 0.3 0.0 19.6 5.7 1.2 2.1 22.5 10.9 61.4 1.3 0.1 3.6 42.2 PCDH11X "PCDH-X, PCDH11, PCDHX, PPP1R119" ENSG00000102290 "Protocadherin 11 X-linked" Q9BZA7 X 91779261-92623230 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 11.6;ovary: 7.5" "Group enriched" "Detected in many" 6 "Excitatory neurons: 120.4;Inhibitory neurons: 349.7;Oligodendrocyte precursor cells: 173.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;AN3-CA: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077495 Approved NA NA "HPA077495: " "unprognostic (4.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.39e-4)" "unprognostic (1.18e-1)" "unprognostic (8.20e-3)" "unprognostic (6.32e-2)" "unprognostic (9.10e-2)" "unprognostic (6.19e-2)" "unprognostic (4.58e-1)" "unprognostic (1.58e-1)" "unprognostic (2.45e-2)" "unprognostic (3.86e-1)" 0.0 0.2 11.6 0.2 7.9 0.0 0.2 0.0 3.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.7 5.0 0.0 0.0 0.0 0.2 1.8 4.6 3.1 7.5 0.0 1.0 0.3 0.8 1.3 0.0 0.0 0.7 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 5.6 0.0 0.1 0.2 0.2 0.0 0.0 1.6 0.0 0.0 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 7.9 0.0 3.5 2.7 5.0 1.8 4.6 3.1 1.3 0.0 5.6 1.6 0.5 9.6 7.4 2.3 0.2 1.5 0.5 0.2 1.2 4.2 1.0 1.8 0.7 0.0 3.2 0.0 0.0 20.8 0.1 0.1 0.0 0.0 0.6 0.2 0.1 2.1 0.0 0.0 120.4 0.0 0.3 1.0 0.0 0.2 1.3 0.1 4.6 0.3 1.0 33.7 349.7 0.0 0.0 0.0 2.0 0.6 9.6 1.0 10.6 12.2 0.0 0.2 0.0 173.9 5.3 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.8 1.4 6.6 0.6 0.8 0.3 1.0 0.1 0.9 15.7 0.6 0.1 0.1 0.4 FGD1 "FGDY, ZFYVE3" ENSG00000102302 "FYVE, RhoGEF and PH domain containing 1" P98174 X 54445454-54496234 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2" "Cancer enhanced" "Detected in all" "testis cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000911, HPA076516" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA000911: AB_1078853, HPA076516: " "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (8.74e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-2)" "unprognostic (2.77e-3)" "unprognostic (1.49e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-2)" "unprognostic (4.92e-2)" "unprognostic (3.41e-2)" "unprognostic (9.40e-3)" 3.9 5.1 8.0 1.6 6.0 0.0 3.6 4.9 7.7 6.9 2.2 4.7 1.0 7.2 1.6 5.9 5.1 2.2 4.9 7.5 4.3 3.5 1.2 2.8 0.5 3.6 4.0 6.2 7.4 3.2 3.6 3.6 3.5 4.6 4.3 1.6 1.6 3.5 3.3 1.3 5.2 2.8 5.5 2.8 2.4 3.6 2.4 4.1 0.4 3.4 1.0 1.0 4.8 5.4 4.4 18.5 6.9 13.2 19.3 7.8 13.8 6.2 10.4 12.8 10.6 8.5 0.6 0.4 0.0 8.2 19.9 9.6 5.3 14.6 9.0 5.8 1.0 8.9 0.0 5.0 2.2 8.3 0.0 0.0 11.3 5.6 16.1 7.6 9.4 9.7 2.3 2.0 0.0 8.4 2.4 0.7 0.0 12.6 0.0 10.2 9.4 6.7 0.0 9.1 0.3 13.1 11.9 10.3 0.2 16.6 21.0 10.3 0.4 6.9 10.5 8.7 23.0 9.4 0.1 0.2 0.1 11.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 6.0 4.9 7.7 7.5 4.3 3.6 4.0 6.2 4.6 2.8 4.1 4.4 3.2 0.0 0.0 4.6 0.0 2.9 1.2 2.0 5.2 2.5 3.2 3.9 3.4 0.0 0.7 0.0 0.0 0.5 0.1 0.2 0.0 1.6 0.4 1.3 7.0 4.2 1.2 0.0 16.1 1.1 1.0 5.1 1.5 2.1 0.0 12.6 2.9 0.3 0.4 1.7 15.2 1.0 0.0 0.0 1.0 0.6 2.8 0.1 7.2 5.6 0.0 2.3 0.0 7.1 1.8 0.5 0.5 4.1 0.1 1.6 0.1 1.4 0.3 3.5 0.0 2.3 4.0 0.3 2.2 5.5 4.1 0.3 0.1 2.9 2.8 1.0 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.3 14.9 24.5 10.5 24.7 8.7 17.1 26.1 36.6 15.3 24.8 15.2 11.6 14.8 21.7 14.6 13.0 7.3 18.0 24.6 24.6 19.7 28.8 10.7 10.6 25.2 25.1 24.1 16.2 13.2 20.6 14.0 11.9 25.4 15.7 12.8 18.4 16.2 10.2 19.6 10.6 12.8 10.9 24.6 14.0 16.0 5.8 25.0 17.7 16.7 20.6 11.2 13.3 15.0 27.1 36.8 41.2 42.5 29.9 28.1 23.4 23.1 24.6 26.8 28.7 29.1 20.8 26.4 11.2 68.6 25.2 39.2 25.8 38.6 43.0 35.6 26.9 83.3 18.8 51.1 55.3 14.9 29.9 14.8 15.7 22.5 32.0 11.1 32.4 29.1 32.5 32.1 46.6 20.4 43.4 25.3 49.9 30.3 42.4 36.7 25.8 34.7 32.3 37.1 24.7 27.0 48.1 28.5 13.3 27.0 32.0 20.3 25.9 30.7 13.4 19.9 36.8 17.7 15.4 18.5 17.9 38.5 28.3 14.7 42.7 37.1 40.6 41.8 41.1 41.7 49.2 43.7 40.3 38.0 45.6 44.1 44.8 15.7 41.1 39.4 44.6 58.1 39.6 24.5 24.7 26.1 36.6 24.6 24.6 25.2 25.1 24.1 25.4 24.6 25.0 27.1 68.3 67.3 48.2 14.0 44.4 43.2 63.3 167.9 36.5 26.7 67.2 94.5 84.9 78.6 89.4 119.5 8.4 162.8 44.5 99.2 181.9 125.0 13.5 78.6 66.7 71.5 92.7 71.7 17.8 117.9 89.0 59.9 45.3 56.6 57.6 46.3 92.4 288.5 110.3 28.6 17.8 93.7 128.1 72.9 44.9 9.3 74.6 50.7 60.5 7.5 69.6 90.7 80.3 16.6 27.3 136.3 114.9 81.3 38.7 51.5 162.0 296.1 95.9 42.9 85.5 65.9 94.6 19.6 42.6 51.3 46.9 120.7 44.8 53.9 88.5 54.8 PORCN "DHOF, MG61, por, PORC, PPN" ENSG00000102312 "Porcupine O-acyltransferase" Q9H237 X 48508962-48520814 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 37.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 68.5;Club cells: 44.2;Pancreatic endocrine cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 176.9;LHCN-M2: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049215, HPA058413" Enhanced Approved Vesicles NA NA Vesicles "HPA049215: , HPA058413: AB_2683711" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (1.26e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (2.35e-1)" 4.9 37.6 7.4 3.3 8.2 3.0 4.7 6.9 10.7 9.1 4.0 5.2 2.3 7.1 2.1 10.9 5.9 4.6 11.0 10.7 7.0 3.7 1.5 4.7 3.6 7.1 6.7 8.5 4.3 3.5 9.8 4.7 2.5 7.4 4.6 1.6 7.4 5.0 11.8 7.7 5.7 3.7 4.7 5.6 4.5 5.3 5.1 7.0 2.4 6.4 3.6 3.3 6.2 7.2 7.9 13.1 15.6 3.8 26.6 15.9 9.4 1.6 3.7 7.7 5.8 3.9 1.8 19.7 1.1 15.9 8.3 6.5 17.3 5.5 176.9 1.8 8.3 1.8 2.2 9.0 3.8 23.4 2.0 22.5 12.2 20.6 16.8 36.0 13.5 5.3 6.4 1.0 12.1 60.8 3.7 2.0 2.8 4.9 4.0 10.4 4.0 4.6 20.5 9.8 5.1 4.2 6.5 30.8 5.9 5.9 2.5 6.7 1.0 3.3 15.0 7.8 36.4 6.8 10.4 6.3 1.5 43.0 4.9 8.7 16.9 5.5 6.8 10.8 4.9 8.5 3.2 7.1 9.0 6.8 3.5 4.7 7.1 1.1 8.4 4.3 3.6 4.9 4.7 7.4 8.2 6.9 10.7 10.7 7.0 7.1 6.7 8.5 7.4 5.6 7.0 7.9 5.4 6.4 2.8 5.2 3.8 4.0 5.3 68.5 8.0 15.4 2.9 4.6 3.4 4.3 44.2 16.5 18.8 0.3 7.3 0.8 1.9 6.9 0.2 13.4 3.5 5.7 6.0 1.3 7.8 9.9 1.3 5.0 3.6 17.8 5.7 3.9 5.0 0.7 3.5 8.4 7.6 2.9 12.2 2.7 4.5 0.1 5.6 2.5 3.6 2.8 3.1 10.1 10.3 6.0 2.8 36.4 1.8 4.1 6.3 2.5 0.2 0.7 8.7 15.5 6.6 4.0 4.8 2.9 4.9 4.2 3.8 8.2 6.9 7.5 1.5 6.6 ITIH6 "ITIH5L, UNQ6369" ENSG00000102313 "Inter-alpha-trypsin inhibitor heavy chain family member 6" Q6UXX5 X 54748918-54798255 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 7 "melanoma: 10.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "WM-115: 50.7" HPA000506 Uncertain "Secreted to blood" NA NA "HPA000506: AB_2666007" "unprognostic (3.40e-1)" "unprognostic (1.04e-1)" "unprognostic (9.73e-3)" "unprognostic (7.24e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-3)" "unprognostic (9.81e-2)" "unprognostic (2.66e-1)" "unprognostic (1.02e-1)" "unprognostic (6.33e-2)" "unprognostic (4.14e-4)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816015 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Granulosa cells: 1684.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No 120000 "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 79.1 126.3 97.5 53.3 90.3 32.1 164.2 98.2 113.1 176.0 103.7 89.4 54.8 135.5 102.8 68.0 150.3 95.1 143.5 89.0 106.1 135.0 58.0 86.6 48.4 112.3 99.6 89.5 258.2 76.1 149.3 196.8 178.6 121.8 210.6 54.0 75.1 104.2 171.5 89.6 57.1 63.0 141.8 96.7 61.3 78.3 63.6 101.2 69.4 150.6 92.2 46.6 112.7 96.5 113.9 34.0 61.4 373.7 111.0 171.6 229.5 66.8 137.9 243.7 106.4 187.5 62.3 84.4 47.1 361.2 279.0 88.5 45.2 106.5 104.2 76.1 84.5 87.0 100.0 68.6 122.1 145.5 25.4 71.8 310.4 43.0 109.3 55.5 223.6 209.9 55.2 24.5 55.7 207.6 94.0 57.0 41.9 134.7 59.1 72.4 37.4 132.9 68.2 148.5 25.3 56.6 149.5 54.7 62.4 330.6 437.5 263.1 42.9 185.0 90.4 141.3 135.9 39.5 35.7 32.7 34.5 132.0 66.7 477.6 178.5 31.9 132.1 119.1 80.0 91.7 59.2 98.1 112.1 41.1 63.9 97.3 112.0 11.8 108.6 140.8 25.8 108.9 127.4 97.5 90.3 98.2 113.1 89.0 106.1 112.3 99.6 89.5 121.8 96.7 101.2 113.9 77.9 44.8 42.8 17.6 37.4 42.4 96.4 198.6 43.3 69.8 123.3 97.8 60.5 44.3 175.4 77.3 29.2 231.5 36.9 11.9 246.5 107.4 3.4 42.4 96.8 116.4 58.3 10.3 12.9 53.7 133.7 151.7 20.9 57.1 102.1 1684.0 79.9 16.2 69.1 138.0 20.3 48.8 173.0 19.5 47.4 17.4 233.3 41.1 158.3 21.5 42.1 175.9 44.3 17.6 20.4 47.9 33.7 320.4 46.7 75.2 25.5 149.3 119.9 66.0 157.8 77.7 236.3 12.8 13.7 15.3 34.9 169.2 51.4 58.6 25.3 76.6 RBM3 IS1-RNPL ENSG00000102317 "RNA binding motif protein 3" P98179 X 48574449-48581162 "Predicted intracellular proteins" "Stress response" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 1442.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA003624, CAB062559" Enhanced Enhanced Nucleoplasm NA NA 130000 Nucleoplasm "CAB062559: AB_2665621, HPA003624: AB_10602123" "unprognostic (1.07e-2)" "unprognostic (1.14e-3)" "prognostic favorable (3.07e-7)" "unprognostic (1.65e-3)" "unprognostic (2.87e-1)" "unprognostic (4.05e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (9.37e-2)" "unprognostic (1.63e-2)" "unprognostic (2.65e-2)" "unprognostic (2.02e-2)" "unprognostic (6.18e-2)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 205.7 130.8 25.1 144.5 27.3 304.4 202.9 27.3 30.7 81.4 30.3 123.6 103.0 119.2 90.1 148.3 102.6 72.5 101.6 25.9 32.2 89.0 71.7 131.7 159.8 46.2 28.1 24.4 100.2 168.6 95.0 80.8 104.9 34.8 76.3 147.4 51.9 127.0 82.6 113.2 181.4 103.5 115.8 32.2 129.6 115.2 56.4 26.7 158.4 90.8 38.6 207.8 136.3 102.5 32.8 128.2 168.7 172.5 187.3 42.4 226.3 117.2 156.0 272.3 381.6 273.6 173.7 322.5 241.4 50.0 302.3 75.9 107.1 153.2 209.1 304.1 236.5 206.7 126.2 270.5 164.0 153.0 360.8 248.0 168.1 143.8 129.7 124.3 46.2 320.4 131.7 69.8 194.6 268.6 215.9 304.9 209.3 100.5 33.3 230.1 280.7 181.4 196.5 177.7 201.8 70.1 179.1 152.2 206.9 187.5 83.7 272.2 363.6 440.7 127.0 213.0 425.8 278.2 93.7 114.0 279.1 176.5 208.0 263.0 33.0 187.0 30.7 118.4 211.9 141.7 147.5 120.6 119.7 264.1 101.5 120.6 119.5 28.7 150.9 187.0 185.0 137.5 256.3 25.1 27.3 27.3 30.7 25.9 32.2 46.2 28.1 24.4 34.8 32.2 26.7 32.8 336.2 166.7 172.1 18.6 391.7 519.4 182.9 379.4 157.6 58.9 326.1 260.5 76.8 154.4 196.7 53.3 47.9 459.9 392.1 165.8 176.1 482.2 6.0 114.6 193.8 292.9 247.4 287.0 18.4 1442.0 726.9 274.2 164.1 234.3 265.2 144.9 195.9 74.6 433.2 42.1 17.7 360.2 136.3 439.5 783.6 17.1 245.7 339.3 522.9 18.7 571.7 181.8 358.4 15.1 18.0 915.3 235.9 147.4 317.7 119.0 143.3 164.3 84.6 87.0 131.5 378.4 299.4 43.6 200.8 285.2 507.8 489.3 352.5 178.2 368.0 202.6 KLF8 "BKLF3, DXS741, ZNF741" ENSG00000102349 "Kruppel like factor 8" O95600 X 56232356-56291531 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.1" "Cell type enhanced" "Detected in many" "Leydig cells: 37.6;Peritubular cells: 27.4;Squamous epithelial cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;hTCEpi: 7.8;RPTEC TERT1: 3.9;RT4: 5.0;SK-BR-3: 5.4;T-47d: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071740 Supported Nucleoplasm NA NA Nucleoplasm "HPA071740: AB_2686440" "unprognostic (2.32e-1)" "unprognostic (1.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.50e-8)" "unprognostic (2.96e-1)" "prognostic favorable (3.32e-4)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (6.13e-2)" "unprognostic (3.15e-1)" "unprognostic (6.83e-2)" "unprognostic (1.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.15e-1)" "unprognostic (7.68e-2)" "unprognostic (2.60e-2)" 13.5 2.1 0.9 1.3 1.6 0.6 14.0 1.6 1.4 10.7 0.7 5.7 0.5 10.1 3.7 23.6 9.5 1.7 4.4 1.2 1.0 7.3 0.7 6.1 1.6 0.7 0.7 1.2 9.9 2.0 1.1 2.0 3.9 0.9 4.9 1.8 0.6 10.0 2.1 3.8 28.1 5.9 5.0 0.4 5.2 3.7 3.1 0.8 1.2 6.2 1.8 3.1 7.5 17.9 1.1 1.3 0.0 0.0 0.1 1.1 0.4 0.7 0.2 1.5 0.0 0.0 0.0 0.0 0.4 1.9 0.1 0.0 2.9 0.0 0.0 0.0 2.0 3.7 1.0 0.0 0.0 0.1 0.1 0.3 0.0 7.8 0.0 0.6 0.0 0.0 0.3 0.9 0.6 0.2 0.1 0.3 0.1 1.0 0.0 0.0 0.2 0.0 0.2 3.9 5.0 0.0 0.0 2.4 5.4 0.0 3.3 9.5 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.2 1.2 0.3 0.4 0.6 1.2 0.1 0.0 0.2 1.5 0.0 0.2 0.1 0.1 0.9 1.6 1.6 1.4 1.2 1.0 0.7 0.7 1.2 0.9 0.4 0.8 1.1 12.1 0.0 4.1 2.3 11.2 6.9 4.5 3.6 6.2 0.4 8.0 4.1 3.5 0.0 2.2 14.7 2.1 6.3 1.3 1.0 0.0 0.8 0.6 1.9 4.1 11.1 0.0 4.8 14.0 1.0 15.0 6.2 0.0 5.6 1.3 3.5 21.4 0.0 1.2 0.0 5.4 0.7 2.0 1.3 13.9 2.0 37.6 3.2 5.4 8.4 2.1 0.5 5.2 2.5 3.6 0.4 0.3 27.4 5.6 7.5 0.4 7.5 1.5 0.1 19.7 5.2 8.1 0.9 1.1 27.0 11.6 4.5 2.2 3.1 1.2 10.9 SRPX2 SRPUL ENSG00000102359 "Sushi repeat containing protein X-linked 2" O60687 X 100644195-100675788 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 30.8" "Cell type enhanced" "Detected in many" "Adipocytes: 20.9;Fibroblasts: 34.3;Granulosa cells: 21.6;Microglial cells: 37.5;Skeletal myocytes: 17.5;Urothelial cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 282.3;ASC TERT1: 116.9;HSkMC: 103.3;HUVEC TERT2: 72.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "spinal cord: 2.8" HPA038786 Approved "Secreted to blood" NA NA "HPA038786: AB_10672724" "unprognostic (4.10e-2)" "unprognostic (4.55e-2)" "unprognostic (2.08e-1)" "unprognostic (3.72e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (3.59e-3)" "unprognostic (5.41e-2)" "unprognostic (3.22e-2)" "unprognostic (1.26e-1)" "unprognostic (2.86e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.84e-3)" "unprognostic (1.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.85e-1)" 30.8 7.6 3.4 6.4 3.3 0.2 20.9 1.0 3.0 10.6 8.1 6.8 1.2 6.1 0.9 17.9 7.1 3.1 12.3 2.4 4.7 5.8 5.5 13.9 0.4 7.7 4.2 0.8 8.3 2.9 0.7 2.5 9.4 5.0 6.3 1.8 0.1 4.7 3.8 3.5 3.3 5.1 4.4 1.6 13.0 4.5 1.1 4.7 0.3 4.3 4.8 1.2 17.0 11.0 2.2 11.7 1.2 2.9 0.1 282.3 116.9 0.0 26.3 19.8 8.0 25.1 1.4 17.6 0.0 1.1 15.9 7.5 0.7 0.2 13.1 8.6 0.1 0.1 0.2 0.9 2.8 29.3 0.2 0.6 103.3 0.3 27.8 0.9 24.6 72.7 0.0 0.0 0.1 27.1 0.0 0.0 0.0 3.4 0.2 0.3 0.0 2.5 0.0 11.4 37.6 0.4 0.0 0.0 0.8 0.2 6.1 0.3 0.1 36.7 13.8 12.3 10.3 0.9 0.1 0.0 0.1 18.3 0.0 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.3 1.0 3.0 2.4 4.7 7.7 4.2 0.8 5.0 1.6 4.7 2.2 20.9 0.0 0.6 10.1 0.3 0.4 5.0 6.5 0.6 0.0 4.8 1.8 0.9 0.0 13.7 0.0 0.0 0.2 0.0 1.9 0.0 1.6 3.6 0.6 11.2 1.6 0.0 0.0 0.4 0.0 0.4 34.3 1.1 0.4 0.0 21.6 4.6 0.2 0.9 0.0 0.2 0.1 4.1 0.3 1.6 2.7 15.8 0.3 0.0 37.5 0.0 0.0 0.0 2.0 0.1 0.8 0.0 6.0 0.2 1.6 0.0 0.1 15.5 0.0 0.0 17.5 14.6 0.2 0.1 0.6 0.4 0.5 0.3 2.6 0.4 49.1 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 43.5;ovary: 68.9" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.1;Leydig cells: 72.7;Sertoli cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HAP1: 29.5;HMC-1: 60.0;RT4: 40.8;TIME: 34.9" "Region enriched" "Detected in many" 5 "hypothalamus: 30.1" "Low region specificity" "Detected in all" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles NA Yes 3300000 Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 6.4 4.1 7.5 2.2 10.2 2.3 6.0 4.6 4.9 20.6 12.1 9.4 2.1 43.5 3.1 3.9 18.0 4.0 2.8 5.5 16.2 5.7 10.6 4.8 0.7 13.9 7.9 2.9 68.9 8.4 1.2 19.0 3.6 8.9 12.8 9.8 1.3 6.1 7.2 2.4 1.8 4.9 32.9 5.3 3.3 7.5 6.9 12.6 0.6 8.9 5.0 1.7 6.1 10.3 7.8 0.3 6.0 1.6 0.0 8.5 4.8 0.1 7.7 4.9 8.0 14.3 0.7 7.6 0.0 2.0 5.4 6.9 6.8 29.5 2.3 8.4 0.0 2.6 0.1 10.8 0.4 2.1 0.0 60.0 1.7 0.5 7.3 0.4 3.1 20.5 0.0 3.0 0.0 3.8 2.0 0.1 0.0 1.2 21.2 0.0 0.0 2.4 0.0 7.0 40.8 14.5 0.6 3.1 11.5 1.7 3.0 7.1 0.6 34.9 4.2 8.8 20.9 1.9 0.1 0.0 0.1 5.2 0.0 4.8 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.8 7.5 10.2 4.6 4.9 5.5 16.2 13.9 7.9 2.9 8.9 5.3 12.6 7.8 15.6 28.9 1.7 41.8 0.5 0.1 7.7 3.1 1.2 0.2 19.0 6.6 3.8 18.6 8.0 3.7 0.0 0.4 0.7 29.1 3.9 8.9 1.6 4.3 25.8 13.5 0.0 5.0 0.5 2.3 0.4 20.0 26.5 6.2 3.8 58.1 11.4 38.6 1.3 0.0 1.0 26.9 8.2 1.6 1.9 3.8 72.7 7.2 3.6 8.4 0.5 5.4 0.0 10.6 0.2 7.2 27.1 41.8 0.5 11.9 5.8 2.6 8.1 0.6 52.6 38.1 11.8 2.6 4.4 2.6 0.9 0.0 0.9 18.0 9.6 13.8 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type palmitoyltransferase 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.2;Inhibitory neurons: 17.7;Oligodendrocyte precursor cells: 17.1" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.2;K-562: 2.1;LHCN-M2: 2.2;MOLT-4: 2.4;NTERA-2: 2.0;RH-30: 3.1;RPTEC TERT1: 1.7;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003618, HPA064901" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA003618: AB_2217686, HPA064901: " "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 0.7 1.6 1.9 0.3 1.7 0.1 1.6 1.8 1.5 1.6 1.2 0.8 0.2 2.0 1.0 0.8 1.2 0.9 1.7 1.6 3.3 1.5 0.2 1.2 0.3 2.3 2.0 1.6 2.5 1.1 1.1 1.1 0.0 1.9 1.1 0.5 1.9 4.5 1.1 0.3 0.7 0.3 1.5 1.9 0.8 0.4 0.7 2.6 0.8 2.0 0.5 0.2 0.7 0.8 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.1 0.0 2.2 0.0 2.4 0.0 2.0 0.0 0.0 0.0 3.1 0.0 1.7 0.0 0.8 2.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.4 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 1.8 1.5 1.6 3.3 2.3 2.0 1.6 1.9 1.9 2.6 2.0 2.9 6.4 3.1 8.5 0.1 4.0 1.6 0.0 3.4 4.2 2.0 1.5 9.5 1.5 1.3 5.5 4.2 0.0 0.3 0.0 0.0 0.7 0.0 0.2 2.9 3.5 1.8 0.4 18.2 0.7 0.0 3.5 0.0 0.3 1.3 2.5 2.2 0.1 0.1 0.0 17.7 0.0 0.0 0.0 4.4 0.2 0.9 0.1 0.0 5.6 0.0 2.2 1.0 17.1 9.1 0.2 0.0 3.8 0.0 0.7 0.0 1.0 0.0 2.3 6.6 5.4 2.5 0.2 0.7 2.2 3.7 0.0 0.5 2.3 0.0 0.6 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 6.8;lymphoid tissue: 7.2" "Cell type enhanced" "Detected in some" "Erythroid cells: 4.8;Excitatory neurons: 2.9;Extravillous trophoblasts: 4.7;Granulosa cells: 3.2;Oligodendrocytes: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" NA Yes "Nuclear bodies" Cytosol "HPA061297: AB_2684471" "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 1.1 0.6 0.9 3.1 1.2 6.8 1.2 1.6 1.1 1.0 0.4 2.7 2.9 1.8 1.4 2.6 0.6 1.4 0.5 1.1 1.0 0.4 0.8 1.0 5.4 1.1 0.7 0.6 2.3 0.9 0.2 0.0 2.5 1.0 1.2 3.5 1.8 0.5 0.6 0.2 3.3 2.3 2.7 0.3 1.6 1.5 1.2 0.8 7.2 0.8 0.7 6.3 1.4 0.8 2.9 44.9 30.3 36.6 28.1 4.6 8.2 16.4 47.5 25.2 47.1 94.5 40.9 28.0 32.7 16.5 18.8 72.5 25.7 54.2 25.3 65.4 20.6 13.8 20.2 43.5 15.6 0.5 26.8 21.2 3.3 2.2 62.5 7.7 13.5 40.7 23.3 14.5 58.3 46.1 31.5 26.7 9.8 28.3 21.2 36.8 24.7 53.0 21.0 11.8 26.4 23.4 12.3 58.1 16.3 9.6 33.0 16.2 8.6 16.7 44.0 36.6 41.2 38.3 9.1 23.3 36.5 17.3 35.2 34.7 0.7 0.5 0.6 0.4 0.7 0.3 0.6 0.4 0.6 0.2 0.4 0.4 0.4 1.1 0.7 0.7 0.7 0.8 0.3 0.9 1.2 1.6 1.1 1.1 1.0 1.1 0.7 0.6 1.0 0.3 0.8 2.9 0.5 0.0 0.0 2.3 0.9 0.3 0.1 0.6 0.0 0.5 0.4 0.3 0.4 0.0 0.7 0.0 0.0 1.9 0.5 0.8 0.0 0.2 0.2 0.4 0.8 0.5 0.0 4.8 2.9 0.0 4.7 0.6 0.0 0.6 0.0 3.2 0.7 0.2 1.4 0.0 2.3 0.7 0.0 0.6 0.8 0.0 0.3 0.3 0.0 1.0 0.6 0.5 0.0 1.5 3.3 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.3 0.0 0.7 1.0 0.3 0.9 1.4 0.1 0.3 0.4 0.8 1.4 0.2 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;lymphoid tissue: 4.7" "Group enriched" "Detected in some" 6 "Excitatory neurons: 35.6;Inhibitory neurons: 24.5;Oligodendrocyte precursor cells: 11.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 10.7;TIME: 18.5;U-87 MG: 4.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 56.0" HPA002949 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 0.4 0.3 3.8 0.2 6.5 0.2 0.4 0.0 8.9 0.6 0.0 2.2 0.2 0.7 0.8 0.2 0.2 0.2 0.2 6.9 2.9 0.0 0.0 0.0 0.0 0.9 3.6 6.7 1.4 0.0 0.0 2.3 0.0 2.4 1.3 0.4 1.0 0.6 0.9 0.2 0.3 0.8 0.6 0.0 0.0 0.3 0.5 1.2 4.7 0.0 1.1 0.0 0.6 1.1 5.6 0.0 0.6 2.2 0.1 0.1 0.2 0.1 0.4 0.1 0.3 0.9 0.0 0.4 0.3 0.2 0.1 0.6 0.0 0.3 0.0 0.7 0.1 0.2 0.2 0.6 0.0 0.2 0.1 0.4 1.4 0.0 0.7 0.0 0.0 1.4 0.5 0.0 0.9 1.5 0.0 1.3 0.5 0.1 0.1 0.1 0.3 10.7 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.4 0.0 0.1 18.5 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.5 0.0 8.9 6.9 2.9 0.9 3.6 6.7 2.4 0.0 1.2 5.6 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 1.8 0.0 35.6 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 24.5 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.3 0.0 11.1 1.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 31.8" "Group enriched" "Detected in some" 4 "Early spermatids: 26.1;Late spermatids: 15.8;Spermatocytes: 39.4;Spermatogonia: 25.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "SiHa: 47.9" "Low region specificity" "Detected in many" "HPA001879, HPA072008" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001879: AB_1857751, HPA072008: " "unprognostic (1.70e-2)" "prognostic favorable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.1 1.3 0.1 0.9 0.3 0.1 0.1 1.5 1.6 1.5 0.3 0.1 0.5 2.5 0.1 0.1 0.0 0.1 1.6 0.4 0.5 1.1 0.0 0.0 0.2 0.4 1.0 0.1 0.1 4.0 0.4 0.3 0.3 0.7 0.1 0.1 0.1 1.7 0.1 0.9 0.1 0.1 0.0 0.0 0.1 31.8 0.5 0.1 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.2 1.0 0.1 0.1 0.0 0.8 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 1.5 0.2 0.9 0.0 0.2 0.3 0.2 2.2 0.1 0.4 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.7 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.6 47.9 0.3 2.7 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.1 1.5 1.6 0.4 0.2 0.4 1.0 0.3 0.0 0.5 0.7 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.3 26.1 1.2 5.5 0.2 0.0 0.0 2.9 0.0 0.2 0.2 0.0 0.4 0.0 0.5 0.4 2.1 0.1 0.0 2.4 0.1 0.0 0.3 0.2 15.8 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 39.4 25.2 0.0 0.1 1.6 0.1 0.6 0.1 0.1 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76173040-76178314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA 14000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favorable (8.57e-4)" "unprognostic (1.62e-1)" 22.5 31.3 14.3 22.8 14.0 47.0 23.3 14.5 20.0 21.8 14.7 27.5 40.6 24.2 23.8 33.5 19.4 19.4 19.5 13.9 15.3 24.2 32.1 22.6 26.5 15.6 14.9 12.9 20.3 19.7 20.9 20.0 23.0 14.9 25.4 28.5 20.3 21.5 19.1 24.5 24.9 33.4 26.3 14.9 25.8 24.1 6.6 14.9 20.8 19.2 19.5 27.0 33.4 22.1 15.6 35.3 50.9 41.5 28.2 53.5 52.3 36.0 62.5 51.2 53.9 46.3 48.9 46.8 47.1 40.3 62.3 68.6 49.7 70.3 68.1 69.5 36.1 45.2 36.0 30.1 72.4 82.0 104.6 49.2 42.2 55.4 74.9 63.2 33.3 69.6 17.0 50.7 22.9 67.8 41.6 49.1 75.3 116.1 87.0 78.9 41.3 43.7 6.0 79.8 64.9 24.3 30.9 27.6 44.0 0.2 53.0 26.8 39.1 60.8 39.9 40.8 48.6 56.7 40.6 77.3 27.8 44.7 35.7 32.3 17.6 41.1 42.6 68.3 62.8 50.6 70.7 61.0 67.8 53.5 57.3 61.9 59.4 7.7 69.6 71.8 56.0 57.0 44.0 14.3 14.0 14.5 20.0 13.9 15.3 15.6 14.9 12.9 14.9 14.9 14.9 15.6 32.8 35.3 29.1 2.6 32.9 52.9 84.4 119.6 50.7 21.0 29.3 35.3 38.5 31.5 64.3 40.5 14.6 55.5 57.5 46.9 49.0 71.0 0.9 51.9 49.1 34.4 27.6 17.5 2.3 62.5 60.4 42.9 28.1 45.7 51.4 33.5 25.7 47.9 69.8 8.4 2.4 50.3 77.3 30.5 31.5 3.8 47.8 38.1 46.2 1.9 68.0 26.4 45.3 2.5 2.8 58.7 44.7 38.7 25.7 58.3 105.5 84.1 49.1 25.0 52.6 35.9 47.0 4.4 18.9 59.4 70.5 55.0 49.2 82.0 51.9 82.1 GLA GALA ENSG00000102393 "Galactosidase alpha" P06280 X 101393273-101408012 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 229.9;Plasma cells: 171.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 328.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000237, HPA000966" Enhanced "Intracellular and membrane" NA NA 1300000 "HPA000237: AB_1078968, HPA000966: AB_1078969" "unprognostic (7.27e-3)" "unprognostic (1.47e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-1)" "unprognostic (1.60e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (5.62e-5)" "unprognostic (2.53e-1)" "unprognostic (3.42e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-2)" "prognostic favorable (6.16e-4)" "unprognostic (1.13e-1)" "unprognostic (5.44e-2)" "unprognostic (2.21e-1)" 15.8 21.7 5.7 12.9 5.9 25.3 27.0 7.0 7.0 14.0 6.6 13.2 22.6 11.0 17.7 9.3 15.4 11.9 8.6 5.8 7.5 15.7 12.8 17.4 13.3 7.3 7.4 5.4 9.3 6.8 32.0 10.0 22.3 7.2 8.0 15.4 6.9 10.1 39.6 6.3 8.8 13.6 15.5 7.4 13.3 9.4 3.9 6.8 12.1 7.9 6.6 15.7 14.8 9.1 7.4 30.5 117.9 30.8 31.9 68.9 26.8 13.8 34.1 51.9 63.5 176.3 64.7 45.9 33.6 70.0 35.3 151.8 70.3 65.9 38.3 53.8 19.3 47.1 18.3 87.9 78.4 19.2 26.7 328.1 24.3 11.3 72.9 21.6 17.4 50.9 18.2 28.6 71.2 60.8 52.3 24.4 53.7 48.2 72.5 46.4 18.2 39.5 81.5 95.1 61.9 11.5 19.4 78.6 34.6 30.9 54.4 15.2 51.2 29.9 20.7 23.8 52.6 27.0 23.0 26.3 25.4 36.9 39.9 23.1 22.5 37.3 11.9 6.9 38.5 9.0 8.8 5.6 8.8 29.8 9.0 5.6 6.9 21.6 5.6 40.6 10.9 7.3 20.4 5.7 5.9 7.0 7.0 5.8 7.5 7.3 7.4 5.4 7.2 7.4 6.8 7.4 31.5 16.0 10.2 3.3 65.8 30.2 32.6 23.7 45.5 4.0 34.0 23.2 7.7 4.3 19.3 11.0 6.2 38.4 25.5 26.5 17.6 22.5 3.9 57.6 19.5 30.8 33.9 12.6 3.2 18.7 26.3 66.1 39.8 97.6 31.0 9.6 8.9 7.1 93.0 8.4 3.9 15.9 20.3 28.5 229.9 0.9 11.1 115.7 88.9 4.7 30.3 17.5 14.4 3.0 3.9 14.4 25.3 18.0 171.4 20.5 30.9 9.5 29.9 5.3 6.6 22.6 70.8 6.4 5.8 31.0 23.7 75.5 33.2 19.8 19.2 27.9 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "thyroid cancer: 88.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 35.2 59.5 34.1 24.6 36.2 14.9 32.5 38.7 38.3 45.4 31.5 28.3 20.4 41.3 106.2 18.3 28.0 34.3 51.5 36.7 40.9 37.6 24.8 29.8 21.9 37.8 37.0 30.9 38.7 57.9 104.4 48.0 45.8 38.0 44.9 22.1 19.2 60.1 47.2 31.0 11.5 21.7 36.6 40.2 41.6 30.0 13.0 37.0 20.3 50.4 64.2 21.7 32.2 22.7 40.7 26.4 18.8 48.8 23.9 109.4 118.3 10.0 56.5 54.3 23.2 68.3 20.7 21.5 9.5 31.7 64.7 50.8 5.0 34.9 20.2 28.7 21.6 23.2 18.7 64.9 30.2 85.2 18.2 41.5 67.0 27.4 30.9 30.3 65.1 47.6 11.6 15.2 78.9 67.4 10.9 15.0 0.8 24.4 49.5 4.3 19.1 62.2 8.9 36.0 10.1 22.1 18.9 28.3 1.5 63.9 67.7 19.2 19.0 67.5 29.8 18.9 70.8 11.2 69.7 20.9 0.1 50.4 14.5 25.5 43.6 15.3 13.6 14.6 15.8 18.3 15.0 14.0 12.4 15.8 9.8 15.2 10.6 5.6 13.7 16.8 25.8 9.0 14.4 34.1 36.2 38.7 38.3 36.7 40.9 37.8 37.0 30.9 38.0 40.2 37.0 40.7 67.4 44.8 36.1 16.3 61.1 37.9 81.2 40.6 42.7 63.1 70.9 42.3 114.6 50.1 48.4 75.4 58.4 55.3 61.1 20.4 37.2 53.9 0.6 42.2 80.9 69.2 82.4 25.6 35.9 30.6 27.4 85.8 33.1 78.8 79.1 45.5 58.2 48.6 50.7 62.2 41.8 67.6 40.7 52.5 84.9 2.8 64.7 72.3 97.8 18.7 27.2 86.6 34.0 28.6 31.0 30.6 22.1 72.6 122.6 75.2 20.1 43.1 25.1 13.3 32.9 57.1 73.2 2.5 0.4 24.6 21.5 114.9 58.0 70.2 32.1 81.2 BEX4 "BEXL1, FLJ10097" ENSG00000102409 "Brain expressed X-linked 4" Q9NWD9 X 103215108-103217246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 309.3;Syncytiotrophoblasts: 364.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 162.5;HMC-1: 188.1;K-562: 232.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045105, HPA051935" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045105: AB_10966792, HPA051935: AB_2681667" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.55e-3)" "unprognostic (1.75e-3)" "unprognostic (3.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-3)" "unprognostic (3.03e-1)" "unprognostic (6.33e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.62e-2)" "prognostic favorable (2.54e-14)" "unprognostic (1.62e-3)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (5.33e-2)" 27.5 100.8 187.0 25.1 195.6 72.0 56.9 178.9 226.8 53.5 161.7 52.0 17.1 70.9 268.2 48.5 66.3 40.6 102.9 193.6 206.9 98.5 13.7 44.4 33.1 191.0 194.9 188.0 103.5 35.0 127.0 135.0 61.1 194.5 80.9 26.7 92.8 75.2 83.9 6.9 25.5 32.4 56.9 184.3 69.3 36.5 46.5 196.4 57.6 132.3 13.8 35.1 47.0 44.6 206.4 0.0 0.2 96.4 0.0 24.1 16.6 86.5 23.2 19.8 42.6 77.7 0.0 1.4 0.3 38.1 16.2 36.0 0.7 39.1 5.3 46.8 0.1 36.8 162.5 0.0 0.1 73.7 123.0 188.1 62.3 12.9 22.3 0.0 47.3 50.2 62.2 232.5 0.5 13.1 0.5 86.4 1.0 117.0 0.0 6.9 0.2 28.0 0.6 39.1 2.4 71.7 109.3 8.1 1.5 5.1 93.0 3.9 1.3 1.3 5.5 34.3 0.8 0.3 12.5 6.0 0.2 16.0 0.0 4.9 118.6 23.1 42.3 31.6 30.0 26.5 37.6 38.2 32.0 51.3 33.7 65.5 52.2 5.2 100.5 26.4 79.0 40.3 43.9 187.0 195.6 178.9 226.8 193.6 206.9 191.0 194.9 188.0 194.5 184.3 196.4 206.4 45.7 35.3 40.4 25.5 38.7 27.3 133.8 86.0 87.0 174.9 99.0 105.4 81.3 81.5 64.0 99.3 25.0 309.3 47.5 6.8 299.3 66.4 4.7 31.2 35.5 59.2 63.1 35.1 70.0 13.7 156.0 65.1 19.4 38.1 109.2 147.8 73.2 0.7 88.3 222.1 69.6 37.2 52.9 55.5 53.2 12.9 63.3 68.9 115.6 22.5 118.4 217.8 34.0 34.2 64.3 10.8 23.3 61.3 22.2 118.1 8.1 186.5 33.2 81.0 52.6 64.4 57.4 27.4 14.3 42.5 24.2 364.3 37.2 115.0 28.7 111.7 RUBCNL "C13orf18, FLJ21562, KIAA0226L, PACER" ENSG00000102445 "Rubicon like autophagy enhancer" Q9H714 13 46334681-46438190 "Predicted intracellular proteins" "Autophagy, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 6.1;B-cells: 20.7;Endometrial stromal cells: 6.7;Hofbauer cells: 16.7;Macrophages: 5.2" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2" "Group enriched" "Detected in many" 15 "B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0" "Group enriched" "Detected in some" 4 "Daudi: 179.1;U-698: 341.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026614 Approved Approved Cytosol NA NA Cytosol "HPA026614: AB_10602693" "unprognostic (3.35e-2)" "unprognostic (2.61e-1)" "unprognostic (1.94e-3)" "prognostic favorable (3.76e-5)" "unprognostic (1.09e-2)" "unprognostic (8.30e-4)" "unprognostic (7.83e-2)" "unprognostic (2.62e-3)" "unprognostic (1.07e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (5.95e-5)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (7.47e-2)" "unprognostic (7.00e-3)" 4.2 1.3 3.8 18.2 4.1 14.9 4.0 3.5 4.6 6.6 3.9 12.0 3.0 3.8 1.2 1.1 3.7 4.0 1.0 4.1 5.7 0.9 2.2 5.3 41.6 5.6 4.2 3.3 0.6 0.7 0.3 2.0 4.3 5.9 1.5 16.4 4.0 3.1 2.6 10.2 2.1 13.4 3.6 5.4 20.5 2.3 15.9 5.6 23.1 1.9 1.4 40.9 7.5 1.3 8.1 0.5 0.1 3.6 0.2 0.1 0.2 0.3 0.0 0.2 0.2 0.1 7.5 0.2 179.1 1.8 0.0 0.9 0.2 0.1 0.0 0.1 0.7 0.3 0.2 0.2 0.1 0.0 0.2 0.2 4.7 0.0 0.6 0.9 0.0 0.0 8.2 0.3 0.4 0.0 0.1 1.9 1.4 1.5 0.0 1.4 62.6 0.1 6.1 0.0 0.1 3.4 0.1 0.2 0.3 4.4 10.8 0.2 53.0 0.1 0.2 1.6 0.3 0.4 0.9 37.3 341.2 1.1 0.3 0.2 0.5 4.5 0.1 0.1 8.9 0.1 161.2 0.3 0.1 5.1 155.8 0.1 0.1 124.0 3.5 7.1 106.2 0.2 7.5 3.8 4.1 3.5 4.6 4.1 5.7 5.6 4.2 3.3 5.9 5.4 5.6 8.1 0.2 3.2 6.1 0.0 20.7 0.0 0.0 0.0 0.0 0.0 2.9 3.9 0.0 0.0 2.5 0.0 0.0 0.3 0.3 0.0 0.0 1.4 0.0 1.3 6.7 0.4 0.0 0.0 0.0 1.2 0.4 1.1 0.0 2.5 2.5 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 NALCN "bA430M15.1, CanIon, VGCNL1" ENSG00000102452 "Sodium leak channel, non-selective" Q8IZF0 13 101053776-101416508 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7" "Group enriched" "Detected in some" 10 "Astrocytes: 125.4;Excitatory neurons: 265.8;Inhibitory neurons: 277.4;Oligodendrocyte precursor cells: 324.7;Oligodendrocytes: 477.4" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "basophil: 2.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.6" "Cell line enhanced" "Detected in many" "HaCaT: 14.2;HHSteC: 14.4;hTERT-RPE1: 11.0;TIME: 19.8;U-87 MG: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031889, HPA031890, HPA031958" Approved NA NA "HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039" "unprognostic (4.66e-1)" "unprognostic (6.55e-3)" "unprognostic (1.86e-3)" "unprognostic (6.78e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-3)" "unprognostic (8.11e-2)" "unprognostic (2.60e-1)" "unprognostic (7.72e-2)" "unprognostic (5.92e-2)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (1.58e-5)" "unprognostic (1.77e-3)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" 0.6 4.3 6.4 0.4 9.4 0.6 2.7 6.5 10.5 1.5 0.0 0.4 0.6 0.5 1.5 0.2 1.0 2.3 3.4 9.6 8.7 0.3 1.2 1.1 0.3 7.6 5.9 7.8 2.9 1.3 3.0 6.8 3.0 7.4 0.3 0.6 6.2 0.8 1.0 0.3 0.5 0.5 0.5 4.4 0.4 0.7 0.6 7.1 0.0 2.4 0.2 0.1 0.6 0.3 12.7 0.1 7.8 1.4 0.2 0.7 0.3 0.1 0.8 0.8 1.8 0.4 0.2 8.9 0.0 0.3 3.6 0.8 14.2 0.0 2.2 5.5 0.0 1.2 0.4 3.8 0.1 14.4 0.2 0.3 0.4 0.5 1.7 4.6 11.0 8.2 0.1 0.1 0.4 5.9 0.0 0.1 0.0 0.4 1.3 1.8 0.0 0.0 0.0 4.6 1.9 1.2 0.6 0.1 0.0 0.8 0.9 0.2 0.1 19.8 0.4 0.1 0.3 1.8 0.1 0.1 0.1 11.4 0.1 0.3 2.6 0.1 0.2 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.1 0.5 0.2 0.1 0.2 0.1 0.1 6.4 9.4 6.5 10.5 9.6 8.7 7.6 5.9 7.8 7.4 4.4 7.1 12.7 0.1 0.0 0.0 125.4 0.0 0.3 0.0 0.3 0.6 15.4 3.5 4.6 6.2 0.0 0.1 0.0 6.2 1.0 0.0 0.0 0.0 0.8 4.5 0.1 0.2 0.6 0.0 0.0 265.8 0.2 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 26.9 277.4 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 23.4 0.0 2.0 0.0 324.7 477.4 0.3 0.0 1.9 0.0 0.0 0.0 0.1 0.0 2.6 0.0 3.6 0.5 0.2 0.8 0.0 0.1 0.5 0.0 0.1 0.0 0.0 FGF14 "FHF4, SCA27" ENSG00000102466 "Fibroblast growth factor 14" Q92915 13 101710804-102402457 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Growth factor" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;cervix: 7.3" "Group enriched" "Detected in many" 31 "Excitatory neurons: 1994.2;Inhibitory neurons: 2754.3;Oligodendrocyte precursor cells: 2271.0" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.0;SH-SY5Y: 5.8;U-87 MG: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049828 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA049828: AB_2680901" "unprognostic (2.12e-1)" "unprognostic (1.57e-1)" "unprognostic (2.83e-2)" "unprognostic (2.27e-2)" "unprognostic (8.55e-2)" "unprognostic (1.28e-1)" "unprognostic (3.33e-1)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (2.45e-1)" "unprognostic (7.80e-3)" "unprognostic (2.20e-3)" "unprognostic (1.65e-1)" "unprognostic (3.86e-2)" "unprognostic (8.48e-2)" 0.4 1.2 2.2 0.0 2.6 0.0 0.3 11.7 5.1 7.3 0.0 0.2 0.1 0.1 0.4 0.5 2.7 0.4 1.5 2.2 6.0 0.1 0.4 1.4 0.0 2.1 1.5 2.3 0.1 0.3 0.0 3.3 0.1 3.0 0.1 0.1 1.6 0.3 0.1 0.1 0.3 0.4 0.0 0.8 0.0 0.7 1.0 3.4 0.0 0.2 0.1 0.0 0.2 0.5 4.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.6 11.7 5.1 2.2 6.0 2.1 1.5 2.3 3.0 0.8 3.4 4.0 0.5 3.2 1.5 74.4 0.0 0.5 0.5 0.2 2.2 33.2 0.3 1.8 7.4 2.8 8.2 0.0 0.0 0.0 0.3 0.1 0.0 0.3 18.3 4.4 0.4 0.3 19.2 0.0 1994.2 0.0 0.1 9.6 2.0 1.4 0.0 0.1 0.4 2.5 0.1 32.0 2754.3 1.0 6.1 0.0 0.0 35.2 2.5 0.1 1.8 36.5 0.0 5.2 3.1 2271.0 32.3 0.1 0.0 0.0 0.0 0.8 0.0 0.3 53.8 2.7 0.0 1.9 1.9 2.5 5.2 0.3 0.6 0.0 0.2 0.1 0.0 0.1 HTR2A "5-HT2A, HTR2" ENSG00000102468 "5-hydroxytryptamine receptor 2A" P28223 13 46831546-46897076 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Behavior, Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.4;choroid plexus: 4.6" "Cell type enriched" "Detected in some" 8 "Excitatory neurons: 81.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;ASC TERT1: 4.6;BEWO: 1.4;HEL: 1.5;U-138 MG: 2.3;U-2 OS: 1.4;U-87 MG: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014011 Enhanced NA NA "HPA014011: AB_1856709" "unprognostic (8.01e-2)" "unprognostic (2.71e-2)" "unprognostic (9.49e-2)" "unprognostic (7.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.99e-1)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (5.27e-2)" "unprognostic (3.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.90e-1)" "unprognostic (9.94e-5)" "unprognostic (4.78e-3)" "unprognostic (2.54e-1)" "unprognostic (2.91e-2)" "unprognostic (8.28e-2)" 0.9 0.3 4.0 0.8 9.6 0.1 0.5 0.0 15.4 0.6 4.6 0.5 0.4 0.5 0.0 0.5 0.3 1.6 0.7 10.1 8.1 0.1 0.1 0.3 0.0 0.9 2.2 8.5 0.3 0.0 0.0 0.2 0.0 3.0 0.2 0.7 0.8 0.0 0.6 0.3 0.1 0.4 2.6 0.0 0.0 0.2 0.6 1.0 0.7 0.1 0.6 0.2 0.8 0.5 9.5 0.0 0.0 0.0 0.0 1.8 4.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 1.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 4.0 9.6 0.0 15.4 10.1 8.1 0.9 2.2 8.5 3.0 0.0 1.0 9.5 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.2 8.6 0.1 0.0 0.0 81.7 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.0 10.1 0.0 0.0 0.3 0.0 2.2 0.9 1.9 0.0 3.7 0.0 4.6 0.0 2.5 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.0 1.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 NDFIP2 "KIAA1165, N4wbp5a" ENSG00000102471 "Nedd4 family interacting protein 2" Q9NV92 13 79481124-79556075 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 342.7;Late spermatids: 290.4;Suprabasal keratinocytes: 367.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.1;eosinophil: 22.7;naive CD4 T-cell: 5.6" "Group enriched" "Detected in many" 16 "granulocytes: 22.7;T-cells: 5.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009160 Uncertain Supported Vesicles NA NA Vesicles "HPA009160: AB_1079456" "unprognostic (2.56e-1)" "unprognostic (5.51e-3)" "unprognostic (1.95e-3)" "unprognostic (9.61e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (5.99e-4)" "unprognostic (1.50e-1)" "unprognostic (5.53e-2)" "unprognostic (2.30e-1)" "unprognostic (3.12e-1)" "unprognostic (1.52e-2)" "unprognostic (2.63e-2)" "prognostic favorable (4.18e-5)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (6.47e-2)" "unprognostic (1.02e-1)" 14.0 19.3 14.2 11.5 22.3 2.6 22.9 12.5 25.1 14.5 9.0 43.1 53.1 10.2 22.6 54.9 17.2 20.3 26.3 28.2 14.2 46.3 46.7 17.9 13.1 13.4 11.9 20.6 7.1 32.1 29.8 6.5 32.2 15.1 22.9 47.4 21.8 21.6 15.8 31.2 71.9 64.8 9.1 11.5 11.8 26.2 18.3 11.7 16.2 19.5 20.1 19.7 36.0 25.4 23.8 134.6 22.6 23.2 29.4 27.7 50.3 43.6 48.5 66.9 50.1 83.0 49.9 146.1 5.6 32.6 64.0 28.5 178.2 20.5 84.9 75.3 69.7 57.1 6.2 66.5 27.1 50.5 106.2 17.8 40.4 109.3 33.4 52.7 55.8 24.1 10.4 27.5 10.0 56.8 19.3 8.7 24.1 17.1 109.7 22.7 0.5 45.7 25.2 123.1 76.7 23.3 33.4 54.9 52.4 40.0 37.8 43.8 88.2 20.4 16.0 20.4 31.1 32.8 37.6 44.2 21.1 65.6 0.5 65.6 12.1 0.0 22.7 3.2 0.0 2.7 0.2 2.8 2.6 0.0 0.6 5.6 3.1 0.1 0.8 0.0 0.2 3.2 2.4 14.2 22.3 12.5 25.1 28.2 14.2 13.4 11.9 20.6 15.1 11.5 11.7 23.8 17.5 41.7 28.9 26.4 4.4 342.7 137.0 180.6 118.4 30.9 32.7 18.8 29.4 57.2 93.2 47.8 6.2 112.6 6.9 161.0 23.5 85.6 271.2 51.5 17.2 22.0 69.4 4.2 189.0 72.2 152.7 33.2 31.1 49.8 88.2 11.5 20.7 69.2 14.4 16.8 44.2 88.1 95.6 17.0 23.5 290.4 17.4 4.0 33.8 27.2 2.7 22.8 5.2 42.3 100.3 101.7 96.7 12.8 13.8 105.6 204.3 104.6 112.6 15.5 13.1 22.2 24.0 56.5 45.1 102.2 367.7 109.7 24.9 35.2 73.3 145.5 TNFSF13B "BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20" ENSG00000102524 "TNF superfamily member 13b" Q9Y275 13 108251240-108308484 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 87.5;Kupffer cells: 141.1;Langerhans cells: 246.7;Macrophages: 170.4;monocytes: 509.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 505.4" "Group enriched" "Detected in all" 11 "dendritic cells: 206.4;granulocytes: 505.4;monocytes: 350.9" "Cell line enriched" "Detected in some" 7 "U-937: 167.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009188, HPA030526" Enhanced Supported "Vesicles,Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 393000 790000 "Plasma membrane" "Vesicles, Focal adhesion sites" "CAB009188: , HPA030526: " "unprognostic (6.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (2.61e-2)" "unprognostic (7.99e-2)" "unprognostic (8.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.53e-11)" "unprognostic (1.23e-1)" "unprognostic (4.14e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" 8.3 5.3 3.3 26.1 4.0 20.3 4.7 3.3 4.1 2.2 6.5 5.5 10.8 1.4 1.5 4.8 2.4 12.5 2.7 3.3 5.6 1.6 5.4 11.0 21.1 5.5 3.3 3.1 1.1 1.5 0.7 1.1 9.1 4.4 1.8 8.4 0.4 3.4 1.2 1.4 1.9 6.4 5.1 4.7 16.0 5.1 1.2 4.5 5.3 3.0 1.6 17.9 11.2 2.1 6.1 0.1 0.4 0.1 0.1 0.7 0.8 0.2 0.3 0.8 0.6 2.1 0.1 1.7 0.3 0.2 0.2 0.3 0.1 0.0 0.1 0.1 11.6 0.0 0.9 0.4 0.0 0.4 10.2 0.3 2.0 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.6 1.2 0.0 0.1 5.3 0.1 1.1 0.0 0.0 0.2 0.0 0.6 0.3 1.3 0.3 0.0 0.0 0.4 0.2 0.1 22.3 0.2 0.3 0.0 0.0 0.4 10.0 0.3 0.1 10.3 167.0 1.7 12.6 350.9 100.1 5.4 272.3 31.5 4.4 21.5 4.4 206.4 7.1 9.9 3.4 505.4 5.0 234.1 77.8 19.4 165.8 3.3 4.0 3.3 4.1 3.3 5.6 5.5 3.3 3.1 4.4 4.7 4.5 6.1 3.1 16.0 12.9 6.2 7.0 7.1 0.7 1.3 1.2 0.9 2.4 3.2 0.6 10.0 4.2 5.5 0.0 0.5 40.6 0.6 1.9 2.3 1.2 0.4 0.7 3.6 1.2 14.5 18.1 32.5 1.1 29.6 3.1 0.5 5.1 0.9 3.9 2.8 87.5 0.0 11.2 0.9 0.0 141.1 246.7 0.6 5.3 170.4 8.8 15.0 509.4 0.2 5.2 55.3 5.1 1.7 0.5 1.9 1.5 2.7 2.2 1.3 2.0 0.3 6.6 1.4 4.1 0.1 0.7 0.5 4.7 1.1 10.5 1.2 1.8 3.1 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 18.0 40.3 17.7 18.9 20.3 17.1 26.5 15.2 18.0 35.5 16.3 23.5 27.7 32.4 39.1 13.2 26.8 27.0 14.1 16.5 32.9 30.0 67.5 21.8 16.9 17.4 16.9 14.8 35.8 43.4 27.9 31.0 44.5 16.9 22.2 24.2 22.1 37.1 34.2 10.2 11.5 24.0 26.3 14.9 22.8 29.1 30.6 28.4 21.5 51.6 13.3 19.1 25.8 14.2 19.3 11.6 13.1 47.1 12.4 58.3 73.0 9.2 53.3 70.8 50.2 36.3 17.9 27.7 8.8 9.7 40.5 21.8 12.4 28.4 18.1 72.6 22.1 21.9 14.3 36.9 33.2 35.3 13.4 2.3 37.7 24.8 44.7 51.4 47.1 52.6 11.9 18.0 21.0 55.4 4.7 13.3 26.7 23.2 25.0 11.0 12.6 18.8 16.4 42.4 21.2 17.8 29.4 20.1 17.8 38.8 29.8 9.6 26.0 41.7 26.1 17.9 24.3 38.3 25.4 14.4 8.1 19.6 16.9 27.4 1.9 3.0 1.9 2.5 2.0 3.6 3.3 2.9 2.2 1.9 2.2 3.7 3.3 4.5 2.1 4.0 4.0 2.6 1.7 17.7 20.3 15.2 18.0 16.5 32.9 17.4 16.9 14.8 16.9 14.9 28.4 19.3 46.7 54.5 49.0 88.2 36.2 18.4 37.4 17.5 44.3 52.0 33.4 25.5 27.1 27.1 28.9 36.8 37.5 13.2 36.4 21.6 13.7 30.6 45.9 42.1 74.3 42.4 43.5 17.9 159.5 36.2 38.2 58.0 57.6 56.4 31.6 38.8 32.9 74.2 25.4 35.3 170.8 37.4 18.3 31.8 24.4 13.1 33.8 45.5 37.4 112.4 27.0 52.7 24.7 177.9 178.2 25.5 29.0 39.5 165.9 44.2 37.8 48.0 35.6 42.5 6.6 48.0 50.8 89.8 33.7 20.3 11.9 32.3 30.9 46.4 24.7 26.4 MLNR GPR38 ENSG00000102539 "Motilin receptor" O43193 13 49220338-49222377 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;thyroid gland: 1.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;THP-1: 4.0" "Not detected" "Not detected" HPA070324 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA070324: " "unprognostic (9.75e-2)" "unprognostic (2.13e-2)" "unprognostic (2.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.03e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-2)" "unprognostic (7.79e-2)" "unprognostic (1.88e-2)" "unprognostic (3.74e-1)" "unprognostic (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.38e-1)" 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.4 0.0 0.2 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CDADC1 NYD-SP15 ENSG00000102543 "Cytidine and dCMP deaminase domain containing 1" Q9BWV3 13 49247925-49293485 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 174.6;Late spermatids: 77.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 9.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047615, HPA058314" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047615: AB_2680104, HPA058314: AB_2683677" "unprognostic (2.81e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-1)" "unprognostic (2.86e-1)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-3)" "prognostic favorable (6.03e-4)" "unprognostic (7.68e-2)" "unprognostic (6.06e-2)" "unprognostic (2.35e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-5)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (5.40e-2)" "unprognostic (8.27e-3)" 5.0 6.8 5.2 2.3 4.8 6.4 4.2 6.0 6.5 4.0 5.7 4.1 3.1 3.9 5.1 3.2 4.2 2.7 4.4 4.7 5.5 9.6 8.2 3.5 3.1 5.2 5.5 5.0 4.5 2.7 5.5 3.3 2.0 5.2 3.9 3.2 5.3 3.5 4.5 4.5 2.2 3.1 3.7 4.9 4.2 3.9 7.9 6.0 4.4 9.5 5.3 2.6 3.5 3.7 5.7 2.1 2.6 2.2 2.7 10.8 5.9 1.1 5.0 3.1 2.5 2.6 2.6 1.7 2.9 1.0 2.2 2.4 3.6 4.6 2.2 3.2 6.3 3.7 3.3 2.5 2.7 4.7 6.3 1.7 4.1 5.5 2.3 3.0 4.4 3.7 5.6 2.1 2.1 3.2 0.7 6.0 5.1 0.8 3.6 2.2 4.0 2.4 2.9 3.6 0.7 1.3 1.1 3.4 2.1 2.9 1.4 1.5 5.4 2.8 1.3 2.4 3.5 2.4 0.6 2.4 1.8 1.1 7.2 3.7 9.9 1.1 0.9 1.4 0.9 1.5 0.4 1.0 1.9 0.8 0.6 0.9 1.3 1.2 1.2 1.8 0.8 1.6 0.9 5.2 4.8 6.0 6.5 4.7 5.5 5.2 5.5 5.0 5.2 4.9 6.0 5.7 12.4 6.4 12.4 9.4 6.6 8.0 7.3 10.7 11.4 12.7 8.5 9.7 15.0 5.7 8.6 18.4 12.5 4.6 19.1 4.7 9.8 5.3 174.6 12.6 14.6 8.7 6.7 10.3 16.0 10.7 10.9 17.1 6.6 6.0 24.7 10.0 11.7 11.5 6.2 3.3 21.4 6.9 4.1 9.1 8.3 77.7 15.8 9.9 7.2 3.7 5.4 25.9 9.2 14.1 12.4 6.7 5.7 14.3 10.6 7.3 7.9 25.4 18.9 12.2 0.0 15.3 17.8 39.3 15.5 7.7 5.4 2.5 14.1 17.2 6.0 5.7 CAB39L "bA103J18.3, FLJ12577, MO2L" ENSG00000102547 "Calcium binding protein 39 like" Q9H9S4 13 49308650-49444064 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 200.0" "Cancer enhanced" "Detected in all" "prostate cancer: 28.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 41.8;RT4: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003686, HPA045954, HPA076632" Approved Approved Vesicles NA NA Vesicles "CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: " "unprognostic (3.90e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-1)" "unprognostic (5.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.94e-1)" "unprognostic (2.82e-1)" "unprognostic (2.94e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (3.08e-2)" "prognostic favorable (7.91e-4)" "prognostic favorable (1.94e-13)" "unprognostic (6.59e-2)" "unprognostic (8.31e-2)" "unprognostic (4.96e-2)" "unprognostic (8.05e-3)" 23.3 37.7 25.1 4.4 25.2 2.2 37.7 23.2 21.2 13.1 59.2 42.5 6.1 15.4 16.5 31.4 18.4 16.6 17.9 23.7 37.2 14.1 5.3 19.7 4.3 28.5 32.8 17.5 21.7 12.1 29.4 8.5 12.5 23.8 41.8 11.7 14.9 17.1 22.7 7.6 15.0 12.6 11.6 26.8 4.1 27.4 33.7 28.3 9.5 9.8 13.1 5.2 26.7 17.4 28.9 1.6 1.7 9.8 2.8 9.3 8.7 14.8 9.3 17.9 5.9 4.1 41.8 6.0 14.2 1.2 6.5 6.5 3.4 5.4 6.2 10.2 4.7 4.5 3.7 2.0 2.6 5.2 3.3 1.6 6.4 4.8 4.4 6.8 7.3 8.0 2.2 0.7 3.2 8.1 2.8 3.2 2.4 7.6 5.4 2.7 2.8 1.3 2.3 8.3 43.4 1.2 3.7 5.1 11.8 12.1 11.8 18.4 4.9 7.6 2.5 2.7 5.3 7.6 2.5 2.3 16.3 2.8 2.5 5.7 6.7 2.6 5.4 2.6 2.4 2.0 2.7 3.2 3.4 2.6 1.6 2.3 2.3 5.6 1.9 2.1 0.4 3.6 2.3 25.1 25.2 23.2 21.2 23.7 37.2 28.5 32.8 17.5 23.8 26.8 28.3 28.9 6.9 16.0 11.9 52.2 2.4 3.1 12.6 6.6 7.4 6.4 27.1 14.4 14.5 4.3 13.4 11.0 6.2 26.4 3.1 3.9 11.7 10.1 200.0 8.3 9.2 5.4 2.4 1.7 45.0 10.6 14.0 42.5 5.6 3.7 4.5 4.2 3.9 1.9 6.4 1.7 32.4 2.4 16.2 3.5 4.7 32.1 15.5 5.0 12.4 24.4 5.6 14.9 7.2 50.3 43.3 10.3 2.0 11.7 4.6 16.7 0.8 5.0 17.7 5.2 6.6 9.4 16.8 46.0 5.0 16.0 4.4 29.0 3.6 3.9 2.3 21.7 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077541 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 244.0;skin 1: 236.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 21 "basophil: 24.0" "Lineage enriched" "Detected in single" 140 "granulocytes: 24.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 23.2" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 6.3 5.9 4.4 18.2 9.1 64.0 36.6 0.7 3.1 40.6 2.5 162.7 131.6 6.8 6.7 244.0 37.8 56.4 2.7 2.7 3.1 8.6 4.7 29.8 2.0 2.5 2.1 2.0 4.6 12.0 0.5 11.0 19.0 1.9 23.3 146.7 0.4 80.5 14.5 19.3 236.8 147.5 6.6 0.7 1.5 82.9 12.1 3.4 12.1 25.9 7.8 54.0 112.6 123.2 1.4 22.3 31.1 0.2 0.4 1.1 1.5 34.1 12.9 29.8 5.6 6.9 28.5 111.8 0.4 68.9 11.4 2.3 128.8 39.0 112.2 8.9 0.9 11.0 0.4 61.9 2.8 7.8 10.5 1.9 8.1 156.1 1.7 61.1 5.7 0.1 3.8 1.6 2.2 25.5 7.9 2.1 0.8 1.4 246.3 43.3 2.0 28.3 2.5 87.3 136.3 2.9 1.3 114.5 18.3 8.5 13.9 2.5 2.5 0.3 7.8 23.1 0.2 5.4 3.7 1.9 3.8 10.8 2.1 9.5 24.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.1 4.4 9.1 0.7 3.1 2.7 3.1 2.5 2.1 2.0 1.9 0.7 3.4 1.4 7.8 163.5 123.3 0.7 5.2 518.9 1105.5 185.6 757.5 0.4 79.9 57.0 6.0 91.5 218.5 36.8 2.1 77.8 4.6 420.7 21.5 31.8 448.3 302.1 44.1 12.5 203.2 0.4 1.6 46.1 98.5 33.4 425.1 678.2 3.8 0.9 2.2 4.7 6.1 10.1 11.6 387.4 46.8 0.9 34.6 241.4 6.5 12.4 58.7 1.9 4.3 0.0 1.0 1.0 0.6 88.6 374.9 1.5 15.7 632.1 260.0 3.5 159.3 0.2 0.0 38.4 32.4 8.8 26.3 1028.4 685.9 58.0 17.4 0.5 505.4 1495.5 STK24 "MST-3, MST3, MST3B, STE20, STK3" ENSG00000102572 "Serine/threonine kinase 24" Q9Y6E0 13 98445185-98577940 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026435, HPA026502" Enhanced Supported Nucleoli,Cytosol No No 1100000 "Nucleoli, Cytosol" "HPA026435: AB_1854151, HPA026502: AB_1854152" "unprognostic (3.49e-2)" "unprognostic (2.39e-2)" "unprognostic (1.78e-1)" "unprognostic (3.44e-2)" "unprognostic (2.86e-1)" "unprognostic (3.25e-2)" "unprognostic (9.67e-3)" "prognostic unfavorable (6.23e-6)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (9.62e-2)" "prognostic favorable (6.91e-5)" "unprognostic (3.10e-2)" "unprognostic (4.49e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-2)" 64.2 32.7 30.3 49.4 32.3 58.5 61.5 34.3 34.7 81.8 46.6 75.5 83.7 54.3 58.9 169.3 51.2 56.3 49.6 33.6 29.8 60.2 32.7 54.6 67.5 27.5 34.6 30.1 44.5 48.4 42.8 31.4 58.0 26.7 50.0 73.0 31.9 71.0 51.7 47.5 148.7 95.1 48.6 27.0 52.0 79.0 37.2 41.1 68.9 55.5 39.2 74.8 87.4 114.9 28.4 161.8 49.4 85.6 79.8 128.6 76.4 121.3 73.8 103.0 100.9 97.7 145.7 212.6 114.1 36.6 92.8 63.1 142.1 80.2 162.3 95.5 286.3 41.2 122.0 59.8 84.2 181.0 124.4 82.8 49.8 253.7 79.3 231.6 106.2 88.2 88.0 45.2 76.6 67.0 70.3 93.5 51.1 76.9 217.3 36.6 116.5 52.5 62.3 98.1 143.2 49.8 71.4 46.7 74.2 103.0 129.7 89.6 119.1 120.0 63.8 46.3 52.8 86.5 74.1 41.7 42.5 99.3 74.0 107.4 5.7 12.7 6.3 5.5 10.9 6.6 6.1 10.2 8.0 10.9 7.9 6.9 5.6 10.9 1.5 13.5 7.1 13.7 6.7 30.3 32.3 34.3 34.7 33.6 29.8 27.5 34.6 30.1 26.7 27.0 41.1 28.4 36.2 12.8 27.4 27.7 37.4 70.9 83.6 51.2 20.5 20.3 41.5 33.5 3.0 55.8 55.8 68.0 56.3 39.2 36.9 203.8 25.4 35.8 3.5 74.2 48.7 32.5 42.6 41.4 39.2 55.0 45.9 43.2 65.7 99.6 18.4 49.1 25.0 26.6 28.0 10.1 34.2 86.0 24.4 82.2 57.9 5.9 26.8 58.4 56.9 49.6 47.6 25.5 20.6 35.7 11.1 84.4 96.5 30.5 25.5 60.4 111.8 39.2 51.6 11.0 39.5 47.7 41.0 2.9 21.2 61.9 82.1 20.0 45.5 20.4 59.1 153.3 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 175.6" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 200.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 4000000 Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 9.5 6.1 2.7 42.8 3.7 9.5 25.9 2.6 21.6 35.0 3.6 46.8 32.2 19.4 7.9 23.5 8.7 26.9 5.2 1.8 7.6 74.6 32.7 175.6 87.8 3.8 3.2 1.1 20.5 12.0 2.4 1.4 13.4 4.5 19.7 36.7 20.3 14.4 7.1 1.5 25.1 30.5 13.4 4.4 43.9 39.0 4.1 12.7 25.6 3.0 5.0 44.0 33.4 11.4 7.1 10.2 1.1 0.0 0.2 0.5 0.0 41.1 1.1 25.8 0.0 0.1 0.4 0.3 1.4 1.8 9.0 5.9 0.3 0.0 4.5 0.1 12.1 0.8 0.3 0.0 5.0 1.4 0.1 0.6 0.0 4.1 0.4 0.0 0.0 0.0 0.0 30.4 0.2 0.0 2.3 0.9 1.4 0.8 0.3 0.7 0.4 1.8 41.4 0.0 0.4 0.7 1.0 0.0 0.0 127.6 1.1 0.2 0.4 0.9 102.9 1.2 1.8 0.3 0.7 5.7 0.6 23.7 0.1 4.0 0.4 35.3 76.6 15.8 36.1 8.8 200.1 26.0 19.6 7.3 110.9 35.3 20.2 10.4 13.3 36.3 62.5 67.8 36.4 2.7 3.7 2.6 21.6 1.8 7.6 3.8 3.2 1.1 4.5 4.4 12.7 7.1 2.2 9.6 7.8 0.0 75.7 10.3 11.0 21.8 25.0 18.3 14.6 18.4 1.4 15.7 5.7 7.3 18.8 33.4 21.2 7.0 9.8 1.8 0.2 0.7 9.1 30.9 3.0 24.5 0.0 11.3 32.7 19.8 10.7 0.9 63.7 0.8 426.9 8.4 426.7 1.7 0.0 4.7 10.2 106.0 68.6 0.7 1.8 298.2 14.2 1.0 79.8 48.5 8.2 0.0 0.1 4.4 20.4 12.0 33.4 14.5 12.7 145.8 2.5 41.4 0.0 0.4 2.8 0.1 0.2 14.6 11.1 26.1 29.5 0.1 6.7 6.1 DNAJC3 "ERdj6, HP58, P58, p58(IPK), P58IPK, PRKRI" ENSG00000102580 "DnaJ heat shock protein family (Hsp40) member C3" Q13217 13 95677139-95794988 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Antiviral defense, Stress response, Translation regulation, Unfolded protein response" "Chaperone, Repressor" "Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039336, HPA041326" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 4900000 "Endoplasmic reticulum" "HPA039336: AB_2676451, HPA041326: AB_2677412" "unprognostic (1.44e-2)" "unprognostic (8.08e-2)" "unprognostic (2.12e-2)" "prognostic favorable (3.47e-5)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (9.69e-2)" "unprognostic (7.19e-2)" "unprognostic (3.37e-2)" "unprognostic (8.30e-3)" "unprognostic (8.18e-2)" 21.2 20.2 10.8 22.7 13.3 46.0 21.5 13.7 13.0 35.4 22.4 25.4 24.0 20.6 39.3 16.1 20.6 22.2 16.8 10.1 18.6 25.8 42.1 23.1 15.1 15.7 13.2 9.1 16.0 36.3 24.6 16.3 24.9 15.2 34.8 26.7 10.0 36.6 26.3 9.4 11.0 24.2 22.5 15.0 20.0 29.0 12.8 14.0 11.4 53.2 11.3 17.9 22.3 12.0 17.1 32.4 18.0 14.2 40.7 57.7 28.6 42.6 44.6 40.3 20.2 18.4 22.7 66.5 29.5 41.5 45.0 28.5 32.3 18.7 34.1 30.7 28.8 8.4 40.7 24.6 36.5 79.1 49.8 51.6 34.3 35.7 29.7 68.2 36.9 44.4 13.2 13.9 0.3 34.4 13.1 17.0 17.8 10.6 75.2 13.9 17.1 24.8 22.9 44.9 39.5 8.2 15.6 31.6 74.9 22.5 32.4 37.3 54.6 50.8 39.0 13.3 26.2 23.3 60.6 28.4 13.4 65.6 29.6 54.9 64.7 25.5 86.2 23.9 32.1 25.3 11.2 19.6 20.1 17.2 9.0 13.7 18.7 77.1 22.8 36.0 45.9 13.4 15.7 10.8 13.3 13.7 13.0 10.1 18.6 15.7 13.2 9.1 15.2 15.0 14.0 17.1 81.7 80.1 71.3 47.3 61.1 94.1 88.5 81.1 33.6 25.7 65.2 35.9 58.2 81.5 83.4 47.8 27.1 57.1 109.6 69.0 21.5 98.8 160.5 58.0 87.5 64.8 41.9 33.7 30.1 118.7 135.5 99.6 56.6 94.5 67.8 34.4 68.6 140.7 78.8 25.2 37.3 84.9 69.2 70.5 130.2 33.6 71.7 82.0 119.2 47.8 63.1 38.7 51.5 53.3 58.9 97.6 52.4 75.6 214.3 151.2 58.1 71.1 96.7 19.6 92.1 80.8 104.5 47.1 79.9 38.1 92.9 189.8 67.0 53.3 63.8 124.4 UGGT2 "FLJ10873, FLJ11485, HUGT2, MGC117360, MGC150689, MGC87276, UGCGL2" ENSG00000102595 "UDP-glucose glycoprotein glucosyltransferase 2" Q9NYU1 13 95801580-96053482 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 112.0;Excitatory neurons: 215.1;Inhibitory neurons: 169.6;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 207.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.9;eosinophil: 2.6;intermediate monocyte: 6.2;myeloid DC: 3.6;non-classical monocyte: 6.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047955 Uncertain "Intracellular and membrane" NA NA "HPA047955: AB_2680222" "unprognostic (5.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.51e-2)" "unprognostic (1.83e-1)" "unprognostic (9.33e-2)" "unprognostic (8.70e-2)" "prognostic unfavorable (9.99e-4)" "prognostic unfavorable (5.47e-4)" "unprognostic (1.55e-1)" "unprognostic (9.21e-2)" "unprognostic (7.75e-3)" "unprognostic (6.27e-2)" "unprognostic (5.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.61e-2)" 10.2 6.9 4.5 5.2 6.9 3.8 9.4 2.2 9.1 8.0 6.0 6.1 5.4 10.4 16.2 4.0 7.9 6.0 7.1 6.2 5.6 7.6 8.4 6.7 3.0 4.2 4.7 5.7 7.9 10.7 7.7 8.9 11.2 4.9 7.5 6.3 7.8 8.1 7.3 4.1 4.5 4.6 10.1 2.4 3.9 7.9 12.1 4.3 1.2 11.5 4.3 2.6 8.3 6.1 9.5 20.3 9.6 19.8 10.2 32.5 34.4 16.0 32.5 25.2 15.6 26.6 14.6 17.2 7.0 11.8 22.0 11.4 12.4 7.0 7.0 22.9 0.2 8.6 9.0 19.1 9.6 19.0 25.4 20.9 20.6 7.4 5.9 18.7 28.8 14.2 0.1 5.8 11.5 22.1 6.0 0.2 10.9 8.4 15.1 5.8 0.1 14.4 10.5 13.6 19.4 4.1 15.3 18.6 18.4 13.2 26.9 16.4 12.1 23.1 15.7 10.2 17.6 17.1 16.1 8.3 8.8 40.9 13.3 21.2 0.4 5.9 2.6 0.1 6.2 0.0 1.2 0.1 0.1 3.6 0.4 0.1 0.1 0.4 1.1 6.0 0.3 0.0 1.9 4.5 6.9 2.2 9.1 6.2 5.6 4.2 4.7 5.7 4.9 2.4 4.3 9.5 22.2 16.0 19.9 112.0 3.9 4.0 10.3 10.6 10.2 19.5 11.0 13.1 13.1 7.2 16.3 14.7 31.3 18.3 0.5 5.8 0.0 13.9 44.7 13.2 34.3 17.7 4.8 7.8 215.1 18.9 17.3 32.4 12.2 20.9 18.3 22.4 12.8 8.6 7.5 18.5 169.6 7.1 8.2 7.1 11.9 15.4 22.1 8.5 3.6 76.8 6.8 11.8 0.0 209.1 207.3 18.6 5.2 16.6 9.8 9.9 4.0 5.6 15.1 17.1 32.9 28.2 32.3 38.1 26.3 8.0 3.1 13.8 1.6 19.5 7.8 7.5 ARHGEF7 "BETA-PIX, COOL1, DKFZp686C12170, DKFZp761K1021, KIAA0142, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB" ENSG00000102606 "Rho guanine nucleotide exchange factor 7" Q14155 13 111114559-111305737 "Predicted intracellular proteins" Neurogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 280.1;Inhibitory neurons: 189.9;Oligodendrocyte precursor cells: 169.4;Oligodendrocytes: 269.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004744 Approved NA NA "HPA004744: AB_1845332" "unprognostic (1.84e-1)" "unprognostic (1.74e-2)" "unprognostic (2.07e-1)" "unprognostic (2.46e-1)" "prognostic favorable (8.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.60e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-2)" "unprognostic (7.34e-3)" "unprognostic (1.73e-2)" "unprognostic (4.54e-2)" "unprognostic (4.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.76e-2)" "unprognostic (6.84e-2)" "unprognostic (1.40e-3)" 55.0 26.9 33.0 28.1 41.2 38.2 51.4 46.8 53.1 34.9 17.3 29.3 27.8 29.9 21.9 26.3 28.6 28.3 39.3 43.0 33.9 30.8 32.1 41.1 37.2 26.9 33.3 43.4 35.4 26.4 20.6 32.4 46.1 34.2 37.9 29.4 28.7 27.6 18.3 51.2 46.7 31.5 23.9 19.2 47.2 27.9 28.9 35.5 66.0 36.3 34.0 33.5 27.5 33.1 58.9 46.2 24.2 52.1 25.7 39.5 54.6 33.8 35.3 31.4 29.0 35.5 29.3 32.0 77.2 35.7 28.5 34.9 38.5 26.5 24.7 32.9 37.2 33.4 54.5 45.7 19.6 21.3 59.7 31.0 39.1 30.0 23.9 29.6 28.4 79.7 77.1 33.2 13.8 25.7 18.1 54.7 36.2 31.5 65.1 15.0 50.8 27.1 15.9 17.3 32.4 36.3 53.4 25.2 37.0 23.3 37.8 33.1 52.5 78.4 19.4 22.3 18.4 22.2 31.6 29.7 91.4 44.6 27.5 26.4 29.7 5.5 6.2 7.0 6.2 10.2 9.9 6.5 6.1 6.1 9.1 8.0 6.0 4.3 12.0 8.1 6.6 8.4 6.1 33.0 41.2 46.8 53.1 43.0 33.9 26.9 33.3 43.4 34.2 19.2 35.5 58.9 128.2 9.6 19.1 78.0 32.8 15.9 9.8 8.5 25.6 35.8 21.2 16.8 26.8 10.0 15.6 16.5 18.8 18.4 29.6 24.7 1.9 11.7 79.7 13.6 26.7 49.6 13.2 13.7 280.1 8.5 15.5 21.2 23.4 26.8 8.2 18.6 40.0 17.6 12.9 60.6 189.9 22.8 20.3 16.4 19.8 64.1 17.4 19.6 24.9 71.2 15.7 20.3 20.6 169.4 269.4 14.6 19.1 18.0 30.3 19.3 19.8 6.9 14.3 28.7 65.7 24.5 78.0 31.2 23.9 20.0 23.0 18.3 29.3 17.3 18.9 16.2 FGF9 ENSG00000102678 "Fibroblast growth factor 9" P31371 13 21671073-21704498 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.9;kidney: 10.9;retina: 8.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 39.2;Excitatory neurons: 36.7;Horizontal cells: 40.4;Inhibitory neurons: 54.7;Muller glia cells: 138.8" "Group enriched" "Detected in some" 5 "endometrial cancer: 3.7;ovarian cancer: 1.2;renal cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;HEK 293: 1.4;JURKAT: 2.1;RPMI-8226: 2.1;RPTEC TERT1: 3.0;SCLC-21H: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067007 Enhanced Approved "Secreted in other tissues" NA NA "HPA067007: AB_2732755" "unprognostic (6.59e-3)" "unprognostic (9.09e-3)" "unprognostic (2.15e-2)" "unprognostic (9.24e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.42e-4)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (3.86e-1)" "unprognostic (2.38e-3)" "unprognostic (7.93e-2)" "prognostic favorable (1.70e-6)" "unprognostic (5.38e-2)" "unprognostic (1.27e-1)" "unprognostic (3.49e-1)" "unprognostic (6.92e-2)" 1.2 4.0 1.6 0.1 1.6 0.2 0.2 5.9 4.8 1.6 0.5 0.8 0.7 1.6 0.2 0.2 0.4 0.4 2.7 1.6 2.0 10.9 0.0 0.9 0.1 3.5 2.2 1.3 1.1 0.5 0.1 2.2 0.1 4.5 0.3 1.2 8.3 0.3 0.5 0.5 0.1 1.8 0.3 1.4 0.1 0.8 0.5 3.4 0.1 0.1 0.5 0.0 1.3 0.8 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.5 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.6 2.1 3.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.6 5.9 4.8 1.6 2.0 3.5 2.2 1.3 4.5 1.4 3.4 4.3 0.9 9.6 5.6 12.1 1.8 1.7 0.2 0.6 0.0 14.4 0.7 2.7 25.7 0.0 1.3 3.7 0.0 0.1 3.2 1.7 39.2 0.4 9.4 13.1 2.6 1.6 18.6 0.0 36.7 0.0 0.0 3.9 0.0 26.6 0.0 1.2 0.0 0.0 0.1 40.4 54.7 2.7 0.0 0.0 1.6 2.9 0.6 0.5 1.8 1.9 1.6 138.8 3.1 9.5 1.7 0.2 0.5 0.0 1.9 0.1 10.9 1.1 0.0 5.9 0.0 1.0 0.7 6.3 6.2 0.1 1.4 0.3 3.2 0.1 7.5 0.1 SGCG "A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE" ENSG00000102683 "Sarcoglycan gamma" Q13326 13 23180979-23325162 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "heart muscle: 119.9;skeletal muscle: 159.5;tongue: 145.3" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 134.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 66.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA007476 Enhanced NA NA "HPA007476: AB_1079946" "unprognostic (5.19e-2)" "unprognostic (8.28e-2)" "unprognostic (5.15e-3)" "unprognostic (1.64e-4)" "unprognostic (3.00e-3)" "unprognostic (3.61e-2)" "unprognostic (8.14e-3)" "unprognostic (1.46e-1)" "unprognostic (2.29e-1)" "unprognostic (4.49e-1)" "unprognostic (6.05e-2)" "unprognostic (2.23e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (2.98e-3)" "unprognostic (1.07e-1)" 14.4 0.6 0.0 0.1 0.0 0.0 2.2 0.0 1.8 0.3 0.0 0.9 0.1 0.1 8.0 3.3 1.1 0.8 119.9 0.3 0.0 0.3 0.0 4.9 0.0 0.3 0.0 0.0 0.2 0.1 2.1 0.3 0.0 0.3 3.2 0.6 0.3 4.3 0.4 159.5 3.4 0.6 0.1 0.0 0.1 0.9 1.6 0.2 0.1 0.1 145.3 0.1 3.0 1.4 0.3 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 66.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 0.2 0.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.3 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.1 134.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 1.3 0.0 0.0 12.5 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.0 0.0 0.0 3.4 3.0 7.5 0.2 5.4 1.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.2 3.8 13.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 PARP4 "ADPRTL1, ARTD4, p193, VAULT3, VPARP, VWA5C" ENSG00000102699 "Poly(ADP-ribose) polymerase family member 4" Q9UKK3 13 24420931-24512778 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Ribonucleoprotein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "granulocytes: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011739 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA011739: AB_1854986" "unprognostic (1.61e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-2)" "unprognostic (4.35e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (2.52e-1)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (4.12e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.21e-5)" "unprognostic (3.23e-2)" "unprognostic (1.71e-1)" "unprognostic (3.80e-2)" "unprognostic (2.84e-3)" 17.4 23.0 7.7 24.4 10.8 22.3 16.9 11.1 8.2 24.5 12.2 39.0 39.2 18.1 18.2 22.2 21.3 29.7 12.8 6.9 12.1 27.2 25.1 29.0 23.8 15.3 10.8 5.3 18.7 14.9 18.6 5.9 16.1 13.9 13.2 39.9 8.3 16.9 18.8 6.4 11.1 39.4 19.7 11.6 26.6 34.8 9.1 10.2 21.8 21.4 11.4 25.4 28.6 14.1 15.3 42.9 37.7 18.1 32.7 48.7 68.8 15.3 48.7 63.5 41.8 37.1 15.5 108.5 32.0 47.3 44.5 46.3 48.5 27.2 49.4 34.1 73.7 19.0 45.9 33.0 35.9 27.8 59.3 43.3 39.9 16.3 34.6 18.3 81.4 69.7 24.5 13.2 13.8 50.2 19.9 37.6 28.5 20.5 100.6 45.9 35.0 33.8 45.0 77.6 86.7 16.4 20.9 35.7 14.2 33.5 23.4 7.1 48.2 99.7 18.9 19.8 24.4 50.4 15.6 19.3 41.4 34.3 30.6 42.1 50.0 21.1 45.9 20.4 25.7 20.4 14.2 16.8 20.5 27.9 8.0 12.2 14.8 24.0 21.1 34.6 10.4 21.9 20.1 7.7 10.8 11.1 8.2 6.9 12.1 15.3 10.8 5.3 13.9 11.6 10.2 15.3 20.5 51.3 51.8 21.2 20.5 2.8 6.9 29.2 6.2 6.3 10.2 5.8 17.6 17.2 52.6 25.8 2.1 5.0 33.8 74.2 5.9 26.1 5.4 35.9 19.4 19.8 4.9 13.9 1.5 22.5 8.9 18.3 42.8 50.9 99.2 30.7 31.1 16.0 17.7 1.7 2.1 27.0 18.3 23.4 6.9 4.7 11.8 35.3 8.8 36.5 37.1 6.7 36.0 21.1 40.8 30.9 53.8 8.2 27.0 10.6 59.7 18.2 69.7 7.4 6.6 12.2 10.4 2.5 8.9 13.5 3.8 1.9 28.9 24.1 30.8 20.5 SUPT20H "bA421P11.4, C13orf19, FAM48A, P38IP, SPT20" ENSG00000102710 "SPT20 homolog, SAGA complex component" Q8NEM7 13 37009312-37059713 "Predicted intracellular proteins" "Autophagy, Gastrulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 56.8" "Cell type enhanced" "Detected in all" "Early spermatids: 145.7;Spermatocytes: 316.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038906, HPA038907" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA038906: AB_10673482, HPA038907: AB_10697401" "unprognostic (4.04e-1)" "unprognostic (9.67e-3)" "unprognostic (2.97e-1)" "unprognostic (2.01e-2)" "unprognostic (1.36e-1)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.61e-1)" "unprognostic (4.46e-2)" "unprognostic (6.75e-2)" "unprognostic (2.05e-2)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.56e-2)" "unprognostic (2.21e-3)" 10.1 9.2 7.9 12.4 8.7 19.4 10.1 10.1 12.8 13.3 9.8 13.7 7.6 13.5 8.9 10.4 15.4 10.7 12.2 7.8 9.1 9.6 6.5 11.9 14.0 9.1 8.4 7.8 13.2 7.5 9.9 9.9 13.7 9.2 11.5 11.4 11.1 9.0 12.6 14.7 9.2 10.7 16.3 8.1 13.5 9.9 56.8 8.5 23.9 9.3 11.5 16.0 13.7 10.6 10.2 13.8 16.7 52.0 29.5 19.2 26.1 21.7 36.4 22.6 40.8 29.4 28.0 26.3 27.3 14.7 29.4 45.3 23.4 32.6 37.7 54.2 38.1 29.5 82.9 11.7 30.6 36.9 33.9 35.4 19.9 23.1 37.0 63.2 24.9 49.3 36.7 27.5 6.9 47.9 20.5 47.6 23.7 32.7 31.9 18.8 38.2 36.3 5.9 30.6 21.5 9.7 26.1 23.4 20.9 26.0 41.3 15.1 29.8 29.8 16.5 14.4 19.4 31.1 11.5 12.3 26.8 18.8 19.9 31.7 18.9 16.1 22.6 18.9 21.1 16.7 12.9 18.0 17.0 15.3 14.1 20.6 19.7 28.1 19.3 20.4 11.9 21.7 15.2 7.9 8.7 10.1 12.8 7.8 9.1 9.1 8.4 7.8 9.2 8.1 8.5 10.2 25.9 22.4 29.6 34.9 29.0 13.5 16.1 18.8 19.4 36.0 20.3 22.6 16.4 14.3 28.1 31.3 35.5 32.4 26.4 13.1 21.5 24.7 145.7 48.5 35.6 21.4 31.2 33.9 41.8 14.5 31.0 23.3 25.0 25.3 45.5 60.2 23.2 9.8 19.6 21.9 47.7 20.4 26.4 18.2 16.8 29.4 34.2 22.6 7.2 54.4 33.2 17.3 37.0 45.2 60.1 21.6 14.9 33.4 25.4 19.6 17.9 17.6 40.5 34.4 32.9 20.1 27.8 316.0 74.2 23.3 9.9 26.4 34.5 69.4 19.9 15.7 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729128-40771190 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 412.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA039083: AB_2676340, HPA046344: AB_2679629" "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 11.8 14.9 9.5 14.1 9.9 14.5 17.1 10.8 12.6 10.8 9.4 16.0 14.9 16.8 13.9 14.8 15.2 10.3 24.2 9.3 10.2 19.8 29.1 11.6 23.7 10.4 10.7 9.2 19.4 10.5 14.5 7.6 12.7 10.4 11.4 15.8 13.9 13.9 11.1 27.8 13.7 15.4 15.3 9.4 13.3 15.1 18.1 9.9 18.0 19.7 26.4 25.1 13.3 10.1 12.1 19.0 17.9 29.5 19.5 19.8 23.2 29.6 23.7 16.5 30.7 20.5 46.0 27.4 110.5 22.6 13.7 41.3 48.8 37.4 29.6 36.2 29.4 28.1 45.9 12.7 29.7 16.5 47.4 21.3 18.8 21.4 25.3 21.2 20.3 23.8 31.2 31.3 11.3 19.8 21.5 37.2 46.2 28.7 64.2 20.9 35.0 24.3 20.8 40.3 21.6 12.9 18.7 16.5 27.0 39.3 35.1 23.7 41.5 14.6 9.5 16.0 22.3 24.9 8.7 17.4 55.7 19.5 33.3 18.6 30.9 15.3 24.9 29.4 16.4 28.8 36.8 32.5 29.9 19.5 33.5 38.5 34.3 11.3 28.7 18.4 19.1 36.5 17.8 9.5 9.9 10.8 12.6 9.3 10.2 10.4 10.7 9.2 10.4 9.4 9.9 12.1 27.5 48.1 19.2 24.5 35.0 9.7 33.0 106.0 33.0 35.1 22.4 31.6 73.7 28.6 77.2 22.0 18.8 62.7 31.2 18.7 109.5 43.0 74.9 55.5 38.6 32.5 23.4 29.8 28.8 33.6 41.5 27.9 18.8 38.1 23.4 32.8 37.9 76.9 26.0 42.1 37.8 37.4 91.6 17.0 12.5 14.2 35.4 18.1 19.6 26.2 39.8 32.3 32.0 36.7 45.1 30.0 19.5 30.5 52.1 15.8 32.4 93.4 412.5 51.2 46.0 39.5 38.1 72.6 49.8 30.2 13.4 68.0 37.7 45.2 35.5 25.5 SLC25A15 "D13S327, HHH, ORC1, ORNT1" ENSG00000102743 "Solute carrier family 25 member 15" Q9Y619 13 40789412-40812460 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 38.0;liver: 89.0;pancreas: 52.6" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 44.5;Hepatocytes: 39.8;Proximal enterocytes: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042146 Approved NA NA "HPA042146: AB_2677874" "unprognostic (4.17e-1)" "unprognostic (4.50e-2)" "unprognostic (2.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.85e-1)" "prognostic favorable (2.16e-4)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.37e-2)" "prognostic favorable (1.74e-4)" "unprognostic (4.04e-3)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (5.46e-4)" 2.3 1.5 2.1 4.1 2.4 5.7 4.7 2.3 2.5 2.1 2.1 6.0 38.0 3.1 1.2 3.3 2.6 5.0 2.8 2.1 2.3 5.6 89.0 2.3 4.9 2.9 2.3 1.9 2.9 52.6 3.5 1.3 2.9 2.6 2.9 6.6 2.8 3.4 1.8 6.0 3.8 27.0 3.5 2.1 2.5 5.6 9.5 2.4 5.4 17.4 6.0 5.3 2.6 1.6 3.0 7.4 14.7 16.5 21.3 6.5 8.2 17.3 5.6 2.9 6.8 3.9 17.6 15.2 48.0 6.4 10.3 12.7 12.6 26.6 15.5 7.0 11.9 12.4 37.0 8.6 26.6 12.7 15.0 5.3 9.0 8.6 9.6 21.9 4.6 11.2 23.8 18.1 7.8 11.8 28.2 10.2 9.9 33.2 32.7 7.9 25.5 12.0 10.6 11.7 7.0 7.7 20.1 10.2 18.4 10.1 11.5 13.6 23.2 8.4 8.4 12.1 12.7 17.0 8.9 9.6 27.9 8.4 11.4 16.4 1.3 0.5 0.1 1.6 0.9 1.0 0.6 1.0 1.1 1.1 0.7 1.0 2.0 0.7 1.4 0.5 0.5 0.9 0.5 2.1 2.4 2.3 2.5 2.1 2.3 2.9 2.3 1.9 2.6 2.1 2.4 3.0 0.3 3.2 0.5 3.9 1.3 0.3 1.0 0.8 2.2 1.4 2.1 1.4 1.1 1.5 0.2 0.0 0.0 2.2 1.3 0.6 7.9 2.1 4.6 1.2 2.1 0.9 1.2 9.0 2.4 4.3 44.5 1.0 1.5 2.1 0.0 1.5 0.7 39.8 1.7 0.0 4.3 0.6 2.0 1.6 0.3 6.8 0.6 1.0 1.8 1.0 0.0 0.4 2.1 5.0 1.4 1.7 2.7 0.0 6.2 1.6 19.0 4.3 0.1 1.9 0.0 1.0 1.1 5.4 9.3 2.1 0.1 1.5 3.2 4.3 3.5 0.8 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699320-49792682 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 146.8;tongue: 95.0" "Cell type enhanced" "Detected in all" "Early spermatids: 316.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046852, HPA077643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046852: AB_2679840, HPA077643: " "unprognostic (4.20e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 21.0 10.7 16.1 17.1 17.8 29.9 11.8 16.6 19.8 13.8 12.9 17.2 12.4 14.0 11.4 25.7 12.5 14.8 32.2 18.3 17.1 14.0 23.6 17.4 18.6 16.9 17.1 16.4 8.4 10.4 12.7 7.2 15.0 16.6 15.9 16.8 33.7 10.5 19.3 146.8 16.4 12.3 25.9 18.1 13.7 13.6 28.7 17.8 20.0 19.4 95.0 20.3 20.3 11.1 20.1 41.3 28.3 53.0 44.6 53.2 58.1 26.6 73.3 60.8 63.5 46.0 86.2 37.6 89.2 14.4 86.6 42.7 47.1 64.1 59.5 105.2 53.8 44.7 65.3 25.4 101.1 51.8 98.7 40.6 42.9 42.3 53.3 69.8 41.7 79.7 36.9 36.7 23.4 88.8 19.1 53.2 53.7 61.4 57.8 19.7 68.6 52.1 27.3 39.1 33.8 22.2 34.8 27.1 33.3 29.5 43.8 19.8 39.3 73.0 46.7 37.5 43.0 49.8 18.8 27.9 76.7 28.4 44.9 47.2 10.3 3.8 3.6 6.7 4.5 9.3 4.9 6.7 6.6 4.2 2.8 6.4 5.9 2.2 6.7 6.0 2.3 8.5 3.4 16.1 17.8 16.6 19.8 18.3 17.1 16.9 17.1 16.4 16.6 18.1 17.8 20.1 44.3 67.3 33.8 64.9 35.2 43.1 30.5 21.4 43.9 29.9 23.4 15.0 76.5 21.5 25.7 12.9 33.3 15.5 31.8 26.0 17.6 49.0 316.7 57.4 35.7 44.2 30.5 39.1 90.6 53.7 17.7 30.0 27.0 40.7 33.0 25.4 30.4 36.2 33.1 52.2 83.9 18.4 20.3 37.3 38.7 168.8 22.1 41.9 19.6 55.3 47.1 49.0 35.0 73.4 85.6 51.7 15.0 50.0 36.9 41.7 14.3 28.1 45.8 65.7 26.3 29.1 32.1 66.1 31.8 52.9 49.9 10.5 38.6 61.9 24.9 33.1 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related receptor tyrosine kinase 1" P17948 13 28300346-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 435.9" "Cell type enhanced" "Detected in many" "Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" NA NA 876000 87000 "Plasma membrane" "Actin filaments" "CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 41.4 9.6 44.2 9.1 33.4 1.1 31.5 36.1 39.4 16.5 27.8 9.4 7.6 17.4 3.7 6.0 11.8 16.8 40.3 32.4 37.6 34.5 18.3 26.1 5.4 43.9 39.6 21.0 4.4 12.8 30.8 9.1 435.9 45.4 14.1 6.1 52.9 7.0 11.1 20.0 5.9 9.3 17.5 31.9 18.8 11.0 17.5 53.3 3.7 49.3 39.2 5.7 14.1 9.6 41.4 0.1 0.0 0.0 0.6 0.6 0.9 0.3 71.8 57.2 25.8 14.9 0.0 0.2 0.1 0.1 9.6 0.0 0.3 6.7 0.0 45.4 0.0 2.0 0.2 0.1 0.0 0.1 0.0 349.2 0.6 0.0 0.1 1.0 0.1 64.9 6.1 1.7 0.3 0.0 0.3 4.5 3.7 37.5 0.0 0.1 2.9 0.0 0.1 0.1 0.1 8.1 0.6 0.0 0.1 0.2 44.4 0.3 0.2 6.3 0.2 1.2 0.1 0.1 2.1 1.0 0.2 0.4 0.3 127.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 44.2 33.4 36.1 39.4 32.4 37.6 43.9 39.6 21.0 45.4 31.9 53.3 41.4 411.6 0.0 6.0 2.0 4.7 4.1 0.7 0.2 3.4 17.8 1.2 1.5 26.5 2.8 2.9 0.0 4.2 197.2 1.4 0.1 1.9 0.6 157.2 0.5 1.5 263.1 0.0 0.0 0.9 0.0 815.4 32.1 0.5 2.1 1.3 0.1 234.9 6.9 30.8 1.7 14.5 0.0 0.0 12.5 23.6 173.8 18.6 15.3 0.0 433.8 0.0 153.2 0.0 9.5 2.0 0.0 0.0 48.5 4.1 1.3 0.0 0.1 1.8 9.7 92.1 11.4 30.1 14.6 4.6 1.0 4.8 1127.1 2.8 1.5 0.0 1.1 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457550-41470871 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 419.0;lung: 700.9" "Cell type enhanced" "Detected in many" "Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 159.9;T-reg: 90.9" "Lineage enriched" "Detected in many" 15 "T-cells: 159.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 910000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 199.4 21.7 183.1 28.0 214.1 419.0 133.7 212.7 238.7 36.4 145.1 32.6 17.0 44.0 7.7 18.8 31.4 42.5 109.3 187.0 202.9 56.9 25.2 700.9 38.4 204.9 202.8 165.7 9.2 41.6 48.5 35.6 151.9 203.4 62.0 9.3 5.7 112.4 19.2 47.7 54.0 29.4 33.7 189.3 37.3 38.2 25.0 194.5 71.2 145.2 62.3 21.1 48.0 40.0 237.6 1.1 0.5 34.9 0.0 6.7 57.5 1.4 0.8 316.0 0.2 1.2 44.8 0.7 105.1 0.9 4.0 0.1 1.0 1.2 2.1 0.4 11.1 5.1 0.0 7.9 3.5 3.3 3.7 1.2 4.5 6.7 1.2 43.1 0.6 36.1 24.0 8.3 0.1 1.0 0.3 24.0 2.3 0.5 4.7 0.8 0.1 0.0 0.1 0.3 0.0 1.3 0.4 0.3 0.0 0.7 3.0 0.9 20.1 24.6 0.2 3.8 2.2 0.4 0.2 0.1 111.9 0.3 2.4 0.8 0.0 0.8 0.1 5.6 0.5 5.6 5.3 46.5 14.7 6.1 10.7 159.9 35.0 0.6 0.4 0.1 1.8 90.9 10.2 183.1 214.1 212.7 238.7 187.0 202.9 204.9 202.8 165.7 203.4 189.3 194.5 237.6 1286.2 246.8 39.8 57.5 131.8 86.5 676.2 15.2 14.2 1.0 269.9 314.7 25.8 1.5 37.5 3.7 2.1 6.4 249.2 3.0 35.2 0.6 42.3 103.0 47.2 474.6 84.8 322.7 2.5 0.0 9.3 205.1 65.2 69.0 48.9 0.3 31.8 2.5 349.1 0.0 1.2 22.1 14.2 32.0 590.1 13.2 8.1 315.9 193.9 36.5 6.4 1.5 4.1 51.8 115.3 0.3 4.5 2.2 371.2 1415.5 0.1 0.8 33.7 3.1 124.9 45.4 116.0 155.3 5.0 11.2 65.1 11.1 532.4 43.8 7.8 159.7 VWA8 KIAA0564 ENSG00000102763 "Von Willebrand factor A domain containing 8" A3KMH1 13 41566835-41961120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 161.9;Excitatory neurons: 183.9;Inhibitory neurons: 252.6;Oligodendrocyte precursor cells: 151.3;Oligodendrocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039075, HPA045478" Uncertain Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA039075: AB_2676334, HPA045478: AB_2679341" "unprognostic (9.93e-2)" "unprognostic (4.12e-2)" "unprognostic (2.11e-1)" "unprognostic (2.57e-3)" "unprognostic (4.14e-2)" "unprognostic (1.50e-2)" "prognostic favorable (8.56e-4)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (3.31e-3)" "unprognostic (5.35e-2)" "unprognostic (2.44e-1)" "prognostic favorable (6.38e-14)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" 8.1 7.9 5.0 3.7 6.3 5.7 8.8 9.7 5.7 9.3 11.9 6.9 7.2 7.2 5.5 5.7 6.5 5.3 13.8 3.2 5.0 17.8 21.8 4.9 4.6 5.7 6.5 3.0 6.4 7.4 14.7 3.8 5.1 6.3 6.1 7.6 15.2 7.8 5.8 29.6 4.1 5.4 6.0 3.6 3.7 6.7 4.1 8.7 7.8 7.2 35.4 4.5 6.2 3.8 5.0 5.2 7.6 7.6 10.5 7.0 10.2 7.1 8.2 12.0 7.3 5.8 10.0 8.2 13.8 5.4 7.2 5.9 18.3 7.1 20.0 9.1 15.6 12.3 13.1 7.0 12.7 7.5 17.3 1.7 12.0 12.2 7.0 16.7 9.9 7.4 10.8 12.7 9.6 6.5 7.0 9.8 8.9 11.4 13.6 7.0 0.1 4.8 14.5 19.7 18.8 4.7 10.0 10.2 15.9 11.4 8.3 6.6 13.2 6.6 5.5 5.8 7.1 7.8 9.7 9.9 21.4 6.1 8.2 7.3 0.6 0.4 0.0 1.1 0.4 1.6 0.7 0.6 1.0 0.9 1.0 0.8 1.2 0.2 1.6 0.6 0.5 0.4 0.8 5.0 6.3 9.7 5.7 3.2 5.0 5.7 6.5 3.0 6.3 3.6 8.7 5.0 7.5 16.0 2.6 161.9 9.2 4.0 16.5 8.2 9.6 10.7 13.1 5.7 45.5 11.5 10.4 5.5 35.5 7.6 7.3 7.5 1.9 3.7 35.4 10.1 7.6 5.3 3.0 12.0 183.9 1.6 2.1 6.2 15.8 14.4 0.0 5.8 2.2 16.5 3.9 3.3 252.6 7.8 4.1 3.8 4.0 14.2 5.9 11.5 5.4 69.3 4.1 4.9 4.1 151.3 146.1 4.0 9.3 5.3 18.2 16.0 9.4 8.2 6.7 42.6 0.0 7.6 8.9 5.5 4.8 12.5 2.8 2.9 10.4 8.5 9.4 11.9 DGKH DGKeta ENSG00000102780 "Diacylglycerol kinase eta" Q86XP1 13 42040036-42256578 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell type enhanced" "Detected in all" "Prostatic glandular cells: 137.8;Urothelial cells: 147.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039533, HPA040355, HPA061538" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: " "unprognostic (2.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.55e-3)" "unprognostic (7.62e-2)" "unprognostic (1.04e-2)" "unprognostic (9.60e-2)" "unprognostic (7.00e-3)" "unprognostic (4.37e-2)" "unprognostic (1.86e-1)" "unprognostic (2.41e-1)" "unprognostic (3.43e-3)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (1.43e-2)" 3.7 1.3 4.3 2.0 22.3 1.3 3.6 9.5 5.8 4.4 0.5 3.7 1.5 6.5 7.0 4.1 4.3 2.5 2.9 6.9 4.5 3.1 1.0 7.8 2.2 4.1 8.1 4.4 2.9 1.1 0.7 2.6 4.5 8.8 2.8 3.4 2.6 3.0 2.2 1.5 3.2 2.7 4.1 0.1 1.7 2.6 2.3 8.8 2.7 2.5 2.2 1.3 5.3 4.7 3.6 5.6 6.6 4.3 3.6 1.9 4.2 0.5 3.4 2.7 2.2 2.8 0.6 4.7 4.3 4.1 3.7 8.3 11.8 3.8 7.7 3.3 3.4 12.4 7.6 3.6 0.4 2.4 3.3 2.0 1.6 7.7 4.3 17.0 3.4 9.9 5.3 3.0 2.9 3.8 5.1 3.4 1.7 1.9 5.2 4.3 5.0 3.8 2.9 7.4 16.7 2.5 2.6 3.1 4.0 3.0 1.8 3.4 8.9 9.8 4.1 3.8 4.5 4.7 1.5 1.5 4.8 2.4 2.9 3.1 0.6 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.4 0.0 0.2 0.2 0.4 0.9 0.1 0.1 0.3 0.3 0.1 4.3 22.3 9.5 5.8 6.9 4.5 4.1 8.1 4.4 8.8 0.1 8.8 3.6 64.8 22.4 20.1 8.8 1.9 61.7 58.1 61.1 15.9 44.5 13.6 8.9 8.5 24.3 44.7 11.0 4.2 3.7 2.2 29.0 1.9 11.3 25.9 64.1 26.0 50.8 47.4 2.7 85.4 7.2 2.2 17.5 15.3 46.2 7.6 5.7 23.2 3.2 6.8 1.7 60.2 18.7 14.2 5.6 43.1 20.1 3.4 8.0 8.8 56.2 8.6 18.8 1.0 54.3 11.0 27.6 19.2 9.1 6.2 137.8 13.1 8.4 91.8 2.6 26.3 16.2 54.1 3.8 3.8 19.7 33.1 2.9 13.0 11.5 22.0 147.3 KATNAL1 MGC2599 ENSG00000102781 "Katanin catalytic subunit A1 like 1" Q9BW62 13 30202630-30307551 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 144.3;Excitatory neurons: 80.6;Oligodendrocytes: 78.5;Spermatocytes: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 63.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046205 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046205: AB_10965325" "unprognostic (3.34e-1)" "unprognostic (6.44e-3)" "unprognostic (2.08e-2)" "unprognostic (6.91e-2)" "unprognostic (2.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.57e-2)" "unprognostic (2.84e-2)" "unprognostic (3.43e-1)" "unprognostic (4.68e-3)" "unprognostic (4.54e-2)" "unprognostic (2.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.41e-2)" "unprognostic (6.42e-2)" "unprognostic (5.12e-2)" "unprognostic (1.83e-3)" 8.8 3.9 7.9 5.0 9.5 6.5 4.8 8.4 10.0 9.7 0.1 6.5 1.4 9.4 2.7 5.8 4.9 3.9 18.1 8.1 10.4 4.1 3.9 5.0 6.6 7.5 7.4 6.8 4.3 1.9 2.2 3.0 3.0 8.9 4.6 4.1 7.9 2.2 5.9 5.1 2.6 2.8 15.1 9.0 3.4 2.8 21.0 8.9 9.3 3.0 6.7 7.1 5.0 5.3 12.5 11.7 9.6 16.5 8.8 12.3 26.0 0.4 47.5 15.2 24.9 19.4 1.9 11.6 18.8 5.5 63.7 31.3 3.2 11.8 12.2 37.5 16.3 4.4 13.4 11.2 4.4 6.5 6.7 8.7 10.1 6.0 28.0 6.8 23.3 26.4 10.2 7.3 8.1 30.8 2.4 15.2 6.1 7.1 0.2 6.1 16.8 19.4 1.9 8.8 0.8 6.8 14.3 12.6 2.6 9.0 13.6 4.1 4.1 24.2 21.8 32.7 12.1 19.3 4.2 8.2 25.8 8.7 6.5 32.1 1.5 0.7 2.9 4.4 0.4 2.1 1.9 3.4 4.4 1.9 4.5 0.8 1.8 0.2 7.7 0.9 5.5 5.8 1.2 7.9 9.5 8.4 10.0 8.1 10.4 7.5 7.4 6.8 8.9 9.0 8.9 12.5 12.9 9.6 1.8 30.3 7.2 5.9 3.9 4.7 6.2 10.2 4.0 5.6 41.4 2.8 2.3 5.5 27.1 0.4 6.6 0.3 3.9 6.5 144.3 10.3 26.5 9.3 10.2 16.4 80.6 1.5 0.8 12.3 1.5 3.6 10.1 10.3 7.9 10.6 2.9 21.9 34.5 1.0 0.0 2.8 8.9 50.7 9.0 5.9 17.8 21.5 21.9 9.6 13.4 29.1 78.5 5.7 0.0 5.3 6.4 1.9 0.3 8.4 14.7 18.7 6.6 11.9 13.7 59.0 24.6 5.2 5.7 0.3 9.8 19.2 0.7 1.7 INTS6 "DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2" ENSG00000102786 "Integrator complex subunit 6" Q9UL03 13 51354077-51454264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 374.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA001846" Supported Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA001552: AB_1078659, HPA001846: AB_1847669" "unprognostic (1.99e-1)" "unprognostic (4.81e-2)" "unprognostic (3.58e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.19e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (3.32e-2)" "unprognostic (3.18e-2)" "unprognostic (2.80e-1)" "unprognostic (5.83e-2)" "unprognostic (2.36e-1)" "unprognostic (6.26e-2)" 14.1 14.9 8.5 16.8 9.6 15.1 12.0 18.8 10.8 12.9 11.5 12.2 11.3 14.9 11.7 19.9 10.6 14.1 14.1 9.5 12.2 13.0 28.5 10.1 21.0 9.5 10.3 9.0 13.9 38.2 16.0 9.5 14.9 10.8 10.8 11.0 19.0 11.6 9.8 8.4 15.4 13.2 13.5 9.1 15.3 15.6 62.7 8.5 20.9 15.9 16.9 17.4 16.1 11.8 19.1 17.6 13.8 32.8 17.2 17.2 40.6 17.8 36.3 33.5 35.9 25.1 16.2 46.9 20.3 8.5 26.3 22.7 31.0 45.2 20.0 50.6 39.3 12.6 38.7 21.9 19.1 41.6 43.4 33.6 25.3 36.5 33.7 50.7 46.1 31.3 25.5 24.1 30.2 35.9 13.3 26.9 26.8 23.5 51.6 12.4 20.2 23.4 20.3 26.8 11.6 18.2 18.0 36.5 30.2 24.3 24.2 15.4 41.5 17.7 22.1 15.2 23.6 20.8 26.5 21.7 33.0 18.2 22.7 39.2 8.0 2.0 3.2 5.9 1.3 6.7 3.9 4.0 5.0 2.1 4.0 5.6 6.5 5.5 5.0 1.5 4.6 5.0 2.4 8.5 9.6 18.8 10.8 9.5 12.2 9.5 10.3 9.0 10.8 9.1 8.5 19.1 241.6 25.6 49.5 75.4 121.4 76.3 68.7 12.0 162.8 58.3 157.5 215.6 78.4 47.1 18.3 22.0 118.9 81.4 164.8 107.2 15.6 23.4 94.3 48.4 67.4 94.5 76.0 29.5 82.2 26.3 47.5 127.4 61.7 64.5 48.2 71.4 57.8 37.3 34.8 45.4 66.7 94.8 12.2 44.2 60.1 81.3 44.1 97.5 23.2 78.7 33.3 55.9 53.5 94.0 118.9 25.9 59.7 31.6 90.9 53.7 77.1 11.9 12.9 74.9 26.3 374.7 119.4 122.4 40.5 161.3 72.5 73.7 137.8 66.5 90.3 68.0 ACOD1 "CAD, IRG1" ENSG00000102794 "Aconitate decarboxylase 1" A6NK06 13 76948511-76958638 "Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA040143 Uncertain NA NA "HPA040143: AB_10793916" "unprognostic (2.39e-1)" "unprognostic (6.42e-2)" "unprognostic (2.37e-1)" "unprognostic (3.54e-2)" "unprognostic (3.09e-1)" "unprognostic (8.30e-2)" "unprognostic (4.30e-2)" "unprognostic (1.64e-5)" "unprognostic (7.70e-2)" "unprognostic (3.68e-2)" "unprognostic (6.51e-3)" 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804162 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pancreas: 67.4" "Cell type enhanced" "Detected in many" "Late spermatids: 69.1;Proximal tubular cells: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB034238, HPA057028, HPA058315" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 19.9 10.7 7.6 2.9 7.0 4.6 20.7 8.5 7.9 13.4 6.0 12.8 5.5 13.2 5.0 10.4 14.6 6.2 14.0 7.3 7.1 24.6 29.1 11.8 5.4 8.5 6.0 5.8 18.5 67.4 6.6 18.9 3.7 7.8 15.5 3.7 6.0 15.1 6.0 16.2 14.2 12.6 4.0 7.4 15.8 15.1 8.3 6.6 2.3 18.9 4.2 3.5 13.3 11.3 8.1 1.1 2.5 3.8 5.6 1.2 2.6 4.4 1.6 4.1 1.8 1.3 4.5 8.6 4.2 1.2 2.5 2.5 2.0 0.0 0.3 0.3 4.2 3.4 0.6 1.1 3.2 6.6 0.4 0.7 2.7 3.9 0.6 2.4 4.5 5.2 4.0 2.0 3.0 1.3 5.5 1.0 3.5 6.1 4.2 0.6 0.5 0.8 5.8 5.6 3.2 3.4 6.9 2.9 2.5 7.1 5.0 2.8 2.8 3.7 1.3 1.5 0.1 1.7 1.4 1.8 1.9 2.3 1.4 3.7 6.6 16.6 0.5 14.0 14.2 24.1 13.7 19.7 16.9 9.0 13.4 16.4 12.9 31.4 3.8 16.5 10.6 19.8 13.5 7.6 7.0 8.5 7.9 7.3 7.1 8.5 6.0 5.8 7.8 7.4 6.6 8.1 14.1 12.8 14.8 11.1 11.4 11.3 12.1 22.2 10.8 11.9 23.5 22.9 15.7 18.6 13.3 16.5 8.4 24.9 8.0 7.8 52.8 12.5 26.1 5.6 7.7 10.1 10.3 2.1 4.9 16.7 17.5 17.1 7.1 6.4 12.0 6.8 8.6 30.7 17.1 3.3 5.4 12.4 22.4 11.2 11.6 69.1 11.1 10.1 14.2 3.7 10.5 32.4 8.2 24.6 12.9 12.6 21.9 9.8 4.8 12.2 25.5 83.5 19.5 18.5 0.0 14.2 11.4 1.4 8.2 10.5 14.9 23.8 13.7 13.4 11.0 12.2 MEDAG "AWMS3, C13orf33, FLJ14834, MEDA-4" ENSG00000102802 "Mesenteric estrogen dependent adipogenesis" Q5VYS4 13 30906271-30925572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 132.8" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 80.2;Fibroblasts: 122.4;Skeletal myocytes: 80.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 312.4;ASC TERT1: 87.4;U-2197: 175.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.44e-2)" "unprognostic (3.42e-2)" "unprognostic (6.06e-3)" "unprognostic (8.80e-2)" "unprognostic (1.07e-1)" "unprognostic (3.71e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (8.69e-3)" "unprognostic (2.48e-1)" "unprognostic (5.41e-3)" "unprognostic (7.52e-2)" 132.8 4.0 0.6 16.0 0.7 0.3 57.5 0.5 1.4 17.4 5.0 13.9 2.5 28.3 27.1 8.4 36.7 15.2 23.9 0.6 1.7 3.5 0.8 16.2 1.5 1.2 1.1 0.8 11.9 14.3 0.8 6.2 6.8 0.7 7.6 6.5 0.1 15.6 2.5 14.9 19.8 11.6 23.6 0.7 0.4 15.5 7.0 1.0 1.9 27.1 6.2 0.8 67.1 10.1 0.8 0.0 0.0 0.0 0.0 312.4 87.4 0.0 0.6 0.1 1.3 1.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 0.5 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.1 37.1 0.0 45.9 0.0 0.2 42.7 0.0 0.0 0.0 4.2 0.0 0.0 0.2 4.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 6.6 0.0 0.0 0.3 0.0 6.0 0.1 0.0 46.9 0.0 0.2 175.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 1.4 0.6 1.7 1.2 1.1 0.8 0.7 0.7 1.0 0.8 12.0 0.0 0.5 0.3 0.0 11.5 0.2 0.1 0.0 0.0 0.1 0.3 4.5 5.7 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 1.1 2.0 80.2 13.9 0.0 0.0 0.4 0.0 0.5 122.4 2.0 1.7 0.0 0.0 2.2 0.0 1.0 0.0 0.3 0.0 0.0 0.0 20.6 2.2 19.0 1.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 9.8 0.1 1.7 0.0 0.2 0.7 0.0 0.0 80.4 19.6 0.0 0.0 0.7 10.4 0.3 1.1 5.3 0.0 0.6 TSC22D1 "MGC17597, TGFB1I4, TSC22" ENSG00000102804 "TSC22 domain family member 1" Q15714 13 44432143-44577147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 44.7" "Group enriched" "Detected in all" 5 "dendritic cells: 17.9;granulocytes: 44.7;NK-cells: 16.7" "Cell line enhanced" "Detected in many" "HEL: 247.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077414 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA077414: AB_2686839" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (5.22e-2)" "unprognostic (4.78e-3)" "unprognostic (6.30e-2)" "unprognostic (2.04e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (4.24e-2)" "unprognostic (9.08e-2)" "prognostic favorable (4.54e-4)" "unprognostic (8.14e-2)" "unprognostic (6.52e-2)" "unprognostic (1.83e-2)" "unprognostic (4.48e-2)" 125.4 89.6 255.2 59.4 266.5 16.6 144.3 214.5 298.2 163.7 263.1 129.0 65.5 160.9 139.7 108.5 153.4 116.7 116.9 263.0 412.4 110.1 87.6 121.3 38.9 242.8 253.8 257.3 181.6 35.7 115.0 111.2 88.8 260.8 183.0 110.1 74.3 76.7 85.5 192.3 65.2 119.2 148.8 226.9 26.9 115.9 62.3 250.9 170.1 89.1 126.8 41.7 139.5 88.0 242.3 21.7 67.7 62.1 24.6 36.3 45.7 75.5 22.4 93.9 23.1 25.8 77.1 74.9 35.4 48.6 47.9 52.6 53.8 25.1 191.2 33.4 6.5 22.2 247.3 116.9 23.4 36.1 12.8 30.1 65.0 80.2 65.6 162.0 184.8 55.6 18.6 6.9 0.2 45.5 21.0 44.9 10.3 45.3 148.8 61.6 31.1 11.6 10.6 47.7 35.5 33.5 45.3 64.3 61.8 18.6 65.1 30.8 19.5 49.6 26.4 25.8 59.1 34.9 0.6 6.6 10.2 70.0 10.6 65.7 44.7 1.9 5.8 4.6 1.9 4.4 1.3 1.4 2.1 1.8 2.0 1.5 2.2 8.6 16.7 5.1 17.9 3.4 50.0 255.2 266.5 214.5 298.2 263.0 412.4 242.8 253.8 257.3 260.8 226.9 250.9 242.3 739.9 118.6 368.2 77.7 21.4 441.9 415.0 905.0 870.2 147.8 464.9 296.5 279.9 97.2 425.3 435.9 114.7 584.7 34.9 660.8 369.8 190.8 851.5 186.0 105.0 643.0 225.0 118.9 302.4 157.0 177.2 234.3 211.0 313.8 314.2 108.2 88.9 74.5 106.5 127.9 261.0 254.0 526.9 21.1 153.3 1231.0 91.6 218.4 402.0 148.0 16.2 246.2 26.8 207.1 103.8 229.5 339.6 136.5 17.2 550.9 212.0 155.1 265.8 149.9 447.0 268.2 500.9 80.9 34.6 178.2 610.0 1170.1 65.0 80.6 273.6 445.8 CLN5 ENSG00000102805 "CLN5 intracellular trafficking protein" O75503 13 76990660-77019143 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041788 Approved "Intracellular and membrane" NA NA 470000 "HPA041788: AB_10962726" "unprognostic (1.19e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (9.82e-2)" "unprognostic (2.07e-3)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (2.29e-1)" "unprognostic (2.90e-1)" "unprognostic (6.98e-2)" "unprognostic (2.65e-1)" "prognostic favorable (1.52e-9)" "unprognostic (2.35e-1)" "unprognostic (7.04e-2)" "unprognostic (5.64e-2)" "unprognostic (8.15e-2)" 21.1 20.0 14.5 14.5 14.1 13.5 22.1 28.1 20.5 25.3 14.8 16.3 11.4 19.3 42.2 11.0 24.7 25.4 14.3 14.7 8.8 50.9 35.8 20.6 20.0 14.2 12.7 12.3 26.8 17.0 46.0 14.5 23.5 15.5 22.5 16.6 24.3 21.6 22.9 8.5 14.7 13.7 16.0 8.8 16.8 19.0 16.3 13.1 18.4 73.5 10.8 18.6 18.9 12.1 21.6 25.0 11.7 16.4 13.7 74.4 48.5 21.1 23.7 43.3 18.4 31.9 12.3 23.2 9.7 17.3 33.5 21.0 25.0 11.5 25.5 20.0 18.4 21.5 13.9 13.1 12.2 33.8 19.5 20.4 43.6 28.4 8.9 18.7 37.1 33.0 13.5 9.4 17.2 43.2 7.7 11.6 12.5 10.7 48.6 10.4 9.5 14.4 9.0 42.6 13.8 7.3 11.3 14.1 17.4 26.3 21.3 19.0 26.0 31.2 13.2 10.4 15.4 14.2 21.7 30.0 12.2 35.4 13.5 29.2 58.4 15.6 39.4 3.5 22.4 3.1 13.2 17.0 6.0 10.8 14.5 21.5 13.3 11.4 1.0 27.7 11.0 25.6 14.1 14.5 14.1 28.1 20.5 14.7 8.8 14.2 12.7 12.3 15.5 8.8 13.1 21.6 30.5 16.0 32.4 16.6 29.2 11.5 32.5 75.1 17.1 19.8 22.3 20.2 8.7 25.8 59.2 68.0 10.4 53.2 15.2 24.0 9.8 39.3 1.6 26.6 25.0 24.1 13.8 7.8 9.7 38.4 128.5 36.9 13.3 24.8 22.2 23.5 25.7 33.0 48.1 6.7 12.6 13.6 97.6 22.4 16.7 4.5 49.7 22.7 24.9 11.2 31.5 50.4 5.2 15.6 21.5 25.0 14.4 47.4 18.8 23.1 23.9 44.1 48.2 25.4 19.7 24.4 27.2 25.8 34.7 14.6 11.5 46.4 15.2 34.0 11.4 21.8 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028813-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1307.0;pancreas: 677.1" "Cell type enhanced" "Detected in many" "Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted to digestive system" Yes NA 9300 "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: AB_2732358" "prognostic favorable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 1.9 0.1 0.3 197.1 0.6 127.1 6.8 0.2 0.5 4.2 0.2 455.9 1222.9 5.6 3.5 0.8 8.4 10.5 0.7 0.3 0.4 26.3 0.9 3.8 1.4 0.2 0.3 0.3 0.2 677.1 0.0 0.5 0.6 0.3 93.1 574.7 0.4 16.3 0.9 0.6 0.4 1307.0 53.0 0.2 18.2 16.2 0.3 0.2 4.2 0.4 2.2 0.2 128.1 288.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 5.4 2.4 18.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 26.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 10.4 0.0 0.0 0.8 6.2 0.2 0.0 1.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.6 0.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.2 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.3 3.8 0.1 168.5 0.3 0.0 0.0 9.8 2.5 0.5 0.0 11.9 139.8 0.0 0.0 0.0 98.7 1.9 497.1 0.2 13.5 0.5 1.4 92.3 0.8 1.0 900.9 0.0 1.5 0.0 17.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 791.9 2.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 10.3 4.0 0.0 0.0 0.2 933.7 556.9 0.0 0.4 209.4 300.6 0.0 0.5 0.2 0.0 2.1 9.2 0.0 0.1 0.0 0.0 0.0 3.1 0.2 2419.9 1989.0 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760734-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 280.6;lung: 72.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 39 "dendritic cells: 5.9;monocytes: 1.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "spinal cord: 1.7" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 17000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favorable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 42.4 0.2 0.7 1.1 0.9 3.2 0.5 0.5 1.2 16.0 0.3 9.0 7.1 6.3 24.3 7.2 280.6 16.5 4.5 0.6 1.2 6.4 0.2 72.4 0.2 1.8 0.9 0.7 3.7 0.9 0.1 0.7 2.7 1.3 3.8 4.0 0.7 39.6 9.9 0.0 1.3 2.9 3.4 0.8 0.4 13.1 1.1 0.9 0.8 0.2 0.0 27.5 3.0 2.9 1.5 0.4 2.1 0.0 1.0 0.0 0.0 2.3 0.3 7.7 8.7 2.0 7.4 513.4 0.0 77.4 0.7 0.1 1.3 0.0 0.7 0.7 0.2 0.3 0.0 173.4 5.9 4.4 0.2 0.1 0.0 111.5 0.0 2.0 7.8 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.1 0.6 96.4 0.8 0.2 0.2 0.6 2.4 0.1 0.1 0.0 29.7 0.1 0.0 0.1 0.7 0.0 0.0 0.4 12.1 0.1 0.0 0.3 0.3 0.4 0.0 0.0 0.6 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.3 0.7 0.9 0.5 1.2 0.6 1.2 1.8 0.9 0.7 1.3 0.8 0.9 1.5 0.0 189.1 85.6 0.0 0.0 0.3 3.0 49.0 0.0 1.4 0.3 0.3 1.6 52.9 121.9 25.8 0.0 0.2 0.0 4.1 0.0 9.3 1.6 35.8 3.3 0.7 3.0 0.0 0.0 0.9 0.0 4.6 0.0 57.1 0.0 0.0 0.4 0.1 2.9 0.0 0.0 1.6 22.4 1.0 1.9 7.4 4.7 3.7 1.8 1.0 4.4 0.0 0.0 0.0 0.0 33.0 214.4 0.0 1.4 3.3 1.7 0.1 54.2 0.6 0.0 0.0 2.8 0.6 0.7 0.5 0.1 0.1 1.3 0.0 3.1 50.8 MGRN1 "KIAA0544, RNF156" ENSG00000102858 "Mahogunin ring finger 1" O60291 16 4616493-4690974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 16.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007653, HPA008033" Approved Supported "Endoplasmic reticulum,Vesicles" NA NA Vesicles "Endoplasmic reticulum" "HPA007653: AB_1846304, HPA008033: " "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (4.24e-1)" "unprognostic (1.26e-2)" "unprognostic (9.96e-2)" "unprognostic (1.70e-1)" "unprognostic (4.03e-2)" "unprognostic (9.47e-2)" "unprognostic (6.41e-2)" "unprognostic (2.32e-1)" "unprognostic (9.06e-2)" "unprognostic (1.79e-1)" "unprognostic (5.04e-2)" 23.4 34.6 14.2 25.3 12.6 32.9 23.0 7.0 25.6 26.8 1.4 30.1 29.1 37.2 6.9 20.6 32.4 19.9 27.0 22.1 7.7 24.1 53.9 30.6 18.2 10.1 6.4 15.7 30.8 34.9 18.7 33.5 18.7 13.2 30.3 11.0 9.0 25.8 20.7 52.5 22.3 30.1 17.6 3.2 38.0 35.6 18.2 6.0 11.8 29.0 16.9 11.0 28.5 20.7 20.1 13.6 63.9 32.4 33.2 19.0 18.4 44.0 28.7 20.0 23.6 20.0 42.5 31.4 40.0 36.2 35.0 17.6 21.4 26.0 23.6 7.0 56.0 28.8 22.0 45.2 59.6 34.7 32.1 52.3 34.2 15.0 33.0 14.1 17.0 23.0 26.0 32.7 28.6 16.4 59.7 33.3 42.9 48.0 19.2 27.4 60.7 17.0 54.3 20.8 39.3 51.8 42.8 47.6 50.6 28.2 14.8 30.7 31.4 40.8 43.7 24.1 124.3 25.0 44.6 37.8 27.2 18.6 31.8 32.0 5.4 3.5 3.8 2.5 3.9 2.3 1.3 1.4 2.3 2.4 1.5 3.2 1.9 16.2 1.4 2.6 4.1 1.7 3.7 14.2 12.6 7.0 25.6 22.1 7.7 10.1 6.4 15.7 13.2 3.2 6.0 20.1 14.7 25.6 34.0 24.2 22.2 9.2 29.5 10.0 6.2 27.3 15.8 11.0 11.4 22.8 9.6 18.4 43.8 23.5 28.2 27.7 5.9 18.6 16.2 20.1 24.2 16.9 37.0 13.7 26.6 22.7 17.7 19.0 44.9 24.5 14.0 30.4 15.0 34.8 30.4 25.2 25.0 23.5 4.1 30.1 21.4 27.2 26.8 27.0 21.4 8.4 36.5 20.8 23.7 18.6 29.8 32.0 15.8 24.8 29.0 23.7 31.7 13.9 11.1 35.2 0.0 20.4 17.6 9.3 12.5 11.9 16.3 34.2 24.0 29.8 23.1 27.8 ZNF629 "KIAA0326, ZNF65" ENSG00000102870 "Zinc finger protein 629" Q9UEG4 16 30778456-30787205 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019550, HPA056051" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA019550: AB_1859386, HPA056051: AB_2683020" "unprognostic (1.03e-2)" "unprognostic (2.15e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (3.17e-1)" "unprognostic (6.38e-2)" "unprognostic (6.14e-2)" "unprognostic (2.98e-2)" "unprognostic (3.15e-1)" "unprognostic (6.24e-2)" "unprognostic (4.87e-3)" "unprognostic (2.66e-2)" "prognostic favorable (4.57e-10)" "unprognostic (8.41e-2)" "unprognostic (1.96e-1)" "unprognostic (5.71e-2)" "unprognostic (9.70e-2)" 5.3 9.0 5.6 3.0 5.8 4.2 5.7 7.2 6.0 6.0 4.0 6.6 5.6 8.1 4.3 5.1 6.7 3.6 12.2 6.0 5.9 6.1 4.4 5.4 1.9 6.3 6.8 4.5 6.8 6.0 15.2 6.7 3.7 6.8 6.4 4.6 7.9 6.6 6.1 9.7 8.0 5.4 6.9 5.1 4.0 7.4 4.1 6.7 3.9 5.9 9.7 2.3 6.6 5.1 5.5 9.8 15.8 23.9 18.5 11.5 10.6 3.6 10.8 15.6 16.6 14.0 9.7 8.8 1.8 10.2 17.6 5.2 11.4 11.7 14.3 11.0 0.4 17.6 13.6 14.0 10.2 12.3 4.8 8.0 17.7 10.5 10.3 8.6 13.0 8.9 0.8 20.2 0.4 14.6 20.8 7.2 6.3 12.6 4.7 6.4 24.3 18.4 0.8 13.9 15.9 22.6 25.3 10.5 19.4 2.6 7.8 14.6 17.4 10.8 15.5 10.1 10.6 8.3 0.3 0.1 0.5 10.2 11.9 5.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.3 0.1 0.6 0.0 0.1 5.6 5.8 7.2 6.0 6.0 5.9 6.3 6.8 4.5 6.8 5.1 6.7 5.5 4.9 19.2 9.4 5.9 2.6 1.9 3.4 4.3 5.7 16.7 4.2 3.4 28.3 4.3 6.5 9.2 4.2 1.3 1.6 5.4 1.9 8.7 1.7 5.1 9.5 8.0 11.5 4.6 2.4 8.0 0.6 5.3 7.1 5.3 2.5 10.7 8.2 4.7 4.4 16.8 3.7 7.9 6.1 5.2 3.0 4.7 9.3 2.6 1.8 1.0 7.7 13.4 1.0 4.5 3.4 10.9 5.0 4.5 3.0 4.8 5.1 4.3 5.9 12.4 0.0 6.7 5.6 4.6 1.5 3.8 1.8 0.5 1.4 8.3 9.0 3.8 TRADD Hs.89862 ENSG00000102871 "TNFRSF1A associated via death domain" Q15628 16 67154185-67159909 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 163.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004602, HPA071341" Enhanced Approved Cytosol NA NA Cytosol "CAB004602: AB_2209061, HPA071341: AB_2732178" "unprognostic (2.66e-1)" "unprognostic (3.11e-1)" "unprognostic (2.23e-2)" "prognostic favorable (1.40e-4)" "unprognostic (1.50e-2)" "unprognostic (1.21e-1)" "unprognostic (5.68e-2)" "unprognostic (4.96e-2)" "unprognostic (4.15e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (8.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (1.83e-1)" 15.5 19.6 9.9 12.9 10.1 4.9 15.7 10.8 10.3 17.7 10.7 15.3 8.5 14.3 3.7 27.1 16.7 4.1 11.3 9.5 10.5 22.2 18.6 17.8 12.5 13.1 10.3 8.3 10.6 18.0 7.1 12.2 6.7 12.6 21.4 5.7 1.1 24.0 6.2 6.3 22.0 19.3 4.9 11.4 30.1 19.2 5.1 9.7 7.5 18.3 2.1 10.7 18.4 18.0 11.8 17.3 14.0 0.2 4.8 12.6 10.0 16.8 12.6 9.5 6.0 9.3 8.2 13.0 9.0 21.8 11.0 12.6 29.0 2.0 11.4 4.9 26.1 12.8 5.7 6.4 9.0 15.7 7.3 13.7 10.5 16.0 8.0 3.1 15.3 11.8 8.7 8.4 13.1 9.1 15.5 8.8 14.5 0.2 16.0 42.2 17.1 6.6 36.4 10.4 10.9 2.2 8.1 28.6 6.4 9.0 4.7 11.0 10.3 13.2 7.5 8.2 13.3 9.5 26.3 9.4 10.6 19.9 6.5 9.4 51.9 42.4 95.1 54.4 56.2 84.2 72.0 166.0 96.2 54.2 71.8 46.7 38.5 75.7 40.7 78.6 76.4 82.1 49.5 9.9 10.1 10.8 10.3 9.5 10.5 13.1 10.3 8.3 12.6 11.4 9.7 11.8 24.0 3.2 8.6 3.9 37.7 17.3 22.9 60.2 12.5 0.9 29.8 25.0 3.5 30.0 32.8 5.5 0.0 32.0 47.9 24.9 31.3 70.0 1.4 31.0 18.1 20.5 19.2 9.9 1.8 38.1 41.5 22.3 44.9 27.6 8.9 25.9 17.2 19.2 47.0 0.0 2.4 28.2 38.7 37.7 35.0 2.9 30.1 28.6 56.9 0.0 163.4 5.0 48.4 1.0 8.3 62.0 35.7 30.5 52.5 57.7 28.1 80.3 40.7 2.1 26.3 16.0 21.9 2.2 7.6 29.7 25.7 30.5 46.7 23.3 23.8 42.1 HSF4 CTM ENSG00000102878 "Heat shock transcription factor 4" Q9ULV5 16 67164681-67169945 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.7" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Excitatory neurons: 30.9;Horizontal cells: 43.7;Inhibitory neurons: 30.0;Leydig cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 17.1;T-47d: 12.9;U-266/70: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048584 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA048584: AB_2680452" "unprognostic (1.90e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (9.20e-3)" "unprognostic (2.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.06e-2)" "unprognostic (2.45e-1)" "unprognostic (2.85e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (2.19e-6)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (8.74e-3)" 10.3 23.9 37.5 1.3 38.4 1.8 12.8 38.3 69.7 17.0 33.5 9.9 4.8 12.5 4.9 11.1 21.3 3.7 17.5 38.6 36.9 17.0 20.5 8.8 1.6 39.6 37.5 38.6 20.0 36.2 4.3 30.4 3.3 40.3 28.5 1.8 5.6 19.1 1.9 26.1 13.4 6.2 2.2 35.5 6.1 14.6 7.0 37.8 1.1 18.1 4.1 1.1 19.0 11.0 39.4 1.6 1.1 0.0 1.1 0.5 3.0 5.2 0.5 0.6 0.2 0.0 2.4 3.5 0.1 2.5 1.1 0.7 5.9 0.4 0.7 0.2 2.3 2.2 0.6 4.5 3.1 2.3 0.3 4.4 1.3 4.8 0.2 2.5 17.1 0.9 4.0 1.5 5.1 2.3 1.5 0.8 1.8 0.1 3.4 3.2 2.0 1.7 8.7 4.4 2.5 3.5 7.6 4.9 3.0 7.8 2.1 12.9 4.5 0.9 1.6 1.6 6.4 1.5 22.3 3.7 1.5 4.9 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.5 38.4 38.3 69.7 38.6 36.9 39.6 37.5 38.6 40.3 35.5 37.8 39.4 2.6 3.2 7.7 38.5 1.1 3.1 3.4 2.9 4.6 10.8 9.1 7.7 5.3 4.3 2.7 3.7 2.1 1.0 0.7 2.9 0.0 1.0 0.5 4.1 2.8 1.6 1.2 0.0 30.9 1.3 0.6 6.0 14.8 7.0 1.3 2.3 2.9 5.7 21.9 43.7 30.0 3.0 2.0 0.8 2.5 1.8 32.9 4.6 10.6 5.6 1.5 8.8 0.0 4.0 15.2 1.4 3.5 22.2 1.5 4.0 0.4 2.4 4.8 11.4 0.0 5.4 3.2 0.4 2.3 3.6 3.4 0.7 0.9 1.9 2.9 2.0 CORO1A "coronin-1, HCORO1, p57" ENSG00000102879 "Coronin 1A" P31146 16 30182827-30189076 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 573.9;lymphoid tissue: 588.5" "Cell type enhanced" "Detected in many" "B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046473, HPA051132" Enhanced Approved Cytosol NA NA 45000000 Cytosol "CAB046473: AB_10602363, HPA051132: AB_2681355" "unprognostic (4.17e-3)" "unprognostic (3.64e-3)" "unprognostic (3.86e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.41e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.99e-2)" "unprognostic (8.27e-3)" "unprognostic (8.26e-3)" "unprognostic (4.30e-1)" "unprognostic (1.54e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.74e-7)" "unprognostic (2.55e-1)" "unprognostic (2.37e-2)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" 29.4 21.0 31.6 309.3 34.6 573.9 11.3 22.7 52.4 9.8 22.6 27.0 44.7 10.1 3.1 22.8 18.1 45.5 11.4 33.8 30.8 11.6 13.2 49.9 588.5 31.1 28.5 35.9 6.4 8.5 4.3 9.3 18.5 29.6 11.5 15.5 1.0 33.2 7.3 6.7 17.8 111.9 22.5 36.4 324.0 49.4 4.8 32.3 259.9 12.8 8.9 311.6 58.1 10.5 38.7 3.1 3.6 10.9 21.5 0.1 0.1 6.1 2.6 0.7 5.4 3.0 0.7 6.9 924.0 6.1 0.9 1.5 4.4 5.2 10.8 1.3 302.3 2.5 97.9 0.5 15.0 1.7 645.7 1086.7 2.8 0.0 4.3 0.5 0.4 2.0 603.0 1.5 467.6 3.4 80.7 632.5 771.8 4.0 3.1 6.4 340.0 17.5 980.9 1.3 5.1 17.3 13.0 2.2 110.7 2.0 0.2 1.9 373.0 1.6 4.0 9.0 2.7 3.1 348.5 497.7 618.2 3.0 829.6 6.3 797.2 773.6 2671.1 637.5 859.7 597.8 505.5 567.3 625.6 843.2 512.0 537.1 566.2 1318.9 531.0 898.0 482.1 858.7 1647.2 31.6 34.6 22.7 52.4 33.8 30.8 31.1 28.5 35.9 29.6 36.4 32.3 38.7 6.3 22.4 32.5 0.3 523.9 11.3 1.2 3.2 2.2 1.2 4.7 5.5 1.5 17.2 6.0 1.8 0.0 4.6 588.7 2.3 0.0 3.5 0.5 1.1 2.0 12.3 6.0 60.2 3.3 0.9 17.4 9.5 18.8 1.3 83.7 0.6 21.8 4.8 494.4 0.0 1.7 2.2 6.1 395.8 197.9 1.2 0.6 342.7 32.0 4.7 583.7 0.8 968.1 1.5 0.4 11.1 47.5 0.0 201.4 0.8 1.0 4.8 3.5 0.9 6.6 2.9 5.1 0.1 0.9 2.4 9.1 4.9 663.0 2.7 3.3 0.9 MAPK3 "ERK1, p44erk1, p44mapk, PRKM3" ENSG00000102882 "Mitogen-activated protein kinase 3" P27361 16 30114105-30123506 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 336.9;Early spermatids: 267.2;Proximal enterocytes: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 49.1;neutrophil: 21.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 49.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002683, HPA003995, HPA005700, HPA030069" Approved Supported Nucleoplasm NA NA 46000 Nucleoplasm "CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (5.03e-2)" "unprognostic (4.62e-2)" "unprognostic (3.46e-2)" "unprognostic (1.60e-1)" "unprognostic (4.70e-3)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.51e-2)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-2)" 100.3 64.9 172.1 42.8 157.1 45.6 87.0 107.5 202.5 85.1 84.0 118.4 104.0 75.6 27.7 130.6 72.2 65.8 64.6 156.1 131.1 49.5 21.3 71.9 38.2 130.3 126.7 150.3 79.4 34.0 61.7 56.2 70.8 126.7 49.7 92.8 72.2 61.5 43.7 52.1 72.2 114.1 59.3 119.0 57.8 87.2 31.8 125.9 31.7 58.5 57.5 49.7 65.4 89.7 126.2 56.3 30.0 62.2 35.7 153.7 202.4 35.1 40.7 101.1 63.4 75.3 36.4 110.0 56.3 39.7 115.5 73.2 20.6 53.3 47.8 61.0 106.9 61.8 17.3 31.6 61.8 154.2 13.0 46.2 125.8 27.3 72.5 32.2 96.1 163.7 60.3 24.3 70.0 85.2 147.1 59.2 21.5 16.9 113.6 26.1 68.9 37.3 127.4 58.0 35.0 55.2 39.3 23.2 81.8 24.1 50.5 53.5 30.7 117.2 41.7 35.4 48.4 14.5 79.1 39.3 29.6 83.3 27.1 30.0 6.2 5.1 49.1 1.6 3.7 2.6 2.3 3.7 3.0 2.8 2.5 2.6 2.9 21.5 2.2 2.0 2.8 6.6 2.8 172.1 157.1 107.5 202.5 156.1 131.1 130.3 126.7 150.3 126.7 119.0 125.9 126.2 95.5 22.4 17.5 7.5 10.7 9.8 22.2 11.4 5.7 30.4 23.3 19.9 15.4 20.0 13.0 9.2 22.9 77.6 15.2 336.9 23.5 39.8 267.2 24.8 25.1 68.1 54.7 6.1 7.7 61.2 134.2 34.7 79.0 15.7 2.5 19.1 71.7 7.0 45.2 8.4 10.3 159.3 22.4 26.4 12.3 176.0 32.3 20.6 23.2 7.5 24.5 67.0 13.4 7.1 9.8 118.8 167.2 27.4 6.2 13.5 235.6 23.9 24.7 41.5 19.7 18.8 29.3 10.9 19.8 15.8 13.2 33.8 14.5 40.0 94.9 22.4 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113537 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 46.0" "Cell type enriched" "Detected in many" 4 "Late spermatids: 447.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.4" "Cell line enhanced" "Detected in many" "Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 6.5 2.4 6.4 6.1 6.4 1.8 5.4 7.0 11.5 13.5 6.4 26.1 8.5 5.4 9.4 46.0 5.8 2.5 4.7 6.2 6.4 18.1 2.1 6.5 4.3 7.7 6.3 6.1 6.8 2.2 0.4 4.8 11.5 8.2 5.7 17.3 6.6 9.1 2.2 2.1 10.2 10.2 5.3 6.5 9.1 18.9 1.8 6.4 4.2 4.8 0.9 21.1 5.5 19.3 7.1 21.8 0.3 5.2 1.5 1.6 5.5 5.5 0.6 1.3 1.8 1.7 1.0 15.2 0.6 2.9 1.5 0.6 1.8 1.6 0.5 1.8 2.5 4.0 0.2 1.0 32.1 1.0 0.7 1.3 0.2 1.6 4.5 0.3 4.1 5.1 4.2 1.0 2.3 2.2 50.6 1.5 2.0 2.6 53.3 0.6 6.3 1.4 7.1 2.6 7.4 1.1 2.2 0.2 165.0 0.5 1.6 3.0 2.7 2.7 0.9 1.1 1.9 1.8 2.7 0.9 1.5 4.2 2.7 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.1 0.0 6.4 6.4 7.0 11.5 6.2 6.4 7.7 6.3 6.1 8.2 6.5 6.4 7.1 5.9 6.4 1.1 1.6 1.0 1.3 0.9 4.4 1.2 1.6 4.1 3.0 1.5 0.0 22.2 5.5 0.0 24.2 1.2 98.2 5.9 0.9 67.8 2.6 3.8 4.3 3.5 0.0 0.6 1.3 71.9 2.1 30.1 4.1 0.0 2.0 3.9 0.3 3.1 1.7 0.8 34.2 6.1 1.9 1.0 447.4 3.4 1.4 1.8 1.9 1.2 0.6 0.0 1.5 1.2 19.2 36.7 3.0 0.1 1.1 46.0 100.6 9.0 1.7 6.6 0.6 2.7 1.4 1.3 5.1 2.0 9.3 1.9 1.3 13.9 4.8 ELMO3 "CED-12, CED12, ELMO-3, FLJ13824" ENSG00000102890 "Engulfment and cell motility 3" Q96BJ8 16 67199111-67204029 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 63.9;Paneth cells: 50.3;Proximal enterocytes: 100.3;Undifferentiated cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.1;CAPAN-2: 49.3;HaCaT: 46.9;T-47d: 45.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021484 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA021484: AB_1848129" "unprognostic (4.49e-3)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (8.08e-2)" "unprognostic (1.39e-1)" "unprognostic (6.16e-3)" "unprognostic (3.14e-1)" "unprognostic (8.17e-3)" "unprognostic (1.73e-1)" "unprognostic (8.06e-2)" "unprognostic (3.40e-2)" "unprognostic (6.95e-3)" "prognostic favorable (2.77e-5)" "unprognostic (3.47e-1)" "unprognostic (2.66e-1)" "unprognostic (1.84e-1)" "unprognostic (1.97e-2)" 2.2 1.9 1.6 4.4 1.5 5.7 8.9 2.1 2.2 5.5 0.3 16.6 33.4 2.1 4.2 26.0 8.5 8.7 1.6 1.3 1.9 20.6 8.1 8.4 2.9 2.0 1.8 1.2 1.8 41.3 8.6 30.1 7.2 3.0 19.4 9.2 0.7 20.5 9.7 1.2 33.8 26.5 0.8 0.4 5.6 26.2 13.1 1.2 2.1 19.5 0.3 2.6 8.5 13.4 1.6 22.1 2.5 2.4 3.0 0.4 0.6 33.1 1.3 0.7 1.6 1.4 14.2 49.3 3.0 1.5 0.7 0.7 46.9 2.2 21.6 0.3 1.4 2.9 3.2 4.8 4.7 1.0 1.9 7.5 0.5 15.6 1.2 1.1 1.6 1.7 2.6 3.1 1.5 0.9 18.4 2.0 9.3 3.2 20.7 1.9 4.6 2.3 4.9 2.0 2.9 16.2 3.6 3.2 14.4 1.5 1.3 45.8 3.4 2.8 3.7 4.5 2.3 2.3 4.9 1.7 5.8 1.9 4.4 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 1.6 1.5 2.1 2.2 1.3 1.9 2.0 1.8 1.2 3.0 0.4 1.2 1.6 1.8 0.0 13.1 0.0 2.0 8.8 11.9 21.9 13.1 0.9 20.6 16.3 1.2 15.7 12.6 20.2 0.0 33.8 1.0 63.9 17.6 20.1 22.9 8.8 1.7 1.6 13.1 6.9 0.4 24.0 15.0 1.7 47.4 12.2 4.5 1.3 1.4 3.6 3.6 0.0 0.3 33.8 22.4 1.6 3.1 36.3 0.9 2.6 3.6 1.9 2.8 0.4 0.0 0.0 1.0 24.8 50.3 0.7 1.4 7.9 100.3 28.6 12.3 1.5 0.0 0.4 1.6 14.5 5.9 14.4 13.5 16.8 2.3 5.0 52.3 13.0 MT4 MTIV ENSG00000102891 "Metallothionein 4" P47944 16 56565073-56568957 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skin 1: 116.0" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 19.7" "Group enriched" "Detected in many" 6 "cervical cancer: 6.7;endometrial cancer: 11.6" "Region enriched" "Detected in single" 9 "cerebral cortex: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (8.81e-2)" 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.1 1.9 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 116.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 6.3 0.0 0.0 0.0 0.0 18.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.8 19.7 0.0 0.0 0.0 0.0 0.0 PHKB ENSG00000102893 "Phosphorylase kinase regulatory subunit beta" Q93100 16 47461123-47701523 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 160.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073380 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA073380: AB_2686598" "unprognostic (2.87e-3)" "unprognostic (2.41e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.98e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-2)" "unprognostic (6.73e-2)" "unprognostic (2.99e-2)" "unprognostic (2.35e-3)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (3.01e-2)" "prognostic favorable (3.89e-9)" "unprognostic (3.56e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.53e-2)" 30.0 42.8 13.9 22.1 15.6 28.5 36.5 17.6 19.6 34.0 29.4 39.4 38.2 27.1 33.1 34.8 25.8 30.9 33.0 12.9 19.7 47.6 30.3 30.2 26.4 15.0 15.2 11.9 24.4 26.8 57.2 21.8 37.4 17.6 36.5 41.9 19.1 46.5 32.5 160.5 19.0 38.3 32.4 11.5 29.3 40.7 30.9 18.0 31.2 54.6 81.4 29.2 26.8 21.3 16.1 36.7 53.3 60.3 39.1 41.2 38.8 74.9 42.8 41.2 30.1 15.0 29.4 62.2 44.5 63.5 62.7 23.7 50.6 57.0 66.9 42.3 13.8 29.8 42.1 45.4 98.3 37.0 46.2 47.7 35.1 33.4 20.3 38.2 65.4 59.8 53.5 58.8 27.4 43.7 26.3 45.2 44.1 25.5 61.1 39.8 75.7 73.3 74.3 59.2 31.1 31.5 35.8 70.9 92.4 12.0 66.1 36.0 37.7 66.5 54.4 25.4 28.0 22.9 31.1 24.6 57.2 34.5 30.2 22.7 11.1 21.0 18.4 11.8 18.9 15.3 30.6 12.2 9.7 20.6 34.7 11.8 11.7 10.4 18.5 23.7 13.9 15.8 12.6 13.9 15.6 17.6 19.6 12.9 19.7 15.0 15.2 11.9 17.6 11.5 18.0 16.1 49.3 19.2 38.0 66.9 46.8 8.9 17.5 28.8 18.8 34.9 28.7 23.4 61.2 32.9 39.9 42.3 100.1 48.5 29.3 43.1 23.5 19.6 64.7 33.5 31.1 42.9 30.5 40.1 109.8 15.6 26.3 28.8 47.9 38.3 18.3 52.6 39.3 30.9 28.4 23.5 149.0 37.8 20.3 58.7 17.0 89.8 25.4 45.1 8.8 104.0 72.2 25.8 32.0 133.2 118.4 27.2 26.4 35.7 28.1 30.2 48.9 35.9 26.7 71.8 26.3 33.3 30.6 53.9 19.5 47.2 7.2 33.8 24.7 74.9 38.6 26.7 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 188.1;Late spermatids: 464.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 154.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 154.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA059840: AB_2684137" "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favorable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favorable (9.50e-4)" 38.1 31.3 27.9 16.6 28.3 24.4 30.3 30.1 31.7 28.5 31.4 27.3 14.0 27.8 35.5 18.9 34.7 16.4 40.2 27.8 30.1 52.2 96.6 18.9 24.4 29.6 28.4 27.0 34.3 27.6 33.8 21.4 13.7 29.6 29.4 20.6 26.8 16.4 27.1 42.6 19.2 18.1 22.8 28.8 17.0 28.2 38.0 29.3 25.3 23.0 34.4 22.1 35.1 23.2 30.7 33.2 29.7 30.3 25.9 74.1 64.0 9.6 27.9 39.3 14.8 21.7 42.8 39.2 22.6 92.2 31.5 21.6 21.6 14.1 25.5 25.6 41.6 19.8 10.1 8.3 112.1 56.6 35.9 20.4 45.0 24.5 40.0 98.6 41.4 58.5 37.3 23.2 39.6 59.0 43.5 39.1 26.3 34.3 46.5 17.2 47.8 18.4 30.8 56.3 15.1 29.8 27.7 16.6 26.3 45.1 18.5 27.5 19.5 16.0 21.4 15.8 35.1 19.6 35.1 51.2 38.5 59.7 35.6 20.1 154.9 16.7 59.3 19.7 21.8 28.2 29.5 29.8 24.2 14.3 24.8 24.3 24.1 63.8 22.1 25.9 17.9 33.0 24.5 27.9 28.3 30.1 31.7 27.8 30.1 29.6 28.4 27.0 29.6 28.8 29.3 30.7 32.5 19.2 18.9 9.1 29.9 21.0 57.6 26.8 25.6 28.9 41.2 39.4 55.1 27.1 17.2 23.9 14.6 29.1 24.6 9.6 76.3 41.3 188.1 24.2 12.9 35.8 30.0 8.4 10.6 44.2 10.6 30.8 21.9 15.9 15.8 20.5 15.0 53.9 16.5 15.2 14.1 15.0 28.5 16.4 14.5 464.6 28.9 16.2 17.8 4.7 45.7 48.0 22.6 9.5 11.2 30.2 14.6 38.0 15.8 41.6 19.2 125.4 25.4 34.0 13.1 25.8 26.3 112.5 27.5 18.2 20.9 14.9 22.9 16.3 24.5 56.7 NUTF2 "NTF2, PP15" ENSG00000102898 "Nuclear transport factor 2" P61970 16 67846923-67872567 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 336.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040915, HPA040956" Supported NA NA 2300000 "HPA040915: AB_10794073, HPA040956: AB_10796233" "unprognostic (1.74e-1)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.41e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.08e-3)" "unprognostic (1.56e-3)" "unprognostic (2.25e-1)" "unprognostic (2.33e-2)" "unprognostic (5.17e-3)" "unprognostic (9.80e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" 53.8 54.1 85.9 36.8 82.9 42.3 50.2 85.9 94.1 47.4 72.6 54.2 27.6 61.3 49.9 54.2 48.3 26.9 67.2 86.3 86.6 48.5 51.9 50.3 48.2 93.3 92.4 80.7 42.7 57.4 42.0 43.4 50.2 92.9 45.0 43.0 17.4 40.8 32.8 94.1 56.9 43.1 58.5 90.2 41.7 46.3 57.1 88.5 58.0 39.6 79.9 53.8 58.4 45.6 93.4 149.0 174.8 186.9 212.2 92.8 94.1 249.9 118.8 102.8 165.4 134.1 222.3 152.5 169.2 107.7 161.3 95.9 130.3 235.4 176.2 179.3 65.9 225.5 114.2 73.6 357.5 124.0 161.6 83.1 123.4 114.1 152.9 190.7 91.0 175.5 127.7 164.2 59.1 173.6 301.8 257.3 311.1 318.9 152.4 117.6 228.2 121.5 254.2 218.9 128.5 169.6 164.4 266.4 109.5 93.6 174.5 161.0 137.3 147.4 140.3 168.3 104.2 144.0 94.8 131.0 367.5 92.9 113.0 147.8 47.8 64.0 27.4 61.0 95.7 70.1 52.7 64.9 60.3 81.5 51.8 48.8 55.9 17.9 71.9 88.3 78.7 72.8 101.8 85.9 82.9 85.9 94.1 86.3 86.6 93.3 92.4 80.7 92.9 90.2 88.5 93.4 67.6 57.7 20.2 4.9 58.6 68.2 79.5 136.5 64.9 15.9 62.8 53.7 38.7 27.1 58.5 49.7 2.1 208.2 62.4 66.2 137.0 196.5 9.9 71.4 66.1 71.9 98.3 126.4 6.9 105.1 336.1 57.6 60.6 52.7 39.3 65.1 28.2 22.5 149.4 20.2 7.4 69.1 89.5 32.4 83.6 20.8 33.2 75.2 58.7 4.7 130.2 26.5 69.0 4.0 8.3 198.8 93.3 42.9 86.2 166.0 96.5 124.1 53.7 7.6 13.1 48.5 187.5 54.6 82.0 88.7 87.7 183.5 62.9 62.1 95.6 114.5 NUP93 KIAA0095 ENSG00000102900 "Nucleoporin 93" Q8N1F7 16 56730118-56850286 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017937 Uncertain NA NA 38000 "HPA017937: AB_1854726" "unprognostic (6.31e-2)" "unprognostic (3.22e-2)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (3.99e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.18e-2)" "unprognostic (9.35e-3)" "unprognostic (5.22e-2)" "unprognostic (4.55e-2)" "unprognostic (1.97e-1)" "unprognostic (2.66e-2)" "unprognostic (3.71e-1)" "unprognostic (1.85e-1)" "unprognostic (9.68e-2)" "unprognostic (3.74e-2)" 16.2 14.1 9.4 21.5 13.8 53.2 15.7 6.6 24.1 15.5 1.0 17.9 10.0 17.1 12.5 22.6 15.4 12.5 14.3 27.7 8.9 11.0 9.4 15.4 27.9 11.1 9.6 12.2 15.0 14.3 14.9 10.9 19.2 9.0 17.8 18.3 32.0 12.3 12.8 20.1 21.8 14.6 19.6 5.4 24.4 15.3 40.2 11.9 34.5 34.6 14.3 30.6 17.3 16.3 11.6 71.3 84.5 71.6 81.0 25.9 34.8 81.0 58.7 48.2 156.2 100.1 119.4 66.1 107.7 60.4 54.9 54.2 120.6 143.3 90.1 149.8 34.0 81.3 72.6 64.7 97.3 35.0 96.7 82.8 29.3 35.7 104.2 64.7 31.6 90.8 95.3 87.8 22.3 72.3 52.4 136.2 81.1 92.1 44.2 95.4 163.9 129.4 108.9 53.1 47.8 66.6 44.1 159.1 54.6 47.3 77.4 43.0 57.9 55.3 68.1 74.0 57.8 67.5 35.0 60.7 190.2 47.4 88.5 67.5 19.3 49.9 195.7 38.9 77.2 45.2 45.4 28.3 40.9 60.9 45.4 28.7 41.0 11.8 51.8 77.5 28.7 39.7 47.4 9.4 13.8 6.6 24.1 27.7 8.9 11.1 9.6 12.2 9.0 5.4 11.9 11.6 11.3 6.4 12.3 17.6 13.4 12.0 13.6 20.7 6.2 68.6 9.0 7.6 11.8 1.5 20.2 9.2 10.4 21.1 9.4 8.6 11.7 24.6 11.7 10.9 8.8 16.5 4.9 33.2 51.1 25.5 31.7 12.8 13.7 10.6 17.2 22.3 10.8 7.2 26.6 38.7 49.4 11.2 24.4 17.8 23.8 7.7 23.3 17.3 16.0 33.7 30.3 11.7 8.2 18.1 22.1 21.4 7.2 13.5 8.1 16.5 3.6 11.0 13.0 20.8 13.1 11.4 27.9 54.6 62.2 14.3 16.1 10.3 13.5 22.3 15.3 18.0 CENPT "C16orf56, CENP-T, FLJ13111" ENSG00000102901 "Centromere protein T" Q96BT3 16 67828157-67847811 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Spermatocytes: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041220, HPA058036" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA041220: AB_2677367, HPA058036: AB_2683585" "unprognostic (9.84e-2)" "unprognostic (2.86e-2)" "unprognostic (3.04e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (6.66e-3)" "unprognostic (1.18e-2)" "unprognostic (2.81e-1)" "unprognostic (8.04e-2)" "unprognostic (3.15e-2)" "prognostic favorable (2.96e-4)" "unprognostic (6.64e-3)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (9.74e-3)" 6.7 5.7 6.9 3.1 6.9 5.3 6.4 7.2 10.0 7.9 5.6 7.8 2.5 7.0 1.4 6.6 7.3 1.8 7.4 7.3 7.0 6.3 5.3 6.4 3.6 7.4 6.9 6.6 7.8 9.7 4.9 4.4 4.2 7.0 6.6 2.0 0.8 5.9 4.4 8.3 24.9 6.4 4.7 6.5 5.5 7.5 19.8 6.7 4.4 5.2 5.6 2.4 7.4 6.9 7.1 7.6 7.4 10.0 10.2 8.1 7.8 14.7 29.5 13.6 30.2 24.1 7.9 5.6 3.3 7.1 19.8 5.3 12.4 7.5 13.2 10.3 5.3 9.5 1.2 3.2 11.3 5.1 0.6 6.9 8.5 7.7 20.7 4.4 4.4 12.3 8.1 19.3 3.6 14.5 11.9 9.8 10.7 13.5 5.9 7.1 13.4 4.5 17.6 11.2 3.1 3.9 6.8 22.2 4.6 5.8 6.3 6.1 10.0 9.7 4.3 7.4 6.6 7.0 7.0 5.8 19.4 3.3 6.1 7.4 1.4 7.2 6.3 6.5 6.6 7.0 4.9 6.0 8.2 6.0 6.1 5.3 7.0 3.4 5.4 4.3 6.0 8.5 5.1 6.9 6.9 7.2 10.0 7.3 7.0 7.4 6.9 6.6 7.0 6.5 6.7 7.1 21.0 16.0 11.3 10.4 17.4 21.0 20.2 24.4 12.5 24.9 20.3 19.3 8.2 14.3 17.2 20.2 8.4 31.5 25.4 27.5 5.9 19.0 52.2 8.8 17.8 19.7 13.1 30.3 16.9 14.2 25.0 23.0 34.1 11.2 8.2 20.9 17.5 9.4 15.2 25.2 12.3 11.3 24.4 8.5 17.8 47.9 24.2 17.9 17.8 7.5 9.8 13.7 21.6 12.1 8.4 19.7 17.8 22.2 26.9 11.1 16.3 10.3 12.2 10.5 26.3 19.9 25.1 89.8 33.5 12.8 19.5 30.1 22.6 24.3 13.7 13.6 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.7;testis: 21.7" "Cell type enhanced" "Detected in many" "Early spermatids: 99.9;Endometrial ciliated cells: 41.1;Late spermatids: 178.6;Respiratory ciliated cells: 51.9;Spermatocytes: 53.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.0;SiHa: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA053516 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053516: AB_2682175" "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.4 1.0 2.0 0.4 1.4 0.1 0.6 1.1 1.8 1.1 2.6 0.7 0.0 0.9 0.9 0.3 8.7 0.4 0.3 1.6 1.5 1.2 0.8 1.3 0.1 1.9 2.3 1.0 1.5 1.2 1.3 6.5 0.1 1.7 0.9 0.1 3.5 0.3 0.4 0.2 0.2 0.3 0.4 1.7 0.3 0.5 21.7 1.3 0.2 0.7 0.0 0.1 0.6 0.5 1.3 0.5 0.1 1.1 3.0 1.4 0.4 0.4 0.1 0.7 0.2 1.0 0.3 0.3 0.4 0.4 0.1 0.3 0.6 0.3 0.4 0.6 0.1 0.4 0.0 0.4 0.0 0.4 0.7 0.0 0.3 0.4 1.4 0.2 0.2 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.8 0.3 0.0 1.3 0.3 0.8 1.0 2.0 0.0 0.2 0.3 0.8 0.0 0.3 0.1 0.0 0.3 0.1 0.5 1.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 1.1 1.8 1.6 1.5 1.9 2.3 1.0 1.7 1.7 1.3 1.3 0.6 0.0 2.7 9.1 0.2 0.1 0.4 2.5 0.6 2.9 1.0 1.1 12.0 0.0 4.8 5.5 4.2 0.4 0.2 0.2 0.0 0.7 99.9 41.1 2.0 1.1 0.0 0.4 7.9 0.0 0.2 1.6 0.0 1.3 0.0 1.3 0.7 0.7 0.3 3.3 4.9 0.0 10.2 0.0 0.2 178.6 2.8 0.3 0.0 3.7 0.0 3.7 0.0 3.0 1.3 0.1 0.0 1.9 0.0 0.3 0.0 2.5 51.9 10.2 6.6 0.6 1.7 53.3 8.9 0.1 0.3 0.5 0.2 1.4 0.0 0.2 NFAT5 "KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP" ENSG00000102908 "Nuclear factor of activated T cells 5" O94916 16 69565094-69704666 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 281.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057304, HPA069711" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057304: AB_2683407, HPA069711: AB_2686180" "unprognostic (2.71e-1)" "unprognostic (1.50e-2)" "unprognostic (1.77e-1)" "unprognostic (3.57e-2)" "unprognostic (5.65e-3)" "unprognostic (2.08e-1)" "unprognostic (2.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (3.56e-2)" "unprognostic (4.05e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.08e-4)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (6.32e-2)" "unprognostic (9.42e-2)" 2.2 3.2 0.8 2.9 1.7 5.6 2.1 0.7 4.1 3.0 2.0 1.9 0.7 3.3 0.7 2.9 2.0 1.5 1.7 1.4 1.9 2.7 2.3 3.2 1.1 0.6 0.4 0.2 2.5 1.7 4.1 2.0 4.2 1.1 2.4 1.5 4.2 3.7 2.4 2.7 3.4 1.9 1.9 0.0 2.5 2.3 1.5 2.1 2.3 3.6 4.8 1.4 2.7 3.1 0.4 8.4 10.1 4.8 5.0 5.8 6.0 6.4 7.2 8.6 6.6 4.2 4.5 4.2 4.5 5.8 5.8 3.4 7.3 3.9 3.1 4.2 2.9 3.2 2.6 2.8 6.2 3.4 3.5 5.5 3.5 1.1 6.4 5.9 5.4 5.5 2.3 7.2 1.1 3.3 3.2 2.8 1.7 2.5 1.1 2.5 4.5 2.2 1.7 2.5 8.0 3.1 0.9 22.2 1.3 2.6 4.1 3.3 1.3 13.1 5.7 5.6 4.8 2.2 4.6 4.9 7.3 5.1 3.4 3.6 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.0 0.9 0.0 0.2 0.5 0.1 0.0 0.8 1.7 0.7 4.1 1.4 1.9 0.6 0.4 0.2 1.1 0.0 2.1 0.4 65.0 48.1 49.7 236.7 55.7 148.1 94.8 42.5 155.4 51.8 61.6 42.9 9.2 30.0 43.3 145.3 85.5 60.6 69.4 27.8 5.9 17.8 7.2 93.7 87.8 93.6 24.5 27.3 281.8 12.7 15.9 60.9 38.2 158.3 19.7 31.0 52.8 28.3 17.6 60.6 189.3 29.1 28.5 21.7 169.5 6.9 59.4 58.2 58.7 172.4 37.4 45.7 36.0 177.4 167.2 23.7 29.3 54.9 50.2 83.1 24.7 14.6 31.8 62.4 26.3 72.0 51.4 84.5 48.8 77.9 140.1 50.9 57.4 43.1 20.8 105.7 LONP2 "LONP, LONPL, MGC4840" ENSG00000102910 "Lon peptidase 2, peroxisomal" Q86WA8 16 48244300-48363122 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008862 Uncertain NA NA "HPA008862: AB_2137156" "unprognostic (8.08e-3)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.75e-2)" "unprognostic (2.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.60e-2)" "unprognostic (7.59e-3)" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (3.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.71e-7)" "unprognostic (6.53e-2)" "unprognostic (1.49e-1)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" 22.0 19.4 20.7 14.9 22.0 13.7 46.5 22.8 24.9 19.6 25.5 16.9 20.5 19.5 26.1 16.9 22.4 14.9 22.6 22.5 29.2 20.3 87.6 14.8 15.8 20.3 19.7 20.8 24.6 22.3 38.5 25.5 14.0 20.9 29.9 18.9 39.3 21.1 22.4 23.9 18.1 18.6 21.0 20.0 17.5 20.2 9.2 19.9 17.3 32.9 22.7 16.5 19.5 16.1 22.7 24.3 33.1 18.3 25.5 42.1 34.6 30.9 30.4 23.1 28.0 12.8 17.3 12.4 11.0 29.2 30.9 14.1 29.8 33.4 33.6 38.7 18.0 21.7 16.1 20.1 38.2 25.8 27.5 20.7 32.2 36.6 26.2 24.4 33.8 21.1 20.7 27.6 12.6 29.2 22.4 26.5 13.6 13.7 22.8 32.5 34.0 33.1 35.1 31.7 16.1 28.6 17.7 34.6 38.1 31.6 22.8 17.6 20.5 28.3 28.7 16.9 25.2 23.7 25.6 22.8 18.0 33.7 18.5 21.3 6.8 11.6 8.0 10.6 12.0 11.7 10.5 12.9 11.2 11.4 11.7 12.3 11.4 4.4 8.4 12.7 8.5 10.7 10.7 20.7 22.0 22.8 24.9 22.5 29.2 20.3 19.7 20.8 20.9 20.0 19.9 22.7 33.0 57.7 66.3 70.8 44.6 34.9 43.1 38.3 40.5 104.5 51.0 39.1 62.7 75.8 52.0 27.6 85.5 40.1 37.9 31.9 13.7 35.0 30.8 43.7 48.2 34.2 49.7 23.4 97.2 30.7 29.0 43.3 39.8 53.6 30.4 65.2 42.5 194.6 30.5 85.8 95.4 36.8 38.7 53.8 42.7 10.1 59.0 38.3 39.2 60.0 45.1 63.9 32.0 73.9 87.6 31.3 38.9 54.5 41.5 52.3 40.9 30.0 56.3 141.7 39.5 67.2 42.5 22.0 17.0 36.7 36.8 64.0 39.8 41.4 41.2 45.8 N4BP1 ENSG00000102921 "NEDD4 binding protein 1" O75113 16 48538726-48620148 "Predicted intracellular proteins" "Immunity, Innate immunity" "Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040849, HPA041080" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040849: AB_10794866, HPA041080: AB_10794186" "unprognostic (1.07e-1)" "unprognostic (2.17e-1)" "unprognostic (5.07e-2)" "unprognostic (2.50e-3)" "unprognostic (1.16e-1)" "unprognostic (3.19e-1)" "unprognostic (4.35e-3)" "unprognostic (9.18e-2)" "unprognostic (4.36e-1)" "unprognostic (1.10e-1)" "unprognostic (3.71e-1)" "unprognostic (1.35e-1)" "prognostic favorable (9.03e-8)" "unprognostic (9.00e-2)" "unprognostic (1.49e-1)" "unprognostic (1.96e-1)" "unprognostic (8.36e-2)" 8.8 6.8 7.4 7.3 7.0 10.4 9.1 8.8 7.7 9.3 6.8 8.6 6.0 8.7 8.4 19.0 8.5 6.4 6.9 7.0 9.1 7.4 7.1 14.8 7.6 8.1 7.0 6.8 9.8 7.7 11.5 9.2 7.5 7.6 8.8 6.4 7.0 10.8 6.4 10.6 19.2 9.4 6.3 5.5 11.0 9.3 4.7 9.4 10.4 8.3 7.9 9.1 8.2 11.4 8.5 7.1 11.8 8.3 8.5 11.4 9.0 6.9 6.5 9.9 12.4 6.3 9.3 5.8 7.9 5.9 10.0 5.5 14.4 7.5 10.3 6.8 4.9 6.2 4.1 4.7 8.3 11.1 6.2 10.8 13.0 15.5 4.4 6.4 9.1 6.3 8.1 6.4 8.2 7.5 4.0 7.4 11.2 6.6 7.3 6.7 11.1 13.5 12.4 6.2 11.9 9.3 6.6 5.5 10.0 9.2 8.6 4.2 8.5 9.3 6.3 5.6 3.5 3.9 12.2 7.8 12.0 7.3 4.9 5.6 0.9 1.3 1.8 1.0 1.2 1.3 0.9 1.3 1.6 0.8 0.6 1.1 1.1 8.4 0.4 0.9 1.0 1.0 0.6 7.4 7.0 8.8 7.7 7.0 9.1 8.1 7.0 6.8 7.6 5.5 9.4 8.5 41.2 134.6 32.7 28.4 15.3 20.0 21.6 32.4 19.4 24.1 21.3 21.2 15.1 22.8 25.8 7.3 16.7 13.4 53.8 35.4 5.9 8.4 6.4 36.8 35.8 25.7 9.6 6.5 47.5 13.2 10.5 20.1 30.5 113.8 12.6 23.1 24.3 13.4 19.5 26.9 50.1 21.2 6.1 25.9 40.3 3.7 16.1 36.5 5.4 58.1 31.9 15.3 21.6 38.7 54.8 26.7 21.6 20.7 30.2 30.6 16.1 9.4 18.4 23.0 0.0 26.3 17.6 12.6 24.4 26.8 22.7 28.5 36.5 23.8 13.4 47.5 CBLN1 ENSG00000102924 "Cerebellin 1 precursor" P23435 16 49277917-49281838 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 114.6;testis: 32.1" "Cell type enhanced" "Detected in some" "Early spermatids: 100.9;Late spermatids: 291.0;Spermatocytes: 61.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.5" "Region enhanced" "Detected in all" "cerebellum: 114.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "NTERA-2: 40.0;SCLC-21H: 126.0" "Region enriched" "Detected in all" 9 "cerebellum: 613.4" "Region enriched" "Detected in many" 13 "cerebellum: 369.4" "Secreted in brain" NA NA 6000000 "unprognostic (1.39e-2)" "unprognostic (1.88e-2)" "unprognostic (1.53e-1)" "unprognostic (3.16e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.65e-3)" "unprognostic (1.18e-2)" "unprognostic (6.31e-2)" "unprognostic (1.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.04e-2)" "unprognostic (7.68e-2)" "unprognostic (2.45e-1)" "unprognostic (1.06e-2)" "prognostic favorable (7.10e-4)" "unprognostic (1.60e-2)" 11.9 1.1 9.1 0.2 3.4 0.0 3.8 114.6 6.4 2.1 1.1 0.7 1.0 5.8 0.4 1.0 1.3 7.5 4.6 2.3 13.5 0.2 1.0 0.1 0.8 11.7 17.8 3.4 1.3 2.8 0.2 4.3 0.0 31.1 0.5 0.7 3.6 0.6 0.6 0.9 0.7 1.3 1.8 4.8 0.1 0.7 32.1 21.7 0.2 2.3 1.8 2.8 1.5 0.5 8.4 0.0 0.0 0.6 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 2.7 2.6 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 126.0 3.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 3.4 114.6 6.4 2.3 13.5 11.7 17.8 3.4 31.1 4.8 21.7 8.4 4.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.3 2.2 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 100.9 0.1 2.4 6.7 13.2 0.0 0.6 0.4 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.7 4.7 0.5 0.0 0.0 0.0 291.0 2.1 0.4 0.0 0.0 0.0 0.8 0.0 0.5 0.4 0.2 0.0 0.4 0.0 0.1 0.3 0.0 0.0 1.8 26.3 0.1 19.2 61.7 5.8 0.0 0.1 0.0 0.0 8.8 0.2 0.0 ARL2BP "BART, BART1, RP66" ENSG00000102931 "ADP ribosylation factor like GTPase 2 binding protein" Q9Y2Y0 16 57245259-57253635 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 264.6;Late spermatids: 503.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043066, HPA048440" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043066: AB_2678302, HPA048440: AB_2680393" "unprognostic (1.17e-1)" "unprognostic (4.05e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.33e-3)" "unprognostic (1.26e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.06e-5)" "unprognostic (2.38e-1)" "unprognostic (3.06e-1)" "unprognostic (2.07e-1)" "unprognostic (4.10e-2)" "unprognostic (2.71e-3)" "unprognostic (1.44e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-2)" "unprognostic (6.78e-2)" 48.9 43.0 53.1 30.4 54.2 36.0 37.7 54.0 58.6 35.8 54.6 33.9 21.0 45.4 35.1 50.1 44.5 36.5 54.9 54.1 55.0 44.4 33.0 44.9 38.0 54.0 54.9 53.2 51.0 29.9 48.4 27.8 37.7 54.1 35.2 36.3 37.6 25.6 46.4 32.2 31.5 25.0 59.8 54.2 49.8 27.8 57.6 54.4 45.2 30.1 46.6 46.7 40.3 30.1 55.1 74.2 49.4 93.3 48.7 82.6 106.0 23.2 91.2 105.4 104.2 65.9 37.4 28.9 61.9 104.0 126.3 48.8 48.5 60.3 74.0 97.8 28.5 57.8 54.9 36.3 64.2 112.3 50.8 113.6 91.6 94.8 75.4 103.3 77.4 127.5 46.7 42.5 23.3 73.0 28.7 52.3 63.9 32.7 25.7 98.7 71.3 91.7 120.8 113.8 26.4 29.2 61.1 140.1 66.1 82.8 58.1 48.8 66.6 114.6 61.2 37.8 53.3 70.8 58.8 49.6 58.9 79.8 33.2 60.2 35.5 46.1 27.3 40.5 45.3 42.3 37.6 36.7 44.1 56.5 29.8 49.5 42.0 7.6 63.6 51.3 16.3 33.7 55.1 53.1 54.2 54.0 58.6 54.1 55.0 54.0 54.9 53.2 54.1 54.2 54.4 55.1 60.3 51.3 27.4 9.8 47.0 36.7 43.3 57.0 42.7 44.4 30.6 27.8 0.2 40.0 28.7 36.8 4.2 51.0 50.5 23.4 76.3 46.2 264.6 49.2 57.8 63.7 26.4 105.7 20.6 58.0 30.2 66.6 30.1 58.7 74.3 105.7 62.8 34.3 63.3 55.5 22.5 21.5 46.8 52.8 36.5 503.7 82.3 42.2 48.0 7.5 71.2 66.0 66.9 42.7 33.9 44.6 18.5 109.1 50.3 24.0 23.2 65.8 32.9 38.0 13.1 39.7 45.5 122.2 51.8 66.8 37.1 22.3 60.8 170.2 23.6 22.6 PLLP "PMLP, TM4SF11" ENSG00000102934 Plasmolipin Q9Y342 16 57248547-57284672 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "brain: 950.4;choroid plexus: 1044.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 161.5;Glandular and luminal cells: 134.3;Oligodendrocyte precursor cells: 140.2;Oligodendrocytes: 193.4;Pancreatic endocrine cells: 119.0;Proximal enterocytes: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "naive CD4 T-cell: 14.5;naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 8 "T-cells: 14.5" "Cell line enhanced" "Detected in many" "EFO-21: 27.8;Hep G2: 81.1;OE19: 79.6;RPTEC TERT1: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041862 Enhanced NA NA "HPA041862: AB_2677712" "unprognostic (7.96e-2)" "unprognostic (2.07e-3)" "unprognostic (3.86e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-1)" "unprognostic (9.56e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (5.64e-2)" "unprognostic (6.99e-3)" "unprognostic (2.83e-2)" "prognostic favorable (6.21e-9)" "unprognostic (2.06e-2)" "unprognostic (9.06e-3)" "unprognostic (3.86e-1)" "unprognostic (3.32e-2)" 10.6 2.8 707.5 2.3 701.2 2.3 12.2 414.5 653.4 24.8 1044.7 10.6 33.8 6.4 2.4 34.6 22.8 27.6 8.3 562.5 686.1 40.9 9.9 51.2 2.4 835.0 659.8 364.6 3.0 53.0 14.9 4.4 2.6 950.4 12.9 12.7 2.0 42.3 28.2 3.8 99.3 33.7 2.4 778.4 19.8 80.5 6.3 873.2 1.1 12.9 6.4 5.0 9.7 26.3 891.3 1.6 5.7 7.1 1.4 0.0 0.1 3.6 1.1 0.3 0.4 0.3 15.9 6.8 0.5 27.8 0.0 1.8 5.2 3.3 5.0 0.1 1.6 2.7 7.3 3.0 81.1 1.0 0.7 1.8 0.2 1.2 0.1 0.6 3.6 8.0 1.7 1.3 1.9 0.1 2.0 0.9 1.8 5.9 79.6 2.3 0.9 1.3 1.4 33.5 17.1 1.6 2.8 1.9 2.2 3.3 2.2 11.7 2.2 6.0 1.2 1.6 1.0 1.3 1.4 1.7 0.9 1.6 0.5 4.7 1.7 1.0 0.7 0.8 0.5 0.6 0.7 2.2 0.6 0.2 1.2 14.5 5.7 1.8 0.6 0.5 0.5 0.6 2.2 707.5 701.2 414.5 653.4 562.5 686.1 835.0 659.8 364.6 950.4 778.4 873.2 891.3 18.4 64.1 26.5 0.3 1.4 13.9 15.9 61.4 22.8 2.7 23.8 23.6 3.2 161.5 26.4 90.1 2.1 2.2 1.8 26.6 15.6 61.3 0.9 66.9 12.4 20.5 1.2 5.3 0.5 70.2 1.3 5.1 76.0 134.3 3.8 13.4 11.0 4.2 0.7 5.0 0.7 23.7 93.6 0.8 2.2 1.5 4.7 2.1 3.6 25.3 1.3 0.5 0.0 140.2 193.4 119.0 66.8 22.2 1.3 5.8 149.9 28.6 4.0 7.7 0.0 3.6 4.0 1.6 3.3 54.2 42.8 1.1 2.4 1.2 36.1 13.3 ZNF423 "Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104" ENSG00000102935 "Zinc finger protein 423" Q2M1K9 16 49487524-49857919 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.3;skeletal muscle: 27.8" "Cell type enhanced" "Detected in many" "Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015258, HPA065820" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015258: , HPA065820: AB_2685563" "unprognostic (2.81e-1)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.65e-3)" "unprognostic (3.37e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.77e-1)" "unprognostic (9.13e-2)" "unprognostic (8.97e-2)" "unprognostic (1.22e-1)" "unprognostic (6.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.92e-2)" "unprognostic (5.84e-2)" 9.2 2.9 12.0 2.3 9.0 0.3 6.8 13.4 10.5 6.4 1.9 3.8 1.3 5.4 3.4 4.8 9.4 5.8 6.7 9.2 8.6 1.6 0.7 2.9 1.9 15.3 29.3 3.5 7.7 3.4 3.0 4.0 4.2 11.7 6.0 2.7 3.7 2.9 9.5 27.8 1.9 2.6 6.6 7.8 1.4 2.0 4.5 25.6 1.8 4.4 14.9 1.2 4.0 5.4 7.9 0.0 0.0 62.6 3.3 5.1 0.6 7.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.4 0.0 0.0 1.9 0.5 0.0 3.6 0.1 0.2 0.0 0.0 4.4 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 8.8 0.4 33.2 0.0 0.0 27.5 0.1 0.0 0.0 1.7 35.1 87.7 0.0 0.1 0.0 17.6 0.0 0.0 0.0 0.0 1.0 16.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 9.0 13.4 10.5 9.2 8.6 15.3 29.3 3.5 11.7 7.8 25.6 7.9 12.7 0.0 0.0 75.4 0.0 2.7 0.3 0.1 1.2 9.8 0.6 0.6 2.6 0.0 0.0 0.0 0.0 0.5 0.1 2.3 1.9 0.2 23.5 2.7 7.6 11.4 0.0 0.0 10.9 0.2 0.7 15.8 0.0 0.6 0.0 1.6 15.4 0.9 0.7 0.0 7.4 1.0 0.0 0.3 5.1 115.7 27.7 0.4 1.8 53.4 0.0 11.7 0.0 38.7 5.1 0.2 0.4 54.5 0.2 0.1 0.2 0.6 0.0 1.1 0.0 4.5 6.4 0.8 1.9 0.1 1.7 0.3 0.3 5.5 0.7 0.1 CCL22 "A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1" ENSG00000102962 "C-C motif chemokine ligand 22" O00626 16 57358783-57366189 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 5.2;lymphoid tissue: 15.0;skin 1: 6.6;urinary bladder: 4.5" "Cell type enriched" "Detected in some" 27 "monocytes: 5366.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 18 "HDLM-2: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 617000 "unprognostic (2.67e-2)" "unprognostic (7.68e-3)" "prognostic favorable (2.98e-4)" "prognostic favorable (2.23e-6)" "unprognostic (8.87e-2)" "prognostic favorable (9.17e-5)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (1.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (7.71e-2)" "unprognostic (3.43e-2)" "unprognostic (3.12e-2)" "unprognostic (3.88e-2)" 0.5 0.3 0.2 13.6 0.2 0.6 1.4 0.6 0.3 0.7 0.4 1.6 1.2 0.3 0.1 1.8 0.3 1.8 0.1 0.2 0.1 0.2 0.7 1.8 5.9 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.3 0.4 5.2 0.2 0.7 0.4 0.4 6.6 3.1 0.9 0.0 2.0 1.5 0.4 0.2 15.0 0.3 0.3 14.6 4.5 0.6 0.7 0.5 0.2 0.2 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.7 0.3 0.1 0.1 0.0 1.2 0.1 0.1 0.1 49.6 0.1 0.2 0.3 0.5 0.0 0.2 1.4 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.3 0.3 0.0 0.1 0.2 0.4 0.4 0.2 0.0 0.1 0.2 1.8 0.0 2.7 0.3 0.2 0.2 2.1 0.0 0.2 0.2 2.4 0.4 0.2 0.2 0.1 0.2 0.2 0.1 0.4 0.0 0.2 0.1 1.6 0.2 0.2 0.2 0.1 0.1 1.0 0.1 0.1 0.9 0.4 0.1 0.2 1.2 0.4 0.1 0.3 0.1 0.1 0.2 0.2 0.6 0.3 0.2 0.1 0.2 0.1 0.1 0.3 0.0 0.2 0.7 0.1 3.2 1.1 0.0 4.2 6.6 0.3 0.6 0.0 0.0 1.3 0.6 0.4 0.0 1.2 0.0 0.0 0.0 0.1 0.1 1.9 5.9 0.0 0.3 0.1 0.8 0.0 0.0 0.0 21.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 194.6 0.0 0.0 10.4 3.6 0.0 5366.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.1 3.9 0.0 0.0 0.0 8.0 0.1 1.2 0.0 0.1 0.4 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "liver: 106.7" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 7.5 4.9 2.9 4.3 3.3 3.9 5.9 3.2 3.3 4.1 3.4 5.5 3.9 5.5 2.9 4.2 6.1 2.3 9.7 2.6 2.1 8.0 106.7 4.0 4.2 3.2 3.0 2.1 5.0 4.2 6.3 2.6 2.7 3.1 4.0 5.8 3.2 5.5 4.5 10.1 4.5 3.2 5.7 1.9 4.1 4.2 3.7 2.6 3.9 4.1 8.2 5.5 4.0 3.4 5.0 12.5 25.7 6.9 12.1 3.8 5.0 13.9 10.5 4.2 15.6 11.6 20.4 11.1 27.8 13.6 5.7 8.6 12.5 13.7 11.4 18.2 6.0 13.3 15.4 12.6 20.3 10.6 21.4 10.8 4.9 11.3 18.6 19.7 4.7 11.3 18.3 23.9 4.4 9.7 32.7 20.2 17.0 15.9 21.1 10.0 24.9 9.6 29.4 9.4 7.8 8.5 10.2 14.1 14.8 6.8 8.7 13.0 10.3 5.1 14.1 8.3 13.1 15.2 8.8 18.7 46.3 7.1 22.4 12.8 6.1 8.4 1.0 9.4 8.8 12.9 12.0 8.5 9.3 14.5 11.7 11.7 12.6 2.1 10.1 6.3 13.5 8.0 7.2 2.9 3.3 3.2 3.3 2.6 2.1 3.2 3.0 2.1 3.1 1.9 2.6 5.0 6.3 3.2 13.1 1.6 7.1 5.6 7.8 11.2 6.8 5.6 6.6 7.1 14.8 15.7 5.5 7.3 4.2 12.3 6.9 1.6 5.9 10.3 2.9 3.8 6.3 9.1 1.2 7.8 2.0 5.1 12.4 7.4 2.6 3.2 8.2 10.2 5.3 124.1 7.9 3.3 2.3 6.6 10.2 6.0 3.1 3.6 2.8 3.3 12.4 1.0 3.8 5.2 8.2 4.0 4.4 5.9 2.4 2.2 4.6 11.2 1.0 20.8 8.1 5.2 0.0 9.7 9.1 6.8 8.1 5.0 3.8 2.9 4.3 13.5 6.7 4.2 CCL17 "ABCD-2, SCYA17, TARC" ENSG00000102970 "C-C motif chemokine ligand 17" Q92583 16 57404767-57416063 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 21.3" "Cell type enriched" "Detected in some" 55 "monocytes: 12161.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 640 "HDLM-2: 2395.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "basal ganglia: 4.3" CAB002583 Uncertain "Secreted to blood" NA NA 248000 "CAB002583: AB_564022" "unprognostic (4.62e-3)" "prognostic favorable (1.91e-5)" "unprognostic (5.83e-2)" "unprognostic (3.52e-4)" "unprognostic (4.51e-2)" "unprognostic (1.78e-3)" "unprognostic (4.44e-1)" "unprognostic (3.41e-2)" "unprognostic (6.36e-2)" "unprognostic (4.28e-2)" "unprognostic (4.11e-1)" "unprognostic (2.91e-2)" "unprognostic (6.04e-2)" "unprognostic (2.35e-1)" "unprognostic (7.72e-3)" "unprognostic (4.14e-3)" "prognostic favorable (5.80e-4)" 1.2 0.1 0.2 8.4 0.2 0.0 1.9 0.2 0.4 1.4 0.0 1.5 0.1 0.1 0.0 3.1 0.6 2.9 1.3 0.3 0.1 0.6 0.3 4.6 8.5 0.2 0.1 0.1 0.2 0.5 0.1 0.0 0.1 0.3 0.3 2.8 0.0 2.6 0.2 0.1 2.5 3.7 2.6 0.2 0.8 0.7 0.5 0.2 21.3 0.8 0.2 5.7 3.4 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 3.3 0.0 0.0 0.0 2395.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 2.9 1.5 0.1 0.1 2.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.3 0.2 0.2 0.3 1.3 0.0 5.1 0.0 0.4 10.8 0.1 3.4 0.0 0.0 1.1 1.5 0.0 0.0 3.8 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.3 0.1 0.0 0.6 0.0 0.0 0.2 37.4 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.0 1.0 217.9 0.3 0.0 48.7 0.0 0.0 12161.5 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 0.0 0.0 0.0 12.0 0.0 0.5 0.0 2.7 0.0 0.4 0.0 0.0 0.7 CTCF "CFAP108, FAP108" ENSG00000102974 "CCCTC-binding factor" P49711 16 67562467-67639177 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Chromosome partition, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004122, CAB062550, CAB068181, CAB068182" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139" "unprognostic (2.70e-1)" "unprognostic (4.21e-2)" "unprognostic (3.41e-2)" "unprognostic (4.70e-2)" "unprognostic (4.41e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.71e-2)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.36e-2)" "unprognostic (1.99e-2)" "prognostic favorable (4.06e-4)" "unprognostic (3.47e-1)" "unprognostic (5.99e-2)" "unprognostic (4.58e-2)" "unprognostic (1.11e-2)" 17.0 14.7 11.4 20.8 12.9 34.9 17.7 18.6 13.6 20.4 8.7 19.0 16.0 21.0 13.9 20.4 20.0 14.8 15.5 11.6 11.1 18.1 18.8 16.6 29.2 11.4 11.2 9.8 22.5 18.5 28.5 13.0 20.6 11.6 17.3 21.8 18.6 17.2 17.9 30.8 23.3 19.5 20.5 10.0 22.9 18.4 10.5 11.1 70.3 19.5 28.6 35.7 19.8 20.1 17.1 34.6 51.2 66.9 26.7 29.9 25.5 54.2 32.4 33.6 45.9 43.5 42.3 34.5 106.6 26.0 27.7 26.2 43.8 65.3 35.7 51.5 38.5 44.0 63.9 28.5 49.3 20.4 73.7 59.7 20.8 42.5 34.6 38.2 27.5 35.5 83.1 57.7 43.3 38.6 66.7 156.8 27.4 58.3 38.7 34.5 113.5 54.9 58.7 28.2 48.7 57.0 40.0 57.3 33.2 27.9 35.2 41.0 45.3 33.8 39.3 41.3 30.5 35.7 38.6 52.6 151.2 23.1 43.1 43.1 6.8 2.3 3.4 4.3 2.4 4.1 5.5 4.8 3.5 2.1 7.4 3.8 4.4 6.8 3.5 4.8 5.6 3.9 1.4 11.4 12.9 18.6 13.6 11.6 11.1 11.4 11.2 9.8 11.6 10.0 11.1 17.1 38.0 22.4 29.8 19.9 50.4 22.3 24.3 11.4 35.3 35.5 35.6 33.9 32.6 27.1 28.1 23.9 8.4 27.4 54.0 29.2 19.6 31.3 2.1 29.8 43.9 37.3 31.2 52.6 23.0 33.6 33.7 29.9 27.0 40.2 19.6 39.1 23.9 24.0 24.0 45.4 24.2 26.4 16.2 26.7 12.6 3.6 24.8 31.1 12.4 32.8 29.2 32.3 49.4 17.1 32.8 32.5 16.5 28.6 62.6 35.6 18.8 24.5 16.7 27.6 19.7 38.6 41.4 18.4 27.3 38.8 24.7 29.6 47.9 32.6 23.8 30.0 ACD "Pip1, Ptop, Tint1, Tpp1" ENSG00000102977 "ACD shelterin complex subunit and telomerase recruitment factor" Q96AP0 16 67657512-67660815 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049411, HPA057660" Approved Enhanced "Nuclear bodies" NA Yes "Nuclear bodies" "HPA049411: AB_2680752, HPA057660: AB_2683493" "unprognostic (1.47e-1)" "unprognostic (3.77e-2)" "unprognostic (1.09e-2)" "unprognostic (7.15e-3)" "unprognostic (2.22e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (2.42e-6)" "unprognostic (1.50e-2)" "unprognostic (4.75e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-3)" "unprognostic (3.27e-2)" "unprognostic (8.88e-2)" "unprognostic (6.34e-2)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.30e-1)" 12.1 10.0 11.9 7.3 11.7 10.2 13.1 12.0 17.9 16.9 9.8 12.7 4.3 16.6 4.1 9.2 15.7 5.3 10.4 12.2 11.7 10.8 6.7 10.0 10.2 12.0 11.9 10.7 20.1 12.5 6.4 13.8 4.7 12.6 12.3 2.4 2.7 9.5 6.4 9.9 11.3 12.2 4.7 11.6 15.0 11.3 23.9 11.8 5.5 10.1 3.2 5.6 15.6 12.3 12.3 42.1 32.3 18.4 19.2 8.3 5.8 39.5 17.1 11.3 25.0 30.3 42.0 20.3 11.6 19.4 9.4 22.5 32.7 11.3 32.8 8.2 12.6 37.4 24.9 13.4 42.4 5.8 32.5 37.6 8.3 10.0 33.7 17.7 9.4 15.9 34.3 15.7 8.1 12.6 45.2 31.8 31.8 23.5 16.3 21.5 44.1 19.8 48.0 10.5 16.6 26.3 23.1 64.0 6.7 14.5 5.3 15.8 17.9 13.8 26.6 22.4 31.9 26.1 21.7 28.6 35.9 24.7 20.5 23.3 34.5 18.2 22.8 40.2 22.2 34.1 46.4 36.7 34.8 21.0 37.7 28.5 30.3 25.9 43.5 25.8 22.9 39.5 24.7 11.9 11.7 12.0 17.9 12.2 11.7 12.0 11.9 10.7 12.6 11.6 11.8 12.3 19.4 6.4 11.9 5.5 22.3 14.4 15.9 22.6 21.6 14.7 13.7 16.0 2.8 8.6 12.6 11.0 4.2 25.1 22.5 5.5 9.8 21.3 59.3 6.6 7.7 15.4 12.5 11.6 6.2 19.6 22.8 14.1 9.7 6.8 27.9 13.6 12.8 4.7 15.5 13.5 6.1 6.4 6.1 7.6 20.6 71.4 15.2 13.4 23.2 4.7 19.3 14.3 30.9 4.0 3.6 18.4 9.2 11.7 17.0 9.9 10.2 13.2 16.1 10.8 6.6 11.8 14.8 58.1 24.1 7.1 9.7 11.4 27.0 6.9 9.0 10.0 POLR2C RPB3 ENSG00000102978 "RNA polymerase II subunit C" P19387 16 57462660-57472009 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040919, HPA041826" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040919: AB_10795483, HPA041826: AB_10793935" "unprognostic (2.10e-2)" "unprognostic (4.42e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.90e-1)" "unprognostic (9.54e-2)" "unprognostic (1.95e-1)" "unprognostic (2.48e-2)" "unprognostic (2.60e-2)" "unprognostic (6.63e-2)" "prognostic favorable (3.03e-6)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.20e-1)" "unprognostic (5.43e-3)" 33.8 41.9 50.5 30.7 51.7 44.3 40.0 52.7 60.8 37.1 49.5 35.0 33.4 39.6 67.7 31.5 47.4 31.6 52.6 51.0 53.7 60.3 62.8 48.1 39.1 52.3 51.5 50.9 54.8 45.5 55.6 47.2 39.8 52.2 40.8 40.4 59.8 39.3 46.4 74.8 33.9 32.0 41.0 52.2 31.1 36.7 25.6 51.4 48.1 41.2 61.9 45.3 39.5 31.4 55.1 59.3 94.0 81.2 72.7 72.7 62.9 67.6 75.4 84.9 126.0 82.3 121.7 74.7 65.8 86.4 89.3 75.6 60.5 111.9 83.5 134.2 30.2 77.0 51.1 53.5 142.0 81.8 95.0 94.4 57.8 66.4 96.7 88.7 66.6 74.8 90.0 90.2 37.3 81.6 78.6 106.9 98.6 118.4 72.1 138.0 151.4 94.4 120.5 99.7 56.7 102.5 117.4 122.9 69.8 81.4 74.0 51.6 85.2 54.4 76.3 76.3 56.8 89.0 82.2 76.2 135.0 75.3 79.5 102.5 79.8 38.3 70.3 44.6 37.8 49.2 52.4 50.6 42.8 38.1 48.4 60.4 57.4 96.9 64.6 49.5 31.2 54.9 60.5 50.5 51.7 52.7 60.8 51.0 53.7 52.3 51.5 50.9 52.2 52.2 51.4 55.1 49.5 25.6 43.0 11.1 49.2 31.0 46.0 51.3 30.1 81.6 39.4 52.5 11.0 41.5 31.9 27.6 56.3 78.8 49.8 38.2 92.0 62.9 5.6 25.0 25.4 39.0 38.2 35.6 13.3 65.8 80.8 40.5 15.8 22.3 61.0 46.1 23.2 25.1 41.2 52.2 13.9 34.5 48.8 22.9 30.3 8.4 51.6 22.7 40.9 8.4 49.1 102.7 58.7 8.0 9.6 59.5 44.6 51.9 40.0 43.9 63.8 120.4 29.4 93.9 46.0 30.0 49.1 50.4 66.4 30.0 30.0 92.9 52.9 49.0 38.4 43.5 PARD6A "PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40" ENSG00000102981 "Par-6 family cell polarity regulator alpha" Q9NPB6 16 67660946-67662774 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8;testis: 43.2" "Cell type enriched" "Detected in many" 4 "Late spermatids: 266.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 27.9;RPMI-8226: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009733, HPA041551" Approved Supported "Cell Junctions,Actin filaments,Cytosol" No No "Cell Junctions, Actin filaments" Cytosol "CAB009733: AB_2159676, HPA041551: AB_2677545" "prognostic favorable (5.40e-4)" "unprognostic (6.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (6.59e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-3)" "unprognostic (9.13e-2)" "prognostic favorable (3.08e-7)" "unprognostic (9.22e-3)" "unprognostic (6.69e-2)" "unprognostic (1.25e-1)" "unprognostic (1.39e-2)" 3.0 8.1 23.4 2.4 23.1 1.3 2.8 30.9 38.8 2.0 17.6 6.1 1.1 2.6 2.1 2.0 2.7 1.9 3.5 26.7 21.0 7.2 6.6 3.1 3.1 23.3 22.2 23.2 3.9 28.1 6.7 30.4 0.7 25.3 3.6 1.0 2.7 2.7 2.7 8.8 1.7 4.1 1.6 20.0 4.9 6.0 43.2 24.4 3.5 2.4 5.3 2.2 3.8 1.7 24.1 8.9 9.4 2.6 23.5 1.7 0.4 4.7 0.2 1.1 3.4 3.2 4.7 3.6 14.8 4.3 0.3 1.2 7.0 5.2 1.1 0.7 6.9 5.0 6.0 4.1 5.5 2.4 2.5 13.5 0.1 0.5 3.2 1.3 2.1 1.7 21.7 0.6 3.4 0.6 8.7 15.6 3.2 3.3 12.0 6.0 27.9 1.7 24.5 8.8 5.1 21.8 11.7 1.4 3.2 3.7 0.7 19.9 0.9 1.4 0.3 0.8 2.1 4.6 3.5 12.1 13.5 2.6 5.3 1.0 2.1 0.9 0.4 4.3 0.6 7.8 10.9 5.9 5.4 1.1 8.3 2.8 2.2 3.4 1.3 0.1 5.1 6.3 2.0 23.4 23.1 30.9 38.8 26.7 21.0 23.3 22.2 23.2 25.3 20.0 24.4 24.1 4.4 3.2 5.8 2.0 17.0 0.9 2.2 1.6 1.2 11.1 7.7 6.7 1.7 10.0 2.6 20.2 4.2 5.7 8.2 3.5 33.2 7.2 61.0 4.1 0.5 3.2 34.0 4.0 7.2 15.0 0.4 3.3 6.1 2.7 5.7 5.2 3.9 4.6 4.3 32.0 7.3 3.3 0.0 4.1 5.7 266.5 3.7 4.7 5.4 3.7 2.2 19.1 1.0 2.0 2.2 6.0 2.1 1.5 12.1 2.1 2.9 16.3 3.4 10.1 0.0 8.0 9.7 5.5 3.9 1.4 1.6 2.9 15.0 1.9 4.7 2.4 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 21.4" "Cell type enhanced" "Detected in many" "Early spermatids: 143.0;Spermatocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 9.5;naive B-cell: 13.4;T-reg: 5.6" "Group enriched" "Detected in many" 9 "B-cells: 13.4;T-cells: 5.6" "Cell line enhanced" "Detected in many" "AF22: 13.2;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: AB_2678140" "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favorable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favorable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 2.9 4.9 1.6 5.5 2.5 3.3 9.7 6.0 5.4 2.9 2.8 1.4 4.5 7.6 2.6 3.1 2.6 2.4 5.4 5.9 4.0 1.9 3.0 4.4 5.1 5.2 5.3 4.9 2.4 4.1 9.0 1.7 5.7 4.2 3.4 9.4 3.4 3.3 3.6 5.2 4.3 1.9 4.7 3.9 2.6 21.4 5.1 3.4 4.2 4.1 5.5 2.1 4.2 5.6 1.1 0.9 13.2 6.4 2.6 3.3 2.2 1.4 3.0 2.9 4.6 1.9 0.8 2.5 2.3 2.6 3.2 1.9 4.4 2.0 3.5 3.9 5.0 0.5 0.8 0.8 1.6 0.9 2.8 2.9 3.2 2.0 1.2 5.0 2.3 0.6 1.7 1.8 3.2 3.3 1.5 0.9 5.2 3.9 0.6 6.0 2.8 4.5 3.3 0.4 13.2 6.3 1.8 1.1 1.5 5.6 4.5 3.0 4.5 3.1 3.2 1.1 0.9 4.4 2.4 10.2 1.0 2.5 3.0 0.0 0.5 0.4 2.0 0.0 1.8 9.5 2.1 1.5 0.9 13.4 1.3 0.5 0.4 1.0 0.5 0.0 5.6 0.8 4.9 5.5 9.7 6.0 5.4 5.9 5.1 5.2 5.3 5.7 4.7 5.1 5.6 7.4 0.0 4.2 13.7 28.7 8.0 8.7 7.2 23.3 41.8 15.2 12.4 1.2 11.5 4.9 16.5 45.9 5.8 11.8 23.5 21.5 9.7 143.0 8.5 11.5 8.4 23.4 6.1 28.3 4.8 5.2 7.7 29.0 14.8 9.5 13.5 12.5 1.8 7.9 32.0 30.4 11.3 6.1 10.6 13.4 57.4 12.5 10.3 3.6 8.4 3.7 25.8 9.2 22.1 13.7 6.2 16.7 12.4 22.6 8.0 42.8 10.8 4.7 51.6 13.1 6.3 9.2 79.4 20.8 16.1 7.5 6.2 15.4 6.3 7.7 4.3 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025754-58046901 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 11.4 3.9 8.1 4.5 5.4 0.5 7.6 6.3 10.5 5.7 4.5 26.9 40.5 3.6 1.1 4.6 6.1 14.4 35.9 6.2 7.6 15.0 50.5 10.0 2.1 13.3 9.7 5.4 1.1 18.6 12.8 8.9 28.7 16.0 4.4 14.5 1.5 8.5 9.5 7.0 4.3 33.3 3.7 4.9 9.4 29.9 35.1 17.9 1.0 47.1 5.6 1.3 5.1 2.8 11.2 15.3 11.4 5.8 30.4 6.0 0.3 93.6 1.4 0.8 5.4 1.2 9.1 38.3 0.2 17.7 1.6 4.2 21.0 5.1 4.4 1.6 0.1 10.0 0.1 4.9 51.1 7.7 0.3 19.5 3.1 7.8 0.9 2.3 8.4 3.7 8.5 12.9 0.1 1.8 7.6 0.7 2.6 17.2 44.6 3.2 7.6 0.7 8.3 16.6 5.4 1.6 10.4 20.0 47.3 9.5 13.2 5.2 8.2 3.4 0.4 9.1 3.5 1.3 0.2 0.1 0.3 1.9 2.3 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.1 5.4 6.3 10.5 6.2 7.6 13.3 9.7 5.4 16.0 4.9 17.9 11.2 14.3 19.2 14.4 9.1 0.7 2.5 1.0 4.9 2.8 3.4 5.0 3.0 24.7 55.8 12.6 18.4 16.7 48.2 1.6 109.3 1.9 35.7 5.0 3.6 1.1 17.2 11.4 2.7 1.4 12.0 49.2 4.5 35.2 6.4 0.0 18.6 13.6 39.2 12.9 1.7 1.2 33.3 10.2 3.0 0.3 6.9 0.9 0.9 1.8 1.0 0.0 2.1 0.0 4.5 1.4 13.3 38.5 3.4 0.3 1.3 67.3 7.3 6.0 1.9 0.0 0.7 2.4 0.9 4.6 3.3 2.3 48.4 0.7 23.2 45.0 1.7 USB1 "C16orf57, FLJ13154, HVSL1, Mpn1" ENSG00000103005 "U6 snRNA biogenesis phosphodiesterase 1" Q9BQ65 16 57999546-58021618 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041791, HPA059854" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041791: AB_10793933, HPA059854: AB_2684143" "unprognostic (2.79e-1)" "unprognostic (3.84e-2)" "unprognostic (1.21e-2)" "unprognostic (9.65e-2)" "unprognostic (2.03e-1)" "unprognostic (2.23e-3)" "prognostic unfavorable (6.69e-7)" "unprognostic (4.30e-3)" "unprognostic (2.92e-1)" "unprognostic (4.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (1.06e-3)" "unprognostic (5.04e-2)" 21.7 27.7 23.6 27.9 23.0 31.2 14.9 22.0 25.7 15.6 20.8 21.5 14.4 19.2 16.4 17.6 15.8 14.9 25.0 23.3 25.5 16.9 30.1 20.7 20.3 26.1 24.3 22.9 11.9 17.8 14.9 13.6 16.8 25.9 17.4 18.8 6.8 14.2 18.5 15.7 15.3 18.2 25.0 22.8 26.0 19.6 20.3 25.3 18.6 19.2 13.1 21.0 28.4 15.5 27.9 53.2 109.2 36.5 69.7 46.4 32.5 57.6 43.9 58.2 68.6 48.3 70.9 31.0 32.5 56.6 65.3 61.0 38.6 58.2 93.6 97.6 31.9 32.9 40.5 43.0 103.8 52.7 54.2 114.1 46.6 54.7 87.2 50.8 45.4 76.1 69.7 55.4 15.4 58.2 56.0 50.1 62.3 60.6 47.7 88.5 49.3 32.9 53.8 49.1 63.4 17.6 41.6 114.8 29.8 27.6 57.6 14.8 54.5 82.6 40.2 59.0 43.3 60.5 23.4 37.3 58.9 48.3 51.1 50.0 112.3 58.4 86.8 57.1 67.8 37.4 19.5 33.2 43.7 54.8 13.4 20.3 36.7 162.2 45.5 95.5 23.8 45.1 32.4 23.6 23.0 22.0 25.7 23.3 25.5 26.1 24.3 22.9 25.9 22.8 25.3 27.9 12.9 0.0 9.2 6.2 12.2 18.1 17.7 22.8 13.1 3.2 15.2 13.0 13.0 14.3 12.4 9.2 4.2 29.3 33.2 30.2 11.7 39.5 1.3 9.5 10.7 13.5 12.6 9.0 10.4 46.2 55.3 13.3 14.3 9.7 16.5 6.3 17.5 13.0 42.0 6.7 6.2 15.9 28.5 19.8 16.4 1.4 8.1 26.5 14.2 5.6 37.2 11.5 48.4 2.5 5.2 49.7 20.0 11.7 16.4 14.7 18.3 16.2 9.7 3.6 6.6 7.7 15.3 12.6 22.5 10.9 13.1 20.5 24.3 13.0 10.2 15.2 CYB5B CYB5-M ENSG00000103018 "Cytochrome b5 type B" O43169 16 69424619-69466264 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 320.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007893 Approved Approved "Endoplasmic reticulum,Centriolar satellite,Cytosol" NA NA 99000 "Endoplasmic reticulum" "Centriolar satellite, Cytosol" "HPA007893: AB_1847369" "unprognostic (1.13e-1)" "unprognostic (4.47e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (2.87e-3)" "unprognostic (4.35e-3)" "unprognostic (3.87e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-2)" "unprognostic (3.10e-1)" "prognostic favorable (6.38e-5)" "unprognostic (9.69e-3)" "unprognostic (4.66e-2)" "unprognostic (3.78e-2)" "unprognostic (1.30e-2)" 60.7 320.6 49.7 51.9 51.4 21.0 50.9 44.1 70.5 46.2 41.9 93.5 70.1 49.7 73.4 59.9 58.7 45.8 58.5 52.7 50.1 72.6 84.5 54.6 69.3 47.9 43.5 48.3 44.4 40.5 78.3 28.8 74.4 49.7 48.0 117.1 49.8 36.6 48.7 66.4 46.2 68.3 62.1 41.5 50.0 49.7 39.0 47.3 74.9 54.6 78.9 77.6 81.2 38.5 47.7 186.2 576.4 232.9 144.9 105.1 139.3 99.5 162.3 224.1 266.0 249.2 406.1 221.3 168.0 159.3 157.9 216.0 214.5 224.4 235.0 300.0 90.2 85.5 81.2 97.1 479.1 154.7 169.1 172.4 120.9 116.3 315.9 149.6 111.8 254.7 190.5 133.6 78.4 165.2 241.2 278.9 204.1 173.5 171.4 78.4 260.0 128.7 184.3 359.3 208.7 135.7 69.7 431.6 82.0 142.2 119.0 159.0 133.2 115.9 152.2 124.5 102.2 145.5 94.7 227.0 516.6 157.0 138.0 180.0 121.1 57.6 71.5 103.8 80.0 85.0 68.8 76.9 81.8 69.8 63.1 62.8 75.5 17.1 96.4 59.7 124.2 134.6 105.6 49.7 51.4 44.1 70.5 52.7 50.1 47.9 43.5 48.3 49.7 41.5 47.3 47.7 36.2 44.8 46.8 44.7 47.2 49.8 49.2 84.0 66.0 22.8 28.6 26.0 25.0 30.0 51.4 62.5 6.2 159.8 66.7 112.7 78.2 66.2 18.8 56.4 33.3 61.7 23.4 38.7 40.9 70.4 94.1 38.4 27.5 87.7 60.2 36.6 43.9 54.9 64.8 30.3 30.4 76.6 83.4 30.1 57.5 22.7 44.4 33.4 62.2 24.4 55.8 63.0 96.8 23.6 39.4 70.5 78.8 44.4 28.1 34.9 75.9 62.9 49.5 31.6 46.0 22.2 36.5 48.1 46.6 44.9 42.3 59.8 54.1 84.8 61.6 50.4 CCDC113 "DKFZp434N1418, HSPC065" ENSG00000103021 "Coiled-coil domain containing 113" Q9H0I3 16 58231157-58283836 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 31.6;testis: 18.3" "Group enriched" "Detected in many" 5 "Early spermatids: 182.3;Endometrial ciliated cells: 140.3;Late spermatids: 171.8;Respiratory ciliated cells: 194.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "basophil: 6.5" "Lineage enriched" "Detected in single" 27 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "SiHa: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040759, HPA040869" Uncertain NA NA "HPA040759: AB_2677121, HPA040869: AB_2677180" "unprognostic (8.50e-2)" "unprognostic (3.39e-2)" "prognostic favorable (8.65e-4)" "prognostic favorable (7.01e-4)" "unprognostic (2.40e-1)" "unprognostic (4.87e-4)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "unprognostic (3.21e-1)" "unprognostic (4.59e-1)" "unprognostic (2.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.09e-2)" "unprognostic (1.21e-1)" "unprognostic (6.74e-2)" "unprognostic (1.65e-3)" "unprognostic (5.61e-2)" 2.2 2.8 9.9 1.1 5.5 0.3 2.5 4.5 5.3 2.5 9.1 1.4 0.5 2.0 1.8 1.8 31.6 1.7 3.7 5.5 5.5 1.8 1.1 3.8 0.7 7.1 7.7 4.2 1.7 1.4 6.9 3.4 0.7 6.0 2.4 1.6 9.6 1.2 2.0 3.1 2.5 0.6 1.6 9.2 0.4 1.7 18.3 5.4 0.4 2.7 2.4 0.6 1.5 0.9 5.8 5.7 4.7 2.1 8.6 4.6 4.9 6.8 3.3 2.1 2.7 0.6 0.6 7.2 0.1 4.3 1.0 2.9 0.8 0.7 3.1 2.6 0.6 1.6 0.1 3.4 0.6 4.6 2.9 0.6 2.6 5.4 0.7 7.4 1.7 0.5 2.7 5.1 0.0 0.6 4.2 0.2 0.8 3.2 0.4 7.0 1.7 0.0 1.1 4.8 1.6 2.2 3.5 28.3 2.3 1.2 0.9 8.0 2.9 0.2 2.8 2.8 1.8 1.0 2.2 1.5 1.5 6.6 1.8 2.0 6.5 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.0 9.9 5.5 4.5 5.3 5.5 5.5 7.1 7.7 4.2 6.0 9.2 5.4 5.8 1.4 0.0 2.8 6.2 0.3 0.5 1.4 5.4 3.4 5.7 3.8 4.1 11.2 2.8 19.9 1.8 12.5 0.0 0.1 1.2 3.9 5.5 182.3 140.3 6.7 1.8 1.2 0.0 9.6 3.8 1.9 3.4 0.5 4.5 0.0 2.9 0.4 2.1 0.1 3.3 8.6 1.2 4.1 0.0 0.7 171.8 4.7 0.6 1.8 1.0 0.0 7.7 0.0 4.0 5.8 2.7 0.3 4.1 0.5 1.3 0.1 1.3 194.6 12.1 0.0 3.3 3.4 32.1 8.7 1.0 1.6 1.1 0.6 10.4 1.1 0.8 PRSS54 "CT67, FLJ25339, KLKBL4" ENSG00000103023 "Serine protease 54" Q6PEW0 16 58279997-58295047 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 125 "testis: 41.7" "Group enriched" "Detected in some" 34 "Early spermatids: 526.0;Late spermatids: 208.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041549 Enhanced "Secreted in male reproductive system" NA NA "HPA041549: AB_10795640" "unprognostic (1.13e-1)" "unprognostic (3.24e-2)" "unprognostic (3.09e-2)" "unprognostic (3.08e-1)" "unprognostic (4.88e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 526.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 208.3 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NME3 "DR-nm23, NDPKC, NM23-H3" ENSG00000103024 "NME/NM23 nucleoside diphosphate kinase 3" Q13232 16 1770286-1771730 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 70.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041113, HPA052733" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 12000000 Nucleoplasm Cytosol "HPA041113: AB_2677305, HPA052733: AB_2681930" "prognostic favorable (6.81e-5)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.22e-3)" "unprognostic (4.40e-2)" "unprognostic (4.43e-2)" "unprognostic (7.09e-3)" "unprognostic (1.79e-1)" "unprognostic (3.84e-1)" "unprognostic (3.64e-1)" "unprognostic (6.11e-3)" 31.6 85.1 16.5 8.1 16.5 3.9 34.5 16.8 36.6 41.8 12.4 42.7 16.0 37.0 3.4 27.4 44.7 2.1 35.0 15.7 20.1 44.4 36.6 29.3 5.4 20.3 17.9 14.5 44.1 37.5 4.6 72.4 5.3 18.1 59.9 3.1 1.8 36.2 13.1 17.2 28.4 34.1 3.3 18.2 39.7 38.9 16.2 17.1 1.0 40.7 3.1 1.9 38.8 33.8 20.8 1.6 26.9 0.6 21.8 6.1 3.2 2.5 15.7 4.5 2.7 2.1 0.0 31.8 0.4 42.6 2.2 2.8 23.0 1.3 8.8 0.3 32.1 70.9 0.0 12.0 13.0 11.3 5.5 9.8 14.0 7.9 2.7 1.5 5.1 5.6 0.2 11.2 4.4 2.7 40.4 0.4 10.8 28.0 5.4 21.5 15.3 0.3 43.5 4.5 1.2 30.6 23.6 47.1 35.2 4.2 1.2 33.7 13.1 19.9 5.8 21.4 18.5 10.8 11.1 3.7 2.5 8.1 0.9 13.3 10.0 50.7 34.6 33.3 49.6 32.9 36.8 46.3 31.4 45.1 31.9 39.6 31.3 10.8 44.8 55.4 70.3 45.4 41.3 16.5 16.5 16.8 36.6 15.7 20.1 20.3 17.9 14.5 18.1 18.2 17.1 20.8 128.8 35.3 62.7 69.9 64.6 72.5 141.3 97.7 179.8 116.3 147.3 165.6 28.0 90.1 76.6 126.9 60.5 86.6 77.9 76.2 60.7 62.9 22.1 66.5 102.9 84.1 135.5 25.7 34.6 37.6 46.3 100.9 76.0 77.6 50.8 71.6 99.9 63.0 74.8 65.6 30.2 109.4 50.8 60.3 91.0 20.3 149.5 71.1 81.8 29.0 136.5 126.9 77.2 40.7 63.7 37.0 104.7 127.5 93.1 98.4 157.2 150.2 70.9 126.7 118.3 75.9 100.8 2.0 40.4 100.9 65.6 46.1 87.3 183.8 107.6 100.6 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 499.7;heart muscle: 227.5" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 433.0;Horizontal cells: 516.5" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 13.2 129.9 112.4 2.9 149.7 0.1 11.5 250.9 262.4 13.1 0.0 5.6 3.7 25.7 6.8 20.9 8.1 3.6 227.5 197.8 167.9 1.7 1.0 17.9 4.1 345.2 143.8 171.9 1.8 2.7 12.1 72.1 2.1 402.4 3.1 3.2 116.5 5.3 30.5 8.8 20.0 4.0 13.4 50.4 22.1 4.1 48.4 250.9 4.5 2.8 3.6 4.0 3.7 58.0 499.7 0.2 16.9 15.8 3.1 0.4 2.9 1.3 5.2 8.2 2.5 1.7 6.5 4.3 0.4 32.5 4.0 28.6 1.5 1.2 0.9 2.2 0.0 3.3 0.7 3.3 4.7 4.4 0.3 0.3 3.6 0.3 1.6 0.0 26.8 21.0 0.1 0.3 0.2 2.4 4.3 1.7 0.2 1.4 0.6 12.4 0.4 4.4 0.4 0.7 10.6 49.2 18.4 0.5 1.4 0.1 2.0 0.6 0.2 7.7 2.1 6.0 0.6 0.8 0.9 0.5 5.7 11.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.4 149.7 250.9 262.4 197.8 167.9 345.2 143.8 171.9 402.4 50.4 250.9 499.7 8.9 0.0 1.9 53.5 0.2 2.0 6.8 0.6 1.2 52.3 0.7 1.5 433.0 0.0 0.3 0.0 4.2 0.0 0.1 0.6 0.0 4.0 5.9 4.0 5.6 17.0 1.8 0.0 95.7 0.2 0.1 10.1 1.5 11.5 0.0 13.6 29.3 0.3 0.0 516.5 94.3 0.1 2.0 1.0 1.2 10.8 4.4 0.3 7.2 22.5 0.0 82.6 0.0 29.7 14.1 3.7 0.0 2.6 0.0 4.9 0.0 0.2 0.2 33.4 6.6 3.5 6.7 4.8 6.5 14.5 5.8 0.0 0.3 0.3 0.0 8.8 PSMD7 "MOV34, P40, Rpn8, S12" ENSG00000103035 "Proteasome 26S subunit, non-ATPase 7" P51665 16 74296814-74306288 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 596.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019379, HPA049824, HPA056069" Enhanced Enhanced Nucleoplasm NA NA 190000 Nucleoplasm "CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025" "unprognostic (4.75e-3)" "unprognostic (1.30e-1)" "unprognostic (2.84e-2)" "unprognostic (6.95e-2)" "unprognostic (7.62e-2)" "prognostic unfavorable (6.64e-5)" "prognostic unfavorable (7.71e-6)" "unprognostic (1.97e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (1.34e-2)" "unprognostic (2.52e-2)" "unprognostic (5.06e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.86e-2)" 65.1 79.4 56.3 52.5 57.5 127.8 58.0 58.0 69.8 46.3 54.9 70.8 47.8 60.0 59.8 86.4 44.3 41.5 107.9 57.0 58.4 51.4 75.7 53.0 62.8 58.5 58.5 56.2 38.1 49.4 49.4 42.1 70.8 59.3 68.9 66.1 47.7 60.1 59.7 268.0 85.2 56.0 62.9 59.5 56.9 58.5 42.3 57.7 72.6 42.4 160.9 71.7 73.8 62.7 61.1 140.1 226.2 170.6 89.0 120.1 122.1 209.8 191.6 166.2 236.2 212.7 301.9 189.8 190.1 207.7 156.7 103.2 176.3 135.0 175.1 215.4 113.3 146.3 147.2 169.1 235.9 156.0 241.3 241.3 112.4 176.3 213.4 213.0 106.0 207.0 119.2 222.2 82.1 153.5 345.4 147.0 232.1 184.9 145.0 113.8 198.8 106.9 251.6 125.1 207.3 106.9 119.3 185.7 70.4 114.9 130.5 148.7 166.6 187.5 137.5 116.0 152.5 146.5 174.6 241.4 560.2 186.6 174.1 145.2 152.4 163.6 193.4 133.2 176.2 130.5 149.7 131.8 141.2 201.9 110.5 126.6 131.2 98.7 139.5 187.4 172.2 168.2 187.8 56.3 57.5 58.0 69.8 57.0 58.4 58.5 58.5 56.2 59.3 59.5 57.7 61.1 74.4 67.3 59.4 16.6 84.2 104.4 183.5 167.8 64.3 59.6 47.0 47.5 53.3 57.2 114.9 46.0 8.4 337.1 69.5 120.4 80.3 158.5 153.8 76.3 80.6 96.2 85.5 121.0 22.7 190.9 229.8 87.7 67.8 80.3 103.9 76.7 66.0 147.6 188.5 57.2 21.3 100.1 122.1 75.1 91.2 25.3 56.5 95.1 99.6 9.4 119.5 86.0 81.4 15.6 25.7 164.0 104.1 65.5 121.4 259.6 93.9 109.4 88.1 59.9 92.1 68.4 186.1 184.2 88.7 103.6 129.3 596.1 86.2 114.0 110.3 197.8 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6, protein lysine methyltransferase" Q8TBK2 16 58515479-58523842 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: AB_2682182" "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 7.8 12.5 4.0 3.0 3.9 2.6 9.2 8.9 4.6 9.5 3.8 8.1 3.9 8.5 5.5 13.5 9.8 2.7 9.2 4.1 4.1 10.3 13.6 7.0 4.6 3.9 4.2 4.0 9.1 19.8 6.5 12.6 2.5 5.2 11.0 4.3 7.9 11.2 6.0 15.1 14.6 9.3 3.4 3.7 10.7 11.5 12.8 3.9 2.8 12.3 4.0 4.5 8.4 10.9 4.1 2.5 6.1 1.3 10.7 4.3 2.8 15.9 4.0 5.4 7.1 3.8 10.1 6.1 19.9 5.4 4.6 0.9 8.1 9.0 6.3 4.9 2.2 23.6 0.9 11.0 17.2 4.3 14.4 7.8 3.8 13.2 5.6 8.8 4.8 4.5 0.2 14.7 2.6 1.5 10.1 0.3 17.7 21.0 9.7 9.6 0.4 2.5 26.7 7.3 0.4 19.6 12.6 16.8 15.9 7.8 6.2 10.0 2.0 3.7 2.5 6.0 3.1 7.3 11.7 8.1 13.7 5.3 6.9 4.6 2.5 1.1 0.2 2.0 1.5 1.4 1.5 1.6 2.2 1.8 1.5 2.0 2.2 0.7 4.4 1.6 2.0 1.6 1.3 4.0 3.9 8.9 4.6 4.1 4.1 3.9 4.2 4.0 5.2 3.7 3.9 4.1 5.2 6.4 6.9 6.8 7.1 13.9 10.5 7.5 13.6 14.3 12.0 11.0 7.6 17.2 8.5 9.2 14.6 17.5 8.6 5.3 1.9 10.1 9.2 10.8 6.9 6.8 4.8 10.3 11.5 12.2 9.9 8.4 8.2 10.0 1.3 14.9 4.2 7.9 3.5 11.8 11.3 5.0 2.0 3.5 5.6 16.9 9.0 3.4 5.4 5.6 5.6 15.0 6.2 7.5 4.7 6.1 4.2 10.1 6.8 13.8 6.5 9.4 12.0 13.4 13.1 10.1 7.4 15.0 22.9 12.1 12.1 12.6 7.1 6.1 7.4 6.2 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58684770 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.1" "Group enriched" "Detected in all" 13 "Early spermatids: 271.8;Late spermatids: 753.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041777, HPA049428" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782, HPA049428: " "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 6.1 11.5 7.3 6.1 7.5 2.6 5.3 5.7 9.0 5.2 5.9 5.1 4.3 5.6 6.3 6.5 4.0 5.6 12.7 7.5 7.4 7.3 13.7 5.5 4.3 7.4 7.4 8.4 4.6 4.9 14.2 7.2 7.5 7.4 5.6 5.9 4.8 6.2 4.6 9.5 5.1 5.5 7.5 5.6 10.4 5.4 33.1 8.7 3.6 7.9 8.4 4.7 5.4 5.0 7.3 6.9 10.9 10.8 16.5 22.0 12.9 19.3 16.2 18.7 22.7 15.6 9.9 11.0 4.5 8.9 22.9 17.9 15.9 10.2 11.7 13.3 2.8 9.4 5.1 9.3 16.5 32.9 10.6 14.0 25.9 23.6 16.1 10.3 12.3 23.5 10.4 14.9 6.3 16.7 8.0 4.3 6.3 11.7 7.5 16.0 15.2 11.6 12.1 10.0 15.4 7.9 11.3 25.7 17.0 7.0 14.4 7.6 4.2 18.7 12.3 9.3 21.8 5.0 9.7 6.7 5.2 16.8 6.3 9.3 0.1 6.8 2.0 4.0 6.6 2.2 1.3 2.4 2.9 4.5 2.5 1.9 2.1 0.5 1.8 6.4 1.7 1.8 5.5 7.3 7.5 5.7 9.0 7.5 7.4 7.4 7.4 8.4 7.4 5.6 8.7 7.3 3.3 3.2 4.4 7.8 2.0 3.8 4.0 4.4 1.2 9.8 4.7 3.2 12.8 4.3 4.8 11.0 12.5 8.4 5.0 3.7 3.9 14.0 271.8 3.5 6.8 6.2 13.1 2.1 13.3 8.5 9.5 5.1 9.7 6.0 1.3 10.7 8.2 9.3 38.6 16.8 15.5 3.1 12.2 10.1 8.2 753.3 9.6 11.6 8.8 9.4 4.0 7.1 8.2 5.0 7.6 12.8 2.7 8.6 1.8 3.7 4.8 5.9 3.8 7.1 6.6 4.8 5.1 6.9 7.6 4.6 4.3 15.3 2.7 8.6 4.9 3.2 VAC14 "ArPIKfyve, FLJ10305, TAX1BP2" ENSG00000103043 "VAC14 component of PIKFYVE complex" Q08AM6 16 70687439-70801160 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027766, HPA075382" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA027766: AB_1848651, HPA075382: " "unprognostic (9.25e-2)" "prognostic favorable (8.33e-5)" "unprognostic (2.83e-2)" "unprognostic (1.51e-1)" "unprognostic (8.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.21e-2)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.26e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.61e-1)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (1.80e-1)" 16.9 25.2 20.8 14.6 18.8 11.4 17.2 18.8 24.9 15.6 16.9 16.7 12.2 17.1 8.7 19.1 15.2 10.3 19.3 20.1 19.1 26.2 27.3 17.0 24.9 20.7 19.4 18.6 14.4 23.9 17.6 16.7 11.0 21.1 17.7 8.4 6.9 17.5 10.8 24.5 22.6 18.0 11.7 19.0 22.7 20.8 16.3 21.1 15.7 21.6 12.1 14.0 18.2 15.0 20.8 25.9 25.3 21.0 23.6 29.9 20.3 32.0 18.5 29.0 34.6 15.5 31.6 41.0 33.3 23.3 22.5 39.9 32.3 27.8 30.1 16.3 10.0 28.2 16.9 18.6 39.5 76.8 29.1 33.7 36.0 30.9 50.7 45.1 20.7 33.0 29.2 30.1 14.6 30.1 37.3 27.1 48.5 36.9 20.4 22.7 32.3 14.9 48.6 16.7 17.4 24.9 26.7 60.9 18.5 43.0 15.2 27.4 27.0 26.7 45.7 25.9 29.2 20.4 20.4 27.5 62.9 76.1 25.1 21.3 0.8 2.7 4.4 1.5 3.6 1.4 2.5 2.2 3.1 5.6 3.9 2.0 1.8 1.0 2.4 3.6 3.1 1.3 1.1 20.8 18.8 18.8 24.9 20.1 19.1 20.7 19.4 18.6 21.1 19.0 21.1 20.8 5.1 3.2 4.2 15.0 10.1 4.2 7.8 7.0 9.6 8.4 8.4 7.4 12.6 12.8 8.0 3.7 2.1 16.7 4.0 11.5 5.9 19.2 20.4 14.2 5.4 8.2 9.1 5.7 11.7 22.5 29.2 5.9 11.7 6.7 5.7 11.6 16.4 15.9 42.9 10.1 13.8 10.0 14.2 18.3 13.5 74.4 6.2 15.6 10.6 10.3 19.2 6.8 8.2 8.5 16.3 20.8 10.8 3.4 15.8 8.9 13.7 15.0 14.6 7.7 6.6 5.9 7.9 4.8 13.5 10.3 9.1 19.6 6.5 8.7 12.6 7.1 HAS3 ENSG00000103044 "Hyaluronan synthase 3" O00219 16 69105653-69118719 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.8;urinary bladder: 93.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 162.3;Basal prostatic cells: 51.6;Basal respiratory cells: 107.1;Suprabasal keratinocytes: 158.6;Urothelial cells: 115.5" "Group enriched" "Detected in many" 8 "cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 52.5;PC-3: 270.5;RT4: 111.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031554, CAB033850" Supported Approved Microtubules NA NA Microtubules "CAB033850: AB_2116418, HPA031554: AB_10670703" "unprognostic (3.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (7.59e-3)" "unprognostic (2.86e-3)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (2.46e-1)" "unprognostic (3.27e-3)" "unprognostic (3.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-2)" "unprognostic (3.40e-3)" 0.8 0.5 0.8 0.8 1.0 0.9 7.5 1.1 1.1 2.8 0.7 5.4 2.9 0.9 1.2 33.8 1.2 4.9 0.7 0.5 0.9 1.1 1.3 20.2 0.4 0.9 0.9 0.7 1.4 1.3 0.4 1.7 3.4 1.2 3.7 3.1 0.8 5.4 1.5 1.2 7.8 2.3 0.6 0.3 0.8 12.9 3.6 0.9 0.6 6.0 1.0 2.9 93.7 10.4 1.0 3.5 17.1 1.0 0.9 0.3 0.4 6.6 1.1 0.4 1.0 0.4 3.4 9.0 0.7 2.0 0.4 4.0 52.5 2.9 31.5 1.0 0.2 1.3 0.0 0.2 0.6 0.1 0.3 0.9 0.5 8.6 1.0 3.0 4.0 0.7 0.6 0.1 0.4 0.3 1.8 1.2 0.7 15.5 18.7 270.5 2.0 0.1 0.2 28.3 111.6 19.2 0.8 1.8 0.1 0.3 3.1 0.6 0.8 0.3 0.9 0.9 29.9 1.8 1.0 0.9 0.2 1.0 0.0 0.6 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.8 1.0 1.1 1.1 0.5 0.9 0.9 0.9 0.7 1.2 0.3 0.9 1.0 4.2 0.0 30.8 0.7 0.2 162.3 51.6 107.1 8.6 1.1 1.6 6.1 1.4 0.0 12.2 0.0 2.1 1.0 0.1 16.4 0.0 4.5 10.2 0.7 0.3 2.4 0.0 0.4 1.0 3.6 0.9 1.1 5.1 2.7 0.0 0.4 1.1 0.2 0.3 0.0 2.1 0.7 2.0 0.0 6.5 22.7 1.2 0.5 3.6 0.0 0.0 0.1 0.0 0.5 0.8 2.4 0.2 0.4 0.6 18.4 0.1 0.7 3.0 1.0 0.0 0.9 1.9 0.5 0.7 25.6 158.6 0.3 1.1 0.1 2.2 115.5 TANGO6 "FLJ12688, KIAA1746, TMCO7" ENSG00000103047 "Transport and golgi organization 6 homolog" Q9C0B7 16 68843531-69085182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041312 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA041312: AB_10796342" "unprognostic (8.55e-2)" "unprognostic (6.64e-2)" "unprognostic (4.66e-2)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (2.22e-1)" "unprognostic (9.82e-3)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.55e-2)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (6.02e-2)" 4.8 3.0 2.5 4.5 3.8 3.4 4.6 3.5 3.1 4.3 4.6 3.5 2.5 4.3 1.9 3.6 3.8 2.8 3.2 2.5 3.4 5.8 13.0 3.7 4.9 2.8 3.0 2.6 4.2 3.2 6.0 2.5 3.4 3.2 4.0 3.2 4.2 3.2 4.3 8.9 4.2 3.1 4.8 2.4 4.5 4.1 4.4 3.2 4.8 3.3 5.7 4.6 5.6 4.3 3.8 7.1 14.3 4.6 9.9 7.6 8.6 3.3 9.5 7.7 11.5 9.3 9.1 5.7 15.8 5.1 13.2 6.0 5.8 10.6 12.8 14.0 3.8 6.3 3.0 5.4 8.5 6.3 8.0 7.2 6.6 6.7 16.3 14.7 4.7 11.2 7.6 10.6 2.7 10.7 7.1 8.3 6.4 10.2 6.9 7.6 8.9 6.8 17.8 8.4 3.9 4.8 5.6 23.3 1.3 6.3 5.5 4.6 8.9 6.5 10.9 3.9 11.2 6.8 4.9 4.5 10.7 6.9 3.0 7.4 0.0 3.8 2.0 3.4 6.6 3.5 2.7 3.3 3.5 4.8 2.4 2.0 3.3 0.2 2.0 6.2 1.3 4.9 3.1 2.5 3.8 3.5 3.1 2.5 3.4 2.8 3.0 2.6 3.2 2.4 3.2 3.8 5.1 0.0 4.2 23.5 5.4 5.2 9.5 5.0 2.8 8.8 1.5 1.8 3.8 5.7 2.2 7.3 10.4 5.6 3.1 2.1 0.0 2.2 110.2 1.5 3.5 4.8 0.0 7.8 45.4 3.3 2.7 4.0 6.1 3.0 1.3 3.7 3.9 12.3 4.7 5.0 57.4 1.8 4.1 7.6 3.5 50.5 5.6 4.2 5.4 25.3 3.5 3.3 4.1 38.7 51.3 2.7 4.4 3.4 2.9 3.7 1.1 6.0 0.5 10.5 0.0 3.9 3.4 5.7 4.7 4.0 3.0 2.5 7.0 3.2 2.2 9.2 COG4 "COD1, DKFZP586E1519" ENSG00000103051 "Component of oligomeric golgi complex 4" 16 70480568-70523560 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040924, HPA042539" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA040924: AB_2677203, HPA042539: AB_2678044" "unprognostic (1.30e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (1.64e-5)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "unprognostic (3.02e-1)" "unprognostic (3.35e-1)" "unprognostic (1.99e-2)" "unprognostic (1.79e-1)" 18.0 22.2 23.9 13.0 25.0 14.3 15.8 25.7 27.2 20.3 26.3 20.5 10.6 17.6 11.2 30.3 19.9 12.9 23.3 23.5 25.0 16.9 17.1 18.4 15.6 25.6 24.6 22.6 18.9 10.7 28.1 19.2 20.0 26.0 14.6 16.7 14.7 17.2 16.7 68.3 23.3 16.5 19.4 25.0 18.0 17.5 19.4 25.7 22.5 16.1 49.8 17.9 18.6 20.8 26.5 37.3 59.9 47.1 31.3 62.6 43.7 53.0 41.0 53.7 51.0 43.9 48.3 66.7 25.0 57.7 64.9 35.5 53.4 60.8 65.3 70.9 21.5 36.7 23.1 59.8 47.5 36.7 15.3 15.0 51.9 41.9 66.1 40.6 59.7 51.7 31.6 55.9 18.1 57.6 75.9 25.1 23.4 45.2 50.4 30.9 46.8 31.2 57.4 42.3 31.0 43.9 45.5 80.7 30.5 24.3 48.0 77.9 26.4 49.7 46.3 29.1 35.3 29.8 19.1 26.2 78.0 50.7 15.8 46.1 20.6 26.4 23.8 19.7 28.8 14.4 11.8 19.3 17.9 32.8 14.6 16.9 15.7 13.8 14.4 34.4 15.2 24.4 25.1 23.9 25.0 25.7 27.2 23.5 25.0 25.6 24.6 22.6 26.0 25.0 25.7 26.5 13.6 16.0 16.0 21.9 11.0 9.1 12.1 22.6 11.4 24.5 9.2 8.0 23.3 2.8 21.1 3.7 14.6 47.7 13.1 20.8 9.8 23.4 3.1 11.9 13.0 16.8 12.6 12.6 10.9 16.0 26.8 16.5 18.8 13.4 8.8 28.7 16.8 17.8 24.7 8.4 13.0 18.0 24.4 14.1 8.9 6.7 14.6 11.1 8.8 7.5 14.7 29.3 12.3 19.6 19.1 17.6 21.0 19.2 12.3 6.3 21.7 13.8 18.5 29.9 32.9 14.0 18.6 37.5 25.7 13.1 10.7 39.0 12.9 37.3 19.4 8.9 SMPD3 NSMASE2 ENSG00000103056 "Sphingomyelin phosphodiesterase 3" Q9NY59 16 68358327-68448508 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Lipid metabolism, Sphingolipid metabolism" "Developmental protein, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.1;lymphoid tissue: 52.5" "Cell type enhanced" "Detected in many" "dendritic cells: 77.1;Gastric mucus-secreting cells: 70.8;Horizontal cells: 301.2;Proximal enterocytes: 115.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "plasmacytoid DC: 138.9" "Lineage enriched" "Detected in many" 7 "dendritic cells: 138.9" "Cell line enhanced" "Detected in some" "HMC-1: 9.7;MOLT-4: 14.7;RPMI-8226: 12.4;SCLC-21H: 13.4" "Region enhanced" "Detected in all" "basal ganglia: 115.2" "Region enhanced" "Detected in all" "basal ganglia: 67.7" "CAB033885, HPA065535, HPA069383" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB033885: AB_1126788, HPA065535: , HPA069383: " "unprognostic (1.21e-1)" "prognostic favorable (7.72e-4)" "unprognostic (5.61e-3)" "prognostic favorable (3.86e-4)" "unprognostic (2.46e-1)" "unprognostic (5.85e-4)" "unprognostic (7.87e-2)" "unprognostic (8.12e-3)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-3)" "unprognostic (5.02e-3)" "unprognostic (2.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.93e-3)" 3.8 2.1 8.5 3.7 23.3 1.8 2.8 1.6 26.7 2.6 0.1 12.3 62.1 1.4 0.1 2.1 3.8 9.1 1.4 22.8 3.3 1.5 7.5 2.5 4.2 7.3 0.8 5.0 4.9 2.6 0.1 16.7 0.2 6.6 4.6 7.0 6.6 3.0 0.3 2.4 13.2 58.2 0.8 0.0 3.4 23.4 8.7 3.5 52.5 2.7 0.0 2.0 1.7 2.5 2.6 0.3 0.8 0.4 0.1 0.0 0.0 5.5 0.4 0.0 0.4 0.1 3.1 1.0 0.4 0.6 0.3 0.2 1.2 0.0 0.0 0.1 0.3 0.7 0.1 2.7 0.3 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.5 0.0 0.9 0.9 0.3 0.3 0.2 14.7 2.8 0.6 4.9 0.1 0.7 0.2 12.4 0.0 0.1 13.4 2.7 0.4 1.6 0.7 0.2 1.1 0.9 0.0 0.4 0.8 1.4 0.1 2.3 1.2 0.3 0.2 0.9 0.2 4.4 0.0 20.7 2.3 0.1 0.3 1.7 0.2 0.6 0.1 0.9 0.6 0.3 0.1 0.1 0.0 138.9 1.9 1.2 8.5 23.3 1.6 26.7 22.8 3.3 7.3 0.8 5.0 6.6 0.0 3.5 2.6 0.3 3.2 1.1 1.0 2.6 0.1 1.5 0.6 0.0 50.8 1.8 0.6 2.9 15.7 1.5 0.0 0.0 0.0 77.1 44.7 0.0 1.3 8.5 3.0 0.3 0.6 25.8 0.4 33.8 0.9 0.1 5.2 70.8 0.5 0.0 0.2 0.7 9.4 0.3 301.2 20.4 34.7 2.0 1.0 0.5 18.6 15.2 2.9 0.0 1.9 0.6 0.9 1.0 10.6 1.7 1.6 39.9 45.9 2.5 3.6 115.1 0.0 14.6 3.9 0.0 0.2 0.3 10.0 2.1 0.1 1.0 0.0 6.2 0.2 21.6 5.4 SLC7A6OS "FLJ13291, Iwr1" ENSG00000103061 "Solute carrier family 7 member 6 opposite strand" Q96CW6 16 68284503-68310946 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041533 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041533: AB_10794298" "unprognostic (1.43e-1)" "unprognostic (2.02e-2)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "unprognostic (5.51e-2)" "unprognostic (4.62e-4)" "unprognostic (2.44e-4)" "unprognostic (2.05e-1)" "unprognostic (3.41e-1)" "unprognostic (2.38e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.84e-1)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" 12.8 8.9 9.6 10.2 10.8 14.0 12.1 11.7 10.9 9.9 9.4 9.8 8.3 9.1 10.2 8.3 9.7 6.2 12.1 9.1 10.8 9.1 6.2 8.6 16.2 11.2 10.8 8.9 9.6 9.0 8.1 6.7 9.5 10.8 9.1 7.7 8.9 9.3 7.0 17.2 9.1 11.4 6.9 10.7 13.3 9.6 6.8 10.6 13.1 10.3 8.7 12.4 9.4 8.9 12.6 11.3 11.4 16.4 12.3 9.4 12.8 18.2 14.4 8.1 16.7 14.4 29.3 15.9 19.4 12.6 9.3 10.4 20.0 15.6 12.1 14.5 7.4 10.0 13.1 20.1 24.2 12.1 18.7 13.8 9.9 13.5 13.9 21.7 14.6 12.5 16.6 20.7 8.6 15.2 16.9 24.3 19.1 11.8 13.0 9.7 28.4 10.1 24.3 10.4 14.8 17.3 12.6 27.4 6.1 15.7 12.7 16.5 17.2 18.5 13.0 11.2 12.7 11.3 21.0 18.6 29.2 13.4 22.4 13.8 28.5 12.8 26.3 14.3 15.1 16.6 14.2 14.4 13.3 10.3 15.1 15.5 12.1 11.6 14.8 14.2 12.7 16.2 12.7 9.6 10.8 11.7 10.9 9.1 10.8 11.2 10.8 8.9 10.8 10.7 10.6 12.6 15.8 9.6 6.3 2.9 20.6 9.2 13.0 12.4 9.6 22.9 8.3 11.0 1.4 12.8 9.3 12.9 35.5 24.1 24.7 7.0 17.6 13.0 3.0 10.8 16.2 13.6 13.8 8.0 4.8 11.2 12.4 12.7 11.2 10.5 14.0 20.5 13.9 6.2 21.5 16.8 5.2 7.8 12.2 14.1 7.4 2.5 15.8 11.9 12.4 1.0 20.2 25.5 30.9 5.0 4.8 17.0 7.3 16.1 15.7 16.9 10.0 9.8 13.9 23.5 0.0 11.4 11.0 16.7 18.5 10.2 6.7 22.0 21.6 19.7 9.5 14.2 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.7" "Cell type enhanced" "Detected in many" "Microglial cells: 55.3;Syncytiotrophoblasts: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Uncertain "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA050713: AB_2681218" "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.84e-4)" 31.9 8.8 1.5 15.6 1.7 8.5 27.1 6.0 2.3 5.1 14.7 8.2 3.9 5.9 11.6 4.5 8.7 4.5 16.5 3.2 1.4 4.8 2.0 11.0 18.8 1.3 1.6 1.3 2.8 3.8 2.5 9.7 18.8 2.6 6.2 11.3 5.0 7.3 5.3 75.7 9.6 12.1 7.7 0.8 10.8 6.6 5.2 1.9 38.0 16.8 27.1 21.7 6.9 4.9 2.1 22.6 22.1 16.3 16.8 46.9 27.6 42.9 24.9 18.7 36.9 30.6 97.9 16.2 43.7 19.8 33.4 10.9 33.1 32.0 32.2 39.7 9.5 22.9 23.8 47.3 31.0 7.7 28.2 20.3 19.3 26.1 27.5 13.5 11.4 25.3 21.0 35.1 7.3 20.5 11.7 36.4 19.3 12.4 14.6 8.1 45.0 10.2 36.0 12.0 19.6 23.7 13.5 75.7 20.8 6.8 13.4 30.9 13.3 38.4 24.6 19.0 20.5 32.8 16.7 33.5 50.3 15.6 20.1 17.2 3.4 3.2 2.8 4.3 1.7 5.4 6.8 6.6 4.3 3.6 6.3 11.7 6.7 6.1 7.1 1.4 16.8 3.1 1.5 1.5 1.7 6.0 2.3 3.2 1.4 1.3 1.6 1.3 2.6 0.8 1.9 2.1 8.5 41.7 18.8 12.4 18.4 19.6 9.3 8.5 13.6 6.1 5.9 4.8 19.9 2.8 4.9 18.4 37.5 25.1 23.3 7.3 0.0 3.3 5.5 10.7 16.8 12.0 2.4 2.1 39.3 4.0 2.5 12.8 4.1 3.3 4.5 1.8 6.8 1.4 14.6 10.1 40.3 10.5 4.1 8.5 12.1 18.3 5.9 9.9 10.6 55.3 10.0 1.8 14.4 13.0 10.7 5.6 5.9 3.8 16.0 8.0 2.5 0.6 10.4 2.7 0.0 10.8 7.2 17.3 10.9 6.7 21.9 47.9 23.5 4.3 7.8 2.6 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261058 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 38000000 "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 13.8 11.6 13.2 7.7 12.7 7.0 9.9 13.3 18.2 6.6 10.3 7.6 7.0 6.3 8.7 6.3 7.4 9.3 35.8 13.2 14.4 33.0 17.5 17.7 13.7 13.0 14.4 13.3 7.7 7.5 11.5 11.5 27.5 14.2 8.2 5.9 4.4 9.2 5.7 58.8 13.2 6.6 8.9 13.9 20.5 8.5 10.9 15.5 11.8 13.4 22.6 5.1 8.9 6.4 14.2 10.0 10.0 7.9 25.5 36.7 26.8 19.0 24.6 31.6 35.7 30.2 26.1 18.6 17.4 31.2 34.1 28.5 15.2 8.5 10.4 15.9 6.0 16.4 5.0 10.4 19.0 19.6 4.6 25.0 19.0 11.2 35.2 5.5 44.6 22.5 8.9 7.9 9.8 23.0 21.3 7.2 14.5 5.1 9.4 12.1 9.9 11.3 55.3 17.7 8.7 3.0 5.1 31.2 9.6 19.2 6.6 25.2 23.7 18.8 31.5 15.0 41.1 16.5 34.6 33.5 22.1 28.6 13.8 12.0 19.6 24.1 16.0 4.7 27.5 4.8 5.0 5.2 7.0 14.1 5.3 6.5 5.5 1.0 2.3 32.4 12.2 5.1 14.6 13.2 12.7 13.3 18.2 13.2 14.4 13.0 14.4 13.3 14.2 13.9 15.5 14.2 4.4 6.4 3.3 3.6 3.0 4.8 2.4 6.8 2.8 12.1 7.0 6.0 22.5 1.5 5.1 9.2 8.4 20.9 4.9 8.1 5.9 10.1 1.9 4.3 4.8 5.9 0.0 1.7 7.0 7.2 7.6 8.2 8.6 9.0 15.2 6.6 9.3 13.7 116.0 38.7 6.7 8.5 2.0 37.1 6.8 6.1 2.1 21.4 12.4 10.3 7.7 4.4 3.1 5.5 3.9 6.3 5.0 1.5 2.6 2.6 3.0 19.5 2.7 6.1 0.0 5.5 6.7 3.4 2.8 4.1 3.4 50.8 3.9 3.1 4.1 2.0 ESRP2 "FLJ21918, RBM35B" ENSG00000103067 "Epithelial splicing regulatory protein 2" Q9H6T0 16 68229033-68238102 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 55.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 36.3;Gastric mucus-secreting cells: 44.9;Late spermatids: 82.4;Syncytiotrophoblasts: 58.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 55.5;MCF7: 113.2;RT4: 60.4;SK-BR-3: 59.8;T-47d: 90.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040751, HPA048597, HPA048618" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463" "unprognostic (3.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.62e-2)" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (8.80e-2)" "prognostic favorable (1.30e-6)" "unprognostic (1.24e-1)" "unprognostic (3.16e-1)" "unprognostic (9.04e-3)" "unprognostic (8.75e-3)" 0.4 0.1 0.2 2.3 0.1 0.0 9.7 0.6 0.4 5.3 0.6 18.2 10.0 1.1 7.5 55.7 4.9 4.1 0.1 0.2 0.0 9.6 39.2 13.4 0.0 0.1 0.1 0.0 0.2 29.2 13.5 3.3 8.1 0.2 11.7 14.8 0.0 18.0 2.6 0.2 36.8 8.2 0.5 0.0 0.0 27.2 10.9 0.3 3.5 16.8 0.0 7.2 13.1 19.4 0.3 38.6 0.2 0.1 0.0 0.0 0.0 55.5 0.2 0.0 0.1 0.2 36.7 19.1 0.0 1.7 0.0 0.0 40.4 0.1 30.1 0.0 0.1 24.1 0.1 12.5 30.9 0.6 0.0 0.2 0.0 43.4 0.0 16.4 0.1 0.0 0.1 0.1 0.0 0.0 113.2 0.0 0.3 4.1 31.4 12.0 0.1 0.0 0.2 14.5 60.4 4.2 0.0 19.6 59.8 0.1 5.4 90.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.4 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.3 0.3 0.2 19.2 17.2 0.0 0.3 6.4 5.3 6.8 5.7 0.8 10.7 6.9 1.0 20.0 11.1 23.9 0.0 36.3 0.3 18.8 0.0 11.0 29.1 7.3 1.4 0.4 8.4 0.0 0.0 14.0 5.5 0.5 44.9 13.8 0.0 0.6 0.4 31.1 2.7 0.0 0.0 25.3 8.2 0.8 0.8 82.4 0.9 0.2 1.8 0.0 0.6 0.3 1.0 0.0 0.0 13.7 8.5 0.0 0.3 7.9 5.1 5.6 4.2 0.2 0.0 0.2 0.7 10.4 1.2 27.2 8.5 58.4 0.5 0.0 18.3 8.9 FA2H "FAAH, FAXDC1, FLJ25287, SPG35" ENSG00000103089 "Fatty acid 2-hydroxylase" Q7L5A8 16 74712955-74774831 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 175.1;stomach 1: 61.6" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 85.1;Oligodendrocyte precursor cells: 61.3;Oligodendrocytes: 307.9;Paneth cells: 75.2;Urothelial cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 38.1;HAP1: 48.6;JURKAT: 89.8;OE19: 61.5;SK-BR-3: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056614, HPA077840" Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA056614: AB_2683191, HPA077840: AB_2686858" "unprognostic (1.33e-1)" "unprognostic (4.97e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.85e-2)" "unprognostic (1.48e-2)" "unprognostic (2.47e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.74e-4)" "unprognostic (6.01e-2)" "prognostic favorable (5.01e-6)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-2)" "unprognostic (2.11e-3)" 0.2 0.3 41.6 4.3 76.2 0.3 2.8 67.1 61.7 1.9 6.6 21.4 10.4 0.2 2.2 7.9 1.8 18.0 0.2 36.8 53.4 5.1 0.2 1.4 0.7 100.2 73.7 20.6 0.0 8.4 10.1 0.6 0.7 91.3 1.9 19.6 0.4 11.1 0.7 0.0 7.5 14.6 1.1 75.5 0.6 61.6 3.0 67.0 4.8 2.0 0.1 5.9 26.5 2.2 175.1 9.2 38.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.5 0.0 20.8 21.0 0.0 0.2 0.0 2.0 3.6 48.6 0.6 0.1 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 89.8 0.0 0.0 0.0 15.2 0.8 0.0 0.9 61.5 2.1 0.0 0.0 1.6 23.4 15.6 6.5 0.0 0.0 28.8 0.0 1.3 8.6 0.0 0.0 0.0 0.1 0.0 0.2 1.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.6 76.2 67.1 61.7 36.8 53.4 100.2 73.7 20.6 91.3 75.5 67.0 175.1 0.0 0.0 1.3 1.0 2.6 0.5 11.1 8.5 1.8 0.0 5.0 3.3 0.2 8.6 14.6 0.0 0.0 0.5 0.2 43.0 7.9 13.5 10.8 2.4 0.5 0.2 6.7 0.0 0.7 14.2 0.2 1.1 85.1 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.9 34.8 4.1 0.0 0.0 4.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 61.3 307.9 38.4 75.2 0.4 6.2 22.9 17.6 0.2 10.5 0.0 0.0 0.0 0.6 2.4 3.3 12.4 0.9 0.1 0.2 0.0 15.3 192.8 WDR59 FLJ12270 ENSG00000103091 "WD repeat domain 59" Q6PJI9 16 74871362-75000173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041084, HPA048218" Approved Approved Cytosol NA NA Cytosol "HPA041084: AB_10793867, HPA048218: AB_2680318" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (4.16e-2)" "unprognostic (6.14e-2)" "unprognostic (3.99e-1)" "unprognostic (2.28e-2)" "unprognostic (8.83e-2)" "unprognostic (3.43e-1)" "unprognostic (2.37e-2)" "unprognostic (4.21e-3)" "unprognostic (3.25e-3)" "unprognostic (2.05e-2)" "unprognostic (9.08e-2)" "unprognostic (3.88e-2)" "unprognostic (1.78e-1)" "unprognostic (5.61e-2)" 11.5 19.2 18.1 13.9 21.5 16.2 14.3 17.9 21.5 19.4 14.8 14.4 13.2 16.3 21.3 17.4 15.0 9.8 16.8 17.8 18.9 17.3 36.0 11.2 12.8 20.4 19.0 18.7 22.6 17.0 22.8 23.1 14.2 22.2 16.0 14.2 38.2 14.2 11.7 25.1 21.3 16.5 13.3 16.3 15.4 14.3 14.0 19.9 22.6 23.1 17.5 16.2 14.6 17.5 28.7 15.6 23.8 27.1 25.8 20.8 18.7 22.9 9.8 17.0 20.7 23.5 32.3 27.1 21.8 10.6 18.3 19.3 24.6 21.7 23.4 29.3 13.2 23.1 27.9 16.3 52.5 12.6 20.4 32.7 21.8 18.7 25.1 23.7 26.7 21.7 52.5 42.0 10.6 9.9 46.1 31.4 36.4 21.6 34.0 9.7 31.3 11.9 18.3 22.2 13.9 16.5 18.2 28.0 16.2 12.6 28.5 24.5 17.8 19.0 12.9 19.6 14.8 8.5 20.1 29.3 47.2 22.8 14.1 14.3 0.7 0.7 0.7 1.0 0.4 3.4 1.9 1.9 1.5 0.4 1.1 1.2 1.4 0.7 1.0 0.8 0.7 1.0 0.4 18.1 21.5 17.9 21.5 17.8 18.9 20.4 19.0 18.7 22.2 16.3 19.9 28.7 9.8 16.0 16.5 77.1 15.0 22.4 20.0 12.7 21.6 38.8 15.0 16.3 17.6 21.5 15.0 22.0 62.6 34.4 9.6 13.1 9.8 13.0 37.4 13.1 14.6 11.8 22.1 21.0 41.5 9.6 16.5 13.6 17.3 20.1 13.3 22.4 17.9 24.6 10.8 20.2 53.8 11.9 12.2 13.2 17.1 79.2 13.4 12.7 8.8 29.0 15.3 11.9 14.4 65.9 88.8 11.9 14.0 11.7 5.9 24.1 17.0 19.6 16.7 55.5 19.7 17.1 9.7 17.7 19.1 16.5 24.2 47.3 15.3 13.8 16.8 23.4 MON1B "HSRG1, KIAA0872, SAND2" ENSG00000103111 "MON1 homolog B, secretory trafficking associated" Q7L1V2 16 77190835-77202398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046285 Approved Approved Cytosol NA NA Cytosol "HPA046285: AB_10959467" "unprognostic (1.73e-2)" "unprognostic (9.99e-2)" "unprognostic (9.97e-2)" "prognostic favorable (6.90e-4)" "unprognostic (1.94e-1)" "unprognostic (7.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-2)" "unprognostic (9.78e-2)" "unprognostic (2.42e-2)" "unprognostic (1.76e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.42e-5)" "unprognostic (2.21e-2)" "unprognostic (3.62e-2)" "unprognostic (8.34e-3)" "unprognostic (1.75e-1)" 13.1 9.7 21.1 17.3 24.3 15.8 9.1 20.7 18.4 11.2 10.1 15.8 16.4 10.7 12.1 13.4 10.9 13.3 10.6 18.2 19.3 10.6 12.5 12.7 18.4 25.2 23.9 15.0 8.9 13.8 17.7 8.4 8.2 21.7 19.9 13.3 21.2 14.0 10.3 11.5 13.7 16.1 9.7 22.0 15.3 13.8 5.7 22.5 15.5 19.8 7.8 15.6 11.9 7.2 23.2 14.8 35.7 15.0 15.5 16.0 15.9 20.5 14.6 17.4 13.0 13.9 20.9 22.4 26.9 24.1 11.9 23.3 29.8 15.7 14.5 11.5 19.6 17.9 19.0 12.7 20.5 22.4 20.9 52.5 15.7 28.5 19.3 17.2 14.0 24.5 24.7 25.6 9.0 11.3 29.9 26.3 24.6 15.5 19.9 9.6 34.0 10.3 30.4 14.9 11.9 22.4 18.8 25.5 10.2 17.6 10.7 23.3 30.6 26.2 16.2 18.5 18.4 13.0 30.0 21.4 72.9 28.7 21.4 20.3 17.8 9.7 16.6 9.5 16.3 9.8 6.0 7.6 8.8 8.3 7.0 5.6 7.2 21.7 10.3 11.1 4.7 9.9 9.0 21.1 24.3 20.7 18.4 18.2 19.3 25.2 23.9 15.0 21.7 22.0 22.5 23.2 19.4 38.5 34.8 1.6 17.3 7.5 10.0 12.7 8.0 15.0 16.6 14.4 12.6 12.8 19.8 14.7 18.8 10.5 16.9 42.3 3.9 14.0 17.8 13.1 15.6 20.7 24.0 16.2 1.9 19.5 12.4 12.6 21.9 20.0 12.7 17.4 19.6 28.4 13.2 8.4 3.0 27.9 10.2 32.0 7.8 14.1 9.0 18.7 8.8 4.7 26.1 21.5 26.8 3.0 5.0 20.0 18.7 10.1 13.8 21.0 23.8 11.7 14.6 23.5 19.7 21.6 11.0 10.4 5.3 14.6 9.5 16.8 17.2 10.9 23.5 18.8 CMC2 "C16orf61, DC13, MGC45036" ENSG00000103121 "C-X9-C motif containing 2" Q9NRP2 16 80966448-81020270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 263.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006871, CAB026396" Approved Supported Mitochondria NA Yes Mitochondria "CAB026396: , HPA006871: AB_1845581" "unprognostic (2.43e-1)" "unprognostic (3.63e-2)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "unprognostic (1.50e-1)" "unprognostic (3.01e-3)" "unprognostic (2.48e-2)" "unprognostic (6.36e-2)" "unprognostic (9.20e-2)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (4.57e-3)" "prognostic favorable (2.64e-5)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (2.68e-1)" 19.1 24.8 49.8 14.1 51.8 45.6 17.2 50.8 60.7 16.1 44.1 22.4 19.3 12.5 16.8 20.6 11.7 17.2 67.0 51.4 53.1 40.6 44.3 24.5 22.6 50.3 50.3 48.6 13.8 27.5 30.6 26.3 16.4 49.8 35.2 17.1 16.2 14.9 12.5 54.5 14.2 20.5 15.1 51.0 21.9 27.5 47.4 52.5 30.3 16.4 34.2 17.2 20.9 17.2 56.3 74.8 103.1 76.1 43.7 25.1 25.0 44.9 73.4 33.1 64.0 32.9 71.7 49.9 33.5 53.3 35.8 62.9 52.6 52.5 42.8 84.9 50.9 63.3 51.9 68.4 78.6 40.6 43.5 85.4 21.8 23.8 77.7 43.5 29.2 57.1 83.1 124.2 43.5 63.3 140.1 68.1 138.4 45.2 59.7 62.0 84.2 41.2 43.8 50.4 35.9 64.1 37.1 110.6 39.8 87.3 39.4 78.7 39.2 32.8 57.9 82.0 56.6 75.3 45.4 107.6 193.8 44.6 55.3 69.1 33.2 28.0 37.3 28.8 29.6 27.5 39.1 36.5 30.1 31.6 34.9 25.3 29.2 12.0 44.6 34.2 45.3 64.4 18.0 49.8 51.8 50.8 60.7 51.4 53.1 50.3 50.3 48.6 49.8 51.0 52.5 56.3 41.2 35.3 38.8 48.0 54.9 97.6 75.5 53.9 48.9 31.9 48.0 50.7 204.7 42.9 36.5 47.8 54.2 44.8 78.9 29.5 158.5 34.4 95.4 44.2 33.7 36.0 38.3 55.5 88.6 38.0 62.8 45.0 42.8 45.2 95.5 37.3 25.4 86.0 51.4 30.3 62.2 42.9 59.0 70.5 84.1 168.3 24.5 59.7 65.8 14.0 33.8 29.3 51.5 48.7 74.0 39.0 31.9 29.3 83.5 69.1 48.5 166.1 31.4 16.7 59.2 33.3 47.0 263.5 121.5 65.0 102.1 38.0 84.7 55.3 44.8 74.4 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352723 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 12.0 9.4 9.4 9.2 9.6 23.2 11.6 13.2 12.6 13.0 7.8 16.4 12.4 13.3 3.1 16.5 11.9 6.3 10.8 9.1 8.1 10.7 11.2 13.8 10.5 10.0 9.3 8.4 13.9 13.1 7.3 12.7 5.8 10.1 13.0 6.9 2.7 11.6 6.0 21.3 20.1 15.1 5.5 8.4 15.1 13.0 11.8 9.1 12.7 12.0 7.1 6.6 14.6 13.2 10.0 18.1 25.6 13.4 23.7 9.8 9.0 28.0 11.9 10.8 16.1 13.8 37.9 20.4 27.7 18.0 12.3 19.4 25.4 21.1 18.5 7.2 27.5 34.6 18.0 21.9 27.6 16.6 20.9 19.3 9.0 31.7 16.6 20.3 14.1 10.7 19.8 45.6 14.8 7.4 48.1 22.7 14.5 30.6 21.6 15.4 42.4 12.2 38.8 12.2 10.5 30.4 18.6 22.6 24.9 38.3 10.0 16.5 26.1 12.4 15.9 17.0 18.5 17.5 17.3 18.1 34.2 7.5 13.7 15.9 1.2 0.9 5.0 8.3 0.8 7.6 1.5 2.4 5.8 0.7 1.2 2.4 3.4 2.7 3.5 0.6 1.2 2.6 2.3 9.4 9.6 13.2 12.6 9.1 8.1 10.0 9.3 8.4 10.1 8.4 9.1 10.0 7.9 3.2 8.6 4.9 5.7 18.4 7.6 8.5 5.7 4.3 11.2 9.5 4.9 5.7 7.2 3.7 0.0 3.5 30.1 27.4 0.0 7.2 1.4 10.2 7.0 6.3 10.8 8.6 18.5 6.9 27.5 6.7 15.3 14.4 10.8 10.5 5.7 5.1 7.5 5.0 12.7 15.1 6.1 6.2 9.0 2.1 5.3 6.7 10.6 1.0 5.7 4.5 28.8 8.5 8.9 11.0 12.2 4.9 7.0 13.4 11.1 2.4 7.7 5.7 13.1 8.7 7.6 5.5 8.8 7.2 15.2 3.7 12.4 5.0 15.7 10.5 HCFC1R1 "FLJ20568, HPIP" ENSG00000103145 "Host cell factor C1 regulator 1" Q9NWW0 16 3022625-3024286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 516.6" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 396.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 376.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059647: AB_2684094" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.85e-3)" "unprognostic (6.03e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (1.61e-2)" "unprognostic (2.12e-1)" "unprognostic (3.43e-3)" "unprognostic (2.23e-1)" "unprognostic (2.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.23e-1)" 82.8 99.3 158.7 21.1 158.2 18.1 75.4 147.7 250.0 106.2 117.0 101.7 30.7 141.8 29.4 59.5 82.4 43.5 123.4 156.4 160.4 135.3 48.6 72.6 24.4 162.3 157.4 154.0 87.4 44.3 41.2 98.4 32.4 170.5 103.7 19.0 21.8 51.0 88.2 516.6 75.1 53.6 47.9 135.8 46.3 66.1 36.9 169.5 17.2 68.6 197.9 18.4 85.9 103.9 174.0 59.6 175.6 32.5 38.1 123.0 160.9 33.4 26.0 115.0 57.8 161.2 37.9 75.8 49.2 66.1 108.3 52.8 81.0 32.7 121.5 26.3 62.7 88.4 21.3 132.2 65.5 105.2 37.3 39.5 205.7 73.9 62.1 63.4 376.5 81.5 33.0 30.4 81.6 63.3 63.0 20.1 53.0 70.5 34.7 36.5 70.1 31.3 124.6 209.4 13.7 57.3 48.4 54.7 70.7 78.5 77.5 48.6 28.1 35.5 98.4 256.8 85.8 50.7 53.0 59.1 40.7 42.9 22.1 23.8 5.3 36.3 16.3 20.1 28.2 19.3 23.2 25.5 21.7 44.9 21.7 18.5 22.9 8.0 25.8 26.5 22.1 36.7 17.9 158.7 158.2 147.7 250.0 156.4 160.4 162.3 157.4 154.0 170.5 135.8 169.5 174.0 51.3 57.7 15.0 17.9 30.7 85.4 58.0 123.7 92.2 29.3 45.2 80.0 45.8 47.1 37.4 198.6 6.2 116.2 23.7 53.7 240.7 49.7 5.2 38.0 56.0 38.3 43.7 37.0 19.3 26.5 120.7 98.4 34.1 45.3 40.0 26.1 60.3 45.9 117.9 20.2 19.8 40.9 40.7 57.5 57.0 15.8 96.3 42.2 64.0 13.1 51.0 52.6 39.1 6.6 19.0 26.7 55.4 178.3 35.0 37.8 114.2 396.2 28.4 28.1 124.9 39.7 149.2 15.2 44.3 69.5 65.8 53.9 35.0 26.7 45.9 41.3 NPRL3 "C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11" ENSG00000103148 "NPR3 like, GATOR1 complex subunit" Q12980 16 84271-138677 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 134.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011741 Uncertain Approved Cytosol NA NA Cytosol "HPA011741: AB_1845577" "unprognostic (1.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.24e-2)" "unprognostic (4.87e-2)" "unprognostic (6.18e-3)" "unprognostic (9.50e-2)" "unprognostic (7.28e-2)" "unprognostic (4.85e-2)" "unprognostic (9.07e-3)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (8.69e-2)" "unprognostic (1.65e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" 9.7 10.5 16.0 7.3 16.0 19.2 8.5 14.8 22.4 9.5 14.0 6.1 7.3 10.6 5.3 9.3 12.2 6.4 9.0 15.4 15.8 8.0 10.1 7.9 9.5 15.1 16.2 15.2 13.0 11.0 12.8 11.8 6.6 16.0 8.9 4.9 7.1 11.1 7.1 15.7 10.0 5.7 7.2 13.7 8.4 6.9 9.5 16.1 7.0 11.1 10.4 6.7 6.6 8.2 16.6 14.5 29.0 12.6 32.2 33.7 16.9 19.8 17.2 16.8 21.3 16.6 46.6 25.6 26.5 22.5 25.5 13.8 17.0 20.5 29.7 12.3 29.2 16.0 38.8 17.3 34.2 31.1 15.9 25.6 20.7 22.2 28.4 24.9 16.0 20.3 21.1 38.6 24.6 19.1 51.2 17.6 12.3 11.9 10.0 20.8 30.1 10.8 37.9 21.6 12.2 26.9 17.1 22.8 30.1 14.3 6.5 22.2 11.1 19.2 32.9 18.2 20.0 13.3 25.9 14.7 37.7 1.1 19.2 18.3 0.0 2.4 0.3 3.0 2.2 3.2 2.0 2.6 2.5 3.5 2.0 2.5 2.9 0.2 2.0 3.1 2.6 2.9 2.2 16.0 16.0 14.8 22.4 15.4 15.8 15.1 16.2 15.2 16.0 13.7 16.1 16.6 10.4 12.8 11.7 30.0 22.2 9.4 17.6 15.7 14.8 58.1 16.6 16.8 9.0 12.8 9.2 11.0 66.7 24.6 20.4 6.8 23.5 16.4 31.0 11.8 18.1 13.0 9.6 134.5 29.7 8.9 35.2 17.3 15.8 9.4 3.8 49.2 15.7 10.2 19.7 55.5 30.8 11.7 10.2 14.2 6.4 73.8 22.7 12.8 12.4 15.9 16.4 29.5 79.3 21.1 40.4 11.4 6.6 19.5 14.0 23.3 8.0 23.9 11.0 57.2 6.6 15.6 14.9 62.2 43.0 16.0 5.5 15.3 18.8 28.2 14.4 10.4 MLYCD "hMCD, MCD" ENSG00000103150 "Malonyl-CoA decarboxylase" O95822 16 83899115-83951445 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 21.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 97.5;Cone photoreceptor cells: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031625 Enhanced NA NA "HPA031625: AB_10602028" "unprognostic (6.23e-2)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.26e-1)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (6.23e-2)" "unprognostic (1.84e-4)" "unprognostic (2.33e-1)" "prognostic favorable (2.61e-7)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.56e-2)" "unprognostic (1.51e-3)" 2.5 2.1 1.7 1.0 2.3 0.4 1.5 1.3 2.0 1.1 2.1 1.6 1.7 1.3 1.3 1.0 1.4 0.7 9.1 1.5 1.2 2.7 5.8 1.2 1.2 3.7 2.2 0.9 1.9 5.2 2.1 1.2 0.9 3.1 1.3 1.7 2.4 2.1 1.6 8.2 1.0 1.4 1.2 1.3 1.0 2.5 1.4 2.2 1.0 1.5 21.7 0.9 1.6 0.9 2.1 0.6 1.9 1.6 1.9 2.5 0.9 2.9 0.8 1.2 0.7 0.4 0.9 1.5 0.1 2.4 1.2 2.6 1.5 1.4 0.6 0.7 0.8 1.9 0.9 0.8 1.9 3.0 1.2 2.1 1.1 1.4 0.4 0.4 1.3 0.8 1.4 1.4 0.4 1.1 2.4 0.7 2.7 1.6 2.7 0.4 2.2 1.1 1.1 1.6 1.1 1.4 0.9 3.0 1.1 2.4 2.1 3.4 2.5 0.6 1.8 0.3 1.0 0.2 2.1 1.3 2.0 1.0 0.9 1.9 0.5 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.7 2.3 1.3 2.0 1.5 1.2 3.7 2.2 0.9 3.1 1.3 2.2 2.1 6.1 6.4 7.3 8.5 10.9 2.0 7.4 1.5 4.6 25.2 7.2 5.2 97.5 17.2 5.5 23.9 125.1 20.2 10.6 12.9 31.3 5.7 4.6 10.4 6.9 8.2 10.2 9.1 3.1 5.5 11.1 10.5 15.3 8.7 5.7 20.1 12.8 46.2 12.3 16.8 6.2 15.2 4.1 10.1 2.0 8.6 14.6 8.2 3.6 3.7 7.7 14.7 27.8 12.5 8.2 6.7 13.1 19.5 6.5 10.4 19.4 19.4 2.4 53.3 6.6 19.0 8.1 12.1 14.4 5.2 2.0 8.2 9.0 17.5 17.1 8.6 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85851 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 45.8 63.6 23.1 24.8 21.9 33.1 46.2 22.5 44.2 43.5 20.0 39.9 24.0 47.0 9.5 40.2 40.7 27.7 54.0 22.5 22.0 33.5 67.5 45.0 40.8 21.6 22.1 21.9 43.5 59.7 12.0 44.8 21.4 22.2 50.7 7.7 2.0 56.1 21.4 69.7 37.6 37.4 14.8 22.0 53.4 47.2 16.3 22.9 14.3 46.9 21.2 15.3 47.0 38.8 22.5 50.2 70.4 18.1 54.9 34.1 77.2 51.9 78.0 95.1 44.1 49.3 44.2 61.5 40.2 65.0 39.8 20.5 64.7 13.1 30.4 6.7 67.6 59.3 25.3 34.3 67.1 99.3 25.4 141.9 75.4 41.9 50.0 20.4 57.4 80.0 39.9 56.1 58.6 57.8 167.5 43.6 118.1 36.4 27.3 86.1 84.2 25.7 140.5 37.5 17.1 15.5 42.5 41.0 36.2 91.9 8.3 54.1 119.4 80.6 34.1 47.9 49.4 34.4 67.7 23.6 49.6 67.8 71.2 129.9 47.3 75.3 80.9 60.6 56.6 55.0 92.5 57.1 60.3 80.3 85.9 42.5 43.7 38.9 130.2 47.6 110.3 90.8 67.0 23.1 21.9 22.5 44.2 22.5 22.0 21.6 22.1 21.9 22.2 22.0 22.9 22.5 72.6 3.2 25.6 14.0 73.9 35.8 82.9 102.9 47.8 13.8 76.8 80.4 1.3 37.1 63.0 40.5 4.2 78.7 74.2 59.1 33.2 76.4 9.9 33.5 63.1 59.3 49.8 39.9 14.2 114.2 89.4 78.7 43.8 36.1 56.3 57.1 62.8 55.6 89.8 10.1 13.9 92.5 83.4 69.4 43.7 5.0 65.9 55.6 56.9 10.3 77.9 39.8 66.9 14.1 12.9 134.8 78.6 57.9 80.1 110.6 83.1 67.7 43.5 11.4 85.5 51.5 73.3 15.1 36.7 53.9 41.1 61.8 59.8 197.2 68.3 114.0 NECAB2 EFCBP2 ENSG00000103154 "N-terminal EF-hand calcium binding protein 2" Q7Z6G3 16 83968244-84002776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 107.2" "Cell type enhanced" "Detected in some" "Early spermatids: 16.6;Hepatocytes: 10.7;Inhibitory neurons: 22.2;Late spermatids: 49.2;Muller glia cells: 17.8;Proximal tubular cells: 27.8" "Cancer enhanced" "Detected in many" "liver cancer: 7.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 66 "neutrophil: 55.4" "Lineage enriched" "Detected in single" 66 "granulocytes: 55.4" "Cell line enhanced" "Detected in some" "AF22: 10.1;MCF7: 6.8;SCLC-21H: 37.6;U-87 MG: 12.2" "Low region specificity" "Detected in all" "HPA013998, HPA014144, CAB068211" Enhanced Supported NA NA "CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017" "unprognostic (5.27e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (3.48e-5)" "unprognostic (3.45e-2)" "unprognostic (4.20e-2)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" "unprognostic (4.15e-1)" "unprognostic (2.59e-1)" "unprognostic (5.75e-3)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (8.89e-3)" "unprognostic (3.48e-1)" "unprognostic (8.61e-3)" "unprognostic (3.75e-2)" 0.9 0.5 65.0 0.6 70.0 0.5 0.7 19.5 107.2 1.5 23.5 1.2 1.2 1.2 0.3 0.1 0.4 0.5 1.2 71.8 58.7 11.1 26.2 0.5 0.2 35.5 48.1 78.8 0.5 1.9 6.7 16.3 0.3 63.1 0.3 0.2 3.1 0.1 0.1 0.2 0.2 1.2 0.4 22.2 1.6 1.8 10.5 46.5 0.2 0.5 0.2 0.0 0.3 0.2 43.3 0.2 4.4 10.1 0.0 0.0 1.4 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.0 1.6 0.2 0.8 0.0 1.9 0.0 0.0 0.1 2.9 0.0 0.0 0.5 0.1 0.0 1.7 0.5 0.2 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.0 6.8 0.0 0.0 5.0 0.4 0.6 0.1 0.0 0.6 0.0 0.0 37.6 1.5 0.0 0.2 3.1 1.4 5.2 1.4 0.3 0.2 2.8 0.4 0.0 0.1 0.0 0.0 12.2 0.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.1 65.0 70.0 19.5 107.2 71.8 58.7 35.5 48.1 78.8 63.1 22.2 46.5 43.3 0.1 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 16.6 0.0 0.1 0.1 7.2 0.0 2.2 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.0 10.7 3.4 0.0 22.2 0.0 0.0 0.0 0.0 49.2 0.3 0.3 0.0 3.7 0.2 17.8 0.0 4.0 0.6 0.0 0.0 0.7 0.0 0.0 0.3 27.8 0.0 0.3 0.0 0.1 0.0 2.1 3.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122141-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 45.4;Rod photoreceptor cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Supported "Vesicles,Intermediate filaments,Mitochondria" No No Mitochondria "Vesicles, Intermediate filaments" "HPA045745: AB_2679440" "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favorable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 7.6 15.5 12.9 7.1 14.4 4.4 12.0 10.5 12.1 10.7 9.1 6.5 6.3 13.3 10.6 7.9 12.8 7.2 15.9 12.9 17.2 10.9 5.1 9.2 9.0 14.0 12.7 12.2 22.2 5.0 15.2 12.0 9.2 16.5 9.9 7.0 34.6 7.4 11.2 20.9 8.0 5.7 10.9 9.0 8.0 6.5 13.4 15.6 14.2 27.0 30.8 9.3 7.3 7.2 16.8 11.1 12.6 57.4 19.8 20.7 14.5 14.6 13.8 13.1 17.0 8.9 14.5 18.8 22.7 24.7 12.4 18.8 7.6 31.1 12.1 26.9 4.9 18.9 10.9 7.9 32.5 21.0 17.1 19.2 11.0 20.0 24.1 15.4 21.9 20.9 30.6 23.0 28.2 34.3 27.3 37.8 17.4 29.5 6.4 13.3 36.7 20.4 8.4 16.6 12.0 27.1 20.2 35.0 5.6 39.0 28.5 34.4 10.2 17.5 19.2 22.9 13.9 11.3 44.1 38.1 36.9 22.8 12.3 18.2 21.2 5.0 11.1 3.8 3.4 5.0 5.0 4.1 4.6 2.8 7.5 5.3 5.6 5.5 4.3 6.3 0.0 5.4 4.4 12.9 14.4 10.5 12.1 12.9 17.2 14.0 12.7 12.2 16.5 9.0 15.6 16.8 8.9 12.8 16.4 7.8 8.2 4.8 4.6 6.4 8.6 20.2 10.2 8.3 16.7 1.5 8.6 3.7 14.6 6.9 4.4 3.7 5.9 7.9 38.5 11.4 10.5 7.7 9.5 5.7 12.4 6.7 6.6 7.7 3.6 11.0 1.3 38.6 9.3 4.1 12.2 45.4 15.8 3.7 4.1 6.9 3.5 12.2 5.9 10.4 5.4 11.2 6.1 28.4 5.2 15.6 13.0 6.8 2.5 10.1 10.1 5.2 3.9 8.0 13.7 44.2 0.0 8.0 7.8 35.8 30.1 8.8 7.0 8.8 6.6 12.7 4.5 4.8 TAF1C "MGC:39976, SL1, TAFI110, TAFI95" ENSG00000103168 "TATA-box binding protein associated factor, RNA polymerase I subunit C" Q15572 16 84177847-84187070 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072229 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA072229: AB_2686499" "unprognostic (9.39e-2)" "unprognostic (1.13e-1)" "unprognostic (6.86e-3)" "unprognostic (8.20e-3)" "unprognostic (4.45e-2)" "unprognostic (3.47e-2)" "unprognostic (6.21e-2)" "unprognostic (1.26e-1)" "unprognostic (2.52e-1)" "unprognostic (3.53e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.06e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (5.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "prognostic favorable (3.22e-4)" 19.1 15.9 6.6 7.3 8.0 13.6 20.8 6.2 13.0 22.9 3.8 15.7 7.9 23.7 2.2 16.0 21.6 10.2 16.2 9.0 6.5 19.2 14.9 17.1 11.2 8.5 6.7 4.8 32.0 18.0 4.3 20.8 6.3 7.5 21.9 2.9 1.8 15.4 8.4 12.4 17.5 19.5 5.3 5.4 32.4 18.8 13.9 7.6 7.5 23.9 6.8 3.6 18.6 19.3 9.6 11.8 12.7 7.5 23.6 5.7 5.9 34.3 13.8 5.3 11.5 3.7 15.0 8.3 12.7 17.3 5.0 6.1 21.2 4.3 5.4 2.6 11.4 18.2 6.8 21.0 9.7 4.8 7.6 21.8 8.9 6.9 9.1 3.7 5.0 20.4 20.7 17.9 4.1 5.6 25.4 11.3 24.9 27.8 5.1 12.2 29.2 6.1 10.5 4.7 9.5 34.0 16.8 26.3 7.8 43.0 4.6 28.9 8.1 8.9 19.2 16.5 19.2 12.0 19.6 16.9 26.7 9.8 9.2 12.4 0.0 1.3 0.4 1.5 1.3 1.8 0.9 0.6 0.9 1.5 1.1 0.7 1.3 0.0 1.5 0.5 0.6 0.9 1.2 6.6 8.0 6.2 13.0 9.0 6.5 8.5 6.7 4.8 7.5 5.4 7.6 9.6 24.9 19.2 15.8 22.5 9.2 6.5 5.1 5.2 5.2 9.3 10.2 10.2 3.0 2.8 8.2 3.7 20.9 9.4 6.5 9.9 5.9 5.1 0.5 6.9 7.4 18.7 7.2 7.4 16.5 7.1 6.7 8.4 20.9 8.8 6.3 24.6 22.9 12.9 6.6 1.7 13.0 8.2 0.0 9.8 6.3 2.5 11.8 7.3 7.2 15.9 6.3 7.8 5.2 13.6 12.5 5.2 5.1 9.1 12.1 3.9 7.6 4.0 6.1 10.4 6.6 8.3 7.8 9.9 10.6 8.7 5.3 7.4 8.0 16.8 10.2 4.4 NAGPA "APAA, UCE" ENSG00000103174 "N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase" Q9UK23 16 5024844-5034141 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064055 Approved NA NA 7800000 "HPA064055: AB_2685183" "unprognostic (9.93e-2)" "unprognostic (1.61e-2)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (7.12e-3)" "unprognostic (3.30e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.05e-2)" "unprognostic (2.98e-2)" "unprognostic (1.35e-1)" "unprognostic (9.51e-3)" "unprognostic (9.41e-2)" "prognostic unfavorable (2.67e-5)" "unprognostic (1.26e-1)" "unprognostic (6.09e-2)" "unprognostic (7.47e-2)" "unprognostic (1.02e-1)" 6.3 7.0 17.1 5.7 18.8 6.3 5.5 15.4 29.8 5.4 15.2 7.7 6.6 6.7 2.6 6.4 4.8 3.4 5.1 20.9 15.8 8.2 9.0 5.8 6.5 16.6 15.5 18.6 3.6 6.2 4.8 5.4 4.1 16.8 5.8 3.0 0.6 5.5 3.3 6.1 6.6 9.9 3.4 15.5 11.9 9.5 3.4 16.5 3.5 5.7 2.5 2.8 6.5 5.1 18.8 2.5 9.7 1.6 10.4 4.0 5.0 10.8 7.1 12.7 9.3 11.2 8.0 19.9 1.0 8.8 9.6 15.8 7.3 4.4 7.8 2.6 11.8 13.3 3.6 5.7 53.1 12.7 8.8 14.6 7.7 8.1 6.0 2.7 11.0 14.6 8.8 11.5 14.1 5.5 11.3 4.0 23.6 5.0 6.3 10.2 10.4 3.7 19.3 5.8 3.9 4.0 5.6 5.6 14.2 15.1 1.4 9.7 10.5 11.0 9.9 7.2 24.0 5.3 6.9 6.3 2.3 4.6 13.1 8.3 3.9 39.3 10.4 17.9 35.0 14.2 17.3 17.1 15.4 50.5 14.2 14.0 13.2 1.2 10.6 23.6 12.9 16.3 20.1 17.1 18.8 15.4 29.8 20.9 15.8 16.6 15.5 18.6 16.8 15.5 16.5 18.8 8.1 0.0 2.7 7.8 15.0 2.9 4.7 4.5 7.4 14.7 5.2 5.1 3.1 8.6 4.7 5.5 31.3 13.3 10.2 21.8 1.9 11.3 0.4 3.0 3.7 8.4 1.2 9.1 44.5 8.5 14.9 4.6 28.1 4.1 1.3 8.9 9.7 7.7 27.2 16.8 21.5 13.6 2.0 24.9 8.6 1.0 8.1 20.6 3.6 2.8 24.0 4.5 18.6 4.0 6.9 9.5 18.4 6.4 13.2 4.1 28.9 9.0 3.2 13.8 0.0 4.3 4.8 4.4 8.4 8.8 2.4 9.4 12.1 5.8 12.4 3.2 WFDC1 PS20 ENSG00000103175 "WAP four-disulfide core domain 1" Q9HC57 16 84294846-84329844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 100.7;seminal vesicle: 116.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 111.1;Fibroblasts: 72.6;Peritubular cells: 257.3;Smooth muscle cells: 95.8;Theca cells: 325.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 29.8;BJ: 20.5;HEL: 18.2;HeLa: 27.6;THP-1: 9.9;U-937: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031411 Uncertain "Secreted to extracellular matrix" NA NA "HPA031411: AB_10600921" "unprognostic (6.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.61e-2)" "unprognostic (8.66e-4)" "unprognostic (1.41e-2)" "unprognostic (1.50e-3)" "unprognostic (1.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.78e-2)" "unprognostic (5.49e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (3.04e-1)" 8.2 27.1 15.6 10.6 15.6 1.9 4.3 18.4 21.3 21.7 12.7 57.8 9.0 17.4 18.9 24.8 8.0 35.4 4.4 15.5 14.5 16.7 5.6 29.8 0.6 16.1 15.3 15.6 3.8 1.0 0.4 5.7 100.7 15.0 69.6 17.5 8.4 6.2 116.2 1.2 3.1 14.7 32.5 14.1 3.5 20.9 12.6 14.6 0.3 4.8 1.6 0.8 54.7 13.6 14.3 0.0 0.0 4.4 29.8 0.0 0.1 0.2 20.5 2.5 0.0 0.0 0.0 0.0 0.0 5.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 27.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.5 0.0 0.4 0.0 0.0 2.3 0.0 0.0 5.3 0.1 0.0 0.5 3.2 0.1 0.1 9.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 15.6 18.4 21.3 15.5 14.5 16.1 15.3 15.6 15.0 14.1 14.6 14.3 3.4 3.2 0.5 9.1 0.0 1.8 0.9 0.1 0.0 111.1 2.0 0.9 1.4 0.0 0.1 1.8 0.0 2.1 0.1 0.9 11.7 0.0 27.8 0.6 10.6 3.9 4.2 0.0 4.1 0.0 2.0 72.6 7.7 0.5 0.0 0.2 12.5 0.0 6.6 5.0 0.9 4.7 0.0 0.0 3.0 41.1 15.8 2.3 0.0 2.8 0.0 1.4 0.0 29.1 0.6 0.1 0.6 257.3 0.3 1.3 0.4 1.3 0.7 4.2 0.0 1.0 95.8 5.5 0.9 0.1 0.4 3.8 0.5 325.9 3.1 1.0 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958330-5019157 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 78.5" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 85.5;Excitatory neurons: 67.0;Oligodendrocytes: 189.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;RPMI-8226: 1.6;SCLC-21H: 2.5;T-47d: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 0.3 0.5 14.7 0.3 40.2 0.4 0.3 24.3 31.7 0.9 0.0 0.5 0.3 0.1 0.2 0.6 0.7 0.2 3.6 16.1 24.9 0.2 0.1 0.2 0.3 31.6 37.9 13.0 0.4 0.6 0.0 2.2 0.3 38.3 0.4 0.6 4.0 0.6 0.2 5.6 1.0 0.2 0.1 32.5 0.3 1.4 0.4 28.4 0.4 0.1 11.0 0.5 0.2 0.4 78.5 0.0 0.1 0.1 0.1 0.2 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.1 0.0 0.1 1.6 0.0 0.0 2.5 0.0 0.1 0.1 0.1 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 14.7 40.2 24.3 31.7 16.1 24.9 31.6 37.9 13.0 38.3 32.5 28.4 78.5 0.2 0.0 0.0 2.3 0.0 0.3 0.1 0.0 0.0 4.1 0.2 0.1 9.1 1.5 0.1 0.0 85.5 1.1 1.3 0.3 0.0 0.1 1.6 1.0 0.1 0.3 0.0 0.0 67.0 0.2 0.1 0.6 0.0 0.1 0.0 1.5 0.4 0.3 0.3 5.0 7.1 0.6 4.1 0.0 0.3 0.5 0.3 2.0 0.0 1.9 0.5 0.0 0.0 3.5 189.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.7 0.2 0.1 0.3 0.0 0.1 0.3 0.0 0.1 0.6 0.0 COTL1 CLP ENSG00000103187 "Coactosin like F-actin binding protein 1" Q14019 16 84565596-84618078 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Chaperone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 275.7;lymphoid tissue: 377.4" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1402.6;Hofbauer cells: 595.3;Kupffer cells: 1015.5;Langerhans cells: 1146.3;Macrophages: 1046.2;monocytes: 949.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 2441.1;eosinophil: 3418.8;intermediate monocyte: 4072.1;myeloid DC: 2395.7;neutrophil: 1758.0;non-classical monocyte: 4579.3" "Group enriched" "Detected in all" 5 "dendritic cells: 2395.7;granulocytes: 3418.8;monocytes: 4579.3" "Cell line enhanced" "Detected in all" "WM-115: 1271.3" "Low region specificity" "Detected in all" "HPA008918, CAB062328" Enhanced Supported Cytosol NA NA 10000000 Cytosol "CAB062328: AB_2084785, HPA008918: AB_2668176" "unprognostic (2.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (3.21e-3)" "unprognostic (8.95e-2)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (7.70e-2)" "unprognostic (5.99e-2)" "unprognostic (5.43e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (5.48e-2)" "unprognostic (7.73e-2)" "unprognostic (3.35e-3)" 83.3 37.1 63.0 298.7 74.4 275.7 54.7 81.1 67.9 29.7 63.2 69.3 91.2 47.1 12.2 32.7 49.9 75.9 23.1 67.0 105.9 141.8 44.9 111.6 377.4 86.9 74.3 48.7 24.3 30.6 32.7 47.8 78.6 86.5 44.9 66.6 44.8 25.2 28.8 11.0 20.6 105.7 67.2 94.4 333.2 127.7 20.7 92.4 89.4 38.3 12.3 265.6 119.5 28.6 87.5 546.3 445.0 994.2 1058.1 111.5 305.0 299.5 462.0 295.8 355.8 136.6 609.1 818.7 149.6 137.6 349.7 211.7 266.8 61.3 364.1 355.1 1.1 77.9 281.9 87.7 162.7 314.0 320.1 1069.3 245.6 57.6 344.2 305.0 222.2 172.2 326.4 26.5 60.5 215.3 88.3 99.1 191.7 123.1 178.5 448.8 10.4 33.7 9.3 529.2 227.5 156.7 7.9 430.7 101.9 238.8 116.9 77.1 256.7 445.9 509.0 290.2 165.8 341.4 11.5 58.1 123.7 397.7 154.1 1271.3 740.1 2441.1 3418.8 69.9 4072.1 92.5 546.6 441.0 417.2 2395.7 279.2 192.6 229.6 1758.0 667.2 4579.3 123.7 685.2 2954.6 63.0 74.4 81.1 67.9 67.0 105.9 86.9 74.3 48.7 86.5 94.4 92.4 87.5 44.0 3.2 12.2 20.5 331.8 63.5 116.5 7.5 27.3 10.4 22.2 32.9 5.1 17.2 6.2 77.3 244.0 136.4 104.5 47.0 39.2 73.0 6.8 17.6 74.5 94.4 145.6 78.4 6.8 34.5 1402.6 59.9 181.0 29.8 141.8 126.0 189.2 6.6 595.3 25.2 14.1 77.8 2.0 1015.5 1146.3 10.8 8.1 1046.2 96.0 39.4 949.1 31.5 74.2 27.6 2.1 108.2 19.8 16.1 130.1 165.3 52.8 305.3 4.5 43.2 6.6 15.4 75.7 5.1 39.5 9.2 38.2 172.8 354.9 11.9 140.2 179.6 USP10 "KIAA0190, UBPO" ENSG00000103194 "Ubiquitin specific peptidase 10" Q14694 16 84699986-84779922 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 742.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 742.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006731, HPA006749" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006731: AB_1080495, HPA006749: AB_1080492" "unprognostic (4.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (6.93e-2)" "unprognostic (1.77e-3)" "unprognostic (1.03e-3)" "unprognostic (2.91e-3)" "unprognostic (1.75e-1)" "unprognostic (3.84e-2)" "unprognostic (2.56e-2)" "unprognostic (1.82e-3)" "prognostic favorable (1.00e-4)" "unprognostic (5.91e-2)" "unprognostic (4.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.38e-1)" 25.0 21.9 18.8 29.6 20.6 29.7 23.6 22.4 23.1 21.2 17.7 31.5 29.8 26.1 24.1 29.4 27.3 18.7 25.6 20.5 20.4 29.1 34.1 18.9 37.0 19.1 18.7 20.1 27.4 23.2 41.8 6.0 40.7 19.3 28.5 26.7 52.9 21.2 26.2 47.1 25.9 27.6 31.2 19.7 32.9 24.0 22.2 20.2 29.4 27.6 39.8 38.0 32.4 10.2 21.9 63.6 72.9 78.5 104.7 31.4 50.2 111.5 58.0 60.1 96.9 51.5 106.9 54.9 102.9 65.2 61.1 47.7 69.8 108.2 89.7 139.0 41.3 63.3 63.2 37.3 92.2 39.4 95.0 37.9 30.0 74.8 95.6 112.3 57.5 76.4 68.5 153.4 22.7 73.1 129.4 92.4 96.8 102.5 71.8 56.7 119.9 44.5 55.0 81.9 48.4 73.0 48.6 130.5 48.7 54.0 72.3 108.4 76.8 55.7 66.9 60.2 39.4 62.2 38.8 53.7 272.3 44.5 64.6 73.2 29.0 77.3 15.6 46.1 61.9 58.0 60.6 148.0 53.9 92.6 59.7 82.9 49.6 742.4 65.9 58.6 30.7 57.3 97.3 18.8 20.6 22.4 23.1 20.5 20.4 19.1 18.7 20.1 19.3 19.7 20.2 21.9 21.3 54.5 50.0 26.4 51.5 51.5 46.1 25.8 54.1 25.1 27.6 28.6 66.6 25.8 45.2 27.6 29.2 106.9 38.1 25.8 31.3 29.0 63.3 31.0 35.8 30.4 28.9 42.5 39.3 25.1 73.4 40.1 35.7 42.1 58.0 38.7 21.0 37.2 31.4 20.2 38.9 28.1 16.2 34.8 33.4 116.6 23.6 40.6 24.9 41.2 52.6 23.7 32.0 49.8 35.8 23.6 23.9 22.6 50.8 48.6 30.4 45.0 90.7 52.7 26.3 58.4 34.3 35.0 29.5 54.5 49.6 60.9 42.5 33.6 40.6 45.2 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819985-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 87.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 87.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 15.6" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 79.9 29.2 3.9 47.0 4.4 8.2 64.8 3.7 4.9 111.5 3.9 75.9 10.9 116.7 20.5 40.2 130.1 104.9 34.4 3.8 6.8 22.0 17.2 93.5 7.4 6.0 4.7 2.6 81.3 23.7 2.5 19.4 123.7 5.9 99.8 18.3 2.4 18.2 28.0 15.1 35.8 59.0 95.9 4.5 25.1 66.5 21.6 4.2 8.2 48.3 12.3 3.8 121.0 70.4 5.7 0.9 2.2 0.6 6.0 43.7 16.2 69.2 34.5 30.4 27.2 19.1 4.7 2.9 0.1 3.0 30.5 8.0 1.0 0.1 0.1 27.3 0.0 0.2 0.5 0.9 0.1 161.4 0.0 0.3 68.0 0.1 8.0 0.1 9.0 0.2 0.0 0.3 0.3 3.1 1.4 0.3 1.7 2.0 4.6 2.0 0.1 0.3 0.4 0.2 5.5 6.7 0.5 8.1 3.5 0.7 9.4 13.7 0.9 3.8 0.4 1.8 28.3 1.0 0.4 0.1 5.8 0.2 0.5 4.1 14.8 20.2 0.7 0.0 1.2 0.0 0.1 0.2 0.0 1.3 0.0 0.1 0.0 87.2 0.0 0.0 0.1 0.0 4.2 3.9 4.4 3.7 4.9 3.8 6.8 6.0 4.7 2.6 5.9 4.5 4.2 5.7 5.9 3.2 2.3 0.7 0.7 46.1 8.6 0.6 9.6 0.5 3.9 7.6 8.6 2.8 1.6 0.0 0.0 7.4 0.8 1.8 0.0 1.4 12.6 7.0 137.3 21.7 3.0 0.0 2.2 0.5 42.4 185.5 27.0 6.3 7.0 11.5 38.6 0.8 4.7 1.7 1.5 4.1 0.0 36.6 39.6 19.6 271.5 14.8 48.0 9.4 41.5 5.1 3.1 54.3 0.6 0.9 0.3 265.9 0.9 17.1 0.2 0.1 0.9 0.7 92.1 146.2 341.2 1.0 1.9 3.7 42.8 9.0 5.4 5.7 2.2 6.5 TSC2 "LAM, PPP1R160, TSC4, tuberin" ENSG00000103197 "TSC complex subunit 2" P49815 16 2047967-2089491 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002225, HPA030409, HPA049679" Approved Enhanced Cytosol NA NA Cytosol "CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848" "unprognostic (2.80e-1)" "unprognostic (1.01e-1)" "unprognostic (1.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-3)" "unprognostic (2.04e-2)" "unprognostic (6.05e-3)" "unprognostic (3.43e-1)" "unprognostic (8.94e-2)" "prognostic favorable (5.06e-4)" "unprognostic (4.32e-2)" "unprognostic (3.91e-2)" "unprognostic (2.14e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-2)" "unprognostic (8.96e-2)" 12.7 10.1 2.3 10.3 3.4 11.0 12.7 3.8 6.2 16.7 0.5 15.5 12.5 17.5 7.3 12.1 16.1 11.0 12.0 4.0 1.6 9.5 9.1 12.1 7.7 2.1 1.1 2.7 18.5 14.9 14.8 16.7 9.3 2.6 12.5 9.2 17.9 21.5 15.8 31.4 14.4 12.9 11.5 0.0 11.5 15.9 16.4 1.4 11.8 18.8 14.6 7.9 14.1 12.9 11.3 13.5 21.4 28.9 32.5 33.7 28.1 24.3 31.7 21.7 23.4 19.7 25.7 25.4 20.5 27.6 26.2 11.0 22.0 17.5 23.1 17.3 15.5 28.5 19.2 39.6 10.7 23.0 24.0 22.4 33.5 14.3 18.9 13.9 27.9 22.3 14.4 19.0 17.7 21.0 27.0 28.9 7.1 29.8 10.1 21.2 45.3 31.6 25.7 9.4 12.1 22.1 41.3 45.2 29.4 15.3 28.2 26.8 17.5 35.5 24.5 16.5 22.0 16.5 39.0 42.7 40.8 10.2 9.7 29.6 3.2 2.7 2.8 3.1 2.1 2.8 1.8 1.9 1.7 2.5 1.8 1.3 2.1 3.5 1.6 1.7 0.6 1.4 2.2 2.3 3.4 3.8 6.2 4.0 1.6 2.1 1.1 2.7 2.6 0.0 1.4 11.3 23.8 25.6 18.9 43.8 16.8 9.2 8.1 10.1 14.8 53.8 23.7 20.2 41.8 21.5 15.3 20.2 93.8 13.0 17.3 34.5 3.9 15.2 13.1 47.8 26.3 25.6 32.5 17.4 22.8 14.1 8.0 19.7 44.9 62.1 8.8 49.0 32.2 38.7 11.4 45.4 22.4 26.6 8.2 17.6 9.9 29.3 28.3 13.8 8.8 15.9 12.1 19.0 36.0 18.6 25.7 21.4 17.5 25.9 14.4 9.4 25.4 8.9 17.8 64.7 13.1 17.2 20.4 18.3 37.7 12.9 9.8 9.3 18.8 31.6 28.9 10.6 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 3.6 3.2 1.7 2.6 1.9 2.3 4.2 3.5 3.1 5.4 1.5 4.2 2.9 6.0 1.6 3.2 5.0 1.9 2.8 2.5 1.2 3.0 2.7 3.1 3.1 2.2 1.6 2.3 6.6 3.7 2.6 4.0 2.2 2.2 4.8 1.7 1.7 4.2 2.6 3.4 4.2 3.5 1.5 0.5 4.7 3.6 3.8 1.8 2.4 4.6 1.4 2.2 4.9 4.4 2.9 1.8 7.2 2.3 6.2 2.7 2.4 10.7 5.2 5.7 6.4 4.3 3.2 3.4 3.8 4.4 2.8 2.3 4.0 4.5 2.7 4.6 2.8 7.4 3.1 10.8 4.4 3.8 2.3 3.3 2.9 6.5 2.9 5.3 6.2 3.6 4.8 4.7 5.9 2.5 4.0 4.7 4.0 3.0 1.4 2.6 8.1 5.6 7.6 2.1 2.0 8.7 5.7 4.5 6.6 2.0 1.6 4.3 3.6 4.1 6.0 4.4 6.7 2.5 5.6 4.1 3.4 1.8 1.9 3.8 1.3 1.0 1.5 1.5 1.0 1.2 2.1 0.9 1.1 0.5 1.9 1.5 1.9 1.1 1.2 0.7 2.6 1.7 1.0 1.7 1.9 3.5 3.1 2.5 1.2 2.2 1.6 2.3 2.2 0.5 1.8 2.9 4.8 12.8 2.7 5.5 5.8 2.4 3.2 3.6 1.8 19.1 3.7 3.0 5.3 5.7 3.0 7.3 25.0 6.8 10.1 4.6 1.9 4.6 8.9 5.1 6.4 5.5 8.4 5.7 8.8 3.1 4.4 5.9 4.6 2.9 7.0 12.0 12.1 4.1 3.3 18.5 6.3 6.8 4.1 4.8 3.8 1.8 11.5 3.4 1.8 3.7 8.4 11.1 6.2 6.0 5.9 3.5 2.3 11.3 4.3 5.2 7.3 3.3 6.6 20.8 0.0 8.0 4.8 13.2 8.8 1.7 2.3 4.5 5.0 9.8 5.5 1.8 NME4 "NDPKD, nm23-H4, NM23H4" ENSG00000103202 "NME/NM23 nucleoside diphosphate kinase 4" O00746 16 396725-410367 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid transport, Nucleotide metabolism, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 250.5;Erythroid cells: 311.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045997, HPA072588" Approved Supported Mitochondria Yes No Mitochondria "CAB045997: AB_11126630, HPA072588: AB_2686538" "unprognostic (3.27e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (3.70e-2)" "unprognostic (7.16e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (4.46e-3)" "unprognostic (1.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.74e-2)" "unprognostic (7.79e-3)" "prognostic unfavorable (1.61e-7)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "unprognostic (3.08e-1)" 87.1 137.2 68.1 26.5 65.3 128.8 73.6 63.3 102.3 84.5 66.0 144.6 22.1 80.2 56.2 50.5 89.9 41.5 91.0 66.4 71.4 55.7 176.7 48.7 21.2 80.5 66.4 62.5 87.5 44.1 57.2 64.8 31.1 67.8 144.9 23.7 11.2 71.0 82.6 35.0 31.3 60.2 52.3 66.7 44.1 98.5 45.1 69.7 29.6 52.1 27.4 15.9 146.9 64.8 68.2 1.0 305.4 265.6 366.7 104.0 181.0 59.5 143.6 170.4 211.8 180.6 205.4 176.2 3.0 105.8 230.2 76.9 3.9 145.0 153.9 62.0 126.5 218.7 151.9 40.2 279.9 195.7 111.0 53.1 234.7 79.8 130.5 12.8 152.2 137.6 210.7 159.6 25.8 160.4 255.4 98.5 139.2 271.8 76.1 67.8 485.8 59.3 79.0 150.6 1.2 77.7 419.2 36.8 2.7 139.9 97.2 178.3 257.5 174.0 149.7 216.8 101.8 36.8 2.7 2.0 83.1 65.8 19.8 177.2 12.9 13.3 39.8 14.9 11.9 12.7 27.6 14.4 16.3 17.6 29.9 26.0 13.4 4.2 2.5 10.6 58.3 0.9 10.7 68.1 65.3 63.3 102.3 66.4 71.4 80.5 66.4 62.5 67.8 66.7 69.7 68.2 52.2 0.0 13.9 18.6 40.6 32.2 56.3 49.0 40.9 15.2 116.6 135.8 44.5 52.9 25.1 58.8 2.1 71.7 45.7 19.3 250.5 116.5 5.0 30.8 113.3 55.3 45.1 311.8 16.8 40.3 26.1 87.3 29.6 59.8 29.9 199.9 55.6 132.2 131.2 8.4 21.1 38.6 26.4 46.5 68.6 21.6 89.2 35.4 62.2 10.3 46.5 45.9 19.6 10.1 3.6 58.3 23.8 94.8 34.5 121.8 9.0 75.5 7.9 5.6 52.6 40.1 105.8 1.7 32.7 38.6 24.6 21.8 26.2 89.4 54.9 60.9 ABCC1 "GS-X, MRP, MRP1" ENSG00000103222 "ATP binding cassette subfamily C member 1" P33527 16 15949138-16143257 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Hydrolase, Translocase" "Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002380, HPA076011" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA002380: AB_1844432, HPA076011: " "unprognostic (9.97e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.42e-1)" "unprognostic (3.31e-1)" "unprognostic (4.07e-2)" "unprognostic (9.78e-3)" "unprognostic (7.19e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-2)" 9.9 11.6 0.7 4.1 0.1 3.7 8.7 0.3 0.5 10.0 3.2 13.4 1.1 11.1 0.1 23.0 7.0 3.1 10.3 0.4 3.1 7.0 2.4 15.6 4.5 1.1 0.5 0.1 9.0 9.0 3.6 7.3 2.0 1.1 15.3 0.7 0.4 9.3 0.9 21.4 9.8 12.5 6.3 0.7 15.8 15.1 13.2 0.6 4.3 21.2 0.1 1.1 15.6 12.9 2.3 4.3 43.7 0.3 11.7 3.2 4.5 0.5 15.4 19.0 13.1 13.8 6.7 34.8 7.0 79.6 29.6 11.0 12.1 3.4 12.4 4.6 22.2 4.4 16.4 22.0 16.3 25.1 5.9 39.5 15.0 9.0 1.1 2.3 3.8 10.2 28.6 17.8 6.8 0.5 5.4 12.0 0.9 3.5 1.8 8.2 41.9 7.8 5.3 0.7 15.2 6.4 11.8 18.9 17.8 3.6 11.9 6.2 0.8 3.5 0.4 2.0 11.4 11.9 13.5 7.4 3.3 6.6 0.6 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.3 0.5 0.4 3.1 1.1 0.5 0.1 1.1 0.7 0.6 2.3 8.6 25.6 5.6 10.7 13.1 8.8 8.5 18.2 9.6 3.1 4.4 3.7 6.0 4.3 14.4 5.5 22.9 0.9 9.8 2.7 3.9 9.1 11.0 15.7 12.9 8.6 18.6 16.0 26.6 6.2 3.2 12.3 49.5 17.8 22.1 16.8 8.6 0.4 8.5 5.0 38.5 6.6 14.2 21.4 9.1 14.3 7.5 12.2 3.6 11.2 10.5 1.2 5.2 12.1 15.9 11.2 4.5 6.8 15.7 18.7 0.5 1.1 9.9 8.8 0.0 6.4 5.1 4.9 6.6 18.1 5.1 0.5 17.4 37.1 3.7 11.6 NOMO3 ENSG00000103226 "NODAL modulator 3" P69849 16 16232506-16300806 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 30.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 9.3" "HPA046697, HPA061174" Approved NA NA "HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (1.21e-1)" "unprognostic (1.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.33e-1)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (8.02e-2)" "unprognostic (6.25e-2)" "unprognostic (8.43e-2)" "unprognostic (7.86e-3)" "unprognostic (1.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" 5.7 5.9 3.2 0.7 3.6 2.8 5.3 4.5 4.7 5.0 1.9 6.2 0.7 7.7 0.8 4.9 5.5 0.3 16.0 3.7 3.3 4.3 4.5 6.8 0.4 3.6 3.4 3.2 5.5 30.2 0.5 4.3 0.8 3.7 3.8 1.0 3.1 5.5 0.4 22.3 5.0 5.1 0.4 2.8 4.0 8.8 3.5 3.4 0.5 5.0 0.1 0.7 6.7 4.5 4.7 1.3 2.9 0.8 2.8 0.6 2.6 1.2 1.9 1.8 2.4 1.3 1.1 1.5 1.3 9.3 1.0 0.4 1.0 2.7 1.7 1.9 1.3 1.9 1.3 3.5 6.6 0.9 1.6 7.0 1.0 6.1 3.4 0.8 1.5 0.8 2.0 1.1 2.1 1.0 5.9 0.5 3.0 0.8 0.4 1.9 2.2 2.6 4.7 0.7 1.1 1.1 1.8 1.3 2.0 1.3 1.5 1.8 1.3 1.5 1.1 1.8 1.9 1.1 2.4 1.9 1.7 2.4 3.0 1.7 0.0 0.2 0.3 0.2 0.3 0.1 0.4 0.3 0.4 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.2 0.3 0.3 3.2 3.6 4.5 4.7 3.7 3.3 3.6 3.4 3.2 3.7 2.8 3.4 4.7 1.3 3.2 4.1 2.9 3.3 10.5 3.7 3.0 2.2 5.7 2.8 1.8 8.2 8.6 4.3 3.7 12.5 2.0 5.2 2.0 0.0 1.2 1.8 2.2 2.2 3.6 3.5 4.0 4.4 1.5 1.4 3.1 5.1 2.2 4.5 8.7 5.3 2.9 1.6 6.7 5.4 1.5 2.0 4.9 4.4 2.2 2.1 2.7 1.8 2.8 3.3 1.1 7.2 5.0 7.2 1.8 1.6 1.2 3.2 2.9 2.1 1.0 6.1 5.2 6.6 4.3 2.3 8.2 6.6 1.5 11.2 2.5 3.5 5.2 1.9 3.2 LMF1 "C16orf26, FLJ12681, FLJ22302, JFP11, TMEM112, TMEM112A" ENSG00000103227 "Lipase maturation factor 1" Q96S06 16 853634-981318 "Disease related genes, Human disease related genes, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 67.6;Excitatory neurons: 90.8;Oligodendrocyte precursor cells: 217.6;Oligodendrocytes: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.42e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-2)" "unprognostic (1.16e-3)" "unprognostic (5.58e-3)" "unprognostic (1.20e-2)" "unprognostic (5.24e-3)" "unprognostic (1.41e-2)" "unprognostic (6.22e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (4.01e-3)" "prognostic favorable (7.95e-8)" "unprognostic (2.00e-1)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (2.03e-3)" 7.7 12.0 8.5 4.1 12.5 4.4 8.5 7.7 13.6 7.9 6.6 6.5 4.3 7.3 14.1 7.0 8.3 4.5 6.1 7.7 8.4 8.3 11.9 6.3 4.5 12.5 9.6 8.6 8.5 22.0 10.5 7.3 3.3 11.7 10.1 3.1 4.4 15.1 5.3 4.3 9.0 6.5 4.8 9.7 7.3 10.4 5.5 9.2 3.5 12.7 3.2 3.8 7.5 7.6 17.6 0.9 11.2 7.8 14.1 9.6 9.8 3.4 5.5 17.7 1.9 3.4 2.3 14.8 2.4 8.3 14.2 5.1 4.1 2.9 0.1 1.1 7.4 4.0 0.8 0.5 2.7 4.9 2.1 2.8 5.7 0.0 0.4 4.6 8.7 4.2 4.1 1.8 9.5 6.5 13.1 4.4 1.2 4.0 9.0 6.2 4.4 7.9 16.3 7.1 2.5 0.0 4.2 2.7 2.9 10.3 4.0 6.7 6.8 4.5 1.2 1.7 4.3 0.8 11.6 1.7 3.5 2.9 2.2 8.9 2.0 5.4 1.2 6.9 5.9 3.9 2.6 3.8 4.7 8.2 2.2 3.8 3.2 0.2 6.2 3.8 7.6 4.1 4.4 8.5 12.5 7.7 13.6 7.7 8.4 12.5 9.6 8.6 11.7 9.7 9.2 17.6 11.9 12.8 12.4 67.6 12.0 4.1 7.7 16.6 4.6 12.1 8.3 8.8 3.6 11.5 13.2 5.5 14.6 1.5 5.4 6.0 3.9 13.9 0.7 5.0 6.5 8.5 8.4 1.3 90.8 17.3 1.8 9.9 12.2 4.7 2.5 10.0 6.1 9.3 7.0 13.5 27.0 6.5 18.3 6.3 3.4 3.7 14.6 5.9 16.0 27.2 4.4 19.4 10.3 217.6 167.4 16.9 4.1 9.8 23.7 6.0 15.0 9.0 13.1 10.7 6.6 5.7 6.5 10.2 9.3 6.2 2.0 1.1 6.8 10.1 6.2 6.7 FOXF1 "FKHL5, FREAC1" ENSG00000103241 "Forkhead box F1" Q12946 16 86510527-86515422 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.8;urinary bladder: 50.3" "Group enriched" "Detected in some" 4 "Endothelial cells: 17.1;Fibroblasts: 46.3;Smooth muscle cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ: 12.8;BJ hTERT+: 27.9;HHSteC: 26.5;U-2197: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028886 Approved Nucleoplasm NA NA Nucleoplasm "HPA028886: AB_10601652" "unprognostic (7.91e-2)" "unprognostic (3.02e-3)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.08e-1)" "unprognostic (8.22e-2)" "unprognostic (6.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (4.89e-2)" "unprognostic (4.20e-2)" "unprognostic (7.11e-2)" "unprognostic (2.44e-1)" 2.5 0.2 7.2 10.3 4.4 0.0 1.2 4.3 6.3 12.9 3.5 47.8 9.0 2.7 1.1 10.2 1.8 15.1 0.7 4.5 4.3 2.1 3.2 34.4 3.3 5.5 4.7 3.0 0.7 1.4 1.1 0.4 23.2 5.4 26.0 10.9 0.2 1.2 5.5 0.2 0.3 21.3 11.8 4.4 0.6 26.6 0.7 7.2 0.1 5.5 1.4 1.5 50.3 11.9 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 27.9 3.8 1.3 0.0 0.1 0.0 0.0 1.2 2.6 0.0 2.2 0.0 3.3 0.0 1.5 0.0 2.1 0.0 26.5 0.0 2.3 2.8 0.0 4.5 0.5 0.4 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.9 11.9 0.0 0.0 0.0 0.0 2.5 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 4.4 4.3 6.3 4.5 4.3 5.5 4.7 3.0 5.4 4.4 7.2 6.7 2.0 0.0 0.6 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.4 0.3 17.1 0.0 0.0 0.0 0.0 0.4 46.3 1.1 0.2 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.2 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.0 0.0 0.0 0.0 0.4 0.0 0.1 18.7 0.0 1.3 0.6 0.3 1.2 0.1 0.1 0.0 0.6 CIAO3 "FLJ21988, HPRN, IOP1, NAR1, NARFL, PRN" ENSG00000103245 "Cytosolic iron-sulfur assembly component 3" Q9H6Q4 16 729760-741329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 11.6;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 10.9;Hofbauer cells: 16.0;Syncytiotrophoblasts: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 142.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040851 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA040851: AB_10794427" "unprognostic (6.31e-2)" "prognostic favorable (1.32e-5)" "unprognostic (7.61e-2)" "unprognostic (8.25e-2)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (8.85e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (8.39e-2)" "unprognostic (4.45e-3)" "unprognostic (3.02e-1)" "prognostic favorable (9.83e-5)" "unprognostic (2.49e-2)" "unprognostic (8.15e-2)" "unprognostic (2.62e-1)" "unprognostic (8.33e-3)" 10.2 13.9 14.1 7.6 15.2 10.8 12.4 14.8 27.4 11.6 11.5 15.2 13.4 12.2 11.6 18.7 12.3 6.7 19.9 15.1 13.7 19.6 22.6 9.5 11.8 15.2 15.1 15.9 10.2 15.9 12.2 15.0 5.9 15.7 19.0 4.9 4.6 16.9 9.3 20.6 18.1 16.6 4.9 14.1 17.4 16.3 11.4 14.4 12.1 13.1 13.3 8.0 13.2 13.8 15.1 9.1 26.1 10.1 14.9 10.3 7.3 24.6 12.7 9.4 17.2 15.0 18.8 22.0 12.9 19.2 8.0 12.7 20.3 10.0 15.4 6.1 24.1 22.8 10.9 14.7 15.5 13.2 19.3 15.0 9.2 19.1 10.2 8.5 11.4 12.9 50.7 20.3 12.0 8.5 33.9 17.5 9.0 8.6 18.4 16.5 142.5 15.3 23.7 10.6 9.0 11.8 16.1 15.3 36.0 13.4 6.0 33.0 19.7 14.0 14.5 13.6 16.1 11.5 15.8 12.1 35.7 9.9 11.0 19.0 2.7 11.1 8.9 10.9 9.9 8.3 14.8 11.0 8.9 11.9 9.2 8.6 12.4 2.3 15.5 11.6 9.4 11.7 9.9 14.1 15.2 14.8 27.4 15.1 13.7 15.2 15.1 15.9 15.7 14.1 14.4 15.1 3.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 20.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 10.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 14.2 0.5 0.0 0.0 0.0 MTHFSD FLJ12998 ENSG00000103248 "Methenyltetrahydrofolate synthetase domain containing" Q2M296 16 86530178-86555235 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041333 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041333: AB_10795006" "unprognostic (4.09e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (9.88e-5)" "unprognostic (2.66e-2)" "unprognostic (7.71e-2)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (6.24e-2)" "unprognostic (3.29e-1)" "unprognostic (4.05e-2)" "unprognostic (2.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.94e-3)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (4.77e-1)" "unprognostic (5.85e-3)" 7.1 8.3 5.3 8.8 6.3 6.3 10.5 6.1 6.2 9.1 7.0 8.8 7.5 9.7 10.7 10.1 13.1 8.5 8.0 5.0 6.1 7.6 8.0 8.4 11.8 6.2 6.0 4.5 11.6 9.9 11.9 9.3 8.2 6.2 10.3 10.6 6.7 11.1 8.1 11.4 12.8 8.7 8.3 6.2 10.7 9.8 17.9 6.2 10.7 11.1 8.4 11.8 8.9 8.9 9.6 15.7 14.6 14.2 12.3 11.8 18.0 17.0 15.3 11.1 19.0 9.4 13.0 25.8 14.2 16.3 13.4 10.2 21.4 15.8 15.0 17.7 9.4 12.8 12.9 20.0 12.0 16.0 10.1 6.9 11.4 23.4 24.4 20.9 16.4 11.5 20.5 26.9 0.0 13.9 19.8 12.6 15.0 9.3 12.9 18.3 38.6 8.0 11.2 11.1 9.4 13.8 9.5 34.7 6.8 12.6 14.1 34.5 10.3 11.9 18.3 15.7 12.2 15.1 11.1 14.7 41.6 16.7 15.8 18.2 5.9 4.8 2.4 4.7 3.5 5.0 4.6 5.2 4.9 6.0 3.4 4.2 5.0 1.9 6.3 4.3 2.7 4.5 4.8 5.3 6.3 6.1 6.2 5.0 6.1 6.2 6.0 4.5 6.2 6.2 6.2 9.6 6.4 6.4 5.9 10.4 6.4 1.1 2.7 4.2 1.2 0.0 6.8 7.1 4.4 2.8 4.7 5.5 0.0 7.9 5.6 7.2 11.7 5.2 35.6 7.4 5.9 4.6 4.2 7.4 6.6 4.2 4.5 4.5 2.6 4.9 4.5 9.4 5.7 3.4 6.1 0.0 7.1 5.3 2.0 5.5 2.0 18.8 6.5 4.3 3.6 3.7 4.7 0.0 6.2 5.5 13.5 3.6 3.6 8.2 4.1 2.6 5.3 4.4 8.2 0.0 6.6 2.2 5.5 11.4 4.0 4.5 1.4 7.7 3.8 5.7 5.5 2.0 CLCN7 "CLC-7, CLC7, OPTA2, PPP1R63" ENSG00000103249 "Chloride voltage-gated channel 7" P51798 16 1444934-1475084 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 74.0" "Cancer enhanced" "Detected in all" "melanoma: 42.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043019, HPA043586" Supported NA NA "HPA043019: AB_10964727, HPA043586: AB_10965322" "unprognostic (2.69e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (5.61e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.59e-2)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.41e-2)" "unprognostic (3.98e-1)" "unprognostic (3.49e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (2.80e-1)" "unprognostic (2.54e-1)" 17.5 37.6 12.6 17.0 11.5 34.6 17.4 10.4 17.8 17.7 13.6 18.6 16.8 20.5 6.4 12.5 17.1 12.4 16.0 11.8 11.2 21.2 22.2 19.2 18.4 15.2 16.7 12.7 15.2 22.0 20.9 21.9 12.5 17.0 16.7 7.2 9.3 16.9 12.1 28.2 22.9 22.9 13.3 9.5 27.5 22.5 19.4 14.6 15.7 23.3 8.4 12.2 16.1 12.0 13.2 14.2 36.9 21.0 33.7 41.3 21.5 34.3 18.9 36.4 35.2 41.5 30.8 51.2 16.3 38.6 23.7 73.8 29.4 18.4 21.0 11.4 26.1 31.5 11.6 37.9 30.0 72.4 29.4 45.1 42.9 28.4 32.1 28.5 23.9 23.0 36.3 48.0 29.2 18.5 28.4 21.3 50.6 21.7 9.0 21.8 96.7 13.3 45.2 16.4 18.2 22.5 24.9 30.8 37.5 120.2 11.8 33.6 78.0 26.3 34.9 16.2 39.1 18.4 47.3 32.1 16.5 28.2 54.3 22.6 0.0 1.6 1.2 0.8 2.7 0.3 1.0 0.4 0.4 1.2 1.0 0.2 0.3 0.3 0.3 3.4 1.1 0.1 1.0 12.6 11.5 10.4 17.8 11.8 11.2 15.2 16.7 12.7 17.0 9.5 14.6 13.2 12.6 0.0 7.5 25.1 16.5 7.4 5.5 6.3 9.1 45.0 14.5 12.7 4.4 4.3 8.2 20.2 35.5 10.2 12.3 20.4 1.9 16.2 10.2 14.0 14.9 11.1 12.0 8.0 22.3 17.8 8.9 11.0 18.8 17.9 6.3 24.0 16.8 15.6 36.3 74.0 20.6 14.5 4.1 28.3 11.5 8.6 11.5 29.6 39.2 24.4 22.4 27.3 13.4 8.5 17.9 17.9 7.3 8.2 9.3 9.0 14.5 14.7 7.8 28.1 0.0 9.9 11.9 13.5 10.7 5.6 6.8 15.5 9.4 19.4 15.1 5.2 HAGHL MGC2605 ENSG00000103253 "Hydroxyacylglutathione hydrolase like" Q6PII5 16 726936-735525 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 43.8;Bipolar cells: 53.5;Endometrial ciliated cells: 40.5;Hofbauer cells: 41.0;Respiratory ciliated cells: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.3;U-266/70: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074402 Approved NA NA "HPA074402: AB_2732254" "unprognostic (6.74e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.49e-1)" "unprognostic (4.56e-2)" "unprognostic (5.62e-3)" "unprognostic (9.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-2)" "unprognostic (6.37e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.92e-2)" "unprognostic (5.36e-1)" "unprognostic (3.41e-2)" "unprognostic (2.41e-1)" 2.8 2.7 5.8 2.2 10.3 1.5 3.1 13.3 11.6 5.5 15.1 4.7 0.8 4.8 0.0 2.6 18.1 0.7 11.1 4.0 7.6 8.7 1.9 7.6 3.1 10.8 8.2 4.1 4.0 2.1 1.7 22.0 0.4 10.5 5.7 0.0 0.5 3.7 0.9 0.5 3.3 13.7 0.1 13.3 15.4 3.5 8.5 10.0 2.0 3.6 0.1 1.1 4.1 3.8 11.0 4.4 4.4 0.8 4.9 0.9 2.0 3.9 4.1 1.7 0.7 0.6 2.0 5.3 9.6 5.5 0.3 1.2 5.9 0.9 1.3 0.1 26.3 3.7 3.1 11.4 3.6 4.6 12.1 8.5 3.4 1.2 0.0 1.2 1.4 0.5 7.8 5.5 7.5 1.0 26.5 0.3 16.5 5.6 4.3 8.8 6.3 2.7 49.3 1.5 1.2 19.5 11.6 1.9 15.1 17.8 0.1 9.0 19.5 4.3 4.2 6.5 1.5 2.2 60.3 8.6 14.2 6.0 11.4 8.1 0.0 0.7 1.0 3.6 0.3 4.1 8.8 2.9 4.2 0.9 2.1 0.8 2.7 0.0 4.3 0.1 3.5 3.4 2.2 5.8 10.3 13.3 11.6 4.0 7.6 10.8 8.2 4.1 10.5 13.3 10.0 11.0 1.1 3.2 0.6 43.8 19.7 1.1 2.0 16.2 0.6 53.5 6.3 10.9 10.6 0.0 7.1 3.7 0.0 0.5 10.4 1.6 35.2 2.4 6.6 40.5 7.9 1.4 3.6 10.9 24.6 0.0 1.4 2.8 3.6 1.9 8.2 0.6 1.1 0.5 41.0 11.8 15.4 2.6 4.1 6.9 3.2 18.4 6.8 10.4 19.6 6.5 5.9 10.6 13.4 6.6 30.9 3.2 1.2 6.0 5.7 10.0 0.0 9.0 65.8 9.9 0.0 0.5 3.3 8.5 6.8 0.8 0.3 0.4 12.8 0.9 1.7 0.9 ANTKMT "C16orf24, FAM173A, MGC2494" ENSG00000103254 "Adenine nucleotide translocase lysine methyltransferase" Q9BQD7 16 720581-722590 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.1;Cytotrophoblasts: 46.0;dendritic cells: 14.9;Extravillous trophoblasts: 37.4;Hofbauer cells: 88.4;Syncytiotrophoblasts: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 74.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046262 Approved Approved Cytosol NA NA Cytosol "HPA046262: AB_10963070" "unprognostic (3.94e-2)" "unprognostic (8.78e-2)" "unprognostic (1.55e-1)" "unprognostic (2.61e-1)" "unprognostic (6.54e-2)" "prognostic favorable (8.88e-4)" "unprognostic (2.11e-1)" "unprognostic (4.49e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (4.02e-2)" "unprognostic (5.70e-2)" "prognostic favorable (4.24e-5)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (9.28e-2)" "unprognostic (3.60e-3)" 13.3 22.8 19.5 4.2 19.3 3.7 13.1 19.4 38.4 11.6 16.7 18.7 10.0 14.1 0.3 14.9 11.5 1.0 23.0 18.8 18.2 30.6 37.8 13.1 3.6 22.9 21.0 18.7 8.5 23.4 3.0 28.1 2.3 19.1 16.3 1.0 1.8 13.9 3.5 21.7 9.9 18.3 1.3 20.0 23.3 21.1 23.7 21.6 2.7 17.6 3.4 1.5 15.7 11.2 21.6 15.9 10.5 1.7 5.2 0.4 0.8 24.7 14.9 3.3 3.2 3.5 9.4 13.0 21.0 24.2 1.6 5.2 24.7 1.7 5.6 0.8 44.5 27.1 8.4 10.4 10.1 4.1 15.4 10.9 2.0 4.2 1.3 3.3 6.0 1.2 12.8 18.3 8.5 2.5 22.8 1.9 32.6 7.8 7.8 31.8 8.3 5.0 37.3 7.8 4.5 7.8 21.6 7.4 12.2 24.6 1.1 12.5 12.6 12.1 2.6 23.2 8.7 10.3 74.0 36.0 23.1 6.2 9.8 7.1 0.1 11.5 9.6 12.0 7.2 25.0 17.5 8.7 19.6 7.3 21.4 9.0 26.7 1.3 11.6 8.2 10.0 23.3 6.9 19.5 19.3 19.4 38.4 18.8 18.2 22.9 21.0 18.7 19.1 20.0 21.6 21.6 7.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 46.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 37.4 8.3 0.0 0.0 0.0 0.0 0.0 0.0 88.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 25.6 1.5 0.0 0.0 0.0 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869507 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 111.7;brain: 120.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 178.7;Microglial cells: 109.6;Plasma cells: 135.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 17.2" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.2" "Cell line enhanced" "Detected in all" "HBEC3-KT: 1326.5;hTCEpi: 2229.0;MCF7: 1264.6;SiHa: 1873.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA 51000 "Plasma membrane, Cytosol" Vesicles "HPA052673: AB_2681909, HPA056077: AB_2683031" "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.7 4.0 120.1 18.4 79.6 111.7 6.0 76.5 120.3 7.6 51.0 10.6 6.7 5.2 36.0 101.0 6.4 6.7 14.8 81.3 82.8 8.7 26.8 9.9 14.2 97.2 85.8 63.7 8.2 14.1 1.8 23.0 17.1 90.7 9.8 2.8 42.9 28.8 10.5 30.3 22.2 9.0 3.2 79.8 16.8 34.7 66.1 98.4 7.0 3.9 2.8 11.6 24.8 22.7 88.6 187.4 693.5 13.2 192.1 5.1 10.6 487.3 147.1 52.8 87.4 56.3 456.3 260.4 170.1 126.7 187.6 30.5 818.3 142.5 1326.5 61.0 179.9 71.9 140.3 618.0 331.2 199.5 131.2 246.0 35.9 2229.0 107.8 791.4 28.5 18.0 588.8 212.6 185.1 71.1 1264.6 159.2 192.7 63.3 116.7 166.0 152.0 52.4 264.1 98.3 15.7 109.2 43.5 1873.1 368.9 406.9 123.0 170.0 171.8 14.3 30.9 201.3 127.8 114.5 237.9 213.2 728.2 120.1 322.1 296.4 1.0 0.0 0.0 1.0 0.0 1.3 0.5 0.5 0.9 0.4 0.0 0.1 0.4 0.2 0.2 0.0 17.2 1.6 0.5 120.1 79.6 76.5 120.3 81.3 82.8 97.2 85.8 63.7 90.7 79.8 98.4 88.6 3.7 0.0 0.6 8.1 23.0 73.3 17.9 27.0 178.7 15.2 12.0 8.9 2.9 2.8 6.3 1.8 16.7 15.4 80.0 3.4 0.0 18.1 1.0 20.5 7.6 29.1 86.3 86.3 12.0 9.6 35.4 9.5 43.3 51.0 66.9 4.5 1.8 17.3 9.2 10.1 13.2 6.3 8.2 3.0 50.5 5.0 1.8 51.0 39.2 109.6 2.6 14.8 2.1 15.1 1.6 25.7 2.3 1.5 135.1 18.2 1.0 0.4 3.2 52.7 0.0 33.6 31.5 1.6 4.5 58.8 37.5 107.4 65.8 2.7 4.2 42.8 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715118-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 301.7;choroid plexus: 180.5" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 1153.9" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5" "Region enhanced" "Detected in all" "cerebellum: 612.9" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 14.1 36.6 198.3 4.0 188.3 1.5 14.2 174.4 301.7 14.2 180.5 24.6 4.2 17.4 3.0 10.5 37.4 2.5 50.4 167.3 216.1 29.2 50.4 17.0 2.1 267.9 188.0 143.1 5.2 46.5 5.5 88.7 3.8 201.2 25.6 1.2 3.0 25.4 13.2 23.5 11.9 12.1 2.9 207.8 12.4 22.4 15.5 207.7 2.5 30.9 5.2 1.8 20.7 11.4 204.4 8.9 73.4 14.2 72.4 24.6 13.8 22.9 17.5 8.7 6.9 4.4 11.0 21.5 1.5 39.6 12.4 26.3 32.6 2.1 17.0 1.1 4.7 32.0 2.9 13.3 57.1 15.1 6.5 9.2 33.3 18.3 2.1 4.2 21.3 2.3 20.3 5.3 1.7 5.2 178.2 2.4 22.0 5.2 9.8 133.1 24.3 16.4 24.4 18.4 2.6 22.5 28.5 6.9 18.9 93.5 1.6 28.6 12.6 8.0 19.4 36.8 22.7 15.4 11.0 3.3 1.7 30.3 4.8 46.6 0.0 0.1 0.2 0.8 0.3 0.5 1.2 0.4 0.8 0.0 0.1 0.2 0.5 0.0 0.5 0.3 0.2 1.0 0.1 198.3 188.3 174.4 301.7 167.3 216.1 267.9 188.0 143.1 201.2 207.8 207.7 204.4 46.7 0.0 2.2 91.4 8.5 3.8 17.1 3.3 0.0 45.5 79.5 75.8 16.3 48.6 1.8 16.5 14.6 0.6 26.7 29.0 50.9 8.4 8.0 230.7 54.8 21.5 27.4 2.7 6.6 5.1 2.1 15.1 5.6 14.4 0.0 2.7 20.0 39.5 6.4 70.7 5.7 10.7 2.0 7.8 6.5 25.8 11.1 6.6 10.6 8.4 1.1 1153.9 23.7 44.2 57.6 5.3 26.7 9.4 7.9 27.7 6.2 55.6 9.5 37.9 26.3 11.8 26.7 4.6 11.7 1.4 3.0 0.4 12.7 5.2 9.2 16.2 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Cell type enhanced" "Detected in many" "Adipocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 27.1 12.9 5.9 6.1 8.5 5.8 24.5 39.5 14.3 15.0 2.5 18.9 8.7 21.9 4.4 10.2 16.9 6.2 17.5 11.6 10.7 5.3 16.0 8.8 6.4 8.5 6.0 8.4 15.2 13.2 8.3 19.5 5.0 16.3 10.3 5.8 8.2 11.2 10.8 65.8 16.1 16.1 11.2 3.1 5.2 11.6 18.9 8.4 5.8 8.7 37.2 4.6 22.0 13.1 9.3 7.0 13.1 4.3 11.7 21.6 12.9 12.5 12.0 11.9 11.6 6.1 11.9 5.8 16.3 12.9 12.7 5.9 10.6 8.3 10.0 7.7 7.5 15.5 5.5 8.7 34.1 12.1 5.3 4.4 15.4 8.3 15.2 14.3 7.6 7.2 8.3 15.9 6.3 6.3 10.1 13.0 7.3 8.4 7.3 11.5 16.1 5.1 7.0 5.2 4.9 20.0 9.7 26.7 5.4 8.3 3.1 8.5 4.6 10.1 11.2 8.5 10.8 9.6 14.4 12.0 20.1 9.0 9.8 7.0 0.5 0.1 0.0 0.2 0.1 0.4 0.6 0.4 0.6 0.1 0.3 0.4 0.5 0.2 0.0 0.2 0.2 1.1 0.4 5.9 8.5 39.5 14.3 11.6 10.7 8.5 6.0 8.4 16.3 3.1 8.4 9.3 61.3 0.0 4.6 13.1 7.3 14.7 5.1 3.3 17.1 13.8 6.4 6.7 20.6 2.8 2.1 5.5 33.3 10.8 4.6 19.3 0.0 3.6 9.2 18.0 10.6 16.0 9.0 9.5 21.6 5.1 3.1 10.1 6.6 11.1 0.0 5.3 5.3 29.5 4.0 0.0 21.9 11.7 4.1 4.4 7.7 26.3 8.1 2.9 3.6 10.3 4.1 5.3 3.1 8.5 13.6 3.5 17.2 11.3 7.2 5.4 33.6 5.5 11.7 11.9 19.7 8.6 9.8 17.9 6.1 14.6 12.9 7.3 9.0 5.9 16.5 4.5 STUB1 "CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1" ENSG00000103266 "STIP1 homology and U-box containing protein 1" Q9UNE7 16 680224-682870 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037202, CAB037209, HPA041222, HPA043531" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533" "unprognostic (5.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.90e-1)" "unprognostic (3.89e-1)" "unprognostic (9.00e-2)" "unprognostic (3.06e-1)" "unprognostic (4.09e-3)" "unprognostic (2.21e-1)" "unprognostic (2.23e-1)" "unprognostic (8.31e-2)" "unprognostic (5.78e-2)" "unprognostic (6.77e-2)" "prognostic favorable (6.49e-9)" "unprognostic (9.67e-2)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.30e-1)" 79.4 127.3 176.2 36.0 175.3 49.3 76.7 172.4 244.6 72.8 160.0 88.0 51.2 67.5 60.8 87.5 65.9 42.5 128.9 174.2 172.1 91.4 101.6 65.6 53.0 175.9 174.6 172.6 66.3 94.5 91.4 94.4 24.1 174.9 80.9 32.9 33.5 87.3 54.0 203.5 112.2 63.6 40.4 168.9 70.6 86.9 45.4 179.7 42.7 73.6 126.3 38.5 81.3 69.7 177.5 81.6 107.6 59.4 108.0 123.4 102.5 43.8 112.8 95.1 100.9 90.5 131.0 97.1 83.0 78.2 147.5 69.1 69.7 73.0 137.3 42.9 93.6 318.8 53.4 154.1 104.7 183.7 85.9 96.4 141.1 134.3 118.2 71.4 76.3 106.2 72.3 87.1 119.2 149.3 318.4 90.1 85.4 76.4 107.1 127.5 143.5 46.8 200.6 132.5 72.6 121.1 103.4 89.4 165.8 137.1 35.9 114.1 147.8 108.7 104.3 99.8 94.3 125.9 137.6 150.2 132.3 83.8 73.9 122.0 17.7 13.6 21.7 15.7 12.9 14.5 19.6 13.5 13.8 12.1 21.0 12.8 11.6 13.4 11.2 13.9 20.7 13.2 7.2 176.2 175.3 172.4 244.6 174.2 172.1 175.9 174.6 172.6 174.9 168.9 179.7 177.5 96.2 38.5 27.9 24.5 88.9 114.7 107.2 63.9 83.1 93.3 137.1 158.7 1.0 104.4 52.4 130.6 52.1 80.1 101.4 142.7 285.7 139.6 8.6 82.8 69.6 71.6 76.0 68.5 23.2 169.7 93.8 85.7 68.3 65.0 21.0 97.9 80.3 122.1 113.1 84.1 21.1 101.4 85.5 69.4 94.9 16.7 109.0 79.0 117.4 15.0 154.4 184.3 110.2 14.1 24.8 190.2 110.8 112.1 108.6 160.8 165.5 324.1 61.2 83.9 72.3 82.3 129.7 50.4 62.4 107.0 120.5 100.7 96.2 132.5 109.3 118.8 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675671-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 0.7 5.0 5.4 0.4 8.0 1.0 1.0 7.6 17.8 1.9 0.0 2.2 2.4 1.0 0.6 1.3 1.6 0.4 2.1 6.4 6.3 4.0 2.0 1.1 0.4 4.3 3.8 9.4 2.1 2.6 0.6 8.3 0.3 4.9 2.7 0.3 2.1 2.4 0.9 0.5 2.3 2.5 0.2 1.5 0.9 2.7 4.2 4.8 1.4 0.9 0.0 0.1 1.5 1.5 6.3 1.7 2.1 1.2 1.8 0.9 2.3 6.1 0.7 1.1 0.4 0.1 4.4 1.2 0.6 1.4 0.4 0.2 1.1 0.1 0.3 0.0 1.5 7.7 0.8 9.8 1.8 0.8 1.6 1.1 1.6 2.8 0.3 0.0 0.9 0.1 2.8 1.3 1.2 0.1 9.2 0.4 4.4 1.1 2.3 0.6 7.6 1.1 1.6 0.1 1.5 1.5 2.0 0.9 0.4 2.2 0.7 3.2 4.5 0.5 2.5 2.2 0.8 0.6 10.5 1.5 2.2 0.9 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 5.4 8.0 7.6 17.8 6.4 6.3 4.3 3.8 9.4 4.9 1.5 4.8 6.3 0.6 0.0 0.0 15.3 2.8 2.2 3.8 10.3 12.5 17.6 2.5 4.2 0.9 0.0 2.4 0.0 12.5 0.2 0.3 2.7 0.0 0.7 2.7 1.4 1.1 0.3 2.4 0.0 30.1 0.5 0.2 1.1 3.1 1.0 0.0 1.9 0.4 0.7 0.3 15.2 27.1 6.1 18.3 0.9 1.2 1.4 1.5 0.4 0.0 1.9 0.2 2.9 0.0 10.6 4.1 1.4 3.8 2.6 0.9 1.6 17.3 9.9 10.8 31.8 0.0 0.4 1.2 1.5 1.7 1.4 1.8 0.3 0.6 3.0 5.5 2.8 NUBP1 "CIAO5, NBP1, NBP35" ENSG00000103274 "Nucleotide binding protein 1" P53384 16 10743786-10769351 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041656, HPA041799" Enhanced Supported Cytosol NA NA Cytosol "HPA041656: AB_10960278, HPA041799: AB_10960692" "unprognostic (2.51e-2)" "prognostic favorable (2.81e-5)" "unprognostic (4.01e-3)" "unprognostic (1.66e-3)" "unprognostic (2.81e-1)" "unprognostic (7.04e-2)" "unprognostic (1.33e-1)" "unprognostic (7.30e-3)" "unprognostic (8.28e-2)" "unprognostic (5.08e-2)" "unprognostic (1.61e-1)" "unprognostic (2.50e-1)" "prognostic favorable (7.61e-8)" "unprognostic (2.12e-1)" "unprognostic (1.04e-1)" "unprognostic (8.23e-2)" "unprognostic (1.69e-2)" 22.2 39.6 12.7 26.1 13.0 31.3 22.2 13.7 16.6 20.1 15.0 25.1 21.8 21.5 25.1 19.9 25.8 19.8 42.2 12.8 15.4 26.6 31.4 21.4 31.4 13.7 12.7 12.3 23.1 32.2 30.6 17.2 19.8 13.2 21.3 20.2 12.1 21.9 21.1 38.0 15.8 22.3 22.9 13.6 28.7 28.9 17.5 13.2 21.6 23.7 35.0 37.2 24.6 16.9 14.1 31.3 55.9 37.2 23.1 16.8 31.0 35.5 29.9 27.9 51.4 42.6 49.0 33.2 53.7 60.5 36.7 40.0 33.5 34.9 30.7 38.2 84.8 43.9 30.3 39.3 80.4 33.7 27.7 34.3 29.2 23.0 35.2 19.2 28.6 34.2 20.6 43.3 31.7 38.3 72.0 18.2 40.2 46.1 25.5 29.9 72.5 48.2 58.6 37.0 37.7 22.9 33.5 51.8 38.6 29.2 23.7 39.3 30.2 30.5 40.0 40.8 49.9 38.2 56.0 52.0 42.4 36.7 55.3 48.0 3.8 82.7 41.3 39.2 88.2 35.9 75.6 34.7 39.1 89.7 69.3 29.9 31.1 9.7 35.2 66.7 44.0 46.5 52.9 12.7 13.0 13.7 16.6 12.8 15.4 13.7 12.7 12.3 13.2 13.6 13.2 14.1 20.3 6.4 23.1 3.9 33.7 14.3 26.6 39.8 10.8 17.0 14.9 17.3 6.0 34.3 32.2 23.9 6.2 49.6 19.0 12.3 66.5 54.2 2.4 17.3 12.2 21.3 16.8 12.0 8.4 79.1 29.2 16.7 15.8 17.2 24.1 17.3 14.6 29.6 56.4 6.7 8.1 19.2 40.7 38.4 91.2 3.6 25.7 38.0 16.0 3.7 72.7 30.1 20.6 3.0 5.2 48.7 18.4 19.5 17.6 17.9 27.2 65.0 31.6 18.5 6.6 20.0 15.9 33.1 29.4 12.3 11.9 60.7 17.8 25.3 18.0 29.2 UBE2I UBC9 ENSG00000103275 "Ubiquitin conjugating enzyme E2 I" P63279 16 1308880-1327018 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003909, CAB009021, CAB079920" Approved Supported Nucleoplasm,Nucleoli NA NA 130000 Nucleoplasm Nucleoli "CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.88e-3)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (7.60e-3)" "unprognostic (3.56e-1)" "unprognostic (7.28e-2)" "unprognostic (9.30e-2)" "unprognostic (1.57e-1)" "prognostic favorable (5.68e-4)" "unprognostic (1.15e-3)" 62.4 76.9 42.1 60.9 44.2 82.3 62.5 46.3 49.7 64.2 37.9 61.0 45.5 73.4 49.1 74.8 67.8 34.6 65.3 45.1 44.2 53.0 41.1 53.5 76.7 39.4 42.2 43.1 93.9 49.5 72.6 62.1 58.6 41.3 53.8 47.8 31.9 56.8 47.2 58.5 68.1 61.6 54.3 41.9 72.5 53.3 47.9 44.5 111.4 53.6 57.5 90.0 67.1 63.6 41.9 121.3 161.1 269.0 157.7 112.7 135.8 114.4 170.0 121.7 154.3 152.9 191.8 190.1 208.2 137.7 148.1 140.7 142.4 193.2 159.2 197.9 151.2 133.4 130.6 136.6 188.4 178.6 194.9 148.0 127.1 100.7 152.1 180.0 149.0 170.0 169.9 190.3 124.3 148.0 254.4 349.6 193.0 219.0 136.0 118.5 434.0 170.9 238.4 145.7 106.6 150.3 159.8 149.3 164.1 177.7 152.8 167.5 234.4 139.4 149.2 172.6 134.0 155.5 132.1 170.4 423.4 85.3 142.9 164.7 278.7 214.3 327.1 165.9 256.6 200.9 297.8 167.8 170.3 214.7 241.1 148.2 149.6 149.5 202.6 249.5 186.3 196.5 260.9 42.1 44.2 46.3 49.7 45.1 44.2 39.4 42.2 43.1 41.3 41.9 44.5 41.9 109.5 51.3 67.0 16.3 172.8 178.6 186.4 275.6 97.3 64.6 101.9 105.7 89.1 84.4 140.9 62.5 50.1 312.8 153.9 77.4 105.7 211.9 64.4 66.6 100.6 118.3 102.3 127.4 17.2 148.2 293.1 134.4 55.5 104.6 109.5 149.7 94.2 43.7 213.5 47.1 16.8 97.1 162.8 104.8 182.1 37.8 129.8 124.8 128.1 15.9 220.2 104.7 209.1 16.6 26.7 212.3 91.8 107.6 144.1 294.8 90.4 117.7 65.7 63.1 78.9 82.1 185.4 139.6 145.7 158.4 206.7 418.1 144.7 134.9 134.7 304.5 ZP2 ZPA ENSG00000103310 "Zona pellucida glycoprotein 2" Q05996 16 21197450-21214510 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 4.9" "Cell type enriched" "Detected in single" 15 "Proximal enterocytes: 7.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 37 "HDLM-2: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA011296 Enhanced "Secreted in female reproductive system" NA NA "HPA011296: AB_1859485" "unprognostic (2.35e-2)" "unprognostic (3.12e-2)" "unprognostic (6.60e-2)" "unprognostic (9.83e-2)" "unprognostic (3.44e-3)" "unprognostic (3.12e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.2 0.1 0.1 0.0 0.2 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 MEFV "FMF, MEF, TRIM20" ENSG00000103313 "MEFV innate immuity regulator, pyrin" O15553 16 3242027-3256633 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" Actin-binding "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.2;lymphoid tissue: 8.9" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 7.6;Kupffer cells: 15.1;Macrophages: 15.5;monocytes: 26.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "neutrophil: 8.3" "Group enriched" "Detected in many" 4 "granulocytes: 8.3;monocytes: 5.7" "Cell line enriched" "Detected in some" 6 "THP-1: 6.6" "Not detected" "Not detected" HPA077497 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077497: " "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (2.01e-1)" "unprognostic (2.49e-2)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "unprognostic (3.35e-2)" "unprognostic (2.97e-2)" "unprognostic (1.09e-1)" "unprognostic (8.89e-2)" "unprognostic (3.27e-1)" "unprognostic (7.58e-7)" "unprognostic (1.08e-1)" "unprognostic (7.16e-4)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" 2.5 0.6 0.1 6.6 0.2 6.2 0.3 0.4 0.9 0.2 0.7 0.4 0.5 0.2 0.2 0.3 0.7 1.0 0.5 0.3 0.2 0.4 0.7 4.0 0.4 0.3 0.2 0.1 0.1 0.2 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.3 0.0 0.7 0.2 0.6 1.0 0.0 8.9 0.4 1.3 0.2 0.4 0.3 0.3 0.3 1.8 0.3 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.2 1.1 0.0 2.4 3.2 0.1 0.0 3.4 0.0 0.1 0.1 0.0 1.7 0.2 0.0 0.1 8.3 0.3 5.7 0.1 0.0 1.2 0.1 0.2 0.4 0.9 0.3 0.2 0.3 0.2 0.1 0.4 0.0 0.2 0.6 0.2 0.0 1.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.3 7.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.4 0.2 1.0 0.0 0.1 0.0 0.0 15.1 2.4 0.3 0.0 15.5 0.0 0.0 26.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.2 0.3 0.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 CRYM DFNA40 ENSG00000103316 "Crystallin mu" Q14894 16 21238874-21303083 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7;heart muscle: 177.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1" "Cancer enhanced" "Detected in many" "prostate cancer: 14.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 21 "plasmacytoid DC: 82.0" "Lineage enriched" "Detected in many" 21 "dendritic cells: 82.0" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 100.3" "Group enriched" "Detected in all" 11 "amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4" "Low region specificity" "Detected in all" "HPA019086, HPA030619" Enhanced Supported Cytosol NA NA 150000 Cytosol "HPA019086: AB_1847260, HPA030619: AB_2673551" "unprognostic (1.32e-1)" "unprognostic (2.93e-3)" "unprognostic (8.96e-2)" "unprognostic (1.44e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.88e-1)" "unprognostic (5.75e-3)" "unprognostic (2.81e-1)" "unprognostic (7.37e-2)" "unprognostic (2.05e-2)" "unprognostic (5.95e-2)" "unprognostic (2.11e-3)" "unprognostic (7.79e-3)" "unprognostic (2.49e-2)" "unprognostic (1.87e-3)" "unprognostic (1.31e-1)" 1.2 0.8 37.1 0.9 87.7 1.0 2.7 52.4 60.1 3.8 24.4 7.0 1.7 1.0 0.2 7.7 1.2 7.0 177.0 58.8 74.3 65.0 14.3 8.6 1.1 25.7 27.9 66.9 0.3 1.9 9.0 56.1 0.4 32.3 35.7 8.5 55.1 20.7 0.2 13.5 4.1 2.6 0.3 24.1 0.3 1.4 5.1 29.2 0.3 0.4 0.9 3.8 22.0 3.7 43.8 0.2 4.0 0.0 0.0 0.2 0.4 0.7 0.0 2.1 0.1 0.2 0.2 0.2 0.3 1.0 0.0 1.8 0.6 5.4 0.0 0.0 0.0 0.8 23.2 0.1 2.3 0.0 0.1 2.2 0.8 0.0 0.8 1.0 0.0 0.0 0.5 0.0 0.4 0.7 0.3 0.0 0.9 9.7 1.6 0.1 0.1 0.0 0.5 100.3 0.1 3.7 5.2 0.2 0.1 2.6 4.8 0.1 0.0 0.0 0.5 0.7 6.8 0.0 0.2 0.0 0.5 16.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.1 3.9 0.0 0.0 0.3 0.0 0.0 82.0 0.0 1.2 37.1 87.7 52.4 60.1 58.8 74.3 25.7 27.9 66.9 32.3 24.1 29.2 43.8 0.3 0.0 20.1 5.2 4.1 2.3 25.4 16.3 0.0 6.3 0.4 11.7 126.0 2.8 56.1 14.7 4.2 0.0 11.4 7.1 17.6 0.1 19.7 3.2 1.5 3.0 13.1 4.8 43.8 0.0 0.0 7.1 6.1 7.7 1.3 1.3 0.4 8.3 0.1 1.7 5.9 20.6 114.0 1.6 0.7 12.4 0.0 1.5 33.8 10.3 0.7 640.7 0.0 7.1 6.6 0.4 2.8 0.0 0.3 19.0 7.5 190.1 19.9 26.2 0.0 0.2 4.3 6.7 7.3 0.2 1.3 0.1 1.1 0.1 8.2 68.0 EEF2K "CaMKIII, eEF-2K" ENSG00000103319 "Eukaryotic elongation factor 2 kinase" O00418 16 22206278-22288738 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 47.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 69.1;Late spermatids: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;HL-60: 1.6;HMC-1: 1.8;NB-4: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007818, HPA056061" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB007818: AB_598150, HPA056061: AB_2683021" "unprognostic (4.79e-2)" "unprognostic (6.10e-1)" "unprognostic (3.89e-2)" "unprognostic (3.49e-1)" "unprognostic (1.94e-2)" "unprognostic (5.09e-3)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (1.74e-1)" "unprognostic (8.50e-2)" "unprognostic (2.01e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 17.0 7.1 1.2 0.4 1.2 0.7 16.1 1.7 1.8 16.2 1.1 16.6 0.3 14.4 0.7 9.2 13.2 0.3 9.2 1.1 1.3 3.7 7.9 9.1 0.5 1.3 1.3 1.2 8.3 13.0 0.0 5.2 0.4 1.4 19.7 0.2 0.3 15.2 0.2 25.1 47.3 8.2 0.3 1.1 8.1 9.8 2.3 1.4 0.0 6.3 0.0 0.2 18.9 15.5 1.5 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.6 0.2 1.0 0.0 1.6 1.8 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.2 1.3 0.0 0.0 0.1 1.6 0.1 0.4 0.0 0.4 1.0 0.2 0.4 0.0 0.3 0.6 0.0 0.0 0.2 0.1 0.2 0.5 0.5 0.7 0.3 1.4 0.0 0.3 0.1 0.3 1.0 1.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.4 0.1 0.0 1.2 1.2 1.7 1.8 1.1 1.3 1.3 1.3 1.2 1.4 1.1 1.4 1.5 43.7 22.4 13.3 22.5 7.3 12.6 9.6 3.9 31.3 69.1 15.4 9.3 17.3 12.8 9.8 9.2 14.6 16.3 12.7 24.2 0.0 4.9 42.9 42.4 12.6 18.4 3.0 7.6 21.2 13.4 11.7 19.2 26.0 34.9 29.2 12.0 22.5 17.7 18.7 1.7 37.4 12.3 4.1 15.3 16.2 76.6 14.3 8.7 8.8 15.9 7.9 6.1 6.2 31.7 8.6 10.2 26.3 15.8 19.6 6.6 12.5 4.0 14.9 21.6 6.6 43.5 10.0 1.3 4.2 16.9 23.0 7.8 7.8 5.7 8.1 6.7 CAPN15 SOLH ENSG00000103326 "Calpain 15" O75808 16 527712-554636 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 4.7;neutrophil: 16.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011960 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011960: AB_10610556" "unprognostic (4.11e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-3)" "unprognostic (8.31e-3)" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.86e-1)" "unprognostic (4.02e-2)" "unprognostic (2.53e-3)" "unprognostic (2.54e-3)" "unprognostic (5.91e-2)" "unprognostic (1.83e-1)" "unprognostic (9.23e-3)" 12.1 12.1 3.8 7.3 2.6 8.2 10.9 10.6 6.4 11.7 0.1 16.3 16.4 13.5 0.4 18.6 13.3 1.6 11.0 3.4 0.5 15.8 17.4 15.5 5.1 3.9 1.4 1.8 13.3 25.0 2.2 15.3 2.6 5.8 12.4 2.4 1.1 12.7 2.9 15.0 21.1 22.9 1.2 1.6 21.3 16.7 18.9 3.3 2.8 11.8 0.9 2.5 12.6 12.9 2.9 16.8 21.5 3.0 9.3 1.7 3.4 46.2 17.5 4.6 4.9 3.3 28.2 12.1 24.0 16.3 3.2 5.0 21.9 2.0 6.9 1.8 25.2 37.1 20.2 25.7 17.6 7.3 23.8 27.3 3.9 4.0 4.9 2.2 2.9 5.3 14.7 37.6 7.1 1.6 25.9 27.1 26.0 26.7 8.6 20.2 46.5 8.7 24.2 3.3 11.0 19.6 17.8 11.7 16.2 10.2 1.8 13.3 24.7 26.2 15.3 21.4 15.7 22.0 18.2 11.0 21.3 6.7 13.8 9.7 4.7 1.3 0.8 0.3 0.8 0.1 0.4 0.1 0.4 0.3 2.3 0.1 0.2 16.2 1.1 1.3 0.5 0.2 0.3 3.8 2.6 10.6 6.4 3.4 0.5 3.9 1.4 1.8 5.8 1.6 3.3 2.9 7.6 3.2 8.4 10.1 5.9 8.9 5.7 6.2 3.4 12.1 7.6 6.6 3.1 8.6 5.6 7.3 16.7 3.7 22.3 54.3 1.9 6.2 16.5 6.1 8.9 8.7 4.2 1.7 10.6 15.7 4.4 6.9 20.4 13.3 7.0 10.8 8.9 16.5 6.8 20.2 11.3 26.9 8.2 12.0 6.8 6.2 7.5 8.2 1.8 7.5 6.5 9.1 23.7 10.6 7.8 14.3 37.1 4.5 5.8 13.4 33.1 5.7 4.6 11.2 0.0 10.2 5.2 5.3 7.4 5.8 8.0 2.5 9.2 9.6 25.9 11.6 PIEZO1 "FAM38A, KIAA0233" ENSG00000103335 "Piezo type mechanosensitive ion channel component 1" Q92508 16 88715338-88785220 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Pancreatic endocrine cells: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 270.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA047185 Uncertain NA NA "HPA047185: AB_2679973" "unprognostic (1.76e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.77e-1)" "unprognostic (1.12e-2)" "unprognostic (4.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (4.39e-2)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.51e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (2.04e-1)" "unprognostic (3.59e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-1)" 70.6 26.7 13.4 20.7 12.7 30.1 65.6 13.9 19.2 28.5 9.2 70.5 7.8 40.7 0.5 48.8 38.5 9.1 27.0 10.5 15.6 56.9 48.6 67.7 14.9 22.2 14.4 8.0 16.0 22.1 5.2 6.8 18.8 18.4 49.8 4.8 1.7 33.6 11.4 6.9 48.2 41.5 14.4 15.7 55.7 38.4 5.2 14.9 7.3 32.7 4.3 5.9 65.9 40.7 19.1 42.0 42.1 6.5 31.3 27.6 30.0 155.2 99.9 43.9 36.1 14.0 61.3 68.5 34.2 68.2 48.4 18.0 88.4 13.9 36.0 7.3 33.8 56.0 58.3 77.9 49.4 41.6 26.4 9.3 24.6 19.4 28.3 23.3 21.3 43.9 56.1 80.4 42.8 21.2 270.1 32.7 91.2 14.7 19.7 25.7 77.7 9.3 86.9 16.4 61.1 12.8 3.4 130.5 68.0 17.8 6.5 93.0 76.5 120.1 86.0 49.6 58.4 51.6 8.7 21.1 21.2 67.9 46.5 52.2 1.8 5.0 3.3 8.1 9.7 7.8 2.3 6.0 5.5 9.7 3.1 1.0 2.5 0.1 1.0 13.1 1.7 5.0 3.9 13.4 12.7 13.9 19.2 10.5 15.6 22.2 14.4 8.0 18.4 15.7 14.9 19.1 69.1 73.7 19.8 27.1 14.3 19.1 12.9 27.6 5.2 2.2 23.5 16.3 5.0 10.0 17.1 58.8 16.7 6.7 16.8 19.3 0.0 37.3 1.6 6.2 15.4 45.0 21.0 12.6 0.4 21.7 30.5 13.7 25.0 9.9 8.8 0.7 55.3 22.0 23.6 3.3 0.5 29.5 10.2 16.8 19.0 1.0 5.6 21.8 16.0 21.5 15.6 1.5 3.1 16.6 5.0 85.9 18.0 2.6 30.8 48.3 8.1 5.5 9.7 4.1 0.0 30.3 9.0 0.3 2.0 18.9 15.9 5.1 21.6 5.6 12.0 21.8 GSPT1 "eRF3a, ETF3A, GST1" ENSG00000103342 "G1 to S phase transition 1" P15170 16 11868128-11916082 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052488, HPA074588" Approved Approved Vesicles,Cytosol NA NA 210000 Cytosol Vesicles "HPA052488: AB_2681849, HPA074588: " "unprognostic (4.13e-2)" "unprognostic (1.66e-1)" "prognostic favorable (2.10e-5)" "unprognostic (1.64e-1)" "unprognostic (2.05e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "unprognostic (1.74e-1)" "unprognostic (1.41e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-3)" "unprognostic (3.13e-2)" 61.4 58.0 22.6 50.0 24.8 76.9 46.5 24.2 33.6 42.3 27.1 56.5 34.1 34.8 47.0 68.4 30.4 35.5 53.2 24.3 25.2 54.1 76.9 48.1 55.8 25.4 23.7 21.5 33.6 62.8 63.2 27.7 50.4 26.2 48.3 60.2 35.6 41.3 42.2 128.1 42.5 34.6 47.3 25.1 40.5 50.2 69.3 23.1 56.8 58.2 98.7 82.7 86.5 40.0 29.5 220.1 212.9 116.1 161.0 164.2 169.3 167.5 238.0 245.9 187.1 185.4 153.1 197.8 295.7 303.9 207.5 130.1 164.3 297.8 220.3 312.9 142.4 153.6 202.0 163.1 325.5 137.9 258.7 103.5 133.5 170.0 212.0 288.3 122.4 210.4 146.2 331.7 148.7 220.0 211.2 219.8 134.0 232.9 163.0 120.1 256.4 200.5 345.6 184.7 189.3 186.4 99.6 342.0 256.3 144.2 164.3 222.4 122.6 163.3 206.8 129.5 151.5 190.3 146.6 233.2 253.8 145.4 258.1 128.5 1.4 5.8 7.7 6.3 11.1 8.8 7.9 8.1 7.7 7.0 6.5 8.2 8.1 1.9 7.2 9.9 3.8 10.5 4.3 22.6 24.8 24.2 33.6 24.3 25.2 25.4 23.7 21.5 26.2 25.1 23.1 29.5 69.4 76.9 160.2 39.5 92.3 242.2 232.0 47.1 170.8 47.7 95.0 61.6 123.4 57.2 69.1 86.5 50.1 76.1 94.5 88.1 103.7 58.9 94.9 109.0 95.6 74.4 66.6 328.5 61.6 63.4 118.3 77.2 81.1 153.9 24.7 93.2 43.5 77.9 75.2 52.2 47.0 107.2 32.6 60.8 116.3 51.6 47.8 80.9 64.0 35.6 50.1 43.6 25.7 38.7 42.9 73.0 66.9 47.4 166.2 271.0 38.3 120.3 52.7 41.5 59.2 94.6 123.0 138.3 83.5 198.5 257.7 102.1 132.1 128.1 114.1 270.4 ZNF174 ZSCAN8 ENSG00000103343 "Zinc finger protein 174" Q15697 16 3401215-3409364 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009656, HPA070692" Approved Supported "Nucleoli fibrillar center,Nuclear bodies" NA NA "Nucleoli fibrillar center" "Nuclear bodies" "HPA009656: AB_1080679, HPA070692: " "unprognostic (4.33e-2)" "unprognostic (6.81e-3)" "unprognostic (2.08e-1)" "unprognostic (7.68e-2)" "unprognostic (1.94e-3)" "unprognostic (5.19e-2)" "unprognostic (2.03e-3)" "unprognostic (6.39e-3)" "unprognostic (2.41e-1)" "unprognostic (4.25e-3)" "unprognostic (2.06e-3)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (2.55e-1)" "unprognostic (1.83e-1)" 6.0 7.1 7.2 5.6 8.0 4.0 6.9 7.8 9.2 8.0 6.5 8.9 6.2 9.6 11.6 6.1 10.9 5.7 10.1 7.2 7.8 6.6 6.7 5.5 8.2 8.1 7.8 7.0 12.8 5.9 14.2 9.4 5.1 8.4 8.9 7.2 10.0 8.0 11.0 10.0 7.2 6.5 10.4 7.4 7.3 6.9 9.6 7.9 9.6 7.6 10.7 8.5 9.1 6.9 9.1 7.1 11.6 13.1 14.9 15.8 11.3 8.4 6.1 16.2 14.2 12.7 8.8 12.3 23.0 9.3 11.9 12.7 10.1 12.4 11.0 13.1 14.0 11.7 12.2 11.2 11.4 11.3 14.5 13.9 13.3 12.6 11.9 11.9 13.6 11.7 16.8 18.9 10.8 14.7 12.2 14.7 12.4 13.9 10.5 14.2 19.8 14.3 19.3 10.0 3.6 12.0 9.1 12.7 14.1 11.0 12.2 13.7 15.4 9.1 10.4 10.8 8.3 8.5 12.9 14.9 19.5 5.6 9.1 10.1 17.4 6.4 27.0 9.6 7.5 9.1 10.3 10.0 11.0 7.9 8.0 12.0 8.9 7.8 8.5 5.1 4.2 10.2 7.6 7.2 8.0 7.8 9.2 7.2 7.8 8.1 7.8 7.0 8.4 7.4 7.9 9.1 4.3 3.2 2.0 4.9 4.1 1.9 1.4 2.6 6.2 6.4 3.3 4.3 5.3 4.3 1.8 0.0 6.2 6.1 5.6 3.0 3.9 5.0 7.1 5.4 4.4 5.2 3.6 5.5 3.4 4.3 3.8 4.7 1.5 2.5 1.3 4.9 2.9 3.5 4.5 3.3 4.3 2.2 8.2 2.5 0.9 4.0 8.7 2.6 3.6 1.0 2.4 7.7 8.2 3.5 10.6 4.0 5.0 9.8 4.6 2.2 4.7 4.7 1.6 8.8 0.0 4.7 4.0 15.1 10.3 4.7 1.8 2.9 4.0 5.8 3.4 0.8 CLUAP1 "CFAP22, FAP22, FLJ13297, IFT38, KIAA0643" ENSG00000103351 "Clusterin associated protein 1" Q96AJ1 16 3500976-3539048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 215.5;Endometrial ciliated cells: 119.2;Respiratory ciliated cells: 181.3;Rod photoreceptor cells: 116.8;Spermatocytes: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036976, HPA044191" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA036976: AB_10602209, HPA044191: AB_2678852" "unprognostic (1.78e-1)" "unprognostic (9.28e-3)" "unprognostic (1.21e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.57e-1)" "unprognostic (3.67e-1)" "unprognostic (4.53e-2)" "unprognostic (3.63e-2)" "unprognostic (2.04e-1)" "unprognostic (8.44e-2)" "unprognostic (3.13e-1)" "unprognostic (6.94e-3)" "unprognostic (5.11e-3)" "unprognostic (8.43e-2)" "unprognostic (2.07e-1)" "unprognostic (8.94e-3)" "unprognostic (1.12e-2)" 9.8 10.8 13.6 5.9 13.4 4.0 14.8 15.4 14.6 21.2 16.8 9.4 4.3 24.4 16.1 11.3 32.0 10.7 11.5 12.3 14.9 18.8 7.8 12.2 7.4 11.8 13.7 11.3 24.9 12.3 31.6 11.8 10.7 11.4 17.2 9.9 29.2 9.2 20.1 10.0 5.7 5.4 20.3 11.1 6.6 9.1 40.3 11.6 12.5 22.2 11.7 6.1 10.9 7.8 11.6 15.7 18.3 20.8 28.9 31.4 32.0 11.0 19.9 26.7 31.4 23.7 5.1 31.3 8.2 16.5 33.7 18.8 16.8 14.7 23.6 26.2 6.6 13.1 6.9 10.3 10.5 36.7 12.5 7.2 21.1 25.4 29.1 29.4 33.1 17.2 16.4 21.7 1.0 23.6 19.3 12.0 14.0 21.5 6.6 11.1 25.9 14.3 15.7 45.7 4.9 23.2 19.8 11.6 8.8 14.3 16.0 18.7 28.8 11.5 20.8 13.8 17.1 15.0 12.8 10.9 2.2 8.0 7.3 15.3 6.2 3.6 1.2 6.2 4.2 12.1 7.3 17.8 10.8 6.8 6.1 26.9 18.4 1.3 9.0 2.4 6.6 10.3 5.8 13.6 13.4 15.4 14.6 12.3 14.9 11.8 13.7 11.3 11.4 11.1 11.6 11.6 14.5 22.4 20.5 17.0 3.5 5.6 12.3 29.1 14.8 41.0 13.4 13.8 11.7 11.5 30.6 14.7 108.4 20.7 7.5 3.3 43.0 24.3 215.5 119.2 49.7 12.4 17.5 4.6 23.6 8.0 7.7 21.9 6.6 26.4 5.1 28.1 13.6 9.2 10.4 38.7 26.3 7.9 18.3 4.9 5.7 63.4 31.4 5.0 3.6 5.6 18.1 40.7 12.3 11.1 10.3 8.6 5.3 33.1 3.5 9.4 5.3 34.6 181.3 116.8 6.6 24.7 22.7 150.0 58.4 6.4 4.1 9.3 12.1 36.7 9.0 6.5 UBFD1 "FLJ38870, FLJ42145, UBPH" ENSG00000103353 "Ubiquitin family domain containing 1" O14562 16 23557721-23574389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.8" "Cell type enhanced" "Detected in many" "Late spermatids: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051746 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA051746: AB_2681587" "unprognostic (2.70e-2)" "unprognostic (1.84e-1)" "unprognostic (9.45e-3)" "unprognostic (2.31e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (2.86e-3)" "unprognostic (1.63e-1)" "unprognostic (2.17e-1)" "unprognostic (3.86e-1)" "unprognostic (8.28e-2)" "unprognostic (8.06e-2)" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "unprognostic (3.13e-1)" "unprognostic (1.46e-1)" 12.8 20.9 18.1 12.0 18.4 10.9 12.8 16.8 19.2 13.7 23.3 12.4 7.5 17.3 18.4 13.2 17.4 12.1 20.2 18.4 22.8 15.2 17.1 9.9 12.5 20.3 21.0 18.3 17.5 13.6 25.4 19.8 18.2 22.8 15.5 11.8 10.8 12.5 15.3 81.8 10.3 9.7 19.0 15.7 11.2 10.8 26.3 20.8 21.2 17.9 39.4 15.8 13.5 11.2 22.9 17.1 40.0 55.0 40.0 62.3 76.9 48.8 45.8 44.2 42.3 39.1 29.9 30.1 39.3 68.5 66.9 28.5 23.6 88.4 36.1 53.9 57.1 47.3 20.8 34.0 66.3 33.2 21.9 34.7 55.1 26.5 41.3 38.4 64.9 41.4 31.1 47.6 20.7 47.1 37.4 30.9 39.5 118.0 29.2 17.2 53.6 33.7 33.0 39.5 14.9 53.5 47.6 17.6 34.3 31.8 52.7 47.1 31.6 43.1 23.3 26.1 25.7 27.2 25.0 29.8 23.6 43.0 25.3 36.6 0.0 0.5 0.5 1.4 0.7 0.7 0.6 0.9 1.3 1.1 1.3 0.5 0.8 0.0 1.2 0.3 1.5 0.8 0.4 18.1 18.4 16.8 19.2 18.4 22.8 20.3 21.0 18.3 22.8 15.7 20.8 22.9 10.0 6.4 2.6 10.1 6.8 8.8 10.2 10.3 13.1 11.6 16.5 13.8 35.1 8.6 6.6 20.2 22.9 19.2 14.9 8.1 15.6 13.0 49.3 20.7 29.4 11.6 7.2 10.3 14.6 11.5 27.2 17.2 7.1 20.6 0.0 26.4 5.3 19.0 13.4 6.7 12.3 10.2 2.0 6.6 5.1 76.1 18.6 6.6 10.6 7.5 10.7 11.0 6.2 5.0 9.8 8.8 8.9 9.8 9.8 20.4 4.8 18.3 8.8 14.9 26.3 17.1 19.2 21.3 21.7 14.0 14.2 36.0 8.3 22.2 9.3 14.8 PRSS33 EOS ENSG00000103355 "Serine protease 33" Q8NF86 16 2783953-2787948 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 4.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Melanocytes: 1.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 65 "eosinophil: 1296.1" "Lineage enriched" "Detected in many" 391 "granulocytes: 1296.1" "Cell line enhanced" "Detected in some" "HMC-1: 2.7;hTERT-RPE1: 5.0;SK-MEL-30: 5.9;U-2 OS: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted to blood" NA NA "unprognostic (4.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.99e-2)" "unprognostic (3.38e-2)" "unprognostic (3.10e-1)" "unprognostic (2.86e-2)" "unprognostic (1.16e-1)" "unprognostic (4.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (2.28e-1)" "unprognostic (1.91e-1)" "unprognostic (2.70e-2)" 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 0.0 4.7 0.4 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.9 0.4 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.4 1296.1 0.2 0.4 0.2 0.1 0.1 0.0 0.2 0.2 0.1 0.3 2.1 3.3 0.3 0.1 0.1 1.0 0.0 0.1 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 EARS2 "KIAA1970, MSE1, mtGlnRS" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23520754-23557731 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favorable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 3.7 7.7 3.0 1.2 3.7 1.5 4.0 2.8 3.6 2.9 3.4 3.0 1.1 3.8 3.0 5.2 3.0 1.0 4.9 3.4 3.1 4.9 9.9 3.1 1.8 3.4 2.3 3.8 3.4 5.7 4.9 3.5 2.5 3.1 3.1 2.3 1.9 4.6 1.4 4.2 5.4 3.0 2.0 1.6 3.3 4.1 3.8 3.1 2.5 4.3 3.8 2.4 3.3 3.4 3.7 2.6 8.3 2.4 4.8 2.9 3.8 3.9 3.2 3.1 3.6 2.4 5.0 2.9 4.8 2.6 3.3 1.8 2.9 9.6 6.4 4.7 2.9 7.7 2.4 5.3 7.1 2.4 3.4 2.1 3.2 4.4 2.4 4.7 4.5 1.4 5.2 7.0 2.5 2.6 5.5 2.1 2.3 7.5 4.4 2.8 4.1 4.5 8.0 5.5 3.8 5.0 4.1 2.1 5.0 2.7 6.3 5.9 3.0 2.3 3.1 2.1 3.1 3.4 5.1 3.7 3.4 4.1 4.0 4.3 0.1 0.8 0.0 1.0 1.5 1.6 0.8 1.4 1.1 1.7 1.0 1.3 1.1 0.4 1.8 1.1 1.6 1.7 1.3 3.0 3.7 2.8 3.6 3.4 3.1 3.4 2.3 3.8 3.1 1.6 3.1 3.7 1.8 9.6 5.9 5.2 3.8 2.2 4.0 4.0 4.0 3.8 6.2 4.7 11.6 2.8 2.9 3.7 2.1 15.1 2.3 2.5 5.9 7.0 2.9 3.3 4.9 3.2 5.4 9.4 8.3 3.5 12.3 4.3 4.1 3.4 5.7 6.5 3.6 11.4 7.1 8.4 7.9 4.3 2.0 3.2 2.5 2.5 2.5 3.4 5.4 3.7 5.3 2.6 4.1 4.0 4.7 3.7 1.7 1.9 8.8 4.9 1.6 8.6 5.3 3.9 0.0 2.7 3.4 5.8 9.8 6.5 3.0 11.4 3.3 12.6 6.2 3.2 ELOB "SIII, TCEB2" ENSG00000103363 "Elongin B" Q15370 16 2771414-2777280 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1279.6;Exocrine glandular cells: 911.2;Pancreatic endocrine cells: 1027.1;Proximal tubular cells: 1789.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064006 Approved NA NA 82000 "HPA064006: " "unprognostic (1.77e-1)" "unprognostic (5.27e-3)" "unprognostic (3.93e-1)" "unprognostic (1.50e-3)" "unprognostic (2.02e-1)" "unprognostic (2.28e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-1)" "unprognostic (1.81e-2)" "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (7.15e-2)" "unprognostic (7.83e-2)" "unprognostic (3.42e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (6.32e-2)" 234.6 295.7 309.3 132.1 311.3 292.3 237.0 316.3 483.4 209.2 289.6 270.1 142.8 215.9 81.5 299.5 219.6 181.8 439.0 319.7 309.9 302.8 342.9 208.4 187.2 314.2 312.3 306.5 189.3 209.3 205.2 282.0 110.7 309.9 235.7 83.9 51.8 335.1 113.9 577.8 251.3 205.2 90.4 320.2 210.5 257.7 431.9 328.3 156.0 201.1 268.6 94.1 222.0 230.5 320.2 185.8 559.0 254.5 407.0 263.5 354.6 265.7 233.1 242.6 254.3 210.0 408.8 372.6 288.6 309.4 256.7 275.1 206.6 146.4 403.4 61.9 349.4 593.0 188.5 773.6 578.7 410.1 276.9 286.6 362.8 517.3 242.4 180.6 254.7 225.8 420.1 258.4 465.0 265.5 1212.8 459.7 708.6 331.4 363.2 570.0 487.9 248.3 636.9 311.8 404.2 461.4 335.2 310.0 472.3 320.1 79.0 434.1 506.3 303.5 323.4 308.9 232.4 277.7 382.8 503.1 619.8 152.5 279.6 347.2 3022.8 1566.1 2928.2 711.2 1154.9 687.1 877.6 741.7 760.1 951.3 757.8 638.9 671.0 1519.2 892.1 1236.0 848.6 1046.2 2212.0 309.3 311.3 316.3 483.4 319.7 309.9 314.2 312.3 306.5 309.9 320.2 328.3 320.2 401.9 182.7 218.4 0.0 89.7 0.0 0.0 0.0 0.0 0.0 633.1 738.0 0.0 0.0 131.8 505.8 0.0 562.9 243.1 0.0 1279.6 752.8 0.0 641.0 734.0 188.1 0.0 0.0 0.0 911.2 689.1 219.6 0.0 551.8 107.2 339.5 0.0 0.0 719.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 304.4 0.0 0.0 419.2 0.0 0.0 0.0 0.0 1027.1 0.0 0.0 46.1 0.0 0.0 1789.2 241.9 0.0 0.0 0.0 233.3 0.0 0.0 0.0 0.0 496.8 132.1 310.6 0.0 0.0 GGA2 "KIAA1080, VEAR" ENSG00000103365 "Golgi associated, gamma adaptin ear containing, ARF binding protein 2" Q9UJY4 16 23463542-23521995 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 159.9;U-698: 170.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034422, HPA043313, HPA063634" Approved Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067" "unprognostic (1.27e-1)" "prognostic favorable (1.71e-5)" "unprognostic (8.53e-2)" "unprognostic (2.22e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.70e-5)" "unprognostic (1.68e-1)" "prognostic favorable (1.68e-4)" "unprognostic (7.82e-3)" "unprognostic (3.88e-2)" "unprognostic (2.15e-3)" "unprognostic (8.55e-2)" "prognostic favorable (3.91e-5)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (3.89e-2)" "unprognostic (2.08e-1)" 14.9 36.6 13.5 32.3 13.9 37.9 20.1 18.3 15.1 20.2 23.0 15.8 10.1 16.3 19.8 18.0 18.6 13.5 18.5 14.5 14.7 27.1 16.6 34.4 73.5 12.3 13.9 13.7 34.3 54.7 29.4 26.2 17.7 14.1 27.7 15.9 80.0 37.9 21.5 25.7 21.3 33.9 15.0 12.0 44.6 25.9 12.5 16.1 37.6 36.5 19.1 88.0 16.5 18.8 13.4 18.8 22.9 29.6 26.1 16.5 17.9 25.3 19.7 20.0 15.2 19.3 32.1 18.9 159.9 31.4 21.1 4.3 28.7 49.1 25.8 19.4 25.1 45.6 28.8 29.5 51.2 16.2 48.0 18.2 18.7 22.7 20.8 9.7 22.1 22.0 12.8 50.3 23.0 19.8 29.8 17.0 31.9 39.6 18.3 20.2 108.3 38.4 41.2 24.8 25.6 21.1 25.3 18.3 27.0 27.1 31.5 23.7 59.7 24.5 18.1 19.6 20.3 18.5 42.0 41.8 170.8 16.5 32.2 20.6 0.2 4.2 7.0 3.1 4.3 3.2 16.2 3.9 3.7 4.9 21.6 4.0 4.0 0.5 3.1 4.0 15.9 4.5 3.1 13.5 13.9 18.3 15.1 14.5 14.7 12.3 13.9 13.7 14.1 12.0 16.1 13.4 11.7 48.1 41.4 28.7 102.3 34.2 33.6 16.5 39.3 73.2 25.0 26.0 27.3 21.5 17.6 22.0 114.7 23.0 80.6 7.3 25.4 19.3 22.0 25.4 17.6 19.0 17.6 9.9 44.2 18.9 40.7 17.3 15.3 37.3 9.5 88.5 12.5 16.1 69.1 6.7 61.5 12.6 12.2 26.1 19.7 30.8 24.5 37.7 26.6 36.5 87.9 23.8 23.7 26.2 8.3 16.2 6.1 26.4 36.1 20.7 8.7 21.5 16.2 153.3 19.7 16.0 16.3 30.5 60.5 25.4 14.6 22.7 34.8 56.8 11.9 18.6 AQP8 ENSG00000103375 "Aquaporin 8" O94778 16 25215731-25228932 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 641 "intestine: 332.9;pancreas: 1291.0" "Group enriched" "Detected in some" 45 "Distal enterocytes: 1005.1;Paneth cells: 379.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.4;pancreatic cancer: 15.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "Hep G2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046259 Enhanced NA NA "HPA046259: AB_10960494" "unprognostic (8.75e-2)" "unprognostic (2.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.93e-2)" "unprognostic (8.67e-2)" "unprognostic (3.34e-3)" "unprognostic (8.47e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-1)" "unprognostic (2.05e-2)" "unprognostic (8.23e-2)" "unprognostic (1.06e-2)" "unprognostic (2.67e-2)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (3.71e-2)" 0.2 0.2 0.7 0.4 0.7 0.4 0.3 0.8 0.8 0.4 0.4 332.9 0.2 0.5 0.0 0.1 0.3 0.0 0.2 0.8 0.5 0.2 0.7 0.1 0.0 0.5 0.5 0.6 0.6 1291.0 0.0 0.1 0.1 0.6 0.3 161.7 0.1 0.1 0.3 0.1 0.3 0.2 1.2 0.5 0.1 0.8 0.5 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.8 0.8 0.8 0.5 0.5 0.5 0.6 0.6 0.5 0.6 0.7 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1005.1 0.0 0.1 1.4 0.2 1.3 0.1 13.1 0.0 0.8 11.0 0.1 0.0 0.0 0.3 8.9 0.4 0.0 0.0 0.1 1.7 0.6 15.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 379.5 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.4 1.7 0.2 12.9 0.1 CPPED1 "CSTP1, FLJ11151" ENSG00000103381 "Calcineurin like phosphoesterase domain containing 1" Q9BRF8 16 12659799-12803887 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 105.2;monocytes: 127.4;Syncytiotrophoblasts: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 674.2" "Group enriched" "Detected in all" 28 "dendritic cells: 168.5;granulocytes: 674.2;monocytes: 320.8" "Cell line enhanced" "Detected in many" "Hep G2: 144.2;HMC-1: 129.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040938, HPA041970" Uncertain Supported "Plasma membrane,Cytosol" No No 470000 Cytosol "Plasma membrane" "HPA040938: AB_10673443, HPA041970: AB_2677774" "prognostic unfavorable (9.72e-4)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (1.13e-3)" "unprognostic (3.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.67e-2)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (6.26e-2)" "unprognostic (3.64e-1)" "prognostic favorable (1.62e-9)" "unprognostic (5.05e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-3)" "unprognostic (2.40e-2)" 12.6 9.5 9.6 19.5 13.9 14.1 8.3 13.2 11.1 11.1 8.5 13.4 21.5 7.9 5.2 25.4 7.2 11.3 10.2 8.8 13.4 34.0 34.7 13.8 11.7 14.4 13.7 7.9 7.6 4.9 3.9 4.2 18.7 15.6 11.2 15.0 3.7 13.2 8.7 8.3 6.5 21.6 13.0 13.0 30.1 8.8 15.7 12.3 9.3 13.4 9.7 16.8 11.6 8.8 17.8 5.0 29.7 3.3 7.7 12.0 25.3 0.5 54.1 14.5 28.4 23.1 14.5 15.2 7.3 54.6 39.6 12.5 0.4 0.0 13.5 29.3 17.0 8.2 62.5 4.2 144.2 7.4 0.1 129.9 25.4 3.0 2.5 20.2 0.1 43.1 9.9 22.1 4.3 70.4 6.3 5.6 29.1 8.7 2.4 4.2 11.9 18.8 15.6 43.0 9.4 15.3 10.0 0.2 48.5 20.0 15.3 10.5 13.7 65.0 40.6 8.5 0.2 0.1 0.1 1.0 11.6 9.1 31.7 8.8 57.1 224.0 146.1 9.1 320.0 7.8 10.8 7.6 10.0 168.5 8.4 2.4 5.7 674.2 13.5 320.8 41.1 13.8 129.7 9.6 13.9 13.2 11.1 8.8 13.4 14.4 13.7 7.9 15.6 13.0 12.3 17.8 12.3 9.6 16.7 8.1 8.7 4.6 3.4 4.9 4.6 3.3 4.7 4.7 10.7 10.0 11.4 14.7 8.4 105.2 18.5 9.2 60.7 43.1 3.6 5.3 13.5 16.7 6.0 31.7 13.1 12.8 15.6 12.6 4.1 9.4 54.4 8.1 7.5 45.8 47.1 10.1 10.2 9.3 6.1 80.3 30.7 4.1 15.5 59.0 7.2 30.0 127.4 13.5 8.2 21.1 70.9 31.9 18.3 24.0 4.4 3.2 40.6 66.0 13.4 6.1 26.3 17.6 11.9 2.5 9.9 14.8 4.5 131.9 8.3 13.6 15.4 1.7 USP31 KIAA1203 ENSG00000103404 "Ubiquitin specific peptidase 31" Q70CQ4 16 23061406-23149270 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 198.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006937 Uncertain Approved Cytosol NA NA Cytosol "HPA006937: AB_1080523" "unprognostic (6.45e-2)" "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.43e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.52e-1)" "unprognostic (6.15e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.41e-5)" "unprognostic (5.59e-2)" "unprognostic (3.75e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-3)" 5.3 2.9 8.8 2.0 20.6 4.4 6.7 16.4 14.9 11.6 0.4 3.6 1.7 11.1 3.8 6.0 5.4 1.9 8.7 9.9 10.0 3.6 5.6 6.2 1.8 20.0 20.1 6.0 2.2 4.3 5.5 5.7 3.9 20.4 7.5 2.3 3.2 4.7 4.2 9.0 9.7 2.6 7.6 16.2 1.6 2.6 11.9 18.5 2.6 3.1 8.5 2.5 7.6 7.9 30.3 12.0 12.4 3.5 4.9 6.2 4.8 3.3 4.1 3.7 5.1 6.1 7.9 7.1 4.0 4.2 5.1 8.3 15.2 8.7 15.9 8.4 2.9 3.5 1.6 7.4 16.7 7.8 4.2 4.3 4.1 13.5 9.5 21.8 1.9 9.3 3.9 4.9 12.0 7.1 8.0 2.0 3.5 6.9 3.9 3.8 9.9 9.8 7.9 7.7 17.5 9.3 6.0 6.3 12.4 3.6 3.9 5.0 9.2 5.5 10.3 7.6 5.3 11.2 3.9 7.0 4.2 7.4 5.5 4.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 8.8 20.6 16.4 14.9 9.9 10.0 20.0 20.1 6.0 20.4 16.2 18.5 30.3 25.9 6.4 3.7 11.1 2.2 66.8 62.7 35.5 44.9 13.7 7.6 19.8 13.6 7.2 10.9 5.5 2.1 13.8 3.6 2.7 0.0 7.0 4.8 20.6 12.8 17.6 4.8 8.2 59.2 8.6 7.5 6.9 2.0 13.2 1.3 23.7 7.5 27.7 4.7 0.0 49.6 3.5 12.2 3.5 10.8 10.4 7.8 5.0 7.2 32.8 3.1 4.0 3.1 31.7 198.7 7.9 2.0 4.5 2.8 32.0 1.5 11.6 17.6 8.1 19.7 8.8 11.2 24.2 57.1 17.4 26.6 7.5 2.9 4.4 6.4 23.9 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 515.3;Late spermatids: 2001.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol NA NA 12000 "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favorable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 63.3 51.7 47.1 23.4 54.5 18.5 56.2 58.7 57.5 38.4 38.1 38.4 35.1 36.1 22.7 85.2 36.2 27.2 121.9 50.4 51.5 70.6 110.4 47.0 33.5 57.0 52.7 49.7 25.8 40.1 39.0 44.1 18.0 60.1 34.8 25.4 22.7 44.5 14.2 38.2 44.5 42.9 22.9 48.4 68.3 101.1 153.4 55.4 24.5 42.3 32.6 36.6 33.5 49.4 61.1 82.9 38.2 20.5 45.6 65.8 31.5 33.8 53.9 26.5 48.3 43.7 48.3 55.5 36.9 64.0 55.7 34.6 51.5 75.4 126.9 48.4 51.5 48.4 27.5 35.2 63.3 43.7 56.8 44.4 48.7 41.7 55.7 37.6 37.9 83.7 46.9 44.7 18.1 44.5 114.3 48.7 58.4 34.2 81.1 35.7 54.3 33.7 84.4 72.3 51.8 34.4 19.4 43.1 95.1 66.4 33.9 58.2 36.3 91.7 25.7 39.9 120.3 30.1 24.3 30.0 78.0 16.5 52.5 35.2 87.6 37.1 252.6 166.3 46.5 142.1 69.8 153.8 168.5 73.6 66.8 145.5 151.6 125.1 99.0 35.7 39.2 155.4 142.3 47.1 54.5 58.7 57.5 50.4 51.5 57.0 52.7 49.7 60.1 48.4 55.4 61.1 33.8 35.3 41.5 7.8 37.2 54.8 35.7 73.5 19.4 29.3 26.4 29.1 70.6 32.9 54.5 36.8 20.9 75.3 59.8 70.7 129.1 79.7 515.3 38.6 30.9 53.4 31.8 14.3 23.0 90.7 69.6 39.4 89.7 53.3 19.7 38.8 75.0 93.0 67.2 28.6 21.6 37.6 85.5 23.9 52.9 2001.6 45.4 30.6 62.2 5.6 29.3 53.9 141.1 9.5 32.9 114.9 70.7 56.1 47.1 37.7 110.8 239.3 39.9 27.8 72.3 14.6 58.0 199.7 149.8 28.2 51.6 38.4 88.3 47.4 48.9 28.7 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Supported Vesicles,Mitochondria NA NA 16000 Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favorable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 17.8 44.7 15.2 11.9 15.7 6.4 18.5 16.8 18.9 19.0 14.2 24.3 17.7 18.8 6.8 28.0 18.1 8.1 37.2 15.2 16.1 26.7 66.2 16.0 13.4 16.1 15.8 14.6 20.9 26.7 24.1 20.3 12.4 16.5 18.9 12.7 8.8 20.4 12.5 91.3 21.9 21.3 10.5 15.1 19.5 24.1 23.8 16.7 11.6 18.9 48.7 12.0 24.0 20.7 16.3 26.4 53.7 16.1 33.1 20.5 18.8 34.6 34.2 22.9 45.1 36.1 40.2 38.7 50.2 32.9 20.3 31.3 38.4 55.7 39.7 24.8 42.2 35.8 25.4 48.8 40.4 50.8 47.5 24.4 22.6 46.6 40.0 66.1 20.5 20.4 36.7 63.1 39.7 27.8 60.9 39.6 33.8 35.6 48.2 43.2 51.5 27.6 92.7 32.5 28.0 43.7 17.3 38.2 77.6 62.0 13.7 46.7 38.3 22.2 35.8 24.5 80.1 44.4 38.5 56.6 69.7 17.9 45.0 39.8 1.4 5.3 3.2 10.3 8.7 12.4 12.1 9.6 9.8 7.6 10.0 12.9 10.4 0.8 11.1 6.9 5.4 10.8 10.5 15.2 15.7 16.8 18.9 15.2 16.1 16.1 15.8 14.6 16.5 15.1 16.7 16.3 10.9 12.8 8.1 11.4 23.7 15.7 18.5 12.6 25.0 23.0 14.8 10.8 36.3 14.3 13.0 25.8 10.4 42.8 8.2 17.9 45.0 21.8 62.6 8.9 13.5 13.3 17.5 18.7 19.4 12.2 34.3 13.6 18.8 10.0 12.7 17.9 8.9 46.1 16.6 23.5 20.4 17.5 16.2 10.1 7.0 30.5 19.3 10.0 21.4 6.5 15.2 18.5 16.5 10.6 15.2 13.9 15.5 22.2 19.9 28.9 21.5 25.9 9.2 23.2 13.1 14.2 14.2 50.5 33.7 23.5 16.9 28.5 17.5 29.8 32.7 16.7 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Club cells: 2.5;Oligodendrocytes: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.0 0.2 0.3 0.2 0.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BFAR "BAR, RNF47" ENSG00000103429 "Bifunctional apoptosis regulator" Q9NZS9 16 14632931-14669236 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (4.88e-3)" "unprognostic (2.81e-2)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.11e-1)" "unprognostic (2.09e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (3.22e-1)" "unprognostic (1.07e-2)" "unprognostic (2.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.42e-2)" "unprognostic (2.51e-2)" 34.6 24.6 12.2 14.9 13.1 17.4 32.9 14.0 12.6 25.9 13.6 27.1 20.0 26.1 14.7 18.5 23.4 17.5 23.6 11.8 14.5 25.0 22.9 35.8 20.8 13.7 12.7 10.5 28.7 46.7 16.3 16.9 25.5 13.3 20.9 15.5 19.6 22.9 13.8 46.0 24.2 25.5 17.6 12.7 22.7 28.5 15.9 13.1 21.5 22.7 26.7 17.6 27.3 23.9 14.0 29.4 37.4 37.3 42.4 35.3 50.6 26.0 44.2 54.9 39.3 41.7 24.3 43.2 47.8 81.9 53.6 33.8 41.1 65.0 41.7 51.4 29.0 25.4 32.2 33.2 78.0 54.7 49.9 36.0 58.4 44.7 37.7 52.4 41.9 61.8 31.2 43.4 36.9 46.0 41.6 34.6 42.1 71.6 26.9 16.0 58.7 48.7 51.1 49.2 33.1 45.9 45.1 36.5 38.7 113.0 37.1 38.4 42.3 49.9 66.3 31.8 35.7 35.7 49.2 54.7 45.4 37.8 44.4 43.7 6.2 7.1 8.4 11.5 9.4 13.4 11.2 9.8 12.0 9.1 8.4 9.4 10.0 4.0 9.8 8.3 6.9 14.7 6.3 12.2 13.1 14.0 12.6 11.8 14.5 13.7 12.7 10.5 13.3 12.7 13.1 14.0 49.3 44.8 58.0 10.1 47.2 39.4 39.7 30.8 43.9 34.2 30.0 33.9 20.8 31.5 26.8 23.9 37.5 44.6 55.1 32.0 31.3 49.9 9.4 28.7 36.6 45.8 33.0 37.0 11.2 92.9 81.1 37.3 35.2 54.6 47.5 54.1 46.4 25.3 38.8 25.2 12.9 49.9 28.5 58.6 25.2 7.9 30.1 41.6 19.6 12.2 46.3 29.6 44.3 13.0 13.0 62.1 35.6 26.7 37.2 30.7 47.5 50.6 17.7 37.1 26.3 27.8 31.9 45.4 42.1 30.7 19.7 44.1 47.3 53.8 39.5 36.6 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7;kidney: 26.5;liver: 36.7" "Cell type enhanced" "Detected in some" "Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3" "Cancer enhanced" "Detected in many" "glioma: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2" "Region enhanced" "Detected in all" "olfactory bulb: 52.6" "Low region specificity" "Detected in all" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.2 0.0 16.4 0.7 26.1 0.1 0.3 28.4 18.5 17.6 1.8 2.6 1.0 17.6 0.0 0.3 11.1 0.4 0.7 15.6 22.4 26.5 36.7 0.0 0.0 39.7 30.5 11.7 4.5 1.0 6.5 6.5 3.9 33.7 0.8 2.7 4.6 0.2 1.6 0.0 0.1 1.4 8.5 31.9 0.0 2.5 1.7 24.5 0.1 24.0 0.2 0.0 2.8 7.2 39.5 0.0 1.7 29.5 0.2 0.8 0.6 0.0 10.0 25.3 0.6 1.4 0.0 0.0 0.0 11.2 14.1 8.8 0.0 18.6 0.0 0.9 0.0 11.3 0.0 0.0 18.5 0.7 0.0 8.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 48.0 0.0 0.0 3.8 1.9 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 46.2 0.0 10.0 0.2 0.6 0.5 0.1 0.4 0.1 0.2 0.2 0.1 0.4 0.2 0.1 0.1 0.3 0.0 0.3 0.4 0.2 0.3 16.4 26.1 28.4 18.5 15.6 22.4 39.7 30.5 11.7 33.7 31.9 24.5 39.5 0.0 0.0 0.0 15.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 1.4 10.0 0.0 9.2 25.0 0.0 0.0 0.0 11.7 0.5 0.7 8.9 17.5 0.9 0.0 2.7 0.2 0.0 0.0 1.6 0.0 14.3 0.0 0.0 0.7 30.1 0.1 0.0 8.2 0.0 0.0 1.0 0.3 0.1 0.0 0.4 0.0 26.2 0.0 0.5 0.0 5.0 47.6 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 1.0 0.0 0.0 0.5 0.2 2.3 0.0 0.1 0.0 0.3 0.6 0.0 0.1 TOX3 "CAGF9, TNRC9" ENSG00000103460 "TOX high mobility group box family member 3" O15405 16 52436417-52547802 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.1;retina: 17.8;stomach 1: 20.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040240, HPA040376" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040240: , HPA040376: AB_10795522" "unprognostic (1.14e-2)" "unprognostic (9.75e-3)" "unprognostic (9.08e-3)" "unprognostic (3.32e-2)" "unprognostic (3.50e-1)" "unprognostic (2.31e-1)" "unprognostic (4.74e-3)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.94e-2)" "unprognostic (2.59e-1)" "unprognostic (4.60e-3)" "prognostic favorable (3.08e-12)" "unprognostic (1.19e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.95e-4)" 0.3 3.0 5.0 1.4 5.9 0.0 3.9 1.1 4.4 7.6 0.2 15.7 9.3 1.3 4.4 0.6 3.1 6.9 0.0 5.1 3.3 9.6 5.2 1.4 0.1 4.0 3.4 5.5 0.9 2.6 0.0 2.3 0.2 2.8 1.8 18.1 17.8 9.0 0.6 4.0 0.6 9.4 1.0 3.4 0.0 20.5 0.6 6.4 1.3 0.0 0.5 0.2 5.8 1.0 7.0 0.0 5.8 46.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 3.5 0.0 0.3 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.6 25.8 0.0 0.0 8.0 0.2 10.7 97.1 30.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 5.9 1.1 4.4 5.1 3.3 4.0 3.4 5.5 2.8 3.4 6.4 7.0 0.2 6.4 8.2 1.3 0.0 1.0 0.5 2.8 0.6 4.1 20.0 12.6 0.7 52.9 7.7 35.0 0.0 0.0 0.0 47.6 3.9 1.6 3.2 1.6 0.4 0.3 61.7 0.0 3.9 5.1 0.0 1.5 29.6 6.1 0.0 0.1 0.7 4.6 0.1 40.4 138.9 31.7 2.0 0.0 0.3 1.8 0.6 0.2 0.0 8.4 0.0 162.1 0.0 51.8 75.0 15.3 15.2 0.0 0.2 11.8 16.6 14.0 12.3 3.8 0.0 3.3 0.8 0.1 0.8 0.3 0.3 0.0 0.4 9.7 32.6 6.5 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491648 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 468.3;Late spermatids: 209.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Nucleoli rim, Mitotic chromosome" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 32.8 25.6 10.1 32.6 12.3 19.3 32.0 11.6 10.5 33.8 13.9 25.9 23.5 32.5 20.4 25.2 32.1 28.0 25.9 8.0 12.2 39.6 60.0 39.3 50.1 11.7 11.2 7.2 38.2 39.3 63.2 17.8 19.5 11.8 43.2 29.5 23.3 34.5 40.3 32.7 26.5 26.4 31.0 11.0 41.4 32.9 48.8 10.0 67.2 40.6 38.0 51.6 31.1 29.1 16.3 25.9 18.1 20.7 20.6 61.2 57.9 9.4 17.8 26.4 23.1 7.9 10.1 30.9 39.0 28.4 32.8 22.3 29.6 17.9 30.1 36.0 12.5 22.4 15.9 14.7 22.0 27.3 23.4 49.0 35.6 34.0 15.3 22.4 43.0 36.3 39.6 12.7 23.2 26.6 7.1 48.6 22.0 7.8 30.8 15.0 33.6 41.8 46.1 25.4 25.3 16.9 14.3 42.2 17.2 19.1 16.8 22.7 30.0 28.3 27.5 14.3 24.1 13.7 35.7 22.9 42.4 34.4 28.2 19.0 53.9 22.5 56.5 53.4 16.2 60.5 22.5 59.7 62.8 21.7 22.0 85.5 75.3 41.8 74.4 28.8 13.1 48.2 76.2 10.1 12.3 11.6 10.5 8.0 12.2 11.7 11.2 7.2 11.8 11.0 10.0 16.3 37.9 41.7 101.1 51.2 49.5 23.1 30.1 15.3 40.9 27.8 27.0 15.5 13.5 45.8 32.5 27.6 20.9 6.0 77.0 26.3 17.6 13.4 468.3 38.9 25.8 31.4 19.8 26.5 55.1 10.2 13.0 35.8 24.5 45.9 55.1 27.9 40.7 46.1 11.2 35.3 54.1 30.0 34.6 43.6 23.7 209.1 42.0 35.4 10.6 58.1 44.9 38.3 79.3 63.3 85.7 10.8 19.0 42.9 48.7 31.4 29.2 25.3 38.3 22.5 39.5 36.2 26.1 161.4 61.3 33.7 27.6 4.1 118.9 25.2 21.7 35.6 QPRT QPRTase ENSG00000103485 "Quinolinate phosphoribosyltransferase" Q15274 16 29663279-29698699 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 120.5;liver: 185.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 404.7;Extravillous trophoblasts: 315.1;Hepatocytes: 367.4;Proximal tubular cells: 598.8;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.2;intermediate monocyte: 5.3;myeloid DC: 5.8;non-classical monocyte: 9.0;plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 8 "dendritic cells: 5.8;monocytes: 9.0" "Cell line enhanced" "Detected in many" "EFO-21: 597.1;Hep G2: 258.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011887, HPA076010" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 780000 Vesicles "HPA011887: AB_2668555, HPA076010: " "prognostic unfavorable (5.10e-5)" "unprognostic (2.00e-1)" "unprognostic (9.48e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (9.31e-4)" "unprognostic (1.44e-2)" "unprognostic (8.75e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (6.81e-2)" "unprognostic (3.37e-2)" "unprognostic (1.33e-2)" "unprognostic (2.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.58e-2)" 5.7 90.1 21.2 4.4 18.3 4.9 6.8 25.6 20.0 51.0 18.1 19.4 62.2 26.4 96.1 4.1 43.9 10.3 24.3 17.6 24.9 120.5 185.0 9.3 6.8 28.2 25.2 16.9 31.2 34.8 16.3 5.8 27.6 27.7 7.1 15.3 7.5 13.5 26.3 5.2 5.1 30.6 13.8 22.1 17.4 7.2 4.2 21.3 8.2 6.5 1.2 5.2 10.6 11.6 23.6 0.6 1.4 51.8 56.4 8.8 21.6 167.8 6.0 5.2 8.6 11.0 145.9 91.9 2.3 597.1 10.8 10.0 1.0 18.5 0.6 4.5 0.8 16.7 27.1 2.2 258.0 52.5 4.1 10.4 69.8 1.4 4.8 0.2 12.8 0.2 28.2 75.1 2.9 0.4 154.6 17.6 100.3 162.1 1.9 0.2 89.3 16.3 58.5 47.9 4.2 48.6 103.5 0.0 142.1 118.8 85.1 106.5 112.8 0.6 2.5 24.9 0.9 0.5 1.8 4.9 18.8 4.4 10.4 8.1 0.0 4.2 0.3 0.8 5.3 0.9 0.1 0.6 0.7 5.8 0.0 0.1 0.4 0.8 0.4 9.0 3.1 0.9 1.9 21.2 18.3 25.6 20.0 17.6 24.9 28.2 25.2 16.9 27.7 22.1 21.3 23.6 3.1 9.6 24.8 5.2 10.1 3.6 11.7 0.5 1.8 3.3 5.0 2.0 43.2 8.6 3.0 64.4 0.0 404.7 5.8 84.5 50.9 1.2 0.0 93.8 49.5 5.5 28.3 10.5 1.3 55.2 315.1 35.8 0.5 81.0 5.1 6.7 9.7 367.4 147.5 6.7 5.6 47.3 0.0 21.2 18.3 0.5 29.2 19.8 42.7 12.2 4.4 20.8 3.1 11.1 0.5 11.5 78.5 27.1 8.7 4.2 161.0 598.8 1.5 5.0 6.6 3.3 16.2 0.5 3.0 0.2 2.0 215.6 5.7 36.5 104.7 8.3 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470960 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Oligodendrocyte precursor cells: 1194.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.0" "Lineage enriched" "Detected in single" 4 "monocytes: 2.0" "Cell line enhanced" "Detected in many" "ASC diff: 55.1;ASC TERT1: 34.0;U-2197: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA 150000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 6.0 6.2 6.4 4.9 8.4 7.2 4.5 2.6 6.3 7.9 7.0 7.4 4.4 8.0 1.0 5.1 3.8 2.4 3.7 9.1 4.2 1.0 0.3 3.6 5.2 4.0 4.4 6.0 5.3 2.8 0.9 0.6 6.1 5.3 2.8 5.2 8.4 2.5 4.5 1.1 4.9 5.3 5.7 2.7 5.4 3.5 2.3 4.6 4.1 2.2 1.2 4.3 4.4 4.7 5.8 0.0 0.3 8.0 0.1 55.1 34.0 9.6 25.6 12.9 2.7 1.0 0.3 0.6 6.1 0.0 31.3 0.9 0.6 0.0 5.1 4.5 12.1 0.6 8.0 0.0 0.0 0.6 11.5 10.2 12.6 0.7 15.0 2.4 4.6 0.0 0.3 0.0 23.8 2.8 0.8 0.1 12.4 8.5 4.4 0.0 3.5 0.0 1.2 0.0 11.5 2.0 15.2 1.9 7.9 1.4 5.9 1.9 7.2 0.0 24.6 2.9 57.2 0.0 26.4 1.4 11.6 28.9 12.8 22.4 0.3 0.2 0.4 0.2 1.2 0.3 0.1 0.1 0.1 0.4 0.3 0.2 0.1 0.1 0.4 2.0 0.1 0.3 0.2 6.4 8.4 2.6 6.3 9.1 4.2 4.0 4.4 6.0 5.3 2.7 4.6 5.8 1.0 3.2 2.5 45.4 9.2 7.9 1.6 0.0 1.2 12.9 3.8 3.7 3.4 0.0 0.7 0.0 98.0 12.7 12.4 9.1 0.0 1.5 0.5 0.5 24.7 2.9 12.6 7.4 172.8 1.6 20.1 12.2 2.6 0.8 2.5 6.4 1.4 0.2 3.5 0.0 72.8 4.3 4.1 9.7 27.6 0.8 12.8 8.5 3.6 29.0 6.1 1.9 11.3 1194.8 63.0 4.0 7.4 50.0 6.2 5.3 6.1 0.2 0.0 4.4 6.6 7.9 5.9 0.3 1.6 4.1 18.5 13.1 7.7 8.1 6.9 6.4 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201486-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 85.4;skin 1: 89.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 425.8;Kupffer cells: 555.8;Macrophages: 344.2;Paneth cells: 360.0;Proximal enterocytes: 504.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 585.7;classical monocyte: 1098.3;eosinophil: 948.1;intermediate monocyte: 1138.3;myeloid DC: 829.2;neutrophil: 1638.4;non-classical monocyte: 1152.8;plasmacytoid DC: 769.2" "Group enriched" "Detected in all" 6 "dendritic cells: 829.2;granulocytes: 1638.4;monocytes: 1152.8" "Cell line enhanced" "Detected in many" "MCF7: 148.9;NB-4: 237.0;THP-1: 186.9;U-937: 112.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 640000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 23.3 11.5 3.3 33.2 4.2 43.7 20.6 4.0 8.6 19.5 5.7 33.9 64.4 10.8 0.0 56.5 17.5 4.9 8.9 2.9 8.1 10.9 10.5 33.1 19.3 6.9 4.3 2.0 15.1 11.4 1.7 7.8 6.2 5.5 20.0 9.6 0.1 24.8 8.8 3.4 89.6 48.9 5.8 6.4 85.4 22.3 2.3 5.6 9.5 9.2 1.2 12.8 20.0 33.4 10.4 23.9 54.8 0.5 0.2 9.2 18.9 0.6 12.6 22.6 8.8 6.5 0.1 31.7 10.6 0.1 17.6 0.0 69.7 2.9 57.4 0.3 73.0 0.0 9.3 7.9 18.3 25.6 86.9 65.7 24.7 30.3 4.0 1.2 0.2 18.4 0.1 42.9 17.5 2.9 148.9 0.2 237.0 15.7 13.2 0.1 75.5 0.0 35.2 1.3 22.3 0.7 0.2 10.4 0.0 12.4 0.3 15.5 186.9 11.8 0.4 0.7 9.9 0.3 0.6 0.1 0.2 6.4 112.1 0.1 585.7 1098.3 948.1 178.4 1138.3 112.2 213.7 146.5 183.3 829.2 210.7 102.1 139.6 1638.4 219.2 1152.8 769.2 206.4 814.2 3.3 4.2 4.0 8.6 2.9 8.1 6.9 4.3 2.0 5.5 6.4 5.6 10.4 35.7 22.4 28.9 0.0 58.5 74.1 66.3 237.0 100.7 0.2 92.2 131.7 2.5 41.5 84.3 25.8 0.0 62.5 158.8 184.5 5.9 90.5 0.8 18.6 16.8 39.2 58.9 42.9 0.1 56.5 11.3 39.3 50.4 7.3 110.9 60.2 48.9 3.3 425.8 0.0 0.1 144.6 75.3 555.8 280.2 2.9 47.2 344.2 97.8 13.1 277.8 0.0 132.8 0.0 0.1 60.4 360.0 22.6 54.1 22.6 504.8 3.6 88.2 0.7 26.3 10.5 28.5 0.3 1.4 83.9 163.7 17.8 70.8 119.9 287.1 70.6 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 40.5;Excitatory neurons: 59.8;Respiratory ciliated cells: 85.9;Spermatocytes: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: AB_2677023" "prognostic unfavorable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 1.7 3.5 2.7 2.1 2.6 1.6 3.2 1.2 5.6 3.2 8.3 1.7 1.3 3.8 3.7 2.2 6.8 2.7 1.9 3.2 2.9 3.1 1.1 1.9 1.8 3.0 3.4 2.2 3.5 2.0 7.7 6.0 2.2 1.8 2.9 1.8 2.9 1.7 2.9 1.1 2.0 1.0 3.5 1.3 0.9 1.9 13.6 2.3 2.6 4.6 1.4 1.8 2.2 1.8 3.6 11.8 13.7 11.6 10.7 13.9 13.3 5.6 12.7 7.9 9.8 2.7 7.1 9.5 7.5 8.5 11.1 7.8 12.5 9.4 11.6 19.1 4.6 7.2 2.8 12.1 7.5 6.0 6.7 5.0 8.1 6.9 11.4 6.9 11.4 8.9 10.0 7.2 4.3 14.8 4.5 11.2 4.7 7.4 3.7 6.3 19.3 15.9 9.4 14.0 3.1 19.9 7.5 14.3 6.4 5.3 6.7 10.0 5.7 7.8 12.2 8.6 9.7 11.0 5.4 6.9 13.1 18.9 3.9 7.3 0.7 0.2 0.3 1.2 0.3 1.2 1.1 0.8 1.0 0.2 1.5 0.8 1.8 0.6 0.8 0.3 0.7 0.7 0.4 2.7 2.6 1.2 5.6 3.2 2.9 3.0 3.4 2.2 1.8 1.3 2.3 3.6 3.1 6.4 4.8 15.7 2.9 4.6 2.8 11.1 4.6 5.5 6.9 8.0 9.8 1.5 15.1 11.0 8.4 5.5 1.5 1.3 17.6 7.4 21.5 40.5 20.7 3.9 0.0 3.0 59.8 3.3 7.4 12.9 5.1 8.6 7.0 12.9 2.5 3.8 2.9 3.3 36.6 5.6 4.1 1.2 3.1 12.0 4.7 1.9 1.8 9.4 1.8 6.3 2.1 14.1 8.6 3.3 0.5 6.4 2.1 1.7 0.2 19.8 85.9 8.7 6.6 7.8 9.7 43.2 11.2 4.7 5.4 1.6 2.7 11.5 4.4 2.4 MAZ "Pur-1, ZF87, Zif87, ZNF801" ENSG00000103495 "MYC associated zinc finger protein" P56270 16 29806106-29811164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048315, HPA059495, HPA065930" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579" "unprognostic (1.05e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.83e-1)" "unprognostic (3.25e-3)" "unprognostic (6.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (2.00e-1)" "unprognostic (6.39e-3)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.20e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (7.08e-2)" 69.2 92.4 153.1 93.0 150.3 272.7 66.1 146.7 181.2 86.3 125.2 140.7 93.6 90.8 51.9 93.3 89.4 74.3 68.6 157.1 134.0 64.2 102.0 73.9 124.9 142.1 142.1 150.4 97.5 106.3 114.2 83.6 62.3 143.9 123.9 102.0 51.3 86.9 76.1 127.2 97.1 88.4 76.5 133.1 98.6 86.2 90.6 141.5 258.4 80.2 93.9 112.1 95.2 68.9 143.6 227.2 294.8 298.8 326.9 158.4 149.6 268.4 161.0 130.6 246.0 177.4 378.5 316.5 402.4 205.2 316.9 121.6 201.3 494.2 210.9 87.5 329.9 792.4 267.7 641.3 526.2 222.1 668.7 318.8 160.7 292.1 207.2 232.5 228.7 249.4 556.7 398.5 343.3 118.3 927.1 644.8 566.3 303.7 246.1 227.6 627.9 281.3 468.5 202.3 242.2 456.1 355.1 153.8 330.1 204.6 190.5 284.3 633.7 172.8 269.8 215.4 103.6 256.1 249.3 344.4 448.5 131.9 435.4 227.9 18.1 14.7 23.9 58.8 24.0 63.6 13.5 39.1 56.5 19.4 10.2 31.6 47.3 11.9 40.1 16.4 19.9 45.8 21.3 153.1 150.3 146.7 181.2 157.1 134.0 142.1 142.1 150.4 143.9 133.1 141.5 143.6 52.1 6.4 5.4 9.4 35.3 32.9 14.7 26.7 35.3 61.6 77.8 66.9 0.3 31.5 14.5 11.0 12.5 26.8 106.7 111.5 29.4 31.6 2.5 58.5 59.0 41.0 133.3 90.3 12.8 41.9 55.6 46.3 34.7 39.6 33.0 103.1 30.7 37.7 57.5 47.1 13.0 103.6 32.6 47.8 47.8 6.6 28.0 47.6 46.2 8.4 26.4 35.6 50.4 9.5 14.2 36.3 68.5 36.9 41.6 32.8 37.8 21.9 25.6 35.1 32.9 30.1 49.1 22.2 24.5 38.6 35.5 16.7 67.5 70.9 126.8 14.9 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favorable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 38.6 44.4 36.9 34.5 38.4 22.5 34.1 39.0 37.8 34.8 34.4 37.4 38.7 31.7 24.6 36.1 30.1 27.9 36.7 35.2 39.2 33.8 36.1 36.5 31.3 40.0 38.6 32.8 30.7 27.9 38.7 23.3 32.6 40.4 30.2 28.8 8.6 30.2 26.7 46.2 44.7 36.2 31.9 38.9 44.0 32.6 15.0 38.1 28.6 29.7 34.1 37.4 38.5 32.8 41.0 51.9 70.6 16.0 36.1 51.1 52.1 33.8 47.7 79.2 47.5 48.7 22.1 53.2 35.4 58.9 80.8 54.4 36.6 15.2 52.6 45.6 60.3 43.8 25.3 48.7 59.7 58.3 29.2 80.1 50.2 36.1 82.1 61.1 58.5 64.3 22.3 29.9 38.6 84.9 80.3 28.0 44.8 33.1 36.9 36.7 24.0 47.1 46.1 45.9 38.7 13.1 24.6 40.6 41.1 17.4 20.7 33.7 38.7 74.4 48.3 21.8 55.8 26.6 41.2 37.0 14.6 73.3 46.4 29.7 21.3 21.7 27.3 17.6 23.8 15.4 12.7 14.7 17.9 18.8 17.5 11.0 14.2 23.0 24.6 21.9 11.1 9.0 11.2 36.9 38.4 39.0 37.8 35.2 39.2 40.0 38.6 32.8 40.4 38.9 38.1 41.0 34.9 44.8 22.7 7.8 32.6 65.1 34.6 56.3 31.9 7.4 22.3 20.6 23.6 48.6 35.2 22.0 12.5 31.1 35.9 69.7 29.4 60.6 12.9 22.1 26.6 46.0 25.7 11.1 4.8 67.7 35.7 51.7 43.3 29.0 60.3 42.1 33.9 20.0 89.5 5.0 3.6 39.5 38.7 49.6 149.9 15.7 38.5 83.2 30.2 2.8 51.7 24.1 42.2 3.0 16.0 73.4 58.5 35.3 23.0 61.6 77.7 50.8 31.3 6.9 39.5 40.6 36.4 9.4 6.7 27.0 65.1 33.1 35.4 39.0 47.9 36.2 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863414 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Enhanced Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: AB_2683182" "unprognostic (7.81e-2)" "prognostic favorable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 89.3 102.5 69.7 32.4 68.3 27.0 81.7 73.9 86.8 85.1 59.0 92.3 39.3 91.9 31.3 61.6 76.9 52.1 104.5 68.1 69.3 81.0 115.5 65.7 36.4 73.2 70.2 68.4 110.5 87.5 88.6 69.3 42.6 71.2 78.8 24.6 34.3 67.8 56.0 50.1 81.8 70.2 39.2 64.1 66.9 89.8 44.2 68.5 41.0 69.6 44.3 25.0 90.4 74.2 65.4 40.0 85.6 23.7 47.3 125.8 86.3 70.5 71.0 76.6 47.9 47.4 50.5 75.1 26.9 125.2 80.3 42.2 62.0 38.7 44.5 21.3 67.5 85.3 19.5 61.4 74.1 87.7 28.5 47.2 148.0 77.2 64.3 29.7 75.8 60.9 49.9 29.5 67.1 44.0 127.7 40.3 56.2 55.5 42.2 65.7 74.8 29.5 78.7 63.7 38.1 96.4 53.8 36.9 76.1 55.7 41.2 57.5 74.8 52.8 70.3 22.1 58.0 35.8 51.4 62.1 19.3 77.2 46.0 43.4 11.7 8.2 28.9 8.5 6.2 5.7 6.5 7.9 9.1 3.8 6.4 7.7 7.2 20.6 11.4 7.9 8.1 12.0 3.8 69.7 68.3 73.9 86.8 68.1 69.3 73.2 70.2 68.4 71.2 64.1 68.5 65.4 54.7 25.6 28.3 10.4 25.1 41.3 41.4 22.9 30.1 53.4 42.1 49.7 57.9 41.5 15.4 46.0 45.9 120.6 31.9 57.5 41.1 72.0 54.0 18.1 30.4 48.0 37.3 22.7 16.4 71.8 127.3 59.3 19.4 29.6 13.4 30.7 46.1 41.7 65.0 58.9 19.3 30.6 10.2 41.8 21.3 12.8 76.7 33.3 23.2 11.2 45.2 57.7 36.0 9.0 11.5 44.9 37.9 61.7 31.7 38.9 87.9 34.5 15.1 56.3 46.0 24.4 44.6 10.2 14.7 32.3 50.7 73.2 30.5 34.1 34.8 39.3 BCKDK ENSG00000103507 "Branched chain keto acid dehydrogenase kinase" O14874 16 31106107-31112791 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Autism, Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 95.9;granulocytes: 89.7;monocytes: 115.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017995, HPA056067" Supported Supported Mitochondria NA NA Mitochondria "HPA017995: AB_1845309, HPA056067: AB_2683024" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (6.94e-2)" "unprognostic (5.20e-2)" "unprognostic (5.39e-2)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (5.47e-2)" "unprognostic (1.60e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.24e-2)" "unprognostic (2.66e-3)" "unprognostic (4.85e-2)" "unprognostic (3.93e-2)" "unprognostic (1.00e-1)" "unprognostic (4.97e-2)" 30.2 56.9 15.7 19.3 16.4 14.6 29.2 14.6 24.0 25.3 14.4 29.7 16.1 27.9 16.8 29.6 25.0 18.1 62.6 16.3 15.3 43.8 77.1 21.9 15.7 18.0 15.3 17.3 27.7 71.0 23.0 16.6 15.4 16.2 29.6 12.6 6.4 47.4 22.0 82.1 45.4 24.3 19.7 14.3 30.5 42.4 17.5 18.0 9.9 22.6 70.3 13.7 30.5 24.8 17.7 47.5 49.1 27.1 41.8 32.8 32.5 31.1 40.4 46.3 57.3 55.9 32.1 29.1 41.5 58.9 47.5 28.0 31.4 19.3 65.6 36.5 34.4 60.1 45.2 32.6 59.5 57.5 23.5 41.9 48.3 26.2 49.2 40.6 52.6 62.4 31.1 23.4 39.4 87.7 75.8 22.9 32.4 23.0 20.5 39.1 45.8 39.6 78.8 44.3 30.1 42.1 38.7 31.3 72.4 24.6 22.9 44.5 24.6 41.1 44.2 26.1 45.8 32.2 44.5 15.7 15.1 50.3 33.7 42.6 58.1 115.0 85.2 17.7 97.6 17.2 22.8 16.5 13.9 95.9 19.0 13.6 16.1 89.7 22.8 71.2 19.3 24.5 53.1 15.7 16.4 14.6 24.0 16.3 15.3 18.0 15.3 17.3 16.2 14.3 18.0 17.7 27.2 19.2 18.1 5.9 20.0 18.5 24.6 61.0 22.2 11.6 30.9 27.6 39.1 25.8 28.5 20.2 0.0 55.4 9.0 31.5 80.3 68.6 2.5 14.6 24.3 29.2 19.9 16.4 5.1 78.0 71.1 24.9 25.5 20.0 33.0 35.4 25.4 43.8 93.0 11.8 4.4 22.3 42.7 44.5 50.3 7.8 20.8 53.1 12.4 1.9 79.3 22.6 9.2 4.5 4.5 54.8 48.4 25.6 51.7 30.9 66.9 95.2 19.6 9.8 46.0 18.4 33.2 25.8 14.1 25.7 27.4 69.4 12.1 45.5 26.0 27.0 KAT8 "FLJ14040, hMOF, MOF, MYST1, ZC2HC8" ENSG00000103510 "Lysine acetyltransferase 8" Q9H7Z6 16 31114489-31131393 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 113.9;Late spermatids: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 29.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066324 Supported Nucleoplasm NA NA Nucleoplasm "HPA066324: AB_2685658" "unprognostic (8.58e-2)" "unprognostic (9.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (3.22e-1)" "prognostic favorable (6.34e-4)" "unprognostic (3.13e-2)" "unprognostic (3.05e-1)" "unprognostic (5.50e-2)" "unprognostic (9.77e-2)" "unprognostic (7.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.29e-1)" "unprognostic (5.00e-1)" "unprognostic (1.41e-1)" 28.9 31.1 40.3 17.9 41.0 33.2 31.6 50.3 50.8 40.5 37.8 33.3 16.7 39.5 46.9 21.2 42.0 14.8 41.2 41.0 41.4 27.3 29.2 31.6 24.8 41.5 40.6 41.7 61.2 32.0 37.7 31.3 20.5 43.1 32.2 17.4 27.7 35.0 23.9 50.3 32.4 30.5 25.7 40.1 40.0 28.4 33.1 40.1 39.9 35.8 50.3 23.5 31.1 31.2 42.3 18.1 27.4 33.5 10.7 38.5 28.9 34.3 16.0 29.6 24.7 26.8 13.6 38.1 42.3 24.5 19.6 22.8 22.5 53.6 26.4 24.1 35.8 35.0 18.7 21.5 43.3 34.5 30.5 31.9 27.9 51.4 18.5 52.4 33.2 23.6 44.1 49.5 33.7 13.1 51.4 47.4 57.2 38.0 43.1 15.9 75.1 28.1 49.5 20.1 10.7 35.2 35.9 9.4 25.9 14.1 20.7 28.6 49.6 14.7 11.0 22.2 12.1 11.6 32.4 34.8 24.2 16.0 40.7 16.3 8.0 7.4 29.9 3.0 4.1 3.7 3.6 3.6 4.1 6.6 2.9 4.6 3.3 28.4 3.2 8.3 2.7 2.4 3.4 40.3 41.0 50.3 50.8 41.0 41.4 41.5 40.6 41.7 43.1 40.1 40.1 42.3 26.2 19.2 18.2 16.0 30.4 20.8 41.9 18.1 34.7 19.0 21.5 26.2 16.8 21.5 21.0 9.2 14.6 30.5 20.9 17.8 21.5 21.9 113.9 17.5 18.2 21.8 24.6 29.5 16.4 26.6 21.7 29.4 17.9 18.0 27.3 33.9 23.2 12.4 29.1 32.0 18.6 21.2 18.3 30.1 25.4 147.5 53.7 28.1 24.9 12.2 32.6 41.0 15.5 11.1 13.2 15.0 25.8 54.2 16.5 35.2 25.1 17.5 11.8 26.9 26.3 32.8 30.6 27.5 26.2 20.6 15.6 45.4 24.6 24.5 22.9 23.2 NOMO1 PM5 ENSG00000103512 "NODAL modulator 1" Q15155 16 14833721-14896157 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 135.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 76.3;Hep G2: 126.5;LHCN-M2: 65.8;RPMI-8226: 90.4;SiHa: 144.9" "CAB025192, HPA046697, HPA061174" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (5.33e-3)" "unprognostic (1.60e-1)" "unprognostic (5.27e-1)" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.51e-1)" "unprognostic (4.18e-3)" "unprognostic (2.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-2)" "unprognostic (8.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.09e-1)" "unprognostic (1.50e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (3.15e-4)" 24.0 27.9 3.8 10.4 5.1 0.0 23.8 3.8 16.2 21.9 4.0 31.8 0.7 25.8 0.0 25.1 20.6 0.4 76.2 3.8 11.4 32.1 28.6 27.1 2.7 8.9 10.1 3.7 21.4 135.0 0.0 29.4 6.9 6.4 21.8 8.3 4.3 31.4 4.5 102.5 27.5 26.3 8.2 3.7 20.0 36.7 31.3 3.9 0.0 21.7 1.4 0.2 29.0 22.4 4.3 1.2 56.8 51.4 76.3 0.0 4.6 42.2 3.4 9.1 11.5 11.0 0.8 2.8 4.3 2.8 8.8 1.0 0.7 8.8 0.7 11.3 6.2 0.0 3.7 57.8 126.5 48.7 5.8 2.7 0.6 0.5 6.2 6.3 1.2 9.0 0.0 29.7 2.6 65.8 0.0 1.6 0.0 0.0 0.0 0.0 1.9 4.3 90.4 0.0 2.6 1.1 45.8 144.9 0.0 0.1 1.7 63.1 0.6 2.1 1.9 0.1 2.6 58.1 0.3 2.1 4.7 2.3 2.3 1.3 3.7 0.2 0.2 0.0 0.4 0.3 0.0 0.1 0.3 0.1 0.5 0.2 0.3 0.6 1.9 2.0 1.6 0.3 0.6 3.8 5.1 3.8 16.2 3.8 11.4 8.9 10.1 3.7 6.4 3.7 3.9 4.3 5.6 3.2 10.5 9.1 5.3 6.4 1.4 10.6 3.4 8.7 7.8 5.8 58.4 7.2 8.6 11.0 6.2 6.8 4.2 14.4 0.0 15.6 32.9 3.3 3.1 7.3 7.7 5.5 12.7 29.4 12.4 7.9 11.7 4.2 23.6 13.0 7.9 7.6 6.3 35.3 16.2 11.7 2.0 12.7 2.8 12.0 2.8 10.3 5.4 7.5 11.2 5.4 16.5 13.6 32.1 27.4 10.8 6.4 16.2 2.1 16.1 7.9 7.4 8.5 6.6 5.7 7.5 16.1 13.1 6.7 5.8 9.6 4.2 9.5 13.0 1.6 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402174-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.6;lymphoid tissue: 24.9" "Cell type enhanced" "Detected in some" "B-cells: 15.5;dendritic cells: 21.8;Langerhans cells: 11.4;NK-cells: 23.7;Plasma cells: 13.4;T-cells: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 25.9;HDLM-2: 110.8;Karpas-707: 49.3;RH-30: 37.2;RPMI-8226: 63.0;U-266/70: 24.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.5 0.4 1.5 12.0 1.5 7.6 0.2 1.0 2.4 0.1 1.1 0.8 0.6 0.3 0.2 0.3 0.2 1.1 0.4 0.9 4.5 0.9 0.4 2.9 24.9 2.2 2.3 1.2 0.2 0.3 0.0 0.5 0.8 2.5 0.4 0.9 1.1 0.6 0.1 0.3 0.8 2.1 0.7 0.7 5.6 1.5 1.1 1.7 14.5 0.6 0.0 19.0 2.2 0.2 3.2 0.1 0.2 0.3 0.2 0.0 1.3 0.8 0.8 0.1 0.1 2.2 0.2 0.2 25.9 0.2 2.1 1.4 0.1 0.0 0.1 0.1 110.8 0.1 5.4 0.2 0.7 3.4 0.2 1.5 3.8 0.0 6.8 0.1 0.7 0.0 0.6 0.3 49.3 3.8 0.2 0.1 0.5 0.9 0.1 0.0 0.4 37.2 63.0 0.0 0.1 0.2 0.2 0.1 0.1 2.7 0.2 0.1 1.3 2.8 1.9 0.7 0.6 0.2 24.7 9.4 5.9 5.2 1.4 0.2 0.5 0.4 0.1 13.4 8.3 4.9 1.8 8.6 14.2 2.3 14.2 9.2 9.3 0.9 9.5 27.0 1.1 10.8 7.3 1.5 1.5 1.0 2.4 0.9 4.5 2.2 2.3 1.2 2.5 0.7 1.7 3.2 0.2 0.0 1.3 0.0 15.5 0.4 0.1 0.0 0.0 2.0 0.2 0.1 1.9 0.0 0.0 0.0 4.2 0.1 21.8 0.1 0.0 0.0 6.5 0.1 0.2 0.9 0.0 0.0 0.4 0.0 0.1 0.3 1.5 0.2 0.0 0.0 1.1 0.2 8.2 0.0 0.5 0.0 0.0 5.0 11.4 5.7 0.0 3.6 1.8 2.8 1.8 0.2 23.7 0.5 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.0 0.5 0.0 0.8 0.8 0.2 0.0 0.0 0.9 0.1 25.1 0.1 0.1 0.1 SYT17 Syt-17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268332 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.6;parathyroid gland: 25.5" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Microglial cells: 51.5;Oligodendrocyte precursor cells: 114.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 6.2;memory B-cell: 7.8;naive B-cell: 19.0;non-classical monocyte: 20.1" "Group enriched" "Detected in many" 9 "B-cells: 19.0;monocytes: 20.1" "Cell line enhanced" "Detected in many" "BEWO: 14.2;CAPAN-2: 28.1;Daudi: 12.6;MCF7: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042059: AB_2677827" "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 4.0 4.9 21.1 1.4 25.6 0.3 4.4 14.0 24.6 3.1 18.0 2.3 4.2 1.0 2.8 4.4 2.2 1.0 1.4 23.9 20.5 5.9 17.5 7.8 3.3 16.9 25.4 22.2 0.6 3.0 25.5 18.9 3.8 16.1 9.2 2.9 1.7 1.6 3.4 0.3 10.0 2.0 0.8 15.9 1.3 6.0 0.4 22.0 0.6 6.9 0.6 4.8 3.4 2.6 16.5 0.1 10.4 0.1 0.1 0.3 0.7 14.2 0.0 0.0 0.1 0.0 0.4 28.1 12.6 3.4 0.0 3.8 5.0 0.7 0.4 0.0 0.0 2.1 0.0 10.9 0.2 0.0 0.0 0.1 0.9 2.5 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 21.8 0.0 0.1 1.2 8.3 5.7 0.0 1.2 1.0 3.5 6.2 2.1 1.2 4.0 11.0 0.5 6.7 10.9 2.8 0.0 0.0 7.1 0.1 0.0 2.0 0.0 11.4 0.0 0.1 0.0 0.4 0.7 0.0 0.0 6.2 0.0 7.8 0.0 0.0 2.2 19.0 0.0 0.0 0.1 0.0 20.1 0.2 0.0 0.9 21.1 25.6 14.0 24.6 23.9 20.5 16.9 25.4 22.2 16.1 15.9 22.0 16.5 0.7 6.4 9.3 90.8 8.6 3.8 12.0 3.8 7.4 1.8 7.6 4.1 1.6 2.8 7.5 22.0 0.0 6.4 0.0 4.3 27.4 4.9 0.2 2.3 0.6 2.9 21.6 5.3 18.6 0.6 15.3 2.3 2.0 2.5 0.0 0.1 3.9 23.2 4.0 1.7 20.9 10.0 34.6 4.0 4.0 0.1 1.5 3.6 12.4 51.5 6.2 12.0 0.0 114.1 1.7 3.6 9.0 0.7 0.0 6.0 0.4 0.6 5.8 0.5 0.0 6.7 1.6 0.3 3.9 3.6 9.7 4.0 0.2 0.1 4.3 8.2 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 53.9;stomach 1: 46.5" "Cell type enhanced" "Detected in many" "Club cells: 282.4;Pancreatic endocrine cells: 302.2;Proximal enterocytes: 374.3;Respiratory ciliated cells: 624.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 69.7;OE19: 41.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.4 0.1 0.3 3.1 0.4 1.5 12.8 0.5 0.3 9.0 4.7 21.8 45.8 2.1 17.7 1.2 5.2 25.8 0.1 0.4 0.0 0.3 0.6 19.1 0.2 0.2 0.2 0.3 0.1 2.3 6.0 0.1 3.2 0.2 12.3 22.9 0.2 23.0 0.2 0.1 1.8 53.9 1.2 0.0 0.1 46.5 3.9 0.3 0.1 0.7 0.0 1.1 3.2 0.5 0.4 6.9 10.8 0.0 0.3 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.1 69.7 0.0 0.3 0.0 0.2 4.4 1.1 0.0 0.0 0.1 0.1 0.0 1.8 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 1.1 0.0 0.2 2.5 41.5 3.1 0.0 0.0 2.6 0.1 0.3 0.7 0.2 0.1 2.1 0.0 1.1 0.9 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.3 0.4 0.0 0.2 0.2 0.3 0.2 0.0 0.3 0.4 0.1 157.0 162.5 0.0 1.8 0.8 22.9 46.6 2.8 0.3 57.4 17.9 0.9 102.9 282.4 22.0 2.1 39.0 1.0 173.7 0.0 121.1 32.8 107.0 6.9 2.9 38.9 8.0 1.9 166.3 3.4 3.3 188.1 88.4 5.7 11.0 0.7 0.6 2.7 3.3 2.0 101.5 26.4 0.0 1.1 32.6 0.3 1.8 1.8 0.0 1.0 0.2 0.0 0.5 0.9 302.2 180.9 0.7 0.5 103.1 374.3 2.0 624.7 1.9 0.0 0.4 9.5 1.3 1.1 2.2 1.7 16.3 1.3 1.5 125.1 55.9 CCP110 "CP110, KIAA0419" ENSG00000103540 "Centriolar coiled-coil protein 110" O43303 16 19523811-19553408 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.1" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 210.2;Respiratory ciliated cells: 118.8;Spermatocytes: 169.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039402 Approved Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA039402: AB_10671041" "unprognostic (2.83e-1)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-1)" "unprognostic (4.88e-2)" "unprognostic (9.68e-2)" "unprognostic (3.25e-2)" "unprognostic (2.68e-1)" "unprognostic (6.50e-2)" "unprognostic (1.92e-2)" "unprognostic (8.99e-3)" "unprognostic (2.74e-2)" "unprognostic (1.82e-1)" "unprognostic (3.01e-2)" "unprognostic (1.37e-1)" 5.6 5.9 25.5 6.7 42.1 15.8 9.3 25.6 33.0 7.4 14.2 4.9 4.0 9.3 7.4 6.6 13.4 6.0 4.7 25.9 29.5 4.6 3.6 8.7 8.3 32.5 33.8 22.1 10.6 4.0 11.6 11.8 4.9 38.0 7.4 5.6 13.9 5.3 7.0 5.0 5.9 4.9 7.9 23.5 6.5 6.5 36.1 34.7 16.6 7.1 5.9 7.7 6.3 5.2 51.1 22.4 10.2 24.7 24.1 12.1 10.7 12.7 23.4 13.5 20.4 22.9 8.3 11.7 32.8 14.5 11.6 15.5 15.4 25.6 7.4 34.2 15.1 11.6 16.4 14.5 14.3 6.0 42.6 20.2 5.3 10.0 23.0 14.0 12.6 15.9 33.1 17.5 16.0 24.1 17.3 43.8 16.5 19.0 10.7 7.6 55.1 46.1 11.5 9.3 9.3 48.5 24.5 25.4 11.9 7.6 16.4 21.9 25.6 9.5 23.7 15.6 16.0 19.5 17.6 17.7 23.5 15.2 18.0 14.1 14.5 2.8 5.2 3.8 2.7 2.4 2.5 3.4 3.7 3.0 3.2 3.8 2.2 5.5 1.7 4.3 2.0 2.9 2.0 25.5 42.1 25.6 33.0 25.9 29.5 32.5 33.8 22.1 38.0 23.5 34.7 51.1 9.3 32.1 34.6 19.9 12.7 13.5 9.2 10.8 14.8 18.1 16.4 11.2 14.7 8.6 27.6 23.9 33.3 11.4 19.4 6.9 5.9 9.2 5.1 75.1 19.5 10.7 1.2 46.3 30.6 4.7 7.0 15.7 10.2 13.5 30.3 12.5 12.1 7.5 7.0 30.3 30.9 9.9 6.1 18.2 12.8 9.0 21.1 10.7 10.6 13.1 11.6 14.5 12.3 21.1 210.2 9.0 6.0 16.6 12.7 9.2 8.0 5.3 118.8 66.0 19.7 22.5 12.5 169.2 38.6 13.3 14.6 24.5 14.4 9.5 6.1 6.9 VPS35L "C16orf62, MGC16824" ENSG00000103544 "VPS35 endosomal protein sorting factor like" Q7Z3J2 16 19555240-19706793 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 32.4;Cytotrophoblasts: 29.4;Distal tubular cells: 29.4;Hofbauer cells: 44.9;Syncytiotrophoblasts: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042969, HPA053547" Uncertain Approved Mitochondria NA NA Mitochondria "HPA042969: AB_10794920, HPA053547: AB_2682183" "unprognostic (7.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.17e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" "unprognostic (2.52e-1)" "unprognostic (1.22e-3)" "unprognostic (3.57e-2)" "unprognostic (2.06e-1)" "prognostic favorable (1.31e-8)" "unprognostic (1.82e-3)" "unprognostic (8.92e-2)" "unprognostic (5.08e-2)" "unprognostic (1.13e-2)" 19.5 22.9 21.6 16.1 30.5 13.3 17.2 20.2 24.2 21.4 11.5 18.9 13.8 20.3 22.6 16.9 19.4 17.6 17.9 19.9 21.5 22.4 14.5 16.4 14.8 22.8 23.8 18.0 23.5 16.6 35.9 20.5 20.4 27.1 16.1 19.6 16.3 12.5 19.0 22.4 13.9 15.4 25.3 20.0 17.4 13.4 31.8 24.1 16.2 22.9 25.5 16.8 18.5 15.7 39.6 22.3 37.5 35.7 28.4 44.2 60.1 5.8 32.5 52.3 33.9 38.9 6.4 37.0 27.1 67.4 51.7 0.2 6.2 27.5 16.7 36.5 1.6 15.7 16.4 32.6 0.6 57.4 25.9 31.6 43.9 24.4 31.7 21.5 48.2 54.4 13.2 22.3 6.2 55.7 15.7 23.0 7.2 24.8 3.9 5.1 19.6 11.7 7.1 38.6 5.2 21.8 22.1 43.7 1.5 18.6 27.2 12.9 22.2 61.0 17.4 16.2 25.7 3.7 23.8 45.2 10.6 33.6 21.1 27.5 26.5 35.3 16.5 18.9 42.0 23.5 14.7 18.0 18.8 42.6 23.5 21.0 18.6 4.2 37.6 37.7 11.5 21.6 28.5 21.6 30.5 20.2 24.2 19.9 21.5 22.8 23.8 18.0 27.1 20.0 24.1 39.6 32.4 6.4 16.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 9.5 9.1 0.0 0.0 8.1 16.5 0.0 29.4 5.0 0.0 29.4 20.4 0.0 8.2 15.8 15.5 0.0 0.0 0.0 17.0 19.5 8.1 0.0 11.1 3.8 18.1 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 1.2 0.0 0.0 21.9 2.9 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 40.2 3.4 21.0 0.0 0.0 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 21.9;brain: 77.2" "Group enriched" "Detected in some" 4 "Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Group enriched" "Detected in many" 12 "midbrain: 40.2;pons: 77.2;white matter: 20.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "SH-SY5Y: 489.1" "Region enriched" "Detected in some" 4 "pons and medulla: 7.8" "Region enriched" "Detected in single" 19 "pons: 13.8" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 0.7 21.9 0.8 0.0 0.1 0.0 0.8 0.0 1.2 2.4 0.0 0.2 0.1 5.4 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.4 0.4 0.1 0.0 3.7 40.2 0.1 0.1 0.0 0.5 0.0 12.7 77.2 0.2 0.3 0.0 1.9 0.6 0.0 13.5 0.2 0.8 0.2 0.0 0.1 6.3 0.3 0.1 0.0 0.0 0.1 0.2 0.5 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.7 489.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.2 0.1 0.1 3.7 40.2 0.1 77.2 0.2 0.3 20.9 1.8 0.0 0.0 0.0 0.0 1.5 0.2 0.4 0.0 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 10.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.5 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 11.5 0.3 0.0 0.4 5.6 0.0 0.0 0.0 0.1 RNF40 "BRE1B, KIAA0661, RBP95, STARING" ENSG00000103549 "Ring finger protein 40" O75150 16 30761745-30776307 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041330, HPA054227" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041330: AB_10793872, HPA054227: AB_2682422" "unprognostic (1.61e-1)" "unprognostic (1.74e-2)" "unprognostic (3.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.21e-1)" "unprognostic (4.01e-1)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-2)" "unprognostic (1.91e-2)" "prognostic favorable (8.11e-8)" "unprognostic (9.96e-2)" "unprognostic (1.36e-1)" "unprognostic (6.55e-3)" "unprognostic (6.60e-3)" 24.6 29.0 21.7 26.9 23.5 55.8 21.7 23.9 25.0 26.7 23.2 26.3 25.1 29.6 15.7 32.1 25.6 26.3 16.4 24.1 28.4 20.1 21.0 22.7 27.2 24.2 22.7 20.3 35.6 30.0 35.4 21.8 21.6 22.9 22.8 17.8 18.3 34.0 22.7 17.6 26.6 24.9 21.7 20.8 24.9 23.6 38.3 23.8 24.8 29.3 16.2 22.4 21.5 22.9 26.0 58.5 87.9 53.0 52.7 41.9 43.3 58.6 58.7 47.4 66.8 52.4 72.4 53.7 46.5 82.9 50.5 45.5 62.1 99.2 55.5 53.0 66.7 120.9 45.2 99.9 77.2 53.3 79.8 54.0 41.3 43.5 83.3 48.8 44.2 57.7 40.6 101.3 46.1 42.5 98.3 76.4 74.4 55.6 47.7 55.4 149.9 58.8 91.6 29.8 52.0 89.9 65.0 45.0 58.7 41.8 27.9 88.9 88.5 60.8 74.6 37.4 53.8 67.7 66.1 87.2 93.0 62.3 70.6 77.1 6.5 13.6 17.1 13.1 14.1 13.1 8.1 7.1 10.0 13.9 5.9 5.3 8.8 16.1 11.1 17.1 6.6 6.7 16.2 21.7 23.5 23.9 25.0 24.1 28.4 24.2 22.7 20.3 22.9 20.8 23.8 26.0 13.5 12.8 24.9 18.3 17.2 13.9 12.3 10.2 16.5 12.8 18.9 15.6 3.2 28.6 11.5 22.0 4.2 16.0 20.7 27.7 88.0 15.2 23.7 24.7 20.8 14.9 13.9 37.4 10.3 13.3 16.9 14.5 26.0 29.2 4.5 19.3 10.8 22.9 21.5 5.0 11.2 23.2 10.2 23.0 12.6 22.0 18.0 16.9 17.8 4.7 16.7 16.5 11.3 13.0 8.7 16.3 15.4 17.7 21.8 15.8 24.2 26.5 12.4 13.7 13.1 15.8 13.3 27.1 11.3 20.6 19.7 22.7 16.0 22.2 25.8 11.2 KNOP1 "101F10.1, C16orf88, FAM191A, TSG118" ENSG00000103550 "Lysine rich nucleolar protein 1" Q1ED39 16 19701937-19718235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 166.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041079, HPA066169" Uncertain Enhanced "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA041079: AB_10962350, HPA066169: AB_2685628" "unprognostic (6.55e-3)" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (2.42e-2)" "unprognostic (8.57e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.75e-6)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.18e-3)" "unprognostic (5.84e-2)" "unprognostic (2.14e-2)" "unprognostic (7.91e-2)" "unprognostic (3.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" 7.3 6.8 17.1 7.0 19.8 4.0 11.6 16.9 21.9 8.3 12.7 8.4 7.2 7.1 8.9 10.5 7.5 6.3 6.4 17.9 18.3 6.1 8.0 5.8 9.1 20.2 18.6 16.3 11.5 8.7 13.7 6.5 8.9 20.3 7.4 9.2 8.9 12.6 6.8 14.6 13.1 7.4 4.9 15.9 6.5 8.2 9.0 17.6 6.0 6.2 5.4 6.8 7.3 8.9 25.6 30.2 45.4 49.7 37.9 12.1 11.3 25.5 18.3 9.9 17.1 17.2 32.2 25.5 35.7 72.6 11.1 15.0 27.4 38.9 25.1 16.6 24.2 27.2 21.1 25.3 42.7 21.9 33.5 15.9 7.2 35.1 22.4 18.4 15.0 18.3 25.0 66.1 15.6 16.2 39.3 29.7 27.6 96.8 29.7 17.9 63.0 26.7 41.4 18.0 28.4 44.4 37.4 22.7 29.0 31.2 28.1 33.8 22.4 21.3 26.7 27.4 16.5 24.5 23.0 51.3 44.7 14.4 25.2 26.6 0.4 3.0 1.5 4.0 7.1 5.9 5.8 5.6 3.9 3.6 7.1 10.1 5.7 0.8 4.4 6.7 4.6 3.8 3.5 17.1 19.8 16.9 21.9 17.9 18.3 20.2 18.6 16.3 20.3 15.9 17.6 25.6 40.3 6.4 17.8 108.7 19.8 12.2 29.9 47.9 17.6 39.2 37.9 31.9 8.9 38.6 29.5 38.6 87.6 57.1 13.6 43.0 46.9 98.2 2.8 33.8 79.8 47.2 15.0 21.7 9.7 66.3 45.4 26.0 26.5 42.1 6.3 66.9 26.0 53.4 36.5 35.3 12.7 41.7 61.1 24.9 12.6 8.5 60.6 17.9 12.4 16.9 27.2 25.8 33.0 15.1 166.6 77.8 19.0 53.8 14.8 46.4 32.3 34.5 21.3 64.1 46.0 18.7 38.9 67.8 125.3 31.5 16.1 24.6 16.8 53.6 64.4 23.3 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 708.5" "Group enriched" "Detected in some" 4 "Hepatocytes: 313.9;Macrophages: 82.1" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Region enhanced" "Detected in many" "cerebral cortex: 13.1" "Immune cell enriched" "Detected in many" 20 "neutrophil: 1161.4" "Lineage enriched" "Detected in many" 20 "granulocytes: 1161.4" "Cell line enriched" "Detected in some" 29 "U-87 MG: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA074762, CAB075684" Enhanced NA NA "CAB075684: , HPA074762: AB_2732267" "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavorable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 18.4 0.8 0.8 73.5 1.2 68.2 2.4 1.0 13.1 1.3 1.8 0.9 0.2 1.2 43.8 1.2 7.2 5.4 1.7 3.3 3.9 0.9 708.5 22.4 0.6 1.0 1.2 1.0 0.5 1.6 5.6 0.3 6.3 4.3 0.9 0.3 0.4 1.1 0.7 0.5 20.6 0.9 6.5 0.8 43.0 1.5 0.3 5.6 1.8 0.6 7.6 0.8 32.9 0.6 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 29.7 0.1 0.0 0.2 58.4 1.2 0.1 17.5 0.1 0.5 0.1 0.0 1.8 0.1 0.1 0.0 1161.4 0.3 23.0 0.6 0.3 18.9 0.8 1.2 1.0 13.1 3.3 3.9 1.0 1.2 1.0 4.3 0.8 5.6 3.0 0.7 0.0 12.2 0.3 2.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 1.1 5.7 3.1 0.0 0.0 0.3 0.5 0.0 0.0 0.1 2.1 0.3 0.1 0.7 0.0 13.9 2.4 0.2 0.9 1.9 0.0 1.8 7.6 0.0 7.9 313.9 40.8 0.0 0.8 0.0 0.0 28.5 6.2 1.9 0.3 82.1 0.0 0.0 18.9 0.0 1.0 0.5 0.2 0.5 0.0 0.0 0.7 0.2 0.0 0.3 1.5 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.6 0.8 1.5 0.0 0.0 0.1 AAGAB "FLJ11506, p34" ENSG00000103591 "Alpha and gamma adaptin binding protein" Q6PD74 15 67200667-67255195 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039371, HPA040174" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA039371: AB_10805476, HPA040174: AB_10805605" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (8.25e-2)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (2.84e-2)" "unprognostic (4.52e-2)" "unprognostic (9.10e-2)" "unprognostic (5.28e-2)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.88e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (1.53e-1)" 15.2 19.2 10.9 19.4 13.6 19.9 22.7 7.3 14.5 18.0 11.9 28.1 15.9 15.0 26.1 20.7 16.6 18.7 15.9 12.0 15.3 27.7 18.2 15.7 20.1 10.0 11.7 10.5 8.1 17.1 35.5 19.1 15.9 11.1 18.9 34.1 22.3 15.5 20.7 33.0 13.0 19.7 21.4 9.2 15.5 24.1 22.1 13.1 30.2 33.3 23.2 26.1 27.8 13.3 12.3 49.7 89.9 63.2 64.8 60.0 49.3 31.1 51.4 74.7 60.6 68.7 66.8 52.9 48.1 51.1 52.9 74.4 98.2 129.9 59.4 62.9 65.0 62.0 46.2 63.2 26.8 66.0 78.8 51.2 48.6 80.6 45.8 94.3 41.0 47.8 59.7 96.5 63.7 60.2 61.3 47.6 32.7 53.1 61.7 31.5 53.1 81.1 57.7 55.9 116.1 89.7 57.3 60.7 44.0 75.7 54.7 71.5 59.2 51.7 54.2 64.5 50.0 73.0 33.7 119.3 69.2 52.7 71.8 55.4 56.4 27.0 28.2 31.3 35.4 36.2 22.0 28.2 29.7 33.2 17.3 23.7 25.0 14.6 42.7 38.1 25.4 37.3 30.2 10.9 13.6 7.3 14.5 12.0 15.3 10.0 11.7 10.5 11.1 9.2 13.1 12.3 10.8 3.2 7.7 26.1 19.0 12.0 18.8 19.4 15.9 13.4 17.8 10.3 12.9 4.3 19.0 27.6 27.1 16.3 8.8 33.4 17.6 28.6 14.6 14.5 11.6 12.0 15.7 10.9 45.4 31.2 14.8 14.1 22.4 18.0 10.8 8.2 8.2 12.7 17.0 18.5 33.1 17.3 14.2 15.5 8.4 8.6 7.8 11.6 7.2 30.0 21.3 14.4 16.5 26.2 31.9 25.3 20.9 11.3 15.5 22.9 15.3 19.1 20.5 19.4 13.1 10.5 10.2 43.0 33.8 17.6 13.8 16.6 17.8 25.3 15.7 24.5 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254786-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.6" "Cell type enhanced" "Detected in many" "Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040845 Uncertain Approved Cytosol NA NA Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.3 1.1 2.1 0.3 0.9 0.1 1.6 1.2 1.4 0.9 3.5 0.5 0.2 0.8 2.6 0.5 6.8 0.6 0.9 0.6 2.2 2.2 1.0 0.9 0.4 2.1 1.9 0.6 0.3 0.7 3.8 2.0 0.4 1.7 0.6 0.7 5.0 0.6 0.8 0.5 0.6 0.2 0.3 2.8 0.4 1.1 11.6 1.5 1.0 4.1 0.0 0.2 0.7 0.3 1.5 1.7 1.6 0.8 1.3 1.1 2.6 0.6 0.9 0.7 1.3 0.9 0.1 1.9 1.2 0.8 1.5 1.5 2.8 2.6 1.0 2.3 0.2 1.2 0.3 1.6 0.2 1.7 0.5 0.3 1.7 1.1 2.9 2.8 1.3 0.5 3.1 2.6 1.1 1.0 1.8 0.4 0.4 0.9 1.0 1.1 0.3 1.2 1.3 1.6 0.7 2.6 0.7 1.2 1.6 4.8 1.6 4.3 0.3 1.2 1.5 0.7 2.4 1.0 2.5 3.2 0.3 3.1 1.3 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 2.1 0.9 1.2 1.4 0.6 2.2 2.1 1.9 0.6 1.7 2.8 1.5 1.5 0.7 3.2 1.1 27.4 0.3 1.3 1.0 1.6 1.8 1.5 2.7 2.2 1.1 0.0 2.8 1.8 8.4 0.2 0.3 0.4 0.0 1.0 59.4 15.9 1.1 0.9 0.0 0.4 26.5 0.8 0.5 0.7 8.2 2.0 0.0 0.7 0.0 0.0 0.3 1.7 18.2 0.5 4.1 0.0 0.7 37.3 0.9 0.3 0.0 8.4 1.0 1.1 0.0 9.0 9.5 0.7 0.0 0.7 0.5 0.3 0.2 2.2 30.3 5.4 0.0 1.5 0.6 48.8 18.2 1.2 0.4 0.3 0.4 4.2 0.4 1.0 LACTB "FLJ14902, MRPL56" ENSG00000103642 "Lactamase beta" P83111 15 63121833-63142061 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protease" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036361, HPA036362" Supported Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA036361: AB_10672244, HPA036362: AB_10670798" "unprognostic (6.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.22e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.10e-2)" "unprognostic (8.08e-2)" "unprognostic (6.25e-2)" "unprognostic (8.98e-2)" "unprognostic (3.08e-1)" "unprognostic (6.22e-3)" "unprognostic (5.16e-3)" "unprognostic (6.28e-2)" "unprognostic (3.24e-1)" "unprognostic (8.64e-2)" "unprognostic (7.90e-2)" "unprognostic (3.88e-3)" 16.0 25.7 7.6 21.4 7.9 57.6 12.7 7.7 8.0 8.5 11.2 18.7 19.7 7.7 8.4 15.0 7.1 14.4 22.2 7.6 9.0 23.8 42.8 19.2 19.9 7.7 7.6 7.5 8.2 10.7 10.0 6.7 11.9 7.6 9.3 16.1 4.7 9.9 6.9 49.6 11.7 17.0 9.1 8.2 18.5 12.9 22.3 8.5 9.2 9.3 36.6 13.4 19.9 9.2 9.2 60.3 37.0 10.4 7.3 51.9 27.4 8.7 25.7 39.4 43.3 79.9 9.3 37.5 8.0 31.0 37.5 46.9 16.6 35.6 16.7 54.2 55.1 8.9 15.6 12.2 23.7 48.0 14.2 26.1 37.3 35.1 44.5 36.4 64.9 45.2 46.4 14.9 22.1 74.7 22.6 10.9 17.3 15.6 36.7 11.7 8.0 26.6 18.5 23.6 92.5 9.3 4.4 18.6 20.7 59.0 36.0 15.9 23.4 81.5 57.8 44.8 26.2 32.9 23.3 21.8 2.2 44.3 39.2 27.3 4.4 8.4 4.4 1.1 8.3 1.8 3.1 0.9 0.9 9.8 2.6 0.8 1.4 5.3 2.1 7.3 0.8 3.0 2.2 7.6 7.9 7.7 8.0 7.6 9.0 7.7 7.6 7.5 7.6 8.2 8.5 9.2 24.6 25.6 22.6 4.9 25.7 58.2 27.2 12.0 19.9 6.5 21.7 16.1 42.5 22.8 10.9 12.9 12.5 15.8 19.3 26.0 25.4 56.0 62.9 13.2 16.4 31.1 7.3 10.8 12.5 43.1 40.5 26.4 17.3 19.3 66.5 12.1 8.9 57.0 88.6 8.4 14.5 27.1 16.2 71.3 72.5 30.6 14.3 97.0 26.6 15.9 152.9 6.9 7.2 10.1 8.1 75.0 19.0 16.1 21.3 35.6 25.2 79.2 9.2 11.3 6.6 37.9 31.5 122.9 25.6 26.3 60.0 18.1 21.8 23.9 20.4 39.6 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578993-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.7;retina: 45.6" "Cell type enhanced" "Detected in many" "Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 13 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Supported Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.0 3.6 46.2 2.0 62.7 0.7 7.3 62.2 67.6 6.7 28.1 4.8 1.2 7.6 2.2 1.4 27.7 4.7 13.9 52.2 49.0 9.1 1.3 5.1 1.8 58.6 65.1 44.3 15.0 2.3 0.5 3.5 3.2 59.6 4.4 1.5 45.6 2.8 4.9 2.6 4.1 2.8 6.3 57.2 3.9 3.1 1.0 62.2 1.3 6.2 4.6 0.8 4.1 3.7 83.7 0.6 0.8 26.2 2.2 26.8 57.5 0.0 13.7 15.0 2.3 3.2 0.3 3.0 3.5 1.6 2.3 3.7 0.2 1.0 0.3 9.5 0.0 1.2 0.0 0.0 1.2 9.8 0.0 0.4 41.6 0.3 34.6 2.0 20.4 1.0 0.0 0.0 0.1 24.4 0.1 0.0 0.1 6.5 0.0 0.1 2.2 0.1 1.2 3.7 0.0 15.3 0.3 0.2 0.0 7.8 4.8 0.0 3.1 0.2 7.8 8.9 1.7 18.3 0.0 0.0 3.5 59.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 62.7 62.2 67.6 52.2 49.0 58.6 65.1 44.3 59.6 57.2 62.2 83.7 2.8 0.0 0.0 57.1 1.1 1.0 0.4 0.0 0.0 43.2 0.1 1.0 1.5 0.0 0.0 7.3 37.5 0.0 0.0 0.0 0.0 3.8 0.4 2.1 11.6 3.0 3.6 0.0 96.6 0.6 0.0 8.0 0.0 0.3 0.0 0.9 6.4 0.0 0.2 0.0 50.0 0.3 0.0 0.3 0.7 0.7 7.8 0.3 7.2 11.2 0.1 12.5 0.0 17.1 146.4 0.6 0.0 0.4 0.0 0.1 0.0 0.1 8.1 21.4 6.6 1.4 2.1 0.2 0.5 0.1 0.9 0.0 0.1 7.5 0.0 0.1 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 170.7" "Cell type enhanced" "Detected in all" "B-cells: 130.9;dendritic cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Enhanced Vesicles,Cytosol No No 150000 "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favorable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favorable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.74e-4)" "prognostic favorable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 20.6 20.0 21.5 89.9 21.3 51.1 19.5 23.4 27.0 26.1 15.6 31.3 37.0 22.5 8.0 99.3 20.2 23.1 28.7 19.1 22.2 20.3 49.2 32.3 170.7 26.1 25.5 16.8 19.2 17.3 16.0 21.3 17.7 30.1 25.0 19.6 6.9 31.9 14.2 15.0 35.6 60.4 18.9 25.4 128.9 30.2 19.3 23.4 69.1 19.7 15.9 107.1 33.3 33.0 26.7 62.2 85.6 41.2 68.1 38.5 29.2 35.3 40.7 38.8 75.7 53.6 78.9 56.0 275.7 52.6 37.0 70.2 62.9 87.2 82.1 21.2 134.7 107.8 233.8 29.5 80.2 53.3 123.6 285.1 41.7 39.6 54.0 48.1 37.9 58.1 127.5 68.7 93.1 45.7 104.6 89.7 72.7 51.2 55.7 60.6 98.0 35.4 201.9 34.9 135.6 68.1 47.2 52.8 109.5 72.3 26.2 75.5 179.5 50.7 91.1 47.8 72.5 71.7 49.6 108.7 283.8 47.1 232.5 63.1 88.7 68.0 176.1 74.3 146.8 63.4 95.6 63.6 73.9 76.6 113.6 48.3 57.0 130.8 58.6 169.8 44.3 106.2 79.5 21.5 21.3 23.4 27.0 19.1 22.2 26.1 25.5 16.8 30.1 25.4 23.4 26.7 21.3 3.2 9.2 8.5 130.9 9.3 8.2 7.6 13.1 16.6 16.7 17.1 11.5 12.8 9.3 9.2 6.2 7.5 99.1 40.6 1.9 9.3 15.8 10.0 15.1 15.3 9.5 29.2 5.3 14.0 13.7 11.3 27.0 15.3 26.6 19.0 12.5 34.3 50.7 28.6 10.0 23.2 6.1 91.2 44.9 3.3 9.0 85.1 8.8 23.4 86.9 6.4 90.6 3.5 4.7 21.2 18.4 8.2 56.7 13.9 27.5 8.0 9.3 5.1 6.6 6.9 18.1 5.7 12.5 49.4 9.1 5.6 90.3 21.5 27.5 14.9 HERC1 "p532, p619" ENSG00000103657 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 1" Q15751 15 63608618-63833948 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 458.8;Inhibitory neurons: 338.0;Oligodendrocytes: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049749 Uncertain NA NA "HPA049749: AB_2680866" "unprognostic (9.72e-2)" "unprognostic (7.51e-2)" "unprognostic (3.43e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.87e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (2.89e-3)" "prognostic favorable (3.66e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.36e-6)" "unprognostic (2.87e-1)" "unprognostic (3.36e-2)" "unprognostic (9.04e-3)" "unprognostic (3.94e-1)" 9.7 7.5 5.4 10.4 10.7 27.7 12.8 15.0 21.0 13.2 4.7 10.3 5.4 10.9 6.6 8.2 7.7 9.7 15.4 8.6 2.0 9.2 9.1 10.7 13.8 3.3 2.1 6.1 18.7 8.5 22.9 8.9 10.4 4.3 8.7 9.3 18.4 8.9 10.4 30.7 12.2 10.0 12.5 0.0 15.4 10.3 11.6 0.3 25.8 14.1 29.5 12.9 9.3 8.0 23.4 13.5 17.1 19.1 6.6 33.3 21.1 6.4 10.3 13.4 10.7 12.3 10.9 5.3 19.8 9.3 19.8 9.7 14.5 31.2 9.0 14.6 15.4 9.6 42.5 26.4 7.8 5.3 31.6 25.1 15.3 8.5 15.1 14.5 9.3 22.7 13.3 44.0 8.6 9.4 21.7 11.3 6.5 9.3 10.4 8.7 12.2 20.6 11.6 4.4 32.9 17.0 8.4 18.2 12.5 10.5 23.0 6.1 12.7 23.6 13.6 12.6 11.9 13.6 9.4 17.4 13.3 7.8 23.3 4.9 24.4 3.8 8.7 4.9 3.4 3.7 5.9 5.5 4.6 3.4 9.5 5.5 5.4 13.5 2.9 6.7 7.5 7.8 1.8 5.4 10.7 15.0 21.0 8.6 2.0 3.3 2.1 6.1 4.3 0.0 0.3 23.4 66.0 6.4 39.5 113.0 44.2 14.9 10.6 16.1 17.1 65.3 19.7 17.1 64.8 17.2 19.9 22.0 66.7 8.8 66.1 11.4 1.9 11.0 28.7 13.5 24.0 44.5 10.2 47.5 458.8 14.1 15.1 28.5 34.7 17.8 50.6 36.5 47.2 21.0 16.2 85.8 338.0 13.1 10.2 43.2 27.4 14.3 27.7 39.2 19.6 137.7 36.0 29.9 35.0 160.4 201.5 11.7 14.7 39.9 44.9 12.7 12.5 15.7 16.6 55.0 6.6 34.4 36.0 43.5 31.3 17.1 15.3 8.9 61.1 31.9 14.4 12.1 TRIP4 "ASC-1, HsT17391, ZC2HC5" ENSG00000103671 "Thyroid hormone receptor interactor 4" Q15650 15 64387748-64455303 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016605, HPA050666" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA016605: AB_1858339, HPA050666: AB_2681211" "unprognostic (1.56e-1)" "unprognostic (1.14e-1)" "unprognostic (2.62e-1)" "unprognostic (4.50e-2)" "unprognostic (5.79e-2)" "unprognostic (1.08e-1)" "unprognostic (7.16e-2)" "unprognostic (3.01e-2)" "unprognostic (4.98e-2)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.37e-2)" "prognostic favorable (6.34e-6)" "unprognostic (2.41e-1)" "unprognostic (2.96e-1)" "unprognostic (2.61e-2)" "unprognostic (1.25e-1)" 14.4 12.5 15.9 13.4 17.0 15.5 17.2 16.4 19.9 12.9 17.3 17.2 17.3 13.4 11.7 19.6 14.3 11.1 14.4 15.9 16.8 27.8 14.4 15.1 16.5 16.7 16.5 15.7 13.2 16.7 20.1 13.1 17.1 16.9 12.8 19.4 16.9 13.4 12.3 9.0 17.5 18.0 16.6 16.5 16.7 15.7 12.1 16.6 20.0 25.8 9.3 18.9 17.9 14.8 17.9 18.6 27.1 23.3 16.7 18.9 24.6 21.8 19.3 24.7 32.7 31.5 22.8 40.5 13.3 6.3 29.4 26.6 25.7 38.3 22.0 30.9 27.0 10.9 19.4 19.2 24.1 33.5 21.2 35.1 30.9 28.2 25.9 27.0 18.7 28.9 19.2 22.7 16.2 30.4 21.2 13.5 21.3 13.7 32.7 14.4 20.4 17.7 22.2 31.6 35.1 12.6 19.8 17.3 20.7 35.3 43.5 26.2 31.3 25.7 23.2 15.8 15.6 27.7 13.5 25.9 13.5 19.2 21.4 29.6 70.1 22.2 54.3 20.8 29.1 17.7 16.0 19.7 21.2 20.5 16.3 16.6 17.3 30.9 21.2 42.4 16.2 23.3 16.9 15.9 17.0 16.4 19.9 15.9 16.8 16.7 16.5 15.7 16.9 16.5 16.6 17.9 12.7 22.4 13.2 15.3 10.0 8.4 9.6 23.3 2.2 11.1 7.6 7.1 10.3 7.2 18.1 12.9 12.5 22.2 20.1 15.3 13.7 25.2 20.4 21.7 10.7 13.2 11.4 9.9 32.5 27.1 26.8 10.2 10.2 16.2 19.6 12.3 10.0 4.4 21.7 15.2 25.8 8.2 24.4 12.9 7.6 3.7 11.8 15.3 14.2 22.5 27.5 10.0 27.8 18.1 30.9 33.6 10.5 12.8 6.5 6.0 13.5 44.6 26.7 17.3 6.6 9.0 15.0 19.3 21.4 5.4 6.3 24.2 14.4 12.1 8.1 7.8 MTFMT FMT1 ENSG00000103707 "Mitochondrial methionyl-tRNA formyltransferase" Q96DP5 15 65001512-65029639 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Transferase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040710 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040710: AB_10794879" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (9.28e-3)" "unprognostic (4.35e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (6.63e-2)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (2.41e-2)" "unprognostic (1.78e-1)" "prognostic favorable (3.31e-8)" "unprognostic (2.75e-2)" "unprognostic (4.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.85e-2)" 1.6 2.2 2.6 0.7 2.9 1.9 1.6 4.0 3.1 2.4 3.9 2.5 1.5 2.5 1.5 2.2 2.6 0.9 3.6 2.8 3.1 2.4 3.6 1.5 1.4 2.8 2.6 3.1 2.7 1.4 1.7 2.3 0.9 3.0 2.8 1.5 1.6 1.8 1.4 3.0 1.7 2.2 1.8 2.1 2.4 2.0 1.5 2.7 1.1 1.8 1.5 1.2 2.5 2.1 3.1 1.4 1.9 1.8 3.2 2.5 1.7 1.7 1.3 2.2 1.6 1.5 1.2 1.5 4.7 1.7 2.3 2.7 4.0 3.3 2.2 1.5 1.9 2.8 1.9 1.9 1.3 2.9 2.7 0.6 2.3 2.8 0.9 1.9 2.2 1.5 4.2 2.3 2.2 2.4 1.9 2.3 3.1 2.4 4.0 3.6 2.0 2.5 2.2 2.7 1.6 1.8 1.8 3.1 2.7 2.5 2.2 1.6 2.0 2.8 1.9 1.9 2.4 2.6 1.9 3.1 1.8 1.7 4.6 1.9 3.7 3.3 2.6 4.8 3.1 4.8 4.8 4.7 5.0 6.0 4.7 5.1 5.4 16.5 4.5 2.2 10.1 5.4 2.3 2.6 2.9 4.0 3.1 2.8 3.1 2.8 2.6 3.1 3.0 2.1 2.7 3.1 8.5 3.2 9.7 17.0 11.8 3.3 15.2 19.1 14.8 0.0 7.0 7.7 15.8 10.0 10.5 3.7 0.0 11.4 18.1 10.5 25.4 11.8 1.7 7.8 11.6 8.2 7.8 9.4 49.8 10.0 11.7 11.8 8.6 7.0 8.8 8.0 12.8 12.2 16.5 0.0 44.2 8.9 2.0 12.2 12.2 1.7 15.5 9.7 8.8 27.2 7.1 0.0 11.3 19.1 12.9 10.3 15.9 15.4 10.3 16.7 17.5 25.1 5.1 0.0 0.0 12.5 14.5 13.3 20.7 10.7 4.5 8.9 10.1 11.4 15.7 14.5 RASL12 RIS ENSG00000103710 "RAS like family 12" Q9NYN1 15 65053337-65076690 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7" "Cancer enhanced" "Detected in all" "glioma: 21.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.13e-3)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (6.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.21e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-3)" "unprognostic (1.60e-1)" "unprognostic (4.45e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (1.76e-2)" "unprognostic (4.72e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.17e-4)" 23.0 3.9 35.6 5.1 34.4 0.0 15.8 33.9 21.6 47.0 10.3 28.7 3.7 62.2 28.1 19.4 55.2 13.4 37.4 26.9 36.8 4.7 1.2 38.8 3.3 47.3 54.4 15.5 16.7 2.5 1.8 7.1 17.2 40.6 52.9 6.8 3.3 8.1 77.1 37.5 10.1 9.4 33.2 38.2 9.7 7.7 15.7 58.7 0.9 8.5 20.8 1.7 40.5 33.8 37.8 0.1 0.1 0.2 0.0 0.6 5.0 0.2 0.0 0.5 0.0 0.0 14.5 0.1 0.0 22.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 9.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 34.4 33.9 21.6 26.9 36.8 47.3 54.4 15.5 40.6 38.2 58.7 37.8 7.4 0.0 0.0 22.5 0.0 1.5 3.9 0.0 0.0 0.3 2.0 5.6 16.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.7 0.3 12.6 3.6 0.0 0.0 0.1 0.0 0.1 15.2 0.5 0.5 0.0 12.3 1.4 0.1 0.3 0.0 0.1 0.0 2.0 0.0 1.3 3.9 13.1 0.2 0.0 2.8 0.0 17.9 0.0 0.0 0.0 0.1 0.0 57.9 0.0 0.4 0.5 0.0 0.0 0.8 98.6 0.9 55.7 0.7 1.1 0.4 0.1 0.3 0.2 0.4 0.2 0.1 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 subunit beta 2" Q13367 15 82659281-82710112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;pituitary gland: 18.9;retina: 33.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 0.5 4.5 15.2 0.9 20.3 1.1 1.4 17.4 20.9 0.9 0.0 0.9 0.7 1.1 2.4 0.7 0.9 0.4 0.2 21.6 9.2 0.6 0.2 0.3 0.5 15.9 6.1 17.7 1.2 2.1 12.8 18.9 0.6 18.7 1.4 0.6 33.3 0.9 1.4 0.3 0.9 0.9 1.3 0.4 0.7 1.1 6.3 7.0 1.0 2.1 0.4 1.3 0.8 0.7 12.8 0.2 0.4 9.5 3.2 1.6 0.2 5.7 0.5 0.0 0.8 0.2 0.4 0.4 0.8 4.9 0.2 1.8 0.9 1.0 0.0 0.2 3.2 0.7 0.3 0.4 0.2 0.3 0.4 1.8 1.0 1.1 0.1 0.7 0.1 0.0 2.8 1.0 0.7 0.1 2.5 0.3 0.5 9.5 0.1 0.1 0.3 0.0 0.2 0.0 17.3 29.0 17.5 3.2 1.4 2.4 1.0 0.2 1.9 0.2 0.3 0.9 0.4 1.3 1.6 8.8 0.7 2.2 0.5 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.2 0.9 0.1 0.1 0.4 0.0 0.1 15.2 20.3 17.4 20.9 21.6 9.2 15.9 6.1 17.7 18.7 0.4 7.0 12.8 0.1 0.0 1.1 20.9 0.1 0.4 2.1 0.6 1.2 18.4 1.5 2.3 0.8 0.0 0.1 0.0 27.1 0.1 0.2 0.1 0.0 0.2 8.0 0.2 0.6 0.1 13.9 0.0 61.7 0.4 0.1 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 13.5 56.9 0.5 6.1 0.0 0.6 5.4 0.9 0.1 0.0 4.7 0.0 4.1 0.0 44.7 22.8 0.0 0.1 0.4 1.2 0.7 0.0 0.4 0.0 58.6 0.0 1.3 0.7 9.8 3.1 0.7 0.1 0.0 0.1 0.2 0.0 0.6 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 62.5" "Cell type enriched" "Detected in some" 5 "Astrocytes: 158.0" "Cancer enriched" "Detected in some" 4 "glioma: 3.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1;SK-MEL-30: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles NA NA Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 0.1 5.6 24.3 0.4 36.6 2.4 1.6 32.2 25.4 0.4 0.0 0.9 0.4 0.2 0.7 0.4 2.8 0.2 0.6 20.1 32.5 0.4 0.4 0.5 0.4 47.9 38.9 13.0 0.3 0.2 0.0 0.5 0.1 46.3 0.8 0.1 0.6 0.3 0.2 0.2 11.5 0.5 0.2 51.0 0.3 0.3 3.7 39.1 3.5 0.2 0.0 0.1 0.3 0.5 62.5 0.3 0.0 0.6 0.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.5 0.3 0.6 0.3 0.0 0.2 0.6 0.2 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.4 0.0 0.1 0.2 0.5 3.1 0.2 0.1 0.1 0.4 0.2 0.0 0.4 0.2 0.3 0.1 0.4 1.5 0.3 0.1 0.2 0.4 0.2 0.2 0.1 0.1 0.3 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 24.3 36.6 32.2 25.4 20.1 32.5 47.9 38.9 13.0 46.3 51.0 39.1 62.5 0.1 0.0 2.0 158.0 0.6 1.1 0.6 0.3 0.6 1.9 0.2 0.1 3.0 0.0 2.7 0.0 4.2 0.2 0.5 0.3 0.0 0.0 1.8 4.4 0.3 0.2 0.0 4.6 0.7 0.0 0.2 0.7 0.5 0.3 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 1.7 0.3 4.0 1.8 2.8 0.1 0.2 1.0 7.5 26.9 0.2 0.0 0.0 0.9 0.3 0.1 0.2 19.1 3.3 0.0 0.3 1.0 2.0 10.0 0.4 0.6 0.4 0.5 1.6 0.1 0.7 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381484-65422947 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.6;skeletal muscle: 10.7;tongue: 14.1" "Cell type enhanced" "Detected in many" "Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 64000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 0.9 2.5 5.0 2.4 5.3 0.0 0.5 6.7 2.1 3.4 0.0 0.8 0.5 1.4 4.2 1.6 1.7 4.2 0.9 2.6 5.2 0.1 0.0 0.2 0.6 10.6 7.9 1.2 8.5 0.1 0.3 0.9 5.6 6.1 0.4 0.6 0.8 0.6 0.4 10.7 0.8 0.9 1.0 6.3 0.2 1.1 0.6 9.9 0.7 1.9 14.1 0.6 2.1 2.1 5.0 0.0 4.4 9.4 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.3 0.5 8.1 0.0 4.5 0.3 0.0 0.0 2.3 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 5.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.8 7.2 0.0 0.0 0.0 2.3 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 0.0 3.7 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 5.3 6.7 2.1 2.6 5.2 10.6 7.9 1.2 6.1 6.3 9.9 5.0 0.2 0.0 0.0 18.6 0.0 2.3 0.0 0.0 0.0 7.7 0.2 0.5 2.2 0.0 0.0 3.7 31.3 0.4 0.1 0.0 0.0 0.4 0.4 0.0 2.1 0.3 0.0 0.0 0.9 0.0 0.6 14.7 1.1 0.0 0.0 8.8 0.0 0.0 0.7 0.0 6.3 0.0 0.0 0.0 2.5 1.4 34.8 0.3 5.4 14.0 0.0 1.0 1.0 17.6 1.0 0.3 0.0 4.1 0.1 0.1 0.0 0.7 0.0 12.2 6.6 29.8 1.0 0.8 2.6 0.1 1.1 0.8 0.3 7.0 0.0 0.0 RAB11A YL8 ENSG00000103769 "RAB11A, member RAS oncogene family" P62491 15 65726054-65891989 "Predicted intracellular proteins" "Cell cycle, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 969.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013097, HPA051697, HPA060686" Approved Enhanced "Vesicles,Centriolar satellite" No No "Vesicles, Centriolar satellite" "CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342" "unprognostic (4.15e-2)" "unprognostic (5.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.85e-2)" "unprognostic (6.07e-2)" "unprognostic (3.17e-2)" "unprognostic (7.12e-2)" "unprognostic (8.60e-2)" "unprognostic (4.83e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.29e-2)" "prognostic favorable (1.46e-5)" "unprognostic (9.93e-2)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (1.21e-1)" 140.0 233.5 80.1 125.1 87.8 127.1 151.6 83.8 105.8 151.0 81.4 225.9 141.0 118.5 132.1 484.4 147.4 186.7 157.7 83.7 93.1 164.4 125.1 149.4 142.3 89.7 86.8 81.7 105.8 108.6 194.1 107.7 216.2 97.0 151.6 226.4 99.9 196.7 127.3 120.6 288.7 160.3 150.5 85.0 185.5 218.1 203.6 86.2 144.9 156.7 110.6 248.1 272.4 234.1 104.6 285.2 330.3 330.1 240.8 294.7 275.0 431.1 297.0 300.4 264.4 313.0 305.8 497.4 370.7 295.8 342.6 262.3 429.0 525.0 393.2 248.2 243.7 314.9 445.3 219.9 274.1 224.7 211.5 254.0 282.8 438.1 260.2 214.7 281.7 595.2 197.8 364.5 214.3 378.1 283.7 209.9 167.3 275.9 1057.4 185.9 176.3 250.5 346.3 716.1 734.7 237.4 251.9 214.0 335.6 286.5 387.8 445.0 243.0 453.7 208.4 296.4 203.1 267.8 112.2 289.5 288.8 193.7 353.5 228.8 183.5 154.8 235.2 56.7 133.9 58.8 78.8 85.3 68.6 137.1 64.1 78.9 63.6 232.8 71.3 154.6 87.6 109.5 340.2 80.1 87.8 83.8 105.8 83.7 93.1 89.7 86.8 81.7 97.0 85.0 86.2 104.6 155.7 57.7 57.8 15.3 90.2 192.2 180.2 375.2 134.3 42.3 107.5 69.6 89.5 105.8 245.4 187.6 33.3 326.4 76.0 313.4 346.3 360.6 413.1 119.3 72.7 260.7 206.2 91.1 31.3 337.0 340.4 96.9 149.9 194.5 74.9 75.9 235.2 88.4 239.2 57.2 27.7 227.4 244.1 114.8 214.2 80.9 97.3 148.1 186.7 42.2 217.8 137.9 65.9 25.6 21.9 391.1 277.0 86.5 72.1 187.6 205.8 271.5 240.0 36.1 46.0 45.2 161.5 407.5 95.3 225.5 284.4 969.3 96.6 97.6 209.2 360.8 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 352.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8" "Group enriched" "Detected in all" 5 "B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" NA NA 8700000 "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favorable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 34.6 36.7 27.5 101.5 28.3 37.3 49.2 28.2 47.5 113.8 29.5 32.8 78.5 47.2 27.0 38.2 58.1 105.5 51.8 27.7 33.9 240.4 90.3 352.7 193.4 29.4 29.4 26.6 30.3 76.1 78.3 10.2 25.9 29.1 60.2 27.6 4.8 63.5 71.4 16.4 48.8 57.2 43.4 30.1 52.3 94.7 10.2 30.9 52.3 28.0 38.0 132.4 204.0 30.9 30.2 122.0 10.0 1.2 30.5 5.4 0.5 20.3 8.6 3.0 13.9 7.0 17.6 306.4 34.6 12.6 0.0 13.5 228.2 5.2 52.6 10.1 183.0 0.4 3.0 1.3 38.4 12.1 0.4 7.1 5.6 10.7 0.2 0.0 59.4 1.0 5.9 76.0 0.0 17.9 2.8 32.6 87.8 8.9 197.4 4.9 0.3 0.4 5.9 49.9 362.1 2.6 5.2 41.5 27.8 75.4 10.1 12.5 48.0 16.4 0.2 6.2 0.0 5.3 0.8 92.4 19.5 0.1 89.2 12.3 0.0 208.5 2.0 7.6 137.7 29.7 83.3 20.5 7.4 183.6 56.0 1.8 3.8 8.7 3.2 94.8 22.9 18.3 147.5 27.5 28.3 28.2 47.5 27.7 33.9 29.4 29.4 26.6 29.1 30.1 30.9 30.2 169.8 237.2 1569.9 59.1 127.4 24.2 280.7 363.9 30.1 1.3 45.5 41.7 26.2 358.9 258.7 367.8 4.2 19.8 8.1 9.1 84.1 225.0 25.3 67.0 86.0 124.5 9.1 3.0 2.2 142.0 39.6 53.8 106.0 42.8 32.8 2.7 14.3 115.5 256.7 0.0 2.9 18.6 101.7 177.8 259.6 22.6 73.0 350.4 80.0 15.9 360.9 22.6 5.2 1.5 1.1 84.6 16.0 6.0 155.8 112.0 153.0 523.2 261.6 6.6 19.7 4.5 22.3 12.3 56.4 41.6 18.6 23.4 29.4 17.8 40.1 340.4 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved Cytosol NA NA Cytosol "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 8.3 10.2 5.5 4.3 6.5 1.1 8.1 5.3 6.3 11.6 6.8 13.9 3.5 11.3 7.0 9.9 10.1 8.9 9.4 4.6 7.2 9.0 8.2 6.7 3.2 6.6 5.7 3.8 15.0 8.1 9.0 5.3 9.4 6.9 10.8 7.9 7.3 6.7 9.3 8.1 8.3 6.9 10.1 5.9 5.2 9.1 13.2 5.7 3.7 12.8 7.6 3.3 13.3 10.2 8.3 9.9 9.8 15.3 17.8 18.0 20.2 6.4 12.0 14.8 12.6 14.2 8.8 17.0 2.4 23.7 13.7 11.4 19.0 5.0 12.0 13.7 3.3 16.3 10.7 17.1 7.0 10.4 2.4 0.7 14.5 10.5 9.9 9.5 13.7 21.6 4.8 8.3 1.4 11.8 6.0 8.6 2.7 8.4 2.7 7.0 2.7 19.9 3.8 10.0 13.2 6.7 3.0 15.8 6.4 14.7 15.4 10.7 10.9 14.3 16.0 9.4 10.7 15.5 8.1 12.4 3.3 14.3 0.8 9.6 1.8 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.5 0.5 0.1 0.5 0.1 0.0 5.5 6.5 5.3 6.3 4.6 7.2 6.6 5.7 3.8 6.9 5.9 5.7 8.3 5.9 3.2 7.0 27.1 0.6 2.4 4.6 4.4 4.6 1.7 4.6 4.3 9.5 4.3 5.2 5.5 0.0 4.6 0.1 4.3 5.9 6.0 12.5 3.3 10.6 7.0 0.0 0.8 3.3 6.2 4.6 7.4 10.2 4.5 1.3 13.5 9.3 5.3 4.0 8.4 3.5 5.7 6.1 3.8 1.7 8.5 9.0 2.5 1.8 15.9 0.6 11.5 0.0 6.6 13.2 3.9 2.6 10.1 0.1 3.1 3.8 5.5 4.0 5.4 6.6 6.5 5.5 18.0 9.2 7.9 4.0 1.9 0.4 10.9 6.7 2.6 CD276 "B7-H3, B7H3, B7RP-2" ENSG00000103855 "CD276 molecule" Q5ZPR3 15 73683966-73714514 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 215.6;Hofbauer cells: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 175.0;U-2197: 231.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009285, HPA017139, CAB017826" Enhanced Approved Vesicles NA NA 16000000 Vesicles "CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246" "unprognostic (1.05e-1)" "unprognostic (4.74e-3)" "unprognostic (4.57e-3)" "unprognostic (9.62e-2)" "unprognostic (1.26e-2)" "unprognostic (5.50e-3)" "prognostic unfavorable (9.81e-4)" "unprognostic (2.57e-3)" "unprognostic (1.89e-1)" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.17e-1)" "unprognostic (9.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.34e-3)" 19.1 19.3 6.9 13.0 4.4 0.7 15.5 0.5 6.6 21.7 12.7 11.0 11.1 20.4 4.4 5.8 10.1 18.4 13.8 4.3 6.0 5.4 11.9 11.7 3.6 5.6 6.2 5.4 13.5 15.5 4.4 6.2 26.4 5.8 16.9 4.3 4.7 15.1 9.6 5.1 14.6 8.5 10.9 6.6 9.1 11.0 6.1 7.9 1.7 8.6 2.2 1.6 14.7 13.2 4.9 43.7 44.6 32.5 82.8 57.7 35.0 102.8 47.5 42.0 33.4 30.4 85.3 90.1 0.6 77.7 39.5 64.1 175.0 31.7 39.9 4.4 30.6 76.3 2.8 47.6 47.1 20.9 0.7 51.8 32.7 17.9 28.3 15.4 19.7 38.7 0.0 15.0 0.8 6.2 66.0 0.3 2.3 84.9 8.6 35.9 0.5 47.9 7.0 27.9 53.8 24.9 59.5 40.1 21.2 88.0 23.0 38.1 26.4 49.8 68.6 60.0 231.6 52.5 0.9 0.8 0.8 114.8 3.4 49.4 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.0 6.9 4.4 0.5 6.6 4.3 6.0 5.6 6.2 5.4 5.8 6.6 7.9 4.9 4.4 19.2 8.1 6.5 1.2 15.0 11.5 12.5 8.0 20.2 14.1 11.8 9.1 2.8 17.0 11.0 31.3 11.6 0.2 6.7 1.9 48.6 0.9 14.4 26.7 22.0 9.0 0.0 18.4 19.0 215.6 43.7 14.3 31.6 14.7 41.4 4.6 14.6 82.5 10.1 12.9 13.1 4.1 8.8 30.8 2.2 9.9 14.7 24.9 7.5 4.2 8.4 0.0 5.5 1.7 24.7 15.1 17.3 1.7 12.1 3.1 2.7 5.8 27.5 13.1 7.0 32.1 1.8 4.9 3.4 10.2 12.3 1.4 8.4 10.6 8.4 FAH ENSG00000103876 "Fumarylacetoacetate hydrolase" P16930 15 80152490-80186946 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 304.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 266.8;Proximal tubular cells: 305.5" "Cancer enhanced" "Detected in all" "liver cancer: 23.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 34.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041370, HPA044093" Enhanced Approved Nucleoplasm,Cytosol NA NA 220000000 Cytosol Nucleoplasm "HPA041370: AB_2677438, HPA044093: AB_2678806" "unprognostic (3.15e-1)" "unprognostic (5.65e-2)" "unprognostic (1.64e-1)" "unprognostic (6.16e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.19e-2)" "unprognostic (5.83e-2)" "unprognostic (2.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "unprognostic (2.93e-1)" "unprognostic (8.98e-2)" 100.0 66.0 13.9 7.1 14.2 20.2 59.5 14.8 21.3 18.4 12.9 13.9 14.7 19.4 50.8 15.4 23.2 9.8 19.0 14.2 15.7 65.7 304.0 20.2 5.8 15.6 16.2 12.2 26.6 10.0 18.5 16.9 7.8 14.8 16.8 12.0 1.7 14.9 13.7 31.3 10.7 17.0 13.6 14.8 19.3 14.3 21.0 15.1 6.8 14.7 28.0 5.9 16.6 15.9 15.5 20.1 34.4 13.5 17.0 60.2 62.2 32.9 24.3 56.8 26.2 22.3 22.0 35.9 0.4 39.0 52.6 36.8 29.1 46.8 59.6 25.1 12.5 28.5 166.6 18.0 112.1 316.6 79.6 88.8 107.5 37.1 22.9 39.7 84.2 37.4 38.3 71.1 35.7 50.3 31.0 22.3 42.0 9.9 15.5 37.6 12.2 19.3 123.4 77.0 25.2 0.7 8.3 27.4 76.7 77.9 21.6 58.3 55.0 126.1 46.8 30.0 25.5 42.7 32.7 69.5 13.8 99.6 187.5 26.9 34.5 18.8 3.3 9.6 8.1 2.3 0.1 2.4 6.0 25.3 0.1 3.1 2.7 1.3 5.7 8.4 1.9 2.5 9.7 13.9 14.2 14.8 21.3 14.2 15.7 15.6 16.2 12.2 14.8 14.8 15.1 15.5 3.0 3.2 13.8 9.8 4.1 6.8 17.5 30.8 15.4 0.4 19.1 13.7 15.5 21.5 12.5 33.1 0.0 37.9 4.9 9.3 52.8 9.3 7.5 3.0 16.2 3.2 4.2 24.4 0.4 3.5 14.1 16.6 3.6 4.0 41.9 6.3 8.9 266.8 72.5 0.0 2.5 13.0 24.4 21.4 6.6 13.5 9.9 30.5 19.6 1.0 5.7 7.3 3.1 2.5 0.6 4.5 12.8 7.9 5.2 9.7 54.1 305.5 5.3 0.4 0.0 9.2 11.2 1.5 2.1 18.2 5.7 22.0 7.7 8.7 22.4 16.4 CEMIP "HYBID, IR2155535, KIAA1199, TMEM2L" ENSG00000103888 "Cell migration inducing hyaluronidase 1" Q8WUJ3 15 80779343-80951776 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 32.5;endometrium 1: 32.2" "Group enriched" "Detected in some" 5 "Excitatory neurons: 62.5;Inhibitory neurons: 40.0;Microglial cells: 101.2" "Cancer enhanced" "Detected in all" "colorectal cancer: 21.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 204.1;BJ hTERT+: 321.8;fHDF/TERT166: 258.7;HSkMC: 169.3;hTERT-RPE1: 187.6;U-138 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 1700000 "unprognostic (1.14e-3)" "unprognostic (6.80e-2)" "unprognostic (5.95e-2)" "unprognostic (3.15e-3)" "unprognostic (3.49e-3)" "unprognostic (6.80e-2)" "unprognostic (5.47e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (1.36e-1)" "unprognostic (5.27e-10)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.65e-4)" 4.8 1.7 4.2 11.3 5.3 1.5 0.8 5.3 14.7 8.1 32.5 1.1 0.8 32.2 7.0 6.4 6.2 2.1 1.4 2.1 2.9 0.9 0.8 15.1 9.5 2.7 3.4 0.7 4.7 1.0 1.5 8.0 2.6 4.1 2.0 1.9 4.1 1.9 1.7 0.4 5.9 1.6 0.6 5.1 1.8 0.9 3.0 2.9 0.3 3.9 0.0 4.8 14.1 2.7 2.6 0.7 7.7 1.5 1.1 0.5 2.8 0.9 204.1 321.8 5.4 4.1 2.4 1.0 1.0 0.6 258.7 0.9 4.9 0.0 0.7 1.1 0.6 1.9 0.7 1.3 17.1 1.9 0.5 1.0 169.3 0.2 39.6 0.2 187.6 0.0 1.0 1.0 0.8 4.8 4.7 0.7 0.5 1.0 68.9 9.2 1.2 0.3 0.9 0.0 3.5 12.7 0.4 3.5 0.5 17.7 2.7 1.0 0.4 1.0 90.6 0.9 6.8 3.5 0.8 0.7 1.2 9.6 1.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.2 5.3 5.3 14.7 2.1 2.9 2.7 3.4 0.7 4.1 5.1 2.9 2.6 0.1 0.0 1.5 2.9 0.1 0.0 0.3 0.0 11.4 2.9 0.0 0.1 1.2 0.0 4.3 0.0 6.2 0.2 0.0 1.1 0.0 0.1 1.0 0.7 4.3 1.6 4.8 0.0 62.5 0.4 0.2 4.3 0.0 7.0 1.3 0.1 0.4 0.0 0.4 3.3 40.0 0.5 0.0 0.0 0.0 0.6 0.3 0.9 0.0 101.2 0.0 0.4 0.0 6.6 8.2 0.7 0.1 0.0 0.1 2.7 0.0 0.1 0.0 3.0 0.0 0.4 0.8 0.2 0.7 1.0 0.0 0.3 0.1 0.1 0.8 0.9 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041739: AB_2677647" "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (4.30e-3)" 7.1 5.7 4.6 6.2 4.7 3.6 5.1 4.0 4.9 5.2 2.8 6.5 5.8 6.4 3.2 8.2 6.7 4.0 6.6 4.6 3.8 4.1 5.0 4.7 7.3 4.6 4.6 4.0 8.0 5.9 7.3 3.9 6.0 4.9 6.2 4.7 2.8 7.0 5.7 19.1 7.0 5.2 6.7 4.3 6.6 6.2 6.6 4.3 7.0 5.3 11.7 6.9 7.0 5.4 5.5 13.3 15.3 20.8 21.9 17.1 12.3 17.7 12.8 11.0 16.4 15.8 42.3 11.7 10.3 20.6 14.2 26.1 30.5 37.9 18.7 13.8 18.3 18.5 19.6 21.2 18.8 10.7 16.3 11.9 12.6 23.3 19.2 13.3 11.0 18.4 23.1 46.4 11.5 15.2 8.3 17.6 10.0 36.9 20.3 14.3 31.4 18.0 11.2 7.2 30.5 19.0 25.4 16.4 16.9 8.8 18.0 28.1 20.0 16.9 25.3 16.4 25.5 20.6 19.2 57.5 11.6 18.1 17.4 24.4 0.0 1.9 0.0 4.6 2.4 4.0 2.9 2.6 2.8 2.9 3.3 3.7 3.4 0.0 3.1 4.4 1.9 3.1 2.5 4.6 4.7 4.0 4.9 4.6 3.8 4.6 4.6 4.0 4.9 4.3 4.3 5.5 4.1 3.2 5.4 10.4 7.7 2.8 4.4 4.6 8.6 10.2 5.1 5.2 9.0 2.8 4.7 5.5 12.5 6.5 6.1 3.9 1.9 5.5 1.5 3.7 6.5 5.8 2.4 11.2 7.7 5.3 5.8 6.1 8.6 5.2 2.5 11.9 5.0 9.6 4.8 16.8 6.7 5.6 6.1 5.2 2.8 1.7 3.7 3.5 1.8 6.5 6.0 5.0 5.2 7.5 9.3 5.3 2.7 9.4 4.4 6.7 4.1 3.0 5.2 7.4 0.0 6.5 4.6 10.6 9.5 6.1 4.1 2.7 7.0 10.8 7.5 3.1 HOMER2 "CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2" ENSG00000103942 "Homer scaffold protein 2" Q9NSB8 15 82836946-82986153 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 228.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 215.9;Endometrial ciliated cells: 184.4;Glandular and luminal cells: 151.9" "Cancer enhanced" "Detected in many" "prostate cancer: 15.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 52.7;Karpas-707: 92.6;SCLC-21H: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040134, CAB079014" Uncertain Supported Supported Cytosol NA NA Cytosol "CAB079014: , HPA040134: AB_10795272" "unprognostic (7.34e-2)" "unprognostic (3.58e-2)" "unprognostic (5.75e-4)" "unprognostic (3.31e-3)" "unprognostic (4.85e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-2)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (2.75e-1)" "unprognostic (8.16e-4)" "unprognostic (2.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.26e-1)" "unprognostic (4.45e-3)" 1.5 6.3 6.7 1.1 7.8 4.7 27.2 8.4 13.5 23.3 56.7 2.7 8.6 8.5 34.0 21.4 26.1 12.9 22.1 16.8 6.2 5.7 46.8 5.3 1.4 5.8 6.6 7.3 2.6 228.1 5.2 7.8 0.6 6.6 58.2 1.0 6.4 71.8 4.7 109.8 41.3 1.3 1.4 3.6 4.8 55.8 6.2 6.0 3.0 29.1 56.4 3.6 1.3 11.8 8.0 16.6 6.9 7.2 18.9 0.2 0.1 1.1 1.1 0.0 1.7 0.6 1.2 11.5 0.1 8.8 8.4 8.3 9.1 52.7 24.9 1.2 45.1 33.5 10.6 0.4 8.3 0.7 0.4 32.6 1.8 37.4 0.6 2.1 1.9 0.0 20.6 0.4 92.6 7.0 48.4 3.2 1.1 11.4 1.4 5.1 2.2 11.5 5.5 25.3 20.1 50.8 13.1 18.6 14.1 17.6 5.2 17.1 3.5 0.2 17.2 31.7 1.3 15.3 11.8 5.9 1.8 29.0 0.4 6.4 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.3 0.1 0.0 0.4 0.0 0.0 0.5 0.2 0.3 6.7 7.8 8.4 13.5 16.8 6.2 5.8 6.6 7.3 6.6 3.6 6.0 8.0 1.9 16.0 10.1 24.8 3.8 4.6 56.1 7.2 10.2 15.0 39.7 20.4 23.0 215.9 14.6 11.0 18.8 1.1 4.4 0.3 7.9 29.6 1.9 184.4 15.4 12.4 3.0 8.2 24.8 76.5 0.4 3.6 14.3 151.9 0.0 11.9 1.4 59.6 13.3 20.2 35.1 0.4 0.0 3.2 73.9 4.0 1.8 9.2 37.4 7.5 7.9 18.5 1.0 6.6 11.8 25.9 0.1 0.7 4.1 81.5 0.7 12.1 4.0 5.1 0.0 7.8 4.8 5.5 16.6 19.4 6.0 0.7 3.1 4.1 0.4 30.5 EHD4 PAST4 ENSG00000103966 "EH domain containing 4" Q9H223 15 41895933-41972557 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 189.5;Urothelial cells: 200.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 103.8;TIME: 172.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA052729, HPA066751" Approved Approved "Plasma membrane" NA NA 440000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713" "unprognostic (1.45e-1)" "unprognostic (1.37e-1)" "unprognostic (4.34e-3)" "unprognostic (3.36e-2)" "unprognostic (3.46e-2)" "unprognostic (4.48e-3)" "unprognostic (1.52e-1)" "unprognostic (3.36e-3)" "unprognostic (2.25e-1)" "unprognostic (3.74e-1)" "unprognostic (6.93e-2)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (3.19e-2)" "unprognostic (8.27e-2)" "unprognostic (2.72e-1)" 20.0 4.6 3.6 11.9 3.1 11.0 16.5 7.1 3.9 9.5 5.2 12.2 5.6 9.7 10.6 15.1 9.9 15.3 23.0 3.2 5.0 13.8 9.7 15.1 12.9 4.8 4.0 2.6 5.6 14.5 12.9 5.9 8.4 4.5 9.6 10.3 6.2 10.5 9.8 4.5 13.3 12.5 13.0 4.9 7.4 10.0 2.8 3.9 5.3 18.5 4.8 8.9 24.0 9.1 6.1 28.7 9.8 9.3 9.6 4.6 6.5 8.1 14.9 31.4 25.9 36.1 41.4 16.1 5.9 39.2 18.8 51.6 28.4 13.9 32.6 19.0 35.7 11.7 8.7 13.5 7.1 11.3 4.0 24.4 5.5 12.6 26.3 28.8 9.9 103.8 8.7 9.2 6.6 21.1 12.2 4.2 4.5 7.1 27.8 33.5 0.1 24.5 9.4 23.4 57.0 15.4 6.5 10.9 23.2 17.0 9.0 22.9 5.6 172.8 8.1 15.7 30.5 73.1 18.1 30.9 12.4 10.3 9.4 71.6 1.1 14.0 9.0 4.0 12.4 6.1 2.1 6.2 5.0 14.9 2.6 2.6 3.8 2.3 4.4 5.2 2.5 7.9 8.0 3.6 3.1 7.1 3.9 3.2 5.0 4.8 4.0 2.6 4.5 4.9 3.9 6.1 94.9 6.4 44.2 3.9 20.0 81.6 189.5 68.1 34.1 4.9 31.4 20.1 36.6 30.0 69.0 44.1 31.3 10.1 22.2 96.0 7.9 71.3 16.1 66.1 9.7 114.9 22.6 5.7 1.2 62.6 20.4 21.3 25.5 72.4 61.6 16.2 54.7 8.7 89.0 1.7 0.7 22.5 28.5 35.6 52.7 34.7 7.5 46.3 19.6 12.2 53.5 37.5 4.1 26.7 2.7 75.1 70.9 4.9 31.5 49.9 71.4 4.6 60.8 27.8 13.1 8.0 29.0 5.4 8.2 29.3 79.8 17.4 27.8 21.2 37.3 200.1 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210447-42273584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 32.1 26.5 24.5 26.4 38.0 89.0 98.6 33.0 30.1 40.6 20.1 57.0 26.8 39.0 49.7 48.6 45.7 32.7 19.9 25.1 32.7 27.3 24.7 73.5 25.7 36.0 32.0 20.5 35.7 35.2 48.3 14.3 43.1 38.0 80.5 61.4 26.3 65.2 36.9 25.1 50.7 27.1 38.3 37.6 23.3 39.0 33.3 30.9 25.1 76.5 22.4 31.2 42.4 34.6 61.0 41.0 20.5 30.5 27.0 58.5 50.3 47.7 55.1 82.0 53.5 52.0 29.8 87.5 17.4 52.9 59.9 60.5 104.0 28.3 51.2 42.8 46.8 25.0 35.6 51.5 33.5 63.4 65.6 48.3 52.3 112.1 39.5 65.3 50.6 41.9 30.1 39.4 67.4 51.7 26.3 21.3 38.8 25.7 60.8 29.3 33.5 46.6 36.8 34.5 127.4 33.7 41.2 53.1 70.1 49.9 24.0 27.4 62.4 41.3 104.4 25.5 68.1 82.6 46.8 95.0 36.5 40.1 47.9 66.8 58.3 26.9 31.2 29.0 32.3 33.3 27.6 35.6 34.0 24.4 24.4 33.6 33.5 15.2 42.4 34.7 22.4 42.2 26.0 24.5 38.0 33.0 30.1 25.1 32.7 36.0 32.0 20.5 38.0 37.6 30.9 61.0 66.2 125.0 264.0 46.0 48.9 68.6 90.2 78.8 58.1 31.2 148.7 105.9 13.9 45.8 98.0 49.7 50.1 78.1 57.5 77.7 1.9 63.7 5.6 57.0 67.0 54.6 32.2 34.5 41.7 64.2 72.7 64.0 50.0 124.7 59.5 42.9 51.0 34.4 41.6 20.2 48.2 74.1 67.1 39.2 37.0 7.9 41.0 41.3 62.2 45.0 60.1 61.8 52.5 74.4 177.5 56.1 62.4 53.8 47.6 118.5 36.6 15.5 86.4 63.0 85.5 77.0 59.0 59.4 61.4 79.1 65.5 110.4 54.8 53.3 76.9 105.6 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491141 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 396.2;tongue: 469.6" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1836.4" "Cancer enhanced" "Detected in all" "melanoma: 29.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 161.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 32.7 11.3 26.3 14.4 28.5 24.6 18.1 22.4 28.2 18.1 95.7 16.9 10.1 16.0 17.4 18.6 12.8 17.4 177.2 24.2 25.6 16.6 8.8 21.1 17.6 28.1 28.2 18.3 16.0 10.4 17.9 10.3 13.0 22.9 21.1 14.1 22.2 13.1 14.9 396.2 11.8 13.4 23.2 22.2 17.3 12.9 14.4 26.0 15.7 13.3 469.6 18.7 14.7 9.2 31.8 27.2 15.1 29.0 33.5 86.8 68.5 16.1 21.7 22.2 19.6 20.5 33.9 7.8 17.8 19.0 27.7 22.8 31.8 28.3 23.4 29.5 29.0 13.1 34.7 37.9 13.6 23.2 43.1 20.2 55.4 17.8 28.0 32.6 19.5 32.3 23.2 43.0 2.7 36.9 11.9 16.2 13.3 11.0 26.1 15.1 15.2 54.3 10.8 12.1 31.5 16.5 10.2 45.0 22.8 28.7 23.4 20.0 30.0 42.2 20.8 32.5 26.1 32.3 14.8 32.2 76.5 18.4 33.6 37.6 86.8 63.8 27.1 15.6 52.3 13.5 21.8 13.0 13.3 35.6 26.8 11.3 10.6 161.0 12.5 66.8 36.0 13.0 18.0 26.3 28.5 22.4 28.2 24.2 25.6 28.1 28.2 18.3 22.9 22.2 26.0 31.8 58.0 134.6 107.7 46.0 49.6 38.5 57.9 41.9 44.3 58.5 50.9 46.0 1836.4 62.9 57.0 29.5 95.9 37.9 67.2 31.7 41.1 43.2 197.2 75.2 67.1 69.9 40.2 50.5 73.3 42.4 39.3 141.7 31.1 37.5 44.9 49.5 62.8 40.1 53.5 35.3 62.9 32.6 32.6 132.7 43.4 105.2 37.6 89.8 65.8 47.8 124.3 53.6 66.9 31.2 34.2 65.7 26.9 92.6 50.7 74.8 39.7 41.5 161.1 79.9 46.0 151.2 70.0 62.3 38.1 49.8 29.8 30.6 46.0 85.9 36.6 68.2 CEP152 "KIAA0912, MCPH9, SCKL5" ENSG00000103995 "Centrosomal protein 152" O94986 15 48712928-48811146 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5" "Cell type enhanced" "Detected in many" "Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039408 Approved Supported Nucleoplasm,Centrosome NA Yes Centrosome Nucleoplasm "HPA039408: AB_10795288" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.61e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.87e-4)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" "unprognostic (1.04e-2)" "unprognostic (5.82e-2)" "unprognostic (4.70e-3)" "unprognostic (3.47e-2)" "unprognostic (6.24e-3)" "unprognostic (5.29e-2)" "unprognostic (3.55e-1)" "unprognostic (4.60e-2)" "unprognostic (1.25e-1)" 2.3 1.3 1.3 3.5 1.7 16.5 1.9 2.1 1.9 1.7 2.5 2.3 3.0 1.4 0.9 2.6 2.0 1.8 1.7 1.1 1.1 2.2 1.0 2.2 4.3 1.3 1.5 0.8 2.5 3.0 1.3 0.9 4.7 1.6 1.7 3.1 1.9 2.4 0.9 1.0 3.0 3.0 2.0 0.9 2.4 2.3 9.9 1.6 5.7 2.9 0.6 3.7 1.4 2.3 2.4 8.0 6.1 12.2 15.0 2.1 3.9 7.9 13.9 5.6 10.0 12.3 13.2 6.8 18.6 5.9 4.0 14.1 18.6 13.6 5.0 14.5 16.5 8.3 30.1 34.6 7.2 1.4 25.6 13.4 1.4 3.9 11.1 6.6 3.9 7.5 19.2 18.4 21.6 8.6 4.5 18.6 23.8 7.7 9.5 6.1 22.7 16.4 22.9 3.6 7.5 14.6 9.8 10.7 8.9 4.2 13.3 6.7 12.3 6.2 24.4 12.9 18.9 15.6 9.2 10.8 21.4 7.8 36.2 17.6 2.1 1.0 1.9 0.8 1.4 0.7 0.9 0.9 0.9 0.8 1.7 1.0 1.0 1.8 1.2 1.5 1.5 1.0 0.5 1.3 1.7 2.1 1.9 1.1 1.1 1.3 1.5 0.8 1.6 0.9 1.6 2.4 3.9 6.4 2.8 22.2 9.3 3.8 4.1 2.8 4.0 1.5 2.9 3.6 3.9 4.3 1.8 3.7 2.1 31.5 6.8 7.8 0.0 4.7 192.5 6.4 5.3 6.7 3.6 29.9 14.7 6.7 8.5 9.0 7.1 5.0 8.2 20.9 6.1 3.3 7.6 0.0 8.4 8.2 4.1 7.2 6.4 49.5 23.9 8.6 1.8 16.9 6.9 2.9 10.3 6.0 7.0 7.9 3.5 27.1 15.9 3.2 9.1 1.7 8.4 3.6 6.6 6.5 5.4 24.4 10.3 7.0 3.4 46.9 9.9 3.4 10.1 4.1 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "bone marrow: 78.8" "Cell type enriched" "Detected in many" 6 "Microglial cells: 248.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.2;NK-cell: 11.0" "Group enriched" "Detected in many" 5 "granulocytes: 15.2;NK-cells: 11.0" "Cell line enhanced" "Detected in some" "HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 1.4 1.1 2.2 2.5 2.3 78.8 0.7 3.5 6.7 1.0 2.4 1.1 0.7 6.5 4.2 0.5 3.1 2.2 0.4 4.6 2.2 1.2 1.6 1.1 1.0 2.1 2.2 1.5 0.4 0.5 0.2 0.3 3.6 2.5 0.6 1.7 0.1 0.6 0.9 0.1 0.3 1.3 3.2 3.5 2.6 0.6 0.4 1.5 0.5 0.1 0.1 1.0 1.4 0.4 4.3 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.5 0.5 0.2 0.0 0.2 12.2 0.0 7.3 1.7 0.1 0.0 13.6 40.2 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 19.2 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.1 1.2 0.0 0.0 0.1 0.0 26.7 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 1.3 103.7 0.0 15.2 2.0 3.8 0.4 1.2 0.1 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.8 11.0 0.4 0.0 0.0 0.9 2.2 2.3 3.5 6.7 4.6 2.2 2.1 2.2 1.5 2.5 3.5 1.5 4.3 1.7 0.0 1.9 1.6 0.8 1.5 0.1 0.2 0.6 0.6 0.2 0.6 1.3 0.0 0.1 0.0 0.0 5.4 12.5 0.3 0.0 0.0 27.6 0.3 1.7 1.0 0.0 12.2 20.3 0.0 1.8 8.1 3.1 0.2 19.7 0.0 1.1 3.7 16.4 0.0 17.5 0.3 2.0 37.0 17.7 25.3 1.8 27.0 1.8 248.3 6.3 0.5 15.5 1.0 2.1 0.0 0.1 0.7 4.8 2.3 0.7 1.2 0.7 0.2 0.0 1.0 7.0 0.5 0.6 0.6 0.3 2.9 13.4 1.1 0.2 0.3 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099315 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 23.3;skin 1: 6.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 30.9;Inhibitory neurons: 40.8;Melanocytes: 42.7;Peritubular cells: 14.7" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 24.6" "Low region specificity" "Detected in some" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.3 0.0 1.7 0.1 1.9 0.0 0.3 0.1 1.8 1.0 23.3 0.1 0.0 0.2 0.3 2.3 1.2 0.0 0.2 1.5 1.4 0.2 0.1 0.6 1.8 0.5 0.9 1.1 0.3 0.0 0.0 0.8 1.5 0.4 0.6 0.0 0.0 0.8 1.1 0.2 6.4 0.2 0.0 0.2 1.1 0.1 1.9 1.6 0.4 4.2 0.0 0.7 0.2 2.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 5.6 0.0 0.0 24.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 0.1 1.8 1.5 1.4 0.5 0.9 1.1 0.4 0.2 1.6 2.0 0.0 0.0 0.0 0.7 0.0 2.0 0.1 0.1 0.6 0.0 0.0 0.4 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.4 5.6 0.2 0.1 0.0 0.0 30.9 0.0 0.1 1.4 0.0 2.8 0.0 2.3 0.0 0.0 0.1 0.0 40.8 0.1 0.0 0.0 0.9 3.0 9.3 0.1 42.7 0.0 0.0 0.0 0.0 2.5 0.8 0.0 1.2 14.7 0.0 0.0 0.0 0.1 2.0 0.0 0.0 1.0 0.8 4.2 4.9 6.1 0.9 0.1 0.1 0.4 0.1 0.2 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49621037-49656232 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Vesicles" "HPA042214: AB_2677903" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 11.9 8.1 13.1 10.0 5.4 18.4 8.3 8.9 26.5 6.7 17.5 7.4 22.8 17.0 13.4 21.3 23.2 11.1 9.2 8.7 11.1 11.6 11.0 13.0 6.6 8.2 8.9 22.9 33.5 11.6 9.2 12.9 6.6 15.9 12.0 8.9 21.7 14.8 10.4 12.3 9.1 20.7 6.5 9.1 15.0 9.6 8.7 11.8 17.8 21.3 10.1 20.6 16.0 10.1 10.0 11.9 21.2 11.5 41.3 84.1 16.6 29.3 28.6 36.8 27.5 4.2 8.3 16.7 20.3 38.7 16.8 17.8 15.6 15.8 37.7 10.8 11.2 13.8 23.5 14.5 29.1 18.0 11.1 38.8 20.4 24.3 29.7 32.9 15.5 19.3 26.3 17.3 41.7 23.3 12.3 15.1 12.4 22.6 15.7 17.4 44.7 64.9 12.3 7.1 18.6 14.4 34.7 11.5 27.3 22.1 12.1 25.4 10.7 43.6 17.3 25.6 32.3 13.2 22.2 10.0 37.5 53.9 28.3 8.7 9.7 5.2 6.8 11.7 9.8 9.7 10.3 11.6 12.8 10.1 12.0 11.5 2.6 13.9 15.3 25.3 8.9 6.0 8.1 10.0 8.3 8.9 9.2 8.7 6.6 8.2 8.9 6.6 6.5 8.7 10.1 39.9 19.2 15.0 36.6 16.6 19.2 15.4 31.9 18.2 41.8 23.0 34.0 18.8 12.8 22.1 35.0 31.3 23.4 27.1 4.7 31.3 20.1 21.0 27.8 88.1 23.6 15.5 20.8 57.2 21.0 27.7 49.9 20.4 14.1 7.0 29.3 25.4 14.9 19.5 18.5 55.2 19.2 40.7 16.4 14.9 11.2 37.9 16.7 16.0 18.7 10.4 20.3 18.6 33.7 66.1 20.8 10.3 28.2 27.0 21.5 9.5 22.0 37.9 40.0 6.6 35.5 46.7 51.2 44.3 19.6 19.0 9.7 16.2 35.4 17.1 12.7 TGM5 "TGMX, TGX" ENSG00000104055 "Transglutaminase 5" O43548 15 43232590-43266928 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.1;skin 1: 38.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.6;Club cells: 4.3;Early spermatids: 3.2;Late spermatids: 4.0;Suprabasal keratinocytes: 6.7;Urothelial cells: 12.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HEL: 16.6" "Region enriched" "Detected in single" 12 "cerebellum: 2.6" "Low region specificity" "Detected in many" NA NA "unprognostic (3.17e-2)" "unprognostic (1.03e-2)" "unprognostic (5.92e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (1.44e-15)" "unprognostic (1.94e-1)" "unprognostic (3.14e-1)" "unprognostic (7.22e-3)" "unprognostic (5.71e-2)" 0.5 0.0 0.0 0.0 0.1 0.2 1.7 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.0 4.3 1.2 0.3 38.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.4 0.5 7.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.3 0.0 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 2.6 1.5 0.0 0.0 1.0 0.5 0.2 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.8 6.7 1.9 0.0 0.0 0.0 12.1 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 5.4;thyroid gland: 3.2" "Group enriched" "Detected in some" 5 "Excitatory neurons: 202.9;Inhibitory neurons: 198.0;Oligodendrocyte precursor cells: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.6;HDLM-2: 12.0;REH: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.3 0.4 2.5 0.0 2.0 0.0 0.1 0.1 2.8 0.2 0.5 2.2 0.1 0.2 0.0 0.0 1.0 0.0 0.4 2.5 0.8 2.0 0.1 1.1 0.0 0.9 0.4 1.2 0.2 5.4 0.4 0.4 0.0 2.7 0.4 0.5 0.1 0.6 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.4 2.0 1.1 0.0 3.2 0.0 0.1 0.9 0.2 1.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.1 12.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.0 0.1 2.8 2.5 0.8 0.9 0.4 1.2 2.7 0.0 1.1 1.2 0.5 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 4.3 0.8 0.0 0.0 0.4 3.0 0.0 202.9 0.2 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.1 0.0 198.0 2.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 29.0 0.0 0.2 0.0 59.8 8.1 0.2 2.6 1.5 0.0 1.0 2.2 0.8 0.0 0.4 0.0 0.0 0.2 0.6 1.7 0.0 0.0 0.0 0.0 1.0 3.2 0.4 GABPB1 "E4TF1-47, GABPB, GABPB2" ENSG00000104064 "GA binding protein transcription factor subunit beta 1" Q06547 15 50275389-50355408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019653, HPA067444" Supported Supported "Nucleoplasm,Cytoplasmic bodies" NA Yes Nucleoplasm "Cytoplasmic bodies" "HPA019653: AB_1849370, HPA067444: AB_2685842" "unprognostic (7.79e-3)" "unprognostic (2.42e-2)" "unprognostic (3.84e-1)" "unprognostic (1.92e-1)" "unprognostic (9.33e-2)" "unprognostic (3.99e-2)" "unprognostic (3.25e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-2)" "unprognostic (8.94e-3)" "unprognostic (1.23e-1)" "unprognostic (4.54e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.18e-2)" "unprognostic (2.37e-1)" "unprognostic (1.13e-1)" "unprognostic (3.93e-3)" 14.3 7.6 5.8 13.7 6.5 35.0 11.7 11.8 7.6 8.6 6.7 9.0 7.7 10.5 9.6 8.0 8.7 9.3 7.2 6.2 8.0 6.8 14.0 9.4 19.0 6.5 6.3 5.9 8.3 7.4 9.9 4.7 14.4 7.3 9.7 10.8 8.2 8.6 7.0 7.5 8.3 8.0 10.1 6.1 12.0 8.9 16.2 6.3 25.0 9.7 8.1 20.3 16.9 7.0 9.8 25.4 28.6 41.0 32.0 10.6 14.8 54.7 32.5 25.5 37.6 32.9 48.9 20.3 33.0 19.3 26.9 29.7 40.8 37.2 27.9 47.5 46.1 22.2 39.2 29.3 33.7 25.3 37.9 29.1 19.7 26.8 35.3 45.6 21.0 66.9 35.6 36.6 40.4 25.4 58.1 56.5 34.1 28.2 27.8 19.2 68.6 29.8 31.7 22.9 31.7 38.9 32.0 29.0 27.0 33.4 38.9 23.5 37.1 32.1 34.2 28.3 60.4 58.9 28.6 42.0 57.8 21.1 34.5 35.2 44.5 16.2 32.7 19.8 20.1 26.5 31.6 19.4 21.4 22.4 26.4 17.7 20.5 16.1 27.3 15.7 17.7 27.9 20.2 5.8 6.5 11.8 7.6 6.2 8.0 6.5 6.3 5.9 7.3 6.1 6.3 9.8 18.2 9.6 11.2 10.7 80.0 47.2 126.7 15.1 23.9 43.1 10.1 9.4 17.7 24.3 7.2 7.3 35.5 43.2 47.3 11.4 3.9 12.2 79.5 8.3 11.9 38.0 50.4 38.7 13.9 7.6 50.5 33.2 23.9 10.9 47.0 8.6 41.7 30.6 37.0 37.0 12.3 24.9 12.2 73.4 22.3 33.3 57.8 42.2 19.6 15.9 54.0 32.4 120.5 22.1 19.1 14.6 21.6 38.4 58.7 89.3 21.4 8.4 8.7 45.8 26.3 64.0 32.5 28.9 34.0 32.7 35.8 55.4 77.2 6.7 27.8 116.6 TJP1 "DKFZp686M05161, MGC133289, ZO-1" ENSG00000104067 "Tight junction protein 1" Q07157 15 29699367-29968915 "Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 893.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001636, HPA001637, CAB010822" Enhanced Enhanced "Cell Junctions" NA NA "Cell Junctions" "CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760" "unprognostic (2.11e-2)" "unprognostic (6.83e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-2)" "unprognostic (9.43e-2)" "unprognostic (1.21e-1)" "unprognostic (4.54e-2)" "unprognostic (6.71e-3)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.86e-3)" "unprognostic (3.54e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.85e-3)" "unprognostic (3.02e-1)" "unprognostic (5.04e-2)" "unprognostic (1.20e-1)" 35.9 16.7 21.3 4.5 35.0 1.1 31.1 22.1 24.3 29.4 19.2 27.1 7.2 42.6 16.6 60.9 28.0 12.7 33.7 21.6 21.8 24.3 18.7 34.3 5.7 29.9 29.4 14.3 22.5 30.2 13.5 16.9 31.9 32.2 20.6 9.6 10.1 29.9 11.0 22.2 26.6 19.9 17.5 23.4 13.6 26.0 29.9 26.5 3.7 25.0 5.0 10.2 24.0 35.6 44.0 62.4 36.8 29.1 18.4 17.0 31.7 28.9 18.6 21.1 18.0 20.2 59.2 22.9 0.3 24.8 24.6 21.3 47.4 20.1 23.8 19.0 0.5 14.9 0.3 22.3 24.7 57.9 0.1 0.8 16.5 15.8 21.4 39.2 23.0 38.2 0.1 24.3 12.5 14.2 32.2 0.2 0.7 21.9 23.4 14.6 0.1 35.0 0.2 28.1 33.4 12.9 16.8 39.2 12.8 16.8 42.9 13.3 0.6 54.7 14.3 23.9 12.5 25.6 4.4 4.6 0.4 17.8 0.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 35.0 22.1 24.3 21.6 21.8 29.9 29.4 14.3 32.2 23.4 26.5 44.0 212.1 169.9 49.2 299.7 1.6 35.8 115.2 36.4 39.3 42.4 53.7 28.6 107.2 51.5 48.6 58.8 10.4 32.3 0.8 87.7 25.4 116.0 19.1 132.2 97.0 166.0 46.0 2.7 293.8 83.7 11.3 56.6 86.6 290.7 5.7 87.7 100.3 49.1 3.8 126.2 187.3 45.4 32.6 6.1 12.1 13.7 33.8 5.2 64.0 266.1 1.6 32.8 0.0 345.3 893.8 178.3 82.0 63.9 5.9 151.4 37.8 26.0 39.2 52.4 78.9 64.1 118.7 63.0 83.9 139.2 60.1 33.7 4.1 120.8 33.1 194.6 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.7" "Cell type enhanced" "Detected in many" "Ductal cells: 14.9;Exocrine glandular cells: 15.1;Kupffer cells: 18.7;Langerhans cells: 12.8;monocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 43.3;HMC-1: 44.2;hTERT-RPE1: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.83e-4)" "prognostic unfavorable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 3.7 2.9 1.7 12.7 2.4 33.3 5.8 2.3 7.5 8.2 3.9 10.2 21.4 16.0 7.3 2.9 12.0 12.3 5.3 1.3 5.3 6.4 3.4 12.9 13.8 4.0 2.5 0.8 14.3 7.8 6.0 2.7 6.5 3.7 6.1 8.5 3.0 10.5 4.8 5.1 5.4 23.8 10.1 3.3 19.1 10.2 2.1 3.0 76.7 17.2 5.4 23.7 7.5 3.8 5.4 1.0 1.4 22.9 5.1 0.6 0.9 15.5 0.1 3.6 0.4 1.1 23.6 1.7 6.8 7.3 1.0 7.0 4.9 5.7 0.1 0.1 16.0 4.7 3.5 43.3 5.5 2.1 0.6 44.2 11.3 1.3 0.4 0.4 57.0 6.0 5.0 1.9 2.9 2.0 1.3 2.3 17.6 6.2 11.8 0.8 4.3 5.2 20.4 1.0 5.4 12.1 9.8 4.4 11.6 10.6 24.3 6.9 13.8 4.6 0.8 3.1 0.7 0.3 28.1 28.4 4.3 1.6 3.3 2.7 0.0 2.6 2.4 0.1 2.9 0.2 2.9 0.2 0.8 1.6 0.9 0.4 0.0 3.2 0.0 4.0 2.0 0.7 0.7 1.7 2.4 2.3 7.5 1.3 5.3 4.0 2.5 0.8 3.7 3.3 3.0 5.4 2.3 3.2 2.2 0.3 7.3 1.1 0.9 1.0 1.2 0.2 2.1 1.3 1.6 4.3 5.0 0.0 0.0 1.4 0.7 7.9 0.0 14.9 1.3 5.9 1.2 3.8 1.2 3.2 0.1 15.1 1.3 2.3 1.5 8.5 0.0 0.8 1.4 1.0 8.4 0.0 0.8 1.1 6.1 18.7 12.8 0.5 1.8 8.8 0.0 3.7 14.2 0.3 0.0 0.5 0.5 10.9 1.2 0.7 7.0 1.7 9.6 2.4 1.0 0.8 0.0 1.3 1.3 0.4 1.4 0.9 0.6 1.8 3.5 0.2 1.2 1.0 DMXL2 "DFNA71, KIAA0856, RC3" ENSG00000104093 "Dmx like 2" Q8TDJ6 15 51447711-51622833 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7" "Group enriched" "Detected in many" 4 "granulocytes: 2.2;monocytes: 2.8" "Cell line enhanced" "Detected in many" "U-937: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039375 Approved NA NA "HPA039375: AB_10673610" "unprognostic (5.66e-2)" "unprognostic (9.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-2)" "unprognostic (8.38e-2)" "unprognostic (3.39e-1)" "unprognostic (2.32e-1)" "unprognostic (3.67e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.09e-1)" "unprognostic (1.67e-1)" "unprognostic (8.60e-3)" "unprognostic (2.70e-2)" 5.2 4.7 2.1 11.2 4.3 17.3 3.4 3.7 5.9 4.2 5.9 6.1 9.3 4.5 14.1 1.9 5.2 4.5 2.6 8.1 4.5 5.8 4.6 6.9 4.8 1.9 2.0 2.6 4.2 5.4 8.0 8.5 7.3 2.5 2.8 7.5 16.5 5.4 2.6 1.1 1.6 7.2 5.4 0.0 6.5 5.3 9.1 3.0 4.8 4.3 1.7 2.7 6.0 2.8 4.2 9.1 11.7 12.6 7.3 5.3 9.1 3.1 6.9 7.5 6.5 8.5 1.7 4.4 0.0 3.3 4.1 12.5 4.8 8.1 4.8 8.7 10.6 3.9 3.6 10.6 2.1 4.9 20.6 5.8 4.2 3.9 8.4 3.7 6.8 4.5 10.9 8.3 0.8 6.7 10.0 8.9 19.2 9.2 4.3 3.8 7.9 10.3 13.5 3.4 18.1 18.0 7.8 7.3 4.1 8.5 11.0 6.9 21.9 5.7 7.8 5.3 11.0 8.2 16.0 25.2 0.0 9.2 44.0 7.4 0.0 2.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 2.7 0.3 0.0 0.4 2.1 4.3 3.7 5.9 8.1 4.5 1.9 2.0 2.6 2.5 0.0 3.0 4.2 5.2 3.2 15.7 68.6 2.1 3.1 2.5 4.1 4.6 41.4 4.9 2.0 8.4 1.5 6.7 7.3 64.6 5.7 13.1 22.7 1.9 3.0 2.5 11.6 18.9 5.4 28.1 0.8 138.9 3.8 4.9 8.7 28.5 5.5 10.8 10.6 5.7 6.0 36.5 58.9 122.9 13.3 2.0 96.1 16.4 3.5 6.5 106.3 3.6 50.6 84.9 8.6 1.0 96.5 50.7 5.2 17.4 9.1 2.1 2.5 24.9 8.1 18.7 31.9 6.6 8.1 8.7 37.2 30.3 2.8 1.7 3.8 3.6 9.1 15.9 2.7 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681492-51721026 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 134.6;pituitary gland: 39.7;retina: 57.3" "Group enriched" "Detected in many" 4 "Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" NA NA 3100000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239" "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 0.5 16.8 61.5 1.1 78.8 0.6 0.5 78.5 134.6 0.1 35.0 1.6 2.3 0.2 0.3 0.3 0.3 0.3 0.2 77.5 88.8 0.2 0.2 0.7 0.4 57.7 58.3 66.7 0.1 15.7 0.2 39.7 0.1 66.3 0.3 2.0 57.3 0.2 0.0 0.1 0.6 2.0 0.5 59.1 0.2 10.0 2.6 66.0 0.5 1.1 0.0 0.2 0.2 0.2 67.0 0.2 0.1 4.8 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.3 0.5 0.0 0.6 0.4 0.1 0.0 0.1 0.1 0.5 0.1 0.3 0.1 0.0 0.3 3.0 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.8 0.0 0.3 0.1 0.1 50.5 0.1 0.2 0.3 0.1 0.4 0.0 0.5 121.2 57.5 0.2 0.4 0.2 15.5 0.1 3.8 0.1 0.3 0.7 0.2 0.2 0.4 0.2 0.4 0.7 0.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 61.5 78.8 78.5 134.6 77.5 88.8 57.7 58.3 66.7 66.3 59.1 66.0 67.0 0.2 0.0 0.0 79.3 0.0 0.3 0.0 0.3 0.0 120.4 0.0 0.1 0.2 0.0 0.1 0.0 102.2 0.0 0.0 0.2 1.9 0.4 20.0 0.0 0.0 4.3 148.4 0.0 46.2 1.0 0.1 4.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 148.0 64.0 3.4 38.7 0.0 0.3 11.3 0.0 0.1 1.8 7.5 6.7 19.2 0.0 63.3 8.9 5.3 0.0 0.4 0.0 0.4 0.1 0.0 0.8 93.3 0.0 0.4 0.2 13.8 5.8 0.0 0.0 0.0 0.0 0.2 0.3 0.3 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765161-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 12.6 11.2 6.6 10.0 6.2 6.3 13.5 8.7 9.4 12.4 4.2 14.0 8.3 14.8 9.6 12.7 14.4 10.2 8.9 6.1 5.9 10.9 14.9 11.2 13.8 6.3 6.2 6.2 17.3 9.9 16.9 9.0 14.0 7.1 9.8 11.5 5.4 9.3 11.3 8.1 12.2 10.9 12.8 5.4 12.3 10.7 4.6 6.2 16.3 11.9 11.3 16.9 11.0 10.8 6.8 10.8 9.6 23.8 23.1 10.5 26.2 10.1 19.9 19.5 32.7 26.7 7.7 15.1 16.6 21.5 23.9 15.0 22.2 24.4 32.6 28.9 30.8 15.3 28.1 19.2 7.6 29.8 14.7 24.0 26.2 20.6 25.8 46.2 18.2 30.5 28.0 20.0 8.6 25.3 13.6 21.5 19.7 8.6 25.3 14.1 15.7 19.8 8.6 33.2 19.5 15.0 9.6 14.4 13.4 10.2 16.8 17.0 29.1 30.0 18.5 16.0 21.0 17.1 9.6 31.0 36.5 11.9 37.1 15.9 30.0 21.5 28.9 24.5 28.6 17.6 19.8 21.2 23.7 24.3 19.4 22.4 21.8 7.9 13.3 17.0 19.8 39.2 14.1 6.6 6.2 8.7 9.4 6.1 5.9 6.3 6.2 6.2 7.1 5.4 6.2 6.8 26.6 12.8 16.4 9.4 16.5 5.6 19.2 40.6 8.6 15.0 24.3 14.7 5.8 22.8 33.2 25.8 12.5 25.1 15.5 17.5 19.6 18.9 3.2 13.4 15.8 16.2 7.8 9.4 13.0 17.5 15.8 14.7 12.8 16.9 22.1 13.6 19.6 14.4 22.5 13.5 15.0 16.1 20.3 10.3 10.6 2.0 15.2 13.1 7.2 12.2 13.0 8.5 36.0 11.6 16.1 16.9 24.6 16.1 9.9 12.8 30.6 27.2 20.2 10.4 0.0 14.5 22.6 5.6 4.7 16.3 5.3 17.2 16.7 16.6 16.9 20.6 EIF3J "eIF3-alpha, eIF3-p35, EIF3S1" ENSG00000104131 "Eukaryotic translation initiation factor 3 subunit J" O75822 15 44537125-44563029 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 211.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050977 Approved Approved Cytosol NA NA 280000 Cytosol "HPA050977: AB_2681297" "unprognostic (4.47e-2)" "unprognostic (1.28e-1)" "unprognostic (7.68e-2)" "unprognostic (3.76e-2)" "unprognostic (1.72e-3)" "unprognostic (1.47e-3)" "unprognostic (2.33e-2)" "unprognostic (1.41e-2)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "unprognostic (3.43e-3)" "unprognostic (1.39e-2)" "unprognostic (1.97e-1)" "unprognostic (4.76e-1)" "prognostic unfavorable (4.96e-5)" 48.6 34.6 40.5 41.1 41.6 39.1 40.3 41.5 52.2 25.5 36.5 36.6 36.5 27.1 31.1 49.2 22.2 26.4 35.5 40.4 42.7 41.3 59.2 26.0 39.3 44.8 43.0 37.9 22.5 66.0 35.2 23.1 45.2 47.0 32.6 37.5 21.4 56.7 30.1 211.6 37.4 31.7 35.8 42.0 30.7 35.6 31.9 44.8 34.3 36.2 104.9 50.3 50.1 31.8 49.1 103.5 55.7 88.4 55.5 60.7 60.0 113.1 161.0 46.9 108.5 72.9 165.6 59.6 96.0 184.6 67.1 102.5 192.3 137.7 99.5 129.5 114.5 79.8 222.5 129.4 108.6 115.1 239.2 98.4 54.6 130.7 72.8 141.6 65.1 117.2 111.1 294.9 119.8 97.8 73.1 124.0 160.8 55.4 190.5 92.9 141.2 145.4 146.1 122.4 118.0 118.4 74.9 150.6 137.1 89.7 69.3 118.0 196.6 140.3 117.6 140.7 127.9 216.4 145.5 302.4 244.8 80.9 249.0 114.0 64.3 40.3 40.7 35.6 41.6 40.8 59.2 45.9 43.7 46.8 53.4 44.1 47.5 18.3 60.4 40.7 76.7 52.9 13.1 40.5 41.6 41.5 52.2 40.4 42.7 44.8 43.0 37.9 47.0 42.0 44.8 49.1 92.8 60.9 54.6 16.3 93.1 175.1 112.6 86.5 49.5 56.2 174.6 114.2 95.2 108.7 79.7 145.3 20.9 148.7 122.8 148.0 193.7 145.2 149.7 118.6 141.0 92.2 117.3 139.5 22.0 149.6 170.8 69.2 50.0 175.5 127.4 73.1 99.2 404.3 110.7 43.7 24.1 172.9 61.1 98.7 106.6 103.4 91.0 78.5 60.5 18.7 108.5 50.1 109.2 16.6 27.4 152.3 118.6 71.1 91.9 119.0 94.9 266.4 43.1 66.8 46.0 74.1 94.3 205.4 153.4 70.6 172.0 247.1 88.5 54.7 180.6 102.8 SPG11 "ALS5, FLJ21439, KIAA1840" ENSG00000104133 "SPG11 vesicle trafficking associated, spatacsin" Q96JI7 15 44562696-44663678 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 20.8 27.3 16.6 18.4 24.2 27.6 21.8 23.3 21.4 21.3 22.9 23.5 17.3 18.0 25.5 25.8 20.3 16.2 23.4 16.6 22.4 23.0 30.0 25.0 28.6 21.4 21.2 15.8 21.5 28.8 26.9 21.5 15.0 23.3 25.5 20.0 30.8 24.9 15.1 23.1 30.7 30.4 12.8 18.8 43.3 26.2 25.7 21.6 23.9 31.1 14.4 18.8 24.0 22.8 32.7 13.2 8.8 21.9 21.6 33.7 33.0 15.8 13.4 17.4 13.0 16.6 10.8 12.5 9.7 16.5 18.2 22.5 29.0 15.1 20.8 12.5 29.3 9.0 22.1 21.1 16.4 23.7 22.2 19.2 25.3 23.3 10.7 30.5 20.4 18.6 16.6 28.8 24.2 18.6 11.5 10.1 19.7 11.5 40.3 11.6 12.9 18.5 10.6 28.0 33.6 14.2 16.8 14.6 23.3 13.1 18.0 22.0 30.2 19.9 17.1 8.5 21.4 16.5 23.8 22.6 19.2 17.6 28.8 17.9 5.7 7.7 11.8 6.5 9.2 6.9 10.0 5.4 4.9 6.2 11.3 4.3 5.3 11.6 6.2 12.4 6.3 6.1 3.7 16.6 24.2 23.3 21.4 16.6 22.4 21.4 21.2 15.8 23.3 18.8 21.6 32.7 21.0 44.8 22.2 56.2 40.4 9.3 15.6 18.8 14.2 25.1 19.0 12.6 20.1 18.6 31.3 27.6 47.9 16.5 30.1 29.3 5.9 21.3 28.2 31.7 23.2 17.6 20.0 22.3 62.9 16.9 10.1 19.3 37.2 33.6 27.3 31.9 21.8 23.5 20.1 16.8 68.1 31.2 26.4 43.3 23.5 33.2 17.7 40.4 14.2 74.9 88.1 14.0 50.4 68.3 121.4 17.7 24.0 13.9 21.4 19.3 30.8 14.9 53.6 21.7 6.6 24.8 16.3 51.7 31.6 20.1 11.1 9.3 29.5 24.4 27.3 22.2 RHOV "ARHV, Chp, WRCH2" ENSG00000104140 "Ras homolog family member V" Q96L33 15 40872214-40874234 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 213.5;skin 1: 126.8;vagina: 93.0" "Cell type enhanced" "Detected in many" "Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1" "Cancer enhanced" "Detected in many" "cervical cancer: 91.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 328.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053343 Enhanced NA NA "HPA053343: AB_2682122" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (8.29e-3)" "unprognostic (4.34e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (3.29e-3)" "unprognostic (1.05e-1)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (8.43e-3)" "unprognostic (5.63e-3)" 0.4 0.1 1.1 0.2 1.2 0.2 16.1 1.3 1.8 13.1 0.8 2.3 0.6 0.8 9.6 213.5 2.7 0.6 0.1 1.2 1.4 3.3 0.2 2.4 0.2 2.2 1.4 1.4 0.3 16.5 2.2 3.0 3.2 2.7 16.8 2.7 0.0 44.6 2.4 0.2 126.8 0.6 0.1 1.0 0.1 1.2 0.3 1.7 2.7 0.5 0.0 23.5 20.9 93.0 2.2 1.6 9.7 0.1 2.7 0.2 0.0 5.2 0.1 0.8 0.4 0.2 4.0 4.4 0.0 2.4 0.0 0.3 77.9 4.5 0.6 0.2 10.5 12.5 0.5 11.3 0.6 0.0 0.5 0.0 0.3 6.0 0.3 0.1 0.4 0.1 2.3 2.1 0.5 0.0 27.2 0.6 2.3 1.7 19.3 3.7 4.0 0.4 1.8 5.1 34.3 4.0 0.8 8.0 328.9 0.2 0.5 40.9 0.3 0.1 0.0 1.1 0.2 0.3 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.3 1.8 1.2 1.4 2.2 1.4 1.4 2.7 1.0 1.7 2.2 0.6 0.0 3.2 0.3 0.5 84.1 42.5 80.9 19.9 0.0 75.2 48.5 0.9 2.8 103.0 29.5 0.0 60.7 1.9 43.1 13.7 107.5 0.0 18.5 1.9 2.5 22.7 0.0 1.5 56.2 6.0 2.0 7.1 25.5 1.3 0.4 0.0 0.0 4.6 0.0 0.5 54.7 67.1 0.0 13.3 0.0 0.0 0.8 32.0 0.0 3.6 0.0 0.0 0.0 0.3 13.8 142.3 0.7 0.1 89.8 1.0 0.9 26.2 0.0 0.0 0.2 7.3 0.0 0.9 375.0 283.0 42.4 1.9 0.0 66.3 275.1 VPS18 "KIAA1475, PEP3" ENSG00000104142 "VPS18 core subunit of CORVET and HOPS complexes" Q9P253 15 40894450-40903975 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040701 Approved NA NA "HPA040701: AB_10794145" "unprognostic (1.81e-1)" "unprognostic (4.53e-1)" "unprognostic (9.69e-3)" "unprognostic (1.55e-2)" "unprognostic (1.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.62e-3)" "unprognostic (1.60e-1)" "unprognostic (9.69e-3)" "unprognostic (2.12e-2)" "prognostic favorable (8.69e-4)" "unprognostic (1.39e-1)" "prognostic favorable (1.61e-6)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (6.73e-2)" "unprognostic (1.06e-2)" 8.7 11.9 9.1 7.4 9.7 21.4 7.4 11.6 10.4 6.9 7.6 9.1 6.8 11.4 8.7 9.3 8.4 7.8 11.3 9.6 10.4 9.9 10.8 9.1 8.8 11.2 10.5 9.3 7.6 6.0 11.3 9.7 6.2 12.0 8.7 4.1 3.9 8.4 8.4 13.1 9.1 9.1 8.3 9.9 12.0 9.7 6.2 12.0 7.5 8.0 9.5 7.3 9.9 6.2 12.1 9.9 23.1 11.1 19.1 35.5 15.1 15.2 20.3 29.4 24.5 29.9 29.5 5.9 5.3 19.0 24.3 31.1 25.7 23.4 23.0 10.3 12.2 15.8 23.5 22.2 17.0 31.3 19.8 30.2 26.2 11.9 24.6 13.6 11.5 26.0 11.8 16.5 13.1 20.9 13.0 13.4 21.8 14.7 10.1 15.7 27.1 12.6 9.9 20.0 52.3 12.8 12.8 14.6 28.4 13.7 13.5 17.7 22.0 25.8 24.8 12.9 25.0 13.4 13.0 20.9 14.4 27.2 21.5 12.5 7.3 10.9 13.1 10.1 7.4 8.3 8.3 5.2 7.8 11.1 5.8 5.4 5.8 12.0 7.8 10.6 4.8 9.8 9.0 9.1 9.7 11.6 10.4 9.6 10.4 11.2 10.5 9.3 12.0 9.9 12.0 12.1 3.3 3.2 7.2 2.0 7.5 2.4 2.3 7.7 4.0 9.0 4.2 2.3 6.7 5.7 10.4 7.3 6.2 7.1 11.0 12.0 3.9 16.7 1.1 6.8 3.7 6.9 11.9 1.3 4.0 7.7 4.6 5.0 12.2 8.2 7.0 8.1 7.5 10.8 21.4 6.7 4.1 6.4 10.2 10.9 6.6 1.8 7.2 9.5 8.8 2.8 13.2 6.8 12.3 1.5 3.1 11.5 5.9 9.8 4.0 3.2 10.3 11.4 5.4 7.1 6.6 4.1 4.5 5.8 6.2 8.0 2.0 10.8 6.9 7.5 5.8 5.8 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309273-41332591 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.4;skeletal muscle: 10.4;testis: 21.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 0.6 1.7 0.1 3.3 0.2 10.4 1.3 1.2 0.4 0.6 0.2 4.2 3.6 0.8 0.3 3.9 0.4 0.6 1.5 0.2 0.4 0.3 1.2 0.5 5.8 0.2 0.4 0.1 1.5 0.3 0.1 0.1 2.3 0.4 0.5 3.9 0.7 0.9 0.6 10.4 3.3 4.0 1.1 0.2 1.7 1.5 21.1 0.2 9.2 0.4 0.8 5.3 0.7 1.3 0.5 33.7 17.8 34.3 24.9 1.7 2.1 32.4 20.0 9.3 24.5 26.1 31.8 16.2 19.8 17.0 7.7 37.8 51.0 35.7 16.1 19.2 42.4 40.1 42.4 49.8 33.6 0.4 46.5 22.1 0.7 3.2 13.8 14.5 5.2 21.1 40.8 59.4 37.3 16.5 16.3 27.1 34.8 30.9 50.4 37.9 32.9 28.4 30.5 11.1 15.4 53.7 17.5 33.7 34.3 9.6 13.7 33.7 26.3 10.0 24.5 37.3 24.6 36.6 17.0 83.2 71.1 7.1 56.5 35.9 0.0 0.4 0.5 0.2 0.7 0.8 1.0 0.7 0.8 0.7 1.2 1.3 0.8 0.0 1.2 0.4 4.1 3.1 0.8 0.1 0.2 1.2 0.4 0.2 0.4 0.2 0.4 0.1 0.4 0.2 0.2 0.5 0.2 0.0 0.5 1.0 2.7 4.1 0.9 3.6 1.2 0.0 1.1 2.2 0.2 0.0 1.8 0.0 0.0 15.0 1.7 2.3 0.0 0.4 12.0 1.9 0.6 0.9 0.0 45.9 2.2 0.4 24.0 1.7 5.1 1.1 1.3 5.2 0.0 0.8 7.5 0.0 2.1 3.0 8.2 2.2 1.8 10.8 0.9 1.2 0.0 0.0 0.6 1.1 2.1 1.5 2.5 0.2 0.5 1.2 10.9 0.4 0.9 0.3 0.0 0.3 6.6 1.0 1.1 110.6 56.8 8.3 2.4 3.8 1.2 2.1 7.6 0.9 SLC30A4 ZNT4 ENSG00000104154 "Solute carrier family 30 member 4" O14863 15 45479606-45522755 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 40.2" "Cell type enhanced" "Detected in many" "Early spermatids: 76.3;Late spermatids: 78.5;Prostatic glandular cells: 39.2;Spermatocytes: 52.1" "Cancer enriched" "Detected in all" 20 "prostate cancer: 34.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-1)" "unprognostic (9.49e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (9.74e-2)" "unprognostic (7.38e-3)" "unprognostic (1.51e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.66e-2)" "unprognostic (4.72e-3)" "unprognostic (1.29e-2)" "unprognostic (9.83e-2)" "unprognostic (8.28e-3)" "unprognostic (2.01e-3)" 2.8 1.8 2.9 1.9 8.3 0.8 1.9 3.5 4.5 2.4 1.8 3.3 7.0 2.9 2.8 4.2 2.0 2.0 2.0 3.0 3.0 4.2 2.6 1.8 2.8 3.2 3.2 3.7 2.5 1.9 4.2 1.5 3.4 3.6 40.2 3.1 3.8 1.4 2.2 1.7 2.5 8.6 3.4 2.3 3.1 2.0 6.4 3.9 1.0 4.8 1.9 3.4 1.8 2.6 7.7 1.8 2.1 0.6 4.7 8.3 5.8 0.4 4.5 4.1 2.7 3.8 0.3 1.5 6.9 1.5 4.7 1.1 1.2 2.0 2.1 2.5 1.7 1.8 0.1 2.0 0.1 5.3 0.1 3.5 4.9 3.4 3.6 0.9 4.2 3.2 3.2 1.0 3.8 5.1 0.8 2.4 0.3 0.1 0.4 0.4 3.6 4.0 1.1 2.2 0.4 1.5 2.3 3.0 3.4 0.8 0.6 2.9 0.2 6.1 4.0 2.3 4.9 1.5 7.0 5.5 1.7 1.7 0.2 3.1 1.3 0.1 0.1 2.2 0.1 2.1 2.0 1.5 1.3 0.2 3.5 1.5 2.1 0.5 1.3 0.1 0.2 0.2 0.7 2.9 8.3 3.5 4.5 3.0 3.0 3.2 3.2 3.7 3.6 2.3 3.9 7.7 6.7 3.2 3.9 5.5 6.6 6.8 2.2 1.1 6.8 3.2 2.8 2.2 3.1 0.0 0.1 1.8 16.7 1.0 3.9 15.2 0.0 1.3 76.3 5.0 8.4 6.9 1.2 0.4 14.0 1.1 0.9 7.5 4.6 12.7 1.3 1.9 11.0 3.3 3.1 13.5 9.4 7.1 0.0 1.6 30.8 78.5 6.2 4.4 7.2 9.4 5.3 4.3 10.3 6.0 28.8 0.7 22.0 8.2 6.0 39.2 32.4 12.5 0.7 2.2 6.6 6.2 5.2 52.1 19.9 7.4 6.5 0.3 5.4 3.6 5.1 1.7 BLOC1S6 "HPS9, PA, PLDN" ENSG00000104164 "Biogenesis of lysosomal organelles complex 1 subunit 6" Q9UL45 15 45587214-45615945 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 230.8;Alveolar cells type 2: 292.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039928 Approved NA NA "HPA039928: AB_10673538" "unprognostic (6.90e-2)" "unprognostic (3.38e-1)" "unprognostic (7.73e-2)" "unprognostic (2.32e-2)" "unprognostic (9.92e-3)" "unprognostic (1.51e-1)" "unprognostic (8.52e-3)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (4.34e-2)" "unprognostic (4.72e-2)" "unprognostic (1.14e-1)" "unprognostic (6.44e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (5.13e-2)" "unprognostic (2.50e-2)" 30.3 31.5 16.7 31.4 18.9 58.7 25.7 17.5 19.2 26.0 15.4 21.4 20.4 31.0 18.5 21.2 18.3 26.7 25.3 18.0 22.7 24.4 27.1 20.6 42.2 17.6 18.3 16.7 38.1 20.6 17.0 19.2 26.5 17.5 36.7 21.7 24.8 20.9 20.6 23.8 18.3 21.5 24.5 15.7 28.2 20.3 17.1 19.8 25.4 44.8 23.4 35.7 28.8 15.7 18.6 31.5 15.9 38.9 46.2 70.1 57.0 22.2 59.0 58.4 28.5 30.4 37.6 15.9 78.1 36.2 47.5 42.6 27.6 41.7 43.2 36.6 52.8 22.0 79.8 34.9 26.2 44.1 82.2 112.9 44.6 36.7 30.7 55.9 43.8 42.4 54.7 62.4 78.7 50.7 11.8 40.0 38.6 22.5 31.4 22.4 55.8 60.3 43.9 36.6 47.9 29.3 49.4 32.7 21.2 33.9 36.8 33.8 83.2 49.0 68.6 35.6 68.6 55.7 81.2 134.8 102.4 69.5 57.1 62.5 19.3 12.5 10.5 7.5 12.6 10.5 12.9 7.3 7.7 16.8 12.8 9.0 10.2 6.0 7.0 11.1 8.1 6.7 8.9 16.7 18.9 17.5 19.2 18.0 22.7 17.6 18.3 16.7 17.5 15.7 19.8 18.6 42.0 230.8 292.6 13.7 59.6 34.5 38.7 21.5 39.3 59.8 33.5 30.4 38.4 21.5 126.0 18.4 37.5 26.0 58.9 15.9 37.2 29.9 37.2 36.2 81.8 54.8 62.1 57.4 31.8 33.0 25.6 75.9 22.4 58.7 197.7 38.0 35.0 36.6 37.6 50.5 27.3 30.4 12.2 67.9 123.0 28.4 28.0 97.6 26.6 17.8 80.4 54.0 40.2 22.6 31.0 40.1 25.9 37.2 67.7 71.8 21.2 60.4 141.5 46.7 19.7 52.1 39.2 51.8 37.8 36.9 32.8 22.0 56.1 34.5 24.7 34.4 MYEF2 "FLJ11213, HsT18564, KIAA1341, MEF-2" ENSG00000104177 "Myelin expression factor 2" 15 48134632-48178353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 87.8;Oligodendrocyte precursor cells: 88.4;Spermatocytes: 106.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 101.9;SCLC-21H: 90.8;SK-MEL-30: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004883: AB_1079436" "unprognostic (4.30e-2)" "unprognostic (8.59e-2)" "unprognostic (5.01e-2)" "unprognostic (2.17e-1)" "unprognostic (2.02e-2)" "unprognostic (7.18e-3)" "unprognostic (2.76e-3)" "unprognostic (6.81e-2)" "unprognostic (2.35e-1)" "unprognostic (4.09e-2)" "unprognostic (1.55e-5)" "unprognostic (1.32e-2)" "unprognostic (3.76e-3)" "unprognostic (7.94e-2)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (4.05e-1)" 4.8 15.2 19.9 5.0 20.0 1.6 7.8 28.2 23.7 1.8 15.0 9.2 3.7 5.8 10.1 2.5 12.3 7.0 8.9 19.2 19.4 18.0 0.5 5.9 7.0 19.2 19.3 17.5 1.8 14.3 14.0 23.0 1.5 19.8 9.0 4.9 33.4 6.5 10.6 1.5 4.5 4.9 7.6 19.2 6.2 9.2 28.5 20.1 10.5 5.5 2.2 7.7 3.7 1.3 22.1 0.3 30.1 101.9 63.9 1.0 0.1 0.0 31.4 8.3 15.7 6.9 12.1 12.8 22.1 40.2 7.1 10.9 0.2 43.1 1.9 20.9 60.3 16.5 13.5 0.0 5.1 5.1 15.6 10.5 0.5 1.2 0.2 2.1 47.5 28.5 30.5 2.2 30.5 12.8 17.6 24.0 0.2 44.1 7.5 5.3 0.0 8.0 0.7 51.2 5.8 90.8 69.7 0.0 9.2 91.9 47.6 49.3 19.7 18.6 5.0 24.3 18.9 73.6 13.5 54.4 0.1 9.3 0.1 20.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.4 0.0 0.2 0.2 0.0 19.9 20.0 28.2 23.7 19.2 19.4 19.2 19.3 17.5 19.8 19.2 20.1 22.1 15.9 12.8 16.8 56.8 13.9 0.8 2.3 1.2 1.2 80.4 26.2 17.0 9.4 7.2 11.6 49.7 79.2 0.6 7.9 3.3 31.3 20.5 70.7 40.1 3.0 10.9 52.1 8.8 80.8 11.3 0.2 5.5 4.1 18.3 4.5 47.6 6.8 0.1 0.4 82.4 87.8 8.2 2.0 1.0 6.8 41.0 2.1 3.9 10.6 22.5 3.8 33.5 3.1 88.4 43.9 11.0 6.8 1.2 5.8 7.3 0.5 26.7 47.7 61.0 0.0 7.1 13.2 106.1 25.3 0.5 1.0 0.0 7.8 2.8 6.9 1.6 SGK3 "SGK2, SGKL" ENSG00000104205 "Serum/glucocorticoid regulated kinase family member 3" Q96BR1 8 66712734-66862022 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 56.0;monocytes: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "HPA006699, HPA027146" Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" "prognostic favorable (5.52e-6)" "prognostic favorable (8.28e-4)" "unprognostic (8.52e-3)" "unprognostic (1.10e-2)" "unprognostic (3.75e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-1)" "unprognostic (1.69e-3)" "unprognostic (9.51e-2)" "unprognostic (8.86e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.94e-2)" "unprognostic (8.95e-2)" "unprognostic (4.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (5.29e-3)" 5.2 5.4 13.0 9.9 26.0 8.6 24.3 20.7 17.7 10.6 31.9 10.4 9.0 8.1 8.6 7.7 7.0 7.6 5.5 13.9 19.3 14.9 13.7 10.1 7.9 26.8 21.7 11.9 9.1 15.7 28.5 6.3 5.8 26.1 7.4 10.4 2.4 7.1 7.2 3.0 13.4 11.4 5.3 21.2 9.0 7.6 9.4 21.0 5.8 17.6 3.6 6.9 5.1 5.7 49.6 14.2 3.7 0.6 2.4 3.9 6.5 7.7 8.1 7.4 4.2 5.1 6.1 8.6 10.2 2.2 7.7 13.6 4.9 7.3 5.5 5.4 5.3 11.7 9.7 2.6 6.7 4.1 8.9 10.5 2.9 3.7 1.7 7.9 4.3 7.4 7.4 1.5 4.6 10.0 2.4 6.2 5.8 1.9 8.5 5.0 11.7 5.3 7.6 6.4 3.3 2.9 2.2 3.4 6.5 14.4 6.0 28.4 16.9 9.0 4.4 3.9 3.9 3.4 6.1 12.8 12.7 4.5 14.2 4.9 21.1 15.0 5.1 8.7 9.9 13.8 4.7 8.8 8.0 13.8 6.4 8.7 7.1 2.0 7.2 5.1 8.9 5.7 9.0 13.0 26.0 20.7 17.7 13.9 19.3 26.8 21.7 11.9 26.1 21.2 21.0 49.6 20.7 6.4 28.1 0.0 12.5 13.3 8.1 3.3 8.6 1.7 56.0 30.5 7.6 7.2 8.5 11.0 18.8 9.2 24.9 13.3 15.6 7.0 0.9 16.7 6.6 15.3 16.2 10.3 0.0 18.2 1.4 8.9 6.6 12.3 15.2 11.0 17.5 20.7 22.9 0.0 0.0 9.3 8.2 41.9 14.3 2.2 4.1 42.6 8.8 0.0 53.4 3.8 19.6 0.0 0.0 14.8 8.4 7.9 18.3 9.3 14.0 36.8 15.4 1.7 0.0 5.9 4.2 5.9 13.7 9.9 15.8 4.8 19.4 5.2 10.4 5.3 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 22.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 34.4 4.2 2.5 3.9 3.4 0.2 52.4 2.8 3.0 28.0 2.1 6.8 0.9 15.9 10.4 3.0 23.5 13.5 9.4 2.3 6.7 1.3 0.7 4.7 1.2 2.7 2.6 2.1 43.3 6.9 9.1 7.5 9.1 2.6 5.5 3.2 0.6 13.2 6.8 18.6 10.2 2.7 26.3 2.4 0.8 6.2 6.5 2.7 3.8 33.3 38.3 2.0 6.5 12.1 3.3 0.0 17.7 1.0 189.4 5.6 2.5 13.8 4.6 159.1 7.5 31.3 1.0 0.2 0.0 0.9 2.5 24.7 0.0 11.6 0.9 3.7 0.2 14.5 0.0 5.3 4.1 14.6 0.0 0.0 86.9 0.1 9.2 0.1 0.0 13.0 1.6 0.0 2.4 1.1 12.5 0.2 0.4 9.9 0.7 3.6 0.0 0.2 0.4 1.0 11.4 0.6 1.2 1.4 1.7 3.3 11.4 0.6 0.0 2.6 0.2 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 3.4 2.8 3.0 2.3 6.7 2.7 2.6 2.1 2.6 2.4 2.7 3.3 15.5 0.0 3.6 2.3 0.3 13.3 0.5 4.3 0.6 0.6 2.9 3.3 4.5 1.5 2.8 0.0 0.0 14.9 0.7 0.4 0.0 4.1 36.0 2.4 5.4 4.1 1.2 0.0 1.1 7.1 19.9 186.2 0.5 4.7 0.0 0.3 1.4 0.2 3.5 0.0 3.5 1.3 2.0 0.0 14.6 6.7 74.6 1.6 10.6 1.9 1.6 1.4 0.0 3.0 1.3 3.1 0.1 70.7 0.2 1.9 0.4 0.1 0.2 0.4 0.0 8.0 10.7 0.8 1.9 0.6 9.9 9.7 1.7 1.5 0.4 0.5 CSPP1 "CSPP, CSPP-L, FLJ22490, JBTS21" ENSG00000104218 "Centrosome and spindle pole associated protein 1" Q1MSJ5 8 67062417-67196778 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 165.8;Endometrial ciliated cells: 177.6;Respiratory ciliated cells: 202.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056174 Supported "Centriolar satellite,Centrosome" NA NA "Centriolar satellite, Centrosome" "HPA056174: " "unprognostic (1.44e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (4.70e-1)" "unprognostic (2.59e-2)" "unprognostic (5.24e-3)" "unprognostic (3.89e-2)" "unprognostic (7.85e-2)" "unprognostic (2.11e-1)" "unprognostic (1.30e-1)" "unprognostic (3.61e-2)" "unprognostic (9.29e-2)" "unprognostic (3.40e-1)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.93e-1)" 4.0 2.9 0.9 1.5 0.9 0.8 4.5 1.7 1.3 5.1 1.3 4.1 2.2 4.3 1.8 3.5 8.5 3.1 3.7 0.7 0.8 5.4 5.5 5.8 1.4 1.1 1.0 0.6 5.7 6.0 4.3 3.3 6.1 1.0 3.6 2.8 2.1 3.6 1.6 13.7 3.5 4.0 2.6 1.0 3.4 4.4 13.0 1.0 3.9 4.6 2.8 2.0 4.1 4.1 1.2 5.7 4.9 4.6 5.9 5.3 5.6 4.9 4.9 6.3 6.5 6.9 4.6 6.6 6.5 1.1 3.3 6.9 4.4 11.4 3.4 9.1 3.6 7.2 9.3 2.3 2.9 4.5 7.7 4.0 4.4 2.9 4.2 8.2 3.9 4.1 7.9 16.1 3.0 5.9 2.1 19.1 3.2 6.1 14.8 4.9 10.4 6.9 5.4 4.9 2.6 3.0 3.0 3.1 5.9 4.7 6.3 10.8 4.4 4.1 4.7 4.7 2.1 4.2 4.6 3.2 8.6 3.6 6.1 5.6 0.6 0.1 0.2 0.5 1.0 0.6 0.5 0.4 0.5 0.4 0.8 0.8 0.3 0.0 0.3 0.3 0.4 1.0 0.3 0.9 0.9 1.7 1.3 0.7 0.8 1.1 1.0 0.6 1.0 1.0 1.0 1.2 20.9 25.6 11.8 63.3 15.0 21.2 11.1 7.6 16.5 20.5 19.4 18.7 39.8 31.5 32.4 7.3 73.0 21.8 23.6 9.6 3.9 14.8 165.8 177.6 29.1 16.6 11.4 16.6 117.5 9.7 13.7 20.2 11.2 27.7 26.0 36.8 12.1 9.3 7.4 21.9 116.1 9.6 8.2 7.2 9.4 91.0 21.5 12.5 7.2 61.8 12.9 13.6 17.5 89.0 98.1 9.8 5.3 19.5 19.4 11.0 10.8 23.0 202.3 133.2 26.3 31.7 20.4 121.6 60.1 15.3 16.2 18.5 15.9 14.6 13.6 6.9 ZDHHC2 "DHHC2, ZNF372" ENSG00000104219 "Zinc finger DHHC-type palmitoyltransferase 2" Q9UIJ5 8 17156482-17224799 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 78.4" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023331, HPA023334" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023331: AB_2671165, HPA023334: " "unprognostic (8.92e-2)" "unprognostic (4.23e-1)" "unprognostic (1.80e-2)" "unprognostic (2.53e-1)" "unprognostic (6.89e-2)" "unprognostic (2.25e-1)" "unprognostic (6.12e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" "prognostic favorable (3.24e-4)" "unprognostic (5.00e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-2)" "unprognostic (5.10e-2)" 10.4 24.6 12.1 11.1 9.2 32.0 7.5 41.5 14.9 13.5 14.0 15.5 10.6 7.6 11.9 3.9 14.0 7.0 9.8 7.2 19.4 26.6 6.5 14.5 9.4 17.3 16.5 7.1 11.9 30.9 29.2 9.6 7.0 21.7 11.8 11.3 78.4 19.8 13.0 18.1 1.8 10.4 9.5 13.8 10.8 16.4 16.7 22.4 12.8 33.9 37.6 11.8 19.9 4.5 21.7 2.3 12.4 23.7 4.9 20.3 36.0 13.8 41.5 49.9 23.0 27.2 3.9 34.3 26.1 15.9 36.2 57.9 1.5 32.2 20.5 42.5 16.8 16.2 23.2 16.8 5.0 20.3 24.7 2.6 15.3 3.2 28.8 26.1 52.7 38.4 29.8 2.7 66.5 28.1 0.6 18.3 15.2 15.0 18.8 19.1 17.9 23.7 9.5 41.8 26.7 12.7 8.3 17.8 0.0 3.8 34.9 1.0 10.9 32.0 11.6 35.2 26.0 41.7 13.2 53.7 30.1 32.1 22.2 5.3 1.6 1.2 2.6 1.9 1.3 3.3 2.5 2.4 2.3 1.1 2.1 2.1 2.3 0.9 2.2 0.8 2.3 1.3 0.7 12.1 9.2 41.5 14.9 7.2 19.4 17.3 16.5 7.1 21.7 13.8 22.4 21.7 20.9 44.8 25.4 34.0 18.8 3.1 15.3 4.1 1.8 54.4 21.1 8.0 15.2 15.7 10.5 51.5 77.2 0.5 27.1 8.7 21.5 22.2 8.3 19.3 6.8 11.6 19.7 22.7 49.8 33.4 1.2 10.4 9.7 25.4 8.2 10.9 10.0 8.0 12.6 11.8 20.1 16.2 6.1 28.6 16.1 11.7 5.0 22.2 23.2 37.5 12.9 40.6 8.2 26.7 61.3 37.0 10.7 3.0 14.0 31.3 6.1 26.1 7.7 90.2 13.1 9.1 7.5 6.6 3.9 3.3 2.7 0.4 17.0 8.7 17.0 36.5 BRF2 "BRFU, FLJ11052, TFIIIB50" ENSG00000104221 "BRF2 RNA polymerase III transcription initiation factor subunit" Q9HAW0 8 37843268-37849861 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019269, HPA023378" Supported Supported Nucleoli NA NA Nucleoli "CAB019269: , HPA023378: AB_1845446" "unprognostic (9.85e-3)" "unprognostic (2.74e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-3)" "unprognostic (3.91e-2)" "unprognostic (2.35e-2)" "unprognostic (9.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (2.52e-3)" "unprognostic (1.33e-1)" "unprognostic (1.93e-1)" "unprognostic (7.41e-2)" 11.0 8.1 6.5 4.6 7.4 14.5 11.1 6.7 7.5 14.8 6.5 10.3 4.1 12.7 6.4 8.3 12.0 4.6 10.1 7.7 7.1 7.3 8.0 7.7 6.7 7.0 7.3 7.4 12.9 8.4 6.6 9.7 7.6 7.4 13.8 5.3 5.9 8.0 7.0 28.8 10.6 7.8 5.7 6.9 9.9 9.0 7.9 7.0 11.1 7.3 12.9 5.4 14.1 10.8 7.6 13.1 9.9 9.6 12.4 13.0 9.5 11.2 15.1 12.0 20.1 13.7 12.9 9.2 16.0 21.3 9.6 7.6 13.3 12.5 9.5 10.0 10.0 12.5 19.7 8.3 10.6 13.6 7.9 11.3 12.8 12.3 20.1 8.5 9.8 6.6 14.0 24.6 13.9 6.6 7.5 25.2 9.9 16.1 9.6 13.1 14.7 10.4 8.1 7.4 8.7 8.1 9.7 7.1 10.5 18.3 11.6 22.1 15.0 8.8 10.0 13.7 25.5 15.4 16.5 24.8 18.8 14.5 10.3 18.2 13.9 10.1 11.7 13.5 9.5 13.7 14.2 14.3 13.8 7.9 14.9 20.3 16.6 4.2 20.0 8.7 9.5 13.7 11.7 6.5 7.4 6.7 7.5 7.7 7.1 7.0 7.3 7.4 7.4 6.9 7.0 7.6 6.9 12.8 4.8 2.0 4.2 4.5 4.2 6.4 0.6 9.8 6.9 7.5 0.3 7.2 4.7 9.2 0.0 22.6 6.2 5.5 7.9 8.7 0.4 14.2 7.9 7.8 6.6 8.6 3.3 11.0 10.4 8.1 5.6 24.7 2.5 8.6 6.8 2.1 11.6 8.4 3.1 8.6 8.2 7.1 5.4 1.4 9.3 3.9 3.6 1.0 7.1 11.4 10.3 2.5 2.3 6.5 2.2 10.5 7.2 4.3 9.3 5.8 7.1 6.9 6.6 5.5 7.5 12.5 12.4 4.6 3.8 14.1 7.5 11.5 7.2 3.0 TRIM35 "HLS5, KIAA1098, MAIR" ENSG00000104228 "Tripartite motif containing 35" Q9UPQ4 8 27284886-27311272 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019647: AB_1858291" "unprognostic (7.67e-3)" "unprognostic (6.53e-2)" "unprognostic (1.61e-2)" "unprognostic (9.64e-3)" "unprognostic (9.35e-2)" "prognostic favorable (1.38e-4)" "unprognostic (8.79e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.59e-7)" "unprognostic (1.74e-2)" "unprognostic (1.69e-1)" "unprognostic (3.99e-2)" "unprognostic (1.92e-1)" 8.9 6.2 6.5 5.9 9.0 7.3 8.5 7.9 9.5 8.0 11.8 7.2 5.5 8.9 4.5 10.8 7.4 3.6 5.3 9.1 8.1 6.3 12.0 6.0 6.9 10.1 8.3 6.4 6.1 6.0 4.6 4.3 5.3 9.2 7.4 3.9 4.1 16.4 9.1 5.1 32.3 6.2 7.2 8.0 6.3 6.0 6.5 9.4 8.2 4.6 4.7 7.0 8.3 10.5 11.9 17.4 12.3 7.0 9.0 68.4 16.9 16.1 10.3 8.1 9.4 10.0 17.6 3.4 15.3 10.3 11.5 8.3 17.0 10.1 19.9 7.1 8.7 7.6 15.1 10.3 15.1 17.8 8.3 12.4 24.6 44.2 13.3 26.1 5.0 9.4 14.5 10.8 16.4 7.7 9.0 27.8 11.3 12.3 11.1 9.8 13.8 9.0 13.3 6.4 13.5 11.9 11.4 8.6 8.1 14.3 6.7 5.2 13.2 10.9 8.5 17.7 27.1 10.2 7.5 8.5 11.1 12.1 12.0 8.5 11.9 3.0 4.0 8.6 3.0 9.7 5.3 11.2 9.7 3.8 3.8 7.5 11.2 1.1 8.9 3.4 6.4 14.5 5.3 6.5 9.0 7.9 9.5 9.1 8.1 10.1 8.3 6.4 9.2 8.0 9.4 11.9 9.4 3.2 4.5 5.2 4.4 20.9 6.0 4.6 40.9 3.5 3.6 2.7 5.0 8.6 3.8 12.9 6.2 3.5 3.2 3.6 0.0 3.7 1.0 4.0 3.7 6.7 2.4 8.6 8.3 5.1 2.8 6.6 6.1 4.6 5.7 3.8 23.9 20.3 2.9 5.0 5.3 2.7 6.1 8.9 6.2 0.6 12.8 6.9 7.2 3.7 5.2 3.5 3.1 4.5 16.8 4.7 2.0 10.9 4.8 3.6 4.5 6.1 0.9 3.5 0.0 3.4 5.5 1.3 3.9 15.0 22.3 1.5 6.9 2.4 3.5 2.5 ZFAND1 FLJ14007 ENSG00000104231 "Zinc finger AN1-type containing 1" Q8TCF1 8 81701334-81732903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023383 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA023383: AB_1859008" "unprognostic (6.45e-2)" "unprognostic (1.48e-2)" "unprognostic (7.74e-2)" "unprognostic (8.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.04e-3)" "unprognostic (8.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.30e-2)" "unprognostic (3.77e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.35e-2)" "unprognostic (2.36e-2)" 30.6 27.1 16.2 14.9 17.6 28.9 42.2 20.8 21.4 31.1 14.8 27.8 26.1 35.6 27.1 28.5 32.3 24.4 22.4 16.6 19.1 31.0 35.8 24.7 27.1 17.2 18.3 16.0 56.2 54.2 32.6 21.9 19.0 18.4 28.3 30.2 21.2 40.3 26.7 21.8 20.9 23.8 32.8 17.0 25.4 30.3 9.3 18.5 32.1 58.6 28.1 29.8 32.4 23.7 20.1 74.1 23.5 31.3 29.4 40.5 86.0 31.0 42.5 57.8 38.3 48.0 26.4 56.8 72.5 49.1 32.5 41.4 47.2 35.9 61.7 57.4 60.1 36.8 41.1 35.1 29.5 78.7 53.9 26.6 70.8 138.4 26.0 239.0 64.6 46.9 70.6 61.1 96.7 38.6 46.0 65.4 35.6 9.6 147.5 70.1 43.8 26.2 32.5 48.1 67.1 30.8 21.6 30.1 19.3 71.6 35.2 62.6 38.7 29.7 27.2 39.4 38.5 60.5 38.2 26.2 45.3 30.9 4.6 21.9 16.8 29.5 8.4 21.8 21.3 36.7 36.4 35.2 28.8 40.8 27.2 46.6 36.1 2.9 37.0 25.8 24.3 44.1 36.0 16.2 17.6 20.8 21.4 16.6 19.1 17.2 18.3 16.0 18.4 17.0 18.5 20.1 44.1 25.6 38.3 14.4 47.9 95.8 73.0 73.0 88.2 27.3 49.7 63.6 18.8 41.5 41.4 25.8 4.2 33.8 32.8 10.0 103.7 27.4 3.4 20.1 25.3 42.8 23.4 31.5 49.2 49.4 45.6 36.3 32.1 21.4 34.9 28.9 41.7 22.5 29.1 23.5 45.3 33.6 36.7 47.7 75.0 3.7 39.7 29.1 49.8 20.6 35.2 15.3 23.7 26.7 29.0 33.6 24.4 29.7 44.4 72.2 28.4 80.1 20.9 15.2 32.9 42.6 48.1 18.5 17.3 53.0 78.4 32.7 42.6 49.1 33.3 61.5 RP1 "DCDC4A, ORP1" ENSG00000104237 "RP1 axonemal microtubule associated" P56715 8 54509422-54871720 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "retina: 238.5" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 333.6;Rod photoreceptor cells: 1115.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;HDLM-2: 5.2;hTERT-RPE1: 2.0;RPTEC TERT1: 10.2;U-2197: 2.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" HPA042257 Enhanced NA NA "HPA042257: AB_10797385" "unprognostic (3.19e-3)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.70e-1)" "unprognostic (9.16e-3)" "unprognostic (6.24e-2)" "unprognostic (4.56e-2)" "unprognostic (4.13e-5)" "unprognostic (2.48e-1)" "unprognostic (2.16e-5)" "unprognostic (8.92e-2)" "unprognostic (6.18e-2)" "unprognostic (1.89e-2)" "unprognostic (8.96e-2)" 0.1 0.0 0.1 0.0 0.1 0.1 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 10.2 0.0 0.0 0.2 0.0 0.7 0.1 3.5 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 238.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.6 0.0 0.1 0.0 0.7 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.2 0.1 0.5 16.0 4.8 0.0 0.0 0.0 0.0 1.2 0.0 72.5 3.0 1.4 0.4 0.0 31.1 5.5 333.6 0.0 0.0 0.0 3.9 0.0 0.3 81.9 0.4 10.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 32.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 130.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 149.0 1115.8 0.0 0.0 0.4 3.2 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 CA2 "CA-II, CAII, Car2" ENSG00000104267 "Carbonic anhydrase 2" P00918 8 85463968-85481493 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "Disease variant, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 693.9;stomach 1: 1118.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1773.2;Erythroid cells: 2448.1;Gastric mucus-secreting cells: 1380.7;Muller glia cells: 1536.4;Paneth cells: 781.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 51.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 263.8;HEK 293: 1097.8;THP-1: 461.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001550, CAB010102" Enhanced NA Yes 570000000 "CAB010102: AB_626796, HPA001550: AB_1078393" "unprognostic (6.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.63e-1)" "unprognostic (2.59e-1)" "unprognostic (9.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.72e-2)" "unprognostic (1.07e-1)" "unprognostic (5.23e-2)" "unprognostic (1.57e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.57e-6)" "unprognostic (2.45e-1)" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (6.49e-3)" 7.5 10.2 103.4 37.1 124.9 248.9 38.3 122.0 137.9 5.0 369.0 693.9 287.8 2.9 10.7 19.9 2.7 113.7 15.1 105.7 109.8 334.3 275.8 43.4 6.6 124.5 114.6 86.8 0.4 55.6 10.2 6.1 19.8 115.7 1.9 649.7 393.8 75.3 69.0 43.1 81.6 31.6 32.6 100.9 8.4 1118.7 21.3 111.9 5.1 16.1 63.4 4.4 2.9 5.3 148.4 3.7 2.8 12.2 0.0 0.1 0.0 31.2 0.0 0.0 0.0 0.0 15.1 0.9 0.0 9.5 0.0 0.1 263.8 37.4 13.2 0.0 0.0 1097.8 35.8 17.0 0.5 0.0 23.7 5.1 0.0 63.9 0.0 3.7 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.4 41.4 3.7 86.5 0.0 21.2 1.3 0.5 3.7 8.8 0.2 0.3 5.0 0.0 0.1 9.6 0.0 461.5 0.0 0.0 6.6 0.0 0.4 0.4 1.0 0.1 1.8 0.1 0.0 51.2 5.3 8.6 0.2 15.0 7.4 1.3 0.1 0.8 15.4 3.0 0.0 0.0 12.6 0.1 13.4 1.4 0.0 33.3 103.4 124.9 122.0 137.9 105.7 109.8 124.5 114.6 86.8 115.7 100.9 111.9 148.4 19.4 16.0 79.9 34.0 19.6 90.6 1.3 152.5 17.6 23.1 56.9 18.4 19.8 430.4 22.4 161.8 64.6 15.2 2.4 1773.2 348.3 60.1 65.9 3.3 1.3 26.7 30.5 2448.1 1.4 11.3 403.1 6.4 1380.7 8.3 15.9 0.4 4.2 135.6 35.4 13.5 22.3 116.0 10.2 11.0 216.5 232.1 3.4 51.8 74.7 6.5 6.6 1536.4 1.0 3.0 226.4 16.1 781.9 2.2 10.3 3.5 0.3 468.2 3.9 66.1 0.0 12.1 8.2 3.1 2.8 31.2 111.7 17.1 11.7 0.7 390.8 0.5 FZD3 ENSG00000104290 "Frizzled class receptor 3" Q9NPG1 8 28494205-28574267 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 14.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 98.0;Excitatory neurons: 155.9;Inhibitory neurons: 82.3;Rod photoreceptor cells: 87.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.3" "Group enriched" "Detected in many" 5 "dendritic cells: 9.3;T-cells: 2.3" "Cell line enhanced" "Detected in many" "AF22: 53.2;Karpas-707: 27.9;SCLC-21H: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024995, HPA042320" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB024995: , HPA042320: AB_2677948" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.17e-4)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.57e-4)" "unprognostic (1.69e-2)" "unprognostic (4.26e-4)" "unprognostic (2.11e-1)" "prognostic favorable (3.71e-4)" "unprognostic (2.86e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-2)" "unprognostic (1.38e-1)" "unprognostic (4.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.09e-3)" 0.9 2.9 5.8 1.5 7.1 1.5 2.3 6.6 10.5 2.2 11.7 1.9 1.4 3.4 7.0 1.9 3.6 1.3 1.0 6.2 9.5 2.6 0.6 1.0 2.1 2.5 2.9 5.1 7.1 3.5 4.3 3.8 1.3 3.5 4.4 1.2 14.8 3.3 5.5 1.2 1.5 1.1 2.5 1.2 0.6 2.5 5.1 2.5 1.8 3.4 1.4 1.4 1.9 1.7 3.1 14.8 3.1 53.2 10.2 0.0 0.8 7.9 0.5 1.1 3.0 1.3 3.1 3.1 6.9 2.6 0.3 6.6 5.2 8.0 8.8 2.1 9.1 5.8 4.8 1.0 2.0 0.0 2.7 7.9 0.6 4.1 0.2 2.3 0.6 0.6 7.3 3.5 27.9 0.1 3.7 0.2 5.8 13.3 6.4 4.6 3.3 8.0 6.8 4.0 4.4 39.6 10.7 2.9 7.5 8.7 7.0 7.4 4.0 0.0 0.0 14.3 2.0 3.7 5.1 6.1 6.7 4.2 0.0 2.7 0.7 0.2 0.0 1.6 0.2 2.1 1.1 1.2 2.3 0.9 0.6 1.6 1.6 0.1 0.9 0.0 9.3 0.0 0.7 5.8 7.1 6.6 10.5 6.2 9.5 2.5 2.9 5.1 3.5 1.2 2.5 3.1 1.7 9.6 12.0 65.6 5.6 6.6 7.9 17.0 10.8 28.1 21.6 11.7 6.0 4.3 17.7 9.2 98.0 10.5 15.7 1.4 1.9 12.1 25.7 24.2 18.7 4.3 28.7 5.0 155.9 14.9 9.7 8.8 8.2 27.7 5.7 29.3 8.6 3.0 4.2 21.9 82.3 6.3 8.2 1.0 7.4 11.9 48.1 2.1 33.8 14.0 0.7 17.0 2.1 52.8 14.3 11.8 3.4 51.1 17.2 14.1 0.8 11.4 17.5 87.1 26.3 8.6 15.0 58.4 45.6 5.6 4.7 4.8 5.0 15.0 5.4 7.7 INTS9 "CPSF2L, FLJ10871, RC-74" ENSG00000104299 "Integrator complex subunit 9" Q9NV88 8 28767661-28890242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051615, HPA066822" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA051615: AB_2681552, HPA066822: AB_2685729" "unprognostic (2.19e-2)" "unprognostic (1.45e-2)" "unprognostic (1.79e-2)" "prognostic favorable (9.45e-4)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (6.91e-3)" "prognostic favorable (7.71e-4)" "unprognostic (3.64e-2)" "unprognostic (5.01e-2)" "unprognostic (4.72e-2)" "unprognostic (2.48e-3)" "prognostic favorable (1.91e-5)" "unprognostic (2.51e-2)" "unprognostic (2.73e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" 8.6 22.2 8.7 11.2 9.6 6.9 8.4 9.3 9.5 9.1 10.7 8.9 7.0 9.3 11.4 11.2 9.8 6.7 11.2 8.6 9.5 10.3 6.0 8.8 14.7 9.2 9.5 8.2 8.3 9.7 9.5 12.6 8.0 9.3 9.2 9.4 10.6 9.0 7.2 11.7 9.8 9.6 9.1 9.2 15.8 9.5 12.9 9.4 17.7 10.7 7.0 18.0 11.1 8.8 10.1 24.7 17.0 20.1 21.4 24.3 11.3 8.8 11.1 15.1 19.0 20.9 11.9 13.4 24.4 15.2 11.4 17.0 20.1 39.2 22.7 26.1 10.3 16.1 24.4 9.5 21.0 17.6 12.3 18.2 13.0 16.0 22.9 16.3 10.2 23.8 34.5 52.2 13.7 12.8 13.5 57.5 22.3 27.4 28.8 10.9 36.5 23.3 12.8 13.4 16.8 14.4 26.4 11.5 14.8 20.5 16.0 14.4 13.8 14.1 10.9 27.6 18.7 14.2 7.0 5.3 29.8 16.8 20.3 15.8 17.0 20.6 19.0 17.3 23.0 16.1 18.0 15.1 19.3 29.1 19.5 13.4 14.5 8.3 25.1 17.4 15.4 20.3 12.0 8.7 9.6 9.3 9.5 8.6 9.5 9.2 9.5 8.2 9.3 9.2 9.4 10.1 3.6 6.4 4.2 28.7 10.9 2.3 2.4 4.7 1.8 2.1 2.7 2.3 5.8 5.7 3.7 3.7 6.2 7.7 6.1 2.8 1.9 3.7 8.3 4.8 6.2 4.6 6.0 4.2 29.5 5.1 4.8 4.7 9.2 5.9 0.0 6.7 3.9 2.5 7.5 1.7 31.3 3.6 4.1 3.8 6.1 4.1 7.8 4.1 3.6 23.4 5.4 2.4 4.1 32.2 39.9 4.9 1.7 4.5 4.3 1.9 3.3 4.3 3.4 6.1 0.0 4.2 4.0 5.1 3.5 7.7 3.0 4.8 5.4 11.2 3.5 1.7 RIPK2 "CARD3, CARDIAK, RICK, RIP2" ENSG00000104312 "Receptor interacting serine/threonine kinase 2" O43353 8 89757806-89791064 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 156.1;Langerhans cells: 121.3;Macrophages: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015273, HPA016499" Approved Enhanced Cytosol NA NA Cytosol "HPA015273: AB_1856299, HPA016499: AB_1856300" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (1.67e-1)" "unprognostic (6.20e-2)" "unprognostic (1.43e-3)" "prognostic unfavorable (6.33e-5)" "unprognostic (2.06e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (6.39e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.84e-2)" "unprognostic (5.08e-2)" "unprognostic (1.05e-2)" "prognostic favorable (8.05e-4)" 4.2 1.6 3.9 5.7 4.1 9.0 5.1 4.1 5.5 4.7 4.0 2.9 1.7 5.6 2.5 3.1 2.7 9.5 4.5 4.1 6.2 3.7 5.6 6.1 6.6 4.7 4.0 3.8 2.5 4.5 4.2 1.9 4.8 5.0 5.4 2.9 1.5 5.0 2.8 0.6 4.2 2.4 5.7 5.2 4.9 2.9 3.0 3.9 2.9 4.2 1.3 6.7 9.5 2.6 6.1 17.8 6.0 3.2 4.9 7.9 10.8 5.5 19.2 36.1 10.7 13.6 4.6 9.7 14.4 28.0 11.7 7.6 4.2 8.9 6.9 20.2 8.7 8.0 11.9 2.8 5.5 22.2 4.5 5.8 8.8 5.6 15.6 49.8 11.4 11.4 0.0 5.4 4.7 10.2 3.4 0.0 9.6 1.5 8.4 14.4 3.2 4.1 7.5 26.1 8.4 0.4 3.1 4.7 12.6 10.0 4.0 12.0 5.6 10.1 6.5 6.0 11.2 9.1 8.9 4.2 8.8 16.2 0.4 4.3 13.7 6.6 23.2 3.5 12.5 4.1 7.6 5.4 4.6 8.1 4.8 4.9 5.4 5.1 4.4 14.9 2.6 1.3 4.6 3.9 4.1 4.1 5.5 4.1 6.2 4.7 4.0 3.8 5.0 5.2 3.9 6.1 19.3 35.3 18.1 25.5 29.8 57.6 33.7 13.3 16.5 2.1 17.2 8.9 5.2 4.3 22.9 3.7 0.0 13.3 32.8 2.8 5.9 80.1 6.6 82.3 23.7 15.0 0.0 9.9 12.9 60.8 45.7 27.3 9.7 156.1 43.1 7.1 6.1 3.2 41.7 3.3 9.1 5.4 24.4 32.4 121.3 2.5 7.8 105.1 19.6 15.0 42.1 12.1 8.2 15.6 12.8 50.0 2.7 6.0 22.0 59.2 2.2 10.4 11.6 0.3 13.1 19.2 19.6 7.9 12.8 14.7 48.3 83.7 30.4 7.5 8.1 49.5 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 16.2;parathyroid gland: 23.9" "Cell type enriched" "Detected in some" 11 "Astrocytes: 214.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 20.7" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 0.6 0.6 2.4 0.1 7.6 0.0 0.2 0.6 2.1 3.0 16.2 0.1 0.1 0.1 0.1 0.4 2.1 0.3 4.6 1.3 1.9 0.1 0.0 0.4 0.0 2.3 3.9 0.0 0.2 0.0 23.9 10.9 0.0 3.2 12.1 0.2 0.4 0.8 4.1 2.8 0.0 0.2 0.2 0.0 0.1 0.9 0.9 4.6 11.8 0.6 2.5 0.1 2.6 4.3 1.8 0.2 0.0 6.4 27.6 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 1.6 0.0 0.0 4.7 0.0 2.2 0.0 0.0 0.5 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 2.0 0.0 1.5 0.0 21.3 9.5 0.0 0.0 2.2 51.4 0.0 0.0 1.6 5.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 6.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 7.6 0.6 2.1 1.3 1.9 2.3 3.9 0.0 3.2 0.0 4.6 1.8 0.2 0.0 0.0 214.5 0.0 0.1 0.0 6.4 0.6 0.1 0.0 0.1 8.8 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 3.1 0.1 0.2 0.0 0.0 1.3 0.0 0.5 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 13.5 0.0 2.0 0.0 0.0 6.4 0.3 0.0 0.0 11.2 0.0 0.1 0.0 18.6 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 10.5 0.2 0.0 0.2 0.5 0.8 1.0 1.1 0.1 0.5 0.0 1.4 0.0 0.1 NBN "AT-V1, AT-V2, ATV, NBS, NBS1" ENSG00000104320 Nibrin O60934 8 89933331-90003228 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 265.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001429, CAB003836" Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB003836: AB_562172, HPA001429: AB_1854460" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-3)" "unprognostic (7.46e-2)" "unprognostic (2.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (5.05e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.15e-1)" "unprognostic (6.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.28e-1)" "unprognostic (2.84e-2)" "unprognostic (1.03e-1)" 22.7 12.5 10.4 28.1 13.4 54.6 25.7 10.1 11.0 17.0 9.5 18.5 15.2 22.5 11.5 20.2 14.6 22.7 12.2 10.5 14.6 20.9 22.5 18.2 24.5 11.3 10.0 9.9 17.1 15.7 15.5 9.1 14.2 10.4 17.7 22.7 9.9 16.8 15.1 10.1 10.3 16.1 24.4 10.2 23.6 12.8 16.6 11.1 19.2 22.9 16.3 26.6 22.0 9.7 15.9 54.8 30.1 29.3 15.6 16.5 38.7 18.9 37.9 49.5 46.6 50.8 17.2 41.8 83.8 42.2 35.5 19.1 17.7 35.7 35.7 59.8 38.0 19.7 67.7 16.8 23.6 30.8 40.0 35.2 30.5 18.3 27.2 57.9 22.8 39.5 33.9 50.6 46.6 55.3 46.9 65.6 26.0 8.5 39.5 31.4 42.3 25.3 47.0 62.8 73.8 8.1 26.6 23.5 265.1 23.1 16.3 49.8 31.4 29.2 40.9 28.0 25.5 38.0 21.2 25.0 45.5 41.3 39.4 39.1 32.4 17.7 32.9 11.9 19.7 12.7 15.2 8.5 8.8 18.9 8.9 8.1 9.0 34.4 16.1 31.5 10.4 5.9 13.1 10.4 13.4 10.1 11.0 10.5 14.6 11.3 10.0 9.9 10.4 10.2 11.1 15.9 36.9 48.1 14.2 24.5 39.8 11.9 13.5 20.4 23.9 25.4 29.7 22.9 30.3 14.3 33.7 27.6 2.1 23.0 29.3 11.2 43.0 35.1 17.6 45.4 46.9 22.9 12.1 31.7 45.0 32.0 19.7 36.3 19.9 31.2 79.7 38.3 18.9 30.6 25.9 13.5 39.9 16.9 16.2 29.2 27.1 7.2 19.0 51.1 12.4 32.8 54.7 29.4 36.0 40.7 40.3 24.7 9.9 26.4 38.8 11.6 9.9 40.5 36.4 11.2 6.6 50.3 31.7 20.2 46.0 31.5 13.5 10.8 35.3 68.7 19.4 11.0 TRPA1 ANKTM1 ENSG00000104321 "Transient receptor potential cation channel subfamily A member 1" O75762 8 72019917-72075584 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.3;stomach 1: 10.4;urinary bladder: 28.0" "Cell type enhanced" "Detected in some" "Early spermatids: 10.9;Excitatory neurons: 5.0;Fibroblasts: 8.1;Intestinal goblet cells: 17.2;Skeletal myocytes: 4.5" "Cancer enhanced" "Detected in many" "breast cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HHSteC: 25.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (2.14e-2)" "unprognostic (2.50e-2)" "prognostic favorable (6.57e-4)" "unprognostic (1.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.37e-2)" "unprognostic (8.11e-3)" "unprognostic (4.22e-2)" "unprognostic (2.47e-1)" "unprognostic (2.78e-3)" "unprognostic (1.49e-1)" "unprognostic (2.16e-4)" "unprognostic (2.37e-1)" "unprognostic (9.67e-2)" "unprognostic (1.57e-1)" "unprognostic (2.90e-1)" 0.4 0.4 0.1 3.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 8.0 6.3 0.3 0.0 1.0 0.2 7.0 0.8 0.7 0.0 0.1 0.0 0.2 0.8 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.7 0.1 0.1 9.3 0.0 0.2 0.0 0.1 0.1 7.5 0.3 0.0 0.5 10.4 0.5 0.0 0.2 0.1 0.0 0.2 28.0 0.3 0.2 0.0 2.8 0.8 0.0 0.0 0.1 0.0 0.3 2.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.0 0.4 1.5 0.1 0.0 0.5 0.0 25.9 0.0 0.2 1.7 0.0 1.2 0.2 5.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 2.6 0.2 0.0 0.4 0.0 0.1 4.0 1.2 0.0 0.3 0.3 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 8.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 17.2 0.0 0.0 0.0 0.8 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.5 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.5 0.0 CPQ "LDP, PGCP" ENSG00000104324 "Carboxypeptidase Q" Q9Y646 8 96645242-97149654 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 228.0" "Cell type enhanced" "Detected in all" "Astrocytes: 150.2;Oligodendrocytes: 299.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 250.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023235, HPA024490" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 51000000 "Golgi apparatus, Vesicles" "HPA023235: AB_1855257, HPA024490: AB_1855258" "unprognostic (4.04e-2)" "unprognostic (5.46e-2)" "unprognostic (4.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "unprognostic (3.98e-3)" "unprognostic (5.24e-2)" "unprognostic (2.92e-2)" "unprognostic (2.67e-2)" "unprognostic (9.19e-2)" "unprognostic (2.38e-3)" "unprognostic (6.16e-3)" "prognostic favorable (5.40e-5)" "unprognostic (6.74e-3)" "unprognostic (8.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" 46.6 36.3 22.9 25.6 32.8 32.1 35.1 27.7 26.9 75.7 22.9 33.3 29.6 46.4 36.6 26.2 40.2 58.3 43.6 21.4 36.3 81.2 70.6 32.6 23.0 32.8 27.1 19.3 88.1 47.1 61.2 25.8 39.5 31.8 40.6 33.5 17.0 33.1 54.7 13.4 20.8 35.3 65.2 25.9 31.6 32.4 14.0 29.9 8.3 228.0 33.5 17.2 46.7 38.9 38.7 0.6 2.1 2.1 0.1 116.1 131.4 0.5 35.3 55.6 12.8 26.5 2.0 0.9 0.4 27.2 59.0 15.7 1.0 2.4 2.8 12.0 31.4 4.4 28.4 1.5 17.7 25.6 4.9 37.0 69.6 6.5 15.0 3.7 108.2 6.0 0.1 27.1 97.0 29.4 1.2 0.5 14.1 2.5 0.2 5.2 4.3 0.0 0.6 26.7 13.2 2.4 0.3 10.2 0.4 28.2 25.8 12.3 28.6 21.3 51.9 4.9 0.8 11.5 7.9 0.9 0.3 32.2 21.6 33.5 32.0 71.3 45.1 27.3 49.6 27.6 5.4 20.3 24.0 51.8 7.4 17.6 24.6 250.5 25.9 47.5 14.8 22.2 40.6 22.9 32.8 27.7 26.9 21.4 36.3 32.8 27.1 19.3 31.8 25.9 29.9 38.7 46.6 12.8 12.5 150.2 11.7 19.4 25.7 21.3 9.6 12.7 12.1 27.9 27.2 42.9 13.9 47.8 29.2 12.1 40.8 9.3 17.6 22.7 5.0 6.6 43.3 27.1 13.8 7.2 24.0 10.7 1.8 123.8 10.7 8.6 38.0 43.1 51.0 48.3 54.0 10.1 31.3 7.9 24.4 56.0 44.9 9.0 72.4 39.4 78.2 131.2 33.7 43.4 39.1 44.7 299.6 11.7 9.5 73.0 11.9 12.4 42.4 56.0 9.7 16.3 52.6 71.1 67.8 5.6 3.4 2.8 13.1 6.0 23.8 38.6 12.2 13.5 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90053633 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 223.9;liver: 274.6" "Cell type enhanced" "Detected in all" "Distal tubular cells: 399.2;Proximal tubular cells: 485.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 120000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 59.9 137.9 12.1 9.6 13.5 25.1 54.8 12.7 14.5 29.0 20.0 48.5 20.3 28.2 15.0 53.1 26.3 7.4 223.9 12.5 15.2 103.7 274.6 34.5 15.2 13.8 12.7 9.6 35.8 44.8 13.3 32.8 6.0 14.2 28.8 18.9 8.1 43.2 6.6 122.8 43.2 61.5 9.2 10.2 47.5 44.8 52.7 14.9 10.3 33.2 34.7 14.1 31.3 36.1 13.0 13.1 7.9 19.6 16.1 8.0 17.3 5.2 13.2 12.9 5.9 8.2 2.8 13.4 7.7 5.3 15.1 4.1 6.8 7.7 11.1 11.0 12.6 1.2 18.4 13.6 14.5 11.6 8.7 4.4 12.0 7.0 7.6 10.7 10.1 17.4 16.5 21.3 15.5 20.7 16.3 12.5 7.6 1.5 9.1 24.9 7.4 5.8 13.4 23.4 43.9 1.3 10.6 13.0 81.1 7.7 1.1 10.7 7.4 20.1 11.4 6.2 12.9 6.0 10.5 7.5 12.8 8.6 12.0 10.8 3.9 9.1 6.2 7.1 10.2 7.9 7.4 6.9 8.6 8.8 4.6 8.1 7.8 15.2 3.9 9.3 3.9 9.6 5.8 12.1 13.5 12.7 14.5 12.5 15.2 13.8 12.7 9.6 14.2 10.2 14.9 13.0 66.1 76.9 59.4 72.5 52.9 41.3 70.6 180.2 35.3 11.4 51.1 57.4 268.3 82.9 96.4 71.7 2.1 50.2 57.6 119.0 399.2 137.8 165.3 68.2 65.5 60.0 104.8 77.4 27.2 92.5 49.0 60.2 61.2 40.6 50.0 81.3 47.8 244.8 115.1 32.0 55.9 105.9 116.0 95.2 82.7 52.6 85.4 85.1 85.4 29.0 107.1 52.5 74.2 66.9 35.0 87.5 111.6 51.6 67.8 30.3 250.3 485.2 69.0 7.6 72.3 54.5 61.7 157.5 24.6 68.6 41.1 41.0 64.4 135.1 139.6 86.8 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 323.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 26.1;Collecting duct cells: 27.6;Cone photoreceptor cells: 91.8;Distal tubular cells: 31.3;Horizontal cells: 99.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.8" "Group enriched" "Detected in many" 6 "granulocytes: 2.8;monocytes: 1.4" "Cell line enhanced" "Detected in many" "A-431: 134.9;EFO-21: 189.8;HeLa: 65.9" "Region enhanced" "Detected in all" "cerebellum: 430.7" "Group enriched" "Detected in all" 4 "basal ganglia: 49.7;cerebellum: 119.6" "CAB002138, HPA023099, HPA056734" Enhanced Approved Vesicles NA NA Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 2.4 1.7 8.3 2.0 33.0 1.3 1.7 67.5 21.2 5.5 0.0 1.7 3.2 1.3 3.4 8.6 1.9 1.4 0.9 10.8 16.7 323.5 2.6 3.7 0.9 14.8 7.2 10.2 1.2 2.5 2.2 8.5 4.0 26.4 0.8 2.5 54.5 1.7 0.5 2.0 3.6 2.8 1.3 9.2 1.3 2.4 3.7 26.2 2.7 2.6 0.3 1.2 0.5 0.1 9.6 134.9 6.1 30.2 1.2 1.1 4.9 4.0 2.0 5.8 0.7 1.1 2.9 15.1 0.5 189.8 0.1 0.8 47.8 46.0 54.6 9.1 0.3 2.5 3.2 65.9 0.7 5.3 0.8 4.4 1.5 17.3 2.5 25.4 7.0 36.1 2.6 9.9 3.4 35.9 0.6 1.9 0.1 45.3 2.9 17.9 1.3 1.2 3.9 12.9 0.7 5.0 2.9 38.2 2.3 0.6 45.8 1.7 1.1 0.1 3.9 28.1 6.6 11.9 3.1 3.9 1.0 0.5 0.9 0.2 1.5 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.4 0.3 0.0 0.4 8.3 33.0 67.5 21.2 10.8 16.7 14.8 7.2 10.2 26.4 9.2 26.2 9.6 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 1.5 0.0 0.0 27.6 91.8 0.0 0.0 0.0 31.3 0.0 14.9 0.0 0.1 0.3 3.5 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 99.3 14.7 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 15.8 0.0 1.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.8 0.0 0.3 0.4 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 BPNT2 "FLJ20421, gPAPP, IMPA3, IMPAD1" ENSG00000104331 "3'(2'), 5'-bisphosphate nucleotidase 2" Q9NX62 8 56957931-56993867 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 480000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 38.0 37.6 14.6 16.3 19.6 12.5 19.5 20.8 20.6 25.7 10.3 17.6 13.4 22.1 16.3 19.3 13.5 16.7 29.7 17.6 19.0 23.6 36.5 17.4 12.4 18.6 19.3 16.7 11.9 19.7 35.9 13.8 25.1 19.0 31.3 17.8 19.8 22.1 23.8 37.7 14.4 12.8 26.0 17.8 15.6 17.0 16.6 18.9 15.5 27.3 30.4 13.4 22.6 12.4 30.4 42.4 34.5 26.0 26.9 78.2 53.3 35.7 62.9 60.9 44.1 38.3 17.4 29.2 26.3 47.0 67.3 31.2 33.7 31.8 42.5 65.0 36.4 22.7 51.4 23.0 31.2 48.5 33.0 35.1 43.2 41.6 39.7 63.9 40.8 59.5 24.3 22.5 46.1 48.9 22.1 40.6 19.8 19.2 48.1 12.7 27.9 23.4 29.7 46.0 24.9 10.1 28.1 35.3 42.9 36.3 27.1 38.4 23.9 50.1 59.3 34.2 59.2 45.8 47.5 42.5 27.8 81.0 27.0 37.3 1.8 0.9 0.5 0.9 0.6 0.7 0.7 0.6 0.5 0.7 0.9 0.6 1.1 2.5 3.2 2.6 1.0 0.4 0.3 14.6 19.6 20.8 20.6 17.6 19.0 18.6 19.3 16.7 19.0 17.8 18.9 30.4 22.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 18.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 91.8 14.4 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 33.8 1.8 0.0 0.0 0.0 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261962-41309473 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 302.3;choroid plexus: 391.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 710.9;Breast myoepithelial cells: 1158.6;Cardiomyocytes: 266.3;Leydig cells: 578.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 3203.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" Yes No 1300000 Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: AB_2685376" "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (3.12e-4)" 89.2 13.0 12.0 10.6 12.4 1.4 302.3 18.3 14.9 205.4 391.4 24.8 12.3 133.7 1.8 26.3 99.3 61.8 126.0 29.6 10.3 116.3 6.2 4.8 4.0 27.2 14.3 9.1 47.2 6.2 1.4 1.2 19.7 29.5 43.0 30.4 2.2 239.0 103.3 2.7 55.0 19.1 83.5 7.8 21.6 24.6 28.7 13.6 3.1 12.8 33.1 3.2 45.3 96.4 24.8 0.1 29.0 75.9 1.9 67.5 3.9 14.5 132.9 694.5 197.9 187.2 0.0 17.8 0.0 0.6 0.7 15.8 0.9 10.8 53.7 277.6 0.0 2.3 0.0 0.0 0.0 6.4 0.0 0.7 11.8 255.9 19.9 19.3 3203.5 6.2 0.2 0.0 0.0 3.7 0.0 0.0 0.2 205.8 0.1 0.3 0.0 15.7 0.0 422.6 0.0 4.1 18.5 5.5 0.0 41.5 264.7 0.1 2.1 1.9 0.1 19.6 0.2 18.3 0.0 0.0 0.0 0.2 0.0 279.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 12.4 18.3 14.9 29.6 10.3 27.2 14.3 9.1 29.5 7.8 13.6 24.8 8.4 0.0 0.0 2.0 1.2 11.2 134.0 1.4 147.4 1.8 710.9 1158.6 266.3 0.0 0.7 62.5 2.1 2.2 9.1 0.0 80.3 4.4 5.0 3.0 131.6 21.0 0.0 0.0 0.2 0.0 82.0 229.5 16.8 3.4 0.0 19.3 53.6 0.3 2.0 1.7 12.1 0.0 0.0 0.3 4.0 25.7 578.4 4.0 99.6 0.0 0.0 76.2 0.0 7.5 20.6 0.1 0.0 130.1 2.1 29.7 0.0 3.2 0.0 1.8 0.0 34.9 18.0 2.3 16.8 53.7 5.5 0.8 7.3 72.6 0.0 9.3 LAPTM4B LC27 ENSG00000104341 "Lysosomal protein transmembrane 4 beta" Q86VI4 8 97775057-97853013 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 383.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 348.5;Rod photoreceptor cells: 575.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.3" "Group enriched" "Detected in many" 7 "granulocytes: 3.3;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HEL: 611.7;RPTEC TERT1: 549.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020782, HPA068830" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB020782: , HPA068830: AB_2686044" "prognostic unfavorable (5.63e-4)" "unprognostic (1.91e-2)" "unprognostic (7.04e-2)" "unprognostic (6.83e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (2.70e-6)" "unprognostic (9.25e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-1)" "unprognostic (7.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.65e-1)" "unprognostic (3.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" 24.4 43.7 31.7 18.2 32.0 5.4 43.3 39.4 30.9 50.6 68.4 34.4 80.4 71.7 29.5 34.0 68.1 46.7 222.9 25.5 35.3 62.4 25.5 39.9 13.8 43.4 37.2 24.8 45.5 29.0 187.2 20.5 28.5 40.3 29.4 33.2 383.5 33.0 45.3 155.2 44.3 43.3 48.2 46.8 38.6 32.5 63.0 43.4 8.6 43.4 118.1 20.4 41.4 28.7 52.8 219.2 170.8 171.9 350.3 80.2 61.0 108.1 98.0 50.1 222.9 188.6 103.1 168.0 1.0 378.0 73.5 75.2 241.2 208.8 94.8 242.9 1.5 282.4 611.7 130.6 169.0 66.1 0.3 101.5 83.8 71.0 130.8 66.0 75.1 29.1 69.5 375.7 0.8 92.4 164.1 54.5 34.1 318.8 116.5 106.5 0.6 90.5 0.7 549.4 100.9 172.8 287.1 133.6 63.8 159.4 188.0 154.3 83.7 8.1 47.7 92.0 99.0 70.7 22.4 68.8 2.2 60.8 0.5 144.9 3.3 0.1 0.0 0.5 0.0 1.4 0.3 0.4 0.3 0.1 0.1 0.8 0.9 0.1 0.3 0.0 0.1 0.2 0.2 31.7 32.0 39.4 30.9 25.5 35.3 43.4 37.2 24.8 40.3 46.8 43.4 52.8 60.5 102.5 56.1 8.5 4.9 55.2 68.1 63.9 89.4 195.9 59.8 55.6 208.1 82.9 30.9 106.7 223.1 26.6 3.9 17.9 39.2 244.5 7.1 70.6 59.6 77.4 35.4 36.6 15.0 123.6 33.2 72.2 19.4 105.6 12.7 348.5 132.8 32.6 8.6 134.6 36.6 29.6 59.0 3.7 10.1 8.6 23.9 6.6 42.7 4.7 2.8 135.0 1.0 19.1 20.1 72.1 34.4 30.9 1.7 77.0 95.9 62.1 10.5 575.3 59.2 62.6 75.4 7.4 35.8 45.1 44.3 14.1 10.2 119.9 52.1 86.4 UBE2W "FLJ11011, UBC-16" ENSG00000104343 "Ubiquitin conjugating enzyme E2 W" Q96B02 8 73780097-73878910 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045161, HPA073181" Uncertain Approved Nucleoli NA NA Nucleoli "HPA045161: AB_10960706, HPA073181: AB_2686578" "unprognostic (5.36e-2)" "unprognostic (1.87e-1)" "unprognostic (7.52e-2)" "unprognostic (1.32e-3)" "unprognostic (3.17e-1)" "unprognostic (9.74e-2)" "unprognostic (3.09e-2)" "unprognostic (6.93e-3)" "unprognostic (1.83e-1)" "unprognostic (3.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" "unprognostic (5.01e-2)" "unprognostic (4.38e-2)" "unprognostic (9.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" 7.3 6.3 3.9 7.6 5.9 11.5 7.0 7.1 7.8 5.9 2.3 5.3 4.5 5.1 5.5 8.8 4.7 8.1 8.4 5.8 3.5 11.3 12.8 7.4 7.1 3.5 3.2 5.6 5.4 6.7 8.6 4.7 7.4 4.2 6.1 6.0 10.5 5.7 5.3 8.6 5.4 4.7 6.3 2.3 6.7 5.5 9.6 4.5 7.1 9.2 10.1 7.2 9.8 6.3 5.3 10.3 7.0 8.2 8.0 13.0 14.4 6.8 10.8 12.6 10.6 10.8 5.9 11.1 4.8 8.6 11.7 15.7 10.0 11.2 11.7 16.7 7.7 7.2 10.3 6.5 9.0 8.9 5.6 12.9 10.6 12.2 12.4 21.9 8.5 13.4 5.6 5.1 9.7 16.1 8.7 11.8 6.4 6.2 14.3 13.0 3.8 7.5 4.1 19.7 11.6 5.6 6.5 8.5 26.4 13.2 8.4 13.4 10.0 11.8 12.2 9.4 9.7 8.2 8.7 9.5 3.6 11.2 8.2 11.2 23.8 13.1 17.4 4.7 12.8 5.8 6.8 4.8 3.6 9.1 6.8 4.3 5.0 33.1 7.0 14.4 11.9 6.1 6.9 3.9 5.9 7.1 7.8 5.8 3.5 3.5 3.2 5.6 4.2 2.3 4.5 5.3 28.7 16.0 14.0 40.1 30.3 55.3 26.4 32.1 19.4 35.5 26.7 14.7 24.3 37.1 22.9 53.3 16.7 18.4 35.0 14.2 50.9 23.2 154.5 18.3 21.0 35.3 23.3 26.5 117.0 17.4 20.0 24.9 13.3 26.9 21.0 16.8 26.0 28.7 39.9 42.1 91.8 12.1 22.4 50.3 107.9 56.8 20.5 45.7 42.7 104.9 67.0 28.8 21.6 66.9 67.7 20.9 12.4 18.8 21.3 34.1 14.7 76.1 19.2 32.2 19.7 27.3 39.9 39.4 30.4 20.9 64.5 55.1 31.0 30.6 12.9 40.9 POP1 ENSG00000104356 "POP1 homolog, ribonuclease P/MRP subunit" Q99575 8 98117293-98159835 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066194 Supported Nucleoli NA NA Nucleoli "HPA066194: AB_2732742" "prognostic unfavorable (2.54e-4)" "unprognostic (9.42e-2)" "unprognostic (5.96e-3)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.26e-6)" "prognostic unfavorable (9.88e-4)" "unprognostic (4.85e-1)" "unprognostic (1.47e-1)" "unprognostic (3.79e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-1)" 2.1 1.6 1.3 3.5 1.5 1.5 2.1 3.2 2.0 1.4 1.0 2.0 1.5 1.7 1.4 3.0 1.8 1.3 1.5 1.3 1.2 2.0 1.9 1.6 3.6 1.2 1.5 1.5 3.0 1.7 1.7 1.5 1.2 1.9 1.5 4.8 2.5 1.4 1.4 1.7 3.0 1.6 1.9 0.7 2.1 1.9 3.2 1.4 2.7 1.5 1.2 4.5 2.5 1.5 1.8 21.9 12.9 13.8 12.8 4.8 3.3 9.1 18.3 15.2 18.7 13.8 13.4 13.8 15.3 25.6 12.9 9.0 14.3 40.3 18.2 18.9 11.1 17.0 30.0 10.2 9.2 2.1 16.4 18.4 2.8 3.3 20.8 8.2 5.7 14.8 7.2 17.0 13.5 17.7 17.4 23.8 8.3 10.4 25.1 17.6 19.4 7.5 11.0 13.5 11.5 32.8 7.7 8.4 14.2 6.4 7.9 19.2 6.0 18.4 16.3 11.6 20.8 36.5 13.3 13.6 32.7 12.8 17.3 14.6 9.4 5.1 3.9 7.4 5.7 6.0 4.9 5.4 5.0 5.0 8.1 6.8 6.5 0.8 3.8 2.9 6.2 4.9 2.1 1.3 1.5 3.2 2.0 1.3 1.2 1.2 1.5 1.5 1.9 0.7 1.4 1.8 2.3 3.2 3.9 10.7 4.7 3.7 8.2 3.8 4.0 7.0 2.5 2.3 3.9 0.0 3.8 5.5 0.0 4.1 4.1 2.7 5.9 8.8 13.8 2.4 6.4 4.2 0.0 5.0 17.7 5.9 3.4 5.8 6.6 2.9 1.3 5.9 1.8 5.4 3.4 1.7 19.0 1.7 2.0 2.4 0.8 3.0 5.3 3.3 0.0 3.7 7.9 2.7 10.3 8.5 11.0 7.8 1.0 4.5 5.2 4.8 1.1 8.5 2.6 9.5 6.6 4.0 6.1 7.7 19.1 9.8 2.4 3.0 4.4 6.1 3.9 5.1 NIPAL2 "FLJ13955, NPAL2" ENSG00000104361 "NIPA like domain containing 2" Q9H841 8 98189826-98294393 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 124.5;Squamous epithelial cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 45.5;OE19: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071759 Uncertain NA NA "HPA071759: AB_2686443" "unprognostic (5.14e-3)" "unprognostic (6.43e-2)" "unprognostic (8.01e-2)" "unprognostic (2.02e-1)" "unprognostic (4.52e-2)" "unprognostic (5.18e-2)" "unprognostic (3.72e-1)" "unprognostic (9.45e-2)" "unprognostic (1.90e-2)" "unprognostic (3.67e-1)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.18e-3)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (4.76e-2)" 10.8 12.6 6.3 7.9 7.9 6.5 17.9 5.6 14.1 21.8 6.7 18.0 9.3 14.6 41.3 30.3 12.3 15.6 8.1 8.4 7.0 5.9 7.8 10.3 8.6 5.7 5.0 7.2 27.7 17.0 11.8 22.0 8.5 6.8 23.2 24.4 11.8 20.7 16.1 2.3 53.6 11.8 7.9 4.9 8.2 19.9 5.0 5.6 3.4 7.3 2.6 13.1 13.3 22.0 10.0 7.9 3.1 1.0 0.1 45.5 27.5 0.2 13.9 17.6 2.5 3.4 0.0 22.7 14.7 15.7 19.5 3.7 9.2 0.7 8.3 1.9 1.3 2.8 5.4 2.1 1.1 5.8 5.7 5.5 28.4 21.6 2.6 7.6 1.4 3.2 0.1 0.0 29.1 10.2 10.9 0.2 3.1 1.8 38.1 1.1 0.0 0.2 1.7 9.1 17.7 1.5 3.0 10.1 8.6 3.5 1.2 9.2 10.5 9.2 1.9 0.2 7.0 0.1 0.3 0.0 0.1 3.4 18.2 9.5 0.1 2.0 2.9 0.7 1.9 0.0 1.7 0.6 0.6 3.7 2.6 0.0 0.5 0.3 1.7 1.6 1.5 2.0 1.6 6.3 7.9 5.6 14.1 8.4 7.0 5.7 5.0 7.2 6.8 4.9 5.6 10.0 6.1 3.2 9.3 3.6 11.0 15.3 8.4 19.2 22.8 16.5 10.4 10.8 5.2 7.2 15.8 3.7 2.1 0.2 3.0 20.6 0.0 8.2 7.3 4.6 21.1 8.0 7.2 11.2 124.5 12.8 1.1 13.2 30.5 5.4 5.7 4.1 8.6 3.6 4.6 21.9 30.5 26.3 6.1 6.8 9.4 4.0 25.7 8.5 3.6 26.2 6.0 9.7 10.3 10.6 3.4 9.4 11.0 23.0 6.6 13.4 8.6 1.2 14.3 2.6 6.6 3.3 6.8 0.8 0.7 57.3 22.9 0.3 3.0 12.4 17.2 22.7 IKBKB "IKK-beta, IKK2, IKKB, NFKBIKB" ENSG00000104365 "Inhibitor of nuclear factor kappa B kinase subunit beta" O14920 8 42271302-42332460 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001249, CAB004447" Enhanced Supported Cytosol NA NA Cytosol "CAB004447: AB_627785, HPA001249: AB_1079126" "unprognostic (1.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-3)" "unprognostic (1.26e-1)" "unprognostic (1.27e-3)" "unprognostic (1.95e-1)" "unprognostic (1.25e-3)" "unprognostic (1.75e-1)" "unprognostic (1.55e-1)" "unprognostic (3.27e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.89e-2)" "unprognostic (9.20e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.46e-6)" 9.4 8.3 9.3 4.8 9.8 4.8 8.3 9.4 11.0 7.3 11.7 6.9 4.9 8.1 7.4 10.3 11.7 8.7 5.7 9.2 11.0 6.8 6.7 11.4 12.3 11.0 10.0 8.7 6.1 6.3 13.6 4.0 8.3 10.2 8.0 6.9 12.4 9.0 9.4 13.8 11.5 4.9 12.8 9.9 10.5 5.6 3.2 10.1 10.9 9.5 24.5 11.7 11.2 6.9 10.4 6.2 15.7 8.0 13.6 17.3 18.9 5.8 9.2 18.2 15.2 17.2 3.1 13.9 14.1 10.0 16.5 12.5 5.6 8.4 18.3 17.8 9.8 10.8 17.8 7.8 5.9 20.9 6.1 24.0 12.3 13.7 15.0 19.1 36.1 20.7 11.6 12.8 6.9 34.6 5.1 13.9 11.3 6.1 18.9 6.0 11.1 15.3 10.0 19.6 5.7 1.3 4.7 6.4 6.4 11.7 10.0 8.7 23.6 13.6 7.2 3.9 13.9 6.1 2.8 4.0 10.3 13.8 7.6 16.7 7.4 5.0 5.6 4.6 4.1 4.3 4.4 5.1 5.5 3.7 4.8 4.8 4.7 5.2 5.1 5.5 8.5 5.9 2.9 9.3 9.8 9.4 11.0 9.2 11.0 11.0 10.0 8.7 10.2 9.9 10.1 10.4 31.3 12.8 26.9 19.2 28.4 24.3 34.1 13.9 25.6 12.7 20.6 15.5 8.8 14.3 15.4 16.5 135.5 10.4 34.1 15.9 1.9 13.4 2.3 13.9 15.6 27.4 11.4 10.1 19.7 13.6 5.3 12.4 21.9 16.5 38.0 24.0 19.6 12.0 18.6 18.5 20.6 16.4 8.2 32.3 24.0 3.4 16.4 23.4 19.6 58.1 33.7 8.7 47.4 17.1 30.2 16.6 15.0 12.8 18.2 31.9 13.2 5.5 20.2 47.9 6.6 13.1 11.4 4.8 7.0 17.8 29.1 15.2 24.3 6.2 14.1 30.8 PLAT ENSG00000104368 "Plasminogen activator, tissue type" P00750 8 42174718-42207709 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 247.9;urinary bladder: 183.2" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 763.3;Urothelial cells: 992.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003412, CAB009335" Supported Approved "Actin filaments" "Secreted to blood" NA NA 9900000 110000 "Actin filaments" "CAB009335: AB_2237146, HPA003412: AB_1858205" "prognostic favorable (7.57e-4)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (3.39e-1)" "unprognostic (4.88e-3)" "unprognostic (9.39e-2)" "unprognostic (4.65e-3)" "unprognostic (5.78e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.98e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (8.72e-3)" "unprognostic (1.37e-2)" "unprognostic (2.63e-2)" "unprognostic (6.09e-2)" 43.8 44.3 15.8 35.9 12.8 0.2 35.4 14.1 17.5 21.3 11.1 53.9 30.2 50.0 16.9 34.0 50.2 40.8 16.1 12.1 15.9 91.5 5.3 41.7 2.3 15.1 14.9 10.5 21.7 16.1 247.9 13.4 44.7 17.8 54.5 25.3 2.1 15.8 29.3 8.8 5.7 34.9 33.2 15.1 2.0 42.1 12.0 16.5 4.4 31.2 9.9 2.7 183.2 33.4 16.7 4.2 1.4 29.0 9.1 43.1 61.9 0.9 125.8 216.4 54.2 43.4 1.4 604.7 0.0 4.4 17.1 28.4 14.5 0.3 23.9 78.5 64.6 8.4 0.7 1.0 0.6 253.9 0.2 425.2 65.6 0.4 140.3 6.0 344.9 103.9 0.2 4.6 0.8 298.2 0.0 0.6 0.5 42.3 0.3 48.2 0.2 103.5 0.3 12.6 0.4 0.3 7.4 0.2 0.4 158.7 39.7 1.0 0.3 189.3 11.6 43.1 441.2 15.6 0.2 1.1 0.2 9.7 0.2 806.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.8 12.8 14.1 17.5 12.1 15.9 15.1 14.9 10.5 17.8 15.1 16.5 16.7 63.5 0.0 13.7 0.0 2.9 10.8 763.3 155.9 7.4 4.7 103.9 66.3 7.4 1.5 19.1 0.0 4.2 0.6 0.9 0.1 0.0 9.3 0.9 4.8 104.2 98.2 0.0 0.0 1.6 0.6 1.3 136.5 2.0 5.1 164.0 89.7 36.4 0.8 1.9 1.7 4.0 0.0 4.1 1.0 17.7 1.5 3.7 4.7 23.2 25.3 1.6 2.1 1.0 42.7 0.3 52.0 0.0 2.6 2.8 193.3 0.2 0.3 4.0 3.8 13.1 10.8 48.3 1.1 0.6 13.6 13.5 0.7 6.0 0.5 0.5 992.1 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321540 "Human disease related genes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "skeletal muscle: 239.7;tongue: 107.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 0.2 0.2 3.2 0.5 7.0 0.0 0.7 8.6 5.6 0.7 11.4 3.3 0.7 3.2 0.8 2.9 0.3 0.3 6.9 6.6 3.5 0.8 0.4 3.8 0.1 4.0 2.7 4.8 0.1 6.6 0.8 0.5 1.4 4.6 2.8 5.1 0.4 2.8 0.5 239.7 0.5 1.0 1.9 3.0 0.1 1.0 1.0 3.1 3.3 1.5 107.0 1.1 2.3 1.4 4.4 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 1.1 1.1 0.5 0.2 4.4 0.0 1.5 0.0 1.0 6.4 5.6 4.3 1.4 0.0 8.3 0.0 5.2 0.0 0.7 2.9 0.3 0.8 3.7 0.0 4.0 0.0 0.0 10.9 0.8 0.0 0.4 4.1 15.1 0.0 9.7 17.7 2.9 7.6 5.4 0.0 0.2 12.7 7.3 1.0 0.1 34.4 1.8 1.6 24.2 0.2 0.0 1.6 2.3 0.6 1.4 0.0 0.0 0.0 2.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.0 8.6 5.6 6.6 3.5 4.0 2.7 4.8 4.6 3.0 3.1 4.4 1.1 38.5 12.9 3.9 0.2 2.8 32.8 3.0 6.2 0.4 2.4 1.5 35.7 0.0 10.8 1.8 6.2 0.0 0.1 7.1 0.0 0.3 2.4 2.9 8.9 1.7 12.6 0.0 82.2 1.4 0.0 2.6 7.7 3.7 0.0 0.0 0.0 0.0 0.1 0.0 50.3 9.9 2.0 0.0 0.4 0.5 0.9 0.4 1.8 3.7 0.0 0.4 0.0 14.1 4.6 3.4 6.2 0.0 0.0 32.8 0.0 1.0 6.2 0.1 0.0 25.0 1.4 0.1 4.3 7.4 2.0 0.0 0.2 0.1 6.7 25.6 DKK4 ENSG00000104371 "Dickkopf WNT signaling pathway inhibitor 4" Q9UBT3 8 42374063-42377229 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;esophagus: 5.0" "Group enriched" "Detected in some" 5 "Basal prostatic cells: 5.2;Early spermatids: 2.1;Pancreatic endocrine cells: 4.4;Prostatic glandular cells: 3.7;Spermatocytes: 2.2;Urothelial cells: 5.3" "Cancer enriched" "Detected in many" 20 "endometrial cancer: 174.4" "Region enhanced" "Detected in some" "cerebellum: 3.4;midbrain: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "OE19: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052916 Uncertain "Secreted in other tissues" NA NA "HPA052916: AB_2681987" "unprognostic (1.64e-1)" "unprognostic (5.84e-2)" "unprognostic (1.97e-1)" "unprognostic (5.37e-3)" "unprognostic (3.23e-1)" "unprognostic (2.91e-2)" "unprognostic (2.13e-2)" "unprognostic (1.99e-1)" "unprognostic (6.80e-2)" "unprognostic (2.71e-2)" "unprognostic (1.63e-2)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (8.11e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 3.4 0.1 0.5 0.0 0.0 2.4 0.0 0.7 5.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.0 0.1 0.9 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.8 1.4 0.5 0.3 0.0 0.0 0.4 1.1 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.1 0.7 3.2 0.0 0.9 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.3 5.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.1 0.3 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 5.3 STK3 "KRS1, MST2" ENSG00000104375 "Serine/threonine kinase 3" Q13188 8 98371228-98942827 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 152.7;Oligodendrocytes: 189.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 7.9;granulocytes: 8.8;monocytes: 8.5" "Cell line enhanced" "Detected in many" "A-431: 85.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007120, CAB025316" Uncertain Approved "Intermediate filaments,Rods & Rings" NA NA "Intermediate filaments, Rods & Rings" "CAB025316: , HPA007120: AB_10601664" "unprognostic (7.88e-3)" "unprognostic (1.96e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.53e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-3)" "unprognostic (9.68e-3)" "prognostic unfavorable (4.25e-4)" "unprognostic (6.71e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (9.21e-5)" "unprognostic (9.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (9.72e-2)" 14.2 14.5 5.5 7.9 6.8 3.5 14.3 6.8 7.5 17.2 7.5 10.6 5.6 25.1 14.5 10.3 17.1 14.4 9.2 5.3 6.9 15.8 14.4 11.2 5.5 7.8 6.7 4.7 25.2 10.0 16.2 6.4 18.6 7.3 16.7 6.8 12.1 10.8 17.8 11.5 9.6 8.4 17.4 6.7 6.9 8.6 11.5 6.6 5.1 12.0 8.7 5.5 13.7 13.8 8.1 85.3 15.7 16.2 22.0 51.2 25.4 16.4 28.8 25.6 26.3 22.8 11.7 35.7 0.0 25.6 28.7 14.1 33.4 11.4 24.8 42.2 20.5 14.8 22.9 7.2 8.0 17.5 7.7 19.0 17.0 41.9 13.5 36.6 17.2 11.5 13.4 9.8 12.2 19.4 10.7 19.3 9.4 4.9 58.0 6.1 17.1 14.1 7.5 29.9 10.7 4.3 9.6 18.4 21.1 18.2 21.0 17.8 12.3 8.7 17.9 11.5 27.1 16.3 9.8 15.5 6.2 15.9 9.5 29.0 2.0 8.3 4.6 1.3 8.5 1.4 1.8 0.7 1.8 7.9 1.1 1.0 0.6 8.8 2.0 5.4 3.3 0.1 2.8 5.5 6.8 6.8 7.5 5.3 6.9 7.8 6.7 4.7 7.3 6.7 6.6 8.1 25.9 38.5 37.4 132.9 6.0 43.7 44.8 25.3 23.3 6.9 29.0 15.5 16.6 31.5 37.7 29.5 14.6 43.6 2.5 11.7 23.5 21.5 118.3 23.7 65.8 31.3 9.1 16.2 34.3 18.9 56.1 39.8 9.7 28.9 17.1 13.3 24.3 23.7 19.2 10.1 33.5 7.8 26.4 17.0 25.1 77.1 91.0 18.6 24.9 152.7 13.8 15.0 3.1 60.3 189.9 24.9 13.1 74.1 6.2 42.1 32.3 25.0 29.0 15.6 39.5 43.8 39.7 16.7 12.6 12.3 40.5 64.7 5.9 47.0 13.8 36.0 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74320613-74518007 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.5 9.7 16.1 3.3 23.5 1.2 4.0 15.9 26.9 2.9 5.2 2.3 2.4 4.0 2.0 4.1 2.8 2.5 2.2 23.7 20.2 4.2 1.5 2.5 3.4 15.5 16.4 21.7 6.0 7.4 12.5 20.8 1.2 18.8 4.2 2.4 19.2 2.4 4.2 2.7 1.6 2.4 2.8 11.6 1.9 2.1 4.7 16.3 4.5 6.7 3.2 2.9 3.9 2.6 21.4 3.5 16.8 17.7 4.8 1.2 1.6 1.5 1.8 8.2 8.3 9.5 7.8 5.0 14.8 2.5 1.2 10.6 6.6 12.4 7.0 16.2 19.7 3.6 7.4 8.9 14.0 0.7 7.6 15.8 4.7 2.3 5.3 8.2 0.9 1.1 7.3 3.4 0.3 4.8 5.7 12.6 0.4 20.1 24.5 17.9 8.7 9.2 3.2 2.9 15.3 18.2 38.9 13.1 3.4 9.7 4.9 14.9 2.6 0.0 11.7 6.2 2.9 5.5 9.3 15.7 6.8 7.3 0.3 13.8 0.5 0.9 1.0 0.8 3.1 1.0 1.4 0.8 1.3 0.8 1.3 0.6 0.6 1.8 0.7 5.5 0.2 4.0 0.8 16.1 23.5 15.9 26.9 23.7 20.2 15.5 16.4 21.7 18.8 11.6 16.3 21.4 6.4 6.4 5.1 27.1 5.9 1.8 7.4 4.2 6.2 46.9 6.2 6.1 5.9 5.7 3.6 3.7 47.9 0.4 3.9 2.1 9.8 5.2 5.4 15.4 7.0 6.7 20.4 2.1 75.7 5.8 0.3 4.8 3.1 2.8 17.2 2.1 6.4 1.8 4.7 47.1 67.3 1.7 12.2 6.3 2.5 1.3 4.1 4.6 1.8 15.0 2.9 23.5 4.1 67.8 41.9 3.7 1.4 5.7 2.6 2.6 3.6 6.6 4.9 47.7 0.0 8.0 5.5 14.7 13.1 3.7 1.3 0.0 3.1 6.5 1.7 3.8 RAB2A RAB2 ENSG00000104388 "RAB2A, member RAS oncogene family" P61019 8 60516936-60623644 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018781 Approved NA NA 170000 "CAB018781: AB_654960" "prognostic unfavorable (8.22e-4)" "unprognostic (1.84e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (9.02e-4)" "unprognostic (1.25e-1)" "unprognostic (6.69e-2)" "unprognostic (1.37e-1)" "unprognostic (3.39e-2)" "unprognostic (1.96e-1)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (5.10e-1)" "unprognostic (7.57e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" 67.6 52.5 44.1 36.8 55.0 49.1 49.5 44.1 63.6 47.0 37.8 54.9 49.5 45.9 49.3 83.9 32.4 38.0 70.8 56.0 55.0 63.9 70.9 41.2 26.6 47.3 46.8 48.1 35.3 43.6 69.2 39.3 51.6 48.4 55.5 48.8 41.5 55.0 38.0 116.9 41.4 53.4 40.4 44.0 33.8 61.1 27.6 50.3 31.4 62.9 69.7 28.0 48.8 60.4 63.1 121.6 68.6 46.2 40.4 152.8 105.9 65.7 101.5 72.5 50.3 58.5 29.5 92.0 39.0 40.2 129.4 83.7 70.8 55.4 64.9 69.2 59.8 45.9 56.3 30.1 40.8 112.9 17.3 48.8 113.9 86.6 57.0 68.6 101.1 62.9 32.6 36.0 51.0 80.1 40.4 75.1 29.3 42.6 176.5 30.6 45.6 20.2 33.9 94.2 55.0 31.6 63.2 43.8 84.2 92.0 60.3 84.1 40.3 104.2 66.9 64.3 100.4 63.0 64.7 49.4 43.6 97.3 37.7 82.7 230.0 164.4 241.2 88.0 149.3 81.5 112.3 90.0 101.2 147.7 108.9 92.2 100.1 310.9 130.2 152.0 97.1 117.7 129.3 44.1 55.0 44.1 63.6 56.0 55.0 47.3 46.8 48.1 48.4 44.0 50.3 63.1 167.5 157.0 129.0 67.3 99.3 214.4 197.0 267.0 135.5 102.2 152.6 148.2 182.0 117.2 190.7 165.5 16.7 214.4 112.2 198.6 426.5 266.4 404.2 133.2 200.4 163.8 178.6 56.0 103.7 278.1 365.2 194.9 107.6 197.1 92.5 103.6 121.3 261.9 204.2 124.5 89.6 332.0 266.5 100.2 146.1 111.6 175.2 129.4 279.3 89.0 159.3 153.6 129.8 133.7 124.9 324.4 168.6 165.5 143.8 315.2 200.2 366.4 142.1 60.8 170.9 149.3 236.2 219.7 106.2 210.6 241.5 467.8 102.8 162.7 169.9 335.6 EIF3E "eIF3-p48, EIF3S6, INT6" ENSG00000104408 "Eukaryotic translation initiation factor 3 subunit E" P60228 8 108162787-108443496 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023973 Approved Supported Cytosol NA NA 21000 Cytosol "HPA023973: AB_1848083" "unprognostic (8.18e-2)" "unprognostic (4.28e-2)" "unprognostic (6.26e-2)" "unprognostic (1.51e-1)" "unprognostic (3.52e-3)" "unprognostic (6.93e-3)" "unprognostic (2.29e-2)" "unprognostic (2.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.96e-1)" "unprognostic (1.67e-3)" "unprognostic (3.63e-1)" "prognostic unfavorable (3.06e-7)" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.77e-2)" 265.5 203.1 111.1 95.0 113.5 253.9 422.3 119.9 179.5 344.1 120.2 251.0 94.3 234.4 245.5 258.4 265.2 164.9 184.9 111.2 116.8 177.7 200.7 175.7 233.0 114.3 114.3 108.3 453.2 412.6 139.6 158.4 162.4 116.8 206.6 157.2 64.1 215.9 188.2 346.0 215.2 183.3 136.8 115.7 158.9 239.0 84.5 113.1 285.6 185.6 243.2 210.6 250.9 269.5 122.8 339.4 208.1 211.3 193.3 518.2 1098.8 139.9 193.0 430.3 415.4 443.0 238.0 260.1 653.0 213.0 288.6 134.2 187.6 421.1 507.6 502.6 216.1 485.0 595.8 218.6 472.3 357.6 287.5 169.0 813.2 745.9 272.8 678.6 534.7 636.8 405.6 477.5 196.8 469.6 453.7 384.2 898.4 196.2 577.7 403.6 300.6 278.8 436.6 520.0 305.2 223.5 192.2 122.0 78.0 363.2 288.2 263.8 413.7 279.1 131.7 241.7 139.9 201.9 167.4 171.6 426.5 171.6 483.1 149.8 79.5 165.6 32.6 104.0 161.0 197.1 214.7 205.5 148.4 218.7 178.0 301.0 225.9 14.6 166.8 153.1 116.6 202.5 317.3 111.1 113.5 119.9 179.5 111.2 116.8 114.3 114.3 108.3 116.8 115.7 113.1 122.8 216.8 134.6 204.6 36.9 565.3 1036.0 1105.8 1174.4 805.3 64.5 569.8 274.2 93.1 317.4 463.5 158.2 54.2 614.4 288.0 101.3 606.5 332.3 377.4 173.8 399.2 365.6 297.5 319.8 36.3 354.3 770.9 366.9 196.7 220.5 378.3 277.1 403.4 212.6 424.2 58.9 36.2 400.5 443.5 662.4 875.2 73.8 454.2 368.7 517.6 37.5 621.8 154.8 268.8 59.8 69.2 272.3 279.1 327.6 251.0 728.2 273.8 799.7 201.7 74.6 190.7 434.6 564.5 276.7 102.8 532.6 1117.1 620.3 488.1 490.0 568.6 914.3 EMC2 "KIAA0103, TTC35" ENSG00000104412 "ER membrane protein complex subunit 2" Q15006 8 108443601-108489196 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 190.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022838 Approved NA NA 11000 "HPA022838: AB_2670967" "prognostic unfavorable (2.64e-4)" "unprognostic (1.45e-1)" "unprognostic (3.52e-1)" "unprognostic (1.33e-2)" "unprognostic (1.54e-1)" "unprognostic (6.64e-2)" "unprognostic (1.10e-1)" "unprognostic (7.87e-2)" "unprognostic (4.36e-1)" "unprognostic (5.46e-2)" "unprognostic (5.76e-2)" "unprognostic (5.53e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-1)" "unprognostic (1.68e-1)" "unprognostic (2.22e-1)" "unprognostic (4.15e-3)" 40.7 38.5 22.0 5.4 23.7 3.6 37.0 23.1 25.5 31.4 21.5 38.9 6.0 28.0 10.2 40.1 31.3 6.7 45.5 21.6 22.7 40.2 34.9 35.8 6.3 23.2 22.4 20.4 29.8 41.4 9.7 32.5 9.4 23.5 27.4 8.6 10.3 33.2 7.6 57.8 30.4 27.8 7.3 23.9 26.8 35.3 39.0 22.3 4.6 30.5 11.0 6.1 34.0 34.1 28.5 10.5 5.8 5.0 6.0 9.0 10.1 4.5 4.1 6.5 7.1 6.5 4.8 6.7 4.9 8.7 6.8 5.2 4.6 9.8 10.7 9.0 10.4 9.7 7.9 12.0 7.0 13.7 4.6 4.8 10.7 13.2 6.1 12.0 10.9 9.3 5.6 7.3 5.2 9.4 11.8 6.4 7.0 4.6 17.1 9.9 2.8 6.0 8.0 16.0 5.6 5.4 3.4 4.8 1.3 10.0 7.4 8.3 7.7 5.4 5.0 4.4 9.2 5.4 5.3 11.8 4.9 12.6 10.8 7.7 11.6 6.1 10.4 9.0 5.9 8.1 6.3 8.1 10.7 6.3 6.0 9.6 9.6 7.9 6.9 6.8 10.3 8.5 5.6 22.0 23.7 23.1 25.5 21.6 22.7 23.2 22.4 20.4 23.5 23.9 22.3 28.5 47.3 32.1 49.5 50.9 22.8 27.5 52.5 157.7 27.3 17.9 18.6 20.8 66.8 37.1 98.7 36.8 14.6 57.2 25.8 19.8 86.1 52.0 72.8 48.4 28.4 37.4 21.1 9.9 30.9 46.5 47.6 43.9 17.3 28.7 35.5 20.8 32.9 24.7 47.7 18.5 37.8 23.6 93.6 20.5 16.1 24.6 36.7 21.3 32.0 24.4 38.6 57.9 16.5 44.7 102.1 34.2 27.5 37.2 27.6 31.4 40.3 102.4 98.6 30.5 65.7 39.3 64.6 190.8 71.6 20.5 27.3 73.5 24.4 45.9 22.2 42.5 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779" "prognostic unfavorable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.2 0.0 0.0 5.3 0.0 0.0 24.4 0.0 0.1 15.7 0.0 57.7 25.4 3.4 29.9 64.8 21.4 8.5 0.1 0.0 0.0 8.6 0.4 15.9 0.0 0.0 0.1 0.0 0.1 43.0 28.6 7.3 12.3 0.0 20.1 63.4 0.0 26.1 10.1 0.1 61.1 22.1 2.6 0.0 0.0 39.0 0.7 0.4 5.3 36.9 0.0 15.5 22.7 29.0 0.0 138.3 0.0 0.0 0.2 0.0 0.0 101.1 0.0 0.0 0.0 0.0 44.6 140.8 0.0 3.8 0.0 0.1 81.6 3.8 70.9 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 226.5 0.0 1.4 0.0 0.0 10.7 0.0 0.0 0.0 67.3 1.9 0.4 12.4 142.6 3.4 0.0 0.0 18.3 17.4 99.1 35.1 0.3 0.0 21.0 14.0 21.4 108.0 0.9 0.0 0.1 0.2 0.1 0.3 12.0 13.8 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 38.5 36.7 0.0 0.6 44.6 18.9 30.4 35.9 0.0 29.4 18.0 1.0 21.5 32.4 27.6 0.0 55.1 0.5 76.2 13.7 19.6 12.9 47.1 3.7 0.9 33.1 0.0 2.6 27.5 69.1 0.9 58.1 46.5 1.3 0.0 0.4 0.1 6.0 0.0 0.4 107.2 16.2 0.0 3.2 10.3 0.0 0.5 24.9 0.0 0.6 0.0 0.0 0.5 0.4 21.7 48.1 0.7 1.8 25.1 25.5 0.3 35.0 0.0 0.0 0.0 1.2 0.6 0.9 71.3 79.1 62.1 0.8 0.0 73.9 40.1 CCN4 "WISP-1, WISP1, WISP1-OT1, WISP1-UT1" ENSG00000104415 "Cellular communication network factor 4" O95388 8 133191039-133231690 "Cancer-related genes, Predicted secreted proteins" "Cell adhesion, Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HSkMC: 110.5;hTEC/SVTERT24-B: 64.5;U-2197: 61.9" "Region enriched" "Detected in some" 6 "olfactory bulb: 9.8" "Low region specificity" "Detected in many" "HPA007121, CAB012205" Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "CAB012205: , HPA007121: AB_1858844" "unprognostic (7.77e-2)" "unprognostic (2.05e-1)" "unprognostic (3.30e-2)" "unprognostic (3.20e-1)" "unprognostic (7.72e-2)" "unprognostic (6.63e-2)" "unprognostic (8.61e-3)" "unprognostic (3.26e-2)" "unprognostic (2.07e-3)" "unprognostic (1.41e-3)" "unprognostic (3.01e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (7.52e-3)" "unprognostic (2.55e-3)" "unprognostic (6.03e-2)" "unprognostic (5.67e-3)" 2.6 10.4 0.9 7.7 2.5 0.0 0.9 0.5 1.1 11.0 1.1 3.1 1.2 14.1 0.9 0.9 5.9 7.9 2.8 1.4 0.6 9.6 2.0 8.4 3.0 1.3 0.6 1.3 6.0 0.8 9.3 2.4 2.9 0.8 3.3 0.8 0.0 1.1 1.4 0.4 1.3 2.4 13.7 0.5 2.2 2.8 1.2 0.7 0.2 1.1 0.2 3.9 6.1 3.7 0.9 0.0 0.5 0.0 0.0 7.6 4.2 0.1 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 110.5 0.0 64.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.0 0.0 0.0 14.8 0.8 61.9 0.0 0.0 0.0 0.0 12.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.5 0.5 1.1 1.4 0.6 1.3 0.6 1.3 0.8 0.5 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NDRG1 "CAP43, DRG1, NDR1, RTP, TDD5" ENSG00000104419 "N-myc downstream regulated 1" Q92597 8 133237175-133302022 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 596.0" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006881 Approved Supported Microtubules,Cytosol NA NA 200000 Cytosol Microtubules "HPA006881: AB_1078392" "unprognostic (6.96e-3)" "unprognostic (3.31e-3)" "unprognostic (8.53e-2)" "unprognostic (1.41e-3)" "unprognostic (1.54e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.04e-3)" "unprognostic (5.33e-2)" "unprognostic (4.29e-2)" "unprognostic (9.09e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.13e-4)" "unprognostic (7.27e-2)" "unprognostic (1.91e-1)" "unprognostic (2.47e-3)" "unprognostic (4.28e-2)" 153.5 73.6 331.2 56.5 475.4 131.2 108.5 379.0 285.3 137.1 148.9 131.2 244.4 93.7 34.6 345.8 107.3 88.6 82.0 223.2 313.0 194.2 50.1 117.7 39.0 460.2 477.3 161.4 127.1 53.3 69.7 82.8 111.7 522.8 357.4 78.5 86.8 131.8 60.5 28.4 253.7 260.3 62.4 357.3 39.7 155.4 28.4 407.2 55.6 81.1 45.0 88.9 106.4 276.1 596.0 191.6 24.0 1.7 0.8 116.3 86.8 26.0 13.7 103.0 9.8 52.5 12.5 27.6 1.5 133.0 58.0 21.9 62.4 1.7 316.8 18.0 13.3 226.8 1.9 55.6 14.7 46.3 7.0 4.6 79.2 606.9 51.2 1226.9 124.2 45.2 27.9 2.0 138.3 17.2 11.0 19.1 20.8 3.0 69.8 155.8 1.7 19.4 86.2 29.7 28.0 13.8 13.0 31.0 312.1 73.3 48.6 1.3 20.0 58.5 84.4 43.6 40.7 10.4 96.3 280.3 0.8 772.5 69.5 161.5 10.9 4.3 0.0 5.8 3.4 9.1 1.6 5.3 6.9 6.0 1.4 3.9 3.1 4.0 1.5 4.2 13.0 8.1 3.7 331.2 475.4 379.0 285.3 223.2 313.0 460.2 477.3 161.4 522.8 357.3 407.2 596.0 123.0 144.2 47.4 14.4 23.6 571.9 141.3 207.3 42.1 68.8 28.6 31.2 20.6 80.1 102.9 187.6 2.1 12.8 68.1 405.4 33.2 33.2 5.3 57.4 59.0 217.7 22.1 17.4 7.7 13.7 138.2 90.5 151.4 167.7 22.2 41.0 112.8 64.0 16.5 588.9 5.7 140.9 83.4 31.1 109.5 5.9 49.0 42.7 101.4 28.1 25.7 81.2 14.4 20.6 136.2 62.9 155.9 44.0 23.5 264.3 402.5 87.5 38.7 40.3 46.0 65.2 44.3 1.2 7.1 113.0 667.4 43.4 45.7 32.6 124.7 280.8 ZC2HC1A "C8orf70, CGI-62, FAM164A" ENSG00000104427 "Zinc finger C2HC-type containing 1A" Q96GY0 8 78666089-78719765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 45.0" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 45.1;T-reg: 33.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 42.1;SK-BR-3: 79.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024726 Approved Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA024726: AB_1846597" "unprognostic (1.12e-1)" "unprognostic (3.02e-1)" "unprognostic (5.36e-3)" "unprognostic (4.00e-2)" "unprognostic (1.13e-1)" "unprognostic (7.79e-2)" "unprognostic (1.19e-7)" "unprognostic (2.96e-1)" "unprognostic (7.25e-2)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.26e-1)" "unprognostic (1.63e-2)" "unprognostic (5.41e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.34e-1)" "unprognostic (5.40e-2)" "unprognostic (4.05e-3)" 6.6 5.6 7.7 5.7 9.9 1.6 14.0 11.4 9.6 10.8 2.5 5.8 2.8 19.7 8.4 11.2 19.2 9.8 8.3 9.1 10.1 7.8 2.3 12.7 5.3 9.1 8.0 7.3 22.9 3.8 24.2 8.6 6.7 10.5 12.3 7.4 11.0 7.4 10.0 2.4 45.0 4.2 12.2 6.5 5.9 5.6 8.9 7.2 5.2 19.9 6.4 8.4 9.1 8.8 11.0 5.2 6.3 11.6 9.5 24.1 25.2 5.0 14.1 9.4 6.9 8.8 1.7 9.0 8.6 5.8 14.2 14.5 4.2 7.0 7.8 10.1 28.6 4.5 1.0 5.5 5.2 14.3 1.5 2.8 18.2 13.0 5.6 16.8 21.1 9.6 2.9 1.6 42.1 14.6 5.1 1.7 2.5 2.9 0.4 9.9 0.0 14.8 1.8 10.4 11.0 4.5 18.0 11.0 79.2 15.8 10.7 2.0 0.3 7.9 21.4 8.9 9.9 7.1 10.5 11.4 5.8 10.1 0.1 8.3 45.1 6.7 0.2 0.1 7.5 0.0 8.8 6.7 0.4 6.0 6.3 2.0 0.7 0.3 1.2 15.9 0.5 33.3 2.7 7.7 9.9 11.4 9.6 9.1 10.1 9.1 8.0 7.3 10.5 6.5 7.2 11.0 21.7 67.3 23.7 71.8 17.0 29.2 38.7 39.9 52.3 26.3 12.3 47.5 15.9 5.7 27.4 18.4 4.2 29.0 1.0 1.8 27.4 18.1 16.3 55.5 38.0 17.5 9.0 1.7 96.4 8.2 29.9 34.5 13.3 25.8 6.3 18.8 21.8 0.8 15.9 47.1 68.3 4.2 16.2 6.0 11.3 5.9 19.3 11.1 16.0 14.0 18.5 39.2 0.0 65.9 52.4 9.4 2.4 36.9 12.5 13.1 0.1 11.8 105.5 25.5 6.6 32.0 33.9 48.6 32.2 26.0 42.3 17.4 6.5 9.4 4.4 14.6 IL7 IL-7 ENSG00000104432 "Interleukin 7" P13232 8 78675743-78805523 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 108.8;Late spermatids: 145.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 9.7;naive B-cell: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.6;HDLM-2: 15.4;HEL: 18.2;HMC-1: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019590 Approved "Secreted to blood" NA NA 60700 "HPA019590: AB_10794621" "unprognostic (3.19e-3)" "unprognostic (1.44e-1)" "unprognostic (9.57e-3)" "unprognostic (5.45e-2)" "unprognostic (9.37e-3)" "unprognostic (3.36e-1)" "unprognostic (1.71e-1)" "unprognostic (1.65e-2)" "unprognostic (2.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.02e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (6.55e-2)" "unprognostic (2.11e-4)" 2.3 1.2 0.3 4.2 0.3 2.1 1.5 0.3 0.2 2.3 0.5 5.2 6.7 1.1 0.3 3.6 4.8 3.2 0.6 0.3 0.9 1.4 4.2 3.3 8.8 0.5 0.5 0.0 0.9 1.0 0.0 0.5 0.3 0.4 1.8 4.5 0.7 1.1 0.9 0.1 8.8 8.8 1.1 0.3 3.5 3.9 1.7 0.9 0.8 1.3 0.1 4.2 2.9 1.5 0.3 0.3 0.0 0.1 0.0 0.4 0.4 0.0 1.4 1.4 1.3 1.9 0.0 7.6 0.1 0.0 4.4 4.5 4.2 0.1 0.0 0.0 15.4 0.0 18.2 0.6 2.1 0.1 0.1 25.4 1.3 0.0 0.2 0.6 4.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.0 5.4 3.2 0.0 2.4 2.6 0.3 0.2 0.0 0.1 0.0 0.2 0.8 0.9 0.0 2.0 0.3 0.0 0.0 3.4 0.0 1.9 5.2 0.3 0.0 0.4 0.2 0.0 9.7 1.0 1.0 2.2 8.7 0.2 0.3 0.0 0.5 0.8 0.3 7.3 0.6 0.3 0.3 0.3 0.2 0.3 0.9 0.5 0.5 0.0 0.4 0.3 0.9 0.3 0.6 0.0 3.6 5.9 12.2 6.0 3.2 1.2 10.8 0.1 1.3 0.9 0.7 5.7 2.4 1.8 0.0 0.0 1.3 7.8 9.8 1.2 108.8 22.9 0.8 4.9 3.0 10.5 16.0 5.1 0.0 2.5 11.2 0.6 0.0 0.1 1.8 2.4 0.9 0.0 11.0 6.2 2.0 1.0 3.3 145.5 0.6 1.9 0.0 1.0 3.4 2.0 0.0 20.1 6.0 2.6 11.5 1.2 1.0 1.2 12.4 9.5 24.2 0.4 0.0 2.2 0.5 2.3 0.9 5.2 6.5 0.0 1.6 0.1 4.6 1.7 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79611117-79666158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 563.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 182.2;Horizontal cells: 148.0;Inhibitory neurons: 133.0;Rod photoreceptor cells: 53.4" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 2.2" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 663.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" NA NA Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 3.3 69.2 143.3 9.7 179.6 0.1 2.8 193.1 563.3 8.5 7.8 22.2 14.1 1.1 0.0 1.0 0.1 3.6 0.7 152.9 250.8 0.2 0.9 0.3 0.7 208.9 271.8 144.1 0.5 4.7 0.0 8.9 0.1 235.9 2.6 29.2 87.7 0.9 1.7 0.3 11.6 18.7 6.4 87.6 4.5 5.4 1.9 237.0 0.3 0.2 0.3 1.5 0.4 5.0 525.8 0.0 0.0 5.6 0.0 0.9 0.2 0.3 72.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 59.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 60.5 663.5 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 143.3 179.6 193.1 563.3 152.9 250.8 208.9 271.8 144.1 235.9 87.6 237.0 525.8 0.1 0.0 0.0 26.1 0.0 1.0 0.0 0.0 0.0 27.8 0.0 0.3 0.1 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 18.2 0.0 1.5 1.4 24.9 0.0 182.2 0.0 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 148.0 133.0 0.0 0.0 0.0 2.0 8.2 0.3 0.0 1.8 19.7 0.0 16.3 0.0 19.1 23.5 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 53.4 0.0 0.0 0.6 0.5 0.7 0.0 0.9 0.0 0.1 0.0 0.0 0.5 ARMC1 "Arcp, FLJ10511" ENSG00000104442 "Armadillo repeat containing 1" Q9NVT9 8 65602458-65634217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026085 Approved Approved Mitochondria NA NA Mitochondria "HPA026085: AB_1845031" "prognostic unfavorable (4.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (8.18e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (7.73e-4)" "unprognostic (4.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.15e-4)" "unprognostic (1.81e-1)" "unprognostic (3.30e-3)" "unprognostic (1.08e-1)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (1.66e-1)" 16.7 15.6 22.1 13.7 26.2 13.2 18.6 24.0 28.2 15.4 18.9 15.1 15.7 18.7 16.5 17.0 13.3 12.0 21.8 22.2 24.5 22.2 23.4 12.5 19.4 23.9 24.0 21.4 19.0 15.1 21.2 9.1 15.1 23.5 17.9 16.7 12.6 15.8 17.1 19.3 11.6 13.8 21.8 23.5 14.0 13.7 9.5 23.6 22.6 14.9 24.9 20.5 17.0 10.9 28.5 51.3 35.6 34.2 32.0 33.1 30.1 24.8 44.7 33.2 46.5 34.2 26.5 40.3 79.0 11.2 41.0 50.7 33.4 61.9 35.9 62.9 45.0 31.7 61.3 20.6 38.9 44.1 23.4 32.0 27.8 40.9 38.3 52.5 36.6 48.5 55.3 64.5 54.7 50.6 32.9 86.9 30.7 35.7 63.6 38.9 49.9 42.6 27.9 37.2 23.8 25.3 27.3 28.5 35.4 44.3 34.6 56.9 27.2 28.5 43.8 32.1 33.8 42.5 40.3 45.2 53.2 41.5 42.8 43.7 36.3 5.6 7.4 8.3 9.3 11.4 9.8 9.9 10.2 7.2 6.9 9.9 10.1 0.7 11.5 9.2 6.4 11.4 6.5 22.1 26.2 24.0 28.2 22.2 24.5 23.9 24.0 21.4 23.5 23.5 23.6 28.5 26.6 41.7 27.7 16.0 33.0 15.8 12.1 17.5 19.4 23.7 20.7 19.4 33.4 18.6 24.5 16.5 22.9 35.0 32.9 14.4 54.8 28.3 10.4 15.9 26.9 23.7 23.4 62.7 23.9 28.1 43.9 24.4 20.4 15.3 10.8 31.5 21.4 25.6 25.0 20.2 22.7 17.0 24.4 18.9 12.6 5.7 26.1 20.6 21.4 19.7 31.6 47.3 24.7 15.1 47.7 28.0 13.0 33.4 27.2 18.9 19.9 47.7 17.6 21.9 6.6 29.0 32.2 50.7 24.5 29.9 18.5 37.6 28.0 28.1 23.4 9.1 TRPS1 "GC79, LGCR" ENSG00000104447 "Transcriptional repressor GATA binding 1" Q9UHF7 8 115408496-115809673 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1;breast: 61.4" "Cell type enhanced" "Detected in many" "Astrocytes: 758.7;Breast glandular cells: 243.2;Oligodendrocyte precursor cells: 280.5;Oligodendrocytes: 294.0" "Cancer enriched" "Detected in many" 8 "breast cancer: 49.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 47.4;SK-BR-3: 78.1;T-47d: 244.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060380, HPA071767" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA060380: AB_2684270, HPA071767: AB_2732185" "unprognostic (4.34e-2)" "unprognostic (4.65e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-1)" "unprognostic (1.87e-1)" "prognostic favorable (9.42e-4)" "unprognostic (2.23e-3)" "unprognostic (2.08e-1)" "unprognostic (9.31e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (3.02e-1)" "unprognostic (2.17e-2)" "unprognostic (1.93e-2)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (3.07e-3)" 4.1 3.1 14.7 5.7 16.7 7.6 61.4 12.5 11.0 10.7 6.6 4.3 0.9 10.0 3.5 14.4 5.6 10.0 2.9 14.6 38.1 5.5 2.1 4.7 4.9 31.6 21.5 0.2 5.2 1.1 5.3 2.7 2.8 31.7 9.5 2.8 4.2 12.1 8.4 2.6 10.1 2.1 10.6 14.8 4.2 2.7 12.6 18.4 2.5 5.8 3.4 4.1 5.2 14.2 30.3 3.1 0.6 5.9 0.3 5.4 19.8 0.6 4.9 11.3 3.1 5.2 0.5 4.9 2.4 0.0 12.7 2.6 0.1 22.9 4.3 3.5 0.3 6.9 0.1 10.3 0.2 7.2 0.0 0.3 9.5 4.4 8.6 15.8 8.9 2.7 0.3 1.1 37.7 6.0 47.4 0.2 0.0 1.1 1.1 4.8 0.2 0.2 30.0 4.9 0.3 5.2 3.9 2.5 78.1 3.2 2.8 244.8 2.1 0.2 13.7 6.9 4.0 9.7 10.1 0.3 4.5 14.4 0.0 9.2 0.0 4.5 0.0 0.9 1.9 0.9 0.5 1.0 1.0 1.7 0.8 0.9 0.9 0.8 1.0 1.4 0.6 0.5 0.8 14.7 16.7 12.5 11.0 14.6 38.1 31.6 21.5 0.2 31.7 14.8 18.4 30.3 10.0 6.4 3.0 758.7 13.3 9.4 20.0 10.3 34.1 9.2 243.2 125.1 4.6 2.8 9.2 18.4 43.8 0.1 18.7 0.1 11.7 2.9 95.0 58.5 35.7 7.5 0.0 5.5 128.3 2.9 0.2 26.8 4.6 63.5 12.7 0.3 3.6 1.1 16.5 0.0 148.2 0.0 8.2 55.2 104.1 163.2 25.1 55.5 21.4 171.4 32.5 10.6 5.2 280.5 294.0 2.7 0.0 28.2 10.1 16.9 0.0 23.7 8.9 35.9 6.6 60.2 28.2 1.8 8.3 73.6 12.5 0.3 25.6 19.5 0.0 11.2 SPAG1 "CILD28, CT140, FLJ32920, HSD-3.8, SP75, TPIS" ENSG00000104450 "Sperm associated antigen 1" Q07617 8 100157906-100259278 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Fertilization Hydrolase "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 96.0;Endometrial ciliated cells: 190.6;Respiratory ciliated cells: 198.6;Spermatocytes: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023748, HPA053682" Enhanced Supported Cytosol NA NA Cytosol "HPA023748: AB_2671304, HPA053682: AB_2682229" "unprognostic (9.95e-2)" "unprognostic (5.37e-2)" "unprognostic (1.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.46e-1)" "unprognostic (2.57e-1)" "unprognostic (5.86e-2)" "unprognostic (9.19e-2)" "unprognostic (1.53e-1)" "unprognostic (5.62e-2)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (9.11e-3)" "unprognostic (8.83e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.62e-4)" 1.8 1.3 6.5 3.7 3.5 10.2 3.0 4.4 3.4 5.4 11.9 13.0 3.0 2.5 1.5 7.9 10.1 3.8 1.4 3.1 9.0 3.3 4.8 5.1 2.7 6.8 7.5 2.2 1.0 2.5 9.1 5.7 1.9 6.0 3.1 18.4 1.9 4.6 3.6 0.4 8.0 2.7 1.8 7.1 2.0 6.4 19.6 4.5 2.1 3.5 0.6 4.4 5.3 3.0 5.7 31.3 8.3 0.5 1.8 1.8 1.5 4.6 5.7 3.4 6.8 7.1 8.3 13.5 1.2 20.0 1.8 10.1 16.1 5.9 11.1 6.3 18.1 6.1 5.2 9.0 3.1 2.4 1.4 4.5 1.3 5.8 8.4 6.6 5.3 5.8 5.7 0.2 16.1 1.0 11.2 3.1 1.4 0.5 15.6 9.1 0.5 1.3 4.7 26.1 14.8 4.8 3.5 7.8 6.4 7.0 2.2 9.2 5.9 5.3 6.8 9.8 3.6 14.9 10.9 8.9 0.9 6.5 5.0 3.4 0.0 0.1 0.6 0.1 0.0 0.0 0.8 0.1 0.1 0.1 0.3 0.0 0.1 0.7 1.0 0.2 0.2 0.0 0.0 6.5 3.5 4.4 3.4 3.1 9.0 6.8 7.5 2.2 6.0 7.1 4.5 5.7 7.7 48.1 22.8 18.9 7.7 5.6 9.6 18.1 2.2 2.0 13.3 7.7 5.6 22.8 37.2 18.4 0.0 1.3 19.0 32.9 5.9 19.7 96.0 190.6 7.1 6.9 22.1 0.4 30.1 8.6 8.7 5.0 22.4 39.5 10.1 7.3 4.2 8.0 2.8 8.4 21.6 14.9 6.1 2.2 5.3 32.3 5.0 3.9 1.8 6.5 4.5 11.5 5.2 4.5 4.1 14.9 17.7 3.8 15.9 10.3 2.4 10.0 198.6 2.3 0.0 4.8 6.4 91.9 4.7 2.9 5.4 2.3 12.0 1.3 20.1 23.3 CHRAC1 "CHRAC15, YCL1" ENSG00000104472 "Chromatin accessibility complex subunit 1" Q9NRG0 8 140511311-140517154 "Predicted intracellular proteins" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059008 Approved Nucleoplasm NA NA Nucleoplasm "HPA059008: AB_2683878" "unprognostic (6.34e-2)" "unprognostic (7.32e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (4.88e-5)" "unprognostic (8.79e-3)" "unprognostic (1.86e-1)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.43e-4)" "unprognostic (4.19e-1)" "unprognostic (6.22e-3)" "unprognostic (7.61e-2)" "unprognostic (1.01e-1)" "unprognostic (6.92e-2)" "unprognostic (1.49e-1)" 14.8 11.7 10.7 17.0 14.2 28.3 12.6 11.2 12.1 12.8 8.0 15.6 16.2 15.2 11.8 21.7 13.3 16.7 16.0 9.6 10.8 16.3 14.6 14.9 24.2 14.3 13.6 8.8 13.6 18.3 16.6 8.9 15.1 13.8 11.7 16.2 4.7 13.1 11.7 28.2 19.8 18.3 18.2 11.8 12.7 15.8 14.6 12.3 21.6 21.1 25.5 26.4 17.9 11.8 18.4 53.3 25.2 23.1 22.0 22.6 38.1 17.8 22.2 32.2 31.8 38.1 32.5 37.1 54.6 32.2 27.4 25.1 32.3 28.0 22.6 43.6 42.5 30.2 77.5 33.1 37.0 21.4 26.2 39.4 19.2 32.5 23.6 45.3 17.1 30.9 33.1 58.3 50.4 28.4 61.6 91.6 27.9 17.2 46.5 43.6 54.4 24.7 43.5 32.0 21.8 31.7 26.3 31.1 20.9 39.5 12.6 40.4 29.3 29.4 37.4 65.1 46.5 47.8 24.2 34.0 66.3 45.0 61.1 29.6 10.6 20.2 25.4 18.2 26.5 17.5 20.4 15.6 17.7 22.4 24.1 16.0 13.9 24.3 20.3 30.2 22.8 15.6 16.1 10.7 14.2 11.2 12.1 9.6 10.8 14.3 13.6 8.8 13.8 11.8 12.3 18.4 32.3 16.0 29.9 4.2 45.6 38.4 39.2 28.5 29.0 7.4 26.3 18.0 14.7 20.0 25.9 14.7 2.1 24.9 45.0 23.4 43.0 27.4 20.2 25.6 31.4 29.6 21.6 28.8 2.4 36.0 49.3 27.4 19.4 44.8 32.4 13.3 31.8 22.4 25.2 6.7 2.5 23.6 24.4 30.8 51.4 31.7 29.2 37.1 19.6 6.5 43.8 26.9 43.3 4.0 14.9 38.2 20.6 25.2 26.4 35.2 29.0 33.8 13.9 11.7 72.3 34.9 31.1 75.5 58.3 34.5 48.6 24.1 42.4 15.8 22.3 35.9 NCALD ENSG00000104490 "Neurocalcin delta" P61601 8 101686542-102124907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 101.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 251.6;Inhibitory neurons: 460.2;Oligodendrocyte precursor cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 87.3" "Group enriched" "Detected in many" 13 "NK-cells: 87.3;T-cells: 42.2" "Cell line enhanced" "Detected in many" "AF22: 136.4;HDLM-2: 159.9;U-266/70: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Approved NA NA "HPA043245: AB_2678385" "unprognostic (3.49e-1)" "unprognostic (1.55e-1)" "unprognostic (4.85e-2)" "unprognostic (4.97e-2)" "unprognostic (5.48e-3)" "unprognostic (2.60e-3)" "unprognostic (1.25e-1)" "unprognostic (5.63e-3)" "unprognostic (1.54e-1)" "unprognostic (2.48e-1)" "prognostic favorable (5.30e-4)" "unprognostic (2.79e-1)" "unprognostic (6.24e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-1)" "unprognostic (7.87e-2)" "unprognostic (1.00e-2)" 21.6 7.4 18.6 9.5 42.6 1.8 44.4 0.4 57.7 13.6 0.0 17.3 6.1 7.7 4.4 12.7 39.9 12.7 11.9 46.4 24.3 15.1 15.2 19.8 13.7 5.4 17.6 45.3 37.8 10.1 1.9 13.9 10.1 16.7 12.4 8.9 16.0 101.5 15.1 15.6 16.7 10.3 11.1 0.0 8.4 11.3 7.4 29.0 5.5 5.2 11.7 11.1 11.2 4.1 32.3 6.9 9.8 136.4 0.5 1.1 22.3 0.0 2.3 0.3 0.1 0.0 0.1 0.1 9.0 3.0 10.4 0.6 0.0 1.0 0.0 0.0 159.9 1.0 0.7 0.0 0.0 0.0 6.1 0.9 4.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 19.3 0.8 0.2 1.2 2.4 1.5 0.0 0.0 3.7 0.0 0.4 22.0 0.3 0.6 13.4 0.0 3.1 5.7 22.5 0.9 4.8 0.2 1.6 0.3 0.2 0.4 39.3 5.6 0.1 0.3 0.1 2.2 0.4 0.3 0.3 42.2 0.2 37.1 0.9 16.0 24.8 5.0 0.6 3.9 20.6 1.3 87.3 0.3 0.4 17.5 13.6 18.6 42.6 0.4 57.7 46.4 24.3 5.4 17.6 45.3 16.7 0.0 29.0 32.3 17.3 0.0 2.6 11.8 0.5 4.2 0.5 1.0 0.0 14.6 88.6 74.4 7.5 14.3 3.2 0.0 25.0 3.2 28.9 1.7 7.9 9.6 12.8 32.2 5.0 11.3 21.0 4.0 251.6 1.2 13.0 39.8 4.1 23.8 2.5 20.5 14.6 15.0 1.9 13.5 460.2 4.3 61.1 2.6 6.9 6.6 2.8 2.8 103.2 75.9 0.8 46.6 64.9 281.0 26.5 3.5 0.5 1.5 7.1 1.3 0.0 19.5 26.0 4.7 26.3 91.0 24.5 1.5 1.8 3.0 3.1 3.0 17.4 19.4 0.4 1.1 SNX16 ENSG00000104497 "Sorting nexin 16" P57768 8 81799581-81842866 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 82.8;Late spermatids: 137.3;Spermatocytes: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024730, HPA024731, HPA024817" Approved Supported Vesicles NA NA Vesicles "HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313" "unprognostic (5.50e-2)" "unprognostic (3.20e-2)" "unprognostic (1.40e-1)" "unprognostic (8.41e-3)" "unprognostic (3.21e-3)" "unprognostic (7.54e-3)" "unprognostic (1.24e-3)" "unprognostic (1.33e-1)" "unprognostic (2.12e-1)" "unprognostic (2.18e-1)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.73e-3)" "unprognostic (7.60e-3)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-1)" 10.2 5.3 5.6 6.1 6.7 10.8 8.3 7.6 7.6 8.7 3.8 6.3 6.5 9.8 8.4 17.5 6.3 10.9 8.2 6.0 7.9 6.7 5.5 6.8 5.1 7.6 8.4 5.9 9.7 3.1 9.0 3.7 5.6 8.9 7.4 6.6 5.0 5.7 7.8 4.6 11.3 5.8 12.0 7.9 12.1 9.1 15.0 6.9 9.5 8.7 9.4 6.8 7.1 7.7 8.1 13.8 3.8 6.6 6.3 22.9 13.7 7.3 16.6 20.2 14.1 20.6 3.4 11.1 2.2 10.0 11.4 16.5 11.0 5.1 6.8 19.5 19.9 3.1 7.1 5.2 6.2 17.4 2.9 11.5 10.5 10.6 5.4 12.5 15.8 10.0 7.8 4.5 26.0 32.9 7.2 15.6 5.1 2.8 12.6 6.2 6.6 9.5 2.4 12.7 6.7 10.9 8.3 3.1 3.9 8.3 9.8 10.3 5.5 7.7 19.5 15.6 13.5 7.2 15.1 12.5 5.7 8.4 9.1 15.7 9.2 4.5 6.1 2.1 2.8 2.0 1.6 2.5 1.7 4.0 4.4 2.9 2.8 6.2 2.6 2.4 3.0 5.0 1.9 5.6 6.7 7.6 7.6 6.0 7.9 7.6 8.4 5.9 8.9 7.9 6.9 8.1 10.6 6.4 9.4 9.8 6.4 25.2 12.1 5.0 9.6 5.5 12.1 7.6 8.8 7.2 9.3 5.5 4.2 2.3 3.7 7.5 5.9 5.9 82.8 9.4 7.8 11.5 3.0 8.2 24.7 6.0 4.0 8.5 10.7 16.2 8.2 5.0 13.9 3.5 5.7 55.5 18.4 6.2 8.2 7.0 10.0 137.3 23.3 7.2 3.6 8.4 2.3 4.3 1.0 23.1 22.2 6.7 5.5 16.1 8.6 12.6 3.7 7.3 10.9 5.2 19.7 12.1 9.3 74.2 26.5 13.0 32.0 9.9 5.4 4.2 4.7 20.7 GML LY6DL ENSG00000104499 "Glycosylphosphatidylinositol anchored molecule like" Q99445 8 142834247-142916506 "Predicted intracellular proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 56 "adrenal gland: 195.9" "Cell type enhanced" "Detected in some" "granulocytes: 4.5;Sertoli cells: 6.6;Spermatocytes: 24.2;Spermatogonia: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA 0.0 195.9 0.0 0.2 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.5 1.3 0.0 0.5 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 24.2 7.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 UBR5 "DD5, EDD, EDD1, HYD, KIAA0896" ENSG00000104517 "Ubiquitin protein ligase E3 component n-recognin 5" O95071 8 102252273-102412759 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 239.9;Excitatory neurons: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053688 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053688: AB_2682230" "unprognostic (3.79e-3)" "unprognostic (7.44e-3)" "unprognostic (1.25e-1)" "unprognostic (2.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (2.50e-1)" "unprognostic (1.75e-2)" "unprognostic (7.54e-3)" "unprognostic (8.29e-3)" "unprognostic (3.84e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.69e-2)" "unprognostic (2.45e-1)" 30.4 18.4 16.8 22.6 18.3 36.8 31.2 26.9 24.2 25.7 22.1 30.5 15.0 29.8 23.9 27.8 26.3 17.4 24.4 18.0 16.2 17.6 17.8 30.0 33.9 15.3 15.6 14.9 32.4 25.9 30.7 24.6 17.9 16.6 20.2 17.2 45.8 26.3 20.9 50.5 35.3 27.4 17.4 13.1 24.4 25.2 44.3 15.3 43.4 21.2 29.8 28.8 28.4 26.6 20.8 64.5 28.4 53.2 27.5 51.8 52.2 48.9 47.4 41.9 36.6 31.7 28.3 42.1 127.1 39.8 44.5 23.7 38.2 46.2 41.1 51.1 55.3 22.7 106.5 39.7 52.2 46.1 33.7 56.3 60.1 40.4 37.5 64.5 41.5 44.6 35.6 52.3 70.2 34.8 58.0 85.3 40.3 40.1 61.8 31.6 49.3 31.6 60.9 33.5 62.3 39.1 32.5 33.4 31.8 34.3 46.1 51.4 35.1 44.6 38.5 44.9 35.1 33.5 37.3 38.7 129.5 38.0 51.2 32.0 1.8 1.5 2.4 2.4 1.5 2.4 2.1 2.5 2.5 1.8 1.7 2.0 3.0 3.0 1.1 2.7 1.6 3.4 1.0 16.8 18.3 26.9 24.2 18.0 16.2 15.3 15.6 14.9 16.6 13.1 15.3 20.8 51.4 25.6 31.7 239.9 44.8 52.3 41.2 26.3 55.8 52.0 37.3 29.6 39.8 8.6 49.9 31.3 68.8 27.7 36.2 20.9 9.8 18.8 38.6 47.5 47.0 40.1 33.4 33.2 214.2 15.0 18.9 43.7 37.8 69.0 29.8 64.3 22.9 19.0 17.0 57.2 191.7 19.5 26.4 31.4 52.6 23.6 39.7 43.7 44.4 129.3 43.5 31.3 26.8 196.6 174.0 21.4 18.3 36.5 65.9 45.2 18.3 9.0 46.5 44.8 13.1 66.3 48.4 59.4 30.2 46.8 61.1 69.6 46.9 30.8 19.5 53.5 GSDMD "DF5L, FLJ12150, GSDMDC1" ENSG00000104518 "Gasdermin D" P57764 8 143553207-143563062 "Predicted intracellular proteins, Transporters" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 226.7;Proximal enterocytes: 297.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004656, HPA044487" Uncertain Supported Nucleoplasm "Intracellular and membrane" NA NA 11000 Nucleoplasm "CAB004656: AB_426076, HPA044487: AB_2678957" "unprognostic (1.11e-2)" "unprognostic (8.44e-2)" "unprognostic (6.72e-2)" "unprognostic (4.00e-2)" "unprognostic (4.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (7.20e-2)" "unprognostic (6.36e-2)" "unprognostic (4.66e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (8.51e-3)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (6.77e-3)" 41.4 36.3 5.2 34.4 5.5 39.7 41.9 5.6 9.1 42.8 9.6 44.0 51.8 37.0 9.2 22.7 41.9 15.9 24.7 5.1 9.1 50.9 89.6 55.3 42.6 6.5 5.8 4.7 39.8 35.4 19.3 18.4 16.6 6.4 39.3 13.7 1.0 32.8 15.2 11.1 16.7 60.8 12.5 6.0 121.0 38.3 7.3 6.9 24.6 46.8 6.2 16.3 36.1 31.9 6.4 40.8 18.4 0.3 0.1 13.4 14.7 23.8 13.8 36.4 44.0 47.4 3.1 54.6 14.5 21.9 21.1 19.6 12.5 0.7 31.1 11.1 43.8 2.8 23.2 5.4 22.6 17.8 4.2 1.0 35.5 2.6 16.1 9.4 14.5 34.1 34.2 1.4 49.1 2.3 0.8 87.5 7.1 0.3 27.3 67.6 30.2 1.5 48.7 22.5 39.9 0.5 0.6 44.2 39.8 43.4 5.6 69.7 24.8 13.3 0.2 44.6 3.2 22.1 16.5 22.4 0.4 26.5 19.6 21.8 65.4 44.7 45.9 55.0 73.2 44.8 39.9 48.6 53.7 40.7 31.1 33.8 40.4 46.2 41.1 69.1 29.1 71.1 46.8 5.2 5.5 5.6 9.1 5.1 9.1 6.5 5.8 4.7 6.4 6.0 6.9 6.4 91.1 12.8 29.1 6.8 39.8 10.8 47.1 55.7 23.9 0.2 31.6 30.5 12.2 47.1 37.5 31.3 0.0 62.0 54.6 226.7 60.7 68.3 2.2 33.8 20.0 57.0 39.6 14.9 0.1 92.7 98.1 34.0 68.8 27.2 27.3 171.1 75.3 72.3 63.1 0.0 0.1 114.8 30.5 50.1 18.4 7.0 23.6 52.5 17.8 7.5 74.4 28.9 81.4 0.5 0.1 50.2 181.1 22.6 41.1 34.6 297.7 121.8 43.1 1.7 59.2 24.0 34.4 1.4 12.3 13.8 8.9 41.7 61.5 24.2 131.8 45.9 GFUS "FX, P35B, SDR4E1, TSTA3" ENSG00000104522 "GDP-L-fucose synthase" Q13630 8 143612618-143618048 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol Yes No 850000 Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favorable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 30.6 37.5 20.0 27.9 19.2 52.8 34.3 19.4 26.1 24.5 19.7 42.7 69.8 25.0 19.4 89.4 24.2 29.6 27.0 19.6 19.1 37.6 87.3 28.7 29.3 21.4 19.2 17.1 19.1 100.4 23.0 44.4 24.6 21.0 45.4 38.0 6.6 71.5 24.4 30.5 78.9 52.8 19.6 18.3 35.9 112.3 49.8 19.3 26.8 32.3 18.5 27.3 31.3 36.3 20.9 85.6 67.1 29.2 99.7 28.6 26.1 54.1 70.3 73.0 50.2 38.1 78.5 94.3 37.5 64.6 52.5 21.2 60.6 47.8 100.8 23.2 101.7 53.8 58.7 103.0 93.4 57.2 42.2 67.1 30.3 47.4 31.7 127.3 42.2 84.3 61.9 66.4 57.0 41.2 267.5 39.8 53.2 45.8 267.7 87.1 47.1 26.3 122.3 106.1 94.8 67.3 45.9 53.3 100.2 73.0 23.0 133.5 58.8 75.5 34.8 132.0 35.1 67.6 34.1 30.2 29.0 52.8 91.6 54.7 34.9 27.4 42.9 40.3 38.5 43.0 35.2 43.1 46.8 30.1 40.1 31.5 38.5 31.0 63.6 33.8 54.5 57.5 45.7 20.0 19.2 19.4 26.1 19.6 19.1 21.4 19.2 17.1 21.0 18.3 19.3 20.9 32.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 82.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 156.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 69.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 87.7 1.7 0.0 0.0 0.0 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603210-143609773 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053776, HPA063416, HPA069706" Uncertain Supported "Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA Cytosol "Cytokinetic bridge, Mitotic spindle" "HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178" "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 4.6 9.7 2.7 0.5 2.9 0.6 5.3 2.7 3.2 4.8 0.8 3.8 0.5 5.3 1.1 7.1 6.1 0.8 3.7 2.8 1.6 8.9 17.3 3.8 0.9 2.4 2.2 3.2 5.1 9.3 0.6 10.0 0.4 2.7 8.8 0.6 0.7 5.8 0.5 3.0 4.0 4.2 0.4 1.3 6.0 5.5 7.1 2.7 0.4 8.5 0.3 0.7 4.5 3.8 2.7 3.2 4.0 1.6 2.5 1.8 0.6 2.0 3.0 1.4 2.9 1.9 2.9 2.6 6.2 2.1 2.0 1.1 2.6 2.0 4.0 1.1 3.0 5.3 3.7 2.2 2.0 0.6 1.9 1.0 0.8 1.9 3.1 1.9 1.2 0.7 3.7 4.3 3.1 1.9 7.2 3.0 1.7 2.1 4.5 10.4 2.8 1.8 4.3 3.4 2.2 5.3 1.4 3.6 4.9 1.6 0.8 6.4 2.0 0.9 2.9 4.0 3.4 3.1 2.5 0.8 4.2 2.6 2.0 1.9 0.2 0.9 0.0 1.1 0.6 1.2 1.3 0.8 0.8 0.6 4.7 1.1 1.0 0.1 1.3 0.7 3.0 0.9 0.6 2.7 2.9 2.7 3.2 2.8 1.6 2.4 2.2 3.2 2.7 1.3 2.7 2.7 2.9 3.2 3.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 8.8 7.7 0.0 0.0 0.6 14.7 0.0 5.1 1.6 0.0 3.9 10.2 0.0 6.8 6.6 1.9 0.0 0.0 0.0 9.1 11.8 2.9 0.0 5.2 0.0 5.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.8 0.0 0.0 12.4 4.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.5 1.2 14.7 0.0 0.0 EEF1D "EF-1D, FLJ20897" ENSG00000104529 "Eukaryotic translation elongation factor 1 delta" P29692 8 143579697-143599541 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "DNA-binding, Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045101, HPA051002" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 1300000 "Nucleoplasm, Nucleoli fibrillar center" "HPA045101: AB_10963077, HPA051002: AB_2681305" "unprognostic (9.34e-2)" "unprognostic (2.37e-2)" "unprognostic (9.92e-2)" "unprognostic (1.63e-3)" "unprognostic (5.25e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (8.56e-2)" "unprognostic (3.74e-1)" "unprognostic (2.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (3.99e-2)" "unprognostic (2.06e-1)" "unprognostic (2.67e-2)" "unprognostic (2.14e-1)" 531.7 605.8 277.9 256.7 285.8 478.6 556.8 269.0 341.7 636.9 293.5 615.0 207.2 501.7 230.5 529.1 527.6 181.4 751.7 254.6 283.9 494.2 587.7 439.0 383.1 300.2 272.7 244.8 987.6 1360.5 161.5 330.5 148.4 279.6 614.4 149.6 67.6 581.8 203.8 923.7 603.5 510.1 181.5 276.7 614.5 639.5 290.4 278.6 341.8 508.1 436.8 309.8 542.8 558.7 311.5 454.8 644.8 284.2 246.0 251.0 307.0 314.2 344.2 438.4 536.7 424.0 886.7 420.0 345.5 352.2 386.6 160.4 441.8 295.3 556.0 231.7 274.8 487.6 340.6 1211.8 881.5 373.6 214.1 276.9 594.8 796.6 325.1 367.8 309.6 364.5 282.0 325.2 497.6 309.3 1456.4 838.7 539.7 300.3 580.3 852.3 367.2 204.4 681.0 466.3 757.9 280.0 301.6 300.1 726.3 762.5 174.1 544.3 535.7 285.2 309.9 914.8 465.5 757.5 335.2 142.9 380.2 348.4 431.6 275.3 268.2 535.1 259.6 880.1 503.5 1128.3 1400.1 1110.3 922.6 619.1 1461.9 1365.3 1110.3 408.6 864.7 458.9 874.2 1191.8 2020.0 277.9 285.8 269.0 341.7 254.6 283.9 300.2 272.7 244.8 279.6 276.7 278.6 311.5 652.3 163.5 415.9 47.7 1397.8 1846.0 1620.8 1277.4 1438.7 75.7 1568.2 2028.8 3.9 732.0 600.3 342.1 20.9 665.5 942.8 718.8 855.0 751.4 413.0 173.0 441.3 705.7 343.3 639.1 11.3 1793.7 822.0 699.2 520.9 263.8 446.1 931.0 871.7 792.9 799.6 79.1 13.0 971.5 526.9 1361.3 1492.3 1087.1 891.3 823.6 1085.1 17.8 1400.9 502.7 1071.1 15.6 30.2 938.4 799.5 633.1 1098.8 1566.2 998.9 1552.3 241.7 88.9 479.9 1005.6 844.4 34.0 142.2 969.5 1648.6 712.5 1297.8 573.3 870.0 1619.4 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737402 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 145.6;intestine: 296.3" "Cell type enhanced" "Detected in some" "Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A549: 27.8;HDLM-2: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.1 0.0 1.9 1.7 2.7 0.0 0.4 2.8 2.2 0.2 1.4 21.9 296.3 1.5 2.2 0.2 58.9 145.6 0.1 1.3 1.8 7.0 20.3 0.2 0.2 3.9 3.8 1.1 0.4 0.4 0.0 0.0 0.0 3.6 0.5 36.4 4.4 0.1 24.5 0.0 0.1 221.3 2.9 3.9 0.0 0.8 4.2 2.6 0.1 0.0 0.0 0.0 0.5 0.1 5.4 0.0 27.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 14.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.0 0.0 1.7 1.6 0.0 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.7 2.8 2.2 1.3 1.8 3.9 3.8 1.1 3.6 3.9 2.6 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.2 0.1 1.1 0.4 180.1 0.0 0.0 0.0 0.0 0.0 6.2 3.9 1.4 1.1 4.5 3.6 0.2 44.9 2.7 0.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.2 0.0 1.0 161.1 0.0 0.0 0.0 1.4 1.2 0.3 0.0 0.0 0.0 0.3 0.0 0.5 1.2 0.1 58.1 0.0 0.0 0.0 125.2 27.6 2.9 10.9 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.4 0.1 38.5 0.1 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA018038: AB_2669753, HPA020762: AB_2670512" "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 7.9 31.4 20.5 19.8 31.0 23.2 22.3 29.0 24.6 20.2 24.6 21.8 31.3 16.5 9.2 79.3 18.7 10.8 7.3 21.2 25.1 14.8 72.9 31.1 17.8 43.8 29.4 20.9 14.4 10.8 22.9 16.6 47.9 36.4 25.2 18.7 18.0 19.2 7.6 1.4 49.0 14.1 12.4 30.0 9.8 22.0 59.9 28.4 14.4 10.6 1.6 29.6 14.8 46.5 45.5 135.5 51.5 301.6 87.2 91.7 154.1 30.5 34.9 106.3 46.5 84.7 70.6 192.3 92.7 49.2 43.2 186.0 101.0 127.3 192.4 53.6 77.1 268.3 265.2 32.6 181.1 134.6 31.5 74.6 106.1 201.4 138.8 113.3 29.8 51.5 64.2 153.8 174.8 38.1 223.7 109.6 39.3 125.2 92.6 35.2 47.5 55.4 126.6 329.3 153.3 93.9 47.6 71.6 226.3 74.1 96.5 60.7 81.3 50.8 19.2 66.0 22.9 31.6 31.6 69.6 126.6 32.0 93.7 33.8 1.5 6.3 0.7 10.6 10.8 5.0 16.6 6.0 9.5 15.2 17.1 8.2 8.6 0.2 12.6 12.7 10.8 7.1 7.7 20.5 31.0 29.0 24.6 21.2 25.1 43.8 29.4 20.9 36.4 30.0 28.4 45.5 13.2 60.9 97.9 21.5 34.7 22.9 64.0 199.9 16.5 41.8 35.6 27.3 6.1 31.5 129.6 53.3 50.1 99.7 20.6 81.6 7.9 60.3 21.0 95.9 23.3 39.7 31.7 22.3 14.3 83.6 133.7 35.3 51.0 80.5 41.3 77.1 9.7 127.9 61.1 148.0 18.8 58.0 126.1 10.9 30.1 13.2 23.9 22.2 21.4 13.1 91.0 24.3 8.2 20.1 77.9 98.6 38.4 10.9 30.6 118.0 17.3 3.7 123.0 61.1 26.3 12.5 42.0 179.5 128.6 69.5 89.1 217.1 21.1 171.8 35.0 114.8 SH2D4A "FLJ20967, PPP1R38, SH2A" ENSG00000104611 "SH2 domain containing 4A" Q9H788 8 19313693-19396218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 87.7;Pancreatic endocrine cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 181.7;OE19: 102.5;U-2197: 130.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001871, HPA001919" Enhanced Enhanced Cytosol NA NA Cytosol "HPA001871: AB_1079949, HPA001919: AB_1079947" "unprognostic (9.08e-2)" "unprognostic (8.40e-3)" "unprognostic (4.04e-3)" "unprognostic (2.72e-3)" "unprognostic (3.51e-2)" "unprognostic (4.07e-3)" "unprognostic (2.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.67e-1)" "unprognostic (2.70e-2)" "unprognostic (8.84e-3)" "unprognostic (2.81e-1)" "prognostic favorable (6.02e-8)" "unprognostic (1.67e-2)" "unprognostic (2.18e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" 4.5 8.8 1.7 4.1 1.3 0.1 6.3 1.4 2.0 13.7 2.0 13.7 12.8 4.0 1.7 20.6 9.2 11.2 2.8 1.7 1.8 12.7 39.4 15.9 1.0 1.9 1.6 1.1 37.3 13.2 18.4 1.4 17.8 2.0 7.5 10.9 9.7 24.2 10.2 0.6 6.9 12.7 2.0 1.6 3.3 30.1 2.2 1.6 1.3 17.0 1.6 7.4 18.5 10.6 3.5 60.5 67.3 0.2 0.1 6.5 8.0 44.9 73.9 36.6 70.7 68.3 55.7 53.4 0.0 17.4 181.7 11.2 30.5 2.7 20.0 73.6 0.2 1.0 0.0 40.7 8.6 38.3 1.6 0.3 7.8 24.5 48.4 8.8 42.5 0.3 0.0 0.1 0.1 12.0 27.2 0.1 0.7 15.8 102.5 25.4 0.1 0.0 19.5 19.5 62.6 4.1 0.1 66.0 70.6 0.2 10.4 13.3 5.3 1.2 22.9 0.1 130.8 22.4 0.0 0.7 0.2 23.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.2 0.0 1.8 0.1 0.0 0.0 0.1 0.0 1.7 1.3 1.4 2.0 1.7 1.8 1.9 1.6 1.1 2.0 1.6 1.6 3.5 8.5 64.1 33.9 6.5 0.9 1.5 15.0 22.2 5.2 2.2 9.4 5.6 2.0 34.3 26.2 46.0 27.1 87.7 0.3 20.1 43.0 50.3 25.3 30.9 6.0 5.4 3.0 0.0 1.5 67.0 69.4 11.7 67.8 34.4 1.3 43.3 2.5 45.5 37.7 1.7 1.0 24.8 54.9 8.5 1.6 53.5 6.2 6.3 0.0 1.9 0.6 3.5 0.0 11.1 0.3 99.1 8.3 11.3 0.4 14.6 20.5 10.9 46.9 36.2 19.7 3.0 6.5 0.5 2.8 31.9 2.6 30.6 1.0 52.0 26.3 31.2 INTS10 "C8orf35, FLJ10569, INT10" ENSG00000104613 "Integrator complex subunit 10" Q9NVR2 8 19817391-19852083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039129, HPA050570" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA039129: AB_10794424, HPA050570: AB_2681180" "unprognostic (9.11e-2)" "unprognostic (8.41e-3)" "prognostic favorable (4.00e-4)" "prognostic favorable (1.22e-4)" "unprognostic (4.54e-2)" "unprognostic (9.79e-3)" "unprognostic (1.15e-1)" "unprognostic (1.14e-3)" "unprognostic (3.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-2)" "unprognostic (2.62e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (1.33e-1)" 27.9 24.3 45.4 24.8 47.0 34.6 29.4 47.3 58.1 27.7 43.5 28.8 26.8 22.7 20.5 26.8 39.1 21.7 21.9 46.8 46.3 30.2 48.0 24.5 30.7 45.9 44.4 45.6 25.6 43.0 28.5 18.9 23.2 45.4 29.4 27.6 37.5 30.7 20.1 25.8 32.1 24.3 26.3 45.7 22.9 25.2 15.4 45.1 29.5 44.1 18.8 33.5 24.9 18.1 47.8 40.0 57.3 32.5 42.1 48.7 53.3 41.5 29.5 50.6 40.3 38.4 33.6 19.7 113.9 47.9 33.1 43.9 42.3 39.5 38.5 44.8 22.4 40.0 51.7 62.6 63.2 35.0 45.2 34.2 42.3 58.9 29.8 46.5 24.8 40.2 65.4 66.3 88.2 28.4 33.9 86.7 53.4 42.6 92.9 32.2 43.7 35.9 73.1 52.8 60.7 32.2 26.1 41.1 51.0 37.1 29.1 26.2 43.6 29.2 25.5 35.0 59.1 39.5 24.7 30.5 81.5 51.4 64.4 41.1 10.0 23.7 14.5 19.6 21.4 30.8 26.5 25.6 25.2 30.9 21.7 28.1 25.1 7.7 27.7 18.6 27.1 31.8 20.2 45.4 47.0 47.3 58.1 46.8 46.3 45.9 44.4 45.6 45.4 45.7 45.1 47.8 25.5 16.0 51.1 74.4 40.3 37.6 40.9 29.3 43.3 60.2 28.3 20.3 22.5 37.1 39.1 20.2 52.1 33.7 41.5 22.9 35.2 43.6 53.9 78.8 23.1 33.0 20.4 27.3 88.8 40.0 49.2 34.1 25.5 33.4 35.5 63.6 35.3 61.0 42.4 70.7 61.0 34.3 22.4 34.0 25.5 31.9 34.8 35.6 17.8 37.5 37.8 33.9 45.3 80.9 74.9 33.1 27.4 35.0 48.6 53.4 33.9 37.5 70.0 99.0 13.1 29.1 32.5 8.3 32.3 50.8 45.0 22.3 40.6 41.2 42.0 32.7 ERI1 "3'HEXO, THEX1" ENSG00000104626 "Exoribonuclease 1" Q8IV48 8 9002147-9116746 "Predicted intracellular proteins" "RNA-mediated gene silencing, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033838, HPA055548, HPA056074" Uncertain Approved Vesicles,Microtubules NA NA Microtubules Vesicles "CAB033838: AB_2098575, HPA055548: AB_2682845, HPA056074: AB_2683029" "unprognostic (2.49e-1)" "unprognostic (1.13e-1)" "prognostic favorable (8.05e-5)" "unprognostic (1.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.61e-3)" "unprognostic (1.08e-3)" "unprognostic (2.90e-1)" "unprognostic (5.50e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-3)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.27e-2)" "unprognostic (3.57e-1)" "unprognostic (8.75e-2)" "unprognostic (2.36e-2)" 5.4 3.1 3.4 6.6 3.8 13.1 4.9 3.8 4.1 4.3 3.5 3.8 4.8 4.8 2.6 4.3 3.9 3.9 2.8 3.1 4.1 4.0 4.4 5.2 7.4 4.7 3.7 2.8 4.2 3.0 4.3 2.5 6.7 3.7 3.2 4.7 11.4 3.8 3.2 2.5 3.2 3.9 5.2 4.1 5.0 3.6 9.2 3.7 6.9 2.9 2.7 7.5 6.3 3.5 4.2 32.3 19.9 17.2 13.1 13.4 21.7 23.5 27.4 14.4 19.6 24.1 14.8 14.4 36.7 7.0 15.7 32.7 11.2 15.1 18.5 27.3 15.1 10.8 20.3 15.8 11.5 13.7 15.6 28.6 12.9 6.1 16.3 14.4 10.9 26.8 21.6 23.3 22.6 22.8 10.5 47.2 19.3 20.0 24.2 12.1 20.1 25.1 13.7 25.2 45.6 2.4 18.8 16.4 12.5 13.8 12.1 9.3 13.9 23.2 20.7 21.4 39.5 21.6 4.9 18.1 31.9 15.3 22.2 16.5 6.4 4.6 3.4 4.2 5.1 4.3 5.3 4.9 4.4 3.9 3.9 3.8 3.6 3.3 6.0 3.5 2.9 9.8 3.5 3.4 3.8 3.8 4.1 3.1 4.1 4.7 3.7 2.8 3.7 4.1 3.7 4.2 9.2 3.2 8.1 17.6 9.7 18.2 9.6 6.7 3.4 17.4 8.6 5.0 5.7 2.8 10.1 3.7 14.6 25.3 11.3 7.4 3.9 9.0 46.9 14.8 14.4 8.6 3.6 18.7 11.4 12.0 27.6 9.1 8.6 23.3 8.2 7.7 11.4 4.8 13.5 5.0 9.7 5.2 8.2 9.7 15.9 16.7 6.5 12.9 10.6 9.4 11.9 8.0 6.2 9.5 16.7 11.2 5.6 9.1 11.2 6.3 4.3 8.2 9.1 21.6 13.1 7.8 7.5 43.6 45.6 6.1 10.1 20.8 11.7 5.9 6.8 3.8 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367278-22434129 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 555.8;pancreas: 254.9" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 266.7;Hepatocytes: 611.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 321.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016508, HPA056732" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA 1100000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148, HPA056732: " "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favorable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 63.4 73.0 15.4 35.8 12.3 1.4 40.1 12.6 23.4 16.2 33.8 48.6 143.5 30.4 6.2 11.7 26.1 32.3 72.0 15.6 51.8 30.8 555.8 24.2 7.6 48.3 20.8 12.3 27.9 254.9 13.0 21.7 19.2 25.4 22.5 50.8 18.8 21.9 18.9 43.4 18.9 85.7 33.3 16.1 8.1 81.2 26.8 24.4 6.1 88.5 17.5 6.9 56.5 14.6 43.4 51.8 68.3 18.4 37.6 65.1 54.7 40.1 72.8 321.0 111.3 173.5 226.9 47.9 51.1 39.9 86.1 288.9 55.6 92.8 91.1 181.9 53.1 49.2 40.8 51.0 230.7 154.3 28.5 43.2 58.4 72.6 198.0 136.9 56.3 50.5 36.5 36.2 51.2 57.3 24.0 43.4 18.2 113.4 81.9 49.8 60.1 34.9 110.8 40.8 22.3 31.3 48.7 74.3 31.3 151.4 39.7 25.1 39.4 28.0 137.3 69.2 87.4 75.7 29.2 28.7 66.9 194.3 37.7 81.9 0.0 0.4 2.1 6.7 0.1 7.2 4.0 3.8 5.0 1.5 1.9 4.3 5.9 0.1 2.7 0.1 0.7 3.4 3.4 15.4 12.3 12.6 23.4 15.6 51.8 48.3 20.8 12.3 25.4 16.1 24.4 43.4 12.4 3.2 7.7 11.4 9.1 33.3 11.5 10.8 18.8 7.8 20.3 16.6 66.6 41.5 3.8 7.3 2.1 0.4 3.6 91.6 1.9 47.6 0.5 136.1 58.3 32.2 33.4 10.5 26.2 74.7 2.7 58.8 47.9 266.7 0.0 20.8 29.6 611.4 1.8 48.8 24.6 60.6 6.1 15.4 25.8 3.2 23.9 2.9 44.4 6.5 2.7 5.2 2.1 9.0 3.9 47.3 39.1 41.8 13.5 26.5 75.6 24.6 1.1 8.2 0.0 47.1 32.2 0.7 3.0 4.1 21.0 0.5 7.4 14.7 43.5 9.4 MTMR9 "C8orf9, DKFZp434K171, LIP-STYX, MTMR8" ENSG00000104643 "Myotubularin related protein 9" Q96QG7 8 11284816-11328146 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070944 Approved "Actin filaments,Centrosome" NA NA Centrosome "Actin filaments" "HPA070944: AB_2686325" "unprognostic (1.97e-2)" "unprognostic (1.95e-1)" "unprognostic (2.30e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-1)" "unprognostic (2.64e-2)" "unprognostic (8.09e-3)" "unprognostic (3.25e-1)" "unprognostic (2.05e-1)" "unprognostic (1.46e-1)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.08e-1)" "unprognostic (1.43e-2)" 4.6 3.7 7.1 4.4 8.3 3.4 4.9 7.4 8.5 3.5 3.6 5.4 2.4 4.5 2.9 3.4 3.2 3.2 7.6 8.2 8.8 4.5 3.0 3.5 4.0 7.6 8.9 7.7 3.6 2.9 4.2 3.1 4.3 8.5 5.0 3.1 17.7 2.6 3.9 5.8 3.8 3.1 5.8 6.0 3.8 3.0 7.8 7.9 3.5 3.8 8.7 3.9 3.7 3.3 9.5 2.9 4.2 7.1 4.8 8.4 7.1 5.0 8.7 5.6 5.1 4.3 3.7 1.5 6.8 2.1 8.1 5.0 3.7 5.2 5.3 6.7 1.2 3.8 6.8 4.5 3.4 8.9 2.2 5.0 6.9 5.9 6.2 9.1 5.8 7.8 3.8 5.0 3.9 10.5 2.1 3.9 2.6 12.4 6.9 4.0 3.0 9.7 2.0 7.7 5.1 2.2 10.6 4.6 2.7 6.7 10.5 2.7 5.4 11.2 7.9 2.3 4.8 4.8 1.3 1.9 3.3 6.9 5.6 7.9 0.2 0.4 0.3 0.7 0.4 0.5 0.5 0.6 0.5 0.2 1.1 0.7 0.7 0.5 0.5 0.4 1.0 0.4 0.2 7.1 8.3 7.4 8.5 8.2 8.8 7.6 8.9 7.7 8.5 6.0 7.9 9.5 17.8 12.8 16.8 26.4 27.7 13.6 11.6 12.9 11.4 0.0 11.7 8.4 25.3 24.3 14.5 14.7 0.0 12.4 27.4 7.4 3.9 11.6 17.7 5.1 15.0 18.9 16.2 10.8 44.8 7.1 12.7 18.3 4.6 8.0 14.0 24.9 26.7 17.3 14.5 0.0 42.1 10.7 12.2 21.0 32.7 8.5 23.3 20.2 16.0 18.7 24.3 0.0 25.7 32.2 48.7 15.0 11.1 19.5 11.7 21.6 13.4 10.9 18.0 0.0 39.5 19.0 17.7 84.9 33.1 10.1 12.9 4.5 20.7 14.6 9.5 9.3 LEPROTL1 "my047, Vps55" ENSG00000104660 "Leptin receptor overlapping transcript like 1" O95214 8 30095408-30177208 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "T-cells: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047911 Uncertain NA NA "HPA047911: AB_2680206" "unprognostic (4.42e-2)" "unprognostic (1.33e-2)" "prognostic favorable (9.04e-4)" "unprognostic (1.92e-2)" "unprognostic (3.77e-2)" "unprognostic (4.56e-2)" "unprognostic (1.25e-3)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (4.73e-3)" "unprognostic (2.30e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.03e-1)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (2.53e-1)" 31.3 48.9 22.1 32.9 22.6 56.2 25.2 25.7 26.2 20.5 18.6 28.7 20.6 21.6 25.8 18.9 21.3 23.7 34.3 23.5 21.9 29.7 39.2 29.9 39.7 20.9 21.7 22.2 20.6 22.9 22.0 15.4 76.5 21.5 18.0 26.2 25.9 20.9 22.3 13.5 21.9 26.7 24.2 21.1 33.4 25.5 34.4 21.7 66.9 15.4 15.0 36.4 26.6 17.7 23.5 39.3 48.9 67.8 52.0 36.2 27.4 27.0 55.6 45.1 37.9 60.7 40.4 41.2 24.3 45.6 51.7 47.9 37.6 52.3 39.2 60.8 32.9 31.3 75.0 35.0 74.6 55.9 23.1 55.3 31.5 41.4 42.7 27.0 43.7 47.0 57.4 79.4 40.1 45.3 49.6 52.4 31.4 47.1 73.9 30.8 41.8 27.1 28.9 48.7 48.3 15.4 55.3 30.4 31.2 50.5 44.8 29.0 22.5 41.2 23.0 114.6 19.1 42.8 15.6 24.0 49.3 33.8 49.4 55.0 252.3 119.8 171.3 142.3 121.9 188.3 38.2 246.6 174.7 83.3 33.4 347.3 259.9 229.9 102.3 160.6 115.4 338.9 284.5 22.1 22.6 25.7 26.2 23.5 21.9 20.9 21.7 22.2 21.5 21.1 21.7 23.5 97.7 35.3 42.3 13.7 62.2 29.2 16.5 57.5 21.1 23.2 38.6 29.3 40.9 42.9 42.4 42.3 12.5 56.2 196.6 39.1 19.6 113.4 122.2 44.8 40.3 67.2 33.0 30.1 25.2 102.3 105.2 36.4 35.7 34.3 141.4 149.2 69.3 74.9 98.3 20.2 25.6 35.4 67.1 93.1 70.3 79.7 35.4 85.1 62.2 15.9 86.3 27.6 117.4 24.1 21.5 83.9 36.7 26.4 78.0 15.2 48.7 83.1 65.7 26.3 52.6 21.8 71.3 122.6 68.4 31.1 34.7 51.9 351.9 48.2 33.2 19.3 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156319-30183639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA Yes "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 51.0 54.7 55.1 26.8 58.8 44.1 53.6 57.5 74.8 32.6 49.7 33.1 24.1 38.6 43.9 34.7 30.3 33.1 76.3 56.8 60.4 54.7 47.0 34.3 28.6 57.4 58.1 53.3 41.8 32.3 73.4 29.9 54.0 58.1 35.0 36.5 42.8 33.9 37.0 36.9 29.0 26.3 43.0 59.0 27.8 32.1 22.1 56.4 38.2 55.1 43.9 31.5 46.2 31.9 64.9 53.6 51.9 64.4 33.8 59.3 80.7 42.1 72.8 87.0 70.4 74.9 33.6 35.8 41.0 76.0 78.8 64.9 39.6 46.1 64.2 83.8 32.4 34.3 57.8 40.9 54.5 45.8 33.6 47.4 68.2 90.4 51.2 54.8 61.5 65.2 58.0 66.4 44.3 77.0 41.7 62.4 53.0 51.6 93.8 32.0 32.4 48.7 35.3 104.6 54.1 105.4 60.0 42.7 53.0 77.9 32.4 50.4 48.3 60.8 37.4 128.9 31.9 52.4 18.1 22.2 51.8 69.7 38.1 68.1 16.7 13.5 5.0 8.1 15.8 9.1 7.1 7.5 9.8 15.9 5.3 9.5 11.4 3.7 11.2 15.9 20.8 8.1 6.8 55.1 58.8 57.5 74.8 56.8 60.4 57.4 58.1 53.3 58.1 59.0 56.4 64.9 61.3 25.6 39.7 19.9 34.9 57.2 91.3 127.1 25.6 36.4 45.4 43.2 83.4 47.1 85.3 44.1 14.6 88.5 48.9 28.1 123.3 94.5 18.0 32.5 37.2 58.7 40.8 28.2 19.0 84.5 87.7 56.6 25.0 39.6 46.9 44.0 45.7 42.7 71.4 26.9 17.3 31.6 91.6 43.9 54.8 12.5 80.8 43.2 69.4 15.0 58.4 63.3 17.5 17.6 21.3 91.1 43.1 75.2 32.3 48.8 36.3 147.1 71.6 40.3 52.6 63.1 66.0 44.2 47.3 38.0 63.5 203.6 59.8 49.5 33.0 95.0 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 113.2;Rod photoreceptor cells: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" Yes No Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favorable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favorable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 20.5 22.0 43.9 15.4 50.7 29.2 19.8 52.5 45.1 22.5 36.0 28.5 19.9 24.1 14.9 16.2 22.7 16.3 30.5 39.7 44.3 20.2 28.4 16.8 22.7 58.1 50.2 38.2 27.5 43.2 29.2 22.8 13.9 60.1 22.9 15.4 63.3 36.0 20.1 55.0 22.6 20.6 22.4 53.0 20.3 28.6 31.0 48.0 20.5 17.8 31.8 19.0 22.4 18.0 73.4 38.2 48.7 36.7 35.9 15.2 20.6 25.2 24.7 23.4 41.0 29.7 35.0 17.6 38.1 25.6 30.2 28.0 28.3 38.9 45.8 27.5 24.7 41.6 35.7 33.4 29.2 36.0 24.7 25.6 24.8 35.5 35.0 16.4 30.1 31.7 42.9 41.8 31.0 24.3 33.1 55.6 43.8 29.8 40.4 35.8 37.9 44.8 22.8 20.3 41.9 47.2 41.1 28.1 32.8 41.8 25.0 30.3 29.2 27.4 37.9 31.8 32.2 51.1 23.8 22.2 39.3 29.5 34.3 48.5 38.4 50.5 82.5 64.8 44.1 56.5 56.5 52.7 55.0 56.7 42.1 40.5 47.0 31.3 59.5 50.3 52.9 61.5 51.4 43.9 50.7 52.5 45.1 39.7 44.3 58.1 50.2 38.2 60.1 53.0 48.0 73.4 25.2 25.6 14.7 4.9 15.5 14.9 16.5 35.9 10.2 28.0 22.8 32.9 24.1 24.3 20.5 5.5 27.1 18.8 19.8 17.9 56.7 32.3 36.4 15.2 17.0 21.1 19.2 17.9 5.1 50.9 21.3 25.4 20.9 10.2 22.8 24.7 20.0 21.6 30.2 18.5 5.0 21.5 22.4 18.2 12.3 113.2 17.7 16.2 21.4 5.6 18.8 59.3 42.2 4.5 9.5 37.0 22.1 21.8 34.7 11.4 41.7 38.5 22.0 115.7 13.1 19.9 31.1 49.8 32.4 13.6 16.2 7.7 18.3 30.7 22.8 13.6 GSR ENSG00000104687 "Glutathione-disulfide reductase" P00390 8 30678066-30727846 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 32.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001538, CAB008632, HPA064806" Approved Supported Cytosol NA NA 81000000 Cytosol "CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: " "unprognostic (1.23e-1)" "prognostic favorable (3.37e-4)" "prognostic favorable (4.08e-5)" "unprognostic (2.89e-3)" "unprognostic (1.62e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (4.15e-2)" "unprognostic (2.83e-2)" "unprognostic (6.92e-3)" "prognostic favorable (1.80e-4)" "unprognostic (2.31e-3)" "unprognostic (2.26e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 13.1 23.5 12.9 18.9 11.4 26.2 11.1 11.5 12.1 28.7 23.2 42.9 54.8 16.1 21.8 37.6 21.7 30.8 25.7 12.9 12.1 45.8 36.1 17.5 23.8 10.3 14.1 10.8 23.3 26.7 83.0 14.9 23.7 11.2 35.6 47.0 12.9 26.0 29.6 29.1 12.9 51.2 18.1 11.2 22.3 42.1 11.7 15.8 26.9 17.1 21.4 24.2 22.7 27.9 11.0 49.4 197.8 35.9 40.1 35.8 38.3 29.1 23.4 46.8 31.8 36.7 66.0 31.3 95.8 94.8 32.0 96.1 59.2 62.3 51.1 33.1 22.6 40.7 104.6 67.0 197.8 88.4 38.6 159.7 72.6 28.5 48.9 20.9 33.5 43.3 57.3 73.2 55.1 67.9 44.1 147.1 32.0 65.4 191.9 31.5 43.8 41.9 59.3 56.0 124.3 28.2 31.8 31.2 87.8 58.8 40.7 37.5 32.6 63.8 21.0 34.7 37.3 35.2 20.2 29.4 70.0 51.9 51.8 62.4 32.3 5.9 15.0 5.0 5.4 8.8 3.6 4.5 5.4 6.0 2.3 2.8 3.7 8.2 3.6 7.9 3.9 4.5 3.1 12.9 11.4 11.5 12.1 12.9 12.1 10.3 14.1 10.8 11.2 11.2 15.8 11.0 8.2 3.2 20.8 12.7 13.7 4.2 15.2 9.4 52.3 6.7 6.7 5.0 26.8 30.0 15.0 12.9 16.7 17.0 20.3 61.8 9.8 11.4 8.4 61.4 13.4 9.9 34.1 28.6 18.1 19.8 6.3 10.0 33.1 41.3 6.3 64.3 12.1 43.4 18.2 3.3 27.4 51.7 8.2 40.5 5.8 18.9 7.2 22.1 8.8 11.2 20.6 12.6 17.5 12.5 10.0 15.2 32.0 10.9 15.6 27.5 75.7 19.0 11.7 8.0 6.6 7.0 8.6 1.2 3.4 39.6 5.4 6.4 17.3 17.2 47.5 33.5 TNFRSF10A "Apo2, CD261, DR4, TRAILR-1, TRAILR1" ENSG00000104689 "TNF receptor superfamily member 10a" O00220 8 23190452-23225102 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050958, HPA054475" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050958: AB_2681290, HPA054475: AB_2682500" "unprognostic (3.66e-1)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (9.44e-2)" "unprognostic (8.39e-2)" "unprognostic (5.32e-2)" "unprognostic (2.18e-2)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (1.49e-1)" "unprognostic (1.99e-3)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-1)" "unprognostic (2.87e-1)" 5.6 2.4 3.5 10.0 2.3 9.4 5.7 2.1 2.7 4.3 3.1 7.0 6.2 2.9 1.1 8.4 4.1 8.3 2.5 1.9 2.3 3.8 5.3 6.6 13.5 3.3 2.6 1.2 0.8 2.4 2.7 0.8 7.1 3.1 2.9 7.1 0.2 4.8 2.5 1.5 4.7 6.6 4.0 2.4 6.9 6.5 0.5 3.7 6.5 3.1 2.9 14.1 10.9 5.8 4.7 18.7 33.0 1.7 0.1 1.2 6.4 0.1 3.8 2.3 1.9 5.2 25.4 31.8 42.9 41.9 2.4 9.1 34.6 29.5 47.2 3.1 10.7 0.2 22.7 20.4 14.7 16.2 12.3 20.7 11.0 38.2 41.1 35.0 5.5 21.9 1.4 35.7 14.9 8.9 14.5 0.4 7.8 22.6 33.0 20.0 0.3 0.0 31.2 24.4 39.5 0.9 1.1 9.3 23.0 0.0 6.9 12.3 9.3 31.3 0.1 0.2 1.8 0.1 17.4 26.7 32.7 0.2 3.9 0.5 2.8 6.1 5.7 5.0 2.6 13.8 15.3 16.1 10.2 6.3 19.1 15.7 9.2 0.6 6.1 2.6 0.0 20.8 6.5 3.5 2.3 2.1 2.7 1.9 2.3 3.3 2.6 1.2 3.1 2.4 3.7 4.7 21.5 3.2 8.7 0.7 22.3 23.6 20.7 9.1 21.6 0.2 8.2 7.1 1.1 7.2 15.5 11.0 0.0 0.1 3.1 10.1 0.0 10.1 0.1 8.6 1.9 16.6 2.4 1.3 0.4 4.0 0.4 2.2 10.2 23.9 7.6 0.7 2.9 5.1 3.1 0.0 0.4 7.0 8.2 2.2 12.7 0.0 0.0 8.5 3.6 9.4 4.2 0.0 2.1 1.0 0.5 20.3 7.3 0.0 14.0 11.7 4.5 2.9 5.7 0.0 0.0 0.9 1.1 0.0 0.5 25.6 27.4 0.0 12.8 0.1 9.1 27.4 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30729131-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 80.6" "Group enriched" "Detected in many" 5 "Early spermatids: 167.4;Granulosa cells: 191.2;Hepatocytes: 65.7;Late spermatids: 180.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 10.3 17.5 14.7 7.2 12.9 8.8 14.2 13.0 18.1 10.5 0.0 12.6 13.2 10.5 50.3 10.8 13.3 13.6 5.0 14.8 6.8 22.3 44.4 8.8 8.1 9.4 4.9 14.2 80.6 33.2 20.7 2.8 15.7 14.9 16.5 16.5 11.7 8.6 18.8 3.7 17.1 12.2 10.9 1.2 11.2 12.5 37.5 6.8 14.5 26.2 5.4 9.8 10.5 3.4 13.9 16.4 17.0 11.7 12.2 17.9 25.2 14.3 29.5 17.2 15.2 19.6 27.6 6.1 26.8 23.2 24.5 25.9 14.8 3.1 16.8 24.6 23.9 27.2 77.0 14.0 33.0 27.3 18.1 41.8 20.2 17.4 25.6 12.7 13.6 14.1 12.8 71.9 21.8 35.5 16.1 18.6 14.6 22.9 52.2 12.9 21.4 10.9 18.3 27.7 22.4 6.4 17.7 8.3 26.0 52.1 14.1 16.8 30.4 17.3 17.0 7.8 8.2 28.3 8.8 29.2 19.7 15.0 29.0 25.5 0.0 4.6 0.6 6.2 4.9 5.4 4.7 3.3 5.8 5.2 1.9 3.0 5.5 0.8 2.8 2.4 6.5 3.2 2.7 14.7 12.9 13.0 18.1 14.8 6.8 9.4 4.9 14.2 14.9 1.2 6.8 13.9 20.5 3.2 8.2 5.5 5.2 0.0 5.4 0.0 8.0 2.5 7.5 7.6 4.3 17.2 3.1 14.7 20.9 23.8 10.7 7.5 7.9 9.7 167.4 9.1 18.6 12.4 8.5 12.8 5.4 5.3 20.2 22.8 9.7 11.3 14.0 191.2 21.4 65.7 22.0 11.8 7.8 9.7 0.0 16.7 0.0 180.4 14.3 8.9 0.0 6.5 11.6 8.1 12.3 4.5 16.3 3.1 6.0 9.8 6.7 4.9 6.9 25.4 0.7 2.2 6.6 8.7 10.4 16.1 24.2 13.0 0.0 15.2 6.6 27.1 11.8 4.4 PPP2CB PP2Abeta ENSG00000104695 "Protein phosphatase 2 catalytic subunit beta" P62714 8 30774457-30814314 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Peritubular cells: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018600, HPA043236" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB018600: AB_675841, HPA043236: AB_2678379" "unprognostic (9.77e-2)" "unprognostic (1.30e-1)" "unprognostic (2.51e-2)" "unprognostic (3.82e-1)" "unprognostic (6.70e-2)" "unprognostic (7.79e-2)" "unprognostic (1.13e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.89e-2)" "prognostic favorable (5.82e-7)" "unprognostic (9.24e-2)" "unprognostic (2.04e-1)" "unprognostic (1.39e-1)" "unprognostic (2.65e-3)" 90.7 67.2 208.2 42.6 209.7 10.6 69.1 209.9 220.4 84.7 170.9 80.0 73.6 113.0 118.1 95.9 88.5 74.8 92.3 206.5 227.6 133.1 119.6 91.4 32.8 212.6 202.2 183.9 148.7 76.4 94.0 52.9 91.8 207.5 75.5 76.9 78.6 69.2 87.9 106.5 63.9 87.7 123.3 218.5 53.4 71.8 65.3 212.8 41.8 127.8 123.8 47.8 77.5 70.6 225.8 96.5 82.7 136.4 54.4 134.6 120.0 78.0 124.0 114.0 123.1 129.5 86.6 68.3 45.6 118.7 165.4 117.9 56.5 84.4 142.1 167.3 28.5 44.2 61.8 52.7 86.9 157.3 28.1 34.2 108.6 157.4 105.2 115.9 124.2 152.5 73.6 97.7 47.6 212.4 48.4 77.1 34.9 102.6 139.3 47.0 53.9 55.7 34.5 168.5 73.6 134.3 55.0 57.8 61.1 127.0 150.5 34.1 47.8 164.0 109.1 81.7 36.1 105.5 24.0 33.6 53.7 93.4 26.0 141.4 3.4 2.5 1.7 1.8 3.1 2.3 2.9 1.7 1.9 1.7 1.1 1.7 2.1 2.3 3.8 1.5 3.8 1.3 0.8 208.2 209.7 209.9 220.4 206.5 227.6 212.6 202.2 183.9 207.5 218.5 212.8 225.8 81.0 70.5 60.7 68.6 13.0 104.1 115.9 44.4 44.9 36.6 64.9 51.8 80.2 45.8 54.3 86.5 31.3 41.1 23.6 186.1 46.9 40.6 21.8 98.5 109.8 60.9 32.3 16.6 41.0 48.9 52.8 79.0 34.7 89.2 17.7 95.4 87.8 95.5 58.4 47.1 59.1 65.3 28.5 55.4 60.4 20.3 73.3 36.0 40.9 52.5 27.4 127.2 17.5 37.7 60.4 81.1 78.9 264.0 15.8 125.4 115.6 95.9 68.2 26.5 46.0 93.1 73.0 37.2 40.4 50.3 95.6 70.6 17.4 75.3 41.2 149.9 ERICH1 ENSG00000104714 "Glutamate rich 1" Q86X53 8 614746-738106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003725 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA003725: AB_1853023" "unprognostic (7.19e-2)" "unprognostic (1.38e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-2)" "unprognostic (1.02e-1)" "unprognostic (7.51e-3)" "unprognostic (1.55e-1)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (5.11e-2)" "unprognostic (1.27e-1)" "unprognostic (8.63e-2)" "unprognostic (3.07e-1)" "unprognostic (1.42e-1)" 15.4 8.8 8.1 17.3 7.3 23.2 13.9 7.0 8.4 10.1 8.9 11.0 8.5 10.2 6.7 10.5 10.6 9.2 10.5 7.7 7.2 13.4 11.7 14.7 21.2 9.0 7.7 6.0 11.7 9.1 7.9 11.6 10.2 9.1 9.2 7.3 5.1 9.9 5.9 10.9 13.0 12.5 8.0 6.6 15.5 10.6 8.1 8.2 11.9 13.3 5.5 10.8 12.8 11.6 7.9 15.8 22.2 11.7 14.0 12.4 15.0 24.3 14.9 7.9 13.3 14.6 14.4 9.9 36.0 6.9 12.5 25.3 26.0 21.7 22.9 9.4 15.7 28.1 25.1 15.1 20.8 13.9 15.5 22.6 17.4 14.5 10.1 13.0 13.7 14.7 31.2 26.3 20.2 13.5 13.2 30.0 27.5 18.6 17.6 9.9 27.0 7.6 25.0 14.9 28.7 5.4 15.0 10.9 13.8 20.2 19.2 5.8 18.4 23.7 9.7 4.6 0.6 16.2 13.1 36.7 38.9 19.9 24.6 10.5 24.7 33.0 12.5 8.4 32.3 7.5 17.9 9.7 8.4 17.1 20.1 8.1 7.1 30.0 12.3 29.8 12.7 7.5 10.4 8.1 7.3 7.0 8.4 7.7 7.2 9.0 7.7 6.0 9.1 6.6 8.2 7.9 71.0 44.8 36.1 17.9 75.3 36.6 47.0 47.9 32.5 23.3 32.6 32.5 23.0 27.1 31.2 33.1 12.5 62.0 55.4 49.2 109.5 38.4 16.1 35.9 52.2 65.8 19.7 43.9 24.4 36.6 60.4 40.7 66.8 57.4 41.1 48.3 62.4 31.9 41.9 48.8 21.0 50.4 32.6 70.9 68.0 9.2 60.3 69.9 35.6 23.4 126.9 18.2 78.2 11.1 22.5 55.4 54.3 40.6 34.6 51.5 33.3 58.9 26.9 22.1 39.5 33.6 35.6 48.5 58.4 23.2 40.9 54.0 68.3 27.0 39.8 37.0 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913758-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 719.2" "Cell type enhanced" "Detected in many" "Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 25 "HEK 293: 3890.8" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" Yes NA 220000 "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 0.3 19.7 134.7 0.9 62.7 0.0 0.1 176.3 719.2 8.8 0.0 2.4 0.1 4.0 0.0 4.0 5.3 0.2 0.2 103.6 97.0 1.1 0.1 0.2 0.1 465.2 150.0 51.4 1.7 2.0 0.0 18.1 0.2 488.8 1.5 0.7 91.6 0.3 27.9 1.8 0.4 1.3 2.5 107.3 0.1 0.9 19.0 533.3 1.7 0.1 0.7 0.5 0.4 6.6 640.3 0.0 0.0 154.3 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3890.8 0.0 0.0 0.0 79.4 0.0 0.1 2.4 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.2 5.9 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 3.7 32.6 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.7 62.7 176.3 719.2 103.6 97.0 465.2 150.0 51.4 488.8 107.3 533.3 640.3 3.1 0.0 0.0 12.4 0.0 1.3 0.2 0.1 9.1 30.9 1.1 21.2 2.4 0.0 0.6 0.0 6.2 0.0 3.2 0.1 0.0 0.1 92.6 0.7 19.5 2.9 3.5 0.0 46.6 0.2 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 20.2 17.5 0.0 0.0 0.0 0.7 114.6 0.9 0.7 1.8 13.1 0.0 22.8 0.0 9.5 13.6 0.0 0.0 4.5 0.4 0.3 0.0 0.4 0.0 69.1 0.0 3.3 5.7 43.8 1.0 14.0 0.3 0.0 4.1 0.0 0.1 0.4 TUSC3 "MagT2, MGC13453, MRT22, MRT7, N33, OST3A, SLC58A2" ENSG00000104723 "Tumor suppressor candidate 3" Q13454 8 15417215-15766649 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 472.9;Extravillous trophoblasts: 321.8;Syncytiotrophoblasts: 783.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049851, HPA049974" Approved NA NA "HPA049851: AB_2680913, HPA049974: AB_2680976" "unprognostic (3.31e-2)" "unprognostic (7.17e-2)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (4.46e-1)" "unprognostic (2.34e-1)" "unprognostic (7.15e-3)" "unprognostic (5.02e-2)" "unprognostic (7.39e-2)" "unprognostic (4.79e-2)" "unprognostic (1.59e-3)" "unprognostic (4.81e-1)" "unprognostic (1.60e-3)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" "prognostic favorable (7.86e-4)" "unprognostic (1.55e-1)" 20.5 69.4 18.7 8.4 21.4 0.1 28.6 25.9 17.2 25.2 43.7 12.0 9.4 32.2 101.6 11.9 58.1 16.9 35.2 18.3 38.6 25.4 6.9 18.6 6.9 11.2 12.0 18.3 74.2 35.3 54.5 70.1 81.2 11.0 46.8 15.6 41.2 12.2 30.0 4.5 7.5 8.3 32.8 7.0 5.4 10.9 23.4 18.6 7.6 9.6 5.8 5.6 34.3 13.1 18.0 52.1 38.4 104.3 96.7 125.2 126.7 0.2 74.9 168.8 85.2 139.3 0.1 0.1 0.7 24.5 105.9 92.4 39.3 37.5 76.1 116.0 0.1 49.8 0.0 30.1 6.0 51.9 0.2 5.6 111.8 22.8 121.0 43.1 113.7 6.9 15.9 70.9 15.6 123.2 41.2 20.6 0.4 49.2 0.0 33.5 24.8 88.7 0.3 108.3 127.1 40.7 74.6 0.0 40.6 56.5 76.2 49.8 0.2 29.0 71.9 71.3 31.3 36.5 0.0 10.0 0.4 1.2 0.0 102.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 21.4 25.9 17.2 18.3 38.6 11.2 12.0 18.3 11.0 7.0 18.6 18.0 88.6 0.0 10.3 13.4 0.6 9.9 61.1 123.5 63.7 50.4 40.0 52.1 47.5 18.6 47.0 79.1 8.4 472.9 0.9 2.1 17.6 179.0 11.5 100.8 48.6 36.2 95.7 0.0 141.0 12.2 321.8 53.4 7.7 35.0 1.3 39.3 7.5 0.0 41.8 32.0 155.3 26.3 95.6 0.0 6.3 7.6 34.8 1.5 24.9 24.4 1.6 35.9 0.0 61.3 3.9 23.8 4.1 23.0 2.6 63.8 0.0 23.7 172.4 28.1 39.5 2.0 49.7 60.9 47.4 26.2 4.1 783.8 1.6 46.6 7.8 51.4 ARHGEF10 "Gef10, KIAA0294" ENSG00000104728 "Rho guanine nucleotide exchange factor 10" O15013 8 1823926-1958641 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 90.1;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 158.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024649 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024649: AB_1845002" "unprognostic (2.51e-1)" "unprognostic (3.60e-2)" "unprognostic (2.39e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (7.27e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-2)" "unprognostic (9.29e-2)" "unprognostic (3.37e-2)" "unprognostic (1.81e-2)" "unprognostic (4.42e-1)" "unprognostic (3.18e-2)" "unprognostic (4.46e-2)" 17.8 10.2 9.7 2.3 10.0 0.4 15.3 9.4 9.9 14.8 9.4 15.3 0.5 18.8 2.7 5.5 15.1 2.0 17.7 9.1 10.3 10.2 3.4 28.1 1.6 10.1 10.0 7.9 13.6 6.6 1.1 7.3 3.0 10.3 12.9 1.6 1.9 12.2 3.1 4.0 13.4 9.3 4.7 8.9 6.9 14.3 24.5 9.8 2.1 13.1 1.1 1.1 12.4 13.5 12.0 7.1 7.6 7.7 4.0 6.8 7.4 1.9 9.4 6.9 6.5 7.8 2.5 3.2 0.0 1.0 11.7 11.1 5.3 8.4 10.9 8.8 0.0 3.0 3.2 8.6 0.0 6.0 0.0 2.1 6.5 6.2 7.7 6.1 10.0 11.8 2.5 3.1 0.0 8.0 3.8 5.8 1.1 6.6 5.3 4.2 0.3 8.6 0.0 6.2 2.7 1.5 1.6 5.7 0.2 5.3 9.4 3.1 2.1 13.2 5.9 3.8 0.1 8.4 0.0 2.9 0.1 6.0 8.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.7 10.0 9.4 9.9 9.1 10.3 10.1 10.0 7.9 10.3 8.9 9.8 12.0 11.7 3.2 4.1 90.1 0.9 38.4 13.4 8.1 5.7 7.7 7.8 6.3 13.3 15.7 5.0 7.3 10.4 0.6 2.6 1.4 0.0 7.5 17.8 3.3 11.4 27.7 1.2 3.6 17.3 2.0 1.6 30.0 4.1 6.9 0.0 11.3 13.9 1.2 1.7 21.9 16.3 4.5 8.2 1.6 9.4 20.5 35.1 2.1 23.2 50.6 0.3 10.1 4.1 69.9 158.9 12.4 0.3 26.4 2.3 22.6 0.7 0.8 2.8 9.2 0.0 22.6 14.2 54.9 38.3 1.4 15.2 0.3 2.1 7.7 2.4 6.3 KLHDC4 DKFZp434G0522 ENSG00000104731 "Kelch domain containing 4" Q8TBB5 16 87696485-87765992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.6;Late spermatids: 79.9;NK-cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 112.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041665 Approved Approved "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA041665: AB_10796352" "unprognostic (2.96e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-3)" "unprognostic (3.54e-1)" "unprognostic (2.94e-1)" "unprognostic (2.26e-2)" "unprognostic (7.61e-3)" "unprognostic (6.40e-2)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "prognostic favorable (1.14e-4)" "unprognostic (3.84e-2)" "unprognostic (2.73e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (3.88e-1)" "prognostic favorable (1.69e-4)" 10.5 10.8 7.4 11.7 6.9 13.4 10.8 10.7 9.0 11.7 4.6 13.6 9.0 11.7 4.5 12.0 12.1 6.7 8.9 7.5 6.4 11.8 14.7 11.5 16.3 7.1 6.8 6.6 12.3 18.6 10.4 13.2 5.5 8.3 13.4 11.0 6.3 11.9 7.9 12.6 11.9 13.8 7.1 6.0 20.0 14.1 12.6 6.6 15.8 13.2 6.4 13.5 11.6 13.0 7.5 16.6 29.7 14.8 22.8 6.0 7.9 23.3 15.1 14.5 24.8 11.6 43.9 23.3 25.6 19.6 12.1 8.8 26.6 23.1 20.0 18.0 4.2 24.9 15.0 20.6 29.4 14.9 14.3 14.8 3.6 10.7 21.9 25.0 12.4 20.8 42.5 48.3 13.4 17.1 72.0 32.7 40.3 25.5 18.9 21.8 31.3 17.3 15.3 15.0 19.2 22.5 21.4 31.9 16.4 7.8 12.6 25.8 22.0 13.4 13.1 23.3 7.1 29.5 63.2 23.4 112.0 13.2 35.2 9.7 0.0 7.8 5.9 18.3 10.8 16.2 7.8 7.2 14.1 6.0 7.7 7.3 11.3 0.6 25.7 16.0 8.0 6.8 8.7 7.4 6.9 10.7 9.0 7.5 6.4 7.1 6.8 6.6 8.3 6.0 6.6 7.5 8.4 0.0 16.8 11.1 14.7 4.6 10.9 6.8 12.5 17.8 12.7 9.9 9.9 14.3 14.2 9.2 27.1 14.4 36.1 16.5 11.7 12.3 61.6 8.9 6.0 8.8 24.0 16.0 9.1 16.7 9.4 9.0 19.4 11.4 3.8 17.7 12.1 13.3 13.3 11.8 10.1 15.9 8.2 13.3 6.1 79.9 6.5 9.9 8.8 7.5 10.2 6.5 77.2 7.1 9.2 13.1 9.3 7.5 35.9 15.1 13.8 25.1 9.0 18.0 0.0 16.7 8.5 22.8 11.8 8.6 6.7 11.9 25.5 11.6 21.8 16.5 MCM4 "CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21" ENSG00000104738 "Minichromosome maintenance complex component 4" P33991 8 47960185-47978160 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.8" "Cell type enhanced" "Detected in many" "Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004497, HPA004873, HPA031052" Enhanced Enhanced Nucleoplasm NA Yes 140000 Nucleoplasm "CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712" "unprognostic (4.55e-2)" "unprognostic (3.16e-3)" "prognostic favorable (2.19e-4)" "prognostic unfavorable (2.84e-5)" "unprognostic (7.71e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.70e-2)" "unprognostic (1.40e-1)" 6.6 8.8 4.6 21.9 4.9 63.8 16.1 5.9 5.3 6.9 1.7 17.9 13.4 7.0 4.7 22.6 9.8 5.7 14.6 4.9 4.5 8.2 9.3 6.3 39.1 4.3 4.1 4.5 7.2 5.6 7.8 4.1 18.4 4.3 5.7 21.5 12.4 8.9 4.9 13.5 24.3 16.8 9.3 4.1 8.2 10.7 42.0 4.5 47.4 6.6 16.0 42.1 11.9 11.0 5.0 184.0 139.6 188.1 83.2 20.7 36.6 102.8 122.6 99.8 178.5 190.3 156.6 181.1 229.8 70.3 72.1 119.2 143.2 278.7 128.2 199.8 64.2 190.4 371.8 133.3 169.2 5.4 189.7 82.0 20.3 24.1 147.8 54.3 28.6 72.0 136.8 216.2 167.0 129.9 155.6 435.5 141.5 241.2 246.5 54.2 266.6 159.6 139.2 64.9 168.1 209.0 97.8 325.6 133.6 46.3 117.7 154.9 110.5 45.1 138.1 125.4 144.5 131.9 54.7 104.6 347.2 114.8 185.7 131.5 2.3 1.8 1.1 4.0 3.1 2.0 3.9 3.8 5.4 3.9 1.6 3.3 2.7 0.1 4.1 3.5 1.5 10.2 3.6 4.6 4.9 5.9 5.3 4.9 4.5 4.3 4.1 4.5 4.3 4.1 4.5 5.0 3.3 0.0 6.3 3.3 6.5 21.7 11.1 9.0 13.6 12.2 9.0 7.7 25.1 1.5 8.4 5.5 10.4 36.7 5.8 12.1 3.9 8.0 153.2 11.0 7.9 6.7 6.7 60.8 5.0 6.0 40.2 10.6 11.2 13.4 1.3 24.9 2.2 3.2 12.3 16.8 5.7 13.9 4.1 2.9 6.5 77.9 5.3 7.9 3.6 1.9 2.4 7.0 3.1 4.0 2.9 4.5 4.8 3.0 22.3 7.7 5.6 3.0 13.1 16.7 0.0 9.5 11.4 65.8 39.9 19.1 19.0 29.8 9.0 11.7 26.2 9.7 ADAM2 "CT15, FTNB, PH-30b, PH30" ENSG00000104755 "ADAM metallopeptidase domain 2" Q99965 8 39743735-39838289 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 133 "testis: 38.5" "Group enriched" "Detected in some" 4 "Early spermatids: 28.2;Spermatocytes: 96.8" "Cancer enriched" "Detected in single" 5 "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB022390, HPA024621, HPA026581" Enhanced NA NA "CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577" "unprognostic (4.74e-2)" "unprognostic (1.67e-3)" "unprognostic (3.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.8 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" No No Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: AB_2680205" "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favorable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 18.4 8.2 6.2 11.6 6.5 21.7 22.5 8.9 7.3 13.8 9.5 21.3 19.8 11.4 13.1 24.0 14.7 13.5 38.7 6.3 7.5 12.9 10.9 13.5 12.3 9.4 8.1 4.9 14.3 11.3 11.1 9.9 12.1 10.8 17.6 22.8 13.0 17.7 15.8 29.7 19.1 17.8 14.7 8.9 9.5 12.9 13.0 7.7 14.8 13.8 37.0 14.5 15.7 18.9 9.1 46.4 32.4 34.5 11.9 44.0 58.0 28.2 68.6 61.4 44.1 44.5 23.4 33.2 30.1 28.6 69.0 62.3 30.3 30.6 32.3 52.9 15.4 18.2 35.3 30.2 21.7 53.2 12.3 25.1 44.8 38.5 40.2 33.2 26.9 37.8 29.6 37.8 23.0 50.7 12.4 48.2 21.6 16.8 35.8 17.0 18.6 39.8 11.2 45.0 26.1 8.8 11.4 52.7 23.1 35.8 30.8 17.8 14.2 42.2 48.5 28.2 94.1 37.6 6.6 12.9 39.1 33.9 21.8 35.8 0.7 0.5 1.2 1.0 0.7 1.0 0.6 1.0 1.0 0.3 0.3 0.6 0.9 0.5 0.2 0.9 1.0 1.1 0.4 6.2 6.5 8.9 7.3 6.3 7.5 9.4 8.1 4.9 10.8 8.9 7.7 9.1 19.5 32.1 18.5 18.6 8.9 74.4 36.4 26.0 31.9 13.7 20.4 12.7 61.1 5.7 24.2 27.6 25.0 9.4 23.3 53.8 13.7 17.6 6.5 12.8 12.7 16.8 10.2 20.2 14.3 27.2 17.6 32.5 8.2 17.9 20.3 10.9 12.5 9.0 9.3 3.3 12.9 16.0 18.3 9.3 18.5 5.2 30.7 12.9 30.2 36.5 8.5 8.1 18.6 17.1 13.6 36.6 21.6 55.7 17.1 52.6 25.8 10.4 17.4 19.6 6.6 21.6 26.2 35.6 26.4 41.6 54.7 11.2 19.8 14.4 17.7 46.0 FGL1 "HFREP-1, HPS" ENSG00000104760 "Fibrinogen like 1" Q08830 8 17864380-17910365 "Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 4198.1" "Cell type enriched" "Detected in many" 27 "Hepatocytes: 8261.7" "Cancer enriched" "Detected in some" 40 "liver cancer: 399.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "A549: 55.4;Hep G2: 131.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 57000000 "unprognostic (3.62e-2)" "unprognostic (1.14e-2)" "unprognostic (1.75e-5)" "unprognostic (3.00e-1)" "unprognostic (3.54e-2)" "unprognostic (7.89e-2)" "unprognostic (2.15e-1)" "unprognostic (2.62e-1)" "unprognostic (2.71e-1)" "unprognostic (1.09e-2)" "unprognostic (2.86e-7)" "prognostic unfavorable (5.38e-4)" "unprognostic (3.62e-1)" "unprognostic (2.58e-2)" "unprognostic (1.35e-1)" 0.5 0.4 1.0 0.0 1.2 0.0 1.0 0.8 1.7 0.3 0.7 0.2 0.0 0.7 0.8 0.2 0.2 0.1 0.3 1.1 2.4 0.5 4198.1 1.2 0.0 1.1 1.3 1.0 0.3 665.7 0.0 0.2 6.3 1.1 3.8 0.1 0.2 0.2 0.0 0.1 0.1 0.3 0.2 0.9 3.8 0.7 4.3 1.1 0.0 0.3 0.0 0.0 0.1 0.1 2.1 0.0 55.4 0.0 6.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 131.9 0.0 1.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 1.3 0.8 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.8 1.7 1.1 2.4 1.1 1.3 1.0 1.1 0.9 1.1 2.1 0.0 0.0 1.9 12.4 24.6 0.0 0.2 0.0 0.0 0.0 1.3 0.9 2.1 301.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.3 42.9 5.4 1.0 7.6 0.0 176.4 0.1 71.2 0.4 0.1 0.0 7.8 0.0 0.0 173.8 8261.7 20.4 0.0 0.3 0.0 0.0 231.6 0.0 32.7 0.6 0.2 0.0 14.0 1.6 0.0 0.0 2.5 0.0 74.1 0.0 0.4 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 0.0 1.0 12.8 0.1 0.3 0.2 ASAH1 "AC, ACDase, ASAH, FLJ21558, PHP32" ENSG00000104763 "N-acylsphingosine amidohydrolase 1" Q13510 8 18055992-18084998 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 579.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 777.0;Hofbauer cells: 921.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 392.8;SK-MEL-30: 590.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005468 Supported "Intracellular and membrane" NA NA 400000 "HPA005468: AB_1845062" "unprognostic (1.99e-1)" "unprognostic (1.86e-1)" "unprognostic (4.15e-3)" "unprognostic (9.23e-2)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-2)" "unprognostic (4.29e-3)" "unprognostic (2.44e-1)" "unprognostic (4.85e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-2)" "prognostic favorable (3.08e-8)" "unprognostic (1.95e-1)" "unprognostic (3.91e-2)" "unprognostic (6.54e-3)" "unprognostic (7.36e-3)" 216.2 72.6 48.4 52.1 50.8 108.7 96.8 60.0 56.9 99.3 61.5 85.1 55.2 56.3 132.6 73.9 71.0 99.9 579.4 48.0 67.2 205.8 61.4 192.0 66.4 64.9 61.3 44.1 50.5 50.0 118.8 84.3 122.5 64.7 85.0 87.8 80.2 67.1 78.6 66.5 53.0 57.3 62.3 70.3 86.1 61.7 18.3 55.7 26.2 328.5 71.3 58.2 113.9 55.2 88.8 48.1 66.4 25.9 63.3 392.8 46.0 39.2 48.2 67.3 23.0 41.0 35.4 66.1 30.2 60.3 54.5 159.1 62.6 15.0 25.3 28.4 22.9 38.9 134.4 46.7 96.7 107.5 27.7 140.7 100.2 86.5 33.6 22.9 53.2 6.2 50.6 24.3 61.7 67.9 46.0 15.5 48.3 30.3 105.2 40.5 19.4 25.5 41.4 112.0 273.0 40.4 55.0 43.8 145.2 590.5 35.6 47.9 31.3 43.6 30.3 43.1 55.8 23.7 75.5 184.3 22.0 89.5 61.3 24.6 285.2 455.4 318.7 47.6 676.4 43.1 83.9 35.5 36.1 175.1 65.9 40.8 37.9 627.6 60.5 731.4 33.0 43.7 407.2 48.4 50.8 60.0 56.9 48.0 67.2 64.9 61.3 44.1 64.7 70.3 55.7 88.8 98.5 317.3 405.0 36.9 92.8 58.6 83.3 103.7 35.3 97.5 105.6 87.8 777.0 100.1 280.9 450.6 45.9 177.4 67.6 83.4 60.7 150.6 2.8 85.7 51.5 79.7 98.1 106.3 49.8 104.1 65.2 122.0 43.3 133.8 257.0 49.3 134.6 50.6 921.2 77.4 53.2 99.3 201.4 564.3 89.9 6.0 88.6 524.6 318.4 56.2 259.2 532.6 53.5 49.8 49.0 64.7 125.5 105.7 87.4 87.8 77.6 304.2 147.3 88.0 177.5 74.5 157.0 14.0 63.6 84.9 64.2 148.2 61.3 53.4 89.7 139.9 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26383054-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 913.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (7.59e-3)" 131.7 53.9 48.8 37.6 62.9 194.3 78.6 60.0 60.4 64.4 53.6 34.3 22.5 53.3 66.8 48.8 50.9 55.2 55.4 56.2 55.3 80.1 45.8 63.4 39.7 65.6 55.5 45.8 120.7 20.3 55.6 25.6 105.4 62.1 44.8 28.5 147.8 44.5 65.0 39.3 68.1 28.6 51.8 57.0 41.1 29.2 69.2 65.5 40.3 42.3 32.0 52.5 49.3 49.9 86.0 90.6 33.8 79.1 53.9 214.5 134.0 66.8 89.0 259.9 81.9 179.6 15.3 42.7 27.7 82.5 169.0 113.4 44.8 39.6 114.5 270.0 17.8 21.8 114.9 32.0 26.9 119.3 10.3 191.1 162.5 89.2 92.9 55.3 269.2 106.2 66.9 52.6 65.0 173.7 39.1 72.7 38.5 26.2 56.7 36.6 38.4 99.9 55.6 85.3 58.3 83.9 74.4 43.2 8.8 70.0 85.9 43.7 21.7 140.4 152.2 64.6 96.2 20.5 93.2 46.0 36.8 232.6 20.6 35.1 334.9 298.3 182.9 39.5 154.8 34.9 68.4 58.4 43.3 166.9 78.0 89.3 65.5 369.0 47.6 104.1 38.0 86.1 239.3 48.8 62.9 60.0 60.4 56.2 55.3 65.6 55.5 45.8 62.1 57.0 65.5 86.0 118.3 86.6 157.4 28.7 72.2 98.8 56.0 231.7 82.6 142.5 90.6 85.3 34.0 50.1 126.4 103.0 33.3 33.2 55.6 32.7 49.0 115.4 194.1 173.5 140.8 101.2 120.6 913.9 50.6 39.1 166.5 179.9 38.7 341.2 120.9 96.5 167.0 32.2 132.1 82.4 39.4 46.8 118.0 221.3 300.4 206.7 320.3 233.6 106.7 30.0 165.0 406.4 32.0 29.1 75.8 154.1 39.8 347.5 64.6 83.6 44.0 306.4 107.6 64.0 144.7 59.1 183.9 154.4 110.7 65.4 126.6 162.5 67.0 117.6 27.6 79.3 MAN2B1 "LAMAN, MANB" ENSG00000104774 "Mannosidase alpha class 2B member 1" O00754 19 12646511-12666742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 32.8;Plasma cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5" "Group enriched" "Detected in all" 5 "dendritic cells: 187.5;monocytes: 201.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041530, HPA053404" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 3200000 "Nucleoplasm, Vesicles" "HPA041530: AB_10795639, HPA053404: " "unprognostic (6.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.20e-2)" "unprognostic (5.48e-2)" "unprognostic (3.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (1.95e-1)" "unprognostic (2.79e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.94e-5)" "unprognostic (4.00e-1)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.51e-1)" 33.2 21.6 5.1 55.1 6.0 84.3 25.0 6.7 8.7 19.8 18.6 30.6 31.3 22.0 9.0 20.0 20.1 28.6 14.5 4.6 11.7 17.3 23.9 47.2 52.6 9.8 6.5 3.1 16.9 40.0 16.7 9.9 24.8 9.1 20.7 22.8 1.6 35.5 15.0 12.2 29.1 33.9 20.4 9.2 70.7 33.0 6.5 7.8 23.3 16.4 9.5 39.6 36.0 16.8 9.5 52.4 26.3 26.4 31.3 85.8 57.3 74.0 37.9 79.2 33.1 32.4 21.3 21.4 56.9 44.9 30.4 9.4 40.1 13.6 25.6 15.7 28.5 41.6 19.8 13.6 34.9 43.5 131.6 130.2 68.5 49.2 18.5 23.3 35.6 31.7 21.1 25.6 41.9 17.8 40.9 17.9 74.2 21.9 26.2 32.8 40.8 36.1 28.8 38.9 59.8 8.2 25.5 37.7 32.0 63.0 15.8 49.4 80.0 42.0 44.8 18.4 44.0 36.2 55.4 65.5 28.0 30.4 127.5 51.2 12.2 201.8 29.7 31.9 178.8 35.4 32.9 28.9 29.0 158.8 26.4 15.4 15.9 29.4 13.2 138.4 187.5 30.7 150.3 5.1 6.0 6.7 8.7 4.6 11.7 9.8 6.5 3.1 9.1 9.2 7.8 9.5 1.6 6.4 7.5 8.5 25.1 3.6 2.0 2.7 14.2 2.6 1.9 1.0 0.9 2.8 2.0 1.8 0.0 2.5 20.5 2.0 1.9 1.7 3.7 1.4 2.5 3.1 1.8 9.4 7.8 2.3 2.8 7.2 20.9 1.3 1.3 3.4 1.8 0.8 8.4 0.0 6.4 0.9 0.0 15.4 24.7 11.1 3.7 32.8 1.8 17.8 11.0 1.5 9.2 3.5 13.4 1.5 2.5 4.5 78.1 2.5 3.8 1.5 3.9 4.0 13.1 2.3 2.0 0.6 1.6 11.5 3.3 2.7 9.4 2.7 2.0 2.0 KCNN4 "hIKCa1, hKCa4, hSK4, IK, KCa3.1" ENSG00000104783 "Potassium calcium-activated channel subfamily N member 4" O15554 19 43766533-43781257 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 132.0" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 231.1;Syncytiotrophoblasts: 763.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.7;WM-115: 258.6" "Region enhanced" "Detected in single" "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA013367, HPA053841, HPA059622" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085" "unprognostic (1.23e-2)" "unprognostic (3.22e-2)" "unprognostic (4.29e-1)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.98e-2)" "unprognostic (7.33e-2)" "unprognostic (1.42e-2)" "unprognostic (2.48e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (9.96e-3)" "prognostic unfavorable (1.05e-14)" "unprognostic (3.70e-2)" "unprognostic (2.17e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.75e-4)" 2.9 0.8 1.6 11.9 1.9 18.4 12.5 1.3 2.9 11.9 2.5 11.9 6.4 1.7 1.8 6.6 5.8 3.5 1.1 1.4 1.4 1.4 0.8 7.3 12.6 1.6 1.4 1.3 0.6 1.1 0.0 0.7 14.4 1.6 28.8 6.2 0.2 132.0 7.6 0.4 27.1 26.2 0.7 2.0 20.6 35.4 2.7 1.9 5.1 2.1 0.2 9.3 18.3 6.5 1.6 22.4 35.2 0.1 0.2 0.0 2.2 55.0 0.8 1.7 0.7 0.1 0.5 85.7 6.7 9.8 0.9 9.1 13.6 0.0 28.8 1.7 40.9 0.0 29.8 48.6 0.5 0.0 0.3 0.3 0.0 2.9 1.3 6.6 52.7 0.0 0.3 2.6 2.3 0.3 18.7 4.8 17.9 0.2 43.1 42.4 16.8 0.7 21.0 13.0 55.3 0.2 0.1 62.2 70.1 32.6 1.7 0.3 15.1 1.5 12.6 75.9 0.4 45.3 0.1 1.4 2.6 45.9 5.1 258.6 5.8 21.1 0.0 0.5 35.3 0.7 37.3 10.4 5.0 30.7 21.6 6.6 6.3 1.1 0.0 20.1 0.9 15.2 11.2 1.6 1.9 1.3 2.9 1.4 1.4 1.6 1.4 1.3 1.6 2.0 1.9 1.6 1.6 0.0 1.9 1.3 24.7 2.8 45.7 79.5 3.4 0.2 69.7 56.6 0.4 7.2 18.4 1.8 4.2 231.1 4.1 22.0 0.0 5.9 1.2 1.7 0.2 4.0 0.0 32.4 1.5 3.9 14.1 2.3 57.1 4.2 0.0 0.0 0.4 0.0 43.7 0.0 1.1 8.9 2.0 7.2 78.2 0.3 0.0 23.3 21.4 1.0 2.5 0.1 1.0 0.5 0.8 63.8 22.3 0.0 22.4 63.5 1.0 0.1 2.2 0.5 0.0 0.3 1.4 0.4 1.4 2.1 2.3 763.3 9.5 0.0 51.1 65.6 TULP2 "CT65, TUBL2" ENSG00000104804 "TUB like protein 2" O00295 19 48880967-48898744 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 37.9" "Group enriched" "Detected in some" 16 "Early spermatids: 281.1;Late spermatids: 233.0" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 3.0" "Cell line enhanced" "Detected in some" "BEWO: 2.6;U-266/70: 3.0;U-266/84: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075828 Approved Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA075828: " "unprognostic (9.97e-2)" "unprognostic (5.55e-3)" "unprognostic (1.15e-1)" "unprognostic (9.39e-2)" "unprognostic (1.69e-4)" "unprognostic (6.79e-4)" "unprognostic (1.07e-2)" "unprognostic (2.57e-1)" "unprognostic (5.94e-3)" "unprognostic (1.08e-2)" "unprognostic (9.82e-2)" "unprognostic (1.33e-1)" "unprognostic (4.59e-4)" "unprognostic (6.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.08e-1)" "unprognostic (1.97e-1)" 0.3 0.5 2.3 0.1 2.6 5.3 0.5 3.8 8.6 0.3 1.9 0.3 0.0 1.0 0.1 0.8 0.8 0.8 0.5 2.5 2.1 0.2 0.1 0.5 0.2 2.0 2.3 2.4 1.5 0.1 0.1 0.1 0.1 2.5 0.7 0.2 0.5 0.1 0.2 0.5 0.1 0.5 0.4 1.8 1.4 0.4 37.9 2.2 0.1 0.3 0.1 0.3 0.3 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.9 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.0 0.0 0.0 2.3 2.6 3.8 8.6 2.5 2.1 2.0 2.3 2.4 2.5 1.8 2.2 3.3 0.2 0.0 0.5 0.3 0.8 0.3 0.1 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 281.1 0.8 2.7 1.0 0.0 0.0 0.9 0.0 0.1 0.6 0.0 2.2 2.5 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.0 0.3 0.7 233.0 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 6.4 1.4 15.4 1.4 0.4 0.4 0.0 0.6 0.1 0.0 0.0 NUCB1 "Calnuc, NUC" ENSG00000104805 "Nucleobindin 1" Q02818 19 48900312-48923372 "Plasma proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 453.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008176 Supported Supported "Golgi apparatus,Microtubules" "Secreted to blood" NA NA 27000000 "Golgi apparatus" Microtubules "HPA008176: AB_1845923" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (4.36e-3)" "unprognostic (6.28e-2)" "unprognostic (1.06e-2)" "unprognostic (2.95e-1)" "unprognostic (6.86e-2)" "unprognostic (1.98e-1)" "unprognostic (9.51e-2)" "unprognostic (8.14e-3)" "unprognostic (2.34e-3)" "unprognostic (9.89e-2)" "unprognostic (5.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (8.90e-3)" "unprognostic (3.41e-1)" 182.9 104.4 60.2 107.7 53.3 83.0 142.8 60.8 68.8 115.0 79.0 117.5 181.5 128.6 61.8 112.2 117.9 109.3 190.4 57.5 64.1 153.1 266.7 158.4 82.8 62.6 57.4 49.2 126.7 131.2 174.9 70.0 115.7 63.3 110.2 55.3 30.4 118.8 104.0 181.8 95.3 164.9 107.0 56.2 112.0 119.8 35.0 64.4 50.0 123.3 111.7 53.5 131.2 109.8 82.0 54.8 182.1 84.2 188.5 304.6 249.2 97.6 208.1 189.9 103.3 144.2 92.9 203.1 54.7 151.8 250.6 98.9 132.0 48.6 107.0 43.3 194.6 90.3 141.6 119.0 131.6 156.6 85.1 183.6 288.0 52.1 96.8 62.9 275.2 167.2 60.7 173.1 278.8 107.0 71.6 42.3 68.6 42.2 132.1 93.5 78.7 125.3 114.9 90.2 134.6 61.2 123.2 247.1 152.2 88.1 79.7 78.8 112.1 234.6 172.3 114.3 107.0 99.3 210.8 501.1 37.1 132.5 54.3 207.3 102.9 108.5 105.7 100.6 128.5 75.3 46.8 67.5 77.2 79.0 37.3 55.3 56.7 104.7 69.2 114.2 113.9 74.6 129.5 60.2 53.3 60.8 68.8 57.5 64.1 62.6 57.4 49.2 63.3 56.2 64.4 82.0 154.5 41.7 72.1 17.6 51.0 48.3 67.2 81.3 66.0 21.7 57.6 57.5 58.0 78.6 51.5 69.9 14.6 101.5 69.6 153.0 41.1 148.0 10.8 27.4 65.5 116.0 74.4 54.5 14.5 118.3 150.9 126.7 76.0 50.2 95.2 64.1 122.0 149.2 213.7 20.2 18.9 109.9 69.2 138.3 74.6 9.3 110.3 101.9 101.4 17.8 120.3 52.6 74.2 8.5 11.8 100.0 149.2 124.1 126.3 63.8 453.3 135.4 24.4 20.5 92.1 51.0 79.0 21.9 37.6 65.6 49.9 102.1 73.0 103.9 123.3 68.1 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933699-48944969 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 17.4;kidney: 18.2" "Group enriched" "Detected in many" 11 "Proximal enterocytes: 213.7;Proximal tubular cells: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.2" "Group enriched" "Detected in many" 33 "granulocytes: 4.2;T-cells: 2.3" "Cell line enhanced" "Detected in some" "JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.2 0.4 1.5 0.0 1.6 0.1 0.2 1.9 3.5 0.2 1.2 0.3 10.6 0.1 0.0 0.8 0.3 0.2 0.1 1.7 1.7 18.2 0.4 1.1 0.2 1.3 1.3 1.8 0.6 0.4 0.5 1.8 1.3 1.4 3.2 0.0 1.7 0.4 0.1 0.2 0.2 17.4 0.0 1.4 1.7 0.7 2.0 2.2 0.1 0.1 0.0 0.2 0.3 0.4 1.7 1.4 0.0 0.1 0.7 0.4 0.3 0.5 0.0 0.2 0.2 0.7 1.4 1.1 0.0 0.2 0.0 0.9 0.4 0.5 1.0 0.4 0.5 1.1 2.0 0.5 0.5 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.3 0.0 3.2 0.7 0.2 0.0 0.3 0.0 0.1 0.3 2.1 0.9 0.7 0.1 1.0 0.1 0.4 2.1 1.1 0.2 0.1 0.5 0.1 1.0 0.0 0.0 0.0 0.8 0.3 0.0 3.2 2.8 0.8 0.7 0.0 0.2 4.2 0.0 0.5 0.7 0.0 0.4 0.0 0.8 0.3 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.6 0.2 1.5 1.6 1.9 3.5 1.7 1.7 1.3 1.3 1.8 1.4 1.4 2.2 1.7 0.5 3.2 6.4 1.0 1.0 0.8 2.4 3.3 2.2 2.4 1.0 3.4 0.7 1.5 4.6 3.7 0.0 0.2 0.4 1.5 9.8 2.2 0.7 0.3 0.5 0.8 0.0 0.4 1.0 0.4 0.2 0.5 4.1 0.8 1.3 0.1 0.0 0.0 12.9 0.0 1.2 5.0 2.0 0.8 0.0 2.4 0.0 1.7 0.0 0.0 0.0 1.6 0.0 0.0 0.5 1.5 3.6 0.0 0.0 3.5 213.7 77.8 0.5 4.5 0.0 1.2 0.4 0.0 0.8 3.1 0.1 0.1 0.6 0.4 2.7 3.2 GYS1 "GSY, GYS" ENSG00000104812 "Glycogen synthase 1" P13807 19 48968130-48993310 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 103.5;skeletal muscle: 322.4;tongue: 203.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007793, HPA041598" Enhanced Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "CAB007793: AB_562291, HPA041598: AB_2677571" "unprognostic (3.37e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (6.83e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (3.30e-2)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (4.04e-2)" "unprognostic (6.76e-2)" "unprognostic (5.87e-3)" "unprognostic (3.81e-2)" 28.3 26.5 16.6 16.3 17.1 46.4 23.9 22.9 21.0 16.6 20.0 21.4 15.4 19.0 8.9 38.5 18.9 10.2 103.5 18.4 15.5 21.8 15.0 16.1 15.6 20.7 16.9 14.9 19.8 13.7 15.9 15.6 11.4 17.9 27.6 14.8 19.4 22.4 15.7 322.4 20.9 20.1 16.9 15.1 18.6 23.4 6.1 20.2 14.9 16.0 203.4 14.5 24.5 23.4 16.8 67.3 26.3 19.0 26.3 43.2 16.9 37.6 45.5 31.7 46.8 54.3 25.8 21.3 28.0 27.0 44.7 12.4 46.6 32.0 57.7 40.6 17.4 46.5 23.1 33.3 23.1 24.3 25.4 15.9 41.8 27.2 30.2 25.4 40.5 39.8 28.8 16.4 36.1 59.4 25.4 31.8 21.9 10.2 29.0 29.8 26.6 33.2 27.5 46.7 70.6 11.8 16.4 40.5 52.1 10.4 25.2 27.7 26.1 31.0 57.1 22.0 26.1 50.5 29.8 33.1 13.5 58.3 22.2 13.1 7.7 9.4 6.6 7.0 5.3 8.6 5.2 6.0 6.5 13.4 3.9 4.7 4.4 3.7 10.6 8.0 7.2 8.6 7.1 16.6 17.1 22.9 21.0 18.4 15.5 20.7 16.9 14.9 17.9 15.1 20.2 16.8 3.5 0.0 14.2 21.9 5.9 5.1 3.7 11.7 11.4 4.2 7.3 5.5 67.9 2.8 5.8 0.0 16.7 7.6 6.8 13.2 0.0 8.1 0.3 6.9 8.9 7.1 7.2 4.8 14.7 6.9 31.7 5.0 12.8 11.9 4.5 6.7 9.7 5.2 8.3 0.0 16.6 9.2 4.1 7.0 5.7 0.7 5.3 7.2 7.2 4.7 9.8 3.3 10.3 8.5 6.9 11.8 8.2 5.7 9.7 5.4 9.2 6.0 6.2 11.7 0.0 5.0 7.3 1.3 2.9 15.3 4.1 4.0 5.2 3.8 11.7 3.3 MAP4K1 HPK1 ENSG00000104814 "Mitogen-activated protein kinase kinase kinase kinase 1" Q92918 19 38587641-38618882 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 30.3;lymphoid tissue: 57.3" "Cell type enhanced" "Detected in many" "B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6" "Cancer enhanced" "Detected in all" "testis cancer: 15.2" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA007419, CAB007754" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB007754: AB_562299, HPA007419: AB_1853778" "unprognostic (1.99e-3)" "prognostic favorable (6.17e-5)" "unprognostic (9.50e-3)" "unprognostic (3.27e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.88e-3)" "unprognostic (5.32e-3)" "unprognostic (2.79e-1)" "unprognostic (2.51e-1)" "unprognostic (3.92e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (7.99e-10)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-2)" "unprognostic (1.50e-2)" 2.6 1.5 0.6 14.7 0.7 9.3 1.7 0.7 1.2 1.6 0.7 3.3 2.7 1.3 0.8 2.8 1.9 2.3 1.4 0.7 0.7 2.7 3.0 6.2 32.5 0.8 0.7 0.5 0.9 1.2 0.2 1.8 1.8 0.8 2.5 2.3 16.2 2.8 0.5 0.8 1.9 30.3 0.9 0.8 57.3 3.1 1.5 0.8 13.3 3.2 0.2 29.5 2.9 2.2 0.9 0.2 0.3 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 45.2 0.7 0.0 0.0 0.1 0.1 0.0 0.0 46.4 0.3 9.8 0.1 0.1 0.0 3.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 21.3 0.2 46.9 0.1 0.3 11.0 12.0 1.4 0.3 0.1 25.5 0.1 29.8 0.0 0.0 0.4 0.1 0.1 0.2 0.1 0.3 0.2 10.8 0.1 0.1 0.3 0.1 0.1 36.0 38.2 57.8 0.0 13.5 0.1 2.9 4.9 2.0 18.9 9.4 17.4 22.7 15.8 20.1 23.9 15.5 8.6 12.1 0.5 6.1 5.7 22.2 22.2 12.1 0.6 0.7 0.7 1.2 0.7 0.7 0.8 0.7 0.5 0.8 0.8 0.8 0.9 0.7 3.2 4.9 0.3 42.6 2.3 0.2 0.4 1.2 6.7 0.7 1.0 0.9 0.0 0.6 0.0 12.5 0.2 42.6 0.1 0.0 0.0 0.0 0.3 0.2 1.6 0.0 5.5 0.7 0.2 0.3 1.5 2.0 0.3 15.8 0.4 1.1 1.1 2.6 1.7 1.0 0.1 0.0 8.8 27.8 0.2 0.0 11.6 3.6 1.9 10.3 11.5 15.5 1.0 0.5 0.0 0.0 0.0 30.4 0.3 0.0 0.2 0.0 77.9 0.0 1.0 0.4 0.7 6.4 0.6 1.0 0.1 43.6 0.3 0.3 0.1 CGB2 ENSG00000104818 "Chorionic gonadotropin subunit beta 2" Q6NT52 19 49031890-49033238 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Cell type enriched" "Detected in some" 6 "Syncytiotrophoblasts: 40.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 29.9;U-266/70: 12.1;U-266/84: 15.6" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.05e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.8 0.7 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 4.1 0.0 0.5 0.0 0.1 0.3 0.0 29.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.3 0.8 0.0 3.9 12.1 15.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.1 0.2 0.1 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.5 1.8 0.0 0.0 40.0 0.0 0.0 0.0 0.0 ECH1 HPXEL ENSG00000104823 "Enoyl-CoA hydratase 1" Q13011 19 38815422-38831841 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 914.3" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 796.9;Proximal tubular cells: 880.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA005835" Supported Supported Supported Mitochondria No No 720000 Mitochondria "HPA002907: AB_1847964, HPA005835: AB_1847965" "unprognostic (1.91e-1)" "unprognostic (3.03e-2)" "unprognostic (3.64e-2)" "unprognostic (6.43e-2)" "unprognostic (5.73e-3)" "unprognostic (6.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (5.86e-2)" "unprognostic (2.24e-1)" "unprognostic (3.37e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.54e-1)" "unprognostic (3.52e-1)" "unprognostic (1.74e-2)" 197.3 345.8 46.8 48.1 48.3 62.8 195.8 50.2 60.8 111.7 51.8 219.1 94.4 116.3 32.5 169.7 115.0 67.4 595.8 45.0 47.8 269.5 560.7 123.1 68.4 47.7 47.2 43.6 108.1 142.6 56.5 77.7 67.6 49.1 100.4 100.9 12.9 139.7 43.7 914.3 141.2 168.8 60.2 46.4 193.8 182.0 101.5 49.8 51.4 118.8 459.2 66.3 143.6 133.5 49.1 64.0 273.8 42.0 68.8 161.0 82.0 61.8 31.7 53.2 26.6 27.1 178.8 124.8 98.6 117.2 72.8 24.1 30.1 70.9 72.9 21.1 345.3 37.7 120.7 76.5 146.1 161.3 131.9 116.9 109.0 186.6 35.1 61.2 52.3 63.4 127.3 58.4 160.8 59.6 120.0 91.8 82.2 27.8 278.8 65.9 101.8 126.2 199.0 168.7 142.6 51.4 67.2 161.0 77.1 86.5 27.3 106.4 288.4 53.7 45.5 39.3 46.5 29.6 121.0 153.2 96.4 71.4 164.9 90.7 316.1 312.9 268.0 253.6 248.2 237.2 368.4 243.5 249.1 308.6 361.3 216.5 242.4 41.6 342.7 212.8 221.5 391.8 541.8 46.8 48.3 50.2 60.8 45.0 47.8 47.7 47.2 43.6 49.1 46.4 49.8 49.1 125.4 86.6 104.7 13.1 111.1 82.2 220.0 320.8 80.8 22.4 124.0 143.8 302.7 205.9 203.2 145.3 16.7 796.9 103.4 257.7 510.6 195.4 64.5 95.7 56.9 96.4 189.2 99.9 7.1 90.1 370.6 104.1 112.7 77.0 120.9 177.6 90.7 549.4 277.6 37.0 8.6 298.9 193.3 99.0 85.2 56.7 130.8 97.5 145.9 8.4 205.1 53.0 113.3 7.1 16.0 97.0 257.5 143.0 122.1 100.1 383.0 880.0 182.6 21.4 78.9 88.4 119.7 73.3 51.3 121.6 90.8 580.9 118.6 624.2 350.0 218.1 HNRNPL HNRPL ENSG00000104824 "Heterogeneous nuclear ribonucleoprotein L" P14866 19 38836370-38852347 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016326, HPA051748, HPA052661" Supported Enhanced Nucleoplasm NA NA 420000 Nucleoplasm "CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905" "unprognostic (5.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-1)" "unprognostic (9.67e-3)" "unprognostic (8.99e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.25e-6)" "unprognostic (1.45e-1)" "unprognostic (8.85e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (1.96e-11)" "unprognostic (2.17e-2)" "unprognostic (4.23e-2)" "unprognostic (1.58e-2)" "unprognostic (4.39e-2)" 111.6 109.4 44.0 70.3 45.3 196.8 111.2 49.4 47.3 109.2 42.8 112.0 73.4 120.9 48.5 135.5 98.5 37.7 96.5 41.8 50.1 91.9 99.6 118.8 84.9 47.1 43.5 41.4 104.7 88.3 68.2 71.1 58.1 46.9 82.2 77.2 53.6 100.6 46.2 126.7 143.2 114.3 80.6 47.9 114.4 105.1 84.4 46.0 129.9 102.6 57.8 115.4 102.7 112.6 58.9 293.6 214.8 256.4 157.9 94.8 108.7 257.7 233.3 138.9 187.1 177.4 229.9 189.7 436.8 196.2 130.5 152.1 167.0 299.6 228.9 270.7 354.4 231.0 349.9 128.3 205.9 101.2 334.0 228.2 122.7 106.9 187.1 182.1 108.8 209.4 186.7 353.7 200.0 197.6 216.0 347.7 202.9 307.6 186.6 185.6 440.8 296.4 271.7 212.1 203.8 218.6 226.0 225.1 157.7 90.0 172.2 213.4 176.7 207.1 194.9 238.1 184.2 349.4 224.0 312.5 473.1 128.4 293.1 220.0 1.2 1.9 1.2 2.6 3.0 2.0 1.7 2.0 1.7 2.6 2.2 2.0 1.7 1.9 1.8 2.5 5.1 2.6 1.1 44.0 45.3 49.4 47.3 41.8 50.1 47.1 43.5 41.4 46.9 47.9 46.0 58.9 62.2 22.4 53.8 40.1 105.1 35.4 52.1 18.0 135.5 76.7 63.6 47.6 22.9 31.5 29.1 22.0 64.6 42.9 100.0 59.0 7.9 37.4 15.9 61.2 64.8 48.7 62.9 83.3 38.0 44.1 35.3 57.0 91.7 88.4 39.3 33.8 43.5 63.0 27.4 33.7 39.0 70.4 12.2 63.7 35.1 11.7 28.3 60.3 26.6 31.9 42.4 39.0 48.4 31.2 56.3 44.1 45.6 22.6 123.0 55.6 55.4 23.9 25.5 78.7 19.7 64.1 59.0 25.5 22.1 117.6 47.5 52.3 95.0 42.4 70.2 41.9 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 77.0" "Group enriched" "Detected in all" 15 "Early spermatids: 892.6;Late spermatids: 1179.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA063734: AB_2685107" "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 12.6 12.8 3.6 5.2 4.4 10.9 11.8 3.9 3.3 8.9 2.1 12.1 4.2 10.7 0.5 16.1 10.0 1.1 15.5 2.5 3.4 10.6 22.7 13.2 3.6 4.7 4.2 2.0 8.1 11.2 1.8 7.8 1.8 4.9 9.9 1.1 1.0 11.9 1.9 30.8 14.9 12.9 0.9 4.1 13.6 14.0 77.0 4.0 2.0 9.8 1.6 1.7 13.6 10.6 4.7 13.7 16.9 2.4 6.2 2.4 1.4 7.8 9.0 3.5 4.7 5.4 11.7 7.2 15.0 9.8 2.0 4.5 7.6 6.2 4.4 1.6 46.2 7.8 10.1 3.0 6.7 8.2 11.7 20.6 1.9 4.9 5.2 6.6 1.3 2.7 10.9 12.0 13.4 1.8 8.7 14.3 11.1 8.2 11.6 7.0 20.0 10.1 14.1 2.3 5.4 14.1 8.6 5.7 8.1 6.7 1.4 5.0 9.8 6.5 8.1 10.5 14.0 14.0 27.5 26.4 32.8 5.2 12.1 10.1 1.2 3.3 10.4 4.0 4.9 3.1 2.9 2.3 3.4 3.0 2.6 1.7 2.5 7.4 7.1 4.2 4.3 5.9 2.5 3.6 4.4 3.9 3.3 2.5 3.4 4.7 4.2 2.0 4.9 4.1 4.0 4.7 17.5 9.6 24.3 3.3 34.6 31.6 40.2 25.8 37.0 11.9 17.8 12.6 6.7 11.5 16.6 12.9 4.2 27.0 48.1 56.9 7.9 33.2 892.6 23.7 19.9 23.4 22.1 14.5 4.4 31.0 25.7 19.8 59.1 43.8 66.7 7.6 10.4 21.3 24.6 25.2 5.0 31.1 16.2 17.9 29.9 1179.8 13.7 30.0 17.8 3.7 29.1 16.6 33.0 4.0 8.9 52.4 36.6 15.1 50.2 43.3 49.1 26.3 10.5 12.1 19.7 27.8 28.8 21.3 16.5 33.4 24.2 59.1 38.4 9.5 28.4 38.7 LHB "CGB4, hLHB, LSH-B" ENSG00000104826 "Luteinizing hormone subunit beta" P01229 19 49015980-49017091 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 248 "pituitary gland: 4528.6" "Cell type enhanced" "Detected in some" "Early spermatids: 3.7;Late spermatids: 4.1;Pancreatic endocrine cells: 8.2;Syncytiotrophoblasts: 10.3" "Cancer enhanced" "Detected in many" "melanoma: 2.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.7;HEK 293: 1.5;Hep G2: 1.4;K-562: 1.3;U-266/84: 2.0" "CAB022241, CAB022707, HPA038925" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB022241: , CAB022707: , HPA038925: AB_2676272" "unprognostic (8.12e-2)" "unprognostic (3.59e-1)" "unprognostic (2.34e-3)" "unprognostic (1.41e-2)" "unprognostic (8.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (5.69e-2)" "unprognostic (7.04e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.47e-2)" "unprognostic (1.68e-3)" "unprognostic (1.38e-1)" "unprognostic (4.46e-1)" "unprognostic (9.52e-2)" "unprognostic (4.86e-2)" 0.8 5.1 0.4 0.0 0.1 0.0 0.6 0.4 0.4 0.5 0.0 0.4 1.3 0.5 0.0 1.3 0.6 0.0 0.7 0.3 0.2 1.4 1.9 0.9 0.2 0.3 0.1 0.0 0.6 18.2 0.7 4528.6 0.0 0.2 0.9 0.0 0.0 1.1 0.0 0.5 2.1 1.5 0.0 0.0 1.2 4.5 5.0 0.2 0.0 0.8 0.0 0.0 0.3 0.6 1.3 0.1 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.9 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.5 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.3 0.3 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.7 0.4 0.4 0.0 0.6 1.2 0.6 0.5 0.0 0.6 0.0 0.5 0.0 0.0 0.9 0.6 0.0 0.1 0.1 2.0 0.3 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.4 0.4 0.3 0.2 0.3 0.1 0.0 0.2 0.0 0.2 1.3 0.2 0.0 0.0 0.0 0.0 0.8 0.3 0.5 0.0 0.0 0.1 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.0 3.7 0.3 0.0 0.2 0.0 0.0 0.0 0.9 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 1.4 0.1 0.2 0.0 0.0 0.0 0.2 1.1 1.6 0.0 0.0 10.3 0.1 0.1 0.1 0.1 CGB3 CGB ENSG00000104827 "Chorionic gonadotropin subunit beta 3" P0DN86 19 49022869-49024333 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 9.9" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 865.9" "Group enriched" "Detected in some" 5 "pancreatic cancer: 2.9;testis cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "BEWO: 65.8" "CAB000042, CAB010884, HPA038925, HPA038934" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.39e-1)" "unprognostic (7.88e-2)" "unprognostic (6.92e-2)" "unprognostic (1.04e-2)" 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 2.1 9.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 65.8 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.2 0.3 0.0 0.3 0.2 0.1 0.4 0.0 0.0 2.1 0.7 0.0 0.0 0.1 0.4 0.0 3.3 1.3 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 118.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 865.9 0.0 0.0 0.0 0.0 TUBB4A "beta-5, DYT4, TUBB4" ENSG00000104833 "Tubulin beta 4A class IVa" P04350 19 6494319-6502848 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Dystonia, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 205.0;brain: 805.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7" "Group enriched" "Detected in many" 9 "glioma: 50.1;melanoma: 83.2;testis cancer: 49.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 3.8;T-cells: 5.4" "Cell line enhanced" "Detected in many" "AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010768, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 110000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.72e-1)" "prognostic unfavorable (8.42e-7)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (8.08e-2)" "unprognostic (6.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.58e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" 0.9 205.0 165.6 1.7 350.9 0.2 0.7 442.1 461.6 0.6 0.0 5.2 1.2 0.6 0.3 0.7 0.9 0.6 2.4 248.6 342.6 2.2 1.2 0.6 1.1 415.2 353.9 232.6 1.5 3.0 0.6 4.0 0.7 495.6 0.8 0.8 22.8 1.2 0.4 4.4 5.3 3.0 0.8 261.5 9.6 2.2 76.6 361.0 0.3 0.6 1.0 0.7 0.6 1.8 805.8 0.2 28.3 0.1 100.7 0.2 0.0 0.2 0.7 0.0 0.1 0.0 1.4 0.4 0.1 30.3 0.0 3.5 0.7 58.3 0.0 0.6 0.0 10.7 91.7 1.9 0.9 0.0 0.0 5.5 0.0 0.0 2.3 0.0 1.0 0.0 17.1 8.6 0.8 0.0 3.0 18.1 4.1 7.5 0.0 49.6 43.4 0.1 20.3 10.9 0.1 0.2 36.6 0.3 0.2 30.9 2.7 0.8 1.9 0.0 0.2 12.2 0.1 0.4 2.4 1.7 11.7 1.1 0.1 0.5 0.0 0.0 0.0 5.4 0.0 3.3 3.8 0.7 5.0 0.0 1.1 1.6 3.8 0.1 0.3 0.0 0.0 0.0 1.4 165.6 350.9 442.1 461.6 248.6 342.6 415.2 353.9 232.6 495.6 261.5 361.0 805.8 0.1 0.0 0.0 6.8 3.2 1.9 0.7 0.3 0.0 2.8 0.1 0.1 9.8 1.5 0.0 0.0 0.0 0.2 1.6 0.1 5.9 1.6 2.9 0.1 0.2 1.2 0.0 2.1 22.2 0.0 0.2 1.8 0.0 0.1 0.0 16.3 1.4 0.3 0.4 10.1 15.0 0.0 0.0 0.0 1.2 9.4 5.3 0.3 14.2 13.1 0.0 33.0 1.0 8.5 94.1 0.1 0.0 0.4 0.9 0.2 0.0 1.8 0.5 2.3 6.6 0.4 4.6 1.9 1.1 0.0 1.6 0.1 3.8 81.7 0.0 0.2 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930763 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.1;Late spermatids: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 7.0 17.5 3.5 7.2 4.0 9.3 8.3 3.8 6.9 9.4 2.9 9.3 9.4 9.4 2.8 14.4 8.5 6.0 11.1 3.9 3.8 14.7 18.9 6.7 9.9 4.6 3.8 3.9 9.9 16.0 7.8 12.0 7.7 4.6 12.3 5.3 2.3 11.4 6.2 16.6 11.9 10.3 5.2 3.4 12.1 12.0 10.8 3.7 7.6 14.5 11.6 6.7 9.5 9.6 4.8 17.6 47.3 15.5 10.7 5.8 13.3 23.7 10.7 12.6 23.1 17.7 36.0 18.4 17.2 16.3 12.5 9.7 13.9 14.7 29.2 5.3 12.7 24.4 33.7 17.7 32.0 15.4 29.1 31.9 20.7 13.5 14.5 7.6 9.5 14.2 26.3 29.9 14.2 10.6 28.4 21.4 20.7 18.5 21.6 8.5 31.2 16.4 18.6 20.5 36.2 29.1 18.1 14.2 32.7 8.9 4.6 21.8 19.1 11.4 13.7 17.7 11.7 15.1 11.0 7.1 13.2 10.9 18.5 13.8 0.0 8.0 1.0 14.2 14.4 11.5 12.0 10.7 14.7 25.2 10.7 7.5 8.6 0.5 14.0 13.7 9.9 13.4 8.9 3.5 4.0 3.8 6.9 3.9 3.8 4.6 3.8 3.9 4.6 3.4 3.7 4.8 2.7 6.4 7.9 6.2 8.4 4.2 3.8 8.3 3.4 8.0 7.0 5.3 8.1 7.2 6.8 5.5 8.4 40.1 5.6 8.9 15.6 15.5 15.7 3.6 3.6 3.8 11.4 13.2 6.8 12.7 23.0 4.8 9.7 3.9 5.7 7.4 6.1 10.1 12.9 5.0 6.7 9.2 10.2 6.7 4.2 56.9 4.7 4.8 3.6 1.9 7.7 3.1 5.2 1.5 3.1 8.4 5.6 4.9 10.1 2.6 7.4 10.3 5.1 13.4 0.0 2.7 4.2 1.9 8.2 12.8 4.1 29.1 7.4 10.6 17.8 3.2 KCNA7 "HAK6, Kv1.7" ENSG00000104848 "Potassium voltage-gated channel subfamily A member 7" Q96RP8 19 49067418-49072941 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 61 "skeletal muscle: 76.4;tongue: 19.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 16.9;Cone photoreceptor cells: 6.2;granulocytes: 3.8;Pancreatic endocrine cells: 3.8;Skeletal myocytes: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-251 MG: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (1.68e-1)" "unprognostic (4.31e-2)" "unprognostic (3.17e-2)" "unprognostic (6.97e-2)" "unprognostic (2.94e-2)" "unprognostic (1.26e-1)" "unprognostic (2.21e-8)" "unprognostic (1.70e-1)" "unprognostic (2.62e-1)" "unprognostic (5.80e-2)" "unprognostic (5.29e-2)" 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.4 0.0 76.4 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.3 0.1 0.1 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.1 0.3 0.2 0.2 0.2 0.1 0.2 0.5 0.2 6.4 16.9 0.0 0.1 0.4 1.2 0.1 0.0 0.4 0.3 0.1 3.4 0.0 3.2 0.0 6.2 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.9 0.8 0.0 0.0 0.1 0.2 0.2 1.8 0.0 0.9 3.8 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.7 0.0 0.2 0.9 1.4 0.0 4.7 0.6 0.2 0.6 0.0 0.3 1.1 1.5 0.0 0.0 0.5 SNRNP70 "RNPU1Z, RPU1, Snp1, SNRP70, U1-70K" ENSG00000104852 "Small nuclear ribonucleoprotein U1 subunit 70" P08621 19 49085419-49108605 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001718, HPA042050, HPA043516" Supported Enhanced Nucleoplasm NA NA 74000 Nucleoplasm "CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523" "unprognostic (2.22e-3)" "unprognostic (5.27e-2)" "unprognostic (9.13e-3)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (2.58e-2)" "unprognostic (4.01e-3)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.59e-5)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.12e-5)" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "prognostic favorable (5.35e-5)" 73.2 106.8 29.2 41.7 26.5 49.9 79.8 27.6 46.3 107.9 27.9 88.2 39.8 97.4 21.2 104.7 96.2 13.9 86.3 27.3 27.3 83.9 97.1 81.9 43.9 28.0 25.6 23.3 108.6 96.8 28.8 105.7 27.0 27.0 108.3 22.1 18.7 93.6 23.5 105.1 91.0 91.2 20.9 23.2 107.6 95.1 73.5 26.5 46.2 104.4 16.9 33.3 82.6 95.2 33.1 178.5 224.0 142.3 101.6 56.4 34.3 155.3 125.4 81.7 136.1 118.1 140.4 103.5 203.9 127.1 89.0 123.1 152.2 176.6 128.2 101.0 137.0 468.2 185.9 103.6 164.9 29.2 209.1 125.2 48.0 35.4 99.6 67.2 64.5 103.0 107.2 195.4 65.7 84.4 175.3 218.8 338.3 175.3 102.9 167.4 254.7 133.7 124.6 87.9 113.7 112.3 136.9 158.3 96.1 94.8 94.5 98.9 132.3 147.0 101.8 190.5 86.7 223.5 164.3 156.5 263.2 84.1 135.9 95.2 0.8 2.0 1.8 1.8 1.5 1.1 4.0 1.4 0.8 2.0 1.7 2.0 1.5 0.8 4.1 1.8 1.7 1.2 0.8 29.2 26.5 27.6 46.3 27.3 27.3 28.0 25.6 23.3 27.0 23.2 26.5 33.1 86.6 19.2 63.0 198.5 107.2 139.4 166.8 78.4 93.9 108.7 97.8 109.5 31.6 55.8 66.0 75.4 89.6 179.7 97.5 89.8 46.9 108.1 23.7 101.8 141.9 84.2 118.0 76.6 81.0 105.1 208.6 92.3 110.1 123.0 55.1 111.7 61.4 97.4 125.8 114.4 99.2 121.4 77.3 58.7 97.7 21.3 130.1 77.8 69.4 74.0 75.8 82.6 76.2 110.6 151.9 116.0 80.0 110.6 112.0 177.1 95.0 77.5 59.3 109.6 124.9 102.3 101.2 109.7 108.6 92.3 130.7 176.4 96.3 115.4 119.6 154.7 CLPTM1 ENSG00000104853 "CLPTM1 regulator of GABA type A receptor forward trafficking" O96005 19 44954585-44993341 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068767 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA068767: " "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (4.07e-1)" "unprognostic (2.19e-1)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.94e-1)" "unprognostic (5.93e-2)" "unprognostic (6.60e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (2.62e-1)" "unprognostic (1.02e-2)" "unprognostic (3.30e-1)" "unprognostic (2.56e-1)" "unprognostic (7.46e-2)" "unprognostic (1.59e-1)" 65.4 154.1 46.4 34.6 42.9 27.6 63.2 32.1 104.1 56.7 23.3 61.5 51.1 59.0 36.3 70.8 52.0 27.7 94.7 46.8 38.7 92.2 131.8 55.0 33.7 48.3 42.3 37.2 64.0 87.3 78.7 60.7 39.1 46.7 63.9 33.2 35.4 67.2 43.5 109.9 86.9 66.5 37.3 27.5 65.4 81.7 76.8 51.7 25.6 63.7 51.8 43.7 55.4 58.1 47.0 88.5 213.8 48.6 96.9 158.3 63.4 52.5 90.8 102.0 107.5 114.9 93.3 95.0 96.1 93.1 124.2 79.0 112.0 87.2 84.4 72.3 72.4 126.8 74.5 74.7 79.3 111.6 59.9 83.2 99.8 87.8 102.9 66.1 76.3 75.9 54.7 78.7 129.3 96.2 86.9 58.1 35.0 43.9 139.3 73.6 60.4 52.8 93.1 100.1 132.7 57.4 59.5 115.6 169.1 51.4 43.0 92.7 47.1 72.4 119.9 73.7 60.4 116.0 82.4 180.2 65.5 98.9 58.3 112.7 17.7 28.4 43.5 25.8 38.4 21.4 27.1 27.9 37.3 24.9 27.4 21.7 18.7 24.6 21.4 49.5 38.8 26.3 22.9 46.4 42.9 32.1 104.1 46.8 38.7 48.3 42.3 37.2 46.7 27.5 51.7 47.0 33.9 6.4 7.8 25.5 31.9 36.7 36.1 68.4 25.0 40.3 36.6 26.8 12.3 41.5 42.1 36.8 39.6 94.0 27.7 82.7 13.7 77.3 53.0 23.5 27.5 32.7 40.7 21.5 20.7 74.1 83.7 35.7 30.1 36.0 10.8 31.7 31.4 46.6 75.2 43.7 22.9 47.1 65.1 29.3 29.9 51.1 30.1 31.2 33.8 9.4 87.8 57.2 23.7 24.6 19.1 68.4 64.7 30.1 58.3 40.3 106.0 62.7 17.7 36.3 26.3 30.3 32.5 33.5 29.6 31.5 44.0 120.0 26.0 67.3 49.4 35.6 RELB REL-B ENSG00000104856 "RELB proto-oncogene, NF-kB subunit" Q01201 19 45001449-45038198 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 108.5;monocytes: 112.5;Plasma cells: 108.8;Prostatic glandular cells: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 61.9;HDLM-2: 79.5;U-698: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007753, HPA040506" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007753: AB_562340, HPA040506: AB_2677011" "prognostic favorable (1.55e-4)" "unprognostic (1.20e-1)" "unprognostic (7.13e-2)" "unprognostic (5.52e-2)" "unprognostic (1.12e-2)" "unprognostic (3.41e-2)" "unprognostic (1.71e-2)" "unprognostic (4.30e-2)" "unprognostic (5.81e-3)" "unprognostic (1.02e-3)" "unprognostic (6.01e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.68e-2)" "unprognostic (4.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.20e-2)" 14.5 13.2 3.5 18.8 2.8 40.5 12.7 2.8 4.3 8.5 3.8 12.2 10.9 14.2 0.9 8.7 9.3 7.4 11.0 3.2 5.3 19.8 13.1 23.2 19.4 4.7 3.1 2.3 6.5 16.7 2.1 4.0 4.8 3.9 15.4 4.0 0.2 12.2 5.3 14.1 15.9 17.8 4.9 4.3 29.3 12.1 4.3 4.0 9.3 10.1 1.4 15.7 13.9 8.2 5.5 22.2 13.0 1.3 5.7 2.8 9.1 4.5 3.9 27.5 5.9 9.6 4.5 23.6 61.9 11.0 6.4 20.8 9.8 0.5 9.0 5.1 79.5 2.0 2.2 0.8 2.5 23.8 4.9 35.3 15.0 3.7 12.3 14.4 5.4 3.9 1.7 0.5 39.2 2.1 5.3 1.1 14.9 2.0 6.3 2.4 4.8 3.2 7.7 10.0 33.7 0.1 2.0 4.1 11.4 11.6 1.4 4.0 11.8 12.6 14.4 7.1 5.3 14.4 49.0 31.2 67.0 15.6 1.7 8.1 0.0 5.1 2.5 1.4 3.4 2.0 9.2 2.2 1.9 3.8 8.0 1.7 0.8 15.2 2.1 2.8 4.1 1.1 2.0 3.5 2.8 2.8 4.3 3.2 5.3 4.7 3.1 2.3 3.9 4.3 4.0 5.5 16.4 6.4 12.4 2.3 64.4 37.9 108.5 20.3 40.9 0.0 17.6 11.3 1.8 24.3 15.7 3.7 0.0 4.2 35.0 53.0 9.8 33.1 5.2 15.1 15.2 30.8 22.8 22.5 3.0 31.5 7.3 35.4 65.2 29.1 50.9 3.8 5.0 3.5 18.4 3.3 1.7 33.3 8.2 15.1 74.9 3.4 4.7 44.7 24.9 3.7 112.5 0.8 7.2 1.5 2.5 37.4 90.3 2.6 108.8 145.3 48.0 19.4 7.4 0.3 6.6 28.9 27.3 1.1 1.7 27.7 31.8 9.9 53.8 4.1 16.8 89.7 CLASRP "CLASP, SFRS16, SWAP2" ENSG00000104859 "CLK4 associating serine/arginine rich protein" Q8N2M8 19 45039045-45070956 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060469, HPA062455" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA060469: AB_2684289, HPA062455: AB_2684770" "unprognostic (2.99e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (9.77e-4)" "unprognostic (9.03e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-3)" "unprognostic (1.58e-2)" "unprognostic (2.62e-1)" "unprognostic (8.52e-2)" "unprognostic (4.01e-2)" "unprognostic (1.76e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.69e-8)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (3.36e-1)" "prognostic favorable (1.02e-5)" 11.2 8.7 7.1 6.4 7.8 19.7 12.4 6.8 11.3 12.4 4.4 12.3 7.0 12.6 2.6 14.1 14.0 2.8 9.0 7.0 8.4 9.8 11.2 12.2 7.5 9.7 9.5 5.5 15.8 15.7 4.6 13.5 4.2 13.2 13.3 3.2 2.6 11.2 4.3 12.4 14.2 13.4 4.1 8.3 14.2 13.5 14.7 8.8 6.2 13.2 3.1 5.4 11.4 12.6 11.0 18.5 25.8 10.4 7.7 3.3 5.1 23.0 15.7 5.8 11.6 11.7 12.2 17.1 28.7 11.7 6.1 4.6 19.9 15.7 11.7 5.1 14.5 23.8 17.0 15.0 15.3 7.6 11.4 22.4 6.5 6.4 7.9 13.9 5.6 8.0 19.0 27.6 15.9 4.1 18.6 30.9 38.2 14.4 11.9 14.8 24.4 11.6 22.0 7.9 18.2 12.0 18.6 12.6 11.9 12.3 5.6 15.2 24.9 12.3 11.5 14.4 9.7 24.0 23.1 20.0 25.3 8.0 18.4 9.6 0.4 2.2 3.7 2.3 1.7 2.0 4.0 1.4 2.4 2.0 3.4 1.9 1.7 5.5 1.8 2.0 3.2 1.1 1.4 7.1 7.8 6.8 11.3 7.0 8.4 9.7 9.5 5.5 13.2 8.3 8.8 11.0 16.1 3.2 3.2 28.1 39.0 23.3 25.5 19.5 46.1 25.3 22.7 16.9 4.7 18.6 10.9 16.5 16.7 24.3 24.7 31.7 5.9 12.2 19.2 12.2 16.0 14.6 9.6 17.5 25.2 15.1 32.9 16.9 67.2 18.7 12.7 22.9 15.4 15.0 17.4 20.2 21.5 27.1 14.2 18.5 21.7 10.2 21.8 21.2 3.6 18.7 19.6 19.7 15.5 13.0 65.1 15.0 40.0 17.7 35.0 25.2 30.6 7.0 8.5 29.6 32.9 21.1 18.5 76.7 33.9 29.8 21.6 36.3 20.9 17.6 25.6 21.6 LIN7B "LIN-7B, MALS-2, VELI2" ENSG00000104863 "Lin-7 homolog B, crumbs cell polarity complex component" Q9HAP6 19 49114324-49118460 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.3" "Cell type enhanced" "Detected in all" "Spermatogonia: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" "unprognostic (3.70e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.02e-1)" "unprognostic (5.59e-3)" "unprognostic (2.15e-2)" "unprognostic (4.33e-2)" "unprognostic (9.72e-2)" "unprognostic (3.94e-2)" "unprognostic (1.05e-3)" "unprognostic (1.10e-1)" "unprognostic (3.35e-2)" "unprognostic (4.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.23e-1)" "unprognostic (5.69e-2)" 3.7 6.5 18.9 1.5 20.1 1.8 4.8 17.1 30.3 5.1 9.1 6.8 4.8 4.8 2.2 9.4 5.0 2.4 20.5 19.6 22.9 5.4 4.1 4.2 2.1 18.9 19.2 22.6 4.4 7.8 3.7 25.1 1.2 19.2 7.8 2.3 7.2 7.5 3.7 54.3 18.6 5.3 1.4 15.5 3.9 5.9 12.1 19.1 1.7 5.3 9.2 2.0 6.2 7.6 24.2 3.2 7.3 3.6 6.7 1.0 1.4 3.1 3.9 1.7 2.4 5.6 3.9 0.6 1.3 3.8 4.9 4.6 5.9 4.3 0.5 1.2 7.8 16.3 1.2 7.9 5.4 4.9 1.4 0.9 1.4 3.0 2.2 0.4 4.4 0.8 4.8 2.3 4.0 3.7 4.4 3.0 4.8 1.8 4.1 8.0 4.8 4.6 3.5 2.6 5.6 5.1 4.3 5.5 3.2 4.0 1.5 4.2 0.7 2.6 9.2 3.9 4.7 2.3 6.6 13.7 2.1 3.3 3.0 2.8 0.0 4.9 1.4 6.4 2.5 5.0 4.5 5.1 4.6 3.3 3.9 7.0 6.0 1.0 1.5 4.5 11.6 3.2 4.0 18.9 20.1 17.1 30.3 19.6 22.9 18.9 19.2 22.6 19.2 15.5 19.1 24.2 11.6 3.2 4.8 11.8 6.5 6.6 6.5 18.1 7.4 31.9 15.6 15.4 22.5 4.3 12.7 9.2 12.5 1.0 8.0 18.0 21.5 4.6 4.8 7.8 4.2 7.4 16.9 7.0 11.1 4.7 3.3 7.3 4.1 4.5 5.1 5.0 7.5 5.5 8.5 16.8 12.8 13.0 20.3 10.3 6.3 5.1 7.5 6.0 17.8 1.0 4.1 17.7 9.2 5.5 7.9 2.7 18.4 9.4 7.9 8.4 21.7 20.3 10.9 33.5 26.3 5.9 10.9 8.2 85.0 11.0 13.1 2.2 5.8 2.7 10.3 8.2 PPP1R37 LRRC68 ENSG00000104866 "Protein phosphatase 1 regulatory subunit 37" O75864 19 45091396-45148077 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "RT4: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041500 Approved Approved Cytosol NA NA Cytosol "HPA041500: AB_10795122" "unprognostic (8.45e-2)" "unprognostic (5.23e-2)" "unprognostic (8.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (1.79e-1)" "unprognostic (1.04e-3)" "unprognostic (2.16e-1)" "unprognostic (1.08e-1)" "unprognostic (2.89e-3)" "unprognostic (7.72e-3)" "unprognostic (5.44e-2)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (4.71e-2)" "prognostic favorable (2.04e-4)" 10.3 27.1 10.6 5.9 9.9 4.8 13.1 6.8 16.8 17.4 0.5 14.3 12.2 15.8 3.2 20.0 13.3 5.4 14.3 11.2 4.6 18.3 14.1 11.8 5.3 6.6 5.2 10.9 13.7 16.6 7.3 39.6 5.4 7.7 20.2 3.6 8.1 18.6 8.9 21.0 20.8 14.7 4.1 1.8 14.1 28.5 16.6 6.1 5.7 20.6 5.5 3.1 21.9 17.1 10.0 26.2 25.4 9.2 13.4 11.6 7.8 18.4 18.8 10.6 12.8 14.6 11.5 14.2 7.1 13.4 10.0 11.8 20.1 6.3 14.4 3.6 9.3 15.7 6.1 13.6 14.3 14.4 6.4 10.1 10.0 11.1 12.1 7.7 13.7 10.4 9.6 10.8 5.5 7.1 34.2 13.5 8.9 8.7 18.7 15.1 16.3 10.9 5.3 8.4 69.5 28.2 13.0 16.0 33.2 29.3 4.7 21.3 9.4 16.4 15.2 18.2 9.1 17.0 9.3 6.3 5.3 19.7 6.4 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 9.9 6.8 16.8 11.2 4.6 6.6 5.2 10.9 7.7 1.8 6.1 10.0 9.4 6.4 3.4 8.5 8.1 7.6 11.1 6.8 13.1 48.6 16.9 11.7 6.2 15.7 5.6 3.7 39.6 21.1 9.7 21.9 7.9 17.9 8.8 9.8 12.1 10.3 30.6 4.8 18.9 9.8 19.0 9.8 30.5 10.9 0.0 12.1 11.0 7.4 17.9 77.4 15.2 27.7 10.2 6.4 6.3 7.0 12.2 6.2 12.4 5.6 4.4 22.7 9.2 11.6 14.3 12.0 23.4 12.4 13.1 10.6 25.6 18.2 5.9 44.1 19.7 10.3 10.1 21.6 23.9 14.3 9.5 18.3 10.4 16.0 22.3 11.4 FCGRT "alpha-chain, FCRN" ENSG00000104870 "Fc fragment of IgG receptor and transporter" P55899 19 49506816-49526428 "Predicted intracellular proteins, Predicted membrane proteins" "IgG-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 1362.6;Kupffer cells: 877.7;Paneth cells: 883.9;Proximal enterocytes: 1787.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 2346.7" "Group enriched" "Detected in all" 17 "dendritic cells: 922.9;granulocytes: 2346.7;monocytes: 1364.4" "Cell line enhanced" "Detected in many" "ASC diff: 153.7;Hep G2: 144.0;OE19: 165.4;THP-1: 196.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012122, HPA015130" Enhanced NA NA 24000000 "HPA012122: AB_1848474, HPA015130: AB_1848475" "unprognostic (2.19e-3)" "unprognostic (2.05e-2)" "unprognostic (1.89e-1)" "unprognostic (1.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.26e-1)" "unprognostic (8.58e-2)" "unprognostic (3.87e-3)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (2.00e-3)" "unprognostic (3.64e-1)" "unprognostic (3.67e-3)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (2.18e-3)" 245.9 128.8 65.6 100.5 67.7 148.6 200.5 66.6 103.3 213.1 106.7 194.4 307.2 144.3 49.2 60.8 156.9 145.9 110.0 63.6 89.4 176.6 404.8 179.1 144.6 71.9 68.0 60.1 194.8 130.5 115.4 80.4 138.6 70.5 105.5 150.7 4.9 107.1 95.6 64.9 107.5 301.8 92.4 73.0 321.4 127.6 28.5 71.9 63.5 112.8 78.5 39.4 138.0 133.1 73.8 0.4 37.1 4.3 123.7 153.7 78.2 6.0 32.1 73.4 20.9 22.9 50.5 22.5 0.2 59.4 45.9 10.8 8.5 1.2 1.1 11.7 0.3 45.5 74.2 0.6 144.0 95.8 1.1 14.2 95.1 1.9 17.5 0.2 86.5 81.3 48.0 12.2 10.9 53.7 0.8 0.6 14.3 2.1 165.4 22.0 2.6 35.3 3.7 96.0 9.3 2.6 23.1 5.6 0.2 4.5 18.3 26.5 196.1 28.1 52.8 11.8 0.9 1.3 2.4 13.5 9.8 10.8 70.2 7.9 566.8 1364.4 1011.5 24.7 904.8 29.8 58.0 39.8 39.7 922.9 62.5 89.4 51.0 2346.7 28.6 630.2 536.4 28.2 1276.9 65.6 67.7 66.6 103.3 63.6 89.4 71.9 68.0 60.1 70.5 73.0 71.9 73.8 479.6 67.3 89.3 21.2 44.2 126.1 130.4 130.7 52.9 0.7 125.5 151.3 30.7 158.7 79.9 73.5 4.2 12.7 83.8 652.3 60.7 86.3 6.5 29.1 89.6 259.2 158.1 55.8 0.2 61.6 24.9 269.9 108.6 24.8 70.5 181.2 587.6 343.9 1362.6 0.0 0.2 349.0 57.0 877.7 438.1 21.8 362.2 608.6 186.7 24.4 190.6 13.4 11.3 10.1 0.2 90.6 883.9 183.6 63.2 87.9 1787.7 329.5 53.4 5.2 216.9 149.2 105.6 21.1 17.6 27.7 107.1 20.7 32.4 129.9 565.1 115.4 PIH1D1 "FLJ20643, MOT48, NOP17, Pih1" ENSG00000104872 "PIH1 domain containing 1" Q9NWS0 19 49446298-49453497 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047258 Approved Approved Cytosol NA NA Cytosol "HPA047258: AB_10964561" "unprognostic (2.28e-1)" "unprognostic (1.56e-1)" "unprognostic (2.14e-1)" "unprognostic (8.99e-2)" "unprognostic (7.77e-3)" "unprognostic (9.66e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (5.13e-2)" "unprognostic (1.22e-2)" "unprognostic (1.86e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" 36.4 37.4 30.3 27.1 30.2 34.8 37.5 29.8 39.8 37.3 30.8 39.2 43.9 32.6 13.3 45.3 40.0 27.2 30.8 31.1 30.5 41.7 48.1 30.7 44.0 29.9 28.9 29.3 30.1 40.1 50.8 34.8 33.4 30.7 40.0 29.8 11.9 50.0 34.1 68.1 45.4 37.5 26.6 29.6 39.7 41.6 17.9 31.8 46.5 37.4 58.1 36.4 33.3 39.7 30.5 133.6 67.0 84.6 130.3 40.1 37.2 54.0 52.9 68.8 79.8 122.3 72.4 89.6 89.1 48.6 56.7 20.0 79.9 44.8 96.6 46.2 85.5 85.1 79.9 89.6 93.0 63.1 86.7 115.3 43.5 40.4 59.0 55.8 74.8 74.8 79.2 119.5 76.8 50.5 59.9 98.4 173.3 101.1 118.4 63.2 83.1 93.6 90.4 65.1 107.2 109.2 158.0 54.3 91.2 53.2 41.1 44.0 104.3 44.9 66.9 52.0 26.9 84.2 205.5 172.8 49.8 36.6 93.6 47.5 166.8 104.5 121.0 88.3 104.0 75.6 116.1 98.8 94.9 105.1 110.1 79.5 73.4 11.8 103.7 108.7 100.2 158.3 107.0 30.3 30.2 29.8 39.8 31.1 30.5 29.9 28.9 29.3 30.7 29.6 31.8 30.5 45.5 38.5 36.6 10.7 54.8 55.8 61.9 80.2 59.7 20.9 46.8 50.0 11.2 41.5 46.4 20.2 18.8 101.7 48.8 48.6 62.6 74.1 18.1 47.4 24.1 39.2 57.5 33.4 10.5 46.3 116.5 59.9 43.8 30.6 52.6 30.8 35.3 44.3 71.2 23.5 8.5 63.9 38.7 40.8 55.7 9.9 62.4 40.7 64.0 11.2 59.0 55.0 40.2 10.1 10.9 47.3 75.4 47.0 60.3 65.6 90.2 115.9 59.4 22.6 26.3 44.5 46.8 40.6 29.9 49.0 67.1 94.0 50.4 48.2 59.4 66.2 CKM CKMM ENSG00000104879 "Creatine kinase, M-type" P06732 19 45306413-45322875 "Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "skeletal muscle: 74254.4;tongue: 26289.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 5353.0" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 64.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 68.8" "Region enriched" "Detected in single" 15 "olfactory bulb: 1.5" "Low region specificity" "Detected in many" HPA047859 Enhanced NA NA 170000000 "HPA047859: AB_2680186" "unprognostic (3.51e-1)" "unprognostic (7.63e-2)" "unprognostic (2.61e-2)" "unprognostic (4.14e-1)" "unprognostic (7.68e-3)" "unprognostic (4.04e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (5.19e-2)" "unprognostic (1.81e-1)" "unprognostic (5.00e-1)" "unprognostic (9.46e-3)" "unprognostic (9.67e-8)" "unprognostic (3.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" 6.8 2.7 0.6 0.0 0.2 0.7 12.5 0.2 0.4 0.7 0.0 5.3 0.1 1.8 0.0 516.9 0.4 0.2 3834.2 0.4 0.0 2.1 5.3 8.7 0.5 1.0 0.0 0.0 2.8 5.3 0.0 2.1 0.3 1.1 136.0 0.1 0.2 343.7 2.1 74254.4 15.3 4.3 2.4 0.3 2.5 23.7 10.0 0.5 2.5 8.6 26289.9 0.4 1.5 3.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 5.8 0.0 0.3 16.3 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.0 0.0 0.0 6.3 0.2 0.2 0.0 0.0 68.8 0.0 0.0 0.1 0.1 0.0 0.1 16.3 0.1 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.2 0.4 0.4 0.0 1.0 0.0 0.0 1.1 0.3 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 5353.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.7 0.1 15.3 0.8 0.9 51.2 0.0 0.0 0.4 0.0 0.7 141.8 0.0 0.1 1.3 0.4 0.4 0.0 6.6 0.0 0.5 0.0 0.0 0.9 0.3 53.2 1.5 3.2 0.0 0.0 0.9 0.0 0.0 0.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.8 0.0 0.0 639.9 47.3 16.5 1.6 0.0 0.1 0.3 2.6 3.6 0.0 0.1 ARHGEF18 "KIAA0521, MGC15913, P114-RhoGEF, p114RhoGEF" ENSG00000104880 "Rho/Rac guanine nucleotide exchange factor 18" Q6ZSZ5 19 7348937-7472485 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 17.0;Excitatory neurons: 22.2;Inhibitory neurons: 18.0;Microglial cells: 14.0;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042689, HPA049151, HPA071867" Approved Enhanced Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA049151: AB_2680654, HPA071867: AB_2686466" "unprognostic (2.55e-1)" "unprognostic (1.31e-2)" "unprognostic (1.57e-1)" "unprognostic (6.01e-2)" "unprognostic (1.65e-2)" "prognostic favorable (4.21e-4)" "unprognostic (1.13e-1)" "unprognostic (1.52e-3)" "unprognostic (3.56e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (8.26e-2)" "prognostic favorable (3.11e-5)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (3.79e-3)" 8.0 16.1 9.7 20.2 12.4 27.4 8.2 8.9 12.2 11.6 6.3 21.4 13.5 16.9 3.1 20.0 9.8 10.8 6.8 9.1 8.5 19.8 13.2 14.7 30.0 11.4 12.4 7.7 10.2 21.2 11.3 15.9 7.8 12.3 14.3 7.8 5.0 11.0 7.4 5.3 13.4 31.4 14.0 9.1 36.2 22.8 9.0 10.6 33.4 10.9 3.0 17.7 14.1 12.3 14.6 31.2 17.9 10.2 13.9 9.4 7.8 30.8 13.4 12.9 20.5 20.8 24.5 17.4 62.9 29.4 15.2 15.3 24.6 12.7 29.7 11.8 37.6 16.1 15.5 11.7 16.4 22.1 31.2 30.4 12.8 20.2 19.7 16.3 10.1 11.2 20.2 13.4 14.7 21.3 11.0 36.0 26.8 16.0 16.9 29.2 42.2 17.6 17.2 9.0 34.6 9.8 13.7 16.4 16.1 18.8 9.6 17.4 36.4 21.9 16.8 20.1 25.9 17.2 35.6 23.2 40.2 16.7 27.5 15.1 6.4 3.7 23.0 3.9 4.5 4.0 8.8 5.3 4.3 2.3 12.4 5.4 4.1 12.5 0.9 6.9 2.8 3.9 3.5 9.7 12.4 8.9 12.2 9.1 8.5 11.4 12.4 7.7 12.3 9.1 10.6 14.6 0.2 0.0 1.1 17.0 2.2 2.9 0.0 6.5 2.8 0.2 0.4 0.1 0.2 0.0 4.3 0.0 4.2 0.1 0.3 0.5 0.0 0.3 0.1 2.4 0.8 0.5 1.8 3.0 22.2 0.4 0.1 1.1 6.1 2.9 0.0 0.5 0.0 0.0 0.2 0.0 18.0 0.0 4.1 0.3 2.1 0.1 0.0 1.6 1.8 14.0 0.7 0.0 0.0 18.1 30.5 0.6 2.3 0.0 4.3 0.0 0.7 0.1 9.3 0.4 0.0 0.1 1.2 0.0 0.0 3.9 3.8 0.0 1.6 0.0 0.0 0.3 PPP1R13L "IASPP, RAI" ENSG00000104881 "Protein phosphatase 1 regulatory subunit 13 like" Q8WUF5 19 45379638-45406349 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 180.9;heart muscle: 114.5;salivary gland: 56.0;skin 1: 217.1;vagina: 85.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 85.6;Granulosa cells: 118.3;Syncytiotrophoblasts: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HBEC3-KT: 130.1;hTCEpi: 189.0;hTERT-HME1: 131.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005016, HPA041231, HPA059883" Approved Enhanced Cytosol NA Yes Cytosol "CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151" "unprognostic (1.87e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (2.92e-1)" "unprognostic (3.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.31e-3)" "prognostic unfavorable (3.39e-5)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.40e-4)" "unprognostic (2.52e-3)" "unprognostic (1.92e-2)" "unprognostic (1.55e-3)" "unprognostic (1.34e-1)" "unprognostic (7.69e-2)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" 17.8 20.2 10.7 2.9 10.5 0.6 29.9 10.7 14.2 28.2 9.9 9.6 5.1 8.3 15.3 180.9 9.7 6.1 114.5 9.9 12.2 18.3 12.7 20.5 2.7 10.9 10.2 8.4 8.9 31.8 12.3 11.9 26.8 11.1 31.1 6.9 13.7 56.0 13.4 5.8 217.1 9.2 5.5 9.3 6.5 12.1 3.2 11.3 4.0 17.9 4.4 19.0 23.8 85.6 11.5 72.3 10.7 4.6 3.8 4.7 2.9 61.5 14.5 2.5 17.5 24.3 23.1 70.6 9.5 5.9 11.9 36.5 97.2 4.0 130.1 16.0 24.0 5.9 1.4 36.3 8.7 10.0 1.0 3.4 4.0 189.0 27.9 131.9 79.2 33.2 7.9 8.1 3.6 1.2 64.7 1.8 1.9 5.3 36.9 18.3 7.4 5.6 1.7 22.9 95.0 2.4 7.6 64.5 68.4 1.6 30.0 58.2 1.9 46.3 23.1 60.9 1.8 76.2 35.1 42.1 6.5 3.3 2.9 5.6 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 10.7 10.5 10.7 14.2 9.9 12.2 10.9 10.2 8.4 11.1 9.3 11.3 11.5 14.3 35.3 13.0 9.4 2.0 68.7 85.6 38.4 67.2 1.7 21.9 28.6 38.8 20.0 27.8 20.2 10.4 83.2 2.5 17.8 5.9 34.9 0.7 8.7 3.0 13.4 7.2 10.1 0.8 15.8 37.7 5.6 8.6 17.1 4.5 118.3 11.7 2.5 7.6 0.0 0.9 6.9 14.2 1.6 5.0 0.5 5.9 2.2 12.4 9.4 1.9 2.4 2.1 2.5 1.6 50.4 17.2 12.4 6.1 44.2 22.6 3.9 16.3 26.8 6.6 8.4 14.1 2.7 2.1 81.2 71.0 128.5 2.5 2.8 9.0 63.4 PEX11G ENSG00000104883 "Peroxisomal biogenesis factor 11 gamma" Q96HA9 19 7476875-7497449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.7;testis: 29.2" "Cell type enhanced" "Detected in many" "Early spermatids: 85.3;Late spermatids: 69.6;Proximal enterocytes: 37.0;Proximal tubular cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 24.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA069817 Uncertain NA NA "HPA069817: AB_2686207" "unprognostic (2.26e-2)" "unprognostic (6.44e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.60e-4)" "unprognostic (1.01e-1)" "unprognostic (4.09e-3)" "prognostic favorable (3.27e-4)" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" "unprognostic (2.32e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.83e-9)" "unprognostic (1.21e-3)" "unprognostic (1.67e-1)" "unprognostic (1.56e-1)" "unprognostic (1.19e-2)" 4.3 12.2 2.5 1.4 4.0 1.2 5.4 3.1 3.5 3.7 1.9 4.2 6.6 3.0 2.3 4.9 3.6 1.6 2.3 2.6 2.8 8.5 26.7 3.5 1.0 3.8 3.3 2.3 3.4 5.5 4.1 4.3 0.9 4.1 6.5 1.5 1.1 4.8 1.9 2.1 5.8 5.8 0.7 3.1 5.0 5.0 29.2 2.9 1.0 6.4 0.9 0.4 4.3 3.6 4.5 1.9 3.6 0.8 3.2 2.5 1.4 4.7 1.0 0.7 0.8 0.8 1.3 6.3 1.1 5.9 0.5 1.4 3.3 0.6 1.1 0.3 0.5 1.3 0.7 1.0 0.3 2.2 0.1 3.7 2.9 1.3 0.8 1.1 0.6 0.5 3.1 1.7 0.1 1.0 1.0 0.6 0.7 0.2 3.0 2.1 0.1 0.2 0.1 2.2 2.4 2.3 2.1 1.6 0.3 0.5 0.5 5.2 1.2 0.0 0.1 0.5 3.1 0.1 1.9 1.3 0.6 0.5 0.1 0.6 24.5 3.9 16.0 1.6 3.9 1.1 2.5 1.1 0.6 3.5 4.1 1.2 0.9 12.8 7.9 3.5 2.3 0.4 2.4 2.5 4.0 3.1 3.5 2.6 2.8 3.8 3.3 2.3 4.1 3.1 2.9 4.5 3.8 0.0 9.2 2.3 1.0 3.2 4.3 15.9 5.2 2.6 10.2 9.4 2.1 7.2 8.1 3.7 2.1 3.0 0.4 12.6 17.6 9.3 85.3 16.5 4.2 3.7 5.4 0.4 0.6 3.6 3.1 5.2 7.7 6.9 0.0 7.6 4.6 35.9 18.1 0.0 0.9 11.4 16.2 7.5 0.4 69.6 4.4 3.5 3.6 1.0 1.8 7.0 0.0 1.5 3.6 4.5 9.6 3.8 0.9 3.2 37.0 41.5 29.3 3.2 6.6 3.2 4.0 22.4 3.1 5.8 2.7 1.4 1.1 11.6 11.3 3.8 ERCC2 "EM9, MAG, MGC102762, MGC126218, MGC126219, XPD" ENSG00000104884 "ERCC excision repair 2, TFIIH core complex helicase subunit" P18074 19 45349837-45370918 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005375, HPA038057, HPA069266" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104" "unprognostic (1.10e-1)" "unprognostic (5.48e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-3)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.26e-4)" "unprognostic (3.36e-2)" "unprognostic (2.44e-3)" "unprognostic (1.94e-1)" "unprognostic (5.47e-1)" "unprognostic (8.99e-2)" "unprognostic (3.45e-2)" 6.6 13.1 9.9 6.9 9.4 4.8 6.6 8.0 11.8 7.4 7.3 7.3 4.9 9.8 3.2 6.3 8.0 4.1 6.9 10.1 8.5 7.6 9.1 5.8 5.8 10.1 8.9 10.5 7.9 7.8 7.8 9.8 4.6 9.9 6.8 4.0 3.1 7.3 6.8 11.8 7.0 6.6 6.9 7.2 8.2 7.5 14.0 10.0 5.3 8.5 6.4 5.3 7.6 6.0 8.9 28.0 13.3 27.1 38.4 16.3 19.4 15.2 38.8 27.4 50.2 40.2 32.6 18.6 10.0 21.6 39.9 19.1 14.0 19.1 32.9 18.5 24.4 31.8 16.9 26.8 35.4 33.3 27.1 28.4 22.4 5.6 55.8 31.9 28.2 29.1 28.8 41.8 10.9 34.8 14.7 16.1 17.9 12.7 27.2 24.6 30.3 19.4 8.3 14.0 24.9 15.8 17.1 34.2 23.9 13.6 20.6 22.8 35.4 37.9 46.4 25.3 19.9 88.0 24.9 15.8 14.2 13.8 16.4 21.2 0.0 17.2 6.5 9.1 18.0 11.9 9.1 8.9 8.9 21.8 6.5 8.2 8.7 0.5 15.6 14.9 10.4 9.8 12.1 9.9 9.4 8.0 11.8 10.1 8.5 10.1 8.9 10.5 9.9 7.2 10.0 8.9 4.2 6.4 3.4 6.2 5.8 6.2 5.5 8.6 4.6 0.0 6.1 4.3 6.7 8.6 8.7 5.5 0.0 10.5 4.1 5.9 13.7 10.7 4.7 3.3 4.5 5.5 7.2 5.5 2.9 8.2 12.1 6.8 6.1 3.8 0.0 34.1 7.9 12.3 11.5 0.0 3.1 8.5 4.1 8.2 4.2 2.8 6.5 6.3 3.6 1.0 4.2 0.0 5.2 5.0 1.4 8.1 3.1 7.9 7.5 4.2 4.1 13.0 7.5 0.0 0.0 3.5 9.9 30.5 13.1 5.1 5.7 4.8 4.7 29.1 8.8 3.2 DOT1L "DOT1, KIAA1814, KMT4" ENSG00000104885 "DOT1 like histone lysine methyltransferase" Q8TEK3 19 2163933-2232578 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 100.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011875, HPA071217, HPA074977" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: " "unprognostic (1.41e-2)" "unprognostic (1.44e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.08e-1)" "prognostic favorable (6.00e-4)" "unprognostic (2.53e-3)" "unprognostic (2.21e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (5.25e-3)" "unprognostic (8.18e-3)" "unprognostic (2.56e-1)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" 9.5 13.0 2.7 10.6 6.3 22.3 8.9 7.0 6.8 8.3 2.9 10.5 12.6 10.1 1.1 14.8 8.7 5.2 9.5 4.0 2.7 19.8 15.3 18.5 8.1 6.0 3.7 1.1 10.6 15.6 2.0 14.0 5.4 9.3 9.8 3.9 8.6 9.9 2.0 12.3 14.0 17.8 3.4 0.9 17.5 12.8 100.5 5.8 7.1 15.7 2.8 5.0 7.3 9.9 9.2 27.7 14.4 48.4 26.5 3.5 5.2 63.5 15.2 3.4 8.3 6.6 18.4 10.1 31.6 7.3 10.0 7.0 24.0 16.1 8.6 3.9 16.4 20.0 29.6 26.7 18.3 5.5 42.8 52.6 5.0 6.3 15.9 8.1 6.8 6.7 17.8 36.2 32.7 6.6 15.6 34.1 46.4 37.4 17.4 25.2 34.8 13.6 21.8 4.6 12.9 31.9 24.7 10.7 31.8 20.2 12.7 14.3 32.4 9.6 22.9 20.7 34.2 30.1 29.9 42.8 22.0 22.6 28.6 13.7 0.1 0.1 0.8 0.2 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.2 2.7 6.3 7.0 6.8 4.0 2.7 6.0 3.7 1.1 9.3 0.9 5.8 9.2 9.3 32.1 16.3 12.4 9.5 17.7 14.7 4.7 10.2 27.2 12.7 8.4 7.1 11.5 7.2 9.2 66.7 6.1 15.9 29.1 3.9 11.5 37.6 14.2 10.7 10.2 20.8 8.6 7.8 12.2 13.8 11.0 27.5 28.2 6.3 15.9 5.3 14.4 9.9 13.5 6.8 12.0 4.1 12.3 30.4 18.2 3.1 19.0 12.4 10.3 8.5 5.5 8.2 10.6 15.0 13.9 28.6 3.4 8.6 12.9 35.6 3.1 7.6 28.1 0.0 14.2 10.3 32.4 23.0 12.2 19.9 16.3 6.3 15.3 15.9 15.3 PLEKHJ1 FLJ10297 ENSG00000104886 "Pleckstrin homology domain containing J1" Q9NW61 19 2230084-2237704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 356.3;Proximal enterocytes: 372.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048989 Approved Approved Mitochondria No No Mitochondria "HPA048989: AB_2680590" "unprognostic (5.11e-1)" "unprognostic (4.84e-3)" "unprognostic (2.33e-1)" "unprognostic (9.82e-2)" "unprognostic (1.38e-1)" "unprognostic (7.83e-2)" "unprognostic (2.03e-3)" "unprognostic (2.89e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (9.03e-3)" "unprognostic (3.49e-2)" "prognostic favorable (1.10e-5)" "prognostic favorable (6.99e-4)" "unprognostic (5.67e-2)" "unprognostic (1.15e-1)" "unprognostic (6.26e-3)" 39.7 64.6 37.5 26.6 34.7 38.7 40.9 36.5 51.7 38.5 35.1 81.2 106.1 33.9 18.1 61.8 30.2 19.7 66.8 35.9 35.0 101.2 79.4 42.4 39.6 36.6 38.0 35.2 44.5 94.9 14.9 36.7 19.9 39.4 43.8 34.3 4.7 52.7 14.4 89.7 51.6 102.4 12.3 35.1 61.8 100.5 68.5 39.9 28.1 69.8 33.5 24.2 41.2 40.1 36.3 93.9 38.2 68.2 83.0 21.8 28.3 40.3 51.6 24.1 54.1 48.9 98.1 43.1 88.4 42.1 35.6 34.7 71.6 65.4 34.0 16.1 90.8 83.7 46.3 44.5 129.0 34.7 98.6 68.9 41.6 34.2 25.8 23.1 21.5 34.9 75.4 99.5 101.0 39.8 61.3 97.0 88.0 122.6 55.6 52.1 114.7 47.5 108.8 55.7 92.0 170.2 94.1 32.6 58.7 104.5 27.3 78.6 98.2 36.6 23.0 68.7 69.7 56.7 147.3 97.2 101.3 67.4 94.8 30.1 88.2 76.4 129.6 86.9 98.2 77.1 118.8 85.9 91.8 80.8 143.2 69.0 67.2 66.1 53.8 108.3 159.0 112.6 97.2 37.5 34.7 36.5 51.7 35.9 35.0 36.6 38.0 35.2 39.4 35.1 39.9 36.3 25.9 38.5 21.1 9.8 67.0 34.8 54.6 61.5 20.5 22.0 60.0 68.1 40.0 87.2 37.8 46.0 16.7 89.8 65.8 356.3 164.4 121.1 68.5 33.2 33.4 26.7 54.0 39.8 12.1 179.5 99.3 46.0 121.8 35.2 18.4 117.1 25.7 49.2 95.4 25.2 11.7 228.5 95.6 43.9 33.3 115.6 47.2 48.1 30.2 9.4 74.7 31.9 65.9 12.1 7.6 146.6 233.3 35.3 49.0 82.2 372.5 148.4 29.1 22.7 32.9 18.9 47.5 93.7 100.7 47.2 42.6 47.7 52.6 81.4 254.1 58.4 SLC17A7 "BNPI, VGLUT1" ENSG00000104888 "Solute carrier family 17 member 7" Q9P2U7 19 49429401-49442360 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 68 "brain: 401.4;retina: 318.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 362.7;Cone photoreceptor cells: 369.1;Excitatory neurons: 107.8;Rod photoreceptor cells: 358.0" "Cancer enriched" "Detected in some" 6 "glioma: 7.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 20.8;K-562: 7.0;REH: 4.0;SCLC-21H: 4.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 201.2;cerebellum: 204.6;cerebral cortex: 339.5;hippocampal formation: 471.2" "CAB037183, HPA050458, HPA063679" Enhanced Supported NA NA "CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086" "unprognostic (1.79e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (1.52e-2)" "unprognostic (9.12e-2)" "unprognostic (3.03e-2)" "unprognostic (1.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.32e-2)" "unprognostic (6.61e-2)" "unprognostic (4.26e-12)" "unprognostic (8.36e-4)" "unprognostic (4.27e-1)" "unprognostic (1.35e-2)" "unprognostic (6.17e-3)" 4.8 1.4 202.3 0.2 267.8 0.0 3.0 66.4 299.1 1.7 5.2 1.4 0.4 1.2 0.6 1.2 2.2 0.9 2.4 401.4 27.0 0.6 0.3 0.6 1.0 78.2 39.8 269.3 0.6 0.6 0.6 1.6 0.1 110.4 0.5 0.5 318.5 1.2 0.3 1.7 2.2 1.6 0.6 0.0 0.1 0.9 2.3 8.5 0.3 2.4 2.5 0.6 1.6 1.8 210.0 0.0 0.3 0.2 0.4 1.6 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.3 0.5 1.2 0.1 1.9 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.1 0.3 0.0 0.3 0.0 0.3 7.0 1.0 0.0 0.2 0.0 0.1 0.0 0.3 0.3 4.0 0.1 0.1 0.0 0.0 4.9 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 2.3 0.9 0.0 0.4 0.3 0.3 0.6 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.3 267.8 66.4 299.1 401.4 27.0 78.2 39.8 269.3 110.4 0.0 8.5 210.0 1.9 0.0 0.0 9.4 0.0 1.3 0.2 0.0 0.0 362.7 0.5 0.8 3.2 0.0 0.0 0.0 369.1 0.1 0.0 0.2 0.0 0.0 5.6 0.0 0.0 1.7 0.0 0.0 107.8 0.0 0.1 5.5 0.0 0.1 0.0 0.1 0.0 0.0 0.3 11.8 3.4 0.0 0.0 0.0 1.3 0.5 6.5 0.3 1.8 11.2 0.0 22.6 0.0 6.0 8.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 358.0 6.6 0.4 4.3 3.5 4.4 0.6 0.6 0.0 0.1 0.0 0.3 0.1 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806584-12813640 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favorable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavorable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 8.3 6.8 6.8 11.9 7.0 28.2 9.1 9.9 9.2 9.5 6.0 10.6 10.4 8.5 5.0 18.4 10.7 5.0 7.2 6.9 6.1 6.8 6.9 7.3 17.2 7.0 6.8 7.2 9.0 9.3 5.3 5.4 10.4 7.9 6.1 10.8 8.4 8.6 5.1 9.0 14.0 10.1 8.3 5.9 14.6 9.4 20.0 6.5 24.6 7.6 6.7 18.8 8.2 10.9 9.3 130.0 103.8 94.8 75.7 12.3 23.4 76.2 68.4 40.0 126.3 136.0 76.2 58.7 126.9 106.2 36.6 59.6 79.4 82.6 89.2 83.5 82.7 118.1 67.7 112.9 89.9 7.1 70.6 60.5 10.4 19.7 110.7 43.9 21.4 47.3 114.8 91.2 46.8 82.0 251.4 132.8 83.0 56.4 79.1 167.4 146.1 102.0 113.7 39.6 63.8 119.8 76.7 67.0 39.8 46.7 39.8 76.1 78.4 29.3 129.2 55.7 197.0 126.1 97.6 130.3 108.5 77.4 129.4 105.5 9.4 19.1 17.2 23.9 27.6 23.3 36.8 19.6 22.5 19.0 36.3 15.9 19.6 4.4 44.8 27.7 21.0 25.8 19.1 6.8 7.0 9.9 9.2 6.9 6.1 7.0 6.8 7.2 7.9 5.9 6.5 9.3 5.3 0.0 2.6 1.3 15.3 14.0 15.7 22.9 6.8 16.2 2.8 11.7 2.7 12.8 7.6 0.0 4.2 62.3 9.1 11.3 0.0 5.4 16.1 0.8 1.6 9.0 8.4 38.7 2.2 6.0 117.4 10.3 10.7 1.1 3.8 2.5 11.7 4.4 48.9 8.4 3.0 13.9 22.4 9.1 13.2 18.8 8.4 9.3 12.4 1.9 8.5 10.4 14.4 1.0 2.4 2.1 6.8 4.9 33.0 5.3 6.2 1.0 9.5 13.9 6.6 15.6 9.8 51.2 44.9 23.8 13.2 22.7 10.2 0.8 24.8 16.1 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.3;skin 1: 101.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 142.0;Basal prostatic cells: 50.8;Ductal cells: 39.1;Prostatic glandular cells: 66.9;Suprabasal keratinocytes: 183.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 36.1;HaCaT: 16.2;HBEC3-KT: 10.5;hTCEpi: 12.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: AB_2681954, HPA056508: AB_2683159" "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavorable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.2 0.2 0.4 0.3 1.1 3.0 3.3 1.2 0.8 4.9 0.0 0.1 0.1 0.2 2.1 26.3 0.3 0.2 0.2 0.5 0.1 2.9 0.2 0.9 0.3 1.1 0.1 0.5 0.2 4.1 4.0 2.7 0.2 0.9 2.7 0.2 1.0 11.7 1.0 0.9 101.4 0.3 0.0 0.2 0.3 0.5 3.7 0.2 1.0 0.7 0.0 1.8 0.2 20.7 0.7 36.1 0.2 0.2 0.4 0.1 0.1 2.8 0.2 0.0 0.0 0.1 3.5 6.5 0.3 2.8 0.0 3.7 16.2 2.2 10.5 0.2 0.8 5.3 0.1 1.1 0.7 0.0 0.3 2.2 0.0 12.9 0.1 2.5 0.4 0.0 0.5 0.6 0.4 0.1 4.7 0.1 0.4 0.8 0.6 1.1 5.6 0.0 0.3 0.3 1.3 4.5 0.7 0.3 7.3 1.0 0.4 6.5 0.1 0.0 0.4 3.6 0.3 0.4 0.7 0.8 0.3 0.2 0.2 0.4 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.1 0.0 0.4 1.1 1.2 0.8 0.5 0.1 1.1 0.1 0.5 0.9 0.2 0.2 0.7 0.2 0.0 2.4 0.3 0.0 142.0 50.8 17.5 14.8 0.8 10.3 25.3 0.4 2.8 7.3 1.8 0.0 0.2 0.2 0.2 9.8 39.1 3.0 0.9 0.3 1.7 0.0 2.7 0.3 3.1 0.7 1.4 0.0 2.4 0.0 6.7 0.4 0.0 0.3 1.7 0.4 0.5 6.1 0.0 10.9 12.0 1.8 0.4 14.2 0.0 0.8 0.7 0.0 0.0 0.0 11.8 0.0 0.4 0.0 66.9 0.0 1.4 3.8 2.0 0.0 1.1 2.5 0.6 11.3 25.6 183.3 0.7 1.0 0.0 0.1 22.0 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 156.6;intestine: 117.3;lymphoid tissue: 237.6" "Cell type enhanced" "Detected in many" "B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 13.4 7.1 7.1 101.2 8.0 156.6 6.6 9.4 13.8 4.2 9.0 9.9 8.3 3.8 0.7 7.3 5.9 14.1 4.9 5.8 18.4 7.5 6.5 47.3 216.7 16.3 9.5 4.0 1.7 3.2 1.8 3.5 15.3 15.4 7.0 3.8 0.4 11.6 2.8 1.9 3.8 117.3 3.9 17.9 237.6 14.9 7.4 11.9 58.0 8.4 2.4 88.7 19.3 5.2 23.6 0.2 0.6 1.5 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 306.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 49.5 0.2 53.1 0.0 0.5 0.0 9.4 290.0 0.0 0.0 0.0 0.0 0.2 0.0 18.5 2.6 16.3 0.0 0.0 0.4 5.8 0.2 0.0 0.0 2.9 0.3 110.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 109.0 0.8 0.3 1.0 0.2 0.0 0.3 0.1 69.4 0.2 81.4 0.1 550.2 658.2 829.6 353.2 601.6 357.4 1511.6 426.3 376.2 449.7 1722.2 435.3 368.6 903.8 321.8 747.8 586.3 467.1 816.2 7.1 8.0 9.4 13.8 5.8 18.4 16.3 9.5 4.0 15.4 17.9 11.9 23.6 7.1 9.6 14.3 0.3 1643.9 11.7 1.3 0.1 4.6 12.1 4.6 12.1 1.6 2.8 2.5 1.8 6.2 1.9 489.6 2.2 0.0 0.5 94.2 1.2 1.9 9.7 1.2 67.7 0.1 0.0 2.3 6.9 11.7 1.5 264.6 0.3 11.4 4.1 345.3 0.0 0.2 1.7 0.0 272.0 358.4 221.3 2.8 319.7 28.4 21.5 365.0 1.1 394.4 0.0 0.1 0.0 8.0 0.7 119.8 1.1 0.6 2.9 0.9 6.3 0.0 3.2 5.7 1.1 1.3 2.6 11.8 2.9 390.3 0.9 1.9 1.1 SF3A2 "Prp11, PRPF11, SAP62, SF3a66" ENSG00000104897 "Splicing factor 3a subunit 2" Q15428 19 2236824-2248655 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042843, HPA049439" Enhanced Approved Nucleoplasm NA NA 43000 Nucleoplasm "HPA042843: AB_2678199, HPA049439: AB_2680766" "unprognostic (5.29e-2)" "prognostic favorable (7.16e-4)" "prognostic unfavorable (8.64e-4)" "unprognostic (3.09e-3)" "unprognostic (9.19e-2)" "unprognostic (7.98e-2)" "prognostic unfavorable (3.23e-5)" "unprognostic (1.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.71e-1)" "unprognostic (5.72e-3)" "unprognostic (7.94e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.85e-1)" "unprognostic (8.73e-2)" 40.8 22.8 18.2 26.0 19.2 41.1 44.4 26.3 35.5 58.7 11.1 44.7 29.7 65.9 5.4 48.0 52.6 11.5 31.8 16.8 15.9 30.5 30.1 38.6 30.5 21.5 18.0 13.8 74.8 38.6 9.2 35.9 17.8 19.6 47.2 6.4 7.1 36.8 19.4 39.1 60.7 43.1 11.6 15.0 49.6 37.6 79.6 18.5 34.5 38.1 12.0 18.1 43.5 49.7 22.1 110.8 50.3 65.2 66.2 17.1 25.8 110.2 40.4 27.9 57.9 56.5 73.5 39.3 121.4 41.3 28.6 38.8 89.0 57.8 49.8 13.2 93.9 94.2 79.8 51.7 63.9 46.9 100.9 94.8 39.3 43.8 49.3 35.6 28.7 56.4 93.5 92.7 111.7 20.9 62.4 127.7 90.4 124.6 41.9 39.6 221.5 40.7 108.9 26.2 33.5 81.4 128.6 60.4 46.0 53.3 24.8 61.9 111.8 57.4 61.7 68.0 133.2 125.4 122.7 123.4 120.8 47.0 75.4 64.7 0.8 1.9 7.2 2.9 2.5 2.2 1.7 2.4 3.0 1.8 1.6 2.1 1.9 1.7 1.3 1.9 2.5 3.0 2.1 18.2 19.2 26.3 35.5 16.8 15.9 21.5 18.0 13.8 19.6 15.0 18.5 22.1 31.7 3.2 4.5 5.9 49.0 39.0 28.1 38.3 64.3 6.4 21.4 19.9 2.0 18.6 16.8 11.0 4.2 70.7 32.3 18.0 25.4 24.4 66.7 14.2 18.5 24.0 13.1 49.4 6.1 9.6 79.9 28.8 36.2 17.0 16.5 32.6 35.0 4.0 32.6 8.4 5.6 22.1 24.4 24.9 34.3 91.0 46.0 26.4 32.0 9.4 14.1 6.2 11.3 8.0 9.5 11.8 24.5 32.0 51.7 20.1 38.7 20.2 10.7 12.3 13.1 20.4 27.4 63.6 71.6 41.7 25.3 59.0 51.5 15.8 26.2 24.7 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease variant, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "pituitary gland: 3.9;testis: 10.5" "Cell type enriched" "Detected in many" 61 "Granulosa cells: 1567.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 16.9;NTERA-2: 6.4;REH: 7.0;SH-SY5Y: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" NA NA 1580000 280000 "Vesicles, Aggresome" "HPA066973: AB_2732754" "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.1 0.2 0.5 0.0 0.8 0.0 0.2 1.1 1.3 0.3 0.0 0.6 0.0 0.3 0.0 0.3 0.4 0.0 0.2 0.2 0.4 0.5 0.3 0.3 0.0 0.5 0.4 0.3 1.1 1.3 0.0 3.9 0.0 0.6 0.5 0.0 0.0 0.2 0.0 1.5 0.2 0.4 0.0 0.2 0.2 0.2 10.5 0.4 0.0 0.3 0.0 0.0 0.2 0.3 0.5 2.8 0.2 0.1 0.4 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.1 0.2 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 16.9 0.1 0.8 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.4 0.0 0.5 0.1 1.3 6.4 0.0 1.5 7.0 1.4 0.9 0.0 0.2 0.4 7.7 0.1 0.0 1.7 0.0 0.8 0.0 0.7 0.6 1.3 0.9 2.5 4.7 3.7 0.8 0.3 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 1.1 1.3 0.2 0.4 0.5 0.4 0.3 0.6 0.2 0.4 0.5 0.3 0.0 0.0 2.0 0.0 0.1 0.2 0.1 0.6 12.1 1.6 2.2 1.1 1.5 0.0 0.0 2.1 0.3 0.4 1.1 0.0 0.3 2.0 0.7 0.8 0.5 1.2 0.4 1.6 0.2 0.3 0.4 0.0 1.5 0.0 1567.5 0.7 0.3 0.1 8.4 11.5 1.0 0.0 0.0 0.0 9.2 1.5 2.3 0.0 1.9 0.1 6.3 0.0 1.0 2.2 0.0 0.0 0.4 0.1 0.1 0.9 0.2 0.1 2.3 0.0 9.2 25.6 8.1 0.6 0.7 0.1 0.0 0.4 0.0 0.8 0.2 DKKL1 "CT34, SGY-1" ENSG00000104901 "Dickkopf like acrosomal protein 1" Q9UK85 19 49361783-49375116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 277 "testis: 347.5" "Group enriched" "Detected in some" 4 "Early spermatids: 2188.8;Late spermatids: 2340.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Cell line enhanced" "Detected in some" "AF22: 5.1;AN3-CA: 9.8;HeLa: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025410, HPA047194" Enhanced Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "CAB025410: , HPA047194: AB_2679979" "unprognostic (1.64e-1)" "unprognostic (5.30e-1)" "unprognostic (5.39e-4)" "unprognostic (1.85e-4)" "unprognostic (3.79e-2)" "unprognostic (4.30e-2)" "unprognostic (5.52e-4)" "unprognostic (1.00e-1)" "unprognostic (6.76e-2)" "unprognostic (4.08e-1)" "unprognostic (1.90e-1)" "unprognostic (5.65e-2)" "unprognostic (2.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.13e-1)" "unprognostic (1.18e-1)" "unprognostic (5.57e-2)" 0.7 0.5 0.3 0.5 0.3 0.0 0.5 0.2 0.5 0.6 0.4 0.4 0.3 1.1 0.3 0.2 1.2 0.7 0.4 0.2 0.4 0.3 0.3 0.3 0.5 0.4 0.3 0.1 0.9 1.0 0.2 0.1 0.3 0.2 0.6 0.1 0.3 0.9 0.6 0.2 0.2 0.3 0.4 0.3 0.4 0.3 347.5 0.1 0.0 0.2 0.4 0.2 0.4 0.4 0.3 0.0 1.2 5.1 9.8 0.0 0.3 0.4 0.9 0.0 0.1 0.3 0.0 0.5 0.0 0.7 0.1 0.4 0.0 0.1 0.0 0.0 0.0 1.7 0.0 2.9 0.2 0.0 0.0 0.9 0.7 0.3 0.2 0.3 0.9 0.8 0.0 1.2 0.3 0.1 0.4 0.0 0.0 2.0 0.5 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.5 1.0 1.0 2.0 1.2 1.0 0.6 0.6 0.0 0.4 0.6 0.2 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.5 0.2 0.4 0.4 0.3 0.1 0.2 0.3 0.1 0.3 1.3 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.6 0.6 1.2 2.2 0.4 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.4 2188.8 0.5 1.0 1.9 0.0 0.0 0.2 0.5 0.2 0.7 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 2340.4 16.8 1.4 1.8 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 12.0 0.0 0.2 0.0 0.0 0.0 0.4 6.6 0.7 0.9 491.0 15.2 0.2 0.0 0.0 0.1 0.5 0.2 0.2 LYL1 bHLHa18 ENSG00000104903 "LYL1 basic helix-loop-helix family member" P12980 19 13099033-13103161 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.2;lymphoid tissue: 37.0" "Cell type enhanced" "Detected in many" "Early spermatids: 335.4;Erythroid cells: 298.9;Late spermatids: 763.9;Spermatocytes: 120.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 6.4" "Group enriched" "Detected in many" 4 "B-cells: 3.7;granulocytes: 6.4;monocytes: 2.8" "Cell line enhanced" "Detected in many" "HEL: 127.7;HL-60: 90.5;HMC-1: 206.6;K-562: 102.1;NB-4: 131.9;REH: 96.5;THP-1: 86.1;U-937: 86.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA072177 Approved Nucleoplasm NA NA Nucleoplasm "HPA072177: " "unprognostic (8.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.27e-2)" "unprognostic (3.29e-3)" "unprognostic (2.76e-1)" "unprognostic (3.64e-3)" "unprognostic (2.46e-1)" "unprognostic (1.05e-2)" "unprognostic (1.90e-2)" "unprognostic (5.87e-2)" "unprognostic (1.78e-3)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.18e-1)" "unprognostic (6.54e-2)" "unprognostic (1.33e-1)" "unprognostic (4.28e-1)" 9.6 4.1 5.4 11.0 5.6 36.2 7.3 6.6 7.6 6.6 6.2 6.2 2.0 7.7 0.3 3.2 5.8 1.4 9.0 5.5 6.7 5.4 2.6 12.4 12.4 7.9 6.1 3.5 2.8 2.0 0.5 2.6 5.7 7.4 5.7 0.6 0.0 3.7 1.3 2.8 3.0 14.2 1.8 8.9 37.0 4.2 21.0 8.4 2.3 5.3 1.9 6.2 7.8 5.6 7.9 0.1 0.3 0.2 0.0 0.0 0.3 0.0 1.4 0.2 0.4 0.1 0.5 0.0 24.8 8.4 0.2 0.0 0.1 0.4 0.0 0.0 14.7 0.0 127.7 0.1 1.2 1.4 90.5 206.6 0.4 0.0 0.1 0.0 0.0 31.9 0.0 102.1 4.4 0.0 0.0 0.5 131.9 0.0 0.4 3.2 96.5 0.3 11.2 0.0 0.0 0.1 9.1 2.8 0.0 6.0 0.0 0.0 86.1 51.8 0.0 0.1 3.6 0.1 0.0 0.0 20.3 0.1 86.1 0.1 2.4 1.4 6.4 0.0 1.9 0.1 2.1 0.2 0.1 1.0 3.7 0.1 0.1 2.4 0.0 2.8 0.3 0.4 0.4 5.4 5.6 6.6 7.6 5.5 6.7 7.9 6.1 3.5 7.4 8.9 8.4 7.9 33.7 0.0 0.5 0.0 80.1 2.5 0.5 0.1 0.6 0.0 1.0 1.4 2.3 2.8 0.2 1.8 0.0 0.7 6.6 1.6 0.0 0.4 335.4 0.4 1.9 40.1 1.8 298.9 0.4 0.0 1.3 3.2 1.1 0.2 45.1 0.8 32.9 1.1 113.2 0.0 0.3 1.2 0.0 60.3 35.1 763.9 8.1 68.3 7.2 13.1 36.4 1.5 4.1 0.5 1.3 2.0 1.6 12.0 6.3 0.4 1.7 0.5 1.7 0.2 13.1 1.8 2.2 120.6 5.8 1.4 1.8 1.5 9.0 0.5 1.0 0.6 OAZ1 "AZ1, AZI, MGC138338, OAZ" ENSG00000104904 "Ornithine decarboxylase antizyme 1" P54368 19 2269509-2273490 "Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009291 Uncertain Approved "Vesicles,Centriolar satellite" NA NA Vesicles "Centriolar satellite" "HPA009291: AB_1079519" "unprognostic (2.37e-1)" "unprognostic (9.69e-3)" "unprognostic (1.72e-1)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (3.75e-2)" "unprognostic (3.19e-2)" "unprognostic (6.22e-2)" "prognostic favorable (4.10e-5)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.72e-1)" "unprognostic (2.44e-2)" "unprognostic (6.01e-2)" 197.2 254.4 109.0 171.5 120.5 333.2 179.1 101.0 191.2 143.7 107.9 196.5 162.9 135.4 92.2 168.5 152.9 110.0 273.6 127.1 116.6 203.6 174.1 195.8 246.8 113.8 116.6 110.6 141.0 211.6 46.9 174.8 135.3 111.0 152.2 78.5 36.7 228.7 90.0 530.6 173.5 199.3 85.9 115.1 297.3 189.9 68.0 113.6 68.6 145.8 124.4 139.4 172.1 154.0 136.0 577.1 117.7 88.3 152.7 181.1 287.5 228.9 400.4 275.4 197.9 269.7 169.5 181.2 389.7 210.6 187.6 78.3 163.1 87.7 120.8 129.6 523.1 303.3 301.2 108.7 267.3 184.6 425.7 456.4 192.6 207.3 74.8 112.7 177.8 227.4 141.3 297.8 439.1 226.1 210.8 357.1 442.7 291.5 83.5 210.7 291.3 176.1 519.0 184.3 164.0 207.9 220.2 264.0 236.7 464.8 70.6 198.4 890.0 293.1 140.2 173.9 610.5 427.8 423.8 188.0 468.9 636.6 660.5 217.3 1887.3 1649.6 1940.9 466.4 1685.5 469.7 962.1 506.3 502.1 1155.4 941.6 464.3 466.0 2063.4 366.1 2039.6 778.3 779.9 2803.0 109.0 120.5 101.0 191.2 127.1 116.6 113.8 116.6 110.6 111.0 115.1 113.6 136.0 492.6 365.4 510.0 54.5 1096.3 1476.0 1102.4 828.6 715.9 325.4 748.2 626.1 746.8 579.0 543.0 294.3 106.3 1065.2 1149.3 1018.3 1230.6 1043.4 95.1 452.9 335.6 591.2 613.7 1446.6 85.6 1018.2 1605.0 711.4 305.3 325.4 713.5 385.8 529.0 773.2 2248.7 222.1 78.6 816.9 547.3 2400.4 2984.5 286.7 558.6 2391.4 1136.6 60.0 2929.3 362.0 1001.1 46.3 62.2 1071.2 1388.3 477.3 1143.0 1314.8 1700.6 1540.0 553.2 285.5 460.2 487.9 821.8 251.8 256.5 751.8 1283.3 1683.5 911.1 666.9 733.6 1692.6 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavorable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 20.5 20.0 14.3 16.3 14.1 21.3 21.2 13.3 22.3 23.9 13.5 19.5 11.9 23.1 6.3 22.5 23.8 9.0 16.7 14.2 14.0 18.1 22.3 17.5 23.4 14.8 13.6 14.7 28.9 25.6 10.1 17.4 11.3 15.4 23.2 11.0 6.5 17.1 11.5 29.1 22.8 21.9 12.6 13.2 30.8 19.0 16.9 14.4 11.7 19.4 10.6 16.0 22.5 22.4 16.3 38.6 25.3 26.9 46.0 26.7 34.1 38.7 42.1 20.9 45.3 39.1 27.4 30.8 47.7 53.6 22.9 23.7 34.8 45.2 37.3 20.9 31.3 62.8 38.0 68.7 46.5 48.7 77.2 43.1 48.4 48.4 47.3 44.1 28.9 33.8 35.2 83.7 14.9 28.6 42.6 31.7 83.3 64.0 24.2 57.5 52.5 34.6 65.8 28.3 38.2 63.5 28.9 26.2 53.7 44.8 19.4 21.0 42.8 38.2 65.1 25.5 39.8 75.1 25.6 53.4 44.1 30.3 80.7 34.7 1.8 18.9 0.6 8.9 15.0 8.6 12.4 9.6 8.6 18.2 12.9 11.1 8.5 3.7 5.6 9.9 10.6 6.9 10.7 14.3 14.1 13.3 22.3 14.2 14.0 14.8 13.6 14.7 15.4 13.2 14.4 16.3 15.5 12.8 13.1 8.5 47.5 24.0 27.0 16.8 22.8 8.9 16.6 20.2 8.3 11.5 9.6 12.9 2.1 21.7 19.6 16.6 5.9 17.3 22.4 7.9 11.7 17.6 7.2 13.0 12.0 14.9 22.6 14.3 17.9 9.8 29.8 19.7 6.1 10.8 47.7 8.4 9.1 14.1 4.1 80.0 51.0 47.9 14.0 57.4 17.8 10.3 64.8 6.1 12.3 2.5 7.5 12.8 6.8 12.8 24.2 29.0 7.8 14.2 9.2 12.6 13.1 17.5 16.1 21.1 20.0 20.7 20.6 15.5 24.4 14.6 22.5 20.3 STX10 "hsyn10, SYN10" ENSG00000104915 "Syntaxin 10" O60499 19 13144058-13150383 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035303, HPA056439" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA035303: AB_10671932, HPA056439: AB_2683135" "unprognostic (1.72e-2)" "unprognostic (2.26e-2)" "unprognostic (1.62e-2)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (1.21e-2)" "unprognostic (2.54e-3)" "prognostic favorable (8.26e-4)" "unprognostic (4.09e-1)" "unprognostic (3.66e-2)" "unprognostic (4.57e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (2.39e-3)" "unprognostic (7.95e-2)" "unprognostic (2.23e-1)" "unprognostic (2.98e-2)" 45.3 59.2 40.4 36.0 42.3 72.9 47.5 43.3 52.7 65.5 44.7 55.3 48.1 49.1 17.2 81.3 50.0 29.7 50.1 40.6 40.4 61.2 79.4 67.5 42.9 42.0 42.1 38.0 51.2 48.7 28.2 49.5 17.2 41.7 50.3 19.9 11.7 52.5 20.6 36.1 67.1 61.2 21.1 40.1 87.7 60.8 17.8 41.2 35.7 57.1 16.8 28.4 51.9 55.9 47.2 99.9 68.8 51.8 138.1 51.5 52.8 17.2 55.4 49.4 46.1 48.4 31.8 88.3 66.5 80.5 66.8 33.7 76.3 44.9 67.0 26.6 113.4 86.0 60.8 154.4 66.5 38.2 71.4 63.2 54.3 55.3 57.4 37.2 62.8 58.1 85.9 32.9 34.6 31.8 87.2 105.6 125.2 55.2 51.3 112.5 117.3 54.1 96.6 44.4 47.2 60.0 121.3 57.9 66.2 127.6 14.9 45.1 67.9 58.4 75.3 38.7 145.9 77.5 78.1 75.2 57.0 98.0 172.8 59.8 41.5 162.3 120.4 48.1 128.4 40.7 39.9 41.4 48.7 119.1 40.3 36.3 37.3 267.6 32.1 151.5 31.2 51.4 80.7 40.4 42.3 43.3 52.7 40.6 40.4 42.0 42.1 38.0 41.7 40.1 41.2 47.2 31.6 16.0 21.6 13.1 29.9 35.4 34.5 52.0 31.3 21.3 43.0 37.5 12.6 30.0 53.6 20.2 6.2 17.7 32.2 54.3 27.4 42.5 1.0 23.9 28.3 31.3 16.3 33.2 16.6 56.1 26.2 27.6 40.8 24.7 53.8 33.7 31.1 18.8 82.4 13.5 11.8 48.0 46.8 86.7 45.8 3.0 25.1 62.0 48.0 7.5 86.1 21.4 48.4 11.1 14.0 57.0 53.8 31.2 25.3 19.9 77.9 28.3 38.2 17.1 26.3 21.2 31.0 9.0 16.2 38.6 43.2 19.4 39.1 23.6 55.5 38.4 RETN "ADSF, FIZZ3, RETN1" ENSG00000104918 Resistin Q9HD89 19 7669049-7670455 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Hormone "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 249.4" "Group enriched" "Detected in some" 6 "Hofbauer cells: 118.2;Kupffer cells: 47.0;Macrophages: 90.4;monocytes: 58.2" "Group enriched" "Detected in many" 4 "lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Group enriched" "Detected in many" 8 "classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4" "Group enriched" "Detected in many" 11 "dendritic cells: 118.7;monocytes: 170.4" "Group enriched" "Detected in some" 11 "NB-4: 524.3;U-937: 243.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 5120000 1200000 "unprognostic (5.61e-2)" "unprognostic (6.20e-3)" "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (5.19e-4)" "unprognostic (1.53e-4)" "unprognostic (7.34e-2)" "unprognostic (3.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.35e-2)" "unprognostic (1.20e-1)" "unprognostic (4.02e-1)" "unprognostic (7.16e-5)" "unprognostic (4.23e-2)" "unprognostic (2.26e-1)" "unprognostic (8.91e-2)" "unprognostic (1.20e-1)" 3.1 1.0 0.1 5.2 0.2 249.4 1.4 0.0 1.0 0.5 0.0 0.7 6.1 0.7 0.0 0.5 2.4 0.3 2.0 0.4 0.0 1.7 3.3 34.3 0.1 0.1 0.1 0.1 0.4 0.9 0.1 0.5 1.2 0.2 1.0 0.2 0.0 1.1 0.0 0.6 0.6 0.7 4.3 0.0 53.7 1.0 0.2 0.2 4.0 0.8 0.0 0.0 0.6 0.8 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.9 524.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 243.2 0.0 0.1 170.4 0.1 0.4 91.7 1.2 0.0 1.9 1.5 118.7 0.1 4.4 9.0 13.6 0.3 47.4 4.5 0.0 64.3 0.1 0.2 0.0 1.0 0.4 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.3 0.0 12.8 9.9 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.5 0.0 0.0 1.1 0.6 0.0 0.0 3.8 0.0 0.4 0.1 118.2 0.0 0.0 0.0 0.0 47.0 8.7 0.2 0.0 90.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.5 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.1 2.2 0.0 0.0 0.1 FCER2 "CD23, CD23A, CLEC4J, FCE2" ENSG00000104921 "Fc fragment of IgE receptor II" P06734 19 7688758-7702146 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgE-binding protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 42.6" "Cell type enriched" "Detected in some" 16 "B-cells: 157.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 2.1" "Region enriched" "Detected in single" 9 "cerebral cortex: 2.7" "Group enriched" "Detected in many" 24 "memory B-cell: 200.9;naive B-cell: 496.2" "Lineage enriched" "Detected in many" 34 "B-cells: 496.2" "Cell line enriched" "Detected in some" 14 "HDLM-2: 449.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002624, HPA008928, HPA067430" Enhanced "Secreted to blood" NA NA 240000 "CAB002624: , HPA008928: AB_1846285, HPA067430: " "unprognostic (3.20e-4)" "unprognostic (1.87e-3)" "unprognostic (1.95e-2)" "unprognostic (2.44e-2)" "unprognostic (4.77e-2)" "unprognostic (1.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.89e-3)" "unprognostic (2.71e-1)" "unprognostic (1.88e-1)" "unprognostic (2.04e-2)" "unprognostic (8.55e-2)" "unprognostic (2.46e-4)" "unprognostic (2.99e-1)" "unprognostic (1.80e-1)" "unprognostic (4.89e-2)" "unprognostic (5.17e-2)" 4.9 0.1 0.0 17.6 0.0 5.2 1.2 0.2 2.7 0.4 0.1 1.8 2.8 0.1 0.1 0.4 0.3 1.1 0.5 0.3 0.0 0.3 0.5 0.6 39.8 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.5 0.2 0.1 1.9 0.0 1.9 0.1 0.3 0.4 9.7 0.2 0.0 38.7 2.2 0.4 0.0 6.4 0.7 0.1 42.6 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 449.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.1 32.7 0.0 0.5 4.2 0.3 0.0 14.7 0.1 200.9 0.2 0.0 4.4 496.2 0.3 0.1 1.5 0.3 4.4 0.6 0.2 21.6 0.0 0.0 0.2 2.7 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 157.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.1 0.0 1.2 0.0 0.1 0.0 0.0 1.3 1.7 0.0 0.0 9.4 1.8 1.0 0.9 0.0 2.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 1.2 1.2 0.0 0.0 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769709-45782552 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.0" "Cell type enhanced" "Detected in many" "Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 85.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 8.7" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favorable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 23.4 68.9 18.6 17.7 19.7 3.0 19.3 18.8 33.4 42.3 21.9 89.4 16.0 93.5 5.4 33.7 61.8 14.1 151.2 18.5 18.6 20.4 8.9 30.0 5.2 21.0 20.0 16.8 31.4 34.6 2.9 38.2 8.9 20.7 56.8 4.9 4.1 18.7 37.9 175.0 12.2 34.9 60.5 18.1 17.9 52.1 13.3 20.3 4.2 21.9 144.5 1.3 69.6 34.6 19.7 11.7 16.7 13.5 10.7 13.4 12.9 10.5 26.1 22.2 10.5 8.8 2.2 6.6 2.9 2.8 32.9 9.2 15.1 3.0 1.5 2.2 12.4 16.6 0.8 22.6 1.4 12.6 0.1 5.4 22.8 8.0 6.4 1.7 24.2 3.6 2.1 8.6 8.0 15.4 13.7 1.6 3.8 8.8 4.8 3.3 5.0 85.1 6.4 4.7 11.5 10.2 13.5 13.6 27.6 9.3 4.8 28.6 5.5 8.4 9.2 10.4 8.3 15.0 16.8 11.5 2.9 9.5 1.3 13.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 19.7 18.8 33.4 18.5 18.6 21.0 20.0 16.8 20.7 18.1 20.3 19.7 10.5 0.0 2.2 44.1 3.7 8.0 8.1 3.8 5.7 5.7 9.6 9.9 3.7 4.3 3.2 3.7 8.4 2.7 4.2 4.7 1.9 2.7 1.5 8.7 8.6 7.9 10.1 0.4 16.4 17.3 2.0 8.4 8.2 6.3 0.0 9.7 9.3 1.5 0.8 5.0 12.4 8.2 8.2 1.6 9.8 1.8 7.2 0.8 7.2 10.3 0.4 2.6 5.2 26.7 10.0 5.8 4.5 23.3 3.1 4.0 3.8 31.7 7.1 7.4 59.2 27.6 34.9 7.2 6.4 10.1 6.8 1.6 4.5 5.4 5.1 4.6 CLEC4M "CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN" ENSG00000104938 "C-type lectin domain family 4 member M" Q9H2X3 19 7763210-7769605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "liver: 63.1;lymphoid tissue: 16.6" "Cell type enriched" "Detected in some" 11 "Hepatic stellate cells: 270.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033689, CAB033691, HPA042661" Supported "Intracellular and membrane" NA NA 3400000 "CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.00e-1)" "unprognostic (1.71e-2)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (1.27e-1)" "unprognostic (4.58e-3)" "unprognostic (4.60e-2)" "unprognostic (5.15e-2)" "unprognostic (1.43e-1)" 1.4 1.1 0.5 0.3 0.1 0.1 0.2 0.3 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.1 63.1 3.2 16.6 0.9 0.5 0.1 3.0 0.1 0.0 0.1 7.4 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.4 0.0 2.2 0.3 0.0 0.1 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.4 0.1 0.1 0.9 0.5 0.1 0.6 0.4 0.3 0.5 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 3.5 0.0 18.7 0.1 0.0 0.0 1.3 0.0 0.0 0.0 15.7 270.2 2.8 0.7 0.0 0.2 0.0 0.0 14.8 2.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.4 0.1 0.0 0.0 0.3 0.3 23.4 0.0 0.2 RSPH6A "RSHL1, RSP4, RSP6, RSPH4B" ENSG00000104941 "Radial spoke head 6 homolog A" Q9H0K4 19 45795713-45815308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 29.9" "Group enriched" "Detected in some" 4 "Early spermatids: 80.7;Spermatocytes: 49.0" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RPMI-8226: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA045382 Enhanced NA NA "HPA045382: AB_10959735" "unprognostic (1.99e-1)" "unprognostic (3.23e-1)" "unprognostic (6.55e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" "unprognostic (4.16e-4)" "unprognostic (2.33e-1)" "unprognostic (5.89e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-5)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (5.99e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 49.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 TBC1D17 FLJ12168 ENSG00000104946 "TBC1 domain family member 17" Q9HA65 19 49877425-49888750 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068119 Uncertain NA NA "HPA068119: AB_2685958" "unprognostic (5.88e-2)" "unprognostic (8.04e-2)" "unprognostic (3.16e-3)" "unprognostic (4.33e-2)" "unprognostic (8.39e-2)" "prognostic favorable (7.18e-4)" "unprognostic (6.41e-2)" "unprognostic (8.48e-2)" "unprognostic (3.56e-1)" "unprognostic (1.49e-1)" "prognostic favorable (4.02e-4)" "unprognostic (1.41e-1)" "unprognostic (1.78e-2)" "unprognostic (2.17e-1)" "unprognostic (2.52e-1)" "unprognostic (2.38e-1)" "unprognostic (9.52e-2)" 26.3 26.7 27.8 9.7 30.5 6.5 26.8 28.0 41.4 22.5 13.4 27.0 14.3 30.5 12.7 17.9 24.5 10.7 32.5 27.2 24.5 20.5 28.6 15.9 10.4 34.7 28.6 24.2 30.9 27.8 18.3 21.2 13.3 30.7 20.8 5.8 13.3 28.2 17.9 125.2 36.9 19.2 12.4 26.6 15.5 28.0 10.3 28.6 12.4 20.8 39.8 7.1 31.2 20.3 37.1 12.4 25.3 7.9 11.5 36.0 24.5 18.2 14.2 48.0 15.5 25.0 13.8 18.0 7.3 13.8 26.6 26.5 13.7 7.0 19.3 8.4 22.3 18.3 8.7 20.6 15.3 30.4 4.5 12.8 29.0 19.7 14.7 11.5 27.9 14.6 11.5 9.9 41.9 13.7 14.3 5.9 9.4 13.4 13.5 20.4 8.9 11.1 20.1 21.3 22.9 14.5 16.0 18.6 20.0 12.3 10.2 18.5 6.9 17.8 34.2 11.5 12.8 7.3 26.4 37.0 5.3 35.6 5.1 13.2 13.8 3.9 8.5 7.9 3.9 7.1 8.1 7.2 8.3 3.7 10.9 7.1 6.0 5.1 10.8 3.7 4.9 4.4 6.0 27.8 30.5 28.0 41.4 27.2 24.5 34.7 28.6 24.2 30.7 26.6 28.6 37.1 18.1 12.8 12.2 19.2 14.9 14.5 16.3 27.1 17.6 32.0 22.4 23.2 7.8 25.8 15.9 20.2 39.6 49.5 15.3 21.3 25.4 16.1 2.8 16.9 12.3 14.4 48.7 12.2 6.9 18.9 17.6 17.7 23.4 23.7 4.5 12.7 21.8 27.7 13.6 48.8 8.9 28.7 28.5 13.1 26.5 5.0 27.4 12.9 14.2 5.6 22.0 23.9 15.5 11.6 16.0 12.2 19.1 31.2 16.2 15.1 31.7 22.5 7.5 52.6 13.1 18.1 17.7 10.5 13.1 10.8 12.9 66.4 17.2 16.1 16.2 10.5 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 18.5;testis: 27.0" "Group enriched" "Detected in many" 5 "Langerhans cells: 295.1;monocytes: 682.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 35.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 103.4" "Group enriched" "Detected in many" 6 "monocytes: 36.8;T-cells: 103.4" "Cell line enhanced" "Detected in many" "EFO-21: 34.3;HDLM-2: 62.4;Karpas-707: 47.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 1.6 0.6 2.3 18.5 0.5 4.2 0.9 0.8 0.8 1.1 0.7 1.7 4.1 1.6 0.2 0.6 4.0 2.0 0.5 0.5 1.1 3.7 1.2 2.4 9.4 1.8 0.6 0.3 0.5 0.7 0.2 0.6 2.0 1.7 0.8 1.4 0.1 0.9 0.5 0.3 1.3 2.7 1.5 2.1 4.1 3.1 27.0 1.4 3.4 0.5 0.2 6.8 4.6 0.5 2.5 1.0 1.2 0.8 0.7 0.0 0.8 0.3 0.5 2.0 1.4 2.1 0.7 1.9 3.5 34.3 0.4 2.9 0.5 0.4 0.0 0.2 62.4 0.2 1.6 0.1 0.5 0.1 1.2 12.3 1.0 0.4 0.6 0.1 0.4 2.6 0.4 0.4 47.3 0.1 0.4 0.7 2.1 0.4 0.9 0.1 1.0 0.9 3.6 2.5 3.2 0.7 0.8 0.5 0.9 0.5 0.2 0.4 2.8 2.9 7.1 1.0 0.1 1.0 4.1 9.7 2.0 1.0 0.5 0.7 0.3 22.0 0.3 6.4 36.8 103.4 0.4 13.2 11.5 11.6 0.2 0.3 0.1 0.5 1.3 5.3 1.3 0.7 8.8 2.3 0.5 0.8 0.8 0.5 1.1 1.8 0.6 0.3 1.7 2.1 1.4 2.5 0.8 0.0 0.0 0.0 3.6 9.7 0.6 9.8 0.0 0.1 1.2 1.3 0.5 0.0 5.5 3.7 0.0 0.4 1.0 0.2 0.0 3.5 75.4 2.9 0.6 6.7 0.0 0.0 0.4 4.0 0.7 1.3 0.5 2.1 1.3 0.1 1.1 0.2 97.4 0.0 0.4 0.3 6.1 3.0 295.1 18.4 0.3 38.8 3.6 1.9 682.5 0.1 1.0 0.0 0.4 0.5 0.1 0.4 0.7 1.4 0.3 2.7 1.6 0.2 0.0 0.2 2.5 45.2 3.6 0.4 8.2 0.8 6.3 0.0 0.2 2.1 TLE6 "FLJ14009, GRG6" ENSG00000104953 "TLE family member 6, subcortical maternal complex member" Q9H808 19 2977538-2995179 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 7.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 8.6;Collecting duct cells: 12.9;Distal tubular cells: 7.9;Extravillous trophoblasts: 10.1;Syncytiotrophoblasts: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 18.6;SK-BR-3: 14.0;U-266/70: 14.5;U-698: 16.5;U-937: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.32e-1)" "unprognostic (1.28e-2)" "unprognostic (1.63e-5)" "unprognostic (4.05e-3)" "unprognostic (4.36e-2)" "unprognostic (4.58e-2)" "unprognostic (3.85e-2)" "unprognostic (1.24e-1)" "unprognostic (4.85e-3)" "unprognostic (8.00e-2)" "unprognostic (2.62e-3)" "unprognostic (1.52e-1)" "unprognostic (3.31e-4)" "unprognostic (3.34e-1)" "unprognostic (2.81e-1)" "unprognostic (1.92e-2)" "unprognostic (7.60e-3)" 0.8 1.1 0.7 0.2 0.7 0.0 1.8 1.5 0.8 1.0 0.3 1.2 0.6 1.6 2.7 0.6 0.9 0.2 0.8 0.4 1.6 2.5 3.8 2.3 0.8 0.9 0.9 0.5 0.4 1.8 2.6 1.7 4.9 0.8 1.3 1.3 1.9 3.3 3.2 0.3 0.7 0.4 0.8 0.8 1.2 1.1 3.3 2.2 1.1 7.4 0.1 0.5 1.0 0.6 0.9 4.7 6.1 0.1 2.6 0.1 0.0 18.6 0.0 0.1 0.4 1.0 0.0 1.4 8.6 1.4 0.5 1.5 0.1 2.3 1.3 0.3 7.2 1.1 0.0 0.2 0.7 0.7 0.2 1.5 1.1 0.9 0.0 0.2 1.4 1.1 6.3 1.5 0.1 0.5 3.1 0.0 0.4 0.0 9.1 1.2 5.0 0.4 7.2 1.7 1.1 0.4 1.7 0.4 14.0 5.6 0.5 3.7 0.8 1.0 0.6 0.8 0.4 0.4 14.5 10.6 16.5 3.4 12.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.5 0.0 0.1 0.0 1.0 0.1 0.0 0.3 0.1 0.7 0.7 1.5 0.8 0.4 1.6 0.9 0.9 0.5 0.8 0.8 2.2 0.9 0.5 0.0 8.6 0.0 0.8 0.1 1.9 1.3 1.8 3.1 4.0 3.7 1.6 4.3 1.6 12.9 0.0 6.1 0.2 2.4 7.9 1.7 0.8 1.0 0.6 0.7 3.6 0.0 0.5 1.0 10.1 0.7 1.5 2.6 0.0 0.2 0.4 3.1 1.4 0.0 0.9 2.4 2.0 0.3 0.4 2.9 0.3 0.3 5.4 0.0 0.0 6.9 0.0 0.0 0.5 1.0 0.6 0.4 0.2 0.6 0.1 0.7 0.1 0.9 0.0 0.0 0.5 0.2 4.8 0.7 0.0 8.6 0.2 0.5 1.5 0.9 CCDC130 MGC10471 ENSG00000104957 "Coiled-coil domain containing 130" P13994 19 13731760-13763296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056977 Approved Approved Vesicles NA NA Vesicles "HPA056977: AB_2683297" "unprognostic (6.54e-2)" "unprognostic (5.72e-3)" "unprognostic (2.13e-3)" "unprognostic (1.27e-3)" "unprognostic (2.71e-1)" "prognostic favorable (7.83e-5)" "unprognostic (7.04e-2)" "unprognostic (1.25e-2)" "unprognostic (2.47e-1)" "unprognostic (9.69e-2)" "prognostic favorable (2.34e-4)" "unprognostic (2.06e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.82e-4)" 23.2 21.1 15.5 20.7 17.8 23.3 26.5 15.5 25.0 30.4 16.7 24.9 17.3 27.5 3.7 22.7 29.2 11.8 26.5 14.5 17.4 27.1 24.9 27.5 23.6 19.9 17.0 14.4 37.8 26.0 13.2 29.2 15.1 21.2 27.4 7.5 13.5 24.5 10.7 28.5 26.5 29.9 11.0 15.6 31.6 25.2 20.6 17.4 16.6 32.9 11.7 12.3 25.7 27.4 26.1 14.9 10.1 19.3 19.7 12.5 9.7 11.9 15.6 13.2 14.3 13.5 9.5 10.2 12.6 11.3 12.5 11.4 14.4 8.9 8.0 4.6 21.6 26.2 9.7 34.3 14.5 24.4 9.5 24.9 13.8 17.3 17.6 12.0 15.2 16.6 23.2 9.9 22.9 9.0 11.1 25.8 21.1 13.2 7.7 20.1 22.1 9.4 17.1 11.4 16.8 11.8 15.5 10.0 10.4 25.0 9.7 8.3 22.5 13.7 23.2 9.6 27.9 20.4 36.5 14.8 10.3 20.2 22.6 16.2 18.3 12.9 20.3 13.2 11.3 16.4 15.2 14.2 14.1 13.1 18.0 13.0 14.8 13.5 14.4 15.2 10.8 12.8 11.3 15.5 17.8 15.5 25.0 14.5 17.4 19.9 17.0 14.4 21.2 15.6 17.4 26.1 25.5 9.6 17.9 21.5 29.0 13.4 15.4 20.2 15.4 30.3 18.6 18.4 14.5 8.6 18.6 29.5 27.1 17.3 31.4 25.6 7.9 17.6 40.2 22.7 24.8 22.4 18.7 16.0 19.8 15.7 19.1 19.5 53.0 26.9 24.6 34.9 17.5 10.8 18.0 26.9 24.9 18.1 24.4 18.6 33.8 24.4 19.0 21.9 24.9 15.0 24.9 26.0 17.5 14.1 30.3 18.1 25.5 17.0 27.3 12.8 32.1 18.9 23.0 41.7 26.3 16.6 23.6 35.5 20.3 19.2 15.6 35.0 31.0 31.8 17.5 11.0 PTOV1 ENSG00000104960 "PTOV1 extended AT-hook containing adaptor protein" Q86YD1 19 49850735-49860744 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 326.5;Late spermatids: 631.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051812, HPA075125" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA051812: , HPA075125: AB_2732280" "unprognostic (2.70e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (1.94e-2)" "unprognostic (1.40e-1)" "unprognostic (2.70e-1)" "unprognostic (9.08e-2)" "prognostic favorable (9.20e-4)" "unprognostic (4.65e-2)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-2)" "unprognostic (5.27e-2)" "unprognostic (6.70e-2)" 43.5 108.2 109.5 24.4 109.5 30.0 47.2 110.0 162.7 72.0 109.3 56.9 23.9 66.4 15.2 44.1 62.7 18.0 65.5 111.0 114.2 69.8 68.4 40.3 23.8 120.4 114.3 112.2 91.8 62.1 27.8 106.8 23.3 113.3 74.1 5.9 19.1 55.5 23.4 107.4 50.9 43.3 11.6 113.4 47.9 59.2 67.0 113.3 18.8 62.9 16.7 8.8 54.4 52.6 123.4 43.5 88.0 87.5 94.4 12.1 19.7 53.7 52.3 45.7 47.8 50.1 48.1 73.1 46.7 49.0 26.4 32.8 47.1 32.5 40.6 11.5 122.5 218.8 30.3 72.2 76.1 31.0 25.1 59.2 37.6 25.7 20.2 8.2 32.2 40.2 64.9 71.9 54.9 22.5 53.2 113.3 113.1 56.6 31.2 79.6 135.8 35.5 65.8 42.2 75.1 113.1 123.4 44.8 51.6 23.9 21.9 50.5 27.3 58.6 56.6 93.5 34.1 43.3 57.5 37.4 63.7 58.5 35.2 73.7 8.8 2.6 4.3 2.7 2.4 3.6 7.1 3.0 2.4 1.9 6.3 3.8 3.5 7.4 4.7 1.4 7.7 1.3 1.1 109.5 109.5 110.0 162.7 111.0 114.2 120.4 114.3 112.2 113.3 113.4 113.3 123.4 42.9 38.5 25.7 18.3 43.3 36.6 82.3 21.5 55.2 50.5 56.2 60.1 32.6 65.8 26.4 44.1 18.8 110.6 29.9 69.8 90.1 28.9 326.5 87.4 68.5 37.4 99.8 46.3 14.7 26.8 91.4 62.7 56.6 78.9 15.2 92.7 38.2 57.2 52.1 35.3 17.1 72.7 20.3 28.9 39.1 631.4 64.3 28.8 44.4 10.3 18.6 75.0 18.6 17.1 23.7 35.8 61.2 80.5 72.0 74.8 68.4 141.0 38.4 44.1 59.2 44.2 56.2 30.3 93.3 40.1 36.2 153.6 34.0 88.0 55.3 70.2 TLE5 "AES, GRG5" ENSG00000104964 "TLE family member 5, transcriptional modulator" Q08117 19 3052910-3063107 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 92.3;dendritic cells: 167.1;Extravillous trophoblasts: 372.2;Hofbauer cells: 84.2;Plasma cells: 57.5;Syncytiotrophoblasts: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049499 Supported Nucleoplasm NA NA Nucleoplasm "HPA049499: AB_2680795" "unprognostic (1.08e-1)" "unprognostic (3.32e-3)" "unprognostic (7.15e-2)" "prognostic favorable (3.89e-4)" "unprognostic (1.45e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (3.58e-1)" "unprognostic (7.58e-2)" "unprognostic (1.38e-3)" "unprognostic (2.15e-1)" "prognostic favorable (7.74e-4)" "unprognostic (7.17e-3)" "unprognostic (2.60e-1)" "unprognostic (2.08e-2)" "unprognostic (1.78e-3)" 228.3 360.9 329.3 94.7 324.7 100.5 216.7 348.1 438.4 302.0 221.8 384.5 82.8 339.4 81.5 284.4 318.7 91.4 505.8 324.9 330.8 261.6 241.5 286.2 146.4 335.2 310.7 320.7 286.4 236.4 176.0 279.1 95.4 357.5 317.5 91.8 83.6 290.5 199.0 554.6 230.1 235.2 110.8 278.3 327.8 276.5 109.8 354.3 211.9 318.5 316.5 120.9 364.9 287.8 340.3 120.8 138.7 101.8 180.7 122.1 140.8 78.9 155.1 211.9 192.6 173.0 57.2 120.3 195.9 169.1 200.7 69.5 100.6 122.9 226.7 112.6 292.8 56.5 68.8 141.9 109.6 217.1 99.4 85.1 152.3 182.1 93.2 89.7 226.9 191.8 100.8 245.5 80.0 169.0 120.0 221.7 119.5 89.4 85.3 140.3 251.3 123.4 135.1 241.7 247.7 258.1 283.3 152.2 174.1 163.9 55.8 138.3 134.2 266.5 161.1 106.6 152.8 143.5 4.7 0.9 265.0 151.1 165.7 151.7 38.9 6.6 18.1 130.8 10.7 100.8 62.0 169.3 134.9 12.5 74.3 220.8 149.5 4.6 41.6 9.2 28.8 242.0 89.2 329.3 324.7 348.1 438.4 324.9 330.8 335.2 310.7 320.7 357.5 278.3 354.3 340.3 92.3 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 24.5 167.1 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 372.2 27.7 0.0 0.0 0.0 0.0 0.0 0.0 84.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 94.0 27.8 0.0 0.0 0.0 NOVA2 "ANOVA, NOVA-2, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45974044 "Human disease related genes, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5" "Cell type enhanced" "Detected in some" "Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9" "Cancer enriched" "Detected in many" 4 "glioma: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 6.1 1.9 11.8 0.7 15.6 0.0 5.7 0.4 16.5 3.0 0.0 1.7 0.6 3.4 0.6 1.4 2.9 1.4 5.0 16.0 4.6 3.6 1.0 9.4 0.5 4.6 3.6 15.6 1.2 1.1 1.0 6.3 4.0 7.1 2.3 0.5 5.7 1.1 0.8 2.3 1.1 1.8 2.0 0.2 1.5 1.5 2.1 5.0 0.4 4.6 2.6 0.2 2.5 2.1 9.5 0.0 0.1 9.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 1.3 0.0 0.0 11.0 0.4 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 5.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.6 0.4 16.5 16.0 4.6 4.6 3.6 15.6 7.1 0.2 5.0 9.5 39.4 0.0 0.0 5.9 0.1 0.6 0.2 0.0 0.6 56.7 0.1 0.5 3.4 1.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.1 32.0 0.0 0.0 21.8 0.2 0.0 1.2 0.0 0.1 0.0 0.1 42.5 0.5 0.1 21.9 20.9 0.0 0.0 1.6 1.5 3.5 0.0 0.1 0.0 9.4 0.0 1.3 0.0 11.6 9.5 0.2 0.0 0.4 1.2 0.3 0.0 0.0 0.0 3.3 0.0 0.6 0.6 2.4 2.3 0.3 0.1 0.0 0.5 0.4 0.0 0.3 SGTA SGT ENSG00000104969 "Small glutamine rich tetratricopeptide repeat containing alpha" O43765 19 2754715-2783362 "Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056309 Approved Approved Nucleoplasm NA NA 81000 Nucleoplasm "HPA056309: AB_2683096" "unprognostic (2.31e-2)" "prognostic favorable (9.70e-4)" "unprognostic (1.13e-1)" "prognostic favorable (1.04e-4)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" "unprognostic (2.52e-3)" "unprognostic (1.47e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-1)" "unprognostic (7.58e-3)" "unprognostic (2.89e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.04e-1)" "unprognostic (3.04e-1)" 37.7 46.7 51.7 16.9 51.7 29.3 40.2 52.1 76.6 40.1 37.1 48.7 27.5 44.6 18.7 53.7 42.3 13.9 85.6 51.7 49.2 55.2 72.9 37.8 20.0 56.7 54.9 47.7 53.2 58.2 22.3 56.9 22.2 54.3 51.6 9.4 17.3 36.4 18.8 111.7 39.7 37.9 15.0 53.9 49.6 48.1 54.6 52.7 31.8 48.3 43.8 13.3 44.1 38.4 58.6 67.9 58.8 57.4 56.5 21.7 23.9 45.9 46.8 35.7 71.3 60.8 95.4 31.4 61.5 37.7 39.4 44.4 53.3 70.2 79.5 24.6 0.0 59.3 37.8 25.0 81.8 56.0 49.0 46.5 39.1 39.2 58.5 45.6 27.5 51.5 60.5 95.6 57.6 38.3 46.4 87.8 70.8 98.2 51.6 57.3 113.8 43.7 80.8 48.0 43.0 104.2 85.6 31.6 61.0 73.4 21.5 66.8 76.0 41.0 50.7 53.2 91.3 86.8 101.1 88.1 82.6 65.6 122.2 81.1 17.3 21.4 20.9 17.4 28.1 20.4 15.4 19.0 19.1 23.6 13.9 14.4 14.4 20.7 21.2 27.8 20.5 25.4 21.8 51.7 51.7 52.1 76.6 51.7 49.2 56.7 54.9 47.7 54.3 53.9 52.7 58.6 31.6 9.6 15.7 15.3 26.3 23.7 24.0 21.2 17.1 42.3 32.5 30.4 46.8 12.8 14.9 18.4 25.0 52.2 19.3 54.1 35.2 40.0 65.4 26.1 21.9 26.9 32.2 16.6 9.8 45.1 56.5 25.8 30.5 31.0 28.5 34.4 17.5 24.8 37.4 38.7 9.6 36.3 26.4 22.0 23.6 49.8 22.1 26.2 19.6 4.7 30.3 42.9 17.5 10.6 34.2 40.5 38.2 27.4 24.9 27.4 36.1 27.5 10.6 48.8 13.1 26.6 25.9 39.3 21.6 23.2 24.6 92.8 19.9 31.5 46.2 29.7 LILRB1 "CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB" ENSG00000104972 "Leukocyte immunoglobulin like receptor B1" 19 54617158-54637528 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.4" "Cell type enhanced" "Detected in some" "B-cells: 32.3;dendritic cells: 37.4;Kupffer cells: 87.3;Macrophages: 73.8;Microglial cells: 30.9;monocytes: 39.6;Plasma cells: 34.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "intermediate monocyte: 39.3;non-classical monocyte: 63.7" "Lineage enriched" "Detected in many" 11 "monocytes: 63.7" "Group enriched" "Detected in some" 19 "Daudi: 5.6;THP-1: 2.9" "Intracellular and membrane" NA NA "unprognostic (9.23e-2)" "unprognostic (4.20e-2)" "unprognostic (4.95e-2)" "unprognostic (3.29e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (1.24e-1)" "unprognostic (3.89e-2)" "unprognostic (3.58e-1)" "unprognostic (9.64e-2)" "unprognostic (1.24e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (6.57e-2)" "unprognostic (1.62e-2)" "unprognostic (7.06e-2)" "unprognostic (8.03e-2)" 2.1 1.7 0.4 7.1 0.1 1.3 1.0 0.2 0.5 0.5 0.2 1.5 0.1 0.4 0.0 0.7 1.5 0.0 0.8 0.1 0.6 1.1 2.3 7.7 5.7 0.7 0.5 0.1 0.6 0.7 0.0 0.9 0.1 0.5 1.1 0.4 0.0 1.2 0.2 0.2 0.1 6.1 2.7 0.7 36.4 1.1 0.2 0.6 0.0 0.8 0.0 0.3 2.2 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 8.1 0.0 1.4 39.3 0.0 2.3 0.0 1.2 5.6 2.4 0.0 0.8 0.2 0.0 63.7 2.2 0.0 5.5 0.4 0.1 0.2 0.5 0.1 0.6 0.7 0.5 0.1 0.5 0.7 0.6 2.1 0.9 0.0 2.2 0.0 32.3 0.3 0.3 0.0 0.0 0.0 0.3 0.8 1.0 1.5 2.5 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 1.3 0.0 0.0 0.1 0.2 0.5 0.0 2.5 0.0 2.5 0.7 15.9 0.0 0.1 0.0 0.0 87.3 2.2 0.0 0.0 73.8 0.0 30.9 39.6 0.3 9.2 0.0 0.1 0.0 0.0 0.0 34.0 0.3 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 9.5 0.0 0.1 2.2 MED25 "ACID1, ARC92, DKFZp434K0512, TCBAP0758" ENSG00000104973 "Mediator complex subunit 25" Q71SY5 19 49818282-49840383 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 111.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 13.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068802 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA068802: AB_2686039" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (6.67e-2)" "unprognostic (8.16e-2)" "unprognostic (2.20e-1)" "prognostic favorable (9.85e-4)" "unprognostic (1.02e-3)" "unprognostic (2.10e-1)" "unprognostic (3.59e-2)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (1.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" "unprognostic (3.04e-3)" 21.5 76.8 13.9 18.7 12.0 34.8 23.9 12.4 23.5 28.1 21.2 29.7 18.7 36.5 8.7 32.6 33.6 15.0 36.3 14.1 12.4 27.7 15.9 26.6 18.5 13.8 13.5 11.3 45.2 30.9 16.0 44.1 19.0 13.9 24.0 13.3 16.1 27.1 12.0 98.6 28.1 28.2 16.2 10.2 30.8 39.6 82.7 14.4 17.0 40.1 18.5 18.0 27.5 26.6 11.4 44.6 65.3 30.5 33.3 20.8 18.4 30.7 23.6 27.4 37.3 36.6 58.7 50.1 51.2 16.3 30.9 25.6 38.4 32.8 34.0 23.1 30.9 58.3 33.7 45.6 41.2 24.6 36.0 46.1 22.7 28.3 32.8 22.9 31.4 32.3 29.0 61.6 36.3 20.8 25.5 36.0 69.8 22.5 36.9 40.6 43.5 30.3 53.3 33.6 64.1 54.4 50.1 32.4 48.9 15.2 23.3 29.1 27.1 39.3 40.1 29.2 19.4 26.6 41.3 63.1 55.3 35.6 30.8 24.4 0.8 2.2 3.8 1.3 1.7 1.5 2.3 1.1 1.4 1.8 3.3 1.2 0.8 13.8 0.9 1.6 2.2 1.4 2.0 13.9 12.0 12.4 23.5 14.1 12.4 13.8 13.5 11.3 13.9 10.2 14.4 11.4 10.6 35.3 22.9 17.0 18.5 5.6 15.8 16.0 10.2 10.8 17.7 13.3 5.7 8.6 16.8 20.2 43.8 27.5 16.1 28.8 1.9 23.6 54.3 58.3 18.3 10.8 44.3 54.7 10.5 24.3 22.8 15.8 23.0 24.1 7.6 62.5 7.1 5.8 21.5 8.4 12.6 18.8 18.3 13.8 11.6 111.7 15.8 16.5 3.6 7.5 22.8 9.1 11.3 10.6 10.9 28.7 28.6 11.3 20.4 8.8 27.8 17.6 77.4 28.3 13.1 11.9 19.8 49.1 39.0 11.3 5.3 33.8 14.5 62.0 18.0 16.5 LILRA1 "CD85i, LIR-6, LIR6" ENSG00000104974 "Leukocyte immunoglobulin like receptor A1" O75019 19 54593582-54602381 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 12.0" "Group enriched" "Detected in some" 8 "Kupffer cells: 42.3;Macrophages: 38.7;monocytes: 39.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 126.8;non-classical monocyte: 169.2" "Lineage enriched" "Detected in many" 5 "monocytes: 169.2" "Group enriched" "Detected in some" 8 "THP-1: 1.0;U-937: 1.5" NA NA 94000000 "unprognostic (4.52e-2)" "unprognostic (1.12e-1)" "unprognostic (6.30e-2)" "unprognostic (1.59e-1)" "unprognostic (2.34e-1)" "unprognostic (9.46e-3)" "unprognostic (1.17e-1)" "unprognostic (4.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.90e-2)" "unprognostic (8.72e-2)" "unprognostic (1.13e-1)" "unprognostic (8.28e-3)" "unprognostic (8.82e-2)" "unprognostic (3.79e-4)" "unprognostic (2.53e-1)" "unprognostic (9.83e-2)" 0.7 0.5 0.2 8.3 0.3 2.7 0.2 0.4 0.3 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.3 0.8 0.3 0.2 0.3 0.3 0.9 1.9 1.1 0.6 0.5 0.0 0.1 0.2 0.1 0.2 0.4 0.7 0.3 0.6 0.0 0.2 0.2 0.1 0.0 0.5 0.7 0.8 12.0 0.2 0.0 0.5 0.3 0.2 0.6 1.1 2.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 47.0 36.0 0.0 126.8 0.0 0.0 0.0 0.1 32.6 0.1 0.1 0.1 35.8 0.4 169.2 4.2 0.1 22.7 0.2 0.3 0.4 0.3 0.2 0.3 0.6 0.5 0.0 0.7 0.8 0.5 1.1 0.1 0.0 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 4.9 0.0 0.0 0.0 0.0 42.3 0.7 0.0 0.0 38.7 0.0 2.8 39.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 SNAPC2 "PTFdelta, SNAP45" ENSG00000104976 "Small nuclear RNA activating complex polypeptide 2" Q13487 19 7920338-7923250 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049843, HPA077597" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049843: AB_2680910, HPA077597: AB_2732354" "unprognostic (4.56e-3)" "unprognostic (1.89e-1)" "unprognostic (7.98e-3)" "unprognostic (8.11e-3)" "unprognostic (2.03e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (3.22e-1)" "unprognostic (5.30e-2)" "unprognostic (9.78e-2)" 20.5 21.8 12.9 10.5 14.5 16.8 19.8 12.3 20.3 34.6 8.9 28.8 9.8 51.2 5.7 14.4 35.3 8.4 16.0 14.8 13.3 17.3 12.0 17.3 9.2 13.3 13.0 12.4 20.9 18.0 10.2 25.7 6.6 13.7 27.3 3.8 1.8 16.8 17.4 9.1 20.1 15.4 12.5 11.9 21.6 18.9 32.8 13.6 7.6 13.2 9.8 4.9 31.9 25.3 12.9 20.6 22.9 10.8 42.0 14.7 31.1 10.0 21.4 22.6 20.5 18.5 10.6 17.4 17.6 25.8 25.0 16.4 24.7 7.7 15.9 5.9 22.7 19.7 24.5 9.6 15.4 26.6 15.4 38.7 25.5 24.0 24.3 14.9 16.6 23.5 18.1 24.5 28.3 12.7 18.1 19.9 43.6 13.9 10.4 51.8 23.4 10.7 17.6 19.1 7.1 12.7 28.7 11.0 11.8 48.6 4.8 19.2 16.6 30.9 68.8 24.5 65.2 26.8 27.4 48.1 10.8 43.1 31.6 22.2 7.0 23.8 23.5 19.0 30.8 19.2 15.7 16.1 16.5 30.1 14.5 16.6 16.9 3.5 27.7 33.4 19.9 24.0 16.4 12.9 14.5 12.3 20.3 14.8 13.3 13.3 13.0 12.4 13.7 11.9 13.6 12.9 19.8 3.2 3.7 3.3 15.4 24.3 20.0 25.1 35.9 8.6 25.8 26.2 3.2 7.2 10.7 11.0 0.0 12.2 22.9 9.8 17.6 21.2 1.9 10.7 25.0 20.7 12.0 20.2 4.1 24.5 24.2 18.5 8.6 15.0 18.4 15.4 12.5 5.2 28.6 23.5 2.6 11.9 14.2 19.6 28.0 6.0 13.7 19.2 19.6 1.0 31.3 6.0 13.4 2.0 3.0 28.9 6.6 14.3 8.4 28.5 16.7 16.1 3.0 6.1 13.1 7.3 30.1 9.5 38.6 19.0 24.3 9.9 18.4 29.2 15.5 24.1 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774456-13778773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059928: AB_2684165, HPA061291: AB_2684469" "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 88.9 118.7 141.9 52.5 144.8 81.1 89.6 147.7 211.2 97.0 136.8 85.4 45.8 92.4 86.3 93.1 88.3 50.3 147.7 139.9 146.4 125.2 111.9 80.8 77.5 146.5 141.4 136.1 112.6 96.3 93.6 112.5 40.6 148.5 99.6 42.0 36.1 77.5 53.3 168.9 93.4 73.0 63.6 144.0 82.7 91.9 52.0 147.3 102.4 91.1 108.1 71.3 89.3 83.3 145.4 176.4 249.9 123.0 98.9 169.6 191.1 80.1 167.0 145.5 201.0 200.7 235.8 83.5 95.4 198.2 202.4 146.6 90.1 111.6 250.1 102.7 113.5 362.3 90.1 254.6 260.5 174.9 140.7 109.4 237.8 174.7 188.1 105.9 129.0 171.0 136.6 140.9 154.2 157.9 406.2 193.6 145.9 152.6 133.8 441.8 105.7 94.9 160.5 177.1 221.3 108.6 132.4 115.1 130.8 172.5 89.2 120.0 139.0 118.4 221.9 89.2 239.4 227.5 172.3 240.3 144.4 132.3 157.6 121.8 264.1 220.1 275.7 211.0 238.2 240.4 333.2 270.7 248.4 202.2 321.1 318.1 289.7 107.1 184.7 214.3 289.4 337.9 496.3 141.9 144.8 147.7 211.2 139.9 146.4 146.5 141.4 136.1 148.5 144.0 147.3 145.4 167.0 115.4 97.8 13.7 205.2 291.1 260.1 349.2 147.4 50.5 258.7 352.9 263.3 213.1 207.8 268.5 22.9 218.6 176.5 230.1 628.0 242.5 176.8 229.3 189.8 194.4 227.3 174.0 10.5 335.2 406.3 184.4 109.6 233.0 128.7 132.4 179.9 367.5 368.2 35.3 10.2 254.3 236.0 247.1 287.1 621.4 218.7 187.5 231.3 5.6 338.9 220.3 260.6 6.6 18.8 269.6 272.8 182.4 164.1 360.5 353.9 820.0 189.3 65.9 92.1 138.5 206.0 102.6 137.0 187.7 348.5 213.0 216.0 169.8 257.5 345.2 TIMM44 TIM44 ENSG00000104980 "Translocase of inner mitochondrial membrane 44" O43615 19 7926718-7943667 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043052, HPA073108" Supported Enhanced Mitochondria NA NA 9100 Mitochondria "HPA043052: AB_10795713, HPA073108: " "unprognostic (1.75e-1)" "unprognostic (7.44e-3)" "unprognostic (2.68e-2)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-2)" "unprognostic (5.81e-3)" "unprognostic (8.78e-2)" "unprognostic (2.42e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (8.93e-2)" "unprognostic (1.80e-2)" "unprognostic (6.01e-2)" "unprognostic (6.43e-2)" "unprognostic (2.07e-2)" "unprognostic (4.18e-2)" 14.1 25.4 13.9 11.3 12.9 8.5 13.2 13.8 23.0 18.6 14.0 24.6 17.1 18.5 7.1 21.0 14.1 6.8 40.5 15.1 13.2 20.0 34.9 10.8 11.2 13.5 13.4 12.7 16.3 17.7 13.6 14.5 8.4 13.5 17.6 8.3 4.3 14.1 11.7 62.6 15.6 14.4 10.3 14.7 19.5 21.0 11.1 16.0 7.8 13.9 49.7 8.2 20.2 15.4 14.2 64.5 37.2 24.4 52.0 28.6 28.6 33.3 34.9 26.6 43.8 39.6 82.5 18.1 98.5 45.5 27.5 37.3 46.6 75.7 38.4 21.7 45.5 98.7 53.6 31.4 70.1 72.4 66.3 21.9 31.6 60.1 37.0 53.5 19.4 30.4 53.3 97.2 55.7 20.7 58.5 59.2 53.7 61.3 61.8 116.8 60.4 35.6 68.8 24.9 42.0 46.2 28.3 39.0 50.5 112.8 19.3 29.7 64.4 19.6 30.1 40.2 69.7 72.5 70.4 84.8 99.5 24.2 92.7 48.6 14.3 12.9 4.1 11.3 14.1 10.4 8.6 11.0 10.9 16.4 7.9 9.9 10.6 1.1 10.3 8.7 12.5 9.8 9.5 13.9 12.9 13.8 23.0 15.1 13.2 13.5 13.4 12.7 13.5 14.7 16.0 14.2 20.0 35.3 16.4 13.7 31.8 27.9 33.7 41.9 14.2 53.0 43.8 37.6 36.1 32.9 21.5 29.5 41.7 38.5 25.6 48.4 66.5 47.8 11.7 24.8 42.1 22.2 40.1 28.2 13.5 42.9 43.2 25.4 19.4 31.6 33.0 26.4 20.3 62.2 34.9 52.2 13.9 45.5 26.4 21.7 11.1 13.7 36.7 17.2 21.4 1.9 22.9 23.5 44.3 11.1 10.9 42.1 29.0 29.3 25.8 31.8 45.9 75.1 12.4 63.6 32.9 25.0 33.7 38.7 33.9 18.7 19.9 32.6 20.2 29.5 64.6 30.9 CCDC61 ENSG00000104983 "Coiled-coil domain containing 61" Q9Y6R9 19 45995461-46021318 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in all" "NB-4: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040325, HPA061548" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040325: AB_10672970, HPA061548: AB_2684559" "unprognostic (1.30e-1)" "unprognostic (1.51e-3)" "unprognostic (2.56e-1)" "unprognostic (6.23e-3)" "unprognostic (7.27e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" "unprognostic (2.93e-2)" "unprognostic (2.73e-2)" "unprognostic (1.34e-1)" "unprognostic (2.13e-3)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (1.09e-1)" 8.7 11.3 6.6 8.1 7.6 6.0 9.4 11.5 11.3 11.6 4.0 10.5 8.0 10.1 7.2 10.5 16.4 5.1 8.3 7.8 5.5 11.5 12.6 8.6 11.1 6.3 5.9 7.4 12.6 10.4 9.9 13.4 6.0 7.9 11.3 5.0 1.6 9.1 8.1 5.6 12.8 10.4 5.2 3.1 14.0 11.1 25.1 5.9 9.7 12.5 4.1 7.0 11.3 10.1 7.5 13.9 10.0 5.2 9.0 9.6 7.0 7.9 9.8 5.0 5.8 9.7 6.1 12.0 8.7 4.7 6.9 8.0 11.6 5.7 13.1 4.3 16.6 5.4 9.3 8.6 10.1 10.6 8.9 12.2 7.6 17.9 5.0 10.4 9.9 11.7 16.3 10.5 17.5 7.5 4.4 20.4 57.2 1.9 14.9 4.3 13.7 1.7 14.1 9.5 11.4 5.6 5.1 9.7 12.5 7.6 5.1 5.3 12.7 10.0 4.2 1.7 2.0 11.2 10.6 5.5 8.9 9.4 9.8 7.1 6.5 0.4 0.4 0.9 0.4 0.5 0.8 0.5 0.5 0.2 1.2 0.6 0.5 1.3 0.3 0.5 0.3 0.5 0.2 6.6 7.6 11.5 11.3 7.8 5.5 6.3 5.9 7.4 7.9 3.1 5.9 7.5 8.8 0.0 4.4 4.6 7.0 6.2 7.1 1.1 4.6 4.3 4.3 5.3 6.0 4.3 3.0 11.0 0.0 11.2 5.1 11.9 9.8 1.6 3.4 9.0 5.7 5.3 3.6 2.1 4.0 2.0 8.5 6.4 12.8 5.6 0.0 11.8 4.2 4.4 8.0 3.3 4.1 8.6 0.0 5.3 2.7 1.6 5.3 5.5 3.6 1.9 2.3 3.3 2.1 1.5 2.6 1.8 5.8 5.7 6.1 4.3 6.6 8.4 3.5 1.9 6.6 4.6 6.0 13.9 6.2 6.4 5.3 7.8 7.3 9.8 10.9 4.3 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031762-14053218 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.6" "Cell type enhanced" "Detected in many" "B-cells: 49.1;dendritic cells: 56.6;Kupffer cells: 41.1;Langerhans cells: 44.2;NK-cells: 69.0;T-cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles NA NA 4900000 Vesicles "HPA073441: " "prognostic favorable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 6.3 1.7 2.4 8.7 2.3 2.7 6.6 2.2 2.6 2.4 2.3 2.5 2.3 2.4 0.7 2.6 3.3 2.3 5.7 2.7 2.7 3.9 1.5 8.1 12.7 2.5 2.4 2.2 1.1 2.8 5.6 0.8 1.3 2.5 3.6 2.1 0.2 3.0 1.2 2.1 2.0 8.2 1.9 2.4 14.8 2.8 2.1 2.8 11.2 4.0 2.4 16.6 3.9 2.8 2.9 7.7 3.3 3.2 4.4 0.2 1.6 1.3 3.5 7.3 6.3 9.0 1.6 6.1 0.1 3.6 3.1 2.9 1.4 5.1 2.1 4.8 14.8 3.5 18.6 0.7 2.7 0.5 9.0 0.2 1.6 0.8 3.0 0.6 5.1 2.5 4.6 13.1 13.5 0.3 10.7 6.8 19.5 4.2 4.5 2.2 5.8 1.9 7.1 3.9 1.8 2.8 1.5 4.5 0.3 5.2 1.7 5.6 5.4 4.0 0.6 7.7 6.4 3.8 13.9 7.2 6.7 0.6 18.2 4.2 7.9 22.5 0.6 24.3 18.4 21.4 15.6 24.0 20.2 20.7 12.8 26.1 20.6 1.6 22.9 9.5 7.6 23.1 21.4 2.4 2.3 2.2 2.6 2.7 2.7 2.5 2.4 2.2 2.5 2.4 2.8 2.9 30.4 0.0 10.0 0.0 49.1 1.9 13.3 8.5 3.4 0.3 14.0 11.9 5.4 5.7 5.7 3.7 0.0 0.6 56.6 0.7 0.0 10.7 0.4 1.9 1.2 22.8 2.4 7.2 2.4 2.7 1.4 4.0 3.6 1.5 17.7 1.4 22.9 0.7 21.4 1.7 2.1 0.9 4.1 41.1 44.2 0.5 3.4 32.8 5.4 1.0 22.8 0.3 69.0 1.0 0.6 3.8 0.8 3.4 26.0 12.4 0.0 0.9 2.0 0.0 0.0 1.9 2.2 0.1 11.5 2.6 1.3 0.1 63.5 0.4 2.4 3.5 ASF1B FLJ10604 ENSG00000105011 "Anti-silencing function 1B histone chaperone" Q9NVP2 19 14119512-14136613 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.4;testis: 32.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 36.1;Early spermatids: 36.4;Erythroid cells: 43.6;Extravillous trophoblasts: 35.4;Spermatocytes: 73.2;Spermatogonia: 87.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "neutrophil: 60.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 60.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA054036, HPA069385" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA054036: AB_2682350, HPA069385: " "unprognostic (3.14e-1)" "prognostic favorable (4.45e-5)" "unprognostic (2.41e-3)" "unprognostic (2.40e-1)" "unprognostic (2.15e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.87e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.48e-3)" "prognostic unfavorable (2.22e-16)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (3.92e-2)" "unprognostic (4.31e-2)" 0.8 1.4 0.2 5.6 0.3 11.8 1.3 0.4 0.3 1.2 0.1 7.5 5.3 1.0 0.1 10.4 0.7 0.7 0.5 0.2 0.3 1.0 1.3 2.1 12.6 0.2 0.2 0.1 0.7 0.7 0.3 0.7 3.6 0.3 0.8 7.8 0.0 1.9 0.3 0.5 3.3 6.1 2.0 0.2 6.8 3.2 32.3 0.3 23.4 0.6 0.4 14.8 1.8 3.3 0.5 64.6 25.3 37.7 28.9 3.8 3.6 16.2 33.1 28.3 63.8 79.5 26.5 31.6 59.1 30.0 17.5 26.5 38.0 41.8 24.1 49.7 54.0 26.9 55.5 48.7 18.6 0.2 39.0 35.1 0.7 1.7 35.8 12.4 7.2 25.1 44.1 50.2 83.8 31.8 75.7 80.8 34.3 17.3 69.1 56.7 77.0 56.0 51.6 20.1 28.3 46.0 16.5 39.8 29.2 17.4 10.3 22.1 41.5 10.6 36.0 21.6 91.0 56.6 43.2 46.5 80.3 28.0 71.9 36.1 0.7 6.2 1.5 1.7 8.0 0.9 1.1 1.5 2.0 1.2 0.9 0.9 1.7 60.1 1.7 8.5 0.5 5.1 3.2 0.2 0.3 0.4 0.3 0.2 0.3 0.2 0.2 0.1 0.3 0.2 0.3 0.5 1.0 0.0 0.6 0.3 5.6 2.5 2.4 4.5 1.2 0.1 4.8 8.5 1.2 1.5 1.1 0.0 0.0 36.1 3.8 11.7 0.0 1.0 36.4 2.1 1.3 2.1 1.2 43.6 0.5 1.2 35.4 4.1 23.4 2.3 4.5 9.2 0.4 0.3 21.5 0.0 0.4 9.9 8.2 5.6 5.6 29.1 0.0 5.0 1.8 1.0 2.1 0.3 4.1 0.0 0.5 1.1 2.2 0.7 20.1 1.0 2.4 0.3 0.2 0.9 0.0 1.1 3.3 73.2 87.8 8.3 1.1 10.4 5.3 3.0 20.9 2.4 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132698-55149206 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 29 "skeletal muscle: 21770.2;tongue: 13491.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "eosinophil: 211.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 211.5" "Cell line enhanced" "Detected in many" "HMC-1: 829.4;RH-30: 638.8" "Region enriched" "Detected in many" 5 "thalamus: 125.0" "Region enhanced" "Detected in all" "thalamus: 23.1" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 79000 "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: AB_2683720" "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavorable (4.66e-4)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 4.9 1.2 36.6 0.4 39.4 3.3 5.0 38.5 55.8 1.1 31.1 2.2 1.0 1.1 1.0 598.6 8.5 1.0 168.7 38.4 33.9 1.3 2.5 8.3 0.4 32.1 34.6 39.0 1.5 2.6 2.3 8.5 6.0 34.5 202.1 0.6 0.6 172.6 0.4 21770.2 47.6 2.0 0.4 30.3 1.9 2.0 10.7 35.1 3.4 3.8 13491.2 2.0 1.8 5.8 38.5 178.4 102.3 1.0 22.4 0.0 1.7 33.3 8.0 30.1 11.1 32.7 37.9 115.8 2.6 66.5 3.2 88.8 88.5 24.0 76.0 9.4 11.8 192.2 33.6 11.8 6.7 3.7 2.7 829.4 36.6 121.3 3.4 127.0 125.7 0.5 35.1 171.7 158.6 10.3 168.0 3.4 0.3 21.4 45.0 202.1 113.9 638.8 21.2 26.5 5.8 6.6 49.3 10.7 1.3 57.9 8.5 106.3 102.7 2.9 163.6 238.9 6.5 12.4 1.2 7.0 8.8 171.8 26.4 50.9 2.4 39.4 211.5 0.3 21.7 0.3 0.2 0.3 0.3 37.4 0.4 0.3 0.4 1.9 0.6 10.2 0.9 0.1 12.2 36.6 39.4 38.5 55.8 38.4 33.9 32.1 34.6 39.0 34.5 30.3 35.1 38.5 0.0 0.0 0.0 0.7 0.3 61.2 0.6 25.1 47.8 4.5 0.5 5.3 51.5 0.0 2.8 0.0 0.0 2.2 0.0 0.5 0.0 2.1 2.1 9.7 0.3 2.6 2.4 2.7 0.4 0.0 18.0 18.8 0.0 3.4 0.0 22.1 1.4 0.0 12.9 0.0 0.7 0.3 0.0 13.2 3.8 10.7 0.3 8.9 3.6 0.0 25.8 0.7 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.7 0.0 192.0 3.5 4.3 34.1 2.5 30.4 3.6 1.6 1.2 0.8 0.2 VRK3 ENSG00000105053 "VRK serine/threonine kinase 3" Q8IV63 19 49976468-50025946 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 136.7" "Group enriched" "Detected in all" 7 "Early spermatids: 557.6;Late spermatids: 1646.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056489 Approved Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056489: AB_2683150" "unprognostic (2.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-1)" "unprognostic (4.94e-3)" "unprognostic (1.23e-1)" "unprognostic (2.22e-3)" "unprognostic (9.78e-2)" "unprognostic (3.47e-1)" "unprognostic (8.79e-2)" "unprognostic (2.48e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.83e-4)" "unprognostic (9.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.66e-4)" 16.6 23.5 26.1 17.7 26.4 23.8 17.9 26.1 28.9 18.1 28.8 22.1 26.1 16.0 19.7 17.7 33.5 21.1 16.5 25.4 27.1 36.1 35.8 17.1 28.7 27.7 27.6 24.4 21.4 22.3 16.0 20.8 17.0 29.3 20.4 22.2 65.4 22.1 15.5 27.1 16.7 33.2 14.2 25.4 26.2 21.7 136.7 27.5 36.0 19.9 17.5 25.9 18.2 16.9 30.4 31.0 31.3 22.6 24.5 29.2 26.9 23.3 21.7 25.7 31.6 34.5 16.8 33.7 37.1 15.2 21.2 22.1 22.5 21.3 18.6 25.5 32.6 43.5 28.9 20.4 29.4 21.9 36.7 48.7 24.2 27.3 18.3 19.2 28.4 26.5 39.9 35.8 53.7 23.2 13.0 49.7 24.5 12.2 54.6 26.7 39.3 23.9 47.6 27.2 32.2 25.3 12.3 21.5 26.0 24.7 20.0 23.9 38.5 20.2 32.2 18.6 13.1 17.1 34.3 47.4 19.6 25.8 22.3 22.5 110.0 42.8 81.1 53.7 46.1 43.3 58.9 48.7 51.9 47.9 53.3 49.2 45.3 112.5 82.7 55.1 45.4 76.1 48.4 26.1 26.4 26.1 28.9 25.4 27.1 27.7 27.6 24.4 29.3 25.4 27.5 30.4 19.6 6.4 28.6 10.1 26.6 6.6 16.0 27.2 6.8 34.3 17.9 14.5 8.4 24.3 29.8 14.7 143.9 43.8 27.9 49.9 31.3 31.0 557.6 50.7 12.0 16.0 22.2 38.7 13.9 32.7 38.6 15.5 18.8 26.8 18.3 24.1 28.5 44.5 34.8 32.0 15.9 35.4 34.6 25.4 9.3 1646.8 22.1 22.9 14.2 6.5 40.6 33.2 41.2 10.1 15.3 34.2 67.9 25.9 18.6 20.6 87.5 91.4 71.8 116.0 13.1 12.0 15.2 142.8 52.6 10.5 10.9 57.3 28.0 24.9 36.0 30.1 FAM32A "DKFZP586O0120, OTAG-12" ENSG00000105058 "Family with sequence similarity 32 member A" Q9Y421 19 16185380-16192046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051712 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051712: AB_2681582" "unprognostic (3.20e-2)" "unprognostic (1.44e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-3)" "unprognostic (1.23e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (1.37e-2)" "unprognostic (3.86e-3)" "unprognostic (1.18e-3)" "unprognostic (1.56e-1)" "unprognostic (9.31e-2)" "unprognostic (3.23e-2)" "unprognostic (4.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (6.49e-3)" 63.9 70.5 64.1 48.6 65.9 95.5 57.6 60.0 69.8 43.8 57.5 69.3 78.9 57.7 49.9 70.2 45.7 54.3 50.5 64.9 62.4 61.2 96.1 51.8 61.4 61.0 62.5 63.3 43.7 53.3 54.5 38.1 61.9 61.7 50.4 58.3 28.4 56.8 47.9 51.2 72.0 75.6 53.4 59.4 68.2 69.5 30.9 65.7 64.7 49.0 49.5 60.0 64.0 50.3 64.3 102.8 76.7 118.3 76.8 137.1 104.7 111.8 97.1 109.8 117.5 128.3 106.1 120.4 67.6 165.2 126.4 84.4 76.8 122.4 106.2 102.6 89.6 134.2 125.5 66.2 95.6 110.4 159.4 141.0 121.6 109.4 94.5 86.2 103.8 128.4 137.2 100.2 96.6 117.6 136.0 124.4 165.9 170.6 168.9 187.7 129.3 81.9 111.6 129.6 100.6 101.6 154.3 82.3 77.2 107.8 84.5 65.5 179.5 120.5 90.8 53.9 167.4 123.5 114.5 204.5 107.8 132.0 191.7 80.2 278.1 266.5 547.9 127.5 339.2 136.3 152.9 122.0 140.3 228.8 159.1 146.2 160.5 220.6 161.5 390.0 157.5 185.6 343.3 64.1 65.9 60.0 69.8 64.9 62.4 61.0 62.5 63.3 61.7 59.4 65.7 64.3 59.2 44.8 46.2 3.3 54.7 46.7 32.4 61.7 40.9 26.8 56.5 51.9 36.8 55.8 45.6 36.8 20.9 100.9 65.3 119.8 92.0 102.1 17.9 39.5 56.5 58.7 67.8 49.6 6.2 103.5 108.2 52.5 40.2 53.3 62.7 55.0 45.7 99.8 86.5 42.1 6.9 63.8 34.6 75.5 45.8 40.7 38.8 57.2 58.7 6.5 93.4 56.4 84.5 7.1 7.1 136.4 157.3 52.3 49.1 49.6 120.1 85.5 37.8 24.5 26.3 27.9 61.0 26.5 44.3 47.7 53.3 105.8 53.5 56.0 59.6 54.8 PPP6R1 "KIAA1115, SAP190, SAPS1" ENSG00000105063 "Protein phosphatase 6 regulatory subunit 1" Q9UPN7 19 55229779-55259017 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 237.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 28.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043989, HPA063681" Approved Enhanced Cytosol No No 19000 Cytosol "HPA043989: AB_10987309, HPA063681: AB_2685087" "unprognostic (1.15e-1)" "unprognostic (2.34e-1)" "unprognostic (1.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.82e-6)" "unprognostic (2.22e-2)" "unprognostic (5.44e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-3)" "unprognostic (1.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.65e-2)" "unprognostic (3.30e-2)" "unprognostic (2.20e-1)" 22.0 37.1 30.0 53.2 30.4 97.2 20.5 7.0 34.6 21.6 15.9 28.2 38.5 25.9 5.2 35.5 26.9 24.0 25.8 39.3 10.8 23.9 25.7 28.5 83.0 16.0 13.0 23.9 21.2 20.5 22.8 29.9 21.4 17.0 23.7 12.3 8.9 24.3 21.6 39.0 28.6 42.8 18.6 6.3 62.0 43.0 90.4 13.3 62.8 27.5 20.4 49.7 33.7 23.6 16.6 101.2 143.4 28.7 46.1 33.5 30.8 73.1 63.1 54.7 64.8 55.2 95.4 67.9 261.0 33.7 56.6 48.2 48.2 10.3 65.9 25.1 98.2 241.8 198.5 71.8 71.0 57.5 295.9 187.6 45.4 37.4 64.5 43.4 34.7 42.2 178.7 105.5 112.1 42.5 64.5 218.1 105.5 39.3 82.2 116.5 131.8 56.4 216.0 45.9 126.6 81.8 45.5 58.7 69.7 62.2 24.6 38.3 219.7 55.3 101.3 49.7 39.4 96.4 55.4 108.7 184.1 92.4 240.5 79.1 0.0 2.8 6.5 11.7 3.9 6.6 3.3 4.8 9.3 4.0 2.7 4.9 7.5 3.1 7.8 3.4 28.6 3.6 6.8 30.0 30.4 7.0 34.6 39.3 10.8 16.0 13.0 23.9 17.0 6.3 13.3 16.6 14.7 12.8 19.8 11.1 27.2 2.8 8.9 1.0 11.4 16.3 14.2 10.4 2.6 18.6 6.2 18.4 10.4 11.1 66.2 21.7 0.0 21.2 237.3 36.3 13.6 15.8 15.1 41.4 14.4 28.7 9.3 9.7 50.4 19.7 7.6 19.7 16.1 22.3 32.4 30.3 10.6 15.7 2.0 31.2 4.8 55.3 18.6 34.0 0.0 9.4 21.9 14.7 51.5 6.0 11.3 47.3 18.8 19.5 27.0 22.1 34.2 12.3 12.6 15.3 19.7 12.5 10.7 38.5 41.0 13.9 3.4 11.4 39.6 31.3 14.2 50.7 C19orf44 FLJ21742 ENSG00000105072 "Chromosome 19 open reading frame 44" Q9H6X5 19 16496394-16521352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 46.7;Late spermatids: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041683, HPA049414" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA041683: AB_10793929, HPA049414: AB_2680754" "unprognostic (2.16e-1)" "unprognostic (2.16e-2)" "unprognostic (1.25e-1)" "unprognostic (8.52e-2)" "unprognostic (2.05e-1)" "unprognostic (8.38e-3)" "unprognostic (1.83e-1)" "unprognostic (4.19e-2)" "unprognostic (6.45e-2)" "unprognostic (1.36e-1)" "unprognostic (2.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.04e-1)" "unprognostic (7.02e-2)" "unprognostic (7.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.90e-1)" 3.0 2.7 4.1 1.8 3.9 3.2 3.4 3.5 5.4 5.3 5.0 4.1 1.9 5.0 2.9 2.8 6.0 3.8 3.3 3.8 4.9 4.3 2.8 2.6 2.2 3.9 3.8 3.1 8.1 4.2 5.6 5.3 2.1 3.3 4.9 1.5 3.7 5.9 4.4 4.7 4.3 2.3 3.4 2.9 2.5 3.3 14.7 3.4 3.5 4.9 2.8 1.9 4.4 3.7 3.7 4.7 4.9 5.1 6.4 3.3 6.1 5.4 3.6 3.5 4.5 6.6 3.0 6.5 3.6 6.9 2.9 3.0 3.9 3.9 3.1 3.4 2.5 10.0 1.4 8.0 4.6 4.4 2.0 2.2 3.3 3.1 5.7 4.3 8.8 2.5 5.5 5.7 1.5 2.9 6.6 3.6 5.7 3.0 6.3 7.3 3.5 2.3 5.9 4.7 1.8 5.9 3.2 4.1 5.6 3.3 4.4 5.7 2.9 4.4 6.2 3.5 5.9 5.7 4.3 3.3 2.5 4.6 2.0 5.4 3.5 0.5 0.1 0.5 0.3 0.1 1.5 0.6 0.2 0.2 1.1 0.6 1.0 1.0 0.3 0.8 0.4 0.2 0.4 4.1 3.9 3.5 5.4 3.8 4.9 3.9 3.8 3.1 3.3 2.9 3.4 3.7 1.7 0.0 5.6 9.4 2.5 0.4 1.0 1.3 1.2 3.4 2.1 2.3 3.7 2.8 4.8 7.3 12.5 1.9 1.1 0.8 0.0 1.8 46.7 9.9 6.0 2.5 7.2 2.1 3.9 1.2 1.8 3.1 2.6 5.4 0.0 6.7 1.4 1.7 0.8 0.0 4.8 1.6 0.0 0.6 1.0 72.6 3.1 0.9 0.0 5.6 1.3 2.7 0.0 0.5 2.9 1.1 1.6 5.3 1.2 0.7 0.4 3.4 6.6 8.4 0.0 3.7 2.9 10.9 2.1 1.6 0.4 0.5 0.9 4.1 1.2 0.3 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.2" "Cell type enhanced" "Detected in many" "Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 4.5 3.8 4.1 3.8 3.5 11.1 4.1 4.6 4.3 4.0 3.0 3.9 2.4 4.3 1.8 5.3 3.2 2.4 3.2 4.8 3.7 2.5 3.7 4.0 4.9 4.8 3.7 3.1 4.7 3.9 3.5 3.7 3.2 4.9 4.2 1.9 2.0 4.6 2.4 7.0 6.1 3.7 2.5 3.5 4.8 3.6 36.2 4.4 4.4 3.2 3.3 4.6 3.9 4.6 3.9 11.1 4.2 3.8 8.3 4.8 3.8 11.1 6.3 4.4 6.7 6.0 6.3 6.5 17.6 6.5 4.0 2.1 8.2 5.9 6.3 4.6 13.0 12.2 6.9 4.2 5.1 4.7 7.9 6.3 4.6 6.1 5.7 5.9 4.0 3.6 9.1 11.5 20.7 4.2 11.1 8.4 7.4 9.0 5.2 13.4 8.7 5.8 19.3 4.0 4.3 10.0 5.4 5.5 5.3 6.4 2.7 3.9 10.3 4.5 8.5 6.8 10.4 8.5 14.3 12.6 14.4 6.0 10.4 5.0 0.7 0.1 0.1 0.5 0.3 0.1 0.4 0.0 0.2 0.2 0.7 0.3 0.0 0.3 0.4 0.1 1.4 0.7 0.1 4.1 3.5 4.6 4.3 4.8 3.7 4.8 3.7 3.1 4.9 3.5 4.4 3.9 13.7 3.2 12.7 11.4 11.8 14.1 5.0 3.8 11.4 4.2 14.3 12.2 1.1 2.8 3.0 5.5 10.4 6.2 15.8 5.9 3.9 4.4 65.4 12.9 7.7 6.1 2.4 5.0 8.6 4.0 11.1 7.0 5.6 16.6 1.3 5.8 4.2 5.6 5.0 5.0 7.6 4.7 2.0 8.5 10.7 67.4 6.5 9.9 1.8 1.9 4.9 6.0 4.1 7.1 8.5 6.0 3.0 3.8 15.9 6.7 3.6 2.0 3.5 6.4 0.0 17.7 8.0 54.1 19.4 11.5 10.7 16.8 11.0 6.1 5.1 8.7 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 204.2;skin 1: 95.5" "Cell type enhanced" "Detected in many" "Astrocytes: 108.4;Basal keratinocytes: 125.0;Muller glia cells: 91.1;Oligodendrocyte precursor cells: 124.7;Suprabasal keratinocytes: 118.1" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 49.7" "Group enriched" "Detected in many" 26 "granulocytes: 49.7;T-cells: 17.0" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;ASC diff: 23.4;BJ hTERT+: 18.5;SH-SY5Y: 24.3;U-2 OS: 28.7;WM-115: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA 2700000 Nucleoplasm "HPA049961: AB_2680972, HPA057771: AB_2683524" "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 37.2 30.9 123.3 3.4 118.6 0.2 25.2 108.1 204.2 15.7 72.6 4.2 2.2 16.8 4.6 5.7 11.2 6.7 7.2 122.5 112.4 2.3 42.3 10.2 7.9 141.7 161.4 115.7 9.8 11.3 9.7 19.3 7.1 132.5 10.1 1.1 24.8 10.1 13.6 1.8 95.5 3.8 6.8 119.9 2.5 2.3 10.8 115.5 16.6 13.3 1.0 4.8 3.0 14.2 125.1 0.0 3.7 3.0 25.6 23.4 14.3 1.7 5.6 18.5 1.2 1.5 0.3 2.4 0.1 2.3 4.2 2.1 1.5 9.8 1.7 0.1 0.1 2.1 0.0 0.2 0.3 0.1 0.0 4.3 7.5 1.5 0.1 0.2 0.7 0.1 4.8 0.3 0.3 0.0 8.2 0.3 0.2 15.8 2.5 0.0 0.1 0.0 0.0 0.0 0.9 0.1 24.3 0.9 0.1 5.2 9.7 0.9 0.0 0.3 10.5 28.7 0.1 0.1 0.0 0.0 0.0 0.3 0.0 25.6 21.2 0.0 49.7 6.2 0.0 6.6 0.0 7.0 5.5 0.0 0.0 13.5 8.9 0.5 1.2 0.0 0.1 17.0 2.9 123.3 118.6 108.1 204.2 122.5 112.4 141.7 161.4 115.7 132.5 119.9 115.5 125.1 12.9 0.0 0.0 108.4 0.3 125.0 4.7 5.9 8.6 4.9 6.9 13.8 0.8 7.2 0.4 7.3 0.0 0.1 1.0 0.1 1.9 0.9 8.6 0.9 2.2 4.3 1.2 0.4 27.3 2.4 0.0 17.2 0.0 1.0 4.5 6.5 1.4 24.7 0.3 1.7 51.0 0.2 2.0 0.3 32.6 52.8 13.7 0.6 17.8 15.0 0.4 91.1 7.2 124.7 3.5 4.1 0.0 9.8 0.5 7.9 0.0 0.2 0.2 3.7 0.0 7.4 24.3 3.0 10.4 1.4 118.1 0.1 7.7 0.6 0.1 2.9 RASAL3 FLJ21438 ENSG00000105122 "RAS protein activator like 3" Q86YV0 19 15451624-15464544 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 23.8;intestine: 20.0;lung: 10.7;lymphoid tissue: 39.7" "Cell type enhanced" "Detected in many" "B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043417 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA043417: AB_2678473" "unprognostic (2.72e-2)" "prognostic favorable (8.75e-4)" "unprognostic (3.27e-2)" "prognostic favorable (3.58e-5)" "unprognostic (2.31e-1)" "prognostic favorable (3.07e-4)" "unprognostic (1.82e-2)" "unprognostic (6.21e-3)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (3.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.98e-1)" "unprognostic (1.90e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" 2.9 2.6 2.6 17.5 2.8 23.8 1.9 3.0 3.7 1.8 3.0 2.9 4.6 1.5 0.7 2.8 2.2 3.6 1.3 2.7 3.8 3.7 3.7 10.7 33.0 4.0 3.3 2.2 0.9 1.4 1.2 1.5 1.0 3.8 2.9 2.3 0.1 3.5 0.9 0.7 1.5 20.0 1.2 4.4 39.7 5.4 0.5 3.9 24.1 3.9 0.4 19.5 4.2 2.3 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 6.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 30.6 0.0 25.5 0.0 0.0 0.4 20.4 46.7 0.1 0.0 0.0 0.0 0.0 0.2 8.0 0.0 52.5 0.0 0.4 10.9 27.8 0.0 0.0 0.0 3.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.7 35.5 0.0 0.0 0.0 0.0 0.4 10.1 15.1 0.0 34.1 0.1 6.4 2.3 12.9 18.4 4.7 10.7 3.1 11.7 20.4 3.4 3.5 9.7 11.8 3.4 12.4 12.8 4.2 9.2 5.5 2.6 2.8 3.0 3.7 2.7 3.8 4.0 3.3 2.2 3.8 4.4 3.9 4.2 4.1 3.2 5.6 0.0 39.4 0.3 0.0 0.3 0.0 0.0 2.0 2.2 2.5 2.8 1.4 0.0 0.0 0.2 70.9 0.0 0.0 0.2 0.7 5.4 0.4 5.4 0.0 7.4 0.1 0.6 0.2 1.0 2.6 0.4 39.3 0.0 3.9 4.6 11.3 0.0 0.1 0.0 0.0 11.6 3.5 1.7 0.0 17.2 0.0 13.1 14.2 0.1 139.0 0.5 0.1 0.2 0.0 1.2 23.7 0.2 0.0 1.5 5.7 0.1 0.0 0.5 1.5 0.4 0.6 0.3 0.6 0.4 76.7 1.0 0.2 0.1 AKAP8 "AKAP95, DKFZp586B1222" ENSG00000105127 "A-kinase anchoring protein 8" O43823 19 15353385-15379815 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004776 Supported Supported Nucleoplasm NA NA 10000 Nucleoplasm "HPA004776: AB_1078122" "unprognostic (9.04e-3)" "unprognostic (3.67e-3)" "unprognostic (1.03e-1)" "unprognostic (4.17e-2)" "unprognostic (8.03e-2)" "unprognostic (1.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.17e-2)" "unprognostic (3.34e-3)" "unprognostic (1.27e-1)" "unprognostic (2.82e-1)" "unprognostic (1.78e-3)" "unprognostic (5.04e-3)" "unprognostic (1.22e-2)" "unprognostic (3.57e-1)" "unprognostic (6.06e-2)" "unprognostic (3.83e-2)" 12.3 10.5 0.0 1.5 0.1 3.1 12.4 0.3 1.0 10.2 0.1 11.4 5.4 12.4 0.0 11.7 11.1 0.0 9.2 0.1 0.1 8.8 12.6 10.4 0.3 0.2 0.1 0.0 10.9 10.6 1.5 7.5 0.4 0.3 9.5 0.1 0.3 11.3 1.1 23.2 14.6 13.0 0.4 0.0 13.5 10.8 7.5 0.1 1.8 10.2 2.5 0.2 10.8 10.3 0.2 18.2 12.2 8.4 5.6 2.6 2.3 12.2 10.1 7.1 7.2 7.2 19.4 10.6 19.9 10.2 8.9 6.8 8.5 5.1 12.3 0.4 17.9 12.8 21.1 11.7 18.8 4.3 28.0 8.0 4.5 2.7 7.8 0.0 0.6 7.3 11.5 15.1 6.4 2.3 23.7 15.1 5.7 17.8 9.7 15.8 12.1 12.3 16.8 0.0 22.5 10.5 11.4 13.0 9.9 8.9 1.5 4.3 2.2 18.8 12.4 10.1 7.0 21.0 12.9 12.8 21.0 9.8 10.4 11.5 0.0 4.4 0.9 4.4 4.6 4.7 3.8 4.0 4.8 6.5 4.2 2.9 3.6 0.3 4.1 6.3 4.4 5.6 3.0 0.0 0.1 0.3 1.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.2 25.6 12.8 28.1 17.0 24.6 19.2 21.0 14.5 19.9 14.7 16.0 14.7 18.0 10.0 22.3 12.9 27.1 30.0 25.9 26.0 5.9 18.9 3.6 22.8 24.1 20.9 10.8 28.2 14.4 21.6 23.9 17.6 20.9 39.9 30.4 14.3 10.4 13.8 13.1 21.9 14.0 21.9 2.0 13.5 16.1 2.7 19.0 19.8 12.4 10.3 21.3 16.5 12.3 12.1 15.3 18.6 13.1 13.9 25.6 16.7 14.8 9.7 22.1 19.5 6.6 26.3 22.5 19.6 23.2 21.3 16.1 40.2 25.6 15.4 22.6 20.9 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "esophagus: 69.5;lymphoid tissue: 26.9;skin 1: 76.3;vagina: 36.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 19 "dendritic cells: 1.3;monocytes: 2.4" "Cell line enhanced" "Detected in some" "EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favorable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.4 0.3 0.7 0.2 0.7 0.2 1.5 0.6 0.8 7.6 0.6 0.2 0.2 0.5 0.3 69.5 1.7 1.3 0.5 0.7 0.9 1.8 0.3 1.8 0.1 0.8 0.7 0.6 0.7 0.2 3.1 1.8 0.4 0.7 1.5 0.2 0.2 7.7 0.9 0.4 76.3 0.3 0.4 0.7 2.6 0.8 2.1 0.7 1.7 0.4 0.1 26.9 8.7 36.9 0.8 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.2 2.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 2.3 8.4 0.3 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.0 0.2 0.7 0.7 0.6 0.8 0.7 0.9 0.8 0.7 0.6 0.7 0.7 0.7 0.8 0.2 0.0 1.1 0.0 0.2 7.0 2.6 15.5 0.0 0.4 0.9 0.6 0.5 5.7 19.3 5.5 0.0 1.6 0.0 0.1 1.9 0.5 0.2 0.7 0.4 0.6 0.0 0.0 0.1 0.0 3.4 0.6 0.0 1.7 0.0 0.4 1.1 0.0 0.6 0.0 0.1 0.1 2.0 3.2 1.4 0.0 0.0 1.5 0.0 0.0 0.6 2.5 0.0 0.0 0.1 0.6 0.0 0.0 0.0 2.6 0.2 0.0 3.3 0.0 0.0 0.8 2.5 4.6 2.1 30.7 43.3 2.6 0.2 0.2 0.1 23.3 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125786 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 148.2;Syncytiotrophoblasts: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA067682: AB_2685885" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 28.7 45.9 21.6 14.0 25.5 15.7 27.7 29.6 25.3 27.3 28.3 45.3 50.6 24.5 14.6 41.2 22.8 25.8 67.8 20.2 24.4 41.7 57.3 19.4 15.7 27.9 24.1 20.4 28.6 42.8 66.4 34.6 19.4 25.0 24.4 18.8 14.0 27.9 23.4 18.9 41.9 44.1 13.8 25.2 17.7 41.5 25.7 23.8 10.6 48.5 25.3 10.7 28.7 30.8 31.5 68.8 41.0 34.4 40.7 43.8 29.7 39.6 31.6 42.2 37.2 47.5 65.5 162.1 29.7 61.1 34.2 22.3 50.6 20.9 38.5 10.8 27.5 41.1 43.7 41.3 72.4 70.1 37.2 37.0 44.6 43.9 21.7 28.3 30.4 35.0 29.6 17.9 37.6 29.3 159.0 24.9 29.6 31.9 54.9 58.8 36.0 31.1 46.5 32.3 33.6 28.4 38.3 18.8 81.2 62.1 13.2 37.2 31.2 37.7 55.9 30.7 71.0 45.1 26.1 29.2 15.1 35.9 35.8 43.1 22.7 22.2 5.5 21.1 31.8 24.0 11.9 17.7 22.0 26.3 12.9 22.9 23.6 2.5 23.7 30.3 19.1 20.2 23.3 21.6 25.5 29.6 25.3 20.2 24.4 27.9 24.1 20.4 25.0 25.2 23.8 31.5 28.0 25.6 11.7 18.3 12.7 12.7 26.8 53.8 22.2 95.3 18.0 14.9 36.1 62.9 43.0 25.8 27.1 84.2 15.8 67.8 19.6 48.4 6.2 9.9 13.4 23.2 44.4 12.6 4.9 50.6 148.2 21.4 40.2 13.0 11.4 29.0 26.7 59.3 43.2 18.5 8.3 60.6 28.5 12.1 9.5 6.5 25.7 15.8 83.6 5.6 6.8 48.0 7.2 9.0 15.7 32.3 68.4 19.9 17.2 18.6 123.0 50.4 26.1 36.8 19.7 14.7 21.2 20.3 20.8 25.0 16.2 253.4 11.8 48.2 73.2 23.4 ZNF419 "ZAPHIR, ZNF419A" ENSG00000105136 "Zinc finger protein 419" Q96HQ0 19 57487711-57496098 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 31.9" "HPA003152, HPA003274" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716, HPA003274: AB_1080714" "unprognostic (3.50e-2)" "unprognostic (1.40e-5)" "unprognostic (1.12e-1)" "unprognostic (2.63e-2)" "unprognostic (2.55e-2)" "unprognostic (8.26e-2)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (3.18e-1)" "unprognostic (1.33e-1)" "unprognostic (8.55e-5)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.20e-1)" "unprognostic (2.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.53e-5)" 5.7 8.7 9.6 4.7 10.0 3.0 6.2 10.5 12.7 4.8 9.3 5.6 3.8 5.3 9.8 4.7 6.3 3.6 7.2 10.0 9.2 8.1 6.7 7.1 7.5 9.3 9.2 9.7 7.9 4.7 9.1 13.5 6.2 9.7 9.0 3.7 11.2 6.4 6.4 10.5 7.4 6.2 4.1 8.8 10.7 5.3 5.4 9.4 8.1 10.9 7.8 8.9 5.5 4.7 10.3 5.4 6.0 10.3 10.5 4.7 7.1 8.9 6.4 8.8 5.8 31.9 3.8 3.4 1.8 5.1 4.5 5.2 1.6 4.9 13.3 8.0 0.5 22.4 8.3 9.1 4.2 16.8 6.5 6.0 9.7 19.3 5.8 13.8 12.0 6.4 8.0 0.9 1.3 7.3 0.9 10.9 6.7 6.8 0.7 7.9 10.1 9.9 7.6 6.3 11.5 8.4 9.4 6.5 6.0 6.2 8.8 5.3 9.7 6.6 7.0 7.7 2.5 5.6 15.2 18.0 4.5 5.6 3.5 5.7 4.5 2.7 6.1 5.2 3.3 8.9 14.3 8.9 6.6 4.7 15.8 13.8 7.4 3.2 9.7 2.7 3.4 6.5 4.4 9.6 10.0 10.5 12.7 10.0 9.2 9.3 9.2 9.7 9.7 8.8 9.4 10.3 3.1 0.0 5.3 3.6 7.2 4.1 5.7 4.9 2.8 8.1 4.3 5.2 5.3 4.3 5.2 7.3 6.2 5.0 4.2 1.3 0.0 5.8 0.3 2.0 2.1 4.8 1.2 2.5 3.3 1.8 2.4 3.7 0.5 1.7 4.5 7.4 5.7 4.6 3.2 10.1 2.8 1.8 8.2 3.2 1.7 0.5 1.8 1.8 5.4 0.0 4.1 6.8 7.2 3.5 1.9 2.5 2.8 5.7 1.6 9.0 2.0 1.9 1.8 9.5 6.6 2.9 3.3 4.9 10.4 2.1 3.8 8.3 4.8 4.2 1.8 5.6 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107401-15114985 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 140.3;Peritubular cells: 42.2;Sertoli cells: 85.5;Syncytiotrophoblasts: 134.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 107.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 22.0 12.7 7.3 5.7 6.9 0.0 17.7 7.0 7.9 27.3 13.6 22.2 3.9 33.2 4.7 6.6 23.4 5.8 19.6 6.1 11.7 16.4 5.0 18.3 3.5 8.9 7.0 4.9 23.7 6.0 2.5 6.8 15.5 6.9 18.3 2.5 1.4 6.2 11.6 5.5 7.9 11.8 10.9 7.2 13.1 13.6 4.8 7.5 0.9 12.5 3.9 1.4 24.1 18.9 7.7 11.2 17.4 9.0 23.9 19.9 18.2 7.1 46.9 33.7 44.4 37.5 4.1 7.0 0.0 30.3 46.5 15.2 7.0 7.0 8.1 24.6 0.3 8.0 1.6 34.2 7.6 37.7 0.1 0.1 32.1 5.9 26.6 12.0 26.8 8.2 0.0 0.0 0.1 33.6 5.9 0.0 0.0 14.7 0.3 17.3 0.0 22.4 0.2 11.1 1.8 0.3 17.8 25.9 15.9 31.6 8.7 1.9 1.2 17.5 107.3 32.8 49.6 50.4 0.1 0.3 0.2 29.3 0.1 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 6.9 7.0 7.9 6.1 11.7 8.9 7.0 4.9 6.9 7.2 7.5 7.7 18.6 3.2 1.1 3.6 0.2 2.4 0.8 1.2 1.8 0.3 0.9 3.2 4.1 1.5 0.8 1.8 0.0 7.6 0.0 0.0 0.0 4.7 10.0 0.7 13.6 15.2 0.0 0.0 0.0 0.4 140.3 16.2 0.0 0.5 0.0 12.8 20.0 0.3 3.4 1.7 0.0 0.0 0.0 1.0 2.7 19.3 29.5 0.6 14.2 6.5 0.0 20.0 0.0 1.0 0.2 1.7 0.0 42.2 0.0 0.5 0.0 6.1 0.1 0.8 85.5 10.7 30.8 3.1 0.6 0.3 2.6 134.5 0.4 7.5 0.0 0.2 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049480-15058293 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "skin 1: 489.9" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 96.0" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "hTCEpi: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010059, HPA027062" Enhanced Supported Nucleoplasm,Mitochondria,Cytosol NA NA 3600000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: AB_2672101" "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.3 0.0 0.1 0.0 0.3 0.4 7.9 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.8 0.0 0.1 1.1 4.3 1.4 489.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 1.0 0.0 0.0 0.0 0.0 20.0 0.9 1.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 19.1 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 2.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 96.0 0.7 0.1 0.0 0.0 0.8 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 91.5;testis: 28.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enhanced" "Detected in all" "cerebellum: 91.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3" "Region enriched" "Detected in all" 6 "cerebellum: 136.3" "Region enhanced" "Detected in all" "cerebellum: 53.8" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.1 0.2 8.6 0.2 11.1 0.9 0.4 91.5 15.1 0.1 1.3 0.2 0.3 0.4 1.7 0.1 0.2 0.2 0.2 15.2 7.4 0.1 0.2 0.2 0.3 3.9 7.3 10.2 0.3 0.6 0.9 0.3 0.7 29.7 0.5 0.3 2.3 0.4 0.5 0.3 8.3 0.3 0.2 2.5 0.4 0.2 28.2 6.3 0.2 0.3 0.1 0.3 0.1 0.1 5.7 0.1 0.1 0.3 0.4 0.2 0.2 0.9 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.4 7.4 0.2 0.1 0.2 0.1 0.2 0.4 0.3 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.6 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.2 0.2 2.8 0.0 1.1 0.3 0.1 0.0 0.3 1.1 0.3 0.1 0.5 0.1 28.3 0.1 0.3 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 8.6 11.1 91.5 15.1 15.2 7.4 3.9 7.3 10.2 29.7 2.5 6.3 5.7 0.0 0.0 0.0 0.7 0.0 3.2 0.7 0.0 0.0 17.1 0.0 0.1 2.1 0.0 0.0 1.8 0.0 1.9 0.0 0.0 0.0 0.0 35.3 0.0 0.1 0.1 0.0 0.0 8.2 0.4 9.9 0.4 0.0 0.0 0.0 5.8 0.0 0.0 0.5 23.5 8.6 0.0 0.0 0.0 0.7 31.8 0.6 0.0 0.0 1.0 0.0 0.7 0.0 4.5 0.9 0.0 0.0 0.7 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.0 0.4 2.2 6.3 0.0 6.8 40.0 0.0 0.0 0.0 0.1 AURKC "ARK3, AurC, STK13" ENSG00000105146 "Aurora kinase C" Q9UQB9 19 57230802-57235548 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 47.3" "Group enriched" "Detected in many" 4 "Early spermatids: 150.2;Spermatocytes: 116.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 38.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA034859 Uncertain NA NA "HPA034859: AB_10670298" "unprognostic (7.27e-2)" "unprognostic (1.76e-1)" "unprognostic (6.45e-2)" "unprognostic (8.07e-3)" "unprognostic (3.29e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (7.02e-2)" "unprognostic (1.13e-1)" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-5)" "unprognostic (4.26e-2)" "unprognostic (1.61e-1)" "unprognostic (1.55e-1)" "unprognostic (6.46e-4)" 1.2 1.1 3.8 1.3 3.9 1.4 2.1 4.1 6.3 0.6 3.3 0.9 0.2 1.3 1.8 1.0 1.1 1.4 1.7 3.8 4.2 1.3 2.7 1.1 3.5 4.0 3.9 3.6 0.5 0.9 0.6 1.4 1.9 4.2 0.9 1.3 1.2 0.8 1.4 2.0 1.1 0.9 1.1 4.0 5.0 0.8 47.3 3.9 1.2 1.2 0.5 2.2 1.4 0.8 4.6 0.3 0.1 0.9 0.4 0.3 0.9 0.5 1.7 0.8 1.2 4.4 1.3 0.2 0.1 0.2 0.6 1.0 0.0 0.0 0.9 0.8 0.0 4.9 0.2 0.4 0.0 1.4 0.0 0.3 1.2 0.9 0.9 0.7 1.5 0.8 0.5 0.2 0.0 1.6 0.0 1.5 0.9 38.4 0.2 1.0 0.1 0.3 0.8 0.9 1.7 1.9 0.6 0.0 0.3 0.2 0.1 0.1 1.8 0.4 0.3 5.1 0.4 1.0 1.9 2.7 0.8 1.1 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.8 3.9 4.1 6.3 3.8 4.2 4.0 3.9 3.6 4.2 4.0 3.9 4.6 1.9 0.0 0.5 0.7 0.1 1.1 0.8 0.9 0.0 2.4 1.2 3.8 1.2 0.0 2.5 1.8 0.0 0.4 0.9 0.7 1.9 2.1 150.2 0.8 0.4 0.8 1.8 0.4 1.3 1.0 0.9 1.0 0.0 0.6 0.0 0.5 1.8 0.6 4.1 0.0 1.3 0.3 0.0 2.6 0.8 28.9 1.5 1.2 5.4 0.0 1.0 1.8 1.0 0.0 0.9 1.3 1.4 0.4 0.6 1.3 0.0 0.5 2.7 1.0 6.6 0.4 0.7 116.8 22.9 0.5 1.1 0.3 0.9 0.5 0.4 1.6 POP4 RPP29 ENSG00000105171 "POP4 homolog, ribonuclease P/MRP subunit" O95707 19 29606283-29617237 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042748, HPA064577" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA042748: AB_10964774, HPA064577: " "unprognostic (5.88e-2)" "unprognostic (2.78e-2)" "unprognostic (7.21e-2)" "unprognostic (4.00e-3)" "unprognostic (4.50e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (8.35e-2)" "unprognostic (2.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.20e-2)" "unprognostic (9.47e-2)" "unprognostic (5.84e-2)" "unprognostic (4.21e-1)" "unprognostic (1.77e-2)" "unprognostic (5.23e-3)" "unprognostic (8.08e-3)" 11.2 13.7 9.0 5.2 8.9 6.3 10.7 9.7 9.6 8.7 8.2 11.0 4.8 9.7 3.8 13.4 7.7 2.6 13.0 9.3 8.9 13.5 14.5 8.2 5.9 10.0 9.3 8.2 7.8 9.6 3.9 8.3 3.7 9.3 8.9 3.0 3.6 10.6 3.2 19.0 11.5 10.6 3.5 9.5 11.5 11.7 12.9 9.3 5.1 9.3 4.0 4.7 9.6 9.4 10.3 44.5 61.9 5.3 5.4 7.8 3.9 26.5 42.1 4.9 9.3 9.3 28.6 10.5 35.2 72.1 7.3 10.1 20.6 10.8 10.0 5.3 79.9 65.1 42.0 19.4 18.2 7.5 51.4 21.6 4.4 8.0 7.9 4.8 5.0 8.2 18.5 34.8 8.0 8.2 36.9 29.7 8.6 10.3 13.6 39.5 19.0 44.7 18.0 5.6 17.1 15.1 16.6 44.4 15.4 18.5 5.0 15.5 12.5 30.0 13.4 40.5 23.1 37.1 30.3 59.7 44.1 17.1 24.8 13.5 73.1 39.7 40.3 35.5 52.1 26.1 48.1 34.2 37.5 39.9 36.4 27.1 32.4 23.3 36.5 43.0 33.2 53.0 45.8 9.0 8.9 9.7 9.6 9.3 8.9 10.0 9.3 8.2 9.3 9.5 9.3 10.3 26.4 22.4 20.0 4.9 29.8 12.6 20.0 61.0 15.9 16.6 18.5 21.0 26.1 27.1 29.6 33.1 8.4 53.4 25.8 29.5 80.3 59.5 18.2 29.8 21.5 27.1 17.4 21.4 4.6 78.3 45.0 22.8 17.3 22.6 26.0 22.1 25.4 40.2 62.1 11.8 4.3 27.5 46.8 26.2 18.3 15.3 16.4 27.3 24.9 0.0 57.4 34.1 52.5 4.0 5.8 66.2 26.6 28.2 33.6 20.3 39.4 72.4 38.0 15.5 26.3 18.6 27.8 71.0 15.4 21.4 16.1 47.3 27.4 31.7 26.2 19.5 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811991-29824312 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.1;placenta: 31.1" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1756.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "BEWO: 293.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.2 5.7 1.9 4.4 1.9 36.1 0.8 2.8 2.7 0.8 1.0 3.9 3.0 1.4 0.6 4.5 0.9 1.0 2.3 2.1 2.3 0.9 0.7 1.1 6.2 1.9 2.2 1.9 0.8 1.8 2.9 0.9 31.1 2.2 1.0 4.7 2.0 1.6 1.4 2.1 3.9 2.5 2.2 1.6 4.2 2.1 12.2 2.4 4.5 1.6 1.8 7.9 3.0 1.9 2.3 15.6 31.8 24.3 34.0 5.2 6.0 293.1 24.7 5.3 10.8 13.2 33.0 31.2 13.3 55.9 11.1 14.0 4.9 28.8 12.8 15.2 41.9 17.7 11.2 30.0 34.5 4.1 44.0 28.7 6.2 7.1 14.8 1.9 3.4 13.3 13.2 45.6 5.8 16.8 24.4 24.5 13.0 40.1 36.2 7.2 36.2 28.6 10.1 8.4 24.6 20.5 17.4 35.4 42.7 3.9 35.4 9.5 32.7 8.0 25.0 92.8 14.9 16.9 24.1 18.2 91.6 13.8 5.6 13.7 0.0 0.0 0.0 0.1 0.5 0.3 0.6 0.1 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.3 0.1 1.9 1.9 2.8 2.7 2.1 2.3 1.9 2.2 1.9 2.2 1.6 2.4 2.3 3.1 0.0 0.6 0.7 4.8 4.8 1.5 0.3 2.2 2.9 8.2 11.3 3.1 0.0 1.4 0.0 0.0 122.4 3.7 3.5 0.0 0.4 14.6 7.5 4.1 1.9 3.0 30.7 2.9 0.7 1756.5 6.0 5.6 20.1 0.0 4.6 1.4 0.2 43.4 3.3 5.1 3.3 0.0 1.0 2.5 3.6 1.2 4.2 1.8 0.0 0.2 1.7 0.0 2.5 1.3 1.4 2.2 2.2 18.4 2.2 1.0 0.4 0.1 1.1 6.6 4.1 3.4 25.0 17.6 8.5 6.0 115.7 4.5 6.9 4.9 3.5 URI1 "C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI" ENSG00000105176 "URI1 prefoldin like chaperone" O94763 19 29923644-30016612 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Protein phosphatase inhibitor, Repressor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 499.7;Late spermatids: 514.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071709 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA071709: AB_2686434" "unprognostic (4.22e-2)" "unprognostic (2.75e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.96e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-3)" "unprognostic (8.12e-2)" "unprognostic (1.26e-2)" "unprognostic (4.42e-3)" "unprognostic (1.57e-1)" "unprognostic (3.71e-1)" "unprognostic (1.33e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" 25.2 30.9 37.1 25.0 43.4 36.8 37.0 63.6 36.0 28.1 25.2 26.3 23.7 34.5 32.6 28.8 30.5 25.3 28.4 30.6 35.3 25.9 30.7 23.1 40.3 39.6 38.1 23.8 44.5 22.1 31.7 11.0 24.3 41.4 38.0 32.4 32.7 27.5 30.7 53.3 45.3 23.6 23.0 36.5 30.3 25.2 52.0 36.4 32.0 55.9 36.5 37.6 25.0 10.8 50.6 64.8 85.9 39.5 61.7 27.5 39.8 66.5 41.3 34.4 29.5 33.7 45.4 41.5 99.7 79.4 48.2 23.4 44.6 84.8 52.7 66.5 69.7 48.5 90.8 44.3 59.7 39.7 88.5 37.3 35.1 70.6 25.7 95.7 31.7 22.1 58.2 109.7 27.2 37.4 55.3 58.0 37.1 37.1 83.4 26.2 56.7 73.2 40.5 19.4 75.3 63.4 49.7 47.1 56.3 62.2 41.7 23.5 54.8 29.1 72.1 63.9 35.6 63.3 74.4 86.2 67.7 35.5 76.5 44.4 3.4 1.3 1.8 2.9 1.4 2.5 1.9 2.6 3.0 1.1 4.5 3.1 3.1 0.1 2.2 1.4 1.6 2.2 0.8 37.1 43.4 63.6 36.0 30.6 35.3 39.6 38.1 23.8 41.4 36.5 36.4 50.6 51.6 44.8 38.8 59.1 48.6 57.0 95.3 19.4 40.5 60.6 67.6 68.1 52.8 48.6 28.2 40.5 25.0 19.2 84.4 21.7 105.7 16.9 499.7 48.5 82.8 32.5 28.9 38.5 79.9 27.8 28.7 45.6 41.3 41.8 30.9 54.5 31.8 50.9 15.4 52.2 122.3 36.5 18.3 33.6 24.0 514.0 43.8 32.9 32.0 74.9 25.0 58.5 70.0 137.7 178.4 19.4 23.7 41.3 53.3 123.9 19.4 85.2 38.8 59.8 13.1 82.3 48.5 72.2 52.2 44.8 73.6 13.1 74.2 91.6 37.0 94.3 PDCD5 "MGC9294, TFAR19" ENSG00000105185 "Programmed cell death 5" O14737 19 32581190-32587453 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018471 Enhanced Approved Nucleoplasm,Cytosol NA NA 47000 Cytosol Nucleoplasm "HPA018471: AB_1855108" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.02e-1)" "unprognostic (8.64e-2)" "unprognostic (3.64e-3)" "unprognostic (2.43e-2)" "unprognostic (6.22e-2)" "unprognostic (8.49e-2)" "unprognostic (3.87e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.00e-2)" "unprognostic (3.35e-2)" "unprognostic (1.10e-1)" "unprognostic (9.54e-2)" 90.7 96.9 87.9 74.5 88.8 47.2 82.7 86.6 111.0 70.8 83.2 90.2 66.4 69.4 51.3 110.1 71.5 35.1 153.2 88.1 91.3 80.0 102.0 68.6 59.1 88.3 89.1 86.9 72.5 103.2 53.0 95.9 61.7 90.1 64.8 56.3 39.6 70.7 42.3 226.3 57.5 62.6 66.4 87.4 57.2 79.5 145.5 96.0 42.2 61.1 133.4 59.9 91.9 81.0 91.4 499.0 630.0 168.8 163.7 223.8 334.0 190.0 353.2 225.6 295.2 252.2 525.0 188.3 272.6 498.7 177.1 286.3 133.2 213.6 281.7 254.4 493.1 333.6 412.4 303.9 382.8 284.0 587.0 157.3 219.7 253.8 195.9 315.0 145.1 198.8 214.9 381.0 298.8 247.2 332.0 243.6 298.6 164.9 410.5 211.6 238.9 248.8 323.6 231.9 167.6 326.0 178.4 338.1 351.8 283.4 125.2 152.6 294.6 299.4 272.6 291.7 274.2 602.7 270.6 413.0 504.4 302.3 459.8 244.2 40.7 93.4 50.9 106.4 149.0 134.3 147.3 167.4 132.1 120.6 116.3 115.3 114.3 13.7 116.9 197.6 123.6 217.8 122.7 87.9 88.8 86.6 111.0 88.1 91.3 88.3 89.1 86.9 90.1 87.4 96.0 91.4 115.4 73.7 62.7 16.6 70.4 121.6 174.0 292.0 97.3 43.2 129.1 216.4 336.1 94.4 119.4 75.4 27.1 194.7 69.0 94.6 189.8 245.3 469.7 94.0 166.4 121.3 71.3 44.8 24.0 247.3 216.5 150.4 64.2 115.0 46.9 84.9 83.6 151.1 146.7 50.5 29.3 113.6 140.4 48.3 93.1 481.2 142.6 67.4 124.5 11.2 113.8 104.0 66.9 17.6 16.8 292.2 100.4 123.0 124.4 392.4 125.1 216.8 107.9 45.3 72.3 126.8 218.4 487.0 413.1 170.9 119.9 143.0 78.4 164.9 157.8 140.4 ANKRD27 "DKFZp434L0718, FLJ00040, VARP" ENSG00000105186 "Ankyrin repeat domain 27" Q96NW4 19 32597006-32676597 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 137.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042769 Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA042769: AB_10796584" "unprognostic (2.16e-3)" "unprognostic (6.04e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.63e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (9.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.90e-2)" "unprognostic (6.22e-3)" "unprognostic (3.74e-2)" "unprognostic (2.14e-1)" "unprognostic (4.94e-2)" "unprognostic (4.07e-1)" "unprognostic (2.26e-2)" 8.9 7.5 11.2 9.0 12.8 10.5 8.8 12.0 12.7 9.3 19.3 15.2 7.7 10.1 8.9 14.5 8.0 7.7 9.7 12.0 10.5 9.8 4.5 10.4 11.2 12.4 13.7 11.8 8.4 7.3 9.3 6.9 13.7 12.2 12.4 12.0 11.8 9.8 13.7 20.8 12.5 10.8 11.7 9.8 9.1 11.1 17.4 12.3 16.8 13.4 10.9 11.6 17.0 11.2 12.4 32.0 36.0 11.5 20.8 23.5 18.0 28.1 18.0 18.0 19.4 25.4 28.8 19.0 34.7 16.5 23.0 20.4 19.4 29.6 22.3 32.0 47.3 15.1 137.9 13.7 23.9 29.4 53.5 47.6 13.1 28.8 20.9 33.8 13.5 19.7 25.3 37.5 76.3 15.1 31.5 20.8 46.2 6.0 40.2 13.8 30.6 15.6 12.7 15.6 30.5 21.3 8.6 17.6 29.6 21.0 15.2 12.4 25.7 18.5 21.1 22.4 19.6 28.0 19.7 12.7 23.8 21.0 51.8 13.8 36.5 11.1 28.5 13.9 15.7 17.5 7.5 14.3 15.6 12.6 6.9 10.9 11.7 9.0 30.6 13.3 6.2 13.2 13.3 11.2 12.8 12.0 12.7 12.0 10.5 12.4 13.7 11.8 12.2 9.8 12.3 12.4 6.8 16.0 9.4 18.3 10.0 15.6 5.5 5.6 14.2 9.4 9.0 5.1 9.2 7.2 5.7 9.2 20.9 14.9 9.7 9.3 0.0 3.3 5.1 7.5 9.4 7.1 9.1 26.5 35.5 5.9 10.6 7.6 5.6 11.6 12.0 10.1 4.6 4.8 8.4 11.8 16.3 9.6 8.2 12.0 12.1 16.2 10.8 8.7 16.0 12.2 6.0 5.8 9.2 11.1 18.7 7.1 10.3 9.4 8.0 10.0 10.8 7.7 7.1 14.7 0.0 6.8 9.3 4.1 17.1 14.7 15.5 15.2 14.0 7.2 8.9 8.4 RPS16 S16 ENSG00000105193 "Ribosomal protein S16" P62249 19 39433137-39435949 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064222 Approved Enhanced "Endoplasmic reticulum,Cytosol" No No 66000 "Endoplasmic reticulum, Cytosol" "HPA064222: AB_2685218" "unprognostic (4.63e-3)" "unprognostic (4.78e-2)" "unprognostic (2.73e-1)" "unprognostic (9.49e-2)" "unprognostic (2.20e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.96e-1)" "unprognostic (1.89e-3)" "unprognostic (4.40e-2)" "unprognostic (5.28e-2)" "unprognostic (5.73e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-2)" "unprognostic (2.06e-1)" "unprognostic (4.62e-2)" 1977.4 1335.6 752.6 887.9 767.3 1634.5 2025.8 739.1 975.7 2435.0 781.6 1949.7 745.6 1874.2 483.7 2114.6 1995.7 627.7 1739.7 707.3 751.2 1401.6 1578.7 1523.4 1724.5 774.0 734.5 684.8 4238.7 2995.1 552.5 941.6 745.2 770.9 1629.2 545.8 357.0 1560.6 500.6 2769.2 2443.6 1679.0 577.2 794.3 1904.5 1934.4 464.7 794.7 1201.7 1335.4 1403.8 1162.4 1893.1 2044.7 787.6 2467.5 5000.7 1350.4 1532.5 1939.7 2339.0 1237.4 1101.9 1229.3 1357.5 1238.9 3198.4 1315.0 2031.9 1385.6 1352.5 532.5 799.6 1562.2 2618.4 848.4 2412.3 3743.7 1628.3 1567.4 3393.7 1972.1 2412.1 1062.9 2779.4 3934.7 1215.3 1923.9 1896.4 1761.4 2602.9 2091.4 2251.5 1431.2 3675.5 3334.0 2400.6 1675.5 3079.8 1839.9 2199.4 1395.6 2489.8 1527.5 2664.4 1347.7 1950.3 825.4 3672.6 2999.5 905.9 1052.2 4589.3 1111.5 1149.8 1537.2 1247.2 2447.7 3155.8 3400.5 2644.9 1202.5 2217.9 1146.0 350.3 1144.7 180.1 1224.6 931.6 1759.2 2334.1 2023.4 1543.3 1424.7 2147.3 2531.4 2095.3 201.2 1187.1 800.4 1650.5 1520.8 4276.8 752.6 767.3 739.1 975.7 707.3 751.2 774.0 734.5 684.8 770.9 794.3 794.7 787.6 910.4 1131.4 1882.8 14.4 3414.1 3891.4 3738.4 2461.1 2290.1 317.5 2872.0 2269.1 1043.3 1983.2 1869.9 814.7 193.9 4378.5 2221.4 1360.9 2208.9 2060.1 596.1 1173.6 2134.8 1782.9 1477.7 1833.5 9.9 4296.3 6085.5 1656.8 846.6 1591.3 1121.0 1849.0 1788.3 2609.9 2812.3 114.4 14.5 2971.8 767.0 3231.7 4694.9 1402.8 4220.6 2451.1 2036.6 23.4 4047.9 1192.7 2671.5 6.0 23.9 2510.0 2427.6 1858.1 1983.1 3836.9 1742.4 3524.6 1041.6 614.4 1281.9 2376.7 1775.6 466.9 929.6 2878.6 4533.1 4741.0 2853.2 1988.4 3314.4 4435.0 TIMM50 "TIM50, TIM50L" ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 185.5;Late spermatids: 662.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria NA NA 12000 "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: AB_2683137" "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 37.7 37.5 29.5 30.7 31.3 45.8 29.9 31.9 44.5 27.1 26.4 31.6 30.7 33.5 11.3 36.2 28.1 18.7 70.7 31.2 31.7 33.0 44.2 25.9 28.0 32.0 30.5 31.0 27.6 35.6 36.5 22.9 25.4 30.5 27.6 15.5 8.9 32.3 17.6 128.2 26.6 29.9 23.2 28.4 26.4 32.0 81.1 30.2 21.8 32.0 77.3 18.4 31.1 26.3 31.2 147.2 365.3 59.6 155.1 43.8 33.4 116.8 115.8 54.2 119.6 97.4 262.6 96.6 156.5 126.0 67.9 71.9 81.6 100.9 114.8 56.4 148.7 170.8 140.3 94.5 197.3 81.5 282.8 106.6 51.9 73.2 97.2 78.7 33.9 76.4 184.5 237.8 91.3 77.2 202.9 178.4 110.5 113.7 159.2 123.3 190.8 112.5 119.3 88.1 195.5 166.3 99.4 133.6 190.0 251.8 35.7 89.1 168.0 86.4 154.7 165.6 140.1 262.7 96.1 181.1 232.8 117.9 146.7 179.2 42.5 53.7 13.4 36.3 58.5 34.9 41.8 34.1 40.0 60.5 46.4 41.4 35.7 5.9 45.2 58.1 47.0 47.8 62.1 29.5 31.3 31.9 44.5 31.2 31.7 32.0 30.5 31.0 30.5 28.4 30.2 31.2 20.0 22.4 26.0 4.6 19.3 26.0 43.6 57.4 18.8 10.4 23.8 28.7 47.6 24.3 37.6 25.8 12.5 83.8 14.7 27.4 66.5 56.3 185.5 19.8 24.2 28.6 23.4 29.6 8.7 51.8 84.4 30.9 25.0 21.5 39.3 29.5 19.2 31.3 67.1 28.6 9.3 27.5 48.8 18.8 27.7 662.8 23.3 22.3 30.2 3.7 22.1 17.4 21.6 6.6 4.9 50.9 22.2 21.1 34.6 68.0 35.7 66.0 22.1 11.4 6.6 27.2 55.7 111.5 46.5 32.3 26.7 94.5 19.9 34.1 48.1 47.6 LGALS13 "PLAC8, PP13" ENSG00000105198 "Galectin 13" Q9UHV8 19 39602501-39607474 "Metabolic proteins, Predicted intracellular proteins" Apoptosis Hemagglutinin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "placenta: 11.9" "Cell type enriched" "Detected in some" 17 "Syncytiotrophoblasts: 319.9" "Cancer enriched" "Detected in single" 4 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 22 "SuSa: 2.1" HPA046803 Supported Nucleoplasm NA NA Nucleoplasm "HPA046803: AB_10965990" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 11.9 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.7 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 319.9 0.0 0.0 0.0 0.0 FBL "FIB, FLRN, Nop1, RNU3IP1" ENSG00000105202 Fibrillarin P22087 19 39834458-39846379 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 747.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001514, HPA049546, HPA077724" Supported Supported "Nucleoli fibrillar center" NA NA 79000 "Nucleoli fibrillar center" "CAB001514: AB_367009, HPA049546: AB_2680811, HPA077724: " "prognostic favorable (1.65e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.32e-2)" "unprognostic (4.23e-3)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.56e-2)" "unprognostic (1.92e-1)" "unprognostic (4.09e-3)" "unprognostic (4.69e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (4.52e-6)" "unprognostic (4.04e-2)" "unprognostic (5.94e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" 126.7 87.4 30.8 66.9 31.3 125.9 149.1 29.4 32.4 178.6 29.7 105.3 52.7 138.1 61.7 193.0 146.5 33.1 72.0 28.5 29.5 78.4 74.0 89.0 100.1 30.3 30.1 27.6 257.3 157.2 50.5 66.5 43.2 30.5 110.9 86.4 23.5 111.4 48.6 128.7 218.7 114.4 67.9 31.2 131.8 105.6 77.8 32.5 103.9 90.2 57.7 158.6 126.6 157.6 31.4 248.5 510.6 208.0 237.2 82.6 140.5 125.0 137.5 122.8 237.6 225.9 301.8 142.8 555.9 125.9 119.7 72.0 98.3 308.2 295.4 290.8 101.2 405.3 225.2 181.9 276.8 106.5 528.3 169.1 114.2 105.9 190.3 395.0 107.4 184.2 239.5 361.8 228.0 133.2 340.3 468.9 232.7 206.4 353.8 156.1 256.3 209.7 282.5 131.4 282.1 280.2 163.2 133.5 210.9 87.7 116.2 107.1 190.6 99.8 112.3 177.2 156.8 324.8 155.5 176.1 374.1 113.4 341.6 105.2 2.7 41.8 6.4 70.6 36.3 101.7 83.5 73.9 70.3 74.8 84.5 100.6 97.3 3.2 92.5 40.5 78.1 58.3 71.6 30.8 31.3 29.4 32.4 28.5 29.5 30.3 30.1 27.6 30.5 31.2 32.5 31.4 45.9 32.1 48.1 2.3 166.6 350.3 323.8 150.2 200.9 18.8 168.3 177.3 37.5 105.8 77.4 40.5 25.0 130.7 118.9 88.5 74.3 108.8 361.1 43.4 97.9 105.4 92.8 129.3 2.7 190.9 283.2 84.2 65.7 53.7 95.9 139.0 105.7 54.1 104.8 15.2 2.6 170.0 46.8 104.3 169.8 747.7 118.1 66.5 97.8 2.8 135.8 33.3 151.4 1.0 4.1 94.5 95.6 78.6 102.8 266.6 59.1 78.7 43.7 24.9 72.3 193.9 122.8 41.7 83.4 201.8 330.7 121.6 123.3 157.3 265.3 240.1 DYRK1B MIRK ENSG00000105204 "Dual specificity tyrosine phosphorylation regulated kinase 1B" Q9Y463 19 39825350-39834201 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.3;testis: 84.5" "Group enriched" "Detected in many" 12 "Early spermatids: 179.4;Late spermatids: 580.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028522, HPA028786" Uncertain Supported "Nucleoplasm,Mitotic chromosome" Yes No Nucleoplasm "Mitotic chromosome" "HPA028522: AB_2672656, HPA028786: AB_10670831" "unprognostic (2.22e-2)" "unprognostic (9.86e-2)" "unprognostic (4.55e-2)" "unprognostic (3.45e-3)" "unprognostic (1.96e-1)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (2.39e-1)" "unprognostic (6.02e-2)" "unprognostic (3.67e-2)" "unprognostic (8.93e-2)" "unprognostic (4.22e-2)" "prognostic favorable (8.83e-4)" "unprognostic (9.73e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-2)" "unprognostic (3.88e-2)" 9.2 19.8 4.2 2.7 4.3 4.8 11.0 3.4 6.3 11.7 3.3 11.5 5.3 12.0 7.8 11.8 13.9 3.3 15.0 4.3 2.5 16.3 7.6 8.9 4.6 2.9 3.0 4.1 11.7 10.4 6.5 31.7 2.7 4.3 13.2 2.2 4.1 14.4 3.3 132.3 14.7 10.3 2.7 0.8 14.1 12.2 84.5 3.1 5.2 16.7 50.4 2.5 11.5 10.6 2.5 0.4 9.3 8.8 6.2 4.9 4.6 0.7 2.9 1.8 2.6 2.3 0.9 3.6 1.4 11.0 3.4 0.1 3.2 1.3 2.0 2.3 5.4 7.8 0.6 5.9 0.9 4.1 0.3 1.9 6.2 1.2 0.8 2.9 8.6 0.6 3.5 1.5 2.0 0.4 4.7 2.1 0.8 2.2 2.7 2.1 1.0 0.2 0.6 5.7 2.2 12.7 14.5 4.5 4.4 0.2 4.6 4.4 0.5 4.5 1.1 2.0 1.0 0.9 3.2 1.1 1.0 7.4 0.9 0.4 0.7 1.6 1.8 3.0 1.7 3.6 2.4 2.0 3.1 1.9 1.6 1.0 1.7 2.5 3.3 1.6 4.5 2.2 1.7 4.2 4.3 3.4 6.3 4.3 2.5 2.9 3.0 4.1 4.3 0.8 3.1 2.5 6.0 0.0 0.6 6.2 10.9 3.4 3.8 8.4 10.2 15.2 9.0 6.1 6.1 7.2 3.4 16.5 20.9 2.1 21.7 10.3 9.8 13.1 179.4 15.4 6.7 7.3 20.4 19.8 4.6 4.3 1.7 5.1 7.7 10.1 1.3 11.9 12.1 3.9 5.9 10.1 6.3 9.8 10.2 8.2 3.0 580.2 7.2 4.7 5.4 7.5 5.7 8.3 10.3 5.0 3.2 9.7 9.7 5.3 5.0 4.8 11.5 17.4 10.7 13.0 0.0 11.1 4.8 30.1 13.4 6.1 2.8 1.4 10.8 20.2 7.4 3.6 CLC "Gal-10, LGALS10, MGC149659" ENSG00000105205 "Charcot-Leyden crystal galectin" Q05315 19 39731255-39738029 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "bone marrow: 456.3" "Cell type enriched" "Detected in some" 15 "Erythroid cells: 127.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.0" "Not detected" "Not detected" "Group enriched" "Detected in all" 312 "basophil: 28756.2;eosinophil: 21481.0" "Lineage enriched" "Detected in all" 2254 "granulocytes: 28756.2" "Cell line enriched" "Detected in some" 12 "HMC-1: 7553.4" "Not detected" "Not detected" HPA041751 Enhanced NA NA 400000 "HPA041751: AB_10793973" "unprognostic (4.53e-2)" "unprognostic (3.04e-2)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-1)" "unprognostic (1.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.21e-1)" "unprognostic (4.28e-2)" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" 2.0 0.1 0.0 30.3 0.0 456.3 0.3 0.2 0.4 0.3 0.0 10.3 25.6 0.3 0.1 0.9 1.8 16.7 0.5 0.0 0.3 0.3 4.9 6.3 1.8 0.1 0.0 0.0 0.1 0.4 0.2 0.4 1.4 0.0 0.1 8.2 0.0 0.9 0.2 0.2 1.5 41.9 24.7 0.1 11.4 15.8 0.6 0.6 7.3 0.3 0.2 0.2 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 619.0 7553.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 3.5 0.7 0.9 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 2.3 0.0 0.0 3.8 0.0 2.4 28756.2 5.0 21481.0 2.5 11.1 6.0 4.8 6.9 1.7 5.3 6.2 3.1 9.2 80.3 2.5 12.7 7.8 4.0 100.3 0.0 0.0 0.2 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 127.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CCNP "CNTD2, FLJ13265" ENSG00000105219 "Cyclin P" Q9H8S5 19 40222208-40226697 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.9;liver: 3.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Syncytiotrophoblasts: 3.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 2.9" "Immune cell enriched" "Detected in single" 45 "basophil: 4.5" "Lineage enriched" "Detected in single" 45 "granulocytes: 4.5" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Not detected" "Not detected" HPA045615 Uncertain NA NA "HPA045615: AB_2679390" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (4.41e-2)" "unprognostic (1.07e-2)" "unprognostic (9.79e-4)" "unprognostic (5.27e-2)" "unprognostic (3.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (2.23e-1)" "unprognostic (9.43e-3)" "unprognostic (1.97e-2)" "unprognostic (3.10e-1)" "unprognostic (7.65e-2)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" 0.7 0.5 0.4 0.0 0.4 0.0 0.6 2.9 0.7 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.9 0.0 0.2 0.6 0.2 1.8 3.7 0.2 0.0 0.4 0.3 0.2 0.4 0.1 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.1 0.6 0.1 0.0 1.0 0.0 0.0 0.1 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.9 0.7 0.6 0.2 0.4 0.3 0.2 1.2 0.3 0.1 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 331.0;Late spermatids: 1127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" No No 86000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 171.0 285.6 72.0 75.1 108.0 224.8 130.1 75.9 137.0 88.2 77.3 159.4 114.8 93.2 27.4 199.4 89.5 87.9 361.4 103.7 89.6 197.4 224.5 92.0 67.0 76.1 73.0 94.0 97.8 84.9 167.7 148.4 47.9 85.9 95.2 85.1 157.5 106.0 61.6 420.6 117.9 127.6 79.1 40.1 103.0 123.5 96.6 99.5 50.6 101.7 378.0 76.6 149.1 122.5 124.0 572.9 596.1 58.7 433.3 167.5 121.9 134.1 183.4 132.4 206.3 253.7 314.9 169.6 303.5 311.4 177.9 149.1 343.7 337.7 437.0 259.4 461.0 105.1 382.1 252.3 310.8 108.4 517.6 259.3 173.7 136.6 289.0 132.7 273.3 209.3 230.5 210.3 261.8 140.2 319.2 245.5 133.5 158.0 421.3 174.6 242.7 149.1 649.4 254.1 275.4 304.9 185.8 331.9 634.3 131.7 100.5 144.4 161.7 171.9 80.8 185.5 256.7 312.8 535.5 383.7 318.4 287.4 372.3 170.6 188.8 93.2 331.3 80.4 141.2 99.1 59.9 73.7 93.1 101.0 50.5 61.8 72.8 7.4 58.0 180.3 31.6 83.4 123.4 72.0 108.0 75.9 137.0 103.7 89.6 76.1 73.0 94.0 85.9 40.1 99.5 124.0 34.2 28.9 40.0 98.9 43.8 25.9 30.1 104.5 42.7 98.8 34.1 27.2 232.5 42.9 51.4 57.0 75.0 44.5 41.6 76.7 115.4 101.7 331.0 35.9 41.2 38.0 63.7 46.7 121.8 66.9 69.2 47.1 109.1 58.0 23.4 36.1 42.8 89.5 89.6 237.2 127.2 75.8 50.8 52.9 40.5 1127.2 37.0 58.1 35.6 17.8 44.4 32.6 23.7 43.7 87.7 77.6 39.4 30.5 77.1 31.5 111.8 103.0 33.1 68.3 19.7 44.3 65.0 7.8 22.3 139.1 32.8 39.3 64.3 74.8 126.9 37.2 AKT2 PKBβ ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: AB_2685278" "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 63.3 40.3 32.1 37.6 30.9 48.8 39.0 55.9 40.4 49.7 46.3 38.3 24.7 43.8 49.9 42.9 46.5 25.4 41.2 31.8 23.4 43.7 59.6 31.0 38.4 31.7 26.0 28.1 54.4 42.3 59.0 48.2 27.9 36.7 41.5 23.5 41.6 32.8 45.4 102.1 39.3 35.9 34.5 21.7 38.4 33.3 30.0 27.6 53.9 101.0 119.8 37.3 40.1 41.8 33.4 66.2 160.1 63.1 61.5 72.0 88.9 32.5 41.7 63.5 87.6 77.9 71.8 60.8 67.4 36.8 96.3 37.2 28.2 66.8 90.0 56.1 62.5 74.3 43.4 116.5 44.7 45.8 50.7 50.5 82.7 53.6 58.6 56.4 71.9 19.0 73.0 57.3 67.5 49.8 54.6 81.1 24.7 31.7 73.7 41.5 54.2 32.1 48.5 68.3 105.7 82.7 49.8 43.3 75.0 35.0 62.5 59.8 64.9 18.8 52.7 51.5 47.3 67.6 61.5 59.0 56.4 52.6 59.7 44.3 5.7 2.6 2.1 2.2 1.2 2.2 1.9 1.8 1.5 1.7 2.9 1.7 2.6 4.0 1.7 1.6 4.9 1.6 1.7 32.1 30.9 55.9 40.4 31.8 23.4 31.7 26.0 28.1 36.7 21.7 27.6 33.4 18.1 16.0 15.9 51.2 33.0 23.8 23.9 20.9 26.2 67.6 25.3 23.9 31.2 30.0 18.1 60.7 41.7 31.3 26.0 23.7 21.5 19.7 5.5 26.2 26.7 17.4 19.2 19.1 30.4 30.4 25.2 27.9 20.9 25.8 14.0 44.2 13.9 87.5 22.3 60.6 25.3 20.1 22.4 23.2 17.5 10.5 42.9 20.0 23.2 23.4 21.7 46.2 50.4 41.7 40.6 24.8 16.9 26.7 30.4 29.7 21.8 24.8 24.9 97.4 19.7 29.3 25.0 14.8 15.6 31.1 27.4 38.7 23.1 56.9 23.3 29.4 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 717.4" "Cell type enhanced" "Detected in all" "Hofbauer cells: 688.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 1727.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 1727.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 450000 "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 161.0 201.7 123.4 79.1 149.5 48.7 139.6 31.7 231.6 136.2 37.5 124.3 72.4 157.0 85.4 85.5 134.6 97.6 182.4 173.9 218.0 130.2 122.3 183.0 98.9 112.5 119.9 166.8 200.7 152.3 106.7 717.4 124.5 129.5 134.5 49.7 51.9 139.8 107.2 106.0 121.5 106.2 79.7 46.4 198.6 127.6 78.4 161.7 44.7 121.8 83.0 41.8 127.2 127.1 182.7 85.6 257.8 163.7 259.1 444.2 210.2 124.5 206.5 208.6 146.4 166.6 49.4 93.8 36.9 211.0 180.9 47.8 39.3 39.9 81.2 63.5 138.4 145.3 39.9 82.1 63.2 302.7 16.8 435.1 402.5 167.0 112.1 76.6 244.2 125.0 59.3 142.5 144.5 106.7 111.5 29.5 79.6 107.4 138.7 52.8 37.0 124.5 154.2 75.2 63.2 116.7 193.9 99.0 60.6 113.8 169.5 83.6 283.2 222.3 122.8 58.5 105.6 47.0 148.9 173.3 38.8 197.7 66.2 77.9 1727.4 256.7 378.7 75.0 129.5 62.0 34.4 59.5 67.7 235.0 28.1 60.8 61.3 25.7 102.3 64.2 34.7 64.5 208.6 123.4 149.5 31.7 231.6 173.9 218.0 112.5 119.9 166.8 129.5 46.4 161.7 182.7 66.7 32.1 69.6 59.4 27.0 35.4 93.6 263.1 39.9 101.5 45.9 61.2 22.0 45.8 90.4 57.0 33.3 158.2 27.2 42.5 21.5 52.5 8.7 32.0 49.8 53.9 72.8 18.7 99.1 58.3 107.2 158.8 38.2 31.5 60.3 134.7 88.2 43.1 688.4 121.1 113.4 41.3 126.1 280.9 59.1 15.7 151.6 261.3 92.5 50.6 54.2 94.1 35.0 53.3 70.2 54.3 42.6 143.7 85.8 57.9 78.8 37.1 35.2 47.6 19.7 73.1 59.7 24.2 67.9 32.4 33.4 195.9 28.8 114.1 41.6 68.2 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393766-40414793 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 34.9" "Cell type enhanced" "Detected in many" "Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in some" 8 "spinal cord: 114.2" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.7 6.1 1.3 5.8 1.7 4.0 4.8 6.5 4.4 3.0 3.1 1.1 4.5 1.0 2.1 4.2 1.9 3.1 4.5 4.2 6.6 1.0 34.9 1.3 5.2 4.8 3.7 6.3 3.9 5.9 1.5 5.2 6.0 4.6 0.7 0.8 3.8 3.5 5.0 3.2 2.2 2.0 4.5 2.0 3.7 1.6 5.0 0.7 9.6 5.6 0.8 4.4 3.1 4.3 1.6 2.6 2.1 2.7 1.3 4.4 2.6 1.4 1.5 1.9 1.4 1.0 1.7 0.5 1.6 1.3 1.2 0.9 1.0 0.6 0.7 0.8 0.9 0.3 0.3 0.5 2.1 0.1 2.3 3.3 3.2 1.2 1.1 1.7 1.6 2.9 2.0 0.5 1.0 2.2 1.0 0.6 0.6 3.8 1.7 3.2 1.8 1.5 0.4 1.8 0.2 1.0 2.7 2.3 2.0 0.9 3.2 1.2 1.4 3.8 2.9 1.6 0.8 5.3 5.0 0.7 1.1 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 6.1 5.8 4.8 6.5 4.5 4.2 5.2 4.8 3.7 6.0 4.5 5.0 4.3 17.8 3.2 5.9 0.7 1.4 6.2 2.3 0.3 5.7 0.1 8.1 23.2 15.4 2.8 0.9 1.8 0.0 1.1 1.7 1.0 0.0 0.3 0.1 1.3 1.7 9.2 0.0 0.4 0.6 0.6 0.7 7.0 0.0 3.0 0.0 2.0 6.8 1.3 1.1 0.0 0.5 0.7 2.0 1.6 2.5 0.1 3.4 2.5 3.6 7.5 0.3 3.3 0.0 0.0 0.5 0.5 1.4 4.5 0.9 1.7 1.2 1.9 0.2 0.1 0.0 30.3 6.1 0.3 0.7 5.0 4.1 2.7 1.1 1.3 1.5 1.0 PIAS4 "FLJ12419, Piasg, PIASY, ZMIZ6" ENSG00000105229 "Protein inhibitor of activated STAT 4" Q8N2W9 19 4007736-4039386 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 103.7;Late spermatids: 264.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010598, HPA076008" Enhanced Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA010598: AB_1079616, HPA076008: " "unprognostic (1.23e-1)" "unprognostic (8.94e-3)" "unprognostic (3.50e-2)" "prognostic favorable (1.18e-5)" "unprognostic (2.45e-1)" "unprognostic (4.77e-3)" "unprognostic (4.01e-3)" "unprognostic (9.79e-2)" "unprognostic (6.89e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.04e-4)" "unprognostic (1.33e-2)" "unprognostic (5.98e-2)" "unprognostic (4.52e-3)" "unprognostic (5.76e-2)" "unprognostic (1.25e-1)" "unprognostic (4.67e-3)" 8.0 10.8 7.9 6.0 9.7 4.8 9.1 9.9 11.5 10.7 2.5 13.4 6.7 10.6 2.4 11.2 8.9 3.0 8.2 7.0 6.3 8.7 15.7 8.0 5.7 10.5 10.1 5.8 10.7 14.0 3.5 10.5 5.3 10.5 11.5 2.4 3.7 9.9 3.9 10.7 12.3 9.9 3.8 7.9 11.7 12.2 37.4 8.1 6.0 7.5 4.8 4.0 10.5 9.8 15.9 15.1 10.6 9.7 9.3 4.7 4.2 15.4 9.0 4.9 9.2 8.4 16.7 6.8 11.4 7.9 4.8 10.1 15.5 10.0 7.1 4.0 18.5 15.8 8.2 7.8 13.1 9.6 12.0 13.8 4.9 7.8 8.3 5.1 5.1 11.1 11.6 15.5 15.2 4.5 15.5 21.9 13.9 21.6 7.3 9.7 19.3 9.9 15.0 6.1 8.3 17.8 19.8 12.8 12.4 10.3 7.3 11.5 11.0 8.2 9.2 13.2 19.4 14.2 28.3 22.8 14.4 7.7 14.6 11.5 10.5 13.2 19.8 15.2 15.3 10.8 16.1 10.8 14.0 11.0 14.6 9.3 10.6 15.8 17.1 19.5 11.0 13.0 10.3 7.9 9.7 9.9 11.5 7.0 6.3 10.5 10.1 5.8 10.5 7.9 8.1 15.9 12.8 3.2 15.0 15.0 10.1 18.4 8.4 15.8 7.4 18.8 14.5 11.2 3.6 11.5 11.5 9.2 12.5 24.3 12.3 13.2 7.9 17.1 103.7 13.9 10.7 12.3 22.1 9.9 7.3 17.6 16.9 9.1 11.7 12.4 7.0 15.2 11.4 12.3 14.6 26.9 5.7 15.6 20.3 8.3 9.2 264.3 14.0 10.6 7.2 2.8 12.8 11.3 10.3 6.6 18.0 13.5 7.8 18.4 12.0 11.9 14.0 12.5 15.6 23.1 6.6 8.1 9.3 69.1 42.1 7.4 15.5 36.4 10.1 13.3 12.4 9.0 NUMBL "CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23" ENSG00000105245 "NUMB like endocytic adaptor protein" Q9Y6R0 19 40665905-40690972 "Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 42.6;Peritubular cells: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058251, HPA058380" Approved NA NA "HPA058251: AB_2683653, HPA058380: AB_2683698" "unprognostic (2.78e-2)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.78e-2)" "unprognostic (1.27e-1)" "unprognostic (7.29e-2)" "unprognostic (7.14e-3)" "unprognostic (7.50e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (7.55e-15)" "unprognostic (1.91e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (1.69e-3)" 31.2 16.3 24.8 8.2 28.1 3.0 22.4 16.4 26.2 48.8 0.0 28.4 8.5 45.6 6.2 17.7 47.0 11.5 23.4 28.0 17.6 12.4 15.5 25.8 3.9 6.5 10.8 29.3 39.2 10.2 2.4 72.9 5.8 9.0 35.5 3.8 5.2 14.8 14.1 11.5 17.9 18.4 12.6 2.6 12.7 22.4 25.5 14.2 2.4 28.6 6.1 2.6 36.5 38.4 14.0 17.0 46.4 9.7 25.7 22.8 22.4 5.4 20.2 17.5 11.7 14.1 17.5 12.4 6.2 19.7 29.4 8.8 16.4 7.1 8.8 6.2 16.8 11.8 6.8 47.0 2.4 24.2 3.4 7.7 21.5 5.9 19.2 8.1 18.2 16.7 5.4 20.0 7.1 8.2 15.5 10.8 3.3 11.3 9.9 10.7 9.1 26.5 12.7 3.4 4.7 19.3 34.1 22.2 12.9 19.7 6.1 13.1 5.7 31.9 21.2 24.1 33.7 25.6 9.3 11.9 3.9 34.1 10.8 12.3 0.0 0.1 0.0 1.1 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.4 0.2 0.0 0.8 0.2 0.0 0.2 24.8 28.1 16.4 26.2 28.0 17.6 6.5 10.8 29.3 9.0 2.6 14.2 14.0 6.9 0.0 3.4 13.4 2.7 13.6 14.6 2.4 4.6 14.2 4.9 6.1 4.0 4.3 3.4 0.0 0.0 2.8 4.1 1.8 0.0 2.5 24.7 10.4 24.7 6.0 7.2 1.7 12.9 1.8 5.4 24.2 6.6 7.9 0.0 5.5 5.7 2.2 1.6 11.8 7.4 3.5 0.0 1.9 6.8 10.1 42.6 2.3 3.6 3.7 0.5 3.0 0.0 9.0 4.9 1.7 3.3 51.6 1.4 18.7 2.5 0.6 9.2 4.6 0.0 20.6 10.4 1.4 3.3 5.6 21.0 2.2 2.3 6.9 3.3 8.8 EBI3 "IL27B, IL35B" ENSG00000105246 "Epstein-Barr virus induced 3" Q14213 19 4229523-4237528 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 148.8" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 485.6;monocytes: 505.7;Syncytiotrophoblasts: 336.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "intermediate monocyte: 4.8;memory B-cell: 18.7;naive B-cell: 14.7;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 14 "B-cells: 18.7;monocytes: 6.3" "Cell line enriched" "Detected in some" 13 "HDLM-2: 218.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046635 Enhanced "Secreted to blood" NA NA 203000 1400000 "HPA046635: AB_2679729" "unprognostic (7.26e-2)" "unprognostic (1.49e-2)" "unprognostic (9.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.59e-1)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.10e-2)" "unprognostic (7.78e-2)" "unprognostic (4.87e-2)" "unprognostic (4.25e-3)" "unprognostic (8.27e-2)" "prognostic unfavorable (1.04e-8)" "unprognostic (1.97e-1)" "unprognostic (2.78e-2)" "unprognostic (9.29e-2)" "unprognostic (4.67e-2)" 4.8 4.7 3.1 14.8 3.5 1.2 1.7 3.0 5.4 1.5 3.0 2.5 4.3 1.1 0.1 1.0 2.4 5.4 1.4 3.2 4.7 2.1 3.3 2.9 20.4 5.2 3.3 2.5 1.4 2.6 0.4 1.7 148.8 4.5 1.9 1.6 0.1 1.8 1.4 0.2 0.5 8.4 2.2 4.0 34.2 3.8 0.9 4.9 9.5 0.9 0.4 7.4 4.8 1.0 5.1 0.1 1.7 0.1 0.0 0.0 0.0 7.3 0.7 4.2 0.4 0.2 1.3 1.2 4.2 16.4 0.0 2.0 0.1 0.0 0.0 0.0 218.8 0.0 0.0 0.1 0.2 0.3 0.0 7.7 0.4 0.0 2.1 0.6 1.6 0.1 0.0 0.4 0.5 0.1 0.1 0.0 3.0 0.4 0.0 0.0 0.0 0.6 0.3 2.6 0.0 0.2 0.4 0.0 0.0 0.0 2.7 0.2 0.2 0.9 0.3 5.1 0.0 0.2 0.4 0.0 0.2 0.3 0.0 0.6 0.0 0.1 0.0 0.0 4.8 0.0 18.7 0.0 0.0 0.8 14.7 0.0 0.0 0.2 0.0 6.3 0.0 0.0 0.6 3.1 3.5 3.0 5.4 3.2 4.7 5.2 3.3 2.5 4.5 4.0 4.9 5.1 0.5 0.0 0.5 0.3 8.4 0.4 0.0 13.3 0.0 0.0 0.2 0.6 0.1 1.5 10.7 0.0 0.0 10.6 0.5 0.0 0.0 2.8 0.0 0.3 0.4 1.3 0.0 0.0 0.6 0.9 485.6 0.7 0.0 0.3 11.4 0.0 1.1 0.1 9.6 0.0 0.4 0.0 6.1 102.6 11.3 0.0 0.0 19.0 0.0 5.6 505.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 2.6 0.1 0.0 0.6 1.5 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 336.4 1.0 0.1 0.0 0.1 YJU2 "CCDC94, FLJ10374" ENSG00000105248 "YJU2 splicing factor homolog" Q9BW85 19 4247080-4269088 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.7;Distal tubular cells: 23.5;Ductal cells: 23.5;Exocrine glandular cells: 32.9;Extravillous trophoblasts: 23.3;Pancreatic endocrine cells: 21.9;Syncytiotrophoblasts: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043606, HPA055675" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA043606: AB_10963431, HPA055675: AB_2682880" "unprognostic (1.75e-2)" "unprognostic (2.11e-3)" "unprognostic (1.81e-2)" "unprognostic (6.91e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.53e-2)" "unprognostic (1.01e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.32e-4)" "prognostic favorable (8.04e-4)" "unprognostic (7.61e-2)" "unprognostic (3.12e-2)" "unprognostic (9.46e-3)" 15.6 17.2 15.0 11.1 16.7 44.7 16.8 16.7 22.4 14.9 12.6 16.0 13.4 18.7 7.6 20.2 15.5 7.4 14.3 14.9 14.6 16.6 20.6 12.6 15.3 17.0 15.6 14.2 18.5 24.0 11.9 11.3 10.0 16.3 17.7 7.7 8.1 16.4 8.8 23.6 22.3 18.0 7.2 14.9 20.6 19.5 15.5 15.5 12.7 17.6 14.0 10.8 16.5 14.9 19.4 30.7 29.1 16.0 12.9 9.3 12.3 16.3 12.2 15.3 22.2 24.4 26.2 18.3 35.5 13.5 18.3 19.1 22.8 26.1 28.8 15.4 20.6 25.8 22.9 19.4 31.0 13.7 30.1 30.6 13.1 17.0 19.6 28.8 13.5 18.2 16.9 33.0 40.1 9.3 42.2 31.9 18.7 38.3 13.9 22.0 18.4 13.5 31.6 21.1 29.7 22.9 23.9 10.8 23.3 21.8 9.2 16.8 27.9 20.5 15.7 16.4 31.8 30.5 43.2 33.0 35.2 21.9 31.6 17.1 21.3 19.6 31.0 25.7 25.5 23.2 31.0 24.6 23.8 24.0 33.1 29.0 24.2 12.1 23.4 19.3 25.0 33.4 18.9 15.0 16.7 16.7 22.4 14.9 14.6 17.0 15.6 14.2 16.3 14.9 15.5 19.4 11.2 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 9.4 9.0 0.0 0.0 0.0 9.2 0.0 29.7 10.1 0.0 23.5 23.5 0.0 7.6 7.7 7.0 0.0 0.0 0.0 32.9 23.3 4.4 0.0 11.6 0.0 10.4 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 18.6 0.0 0.0 0.0 0.0 21.9 0.0 0.0 1.7 0.0 0.0 19.6 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 45.7 4.7 11.9 0.0 0.0 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4279266-4290722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.1;heart muscle: 8.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 178 "plasmacytoid DC: 17.8" "Lineage enriched" "Detected in single" 178 "dendritic cells: 17.8" "Group enriched" "Detected in some" 45 "RH-30: 58.4;SH-SY5Y: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.0 0.1 4.4 0.7 2.5 0.7 0.0 6.6 7.6 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.1 8.9 2.2 8.1 0.0 1.5 0.0 0.6 7.2 5.9 1.5 0.0 0.0 0.1 0.2 0.0 5.4 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 4.1 0.1 0.0 0.1 8.0 0.1 0.0 1.7 0.3 0.1 0.0 4.7 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 58.4 0.1 0.0 0.0 0.5 193.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 4.4 2.5 6.6 7.6 2.2 8.1 7.2 5.9 1.5 5.4 4.1 8.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.8 21.7 137.5 1.9 0.0 0.1 0.1 0.0 0.2 13.2 5.3 2.8 0.0 0.6 0.4 0.0 0.1 8.9 0.0 0.7 57.3 0.4 10.1 4.2 54.6 0.0 0.6 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.9 0.0 9.0 0.3 0.0 78.8 0.0 0.0 0.0 43.1 0.0 0.0 0.4 0.0 2.5 0.1 0.0 2.9 0.0 0.0 4.4 0.8 0.0 49.4 0.0 TBCB "CG22, CKAP1, CKAPI" ENSG00000105254 "Tubulin folding cofactor B" Q99426 19 36114289-36125947 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 452.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041428, HPA041722" Approved Supported Cytosol NA NA 120000 Cytosol "HPA041428: AB_10794517, HPA041722: AB_10804007" "unprognostic (3.88e-3)" "unprognostic (3.05e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-2)" "unprognostic (7.94e-2)" "unprognostic (1.25e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.15e-2)" "unprognostic (5.19e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.11e-4)" "unprognostic (4.54e-2)" "unprognostic (6.34e-3)" "unprognostic (9.20e-2)" "unprognostic (6.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.02e-1)" 81.4 84.5 342.1 50.4 366.5 53.2 78.5 369.5 452.2 95.9 300.0 90.7 35.2 118.5 33.3 84.0 89.5 31.3 98.4 339.5 358.8 92.8 58.0 73.9 52.6 376.5 361.7 340.1 90.3 45.2 48.0 117.3 36.9 377.2 67.9 30.1 62.8 52.1 47.2 88.5 58.4 67.2 48.5 376.2 76.7 70.3 90.1 366.3 53.8 59.3 49.9 42.6 100.5 82.6 419.7 119.8 361.0 122.7 89.0 84.2 83.4 54.8 95.6 72.6 158.0 111.5 161.0 62.0 99.4 167.4 144.9 114.3 59.0 99.8 102.6 84.0 231.4 127.9 85.5 89.4 224.9 104.7 96.6 166.8 97.6 74.7 123.9 76.4 105.7 102.5 139.7 39.7 141.1 125.3 189.2 152.6 117.5 83.0 137.8 139.8 135.2 69.5 93.2 137.9 108.3 139.6 153.0 89.3 112.2 102.9 109.2 58.7 120.2 106.5 156.9 166.9 91.3 181.4 70.9 182.3 113.1 140.7 99.2 87.5 310.8 240.3 318.5 286.0 335.8 190.5 258.8 260.4 249.5 265.2 246.6 155.9 195.5 103.8 246.1 409.3 280.2 386.5 358.2 342.1 366.5 369.5 452.2 339.5 358.8 376.5 361.7 340.1 377.2 376.2 366.3 419.7 110.6 60.9 29.7 13.1 76.9 66.9 89.8 170.1 56.9 61.3 73.5 98.9 53.5 58.6 90.9 138.0 12.5 136.7 111.5 64.8 180.0 147.2 143.5 88.7 85.6 100.9 107.2 52.4 14.0 111.8 212.5 93.0 53.0 80.5 83.7 99.4 80.7 33.7 160.5 72.3 14.9 58.4 160.7 70.9 154.0 274.0 90.1 95.8 129.9 13.1 239.2 127.8 142.2 11.6 68.3 129.8 95.3 101.2 53.3 61.7 63.1 188.4 115.8 85.6 65.7 75.6 195.8 108.3 156.9 71.7 67.6 82.6 114.3 88.2 56.7 78.5 FSD1 "MGC3213, MIR1" ENSG00000105255 "Fibronectin type III and SPRY domain containing 1" Q9BTV5 19 4304598-4323843 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 17.8;testis: 7.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.6;Distal tubular cells: 15.6;Excitatory neurons: 26.6;Horizontal cells: 16.8;Inhibitory neurons: 19.7;NK-cells: 16.5;Spermatogonia: 30.4" "Group enriched" "Detected in many" 6 "glioma: 9.2;testis cancer: 11.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.6;NK-cell: 5.4;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 35 "dendritic cells: 1.4;NK-cells: 5.4;T-cells: 3.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 55.3;SH-SY5Y: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043141 Supported NA NA "HPA043141: AB_10797137" "unprognostic (8.31e-3)" "unprognostic (2.38e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.29e-2)" "unprognostic (9.72e-4)" "unprognostic (1.33e-1)" "unprognostic (9.87e-2)" "unprognostic (1.00e-1)" "unprognostic (3.15e-1)" "unprognostic (8.16e-3)" "unprognostic (1.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.82e-1)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" 0.4 0.7 10.6 0.7 12.7 0.7 0.0 9.1 15.7 0.6 2.6 0.6 1.0 0.5 0.1 0.2 0.1 0.3 0.1 14.2 11.0 0.1 0.4 0.2 1.2 14.1 10.6 14.5 0.2 0.1 0.0 2.0 0.8 16.3 0.3 0.1 1.9 0.1 0.1 0.0 0.2 0.9 0.4 7.1 0.9 0.3 7.7 14.7 0.9 0.1 0.0 0.4 0.1 0.3 17.8 0.1 6.7 18.6 9.7 0.1 1.8 7.9 7.9 3.2 25.0 19.3 15.6 0.5 24.3 6.7 5.5 13.1 1.6 17.0 12.8 8.0 15.6 24.9 6.8 5.6 0.5 9.9 0.0 1.6 4.2 0.1 14.6 0.9 10.1 13.5 21.5 1.1 0.0 1.2 18.4 11.2 0.0 23.9 0.1 12.7 0.0 8.8 0.0 0.1 0.6 55.3 57.6 2.1 0.9 1.7 3.0 0.2 0.2 15.3 3.9 17.6 7.3 7.3 13.7 18.4 6.1 9.4 0.0 9.7 0.0 0.0 0.0 0.5 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 5.4 0.0 1.4 0.4 0.7 10.6 12.7 9.1 15.7 14.2 11.0 14.1 10.6 14.5 16.3 7.1 14.7 17.8 0.2 0.0 1.1 2.0 0.4 0.1 0.7 0.0 0.0 12.6 0.1 0.0 0.5 0.0 0.6 3.7 2.1 3.2 6.1 0.3 15.6 0.1 4.0 0.1 1.1 0.5 2.4 2.7 26.6 0.0 1.3 1.4 0.5 0.2 2.5 3.5 0.7 0.4 0.8 16.8 19.7 0.4 0.0 0.0 0.0 5.3 0.9 0.3 0.0 3.7 0.1 1.7 16.5 8.5 9.5 0.0 0.1 0.4 0.5 0.3 0.0 0.3 0.0 7.1 0.0 0.9 1.6 3.7 30.4 0.0 0.0 2.7 5.6 0.1 0.3 0.4 POLR2I "hRPB14.5, RPB9" ENSG00000105258 "RNA polymerase II subunit I" P36954 19 36113709-36115213 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 1145.8;Late spermatids: 2796.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035632, HPA045156" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035632: AB_2674711, HPA045156: AB_10964748" "unprognostic (1.95e-2)" "unprognostic (7.88e-3)" "unprognostic (3.54e-1)" "unprognostic (7.41e-3)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (1.24e-2)" "unprognostic (4.12e-2)" "unprognostic (7.39e-2)" "unprognostic (4.69e-3)" "unprognostic (2.86e-2)" "unprognostic (8.16e-2)" "unprognostic (1.83e-1)" "unprognostic (3.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" 32.9 41.4 91.5 23.5 95.7 44.7 35.1 95.4 119.5 30.9 78.3 35.3 29.1 28.7 40.1 40.6 56.2 27.5 79.7 87.4 91.2 33.2 40.5 25.8 31.8 91.1 91.0 80.9 50.5 84.6 61.8 26.3 22.0 94.0 30.5 20.4 26.2 67.5 36.3 197.0 41.8 30.2 21.9 92.5 30.0 31.8 67.4 93.1 30.6 37.5 120.8 24.4 28.6 15.8 113.5 96.7 364.7 61.9 103.8 38.5 44.6 67.7 35.5 47.5 80.5 67.5 179.0 62.0 61.6 80.4 38.2 46.8 49.6 60.4 82.5 42.1 107.8 115.5 59.1 88.8 180.9 70.0 88.7 53.1 47.5 71.4 51.7 75.1 51.1 52.8 112.2 66.6 117.1 48.5 292.1 124.6 111.0 74.5 201.6 151.7 130.4 51.6 114.0 94.0 121.3 145.0 74.0 60.1 172.5 59.5 53.7 81.3 92.7 35.7 88.6 91.6 60.3 128.2 83.2 88.4 99.6 102.3 88.0 94.7 130.7 109.5 128.4 113.9 115.2 130.6 168.7 148.3 134.1 90.2 134.8 150.4 117.2 72.5 111.0 113.0 223.8 176.5 114.0 91.5 95.7 95.4 119.5 87.4 91.2 91.1 91.0 80.9 94.0 92.5 93.1 113.5 108.2 83.3 66.3 2.9 62.9 79.0 94.9 156.4 75.1 63.1 203.5 279.4 253.5 133.0 124.7 163.7 25.0 144.5 76.3 141.5 352.1 178.2 1145.8 380.4 114.9 101.6 106.2 199.9 2.9 240.5 166.2 96.9 71.4 126.0 82.4 150.0 111.0 282.5 124.3 33.7 3.2 163.3 126.1 72.9 63.8 2796.6 139.1 68.7 168.9 0.0 122.5 183.2 77.2 1.5 7.9 196.8 196.8 154.2 88.5 127.9 221.4 528.2 386.6 73.6 111.7 111.1 125.1 378.2 183.1 155.9 109.0 103.8 68.1 133.7 167.7 90.1 OVOL3 HOVO3 ENSG00000105261 "Ovo like zinc finger 3" O00110 19 36111151-36113711 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.5;testis: 3.8" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;Oligodendrocyte precursor cells: 1.0;Rod photoreceptor cells: 1.8;Spermatocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.3;U-266/84: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.70e-1)" "unprognostic (6.14e-3)" "unprognostic (3.19e-2)" "unprognostic (1.99e-2)" "unprognostic (7.38e-2)" "unprognostic (1.61e-2)" "unprognostic (1.31e-1)" "unprognostic (4.91e-2)" "unprognostic (1.19e-2)" "unprognostic (2.55e-2)" "unprognostic (6.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.96e-5)" "unprognostic (1.85e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" 0.0 0.0 0.8 0.2 1.1 0.1 0.0 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.5 0.0 0.0 0.0 0.1 1.1 0.9 0.2 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.2 0.9 0.1 0.0 0.4 0.1 0.0 3.8 0.8 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.6 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.1 0.6 0.0 0.0 0.1 0.3 0.4 0.1 1.3 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.7 0.2 0.5 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.2 0.2 0.8 3.2 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 3.0 1.0 0.6 0.5 1.1 0.9 0.2 1.3 0.4 0.8 3.5 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLIP3 "CLIPR-59, RSNL1" ENSG00000105270 "CAP-Gly domain containing linker protein 3" Q96DZ5 19 36014660-36033343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 143.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.9;Excitatory neurons: 24.8;Granulosa cells: 25.7;Horizontal cells: 42.1;Inhibitory neurons: 30.7;Muller glia cells: 26.9;Peritubular cells: 24.5" "Cancer enhanced" "Detected in all" "glioma: 65.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 83.3;fHDF/TERT166: 61.5;HSkMC: 93.1;hTERT-RPE1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079430 Uncertain NA NA "HPA079430: " "unprognostic (1.91e-2)" "unprognostic (8.70e-2)" "unprognostic (1.16e-2)" "unprognostic (5.01e-2)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (3.60e-2)" "unprognostic (2.92e-2)" "unprognostic (2.55e-2)" "unprognostic (3.26e-2)" "prognostic favorable (2.80e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.56e-10)" "unprognostic (6.31e-3)" "unprognostic (1.52e-1)" "unprognostic (9.63e-2)" "unprognostic (1.09e-2)" 15.9 13.7 108.6 9.8 115.4 0.5 14.1 94.1 143.6 48.5 2.2 54.3 6.5 66.7 12.8 16.4 36.0 23.7 9.8 118.8 119.8 11.3 2.9 10.1 7.0 97.3 110.3 109.2 49.0 3.6 2.7 47.3 9.4 119.2 29.5 8.7 55.4 6.4 33.7 3.4 7.3 21.6 38.2 52.4 10.0 25.9 12.1 95.0 9.5 5.6 3.6 6.3 68.8 32.7 109.6 1.3 3.8 33.0 1.4 53.8 83.3 1.1 19.1 45.9 15.6 23.4 4.0 1.3 1.8 7.6 61.5 1.3 1.6 0.6 0.2 11.1 2.4 1.3 1.0 4.1 0.8 54.1 1.0 1.0 93.1 0.9 13.4 0.3 80.8 17.7 13.0 1.9 3.5 35.2 2.9 18.6 1.3 4.0 1.3 0.9 2.4 0.6 1.1 0.5 1.2 32.2 37.6 2.2 0.8 1.0 13.5 1.2 0.4 4.9 26.8 21.9 1.3 1.2 2.8 2.5 1.4 41.1 1.8 10.2 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.3 0.2 0.1 0.4 0.0 0.1 0.2 0.1 108.6 115.4 94.1 143.6 118.8 119.8 97.3 110.3 109.2 119.2 52.4 95.0 109.6 1.1 0.0 0.0 11.4 0.1 0.6 0.6 0.5 0.6 30.9 0.4 4.3 4.3 0.0 0.1 1.8 2.1 0.6 0.0 0.3 0.0 0.1 11.3 0.7 15.3 3.6 2.4 0.0 24.8 0.2 0.5 16.1 1.1 0.7 0.0 25.7 5.0 0.2 0.8 42.1 30.7 0.9 0.0 0.3 2.3 19.2 22.1 0.5 3.6 10.3 0.0 26.9 0.0 14.6 15.3 0.3 0.0 24.5 0.2 0.4 0.3 0.3 0.7 13.7 6.6 8.7 12.8 2.3 3.5 0.5 1.3 1.2 0.6 2.9 0.2 0.1 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 17.1;pituitary gland: 26.4;retina: 11.0;testis: 13.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.7;Cone photoreceptor cells: 27.1;Early spermatids: 25.3;Excitatory neurons: 39.3;Horizontal cells: 32.0;Inhibitory neurons: 42.7;Rod photoreceptor cells: 38.5;Spermatocytes: 29.4" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 16.3;NTERA-2: 31.7;SiHa: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 0.1 2.5 7.9 0.4 10.1 0.2 0.1 0.3 17.1 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.7 0.1 0.2 8.5 7.6 0.2 0.1 0.3 0.2 4.3 2.7 9.9 0.1 0.4 2.5 26.4 0.0 5.6 0.4 0.1 11.0 0.1 0.1 0.1 0.2 0.3 0.0 0.5 0.3 0.3 13.5 5.1 0.0 0.3 0.0 0.2 0.1 0.2 5.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 31.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.5 6.9 0.0 0.4 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 1.1 0.0 1.2 0.0 0.7 0.5 0.0 0.2 1.0 0.8 0.2 0.4 0.0 0.0 0.2 0.3 7.9 10.1 0.3 17.1 8.5 7.6 4.3 2.7 9.9 5.6 0.5 5.1 5.6 0.2 0.0 1.1 2.9 0.2 1.0 0.5 0.1 0.0 33.7 0.2 1.0 1.6 0.0 0.0 0.0 27.1 0.0 1.1 0.0 0.0 0.5 25.3 0.7 0.2 0.5 0.0 0.0 39.3 0.2 0.1 0.2 1.1 0.2 1.3 0.3 0.0 0.1 0.1 32.0 42.7 0.2 0.0 0.0 0.4 11.0 0.9 0.2 1.8 1.9 0.1 4.4 1.0 16.1 4.5 0.2 0.0 0.0 0.3 0.4 0.0 0.3 1.5 38.5 0.0 0.6 0.2 29.4 15.9 0.0 0.1 0.0 1.5 0.1 0.0 0.4 SLC1A5 "AAAT, ASCT2, M7V1, RDRC" ENSG00000105281 "Solute carrier family 1 member 5" Q15758 19 46774883-46788594 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Host-virus interaction, Symport, Transport" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 148.6;Erythroid cells: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 95.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035239, HPA035240" Enhanced Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA035239: AB_10670587, HPA035240: AB_10604092" "unprognostic (8.26e-3)" "unprognostic (6.38e-2)" "unprognostic (7.24e-2)" "unprognostic (7.94e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.66e-8)" "unprognostic (2.08e-1)" "unprognostic (1.06e-2)" "unprognostic (9.82e-2)" "unprognostic (9.40e-3)" "unprognostic (9.57e-3)" "prognostic unfavorable (1.18e-7)" "unprognostic (1.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.06e-2)" "unprognostic (9.83e-2)" 98.1 16.1 6.7 29.9 7.4 61.4 78.4 7.1 6.2 57.9 7.7 50.6 16.4 39.4 98.8 98.8 49.3 36.8 22.2 6.1 22.2 39.0 8.2 65.9 28.2 15.8 8.9 4.9 46.1 73.8 2.9 24.7 47.3 13.8 99.4 42.8 1.4 121.5 77.7 8.5 55.3 36.5 33.3 10.4 40.7 55.9 40.6 9.6 20.1 14.2 10.7 30.5 110.5 83.7 10.4 179.6 323.6 76.3 116.1 194.7 164.3 180.0 249.6 283.0 183.2 264.1 296.1 197.1 194.8 118.9 624.2 105.2 281.1 224.9 296.9 135.5 130.1 203.7 324.3 115.1 281.9 501.3 228.2 182.9 268.6 727.3 215.5 541.1 61.3 98.9 255.0 348.9 500.1 99.5 304.5 105.4 611.1 134.0 636.5 140.9 117.8 86.5 282.7 104.2 384.8 117.3 86.0 123.4 331.8 275.4 58.8 191.6 296.6 74.1 109.4 174.1 86.4 205.7 308.0 325.3 164.0 206.3 281.0 274.3 0.1 36.1 2.9 14.1 55.0 11.4 17.8 8.0 9.9 50.2 8.1 1.9 6.0 1.0 21.0 66.3 95.8 15.5 27.8 6.7 7.4 7.1 6.2 6.1 22.2 15.8 8.9 4.9 13.8 10.4 9.6 10.4 63.6 0.0 17.3 0.0 31.1 57.7 148.6 95.9 64.9 0.2 52.0 43.1 20.3 21.5 41.2 0.0 0.0 80.8 86.3 44.6 3.9 38.5 27.0 2.6 32.9 29.0 10.7 143.3 0.6 65.7 129.3 48.0 21.9 2.7 29.2 20.9 29.6 0.7 38.4 0.0 0.8 111.3 40.7 21.6 34.7 14.0 19.0 39.8 19.6 3.7 26.0 0.6 12.3 0.0 0.6 43.4 74.8 19.5 68.6 59.0 6.5 23.1 13.0 0.8 6.6 15.8 44.0 35.9 4.0 69.0 28.3 24.4 38.7 6.1 62.9 100.0 PRKD2 "DKFZP586E0820, HSPC187, PKD2" ENSG00000105287 "Protein kinase D2" Q9BZL6 19 46674275-46717127 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Cell adhesion, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 149.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021490, HPA056727" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021490: AB_1855708, HPA056727: AB_2683217" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.06e-2)" "unprognostic (8.91e-2)" "unprognostic (1.99e-2)" "unprognostic (8.79e-3)" "unprognostic (2.61e-1)" "unprognostic (6.22e-2)" "unprognostic (4.21e-3)" "unprognostic (8.89e-2)" "unprognostic (2.74e-1)" "unprognostic (3.45e-3)" "unprognostic (1.04e-2)" "unprognostic (7.19e-2)" "unprognostic (4.34e-2)" "prognostic favorable (9.15e-4)" 27.3 11.6 8.2 23.8 6.9 29.6 29.6 4.9 11.3 23.9 11.8 17.8 17.3 22.0 4.7 27.7 24.3 11.3 12.9 6.6 7.2 18.8 13.9 34.6 31.3 10.0 5.4 2.4 22.0 19.3 8.4 24.2 11.2 6.0 24.1 7.2 4.5 24.9 10.1 8.1 46.7 30.1 6.1 5.1 54.7 20.4 6.7 7.9 25.8 29.1 4.9 21.3 19.7 27.1 12.4 19.6 34.5 12.8 16.6 7.3 6.4 15.1 11.5 13.2 19.6 19.7 19.7 21.0 22.3 16.3 13.2 13.2 27.5 9.5 26.0 5.9 19.8 17.5 25.9 11.5 10.2 12.8 21.2 34.7 11.0 15.8 12.7 9.8 12.8 30.1 21.5 14.6 35.4 7.0 23.8 32.7 53.1 9.7 27.4 17.4 25.8 5.8 37.5 11.4 32.7 7.7 22.4 18.8 18.8 4.6 10.6 11.6 7.5 17.6 8.7 18.8 7.1 10.0 31.8 149.1 13.5 8.5 17.7 11.0 0.6 0.7 2.6 3.9 0.7 3.3 4.3 3.9 4.3 0.3 4.1 3.3 3.3 5.3 2.2 0.5 0.0 2.9 1.5 8.2 6.9 4.9 11.3 6.6 7.2 10.0 5.4 2.4 6.0 5.1 7.9 12.4 37.8 9.6 9.9 5.9 46.5 22.0 32.0 13.2 22.8 6.4 13.9 11.3 17.2 12.8 13.0 9.2 0.0 13.8 17.5 43.6 7.9 18.6 1.2 15.3 6.7 37.2 21.6 4.0 6.5 28.2 13.8 9.6 23.4 15.0 14.5 14.1 37.1 8.5 9.0 1.7 2.8 21.7 4.1 12.3 11.4 3.1 11.8 8.3 12.4 11.2 9.3 6.5 42.2 4.0 3.1 29.5 35.1 6.8 47.0 22.9 34.1 9.3 15.6 4.4 13.1 6.1 7.6 2.9 17.9 21.2 26.7 29.7 31.9 6.6 15.3 30.2 TJP3 ZO-3 ENSG00000105289 "Tight junction protein 3" O95049 19 3708362-3750813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.4;stomach 1: 27.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 238.7;Early spermatids: 405.1;Paneth cells: 140.4;Proximal enterocytes: 130.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 1.2;MAIT T-cell: 3.9;memory CD4 T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.2;T-reg: 3.8" "Lineage enriched" "Detected in single" 7 "T-cells: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 44.0;CAPAN-2: 41.1;MCF7: 20.3;OE19: 37.4;SK-BR-3: 25.7;T-47d: 52.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB013244, HPA046863, HPA053337" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.83e-6)" "unprognostic (2.78e-1)" "prognostic favorable (9.52e-4)" "unprognostic (1.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.52e-1)" "unprognostic (6.52e-2)" "unprognostic (2.15e-2)" "unprognostic (1.78e-1)" "prognostic favorable (9.36e-8)" "unprognostic (8.58e-3)" "unprognostic (5.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.62e-3)" 0.1 0.0 0.4 4.7 0.2 0.1 4.0 0.2 0.5 6.4 5.9 31.8 43.4 1.5 2.4 25.7 13.8 6.3 0.0 0.5 0.1 5.8 7.2 5.3 0.4 0.3 0.2 0.3 0.1 6.4 7.5 1.7 1.7 0.6 4.0 13.3 0.1 21.0 5.4 0.8 6.5 37.7 0.6 0.0 0.5 27.2 2.5 0.2 0.2 7.0 0.0 2.6 4.2 6.0 0.5 0.3 8.3 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 13.0 41.1 8.2 1.3 0.0 0.1 10.4 0.6 0.0 0.0 0.5 0.2 0.0 0.7 2.9 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.3 0.0 20.3 0.0 0.3 0.9 37.4 0.2 0.1 0.0 6.2 1.4 6.8 0.2 0.2 1.6 25.7 0.0 3.3 52.2 0.2 0.0 0.1 1.0 0.1 0.0 1.7 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 3.9 0.4 3.1 2.4 0.0 0.6 3.3 1.2 0.0 0.0 0.0 0.0 3.8 1.2 0.4 0.2 0.2 0.5 0.5 0.1 0.3 0.2 0.3 0.6 0.0 0.2 0.5 0.1 9.6 13.7 0.3 1.9 0.0 7.0 21.0 0.0 0.0 20.3 6.3 0.9 34.3 42.1 31.3 0.0 32.1 0.8 238.7 19.6 21.1 405.1 31.2 1.1 0.5 12.5 0.0 0.9 23.6 4.2 0.6 52.5 13.2 4.5 0.1 0.0 7.3 2.7 0.0 0.9 50.9 24.4 0.3 0.3 36.5 1.8 0.8 3.6 0.0 0.1 0.0 0.0 0.5 1.4 21.8 140.4 1.2 0.2 6.5 130.4 8.0 86.1 0.0 0.0 0.0 3.4 4.3 4.8 8.0 0.1 40.2 4.3 0.0 62.1 25.6 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879792 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 1182.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 6400000 "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 2.4 31.8 442.9 3.1 660.6 0.4 1.4 638.5 574.3 2.8 216.8 3.7 1.8 3.1 1.3 1.5 2.7 5.5 10.1 433.0 565.8 4.7 0.6 1.9 1.4 697.2 628.3 406.8 1.4 75.7 22.5 152.6 0.9 690.9 2.2 2.2 56.8 1.8 1.9 0.6 1.1 2.1 3.2 680.3 0.5 28.4 13.2 590.9 0.8 1.5 0.5 1.5 1.2 2.1 1182.3 4.4 40.0 81.6 162.9 7.1 3.2 10.4 5.6 3.5 7.8 1.1 7.3 6.3 0.8 66.5 21.0 27.7 2.2 26.1 2.6 5.2 48.9 3.7 0.3 10.6 5.2 2.0 0.2 76.0 3.6 1.8 3.2 0.1 28.8 3.1 6.1 2.7 1.2 25.0 8.3 0.2 0.3 3.9 16.5 16.5 7.2 0.4 1.1 1.4 1.1 87.2 89.3 23.1 3.8 0.8 23.9 20.8 4.3 1.3 61.3 28.8 32.9 4.3 2.4 1.6 0.3 42.3 1.1 33.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 442.9 660.6 638.5 574.3 433.0 565.8 697.2 628.3 406.8 690.9 680.3 590.9 1182.3 2.5 6.4 0.0 12.4 0.6 1.3 2.6 0.7 1.2 147.1 0.4 1.1 6.2 1.5 0.2 0.0 12.5 0.3 0.3 0.4 0.0 2.0 27.6 1.3 1.2 2.8 34.9 0.0 55.5 4.2 6.4 2.8 10.2 3.2 0.0 0.1 0.7 0.4 0.4 161.5 46.8 1.1 2.0 0.3 1.6 15.8 1.2 1.1 5.4 12.2 0.0 14.6 0.0 19.1 461.3 3.1 0.1 0.0 0.4 1.9 0.0 0.1 0.2 38.6 0.0 1.9 1.8 14.5 28.7 0.1 0.6 0.4 0.5 0.1 0.2 1.3 CACTIN "C19orf29, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610645-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favorable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 14.3 14.3 19.0 7.9 18.0 10.1 15.0 17.6 24.2 15.6 15.1 15.1 6.2 16.8 2.6 15.5 17.0 3.0 14.9 18.8 17.3 15.7 20.1 12.5 7.7 19.5 18.1 17.7 24.9 17.4 4.2 13.5 4.6 18.3 17.4 3.2 4.6 13.3 4.2 19.6 17.8 15.3 2.9 17.0 18.5 16.0 18.4 18.6 8.8 15.4 6.2 4.4 16.7 14.7 18.7 22.2 12.5 10.3 17.9 7.4 7.2 15.6 15.4 6.3 9.1 10.2 12.5 9.7 18.4 12.9 9.7 10.6 20.4 10.8 12.9 5.5 18.7 14.8 11.4 19.2 15.1 10.3 15.7 15.9 7.1 12.2 8.4 5.8 5.4 13.2 15.6 25.9 19.8 4.9 13.3 28.0 13.5 22.0 13.4 14.8 29.4 13.5 17.5 8.5 11.0 14.2 19.9 17.4 12.1 13.3 5.5 9.8 17.7 17.2 12.3 15.5 27.0 27.4 30.3 21.6 20.7 15.2 24.8 16.8 0.0 0.4 0.0 1.2 1.0 0.4 0.6 0.5 0.5 0.3 0.6 0.6 0.8 0.2 0.3 0.1 1.4 0.5 0.4 19.0 18.0 17.6 24.2 18.8 17.3 19.5 18.1 17.7 18.3 17.0 18.6 18.7 7.4 0.0 2.7 5.9 6.3 6.0 4.1 2.8 5.7 5.1 6.9 7.1 3.1 5.7 2.2 1.8 2.1 3.6 7.2 6.9 0.0 5.1 3.3 6.7 5.8 5.3 1.2 7.4 3.9 4.9 5.2 5.1 9.2 7.4 4.5 8.5 3.3 4.8 5.1 0.0 4.1 5.8 2.0 3.9 6.5 4.5 5.9 5.3 1.8 3.7 6.1 6.0 8.2 2.5 5.8 5.2 4.4 5.7 6.0 6.0 3.6 3.1 2.4 6.2 0.0 7.2 6.4 10.8 8.8 7.9 8.0 3.3 5.6 7.6 6.1 3.6 CCDC9 DKFZP586M1019 ENSG00000105321 "Coiled-coil domain containing 9" Q9Y3X0 19 47255980-47273701 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 50.6;Late spermatids: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 116.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045624, HPA072007" Enhanced Approved Cytosol NA NA Cytosol "HPA045624: AB_10961402, HPA072007: AB_2686482" "unprognostic (4.53e-3)" "unprognostic (1.75e-1)" "unprognostic (3.70e-3)" "unprognostic (8.22e-2)" "unprognostic (7.47e-2)" "unprognostic (1.15e-2)" "unprognostic (8.35e-3)" "unprognostic (1.45e-1)" "unprognostic (4.99e-1)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (9.78e-2)" "unprognostic (2.58e-1)" "unprognostic (2.45e-2)" "unprognostic (1.02e-1)" "unprognostic (7.46e-3)" "unprognostic (4.02e-1)" 22.0 21.2 12.5 16.3 11.2 41.0 22.4 9.5 16.2 28.0 15.8 23.3 13.8 24.9 8.8 18.3 25.0 10.4 21.0 12.4 14.0 21.4 22.9 26.9 10.7 15.9 11.6 8.6 31.0 49.4 14.1 16.8 13.7 12.5 26.0 8.6 12.7 20.2 12.4 26.4 34.8 19.0 9.9 9.4 23.3 25.0 36.1 12.5 9.4 23.2 11.8 7.8 24.0 24.1 15.3 27.5 27.7 21.2 23.7 6.6 17.9 24.1 37.2 16.4 22.4 24.5 29.5 21.1 12.5 10.0 24.8 18.6 25.5 19.7 16.0 12.1 33.3 12.3 32.3 27.3 22.7 21.1 13.2 31.9 19.2 23.0 21.4 20.0 19.0 15.1 15.6 45.0 61.8 15.0 32.8 15.4 116.9 23.7 45.3 10.8 26.9 20.2 14.4 10.2 19.7 8.3 21.1 50.5 36.4 20.3 17.3 30.2 26.7 20.9 25.8 23.0 15.6 32.2 20.5 38.5 19.0 24.2 17.8 20.3 0.4 1.1 2.0 1.3 1.4 0.7 0.6 1.0 1.0 0.9 0.9 1.0 0.7 3.6 1.1 0.8 1.4 1.9 0.4 12.5 11.2 9.5 16.2 12.4 14.0 15.9 11.6 8.6 12.5 9.4 12.5 15.3 13.6 6.4 1.7 1.3 16.4 14.0 15.7 1.8 12.0 3.1 8.9 5.2 3.0 2.8 1.9 1.8 4.2 5.4 9.3 13.1 5.9 7.5 50.6 13.0 10.3 9.7 3.6 8.2 1.4 11.2 9.1 7.6 14.3 16.8 8.2 4.3 3.3 3.6 5.8 0.0 1.0 12.0 2.0 7.8 14.4 79.3 4.4 9.8 7.2 1.9 10.4 1.8 7.2 0.5 0.9 11.1 11.5 3.8 15.2 8.9 7.8 6.7 2.1 7.6 6.6 8.7 10.5 2.8 7.5 12.7 17.8 15.3 12.2 5.3 8.4 13.5 HNRNPUL1 "E1B-AP5, E1BAP5, FLJ12944, HNRPUL1" ENSG00000105323 "Heterogeneous nuclear ribonucleoprotein U like 1" Q9BUJ2 19 41262496-41307787 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046290, CAB046477, HPA049475" Enhanced Enhanced Nucleoplasm NA NA 26000 Nucleoplasm "CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783" "unprognostic (5.52e-2)" "unprognostic (6.37e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.39e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-3)" "unprognostic (1.94e-1)" "unprognostic (6.08e-2)" "unprognostic (2.86e-1)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (5.78e-2)" "unprognostic (2.32e-1)" "unprognostic (1.66e-1)" "unprognostic (8.05e-2)" "unprognostic (2.39e-1)" 81.8 66.5 51.0 89.9 59.3 177.8 75.7 61.5 64.3 78.1 55.4 80.6 82.1 85.7 49.5 82.2 83.5 58.5 76.4 50.5 53.2 48.6 53.0 75.7 103.2 64.7 53.8 45.0 117.3 72.3 65.2 58.8 49.2 57.7 60.1 73.8 92.0 85.5 67.4 93.5 91.3 79.4 79.7 52.1 87.2 74.1 80.5 52.9 141.3 70.6 76.2 110.5 75.8 72.7 64.4 284.3 371.2 216.5 200.4 104.3 124.0 82.2 163.1 194.1 207.1 187.8 218.7 213.2 250.1 112.3 206.4 116.8 91.2 208.1 191.3 234.6 248.5 172.9 272.9 168.8 170.4 121.0 259.5 244.3 132.9 116.8 185.8 171.6 186.5 195.7 187.1 203.1 233.8 185.9 217.0 341.0 151.8 165.0 270.8 126.7 219.0 171.6 142.3 149.0 298.8 171.2 154.2 363.3 212.6 95.4 147.7 163.7 290.2 188.4 231.6 218.6 105.4 318.3 264.3 184.5 238.4 147.5 210.8 311.6 13.2 6.2 11.0 11.9 6.7 18.1 8.8 14.4 12.4 7.3 9.0 9.9 7.9 13.5 12.6 7.9 13.7 10.9 5.7 51.0 59.3 61.5 64.3 50.5 53.2 64.7 53.8 45.0 57.7 52.1 52.9 64.4 57.0 80.1 69.6 14.7 105.4 56.2 42.9 35.9 71.7 63.2 69.0 58.5 64.1 52.9 36.1 31.3 73.0 50.1 151.9 51.4 45.0 65.1 51.6 52.7 76.8 57.7 76.7 129.4 13.9 62.2 58.8 67.7 55.5 54.2 58.9 78.8 60.3 43.0 63.6 48.8 16.2 66.4 30.5 102.4 76.5 73.9 86.3 92.3 35.6 16.9 81.1 70.8 93.7 21.6 22.2 68.6 39.4 71.5 152.2 48.6 49.5 29.5 49.9 97.3 78.9 74.7 70.3 113.6 108.9 99.1 60.2 53.4 134.2 60.3 73.6 43.6 FZR1 "CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242" ENSG00000105325 "Fizzy and cell division cycle 20 related 1" Q9UM11 19 3506311-3538334 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 104.2;Late spermatids: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043536 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA043536: AB_10968058" "unprognostic (2.78e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (9.20e-2)" "unprognostic (1.61e-1)" "unprognostic (9.70e-2)" "unprognostic (1.18e-1)" "unprognostic (4.15e-3)" "unprognostic (1.41e-2)" "unprognostic (3.75e-1)" "unprognostic (5.41e-3)" "unprognostic (1.75e-1)" "unprognostic (9.04e-2)" "unprognostic (1.04e-1)" 13.5 25.4 16.1 9.4 13.0 33.8 16.6 17.3 17.3 20.9 4.1 17.0 22.1 19.4 4.1 23.7 18.4 9.5 13.0 15.8 15.1 18.1 23.7 15.7 11.5 18.1 16.5 13.8 23.1 17.5 11.0 34.3 9.0 16.4 19.2 3.7 5.7 19.8 10.5 18.6 26.0 18.6 6.3 10.4 18.9 15.8 53.1 14.7 14.0 24.2 7.6 7.0 16.3 21.1 13.8 44.0 25.7 24.3 22.4 7.5 10.4 18.9 26.7 17.8 31.0 24.2 26.2 21.1 24.3 13.5 19.7 15.0 25.2 13.7 23.4 6.2 32.9 23.5 11.6 19.5 26.2 13.4 20.9 23.8 9.8 13.5 18.8 11.2 11.7 18.4 23.0 21.0 41.1 16.1 22.8 37.5 15.2 20.5 13.6 20.1 28.0 20.6 23.6 15.6 21.6 22.3 25.0 24.1 17.5 13.1 5.5 18.2 19.1 24.9 17.6 21.3 42.9 47.4 42.9 10.8 18.5 24.4 41.5 22.3 1.1 0.7 2.0 1.0 0.7 0.6 1.0 1.0 0.7 0.6 0.8 0.6 0.8 1.3 1.2 0.5 0.5 0.9 0.6 16.1 13.0 17.3 17.3 15.8 15.1 18.1 16.5 13.8 16.4 10.4 14.7 13.8 8.1 0.0 5.0 6.5 15.4 17.8 35.8 10.6 6.2 20.7 14.5 11.2 3.4 17.2 8.6 12.9 10.4 21.9 11.0 25.8 5.9 16.5 104.2 14.1 8.2 11.0 21.6 26.5 6.3 14.9 14.2 10.1 26.5 14.3 3.8 20.4 10.0 17.9 16.4 30.3 9.1 18.1 18.3 7.9 11.4 208.2 12.8 11.9 12.4 3.7 18.1 8.5 9.2 6.6 10.4 28.1 17.0 9.4 13.7 20.6 17.4 13.5 10.8 15.6 6.6 7.3 12.9 58.4 15.8 11.9 22.6 45.4 11.9 15.6 16.1 28.3 BBC3 "JFY1, PUMA" ENSG00000105327 "BCL2 binding component 3" "Q96PG8, Q9BXH1" 19 47220822-47232766 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.4;Basal squamous epithelial cells: 111.5;Prostatic glandular cells: 132.9;Suprabasal keratinocytes: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 4.5;neutrophil: 3.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "HHSteC: 28.4;NB-4: 34.9" "CAB007752, HPA070403" Approved Approved Cytosol NA NA Cytosol "CAB007752: AB_562336, HPA070403: " "unprognostic (4.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.31e-4)" "unprognostic (2.95e-2)" "unprognostic (4.74e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (1.93e-1)" "unprognostic (8.38e-3)" "unprognostic (7.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-2)" "unprognostic (4.66e-3)" "unprognostic (5.06e-2)" "unprognostic (3.57e-1)" "prognostic favorable (2.62e-5)" 2.9 4.5 2.5 2.1 2.5 4.9 4.1 4.2 4.8 2.9 1.5 5.3 2.4 3.5 0.6 2.0 3.6 2.0 3.3 3.1 2.2 3.8 5.6 7.7 2.8 2.4 3.2 2.8 3.2 7.8 2.0 2.1 1.9 2.8 4.2 1.9 0.2 7.5 1.2 10.5 8.3 5.0 0.7 2.4 6.2 5.0 2.7 2.3 4.0 3.1 1.1 0.8 4.9 3.4 2.7 3.8 8.3 9.0 1.9 2.1 4.1 22.1 5.9 7.9 1.4 3.5 2.5 6.3 14.7 2.5 1.5 2.5 1.2 1.3 5.3 0.2 9.3 15.9 4.2 2.8 16.4 28.4 0.7 13.4 9.8 8.4 3.0 2.8 3.7 10.3 4.4 10.9 9.0 1.0 8.6 1.6 34.9 5.6 6.5 1.1 4.1 1.3 17.7 0.4 1.3 1.5 13.5 2.7 5.6 18.7 7.1 1.9 11.7 6.9 1.7 11.1 0.2 1.9 14.4 3.4 9.5 2.6 2.2 6.2 4.5 0.4 0.2 0.4 0.5 0.4 0.1 0.1 0.3 0.2 0.0 0.5 0.3 3.4 0.6 0.4 0.1 0.3 0.2 2.5 2.5 4.2 4.8 3.1 2.2 2.4 3.2 2.8 2.8 2.4 2.3 2.7 16.2 9.6 7.4 1.6 21.7 117.4 78.8 40.3 111.5 6.5 46.4 29.1 5.6 10.0 21.8 7.3 0.0 4.7 28.3 51.9 0.0 52.4 14.6 65.2 14.0 15.8 21.4 16.8 3.2 39.8 5.5 12.1 23.4 66.2 12.7 8.4 3.9 3.5 7.1 0.0 3.9 40.6 30.5 10.3 31.9 3.3 6.2 17.1 64.0 2.8 15.7 3.7 32.0 1.0 0.5 55.2 49.3 4.1 19.3 132.9 16.2 4.1 22.9 4.4 6.6 12.4 34.9 0.5 1.7 59.4 143.3 20.5 28.5 10.2 27.4 66.2 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" 19 41301587-41353922 "Human disease related genes, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 1290000 "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 39.0 28.8 9.9 40.1 10.4 83.6 25.7 10.7 9.5 52.5 13.3 28.5 14.5 46.3 7.5 52.6 28.0 18.3 30.6 7.6 16.1 36.0 14.8 64.0 34.3 16.1 12.4 3.6 17.6 14.4 11.6 18.2 32.4 15.4 31.9 8.4 0.6 21.3 20.0 8.2 27.9 38.1 22.0 16.8 89.7 20.2 8.2 21.1 16.9 20.4 8.4 25.9 44.5 45.7 17.3 57.7 87.6 3.4 0.3 41.7 35.3 10.0 81.9 64.4 25.2 15.4 40.4 30.1 57.0 88.6 110.5 26.8 30.1 17.8 54.6 11.1 76.6 17.9 199.0 18.0 50.4 47.7 54.9 119.6 45.0 17.5 50.5 32.7 138.7 135.2 21.1 108.0 116.8 27.9 42.1 43.1 79.6 9.4 12.0 52.7 44.4 13.1 85.4 46.8 20.3 0.3 6.5 23.9 0.1 15.1 32.5 1.9 36.3 170.3 96.4 77.2 20.7 91.2 74.4 31.7 36.3 90.3 106.4 16.4 1.1 0.8 3.9 0.7 1.2 0.6 0.2 0.3 0.4 0.5 0.3 0.2 0.3 2.4 0.3 0.8 0.9 0.3 0.9 9.9 10.4 10.7 9.5 7.6 16.1 16.1 12.4 3.6 15.4 16.8 21.1 17.3 55.0 0.0 0.0 3.3 120.6 44.4 36.5 64.8 38.7 0.2 14.4 9.7 2.3 4.3 17.2 16.5 0.0 5.4 438.3 1.4 0.0 12.8 1.0 5.7 18.2 63.1 0.0 28.0 1.6 17.1 452.1 34.3 14.3 5.0 64.9 20.0 71.4 2.7 141.2 0.0 2.1 1.4 22.4 136.1 158.6 1.8 12.2 188.8 23.2 30.0 105.8 0.3 223.5 0.0 0.6 45.1 16.4 18.0 156.5 32.9 0.4 9.0 9.7 0.7 39.5 13.9 78.6 3.1 8.0 40.3 18.9 55.7 221.9 4.1 0.8 31.1 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 107.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 157.0;Microglial cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 34.6;neutrophil: 39.8" "Group enriched" "Detected in many" 5 "granulocytes: 39.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "HDLM-2: 64.6;HeLa: 89.5;U-937: 58.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA024491: AB_2671581, HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 37.7 8.9 21.0 27.5 19.4 107.4 28.5 12.6 25.1 21.7 18.8 30.1 5.7 17.9 2.1 7.6 19.3 13.7 21.0 18.5 27.0 21.4 6.5 58.4 28.8 33.1 21.8 18.5 15.2 7.6 4.1 10.1 15.3 24.7 17.0 7.9 3.7 18.3 8.6 13.9 13.7 23.9 8.4 17.2 44.2 15.9 6.1 25.6 7.2 20.8 11.8 25.3 12.5 17.7 32.2 16.4 14.8 1.0 3.1 4.4 6.4 2.4 8.5 27.4 3.8 3.0 4.6 15.3 4.2 22.8 17.5 7.5 7.8 4.2 10.0 2.7 64.6 3.6 17.3 89.5 1.4 3.9 17.2 2.4 0.5 5.1 4.2 5.3 9.2 21.1 7.8 0.2 40.7 2.9 5.2 2.6 24.1 1.1 3.2 16.6 2.9 0.8 16.6 14.8 5.6 4.7 3.0 1.8 1.3 1.1 7.3 6.8 27.6 16.7 0.7 6.8 10.6 0.3 8.0 37.0 1.3 2.6 58.6 1.0 24.3 5.4 34.6 0.8 8.0 0.8 5.0 0.6 0.3 4.1 4.3 0.1 0.2 39.8 2.7 10.0 0.1 0.2 3.5 21.0 19.4 12.6 25.1 18.5 27.0 33.1 21.8 18.5 24.7 17.2 25.6 32.2 49.0 157.0 35.2 2.6 39.7 15.7 7.6 11.7 7.4 4.5 6.3 2.0 10.1 10.0 18.8 22.0 4.2 0.7 29.5 18.3 1.9 3.5 6.1 15.1 8.1 31.7 4.8 5.7 53.9 3.5 0.6 4.8 16.8 14.5 10.8 1.9 16.4 0.3 24.4 1.7 5.2 7.9 4.1 55.6 22.2 2.8 1.5 39.7 8.8 79.6 33.0 0.7 21.6 1.5 1.1 11.0 9.9 0.7 38.8 20.3 1.5 2.7 15.1 0.5 39.5 2.1 21.5 8.7 8.5 2.9 9.1 0.5 12.5 0.6 4.1 6.3 DMAC2 "ATP5SL, FLJ10241" ENSG00000105341 "Distal membrane arm assembly complex 2" Q9NW81 19 41431318-41440717 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Distal tubular cells: 39.2;Ductal cells: 44.0;Exocrine glandular cells: 40.5;Extravillous trophoblasts: 67.9;Hofbauer cells: 40.4;Proximal tubular cells: 46.3;Syncytiotrophoblasts: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041427 Approved Approved Mitochondria NA NA Mitochondria "HPA041427: AB_2677473" "unprognostic (1.42e-3)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.20e-1)" "unprognostic (6.88e-3)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.77e-4)" "unprognostic (4.37e-1)" "unprognostic (3.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "prognostic favorable (4.07e-5)" "unprognostic (5.20e-2)" "unprognostic (2.48e-1)" "unprognostic (6.60e-2)" "unprognostic (7.29e-3)" 26.5 33.5 29.7 16.3 28.7 18.3 26.4 30.0 35.0 26.9 25.8 37.5 45.3 31.8 10.5 34.8 27.2 14.2 85.7 28.6 30.0 40.9 36.5 32.9 20.7 30.6 31.0 27.7 24.6 36.2 33.5 16.3 19.0 30.6 27.7 18.1 18.9 26.6 20.4 69.1 30.3 42.9 22.5 29.8 27.0 38.5 14.0 31.1 25.9 27.1 80.8 17.3 37.4 26.4 30.1 39.1 134.9 48.4 32.4 33.2 32.9 28.8 31.9 36.9 55.7 49.5 96.7 43.5 40.4 47.8 47.3 30.1 28.6 36.9 59.0 28.4 37.3 47.4 38.1 35.2 70.8 49.5 64.6 36.8 52.5 53.3 44.6 31.3 37.9 66.2 54.7 52.3 39.2 38.0 48.4 59.2 26.4 60.5 55.7 40.3 48.7 38.1 35.8 53.8 53.4 34.6 57.1 51.4 41.9 35.0 38.4 39.2 72.3 50.0 47.7 52.0 29.3 55.7 41.0 41.7 36.6 42.5 46.5 35.0 15.0 28.4 24.2 22.0 25.7 22.9 16.8 16.7 22.2 40.3 19.7 17.7 17.2 9.3 22.9 22.8 26.6 21.0 23.2 29.7 28.7 30.0 35.0 28.6 30.0 30.6 31.0 27.7 30.6 29.8 31.1 30.1 25.4 28.9 16.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 25.7 19.7 0.0 0.0 5.6 12.9 0.0 47.9 9.6 0.0 39.2 44.0 0.0 10.3 17.3 11.6 0.0 0.0 0.0 40.5 67.9 9.3 0.0 14.7 7.6 22.4 0.0 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 31.6 0.0 0.0 0.0 0.0 29.2 0.0 0.0 1.4 0.0 0.0 46.3 2.9 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 46.4 6.5 21.0 0.0 0.0 CEACAM4 CGM7 ENSG00000105352 "CEA cell adhesion molecule 4" O75871 19 41618971-41627074 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 21.5;lymphoid tissue: 32.9" "Cell type enhanced" "Detected in some" "Kupffer cells: 41.1;Macrophages: 20.9;monocytes: 9.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 4 "neutrophil: 122.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 122.7" "Cell line enriched" "Detected in single" 6 "U-937: 4.1" NA NA "unprognostic (1.10e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (4.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.83e-2)" "unprognostic (9.11e-2)" "unprognostic (5.59e-2)" "unprognostic (1.79e-2)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (2.17e-1)" "unprognostic (2.09e-9)" "unprognostic (3.65e-2)" "unprognostic (2.95e-2)" "unprognostic (1.47e-1)" "unprognostic (4.34e-1)" 1.4 0.5 0.1 4.9 0.1 21.5 0.5 0.1 0.2 0.4 0.2 0.6 0.3 0.3 0.8 1.0 1.0 1.0 0.7 0.1 0.2 0.8 1.0 5.8 0.9 0.2 0.1 0.0 0.2 1.2 0.0 0.3 0.3 0.3 1.1 0.2 0.0 0.8 0.0 0.2 0.3 1.8 1.0 0.1 32.9 0.8 0.2 0.2 0.3 0.4 0.6 0.6 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 30.1 5.6 0.0 23.1 0.1 0.7 1.2 0.0 23.3 0.0 0.7 0.0 122.7 0.0 9.9 0.2 11.3 12.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.0 3.9 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.1 0.0 0.0 0.0 0.0 41.1 1.6 0.2 0.0 20.9 1.8 1.9 9.2 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 PLIN3 "M6PRBP1, PP17, TIP47" ENSG00000105355 "Perilipin 3" O60664 19 4838341-4867694 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 268.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006427, HPA066538" Uncertain Supported "Lipid droplets" NA Yes 11000000 "Lipid droplets" "HPA006427: AB_1079289, HPA066538: AB_2685687" "unprognostic (1.18e-1)" "unprognostic (4.86e-2)" "unprognostic (1.55e-2)" "prognostic favorable (2.62e-4)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.27e-5)" "prognostic unfavorable (7.67e-6)" "unprognostic (2.27e-1)" "unprognostic (1.28e-1)" "unprognostic (4.34e-2)" "unprognostic (8.24e-2)" "prognostic unfavorable (9.15e-7)" "unprognostic (2.62e-1)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (2.39e-2)" 28.5 70.5 23.5 41.8 37.1 71.5 29.8 43.9 30.6 39.7 27.2 33.2 71.4 22.7 14.6 125.7 23.1 34.8 24.2 21.9 41.3 26.4 26.7 26.0 29.4 50.0 40.2 19.4 40.4 20.5 9.9 9.4 33.5 46.4 28.2 21.1 1.8 46.2 21.2 113.0 84.0 74.5 24.1 39.5 32.5 28.7 34.5 34.5 28.3 25.1 36.7 33.3 37.8 55.8 67.8 138.2 79.1 53.6 50.5 59.8 189.8 24.1 196.8 178.9 152.0 142.9 52.6 124.9 72.5 43.3 242.2 82.1 61.3 25.1 108.2 88.2 82.7 35.4 79.1 43.0 97.8 41.4 56.7 112.9 147.1 46.2 107.4 23.6 90.5 81.2 23.5 122.4 31.3 192.1 57.1 78.3 72.9 42.5 63.3 127.7 136.2 74.9 40.2 133.8 31.7 2.3 26.3 62.5 55.5 49.5 43.2 70.4 125.9 125.1 83.3 80.5 333.8 102.9 44.1 58.9 50.8 250.7 79.6 97.3 128.3 141.7 64.8 13.8 100.4 14.6 46.3 24.7 15.9 109.1 36.3 19.4 12.4 173.9 39.5 76.7 82.8 34.1 86.4 23.5 37.1 43.9 30.6 21.9 41.3 50.0 40.2 19.4 46.4 39.5 34.5 67.8 19.2 19.2 25.6 5.5 28.5 142.2 62.9 58.8 90.0 0.4 108.0 43.1 2.3 14.3 51.3 11.0 2.1 152.2 34.4 169.7 37.2 114.7 9.7 65.2 50.9 27.7 40.7 18.5 0.8 86.8 77.3 62.9 33.1 78.4 55.8 112.9 26.0 18.2 101.2 0.0 1.1 67.0 28.5 57.8 103.4 14.0 35.8 74.7 55.2 2.8 62.3 23.9 15.5 5.0 17.1 243.4 223.0 53.0 37.1 39.3 268.8 38.8 65.2 0.7 52.6 37.8 66.2 75.1 14.6 109.0 229.3 194.8 20.3 193.4 54.8 69.2 MYH14 "DFNA4, FLJ13881, KIAA2034, MHC16, MYH17" ENSG00000105357 "Myosin heavy chain 14" Q7Z406 19 50188186-50310542 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 192.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062391, HPA067889, HPA070260" Enhanced Approved Nucleoplasm NA NA 9600000 Nucleoplasm "HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243" "unprognostic (2.52e-1)" "unprognostic (5.81e-2)" "unprognostic (9.63e-2)" "unprognostic (3.73e-3)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.71e-1)" "unprognostic (3.48e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "prognostic favorable (3.97e-8)" "prognostic favorable (7.83e-4)" "unprognostic (8.50e-2)" "unprognostic (3.12e-1)" "unprognostic (2.77e-1)" 12.7 1.0 27.2 7.0 31.4 0.0 8.8 36.1 21.1 8.1 17.7 56.1 84.5 1.6 0.2 64.2 15.5 3.7 33.9 18.8 28.1 10.2 25.6 24.6 0.1 36.7 34.3 12.3 0.4 17.5 16.8 18.6 0.4 40.3 8.9 19.7 5.2 44.4 5.8 192.9 85.1 77.4 1.3 31.0 0.1 45.9 2.7 31.2 1.5 33.5 35.4 6.2 11.1 32.1 36.2 48.6 5.0 0.0 25.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 33.1 59.4 0.2 30.1 0.0 3.7 119.0 0.1 0.0 0.0 0.1 8.7 0.0 0.0 25.7 0.0 0.0 17.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 59.0 0.0 0.3 0.8 61.7 0.7 0.1 29.4 0.7 0.0 147.8 0.1 0.2 2.9 51.8 0.0 0.2 9.7 1.9 0.0 0.1 11.7 0.2 0.1 0.9 11.2 0.3 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 31.4 36.1 21.1 18.8 28.1 36.7 34.3 12.3 40.3 31.0 31.2 36.2 0.1 80.1 36.5 23.5 2.8 3.3 18.7 29.3 0.0 3.7 17.9 9.3 21.8 44.3 50.9 57.0 2.1 0.1 0.3 487.2 0.0 53.2 0.9 58.1 6.0 1.2 51.6 0.0 10.9 27.2 0.1 1.1 85.1 70.7 14.7 0.0 2.9 45.8 0.1 16.8 21.7 109.4 22.4 0.8 1.6 0.8 0.3 1.3 5.4 2.8 0.0 19.7 0.0 23.6 27.5 67.5 306.4 0.0 0.3 30.8 376.1 7.6 80.6 11.5 0.0 17.7 3.5 0.5 4.6 30.8 21.0 0.0 2.0 0.0 122.8 86.2 MRPL4 CGI-28 ENSG00000105364 "Mitochondrial ribosomal protein L4" Q9BYD3 19 10251901-10260055 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 1034.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051261 Approved NA NA "HPA051261: AB_2681413" "unprognostic (3.33e-1)" "unprognostic (2.49e-2)" "unprognostic (8.92e-2)" "unprognostic (1.22e-2)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (2.48e-2)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (2.39e-2)" "unprognostic (4.06e-2)" "unprognostic (1.01e-3)" "unprognostic (1.15e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-1)" "unprognostic (3.03e-1)" "unprognostic (1.11e-1)" 40.0 66.5 29.9 27.8 30.0 37.8 40.5 31.7 51.6 35.4 26.1 48.7 33.4 41.4 8.8 73.8 37.7 12.3 73.8 31.6 29.1 55.0 91.6 31.3 31.1 33.3 29.4 29.6 50.3 32.0 26.2 36.0 22.0 34.0 39.2 13.5 8.8 38.6 21.3 79.8 60.2 40.8 15.0 27.4 46.9 45.5 31.6 32.0 19.7 40.8 49.8 19.5 45.8 43.2 32.7 146.6 81.9 34.4 95.2 26.9 35.6 76.0 66.3 41.4 86.7 70.6 138.1 55.2 215.6 148.5 36.5 51.3 128.0 71.6 93.2 26.6 80.4 302.6 181.0 62.6 136.4 80.9 136.1 96.7 46.5 63.1 58.7 54.2 27.2 53.4 97.8 155.7 100.8 33.7 213.0 189.6 1034.0 98.3 91.4 300.4 140.3 51.1 219.8 53.2 89.1 85.6 75.4 56.6 124.2 104.6 16.5 67.3 90.4 71.2 83.7 75.3 182.3 134.8 148.5 189.7 218.2 72.7 189.2 74.0 6.4 53.7 17.5 35.1 74.0 38.2 36.9 34.4 39.5 83.2 41.1 31.1 31.4 4.9 47.4 60.1 71.7 43.2 36.8 29.9 30.0 31.7 51.6 31.6 29.1 33.3 29.4 29.6 34.0 27.4 32.0 32.7 46.9 16.0 27.4 11.4 53.0 86.2 60.4 115.9 76.8 50.4 58.5 85.0 12.9 44.3 49.8 40.5 8.4 187.6 43.0 57.8 144.8 74.0 25.4 44.0 52.2 39.7 44.9 37.0 17.5 77.7 76.6 46.8 63.7 45.3 26.0 81.6 25.7 80.5 95.0 32.0 17.6 70.1 52.9 36.1 38.7 10.8 51.0 42.4 46.2 8.4 58.0 45.0 45.3 10.6 12.3 84.8 39.7 50.4 79.4 79.7 59.6 133.5 27.6 35.8 13.1 39.8 61.4 38.7 42.2 120.4 98.7 149.4 42.5 141.3 104.9 78.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.1;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in some" "granulocytes: 44.9;Kupffer cells: 17.7;Microglial cells: 11.2" "Group enriched" "Detected in many" 4 "glioma: 7.2;renal cancer: 2.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 38 "eosinophil: 290.2" "Lineage enriched" "Detected in single" 719 "granulocytes: 290.2" "Cell line enriched" "Detected in some" 44 "HMC-1: 147.5" HPA012556 Uncertain Uncertain Cytosol NA NA Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.3 4.0 4.1 1.6 7.1 0.5 1.4 5.3 6.8 0.9 1.5 1.8 1.8 0.6 0.7 0.7 0.7 1.4 0.2 4.4 5.0 0.1 0.8 2.5 6.9 9.7 5.7 2.6 0.2 0.5 1.0 0.5 0.1 9.5 0.6 1.7 0.7 0.6 0.5 0.1 0.5 2.8 0.9 6.6 6.3 1.4 0.3 9.4 2.1 0.4 0.2 2.6 1.0 0.3 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 2.3 0.1 0.1 0.0 0.0 147.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.3 0.0 0.0 0.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 1.1 0.1 7.6 0.4 290.2 0.2 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.1 0.2 2.5 0.3 0.4 0.2 0.1 0.2 4.1 7.1 5.3 6.8 4.4 5.0 9.7 5.7 2.6 9.5 6.6 9.4 14.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.9 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 2.5 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CD79A "IGA, MB-1" ENSG00000105369 "CD79a molecule" P11912 19 41877279-41881372 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 153.5;lymphoid tissue: 549.7" "Group enriched" "Detected in some" 5 "B-cells: 1186.4;Plasma cells: 956.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 38 "memory B-cell: 1273.8;naive B-cell: 1457.5" "Lineage enriched" "Detected in all" 40 "B-cells: 1457.5" "Group enriched" "Detected in some" 22 "Daudi: 1598.7;REH: 491.0;U-698: 1366.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000019, HPA056444" Enhanced NA NA "CAB000019: AB_2244527, HPA056444: " "prognostic favorable (8.45e-5)" "unprognostic (1.63e-3)" "unprognostic (4.13e-3)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.23e-2)" "unprognostic (8.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.12e-2)" "unprognostic (2.53e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (6.08e-2)" "unprognostic (3.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" 4.8 4.9 0.2 215.4 0.2 47.7 9.6 0.2 0.4 3.6 0.2 47.8 38.3 2.4 1.4 10.0 1.8 13.1 3.0 0.1 0.5 3.4 2.7 9.0 486.3 0.3 0.9 0.1 3.7 0.7 0.1 0.3 1.2 0.2 4.3 29.2 0.0 28.7 2.2 0.7 0.4 153.5 2.2 0.6 288.8 77.6 2.4 0.3 94.6 8.2 0.4 549.7 32.6 1.9 0.3 1.1 0.8 0.3 0.1 0.2 0.7 0.2 0.2 0.0 0.3 0.0 0.0 0.1 1598.7 1.2 0.0 0.1 0.0 0.2 0.2 0.0 0.5 0.7 2.7 0.0 1.7 0.2 2.6 1.8 0.5 0.6 0.2 0.0 0.0 0.0 8.0 3.1 0.4 0.1 1.1 1.6 9.9 0.1 0.1 0.4 491.0 0.8 2.5 0.1 0.0 0.5 0.5 0.8 0.5 1.3 0.0 0.0 4.8 1.6 0.1 4.3 0.3 0.8 7.8 1.4 1366.7 0.0 52.1 0.1 12.4 1.5 6.9 1.7 1.8 0.7 1273.8 4.1 2.1 2.5 1457.5 4.9 26.3 4.6 2.6 4.3 36.3 10.4 62.7 0.2 0.2 0.2 0.4 0.1 0.5 0.3 0.9 0.1 0.2 0.6 0.3 0.3 0.2 0.0 2.4 0.0 1186.4 1.8 0.5 0.5 0.6 0.0 0.7 0.9 0.2 1.5 0.2 0.0 0.0 0.2 18.2 0.7 0.0 1.8 0.2 0.1 0.3 0.5 0.0 10.5 0.0 25.6 0.4 2.2 6.6 0.2 0.0 0.4 2.2 1.0 0.8 0.0 0.0 0.4 0.0 4.1 1.4 0.0 0.3 5.3 138.7 0.0 6.3 0.0 15.5 0.0 0.0 181.7 0.4 0.4 956.7 0.3 0.2 0.9 0.0 0.0 0.0 0.2 0.7 0.3 0.6 0.9 1.4 0.1 23.5 0.2 5.3 0.2 LIM2 "MP17, MP19" ENSG00000105370 "Lens intrinsic membrane protein 2" P55344 19 51379909-51387974 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "NK-cells: 20.6" "Cancer enriched" "Detected in single" 40 "testis cancer: 18.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 7 "gdT-cell: 11.3" "Lineage enriched" "Detected in many" 7 "T-cells: 11.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.25e-2)" "unprognostic (1.09e-3)" "unprognostic (1.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 ICAM4 "CD242, LW" ENSG00000105371 "Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)" Q14773 19 10286955-10288522 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 13.5;lung: 9.4" "Cell type enhanced" "Detected in many" "Adipocytes: 24.9;Alveolar cells type 1: 67.3;Alveolar cells type 2: 76.5;Erythroid cells: 46.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 6 "non-classical monocyte: 215.4" "Lineage enriched" "Detected in many" 7 "monocytes: 215.4" "Cell line enhanced" "Detected in some" "HEL: 71.0;HMC-1: 17.1;K-562: 37.4;NB-4: 30.7;U-937: 17.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Intracellular and membrane" NA NA 0.8 0.3 0.4 0.8 0.4 13.5 0.4 0.3 0.9 0.2 0.2 0.7 0.9 0.3 0.2 0.3 0.4 1.1 0.5 0.3 0.3 0.2 0.8 9.4 1.0 0.6 0.0 0.3 0.5 0.1 0.3 0.1 1.8 0.3 0.7 0.6 0.7 1.0 0.4 0.4 0.5 0.9 0.4 0.1 1.2 1.5 0.3 0.2 1.1 0.3 0.1 1.4 1.8 0.2 0.6 0.2 0.1 0.3 0.4 0.0 0.0 5.9 0.6 0.2 0.0 0.0 7.8 0.4 0.8 0.8 0.0 0.3 0.6 0.1 0.1 0.1 0.6 0.2 71.0 0.6 10.6 1.9 1.2 17.1 0.4 0.0 0.2 0.2 0.0 0.1 11.2 37.4 3.1 0.1 0.2 2.0 30.7 0.2 0.0 0.3 5.2 2.9 13.6 0.1 0.3 0.1 0.2 0.6 0.1 0.3 0.8 0.2 2.1 0.4 0.2 0.1 0.5 0.0 1.0 2.0 0.2 0.6 17.1 0.4 24.0 10.0 10.2 0.9 38.5 1.8 2.2 1.1 0.8 30.8 2.2 1.3 0.3 2.3 0.5 215.4 10.2 2.6 9.1 0.4 0.4 0.3 0.9 0.3 0.3 0.6 0.0 0.3 0.3 0.1 0.2 0.6 24.9 67.3 76.5 0.3 2.3 1.0 1.9 8.0 1.2 0.0 4.9 3.6 0.0 0.0 21.0 0.0 0.0 0.3 3.0 0.4 0.0 0.6 0.0 2.9 2.0 18.3 0.0 46.7 0.0 2.1 0.6 10.3 1.5 5.6 22.1 0.0 2.5 0.2 5.6 0.0 0.0 0.0 0.0 5.5 6.9 0.0 0.0 16.8 5.4 0.0 14.6 0.2 0.0 0.0 0.0 0.9 0.0 0.0 17.5 1.4 0.0 0.1 4.4 0.1 0.0 9.1 3.3 0.0 1.0 0.7 1.3 0.8 1.8 0.2 0.0 2.4 RPS19 "DBA, eS19, LOH19CR1, S19" ENSG00000105372 "Ribosomal protein S19" P39019 19 41860255-41872925 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063217 Supported Nucleoplasm NA NA 260000 Nucleoplasm "HPA063217: AB_2732699" "unprognostic (8.02e-3)" "unprognostic (9.04e-2)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (7.32e-3)" "unprognostic (1.32e-1)" "unprognostic (2.69e-2)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (6.68e-2)" "unprognostic (5.78e-2)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.16e-1)" "unprognostic (7.55e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" 1773.9 1916.1 1456.4 1430.3 1448.3 2957.9 2072.5 1411.9 2054.4 2478.0 1451.2 2016.7 1402.4 1641.8 685.2 3517.1 2169.7 772.9 1291.0 1375.9 1480.4 1432.1 2281.1 1654.7 2290.7 1509.0 1421.2 1351.5 3819.7 4015.0 590.6 1023.8 825.7 1467.5 2250.9 1115.6 373.6 1763.2 767.9 1586.3 3832.1 2186.7 774.3 1512.1 2932.4 2117.0 644.2 1501.8 1842.2 1529.0 735.0 1884.6 2042.7 2533.5 1497.1 3536.2 4978.2 3109.1 2770.4 3924.8 5205.4 3456.4 2731.6 3132.5 3378.6 2982.1 3854.2 2341.3 5185.2 2985.2 2483.1 1670.6 1819.8 2701.4 4647.3 1563.5 2183.2 5098.9 2626.1 1471.5 4029.3 6775.6 4355.4 2564.0 7419.1 8959.5 2132.0 3942.4 5453.7 3421.0 4849.8 2911.6 3476.5 2845.7 4010.8 3975.9 3021.3 3619.2 9954.1 2087.6 4372.0 2503.1 2511.1 3188.1 3714.9 2216.7 2693.9 1539.3 4915.7 3951.2 4649.7 2787.7 6840.6 2694.1 2157.5 3396.5 1451.9 4383.8 3886.3 4520.6 5054.3 2348.3 3672.5 2498.9 1309.9 5303.2 586.8 9147.6 9536.3 13783.0 18138.6 13464.4 11872.3 8174.5 17813.4 15114.7 13788.0 724.9 12054.7 12053.9 11257.8 11367.1 30500.3 1456.4 1448.3 1411.9 2054.4 1375.9 1480.4 1509.0 1421.2 1351.5 1467.5 1512.1 1501.8 1497.1 2154.8 1644.2 2318.8 17.6 7536.2 13338.7 9463.4 12098.6 8008.7 295.5 11387.2 17068.7 680.0 2778.1 4886.7 1430.8 127.2 6635.1 4648.2 1753.9 2641.3 4446.2 482.4 1178.2 3145.6 3665.9 2227.6 2708.0 15.4 8576.4 9609.3 2834.8 2442.4 1645.3 1825.2 4566.6 3793.4 3258.5 4591.9 136.3 20.2 4777.7 3497.2 6041.3 8631.8 1752.6 4036.7 4053.7 4557.0 52.5 5989.0 991.8 4541.7 13.6 42.4 7669.3 4181.6 1892.7 4036.1 8714.9 4183.2 3284.5 1889.5 479.3 1584.3 3428.0 5508.3 608.5 1952.5 7919.1 16952.4 6534.4 6030.8 3718.5 6131.8 8160.5 NOP53 "GLTSCR2, PICT-1, PICT1" ENSG00000105373 "NOP53 ribosome biogenesis factor" Q9NZM5 19 47745546-47757058 "Predicted intracellular proteins" "Host-virus interaction, Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1" "Cell line enhanced" "Detected in all" "NB-4: 1305.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018999, HPA049600" Approved Supported Nucleoli NA NA Nucleoli "HPA018999: AB_1849733, HPA049600: AB_2680831" "unprognostic (2.08e-3)" "unprognostic (1.84e-1)" "unprognostic (4.02e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.56e-2)" "unprognostic (3.62e-3)" "unprognostic (1.89e-1)" "unprognostic (9.27e-2)" "unprognostic (2.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" 377.7 247.3 102.3 176.8 102.8 244.0 424.0 98.3 127.0 569.0 111.6 386.3 186.7 409.1 77.9 322.6 428.1 39.7 273.4 94.3 101.4 260.6 226.5 221.0 215.4 110.1 103.4 86.7 796.7 1025.0 124.0 203.3 79.0 107.0 389.6 64.7 70.8 400.3 105.5 311.2 627.8 336.4 60.6 110.1 361.8 448.9 117.4 108.7 227.4 305.3 110.9 129.4 415.3 426.1 104.9 99.7 103.0 90.7 214.6 110.6 184.2 176.8 60.6 110.5 57.8 85.3 95.5 194.8 440.3 87.0 71.2 44.2 139.8 52.9 88.8 30.2 133.0 177.8 142.6 85.1 113.5 163.0 207.4 271.6 162.5 198.9 50.8 136.1 188.0 92.3 183.1 176.8 206.5 52.3 86.9 577.2 1305.4 209.4 173.4 60.0 380.4 160.8 209.8 112.6 151.9 96.8 340.9 50.6 330.7 330.0 65.8 156.2 493.7 114.4 56.4 150.2 49.2 125.8 306.3 290.6 120.9 71.2 145.4 92.4 21.5 23.3 26.3 55.3 35.3 74.5 311.8 108.2 96.0 33.1 238.5 244.1 108.6 3.3 96.7 25.1 41.6 120.0 15.8 102.3 102.8 98.3 127.0 94.3 101.4 110.1 103.4 86.7 107.0 110.1 108.7 104.9 229.4 41.7 120.7 0.0 210.4 0.0 0.0 0.0 0.0 0.0 605.5 415.5 0.0 0.0 69.3 104.8 0.0 454.3 224.1 0.0 266.1 266.5 0.0 100.6 156.9 94.5 0.0 0.0 0.0 989.2 570.3 107.2 0.0 115.5 68.1 268.3 0.0 0.0 259.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.1 0.0 0.0 269.8 0.0 0.0 0.0 0.0 348.1 0.0 0.0 61.8 0.0 0.0 369.7 18.2 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 506.8 131.3 226.3 0.0 0.0 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372701 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 607.8;lymphoid tissue: 155.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3163.4;NK-cells: 7721.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8" "Group enriched" "Detected in all" 44 "NK-cells: 4796.8;T-cells: 6827.0" "Group enriched" "Detected in some" 5 "NB-4: 180.8;THP-1: 54.5;U-937: 46.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 10.8 7.9 3.9 23.5 4.3 607.8 7.8 3.8 6.1 6.0 5.5 9.6 11.1 12.6 6.2 7.3 8.0 21.6 6.4 3.6 4.1 6.4 23.7 49.7 137.6 5.2 4.3 3.1 4.2 2.2 2.3 3.2 7.9 4.4 4.9 7.3 0.4 9.6 4.5 6.6 2.7 14.8 7.8 4.2 155.8 10.7 3.4 5.1 9.5 6.6 3.4 22.1 16.8 4.4 5.7 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.9 7.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.6 2.0 0.8 0.2 0.0 20.1 3.6 0.0 0.0 0.3 0.0 0.2 0.0 2.5 0.5 0.8 0.0 0.0 2.4 180.8 0.0 0.2 0.3 4.4 9.4 0.4 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.3 0.0 54.5 0.4 0.1 0.2 0.6 0.1 2.6 0.9 0.9 0.1 46.6 0.0 76.9 34.1 15.2 6827.0 131.7 2871.2 37.9 811.1 4295.0 87.1 15.4 261.0 3114.2 111.7 4796.8 104.8 67.1 17.5 4929.2 3.9 4.3 3.8 6.1 3.6 4.1 5.2 4.3 3.1 4.4 4.2 5.1 5.7 17.2 3.2 8.0 0.0 24.5 5.0 0.1 0.0 0.0 0.0 5.7 3.7 0.7 28.6 1.3 5.5 0.0 1.0 3163.4 1.9 3.9 1.0 0.2 2.7 3.6 7.1 0.0 186.5 0.0 0.0 0.8 5.2 17.3 4.2 24.1 0.2 55.3 9.9 15.0 0.0 0.0 0.5 0.0 132.9 10.2 0.3 0.0 55.5 17.8 1.0 49.4 0.0 7721.0 0.0 0.2 0.0 1.2 0.0 120.4 0.0 0.6 9.2 0.7 0.0 0.0 6.4 4.7 0.0 0.5 1.1 6.5 1.1 1321.5 0.0 1.1 0.1 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289952-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 36.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Cardiomyocytes: 33.9;Erythroid cells: 8.2;Excitatory neurons: 17.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 6 "amygdala: 14.1;basal ganglia: 18.4;cerebral cortex: 19.5;hippocampal formation: 36.4;olfactory bulb: 24.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 16.3;K-562: 13.2;RPMI-8226: 14.7;U-266/70: 17.5;U-87 MG: 9.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 14 "amygdala: 40.8;basal ganglia: 45.1;cerebral cortex: 50.7;hippocampal formation: 76.2;olfactory bulb: 27.4" "HPA008943, HPA009083, CAB025178" Enhanced NA NA 3300000 "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.1 0.0 14.1 0.0 18.4 0.6 0.2 0.0 19.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.7 36.4 2.8 0.3 0.0 6.2 0.2 2.9 0.2 24.6 2.1 0.0 0.1 0.2 0.1 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.0 0.6 0.0 0.0 0.2 0.5 3.9 3.5 0.0 0.0 7.4 0.0 0.0 0.3 5.0 0.8 0.2 0.5 0.0 0.1 5.6 2.3 0.0 0.0 6.5 0.2 0.0 0.0 0.2 1.0 16.3 6.1 0.5 0.1 0.0 3.1 0.0 0.6 0.1 0.0 0.0 0.0 2.0 13.2 0.1 0.0 0.8 0.0 2.3 0.0 0.3 4.9 0.1 0.0 14.7 0.2 0.0 0.9 0.1 2.3 0.2 0.5 0.0 2.7 0.0 0.0 1.5 0.0 0.9 0.0 17.5 3.1 3.5 9.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 18.4 0.0 19.5 36.4 2.8 2.9 0.2 24.6 2.8 0.0 0.5 3.9 3.2 6.4 2.8 1.6 0.4 0.3 0.2 0.3 1.8 0.7 1.6 5.2 33.9 0.0 1.3 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.5 0.6 0.5 2.8 0.0 8.2 17.7 0.0 0.1 1.1 1.1 1.3 2.5 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.3 1.7 0.0 0.0 2.1 0.0 2.8 0.3 0.0 0.0 1.5 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.4 0.5 0.0 0.0 0.7 1.7 1.7 1.3 0.4 0.1 0.1 0.7 0.1 0.2 0.2 ETFB ENSG00000105379 "Electron transfer flavoprotein subunit beta" P38117 19 51345169-51366388 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 497.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7" "Cancer enhanced" "Detected in all" "liver cancer: 53.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 1693.9;OE19: 770.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria NA NA 170000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favorable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favorable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 160.5 172.9 111.8 44.4 123.0 70.8 116.3 125.3 146.6 47.9 111.0 91.3 137.5 49.3 17.1 141.8 53.8 63.3 319.9 104.2 111.7 143.3 497.6 50.8 58.6 121.4 116.1 102.8 55.7 82.6 107.3 73.7 39.4 121.9 55.7 41.6 24.3 173.7 38.2 283.4 78.0 130.8 32.0 112.6 65.1 90.7 54.1 121.6 82.2 70.9 282.8 37.2 66.2 69.6 128.3 118.9 304.3 41.3 113.9 129.4 150.4 65.6 82.4 61.0 63.5 63.1 257.3 192.1 121.5 80.2 129.8 33.8 104.0 83.3 171.1 19.2 182.0 323.3 98.1 188.9 1693.9 141.8 92.1 67.6 235.3 50.3 86.1 88.2 79.2 54.9 115.0 146.6 130.2 83.2 243.7 95.2 86.2 26.7 770.2 372.0 104.5 114.4 224.6 88.5 135.7 91.7 44.5 184.5 49.9 94.4 29.4 130.3 86.3 77.8 65.9 67.6 71.4 73.3 195.8 130.0 109.8 335.0 135.1 172.5 127.7 190.1 119.6 104.3 212.3 137.4 281.6 156.0 134.2 225.3 303.1 163.6 136.0 97.8 205.3 165.7 265.1 225.7 140.5 111.8 123.0 125.3 146.6 104.2 111.7 121.4 116.1 102.8 121.9 112.6 121.6 128.3 90.9 80.1 93.8 15.3 75.6 65.0 114.9 196.4 55.2 77.1 129.9 170.1 243.8 234.4 122.5 121.4 31.3 240.7 58.7 440.9 571.3 188.0 139.2 67.5 70.2 76.2 168.4 120.0 4.1 140.5 206.6 93.8 128.9 48.2 88.8 63.2 144.9 1105.3 217.5 43.7 4.2 335.2 158.7 147.7 73.4 354.4 107.5 86.9 286.4 5.6 95.2 158.8 50.4 7.1 18.9 155.4 339.4 114.3 69.9 74.9 710.7 1118.7 118.8 67.9 98.6 87.4 144.5 71.0 52.8 135.3 63.6 160.1 74.0 217.3 354.4 140.3 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7;lymphoid tissue: 24.2" "Group enriched" "Detected in some" 6 "granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8" "Group enriched" "Detected in many" 9 "dendritic cells: 213.5;monocytes: 166.5" "Cell line enhanced" "Detected in some" "HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1" "CAB011442, HPA035832, HPA064807, CAB079996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 3400000 "Nucleoplasm, Plasma membrane" "CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356" "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 8.0 3.4 0.9 11.3 1.4 32.7 2.5 1.3 1.6 3.0 2.8 3.3 3.3 1.7 1.4 2.0 2.6 6.7 2.0 0.9 2.1 1.4 5.5 12.7 10.2 2.3 1.4 0.6 1.4 1.5 1.2 0.9 6.9 2.1 1.5 4.2 0.2 1.8 2.6 0.9 2.7 4.4 7.2 1.7 24.2 2.4 1.0 1.8 3.5 1.0 0.8 3.6 6.3 1.3 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.0 5.5 0.4 0.0 1.3 0.3 0.0 0.2 0.0 0.1 0.1 86.1 0.3 0.0 0.0 115.6 82.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 16.2 21.2 0.2 0.0 0.0 55.2 0.2 0.0 25.9 0.0 4.4 62.5 0.4 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 67.0 0.7 14.0 1.1 1.8 0.1 0.3 7.6 0.2 9.6 84.1 0.4 17.9 166.5 11.0 0.3 122.0 0.4 0.1 0.2 0.5 213.5 0.4 0.3 0.2 20.5 15.5 57.8 6.3 1.1 77.8 0.9 1.4 1.3 1.6 0.9 2.1 2.3 1.4 0.6 2.1 1.7 1.8 3.2 0.7 0.0 6.7 0.0 1.0 1.8 0.5 0.0 0.0 0.2 1.4 0.4 0.8 0.0 0.6 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.7 0.1 0.1 3.0 0.0 4.2 0.0 0.0 0.5 1.1 0.0 0.1 76.0 0.1 5.3 0.7 78.8 0.0 0.0 0.0 0.0 131.2 41.4 1.7 0.3 53.5 1.8 11.2 65.0 0.2 1.0 0.5 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.7 0.6 0.0 1.1 0.3 0.7 0.5 0.0 1.0 0.8 2.5 0.1 0.0 0.4 CEACAM5 "CD66e, CEA" ENSG00000105388 "CEA cell adhesion molecule 5" P06731 19 41708585-41730433 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 990.4" "Group enriched" "Detected in some" 4 "Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 1007.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 56.9" "CAB000021, CAB000022, HPA011041, HPA019758" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 23000000 "Plasma membrane" "CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326" "unprognostic (1.54e-2)" "unprognostic (7.59e-2)" "unprognostic (5.49e-3)" "unprognostic (1.80e-1)" "unprognostic (1.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.49e-1)" "unprognostic (2.11e-1)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (8.67e-9)" "unprognostic (2.92e-1)" "unprognostic (2.71e-2)" "unprognostic (6.31e-2)" "unprognostic (1.85e-1)" 3.3 0.1 0.1 187.3 0.1 0.2 4.0 0.3 0.1 18.7 0.2 990.4 22.9 1.3 0.2 233.9 0.8 0.8 0.1 0.1 0.0 0.9 0.2 30.5 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.3 0.0 0.1 0.5 952.0 0.0 29.4 3.3 0.1 3.6 61.9 29.0 0.0 0.1 164.6 0.3 0.1 0.2 1.0 0.0 37.2 10.5 71.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.1 0.0 0.0 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.3 56.9 1.1 0.2 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 32.1 4.1 0.0 2.7 0.0 1.0 12.3 0.0 0.0 0.1 0.0 0.4 0.0 34.8 0.0 0.0 0.0 0.0 1389.2 0.0 3.4 0.4 0.0 0.0 0.2 65.7 0.0 0.1 0.9 0.0 0.4 22.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 395.0 4.1 0.0 0.4 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 21.3 777.3 0.0 0.1 16.5 10.2 0.0 4.5 0.0 0.0 0.1 0.4 0.8 0.5 1.9 0.0 0.0 1.2 0.0 192.3 124.4 CRX "CORD2, CRD, LCA7, OTX3" ENSG00000105392 "Cone-rod homeobox" O43186 19 47819779-47843330 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Cone-rod dystrophy, Disease variant, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 65 "retina: 240.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 136.5;Cone photoreceptor cells: 285.7;Rod photoreceptor cells: 501.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "midbrain: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036762, HPA036763" Enhanced NA NA "HPA036762: AB_10673663, HPA036763: AB_10670922" "unprognostic (1.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-10)" "unprognostic (9.27e-2)" "unprognostic (1.82e-2)" "unprognostic (8.94e-2)" "unprognostic (1.78e-3)" 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.3 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.2 3.7 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 240.6 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.3 0.4 0.4 0.2 3.7 0.2 0.2 0.1 0.1 0.3 0.8 6.4 14.3 0.0 0.6 0.9 2.3 0.1 0.0 136.5 0.3 0.4 0.5 1.5 13.6 0.0 285.7 0.2 1.7 0.1 0.0 0.0 0.7 0.5 0.5 5.5 0.0 0.0 0.4 0.0 0.2 3.9 0.0 0.8 10.1 0.1 1.8 0.5 0.2 32.0 0.3 0.2 0.0 1.0 1.8 0.5 4.7 2.2 0.0 0.0 0.2 59.3 0.0 0.0 0.1 0.0 0.0 0.7 0.3 1.3 0.2 0.0 9.7 501.5 0.0 0.9 0.3 0.2 0.6 0.0 1.1 0.0 1.3 0.1 0.1 1.7 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267376-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 45.9 54.6 47.8 40.4 52.3 71.0 47.2 41.3 67.2 48.0 37.2 57.7 42.0 50.7 29.0 48.7 44.9 29.2 66.5 53.7 49.1 53.6 55.7 43.1 55.8 47.2 50.0 49.6 44.5 50.3 47.2 32.5 47.1 50.1 48.5 36.7 26.6 50.7 37.5 135.4 45.5 51.0 37.6 40.0 61.2 54.6 41.9 48.5 51.7 37.6 97.7 51.7 49.7 43.7 52.0 126.8 69.5 68.8 66.0 72.9 51.9 154.9 73.5 96.0 143.2 142.1 78.2 146.5 87.8 172.1 102.2 64.9 61.2 79.7 102.2 89.1 127.5 130.9 78.6 91.6 99.0 60.4 142.4 96.0 79.6 68.3 96.4 56.1 79.3 122.5 123.9 132.9 101.1 103.3 104.1 138.7 135.8 182.0 106.3 147.0 95.5 92.2 119.4 104.1 62.1 66.3 120.3 90.5 92.8 84.6 77.2 81.4 115.2 91.7 87.8 55.7 108.8 124.3 133.1 172.5 119.7 125.6 187.0 85.5 201.3 154.3 167.7 132.9 148.1 128.3 141.9 121.7 129.2 161.3 143.4 111.8 109.9 37.9 114.3 147.8 134.3 180.2 214.1 47.8 52.3 41.3 67.2 53.7 49.1 47.2 50.0 49.6 50.1 40.0 48.5 52.0 40.8 12.8 29.7 11.1 45.0 34.9 41.5 63.4 19.4 21.9 53.9 60.7 37.8 41.5 44.9 35.0 14.6 172.4 51.0 51.1 101.8 70.1 65.8 18.4 30.4 39.9 43.8 78.5 18.6 72.4 155.4 41.4 26.0 28.1 46.3 54.3 40.0 50.4 98.7 16.8 16.2 60.6 48.8 46.8 45.6 106.3 36.7 43.2 65.8 8.4 80.4 35.3 68.0 8.5 12.3 69.8 63.8 44.4 51.7 44.6 68.1 89.3 23.5 18.5 39.5 34.7 52.5 57.8 74.2 27.9 41.3 158.0 46.4 43.0 64.7 45.5 TYK2 JTK1 ENSG00000105397 "Tyrosine kinase 2" P29597 19 10350529-10380572 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 206.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005157 Uncertain Approved Cytosol NA NA Cytosol "HPA005157: AB_1858480" "unprognostic (1.60e-2)" "unprognostic (6.12e-3)" "unprognostic (3.67e-2)" "prognostic favorable (9.62e-4)" "unprognostic (7.61e-2)" "prognostic favorable (1.05e-5)" "unprognostic (1.20e-2)" "unprognostic (6.16e-3)" "unprognostic (4.93e-2)" "unprognostic (1.90e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.10e-3)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "prognostic favorable (4.16e-4)" 53.1 61.0 71.6 37.3 73.5 83.4 52.9 72.5 82.9 54.0 73.9 48.3 29.7 45.2 22.8 46.6 49.4 26.4 59.2 71.2 73.0 77.2 112.1 73.2 51.9 76.5 73.3 70.7 56.9 65.7 28.8 66.7 20.3 73.1 65.0 26.0 25.4 51.2 20.8 41.6 51.5 74.5 23.7 72.6 142.0 55.1 16.7 73.0 54.9 60.7 34.0 52.3 49.8 46.4 78.4 29.1 41.1 24.1 38.0 31.9 44.2 23.5 38.9 39.1 48.1 52.2 31.5 18.7 44.5 44.5 43.4 32.8 28.4 29.4 45.5 24.2 78.0 45.5 81.4 90.5 80.2 49.4 34.4 89.4 43.2 31.3 54.5 32.2 29.9 46.5 56.6 35.0 116.1 42.3 90.1 50.7 206.9 7.7 28.4 71.8 49.9 21.1 45.1 40.0 90.1 22.4 28.0 37.6 38.6 28.1 18.4 21.5 57.2 41.1 61.7 22.7 74.1 45.9 97.2 81.4 40.2 32.4 70.8 36.6 9.8 20.8 27.2 12.8 15.2 7.9 7.5 7.6 11.6 23.5 8.0 5.0 7.1 33.0 8.6 15.7 13.0 10.1 13.0 71.6 73.5 72.5 82.9 71.2 73.0 76.5 73.3 70.7 73.1 72.6 73.0 78.4 18.6 12.8 17.9 13.1 17.5 6.6 5.4 7.6 13.1 9.2 10.3 11.0 25.7 11.5 11.1 9.2 4.2 7.0 23.2 14.6 52.8 7.6 2.1 10.2 12.6 12.8 4.8 8.6 10.4 11.1 9.7 11.1 27.0 12.0 19.6 17.1 15.4 27.1 14.6 0.0 9.2 8.7 8.2 28.2 14.6 8.8 7.5 30.8 16.0 12.2 25.3 8.7 17.5 11.1 11.1 11.8 12.9 9.8 19.5 5.9 12.1 29.0 11.2 11.0 0.0 10.5 12.6 1.5 4.5 8.8 7.2 6.7 19.4 13.6 11.1 6.3 SULT2A1 "DHEA-ST, STD" ENSG00000105398 "Sulfotransferase family 2A member 1" Q06520 19 47870467-47886315 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 1081.0" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 1578.7" "Cancer enriched" "Detected in some" 52 "liver cancer: 244.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Group enriched" "Detected in some" 34 "Hep G2: 39.6;RT4: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB018755, HPA041487, HPA063633" Enhanced Supported Cytosol NA NA 1200000 Cytosol "CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066" "unprognostic (2.14e-1)" "unprognostic (6.79e-3)" "unprognostic (6.82e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-2)" 0.1 237.6 0.3 0.1 0.2 0.4 0.0 0.5 0.5 0.0 0.4 0.6 60.1 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 1081.0 0.0 0.2 0.1 0.2 0.3 0.1 0.1 37.2 0.0 0.1 0.3 0.1 0.9 1.0 0.1 3.1 0.1 0.3 87.3 0.0 0.0 0.4 24.6 4.2 0.3 0.0 0.1 0.0 0.1 2.0 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 39.6 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.5 0.3 0.0 26.7 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.1 2.9 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.4 0.4 0.3 0.8 0.5 0.1 0.3 0.2 0.2 0.3 0.2 0.5 0.5 0.2 0.1 0.1 0.2 0.3 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.3 2.9 0.1 0.6 0.0 0.0 1.3 0.0 0.0 0.6 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 18.7 0.3 0.0 0.0 0.3 5.1 0.1 0.0 0.1 30.0 1578.7 0.0 0.0 0.3 2.8 0.0 31.8 0.4 0.2 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 8.8 0.4 0.0 0.3 171.7 0.1 0.0 2.7 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.5 1.8 81.7 2.2 0.3 CDC37 P50CDC37 ENSG00000105401 "Cell division cycle 37, HSP90 cochaperone" Q16543 19 10391133-10420121 "Cancer-related genes, Predicted intracellular proteins, Transporters" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003928, CAB004214" Supported Supported Cytosol NA NA 610000 Cytosol "CAB004214: AB_627232, HPA003928: AB_1846373" "unprognostic (2.40e-1)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (2.33e-2)" "unprognostic (2.46e-3)" "unprognostic (6.21e-2)" "unprognostic (1.37e-1)" "unprognostic (7.90e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-3)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "prognostic favorable (2.33e-4)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (3.02e-2)" 138.5 94.4 78.4 82.1 79.9 90.3 131.7 70.9 104.9 110.4 69.9 107.8 58.7 110.9 34.5 126.7 99.3 40.2 164.3 81.0 77.7 115.0 103.0 131.1 67.1 79.6 74.9 74.7 106.7 101.2 59.7 75.2 63.3 82.6 105.9 48.7 34.9 97.4 52.7 316.2 100.5 97.2 50.7 71.0 138.6 103.6 78.1 78.4 70.0 101.7 224.6 52.8 111.2 103.9 83.4 279.2 181.2 95.5 137.5 128.8 111.8 122.9 322.8 144.6 198.3 168.8 209.1 106.7 165.3 254.7 198.3 117.2 169.9 130.6 208.7 136.4 133.6 387.2 313.9 147.2 300.9 202.5 183.9 137.9 136.9 112.5 231.8 104.0 113.5 258.1 142.2 248.2 193.8 156.1 265.3 184.3 450.2 234.6 175.5 317.8 181.0 128.3 190.3 185.1 178.2 111.5 161.9 151.5 158.1 143.1 72.7 108.4 195.7 290.0 230.8 133.9 319.9 262.2 261.3 276.5 204.4 181.4 294.1 191.2 77.2 110.8 97.1 114.4 107.9 103.1 73.2 91.8 103.5 105.2 62.9 70.0 81.8 60.2 101.1 112.6 89.4 106.8 145.6 78.4 79.9 70.9 104.9 81.0 77.7 79.6 74.9 74.7 82.6 71.0 78.4 83.4 420.1 54.5 95.5 51.6 163.7 148.6 119.3 149.0 127.5 78.0 85.0 75.8 71.3 75.8 114.8 64.4 39.6 188.9 166.1 192.3 101.8 199.8 119.0 88.2 120.5 267.5 81.3 89.8 35.0 199.0 430.2 108.3 226.8 126.4 134.3 90.8 172.1 45.3 210.2 89.2 24.6 181.3 105.8 83.9 313.8 253.8 106.2 165.6 138.7 29.0 165.1 75.8 135.9 21.1 32.5 297.6 183.5 103.4 170.5 120.1 117.9 89.7 78.2 84.4 78.9 94.4 138.6 72.4 73.5 138.1 133.7 242.4 164.2 123.0 186.1 156.1 NAPA ENSG00000105402 "NSF attachment protein alpha" P54920 19 47487637-47515091 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010100, HPA046149, HPA050196" Approved Uncertain Cytosol NA NA 2200000 Cytosol "CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (9.83e-2)" "unprognostic (9.43e-3)" "unprognostic (1.12e-2)" "unprognostic (1.76e-3)" "unprognostic (9.72e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (5.61e-2)" "unprognostic (2.42e-3)" "unprognostic (1.09e-3)" "prognostic favorable (4.26e-9)" "unprognostic (4.04e-2)" "unprognostic (4.17e-2)" "unprognostic (8.55e-2)" "unprognostic (2.90e-2)" 78.1 148.7 100.3 57.3 111.7 116.2 84.3 110.8 144.0 77.9 86.7 77.8 62.5 102.9 55.0 123.7 86.8 64.3 108.0 125.3 100.4 98.8 154.5 80.5 57.5 117.8 102.3 114.6 67.0 92.8 102.0 97.3 57.4 119.6 106.1 51.3 84.5 125.4 95.5 181.7 130.1 63.0 73.2 91.7 67.0 84.2 79.9 113.5 86.0 75.2 117.8 53.5 77.3 86.4 139.6 73.1 99.3 48.1 85.3 100.4 80.9 36.7 78.1 98.7 189.3 229.1 76.1 44.3 55.8 41.5 110.4 119.1 56.3 77.7 98.1 72.8 89.2 84.6 70.1 88.5 93.6 256.9 80.6 124.5 122.0 70.2 77.0 47.6 38.1 92.1 74.9 67.0 150.0 123.7 66.2 115.7 284.6 40.5 110.7 75.7 79.8 42.2 82.6 149.6 133.5 174.9 67.6 101.0 126.4 76.6 43.8 98.9 136.9 91.0 97.4 51.3 83.9 93.6 94.5 143.7 76.9 176.3 89.5 102.5 196.4 165.0 313.1 96.1 189.8 81.3 68.7 82.9 94.3 132.3 70.3 84.8 85.3 187.9 111.1 201.1 209.9 112.2 209.4 100.3 111.7 110.8 144.0 125.3 100.4 117.8 102.3 114.6 119.6 91.7 113.5 139.6 59.1 12.8 41.5 19.9 48.6 63.3 91.1 73.5 92.2 55.1 69.5 63.5 3.8 72.9 44.5 51.5 27.1 106.4 73.3 89.1 178.1 110.9 44.2 40.8 37.5 49.3 83.6 89.9 30.5 99.8 69.0 48.0 94.8 70.0 64.7 23.8 39.7 89.6 131.1 35.3 21.7 62.6 99.7 58.4 69.1 37.4 42.9 87.7 97.8 14.0 79.1 76.7 66.9 11.1 21.8 100.2 69.8 46.3 92.9 50.5 80.3 99.0 20.1 47.3 92.1 44.3 63.0 119.0 73.7 97.4 68.6 228.9 58.0 61.7 50.7 75.5 RABAC1 "PRA1, PRAF1, YIP3" ENSG00000105404 "Rab acceptor 1" Q9UI14 19 41956681-41959321 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019320, HPA029171" Supported NA NA "CAB019320: , HPA029171: AB_10602121" "unprognostic (7.70e-2)" "unprognostic (5.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.93e-1)" "unprognostic (3.41e-2)" "unprognostic (1.19e-2)" "unprognostic (3.32e-3)" "unprognostic (9.69e-2)" "unprognostic (1.76e-1)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.97e-2)" "unprognostic (7.45e-2)" 178.5 164.9 111.8 61.6 110.5 53.6 171.8 117.6 179.0 212.9 113.2 181.3 75.9 236.4 28.5 116.8 175.7 38.2 159.2 102.9 116.3 182.0 200.5 182.3 52.4 133.7 112.3 102.5 185.9 179.4 69.3 244.3 55.9 131.1 161.7 28.7 14.8 198.8 58.4 126.9 143.5 150.1 49.4 124.3 167.3 191.5 156.6 125.2 34.3 172.8 38.4 31.6 170.0 172.9 132.3 95.7 261.0 35.5 94.6 234.8 136.7 47.7 278.8 144.9 67.3 93.8 46.8 60.6 277.0 140.4 161.9 39.1 70.0 21.9 89.0 25.5 102.1 151.6 40.4 73.0 82.1 130.8 35.5 106.7 137.5 86.5 45.5 31.0 84.4 94.2 76.0 17.9 346.6 61.0 149.2 62.6 32.0 44.4 136.8 167.6 83.3 77.4 54.4 65.0 71.8 67.0 97.4 73.5 157.3 71.3 26.2 59.1 29.4 187.2 119.3 77.4 116.2 40.4 303.8 111.0 96.1 172.3 66.3 131.3 720.0 389.3 551.7 372.2 217.3 313.6 398.7 331.0 325.0 232.5 339.4 222.3 298.8 774.6 253.4 220.1 410.2 403.4 511.2 111.8 110.5 117.6 179.0 102.9 116.3 133.7 112.3 102.5 131.1 124.3 125.2 132.3 333.1 128.2 109.8 19.2 203.4 124.7 160.1 242.1 119.5 62.6 173.6 232.3 59.9 163.0 162.3 182.1 16.7 187.5 173.6 411.2 137.0 339.7 203.1 91.9 247.0 234.4 195.0 35.1 14.8 301.4 467.1 309.7 138.6 143.8 142.7 163.5 241.3 237.7 174.0 57.2 18.8 507.5 246.2 119.8 187.0 658.2 307.0 133.1 405.6 21.5 230.8 168.4 161.7 21.1 43.1 427.9 371.7 251.3 625.9 222.3 358.3 326.7 154.8 69.2 230.1 129.4 337.8 234.3 136.1 89.7 136.4 271.7 188.7 176.1 247.4 223.3 ATP1A3 DYT12 ENSG00000105409 "ATPase Na+/K+ transporting subunit alpha 3" P13637 19 41966582-41997497 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Deafness, Disease variant, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 914.7;retina: 295.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 418.1;Cone photoreceptor cells: 171.0;Horizontal cells: 213.7;Inhibitory neurons: 119.1;Late spermatids: 115.6;Rod photoreceptor cells: 291.4" "Cancer enriched" "Detected in many" 5 "glioma: 21.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 57.7;JURKAT: 36.3;Karpas-707: 35.9;REH: 37.1;SCLC-21H: 128.2;SH-SY5Y: 57.7" "CAB033630, HPA045367, HPA056446" Enhanced Approved NA NA 220000 "CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136" "unprognostic (1.90e-1)" "unprognostic (8.65e-2)" "unprognostic (4.57e-2)" "unprognostic (8.20e-3)" "unprognostic (8.94e-2)" "unprognostic (2.52e-1)" "unprognostic (3.16e-2)" "unprognostic (7.66e-2)" "unprognostic (8.02e-2)" "prognostic unfavorable (3.44e-4)" "prognostic favorable (6.15e-5)" "unprognostic (4.02e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "unprognostic (3.45e-1)" "unprognostic (1.27e-1)" 0.2 18.2 96.6 1.4 132.1 0.6 0.1 84.4 634.7 0.0 0.0 2.8 0.9 0.0 0.0 0.3 0.0 0.2 135.0 189.7 177.3 0.1 0.1 0.2 0.9 365.2 175.7 147.8 0.1 0.8 1.2 15.6 0.0 347.6 0.2 0.8 295.0 0.8 0.0 0.2 0.3 1.5 0.8 10.0 0.5 1.3 31.7 308.9 2.1 0.2 1.8 0.6 0.1 0.7 914.7 0.0 2.1 0.7 23.1 0.0 0.1 0.1 0.3 0.0 1.6 1.6 0.8 4.3 57.7 2.6 0.4 5.6 0.5 16.2 0.2 0.6 10.7 3.1 5.0 0.2 0.4 0.0 0.0 18.2 0.0 0.2 0.0 0.3 0.3 0.0 36.3 0.0 35.9 0.4 0.8 10.4 0.1 3.0 8.4 14.3 37.1 18.5 1.8 0.0 0.6 128.2 57.7 0.3 4.2 0.1 0.0 3.4 2.6 0.0 3.0 3.2 0.0 1.1 3.7 2.6 12.7 5.5 20.6 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 96.6 132.1 84.4 634.7 189.7 177.3 365.2 175.7 147.8 347.6 10.0 308.9 914.7 0.2 0.0 4.4 9.1 1.1 0.3 0.4 0.0 0.6 418.1 0.3 0.3 19.3 0.0 0.0 0.0 171.0 0.0 3.2 0.8 0.0 0.0 43.7 0.1 0.1 1.4 0.0 0.0 59.1 0.0 0.1 1.0 1.1 0.1 1.3 0.1 0.0 0.0 0.2 213.7 119.1 0.4 0.0 0.0 0.4 115.6 1.8 0.7 0.0 8.4 0.4 40.0 6.2 14.6 11.4 0.0 0.0 0.4 1.0 0.2 0.0 0.1 0.0 291.4 0.0 0.7 0.4 21.2 2.8 0.2 0.3 0.3 3.6 0.4 0.5 0.4 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419527 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.1;endometrium 1: 78.0" "Cell type enhanced" "Detected in many" "Early spermatids: 22.4;Endometrial stromal cells: 23.5;Excitatory neurons: 39.1;Horizontal cells: 45.4;Late spermatids: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavorable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 11.8 7.0 68.0 9.0 62.5 0.0 16.5 17.8 103.1 34.7 14.9 15.6 6.6 78.0 2.3 10.9 52.2 11.3 9.2 65.4 39.6 4.7 2.1 8.2 3.0 26.3 19.0 69.5 22.0 4.2 6.7 17.3 13.8 35.9 19.0 4.0 8.0 7.0 11.0 2.6 5.8 14.2 39.2 14.3 6.7 6.4 12.3 29.0 1.2 6.3 2.8 1.7 17.3 15.9 46.1 1.0 33.4 76.3 0.3 42.0 36.4 1.3 33.1 53.8 27.5 47.5 3.0 5.3 0.3 3.8 58.2 22.6 3.8 8.1 9.6 8.8 50.4 11.3 0.0 12.7 0.3 26.4 0.6 65.0 26.5 1.9 10.5 5.6 9.5 0.0 0.0 0.8 7.7 3.0 32.2 0.0 0.4 22.1 1.0 1.9 0.1 5.8 0.8 1.8 2.4 3.1 59.9 29.3 2.6 14.4 30.5 1.8 9.8 0.0 20.2 49.3 15.1 4.7 0.1 0.0 0.1 56.3 3.2 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.0 62.5 17.8 103.1 65.4 39.6 26.3 19.0 69.5 35.9 14.3 29.0 46.1 1.7 0.0 3.2 2.3 0.0 0.8 1.2 0.6 0.0 10.0 8.7 4.6 1.4 0.0 1.9 3.7 6.2 0.2 0.1 0.0 0.0 0.1 22.4 0.7 23.5 0.9 0.0 0.0 39.1 0.0 0.4 11.1 0.5 1.6 0.0 0.3 1.4 0.1 0.7 45.4 11.2 0.0 0.0 0.0 1.9 57.4 11.5 0.4 7.2 4.7 0.0 17.0 0.0 13.0 2.0 0.1 0.0 4.1 0.3 4.0 0.0 0.0 1.5 2.9 13.1 0.9 11.8 3.1 4.8 0.1 1.0 0.8 1.2 0.9 0.0 0.9 PTPRS ENSG00000105426 "Protein tyrosine phosphatase receptor type S" Q13332 19 5158495-5340803 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 76.8;Inhibitory neurons: 104.2;Melanocytes: 80.0;Oligodendrocytes: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 89 "plasmacytoid DC: 12.5" "Lineage enriched" "Detected in single" 89 "dendritic cells: 12.5" "Cell line enhanced" "Detected in many" "AN3-CA: 121.8;HaCaT: 124.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 150000000 "Plasma membrane, Cytosol" "HPA054747: AB_2682591" "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 55.2 21.3 30.4 5.1 21.0 1.5 36.5 1.0 20.8 38.0 0.0 20.5 2.6 30.7 2.2 16.7 41.5 13.8 26.1 28.8 6.7 11.2 6.1 27.1 5.6 14.0 13.8 21.7 36.1 32.7 9.8 29.3 2.3 22.7 30.8 1.6 5.8 18.7 14.8 14.5 19.9 13.7 8.6 0.6 9.1 23.4 10.0 24.0 4.2 29.6 7.5 4.4 32.3 32.1 30.8 11.3 64.0 56.2 121.8 25.3 20.5 7.4 19.4 22.5 22.8 18.5 0.7 6.2 0.2 44.5 32.2 18.0 124.6 15.1 0.2 10.0 1.5 24.3 0.0 27.2 40.5 11.7 0.0 14.1 21.8 5.4 4.8 0.9 29.4 0.6 7.9 18.5 0.2 9.1 48.0 5.2 12.3 31.7 0.4 27.0 0.0 12.4 0.0 4.7 22.5 43.1 58.9 18.3 3.4 34.6 10.7 22.0 4.8 2.8 20.2 34.3 46.9 23.6 6.2 0.1 36.9 10.5 0.0 44.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 30.4 21.0 1.0 20.8 28.8 6.7 14.0 13.8 21.7 22.7 0.6 24.0 30.8 1.1 6.4 1.1 53.8 3.2 60.9 42.4 16.1 22.2 49.6 3.3 5.5 14.1 27.1 4.9 12.9 2.1 0.7 56.4 0.1 9.8 1.4 3.4 5.4 11.4 9.7 3.0 0.0 76.8 0.9 32.2 51.2 5.1 5.3 0.0 4.0 25.4 20.2 1.7 11.8 104.2 0.0 10.2 0.3 20.0 5.4 46.6 3.4 80.0 15.9 0.8 46.6 0.0 71.9 90.2 0.5 0.0 36.1 6.3 35.0 0.0 2.9 1.7 10.1 13.1 46.4 22.6 7.4 14.8 16.8 36.7 1.0 2.0 2.7 0.4 30.0 CNFN PLAC8L2 ENSG00000105427 Cornifelin Q9BYD5 19 42387019-42390297 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 3118.1;vagina: 1454.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8" "Cancer enhanced" "Detected in all" "head and neck cancer: 367.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "memory B-cell: 61.2;naive B-cell: 70.2" "Lineage enriched" "Detected in many" 12 "B-cells: 70.2" "Cell line enhanced" "Detected in many" "A549: 18.1;HEK 293: 25.7;MCF7: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA049073, HPA053997" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "HPA049073: AB_2680620, HPA053997: AB_2682337" "unprognostic (5.08e-2)" "unprognostic (4.21e-3)" "unprognostic (2.52e-1)" "unprognostic (7.22e-2)" "unprognostic (3.15e-2)" "unprognostic (8.35e-3)" "unprognostic (6.04e-2)" "unprognostic (2.06e-3)" "unprognostic (3.52e-1)" "unprognostic (9.44e-2)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (8.42e-2)" "unprognostic (4.83e-2)" "unprognostic (7.77e-3)" "prognostic favorable (4.02e-5)" "unprognostic (2.45e-1)" 4.2 5.4 1.5 0.4 3.2 0.6 13.0 1.7 2.2 455.9 1.0 2.4 0.4 1.5 7.4 3118.1 1.6 0.1 1.6 1.7 2.4 2.3 1.4 0.9 0.7 1.8 1.6 1.2 1.0 3.3 1.6 2.2 0.1 1.9 8.7 1.3 0.1 666.9 1.1 1.7 538.9 3.6 0.5 1.7 3.3 3.3 2.5 2.2 2.9 1.8 0.0 279.2 2.5 1454.5 1.9 6.0 18.1 0.4 1.6 0.8 0.9 0.2 1.0 0.3 0.4 0.4 1.0 1.6 5.1 8.0 0.2 1.2 2.4 1.5 2.3 0.1 0.0 25.7 0.4 6.9 1.9 0.0 0.0 0.1 1.8 4.0 1.0 0.0 0.1 0.0 4.7 1.1 0.2 0.0 12.6 0.1 0.1 6.6 8.1 5.4 2.2 0.3 2.9 1.6 2.3 2.7 7.7 3.4 5.1 2.5 2.7 6.2 2.6 0.0 0.0 5.3 0.2 0.1 5.8 7.6 3.6 0.1 2.2 0.3 0.1 4.6 0.1 1.7 3.9 0.4 61.2 1.3 1.2 5.9 70.2 0.6 0.9 1.3 0.0 0.9 1.3 0.1 2.2 1.5 3.2 1.7 2.2 1.7 2.4 1.8 1.6 1.2 1.9 1.7 2.2 1.9 32.7 3.2 2.2 0.0 24.6 4.6 16.8 28.5 14.8 0.1 57.9 51.6 0.8 2.8 20.2 33.1 0.0 0.2 2.1 24.5 7.9 13.1 1.5 20.6 3.9 9.3 32.5 3.6 0.1 2.5 0.3 2.3 4.6 23.9 4.5 7.2 3.9 0.7 5.7 0.0 0.2 33.4 14.2 3.8 7.7 3.9 5.3 6.3 3.6 0.0 6.4 0.3 7.2 0.0 0.1 2.4 39.4 4.5 0.5 11.5 43.8 12.3 10.5 0.1 0.0 0.9 8.0 0.4 17.4 71.8 12.9 0.3 1.3 1.1 41.8 27.0 ZNRF4 "RNF204, spzn, Ssrzf1" ENSG00000105428 "Zinc and ring finger 4" Q8WWF5 19 5455417-5456856 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 981 "testis: 121.0" "Group enriched" "Detected in some" 62 "Early spermatids: 636.6;Late spermatids: 593.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 636.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 593.9 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEGF8 "C19orf49, EGFL4, FLJ22365, SBP1" ENSG00000105429 "Multiple EGF like domains 8" Q7Z7M0 19 42325609-42378769 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 38.7;Cone photoreceptor cells: 77.2;Horizontal cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049248 Approved NA NA 510000000 "HPA049248: AB_2680691" "unprognostic (5.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.35e-2)" "unprognostic (1.66e-2)" "unprognostic (1.20e-1)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (8.58e-2)" "unprognostic (9.25e-2)" "unprognostic (3.64e-2)" "prognostic favorable (6.03e-4)" "unprognostic (4.33e-2)" "prognostic favorable (2.17e-7)" "unprognostic (1.18e-1)" "unprognostic (7.34e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" 13.1 12.4 23.5 4.3 21.5 2.3 10.0 12.4 30.9 9.7 5.4 11.3 4.8 12.0 7.0 7.4 9.8 4.6 15.2 21.9 18.2 11.3 7.0 6.9 3.9 16.6 19.0 21.6 13.6 8.8 20.6 12.4 6.2 22.5 10.1 4.3 11.0 8.5 8.2 10.3 6.8 8.6 6.8 12.7 9.2 9.4 8.0 23.6 3.8 10.8 6.8 3.3 10.3 8.0 17.6 12.7 21.1 22.2 5.5 48.6 23.1 8.2 10.6 14.8 6.0 9.3 4.2 11.6 10.7 22.4 14.7 7.9 6.6 16.2 13.8 6.0 13.1 14.1 8.0 10.3 6.9 18.7 10.9 9.5 28.0 13.6 7.3 10.9 39.9 20.7 3.1 11.8 4.7 11.3 8.3 2.5 6.6 11.3 11.5 3.5 10.4 20.0 2.4 16.1 16.6 11.5 29.3 13.0 6.8 14.4 23.8 7.2 24.3 31.1 12.7 12.3 4.0 14.6 10.9 6.4 5.9 13.8 6.5 31.2 0.4 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.1 23.5 21.5 12.4 30.9 21.9 18.2 16.6 19.0 21.6 22.5 12.7 23.6 17.6 6.2 6.4 10.8 13.7 3.2 2.2 2.4 7.3 4.6 38.7 5.7 6.3 15.9 2.8 10.3 7.3 77.2 3.7 3.2 8.4 0.0 7.2 3.4 7.9 9.8 7.0 13.2 1.7 24.4 3.7 1.5 9.2 4.6 6.7 3.8 26.2 7.1 8.9 5.9 40.4 27.2 6.7 6.1 4.7 3.9 1.2 12.8 3.2 8.8 8.4 4.0 13.1 2.1 10.1 10.0 4.6 3.1 14.3 3.2 2.6 5.4 4.4 7.2 16.3 0.0 11.9 8.9 5.9 4.2 5.7 1.0 2.3 2.5 18.9 10.9 1.4 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382575-48391551 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 605.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 856.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.49e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 109.9 125.5 58.0 62.2 57.0 46.3 107.5 55.2 60.2 133.6 77.0 120.2 133.7 110.9 118.3 108.2 113.2 101.8 94.2 56.0 67.5 119.9 128.2 102.2 53.7 61.8 57.6 53.2 167.2 140.1 193.2 117.1 129.8 58.7 103.4 129.8 39.4 138.9 106.0 77.4 103.9 115.5 101.5 56.3 80.2 121.0 94.5 60.9 52.0 122.9 58.9 73.8 103.4 103.3 60.0 216.2 305.3 173.1 184.7 379.7 440.6 126.5 207.4 363.9 247.0 281.0 202.3 238.7 89.1 132.6 456.4 154.4 187.6 211.1 222.2 234.0 72.7 224.5 74.4 99.4 382.2 329.6 84.1 133.4 419.6 268.0 168.5 178.5 387.4 233.0 75.3 131.7 160.9 333.1 173.6 79.4 856.7 126.3 426.8 122.5 112.1 103.4 141.0 316.2 176.3 172.9 134.5 182.1 160.6 113.1 196.7 126.6 102.1 182.6 173.4 142.6 145.3 179.3 451.1 382.0 60.2 110.1 112.4 181.1 10.8 41.0 12.6 18.1 34.7 20.8 17.0 17.6 19.7 30.6 14.3 14.3 16.1 9.9 20.2 30.2 45.4 20.4 18.2 58.0 57.0 55.2 60.2 56.0 67.5 61.8 57.6 53.2 58.7 56.3 60.9 60.0 150.8 35.3 54.2 8.5 82.2 75.3 130.6 147.1 124.7 39.4 141.0 154.4 28.8 98.7 110.9 93.8 6.2 231.7 59.5 153.0 56.7 224.1 6.2 72.0 188.8 111.4 145.0 56.8 8.7 169.0 605.5 161.0 120.3 166.3 62.7 149.2 102.8 79.6 180.0 40.4 12.7 379.6 93.6 107.6 73.5 14.2 163.5 103.1 92.5 8.4 102.3 89.8 35.0 10.6 10.6 190.3 199.8 132.0 365.9 161.2 213.8 149.6 49.2 28.1 85.5 87.9 131.6 41.8 69.1 127.7 70.2 387.7 55.4 191.3 202.9 157.6 CYTH2 "ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like" ENSG00000105443 "Cytohesin 2" Q99418 19 48469208-48482314 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014872, HPA060662" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "CAB014872: , HPA060662: AB_2732652" "unprognostic (2.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.66e-1)" "unprognostic (2.83e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (2.33e-2)" "unprognostic (9.19e-2)" "unprognostic (3.14e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.21e-4)" 8.2 12.2 18.4 11.5 18.0 8.1 14.3 20.1 19.1 16.1 15.4 9.3 21.7 10.8 13.8 15.4 7.6 23.4 7.5 16.1 16.8 20.4 7.2 11.3 8.3 18.2 19.0 15.2 7.6 16.8 19.8 14.9 16.5 17.8 15.2 8.4 39.3 22.8 9.2 3.6 15.2 21.5 8.2 15.6 10.7 17.6 35.9 20.5 15.1 53.0 5.7 8.9 11.0 10.6 21.2 24.7 36.8 107.9 24.7 16.2 13.9 19.6 18.9 17.3 19.9 18.7 20.1 32.9 16.1 19.2 16.6 16.5 30.4 21.1 23.1 12.5 24.6 28.1 22.5 52.6 22.0 14.6 14.0 29.7 18.0 38.5 24.6 15.9 90.2 26.0 23.4 22.9 55.0 26.6 20.0 23.9 102.5 11.8 22.1 14.9 29.6 15.9 11.2 34.2 52.1 31.9 30.9 20.7 57.6 16.8 34.0 27.1 18.8 28.3 42.6 21.3 10.3 27.8 54.1 30.8 10.8 15.5 27.1 30.7 2.8 2.7 2.3 2.6 2.1 1.8 2.6 3.2 3.7 2.4 1.8 2.8 2.0 7.2 1.4 2.7 3.9 3.6 2.1 18.4 18.0 20.1 19.1 16.1 16.8 18.2 19.0 15.2 17.8 15.6 20.5 21.2 48.5 28.9 33.5 15.0 18.7 45.9 115.0 81.1 26.7 35.6 47.6 28.7 11.5 55.8 63.2 40.5 25.0 51.2 42.6 35.0 35.2 82.7 285.9 85.3 26.5 56.0 26.0 4.6 5.7 93.6 47.0 33.5 55.0 56.3 17.7 32.5 50.3 8.3 43.7 21.9 6.8 29.3 67.1 27.9 39.7 163.0 37.3 34.9 35.6 9.4 52.0 42.6 22.6 4.5 12.0 136.6 36.2 36.9 23.2 77.1 57.9 53.3 80.6 59.5 52.6 42.9 70.9 63.5 53.2 23.2 47.5 142.7 33.2 26.0 25.4 139.2 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445841-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 15.1 13.9 6.3 14.1 5.6 14.1 14.5 6.5 6.9 13.3 6.3 11.5 13.2 16.3 4.2 18.3 13.2 8.7 12.5 5.6 5.6 10.8 16.5 11.0 16.1 6.2 6.9 4.8 13.8 18.8 13.1 8.6 11.5 6.8 12.3 6.5 3.8 12.8 8.9 28.6 17.6 11.0 8.7 5.4 14.2 13.9 7.5 7.7 11.6 11.9 14.6 10.7 14.7 13.6 6.5 58.3 148.9 25.0 47.3 20.2 19.8 21.6 44.9 20.8 62.2 51.8 84.0 42.4 83.4 37.8 28.7 35.0 48.8 62.7 67.9 24.9 63.8 86.5 78.2 48.6 60.4 23.0 71.9 47.8 23.8 37.0 58.9 29.4 14.3 31.5 43.8 107.3 50.1 27.0 59.1 75.1 180.1 68.1 63.8 43.2 92.9 28.3 58.5 26.4 70.4 56.2 32.1 51.3 71.0 22.4 15.4 34.6 36.5 35.2 57.9 49.1 25.9 107.1 50.6 126.8 78.3 19.7 64.8 69.0 0.3 24.8 3.3 41.5 40.7 46.4 44.4 37.1 41.0 40.9 44.8 42.6 40.3 2.0 41.6 32.4 29.7 36.3 37.4 6.3 5.6 6.5 6.9 5.6 5.6 6.2 6.9 4.8 6.8 5.4 7.7 6.5 17.3 3.2 17.5 1.0 26.8 46.3 31.7 18.6 23.3 13.4 16.0 13.7 7.1 14.3 14.3 12.9 0.0 41.4 15.1 14.4 23.5 29.0 3.8 13.1 20.5 19.1 19.2 28.8 1.6 18.2 39.7 18.1 13.3 14.3 19.7 16.8 13.6 18.5 24.4 21.9 3.9 14.5 14.2 11.1 14.3 19.4 17.1 11.4 28.4 2.8 25.3 6.1 19.6 3.0 2.6 22.4 6.5 12.4 28.5 24.2 6.8 18.8 16.8 15.7 19.7 22.7 20.4 9.4 34.3 20.5 40.6 35.0 17.9 26.3 17.1 24.0 GRIN2D "EB11, GluN2D, NMDAR2D, NR2D" ENSG00000105464 "Glutamate ionotropic receptor NMDA type subunit 2D" O15399 19 48393668-48444931 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 6.7" "Group enriched" "Detected in some" 5 "Inhibitory neurons: 36.5;Oligodendrocyte precursor cells: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 17.3;EFO-21: 11.5;HMC-1: 28.4;NB-4: 17.6;SK-BR-3: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB009006 Approved NA NA "CAB009006: AB_2279191" "unprognostic (9.96e-2)" "unprognostic (6.98e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-3)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.43e-4)" "unprognostic (7.84e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.66e-13)" "unprognostic (2.15e-2)" "unprognostic (1.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.14e-1)" 0.5 0.3 3.4 0.3 1.1 0.1 0.3 2.9 2.5 0.1 0.0 0.2 0.5 0.1 0.0 0.1 0.4 0.3 0.3 1.0 3.7 0.1 0.2 0.2 0.1 4.6 5.4 1.2 0.2 0.1 0.9 0.2 0.9 3.2 0.3 0.0 0.8 0.3 0.0 0.1 0.5 0.8 0.1 1.5 0.2 0.2 1.1 6.7 0.0 0.7 0.0 0.0 0.1 0.3 3.3 1.5 17.3 0.4 0.0 1.2 3.5 9.8 2.1 0.0 0.5 0.1 1.3 10.0 0.5 11.5 1.1 0.1 0.1 0.1 0.2 0.3 2.3 0.4 5.4 0.6 2.2 1.8 0.4 28.4 1.3 0.0 1.0 0.0 0.1 0.4 0.1 9.9 0.5 0.1 3.2 0.0 17.6 0.5 8.6 0.3 0.1 0.0 0.3 0.3 0.0 1.8 1.7 0.8 15.0 0.1 0.2 0.0 6.6 5.8 0.0 0.1 0.0 0.0 5.8 3.5 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.1 2.9 2.5 1.0 3.7 4.6 5.4 1.2 3.2 1.5 6.7 3.3 0.3 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.9 0.2 0.3 0.4 0.0 0.0 2.3 0.2 4.6 0.9 0.0 0.1 0.0 0.1 1.8 0.2 1.3 0.0 36.5 0.0 0.0 0.3 0.2 1.5 0.6 0.6 0.0 1.0 0.2 0.7 0.0 15.6 1.3 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.2 0.4 0.0 0.0 1.8 0.2 0.2 0.1 0.0 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364367-48376377 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 54.9" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 159.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 9.8;SCLC-21H: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.3 0.0 0.3 0.1 0.0 2.9 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.6 0.0 0.1 0.0 0.0 0.3 0.6 0.3 0.0 1.0 3.9 0.3 0.0 1.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 54.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 9.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 3.2 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.1 3.6 0.1 0.3 0.5 0.2 0.0 0.7 1.8 0.7 0.0 2.8 0.0 0.0 24.1 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.2 1.1 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.9 1.0 0.7 0.6 0.3 0.6 0.3 1.7 0.3 0.3 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 32.6 0.0 0.1 0.1 9.1 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 24.6 0.9 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 6.6 0.0 0.0 159.5 33.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 CLEC11A "CLECSF3, LSLCL, P47, SCGF" ENSG00000105472 "C-type lectin domain containing 11A" Q9Y240 19 50723364-50725718 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 133.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Fibroblasts: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042690 Approved Approved Centrosome "Secreted in other tissues" NA NA 1300000 Centrosome "HPA042690: AB_10795511" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.40e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.33e-1)" "unprognostic (8.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.29e-2)" "unprognostic (5.26e-2)" "unprognostic (4.99e-2)" "unprognostic (2.79e-2)" "unprognostic (8.30e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (6.09e-2)" "unprognostic (8.66e-3)" "unprognostic (4.00e-2)" "unprognostic (1.57e-2)" 13.5 17.6 4.6 7.1 4.0 133.7 14.2 7.4 8.8 41.4 3.3 11.9 4.8 32.2 1.6 8.5 37.8 6.3 14.3 3.6 6.3 21.3 12.2 15.1 2.8 9.1 5.9 3.3 31.8 7.6 2.5 22.5 5.6 7.7 22.7 2.0 0.7 6.9 4.9 4.5 16.8 9.8 8.2 5.9 14.1 8.0 9.2 4.7 2.6 12.9 1.0 0.8 19.4 28.4 5.3 2.6 3.5 0.0 2.9 33.7 45.3 79.2 139.3 37.9 15.6 15.7 0.1 0.0 0.4 1.7 70.2 0.8 1.6 0.4 0.2 10.7 0.6 22.9 363.0 0.1 0.0 21.3 0.2 637.3 33.7 0.2 1.9 2.3 0.1 17.9 16.1 4.1 2.2 29.0 2.6 3.1 901.1 1.6 0.3 4.6 30.7 0.2 0.2 0.8 0.4 0.0 3.8 4.2 0.0 58.1 0.0 0.9 694.7 100.3 1.1 41.6 0.7 0.7 2.1 2.2 0.5 47.3 358.7 44.2 1.4 24.3 0.4 0.9 11.5 0.1 0.6 0.3 0.2 17.7 0.4 2.0 4.5 1.6 5.7 5.6 4.8 0.2 8.2 4.6 4.0 7.4 8.8 3.6 6.3 9.1 5.9 3.3 7.7 5.9 4.7 5.3 12.4 3.2 5.4 10.4 3.9 32.0 32.2 2.9 27.3 20.5 30.8 31.9 3.4 8.6 4.0 29.5 10.4 8.6 5.0 1.7 119.3 11.0 6.5 17.0 70.7 16.9 26.5 36.4 9.0 3.1 72.4 107.2 4.1 14.1 5.7 18.9 51.4 6.3 49.4 21.9 8.3 4.5 10.2 21.5 73.3 19.9 70.8 29.6 78.2 9.4 11.2 70.4 14.4 8.0 12.9 3.1 1.7 67.4 0.9 21.4 0.5 13.7 5.0 20.7 65.7 20.2 59.2 17.2 21.7 26.3 45.9 18.3 5.8 56.7 3.5 17.8 CCDC114 "CILD20, FLJ32926" ENSG00000105479 "Coiled-coil domain containing 114" Q96M63 19 48296457-48321971 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 7.3;choroid plexus: 23.9;fallopian tube: 25.7;testis: 13.4" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 106.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;U-266/70: 1.7" HPA042524 Approved NA NA "HPA042524: AB_10795706" "unprognostic (8.55e-2)" "unprognostic (2.40e-2)" "unprognostic (2.70e-5)" "unprognostic (1.54e-2)" "unprognostic (5.09e-4)" "unprognostic (1.16e-1)" "unprognostic (2.33e-2)" "unprognostic (3.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (1.30e-1)" "unprognostic (7.50e-3)" "unprognostic (4.35e-2)" "unprognostic (4.25e-2)" "unprognostic (1.30e-1)" "unprognostic (5.15e-2)" 0.0 0.1 5.6 0.0 2.2 0.5 0.1 3.0 1.9 0.7 23.9 0.0 0.0 0.7 0.1 0.0 25.7 0.0 0.1 1.8 3.2 0.1 0.0 3.0 0.1 6.5 7.3 0.2 0.8 0.1 0.7 0.4 0.0 5.0 0.1 0.0 0.4 0.0 0.5 0.0 0.5 0.0 0.0 6.4 0.1 0.2 13.4 2.6 0.2 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.1 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.4 0.0 0.6 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.5 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.2 1.7 0.8 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 2.2 3.0 1.9 1.8 3.2 6.5 7.3 0.2 5.0 6.4 2.6 2.1 0.1 0.0 3.4 0.7 0.1 0.1 0.2 4.7 0.0 0.7 0.6 0.4 0.5 0.0 9.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.9 60.4 0.6 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 1.5 3.8 0.2 0.0 0.2 0.0 1.7 0.4 0.3 6.1 0.0 0.3 6.5 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 106.5 0.6 0.0 0.2 1.4 20.8 2.2 0.1 0.1 0.0 1.0 0.5 0.2 0.1 CARD8 "CARDINAL, Dakar, KIAA0955, NDPP, TUCAN" ENSG00000105483 "Caspase recruitment domain family member 8" Q9Y2G2 19 48180770-48255946 "Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 114.4;HUVEC TERT2: 154.6;NB-4: 131.8;TIME: 148.6" "HPA042071, HPA043513" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042071: AB_2677831, HPA043513: AB_2678522" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "unprognostic (7.84e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.58e-2)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (9.19e-2)" "unprognostic (7.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.78e-1)" "unprognostic (1.69e-1)" "unprognostic (9.19e-2)" "prognostic favorable (1.72e-5)" 28.0 8.7 7.8 29.3 9.3 23.9 17.3 9.2 8.3 13.2 12.0 11.4 12.8 11.0 7.9 8.3 9.0 14.5 12.4 7.6 10.3 9.0 12.5 19.3 38.5 11.3 9.5 4.8 8.6 11.6 9.8 5.8 23.8 10.2 7.2 12.1 5.4 8.1 7.9 16.5 7.8 14.8 16.0 10.3 39.1 13.9 10.7 10.9 31.6 13.1 20.3 37.2 15.6 7.7 11.0 13.4 31.1 28.1 9.1 10.0 15.3 10.9 12.4 15.6 19.0 29.1 10.8 20.1 28.7 15.8 11.9 12.8 8.2 16.9 9.2 17.1 43.8 14.9 114.4 17.0 21.6 11.8 59.2 87.3 11.2 7.0 10.8 11.7 16.5 154.6 28.6 16.8 32.5 15.6 9.5 24.4 131.8 7.1 27.9 7.8 40.9 13.4 7.1 11.2 17.1 9.7 14.6 20.4 14.2 18.5 13.6 8.9 52.2 148.6 11.3 14.3 5.0 21.2 28.9 78.3 18.0 5.2 42.1 21.2 104.9 45.8 76.8 29.2 63.5 33.8 30.7 29.4 34.4 39.9 31.2 27.4 29.5 167.3 28.1 68.2 27.9 45.0 32.2 7.8 9.3 9.2 8.3 7.6 10.3 11.3 9.5 4.8 10.2 10.3 10.9 11.0 115.7 3.2 29.2 11.4 38.9 9.3 4.9 6.5 2.2 8.9 11.4 8.3 9.9 12.8 8.6 12.9 12.5 26.9 50.9 5.1 5.9 7.9 25.3 5.8 10.3 68.6 5.4 36.2 2.0 10.8 11.2 12.1 7.1 6.7 34.1 25.6 73.5 25.9 41.9 6.7 2.7 7.4 6.1 79.5 30.9 59.3 7.8 61.6 21.4 55.3 47.6 4.2 79.3 13.6 17.3 11.2 6.7 7.9 40.1 3.5 9.7 11.7 9.3 3.4 6.6 11.2 11.3 19.6 14.2 6.5 7.1 15.5 55.6 8.6 7.0 3.4 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248" "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavorable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 2.6 3.2 3.6 9.1 2.9 34.8 3.6 3.4 3.5 5.1 2.0 6.9 8.7 4.0 2.6 7.5 5.9 2.4 1.6 2.6 2.9 2.9 4.1 3.5 15.8 4.0 3.2 2.8 6.0 7.1 4.2 4.8 5.1 4.3 4.0 4.2 2.7 4.9 3.1 3.8 10.5 9.7 2.2 2.2 6.0 5.2 8.2 2.5 20.9 5.1 1.0 9.8 3.5 5.0 3.6 43.4 64.1 57.1 37.6 2.6 4.2 41.7 27.0 19.1 44.1 47.2 35.0 42.9 83.7 15.3 11.2 11.9 30.1 24.7 26.7 16.9 45.2 48.8 56.4 38.7 47.5 1.0 63.0 43.7 5.7 2.5 23.0 3.4 5.0 24.0 51.0 46.3 29.8 23.3 44.0 107.3 123.7 33.6 46.7 15.9 84.1 48.4 43.6 12.3 64.8 36.3 36.5 32.3 33.6 10.1 12.5 22.7 44.5 22.6 31.7 54.3 23.9 40.3 29.3 49.0 83.1 12.7 38.0 33.3 0.0 1.6 2.6 7.8 6.8 7.7 10.9 8.8 8.3 1.6 10.0 11.5 8.2 1.3 12.1 3.3 1.5 10.9 5.7 3.6 2.9 3.4 3.5 2.6 2.9 4.0 3.2 2.8 4.3 2.2 2.5 3.6 3.9 3.2 13.6 5.9 16.1 8.3 9.5 8.7 24.5 21.5 7.8 12.3 3.9 7.2 10.3 3.7 10.4 31.1 9.6 10.2 7.9 5.8 19.3 12.0 5.1 8.3 0.0 36.2 4.2 5.2 35.8 6.8 5.1 8.3 6.3 23.1 5.0 5.3 16.4 8.4 5.6 10.0 6.1 3.5 6.8 8.5 2.1 6.6 3.6 3.7 7.2 10.9 11.3 3.5 8.4 3.0 4.4 1.9 23.0 2.8 7.6 4.7 19.5 11.3 13.1 4.5 6.5 13.5 26.1 15.9 9.1 10.0 13.9 6.0 15.3 8.7 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51517819-51531856 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "placenta: 107.6" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0" "Group enriched" "Detected in many" 13 "B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9" "Cell line enriched" "Detected in some" 7 "HMC-1: 500.7" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 0.5 0.1 0.2 3.0 0.3 0.5 0.7 0.3 0.3 1.6 0.1 2.2 2.2 1.5 1.0 2.5 0.3 2.5 0.4 0.2 0.1 0.1 0.1 4.4 3.8 0.2 0.1 0.2 0.1 0.3 0.1 0.0 107.6 0.3 1.0 3.1 0.4 0.5 0.8 0.5 0.5 3.3 1.4 0.0 1.7 2.6 0.3 0.1 0.7 0.0 0.6 4.3 1.8 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 15.8 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 1.2 500.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.3 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 19.1 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.2 4.9 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 1.6 4.5 0.0 0.0 0.2 0.6 0.0 11.0 0.0 0.4 0.2 0.3 0.3 0.3 0.2 0.1 0.2 0.1 0.2 0.3 0.0 0.1 0.5 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 76.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 5.2 0.7 0.0 0.0 55.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.7 0.5 0.0 0.0 0.0 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571283-51592510 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 50.6;RT4: 45.4;TIME: 45.7" "Low region specificity" "Detected in all" "HPA002717, HPA074615" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA002717: AB_1080681, HPA074615: " "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (3.50e-3)" 3.1 3.9 4.4 4.3 5.2 3.5 5.4 10.1 6.2 3.9 5.6 3.9 5.6 5.9 5.2 3.1 4.7 3.1 4.5 3.9 4.9 4.4 3.1 4.9 6.1 4.5 4.5 3.3 9.0 3.3 10.1 6.2 8.1 6.0 4.1 3.8 11.4 6.0 4.9 4.7 3.6 4.4 5.1 4.1 6.1 4.5 10.4 5.4 5.3 6.9 3.6 6.2 3.9 3.2 6.7 3.6 6.3 6.2 6.6 6.5 9.0 0.1 8.1 10.3 7.4 8.9 6.4 5.5 6.6 4.6 8.2 4.6 5.9 6.8 5.6 13.2 0.0 10.0 50.6 10.5 2.2 5.7 8.5 31.1 3.5 5.1 15.1 7.3 37.2 12.1 6.3 17.3 6.7 8.1 0.0 9.2 6.3 3.5 4.4 6.4 0.0 8.1 3.2 4.0 45.4 7.9 5.7 7.6 2.5 4.7 5.0 1.8 6.9 45.7 11.3 5.1 2.6 7.9 8.8 17.6 6.8 31.4 5.0 5.8 0.0 0.4 0.0 0.4 0.1 0.5 0.5 0.4 0.4 0.4 0.5 0.6 0.5 0.2 0.2 0.1 1.4 0.1 0.2 4.4 5.2 10.1 6.2 3.9 4.9 4.5 4.5 3.3 6.0 4.1 5.4 6.7 3.6 6.4 5.4 12.1 3.4 1.1 1.5 1.7 1.8 8.0 2.7 2.5 3.5 1.5 5.3 5.5 2.1 7.9 4.1 1.5 1.9 1.9 11.6 1.4 2.9 3.9 1.8 16.2 11.6 1.6 1.5 3.4 2.6 1.5 14.0 5.5 6.4 2.4 3.2 16.8 12.8 1.3 2.0 5.9 2.1 10.6 3.4 2.4 3.6 10.3 3.1 2.6 5.2 12.5 17.5 6.9 0.6 2.6 1.6 1.8 4.4 2.0 4.4 7.8 0.0 4.3 2.6 6.3 4.3 2.1 1.4 12.0 2.4 3.2 2.0 0.8 PLA2G4C cPLA2-gamma ENSG00000105499 "Phospholipase A2 group IVC" Q9UP65 19 48047843-48110817 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid metabolism, Phospholipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 79.5;skeletal muscle: 67.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 77.1;Cone photoreceptor cells: 66.7;Muller glia cells: 57.1;Oligodendrocytes: 137.1;Rod photoreceptor cells: 153.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 5.7" "Group enriched" "Detected in many" 4 "B-cells: 4.0;monocytes: 5.7" "Cell line enhanced" "Detected in many" "HHSteC: 13.1;TIME: 19.4" "Not detected" "Not detected" HPA043083 Approved Approved Cytosol NA NA Cytosol "HPA043083: AB_10795714" "unprognostic (1.27e-1)" "unprognostic (3.88e-2)" "unprognostic (4.18e-2)" "unprognostic (2.82e-2)" "unprognostic (7.37e-2)" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (6.53e-2)" "unprognostic (8.30e-2)" "unprognostic (1.94e-1)" "unprognostic (5.11e-3)" "unprognostic (1.90e-1)" "unprognostic (4.66e-2)" "unprognostic (9.45e-2)" "unprognostic (2.28e-3)" "unprognostic (1.87e-1)" "unprognostic (9.01e-2)" 5.1 17.4 15.4 5.5 24.1 0.3 4.3 21.2 21.5 4.1 7.2 5.3 6.4 8.7 3.0 4.4 5.1 5.8 25.4 15.2 21.0 6.1 4.7 8.1 10.3 26.2 25.1 13.8 1.7 5.0 12.9 6.6 5.1 28.3 6.9 3.4 79.5 4.1 8.1 67.3 6.4 8.6 10.4 17.7 11.3 3.3 2.8 23.3 4.8 4.9 41.6 5.6 5.2 2.7 42.7 0.7 1.3 0.0 0.3 5.7 3.0 0.1 1.3 8.5 1.4 3.4 0.0 2.1 0.0 1.8 3.7 2.7 0.3 0.0 0.2 2.2 0.9 0.2 0.0 0.5 1.3 13.1 0.0 1.9 0.6 0.3 0.7 5.7 2.6 4.9 0.1 0.0 8.0 2.2 2.2 0.1 0.2 0.1 1.0 0.1 0.1 2.0 0.8 2.7 0.6 0.9 0.1 1.5 2.9 7.1 4.3 0.8 2.2 19.4 2.2 0.8 2.8 1.0 0.5 1.8 0.2 1.9 0.0 4.8 0.0 2.1 0.0 0.1 5.7 0.4 4.0 0.5 0.0 1.2 0.9 0.0 0.0 0.0 1.1 1.4 0.8 0.1 1.4 15.4 24.1 21.2 21.5 15.2 21.0 26.2 25.1 13.8 28.3 17.7 23.3 42.7 7.2 3.2 1.7 30.7 2.4 2.8 1.0 1.5 1.2 77.1 2.4 2.9 35.3 5.7 0.5 0.0 66.7 0.2 0.6 1.2 1.9 13.0 0.3 0.5 4.6 14.3 0.0 0.0 31.6 2.9 0.2 7.4 1.1 0.7 0.0 0.1 4.6 2.0 5.6 33.7 34.7 1.6 18.3 1.2 11.1 0.2 0.6 4.9 7.2 15.0 3.1 57.1 1.0 25.1 137.1 2.7 1.4 7.9 0.7 2.5 5.7 5.2 0.2 153.8 13.1 18.0 9.9 0.9 1.0 0.2 3.0 0.1 1.1 1.6 0.3 0.4 SIGLEC5 "CD170, CD33L2, OB-BP2, SIGLEC-5" ENSG00000105501 "Sialic acid binding Ig like lectin 5" O15389 19 51611927-51645545 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 14.9;lymphoid tissue: 12.5" "Cell type enhanced" "Detected in some" "granulocytes: 8.2;Hofbauer cells: 5.6;Kupffer cells: 10.4;Macrophages: 4.4;monocytes: 3.0" "Cancer enriched" "Detected in single" 5 "urothelial cancer: 1.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "neutrophil: 152.5;non-classical monocyte: 49.3" "Group enriched" "Detected in many" 6 "granulocytes: 152.5;monocytes: 49.3" "Group enriched" "Detected in some" 5 "HMC-1: 59.2;U-937: 25.6" "HPA009085, CAB024900" Supported NA NA "CAB024900: , HPA009085: AB_1079965" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (2.02e-2)" "unprognostic (1.03e-2)" "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (3.28e-1)" "unprognostic (7.44e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (3.55e-3)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" 1.5 0.4 0.3 6.7 0.6 14.9 0.2 0.3 1.1 0.2 0.1 0.7 0.1 0.3 0.0 0.3 0.7 0.7 0.4 0.3 0.3 0.3 1.5 3.4 3.1 0.4 0.3 0.2 0.1 0.2 0.3 0.1 0.9 0.6 0.3 0.7 0.2 0.3 0.1 0.0 0.0 2.0 0.9 0.4 12.5 0.6 0.8 0.4 0.7 0.2 0.4 2.2 1.5 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 15.5 22.2 0.5 0.0 24.2 0.0 2.5 0.0 0.0 15.6 2.0 0.0 0.0 152.5 0.7 49.3 5.0 0.0 8.4 0.3 0.6 0.3 1.1 0.3 0.3 0.4 0.3 0.2 0.6 0.4 0.4 0.7 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 8.2 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.0 10.4 1.2 0.5 0.3 4.4 0.0 1.0 3.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 CABP5 CABP3 ENSG00000105507 "Calcium binding protein 5" Q9NP86 19 48029383-48044079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 600 "retina: 392.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 153.8;Rod photoreceptor cells: 284.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enriched" "Detected in single" 10 "U-2197: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043698 Enhanced NA NA "HPA043698: AB_10797147" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 392.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 153.8 0.0 0.0 0.3 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 21.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 284.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723991 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.6;ovary: 21.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 26.6;Bipolar cells: 20.3;Cholangiocytes: 38.6;Fibroblasts: 64.2;Suprabasal keratinocytes: 17.8" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "eosinophil: 2.5" "Lineage enriched" "Detected in single" 18 "granulocytes: 2.5" "Cell line enriched" "Detected in some" 4 "U-87 MG: 112.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067602: AB_2685871" "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.6 0.6 1.1 6.3 1.2 3.6 1.3 1.2 1.1 0.1 0.0 2.3 0.1 1.0 0.0 0.8 9.0 5.5 5.8 1.0 2.4 0.1 0.6 3.8 0.0 1.9 1.0 1.1 21.0 2.1 0.3 0.9 0.4 0.9 0.2 0.5 0.2 0.2 0.0 0.2 4.1 1.3 0.7 0.4 0.3 1.7 0.3 1.6 0.1 0.7 0.0 0.0 6.4 0.6 1.8 0.0 0.5 0.0 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 3.2 0.0 27.0 0.0 0.1 0.0 0.0 0.0 0.2 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.8 0.0 0.0 0.0 0.0 112.6 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.2 1.1 1.0 2.4 1.9 1.0 1.1 0.9 0.4 1.6 1.8 1.5 0.0 1.8 0.0 0.2 26.6 0.1 0.8 0.6 20.3 0.0 0.0 1.3 38.6 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.5 0.0 0.0 1.7 0.0 0.2 64.2 2.6 0.0 2.5 0.0 0.0 0.1 0.2 0.0 1.5 0.0 0.0 0.8 9.0 0.2 0.3 8.3 8.8 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.5 0.0 3.1 10.6 0.1 0.5 0.4 17.8 0.1 0.3 0.0 0.0 0.2 RAB3D "D2-2, GOV, RAB16, RAD3D" ENSG00000105514 "RAB3D, member RAS oncogene family" O95716 19 11322068-11346270 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 69.0;skin 1: 53.5" "Cell type enhanced" "Detected in many" "monocytes: 53.1;Squamous epithelial cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 169.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 47.3;Karpas-707: 45.6;MCF7: 54.6;SK-BR-3: 68.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "spinal cord: 73.1" "CAB018067, HPA063283" Approved Approved Vesicles NA NA Vesicles "CAB018067: AB_606903, HPA063283: AB_2684976" "unprognostic (4.71e-3)" "unprognostic (3.00e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (4.17e-3)" "unprognostic (7.27e-3)" "unprognostic (1.55e-1)" "unprognostic (2.80e-1)" "unprognostic (8.76e-2)" "unprognostic (9.92e-2)" "unprognostic (4.45e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-1)" "unprognostic (9.15e-2)" "unprognostic (1.34e-1)" 5.6 3.5 11.7 5.1 10.1 17.8 12.3 8.6 13.2 15.1 7.1 7.7 8.2 7.3 6.1 34.4 8.7 3.9 3.6 15.8 12.2 4.7 1.8 8.7 2.4 19.2 10.2 10.2 4.2 69.0 4.4 4.8 7.2 23.2 17.3 8.7 1.7 30.4 8.1 2.5 53.5 6.2 8.9 11.8 8.9 19.6 1.5 13.0 4.8 6.2 4.2 9.2 7.1 15.3 14.8 1.5 14.2 4.4 17.7 7.1 12.3 0.9 1.3 3.8 2.5 2.5 5.1 0.5 0.6 16.0 8.6 4.7 19.1 7.5 11.9 2.2 7.8 1.1 5.8 6.7 5.8 4.4 3.1 13.2 5.3 47.3 2.1 5.1 6.5 20.5 4.3 2.1 45.6 0.8 54.6 2.2 6.9 3.7 28.7 14.4 2.1 0.0 16.1 22.0 14.2 4.9 9.5 4.3 68.8 9.3 6.0 41.1 35.1 7.9 2.4 0.8 11.4 0.2 15.5 21.3 3.2 8.4 19.0 2.6 123.5 84.1 95.6 3.2 51.4 5.6 2.2 3.2 2.6 35.5 2.2 2.2 2.7 169.1 1.6 41.3 0.9 5.7 26.3 11.7 10.1 8.6 13.2 15.8 12.2 19.2 10.2 10.2 23.2 11.8 13.0 14.8 10.0 6.4 17.2 4.6 4.0 15.7 4.5 13.7 12.5 0.7 23.6 14.1 4.3 10.0 19.1 14.7 0.0 8.0 4.4 5.7 11.7 4.8 0.5 5.4 6.6 9.7 18.6 5.9 9.2 25.6 6.6 5.4 23.0 14.0 12.7 4.1 17.9 1.5 9.4 0.0 5.4 29.3 4.1 40.0 2.4 0.2 4.4 16.0 8.8 5.6 53.1 5.3 2.1 1.0 1.3 12.7 5.8 4.9 8.5 11.7 1.4 3.6 1.8 0.4 6.6 3.3 8.5 0.1 2.5 47.8 37.8 10.4 3.9 3.8 15.4 5.9 DBP DABP ENSG00000105516 "D-box binding PAR bZIP transcription factor" Q10586 19 48630030-48637379 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 318.3;Horizontal cells: 215.4;Muller glia cells: 194.2;Rod photoreceptor cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 61.7;NB-4: 235.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (3.68e-3)" "unprognostic (2.16e-3)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "prognostic favorable (5.49e-4)" "unprognostic (2.00e-1)" "prognostic favorable (1.16e-5)" "unprognostic (3.32e-2)" "unprognostic (2.39e-1)" "unprognostic (4.24e-3)" "unprognostic (4.75e-2)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (2.52e-1)" "unprognostic (1.46e-2)" "unprognostic (3.61e-2)" 11.3 53.4 21.0 6.7 29.2 7.5 12.8 34.7 33.2 11.6 8.4 14.8 19.4 13.3 7.2 21.3 11.7 6.1 18.5 20.0 21.7 17.8 24.9 9.8 14.7 20.0 23.8 20.2 33.8 14.1 15.7 35.1 2.8 22.1 17.0 3.8 32.9 42.6 14.0 57.6 54.6 15.6 4.5 20.3 19.3 16.6 16.5 27.0 13.8 34.7 7.8 8.4 8.9 16.4 19.6 4.3 7.3 3.6 17.6 2.6 3.4 3.8 1.0 9.8 3.0 7.4 4.6 39.7 8.5 4.8 4.8 3.6 9.8 12.6 2.5 2.5 8.9 6.0 17.2 6.1 2.4 12.9 10.6 12.5 12.1 2.3 0.5 2.0 21.1 0.6 17.9 1.3 61.7 2.7 5.9 32.8 235.3 2.5 11.3 4.9 15.8 2.9 22.2 1.5 1.3 11.7 14.7 5.5 26.5 15.6 1.6 4.8 10.5 1.1 6.5 17.8 3.4 1.9 28.4 50.7 15.6 3.1 15.0 3.9 3.3 3.0 4.9 1.9 3.5 3.9 2.7 3.2 1.6 4.1 1.7 2.5 3.1 0.1 0.7 1.9 3.5 3.7 1.1 21.0 29.2 34.7 33.2 20.0 21.7 20.0 23.8 20.2 22.1 20.3 27.0 19.6 14.1 12.8 6.2 9.4 21.7 21.9 15.3 3.1 52.3 318.3 17.2 23.5 4.7 12.8 3.2 7.3 87.6 5.2 15.9 8.0 45.0 5.8 1.4 9.0 25.4 10.8 1.8 6.9 4.2 5.6 1.9 25.5 7.1 13.1 0.0 17.6 10.4 10.0 10.9 215.4 5.7 8.1 6.1 15.1 9.6 3.3 16.8 19.4 17.8 1.9 12.9 194.2 32.0 1.5 4.8 3.0 11.3 25.6 6.8 7.8 63.7 26.6 1.3 108.4 0.0 22.8 13.6 1.3 8.4 32.2 22.6 1.6 20.8 85.8 7.5 18.3 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 405.8;Hepatocytes: 520.1;Late spermatids: 662.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 69.6 179.0 101.3 37.1 101.6 55.6 76.6 100.9 144.0 93.5 116.9 67.7 62.9 70.0 93.4 54.1 85.9 61.6 120.5 107.0 117.4 138.2 279.2 74.5 39.2 104.0 105.0 97.5 87.6 156.4 211.7 98.1 54.0 103.1 94.0 36.7 26.1 93.2 79.4 123.2 73.2 57.7 42.6 104.5 63.1 87.0 79.5 104.3 39.7 133.2 66.6 34.4 93.2 64.5 111.8 95.5 229.7 28.5 96.2 54.1 64.5 52.6 35.2 80.9 75.9 59.4 70.0 29.5 84.7 209.3 71.6 74.5 95.6 40.5 106.6 50.5 100.7 39.2 23.0 76.5 117.7 135.9 38.9 69.8 61.3 106.7 48.7 81.0 78.5 92.3 79.9 70.4 349.8 47.0 238.8 58.6 108.9 49.9 123.0 174.5 54.3 43.4 225.9 186.9 169.0 50.2 76.7 37.3 151.1 88.1 33.1 132.2 111.3 54.0 94.3 36.2 104.4 80.2 207.0 225.3 51.5 90.4 172.2 74.0 31.8 336.5 36.7 67.2 150.0 67.9 112.7 54.7 58.5 208.2 95.8 43.9 52.2 52.6 55.8 91.0 150.9 73.7 175.8 101.3 101.6 100.9 144.0 107.0 117.4 104.0 105.0 97.5 103.1 104.5 104.3 111.8 80.5 67.3 70.5 40.1 44.1 51.5 135.9 281.3 62.0 32.5 113.3 134.4 68.5 175.8 202.3 152.6 12.5 123.7 27.7 53.7 60.7 159.2 405.8 63.2 65.8 72.4 117.6 14.5 30.8 162.7 83.0 76.4 26.0 97.0 29.2 45.4 69.3 520.1 94.4 26.9 27.3 81.4 136.3 67.5 50.0 662.3 80.8 61.2 96.0 5.6 62.1 91.9 19.6 17.6 22.2 97.7 68.6 68.1 70.7 136.7 104.1 224.6 69.3 33.1 46.0 76.3 70.9 38.1 15.6 46.4 54.0 96.7 29.8 101.6 79.3 130.9 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine Q13938 19 5912339-5916211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 114.3;fallopian tube: 337.7" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8" "Low region specificity" "Detected in all" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 10.8 26.1 47.5 11.0 31.9 10.1 11.7 72.1 30.3 35.8 46.2 16.0 7.0 21.9 4.7 13.0 337.7 11.3 11.6 31.7 114.3 32.0 21.7 49.9 12.3 60.8 69.8 16.8 13.9 24.2 3.3 28.2 9.4 82.5 40.7 2.8 2.2 25.1 31.1 4.4 15.4 18.8 2.3 70.2 25.4 37.8 6.5 51.5 5.7 31.0 1.1 4.2 44.6 13.8 65.7 2.2 2.3 0.9 6.3 2.1 3.2 4.0 0.7 0.7 0.3 0.6 1.5 13.8 0.9 4.0 1.5 0.7 2.3 0.1 0.6 0.0 4.7 1.9 0.8 4.8 4.7 2.5 0.8 3.5 4.1 4.2 0.4 0.8 4.0 1.0 4.7 0.7 5.4 0.7 4.4 2.4 4.0 0.7 19.4 12.6 3.1 0.3 4.7 1.8 6.2 1.0 4.9 1.0 65.1 6.6 2.0 4.3 4.7 1.5 0.6 0.4 4.6 17.1 19.8 6.5 1.1 7.7 1.8 2.8 0.4 0.7 0.3 1.7 0.6 0.9 0.9 1.0 1.3 0.8 1.8 0.8 0.7 0.7 1.8 0.4 1.5 1.0 0.8 47.5 31.9 72.1 30.3 31.7 114.3 60.8 69.8 16.8 82.5 70.2 51.5 65.7 5.3 12.8 16.5 11.1 3.3 4.8 32.1 122.8 1.8 2.5 8.9 8.8 2.2 0.0 161.5 121.4 4.2 24.3 7.4 5.3 35.2 34.7 6.5 2622.9 48.3 5.5 19.2 0.4 2.6 5.9 22.8 12.9 33.6 330.8 6.3 8.1 0.0 0.0 5.2 6.7 3.2 25.1 197.4 0.0 5.9 5.7 4.7 6.6 10.6 6.5 3.0 7.7 9.2 3.5 12.9 36.9 3.3 4.9 3.8 20.4 4.2 4.5 1557.4 4.2 6.6 3.5 42.7 0.4 0.6 0.9 4.1 20.5 9.2 3.3 9.3 128.6 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 72.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 72.3" "Cell line enhanced" "Detected in many" "U-2197: 95.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA048973: AB_2680580" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 21.7 36.1 79.1 10.7 60.9 16.0 21.3 26.4 80.3 38.6 20.7 32.6 5.6 33.2 7.6 16.2 35.8 13.5 27.6 111.4 55.6 19.0 26.2 30.1 5.2 37.5 38.9 64.3 40.8 17.1 13.1 74.1 11.2 37.8 41.2 4.4 10.7 22.4 13.7 33.2 24.5 17.6 16.7 27.0 29.1 26.7 17.6 59.9 3.0 26.2 5.5 2.8 32.6 27.8 41.4 23.6 14.3 7.8 32.2 31.8 30.3 2.1 40.8 37.7 24.7 25.2 2.8 4.3 4.5 23.6 52.5 5.2 4.2 4.4 12.3 13.3 12.3 8.4 1.4 9.5 2.8 16.5 1.4 45.3 27.3 21.7 21.4 4.2 35.8 17.0 7.2 22.9 36.0 21.1 34.6 0.8 6.4 8.5 7.9 78.6 0.5 1.1 12.9 11.7 11.0 8.3 27.6 17.1 14.6 9.0 2.4 20.9 29.6 19.8 55.7 11.8 95.2 21.8 22.4 14.7 1.6 54.1 21.2 22.4 2.0 17.7 9.1 0.6 15.3 0.1 0.1 0.2 0.0 6.7 0.0 0.3 0.1 72.3 0.0 10.8 0.2 0.6 6.7 79.1 60.9 26.4 80.3 111.4 55.6 37.5 38.9 64.3 37.8 27.0 59.9 41.4 9.5 6.4 8.3 0.0 1.5 0.0 6.9 0.0 11.4 7.0 9.9 10.7 0.0 8.6 1.3 3.7 12.5 0.6 1.5 0.1 1.9 6.2 11.7 2.0 11.0 10.1 17.0 0.4 0.0 8.7 2.3 12.7 3.1 3.4 2.5 3.6 11.4 8.3 4.2 8.4 0.0 2.0 0.0 11.1 0.0 13.5 14.3 7.9 0.0 0.0 12.1 16.0 6.2 0.0 0.0 9.6 0.4 16.6 1.3 11.6 0.6 1.5 1.5 6.9 6.6 5.7 13.0 2.3 7.4 2.6 0.0 2.9 1.5 11.2 0.7 5.3 FAM83E FLJ20200 ENSG00000105523 "Family with sequence similarity 83 member E" Q2M2I3 19 48599961-48615076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 30.3;salivary gland: 28.7;stomach 1: 37.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 2.9;OE19: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049305, HPA075968" Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA049305: AB_2680705, HPA075968: " "unprognostic (1.36e-1)" "unprognostic (9.81e-3)" "unprognostic (3.83e-2)" "unprognostic (7.39e-2)" "unprognostic (4.77e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (2.26e-2)" "unprognostic (3.18e-1)" "unprognostic (2.71e-1)" "unprognostic (8.00e-2)" "unprognostic (9.31e-2)" "unprognostic (7.05e-8)" "unprognostic (5.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.70e-1)" "unprognostic (8.90e-3)" 0.1 0.1 0.2 3.8 0.3 0.4 1.4 0.8 0.6 10.7 0.2 24.0 30.3 1.2 0.1 7.0 3.9 6.5 0.2 0.3 0.2 0.8 0.3 8.1 0.2 0.2 0.2 0.3 0.1 1.2 0.0 0.2 0.6 0.3 3.2 16.8 0.2 28.7 0.4 2.7 1.9 30.3 1.0 0.1 0.2 37.7 2.3 0.3 0.1 0.1 0.0 1.3 1.2 4.1 0.6 0.4 0.4 0.0 0.7 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 2.9 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.4 0.1 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.6 0.1 0.8 1.1 9.4 0.9 0.2 0.1 0.3 0.0 0.2 0.5 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.2 0.5 0.1 0.1 0.2 0.1 1.0 0.1 0.2 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.8 0.6 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.3 0.6 0.0 9.6 13.4 1.3 0.4 0.0 1.4 0.8 0.6 0.0 1.8 0.8 2.1 8.6 6.5 1.8 0.0 0.1 0.3 22.8 0.0 0.1 26.0 4.8 0.5 0.2 5.4 0.0 0.3 1.1 0.1 0.2 74.9 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 26.9 2.0 0.0 0.0 9.3 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 1.6 16.5 0.0 0.4 3.3 12.7 0.0 5.1 0.0 0.0 0.2 0.2 0.8 0.5 2.3 0.0 0.1 0.3 0.1 12.8 6.9 RASIP1 "FLJ20401, RAIN" ENSG00000105538 "Ras interacting protein 1" Q5U651 19 48720585-48740610 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 121.8;Endothelial cells: 83.9;Hepatic stellate cells: 94.2;Theca cells: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 14.7;HeLa: 13.9;HUVEC TERT2: 38.5;SiHa: 21.1;TIME: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077251 Approved NA NA "HPA077251: AB_2732337" "unprognostic (9.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (3.64e-2)" "prognostic favorable (7.17e-5)" "unprognostic (8.44e-2)" "unprognostic (2.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.46e-4)" "unprognostic (5.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.43e-2)" "unprognostic (1.32e-1)" "unprognostic (2.90e-1)" "unprognostic (1.19e-1)" 22.3 7.1 6.2 2.6 3.5 0.7 21.2 3.7 4.7 8.3 2.0 5.4 2.6 11.3 1.1 5.1 9.9 3.8 14.8 3.1 3.6 8.0 2.7 28.1 2.3 4.4 5.0 2.4 5.0 13.3 1.6 4.1 8.0 4.3 5.6 0.7 0.1 4.8 2.8 7.7 6.0 5.7 4.3 3.7 16.9 10.4 6.8 6.7 1.5 10.6 4.0 1.4 7.7 7.7 5.5 10.2 0.1 0.2 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.6 1.1 0.8 2.2 0.0 0.0 2.5 0.2 2.2 0.0 0.0 14.7 0.2 13.9 0.4 2.2 0.0 0.7 2.2 1.2 0.0 0.0 0.0 38.5 1.3 1.3 0.1 0.0 0.9 0.0 1.3 0.3 0.4 0.0 0.2 0.0 0.4 0.0 0.8 6.7 0.5 21.1 0.0 0.0 0.1 0.1 0.0 52.4 0.0 0.4 0.2 0.0 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.5 3.7 4.7 3.1 3.6 4.4 5.0 2.4 4.3 3.7 6.7 5.5 121.8 0.0 1.3 0.0 1.2 6.5 5.7 2.0 0.6 1.1 5.9 10.8 7.3 1.5 1.2 1.8 0.0 0.4 0.7 0.1 0.0 0.7 5.9 3.2 4.8 83.9 0.0 2.7 3.4 0.7 1.9 9.5 2.0 3.8 0.0 6.0 94.2 1.9 0.7 6.7 1.1 0.1 4.1 6.3 3.0 5.2 10.2 1.0 19.6 16.9 0.0 2.1 0.0 1.5 1.5 0.8 0.0 11.3 1.4 10.1 0.2 0.3 2.1 0.7 19.7 1.9 6.2 1.0 11.0 3.7 6.0 0.3 1.0 40.2 0.2 6.4 THEG "CT56, THEG1" ENSG00000105549 "Theg spermatid protein" Q9P2T0 19 361747-376026 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 42.8" "Group enriched" "Detected in some" 45 "Early spermatids: 163.2;Late spermatids: 560.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HDLM-2: 64.4;MCF7: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.48e-1)" "unprognostic (6.37e-3)" "unprognostic (7.89e-3)" "unprognostic (2.34e-1)" "unprognostic (3.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.57e-1)" "unprognostic (5.57e-2)" "unprognostic (7.09e-4)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.14e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.3 0.6 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.8 0.1 0.3 0.0 0.0 0.0 42.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 560.0 1.2 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FGF21 ENSG00000105550 "Fibroblast growth factor 21" Q9NSA1 19 48755524-48758333 "Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 106 "liver: 84.8" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 116.4" "Cancer enriched" "Detected in single" 315 "liver cancer: 33.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HHSteC: 1.4;U-2 OS: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061286 Supported "Secreted to blood" NA NA 254000 73000 "HPA061286: AB_2684466" "unprognostic (1.64e-2)" "unprognostic (3.62e-1)" "unprognostic (3.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 BCAT2 "BCAM, BCT2" ENSG00000105552 "Branched chain amino acid transaminase 2" O15382 19 48795062-48811029 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 254.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054091 Enhanced Approved Nucleoplasm,Mitochondria NA NA 25000 "Nucleoplasm, Mitochondria" "HPA054091: AB_2682374" "unprognostic (2.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.16e-1)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.97e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (2.98e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.87e-3)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (7.50e-3)" 26.6 86.1 24.4 11.5 24.6 6.1 25.4 31.2 34.8 29.1 60.7 35.3 14.9 27.2 5.4 34.0 30.5 10.8 48.3 25.9 24.4 40.2 22.3 30.6 14.1 24.6 25.7 21.5 53.7 77.4 20.3 31.0 12.5 26.2 38.7 17.6 5.6 29.4 17.1 59.1 25.6 23.9 13.6 23.1 19.8 66.9 20.4 26.2 12.1 29.2 29.7 16.6 57.0 29.2 26.0 62.9 73.3 19.3 40.6 78.1 26.3 34.2 27.3 13.8 32.7 31.7 74.5 37.4 73.3 30.2 24.3 10.1 28.8 29.8 47.4 16.5 46.0 76.0 27.0 32.7 5.0 75.3 36.9 24.2 38.5 29.8 24.2 35.0 31.8 45.5 55.3 34.9 43.8 12.2 74.8 50.4 38.9 16.9 98.5 35.7 75.2 33.1 80.8 30.8 254.3 102.6 29.4 41.0 66.7 20.7 13.3 42.3 17.9 25.9 31.5 30.3 37.6 34.3 40.8 58.4 35.8 17.2 56.7 21.0 0.0 14.4 3.0 14.3 16.1 20.1 23.5 17.5 18.8 25.6 20.3 15.7 14.1 0.6 14.8 6.2 28.9 24.9 12.3 24.4 24.6 31.2 34.8 25.9 24.4 24.6 25.7 21.5 26.2 23.1 26.2 26.0 13.1 28.9 44.8 59.7 14.1 6.0 28.3 32.3 14.2 10.4 23.5 17.9 25.5 31.5 20.6 12.9 20.9 67.6 11.0 28.8 72.4 38.6 8.0 16.2 22.4 13.5 19.9 6.3 11.2 21.3 25.2 15.3 32.6 23.8 23.5 18.3 12.8 11.2 26.2 1.7 10.6 30.4 38.7 7.9 10.5 10.2 17.4 7.5 24.9 8.4 21.6 7.3 7.2 9.0 11.2 15.8 17.7 30.1 15.1 16.1 13.9 39.4 13.2 13.4 19.7 9.9 17.3 8.0 19.5 32.6 7.1 45.8 9.5 21.9 33.9 47.7 MIER2 KIAA1193 ENSG00000105556 "MIER family member 2" Q8N344 19 301444-344815 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041439 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041439: AB_2677481" "unprognostic (1.48e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.89e-4)" "prognostic favorable (1.72e-5)" "unprognostic (6.71e-2)" "unprognostic (2.96e-1)" "unprognostic (6.95e-3)" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (4.24e-1)" "unprognostic (1.18e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (7.22e-6)" "unprognostic (8.05e-2)" "unprognostic (4.28e-2)" "unprognostic (4.94e-3)" "unprognostic (1.68e-2)" 22.0 13.2 11.9 4.6 10.5 2.1 21.4 8.7 18.9 21.3 6.1 15.9 4.6 23.1 2.9 19.8 16.7 3.3 25.1 10.0 8.9 15.3 8.4 28.4 3.8 11.4 10.8 9.1 15.4 11.6 2.3 15.8 6.4 11.4 23.3 1.2 2.0 13.0 4.6 18.2 24.7 14.3 2.8 8.6 33.7 13.5 29.6 10.6 3.4 17.2 7.8 1.8 19.9 19.9 10.4 12.8 7.9 7.0 8.1 2.5 3.7 15.1 10.3 4.8 7.6 7.9 12.3 4.0 6.6 5.4 5.4 3.0 10.7 4.5 6.0 2.3 16.0 21.8 3.9 6.9 9.5 7.5 0.0 30.1 4.8 4.6 6.2 2.2 5.1 8.6 8.8 11.3 0.1 4.3 13.5 10.5 14.3 18.1 3.8 0.0 9.1 2.3 1.8 3.7 7.2 11.2 10.1 6.0 4.5 10.7 4.2 5.1 7.1 9.3 10.3 7.2 15.8 11.6 18.5 9.9 5.5 9.7 5.7 10.4 3.7 3.6 2.5 1.1 3.1 0.9 0.5 1.4 1.6 3.9 1.0 1.8 1.2 0.2 0.9 3.5 2.1 0.7 2.3 11.9 10.5 8.7 18.9 10.0 8.9 11.4 10.8 9.1 11.4 8.6 10.6 10.4 28.7 0.0 5.4 4.2 5.0 11.2 11.2 8.8 7.4 7.6 7.7 6.9 1.3 7.2 6.0 3.7 16.7 22.3 3.7 4.4 1.9 9.2 6.4 3.4 6.3 24.1 10.7 6.1 4.9 5.4 19.2 6.9 10.2 4.8 0.0 6.9 7.9 2.3 10.2 3.3 4.4 4.6 4.1 8.5 6.3 19.0 6.2 8.7 5.4 13.1 6.7 7.4 5.2 3.0 6.7 8.5 5.9 5.7 4.5 11.9 3.8 0.9 5.7 12.8 6.6 4.1 5.7 18.4 25.1 6.3 10.7 29.4 5.5 6.5 4.9 12.7 PLEKHA4 PEPP1 ENSG00000105559 "Pleckstrin homology domain containing A4" Q9H4M7 19 48837097-48868617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Peritubular cells: 53.4;Smooth muscle cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "spinal cord: 45.0" "HPA042978, HPA048473" Uncertain Approved "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" Yes No "Plasma membrane, Cytosol" "Cytokinetic bridge, Centriolar satellite" "HPA042978: AB_2678249, HPA048473: AB_2680409" "prognostic favorable (1.97e-4)" "unprognostic (4.39e-1)" "unprognostic (8.16e-2)" "unprognostic (2.85e-2)" "unprognostic (3.98e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (5.09e-2)" "unprognostic (1.01e-2)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.84e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-3)" "unprognostic (6.38e-2)" 32.3 24.8 7.6 12.2 8.3 0.7 32.0 7.6 9.5 25.8 9.7 32.5 5.7 34.9 5.0 14.4 30.8 11.2 38.4 7.4 23.1 24.8 33.0 25.9 5.8 16.4 10.6 6.0 47.9 13.3 9.6 30.2 5.6 8.7 28.6 3.9 2.5 15.2 8.5 19.5 16.6 16.1 10.8 9.7 16.3 21.2 11.1 13.0 5.5 31.3 13.2 3.3 34.7 21.9 9.9 9.0 0.5 9.9 63.4 14.2 41.7 8.0 7.0 24.7 26.8 49.5 5.9 2.5 0.4 11.8 9.8 10.4 2.7 3.5 3.6 4.2 0.0 3.4 2.3 1.7 6.6 11.0 0.0 14.2 21.5 2.2 15.6 1.0 11.1 8.0 11.2 9.5 5.3 7.4 5.4 3.2 0.5 1.5 6.0 0.8 0.3 31.5 0.6 8.3 0.1 0.0 11.0 3.0 2.6 77.0 2.5 3.9 3.0 1.3 8.5 6.8 11.2 1.8 28.3 25.4 5.3 10.2 0.7 23.0 0.0 0.3 0.9 1.8 0.3 1.3 1.7 1.7 1.1 0.1 3.9 2.8 2.6 0.1 0.8 0.3 1.2 0.6 0.9 7.6 8.3 7.6 9.5 7.4 23.1 16.4 10.6 6.0 8.7 9.7 13.0 9.9 6.4 0.0 18.7 2.3 1.4 9.6 31.3 17.6 12.0 0.7 11.4 18.3 37.1 17.2 27.2 7.3 0.0 3.3 2.9 3.2 1.9 23.3 0.8 11.6 34.1 7.0 1.2 3.2 0.4 5.1 6.8 41.7 7.7 11.6 0.0 18.8 6.4 13.3 2.9 0.0 0.5 2.5 4.1 0.8 9.2 2.0 41.3 1.9 12.4 1.9 1.3 9.9 2.1 0.5 0.2 6.9 0.5 53.4 0.7 29.8 0.7 14.6 20.5 1.0 6.6 33.0 48.4 4.0 3.7 5.7 9.8 2.9 2.4 16.0 3.3 21.4 PPP2R1A "PP2A-Aalpha, PP2AA, PR65A" ENSG00000105568 "Protein phosphatase 2 scaffold subunit Aalpha" P30153 19 52190048-52229518 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromosome partition" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018599 Approved Cytosol NA NA 2000000 Cytosol "CAB018599: AB_628178" "unprognostic (1.78e-1)" "unprognostic (2.31e-2)" "unprognostic (4.52e-2)" "unprognostic (2.87e-1)" "unprognostic (6.67e-2)" "unprognostic (7.82e-2)" "prognostic unfavorable (1.76e-4)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.30e-2)" "unprognostic (3.06e-1)" "unprognostic (6.48e-3)" "unprognostic (8.28e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.97e-1)" "unprognostic (3.57e-2)" "unprognostic (1.70e-2)" "unprognostic (9.19e-2)" 97.6 303.2 286.4 61.0 292.3 58.6 99.6 273.7 397.2 119.0 241.4 116.3 92.3 127.8 101.9 165.7 127.9 63.7 293.9 317.2 281.8 158.0 106.9 88.3 73.3 285.4 284.3 300.7 165.0 101.6 130.9 124.8 69.7 294.7 124.3 83.0 90.6 100.6 93.1 241.6 119.3 99.3 96.8 258.2 88.3 106.8 67.7 311.8 77.6 108.8 172.2 90.8 124.5 122.9 300.8 153.6 248.4 210.9 182.0 166.9 173.4 105.3 130.3 173.2 174.1 151.1 129.3 122.1 132.5 91.0 213.9 95.7 108.8 228.0 197.9 100.6 101.3 562.8 99.6 126.9 148.2 152.6 105.6 93.1 234.3 163.8 163.5 149.2 162.9 167.9 92.1 114.3 96.8 196.3 178.6 159.6 215.4 204.6 162.2 218.4 148.6 118.3 152.5 285.0 251.7 153.3 161.3 149.0 160.1 100.3 136.3 141.9 197.3 153.1 133.2 120.5 65.7 154.2 96.9 151.5 160.0 143.1 109.7 170.5 172.6 172.0 169.4 143.9 212.2 131.0 143.1 126.3 134.3 192.8 157.1 101.6 119.6 103.7 228.6 199.0 119.7 177.5 255.6 286.4 292.3 273.7 397.2 317.2 281.8 285.4 284.3 300.7 294.7 258.2 311.8 300.8 55.3 44.8 35.4 21.5 76.0 70.4 99.0 178.0 56.9 114.0 64.5 71.1 100.2 74.4 99.5 119.5 25.0 203.7 47.3 157.0 117.4 213.5 4.4 77.5 79.7 72.4 107.0 39.7 27.4 155.7 259.9 85.7 77.5 100.7 68.5 96.7 65.0 52.8 146.2 144.7 39.5 128.8 144.5 68.1 39.3 10.4 72.4 58.0 53.4 17.8 103.7 118.0 62.8 25.6 29.9 168.2 189.0 85.4 60.3 88.3 147.5 135.3 80.6 61.5 78.9 49.2 90.3 16.5 68.8 74.4 63.2 182.0 64.2 99.7 185.2 104.2 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: AB_2686405" "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favorable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 28.6 33.3 51.9 21.9 55.9 27.1 25.0 38.5 58.7 31.0 28.6 27.0 17.4 33.6 25.8 31.6 30.6 20.7 26.8 55.3 44.8 22.7 18.6 23.2 23.6 52.3 47.6 55.8 40.7 20.8 32.6 33.8 21.1 52.7 26.8 20.0 33.3 22.4 24.1 25.9 48.5 23.6 28.3 40.3 26.5 23.7 32.9 52.7 28.0 27.0 20.3 24.1 28.8 27.8 52.6 54.4 40.5 61.0 78.3 36.3 47.6 39.5 61.0 40.1 86.5 60.6 55.9 28.5 36.6 46.5 51.7 24.1 70.5 109.2 60.3 47.9 45.6 87.6 56.5 72.1 68.4 40.9 100.6 52.0 42.9 46.8 57.5 60.4 55.8 41.0 72.7 89.4 33.9 48.5 93.4 84.8 68.8 71.0 39.8 120.8 80.7 47.6 67.0 51.2 38.9 148.6 73.8 49.6 62.2 30.7 41.2 43.5 35.2 41.5 131.5 34.9 71.3 91.2 66.8 70.4 62.3 39.2 89.9 47.9 0.2 0.2 0.1 0.6 0.3 0.9 0.4 0.4 0.5 0.4 0.4 0.8 1.0 0.8 0.1 0.4 1.5 0.2 0.2 51.9 55.9 38.5 58.7 55.3 44.8 52.3 47.6 55.8 52.7 40.3 52.7 52.6 13.2 6.4 17.9 24.2 10.7 31.0 8.9 10.6 14.8 42.4 22.8 17.1 17.6 11.5 10.0 22.0 100.1 10.9 11.0 14.1 5.9 9.7 12.2 16.2 20.6 17.0 22.9 14.9 22.3 8.5 6.6 18.0 10.2 12.9 3.8 20.7 19.2 17.8 10.5 57.2 26.6 17.7 8.2 13.0 14.9 19.5 31.1 8.7 8.8 22.5 11.1 24.6 6.2 19.6 24.7 15.2 9.1 32.4 8.7 19.3 11.9 16.7 11.3 33.6 6.6 23.8 15.3 23.8 11.3 21.9 41.5 14.5 9.5 16.5 16.6 9.3 WDR83OS "Asterix, C19orf56, PTD008" ENSG00000105583 "WD repeat domain 83 opposite strand" Q9Y284 19 12668073-12669415 "Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065685 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065685: AB_2685531" "unprognostic (1.73e-1)" "unprognostic (5.37e-3)" "unprognostic (1.03e-1)" "unprognostic (4.86e-2)" "unprognostic (1.27e-1)" "unprognostic (3.29e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.09e-4)" "unprognostic (1.71e-1)" "prognostic favorable (8.84e-4)" "unprognostic (4.17e-3)" "unprognostic (1.09e-1)" "unprognostic (7.87e-3)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" 151.0 221.0 198.2 80.8 204.4 205.1 158.2 205.8 228.3 163.6 195.3 138.5 104.9 148.1 278.6 175.4 225.2 139.2 198.5 191.7 205.5 195.8 190.7 134.4 129.7 204.2 200.8 190.1 228.2 211.8 206.4 166.0 120.7 203.8 161.9 152.8 50.6 182.5 137.2 228.5 175.5 129.6 171.1 213.7 147.6 166.1 81.1 203.3 131.0 191.8 236.2 175.6 165.9 146.0 218.8 190.9 204.4 223.1 252.8 338.2 267.0 96.4 135.3 230.3 211.6 181.7 170.0 161.1 86.2 310.0 390.4 143.5 150.9 242.7 255.9 175.2 180.9 333.0 107.4 170.3 259.6 262.1 183.5 148.5 287.1 343.2 208.0 243.7 309.9 265.2 161.2 196.2 196.3 253.5 661.5 136.8 399.3 187.7 254.4 584.9 110.0 117.7 310.1 241.7 217.2 182.3 278.6 155.2 162.4 193.5 148.2 197.6 295.1 156.7 289.8 78.2 317.2 205.8 342.4 428.4 126.5 245.4 313.2 189.0 612.8 502.8 492.3 329.2 469.3 312.0 445.2 308.6 336.5 466.7 394.4 280.0 305.8 485.8 451.4 503.7 319.2 396.0 635.4 198.2 204.4 205.8 228.3 191.7 205.5 204.2 200.8 190.1 203.8 213.7 203.3 218.8 198.5 80.1 54.6 11.8 156.8 171.7 193.7 391.7 272.0 42.3 310.7 424.2 129.4 168.7 204.5 342.1 27.1 435.7 153.8 233.0 401.1 255.5 7.9 128.6 184.0 185.7 195.3 126.4 10.5 255.8 333.8 205.2 162.6 162.7 147.9 239.7 183.1 314.3 287.5 50.5 10.6 282.6 301.1 212.5 230.2 22.7 170.6 209.3 297.1 13.1 254.5 264.8 179.2 13.0 39.4 243.4 295.7 144.8 256.0 230.9 398.1 586.3 103.6 55.7 98.6 140.9 187.6 87.3 98.4 353.6 221.3 405.1 172.2 279.8 262.4 241.1 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909278-53943950 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 54.3;retina: 17.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 32.0;Horizontal cells: 134.6;Inhibitory neurons: 43.3;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.3" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 52.8;GAMG: 14.6;HMC-1: 40.8;hTERT-RPE1: 51.4;SH-SY5Y: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 0.0 0.4 41.2 0.0 35.7 0.0 0.0 33.8 54.3 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 34.3 0.0 0.0 0.0 0.0 37.4 36.8 35.0 0.0 0.1 0.1 6.6 0.0 41.8 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.0 30.4 0.0 0.1 0.5 46.7 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 7.0 52.8 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.6 0.1 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 40.8 0.4 0.0 0.1 0.0 51.4 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 10.9 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 35.7 33.8 54.3 40.8 34.3 37.4 36.8 35.0 41.8 30.4 46.7 43.6 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 32.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 134.6 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.2 0.0 23.1 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GCDH ACAD5 ENSG00000105607 "Glutaryl-CoA dehydrogenase" Q92947 19 12891160-12914207 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 115.5;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043252, HPA048492" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043252: AB_2678390, HPA048492: AB_2680418" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" "unprognostic (6.79e-3)" "unprognostic (8.07e-3)" "unprognostic (8.20e-3)" "unprognostic (3.14e-2)" "prognostic favorable (7.28e-5)" "prognostic favorable (3.35e-4)" "unprognostic (1.62e-1)" "unprognostic (3.03e-2)" "unprognostic (7.50e-3)" "unprognostic (7.46e-2)" "prognostic favorable (6.79e-8)" "unprognostic (7.09e-3)" "unprognostic (3.42e-1)" "unprognostic (5.32e-2)" "unprognostic (1.59e-1)" 16.9 17.9 19.0 11.3 20.7 13.1 15.7 21.0 23.5 10.0 19.4 13.3 11.9 12.7 8.7 14.1 15.3 8.5 27.4 18.1 17.9 24.8 89.8 9.4 16.9 20.7 19.8 17.3 17.0 15.6 11.5 10.7 5.5 20.4 13.7 8.6 5.6 20.2 11.6 30.7 9.8 13.2 8.2 18.3 12.9 18.7 4.5 19.7 18.0 12.0 27.4 12.0 15.0 10.0 21.5 22.9 14.1 15.0 27.5 21.4 9.8 13.8 17.2 11.1 21.6 15.7 26.9 10.8 33.0 31.9 10.5 10.8 15.6 20.8 16.4 10.6 28.6 22.8 21.0 24.6 33.1 24.8 43.7 18.8 13.8 19.9 15.3 16.1 8.8 18.1 44.4 51.8 11.4 10.7 28.9 51.7 41.7 16.7 22.0 36.1 48.2 15.3 68.9 12.6 12.1 32.3 18.9 22.8 22.6 16.7 9.6 17.8 29.3 13.3 18.0 12.9 29.9 18.2 59.5 32.2 34.6 11.0 50.7 15.4 13.9 13.9 8.5 18.8 12.1 18.8 18.1 23.2 21.0 24.0 19.5 30.9 23.8 3.1 38.8 9.8 14.7 21.4 20.0 19.0 20.7 21.0 23.5 18.1 17.9 20.7 19.8 17.3 20.4 18.3 19.7 21.5 6.0 3.2 5.3 25.5 21.2 7.9 14.5 13.3 11.4 14.2 17.3 10.8 10.0 22.8 8.6 11.0 25.0 16.2 17.2 11.6 52.8 14.0 2.6 7.7 10.0 7.3 15.6 60.4 7.1 11.2 21.5 10.2 12.8 10.9 7.0 19.5 13.6 115.5 21.5 8.4 7.4 13.8 16.2 14.4 5.0 1.8 13.1 9.9 17.8 5.6 20.7 18.6 18.6 14.6 15.1 10.2 9.7 12.8 25.4 11.3 17.4 147.8 7.2 12.3 0.0 13.7 9.8 8.3 7.4 13.4 5.3 16.3 20.9 33.0 20.6 12.1 LILRB5 "CD85c, LIR-8, LIR8" ENSG00000105609 "Leukocyte immunoglobulin like receptor B5" O75023 19 54249421-54257301 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 17.9;lymphoid tissue: 49.5" "Group enriched" "Detected in some" 6 "Hofbauer cells: 61.1;Kupffer cells: 103.4;Macrophages: 40.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012069 Approved NA NA 58000000 "HPA012069: AB_1852873" "unprognostic (3.55e-3)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-2)" "unprognostic (8.86e-2)" "unprognostic (5.44e-2)" "unprognostic (3.02e-5)" "unprognostic (6.80e-2)" "unprognostic (2.23e-1)" "unprognostic (2.33e-1)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (4.14e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" 17.9 10.4 0.2 1.7 0.5 0.9 7.3 0.3 1.0 1.6 1.6 5.2 4.7 1.1 0.8 1.8 4.4 2.8 4.0 0.2 0.7 1.5 7.1 5.3 1.8 0.6 0.4 0.2 1.3 0.8 0.3 0.7 4.9 0.5 0.6 4.8 0.1 2.9 0.6 1.8 2.0 6.9 2.4 0.2 49.5 2.5 1.1 0.7 1.1 1.4 1.3 0.7 4.2 1.2 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.2 0.5 0.3 1.0 0.2 0.7 0.6 0.4 0.2 0.5 0.2 0.7 1.0 0.5 0.0 1.1 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 1.7 0.0 0.1 0.2 0.0 2.7 0.0 0.0 0.4 0.7 0.0 0.1 0.0 0.1 8.6 0.9 61.1 0.0 0.0 0.0 0.0 103.4 9.8 1.8 0.0 40.1 1.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.5 0.0 0.1 0.3 1.1 0.8 0.4 0.5 0.0 0.0 KLF1 EKLF ENSG00000105610 "Kruppel like factor 1" Q13351 19 12884422-12887201 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "bone marrow: 41.5" "Cell type enriched" "Detected in some" 199 "Erythroid cells: 519.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 8 "monocytes: 1.9" "Group enriched" "Detected in some" 29 "HEL: 61.6;K-562: 150.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051850 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051850: AB_2616460" "unprognostic (1.17e-1)" "unprognostic (1.38e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-3)" "unprognostic (7.13e-2)" "unprognostic (3.90e-4)" "unprognostic (3.25e-2)" "unprognostic (3.19e-2)" "unprognostic (1.97e-1)" "unprognostic (1.08e-2)" "unprognostic (6.51e-2)" "unprognostic (7.71e-2)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (2.44e-1)" 0.0 0.0 0.1 0.0 0.1 41.5 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 61.6 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 150.5 0.0 0.0 0.2 0.3 0.4 0.7 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 3.6 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 519.2 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.1 0.0 0.1 0.1 DNASE2 "DNL, DNL2" ENSG00000105612 "Deoxyribonuclease 2, lysosomal" O00115 19 12875209-12881466 "Enzymes, Predicted intracellular proteins" Apoptosis "Developmental protein, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 226.7;Paneth cells: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066185 Enhanced "Intracellular and membrane" NA NA 560000 "HPA066185: AB_2685632" "unprognostic (9.62e-2)" "unprognostic (2.19e-3)" "unprognostic (8.97e-2)" "unprognostic (7.45e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (5.42e-2)" "unprognostic (4.85e-2)" "unprognostic (1.40e-1)" "unprognostic (5.12e-2)" "unprognostic (4.37e-2)" "unprognostic (2.58e-2)" "unprognostic (4.69e-2)" "unprognostic (3.57e-1)" "unprognostic (1.98e-1)" 27.2 26.9 17.4 24.2 17.7 9.7 23.5 18.1 19.2 22.9 19.5 24.5 23.9 25.3 29.8 19.0 25.5 25.5 21.7 17.0 22.9 19.3 36.3 38.1 42.5 19.3 18.2 15.8 26.3 42.1 43.5 24.0 20.7 19.3 28.0 19.4 5.7 33.3 26.4 19.9 28.4 22.8 22.2 21.2 26.4 30.2 5.9 18.9 21.0 39.0 13.2 26.7 24.5 20.1 21.4 63.7 36.3 2.9 80.8 86.8 46.2 55.0 34.4 87.2 33.2 79.6 3.8 43.6 27.9 97.3 54.9 73.0 71.8 30.7 33.2 16.2 89.8 41.0 13.1 36.8 17.5 68.3 26.5 119.8 46.5 74.5 24.8 36.7 80.2 50.2 42.4 14.0 112.1 20.3 82.7 27.3 14.1 6.1 66.3 60.8 17.1 14.2 64.3 32.9 29.7 17.3 28.6 46.1 65.8 123.5 11.8 98.5 23.4 32.5 67.8 21.4 70.3 31.1 139.9 153.6 35.7 112.9 24.6 34.4 73.5 71.0 10.9 64.5 95.8 53.5 31.1 56.1 68.8 14.0 35.6 49.0 53.7 40.6 70.9 114.2 28.3 85.8 66.4 17.4 17.7 18.1 19.2 17.0 22.9 19.3 18.2 15.8 19.3 21.2 18.9 21.4 18.7 25.6 22.4 7.5 25.5 14.5 23.6 56.9 14.2 6.7 22.7 18.5 10.6 28.6 31.0 36.8 4.2 60.0 23.5 17.3 3.9 67.1 0.5 24.1 15.1 21.4 16.4 5.7 1.3 58.3 96.2 27.9 13.7 25.4 22.2 23.8 28.9 26.4 226.7 5.0 1.7 15.0 83.4 87.5 6.8 2.5 32.0 55.5 46.2 2.8 28.4 32.2 33.0 3.0 1.7 39.5 125.0 33.4 36.6 15.1 10.8 6.8 29.9 3.3 13.1 16.5 16.9 0.6 4.8 12.4 12.4 48.0 23.9 23.0 26.2 18.5 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874952 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 41.6;pituitary gland: 23.4;retina: 15.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 9 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA028181: AB_10603872, HPA073106: AB_2732218" "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 0.0 2.2 8.4 0.3 14.2 0.3 0.1 7.4 41.6 0.1 0.0 0.9 0.3 0.0 0.0 0.2 0.1 0.2 0.2 10.8 4.4 0.0 0.6 0.1 0.1 12.0 2.7 13.5 0.3 0.6 0.5 23.4 0.0 11.5 0.2 0.1 15.5 0.2 0.0 0.0 3.3 0.4 0.0 0.0 0.1 0.6 5.0 6.7 0.8 0.1 0.0 0.0 0.2 0.3 20.3 3.6 1.6 1.5 23.3 0.0 0.0 1.9 0.2 0.1 0.3 0.9 0.8 1.5 5.8 2.6 0.0 3.9 0.1 6.8 0.1 0.1 4.1 4.5 0.5 5.8 2.6 0.0 1.3 1.2 0.5 0.1 0.8 0.7 1.3 0.0 15.2 5.2 3.0 0.0 0.8 2.4 0.6 6.9 0.6 7.2 15.9 4.6 8.3 0.3 0.2 40.5 20.2 0.8 1.4 4.3 1.2 3.8 2.1 0.0 2.8 4.2 3.1 0.8 16.7 14.5 3.7 5.1 3.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 8.4 14.2 7.4 41.6 10.8 4.4 12.0 2.7 13.5 11.5 0.0 6.7 20.3 0.5 0.0 2.4 7.8 0.2 0.9 1.6 0.6 0.6 24.7 0.8 2.5 1.0 0.0 0.3 0.0 43.8 0.6 0.4 0.6 0.0 0.4 14.0 0.2 0.2 1.3 0.0 0.0 64.7 0.5 0.6 1.3 0.0 0.3 1.3 0.5 1.1 0.5 0.2 15.2 70.3 0.1 0.0 1.0 1.2 8.2 0.6 0.7 5.4 6.5 0.1 3.7 0.0 22.1 3.0 0.3 2.5 1.2 0.0 1.0 0.9 0.2 1.0 20.4 0.0 2.0 0.5 8.0 5.2 0.7 1.4 0.3 1.0 0.4 0.7 1.2 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 98.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 4.0;HaCaT: 5.7;HDLM-2: 3.6;HSkMC: 2.1;LHCN-M2: 3.1;U-87 MG: 4.1;WM-115: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favorable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favorable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 8.1 8.9 0.1 0.0 0.3 0.1 8.2 0.5 0.3 9.2 0.0 9.1 0.0 8.9 0.2 6.6 9.6 0.0 10.8 0.1 0.1 8.4 8.3 7.2 0.0 0.3 0.3 0.1 10.4 10.2 0.1 8.7 0.0 0.8 8.8 0.2 0.2 7.2 0.1 15.3 7.4 8.5 0.0 0.3 11.3 10.0 14.9 0.2 0.1 8.4 0.0 0.1 9.6 7.6 0.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 2.2 0.0 0.6 1.1 0.4 0.5 0.6 0.4 0.9 0.7 0.5 0.6 0.6 0.5 0.8 0.7 0.0 0.4 0.4 0.1 0.1 0.3 0.5 0.3 0.1 0.1 0.3 0.3 0.1 0.8 0.3 0.2 0.5 28.8 19.2 8.8 2.3 31.4 20.6 22.1 28.6 11.4 10.1 15.2 14.5 7.8 17.2 17.6 18.4 0.0 27.5 30.9 33.7 23.5 21.5 98.8 23.6 18.6 24.2 27.0 17.7 1.1 28.4 14.6 18.3 10.7 17.6 54.6 15.3 29.3 17.0 30.6 6.7 1.2 27.2 34.6 21.8 23.9 15.6 22.4 22.3 21.4 0.0 26.9 19.4 51.5 1.5 4.7 26.1 28.0 15.1 18.0 15.6 35.9 38.2 26.4 15.6 39.5 14.5 24.8 37.3 31.2 10.8 21.5 42.8 38.7 21.3 18.8 16.7 PRPF31 "hPrp31, NY-BR-99, PRP31, RP11, SNRNP61" ENSG00000105618 "Pre-mRNA processing factor 31" Q8WWY3 19 54115410-54131719 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041939, HPA061873" Supported Supported Nucleoplasm NA NA 13000 Nucleoplasm "HPA041939: AB_10793938, HPA061873: AB_2684630" "unprognostic (1.32e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-2)" "unprognostic (7.98e-2)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (9.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (5.26e-3)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (2.16e-1)" "unprognostic (5.94e-2)" "unprognostic (2.53e-1)" "unprognostic (7.04e-2)" 33.9 36.3 23.2 24.5 24.3 33.5 35.4 23.8 31.6 39.8 23.5 38.6 23.3 40.0 12.6 38.1 35.6 19.1 36.4 23.6 23.2 34.4 44.9 30.0 33.5 24.1 23.4 23.7 39.4 29.6 28.8 33.9 23.3 24.1 37.9 14.1 8.2 34.2 23.9 48.6 40.2 34.9 19.2 22.7 40.0 36.0 33.3 23.9 26.5 36.8 24.0 23.6 38.6 35.9 25.6 83.7 169.4 55.0 89.8 34.6 33.0 59.4 68.3 53.1 74.6 72.5 82.4 63.8 89.1 54.2 49.9 36.0 49.8 64.6 78.6 46.4 82.4 298.4 66.6 108.3 97.0 51.7 120.9 59.7 54.2 36.0 62.3 43.1 39.4 79.4 74.4 96.8 46.2 49.9 82.8 103.3 64.1 53.4 78.5 187.1 89.2 71.7 81.5 51.8 120.8 61.6 72.8 88.0 83.2 44.7 24.5 52.3 62.5 81.2 100.4 84.7 43.6 109.0 58.6 97.7 98.5 75.7 81.9 71.0 25.0 44.3 30.1 47.9 53.1 51.8 43.5 47.2 51.4 52.9 44.5 39.7 40.5 9.1 54.4 48.6 45.6 61.0 51.1 23.2 24.3 23.8 31.6 23.6 23.2 24.1 23.4 23.7 24.1 22.7 23.9 25.6 38.7 35.3 26.7 17.0 35.0 42.7 38.9 96.1 46.7 31.4 31.3 37.6 35.9 32.9 54.2 25.8 14.6 95.0 40.2 29.3 60.7 74.6 5.9 34.9 34.9 47.3 34.8 32.4 13.4 62.9 90.8 42.0 33.6 31.0 31.7 53.5 27.8 27.3 66.4 30.3 12.4 38.9 57.0 22.2 43.2 7.4 38.2 33.7 40.9 9.4 61.2 51.1 48.4 13.6 14.9 63.2 30.1 48.9 34.0 37.6 46.9 62.0 43.6 32.2 39.5 36.1 53.4 125.2 77.9 33.9 42.1 76.2 41.5 54.3 46.3 32.8 TFPT "amida, FB1, INO80F" ENSG00000105619 "TCF3 fusion partner" P0C1Z6 19 54107020-54115657 "Disease related genes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034958, HPA058534" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA034958: AB_10603036, HPA058534: AB_2683745" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (6.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.85e-1)" "unprognostic (2.85e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.00e-2)" "unprognostic (2.61e-1)" "unprognostic (3.43e-1)" "unprognostic (3.66e-2)" 12.0 15.9 25.9 9.0 23.1 10.5 12.9 21.3 41.6 11.1 17.0 14.4 9.8 11.8 4.4 10.1 10.0 7.2 15.6 24.7 21.8 12.0 10.6 12.4 10.8 22.5 22.1 22.2 9.6 8.8 9.3 10.9 8.4 23.1 22.4 4.1 5.1 13.2 5.5 19.5 13.2 12.3 6.2 19.2 19.3 14.2 9.1 23.6 13.6 11.3 10.7 6.5 12.4 9.5 26.8 23.5 28.5 18.2 12.9 6.7 9.5 11.8 25.1 15.5 23.9 24.5 17.8 23.6 20.5 20.2 12.8 12.5 11.2 10.8 19.6 7.8 43.5 52.2 30.7 27.5 20.8 39.6 16.1 34.7 11.2 9.5 18.8 15.7 11.5 18.7 30.8 19.3 45.8 9.2 30.2 34.3 47.2 11.0 34.1 19.8 30.6 10.0 15.4 10.0 35.9 19.2 17.4 9.2 38.4 45.1 5.6 14.0 48.9 37.8 52.4 19.3 7.5 36.9 33.8 48.2 18.5 20.7 40.4 34.4 10.5 9.2 6.4 15.4 10.7 14.6 9.4 19.4 20.1 19.0 9.3 16.2 17.2 6.5 21.4 3.9 43.3 26.0 11.2 25.9 23.1 21.3 41.6 24.7 21.8 22.5 22.1 22.2 23.1 19.2 23.6 26.8 25.3 16.0 7.2 5.2 12.2 17.0 9.8 25.5 12.0 10.9 31.4 32.3 2.5 12.8 28.6 22.0 2.1 22.4 30.3 22.5 15.6 21.0 9.6 27.1 8.2 29.5 15.6 7.8 5.0 27.6 29.1 11.3 11.2 13.3 15.2 20.8 37.9 9.6 135.7 0.0 4.1 35.7 32.6 28.1 41.0 5.5 12.2 43.5 39.2 1.0 49.7 17.8 25.7 2.5 3.6 55.9 18.4 17.0 13.1 31.9 23.0 24.8 46.4 12.4 6.6 7.8 16.5 11.0 16.0 5.8 17.3 26.1 22.8 41.1 16.1 13.0 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.5" "Cell type enhanced" "Detected in many" "B-cells: 27.8;dendritic cells: 20.1;Macrophages: 17.9;NK-cells: 18.6;Plasma cells: 18.4;T-cells: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 35.7;HEL: 15.9;HMC-1: 15.5;Karpas-707: 40.2;U-266/70: 15.4;U-266/84: 24.7;U-937: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA070314: AB_2686251" "unprognostic (5.59e-3)" "prognostic favorable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 5.3 2.5 4.6 36.6 5.4 18.8 4.1 4.0 6.8 3.0 6.6 3.1 3.0 2.2 2.5 2.9 5.3 4.8 2.9 4.7 8.7 5.3 2.9 13.2 40.8 7.7 5.4 4.6 15.6 1.8 1.9 3.1 5.7 6.4 4.4 3.1 0.6 3.5 1.9 0.7 1.7 15.5 3.5 5.1 55.5 4.6 2.7 6.8 11.4 5.0 0.9 29.9 7.4 3.1 7.5 0.2 0.6 0.5 1.8 0.6 2.4 0.4 0.8 0.0 0.1 0.1 0.0 1.6 0.7 3.3 0.7 0.4 0.2 0.0 0.4 0.0 35.7 0.0 15.9 0.1 1.5 1.2 0.0 15.5 8.4 0.5 0.1 0.0 0.1 0.3 3.6 0.1 40.2 0.0 0.7 6.5 0.0 0.3 0.9 1.3 8.2 0.0 0.7 0.8 0.0 0.0 0.6 0.2 0.4 0.1 0.2 3.5 2.4 0.7 0.0 0.7 0.0 0.0 15.4 24.7 4.3 0.1 24.2 0.3 2.0 7.5 0.3 17.8 14.6 20.2 9.4 21.1 18.6 6.8 10.3 20.2 18.5 25.1 13.4 14.2 5.5 18.0 12.4 4.6 5.4 4.0 6.8 4.7 8.7 7.7 5.4 4.6 6.4 5.1 6.8 7.5 5.5 0.0 4.6 2.3 27.8 0.8 0.6 0.5 0.6 0.6 0.5 0.8 1.9 0.0 1.0 1.8 0.0 1.1 20.1 0.0 0.0 0.5 1.0 0.3 2.1 8.0 0.0 6.1 4.3 0.4 0.8 4.6 2.0 0.4 5.1 0.8 9.7 0.4 14.5 0.0 2.6 0.0 0.0 9.2 1.9 2.0 12.5 17.9 3.6 4.7 16.6 0.9 18.6 0.0 0.4 0.5 0.0 14.7 18.4 0.5 0.0 0.3 0.9 0.7 6.6 0.3 2.9 0.3 0.7 0.3 1.0 1.4 37.7 14.8 0.1 0.6 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859910-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "ovarian cancer: 682.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol No No 44000 "Nucleoli, Cytosol" "HPA055259: AB_2682764" "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 1966.1 1336.8 669.6 1218.4 669.0 2698.6 2023.7 650.4 974.2 2170.7 850.5 1828.9 1082.3 1698.5 417.8 2451.7 1916.5 856.0 1187.1 621.8 685.6 1210.4 1170.7 1362.3 2531.7 682.4 650.9 597.5 3658.0 3940.1 546.2 930.4 763.5 669.0 1610.2 725.2 207.6 2613.0 641.4 2554.0 3535.7 1736.3 692.4 711.6 2064.9 1944.6 353.3 721.5 1588.3 1409.7 1224.1 1500.5 1751.8 2182.3 680.8 2623.4 2001.4 1299.0 1847.0 1923.3 3152.4 3291.2 1559.5 1979.9 2038.9 1930.5 2789.2 2550.3 3921.7 3523.0 1365.1 805.3 1913.5 1555.9 3350.6 708.6 2020.7 4206.5 1833.5 1792.6 3238.9 3314.5 2660.3 1916.4 3952.5 4349.3 1127.8 2410.2 2094.2 2265.6 3157.8 2386.5 2462.6 1313.5 4085.3 3633.0 3514.7 3067.9 2909.3 3049.2 3210.9 1376.3 4708.0 1887.0 2464.1 1879.4 2817.6 554.3 3813.0 5042.2 637.7 1814.7 5079.9 1738.1 1244.6 1438.8 2512.2 2674.5 3251.9 3283.4 2639.9 1632.9 4270.0 1580.0 1247.5 4513.0 690.0 4974.8 4521.9 8679.3 14996.3 8499.1 6207.0 6569.7 15438.5 9988.2 7821.6 433.2 5415.3 3633.6 7634.4 8027.2 21239.5 669.6 669.0 650.4 974.2 621.8 685.6 682.4 650.9 597.5 669.0 711.6 721.5 680.8 1797.3 519.2 1033.4 1.3 6570.0 8683.5 6503.8 6346.6 5314.4 252.0 7203.4 8120.9 437.2 2077.4 2572.8 923.2 127.2 4676.6 3414.9 1440.2 2387.0 3503.1 57.0 1112.5 3101.7 2919.9 1842.7 2735.0 1.8 8949.1 8763.1 2652.7 2316.6 1639.3 1447.9 3627.9 2837.8 2144.2 3317.2 131.2 2.2 3965.3 1881.8 4748.0 8399.9 194.1 4165.1 3240.6 4747.4 1.9 6119.2 908.2 3084.5 1.5 2.5 5684.1 3130.7 1627.9 3619.6 6541.4 3169.3 3629.8 1019.5 499.6 1255.6 3061.1 4561.4 199.9 834.7 6806.4 11135.4 4659.3 4511.8 4057.7 4606.2 8094.9 SLC5A5 NIS ENSG00000105641 "Solute carrier family 5 member 5" Q92911 19 17871945-17895174 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Congenital hypothyroidism, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 132.1;salivary gland: 65.0;stomach 1: 59.3" "Cell type enriched" "Detected in some" 40 "Gastric mucus-secreting cells: 244.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.7" "Region enhanced" "Detected in many" "hippocampal formation: 11.1" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "BEWO: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022364, HPA049055" Enhanced NA NA "CAB022364: , HPA049055: AB_2680614" "unprognostic (2.72e-2)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (4.02e-2)" "unprognostic (2.57e-1)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.01e-2)" "unprognostic (3.03e-1)" "unprognostic (3.93e-2)" "unprognostic (5.51e-8)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.54e-2)" "unprognostic (3.23e-1)" 0.0 0.0 0.5 0.2 0.2 0.3 0.1 5.4 3.0 5.6 132.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 11.1 0.2 0.0 0.0 0.1 0.3 0.2 3.1 0.2 0.0 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.1 65.0 0.0 0.4 0.2 0.2 0.0 0.1 0.2 59.3 0.4 2.7 0.0 12.1 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 1.1 0.1 0.1 0.3 0.4 0.4 0.3 0.9 0.1 0.2 0.3 1.2 0.9 0.6 0.2 0.1 0.1 0.6 0.3 0.5 0.2 5.4 3.0 11.1 0.2 0.2 3.1 0.2 1.3 0.1 2.7 0.3 0.0 0.0 0.6 0.3 1.1 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.0 0.0 0.5 0.6 1.3 0.1 244.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.9 0.1 0.0 0.0 2.9 0.0 0.0 1.2 0.2 0.1 6.1 0.2 0.3 0.0 0.9 0.0 0.0 0.2 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "brain: 83.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 12.8;Langerhans cells: 19.8;Skeletal myocytes: 6.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "REH: 155.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" Yes No "Actin filaments, Cytosol" "HPA065938: AB_2685582" "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.1 0.2 33.9 0.4 22.7 0.1 0.2 0.0 66.1 0.7 0.0 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.6 83.2 0.6 0.2 0.0 0.1 0.1 14.7 2.6 16.0 1.8 0.1 1.6 1.0 0.0 15.5 0.6 0.0 0.8 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 2.2 3.0 0.2 0.1 0.0 0.1 0.1 0.3 30.2 0.1 0.6 0.2 6.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.2 5.3 0.0 0.2 0.2 2.5 5.0 0.3 0.1 0.0 0.0 12.8 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.4 0.0 0.0 1.8 0.0 0.1 155.3 0.0 0.2 0.0 0.0 0.2 8.6 0.0 0.0 0.1 0.4 0.3 0.2 0.1 0.0 4.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 22.7 0.0 66.1 83.2 0.6 14.7 2.6 16.0 15.5 0.0 3.0 30.2 0.4 0.0 0.0 3.6 1.1 2.5 3.7 0.0 0.0 2.3 0.2 0.3 0.8 0.0 0.7 0.0 2.1 0.1 1.5 0.2 0.0 0.0 0.2 1.3 1.5 1.9 0.0 0.0 12.8 0.0 0.2 2.6 0.0 1.9 0.0 3.6 0.4 0.2 0.1 0.0 4.4 0.0 0.0 0.3 19.8 0.4 0.9 2.1 5.4 1.9 2.2 1.4 1.0 3.0 0.7 0.2 0.0 1.9 0.7 2.8 0.0 0.2 0.0 1.0 0.0 6.8 1.8 0.6 4.0 0.0 3.8 0.1 1.5 2.2 0.0 1.8 ARRDC2 "CLONE24945, PP2703" ENSG00000105643 "Arrestin domain containing 2" Q8TBH0 19 18001132-18014102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 206.5" "Cell type enhanced" "Detected in many" "Adipocytes: 114.2;B-cells: 80.3;Cholangiocytes: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 57.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053788, HPA074216" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053788: AB_2682262, HPA074216: " "unprognostic (8.10e-2)" "prognostic favorable (5.93e-4)" "unprognostic (2.20e-3)" "unprognostic (8.67e-2)" "unprognostic (4.81e-3)" "unprognostic (4.26e-3)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (1.16e-1)" "unprognostic (8.37e-2)" "unprognostic (4.87e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-1)" "prognostic favorable (6.91e-4)" "prognostic favorable (2.92e-4)" 54.3 10.8 61.5 23.9 69.9 80.6 50.2 63.6 62.7 31.8 50.7 30.1 12.3 23.0 7.7 22.3 27.9 23.0 31.6 54.0 62.9 33.0 20.6 75.7 39.1 75.0 72.0 48.2 13.8 16.6 72.2 17.3 14.5 71.5 33.9 12.2 1.3 44.6 19.0 206.5 27.8 43.7 11.2 62.0 58.9 27.9 5.2 64.0 25.0 44.4 49.8 35.3 32.8 32.3 87.0 12.1 21.2 0.4 10.6 8.5 7.8 8.4 6.8 19.3 5.6 5.5 4.8 22.9 22.1 18.9 5.8 9.1 7.9 8.4 6.2 4.4 14.5 12.3 16.8 18.0 6.8 7.8 12.9 24.0 8.4 9.6 6.5 9.9 10.5 9.6 13.9 19.7 0.6 5.4 18.4 9.8 35.6 2.7 26.4 34.9 57.7 0.2 16.8 8.1 11.0 5.0 5.2 11.1 11.0 11.5 1.7 6.7 32.5 21.1 9.7 7.5 32.9 8.6 1.6 0.1 24.8 15.5 48.6 7.7 3.7 5.8 3.6 3.6 4.8 2.5 3.4 6.1 4.6 3.0 5.3 14.1 7.5 2.3 6.6 5.7 1.8 5.1 4.4 61.5 69.9 63.6 62.7 54.0 62.9 75.0 72.0 48.2 71.5 62.0 64.0 87.0 114.2 16.0 15.5 1.6 80.3 6.4 19.8 14.0 13.1 0.4 16.7 11.0 7.3 64.3 15.8 9.2 0.0 0.7 47.7 12.7 1.9 10.8 0.8 10.7 13.0 29.9 18.5 44.6 3.8 6.2 7.8 9.2 23.4 29.8 26.6 3.3 17.2 7.0 17.9 0.0 0.5 12.3 16.2 31.0 58.7 1.2 4.7 50.3 5.4 9.4 14.5 1.1 13.4 0.5 20.0 15.4 9.4 7.5 13.6 24.9 3.5 0.5 15.9 0.4 13.1 14.0 15.9 0.5 3.9 7.6 7.1 1.2 38.6 5.0 5.6 26.7 PIK3R2 "p85, P85B" ENSG00000105647 "Phosphoinositide-3-kinase regulatory subunit 2" O00459 19 18153163-18170532 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Protein transport, Stress response, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 14.4;Undifferentiated cells: 16.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" HPA069291 Approved NA NA "HPA069291: AB_2686109" "unprognostic (2.50e-1)" "unprognostic (1.90e-3)" "unprognostic (1.68e-2)" "unprognostic (1.87e-1)" "unprognostic (2.00e-2)" "unprognostic (9.65e-3)" "unprognostic (1.69e-3)" "unprognostic (2.36e-3)" "unprognostic (9.24e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (3.36e-1)" "unprognostic (1.69e-2)" "unprognostic (2.02e-1)" "unprognostic (6.35e-3)" "unprognostic (8.63e-2)" "unprognostic (2.00e-2)" 7.0 25.8 25.8 7.0 23.6 9.8 7.7 1.6 41.6 17.4 2.5 13.5 20.7 17.7 12.1 26.2 16.9 12.4 12.9 40.8 6.8 9.6 10.6 9.1 5.2 8.8 7.5 24.0 21.7 11.1 21.0 21.6 8.7 11.8 15.6 9.7 7.9 15.1 10.4 12.5 26.5 16.9 9.9 3.1 8.8 15.2 11.6 9.6 11.7 10.6 10.0 6.2 15.4 15.4 16.0 39.1 18.0 25.4 36.8 35.3 36.6 40.5 29.4 38.3 21.6 16.6 18.3 20.4 28.0 48.8 41.9 17.5 28.7 15.6 33.2 11.3 25.0 65.5 10.8 21.3 44.0 29.7 24.6 13.4 45.7 36.4 15.0 21.5 36.8 6.6 11.9 33.6 10.8 30.3 57.0 21.5 17.0 32.9 35.8 48.5 19.6 33.4 23.5 37.7 22.8 63.0 68.0 27.1 28.5 28.9 16.0 19.1 15.8 11.4 40.9 20.8 49.2 27.5 22.9 26.4 10.9 33.9 39.4 26.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 25.8 23.6 1.6 41.6 40.8 6.8 8.8 7.5 24.0 11.8 3.1 9.6 16.0 1.0 6.4 1.1 7.2 0.8 1.9 1.3 1.0 1.8 6.3 3.6 3.2 1.5 2.8 1.0 3.7 4.2 1.7 0.8 6.9 0.0 6.0 0.3 1.3 1.7 0.8 6.1 7.4 11.7 6.2 2.9 1.7 1.1 0.8 2.5 1.4 1.4 1.3 2.2 10.1 11.2 10.5 0.0 4.7 1.0 0.0 1.8 1.7 0.0 3.7 1.6 5.7 0.0 10.6 9.2 6.4 7.0 1.9 0.9 1.1 14.4 1.1 0.5 4.3 0.0 1.4 1.4 0.5 2.1 1.3 2.3 1.2 0.9 3.2 16.4 0.6 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204042 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 301.9;retina: 78.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 102.4;Distal tubular cells: 39.2;Excitatory neurons: 34.0;Horizontal cells: 92.5;Inhibitory neurons: 41.0;Rod photoreceptor cells: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 20.8;SCLC-21H: 37.5;SH-SY5Y: 18.0;U-2197: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favorable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 15.8 30.0 1.7 71.7 0.9 2.1 8.3 301.9 3.2 0.0 5.5 3.1 2.7 1.6 2.6 5.2 2.0 24.3 68.9 68.2 5.9 3.9 2.6 1.6 38.4 46.7 86.3 26.0 2.0 12.9 38.7 1.4 55.7 4.0 1.9 78.2 4.0 4.0 10.0 4.0 3.2 2.1 0.0 2.8 4.5 2.2 65.7 1.3 2.3 9.0 1.0 2.6 3.6 197.1 1.4 1.6 3.5 4.9 5.7 1.4 2.2 3.2 1.9 2.2 2.9 1.4 0.9 5.2 3.4 2.6 2.0 4.2 16.6 2.0 1.0 1.1 5.3 2.1 6.3 6.0 1.4 3.6 6.2 4.6 2.0 1.2 0.6 4.2 0.6 6.4 1.1 1.8 2.0 5.2 8.0 1.0 2.9 4.4 20.8 5.5 0.3 4.4 2.3 0.8 37.5 18.0 1.6 6.6 3.7 1.4 1.4 0.6 0.7 1.8 1.4 26.2 1.8 3.2 7.4 1.3 4.9 2.7 1.7 0.0 1.3 1.8 1.3 0.9 1.8 1.9 1.3 1.3 2.9 0.9 1.7 1.8 2.2 0.3 1.3 2.6 0.8 1.3 30.0 71.7 8.3 301.9 68.9 68.2 38.4 46.7 86.3 55.7 0.0 65.7 197.1 2.3 0.0 0.0 8.5 4.7 3.2 2.5 3.7 8.6 102.4 4.8 4.8 1.3 2.8 2.2 16.5 8.4 1.6 7.4 1.6 39.2 2.3 2.4 1.0 1.3 2.6 9.6 0.0 34.0 0.9 5.2 3.1 2.0 1.4 0.0 1.6 2.5 1.6 5.2 92.5 41.0 2.8 4.1 2.2 15.3 0.2 4.4 4.5 10.6 13.1 2.9 15.4 1.0 7.5 10.1 1.0 2.0 5.7 1.1 1.1 5.3 8.3 1.2 46.5 0.0 1.8 8.2 0.4 3.6 6.0 4.8 1.8 5.3 4.5 4.2 2.1 PDE4C DPDE1 ENSG00000105650 "Phosphodiesterase 4C" Q08493 19 18208652-18248200 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 21.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4" "HPA048975, HPA054218" Approved Approved "Midbody ring,Centrosome,Cytosol" Yes NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (5.22e-4)" "unprognostic (1.44e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (4.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-3)" "unprognostic (2.21e-1)" "unprognostic (7.25e-10)" "unprognostic (2.73e-2)" "unprognostic (2.65e-1)" "unprognostic (9.21e-2)" "unprognostic (2.45e-2)" 1.3 0.6 0.2 0.1 1.1 0.5 0.7 0.0 1.1 2.7 0.0 4.3 0.7 3.5 3.4 0.7 3.0 1.2 3.6 0.3 0.3 2.9 1.3 3.4 0.2 0.3 0.0 0.8 1.8 0.7 0.2 2.8 3.7 0.2 2.3 0.6 0.2 0.5 2.8 8.3 0.3 2.4 1.8 0.0 2.1 3.9 2.5 0.0 0.0 1.1 21.5 0.1 1.0 1.7 0.2 0.0 0.1 0.0 0.1 0.0 0.1 2.9 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.1 0.0 0.2 0.3 0.0 1.2 0.0 0.2 0.0 0.1 0.4 0.9 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.7 0.2 0.2 0.0 0.1 0.0 0.3 0.0 0.6 0.3 0.1 4.4 0.1 0.0 1.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.2 0.1 0.1 0.0 0.0 0.2 1.1 0.0 1.1 0.3 0.3 0.3 0.0 0.8 0.2 0.0 0.0 0.2 0.6 3.2 10.6 2.0 0.8 5.5 5.8 8.6 5.2 3.9 0.2 0.4 35.3 4.3 22.4 0.0 6.2 2.1 0.0 255.9 0.0 0.0 32.9 0.1 0.1 4.6 7.2 0.0 8.2 0.0 4.3 6.3 141.2 0.1 4.5 0.0 1.1 0.3 0.5 0.0 2.1 55.2 4.1 1.4 4.5 38.4 0.6 2.1 1.8 0.0 0.4 1.9 1.0 0.5 0.9 0.0 251.4 4.1 1.6 1.8 73.0 0.0 9.4 3.0 46.0 106.5 17.2 1.9 2.2 28.6 3.8 1.1 1.2 0.0 103.3 17.3 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438167 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 183.8;testis: 225.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9" "Cell line enriched" "Detected in many" 4 "BEWO: 492.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 33.9 32.9 16.3 2.8 11.6 5.9 30.8 10.7 19.7 45.6 183.8 13.8 3.6 44.6 4.5 15.3 79.6 3.8 35.9 17.9 19.0 49.7 13.2 22.4 4.5 13.2 14.9 9.6 96.8 40.5 12.9 51.1 46.7 11.2 41.8 0.7 0.9 17.8 26.9 13.3 15.2 16.2 2.8 10.6 35.4 11.4 225.6 18.6 3.0 23.9 3.1 1.8 23.7 32.2 10.6 13.9 42.4 98.6 31.0 0.8 0.2 492.7 6.6 1.0 0.6 0.3 24.5 26.1 0.2 33.5 3.2 0.2 36.6 3.0 0.1 0.0 39.8 116.4 52.0 3.1 80.3 10.2 0.6 1.1 9.4 0.4 2.8 0.4 0.4 6.3 1.1 106.0 2.1 0.0 84.1 4.0 3.4 51.7 14.2 33.7 71.2 0.2 24.6 9.5 0.3 30.4 74.3 1.7 9.9 53.1 20.2 68.2 7.1 18.7 0.5 1.1 0.7 1.6 13.9 7.3 3.2 3.0 1.9 17.7 1.0 0.1 0.0 8.1 0.2 6.2 4.5 8.1 6.9 0.8 2.4 6.2 8.9 0.8 14.4 0.1 2.2 6.2 5.0 16.3 11.6 10.7 19.7 17.9 19.0 13.2 14.9 9.6 11.2 10.6 18.6 10.6 38.8 3.2 1.1 2.6 9.0 12.0 82.1 74.9 72.8 0.8 26.1 47.0 4.7 20.0 24.0 47.8 2.1 1141.3 8.4 4.1 52.8 39.4 101.3 33.4 10.9 30.5 64.8 21.5 1.0 8.2 114.0 30.2 7.1 14.8 14.0 36.9 25.7 1.1 84.9 0.0 4.3 4.0 28.5 9.0 7.8 230.1 37.3 4.1 23.2 11.2 5.4 8.6 13.4 0.0 0.3 3.4 1.8 50.4 1.8 21.6 0.7 6.1 23.6 0.7 315.5 5.6 163.6 53.7 21.0 10.6 5.7 1034.6 14.9 14.5 6.2 36.8 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522116 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 297.2;Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 14.4 7.8 4.0 9.1 5.8 30.1 11.9 7.8 6.7 11.1 5.6 10.6 6.6 11.1 2.0 10.4 10.7 5.8 9.4 3.7 4.7 11.1 14.2 16.7 7.7 5.0 4.3 3.5 13.1 10.1 4.1 11.4 10.0 5.3 10.0 2.3 1.3 8.4 3.6 20.3 14.9 13.0 3.6 3.8 17.4 10.2 38.8 6.4 6.8 8.3 10.0 4.4 10.6 11.1 5.2 12.7 5.7 3.2 6.8 3.4 4.2 22.7 10.0 8.8 7.5 7.1 7.1 9.8 15.6 11.8 6.7 5.2 8.6 4.7 11.1 3.8 13.3 10.9 9.4 5.9 6.3 5.2 10.3 11.8 8.6 9.3 9.8 7.7 5.6 5.4 8.5 13.5 21.8 4.0 10.3 12.5 11.9 10.6 7.8 16.8 10.9 4.8 17.4 5.3 8.8 5.7 6.4 7.4 12.3 11.0 4.1 6.4 12.4 9.0 8.6 6.6 11.6 9.3 34.8 23.4 11.7 11.4 17.6 12.5 0.3 5.9 4.5 4.5 4.1 7.3 2.9 2.6 3.9 5.0 2.1 1.7 2.7 18.1 2.3 2.1 8.6 3.1 4.1 4.0 5.8 7.8 6.7 3.7 4.7 5.0 4.3 3.5 5.3 3.8 6.4 5.2 12.3 6.4 6.1 9.1 16.3 28.0 26.4 11.9 23.3 4.5 19.7 10.7 5.1 11.5 7.2 3.7 4.2 47.5 29.5 15.2 11.7 8.7 297.2 22.9 16.0 11.4 19.7 10.3 9.1 8.0 17.6 17.2 12.8 37.7 11.4 5.1 7.5 15.5 19.3 1.7 11.2 10.1 6.1 12.8 21.7 235.9 6.5 20.4 7.2 9.4 13.8 5.3 4.1 7.1 8.0 10.8 3.7 3.0 53.6 14.2 11.8 7.0 8.4 3.4 19.7 13.0 16.7 18.2 24.7 19.4 30.4 68.7 19.2 5.9 7.1 19.9 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683678-18782333 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.4;Horizontal cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022035, HPA063619" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255, HPA063619: " "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favorable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favorable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.5 11.4 15.5 5.2 9.7 2.2 8.3 24.1 24.5 10.8 0.0 8.4 4.1 9.3 3.4 5.3 10.4 3.2 9.7 24.9 0.8 12.4 10.5 8.0 4.2 6.1 1.0 6.5 9.5 9.9 4.8 23.8 4.0 8.5 11.7 1.5 4.4 7.3 5.2 14.5 7.4 8.6 2.6 0.0 9.7 10.0 11.4 1.0 3.6 14.5 3.6 2.2 9.8 7.5 7.8 5.2 7.9 6.7 10.7 6.3 4.5 18.6 5.4 3.6 5.3 4.8 5.1 6.6 7.1 11.6 5.2 3.9 5.5 2.1 3.5 1.3 3.1 15.1 6.0 7.8 9.3 5.5 8.3 16.3 7.8 2.9 4.4 1.3 6.8 3.1 7.2 4.8 6.3 3.0 15.2 5.7 10.0 8.8 2.7 13.1 8.7 2.9 8.1 3.2 8.0 12.1 10.7 6.0 5.8 7.0 2.2 6.6 5.2 5.4 6.0 9.1 10.8 6.4 4.4 3.6 4.6 6.9 8.6 4.6 0.3 0.6 0.4 0.4 0.2 0.3 0.5 0.5 0.6 0.7 0.7 0.5 0.3 0.2 0.3 0.4 0.8 0.4 0.4 15.5 9.7 24.1 24.5 24.9 0.8 6.1 1.0 6.5 8.5 0.0 1.0 7.8 4.9 0.0 5.3 31.0 6.9 2.7 8.9 7.8 5.7 29.1 5.8 6.1 17.7 10.0 3.5 18.4 27.1 9.7 7.9 6.8 11.7 4.6 1.1 9.6 14.0 5.6 19.2 3.6 37.4 6.0 2.7 7.5 8.6 9.8 2.5 14.7 3.9 4.7 8.8 43.7 26.7 7.1 12.2 6.0 4.0 3.2 9.3 6.3 3.6 10.3 5.5 9.1 8.2 12.1 20.2 3.5 9.6 4.9 2.0 3.0 6.1 5.0 4.8 14.7 0.0 14.2 6.6 2.9 8.8 2.4 2.0 10.4 5.1 8.3 5.2 3.6 COMP "EDM1, EPD1, MED, PSACH, THBS5" ENSG00000105664 "Cartilage oligomeric matrix protein" P49747 19 18782773-18791305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cell adhesion" Heparin-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.8;skin 1: 60.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 19.3;Early spermatids: 37.0;Fibroblasts: 32.0;Glandular and luminal cells: 32.0;Late spermatids: 75.3;Spermatocytes: 16.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 859.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077555 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 1500000000 "Golgi apparatus" "HPA077555: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (9.08e-5)" "prognostic unfavorable (2.04e-4)" "unprognostic (8.05e-2)" "unprognostic (8.45e-2)" "unprognostic (3.62e-2)" "unprognostic (5.12e-2)" "unprognostic (1.65e-1)" "unprognostic (1.55e-2)" "unprognostic (2.18e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (5.96e-3)" "unprognostic (1.44e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (6.95e-4)" 48.8 0.2 0.0 1.1 0.1 0.0 11.1 1.1 1.4 4.9 1.7 1.9 0.0 4.6 7.7 9.5 1.2 16.2 36.8 0.0 0.0 5.0 0.3 8.0 3.7 0.3 0.0 0.0 0.4 2.9 2.2 0.4 8.2 0.1 10.2 0.0 0.0 14.2 6.7 18.2 60.5 0.9 12.2 0.3 0.3 2.5 15.0 0.0 0.1 10.3 0.6 0.3 6.6 22.9 0.1 0.0 0.0 0.0 0.0 178.4 0.4 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 859.6 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.3 0.0 0.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.1 3.2 0.5 0.0 0.0 11.5 0.6 19.3 0.0 1.4 0.3 0.3 0.8 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 37.0 2.8 3.7 1.0 0.0 0.0 0.1 0.2 0.2 32.0 0.0 32.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 1.3 0.0 0.0 10.7 75.3 0.9 0.7 10.6 0.0 0.1 1.6 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.3 0.0 0.0 0.7 0.4 6.6 2.4 4.2 16.8 1.6 0.0 7.1 0.5 1.0 0.0 0.2 0.3 UPK1A TSPAN21 ENSG00000105668 "Uroplakin 1A" O00322 19 35666516-35678483 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 43.5;urinary bladder: 207.4;vagina: 52.8" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 29.1" "Cancer enriched" "Detected in many" 41 "urothelial cancer: 148.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 39.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049879 Enhanced NA NA "HPA049879: AB_2680929" "unprognostic (3.29e-1)" "unprognostic (1.78e-1)" "unprognostic (1.19e-3)" "unprognostic (3.40e-4)" "unprognostic (4.05e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-2)" "unprognostic (3.11e-3)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (2.34e-1)" "unprognostic (2.48e-9)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (2.45e-2)" "unprognostic (1.72e-1)" 0.8 0.0 0.2 0.1 0.2 0.1 0.3 0.5 0.4 15.2 0.2 0.1 0.0 0.0 0.0 43.5 0.5 0.2 0.1 0.3 0.3 0.5 0.2 0.1 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.3 6.9 0.0 0.1 4.3 0.2 0.1 19.7 0.1 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.0 0.0 0.3 207.4 52.8 0.2 0.0 0.4 0.2 0.2 0.4 0.1 0.4 0.0 0.1 0.2 0.6 1.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.2 3.8 0.3 0.0 0.2 0.2 0.2 0.1 0.5 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.2 0.5 8.1 0.0 0.0 0.0 0.1 0.0 39.2 0.1 0.1 0.2 0.2 0.5 0.2 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.2 0.0 0.1 0.0 0.1 0.2 0.2 0.5 0.4 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.3 0.9 0.2 0.0 0.0 0.2 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.4 1.3 0.0 0.4 0.1 0.1 0.0 0.0 29.1 COPE epsilon-COP ENSG00000105669 "COPI coat complex subunit epsilon" O14579 19 18899514-18919387 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034345, HPA041605, HPA043576" Supported Enhanced "Golgi apparatus" NA NA 66000 "Golgi apparatus" "CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563" "unprognostic (1.48e-1)" "prognostic favorable (2.41e-4)" "unprognostic (1.15e-1)" "unprognostic (5.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.40e-2)" "unprognostic (3.39e-2)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (1.97e-2)" "unprognostic (8.75e-2)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.26e-1)" "unprognostic (3.16e-2)" "unprognostic (6.75e-2)" 101.1 165.1 108.0 86.2 109.9 160.9 101.2 119.7 177.4 100.8 106.6 107.3 91.4 104.9 45.4 161.6 90.6 44.5 136.0 103.2 108.5 141.9 195.9 109.2 92.4 120.7 109.8 101.1 81.5 153.2 81.5 161.3 59.8 110.2 128.5 38.0 23.7 145.4 66.0 129.0 120.3 108.7 43.3 117.7 151.2 127.9 173.2 116.2 83.2 124.7 50.4 57.3 100.0 108.0 131.7 186.7 177.4 99.3 177.3 89.0 104.7 287.2 159.2 150.8 174.8 198.7 215.1 148.2 150.8 210.5 134.9 112.9 123.2 82.5 161.0 33.9 94.2 369.9 89.6 150.9 331.1 236.1 180.0 221.1 128.3 149.2 106.2 115.6 92.5 138.9 170.5 140.2 373.6 90.0 443.0 196.9 341.0 188.4 243.0 420.2 222.4 89.6 448.2 115.8 185.4 138.8 222.4 100.0 159.1 181.1 44.9 134.8 291.3 140.9 110.5 81.5 283.3 170.9 357.7 337.5 187.7 189.1 309.9 187.3 656.0 598.5 639.1 337.1 533.1 298.1 391.2 321.9 298.6 528.4 381.9 236.4 270.9 594.9 344.4 468.5 659.3 449.3 930.0 108.0 109.9 119.7 177.4 103.2 108.5 120.7 109.8 101.1 110.2 117.7 116.2 131.7 110.5 3.2 16.2 22.2 204.7 159.8 197.9 390.9 54.1 53.2 140.5 111.6 10.4 111.5 205.8 115.8 29.2 386.5 242.8 408.9 463.7 323.7 179.7 134.4 131.8 127.1 168.5 130.5 8.6 368.7 439.1 140.7 166.2 187.8 102.9 176.7 113.6 153.4 447.2 57.2 11.3 445.5 303.2 189.4 286.8 381.0 144.8 217.8 245.5 4.7 373.5 251.9 187.4 8.5 20.8 336.7 421.4 133.2 417.5 255.7 425.6 493.1 152.6 72.1 124.9 92.8 200.5 178.4 202.1 108.6 196.6 542.2 174.9 235.3 297.4 267.2 DDX49 "Dbp8, FLJ10432" ENSG00000105671 "DEAD-box helicase 49" Q9Y6V7 19 18919705-18929189 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041870, HPA048093" Enhanced Approved Mitochondria NA NA Mitochondria "HPA041870: AB_2677717, HPA048093: AB_2680262" "unprognostic (3.51e-1)" "prognostic favorable (2.01e-6)" "unprognostic (2.28e-2)" "unprognostic (1.28e-1)" "unprognostic (8.56e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (4.12e-2)" "unprognostic (2.41e-3)" "unprognostic (8.67e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "prognostic unfavorable (7.44e-5)" "unprognostic (3.93e-2)" "unprognostic (2.99e-2)" "unprognostic (4.97e-2)" "unprognostic (3.24e-1)" 15.9 17.9 15.4 14.1 14.9 23.5 15.6 15.5 22.3 16.0 11.8 17.4 15.8 16.1 6.0 26.1 14.0 8.0 16.7 16.0 14.4 15.3 25.1 13.9 16.2 15.4 14.1 15.2 14.7 20.3 12.7 11.4 13.5 15.0 16.5 7.5 4.8 18.1 10.9 33.9 27.1 15.0 10.0 16.1 16.2 15.8 19.4 14.9 14.3 13.7 13.8 10.4 17.6 17.6 17.4 46.5 47.4 19.0 61.3 28.1 21.1 71.0 29.2 19.8 50.9 40.1 54.6 45.8 60.6 86.7 29.1 16.1 39.4 42.9 39.8 14.8 18.9 110.5 29.9 49.9 48.6 63.5 77.5 40.1 44.4 35.9 40.7 41.9 14.4 23.3 46.9 58.2 43.1 18.2 104.4 56.6 37.9 62.7 50.3 112.8 62.8 31.5 65.9 27.4 28.2 67.2 69.7 38.2 36.6 48.2 9.8 39.2 37.6 29.5 24.3 27.9 92.0 48.7 55.5 73.0 57.1 31.1 88.8 39.3 17.1 21.9 16.7 14.8 26.2 12.0 9.1 11.0 11.1 31.1 9.8 10.9 12.1 8.6 19.5 18.1 13.7 18.0 12.7 15.4 14.9 15.5 22.3 16.0 14.4 15.4 14.1 15.2 15.0 16.1 14.9 17.4 15.6 3.2 10.0 4.9 20.5 22.6 18.7 28.0 14.8 19.5 25.2 29.1 13.8 27.1 20.5 18.4 4.2 46.5 27.0 48.0 37.2 35.0 37.2 18.8 26.5 15.3 25.8 18.3 7.4 52.2 50.3 19.0 19.4 24.7 18.4 25.1 7.5 14.8 33.5 10.1 7.6 31.5 30.5 21.0 22.0 103.0 21.5 18.8 26.6 4.7 28.5 18.3 29.9 6.0 8.2 29.8 30.7 19.9 29.5 21.5 48.0 25.0 12.5 24.1 19.7 21.1 26.9 33.4 31.8 29.5 28.3 42.1 20.8 38.1 39.4 21.5 ETV2 ER71 ENSG00000105672 "ETS variant transcription factor 2" O00321 19 35641745-35644871 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "testis: 19.2" "Group enriched" "Detected in many" 10 "Early spermatids: 146.6;Late spermatids: 443.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 24.4" "Lineage enriched" "Detected in all" 6 "dendritic cells: 24.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.14e-1)" "unprognostic (3.24e-2)" "unprognostic (1.73e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (2.83e-1)" "unprognostic (2.69e-3)" "unprognostic (8.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-4)" "unprognostic (2.48e-1)" "unprognostic (1.41e-1)" "unprognostic (2.74e-1)" 1.4 2.2 0.6 0.8 0.4 0.5 1.2 1.9 1.0 1.7 0.4 1.2 2.1 0.9 0.1 3.7 1.0 0.3 0.7 0.5 0.6 1.8 2.7 1.1 0.6 0.7 0.7 0.4 1.5 3.6 1.2 1.3 0.3 0.8 1.5 0.4 0.4 2.3 0.6 0.2 3.3 1.5 0.3 0.6 1.0 1.7 19.2 0.5 0.4 1.1 0.0 0.2 1.0 2.1 0.7 1.4 1.9 1.2 1.5 1.4 2.7 0.2 0.5 0.8 1.4 2.2 0.7 0.7 0.2 2.0 1.0 0.3 0.5 0.1 1.0 0.1 2.3 2.3 2.6 1.1 1.3 2.4 0.8 3.4 2.4 2.0 0.7 1.1 0.8 0.4 0.8 0.8 1.0 0.8 1.7 1.2 0.8 0.1 2.3 0.6 1.7 3.1 2.0 2.1 1.3 1.6 1.1 1.7 0.3 3.0 0.3 1.2 3.0 0.4 4.2 2.1 2.3 1.7 1.1 2.5 0.4 2.0 0.9 4.1 0.0 2.2 1.1 3.1 3.3 3.4 2.3 3.8 3.9 2.6 1.2 2.1 2.7 0.8 1.0 3.8 24.4 3.3 1.8 0.6 0.4 1.9 1.0 0.5 0.6 0.7 0.7 0.4 0.8 0.6 0.5 0.7 2.4 0.0 1.1 0.0 2.8 5.7 3.5 8.4 12.0 5.1 9.0 12.2 1.4 4.3 2.6 5.5 0.0 1.9 7.0 12.1 7.9 1.9 146.6 1.7 2.7 2.4 7.7 1.7 0.0 5.3 2.8 3.3 2.6 3.4 1.3 1.0 4.6 19.9 2.2 0.0 0.1 9.7 2.0 2.0 5.1 443.3 9.0 2.8 1.8 0.0 2.0 3.1 1.0 0.0 0.1 1.7 4.8 2.6 8.4 3.3 28.6 20.9 1.1 2.8 0.0 6.7 2.3 6.7 2.8 11.3 12.9 1.9 3.6 3.5 7.1 6.1 ATP4A ATP6A ENSG00000105675 "ATPase H+/K+ transporting subunit alpha" P20648 19 35550031-35563658 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 83 "stomach 1: 848.7" "Group enriched" "Detected in some" 6 "Gastric mucus-secreting cells: 66.3;Late spermatids: 21.0" "Cancer enriched" "Detected in single" 21 "stomach cancer: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039154, HPA076684" Enhanced NA NA "HPA039154: AB_10672772, HPA076684: " "unprognostic (3.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.77e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (9.68e-2)" "unprognostic (1.47e-3)" "unprognostic (3.90e-3)" "unprognostic (3.92e-2)" "unprognostic (4.86e-2)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.1 0.0 0.0 10.2 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 848.7 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 66.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.0 0.6 1.2 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ARMC6 MGC19595 ENSG00000105676 "Armadillo repeat containing 6" Q6NXE6 19 19033575-19060311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 111.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041420, HPA041681" Supported Enhanced Cytosol NA NA Cytosol "HPA041420: AB_2677469, HPA041681: AB_10793928" "unprognostic (2.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (3.55e-2)" "unprognostic (2.43e-1)" "unprognostic (8.98e-2)" "unprognostic (2.36e-1)" "unprognostic (7.04e-3)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-2)" "unprognostic (1.70e-1)" "unprognostic (3.73e-2)" "unprognostic (1.40e-1)" 11.2 16.7 19.8 11.5 19.5 16.8 11.8 20.1 28.0 13.2 17.8 11.7 10.1 14.8 6.2 18.9 11.8 6.9 15.7 20.4 19.8 16.1 111.4 12.0 16.0 21.9 20.7 20.8 12.1 11.3 12.0 17.9 8.9 21.0 15.7 9.0 7.8 13.4 8.1 21.4 12.1 12.4 9.2 18.7 18.0 12.4 24.2 20.1 23.4 19.5 18.3 12.5 14.5 12.8 20.3 64.1 42.8 30.7 38.0 14.5 24.7 39.7 40.3 23.5 64.5 47.7 59.8 56.0 96.3 63.8 34.1 23.8 31.8 73.7 47.8 35.5 20.4 104.0 48.5 39.0 49.0 32.0 87.1 54.3 31.2 44.9 44.0 30.7 14.5 41.6 56.3 86.4 36.0 36.0 78.0 93.2 70.5 71.5 71.9 86.8 76.3 27.7 68.9 31.9 42.6 70.5 30.6 32.4 41.1 33.9 20.7 35.0 54.1 27.2 33.0 28.8 47.3 83.8 27.5 53.2 93.2 27.3 117.1 44.0 10.6 19.0 5.3 22.1 20.3 16.6 13.4 12.0 19.3 28.3 15.1 15.7 18.0 3.8 30.6 16.7 18.2 23.4 18.3 19.8 19.5 20.1 28.0 20.4 19.8 21.9 20.7 20.8 21.0 18.7 20.1 20.3 7.1 0.0 5.9 4.6 10.7 6.6 6.8 9.2 9.1 14.1 11.5 11.4 5.9 17.2 8.9 12.9 12.5 20.5 21.3 12.3 7.9 16.0 25.5 6.3 11.8 10.2 15.0 13.7 4.0 10.7 20.3 10.7 12.2 9.6 1.3 11.1 8.2 52.4 20.7 5.0 5.0 10.9 6.1 15.6 6.0 47.9 10.2 9.2 5.4 0.0 14.9 16.4 20.6 5.0 5.5 10.8 10.8 8.2 10.3 12.4 10.4 12.3 4.5 17.9 13.1 7.4 9.1 22.0 31.0 10.0 10.1 13.0 10.3 16.5 17.3 5.5 TMEM147 "MGC1936, NIFIE14" ENSG00000105677 "Transmembrane protein 147" Q9BVK8 19 35545600-35547526 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.98e-2)" "unprognostic (1.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (4.98e-6)" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (7.34e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (4.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" 73.3 154.5 72.9 36.9 76.9 42.2 71.7 82.3 86.5 69.9 106.1 67.0 43.6 78.1 102.7 105.8 64.7 36.7 105.4 71.2 81.0 97.0 64.3 68.8 30.1 79.2 75.1 69.1 69.7 150.9 130.6 76.7 46.5 77.6 55.2 54.5 42.4 81.2 58.6 138.9 118.2 52.7 58.0 78.9 59.1 84.7 76.8 80.2 27.0 100.5 86.6 45.5 77.8 74.1 83.2 161.2 353.2 68.9 162.0 298.4 135.8 110.5 94.3 167.2 124.6 115.2 168.6 96.9 93.3 156.8 156.4 135.1 62.8 119.9 147.4 101.7 140.8 156.3 99.3 98.9 200.3 237.2 145.4 105.6 148.8 226.3 117.5 291.5 107.2 115.6 126.8 127.9 325.2 134.1 201.6 82.4 80.8 96.9 492.8 141.3 79.1 62.3 225.4 198.5 164.6 60.5 101.0 93.7 215.3 204.9 69.2 78.2 121.4 73.8 140.5 109.9 81.0 205.0 165.9 182.2 52.8 122.3 195.7 115.6 41.0 219.7 103.3 100.6 212.6 142.6 177.0 135.9 116.3 199.9 149.0 101.0 102.6 12.2 106.1 154.0 237.5 147.1 237.4 72.9 76.9 82.3 86.5 71.2 81.0 79.2 75.1 69.1 77.6 78.9 80.2 83.2 74.4 44.8 44.1 7.2 71.5 101.2 135.7 195.5 63.2 55.3 167.2 165.1 101.5 118.7 110.2 156.3 18.8 176.3 63.2 59.6 111.6 223.0 102.5 56.4 72.5 96.8 88.9 42.5 6.0 255.2 228.7 94.7 51.0 68.1 50.2 90.9 82.8 95.5 260.6 45.4 8.0 105.9 140.4 133.6 113.3 333.8 139.4 96.5 240.1 7.5 83.7 138.9 71.1 10.1 12.2 179.9 74.1 121.1 136.0 349.1 100.3 277.1 77.9 62.8 118.3 58.1 138.9 327.9 155.7 94.9 167.8 138.3 60.6 86.1 144.3 200.6 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533455-35545319 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "testis: 272.0" "Cell type enriched" "Detected in some" 4 "Late spermatids: 8717.5" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 22.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome NA NA 7500000 Nucleoplasm Centrosome "HPA042666: AB_2678104" "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 1.2 2.8 0.2 4.1 0.8 2.4 0.2 0.8 0.7 0.0 0.0 0.6 3.3 2.7 0.0 3.0 1.9 3.6 4.1 0.1 0.1 0.9 0.3 1.9 6.5 0.8 0.1 0.1 3.4 5.2 0.0 0.1 1.1 1.3 2.0 0.0 3.6 5.2 0.0 1.7 14.0 3.2 0.0 0.1 5.3 2.5 272.0 0.4 0.0 11.5 0.0 0.0 1.5 0.1 1.0 6.5 22.4 6.4 9.6 0.0 0.0 5.4 1.9 0.0 0.0 0.0 13.8 10.4 10.7 2.9 0.0 2.6 7.6 0.0 0.0 0.0 10.5 11.2 7.1 16.7 7.1 0.1 6.4 8.3 0.0 0.0 0.0 0.0 3.9 0.0 10.3 17.6 6.0 0.0 19.6 2.5 3.0 8.6 4.1 3.1 7.6 4.3 8.3 0.0 6.1 11.3 5.1 2.4 5.7 7.0 4.3 4.8 2.7 2.1 7.2 7.9 1.8 2.7 16.9 4.8 6.2 3.9 11.4 2.6 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.3 0.2 0.3 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.8 0.8 0.7 0.1 0.1 0.8 0.1 0.1 1.3 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1915.7 0.0 0.0 1.6 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.4 8717.5 24.8 2.4 44.4 0.0 0.2 0.0 0.0 1.0 0.5 0.0 0.0 28.6 0.0 0.0 0.0 0.1 0.0 0.0 26.3 0.0 0.1 33.4 18.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 MAG "GMA, S-MAG, SIGLEC-4A, SIGLEC4A" ENSG00000105695 "Myelin associated glycoprotein" P20916 19 35292125-35313807 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "brain: 690.0" "Cell type enriched" "Detected in some" 12 "Oligodendrocytes: 267.8" "Cancer enriched" "Detected in some" 7 "glioma: 20.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 2.9" "Cell line enriched" "Detected in some" 22 "WM-115: 36.6" "Region enhanced" "Detected in all" "white matter: 2742.2" "Low region specificity" "Detected in all" "CAB009345, HPA012499" Enhanced NA NA "CAB009345: AB_670104, HPA012499: AB_1854238" "unprognostic (2.70e-3)" "unprognostic (2.70e-2)" "unprognostic (8.06e-3)" "unprognostic (1.23e-1)" "unprognostic (6.93e-2)" "unprognostic (3.74e-1)" "unprognostic (1.50e-1)" "unprognostic (2.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.62e-2)" "unprognostic (5.18e-4)" "unprognostic (6.29e-2)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-1)" 0.2 1.3 99.7 0.0 295.4 0.0 0.3 256.6 225.9 0.2 0.0 0.1 0.0 0.2 0.0 0.0 4.2 0.0 0.3 111.3 205.6 0.3 0.2 0.3 0.1 432.2 287.2 42.8 22.6 0.1 0.0 0.5 0.3 361.2 0.3 0.0 0.0 0.2 0.3 0.1 0.1 0.1 0.0 262.6 1.1 0.1 0.6 239.2 0.0 1.0 0.0 0.0 0.2 0.5 690.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 99.7 295.4 256.6 225.9 111.3 205.6 432.2 287.2 42.8 361.2 262.6 239.2 690.0 1.2 0.0 0.0 1.6 0.2 0.0 0.2 0.0 0.0 0.0 0.3 4.4 4.1 0.0 0.0 0.0 0.0 0.2 4.0 0.0 1.9 0.0 0.1 0.0 0.0 4.2 0.0 0.4 0.5 0.5 5.4 2.7 0.0 0.0 4.5 21.0 12.8 0.0 1.0 0.0 0.6 0.0 0.0 0.6 0.0 0.1 1.8 1.2 0.0 1.0 0.1 0.0 0.0 0.5 267.8 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 4.3 0.0 0.0 0.3 0.4 11.0 0.0 0.0 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 284.8;pituitary gland: 82.7" "Cell type enhanced" "Detected in some" "Astrocytes: 35.9;Bipolar cells: 92.2;Excitatory neurons: 110.7;Horizontal cells: 50.5;Inhibitory neurons: 88.0;Muller glia cells: 67.9;Oligodendrocyte precursor cells: 42.3" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 36.0;ASC diff: 42.6;EFO-21: 25.3;Hep G2: 27.3;hTERT-RPE1: 23.3;SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010661 Approved NA NA "HPA010661: AB_1078338" "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favorable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 1.5 17.0 168.0 1.3 223.2 0.0 1.6 81.4 284.8 2.2 24.4 7.0 0.5 2.6 0.4 2.3 1.4 1.9 7.3 215.4 210.9 3.1 0.5 1.3 0.2 132.4 115.1 239.6 0.6 3.2 4.0 82.7 0.9 128.7 1.8 0.8 21.4 1.2 1.3 3.0 0.6 3.5 2.2 78.2 0.5 2.6 2.5 149.6 0.1 5.8 0.2 0.1 0.7 2.3 161.6 0.0 1.0 0.3 36.0 42.6 2.0 0.0 3.9 0.7 1.4 0.8 0.1 1.8 0.1 25.3 2.3 3.6 0.5 10.7 0.1 1.2 0.2 1.7 0.0 0.5 27.3 6.5 0.0 0.5 15.8 0.0 0.5 1.2 23.3 0.0 1.5 0.0 0.3 1.0 1.6 0.2 0.0 3.3 0.0 1.1 0.2 0.0 0.4 0.0 0.0 0.6 21.0 2.5 0.0 0.0 0.3 0.3 0.0 0.4 0.8 8.4 0.3 2.4 5.3 2.1 0.3 1.4 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.0 223.2 81.4 284.8 215.4 210.9 132.4 115.1 239.6 128.7 78.2 149.6 161.6 0.2 0.0 0.0 35.9 0.0 0.0 0.2 1.9 0.0 92.2 0.1 2.5 0.5 0.0 0.1 0.0 14.6 0.0 0.1 0.0 0.0 0.5 1.7 0.4 11.7 0.4 0.0 0.0 110.7 0.0 0.1 4.1 0.0 0.3 0.0 0.3 0.0 0.0 0.2 50.5 88.0 0.0 0.0 0.0 0.3 1.6 0.3 0.1 0.0 18.7 0.6 67.9 0.0 42.3 18.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 27.5 0.0 1.2 4.1 3.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 HAMP "HEPC, HFE2B, LEAP-1, LEAP1" ENSG00000105697 "Hepcidin antimicrobial peptide" P81172 19 35280716-35285143 "Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hormone" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 2071.6" "Cell type enriched" "Detected in many" 17 "Hepatocytes: 3227.7" "Group enriched" "Detected in many" 12 "glioma: 6.5;liver cancer: 16.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "myeloid DC: 1.5;plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.6" "Cell line enriched" "Detected in some" 440 "Hep G2: 448.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 1900000 10000000 "unprognostic (5.53e-2)" "unprognostic (5.02e-4)" "unprognostic (2.10e-3)" "unprognostic (4.69e-3)" "unprognostic (5.35e-2)" "unprognostic (2.24e-1)" "unprognostic (3.92e-2)" "unprognostic (9.36e-2)" "unprognostic (2.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.61e-1)" "unprognostic (1.86e-1)" "unprognostic (3.68e-7)" "unprognostic (4.11e-2)" "unprognostic (3.93e-2)" "unprognostic (4.08e-2)" "unprognostic (7.77e-2)" 0.8 1.3 16.5 2.1 18.9 5.4 1.5 16.8 30.7 1.4 19.3 0.5 0.9 0.3 0.6 0.5 2.8 0.6 211.1 17.1 70.1 0.3 2071.6 3.2 4.0 48.6 22.6 17.3 3.2 88.7 0.4 5.9 2.3 24.5 2.8 0.0 4.3 1.2 1.3 1.2 1.0 0.5 1.0 19.1 1.1 1.1 0.7 22.3 0.1 0.4 0.2 4.4 1.6 0.2 26.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.7 448.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.7 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 4.6 0.0 0.0 16.5 18.9 16.8 30.7 17.1 70.1 48.6 22.6 17.3 24.5 19.1 22.3 26.8 0.8 0.0 0.0 0.0 5.7 0.5 1.5 0.0 0.0 0.0 26.2 8.0 1.7 30.0 0.6 0.0 0.0 0.9 0.6 0.1 0.0 0.4 0.0 1.9 1.0 13.7 0.0 89.7 0.2 99.0 1.2 0.4 10.7 1.8 75.7 0.7 45.3 3227.7 187.9 0.0 0.0 0.7 0.0 63.2 1.2 0.0 0.0 28.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 22.6 0.1 0.0 0.1 4.2 0.0 0.1 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 18.6 0.7 4.3 0.5 0.2 2.2 USF2 "bHLHb12, FIP" ENSG00000105698 "Upstream transcription factor 2, c-fos interacting" Q15853 19 35268962-35279821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029764, HPA046567" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029764: AB_2673190, HPA046567: AB_2679702" "unprognostic (6.10e-3)" "unprognostic (2.27e-1)" "unprognostic (1.06e-2)" "unprognostic (5.03e-3)" "unprognostic (4.60e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "unprognostic (2.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.07e-2)" "prognostic favorable (5.12e-5)" "unprognostic (7.75e-2)" "unprognostic (8.12e-2)" "unprognostic (7.47e-2)" "unprognostic (5.75e-2)" "unprognostic (6.90e-2)" "prognostic favorable (3.28e-4)" 127.8 133.7 191.3 131.6 190.8 179.3 106.3 193.5 192.0 107.8 153.9 108.2 106.3 105.3 52.0 105.4 105.0 66.9 195.5 181.5 186.3 98.4 186.7 103.1 156.2 201.6 187.0 166.5 165.9 122.1 110.3 150.2 64.0 194.3 100.6 54.6 91.2 98.7 57.7 362.7 121.2 113.6 52.8 187.9 161.8 105.0 52.1 193.5 102.2 126.8 196.8 97.5 101.1 100.7 188.7 189.2 190.2 93.6 91.1 161.7 81.5 89.2 101.0 119.7 90.4 69.3 87.3 95.5 183.7 157.6 86.3 96.4 56.5 88.6 79.6 45.4 306.4 135.8 107.5 111.1 143.1 97.8 182.5 177.5 71.7 108.3 58.6 89.1 151.3 62.2 119.6 135.3 260.0 70.5 218.8 200.7 69.8 78.7 171.3 61.1 190.9 123.2 171.2 74.8 119.5 159.3 120.7 188.2 200.4 346.7 80.7 81.8 142.4 107.4 150.0 101.0 99.5 134.4 260.0 286.6 199.7 139.4 114.8 201.0 44.5 8.3 11.1 6.8 11.2 8.2 10.2 7.0 9.0 13.4 13.5 6.3 6.0 7.8 11.7 6.9 50.6 13.8 7.7 191.3 190.8 193.5 192.0 181.5 186.3 201.6 187.0 166.5 194.3 187.9 193.5 188.7 58.2 6.4 22.4 29.7 72.5 23.7 23.7 18.7 20.5 66.0 42.2 38.4 71.6 35.8 15.5 31.3 33.3 24.2 108.1 50.7 56.7 33.5 1.1 25.6 31.3 36.5 52.1 37.2 19.7 57.8 38.5 32.7 30.5 34.0 20.3 45.7 38.6 50.5 107.0 94.2 16.9 33.6 20.3 66.8 42.9 3.4 32.0 91.9 26.6 28.1 37.8 118.9 35.0 12.1 19.5 36.0 37.1 31.2 63.8 23.1 58.1 51.7 11.0 53.9 13.1 40.9 35.8 9.0 10.6 34.3 24.7 17.5 56.2 52.0 33.0 35.6 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 146.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 335.6;Ductal cells: 260.5;Exocrine glandular cells: 278.9;Pancreatic endocrine cells: 336.0;Paneth cells: 273.6;Syncytiotrophoblasts: 248.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 500.5;CACO-2: 215.6;CAPAN-2: 225.3;HaCaT: 203.9;OE19: 300.4;RT4: 198.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007270, HPA075309" Approved Supported "Plasma membrane" NA NA 3500000 "Plasma membrane" "HPA007270: AB_1079253, HPA075309: " "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favorable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 14.4 31.5 14.7 18.0 11.5 3.7 25.6 11.4 14.8 20.0 32.9 97.8 85.8 14.5 14.0 60.5 30.0 36.7 6.5 10.6 11.3 28.5 146.0 30.2 14.6 15.2 13.0 8.1 6.4 115.2 16.9 27.5 47.3 14.6 25.9 44.1 8.7 70.0 18.7 4.4 50.3 75.6 5.3 10.5 18.1 134.3 27.5 16.5 6.7 33.2 2.8 14.2 30.1 29.5 14.1 500.5 8.1 0.7 1.0 1.4 0.5 86.8 1.2 1.9 2.2 1.6 215.6 225.3 19.6 73.0 1.3 7.2 203.9 44.3 75.0 0.3 30.1 82.6 0.2 6.5 96.1 1.7 0.3 0.9 1.0 81.2 2.0 24.2 1.0 0.8 0.6 80.2 17.2 1.1 177.4 0.9 1.1 69.0 300.4 3.2 3.8 0.8 54.6 46.2 198.2 37.7 1.4 40.9 130.5 35.8 21.7 112.5 2.6 0.4 3.9 44.7 3.1 2.2 27.2 52.5 45.7 3.4 0.8 12.4 6.4 0.2 0.1 2.5 0.0 2.6 4.3 5.8 5.4 0.1 3.0 4.2 4.9 0.0 5.6 0.0 0.2 4.1 2.9 14.7 11.5 11.4 14.8 10.6 11.3 15.2 13.0 8.1 14.6 10.5 16.5 14.1 38.2 16.0 21.7 0.3 26.3 51.7 123.4 90.7 50.1 2.1 60.9 49.7 5.6 78.6 71.2 36.8 16.7 210.3 4.7 335.6 11.7 260.5 9.4 41.7 27.4 44.6 56.4 3.2 0.8 278.9 93.0 11.9 214.1 61.5 31.1 30.3 20.3 89.7 21.7 0.0 0.9 145.5 73.2 2.2 14.3 2.9 6.5 4.6 14.2 22.5 7.2 11.5 3.1 1.5 0.8 336.0 273.6 3.4 41.1 113.6 117.8 24.6 43.8 12.3 0.0 4.1 24.4 7.9 19.1 57.2 51.7 248.0 24.3 3.4 124.2 206.3 KXD1 "BORCS4, C19orf50, FLJ25480, KXDL, MGC2749" ENSG00000105700 "KxDL motif containing 1" Q9BQD3 19 18557762-18569387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041507, HPA041599" Approved Approved "Nucleoli fibrillar center,Centrosome,Cytosol" NA NA "Nucleoli fibrillar center, Centrosome, Cytosol" "HPA041507: AB_10795698, HPA041599: AB_10795502" "unprognostic (8.48e-2)" "unprognostic (5.30e-2)" "unprognostic (3.16e-3)" "unprognostic (1.35e-1)" "unprognostic (8.60e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (8.46e-4)" "unprognostic (7.36e-2)" "unprognostic (1.81e-2)" "unprognostic (5.25e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (7.71e-10)" "unprognostic (7.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.45e-2)" "unprognostic (1.63e-1)" 84.1 79.8 84.5 68.5 87.4 75.9 82.0 83.0 95.7 77.7 77.7 82.8 58.9 75.6 55.3 79.9 70.1 53.0 81.2 81.2 87.3 71.9 101.3 80.5 81.9 96.4 88.3 79.2 85.6 92.7 46.6 86.9 63.4 90.6 88.5 55.7 48.5 66.7 51.6 98.7 71.2 73.3 64.3 86.8 90.1 79.1 79.4 88.8 58.8 71.9 57.8 73.0 90.7 75.4 100.1 125.1 122.2 98.7 114.0 102.0 117.4 157.3 133.6 108.0 99.2 114.2 102.1 145.3 84.6 153.5 118.7 82.1 92.3 153.0 164.5 89.7 103.3 206.5 91.7 98.5 92.6 116.7 147.2 98.4 123.7 117.6 147.8 175.1 107.7 143.4 114.4 146.7 130.2 105.3 144.5 135.2 109.5 124.2 158.3 187.9 127.0 76.9 126.7 103.5 110.0 91.0 115.7 87.6 79.1 113.8 103.3 66.5 102.4 115.2 88.1 76.8 285.9 177.8 153.9 124.1 128.0 151.9 172.2 131.4 45.3 109.5 97.7 73.7 125.0 68.2 69.8 68.4 74.1 99.5 71.5 54.1 59.0 107.6 83.2 125.1 58.9 103.4 95.9 84.5 87.4 83.0 95.7 81.2 87.3 96.4 88.3 79.2 90.6 86.8 88.8 100.1 48.3 19.2 29.3 0.3 41.8 34.5 71.8 68.9 34.1 20.5 46.7 54.7 5.7 35.8 37.8 16.5 12.5 97.8 38.1 45.6 80.3 80.3 179.6 26.3 30.2 57.2 43.1 48.0 2.2 113.3 121.9 50.3 43.8 25.1 43.7 37.4 51.0 33.6 123.5 16.8 2.0 52.0 30.5 56.2 49.5 38.5 33.5 49.7 58.7 0.0 110.5 30.2 61.8 0.5 4.4 94.8 46.9 29.3 47.9 125.7 66.4 51.7 27.6 19.2 39.5 36.2 48.3 45.8 23.2 51.7 41.5 111.5 43.8 37.5 49.5 73.6 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FKBP prolyl isomerase 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 719.1;Late spermatids: 1236.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 93.4;neutrophil: 78.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 93.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" NA NA 10000 Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: AB_2679244" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favorable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 199.8 162.9 367.1 80.5 362.0 275.2 199.0 300.9 650.5 228.7 276.3 250.5 86.2 190.2 59.5 240.2 199.8 86.2 244.9 369.4 335.0 195.1 235.6 189.2 98.7 375.0 350.2 354.2 265.8 168.6 110.0 314.7 92.0 365.1 251.5 33.9 51.8 201.8 116.3 204.3 181.0 160.5 63.0 318.3 195.2 190.9 381.4 389.9 86.9 207.6 106.4 53.2 230.2 224.3 379.3 196.3 139.0 106.0 201.7 106.2 165.6 266.8 155.0 163.1 116.5 160.2 133.3 259.1 111.6 245.0 191.7 77.7 104.4 65.0 216.5 31.4 136.6 316.5 105.3 175.4 162.3 183.3 105.5 220.6 217.3 204.8 104.0 65.4 216.1 121.9 213.2 222.4 254.8 102.1 329.1 190.4 313.1 216.3 174.6 200.2 197.8 88.4 387.3 154.9 126.6 117.1 213.2 108.8 87.7 197.5 77.8 104.5 299.4 143.2 143.2 130.3 282.1 120.0 194.6 118.2 130.8 321.5 166.7 130.8 18.1 14.7 93.4 14.2 15.5 13.3 10.2 14.6 16.3 11.1 9.8 11.1 12.6 78.0 8.8 19.0 11.3 15.8 30.1 367.1 362.0 300.9 650.5 369.4 335.0 375.0 350.2 354.2 365.1 318.3 389.9 379.3 115.9 9.6 1.1 35.3 115.1 95.3 164.1 118.4 68.3 64.8 110.9 107.4 2.0 115.8 58.0 101.2 14.6 246.4 107.0 287.7 248.4 178.4 412.3 65.6 59.2 92.3 205.9 719.1 32.0 126.9 234.8 126.5 80.5 64.6 52.8 125.0 99.6 66.4 237.3 99.3 33.2 156.8 126.1 184.1 145.0 1236.4 203.8 152.1 202.7 8.4 221.9 149.0 183.4 12.5 32.8 166.9 283.4 165.5 127.2 139.4 339.3 290.4 51.9 56.4 98.6 95.7 129.9 193.5 212.4 96.5 117.9 312.9 145.0 121.7 158.3 158.0 SUGP1 "DKFZp434E2216, F23858, RBP, SF4" ENSG00000105705 "SURP and G-patch domain containing 1" Q8IWZ8 19 19276018-19320509 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 115.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004890 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004890: AB_1079935" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "unprognostic (5.21e-2)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (7.34e-3)" "unprognostic (1.67e-2)" "unprognostic (4.90e-3)" "unprognostic (2.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-3)" "unprognostic (4.25e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-3)" "unprognostic (5.51e-2)" "unprognostic (1.50e-2)" "unprognostic (3.42e-3)" 5.2 5.6 2.6 4.1 3.0 2.5 5.1 2.2 3.3 4.6 2.3 6.1 4.0 6.4 2.6 6.8 5.0 1.7 7.7 3.0 2.8 4.7 4.1 4.0 3.0 3.0 2.9 2.6 4.5 4.4 4.0 4.1 2.8 3.2 4.1 2.4 2.1 5.7 3.0 15.1 5.9 5.7 3.0 2.1 5.6 6.0 15.0 2.5 5.7 4.5 5.7 3.5 5.4 4.8 4.0 13.2 2.7 6.3 8.1 5.8 5.7 15.6 8.1 11.2 11.1 8.9 3.9 9.4 11.1 12.8 10.9 6.7 9.4 6.4 10.3 6.4 7.9 5.2 9.3 3.5 4.0 6.0 8.3 11.9 10.4 5.4 10.0 3.7 6.3 7.4 7.8 14.1 6.9 9.9 8.2 16.1 12.1 14.9 10.2 8.0 15.0 7.1 11.9 8.5 6.0 10.5 12.5 6.3 8.6 15.4 6.9 8.4 13.1 14.7 9.0 9.6 12.8 11.0 11.4 11.8 13.3 11.8 9.1 11.0 6.4 8.9 9.0 9.2 10.8 7.2 7.6 7.9 9.5 9.0 7.4 7.8 8.1 10.2 10.9 13.9 6.9 8.3 9.5 2.6 3.0 2.2 3.3 3.0 2.8 3.0 2.9 2.6 3.2 2.1 2.5 4.0 6.4 16.0 14.1 14.4 11.4 4.7 6.5 20.1 12.5 11.5 6.2 6.9 21.5 14.3 16.9 14.7 4.2 18.6 10.7 11.8 17.6 15.1 44.1 9.2 7.6 9.5 9.6 19.0 12.1 14.1 14.3 8.9 13.7 7.2 9.5 11.8 10.4 8.2 14.2 1.7 13.4 10.3 8.2 9.4 7.2 115.2 11.1 10.3 10.6 3.7 17.6 15.2 14.4 10.1 8.6 13.4 13.7 12.4 8.4 3.3 16.5 16.4 10.4 10.2 6.6 8.9 13.7 32.5 17.8 7.1 5.7 16.8 12.0 24.1 11.1 4.4 HPN TMPRSS1 ENSG00000105707 Hepsin P05981 19 35040506-35066573 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 198.2;liver: 873.3;pancreas: 274.4" "Group enriched" "Detected in many" 6 "Hepatocytes: 442.2;Proximal tubular cells: 201.0" "Cancer enhanced" "Detected in many" "liver cancer: 127.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006804 Approved NA NA 3300000 "HPA006804: AB_1079046" "unprognostic (6.74e-3)" "unprognostic (6.00e-2)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (9.96e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.13e-3)" "unprognostic (9.54e-2)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" "prognostic favorable (5.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (7.96e-2)" 1.5 0.9 4.8 0.2 7.6 0.0 11.7 6.0 7.3 1.2 3.5 1.1 1.5 4.0 3.9 0.3 7.5 4.0 5.0 4.7 5.6 198.2 873.3 11.9 0.4 6.6 7.3 3.9 1.4 274.4 24.4 14.9 0.5 7.7 20.3 0.3 0.3 15.7 4.7 22.2 0.7 1.1 0.2 5.9 2.6 58.6 1.3 6.5 0.2 20.1 5.5 0.1 0.6 0.5 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.5 0.0 0.1 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.3 0.1 0.0 0.0 3.2 0.2 0.1 0.0 0.2 0.5 22.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 7.6 6.0 7.3 4.7 5.6 6.6 7.3 3.9 7.7 5.9 6.5 10.9 0.5 9.6 32.4 8.8 3.0 0.1 5.1 0.0 0.0 7.2 12.0 8.9 3.4 51.5 1.3 33.1 0.0 0.1 0.0 0.1 52.8 7.5 8.9 4.9 1.0 1.1 2.4 10.7 2.3 26.5 0.3 1.9 18.3 12.5 2.5 0.1 8.6 442.2 1.1 0.0 1.7 2.4 0.0 9.7 0.3 26.0 0.0 1.8 0.0 2.8 0.6 1.6 0.0 0.0 41.6 14.4 0.0 0.4 0.0 7.5 0.0 201.0 0.0 0.6 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.8 1.8 0.1 0.1 0.5 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710472-19733112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049863 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049863: AB_2680921" "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favorable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 2.8 2.7 2.9 3.3 3.4 8.4 7.4 7.1 4.4 5.6 1.7 3.0 2.2 5.3 5.3 2.8 5.1 2.9 3.9 2.7 3.2 4.7 0.8 2.8 6.8 2.5 3.2 2.8 8.8 3.2 7.7 3.3 4.2 3.6 5.5 2.8 4.9 3.8 5.2 2.0 3.7 3.1 3.5 2.2 5.3 4.1 3.6 3.3 5.0 7.9 4.4 6.6 3.6 3.2 4.9 2.8 2.7 4.7 6.1 3.1 3.4 5.6 2.9 4.0 4.2 4.5 2.7 2.1 7.6 4.7 3.0 2.4 2.8 4.9 2.9 5.2 1.9 5.6 3.5 2.0 3.5 3.7 0.1 5.2 3.3 3.0 2.9 2.5 5.5 2.6 3.7 4.2 3.5 4.2 4.7 6.6 4.1 6.1 5.3 8.1 3.4 7.6 3.6 3.0 5.6 4.6 3.3 0.0 3.3 4.7 4.0 4.6 7.3 1.7 3.6 1.0 4.3 3.8 2.7 3.5 6.5 0.2 3.9 2.2 22.4 2.7 9.4 13.3 4.7 21.0 14.9 18.1 16.6 3.8 12.0 24.8 19.9 6.1 10.1 5.8 4.4 12.7 9.1 2.9 3.4 7.1 4.4 2.7 3.2 2.5 3.2 2.8 3.6 2.2 3.3 4.9 3.6 0.0 3.7 11.4 8.5 2.4 4.4 1.5 3.4 4.6 3.2 3.4 2.8 0.0 1.4 3.7 0.0 3.4 5.3 0.4 3.9 1.7 0.6 1.5 2.1 3.4 3.0 4.8 9.7 1.3 1.5 3.5 2.6 2.5 1.3 4.7 3.3 0.2 1.8 6.7 12.5 1.4 4.1 0.8 1.4 0.9 1.8 1.8 3.6 11.2 0.3 3.8 4.1 12.5 13.7 0.8 2.5 3.8 2.8 2.2 1.0 3.0 2.9 5.7 6.6 3.2 2.9 3.4 3.0 1.5 1.4 2.2 9.5 2.2 1.3 2.5 SCN1B ENSG00000105711 "Sodium voltage-gated channel beta subunit 1" Q07699 19 35030470-35040449 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 236.7;skeletal muscle: 576.7;tongue: 229.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 67.9;Excitatory neurons: 50.4;Hofbauer cells: 31.3;Inhibitory neurons: 48.3;Kupffer cells: 35.1;Macrophages: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 17.5;EFO-21: 12.7;TIME: 26.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 349.1" "Secreted in other tissues" NA NA "unprognostic (8.18e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-2)" "unprognostic (2.69e-2)" "unprognostic (4.40e-2)" "unprognostic (1.20e-1)" "unprognostic (3.34e-2)" "unprognostic (4.72e-3)" "prognostic favorable (1.38e-4)" "unprognostic (2.25e-1)" "unprognostic (2.05e-2)" "unprognostic (9.68e-3)" "unprognostic (5.81e-2)" "unprognostic (4.12e-2)" "unprognostic (4.78e-2)" 19.7 13.7 53.6 3.4 50.8 2.3 16.4 90.0 236.7 15.3 13.5 9.0 1.9 9.4 2.2 8.7 21.9 4.9 73.4 60.8 89.2 8.3 8.6 11.2 3.0 107.3 73.5 23.9 7.9 12.4 18.4 17.6 5.4 113.0 8.7 2.7 10.7 15.5 3.6 576.7 5.6 8.1 4.5 49.8 19.9 8.5 2.8 148.2 1.3 11.2 229.8 0.8 13.5 10.6 117.2 0.4 17.5 0.2 1.0 5.2 7.8 0.1 7.1 6.1 3.4 0.9 0.7 0.2 0.2 12.7 7.1 3.0 0.3 1.1 0.7 1.6 0.2 0.8 0.2 2.5 4.5 6.9 0.1 0.1 2.5 0.1 0.4 0.2 6.8 11.6 0.2 0.4 0.1 2.2 1.7 0.2 0.2 0.8 1.6 5.1 0.9 1.8 0.2 0.5 0.1 8.1 4.3 0.9 0.1 1.4 0.6 1.6 0.4 26.1 6.7 6.6 0.3 4.6 0.3 0.5 1.0 4.0 0.8 4.8 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.1 0.1 0.6 0.2 0.1 0.1 0.7 0.2 0.1 0.1 0.3 0.7 53.6 50.8 90.0 236.7 60.8 89.2 107.3 73.5 23.9 113.0 49.8 148.2 117.2 12.8 0.0 3.3 11.8 1.1 1.8 0.8 1.6 0.0 67.9 1.6 7.7 20.3 0.0 0.6 0.0 2.1 0.4 2.9 0.0 9.8 0.3 0.3 2.0 2.0 9.7 0.0 0.4 50.4 2.6 0.6 9.9 2.0 1.8 2.5 0.1 20.7 1.2 31.3 8.4 48.3 1.6 0.0 35.1 3.7 0.0 7.5 29.5 3.6 15.9 3.0 13.3 0.0 6.0 18.5 0.7 0.1 2.2 2.7 1.1 0.1 2.5 1.0 22.8 0.0 25.3 3.6 0.2 0.7 0.1 1.1 1.0 2.0 0.1 0.8 0.3 PBX4 ENSG00000105717 "PBX homeobox 4" Q9BYU1 19 19561707-19618693 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.1;thyroid gland: 2.3" "Cell type enhanced" "Detected in many" "dendritic cells: 14.5;Gastric mucus-secreting cells: 17.3;Plasma cells: 18.8;Spermatocytes: 26.6;T-cells: 50.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.0;T-reg: 3.1" "Lineage enriched" "Detected in single" 12 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "A-431: 2.5;RT4: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049859, HPA056469" Enhanced Approved Vesicles NA NA Vesicles "HPA049859: AB_2680918, HPA056469: AB_2797256" "unprognostic (5.36e-3)" "prognostic favorable (8.69e-6)" "unprognostic (9.39e-3)" "unprognostic (1.03e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-4)" "unprognostic (2.87e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.86e-2)" "unprognostic (3.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.44e-6)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "unprognostic (5.89e-2)" "prognostic favorable (5.94e-7)" 0.2 0.0 0.5 0.4 0.5 0.4 0.2 0.3 0.8 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.0 0.3 1.2 0.4 0.4 0.5 0.2 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.4 0.0 0.3 0.3 0.4 2.1 0.7 1.0 2.3 0.0 0.6 0.1 0.1 0.4 2.5 0.1 1.0 0.0 0.2 0.0 1.7 0.0 0.8 1.1 0.8 0.0 1.1 0.3 0.4 0.6 0.9 1.1 1.4 0.0 0.3 0.1 0.5 0.0 0.4 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.5 1.0 0.7 0.2 1.8 1.9 0.5 0.0 0.0 0.8 3.2 0.8 1.1 1.1 0.1 0.8 0.1 0.4 0.1 0.0 0.0 0.5 1.5 0.3 0.2 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.2 1.2 1.9 0.0 0.0 1.2 1.0 0.2 0.0 0.0 0.0 3.1 0.5 0.5 0.5 0.3 0.8 0.5 0.5 0.4 0.4 0.5 0.4 0.3 0.7 0.4 0.7 0.0 4.1 9.8 8.7 4.8 2.6 1.3 1.8 0.6 1.1 1.8 0.4 1.5 1.6 0.0 0.0 0.0 14.5 1.1 1.9 0.7 3.1 8.3 1.1 0.4 0.0 0.8 5.0 0.0 1.1 3.4 17.3 3.5 0.0 1.2 0.4 0.0 0.4 0.0 7.3 2.9 0.0 0.3 3.8 1.5 0.3 1.6 1.8 1.0 1.5 1.4 6.2 1.5 1.4 2.4 0.1 0.7 18.8 2.6 0.2 0.0 5.4 0.1 6.6 1.4 1.4 26.6 10.7 0.7 2.6 0.0 50.4 0.5 0.7 3.1 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247569-42255128 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 157.0;Suprabasal keratinocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 35.6 32.1 19.4 22.1 20.3 15.4 35.4 15.1 24.5 34.4 9.1 34.2 34.7 48.6 17.6 25.9 50.3 50.5 37.8 17.6 21.3 37.5 43.7 42.0 20.2 22.4 20.4 14.6 43.3 29.3 21.2 40.6 18.6 27.5 31.2 10.1 14.7 26.6 17.3 11.7 33.4 34.7 20.1 15.7 31.6 30.0 33.1 19.7 24.4 39.1 18.1 15.7 30.0 31.6 36.6 57.6 136.4 57.7 65.8 12.7 32.4 16.4 53.3 37.4 53.5 54.0 63.2 65.1 47.4 32.9 49.3 48.0 61.7 42.1 124.4 39.2 23.5 29.1 28.5 82.9 80.1 34.3 33.2 45.5 37.1 41.3 41.4 45.5 69.6 45.0 37.9 62.0 38.4 29.8 115.8 38.0 25.0 48.5 54.4 29.3 46.6 21.0 20.1 33.5 49.1 26.6 54.2 59.4 43.4 61.8 39.1 43.6 58.7 54.2 78.4 112.9 27.4 100.0 43.2 53.1 39.0 76.9 35.3 108.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 19.4 20.3 15.1 24.5 17.6 21.3 22.4 20.4 14.6 27.5 15.7 19.7 36.6 63.3 3.2 1.7 7.8 25.0 157.0 30.2 19.8 77.4 14.1 95.0 57.9 7.3 25.8 6.3 9.2 22.9 7.2 21.7 21.6 7.9 19.1 9.4 35.1 20.5 43.7 26.4 7.8 4.2 15.8 4.9 27.2 13.7 23.4 11.4 10.0 41.4 30.2 11.7 10.1 1.5 22.9 2.0 14.5 58.6 4.1 11.1 22.9 55.2 7.5 7.3 19.0 3.1 3.5 8.5 15.3 27.2 10.1 11.2 18.8 34.6 23.3 11.9 12.3 13.1 61.0 39.8 3.0 16.2 37.9 109.7 14.8 25.5 10.2 21.7 17.6 GSK3A ENSG00000105723 "Glycogen synthase kinase 3 alpha" P49840 19 42226225-42242625 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004422, HPA028423" Approved Approved Cytosol NA NA Cytosol "CAB004422: AB_627680, HPA028423: AB_10612116" "unprognostic (5.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.80e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (4.49e-2)" "unprognostic (7.22e-2)" "unprognostic (8.22e-3)" 30.2 43.6 38.1 22.3 43.5 31.0 29.7 35.2 89.7 34.1 13.7 38.0 41.3 38.4 21.9 40.5 32.0 18.8 41.3 50.1 29.9 39.2 30.6 30.7 23.9 40.8 31.8 39.7 34.8 29.9 34.7 32.4 20.0 49.6 33.6 21.3 32.8 31.9 26.2 79.8 42.7 37.4 23.2 21.8 31.5 35.7 30.9 38.5 33.2 29.8 42.3 22.8 38.1 33.3 49.5 57.0 102.1 54.3 53.2 30.3 29.5 25.9 42.7 36.1 49.6 46.0 39.0 39.6 41.0 39.6 33.9 44.8 25.6 49.5 51.3 38.5 33.8 74.5 41.5 41.3 42.7 42.7 51.7 54.0 27.2 45.8 41.9 47.7 44.8 46.5 34.7 73.9 63.0 41.1 80.0 87.7 39.0 42.8 84.5 40.0 58.4 33.8 30.4 43.4 76.1 63.7 67.5 52.8 71.6 36.6 42.8 39.5 69.5 40.6 52.0 40.9 31.0 71.9 65.8 82.8 38.7 66.4 49.8 58.2 0.9 0.5 1.4 0.5 0.8 0.9 0.3 0.3 0.7 0.2 0.2 0.2 0.8 1.7 0.3 0.4 0.6 0.5 0.7 38.1 43.5 35.2 89.7 50.1 29.9 40.8 31.8 39.7 49.6 21.8 38.5 49.5 45.6 6.4 16.2 5.2 16.4 24.6 17.7 7.3 14.8 40.8 35.0 39.2 12.9 17.2 7.9 16.5 62.6 23.4 31.4 42.3 3.9 15.2 8.6 19.6 21.5 26.6 23.4 28.6 15.1 17.2 25.3 21.3 16.8 25.0 2.5 27.2 18.2 13.9 20.3 60.6 14.9 29.7 6.1 21.3 15.4 14.6 17.7 25.2 16.0 8.4 14.4 41.8 21.6 11.1 12.2 24.2 24.3 16.6 12.6 29.0 45.0 16.0 5.9 47.0 6.6 50.4 27.4 16.4 19.4 20.2 28.1 44.1 20.6 42.6 28.8 30.1 ATP13A1 "ATP13A, CGI-152, FLJ31858, KIAA1825" ENSG00000105726 "ATPase 13A1" Q9HD20 19 19645198-19663676 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031798, HPA049717" Approved Approved Vesicles NA NA Vesicles "HPA031798: AB_2674048, HPA049717: AB_2680858" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (4.30e-2)" "unprognostic (7.29e-2)" "unprognostic (3.33e-1)" "unprognostic (4.40e-3)" "unprognostic (3.97e-3)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (2.60e-2)" "unprognostic (1.16e-2)" "unprognostic (9.43e-3)" "prognostic unfavorable (6.51e-4)" "unprognostic (2.26e-3)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.57e-1)" 12.9 17.2 6.4 22.0 6.0 16.3 14.0 5.0 8.7 17.2 10.4 14.7 18.8 16.4 8.0 15.7 15.1 14.1 9.7 6.9 7.5 12.9 13.0 14.1 21.6 7.3 6.1 6.5 21.0 21.2 23.6 18.3 13.0 6.4 15.2 13.1 8.9 17.8 12.7 12.9 15.9 22.4 11.7 4.9 26.6 16.8 15.9 6.6 16.1 20.4 5.8 17.7 14.0 14.5 8.5 32.8 45.2 24.3 52.8 38.2 25.3 66.1 28.9 40.1 24.5 24.9 43.5 54.3 44.9 48.6 34.4 14.0 17.8 37.2 37.0 13.4 16.5 77.6 24.6 48.7 34.5 39.3 46.8 70.1 36.7 34.2 26.5 31.8 27.1 17.9 32.1 43.0 97.5 24.7 53.9 31.8 33.7 44.5 40.6 54.7 25.0 17.4 100.9 25.8 44.7 33.4 56.7 26.8 42.6 30.0 11.4 26.9 50.6 28.7 51.5 7.7 59.2 35.3 78.8 50.6 26.8 36.0 59.6 39.5 0.0 3.5 3.5 2.8 5.6 3.1 2.2 3.3 3.1 6.5 1.9 2.1 2.7 0.1 1.4 8.6 5.0 2.9 2.4 6.4 6.0 5.0 8.7 6.9 7.5 7.3 6.1 6.5 6.4 4.9 6.6 8.5 11.3 9.6 5.8 12.1 22.7 5.9 7.4 8.2 9.6 12.0 13.0 8.5 5.5 11.5 9.0 14.7 18.8 20.3 12.5 28.5 1.9 19.1 10.3 11.5 9.8 9.0 18.6 11.1 11.2 18.4 18.2 10.2 31.6 13.6 5.7 16.2 10.8 13.2 20.0 5.0 11.0 22.9 12.2 12.2 9.5 5.1 14.0 18.3 7.2 7.5 13.6 12.6 8.2 9.0 11.0 15.6 22.4 9.8 50.4 11.9 28.6 6.6 12.8 10.8 6.6 9.2 11.4 14.7 14.6 12.6 6.1 15.3 13.9 20.2 22.2 6.4 ZNF574 FLJ22059 ENSG00000105732 "Zinc finger protein 574" Q6ZN55 19 42068477-42081552 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023196, HPA057274" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA023196: AB_2671105, HPA057274: AB_2683392" "unprognostic (3.90e-1)" "unprognostic (3.68e-2)" "unprognostic (3.39e-2)" "unprognostic (7.84e-2)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (9.49e-2)" "unprognostic (2.84e-2)" "unprognostic (5.24e-2)" "unprognostic (1.55e-3)" "unprognostic (6.36e-3)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (6.48e-2)" "unprognostic (3.51e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" 7.3 5.4 5.7 4.7 5.3 11.2 8.0 8.6 7.8 8.0 3.2 8.9 6.8 10.4 2.8 9.7 8.9 5.2 6.1 6.4 4.8 5.2 5.5 5.6 6.6 6.1 5.0 5.6 9.7 7.9 6.1 6.5 5.1 5.9 7.6 2.9 4.2 8.2 6.8 9.4 12.5 7.5 3.7 5.0 8.4 7.3 27.4 5.6 6.4 6.0 6.4 4.3 8.3 7.5 5.7 15.0 41.1 9.0 11.4 8.1 8.0 9.7 11.0 9.6 14.2 13.6 16.2 10.1 21.4 9.7 9.1 7.5 8.9 10.4 14.1 5.6 11.4 17.6 20.5 10.1 14.0 8.6 12.6 13.5 9.5 13.9 13.2 11.1 8.7 7.9 11.8 17.1 13.3 10.1 31.2 15.2 10.9 16.1 13.5 16.2 20.7 8.6 9.3 7.4 19.7 14.9 12.8 11.3 24.0 7.3 6.2 11.0 20.5 9.5 19.2 14.9 5.8 16.4 14.3 9.3 15.7 10.6 11.9 11.0 12.3 10.5 16.7 16.2 7.8 17.6 17.3 12.1 17.8 12.5 12.8 12.6 11.9 13.3 10.9 11.2 11.1 10.3 12.9 5.7 5.3 8.6 7.8 6.4 4.8 6.1 5.0 5.6 5.9 5.0 5.6 5.7 6.0 0.0 3.3 1.3 11.3 29.3 15.1 6.1 40.9 7.5 11.0 7.6 4.3 4.3 6.0 1.8 2.1 7.9 6.3 5.8 1.9 6.9 25.3 6.1 5.7 7.6 3.5 8.6 1.4 5.1 6.7 6.6 7.7 5.7 12.7 5.4 6.8 3.1 5.1 3.3 1.7 7.6 6.1 2.5 11.0 15.7 5.6 3.0 8.8 1.0 7.5 3.9 4.1 1.5 0.9 4.3 8.5 8.6 8.1 10.6 6.4 4.3 5.2 9.8 6.6 8.8 8.0 35.5 20.5 22.1 22.7 4.8 10.6 3.8 7.9 9.6 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;testis: 33.2" "Cell type enhanced" "Detected in some" "Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2" "Group enriched" "Detected in many" 5 "glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074001: AB_2732248" "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.3 4.0 19.3 1.7 15.8 3.0 1.3 5.3 26.9 4.5 0.0 11.8 0.8 7.3 1.8 1.6 6.9 1.9 3.3 36.5 10.1 5.6 0.3 0.6 0.7 5.0 5.1 18.3 3.6 2.7 14.9 18.4 0.0 7.1 6.3 1.0 12.6 0.7 6.6 0.5 0.9 3.4 5.2 1.0 1.3 5.4 33.2 9.0 0.9 11.4 0.7 0.6 5.0 2.7 6.3 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.3 13.7 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 21.2 0.0 0.6 0.1 0.6 0.0 0.2 0.2 0.0 13.1 0.1 0.0 37.5 0.0 0.1 5.8 0.1 10.3 22.7 0.1 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 15.8 5.3 26.9 36.5 10.1 5.0 5.1 18.3 7.1 1.0 9.0 6.3 0.2 0.0 0.0 17.9 0.1 0.4 0.1 0.0 0.0 23.0 0.2 0.8 3.1 0.0 0.0 1.8 2.1 0.0 0.0 0.1 0.0 0.8 1.6 0.2 0.2 0.4 0.0 0.0 32.4 0.0 0.0 0.6 0.0 0.3 4.5 7.2 0.0 0.0 0.0 18.5 31.1 0.0 0.0 0.0 0.0 2.3 0.9 0.1 0.0 2.8 0.0 9.1 0.0 31.7 0.9 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 21.2 0.0 4.9 1.7 4.2 2.2 0.2 0.4 0.0 0.0 0.0 0.0 0.1 SIPA1L3 "KIAA0545, SPAR3" ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907208-38208369 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 59.6" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 2.2 3.1 5.9 6.6 2.9 2.9 5.2 10.3 16.4 4.9 2.0 10.7 18.6 3.4 1.3 5.0 4.8 3.9 6.3 28.8 2.2 6.4 3.5 5.8 6.8 4.4 4.2 1.2 2.9 9.8 3.3 3.2 1.4 4.5 5.4 7.1 5.0 8.4 3.5 6.6 11.2 18.2 1.8 2.7 7.3 9.2 4.4 6.2 3.8 10.1 7.4 5.5 4.3 3.6 5.4 34.4 59.6 7.3 9.3 4.3 4.3 4.9 14.5 12.2 9.4 8.8 20.6 19.5 19.5 12.2 12.4 7.9 7.6 6.7 27.1 10.4 6.7 3.3 5.3 5.5 6.5 8.3 3.7 5.5 3.3 14.1 17.5 37.3 13.9 10.8 5.6 3.9 4.1 16.6 10.6 5.0 5.1 6.0 27.2 15.8 10.8 5.9 2.9 20.7 29.1 17.3 9.3 16.0 27.1 2.2 3.9 18.0 3.5 23.2 15.6 5.5 48.4 22.6 5.4 10.0 6.6 20.1 4.9 20.6 0.1 0.1 0.4 0.1 0.2 0.0 1.1 0.1 0.2 0.1 1.5 0.1 0.5 0.1 0.3 1.5 0.3 0.1 0.1 5.9 2.9 10.3 16.4 28.8 2.2 4.4 4.2 1.2 4.5 2.7 6.2 5.4 4.8 6.4 10.1 41.4 24.5 12.0 5.2 10.4 6.2 21.9 22.6 12.1 5.2 22.8 10.8 23.9 14.6 2.1 9.3 93.7 3.9 7.2 4.5 19.8 4.8 5.4 25.2 10.8 61.1 15.3 1.4 3.7 40.2 16.5 2.5 4.8 6.4 23.5 3.5 33.7 87.3 46.3 20.3 5.1 13.9 9.2 2.1 8.3 5.4 50.6 7.1 3.0 5.2 99.5 58.7 13.4 38.7 1.9 12.8 6.6 50.0 21.1 19.1 5.7 6.6 4.5 3.6 1.7 5.1 8.9 16.1 0.8 5.1 1.7 30.4 5.6 ZNF85 "HPF4, HTF1" ENSG00000105750 "Zinc finger protein 85" Q03923 19 20923222-20950697 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Early spermatids: 128.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044760 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA044760: AB_10960412" "unprognostic (1.26e-2)" "unprognostic (1.92e-1)" "unprognostic (4.69e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.98e-2)" "unprognostic (4.27e-2)" "unprognostic (2.01e-2)" "unprognostic (1.31e-1)" "unprognostic (2.01e-4)" "prognostic favorable (6.45e-6)" "unprognostic (2.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.75e-2)" "unprognostic (2.05e-1)" "unprognostic (2.24e-1)" "unprognostic (3.90e-3)" "unprognostic (6.01e-2)" 2.5 5.0 0.9 2.0 1.0 5.0 5.2 3.4 1.2 2.7 0.6 1.9 0.4 2.4 1.6 2.9 2.5 1.7 1.8 1.0 1.0 2.5 0.9 1.8 5.8 1.0 1.1 1.0 6.6 8.2 2.1 1.4 3.6 1.8 2.4 2.6 1.1 2.9 1.6 0.7 2.9 2.3 2.4 0.9 3.6 5.6 11.6 1.0 5.5 7.8 0.3 6.1 2.3 2.8 1.4 0.9 0.6 12.6 12.5 3.5 3.2 9.0 8.1 3.6 12.5 12.7 0.1 4.9 13.8 9.1 3.4 5.6 1.1 0.2 7.9 13.2 0.5 6.4 2.1 0.9 0.9 0.9 0.1 3.1 1.6 2.3 5.8 6.9 2.6 3.6 12.5 0.2 4.2 6.6 1.8 20.9 7.5 11.0 0.0 11.4 9.9 17.6 6.9 4.0 5.3 10.3 5.4 0.2 0.3 2.6 10.7 5.2 9.7 3.0 7.2 1.3 15.7 10.4 5.4 15.3 13.2 0.2 0.0 5.1 0.4 0.7 2.8 1.8 2.3 1.5 5.4 2.2 1.3 1.7 3.6 2.6 2.1 2.1 5.3 1.3 2.0 2.8 1.4 0.9 1.0 3.4 1.2 1.0 1.0 1.0 1.1 1.0 1.8 0.9 1.0 1.4 5.4 3.2 1.7 2.0 8.5 0.8 2.2 1.5 1.8 4.7 4.5 4.4 3.4 1.5 2.0 5.5 0.0 9.9 8.5 1.0 1.9 6.9 128.4 2.4 4.1 8.3 0.0 9.0 3.4 6.1 14.2 5.0 3.6 3.9 12.0 10.3 5.7 0.3 8.8 3.3 4.8 2.6 4.1 1.9 3.3 24.1 3.1 4.3 5.4 6.5 5.0 3.7 5.2 9.0 5.3 3.5 2.1 3.8 3.8 2.4 0.1 3.9 2.6 2.0 19.7 2.5 5.3 23.2 13.6 3.1 1.4 7.5 4.7 6.5 1.3 3.3 ETHE1 "HSCO, YF13H12" ENSG00000105755 "ETHE1 persulfide dioxygenase" O95571 19 43506719-43527230 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 258.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1037.7;Paneth cells: 788.4;Proximal enterocytes: 376.3;Undifferentiated cells: 447.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 222.6;OE19: 360.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028360, HPA029028, HPA029029" Enhanced Enhanced Mitochondria No No Mitochondria "HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998" "unprognostic (8.04e-2)" "unprognostic (3.33e-1)" "unprognostic (1.50e-2)" "unprognostic (2.45e-1)" "unprognostic (8.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.58e-4)" "unprognostic (7.75e-2)" "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" "unprognostic (2.73e-2)" 22.7 28.1 14.9 35.1 15.3 46.2 27.0 15.3 17.5 24.1 15.0 258.4 86.2 18.4 30.1 81.7 20.8 21.2 17.9 14.5 24.0 40.6 53.1 30.8 23.6 16.0 15.8 13.6 13.6 29.1 16.2 19.3 26.5 15.1 27.3 228.7 3.2 40.4 18.7 23.0 26.2 77.6 35.9 15.8 28.0 38.1 3.0 17.5 20.0 24.3 22.1 42.0 34.8 39.4 16.1 54.1 68.9 14.1 49.6 75.1 50.9 5.5 82.1 222.6 69.8 71.1 21.1 54.3 0.2 60.0 79.8 22.2 42.9 20.6 123.4 19.6 26.2 6.2 13.8 29.7 59.2 34.0 19.3 18.4 52.2 95.1 26.9 76.0 92.2 52.0 49.8 9.0 87.6 35.1 35.7 22.2 18.9 3.8 360.5 32.9 26.6 6.1 12.0 153.0 110.9 0.2 16.6 20.8 74.8 50.6 23.6 22.4 34.3 41.6 10.9 46.9 13.1 15.3 23.1 20.2 1.4 48.4 83.8 57.7 24.2 63.3 1.6 41.1 34.5 48.3 20.5 47.6 39.4 95.8 7.5 36.4 35.0 2.1 29.3 22.8 17.9 50.4 40.2 14.9 15.3 15.3 17.5 14.5 24.0 16.0 15.8 13.6 15.1 15.8 17.5 16.1 32.0 22.4 23.4 3.9 25.5 34.5 82.2 242.5 57.5 9.8 85.8 95.2 9.8 47.1 84.5 55.2 0.0 191.6 38.0 1037.7 54.8 71.7 0.9 31.0 41.2 44.9 63.7 17.4 6.2 63.6 95.7 42.1 53.5 68.2 38.0 12.6 42.1 89.2 115.1 5.0 6.8 324.2 79.3 105.0 78.5 2.1 17.7 74.6 80.0 3.7 78.5 11.7 63.8 4.0 5.6 102.7 788.4 16.1 34.9 75.0 376.3 136.4 23.1 5.8 19.7 32.0 45.1 2.1 6.2 82.8 23.2 92.5 50.4 15.8 447.5 146.5 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639850 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 193.1;choroid plexus: 112.2" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 42.3;Oligodendrocytes: 50.8;Proximal tubular cells: 31.2" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 7 "dendritic cells: 1.5" "Cell line enriched" "Detected in many" 5 "WM-115: 557.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 8200000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.6 23.5 146.0 4.6 167.0 0.6 8.9 171.7 147.0 13.5 112.2 20.0 3.7 14.4 8.8 20.9 5.9 4.8 10.0 141.1 158.3 19.1 6.0 3.9 2.0 167.6 171.9 127.2 13.3 15.8 38.4 31.9 0.8 164.0 20.0 3.2 14.6 20.0 14.3 7.6 19.9 7.7 9.2 162.0 2.1 15.3 4.7 170.3 2.9 4.7 2.4 4.5 8.8 14.8 193.1 45.2 12.9 67.3 88.8 0.3 1.4 3.8 2.1 3.6 6.2 9.1 19.4 7.7 0.3 16.2 0.7 3.8 10.5 15.1 9.1 7.5 0.4 11.9 0.4 3.1 28.7 7.9 0.1 6.9 2.7 19.5 32.3 1.2 31.5 4.2 3.9 4.7 0.7 0.7 6.7 6.7 0.9 7.4 9.4 4.4 36.3 0.9 4.3 9.0 9.3 7.8 43.2 4.7 13.7 17.9 10.0 10.1 2.1 1.9 0.9 101.8 0.8 4.4 6.4 4.4 0.3 4.8 0.9 557.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 146.0 167.0 171.7 147.0 141.1 158.3 167.6 171.9 127.2 164.0 162.0 170.3 193.1 0.8 0.0 1.7 23.5 1.0 5.0 19.1 7.6 9.1 17.5 8.5 11.8 3.5 4.3 5.4 7.3 2.1 0.2 5.7 0.4 5.9 10.6 21.3 2.5 3.8 2.9 0.0 0.0 11.4 3.2 0.1 1.7 4.1 5.3 0.0 15.5 4.6 3.2 0.4 20.2 22.0 0.4 12.2 0.0 8.2 21.8 0.3 1.1 14.2 3.7 0.1 21.4 0.0 42.3 50.8 3.5 0.0 1.5 2.3 26.3 0.0 31.2 3.3 4.0 0.0 1.9 8.7 0.7 0.7 6.7 8.5 0.0 1.0 1.5 1.2 13.4 SMG9 "C19orf61, FLJ12886" ENSG00000105771 "SMG9 nonsense mediated mRNA decay factor" Q9H0W8 19 43727983-43754962 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 103.2;Late spermatids: 329.5;Syncytiotrophoblasts: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041763, HPA042096" Uncertain Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Mitochondria, Cytosol" "Plasma membrane" "HPA041763: AB_2677659, HPA042096: AB_2677845" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (7.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-2)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.71e-1)" "unprognostic (4.11e-2)" "unprognostic (9.24e-3)" "unprognostic (3.88e-2)" "unprognostic (8.76e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.09e-4)" 8.6 11.8 9.9 11.0 10.1 8.5 8.7 10.8 13.0 10.6 5.7 9.1 8.1 9.1 7.7 9.3 7.8 6.9 7.5 9.9 10.7 7.7 6.6 10.1 13.1 13.1 11.3 9.1 7.9 5.9 8.9 9.5 10.2 12.6 11.6 6.3 6.0 12.1 7.0 7.5 10.2 10.1 8.2 8.8 13.6 8.7 34.0 10.9 11.9 8.3 7.2 12.1 10.0 10.0 14.4 25.3 27.2 19.5 12.5 13.4 18.9 13.1 35.1 20.8 38.4 28.7 19.4 32.5 27.4 16.9 24.1 13.2 10.7 22.9 19.7 24.9 21.1 13.2 49.2 20.5 12.9 15.6 37.4 25.9 10.1 16.6 27.9 29.6 32.1 15.8 25.0 37.7 23.6 18.0 17.9 39.9 10.6 9.4 48.0 18.2 21.2 16.1 12.3 20.4 20.4 32.4 15.9 36.7 27.4 21.3 15.4 16.6 20.5 19.2 59.7 35.4 22.3 27.1 11.5 26.8 33.4 17.9 28.4 49.7 1.0 5.3 3.3 5.1 7.7 4.5 7.4 5.1 4.3 6.9 5.3 6.7 4.5 1.3 4.2 11.7 6.1 4.1 11.3 9.9 10.1 10.8 13.0 9.9 10.7 13.1 11.3 9.1 12.6 8.8 10.9 14.4 7.7 32.1 8.3 20.9 13.7 9.3 15.0 16.8 11.4 13.2 10.0 11.0 4.4 4.3 9.0 9.2 4.2 49.5 11.3 9.5 1.9 12.2 103.2 5.5 7.0 12.0 4.2 7.8 19.5 8.7 15.8 11.4 15.8 8.9 9.5 12.1 11.0 3.3 21.4 13.5 23.0 11.3 8.2 10.3 9.2 329.5 13.1 12.1 10.6 11.2 16.2 6.0 4.1 16.1 29.6 13.6 9.2 12.0 11.2 15.9 8.5 6.8 8.4 9.2 6.6 11.2 8.5 42.6 16.2 8.4 7.1 95.4 9.3 11.8 12.2 11.1 AVL9 KIAA0241 ENSG00000105778 "AVL9 cell migration associated" Q8NBF6 7 32495426-32588726 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 93.9;Inhibitory neurons: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050957 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA050957: AB_2681289" "unprognostic (2.33e-2)" "unprognostic (8.75e-3)" "unprognostic (3.45e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-2)" "unprognostic (5.72e-3)" "unprognostic (5.14e-3)" "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (9.03e-2)" "unprognostic (1.68e-2)" "unprognostic (3.68e-2)" "unprognostic (9.22e-2)" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" 7.1 9.1 8.2 10.3 11.5 9.4 10.8 8.7 9.6 9.1 8.3 16.0 13.4 8.2 12.3 8.1 8.6 7.6 5.2 10.9 11.1 10.6 8.4 8.1 10.7 7.0 8.7 9.4 8.3 11.1 9.4 7.1 10.9 8.0 9.6 18.1 22.6 9.3 7.2 8.1 7.7 13.4 8.3 4.8 8.6 12.3 7.1 10.9 12.8 13.3 6.2 11.4 9.2 7.1 9.8 19.6 17.0 17.4 23.6 10.3 14.8 12.1 17.3 22.8 16.7 22.3 13.4 25.8 24.7 0.3 15.3 64.4 15.8 16.7 17.1 28.1 10.8 10.3 18.5 11.8 14.6 37.8 31.8 23.3 16.1 16.5 21.4 24.3 18.5 25.0 19.6 45.9 22.1 52.9 20.2 12.9 26.5 19.6 27.1 14.8 12.4 19.3 18.9 17.8 32.7 37.4 23.8 14.6 35.5 15.4 23.2 25.4 28.8 19.2 17.3 20.2 13.8 15.2 50.6 47.4 38.8 34.2 29.5 38.6 21.0 15.0 23.3 13.8 11.8 11.7 12.9 11.5 13.1 11.5 16.0 14.1 12.8 37.9 7.0 11.5 13.6 11.5 16.2 8.2 11.5 8.7 9.6 10.9 11.1 7.0 8.7 9.4 8.0 4.8 10.9 9.8 11.0 6.4 11.7 85.5 23.8 11.5 12.4 12.4 13.6 31.6 16.2 8.1 9.5 15.7 15.2 12.9 62.6 16.2 21.4 46.7 3.9 12.8 5.8 14.9 11.6 13.1 22.3 9.0 93.9 17.2 15.7 11.1 28.5 19.4 17.7 25.5 16.8 13.4 15.1 32.0 92.6 27.6 6.1 24.6 14.2 2.8 10.2 17.8 12.4 78.7 18.3 12.5 19.6 56.8 88.6 24.5 24.8 9.4 22.3 21.1 22.5 15.8 18.4 36.8 6.6 9.7 12.7 9.9 8.4 12.2 10.5 17.5 16.6 15.7 29.0 23.3 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.4;brain: 6.4;liver: 5.6" "Group enriched" "Detected in many" 4 "Excitatory neurons: 167.5;Inhibitory neurons: 170.9;Microglial cells: 108.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.2;HEK 293: 1.0;SCLC-21H: 2.7;SH-SY5Y: 1.2;U-138 MG: 1.0;U-266/70: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 0.4 7.4 2.3 0.1 2.6 0.0 0.6 6.4 4.0 1.4 0.0 1.3 2.8 1.9 0.6 0.5 1.0 0.9 0.7 1.8 3.1 1.9 5.6 0.4 0.2 2.4 1.7 2.3 1.2 0.1 0.3 0.2 0.0 2.5 0.6 1.5 1.7 0.3 0.4 0.1 0.5 2.5 2.1 0.7 0.1 0.1 1.9 3.3 0.1 0.2 0.1 0.2 0.5 0.3 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.0 0.0 0.5 0.4 0.0 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.7 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.6 6.4 4.0 1.8 3.1 2.4 1.7 2.3 2.5 0.7 3.3 3.7 15.3 0.0 0.0 5.5 0.6 4.8 0.1 0.1 2.2 7.9 1.0 1.1 2.5 7.2 0.1 0.0 6.2 0.5 0.9 12.2 1.9 1.1 4.6 5.6 0.5 30.8 0.0 2.7 167.5 0.2 0.8 1.1 0.0 2.0 0.0 0.7 1.4 18.9 0.1 11.8 170.9 2.9 0.0 0.0 2.3 1.7 4.1 0.6 3.6 108.7 0.2 0.7 4.1 15.1 5.7 0.6 6.5 1.5 0.1 0.2 18.2 11.6 0.2 8.0 0.0 0.3 2.0 21.2 18.8 0.4 3.0 1.2 0.8 1.6 4.2 0.1 CFAP69 "C7orf63, FAP69, FLJ21062" ENSG00000105792 "Cilia and flagella associated protein 69" A5D8W1 7 90245174-90311063 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Olfaction, Sensory transduction, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 28.4;Endometrial ciliated cells: 55.3;Excitatory neurons: 57.6;Inhibitory neurons: 46.4;Respiratory ciliated cells: 51.7" "Cancer enhanced" "Detected in many" "prostate cancer: 4.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062883 Uncertain NA NA "HPA062883: AB_2684893" "unprognostic (7.69e-4)" "unprognostic (9.93e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-2)" "unprognostic (3.13e-3)" "unprognostic (3.12e-2)" "unprognostic (4.11e-1)" "unprognostic (2.83e-1)" "unprognostic (4.51e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-2)" "unprognostic (9.83e-2)" "unprognostic (1.30e-1)" "unprognostic (6.46e-3)" "unprognostic (2.44e-3)" 7.8 3.0 5.9 1.7 4.1 0.0 8.1 3.4 5.1 6.0 17.2 5.1 1.9 4.7 12.6 3.0 14.4 3.1 4.0 3.8 5.3 8.1 6.7 7.5 0.4 6.8 5.4 3.2 6.9 4.8 5.1 11.9 0.7 4.6 25.0 2.2 12.0 5.9 3.0 1.9 4.3 3.4 3.4 7.1 3.7 4.5 7.7 3.7 0.1 10.3 0.6 0.7 4.7 3.8 4.2 2.8 1.7 0.2 3.2 3.5 3.6 0.6 0.1 2.5 1.0 1.5 6.0 2.4 0.3 0.1 2.9 3.9 1.0 1.1 1.4 1.7 0.0 1.1 0.0 0.8 1.7 2.0 0.3 0.0 4.1 1.6 4.2 1.5 5.6 1.1 0.3 1.4 0.0 1.8 1.6 0.0 2.6 1.6 0.1 0.8 0.0 0.4 0.0 5.6 0.7 0.6 1.4 2.6 0.3 0.7 0.6 1.0 0.1 0.2 3.2 0.7 3.2 1.1 0.6 0.2 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 4.1 3.4 5.1 3.8 5.3 6.8 5.4 3.2 4.6 7.1 3.7 4.2 1.5 3.2 6.3 28.4 0.2 0.0 1.5 0.0 3.4 4.8 5.5 4.3 3.0 8.6 6.8 5.5 18.8 0.2 0.0 0.9 1.9 1.9 24.1 55.3 5.6 1.0 0.0 0.8 57.6 1.6 0.1 9.1 2.6 3.4 0.0 4.2 1.1 1.6 0.1 8.4 46.4 0.8 0.0 0.3 0.0 6.2 1.2 0.4 0.0 12.2 0.0 4.2 0.0 13.0 8.2 0.6 1.0 2.2 0.0 7.0 1.9 3.7 51.7 18.2 0.0 9.5 3.8 22.7 1.8 1.5 0.0 0.1 0.1 4.9 1.1 1.4 GTPBP10 "DKFZP686A10121, FLJ38242, OBGH2" ENSG00000105793 "GTP binding protein 10" A4D1E9 7 90335223-90391453 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021076 Approved NA NA "HPA021076: AB_1850411" "unprognostic (2.74e-1)" "unprognostic (2.91e-1)" "unprognostic (2.35e-1)" "unprognostic (6.17e-2)" "unprognostic (1.35e-1)" "unprognostic (3.18e-1)" "unprognostic (3.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (5.38e-2)" "unprognostic (2.32e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.76e-5)" "unprognostic (8.34e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" "unprognostic (2.72e-3)" 8.6 7.3 3.4 9.0 3.7 6.6 10.7 5.7 5.8 7.0 2.6 8.9 8.8 7.7 6.5 8.3 6.4 5.6 10.1 3.4 4.6 12.7 18.9 5.8 11.1 4.0 3.7 3.1 8.6 7.7 8.1 4.6 6.1 4.4 7.0 9.7 7.3 6.1 5.4 12.4 6.9 7.2 7.2 3.6 7.4 10.7 11.4 3.9 12.8 9.9 10.1 9.8 9.6 5.7 4.9 33.9 21.1 14.1 21.3 17.1 15.3 23.2 21.2 13.9 19.5 15.4 31.1 25.0 42.2 34.6 14.5 41.6 21.3 32.4 28.3 25.3 26.5 16.6 17.4 12.8 16.4 16.3 51.0 14.9 18.3 12.1 32.4 64.3 15.5 11.5 35.0 64.8 30.1 17.6 34.6 35.8 14.5 17.4 30.8 25.5 22.7 41.3 35.2 14.3 18.4 17.4 16.3 27.2 41.3 41.2 20.1 20.0 21.9 21.1 27.3 31.9 48.9 41.2 22.6 30.7 59.3 20.5 35.4 29.5 23.6 5.3 9.4 6.3 7.4 10.9 11.7 10.2 7.7 6.4 9.2 10.8 10.2 5.1 7.8 4.5 5.7 13.3 5.6 3.4 3.7 5.7 5.8 3.4 4.6 4.0 3.7 3.1 4.4 3.6 3.9 4.9 11.0 12.8 21.1 21.5 17.6 5.9 8.5 13.5 9.6 12.6 9.8 11.0 14.3 7.2 17.0 16.5 14.6 7.6 9.7 6.2 13.7 8.7 21.8 8.8 12.1 9.4 9.6 12.8 29.7 15.8 7.2 10.8 10.2 8.9 12.0 12.7 8.6 14.3 6.4 5.0 35.5 7.4 14.2 7.5 6.0 4.4 9.3 7.4 7.2 42.2 7.4 11.2 9.2 36.7 50.8 10.2 4.9 9.4 7.4 8.4 7.8 21.8 15.3 12.4 6.6 18.9 10.5 26.2 18.9 12.0 6.1 6.7 15.5 15.6 9.1 8.4 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616756 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 257.4;tongue: 89.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 73.9;Enteroendocrine cells: 71.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 48.9" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 33.2 17.6 22.1 10.9 18.1 6.1 31.5 19.8 23.2 33.8 5.3 24.9 11.0 38.0 4.7 10.9 28.6 6.3 13.5 21.8 18.7 28.7 2.6 22.3 13.9 21.6 21.1 16.5 25.4 12.4 12.9 24.4 13.1 22.5 23.6 4.0 13.4 13.0 18.1 257.4 17.3 21.8 7.5 17.4 16.9 16.2 5.4 19.6 4.9 17.4 89.4 7.2 26.2 29.3 17.9 1.1 1.5 14.1 2.6 1.8 5.8 0.6 16.3 7.6 4.3 4.9 6.1 3.1 9.9 11.9 24.0 0.3 12.7 0.6 0.1 1.7 1.7 2.4 3.2 4.1 1.0 2.1 2.0 4.4 6.4 1.4 1.4 0.4 18.7 2.7 6.5 5.9 17.0 1.4 4.0 8.6 7.1 1.0 6.6 7.3 17.5 2.9 16.5 0.4 5.0 12.7 25.3 2.3 2.3 1.9 7.5 1.1 5.7 3.0 48.9 22.3 4.9 4.1 28.9 18.5 7.7 4.3 4.5 5.9 0.4 7.9 0.2 1.3 8.6 3.0 3.2 2.4 1.8 10.9 2.9 2.5 1.5 1.8 1.4 1.1 9.2 3.3 3.8 22.1 18.1 19.8 23.2 21.8 18.7 21.6 21.1 16.5 22.5 17.4 19.6 17.9 26.8 12.8 10.9 15.0 8.3 3.8 4.5 1.3 0.6 73.9 2.0 3.0 1.1 2.8 5.2 3.7 16.7 0.2 7.2 5.9 13.7 1.1 0.4 3.3 13.0 24.9 71.8 5.7 5.6 0.7 0.2 5.0 3.1 2.9 1.3 13.6 3.3 1.4 6.0 28.6 6.6 11.8 0.0 11.6 22.8 0.3 8.4 13.3 1.8 4.7 14.2 9.4 6.2 5.5 1.4 1.7 2.8 7.9 4.0 2.9 19.9 8.4 6.2 11.7 13.1 21.3 10.0 3.4 3.3 1.3 3.4 0.4 6.4 5.6 2.9 4.1 CDK6 PLSTIRE ENSG00000105810 "Cyclin dependent kinase 6" Q00534 7 92604921-92836573 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.5" "Cell type enhanced" "Detected in many" "Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 378.4;REH: 173.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002637, CAB004363" Enhanced Supported Nucleoplasm,Cytosol NA NA 26000 Nucleoplasm Cytosol "CAB004363: AB_627242, HPA002637: AB_1846432" "unprognostic (1.29e-1)" "unprognostic (5.98e-3)" "unprognostic (9.07e-2)" "unprognostic (2.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.24e-2)" "unprognostic (3.39e-1)" "unprognostic (2.42e-3)" "unprognostic (7.19e-2)" "unprognostic (7.78e-3)" "prognostic unfavorable (3.86e-6)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.09e-1)" "unprognostic (7.88e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.33e-5)" 3.3 7.3 8.0 4.7 7.1 18.2 5.0 5.3 4.8 4.8 2.8 5.9 6.1 3.1 2.1 4.2 2.9 3.7 3.7 4.1 4.8 4.4 6.0 4.1 6.6 6.6 6.7 2.8 2.7 6.3 9.9 1.7 17.5 7.5 3.1 7.6 0.5 5.7 4.2 1.0 6.5 7.3 3.2 6.1 5.0 9.1 3.3 6.3 41.5 2.4 2.3 6.2 3.9 4.6 8.1 27.1 11.3 34.9 23.9 10.6 11.5 5.8 27.2 18.4 14.3 13.5 34.7 20.9 21.7 14.4 19.9 8.4 15.8 20.8 42.6 34.4 43.0 10.6 50.8 23.3 34.7 6.3 33.0 2.7 11.5 23.1 17.9 90.8 13.4 5.6 75.1 49.3 55.5 26.7 5.9 378.4 3.8 9.8 37.4 9.1 173.7 112.0 36.4 20.3 0.7 18.1 113.8 3.7 9.8 17.1 26.0 0.6 54.9 19.3 44.1 63.7 18.0 54.2 27.4 0.5 27.6 6.9 112.1 60.8 0.9 0.2 0.6 0.6 0.4 0.9 0.2 0.6 0.8 0.5 0.3 0.7 0.7 0.1 0.7 0.4 0.9 0.3 0.3 8.0 7.1 5.3 4.8 4.1 4.8 6.6 6.7 2.8 7.5 6.1 6.3 8.1 38.6 25.6 3.7 2.9 17.7 60.3 23.5 55.0 62.6 0.4 20.7 21.2 18.1 22.8 32.8 22.0 0.0 53.8 30.5 12.1 9.8 37.0 215.9 3.1 29.0 30.7 16.8 213.5 114.7 23.3 5.3 28.5 42.3 6.9 25.3 39.2 11.4 27.0 16.0 0.0 60.3 63.7 28.5 23.0 48.6 237.0 5.0 27.6 19.6 108.7 22.4 0.8 39.1 119.6 235.3 94.7 22.8 3.4 85.3 47.1 20.1 8.2 11.9 0.0 6.6 100.8 32.2 2.7 33.6 36.7 50.4 17.6 42.5 62.8 92.7 27.3 PMPCB "MPPB, MPPP52" ENSG00000105819 "Peptidase, mitochondrial processing subunit beta" O75439 7 103297435-103329511 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040674, HPA074168" Approved Enhanced Mitochondria No No 19000 Mitochondria "HPA040674: AB_10961998, HPA074168: AB_2686671" "prognostic favorable (2.79e-4)" "unprognostic (3.11e-1)" "unprognostic (7.18e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" "unprognostic (1.06e-1)" "unprognostic (7.67e-2)" "unprognostic (7.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.42e-3)" "prognostic favorable (2.95e-8)" "unprognostic (2.59e-2)" "unprognostic (9.79e-2)" "unprognostic (2.40e-1)" "unprognostic (4.39e-2)" 29.4 42.3 20.0 22.5 20.8 54.0 32.8 21.4 22.3 32.0 25.6 32.6 38.4 30.1 26.4 27.9 29.5 25.3 45.3 20.7 20.5 47.9 46.4 22.8 36.7 19.3 19.8 19.9 35.7 41.4 40.0 22.5 26.0 19.7 31.8 33.5 25.7 30.9 28.4 35.1 32.9 32.7 26.5 19.3 28.5 36.1 27.0 19.8 30.5 33.7 38.6 34.2 29.6 28.7 22.3 30.2 42.8 49.9 69.4 28.5 57.1 38.0 26.7 45.6 54.3 62.8 47.7 33.7 76.9 41.7 47.9 58.0 37.5 59.7 43.2 49.2 26.4 69.4 26.4 74.0 61.6 35.0 35.0 30.6 53.4 40.5 41.8 39.6 51.3 28.8 55.9 52.5 77.9 48.5 71.1 59.2 82.0 59.2 60.4 52.4 42.7 34.3 79.4 50.3 54.2 62.2 76.5 37.3 108.6 55.8 49.5 45.3 49.1 24.9 48.3 57.9 85.1 52.3 57.4 79.9 61.8 35.7 59.3 38.2 16.7 19.3 13.2 18.3 21.4 20.1 25.9 21.1 18.5 24.7 19.3 26.1 21.7 5.7 17.9 19.7 12.6 30.2 22.3 20.0 20.8 21.4 22.3 20.7 20.5 19.3 19.8 19.9 19.7 19.3 19.8 22.3 32.0 32.1 36.9 27.1 54.5 36.7 68.2 123.2 51.8 31.6 41.3 37.3 70.4 41.5 70.7 27.6 22.9 125.6 55.9 35.8 72.4 75.6 106.3 38.4 37.0 37.1 27.1 65.8 36.8 73.2 61.3 42.5 35.7 35.0 60.2 49.9 31.1 53.7 54.6 23.5 33.9 48.1 75.3 49.4 30.7 24.0 51.9 42.4 26.6 18.7 92.5 35.8 58.7 35.7 44.4 59.7 45.4 49.7 56.1 35.2 60.4 127.5 58.2 37.9 65.7 48.6 73.5 125.4 56.4 47.1 37.5 124.9 55.9 63.3 59.1 62.2 DNAJC2 "MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin" ENSG00000105821 "DnaJ heat shock protein family (Hsp40) member C2" Q99543 7 103312289-103344830 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chaperone, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 248.5;Spermatocytes: 238.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 61.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020454 Approved Supported Cytosol NA Yes Cytosol "HPA020454: AB_1859492" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (7.71e-2)" "unprognostic (2.13e-3)" "unprognostic (2.13e-3)" "unprognostic (1.63e-2)" "unprognostic (5.35e-2)" "unprognostic (2.21e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.30e-1)" "unprognostic (3.51e-1)" "unprognostic (3.28e-1)" 14.7 13.5 10.4 12.3 10.9 42.4 13.5 12.6 19.3 12.9 10.6 11.9 14.8 12.9 9.7 13.9 12.2 9.9 13.3 10.6 10.5 11.8 15.8 11.3 17.0 10.4 10.3 10.6 15.8 13.5 9.0 12.7 12.0 10.9 12.4 12.0 8.7 12.7 7.8 32.8 13.5 12.0 7.5 10.3 12.3 13.0 31.6 11.1 12.5 12.8 12.8 13.4 18.9 13.0 12.0 52.7 38.1 21.4 38.7 16.1 22.6 41.6 35.1 25.8 38.5 28.6 52.9 37.2 74.9 53.7 24.4 55.2 35.5 57.5 25.7 58.4 40.6 43.4 55.1 38.7 47.3 28.6 97.9 41.2 19.6 21.9 44.9 39.4 16.2 25.6 27.8 128.3 46.2 32.0 83.8 95.0 102.1 75.9 56.8 57.0 59.7 43.0 70.1 22.8 24.8 40.6 38.7 47.7 66.2 39.7 39.6 28.1 49.8 30.8 37.5 59.9 83.3 68.1 48.9 67.8 146.0 27.3 97.9 47.6 61.3 9.0 9.3 10.9 10.3 12.1 11.7 10.9 11.7 9.4 13.7 12.5 12.5 3.6 16.4 15.3 11.2 12.8 5.9 10.4 10.9 12.6 19.3 10.6 10.5 10.4 10.3 10.6 10.9 10.3 11.1 12.0 31.3 25.6 47.0 10.7 46.1 64.6 78.7 37.3 35.3 27.1 26.3 36.6 32.3 22.8 50.2 22.0 41.7 43.7 45.9 31.1 35.2 45.0 248.5 43.8 50.1 39.6 35.3 29.9 24.7 46.0 75.5 41.0 42.8 44.2 53.7 50.1 18.5 30.6 39.6 21.9 17.9 39.0 26.4 24.5 41.3 37.3 39.4 37.8 19.6 13.1 42.9 19.3 44.3 24.1 20.6 50.2 32.9 31.2 36.9 79.2 36.4 31.0 43.4 29.0 39.5 63.7 64.8 238.7 131.9 33.5 62.1 55.4 43.2 58.3 51.9 91.5 TFPI2 "PP5, REF1, TFPI-2" ENSG00000105825 "Tissue factor pathway inhibitor 2" P48307 7 93885396-93890753 "Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "placenta: 963.1" "Cell type enhanced" "Detected in many" "Ductal cells: 1476.3;Glandular and luminal cells: 575.6;Prostatic glandular cells: 412.6;Syncytiotrophoblasts: 2184.1" "Cancer enhanced" "Detected in all" "renal cancer: 65.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 3001.0;hTEC/SVTERT24-B: 1373.4;U-138 MG: 1245.9;U-2197: 1050.8;U-87 MG: 2051.0" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 29.7" "CAB010142, HPA049158, HPA070525" Enhanced "Secreted to extracellular matrix" NA NA 51000 "CAB010142: AB_628166, HPA049158: AB_2680659, HPA070525: " "prognostic favorable (8.33e-7)" "unprognostic (2.20e-2)" "unprognostic (2.10e-2)" "prognostic favorable (5.42e-4)" "unprognostic (5.19e-3)" "unprognostic (3.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-2)" "unprognostic (6.86e-2)" "unprognostic (7.54e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (3.38e-3)" "unprognostic (3.65e-2)" "unprognostic (1.97e-1)" "unprognostic (7.91e-2)" 34.3 28.6 0.7 36.8 2.1 0.3 30.4 0.4 1.3 2.7 1.2 3.5 1.3 32.4 5.6 2.3 19.2 15.7 5.9 0.5 3.7 13.5 21.4 11.4 3.0 3.3 0.5 0.4 47.1 77.2 0.1 9.7 963.1 0.5 7.2 2.0 52.1 4.0 5.6 2.6 1.1 1.4 9.6 0.5 4.1 5.1 0.7 1.1 6.9 0.8 1.4 1.2 26.9 1.1 0.8 1.4 179.6 42.0 1.9 99.8 15.4 0.5 178.3 33.5 20.6 15.0 0.3 1.6 0.0 3001.0 47.0 43.9 18.6 1.1 216.1 24.6 2.8 1.3 0.1 10.2 0.7 545.7 0.0 0.9 9.1 10.7 1373.4 90.1 200.0 449.0 0.0 0.4 2.2 210.1 0.3 0.4 0.7 10.8 0.0 45.7 0.5 0.0 0.2 52.1 5.4 1.6 110.2 0.0 12.7 1.2 29.9 1.5 2.9 680.3 1245.9 13.2 1050.8 1.8 0.1 4.4 14.6 2051.0 0.3 140.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 2.1 0.4 1.3 0.5 3.7 3.3 0.5 0.4 0.5 0.5 1.1 0.8 141.3 3.2 3.9 0.0 1.2 0.6 311.3 77.9 0.6 17.5 37.2 7.9 0.5 21.5 122.9 318.2 39.6 16.1 0.6 0.0 0.0 1476.3 0.0 280.3 38.3 122.3 0.0 2.7 0.0 41.9 214.2 137.2 0.0 575.6 0.0 0.1 108.1 1.4 16.2 3.3 0.0 0.5 12.2 4.1 4.0 0.1 1.5 5.2 3.6 2.8 17.1 22.4 0.0 0.0 0.0 39.4 0.0 0.0 0.2 412.6 0.0 1.7 27.4 161.3 0.0 7.0 35.5 0.4 3.6 1.1 1.4 2184.1 4.9 0.7 0.0 35.0 BET1 hbet1 ENSG00000105829 "Bet1 golgi vesicular membrane trafficking protein" O15155 7 93962762-94004382 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 171.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.85e-3)" "unprognostic (1.58e-2)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.60e-2)" "unprognostic (4.19e-2)" "unprognostic (1.51e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (3.36e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.10e-2)" "unprognostic (2.16e-1)" "unprognostic (2.69e-1)" "unprognostic (7.24e-3)" 18.3 28.4 12.2 16.4 12.6 4.9 23.5 12.7 15.8 23.1 15.6 16.0 22.1 18.8 34.6 12.3 18.6 13.5 14.3 11.9 13.6 24.6 32.1 14.1 24.5 13.0 13.3 11.3 24.5 22.9 19.6 18.1 36.8 12.8 21.0 17.1 13.5 26.4 21.3 9.8 13.9 23.6 15.4 12.8 16.8 20.2 14.0 13.2 19.8 22.4 10.5 21.2 17.7 11.6 15.1 26.1 22.2 34.3 31.6 58.6 66.1 23.7 42.6 55.1 35.8 47.0 12.1 28.7 42.5 82.4 23.5 69.8 13.8 18.9 31.7 60.9 25.2 26.4 16.5 21.1 30.2 61.4 30.7 16.9 27.9 56.7 32.6 88.9 52.7 50.5 31.3 37.2 57.4 48.7 22.6 41.1 43.3 34.0 38.2 33.6 26.6 22.5 58.2 74.2 16.0 15.5 28.0 32.2 45.0 85.7 46.3 28.4 30.7 35.3 46.8 24.4 96.4 29.0 37.9 50.3 59.0 67.3 41.2 35.6 62.8 18.0 19.9 20.2 19.0 25.7 40.7 22.8 20.8 17.1 37.4 26.5 22.3 5.5 24.4 22.8 40.3 20.9 19.5 12.2 12.6 12.7 15.8 11.9 13.6 13.0 13.3 11.3 12.8 12.8 13.2 15.1 26.3 12.8 21.4 14.4 39.3 19.5 25.2 69.2 15.9 10.4 34.6 29.8 11.1 27.1 40.2 42.3 4.2 64.7 27.6 16.2 101.8 52.6 19.1 24.8 24.8 33.3 15.6 26.1 17.1 34.7 171.5 34.9 15.3 32.6 11.4 21.2 35.0 53.5 35.6 10.1 21.1 28.7 69.2 23.1 21.1 9.3 36.4 34.6 26.6 15.0 53.7 19.7 23.7 16.6 25.3 35.5 26.6 22.2 49.7 52.6 45.7 90.9 47.8 10.7 26.3 15.5 33.5 72.7 41.1 22.7 25.4 128.3 21.7 31.8 20.7 40.7 NAMPT "PBEF, PBEF1" ENSG00000105835 "Nicotinamide phosphoribosyltransferase" P43490 7 106248298-106285966 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Biological rhythms, Pyridine nucleotide biosynthesis" "Cytokine, Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 580.0;Langerhans cells: 1123.7;Macrophages: 947.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 279.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 279.2" "Cell line enhanced" "Detected in all" "HHSteC: 387.5;U-87 MG: 434.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034349, HPA047776, HPA057722" Approved Approved "Nuclear speckles,Cell Junctions" "Secreted to blood" NA NA 2140000 1400000 "Nuclear speckles" "Cell Junctions" "CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: " "unprognostic (2.87e-1)" "prognostic unfavorable (4.78e-4)" "unprognostic (5.90e-3)" "unprognostic (1.63e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (8.81e-4)" "unprognostic (2.15e-1)" "unprognostic (2.74e-2)" "unprognostic (2.74e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (3.02e-1)" "prognostic unfavorable (2.49e-6)" "unprognostic (6.83e-2)" "unprognostic (6.96e-2)" "unprognostic (7.76e-2)" "unprognostic (6.44e-3)" 214.2 74.9 15.0 363.6 17.0 315.4 104.2 15.9 32.4 42.2 23.9 60.9 38.9 38.9 7.0 230.3 108.6 114.7 98.0 15.4 114.8 43.9 320.5 220.4 23.4 75.8 21.5 13.6 58.9 81.6 26.1 30.4 88.0 28.5 70.7 30.6 17.3 127.1 13.5 137.0 54.1 56.4 48.4 23.3 88.9 103.3 11.8 38.5 15.8 42.5 44.8 40.2 286.0 87.4 32.6 103.6 41.0 14.6 16.8 85.8 95.0 34.4 26.1 194.7 57.0 90.6 25.7 38.7 77.7 78.8 32.1 131.5 58.2 38.8 88.1 93.8 50.5 51.7 35.8 17.2 22.6 387.5 61.3 49.4 94.8 94.2 114.9 115.0 70.6 187.3 32.0 70.5 225.6 68.1 49.4 58.1 19.4 36.6 33.6 59.7 25.8 30.4 147.6 46.2 60.8 33.4 19.3 46.0 61.1 107.9 43.0 25.4 9.4 168.2 75.6 52.9 105.9 51.9 212.1 142.7 115.7 434.3 69.3 105.6 39.6 6.5 16.0 1.8 21.8 2.4 3.9 2.2 2.7 7.0 3.4 2.8 2.2 279.2 4.4 30.5 5.5 7.1 4.8 15.0 17.0 15.9 32.4 15.4 114.8 75.8 21.5 13.6 28.5 23.3 38.5 32.6 323.8 131.4 245.7 12.1 78.0 207.6 321.0 105.7 169.0 23.8 184.2 132.0 94.8 197.3 161.4 42.3 12.5 26.2 67.5 105.8 46.9 320.6 12.2 128.0 160.8 192.8 25.1 29.5 25.3 141.3 58.9 239.6 132.0 296.5 188.4 18.8 159.5 580.0 107.0 40.4 28.8 51.9 63.1 390.3 1123.7 6.9 40.4 947.3 161.9 46.9 102.7 22.6 9.2 12.1 22.4 138.1 49.7 31.2 93.7 364.0 112.8 50.7 94.1 30.8 26.3 264.6 185.6 30.5 65.8 98.3 207.8 25.3 110.3 38.4 79.4 334.5 POLR1F "A43, RPA43, TWISTNB" ENSG00000105849 "RNA polymerase I subunit F" Q3B726 7 19695461-19709037 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 21.6;Cardiomyocytes: 23.1;Cytotrophoblasts: 40.3;dendritic cells: 24.9;Extravillous trophoblasts: 34.1;Hofbauer cells: 34.7;Macrophages: 16.7;Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019071, HPA022416" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA019071: AB_1858465, HPA022416: AB_1858466" "unprognostic (5.66e-3)" "unprognostic (3.43e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.98e-3)" "unprognostic (1.85e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.16e-1)" "unprognostic (5.87e-2)" "unprognostic (2.03e-1)" "unprognostic (5.02e-2)" "unprognostic (4.93e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (9.06e-2)" "unprognostic (4.95e-3)" "unprognostic (2.96e-1)" 8.7 8.0 6.1 8.0 6.6 17.4 10.3 6.4 9.2 9.0 6.0 7.4 5.6 12.0 5.1 9.6 6.7 6.3 7.9 6.6 6.9 8.1 8.8 6.3 10.6 6.6 6.6 6.1 8.9 7.5 9.1 2.7 10.9 6.5 9.8 7.1 3.2 6.1 8.9 7.1 7.7 5.3 11.9 6.7 7.9 5.9 6.2 6.9 8.6 8.8 8.4 13.0 12.3 4.6 7.9 28.0 20.9 15.1 22.6 17.1 21.1 11.7 15.7 11.8 17.9 20.7 17.2 23.9 31.0 44.6 19.6 22.7 24.6 30.9 29.2 33.3 9.9 23.7 28.8 15.9 13.3 26.2 59.4 20.0 19.2 20.3 19.7 23.4 12.1 29.7 21.3 45.0 27.2 26.1 10.1 32.9 55.3 39.3 28.9 23.4 26.3 26.0 32.6 29.7 14.2 10.9 16.4 14.3 38.3 20.0 24.6 15.5 52.5 25.0 37.0 19.8 34.5 38.4 34.4 22.8 77.5 25.0 86.9 55.5 5.7 4.5 1.4 7.9 6.0 12.0 12.5 9.4 10.5 7.0 13.0 10.7 12.6 0.4 17.4 5.9 9.0 9.3 5.8 6.1 6.6 6.4 9.2 6.6 6.9 6.6 6.6 6.1 6.5 6.7 6.9 7.9 21.6 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 40.3 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 34.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 16.6 3.0 0.0 0.0 0.0 PIK3CG ENSG00000105851 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma" P48736 7 106865278-106908980 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 44.0;lymphoid tissue: 19.8" "Cell type enhanced" "Detected in some" "B-cells: 24.9;dendritic cells: 26.5;Early spermatids: 28.9;granulocytes: 20.8;monocytes: 23.8;NK-cells: 25.7;Plasma cells: 88.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 29.4;HL-60: 28.8;HMC-1: 34.9;Karpas-707: 29.1;MOLT-4: 56.0;U-266/70: 71.4;U-937: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069976 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA069976: AB_2686224" "unprognostic (8.34e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.71e-2)" "unprognostic (3.20e-2)" "unprognostic (3.82e-3)" "unprognostic (3.02e-1)" "unprognostic (6.77e-2)" "unprognostic (1.16e-1)" "unprognostic (7.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (9.08e-2)" "unprognostic (1.23e-1)" "unprognostic (5.38e-1)" "unprognostic (5.24e-2)" 3.1 1.9 0.4 11.6 0.9 44.0 1.9 0.9 1.2 1.9 1.7 4.2 4.1 1.3 0.5 1.7 1.4 3.2 1.6 0.5 1.8 1.0 2.0 4.9 19.1 2.6 0.9 0.3 1.6 0.3 0.7 0.2 2.9 2.5 1.0 3.8 0.1 1.3 0.9 0.3 0.8 4.3 2.8 2.4 11.1 4.0 5.2 1.9 16.6 1.1 1.0 19.8 4.4 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 2.7 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 17.9 0.0 0.0 0.0 28.8 34.9 0.0 0.0 0.0 0.0 0.0 11.0 16.9 20.6 29.1 0.0 0.0 56.0 17.6 0.0 0.0 0.0 14.6 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.6 2.9 0.1 0.2 0.1 0.0 71.4 0.0 27.3 0.1 52.1 6.7 10.8 6.0 24.3 8.8 17.8 8.1 7.3 4.1 6.7 9.4 10.2 4.2 5.9 22.7 9.8 43.7 8.6 4.4 6.8 0.4 0.9 0.9 1.2 0.5 1.8 2.6 0.9 0.3 2.5 2.4 1.9 2.7 1.5 0.0 1.8 0.3 24.9 0.8 0.0 0.0 0.6 0.0 0.1 0.1 0.5 0.0 0.6 0.0 0.0 0.0 26.5 0.2 0.0 0.0 28.9 0.1 0.2 1.7 0.0 7.8 5.5 0.0 0.0 0.1 3.6 0.1 20.8 0.4 2.5 0.5 6.8 0.0 0.3 0.0 0.0 11.9 8.3 18.8 0.6 18.9 7.2 15.0 23.8 0.0 25.7 0.0 0.2 0.0 0.0 0.0 88.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 6.6 3.7 0.2 0.3 0.1 18.1 0.6 0.6 0.1 PON3 ENSG00000105852 "Paraoxonase 3" Q15166 7 95359872-95396375 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 621.9" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 509.6" "Group enriched" "Detected in many" 9 "liver cancer: 30.8;lung cancer: 7.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA014848, CAB025250" Enhanced "Secreted to blood" NA NA 1760000000 380000000 "CAB025250: , HPA014848: AB_1855540" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.28e-3)" "unprognostic (5.52e-3)" "unprognostic (1.36e-1)" "unprognostic (4.87e-1)" "unprognostic (1.44e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (6.44e-3)" "unprognostic (9.14e-2)" "unprognostic (7.18e-3)" "unprognostic (8.30e-9)" "unprognostic (1.66e-1)" "unprognostic (1.04e-2)" "unprognostic (8.29e-2)" "unprognostic (5.12e-2)" 1.0 3.9 1.9 0.5 1.6 0.0 31.5 1.6 1.7 5.3 1.2 2.0 7.9 0.9 3.7 0.5 1.3 4.5 0.8 1.6 1.9 2.7 621.9 14.3 0.1 2.1 2.2 1.4 12.5 14.4 0.2 25.1 0.8 3.1 0.9 2.9 0.1 26.5 4.0 0.3 7.5 3.1 0.2 1.9 0.3 2.3 9.1 1.9 1.6 7.2 0.3 6.0 1.4 0.9 1.7 3.1 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 6.5 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.0 0.1 17.4 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 1.6 1.7 1.6 1.9 2.1 2.2 1.4 3.1 1.9 1.9 1.7 2.5 6.4 45.9 24.5 0.6 0.9 0.9 9.3 1.8 0.0 5.4 4.3 0.5 31.5 23.9 3.7 0.0 1.7 0.3 3.2 1.9 0.3 14.5 0.0 0.4 1.9 0.0 8.0 0.1 2.0 2.2 5.2 0.5 0.0 0.0 0.4 10.0 509.6 0.2 0.0 0.2 1.8 12.2 8.1 0.3 4.8 8.1 0.2 14.2 4.7 0.0 3.2 0.0 17.6 0.1 1.2 1.2 3.0 0.0 2.1 6.0 6.7 6.5 0.1 0.0 0.8 2.1 21.4 16.9 0.3 1.3 1.4 0.8 6.6 2.3 0.4 PON2 ENSG00000105854 "Paraoxonase 2" Q15165 7 95404862-95435329 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 261.2" "Cell type enhanced" "Detected in many" "Astrocytes: 341.5;Extravillous trophoblasts: 300.9;Skeletal myocytes: 284.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 33.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025430, HPA029193" Enhanced "Secreted to blood" NA NA 160000 "CAB025430: , HPA029193: AB_10602148" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-5)" "unprognostic (3.80e-1)" "unprognostic (4.14e-1)" "unprognostic (3.89e-2)" "unprognostic (3.77e-3)" "unprognostic (1.19e-3)" "unprognostic (9.87e-3)" "unprognostic (9.54e-2)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.30e-8)" "unprognostic (1.40e-1)" "unprognostic (6.43e-2)" "unprognostic (7.99e-3)" "unprognostic (2.56e-1)" 51.1 130.9 196.9 22.9 203.4 11.0 63.2 188.4 261.2 43.7 154.3 69.7 82.3 46.3 61.8 28.8 41.7 53.8 40.4 194.5 204.8 48.8 185.2 106.3 14.4 193.4 193.5 181.5 31.9 27.1 28.6 50.2 99.1 201.7 39.9 86.8 30.4 30.1 46.1 15.5 57.0 51.4 52.0 182.4 22.4 27.8 28.5 194.3 14.1 38.1 17.7 33.3 38.0 30.5 208.6 51.1 313.4 250.6 137.2 34.2 74.5 69.6 101.5 118.7 77.3 83.7 72.1 113.8 0.0 138.4 100.9 148.2 33.3 46.2 78.3 87.4 0.8 59.8 25.9 186.3 238.1 53.9 0.1 34.1 108.6 88.7 41.7 56.5 157.8 162.7 0.0 16.9 1.0 231.1 46.6 0.1 29.2 49.2 135.4 71.4 0.0 117.5 12.5 239.4 39.4 17.2 53.5 144.7 159.8 102.9 142.7 47.3 17.0 178.3 115.7 83.7 39.6 100.2 26.2 32.5 0.4 108.1 23.9 154.3 0.0 7.8 0.8 5.0 4.3 4.5 1.6 1.9 4.5 33.8 0.5 2.5 3.5 0.0 8.9 2.3 8.1 1.1 4.4 196.9 203.4 188.4 261.2 194.5 204.8 193.4 193.5 181.5 201.7 182.4 194.3 208.6 65.7 128.2 104.3 341.5 4.6 16.8 42.8 201.4 25.6 5.6 51.0 37.6 39.4 67.2 178.5 84.6 0.0 75.6 13.9 121.4 9.8 149.9 5.5 29.9 32.0 86.5 12.6 26.1 0.7 50.6 300.9 36.3 20.4 57.0 14.5 55.2 44.3 151.7 40.5 38.7 1.8 36.3 173.0 20.8 63.7 2.6 16.1 27.4 112.1 72.1 17.4 185.0 10.3 126.2 149.2 75.7 102.2 21.8 4.9 25.7 85.7 55.8 64.6 8.2 19.7 284.5 49.2 2.6 7.5 25.4 16.1 50.3 8.1 44.5 81.0 23.4 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 133 "basophil: 16.5" "Lineage enriched" "Detected in single" 133 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 2.5 2.6 28.4 4.2 39.1 0.3 9.7 59.3 20.1 15.5 35.5 3.1 3.2 7.7 14.1 6.4 7.6 8.8 2.0 22.0 66.0 21.8 0.8 2.4 0.5 41.6 41.6 16.3 4.7 13.4 5.2 5.4 5.2 44.9 6.8 2.9 4.7 13.7 9.1 0.2 6.4 4.3 3.1 40.1 0.0 4.3 6.6 36.3 0.8 2.1 0.9 7.0 7.2 9.0 52.5 28.2 1.1 44.3 5.6 3.7 15.2 0.0 0.1 0.5 0.2 1.5 0.3 6.9 0.0 54.6 2.0 1.7 30.1 1.9 4.5 0.5 0.0 0.7 0.0 23.1 0.0 1.8 0.0 0.1 1.8 12.6 0.5 2.4 27.1 2.4 0.0 0.0 8.3 0.8 0.1 0.0 0.0 3.3 0.4 4.8 0.0 3.7 0.0 88.1 2.5 0.7 1.9 8.6 0.2 23.5 0.8 0.7 0.1 3.0 11.2 7.1 3.2 5.8 10.2 0.1 0.0 2.7 0.0 127.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 28.4 39.1 59.3 20.1 22.0 66.0 41.6 41.6 16.3 44.9 40.1 36.3 52.5 0.7 12.8 4.8 106.4 2.5 33.1 117.2 39.4 34.7 13.3 26.3 18.7 3.0 38.6 57.9 38.6 0.0 20.0 0.4 5.0 7.9 26.3 3.0 376.2 150.6 5.2 34.0 0.0 28.1 17.4 1.2 15.5 7.7 551.9 1.3 0.9 1.4 0.2 3.3 1.7 8.2 7.4 34.6 1.0 4.7 6.5 44.1 9.8 3.6 4.7 31.6 24.3 0.0 192.0 119.2 35.8 6.1 44.8 2.0 149.7 14.5 76.7 100.1 1.4 0.0 4.8 7.0 1.4 1.1 34.6 12.4 4.9 5.5 1.9 9.6 150.7 HBP1 ENSG00000105856 "HMG-box transcription factor 1" O60381 7 107168961-107202522 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 332.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020225, CAB032824" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB032824: AB_2114615, HPA020225: " "unprognostic (9.00e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.43e-1)" "unprognostic (4.79e-2)" "unprognostic (7.49e-3)" "unprognostic (1.99e-1)" "unprognostic (2.25e-2)" "unprognostic (3.47e-2)" "unprognostic (2.07e-2)" "unprognostic (2.99e-3)" "unprognostic (1.50e-1)" "prognostic favorable (7.70e-5)" "unprognostic (7.39e-2)" "unprognostic (2.31e-1)" "unprognostic (7.69e-2)" "unprognostic (5.26e-2)" 52.1 50.2 13.5 15.1 18.5 49.5 52.8 18.0 15.8 48.9 17.0 40.5 16.4 53.5 20.1 54.9 40.3 20.0 40.0 13.4 15.1 26.9 38.2 40.5 17.4 18.9 17.0 13.0 51.6 35.2 29.2 24.3 24.8 18.8 35.7 18.0 16.6 47.0 22.7 87.1 68.7 35.2 22.3 17.0 34.2 38.3 57.5 15.6 23.8 37.1 40.0 20.1 43.8 51.9 26.4 9.0 10.1 18.8 12.2 38.7 36.1 8.8 15.6 35.1 11.2 19.6 3.6 23.5 8.7 20.4 21.8 23.3 11.4 7.7 9.7 13.9 6.5 7.0 6.0 16.7 6.9 22.1 4.3 17.3 42.3 28.3 10.9 13.3 37.7 37.0 8.8 11.3 21.2 14.5 14.8 7.3 13.6 11.8 12.8 11.5 6.9 13.8 22.4 19.9 11.1 7.3 22.0 18.4 26.7 25.9 25.9 8.3 13.2 35.8 14.7 11.4 22.7 4.7 24.6 31.9 9.0 14.4 9.2 15.3 142.1 59.5 80.0 37.5 61.7 35.8 35.6 39.5 36.5 40.3 34.6 45.2 38.5 146.2 53.8 64.1 20.5 55.6 91.8 13.5 18.5 18.0 15.8 13.4 15.1 18.9 17.0 13.0 18.8 17.0 15.6 26.4 67.9 22.4 39.7 37.2 72.9 108.2 77.6 56.2 91.6 29.7 83.1 54.7 22.1 31.5 51.6 33.1 8.4 46.1 95.5 56.1 45.0 50.5 175.9 56.8 45.8 51.8 54.2 59.5 32.6 32.3 26.1 76.8 50.4 93.3 50.7 25.7 35.3 36.8 28.9 42.1 35.2 41.3 85.5 49.8 81.8 332.7 54.0 67.8 74.7 49.6 46.3 33.4 37.0 40.2 91.4 33.7 46.6 57.9 70.2 82.8 55.1 45.3 37.6 29.2 46.0 91.4 70.0 53.0 38.0 55.3 133.0 210.4 94.8 42.6 28.1 89.9 DUS4L "DUS4, PP35" ENSG00000105865 "Dihydrouridine synthase 4 like" O95620 7 107563484-107578523 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044301 Approved Approved Cytosol NA NA Cytosol "HPA044301: AB_10967460" "unprognostic (7.95e-2)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (5.66e-2)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-3)" "unprognostic (2.29e-2)" "unprognostic (9.21e-3)" "unprognostic (7.74e-3)" "unprognostic (6.72e-3)" 1.4 1.9 1.2 0.5 1.3 0.4 1.5 1.3 1.6 1.6 1.1 1.4 0.7 1.5 1.7 1.7 1.3 0.6 2.4 1.2 1.3 2.5 2.0 1.0 0.8 1.3 1.4 1.2 1.8 1.7 1.2 1.5 0.6 1.3 1.5 0.8 1.0 1.6 0.5 1.7 1.5 1.3 0.5 1.3 1.3 1.6 2.3 1.3 0.7 1.6 1.1 0.8 1.8 1.5 1.5 4.1 1.6 1.6 1.0 0.5 1.0 2.3 0.9 1.4 1.7 1.5 2.1 3.6 4.6 2.1 0.6 4.6 1.2 1.7 2.4 2.3 1.2 1.3 1.2 0.9 2.6 1.6 3.0 0.2 1.2 3.5 1.6 5.7 1.8 2.4 3.9 5.4 1.7 2.7 3.0 4.3 5.8 2.8 3.3 3.4 2.3 1.7 5.3 3.2 2.1 1.6 4.4 1.9 4.2 3.6 2.3 1.9 2.6 1.7 2.5 2.0 1.8 2.6 3.0 3.8 4.9 2.3 4.3 2.9 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.2 0.1 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 1.2 1.3 1.3 1.6 1.2 1.3 1.3 1.4 1.2 1.3 1.3 1.3 1.5 4.5 6.4 3.9 4.6 7.6 5.1 11.0 5.6 10.2 10.0 8.6 10.2 9.2 5.7 6.6 11.0 4.2 9.1 4.5 3.3 7.9 13.3 32.8 11.3 7.2 4.6 9.6 5.0 3.5 16.2 8.8 4.6 5.1 11.0 13.4 10.2 4.2 9.3 6.7 3.3 5.1 5.0 10.2 5.0 3.7 24.9 4.4 5.6 3.6 5.6 5.2 15.4 11.3 4.5 9.7 15.7 6.8 3.8 5.6 8.1 7.7 17.3 15.3 9.8 13.1 3.4 5.7 12.4 11.0 11.2 4.0 3.7 6.7 7.6 6.3 6.9 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428043-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: AB_2676959" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 1.8 2.6 2.2 4.5 3.0 6.9 3.6 10.1 2.5 3.8 1.3 2.0 1.8 5.6 3.1 2.2 4.3 2.5 3.8 1.9 2.2 2.9 2.1 3.6 6.5 2.7 2.1 1.7 11.4 2.3 7.2 2.5 2.0 4.0 4.1 2.4 9.0 2.2 2.7 3.7 1.9 2.4 2.9 1.9 5.9 2.9 3.8 2.6 13.6 7.9 7.7 6.9 2.9 1.7 4.5 3.6 2.2 6.7 10.6 2.1 1.4 2.0 3.4 2.2 3.6 4.7 5.5 3.5 14.1 2.3 2.0 9.6 4.2 10.0 2.9 6.9 4.6 4.5 6.5 4.6 2.1 1.5 5.4 7.7 1.4 2.4 3.8 4.3 1.8 7.1 9.6 9.5 9.2 2.9 1.3 13.8 3.7 17.5 6.4 2.7 33.1 11.6 4.6 1.2 2.2 8.8 11.0 7.1 3.0 2.5 6.6 3.6 4.0 3.2 5.7 8.3 3.5 6.5 14.0 15.0 21.0 3.4 8.7 8.1 5.7 0.8 8.9 6.9 1.0 8.2 3.7 6.4 6.6 1.0 5.9 8.2 6.9 2.1 3.9 2.1 1.8 8.4 3.8 2.2 3.0 10.1 2.5 1.9 2.2 2.7 2.1 1.7 4.0 1.9 2.6 4.5 11.0 3.2 9.0 19.6 21.8 12.6 11.6 2.5 14.2 17.5 10.0 7.5 9.7 8.6 5.7 0.0 8.4 0.9 13.1 1.6 0.0 2.2 7.0 5.4 7.0 7.8 10.7 21.9 31.0 2.2 1.3 6.3 5.6 7.9 5.1 10.8 10.8 4.6 1.8 18.5 31.3 2.2 2.0 6.0 6.4 4.8 5.6 6.0 7.2 27.2 4.5 10.3 18.6 50.3 60.2 1.7 12.3 6.8 7.1 7.7 1.2 2.0 1.6 21.0 0.0 17.3 6.9 7.3 8.4 4.8 11.1 1.5 22.2 2.8 3.1 5.3 WDR91 "HSPC049, SORF-1" ENSG00000105875 "WD repeat domain 91" A4D1P6 7 135183839-135211534 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 32.2;THP-1: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024260 Uncertain NA NA "HPA024260: AB_1844392" "unprognostic (5.37e-3)" "unprognostic (7.27e-2)" "unprognostic (1.87e-3)" "unprognostic (1.12e-2)" "unprognostic (2.01e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.96e-3)" "unprognostic (1.53e-3)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" 5.7 5.1 7.6 3.8 8.3 6.1 6.4 7.8 8.6 7.6 16.2 4.1 2.1 5.2 6.8 10.3 9.1 3.2 3.6 9.0 7.1 19.4 7.1 9.8 5.5 7.8 7.5 6.9 12.6 18.8 3.5 5.8 7.7 8.4 6.0 2.3 2.6 6.3 6.9 4.7 6.6 5.1 3.3 7.2 8.7 7.7 6.2 7.5 5.2 3.8 2.8 5.3 5.5 7.1 7.7 3.0 1.2 2.8 7.9 5.0 3.8 3.6 3.4 4.0 3.0 3.7 1.3 1.1 2.0 5.1 2.5 4.1 2.3 4.6 11.8 3.4 10.3 3.8 1.9 3.4 4.9 7.3 3.4 1.6 5.3 6.4 2.7 2.3 2.6 4.0 4.9 7.9 3.1 3.0 2.2 6.5 9.1 4.1 2.5 3.1 8.3 4.3 4.8 32.2 1.8 1.7 3.3 4.3 4.0 10.0 2.8 2.2 23.3 1.4 6.8 1.6 4.8 3.2 6.7 2.8 6.3 6.2 6.6 4.9 0.4 3.7 3.4 1.4 1.3 1.5 1.8 1.7 0.9 2.1 1.6 2.6 1.6 2.1 2.5 1.2 0.9 2.4 1.8 7.6 8.3 7.8 8.6 9.0 7.1 7.8 7.5 6.9 8.4 7.2 7.5 7.7 4.5 6.4 9.3 14.7 7.1 4.2 3.8 11.8 16.5 6.8 4.8 6.1 2.9 8.6 8.8 7.3 6.2 23.2 6.5 1.1 19.6 9.1 33.4 18.7 6.3 5.2 1.2 4.4 11.4 7.1 5.0 5.0 5.6 25.3 16.5 8.6 6.4 7.7 36.4 3.3 12.5 1.8 2.0 11.6 12.3 54.2 5.9 9.9 3.6 7.5 6.8 3.4 0.0 7.1 10.2 3.9 4.8 15.4 5.0 2.4 1.5 18.5 6.8 3.4 13.1 5.6 5.7 9.1 8.6 7.1 4.0 29.0 5.0 7.6 1.2 1.4 DNAH11 "CILD7, DNAHBL, Dnahc11, DNHBL, DPL11" ENSG00000105877 "Dynein axonemal heavy chain 11" Q96DT5 7 21543039-21901839 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "choroid plexus: 29.8;parathyroid gland: 71.9" "Group enriched" "Detected in many" 10 "Endometrial ciliated cells: 136.7;Oligodendrocyte precursor cells: 57.3;Respiratory ciliated cells: 128.8" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.9;U-2 OS: 1.0;U-2197: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 6.7" "HPA045880, HPA056474" Approved NA NA "HPA045880: AB_10962003, HPA056474: AB_2683145" "unprognostic (2.24e-2)" "unprognostic (2.28e-1)" "unprognostic (1.01e-2)" "unprognostic (5.17e-3)" "unprognostic (4.15e-2)" "unprognostic (1.51e-1)" "unprognostic (9.01e-2)" "unprognostic (6.32e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.79e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (4.79e-3)" 0.1 1.8 6.0 0.0 1.6 0.0 0.0 1.8 1.1 0.3 29.8 0.1 0.0 0.3 0.3 0.6 5.3 0.1 0.2 2.3 3.7 0.1 0.3 1.2 0.0 7.6 5.5 0.1 0.3 0.1 71.9 0.1 0.3 4.1 0.4 0.0 0.0 0.1 0.1 0.3 0.7 0.3 0.0 9.1 0.0 0.1 0.5 2.5 0.3 1.0 0.0 0.0 0.0 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.3 0.5 0.0 0.7 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.3 1.0 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.6 1.8 1.1 2.3 3.7 7.6 5.5 0.1 4.1 9.1 2.5 3.4 0.2 6.4 3.9 4.6 0.4 2.4 4.2 6.4 1.2 0.2 0.7 0.3 3.6 5.7 10.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 3.8 136.7 1.0 0.8 0.0 0.4 3.0 0.0 2.1 0.7 0.0 3.9 0.0 0.1 0.0 0.3 0.1 6.7 3.5 0.0 4.1 0.3 1.1 2.3 0.3 0.6 1.8 3.7 0.6 0.0 1.0 57.3 7.3 0.1 0.0 0.4 0.0 8.3 0.0 0.1 128.8 0.1 0.0 3.8 1.9 0.7 1.9 0.3 0.3 1.6 0.3 0.1 0.1 1.5 CBLL1 "FLJ23109, HAKAI, RNF188" ENSG00000105879 "Cbl proto-oncogene like 1" Q75N03 7 107743949-107761667 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021773, HPA026699" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA021773: AB_1846103, HPA026699: AB_1846104" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (8.57e-2)" "unprognostic (3.79e-2)" "unprognostic (8.16e-2)" "unprognostic (7.20e-2)" "unprognostic (1.37e-2)" "unprognostic (3.96e-3)" "unprognostic (4.28e-2)" "unprognostic (2.16e-3)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-3)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (8.71e-2)" 11.3 8.2 3.8 12.7 5.9 40.3 15.3 8.2 9.6 12.1 3.6 10.7 9.6 13.7 8.5 11.4 11.3 8.8 10.4 4.9 4.1 10.1 11.3 10.4 16.2 4.9 4.6 3.7 14.4 11.8 14.2 5.1 12.1 5.1 16.6 11.2 14.5 9.0 12.8 29.3 10.4 10.4 13.5 3.3 14.4 9.3 19.9 4.3 20.4 13.9 21.2 17.9 12.0 7.2 7.1 27.8 31.1 23.7 30.7 21.7 18.6 16.2 20.5 21.6 22.8 22.5 21.4 27.9 40.6 28.5 23.5 37.6 19.3 33.4 25.0 31.0 28.4 21.1 32.5 23.0 18.2 24.9 49.1 30.9 19.6 22.7 30.7 33.0 17.6 23.8 27.8 53.0 33.3 22.4 48.0 66.5 34.4 34.4 23.3 21.3 30.6 25.4 42.0 17.4 25.5 25.4 39.6 30.7 44.9 23.4 27.7 15.1 24.7 23.4 35.0 25.0 33.4 32.0 53.0 62.3 64.1 21.3 29.8 30.3 88.8 31.1 53.3 39.5 32.0 58.2 39.0 61.9 45.8 36.9 39.8 41.8 40.0 48.9 55.1 38.0 20.1 92.6 48.4 3.8 5.9 8.2 9.6 4.9 4.1 4.9 4.6 3.7 5.1 3.3 4.3 7.1 18.2 19.2 11.0 6.5 29.6 23.6 16.7 10.5 27.3 12.2 15.9 13.7 16.4 17.2 10.7 3.7 4.2 10.3 27.6 9.9 7.9 9.7 12.4 15.6 19.8 13.5 16.8 39.1 13.9 10.8 9.5 12.6 10.7 13.7 13.3 16.6 12.5 11.0 10.7 10.1 13.1 8.0 8.2 23.3 12.4 5.4 9.3 15.1 19.6 15.9 15.0 7.6 25.7 10.1 20.5 10.1 15.0 11.7 17.3 16.2 8.5 11.2 8.9 14.4 19.7 13.2 14.5 27.2 14.3 19.5 19.9 10.3 27.3 9.5 10.0 18.4 DLX5 ENSG00000105880 "Distal-less homeobox 5" P56178 7 97020396-97024950 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 14.2;placenta: 11.8;skin 1: 20.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 168.9;Endometrial ciliated cells: 217.8;Extravillous trophoblasts: 245.2;Glandular and luminal cells: 191.2;Syncytiotrophoblasts: 314.8" "Cancer enriched" "Detected in many" 11 "endometrial cancer: 81.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 53.7;HAP1: 27.2;SuSa: 13.4" "Group enriched" "Detected in many" 4 "basal ganglia: 13.5;olfactory bulb: 29.8" "Group enriched" "Detected in many" 4 "basal ganglia: 7.5;olfactory bulb: 18.0" HPA005670 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005670: AB_1078681" "unprognostic (3.99e-1)" "unprognostic (1.05e-1)" "unprognostic (2.96e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (5.89e-2)" "unprognostic (6.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-2)" "unprognostic (7.43e-8)" "unprognostic (1.39e-2)" "unprognostic (3.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" 1.1 0.3 2.3 0.2 3.6 0.0 1.0 0.2 3.1 7.6 0.7 0.4 0.3 14.2 1.0 1.9 1.3 0.4 0.5 1.5 3.6 0.2 0.0 0.2 1.7 1.3 0.4 1.9 1.6 0.0 0.2 0.8 11.8 1.3 1.8 0.0 0.0 3.3 2.9 0.3 20.6 0.1 0.9 0.3 0.1 0.1 0.9 1.7 1.9 1.5 0.0 2.2 0.7 3.0 1.3 0.0 0.0 0.0 8.2 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.2 27.2 0.0 0.0 0.0 4.6 0.0 0.6 0.4 0.0 0.0 0.0 0.1 8.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 3.6 1.5 2.1 0.2 0.0 0.0 13.4 0.0 0.0 0.0 1.7 0.3 0.4 0.0 0.0 0.0 0.0 3.2 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.6 0.2 3.1 1.5 3.6 1.3 0.4 1.9 1.3 0.3 1.7 1.3 1.4 0.0 0.0 0.0 0.0 9.8 1.1 1.7 0.6 0.0 0.3 0.6 0.2 0.0 0.1 0.0 0.0 168.9 0.0 0.0 0.0 0.0 0.2 217.8 13.3 2.9 0.0 0.0 0.1 0.0 245.2 1.5 0.0 191.2 0.0 1.6 0.0 0.0 16.9 0.0 12.8 0.0 0.0 0.0 1.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.1 59.2 0.2 8.0 4.2 11.6 7.9 20.6 314.8 1.6 0.1 0.0 1.6 MTPN "GCDP, MYOTROPHIN, V-1" ENSG00000105887 Myotrophin P58546 7 135926760-135977359 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019735 Approved Approved "Plasma membrane,Cytosol" NA NA 14000000 "Plasma membrane, Cytosol" "HPA019735: AB_1858710" "unprognostic (5.97e-2)" "unprognostic (2.53e-2)" "unprognostic (8.52e-2)" "unprognostic (3.62e-3)" "unprognostic (2.20e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.06e-3)" "unprognostic (3.30e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (4.50e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" "unprognostic (2.43e-1)" "unprognostic (9.00e-3)" "unprognostic (4.86e-3)" 69.5 50.0 70.5 65.7 72.8 152.4 51.2 47.6 80.0 67.6 50.8 51.0 40.6 65.8 51.4 126.5 62.7 51.0 77.8 81.5 62.2 59.0 50.2 58.3 90.1 79.0 62.5 69.5 49.6 24.0 76.5 34.2 62.2 56.9 53.4 55.9 40.2 37.1 51.8 48.0 47.2 47.0 66.7 59.8 80.4 41.6 57.1 69.0 73.2 89.0 48.4 108.7 67.8 59.0 57.5 126.0 90.6 111.5 170.4 160.3 187.2 55.8 189.5 208.0 129.3 137.7 104.5 139.4 229.7 132.7 255.6 188.6 78.9 107.1 161.1 246.1 153.1 84.2 152.9 94.6 77.2 127.3 211.5 213.5 136.5 158.5 152.9 147.7 180.1 205.5 163.6 182.3 138.1 253.2 94.3 208.4 163.0 155.9 121.9 118.9 120.0 83.8 187.7 144.5 103.1 140.6 248.3 157.1 105.8 158.4 102.8 75.4 130.7 215.2 193.5 85.0 192.3 189.7 103.8 160.2 325.9 307.5 185.0 420.2 117.4 75.4 85.2 54.7 105.7 46.0 107.9 33.5 41.7 89.3 125.0 21.5 31.7 180.3 46.0 169.4 82.8 32.6 70.5 70.5 72.8 47.6 80.0 81.5 62.2 79.0 62.5 69.5 56.9 59.8 69.0 57.5 110.6 48.1 40.6 0.0 149.8 119.2 58.9 86.8 72.8 0.0 68.6 72.8 82.0 70.1 61.9 69.9 0.0 63.4 131.6 67.1 90.1 69.6 77.8 83.8 153.3 108.5 33.0 91.9 0.0 51.3 73.1 92.4 45.9 131.9 98.6 64.8 87.4 59.2 100.5 0.0 0.0 46.9 46.8 247.5 232.7 28.6 86.3 214.0 101.4 0.0 234.2 0.0 125.7 0.0 0.0 99.9 67.0 123.8 59.2 96.2 52.6 88.3 50.0 0.0 92.1 99.8 79.8 65.8 123.8 143.3 149.0 68.8 86.1 106.5 52.4 106.9 STEAP1B ENSG00000105889 "STEAP family member 1B" Q6NZ63 7 22419444-22727613 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9;choroid plexus: 3.7" "Cell type enriched" "Detected in some" 10 "Oligodendrocytes: 129.9" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 67 "memory B-cell: 8.4;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 84 "B-cells: 8.4" "Group enriched" "Detected in many" 5 "hTEC/SVTERT24-B: 80.7;HUVEC TERT2: 105.0;K-562: 45.4;WM-115: 112.0" NA NA "unprognostic (7.35e-2)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-3)" "unprognostic (3.96e-2)" "unprognostic (2.18e-1)" "unprognostic (2.31e-5)" "unprognostic (2.29e-3)" "unprognostic (4.96e-2)" "unprognostic (7.37e-3)" "unprognostic (7.38e-2)" "unprognostic (1.27e-2)" "unprognostic (2.85e-10)" "unprognostic (1.06e-4)" "unprognostic (3.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-3)" 1.0 0.5 1.2 1.1 3.2 0.1 0.8 1.9 2.7 0.9 3.7 0.6 0.1 0.2 0.4 0.6 0.3 0.7 0.4 1.7 2.2 0.1 0.2 0.4 1.6 3.5 2.7 1.3 0.1 0.3 0.1 0.3 1.2 3.6 0.5 0.5 0.3 0.4 0.6 1.2 0.4 0.3 0.6 1.5 1.8 0.4 2.3 2.1 1.1 0.2 0.6 1.6 0.8 1.7 6.9 13.5 0.1 8.3 0.0 6.3 9.2 0.0 9.7 1.1 0.2 0.3 0.0 0.3 1.7 2.7 16.9 2.8 0.0 12.3 0.1 0.4 0.5 1.1 0.0 0.3 0.0 0.9 0.0 0.1 10.6 0.0 80.7 0.2 9.7 105.0 0.4 45.4 4.5 0.0 0.0 0.1 0.0 16.8 0.0 0.1 1.7 0.0 5.4 0.1 0.0 0.0 0.2 0.3 0.0 6.4 1.0 0.1 0.0 12.3 1.0 0.4 11.5 0.1 1.1 9.8 12.2 17.7 0.0 112.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 3.2 1.9 2.7 1.7 2.2 3.5 2.7 1.3 3.6 1.5 2.1 6.9 2.4 0.0 0.0 1.6 4.6 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.1 0.4 0.1 1.3 0.0 0.0 9.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 11.8 2.1 0.0 0.0 0.3 0.5 1.5 0.0 1.3 3.6 5.6 11.9 0.0 0.0 7.5 129.9 0.4 0.0 0.4 0.8 0.1 0.0 0.0 0.1 0.2 0.0 0.0 2.7 7.4 11.6 0.1 0.1 0.1 0.0 5.1 0.2 0.1 PTN "HBGF8, HBNF, NEGF1" ENSG00000105894 Pleiotrophin P21246 7 137227341-137343774 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 282.7;parathyroid gland: 386.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9" "Cancer enriched" "Detected in all" 11 "glioma: 514.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "AF22: 1717.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017685, HPA073913" Enhanced Supported "Endoplasmic reticulum" "Secreted to blood" NA NA 167000 1400000 "Endoplasmic reticulum" "CAB017685: AB_1128556, HPA073913: " "unprognostic (1.51e-2)" "unprognostic (7.87e-2)" "unprognostic (5.44e-2)" "unprognostic (4.23e-2)" "unprognostic (1.92e-1)" "unprognostic (7.19e-2)" "unprognostic (2.81e-2)" "unprognostic (7.29e-2)" "unprognostic (1.30e-1)" "unprognostic (1.09e-2)" "unprognostic (3.86e-1)" "unprognostic (1.22e-2)" "prognostic favorable (1.35e-4)" "unprognostic (2.34e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" 22.5 18.4 220.2 4.2 209.7 0.1 83.1 219.5 282.7 90.2 193.2 23.7 5.5 77.5 55.8 79.0 19.4 56.3 88.5 214.5 203.9 38.8 8.6 18.6 7.5 224.9 204.9 203.5 19.2 8.5 386.5 127.1 36.5 210.0 117.1 21.8 64.0 37.7 53.0 2.2 9.2 10.2 54.5 202.1 40.8 15.8 54.3 210.7 21.6 19.1 19.0 11.5 25.1 65.6 208.5 1.2 0.0 1717.6 21.2 0.4 0.9 140.6 45.3 134.3 25.1 34.3 0.4 0.2 0.0 0.2 60.0 15.6 1.0 0.0 0.0 18.9 0.0 1.4 0.0 0.0 0.0 7.7 0.0 0.5 1.9 0.0 16.6 0.2 24.6 0.0 0.0 0.0 8.2 7.0 0.0 0.0 0.6 133.5 0.0 1.1 0.1 2.8 0.4 0.7 0.0 8.0 116.5 0.0 0.0 0.2 24.1 0.2 0.2 0.0 37.4 32.9 1.8 99.4 0.7 0.0 0.0 119.7 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 220.2 209.7 219.5 282.7 214.5 203.9 224.9 204.9 203.5 210.0 202.1 210.7 208.5 10.1 0.0 0.0 303.3 1.3 23.2 1.7 85.0 209.5 27.7 244.6 117.3 14.6 2.8 20.9 1.8 6.2 220.0 2.2 0.0 9.8 1.1 24.5 53.4 672.0 32.0 0.0 0.0 4.9 0.0 416.0 248.8 0.5 24.6 0.0 1.1 7.1 0.3 20.4 526.6 18.1 0.0 0.0 0.3 20.6 14.0 172.7 4.0 44.4 102.1 0.0 548.5 0.0 322.7 218.4 0.3 0.0 185.5 2.5 18.6 0.0 7.5 7.2 32.3 59.2 3.0 91.4 4.0 2.4 439.9 13.9 193.3 4.4 144.7 0.0 2.2 MPP6 "p55T, PALS2, VAM-1" ENSG00000105926 "Membrane palmitoylated protein 6" Q9NZW5 7 24573268-24694193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;testis: 25.2" "Cell type enhanced" "Detected in many" "Astrocytes: 74.1;Excitatory neurons: 140.1;Inhibitory neurons: 146.6;Spermatocytes: 71.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 8.3" "Group enriched" "Detected in many" 4 "B-cells: 8.3;dendritic cells: 2.9;T-cells: 2.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019085, HPA020456" Enhanced NA NA "HPA019085: AB_1858713, HPA020456: AB_1858714" "unprognostic (2.79e-1)" "unprognostic (3.49e-1)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.10e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.18e-3)" "unprognostic (3.80e-2)" "unprognostic (4.07e-2)" "unprognostic (2.84e-1)" "unprognostic (1.29e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.94e-1)" "unprognostic (8.51e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.88e-3)" 3.8 2.7 12.9 3.4 16.0 3.2 4.1 5.7 19.0 1.6 0.2 1.4 3.5 1.9 1.1 3.1 2.6 19.3 1.2 21.3 22.7 8.6 9.5 1.9 4.9 13.8 16.6 8.5 9.5 7.8 0.4 1.5 0.8 12.7 2.6 1.4 2.5 2.8 1.2 9.2 2.2 4.5 3.1 16.0 2.0 2.5 25.2 16.8 4.3 6.1 3.3 4.9 1.9 2.9 16.9 24.4 14.2 15.2 22.7 16.6 11.8 11.1 18.1 10.0 12.3 15.5 42.6 18.1 43.1 14.4 11.1 32.1 15.0 26.7 21.6 24.4 17.1 21.5 7.1 23.6 10.4 12.9 29.2 5.0 12.3 9.1 14.7 26.1 9.0 19.6 25.3 46.7 16.5 14.3 9.7 18.9 7.7 83.9 11.5 22.6 22.9 26.5 23.1 17.2 33.1 11.8 48.4 20.8 20.4 6.3 30.3 10.3 4.2 18.8 8.0 33.7 25.0 34.8 62.4 6.8 83.8 14.3 10.9 30.1 0.2 0.1 0.1 1.9 0.8 1.2 5.7 0.9 2.2 0.2 8.3 2.3 2.0 0.2 1.0 0.0 2.9 0.8 0.4 12.9 16.0 5.7 19.0 21.3 22.7 13.8 16.6 8.5 12.7 16.0 16.8 16.9 0.8 6.4 3.2 74.1 16.9 11.1 16.2 6.3 15.9 2.5 13.0 8.5 5.6 47.1 5.0 5.5 43.8 2.9 8.3 0.8 3.9 36.2 31.9 1.3 9.5 3.0 3.0 8.0 140.1 18.0 2.1 13.2 3.6 3.3 0.0 53.3 2.9 16.0 1.4 3.3 146.6 9.2 2.0 1.8 2.9 30.1 5.3 1.8 1.8 8.4 1.6 1.8 3.1 30.7 4.2 12.6 25.0 7.2 9.7 20.5 26.3 31.0 1.0 5.9 0.0 34.7 16.0 71.7 24.1 9.4 8.8 0.5 10.9 6.8 6.3 10.2 GSDME "DFNA5, ICERE-1" ENSG00000105928 "Gasdermin E" O60443 7 24698355-24757940 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Necrosis "Deafness, Non-syndromic deafness, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011326, CAB019306" Approved Supported Cytosol NA NA Cytosol "CAB019306: , HPA011326: AB_1847629" "unprognostic (1.08e-1)" "unprognostic (1.77e-2)" "unprognostic (6.29e-2)" "unprognostic (6.36e-3)" "unprognostic (6.70e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.35e-2)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-3)" "unprognostic (1.48e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.90e-2)" 10.5 7.9 16.1 2.9 17.6 0.5 7.7 14.7 18.8 16.8 9.9 5.1 7.8 25.0 15.5 3.7 14.4 8.5 9.8 18.8 14.8 13.4 4.5 4.4 5.8 19.2 18.2 15.7 17.0 2.6 7.4 7.1 35.3 16.8 7.6 2.5 6.4 3.2 21.3 7.9 2.6 27.0 15.2 19.0 1.8 3.9 13.0 14.7 5.8 14.6 5.2 3.8 15.1 10.2 27.1 31.4 21.7 9.6 41.2 51.4 28.6 16.4 24.1 63.6 24.5 34.3 22.9 1.1 0.5 20.6 66.4 81.7 20.5 5.8 105.4 42.8 0.1 2.1 0.8 39.3 48.0 43.0 0.1 1.5 31.3 75.3 43.5 103.1 73.0 42.3 13.8 3.0 5.2 55.3 0.4 1.9 0.8 10.2 0.1 15.7 0.2 33.6 0.0 74.5 21.9 0.4 60.0 36.5 0.6 42.3 24.3 2.2 2.8 27.9 23.1 39.7 31.6 29.2 2.4 0.6 15.5 69.8 0.1 5.8 0.0 1.9 0.0 0.0 0.2 0.0 9.0 0.1 0.0 5.9 8.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 16.1 17.6 14.7 18.8 18.8 14.8 19.2 18.2 15.7 16.8 19.0 14.7 27.1 1.0 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.1 3.9 0.0 0.0 0.6 5.5 0.0 168.1 0.0 0.0 41.1 1.9 0.0 0.7 16.9 1.3 0.0 0.0 0.0 0.9 26.5 4.3 0.0 1.0 0.0 4.8 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 8.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 8.8 1.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 104.7 0.7 0.9 0.0 0.0 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "kidney: 64.2;salivary gland: 79.1" "Cell type enhanced" "Detected in some" "Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.4 0.0 0.4 0.0 4.7 0.1 0.5 3.7 2.5 0.0 0.1 0.1 1.2 5.0 0.0 0.0 0.0 0.7 0.2 64.2 0.0 0.4 0.0 0.4 0.2 0.3 0.0 0.1 1.7 0.1 2.5 0.2 0.9 0.0 0.0 79.1 1.5 0.0 9.9 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.4 0.0 0.0 3.7 0.1 0.2 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.6 0.6 1.8 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 5.0 1.9 0.0 0.1 0.0 0.1 0.1 0.6 0.0 4.5 0.2 0.0 0.0 0.1 55.7 1.9 2.9 0.1 0.0 0.2 0.6 1.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.1 0.5 0.7 0.2 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.0 0.0 1.1 0.3 0.0 0.0 1.1 0.9 0.0 0.0 2.5 1.4 0.5 0.0 1.7 16.5 2.1 13.4 0.3 0.0 31.3 0.0 2.2 0.9 0.1 0.1 0.0 0.0 1.4 0.0 0.7 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 57.0 0.0 0.0 2.8 0.3 0.0 7.2 1.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 4.4 0.1 0.0 0.0 0.1 0.6 0.7 0.0 0.1 5.1 0.2 0.0 0.0 1.3 ZC3HAV1 "ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043515-139132122 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 86.7" "Cell type enhanced" "Detected in many" "dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" NA NA 24000 Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: AB_2683903" "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favorable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 12.3 12.8 9.8 19.3 10.0 86.7 11.2 8.3 17.9 8.7 16.1 13.0 9.8 8.7 10.4 13.0 9.8 11.5 6.4 10.3 16.7 11.2 11.1 16.2 24.2 12.1 10.7 6.2 11.0 7.3 9.3 6.3 9.4 11.2 9.6 13.8 2.5 14.5 9.2 3.2 13.2 14.0 14.0 10.1 21.1 10.5 6.5 13.5 24.2 10.7 5.6 24.0 12.0 8.7 17.7 25.1 29.5 4.1 24.7 37.4 35.9 17.6 27.5 21.2 46.9 47.7 21.6 31.4 21.9 25.2 43.9 40.6 27.6 33.2 32.6 26.3 37.2 12.2 43.8 29.7 26.9 21.8 51.1 38.6 37.0 20.3 53.3 11.8 17.4 35.3 32.1 37.6 23.5 20.1 23.3 41.9 59.0 16.6 18.6 17.6 48.5 14.6 21.0 32.0 31.0 7.5 15.4 43.1 29.2 37.8 9.3 17.4 30.9 45.3 9.9 14.3 27.6 23.1 17.9 20.2 49.9 22.4 47.0 24.0 78.7 19.6 30.8 43.0 26.0 56.0 32.2 61.9 53.1 15.2 35.3 59.0 58.6 52.5 38.7 30.6 17.7 58.8 30.6 9.8 10.0 8.3 17.9 10.3 16.7 12.1 10.7 6.2 11.2 10.1 13.5 17.7 150.3 25.6 41.1 8.1 119.4 28.7 21.7 17.5 62.6 2.8 70.8 44.8 6.2 21.5 21.1 53.3 4.2 12.6 194.8 57.0 9.8 20.2 2.8 185.9 77.7 74.5 53.2 64.4 0.8 21.2 23.1 68.1 60.6 359.9 32.3 41.6 49.2 36.1 35.1 0.0 3.0 42.2 8.2 43.9 150.0 1.9 18.6 84.4 39.2 33.7 57.1 13.9 88.6 27.6 1.0 23.8 33.8 26.7 104.2 41.5 28.0 36.4 29.9 1.3 13.1 79.5 53.6 1.0 1.1 61.7 22.3 2.3 222.3 41.3 35.8 28.0 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 45.4;Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 82.5;Spermatocytes: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036338 Enhanced NA NA "HPA036338: AB_10673351" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 2.1 3.1 4.5 1.6 2.4 2.5 3.6 2.5 2.2 3.7 7.7 1.4 0.7 4.3 3.6 1.9 14.3 2.9 1.4 2.1 3.8 4.7 1.1 3.3 1.9 3.1 3.5 1.9 4.8 1.7 8.2 3.8 2.5 2.6 2.8 1.7 4.7 1.9 3.4 1.1 1.9 1.0 2.9 3.8 1.7 1.6 12.3 2.5 2.5 4.8 1.6 2.0 2.5 1.9 2.6 13.2 9.8 8.5 10.1 10.3 11.9 4.2 6.3 6.5 10.1 10.3 6.3 9.3 2.9 10.3 4.9 16.5 6.4 9.5 7.4 14.6 8.3 8.2 3.5 7.5 5.5 5.2 10.3 2.4 6.8 6.5 15.1 6.8 6.3 7.5 6.8 8.1 1.8 8.1 12.9 17.6 12.0 8.4 3.9 8.6 6.1 10.0 4.6 8.8 3.9 12.4 8.9 15.5 6.5 8.9 2.5 7.9 5.5 5.3 9.4 8.1 8.6 11.8 4.0 5.6 2.2 16.3 5.0 11.2 0.6 0.1 0.4 0.6 0.1 0.3 1.2 0.4 0.4 0.4 0.7 0.7 0.5 1.8 0.5 0.5 0.9 0.3 0.3 4.5 2.4 2.5 2.2 2.1 3.8 3.1 3.5 1.9 2.6 3.8 2.5 2.6 2.3 0.0 4.1 13.7 2.3 1.1 2.3 5.5 1.8 6.8 3.3 2.3 2.6 5.7 13.4 5.5 12.5 1.4 0.4 0.7 0.0 5.3 45.4 52.6 8.0 2.3 1.2 6.5 26.9 2.8 3.3 5.9 1.1 11.5 5.7 7.4 4.6 1.8 2.2 0.0 20.3 1.0 12.2 0.8 1.2 17.7 4.1 1.9 3.6 7.5 1.6 4.2 1.0 9.0 6.5 2.2 2.7 5.3 0.3 0.9 0.1 5.5 82.5 18.3 0.0 5.0 4.1 57.5 11.1 2.0 1.7 0.4 1.4 11.0 0.9 0.8 OGDH "E1k, KGD1, OGDC-E1, OGDH2" ENSG00000105953 "Oxoglutarate dehydrogenase" Q02218 7 44606572-44709066 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 367.1;tongue: 378.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019514, HPA020347" Supported Enhanced Mitochondria No No 130000 Mitochondria "HPA019514: AB_1854772, HPA020347: AB_1854773" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (4.39e-1)" "unprognostic (5.64e-3)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (3.45e-1)" "unprognostic (7.58e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-2)" "unprognostic (3.38e-1)" "unprognostic (3.30e-2)" "prognostic favorable (2.22e-14)" "unprognostic (1.53e-1)" "unprognostic (1.62e-1)" "unprognostic (2.23e-2)" "unprognostic (5.88e-3)" 65.4 68.0 33.6 39.6 35.8 32.4 32.3 41.5 43.2 31.6 99.8 56.2 96.4 41.3 16.7 62.1 34.3 27.2 236.7 31.9 45.8 90.5 40.2 43.8 40.3 40.5 41.0 29.2 25.0 27.8 100.7 35.2 33.4 42.5 38.3 41.9 26.1 43.4 47.3 367.1 54.9 88.2 51.5 31.4 39.3 52.9 36.4 39.5 32.4 55.4 378.0 41.8 42.9 38.0 40.3 35.8 73.5 42.2 66.0 63.4 69.8 41.9 54.2 51.3 59.5 50.9 67.2 71.7 156.0 63.0 79.2 119.2 108.2 85.7 81.4 58.4 92.0 22.8 47.4 140.6 33.5 32.8 59.4 51.2 66.0 60.5 85.4 60.9 43.0 82.4 50.7 55.8 45.4 63.7 50.1 59.2 34.1 39.8 97.7 81.8 55.9 30.1 175.9 68.5 104.4 73.2 35.0 78.8 107.6 34.4 75.8 64.2 58.7 66.4 43.4 38.5 76.3 64.0 40.9 84.0 85.9 78.4 65.7 80.4 9.9 21.8 12.6 17.9 28.5 19.5 11.1 20.7 18.1 22.0 9.3 8.5 10.8 12.2 19.3 35.4 10.8 42.1 23.2 33.6 35.8 41.5 43.2 31.9 45.8 40.5 41.0 29.2 42.5 31.4 39.5 40.3 19.6 6.4 22.5 49.3 23.1 19.5 12.3 15.9 22.8 21.4 14.4 18.2 114.3 12.8 14.2 47.8 18.8 24.0 20.0 64.5 31.3 14.9 51.0 26.1 15.6 16.0 23.4 32.0 43.3 16.9 16.4 20.6 35.2 38.9 21.5 15.5 17.9 22.6 33.8 62.2 53.1 32.6 12.2 24.5 43.4 24.5 11.8 33.8 21.4 29.0 22.7 14.3 16.5 22.1 36.6 20.9 38.0 17.3 27.8 16.4 82.0 51.8 17.0 24.0 19.7 24.7 20.2 10.6 19.9 28.1 26.3 36.7 27.7 30.3 33.5 18.1 NPVF "C7orf9, RFRP" ENSG00000105954 "Neuropeptide VF precursor" Q9HCQ7 7 25224570-25228486 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 64 "retina: 222.4" "Cell type enriched" "Detected in some" 40 "Muller glia cells: 526.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "hypothalamus: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "hypothalamus: 6.1" "Region enriched" "Detected in single" 8 "hypothalamus: 3.0" HPA041733 Enhanced "Secreted in other tissues" NA NA "HPA041733: AB_10794524" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 222.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 526.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897900-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.7;intestine: 38.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 97.7;Intestinal goblet cells: 42.5;Oligodendrocytes: 43.6;Paneth cells: 64.4;Proximal enterocytes: 48.5;Undifferentiated cells: 50.6" "Cancer enhanced" "Detected in all" "colorectal cancer: 15.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 108.1;CAPAN-2: 74.1;HMC-1: 71.0;OE19: 191.5;THP-1: 122.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favorable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 4.3 3.8 47.6 11.3 51.6 9.9 3.5 52.6 74.2 3.7 11.0 38.9 19.9 6.1 0.6 9.0 8.8 6.0 6.5 56.3 41.5 22.4 3.7 10.5 3.9 60.3 60.9 52.8 1.5 13.4 6.1 4.7 2.7 57.7 6.7 23.0 1.6 4.7 2.9 0.7 3.9 27.0 8.4 54.4 17.3 19.8 1.2 50.1 0.9 7.7 0.5 2.1 9.0 3.8 81.7 108.1 4.0 0.1 3.7 1.4 0.2 1.1 3.6 0.1 0.7 0.1 43.1 74.1 0.2 10.3 0.5 0.2 44.5 5.9 8.1 0.5 0.6 4.7 0.0 6.0 25.4 1.7 0.7 71.0 1.8 21.4 0.2 0.0 0.1 0.0 3.1 0.4 0.0 0.0 33.2 0.1 30.1 3.2 191.5 0.0 14.4 0.2 0.4 4.7 25.0 3.1 1.0 3.3 1.3 0.5 0.4 25.9 122.6 0.6 0.8 2.8 0.1 0.3 0.0 0.2 0.0 0.2 22.3 3.3 1.0 6.5 3.3 6.0 7.3 2.8 1.1 1.6 5.5 5.1 0.9 0.5 2.6 3.1 1.6 11.7 0.3 0.8 4.0 47.6 51.6 52.6 74.2 56.3 41.5 60.3 60.9 52.8 57.7 54.4 50.1 81.7 0.4 0.0 10.3 2.9 3.6 1.0 2.9 3.3 2.8 4.7 2.5 1.5 8.5 7.2 2.9 7.3 0.0 0.3 19.4 97.7 9.8 3.9 0.2 8.6 0.9 0.5 16.2 0.0 13.2 4.6 0.9 1.5 17.9 7.6 7.0 1.3 0.0 0.6 12.2 0.0 12.6 42.5 4.1 23.0 15.7 0.4 0.0 22.1 10.6 2.8 13.2 1.3 15.5 3.0 43.6 17.5 64.4 0.0 2.6 3.0 48.5 7.1 8.2 1.1 0.0 0.1 1.9 0.3 1.2 1.1 1.3 0.7 9.0 0.0 50.6 5.5 TFEC "bHLHe34, TCFEC, TFECL" ENSG00000105967 "Transcription factor EC" O14948 7 115935148-116159896 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.3;kidney: 20.6;lymphoid tissue: 22.3" "Cell type enhanced" "Detected in some" "Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3" "Group enriched" "Detected in many" 29 "B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1" "Cell line enhanced" "Detected in some" "HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032260, HPA063577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB032260: AB_2202845, HPA063577: AB_2685047" "unprognostic (1.36e-1)" "unprognostic (1.08e-2)" "unprognostic (8.70e-2)" "unprognostic (1.91e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (8.26e-2)" "unprognostic (2.15e-1)" "unprognostic (6.54e-2)" "unprognostic (2.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.05e-3)" "unprognostic (2.92e-1)" "unprognostic (4.14e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-2)" 3.2 2.5 1.1 19.4 1.5 17.3 2.7 1.7 2.6 1.9 3.6 2.7 4.2 1.4 0.6 1.0 1.0 4.9 1.0 0.8 3.0 20.6 3.1 10.0 22.3 2.2 1.7 0.3 1.3 1.0 0.4 0.6 4.8 2.5 1.0 4.3 0.1 1.4 0.9 0.3 0.4 9.8 3.2 3.0 14.8 3.1 1.6 2.9 2.9 0.9 0.4 12.7 4.0 0.6 3.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 3.7 0.0 1.7 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 11.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 21.5 12.5 2.1 0.2 1.3 0.0 5.5 0.0 0.0 0.1 24.4 1.1 0.0 7.1 0.0 0.0 2.8 0.0 3.8 0.0 0.0 6.3 2.5 0.0 0.0 0.1 0.0 0.4 3.3 0.0 1.5 1.1 1.5 1.7 2.6 0.8 3.0 2.2 1.7 0.3 2.5 3.0 2.9 3.8 0.5 0.0 2.2 0.3 18.1 0.5 0.0 0.0 0.0 0.0 0.3 0.8 0.8 1.5 0.0 3.7 0.0 0.2 8.3 0.0 0.0 0.0 2.4 0.0 0.0 1.7 0.0 7.2 0.6 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 45.5 0.0 0.5 0.4 0.0 56.3 17.8 3.8 0.0 61.6 0.0 60.0 44.1 0.0 1.0 1.0 0.1 0.1 0.0 0.0 1.3 0.1 15.6 77.8 0.0 0.0 0.0 0.3 0.1 0.3 2.5 0.1 0.4 0.8 0.8 0.1 0.7 0.1 H2AZ2 "H2AFV, H2AV, MGC10170, MGC10831, MGC1947" ENSG00000105968 "H2A.Z variant histone 2" Q71UI9 7 44826791-44848087 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 238.5;Cytotrophoblasts: 174.1;dendritic cells: 85.4;Extravillous trophoblasts: 435.9;Hofbauer cells: 242.8;Syncytiotrophoblasts: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057236 Supported NA NA "HPA057236: AB_2683377" "unprognostic (2.16e-2)" "prognostic favorable (4.66e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (3.51e-3)" "unprognostic (9.87e-2)" "unprognostic (1.77e-2)" "unprognostic (3.48e-1)" "unprognostic (1.32e-2)" "unprognostic (2.61e-2)" "unprognostic (8.17e-2)" "unprognostic (2.68e-1)" "prognostic favorable (8.04e-4)" "unprognostic (4.86e-2)" "unprognostic (8.74e-3)" "unprognostic (1.96e-1)" "unprognostic (1.25e-1)" 65.3 82.7 103.3 96.6 109.5 319.5 68.8 121.2 107.1 65.0 81.7 107.5 78.9 72.5 70.4 86.2 64.8 57.8 128.9 95.8 105.9 93.7 90.8 77.8 146.4 101.8 112.5 91.6 62.2 72.9 84.0 59.4 66.0 102.9 70.9 104.9 142.9 66.5 67.0 140.5 60.6 96.9 78.7 108.8 91.2 88.0 93.6 111.0 290.8 80.1 136.1 172.1 69.8 64.8 110.0 278.2 280.7 368.9 313.8 147.1 115.0 154.2 184.0 202.9 202.4 245.3 234.7 356.1 349.7 195.1 234.4 393.3 308.2 286.9 237.9 319.6 335.1 175.4 221.8 461.0 298.4 103.6 566.6 296.1 92.3 103.0 236.6 209.2 165.6 248.5 379.1 402.8 383.2 306.3 575.2 536.8 919.1 282.0 342.3 266.2 433.4 411.5 331.0 219.7 244.9 233.7 318.9 330.8 369.3 142.3 363.1 328.6 558.4 220.1 181.9 533.3 168.3 459.5 354.6 401.1 619.7 188.6 448.7 589.5 104.7 62.0 229.9 62.2 54.1 80.5 77.7 86.7 83.4 96.4 76.1 63.2 61.2 74.6 77.0 50.3 147.0 169.1 48.2 103.3 109.5 121.2 107.1 95.8 105.9 101.8 112.5 91.6 102.9 108.8 111.0 110.0 34.6 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 238.5 0.0 0.0 0.0 0.0 174.1 85.4 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 435.9 37.0 0.0 0.0 0.0 0.0 0.0 0.0 242.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 106.9 17.1 0.0 0.0 0.0 CAV2 CAV ENSG00000105971 "Caveolin 2" P51636 7 116287380-116508541 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 229.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 887.8;Basal keratinocytes: 484.0;Pancreatic endocrine cells: 447.4;Prostatic glandular cells: 428.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 114 "basophil: 97.0" "Lineage enriched" "Detected in single" 399 "granulocytes: 97.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 274.1;HBEC3-KT: 329.8;LHCN-M2: 341.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013488, HPA044810" Enhanced Approved Vesicles NA NA Vesicles "CAB013488: AB_2533493, HPA044810: AB_2679098" "unprognostic (4.76e-2)" "unprognostic (3.91e-3)" "unprognostic (4.56e-2)" "unprognostic (2.91e-1)" "unprognostic (5.09e-3)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.66e-2)" "unprognostic (2.27e-2)" "unprognostic (3.81e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (6.32e-2)" "unprognostic (3.44e-3)" "unprognostic (7.84e-3)" "unprognostic (2.88e-1)" "unprognostic (2.42e-1)" "unprognostic (6.34e-3)" 229.4 10.0 8.9 18.9 9.9 0.9 76.2 9.2 13.1 64.7 8.5 32.3 11.5 36.2 23.3 44.0 30.5 72.8 154.4 9.5 11.4 17.3 41.8 162.7 8.8 10.9 9.5 8.7 36.5 28.5 5.9 6.0 94.0 10.9 32.3 16.7 17.1 24.7 32.7 23.6 48.0 17.6 43.2 10.8 52.8 19.9 15.7 10.9 9.5 109.5 38.1 7.4 45.4 37.1 11.1 230.3 61.7 2.9 0.6 103.9 111.5 4.9 157.7 184.4 51.9 45.9 11.8 274.1 0.2 181.9 165.7 160.9 217.4 2.9 329.8 72.9 0.6 16.9 2.1 45.6 0.1 64.4 0.4 1.1 66.7 185.1 70.4 143.5 84.1 173.5 0.1 11.8 8.9 341.1 13.1 0.1 0.3 3.0 7.6 41.7 2.6 76.0 3.1 190.1 7.0 0.3 0.2 120.5 4.3 30.1 32.4 0.4 1.6 240.9 0.5 31.6 101.3 52.6 9.7 0.6 0.8 20.8 0.2 111.4 97.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.1 0.0 0.2 0.0 0.5 8.9 9.9 9.2 13.1 9.5 11.4 10.9 9.5 8.7 10.9 10.8 10.9 11.1 313.9 887.8 89.0 0.3 2.0 484.0 306.6 341.8 121.8 4.8 27.1 65.7 223.9 164.5 207.3 40.5 4.2 15.3 2.1 1.9 35.2 279.1 25.7 5.1 27.6 235.5 1.8 4.0 1.9 100.1 128.2 66.2 2.0 9.8 2.5 9.8 144.2 42.4 4.9 0.0 1.1 12.9 107.8 6.1 48.6 18.2 94.4 5.4 145.9 12.2 2.1 223.3 0.0 5.5 1.0 447.4 1.4 194.1 3.5 428.5 7.9 4.3 48.8 8.0 190.7 44.4 198.9 4.8 1.5 45.4 282.0 12.4 5.9 199.6 4.8 202.5 CAV1 CAV ENSG00000105974 "Caveolin 1" Q03135 7 116524994-116561179 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 626.6" "Cell type enhanced" "Detected in many" "Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 14.6;memory B-cell: 5.1" "Group enriched" "Detected in many" 57 "B-cells: 5.1;granulocytes: 14.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 122.1" "CAB003791, HPA049326" Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB003791: AB_562068, HPA049326: AB_2680714" "unprognostic (5.98e-2)" "unprognostic (1.35e-3)" "unprognostic (3.35e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-3)" "unprognostic (2.35e-3)" "unprognostic (8.07e-2)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.31e-1)" "unprognostic (2.25e-1)" "unprognostic (1.79e-3)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.65e-3)" "unprognostic (2.72e-1)" "unprognostic (7.40e-2)" "unprognostic (6.14e-3)" 626.6 17.6 14.0 45.1 14.5 0.6 287.0 13.8 20.8 269.2 16.7 221.1 32.6 192.5 73.1 136.4 153.8 149.5 279.0 12.0 15.1 18.5 26.9 597.2 30.6 15.4 13.0 11.2 138.7 24.8 21.6 6.8 452.9 15.4 111.3 94.5 31.7 58.5 177.1 103.8 99.5 90.2 276.5 14.4 200.8 121.8 26.0 15.6 25.5 169.8 186.3 20.5 203.7 125.2 16.0 458.7 344.3 9.5 3.7 1406.6 2140.5 20.6 1055.8 2371.6 566.0 591.2 3.0 652.4 0.1 365.8 1228.5 494.8 828.2 2.2 2333.7 840.3 36.0 19.5 0.4 128.7 0.3 196.9 0.1 2.1 736.9 481.6 805.7 536.0 539.0 1749.9 0.2 0.3 23.4 2372.1 45.2 0.5 0.8 33.7 1.2 173.9 5.2 25.2 251.0 317.0 2.0 1.0 0.6 328.3 20.1 52.3 137.8 1.6 3.9 1349.3 1894.8 212.4 730.6 298.9 96.8 15.8 1.9 758.4 0.9 701.0 14.6 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 14.0 14.5 13.8 20.8 12.0 15.1 15.4 13.0 11.2 15.4 14.4 15.6 16.0 2160.5 3557.7 123.0 0.0 15.8 1375.3 392.0 534.8 316.4 8.3 17.9 190.8 286.6 107.2 342.0 7.3 2.1 64.3 7.0 0.3 5.9 76.8 2.6 17.5 102.3 1024.0 1.8 16.0 0.4 0.7 449.5 326.8 1.5 21.3 13.9 6.3 450.5 5.2 15.0 0.0 0.5 7.0 20.3 11.0 187.1 13.4 377.2 10.7 439.4 19.7 3.7 249.0 0.0 1.0 1.3 43.1 0.1 565.4 56.2 512.7 0.7 0.3 30.6 7.7 558.8 152.4 751.4 2.1 5.7 39.4 610.9 117.0 16.7 59.7 2.4 93.3 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672196-116798377 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 103.6;Club cells: 99.8;Glandular and luminal cells: 161.4;Pancreatic endocrine cells: 93.9;Prostatic glandular cells: 149.3;Urothelial cells: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 203.8;CAPAN-2: 219.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005282, CAB018577, HPA055607" Approved Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 179000000 100000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860" "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 9.9 0.8 2.1 3.4 0.7 7.4 9.0 0.2 8.9 13.2 10.3 9.8 6.6 6.5 2.5 6.2 4.7 12.0 6.3 6.4 0.8 20.2 43.3 20.5 2.3 1.0 2.8 0.5 0.8 6.7 0.8 3.8 26.7 2.7 6.7 9.4 4.0 8.8 11.3 14.5 7.7 8.2 5.7 0.3 6.1 15.5 0.5 0.7 3.8 17.8 11.1 3.2 18.5 4.4 7.5 203.8 115.3 0.1 0.6 8.6 8.7 7.9 113.7 48.2 60.3 51.1 25.0 219.0 8.4 179.0 72.1 163.3 51.8 19.7 110.0 123.7 0.3 23.4 0.1 112.5 21.4 1.5 0.3 0.2 11.4 42.4 40.6 129.1 109.4 42.4 0.2 4.5 0.8 114.1 5.0 0.1 0.1 17.3 32.9 113.0 0.2 95.3 0.2 105.8 24.0 16.5 0.0 45.4 15.4 44.9 19.8 0.4 0.9 72.3 89.7 30.6 46.7 88.9 2.5 19.1 1.5 99.3 0.3 12.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.2 8.9 6.4 0.8 1.0 2.8 0.5 2.7 0.3 0.7 7.5 32.6 28.9 103.6 0.3 1.0 39.0 70.5 58.1 38.1 6.7 6.5 6.9 12.3 11.5 99.8 31.3 0.0 76.0 0.4 20.5 0.0 38.5 0.0 52.5 11.6 20.1 7.2 0.0 2.6 46.9 7.5 7.4 32.6 161.4 0.0 0.0 3.9 30.5 7.0 0.0 1.0 20.5 18.3 1.3 2.2 0.1 0.6 4.4 3.6 1.9 1.0 7.6 0.0 0.5 7.7 93.9 5.5 0.0 0.4 149.3 11.2 15.6 34.5 0.3 0.0 37.8 5.2 0.0 0.6 7.9 17.8 21.8 1.2 0.0 16.4 128.6 RNF32 "FKSG33, HSD15, LMBR2" ENSG00000105982 "Ring finger protein 32" Q9H0A6 7 156640281-156677130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 61.4" "Group enriched" "Detected in many" 9 "Early spermatids: 325.5;Late spermatids: 487.1;Spermatocytes: 243.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 12.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "CACO-2: 11.8;HDLM-2: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019516, HPA073560" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA019516: , HPA073560: AB_2686616" "unprognostic (9.23e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.85e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "unprognostic (5.73e-3)" "unprognostic (1.71e-2)" "unprognostic (8.72e-3)" "unprognostic (6.08e-4)" "unprognostic (4.64e-2)" "unprognostic (2.06e-1)" "unprognostic (8.15e-3)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (3.81e-3)" "unprognostic (1.44e-1)" 2.0 1.3 2.6 1.5 2.5 1.7 1.1 1.8 2.3 0.9 1.1 1.9 1.7 0.9 11.1 0.9 3.2 2.4 0.6 2.0 2.6 2.2 1.2 1.6 2.1 2.1 2.1 1.8 2.6 2.1 0.7 1.7 1.5 2.4 2.1 1.6 2.8 0.9 0.9 1.1 2.2 1.4 0.3 2.4 1.4 3.0 61.4 2.2 1.1 2.5 0.1 1.3 0.7 0.9 3.8 4.5 2.3 0.5 1.2 1.0 0.6 0.8 0.7 0.2 1.1 0.9 11.8 5.0 7.2 5.5 0.7 1.2 0.1 0.0 0.2 2.2 13.2 3.0 0.9 1.1 0.5 1.0 2.1 4.1 1.7 0.8 0.6 2.3 0.7 0.5 6.3 10.7 2.0 3.5 7.8 2.9 5.2 2.5 7.6 5.6 2.9 0.1 3.4 1.6 1.5 7.2 5.4 4.3 0.4 2.3 1.1 1.3 1.5 1.9 0.0 0.2 0.9 0.6 10.2 4.8 4.2 0.8 4.8 1.7 12.6 0.4 1.4 0.4 0.2 1.5 2.6 1.5 0.4 1.0 1.6 0.3 0.5 0.0 0.4 0.5 2.6 2.0 0.6 2.6 2.5 1.8 2.3 2.0 2.6 2.1 2.1 1.8 2.4 2.4 2.2 3.8 0.9 6.4 2.6 2.3 1.9 0.3 2.2 2.8 2.8 2.3 1.7 2.2 1.1 4.3 5.4 3.7 0.0 0.0 0.3 2.4 5.9 2.0 325.5 12.7 0.9 1.1 4.2 0.4 2.0 3.2 0.5 0.7 4.6 2.9 5.7 0.6 2.5 2.9 0.4 1.7 1.9 2.5 2.0 0.0 0.9 487.1 6.5 2.1 1.8 1.0 0.1 2.5 0.0 5.0 5.3 3.1 0.5 4.1 2.4 1.3 2.8 6.4 35.4 2.2 0.0 1.4 1.1 243.4 35.6 2.0 0.6 0.1 1.1 0.2 2.1 1.5 LMBR1 "ACHP, C7orf2, FLJ11665, ZRS" ENSG00000105983 "Limb development membrane protein 1" Q8WVP7 7 156668946-156893216 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 110.7;Inhibitory neurons: 128.7;Microglial cells: 99.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016592 Approved Approved Cytosol NA NA Cytosol "HPA016592: AB_1852943" "unprognostic (8.81e-3)" "unprognostic (1.73e-2)" "unprognostic (9.49e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-3)" "unprognostic (6.90e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-1)" "unprognostic (1.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.44e-6)" "unprognostic (3.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.48e-1)" "unprognostic (7.10e-2)" 10.1 26.3 9.5 8.4 10.8 7.9 10.8 11.9 13.7 13.7 8.0 9.0 8.1 13.4 18.2 10.0 14.3 10.3 11.4 9.8 13.7 15.8 13.9 9.1 9.5 10.9 11.2 9.0 16.7 8.9 38.3 7.6 10.2 12.5 12.3 10.4 14.4 8.5 10.8 6.8 8.4 9.4 13.3 9.2 7.7 12.0 17.8 11.6 11.9 17.7 11.5 8.8 12.0 6.0 13.3 26.9 20.6 27.5 33.4 21.1 24.0 16.6 14.5 20.5 14.2 16.8 15.4 42.4 25.3 27.6 19.7 27.3 20.4 28.4 28.9 29.1 19.5 25.5 19.1 11.6 19.7 13.6 23.8 13.6 19.3 27.0 20.4 27.3 22.8 29.6 23.4 35.7 23.8 26.9 24.3 25.1 20.5 29.4 30.4 18.7 13.1 18.1 31.6 22.8 25.1 26.1 51.9 20.4 27.8 15.6 17.8 19.1 14.3 38.4 25.1 9.3 82.7 19.6 25.6 22.6 24.0 40.0 30.2 16.4 1.8 0.7 1.0 0.7 0.4 1.4 0.6 1.2 1.2 1.3 0.8 1.5 1.0 0.6 0.2 0.7 0.9 0.9 0.6 9.5 10.8 11.9 13.7 9.8 13.7 10.9 11.2 9.0 12.5 9.2 11.6 13.3 25.6 3.2 8.1 54.5 23.7 10.5 13.7 9.9 43.3 11.5 12.8 8.5 17.1 11.5 7.2 12.9 2.1 14.3 8.4 8.6 5.9 11.0 7.4 17.0 8.6 24.8 8.3 17.4 110.7 10.1 5.6 15.2 23.0 15.7 5.7 43.2 9.3 19.2 10.2 8.4 128.7 9.9 10.2 10.1 8.0 9.7 10.5 9.3 7.2 99.3 8.2 6.7 3.1 72.4 70.4 12.6 6.1 8.6 23.4 20.0 9.7 12.2 9.7 10.9 0.0 11.9 11.0 18.0 28.7 30.9 12.8 23.1 18.0 26.2 11.1 16.6 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117275451-117323152 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 40.2" "Cell type enhanced" "Detected in some" "Early spermatids: 30.9;Endometrial stromal cells: 33.1;Fibroblasts: 82.5;Late spermatids: 14.7;Spermatocytes: 13.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 11.5" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in many" HPA020920 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 0.9 0.0 0.3 0.1 0.3 0.0 0.8 0.2 0.7 2.7 0.4 0.1 0.0 8.7 0.1 0.0 0.8 0.2 0.3 0.4 0.3 0.1 0.5 7.0 0.0 0.2 0.6 0.2 0.3 0.1 0.0 0.1 40.2 0.2 3.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 1.2 0.2 0.9 0.0 0.5 0.9 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.7 0.4 0.3 0.2 0.6 0.2 0.2 0.2 0.9 0.2 0.5 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 1.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 30.9 0.8 33.1 9.8 0.0 0.0 1.4 0.0 3.6 82.5 0.0 0.6 0.0 0.0 10.8 0.6 7.7 0.0 0.5 0.0 0.0 0.8 0.3 14.7 1.5 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 13.6 0.5 0.0 2.7 9.0 0.2 0.0 0.0 0.2 HOXA1 "HOX1, HOX1F" ENSG00000105991 "Homeobox A1" 7 27092993-27096000 "Human disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "urinary bladder: 5.4" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 7.4;Enteroendocrine cells: 3.0;Kupffer cells: 3.2;Squamous epithelial cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.5;NK-cell: 4.8;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 6 "monocytes: 7.0;NK-cells: 4.8" "Cell line enhanced" "Detected in many" "HMC-1: 14.1" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Region enhanced" "Detected in some" "spinal cord: 2.6" NA NA "unprognostic (7.39e-2)" "unprognostic (1.26e-3)" "unprognostic (1.05e-1)" "unprognostic (2.17e-4)" "unprognostic (2.79e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (4.70e-2)" "unprognostic (2.72e-2)" "unprognostic (6.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-4)" "unprognostic (2.03e-1)" "unprognostic (2.82e-1)" "unprognostic (5.77e-3)" "unprognostic (1.17e-1)" 0.6 0.5 0.1 0.8 0.1 0.3 0.6 0.0 0.1 0.3 0.0 1.1 0.3 0.4 1.9 2.9 0.8 0.3 0.0 0.0 0.0 0.8 0.2 0.3 1.3 1.2 0.2 0.0 1.6 0.0 1.1 0.0 0.1 0.5 0.5 1.0 0.0 0.0 0.4 0.2 2.3 1.1 0.3 0.7 1.2 0.7 0.1 0.1 0.7 0.1 0.0 1.1 5.4 0.6 0.7 6.3 2.6 0.2 3.4 0.0 0.0 5.6 0.8 3.5 2.2 2.6 13.8 3.8 4.2 7.9 2.1 8.5 13.2 4.6 3.7 1.6 0.3 13.9 5.5 0.2 0.1 0.7 4.8 14.1 2.4 3.8 2.6 5.5 0.0 3.5 4.2 6.1 0.0 4.7 0.1 0.0 7.7 0.0 2.4 0.6 5.2 1.6 0.0 7.6 6.0 0.4 0.0 3.0 0.0 3.8 4.4 0.0 2.2 2.7 0.5 5.4 4.1 1.1 0.0 0.0 2.0 2.1 8.1 5.8 0.7 0.2 0.5 0.8 4.5 0.8 0.3 0.9 0.8 0.8 0.0 0.3 0.8 0.2 4.8 7.0 0.0 0.9 0.4 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.5 0.7 0.1 0.7 0.9 0.0 0.0 0.0 0.2 2.3 1.4 0.3 7.4 0.0 0.6 1.8 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 0.4 0.8 3.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 2.5 0.1 2.2 0.0 0.1 0.0 0.0 2.1 0.0 3.2 0.4 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.1 0.3 0.0 1.3 0.2 1.2 0.9 1.2 0.0 0.0 0.3 1.5 0.1 0.8 5.8 1.1 0.0 1.4 0.3 0.9 2.1 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767" "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 80.4 66.7 128.6 56.4 129.1 184.8 87.9 133.7 182.7 71.3 141.9 88.3 43.9 82.2 110.3 117.9 74.5 51.0 117.0 141.3 131.0 72.1 50.3 70.5 55.3 134.6 128.5 122.0 77.3 44.0 58.0 65.7 74.4 133.5 58.6 49.7 88.1 75.4 71.2 331.4 132.2 57.4 73.9 137.8 59.8 62.6 119.3 134.2 81.8 53.0 179.1 68.5 93.6 91.5 149.1 179.8 106.7 127.0 130.9 126.3 113.1 117.6 196.2 159.8 179.1 194.4 146.4 176.0 68.7 359.2 146.9 162.4 111.9 87.3 137.8 275.3 138.3 119.6 123.1 61.7 104.6 116.1 92.4 99.4 100.2 130.7 136.1 64.2 178.9 135.6 72.2 203.8 66.9 232.5 121.7 232.4 181.0 255.7 126.1 141.2 122.7 91.1 96.0 148.9 108.1 76.5 201.2 153.5 119.3 151.2 259.6 87.2 129.8 170.0 113.0 85.4 270.6 172.0 126.1 193.1 80.9 160.1 208.7 146.4 345.1 160.8 201.9 133.8 168.2 135.2 134.8 120.8 138.4 120.2 124.0 152.0 141.7 287.8 148.0 206.3 109.9 159.6 247.0 128.6 129.1 133.7 182.7 141.3 131.0 134.6 128.5 122.0 133.5 137.8 134.2 149.1 225.2 48.1 62.7 41.1 150.9 756.7 640.9 632.6 182.7 100.4 281.8 175.9 115.0 62.9 206.8 97.5 81.3 276.9 287.0 143.0 193.7 134.9 105.8 225.6 125.2 178.8 193.5 131.1 49.4 69.4 241.8 159.8 66.8 296.3 212.7 70.5 101.4 46.7 164.7 94.2 56.4 149.8 223.8 133.7 803.5 126.4 151.0 339.2 282.8 60.9 313.6 122.7 173.0 37.2 73.5 138.5 132.4 202.3 132.9 413.2 82.4 196.1 253.8 104.0 98.6 146.0 198.8 319.4 504.8 204.1 960.5 508.1 288.0 111.4 155.1 876.8 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102686 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9" "Region enriched" "Detected in single" 36 "pons and medulla: 5.8" "Group enriched" "Detected in some" 17 "medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 1.5 1.1 1.7 0.6 0.7 0.0 1.6 0.0 0.4 1.4 0.0 3.3 0.9 2.0 5.1 2.3 4.1 1.0 0.2 0.0 0.2 2.3 0.2 1.7 0.2 4.4 0.5 0.0 0.6 0.3 5.7 0.0 0.0 3.1 1.8 1.8 0.0 0.0 2.1 0.8 1.6 2.6 0.9 4.9 1.2 2.2 0.1 1.6 1.9 0.8 3.1 0.6 2.0 0.9 4.4 1.1 0.6 4.0 14.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.6 3.4 0.1 1.5 0.1 1.8 6.2 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.2 1.8 0.1 0.3 0.8 0.0 3.1 3.1 0.0 2.5 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.9 1.0 0.7 0.0 4.9 0.5 0.9 0.0 0.2 0.0 0.9 0.2 0.0 0.0 2.5 0.0 0.2 1.1 0.5 0.0 0.0 0.1 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.4 0.0 0.2 4.4 0.5 0.0 3.1 4.9 1.6 4.4 1.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 23.3 0.0 1.2 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 1.3 2.5 4.8 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.4 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 1.1 0.5 0.0 0.0 0.0 1.0 1.9 0.0 0.0 6.3 0.3 0.0 0.1 0.0 1.7 0.7 HOXA3 "HOX1, HOX1E" ENSG00000105997 "Homeobox A3" O43365 7 27106184-27152581 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 27.9;Endometrial stromal cells: 17.9;Intestinal goblet cells: 15.8;Proximal tubular cells: 13.2;Undifferentiated cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 38.2;CACO-2: 25.2;CAPAN-2: 66.5;HEK 293: 29.7;WM-115: 35.5" "Region enriched" "Detected in single" 30 "pons and medulla: 3.0" "Region enhanced" "Detected in some" "medulla oblongata: 3.9;spinal cord: 3.1" HPA029157 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029157: AB_10601020" "unprognostic (1.32e-1)" "unprognostic (3.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.85e-3)" "unprognostic (2.94e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.61e-2)" "unprognostic (6.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-2)" "unprognostic (5.82e-2)" 6.2 3.3 1.7 2.3 2.1 0.3 7.4 0.0 1.1 4.7 0.0 10.9 3.9 8.6 6.5 8.2 18.5 2.9 0.6 0.0 0.5 9.8 0.7 6.0 1.4 10.1 2.1 0.0 3.1 0.7 3.9 0.0 0.1 7.6 6.5 4.6 0.0 0.2 2.4 7.7 4.9 9.5 3.5 8.8 2.3 6.7 2.9 2.5 1.6 2.2 3.2 0.2 9.0 3.8 7.7 11.9 13.7 0.0 38.2 0.0 0.0 0.0 0.4 0.4 0.1 0.2 25.2 66.5 1.8 18.7 1.0 5.2 15.9 0.7 1.7 0.0 0.5 29.7 0.5 0.4 20.6 1.3 0.7 0.7 2.4 0.1 3.1 3.6 0.0 3.6 1.7 1.3 0.2 1.5 0.6 0.0 1.0 0.0 3.3 8.6 14.1 4.4 0.0 11.4 5.4 5.6 0.0 2.1 0.0 5.8 0.5 1.1 0.8 16.5 0.0 2.0 3.9 3.1 0.0 0.0 0.6 1.2 2.6 35.5 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.9 0.4 0.3 0.0 0.1 0.0 1.7 2.1 0.0 1.1 0.0 0.5 10.1 2.1 0.0 7.6 8.8 2.5 7.7 6.2 0.0 0.0 0.0 0.2 1.1 3.8 0.0 27.9 0.0 5.7 6.1 1.0 0.0 0.0 3.7 0.0 0.0 0.7 6.2 5.9 0.1 8.1 2.0 17.9 5.8 4.2 1.7 0.0 0.0 0.0 6.8 0.0 0.5 1.3 0.2 9.3 0.3 0.1 0.0 0.0 15.8 0.0 0.3 0.7 9.1 0.6 1.3 3.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 7.3 0.0 0.0 2.4 5.5 13.2 0.0 0.0 0.0 2.9 9.2 2.2 1.4 11.8 1.3 0.0 1.2 0.1 16.6 4.5 LFNG SCDO3 ENSG00000106003 "LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q8NES3 7 2512529-2529177 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 75.1;skin 1: 58.7" "Cell type enhanced" "Detected in many" "dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069130 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 880000 "Golgi apparatus" "Nuclear membrane" "HPA069130: AB_2686091" "unprognostic (4.58e-2)" "unprognostic (1.17e-2)" "unprognostic (2.52e-2)" "prognostic favorable (6.36e-4)" "unprognostic (1.85e-2)" "unprognostic (8.34e-2)" "unprognostic (4.15e-1)" "unprognostic (7.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (5.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.09e-1)" "unprognostic (1.97e-2)" "unprognostic (2.28e-2)" 15.1 6.6 24.3 17.5 25.0 9.9 13.8 30.8 22.6 8.2 11.4 17.2 15.7 9.4 2.2 11.5 6.1 11.9 13.2 16.9 27.1 8.6 2.5 14.5 18.8 33.5 32.7 15.6 1.9 75.1 3.0 3.8 6.5 36.5 17.2 12.1 3.1 33.7 4.6 4.6 58.7 17.4 5.9 22.6 21.1 38.1 4.2 34.0 5.9 6.7 3.6 10.9 12.3 14.0 22.2 1.5 14.3 18.4 2.5 2.0 1.7 1.2 5.4 2.8 4.7 5.9 6.0 37.7 1.1 16.7 14.8 8.1 27.1 2.9 5.1 2.3 8.6 0.6 4.3 7.7 3.2 0.1 6.2 7.7 3.3 12.6 7.8 0.8 3.2 1.9 0.3 0.7 0.2 3.6 34.5 0.1 8.7 22.4 46.4 10.3 1.8 46.0 2.9 1.8 4.5 16.9 4.2 6.2 1.4 0.3 4.7 10.2 7.3 4.5 10.5 49.7 0.4 15.4 0.2 0.0 1.4 11.8 16.4 2.0 6.3 5.3 12.7 1.8 6.9 2.0 1.1 1.7 0.9 2.3 2.0 1.8 1.8 2.8 1.3 6.6 0.6 4.2 1.7 24.3 25.0 30.8 22.6 16.9 27.1 33.5 32.7 15.6 36.5 22.6 34.0 22.2 23.3 6.4 6.0 18.9 15.6 6.8 2.5 10.6 3.4 8.5 5.3 12.4 3.6 5.7 2.8 0.0 0.0 0.1 40.3 23.1 0.0 1.2 0.1 2.4 8.5 16.0 87.4 2.7 0.0 6.4 0.3 5.7 30.5 1.2 17.7 0.1 13.9 0.6 7.0 0.0 0.1 34.5 6.1 30.4 13.8 0.5 1.8 30.6 3.6 11.2 38.2 31.3 19.6 1.5 0.1 21.7 3.1 0.0 12.6 2.2 8.8 0.4 1.2 0.8 0.0 0.6 5.0 0.3 3.1 0.6 4.0 0.0 15.9 0.5 15.3 0.7 HOXA5 "HOX1, HOX1C" ENSG00000106004 "Homeobox A5" P20719 7 27141052-27143681 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 81.7;epididymis: 49.4;fallopian tube: 49.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 99.6;Breast myoepithelial cells: 27.2;Proximal tubular cells: 27.1;Squamous epithelial cells: 46.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "medulla oblongata: 35.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 94.2;HEK 293: 160.4;RPTEC TERT1: 36.2" "Region enriched" "Detected in single" 220 "pons and medulla: 22.0" "Group enriched" "Detected in some" 33 "medulla oblongata: 4.4;spinal cord: 16.3" NA NA "unprognostic (2.43e-1)" "unprognostic (3.98e-3)" "unprognostic (2.99e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.87e-1)" "unprognostic (7.80e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.02e-2)" "unprognostic (5.54e-2)" "unprognostic (2.31e-1)" "unprognostic (5.47e-2)" "unprognostic (3.00e-2)" "unprognostic (4.37e-2)" "unprognostic (3.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.00e-1)" 10.0 81.7 0.5 3.1 8.3 3.2 11.7 0.2 1.6 5.9 0.0 16.2 2.7 12.4 49.4 5.2 49.8 0.9 0.2 0.1 0.4 20.4 0.8 20.1 1.8 35.2 1.5 0.2 3.0 1.4 3.4 0.0 0.2 9.9 8.7 7.0 0.0 0.0 9.8 6.8 7.3 13.8 6.3 24.9 3.3 11.8 0.6 3.9 0.5 1.1 0.3 0.1 11.9 4.6 18.6 5.7 2.8 0.0 94.2 0.1 0.0 0.4 1.6 1.2 1.7 1.5 1.7 9.7 3.1 13.5 3.0 2.0 7.6 5.3 0.4 1.7 1.4 160.4 2.2 1.2 5.7 0.9 3.6 2.5 10.3 0.5 3.1 5.4 0.0 20.8 5.5 0.4 0.0 3.2 1.7 0.0 1.1 0.0 2.1 2.9 13.4 0.4 0.0 36.2 7.6 10.9 0.1 7.2 0.0 3.6 0.3 1.1 1.3 8.3 0.3 1.2 5.6 3.9 0.0 0.1 3.3 0.7 10.8 10.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.1 0.1 0.0 0.0 0.5 8.3 0.2 1.6 0.1 0.4 35.2 1.5 0.2 9.9 24.9 3.9 18.6 9.3 0.0 1.1 0.0 0.9 3.4 6.4 0.1 99.6 0.0 17.3 27.2 8.0 0.0 0.0 0.0 0.0 0.0 2.8 17.0 7.9 0.1 0.0 0.9 19.7 8.4 9.0 2.5 0.0 0.0 0.0 11.5 2.6 0.4 0.0 0.0 21.0 0.0 0.6 0.0 0.0 10.8 0.0 2.5 1.5 0.3 0.3 9.2 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 15.5 0.0 1.0 2.2 9.6 27.1 0.1 0.0 0.0 4.5 14.3 0.9 0.7 46.7 2.8 0.1 1.7 0.2 18.8 6.3 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.0;fallopian tube: 10.1" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 5.2;Distal enterocytes: 7.5;Distal tubular cells: 5.9;Endometrial stromal cells: 14.8;Enteroendocrine cells: 9.0;Smooth muscle cells: 6.2;Undifferentiated cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 3.1" "Lineage enhanced" "Detected in single" "granulocytes: 3.1" "Group enriched" "Detected in many" 9 "AN3-CA: 61.7;HEK 293: 84.4" "Region enriched" "Detected in single" 34 "pons and medulla: 3.3" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.0 2.7 0.1 1.4 1.9 0.2 2.4 0.0 0.4 2.1 0.0 5.1 0.2 5.4 3.8 0.3 10.1 0.2 0.0 0.1 0.1 4.2 0.0 2.1 1.2 6.9 0.4 0.1 0.2 0.0 0.3 0.0 0.1 1.9 2.6 1.5 0.0 0.1 1.9 1.2 2.9 4.2 1.4 8.0 0.3 1.3 0.0 1.0 0.1 0.2 0.0 0.0 3.1 1.4 6.0 1.2 2.1 0.1 61.7 0.1 0.0 0.2 0.5 0.6 0.4 0.6 1.5 7.2 1.5 2.3 0.5 0.2 2.8 1.5 0.0 0.0 1.9 84.4 1.0 1.2 0.8 0.0 1.3 2.1 4.9 0.1 0.0 0.8 0.1 2.9 2.0 0.4 0.0 0.7 0.8 0.1 0.3 0.1 0.4 2.1 8.4 0.0 0.0 5.9 3.9 6.4 0.0 2.9 0.3 1.3 0.0 0.8 0.8 0.0 0.1 0.9 3.3 2.3 0.0 0.0 1.4 0.0 6.2 6.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 1.9 0.0 0.4 0.1 0.1 6.9 0.4 0.1 1.9 8.0 1.0 6.0 2.1 0.0 0.0 0.0 0.3 0.3 1.6 0.0 0.0 0.0 4.0 5.2 0.0 0.0 0.0 1.8 0.0 0.0 0.5 7.5 5.9 0.0 0.0 0.6 14.8 1.9 9.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.9 0.0 0.0 1.0 3.4 1.3 0.1 0.0 0.0 3.7 6.2 0.0 0.0 0.3 0.4 0.0 0.4 0.1 8.0 1.4 BRAT1 "BAAT1, C7orf27, MGC22916" ENSG00000106009 "BRCA1 associated ATM activator 1" Q6PJG6 7 2537810-2555694 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029455, HPA076508" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029455: AB_10600761, HPA076508: AB_2686803" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.04e-3)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (2.46e-1)" "unprognostic (1.10e-3)" "unprognostic (4.69e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (5.37e-2)" "unprognostic (3.12e-2)" "unprognostic (8.88e-2)" "unprognostic (3.71e-2)" 16.9 31.2 8.9 6.9 8.6 8.0 17.9 8.8 14.4 21.8 7.6 16.1 8.9 19.5 2.2 15.2 19.4 3.7 14.5 8.6 9.9 15.3 20.9 12.4 7.3 11.7 9.8 7.9 21.8 20.4 5.3 19.9 4.6 8.7 24.7 1.3 0.9 17.5 6.6 14.9 21.4 16.8 2.5 8.7 21.3 19.8 31.8 9.4 5.0 18.9 3.7 2.1 17.7 19.0 9.3 35.1 31.1 7.5 27.2 6.8 6.3 24.5 11.7 6.5 10.1 8.5 22.5 21.5 26.3 18.1 7.8 19.4 35.1 8.8 13.7 1.6 10.4 44.4 12.2 23.5 14.3 8.7 16.5 18.2 10.6 9.5 10.2 3.0 5.8 11.4 20.2 39.1 9.6 7.1 50.0 11.8 77.9 35.3 8.8 47.0 28.6 21.9 25.5 6.5 11.3 19.5 30.2 17.1 29.8 12.9 3.5 26.5 33.4 11.8 13.8 43.3 28.5 23.2 20.7 17.3 19.0 15.2 32.8 33.2 5.1 30.8 17.5 21.9 28.2 19.3 18.6 19.8 22.6 32.4 15.2 16.3 17.9 25.4 15.9 27.1 22.7 18.4 22.8 8.9 8.6 8.8 14.4 8.6 9.9 11.7 9.8 7.9 8.7 8.7 9.4 9.3 10.1 12.8 6.4 19.9 11.1 7.8 17.5 22.6 16.5 12.8 11.3 8.9 6.8 15.7 14.8 9.2 12.5 21.1 15.0 14.8 15.6 10.6 20.8 7.1 12.3 13.0 11.4 10.3 14.2 13.8 12.9 12.8 26.0 7.5 14.0 34.9 15.4 15.3 34.2 3.3 16.2 14.8 8.2 13.1 6.7 9.4 22.7 13.3 7.2 12.2 17.6 14.4 9.2 13.6 11.3 12.0 12.1 22.2 14.4 9.1 15.0 16.6 8.1 11.9 6.6 9.4 10.7 28.8 39.5 8.0 6.8 14.6 11.9 31.7 17.9 7.6 IQCE KIAA1023 ENSG00000106012 "IQ motif containing E" Q6IPM2 7 2558972-2614733 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 410.0;Late spermatids: 419.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.6" "Group enriched" "Detected in many" 4 "dendritic cells: 2.6;granulocytes: 4.6;monocytes: 1.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019515 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA019515: AB_1851855" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.91e-4)" "unprognostic (7.96e-3)" "unprognostic (3.75e-1)" "unprognostic (2.54e-3)" "unprognostic (1.31e-1)" "unprognostic (4.04e-3)" "unprognostic (1.30e-2)" "unprognostic (1.66e-2)" "unprognostic (2.84e-1)" "unprognostic (2.04e-2)" "unprognostic (2.82e-2)" "unprognostic (6.97e-2)" "unprognostic (7.56e-3)" "unprognostic (3.13e-2)" 4.5 6.6 19.7 6.5 17.3 5.7 6.2 10.0 19.8 6.8 19.2 9.5 12.1 8.4 10.4 5.4 14.7 7.3 6.7 17.9 16.6 6.5 3.4 7.6 4.3 17.0 17.0 16.0 7.7 7.6 11.0 14.5 3.5 14.8 7.9 8.7 9.9 9.1 9.4 4.9 7.4 10.2 6.7 13.7 4.6 9.7 32.0 16.5 4.3 10.6 5.6 3.5 5.8 4.4 15.5 35.5 18.2 7.0 23.0 9.2 13.4 13.2 7.2 11.7 8.8 9.4 9.5 19.6 2.5 8.0 16.7 19.7 17.9 5.1 7.4 8.9 6.3 10.9 4.9 21.9 2.6 6.8 12.8 6.4 5.8 13.5 8.3 9.9 10.4 10.3 8.9 15.4 4.5 11.8 35.8 5.2 8.6 6.6 15.7 12.4 4.9 8.4 8.8 10.1 15.9 15.7 18.7 8.2 33.9 7.1 4.9 41.5 17.1 10.3 7.6 15.7 30.2 12.2 4.9 8.0 0.5 15.3 8.5 22.1 0.8 0.8 2.3 0.6 1.2 0.2 0.2 0.3 0.3 0.3 0.3 0.2 0.6 4.6 0.2 0.4 2.6 0.2 0.2 19.7 17.3 10.0 19.8 17.9 16.6 17.0 17.0 16.0 14.8 13.7 16.5 15.5 4.8 12.8 14.3 14.4 2.1 5.5 5.7 5.3 6.2 8.9 12.3 7.9 9.1 14.3 11.4 12.9 60.5 4.1 13.8 27.4 17.6 20.6 410.0 44.8 15.3 5.7 8.4 1.7 16.6 19.7 10.0 7.0 24.5 9.4 1.3 7.6 6.4 2.8 10.1 20.2 17.4 12.3 12.2 8.1 5.3 419.3 14.0 9.3 0.0 3.7 12.0 14.9 12.3 4.5 4.2 24.1 18.9 15.4 8.0 5.4 12.1 9.5 58.7 36.7 19.7 7.8 6.6 40.9 43.8 3.5 4.3 1.9 4.9 11.2 12.4 4.0 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 431 "testis: 867.8" "Group enriched" "Detected in some" 61 "Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.5 0.2 0.1 0.4 0.0 0.5 0.0 0.7 0.3 0.1 0.2 0.5 0.1 2.0 0.1 0.4 0.1 0.3 0.4 1.4 0.7 0.2 0.1 0.2 0.7 0.6 0.4 0.3 0.7 0.1 0.7 0.0 1.0 0.6 0.1 0.3 0.1 0.1 0.3 0.1 0.2 0.2 0.0 0.2 0.1 867.8 0.7 0.1 0.9 0.1 0.2 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.3 1.2 0.0 2.3 0.0 0.0 0.2 0.1 1.2 0.8 0.0 0.0 0.0 1.4 0.0 0.0 1.7 0.3 0.5 0.0 0.3 0.0 4.6 0.0 1.7 1.1 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 2.0 0.0 0.0 1.5 0.0 0.0 1.0 0.3 0.0 0.8 0.2 0.0 9.8 0.5 0.4 1.4 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.7 0.4 1.4 0.7 0.6 0.4 1.0 0.0 0.7 0.9 0.3 0.0 0.0 0.3 0.3 0.0 0.3 0.4 0.0 0.9 0.1 0.3 0.5 1.5 0.1 0.0 0.0 0.1 0.0 0.1 5.9 0.2 3367.0 0.5 0.3 1.6 0.0 0.4 2.8 0.2 0.1 0.2 0.0 0.0 0.0 1.2 0.4 0.0 0.1 3.3 2.8 0.0 0.0 0.0 0.0 861.1 39.4 2.7 1.8 1.0 0.0 1.8 0.0 0.0 1.0 0.1 0.0 29.3 0.1 0.1 0.0 2.0 0.2 0.0 26.3 0.2 0.2 3073.6 29.9 0.0 0.1 0.0 0.1 2.5 0.0 0.1 VIPR2 "VPAC2, VPAC2R" ENSG00000106018 "Vasoactive intestinal peptide receptor 2" P41587 7 159028175-159144867 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 20.6;Excitatory neurons: 15.2;Muller glia cells: 38.9;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 45.1" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 17 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 17 "dendritic cells: 12.3" "Cell line enhanced" "Detected in some" "HeLa: 6.6;HMC-1: 9.0;MOLT-4: 12.9;U-266/70: 40.5" "Region enhanced" "Detected in many" "olfactory bulb: 27.1" "Low region specificity" "Detected in many" HPA062707 Approved Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA062707: AB_2684842" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (4.26e-2)" "unprognostic (2.04e-2)" "unprognostic (6.31e-2)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (8.58e-2)" "unprognostic (2.32e-2)" "unprognostic (1.02e-1)" "unprognostic (9.60e-2)" "unprognostic (1.74e-1)" "unprognostic (1.88e-1)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (8.89e-2)" 6.3 0.8 2.2 0.9 1.6 0.4 2.6 0.8 6.0 14.2 1.5 10.1 1.7 6.8 12.3 1.4 4.5 2.6 13.0 2.6 5.4 1.1 0.4 0.6 1.1 2.3 1.0 0.9 12.1 17.6 0.9 2.7 5.8 3.0 9.3 1.1 6.6 0.3 20.7 7.5 0.7 4.8 4.3 2.3 0.8 8.7 2.2 1.3 8.3 0.2 5.5 0.4 6.8 11.3 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.2 12.9 0.1 1.0 0.0 0.0 3.2 0.1 0.7 0.0 0.0 2.8 2.3 0.1 0.2 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 40.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.3 0.0 0.1 2.2 1.6 0.8 6.0 2.6 5.4 2.3 1.0 0.9 3.0 2.3 1.3 3.0 0.8 0.0 0.0 2.9 0.7 0.6 2.9 0.0 1.8 1.7 1.6 1.8 7.5 0.0 0.0 0.0 2.1 0.0 20.6 0.0 0.0 0.0 1.3 0.4 6.9 0.4 0.0 0.0 15.2 6.7 0.0 10.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.3 1.9 10.2 0.5 1.8 1.9 0.0 38.9 4.1 49.8 0.3 0.8 0.0 2.6 2.4 2.0 0.0 0.5 0.0 45.1 0.0 2.9 5.6 3.6 10.2 0.1 0.0 0.0 3.8 0.1 0.0 0.3 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 92.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1" "Cancer enhanced" "Detected in all" "renal cancer: 44.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 12.0 66.6 4.9 5.4 4.3 0.4 8.8 5.8 5.2 21.6 3.4 24.2 39.7 10.6 15.1 5.0 11.0 20.6 48.2 3.8 5.0 92.5 36.1 46.2 4.6 7.6 6.4 3.3 1.7 17.6 10.8 7.5 20.5 5.5 6.9 20.6 1.8 47.2 22.6 3.3 1.6 42.4 12.0 4.8 28.5 22.4 4.0 7.1 2.7 23.6 5.5 4.4 17.6 4.1 5.1 0.0 1.4 15.1 0.2 3.1 1.0 14.7 0.3 0.6 1.2 5.0 2.5 4.0 0.0 10.4 0.4 1.8 0.2 7.7 1.6 1.9 0.0 53.0 2.8 14.5 2.2 8.1 0.1 2.5 0.3 0.0 0.4 0.3 2.1 58.3 0.0 0.7 1.8 6.8 2.0 0.2 0.4 24.5 11.1 9.4 0.1 52.2 2.0 90.5 65.4 12.5 7.4 0.7 1.3 0.0 20.0 8.0 1.9 2.5 12.3 3.8 0.1 6.5 15.8 0.0 0.2 1.7 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.3 5.8 5.2 3.8 5.0 7.6 6.4 3.3 5.5 4.8 7.1 5.1 40.0 118.6 45.0 18.6 1.7 2.5 20.3 1.8 14.8 0.0 19.4 3.8 62.5 64.3 19.9 103.0 0.0 40.5 0.0 18.0 189.8 6.8 0.6 63.4 9.0 38.0 9.6 2.7 1.8 7.2 53.5 10.0 14.8 87.5 2.5 1.8 18.2 32.9 4.1 0.0 2.9 16.9 6.1 0.8 3.6 1.5 4.1 1.5 5.4 3.7 0.0 0.5 0.0 10.1 0.4 4.7 30.5 0.7 2.2 9.1 68.3 111.1 5.7 0.1 0.0 11.6 16.6 0.6 8.9 13.8 2.0 24.2 1.9 9.6 35.5 28.3 SSBP1 "mtSSB, SSBP" ENSG00000106028 "Single stranded DNA binding protein 1" Q04837 7 141738334-141787922 "Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002866 Supported Supported Mitochondria NA NA 150000 Mitochondria "HPA002866: AB_1080092" "unprognostic (2.95e-1)" "unprognostic (2.99e-1)" "unprognostic (2.49e-2)" "unprognostic (3.62e-2)" "unprognostic (7.36e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (3.68e-2)" "unprognostic (6.03e-2)" "prognostic favorable (3.40e-4)" "unprognostic (9.23e-3)" "unprognostic (4.02e-1)" "unprognostic (9.65e-3)" "unprognostic (1.62e-1)" "unprognostic (9.38e-2)" "unprognostic (1.25e-2)" "unprognostic (9.58e-2)" 86.5 105.9 76.5 81.6 78.2 90.7 98.0 78.3 101.9 72.1 72.9 91.6 71.0 84.3 108.6 126.9 74.7 54.5 125.3 77.6 82.3 99.7 121.4 63.5 97.8 78.5 77.8 73.9 86.0 88.5 94.4 65.3 79.0 80.1 65.5 86.2 58.7 78.1 71.1 142.4 87.4 78.1 76.7 77.4 81.4 93.9 81.4 77.5 97.5 83.5 94.9 113.8 92.7 82.8 80.4 280.6 333.6 281.6 369.2 125.5 193.2 262.2 208.7 193.0 256.4 287.9 353.7 330.5 414.0 267.6 173.5 421.8 210.2 349.5 347.4 369.6 220.8 339.1 226.1 253.6 322.3 242.6 644.9 166.8 179.9 230.9 257.4 373.0 177.7 316.2 279.9 552.8 184.0 343.4 430.9 477.3 837.2 634.1 476.8 403.0 262.6 258.2 578.5 340.9 286.7 256.4 352.5 236.8 323.7 319.8 213.7 210.7 267.2 239.6 183.0 171.6 282.1 533.8 328.6 465.9 796.1 369.9 577.6 395.8 136.1 69.9 76.8 71.7 96.1 107.7 106.3 113.8 98.9 90.6 92.0 101.1 113.7 20.6 98.8 99.8 104.0 123.8 116.3 76.5 78.2 78.3 101.9 77.6 82.3 78.5 77.8 73.9 80.1 77.4 77.5 80.4 151.0 102.5 104.7 13.7 135.7 116.0 199.6 477.7 98.4 58.6 114.3 178.8 279.1 148.7 242.7 150.8 41.7 311.0 139.2 92.7 350.2 310.3 187.0 160.6 162.3 136.5 96.3 111.7 17.0 353.3 313.7 140.5 92.2 169.8 151.9 163.3 105.3 221.9 251.9 43.7 16.0 163.7 244.1 122.0 126.3 62.2 137.3 131.0 104.9 15.0 221.2 152.1 157.6 16.6 29.1 314.0 130.0 123.8 101.3 166.6 141.9 445.2 178.0 79.1 98.6 170.6 223.5 253.5 190.0 136.3 129.4 261.7 145.2 254.1 188.1 200.2 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200091 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 22.5;placenta: 17.2;prostate: 22.5;seminal vesicle: 23.5" "Cell type enriched" "Detected in some" 4 "Distal enterocytes: 41.3" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046098, HPA069061" Supported "Nucleoplasm,Mitotic chromosome,Intermediate filaments" Yes NA Nucleoplasm "Mitotic chromosome, Intermediate filaments" "HPA046098: AB_2679536, HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.5 0.0 10.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 22.5 12.0 0.0 0.0 23.5 2.1 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.2 14.3 0.0 2.2 1.6 0.0 2.5 0.2 0.0 0.1 13.2 14.4 5.1 3.3 2.8 0.2 0.0 1.6 6.2 0.7 0.0 26.9 0.0 4.3 0.0 37.3 1.9 6.9 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 8.7 0.0 11.8 18.4 2.7 0.6 0.0 0.1 42.1 0.7 0.0 3.3 0.0 0.3 2.0 0.0 18.2 0.0 0.5 4.5 0.3 0.1 0.0 0.0 0.0 0.0 20.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.0 0.0 0.6 0.1 4.0 1.1 8.4 0.0 0.0 0.0 0.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.1 2.8 0.5 0.0 0.0 0.1 0.1 0.1 0.0 10.3 3.1 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988697-121297442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 79.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 48.4;Microglial cells: 229.5;Peritubular cells: 81.6;Theca cells: 94.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 10.8;intermediate monocyte: 11.3;myeloid DC: 25.2;non-classical monocyte: 7.6;plasmacytoid DC: 15.0" "Group enriched" "Detected in many" 9 "dendritic cells: 25.2;monocytes: 11.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 87.6;Hep G2: 51.6;K-562: 182.3;LHCN-M2: 60.0;U-138 MG: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012058 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favorable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 55.5 18.7 2.3 6.6 3.0 0.9 10.1 2.7 7.0 25.4 8.0 14.3 9.2 33.2 13.5 16.6 15.9 26.9 21.7 3.0 3.0 7.1 44.7 16.9 1.8 4.4 3.0 1.2 79.2 3.5 1.4 3.3 25.1 4.7 28.3 15.1 1.1 4.1 37.1 17.6 2.0 11.6 39.0 5.6 17.9 10.4 5.5 3.7 2.0 3.7 39.1 1.8 21.0 6.1 4.3 6.3 0.0 0.3 0.1 14.0 40.7 0.3 25.5 87.6 8.6 23.5 0.8 0.3 0.9 0.3 14.0 9.7 0.3 0.4 0.0 22.4 0.3 0.9 7.1 0.3 51.6 24.3 0.2 0.2 16.7 0.0 20.0 0.4 6.9 4.4 0.1 182.3 12.8 60.0 0.0 0.1 0.2 0.1 0.0 1.1 0.1 34.6 17.3 0.0 0.6 0.0 2.2 0.0 0.1 0.6 0.4 0.1 0.6 2.6 50.2 1.3 42.5 24.3 5.6 0.1 0.6 5.8 0.2 2.5 2.0 10.8 0.0 0.0 11.3 0.1 1.4 0.0 0.0 25.2 0.5 0.0 0.0 0.4 0.0 7.6 15.0 0.0 2.9 2.3 3.0 2.7 7.0 3.0 3.0 4.4 3.0 1.2 4.7 5.6 3.7 4.3 19.1 19.2 0.5 12.4 2.5 3.1 0.6 0.0 1.2 0.1 0.6 1.7 20.3 1.5 0.0 0.0 0.0 0.4 8.3 0.0 0.0 0.0 0.2 0.8 23.2 6.9 0.0 2.1 0.9 0.0 2.9 48.4 0.5 0.5 0.0 11.9 28.2 21.9 4.3 3.3 14.7 0.0 0.0 14.5 28.5 1.9 21.1 23.1 3.6 229.5 5.3 14.0 1.0 1.5 0.7 0.0 0.0 81.6 3.0 1.5 0.0 0.2 0.0 0.4 0.0 9.1 32.1 0.6 0.7 1.0 2.0 0.4 0.8 94.5 0.0 2.6 EVX1 ENSG00000106038 "Even-skipped homeobox 1" P49640 7 27242700-27250493 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.9;prostate: 3.9;seminal vesicle: 3.0;urinary bladder: 3.3;vagina: 3.5" "Group enriched" "Detected in some" 33 "Early spermatids: 62.0;Late spermatids: 73.3" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.6" "Region enhanced" "Detected in some" "medulla oblongata: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "OE19: 25.2;RT4: 16.1" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Not detected" "Not detected" HPA055132 Approved Nucleoplasm NA NA Nucleoplasm "HPA055132: AB_2682707" "unprognostic (2.73e-2)" "unprognostic (3.59e-1)" "unprognostic (4.31e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-3)" "unprognostic (2.08e-2)" "unprognostic (8.48e-3)" "unprognostic (5.94e-2)" "unprognostic (1.26e-8)" "unprognostic (2.94e-1)" "unprognostic (1.39e-1)" "unprognostic (9.12e-2)" "unprognostic (1.83e-2)" 0.0 2.9 0.2 0.0 0.2 0.0 0.0 0.2 0.1 1.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.9 0.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 3.3 3.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 1.7 0.5 0.0 1.0 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 62.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 73.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.0 HIBADH NS5ATP1 ENSG00000106049 "3-hydroxyisobutyrate dehydrogenase" P31937 7 27525442-27662883 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 543.9;Proximal tubular cells: 355.1;Syncytiotrophoblasts: 272.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019522, HPA021002" Enhanced NA NA 820000 "HPA019522: AB_1850690, HPA021002: AB_1850692" "unprognostic (6.76e-2)" "unprognostic (1.09e-1)" "unprognostic (7.50e-2)" "unprognostic (9.79e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-3)" "unprognostic (7.22e-3)" "unprognostic (3.14e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" "unprognostic (2.05e-2)" "prognostic favorable (5.56e-11)" "unprognostic (2.49e-2)" "unprognostic (5.47e-2)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" 62.6 79.8 14.2 12.0 17.3 7.7 57.1 18.2 18.6 37.5 24.6 34.1 35.3 35.6 11.7 20.5 42.0 28.7 67.3 12.2 18.4 162.0 199.5 20.6 15.2 15.5 15.8 11.1 33.7 34.5 98.3 14.2 47.8 16.3 45.1 34.8 31.8 45.8 42.8 118.5 12.9 32.2 37.5 15.1 18.1 34.3 26.6 16.5 21.4 55.0 205.0 14.9 33.9 18.1 17.0 74.0 46.8 31.0 50.1 89.1 109.8 29.3 44.8 83.8 46.3 52.8 27.6 85.2 29.9 38.4 81.4 79.4 67.1 34.5 66.5 67.3 20.9 34.6 14.6 73.0 114.3 73.8 22.4 16.1 101.2 54.1 34.8 120.6 112.1 61.7 35.3 59.7 29.2 117.2 31.2 21.4 34.7 30.0 110.4 56.0 21.2 31.2 33.1 106.5 43.6 28.6 31.7 93.8 173.5 77.9 76.4 75.0 48.6 40.3 28.6 49.5 47.1 31.2 51.8 39.7 17.8 41.2 67.8 85.1 5.3 17.3 8.2 16.7 22.8 22.5 18.2 18.4 19.3 19.3 16.4 24.0 19.8 3.0 22.9 22.0 9.1 13.2 17.4 14.2 17.3 18.2 18.6 12.2 18.4 15.5 15.8 11.1 16.3 15.1 16.5 17.0 17.3 9.6 6.4 56.2 14.1 21.3 43.6 51.9 17.1 15.8 58.8 28.2 105.8 58.6 37.7 47.8 4.2 181.1 8.1 23.3 543.9 35.8 58.5 22.8 28.5 21.5 15.6 33.2 64.4 29.1 138.9 44.6 43.3 27.3 2.5 12.0 25.4 149.8 53.7 23.5 85.9 28.9 40.7 28.3 10.0 62.3 44.7 18.5 65.8 51.5 11.0 34.1 8.2 147.2 131.6 28.0 24.1 36.9 20.1 46.1 58.4 355.1 50.8 11.9 46.0 31.6 35.4 35.0 44.3 22.4 15.5 272.4 15.2 77.3 38.8 47.3 TAX1BP1 "CALCOCO3, TXBP151" ENSG00000106052 "Tax1 binding protein 1" Q86VP1 7 27739331-27844564 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024432 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA024432: AB_1857783" "unprognostic (1.38e-2)" "unprognostic (5.52e-2)" "unprognostic (3.55e-2)" "unprognostic (2.71e-2)" "unprognostic (2.55e-1)" "unprognostic (9.83e-3)" "unprognostic (1.81e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.69e-1)" "prognostic favorable (2.80e-6)" "unprognostic (1.76e-1)" "unprognostic (4.76e-2)" "unprognostic (1.21e-1)" "unprognostic (3.03e-1)" 57.6 108.1 60.2 55.4 62.7 107.6 79.5 64.5 68.2 65.2 71.3 73.0 64.0 64.1 89.0 114.6 79.1 73.7 129.3 58.5 65.9 103.1 81.0 70.1 58.0 65.0 62.5 55.6 55.8 70.5 126.2 45.0 105.1 63.8 84.0 80.3 125.4 92.4 80.5 95.1 57.6 68.5 66.6 63.2 66.8 77.0 77.9 64.4 77.4 99.5 90.0 68.3 102.4 52.8 69.4 180.9 98.2 98.1 93.4 151.9 109.9 66.5 131.5 160.9 96.6 120.1 79.8 142.8 38.3 120.9 193.5 166.1 125.0 92.8 86.1 149.8 72.3 48.2 103.6 98.5 160.2 143.0 152.7 117.9 93.7 175.2 112.4 127.9 115.7 105.5 65.3 117.3 113.9 197.5 66.5 67.4 150.1 110.7 234.6 91.0 55.6 105.3 79.1 136.7 200.8 64.9 105.4 184.5 237.8 280.6 187.1 111.1 226.5 114.6 90.5 140.1 113.8 87.8 207.6 154.1 71.2 106.1 283.6 212.3 155.3 81.3 211.8 68.6 100.4 84.4 70.8 81.7 81.2 59.6 62.3 74.5 75.2 163.7 63.4 114.8 55.0 117.1 85.8 60.2 62.7 64.5 68.2 58.5 65.9 65.0 62.5 55.6 63.8 63.2 64.4 69.4 111.3 214.7 199.3 58.1 122.8 183.3 269.4 220.7 100.7 375.3 161.6 98.2 595.7 134.4 268.4 128.8 95.9 154.7 178.2 209.3 412.8 211.5 124.3 342.9 128.2 142.9 140.0 160.4 107.4 262.9 105.6 156.7 118.3 245.9 148.8 101.3 78.9 106.3 123.1 159.9 107.0 162.1 242.1 144.7 107.3 94.2 116.8 191.4 113.8 86.2 260.0 189.8 141.1 82.0 105.7 301.4 166.1 148.6 157.4 291.0 146.0 323.4 546.6 147.6 105.2 126.6 202.7 221.8 137.5 121.7 191.9 621.4 166.1 197.0 140.3 393.3 CPVL ENSG00000106066 "Carboxypeptidase vitellogenic like" Q9H3G5 7 28995235-29195451 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 220.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 61.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5" "Group enriched" "Detected in all" 52 "dendritic cells: 1319.5;monocytes: 1136.9" "Cell line enhanced" "Detected in many" "BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003697, HPA045715, HPA056466" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 760000 "Endoplasmic reticulum" "CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140" "unprognostic (4.72e-2)" "unprognostic (7.08e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (1.63e-1)" "unprognostic (2.49e-2)" "unprognostic (6.85e-3)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (4.98e-2)" "unprognostic (3.07e-1)" "unprognostic (4.25e-2)" "unprognostic (1.56e-2)" "unprognostic (1.79e-3)" "unprognostic (2.21e-1)" "unprognostic (7.46e-3)" "prognostic unfavorable (4.99e-4)" 44.4 23.8 6.9 66.9 9.6 60.3 25.2 49.0 12.1 28.7 35.0 29.2 33.1 17.3 35.0 25.6 20.0 42.4 80.1 6.1 25.0 95.5 53.3 58.1 93.7 15.3 9.7 4.6 18.3 8.0 5.5 10.2 85.6 20.5 18.1 25.9 0.9 5.3 21.5 12.6 19.5 46.9 34.4 12.5 220.8 15.6 34.7 11.1 67.4 129.5 8.3 36.1 51.1 15.9 18.5 1.5 0.2 20.3 0.1 0.1 0.0 190.8 0.0 0.0 1.9 0.4 59.8 0.1 0.0 90.3 0.8 94.4 3.2 51.8 4.2 0.6 0.4 47.9 67.0 1.2 144.5 0.0 0.0 0.3 0.3 5.9 0.7 1.6 0.0 0.6 27.5 45.5 0.1 1.6 0.0 63.4 0.4 31.6 0.1 16.0 0.3 0.0 0.6 801.1 22.8 11.9 9.4 53.6 125.5 101.7 97.0 15.1 49.6 0.0 0.4 0.8 0.5 12.0 17.5 205.5 1.0 0.2 25.0 20.8 19.5 1136.9 5.7 2.6 953.5 3.4 1.8 1.3 1.9 1319.5 1.2 1.2 1.2 23.4 5.8 327.8 34.8 1.5 1142.7 6.9 9.6 49.0 12.1 6.1 25.0 15.3 9.7 4.6 20.5 12.5 11.1 18.5 12.3 6.4 16.0 3.3 7.2 12.5 1.3 0.7 5.7 0.0 2.6 3.4 69.1 10.0 2.5 71.7 0.0 138.0 2.1 0.2 35.2 0.5 24.7 3.7 0.3 21.1 1.8 34.1 3.7 15.6 118.3 29.4 1.1 0.6 5.1 2.3 6.8 1.1 306.1 0.0 1.7 1.2 0.0 290.3 531.0 7.6 9.3 266.2 10.6 45.9 176.8 0.2 2.1 2.0 1.3 0.8 0.4 3.0 2.9 0.5 0.4 30.6 1.5 0.4 0.0 31.0 3.0 27.1 92.8 27.2 8.8 118.5 3.3 3.6 1.2 0.9 CHN2 "ARHGAP3, RhoGAP3" ENSG00000106069 "Chimerin 2" P52757 7 29146569-29514328 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.3;intestine: 70.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 307.9;Early spermatids: 130.6;Excitatory neurons: 139.5;Late spermatids: 118.1;Microglial cells: 145.2;Oligodendrocytes: 496.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.4;HMC-1: 68.3" "HPA018989, HPA019026" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA018989: AB_1846681, HPA019026: " "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (6.87e-2)" "unprognostic (2.56e-1)" "unprognostic (1.52e-1)" "unprognostic (8.12e-2)" "unprognostic (6.87e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "unprognostic (4.71e-2)" "unprognostic (7.54e-2)" "unprognostic (7.85e-2)" "unprognostic (1.61e-2)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (1.15e-2)" "unprognostic (1.58e-3)" 4.2 6.3 22.2 5.4 36.4 2.2 3.4 103.3 35.2 10.3 18.1 8.6 70.8 4.2 2.3 2.6 8.1 7.0 11.1 26.5 30.1 13.2 38.2 5.7 3.1 31.2 31.7 21.4 20.4 25.3 0.5 3.4 10.9 45.2 8.1 9.9 51.9 2.7 4.1 4.7 1.9 58.4 4.4 30.3 8.3 6.7 2.5 30.2 3.8 7.9 1.4 2.5 6.4 3.2 62.4 0.3 0.8 3.0 0.0 0.0 0.0 19.0 0.0 0.0 0.7 0.0 10.4 2.9 0.9 6.0 0.2 1.2 5.2 10.1 0.1 0.0 18.1 3.8 37.4 1.7 18.4 0.2 0.0 68.3 0.0 6.4 0.0 0.7 0.0 3.5 5.9 1.5 0.5 0.0 0.4 11.2 0.4 1.2 6.8 3.4 0.8 0.0 2.0 18.2 12.0 18.3 1.4 3.9 5.8 10.2 10.7 0.7 2.0 0.4 1.0 0.3 0.1 0.4 3.6 15.2 0.0 0.3 2.2 1.2 4.4 11.6 0.1 2.8 12.7 1.9 0.3 0.4 2.1 10.1 0.1 0.4 1.1 0.5 9.6 7.3 1.1 0.0 3.6 22.2 36.4 103.3 35.2 26.5 30.1 31.2 31.7 21.4 45.2 30.3 30.2 62.4 3.3 6.4 3.6 5.5 2.0 2.7 0.8 0.2 0.6 307.9 0.3 0.3 14.1 5.7 2.0 3.7 43.8 24.6 6.1 15.3 0.0 0.5 130.6 8.8 0.3 8.5 39.4 9.5 139.5 2.1 33.5 3.8 12.2 2.7 23.5 2.2 3.9 84.4 18.5 6.7 28.8 24.0 2.0 29.0 33.1 118.1 5.0 20.5 17.8 145.2 29.3 11.7 22.6 10.1 496.8 0.2 14.3 4.9 1.3 1.0 107.8 2.3 7.6 15.9 0.0 5.4 1.1 2.6 6.2 0.2 0.6 16.4 14.4 0.7 23.6 1.1 GRB10 ENSG00000106070 "Growth factor receptor bound protein 10" Q13322 7 50590063-50793462 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Early spermatids: 143.0;Late spermatids: 212.6;Oligodendrocytes: 124.7;Rod photoreceptor cells: 81.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 10.0;eosinophil: 3.0" "Lineage enriched" "Detected in single" 28 "granulocytes: 10.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB019423, HPA027502, HPA031818" Enhanced Supported Vesicles NA NA Vesicles "CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057" "unprognostic (2.82e-2)" "unprognostic (1.69e-3)" "unprognostic (1.25e-2)" "unprognostic (1.45e-2)" "unprognostic (3.68e-2)" "unprognostic (1.60e-1)" "unprognostic (6.83e-2)" "unprognostic (5.91e-3)" "unprognostic (1.67e-2)" "unprognostic (2.31e-3)" "unprognostic (4.44e-1)" "unprognostic (2.07e-1)" "unprognostic (1.23e-3)" "unprognostic (1.73e-3)" "unprognostic (8.16e-3)" "unprognostic (2.63e-2)" "unprognostic (8.50e-2)" 26.3 26.2 33.6 6.6 35.7 10.1 25.2 26.1 33.7 18.0 29.2 21.8 17.4 20.0 10.4 9.6 18.9 21.8 32.0 28.2 37.7 29.0 32.3 20.7 6.0 33.7 38.1 30.4 14.3 95.1 10.6 24.4 14.8 39.6 20.3 6.5 84.3 16.7 15.2 58.0 8.5 13.4 16.3 24.4 37.1 17.8 18.2 47.2 2.8 28.1 76.7 4.0 31.3 16.0 36.7 0.3 32.5 51.6 21.1 23.5 17.8 27.6 13.1 11.3 24.9 29.7 19.8 0.4 0.7 22.6 16.7 71.0 3.1 53.5 13.9 12.2 0.4 21.6 56.7 32.6 14.4 49.8 36.0 84.1 46.4 21.0 38.6 37.4 23.9 62.7 3.9 109.5 0.6 18.7 4.0 6.4 48.0 56.9 27.2 55.4 16.8 0.0 0.3 16.0 13.1 22.7 0.2 1.6 8.1 68.7 33.0 27.7 71.6 78.7 21.8 29.6 45.4 50.4 2.1 0.7 0.4 68.9 32.2 75.2 10.0 0.1 3.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 33.6 35.7 26.1 33.7 28.2 37.7 33.7 38.1 30.4 39.6 24.4 47.2 36.7 46.3 6.4 8.3 3.9 1.2 7.5 5.3 9.4 7.4 12.1 14.8 9.0 13.5 47.1 5.2 5.5 87.6 4.5 0.3 6.9 1.9 18.3 143.0 5.3 12.4 45.2 0.0 19.0 64.8 24.4 16.5 15.4 5.6 9.7 0.0 0.8 53.2 26.8 1.6 5.0 55.0 2.8 6.1 9.7 5.5 212.6 1.8 4.0 7.2 40.3 0.8 21.8 0.0 41.7 124.7 36.4 3.0 0.4 0.6 22.2 11.2 22.2 2.3 81.9 0.0 9.2 10.9 1.9 16.2 1.2 4.3 2.6 1.5 0.9 3.8 7.0 ABHD11 "PP1226, WBSCR21" ENSG00000106077 "Abhydrolase domain containing 11" Q8NFV4 7 73736094-73738867 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hydrolase "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 156.9;Urothelial cells: 241.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 92.6;SK-BR-3: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024042, HPA049641" Approved Supported Mitochondria NA NA 31000 Mitochondria "HPA024042: AB_1844445, HPA049641: AB_2680838" "unprognostic (4.74e-2)" "unprognostic (8.62e-3)" "unprognostic (1.42e-1)" "unprognostic (2.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-3)" "unprognostic (1.91e-2)" "unprognostic (9.32e-2)" "unprognostic (7.79e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.66e-7)" "unprognostic (3.61e-3)" "unprognostic (4.44e-2)" "unprognostic (1.02e-1)" "unprognostic (7.29e-2)" 7.1 13.6 8.5 5.6 8.8 4.5 12.3 10.2 11.4 8.3 13.8 25.9 16.1 7.3 5.9 13.7 13.9 8.7 21.6 8.5 8.8 29.6 9.6 9.6 4.0 10.7 10.2 8.5 3.9 25.9 13.0 16.5 7.7 10.7 23.4 17.6 3.0 21.5 8.3 11.4 12.8 19.9 3.6 9.4 8.1 9.1 7.3 10.7 3.4 28.4 10.4 5.5 8.6 7.0 10.0 46.9 10.7 7.1 16.4 3.7 5.0 39.7 21.1 8.9 12.7 14.9 13.1 51.4 22.2 6.2 9.0 17.3 20.2 3.2 12.1 8.8 8.2 15.4 10.8 6.7 8.3 6.5 11.8 11.4 4.6 5.0 16.4 7.6 4.6 9.2 7.4 15.1 11.8 12.0 92.6 9.2 14.9 8.3 29.5 39.1 5.0 11.4 41.0 29.7 21.8 18.3 7.6 17.1 113.0 7.1 5.1 36.8 7.8 9.1 10.8 10.2 46.5 22.2 7.3 4.2 14.8 17.3 11.2 20.3 10.2 19.1 19.3 8.2 32.7 6.8 10.1 9.1 8.7 19.4 12.7 8.4 5.9 15.2 14.9 33.5 9.2 6.3 11.9 8.5 8.8 10.2 11.4 8.5 8.8 10.7 10.2 8.5 10.7 9.4 10.7 10.0 7.9 44.8 15.7 3.3 10.6 5.5 60.3 39.8 10.2 16.6 43.1 21.7 16.9 54.3 60.7 57.0 4.2 86.3 8.7 156.9 72.4 52.1 1.2 98.9 17.3 9.7 62.6 9.4 5.8 40.8 120.1 9.9 35.7 98.1 15.2 6.3 4.6 8.7 28.0 5.0 4.0 106.8 95.6 11.3 10.5 2.3 9.0 13.7 14.2 4.7 10.4 26.6 14.4 3.0 3.7 38.2 151.7 3.4 10.5 53.1 128.2 55.3 127.6 15.2 0.0 10.3 14.4 6.8 7.1 23.3 6.3 127.7 9.6 22.1 128.9 241.3 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 124.6;skeletal muscle: 132.6;tongue: 108.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 2.2 1.1 88.9 1.4 97.8 0.0 15.0 68.8 92.1 4.9 47.1 13.5 19.1 2.3 2.1 13.7 19.3 5.8 55.3 89.2 74.1 12.5 19.7 14.0 0.2 86.4 95.7 75.6 2.8 18.5 31.7 12.9 4.8 93.7 14.6 11.0 23.5 47.7 4.2 132.6 26.6 21.7 2.7 75.8 0.4 17.8 3.0 85.4 1.3 8.3 108.9 1.0 1.8 5.9 124.6 12.4 8.8 0.2 0.3 0.0 0.0 33.7 0.0 0.0 0.0 0.0 24.1 18.2 0.0 0.9 0.0 1.4 21.1 12.0 0.0 0.0 0.0 9.6 0.0 57.0 4.7 0.0 0.0 0.1 1.5 2.3 0.0 0.0 0.0 0.0 1.6 6.5 0.2 0.2 7.9 0.1 0.1 9.0 53.4 8.0 0.1 0.5 45.5 17.4 0.0 11.0 0.2 3.2 26.2 3.9 32.6 16.6 0.1 0.0 0.0 9.8 0.3 0.9 0.0 34.1 0.1 0.1 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 88.9 97.8 68.8 92.1 89.2 74.1 86.4 95.7 75.6 93.7 75.8 85.4 124.6 1.4 38.5 19.6 48.0 1.0 17.8 3.4 1.2 4.0 2.3 38.0 34.7 76.2 28.6 13.2 9.2 58.4 23.3 4.6 59.4 0.0 21.5 3.8 65.9 3.3 2.2 18.6 0.0 198.7 9.7 9.2 7.7 35.7 74.6 10.1 4.6 0.4 29.7 2.2 0.0 96.6 35.2 4.1 0.8 1.7 3.1 0.6 0.9 16.0 10.3 1.1 94.4 0.0 353.9 548.8 23.2 35.0 0.4 0.2 25.3 76.8 18.6 31.4 73.6 0.0 10.5 1.5 0.7 8.8 6.8 35.7 40.2 1.7 11.2 14.4 7.3 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FKBP prolyl isomerase 14" Q9NWM8 7 30010587-30026702 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavorable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavorable (4.25e-4)" 6.5 5.1 3.4 7.1 3.6 4.3 6.4 5.6 3.6 10.0 3.1 4.4 3.1 8.6 10.0 4.7 4.3 6.1 6.8 3.3 3.7 3.1 3.2 4.1 3.1 3.3 3.3 3.5 5.4 5.8 6.2 7.8 8.0 3.8 6.8 4.8 7.2 4.4 7.6 2.1 4.7 3.0 14.0 3.1 2.7 4.0 2.2 3.4 1.8 3.4 3.2 3.2 8.9 3.8 3.6 7.0 5.2 14.4 33.6 36.8 46.8 6.5 34.9 32.7 12.0 23.3 4.4 4.3 2.4 16.0 31.0 14.7 14.8 8.1 12.8 23.9 1.3 11.6 5.6 9.2 13.1 18.6 4.0 9.3 29.4 13.1 20.9 24.6 28.2 27.0 3.6 9.2 5.0 21.8 2.9 2.1 4.9 7.5 7.7 9.2 0.1 9.6 8.2 11.8 6.1 3.8 12.5 12.2 27.5 8.8 17.0 6.2 5.3 21.7 12.6 14.6 21.8 14.0 7.6 8.3 4.2 18.0 3.8 40.2 0.5 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.4 0.2 0.0 0.6 0.2 0.1 3.4 3.6 5.6 3.6 3.3 3.7 3.3 3.3 3.5 3.8 3.1 3.4 3.6 13.5 19.2 16.0 7.2 7.9 27.4 22.0 15.8 35.9 16.3 13.3 13.0 15.7 5.7 11.7 18.4 27.1 11.6 9.4 5.3 1.9 7.4 0.4 30.4 44.3 12.9 1.2 6.5 19.4 3.7 27.3 40.0 15.3 40.0 2.5 9.1 8.6 6.5 6.0 15.2 12.7 9.7 8.2 2.5 11.2 0.4 13.1 5.7 10.6 10.3 3.6 26.5 2.1 11.6 16.6 5.7 19.0 20.7 43.8 17.8 3.3 2.7 6.0 21.4 6.6 13.8 20.4 1.4 3.4 27.5 18.3 15.7 6.0 20.8 6.1 28.0 PLEKHA8 "FAPP2, MGC3358" ENSG00000106086 "Pleckstrin homology domain containing A8" Q96JA3 7 30027404-30130483 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072314 Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA072314: AB_2686511" "unprognostic (5.49e-3)" "unprognostic (8.62e-3)" "unprognostic (2.39e-1)" "unprognostic (5.14e-2)" "unprognostic (1.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.70e-4)" "unprognostic (5.96e-2)" "unprognostic (2.86e-1)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.96e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (3.07e-2)" 3.5 2.4 3.9 3.2 3.9 1.5 3.6 5.4 4.8 4.8 3.7 3.9 3.7 3.7 4.2 4.1 3.1 3.0 2.7 4.0 3.5 6.2 3.1 3.6 4.4 4.1 4.0 3.7 4.1 3.7 4.3 3.3 8.0 3.7 3.6 3.7 11.9 4.0 3.7 2.4 3.8 4.2 3.8 3.7 2.4 3.5 3.5 4.4 2.8 2.8 2.4 4.8 3.8 4.3 4.4 11.4 7.8 34.5 35.3 9.4 7.3 23.2 8.2 6.6 6.3 8.3 14.1 4.9 25.8 10.5 7.4 16.4 8.2 18.2 9.1 8.9 5.0 12.5 15.1 12.8 13.4 7.9 6.9 5.2 3.8 7.3 8.6 12.4 7.8 13.6 12.3 14.3 9.3 9.1 7.2 13.2 4.6 22.7 5.5 8.6 0.0 9.4 18.2 7.1 9.0 4.4 25.2 8.8 28.9 11.5 30.5 10.2 7.0 11.5 5.7 22.8 5.6 9.4 18.9 35.6 15.4 10.8 4.4 12.8 0.3 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.3 0.0 0.2 0.1 0.0 0.1 0.0 3.9 3.9 5.4 4.8 4.0 3.5 4.1 4.0 3.7 3.7 3.7 4.4 4.4 8.9 3.2 2.6 32.7 6.6 11.2 6.3 2.3 10.8 14.8 7.0 4.7 3.7 1.5 2.8 12.9 25.0 21.6 4.4 7.2 3.9 11.7 2.0 11.4 10.3 5.8 2.4 3.8 36.0 7.1 19.6 6.0 2.6 14.8 4.5 10.0 3.9 4.6 6.7 10.1 30.2 5.0 8.2 3.4 4.6 1.1 3.4 4.7 10.6 14.0 6.5 6.3 10.3 33.7 24.2 10.2 23.9 4.9 15.8 8.7 9.6 12.2 4.4 18.7 6.6 4.9 10.3 14.0 12.4 7.6 12.6 20.2 4.7 4.9 4.8 10.2 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 129.6;pituitary gland: 99.3" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.9;U-87 MG: 92.2" "Group enriched" "Detected in all" 5 "amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1" "Group enriched" "Detected in all" 8 "amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2" "CAB008372, HPA069176" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA Vesicles "Nuclear membrane" "CAB008372: AB_592786, HPA069176: AB_2686098" "unprognostic (5.12e-3)" "prognostic unfavorable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 2.2 6.9 43.2 2.6 68.7 12.0 2.4 28.0 129.6 5.3 13.8 8.4 4.5 4.0 1.5 1.8 3.8 6.8 1.7 68.2 35.5 2.8 2.3 3.5 1.1 23.1 19.1 69.5 3.2 10.9 0.9 99.3 2.3 34.6 4.6 2.0 2.5 3.0 1.5 2.1 1.8 4.3 2.7 13.8 2.6 7.8 4.6 21.2 1.2 2.8 0.7 0.6 4.1 4.2 59.6 4.6 21.9 3.4 10.1 4.4 11.7 2.3 14.3 9.5 5.9 3.9 7.4 12.2 5.8 2.1 10.3 32.2 3.7 5.0 9.2 4.4 10.2 3.9 1.8 8.7 4.4 4.9 2.7 5.2 6.8 3.8 41.4 14.4 26.7 10.4 0.9 4.9 6.5 11.4 10.8 1.7 21.1 2.7 8.1 47.8 0.0 2.4 5.7 4.9 3.9 139.9 22.5 4.3 12.1 3.0 4.0 3.9 1.8 39.7 28.9 9.6 22.4 39.0 3.7 2.5 2.7 92.2 2.2 34.5 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 43.2 68.7 28.0 129.6 68.2 35.5 23.1 19.1 69.5 34.6 13.8 21.2 59.6 0.9 0.0 2.8 8.1 0.4 4.2 10.7 6.2 0.6 6.2 4.6 3.4 3.2 4.3 5.9 1.8 4.2 0.4 5.0 1.3 0.0 4.0 0.1 4.5 2.9 1.6 52.7 0.4 60.6 3.6 1.9 2.2 3.1 11.1 15.2 2.2 1.8 0.2 0.7 8.4 16.6 2.8 8.2 1.2 2.1 0.2 1.8 6.1 3.6 5.6 0.1 1.0 6.2 8.5 4.8 29.8 1.2 1.5 1.0 10.5 3.4 0.5 7.4 1.9 0.0 1.9 2.8 1.6 3.8 0.6 2.7 0.7 5.3 1.7 1.5 18.9 NOD1 "CARD4, CLR7.1, NLRC1" ENSG00000106100 "Nucleotide binding oligomerization domain containing 1" Q9Y239 7 30424527-30478784 "Human disease related genes, Predicted intracellular proteins" "Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Microglial cells: 26.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 11.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074367 Approved Mitochondria NA NA Mitochondria "HPA074367: AB_2686683" "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (9.73e-2)" "unprognostic (8.09e-3)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-3)" "unprognostic (6.63e-2)" "unprognostic (2.26e-1)" "unprognostic (2.74e-1)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.68e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.95e-4)" "unprognostic (2.64e-1)" 10.6 2.9 3.2 8.9 2.9 6.9 9.6 2.5 2.8 4.9 5.6 5.1 2.2 6.2 2.6 4.8 6.5 5.5 7.3 2.2 7.3 3.9 2.2 12.0 6.1 7.6 3.5 1.7 10.4 1.8 2.8 2.9 12.3 4.7 4.1 4.4 0.6 6.2 3.2 4.0 5.5 5.5 7.4 3.0 11.2 4.9 2.0 4.6 3.5 10.9 4.0 5.0 7.3 5.0 4.5 4.8 2.5 3.5 10.5 2.2 10.3 5.3 3.3 2.3 5.5 7.0 2.2 5.7 6.9 3.8 4.2 6.1 11.2 3.5 5.8 3.7 3.6 3.0 9.7 7.7 2.2 2.8 4.3 7.0 9.6 2.5 3.5 3.0 4.9 18.3 10.1 5.2 2.4 5.0 2.8 6.2 7.7 4.1 5.3 4.5 7.4 4.0 6.3 1.8 3.8 0.6 12.4 4.2 10.7 3.7 4.8 3.6 9.6 7.7 4.8 7.6 6.0 4.5 2.2 8.0 0.3 3.5 15.1 5.1 13.7 3.7 13.5 8.1 5.0 8.9 7.5 5.5 5.3 3.3 10.9 4.9 4.0 2.8 8.5 6.6 8.0 4.8 2.6 3.2 2.9 2.5 2.8 2.2 7.3 7.6 3.5 1.7 4.7 3.0 4.6 4.5 19.3 3.2 15.1 7.2 6.6 0.8 0.5 1.0 5.2 2.4 2.9 2.9 4.9 1.5 5.0 5.5 0.0 5.0 6.7 4.5 0.0 1.3 0.2 4.4 1.7 12.0 0.0 3.4 5.3 2.1 2.3 8.2 1.1 4.6 2.5 7.8 13.6 1.3 4.6 0.0 1.4 5.5 2.0 3.1 3.7 0.0 0.6 4.3 5.4 26.2 4.0 0.6 6.2 2.5 1.1 1.7 1.7 1.9 3.1 0.2 1.6 0.5 2.9 0.2 0.0 2.5 5.6 0.0 0.6 5.4 1.8 1.5 5.3 1.0 5.6 0.8 GARS1 "CMT2D, DSMAV, GARS, GlyRS, SMAD1" ENSG00000106105 "Glycyl-tRNA synthetase 1" P41250 7 30580533-30634033 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 34.1;Cytotrophoblasts: 47.0;Extravillous trophoblasts: 70.0;Hofbauer cells: 44.3;Syncytiotrophoblasts: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017896, HPA019097" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 560000 Cytosol "HPA017896: AB_1849478, HPA019097: AB_1849480" "prognostic unfavorable (1.02e-4)" "unprognostic (2.46e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.04e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.95e-5)" "unprognostic (7.31e-3)" "unprognostic (4.76e-1)" "unprognostic (4.00e-3)" "unprognostic (1.77e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.70e-5)" "unprognostic (3.92e-1)" "unprognostic (3.40e-2)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.04e-5)" 34.5 31.3 34.4 43.7 37.6 32.3 32.0 35.5 46.6 32.9 46.2 40.2 27.8 29.4 37.7 54.3 23.5 30.1 33.2 38.4 43.4 43.1 46.3 34.3 47.6 37.4 37.6 33.7 26.9 79.1 58.5 36.8 40.2 44.0 27.0 49.1 47.3 36.4 29.6 48.5 41.4 26.2 50.2 34.2 22.5 47.9 52.0 46.0 41.1 52.0 45.4 67.9 54.6 29.7 43.4 231.4 119.8 103.4 364.5 191.9 286.8 172.0 332.4 330.5 184.0 369.8 159.5 115.4 375.9 96.2 443.1 281.6 174.5 262.6 230.2 327.7 92.9 82.5 182.6 84.8 141.1 604.0 267.6 149.8 272.5 391.9 265.8 304.9 128.1 241.6 354.1 350.2 465.4 296.7 154.7 216.8 204.3 259.6 222.4 183.4 114.0 90.1 299.0 219.5 109.1 117.9 177.4 88.1 261.5 509.2 182.8 225.3 409.3 208.2 82.2 262.9 164.9 217.9 403.8 390.8 445.9 289.4 398.8 392.9 40.0 27.0 24.1 22.9 35.8 27.4 21.0 26.0 28.8 35.8 16.3 25.2 30.2 5.2 20.9 41.7 18.5 31.9 23.9 34.4 37.6 35.5 46.6 38.4 43.4 37.4 37.6 33.7 44.0 34.2 46.0 43.4 10.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 47.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 70.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 39.8 2.0 0.0 0.0 0.0 CRHR2 "CRF-RB, CRF2, HM-CRF" ENSG00000106113 "Corticotropin releasing hormone receptor 2" Q13324 7 30651942-30700129 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2;choroid plexus: 17.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.0;Excitatory neurons: 8.2;Horizontal cells: 13.5;Inhibitory neurons: 4.9;Smooth muscle cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 8.1" "Low region specificity" "Detected in many" HPA073345 Supported "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA073345: " "unprognostic (7.14e-2)" "unprognostic (4.20e-1)" "unprognostic (1.68e-1)" "unprognostic (1.24e-3)" "unprognostic (5.69e-2)" "unprognostic (8.58e-2)" "unprognostic (6.00e-2)" "unprognostic (1.86e-4)" "unprognostic (2.01e-1)" "unprognostic (3.07e-1)" "unprognostic (5.90e-4)" "unprognostic (4.02e-2)" "unprognostic (8.29e-4)" "unprognostic (3.73e-3)" "unprognostic (2.84e-3)" "unprognostic (1.81e-1)" "unprognostic (3.84e-1)" 0.5 0.1 1.4 0.0 1.1 0.0 0.6 0.4 6.2 0.3 17.7 0.2 0.3 0.3 0.0 0.2 0.5 0.1 1.4 2.4 0.8 0.1 0.0 0.1 0.0 1.5 1.1 0.3 0.4 1.8 0.1 4.2 0.0 1.0 0.2 0.1 2.5 0.3 1.3 1.2 0.2 0.3 0.1 0.3 0.0 0.2 0.8 2.0 0.0 0.7 2.2 0.0 0.3 0.2 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.4 6.2 2.4 0.8 1.5 1.1 0.3 1.0 0.3 2.0 2.6 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 4.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 54.7;skin 1: 62.4" "Cell type enhanced" "Detected in many" "Muller glia cells: 226.6;Sertoli cells: 105.2;Suprabasal keratinocytes: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "MOLT-4: 39.6;RT4: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035784 Uncertain "Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" "HPA035784: AB_2674781" "unprognostic (1.90e-2)" "prognostic favorable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favorable (4.68e-5)" 6.2 0.7 9.5 1.8 24.6 2.3 3.6 0.2 54.7 18.1 0.3 2.4 0.0 9.0 2.3 10.7 13.6 1.5 2.4 14.7 6.6 2.8 1.5 4.1 2.4 8.7 4.2 13.6 7.9 12.5 0.9 2.5 0.4 10.2 14.4 0.1 2.9 5.7 7.3 1.5 62.4 5.0 1.6 1.0 4.3 3.3 5.1 4.5 14.6 9.5 0.7 2.3 7.9 18.6 36.9 0.2 0.0 0.0 0.8 7.5 3.0 0.0 0.9 0.8 0.2 0.1 1.0 2.3 0.0 0.0 0.1 0.0 8.8 0.4 0.0 0.0 2.0 0.3 0.6 0.0 0.3 1.2 9.7 0.4 1.7 0.8 3.0 0.0 0.1 0.5 5.2 2.1 0.0 0.1 0.2 39.6 5.8 6.8 1.4 3.6 0.8 0.0 0.0 0.0 71.7 0.0 0.0 3.3 2.0 0.0 1.5 6.1 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.6 0.0 0.0 3.5 0.0 0.0 0.8 0.4 0.0 0.3 0.3 1.6 1.1 0.6 0.5 0.3 1.4 0.7 0.5 0.0 0.1 0.0 1.0 0.7 9.5 24.6 0.2 54.7 14.7 6.6 8.7 4.2 13.6 10.2 1.0 4.5 36.9 1.9 3.2 1.7 6.2 12.5 54.4 30.7 13.3 42.1 12.1 1.8 6.7 3.0 45.8 10.0 7.3 2.1 0.2 1.9 0.1 5.9 28.2 0.9 5.7 20.0 2.8 1.8 8.6 65.1 6.8 0.0 15.6 6.1 7.2 0.0 3.2 1.8 3.5 4.2 0.0 43.4 0.1 0.0 13.2 10.4 8.3 30.1 8.9 12.4 8.4 7.1 226.6 5.2 5.5 4.6 32.4 0.1 9.8 1.6 11.0 0.0 0.6 4.9 6.6 105.2 31.5 20.5 0.5 7.2 40.0 118.5 0.3 14.0 0.7 0.1 22.2 MINDY4 "C7orf67, FAM188B, FLJ22374" ENSG00000106125 "MINDY lysine 48 deubiquitinase 4" Q4G0A6 7 30771417-30892387 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 36.7;Endometrial stromal cells: 8.9;Respiratory ciliated cells: 18.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019475, HPA030129, HPA030130" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565" "unprognostic (2.96e-1)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.07e-1)" "unprognostic (6.01e-3)" "unprognostic (3.81e-2)" "unprognostic (5.25e-3)" "unprognostic (1.97e-1)" "unprognostic (5.59e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-1)" "unprognostic (9.55e-2)" "unprognostic (1.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" 6.0 3.7 3.3 1.2 2.9 2.4 4.4 1.1 4.3 5.6 9.0 3.7 1.3 5.4 8.4 3.0 11.6 5.6 3.9 1.8 2.3 4.9 2.1 9.6 1.2 2.4 2.9 1.7 9.0 3.4 4.8 5.6 3.3 1.7 5.9 2.1 2.1 3.1 8.2 2.3 3.0 2.2 6.0 2.1 1.2 3.3 9.0 2.0 1.2 6.7 3.5 0.9 4.4 3.7 2.5 2.4 6.0 3.1 9.5 2.7 10.3 4.5 3.5 6.0 2.6 2.2 0.0 4.4 0.0 3.9 2.3 3.6 2.6 2.1 2.0 2.5 0.0 3.5 1.9 3.2 0.0 3.3 2.7 1.3 5.3 3.1 7.7 1.5 0.2 3.8 1.7 19.2 1.1 2.2 0.0 1.5 0.8 8.9 8.5 1.4 0.4 0.0 0.6 7.1 1.2 5.7 7.7 2.3 12.5 1.3 3.5 6.4 2.0 2.3 0.1 1.4 2.7 1.5 2.5 3.5 0.0 4.9 0.1 11.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 3.3 2.9 1.1 4.3 1.8 2.3 2.4 2.9 1.7 1.7 2.1 2.0 2.5 5.2 9.6 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 1.8 12.9 0.0 2.3 0.5 0.0 3.9 2.8 0.0 36.7 8.9 2.3 0.0 0.0 0.0 1.3 4.1 2.7 0.0 3.9 2.5 4.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.4 18.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.2 4.1 0.0 0.0 GHRHR ENSG00000106128 "Growth hormone releasing hormone receptor" Q02643 7 30938669-30993254 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 351 "pituitary gland: 213.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Spermatocytes: 1.2;Spermatogonia: 3.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (8.32e-2)" "unprognostic (1.45e-1)" "unprognostic (9.30e-2)" "unprognostic (1.39e-1)" "unprognostic (7.23e-2)" "unprognostic (4.15e-1)" "unprognostic (2.28e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.43e-2)" "unprognostic (1.47e-1)" "unprognostic (5.87e-3)" 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 213.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CASP2 "ICH1, MGC2181, NEDD2, PPP1R57" ENSG00000106144 "Caspase 2" P42575 7 143288215-143307696 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012175, HPA050678" Approved Approved Nucleoplasm NA Yes Nucleoplasm "CAB012175: , HPA050678: AB_2681214" "unprognostic (6.96e-2)" "prognostic favorable (7.38e-4)" "unprognostic (2.74e-2)" "unprognostic (7.51e-2)" "unprognostic (4.24e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (1.74e-2)" "unprognostic (1.34e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.64e-1)" 9.5 6.6 6.0 14.0 7.0 40.6 10.6 7.9 6.6 11.5 6.7 11.2 10.8 10.3 9.6 15.5 10.4 7.0 7.5 5.8 6.7 7.0 6.5 10.4 22.1 7.2 6.6 5.6 9.3 8.5 11.2 5.3 12.5 7.4 7.7 12.8 7.8 12.0 6.3 3.9 17.6 15.5 9.5 6.7 19.1 9.7 9.1 7.1 27.7 8.9 5.0 27.3 7.6 11.3 10.1 27.5 25.4 28.8 51.0 15.1 17.5 15.4 27.7 13.0 25.4 27.8 26.0 31.3 52.0 25.9 18.4 19.4 27.3 29.4 22.6 34.0 45.8 22.5 31.2 40.4 18.3 8.4 60.7 37.4 13.0 18.1 31.0 11.0 11.3 22.0 41.3 26.3 32.6 27.5 27.5 109.1 64.4 36.5 27.4 26.3 79.1 14.6 32.6 15.1 23.3 31.5 34.2 54.8 24.3 17.3 19.6 26.3 23.4 24.1 22.5 15.5 40.7 28.1 27.0 28.5 59.4 24.9 72.6 41.1 69.2 17.9 17.2 24.5 21.7 24.2 25.7 33.3 25.3 17.3 28.8 24.3 28.3 21.7 24.2 34.1 21.1 38.9 15.3 6.0 7.0 7.9 6.6 5.8 6.7 7.2 6.6 5.6 7.4 6.7 7.1 10.1 14.1 9.6 8.3 4.2 17.4 15.2 7.0 9.4 6.2 4.8 19.0 13.5 6.2 17.2 7.0 7.3 8.4 20.0 19.3 8.7 3.9 8.1 36.6 10.8 17.9 16.4 10.7 9.7 11.2 7.7 14.6 9.3 8.2 20.1 10.1 22.7 18.2 7.2 10.1 6.7 8.8 11.5 0.0 16.9 23.3 51.0 11.8 12.2 21.4 4.7 20.8 4.4 13.4 4.5 22.4 9.4 5.9 8.2 13.0 5.8 9.1 4.2 4.9 15.4 0.0 8.3 10.9 13.7 25.9 16.1 13.8 5.7 16.7 9.3 15.5 7.0 CHCHD2 "C7orf17, MIX17B, MNRR1" ENSG00000106153 "Coiled-coil-helix-coiled-coil-helix domain containing 2" Q9Y6H1 7 56101573-56106476 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transcription Activator "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 3195.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027407, HPA052510" Approved Supported Mitochondria NA NA Mitochondria "HPA027407: AB_10959659, HPA052510: AB_2681856" "unprognostic (8.68e-3)" "unprognostic (2.79e-1)" "unprognostic (8.48e-2)" "unprognostic (2.32e-1)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.90e-5)" "prognostic unfavorable (9.41e-5)" "unprognostic (4.38e-2)" "unprognostic (3.61e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (2.60e-2)" "unprognostic (4.01e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (2.40e-2)" 249.5 671.0 301.1 168.9 304.2 429.9 256.1 337.4 361.3 217.9 317.0 259.0 254.2 220.9 254.6 271.8 212.4 133.3 404.2 296.4 321.6 344.4 319.3 215.7 206.7 322.9 309.9 294.1 248.4 318.5 325.7 274.4 153.1 319.2 239.2 193.5 228.1 283.6 198.6 799.0 234.8 246.0 151.8 329.8 225.1 289.9 121.6 319.9 270.2 209.9 596.5 201.9 219.6 216.0 345.5 3195.8 553.5 351.8 732.5 275.9 379.3 261.7 456.7 436.2 584.6 561.3 513.0 517.4 932.1 589.1 285.1 741.3 527.6 456.5 507.4 469.6 609.1 831.5 549.2 422.0 738.9 510.5 745.9 844.8 339.1 571.9 438.0 532.4 312.3 444.1 800.3 1182.9 546.7 486.4 449.9 1007.2 2306.5 760.6 867.3 872.6 668.3 343.3 1539.3 532.5 417.0 671.5 834.3 360.6 874.7 597.1 239.4 1002.5 1046.8 354.2 354.2 823.5 1473.9 683.6 497.1 785.4 1698.9 555.3 802.0 448.0 354.1 509.1 400.6 362.1 458.7 377.4 461.2 387.4 387.2 575.8 435.0 344.9 354.9 268.0 400.9 467.1 785.2 550.9 1066.7 301.1 304.2 337.4 361.3 296.4 321.6 322.9 309.9 294.1 319.2 329.8 319.9 345.5 465.1 256.4 284.0 44.4 521.9 717.5 956.6 1072.0 387.0 348.7 758.3 929.8 160.8 513.3 612.1 413.8 62.6 955.1 577.6 807.9 1860.7 1034.0 167.2 593.3 396.0 446.5 541.2 666.1 26.7 1325.1 1259.9 514.7 393.0 622.8 394.3 458.8 377.0 727.2 969.6 492.9 35.6 973.0 752.7 483.5 701.2 213.4 614.2 496.2 763.1 28.1 806.5 769.6 593.2 19.6 43.2 1190.3 974.5 505.9 803.3 1321.7 1138.5 1558.4 559.1 353.7 427.3 620.2 583.8 520.4 574.2 680.8 719.3 1228.8 492.5 633.1 929.0 1464.2 CCL24 "Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24" ENSG00000106178 "C-C motif chemokine ligand 24" O00175 7 75810825-75823356 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.1;lymphoid tissue: 72.4" "Cell type enhanced" "Detected in single" "Macrophages: 1.1" "Group enriched" "Detected in many" 5 "colorectal cancer: 67.6;pancreatic cancer: 17.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.6;OE19: 2.3;U-2 OS: 4.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 4 "spinal cord: 9.9" "Secreted to blood" NA NA 276000 "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.26e-2)" "unprognostic (1.44e-2)" "unprognostic (5.56e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (3.15e-1)" "unprognostic (2.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" 2.9 0.4 0.4 16.2 0.3 0.8 1.0 1.0 0.6 0.7 0.5 27.6 23.2 0.5 1.2 2.5 0.3 2.0 0.7 0.4 0.2 0.5 5.1 14.4 14.1 0.5 0.3 0.4 0.4 0.4 0.5 0.1 0.2 0.5 0.4 72.1 0.5 0.9 0.6 0.5 0.9 64.0 2.3 0.3 72.4 3.5 1.4 0.5 1.6 0.5 0.7 3.2 12.3 0.6 1.2 0.1 0.4 0.3 0.3 0.2 0.6 0.3 0.0 0.1 0.1 0.0 0.1 4.6 0.4 1.4 0.0 0.2 0.3 0.2 0.1 0.2 0.1 0.4 0.1 0.4 0.1 0.0 0.1 1.3 0.9 0.3 0.1 0.1 0.2 0.1 0.2 0.4 0.4 0.0 0.0 0.2 0.6 0.1 2.3 0.2 0.3 1.6 0.2 0.1 0.3 0.3 0.2 0.1 0.2 0.0 0.2 0.4 1.2 0.1 0.4 4.8 0.4 0.4 0.3 0.1 0.1 0.5 0.2 0.1 0.7 0.2 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.5 0.3 0.0 0.2 0.1 0.0 0.4 0.3 1.0 0.6 0.4 0.2 0.5 0.3 0.4 0.5 0.3 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302673-76304295 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 5957.2" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 16589.4;Exocrine glandular cells: 6539.7;Squamous epithelial cells: 6300.1;Urothelial cells: 13091.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 2482.8;MCF7: 3979.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 19000000 "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavorable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 773.4 863.5 1067.6 332.6 740.8 52.7 565.3 750.5 1738.4 1439.1 827.5 1523.5 210.6 2848.1 132.8 5957.2 1002.5 219.2 2655.7 1185.2 811.3 989.1 559.6 797.8 99.8 998.6 773.4 650.4 737.8 758.0 223.0 305.7 327.0 1123.9 987.3 74.5 10.3 1084.0 527.3 3699.8 2060.3 528.2 1077.0 912.3 226.3 776.8 100.6 1213.4 220.7 632.3 633.6 281.7 1592.8 3426.5 1536.2 1251.1 902.4 79.5 576.8 487.3 447.5 5.1 514.9 249.8 260.9 325.8 84.8 660.7 8.5 389.1 599.1 514.1 1094.2 359.0 279.6 76.5 690.9 106.4 41.5 611.4 345.5 267.9 69.9 466.5 542.8 2482.8 370.0 50.5 436.6 831.3 169.5 459.4 1079.7 276.5 3979.7 117.1 508.9 407.4 212.7 800.6 417.3 195.8 974.5 342.8 423.2 7.6 529.1 363.8 1323.3 456.0 224.5 1674.9 551.6 504.2 778.8 1200.3 221.7 1310.1 85.7 145.9 10.7 575.9 247.2 579.5 19.7 13.6 10.9 58.8 78.2 28.1 115.0 92.4 62.1 31.5 105.5 102.1 88.2 5.8 79.7 112.8 56.5 64.5 46.7 1067.6 740.8 750.5 1738.4 1185.2 811.3 998.6 773.4 650.4 1123.9 912.3 1213.4 1536.2 708.2 272.4 186.4 78.4 145.4 1849.8 16589.4 3603.0 1728.4 243.4 312.5 174.4 822.3 264.5 1899.4 1144.0 323.2 161.7 62.0 824.2 1500.7 2021.4 11.9 1181.8 1060.9 1038.7 422.0 136.1 4.3 6539.7 399.4 998.5 219.2 1227.1 216.7 136.3 725.7 234.7 1199.8 70.7 2.2 433.0 1245.1 147.7 2828.9 30.8 299.5 1024.8 2056.2 35.6 188.0 171.4 50.4 8.0 2.7 2719.4 1417.1 534.5 296.9 3854.8 95.3 2324.4 1253.9 29.2 611.4 551.2 2129.1 20.3 105.5 6300.1 2241.7 2432.7 758.2 68.2 390.5 13091.2 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617285-98629869 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 157.8;pituitary gland: 212.4" "Cell type enhanced" "Detected in many" "Granulosa cells: 93.5;Peritubular cells: 326.1;Sertoli cells: 151.2;Spermatocytes: 85.2;Spermatogonia: 94.8" "Cancer enhanced" "Detected in all" "renal cancer: 41.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 717.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" NA NA 2490000 360000 "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 6.1 39.5 13.7 1.9 16.2 0.5 3.8 11.8 157.8 8.1 5.0 11.8 0.5 5.8 3.5 3.1 2.8 1.1 7.1 41.2 128.5 0.8 2.6 0.9 0.1 15.6 20.4 21.5 3.7 21.6 0.6 212.4 0.1 16.1 7.3 0.8 4.8 3.7 1.6 9.0 7.1 5.5 2.6 10.0 13.1 6.8 34.6 37.5 0.5 3.2 6.8 0.3 5.6 6.9 38.9 0.0 0.0 6.5 0.2 0.0 0.5 0.0 8.8 0.0 0.1 0.0 0.0 0.0 0.0 21.1 2.8 1.5 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 717.9 0.0 5.7 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.1 33.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.5 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.7 16.2 11.8 157.8 41.2 128.5 15.6 20.4 21.5 16.1 10.0 37.5 38.9 8.6 0.0 0.6 2.9 0.3 3.8 0.5 0.0 0.0 19.9 0.2 1.4 3.4 5.7 1.3 0.0 4.2 0.0 1.0 4.5 0.0 5.4 12.0 8.5 1.8 16.9 16.0 0.0 22.1 12.8 0.2 11.1 1.5 10.5 0.0 93.5 3.9 0.7 0.5 0.0 5.3 1.2 0.0 0.0 5.4 24.2 14.0 1.3 12.4 5.6 0.0 1.6 0.0 1.0 1.8 2.9 1.1 326.1 1.0 5.2 0.5 0.1 0.0 2.8 151.2 57.2 27.1 85.2 94.8 0.1 3.0 0.1 0.8 12.7 2.3 1.2 PDAP1 "HASPP28, PAP, PAP1" ENSG00000106244 "PDGFA associated protein 1" Q13442 7 99392048-99408597 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021103, HPA050294, HPA060836" Approved Enhanced "Plasma membrane,Cytosol" NA NA 410000 Cytosol "Plasma membrane" "CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374" "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.65e-2)" "unprognostic (2.63e-1)" "unprognostic (3.35e-2)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (1.79e-1)" "unprognostic (3.49e-1)" "unprognostic (2.97e-2)" 25.5 29.9 36.7 22.8 37.0 23.4 24.6 37.7 39.6 25.3 34.8 29.5 18.1 27.1 17.6 37.5 22.8 12.0 36.1 35.3 36.9 25.8 31.5 24.3 19.1 38.4 38.6 34.1 25.9 26.9 22.7 22.1 19.4 38.6 26.2 18.2 23.1 26.4 21.1 106.0 27.9 23.5 21.3 38.3 24.0 26.5 19.9 37.7 25.7 24.5 60.3 22.6 29.6 26.6 37.8 96.9 82.4 54.6 71.0 41.5 43.2 34.7 76.7 44.9 61.6 51.8 83.9 47.4 41.3 67.2 74.7 78.4 50.2 66.3 78.4 60.5 59.8 74.4 43.6 80.8 74.1 60.8 80.1 40.5 45.6 58.5 68.1 110.3 56.3 62.7 67.5 103.0 75.6 61.4 200.3 110.4 111.2 68.7 98.1 88.3 50.5 54.3 73.6 63.6 73.0 54.8 110.6 58.0 92.4 43.4 61.3 41.1 42.5 57.6 83.6 91.4 100.8 123.6 71.4 87.5 91.0 67.7 72.2 89.1 13.4 12.1 12.5 15.4 16.6 13.9 15.7 14.2 11.2 10.2 14.9 9.8 13.2 31.6 28.0 15.6 21.1 20.9 6.6 36.7 37.0 37.7 39.6 35.3 36.9 38.4 38.6 34.1 38.6 38.3 37.7 37.8 82.9 86.6 94.7 6.2 73.6 62.2 110.6 104.6 57.5 97.4 84.3 76.6 63.6 72.9 86.7 42.3 33.3 213.1 84.7 101.6 168.3 176.1 60.3 91.3 118.6 99.1 117.9 151.7 10.1 171.0 223.0 87.4 59.7 88.3 72.2 83.4 61.8 80.8 114.9 77.4 11.6 116.5 75.3 38.3 63.3 78.3 83.6 66.1 103.2 5.6 102.1 166.4 119.4 8.0 17.4 177.4 92.2 92.2 102.5 184.3 100.0 134.5 96.8 101.0 52.6 85.6 127.2 132.5 123.0 131.9 65.6 184.4 79.5 115.2 114.0 122.5 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 47.0 47.5 47.4 32.9 46.6 92.5 46.3 50.3 60.2 37.9 47.9 43.9 32.3 38.4 35.7 50.0 40.3 32.5 38.3 47.3 47.4 54.9 43.2 43.8 45.9 48.7 47.2 43.6 39.4 34.2 41.4 54.4 34.2 47.6 42.7 25.9 14.9 38.3 31.1 31.8 40.3 35.5 29.4 48.9 41.3 44.3 68.9 50.3 41.4 41.6 25.3 36.1 40.7 41.0 49.0 111.2 123.9 67.5 153.9 67.3 75.0 67.0 103.7 96.7 113.4 124.1 148.5 104.5 83.7 122.7 98.3 123.8 65.5 76.0 92.9 93.8 102.3 106.9 61.1 83.1 98.2 139.4 106.0 78.2 73.8 112.1 104.1 195.1 66.4 89.8 87.6 151.7 182.3 106.2 283.9 143.3 281.2 152.2 114.6 156.8 73.2 69.5 145.7 100.7 85.6 120.3 145.8 101.8 114.9 216.8 43.8 72.2 129.0 74.8 108.1 138.5 216.8 163.6 115.0 207.2 220.9 94.9 153.6 199.4 390.7 206.8 516.9 175.8 232.0 164.7 226.1 165.5 171.2 175.9 223.9 140.0 145.7 451.2 203.7 252.6 171.2 215.7 360.5 47.4 46.6 50.3 60.2 47.3 47.4 48.7 47.2 43.6 47.6 48.9 50.3 49.0 103.2 83.3 81.2 3.6 88.1 192.7 142.3 192.7 103.6 32.8 94.8 134.1 12.8 68.6 110.5 92.0 10.4 169.9 118.5 157.7 238.7 169.9 173.1 137.3 91.7 98.1 146.8 85.2 5.7 187.1 163.0 97.9 65.2 111.9 91.2 79.6 86.0 84.3 151.5 16.8 5.6 187.2 111.9 89.2 125.1 121.3 82.0 90.8 136.9 5.6 148.5 103.5 116.4 5.0 6.8 248.1 153.8 74.1 68.4 153.9 155.4 242.3 171.2 40.1 59.2 77.4 144.3 298.2 135.7 99.1 183.8 182.4 112.0 86.9 132.3 174.8 PTCD1 KIAA0632 ENSG00000106246 "Pentatricopeptide repeat domain 1" O75127 7 99416739-99466163 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 29.2" "HPA020106, HPA047679" Uncertain Approved Mitochondria NA NA Mitochondria "HPA020106: AB_2176551, HPA047679: AB_2680119" "unprognostic (4.70e-2)" "unprognostic (3.38e-2)" "unprognostic (4.19e-2)" "unprognostic (6.05e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (4.39e-2)" "unprognostic (2.00e-1)" "unprognostic (4.09e-2)" "unprognostic (1.14e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.49e-1)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (7.10e-3)" 3.4 3.6 3.1 2.6 3.1 5.6 3.4 3.8 3.7 3.3 2.2 3.8 2.7 3.7 0.8 4.4 3.8 2.8 3.5 2.8 2.7 3.0 4.8 2.8 3.5 3.7 3.2 2.9 3.5 3.7 1.6 2.9 1.8 3.3 4.2 1.3 1.8 3.4 2.1 6.7 4.4 4.1 1.1 2.7 4.9 3.9 4.4 3.4 1.3 3.3 2.6 1.5 3.6 3.4 3.8 4.8 9.8 3.3 9.3 3.1 2.5 9.2 6.6 2.4 4.6 3.3 29.2 5.7 9.6 7.4 1.8 7.7 5.1 4.0 5.9 1.6 7.7 11.2 4.9 8.1 7.2 4.8 5.1 9.0 2.0 3.7 3.8 3.8 3.1 1.4 6.0 10.0 6.4 2.3 13.8 9.0 12.9 6.1 4.8 8.0 5.4 4.3 11.9 2.5 5.1 6.1 6.5 7.4 24.2 6.3 4.7 5.2 5.3 2.7 6.9 8.1 13.7 7.1 9.5 9.1 10.2 7.1 6.7 9.7 1.8 2.0 0.9 3.3 2.3 2.2 1.8 2.1 2.2 1.4 2.5 2.4 3.0 1.9 2.0 1.7 2.1 1.5 1.5 3.1 3.1 3.8 3.7 2.8 2.7 3.7 3.2 2.9 3.3 2.7 3.4 3.8 3.5 0.0 5.8 0.0 6.6 6.2 4.0 5.2 4.6 7.9 4.9 4.7 5.8 4.3 4.0 5.5 10.4 9.9 4.1 4.2 1.9 5.3 2.1 4.7 8.6 5.3 7.3 2.5 0.0 6.7 5.6 4.2 3.6 5.2 12.7 12.9 4.6 6.1 6.6 8.4 0.0 6.2 6.1 3.2 6.1 1.8 3.7 3.7 3.6 0.0 3.8 5.6 1.0 0.0 0.0 5.0 2.5 3.0 4.1 3.6 4.5 3.2 5.8 9.3 0.0 8.6 6.7 8.7 7.6 5.1 4.1 5.6 5.7 6.2 6.3 2.6 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99679998 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 179.2;liver: 278.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 3.2 14.5 0.2 3.8 0.5 0.6 6.5 0.8 0.9 3.7 0.3 28.7 128.4 3.2 3.0 22.3 3.1 33.0 1.0 0.3 0.0 10.2 278.4 9.3 1.4 0.5 0.1 0.2 0.8 47.4 0.0 0.9 0.4 0.5 21.7 21.2 0.7 3.0 5.8 0.9 19.0 179.2 1.1 0.0 0.8 87.3 0.4 0.1 2.1 1.0 0.0 3.2 10.5 13.2 0.9 1.6 3.3 1.6 1.9 0.4 0.6 0.5 1.5 0.0 0.0 0.0 9.7 7.4 1.0 1.5 0.0 1.2 1.2 0.0 0.0 0.0 1.8 1.2 1.2 0.7 7.9 0.1 2.0 0.6 0.0 2.1 0.0 0.0 1.4 0.0 0.9 3.3 2.0 0.0 0.3 2.6 3.8 0.4 28.3 0.8 0.6 1.6 2.2 0.4 1.5 1.2 1.7 0.9 0.8 3.2 1.6 0.5 0.7 1.2 1.8 1.6 1.6 1.2 1.0 2.6 1.7 1.6 2.6 1.5 0.4 0.3 0.4 0.4 0.3 0.9 0.2 0.6 0.6 0.2 0.1 0.4 0.5 0.5 0.4 0.2 0.3 0.5 0.2 0.2 0.5 0.8 0.9 0.3 0.0 0.5 0.1 0.2 0.5 0.0 0.1 0.9 0.9 12.8 14.8 1.3 4.8 46.1 112.7 31.0 59.7 13.7 1.1 0.4 1.3 377.4 27.3 3.7 12.5 1.7 1.7 382.7 0.0 63.4 2.0 3.1 2.2 6.3 54.6 21.7 8.6 50.7 1.2 8.5 506.6 10.3 10.1 1.8 8.2 454.5 0.6 8.4 11.0 140.5 6.1 9.5 4.5 0.5 2.5 4.1 3.6 2.8 4.9 4.0 10.3 7.1 6.5 80.1 451.6 2.6 6.4 156.3 1074.6 10.8 12.1 21.6 0.0 2.5 3.4 15.1 6.4 107.3 59.0 1.5 7.5 3.1 139.8 380.4 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 272.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 12.1 18.6 20.9 11.7 28.5 8.8 22.9 19.0 23.0 16.5 7.9 21.7 18.4 15.6 17.2 19.0 21.9 14.0 10.2 15.3 21.1 13.4 53.3 11.0 11.8 22.9 26.5 7.6 19.2 26.3 16.6 11.0 11.1 30.0 23.2 23.7 15.9 25.5 10.9 10.5 32.8 17.0 13.8 16.3 13.6 32.9 11.2 22.5 14.3 12.0 8.9 12.0 12.3 17.5 36.5 17.0 12.3 31.8 34.6 32.0 38.7 12.0 18.6 22.5 10.9 11.0 7.4 15.7 19.1 23.0 20.9 19.1 13.7 18.4 16.1 20.6 18.4 11.3 15.5 15.8 19.3 18.0 29.9 17.7 26.1 25.1 14.7 49.0 29.5 24.4 22.2 36.2 16.3 21.7 22.4 28.4 17.6 12.8 31.6 15.2 16.7 16.2 17.3 18.2 26.4 36.8 44.0 28.9 37.4 32.4 17.8 19.1 19.6 36.8 23.7 23.0 27.9 18.9 18.7 35.3 19.5 16.2 20.8 31.7 16.0 4.0 4.1 5.0 3.1 4.9 3.8 3.9 4.9 5.8 4.8 5.3 3.9 4.2 8.8 9.0 3.9 3.5 3.8 20.9 28.5 19.0 23.0 15.3 21.1 22.9 26.5 7.6 30.0 16.3 22.5 36.5 45.3 25.6 55.4 57.5 37.0 15.0 45.7 43.4 71.7 93.9 77.6 38.7 42.8 140.2 61.4 46.0 150.1 41.1 40.1 84.8 15.6 55.9 46.5 89.2 90.9 52.2 220.9 24.6 70.1 43.8 15.3 47.9 103.5 68.0 35.4 120.5 44.6 140.8 19.8 89.2 77.7 99.2 77.3 32.7 18.6 18.4 51.3 31.2 40.9 62.8 45.8 61.2 34.0 102.1 272.5 46.6 81.3 53.4 27.1 93.1 70.4 32.4 153.6 70.1 19.7 87.4 43.9 32.8 16.7 62.9 21.5 65.9 32.3 74.0 114.4 62.0 EIF3B "EIF3S9, PRT1" ENSG00000106263 "Eukaryotic translation initiation factor 3 subunit B" P55884 7 2354086-2380745 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017562, HPA048983" Approved Approved Nucleoplasm,Cytosol NA NA 180000 Cytosol Nucleoplasm "CAB017562: AB_2246341, HPA048983: AB_2680588" "unprognostic (1.50e-3)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (3.92e-2)" "unprognostic (9.45e-3)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (4.41e-9)" "unprognostic (4.64e-3)" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (9.66e-6)" "unprognostic (2.38e-1)" "unprognostic (7.54e-2)" "unprognostic (9.00e-2)" "unprognostic (6.18e-3)" 57.8 55.3 29.2 50.0 30.2 89.6 55.6 31.4 31.1 48.3 29.8 66.4 39.9 55.8 28.7 78.8 53.8 35.1 51.9 30.7 31.1 39.2 60.9 42.6 59.4 32.9 32.6 28.5 51.5 83.8 39.9 38.2 52.3 32.7 50.7 45.1 17.9 64.0 43.3 156.4 83.4 49.3 52.9 32.9 57.1 59.6 61.3 31.2 54.0 37.3 66.3 65.1 70.0 53.8 34.6 510.8 253.3 102.9 280.4 113.5 102.4 254.4 174.5 130.2 193.8 180.5 334.4 193.2 293.9 139.8 186.2 273.5 269.9 287.1 229.0 212.5 88.6 334.6 224.8 240.8 227.0 159.2 277.0 159.8 127.5 147.9 210.1 219.2 101.8 157.9 133.9 580.9 133.2 179.7 358.4 134.7 306.9 322.6 176.2 224.4 163.3 208.3 304.2 123.4 228.9 233.9 174.9 184.5 403.4 102.8 178.8 270.0 301.3 169.0 149.0 326.9 231.7 319.4 145.7 210.6 295.6 169.3 303.9 372.5 2.1 7.2 4.0 7.5 7.2 9.4 6.5 7.0 8.2 8.0 6.1 8.4 8.5 0.6 16.9 6.6 8.2 9.5 4.8 29.2 30.2 31.4 31.1 30.7 31.1 32.9 32.6 28.5 32.7 32.9 31.2 34.6 43.3 25.6 64.1 19.6 35.9 64.2 55.6 25.4 34.1 37.9 74.0 62.4 37.4 30.0 38.8 27.6 64.6 64.9 52.6 49.0 3.9 35.5 11.6 37.1 57.0 50.9 47.8 56.8 20.1 62.6 63.4 47.6 48.9 48.1 17.1 77.0 63.5 67.0 47.4 52.2 19.5 63.0 14.2 39.5 32.3 23.3 43.8 34.3 16.0 8.4 32.6 45.6 38.1 15.6 19.9 70.9 28.9 37.2 42.3 68.8 33.6 31.0 27.4 44.3 26.3 69.2 48.5 34.4 39.4 63.5 78.3 82.6 34.7 119.4 77.0 50.6 SNX8 Mvp1 ENSG00000106266 "Sorting nexin 8" Q9Y5X2 7 2251770-2354318 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 108.9;Late spermatids: 358.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 100.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057296, HPA060194" Approved Supported Vesicles NA NA Vesicles "HPA057296: AB_2683401, HPA060194: AB_2684219" "unprognostic (2.22e-2)" "unprognostic (3.38e-1)" "unprognostic (9.85e-3)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (9.32e-2)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.54e-2)" "unprognostic (3.06e-1)" "unprognostic (6.01e-2)" "unprognostic (1.54e-1)" "unprognostic (5.10e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.35e-1)" 13.9 6.9 14.6 11.4 13.3 11.0 12.5 12.2 13.4 6.7 10.8 7.8 10.7 6.9 3.1 10.3 7.1 9.9 12.9 13.0 11.2 7.3 7.3 9.8 21.6 14.7 13.1 9.6 7.6 7.5 5.9 5.4 9.4 14.5 4.3 6.9 5.8 7.9 3.0 11.1 9.4 9.6 5.7 13.4 32.9 7.0 23.4 15.0 8.0 8.4 7.6 17.9 8.6 5.8 14.3 40.3 38.7 15.6 21.8 21.3 20.5 36.7 19.2 28.4 31.8 39.2 27.3 30.6 23.4 7.7 22.8 100.9 10.6 13.6 10.5 16.1 5.9 12.8 13.0 15.5 22.9 53.9 12.7 20.8 41.4 12.1 39.0 15.0 8.5 12.1 18.3 26.0 26.9 26.4 26.4 4.3 13.5 28.4 22.4 19.0 20.6 32.2 10.7 7.5 18.8 7.5 19.7 17.4 47.8 27.3 17.0 35.5 27.4 18.5 26.6 69.7 44.0 25.4 17.5 22.9 21.9 26.4 16.9 73.6 11.8 15.4 5.1 2.9 17.2 2.1 26.1 2.1 2.9 21.8 30.6 2.0 2.4 2.6 2.2 17.8 5.4 3.4 8.7 14.6 13.3 12.2 13.4 13.0 11.2 14.7 13.1 9.6 14.5 13.4 15.0 14.3 7.4 6.4 9.4 3.9 35.7 5.2 7.8 6.1 2.8 10.0 12.3 10.4 12.4 10.0 4.8 3.7 8.4 16.7 7.7 10.5 13.7 21.0 108.9 3.3 12.8 13.0 6.0 26.3 5.0 30.0 15.4 10.3 10.7 4.5 12.6 8.2 45.3 8.8 78.1 21.9 7.8 10.9 6.1 35.2 75.2 358.9 12.2 36.7 14.2 6.5 41.9 7.8 7.2 2.5 9.1 26.9 7.9 13.2 12.9 8.8 12.5 14.9 5.5 12.5 0.0 5.3 9.6 10.6 22.9 5.7 6.1 43.4 6.3 29.6 9.7 9.2 NUDT1 MTH1 ENSG00000106268 "Nudix hydrolase 1" P36639 7 2242226-2251146 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 78.2" "Cell type enhanced" "Detected in many" "Late spermatids: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012636 Approved Supported Cytosol No No 21000 Cytosol "HPA012636: AB_1854696" "unprognostic (1.31e-1)" "unprognostic (1.19e-2)" "unprognostic (2.13e-2)" "unprognostic (2.37e-1)" "unprognostic (3.01e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.15e-2)" "unprognostic (4.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.81e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (3.49e-2)" "unprognostic (1.70e-1)" 17.0 8.0 12.5 24.0 15.7 78.2 15.1 13.4 18.1 14.6 10.1 17.8 16.3 12.6 5.5 29.4 12.1 10.6 18.0 14.0 13.2 8.6 6.3 12.5 37.4 14.0 13.1 12.3 9.4 9.1 3.2 4.4 10.5 14.3 11.4 11.1 4.4 12.5 7.0 21.5 34.1 16.9 9.3 13.7 23.8 12.3 66.1 13.4 60.0 7.6 13.6 31.7 14.8 18.6 16.9 98.4 155.2 83.3 111.0 30.0 41.3 61.0 42.3 36.5 57.0 65.8 84.2 72.1 102.8 33.7 47.0 115.5 117.1 63.8 64.3 33.1 46.2 109.4 80.6 136.3 72.7 7.2 63.2 78.0 27.4 16.7 82.3 29.0 18.6 31.0 147.1 65.0 111.6 64.5 250.2 119.1 245.3 179.5 48.5 94.7 163.5 123.4 86.4 31.7 54.9 83.5 115.6 43.7 126.9 20.8 59.8 83.9 165.8 29.1 54.2 205.1 126.8 102.3 85.2 70.6 108.9 54.6 155.1 199.8 31.5 60.2 44.4 42.8 78.6 34.3 71.0 49.6 45.6 94.3 65.1 48.9 42.3 16.2 39.4 66.8 211.5 75.5 45.7 12.5 15.7 13.4 18.1 14.0 13.2 14.0 13.1 12.3 14.3 13.7 13.4 16.9 13.0 6.4 7.5 1.0 34.2 40.1 26.5 22.6 14.8 11.2 25.3 39.0 16.8 10.0 13.7 11.0 4.2 38.5 46.1 39.6 19.6 24.3 54.7 14.9 24.3 12.8 7.8 111.7 0.5 37.4 80.0 29.6 13.7 10.7 61.0 32.4 7.9 5.2 89.4 0.0 0.5 35.7 32.6 46.2 86.7 121.2 22.1 52.6 46.2 0.0 47.1 27.4 47.4 1.0 4.3 20.4 18.4 18.8 33.1 21.5 17.3 14.1 13.0 7.9 32.9 27.5 32.4 70.2 54.8 41.0 37.1 23.7 37.3 13.7 45.1 27.3 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.2;skin 1: 32.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 2714.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" NA NA 3400000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavorable (9.36e-4)" 0.8 1.6 66.2 1.2 59.7 0.0 4.0 62.2 89.2 1.4 24.6 3.1 0.6 0.1 0.8 8.0 0.3 0.7 0.8 67.8 73.2 0.1 0.1 1.2 0.0 63.2 60.3 51.9 0.8 2.8 0.0 2.3 0.2 61.6 1.0 1.2 19.2 3.4 0.7 0.1 32.1 1.0 1.3 59.8 1.0 13.9 0.3 63.4 0.2 0.1 0.3 2.6 0.9 2.4 74.9 0.1 0.0 425.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 27.7 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 126.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 5.4 15.2 0.1 0.0 0.0 0.1 0.0 0.0 0.7 10.9 5.6 0.0 0.6 0.0 193.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 66.2 59.7 62.2 89.2 67.8 73.2 63.2 60.3 51.9 61.6 59.8 63.4 74.9 0.1 0.0 1.5 625.2 0.2 25.2 8.6 82.2 44.9 18.3 5.6 12.2 1.3 0.0 39.7 0.0 4.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 37.7 0.7 0.1 1.3 9.2 0.0 0.0 10.1 0.0 0.0 0.1 65.6 72.0 0.0 0.0 0.0 1.6 0.7 0.3 0.1 19.6 22.5 0.0 90.4 0.0 2714.3 3.6 0.9 0.3 0.0 1.2 1.8 0.0 0.1 16.9 6.6 0.0 1.2 1.7 0.1 1.6 14.8 21.5 0.3 0.2 0.5 0.0 7.8 TAF6 "MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85" ENSG00000106290 "TATA-box binding protein associated factor 6" P49848 7 100107070-100119841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006566 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006566: AB_1080194" "unprognostic (5.60e-2)" "unprognostic (3.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (2.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-3)" "unprognostic (1.68e-1)" "unprognostic (4.55e-2)" "unprognostic (1.95e-1)" "unprognostic (3.38e-1)" "unprognostic (4.78e-1)" "unprognostic (1.37e-1)" 24.0 37.3 27.3 23.6 27.6 23.6 24.6 22.9 43.1 38.7 21.3 34.7 17.4 43.3 22.1 27.5 35.2 20.7 30.5 28.7 23.7 31.0 20.8 25.0 22.8 23.4 22.7 27.7 41.6 23.1 30.8 41.4 25.1 25.8 31.0 19.7 19.4 25.8 31.4 45.3 26.4 28.2 34.2 16.9 28.6 28.2 38.8 24.0 29.5 33.2 36.1 25.9 37.6 30.2 24.2 55.1 101.8 64.4 105.7 84.1 44.5 89.3 60.0 66.4 77.2 70.6 76.1 65.6 50.4 65.5 92.7 130.4 45.7 90.6 73.2 81.3 82.0 57.0 49.4 99.3 50.8 86.6 46.2 43.5 46.4 44.5 111.0 121.7 61.0 63.0 87.7 84.6 89.0 69.2 194.4 101.1 76.9 94.7 50.1 82.4 73.2 78.7 75.0 54.5 44.8 57.9 84.4 73.7 115.3 49.3 93.2 42.1 47.2 60.4 113.2 114.6 146.2 77.6 55.0 104.0 85.1 74.9 65.7 99.2 17.2 13.5 17.5 18.0 14.4 21.5 11.9 17.3 18.3 17.6 17.9 17.0 16.3 7.1 18.8 35.3 10.3 18.3 17.5 27.3 27.6 22.9 43.1 28.7 23.7 23.4 22.7 27.7 25.8 16.9 24.0 24.2 13.0 9.6 11.8 10.1 15.4 11.3 21.0 25.1 12.5 12.7 13.2 15.9 0.9 18.6 15.7 25.8 0.0 72.1 13.0 12.9 17.6 25.7 28.3 20.7 18.5 14.8 15.6 12.8 12.6 16.6 34.5 16.3 18.3 14.6 0.0 25.6 13.6 6.1 20.9 13.5 10.7 11.9 26.4 8.8 6.9 50.7 21.8 12.3 12.4 3.7 18.7 18.7 18.6 6.0 7.3 14.9 18.7 31.2 12.8 13.0 14.2 25.8 21.8 14.0 26.3 14.6 23.8 25.5 52.3 15.4 11.8 34.5 18.3 16.2 17.4 14.4 WASL "N-WASP, NWASP, WASPB" ENSG00000106299 "WASP like actin nucleation promoting factor" O00401 7 123681943-123749003 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 282.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 138.3;U-2197: 128.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005399, HPA005750" Supported Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB005399: AB_2288632, HPA005750: AB_1854729" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (8.19e-2)" "unprognostic (1.83e-1)" "unprognostic (3.20e-1)" "unprognostic (4.61e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.30e-5)" "unprognostic (7.32e-2)" "prognostic favorable (4.51e-8)" "unprognostic (9.49e-2)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.14e-1)" 20.1 25.0 22.2 12.9 25.5 5.7 21.9 16.6 45.0 29.3 16.0 42.8 37.6 27.4 18.5 29.7 18.9 28.7 18.4 43.6 21.0 44.5 47.2 20.1 7.9 20.8 21.6 22.0 35.4 29.7 40.3 13.1 34.9 21.8 25.6 38.2 25.1 22.5 24.2 24.9 18.1 41.8 23.8 15.8 17.2 30.4 22.7 24.1 10.4 35.5 28.9 11.1 39.1 22.7 25.5 34.4 24.8 26.7 23.0 41.2 42.4 34.7 23.3 38.7 16.9 21.7 20.5 42.2 3.5 18.1 35.3 36.0 25.1 50.1 25.7 25.9 6.0 19.9 3.0 19.6 22.2 44.7 4.6 2.9 34.2 47.0 25.0 42.2 37.9 29.5 3.6 15.5 6.6 40.6 20.7 6.0 6.1 50.1 36.5 22.4 3.6 21.6 7.7 35.6 138.3 32.9 48.1 32.1 95.0 63.0 41.4 18.6 4.5 33.8 44.9 12.6 128.1 23.2 7.2 2.7 7.5 38.8 3.8 36.7 2.4 1.7 0.8 1.7 1.7 1.4 2.0 1.1 1.0 1.5 1.3 1.4 1.5 0.7 2.5 3.0 1.9 0.6 0.6 22.2 25.5 16.6 45.0 43.6 21.0 20.8 21.6 22.0 21.8 15.8 24.1 25.5 71.2 86.6 61.1 36.9 11.5 60.4 48.9 44.4 46.1 32.9 67.6 57.1 69.8 52.9 53.7 53.3 20.9 41.6 12.6 200.2 52.8 52.6 26.2 58.0 53.1 43.9 67.9 5.9 55.9 54.1 52.4 62.6 50.0 68.8 3.8 35.0 56.4 61.9 12.7 26.9 51.2 105.1 40.7 13.8 25.1 9.3 48.1 15.6 30.2 34.7 14.0 60.9 6.2 42.7 48.7 70.6 113.4 64.7 14.0 104.4 108.0 96.0 49.5 32.4 19.7 54.1 75.3 17.2 21.3 54.9 68.3 81.3 13.1 76.0 74.8 282.3 HYAL4 ENSG00000106302 "Hyaluronidase 4" Q2M3T9 7 123828983-123877481 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 4.0;skeletal muscle: 4.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.8;Cytotrophoblasts: 4.3;Extravillous trophoblasts: 8.1;Spermatogonia: 4.4;Syncytiotrophoblasts: 2.2" "Cancer enriched" "Detected in single" 48 "testis cancer: 8.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.6;CAPAN-2: 5.9;RT4: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA029453 Uncertain NA NA "HPA029453: AB_10601432" "unprognostic (5.19e-5)" "unprognostic (4.18e-2)" "unprognostic (4.82e-2)" "unprognostic (2.20e-1)" "unprognostic (4.14e-2)" "unprognostic (2.60e-1)" "unprognostic (8.24e-2)" "unprognostic (5.26e-2)" "unprognostic (8.15e-3)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (5.55e-3)" 0.1 0.1 0.7 0.0 0.8 0.5 0.1 1.1 1.1 0.1 0.5 0.2 0.0 0.1 0.4 0.4 0.0 0.1 0.2 0.8 0.5 0.4 0.1 0.4 0.2 0.7 0.3 0.4 0.3 0.5 0.0 0.0 4.0 0.8 0.2 0.1 1.0 0.6 0.2 4.0 0.9 0.3 0.0 0.2 0.8 0.2 2.1 0.4 0.1 0.4 0.0 1.0 0.2 0.0 1.4 0.2 0.4 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.0 13.9 0.2 0.0 0.0 0.8 0.0 1.1 0.2 0.0 2.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.6 0.2 0.1 0.1 0.0 0.0 0.7 0.8 1.1 1.1 0.8 0.5 0.7 0.3 0.4 0.8 0.2 0.4 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.3 4.4 0.0 0.0 2.2 0.0 0.0 0.0 0.2 SPAM1 "HYAL5, PH-20, SPAG15" ENSG00000106304 "Sperm adhesion molecule 1" P38567 7 123925237-123971414 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 17.5" "Group enriched" "Detected in some" 73 "Early spermatids: 270.3;Late spermatids: 111.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017984 Enhanced NA NA "HPA017984: AB_1857413" "unprognostic (2.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 270.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 111.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 AIMP2 "JTV-1, JTV1, p38, PRO0992" ENSG00000106305 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 2" Q13155 7 6009255-6023834 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Protein biosynthesis" "Developmental protein" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.1;tongue: 103.4" "Cell type enhanced" "Detected in all" "Early spermatids: 134.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019098, HPA020057" Supported Approved Cytosol NA Yes 35000 Cytosol "HPA019098: AB_1852040, HPA020057: AB_1852042" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (7.30e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (9.29e-2)" "unprognostic (3.41e-2)" "unprognostic (8.75e-2)" "unprognostic (1.11e-1)" "unprognostic (5.13e-2)" "unprognostic (3.96e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.44e-2)" "unprognostic (8.97e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.09e-4)" 18.4 21.1 13.2 14.4 14.4 12.5 17.5 15.0 17.1 10.7 12.3 26.1 48.2 16.8 16.8 22.2 14.5 8.9 34.7 14.6 15.1 21.5 34.1 12.7 14.4 14.5 14.0 12.7 7.5 17.1 28.9 7.8 13.5 14.3 12.0 24.7 12.0 16.6 15.3 156.1 21.0 28.0 19.5 14.3 13.1 14.7 44.5 14.6 15.5 26.0 103.4 19.7 17.1 13.8 15.8 90.3 100.2 33.1 48.3 34.5 37.3 113.7 49.5 33.3 79.9 59.4 110.1 58.5 109.6 46.2 51.4 90.1 98.6 113.6 74.2 49.6 35.6 84.0 61.2 54.8 84.2 106.2 86.7 53.1 57.4 109.1 72.3 117.9 13.3 60.2 43.8 86.7 35.6 59.4 142.6 37.4 157.2 136.0 44.3 70.4 83.5 73.8 93.3 119.1 41.7 66.1 62.6 50.4 101.3 72.9 41.9 94.5 70.1 51.8 46.0 112.9 77.0 111.2 44.5 73.9 95.5 38.5 122.3 75.6 46.7 61.4 19.5 41.5 77.5 34.9 47.3 27.7 32.5 92.4 31.9 27.1 28.9 6.0 48.3 57.9 58.7 32.3 43.4 13.2 14.4 15.0 17.1 14.6 15.1 14.5 14.0 12.7 14.3 14.3 14.6 15.8 15.0 9.6 10.3 8.1 13.0 10.8 22.5 58.5 24.5 10.2 11.8 15.1 2.2 28.6 40.2 12.9 6.2 50.8 10.1 17.6 70.5 52.6 134.7 25.3 23.9 20.0 6.7 24.2 5.8 57.3 64.0 15.1 23.4 20.6 12.6 16.7 13.2 38.8 50.0 6.7 6.7 18.2 57.0 19.1 14.3 84.5 19.9 18.1 19.6 1.9 40.3 17.8 17.5 5.0 10.4 40.1 14.5 18.0 23.8 23.0 59.3 67.7 34.9 11.2 13.1 16.0 24.5 91.1 26.8 37.1 11.6 39.5 12.6 38.0 39.8 17.8 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 348.9" "Group enriched" "Detected in some" 13 "Erythroid cells: 152.8;Hepatocytes: 455.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "basophil: 2.5;eosinophil: 1.9" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Group enriched" "Detected in some" 11 "HEL: 69.7;HMC-1: 92.7;K-562: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016255, HPA017171, HPA073125" Enhanced Approved "Golgi apparatus" NA NA 410000 "Golgi apparatus" "CAB016255: AB_628395, HPA017171: , HPA073125: " "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.0 0.2 0.0 0.0 0.1 22.7 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 348.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.7 0.0 7.2 0.0 1.6 92.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 65.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.3 2.1 0.3 0.9 0.4 0.0 8.5 0.3 0.6 1.2 10.0 0.8 0.0 8.4 0.1 1.7 0.1 0.0 0.4 5.8 0.1 0.6 1.2 0.0 152.8 5.4 0.2 1.1 0.5 1.5 0.2 0.0 0.2 7.1 455.7 0.3 21.9 5.4 0.3 0.0 8.6 1.7 8.4 0.0 0.4 0.0 1.0 0.2 0.4 6.2 1.5 0.7 0.1 0.1 0.0 0.4 0.6 0.1 0.1 0.3 1.9 0.0 0.4 0.7 0.7 2.9 0.2 0.6 0.1 2.6 0.1 0.6 0.5 FSCN3 ENSG00000106328 "Fascin actin-bundling protein 3" Q9NQT6 7 127591409-127602144 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 99.9" "Cell type enriched" "Detected in some" 7 "Late spermatids: 2359.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA075174 Enhanced NA NA "HPA075174: " "unprognostic (7.77e-2)" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (9.59e-2)" "unprognostic (1.39e-1)" "unprognostic (3.87e-1)" "unprognostic (5.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.91e-3)" "unprognostic (2.00e-1)" "unprognostic (1.68e-4)" "unprognostic (1.34e-1)" "unprognostic (1.14e-5)" "unprognostic (1.27e-1)" "unprognostic (9.21e-3)" "unprognostic (2.01e-1)" "unprognostic (7.34e-2)" 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.6 0.4 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.1 99.9 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.4 0.0 1.1 0.0 0.0 0.8 0.4 0.3 1.2 0.0 0.4 0.4 0.5 1.5 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.3 333.6 0.2 0.5 1.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.5 1.3 0.2 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.3 1.3 2359.0 9.3 1.3 1.8 0.0 0.0 0.2 0.0 0.0 0.3 0.3 1.4 8.2 0.0 0.3 0.3 0.0 0.0 0.4 0.0 1.0 1.1 10.7 7.2 0.2 1.3 0.3 0.4 0.2 0.3 0.2 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1472.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: AB_2680325" "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 16.5 36.9 12.8 5.7 11.1 13.9 16.9 10.5 19.2 20.9 8.7 16.1 6.9 18.8 3.1 33.8 16.4 8.4 15.1 11.2 11.1 21.1 39.3 13.7 8.0 13.3 11.1 9.5 19.3 18.6 7.9 15.7 4.2 12.7 18.2 3.0 2.1 19.7 7.1 10.7 39.7 12.9 5.2 10.7 16.5 19.7 58.4 12.4 7.2 15.1 5.5 5.4 17.5 23.6 10.7 12.6 16.2 13.0 22.9 6.6 4.9 9.3 9.3 10.7 9.3 9.3 15.4 16.1 7.7 20.2 8.3 13.3 9.5 7.5 12.9 1.7 20.4 9.9 8.0 12.1 23.2 8.5 6.1 30.0 13.8 10.8 7.9 4.6 8.2 15.8 12.7 19.2 15.4 9.4 35.9 17.4 47.4 11.9 16.0 24.9 16.4 13.6 18.9 14.8 17.9 7.1 42.8 17.5 26.3 9.8 5.3 16.2 18.3 19.0 18.5 28.3 38.2 9.2 12.2 12.4 5.5 18.3 69.5 22.7 38.7 29.1 40.3 31.3 22.7 36.9 21.7 36.0 36.7 31.7 22.4 21.3 22.2 21.3 37.5 15.9 21.1 57.2 14.8 12.8 11.1 10.5 19.2 11.2 11.1 13.3 11.1 9.5 12.7 10.7 12.4 10.7 18.5 9.6 7.0 4.6 10.9 12.1 20.0 31.0 21.1 5.7 28.0 25.8 3.6 21.5 16.9 20.2 6.2 6.6 19.8 9.3 43.0 43.2 324.0 15.7 12.8 16.4 21.6 21.7 4.7 42.8 26.3 16.4 12.8 11.2 3.8 11.5 23.6 31.3 29.8 6.7 7.6 14.2 22.4 25.1 14.8 1472.9 27.7 15.6 26.6 1.9 17.4 19.0 25.7 8.5 4.9 43.9 17.3 21.8 7.8 16.2 15.1 48.7 15.9 4.0 13.1 10.7 17.5 20.3 31.1 26.7 19.6 6.2 24.4 16.7 17.0 25.3 PAX4 MODY9 ENSG00000106331 "Paired box 4" O43316 7 127610292-127618142 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "intestine: 1.0" "Cell type enriched" "Detected in some" 7 "Enteroendocrine cells: 85.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "SCLC-21H: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.52e-1)" "unprognostic (9.71e-2)" "unprognostic (4.86e-3)" "unprognostic (1.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 85.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602363-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 81.1" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 1300000000 "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: AB_2678224" "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 102.4 45.8 2.9 52.0 2.9 0.6 73.2 3.3 10.3 164.2 11.9 29.1 7.9 82.4 11.1 27.1 81.3 113.5 79.4 2.0 3.4 21.8 60.2 73.1 41.7 3.1 2.6 1.8 48.1 20.7 10.3 31.4 60.0 3.1 45.9 16.9 0.2 25.1 33.8 17.1 45.3 21.8 60.4 2.9 14.0 23.0 13.9 3.1 10.6 49.5 33.0 17.5 87.2 87.5 3.2 0.2 0.5 2.2 3.0 321.5 879.0 2.4 355.5 663.0 161.1 142.7 14.5 0.8 1.1 1.2 404.5 0.5 0.2 0.0 1.2 15.9 2.5 2.5 0.3 6.1 19.8 82.1 0.1 3.5 973.2 0.3 86.3 0.6 0.4 0.1 1.7 8.3 2.0 0.7 2.1 0.6 3.3 72.2 0.0 4.2 1.0 1.5 0.8 0.4 0.6 1.1 689.9 0.2 2.4 1.6 8.2 2.0 0.0 3.5 391.8 107.6 1213.4 0.2 0.4 0.5 0.1 136.6 1.2 68.2 0.0 0.0 0.4 0.1 0.3 0.3 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 2.9 2.9 3.3 10.3 2.0 3.4 3.1 2.6 1.8 3.1 2.9 3.1 3.2 33.6 9.6 2.8 2.3 2.5 40.0 3.3 4.2 6.8 4.3 6.6 11.3 16.3 4.3 5.5 5.5 0.0 13.3 4.5 0.8 27.4 6.4 14.8 15.1 491.6 17.2 1.8 5.7 0.5 5.1 11.2 439.9 7.1 11.0 1.3 0.7 33.9 44.8 20.8 16.8 2.5 0.9 6.1 1.9 53.6 27.6 140.5 5.5 32.0 9.4 0.8 12.1 6.2 1.5 0.2 4.1 1.3 50.4 2.1 2.2 0.1 2.5 6.8 2.0 32.9 14.2 442.2 32.8 21.0 3.6 33.1 25.2 9.4 22.6 0.7 3.0 FBXO24 FBX24 ENSG00000106336 "F-box protein 24" O75426 7 100583982-100601117 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "testis: 81.9" "Group enriched" "Detected in some" 45 "Early spermatids: 517.1;Late spermatids: 594.8" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050951 Enhanced NA NA "HPA050951: AB_2681286" "unprognostic (3.73e-1)" "unprognostic (2.83e-1)" "unprognostic (3.76e-4)" "unprognostic (3.52e-2)" "unprognostic (3.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (3.86e-4)" "unprognostic (2.31e-2)" "unprognostic (1.15e-2)" "unprognostic (9.34e-3)" "unprognostic (1.44e-1)" "unprognostic (9.20e-2)" "unprognostic (7.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-2)" "unprognostic (1.48e-2)" 0.3 0.5 0.2 0.7 0.2 0.7 0.5 1.9 0.9 1.4 0.0 0.5 0.2 1.1 0.4 0.7 1.0 0.9 0.7 0.3 0.0 0.6 0.7 0.5 1.2 0.4 0.2 0.0 1.6 0.6 0.2 0.9 0.7 0.4 1.1 0.2 1.0 1.2 0.6 0.5 1.3 0.6 0.4 0.0 0.8 0.4 81.9 0.2 0.2 0.5 0.3 0.4 0.4 1.0 0.2 0.5 0.4 0.6 0.8 1.7 0.0 0.3 0.4 0.2 0.2 0.1 0.8 1.4 0.8 0.3 0.0 0.2 0.4 0.0 0.2 0.0 0.3 1.0 0.1 0.2 0.0 0.3 0.0 1.2 0.8 0.8 0.0 0.0 0.0 0.2 1.0 0.2 1.1 0.0 1.3 0.2 1.7 0.9 1.2 0.5 0.0 0.0 0.2 0.0 0.5 0.1 1.0 0.7 1.0 0.5 1.3 0.8 0.3 0.0 0.6 2.5 2.0 0.1 0.6 0.3 0.2 0.2 0.9 1.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 0.1 0.2 0.3 0.0 0.0 0.5 0.3 0.2 0.2 0.2 1.9 0.9 0.3 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.0 2.3 0.1 0.3 0.7 0.6 0.6 0.6 0.4 0.3 1.3 0.0 0.2 0.0 8.4 0.4 1.4 0.3 0.0 0.6 517.1 0.8 0.4 0.4 0.0 0.0 0.3 0.6 0.6 0.6 0.0 0.2 0.0 0.3 0.7 0.2 0.3 0.0 0.7 0.2 0.0 0.0 0.4 594.8 3.7 0.3 0.0 1.0 0.6 0.7 0.0 0.0 0.5 0.2 0.1 3.8 0.0 0.3 0.3 0.2 0.8 1.4 0.0 0.4 0.8 12.2 5.3 0.4 0.3 0.1 0.5 0.3 0.4 0.4 PPP1R17 "C7orf16, GSBS" ENSG00000106341 "Protein phosphatase 1 regulatory subunit 17" O96001 7 31687215-31708455 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 19.1" "Group enriched" "Detected in some" 35 "Early spermatids: 42.9;Late spermatids: 112.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "non-classical monocyte: 51.9" "Lineage enriched" "Detected in many" 21 "monocytes: 51.9" "Group enriched" "Detected in some" 180 "NTERA-2: 40.4;SCLC-21H: 124.1" "Region enriched" "Detected in many" 32 "cerebellum: 430.8" "HPA047819, HPA073123" Enhanced NA NA "HPA047819: AB_2680166, HPA073123: AB_2732219" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "unprognostic (6.56e-2)" "unprognostic (5.55e-2)" "unprognostic (2.33e-1)" 0.2 4.6 7.9 0.2 1.8 0.3 0.0 18.0 1.6 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 6.8 0.0 0.0 0.5 0.0 1.1 10.1 0.6 0.0 0.0 0.0 2.6 0.0 7.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.8 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 124.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.1 0.0 51.9 0.0 0.0 0.8 7.9 1.8 18.0 1.6 0.2 6.8 1.1 10.1 0.6 7.3 0.2 19.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 112.7 0.3 2.2 0.0 0.0 0.9 0.0 1.0 0.5 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBM28 FLJ10377 ENSG00000106344 "RNA binding motif protein 28" Q9NW13 7 128297685-128343908 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019058, HPA026672, HPA031519" Enhanced Supported Nucleoli NA No Nucleoli "HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920" "unprognostic (2.34e-1)" "unprognostic (1.87e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.72e-11)" "unprognostic (6.83e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.20e-2)" "unprognostic (4.01e-2)" "unprognostic (3.97e-3)" "unprognostic (1.45e-3)" "unprognostic (7.15e-3)" "unprognostic (3.05e-1)" "unprognostic (2.18e-2)" "unprognostic (1.04e-1)" 17.8 13.1 6.5 15.1 8.9 12.3 14.8 7.4 8.7 12.6 6.6 10.9 10.3 12.9 6.3 11.9 11.5 8.3 20.1 6.5 7.1 8.5 15.3 10.6 15.0 7.6 7.8 5.0 15.0 12.5 10.6 13.6 11.3 9.4 10.4 9.4 10.5 10.2 7.8 29.8 13.7 9.3 10.8 6.7 10.9 12.0 16.4 8.8 11.4 12.7 17.8 12.6 12.3 11.7 13.3 56.2 60.5 35.9 103.0 25.1 15.9 49.0 50.3 20.7 44.6 48.0 50.7 47.9 74.0 26.8 23.0 64.8 37.0 53.2 42.6 57.4 37.1 51.0 74.4 43.0 47.1 22.3 94.7 63.9 18.1 27.4 59.4 35.5 16.8 41.9 40.3 141.6 42.0 35.1 45.2 68.3 54.0 68.5 38.5 47.0 53.4 42.8 70.7 21.8 37.5 40.0 48.4 65.0 107.2 34.8 42.6 27.6 28.7 40.4 64.4 33.6 57.7 61.9 42.8 39.5 126.0 42.4 78.2 70.8 3.8 11.0 4.6 12.6 9.2 8.7 12.8 10.7 11.6 11.5 13.4 9.7 11.1 9.7 12.3 8.1 14.1 7.4 5.8 6.5 8.9 7.4 8.7 6.5 7.1 7.6 7.8 5.0 9.4 6.7 8.8 13.3 22.7 16.0 31.4 33.3 23.2 16.2 17.1 16.2 24.5 54.9 16.3 17.8 28.8 10.0 27.7 12.9 93.8 20.8 27.5 9.1 25.4 22.3 2.5 21.3 50.3 25.3 11.4 20.4 13.1 22.9 26.5 25.7 21.4 22.5 36.7 30.3 9.7 14.8 19.1 40.4 17.6 14.9 14.2 12.9 10.2 3.3 27.7 17.9 5.4 7.5 18.9 18.6 37.0 18.6 15.3 18.7 8.2 20.7 17.7 19.0 8.1 16.7 17.1 56.1 6.6 51.3 26.4 42.6 44.7 19.1 14.5 18.6 24.4 34.6 16.4 14.8 USP42 FLJ12697 ENSG00000106346 "Ubiquitin specific peptidase 42" Q9H9J4 7 6104884-6161564 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 89.1;Spermatocytes: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006939, HPA064800" Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA006939: , HPA064800: AB_2685355" "unprognostic (1.48e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (1.19e-2)" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (2.82e-1)" "unprognostic (6.21e-3)" "unprognostic (2.47e-2)" "unprognostic (3.17e-3)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.66e-1)" 3.8 3.0 3.1 3.3 3.2 13.5 3.9 6.0 4.4 4.3 2.4 4.3 4.5 4.9 3.6 3.7 4.3 3.4 3.0 3.2 3.1 3.9 4.1 4.1 3.8 3.1 3.3 2.9 4.9 3.8 4.8 3.9 3.3 3.5 3.8 3.4 5.9 3.5 3.1 4.3 5.4 4.4 4.1 2.9 4.4 3.7 15.3 3.1 5.7 4.0 3.4 3.2 4.1 3.8 3.4 10.2 7.4 13.1 12.9 7.4 5.5 9.0 5.4 6.9 6.2 6.1 5.3 5.2 12.0 3.4 6.7 9.2 9.3 11.1 5.9 6.7 2.9 8.6 5.6 6.1 5.5 6.3 13.0 6.1 6.4 6.8 6.7 8.5 5.7 7.7 10.0 21.7 7.9 4.1 9.1 7.9 14.6 14.8 5.2 5.6 14.9 10.2 8.2 5.9 5.3 10.0 17.7 6.9 14.0 4.3 12.0 6.5 6.6 6.5 5.5 20.5 7.0 6.5 7.0 6.3 10.3 4.6 7.8 11.0 0.6 0.3 0.9 0.5 0.6 0.7 0.4 0.6 0.3 0.3 0.2 0.4 1.0 0.3 0.5 0.3 0.6 0.5 0.2 3.1 3.2 6.0 4.4 3.2 3.1 3.1 3.3 2.9 3.5 2.9 3.1 3.4 13.7 12.8 7.0 19.6 16.1 40.5 18.2 5.2 26.7 18.7 17.4 10.8 10.5 8.6 6.8 1.8 22.9 8.3 16.4 20.7 0.0 10.4 89.1 27.1 15.3 14.4 10.7 10.8 26.1 10.4 8.4 13.4 15.3 25.6 9.5 13.4 12.8 9.8 8.2 21.9 26.2 18.1 8.2 9.1 19.9 42.5 14.3 12.4 10.6 18.7 7.7 10.1 12.3 18.6 26.2 12.0 7.7 12.8 21.7 22.3 12.4 5.7 10.6 18.7 13.1 16.2 14.9 72.4 37.0 23.1 41.5 26.8 19.2 6.4 14.4 15.3 IMPDH1 "LCA11, RP10, sWSS2608" ENSG00000106348 "Inosine monophosphate dehydrogenase 1" P20839 7 128392277-128410252 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 107.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 165.8;Cone photoreceptor cells: 141.8;Horizontal cells: 121.1;Rod photoreceptor cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 89.1;eosinophil: 89.1;intermediate monocyte: 104.5;myeloid DC: 59.9;neutrophil: 197.5;non-classical monocyte: 135.9" "Group enriched" "Detected in all" 5 "dendritic cells: 59.9;granulocytes: 197.5;monocytes: 135.9" "Cell line enhanced" "Detected in all" "SK-BR-3: 374.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001400 Approved Supported "Cytosol,Rods & Rings" NA NA 17000 Cytosol "Rods & Rings" "HPA001400: AB_1079139" "unprognostic (2.84e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.23e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (7.31e-5)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.24e-1)" "unprognostic (7.45e-3)" "unprognostic (1.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.78e-12)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.72e-5)" 46.3 16.1 17.4 34.1 15.7 44.5 39.1 13.6 23.8 18.6 11.4 23.8 8.3 15.2 2.6 30.3 17.9 12.0 19.1 16.1 14.3 15.9 5.8 32.0 25.7 20.9 16.7 15.3 20.7 30.4 5.3 26.9 11.5 24.2 28.0 9.9 107.1 29.7 13.3 4.7 22.7 19.3 19.8 14.0 56.4 49.3 16.7 17.7 8.4 11.6 6.2 16.1 29.6 20.6 18.7 111.5 93.2 13.8 102.8 56.5 40.7 38.8 74.1 46.4 61.9 40.1 68.3 35.0 70.8 24.7 111.1 64.4 83.3 78.6 104.1 30.9 25.8 87.1 46.4 66.8 49.1 51.4 62.1 21.1 49.4 49.5 63.2 62.5 29.2 74.5 42.0 46.9 51.8 21.0 76.1 44.1 164.9 77.4 87.7 108.0 51.9 25.2 150.8 27.5 35.1 58.3 55.6 48.0 374.6 68.3 8.6 42.7 119.7 68.5 103.6 37.7 55.0 53.6 38.5 38.3 90.6 53.0 134.0 64.6 11.2 89.1 89.1 22.7 104.5 24.4 15.5 17.9 20.2 59.9 8.9 10.3 12.7 197.5 11.7 135.9 6.0 21.5 58.3 17.4 15.7 13.6 23.8 16.1 14.3 20.9 16.7 15.3 24.2 14.0 17.7 18.7 66.8 0.0 11.2 4.6 13.5 8.8 9.3 13.6 9.6 165.8 12.8 9.9 5.1 2.8 8.6 5.5 141.8 3.3 11.1 6.3 5.9 8.1 0.5 4.0 10.9 20.3 9.6 9.7 8.2 17.8 21.3 15.1 44.9 6.5 21.0 46.0 13.6 1.0 46.1 121.1 11.2 10.1 28.5 58.5 21.7 2.0 4.7 38.2 16.0 3.7 65.3 27.3 24.7 2.0 1.5 10.9 3.1 6.8 29.6 21.5 0.8 1.1 7.4 205.5 0.0 9.0 17.3 2.9 16.9 15.8 7.4 2.3 20.4 18.6 11.9 10.3 AGFG2 "HRBL, RABR" ENSG00000106351 "ArfGAP with FG repeats 2" O95081 7 100539203-100568220 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "salivary gland: 291.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 34.3;Hepatic stellate cells: 57.5;Hepatocytes: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019689, HPA073562" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019689: AB_1855074, HPA073562: " "unprognostic (7.67e-2)" "unprognostic (1.04e-3)" "unprognostic (7.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (6.99e-3)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "prognostic favorable (9.64e-4)" "unprognostic (3.00e-1)" "prognostic favorable (1.03e-6)" "unprognostic (7.83e-2)" "unprognostic (7.47e-2)" "unprognostic (9.90e-3)" "unprognostic (9.31e-2)" 12.5 35.9 15.9 5.1 18.5 5.0 11.3 9.6 15.1 11.6 5.1 15.3 10.4 22.1 5.4 31.0 16.5 11.2 8.8 21.3 13.8 12.9 54.3 7.9 9.1 18.0 10.8 8.6 30.5 18.9 7.5 17.8 2.2 15.6 13.5 10.0 2.2 291.9 13.6 6.2 24.9 13.5 7.7 9.3 29.3 13.6 12.2 14.8 4.4 10.8 5.7 6.5 11.8 12.6 11.6 10.8 17.2 2.2 5.1 15.1 7.8 3.0 5.1 13.6 7.9 8.2 15.1 9.6 6.8 16.5 6.0 34.8 8.8 2.4 5.2 3.5 24.1 6.7 2.1 8.3 33.1 6.1 2.2 11.7 13.0 3.9 6.4 7.1 4.9 21.6 4.4 6.4 9.2 6.5 9.5 8.8 8.0 1.5 30.0 7.1 4.3 2.5 6.1 4.6 5.7 3.1 3.8 9.9 14.0 4.6 3.4 4.0 3.0 5.5 9.8 6.7 24.5 5.4 5.6 31.4 2.6 7.4 6.5 5.7 2.2 0.0 2.2 1.7 0.2 1.5 0.3 1.7 2.0 0.1 0.6 0.5 0.7 0.4 0.5 0.0 0.4 1.4 0.6 15.9 18.5 9.6 15.1 21.3 13.8 18.0 10.8 8.6 15.6 9.3 14.8 11.6 16.9 0.0 3.9 15.0 3.2 2.0 7.4 2.3 8.6 1.6 4.3 3.6 9.1 34.3 3.1 25.8 2.1 1.8 4.9 25.8 11.7 13.4 1.7 2.8 3.2 13.4 26.5 5.9 6.2 11.6 1.6 3.6 10.2 4.2 2.5 7.2 57.5 37.0 1.5 3.3 4.8 12.0 2.0 5.4 3.1 2.3 5.6 1.3 3.6 3.7 7.1 4.0 7.2 3.0 2.5 7.2 9.6 9.1 7.3 3.6 11.1 2.8 1.0 1.7 13.1 1.5 5.6 14.5 14.5 9.2 5.4 0.8 12.6 6.8 15.2 6.9 LSM5 YER146W ENSG00000106355 "LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y4Y9 7 32485338-32495283 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019054 Uncertain NA NA "HPA019054: AB_10960217" "unprognostic (1.92e-1)" "unprognostic (5.36e-2)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (7.53e-5)" "unprognostic (2.22e-1)" "unprognostic (1.77e-2)" "unprognostic (1.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (1.84e-4)" "unprognostic (3.08e-1)" "unprognostic (3.89e-2)" "unprognostic (2.53e-2)" "unprognostic (1.18e-1)" 35.6 42.2 30.2 36.1 30.1 78.2 63.2 30.5 40.6 33.5 29.1 58.6 42.8 34.3 35.8 46.9 34.8 28.3 47.3 29.6 30.5 47.2 76.6 28.3 62.2 29.9 30.1 29.4 36.8 55.1 30.3 29.3 29.1 30.3 34.6 60.6 29.0 31.7 28.0 58.1 34.1 39.7 36.8 30.3 41.3 47.4 22.7 29.9 68.5 44.8 51.6 72.8 38.0 34.7 30.6 204.6 121.9 162.8 229.4 56.0 62.2 80.9 94.9 79.9 119.3 125.6 168.9 170.0 118.8 49.0 67.7 290.9 119.1 121.1 118.7 161.2 84.6 132.7 124.6 193.5 233.7 49.6 267.4 123.3 52.4 85.1 116.7 137.4 79.2 132.9 203.4 261.0 90.5 169.2 246.3 140.3 598.9 267.9 296.7 139.4 122.3 128.4 200.9 107.3 97.8 140.5 206.4 84.9 237.0 114.6 243.5 148.4 331.6 63.9 102.5 252.6 95.8 246.2 149.2 339.9 354.5 96.9 314.9 296.6 17.9 35.0 34.2 38.6 57.4 58.2 69.2 62.9 50.7 50.7 60.2 89.3 68.9 6.0 44.9 49.5 100.1 57.4 45.2 30.2 30.1 30.5 40.6 29.6 30.5 29.9 30.1 29.4 30.3 30.3 29.9 30.6 68.9 32.1 50.6 13.7 135.3 146.4 152.0 254.1 109.8 52.5 201.8 262.4 109.7 94.4 116.7 114.0 22.9 211.9 93.4 95.6 277.8 137.0 16.1 91.1 68.2 81.0 50.5 184.5 15.9 216.6 286.2 98.8 98.8 74.6 72.2 148.2 79.6 285.6 189.8 43.7 20.4 164.9 175.0 117.9 158.2 21.2 75.8 100.1 122.7 13.1 163.9 94.3 78.2 10.1 13.9 146.3 118.2 82.4 187.0 146.9 107.6 343.4 137.5 59.7 65.7 81.9 141.9 88.5 133.2 167.7 177.6 100.6 111.8 123.2 233.2 152.8 SERPINE1 "PAI, PAI1, PLANH1" ENSG00000106366 "Serpin family E member 1" P05121 7 101127104-101139247 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 363.2;liver: 348.7;placenta: 421.4;urinary bladder: 363.5" "Cell type enhanced" "Detected in many" "Endothelial cells: 165.1;Fibroblasts: 162.1;Pancreatic endocrine cells: 231.8;Smooth muscle cells: 239.3;Syncytiotrophoblasts: 651.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "NK-cell: 9.5" "Lineage enriched" "Detected in single" 20 "NK-cells: 9.5" "Cell line enhanced" "Detected in many" "BJ: 3483.8;HUVEC TERT2: 4014.7;LHCN-M2: 3874.5;TIME: 10032.6;U-138 MG: 4609.6;U-251 MG: 4256.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA050039, CAB068501" Uncertain Approved Cytosol "Secreted to blood" No No 142000000 13000000 Cytosol "CAB068501: AB_1642775, HPA050039: AB_2680997" "unprognostic (5.02e-2)" "prognostic unfavorable (5.01e-4)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.10e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (2.84e-5)" "unprognostic (6.80e-3)" "prognostic unfavorable (4.41e-6)" "unprognostic (2.33e-1)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.88e-8)" "prognostic unfavorable (3.27e-6)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.51e-4)" 182.3 76.0 4.5 92.4 7.6 1.7 56.7 5.8 29.8 62.6 13.5 26.7 7.5 31.3 1.0 16.5 41.7 363.2 128.7 4.3 12.1 53.8 348.7 262.6 21.4 5.6 6.0 2.5 106.5 136.3 11.9 12.4 421.4 6.8 38.1 5.4 4.9 10.7 8.1 18.0 18.5 13.2 74.9 6.1 14.0 30.6 5.5 10.8 6.7 60.0 4.4 3.6 363.5 19.4 6.3 77.3 64.4 1.2 5.1 766.6 1511.0 89.3 3483.8 654.6 1717.6 1487.4 9.4 5.5 2.7 812.6 1117.9 2367.3 18.1 0.4 269.4 1756.2 4.3 0.7 1.1 5.2 61.4 1532.6 0.2 3.8 596.1 106.9 2641.4 1374.8 928.5 4014.7 0.2 6.4 2.5 3874.5 0.4 0.6 2.2 18.2 1.3 41.7 0.6 6.1 4.8 5.1 30.3 1.0 0.8 286.3 77.2 8.3 410.9 3.3 9.9 10032.6 4609.6 204.0 1593.8 4256.0 0.6 2.9 4.2 1150.5 2.4 45.9 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 9.5 0.0 0.3 0.0 0.8 4.5 7.6 5.8 29.8 4.3 12.1 5.6 6.0 2.5 6.8 6.1 10.8 6.3 35.8 0.0 7.7 0.0 1.1 40.0 43.7 97.4 14.2 0.3 0.3 2.3 2.5 4.3 11.0 5.5 0.0 56.0 1.0 0.4 0.0 65.1 0.0 4.7 53.8 165.1 5.3 0.0 0.5 4.5 75.1 162.1 0.5 3.2 10.2 12.4 40.4 112.3 15.9 0.0 0.3 0.2 8.2 4.6 9.6 1.1 17.7 11.1 7.2 5.6 1.1 0.7 0.0 0.0 0.0 231.8 0.0 12.0 3.6 9.7 0.1 0.0 8.2 0.3 39.5 55.4 239.3 0.0 0.1 9.0 24.7 651.7 2.3 2.1 0.5 8.1 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 subunit sigma 1" P61966 7 101154456-101161596 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" NA Yes "Golgi apparatus, Vesicles" "HPA060945: AB_2684393" "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 14.0 24.8 74.2 14.0 78.3 5.8 17.4 46.4 84.1 18.2 38.8 27.6 39.3 17.0 17.1 34.5 13.9 13.0 10.7 82.4 68.0 41.3 36.5 14.8 12.0 54.5 54.8 78.9 13.6 22.1 23.0 31.2 16.0 56.5 22.4 22.6 14.7 20.4 9.4 6.5 38.3 30.6 12.9 48.5 20.3 22.2 16.5 60.6 19.3 15.3 8.6 13.7 20.2 19.6 64.3 121.0 87.3 63.3 118.4 42.8 70.4 138.2 76.8 51.1 50.8 52.8 47.3 147.5 24.9 127.5 84.6 97.1 59.0 35.3 116.0 45.6 57.0 56.6 16.8 52.0 61.4 54.2 46.8 87.7 79.1 91.0 49.4 20.6 76.7 76.8 54.1 56.7 103.2 129.9 292.1 40.4 107.8 97.8 177.0 188.2 24.9 27.2 54.6 127.8 88.8 47.5 157.7 40.4 121.1 151.4 101.6 50.7 46.8 79.0 74.1 132.3 27.6 55.2 21.4 51.4 48.4 195.2 50.1 152.9 0.5 3.3 0.3 2.3 3.1 2.2 2.6 3.2 2.5 4.6 2.0 1.9 1.8 1.2 1.3 1.8 5.0 3.3 2.4 74.2 78.3 46.4 84.1 82.4 68.0 54.5 54.8 78.9 56.5 48.5 60.6 64.3 34.4 6.4 0.0 2.3 17.9 38.7 29.7 173.0 46.7 30.7 54.8 49.0 1.1 45.8 72.9 55.2 8.4 170.7 19.8 88.4 344.4 128.2 2.5 28.8 34.2 36.7 90.3 16.2 21.2 111.7 101.3 27.7 42.8 31.9 5.7 85.3 28.9 43.0 95.2 30.3 10.3 96.5 116.0 24.8 21.6 3.4 35.1 27.3 53.4 7.5 58.0 34.1 17.5 2.5 9.8 183.3 86.1 21.8 17.4 34.9 241.3 304.8 34.9 22.3 19.7 11.4 38.4 13.1 70.9 51.4 45.5 60.5 19.5 157.4 119.9 38.2 MOGAT3 "DC7, DGAT2L2, MGAT3" ENSG00000106384 "Monoacylglycerol O-acyltransferase 3" Q86VF5 7 101195007-101201038 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 24.6;liver: 19.0" "Group enriched" "Detected in some" 4 "Distal enterocytes: 81.9;Paneth cells: 56.3;Proximal enterocytes: 88.9;Undifferentiated cells: 26.3" "Group enriched" "Detected in many" 5 "colorectal cancer: 11.0;liver cancer: 11.1;stomach cancer: 3.2" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "CACO-2: 2.9;Hep G2: 10.7" HPA011940 Approved Approved Centrosome NA NA Centrosome "HPA011940: AB_1854057" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (7.14e-2)" "unprognostic (6.11e-2)" "unprognostic (3.20e-1)" "unprognostic (9.54e-3)" "unprognostic (9.36e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-3)" "unprognostic (1.87e-1)" "unprognostic (1.23e-1)" "unprognostic (9.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.59e-2)" 0.1 0.1 0.5 1.7 0.5 0.9 0.1 1.3 0.8 0.0 0.4 9.1 24.6 0.2 0.2 0.2 0.1 0.2 0.1 0.5 0.2 1.2 19.0 0.1 0.2 0.3 0.2 0.7 0.0 0.2 0.0 0.0 0.1 0.7 0.1 7.3 0.4 0.1 0.1 0.5 0.4 24.0 0.8 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.0 1.2 0.4 0.1 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 2.9 0.8 0.1 0.4 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.4 10.7 0.1 0.2 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.2 0.3 0.1 0.3 0.4 0.1 0.0 0.3 0.4 0.4 0.1 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.6 0.6 0.1 0.6 0.3 0.2 0.1 0.0 0.6 0.3 0.8 0.8 0.2 0.3 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.4 0.2 0.3 1.6 0.5 0.2 0.3 0.1 0.1 0.5 0.5 1.3 0.8 0.5 0.2 0.3 0.2 0.7 0.7 0.2 0.3 1.2 0.3 0.0 0.5 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 81.9 0.0 0.1 0.0 0.1 0.2 0.1 1.8 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 1.1 7.4 0.0 0.0 0.0 14.7 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 56.3 0.0 0.0 0.2 88.9 5.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.1 0.1 0.5 0.1 26.3 0.4 C1GALT1 "C1GALT, T-synthase" ENSG00000106392 "Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1" Q9NS00 7 7156934-7248616 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 204.3;Syncytiotrophoblasts: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "LHCN-M2: 288.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011294, HPA012819" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 43000 "Nuclear bodies, Cytosol" "HPA011294: AB_1845623, HPA012819: AB_1845624" "unprognostic (1.52e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.38e-2)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (2.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-1)" "unprognostic (3.28e-1)" "unprognostic (8.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-1)" 13.1 7.2 13.4 14.3 17.6 38.0 16.7 16.7 15.6 18.7 23.4 15.4 29.7 5.7 6.5 21.8 16.4 16.8 12.8 12.1 16.3 31.1 22.2 15.2 19.2 18.2 17.1 10.9 4.7 6.1 46.1 8.7 27.2 18.5 5.1 18.2 23.8 23.5 6.9 7.6 8.8 19.4 7.4 18.6 15.6 22.6 7.3 16.1 14.4 12.7 11.4 14.2 13.1 7.4 25.8 63.5 25.9 9.6 16.0 28.1 57.0 28.0 71.5 60.7 32.4 51.1 20.0 63.9 33.4 17.0 31.7 93.5 18.3 14.0 27.5 58.3 15.1 8.1 31.1 15.9 62.3 28.1 34.3 13.2 44.0 20.0 75.7 70.0 47.4 30.3 29.9 61.0 19.9 288.7 10.5 8.8 22.8 51.7 47.8 20.3 29.6 53.1 19.3 46.6 32.4 9.9 27.2 46.9 57.0 52.8 57.5 15.6 19.6 30.4 55.2 76.7 74.7 31.3 34.4 28.7 32.9 36.9 42.9 55.8 56.0 12.9 38.4 17.7 20.2 19.7 20.4 16.6 20.6 15.1 16.6 17.7 19.4 29.1 22.7 34.0 16.4 16.2 14.1 13.4 17.6 16.7 15.6 12.1 16.3 18.2 17.1 10.9 18.5 18.6 16.1 25.8 23.2 41.7 54.2 32.3 57.1 26.3 17.0 48.4 29.0 28.1 24.5 10.8 24.0 25.8 40.6 18.4 33.3 91.9 44.8 29.9 5.9 29.1 17.2 28.4 8.7 12.7 15.6 49.7 44.3 25.3 81.1 26.0 41.3 31.7 12.0 36.2 13.9 23.5 38.2 47.1 42.5 18.8 30.5 21.1 20.5 19.9 6.5 33.0 23.2 65.6 21.9 22.9 49.4 52.3 204.3 46.2 22.6 6.4 43.2 14.5 27.7 40.0 29.7 34.8 6.6 17.2 15.3 16.6 35.6 46.4 19.5 204.8 39.6 8.9 26.7 25.7 PLOD3 LH3 ENSG00000106397 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3" O60568 7 101205977-101218420 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "melanoma: 115.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 20.3;monocytes: 22.5;T-cells: 12.6" "Cell line enhanced" "Detected in all" "Karpas-707: 695.6;WM-115: 680.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001236 Uncertain "Secreted to extracellular matrix" NA NA 1600000 "HPA001236: AB_1855474" "unprognostic (1.15e-1)" "prognostic unfavorable (1.91e-5)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.39e-1)" "unprognostic (2.76e-3)" "unprognostic (1.04e-2)" "unprognostic (6.26e-3)" "unprognostic (1.11e-3)" "unprognostic (8.00e-3)" "unprognostic (1.18e-2)" "unprognostic (4.18e-2)" "unprognostic (1.66e-1)" "unprognostic (1.21e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-1)" "unprognostic (8.52e-3)" "unprognostic (9.87e-2)" 38.8 27.5 54.8 23.1 52.4 19.8 33.0 55.0 58.9 32.3 46.1 37.4 26.0 39.2 11.8 12.3 32.8 18.9 41.4 45.4 49.5 36.1 54.5 37.8 14.7 59.3 52.7 42.0 26.6 42.1 21.7 27.3 35.3 57.7 24.4 15.4 4.0 19.6 18.7 15.4 18.8 36.2 26.3 56.0 35.6 30.3 13.0 58.7 8.1 25.5 11.9 7.5 35.5 25.4 72.9 71.7 62.4 27.1 168.2 116.2 83.9 51.4 125.5 135.9 122.7 88.6 98.0 89.0 5.6 140.2 211.4 100.7 83.0 50.0 72.0 31.2 37.8 23.8 7.2 70.7 97.3 157.6 31.5 57.4 90.8 67.6 71.6 55.4 120.2 110.9 4.6 68.4 695.6 84.2 194.5 3.4 72.1 53.5 120.5 94.9 21.8 35.1 108.3 42.0 19.1 21.2 116.0 81.1 116.2 288.1 66.8 21.9 105.2 100.5 188.1 94.9 228.1 155.0 38.5 75.9 5.2 112.4 74.2 680.2 0.0 18.1 4.4 12.6 21.8 10.9 3.7 9.3 8.3 16.5 2.2 4.1 4.5 1.8 3.6 22.5 20.3 6.7 9.5 54.8 52.4 55.0 58.9 45.4 49.5 59.3 52.7 42.0 57.7 56.0 58.7 72.9 34.1 22.4 8.7 11.1 9.7 8.9 10.8 18.9 8.0 5.7 8.1 9.1 16.1 21.5 8.7 25.8 14.6 20.4 22.0 37.6 1.9 40.2 0.6 10.8 29.9 28.5 16.2 19.1 11.9 31.6 71.6 34.2 17.9 20.5 19.7 25.9 26.7 18.3 50.1 8.4 10.8 18.0 4.1 23.3 18.3 2.1 26.1 23.2 62.2 4.7 18.9 7.7 12.3 10.1 33.4 36.1 37.8 14.7 19.7 8.0 45.8 8.8 9.3 7.3 19.7 14.3 29.8 8.9 12.4 1.9 4.8 18.9 12.5 18.4 27.3 5.2 RPA3 REPA3 ENSG00000106399 "Replication protein A3" P35244 7 7636518-7718607 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 428.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005708 Approved NA NA 17000 "HPA005708: AB_1856411" "unprognostic (2.06e-2)" "unprognostic (2.27e-2)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (7.20e-3)" "unprognostic (3.75e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (5.31e-2)" "unprognostic (2.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (7.41e-2)" "unprognostic (1.08e-1)" "unprognostic (7.24e-2)" "unprognostic (2.61e-1)" "unprognostic (5.83e-2)" 15.2 26.0 14.0 23.1 15.7 46.6 24.7 15.8 19.9 11.8 20.1 25.4 15.9 10.6 37.4 19.8 25.7 10.7 19.1 13.8 17.1 35.7 40.8 14.7 38.2 15.3 15.3 13.7 12.8 15.5 46.8 27.4 16.5 16.9 11.6 20.1 34.4 14.6 13.7 18.9 12.9 18.6 9.7 16.2 23.6 21.0 22.7 15.3 52.2 19.5 12.6 35.9 16.5 12.6 17.2 174.1 95.9 94.8 102.3 35.2 31.9 67.2 47.6 44.3 73.0 116.2 92.3 153.1 88.4 45.2 36.0 235.9 129.2 64.5 85.9 106.4 41.1 112.0 48.1 111.9 189.2 15.3 102.5 38.9 23.4 29.9 85.0 59.6 36.0 41.9 168.6 119.5 132.6 70.8 257.0 83.9 198.1 149.9 104.9 125.1 98.3 154.9 141.6 52.3 84.0 70.5 86.8 88.2 91.6 51.0 137.9 122.0 107.4 19.3 60.5 169.1 99.8 113.7 102.7 199.9 167.7 89.7 119.3 118.5 17.9 25.3 27.2 34.1 40.8 40.9 75.4 55.7 44.0 31.9 76.9 45.6 46.3 22.2 29.7 49.0 61.6 68.5 35.7 14.0 15.7 15.8 19.9 13.8 17.1 15.3 15.3 13.7 16.9 16.2 15.3 17.2 35.6 38.5 39.5 2.9 93.2 40.5 65.0 160.8 41.5 24.1 54.7 73.9 39.0 60.1 89.5 71.7 10.4 152.2 53.2 61.9 273.9 84.8 96.9 144.8 34.9 35.7 25.3 218.2 5.2 105.4 257.5 43.3 39.8 61.8 53.9 43.2 36.0 154.5 131.4 16.8 5.6 75.1 83.4 48.7 54.2 24.4 39.1 49.9 56.9 1.9 68.2 63.7 56.7 6.0 5.8 64.1 70.4 24.5 75.8 25.9 74.3 428.6 269.9 44.7 6.6 34.7 46.9 112.7 65.9 59.6 34.4 66.2 68.7 46.1 90.5 66.2 ZNHIT1 "CG1I, H_DJ0747G18.14, ZNFN4A1" ENSG00000106400 "Zinc finger HIT-type containing 1" O43257 7 101218165-101224190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 905.3;Proximal tubular cells: 889.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019043 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA019043: AB_1859481" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.52e-3)" "unprognostic (1.24e-1)" "unprognostic (4.26e-2)" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (3.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-2)" "unprognostic (1.05e-2)" "unprognostic (2.02e-2)" "unprognostic (2.10e-3)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (3.36e-1)" "unprognostic (7.24e-3)" 67.7 58.7 126.6 34.7 131.0 60.0 54.2 135.3 174.9 52.3 131.4 66.0 67.4 38.7 54.6 45.8 61.4 46.9 68.2 124.4 129.7 82.0 200.9 38.4 48.9 134.7 130.3 121.0 32.7 62.8 78.5 45.4 44.4 132.5 49.5 43.6 21.2 74.2 53.2 91.7 46.3 58.5 40.1 134.9 49.1 63.4 20.8 132.9 56.3 49.6 70.6 39.2 45.2 39.4 142.6 100.1 92.5 61.8 128.6 114.4 147.4 63.0 113.8 112.8 111.2 111.2 97.6 120.9 70.1 154.6 132.7 87.8 80.2 56.5 159.8 49.1 76.7 221.5 37.8 83.0 116.6 142.7 75.4 82.9 137.8 190.5 97.6 49.8 94.0 166.4 102.4 121.4 126.8 99.9 280.8 145.0 411.2 121.8 151.5 239.7 73.5 47.7 222.1 154.4 46.6 79.6 176.0 79.8 166.2 197.7 70.5 44.6 99.8 121.8 109.0 94.0 190.6 91.0 95.8 136.8 95.3 101.7 142.5 138.7 231.5 214.5 220.2 121.3 202.7 126.5 130.9 133.6 124.4 186.6 142.4 107.9 114.7 181.3 121.4 205.5 202.3 195.2 234.5 126.6 131.0 135.3 174.9 124.4 129.7 134.7 130.3 121.0 132.5 134.9 132.9 142.6 203.1 93.0 81.8 6.8 85.3 100.7 121.1 214.6 76.2 30.8 146.0 163.3 77.6 183.0 139.4 191.3 16.7 204.4 115.8 358.1 361.9 200.5 30.5 177.2 153.2 158.5 241.4 195.5 4.6 254.5 199.9 124.7 121.3 169.9 78.6 110.4 174.9 905.3 205.9 11.8 5.0 315.6 166.8 205.4 133.7 59.9 135.2 126.3 129.9 5.6 222.1 89.9 176.1 5.0 17.3 271.4 389.9 124.8 119.4 89.4 432.8 889.4 139.4 37.4 151.2 71.7 150.1 70.6 42.0 109.1 116.5 163.5 104.5 153.8 287.1 138.8 CLDN15 ENSG00000106404 "Claudin 15" P56746 7 101232092-101238820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "intestine: 262.2" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 594.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.93e-2)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (1.03e-1)" "unprognostic (6.56e-2)" "unprognostic (1.79e-1)" "prognostic favorable (2.56e-4)" "unprognostic (2.02e-2)" "prognostic unfavorable (5.31e-5)" "unprognostic (9.98e-2)" "unprognostic (2.89e-2)" "unprognostic (9.64e-2)" "prognostic favorable (3.30e-4)" 42.1 3.9 8.8 7.4 9.4 13.7 20.4 8.3 11.1 14.8 5.8 15.8 262.2 11.2 2.3 7.3 16.5 7.4 7.7 7.2 7.5 15.2 22.4 10.8 9.9 10.0 8.7 6.5 18.7 7.8 2.0 6.9 6.0 10.0 11.5 7.9 8.9 6.5 2.6 3.6 11.0 185.5 4.5 8.0 22.8 10.1 8.3 8.6 8.8 9.3 1.3 7.1 9.9 11.7 17.4 3.3 10.1 5.3 8.4 8.1 6.5 3.6 3.2 4.0 3.9 5.6 7.3 3.8 11.0 5.6 2.1 6.4 6.1 8.8 1.8 3.8 13.8 18.5 5.1 6.9 9.0 7.1 5.7 10.6 6.2 8.8 5.1 6.7 8.3 3.3 10.9 24.3 17.4 3.0 11.7 9.1 32.6 4.1 4.9 6.9 12.3 4.5 9.3 2.3 4.1 5.1 18.1 2.9 5.5 16.4 7.2 5.1 11.4 4.7 12.8 11.0 19.5 3.9 18.3 24.9 11.7 3.6 14.9 7.5 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.2 8.8 9.4 8.3 11.1 7.2 7.5 10.0 8.7 6.5 10.0 8.0 8.6 17.4 27.3 3.2 1.1 4.9 5.2 6.8 5.4 12.9 5.2 20.4 7.5 6.1 1.2 18.6 8.2 22.0 31.3 5.1 6.3 18.9 13.7 5.6 17.1 8.6 3.8 22.4 12.1 16.8 1.5 6.5 3.8 17.2 9.2 7.1 0.0 5.2 7.5 10.6 2.7 15.2 1.4 55.7 16.2 4.6 7.5 4.1 15.2 4.0 7.2 4.7 5.1 4.4 10.3 0.5 10.5 6.6 93.1 2.2 1.2 6.1 594.4 3.5 10.1 20.2 6.6 6.4 5.1 5.8 7.2 3.4 5.3 5.1 5.5 3.2 120.6 3.9 NOBOX "OG2, Og2x" ENSG00000106410 "NOBOX oogenesis homeobox" O60393 7 144397240-144410227 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Premature ovarian failure" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLCCI1 "FAM117C, GIG18, TSSN1" ENSG00000106415 "Glucocorticoid induced 1" Q86VQ1 7 7968796-8094272 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.0" "Cell type enhanced" "Detected in all" "Excitatory neurons: 193.3;Inhibitory neurons: 149.3;Oligodendrocyte precursor cells: 276.5;Plasma cells: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 37.7;U-266/70: 86.8;U-698: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001674, HPA005987" Approved Approved Nucleoli NA NA Nucleoli "HPA001674: AB_1078971, HPA005987: AB_1078970" "unprognostic (6.12e-2)" "unprognostic (7.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.45e-1)" "unprognostic (6.17e-3)" "unprognostic (1.02e-2)" "unprognostic (4.40e-1)" "unprognostic (1.68e-3)" "unprognostic (3.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.17e-3)" "unprognostic (3.35e-1)" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.56e-1)" "unprognostic (3.09e-1)" "unprognostic (9.20e-3)" 4.4 3.6 1.0 7.2 3.2 7.4 3.3 5.5 6.8 4.4 0.0 4.5 5.2 2.5 1.1 2.1 2.0 3.5 1.2 0.6 2.7 3.1 3.4 9.0 12.3 0.9 1.0 0.9 4.3 1.1 4.9 2.1 3.9 2.0 2.7 4.1 7.4 3.9 1.7 2.1 3.9 3.8 2.2 0.0 7.1 5.4 11.0 1.1 34.0 16.8 1.6 14.9 4.5 1.4 5.8 5.3 0.8 8.4 2.1 2.5 3.6 1.7 4.4 6.1 2.5 2.4 2.7 1.7 14.3 1.0 3.6 4.3 0.8 7.7 2.3 3.3 7.2 6.0 4.3 10.1 1.9 4.1 6.8 6.0 1.7 2.8 1.7 5.6 4.2 2.3 5.3 15.7 37.7 4.5 3.0 3.1 6.7 20.9 2.3 5.2 15.3 6.3 7.7 2.5 6.0 13.8 26.9 6.7 8.2 0.5 22.3 9.8 17.5 1.9 4.6 2.0 4.1 2.3 86.8 29.8 40.4 4.8 7.0 3.5 2.0 0.0 0.7 1.1 0.1 1.0 0.7 1.1 0.8 0.0 1.4 0.6 0.7 0.5 2.1 0.0 1.0 2.0 0.2 1.0 3.2 5.5 6.8 0.6 2.7 0.9 1.0 0.9 2.0 0.0 1.1 5.8 7.2 83.3 49.5 98.9 28.5 10.3 8.2 4.3 5.7 63.4 13.3 11.2 6.9 1.5 21.6 7.3 43.8 11.6 50.2 3.6 1.9 1.2 87.6 9.5 12.8 4.0 19.3 6.9 193.3 1.6 11.4 8.0 4.6 10.2 5.7 41.5 6.4 9.2 13.5 8.4 149.3 7.6 8.2 2.7 4.6 20.5 8.1 9.4 8.8 112.4 3.1 19.4 71.1 276.5 73.2 3.4 2.6 11.3 132.0 19.6 2.4 2.0 15.4 21.5 6.6 6.6 9.8 76.0 36.0 8.1 13.1 28.7 36.1 8.5 4.3 13.6 MYL10 "MGC3479, MYLC2PL, PLRLC" ENSG00000106436 "Myosin light chain 10" Q9BUA6 7 101613330-101629296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Peritubular cells: 2.6;Skeletal myocytes: 3.7" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "HSkMC: 1.2;PC-3: 2.4;RH-30: 4.2;SuSa: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019763, HPA039262" Uncertain Uncertain Microtubules NA NA Microtubules "HPA019763: AB_1854243, HPA039262: AB_2676418" "unprognostic (2.32e-2)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-2)" "unprognostic (2.78e-3)" "unprognostic (5.04e-3)" "unprognostic (8.93e-2)" "unprognostic (1.10e-2)" 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.8 0.6 0.7 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.6 0.3 0.6 0.1 0.1 0.1 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 2.4 0.0 4.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 1.0 1.9 0.1 0.0 0.1 0.3 1.0 0.0 0.1 0.2 0.1 0.8 0.0 0.2 0.0 1.9 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.3 0.2 0.2 1.1 0.4 0.1 0.3 0.4 0.1 0.2 0.2 0.8 0.6 0.3 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169623 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: AB_2732420" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 10.0 8.0 18.0 8.6 16.4 5.6 13.9 18.3 27.1 9.1 13.5 9.9 8.3 13.2 7.9 8.4 8.9 9.4 5.3 17.5 15.4 9.2 11.5 8.7 10.0 17.2 16.6 14.9 14.6 7.2 9.6 7.9 8.5 18.3 10.1 10.5 6.8 7.9 8.2 6.1 8.6 8.3 11.1 15.3 10.4 10.4 9.4 16.5 18.0 9.3 7.9 10.3 9.3 7.7 17.9 16.4 32.8 46.4 49.2 16.2 15.6 23.1 12.6 10.0 14.5 15.9 29.5 28.9 62.4 22.7 11.7 32.7 22.8 42.4 14.6 16.0 23.1 17.3 31.1 28.1 38.0 14.8 70.2 28.8 14.2 15.0 17.3 30.9 20.4 21.2 24.2 42.4 21.6 17.6 21.6 28.0 30.4 39.3 68.1 24.4 45.9 30.3 19.8 15.0 30.6 42.2 58.3 19.5 64.6 21.1 33.6 34.6 50.1 20.6 20.3 27.1 13.6 25.0 27.7 51.1 43.2 14.4 57.8 48.6 1.0 0.9 0.6 1.3 0.8 1.0 1.8 1.4 1.6 0.5 1.4 1.9 1.7 0.0 1.4 0.8 2.7 1.9 0.4 18.0 16.4 18.3 27.1 17.5 15.4 17.2 16.6 14.9 18.3 15.3 16.5 17.9 80.6 41.7 41.6 141.0 66.9 57.5 68.6 27.5 68.9 92.7 80.3 91.3 22.7 37.1 44.2 33.1 58.4 68.8 58.4 54.6 27.4 92.0 23.9 40.9 82.7 77.4 92.2 46.9 223.8 84.3 80.9 65.9 55.5 48.1 56.5 103.7 64.2 43.6 42.1 79.1 260.6 72.3 42.7 39.6 24.7 16.2 102.9 39.1 37.4 116.2 58.0 36.5 87.6 263.4 200.8 90.4 45.9 116.9 34.3 82.0 46.0 35.9 28.0 63.3 52.6 71.0 67.6 142.3 133.7 56.5 52.4 39.8 58.6 73.7 72.0 54.2 NRF1 "ALPHA-PAL, EWG" ENSG00000106459 "Nuclear respiratory factor 1" Q16656 7 129611720-129757082 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 127.0;Excitatory neurons: 115.4;Inhibitory neurons: 109.4;Microglial cells: 75.9;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029329 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029329: AB_10601240" "unprognostic (2.80e-2)" "unprognostic (2.20e-3)" "unprognostic (4.51e-1)" "unprognostic (4.04e-2)" "unprognostic (2.01e-1)" "unprognostic (4.20e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.09e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (1.83e-2)" "unprognostic (2.06e-1)" "unprognostic (6.52e-2)" "unprognostic (4.20e-1)" "unprognostic (2.06e-3)" 7.7 5.7 9.9 8.0 9.8 16.8 8.0 13.1 11.2 10.7 11.0 8.1 6.5 10.0 6.4 7.3 12.9 5.5 9.5 9.2 9.8 7.7 6.2 8.1 12.4 10.9 9.9 8.5 16.7 7.4 8.6 7.8 7.0 10.6 8.0 6.9 12.8 7.6 6.3 15.8 9.1 8.4 7.7 9.1 10.4 6.7 5.6 10.0 18.1 9.7 8.9 11.2 8.8 8.1 13.0 15.9 12.8 18.1 15.9 10.7 8.5 14.4 10.9 11.2 16.3 12.6 15.6 10.4 18.3 7.8 12.3 10.2 11.9 19.7 11.0 16.5 17.5 14.1 15.1 11.0 10.3 7.8 18.7 14.5 7.3 10.2 16.1 15.5 9.4 12.1 17.4 18.6 13.7 10.1 14.5 36.9 17.6 16.9 14.5 11.3 23.2 14.6 16.2 9.2 11.5 15.6 17.1 16.4 16.8 11.0 14.7 10.5 17.4 9.4 9.2 12.6 10.8 20.3 14.7 15.7 32.0 9.7 17.0 18.1 5.6 4.2 10.6 8.2 5.2 9.8 5.5 6.3 7.7 5.5 5.9 6.8 6.0 8.8 5.0 5.8 3.6 7.2 5.8 9.9 9.8 13.1 11.2 9.2 9.8 10.9 9.9 8.5 10.6 9.1 10.0 13.0 6.8 3.2 6.5 127.0 15.8 6.6 3.2 3.4 4.6 10.8 5.4 5.1 6.2 2.8 4.8 3.7 10.4 2.8 11.3 5.5 0.0 2.3 0.4 8.9 6.4 7.1 6.7 3.0 115.4 3.6 4.1 6.0 7.1 5.7 5.1 6.9 7.1 4.1 3.1 10.1 109.4 5.3 4.1 7.7 9.5 1.9 5.3 5.4 5.4 75.9 4.0 6.4 12.3 143.2 122.3 3.0 10.2 4.5 14.2 6.8 3.7 2.3 13.1 11.2 6.6 10.0 6.4 9.0 6.6 6.2 7.7 3.4 13.8 2.3 4.2 5.4 TMEM106B "FLJ11273, MGC33727" ENSG00000106460 "Transmembrane protein 106B" Q9NUM4 7 12211270-12243367 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Amyotrophic lateral sclerosis, Disease variant, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058342 Approved Supported Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" "HPA058342: AB_2683684" "unprognostic (5.29e-2)" "unprognostic (2.34e-2)" "unprognostic (4.20e-2)" "unprognostic (6.20e-2)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (3.50e-2)" "unprognostic (5.89e-2)" "unprognostic (4.44e-2)" "unprognostic (1.30e-1)" "unprognostic (3.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.75e-3)" "unprognostic (5.52e-2)" "unprognostic (3.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-1)" 9.8 26.3 6.8 7.1 10.0 7.3 11.0 12.0 9.2 13.2 7.5 12.7 8.7 14.8 12.3 10.4 11.3 9.1 10.8 8.2 7.9 17.9 19.0 7.7 8.0 8.5 9.1 6.8 12.1 10.2 12.8 9.9 14.1 9.5 14.7 11.6 14.8 13.2 14.0 14.8 8.9 10.3 12.8 9.6 8.5 8.9 7.0 8.6 6.7 16.1 12.3 6.9 10.8 10.3 15.2 13.9 26.3 14.8 24.2 26.3 21.3 11.5 19.7 33.3 12.6 12.7 8.6 42.1 3.7 21.2 23.5 30.0 14.6 11.9 12.5 10.5 7.2 11.5 5.5 14.5 8.3 20.8 20.5 8.6 22.1 14.1 9.9 19.2 57.5 16.0 10.2 16.1 11.1 14.9 4.4 3.9 8.6 17.4 17.5 13.9 11.1 10.9 10.1 23.5 12.4 15.4 21.4 18.8 15.4 16.7 20.0 13.9 10.0 18.9 14.0 20.3 14.1 16.2 15.0 28.6 5.9 19.6 6.7 35.2 11.6 4.3 5.3 9.1 5.2 12.8 6.1 10.6 10.6 2.9 7.8 17.3 13.2 2.8 14.4 7.9 0.9 10.3 6.8 6.8 10.0 12.0 9.2 8.2 7.9 8.5 9.1 6.8 9.5 9.6 8.6 15.2 45.0 73.7 40.3 41.1 34.3 36.8 42.6 38.5 62.6 55.0 46.0 30.4 46.0 38.6 49.3 66.2 45.9 54.0 18.9 53.6 17.6 115.4 5.0 29.2 56.3 34.6 57.6 24.4 60.1 58.7 36.0 65.8 36.7 37.8 14.5 53.8 41.7 85.1 33.3 65.6 78.6 37.9 57.0 29.2 23.9 4.3 49.0 23.9 37.4 28.1 19.1 95.2 39.1 66.9 82.3 75.3 53.4 60.9 39.9 85.0 57.1 67.7 47.4 51.8 32.9 49.5 41.6 40.1 31.6 56.4 43.3 135.6 41.1 70.7 47.2 81.9 EZH2 "ENX-1, EZH1, KMT6, KMT6A" ENSG00000106462 "Enhancer of zeste 2 polycomb repressive complex 2 subunit" Q15910 7 148807383-148884321 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.3;lymphoid tissue: 43.4;testis: 28.0" "Cell type enhanced" "Detected in many" "Early spermatids: 109.3;Spermatocytes: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009589, HPA029131" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009589: , HPA029131: AB_2672920" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.57e-1)" "unprognostic (3.30e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "prognostic unfavorable (2.11e-6)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.32e-3)" "unprognostic (1.58e-3)" "unprognostic (1.69e-3)" "prognostic unfavorable (8.18e-12)" "prognostic favorable (6.97e-4)" "unprognostic (1.83e-1)" "unprognostic (2.12e-1)" "unprognostic (6.67e-2)" 1.5 1.6 1.2 10.2 1.2 48.3 2.7 2.1 1.4 2.1 1.6 7.1 6.5 2.0 1.2 10.9 1.1 1.9 1.0 1.2 1.3 1.5 3.3 2.3 22.3 1.3 1.3 1.1 1.6 3.8 1.3 0.5 4.9 1.5 1.3 8.3 3.3 2.8 0.2 2.9 10.8 6.9 2.8 1.2 5.7 4.1 28.0 1.5 43.4 1.3 1.9 21.3 3.5 3.8 1.9 65.6 30.1 99.7 66.9 3.1 5.1 54.6 49.7 19.9 39.9 40.2 45.6 73.2 114.3 23.5 18.7 36.3 39.0 52.1 17.1 50.6 164.9 51.8 48.9 38.4 35.5 8.0 110.1 38.5 4.3 9.6 29.9 15.9 12.1 24.0 108.9 105.9 73.6 36.2 74.0 215.7 91.7 79.6 57.0 39.9 131.3 56.0 70.9 18.6 31.0 95.1 60.3 62.3 46.8 16.5 25.3 34.3 46.7 14.8 42.4 19.8 85.2 90.4 65.7 76.6 115.3 38.6 74.2 84.9 0.4 1.7 1.1 1.2 1.2 0.9 1.1 2.6 2.2 3.8 0.6 1.4 0.9 0.1 7.2 3.6 0.8 8.3 1.2 1.2 1.2 2.1 1.4 1.2 1.3 1.3 1.3 1.1 1.5 1.2 1.5 1.9 14.4 0.0 6.7 1.3 14.5 26.5 6.7 6.3 10.2 6.0 15.1 12.2 6.1 2.8 7.1 7.3 35.5 28.8 35.9 14.7 3.9 9.5 109.3 16.3 17.0 9.4 9.0 57.0 6.2 8.5 32.2 9.9 15.8 24.2 21.6 45.9 3.3 2.2 11.9 15.2 9.2 20.5 6.1 9.0 33.6 27.7 3.1 19.1 14.2 14.0 14.9 2.6 12.3 16.6 7.0 12.4 10.5 0.7 37.4 4.8 6.8 1.2 9.7 21.3 6.6 13.8 24.1 142.2 58.2 35.8 29.0 30.5 25.7 4.7 22.1 5.9 CEP41 "DKFZp762H1311, FLJ22445, JBTS15, TSGA14" ENSG00000106477 "Centrosomal protein 41" Q9BYV8 7 130393771-130442433 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Autism, Autism spectrum disorder, Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.4" "Cell type enhanced" "Detected in all" "Early spermatids: 526.8;Late spermatids: 160.6;Spermatocytes: 96.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024090 Uncertain NA NA "HPA024090: AB_10966276" "unprognostic (3.87e-2)" "unprognostic (5.96e-2)" "prognostic favorable (4.54e-4)" "unprognostic (1.17e-3)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-7)" "unprognostic (1.80e-1)" "unprognostic (2.89e-1)" "unprognostic (8.45e-3)" "unprognostic (4.63e-2)" "unprognostic (1.37e-1)" "unprognostic (7.76e-2)" "unprognostic (7.72e-2)" "unprognostic (3.35e-2)" "unprognostic (9.87e-2)" "unprognostic (1.57e-1)" 3.8 5.2 6.4 3.5 5.4 4.3 3.7 4.2 5.7 3.5 7.8 3.0 3.3 4.3 3.7 2.6 9.5 4.7 2.0 5.8 5.3 3.3 2.7 3.2 4.7 4.8 6.1 5.1 3.5 2.2 5.1 4.7 4.5 5.7 3.2 3.6 7.8 17.9 3.6 1.6 2.4 2.2 5.3 5.5 4.2 2.8 47.4 5.4 8.7 4.1 2.3 5.0 3.2 1.4 6.3 15.9 16.5 17.6 11.4 5.1 8.9 3.6 21.0 10.4 12.4 13.9 9.8 19.3 23.1 11.3 12.3 34.4 15.2 17.6 11.3 17.2 8.0 5.0 8.4 7.2 5.2 8.5 16.7 8.0 9.7 8.6 16.2 7.2 12.0 21.9 16.7 4.8 5.3 21.5 10.7 43.2 14.7 15.7 17.4 12.6 30.3 25.7 0.7 9.1 10.3 25.4 21.0 14.0 19.9 16.3 9.9 6.1 12.8 11.0 18.4 7.2 17.6 27.3 12.2 39.9 28.8 20.7 16.4 27.8 7.9 4.6 5.9 7.5 6.9 4.9 3.6 5.4 5.7 8.3 4.5 8.4 13.9 0.8 11.2 3.3 4.0 6.3 7.4 6.4 5.4 4.2 5.7 5.8 5.3 4.8 6.1 5.1 5.7 5.5 5.4 6.3 8.7 9.6 4.1 7.2 5.0 1.8 6.4 13.5 4.6 18.1 11.6 9.0 4.4 4.3 10.1 9.2 37.5 16.2 3.8 3.1 11.7 12.9 526.8 35.9 8.9 9.6 14.4 12.4 14.5 9.2 10.9 7.8 4.6 5.3 11.4 13.3 12.8 3.4 18.7 15.2 12.5 4.7 10.2 8.9 2.2 160.6 10.5 8.0 5.4 5.6 4.0 10.2 9.2 17.1 14.2 7.0 3.7 8.2 1.9 4.0 2.0 5.2 55.5 22.0 6.6 6.3 7.4 96.0 35.0 4.1 1.6 19.2 5.8 8.7 6.3 6.5 ZNF862 ENSG00000106479 "Zinc finger protein 862" O60290 7 149838375-149867479 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 51.2;Excitatory neurons: 44.0;Inhibitory neurons: 45.2;Microglial cells: 31.9;Oligodendrocyte precursor cells: 46.3;Oligodendrocytes: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024154 Uncertain Approved Mitochondria NA NA Mitochondria "HPA024154: AB_1859469" "unprognostic (1.82e-2)" "unprognostic (2.33e-1)" "unprognostic (3.32e-3)" "unprognostic (1.97e-1)" "unprognostic (8.87e-2)" "unprognostic (4.87e-3)" "unprognostic (4.72e-3)" "unprognostic (2.74e-2)" "unprognostic (6.76e-2)" "unprognostic (2.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.73e-2)" "unprognostic (5.88e-2)" "unprognostic (4.29e-2)" "unprognostic (8.90e-2)" "unprognostic (1.30e-2)" "prognostic favorable (8.66e-4)" 5.5 7.1 7.6 6.9 8.1 5.6 7.8 8.6 8.0 7.9 11.4 8.1 4.4 7.5 11.8 6.2 9.7 7.3 6.2 7.2 7.5 8.2 7.7 6.5 9.5 8.0 8.0 6.8 9.8 11.5 10.9 10.5 3.8 8.2 9.0 7.0 9.9 11.8 7.9 6.5 16.9 8.8 6.6 6.9 10.2 7.8 4.2 7.7 12.4 13.7 6.2 9.3 7.5 6.4 10.3 3.3 3.5 7.8 12.3 8.8 9.5 0.2 6.7 6.8 2.2 3.6 0.4 8.6 1.5 8.6 7.7 3.0 2.2 2.3 3.3 1.6 5.0 3.4 1.5 2.9 0.0 7.9 2.4 1.4 10.7 11.8 2.2 3.4 9.7 5.3 9.1 1.7 6.1 4.0 8.5 2.8 6.2 2.6 6.3 3.5 5.1 1.0 9.2 6.2 2.0 3.1 10.3 5.8 4.2 5.8 3.7 3.2 2.9 9.6 5.5 0.2 12.7 2.5 9.4 5.5 1.5 9.5 6.3 6.4 0.0 1.1 0.7 3.2 2.0 0.8 1.8 1.1 1.6 1.4 0.5 1.3 1.2 0.1 0.8 0.7 1.4 0.9 1.0 7.6 8.1 8.6 8.0 7.2 7.5 8.0 8.0 6.8 8.2 6.9 7.7 10.3 2.6 0.0 1.5 51.2 6.4 0.8 0.6 1.8 13.6 5.7 4.4 4.1 4.0 2.8 2.9 7.3 12.5 1.1 1.5 1.6 1.9 1.9 1.3 2.9 2.6 3.2 1.8 3.4 44.0 1.4 0.3 6.0 5.6 3.4 4.5 5.2 1.8 3.0 1.0 10.1 45.2 2.0 2.0 1.0 0.4 1.5 1.5 3.2 0.0 31.9 1.5 2.7 0.0 46.3 58.4 1.3 1.9 2.2 3.3 1.6 2.2 0.9 3.2 6.0 0.0 3.7 2.6 1.3 2.3 7.7 1.3 2.6 9.3 2.7 2.2 0.7 SFRP4 "FRP-4, frpHE, FRZB-2" ENSG00000106483 "Secreted frizzled related protein 4" Q6FHJ7 7 37905932-38025695 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix: 625.2;endometrium 1: 471.5;fallopian tube: 215.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 472.1;Fibroblasts: 196.4;Granulosa cells: 102.8;Peritubular cells: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.0;HSkMC: 3.9;U-937: 3.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "spinal cord: 53.5" "HPA009712, HPA050585" Enhanced "Secreted in female reproductive system" NA NA 2500000 "HPA009712: AB_1856778, HPA050585: AB_2681183" "unprognostic (5.93e-2)" "unprognostic (5.84e-3)" "unprognostic (2.75e-2)" "unprognostic (1.58e-3)" "unprognostic (2.61e-1)" "unprognostic (2.35e-2)" "unprognostic (4.02e-2)" "unprognostic (2.60e-1)" "unprognostic (1.21e-1)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.36e-5)" "unprognostic (7.37e-3)" "unprognostic (1.61e-1)" "unprognostic (4.35e-3)" "unprognostic (1.89e-3)" 29.4 15.7 3.1 1.4 3.0 0.8 60.5 3.4 10.4 625.2 12.3 3.6 1.2 471.5 18.8 2.3 215.9 17.5 22.6 2.9 5.1 4.2 0.6 14.9 7.3 4.6 4.0 2.3 79.9 5.0 2.9 20.6 0.2 4.0 16.2 2.6 2.3 6.6 44.3 4.2 1.4 1.4 88.7 4.8 14.0 2.3 16.9 3.4 1.6 15.0 7.1 2.0 37.7 61.5 4.4 0.0 1.8 2.1 0.0 10.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 2.2 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.2 1.5 0.1 0.3 0.0 3.9 0.5 0.4 0.0 0.7 0.1 0.1 0.0 0.2 0.1 0.3 0.0 1.2 0.1 0.0 0.0 0.1 1.3 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.7 0.0 0.8 1.2 0.1 0.4 0.1 0.1 0.2 3.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.0 3.4 10.4 2.9 5.1 4.6 4.0 2.3 4.0 4.8 3.4 4.4 5.5 0.0 1.8 0.3 0.7 1.0 1.5 0.1 0.6 0.0 0.5 2.3 1.0 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 1.0 22.5 472.1 4.6 0.0 0.0 0.0 0.5 0.3 196.4 0.0 14.1 0.0 102.8 3.3 0.1 0.2 0.0 0.5 0.0 0.0 0.0 4.4 2.8 41.7 7.1 0.0 2.8 0.0 2.7 0.0 17.6 0.2 0.1 0.0 188.4 0.0 2.4 0.0 1.8 0.0 0.3 0.0 30.5 25.3 0.2 0.4 0.1 1.6 0.3 9.2 1.2 0.1 0.5 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "placenta: 778.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 833.5;Syncytiotrophoblasts: 999.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD8 T-cell: 24.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.1;granulocytes: 19.4;T-cells: 24.2" "Cell line enriched" "Detected in many" 6 "AN3-CA: 12338.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 113.0 56.7 25.2 16.3 31.4 12.8 63.6 0.0 20.1 5.7 18.8 27.6 29.0 24.6 6.6 6.9 12.1 23.6 6.5 26.1 62.7 17.9 52.3 43.8 5.5 7.9 13.1 25.1 19.0 30.2 8.1 33.4 778.3 12.5 12.8 21.1 39.6 21.6 5.5 7.0 4.0 21.8 17.9 0.2 91.0 8.9 26.5 51.1 10.4 11.9 5.3 4.8 11.1 3.9 17.4 77.9 41.7 197.1 12338.6 3.9 1.2 1.1 84.7 38.5 85.1 40.3 237.2 114.4 37.7 27.1 2.6 74.7 11.0 2.9 1.1 33.3 0.4 0.5 66.8 57.0 39.9 322.2 3.2 0.5 5.9 3.1 64.3 0.1 427.5 32.3 0.1 76.5 0.3 164.9 107.6 7.8 85.0 124.1 113.3 20.0 0.8 2168.8 24.5 92.0 72.0 693.2 2.0 71.9 234.0 1.0 195.6 9.2 57.3 33.6 29.2 0.7 276.1 5.6 3.4 8.6 0.7 103.3 1.2 9.7 19.4 2.6 9.1 0.9 2.9 2.2 3.9 2.5 1.8 9.1 3.4 9.4 24.2 1.5 4.3 1.7 0.4 0.1 6.7 25.2 31.4 0.0 20.1 26.1 62.7 7.9 13.1 25.1 12.5 0.2 51.1 17.4 7.4 6.4 6.2 12.7 3.3 4.5 47.3 8.6 9.1 13.5 33.3 36.1 0.9 20.0 5.7 16.5 4.2 833.5 2.1 9.3 11.7 20.3 62.7 8.2 12.7 6.0 29.5 35.9 40.8 40.0 187.8 200.3 3.1 9.5 0.0 6.3 44.6 20.4 92.7 1.7 28.1 19.4 6.1 8.8 3.2 37.5 84.8 6.6 1.8 11.2 1.3 45.3 0.0 18.1 1.8 22.8 27.5 13.5 2.3 27.1 24.6 12.3 2.9 22.0 19.7 205.6 12.0 35.7 36.7 10.0 0.6 999.6 2.1 124.8 31.5 23.4 MEOX2 "GAX, MOX2" ENSG00000106511 "Mesenchyme homeobox 2" P50222 7 15611212-15686683 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 33.6;placenta: 42.5" "Cell type enhanced" "Detected in some" "Adipocytes: 84.7;Endothelial cells: 37.2;Leydig cells: 40.4;Peritubular cells: 25.2;Sertoli cells: 26.3;Smooth muscle cells: 27.0" "Cancer enriched" "Detected in many" 8 "glioma: 15.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 248.8;U-138 MG: 62.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "medulla oblongata: 3.5;spinal cord: 9.5" HPA053793 Enhanced NA NA "HPA053793: AB_2682264" "unprognostic (1.10e-1)" "unprognostic (4.72e-2)" "unprognostic (9.82e-3)" "unprognostic (4.22e-2)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (3.12e-2)" "unprognostic (1.21e-1)" "unprognostic (5.56e-2)" "unprognostic (1.47e-3)" "unprognostic (4.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-5)" "unprognostic (3.67e-3)" "unprognostic (1.13e-1)" "unprognostic (5.86e-2)" "unprognostic (1.46e-4)" 33.6 1.1 0.6 2.9 0.4 0.0 26.4 0.3 0.7 4.3 0.3 4.7 0.4 2.9 2.4 2.5 5.0 6.1 11.3 0.4 0.7 0.3 0.7 13.1 9.1 2.0 0.8 0.5 2.4 1.6 1.2 1.2 42.5 1.0 1.9 1.9 0.2 4.5 1.5 10.0 6.4 2.2 4.6 0.7 0.9 2.3 2.3 1.0 3.3 8.6 13.5 5.3 6.1 4.8 0.5 0.0 0.0 0.0 248.8 2.4 8.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 32.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 62.9 0.0 25.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.3 0.7 0.4 0.7 2.0 0.8 0.5 1.0 0.7 1.0 0.5 84.7 0.0 0.5 0.7 0.3 8.2 0.0 0.0 0.6 0.0 0.5 1.3 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 37.2 0.0 0.0 3.8 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 3.7 0.0 0.0 0.0 9.6 0.2 40.4 0.3 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 25.2 0.0 0.1 0.0 0.0 0.0 0.0 26.3 1.5 27.0 0.1 0.1 0.1 7.0 0.1 0.8 0.7 0.0 0.0 ANKMY2 "DKFZP564O043, ZMYND20" ENSG00000106524 "Ankyrin repeat and MYND domain containing 2" Q8IV38 7 16599779-16645817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067100 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA067100: AB_2685777" "unprognostic (3.07e-1)" "unprognostic (4.20e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (1.99e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.11e-2)" "unprognostic (3.00e-2)" "prognostic favorable (1.05e-7)" "unprognostic (5.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.85e-2)" 10.0 11.0 13.5 7.1 17.3 14.5 14.5 14.0 19.3 14.1 15.1 17.1 15.3 13.3 12.2 11.7 15.8 13.7 39.4 16.5 14.9 16.2 11.2 11.9 9.7 12.4 12.9 15.0 25.8 12.0 15.5 11.8 9.3 11.9 13.5 17.2 23.6 13.3 18.6 23.7 10.9 17.4 11.8 10.9 10.6 25.1 9.7 12.4 13.3 22.0 23.5 9.2 14.5 11.4 14.9 20.9 17.0 23.2 22.6 21.5 22.2 12.8 24.2 29.7 18.3 28.4 30.0 30.9 4.2 28.5 26.4 38.3 21.0 15.4 9.6 27.7 9.1 12.0 37.8 20.2 13.4 13.8 28.5 13.5 19.8 4.9 19.3 19.0 25.5 16.8 26.2 41.0 6.5 26.5 5.6 12.5 19.4 15.9 62.5 22.2 20.2 21.0 9.7 28.6 17.2 15.0 8.6 16.0 11.9 10.0 21.2 14.1 24.5 10.2 14.4 12.5 31.8 17.2 24.6 19.6 6.6 21.8 23.1 22.9 30.1 4.0 17.5 11.6 5.0 11.0 7.9 9.4 11.8 6.0 7.9 7.7 9.2 3.0 13.6 11.8 5.7 10.6 6.6 13.5 17.3 14.0 19.3 16.5 14.9 12.4 12.9 15.0 11.9 10.9 12.4 14.9 6.8 3.2 15.1 17.3 6.5 4.7 8.6 9.1 7.4 17.3 7.3 10.9 37.9 10.0 15.1 11.0 6.2 13.6 10.3 13.6 21.5 8.0 42.5 7.9 5.5 7.3 19.2 15.8 57.3 8.9 11.7 13.6 20.9 4.9 6.3 14.7 4.6 5.6 9.5 8.4 36.5 14.2 10.2 7.4 6.7 31.0 12.8 7.4 14.2 15.9 6.1 19.6 8.2 22.6 19.2 5.2 11.7 13.5 8.1 4.1 19.9 12.9 28.8 19.6 26.3 6.3 12.1 9.8 4.0 6.7 4.1 17.0 8.7 15.7 14.1 6.1 ACTR3C ARP11 ENSG00000106526 "Actin related protein 3C" Q9C0K3 7 150243916-150323725 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 64.7" "Group enriched" "Detected in many" 5 "Astrocytes: 87.1;Excitatory neurons: 111.7;Inhibitory neurons: 125.4;Oligodendrocyte precursor cells: 275.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 31.1;RT4: 26.7;SiHa: 17.8" NA NA "unprognostic (3.41e-1)" "unprognostic (4.79e-2)" "unprognostic (9.62e-2)" "unprognostic (8.25e-2)" "unprognostic (6.07e-6)" "unprognostic (2.83e-1)" "unprognostic (6.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.10e-2)" "unprognostic (2.91e-1)" "unprognostic (9.69e-3)" "unprognostic (1.65e-2)" "unprognostic (3.27e-2)" "unprognostic (4.73e-3)" "unprognostic (1.72e-1)" "unprognostic (9.14e-2)" "unprognostic (5.53e-3)" 2.2 12.0 3.8 3.4 3.9 2.0 6.3 2.9 3.7 5.2 20.1 5.2 5.2 2.5 7.0 7.2 5.5 4.3 2.0 5.4 3.2 13.3 23.1 5.1 4.1 4.9 3.1 3.9 1.5 14.6 64.7 5.4 2.2 3.4 4.3 7.0 4.8 4.9 5.4 1.4 2.6 4.1 2.7 2.4 1.9 5.0 4.1 2.5 2.5 6.1 2.8 6.0 4.9 3.3 3.6 6.7 0.6 0.1 0.2 0.0 0.0 1.1 0.1 0.2 1.1 1.4 5.1 31.1 2.5 8.1 1.2 0.8 13.3 0.0 0.0 0.7 7.1 1.9 1.7 7.5 4.7 3.3 0.0 1.1 1.2 4.2 0.0 0.0 0.8 0.3 3.2 13.2 7.1 0.0 9.4 7.1 0.3 3.5 4.5 0.0 0.0 4.9 10.1 5.1 26.7 6.7 5.4 17.8 3.8 2.7 1.0 8.4 1.6 0.1 0.0 0.0 0.2 0.1 2.5 3.4 0.0 0.2 0.1 0.0 0.3 1.1 2.2 4.9 0.9 2.2 3.4 4.0 3.0 1.7 4.6 4.2 3.4 1.7 3.2 0.5 3.0 3.4 1.3 3.8 3.9 2.9 3.7 5.4 3.2 4.9 3.1 3.9 3.4 2.4 2.5 3.6 0.2 3.2 9.5 87.1 3.8 20.1 7.6 5.5 6.8 7.3 4.3 2.4 2.1 7.2 6.4 18.4 29.2 5.6 2.0 7.1 13.7 12.6 4.2 11.7 1.3 1.4 3.5 4.0 111.7 21.3 1.0 1.3 9.7 6.9 11.4 3.4 1.8 20.8 1.2 1.7 125.4 5.1 16.2 1.0 2.8 1.2 0.9 1.2 1.8 9.4 4.6 15.9 7.2 275.5 11.7 11.3 1.3 0.7 6.2 4.8 11.0 14.8 11.1 6.3 0.0 5.0 1.0 6.7 2.8 5.3 14.9 7.1 4.1 2.5 5.7 6.1 POU6F2 RPF-1 ENSG00000106536 "POU class 6 homeobox 2" P78424 7 38977909-39493095 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.9" "Group enriched" "Detected in some" 5 "Astrocytes: 129.3;Excitatory neurons: 471.3;Oligodendrocyte precursor cells: 286.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.2;Karpas-707: 1.3;NTERA-2: 2.6;SK-BR-3: 1.1;SuSa: 1.5;T-47d: 2.9;U-266/70: 2.2;U-266/84: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (1.80e-4)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (7.22e-3)" "unprognostic (2.32e-1)" "unprognostic (1.60e-2)" "unprognostic (5.00e-3)" "unprognostic (4.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.3 0.0 0.4 0.0 0.0 0.2 0.5 0.4 0.1 0.8 0.0 0.1 0.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 1.5 2.9 0.0 0.0 0.0 0.2 0.0 0.0 2.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 1.1 0.8 0.3 0.2 0.5 0.4 0.3 0.0 0.2 1.9 0.0 0.0 1.7 129.3 0.0 0.0 0.3 0.0 0.0 4.9 0.0 0.0 2.1 8.6 0.0 0.0 8.4 0.3 0.0 0.2 0.0 1.5 4.1 0.0 0.0 0.4 0.0 0.0 471.3 0.0 0.3 0.7 0.0 0.0 1.3 0.0 0.0 3.5 0.1 0.0 50.3 0.1 0.0 0.0 0.2 4.1 0.0 0.0 0.0 26.2 0.0 0.1 0.0 286.5 5.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.3 2.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753755-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 303.4;Alveolar cells type 1: 496.8;Cytotrophoblasts: 293.7;Intestinal goblet cells: 404.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 99.6;plasmacytoid DC: 231.7" "Group enriched" "Detected in many" 42 "B-cells: 99.6;dendritic cells: 231.7" "Cell line enhanced" "Detected in many" "OE19: 484.5;SCLC-21H: 215.3;SK-BR-3: 314.0;T-47d: 587.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favorable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 66.2 81.9 41.0 29.3 50.5 26.3 77.1 35.3 80.8 61.2 31.1 84.2 89.7 20.2 37.2 19.8 20.0 56.0 20.3 48.1 65.5 7.9 47.8 187.1 56.6 39.3 46.3 54.2 3.2 96.6 14.3 84.3 67.7 40.0 51.6 100.9 19.6 169.5 36.1 9.4 16.7 78.0 20.4 34.0 26.6 109.0 9.0 44.6 20.6 35.4 13.8 47.6 41.4 16.2 50.5 47.4 38.6 47.8 50.9 6.0 0.2 13.2 99.0 16.1 2.6 4.9 137.4 70.9 1.4 24.7 35.8 12.3 71.2 56.2 83.2 21.6 1.4 60.3 20.3 15.3 14.8 13.3 1.9 4.0 5.6 35.4 5.2 5.9 27.4 30.1 20.7 67.0 0.4 2.9 135.4 2.8 2.6 33.4 484.5 46.5 54.0 0.2 48.5 153.1 90.1 215.3 32.5 18.0 314.0 4.8 68.1 587.9 5.2 2.9 1.4 17.0 1.5 33.1 28.4 0.8 1.0 44.2 0.8 69.1 0.6 0.0 0.2 0.0 0.0 0.1 47.9 0.1 0.0 1.1 99.6 0.0 0.1 3.9 3.6 0.1 231.7 0.0 5.6 41.0 50.5 35.3 80.8 48.1 65.5 39.3 46.3 54.2 40.0 34.0 44.6 50.5 303.4 496.8 82.5 10.1 94.0 42.6 84.9 96.0 31.9 78.2 141.7 46.7 19.1 41.5 137.6 29.5 8.4 293.7 131.6 95.4 7.9 68.0 1.6 27.8 6.5 97.9 107.7 60.2 79.3 203.9 109.3 22.5 89.2 67.1 9.5 1.0 7.5 26.3 40.8 15.2 56.8 404.6 122.1 18.9 22.6 2.5 0.6 9.4 32.0 9.4 61.3 3.5 2.1 23.6 7.6 109.1 88.8 0.7 49.9 127.4 99.8 0.9 63.2 8.1 32.9 2.2 22.0 1.7 19.5 39.4 39.6 201.1 8.9 6.1 125.3 173.6 RARRES2 "HP10433, TIG2" ENSG00000106538 "Retinoic acid receptor responder 2" Q99969 7 150338317-150341662 "Plasma proteins, Predicted secreted proteins" "Chemotaxis, Differentiation, Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 2420.1;liver: 2010.9;pancreas: 1494.7" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 659.2;Hepatocytes: 2819.0;Muller glia cells: 785.1" "Cancer enhanced" "Detected in all" "liver cancer: 420.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 5.4" "Group enriched" "Detected in many" 6 "AF22: 132.9;Hep G2: 213.8;HHSteC: 172.9;NTERA-2: 411.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 75000000 460000000 "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (2.31e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (2.72e-2)" "unprognostic (2.82e-3)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (5.29e-2)" "unprognostic (2.50e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.83e-4)" "unprognostic (2.94e-2)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.17e-2)" 530.2 2420.1 54.8 88.2 51.3 0.4 298.1 50.7 70.8 499.0 269.0 314.1 53.7 362.2 56.4 79.3 412.0 117.6 126.1 54.0 63.1 269.1 2010.9 470.9 110.7 58.2 61.9 39.7 631.6 1494.7 632.0 104.9 59.5 53.6 264.7 79.0 34.2 56.7 115.8 18.4 58.1 187.5 103.9 59.1 150.7 181.5 27.1 57.1 9.9 85.7 34.9 63.6 267.5 383.9 58.8 0.0 0.1 132.9 0.3 0.0 0.0 2.1 11.9 25.2 4.2 17.2 1.2 8.2 1.1 15.0 2.9 1.3 0.5 0.0 0.0 0.0 2.4 0.5 0.6 23.6 213.8 172.9 2.2 0.4 36.4 0.0 0.0 0.0 2.8 0.0 0.4 0.4 0.4 4.2 0.9 2.1 2.4 411.9 1.2 0.0 0.1 17.1 0.4 2.8 1.1 0.6 1.2 2.3 0.1 0.4 1.9 0.6 0.0 0.0 0.4 1.8 0.8 0.6 1.4 0.9 1.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 54.8 51.3 50.7 70.8 54.0 63.1 58.2 61.9 39.7 53.6 59.1 57.1 58.8 47.1 67.3 32.0 9.4 7.0 35.1 80.7 16.8 15.9 7.0 26.2 39.0 75.0 381.8 45.0 82.8 2.1 10.1 1.9 172.6 103.7 19.8 3.7 39.9 128.7 27.1 97.4 32.0 0.4 659.2 4.3 469.6 8.2 16.4 12.0 207.5 84.6 2819.0 11.6 10.1 0.4 233.9 541.2 53.8 42.4 19.3 454.2 8.9 44.4 7.5 1.0 785.1 0.0 9.0 0.3 209.1 107.4 194.9 1.2 82.0 1.2 269.1 29.8 25.4 13.1 302.5 181.1 4.9 5.2 4.4 28.8 14.6 12.3 307.5 418.7 31.9 AGR2 "AG2, HAG-2, PDIA17, XAG-2" ENSG00000106541 "Anterior gradient 2, protein disulphide isomerase family member" O95994 7 16791811-16833433 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 644.1;intestine: 1236.1;stomach 1: 1415.0" "Cell type enhanced" "Detected in many" "Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8" "Cancer enhanced" "Detected in many" "stomach cancer: 475.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 15 "OE19: 20084.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007912 Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 38000 "Endoplasmic reticulum" "HPA007912: AB_1844879" "unprognostic (6.19e-2)" "unprognostic (1.91e-1)" "unprognostic (9.05e-2)" "unprognostic (2.59e-2)" "unprognostic (2.23e-1)" "unprognostic (2.10e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.49e-2)" "unprognostic (1.84e-1)" "unprognostic (1.08e-2)" "unprognostic (3.24e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (8.79e-5)" "unprognostic (6.98e-2)" "unprognostic (2.38e-1)" "unprognostic (2.38e-1)" "unprognostic (3.22e-3)" 2.1 0.8 0.0 67.2 0.0 0.0 73.0 0.2 0.4 644.1 0.0 775.3 490.4 14.2 392.6 16.4 309.1 278.3 0.1 0.0 0.0 11.1 0.9 51.2 0.6 0.0 0.1 0.1 0.3 22.3 0.1 31.7 1.6 0.0 229.3 1236.1 0.0 479.3 182.7 0.2 2.1 382.3 45.6 0.0 1.0 1415.0 0.9 0.0 1.8 7.4 0.1 7.3 162.3 4.0 0.4 0.3 265.5 0.0 0.3 0.0 0.1 2.6 0.0 0.0 0.0 0.0 43.5 39.7 0.0 0.2 0.0 6.6 25.2 0.0 34.5 0.2 0.0 0.0 0.0 0.9 3.8 0.0 0.0 1.0 0.0 88.5 0.0 11.4 0.4 0.4 0.3 0.0 0.0 0.2 44.7 1.3 1.8 0.8 20084.0 154.2 1.0 0.0 5.2 631.3 371.6 1.7 2.1 0.0 98.8 0.0 1.0 1319.9 0.0 0.0 0.7 1.2 0.9 0.2 1.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 1.1 51.3 293.1 0.0 19.0 2.8 127.1 539.8 0.6 0.0 169.3 137.4 0.2 268.8 1515.8 80.9 0.0 6.0 0.4 1026.4 0.0 74.1 4.6 301.9 33.9 4.8 522.1 0.0 0.1 835.1 4.5 6.0 2605.5 365.3 43.9 0.0 0.0 1.7 240.8 0.0 0.1 3710.4 386.6 0.8 0.3 0.4 0.3 6.5 3.6 0.0 1.0 0.0 0.0 0.0 0.0 303.1 1101.6 0.0 2.6 426.9 517.9 0.2 781.0 0.0 0.0 0.0 76.9 0.4 0.2 5.3 2.8 3.3 13.1 0.0 1543.1 1017.8 AHR bHLHe76 ENSG00000106546 "Aryl hydrocarbon receptor" P35869 7 16916359-17346152 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Cancer-related genes, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 262.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 71.0;hTERT-HME1: 73.8;OE19: 61.2;RT4: 63.2" "CAB005072, HPA029722, HPA029723" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025" "unprognostic (1.29e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (7.28e-2)" "unprognostic (1.22e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-1)" "unprognostic (4.32e-2)" "unprognostic (9.98e-2)" "unprognostic (1.24e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-2)" "unprognostic (9.45e-2)" 21.4 15.2 1.6 26.0 2.6 44.5 19.7 1.5 3.9 14.6 4.4 13.9 16.6 8.9 7.1 17.5 10.6 34.0 9.4 2.0 3.7 7.1 45.3 38.0 15.5 5.7 2.2 2.1 7.0 5.8 6.7 3.1 17.9 3.6 11.1 16.4 4.0 10.5 11.3 2.2 22.1 14.6 15.3 3.4 18.8 25.4 2.9 2.2 9.7 12.8 6.5 20.0 50.0 15.1 5.1 8.2 6.6 2.6 0.0 19.2 13.1 1.2 16.5 23.9 7.5 10.8 8.2 17.5 0.0 5.0 24.4 29.7 21.8 1.6 15.1 19.7 0.4 3.6 4.8 8.1 7.3 35.5 8.1 11.5 18.1 71.0 28.8 73.8 33.8 25.3 0.0 0.7 0.2 34.3 4.2 0.0 12.6 2.1 61.2 10.3 0.0 0.0 0.3 23.5 63.2 2.4 0.0 12.4 13.0 12.5 19.0 9.4 2.7 4.3 3.1 0.1 40.7 0.0 3.3 0.1 0.0 51.6 30.6 51.9 0.8 5.6 4.2 0.5 2.6 0.7 0.6 1.7 1.0 6.9 0.7 0.9 0.7 0.6 2.1 1.0 1.6 2.1 1.7 1.6 2.6 1.5 3.9 2.0 3.7 5.7 2.2 2.1 3.6 3.4 2.2 5.1 78.3 150.6 76.2 1.6 15.2 75.3 47.6 67.9 104.2 37.0 23.4 30.0 14.7 34.3 84.9 7.3 8.4 3.3 13.6 23.9 0.0 19.3 6.2 39.1 8.4 78.1 5.4 8.6 18.0 15.7 1.8 57.0 56.1 78.8 133.1 0.6 52.1 48.3 24.4 43.7 39.2 12.9 30.5 88.4 262.6 3.2 3.7 107.1 71.2 8.4 70.1 0.9 5.2 1.5 40.6 33.3 19.8 2.6 16.7 48.6 9.9 6.8 51.3 6.1 6.6 14.8 37.8 2.8 2.2 38.3 89.2 21.5 54.7 3.3 19.3 116.1 CHCHD3 "FLJ20420, Mic19, MICOS19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784870-133082090 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 126.8;skeletal muscle: 355.0;tongue: 245.1" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria NA NA 13000 Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 40.7 33.6 18.3 29.3 19.8 51.9 33.1 22.0 25.6 25.0 21.9 46.0 57.2 28.3 19.4 28.6 25.7 22.7 126.8 20.4 19.6 55.3 32.3 26.6 30.5 19.5 19.4 18.8 27.4 26.9 60.3 17.3 30.5 20.2 25.6 50.2 40.6 24.6 28.8 355.0 21.0 42.5 37.4 17.9 22.1 31.9 17.0 18.2 42.8 35.9 245.1 30.1 32.1 23.2 21.7 102.0 103.8 99.7 138.9 70.6 64.9 60.2 97.0 90.3 106.7 117.4 121.0 108.9 83.1 37.6 61.1 237.1 69.1 117.0 82.7 148.7 113.4 111.8 85.9 101.9 70.7 139.3 194.7 62.1 59.0 55.8 146.9 151.7 53.2 75.9 107.6 186.1 74.2 100.1 134.3 284.0 169.9 165.1 160.3 117.2 140.6 146.2 119.8 103.9 83.1 127.4 158.8 80.5 62.4 186.7 67.6 52.5 116.2 63.5 101.8 44.3 162.0 176.7 71.3 100.4 206.6 161.1 163.9 146.6 42.3 43.7 33.2 30.5 62.8 28.9 38.5 27.6 29.6 57.9 23.2 23.9 26.9 6.4 45.2 52.1 49.5 41.9 34.0 18.3 19.8 22.0 25.6 20.4 19.6 19.5 19.4 18.8 20.2 17.9 18.2 21.7 32.0 25.6 26.2 103.8 36.5 34.9 28.7 56.9 31.9 26.5 29.0 25.7 138.8 38.6 36.2 14.7 22.9 69.7 29.0 40.4 125.2 61.5 99.6 27.8 33.6 34.3 35.9 64.3 201.3 60.7 79.5 38.9 32.6 22.4 34.2 34.6 17.2 20.7 78.4 15.2 210.5 48.9 30.5 27.3 44.4 103.4 31.4 38.3 37.4 100.2 49.7 34.2 37.0 161.4 143.5 50.1 31.0 35.3 46.5 44.4 50.7 88.8 29.6 27.0 32.9 43.4 53.5 20.9 29.2 37.0 40.3 68.4 34.0 55.8 73.1 42.6 GIMAP2 "DKFZp586D0824, HIMAP2, IAN12, IMAP2" ENSG00000106560 "GTPase, IMAP family member 2" Q9UG22 7 150685697-150693641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.0" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 45.0;Kupffer cells: 132.3;monocytes: 74.4;NK-cells: 96.8;T-cells: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 62.7;JURKAT: 34.9;MOLT-4: 79.5;REH: 34.0;U-937: 32.4" "Not detected" "Not detected" "HPA013589, HPA014746" Approved Supported "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "HPA013589: AB_1849666, HPA014746: " "prognostic favorable (3.50e-4)" "unprognostic (4.73e-2)" "unprognostic (2.53e-1)" "unprognostic (3.56e-3)" "unprognostic (6.60e-2)" "unprognostic (6.64e-3)" "unprognostic (4.60e-2)" "unprognostic (5.97e-2)" "unprognostic (3.39e-2)" "unprognostic (3.91e-1)" "unprognostic (5.52e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.56e-2)" "unprognostic (3.08e-2)" 11.8 7.0 5.9 40.6 6.3 11.7 12.0 6.6 9.8 10.7 6.7 11.9 12.5 10.8 9.0 5.0 8.3 17.1 8.1 5.6 7.7 6.1 17.2 22.2 79.0 7.9 6.5 4.7 17.1 2.2 2.8 2.6 19.7 8.0 5.1 15.8 0.5 6.5 6.2 4.2 5.8 19.5 11.5 7.1 62.6 12.0 1.8 8.2 50.7 6.1 12.4 57.9 15.8 5.3 8.5 1.6 0.0 0.0 0.0 0.6 0.6 0.8 0.0 18.1 2.2 5.1 0.0 23.7 4.2 0.4 1.4 9.8 1.0 0.0 1.0 0.2 19.8 0.0 12.8 0.0 0.5 2.8 9.9 12.6 6.8 1.8 1.7 0.1 5.3 62.7 34.9 0.4 4.9 1.0 0.0 79.5 24.9 0.0 0.0 0.0 34.0 0.6 9.7 0.1 5.9 0.0 0.0 0.1 0.1 6.3 0.0 0.9 25.2 14.2 0.9 0.3 0.2 0.1 5.6 5.5 0.0 2.3 32.4 3.4 15.1 83.8 7.3 93.9 118.3 118.3 15.8 122.0 114.8 47.6 15.8 166.7 124.8 40.7 136.2 121.4 5.7 107.6 130.2 5.9 6.3 6.6 9.8 5.6 7.7 7.9 6.5 4.7 8.0 7.1 8.2 8.5 15.5 12.8 2.2 1.0 11.8 3.3 1.9 0.6 1.2 0.1 1.7 1.3 1.1 1.5 1.1 0.0 0.0 0.4 22.8 1.5 0.0 1.6 0.0 3.8 3.8 27.8 0.0 13.5 0.1 0.7 0.7 3.4 1.1 1.1 19.7 1.4 45.0 4.2 38.1 0.0 0.2 4.2 6.1 132.3 11.1 0.1 4.1 38.5 1.8 7.5 74.4 0.9 96.8 2.0 0.3 1.0 2.9 0.7 4.0 2.2 8.4 1.2 4.6 0.1 6.6 1.7 1.1 0.1 0.3 0.5 3.1 0.4 57.7 4.8 3.7 2.5 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 1670.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 865.5;intermediate monocyte: 586.0" "Lineage enriched" "Detected in many" 5 "monocytes: 865.5" "Group enriched" "Detected in some" 17 "HSkMC: 642.7;THP-1: 215.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 122.0 49.9 42.0 192.5 44.4 13.6 78.5 46.1 66.3 75.2 41.3 254.2 169.2 26.2 26.0 50.9 82.2 199.1 144.8 39.5 67.4 359.8 1670.0 96.4 179.0 63.3 51.2 37.3 144.3 54.1 7.4 22.9 116.0 56.7 49.3 247.2 34.4 42.8 28.6 11.1 32.1 289.0 100.0 63.5 87.8 95.3 11.2 51.3 26.3 33.9 36.4 94.5 160.1 93.2 65.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.2 25.7 0.4 0.8 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.6 0.8 0.2 642.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.7 0.1 0.9 0.5 0.1 0.0 0.1 1.0 11.8 0.1 0.0 1.9 1.4 0.6 0.3 0.2 0.2 0.0 215.7 0.0 0.0 3.2 0.5 0.2 0.4 0.2 0.6 0.0 0.3 0.0 5.3 865.5 50.5 2.3 586.0 3.4 2.5 0.6 0.7 164.3 0.6 0.7 0.4 8.6 0.6 309.3 7.7 0.6 498.5 42.0 44.4 46.1 66.3 39.5 67.4 63.3 51.2 37.3 56.7 63.5 51.3 65.5 22.2 3.2 9.3 14.4 16.9 12.6 0.5 0.9 5.7 156.9 52.2 74.0 73.7 190.1 14.4 375.2 2.1 0.9 2.8 419.4 166.3 95.1 18.5 6.1 14.5 19.8 128.1 13.5 0.1 34.0 1.0 243.7 14.8 2.1 54.4 61.9 22.9 1171.9 92.5 6.7 0.6 252.1 46.8 98.5 44.4 12.2 43.5 190.0 16.0 8.4 502.3 87.3 1.0 7.5 0.1 65.4 762.4 3.4 1.5 2.5 922.5 976.5 11.3 17.9 0.0 6.7 34.0 4.0 3.8 1.8 15.6 2.7 9.1 0.4 263.7 2.8 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960949-42264100 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 8 "Astrocytes: 301.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 47.1;WM-115: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 6.0 1.9 9.4 3.7 8.9 0.1 9.0 1.4 5.6 6.8 0.0 8.5 1.3 11.9 2.8 3.8 8.3 3.9 1.6 6.6 5.4 1.7 0.3 3.4 1.0 3.3 9.0 2.6 13.3 0.7 0.5 1.1 12.0 7.0 5.6 2.9 1.8 2.8 8.3 1.1 8.3 3.4 10.8 0.3 1.1 2.6 1.7 13.8 3.0 4.7 2.3 1.7 4.9 7.4 2.4 0.0 0.0 47.1 0.4 16.9 23.6 3.5 3.1 9.0 9.3 12.8 0.0 0.0 0.0 1.7 22.1 22.7 10.1 8.7 8.9 10.8 0.0 7.0 0.0 6.0 0.0 9.0 0.0 0.1 21.0 12.9 10.6 6.8 5.7 10.6 5.4 0.0 0.2 5.6 5.6 0.4 0.0 20.9 0.0 21.2 12.4 0.1 1.4 0.2 6.4 1.5 0.0 6.3 7.0 4.1 23.8 8.0 0.1 11.3 13.6 18.8 16.0 6.0 0.1 0.0 0.0 7.3 0.2 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.9 1.4 5.6 6.6 5.4 3.3 9.0 2.6 7.0 0.3 13.8 2.4 2.9 0.0 7.7 301.3 0.2 23.5 7.2 8.5 31.9 1.6 20.5 27.1 1.8 0.0 2.3 1.8 0.0 21.1 0.5 0.0 0.0 0.0 16.6 2.4 12.6 3.4 0.0 0.0 0.8 0.0 13.6 25.9 0.0 4.6 1.3 10.5 3.9 0.0 3.3 0.0 3.6 0.1 6.1 0.3 6.3 5.4 19.3 0.4 8.8 22.5 0.0 13.6 0.0 8.5 0.7 0.1 0.0 3.4 1.2 6.6 0.0 3.8 1.5 1.1 13.1 17.0 12.1 0.3 2.2 7.9 15.5 34.2 0.7 5.2 0.1 5.0 PSMA2 "HC3, MU, PMSA2" ENSG00000106588 "Proteasome 20S subunit alpha 2" P25787 7 42916828-42932185 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 439.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008188 Uncertain NA NA 61000000 "HPA008188: AB_1855819" "unprognostic (9.40e-3)" "unprognostic (2.08e-2)" "unprognostic (8.21e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.01e-2)" "unprognostic (9.25e-2)" "prognostic favorable (6.73e-5)" "unprognostic (1.77e-1)" "unprognostic (3.42e-1)" "unprognostic (1.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (6.38e-2)" "unprognostic (4.24e-2)" 98.8 114.4 59.2 89.8 59.6 121.2 101.1 61.4 83.4 67.8 62.2 91.8 105.2 76.3 83.9 110.8 71.1 49.9 108.1 58.3 62.4 109.5 322.2 86.6 102.2 61.0 59.9 56.9 67.0 91.7 71.7 64.3 79.5 61.2 91.9 87.7 42.5 76.6 58.8 229.4 85.8 97.5 67.9 64.2 94.9 105.6 56.6 59.7 138.7 68.0 121.1 109.7 93.3 77.7 67.3 202.8 212.5 243.4 296.4 128.1 142.1 181.1 174.7 202.8 274.9 292.3 316.5 322.2 371.5 301.7 155.5 431.6 273.3 254.3 242.4 314.2 270.3 202.3 189.8 279.1 337.1 137.3 325.8 197.7 131.7 172.7 211.7 125.7 196.1 265.1 226.0 389.8 219.4 223.5 235.9 295.0 634.9 482.4 331.3 259.9 282.1 235.5 364.3 268.2 271.6 196.8 199.1 189.5 429.9 200.9 328.3 312.4 375.6 189.9 161.0 295.3 174.5 348.6 282.6 470.3 611.1 276.0 406.0 468.9 278.5 185.4 351.9 133.9 193.4 156.9 195.4 163.3 157.9 199.8 175.2 146.0 155.2 93.1 160.7 210.0 225.0 240.8 363.3 59.2 59.6 61.4 83.4 58.3 62.4 61.0 59.9 56.9 61.2 64.2 59.7 67.3 92.2 89.8 100.5 11.1 100.6 0.1 89.3 0.2 41.5 32.4 125.2 121.4 0.0 123.0 66.8 95.6 22.9 293.3 141.3 130.3 170.2 348.6 23.9 42.3 41.5 93.2 154.9 126.9 15.3 380.0 300.1 67.2 23.9 37.6 166.0 27.5 122.8 204.8 193.5 28.6 16.0 199.8 0.0 173.5 0.3 19.1 79.2 94.1 0.0 12.2 439.1 85.3 153.5 17.1 27.9 314.5 166.9 84.7 72.6 97.8 332.7 301.5 58.3 46.6 131.5 55.3 74.4 125.8 115.6 44.3 0.0 279.1 81.8 39.1 252.8 98.2 MRPL32 "bMRP-59b, HSPC283, L32mt, MRP-L32" ENSG00000106591 "Mitochondrial ribosomal protein L32" Q9BYC8 7 42932376-42948958 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048965 Uncertain "Intracellular and membrane" NA NA "HPA048965: AB_2680576" "unprognostic (1.15e-1)" "unprognostic (2.31e-1)" "unprognostic (3.82e-2)" "unprognostic (1.40e-1)" "unprognostic (5.90e-3)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-2)" "unprognostic (8.22e-3)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (5.05e-3)" "unprognostic (4.09e-2)" "unprognostic (1.43e-2)" "unprognostic (2.97e-1)" "unprognostic (2.21e-2)" 43.1 72.1 37.0 32.6 38.8 28.7 42.2 38.2 43.1 29.7 47.4 47.9 47.2 33.7 57.7 39.0 38.9 42.5 74.8 38.1 41.0 83.2 121.3 29.0 39.5 38.8 38.4 37.2 45.8 52.5 53.4 26.5 34.9 38.9 57.8 46.1 16.0 46.6 35.0 54.1 27.1 39.8 34.7 37.5 30.1 44.1 25.7 38.3 37.3 42.6 66.9 43.7 55.8 27.7 40.5 67.9 94.3 63.3 99.7 97.0 79.9 72.8 101.9 74.2 84.3 95.9 116.3 71.7 145.3 95.8 59.4 141.3 150.3 98.6 112.0 99.1 94.2 116.6 70.7 75.4 128.5 142.2 121.4 66.8 91.8 84.0 62.6 109.2 72.7 106.0 97.6 132.5 73.4 108.1 104.4 83.2 207.1 160.9 160.2 139.3 81.3 73.6 150.4 188.2 138.7 77.4 69.1 82.4 224.2 89.0 92.2 126.3 90.4 93.4 72.5 117.3 77.3 143.6 120.9 215.1 160.4 55.0 156.6 157.9 181.9 89.7 147.1 77.8 101.6 104.3 154.6 114.1 102.3 95.9 122.9 120.3 113.9 18.3 102.9 91.0 94.3 160.6 117.9 37.0 38.8 38.2 43.1 38.1 41.0 38.8 38.4 37.2 38.9 37.5 38.3 40.5 53.3 54.5 39.8 6.2 47.8 131.5 88.5 191.2 55.2 20.5 68.7 87.4 93.3 70.1 92.7 58.8 8.4 110.9 47.6 46.1 180.0 111.5 8.3 50.8 70.5 68.7 46.8 44.4 16.5 101.0 98.4 61.5 38.7 57.4 64.0 43.5 57.8 104.1 61.8 16.8 14.1 64.2 101.7 40.6 50.2 8.4 52.8 34.1 64.0 5.6 57.7 16.3 35.0 11.6 17.1 97.6 55.4 50.8 43.8 103.1 77.4 211.7 70.1 23.2 52.6 73.1 113.5 34.3 72.5 65.2 109.4 89.6 45.4 117.4 104.6 105.1 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011944 Approved Supported Mitochondria NA NA Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 17.2 17.2 22.7 17.4 22.7 24.0 16.2 23.4 26.2 7.8 23.5 12.8 13.0 9.5 14.5 17.1 10.6 12.4 59.7 22.0 23.4 28.6 16.7 13.7 31.8 22.5 22.6 22.6 7.0 28.6 25.9 6.5 13.0 23.3 8.6 16.5 23.7 16.6 8.5 75.2 5.4 11.9 10.5 22.4 15.7 17.3 11.0 22.9 27.5 16.7 78.9 35.5 16.4 8.3 23.2 35.4 93.4 75.6 75.2 21.8 24.4 50.7 47.5 82.7 64.5 66.7 71.9 78.8 67.0 79.7 29.9 135.8 50.4 88.9 74.7 81.1 60.4 81.3 83.5 48.8 67.3 35.9 65.7 35.6 20.2 47.1 47.0 69.1 69.0 59.8 79.3 144.1 56.4 52.7 48.6 97.2 164.2 47.9 73.4 66.8 58.2 69.5 125.0 80.3 39.2 46.5 83.0 48.6 89.1 32.5 108.7 66.9 43.6 44.9 31.7 69.2 31.5 69.7 133.7 117.8 122.9 90.4 82.4 86.4 2.0 23.6 21.3 18.7 27.7 13.4 31.8 17.1 18.9 27.6 33.0 23.4 30.2 32.8 30.3 24.1 24.4 18.7 23.3 22.7 22.7 23.4 26.2 22.0 23.4 22.5 22.6 22.6 23.3 22.4 22.9 23.2 30.0 28.9 38.8 52.9 52.1 13.0 65.3 41.2 38.1 46.1 39.9 43.6 59.0 30.0 34.4 35.0 45.9 33.7 42.9 14.0 117.4 55.3 7.3 39.0 27.8 33.8 27.6 84.4 76.1 42.9 47.9 27.6 29.0 28.6 26.0 40.9 20.7 26.7 58.6 33.7 88.1 22.3 54.9 38.0 19.6 9.6 29.5 32.0 37.4 70.3 45.5 37.3 57.7 100.5 71.7 41.0 15.9 19.5 51.3 59.4 39.8 124.7 30.9 56.3 13.1 35.0 27.4 97.4 85.7 48.9 16.8 17.9 47.1 40.4 26.9 55.2 BLVRA BLVR ENSG00000106605 "Biliverdin reductase A" P53004 7 43758680-43807342 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 259.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019709, HPA042865, HPA054322" Approved Supported Cytosol NA NA 1200000 Cytosol "HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450" "unprognostic (2.47e-2)" "unprognostic (8.38e-3)" "unprognostic (1.79e-2)" "unprognostic (2.16e-3)" "unprognostic (6.45e-3)" "unprognostic (5.01e-2)" "unprognostic (1.63e-2)" "prognostic favorable (8.65e-4)" "unprognostic (1.42e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (5.63e-3)" "unprognostic (3.18e-1)" "unprognostic (2.13e-3)" "unprognostic (4.56e-2)" 53.7 28.3 32.2 40.1 33.6 66.2 50.4 32.1 40.4 44.7 32.2 47.2 12.6 38.8 131.1 68.0 41.3 33.7 53.2 32.3 34.6 41.6 14.7 63.3 59.1 34.0 33.8 32.7 47.0 23.7 55.3 26.4 29.2 34.4 38.7 20.0 25.6 36.8 46.4 60.3 33.7 28.0 54.6 33.1 82.7 35.6 13.2 32.8 43.4 31.6 69.9 53.0 43.9 40.7 33.3 48.6 92.2 26.2 110.5 55.0 72.7 1.3 32.3 99.3 54.0 65.4 22.2 28.3 0.3 60.6 51.5 190.7 62.1 82.1 81.7 46.2 227.3 56.8 104.1 86.6 138.1 139.5 11.8 37.5 49.9 135.7 57.2 37.8 108.5 92.7 51.1 70.2 55.7 41.4 52.5 37.0 6.3 35.9 11.0 104.7 80.4 45.6 261.4 121.1 26.6 34.0 104.4 65.9 65.1 55.2 46.2 146.7 77.7 57.0 49.3 53.9 21.8 56.0 74.7 63.2 0.2 80.8 46.9 78.4 51.1 291.9 169.2 39.1 374.9 36.7 26.9 75.7 64.9 135.4 17.0 39.7 31.0 26.5 22.4 368.4 20.1 82.2 208.5 32.2 33.6 32.1 40.4 32.3 34.6 34.0 33.8 32.7 34.4 33.1 32.8 33.3 22.0 60.9 85.0 7.5 10.7 29.1 64.2 102.4 34.1 18.0 29.6 36.1 59.4 17.2 75.7 35.0 2.1 9.7 9.3 0.3 56.7 52.6 0.7 31.6 20.2 27.3 0.0 74.7 8.4 35.1 8.1 39.7 8.2 41.4 111.5 17.2 24.3 1.9 259.1 8.4 11.5 0.4 59.0 136.5 53.7 1.6 37.0 80.4 46.2 2.8 147.3 36.6 13.4 7.5 4.3 25.2 1.2 29.0 16.6 87.9 7.1 110.5 69.6 13.0 46.0 23.0 50.6 3.0 14.2 52.9 34.4 5.2 23.4 4.9 0.6 48.7 URGCP "DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4" ENSG00000106608 "Upregulator of cell proliferation" Q8TCY9 7 43875894-43926411 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019879, HPA020134, HPA029468" Approved Supported Cytosol NA NA Cytosol "HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831" "unprognostic (5.66e-2)" "unprognostic (1.10e-3)" "unprognostic (1.18e-1)" "unprognostic (2.75e-1)" "unprognostic (2.21e-3)" "unprognostic (2.42e-2)" "unprognostic (3.74e-2)" "unprognostic (1.26e-1)" "unprognostic (3.79e-1)" "unprognostic (2.21e-1)" "unprognostic (3.23e-3)" "unprognostic (3.71e-1)" "prognostic favorable (1.90e-4)" "unprognostic (1.56e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (1.69e-3)" 15.9 35.9 21.8 10.0 23.7 10.4 15.2 23.4 26.1 19.8 21.4 22.3 24.6 17.8 14.9 17.9 19.7 11.2 23.5 23.0 21.2 24.5 29.9 14.4 10.9 19.8 19.7 23.3 20.9 19.3 22.2 27.6 12.0 21.2 21.8 19.2 20.3 15.8 16.3 35.2 18.4 23.0 18.9 17.2 18.7 17.5 9.8 20.8 10.5 18.9 31.9 10.7 20.6 16.7 23.5 28.2 25.1 10.1 32.1 26.3 24.0 9.6 33.2 58.4 35.2 35.6 21.1 21.8 16.5 16.9 31.7 53.5 44.3 28.0 23.8 34.3 31.6 17.3 11.5 25.2 19.0 28.0 17.7 20.3 18.5 28.5 27.8 27.0 23.1 17.7 18.9 28.6 13.1 23.7 21.0 18.6 14.6 19.1 33.1 25.8 24.9 14.6 22.2 33.7 27.7 25.8 44.4 34.4 49.6 15.4 16.5 25.0 21.0 19.5 20.3 9.4 22.8 26.1 34.1 53.6 20.7 23.2 26.7 38.6 4.5 4.7 6.2 8.8 7.4 9.4 5.8 9.2 11.7 10.2 4.9 9.9 8.8 0.5 2.8 8.3 1.6 10.6 6.6 21.8 23.7 23.4 26.1 23.0 21.2 19.8 19.7 23.3 21.2 17.2 20.8 23.5 10.1 3.2 9.2 14.7 12.2 11.1 13.4 7.9 9.1 25.9 17.7 17.8 23.8 12.8 7.3 12.9 8.4 6.3 8.9 41.0 17.6 13.0 1.2 16.3 14.3 10.2 8.4 6.3 28.6 13.2 11.8 13.5 23.9 23.2 7.0 21.1 12.5 27.3 6.5 16.8 25.1 12.5 10.2 5.0 10.2 3.4 18.3 7.5 12.4 6.5 4.8 12.2 7.2 7.5 17.6 15.7 23.4 18.8 4.2 14.1 37.9 26.4 8.7 20.4 6.6 13.8 12.6 8.8 8.3 9.1 14.8 3.4 10.8 15.2 16.2 15.0 TMEM248 "C7orf42, FLJ10099, FLJ13090" ENSG00000106609 "Transmembrane protein 248" Q9NWD8 7 66921225-66958551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016495 Uncertain Approved Vesicles NA NA 1600000 Vesicles "HPA016495: AB_1848643" "unprognostic (6.74e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (4.64e-2)" "unprognostic (6.67e-3)" "unprognostic (9.36e-2)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.54e-2)" "unprognostic (9.18e-2)" "unprognostic (2.80e-3)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.11e-2)" "unprognostic (8.28e-2)" "unprognostic (5.57e-2)" 32.0 40.1 30.5 27.8 31.8 18.0 35.1 25.9 30.3 46.9 52.5 41.2 42.8 44.6 41.0 26.8 45.4 39.0 31.7 33.1 38.1 36.6 49.8 39.0 36.8 27.6 30.4 28.7 50.5 40.6 50.4 31.9 34.8 29.1 43.5 41.5 39.3 39.9 41.3 23.3 29.8 37.7 39.6 27.3 34.5 44.0 32.9 35.6 29.7 46.5 21.6 35.3 34.3 32.7 28.9 46.4 53.3 44.2 63.4 98.2 75.0 38.7 55.7 95.1 51.8 55.9 38.9 59.2 46.7 66.3 75.5 70.8 40.8 38.3 45.9 64.0 43.1 28.2 34.2 36.9 45.4 63.5 57.6 45.5 68.0 52.4 43.6 36.1 75.4 68.5 36.1 66.6 30.6 83.4 28.1 54.3 70.5 65.9 47.5 36.1 39.3 51.4 79.3 70.3 35.1 30.7 65.6 49.1 89.0 50.6 65.6 44.8 52.1 63.9 72.4 35.4 48.0 61.9 37.2 45.4 52.1 60.6 62.9 70.5 2.3 4.0 7.7 6.0 4.3 7.2 8.3 6.5 6.4 3.2 8.1 6.3 6.8 5.8 7.3 2.7 8.3 4.7 1.9 30.5 31.8 25.9 30.3 33.1 38.1 27.6 30.4 28.7 29.1 27.3 35.6 28.9 55.1 51.3 42.7 14.7 66.2 64.5 53.5 23.6 46.7 18.5 60.6 44.2 25.0 51.5 25.2 53.3 6.2 48.3 75.2 100.8 11.7 37.0 106.2 37.8 34.5 51.7 27.6 45.9 25.8 47.2 81.2 60.9 55.5 35.0 28.5 44.8 58.2 109.9 52.7 18.5 26.4 82.6 16.2 65.7 76.5 172.3 63.6 53.0 49.8 20.6 46.2 96.7 62.8 24.1 27.7 60.2 62.3 65.8 76.5 108.8 64.4 34.3 36.9 12.7 32.9 40.3 47.7 111.5 57.9 42.2 73.9 88.1 64.4 46.4 60.3 98.7 RHEB RHEB2 ENSG00000106615 "Ras homolog, mTORC1 binding" Q15382 7 151466012-151520120 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 724.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019436 Uncertain NA NA "CAB019436: AB_2178777" "unprognostic (2.22e-2)" "unprognostic (2.29e-2)" "unprognostic (2.25e-2)" "unprognostic (9.47e-2)" "unprognostic (2.65e-2)" "unprognostic (3.08e-3)" "prognostic unfavorable (9.08e-5)" "unprognostic (9.37e-2)" "unprognostic (4.76e-3)" "unprognostic (9.76e-3)" "unprognostic (1.85e-3)" "unprognostic (3.67e-2)" "unprognostic (2.36e-3)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.91e-1)" "unprognostic (3.15e-1)" 110.3 138.1 122.4 62.6 122.3 109.0 101.7 123.1 175.2 77.1 108.1 106.4 53.4 117.2 161.5 73.6 91.0 56.8 128.0 131.2 131.6 96.3 99.2 93.9 44.7 121.2 126.0 117.4 87.7 87.3 82.2 84.9 105.7 125.0 83.7 61.1 107.7 73.0 97.9 195.1 64.6 63.1 115.4 122.9 64.1 85.9 47.8 125.7 72.5 99.8 162.3 48.0 118.2 77.5 122.9 335.9 100.3 173.3 165.7 211.5 172.3 131.3 241.7 211.1 198.0 240.4 145.0 354.0 86.4 370.3 215.2 517.4 111.6 126.3 116.8 255.5 91.7 96.9 73.7 113.2 109.5 329.6 137.7 115.2 132.7 183.1 158.1 211.1 207.7 155.2 128.6 231.7 387.1 276.5 216.7 196.0 195.7 285.7 241.5 145.0 94.1 152.6 173.9 233.1 118.4 166.3 208.6 245.4 235.0 283.0 167.7 88.0 169.9 171.0 156.1 65.5 271.9 395.5 145.2 212.2 123.8 376.9 252.7 432.0 39.5 34.1 47.0 24.8 30.5 41.0 23.6 34.2 31.5 26.7 23.9 24.5 30.5 33.9 36.5 34.4 47.0 37.3 39.6 122.4 122.3 123.1 175.2 131.2 131.6 121.2 126.0 117.4 125.0 122.9 125.7 122.9 230.5 60.9 45.8 72.5 87.3 398.2 611.3 272.9 114.4 72.8 187.7 179.2 102.0 81.5 169.0 108.5 18.8 207.0 111.9 126.2 416.7 211.7 53.4 107.7 102.6 168.8 98.2 122.9 64.7 213.3 384.1 179.0 40.8 160.8 106.1 95.0 103.9 137.6 233.9 121.1 49.6 76.3 290.9 111.1 384.6 33.2 112.2 174.5 318.4 29.0 114.3 473.6 65.9 30.2 30.6 271.5 109.2 151.6 119.9 620.3 87.8 296.6 85.0 68.7 124.9 149.4 312.2 355.1 173.4 144.7 405.6 421.1 110.4 86.9 79.7 724.9 PRKAG2 "AAKG, AAKG2, CMH6, H91620p, WPWS" ENSG00000106617 "Protein kinase AMP-activated non-catalytic subunit gamma 2" Q9UGJ0 7 151556124-151877125 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.9" "Cell type enhanced" "Detected in all" "Excitatory neurons: 208.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 178.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004246, CAB018641" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB018641: AB_2170355, HPA004246: AB_1078151" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.46e-2)" "unprognostic (9.29e-2)" "unprognostic (1.76e-1)" "unprognostic (4.33e-3)" "unprognostic (7.13e-2)" "unprognostic (8.09e-2)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (2.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.80e-1)" "unprognostic (3.61e-2)" "unprognostic (4.52e-1)" 23.4 7.8 23.5 12.9 22.1 8.2 18.5 18.1 22.4 14.8 13.4 23.2 24.6 20.0 14.4 16.3 18.1 12.9 126.9 25.1 22.0 21.5 36.4 14.3 11.7 20.8 19.4 23.6 11.0 11.0 9.3 9.6 16.3 22.1 25.5 19.1 3.0 15.1 19.6 15.1 13.3 26.4 16.7 17.1 17.8 26.9 13.0 21.2 7.9 16.7 21.8 9.9 48.3 17.7 21.4 46.6 13.6 9.1 10.6 36.4 28.6 14.4 21.5 19.5 22.7 22.3 8.6 52.5 0.0 34.0 28.9 178.2 13.9 5.7 22.4 30.0 15.8 6.2 11.5 1.8 0.9 60.8 8.5 11.4 16.5 49.7 21.8 21.0 34.1 40.2 14.9 4.1 5.6 66.2 17.2 3.5 6.7 9.7 18.8 37.5 5.6 6.9 9.7 39.2 10.9 38.5 6.7 10.7 19.9 10.0 22.9 4.0 13.6 52.8 5.0 4.3 2.8 13.1 3.5 5.1 0.0 63.5 29.8 45.9 26.2 9.3 10.9 5.3 7.0 4.1 9.6 4.9 4.8 6.5 4.0 4.8 7.3 11.1 4.4 6.4 6.0 2.9 5.3 23.5 22.1 18.1 22.4 25.1 22.0 20.8 19.4 23.6 22.1 17.1 21.2 21.4 19.2 6.4 19.8 37.5 24.8 10.6 39.9 25.0 19.9 22.3 20.6 14.5 122.3 8.6 22.9 46.0 8.4 3.9 43.8 29.5 64.6 14.1 49.3 75.1 16.9 20.4 13.1 3.8 208.5 22.7 31.2 24.9 21.9 98.1 22.2 4.6 18.9 76.8 17.7 3.3 85.2 34.5 105.8 57.2 48.2 35.8 7.5 50.9 16.0 73.1 62.9 14.7 37.0 39.2 4.4 27.5 21.9 7.9 23.4 45.7 77.7 19.7 14.2 6.1 13.1 6.9 27.3 4.0 32.3 12.8 10.9 50.6 27.3 5.0 28.0 45.2 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104345-44114562 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 7.6" "Lineage enriched" "Detected in many" 5 "dendritic cells: 7.6" "Cell line enhanced" "Detected in many" "ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 57.6" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2700000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394" "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 175.0 60.5 70.0 60.4 48.7 10.7 154.4 44.7 45.2 291.1 33.6 89.1 19.3 271.1 60.1 66.4 201.5 157.3 100.4 46.9 109.6 69.2 20.5 167.5 45.9 125.0 62.9 29.0 255.8 29.1 10.2 43.6 89.8 73.9 113.0 25.3 1.3 51.1 215.5 21.5 76.3 79.8 120.3 81.7 54.8 71.8 40.7 63.1 74.0 84.4 14.2 16.9 139.9 199.7 81.5 0.6 0.0 44.5 0.1 141.1 49.6 1.0 193.0 126.0 21.6 4.5 0.0 0.1 5.3 20.9 208.9 0.2 0.1 2.4 3.5 9.1 0.6 0.0 13.3 0.1 0.0 39.6 0.1 0.3 75.8 0.0 72.9 0.1 1.1 9.7 145.0 8.3 0.3 0.0 0.2 86.9 16.1 19.1 0.0 0.4 71.3 1.7 1.7 5.0 0.0 4.9 25.3 0.1 0.3 85.9 41.9 0.4 14.4 34.1 0.0 86.2 0.5 0.3 1.0 0.9 102.8 0.4 0.2 117.9 0.0 0.0 0.0 0.3 0.0 0.2 1.5 0.2 0.0 0.0 1.4 0.9 0.5 0.0 0.1 0.0 7.6 0.0 0.3 70.0 48.7 44.7 45.2 46.9 109.6 125.0 62.9 29.0 73.9 81.7 63.1 81.5 23.6 0.0 2.5 32.3 11.8 34.5 5.7 1.3 1.8 0.8 2.0 14.6 26.4 1.5 1.4 7.3 0.0 2.0 22.7 0.0 0.0 0.9 3.1 3.3 103.0 18.0 0.0 1.3 0.1 0.0 3.3 263.2 8.6 2.9 2.5 33.3 30.4 0.6 3.6 0.0 0.3 0.0 0.0 1.8 42.0 18.0 151.6 3.2 85.4 17.8 1.0 0.2 1.0 6.0 0.3 0.4 0.0 508.9 9.7 16.9 0.0 2.2 2.2 0.8 39.5 23.6 173.4 4.0 4.6 1.5 27.4 3.4 4.8 28.7 0.0 2.4 POLD2 ENSG00000106628 "DNA polymerase delta 2, accessory subunit" P49005 7 44114680-44124358 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 288.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026745 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026745: AB_1855520" "unprognostic (9.09e-2)" "unprognostic (1.41e-1)" "unprognostic (9.89e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (2.10e-3)" "unprognostic (1.50e-3)" "unprognostic (4.94e-3)" "unprognostic (8.17e-2)" "unprognostic (1.01e-3)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.72e-2)" "unprognostic (2.14e-1)" "unprognostic (5.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-3)" 45.9 59.3 43.2 35.3 41.3 45.0 44.8 41.8 54.2 50.4 44.0 39.0 32.7 47.7 14.1 87.3 76.5 18.6 86.1 41.1 44.9 51.4 114.4 36.5 37.2 43.6 43.7 37.7 59.8 74.0 62.5 53.4 27.3 43.0 47.2 29.2 22.8 47.0 30.3 119.8 57.9 33.2 32.6 40.8 36.1 48.4 49.0 48.9 46.6 41.0 78.2 33.7 48.6 54.8 42.7 162.2 209.3 114.1 240.5 99.5 105.5 112.9 97.2 97.5 130.6 97.4 178.0 151.4 371.1 121.2 141.1 261.0 218.3 188.9 265.6 84.4 105.9 222.1 82.2 216.3 152.3 112.8 253.4 96.1 96.8 159.6 202.4 195.1 136.3 110.7 245.8 305.4 173.2 146.3 262.7 310.5 476.0 180.0 231.0 203.0 206.4 153.4 528.9 114.0 102.7 225.0 176.2 121.5 430.6 83.7 73.5 249.7 321.6 88.0 171.7 215.8 213.3 310.5 269.3 430.3 359.1 154.1 252.7 248.6 1.7 41.2 10.4 51.6 38.9 77.3 82.2 61.7 52.5 70.8 80.2 81.4 60.5 3.3 44.9 38.8 112.7 54.1 69.7 43.2 41.3 41.8 54.2 41.1 44.9 43.6 43.7 37.7 43.0 40.8 48.9 42.7 25.6 6.4 31.8 11.8 35.3 49.3 83.0 111.8 42.7 41.6 57.1 62.7 58.2 44.3 54.1 29.5 31.3 69.9 24.3 31.0 103.7 71.9 108.9 53.5 52.4 33.6 41.9 52.2 5.0 59.5 84.1 49.3 40.2 24.9 26.6 65.6 19.2 95.6 46.8 53.8 5.1 53.6 30.5 14.4 26.6 288.0 41.7 15.0 49.8 4.7 13.0 58.1 18.6 5.0 7.8 44.5 25.0 53.4 38.0 127.6 10.0 95.2 69.7 52.0 19.7 55.4 78.6 48.2 52.4 70.5 60.5 35.4 25.7 103.9 81.5 71.3 MYL7 "MYL2A, MYLC2A" ENSG00000106631 "Myosin light chain 7" Q01449 7 44138864-44141332 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 588 "heart muscle: 12944.8" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 10772.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "BEWO: 35.6;CACO-2: 124.6;SuSa: 47.6" "Not detected" "Not detected" "HPA013331, CAB033884, HPA039262" Enhanced NA NA "CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418" "unprognostic (1.00e-2)" "unprognostic (7.99e-2)" "unprognostic (4.36e-3)" "unprognostic (2.31e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" "unprognostic (7.85e-2)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" 2.7 1.1 3.5 0.0 3.1 0.0 6.5 3.1 4.2 1.2 2.7 1.5 0.0 1.4 0.2 1.1 0.8 0.6 12944.8 2.9 3.7 1.0 2.3 22.0 0.8 3.1 3.3 3.0 4.4 18.5 0.4 9.8 2.2 3.3 2.0 0.0 0.2 11.7 0.3 3.1 2.3 2.0 0.0 2.9 0.9 1.4 1.0 3.7 0.0 3.6 0.0 0.0 0.4 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.4 0.0 124.6 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.1 0.5 0.0 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.9 0.4 0.0 47.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.1 3.1 4.2 2.9 3.7 3.1 3.3 3.0 3.3 2.9 3.7 3.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.4 30.5 10772.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 78.5 0.0 2.7 0.3 0.0 0.2 695.9 0.0 0.0 0.0 24.9 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GCK "HK4, MODY2" ENSG00000106633 Glucokinase P35557 7 44143213-44198170 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;liver: 21.7;pituitary gland: 24.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7" "Cancer enhanced" "Detected in some" "liver cancer: 4.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.3;naive CD4 T-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007034, HPA007093" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA007034: AB_1079050, HPA007093: AB_1079051" "unprognostic (3.09e-1)" "unprognostic (2.99e-2)" "unprognostic (3.32e-2)" "unprognostic (6.64e-7)" "unprognostic (8.00e-2)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (2.68e-1)" "unprognostic (1.24e-1)" "unprognostic (5.48e-2)" "unprognostic (8.11e-3)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (2.01e-2)" "unprognostic (3.24e-1)" "unprognostic (4.36e-2)" "unprognostic (1.53e-1)" 0.8 0.3 8.6 0.3 7.9 0.2 0.7 7.8 9.6 2.7 7.0 0.5 0.1 1.2 0.8 0.4 1.2 0.5 5.3 7.9 9.8 0.5 21.7 0.4 0.2 8.4 9.4 7.8 1.5 1.8 0.1 24.1 1.6 8.7 1.2 0.2 1.0 0.3 0.7 0.2 0.7 0.5 0.3 7.7 0.6 0.6 0.4 10.7 0.1 0.5 0.1 0.2 1.1 2.0 8.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.2 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.3 2.3 0.7 0.1 0.1 0.3 2.0 0.4 0.8 0.1 0.0 0.1 0.0 0.3 8.6 7.9 7.8 9.6 7.9 9.8 8.4 9.4 7.8 8.7 7.7 10.7 8.7 0.3 0.0 0.0 0.7 0.3 1.1 0.7 0.0 1.2 5.0 0.1 0.8 4.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.5 2.4 0.0 1.8 0.0 0.2 5.2 0.0 0.0 0.0 2.4 0.0 0.4 0.7 5.0 2.4 0.0 0.0 0.0 0.7 0.3 0.9 0.1 0.0 1.0 0.0 2.8 0.0 0.5 1.0 0.1 0.1 2.2 0.2 1.7 0.0 0.1 0.0 0.8 0.0 0.6 3.7 0.5 1.1 0.0 0.1 0.8 0.3 0.5 0.0 0.7 BCL7B ENSG00000106635 "BAF chromatin remodeling complex subunit BCL7B" Q9BQE9 7 73536356-73557690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Wnt signaling pathway" "Allergen, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049943, HPA058069" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA049943: AB_2680963, HPA058069: AB_2683594" "unprognostic (2.79e-2)" "unprognostic (2.87e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-1)" "unprognostic (3.54e-3)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" "unprognostic (4.84e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (5.37e-2)" "unprognostic (9.43e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.41e-2)" "unprognostic (1.32e-1)" 35.9 24.0 34.7 18.9 33.3 90.8 18.6 28.5 43.8 16.4 27.5 27.4 22.0 15.7 17.5 27.7 16.8 22.7 49.9 36.6 32.4 22.1 25.3 27.7 24.6 32.3 31.0 31.8 9.1 25.8 30.6 21.0 21.9 31.7 17.9 16.5 17.9 16.1 23.8 66.6 11.0 23.8 30.1 28.8 23.2 20.8 20.6 33.4 22.6 22.3 56.3 19.5 33.7 11.5 34.0 67.8 46.9 26.7 47.8 21.5 34.0 27.1 56.1 58.9 58.0 52.9 52.0 73.8 56.7 14.0 58.7 84.7 30.4 19.4 45.7 42.7 73.9 27.5 31.5 28.7 28.0 61.3 54.3 85.3 22.8 45.0 59.5 58.7 23.9 38.4 31.7 50.6 65.0 41.6 79.5 93.0 71.2 46.5 43.0 67.7 49.2 28.6 67.6 46.5 51.8 59.7 57.9 49.6 85.0 62.3 11.3 53.0 73.3 39.6 69.8 44.7 47.9 84.1 37.0 35.9 105.2 68.7 82.8 89.0 13.7 13.3 19.7 11.4 15.8 13.8 11.7 13.1 15.3 13.5 17.6 13.7 11.1 6.5 21.2 20.3 15.9 11.4 8.3 34.7 33.3 28.5 43.8 36.6 32.4 32.3 31.0 31.8 31.7 28.8 33.4 34.0 50.4 32.1 20.7 6.8 59.8 64.6 81.9 18.7 39.3 27.5 37.4 32.1 29.5 24.3 17.5 16.5 6.2 72.5 55.9 63.3 54.8 46.7 8.0 35.4 16.8 37.3 34.6 17.9 10.3 45.8 43.6 30.4 21.9 31.6 32.4 21.5 34.2 18.1 51.0 42.1 8.8 40.6 32.6 37.5 46.4 6.7 25.7 48.3 32.0 6.5 41.1 32.4 62.8 6.0 10.0 67.9 58.3 30.5 35.7 61.6 50.4 47.0 15.7 21.8 46.0 52.4 46.7 64.1 71.6 28.7 57.7 101.8 58.3 27.3 37.6 74.1 YKT6 ENSG00000106636 "YKT6 v-SNARE homolog" O15498 7 44200959-44214294 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030817, HPA030818" Approved Approved Mitochondria,Cytosol No No 23000 Cytosol Mitochondria "HPA030817: AB_10599828, HPA030818: AB_10602102" "unprognostic (1.25e-1)" "unprognostic (7.35e-3)" "unprognostic (1.30e-3)" "unprognostic (7.80e-3)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.77e-3)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (8.65e-2)" "unprognostic (1.63e-1)" "unprognostic (2.01e-2)" "unprognostic (1.34e-2)" "unprognostic (7.66e-3)" 31.9 33.7 53.9 32.0 51.6 37.2 26.6 51.6 52.6 23.7 46.3 35.2 30.8 30.6 39.0 50.5 23.0 20.1 36.2 53.6 54.9 33.0 20.4 27.9 27.8 57.0 58.6 49.2 19.6 53.1 34.6 31.9 27.9 57.7 27.4 34.9 16.1 38.0 27.3 50.0 33.0 29.9 35.3 57.6 30.5 40.7 28.7 56.3 38.7 29.1 36.9 35.1 31.5 24.9 57.9 81.9 86.1 71.3 94.8 85.3 72.6 63.1 161.5 130.3 104.5 103.6 93.7 75.9 88.0 71.4 157.7 184.5 94.5 83.1 111.0 140.8 89.4 65.3 53.7 63.1 58.7 105.1 103.4 80.8 66.7 97.6 114.7 123.4 77.5 111.5 75.9 126.2 64.8 125.2 79.4 87.3 106.8 178.8 111.5 120.2 81.9 76.0 68.4 72.2 69.2 94.2 151.6 83.0 126.4 97.8 115.8 100.0 100.4 138.0 112.5 123.9 104.2 199.1 134.5 187.8 130.3 146.2 87.5 219.4 5.6 10.8 18.2 5.3 11.5 7.9 7.1 7.0 9.0 10.0 10.1 5.4 5.4 8.9 5.1 10.6 7.9 7.5 5.5 53.9 51.6 51.6 52.6 53.6 54.9 57.0 58.6 49.2 57.7 57.6 56.3 57.9 12.4 12.8 9.4 9.1 16.2 26.0 18.1 14.1 10.2 8.4 21.6 15.4 19.7 7.2 13.7 20.2 10.4 25.3 13.9 45.4 25.4 47.1 25.4 9.4 15.8 19.3 13.8 9.5 7.0 83.0 63.5 18.7 18.8 17.7 1.3 15.1 14.6 15.7 41.2 13.5 6.5 26.6 16.2 19.4 19.3 8.3 9.9 19.5 26.6 1.0 40.2 11.0 23.7 8.0 8.3 79.0 23.3 13.5 38.8 35.8 33.1 23.1 8.7 7.9 0.0 13.1 23.8 18.9 23.0 22.9 25.9 49.3 15.2 11.8 24.0 44.4 TBL2 "DKFZP43N024, WBSCR13, WS-betaTRP" ENSG00000106638 "Transducin beta like 2" Q9Y4P3 7 73567537-73578791 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Group enriched" "Detected in all" 7 "Early spermatids: 398.2;Late spermatids: 515.4;Spermatocytes: 345.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007477, HPA051533" Supported Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA007477: AB_1080214, HPA051533: AB_2681523" "unprognostic (9.04e-2)" "unprognostic (6.61e-3)" "unprognostic (4.24e-2)" "unprognostic (1.10e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.24e-3)" "unprognostic (7.50e-2)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" 4.8 9.2 2.1 5.3 2.1 1.6 4.2 3.3 5.4 4.6 2.8 4.7 5.5 4.5 8.4 5.4 4.3 2.7 3.9 2.3 2.1 4.2 6.0 5.6 1.9 2.1 2.1 2.2 4.8 16.6 5.6 3.2 4.4 2.5 4.4 5.6 4.0 11.1 4.3 2.9 4.9 4.4 4.6 2.1 3.2 6.5 44.6 2.1 2.3 4.9 1.5 3.2 3.6 4.5 2.2 22.1 27.5 8.7 12.6 19.9 18.2 10.2 26.9 18.4 9.3 17.1 40.9 22.0 18.4 5.4 21.7 19.5 15.9 18.2 9.5 19.4 6.8 10.8 6.6 11.8 26.3 28.5 13.3 22.4 11.4 15.0 28.7 22.1 16.7 10.2 2.4 26.0 12.6 14.7 20.2 13.2 10.7 8.7 23.8 18.1 8.6 14.6 38.8 10.5 16.0 8.4 14.3 25.8 65.8 16.9 10.1 17.2 5.7 18.7 17.1 8.8 17.1 25.7 25.8 18.0 20.0 23.3 15.3 21.3 16.8 11.1 4.9 6.3 7.3 5.9 3.0 5.0 5.2 13.6 4.1 5.9 3.7 1.4 8.8 7.4 10.2 6.5 8.1 2.1 2.1 3.3 5.4 2.3 2.1 2.1 2.1 2.2 2.5 2.1 2.1 2.2 8.6 25.6 9.3 3.3 8.1 4.6 14.5 17.3 4.0 10.8 10.8 6.3 4.7 11.5 13.5 5.5 8.4 45.2 6.5 12.7 1.9 26.1 398.2 11.3 14.9 12.6 9.5 6.3 4.1 30.1 54.6 17.3 7.7 11.6 14.0 13.9 10.0 14.7 27.4 3.3 4.5 16.8 6.1 9.4 3.8 515.4 23.6 17.5 7.2 4.7 17.3 8.1 10.3 4.5 4.1 22.6 13.7 26.7 19.9 17.1 14.6 5.1 9.8 13.4 6.6 13.8 15.1 345.8 27.9 7.8 3.7 43.4 5.0 17.0 15.8 9.0 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019929 "Disease related genes, Metabolic proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 10.9" "Group enriched" "Detected in some" 77 "Early spermatids: 432.4;Late spermatids: 500.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced NA NA "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.9 1.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 1.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.9 1.4 1.1 1.0 1.0 1.0 1.0 1.0 0.9 0.9 1.2 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 432.4 0.0 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 500.9 3.1 0.3 0.0 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 6.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLIP2 "CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4" ENSG00000106665 "CAP-Gly domain containing linker protein 2" Q9UDT6 7 74289407-74405935 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 88.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 48.9;Excitatory neurons: 63.9;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 111.2" "Cancer enhanced" "Detected in all" "glioma: 43.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 70.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020430, CAB020767" Enhanced NA NA "CAB020767: , HPA020430: AB_1846958" "unprognostic (7.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (5.35e-4)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (5.94e-2)" "unprognostic (2.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-3)" "unprognostic (3.18e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.22e-1)" "unprognostic (6.96e-2)" "unprognostic (4.89e-2)" "unprognostic (1.38e-1)" 7.6 9.4 74.2 10.7 72.0 4.1 6.0 69.8 66.0 13.4 24.6 17.0 11.4 11.4 2.1 6.8 7.8 11.0 6.8 62.5 64.3 8.2 3.1 11.0 5.5 88.8 76.5 51.8 17.0 17.8 5.0 11.8 8.9 83.7 9.8 10.1 4.8 4.1 9.3 2.4 9.9 13.7 8.2 73.4 6.6 15.1 3.3 66.9 5.0 3.7 3.1 7.4 11.8 11.1 84.2 7.0 24.1 19.5 21.2 22.5 25.1 0.2 17.2 36.5 10.5 11.5 5.6 33.0 1.3 3.4 33.2 70.3 26.8 3.6 20.3 4.6 46.1 1.8 5.6 3.3 14.4 21.9 1.1 6.8 28.3 9.1 31.9 26.4 27.5 15.5 0.7 1.5 0.4 20.4 2.4 0.8 38.8 8.9 33.5 24.5 37.8 7.2 1.7 13.5 24.1 3.9 21.7 9.8 3.0 35.9 14.8 2.2 4.5 18.3 27.6 16.4 37.1 10.9 1.0 0.4 0.1 32.7 10.4 24.4 0.8 0.3 0.0 0.0 0.6 0.1 0.7 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 74.2 72.0 69.8 66.0 62.5 64.3 88.8 76.5 51.8 83.7 73.4 66.9 84.2 5.8 0.0 0.0 19.9 3.5 30.2 6.2 3.3 31.3 10.2 1.9 3.0 2.3 5.7 1.3 3.7 0.0 0.3 3.3 48.9 0.0 10.3 0.2 5.7 8.1 6.6 10.3 3.0 63.9 6.2 0.4 8.2 42.3 13.3 1.3 3.4 3.9 1.4 6.0 18.5 45.2 16.9 0.0 4.6 33.0 0.6 2.8 8.3 12.4 32.8 7.5 4.2 2.1 84.4 111.2 8.2 17.8 7.9 0.9 4.2 16.3 0.3 1.4 4.3 13.1 5.6 11.2 0.1 3.4 4.4 6.8 1.0 4.1 3.6 12.1 1.6 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174231-74197122 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 990.0;Late spermatids: 2765.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 750000 Cytosol "Nucleoplasm, Nuclear bodies" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 182.3 176.3 151.5 118.9 157.2 285.8 169.8 160.5 158.5 170.2 129.0 198.7 131.4 188.0 77.3 251.3 165.0 100.9 168.5 146.0 149.2 144.5 198.6 159.8 131.3 159.0 156.3 143.6 182.7 228.3 162.0 120.8 164.1 159.1 151.6 101.1 151.1 171.5 126.2 403.1 224.8 150.2 120.2 168.1 138.5 194.5 80.5 160.0 151.6 142.4 174.9 138.4 176.7 181.2 185.9 526.3 341.4 251.3 303.1 220.8 231.8 283.4 359.8 276.3 300.3 289.5 423.3 388.6 444.3 96.6 338.8 424.2 266.6 280.5 481.5 286.3 298.0 329.2 247.5 305.2 345.9 253.1 429.0 236.9 273.2 300.8 326.2 460.7 341.5 326.8 260.1 445.8 186.4 305.2 448.2 342.0 516.8 337.6 430.3 328.9 386.9 342.7 401.5 250.9 324.7 252.7 325.4 340.9 420.3 296.0 331.3 476.8 272.4 340.2 411.6 284.6 345.1 474.4 218.8 299.8 771.4 326.3 435.1 441.4 213.7 229.7 245.6 156.9 255.6 164.5 146.4 161.4 158.3 224.2 132.9 183.9 151.7 150.1 193.5 270.2 95.1 194.7 388.0 151.5 157.2 160.5 158.5 146.0 149.2 159.0 156.3 143.6 159.1 168.1 160.0 185.9 105.8 83.3 81.2 15.7 97.1 119.2 153.8 101.5 78.0 93.1 103.0 95.5 43.3 68.6 68.7 44.1 25.0 198.8 91.9 98.7 107.6 148.1 990.0 104.8 98.3 103.0 90.4 79.5 25.3 157.7 381.4 101.6 61.2 112.5 122.4 112.1 79.6 95.7 124.2 97.6 24.6 87.2 91.6 101.2 102.7 2765.8 103.8 86.8 72.9 15.9 157.4 134.7 119.4 16.6 44.2 147.0 82.8 110.6 82.7 140.7 84.6 69.0 57.8 72.3 85.5 107.3 117.7 61.2 64.6 90.1 116.1 395.3 92.4 116.9 109.5 140.4 LIMK1 LIMK ENSG00000106683 "LIM domain kinase 1" P53667 7 74082933-74122525 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1" "Cell type enhanced" "Detected in many" "Granulosa cells: 27.6;Horizontal cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 136.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028516, HPA073571" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028516: AB_10601751, HPA073571: " "unprognostic (1.45e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (4.95e-5)" "unprognostic (2.77e-2)" "unprognostic (1.40e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.63e-8)" "unprognostic (4.14e-2)" "unprognostic (7.00e-2)" "unprognostic (3.84e-2)" "unprognostic (5.79e-2)" 9.8 10.6 33.7 18.8 29.9 6.9 9.5 25.7 74.1 19.6 0.3 8.0 6.6 13.2 3.5 11.4 7.4 10.2 8.9 32.4 35.9 9.9 4.6 13.3 23.7 63.9 36.6 24.8 13.3 11.5 5.9 14.0 7.4 69.5 12.4 4.1 4.1 18.0 8.3 23.9 10.9 12.2 7.1 24.6 22.5 9.2 15.7 55.8 8.2 11.3 7.9 18.3 13.2 14.8 69.9 47.4 37.2 27.2 45.4 35.1 47.0 20.0 28.8 27.3 22.6 25.4 21.3 45.6 30.2 12.7 35.5 76.9 28.1 10.1 17.8 8.6 53.7 18.6 23.2 13.1 24.6 40.5 17.2 81.4 46.8 15.6 18.5 9.6 68.3 34.4 20.9 15.1 9.0 28.8 41.4 14.8 31.4 52.1 16.6 23.7 21.1 43.3 18.2 26.5 10.1 10.7 25.2 18.6 43.7 23.5 29.7 13.9 15.4 41.1 36.0 33.7 94.5 47.7 10.2 12.5 54.9 136.5 12.4 25.2 0.1 6.1 3.5 1.8 6.0 1.4 3.4 0.4 1.2 7.0 1.7 0.1 0.5 0.5 5.8 3.8 0.7 0.3 3.3 33.7 29.9 25.7 74.1 32.4 35.9 63.9 36.6 24.8 69.5 24.6 55.8 69.9 2.9 3.2 2.7 7.5 14.4 2.9 5.2 6.6 1.8 6.6 7.7 6.9 3.4 7.2 3.8 1.8 2.1 2.5 11.9 2.9 0.0 6.6 1.2 2.7 9.7 4.1 2.4 0.4 15.4 6.5 6.3 9.2 3.1 5.1 5.7 27.6 3.3 2.1 25.0 35.3 20.8 2.7 0.0 13.5 10.8 2.2 7.2 15.6 3.6 6.5 14.9 3.5 22.6 6.6 2.4 13.5 2.3 6.0 10.0 9.0 0.3 2.8 3.1 3.3 0.0 5.3 4.5 3.4 11.5 1.8 3.1 3.7 11.1 6.9 2.4 7.2 SPATA6L "C9orf68, FLJ10058" ENSG00000106686 "Spermatogenesis associated 6 like" Q8N4H0 9 4553386-4666674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 120.1;Late spermatids: 102.8;Respiratory ciliated cells: 40.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;CAPAN-2: 2.4;HDLM-2: 1.4;HeLa: 1.1;RPTEC TERT1: 1.7;SCLC-21H: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039585 Enhanced NA NA "HPA039585: AB_10674984" "unprognostic (8.18e-3)" "unprognostic (1.69e-1)" "unprognostic (4.10e-2)" "unprognostic (2.39e-3)" "unprognostic (5.65e-2)" "unprognostic (4.38e-2)" "unprognostic (3.23e-2)" "unprognostic (8.03e-3)" "unprognostic (4.10e-3)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (5.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.27e-3)" 0.8 0.4 2.4 0.2 1.3 0.0 1.2 1.7 1.5 1.1 2.4 0.5 0.9 0.4 0.2 1.0 3.7 1.4 0.4 1.3 1.4 1.5 5.3 1.5 0.2 1.6 1.8 1.0 0.5 2.8 0.5 4.5 0.4 1.3 1.2 0.3 0.5 0.7 0.5 0.1 0.9 1.4 0.1 1.7 0.2 1.3 5.5 1.6 0.0 2.3 0.0 0.1 0.9 0.9 1.2 0.5 0.1 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 1.4 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.2 1.7 0.0 1.5 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.4 1.3 1.7 1.5 1.3 1.4 1.6 1.8 1.0 1.3 1.7 1.6 1.2 4.3 9.6 12.6 21.9 0.1 0.6 2.8 7.8 1.8 2.9 2.5 1.3 2.0 12.8 10.2 3.7 12.5 2.6 0.8 1.3 3.9 6.6 120.1 21.0 0.8 5.4 0.0 0.8 24.6 5.3 0.3 1.2 8.6 3.1 1.3 1.5 3.3 11.8 0.6 0.0 27.6 6.0 12.2 0.0 1.2 102.8 1.8 0.4 0.0 9.4 0.1 1.1 0.0 10.6 10.0 4.2 3.7 2.6 0.3 2.1 6.5 2.9 40.4 0.8 0.0 1.7 1.5 9.7 3.7 2.9 1.1 2.1 1.3 0.9 2.7 2.6 SLC1A1 "EAAC1, EAAT3" ENSG00000106688 "Solute carrier family 1 member 1" P43005 9 4490468-4587469 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.4;intestine: 65.2;kidney: 51.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062356 Enhanced NA NA "HPA062356: " "unprognostic (1.28e-2)" "unprognostic (2.37e-2)" "unprognostic (6.83e-3)" "unprognostic (3.07e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (4.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-1)" "unprognostic (1.35e-2)" "unprognostic (1.25e-2)" "prognostic favorable (2.86e-8)" "unprognostic (2.68e-1)" "unprognostic (9.49e-2)" "unprognostic (7.78e-2)" "unprognostic (2.64e-1)" 4.4 1.7 16.3 2.3 16.0 0.1 4.2 9.6 14.9 5.8 11.5 12.5 35.1 3.7 45.4 2.3 2.6 25.8 2.0 16.5 17.8 51.5 41.6 21.1 2.6 10.7 14.7 13.4 0.6 2.2 0.3 6.9 8.2 12.7 6.4 10.3 6.0 4.9 3.2 1.4 1.5 65.2 3.2 11.9 0.4 5.3 0.8 14.7 0.4 29.8 1.3 8.2 5.6 1.5 13.3 0.1 2.0 1.6 9.5 24.3 29.1 8.3 10.4 21.4 3.2 3.1 17.2 0.5 13.7 0.6 5.4 3.9 0.0 3.6 5.7 2.9 70.9 4.5 0.0 13.6 0.1 0.8 0.9 0.0 2.0 0.2 12.1 0.0 1.6 32.5 0.2 0.0 0.0 2.2 0.3 0.0 0.3 4.2 10.5 1.8 0.0 0.0 0.2 66.4 6.1 2.2 2.0 0.8 3.8 0.0 7.7 1.4 0.5 17.6 4.9 0.4 9.5 3.0 0.1 0.1 0.0 23.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 16.3 16.0 9.6 14.9 16.5 17.8 10.7 14.7 13.4 12.7 11.9 14.7 13.3 12.2 163.5 3.2 4.2 0.4 0.0 1.1 0.6 4.6 3.9 2.0 0.8 2.3 28.6 6.1 0.0 0.0 0.1 0.0 52.4 3.9 8.1 4.3 10.7 13.3 10.6 0.0 0.0 48.4 0.8 0.0 1.8 2.0 98.7 0.0 0.6 2.5 68.4 0.1 0.0 50.3 10.1 0.0 1.3 0.3 11.2 0.3 1.1 0.0 67.5 0.0 0.8 0.0 161.4 3.5 9.3 10.6 0.0 0.0 2.4 110.6 43.1 3.3 1.1 0.0 0.5 3.1 0.1 0.2 1.0 0.6 0.1 1.4 0.4 8.5 1.8 LHX2 "hLhx2, LH-2" ENSG00000106689 "LIM homeobox 2" P50458 9 124001670-124033301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 100.5;choroid plexus: 45.0;retina: 34.4" "Cell type enhanced" "Detected in some" "Astrocytes: 68.6;Early spermatids: 43.1;Muller glia cells: 254.6" "Group enriched" "Detected in many" 5 "cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 23.2;GAMG: 17.9;HAP1: 23.5;HeLa: 15.5;NTERA-2: 28.5;U-138 MG: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA000838 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA000838: AB_2666109" "unprognostic (3.60e-3)" "prognostic favorable (9.52e-4)" "unprognostic (3.52e-1)" "unprognostic (9.97e-2)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (6.37e-3)" "unprognostic (1.07e-1)" "unprognostic (4.59e-2)" "unprognostic (3.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.32e-2)" "unprognostic (4.66e-15)" "unprognostic (1.72e-1)" "unprognostic (2.92e-1)" "unprognostic (2.46e-2)" "unprognostic (1.77e-1)" 0.1 0.1 71.4 0.2 73.4 0.0 0.2 43.4 100.5 0.0 45.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 86.2 70.0 0.0 6.7 0.0 0.3 50.1 48.7 70.6 0.2 0.0 0.0 9.9 3.4 57.0 0.0 0.1 34.4 0.1 0.0 0.0 4.5 0.2 0.0 42.9 0.1 0.0 3.1 46.3 0.1 0.0 0.0 0.2 0.1 0.0 71.8 0.0 7.2 0.2 23.2 0.0 0.3 2.6 0.7 0.3 1.8 0.2 7.8 0.0 0.2 3.0 1.4 17.9 0.2 23.5 0.0 0.9 0.0 5.0 0.0 15.5 0.4 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 12.1 0.0 0.2 28.5 0.0 7.0 6.5 0.1 0.0 0.0 0.1 9.2 0.1 5.7 0.0 0.0 0.2 8.0 3.1 0.0 14.6 0.6 4.2 1.1 0.4 5.0 0.0 0.8 3.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.4 73.4 43.4 100.5 86.2 70.0 50.1 48.7 70.6 57.0 42.9 46.3 71.8 0.1 0.0 0.0 68.6 0.2 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.6 0.0 0.0 0.0 2.1 0.1 0.0 0.1 0.0 0.0 43.1 0.1 0.0 0.3 0.0 0.0 20.6 0.0 8.9 0.1 0.0 0.0 0.0 0.1 3.9 0.0 4.0 8.4 2.5 0.0 0.0 0.0 0.3 21.7 0.0 0.1 0.0 1.9 0.0 254.6 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.4 0.2 4.2 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FKTN "FCMD, LGMD2M" ENSG00000106692 Fukutin O75072 9 105558122-105653820 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.4;Inhibitory neurons: 51.6;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012820 Approved NA NA "HPA012820: AB_1848478" "unprognostic (3.48e-2)" "unprognostic (1.84e-2)" "unprognostic (7.54e-2)" "unprognostic (2.47e-1)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (2.41e-2)" "unprognostic (4.24e-2)" "unprognostic (8.76e-2)" "unprognostic (3.17e-1)" "unprognostic (3.10e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (3.02e-4)" 4.1 5.1 3.6 3.8 4.3 1.1 5.7 4.0 4.1 4.6 3.0 4.7 3.7 5.1 5.0 4.1 4.9 3.6 4.4 3.7 3.9 4.3 4.6 3.3 3.9 4.1 3.8 3.2 6.1 7.2 7.5 5.7 4.7 3.7 4.5 5.7 10.1 4.2 4.1 3.9 5.3 4.3 4.2 3.1 4.6 5.6 3.7 3.8 3.4 6.3 5.1 3.6 4.4 4.5 5.4 7.1 5.4 8.3 7.1 13.5 20.3 9.5 13.4 12.5 8.1 9.0 4.6 11.1 5.2 7.2 14.3 7.5 12.3 7.9 10.3 12.3 7.6 5.5 3.9 8.3 3.3 9.7 6.9 3.3 15.9 9.8 11.7 17.6 12.6 8.5 6.6 4.4 6.2 18.4 8.8 6.1 5.1 6.5 7.5 8.2 4.3 17.1 3.6 8.5 2.7 7.7 6.7 9.4 10.4 7.8 7.9 19.3 5.3 10.7 8.9 4.7 18.1 12.4 8.4 10.9 3.4 9.0 7.7 13.0 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.5 0.3 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.1 3.6 4.3 4.0 4.1 3.7 3.9 4.1 3.8 3.2 3.7 3.1 3.8 5.4 6.3 6.4 7.7 27.4 5.0 3.2 4.2 5.5 5.7 21.9 6.0 6.1 9.0 8.6 5.7 7.3 8.4 2.4 5.5 4.9 1.9 4.5 2.6 5.2 11.4 5.7 4.2 3.8 49.4 3.3 4.1 10.9 7.7 5.6 2.5 13.5 7.5 5.3 4.4 23.5 51.6 6.4 0.0 3.8 2.1 0.8 6.2 4.1 8.8 13.1 3.4 6.6 5.2 40.7 66.5 3.0 4.3 9.1 3.5 3.9 2.7 3.7 7.3 17.6 6.6 12.9 5.8 12.5 9.1 7.5 4.0 0.8 3.6 10.4 7.5 2.8 FSD1L "CCDC10, CSDUFD1, FSD1CL, FSD1NL" ENSG00000106701 "Fibronectin type III and SPRY domain containing 1 like" Q9BXM9 9 105447796-105552433 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 43.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 423.3;Early spermatids: 97.2;Excitatory neurons: 79.0;Rod photoreceptor cells: 121.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035138 Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA035138: AB_10601324" "unprognostic (9.28e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.88e-3)" "unprognostic (3.93e-2)" "unprognostic (1.82e-2)" "unprognostic (3.17e-5)" "unprognostic (4.20e-2)" "unprognostic (5.65e-2)" "unprognostic (9.64e-3)" "unprognostic (2.66e-3)" "unprognostic (3.32e-2)" "unprognostic (8.28e-2)" "unprognostic (2.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.07e-2)" "unprognostic (1.22e-3)" 1.2 3.5 11.2 2.1 11.9 2.4 1.6 10.3 10.8 1.8 6.5 2.6 4.5 2.1 3.4 0.9 7.2 1.4 4.1 9.6 13.8 2.1 0.7 2.2 1.4 14.4 12.4 9.5 1.4 1.4 2.0 3.3 0.9 12.6 1.6 2.4 43.6 1.1 1.6 7.4 1.1 3.7 1.6 14.1 1.5 2.2 5.9 13.2 1.7 2.0 13.4 1.5 1.1 0.9 14.1 3.3 3.8 5.6 3.9 1.6 3.2 2.0 3.1 1.8 2.5 2.5 1.7 1.4 8.3 1.2 2.7 3.0 1.3 3.6 1.6 3.5 11.1 1.3 1.4 5.3 2.3 2.5 4.9 3.4 1.5 1.6 3.6 5.5 3.2 2.4 3.9 1.8 5.1 2.5 1.1 8.4 3.1 3.5 0.4 2.2 10.6 3.8 0.7 2.6 0.7 12.3 5.9 3.5 0.9 3.0 2.3 3.7 1.7 3.2 4.4 2.7 3.7 4.2 2.6 9.9 2.2 3.1 3.0 1.6 0.4 0.9 0.0 0.5 0.6 0.2 1.8 0.7 0.5 0.6 0.6 0.0 0.3 0.2 0.5 0.4 0.6 0.2 0.2 11.2 11.9 10.3 10.8 9.6 13.8 14.4 12.4 9.5 12.6 14.1 13.2 14.1 2.9 3.2 1.1 23.8 4.2 1.0 2.0 2.5 0.0 23.1 2.3 2.0 6.0 1.5 3.5 7.3 423.3 0.3 3.4 3.0 1.9 22.7 97.2 47.5 5.7 3.3 10.7 1.7 79.0 3.8 1.3 5.2 2.6 15.1 14.0 10.4 1.1 1.3 3.8 52.2 59.2 6.3 2.0 1.2 3.5 68.2 5.0 5.3 10.6 16.9 21.0 12.7 1.0 21.6 66.9 5.2 7.1 6.8 3.0 1.1 7.8 2.4 44.9 121.1 13.1 6.3 4.1 26.0 26.1 0.3 0.9 0.0 2.8 2.2 6.8 0.2 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein family member 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 26.1;Excitatory neurons: 18.6;Hepatic stellate cells: 30.0;Inhibitory neurons: 103.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 74 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "A549: 18.9;AF22: 22.5;TIME: 14.5;WM-115: 37.9" HPA047731 Uncertain "Intracellular and membrane" NA NA "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.7 0.4 3.7 0.6 7.5 1.2 3.2 0.4 2.8 1.1 2.9 3.3 0.8 0.6 0.5 7.3 2.2 1.2 3.6 5.3 2.7 1.8 0.8 1.1 0.3 1.4 5.3 3.0 0.3 0.4 0.1 1.1 1.6 2.1 1.5 1.3 2.7 3.4 1.5 0.4 6.8 1.8 2.3 0.0 2.7 0.6 1.8 1.6 2.5 1.2 0.7 0.6 1.0 2.6 2.8 1.1 18.9 22.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 1.4 4.7 1.9 4.4 0.0 0.0 1.6 0.0 5.2 0.5 0.2 0.3 0.0 0.5 4.1 0.0 1.7 9.4 8.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.9 0.2 5.7 0.0 0.6 5.4 0.4 0.8 2.1 0.7 6.7 0.0 3.7 2.4 0.0 3.2 14.5 0.0 2.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 3.7 7.5 0.4 2.8 5.3 2.7 1.4 5.3 3.0 2.1 0.0 1.6 2.8 8.0 3.2 1.7 26.1 0.0 6.2 4.0 1.8 18.2 1.3 0.9 3.0 3.5 4.3 1.5 1.8 2.1 0.8 0.0 0.1 0.0 0.4 1.9 1.4 0.7 7.5 3.5 0.0 18.6 0.2 2.5 1.2 0.0 0.2 0.0 0.1 30.0 1.3 0.1 0.0 103.1 0.3 0.0 1.6 0.8 0.9 0.3 0.2 0.0 13.1 0.0 10.5 0.0 3.0 13.3 0.7 0.0 0.0 1.2 1.4 0.0 1.9 4.1 0.7 0.0 0.5 0.9 1.7 8.8 10.4 7.7 0.7 0.4 0.0 0.1 2.7 SPIN1 "SPIN, TDRD24" ENSG00000106723 "Spindlin 1" Q9Y657 9 88388430-88478694 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Meiosis, Wnt signaling pathway" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 178.2;Oligodendrocytes: 220.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000162, HPA068784" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA068784: AB_2686033" "unprognostic (1.53e-1)" "unprognostic (2.29e-1)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (6.11e-2)" "unprognostic (1.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.96e-2)" "unprognostic (8.78e-2)" "unprognostic (8.32e-2)" "prognostic favorable (8.69e-6)" "unprognostic (4.73e-3)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (1.56e-1)" 23.5 26.8 44.2 17.6 49.3 14.9 35.6 34.9 46.2 59.8 38.2 26.6 19.5 61.9 77.5 27.9 51.4 32.0 29.8 46.8 47.2 45.2 21.1 26.3 16.0 38.8 42.8 44.6 56.4 21.9 42.0 29.0 33.4 39.9 38.1 25.4 35.1 24.6 42.6 7.0 25.1 22.7 46.5 38.8 19.5 21.4 35.9 44.2 31.3 41.6 14.2 17.4 27.5 31.7 45.2 68.5 32.8 54.0 46.2 36.0 42.1 63.0 67.1 62.0 75.1 54.8 24.6 38.9 37.7 38.5 82.8 48.5 102.4 40.6 61.1 85.7 39.6 24.4 18.0 67.4 26.4 33.3 41.8 19.0 35.2 62.4 50.9 71.2 74.0 43.4 47.2 23.5 0.1 85.5 46.8 71.1 18.8 89.2 56.9 30.5 93.6 58.6 12.2 68.3 47.2 76.1 57.2 79.5 49.7 30.1 62.2 38.3 32.7 41.4 49.6 52.4 74.3 48.2 15.3 24.2 32.3 60.1 38.0 47.3 7.4 2.6 4.1 3.9 2.2 4.1 2.5 2.8 4.0 5.0 1.9 3.9 4.4 0.4 2.6 2.1 2.3 2.8 3.1 44.2 49.3 34.9 46.2 46.8 47.2 38.8 42.8 44.6 39.9 38.8 44.2 45.2 26.4 51.3 15.4 139.4 13.1 40.0 26.1 23.1 47.3 22.9 45.4 31.2 35.8 42.9 22.2 44.1 25.0 28.6 17.0 29.1 25.4 24.2 178.2 56.4 73.3 24.5 41.3 19.6 136.8 18.3 44.4 39.6 22.4 68.5 34.8 74.3 26.4 17.5 33.6 25.2 173.3 23.6 30.5 35.2 21.8 123.4 33.5 22.8 21.4 89.9 13.0 38.5 13.4 123.1 220.1 25.4 17.7 44.4 9.6 34.6 20.9 47.6 22.2 15.1 26.3 28.3 38.0 25.7 54.1 37.7 44.8 24.9 16.9 37.9 21.8 28.9 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 68.6;Karpas-707: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA049795: AB_2680886" "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favorable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favorable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 20.9 11.6 14.9 14.5 15.3 12.7 20.4 17.5 19.1 19.2 16.0 13.7 18.0 11.3 18.7 39.8 16.6 14.3 14.2 15.3 15.8 32.6 54.2 21.8 17.6 15.2 15.2 15.0 22.9 45.5 64.6 19.9 14.9 15.6 23.9 13.2 8.9 31.5 13.7 27.4 22.7 22.6 8.9 15.3 31.4 26.2 9.8 15.1 17.5 25.8 13.5 20.2 19.0 25.8 16.6 11.7 2.7 3.2 7.9 21.4 28.0 18.1 17.0 22.4 3.5 5.8 0.1 29.8 6.8 10.0 13.8 7.2 18.5 3.8 9.4 10.0 68.6 3.5 5.1 5.6 5.7 20.3 4.8 0.8 22.5 23.5 6.3 11.8 20.8 25.1 10.8 0.5 79.0 24.6 8.4 4.3 4.3 3.9 40.2 10.0 1.6 29.7 42.1 28.9 19.5 2.2 0.5 7.3 6.4 9.0 19.2 18.4 4.5 20.6 13.5 2.9 12.9 4.6 37.5 31.4 4.1 23.1 4.9 13.8 16.4 5.4 9.3 25.1 5.1 30.5 13.4 43.7 29.2 6.1 9.1 39.4 30.2 9.8 17.2 14.5 17.2 31.6 18.1 14.9 15.3 17.5 19.1 15.3 15.8 15.2 15.2 15.0 15.6 15.3 15.1 16.6 42.2 38.5 21.7 11.8 22.6 21.0 36.4 38.2 38.7 8.4 33.4 37.5 15.5 21.5 27.9 23.9 8.4 53.3 43.7 32.8 52.8 30.5 17.8 42.4 16.8 33.4 4.2 10.3 26.2 35.5 75.7 22.7 49.5 37.4 1.3 8.3 55.3 45.2 62.4 11.8 20.6 34.8 22.4 32.5 9.6 30.8 23.6 22.9 26.6 14.0 67.6 15.2 43.3 13.6 23.9 21.5 26.1 12.4 68.8 23.4 83.8 92.1 30.5 8.3 13.1 24.5 15.0 10.7 8.3 50.9 27.0 45.6 48.8 22.2 25.0 32.6 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015135-109119947 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 29.5 48.0 19.1 12.5 20.6 7.4 20.4 17.9 20.0 21.2 30.1 18.7 12.7 27.6 26.4 23.4 29.5 19.3 43.5 19.9 20.9 46.3 25.4 28.9 15.2 19.3 20.8 18.1 45.7 24.8 65.6 11.4 29.3 19.1 25.8 17.1 27.9 26.4 34.3 35.7 14.3 16.0 34.5 20.2 18.0 17.9 16.9 21.3 17.1 74.8 39.6 11.7 19.0 12.0 19.5 32.3 42.2 30.5 10.3 69.9 39.9 67.0 45.4 35.0 47.9 37.6 56.9 62.9 28.9 45.3 34.7 46.4 49.5 39.1 29.2 56.2 37.8 16.8 36.0 32.2 33.7 30.5 27.5 27.2 42.9 29.2 46.7 42.8 51.5 40.7 31.5 24.4 31.2 55.1 21.2 36.8 12.6 33.9 43.2 37.5 20.8 60.3 18.0 50.8 31.0 16.8 16.4 30.0 29.6 30.2 44.9 39.6 15.4 44.9 37.0 27.7 34.9 52.4 20.6 56.9 9.2 51.5 14.5 54.9 4.4 1.6 1.5 2.4 1.1 2.9 1.5 4.0 3.4 1.6 2.1 5.2 3.6 0.6 3.3 2.4 2.2 4.3 1.8 19.1 20.6 17.9 20.0 19.9 20.9 19.3 20.8 18.1 19.1 20.2 21.3 19.5 55.0 115.4 93.1 36.6 22.4 25.2 18.8 27.4 27.3 43.8 34.4 23.0 135.6 74.4 33.8 86.5 106.3 50.7 20.1 27.0 3.9 22.7 6.7 31.6 24.8 51.8 31.2 70.5 71.4 31.1 17.7 31.3 25.5 56.4 31.6 62.8 74.3 98.3 18.0 63.9 62.0 31.1 10.2 28.4 14.3 7.8 41.0 18.9 23.2 46.9 18.3 52.6 16.5 60.8 75.8 30.0 35.6 51.1 19.7 23.1 55.3 33.7 45.6 32.4 46.0 40.7 37.9 27.4 43.8 21.0 28.4 15.1 28.2 81.4 35.6 21.7 PRUNE2 "A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367" ENSG00000106772 "Prune homolog 2 with BCH domain" Q8WUY3 9 76611376-76906114 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 117.2" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 918.7" "Cancer enhanced" "Detected in many" "renal cancer: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 51.1;LHCN-M2: 83.2;RH-30: 71.5;RPTEC TERT1: 40.1" "Low region specificity" "Detected in all" "HPA022470, HPA031079" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA022470: AB_1845832, HPA031079: AB_10603230" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.43e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-2)" "unprognostic (9.79e-2)" "prognostic favorable (1.37e-6)" "unprognostic (7.75e-2)" "unprognostic (1.06e-1)" "unprognostic (3.25e-3)" "unprognostic (3.80e-4)" 8.7 23.4 30.7 12.0 72.8 3.0 5.3 47.1 55.2 15.0 0.3 80.9 7.1 51.0 18.7 34.3 29.7 16.6 5.0 25.5 46.4 15.5 1.9 5.2 2.8 79.1 52.7 21.6 4.7 4.4 4.1 31.1 4.0 103.8 48.0 18.6 39.4 14.7 65.4 16.8 4.6 27.9 55.8 39.9 4.5 37.4 5.0 48.4 0.9 2.6 57.3 2.6 69.7 14.5 117.2 0.0 0.0 1.5 0.0 51.1 25.8 0.2 1.8 3.6 6.6 14.7 0.4 0.0 0.3 3.9 4.5 13.6 0.0 0.1 0.0 18.0 0.4 2.9 6.3 3.7 0.0 8.5 0.1 0.3 28.7 0.1 26.7 0.7 15.1 14.4 0.4 0.0 20.8 83.2 0.1 4.6 1.8 4.0 0.0 0.0 0.5 71.5 0.3 40.1 0.0 17.4 0.0 0.0 0.3 4.9 2.8 0.1 0.7 11.9 14.2 0.7 34.9 1.2 22.2 3.2 0.0 11.5 0.3 0.0 0.3 0.5 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.2 30.7 72.8 47.1 55.2 25.5 46.4 79.1 52.7 21.6 103.8 39.9 48.4 117.2 0.4 0.0 1.1 27.7 0.0 2.3 0.4 0.5 0.0 47.5 1.2 3.4 11.1 0.0 1.0 11.0 0.0 0.0 1.6 3.5 1.9 0.0 12.6 37.7 4.7 3.7 54.3 0.0 152.4 0.5 0.2 2.9 3.1 34.7 0.0 0.1 21.8 0.2 3.2 15.2 65.4 36.4 4.1 3.1 3.1 30.0 0.9 2.3 5.4 13.1 1.7 9.9 2.1 134.7 918.7 0.4 8.8 1.5 0.1 5.1 9.9 20.3 17.0 6.5 0.0 27.2 9.6 4.3 4.2 0.0 1.4 0.0 0.7 0.5 5.2 0.6 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600811-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 68.8" "Cell type enhanced" "Detected in many" "Astrocytes: 143.0;Cone photoreceptor cells: 212.7;Oligodendrocytes: 240.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 25.2" "Group enriched" "Detected in many" 5 "granulocytes: 25.2;monocytes: 7.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol NA NA 96000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: AB_2681060" "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favorable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 18.2 10.2 23.8 11.6 27.2 19.0 13.7 29.2 26.3 12.1 5.7 6.9 7.1 6.4 5.7 14.1 14.1 8.5 6.4 25.5 31.8 13.6 39.0 20.5 6.6 36.5 34.2 16.7 9.8 5.7 11.6 5.3 5.2 27.1 8.8 6.1 68.8 7.7 6.7 7.3 21.6 7.3 9.0 29.1 15.4 8.1 3.3 34.3 5.7 28.6 8.6 6.2 9.8 7.5 38.1 5.0 19.4 16.7 5.2 22.6 13.9 5.3 5.0 4.4 1.3 1.8 1.1 2.9 18.6 7.4 4.8 6.0 21.2 24.1 8.7 3.6 15.2 6.9 2.5 34.1 8.1 9.6 7.5 15.3 6.5 26.1 8.2 6.6 46.0 11.8 9.9 6.0 8.6 13.9 14.4 14.8 2.7 0.7 11.1 5.2 11.2 18.6 7.9 34.0 16.1 16.4 13.9 6.0 4.8 14.7 2.7 14.5 7.5 13.9 5.0 2.8 18.4 7.7 15.5 19.5 6.0 7.0 8.7 28.8 0.6 7.4 5.1 0.8 2.5 0.3 0.4 0.7 0.6 3.0 0.4 0.6 0.5 25.2 0.5 4.5 0.2 0.7 1.9 23.8 27.2 29.2 26.3 25.5 31.8 36.5 34.2 16.7 27.1 29.1 34.3 38.1 6.5 86.6 65.0 143.0 8.4 27.4 5.6 8.4 25.0 31.5 30.3 12.8 28.2 14.3 15.6 23.9 212.7 0.5 10.8 7.5 0.0 4.0 0.9 11.8 5.8 7.6 6.6 18.9 85.9 5.4 1.9 10.3 14.3 19.3 7.0 8.4 10.0 48.0 5.8 13.5 63.8 4.7 16.2 45.2 13.9 2.7 11.5 41.3 26.6 22.5 107.2 30.9 13.4 93.0 240.7 13.8 8.6 11.7 11.5 8.3 7.4 6.6 6.1 75.4 13.1 26.5 9.3 14.8 7.3 41.3 43.9 1.2 11.4 4.8 5.5 6.2 TRIM14 KIAA0129 ENSG00000106785 "Tripartite motif containing 14" Q14142 9 98069275-98119222 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 75.0;Kupffer cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053217 Uncertain NA NA "HPA053217: AB_2682082" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-1)" "unprognostic (9.80e-2)" "unprognostic (9.00e-2)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (6.63e-2)" "unprognostic (8.61e-3)" "unprognostic (3.55e-3)" "unprognostic (4.57e-2)" 6.5 5.3 8.7 18.6 8.4 12.2 10.1 4.6 8.5 5.2 5.3 19.1 29.7 4.3 1.8 19.6 6.4 9.7 1.6 7.4 9.2 11.1 22.5 15.0 25.8 10.2 7.4 6.0 3.0 3.2 13.6 5.1 5.0 8.0 9.5 17.0 2.7 10.7 5.6 1.0 10.0 30.6 8.8 7.4 27.0 11.7 7.8 8.4 33.0 2.9 1.0 22.0 12.8 9.2 11.1 25.5 12.9 0.6 11.3 0.0 3.9 8.3 14.8 28.1 79.3 67.8 24.8 14.9 33.5 11.8 16.1 47.2 28.6 24.9 16.5 24.1 43.3 20.0 9.9 20.3 24.6 17.1 53.1 10.7 2.4 8.0 11.6 14.8 10.6 10.1 37.4 39.6 15.5 7.3 32.6 42.2 16.7 14.2 56.3 39.5 27.4 1.4 17.2 6.3 15.6 4.0 3.3 20.8 43.2 14.3 2.8 11.4 30.4 7.1 3.3 8.5 1.2 20.5 6.7 8.3 11.1 9.1 41.1 11.4 1.0 14.4 2.1 15.1 28.4 16.1 8.3 17.1 15.7 15.8 5.6 13.1 11.4 4.0 13.0 59.0 15.3 23.1 17.2 8.7 8.4 4.6 8.5 7.4 9.2 10.2 7.4 6.0 8.0 7.4 8.4 11.1 2.1 3.2 8.8 3.3 15.3 2.8 14.3 11.8 15.4 35.1 8.7 8.3 1.0 7.2 14.2 5.5 75.0 5.0 28.8 40.0 3.9 4.9 8.8 4.8 8.9 4.1 12.6 5.9 7.0 13.6 16.9 3.2 13.3 5.4 1.3 12.0 7.5 22.4 15.4 3.3 5.4 15.3 10.2 80.6 2.4 9.9 0.3 32.6 1.8 2.8 16.5 1.9 30.9 12.1 0.9 15.0 13.5 1.5 8.5 19.1 38.1 21.1 17.0 4.4 0.0 1.4 2.0 16.3 3.8 17.3 3.3 3.3 21.3 5.8 19.4 21.1 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192637 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 76.2;Proximal enterocytes: 93.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 11.4;monocytes: 7.8;T-cells: 11.9" "Cell line enhanced" "Detected in many" "BEWO: 66.6;OE19: 56.4;SK-BR-3: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.6 1.7 1.4 5.0 1.5 15.0 4.7 4.8 3.2 6.2 0.2 17.7 34.6 1.6 0.7 15.3 4.7 18.4 0.3 1.4 2.5 1.1 3.3 7.5 2.9 2.9 3.4 1.5 0.3 0.4 2.5 4.0 2.1 3.5 14.4 13.0 1.2 6.2 1.4 0.3 9.4 35.4 2.2 0.7 3.0 11.2 9.3 3.9 5.7 1.2 0.3 5.9 12.9 7.8 4.4 8.4 2.9 0.6 2.0 1.2 1.3 66.6 0.6 0.7 2.1 3.2 19.1 1.4 0.1 9.4 1.2 3.2 23.1 7.7 12.7 1.3 6.9 1.8 0.2 11.6 17.1 2.7 7.9 0.7 0.4 15.4 1.0 18.6 0.7 0.7 10.0 6.8 3.8 0.3 6.3 1.5 7.8 8.6 56.4 2.2 6.1 0.1 0.2 1.3 23.5 1.7 2.4 4.4 45.3 1.6 15.0 5.3 12.8 0.6 0.2 9.7 0.2 2.4 0.7 4.0 0.7 0.5 2.5 2.8 11.2 1.4 11.4 2.4 2.9 5.2 0.6 3.9 3.7 0.5 0.5 2.5 3.3 1.0 1.7 7.8 0.7 11.9 1.5 1.4 1.5 4.8 3.2 1.4 2.5 2.9 3.4 1.5 3.5 0.7 3.9 4.4 2.8 12.8 27.8 0.7 3.1 6.6 18.9 47.2 14.8 2.1 8.5 4.3 1.9 28.6 46.4 0.0 4.2 10.5 2.1 76.2 0.0 4.5 2.6 15.6 11.6 6.0 7.2 0.8 11.6 5.1 42.2 2.2 36.2 19.9 0.0 38.1 0.7 3.8 6.0 1.7 10.5 15.7 20.3 12.0 2.6 3.9 0.0 10.6 0.0 1.0 1.8 0.7 2.1 0.5 0.8 22.6 19.7 0.4 1.4 15.7 93.0 1.7 35.8 1.7 0.0 1.5 3.7 0.5 3.3 29.4 9.9 15.9 10.7 0.2 36.3 30.4 TGFBR1 "ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI" ENSG00000106799 "Transforming growth factor beta receptor 1" P36897 9 99104038-99154192 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 253.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002441, CAB031481, HPA056473" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144" "unprognostic (2.58e-3)" "unprognostic (1.20e-2)" "unprognostic (3.64e-3)" "unprognostic (2.80e-1)" "unprognostic (8.63e-2)" "unprognostic (3.36e-2)" "unprognostic (1.97e-2)" "unprognostic (1.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.01e-3)" "unprognostic (3.40e-2)" "unprognostic (3.19e-2)" "unprognostic (1.14e-2)" 16.1 10.0 9.3 18.3 10.8 34.0 15.5 13.3 11.4 19.6 14.9 16.0 11.8 20.8 8.9 15.1 8.6 21.8 8.1 6.9 16.7 22.8 14.9 16.5 13.9 19.0 14.3 5.3 13.1 8.4 8.6 7.7 49.2 19.0 17.2 13.5 4.8 8.4 17.0 8.8 6.2 9.4 33.3 18.8 16.6 18.6 18.5 14.8 11.3 11.3 13.3 13.7 22.7 8.5 23.7 13.7 19.5 115.5 36.1 26.2 19.3 17.4 44.1 47.8 40.7 44.9 19.9 9.3 29.7 13.4 34.6 32.1 30.4 39.6 34.1 54.0 77.1 12.3 43.9 20.7 17.8 43.2 27.2 102.8 40.2 35.4 62.8 29.5 25.2 7.4 10.9 62.4 12.1 55.4 20.3 4.0 31.0 24.7 12.2 11.5 11.0 253.1 12.5 9.9 3.8 31.1 36.2 34.3 150.2 46.4 47.3 28.1 36.6 13.6 29.8 25.5 129.3 27.3 12.1 13.4 20.0 62.5 45.9 26.2 16.2 2.4 9.5 7.8 1.6 6.7 1.6 3.3 5.8 2.0 1.2 3.2 6.2 4.9 4.3 2.0 1.4 2.4 2.2 9.3 10.8 13.3 11.4 6.9 16.7 19.0 14.3 5.3 19.0 18.8 14.8 23.7 13.5 6.4 8.8 18.9 18.9 23.6 7.4 19.9 44.3 8.0 18.9 11.7 7.6 4.3 12.8 60.7 0.0 23.0 37.3 5.0 0.0 18.8 128.4 6.4 22.7 17.6 9.6 7.4 14.2 31.2 6.7 36.0 9.2 9.3 29.9 19.5 6.4 12.7 49.4 0.0 8.6 7.3 8.2 32.4 52.5 101.7 9.6 39.7 35.6 116.2 24.3 3.1 35.0 45.8 21.1 33.8 4.2 13.5 11.9 18.4 3.6 13.8 5.0 2.0 32.9 21.8 20.9 11.0 12.7 25.6 16.2 19.4 25.4 7.6 8.3 11.5 SEC61B ENSG00000106803 "SEC61 translocon subunit beta" P60468 9 99222064-99230615 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 1573.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049407 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049407: AB_2680750" "unprognostic (1.11e-1)" "unprognostic (5.99e-3)" "unprognostic (3.46e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.96e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.09e-1)" "unprognostic (6.67e-2)" "unprognostic (1.87e-2)" "unprognostic (2.90e-2)" "unprognostic (7.07e-2)" "unprognostic (1.22e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-1)" "unprognostic (6.87e-2)" "unprognostic (2.75e-1)" 158.6 237.7 96.6 156.1 99.2 257.7 154.7 99.6 121.7 180.3 100.6 140.6 156.4 169.2 261.7 171.2 156.3 131.0 102.0 98.7 115.3 193.7 469.1 170.5 185.5 100.4 98.5 93.5 159.9 550.6 147.1 211.2 99.2 100.0 169.5 103.8 48.9 350.7 125.4 61.5 122.2 134.0 107.2 103.5 174.5 188.0 77.0 101.2 190.5 181.4 44.6 147.9 150.2 140.3 104.7 226.5 213.3 244.1 243.7 234.5 296.0 293.9 327.6 335.8 299.9 259.2 307.3 172.6 305.3 244.3 298.7 328.9 272.0 171.9 259.5 143.1 325.4 238.7 160.7 200.7 440.3 509.9 278.9 198.3 268.0 389.4 237.3 210.3 268.1 369.8 246.7 255.0 581.1 285.6 407.7 255.6 404.9 196.3 533.9 497.7 244.2 207.7 398.1 332.3 158.3 252.7 179.2 183.6 421.1 441.5 190.8 163.4 378.6 265.1 215.3 260.0 363.5 277.7 312.0 226.6 200.7 359.3 176.6 145.6 875.3 460.3 453.3 354.6 387.9 480.8 356.5 389.3 360.4 481.0 257.1 242.9 267.7 388.5 325.7 350.8 1661.8 388.0 525.0 96.6 99.2 99.6 121.7 98.7 115.3 100.4 98.5 93.5 100.0 103.5 101.2 104.7 255.6 102.5 206.1 18.3 370.9 395.8 308.3 712.8 213.9 59.3 499.1 530.7 55.5 271.7 416.8 200.5 31.3 336.6 605.9 239.9 633.9 498.6 184.2 274.7 410.2 286.1 302.0 226.8 16.2 792.5 577.9 343.2 214.1 391.3 214.8 258.8 213.8 822.0 509.8 53.8 15.5 534.0 406.9 295.3 553.2 51.8 328.0 316.3 496.2 17.8 1573.9 197.3 284.2 15.6 25.9 633.4 280.0 304.3 1190.6 654.2 290.3 767.6 331.4 81.5 138.1 237.1 404.7 218.4 171.0 337.5 443.4 553.8 270.1 333.0 334.0 501.5 C5 "C5a, C5b, CPAMD4" ENSG00000106804 "Complement C5" P01031 9 120952335-121050275 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 437.3" "Cell type enriched" "Detected in many" 16 "Hepatocytes: 538.3" "Cancer enriched" "Detected in many" 17 "liver cancer: 73.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 28.4;Hep G2: 30.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA029339 Supported "Secreted to blood" NA NA 113000000000 39000000000 "HPA029339: AB_10601125" "unprognostic (2.51e-1)" "unprognostic (5.88e-3)" "unprognostic (2.50e-3)" "unprognostic (1.57e-2)" "unprognostic (5.05e-2)" "unprognostic (9.52e-3)" "prognostic favorable (9.43e-4)" "unprognostic (1.83e-1)" "unprognostic (3.19e-2)" "unprognostic (1.55e-1)" "unprognostic (2.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.46e-5)" "unprognostic (5.91e-2)" "unprognostic (1.20e-1)" "unprognostic (3.67e-2)" "unprognostic (2.75e-1)" 3.0 1.7 2.9 1.2 3.5 2.2 2.5 2.6 2.6 3.0 3.5 2.3 3.9 2.8 2.7 1.7 3.0 1.5 1.1 2.2 3.0 4.8 437.3 7.1 2.1 3.3 2.9 2.1 3.3 15.0 2.6 3.2 0.9 3.2 3.2 1.6 3.5 1.4 2.2 0.5 3.8 4.0 2.0 2.9 1.5 5.8 1.7 2.7 1.2 2.0 1.2 1.7 2.6 2.1 4.7 1.6 28.4 6.4 11.3 8.0 9.2 0.2 3.4 3.5 0.9 2.0 0.8 2.8 4.1 0.1 1.8 3.8 11.0 0.3 0.3 1.5 0.9 0.0 1.8 1.5 30.4 1.5 1.0 0.7 4.1 0.5 2.0 3.7 1.8 1.0 1.6 0.7 3.8 2.2 5.6 0.4 0.2 1.7 7.0 10.9 2.5 2.8 0.4 1.7 0.8 1.6 6.5 1.6 0.0 2.7 4.4 2.2 3.7 1.3 2.8 0.2 7.5 3.4 2.3 1.8 1.7 2.2 3.8 6.8 0.0 0.3 0.4 0.0 0.0 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 3.5 2.6 2.6 2.2 3.0 3.3 2.9 2.1 3.2 2.9 2.7 4.7 0.8 6.4 28.6 30.0 3.5 1.0 1.0 0.5 1.8 4.8 2.2 1.3 0.8 32.9 7.1 1.8 0.0 0.1 0.1 0.4 1.9 0.2 1.8 1.1 2.2 1.4 0.0 12.0 7.3 0.4 0.0 2.9 2.0 0.8 0.0 3.1 7.5 538.3 1.9 6.7 9.4 1.0 0.0 16.3 1.0 2.8 3.1 3.5 0.0 6.5 2.3 3.2 2.1 25.6 25.4 0.7 3.8 9.1 0.1 0.7 1.0 6.8 3.8 2.6 0.0 4.0 1.6 7.5 2.5 2.0 1.3 0.0 1.4 2.8 2.0 0.6 OGN "mimecan, OIF, SLRR3A" ENSG00000106809 Osteoglycin P20774 9 92383268-92404696 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 217.9" "Group enriched" "Detected in many" 8 "Endometrial stromal cells: 104.1;Fibroblasts: 326.2;Leydig cells: 166.2;Peritubular cells: 212.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "T-reg: 1.7" "Lineage enriched" "Detected in single" 9 "T-cells: 1.7" "Group enriched" "Detected in some" 4 "ASC TERT1: 22.2;HSkMC: 9.7;JURKAT: 15.7;MOLT-4: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013132 Approved Supported "Endoplasmic reticulum" "Secreted in other tissues" NA NA 170000000 "Endoplasmic reticulum" "HPA013132: AB_1854825" "unprognostic (2.31e-1)" "unprognostic (3.94e-3)" "unprognostic (1.74e-1)" "unprognostic (2.08e-2)" "unprognostic (2.60e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-4)" "unprognostic (4.42e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.47e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.37e-3)" "unprognostic (3.86e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (2.03e-4)" 52.6 22.7 2.4 6.0 2.3 0.2 54.3 4.4 6.8 217.9 16.3 33.8 10.7 131.7 45.3 31.1 67.7 166.2 80.5 1.6 4.6 6.4 4.2 18.8 2.1 1.8 2.1 1.0 92.7 11.2 118.0 19.2 22.9 2.4 58.4 32.5 0.0 3.3 19.4 2.6 3.0 23.8 119.0 2.1 2.4 22.2 13.5 1.9 4.5 14.9 22.2 5.7 54.6 23.5 3.2 0.0 0.0 0.0 0.0 4.4 22.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 9.7 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.1 32.2 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 2.4 2.3 4.4 6.8 1.6 4.6 1.8 2.1 1.0 2.4 2.1 1.9 3.2 10.3 6.4 1.5 1.0 0.4 4.2 0.1 0.0 1.2 0.6 0.7 0.4 2.6 10.0 7.4 3.7 0.0 2.0 0.6 0.1 0.0 0.0 1.2 2.9 104.1 5.2 0.0 0.0 1.9 0.0 1.7 326.2 7.7 1.7 1.3 0.0 20.0 0.1 4.6 0.0 1.8 0.0 0.0 0.3 11.1 4.2 166.2 2.3 1.8 16.9 0.2 0.1 0.0 2.0 1.6 0.0 0.0 212.1 0.7 0.4 0.0 0.0 2.9 0.2 6.6 4.7 22.7 0.6 0.6 0.7 4.5 5.7 2.1 1.6 0.0 0.2 ASPN "FLJ20129, PLAP-1, SLRR1C" ENSG00000106819 Asporin Q9BXN1 9 92456205-92482506 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 96.2;smooth muscle: 111.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in all" "breast cancer: 51.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 2.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007894, HPA008435, HPA024230" Approved Uncertain Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 2100000 Nucleoplasm Cytosol "HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (8.13e-3)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (1.01e-2)" "unprognostic (9.50e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-3)" "unprognostic (6.38e-2)" "unprognostic (3.70e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.42e-3)" "unprognostic (3.04e-2)" "unprognostic (6.27e-3)" "unprognostic (2.48e-2)" 29.8 7.6 1.2 5.7 1.4 0.1 12.0 2.2 3.3 41.2 3.5 18.9 9.6 70.3 9.8 10.2 17.0 66.5 96.2 1.1 1.0 11.3 41.4 14.4 3.0 1.3 1.4 0.9 7.1 13.5 3.9 2.6 4.3 1.6 4.8 11.4 0.2 3.3 11.8 7.8 12.2 17.8 111.5 0.8 2.3 12.1 1.2 1.3 2.5 11.2 20.0 5.6 13.5 5.1 1.3 0.1 0.0 0.0 0.0 1.4 16.0 0.2 2.6 5.7 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 23.2 0.2 0.0 4.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 1.2 1.4 2.2 3.3 1.1 1.0 1.3 1.4 0.9 1.6 0.8 1.3 1.3 12.9 0.0 1.1 0.3 0.1 67.2 0.1 0.0 0.0 0.4 0.4 0.1 8.5 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 4.2 6.8 0.0 0.0 2.0 0.0 0.1 94.6 0.5 0.2 1.3 0.1 13.9 0.4 0.2 0.0 1.7 0.0 0.0 0.0 13.5 0.6 5.9 0.8 14.2 24.4 0.0 0.1 0.0 1.5 1.1 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.7 0.6 39.5 4.3 73.5 0.0 0.1 0.3 27.0 0.0 1.7 0.3 0.0 0.0 ECM2 ENSG00000106823 "Extracellular matrix protein 2" O94769 9 92493554-92536655 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 123.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035347, HPA035348" Approved Approved "Mitotic spindle,Centrosome,Cytosol" "Secreted to extracellular matrix" Yes NA 10000000 "Centrosome, Cytosol" "Mitotic spindle" "HPA035347: AB_10669856, HPA035348: " "unprognostic (2.48e-1)" "unprognostic (2.11e-1)" "unprognostic (2.27e-2)" "unprognostic (2.20e-2)" "unprognostic (5.35e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.50e-5)" "unprognostic (6.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.12e-3)" "unprognostic (2.39e-2)" "unprognostic (3.80e-2)" "unprognostic (6.63e-3)" 123.2 14.4 7.6 2.1 4.8 0.6 35.1 5.9 5.6 43.9 12.1 6.9 9.1 41.2 23.4 9.0 30.3 32.0 31.8 4.3 25.9 28.7 82.2 22.7 8.4 5.1 8.8 2.1 92.4 6.3 9.1 6.2 3.5 5.7 21.4 7.5 0.4 7.3 22.5 7.4 9.8 14.9 28.0 4.7 0.9 4.3 16.9 9.0 5.0 11.5 24.8 7.9 13.4 11.2 12.1 0.7 0.1 0.4 0.0 19.1 34.5 1.3 0.8 1.1 0.1 0.5 0.6 0.0 0.0 0.1 1.9 0.3 0.5 0.9 0.8 0.1 4.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 36.8 42.8 0.9 11.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.1 0.0 0.1 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 4.8 5.9 5.6 4.3 25.9 5.1 8.8 2.1 5.7 4.7 9.0 12.1 12.9 0.0 2.3 5.5 0.3 11.5 0.1 0.6 0.6 3.0 0.3 1.3 5.5 1.5 2.0 0.0 2.1 0.1 0.3 0.2 0.0 0.1 5.1 0.6 18.6 5.2 0.0 0.8 3.4 0.0 16.2 73.3 0.5 0.5 0.0 18.2 2.2 49.3 0.4 0.0 2.8 0.4 0.0 1.3 15.4 8.9 122.1 1.1 5.4 17.8 0.1 0.1 0.0 0.5 2.9 0.0 0.2 69.6 1.4 0.1 11.1 9.2 3.3 2.5 26.3 43.6 50.2 0.9 0.6 0.9 9.1 0.8 0.9 13.5 0.6 0.2 TLE4 "E(spl), ESG, GRG4" ENSG00000106829 "TLE family member 4, transcriptional corepressor" Q04727 9 79571773-79726882 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.0" "Cell type enhanced" "Detected in all" "Early spermatids: 818.9;Late spermatids: 1315.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 24.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 99.9;BJ hTERT+: 98.7;BJ hTERT+ SV40 Large T+: 89.4;fHDF/TERT166: 154.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065357 Supported Nucleoplasm NA NA Nucleoplasm "HPA065357: AB_2685479" "unprognostic (6.68e-2)" "unprognostic (8.50e-3)" "unprognostic (2.13e-3)" "unprognostic (2.92e-1)" "unprognostic (1.91e-1)" "unprognostic (9.79e-2)" "unprognostic (1.24e-2)" "unprognostic (4.83e-1)" "unprognostic (2.83e-1)" "unprognostic (1.62e-1)" "unprognostic (9.94e-3)" "unprognostic (1.04e-1)" "prognostic favorable (6.94e-4)" "unprognostic (1.49e-1)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" 8.7 15.9 21.9 16.6 44.5 68.5 8.8 22.9 26.5 9.6 17.9 9.9 8.5 14.4 6.0 17.8 13.0 16.8 8.0 27.8 23.7 6.9 5.6 12.6 16.0 30.8 21.7 15.7 32.6 6.5 10.7 24.4 19.8 30.7 5.7 10.6 24.9 11.0 8.5 23.3 19.1 11.4 14.6 29.8 18.7 14.2 109.0 29.3 28.1 10.5 10.4 20.1 18.9 12.9 65.3 0.0 19.0 70.7 0.5 11.4 9.6 21.2 99.9 98.7 89.4 34.4 2.8 10.3 7.4 0.2 154.3 13.7 20.8 5.0 18.3 39.2 38.2 30.8 0.0 9.1 0.4 13.8 21.4 13.0 11.3 12.6 26.1 5.2 25.2 23.9 14.0 1.5 21.3 28.6 0.7 29.4 9.4 22.5 11.9 4.8 25.7 35.9 7.4 5.5 2.7 28.5 41.5 14.7 1.9 0.1 32.8 0.0 25.1 36.4 34.8 0.1 0.8 5.0 14.4 25.0 10.9 12.3 18.0 16.6 24.2 4.4 17.1 4.8 6.3 5.9 1.3 2.5 3.6 2.9 1.7 1.5 2.5 11.7 3.2 4.9 1.0 0.8 2.6 21.9 44.5 22.9 26.5 27.8 23.7 30.8 21.7 15.7 30.7 29.8 29.3 65.3 108.9 6.4 19.4 77.4 91.9 121.0 57.2 50.6 167.4 76.8 76.0 92.8 15.9 84.4 45.6 14.7 127.2 77.2 228.1 163.5 3.9 13.4 818.9 262.0 230.0 59.7 25.2 22.3 150.8 22.0 67.1 71.4 137.1 158.7 21.0 34.8 53.2 14.1 51.1 218.7 33.3 117.3 61.1 167.9 70.4 1315.5 105.6 101.7 42.7 77.8 75.3 31.0 88.6 301.6 381.0 31.7 207.6 46.6 152.7 37.8 122.0 18.1 50.4 290.2 72.3 280.7 83.9 38.3 146.0 140.0 90.8 65.0 141.0 86.8 96.0 99.9 LHX6 LHX6.1 ENSG00000106852 "LIM homeobox 6" Q9UPM6 9 122202577-122229626 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 13.9" "Cell type enhanced" "Detected in some" "Early spermatids: 77.2;Endothelial cells: 32.1;Inhibitory neurons: 46.0;Late spermatids: 225.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 13.2;K-562: 9.8;NB-4: 18.4;PC-3: 12.3;U-87 MG: 9.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 6.5;basal ganglia: 7.1;cerebral cortex: 7.7;hippocampal formation: 7.2;hypothalamus: 2.2" "HPA047854, HPA058319" Approved Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA047854: AB_2680183, HPA058319: " "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (8.06e-2)" "unprognostic (6.18e-2)" "unprognostic (7.72e-2)" "unprognostic (4.49e-2)" "unprognostic (5.83e-2)" "unprognostic (3.47e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" "unprognostic (9.14e-2)" "unprognostic (5.64e-6)" "unprognostic (1.77e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" 13.9 0.8 5.7 1.9 7.1 0.0 11.9 0.0 6.2 3.8 0.0 3.3 1.1 3.5 0.6 2.1 3.5 2.8 4.6 5.4 9.4 1.6 0.2 3.6 1.0 0.8 0.6 4.8 2.0 1.1 0.9 0.3 2.8 2.1 2.5 1.3 0.1 2.3 0.9 2.3 2.6 3.4 3.3 0.1 0.1 2.3 5.7 1.4 0.7 3.3 2.8 1.0 5.6 4.1 2.5 2.7 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 13.2 3.3 0.0 2.8 0.0 1.1 0.0 1.4 3.6 0.0 0.0 2.1 0.1 1.0 0.6 0.0 2.5 0.6 0.0 0.8 0.0 0.2 0.0 4.7 0.7 9.8 0.0 0.0 2.8 0.0 18.4 2.8 0.4 12.3 0.0 6.2 0.0 2.2 0.0 1.9 0.4 3.3 1.0 3.3 0.5 2.7 0.0 0.8 0.8 1.3 0.0 0.2 0.3 0.2 0.2 9.6 4.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 7.1 0.0 6.2 5.4 9.4 0.8 0.6 4.8 2.1 0.1 1.4 2.5 13.7 0.0 0.0 0.7 0.0 0.1 0.2 3.6 1.8 0.0 1.3 1.5 2.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.2 0.2 0.1 32.1 0.0 2.7 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 46.0 0.0 0.0 0.3 0.3 225.9 1.2 0.1 0.0 5.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.9 2.5 6.7 0.5 0.3 0.0 0.0 0.1 0.0 0.2 PTGR1 "LTB4DH, ZADH3" ENSG00000106853 "Prostaglandin reductase 1" Q14914 9 111549722-111599893 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 280.8;liver: 599.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 791.5;Proximal enterocytes: 1230.1;Proximal tubular cells: 581.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 5.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.9" "Cell line enhanced" "Detected in many" "OE19: 909.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036724 Enhanced NA NA 2400000 "HPA036724: AB_10670239" "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (1.10e-2)" "unprognostic (3.02e-3)" "unprognostic (8.46e-2)" "unprognostic (1.02e-3)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (3.48e-1)" "prognostic favorable (5.53e-4)" "unprognostic (2.25e-1)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" 45.3 88.4 12.8 11.6 15.2 3.1 37.5 14.5 20.4 36.2 16.0 37.7 235.0 32.7 39.4 112.9 72.2 76.0 29.4 21.0 15.9 236.5 599.0 22.3 7.3 11.7 13.4 12.7 25.3 16.8 44.3 23.5 15.4 12.4 60.9 34.2 22.8 47.9 31.4 13.1 31.3 280.8 38.4 10.9 8.0 86.7 8.3 14.0 6.4 28.2 29.3 31.9 89.6 44.8 13.2 49.1 207.1 60.6 0.1 220.1 220.4 45.1 79.4 121.8 74.4 81.2 52.9 67.4 0.1 22.9 78.0 153.9 60.7 47.5 83.4 90.3 0.1 15.4 12.5 129.3 279.0 50.4 7.4 25.6 157.3 127.3 99.8 51.1 88.2 201.0 0.0 8.7 0.1 148.5 16.1 0.4 2.0 22.8 909.3 49.8 0.2 17.1 1.4 82.8 152.8 68.4 3.4 98.9 30.0 31.7 59.6 94.6 34.8 161.8 15.4 29.3 169.7 15.0 0.1 0.5 0.3 72.0 0.1 18.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.3 12.8 15.2 14.5 20.4 21.0 15.9 11.7 13.4 12.7 12.4 10.9 14.0 13.2 28.9 19.2 28.3 16.6 4.3 38.6 57.6 135.5 66.6 18.7 43.7 41.4 37.4 271.7 78.4 141.6 25.0 47.0 6.4 34.4 150.6 73.4 4.2 100.3 36.2 26.1 26.5 18.7 38.4 178.3 32.5 48.6 174.3 89.3 1.3 35.0 49.6 791.5 53.4 0.0 31.2 76.1 59.0 26.8 16.7 3.6 33.2 15.9 35.6 12.2 22.6 47.0 0.0 17.1 16.1 139.6 86.3 39.5 0.5 63.8 1230.1 581.3 80.3 46.4 13.1 17.4 61.8 15.2 5.3 242.9 30.5 20.5 5.8 46.8 145.9 156.5 SUSD1 DKFZP761E1824 ENSG00000106868 "Sushi domain containing 1" Q6UWL2 9 112040783-112175297 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 25.2;Kupffer cells: 31.2;NK-cells: 25.7;Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 11.0;plasmacytoid DC: 44.2" "Group enriched" "Detected in many" 5 "dendritic cells: 44.2;granulocytes: 11.0" "Cell line enhanced" "Detected in many" "HDLM-2: 50.7;HEL: 56.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048554 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 2300000 Nucleoplasm "HPA048554: AB_2680439" "unprognostic (2.25e-1)" "unprognostic (4.02e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (9.29e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.73e-2)" "unprognostic (1.23e-2)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "prognostic favorable (3.63e-6)" "unprognostic (2.14e-3)" "unprognostic (8.38e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" 8.0 9.0 2.0 8.8 2.9 14.2 4.5 0.0 3.4 5.9 1.8 9.0 7.4 3.3 3.7 2.7 4.2 6.5 4.8 2.2 6.7 12.2 3.5 9.7 8.7 2.7 4.4 3.7 1.2 4.0 9.0 4.0 15.4 4.8 4.8 9.5 3.3 5.4 5.4 1.4 1.9 8.7 8.1 2.6 8.3 10.6 4.7 5.2 6.0 4.1 2.1 5.9 12.1 2.2 2.7 2.8 18.7 12.9 0.0 9.4 6.2 41.1 11.8 15.8 16.3 20.8 37.3 24.5 0.3 13.0 20.7 1.1 8.4 4.7 2.1 12.1 50.7 3.9 56.3 13.0 25.7 11.4 14.9 17.4 7.8 1.7 9.0 0.3 11.1 38.9 8.1 31.5 2.3 10.4 3.5 2.1 9.2 4.2 46.1 3.0 12.6 3.0 0.0 3.9 9.7 4.5 10.8 6.5 1.4 0.1 7.1 2.2 16.2 29.7 0.3 6.0 1.8 0.1 0.7 0.7 1.0 11.1 5.8 3.6 6.1 2.4 11.0 2.7 2.9 0.8 0.1 0.7 1.9 1.7 0.3 0.3 1.9 0.9 3.1 5.3 44.2 0.2 2.0 2.0 2.9 0.0 3.4 2.2 6.7 2.7 4.4 3.7 4.8 2.6 5.2 2.7 3.1 0.0 4.8 1.6 3.4 0.5 1.7 1.6 0.0 0.3 2.4 1.0 2.0 1.5 4.5 12.9 0.0 9.0 24.3 7.0 0.0 7.0 1.8 6.0 5.4 2.9 4.2 3.0 25.2 7.1 10.5 5.0 8.6 7.8 5.7 4.5 7.1 0.4 16.3 0.0 21.9 4.3 2.0 31.2 6.0 1.8 0.0 21.5 0.0 13.1 19.8 0.3 25.7 38.2 1.2 11.1 3.4 1.9 1.4 2.6 2.7 2.9 5.3 1.4 0.0 4.0 3.9 0.5 0.4 1.8 0.9 8.6 6.1 1.2 6.4 9.5 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078328 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "liver: 11037.4" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 10517.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 173 "Hep G2: 1398.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 47000000000 Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.5 0.2 0.1 0.0 0.1 0.0 6.5 0.3 0.4 0.1 0.2 0.3 2.3 0.1 0.4 0.3 0.4 161.9 0.4 0.1 0.3 11.1 11037.4 0.3 0.1 0.1 0.1 0.1 0.2 126.4 0.0 0.2 0.4 0.1 0.2 0.5 0.2 0.1 0.0 0.2 0.2 0.7 0.0 0.1 3.1 2.6 1.0 0.1 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.0 6.7 0.1 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 1.8 0.0 1.8 2.1 0.2 0.9 0.5 0.0 0.0 0.0 3.2 0.0 3.0 1.0 1398.1 0.0 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.3 0.0 0.9 3.1 0.0 0.2 8.1 0.4 5.9 0.6 1.7 0.0 2.8 1.1 0.0 0.1 0.0 0.2 1.0 0.0 0.8 0.0 0.4 1.0 0.3 1.5 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.5 0.0 19.1 1.5 0.6 0.0 2.2 0.0 1.9 0.4 0.2 2585.0 0.6 1.8 0.0 0.1 0.0 0.6 3.9 216.5 30.4 0.2 0.1 10.0 2.4 219.2 0.1 28.2 0.8 0.1 0.0 1.0 0.0 0.0 181.3 10517.4 0.7 0.0 0.1 1.6 0.0 243.7 0.5 59.4 0.6 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 14.9 1.7 0.0 0.0 0.6 0.6 13.7 0.0 0.0 0.0 0.0 0.5 0.6 0.2 1.1 0.4 1.4 14.3 0.0 1.2 0.3 AKNA KIAA1968 ENSG00000106948 "AT-hook transcription factor" Q7Z591 9 114334156-114394405 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 148.0;dendritic cells: 240.0;NK-cells: 265.7;Plasma cells: 137.3;Rod photoreceptor cells: 140.1;T-cells: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 108.4;MOLT-4: 98.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052367, HPA063993" Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA052367: AB_2681801, HPA063993: AB_2685169" "unprognostic (5.19e-3)" "prognostic favorable (1.22e-4)" "unprognostic (5.38e-3)" "prognostic favorable (2.14e-5)" "unprognostic (3.12e-1)" "prognostic favorable (1.25e-4)" "unprognostic (1.88e-1)" "unprognostic (3.28e-2)" "unprognostic (4.13e-2)" "unprognostic (6.62e-2)" "unprognostic (5.85e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.19e-2)" "unprognostic (6.61e-3)" "unprognostic (2.93e-1)" "prognostic favorable (2.29e-4)" 23.0 8.5 18.0 55.0 13.2 51.0 19.1 12.9 12.1 43.1 18.6 16.4 16.3 37.5 5.9 8.9 37.7 14.8 7.8 9.5 14.6 9.6 19.3 32.2 83.0 18.0 16.9 8.1 28.2 10.5 2.9 11.5 8.6 17.2 17.0 12.0 36.3 9.3 11.1 3.1 7.8 52.9 22.8 17.2 111.5 21.6 7.9 14.3 75.9 11.6 3.6 62.1 17.8 18.4 15.0 4.7 4.8 5.9 3.7 36.9 4.4 25.1 5.0 6.2 4.8 4.0 7.8 4.9 57.9 4.7 4.3 8.2 10.7 3.7 1.4 1.3 108.4 2.3 6.0 2.4 5.6 42.2 57.5 59.5 8.0 8.1 4.0 3.8 6.7 8.7 49.9 5.3 61.9 2.0 7.5 98.0 63.2 20.1 10.2 5.8 60.4 1.0 12.8 40.3 2.3 2.7 5.2 1.3 4.0 13.4 6.3 11.5 29.2 14.2 2.2 4.8 0.8 4.2 12.5 15.4 47.0 2.8 27.6 2.2 11.5 7.9 12.6 18.9 5.7 14.8 7.6 10.3 16.9 5.0 7.9 9.0 12.1 19.6 14.6 5.5 10.5 8.7 10.3 18.0 13.2 12.9 12.1 9.5 14.6 18.0 16.9 8.1 17.2 17.2 14.3 15.0 13.5 12.8 22.8 2.6 76.0 5.2 6.9 1.6 6.2 36.4 7.4 5.3 4.1 4.3 8.3 23.9 148.0 9.5 240.0 9.5 0.0 3.7 17.5 34.8 14.4 9.7 12.7 34.3 2.6 8.1 6.2 8.8 17.9 12.4 33.5 16.6 12.1 9.6 18.2 5.0 8.4 18.9 2.0 59.1 31.5 26.2 14.6 43.0 5.4 19.7 67.2 7.0 265.7 20.1 4.9 5.4 9.2 6.8 137.3 7.8 12.6 0.9 40.7 140.1 0.0 5.8 13.6 1.1 0.9 1.9 3.4 3.4 145.7 2.8 13.4 9.3 TNFSF8 "CD153, CD30LG" ENSG00000106952 "TNF superfamily member 8" P32971 9 114893343-114930595 "Cancer-related genes, CD markers, Predicted membrane proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.9;lymphoid tissue: 27.1" "Cell type enhanced" "Detected in some" "B-cells: 8.2;dendritic cells: 6.5;Kupffer cells: 6.5;Macrophages: 8.4;Microglial cells: 5.6;monocytes: 5.4;Plasma cells: 9.3;T-cells: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 50.9;SuSa: 23.3;U-698: 40.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.82e-2)" "unprognostic (6.56e-3)" "unprognostic (7.79e-2)" "unprognostic (6.05e-2)" "unprognostic (2.67e-1)" "unprognostic (5.58e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-1)" "unprognostic (1.70e-1)" "unprognostic (2.02e-1)" "unprognostic (4.75e-2)" "unprognostic (3.01e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-2)" "unprognostic (1.82e-1)" 3.3 1.4 0.4 14.0 0.7 18.9 2.0 0.5 0.8 1.9 1.0 2.0 0.7 0.8 1.8 1.7 0.8 5.0 0.9 0.4 1.2 0.8 2.2 2.6 23.6 0.8 0.6 0.2 0.7 0.8 0.4 0.2 2.8 0.8 0.7 2.4 0.0 0.7 0.6 0.2 0.3 5.1 1.8 0.9 7.5 2.5 0.3 1.2 27.1 0.8 0.4 22.4 6.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 40.8 0.0 0.0 0.0 0.0 20.8 0.0 6.0 10.1 19.8 1.8 23.7 14.1 10.7 2.4 26.2 19.6 6.2 1.8 1.4 6.5 9.8 13.0 0.4 0.7 0.5 0.8 0.4 1.2 0.8 0.6 0.2 0.8 0.9 1.2 1.1 0.2 0.0 0.0 0.0 8.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.5 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.4 0.1 0.0 0.0 0.5 1.1 0.0 1.3 0.0 0.7 0.1 3.7 0.0 0.1 0.0 0.0 6.5 4.8 0.0 0.0 8.4 0.0 5.6 5.4 0.0 2.1 0.0 0.1 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 29.3 0.0 0.0 0.0 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 326.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 126.9;U-87 MG: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910" Enhanced NA NA 8800 "CAB005920: , HPA049910: AB_2680948" "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 18.7 8.0 63.6 3.7 141.0 2.0 13.3 15.7 326.3 30.7 0.0 7.9 1.9 8.9 2.4 5.6 9.5 13.5 7.4 132.4 111.8 14.1 5.3 4.7 2.4 65.8 41.3 153.2 2.5 8.5 4.1 33.8 2.6 76.5 9.0 2.8 68.8 9.0 3.0 3.2 14.5 9.1 5.4 0.0 1.0 5.0 4.9 45.9 0.9 5.3 4.0 1.8 10.7 21.8 191.9 8.7 126.9 11.3 2.8 3.6 36.8 0.6 8.0 18.9 15.7 6.5 1.7 2.6 0.2 10.7 16.7 0.6 15.3 1.8 0.8 8.6 0.1 12.1 8.3 19.5 0.5 2.6 1.1 5.6 9.8 0.2 12.4 0.2 15.2 0.0 7.3 3.1 0.5 0.0 3.6 0.7 2.7 12.2 2.2 23.1 15.6 0.4 3.9 2.4 0.0 16.1 27.1 27.1 0.8 1.2 1.4 0.3 11.2 0.6 0.5 34.8 36.2 16.6 1.0 0.4 0.8 46.8 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.6 141.0 15.7 326.3 132.4 111.8 65.8 41.3 153.2 76.5 0.0 45.9 191.9 2.2 0.0 0.0 18.9 0.9 7.9 1.7 0.3 8.0 112.4 2.9 3.9 2.0 5.7 0.8 0.0 89.6 0.3 0.2 0.4 1.9 0.8 0.9 1.3 19.0 1.8 0.0 0.0 176.1 0.9 0.4 24.3 2.6 1.4 1.3 2.8 0.7 0.6 10.6 50.5 182.2 0.9 0.0 0.6 10.5 1.0 2.8 9.2 3.6 22.5 1.3 10.7 0.0 33.7 14.3 0.6 5.0 1.5 0.7 0.8 2.5 5.3 1.1 78.4 0.0 2.1 3.8 1.0 1.8 2.5 7.5 0.8 1.6 2.1 1.6 0.8 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815013-127854658 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 452.6" "Cell type enhanced" "Detected in many" "Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1" "Group enriched" "Detected in many" 4 "dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" NA NA 280000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favorable (6.61e-4)" "prognostic favorable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 220.4 93.3 42.0 80.9 37.5 19.0 166.2 42.2 45.2 114.5 57.2 60.9 33.5 112.1 35.4 43.5 123.4 59.2 452.6 33.4 41.4 210.2 61.2 263.0 43.8 49.5 43.9 25.5 222.8 47.5 30.0 56.6 94.4 46.4 94.7 17.7 2.2 46.6 74.2 72.9 48.5 77.4 66.3 38.8 228.3 58.0 99.7 53.0 17.4 170.6 55.3 17.8 93.8 96.7 48.3 1.3 1.0 7.1 0.4 117.8 81.0 217.8 147.1 102.0 74.4 43.4 0.5 1.3 1.0 70.2 263.8 56.8 2.4 0.0 23.2 24.5 0.7 0.3 42.3 76.7 4.6 91.7 20.2 0.5 137.6 5.4 97.7 34.9 1.0 487.4 1.4 0.7 1.4 88.1 0.9 0.6 1.8 1.7 0.3 4.2 66.9 12.5 1.4 0.0 0.4 0.8 1.8 78.0 65.3 20.1 4.7 13.8 29.8 1027.5 248.1 13.7 164.7 0.7 5.2 1.2 0.9 67.1 52.0 83.2 0.0 19.9 0.5 1.8 28.2 0.6 0.6 3.0 3.4 10.3 1.4 1.9 3.0 0.5 7.6 22.1 3.8 1.2 8.4 42.0 37.5 42.2 45.2 33.4 41.4 49.5 43.9 25.5 46.4 38.8 53.0 48.3 407.5 3.2 16.0 2.0 9.2 12.0 2.3 2.1 2.8 2.8 9.5 9.8 28.4 18.6 2.3 3.7 4.2 30.0 8.6 0.4 0.0 10.2 8.6 7.7 67.9 514.4 2.4 49.2 0.6 1.1 294.4 85.7 3.1 8.1 15.2 0.8 579.0 9.8 132.0 0.0 0.7 1.6 0.0 65.4 29.7 51.4 487.1 56.6 24.9 78.7 36.2 2.0 4.1 1.5 1.1 1.4 0.0 1421.8 2.1 2.0 0.0 0.3 5.1 4.6 72.3 44.0 57.5 4.4 5.2 1.3 8.4 376.4 9.6 308.1 0.5 1.4 AK1 ENSG00000106992 "Adenylate kinase 1" P00568 9 127866486-127877675 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1359.2;tongue: 790.2" "Cell type enhanced" "Detected in all" "Early spermatids: 281.3;Late spermatids: 1031.8;Muller glia cells: 287.6;Peritubular cells: 386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 163.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006456, CAB009893" Enhanced Supported Cytosol NA NA 24000000 Cytosol "CAB009893: AB_2225151, HPA006456: AB_1078116" "unprognostic (6.07e-3)" "unprognostic (1.44e-2)" "unprognostic (2.36e-2)" "unprognostic (1.03e-1)" "unprognostic (3.44e-1)" "unprognostic (3.09e-1)" "unprognostic (1.52e-2)" "unprognostic (3.12e-2)" "unprognostic (2.19e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-3)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "prognostic favorable (7.31e-4)" "unprognostic (2.62e-1)" "unprognostic (8.40e-3)" "unprognostic (6.99e-3)" 28.8 34.8 89.9 11.6 73.8 28.6 17.1 89.6 95.8 37.8 128.2 32.5 18.1 14.4 28.8 32.3 345.2 22.7 252.5 71.7 104.1 24.5 26.7 75.3 5.0 89.5 90.6 67.1 45.4 15.0 47.5 34.1 7.6 91.7 17.2 39.9 29.3 33.4 36.2 1359.2 13.7 12.2 22.1 105.2 21.0 24.1 63.6 82.6 4.0 35.1 790.2 12.7 19.8 19.5 93.0 56.7 23.6 30.1 40.4 71.2 142.9 27.4 38.3 38.2 66.7 40.4 18.0 34.9 1.5 40.8 79.4 44.1 79.2 0.3 43.1 26.6 9.0 26.1 8.3 65.2 31.6 40.1 0.0 1.0 110.9 81.8 49.9 35.5 36.8 90.3 0.8 33.7 2.3 76.7 53.5 0.1 1.1 10.6 139.7 74.2 1.3 30.0 12.6 44.8 4.1 48.3 30.4 101.0 57.4 29.8 15.3 45.8 33.3 75.9 45.9 18.8 163.8 37.3 3.5 0.6 0.2 57.7 0.3 32.4 0.2 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.5 0.2 0.1 0.9 0.0 0.3 89.9 73.8 89.6 95.8 71.7 104.1 89.5 90.6 67.1 91.7 105.2 82.6 93.0 12.8 41.7 148.1 25.8 2.6 26.4 17.2 84.5 6.2 54.6 11.5 7.9 49.7 28.6 79.4 7.3 16.7 7.5 5.7 210.1 17.6 116.7 281.3 7.3 8.0 39.8 106.3 97.0 11.1 60.9 46.8 37.3 46.4 4.8 1.3 2.7 49.2 77.3 59.3 48.8 12.0 62.7 120.1 3.7 22.3 1031.8 226.5 7.9 83.6 2.8 2.3 287.6 10.3 4.5 9.7 57.2 132.7 386.3 4.2 14.4 22.8 8.2 186.5 69.5 26.3 107.2 56.4 20.2 16.7 33.6 28.4 13.5 7.1 83.4 65.5 25.3 CDC37L1 "CDC37B, FLJ20639, HARC" ENSG00000106993 "Cell division cycle 37 like 1" Q7L3B6 9 4679559-4708399 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HDLM-2: 126.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021175 Approved Supported Cytosol NA NA Cytosol "HPA021175: AB_10959752" "unprognostic (1.18e-2)" "unprognostic (8.52e-2)" "unprognostic (2.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.38e-2)" "unprognostic (3.66e-3)" "unprognostic (2.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.82e-3)" "unprognostic (2.78e-2)" "unprognostic (7.97e-2)" "prognostic favorable (2.66e-7)" "unprognostic (8.54e-2)" "unprognostic (1.91e-1)" "unprognostic (2.91e-2)" "unprognostic (4.28e-2)" 20.6 15.7 11.8 9.6 11.8 8.1 13.9 13.1 13.9 14.3 12.3 12.2 10.2 13.0 13.9 20.1 13.3 14.8 31.4 14.4 15.7 16.8 55.5 10.6 13.2 12.1 12.2 11.0 15.2 19.8 11.7 10.2 9.7 12.7 16.0 8.0 13.0 12.6 12.1 87.2 10.2 10.4 12.4 12.2 8.5 11.9 14.4 12.3 9.9 14.9 53.0 9.5 17.7 11.2 13.2 17.1 15.2 7.8 12.7 27.9 20.4 12.1 19.6 13.4 11.7 13.3 4.9 10.4 10.8 5.4 14.3 7.8 7.4 8.8 11.9 11.3 126.8 7.6 28.7 15.8 13.3 16.7 11.6 11.3 13.3 15.3 8.7 13.7 12.9 8.5 9.7 3.4 16.2 13.1 8.2 9.2 24.0 20.0 11.2 5.3 7.3 9.6 6.2 16.6 6.9 22.5 11.2 14.6 11.7 9.8 10.0 9.6 10.9 9.1 17.5 8.2 9.9 13.1 12.5 21.2 7.8 15.6 8.2 5.7 26.5 7.7 15.7 17.0 7.5 16.7 14.1 17.0 18.1 7.5 15.0 25.8 23.5 9.0 12.3 10.0 8.6 17.4 10.6 11.8 11.8 13.1 13.9 14.4 15.7 12.1 12.2 11.0 12.7 12.2 12.3 13.2 17.7 28.9 18.3 23.2 19.6 65.9 48.0 31.9 31.9 28.3 24.7 19.0 80.4 25.8 26.3 16.5 33.3 19.7 27.9 15.1 49.0 33.5 9.8 25.9 23.3 20.7 17.9 5.7 24.2 41.2 17.0 35.1 19.9 16.1 23.5 12.9 17.5 103.9 11.3 20.2 29.4 20.0 40.7 13.6 25.1 5.1 36.1 14.8 40.9 9.4 14.9 36.7 18.6 21.1 23.0 27.3 17.3 36.5 20.9 76.5 15.7 66.0 25.3 22.6 32.9 27.8 43.0 77.3 58.1 25.0 57.4 33.8 31.9 15.5 12.0 44.0 RLN2 "bA12D24.1.1, bA12D24.1.2, H2, RLXH2" ENSG00000107014 "Relaxin 2" P04090 9 5299864-5304716 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 5.2" "Cell type enhanced" "Detected in many" "Early spermatids: 13.0;Muller glia cells: 9.6;Spermatocytes: 17.3;Syncytiotrophoblasts: 13.5" "Group enriched" "Detected in some" 5 "breast cancer: 2.0;prostate cancer: 6.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 26 "gdT-cell: 1.4;MAIT T-cell: 4.2;memory B-cell: 1.9;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.0;naive CD8 T-cell: 3.0;NK-cell: 3.5;T-reg: 1.3" "Group enriched" "Detected in many" 33 "B-cells: 1.9;NK-cells: 3.5;T-cells: 4.2" "Cell line enhanced" "Detected in some" "Daudi: 5.6;HEL: 21.9;T-47d: 6.1;U-266/84: 10.2" "Secreted to blood" NA NA 24400 10000 "unprognostic (1.63e-3)" "unprognostic (1.26e-1)" "unprognostic (2.09e-3)" "unprognostic (2.84e-1)" "unprognostic (2.03e-2)" "unprognostic (9.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (2.50e-3)" "unprognostic (9.18e-2)" "unprognostic (1.74e-6)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.88e-2)" "unprognostic (8.41e-4)" 0.4 0.0 0.4 1.4 0.4 0.3 2.3 0.5 0.7 0.4 0.4 0.5 0.0 0.5 0.3 0.3 5.2 0.2 0.5 0.4 0.5 1.5 0.0 0.7 2.8 0.5 0.4 0.3 0.1 0.5 4.2 3.0 0.6 0.6 4.0 0.4 3.0 0.3 0.6 0.0 0.4 0.5 0.2 0.4 0.9 0.5 2.8 0.5 2.8 0.8 0.2 2.3 0.2 0.1 0.4 3.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.5 1.0 0.3 1.6 5.6 0.4 0.0 0.0 0.9 0.0 2.8 0.7 4.4 2.0 21.9 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.5 0.0 0.0 0.2 0.1 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.6 2.7 3.0 0.0 0.6 0.1 0.2 6.1 0.1 0.2 0.0 0.5 0.0 0.1 1.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.2 1.9 2.8 2.3 0.0 1.4 4.0 3.0 0.0 3.5 0.0 0.0 1.3 0.8 0.4 0.4 0.5 0.7 0.4 0.5 0.5 0.4 0.3 0.6 0.4 0.5 0.4 0.8 3.2 0.6 0.3 2.6 0.5 2.3 1.5 1.2 1.5 3.8 3.0 1.9 1.5 1.2 1.8 0.0 6.3 1.3 0.1 7.9 2.8 13.0 3.3 0.3 0.8 3.6 1.7 0.4 1.5 2.3 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.6 3.3 0.9 1.7 2.0 0.0 0.0 5.3 0.6 0.1 0.0 1.0 0.8 9.6 4.1 0.0 0.9 0.8 0.2 0.4 0.5 1.0 0.1 1.4 5.0 1.7 0.0 0.6 0.4 17.3 5.1 1.4 1.3 13.5 3.4 0.0 1.5 0.5 RLN1 H1 ENSG00000107018 "Relaxin 1" P04808 9 5334930-5339876 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "prostate: 23.7" "Cell type enhanced" "Detected in some" "Cholangiocytes: 2.8;Enteroendocrine cells: 4.8;Prostatic glandular cells: 10.6;Spermatocytes: 2.4;Spermatogonia: 3.1" "Cancer enriched" "Detected in some" 106 "prostate cancer: 67.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.2" "Secreted to blood" NA NA "unprognostic (7.12e-6)" "unprognostic (2.32e-1)" "unprognostic (7.29e-2)" "unprognostic (1.98e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (4.32e-2)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (4.08e-4)" "unprognostic (8.15e-2)" "unprognostic (2.89e-4)" "unprognostic (8.82e-3)" "unprognostic (3.23e-2)" "unprognostic (3.23e-2)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.2 0.0 0.5 1.0 0.8 0.2 2.8 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.6 1.6 0.7 0.2 0.1 4.8 1.7 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.4 10.6 0.0 0.4 1.0 0.8 0.0 0.2 0.1 2.4 3.1 0.0 0.1 1.1 1.6 0.1 0.2 0.3 PLGRKT "AD025, C9orf46, FLJ14688, MDS030, Plg-RKT" ENSG00000107020 "Plasminogen receptor with a C-terminal lysine" Q9HBL7 9 5357971-5437925 "Predicted intracellular proteins" "Chemotaxis, Inflammatory response, Plasminogen activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 191.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 244.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 247.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008214, HPA011144" Supported Uncertain Mitochondria NA NA Mitochondria "HPA008214: AB_1078363, HPA011144: AB_1078364" "prognostic favorable (5.56e-4)" "unprognostic (5.31e-2)" "unprognostic (2.96e-2)" "unprognostic (9.67e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.45e-3)" "unprognostic (2.19e-2)" "unprognostic (1.84e-1)" "prognostic favorable (5.09e-5)" "unprognostic (1.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" 19.1 18.1 9.7 20.4 10.3 13.7 25.6 10.6 14.0 18.2 14.4 41.5 44.5 12.4 27.9 20.5 19.9 15.8 30.8 9.6 12.2 33.7 21.8 14.8 24.1 10.7 9.9 9.0 10.1 12.6 20.0 10.5 15.1 10.6 17.6 47.2 15.9 16.9 13.6 59.1 15.7 36.6 17.4 10.5 14.6 20.2 4.8 10.2 35.6 25.0 37.4 22.9 17.7 12.9 11.2 54.8 15.4 31.8 23.0 20.0 27.7 0.1 26.2 29.0 22.1 25.5 0.2 24.2 12.4 13.7 19.8 32.7 12.6 21.9 72.0 46.1 247.5 14.0 97.6 12.5 17.4 43.3 29.8 22.4 30.6 25.8 20.6 42.0 18.9 32.2 41.0 5.5 86.2 54.3 12.0 32.1 33.6 20.6 44.5 8.9 20.1 15.6 39.6 50.6 11.4 25.1 32.7 26.0 40.6 50.6 22.5 32.8 41.4 23.1 28.0 34.8 24.7 51.7 16.4 25.3 25.6 48.6 18.6 16.1 244.3 18.8 38.3 43.0 25.5 54.0 48.9 53.7 56.7 27.6 42.9 51.1 51.2 22.8 52.7 17.9 44.3 74.9 44.0 9.7 10.3 10.6 14.0 9.6 12.2 10.7 9.9 9.0 10.6 10.5 10.2 11.2 27.8 12.8 25.5 25.5 22.0 26.4 23.4 144.2 27.3 11.8 56.9 58.7 58.7 22.8 49.7 22.0 0.0 88.6 23.1 139.2 109.5 82.5 0.8 39.6 28.1 21.2 26.5 25.2 18.8 51.1 108.7 25.3 20.9 22.0 90.7 14.6 15.0 27.5 82.8 10.1 26.7 124.2 83.4 21.7 35.6 1.9 16.4 33.0 33.8 21.5 84.3 24.4 24.7 20.1 40.5 82.7 157.2 19.9 23.0 27.3 191.3 76.8 52.6 15.1 0.0 26.0 33.2 21.2 13.7 41.1 30.3 65.8 33.0 23.1 106.1 24.0 TBC1D13 FLJ10743 ENSG00000107021 "TBC1 domain family member 13" Q9NVG8 9 128787253-128810430 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 55.5;Oligodendrocytes: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 23.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045865 Approved Approved Nucleoli No No 9300 Nucleoli "HPA045865: AB_10965700" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.98e-3)" "unprognostic (1.98e-2)" "unprognostic (2.74e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-3)" "unprognostic (2.16e-2)" "unprognostic (4.23e-2)" "unprognostic (4.29e-2)" "prognostic favorable (3.14e-6)" "unprognostic (1.82e-2)" "prognostic favorable (1.58e-7)" "unprognostic (1.72e-2)" "unprognostic (1.77e-1)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 13.6 21.8 33.5 9.2 31.2 14.9 13.5 24.9 32.6 13.3 22.0 14.3 12.4 14.0 14.1 11.9 14.7 8.7 16.3 32.6 29.6 27.7 16.8 11.3 10.9 31.6 30.7 32.6 18.9 17.6 28.6 15.5 10.0 31.2 17.4 8.3 7.1 18.7 13.9 20.9 12.3 16.1 13.0 26.5 19.5 17.2 7.3 30.8 11.0 17.9 13.7 11.0 14.3 11.0 31.1 9.5 22.5 23.1 23.2 29.3 14.1 22.5 22.4 19.0 22.7 14.7 24.6 12.5 15.9 15.2 26.6 22.6 25.1 14.2 17.8 13.3 12.6 16.1 17.0 27.4 22.7 18.1 25.9 33.3 19.8 20.7 19.7 11.8 20.1 29.6 16.6 26.7 10.5 27.4 20.5 15.8 15.2 22.0 26.3 33.5 17.7 21.4 36.1 16.7 12.3 23.2 16.3 31.1 19.7 13.4 22.3 21.0 24.1 23.7 28.3 17.7 23.2 18.4 13.3 18.5 15.5 20.7 15.4 20.8 23.0 2.7 4.8 4.2 2.7 4.4 4.7 3.3 4.2 3.0 3.2 2.9 5.0 2.0 3.4 2.1 8.3 2.6 3.6 33.5 31.2 24.9 32.6 32.6 29.6 31.6 30.7 32.6 31.2 26.5 30.8 31.1 6.9 3.2 9.0 9.4 7.2 2.3 2.6 3.4 4.6 10.1 9.6 9.1 12.1 2.8 4.2 16.5 10.4 5.2 6.6 8.8 9.8 6.1 1.5 4.2 6.7 9.4 5.4 7.8 11.2 9.9 4.7 6.4 9.7 5.9 8.2 10.9 16.1 14.8 17.6 6.7 10.5 4.7 4.1 8.5 2.5 2.9 9.3 6.7 0.0 5.6 55.5 6.5 9.2 11.1 36.6 8.5 5.2 7.5 5.4 3.5 15.9 26.0 4.8 5.8 6.6 5.6 4.9 5.1 8.6 5.7 3.1 2.5 6.5 9.7 6.8 2.1 RIC1 "bA207C16.1, KIAA1432" ENSG00000107036 "RIC1 homolog, RAB6A GEF complex partner 1" Q4ADV7 9 5629025-5776557 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 62.3;Excitatory neurons: 84.5;Inhibitory neurons: 79.6;Microglial cells: 98.4;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.6;Plasma cells: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 73.3;HEL: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051578 Supported NA NA "HPA051578: AB_2681541" "unprognostic (1.78e-1)" "unprognostic (4.08e-2)" "unprognostic (3.13e-2)" "unprognostic (2.47e-2)" "unprognostic (4.51e-2)" "unprognostic (8.87e-2)" "unprognostic (8.59e-2)" "unprognostic (1.90e-1)" "unprognostic (3.87e-2)" "unprognostic (7.16e-2)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (3.74e-1)" "unprognostic (3.50e-2)" "unprognostic (4.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.77e-2)" 11.9 7.3 3.0 12.8 6.7 13.3 9.9 10.0 5.4 11.7 10.4 8.1 10.1 11.7 8.8 11.5 8.9 11.5 6.5 4.2 5.2 7.6 10.0 10.2 17.4 7.0 5.5 2.8 10.4 10.6 8.9 4.9 14.4 7.2 8.3 9.5 7.5 11.4 10.6 17.8 13.6 9.4 13.4 5.0 11.9 8.0 11.7 5.4 14.9 11.4 15.9 16.7 11.1 10.1 9.9 18.5 10.7 18.3 12.6 20.8 24.1 15.3 26.1 24.0 17.6 22.8 9.8 3.9 41.8 3.1 27.1 7.0 8.8 13.9 14.4 24.4 73.3 9.2 91.5 23.3 10.6 17.2 14.4 15.7 22.7 9.7 12.1 18.7 20.1 21.2 13.0 5.5 48.5 14.7 4.6 11.9 26.0 9.2 7.0 5.3 22.8 12.0 16.9 9.2 7.1 5.0 12.4 14.2 8.8 7.3 29.1 7.9 24.1 20.5 14.2 17.7 8.0 12.4 13.4 18.0 51.8 5.8 5.5 4.9 0.3 0.6 0.5 0.3 1.0 0.4 0.7 0.4 0.5 0.5 0.2 0.2 0.3 0.3 1.0 0.5 0.7 0.5 0.5 3.0 6.7 10.0 5.4 4.2 5.2 7.0 5.5 2.8 7.2 5.0 5.4 9.9 11.7 9.6 4.8 62.3 45.9 0.0 5.8 0.0 42.1 7.1 6.9 5.5 4.4 10.0 0.0 0.0 4.2 7.4 12.1 5.6 1.9 3.9 9.6 8.1 12.8 8.7 3.6 17.9 84.5 5.4 4.6 13.5 25.0 10.1 5.1 7.6 9.7 10.7 7.8 21.9 79.6 2.7 0.0 25.7 0.0 9.5 8.7 19.8 0.0 98.4 20.8 2.5 7.2 69.9 70.6 5.6 2.7 6.4 80.1 6.1 7.0 3.3 0.7 5.9 13.1 10.1 11.1 8.0 4.1 32.0 0.0 7.3 15.3 6.4 2.8 8.1 KDM4C "GASC1, JMJD2C, KIAA0780, TDRD14C" ENSG00000107077 "Lysine demethylase 4C" Q9H3R0 9 6720863-7175648 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 206.9;Inhibitory neurons: 235.9;Microglial cells: 148.0;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 347.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069357 Approved Nucleoplasm NA NA Nucleoplasm "HPA069357: AB_2686128" "unprognostic (1.56e-2)" "unprognostic (1.91e-2)" "unprognostic (4.38e-2)" "unprognostic (1.38e-1)" "unprognostic (3.52e-1)" "unprognostic (4.36e-2)" "unprognostic (2.50e-2)" "unprognostic (6.89e-3)" "unprognostic (2.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.65e-2)" "unprognostic (2.03e-2)" "unprognostic (1.92e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" "unprognostic (2.23e-2)" "unprognostic (1.64e-3)" 9.4 9.6 10.8 12.9 12.3 30.3 11.5 30.9 11.5 10.3 13.6 13.9 13.2 10.5 11.9 10.2 10.4 9.8 7.5 10.1 12.1 8.8 11.1 10.7 19.3 13.1 12.1 10.2 11.6 16.2 17.9 11.9 8.9 17.6 10.0 16.3 29.1 11.7 8.9 8.4 15.2 14.5 10.9 10.6 14.0 15.3 9.9 12.1 23.9 13.6 6.1 19.0 10.3 10.8 16.7 17.2 9.8 4.0 6.0 13.4 14.3 11.8 7.6 9.6 8.5 8.1 11.3 9.1 20.1 4.6 10.3 8.7 5.1 8.6 12.8 11.1 60.6 7.4 27.9 13.8 15.1 12.4 10.8 18.5 12.5 8.4 6.7 14.0 21.1 10.4 16.4 4.7 13.4 9.3 8.3 18.0 40.4 7.0 18.0 3.8 10.8 3.4 12.9 12.3 9.2 14.0 8.3 7.1 12.7 6.8 10.7 6.6 17.5 11.0 8.4 4.0 9.9 7.5 10.2 8.1 21.3 8.2 10.0 3.3 7.5 7.1 13.5 9.6 7.7 11.2 12.1 10.4 11.2 9.6 13.8 11.3 8.8 1.6 11.2 13.1 3.7 10.0 8.0 10.8 12.3 30.9 11.5 10.1 12.1 13.1 12.1 10.2 17.6 10.6 12.1 16.7 11.3 6.4 14.4 110.4 40.6 19.9 7.9 10.5 18.8 22.6 11.2 8.0 9.2 11.5 9.2 7.3 45.9 5.2 22.7 10.3 3.9 7.0 84.8 10.0 12.2 9.4 9.7 42.1 206.9 6.2 5.3 6.9 34.7 16.8 8.8 6.0 6.8 13.0 6.7 11.8 235.9 14.7 6.1 10.0 19.4 83.3 9.6 16.5 7.2 148.0 15.0 3.3 19.6 189.0 347.2 7.6 9.5 9.4 27.1 6.2 14.1 4.0 10.8 28.3 13.1 7.3 7.6 6.6 5.4 14.4 23.9 5.9 28.2 6.2 8.1 8.0 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 65.4" "Cell type enhanced" "Detected in many" "Microglial cells: 506.8;monocytes: 134.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 53.0;granulocytes: 173.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "Daudi: 52.9;HL-60: 53.3;MOLT-4: 50.1;NB-4: 83.7;REH: 61.9;RT4: 54.3;THP-1: 158.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003218, HPA073349" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol NA NA Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695, HPA073349: " "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favorable (6.89e-6)" 11.1 13.5 3.4 36.1 4.0 42.6 7.4 5.1 4.4 4.3 39.8 7.4 7.3 3.0 2.9 7.2 4.4 14.7 2.0 3.4 7.6 16.7 6.2 19.8 51.5 8.3 6.1 1.4 2.1 4.2 7.8 2.7 15.4 8.0 5.1 7.3 4.5 4.6 2.8 1.0 3.0 15.5 6.3 10.5 46.0 9.6 7.5 6.5 65.4 4.9 2.6 50.1 14.9 3.3 11.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 1.6 1.4 52.9 3.9 0.0 0.0 2.3 0.8 0.3 0.0 18.2 2.3 0.1 0.0 0.2 0.0 53.3 7.1 0.2 9.3 0.0 0.2 0.0 0.0 0.0 11.8 25.9 0.0 3.2 50.1 83.7 0.2 0.2 0.7 61.9 0.1 21.3 0.2 54.3 0.1 0.0 0.0 0.6 3.6 1.0 1.4 158.0 10.2 0.0 0.4 0.7 0.1 10.3 0.1 0.0 0.1 33.3 0.9 65.1 56.9 73.5 12.2 52.0 10.2 25.2 15.7 13.8 53.0 23.2 11.3 11.1 173.6 24.1 84.2 13.8 15.6 22.6 3.4 4.0 5.1 4.4 3.4 7.6 8.3 6.1 1.4 8.0 10.5 6.5 11.0 5.0 9.6 33.5 2.3 112.6 6.4 2.5 1.2 45.5 3.6 12.3 10.8 2.3 18.6 4.9 7.3 77.2 70.9 101.9 1.5 1.9 1.0 33.4 1.9 0.7 9.8 8.4 35.1 1.9 6.5 4.3 5.3 12.8 3.2 24.6 12.7 2.9 2.6 58.4 0.0 4.2 12.9 2.0 115.0 49.4 14.8 3.1 107.7 8.8 506.8 134.3 1.1 74.2 4.5 2.2 1.4 24.9 0.4 94.6 1.5 1.2 12.8 8.0 4.2 13.1 30.2 20.6 22.1 13.3 9.4 3.8 42.7 111.6 1.1 1.3 3.4 KANK1 "ANKRD15, KANK, KIAA0172" ENSG00000107104 "KN motif and ankyrin repeat domains 1" Q14678 9 470291-746106 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 355.5;Late spermatids: 228.7;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 191.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.0" "Group enriched" "Detected in many" 15 "B-cells: 1.1;dendritic cells: 4.0;T-cells: 2.4" "Cell line enhanced" "Detected in many" "Hep G2: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005539, HPA056090" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA005539: AB_1078164, HPA056090: AB_2683034" "unprognostic (6.59e-2)" "unprognostic (3.33e-2)" "unprognostic (1.06e-3)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (7.53e-2)" "unprognostic (3.33e-1)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (3.05e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" 42.9 9.7 46.4 9.6 49.1 1.5 31.5 42.1 47.9 34.4 57.0 40.2 12.2 62.8 13.1 65.1 32.0 15.3 82.3 43.3 46.5 31.6 102.7 13.7 7.7 51.2 43.6 38.9 22.3 28.5 9.5 28.1 26.0 46.2 42.9 15.0 11.1 30.1 32.1 66.9 52.1 23.8 37.7 47.6 7.0 26.1 15.5 48.3 9.5 31.0 40.2 11.9 70.7 52.7 46.8 5.9 12.2 4.0 72.0 57.8 21.9 19.9 37.1 25.8 3.1 3.7 30.2 2.5 46.2 8.9 46.0 7.0 12.3 15.7 30.4 5.3 22.7 8.3 0.1 17.0 96.0 8.1 11.2 0.0 12.6 41.6 3.2 35.6 13.2 31.2 1.6 2.4 56.4 23.1 14.4 4.5 46.9 5.3 8.9 9.0 1.7 7.9 8.6 24.5 36.1 1.8 0.0 3.6 10.9 50.9 33.3 7.1 8.7 46.1 8.4 3.2 10.8 17.1 9.8 61.9 0.2 5.6 21.1 15.8 0.0 0.1 0.0 0.1 0.1 0.0 0.8 1.3 0.4 0.4 1.1 2.4 0.8 0.0 0.1 0.0 4.0 1.7 0.5 46.4 49.1 42.1 47.9 43.3 46.5 51.2 43.6 38.9 46.2 47.6 48.3 46.8 18.3 12.8 34.2 355.5 4.9 23.1 102.1 11.4 37.0 22.2 16.8 18.0 94.1 24.3 8.1 18.4 41.7 89.2 15.7 8.3 7.9 11.6 102.3 14.2 15.4 21.9 18.0 9.1 12.1 7.9 6.8 21.8 7.7 13.1 1.3 38.5 23.6 70.0 13.3 0.0 29.0 12.8 4.1 6.9 6.5 228.7 32.3 3.3 23.2 60.9 1.2 6.5 0.0 322.7 191.4 9.6 7.5 20.7 10.7 50.5 17.6 13.6 7.0 20.2 26.3 129.9 24.0 28.4 25.6 36.2 25.7 66.2 4.7 6.9 26.0 63.6 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.9;testis: 43.5" "Cell type enhanced" "Detected in many" "Early spermatids: 62.2;Excitatory neurons: 135.5;Inhibitory neurons: 390.6;Spermatogonia: 159.2" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.1" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 25.4;AF22: 37.2;SCLC-21H: 119.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022222: , HPA063001: AB_2684918" "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 0.1 1.3 9.6 0.1 18.2 0.5 0.2 2.5 34.9 0.1 0.0 0.4 0.1 0.5 0.5 0.2 0.1 0.2 0.1 11.1 14.1 0.5 0.0 0.2 0.2 16.4 14.3 12.9 1.1 0.0 0.1 1.0 0.1 20.9 0.3 0.5 5.0 0.2 0.1 0.1 0.5 0.2 0.2 0.3 0.1 0.1 43.5 18.3 0.0 0.3 0.0 0.1 0.4 0.2 33.7 25.4 0.3 37.2 0.2 0.1 0.3 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 7.8 9.9 15.9 0.2 0.0 7.1 0.0 0.1 0.3 0.0 0.2 0.6 0.5 9.6 0.0 11.0 0.0 0.3 0.1 0.9 1.2 5.3 0.0 0.1 0.1 9.8 0.0 11.8 0.1 13.3 0.2 0.0 0.0 119.6 11.5 0.3 0.3 0.3 9.4 0.6 1.9 0.0 0.2 7.9 0.2 0.2 0.1 0.1 0.1 1.3 0.1 1.4 1.1 0.3 0.5 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.5 0.3 0.4 1.5 0.4 0.2 0.3 0.2 0.0 9.6 18.2 2.5 34.9 11.1 14.1 16.4 14.3 12.9 20.9 0.3 18.3 33.7 0.9 0.0 0.0 7.8 0.0 1.0 0.4 0.4 0.6 8.8 0.9 0.6 0.9 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.9 0.1 62.2 0.5 0.2 1.8 4.2 0.0 135.5 0.0 0.0 0.8 0.0 0.2 0.0 10.6 0.0 0.0 0.1 16.8 390.6 1.2 0.0 0.0 0.7 39.5 3.1 0.2 0.0 7.5 0.0 2.8 0.0 5.5 5.5 0.0 0.2 1.5 0.0 0.4 0.0 0.1 0.0 10.6 0.0 1.4 1.0 13.9 159.2 0.5 0.9 0.0 0.1 0.7 1.3 0.6 NCS1 "FREQ, NCS-1" ENSG00000107130 "Neuronal calcium sensor 1" P62166 9 130172404-130237303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 277.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 40.9;Horizontal cells: 112.7;Inhibitory neurons: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018587, HPA019713" Enhanced Supported Enhanced "Plasma membrane" NA NA 10000 "Plasma membrane" "CAB018587: AB_649907, HPA019713: AB_1854404" "prognostic unfavorable (5.40e-4)" "unprognostic (1.57e-1)" "unprognostic (4.64e-3)" "prognostic unfavorable (8.69e-4)" "unprognostic (1.29e-1)" "unprognostic (9.23e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.61e-3)" "unprognostic (4.27e-1)" "unprognostic (1.21e-2)" "unprognostic (8.45e-2)" "unprognostic (1.58e-1)" "unprognostic (3.71e-3)" "unprognostic (8.59e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.65e-1)" 8.4 26.4 182.1 13.5 94.1 8.5 5.1 0.0 231.0 22.0 0.0 87.9 5.2 71.3 5.8 41.0 29.6 14.0 9.2 277.6 37.3 17.7 2.9 9.6 1.9 23.9 24.5 103.3 10.9 5.0 2.3 14.6 1.7 53.8 36.4 10.2 8.5 8.2 65.7 3.2 17.9 20.0 59.1 0.2 1.2 25.3 3.1 89.6 4.3 33.1 1.9 3.8 64.3 21.0 85.1 25.6 50.8 25.9 51.9 15.9 35.3 12.3 64.3 29.6 48.2 32.0 24.3 12.8 0.1 22.8 81.6 56.5 45.2 42.5 56.3 21.5 75.3 13.0 0.1 32.3 26.5 24.4 2.2 30.2 41.2 28.0 54.7 34.4 42.9 46.2 9.9 18.8 0.3 70.8 73.1 4.9 25.6 39.6 13.7 21.2 0.1 81.5 17.3 47.4 15.9 67.9 63.9 39.5 18.7 37.7 19.4 34.8 16.2 36.7 92.9 75.4 75.5 84.1 0.1 0.1 0.2 108.7 7.1 102.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 182.1 94.1 0.0 231.0 277.6 37.3 23.9 24.5 103.3 53.8 0.2 89.6 85.1 0.5 0.0 0.0 26.1 0.1 9.7 10.5 16.6 15.4 7.7 3.0 10.0 2.9 1.5 6.3 11.0 4.2 0.1 5.3 0.8 5.9 7.9 0.4 27.8 10.5 1.0 1.2 14.7 40.9 2.9 1.6 9.1 1.1 12.4 3.8 4.4 0.7 0.5 3.7 112.7 42.5 1.0 0.0 0.6 5.8 0.9 1.2 2.5 5.4 2.8 9.8 19.2 0.0 8.0 7.8 5.3 0.1 1.5 1.3 11.0 0.2 17.3 9.7 4.3 0.0 4.2 19.0 0.0 1.9 6.0 7.0 0.5 2.6 1.2 0.5 3.3 TESK1 ENSG00000107140 "Testis associated actin remodelling kinase 1" Q15569 9 35605262-35610041 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (2.82e-1)" "unprognostic (4.96e-3)" "unprognostic (5.18e-2)" "unprognostic (2.04e-2)" "unprognostic (8.76e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (1.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.66e-3)" "unprognostic (1.22e-2)" "unprognostic (2.56e-1)" "unprognostic (5.57e-2)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-3)" 37.7 45.1 23.2 11.3 19.1 6.1 33.8 17.1 24.7 22.2 14.6 25.8 13.4 26.0 11.1 12.9 18.9 13.1 17.9 20.9 19.8 17.9 13.9 20.1 12.0 19.8 22.6 21.4 16.1 16.1 17.0 26.8 9.1 20.1 22.6 8.6 6.8 17.6 20.0 69.7 18.9 19.1 17.2 17.6 16.3 22.4 57.4 26.2 10.5 19.1 27.8 8.6 28.1 16.1 19.4 17.0 16.0 10.7 16.9 42.5 17.5 12.1 19.7 17.3 17.8 11.3 9.3 4.8 30.9 10.3 19.7 47.1 5.8 6.8 14.1 3.4 20.0 9.2 4.6 14.1 8.4 24.4 4.0 14.6 17.2 21.8 13.9 19.0 18.9 12.6 15.3 5.3 11.3 18.0 19.1 7.9 18.4 6.2 16.1 18.6 12.9 6.6 7.3 13.1 8.0 8.8 10.3 11.2 13.0 8.1 7.3 15.9 5.7 11.1 39.2 16.2 27.9 12.0 6.0 10.2 11.2 28.2 4.6 9.1 0.0 0.6 0.1 1.1 0.1 1.0 0.3 0.4 1.8 0.8 0.2 0.5 0.5 0.0 0.9 0.3 0.8 0.1 0.7 23.2 19.1 17.1 24.7 20.9 19.8 19.8 22.6 21.4 20.1 17.6 26.2 19.4 13.4 6.4 7.7 9.1 8.9 14.4 6.3 5.9 4.6 10.9 13.9 11.0 1.9 7.2 4.2 7.3 8.4 3.8 20.0 19.9 1.9 6.6 35.1 5.6 9.2 9.7 9.5 1.7 6.5 10.4 8.6 9.0 18.8 11.2 1.3 10.1 10.8 8.4 13.9 13.5 8.5 14.8 0.0 7.8 22.4 34.9 12.2 19.3 14.2 2.8 6.3 12.6 20.6 4.5 6.8 10.2 11.0 14.3 10.7 19.2 13.4 7.8 4.2 15.3 6.6 10.1 10.9 14.8 10.0 4.7 13.9 3.3 11.8 5.4 7.3 9.7 KCNT1 "KCa4.1, KIAA1422, SLACK, Slo2.2" ENSG00000107147 "Potassium sodium-activated channel subfamily T member 1" Q5JUK3 9 135702185-135795508 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 36.0;lymphoid tissue: 15.9;skeletal muscle: 13.5" "Group enriched" "Detected in some" 8 "Excitatory neurons: 60.1;Inhibitory neurons: 55.0;Theca cells: 21.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Region enhanced" "Detected in many" "cerebral cortex: 36.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.5;RPMI-8226: 1.8;SCLC-21H: 3.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 42.8" HPA059880 Uncertain NA NA "HPA059880: AB_2684149" "unprognostic (1.50e-3)" "unprognostic (1.72e-2)" "unprognostic (2.07e-3)" "unprognostic (2.98e-13)" "unprognostic (9.26e-2)" "unprognostic (7.73e-2)" "unprognostic (9.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.30e-3)" "unprognostic (9.89e-2)" "unprognostic (6.20e-2)" "unprognostic (4.89e-7)" "unprognostic (9.15e-2)" "unprognostic (2.70e-1)" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" 0.4 0.1 2.0 0.1 6.7 0.1 0.3 1.7 36.0 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.6 0.2 0.7 4.3 0.7 0.0 0.1 0.3 0.0 4.7 0.4 5.7 5.0 0.1 0.0 8.7 0.3 5.9 0.1 0.0 0.4 0.2 0.0 13.5 0.1 0.2 0.0 0.0 15.9 0.5 0.9 0.6 0.0 0.1 8.3 0.0 0.2 0.2 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.8 1.8 0.0 0.0 3.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.7 1.7 36.0 4.3 0.7 4.7 0.4 5.7 5.9 0.0 0.6 12.0 0.0 0.0 0.0 3.6 0.1 0.0 0.3 0.0 0.0 1.3 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 60.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.3 0.0 3.5 2.7 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.6 0.0 5.1 1.1 0.3 1.0 0.0 0.0 0.0 0.1 21.2 0.0 0.0 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673918-35681159 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "stomach 1: 291.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 275.3;Cholangiocytes: 62.9;Early spermatids: 205.8;Gastric mucus-secreting cells: 259.5" "Cancer enhanced" "Detected in many" "renal cancer: 85.9" "Group enriched" "Detected in some" 4 "cerebellum: 5.4;pons: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A-431: 189.3;HDLM-2: 98.1;hTERT-RPE1: 113.1;U-87 MG: 374.4" "Region enhanced" "Detected in many" "cerebellum: 12.3" "Low region specificity" "Detected in all" "CAB005100, CAB017107, HPA055207" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738" "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favorable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.7 0.4 0.0 0.2 0.0 0.0 0.1 5.4 0.4 0.4 0.0 0.4 14.6 0.2 0.1 0.8 0.4 24.6 1.1 0.2 0.1 0.2 1.3 0.2 0.0 0.0 0.5 0.0 0.7 6.7 0.0 0.5 0.0 1.6 0.5 0.0 1.0 0.1 0.1 0.2 6.6 13.7 0.1 0.0 0.0 291.6 5.6 0.8 0.0 0.0 0.0 0.0 0.7 0.7 0.0 189.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 3.6 0.3 2.5 0.0 0.1 0.0 0.1 0.0 0.5 5.7 0.0 0.9 1.5 98.1 0.0 0.0 0.7 0.4 0.0 0.0 0.2 0.4 0.0 0.0 0.3 113.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.2 0.5 0.0 0.0 10.6 0.0 0.6 1.6 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 18.9 0.4 0.0 4.7 0.0 0.4 0.1 374.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 0.4 0.2 0.1 0.0 0.5 0.0 1.6 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.2 4.5 0.7 275.3 0.0 0.4 0.1 0.0 0.4 62.9 28.1 0.0 0.0 0.0 0.0 0.1 0.0 49.1 205.8 0.0 0.1 0.2 0.0 0.0 0.1 50.9 0.6 1.2 259.5 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.6 4.0 18.3 0.0 0.0 19.6 1.5 0.1 0.0 0.0 0.6 1.3 0.0 0.0 0.0 26.6 0.0 0.7 0.3 0.8 0.7 0.1 5.5 0.0 0.0 0.0 1.5 0.9 4.0 0.0 3.1 0.3 0.1 0.7 5.3 0.4 FUBP3 FBP3 ENSG00000107164 "Far upstream element binding protein 3" Q96I24 9 130578965-130638352 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047658, HPA058392" Approved Approved Nucleoplasm,Cytosol NA NA 63000 Nucleoplasm Cytosol "HPA047658: AB_2680114, HPA058392: AB_2683703" "unprognostic (1.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.91e-1)" "unprognostic (2.51e-1)" "unprognostic (5.67e-3)" "unprognostic (2.12e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (3.12e-2)" "unprognostic (7.27e-2)" "unprognostic (4.66e-1)" "unprognostic (4.23e-2)" "prognostic favorable (4.39e-5)" "unprognostic (2.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.23e-2)" 30.2 23.8 21.6 21.1 24.6 12.5 21.6 23.9 24.1 22.6 18.2 23.7 21.6 30.6 20.7 25.1 22.0 20.6 26.9 21.1 24.6 23.1 40.7 21.5 22.1 26.1 23.9 18.4 25.1 23.1 34.0 17.6 28.7 24.7 26.9 21.1 20.3 24.0 25.0 16.2 22.1 22.6 27.2 23.0 23.1 22.7 17.1 23.0 26.0 41.9 13.7 21.0 23.0 22.8 26.2 47.3 42.4 61.1 50.8 43.2 48.7 76.8 67.1 59.0 51.9 40.3 62.0 42.3 45.8 34.5 63.4 45.7 80.3 51.5 56.1 61.1 51.2 45.7 50.3 66.8 46.1 59.2 76.4 54.5 47.6 44.1 54.5 51.1 43.8 43.7 37.2 82.1 27.5 54.7 63.3 59.3 38.8 78.2 74.4 54.5 52.6 75.4 61.7 45.6 49.2 39.5 66.4 70.5 51.8 44.4 45.7 71.0 57.9 55.4 93.9 44.4 63.5 78.4 25.1 44.8 57.9 52.8 33.0 68.2 0.0 2.1 1.2 2.4 2.5 3.6 2.3 2.6 2.9 3.1 1.6 3.1 2.7 0.5 4.0 2.0 2.7 2.3 1.5 21.6 24.6 23.9 24.1 21.1 24.6 26.1 23.9 18.4 24.7 23.0 23.0 26.2 26.1 19.2 20.6 45.4 19.5 33.4 20.6 17.6 24.5 26.2 23.0 13.6 20.4 20.0 15.2 16.5 14.6 28.3 18.1 21.1 29.4 19.0 5.1 18.0 24.3 23.9 21.7 20.2 49.4 18.9 31.8 25.0 20.9 26.2 7.6 26.6 26.4 52.0 26.7 32.0 54.1 17.2 20.3 25.4 20.4 9.6 20.5 17.6 37.4 30.0 18.1 59.1 12.3 41.2 56.9 25.7 17.0 27.8 22.8 28.3 15.5 35.9 22.8 28.0 13.1 29.3 29.9 16.8 12.4 31.4 40.9 45.8 19.4 20.7 17.7 26.0 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710285 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 36.0;heart muscle: 60.4;skin 1: 146.2" "Cell type enriched" "Detected in some" 17 "Melanocytes: 2486.6" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 55 "SK-MEL-30: 1395.0" "Group enriched" "Detected in some" 5 "olfactory bulb: 4.6;thalamus: 1.8" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Approved Vesicles NA NA 51000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.3 0.0 0.1 0.6 0.3 0.2 4.9 0.2 0.9 0.0 36.0 2.2 5.1 0.0 1.3 10.1 0.2 4.6 60.4 2.7 0.1 16.3 0.0 3.7 0.0 1.1 1.1 0.2 0.0 0.0 0.0 0.1 0.1 2.1 0.1 5.3 2.7 1.4 0.0 4.8 146.2 4.7 1.9 0.1 0.0 2.1 1.1 0.3 0.0 0.0 7.6 0.0 1.1 0.4 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 25.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 4.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 1395.0 0.1 19.5 1.5 0.0 0.0 0.7 0.0 0.9 0.0 0.7 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.9 2.7 0.1 1.1 1.1 0.2 2.1 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 92.3 0.1 0.0 0.0 11.7 0.0 0.0 44.3 0.0 0.0 3.7 2.1 0.0 0.0 0.0 144.8 0.3 2.5 0.0 0.0 1.3 0.0 0.0 0.9 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 17.5 4.7 0.3 0.0 2486.6 0.0 0.0 15.9 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.6 0.0 0.0 1.4 0.7 0.7 0.0 16.8 0.0 0.5 0.0 0.0 0.2 CREB3 "Luman, LZIP, sLZIP" ENSG00000107175 "CAMP responsive element binding protein 3" O43889 9 35732598-35736999 "Predicted membrane proteins, Transcription factors" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 173.7;Late spermatids: 413.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030978 Supported Cytosol NA NA Cytosol "HPA030978: AB_2673683" "unprognostic (1.73e-3)" "unprognostic (9.72e-2)" "unprognostic (9.32e-2)" "unprognostic (5.62e-3)" "unprognostic (3.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (4.29e-2)" "unprognostic (4.63e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.13e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.77e-5)" "unprognostic (1.48e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" 26.3 45.8 42.3 16.7 42.2 7.7 26.8 39.8 47.5 28.3 37.9 34.6 14.7 34.4 37.8 16.4 28.8 21.0 27.5 40.4 42.5 29.5 26.6 25.1 14.5 44.0 43.5 39.6 26.3 32.9 30.2 38.6 20.8 43.0 37.3 23.3 23.6 32.2 39.0 24.3 17.8 22.8 36.0 42.2 20.5 36.4 45.0 43.1 16.3 26.8 20.1 19.3 32.4 21.6 41.3 39.2 35.6 36.9 30.0 77.5 48.8 22.6 64.1 111.6 69.8 73.1 45.8 19.4 10.5 28.5 108.0 87.8 15.7 25.0 52.7 53.7 37.9 14.5 8.7 44.1 24.8 97.3 16.0 19.2 42.8 45.2 72.0 73.4 66.8 42.6 19.1 11.9 24.7 81.7 22.3 22.3 8.5 19.5 30.9 39.1 18.3 15.3 15.1 69.5 25.2 15.3 21.3 22.6 23.6 17.1 34.6 39.1 7.1 46.4 52.0 27.1 35.6 44.2 12.2 13.2 15.1 55.1 7.4 55.6 24.6 33.5 11.6 26.1 32.8 31.2 28.4 26.1 29.9 37.8 20.0 20.2 18.1 12.8 28.2 29.0 31.4 27.1 28.0 42.3 42.2 39.8 47.5 40.4 42.5 44.0 43.5 39.6 43.0 42.2 43.1 41.3 24.4 28.9 17.8 3.9 27.0 35.8 55.4 62.9 20.5 29.2 35.5 27.9 13.2 30.0 43.5 16.5 12.5 49.0 29.5 50.0 33.2 89.0 173.7 26.3 19.4 33.0 26.4 3.8 4.6 70.3 54.9 34.9 25.0 25.9 32.3 20.6 25.7 23.7 35.9 5.0 5.6 67.6 32.6 16.8 59.3 413.5 30.1 22.5 49.8 1.9 42.4 50.6 38.1 3.0 5.4 72.4 42.1 42.2 53.1 65.5 71.3 62.2 56.0 18.5 32.9 22.2 47.9 73.3 32.7 11.9 22.7 61.0 24.2 22.6 29.0 46.8 RGP1 KIAA0258 ENSG00000107185 "RGP1 homolog, RAB6A GEF complex partner 1" Q92546 9 35749287-35758585 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020414, HPA021085" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA020414: AB_1852289, HPA021085: AB_1852291" "unprognostic (2.10e-1)" "unprognostic (3.22e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.09e-4)" "unprognostic (2.22e-1)" "unprognostic (5.42e-2)" "unprognostic (1.51e-3)" "unprognostic (1.81e-3)" "unprognostic (9.77e-2)" "prognostic favorable (8.55e-13)" "unprognostic (2.46e-2)" "unprognostic (1.68e-1)" "unprognostic (3.03e-3)" "unprognostic (1.18e-1)" 9.9 10.5 7.2 8.7 6.6 5.7 8.6 6.7 6.7 8.0 3.2 13.0 10.8 8.9 7.9 8.7 8.4 6.1 13.0 7.0 7.1 11.6 7.5 9.2 7.5 5.8 6.3 6.3 10.2 10.8 19.3 10.5 9.4 6.3 8.8 13.5 7.9 11.1 11.6 17.4 9.5 11.7 9.9 5.1 7.5 10.4 6.5 6.9 9.0 12.3 18.8 9.7 8.1 6.6 5.7 18.0 16.6 18.9 15.8 17.3 18.6 11.1 13.9 20.1 18.9 17.4 14.2 6.7 13.9 9.7 17.8 34.9 9.9 18.3 26.2 15.5 18.6 10.7 11.9 32.9 10.7 16.3 13.0 16.1 18.8 32.8 19.9 24.0 27.0 22.7 10.6 8.2 7.5 17.3 8.5 4.0 4.7 7.9 14.7 19.2 13.2 13.5 9.9 16.5 12.4 13.8 14.9 12.3 17.0 11.2 16.6 14.2 6.2 29.0 15.1 18.9 10.5 11.8 11.1 16.5 14.3 21.5 5.4 19.7 1.1 0.2 0.4 0.7 0.4 1.1 0.8 0.5 0.8 0.1 1.0 0.6 0.7 0.7 1.1 0.6 0.6 0.5 0.2 7.2 6.6 6.7 6.7 7.0 7.1 5.8 6.3 6.3 6.3 5.1 6.9 5.7 13.9 6.4 12.6 0.0 23.4 5.7 24.5 14.8 9.1 40.8 15.0 10.0 16.6 18.6 15.8 27.6 20.9 10.9 19.1 46.1 13.7 20.1 17.5 9.8 8.3 14.9 43.3 8.6 0.2 17.6 10.6 7.5 18.8 14.9 5.7 33.4 16.1 16.4 7.5 16.8 0.1 26.0 22.4 7.7 6.1 36.8 8.4 5.7 1.8 0.0 11.1 18.8 25.7 0.0 0.1 20.6 38.3 10.9 15.2 25.3 36.3 14.2 17.7 22.3 6.6 11.8 9.3 16.6 6.1 8.1 5.3 10.3 16.4 7.1 28.9 28.8 MPDZ MUPP1 ENSG00000107186 "Multiple PDZ domain crumbs cell polarity complex component" O75970 9 13105706-13279692 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.4" "Cell type enhanced" "Detected in many" "Astrocytes: 121.5;Excitatory neurons: 213.6;Inhibitory neurons: 271.3;Oligodendrocyte precursor cells: 158.8;Oligodendrocytes: 279.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 58.1;HUVEC TERT2: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013512, HPA020255, HPA026686" Enhanced NA NA "CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074" "unprognostic (1.55e-1)" "unprognostic (4.21e-3)" "unprognostic (4.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.28e-2)" "unprognostic (1.03e-1)" "prognostic favorable (8.68e-4)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.50e-1)" "prognostic favorable (7.40e-4)" "unprognostic (1.54e-1)" "unprognostic (2.59e-3)" "unprognostic (1.32e-3)" "unprognostic (2.50e-1)" "unprognostic (1.58e-1)" "unprognostic (9.74e-2)" 22.9 10.0 21.8 5.3 22.3 0.2 13.3 21.2 21.5 13.7 20.1 12.2 2.8 18.0 15.4 7.7 17.7 11.8 30.1 16.8 24.0 18.9 86.4 11.2 3.9 21.2 20.0 17.6 25.8 4.7 11.3 10.8 24.9 20.6 19.3 5.3 33.3 6.3 23.4 20.1 3.5 6.4 18.7 21.8 11.2 7.6 11.6 19.8 4.4 11.8 31.6 1.8 12.7 9.9 36.0 16.1 21.2 58.1 26.0 39.2 35.4 11.8 15.9 16.4 13.8 13.1 0.0 0.0 0.0 4.5 39.6 14.2 0.3 17.3 8.8 22.3 0.0 10.2 10.5 21.9 3.9 20.8 0.1 5.4 26.5 3.6 9.7 6.6 35.3 53.5 0.0 0.3 0.1 12.5 4.2 0.0 0.2 24.9 0.0 9.0 0.0 14.2 0.0 13.7 8.5 7.2 26.9 12.6 2.8 15.5 39.7 8.1 0.1 42.8 14.1 2.7 4.7 12.4 0.0 0.0 0.0 6.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 22.3 21.2 21.5 16.8 24.0 21.2 20.0 17.6 20.6 21.8 19.8 36.0 70.9 32.1 7.9 121.5 0.2 5.1 10.1 4.8 3.4 30.9 8.6 15.6 109.7 1.5 14.7 7.3 39.6 16.1 0.4 0.1 1.9 4.2 4.2 27.0 12.4 44.6 1.8 2.1 213.6 2.0 22.9 27.4 1.5 6.3 1.3 39.5 42.5 74.4 5.8 26.9 271.3 0.2 6.1 0.6 6.8 3.7 24.2 0.9 17.8 60.9 0.6 40.2 0.0 158.8 279.6 1.8 0.0 33.8 0.1 12.9 0.0 16.4 36.6 25.4 39.5 35.1 40.8 6.7 13.9 0.1 4.0 10.8 0.8 7.6 0.0 4.7 LHX3 ENSG00000107187 "LIM homeobox 3" Q9UBR4 9 136196250-136205128 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "pituitary gland: 58.8" "Group enriched" "Detected in some" 11 "Bipolar cells: 24.0;Cardiomyocytes: 22.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.17e-2)" "unprognostic (4.72e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-1)" "unprognostic (3.31e-2)" "unprognostic (6.18e-2)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 58.8 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.8 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 22.8 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DDX58 "DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1" ENSG00000107201 "DExD/H-box helicase 58" O95786 9 32455302-32526208 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8" "CAB012643, HPA047193, HPA073217" Approved Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "CAB012643: , HPA047193: AB_2679978, HPA073217: " "unprognostic (1.10e-1)" "unprognostic (4.65e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.45e-1)" "unprognostic (2.37e-1)" "unprognostic (8.15e-2)" "unprognostic (4.57e-2)" "unprognostic (2.82e-1)" "unprognostic (6.48e-3)" "unprognostic (1.00e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.22e-2)" "unprognostic (3.68e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" 6.2 5.0 3.8 7.5 4.0 1.3 6.0 3.5 4.3 6.0 3.5 5.9 2.9 5.6 4.7 6.4 4.4 6.0 3.9 3.0 5.7 5.6 6.3 7.1 7.4 5.3 3.4 2.5 4.6 5.7 2.6 5.3 5.8 4.3 4.2 5.4 2.3 10.0 3.5 4.8 7.9 7.2 5.7 2.6 9.3 4.9 2.9 3.6 15.7 4.3 1.7 5.3 5.2 5.3 7.6 4.3 2.4 2.5 2.2 7.5 6.4 2.7 2.1 14.6 79.0 76.0 2.4 1.4 0.4 2.7 2.7 22.8 2.8 2.3 1.3 11.4 7.4 0.9 1.1 2.4 3.5 5.0 1.4 4.5 4.9 1.3 6.9 1.3 4.2 14.3 1.5 1.8 1.0 6.6 0.6 3.8 12.4 1.8 0.6 2.0 2.4 3.1 0.0 11.6 0.6 2.0 0.3 1.7 1.7 12.6 1.7 3.5 0.9 13.4 1.5 0.9 1.7 1.1 0.0 0.3 0.9 2.6 3.3 2.1 0.0 0.1 0.3 0.2 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.2 0.2 1.3 0.4 0.2 0.0 0.2 0.0 3.8 4.0 3.5 4.3 3.0 5.7 5.3 3.4 2.5 4.3 2.6 3.6 7.6 41.7 22.4 8.8 20.5 13.9 4.2 5.1 7.2 13.6 4.1 5.8 5.1 5.1 5.7 6.7 1.8 2.1 5.6 13.9 13.8 0.0 19.5 2.7 12.9 8.7 23.6 3.0 5.7 10.4 12.2 7.6 13.9 21.9 20.3 5.1 16.8 9.3 6.7 5.6 6.7 13.2 4.6 4.1 7.3 4.6 0.4 6.5 11.6 0.0 39.4 12.3 6.4 21.6 31.2 17.5 16.2 7.7 6.0 9.1 4.9 16.9 7.2 7.3 2.5 6.6 16.8 13.1 0.5 2.3 10.9 5.4 2.5 17.8 10.4 2.6 5.3 EDF1 "CFAP280, EDF-1" ENSG00000107223 "Endothelial differentiation related factor 1" O60869 9 136862119-136866308 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 2662.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035642 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035642: AB_10611959" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-3)" "unprognostic (4.49e-2)" "unprognostic (2.32e-1)" "unprognostic (9.05e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (4.03e-2)" "unprognostic (2.65e-2)" "unprognostic (9.76e-2)" "unprognostic (1.83e-1)" "unprognostic (2.08e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" 304.8 426.6 377.2 236.2 376.3 302.2 318.4 379.8 515.3 346.2 367.8 340.1 498.7 283.1 213.7 466.6 284.0 193.9 471.9 377.8 384.0 432.7 674.2 281.9 275.6 387.2 376.8 367.1 397.5 721.5 292.3 399.0 204.5 384.4 433.9 208.9 106.0 502.1 232.9 501.7 389.0 490.4 164.1 374.8 312.3 402.4 180.9 380.8 233.4 399.5 324.5 244.2 289.0 346.3 394.4 496.0 646.9 355.3 361.3 342.6 358.5 693.9 555.9 370.3 438.7 339.8 528.1 335.9 429.6 503.5 484.3 392.3 585.0 277.0 424.5 159.7 467.6 338.4 300.4 784.0 727.5 680.2 518.7 394.9 357.4 533.8 344.9 396.9 408.1 426.7 382.7 443.0 540.6 379.7 1071.4 465.6 818.8 375.6 761.1 548.0 404.2 517.5 875.8 592.2 515.4 450.8 433.3 579.8 807.6 587.1 231.9 781.1 715.8 526.6 477.5 363.8 524.5 528.0 311.5 555.7 366.6 625.8 305.7 448.8 290.4 378.6 327.2 351.6 334.9 388.7 430.9 373.6 364.9 379.2 400.3 328.8 343.7 149.3 396.7 282.8 621.6 471.0 544.4 377.2 376.3 379.8 515.3 377.8 384.0 387.2 376.8 367.1 384.4 374.8 380.8 394.4 375.9 227.6 290.8 27.1 357.5 522.1 601.8 717.4 314.1 139.5 530.5 691.1 336.9 480.4 421.8 314.5 39.6 683.0 405.4 1157.4 1154.3 668.1 148.4 266.8 317.2 365.7 443.4 277.0 19.1 1274.9 768.6 332.7 349.7 320.2 291.1 386.5 404.8 822.2 571.2 94.2 20.8 1032.8 376.4 394.7 535.9 292.1 581.6 323.0 526.5 15.9 787.1 352.5 460.3 23.1 39.0 1103.5 1413.9 426.5 409.6 625.2 2662.5 1566.5 314.5 155.6 276.1 389.0 469.0 238.7 237.4 408.3 620.3 1127.5 377.8 364.3 764.7 682.5 PIP5K1B "MSS4, STM7" ENSG00000107242 "Phosphatidylinositol-4-phosphate 5-kinase type 1 beta" O14986 9 68705240-69009176 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 77.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2" "Group enriched" "Detected in many" 4 "colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "eosinophil: 34.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 34.5" "Cell line enhanced" "Detected in some" "AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009687 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA009687: AB_1855391" "unprognostic (2.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.77e-2)" "unprognostic (2.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-3)" "unprognostic (1.80e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.03e-9)" "unprognostic (2.10e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" 3.6 12.0 5.4 6.1 5.2 16.3 4.9 18.0 8.0 6.3 77.5 31.5 35.1 7.5 1.7 1.2 6.1 4.0 32.5 12.2 8.7 7.9 0.3 13.0 2.7 8.1 10.9 4.0 1.0 8.7 13.8 6.7 6.5 7.7 3.1 29.4 38.4 16.5 9.7 2.9 2.1 31.1 2.9 3.8 2.6 26.4 24.9 9.1 1.0 1.2 5.1 3.6 3.3 2.5 6.8 0.0 0.0 43.8 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 4.6 0.0 3.6 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 17.0 0.3 13.4 0.0 0.9 4.4 0.0 2.0 0.0 0.0 0.0 0.1 0.5 0.9 9.3 0.3 1.1 0.1 0.2 2.3 73.1 1.4 1.4 0.1 0.3 0.3 3.4 0.9 0.1 0.0 0.1 0.5 1.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 17.0 3.5 2.3 0.0 3.1 0.0 5.6 0.5 34.5 0.0 0.0 0.0 4.7 0.3 0.1 0.1 5.4 0.7 0.1 1.7 0.0 0.2 1.4 1.6 0.3 5.4 5.2 18.0 8.0 12.2 8.7 8.1 10.9 4.0 7.7 3.8 9.1 6.8 3.6 35.3 34.4 28.7 19.2 0.6 3.2 0.5 0.6 5.1 4.7 3.3 61.6 2.8 2.8 5.5 2.1 21.3 0.0 127.4 27.4 1.6 100.0 12.8 13.6 3.3 37.0 53.6 84.7 14.0 1.3 3.1 40.2 27.5 5.7 3.8 1.4 0.0 3.9 0.0 270.1 32.6 14.2 1.0 1.3 47.6 2.5 5.6 5.4 60.0 2.6 120.2 0.0 80.9 6.4 5.2 46.6 1.5 43.2 2.5 39.2 1.4 6.5 3.3 26.3 2.5 32.2 39.0 4.5 0.7 0.3 8.8 2.1 0.9 29.7 9.8 GLIS3 "MGC33662, ZNF515" ENSG00000107249 "GLIS family zinc finger 3" Q8NEA6 9 3824127-4348392 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Congenital hypothyroidism, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8" "Cell type enriched" "Detected in many" 7 "Astrocytes: 649.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056426 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056426: AB_2683128" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.63e-3)" "unprognostic (4.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.81e-2)" "unprognostic (7.14e-2)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.63e-1)" "unprognostic (1.91e-3)" "unprognostic (6.88e-3)" "unprognostic (8.54e-2)" "unprognostic (1.04e-1)" "unprognostic (6.35e-2)" 3.6 1.6 8.1 2.1 5.2 0.2 1.9 7.9 5.3 7.9 16.8 1.9 0.7 3.4 2.8 0.5 8.8 6.6 2.3 5.2 21.9 7.2 3.3 3.8 1.1 24.8 12.7 2.3 6.6 9.7 2.4 2.4 1.4 9.7 3.3 2.1 1.3 3.1 8.3 1.3 0.7 1.5 2.2 14.8 2.0 1.9 2.8 7.5 0.2 18.8 0.8 0.7 4.0 2.5 14.3 1.0 8.5 2.5 0.0 3.7 9.5 0.4 5.9 21.5 3.1 4.4 1.3 3.4 0.0 4.3 5.5 9.6 0.0 2.0 0.0 6.7 2.5 1.2 0.0 0.4 0.0 11.0 0.9 0.0 29.5 0.0 9.8 1.1 5.8 0.4 0.1 0.0 0.2 2.9 0.4 0.0 1.5 0.2 0.0 0.8 0.0 5.2 0.0 20.8 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 5.5 3.4 0.9 3.2 13.3 0.0 0.0 0.0 8.1 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 8.1 5.2 7.9 5.3 5.2 21.9 24.8 12.7 2.3 9.7 14.8 7.5 14.3 8.1 9.6 24.0 649.7 1.0 1.9 9.3 17.1 0.6 1.0 4.6 1.3 1.6 75.8 34.5 69.9 0.0 3.2 0.3 3.7 0.0 51.0 5.2 79.6 17.5 11.2 43.7 0.0 18.3 22.6 3.2 21.9 4.1 82.3 1.3 1.6 6.8 8.3 2.4 0.0 54.2 1.6 12.2 0.8 4.0 2.4 13.7 3.4 3.6 86.2 2.2 15.6 0.0 26.7 4.1 49.1 3.9 11.3 0.0 16.5 2.4 16.4 35.7 0.4 0.0 34.4 19.0 1.3 7.4 0.6 1.3 4.2 1.2 8.8 6.6 6.1 BAG1 ENSG00000107262 "BAG cochaperone 1" Q99933 9 33247820-33264720 "Cancer-related genes, Predicted intracellular proteins" Apoptosis Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1043.2;Late spermatids: 2944.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 437.5;NB-4: 417.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002486, HPA018121, HPA073236" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB002486: AB_563422, HPA018121: AB_1845255, HPA073236: " "unprognostic (4.49e-3)" "unprognostic (4.52e-2)" "unprognostic (2.33e-2)" "unprognostic (1.32e-3)" "unprognostic (5.46e-2)" "unprognostic (3.67e-3)" "unprognostic (2.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.62e-2)" "unprognostic (7.21e-2)" "unprognostic (4.24e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.22e-16)" "unprognostic (4.45e-2)" "unprognostic (4.03e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-2)" 76.2 77.0 105.9 36.6 113.6 85.8 72.9 111.1 112.6 59.4 111.2 108.7 59.8 60.3 54.4 104.1 55.3 39.5 176.4 96.0 112.5 134.5 84.1 83.2 35.8 117.3 115.1 92.3 46.0 92.5 140.8 100.0 47.5 130.7 88.8 76.1 82.9 98.2 69.1 300.2 110.5 66.7 43.1 109.5 66.5 103.4 88.5 126.5 45.5 72.2 207.9 55.6 122.6 79.5 107.7 56.0 56.1 46.8 103.3 69.9 40.9 63.6 46.5 64.6 68.4 69.8 39.7 54.1 181.2 33.6 46.6 24.5 69.8 54.8 37.9 45.0 96.5 52.1 90.2 437.5 62.5 58.9 210.1 110.0 41.5 205.6 32.3 76.8 32.2 82.4 48.0 108.7 92.1 57.8 89.7 152.4 417.0 90.8 73.9 81.2 78.7 63.7 119.6 87.1 164.8 149.1 88.5 192.7 176.9 46.0 18.7 80.5 261.8 44.1 30.5 37.8 89.9 78.0 74.9 125.3 100.4 25.5 114.1 17.7 29.1 20.7 57.9 10.0 22.2 9.0 14.7 11.2 11.9 26.1 25.6 15.7 9.1 10.2 15.3 22.3 33.9 15.2 10.2 105.9 113.6 111.1 112.6 96.0 112.5 117.3 115.1 92.3 130.7 109.5 126.5 107.7 107.7 89.8 67.5 5.2 69.4 429.9 279.4 193.3 172.4 84.0 134.1 123.6 144.4 127.2 157.0 218.8 58.4 154.7 113.7 211.4 397.2 135.6 1043.2 109.3 72.2 86.6 198.1 259.1 5.9 189.0 59.9 79.4 104.5 193.3 41.9 36.7 66.8 72.8 104.9 38.7 7.1 287.8 170.9 86.4 162.7 2944.9 85.7 93.9 163.7 2.8 81.0 123.9 88.6 4.5 9.7 131.1 259.2 88.8 110.3 505.4 247.9 286.1 71.8 131.3 98.6 98.5 109.9 87.9 64.4 261.1 561.5 245.9 69.6 103.7 222.4 531.4 RAPGEF1 "C3G, GRF2" ENSG00000107263 "Rap guanine nucleotide exchange factor 1" Q13905 9 131576770-131740074 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 230.4" "Cell type enhanced" "Detected in all" "Horizontal cells: 131.2;Langerhans cells: 108.6;Microglial cells: 123.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006426, HPA075984" Enhanced Supported Vesicles NA NA Vesicles "HPA006426: AB_1856070, HPA075984: AB_2686771" "unprognostic (1.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.43e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-1)" "unprognostic (4.11e-2)" "unprognostic (1.74e-1)" "unprognostic (5.50e-2)" "unprognostic (6.04e-2)" "unprognostic (1.94e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.18e-5)" "unprognostic (5.66e-2)" "unprognostic (1.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.73e-2)" 37.7 24.2 41.1 54.4 60.5 53.7 27.0 22.4 34.0 20.6 30.5 29.0 24.2 25.8 8.1 23.9 25.7 23.9 52.2 37.5 36.7 23.2 23.2 43.7 56.5 34.5 31.7 30.6 16.4 48.2 20.3 16.5 56.8 30.0 21.7 23.6 27.7 20.4 21.6 230.4 22.1 35.6 30.7 18.9 42.3 29.3 16.0 34.1 35.4 22.9 105.7 63.6 26.0 18.3 36.0 34.5 39.4 39.1 39.6 39.1 42.0 149.2 29.0 59.0 33.0 23.6 49.0 22.1 61.9 35.6 58.8 70.7 61.4 45.1 40.5 16.4 144.6 18.6 18.3 67.2 26.2 32.8 76.1 80.4 32.2 73.0 43.3 51.0 33.1 60.4 70.8 49.7 119.1 43.4 35.7 54.0 27.0 39.6 34.1 35.2 53.0 91.0 86.8 14.9 41.1 33.0 32.9 42.5 39.8 42.3 39.0 38.1 63.1 64.4 88.1 36.7 56.4 44.7 39.8 37.3 122.0 41.9 32.0 21.6 3.1 1.2 1.6 3.4 2.2 2.0 4.9 2.3 2.3 1.4 2.9 0.5 1.5 1.3 1.3 2.4 1.6 1.8 1.6 41.1 60.5 22.4 34.0 37.5 36.7 34.5 31.7 30.6 30.0 18.9 34.1 36.0 73.5 6.4 13.8 27.1 35.6 18.7 9.3 10.9 5.2 19.5 10.8 13.5 16.2 14.3 12.3 5.5 14.6 22.7 49.7 23.3 5.9 8.2 2.6 13.0 9.4 43.0 12.1 1.7 47.5 18.6 35.3 11.8 17.9 17.8 20.3 14.0 22.5 17.4 26.4 131.2 66.6 14.9 8.2 23.9 108.6 2.5 8.7 51.6 32.0 123.7 59.8 19.7 27.8 61.3 24.7 17.1 19.1 12.0 88.0 11.7 16.8 9.2 16.7 13.4 6.6 13.4 10.3 5.1 11.8 5.6 11.4 51.7 31.0 5.8 14.0 10.8 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039463-137046179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 397.0;Endothelial cells: 307.2;Enteroendocrine cells: 281.6;Hepatic stellate cells: 406.2;Intestinal goblet cells: 589.1" "Cancer enhanced" "Detected in all" "prostate cancer: 146.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 12.3;MAIT T-cell: 14.7;memory CD4 T-cell: 19.0;memory CD8 T-cell: 18.9;T-reg: 15.9" "Lineage enriched" "Detected in many" 5 "T-cells: 19.0" "Cell line enhanced" "Detected in many" "MCF7: 138.4;RPMI-8226: 132.8;T-47d: 140.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol NA NA 240000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.01e-5)" "prognostic favorable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 121.0 46.1 117.4 12.3 105.6 3.5 134.1 86.5 182.8 120.3 42.6 93.4 23.6 122.6 4.3 54.2 149.9 25.2 128.8 120.4 112.2 76.1 23.9 116.5 13.1 117.6 120.6 111.3 68.8 81.8 23.2 268.1 21.3 102.5 262.7 13.6 9.3 138.5 35.4 34.3 50.9 72.7 17.0 92.3 146.4 127.3 35.6 121.0 2.9 68.9 12.6 4.0 98.8 91.2 93.8 33.6 41.9 10.1 67.1 23.7 23.8 2.8 68.7 23.0 16.9 6.7 17.1 18.5 30.3 50.7 28.6 4.6 122.4 8.6 20.5 1.6 25.0 40.4 13.6 123.7 12.9 33.3 11.9 0.3 16.5 31.9 8.7 17.9 43.1 43.6 13.2 0.7 0.8 3.5 138.4 1.0 1.1 21.1 111.0 68.1 19.9 0.0 132.8 28.6 22.7 77.2 50.0 18.4 65.3 46.5 3.6 140.1 17.9 73.9 12.4 21.6 84.1 21.0 0.1 0.4 1.4 17.7 1.2 10.5 0.0 0.6 0.9 12.3 0.1 14.7 0.1 19.0 18.9 1.1 0.0 0.5 3.1 0.0 0.2 0.1 3.4 15.9 3.3 117.4 105.6 86.5 182.8 120.4 112.2 117.6 120.6 111.3 102.5 92.3 121.0 93.8 397.0 0.0 7.7 64.3 3.4 23.6 77.6 15.0 31.3 97.5 174.0 139.7 18.3 71.4 19.8 29.5 16.7 1.1 5.5 122.2 0.0 52.5 1.8 39.0 27.7 307.2 281.6 19.3 71.7 66.0 1.3 61.2 153.9 101.3 0.0 9.2 406.2 1.9 22.2 62.2 64.7 589.1 18.3 21.0 20.0 6.9 161.2 6.6 30.2 37.5 3.0 38.5 1.0 38.2 39.0 33.0 106.0 145.6 1.4 234.9 37.5 0.7 7.5 62.0 39.5 23.9 38.9 2.8 19.0 15.9 23.7 1.8 12.3 9.1 98.1 103.1 APBA1 "D9S411E, MINT1, X11" ENSG00000107282 "Amyloid beta precursor protein binding family A member 1" Q02410 9 69427532-69672371 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3" "Group enriched" "Detected in many" 7 "Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061287 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA061287: AB_2684467" "unprognostic (4.02e-2)" "unprognostic (4.64e-2)" "unprognostic (7.29e-2)" "unprognostic (8.94e-3)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (4.21e-3)" "unprognostic (8.49e-3)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.46e-5)" "unprognostic (1.60e-1)" "unprognostic (3.09e-2)" "unprognostic (4.99e-3)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.66e-3)" 2.8 1.2 13.6 0.7 13.4 0.0 2.5 0.0 16.7 3.4 0.0 2.8 0.6 4.2 0.1 1.8 2.5 1.3 2.6 14.7 8.4 2.2 12.0 1.4 0.6 14.2 13.3 15.3 5.3 1.9 6.9 6.3 1.4 13.4 1.9 1.9 3.2 2.9 1.1 2.0 3.9 1.8 0.8 0.0 3.8 2.0 2.8 9.7 0.2 2.0 0.7 0.3 2.9 3.6 24.3 0.0 0.0 0.6 0.0 3.1 2.2 0.1 7.2 6.0 0.1 0.1 0.0 0.0 0.0 3.2 3.0 0.0 0.1 17.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 2.9 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 2.5 6.5 4.2 0.4 0.9 0.1 0.2 0.0 0.0 7.8 6.9 0.8 0.0 0.5 7.1 3.3 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 13.4 0.0 16.7 14.7 8.4 14.2 13.3 15.3 13.4 0.0 9.7 24.3 1.0 0.0 0.0 53.5 0.0 1.8 1.2 0.2 0.0 15.4 2.0 2.2 4.9 0.0 0.2 0.0 4.2 0.8 0.0 3.7 0.0 0.1 0.3 0.9 1.7 1.4 4.2 0.0 130.3 0.0 0.6 1.7 0.0 1.0 0.0 1.3 3.3 5.8 3.1 69.0 181.6 1.6 0.0 3.7 1.4 0.6 2.5 1.4 0.0 78.7 1.0 3.2 0.0 141.3 106.2 0.2 0.4 10.9 0.0 0.6 0.0 0.4 0.1 9.1 0.0 1.6 2.3 1.1 1.3 0.5 2.4 0.4 0.5 6.0 1.2 0.4 SETX "ALS4, AOA2, KIAA0625, SCAR1, Sen1" ENSG00000107290 Senataxin Q7Z333 9 132261356-132354986 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis" "Helicase, Hydrolase" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024105, HPA057269" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA024105: AB_2671437, HPA057269: AB_2683389" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (3.23e-1)" "unprognostic (2.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-2)" "unprognostic (4.86e-2)" "unprognostic (1.64e-2)" "unprognostic (2.06e-2)" "unprognostic (1.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.32e-1)" "unprognostic (6.76e-3)" "unprognostic (2.47e-1)" "unprognostic (1.13e-1)" "unprognostic (5.64e-3)" "unprognostic (6.42e-2)" 13.8 9.5 6.0 20.1 8.6 17.0 14.1 9.8 6.8 13.3 8.1 13.3 10.7 12.8 11.2 10.7 11.0 12.9 10.6 5.2 10.0 12.0 16.9 15.6 27.6 8.7 7.0 4.2 13.2 9.3 18.5 6.1 14.4 9.0 13.1 12.9 13.4 9.1 12.8 13.0 12.4 13.3 12.9 8.1 27.8 13.0 32.2 7.2 25.6 33.3 12.9 26.5 15.8 8.6 13.2 15.1 19.9 22.5 24.4 28.3 34.1 13.5 19.6 21.9 15.6 14.6 21.1 16.8 25.6 9.4 36.9 38.3 30.2 22.8 17.0 17.0 24.6 9.9 26.9 22.7 18.4 26.5 41.8 31.2 24.0 26.2 26.6 23.6 19.1 25.4 17.8 31.7 20.0 18.3 21.8 25.9 15.8 24.2 25.4 15.4 24.2 32.6 17.2 17.1 19.5 14.0 21.4 32.4 14.2 18.2 29.7 19.7 21.2 29.3 32.5 14.0 22.1 19.0 12.2 22.0 38.6 14.9 16.3 17.8 10.5 4.4 4.7 5.3 4.1 5.6 5.5 3.9 4.1 3.3 6.9 4.2 3.7 15.1 5.2 4.9 5.0 3.2 2.3 6.0 8.6 9.8 6.8 5.2 10.0 8.7 7.0 4.2 9.0 8.1 7.2 13.2 76.2 60.9 45.7 75.1 85.6 30.2 34.6 26.6 38.7 31.2 24.1 22.7 61.3 17.2 43.9 20.2 29.2 13.7 96.8 37.6 3.9 20.0 7.6 62.7 68.0 58.7 14.5 25.5 73.7 14.7 10.6 52.9 44.4 89.7 58.2 38.3 51.4 33.0 28.8 67.3 64.8 30.6 16.2 73.1 37.6 13.8 30.7 75.5 12.4 131.2 75.8 20.7 87.6 65.9 113.0 23.2 31.9 36.1 61.8 49.3 25.6 18.5 54.4 28.7 13.1 44.9 42.5 145.2 38.5 35.1 33.5 9.4 65.9 53.7 26.9 46.4 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579066-17797124 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 114.4;retina: 75.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045" "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 0.2 0.2 56.9 0.1 83.7 0.0 0.1 111.2 114.4 2.3 20.4 0.5 0.2 2.2 1.3 0.5 2.0 0.0 4.3 85.0 60.4 17.0 0.2 1.1 0.0 48.3 51.6 80.0 1.8 3.0 0.3 26.4 0.0 56.1 1.8 0.6 75.6 0.1 0.1 0.1 0.1 0.5 1.7 44.1 0.1 8.8 6.5 53.5 0.7 1.5 0.0 0.0 4.3 0.4 79.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 7.5 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 9.3 0.0 21.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 18.7 0.0 0.1 0.0 0.0 0.1 0.2 2.5 0.0 2.4 0.0 0.0 0.0 0.0 41.8 26.5 0.0 0.3 0.0 0.8 0.8 0.0 0.0 0.0 0.0 2.2 0.0 1.5 0.0 0.4 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 83.7 111.2 114.4 85.0 60.4 48.3 51.6 80.0 56.1 44.1 53.5 79.3 0.0 0.0 0.0 16.3 0.0 0.1 0.4 0.0 0.0 89.4 0.1 0.0 1.8 0.0 0.0 7.3 22.9 0.0 0.0 0.1 11.7 0.0 16.7 0.2 0.1 0.3 5.3 0.0 390.8 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 13.5 140.9 0.7 0.0 0.0 0.3 47.4 1.2 0.1 0.0 13.1 0.1 9.0 0.0 41.7 10.2 0.2 0.1 0.4 0.0 2.2 0.0 22.2 0.0 28.0 0.0 0.0 0.1 2.4 6.1 0.0 0.0 0.1 0.0 1.2 0.7 0.4 PTGDS "L-PGDS, PGDS" ENSG00000107317 "Prostaglandin D2 synthase" P41222 9 136975092-136981742 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 2578.9;heart muscle: 4705.5;testis: 3267.4" "Group enriched" "Detected in many" 11 "Leydig cells: 38051.3;Peritubular cells: 65156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 27 "plasmacytoid DC: 1386.8" "Lineage enriched" "Detected in many" 27 "dendritic cells: 1386.8" "Group enriched" "Detected in some" 6 "HHSteC: 518.7;HSkMC: 252.0" "HPA004938, CAB009916, HPA067456" Uncertain "Secreted to blood" NA NA 2500000000 "CAB009916: AB_2174617, HPA004938: AB_1855745, HPA067456: " "unprognostic (2.79e-2)" "unprognostic (3.96e-3)" "unprognostic (9.70e-2)" "unprognostic (5.71e-3)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (2.85e-1)" "unprognostic (2.01e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.19e-7)" "unprognostic (8.49e-3)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (3.21e-2)" 231.0 299.5 1767.5 249.4 2130.7 10.0 122.1 2234.7 2578.9 1396.7 1396.5 77.6 31.8 323.1 742.3 173.9 496.3 400.3 4705.5 1558.0 1807.7 453.2 80.8 613.1 831.0 2156.5 2083.8 1363.9 67.4 114.1 9.2 401.6 229.7 2083.3 733.2 17.8 147.4 98.7 820.5 109.3 155.9 207.6 100.6 1934.4 320.3 93.8 3267.4 2022.0 128.5 55.6 60.5 308.5 232.4 1191.1 2406.3 0.1 0.0 0.1 0.0 5.4 16.7 8.8 0.3 0.0 0.0 0.0 0.0 0.2 0.6 4.0 24.0 0.0 0.8 0.6 0.2 0.0 0.0 0.0 0.0 1.4 0.3 518.7 0.3 1.3 252.0 0.1 0.0 0.0 1.8 0.0 0.0 0.6 1.0 0.2 0.0 0.0 6.6 0.9 8.2 0.0 0.1 0.2 1.6 0.0 0.0 1.6 2.0 0.0 0.6 0.0 0.1 0.6 68.3 0.7 0.2 0.2 2.1 0.1 0.3 0.0 0.1 3.9 0.0 0.9 0.0 0.3 0.4 50.5 1.0 3.4 0.3 4.3 6.3 1.8 0.2 0.9 9.9 2.3 3.8 0.2 1386.8 1.4 11.2 1767.5 2130.7 2234.7 2578.9 1558.0 1807.7 2156.5 2083.8 1363.9 2083.3 1934.4 2022.0 2406.3 29.3 0.0 0.6 665.0 1.5 70.4 3.2 0.1 5.7 46.8 6.6 14.7 333.6 8.6 0.1 138.0 52.1 14.4 1863.6 0.2 68.4 0.3 215.9 29.7 1156.5 167.8 0.0 13.5 4.0 0.0 55.0 1584.0 1.1 20.1 1.3 0.3 46.1 1.6 57.3 21.9 12.8 0.0 0.0 3.4 161.8 1230.9 38051.3 57.0 209.9 176.1 4.6 4625.8 583.9 63.3 850.4 1.7 0.0 65156.8 6.0 20.7 0.0 1.1 0.0 130.3 164.3 787.4 124.8 130.7 111.1 12.0 80.1 35.4 61.3 0.1 0.0 14.5 ABCA2 ABC2 ENSG00000107331 "ATP binding cassette subfamily A member 2" Q9BZC7 9 137007234-137028922 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 515.5" "Cell type enriched" "Detected in many" 10 "Oligodendrocytes: 388.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 66.4" "Low region specificity" "Detected in all" HPA042886 Approved Supported Vesicles NA NA Vesicles "HPA042886: AB_2678213" "unprognostic (1.01e-2)" "unprognostic (9.21e-3)" "unprognostic (9.59e-2)" "unprognostic (6.15e-2)" "unprognostic (1.02e-1)" "unprognostic (8.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.13e-2)" "unprognostic (5.61e-3)" "unprognostic (1.76e-1)" "unprognostic (2.93e-2)" "unprognostic (2.74e-2)" "unprognostic (6.78e-3)" "unprognostic (3.14e-3)" "unprognostic (1.37e-1)" "unprognostic (2.80e-1)" "unprognostic (1.36e-1)" 9.1 6.1 66.3 4.3 210.6 6.8 6.3 158.1 127.8 5.3 0.0 7.5 3.1 4.3 4.5 3.3 6.3 6.0 8.8 60.6 108.7 7.1 7.4 6.2 4.6 233.6 190.7 32.6 3.2 9.4 13.5 23.5 3.1 243.7 7.2 2.2 2.8 8.5 4.7 7.4 6.6 6.5 2.4 167.3 9.6 11.7 2.9 162.0 2.9 15.3 3.6 1.8 5.7 5.3 515.5 8.6 9.2 4.5 18.2 11.1 11.8 7.9 9.5 3.8 4.2 1.5 2.8 10.3 0.4 26.2 10.2 4.1 14.4 2.9 6.9 0.8 6.4 5.9 0.8 26.2 3.5 5.5 13.3 14.5 5.0 6.3 3.0 0.9 15.3 2.4 2.7 2.2 1.5 5.3 25.7 0.1 29.1 2.4 10.9 9.5 13.3 4.6 13.0 2.9 2.0 17.4 20.0 10.1 19.6 7.2 0.3 66.4 17.4 11.9 11.2 6.1 16.0 3.9 0.3 0.2 0.1 19.0 2.6 5.8 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.6 0.2 0.3 66.3 210.6 158.1 127.8 60.6 108.7 233.6 190.7 32.6 243.7 167.3 162.0 515.5 7.2 0.0 0.0 26.1 2.3 3.3 1.5 7.1 3.4 12.6 6.2 9.1 5.1 17.2 2.3 1.8 14.6 1.0 24.0 15.2 1.9 2.9 1.0 6.7 4.8 4.7 34.7 6.6 23.4 1.5 1.2 6.4 5.1 6.9 0.0 12.6 6.1 8.6 1.2 37.0 20.8 7.0 2.0 3.5 4.6 1.6 22.1 2.7 5.4 4.7 0.9 12.8 24.7 12.5 388.7 2.3 7.1 23.7 6.7 2.4 11.6 1.4 4.9 7.9 0.0 11.4 4.7 0.5 4.7 1.7 2.7 0.8 13.2 2.8 11.0 1.3 SHB ENSG00000107338 "SH2 domain containing adaptor protein B" Q15464 9 37915898-38069227 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 22 "basophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "OE19: 35.3" "Low region specificity" "Detected in all" "CAB010161, HPA049911, HPA052108" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Nucleoplasm, Cytoplasmic bodies" "CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730" "unprognostic (4.57e-2)" "unprognostic (1.13e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (5.96e-3)" "unprognostic (2.48e-2)" "unprognostic (3.31e-3)" "unprognostic (7.68e-3)" "unprognostic (1.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.10e-1)" 10.1 7.6 6.6 1.9 8.6 3.1 9.9 5.4 7.0 6.8 7.0 10.2 3.6 6.6 1.2 26.4 7.3 4.9 19.8 6.2 8.6 17.9 35.5 14.0 1.3 7.9 8.9 3.7 4.8 20.2 4.1 15.1 2.5 10.1 16.2 2.6 0.9 23.4 4.7 6.9 17.3 7.1 3.2 5.3 6.7 10.7 4.1 8.0 1.7 8.4 1.3 2.5 13.7 16.2 11.8 8.3 14.6 1.4 0.2 1.5 3.8 2.5 9.8 11.5 6.9 5.0 4.5 5.8 0.0 10.9 8.5 16.9 8.8 5.8 14.2 4.8 6.7 11.0 0.0 5.3 10.7 10.8 0.4 0.4 3.4 4.9 11.2 7.8 16.1 6.5 1.4 3.6 2.4 7.7 6.2 0.9 0.3 3.7 35.3 13.0 0.4 4.3 0.5 13.1 3.8 15.8 12.1 1.3 10.9 2.2 11.9 6.5 0.4 9.2 3.3 11.0 1.6 16.2 0.7 0.2 0.1 18.3 0.8 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 8.6 5.4 7.0 6.2 8.6 7.9 8.9 3.7 10.1 5.3 8.0 11.8 21.5 6.4 5.6 9.8 0.6 20.4 96.9 9.9 33.0 0.6 12.7 6.0 9.6 35.8 9.0 22.0 8.4 10.2 1.1 17.3 15.6 18.0 1.9 8.3 2.5 19.0 7.8 5.2 6.4 20.3 1.5 5.5 14.8 18.3 0.0 0.9 10.4 21.6 6.1 0.0 5.4 12.1 2.0 2.6 19.4 3.8 0.6 5.8 7.2 8.4 0.4 2.9 0.0 5.0 43.7 22.2 6.8 0.4 1.9 31.1 7.5 24.9 5.1 1.4 0.0 5.7 3.9 1.2 9.4 19.3 34.0 4.0 1.2 9.3 11.1 45.9 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817160-33920399 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 30.0 20.8 26.2 20.3 27.8 15.5 27.4 25.3 28.2 29.2 21.8 28.2 28.2 28.7 16.4 29.4 24.1 18.8 30.5 25.6 25.4 22.1 33.6 28.5 21.9 28.0 26.7 24.0 30.3 53.8 14.6 15.1 24.1 27.9 21.1 19.8 25.2 21.7 18.5 63.7 33.5 25.0 26.1 25.6 23.3 22.3 45.1 26.2 30.4 18.5 45.2 25.6 26.9 29.0 31.0 41.2 42.0 78.7 35.0 42.0 68.2 25.1 34.7 46.5 38.7 38.3 34.0 28.7 33.9 14.4 47.2 28.3 17.8 41.5 38.5 41.8 58.3 22.7 28.7 43.7 43.3 60.1 34.6 31.0 58.4 55.6 31.8 59.2 61.5 65.8 39.8 28.0 35.0 38.7 22.6 68.0 91.4 46.2 33.1 34.7 63.2 24.0 17.6 41.1 28.9 37.6 45.4 40.1 35.2 27.0 49.5 31.3 41.9 50.3 37.8 35.4 26.8 32.9 23.5 23.0 46.5 36.0 19.7 83.5 22.6 10.9 6.3 2.8 11.1 1.7 4.6 2.6 2.2 6.1 4.8 2.5 2.3 31.7 7.4 18.7 3.7 3.3 4.0 26.2 27.8 25.3 28.2 25.6 25.4 28.0 26.7 24.0 27.9 25.6 26.2 31.0 73.7 22.4 30.7 39.8 38.6 105.5 46.3 26.1 32.5 65.8 57.8 60.8 134.8 57.2 26.8 22.0 14.6 69.5 46.4 64.7 15.6 49.7 311.1 65.7 84.9 74.9 72.0 36.6 67.8 69.4 82.0 57.4 25.5 81.8 13.3 99.2 84.9 88.3 76.6 60.6 67.0 55.4 32.6 123.5 112.2 257.4 67.1 110.6 35.6 40.3 116.4 124.3 42.2 45.2 127.8 84.7 49.1 76.0 24.0 83.9 79.1 59.8 25.0 31.2 59.2 48.3 55.6 94.4 64.6 41.8 120.5 82.8 34.9 68.0 48.7 121.2 ABHD17B "C9orf77, CGI-67, FAM108B1" ENSG00000107362 "Abhydrolase domain containing 17B, depalmitoylase" Q5VST6 9 71862452-71911193 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 63.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047862 Uncertain NA NA "HPA047862: AB_10959595" "unprognostic (7.47e-2)" "unprognostic (4.41e-2)" "unprognostic (4.03e-3)" "unprognostic (5.59e-2)" "unprognostic (5.57e-2)" "unprognostic (8.53e-3)" "unprognostic (9.44e-2)" "unprognostic (6.84e-2)" "unprognostic (5.46e-2)" "unprognostic (3.44e-2)" "unprognostic (3.49e-2)" "unprognostic (1.74e-1)" "prognostic favorable (2.59e-4)" "unprognostic (4.33e-2)" "unprognostic (2.12e-1)" "unprognostic (3.06e-3)" "unprognostic (1.34e-2)" 8.1 7.3 16.4 6.9 25.9 19.3 8.0 20.0 21.2 8.3 10.0 10.5 16.1 9.3 4.1 16.2 8.7 8.2 6.1 16.8 20.4 11.8 12.4 8.9 11.0 22.5 22.1 14.1 7.1 6.2 10.5 5.9 7.2 24.0 9.3 10.1 25.7 10.7 4.3 16.5 12.0 13.5 8.6 21.4 8.5 7.5 11.7 20.9 33.4 8.1 10.2 10.2 13.1 10.9 45.0 11.2 11.6 26.7 15.0 12.8 8.6 19.0 12.1 14.8 11.5 9.4 3.8 7.4 25.1 10.0 9.3 9.8 22.5 27.5 8.9 12.5 13.7 11.8 15.3 19.4 11.8 8.9 18.6 24.2 10.5 11.7 10.5 9.4 10.2 14.5 48.2 12.4 13.0 9.4 6.0 50.6 14.9 36.1 15.9 13.9 63.3 19.0 0.2 12.6 25.5 15.9 17.5 12.3 14.3 11.0 19.2 4.8 14.5 11.7 10.5 12.4 19.5 9.9 11.0 14.8 21.0 8.7 13.4 5.1 3.5 1.9 1.9 1.3 0.6 1.2 1.9 1.7 1.9 2.2 4.2 1.3 1.9 1.2 3.2 0.6 2.6 2.5 0.8 16.4 25.9 20.0 21.2 16.8 20.4 22.5 22.1 14.1 24.0 21.4 20.9 45.0 16.1 6.4 6.3 17.6 20.2 17.1 29.4 7.4 12.0 16.9 9.7 7.2 8.8 7.2 10.1 5.5 12.5 10.7 33.0 31.5 11.7 8.7 25.0 20.9 12.4 11.7 8.9 7.4 30.8 5.7 8.2 7.6 16.8 13.0 17.2 7.8 12.1 9.4 6.1 5.0 29.1 32.8 6.1 7.7 16.6 9.6 11.5 11.1 5.4 11.2 8.8 27.5 19.6 37.7 136.7 4.6 19.5 10.5 11.4 20.5 21.8 10.7 17.2 57.8 0.0 24.7 13.7 32.2 18.5 15.2 9.8 7.3 20.0 5.3 13.1 54.2 EXOSC3 "CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p" ENSG00000107371 "Exosome component 3" Q9NQT5 9 37759234-37832117 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020485 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA020485: AB_10960685" "unprognostic (7.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (3.06e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (1.71e-3)" "unprognostic (5.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.20e-2)" "unprognostic (9.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.04e-1)" 9.4 12.4 5.6 9.8 5.9 6.5 9.2 9.0 6.5 10.2 5.4 9.1 7.3 9.8 4.3 14.5 8.9 4.2 7.8 5.5 6.8 8.9 10.2 7.6 11.2 5.3 5.7 4.6 10.4 7.9 6.9 8.6 6.7 6.1 9.5 6.2 5.3 9.4 6.6 11.5 8.2 9.0 5.2 5.7 10.9 9.0 21.8 6.3 13.0 8.5 5.4 11.9 10.3 11.6 7.3 69.2 46.8 25.1 32.5 16.5 13.4 33.7 38.5 15.0 31.7 29.6 63.0 11.1 52.3 29.0 14.3 36.2 26.2 28.3 27.3 35.7 75.1 46.9 43.4 57.5 59.3 19.4 66.7 38.5 9.1 13.5 24.0 15.2 10.2 17.0 38.1 108.7 24.7 22.8 40.9 59.3 53.1 69.6 61.7 53.9 53.9 31.2 29.2 17.9 22.0 36.8 36.4 21.9 18.0 26.3 19.8 23.7 48.0 19.7 25.4 47.1 32.0 62.2 16.5 45.4 70.7 25.7 51.2 28.9 34.1 44.4 36.8 35.6 53.9 45.7 53.1 42.9 47.8 42.4 49.1 43.0 41.3 27.8 40.2 49.3 50.4 51.2 55.6 5.6 5.9 9.0 6.5 5.5 6.8 5.3 5.7 4.6 6.1 5.7 6.3 7.3 14.7 22.4 19.9 3.3 25.8 54.2 32.7 47.2 8.6 7.4 17.1 19.3 7.8 22.8 24.0 7.3 0.0 58.0 22.6 13.5 33.2 40.6 74.3 19.2 20.1 14.6 10.7 29.5 4.3 34.9 76.7 20.9 8.6 13.2 29.2 23.7 12.8 13.1 45.4 6.7 4.1 14.9 22.4 19.9 17.9 16.4 16.8 17.6 19.6 1.9 26.3 11.2 20.6 2.5 5.9 34.9 17.7 13.2 19.9 27.6 15.7 32.7 21.9 7.5 26.3 17.6 30.6 132.4 53.1 20.0 54.1 31.5 19.6 28.9 20.2 27.2 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351413-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 595.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 450.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018129, HPA077824" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA018129: AB_1859012, HPA077824: " "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 315.0 189.5 118.4 55.8 122.6 146.9 151.3 121.4 131.6 94.9 89.1 80.7 39.8 91.7 116.8 100.7 121.6 88.1 118.8 120.1 160.5 115.9 206.4 109.5 47.3 116.4 127.4 118.0 252.5 74.2 69.7 139.8 79.9 131.9 77.5 49.7 51.2 70.4 122.5 595.9 74.7 69.6 95.7 117.2 60.9 96.3 89.3 126.2 52.8 79.9 276.3 59.6 109.9 87.9 124.8 115.9 113.0 138.8 59.4 156.5 77.3 104.3 131.9 178.9 71.1 55.1 14.5 112.6 60.4 81.3 194.5 105.2 122.4 305.1 50.4 103.4 450.1 43.1 53.5 57.7 70.1 120.4 74.7 71.1 99.0 87.6 72.7 79.2 156.3 122.1 60.4 49.8 82.1 82.6 31.3 96.3 38.8 178.9 107.2 74.3 74.1 72.4 70.5 218.4 109.3 101.2 86.4 85.2 91.2 117.2 142.1 42.1 64.3 97.1 57.4 71.7 104.7 90.9 113.9 110.3 38.1 77.2 49.1 146.3 39.0 35.9 37.3 11.2 52.1 12.0 17.0 14.6 14.1 33.6 15.1 13.2 12.2 27.7 19.2 81.6 6.2 11.2 23.9 118.4 122.6 121.4 131.6 120.1 160.5 116.4 127.4 118.0 131.9 117.2 126.2 124.8 370.7 176.3 192.1 102.8 125.8 339.2 573.2 130.6 376.7 93.9 267.0 207.1 322.6 92.9 132.6 132.4 75.0 145.1 118.6 213.3 148.7 145.8 91.8 257.1 291.9 195.3 136.7 155.6 45.7 142.6 164.8 270.8 145.2 527.6 109.2 116.1 97.5 308.3 198.0 40.4 38.6 119.8 126.1 290.6 320.1 44.5 118.4 470.1 208.1 31.9 268.8 84.2 53.5 38.7 67.2 185.9 221.3 93.3 149.3 329.9 87.2 127.1 109.2 70.6 85.5 674.9 285.2 148.7 116.4 298.1 291.2 226.3 165.5 102.9 109.4 528.2 DVL1 ENSG00000107404 "Dishevelled segment polarity protein 1" O14640 1 1335276-1349418 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "PC-3: 154.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011538, HPA073607" Approved NA NA "CAB011538: AB_2093326, HPA073607: " "unprognostic (2.67e-1)" "unprognostic (4.34e-3)" "unprognostic (2.13e-3)" "unprognostic (2.05e-2)" "unprognostic (9.58e-2)" "unprognostic (1.51e-1)" "unprognostic (2.81e-3)" "unprognostic (5.03e-3)" "unprognostic (1.78e-2)" "unprognostic (2.96e-2)" "unprognostic (1.62e-3)" "unprognostic (5.35e-2)" "unprognostic (4.03e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.34e-2)" "unprognostic (2.55e-2)" 33.0 50.3 44.8 11.9 38.8 9.6 34.3 26.5 71.9 41.3 17.9 45.4 29.1 37.9 8.4 65.5 43.1 11.8 60.5 44.8 28.1 36.9 57.3 35.7 9.6 37.0 32.7 42.1 43.3 64.4 21.4 44.0 15.1 34.7 39.7 5.9 8.2 62.3 14.4 232.3 50.8 32.7 8.0 26.6 29.1 53.6 62.3 31.9 6.9 38.6 70.5 4.8 43.9 46.6 36.0 81.5 40.7 16.5 35.2 15.7 19.1 40.5 48.3 22.8 37.3 18.7 31.7 99.3 25.3 70.8 21.5 20.6 48.9 13.2 49.1 5.8 31.4 76.6 14.4 78.4 58.1 33.6 22.5 21.7 16.3 29.6 50.2 34.2 31.7 12.9 33.9 56.5 17.5 15.6 32.6 21.8 37.4 26.3 29.0 154.3 36.9 13.0 44.7 27.5 12.6 64.3 43.8 23.3 62.6 66.6 5.9 34.8 37.4 25.8 21.2 55.0 82.4 82.2 27.6 12.1 32.1 62.2 31.3 13.7 0.1 0.3 0.0 0.2 0.3 0.2 0.3 0.2 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.1 44.8 38.8 26.5 71.9 44.8 28.1 37.0 32.7 42.1 34.7 26.6 31.9 36.0 20.5 19.2 14.8 12.1 4.4 13.8 5.5 8.8 6.2 33.2 19.0 16.3 25.5 8.6 10.1 7.3 6.2 10.7 6.9 32.1 3.9 11.3 1.1 13.4 14.2 12.0 12.1 1.3 11.0 20.4 14.9 11.5 31.6 18.8 1.3 15.8 6.1 21.8 5.1 32.0 10.2 17.6 4.1 5.7 6.8 3.0 13.1 4.9 7.2 9.4 2.6 23.5 1.0 6.0 14.3 52.3 20.8 10.5 5.1 16.6 21.0 5.8 9.1 22.1 13.1 12.2 10.8 14.2 13.3 15.3 15.5 11.4 4.5 25.4 24.3 12.6 PDLIM1 "CLIM1, CLP-36, CLP36, hCLIM1" ENSG00000107438 "PDZ and LIM domain 1" O00151 10 95237572-95291012 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 680.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0" "Group enriched" "Detected in all" 7 "B-cells: 223.8;granulocytes: 189.7" "Cell line enhanced" "Detected in many" "HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017010, CAB072838, CAB072840" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA 93000000 "Actin filaments" "Plasma membrane, Cell Junctions" "CAB072838: , CAB072840: , HPA017010: AB_1855147" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.58e-2)" "prognostic favorable (1.14e-5)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (2.07e-1)" "unprognostic (8.99e-2)" "unprognostic (2.26e-1)" "unprognostic (2.82e-3)" "unprognostic (5.77e-2)" "unprognostic (6.56e-2)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (4.21e-3)" "unprognostic (1.11e-1)" 273.1 32.6 10.7 92.3 10.3 25.2 238.1 9.4 18.7 127.3 34.4 222.1 181.0 115.9 92.6 183.8 156.6 115.9 325.1 10.5 16.7 83.2 161.6 340.2 105.3 17.0 10.8 8.4 35.9 99.1 66.4 29.7 142.3 12.6 117.9 220.6 37.2 167.5 115.8 680.6 137.9 251.1 147.3 12.7 149.5 149.6 13.8 14.3 106.9 196.3 292.6 124.7 278.9 166.7 15.7 274.4 181.8 12.4 0.4 64.1 43.3 277.1 82.6 266.4 218.8 356.5 387.0 429.8 0.3 21.9 233.8 110.4 766.3 91.5 498.1 220.6 0.2 132.0 277.9 50.1 635.3 731.0 0.1 13.2 125.5 257.0 111.9 400.6 233.2 396.8 24.2 60.0 70.3 52.7 51.4 0.8 4.9 24.6 137.7 137.2 234.1 10.0 98.4 114.4 268.9 48.3 18.9 91.2 84.6 0.9 293.8 68.2 125.7 345.1 84.5 19.7 0.7 0.7 31.2 0.1 91.6 92.5 0.2 41.0 0.4 2.4 189.7 11.9 0.8 0.1 223.8 2.3 14.1 31.0 213.0 0.5 8.1 7.5 8.9 1.5 3.2 2.2 44.5 10.7 10.3 9.4 18.7 10.5 16.7 17.0 10.8 8.4 12.6 12.7 14.3 15.7 435.0 76.9 123.5 0.0 145.6 366.3 805.9 763.8 244.7 10.1 100.6 131.4 266.2 223.1 250.2 51.5 29.2 538.2 20.5 657.0 15.6 420.1 8.4 218.6 319.3 359.3 101.3 41.6 0.9 172.5 116.7 149.2 100.9 113.0 12.6 47.2 459.7 100.4 50.0 1.7 0.4 488.9 152.5 19.4 105.2 8.0 5.0 88.8 40.9 2.8 8.8 11.6 32.0 0.0 0.0 227.0 769.2 0.7 103.5 256.5 1059.7 109.0 316.4 59.5 315.5 21.0 213.1 4.3 35.7 170.4 197.9 117.0 25.8 1.9 419.2 554.3 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 42.1;AN3-CA: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: AB_2683623" "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 3.7 4.5 1.8 4.3 2.4 11.6 4.0 2.9 2.1 3.3 1.6 3.3 4.4 4.3 3.1 2.7 2.8 3.8 2.2 1.7 2.3 2.6 2.5 3.1 4.9 2.6 2.3 1.6 2.9 4.4 5.1 2.2 3.5 2.4 3.3 3.7 4.0 2.7 3.1 3.8 2.9 3.6 3.4 2.1 5.0 2.8 4.3 2.2 4.1 3.2 4.0 3.9 4.5 1.8 2.7 9.0 6.6 42.1 42.2 4.2 3.1 6.1 5.6 5.9 7.7 6.9 17.2 3.7 12.3 6.4 5.4 6.5 5.2 27.4 5.9 10.0 6.1 11.8 12.0 5.2 26.0 9.7 12.0 5.4 5.7 8.2 7.5 17.3 7.6 18.8 11.0 17.6 0.2 4.9 8.6 20.9 14.8 23.6 0.8 6.0 24.3 2.0 0.9 9.4 8.1 6.4 22.2 6.2 1.8 12.6 14.1 10.1 13.7 9.1 4.8 11.1 5.6 13.1 2.5 1.0 11.5 5.8 20.5 3.3 0.1 1.7 0.5 0.9 1.4 1.2 0.7 0.8 0.4 2.9 0.7 1.1 1.1 0.1 0.4 1.3 0.6 0.7 0.9 1.8 2.4 2.9 2.1 1.7 2.3 2.6 2.3 1.6 2.4 2.1 2.2 2.7 2.6 6.4 3.1 2.3 3.3 1.9 3.1 1.3 2.8 5.1 3.1 2.0 4.0 1.5 2.4 5.5 14.6 1.5 2.1 3.4 3.9 2.9 3.7 2.6 4.8 4.8 4.2 4.2 4.2 2.7 3.0 3.2 2.0 2.5 0.0 4.6 10.4 1.4 3.6 1.7 5.8 3.5 2.0 6.5 4.6 7.6 1.8 5.0 1.8 1.9 2.8 3.1 1.0 5.5 3.7 4.0 1.5 1.9 1.9 4.0 1.4 2.1 4.3 3.2 0.0 4.1 4.0 10.1 6.9 2.3 1.4 1.1 2.2 3.1 3.2 2.9 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304409-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 332.2" "Group enriched" "Detected in some" 5 "Early spermatids: 11.3;Late spermatids: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MOLT-4: 416.0;REH: 1415.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.0 0.2 0.1 27.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 332.2 0.4 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 195.3 0.0 0.0 0.0 0.0 416.0 0.0 0.1 0.0 0.0 1415.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.3 0.4 0.0 0.0 0.0 0.4 0.7 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GATA3 HDR ENSG00000107485 "GATA binding protein 3" P23771 10 8045378-8075198 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 110.7;skin 1: 160.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9" "Group enriched" "Detected in many" 24 "breast cancer: 190.0;urothelial cancer: 87.0" "Group enriched" "Detected in many" 4 "medulla oblongata: 3.6;midbrain: 9.6;pons: 6.6;thalamus: 4.3;white matter: 3.0" "Group enriched" "Detected in many" 41 "gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6" "Group enriched" "Detected in many" 57 "NK-cells: 36.1;T-cells: 43.6" "Cell line enhanced" "Detected in many" "BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2" "Region enriched" "Detected in single" 6 "midbrain: 6.1" "Group enriched" "Detected in some" 11 "medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1" "CAB016217, HPA029730" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016217: AB_2108591, HPA029730: AB_10601907" "unprognostic (1.70e-1)" "unprognostic (7.23e-2)" "unprognostic (3.58e-2)" "unprognostic (2.00e-1)" "unprognostic (7.03e-3)" "unprognostic (4.68e-3)" "unprognostic (4.23e-2)" "unprognostic (9.65e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (3.83e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (6.31e-2)" "unprognostic (1.82e-3)" 6.8 6.5 1.3 3.9 0.2 4.2 34.6 0.2 1.0 1.9 0.8 0.6 1.0 0.7 8.7 0.6 0.5 1.2 2.0 0.1 0.5 21.0 1.0 3.4 7.9 3.6 9.6 0.0 0.1 0.3 110.7 5.0 32.4 6.6 11.3 0.7 0.0 20.0 25.1 2.1 160.3 2.4 0.3 0.4 7.2 1.5 0.2 4.3 25.2 3.1 1.0 3.8 39.1 10.9 3.0 33.8 8.1 0.0 0.4 0.0 0.0 190.2 0.7 0.0 0.0 0.1 12.4 29.9 0.0 0.1 0.0 0.0 28.9 3.2 0.6 0.1 95.8 10.2 0.2 0.3 0.1 2.1 0.1 0.5 0.0 6.9 0.1 1.8 1.0 15.3 45.8 0.4 0.0 0.1 473.4 54.2 0.5 3.5 6.5 4.5 2.8 2.6 0.8 0.0 194.3 9.8 161.2 0.5 26.8 0.0 34.1 605.2 0.1 0.0 2.4 5.9 1.4 4.3 0.9 0.0 0.0 1.3 0.0 1.7 0.1 0.1 0.0 19.9 0.0 26.9 0.4 36.7 28.8 0.0 0.1 19.9 18.3 0.7 36.1 0.0 0.0 43.6 7.0 1.3 0.2 0.2 1.0 0.1 0.5 3.6 9.6 0.0 6.6 0.4 4.3 3.0 14.6 0.0 6.0 0.0 3.4 94.8 69.6 1.6 0.0 0.0 267.1 167.3 1.3 0.0 1.5 178.4 0.0 323.5 49.2 0.0 0.0 0.2 0.2 0.5 0.4 12.6 0.0 2.1 0.0 0.4 746.6 5.3 2.6 0.7 2.5 0.0 6.8 0.6 30.7 0.0 0.0 0.0 0.0 3.5 9.9 0.1 0.0 3.8 8.8 1.0 1.5 0.0 51.5 0.0 0.0 4.1 1.1 0.0 12.2 45.8 0.0 0.6 0.3 0.0 0.0 1.1 2.8 0.0 1.4 1.0 198.9 1134.9 93.4 0.5 0.0 106.1 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 80.3" "Group enriched" "Detected in many" 13 "Excitatory neurons: 2134.6;Inhibitory neurons: 1473.4;Oligodendrocyte precursor cells: 1456.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 80.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.4;RH-30: 18.4;U-266/70: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Approved Nucleoplasm,Mitochondria NA NA 160000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.4 10.8 6.3 0.2 6.8 0.0 1.0 0.0 80.3 0.9 0.0 2.1 0.3 6.2 0.3 0.6 1.0 0.2 1.8 15.3 18.6 2.1 1.6 0.1 0.4 0.0 2.4 5.5 9.7 1.3 2.2 5.8 1.9 15.3 3.2 0.2 6.3 1.0 3.8 2.9 0.2 0.8 5.8 0.0 0.3 0.5 12.7 0.0 0.4 1.0 0.0 0.4 0.6 1.0 43.0 0.0 0.6 6.3 21.4 0.0 0.0 0.0 0.1 0.6 3.9 4.6 0.2 0.2 0.0 1.5 0.5 5.1 0.0 1.6 0.0 4.0 0.1 4.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 6.4 0.0 11.3 0.0 5.3 10.4 0.2 9.9 0.0 9.1 0.0 0.1 7.5 18.4 11.4 3.9 0.0 3.6 10.5 0.0 0.1 0.4 4.3 1.8 0.0 0.0 0.0 2.7 0.1 3.3 14.2 0.0 4.6 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.8 0.0 80.3 15.3 18.6 0.0 2.4 5.5 15.3 0.0 0.0 43.0 0.0 0.0 0.0 55.8 0.8 0.6 0.1 0.8 0.6 35.4 2.1 0.5 2.5 0.0 0.1 0.0 2.1 0.1 0.2 0.2 0.0 0.7 45.6 0.8 1.5 1.5 0.0 0.0 2134.6 0.4 0.0 5.3 0.0 1.8 0.0 24.9 21.0 0.1 3.0 10.1 1473.4 0.0 0.0 1.9 0.4 47.8 1.5 0.3 0.0 128.4 0.0 4.3 0.0 1456.7 34.2 0.3 0.0 0.7 0.0 0.1 0.0 0.5 0.1 4.7 0.0 2.4 2.6 46.6 11.5 0.0 0.1 0.3 0.1 53.1 0.0 0.1 HPS1 "BLOC3S1, HPS" ENSG00000107521 "HPS1 biogenesis of lysosomal organelles complex 3 subunit 1" Q92902 10 98416198-98446935 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061260 Approved NA NA "HPA061260: AB_2684459" "unprognostic (1.31e-1)" "prognostic favorable (3.37e-5)" "unprognostic (8.95e-2)" "prognostic favorable (2.93e-5)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.19e-1)" "unprognostic (9.38e-3)" "prognostic favorable (1.26e-4)" "unprognostic (2.39e-1)" "unprognostic (2.44e-3)" "unprognostic (5.64e-3)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (3.06e-2)" "unprognostic (8.30e-3)" 15.9 22.4 12.8 13.5 12.2 37.5 15.5 11.4 14.3 15.5 13.6 16.4 18.6 14.2 6.2 14.2 14.0 14.0 12.2 12.7 12.0 16.2 20.1 16.6 21.5 12.7 12.2 11.1 12.4 22.0 6.3 13.5 9.0 13.4 16.2 9.2 2.1 20.5 10.5 7.3 16.0 24.6 8.0 11.9 25.4 18.6 12.9 13.3 10.8 12.8 3.3 12.2 16.4 14.3 15.0 16.9 15.3 1.2 20.6 16.6 19.6 9.4 13.4 43.4 14.3 22.0 10.5 14.7 17.4 16.6 16.3 19.8 20.1 7.7 7.6 6.5 31.4 17.4 27.1 10.0 20.5 37.7 22.0 50.6 21.9 21.1 15.3 19.5 16.7 18.1 11.3 12.0 29.5 15.1 24.0 8.0 18.4 4.2 11.8 9.4 12.8 0.0 12.7 16.6 19.0 3.2 12.3 9.7 7.2 27.6 7.9 16.9 23.5 28.9 10.8 13.8 23.8 14.5 17.3 12.3 12.9 33.0 35.4 12.6 20.2 19.3 36.5 11.3 27.5 11.4 12.4 8.9 10.3 22.6 12.4 6.1 7.4 13.5 16.9 27.4 16.0 14.6 13.6 12.8 12.2 11.4 14.3 12.7 12.0 12.7 12.2 11.1 13.4 11.9 13.3 15.0 16.8 19.2 23.8 17.6 49.9 22.3 48.2 40.8 46.1 3.7 40.5 43.9 24.2 28.6 30.2 23.9 2.1 28.3 33.7 72.0 19.6 50.7 33.5 12.4 18.3 18.5 27.1 83.9 11.4 50.3 29.7 27.9 43.8 14.1 29.8 11.6 28.9 26.6 80.6 0.0 14.1 37.5 22.4 62.6 48.7 56.8 27.7 57.4 35.6 12.2 78.6 17.8 60.8 5.5 18.1 60.5 83.0 26.7 43.7 47.7 80.7 59.3 14.7 3.1 13.1 22.3 22.4 28.6 9.5 33.3 18.0 24.6 39.7 41.3 33.1 69.2 PHYH "PAHX, PHYH1, RD" ENSG00000107537 "Phytanoyl-CoA 2-hydroxylase" O14832 10 13277796-13302412 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 673.3;skeletal muscle: 488.2;tongue: 416.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 258.6;Proximal tubular cells: 414.6" "Cancer enhanced" "Detected in all" "liver cancer: 78.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007598, HPA011796" Enhanced NA NA "HPA007598: AB_1855334, HPA011796: AB_1855335" "unprognostic (5.78e-2)" "unprognostic (3.83e-1)" "unprognostic (6.98e-2)" "unprognostic (3.62e-2)" "unprognostic (5.52e-2)" "unprognostic (1.61e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-2)" "unprognostic (7.09e-2)" "unprognostic (6.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.24e-1)" "prognostic favorable (7.28e-12)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.19e-1)" 58.5 67.1 22.7 9.6 23.1 8.3 32.5 23.4 28.6 29.1 30.1 47.0 59.3 22.3 16.8 23.1 16.8 28.4 127.7 22.3 26.6 193.2 673.3 17.4 7.6 22.3 23.7 20.2 37.1 48.6 57.1 21.0 19.5 22.3 22.7 37.5 28.5 34.0 25.6 488.2 16.6 56.3 23.4 22.2 12.9 44.6 15.3 24.9 5.7 56.5 416.4 5.4 27.2 14.9 23.3 17.2 35.2 15.6 22.5 110.7 69.9 12.4 17.2 23.9 19.4 19.1 9.1 30.3 0.9 12.9 29.0 47.0 7.8 20.5 20.2 11.8 41.4 10.7 14.9 9.3 36.6 54.8 2.5 26.8 50.3 28.9 21.0 8.4 22.7 18.7 16.8 8.4 32.2 45.5 16.3 9.2 12.1 14.4 49.4 12.6 15.7 24.1 5.8 40.6 21.9 5.3 16.8 64.8 1.4 32.9 12.5 64.8 44.2 6.4 29.5 10.6 36.4 11.8 36.6 26.3 3.3 38.3 18.9 11.6 16.3 18.7 8.2 8.0 14.2 17.6 11.0 9.9 10.4 15.8 5.6 12.5 12.7 0.8 4.4 11.2 14.4 10.5 12.3 22.7 23.1 23.4 28.6 22.3 26.6 22.3 23.7 20.2 22.3 22.2 24.9 23.3 53.6 12.8 19.2 8.5 14.5 11.9 27.6 19.1 6.2 47.0 22.6 24.5 258.6 77.2 19.7 35.0 22.9 137.8 20.5 72.9 144.8 40.6 33.1 18.5 29.0 29.7 31.8 15.2 7.1 19.6 34.3 41.3 41.8 26.8 30.4 28.3 25.0 145.5 55.4 21.9 5.6 57.4 46.8 21.0 22.0 45.4 25.4 25.3 17.8 4.7 10.3 69.3 7.2 2.5 2.4 16.7 46.0 37.6 15.1 11.9 141.9 414.6 19.6 41.8 19.7 30.2 37.5 12.5 1.6 7.3 13.4 83.9 25.2 103.3 46.9 18.1 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9" "Group enriched" "Detected in many" 10 "dendritic cells: 84.2;monocytes: 84.8" "Cell line enhanced" "Detected in many" "Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038834, HPA077069" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA038834: AB_10795576, HPA077069: " "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 31.3 7.1 61.4 21.9 70.7 8.3 22.9 69.5 59.5 6.6 51.8 16.6 13.8 3.0 8.7 4.8 6.0 10.9 40.4 58.0 77.0 75.7 17.3 12.0 19.8 66.7 69.3 52.0 3.7 39.8 5.1 13.1 12.8 69.1 8.0 6.1 27.2 16.9 11.0 14.9 4.5 13.9 8.8 61.8 20.3 9.5 9.0 69.9 10.5 41.1 17.8 9.1 11.5 7.1 80.6 1.4 0.3 6.0 11.4 17.9 1.0 4.1 0.7 1.1 2.0 3.5 5.0 0.6 0.1 2.3 0.8 3.9 0.0 2.6 2.8 2.8 37.8 0.0 0.1 0.2 39.7 19.0 2.6 0.0 13.1 0.0 1.9 0.2 10.9 3.0 1.6 0.0 64.3 2.9 0.0 3.0 43.1 1.2 0.2 1.2 8.1 162.7 54.9 0.4 1.2 1.0 0.8 0.0 0.5 2.0 10.7 1.1 32.4 0.0 0.4 3.6 3.0 6.5 0.7 0.7 0.1 18.9 85.4 54.8 0.0 84.8 0.1 8.7 63.9 0.2 0.0 0.6 3.7 84.2 0.0 0.6 2.6 3.0 6.9 37.9 2.2 0.3 48.9 61.4 70.7 69.5 59.5 58.0 77.0 66.7 69.3 52.0 69.1 61.8 69.9 80.6 8.9 19.2 17.2 77.4 3.7 3.7 1.4 3.2 1.2 22.5 9.7 7.0 47.9 37.1 13.1 16.5 4.2 1.2 20.3 10.1 17.6 45.3 1.4 6.4 13.7 9.2 11.5 0.0 17.0 3.8 1.2 28.6 1.5 14.8 1.3 4.2 6.1 20.1 157.0 37.0 33.6 7.4 12.2 84.7 94.3 4.4 10.5 91.0 8.8 35.6 258.7 260.3 54.6 37.7 38.2 4.0 11.3 2.2 4.1 1.0 45.0 128.0 5.9 13.3 26.3 186.4 25.9 0.6 1.9 0.8 1.7 2.6 8.0 4.9 15.0 0.7 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009947 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 12.6 6.1 3.9 5.5 3.7 10.4 10.3 6.0 5.3 14.5 7.8 17.8 22.7 9.7 12.6 10.3 11.4 11.1 7.5 4.8 7.9 12.0 13.2 8.4 4.6 3.9 3.7 3.0 11.6 17.7 32.0 4.0 10.6 4.4 9.0 20.9 16.0 8.5 12.9 13.5 27.5 27.4 8.9 2.8 7.7 24.1 6.9 4.7 20.3 8.1 11.2 5.2 20.0 17.8 3.9 25.7 20.7 18.4 29.2 32.9 27.4 4.4 45.2 43.6 21.5 20.7 14.2 38.0 26.6 18.9 34.9 11.8 19.9 21.6 26.1 29.9 1.4 6.7 3.8 23.7 10.0 17.1 2.6 1.8 13.0 5.7 26.6 23.4 75.5 52.1 8.5 3.6 0.0 44.1 3.2 4.5 5.1 17.7 18.0 12.3 5.5 18.7 1.4 36.6 21.9 3.1 4.2 7.4 1.9 5.7 25.3 1.5 2.4 63.4 16.0 15.3 13.1 29.8 2.1 1.7 36.3 15.2 8.4 12.2 0.0 0.8 0.2 0.7 1.2 0.7 1.2 0.1 0.4 0.3 1.9 0.1 0.3 0.7 2.1 1.2 0.3 0.0 0.6 3.9 3.7 6.0 5.3 4.8 7.9 3.9 3.7 3.0 4.4 2.8 4.7 3.9 6.8 9.6 11.0 11.1 14.8 35.1 7.2 5.0 5.2 6.3 9.3 6.3 6.1 12.8 11.2 12.9 35.5 7.7 4.4 36.7 3.9 7.5 1.0 27.0 11.0 12.6 3.6 0.0 15.9 14.3 1.4 17.6 26.0 43.9 2.5 4.1 11.4 12.8 4.7 13.5 24.8 25.0 6.1 10.7 9.6 3.2 13.7 20.5 3.6 23.4 3.3 4.3 0.0 10.6 2.6 19.3 23.6 9.1 6.1 4.0 36.5 3.7 19.9 26.6 0.0 4.3 6.9 4.2 9.3 9.0 45.6 3.7 4.3 15.0 28.4 21.8 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046941 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.7 6.7 6.0 6.7 7.6 14.0 6.9 5.8 8.5 10.3 3.2 6.8 3.6 19.0 28.8 6.3 11.9 8.3 6.2 7.5 6.0 12.3 5.5 7.6 6.9 4.2 5.6 5.6 10.0 5.7 6.3 4.3 8.3 4.1 10.9 4.9 10.4 4.8 24.9 5.1 5.9 5.5 19.7 3.7 6.6 17.3 7.9 6.2 6.3 11.5 7.6 5.6 7.7 6.2 7.0 7.1 8.8 7.3 9.3 11.9 15.0 7.8 13.8 15.8 8.3 8.6 7.4 7.4 14.5 10.8 14.0 6.1 4.8 10.1 6.1 12.8 3.8 10.9 5.1 9.1 5.1 17.2 9.7 5.5 14.8 11.3 11.6 25.4 11.0 5.1 9.3 3.9 12.1 10.9 2.5 7.5 7.3 6.2 3.1 6.2 6.4 26.0 4.9 12.4 5.6 1.7 13.5 9.8 3.9 17.3 8.7 3.0 8.9 7.7 11.2 8.9 13.3 13.8 8.9 7.8 9.4 11.5 16.4 7.0 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.4 0.4 0.2 0.3 0.1 0.1 0.5 0.1 0.0 6.0 7.6 5.8 8.5 7.5 6.0 4.2 5.6 5.6 4.1 3.7 6.2 7.0 16.7 57.7 31.5 79.7 17.7 10.3 8.8 4.4 12.5 28.1 10.1 10.7 25.8 24.3 6.0 42.3 29.2 11.6 15.1 5.5 7.9 12.6 16.5 13.1 31.0 14.1 14.5 17.4 63.8 18.7 7.9 29.1 14.8 15.7 3.8 28.0 11.4 8.6 11.4 38.7 57.9 6.6 4.1 23.0 12.2 6.6 33.5 16.2 23.2 34.7 19.4 26.0 15.5 53.8 82.9 16.6 4.7 28.6 17.0 11.1 5.4 18.1 7.3 31.4 26.3 34.0 25.8 14.9 21.2 9.2 9.5 5.2 12.9 19.2 6.5 6.4 CXCL12 "PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1" ENSG00000107562 "C-X-C motif chemokine ligand 12" P48061 10 44370165-44386493 "Predicted secreted proteins" "Chemotaxis, Host-virus interaction" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 347.2;Distal tubular cells: 172.1;Fibroblasts: 566.4;Kupffer cells: 191.8;Smooth muscle cells: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 509.6;BJ hTERT+: 303.5;BJ hTERT+ SV40 Large T+: 294.9;BJ hTERT+ SV40 Large T+ RasG12V: 441.2;fHDF/TERT166: 501.8;HSkMC: 1293.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017564 Approved "Secreted to blood" NA NA 1030000 560000 "CAB017564: AB_2088170" "unprognostic (2.41e-1)" "unprognostic (2.95e-2)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.14e-2)" "unprognostic (1.28e-1)" "unprognostic (2.28e-1)" "unprognostic (3.28e-3)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" 370.1 83.4 18.0 145.1 17.5 35.4 239.9 17.8 27.7 247.2 32.9 115.9 54.0 364.1 54.8 139.8 123.2 265.6 192.0 17.0 21.4 125.9 254.9 71.6 217.5 25.0 18.1 12.8 113.3 132.3 127.7 21.4 8.5 22.8 48.2 116.6 2.1 117.3 66.9 160.4 92.6 97.3 346.4 17.2 359.7 45.8 19.6 17.7 143.9 104.3 182.9 120.8 108.0 175.8 38.3 0.0 0.0 0.4 0.6 509.6 78.9 0.4 187.7 303.5 294.9 441.2 0.0 0.1 0.2 1.9 501.8 0.0 0.1 0.8 0.2 97.1 187.2 2.4 0.0 0.0 0.0 172.8 0.4 0.9 1293.8 0.0 63.8 0.1 0.0 0.2 0.1 0.1 0.0 1.0 0.4 0.7 0.6 32.2 0.0 0.6 0.8 0.3 224.3 0.2 0.0 0.6 0.6 0.3 0.7 0.0 63.6 272.2 0.4 0.4 0.4 0.5 205.0 0.2 0.2 0.1 0.1 0.6 0.3 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 17.5 17.8 27.7 17.0 21.4 25.0 18.1 12.8 22.8 17.2 17.7 38.3 347.2 0.0 1.1 1.3 1.4 76.3 0.3 0.0 9.6 1.5 8.1 14.0 25.0 10.0 0.6 5.5 0.0 0.3 2.1 0.0 172.1 0.8 2.2 1.7 46.8 134.1 0.0 0.0 0.6 20.5 0.3 566.4 1.5 1.0 0.0 0.4 55.6 2.5 2.6 0.0 6.6 3.9 0.0 191.8 110.1 3.7 70.2 27.9 135.2 74.0 0.0 1.9 0.0 12.1 0.1 3.0 0.0 8.6 1.0 1.0 0.1 25.5 0.0 0.8 85.5 43.7 146.1 1.8 5.9 6.3 62.7 0.7 9.6 33.2 0.5 0.5 ERLIN1 "C10orf69, Erlin-1, KE04, SPFH1, SPG62" ENSG00000107566 "ER lipid raft associated 1" O75477 10 100150094-100186033 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011252 Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011252: AB_1853965" "unprognostic (3.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (6.98e-3)" "unprognostic (2.69e-1)" "unprognostic (1.70e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (7.63e-4)" "unprognostic (1.26e-1)" "unprognostic (9.68e-2)" "unprognostic (1.99e-3)" "unprognostic (9.09e-2)" "unprognostic (1.32e-3)" "unprognostic (6.10e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" 29.6 14.3 8.4 21.6 10.1 76.9 21.6 9.2 10.2 27.7 9.8 37.3 40.7 22.0 17.8 33.1 31.8 16.5 11.1 9.0 10.0 27.4 115.0 19.3 14.6 8.7 8.1 8.5 30.6 19.4 19.6 5.5 42.6 8.6 17.9 38.5 10.9 15.2 16.6 8.7 22.7 30.4 22.6 8.5 16.7 37.1 28.2 8.7 15.7 26.5 13.7 21.4 28.9 19.2 9.2 97.4 95.3 46.9 86.3 113.5 107.9 96.8 148.7 138.3 120.2 137.5 64.0 109.9 42.6 59.7 139.9 100.5 98.5 42.6 90.0 164.1 26.1 38.8 36.7 38.5 83.5 47.6 128.4 39.4 62.6 53.6 105.8 129.2 114.9 90.1 43.5 36.8 25.2 130.2 40.7 33.5 65.9 33.8 66.2 40.4 28.3 77.2 31.6 53.9 37.6 19.1 31.1 85.6 23.6 56.0 53.8 59.3 109.0 101.7 118.7 92.4 72.4 160.8 19.6 35.2 57.1 105.6 204.8 60.6 8.1 20.4 24.4 10.5 15.1 9.3 7.4 7.9 8.6 16.3 6.7 8.1 10.9 15.0 9.9 11.9 4.1 5.6 9.7 8.4 10.1 9.2 10.2 9.0 10.0 8.7 8.1 8.5 8.6 8.5 8.7 9.2 28.2 0.0 11.5 5.2 6.4 15.8 11.3 16.1 12.5 4.6 13.4 12.3 4.8 5.7 14.6 14.7 6.2 20.6 6.4 31.5 0.0 9.9 28.9 16.3 19.5 18.8 13.2 19.1 16.2 10.9 62.7 17.1 20.4 20.9 8.2 19.7 13.6 77.6 14.3 3.3 14.8 27.5 0.0 14.4 7.2 12.9 15.2 12.9 10.6 12.2 13.3 5.9 6.2 15.6 21.0 9.5 19.8 7.9 4.7 12.7 25.6 12.6 30.2 6.2 0.0 14.3 11.8 50.9 15.4 20.6 20.3 24.8 6.6 19.6 27.6 15.6 EIF3A "EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol Yes No 110000 "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 83.7 53.8 29.4 74.3 31.9 121.8 63.2 30.6 33.0 49.2 37.5 63.5 66.4 60.7 35.2 69.9 45.2 50.6 69.6 27.4 32.3 58.6 78.5 49.9 75.7 37.6 31.4 20.5 62.3 156.5 70.7 24.6 57.5 38.1 56.0 64.6 31.9 73.9 46.8 179.6 70.5 60.5 63.4 33.8 57.9 73.5 45.3 33.0 79.1 70.9 90.6 75.3 77.1 52.2 34.3 258.5 190.9 154.0 211.6 163.6 235.0 119.4 228.9 235.9 144.0 143.7 181.2 165.5 300.2 83.2 190.3 113.3 252.0 202.5 175.7 203.5 166.1 166.3 258.3 143.6 203.2 186.2 382.3 183.9 204.6 193.0 212.7 362.8 240.7 165.7 119.8 269.7 191.9 188.7 152.5 159.4 179.8 147.8 99.4 96.3 162.1 332.1 143.7 137.0 213.9 71.6 151.3 180.2 166.9 244.9 132.0 107.2 241.1 245.6 138.7 128.0 147.1 335.8 164.9 194.0 286.9 147.2 368.2 97.6 49.0 38.2 23.9 27.4 41.8 31.7 25.6 33.1 25.2 36.1 24.7 22.6 24.7 10.0 26.6 58.1 20.5 50.9 28.3 29.4 31.9 30.6 33.0 27.4 32.3 37.6 31.4 20.5 38.1 33.8 33.0 34.3 122.1 233.9 323.8 24.5 147.3 304.2 279.1 129.0 203.7 60.1 155.8 133.7 320.7 111.5 198.5 64.4 62.6 169.1 181.1 130.2 27.4 157.2 199.4 230.3 248.6 145.3 141.2 270.0 32.7 185.4 159.5 152.5 159.0 371.8 145.4 132.6 74.3 184.5 126.3 43.7 34.9 168.2 87.5 200.3 169.0 119.1 108.7 196.5 147.7 29.0 235.9 78.2 135.9 24.6 38.9 192.8 105.4 117.8 258.6 253.6 98.5 58.7 158.3 54.1 59.2 209.7 221.6 158.0 112.9 255.3 363.8 252.3 171.1 145.0 227.7 302.3 PKD2L1 "PCL, PKD2L, PKDL, TRPP3" ENSG00000107593 "Polycystin 2 like 1, transient receptor potential cation channel" Q9P0L9 10 100288149-100330264 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 10.9;choroid plexus: 6.4;lymphoid tissue: 8.0;retina: 13.4" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB022621, HPA070002" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB022621: , HPA070002: " "unprognostic (2.67e-1)" "unprognostic (3.66e-7)" "unprognostic (8.07e-3)" "unprognostic (4.38e-2)" "unprognostic (4.70e-2)" "unprognostic (5.31e-2)" "unprognostic (2.19e-1)" "unprognostic (2.85e-2)" "unprognostic (2.01e-1)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (9.37e-2)" "unprognostic (1.49e-4)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" 0.2 0.1 6.7 0.4 7.1 0.9 0.7 6.3 10.9 0.1 6.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.9 6.5 0.3 1.6 2.4 1.6 6.4 6.7 7.0 0.1 0.1 0.0 0.1 0.5 6.5 0.3 1.2 13.4 0.1 0.0 0.1 0.0 0.6 0.0 6.5 8.0 0.0 2.3 6.5 1.0 0.0 0.0 1.7 0.2 0.0 7.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 6.7 7.1 6.3 10.9 6.9 6.5 6.4 6.7 7.0 6.5 6.5 6.5 7.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 2.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 13.6 60.6 0.4 0.0 0.0 14.4 0.0 20.1 0.3 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CUBN "gp280, IFCR, MGA1" ENSG00000107611 Cubilin O60494 10 16823966-17129811 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 141.6" "Group enriched" "Detected in many" 7 "Proximal enterocytes: 257.7;Proximal tubular cells: 325.0" "Cancer enriched" "Detected in some" 15 "renal cancer: 24.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 14.8;ASC TERT1: 3.0;SK-MEL-30: 2.8;WM-115: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004133, HPA043854" Enhanced "Intracellular and membrane" NA NA "HPA004133: AB_2732398, HPA043854: AB_2732510" "unprognostic (1.75e-1)" "unprognostic (2.35e-1)" "unprognostic (2.12e-3)" "unprognostic (8.61e-4)" "unprognostic (9.54e-2)" "unprognostic (2.78e-2)" "unprognostic (2.88e-2)" "unprognostic (7.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.47e-1)" "prognostic favorable (1.12e-4)" "unprognostic (6.24e-3)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.93e-1)" 0.7 0.8 1.3 0.4 1.0 0.4 0.9 0.7 0.8 1.2 1.3 0.4 0.2 0.7 3.1 0.2 2.1 0.3 0.4 0.8 2.2 141.6 0.1 0.6 0.8 2.2 1.2 0.5 2.5 0.5 0.6 2.2 2.6 2.5 1.1 0.2 3.0 0.7 0.4 0.3 0.8 28.2 0.4 1.9 1.0 0.4 2.0 0.8 1.7 3.8 0.5 0.7 0.4 0.7 1.5 0.0 0.0 1.5 14.8 0.5 3.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.8 1.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.6 1.5 0.6 0.1 0.2 0.2 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.8 0.1 0.0 0.1 1.6 0.1 0.2 0.3 0.1 0.5 0.0 0.0 0.4 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.0 0.7 0.8 0.8 2.2 2.2 1.2 0.5 2.5 1.9 0.8 1.5 3.2 0.0 1.5 23.8 3.7 0.5 0.4 0.2 0.6 2.9 0.6 0.6 1.7 0.0 3.2 5.5 2.1 0.0 3.3 0.1 13.7 0.0 37.3 3.1 2.2 5.7 0.0 0.0 8.4 0.2 0.0 2.3 0.0 2.2 0.0 2.2 1.4 0.0 0.1 0.0 9.0 3.7 0.0 0.3 0.4 31.8 2.8 3.1 7.2 7.5 0.1 6.5 1.0 9.0 5.5 0.1 5.0 1.2 1.6 0.4 257.7 325.0 3.5 4.0 0.0 19.0 1.6 1.1 0.9 0.1 0.9 0.1 2.9 1.2 1.2 0.2 TRDMT1 "DNMT2, RNMT1" ENSG00000107614 "TRNA aspartic acid methyltransferase 1" O14717 10 17137336-17202054 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009468, HPA036945, HPA036946" Approved NA NA "CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399" "unprognostic (4.55e-1)" "unprognostic (3.22e-2)" "unprognostic (4.49e-6)" "unprognostic (7.07e-2)" "unprognostic (3.87e-3)" "unprognostic (1.33e-1)" "unprognostic (3.27e-4)" "unprognostic (3.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (3.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (2.64e-2)" 1.7 1.5 1.3 1.3 1.8 1.5 1.8 4.4 1.5 1.6 1.7 1.2 0.8 2.7 4.6 1.2 2.0 2.0 1.3 1.4 1.9 2.1 0.8 1.4 2.2 1.9 1.4 0.7 3.0 1.5 2.6 1.3 1.5 3.1 1.4 1.0 5.9 1.5 0.9 1.2 1.6 1.3 1.1 1.5 1.4 1.6 1.2 1.2 3.3 3.8 0.2 1.9 1.1 1.5 1.7 3.6 1.3 7.7 1.3 2.3 1.1 0.0 4.0 2.0 4.0 4.0 3.2 3.5 2.1 0.5 1.5 5.7 1.9 3.7 2.0 2.6 5.4 1.6 2.4 3.3 1.8 0.6 2.8 3.1 2.0 1.6 1.7 1.6 2.6 2.6 6.1 3.8 2.7 4.6 0.8 14.6 0.9 4.1 1.1 1.3 2.6 5.3 1.3 0.7 2.4 1.7 2.3 0.0 1.7 2.1 3.3 2.9 2.3 0.9 1.9 5.1 4.7 3.0 3.1 4.1 7.0 2.5 3.2 1.9 4.9 2.5 1.2 2.2 1.7 4.2 3.4 3.8 2.8 3.2 3.5 4.9 3.4 1.6 2.6 0.9 7.0 1.3 2.0 1.3 1.8 4.4 1.5 1.4 1.9 1.9 1.4 0.7 3.1 1.5 1.2 1.7 6.5 6.4 4.8 29.4 9.1 3.3 2.1 3.5 4.6 12.2 2.6 2.8 5.5 2.8 6.1 3.7 4.2 2.1 7.1 2.1 5.9 4.4 6.7 8.1 5.9 6.2 0.0 6.9 21.8 4.9 2.5 5.8 5.6 5.9 12.7 10.2 4.2 1.7 5.1 16.8 23.2 1.2 4.1 5.0 7.0 6.7 6.5 5.8 0.0 8.4 5.4 12.1 7.2 23.6 14.9 2.5 1.7 6.4 10.2 1.1 2.5 5.0 7.5 17.3 0.0 7.7 7.6 12.5 6.1 4.8 3.1 1.8 10.4 7.6 3.1 1.2 DDX50 "GU2, GUB, MGC3199, RH-II/GuB" ENSG00000107625 "DExD-box helicase 50" Q9BQ39 10 68901286-68946847 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037388, HPA037389, HPA058196" Approved Enhanced Nucleoli NA NA Nucleoli "HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635" "unprognostic (2.05e-1)" "unprognostic (3.36e-1)" "unprognostic (9.90e-2)" "unprognostic (9.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-3)" "unprognostic (2.62e-1)" "unprognostic (1.97e-1)" "unprognostic (8.78e-2)" "unprognostic (4.57e-2)" "unprognostic (1.44e-1)" "unprognostic (4.22e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-2)" "unprognostic (4.91e-2)" "unprognostic (1.02e-1)" 21.1 17.0 12.7 19.2 12.6 17.5 25.8 15.0 14.0 24.6 14.6 21.7 13.2 27.6 18.3 20.1 22.7 17.6 18.8 12.7 15.2 18.8 16.4 16.1 28.0 12.5 12.5 11.7 30.6 21.1 23.3 22.0 22.2 12.5 19.8 18.1 23.5 15.9 22.7 21.0 17.8 16.5 27.6 13.0 19.9 17.6 26.0 13.2 30.9 25.9 20.9 27.7 23.9 20.2 14.4 48.3 30.6 53.8 67.0 45.4 58.6 33.5 50.2 56.7 45.7 42.5 69.3 41.3 62.4 29.4 45.7 27.9 41.5 53.4 38.0 58.0 54.6 38.5 33.6 30.0 31.0 45.6 71.7 40.5 45.9 38.2 43.7 120.7 79.3 37.3 52.8 60.8 37.5 57.0 39.7 67.6 67.7 31.3 46.7 67.3 58.0 60.6 11.4 35.5 28.7 36.9 50.2 36.5 43.0 57.1 50.2 50.6 45.3 32.0 35.1 40.0 39.5 69.5 49.7 47.6 52.8 37.6 72.8 20.9 9.2 10.6 15.0 18.5 16.7 22.9 16.8 22.8 19.4 14.0 17.1 24.1 21.9 3.4 20.6 13.6 12.4 21.8 15.0 12.7 12.6 15.0 14.0 12.7 15.2 12.5 12.5 11.7 12.5 13.0 13.2 14.4 27.8 19.2 21.7 21.2 50.5 11.9 35.4 34.6 36.5 44.2 21.1 23.1 27.4 30.0 31.5 20.2 39.6 40.6 36.0 11.4 56.7 28.7 80.3 25.2 41.6 30.3 16.2 29.5 37.5 25.1 39.3 32.2 22.4 22.8 43.0 30.3 23.2 16.2 23.2 37.0 36.4 19.2 26.4 21.6 9.1 20.0 36.4 21.3 12.4 22.5 41.2 22.7 51.5 28.1 29.5 22.8 14.3 39.1 46.3 30.1 11.1 41.3 26.7 55.1 19.7 35.8 53.5 72.8 58.4 31.7 14.3 41.2 40.8 35.4 21.4 20.7 MAPK8 "JNK, JNK1, PRKM8, SAPK1" ENSG00000107643 "Mitogen-activated protein kinase 8" P45983 10 48306639-48439360 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 160.5;Excitatory neurons: 199.1;Inhibitory neurons: 218.2;Oligodendrocyte precursor cells: 233.7;Oligodendrocytes: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004463, CAB069396" Approved NA NA "CAB004463: AB_675868, CAB069396: AB_1619977" "unprognostic (7.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.74e-2)" "unprognostic (1.46e-1)" "unprognostic (3.07e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (4.23e-2)" "unprognostic (5.98e-2)" "unprognostic (4.31e-3)" "unprognostic (2.33e-1)" "unprognostic (6.06e-2)" "prognostic favorable (8.66e-4)" "unprognostic (1.58e-1)" "unprognostic (9.95e-2)" "unprognostic (1.85e-2)" "unprognostic (1.01e-3)" 7.3 6.8 11.0 7.1 13.6 11.4 13.9 19.5 13.6 8.8 6.0 9.1 10.5 11.1 7.8 9.5 7.6 9.3 7.3 12.6 12.1 13.8 15.7 6.8 7.8 12.4 11.4 11.1 11.1 7.6 8.7 7.9 8.4 14.3 8.3 10.0 22.1 9.7 8.3 11.8 6.6 11.2 9.7 10.6 6.8 8.2 13.3 12.8 13.9 14.3 9.7 9.7 8.4 7.0 15.6 29.2 7.2 21.8 12.8 11.3 10.4 16.5 37.9 23.6 20.0 17.8 7.7 19.2 10.9 10.5 21.3 10.7 13.1 10.2 15.2 31.2 45.4 16.5 15.9 6.8 12.7 16.0 24.2 13.2 9.5 18.5 14.4 21.8 12.5 22.0 22.4 25.1 14.5 13.2 8.6 22.1 15.4 14.4 10.0 4.7 17.8 25.8 12.6 17.1 11.1 38.3 34.8 13.5 11.9 16.1 14.8 12.4 11.4 16.7 14.4 31.9 14.6 30.4 6.2 18.0 16.4 14.3 24.9 8.7 0.0 1.1 1.4 1.1 1.1 2.1 0.6 1.7 1.3 1.0 0.8 1.7 1.0 0.8 1.3 1.4 1.8 1.1 1.0 11.0 13.6 19.5 13.6 12.6 12.1 12.4 11.4 11.1 14.3 10.6 12.8 15.6 21.2 3.2 17.1 145.3 21.9 44.7 50.6 19.3 20.5 56.2 34.4 17.7 10.0 22.8 18.0 7.3 31.3 15.5 22.3 19.1 11.7 28.9 160.5 25.7 21.9 22.0 31.0 12.4 199.1 25.3 7.4 21.8 16.3 42.9 12.0 25.8 10.4 22.3 9.8 70.7 218.2 16.5 28.5 11.0 34.9 99.2 14.6 18.4 21.4 93.7 25.4 18.9 11.3 233.7 163.0 35.9 22.5 10.1 31.2 39.3 25.4 24.3 16.6 34.6 6.6 23.0 24.5 28.1 28.1 17.5 36.7 15.7 21.6 41.0 11.9 45.5 SEC23IP p125 ENSG00000107651 "SEC23 interacting protein" Q9Y6Y8 10 119892730-119944657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038403, HPA043305" Approved Enhanced Vesicles NA NA Vesicles "HPA038403: AB_10675796, HPA043305: AB_2678416" "unprognostic (4.05e-2)" "unprognostic (5.01e-2)" "unprognostic (8.70e-2)" "unprognostic (1.35e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.78e-1)" "unprognostic (3.36e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (6.81e-3)" "unprognostic (3.43e-2)" 10.4 9.8 3.9 12.1 4.3 14.2 11.9 6.4 4.6 11.3 6.7 12.8 10.5 12.0 12.2 9.5 8.8 9.6 7.6 4.3 4.6 10.4 12.7 10.3 13.9 4.3 4.1 4.0 10.1 11.2 9.9 8.6 12.5 4.8 13.2 13.1 9.1 10.4 10.0 9.9 10.1 9.6 16.6 3.3 11.8 17.7 11.6 4.6 11.2 12.6 8.5 13.5 12.2 8.4 6.6 32.4 30.2 24.3 31.9 22.4 25.3 19.0 27.2 39.5 26.1 31.6 31.0 22.9 30.2 14.7 36.2 32.5 23.9 27.9 29.2 39.5 27.2 28.7 25.1 16.3 34.0 31.0 29.6 29.9 31.4 18.4 30.8 30.5 28.3 36.3 15.5 19.1 21.4 28.7 19.2 25.9 28.2 29.5 28.6 20.9 23.7 44.7 17.3 26.1 25.6 9.6 25.5 25.0 19.9 24.1 24.9 17.5 21.7 29.6 15.8 18.5 23.8 35.1 33.5 32.6 38.7 27.6 37.4 14.1 14.3 10.5 10.3 10.7 16.3 13.9 11.3 10.5 12.4 11.9 9.1 11.1 10.7 3.8 13.0 18.1 7.2 11.9 9.6 3.9 4.3 6.4 4.6 4.3 4.6 4.3 4.1 4.0 4.8 3.3 4.6 6.6 15.1 12.8 28.3 21.9 20.9 8.4 19.3 18.1 13.1 17.3 19.1 12.1 17.4 27.1 24.5 18.4 6.2 17.8 18.7 19.7 5.9 16.8 26.1 15.1 22.1 19.9 19.9 21.2 28.3 14.4 18.9 21.4 44.9 15.5 22.1 21.0 14.3 25.5 23.3 11.8 30.2 24.3 26.4 24.6 12.2 24.9 14.0 23.3 8.8 39.4 21.3 14.6 16.5 31.7 37.5 20.2 19.8 15.1 23.7 23.4 16.0 19.2 25.4 23.7 0.0 16.8 17.9 25.0 19.8 19.1 13.9 23.1 18.2 24.2 20.8 21.1 ATE1 ENSG00000107669 "Arginyltransferase 1" O95260 10 121740424-121928492 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 220.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038444, HPA057549" Approved Supported Nucleoplasm NA NA 83000 Nucleoplasm "HPA038444: AB_10672745, HPA057549: AB_2683463" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (2.75e-3)" "unprognostic (2.40e-1)" "unprognostic (4.67e-2)" "unprognostic (6.65e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.20e-1)" "unprognostic (8.08e-2)" "unprognostic (2.16e-1)" "unprognostic (1.02e-1)" 10.2 11.8 8.4 8.6 9.5 7.4 10.5 8.4 9.3 12.2 15.9 13.6 11.5 10.7 8.4 10.8 9.1 10.5 22.4 9.1 10.7 18.4 18.4 9.6 9.6 7.8 8.8 8.1 10.1 6.3 15.5 4.8 11.1 8.4 12.9 14.7 15.7 7.9 10.1 18.5 6.8 11.2 11.8 8.0 10.5 8.9 13.4 10.6 13.1 16.1 15.5 10.7 12.8 6.7 9.7 13.0 19.5 15.4 15.0 15.1 16.8 12.3 12.0 24.0 13.1 13.2 23.6 19.1 16.1 9.5 14.3 8.8 16.1 14.5 14.2 16.3 20.3 13.1 5.8 8.8 31.1 15.5 26.7 13.4 11.9 15.2 13.8 32.0 19.3 18.7 9.0 7.8 29.4 14.5 7.9 14.0 15.2 7.5 19.6 11.4 13.1 18.1 10.6 23.4 11.2 4.8 19.4 17.2 12.9 28.2 11.3 8.9 9.2 19.2 8.2 7.0 12.5 21.1 28.0 33.6 12.0 12.6 20.6 7.4 12.8 3.8 6.1 5.3 4.5 6.3 4.5 5.0 5.3 3.4 4.2 5.5 5.6 2.3 5.1 3.5 4.8 6.7 4.0 8.4 9.5 8.4 9.3 9.1 10.7 7.8 8.8 8.1 8.4 8.0 10.6 9.7 23.0 9.6 22.0 76.4 17.3 8.4 12.8 9.4 24.5 31.3 17.5 14.6 75.6 11.5 12.7 20.2 12.5 7.2 20.9 42.8 17.6 11.3 6.5 15.8 19.4 19.3 22.1 16.2 100.5 13.3 10.5 25.0 29.6 16.4 12.6 13.5 20.0 26.6 10.0 23.5 93.8 17.7 10.2 14.8 7.2 7.7 20.5 23.6 14.2 74.0 12.8 21.7 27.8 137.7 220.4 15.6 18.3 25.9 24.8 21.0 19.5 39.4 11.5 35.8 0.0 23.4 21.1 26.9 40.2 30.7 17.5 8.6 17.9 29.1 16.8 16.6 NSMCE4A "bA500G22.3, C10orf86, FLJ20003, NSE4A" ENSG00000107672 "NSE4 homolog A, SMC5-SMC6 complex component" Q9NXX6 10 121957091-121975217 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037459, HPA038412, HPA044872" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124" "unprognostic (1.16e-3)" "unprognostic (2.86e-2)" "unprognostic (1.56e-1)" "unprognostic (3.73e-2)" "unprognostic (4.09e-3)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.16e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.64e-1)" "unprognostic (8.13e-2)" "unprognostic (1.35e-1)" "unprognostic (7.01e-3)" 25.6 20.8 10.0 14.7 12.3 20.4 27.6 11.2 13.4 23.0 9.9 32.6 24.9 23.6 12.5 19.4 22.9 14.5 20.4 10.1 10.7 15.7 25.4 17.1 24.0 11.8 11.5 9.8 22.9 30.2 15.2 11.3 14.3 11.7 25.0 21.2 10.8 24.6 16.7 20.7 19.0 27.0 17.9 10.7 23.5 29.7 4.9 11.3 21.7 21.2 8.4 19.8 30.2 21.0 13.8 43.4 51.9 55.0 49.0 18.9 24.7 40.3 23.7 42.3 40.0 55.2 40.5 32.8 57.2 17.9 18.9 22.0 36.7 32.5 26.0 31.5 69.0 76.3 37.5 17.0 76.5 16.0 43.2 25.5 16.9 19.4 23.5 37.9 22.4 42.8 51.5 35.1 40.3 22.6 35.1 78.2 62.8 28.7 30.7 40.4 66.9 42.4 61.2 27.7 35.4 14.9 29.1 27.0 18.1 38.2 22.0 20.0 40.3 35.3 15.8 28.0 26.8 49.6 53.0 60.6 88.0 19.7 57.5 17.3 0.3 31.5 19.5 29.6 38.3 34.4 50.6 39.5 38.7 33.1 46.6 41.4 33.6 2.9 41.7 38.5 51.5 48.3 36.5 10.0 12.3 11.2 13.4 10.1 10.7 11.8 11.5 9.8 11.7 10.7 11.3 13.8 49.3 22.4 33.1 9.4 35.5 17.0 45.0 47.0 23.9 20.3 30.4 34.3 23.1 30.0 31.8 12.9 33.3 56.4 40.0 35.8 35.2 28.0 0.7 16.8 15.4 33.9 21.6 26.1 5.3 61.2 38.0 25.9 28.5 17.0 11.4 34.6 18.5 33.3 35.6 26.9 5.4 35.1 46.8 20.0 19.2 1.6 35.4 22.4 21.4 7.5 48.6 33.3 40.2 7.5 17.4 30.4 37.0 33.4 36.3 41.9 36.8 39.2 21.6 37.4 26.3 27.1 31.3 6.7 16.6 35.5 21.6 66.2 29.3 39.6 44.8 47.9 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 203.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: AB_2685354" "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 18.2 10.5 21.5 14.0 31.6 4.5 19.8 16.3 40.5 18.7 13.0 19.7 26.1 26.2 20.7 39.7 12.9 24.2 29.5 30.3 23.6 39.5 39.0 36.9 15.0 20.2 22.1 26.1 19.4 27.5 27.8 22.0 37.6 23.9 18.0 20.3 19.9 25.4 19.0 32.0 67.0 25.3 23.8 19.8 13.8 21.4 41.1 21.2 15.8 27.6 57.9 18.1 25.1 21.8 43.1 25.9 23.5 23.3 16.1 33.1 37.5 28.0 28.2 49.1 16.8 18.0 20.0 31.8 16.1 13.3 25.6 17.0 55.4 22.3 86.1 15.4 11.4 21.8 0.0 22.6 23.6 21.8 2.9 7.3 20.5 69.7 13.9 58.3 27.5 56.8 33.2 24.3 0.1 15.6 9.9 14.8 2.5 18.1 39.3 15.5 4.0 33.1 3.2 203.2 28.3 31.6 15.5 36.4 26.8 28.9 32.7 14.9 0.3 54.6 14.1 11.5 15.4 14.3 0.1 0.0 5.4 21.6 0.1 8.8 0.3 2.7 2.3 27.1 2.4 17.5 5.1 16.3 21.9 3.2 10.3 25.4 21.9 0.8 21.3 2.9 1.6 11.9 11.6 21.5 31.6 16.3 40.5 30.3 23.6 20.2 22.1 26.1 23.9 19.8 21.2 43.1 48.6 144.2 42.0 19.9 28.0 72.8 54.7 51.6 97.9 46.5 25.6 19.2 55.9 55.8 46.0 57.0 75.0 58.4 47.6 39.1 41.1 63.1 202.0 50.2 30.6 70.8 22.3 6.9 133.8 85.3 53.9 34.3 28.1 83.7 5.1 20.8 32.5 45.1 37.2 26.9 92.9 19.6 22.4 23.7 23.6 336.5 44.1 20.4 24.9 35.6 28.5 20.2 147.2 35.2 161.9 71.4 26.9 36.1 7.4 91.4 64.4 118.1 29.1 49.5 26.3 32.2 28.9 119.4 86.1 71.6 84.8 39.7 39.7 14.7 27.5 83.5 PALD1 "KIAA1274, PALD" ENSG00000107719 "Phosphatase domain containing paladin 1" Q9ULE6 10 70478767-70568450 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Microglial cells: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in single" 27 "dendritic cells: 5.0" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;Daudi: 26.7;NB-4: 25.7;RPMI-8226: 32.8;U-698: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015696, HPA017343" Uncertain NA NA "HPA015696: AB_1852399, HPA017343: AB_1852397" "unprognostic (1.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-1)" "unprognostic (7.94e-2)" "unprognostic (2.52e-3)" "unprognostic (4.52e-3)" "unprognostic (3.55e-2)" "unprognostic (4.96e-2)" "unprognostic (3.34e-2)" "unprognostic (6.56e-2)" "unprognostic (2.48e-1)" "unprognostic (8.20e-3)" "unprognostic (2.73e-2)" "unprognostic (9.27e-2)" "unprognostic (2.46e-1)" "unprognostic (8.81e-3)" 6.9 4.5 14.5 5.2 14.4 2.5 5.4 15.7 15.7 5.2 10.7 10.3 2.7 4.9 1.3 4.7 5.8 4.6 6.1 14.2 15.5 5.1 1.6 20.0 9.3 22.4 15.6 10.2 5.6 7.3 1.6 5.4 7.7 21.0 6.0 2.2 1.0 4.0 2.1 5.6 5.2 8.2 4.8 18.3 14.8 7.6 3.7 18.9 4.6 8.3 3.1 8.1 5.3 3.7 18.4 0.0 6.4 7.2 21.5 0.0 0.0 0.0 0.0 0.0 1.8 0.4 2.7 0.2 26.7 5.5 0.0 0.3 0.1 11.9 0.0 0.5 0.1 13.6 0.0 0.9 0.5 2.2 9.0 0.0 0.0 0.0 0.7 0.0 1.9 3.1 8.2 1.4 3.6 0.2 2.2 4.6 25.7 7.6 0.0 0.0 13.5 0.1 32.8 1.9 0.0 7.1 5.3 0.3 0.1 0.6 0.9 0.0 1.9 0.6 0.0 9.7 0.0 0.8 0.3 0.0 26.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 14.5 14.4 15.7 15.7 14.2 15.5 22.4 15.6 10.2 21.0 18.3 18.9 18.4 15.0 0.0 1.1 4.6 3.2 1.3 0.1 0.1 4.0 0.5 1.3 2.2 3.6 1.5 0.0 1.8 0.0 0.0 11.4 0.0 0.0 1.7 0.9 1.1 0.6 20.3 0.0 0.0 4.9 0.2 0.1 3.5 0.0 1.8 1.3 0.7 12.5 0.2 7.4 0.0 2.2 0.0 0.0 10.8 3.3 0.5 1.8 12.2 1.8 129.3 0.3 3.0 0.0 6.6 0.9 0.1 0.0 0.7 5.1 0.3 0.0 0.1 0.0 0.4 0.0 3.0 5.1 0.2 2.7 0.5 1.3 0.0 0.6 1.2 0.0 0.0 UNC5B "p53RDL1, UNC5H2" ENSG00000107731 "Unc-5 netrin receptor B" Q8IZJ1 10 71212570-71302864 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.4" "Cell type enhanced" "Detected in many" "Horizontal cells: 112.7;Muller glia cells: 54.1;Oligodendrocytes: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 46.2;HHSteC: 146.3;hTCEpi: 132.1;SH-SY5Y: 123.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076687 Approved NA NA "HPA076687: " "unprognostic (3.98e-2)" "unprognostic (3.14e-2)" "unprognostic (9.28e-2)" "unprognostic (2.71e-1)" "unprognostic (5.64e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.01e-5)" "unprognostic (8.82e-3)" "unprognostic (6.79e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (7.70e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.17e-2)" "unprognostic (4.62e-2)" "unprognostic (9.89e-3)" "unprognostic (2.25e-1)" 3.1 10.3 17.2 4.1 25.4 0.1 2.3 23.5 17.1 5.2 13.7 7.2 2.6 5.9 6.1 18.7 7.5 8.9 13.2 13.5 16.4 7.9 2.4 9.5 3.5 27.3 27.6 9.2 3.7 4.3 2.2 5.9 5.1 30.8 9.8 4.9 7.8 5.4 27.3 2.6 6.9 5.3 4.4 20.5 7.8 8.8 5.6 22.2 2.9 3.8 4.2 3.0 9.1 12.3 46.4 0.0 0.2 0.8 3.9 11.6 18.9 0.3 6.6 19.3 0.2 0.6 3.8 17.9 0.0 6.7 41.6 0.4 46.2 1.4 2.7 0.0 0.1 4.3 10.7 0.7 0.2 146.3 0.2 1.1 16.4 132.1 1.6 8.4 1.7 2.8 0.2 0.4 0.1 0.2 1.5 0.0 0.0 10.3 9.6 0.3 0.0 4.5 0.1 0.1 20.5 20.3 123.7 1.4 1.6 1.0 18.2 1.9 0.6 8.0 1.4 5.9 2.5 2.7 0.0 0.0 0.0 42.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 25.4 23.5 17.1 13.5 16.4 27.3 27.6 9.2 30.8 20.5 22.2 46.4 18.6 0.0 3.3 5.5 0.0 3.1 19.3 21.8 2.8 13.1 1.6 3.0 7.6 0.0 11.3 5.5 0.0 0.4 0.0 34.3 0.0 5.7 0.4 12.7 4.8 22.7 3.0 0.0 8.9 1.6 0.4 6.5 12.2 25.8 22.9 27.0 7.5 0.0 1.2 112.7 11.3 6.3 32.6 8.5 2.4 1.0 0.6 5.9 1.8 29.0 0.6 54.1 0.0 11.6 89.0 12.1 20.1 0.7 0.0 14.7 8.1 0.2 14.4 3.5 0.0 2.7 12.7 0.8 5.4 20.3 4.3 0.3 0.8 0.7 4.7 44.8 CDH23 "CDHR23, DFNB12, USH1D" ENSG00000107736 "Cadherin related 23" Q9H251 10 71396920-71815947 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2;ovary: 35.6" "Cell type enhanced" "Detected in many" "Early spermatids: 78.4;Late spermatids: 67.7;Microglial cells: 33.7;Muller glia cells: 90.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 26.8;non-classical monocyte: 38.1;plasmacytoid DC: 9.5" "Lineage enhanced" "Detected in many" "monocytes: 38.1" "Group enriched" "Detected in some" 4 "RT4: 13.4;SCLC-21H: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017232 Approved NA NA 950000 "HPA017232: AB_1845903" "unprognostic (6.76e-2)" "unprognostic (2.86e-3)" "unprognostic (3.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.07e-1)" "unprognostic (5.52e-2)" "unprognostic (7.93e-2)" "unprognostic (2.88e-1)" "unprognostic (6.44e-3)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (9.23e-3)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "prognostic favorable (3.40e-4)" 10.2 3.3 9.8 2.1 10.3 2.2 6.2 11.2 10.9 3.3 12.1 1.6 1.1 5.0 1.6 1.8 9.0 2.2 4.1 6.1 19.8 0.9 14.6 7.8 1.7 30.8 18.0 4.1 35.6 8.5 10.0 1.2 0.5 36.2 3.7 1.2 14.5 1.2 0.8 2.7 1.4 2.3 2.2 7.6 7.1 1.7 11.1 21.0 5.4 1.8 2.5 1.4 4.2 2.6 20.5 0.0 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.9 0.4 1.3 0.0 0.0 0.1 1.2 1.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.1 1.5 0.4 0.0 1.1 0.0 0.1 0.0 13.4 5.3 1.1 0.8 0.2 0.1 1.1 0.1 2.2 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.2 1.5 1.0 0.0 0.0 6.0 5.1 0.1 26.8 0.4 0.0 0.2 0.1 4.9 0.0 0.2 0.6 6.1 0.0 38.1 9.5 0.0 2.9 9.8 10.3 11.2 10.9 6.1 19.8 30.8 18.0 4.1 36.2 7.6 21.0 20.5 8.2 0.0 0.6 9.4 1.1 0.8 4.1 0.3 0.6 1.9 0.2 1.1 4.7 0.0 1.0 1.8 0.0 1.5 11.5 0.9 0.0 0.4 78.4 1.9 0.7 10.0 7.2 0.0 1.1 0.4 4.4 3.4 1.1 0.3 0.0 0.4 7.9 20.4 2.2 0.0 2.7 1.1 0.0 12.2 11.6 67.7 2.5 15.0 7.2 33.7 10.6 90.7 3.1 1.5 8.5 0.2 7.5 0.7 0.4 2.6 1.6 0.8 0.7 4.2 6.6 5.1 1.7 3.4 1.0 0.0 1.1 0.3 1.0 0.2 0.7 3.6 VSIR "B7-H5, B7H5, C10orf54, Dies1, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747556-71773520 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 82.2;lymphoid tissue: 91.1" "Cell type enhanced" "Detected in many" "Adipocytes: 217.1;Cytotrophoblasts: 324.4;Extravillous trophoblasts: 293.4;Syncytiotrophoblasts: 677.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1006.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 63.1;HaCaT: 48.0;HMC-1: 78.6;U-937: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm NA NA 320000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 38.2 8.1 28.4 31.9 28.1 82.2 28.8 28.1 38.6 18.2 22.0 18.2 21.3 24.0 3.5 23.9 24.7 12.8 21.6 26.1 32.2 8.3 4.9 35.0 25.9 34.7 29.0 23.5 17.8 6.4 2.9 5.5 23.8 30.6 15.6 8.3 0.7 12.3 9.8 7.7 15.2 25.5 16.0 27.8 91.1 14.6 3.7 34.4 10.8 12.4 13.0 20.7 19.8 20.9 28.3 8.2 15.7 0.0 0.2 8.1 6.7 7.4 2.9 18.8 3.7 6.1 6.5 63.1 0.5 3.9 27.1 0.0 48.0 0.0 1.8 1.0 0.3 0.1 10.7 3.1 0.6 11.2 1.8 78.6 5.6 1.8 0.5 0.3 5.3 1.3 1.4 0.2 5.9 2.3 0.3 1.9 13.5 0.0 12.3 3.1 0.1 0.8 3.8 0.0 3.8 0.0 0.3 4.1 3.0 3.0 0.9 0.2 23.0 4.2 0.0 0.0 12.7 0.0 4.4 2.3 0.1 0.4 71.5 0.2 237.3 400.9 768.1 75.4 371.8 99.5 15.0 75.2 71.7 220.3 16.8 68.6 69.2 1006.0 56.8 435.5 58.0 82.9 472.3 28.4 28.1 28.1 38.6 26.1 32.2 34.7 29.0 23.5 30.6 27.8 34.4 28.3 217.1 28.9 6.8 0.0 15.6 0.0 0.0 0.0 0.0 0.0 10.5 15.5 0.0 0.0 6.2 11.0 0.0 324.4 51.6 0.0 0.0 41.3 0.0 1.9 8.1 33.0 0.0 0.0 0.0 10.6 293.4 32.5 0.0 1.7 31.5 0.3 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.5 0.0 0.0 67.7 0.0 0.0 0.0 0.0 59.8 0.0 0.0 12.6 0.0 0.0 14.5 3.6 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 677.7 34.7 5.1 0.0 0.0 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2" Q92563 10 72059034-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 215.9;lymphoid tissue: 115.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3" "Lineage enriched" "Detected in all" 8 "T-cells: 198.8" "Group enriched" "Detected in some" 7 "Hep G2: 50.2;SCLC-21H: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 34000 "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 5.9 47.0 148.7 44.9 100.5 58.6 3.8 155.9 139.6 3.3 4.9 7.1 9.3 4.0 3.1 3.3 6.3 15.5 8.4 113.7 127.4 66.6 2.7 87.3 67.8 184.7 155.3 98.0 7.1 1.6 2.0 44.3 3.5 215.9 4.7 5.4 33.7 3.3 5.7 5.2 1.8 32.6 4.4 109.4 29.4 13.7 25.3 193.0 115.5 10.5 6.7 45.7 10.0 3.8 196.3 0.2 0.4 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 8.2 0.3 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.8 0.2 1.4 50.2 1.6 0.4 1.2 0.1 0.4 0.0 0.0 0.2 0.1 2.7 0.1 0.8 0.0 0.3 0.9 0.3 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.3 68.2 4.1 0.1 1.5 0.4 0.3 0.0 1.9 0.2 0.0 0.3 0.3 0.1 0.7 1.7 7.3 0.3 0.1 0.2 0.6 0.4 0.2 117.5 1.2 198.8 23.6 115.9 93.5 0.3 18.3 87.8 89.4 13.5 14.4 0.4 3.5 174.3 48.4 148.7 100.5 155.9 139.6 113.7 127.4 184.7 155.3 98.0 215.9 109.4 193.0 196.3 17.3 288.4 10.0 51.9 54.6 3.8 0.4 2.1 0.0 116.5 1.9 2.0 3.1 1.5 4.1 14.7 6.2 0.1 86.4 2.4 0.0 3.6 8.1 2.5 1.0 29.9 4.9 3.6 39.6 0.8 0.1 8.4 3.6 1.0 3.8 0.2 7.9 0.4 0.2 3.3 81.1 1.3 2.0 1.6 7.9 10.5 5.3 5.5 5.4 75.9 4.1 5.0 90.6 28.6 8.3 0.0 4.4 6.0 34.2 0.5 0.1 0.5 2.4 17.6 0.0 17.9 2.4 6.3 1.1 0.5 4.4 0.4 195.1 0.8 0.7 0.3 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 185.5;Inhibitory neurons: 205.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Approved Supported Mitochondria NA NA Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favorable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 31.2 55.7 33.3 21.3 36.7 34.5 26.6 51.0 47.5 28.5 27.2 30.4 37.7 36.9 24.0 20.9 34.9 32.6 44.3 36.8 32.9 106.3 117.7 29.9 20.2 31.4 31.4 34.3 42.0 20.2 43.6 24.6 23.8 33.9 25.1 33.2 31.8 21.0 22.5 72.8 27.9 33.0 38.7 27.8 27.2 43.7 20.3 30.2 26.3 23.2 77.6 21.8 31.1 21.9 35.9 42.2 71.8 45.4 53.3 70.8 66.6 20.6 45.8 101.6 65.7 89.8 42.2 77.2 56.8 37.3 63.5 54.0 49.1 57.7 40.7 76.9 51.9 46.6 38.3 37.1 61.2 56.4 53.3 40.1 66.6 36.2 72.4 66.5 90.4 57.7 53.4 60.0 64.5 77.6 37.9 46.7 49.9 19.0 45.0 17.3 50.5 60.9 37.4 80.8 31.0 34.8 49.8 54.2 65.9 42.0 45.2 39.3 50.5 36.2 32.6 50.1 65.7 38.4 33.9 62.6 39.2 65.1 69.6 22.5 21.5 60.0 110.8 16.8 49.8 14.7 15.1 14.7 15.5 26.0 17.5 14.4 12.0 48.8 15.2 54.5 16.5 15.3 35.4 33.3 36.7 51.0 47.5 36.8 32.9 31.4 31.4 34.3 33.9 27.8 30.2 35.9 30.4 54.5 36.0 47.7 23.4 9.9 16.0 22.6 14.2 31.9 25.3 19.6 35.8 25.8 38.3 35.0 20.9 20.7 16.9 25.9 80.3 35.6 10.7 42.0 43.0 22.7 14.4 25.0 185.5 26.7 18.8 31.1 45.9 48.2 18.3 31.5 23.9 60.4 34.8 16.8 205.9 24.4 16.2 36.9 13.4 12.5 26.8 40.1 12.4 64.6 38.0 51.3 10.3 146.8 97.5 51.4 24.9 25.9 25.0 10.7 29.3 110.7 34.0 33.8 6.6 29.0 27.2 54.5 40.0 14.2 14.2 21.5 19.0 73.4 23.6 14.2 PPP3CB "CALNA2, CALNB, CNA2, PP2Bbeta" ENSG00000107758 "Protein phosphatase 3 catalytic subunit beta" P16298 10 73436433-73496024 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 382.9;tongue: 181.3" "Cell type enhanced" "Detected in all" "Excitatory neurons: 119.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008233, HPA008823" Uncertain Approved Mitochondria NA NA Mitochondria "HPA008233: AB_1855661, HPA008823: AB_2668148" "unprognostic (3.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "unprognostic (8.93e-2)" "unprognostic (4.28e-2)" "prognostic unfavorable (9.59e-4)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (2.12e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" 45.2 37.9 37.5 30.0 57.4 19.9 32.4 57.1 64.0 29.9 32.4 34.2 24.4 40.7 34.8 33.4 31.1 28.6 41.7 57.7 49.7 28.3 22.0 23.7 35.2 31.8 34.4 51.1 40.0 25.5 39.5 30.9 25.7 38.1 39.4 29.9 57.5 26.8 40.2 382.9 26.5 22.8 48.7 30.5 25.6 24.5 29.3 36.4 33.2 23.8 181.3 36.4 34.6 24.5 49.6 53.7 29.0 50.9 53.0 71.4 98.3 24.5 48.0 65.7 46.1 45.4 18.6 26.8 47.1 15.3 70.0 21.8 28.1 41.6 36.9 64.5 66.6 34.0 20.3 25.0 35.5 42.7 45.2 40.2 70.1 43.5 43.6 58.1 84.7 32.3 40.6 25.6 54.0 94.1 16.9 40.7 41.6 20.7 23.3 83.8 26.9 27.7 22.4 45.1 25.6 27.2 31.5 28.1 69.5 36.4 42.1 52.4 43.2 35.6 36.6 33.7 29.5 66.1 35.8 105.3 33.0 45.3 64.0 21.3 2.2 2.0 3.5 4.0 2.7 4.8 2.7 4.3 4.4 2.1 2.3 3.4 5.1 1.1 3.5 1.7 4.0 7.8 1.9 37.5 57.4 57.1 64.0 57.7 49.7 31.8 34.4 51.1 38.1 30.5 36.4 49.6 23.0 3.2 14.3 72.5 31.6 25.6 29.8 13.2 27.3 54.8 25.7 16.9 48.9 14.3 12.8 18.4 20.9 21.0 23.7 11.1 62.6 18.1 11.8 20.0 24.2 21.5 42.6 30.7 119.5 19.4 16.8 32.6 20.4 18.8 21.0 35.4 18.9 14.2 20.3 38.7 111.0 13.2 18.3 31.7 24.2 9.9 33.5 25.2 26.6 51.5 29.6 34.8 18.6 79.4 54.4 16.7 12.9 29.0 34.1 27.1 13.4 34.2 17.6 30.1 6.6 41.8 36.4 43.8 49.2 32.1 31.5 22.2 27.3 28.4 13.1 22.1 CCSER2 "FAM190B, KIAA1128" ENSG00000107771 "Coiled-coil serine rich protein 2" Q9H7U1 10 84328586-84518521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 16 "Early spermatids: 1945.3;Late spermatids: 5466.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037481, HPA037482" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037481: AB_10672385, HPA037482: AB_10671501" "unprognostic (4.06e-3)" "unprognostic (4.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.71e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-1)" "unprognostic (5.60e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-1)" "unprognostic (3.02e-2)" "unprognostic (1.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.83e-2)" "unprognostic (8.56e-2)" "unprognostic (1.33e-1)" "unprognostic (5.74e-2)" 20.3 10.1 24.3 9.5 23.6 9.7 13.9 30.0 24.3 18.6 20.0 16.6 11.6 19.1 15.5 28.0 10.3 12.3 56.2 23.6 29.9 11.7 12.8 16.6 12.2 31.0 26.3 21.5 13.7 11.9 11.5 6.6 10.8 34.2 14.8 12.3 18.7 9.6 15.6 66.8 13.4 11.4 24.9 29.0 10.4 10.9 63.7 28.5 16.4 24.8 63.5 11.4 16.7 11.1 28.4 17.1 13.0 15.2 33.7 21.4 35.1 10.7 20.2 33.1 12.3 23.8 7.4 17.7 11.4 12.9 37.1 19.7 14.2 11.5 12.8 18.4 37.5 7.2 4.1 5.8 9.3 20.1 6.1 8.3 17.4 18.1 19.8 62.2 31.5 33.7 21.0 5.4 33.6 22.2 10.6 10.6 4.3 6.6 5.9 10.3 10.6 7.8 4.2 11.0 17.8 4.6 8.4 11.1 7.3 34.7 20.9 13.4 3.0 30.5 36.7 16.6 18.2 21.5 33.5 12.2 9.0 23.7 7.7 16.2 4.9 4.3 7.7 19.4 3.9 19.8 7.5 14.3 18.2 4.1 6.9 12.8 13.8 5.9 20.3 3.2 6.2 9.6 8.5 24.3 23.6 30.0 24.3 23.6 29.9 31.0 26.3 21.5 34.2 29.0 28.5 28.4 50.9 41.7 40.8 120.2 28.8 35.3 57.8 28.1 22.8 87.0 43.7 43.1 218.6 12.8 32.6 16.5 31.3 24.9 101.2 16.1 37.2 31.3 1945.3 21.2 33.9 54.1 16.3 3.0 146.7 45.8 19.3 52.2 21.4 28.8 14.5 28.5 37.1 24.0 20.9 62.2 142.5 28.9 22.4 21.4 66.2 5466.2 51.6 29.2 26.6 124.6 39.5 58.5 81.4 209.6 222.3 34.1 13.8 59.8 42.1 55.4 49.6 26.1 22.0 55.9 13.1 61.8 65.3 103.6 84.0 36.4 47.0 68.4 90.4 30.0 21.4 67.2 BMPR1A "ACVRLK3, ALK3, CD292" ENSG00000107779 "Bone morphogenetic protein receptor type 1A" P36894 10 86756601-86932825 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 142.7;Inhibitory neurons: 79.9;Oligodendrocyte precursor cells: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019398 Approved Approved Cytosol NA NA Cytosol "CAB019398: " "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (3.34e-1)" "unprognostic (9.61e-2)" "unprognostic (1.05e-3)" "unprognostic (9.34e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (3.64e-1)" "unprognostic (2.38e-2)" "unprognostic (1.53e-1)" "unprognostic (9.24e-2)" "unprognostic (9.42e-2)" "unprognostic (4.32e-2)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "unprognostic (1.01e-2)" "unprognostic (1.07e-1)" 9.2 6.4 5.9 4.6 5.9 0.0 10.4 6.1 5.5 8.2 5.4 9.7 5.5 13.0 12.0 7.9 7.5 9.7 7.9 4.9 11.2 7.0 4.4 7.4 2.9 6.9 6.0 3.8 11.7 5.9 10.0 2.7 6.6 6.4 12.6 8.3 4.8 12.2 13.1 8.0 9.4 8.7 12.6 7.0 2.9 7.3 5.3 5.5 2.9 19.2 4.8 3.0 8.0 4.1 7.3 14.6 7.8 27.6 26.8 15.0 10.6 5.5 14.5 18.3 9.4 11.3 11.0 13.1 4.7 6.1 19.2 5.9 15.0 15.8 14.3 14.1 5.5 8.2 5.9 6.9 19.0 10.2 7.4 37.7 10.7 8.5 11.2 9.5 13.9 0.0 8.1 7.6 2.7 12.3 7.0 6.7 7.8 17.6 5.2 4.2 0.0 12.3 0.1 18.9 12.1 3.7 12.8 17.8 8.4 12.6 34.1 15.0 4.1 6.2 7.0 9.8 12.7 13.3 0.3 12.3 5.3 6.5 5.6 6.0 0.3 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.0 5.9 5.9 6.1 5.5 4.9 11.2 6.9 6.0 3.8 6.4 7.0 5.5 7.3 3.5 35.3 22.4 142.7 3.5 12.1 7.1 9.9 17.6 7.5 10.2 10.2 22.6 18.6 10.5 11.0 20.9 14.1 2.3 10.7 1.9 10.6 0.7 10.7 19.7 4.5 18.0 0.0 63.8 9.5 1.0 20.6 19.4 13.9 15.2 22.9 9.3 7.2 3.4 11.8 79.9 13.9 8.2 4.8 6.1 4.1 33.5 2.3 8.8 34.7 0.8 12.9 2.1 122.2 64.3 8.9 4.9 31.2 3.2 13.7 10.6 5.5 16.5 20.4 6.6 20.3 19.2 2.1 6.6 11.5 9.8 5.1 4.3 11.9 11.1 6.7 MINPP1 MIPP ENSG00000107789 "Multiple inositol-polyphosphate phosphatase 1" Q9UNW1 10 87504875-87553461 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026859 Approved "Intracellular and membrane" NA NA 370000000 "HPA026859: AB_1853961" "unprognostic (9.15e-2)" "unprognostic (8.76e-3)" "unprognostic (2.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (5.20e-3)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (4.55e-1)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.01e-2)" 8.5 21.5 7.3 7.3 7.4 31.3 9.5 7.6 9.1 8.9 9.8 12.7 17.8 7.0 10.1 3.6 8.6 8.5 5.8 7.4 8.1 17.7 29.3 8.4 7.8 7.2 7.3 7.3 8.9 12.0 9.1 8.2 19.1 7.3 11.8 13.0 12.1 7.0 7.7 4.9 9.2 13.7 7.7 7.5 6.9 8.6 7.9 8.0 8.2 11.7 5.7 7.0 8.7 5.7 8.1 18.6 28.1 28.1 40.9 46.4 38.1 23.2 29.5 51.1 28.8 38.3 15.0 35.5 16.4 27.0 35.9 19.4 28.2 29.9 27.1 33.2 37.1 35.7 41.1 10.4 55.7 34.6 18.0 36.0 33.7 34.7 32.6 19.5 52.5 37.0 14.3 24.5 75.9 34.4 13.8 11.9 25.6 20.0 14.2 20.2 0.0 15.8 11.0 38.5 10.4 10.2 31.5 28.1 5.9 51.5 31.5 16.7 14.7 32.4 18.3 21.9 22.1 28.7 24.5 27.1 4.2 29.3 26.8 13.7 10.5 10.8 4.9 11.5 13.8 10.1 8.7 10.8 13.0 14.3 8.2 10.2 11.4 0.7 11.7 12.5 8.2 17.3 10.5 7.3 7.4 7.6 9.1 7.4 8.1 7.2 7.3 7.3 7.3 7.5 8.0 8.1 11.7 6.4 12.8 9.1 8.1 2.8 8.3 25.5 8.0 14.4 9.0 4.3 4.9 15.7 16.2 7.3 2.1 20.4 4.9 14.0 5.9 17.2 15.9 7.1 13.4 10.5 13.1 288.9 18.3 16.7 19.2 17.9 7.1 6.7 24.7 17.8 16.4 58.3 12.9 10.1 20.8 25.5 20.3 16.0 5.8 4.0 9.3 8.7 10.6 7.5 11.7 11.1 10.3 25.6 19.1 10.5 17.2 8.2 18.6 6.8 17.1 26.0 19.0 14.8 0.0 4.8 11.1 10.6 12.1 4.0 3.4 8.1 8.2 13.7 11.6 4.4 ACTA2 ACTSA ENSG00000107796 "Actin alpha 2, smooth muscle" P62736 10 88935074-88991339 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 6735.1;seminal vesicle: 5976.7;smooth muscle: 8165.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 58.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "midbrain: 101.0" "CAB000002, CAB003761, CAB013531, HPA041264, HPA041271" Enhanced Supported "Actin filaments" NA NA "Actin filaments" "CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.30e-3)" "unprognostic (3.18e-2)" "unprognostic (3.33e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-2)" "unprognostic (1.71e-2)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.87e-3)" "unprognostic (2.30e-1)" "unprognostic (7.91e-2)" "unprognostic (2.09e-3)" 941.5 243.9 50.0 734.6 53.3 3.9 845.7 49.4 122.1 1876.3 103.1 2062.0 251.1 6735.1 1372.0 1524.1 3131.6 914.1 671.1 49.6 53.5 309.3 163.2 739.2 175.1 59.8 51.7 48.3 804.7 92.2 81.2 61.3 777.7 52.8 2666.3 874.6 8.3 418.4 5976.7 203.8 296.7 707.6 8165.6 50.3 455.7 1439.1 266.0 51.7 57.0 314.6 215.9 48.8 3027.7 1378.7 58.3 3.9 19.0 49.3 102.7 198.1 390.6 9.5 109.8 136.8 11.9 45.4 0.0 8.8 7.2 11.5 641.1 8.6 1.4 1.8 25.4 11.3 60.6 11.3 0.4 5.6 119.3 625.8 0.8 3.2 345.1 44.9 73.9 28.5 743.4 11.3 3.0 0.0 7.1 128.8 10.8 1.0 28.3 2.5 0.2 1.2 1.4 0.2 4.6 27.1 5.0 0.7 7.6 10.2 7.9 1.0 296.8 32.4 1.0 27.9 24.0 4.0 30.2 9.3 21.1 1.6 0.6 29.6 10.2 26.1 28.1 12.3 17.5 17.6 8.7 13.8 6.0 14.1 19.8 10.8 1.8 1.5 10.7 11.1 4.0 14.2 0.4 58.7 10.7 50.0 53.3 49.4 122.1 49.6 53.5 59.8 51.7 48.3 52.8 50.3 51.7 58.3 65.4 9.6 6.1 5.5 4.4 43.2 23.4 16.5 22.8 1.1 22.7 1007.7 25.1 2.8 5.2 0.0 6.2 16.3 7.3 1.9 1.9 1.8 11.1 11.1 225.4 41.1 0.0 4.0 3.6 0.9 16.8 316.3 10.7 8.2 5.7 448.9 474.0 4.6 37.7 0.0 1.1 2.7 4.1 5.4 67.6 48.8 141.4 12.6 55.2 61.8 4.2 13.4 4.1 1.0 0.3 2.0 3.0 5290.7 3.7 17.5 3.4 9.5 10.9 1.4 3030.6 72.0 2394.6 4.0 13.8 11.1 40.5 23.7 16.5 36.0 5.7 10.4 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 401.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5" "Group enriched" "Detected in all" 6 "dendritic cells: 123.6;monocytes: 355.1" "Cell line enhanced" "Detected in many" "A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Intracellular and membrane" NA NA 280000 "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "CAB034892: AB_784329, HPA057052: AB_2683322" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 76.7 46.7 49.9 67.3 67.9 40.2 48.2 70.3 75.1 54.4 50.6 68.4 169.2 39.2 21.8 28.9 38.2 84.2 24.4 49.9 73.3 45.3 220.7 171.0 160.6 81.7 63.8 44.7 33.0 21.6 69.4 12.8 79.8 83.2 31.0 72.7 12.7 22.6 34.1 11.9 18.8 229.4 48.2 78.4 401.8 34.6 13.5 64.7 44.9 31.9 22.7 45.9 59.0 19.4 114.4 354.4 49.4 30.7 367.8 343.5 450.8 10.0 171.4 194.8 65.5 121.5 18.6 176.6 63.9 34.0 264.4 73.7 338.7 13.8 92.8 53.6 86.1 34.7 25.1 19.1 81.5 87.6 48.8 48.9 190.4 69.2 72.9 40.6 88.2 14.9 45.4 0.3 108.5 58.3 28.2 45.7 34.6 22.7 62.4 60.0 26.4 39.0 60.5 69.2 50.9 10.5 21.8 41.4 49.9 133.9 20.4 64.4 65.8 26.2 58.8 15.5 132.1 44.6 60.0 65.7 25.8 71.4 112.9 82.1 4.2 167.3 16.9 40.0 355.1 40.6 31.9 35.8 38.8 123.6 33.4 36.7 40.4 7.1 29.8 198.5 25.0 38.2 159.6 49.9 67.9 70.3 75.1 49.9 73.3 81.7 63.8 44.7 83.2 78.4 64.7 114.4 75.5 41.7 33.8 11.1 35.9 17.7 30.3 58.1 25.6 5.4 16.1 14.1 9.6 45.8 31.9 33.1 0.0 34.8 31.4 2.8 21.5 35.1 6.8 11.4 20.4 56.7 21.8 27.4 34.4 36.2 32.9 34.6 21.4 15.5 28.5 10.8 54.7 66.7 515.0 16.8 15.1 8.9 40.7 714.8 69.0 2.7 11.5 303.1 48.0 30.0 71.7 33.1 29.9 15.1 143.0 19.3 12.0 21.8 15.4 11.3 161.0 14.0 28.8 2.2 6.6 19.7 21.0 5.1 13.8 31.9 12.5 20.0 33.1 17.6 9.1 24.0 TLX1 "HOX11, TCL3" ENSG00000107807 "T cell leukemia homeobox 1" P31314 10 101131300-101137789 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "lymphoid tissue: 44.3;salivary gland: 16.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "medulla oblongata: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.5;HEK 293: 2.5;K-562: 13.8;SCLC-21H: 2.2;SH-SY5Y: 3.3;SiHa: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.06e-5)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (5.07e-1)" "unprognostic (1.57e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-2)" "unprognostic (2.52e-3)" "unprognostic (1.81e-1)" "unprognostic (2.63e-1)" "unprognostic (3.26e-1)" "unprognostic (3.06e-1)" "unprognostic (7.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.7 0.0 0.1 0.0 16.7 0.0 0.0 0.0 0.8 0.0 0.0 44.3 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 3.3 2.7 0.0 0.0 0.2 0.1 0.4 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 TWNK "C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL" ENSG00000107815 "Twinkle mtDNA helicase" Q96RR1 10 100987367-100994403 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "Helicase, Hydrolase" "Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002532 Uncertain NA NA "HPA002532: AB_1078311" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "unprognostic (1.16e-1)" "unprognostic (2.19e-2)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (7.82e-3)" "unprognostic (7.99e-2)" "unprognostic (1.22e-1)" "unprognostic (7.95e-2)" "unprognostic (7.52e-2)" "unprognostic (1.96e-2)" "unprognostic (9.46e-2)" "unprognostic (9.82e-3)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" "unprognostic (1.45e-1)" 4.9 7.1 3.6 5.6 3.6 3.0 7.5 3.5 3.5 3.5 3.1 4.4 3.4 4.7 5.3 5.5 6.6 2.7 4.1 3.3 3.6 4.0 6.0 2.2 6.2 3.9 3.9 3.1 5.2 5.2 4.9 2.4 3.9 3.9 4.0 4.8 1.7 4.0 3.4 11.7 5.5 3.9 4.5 3.7 4.7 4.0 8.4 3.9 8.2 4.1 12.7 8.3 6.7 3.6 3.6 15.5 32.0 12.5 39.7 11.1 7.2 14.7 11.4 14.8 17.3 16.6 52.6 13.1 55.4 21.1 7.0 10.4 25.0 52.2 27.7 21.1 25.5 31.0 42.1 17.4 40.2 19.1 54.8 16.7 14.9 30.7 25.5 77.6 15.8 10.6 26.3 45.9 15.0 12.3 21.2 37.0 18.8 35.8 28.2 25.9 35.5 27.5 33.2 10.7 15.4 20.1 38.5 12.0 16.0 37.8 13.8 20.9 16.0 12.4 8.6 17.4 10.6 32.5 28.0 31.3 46.0 10.6 47.8 9.8 1.2 0.6 0.1 1.2 0.5 3.7 2.4 1.8 2.7 1.2 2.1 2.0 2.2 0.0 2.5 0.8 1.3 0.4 1.4 3.6 3.6 3.5 3.5 3.3 3.6 3.9 3.9 3.1 3.9 3.7 3.9 3.6 3.5 0.0 2.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 6.8 6.6 0.0 0.0 3.1 1.8 0.0 4.2 1.9 0.0 3.9 5.4 0.0 2.3 7.2 2.0 0.0 0.0 0.0 3.0 3.7 1.3 0.0 2.8 1.3 7.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.6 1.1 9.1 0.0 0.0 LZTS2 "KIAA1813, LAPSER1" ENSG00000107816 "Leucine zipper tumor suppressor 2" Q9BRK4 10 100996618-101007836 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044956 Approved Approved "Plasma membrane,Cytosol" No Yes "Plasma membrane, Cytosol" "HPA044956: AB_10795989" "unprognostic (1.42e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (8.18e-2)" "unprognostic (4.64e-2)" "unprognostic (1.56e-1)" "unprognostic (5.49e-3)" "unprognostic (3.56e-1)" "unprognostic (7.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.63e-2)" "unprognostic (1.86e-1)" "unprognostic (5.46e-3)" "unprognostic (1.76e-3)" 69.7 66.5 43.1 15.0 57.5 14.5 63.8 51.9 51.4 70.6 23.1 76.8 17.6 91.1 17.9 41.3 69.8 20.0 57.7 37.1 41.5 51.9 18.1 57.6 12.2 56.8 60.6 32.4 79.3 29.8 29.3 44.0 28.8 69.3 70.1 8.9 6.0 44.7 41.0 38.1 47.9 43.4 26.8 47.6 44.8 55.3 36.4 52.8 10.9 58.1 18.2 8.2 84.9 54.9 74.3 32.9 43.1 34.6 59.7 45.0 36.3 70.8 38.7 72.8 31.9 36.0 50.5 26.6 13.1 35.1 52.5 23.0 54.6 21.5 28.2 7.8 12.8 31.9 12.1 46.4 66.3 63.6 6.4 15.2 66.1 20.2 25.1 30.1 67.3 32.8 15.6 38.7 7.3 28.7 31.6 5.8 15.8 38.8 12.6 35.2 74.7 101.3 13.5 24.4 39.3 8.4 62.8 26.3 11.9 99.9 18.6 61.0 51.6 42.1 37.9 42.6 40.5 20.7 14.0 10.2 3.3 64.0 17.7 19.4 0.0 0.7 0.4 2.7 0.4 3.7 2.3 3.4 3.0 1.1 2.9 3.5 3.0 0.3 2.9 0.1 1.8 3.0 1.5 43.1 57.5 51.9 51.4 37.1 41.5 56.8 60.6 32.4 69.3 47.6 52.8 74.3 34.7 16.0 10.5 20.2 5.3 13.4 9.0 12.4 19.4 14.4 21.7 20.3 5.2 11.5 9.4 5.5 6.2 18.6 1.9 8.0 7.9 19.1 6.8 7.9 20.5 22.9 16.7 5.0 6.8 12.6 13.2 21.8 14.8 13.0 1.3 38.9 18.5 2.6 22.2 18.5 7.7 17.8 16.2 7.2 9.2 4.1 25.7 8.4 16.0 13.1 4.8 18.9 4.1 9.0 70.3 13.3 7.9 29.3 5.4 18.1 6.5 8.3 6.1 4.0 26.3 21.1 40.7 3.8 15.0 10.8 12.1 47.1 6.0 26.9 15.1 9.7 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Metabolic proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 177.5;Proximal enterocytes: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria NA NA Mitochondria "HPA008028: AB_1079938, HPA048105: AB_2680265" "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 18.8 10.8 15.6 11.9 18.1 6.3 15.1 19.0 21.4 17.8 14.8 12.7 32.0 18.1 21.6 8.1 18.4 16.5 15.3 18.2 13.7 11.8 4.4 21.4 8.0 17.5 16.4 17.8 12.8 9.2 18.4 9.1 21.1 18.3 12.1 10.5 23.6 11.2 16.6 3.6 21.1 37.8 25.6 13.0 10.7 11.1 7.3 18.5 6.5 10.0 8.0 7.2 15.0 14.8 19.5 44.4 16.9 1.7 5.2 43.5 46.0 4.4 26.4 92.7 33.0 26.4 28.1 47.4 1.9 24.8 62.1 27.7 31.8 7.9 57.7 14.4 12.3 10.2 5.3 27.1 20.4 29.8 4.2 41.2 31.8 8.3 29.1 27.3 91.8 73.5 12.5 0.4 1.4 54.4 7.3 1.9 6.4 2.1 16.2 40.3 4.3 32.5 12.0 48.5 6.8 9.0 44.1 14.4 1.7 39.3 11.8 13.8 31.2 60.9 29.0 22.7 26.0 13.1 6.6 2.7 0.2 70.7 23.7 23.7 10.6 18.1 9.1 11.0 13.4 8.5 2.4 7.4 7.6 19.1 1.1 4.5 5.6 3.2 5.5 7.8 2.9 8.7 11.7 15.6 18.1 19.0 21.4 18.2 13.7 17.5 16.4 17.8 18.3 13.0 18.5 19.5 17.1 12.8 5.3 7.5 3.9 13.9 5.0 6.3 2.8 60.2 6.9 7.0 3.2 18.6 4.6 5.5 47.9 1.2 21.2 7.3 1.9 31.7 51.9 25.2 13.4 17.5 5.4 4.8 14.2 15.3 40.9 17.4 7.7 5.6 14.5 55.5 20.0 0.9 37.4 10.1 12.2 7.8 4.1 21.3 29.9 177.5 17.4 24.3 33.8 1.0 12.0 7.7 9.2 5.0 16.0 38.5 10.8 14.7 10.4 2.9 119.1 14.3 38.8 24.0 13.1 6.7 12.0 1.4 0.7 1.3 10.9 10.9 19.7 2.7 5.6 3.4 KAZALD1 "FKSG28, FKSG40" ENSG00000107821 "Kazal type serine peptidase inhibitor domain 1" Q96I82 10 101061989-101068131 "Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 23.0;Gastric mucus-secreting cells: 44.4;Intestinal goblet cells: 53.5;Proximal enterocytes: 78.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 30.8;T-47d: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA011800 Uncertain "Secreted to extracellular matrix" NA NA 65000 "HPA011800: AB_1852082" "unprognostic (3.34e-1)" "unprognostic (8.86e-3)" "unprognostic (1.16e-2)" "unprognostic (4.43e-3)" "unprognostic (4.88e-2)" "unprognostic (1.35e-2)" "unprognostic (6.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.39e-2)" "unprognostic (1.70e-2)" "unprognostic (1.35e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (3.44e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.11e-1)" 2.9 0.6 0.3 0.6 0.2 0.3 2.8 0.4 0.4 7.2 0.3 1.9 2.8 2.0 1.3 0.6 2.1 0.6 7.8 0.4 0.2 1.6 0.5 1.2 0.7 0.3 0.4 0.1 0.5 0.9 0.8 3.6 0.8 0.4 5.2 1.6 0.4 6.9 2.2 4.2 1.6 3.2 1.5 0.2 18.2 6.7 1.9 0.4 1.0 2.6 3.2 0.3 3.6 2.9 0.3 3.3 1.6 1.8 30.8 1.8 7.4 2.0 5.2 5.6 1.0 1.0 6.2 2.0 0.2 2.8 4.6 0.5 0.7 1.9 0.1 0.3 3.1 0.8 0.4 6.5 6.7 0.5 0.4 2.3 1.1 0.4 0.1 0.9 0.4 0.0 0.9 0.7 3.2 0.9 5.3 0.1 1.9 0.5 7.2 11.7 12.4 9.1 0.4 0.6 1.6 0.3 1.2 0.5 0.8 1.7 0.7 36.7 0.5 0.1 0.7 2.1 0.5 1.2 0.9 2.6 2.5 1.3 3.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.4 0.4 0.2 0.3 0.4 0.1 0.4 0.2 0.4 0.3 8.3 0.0 1.5 0.7 0.3 2.0 0.9 1.6 0.6 1.5 2.5 3.0 3.4 1.5 1.6 0.0 2.1 0.3 0.3 23.0 1.9 0.5 0.1 4.1 1.3 5.1 2.4 2.7 0.1 2.1 0.6 16.9 44.4 7.2 0.0 0.2 3.6 0.3 0.8 0.0 0.1 53.5 4.1 4.8 1.9 0.1 9.9 0.9 1.8 0.0 0.0 0.8 0.0 0.0 0.1 1.5 12.8 0.4 0.2 5.0 78.1 0.4 0.7 2.2 0.0 10.4 6.1 3.9 1.4 0.7 2.8 0.5 0.6 0.2 8.1 0.4 FBXW4 "dactylin, Fbw4, SHFM3" ENSG00000107829 "F-box and WD repeat domain containing 4" P57775 10 101610664-101695295 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043496 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA043496: AB_2678514" "unprognostic (4.31e-2)" "unprognostic (5.43e-3)" "unprognostic (8.40e-3)" "prognostic favorable (4.91e-4)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (9.96e-3)" "unprognostic (1.87e-1)" "unprognostic (3.96e-1)" "prognostic favorable (4.67e-4)" "unprognostic (1.13e-2)" "prognostic favorable (3.41e-5)" "unprognostic (2.94e-3)" "unprognostic (1.81e-1)" "unprognostic (4.99e-2)" "unprognostic (1.85e-2)" 34.1 30.6 101.3 10.5 101.0 16.1 35.1 92.3 97.1 32.4 79.5 48.9 16.6 26.9 29.8 39.0 29.1 13.1 58.6 89.5 89.8 36.7 35.2 36.1 18.1 101.1 99.7 84.0 30.4 44.5 47.4 47.1 16.6 102.9 49.5 16.7 14.4 41.8 27.1 80.6 49.0 31.8 14.8 103.3 30.3 41.1 23.0 101.3 18.3 40.5 44.8 18.0 49.4 33.2 101.0 22.1 25.7 4.0 28.9 20.1 16.5 18.9 11.3 31.1 12.8 10.0 12.0 22.9 25.1 17.5 23.4 13.1 13.4 11.0 16.7 4.3 26.8 15.2 6.0 9.1 26.1 35.7 10.0 7.6 15.2 52.0 6.9 42.8 29.8 11.0 17.6 6.2 15.3 14.2 45.9 11.4 14.2 11.3 11.4 12.3 9.4 29.6 10.7 25.1 14.7 12.3 21.6 21.8 8.1 20.7 6.0 33.6 17.8 11.8 13.8 1.8 5.8 11.5 31.9 15.4 11.1 11.3 12.7 8.1 1.3 1.4 2.2 4.3 0.8 2.6 3.8 4.3 4.2 1.1 4.8 4.5 3.7 0.2 4.2 1.4 4.1 1.4 1.2 101.3 101.0 92.3 97.1 89.5 89.8 101.1 99.7 84.0 102.9 103.3 101.3 101.0 13.6 3.2 36.9 45.4 14.0 11.2 16.4 11.9 6.8 28.5 25.7 21.8 35.8 12.8 11.1 11.0 18.8 17.0 24.4 29.1 3.9 15.2 50.2 15.3 16.3 10.0 20.4 7.0 57.5 26.1 9.2 11.3 17.3 27.2 5.1 32.3 8.9 24.7 8.8 37.0 55.7 27.8 14.2 8.6 7.4 28.9 14.3 8.7 14.2 55.3 10.7 29.9 15.5 54.8 70.3 19.4 24.4 17.0 14.1 22.2 21.1 13.3 7.5 22.7 13.1 15.4 14.7 4.9 6.0 11.3 12.5 15.6 16.9 10.9 21.7 18.7 FGF8 AIGF ENSG00000107831 "Fibroblast growth factor 8" P55075 10 101770130-101780369 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "skeletal muscle: 49.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.1;testis cancer: 3.3" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "RH-30: 37.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.56e-1)" "unprognostic (3.90e-3)" "unprognostic (1.12e-2)" "unprognostic (4.88e-1)" "unprognostic (2.47e-2)" "unprognostic (9.09e-2)" "unprognostic (8.75e-3)" "unprognostic (8.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.35e-9)" "unprognostic (6.17e-3)" "unprognostic (9.01e-2)" "unprognostic (1.97e-1)" 0.5 0.0 0.7 0.0 0.6 0.2 0.2 0.5 1.2 0.1 0.8 0.2 0.3 0.2 0.2 0.9 0.1 0.3 0.3 0.9 0.8 0.1 0.1 0.3 0.3 0.6 0.7 0.7 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.1 0.5 0.0 0.1 49.2 0.2 0.0 0.0 0.4 0.6 0.1 1.1 0.6 0.0 0.2 0.0 0.0 0.2 0.0 1.0 0.6 0.1 0.3 1.4 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.6 0.7 0.4 0.6 0.0 0.0 0.5 0.3 0.0 0.0 1.1 1.0 0.4 0.3 0.5 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.0 1.0 0.3 0.9 0.0 0.4 0.6 2.2 0.2 0.0 0.1 0.6 37.8 0.8 0.0 0.2 0.9 0.9 0.0 0.6 0.5 0.0 0.6 0.1 0.6 0.6 1.1 0.8 0.2 0.2 0.8 1.3 0.8 0.7 0.8 1.9 0.4 0.5 0.3 0.5 0.6 0.4 0.4 0.4 0.4 0.5 0.6 0.5 1.1 0.7 0.9 0.4 0.5 0.3 0.7 0.6 0.5 1.2 0.9 0.8 0.6 0.7 0.7 0.6 0.4 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 12.4 19.6 10.0 18.7 10.9 27.4 19.2 8.5 10.5 18.8 10.2 15.7 8.4 17.4 10.2 26.8 15.4 9.9 8.4 10.3 11.3 15.1 12.4 10.3 23.5 9.1 9.1 10.2 20.8 30.6 16.6 12.5 16.5 9.2 13.5 19.5 1.2 15.3 8.2 13.4 16.8 10.8 20.0 9.3 14.9 13.2 17.3 11.2 20.5 11.2 10.2 26.2 21.1 16.8 9.9 94.8 117.2 34.2 226.2 76.5 80.0 36.1 50.0 75.7 75.8 64.4 126.5 117.1 154.8 91.0 56.0 41.6 99.2 192.6 211.8 59.3 66.1 199.8 124.5 50.5 206.0 86.1 286.6 87.4 69.6 100.8 105.2 417.0 39.0 100.6 187.1 156.9 83.7 63.3 173.8 121.0 371.8 60.7 131.1 89.1 93.3 179.2 158.0 75.0 45.8 70.0 45.1 31.2 72.5 144.7 41.8 94.4 59.0 40.1 30.0 95.8 44.8 94.1 36.0 39.9 179.7 41.9 263.4 31.8 0.0 2.8 0.0 3.6 4.0 6.5 4.0 5.9 6.9 6.4 4.8 9.5 9.8 0.1 8.1 0.8 8.3 2.6 5.1 10.0 10.9 8.5 10.5 10.3 11.3 9.1 9.1 10.2 9.2 9.3 11.2 9.9 5.1 3.2 5.0 1.0 15.3 62.7 79.6 121.4 28.5 1.4 55.5 54.4 2.9 28.6 32.0 36.8 0.0 91.4 15.6 16.3 78.2 54.0 8.9 7.3 22.1 21.6 24.2 17.9 2.7 41.2 90.6 29.7 13.7 10.5 16.5 19.6 15.0 19.0 68.6 0.0 2.0 33.1 46.8 21.1 69.9 10.9 28.0 18.0 30.2 1.9 14.7 2.5 18.6 1.5 1.0 34.2 12.7 23.7 19.1 118.5 3.1 61.6 16.4 2.0 6.6 47.9 21.6 46.5 91.3 21.3 49.9 60.7 18.5 29.0 46.9 62.8 TNKS2 "ARTD6, PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL" ENSG00000107854 "Tankyrase 2" Q9H2K2 10 91798426-91865475 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036606 Approved Microtubules NA NA Microtubules "HPA036606: AB_10673470" "unprognostic (1.12e-1)" "unprognostic (2.66e-1)" "unprognostic (4.16e-1)" "unprognostic (1.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (2.93e-1)" "unprognostic (2.59e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (2.35e-1)" "unprognostic (1.69e-1)" "unprognostic (7.97e-2)" "unprognostic (2.53e-1)" 18.6 19.5 16.4 21.4 17.7 38.9 22.5 19.8 17.1 21.3 24.3 14.9 15.1 22.7 20.0 23.0 18.0 21.0 11.2 15.6 23.4 17.6 21.3 19.9 28.3 16.2 17.0 14.6 30.6 22.1 22.0 14.5 31.4 16.8 19.8 17.2 31.4 18.6 16.7 56.1 27.5 15.4 20.9 16.7 30.2 20.0 11.9 17.5 38.1 29.9 40.8 29.7 24.3 17.2 21.4 29.1 24.3 48.9 41.7 33.8 30.6 54.5 30.6 55.5 36.5 44.5 21.7 23.2 27.2 14.3 40.0 24.6 30.6 31.0 23.6 51.3 27.7 29.9 22.6 22.9 24.3 32.9 44.0 32.3 31.4 30.6 37.0 65.3 54.8 34.8 24.1 16.9 29.4 38.5 15.6 38.1 29.9 24.6 13.2 16.1 35.2 30.5 20.9 25.0 30.9 12.8 22.9 30.8 13.4 38.7 39.2 32.5 30.3 37.8 19.6 16.5 26.1 29.5 36.7 32.1 34.8 25.9 32.4 17.9 0.2 0.7 1.2 0.9 0.6 0.8 1.0 0.9 0.8 1.0 1.0 0.7 0.6 0.7 1.0 0.6 1.5 0.5 0.4 16.4 17.7 19.8 17.1 15.6 23.4 16.2 17.0 14.6 16.8 16.7 17.5 21.4 39.1 41.7 22.3 63.3 51.6 74.6 32.5 23.8 56.9 41.7 38.8 24.0 23.2 8.6 31.0 44.1 47.9 45.2 48.7 19.2 7.9 16.0 4.7 41.1 29.3 37.1 33.0 27.5 77.5 24.5 55.1 30.9 50.4 52.1 2.5 34.8 35.7 35.9 26.1 42.1 78.5 19.3 26.4 55.3 49.4 8.1 31.1 48.4 33.8 67.5 46.5 24.9 37.0 66.9 68.0 29.0 12.3 35.3 45.7 44.7 16.1 16.6 47.4 34.8 46.0 40.5 28.0 19.1 21.7 75.9 109.1 101.0 49.1 30.5 14.9 61.7 PITX3 ASMD ENSG00000107859 "Paired like homeodomain 3" O75364 10 102230186-102241512 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 5.0;skeletal muscle: 16.7;tongue: 6.0" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 22.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "midbrain: 5.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "RH-30: 30.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 9.1" NA NA "unprognostic (8.13e-2)" "unprognostic (4.07e-1)" "unprognostic (5.15e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (6.04e-5)" "unprognostic (6.30e-3)" "unprognostic (2.02e-1)" "unprognostic (6.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.73e-2)" "unprognostic (1.76e-2)" "unprognostic (6.76e-3)" "unprognostic (4.13e-2)" 1.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 5.0 0.1 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 22.1 0.3 1.4 1.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 GBF1 "ARF1GEF, KIAA0248" ENSG00000107862 "Golgi brefeldin A resistant guanine nucleotide exchange factor 1" Q92538 10 102245371-102382899 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037759, HPA037760" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA037759: AB_10671884, HPA037760: AB_2675651" "unprognostic (5.97e-2)" "unprognostic (3.33e-1)" "unprognostic (2.74e-3)" "unprognostic (7.02e-2)" "unprognostic (2.03e-1)" "unprognostic (6.72e-2)" "unprognostic (3.78e-2)" "unprognostic (8.28e-2)" "unprognostic (1.12e-2)" "unprognostic (5.34e-3)" "unprognostic (2.04e-2)" "unprognostic (6.06e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (3.02e-1)" "unprognostic (3.09e-2)" 18.5 21.3 28.2 16.1 28.5 25.3 19.5 25.4 47.6 21.7 29.2 23.8 20.8 23.7 12.9 22.1 19.8 9.8 26.7 28.9 25.7 21.3 23.4 20.7 14.7 25.1 33.7 28.0 21.8 25.8 24.6 31.7 11.6 26.1 24.4 14.0 19.4 24.7 15.3 48.5 24.7 26.0 16.6 22.0 21.9 21.3 20.7 26.2 12.0 25.7 30.3 14.0 21.8 20.7 25.8 19.4 49.7 23.3 25.1 62.9 40.7 28.1 37.7 56.0 45.3 48.1 52.7 35.1 21.7 29.7 59.6 33.8 38.6 45.9 52.8 33.8 35.4 36.9 33.3 38.1 44.6 26.4 35.2 46.8 37.3 28.0 60.7 57.5 77.2 45.2 22.5 20.7 53.7 41.8 36.9 24.2 38.9 15.4 29.5 35.6 33.6 72.1 18.8 39.3 30.9 15.0 16.3 30.2 22.3 26.5 33.1 50.4 30.8 60.5 29.1 29.6 37.7 55.6 32.4 36.3 26.5 30.0 36.3 22.1 28.6 4.5 4.3 4.9 5.0 5.9 6.5 3.6 6.5 5.0 3.9 5.7 5.3 4.6 4.6 4.1 4.2 7.4 3.9 28.2 28.5 25.4 47.6 28.9 25.7 25.1 33.7 28.0 26.1 22.0 26.2 25.8 12.5 12.8 10.1 56.5 15.5 9.8 5.5 10.6 17.6 24.7 15.7 12.8 17.0 15.7 10.9 12.9 56.3 12.2 15.1 31.4 3.9 12.5 4.9 14.3 18.1 12.3 12.0 13.9 72.1 16.7 16.3 14.6 31.1 15.6 7.6 10.3 8.2 17.6 12.2 52.2 73.0 21.9 12.2 11.0 5.0 4.7 10.2 13.4 12.4 66.5 9.5 11.1 9.2 80.9 71.1 18.6 20.7 11.3 46.0 7.7 27.1 9.0 12.3 41.0 6.6 21.7 12.3 36.0 25.4 20.7 13.1 17.6 16.0 19.1 19.4 6.7 ARHGAP21 "ARHGAP10, KIAA1424" ENSG00000107863 "Rho GTPase activating protein 21" Q5T5U3 10 24583609-24723887 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 113.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 266.5;Oligodendrocyte precursor cells: 336.7;Oligodendrocytes: 827.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036610, HPA057861" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA "Cell Junctions, Actin filaments" "Plasma membrane" "HPA036610: AB_10669910, HPA057861: AB_2683546" "unprognostic (7.65e-2)" "unprognostic (1.61e-2)" "unprognostic (1.88e-1)" "unprognostic (5.84e-2)" "unprognostic (2.69e-1)" "unprognostic (3.59e-1)" "unprognostic (1.12e-3)" "unprognostic (5.35e-2)" "unprognostic (9.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-3)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.53e-1)" "unprognostic (3.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" 28.7 18.1 48.8 10.4 75.2 7.3 16.3 61.2 64.7 19.9 6.2 16.8 13.0 20.1 8.6 10.9 17.7 18.0 21.4 51.4 52.1 11.1 13.2 21.9 5.3 72.3 67.5 35.3 32.2 15.0 14.7 12.2 16.8 70.3 10.9 18.7 41.7 24.7 11.6 17.8 6.9 16.5 17.9 58.1 9.0 27.4 14.7 57.0 11.5 12.9 23.2 6.0 13.9 9.1 113.8 59.0 25.1 60.9 52.3 42.2 59.1 21.6 41.6 26.6 24.5 34.0 18.4 36.8 10.9 14.0 64.3 37.7 38.1 31.6 40.4 35.9 38.0 20.5 64.9 54.7 13.8 25.5 0.0 9.9 24.4 45.0 32.1 34.4 36.9 42.3 16.1 27.9 96.3 50.0 11.6 30.2 2.3 9.7 20.8 13.6 7.0 21.4 6.2 17.2 10.2 10.5 10.9 27.9 16.0 32.6 18.1 16.3 9.1 47.8 35.3 22.7 40.0 30.6 11.0 20.3 7.8 36.2 11.4 24.7 0.9 0.2 0.4 0.1 0.4 0.1 0.0 0.2 0.3 0.3 0.0 0.6 0.3 0.0 0.2 0.2 0.4 0.4 0.2 48.8 75.2 61.2 64.7 51.4 52.1 72.3 67.5 35.3 70.3 58.1 57.0 113.8 47.9 86.6 33.1 246.8 6.5 29.6 13.2 23.6 14.8 144.0 17.5 26.0 37.4 24.3 45.0 5.5 68.8 23.8 6.9 44.6 1.9 21.4 5.0 36.2 148.7 34.9 16.2 15.2 266.5 27.6 21.0 73.0 82.0 54.2 17.1 135.8 26.0 20.9 14.6 132.9 153.8 28.3 14.2 32.8 31.8 8.3 92.9 38.9 19.6 171.4 11.0 194.0 2.1 336.7 827.4 37.1 34.6 59.5 15.2 27.4 21.9 6.5 30.3 53.5 26.3 60.4 43.2 27.4 35.6 18.1 20.2 12.6 11.8 62.2 29.0 29.5 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291078 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 32.5" "Cell type enhanced" "Detected in many" "Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 12.1;U-266/70: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" Yes No Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 1.9 3.9 4.5 1.8 8.1 1.7 3.3 6.8 18.3 2.3 2.4 2.4 3.1 1.9 4.5 4.7 1.8 2.0 5.1 6.7 5.2 4.7 32.5 2.2 1.9 10.3 6.1 6.0 3.6 3.6 3.3 4.0 1.6 12.2 4.3 2.6 7.2 7.6 2.4 19.9 3.9 3.0 2.0 0.8 2.7 2.9 13.0 8.3 1.5 6.5 9.6 2.1 1.9 3.2 13.2 0.9 0.2 0.3 1.9 0.5 0.5 0.7 0.8 0.6 1.2 0.9 0.6 1.9 1.1 1.0 0.3 0.5 2.5 0.9 0.6 0.7 1.1 0.9 1.4 1.3 0.8 1.4 0.6 1.4 0.4 1.5 0.6 2.4 1.0 1.1 1.3 0.9 12.1 0.5 0.7 0.9 0.8 0.2 1.3 0.9 1.1 1.6 2.1 1.2 0.4 1.4 0.5 0.8 2.2 1.6 1.0 2.7 1.6 0.8 0.6 0.6 0.4 0.7 6.3 1.7 1.1 0.3 2.2 0.1 2.6 0.4 0.8 0.2 0.5 0.2 0.7 0.1 0.3 0.3 0.1 0.1 0.1 0.5 0.2 0.6 0.2 0.1 0.2 4.5 8.1 6.8 18.3 6.7 5.2 10.3 6.1 6.0 12.2 0.8 8.3 13.2 6.1 6.4 7.0 176.0 6.2 8.8 4.0 4.0 7.4 26.0 20.5 10.7 25.3 5.7 4.4 12.9 50.1 2.1 3.0 11.3 5.9 3.2 226.2 9.0 3.0 7.1 19.8 3.6 233.7 2.6 1.6 5.5 4.1 10.8 3.8 4.1 12.5 75.2 4.8 30.3 286.9 9.9 8.2 23.9 3.4 408.9 5.9 10.3 5.4 87.1 8.9 3.2 4.1 148.8 128.6 3.2 4.0 7.9 4.2 10.7 10.1 5.0 8.7 24.7 0.0 4.4 4.1 13.2 7.2 22.0 13.9 1.2 3.3 3.4 5.9 6.5 FBXL15 "Fbl15, FBXO37, MGC11279" ENSG00000107872 "F-box and leucine rich repeat protein 15" Q9H469 10 102419189-102423136 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell type enhanced" "Detected in all" "Distal tubular cells: 211.3;Proximal enterocytes: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.08e-1)" "unprognostic (3.96e-1)" "unprognostic (7.35e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (1.72e-1)" "prognostic favorable (7.82e-4)" "unprognostic (3.99e-2)" "unprognostic (2.62e-1)" "unprognostic (9.97e-2)" "prognostic favorable (7.92e-4)" 6.3 7.1 10.6 2.8 11.2 4.6 3.2 9.4 22.0 3.5 5.7 7.6 9.2 5.9 0.3 4.2 4.1 0.7 4.0 11.5 9.3 5.7 4.3 3.8 2.1 15.1 11.2 12.3 3.8 4.6 3.8 16.4 1.4 13.1 3.8 1.2 4.7 5.3 2.3 9.2 3.4 8.0 1.4 7.0 6.6 8.6 8.1 15.5 1.0 3.1 1.4 1.1 5.5 3.6 13.2 19.9 3.5 3.8 3.6 2.2 2.5 13.4 6.4 4.3 2.4 2.0 5.0 4.9 7.4 16.4 1.9 2.1 9.7 1.8 2.3 0.3 13.0 24.4 10.7 6.8 8.2 3.2 7.8 11.2 1.9 5.2 1.7 3.0 4.5 2.8 3.7 15.1 4.5 0.4 7.2 5.2 44.7 5.2 4.3 14.3 13.8 4.6 8.6 2.4 3.5 15.1 18.6 4.7 4.1 20.5 0.8 8.6 6.2 8.3 1.9 6.9 7.4 5.4 15.4 8.8 8.2 4.7 7.5 0.7 43.9 51.6 60.2 39.0 40.2 31.3 33.2 37.0 32.7 50.1 37.5 36.5 31.3 23.8 33.0 47.7 44.5 43.1 39.7 10.6 11.2 9.4 22.0 11.5 9.3 15.1 11.2 12.3 13.1 7.0 15.5 13.2 34.7 16.0 16.0 4.9 29.6 25.0 28.8 47.5 21.1 60.2 31.6 35.9 21.5 51.5 34.3 31.3 20.9 24.6 38.3 75.3 211.3 52.7 44.3 21.5 13.3 30.7 84.9 12.0 16.7 77.2 20.7 23.8 30.1 22.0 32.4 20.4 43.5 48.5 66.7 26.9 17.2 59.3 57.0 44.0 49.7 21.0 29.8 36.8 39.2 6.5 84.1 54.1 61.8 4.5 6.6 47.4 76.7 30.5 19.6 34.3 176.2 139.0 22.3 53.3 13.1 18.2 40.3 20.6 23.2 24.3 31.4 30.0 31.1 37.2 59.9 24.8 CUEDC2 "C10orf66, MGC2491" ENSG00000107874 "CUE domain containing 2" Q9H467 10 102423245-102432584 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036544, HPA041829" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036544: AB_10670111, HPA041829: AB_2677694" "unprognostic (2.10e-1)" "unprognostic (2.80e-2)" "unprognostic (7.31e-2)" "unprognostic (4.24e-2)" "unprognostic (9.78e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (3.48e-3)" "unprognostic (4.34e-1)" "unprognostic (1.67e-1)" "unprognostic (8.38e-2)" "unprognostic (1.58e-2)" 44.6 67.1 82.2 28.6 81.9 30.0 42.7 85.9 91.9 48.7 76.3 53.6 19.9 53.9 34.0 30.9 48.8 31.8 85.3 80.5 84.6 56.2 45.3 38.4 33.4 84.1 81.1 78.7 56.8 41.3 59.4 45.8 28.0 83.6 48.5 23.5 31.3 41.2 37.7 120.6 37.7 34.5 42.9 81.2 43.2 48.4 38.7 84.2 43.5 42.5 120.2 30.7 48.6 38.0 84.0 53.8 58.2 98.3 120.0 77.3 95.8 35.8 42.4 147.8 95.6 71.6 18.9 56.5 94.4 91.7 76.3 41.7 54.7 65.0 97.3 50.5 75.5 66.4 58.7 50.1 20.8 130.4 45.2 38.0 116.2 89.9 93.6 95.3 187.0 100.1 108.5 46.6 96.5 109.4 58.8 110.2 101.6 35.4 44.1 37.9 124.6 115.0 49.9 101.9 24.8 49.7 113.0 29.6 31.6 96.8 41.5 94.3 71.7 59.5 48.2 45.4 60.6 62.9 112.3 93.2 63.3 84.4 154.2 41.4 98.9 111.5 84.4 69.2 91.5 77.3 80.5 66.9 72.4 112.0 89.5 66.2 63.2 43.0 93.0 58.0 97.9 84.3 86.7 82.2 81.9 85.9 91.9 80.5 84.6 84.1 81.1 78.7 83.6 81.2 84.2 84.0 56.6 32.1 21.9 10.7 36.1 31.7 49.0 73.1 44.9 54.7 58.8 81.0 56.8 40.0 37.4 46.0 25.0 66.9 40.6 24.0 80.3 70.0 21.0 28.3 52.9 46.4 55.7 35.7 12.2 46.6 33.2 58.5 31.6 26.6 51.4 89.6 59.3 49.9 75.1 67.3 16.0 36.4 63.1 49.1 47.7 42.2 57.2 44.3 51.6 3.7 97.0 94.7 44.3 13.6 23.4 40.0 32.0 60.2 45.4 38.3 34.5 151.7 28.1 47.5 39.5 46.5 164.9 56.6 31.3 42.6 33.8 45.6 38.7 92.5 39.3 41.9 SUFU "PRO1280, SUFUH, SUFUXL" ENSG00000107882 "SUFU negative regulator of hedgehog signaling" Q9UMX1 10 102503972-102633535 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ciliopathy, Disease variant, Joubert syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 129.2;Late spermatids: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008700 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA008700: AB_1080125" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-1)" "unprognostic (4.69e-2)" "unprognostic (5.68e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "unprognostic (1.64e-1)" "unprognostic (3.15e-3)" "unprognostic (9.60e-2)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.82e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-2)" "unprognostic (3.82e-3)" 6.3 7.3 8.5 7.2 8.4 2.0 6.2 8.1 8.1 8.5 5.2 6.1 4.0 7.5 5.0 9.3 7.1 6.6 6.2 7.4 7.3 6.2 6.3 5.9 7.2 8.4 7.3 6.7 9.0 4.2 11.2 4.3 7.4 7.7 8.6 4.4 4.7 7.1 5.3 8.7 13.7 5.8 7.4 6.2 7.5 4.6 11.6 7.3 7.9 3.4 7.3 8.2 8.8 9.3 7.1 8.7 9.1 14.4 20.8 14.5 12.1 7.0 8.8 17.0 12.5 11.3 8.5 6.3 8.9 24.5 9.9 5.0 6.0 17.8 9.8 8.2 5.5 13.8 21.2 5.2 8.0 6.9 7.7 14.6 13.9 7.5 9.3 7.5 22.9 16.3 8.5 4.8 7.9 7.8 7.2 14.8 11.6 4.1 5.6 6.7 15.8 15.5 4.7 8.3 12.8 4.8 7.8 7.0 6.4 8.1 13.1 14.2 5.0 18.1 5.5 7.8 6.0 9.8 6.4 4.5 6.4 6.9 14.9 3.8 2.0 2.0 2.9 1.0 2.4 0.8 0.9 1.2 1.1 1.9 0.8 0.8 1.0 0.4 1.1 2.5 1.1 0.8 1.4 8.5 8.4 8.1 8.1 7.4 7.3 8.4 7.3 6.7 7.7 6.2 7.3 7.1 3.3 0.0 3.7 28.7 4.9 3.1 2.1 2.9 6.8 4.2 3.5 3.0 4.0 1.5 4.6 3.7 8.4 7.8 3.1 3.5 1.9 4.4 129.2 4.5 6.2 5.1 1.2 2.5 25.9 3.0 3.5 6.0 4.6 8.5 3.8 3.8 10.8 5.4 12.4 1.7 22.2 2.2 0.0 9.4 6.3 115.9 5.0 8.7 0.0 32.8 7.8 2.7 4.1 17.6 16.8 4.1 1.3 6.8 4.0 2.0 5.7 5.8 5.7 4.8 0.0 3.0 4.5 8.7 5.3 8.9 6.5 7.0 7.1 7.6 3.0 1.3 ANKRD26 "KIAA1074, THC2" ENSG00000107890 "Ankyrin repeat domain 26" Q9UPS8 10 26973793-27100494 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA040654, HPA041460" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA040654: AB_10795370, HPA041460: AB_10795120" "unprognostic (1.92e-1)" "unprognostic (3.41e-1)" "unprognostic (2.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (1.53e-2)" "unprognostic (1.03e-2)" "unprognostic (2.53e-3)" "unprognostic (5.35e-2)" "unprognostic (1.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.99e-1)" 2.2 2.6 5.4 1.7 5.9 1.5 3.8 6.6 9.1 3.9 4.8 2.4 1.7 3.4 3.0 2.0 3.1 2.0 4.1 5.3 4.3 2.8 2.8 1.9 3.6 5.8 4.6 4.3 4.0 2.6 4.1 4.6 3.2 3.7 2.6 2.8 10.1 2.3 2.5 6.8 2.5 2.1 2.5 3.7 2.6 2.2 4.0 4.4 3.2 2.7 7.6 2.2 2.2 2.8 6.3 7.7 5.4 9.8 3.7 6.1 6.7 3.4 10.1 3.7 9.2 8.5 5.2 5.1 17.9 3.1 4.7 6.5 8.1 9.6 4.7 11.0 7.4 7.2 1.1 7.9 7.9 4.5 4.5 1.2 4.7 2.9 9.5 3.2 7.5 8.4 5.5 14.8 4.8 9.3 4.3 5.5 2.8 3.9 2.8 3.5 6.6 13.8 4.3 5.7 3.1 8.5 4.7 9.6 2.0 8.1 7.1 8.5 3.1 7.6 7.7 5.2 9.9 5.7 1.9 2.6 11.7 7.3 9.9 3.5 1.0 0.2 0.2 0.2 0.1 0.7 1.2 0.4 0.4 0.3 0.6 1.6 0.5 0.1 1.6 0.1 2.1 0.4 0.2 5.4 5.9 6.6 9.1 5.3 4.3 5.8 4.6 4.3 3.7 3.7 4.4 6.3 19.5 22.4 28.8 130.6 14.3 4.2 7.6 9.0 8.6 77.8 13.5 17.7 70.9 7.2 19.4 3.7 200.1 24.8 8.6 8.3 5.9 14.5 19.0 47.7 38.6 20.4 20.9 6.3 136.8 13.1 13.1 21.3 8.2 16.5 5.1 43.5 13.6 8.3 11.9 79.1 185.9 9.3 10.2 5.7 5.4 6.4 30.4 11.8 3.6 45.0 12.4 45.0 18.6 87.0 67.2 11.3 4.2 27.1 7.8 5.3 12.1 5.6 49.5 117.9 32.9 30.1 15.6 60.7 57.2 8.9 8.0 13.7 12.9 46.1 14.6 5.0 ACBD5 "DKFZp434A2417, KIAA1996" ENSG00000107897 "Acyl-CoA binding domain containing 5" Q5T8D3 10 27168135-27243046 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Transport" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011861, HPA012145" Enhanced Enhanced Peroxisomes NA NA Peroxisomes "HPA011861: AB_1844493, HPA012145: AB_1844494" "prognostic unfavorable (3.33e-4)" "unprognostic (4.93e-1)" "unprognostic (3.68e-1)" "unprognostic (1.34e-1)" "unprognostic (6.21e-2)" "unprognostic (5.98e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (2.69e-1)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.91e-3)" "unprognostic (1.71e-1)" "unprognostic (3.63e-2)" "unprognostic (3.37e-3)" 14.7 25.4 34.5 13.6 39.1 18.3 12.4 39.7 35.2 13.3 27.1 20.5 40.2 9.5 9.8 12.1 12.1 15.6 40.7 31.2 36.1 37.7 74.4 14.9 14.8 40.1 37.6 28.9 10.0 11.2 31.4 6.4 13.5 40.5 15.3 21.1 36.5 10.4 11.6 31.3 17.5 39.5 8.9 40.4 14.9 21.2 19.5 37.8 12.3 28.0 36.9 12.8 13.6 7.5 42.5 25.8 76.5 17.1 18.0 19.1 17.3 20.1 32.3 12.1 28.1 33.5 19.4 39.9 10.7 27.0 22.4 23.4 21.1 23.2 16.3 23.0 26.2 23.9 16.5 23.1 15.2 20.6 11.0 20.9 16.7 17.7 23.5 12.8 24.9 20.5 16.7 13.6 19.5 35.7 20.0 21.1 9.4 13.1 35.2 10.0 17.4 42.5 20.2 44.1 22.4 21.3 45.5 35.4 38.3 17.9 18.9 18.8 11.5 30.4 27.2 15.2 43.7 25.9 19.4 28.1 20.7 27.4 24.6 12.0 12.5 13.0 10.2 15.3 12.7 15.2 6.4 7.5 12.4 13.0 7.0 5.0 11.0 11.1 10.3 15.1 8.5 7.4 8.0 34.5 39.1 39.7 35.2 31.2 36.1 40.1 37.6 28.9 40.5 40.4 37.8 42.5 23.3 25.6 29.9 17.9 16.0 9.7 4.1 14.5 7.4 30.8 14.5 10.8 83.0 15.7 25.2 31.3 25.0 9.6 27.4 22.4 33.2 22.1 43.1 33.7 20.2 18.7 10.2 8.6 20.6 16.2 12.6 16.4 19.4 41.1 12.6 11.5 12.8 56.9 19.0 23.5 26.9 30.4 10.2 25.5 12.5 16.9 16.4 22.4 21.4 15.9 22.4 47.7 29.9 17.6 24.8 17.8 26.1 16.6 14.2 11.7 64.4 48.2 32.7 47.2 19.7 20.9 16.1 41.0 8.3 16.5 15.5 10.4 22.3 27.1 26.5 9.2 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461823-124617888 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 210.3;choroid plexus: 116.4" "Cell type enhanced" "Detected in many" "Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 820000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 13.0 32.3 158.8 8.3 176.7 10.6 13.1 168.9 192.0 16.8 116.4 23.1 23.6 20.4 13.5 24.3 10.1 10.3 14.5 141.5 153.1 28.0 60.6 9.3 11.9 180.2 175.8 130.1 9.1 16.1 9.2 14.6 8.7 180.5 14.2 8.6 7.5 18.4 12.6 10.2 13.8 21.3 10.3 170.2 14.1 20.3 24.4 171.3 9.7 29.7 4.8 15.3 14.8 16.3 210.3 24.7 12.0 4.7 12.1 18.2 14.7 12.8 8.2 18.0 5.5 10.0 2.1 22.4 24.4 19.7 13.5 6.1 26.1 1.4 4.7 5.7 5.4 16.3 17.6 4.1 11.4 18.5 3.6 27.6 11.0 20.0 5.4 13.0 16.0 8.8 21.4 8.9 9.5 6.9 24.5 12.0 11.3 8.5 10.4 6.8 12.4 5.3 31.8 12.1 3.2 2.7 14.2 6.3 22.6 8.2 6.5 17.2 0.6 4.2 8.5 12.2 7.2 2.3 7.9 2.5 7.8 7.7 6.8 2.0 8.1 28.8 25.3 16.1 24.5 20.8 41.0 18.7 17.2 35.6 43.3 22.4 16.0 4.8 7.9 29.0 13.4 32.1 24.4 158.8 176.7 168.9 192.0 141.5 153.1 180.2 175.8 130.1 180.5 170.2 171.3 210.3 5.0 3.2 14.8 22.9 29.1 7.4 9.4 22.1 13.1 6.0 19.8 19.8 15.8 12.8 19.4 7.3 0.0 54.2 6.2 17.9 33.2 5.3 114.9 17.7 12.7 4.6 9.5 19.8 29.4 2.3 24.7 11.2 19.9 8.2 10.8 23.3 6.1 61.1 26.5 11.8 27.8 21.3 24.4 16.0 8.1 163.3 5.9 12.9 17.8 8.4 15.6 9.8 8.2 15.6 76.4 3.3 30.2 10.5 19.7 6.7 80.5 93.8 24.9 6.4 13.1 5.2 9.5 33.1 11.3 30.7 5.4 24.2 12.1 12.4 23.0 16.3 LARP4B "KIAA0217, LARP5" ENSG00000107929 "La ribonucleoprotein 4B" Q92615 10 806914-931705 "Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036566, HPA042738" Approved Enhanced Cytosol NA NA Cytosol "HPA036566: AB_10673624, HPA042738: AB_2678137" "unprognostic (3.02e-3)" "unprognostic (1.43e-1)" "unprognostic (9.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.00e-2)" "unprognostic (3.13e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.95e-2)" "unprognostic (2.74e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (8.10e-3)" "unprognostic (1.62e-1)" "unprognostic (6.47e-2)" "unprognostic (2.54e-2)" 14.4 20.0 13.1 17.3 13.4 18.6 13.7 15.0 17.2 12.9 19.4 17.2 19.6 13.2 10.4 25.4 13.4 13.0 19.7 16.0 13.3 12.9 13.1 20.4 22.3 15.2 12.6 13.6 13.1 16.7 17.3 12.8 15.2 16.2 16.4 15.8 14.6 16.9 12.4 39.1 22.5 18.7 11.0 11.9 19.5 22.1 19.1 14.2 16.1 22.4 22.5 19.8 16.0 16.9 15.6 50.0 42.7 21.7 24.5 19.0 19.1 32.2 33.0 15.7 35.6 34.2 58.1 56.4 59.9 12.0 33.0 10.6 51.6 38.5 28.0 30.5 38.1 27.9 51.6 29.5 33.9 31.3 37.3 42.5 21.2 31.7 36.8 20.4 19.9 24.8 28.8 65.5 39.3 28.9 50.9 53.0 33.8 23.2 49.5 16.5 36.1 18.7 41.5 28.6 38.5 21.4 30.2 32.5 62.5 25.4 21.1 59.3 35.6 34.4 27.6 7.2 87.8 34.2 39.2 51.2 58.3 30.5 30.0 17.6 11.4 8.2 9.7 5.4 9.0 5.7 4.2 6.0 6.2 7.3 5.2 5.7 6.0 8.0 5.4 7.9 8.3 6.1 3.9 13.1 13.4 15.0 17.2 16.0 13.3 15.2 12.6 13.6 16.2 11.9 14.2 15.6 23.7 51.3 62.1 59.4 22.4 30.3 15.6 16.2 23.9 20.5 21.6 15.4 43.5 28.6 30.7 23.9 27.1 17.2 24.6 38.5 5.9 17.4 14.7 42.0 24.5 21.2 13.8 22.7 87.7 16.3 13.2 19.4 44.9 43.4 7.6 31.0 14.6 19.1 21.5 23.5 84.1 35.1 18.3 34.7 25.3 7.1 17.4 30.3 17.8 83.4 33.4 15.7 14.4 65.9 71.6 33.2 27.2 24.0 25.5 27.0 32.5 16.2 33.4 22.4 26.3 23.4 18.3 27.8 23.8 28.8 42.6 46.2 20.7 26.1 34.7 35.6 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988434-1019932 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: AB_2683141" "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 15.7 19.8 8.5 12.7 9.0 27.2 13.0 9.1 9.1 8.3 9.7 9.6 8.7 11.1 8.8 11.4 9.3 8.0 10.8 9.2 9.6 8.7 10.9 8.6 14.0 9.6 9.3 8.4 9.8 12.0 10.4 7.8 10.3 9.8 9.1 10.9 8.9 7.9 8.5 26.9 9.5 8.2 12.4 10.2 9.4 9.3 21.1 9.6 12.1 9.9 14.9 15.7 18.4 8.7 10.6 57.0 49.4 37.1 34.9 27.9 31.1 27.3 52.3 18.8 62.6 53.3 73.2 43.3 87.0 15.2 45.5 21.3 43.6 77.4 52.0 71.2 41.8 50.9 94.7 35.3 45.4 44.5 41.3 47.1 43.1 42.7 72.7 51.6 25.5 34.7 62.9 98.3 33.5 60.1 57.0 62.0 40.3 56.2 77.9 33.8 59.3 35.5 57.6 37.9 37.4 19.3 57.3 37.3 44.7 66.3 36.7 61.8 42.3 32.4 30.3 16.4 71.5 65.2 45.0 86.9 103.5 33.9 43.5 24.9 18.2 9.6 3.6 12.4 16.2 14.3 12.0 11.7 12.6 12.9 11.2 12.7 12.5 1.5 18.4 13.3 8.6 16.6 8.9 8.5 9.0 9.1 9.1 9.2 9.6 9.6 9.3 8.4 9.8 10.2 9.6 10.6 36.2 57.7 74.3 5.9 41.8 62.7 100.0 52.8 35.3 26.1 28.1 27.4 32.6 21.5 83.5 29.5 18.8 50.3 37.4 18.4 33.2 57.7 70.9 46.8 51.9 49.2 22.1 37.4 9.3 44.1 54.9 48.9 33.6 78.8 66.9 40.1 20.0 27.5 34.7 23.5 8.9 29.9 40.7 26.0 24.4 20.9 24.8 33.1 23.2 8.4 39.5 26.5 22.6 6.0 10.2 72.2 17.3 29.3 37.0 84.7 10.6 25.6 55.8 32.7 19.7 58.5 51.4 88.7 84.9 47.0 67.2 95.4 37.5 57.7 32.6 102.6 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavorable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 4.1 4.0 2.1 6.1 2.7 22.0 5.7 5.5 2.9 5.6 2.7 4.1 5.1 7.4 4.9 4.8 4.7 4.2 5.2 2.7 1.9 3.6 2.8 4.2 9.7 1.9 1.9 2.4 8.0 7.3 4.3 2.9 5.7 2.9 6.8 5.2 4.7 12.4 4.1 5.7 5.1 4.6 5.2 1.9 5.5 4.8 15.2 2.0 9.5 5.2 5.2 8.3 4.4 3.3 4.2 12.6 11.7 15.4 16.5 7.2 10.0 7.8 14.8 13.6 16.3 18.5 15.7 10.4 16.5 6.9 9.6 9.5 15.3 22.6 4.7 18.0 10.3 18.3 12.0 12.5 8.9 9.6 17.0 12.1 6.5 6.0 16.2 8.1 15.6 7.8 8.9 11.1 11.2 10.6 5.3 16.9 11.8 20.6 7.7 10.2 14.0 13.2 9.7 6.5 7.2 7.6 14.9 10.7 5.9 10.1 13.9 10.3 6.8 5.4 8.8 9.6 12.4 17.1 15.0 11.4 26.1 9.3 8.8 5.0 5.9 2.3 1.4 2.7 2.0 3.4 3.1 2.2 2.5 3.0 2.3 2.2 2.8 2.9 2.9 1.3 2.9 3.1 1.4 2.1 2.7 5.5 2.9 2.7 1.9 1.9 1.9 2.4 2.9 1.9 2.0 4.2 12.4 12.8 9.7 26.1 19.1 5.9 5.7 5.1 15.4 23.9 9.3 8.4 12.9 8.6 9.0 11.0 33.3 6.7 28.5 5.1 0.0 4.3 145.1 11.2 14.6 9.5 4.2 7.6 40.9 7.2 6.0 12.1 17.3 27.2 20.3 24.7 7.5 7.0 4.1 20.2 31.7 7.5 4.1 7.7 4.2 61.5 21.1 9.2 7.2 22.5 12.2 9.1 13.4 22.1 36.2 8.3 4.9 19.9 27.1 6.6 7.1 2.7 8.6 24.4 6.6 13.0 11.0 26.8 21.4 10.6 8.2 4.5 20.1 18.5 7.3 5.2 BCCIP "BCCIPalpha, TOK-1" ENSG00000107949 "BRCA2 and CDKN1A interacting protein" Q9P287 10 125823546-125853695 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038011 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038011: AB_2675784" "unprognostic (1.05e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-2)" "unprognostic (1.93e-3)" "unprognostic (2.51e-1)" "unprognostic (3.04e-2)" "unprognostic (6.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.30e-3)" "unprognostic (1.90e-3)" "unprognostic (4.75e-2)" "unprognostic (1.58e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" 39.2 35.4 38.9 38.7 39.9 63.0 52.9 42.3 43.7 31.6 42.6 38.0 32.6 31.3 55.1 38.9 33.3 26.8 48.5 38.5 41.9 55.8 68.5 27.5 49.7 39.9 39.5 38.2 43.2 47.5 42.0 25.0 32.8 40.3 42.8 41.5 56.1 58.7 28.9 78.1 32.0 31.9 31.6 39.6 30.0 43.2 48.8 40.5 50.4 40.2 64.2 49.1 56.5 30.4 42.5 225.6 114.4 126.9 141.3 70.9 77.2 105.9 117.9 112.1 142.3 131.2 188.2 146.4 156.6 72.1 108.6 107.1 121.4 219.3 167.0 197.6 145.3 148.5 157.9 97.5 210.0 89.4 219.7 96.1 79.9 98.7 170.1 178.3 108.0 137.7 145.1 177.7 78.1 122.5 134.7 142.7 220.4 98.2 188.0 170.2 134.7 133.5 94.3 126.6 106.0 67.2 68.5 88.1 142.4 149.9 102.7 76.9 96.3 93.0 65.9 116.9 98.2 215.9 79.3 94.9 233.0 129.7 112.5 52.0 30.3 68.3 41.1 56.2 86.6 77.8 76.8 63.7 61.9 75.2 71.4 71.1 64.4 11.2 68.2 94.3 65.0 75.6 48.1 38.9 39.9 42.3 43.7 38.5 41.9 39.9 39.5 38.2 40.3 39.6 40.5 42.5 21.6 64.1 67.9 16.6 46.9 66.9 59.3 60.6 58.1 24.2 32.2 27.3 80.4 28.6 67.0 23.9 22.9 41.4 28.2 16.7 78.2 52.7 14.7 37.6 36.6 30.4 25.8 47.3 21.3 44.1 38.0 43.2 40.2 33.2 27.1 33.6 23.2 50.4 35.8 16.8 21.0 23.1 42.7 28.9 22.2 9.4 37.0 29.3 23.2 11.2 36.2 30.2 28.8 22.1 25.7 45.1 19.6 31.2 57.7 51.9 22.7 62.4 74.7 25.1 26.3 47.5 37.5 105.3 117.2 57.8 52.1 33.8 38.6 28.3 33.3 55.5 MTPAP "FLJ10486, PAPD1, SPAX4, TENT6" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 37.1" "Cell type enriched" "Detected in many" 7 "Early spermatids: 240.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria NA NA Mitochondria "HPA038620: AB_10673015, HPA058232: AB_2683646" "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 9.0 7.5 3.2 10.3 4.4 37.1 9.8 12.4 6.3 6.2 2.4 9.7 10.7 9.1 6.3 8.4 6.7 5.2 8.9 4.2 4.2 9.7 10.7 6.4 10.7 3.4 3.8 4.3 8.3 10.0 8.5 2.8 9.7 4.8 7.3 11.2 7.1 8.1 5.0 13.3 8.4 9.0 9.2 2.9 9.4 7.2 5.1 3.3 9.3 10.3 12.1 10.4 8.2 5.3 5.3 26.0 25.3 15.8 23.0 15.2 14.2 20.6 17.6 6.2 17.7 18.4 27.0 35.4 36.9 12.3 11.7 16.3 29.7 31.1 20.7 21.6 18.7 24.0 37.3 23.7 27.5 16.0 24.6 28.2 14.3 19.0 19.9 11.7 9.8 19.6 34.0 41.2 28.1 13.5 21.8 29.8 21.8 10.8 19.5 13.3 29.6 27.9 34.4 16.2 17.1 25.9 20.8 16.0 16.4 24.7 14.8 15.8 15.6 18.7 18.4 23.8 26.0 19.8 6.2 16.3 50.8 15.9 44.5 6.6 27.4 25.2 27.3 21.7 35.0 23.0 20.8 20.4 21.1 33.0 17.1 21.6 22.0 4.2 25.1 27.9 17.3 23.1 13.1 3.2 4.4 12.4 6.3 4.2 4.2 3.4 3.8 4.3 4.8 2.9 3.3 5.3 12.2 9.6 7.4 9.1 11.2 25.2 13.9 7.4 4.6 0.0 9.8 9.8 16.7 15.7 9.2 3.7 0.0 13.1 13.9 8.1 19.6 9.6 240.7 9.9 14.8 12.9 4.2 16.6 12.7 9.1 12.0 12.7 7.7 12.5 5.1 18.8 12.5 14.6 14.7 0.0 14.5 15.6 6.1 15.8 13.6 34.3 12.2 10.8 8.8 8.4 14.8 0.0 5.2 4.5 14.4 8.9 5.2 16.6 5.3 14.1 8.7 14.2 8.6 0.0 13.1 14.7 10.8 25.3 19.5 11.4 24.9 11.5 8.8 12.6 18.4 16.6 NEURL1 "h-neu, neu-1, NEURL, RNF67" ENSG00000107954 "Neuralized E3 ubiquitin protein ligase 1" O76050 10 103493979-103592552 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Notch signaling pathway, Translation regulation, Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 148.3;tongue: 61.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 93.8;Early spermatids: 128.7;Intestinal goblet cells: 105.4;Late spermatids: 461.2;Paneth cells: 183.4;Syncytiotrophoblasts: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "intermediate monocyte: 45.1;non-classical monocyte: 112.0" "Lineage enriched" "Detected in many" 19 "monocytes: 112.0" "Cell line enhanced" "Detected in some" "BEWO: 13.7;HeLa: 8.6;HMC-1: 6.9;JURKAT: 7.4;SCLC-21H: 17.1;SiHa: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044204 Enhanced NA NA "HPA044204: AB_10959383" "unprognostic (1.21e-2)" "unprognostic (8.14e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-4)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (5.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (4.31e-2)" "unprognostic (1.32e-3)" "unprognostic (1.08e-1)" "unprognostic (8.61e-3)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.91e-4)" "unprognostic (3.23e-1)" 0.5 4.6 26.8 3.9 30.3 2.2 0.4 19.8 39.4 13.0 0.0 12.6 11.0 26.0 15.2 4.3 2.6 2.0 0.5 34.1 9.3 2.4 1.2 0.9 0.8 7.4 5.9 29.2 1.9 18.9 8.4 16.0 4.7 13.6 1.4 10.4 39.9 2.9 1.3 148.3 1.8 17.3 5.3 0.0 1.9 5.3 13.1 5.0 1.1 0.5 61.1 0.5 18.8 2.6 19.2 0.9 0.2 1.3 0.0 0.2 0.1 13.7 0.5 0.9 0.2 0.1 0.3 0.2 0.4 0.7 0.1 0.9 0.6 0.4 0.2 0.1 0.4 0.8 0.2 8.6 0.3 0.0 0.3 6.9 0.2 0.5 0.1 0.7 0.2 0.0 7.4 2.3 0.5 0.2 1.2 1.4 0.9 0.0 0.5 4.2 0.2 0.7 1.5 0.0 0.5 17.1 5.9 8.8 0.0 0.4 2.5 0.7 1.7 0.0 0.1 0.9 0.3 0.2 1.0 0.2 0.3 0.5 0.0 0.4 0.8 2.8 0.5 0.7 45.1 1.1 1.1 1.0 1.1 5.8 0.7 1.2 0.8 2.3 0.6 112.0 4.7 0.4 4.1 26.8 30.3 19.8 39.4 34.1 9.3 7.4 5.9 29.2 13.6 0.0 5.0 19.2 0.3 0.0 0.6 1.3 1.5 0.5 1.5 0.2 0.0 53.2 2.0 2.7 1.6 0.0 0.2 0.0 93.8 4.6 3.1 7.9 0.0 12.0 128.7 0.0 0.8 2.2 78.3 4.6 47.9 0.7 12.9 2.2 13.3 0.1 0.0 1.2 0.0 0.2 4.5 3.3 32.9 105.4 32.6 4.6 2.4 461.2 5.6 4.8 0.0 0.0 5.5 9.0 2.1 1.0 4.2 0.5 183.4 5.3 0.6 1.3 7.2 0.0 0.2 88.0 6.6 2.4 1.0 56.6 33.6 0.0 1.8 113.4 1.7 8.4 9.4 0.7 SH3PXD2A "FISH, KIAA0418, SH3MD1" ENSG00000107957 "SH3 and PX domains 2A" Q5TCZ1 10 103594027-103855543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 86.8;BJ hTERT+: 84.8;fHDF/TERT166: 68.5;HSkMC: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037922, HPA037923" Approved NA NA "HPA037922: AB_10697088, HPA037923: AB_10672612" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.95e-2)" "unprognostic (3.00e-2)" "unprognostic (1.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (5.83e-2)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (1.25e-1)" "unprognostic (2.59e-1)" "unprognostic (5.78e-3)" "unprognostic (2.62e-2)" 17.4 8.6 57.0 11.6 42.8 1.4 14.6 27.5 44.1 48.6 5.3 23.9 5.8 31.5 7.2 30.5 25.9 17.5 15.8 35.3 29.6 5.9 23.2 17.4 4.7 41.2 43.1 23.0 29.8 8.5 1.3 14.1 16.5 49.2 18.7 13.5 17.3 14.2 14.0 19.2 29.6 14.4 27.0 47.1 13.4 13.1 3.1 40.1 6.8 9.2 14.4 6.0 21.6 32.1 54.6 1.3 5.3 13.7 16.5 48.1 86.8 7.3 39.5 84.8 13.1 12.4 0.5 0.4 0.0 7.7 68.5 1.5 13.3 0.8 35.5 11.6 2.3 14.3 16.5 21.8 19.2 31.0 8.2 4.5 64.5 27.2 20.1 43.5 9.8 8.8 17.9 6.1 9.7 16.6 0.5 0.2 8.0 5.8 11.4 2.5 6.8 5.2 1.0 5.5 4.8 10.2 5.5 3.8 0.9 19.9 7.4 0.2 5.8 15.4 11.0 7.6 14.3 17.7 10.9 24.1 0.5 10.7 11.1 42.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 57.0 42.8 27.5 44.1 35.3 29.6 41.2 43.1 23.0 49.2 47.1 40.1 54.6 22.6 6.4 45.4 10.1 7.6 91.0 26.4 45.2 56.3 46.1 9.3 13.5 22.9 22.8 37.8 3.7 27.1 12.1 3.4 48.1 0.0 5.3 3.2 7.7 109.9 23.9 37.1 10.5 59.5 0.6 32.0 42.2 12.8 11.5 17.7 21.8 23.9 87.3 13.0 89.2 96.6 74.8 22.4 7.6 34.9 7.3 105.9 7.7 33.8 15.0 19.0 1.7 2.1 5.0 117.2 6.2 27.0 80.5 7.9 32.1 4.1 1.3 21.6 35.7 39.5 32.1 55.6 1.9 3.7 37.5 38.1 4.7 6.8 15.0 22.7 61.1 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 186.1;Late spermatids: 98.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria NA NA Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 39.5 65.5 23.7 19.3 26.0 26.2 37.2 24.6 34.5 40.8 22.6 37.7 19.8 40.8 24.0 38.7 38.4 18.5 56.1 25.4 24.0 37.1 45.3 40.8 21.2 25.6 27.0 23.6 54.8 41.5 33.6 42.7 17.1 27.4 43.0 22.3 50.0 41.6 22.3 95.7 38.7 32.9 26.0 22.0 30.7 37.3 43.9 25.7 42.8 42.1 60.1 21.8 44.0 38.7 29.9 81.8 67.2 21.7 31.7 62.1 67.6 22.3 125.9 51.0 92.5 49.1 55.5 45.5 38.5 39.5 70.7 33.2 55.8 37.8 82.4 74.3 72.3 55.0 61.1 42.9 39.2 36.2 21.8 62.3 50.4 57.0 103.5 55.8 55.4 81.2 56.3 60.1 44.5 115.7 67.1 59.6 14.0 15.0 97.9 71.0 27.5 34.1 54.0 67.9 54.8 29.4 16.4 95.9 57.5 46.6 35.8 67.2 23.9 114.5 63.7 17.2 160.5 47.8 36.1 48.6 41.7 108.8 38.2 31.5 3.1 6.9 1.5 10.3 8.8 10.5 10.4 9.5 10.9 13.3 5.3 9.7 11.1 0.3 13.7 11.9 5.3 12.6 8.5 23.7 26.0 24.6 34.5 25.4 24.0 25.6 27.0 23.6 27.4 22.0 25.7 29.9 12.2 28.9 29.0 13.4 9.3 6.8 17.6 11.1 6.2 13.1 10.7 12.2 44.9 8.6 23.5 3.7 20.9 13.4 7.9 12.4 7.9 18.2 186.1 14.5 14.6 14.0 18.0 10.7 18.4 29.2 20.0 14.7 16.8 23.1 14.5 18.0 7.1 16.3 14.8 6.7 17.9 12.7 20.3 10.1 6.3 98.7 17.1 10.0 19.6 6.5 9.9 7.1 4.1 11.1 14.7 34.8 10.0 14.7 13.7 23.9 10.6 8.5 19.1 19.7 6.6 16.9 15.3 28.1 21.6 17.0 5.7 13.5 10.1 30.4 12.9 17.7 STN1 "bA541N10.2, FLJ22559, OBFC1" ENSG00000107960 "STN1 subunit of CST complex" Q9H668 10 103877569-103918184 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 37.4;Distal tubular cells: 41.1;Ductal cells: 34.6;Exocrine glandular cells: 79.2;Pancreatic endocrine cells: 62.9;Theca cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037924, HPA037925" Supported Nucleoplasm NA NA Nucleoplasm "HPA037924: AB_10671636, HPA037925: AB_10672469" "unprognostic (1.50e-1)" "unprognostic (4.22e-2)" "unprognostic (2.18e-2)" "unprognostic (5.58e-3)" "unprognostic (6.01e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (5.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.12e-3)" "unprognostic (3.76e-1)" "prognostic favorable (1.12e-6)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.83e-2)" 15.0 22.4 8.5 12.3 9.8 13.6 17.3 10.7 9.2 13.4 11.7 14.7 12.1 12.1 9.8 41.3 12.3 18.5 35.3 7.9 10.8 17.9 13.2 25.4 16.1 12.6 10.5 7.8 22.4 21.1 33.9 15.0 17.2 11.1 10.3 16.6 6.5 18.9 13.4 22.6 13.4 11.1 15.5 9.7 15.4 22.4 23.6 10.8 24.8 17.8 29.2 23.0 22.7 18.7 10.8 26.8 19.7 23.8 19.6 18.6 57.6 7.6 12.6 36.5 16.4 14.6 11.4 43.6 16.7 22.2 16.1 14.7 24.8 8.7 31.0 15.3 24.1 11.9 15.3 7.0 23.5 25.6 12.7 12.9 37.2 52.1 15.9 43.9 42.9 32.0 31.2 8.5 34.9 27.3 21.7 31.5 22.0 5.5 38.7 28.5 22.7 16.4 19.2 40.5 31.3 13.7 16.1 9.3 14.9 24.4 13.4 12.5 11.0 47.1 20.4 14.1 14.5 19.4 47.3 13.1 16.6 30.4 26.4 9.0 41.7 33.2 110.3 65.1 21.3 103.4 25.5 71.9 60.4 40.2 29.6 52.3 62.6 48.8 71.3 23.7 37.1 100.2 51.5 8.5 9.8 10.7 9.2 7.9 10.8 12.6 10.5 7.8 11.1 9.7 10.8 10.8 14.7 22.4 20.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.7 16.9 0.0 0.0 5.0 9.2 0.0 37.4 17.2 0.0 41.1 34.6 0.0 9.2 9.9 6.4 0.0 0.0 0.0 79.2 14.0 3.9 0.0 15.4 5.1 23.8 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 62.9 0.0 0.0 1.0 0.0 0.0 12.8 7.3 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 27.0 13.3 52.4 0.0 0.0 MAP3K8 "c-COT, COT, EST, ESTF, MEKK8, Tpl-2" ENSG00000107968 "Mitogen-activated protein kinase kinase kinase 8" P41279 10 30434021-30461833 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 335.0" "Cell type enhanced" "Detected in many" "Macrophages: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 44.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB005120, HPA017962" Supported Supported Cytosol NA NA Cytosol "CAB005120: AB_2140669, HPA017962: AB_1853776" "unprognostic (1.91e-2)" "unprognostic (2.94e-1)" "unprognostic (3.07e-1)" "unprognostic (9.29e-2)" "unprognostic (6.73e-2)" "unprognostic (1.00e-2)" "unprognostic (1.44e-1)" "unprognostic (3.36e-2)" "unprognostic (1.41e-2)" "unprognostic (8.04e-3)" "unprognostic (8.23e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.76e-7)" "unprognostic (1.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.63e-2)" "unprognostic (5.98e-3)" 64.1 19.0 6.8 40.2 6.4 335.0 32.0 6.6 10.4 14.8 20.6 18.7 8.4 18.4 6.0 23.4 38.4 37.7 15.6 6.6 19.9 12.7 16.4 65.0 34.0 10.7 7.4 5.2 12.1 7.5 6.9 8.5 46.9 10.3 11.2 16.6 11.0 12.6 11.3 6.7 32.4 21.2 36.0 8.5 42.0 20.4 3.0 13.4 9.4 14.9 6.2 29.1 49.9 20.6 9.6 15.5 13.7 3.6 7.7 18.3 15.4 17.3 3.8 20.3 8.2 9.6 9.4 34.2 10.3 9.2 8.1 8.1 28.2 8.4 3.7 3.0 23.3 4.4 19.2 25.6 30.8 16.0 6.0 44.2 19.5 2.1 7.4 1.6 7.7 3.6 0.2 8.8 14.7 1.4 8.8 0.2 22.3 1.4 8.3 4.9 1.3 3.0 5.8 7.9 30.8 0.3 1.6 13.7 11.3 1.9 10.0 3.7 12.7 0.1 4.8 4.3 18.0 0.6 22.4 22.7 3.2 6.9 25.3 0.2 45.8 14.7 53.1 15.7 26.4 8.7 20.8 3.3 10.3 14.5 38.0 0.2 6.0 35.5 28.3 38.7 30.0 1.0 10.3 6.8 6.4 6.6 10.4 6.6 19.9 10.7 7.4 5.2 10.3 8.5 13.4 9.6 51.0 38.5 49.6 11.8 147.3 116.9 50.0 91.1 109.8 19.0 51.7 24.3 10.1 11.5 67.5 3.7 0.0 29.3 203.6 13.6 1.9 31.4 0.5 149.3 51.4 55.7 12.0 21.2 7.7 11.3 86.8 66.2 33.1 205.6 71.1 1.1 25.0 3.1 128.2 0.0 7.1 6.3 83.4 113.8 205.5 1.1 8.4 225.1 42.7 30.9 64.7 6.1 36.0 2.0 0.7 23.4 20.7 4.1 107.8 46.8 3.9 3.5 78.8 1.6 6.6 23.6 62.3 0.3 0.8 129.1 84.8 159.4 97.8 1.5 6.5 195.6 DKK1 "DKK-1, SK" ENSG00000107984 "Dickkopf WNT signaling pathway inhibitor 1" O94907 10 52314281-52318042 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 34.3;placenta: 49.3;urinary bladder: 22.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 486.2;Endometrial stromal cells: 337.6;Pancreatic endocrine cells: 194.6;Prostatic glandular cells: 992.9;Urothelial cells: 320.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 1141.1;BJ hTERT+: 620.0;CACO-2: 1011.3;fHDF/TERT166: 1590.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA "unprognostic (5.65e-2)" "unprognostic (4.21e-2)" "unprognostic (7.09e-2)" "unprognostic (7.99e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.35e-8)" "unprognostic (7.93e-2)" "prognostic unfavorable (7.80e-6)" "unprognostic (1.54e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.81e-1)" "unprognostic (1.68e-1)" "unprognostic (7.47e-3)" "unprognostic (4.05e-1)" "unprognostic (1.19e-1)" "unprognostic (2.06e-2)" 13.5 0.3 0.8 0.3 0.9 0.0 5.7 1.7 1.1 34.3 0.6 0.3 0.1 1.8 0.0 7.9 0.4 4.0 0.6 0.6 2.1 0.4 0.2 1.2 0.4 0.8 1.5 0.7 1.0 0.2 0.1 0.1 49.3 1.0 4.8 0.1 7.1 2.3 1.9 0.3 15.1 0.2 0.2 0.8 0.8 1.2 0.2 1.7 0.0 0.3 0.0 0.5 22.1 10.6 0.8 315.3 215.8 0.1 32.4 149.6 30.4 0.1 1141.1 620.0 383.8 202.5 1011.3 64.2 0.0 1.6 1590.5 93.5 245.1 0.3 130.7 361.3 0.1 0.7 0.0 4.4 26.2 31.8 0.0 0.1 30.3 16.0 83.0 488.3 19.8 35.8 0.0 0.0 0.1 255.8 135.7 0.0 0.1 0.2 13.7 543.9 0.2 34.8 0.0 148.6 25.6 0.2 342.4 102.8 1.1 17.7 0.4 1.1 0.9 78.9 0.2 0.2 338.5 211.9 0.1 0.3 0.1 4.6 0.1 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 1.7 1.1 0.6 2.1 0.8 1.5 0.7 1.0 0.8 1.7 0.8 1.9 25.6 0.0 0.0 1.0 5.4 486.2 28.5 0.0 0.2 0.8 6.9 1.1 0.0 15.2 0.0 0.0 4.6 0.0 0.9 0.0 10.7 1.2 11.0 337.6 8.5 0.0 0.0 1.2 4.1 4.0 91.5 2.6 8.1 4.5 0.0 1.1 0.0 9.3 0.0 2.2 2.4 6.1 0.0 1.6 0.6 0.0 4.9 0.0 1.0 0.0 6.1 0.0 1.5 0.2 194.6 5.0 0.0 1.3 992.9 0.4 0.0 9.8 0.4 0.0 0.0 10.6 0.4 2.2 1.4 3.1 8.3 2.8 0.0 1.0 320.0 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "EBF transcription factor 3" Q9H4W6 10 129835233-129973053 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.4" "Group enriched" "Detected in some" 5 "Adipocytes: 29.6;Endothelial cells: 13.1;Fibroblasts: 14.9;Skeletal myocytes: 33.5;Smooth muscle cells: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;HAP1: 13.6;LHCN-M2: 25.4;NB-4: 35.7;RH-30: 13.2;SCLC-21H: 28.7;THP-1: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 20.4 0.6 0.9 1.0 1.0 0.1 13.8 1.6 1.1 3.5 0.6 2.2 0.2 2.3 0.8 1.4 4.9 2.4 9.4 0.1 2.2 0.5 0.5 0.2 6.9 7.3 7.4 0.1 1.0 1.3 2.1 0.9 2.5 3.3 2.4 0.5 2.0 3.0 1.1 8.0 3.1 1.0 1.5 9.8 0.2 1.6 1.6 2.6 1.4 7.4 7.8 1.0 3.3 5.5 5.7 0.0 0.0 0.6 0.1 12.5 10.3 0.1 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 0.0 13.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 25.4 0.0 0.0 35.7 0.0 0.0 0.0 0.3 13.2 0.0 0.0 0.1 28.7 0.4 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 1.3 8.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 1.6 1.1 0.1 2.2 7.3 7.4 0.1 3.3 9.8 2.6 5.7 29.6 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 1.8 0.3 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 13.1 0.0 0.0 0.9 0.0 0.0 14.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.5 0.4 0.3 0.4 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.7 0.0 33.5 11.7 0.0 3.4 0.1 0.9 0.0 0.2 0.1 0.0 0.1 GLRX3 "bA500G10.4, GLRX4, GRX3, GRX4, PICOT, TXNL2" ENSG00000108010 "Glutaredoxin 3" O76003 10 130136391-130184521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 280.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028941 Approved NA NA 350000 "HPA028941: AB_10601015" "unprognostic (7.11e-3)" "unprognostic (4.02e-2)" "unprognostic (1.67e-2)" "unprognostic (5.39e-3)" "unprognostic (5.66e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (9.03e-6)" "unprognostic (9.29e-2)" "unprognostic (1.13e-1)" "unprognostic (5.76e-2)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "prognostic unfavorable (9.24e-6)" "unprognostic (4.01e-1)" "unprognostic (1.20e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" 36.3 45.0 25.2 40.8 26.8 38.3 35.5 26.7 31.2 26.9 28.4 33.2 36.2 29.6 28.7 58.9 25.5 28.8 51.3 26.8 27.9 38.0 43.2 28.6 55.0 28.4 27.8 25.5 24.2 35.7 36.4 21.3 41.2 29.2 27.3 39.1 28.1 32.6 29.8 53.9 41.7 31.5 41.2 27.5 27.3 33.7 65.0 27.4 40.0 32.8 55.6 63.5 50.3 38.4 29.9 209.9 134.2 126.8 195.3 84.0 130.8 136.5 149.9 148.3 182.5 153.5 234.4 164.5 157.8 94.2 118.3 160.4 133.7 170.8 179.5 198.0 123.6 145.7 84.0 87.2 201.9 108.8 163.9 80.8 85.4 205.0 167.2 227.3 164.2 147.3 116.8 190.1 72.4 201.1 103.0 119.4 239.8 146.7 121.5 142.8 161.3 131.8 59.8 179.5 114.1 62.4 84.7 85.8 93.2 194.2 139.2 69.2 103.0 111.6 96.2 96.4 130.7 219.2 52.7 87.4 316.0 201.6 88.9 59.5 25.7 45.2 21.5 40.6 58.8 48.2 52.1 45.1 45.4 70.3 37.8 34.4 41.7 7.3 59.1 51.8 44.8 76.7 49.5 25.2 26.8 26.7 31.2 26.8 27.9 28.4 27.8 25.5 29.2 27.5 27.4 29.9 47.6 41.7 28.1 20.9 38.4 82.8 90.1 167.1 32.5 24.1 42.1 40.5 61.5 40.0 74.4 27.6 14.6 122.9 47.3 38.3 62.6 160.1 252.7 39.6 43.4 57.0 34.0 44.6 24.7 147.7 162.2 48.3 28.5 38.7 42.5 47.7 43.2 36.2 113.2 42.1 24.6 50.7 77.3 44.6 54.2 138.9 40.7 46.1 49.8 15.0 72.9 37.9 47.4 22.1 22.5 150.2 32.3 50.4 41.0 115.2 58.7 100.7 58.3 25.1 19.7 41.2 95.1 280.9 188.1 62.7 99.0 163.1 41.8 49.7 64.7 100.5 SORCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.8;retina: 9.7;thyroid gland: 11.1" "Group enriched" "Detected in some" 7 "Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "RH-30: 80.8;SH-SY5Y: 104.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 0.6 3.2 2.1 2.0 6.7 0.0 1.3 0.0 10.8 2.0 0.0 7.1 0.7 1.1 0.3 1.0 1.7 1.1 2.2 4.9 4.0 4.8 0.1 0.1 1.0 1.4 1.6 4.6 0.7 1.7 0.0 0.9 0.0 2.5 2.2 1.9 9.7 1.1 2.5 0.3 1.3 3.6 1.5 0.8 0.8 2.5 1.2 4.5 1.0 11.1 1.7 1.5 3.6 2.9 7.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 80.8 0.1 0.0 0.0 0.0 104.9 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 6.7 0.0 10.8 4.9 4.0 1.4 1.6 4.6 2.5 0.8 4.5 7.1 0.0 0.0 0.5 7.2 0.0 0.6 0.0 0.0 1.2 2.0 0.1 0.5 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 16.6 0.1 4.9 0.2 0.0 0.0 522.2 0.0 0.0 3.6 0.0 0.1 0.0 1.0 0.0 0.0 0.2 1.7 179.7 0.0 0.0 0.3 0.3 5.2 0.0 0.2 1.8 26.2 0.0 49.1 0.0 381.5 10.0 0.1 0.0 0.4 0.0 0.0 0.0 2.2 0.0 2.1 0.0 1.0 0.3 0.2 1.9 0.2 0.1 0.0 0.3 0.0 0.0 0.0 TASOR2 "bA318E3.2, C10orf18, FAM208B, FLJ20360, KIAA2006" ENSG00000108021 "Transcription activation suppressor family member 2" Q5VWN6 10 5684838-5763740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.0;Cardiomyocytes: 28.0;Cytotrophoblasts: 11.7;dendritic cells: 18.4;Extravillous trophoblasts: 10.5;Fibroblasts: 8.1;Hofbauer cells: 10.3;Plasma cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038042, HPA038043, HPA061547" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558" "unprognostic (3.69e-2)" "unprognostic (3.13e-2)" "unprognostic (9.25e-2)" "unprognostic (8.83e-2)" "unprognostic (8.12e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.39e-1)" "unprognostic (9.21e-2)" "unprognostic (8.36e-2)" "unprognostic (8.85e-2)" "unprognostic (4.88e-3)" "unprognostic (2.90e-3)" "unprognostic (2.98e-1)" "unprognostic (3.50e-1)" "unprognostic (7.79e-3)" "unprognostic (5.23e-2)" 9.4 8.7 3.3 12.1 4.1 14.5 12.7 19.4 7.9 13.4 8.6 11.0 6.7 13.1 15.4 9.8 10.8 10.3 9.4 2.5 4.9 9.0 10.9 8.2 17.4 3.7 5.8 0.6 12.8 11.0 14.6 10.7 12.7 6.5 10.0 12.0 14.2 9.5 11.0 12.2 9.0 9.3 13.4 1.3 10.1 10.4 24.9 3.8 15.0 16.6 14.5 17.2 17.7 8.1 10.8 38.2 31.7 19.9 34.0 25.1 29.7 28.0 31.7 20.1 26.7 33.6 33.7 22.0 77.2 19.8 31.4 16.9 29.3 57.5 32.5 43.0 15.2 38.7 36.1 24.7 22.8 25.0 26.9 20.7 22.9 35.6 43.5 36.8 17.9 31.4 29.4 59.1 17.6 30.2 25.7 35.0 9.5 24.3 24.6 20.3 25.8 27.7 27.1 16.0 34.1 24.4 27.5 31.5 28.3 22.2 22.3 37.2 20.9 31.6 33.6 36.2 65.5 43.7 21.3 21.9 67.8 16.6 26.1 18.1 1.0 1.2 0.2 1.2 1.2 1.1 1.0 0.9 1.1 0.7 1.8 0.9 1.5 0.9 4.3 0.4 1.1 1.3 0.5 3.3 4.1 19.4 7.9 2.5 4.9 3.7 5.8 0.6 6.5 1.3 3.8 10.8 19.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 11.7 18.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 10.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.0 0.0 XPNPEP1 "XPNPEP, XPNPEPL, XPNPEPL1" ENSG00000108039 "X-prolyl aminopeptidase 1" Q9NQW7 10 109864766-109923553 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025196, HPA030419, HPA030420, HPA030422" Supported Enhanced Cytosol NA NA 810000 Cytosol "CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783" "unprognostic (3.17e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.46e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (2.12e-5)" "unprognostic (8.03e-2)" "unprognostic (2.10e-2)" "unprognostic (1.88e-1)" "unprognostic (4.89e-2)" "unprognostic (7.61e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (5.18e-2)" 19.3 19.6 13.5 23.1 13.9 23.6 20.3 13.4 14.9 19.8 16.6 32.5 52.2 19.5 22.9 25.3 22.5 27.8 28.2 15.1 14.2 21.5 19.1 19.4 25.6 13.4 13.2 13.6 20.0 62.5 24.7 19.4 26.8 13.5 21.9 40.8 18.8 30.6 15.9 28.7 29.5 62.3 28.5 13.1 19.5 24.7 18.3 13.5 19.7 23.8 22.3 28.6 24.9 19.5 14.1 78.1 33.6 52.3 72.1 83.6 77.4 40.2 42.4 85.5 61.8 66.5 65.4 65.2 110.3 35.9 65.0 31.3 40.5 41.7 52.2 60.4 33.0 40.3 74.0 20.5 27.6 58.2 58.3 59.0 76.9 31.8 67.8 60.1 94.6 103.1 70.0 24.3 34.3 80.1 26.3 41.7 36.0 20.6 58.7 35.7 46.1 105.3 19.8 78.5 24.3 15.9 60.5 36.9 23.1 70.6 56.9 28.3 53.6 53.9 25.3 32.9 40.4 38.1 58.4 30.4 92.8 59.4 80.0 20.3 25.7 26.8 11.3 19.5 42.2 13.4 10.6 12.6 17.5 46.4 8.9 8.7 11.7 2.2 30.5 36.8 36.4 15.5 29.6 13.5 13.9 13.4 14.9 15.1 14.2 13.4 13.2 13.6 13.5 13.1 13.5 14.1 13.4 6.4 14.4 24.5 14.6 8.9 13.2 32.9 11.4 20.5 12.1 9.7 17.0 18.6 26.3 3.7 6.2 38.2 33.1 34.5 17.6 37.4 6.4 12.3 16.5 18.2 16.8 14.7 18.9 72.9 29.6 22.7 24.5 13.6 11.4 17.0 15.7 12.1 30.9 26.9 25.3 37.1 18.3 20.5 9.6 5.1 18.3 37.5 8.8 15.9 33.5 27.1 24.7 21.6 27.0 54.4 35.1 29.7 18.1 22.5 63.5 31.1 22.8 19.5 13.1 9.8 14.2 17.5 35.9 18.6 8.7 25.2 19.4 30.0 36.5 27.1 SMC3 "BAM, bamacan, CSPG6, HCAP, SMC3L1" ENSG00000108055 "Structural maintenance of chromosomes 3" Q9UQE7 10 110567695-110606048 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Spermatocytes: 994.2;Spermatogonia: 799.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043206 Approved Supported Nucleoplasm NA NA 630000 Nucleoplasm "HPA043206: AB_2678362" "unprognostic (3.40e-1)" "unprognostic (1.73e-2)" "unprognostic (9.05e-2)" "unprognostic (3.00e-2)" "unprognostic (3.73e-2)" "unprognostic (8.89e-3)" "unprognostic (9.74e-3)" "unprognostic (8.06e-2)" "unprognostic (5.31e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.17e-2)" "unprognostic (8.73e-3)" "unprognostic (7.22e-2)" "unprognostic (5.18e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" 18.2 13.4 9.5 18.9 11.5 44.3 19.3 19.1 11.8 18.2 11.8 17.6 15.6 20.5 15.8 19.4 16.7 11.2 13.0 9.3 9.9 14.1 15.4 14.6 25.4 10.6 10.2 8.0 25.9 19.8 20.2 14.4 20.8 11.8 14.1 16.9 27.8 16.3 15.4 21.3 20.5 19.5 17.0 9.9 18.8 14.9 38.4 10.1 39.6 16.6 14.3 24.5 15.6 18.0 13.4 73.1 44.5 95.4 67.8 30.7 26.3 40.9 57.7 56.7 51.9 50.7 56.4 59.7 94.2 24.5 38.6 40.0 56.5 68.7 35.0 78.6 77.3 60.1 76.5 56.2 51.2 30.8 109.8 56.6 21.1 28.0 57.4 89.5 48.5 38.8 31.7 61.7 70.4 45.4 38.1 85.2 58.3 66.1 38.6 35.1 71.1 171.5 51.4 32.4 31.7 53.7 61.8 62.0 17.7 48.6 61.8 28.5 53.1 40.1 41.6 65.5 47.6 84.4 40.9 38.8 99.6 37.5 103.9 34.8 20.7 6.1 15.8 9.6 8.4 12.1 11.0 11.3 10.6 6.8 11.0 11.3 11.2 6.5 12.6 7.6 8.7 14.5 6.2 9.5 11.5 19.1 11.8 9.3 9.9 10.6 10.2 8.0 11.8 9.9 10.1 13.4 74.9 80.1 62.0 16.6 73.5 60.5 53.2 64.1 34.7 81.3 44.3 49.9 64.5 47.1 64.4 55.2 75.0 119.6 94.3 29.8 25.4 96.9 56.9 52.0 65.0 74.9 40.7 104.6 26.2 45.6 111.4 66.0 20.9 49.0 56.3 124.9 40.4 31.9 59.1 60.6 29.2 40.7 54.9 37.9 42.5 34.6 115.2 49.8 37.4 19.7 96.1 54.9 98.9 33.2 43.4 53.0 70.1 114.0 65.0 44.7 70.7 30.3 68.3 78.9 184.1 102.0 110.6 994.2 799.1 48.1 64.5 49.1 80.9 112.7 51.9 37.5 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2 leucine rich repeat scaffold protein" Q9UQ13 10 110919593-111013666 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 25.2 16.5 17.3 22.7 19.6 46.1 19.5 21.2 22.3 20.5 14.8 20.6 16.6 20.9 21.2 21.8 16.5 20.2 19.7 19.9 23.1 22.1 23.9 18.0 30.1 18.5 22.8 17.1 20.0 20.6 30.5 14.7 20.9 20.9 18.2 21.7 19.8 14.3 17.6 21.5 15.5 18.5 23.5 17.8 22.4 17.4 36.8 19.8 27.1 25.5 27.1 31.5 25.2 14.9 21.5 29.2 17.8 22.7 38.2 50.9 51.2 14.5 35.0 51.9 31.9 38.5 16.5 25.8 63.1 17.1 62.8 19.9 24.1 27.8 25.0 46.2 34.7 16.5 28.8 25.7 16.2 37.0 49.6 49.4 57.3 38.6 36.9 69.1 43.6 32.8 22.1 18.3 43.8 45.7 15.6 24.7 38.9 14.1 15.6 18.6 34.8 45.2 18.1 33.3 19.4 11.7 23.4 30.7 15.0 34.9 25.8 77.2 41.5 33.3 25.6 22.6 32.5 24.3 40.2 44.0 100.1 30.6 50.3 18.6 52.3 22.8 33.5 12.6 26.8 15.5 30.3 14.8 15.0 22.3 24.4 15.6 15.2 65.8 19.5 27.8 15.2 19.2 23.9 17.3 19.6 21.2 22.3 19.9 23.1 18.5 22.8 17.1 20.9 17.8 19.8 21.5 73.8 54.5 48.1 35.6 95.4 55.8 35.2 37.5 27.9 27.6 51.4 39.1 83.6 45.8 42.3 31.3 16.7 22.2 77.5 80.8 64.6 48.5 44.2 65.1 54.6 63.5 26.3 67.5 59.9 59.2 23.0 50.7 49.5 54.9 73.4 20.2 53.2 69.0 29.4 30.3 53.1 36.2 46.8 78.3 67.3 89.7 65.6 76.0 49.8 57.1 116.5 31.5 57.7 46.3 61.0 64.0 51.6 80.9 53.4 37.1 51.7 67.7 57.0 32.7 72.3 59.9 58.7 108.8 69.3 38.1 69.9 60.6 65.8 17.0 30.1 49.7 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385345-58399220 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 631.4;Late spermatids: 933.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favorable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favorable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 16.6 20.3 6.0 21.8 6.4 38.4 17.5 11.1 8.7 11.5 7.4 20.2 21.2 13.8 9.6 14.8 12.7 10.8 18.7 6.0 8.7 21.7 22.8 11.0 27.9 6.3 7.3 5.0 18.0 14.0 16.3 6.3 20.5 6.7 14.7 17.4 9.9 17.4 11.5 17.8 9.0 17.9 11.7 7.1 17.5 16.2 33.3 6.7 25.1 19.8 16.3 23.2 16.9 7.6 9.1 85.7 47.7 52.8 54.7 15.3 19.4 59.8 37.9 37.3 46.8 51.1 170.0 88.6 170.1 53.9 17.6 34.8 65.2 97.6 53.5 73.4 73.4 85.7 64.1 33.4 64.5 23.3 164.7 49.4 19.2 24.4 57.0 51.6 22.2 41.1 49.9 153.4 74.8 33.2 46.4 130.2 65.1 100.0 39.2 49.9 102.9 113.0 76.0 28.3 57.0 69.8 48.1 75.1 103.7 97.0 42.9 112.8 47.9 32.0 34.4 109.5 39.5 102.5 75.6 125.8 214.2 44.1 125.1 26.4 1.0 9.5 4.0 8.3 9.5 10.8 12.8 10.0 8.8 12.1 12.5 12.4 10.1 7.1 15.0 8.3 14.7 9.0 6.9 6.0 6.4 11.1 8.7 6.0 8.7 6.3 7.3 5.0 6.7 7.1 6.7 9.1 46.4 54.5 27.9 6.2 52.5 50.1 44.0 52.4 59.2 25.1 48.6 62.9 35.0 38.6 51.0 20.2 16.7 98.1 56.8 17.1 88.0 41.0 631.4 36.8 44.5 39.5 15.5 46.7 10.1 44.7 77.4 38.8 25.0 41.2 29.7 34.1 26.0 64.1 44.0 38.7 11.5 37.5 18.3 21.9 19.3 933.1 41.3 32.3 23.2 2.8 36.3 38.2 48.4 10.6 11.7 35.2 23.0 30.9 35.8 47.3 14.1 72.0 31.4 21.4 26.3 74.8 40.5 55.3 63.9 48.6 54.7 52.5 38.3 69.1 48.1 31.8 CCDC6 "D10S170, H4, PTC, TPC, TST1" ENSG00000108091 "Coiled-coil domain containing 6" Q16204 10 59788747-59906556 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019049, HPA019051" Enhanced Supported Cytosol No No 12000 Cytosol "HPA019049: AB_1846163, HPA019051: AB_1846164" "unprognostic (1.88e-2)" "unprognostic (1.72e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-3)" "unprognostic (5.98e-3)" "prognostic favorable (5.48e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.39e-2)" "unprognostic (2.45e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (4.08e-1)" "unprognostic (4.69e-2)" "unprognostic (2.23e-1)" "unprognostic (2.56e-1)" "unprognostic (9.95e-2)" "unprognostic (4.19e-2)" 12.0 12.3 21.7 14.0 23.6 17.0 22.6 11.3 20.5 23.6 9.6 20.0 23.0 25.1 16.8 34.4 25.5 16.9 10.1 24.1 20.1 21.4 12.2 17.4 21.6 13.3 15.8 18.0 15.8 25.4 18.1 11.6 13.3 15.2 19.5 20.0 18.4 29.3 14.5 17.4 28.9 16.3 31.1 12.6 14.8 18.7 11.5 18.6 12.2 18.5 12.3 21.8 17.4 23.2 15.2 42.9 38.0 18.7 41.9 27.8 41.6 37.9 20.6 27.2 20.2 23.7 74.4 81.8 36.5 30.2 34.6 11.7 61.7 37.7 37.5 30.0 55.1 18.7 29.8 29.1 45.5 33.5 34.5 26.9 30.3 48.7 33.7 81.8 28.3 30.2 20.4 22.6 22.7 26.6 57.6 14.5 19.8 29.9 40.1 25.6 19.2 30.5 23.0 33.9 36.2 19.0 16.6 26.1 107.8 23.1 24.1 68.7 18.4 31.1 18.8 33.9 29.3 34.9 12.0 14.9 16.3 29.6 64.6 11.9 0.0 2.0 0.0 1.0 2.3 1.1 4.3 1.5 1.3 5.0 4.9 1.3 1.0 0.1 0.8 1.3 1.3 1.4 1.0 21.7 23.6 11.3 20.5 24.1 20.1 13.3 15.8 18.0 15.2 12.6 18.6 15.2 24.0 99.3 25.9 45.1 41.6 95.0 51.7 25.3 70.0 15.1 51.2 38.7 16.5 28.6 46.3 25.8 41.7 37.8 31.4 42.6 29.4 50.2 27.6 105.2 54.6 22.4 27.0 25.7 83.2 65.3 18.8 27.8 39.8 134.5 29.1 45.2 17.2 20.1 23.1 16.8 58.4 38.9 30.5 40.7 35.3 80.6 24.5 36.4 16.0 32.8 23.0 11.5 13.4 55.3 34.2 50.2 25.0 19.5 26.4 52.2 47.1 48.4 28.1 49.8 19.7 31.4 27.0 2.3 22.4 92.3 80.1 27.0 24.3 32.5 46.3 46.1 CUL2 ENSG00000108094 "Cullin 2" Q13617 10 35008551-35090642 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 319.6;Late spermatids: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002677, HPA024578" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002677: , HPA024578: AB_1847338" "unprognostic (8.11e-3)" "unprognostic (1.12e-1)" "unprognostic (9.77e-2)" "unprognostic (1.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (8.24e-6)" "unprognostic (2.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (4.70e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (2.26e-2)" "unprognostic (2.31e-1)" "unprognostic (3.70e-1)" "unprognostic (2.29e-1)" 15.4 13.5 10.9 16.3 12.8 20.3 15.7 12.8 13.2 13.1 10.9 14.3 14.6 14.9 10.5 16.9 11.1 12.1 19.4 12.9 13.7 14.5 21.2 13.5 20.0 12.2 12.1 11.2 12.9 13.5 22.3 8.8 18.9 12.5 15.4 15.4 13.4 11.6 15.9 45.6 13.6 14.0 19.2 12.2 15.1 14.1 36.1 13.1 18.4 16.3 37.9 21.0 17.2 10.1 13.0 50.4 29.2 37.7 32.5 42.0 46.0 39.8 57.8 32.1 56.1 56.2 38.7 47.0 39.9 31.0 61.6 41.1 45.3 55.4 53.4 63.9 46.9 35.9 51.8 29.0 34.8 46.0 28.6 32.6 44.5 43.7 61.6 21.4 43.3 63.6 41.5 60.5 35.2 62.2 34.4 47.7 15.9 13.8 34.4 117.3 39.4 61.0 25.0 51.3 38.9 18.4 24.4 32.4 40.3 47.0 41.6 30.7 32.4 58.6 34.5 38.3 59.6 38.4 14.7 21.2 47.4 66.4 63.2 24.8 12.8 9.9 11.6 12.3 14.9 17.4 10.9 13.5 14.6 12.6 12.6 16.1 15.2 4.8 13.3 15.3 5.7 17.8 8.5 10.9 12.8 12.8 13.2 12.9 13.7 12.2 12.1 11.2 12.5 12.2 13.1 13.0 24.8 22.4 12.6 21.9 23.0 12.0 8.6 13.1 9.6 13.1 12.0 12.4 26.4 5.7 20.7 9.2 10.4 24.7 27.8 9.9 15.6 18.4 319.6 17.5 25.4 22.3 10.7 9.4 39.7 17.8 20.1 15.7 9.2 20.5 20.3 19.2 16.4 18.2 20.1 23.5 35.6 10.6 14.2 17.2 12.3 181.0 14.0 20.3 10.6 27.2 23.0 16.0 27.8 30.7 41.7 17.5 6.9 11.7 17.3 8.3 15.2 15.0 19.9 13.7 0.0 16.1 26.9 40.1 32.8 14.4 13.1 37.1 25.3 23.0 13.1 9.9 CCNY "C10orf9, CBCP1, CFP1" ENSG00000108100 "Cyclin Y" Q8ND76 10 35247025-35572669 "Predicted intracellular proteins" "Cell cycle, Cell division, Wnt signaling pathway" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Late spermatids: 3651.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 26.4" "Group enriched" "Detected in all" 5 "dendritic cells: 7.8;granulocytes: 26.4;monocytes: 23.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036290 Approved NA NA "HPA036290: AB_10600860" "unprognostic (1.25e-2)" "unprognostic (1.48e-1)" "unprognostic (4.30e-2)" "unprognostic (2.23e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "prognostic unfavorable (6.75e-5)" "unprognostic (3.37e-2)" "unprognostic (6.15e-3)" "unprognostic (4.06e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.74e-2)" "unprognostic (1.31e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" 28.3 22.1 35.3 21.4 37.1 36.2 23.9 32.9 35.4 21.9 26.0 25.4 21.7 28.7 27.2 20.6 22.4 22.9 30.7 38.0 33.0 25.0 31.3 26.1 23.6 33.9 35.0 34.4 25.4 20.8 18.1 15.6 39.1 33.4 18.5 20.2 19.5 17.2 20.3 25.7 18.9 22.4 25.9 33.8 24.6 26.5 81.8 34.9 22.7 29.9 23.1 21.2 25.6 17.5 34.9 52.3 22.2 29.3 28.2 41.6 56.5 38.2 27.4 27.7 26.0 24.9 32.4 51.7 33.2 38.1 44.1 22.7 27.1 26.3 34.6 27.7 105.0 17.3 62.0 16.0 42.4 45.8 22.7 28.3 40.3 48.1 39.9 27.1 57.6 63.3 38.3 49.1 27.3 51.6 33.2 39.9 19.6 11.2 29.6 46.2 33.0 54.4 20.7 33.2 24.6 25.8 39.3 21.5 42.7 38.6 25.4 36.9 41.8 75.5 32.1 38.6 49.4 23.9 18.3 16.6 24.4 56.0 46.6 15.1 1.7 23.4 5.2 3.3 6.5 3.6 3.1 3.2 3.5 7.8 2.4 3.2 3.6 26.4 2.9 3.4 4.0 2.3 7.6 35.3 37.1 32.9 35.4 38.0 33.0 33.9 35.0 34.4 33.4 33.8 34.9 34.9 102.2 32.1 25.9 91.1 23.4 26.9 14.1 29.0 13.6 43.5 30.2 28.7 33.1 41.5 32.1 38.6 20.9 12.0 35.2 25.8 5.9 16.5 709.0 29.5 37.2 59.8 52.8 12.4 205.5 27.8 18.1 34.4 20.4 33.4 16.5 35.3 32.5 85.3 28.9 48.8 130.0 29.0 26.4 80.4 46.9 3651.5 41.3 56.6 16.0 192.0 89.3 62.4 24.7 167.9 445.2 27.9 19.2 38.7 11.7 27.7 31.5 23.1 28.5 39.6 6.6 56.0 26.5 33.8 40.2 17.1 29.5 9.4 26.2 43.2 28.6 20.9 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407788 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 116.9;testis: 159.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 341.4;dendritic cells: 432.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 14.1 17.7 14.2 22.0 15.7 116.9 11.1 13.5 22.7 14.6 8.4 18.1 11.5 17.3 5.6 37.4 15.2 13.2 23.3 23.4 19.2 13.1 11.6 16.4 36.0 15.7 14.8 15.0 14.9 7.8 6.8 29.0 13.7 18.3 15.2 9.4 9.5 12.1 6.3 15.6 11.2 16.3 15.2 15.3 25.9 17.7 159.6 17.4 48.2 10.4 5.7 31.2 16.4 18.0 19.5 532.9 279.4 241.3 193.8 15.3 21.6 42.9 419.3 126.1 253.2 229.1 191.1 183.6 508.6 169.5 106.4 304.5 152.9 243.6 109.5 111.4 402.0 810.5 305.8 162.8 62.5 45.1 370.0 286.0 23.8 30.2 186.7 179.1 55.0 100.6 272.7 310.0 347.0 161.3 139.5 503.2 191.3 605.3 147.2 470.6 437.4 185.5 185.8 69.2 111.5 609.3 330.0 534.5 131.2 248.6 72.6 93.8 198.1 155.9 151.9 432.8 130.7 1013.5 277.1 734.4 617.0 159.2 257.5 562.7 0.5 0.8 1.3 0.7 0.6 0.5 2.5 1.0 1.0 0.6 0.6 1.0 0.5 2.4 0.2 0.4 1.3 0.4 0.1 14.2 15.7 13.5 22.7 23.4 19.2 15.7 14.8 15.0 18.3 15.3 17.4 19.5 308.0 0.0 3.4 5.9 161.3 162.6 151.2 31.5 81.4 59.3 235.9 341.4 3.1 8.6 9.9 20.2 54.2 87.8 432.7 59.2 15.6 42.8 127.5 89.3 68.2 72.5 92.6 166.5 8.7 30.5 247.9 99.3 44.9 68.0 18.4 200.9 31.8 10.6 65.5 32.0 11.0 69.1 38.7 26.8 125.3 52.2 17.4 131.7 74.7 3.7 36.7 91.1 21.6 7.5 13.5 82.3 44.1 12.4 100.6 82.9 20.4 18.4 9.7 75.7 13.1 125.2 186.7 196.9 174.0 74.1 115.9 59.8 233.3 64.6 55.8 121.1 RPL28 "FLJ43307, L28" ENSG00000108107 "Ribosomal protein L28" P46779 19 55385932-55403250 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050459 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 59000 "Endoplasmic reticulum, Cytosol" "HPA050459: AB_2681135" "unprognostic (4.70e-3)" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (6.53e-2)" "unprognostic (9.73e-2)" "unprognostic (3.38e-2)" "unprognostic (2.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.93e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.61e-5)" "unprognostic (4.28e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-1)" "unprognostic (8.93e-3)" 1573.0 1636.7 719.2 1046.2 745.3 1707.5 1601.9 703.1 1096.2 1659.5 695.6 1342.5 793.5 1139.8 430.9 2666.5 1335.8 659.2 1142.7 702.2 760.9 1351.9 1465.0 1345.0 1749.1 763.3 721.5 652.1 2674.3 1985.6 381.7 1124.9 556.8 752.0 1642.7 527.0 210.6 1410.7 404.5 1196.5 2491.7 1479.7 480.6 756.7 1957.3 1294.1 571.6 791.7 1204.8 1276.5 502.9 1365.4 1506.3 1871.0 752.4 2243.1 2533.7 864.1 1730.7 1508.5 2405.0 1458.3 1477.7 1395.5 1261.2 1162.7 2486.9 1155.9 3331.0 1034.2 1346.2 537.3 1368.2 990.0 1898.1 555.1 1300.1 5651.9 2060.0 1543.0 3091.3 2500.4 2420.6 1734.1 3402.5 2668.8 941.2 1887.2 1654.8 1374.4 1572.5 1626.1 2656.3 1143.0 2568.8 2720.0 2234.9 2081.9 1893.1 2751.4 2723.1 1246.5 2559.5 1626.4 4386.3 1096.5 1810.3 938.4 3055.7 2388.9 476.2 1271.7 2542.5 1684.9 1122.2 1263.5 907.5 2391.6 2167.6 3426.2 2120.9 1433.4 2921.9 969.0 496.8 1137.3 329.5 1018.8 1004.1 1587.4 1951.6 1708.1 1346.5 1318.5 1929.0 1893.1 1734.6 340.9 999.2 858.7 1243.7 1726.0 3392.3 719.2 745.3 703.1 1096.2 702.2 760.9 763.3 721.5 652.1 752.0 756.7 791.7 752.4 2277.5 314.1 560.5 22.5 7020.4 3787.2 4681.7 3181.0 5272.9 276.7 5169.2 6848.9 155.6 1921.6 1378.1 1166.0 162.6 3178.0 4378.0 2153.4 2551.3 2493.5 1487.6 1657.5 3885.3 2452.6 2284.3 3256.0 27.3 4366.2 5807.8 2324.7 2571.4 2448.5 856.5 4232.7 3114.5 2411.6 4091.1 180.0 34.4 4783.0 842.3 6210.8 5627.4 4180.3 3448.6 4457.1 2114.8 50.6 5756.7 1363.1 3267.8 27.2 73.5 4770.7 4210.6 1643.7 4445.1 5429.7 4982.5 3325.8 652.2 516.8 972.9 2174.1 2361.8 832.0 896.6 8321.4 4904.2 3384.7 6066.8 4186.4 5252.8 7113.6 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79068966-79316519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 259.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 176.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045144, HPA071156" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045144: AB_10962360, HPA071156: " "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favorable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 30.1 24.6 23.2 19.4 25.2 26.9 27.9 23.9 29.5 45.0 6.0 26.6 19.4 52.0 19.0 37.8 26.8 26.1 30.3 24.2 25.2 17.2 8.8 26.7 17.7 34.1 31.2 19.1 48.9 23.5 19.4 12.6 21.9 30.3 19.7 14.6 14.8 28.6 29.0 34.9 32.5 22.4 27.1 24.0 45.2 27.8 4.5 29.9 16.6 37.6 17.1 18.3 28.7 31.2 24.3 24.0 29.3 54.8 23.6 55.8 16.0 19.1 22.4 40.2 15.6 8.8 8.7 10.8 12.2 17.8 52.8 40.9 33.0 9.2 16.6 8.4 26.5 5.1 43.5 11.1 25.9 39.2 24.3 88.1 21.0 18.2 22.3 15.9 98.4 25.3 10.2 16.9 62.9 13.3 45.4 24.4 37.6 16.2 13.8 44.0 107.5 10.3 12.3 11.6 20.0 56.8 82.8 14.8 176.2 46.8 19.4 56.5 23.4 35.5 58.7 23.5 29.9 29.2 11.5 21.9 0.2 77.0 42.7 11.5 1.3 2.1 1.6 1.2 3.6 0.8 0.5 0.8 0.7 2.6 0.2 0.3 0.6 3.0 3.4 3.0 2.5 1.0 1.2 23.2 25.2 23.9 29.5 24.2 25.2 34.1 31.2 19.1 30.3 24.0 29.9 24.3 49.3 38.5 26.0 64.9 14.5 22.8 8.4 14.9 15.4 49.8 27.1 18.0 54.4 20.0 15.8 16.5 0.0 7.1 14.7 39.1 7.9 22.1 47.2 17.9 75.3 49.9 13.8 25.7 23.1 24.1 5.6 36.2 38.7 33.2 50.6 16.8 56.4 9.6 37.9 63.9 16.4 14.5 14.2 34.9 86.0 259.7 28.3 52.4 24.9 46.9 27.2 12.9 4.1 92.5 45.5 19.3 22.5 23.7 14.2 13.0 19.7 8.1 14.7 3.4 19.7 24.7 32.6 1.8 3.2 40.8 23.7 3.6 12.1 14.3 14.8 12.7 DNAJC12 JDP1 ENSG00000108176 "DnaJ heat shock protein family (Hsp40) member C12" Q9UKB3 10 67796669-67838188 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 70.9;liver: 68.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 75.9;Enteroendocrine cells: 166.2;Hepatocytes: 74.5;Intestinal goblet cells: 98.0;Proximal tubular cells: 163.2" "Cancer enhanced" "Detected in many" "breast cancer: 22.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 7.7" "Lineage enriched" "Detected in single" 24 "dendritic cells: 7.7" "Cell line enhanced" "Detected in many" "Daudi: 91.5;NB-4: 76.0;SCLC-21H: 72.0;U-698: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036289 Enhanced NA NA "HPA036289: AB_10670794" "unprognostic (1.52e-2)" "unprognostic (3.65e-3)" "unprognostic (4.12e-2)" "unprognostic (2.28e-2)" "unprognostic (5.28e-2)" "unprognostic (6.59e-3)" "unprognostic (6.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (5.05e-2)" "unprognostic (3.97e-2)" "unprognostic (7.31e-3)" "prognostic unfavorable (1.97e-10)" "unprognostic (7.35e-3)" "unprognostic (1.37e-1)" "unprognostic (5.81e-3)" "unprognostic (7.99e-2)" 1.3 70.9 24.5 2.3 28.9 1.5 30.5 39.0 28.8 6.0 16.0 9.2 3.2 7.3 6.0 1.2 3.5 5.4 5.5 27.6 29.9 29.8 68.1 1.7 0.6 25.1 31.8 27.0 15.1 37.3 6.6 41.5 0.1 26.9 7.7 14.3 13.8 5.4 4.9 11.0 0.3 4.8 6.1 22.3 1.2 6.6 7.1 27.9 2.1 1.5 10.0 0.7 4.5 3.4 29.2 0.0 32.9 5.3 0.9 7.5 6.1 0.1 0.1 2.0 1.1 6.8 0.5 0.0 91.5 13.4 0.1 0.4 0.0 0.9 1.2 0.3 4.4 36.9 21.9 26.9 8.5 7.9 41.7 0.5 19.3 7.6 3.2 1.9 0.1 11.4 2.6 40.5 1.2 3.2 1.8 2.0 76.0 1.5 0.4 36.4 1.2 3.0 48.2 0.8 0.0 72.0 41.1 0.5 14.4 1.3 0.3 0.7 0.4 0.0 3.5 1.0 0.8 1.0 8.6 1.0 68.2 6.6 49.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.1 0.3 0.0 0.0 0.0 7.7 0.0 0.0 24.5 28.9 39.0 28.8 27.6 29.9 25.1 31.8 27.0 26.9 22.3 27.9 29.2 1.5 0.0 1.1 2.9 2.1 0.3 2.2 1.4 0.6 31.9 75.9 35.6 9.3 1.5 13.0 5.5 6.2 0.1 0.6 7.2 9.8 1.5 5.6 2.2 24.8 2.3 166.2 9.1 12.3 55.9 0.1 8.7 6.1 1.6 0.0 2.0 1.4 74.5 0.6 38.7 14.8 98.0 8.2 2.6 0.4 4.2 16.1 3.1 0.0 1.0 3.7 13.5 0.0 11.6 13.6 43.4 4.1 21.4 0.4 26.3 1.1 163.2 20.3 5.5 0.0 4.6 5.3 2.8 0.7 0.2 0.1 0.0 0.9 21.6 4.4 1.3 PPIF "Cyp-D, hCyP3" ENSG00000108179 "Peptidylprolyl isomerase F" P30405 10 79347469-79355334 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Necrosis" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 370.9;Macrophages: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 75.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077416 Supported Mitochondria NA NA 320000 Mitochondria "HPA077416: AB_2686840" "unprognostic (2.21e-1)" "unprognostic (5.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.72e-3)" "unprognostic (1.69e-1)" "unprognostic (3.16e-3)" "unprognostic (3.45e-1)" "unprognostic (4.33e-3)" "unprognostic (1.66e-1)" "unprognostic (1.97e-1)" "unprognostic (2.82e-1)" "unprognostic (9.37e-3)" "unprognostic (1.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.88e-2)" 43.3 229.5 41.4 43.2 48.6 170.3 42.8 58.3 63.1 20.8 58.3 50.4 36.6 14.1 7.3 66.6 23.1 19.7 103.9 37.5 44.0 56.5 176.3 29.4 32.6 55.8 55.8 33.7 19.5 87.7 78.2 18.4 27.3 48.7 18.9 52.9 8.9 39.8 45.9 100.3 66.8 31.5 21.2 51.1 59.1 99.1 35.3 56.2 28.5 26.2 134.8 56.0 60.6 35.3 59.0 220.4 90.6 62.3 123.5 57.0 73.6 79.8 124.2 161.2 265.7 249.6 213.5 102.7 224.8 68.0 87.4 188.6 127.8 195.3 115.4 410.5 72.2 186.4 352.8 87.5 380.7 96.4 245.7 80.4 173.2 81.3 264.5 262.3 86.5 47.5 86.4 351.6 268.3 91.6 111.7 64.1 204.2 53.0 99.6 500.6 109.8 96.4 114.7 103.9 200.0 124.1 92.0 63.6 253.8 97.9 40.5 111.4 187.2 43.5 116.1 106.3 137.9 242.0 124.7 137.7 181.9 114.5 313.9 32.0 15.2 34.3 18.0 10.4 27.5 10.9 19.1 9.1 9.6 43.3 7.7 8.1 7.9 75.0 9.0 10.4 5.4 10.0 16.6 41.4 48.6 58.3 63.1 37.5 44.0 55.8 55.8 33.7 48.7 51.1 56.2 59.0 8.4 6.4 6.8 7.2 32.7 42.6 30.2 23.8 31.3 4.0 41.8 40.8 124.6 14.3 14.4 12.9 6.2 99.4 26.4 39.9 92.0 42.1 14.5 12.4 24.0 10.1 21.6 37.0 4.1 28.0 127.1 25.1 78.0 15.5 13.4 73.4 6.1 98.5 91.1 8.4 5.7 69.5 18.3 40.3 370.9 14.1 6.2 160.8 35.6 4.7 32.0 13.0 5.2 5.5 15.0 39.8 26.6 6.0 48.7 41.4 21.3 41.2 12.6 5.2 19.7 18.2 28.6 14.8 22.5 52.9 37.6 142.3 23.9 60.2 81.1 34.2 PBLD "FLJ14767, MAWBP, MAWDBP" ENSG00000108187 "Phenazine biosynthesis like protein domain containing" P30039 10 68282660-68333049 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "intestine: 173.1;kidney: 272.6;liver: 337.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 97.5;Distal tubular cells: 109.5;Hepatocytes: 216.9;Proximal enterocytes: 380.2;Proximal tubular cells: 426.5" "Cancer enhanced" "Detected in all" "liver cancer: 16.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038035, HPA038036" Enhanced Approved Vesicles NA NA 1100000 Vesicles "HPA038035: AB_10672470, HPA038036: AB_10675625" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (6.14e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "prognostic favorable (1.44e-4)" "unprognostic (8.25e-2)" "unprognostic (3.62e-2)" "unprognostic (3.36e-3)" "unprognostic (1.19e-1)" "unprognostic (6.26e-3)" "unprognostic (3.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.07e-2)" "unprognostic (8.28e-2)" "unprognostic (6.68e-2)" 9.0 11.3 4.0 8.5 6.1 9.3 4.5 5.7 4.9 4.0 4.6 33.5 173.1 6.0 3.8 3.4 7.3 9.5 6.3 3.4 5.6 272.6 337.9 3.9 5.5 4.9 4.6 3.2 3.6 63.5 5.7 2.3 4.2 5.1 5.7 27.9 8.8 4.6 5.1 5.7 5.7 147.6 5.1 3.8 4.6 55.3 3.8 4.6 2.1 5.6 3.1 2.2 5.5 2.2 9.7 3.8 7.5 7.1 4.9 6.4 3.6 3.3 15.1 9.5 5.6 5.8 6.9 9.5 4.2 5.6 10.6 2.3 5.8 3.3 3.9 4.8 2.0 5.4 3.3 9.3 6.4 3.0 5.0 3.3 6.4 4.0 3.4 4.2 10.1 3.5 4.0 3.1 9.2 8.9 5.9 4.7 8.7 2.1 3.0 3.2 8.0 9.4 7.1 11.3 5.4 4.1 5.5 10.1 5.8 7.0 2.0 20.0 5.9 10.9 5.5 3.9 2.7 2.5 5.5 4.3 6.3 6.6 2.7 1.4 2.6 2.8 1.5 0.4 1.4 0.8 0.8 0.6 0.4 2.8 0.6 1.1 0.7 3.3 1.8 0.9 1.2 1.1 1.2 4.0 6.1 5.7 4.9 3.4 5.6 4.9 4.6 3.2 5.1 3.8 4.6 9.7 1.6 3.2 4.2 3.6 4.5 1.9 1.7 2.2 1.2 5.0 6.2 2.8 3.5 24.3 4.3 55.2 10.4 3.9 3.7 97.5 109.5 8.8 1.2 17.9 5.7 3.4 7.2 6.6 1.8 31.8 2.0 3.2 33.1 6.5 1.3 8.2 6.4 216.9 3.1 10.1 2.8 42.6 2.0 10.4 4.4 0.4 4.1 5.5 1.8 3.7 5.0 5.5 3.1 3.0 7.5 12.5 46.4 3.0 1.5 2.0 380.2 426.5 12.9 17.2 0.0 2.0 6.6 1.6 1.4 1.8 0.6 3.1 2.8 9.6 57.3 3.0 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533124 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 156.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 276.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles NA NA Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favorable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 91.4 20.9 26.5 43.5 22.9 57.8 80.7 23.9 30.0 63.7 21.0 32.8 31.1 38.7 44.5 92.9 47.5 33.2 39.6 24.3 22.2 39.4 21.3 71.4 54.6 28.2 30.5 23.5 47.6 33.4 36.0 15.9 82.6 26.5 35.1 27.4 8.0 48.1 34.4 25.1 70.9 35.1 33.6 27.5 48.8 24.9 23.3 33.0 40.5 46.9 42.5 45.0 55.6 56.6 29.2 96.2 135.6 128.3 44.5 186.6 59.3 59.6 49.3 91.8 51.1 38.0 134.8 54.6 31.5 93.2 26.4 18.9 97.0 35.9 88.5 41.4 55.9 13.9 88.9 15.8 118.2 63.5 31.8 20.3 58.8 77.2 52.8 92.1 94.8 191.5 31.8 48.8 23.0 15.0 83.3 50.0 23.3 29.5 61.2 0.1 167.9 14.9 5.3 203.9 131.9 27.5 42.3 19.7 133.7 149.5 43.7 54.1 79.8 276.3 13.0 52.8 12.4 35.1 10.7 42.0 11.8 42.2 65.4 57.5 16.2 51.5 56.3 92.1 102.1 41.3 13.8 70.7 81.1 33.9 13.7 82.3 79.3 54.7 95.2 172.8 13.6 61.8 84.3 26.5 22.9 23.9 30.0 24.3 22.2 28.2 30.5 23.5 26.5 27.5 33.0 29.2 141.9 16.0 55.1 13.1 18.5 34.9 40.3 54.6 35.3 2.1 29.5 23.2 11.3 25.8 39.0 33.1 77.2 7.8 38.4 32.8 7.9 43.8 2.4 44.7 38.9 95.3 64.2 35.6 12.9 24.8 74.4 18.8 18.3 75.1 7.6 41.2 156.7 21.1 50.5 3.3 7.4 37.0 34.6 129.3 12.9 4.1 39.1 66.5 14.2 35.6 51.8 23.7 89.6 4.5 13.5 64.2 21.6 41.0 18.4 55.7 23.4 8.0 29.6 7.1 98.6 10.2 43.1 5.0 19.0 80.2 36.4 7.7 55.7 10.4 30.6 69.7 LGI1 "EPITEMPIN, EPT, ETL1, IB1099" ENSG00000108231 "Leucine rich glioma inactivated 1" O95970 10 93757840-93806272 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 40.0;choroid plexus: 39.0" "Cell type enhanced" "Detected in some" "Astrocytes: 242.9;Excitatory neurons: 57.1;Inhibitory neurons: 74.7;Oligodendrocyte precursor cells: 28.6" "Group enriched" "Detected in some" 7 "glioma: 1.8;testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.4;CACO-2: 2.0;NTERA-2: 6.1;SuSa: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (1.26e-1)" "unprognostic (4.68e-2)" "unprognostic (2.45e-2)" "unprognostic (1.01e-1)" "unprognostic (8.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.24e-3)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" "unprognostic (8.71e-2)" "unprognostic (2.21e-1)" "unprognostic (5.93e-2)" "unprognostic (4.65e-1)" 0.4 1.9 25.9 0.1 28.0 0.0 0.2 23.2 40.0 0.1 39.0 3.2 0.5 0.1 0.0 4.3 0.1 1.0 0.3 28.7 23.3 0.0 2.7 0.0 0.0 28.6 24.5 24.8 0.0 0.2 0.0 7.7 0.0 32.9 0.7 2.7 0.4 0.1 0.5 5.9 0.2 1.5 0.7 21.6 0.0 1.8 0.4 26.6 0.0 0.2 3.6 0.1 1.0 0.3 29.3 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 28.0 23.2 40.0 28.7 23.3 28.6 24.5 24.8 32.9 21.6 26.6 29.3 0.2 0.0 0.0 242.9 0.0 0.3 0.4 0.0 0.0 0.5 0.4 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.4 0.0 0.0 57.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 74.7 0.0 0.0 0.0 0.4 1.6 1.5 0.0 0.0 10.3 0.0 0.1 0.0 28.6 3.9 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.2 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402541-94536332 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.7" "Cell type enhanced" "Detected in many" "Microglial cells: 110.5;Oligodendrocytes: 397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favorable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 5.8 3.6 15.9 3.1 25.2 1.1 5.7 28.0 17.6 4.5 9.5 6.2 4.5 4.2 2.8 3.3 3.8 3.7 3.5 12.8 19.8 4.1 3.7 4.7 2.6 38.3 27.8 10.0 4.0 4.6 13.4 2.7 5.7 32.8 4.1 6.9 7.1 3.2 4.3 4.1 4.7 5.1 4.3 31.5 4.9 3.7 8.4 23.8 1.3 3.3 4.1 2.7 4.6 4.1 46.7 7.3 3.2 4.1 6.1 5.6 6.8 5.4 4.6 9.5 5.1 4.7 12.8 3.1 0.0 2.7 6.8 4.9 4.0 4.9 3.4 6.5 0.0 5.7 2.3 2.9 4.1 4.2 0.0 1.8 4.6 4.3 5.3 6.9 8.6 5.5 0.0 3.4 7.4 8.2 4.0 0.0 0.0 1.3 5.2 3.3 0.0 5.3 3.9 4.6 3.2 1.7 4.1 4.6 4.0 3.9 3.7 8.6 4.4 5.4 3.5 4.8 5.7 3.7 5.1 5.3 0.0 3.5 0.0 1.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 25.2 28.0 17.6 12.8 19.8 38.3 27.8 10.0 32.8 31.5 23.8 46.7 11.0 9.6 5.3 34.9 7.6 19.5 6.5 2.9 10.8 17.5 10.6 9.1 6.5 4.3 4.3 9.2 10.4 19.4 0.6 18.1 0.0 5.8 22.6 7.6 9.5 13.7 8.4 5.2 46.8 5.1 13.4 23.8 13.7 10.3 5.7 3.5 8.9 4.8 19.1 8.4 66.7 8.7 4.1 23.6 25.9 9.2 8.4 20.9 16.0 110.5 11.7 8.9 1.0 60.8 397.2 7.6 13.2 10.5 12.0 11.7 11.7 5.9 4.0 28.0 13.1 11.7 12.0 64.3 13.5 11.4 19.2 24.4 1.5 6.3 11.8 10.3 CYP2C18 "CPCI, CYP2C, CYP2C17, P450IIC17" ENSG00000108242 "Cytochrome P450 family 2 subfamily C member 18" P33260 10 94683729-94736190 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 103.7;liver: 198.7;stomach 1: 67.8" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8" "Cancer enhanced" "Detected in many" "liver cancer: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;OE19: 1.9" "Not detected" "Not detected" HPA074424 Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Plasma membrane" "HPA074424: " "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-1)" "unprognostic (9.78e-2)" "unprognostic (2.28e-1)" "unprognostic (4.22e-3)" "unprognostic (1.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-3)" 0.3 0.0 0.1 1.6 0.1 0.0 0.3 0.2 0.1 2.5 0.0 6.0 103.7 0.1 0.0 31.2 0.0 16.4 0.0 0.1 0.1 0.3 198.7 0.8 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 2.5 0.0 5.4 0.0 0.0 4.4 83.8 0.1 0.2 0.0 67.8 0.1 0.1 0.3 0.0 0.0 7.1 0.2 9.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.0 3.3 0.0 0.3 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.1 17.2 3.2 0.0 0.0 0.1 0.0 6.7 0.0 1.5 0.0 0.6 0.1 0.0 0.0 2.7 0.5 6.9 0.2 0.1 68.8 1.3 0.0 0.0 1.8 124.0 0.0 0.0 0.8 2.1 2.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 9.1 3.9 0.0 0.3 0.0 62.5 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.3 22.8 1.7 1.5 0.1 0.1 5.7 0.0 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922700-40937646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "salivary gland: 149.0;skin 1: 161.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1328.6;Cytotrophoblasts: 679.8;Prostatic glandular cells: 2203.0;Syncytiotrophoblasts: 3890.8;Urothelial cells: 1590.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 61.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "HBEC3-KT: 9.6;Hep G2: 11.0;SuSa: 7.1;T-47d: 16.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" NA NA 590000 "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.26e-4)" 0.4 0.0 0.0 0.3 0.0 1.1 15.8 0.0 0.0 6.8 0.0 0.1 0.2 1.1 2.1 6.6 3.0 1.5 0.1 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.1 3.6 0.1 2.9 15.7 0.0 20.8 0.0 0.6 149.0 0.4 0.3 161.7 0.2 0.0 0.0 3.1 0.2 21.8 0.0 0.4 0.1 0.4 2.5 4.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.0 9.6 0.0 0.0 0.0 0.0 0.1 11.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 7.1 16.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.3 0.3 4.6 1328.6 242.1 0.6 0.0 78.0 27.9 0.4 12.8 390.5 3.7 0.0 679.8 1.1 0.1 1.9 462.9 66.2 49.8 7.8 15.1 7.1 0.0 0.5 0.8 109.3 15.0 0.0 66.4 0.0 0.0 0.0 0.0 63.8 0.0 0.3 0.7 57.0 0.0 0.7 10.6 0.6 3.0 5.4 0.0 5.4 15.8 0.0 0.5 0.3 17.7 1.1 0.7 0.0 2203.0 0.0 0.4 275.0 0.2 0.0 0.0 48.4 62.1 0.7 7.9 8.1 3890.8 7.6 0.1 0.9 1590.3 CRYBA1 CRYB1 ENSG00000108255 "Crystallin beta A1" P05813 17 29246859-29254494 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 2.2" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 1.1;Syncytiotrophoblasts: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 3.2;BEWO: 4.1;SuSa: 1.0" "Group enriched" "Detected in some" 7 "hippocampal formation: 2.7;hypothalamus: 1.2;thalamus: 1.2" "Low region specificity" "Detected in all" HPA022016 Supported NA NA "HPA022016: AB_2732426" "unprognostic (2.89e-2)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (1.37e-1)" "unprognostic (9.62e-2)" "unprognostic (4.27e-3)" "unprognostic (2.08e-1)" "unprognostic (5.60e-2)" "unprognostic (2.52e-2)" "unprognostic (9.90e-2)" "unprognostic (5.85e-3)" "unprognostic (2.83e-1)" "unprognostic (2.09e-6)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.31e-2)" "unprognostic (6.84e-3)" 0.0 0.0 0.5 0.1 0.7 0.1 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.2 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.3 0.6 0.2 0.3 0.9 0.6 0.0 1.0 0.3 0.7 2.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.1 0.0 0.0 0.0 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "Nuclear FMR1 interacting protein 2" Q7Z417 17 29255839-29294148 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "white matter: 63.9" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 15.0 15.0 10.5 22.9 3.8 80.6 12.6 10.0 19.2 12.8 9.4 15.1 16.3 11.6 12.0 17.3 11.0 14.2 13.2 11.3 8.6 13.1 24.2 21.2 20.0 16.5 5.1 0.0 12.2 14.8 18.6 11.1 29.8 8.2 12.2 13.1 23.3 15.6 9.9 16.1 11.7 13.3 10.4 2.9 20.9 18.9 14.3 9.2 18.2 13.6 17.7 17.7 16.5 14.3 63.9 42.5 67.1 38.9 27.2 32.8 38.0 65.1 41.3 24.8 31.1 28.4 75.0 22.5 68.5 60.1 28.5 27.7 58.6 31.4 28.9 39.3 74.0 55.9 51.8 64.7 19.8 30.3 66.6 53.8 33.1 34.5 34.4 36.7 35.9 23.2 24.8 86.2 49.5 32.1 34.8 70.6 30.1 40.2 32.2 24.9 57.2 66.8 29.4 26.1 68.4 37.1 23.5 73.6 136.6 44.6 51.5 47.3 44.2 38.5 59.1 59.1 35.0 71.3 68.4 68.9 79.3 39.0 34.9 51.6 13.6 6.1 8.5 5.6 5.9 4.3 8.5 5.5 6.2 5.2 7.6 7.0 5.9 25.4 5.1 9.6 12.1 3.2 2.3 10.5 3.8 10.0 19.2 11.3 8.6 16.5 5.1 0.0 8.2 2.9 9.2 63.9 139.7 80.1 67.0 58.1 76.8 99.5 78.2 40.0 118.4 55.3 105.0 124.8 81.7 38.6 69.3 31.3 95.9 69.2 124.3 72.6 15.6 33.9 35.2 108.2 139.0 85.9 48.3 55.6 47.4 27.9 31.3 86.4 82.6 154.2 46.2 41.2 55.0 54.6 44.6 57.2 47.1 62.5 20.3 74.7 108.8 24.9 35.4 122.9 40.9 41.2 50.0 35.2 37.0 44.7 85.9 37.4 43.1 35.0 65.2 91.8 26.5 27.6 88.8 60.6 19.7 171.7 78.5 36.6 29.8 120.8 97.7 182.0 93.8 51.8 57.1 111.9 GIT1 ENSG00000108262 "GIT ArfGAP 1" Q9Y2X7 17 29573475-29594054 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 118.7" "Cell type enhanced" "Detected in all" "Early spermatids: 97.8;Late spermatids: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004059, HPA004186" Enhanced Supported "Focal adhesion sites,Mitochondria,Cytosol" NA NA 36000 "Focal adhesion sites, Cytosol" Mitochondria "HPA004059: AB_1078966, HPA004186: AB_1078967" "unprognostic (3.66e-1)" "unprognostic (4.46e-2)" "unprognostic (3.24e-2)" "unprognostic (6.30e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.00e-3)" "unprognostic (2.79e-1)" "unprognostic (5.23e-2)" "unprognostic (2.12e-2)" "unprognostic (3.08e-1)" "unprognostic (8.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.30e-2)" "unprognostic (2.10e-1)" "unprognostic (1.69e-1)" 30.0 13.7 75.9 18.2 77.7 14.5 30.1 27.0 118.7 21.5 16.3 20.0 18.1 21.1 7.6 28.9 22.7 15.7 26.3 97.7 39.4 18.5 7.7 35.1 21.4 42.6 45.2 70.9 21.5 22.1 18.1 23.9 21.3 48.9 21.5 10.2 12.2 19.2 14.5 32.1 34.4 20.7 13.0 28.0 22.4 19.2 89.5 46.6 23.3 23.4 18.7 15.3 21.8 23.8 60.5 49.7 80.9 39.1 69.9 30.4 19.1 45.3 23.9 23.4 28.2 25.1 33.1 18.0 37.3 37.3 31.5 50.5 79.5 41.6 61.4 14.4 48.3 49.7 26.9 39.8 29.8 37.0 34.4 21.3 23.4 69.2 32.4 50.5 40.0 53.0 48.6 22.3 31.2 20.5 50.9 109.0 45.7 29.2 49.9 19.2 81.7 52.3 55.6 25.8 26.7 82.0 70.0 33.8 77.2 117.7 27.9 38.0 45.0 66.2 26.7 38.2 59.3 49.0 25.8 39.3 41.5 43.9 29.0 45.9 0.1 1.6 1.4 1.9 2.5 0.9 0.7 1.9 2.1 2.2 0.6 1.6 1.1 0.5 2.4 1.8 1.8 1.3 1.8 75.9 77.7 27.0 118.7 97.7 39.4 42.6 45.2 70.9 48.9 28.0 46.6 60.5 54.6 3.2 1.5 21.9 9.5 27.1 6.7 9.2 10.2 15.5 12.6 16.3 8.7 4.3 4.9 5.5 10.4 5.1 17.3 19.2 1.9 7.5 97.8 9.4 16.8 30.8 14.9 1.7 16.8 9.4 8.0 9.7 11.2 10.5 1.3 17.9 22.5 4.0 8.3 11.8 14.1 13.8 8.2 9.5 18.9 99.2 14.3 10.6 8.8 15.9 7.4 13.3 9.2 12.5 16.9 9.5 11.5 10.5 8.7 13.4 17.2 6.1 9.8 10.2 13.1 17.3 9.5 30.5 11.5 14.4 28.1 3.6 12.4 8.6 14.6 8.3 RPL19 "DKFZp779D216, FLJ27452, L19, MGC71997" ENSG00000108298 "Ribosomal protein L19" P84098 17 39200283-39204840 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 37509.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043014, HPA051987" Approved Enhanced Nucleoli,Cytosol NA NA 160000 "Nucleoli, Cytosol" "HPA043014: AB_10965840, HPA051987: AB_2681682" "unprognostic (4.07e-3)" "unprognostic (1.33e-1)" "unprognostic (3.18e-1)" "unprognostic (4.46e-2)" "unprognostic (4.25e-2)" "unprognostic (6.40e-2)" "unprognostic (9.70e-3)" "unprognostic (1.50e-1)" "unprognostic (5.46e-1)" "unprognostic (1.16e-2)" "unprognostic (3.32e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.48e-2)" "unprognostic (8.60e-2)" 2114.1 1655.3 1190.9 1337.9 1217.5 3474.7 2235.4 1176.6 1485.4 2377.8 1202.8 1867.6 1171.8 1731.6 1267.1 2177.3 2015.0 1169.7 1531.2 1113.8 1202.6 1734.2 1497.3 1466.2 2858.2 1231.8 1188.9 1075.5 3668.5 3031.3 1550.1 1373.1 1059.4 1232.6 1748.5 1243.1 387.0 2154.6 1225.9 2785.7 2781.6 1748.3 1114.3 1281.7 2019.6 1887.9 620.3 1265.7 2357.3 1474.7 1895.9 2564.6 1931.3 2139.0 1265.8 1943.7 2617.7 1849.0 2258.4 3300.1 4133.6 1894.3 1788.5 3631.1 3629.7 2895.6 2872.0 1801.2 4740.4 3047.1 2580.8 2122.7 3228.2 2807.4 3714.8 1852.4 1922.4 4931.8 1693.5 1876.5 3797.5 5133.2 4201.0 2240.4 4647.6 3995.5 2805.3 5031.4 3396.2 3177.6 3991.6 3007.3 2696.5 2544.2 1939.5 5610.7 5814.7 1891.0 2269.3 1912.1 3270.3 2620.6 4777.9 3324.4 2419.1 2225.5 2457.9 1084.0 37509.3 5867.6 1982.1 3626.8 5201.1 1883.8 1410.9 1894.7 2165.8 3336.2 3504.5 3756.7 3505.5 1906.0 3147.3 1854.1 1051.1 2648.2 975.0 2486.9 2147.2 3862.3 4698.0 3984.2 3158.7 3263.9 4349.1 4920.5 4086.9 380.6 2830.2 1793.7 3012.9 3456.9 9398.3 1190.9 1217.5 1176.6 1485.4 1113.8 1202.6 1231.8 1188.9 1075.5 1232.6 1281.7 1265.7 1265.8 2477.2 884.6 1438.4 49.0 5591.4 5551.7 6227.1 4092.6 3998.1 241.7 5532.9 7926.2 556.3 2332.0 2100.3 1138.5 93.8 3720.2 4011.1 1443.7 3623.4 3025.0 1451.9 1129.0 2357.2 2714.5 1957.2 2708.2 30.8 6238.2 5441.3 2425.2 1705.4 1503.7 1586.0 3024.3 2836.8 2406.3 4189.9 132.9 33.6 3550.3 1464.8 4218.0 5326.1 4539.9 3920.2 3259.8 3272.8 46.9 4282.6 1495.1 3932.1 20.1 51.1 3972.8 3267.4 2040.2 3289.0 6219.8 3226.4 5182.0 1049.1 390.5 1531.7 3215.1 3875.5 962.9 981.4 5376.4 6619.2 3899.7 4615.5 3399.1 3895.2 7406.6 FBXL20 "Fbl2, Fbl20, MGC15482" ENSG00000108306 "F-box and leucine rich repeat protein 20" Q96IG2 17 39252663-39402523 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.6;Inhibitory neurons: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 65.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044748, HPA050397" Uncertain Supported Microtubules NA NA Microtubules "HPA044748: AB_2679072, HPA050397: AB_2681112" "unprognostic (7.21e-2)" "unprognostic (1.00e-1)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (1.33e-1)" "unprognostic (7.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.65e-1)" "unprognostic (3.29e-1)" "unprognostic (9.95e-2)" "unprognostic (2.19e-1)" "unprognostic (2.60e-1)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" 4.1 5.5 7.8 3.4 9.0 8.3 4.5 7.1 11.5 4.5 2.8 3.9 3.6 4.4 3.5 4.1 4.1 3.7 3.4 9.3 7.8 4.2 4.7 4.0 3.7 4.0 6.0 9.3 4.8 4.4 4.6 3.5 5.6 5.9 3.7 4.1 8.4 3.7 3.5 3.6 6.5 4.2 5.1 0.4 4.5 3.8 12.8 7.0 7.6 3.9 5.3 4.0 3.9 4.3 5.8 4.0 8.2 8.0 8.5 10.1 7.2 4.6 5.6 7.5 6.3 7.7 2.6 9.3 6.3 12.3 7.3 12.6 9.3 9.4 6.5 9.1 12.1 12.5 6.7 7.2 7.9 7.3 9.5 8.1 6.0 7.5 6.2 7.2 8.9 7.7 8.0 13.4 4.5 6.1 5.9 9.4 6.7 2.1 8.1 3.5 4.6 15.9 4.2 3.2 6.2 5.1 4.0 10.6 65.7 7.1 10.4 10.3 9.0 6.3 7.0 6.9 5.3 5.3 7.9 8.9 5.2 8.7 4.3 5.5 30.2 5.5 18.3 4.2 4.5 3.9 4.0 3.9 3.9 4.1 6.2 3.6 3.5 26.9 8.2 6.7 5.3 8.3 2.4 7.8 9.0 7.1 11.5 9.3 7.8 4.0 6.0 9.3 5.9 0.4 7.0 5.8 13.5 19.2 20.4 61.4 15.4 4.0 7.1 2.6 10.2 31.4 13.0 10.9 6.5 11.5 6.7 12.9 58.4 14.4 23.9 18.4 1.9 11.2 14.1 28.3 16.3 12.5 9.6 34.9 122.6 6.1 8.2 14.4 5.1 25.6 8.8 23.7 22.5 12.0 10.5 20.2 126.8 10.0 12.2 25.2 3.8 15.6 18.0 16.1 1.8 71.2 24.0 12.0 32.0 74.9 79.6 13.8 10.0 11.3 14.2 15.9 26.5 6.3 8.8 39.2 6.6 15.3 14.3 51.2 39.9 10.5 5.5 24.2 18.1 11.7 10.6 15.3 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 210.0;choroid plexus: 52.3;pituitary gland: 99.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4" "Group enriched" "Detected in many" 5 "glioma: 8.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 62.5;SH-SY5Y: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Enhanced Vesicles NA NA Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 0.2 14.5 150.5 0.4 160.0 2.3 0.3 95.7 210.0 0.2 52.3 2.7 1.2 0.5 0.2 0.8 0.2 0.3 1.2 170.3 118.2 1.8 0.2 0.4 0.2 110.5 114.0 161.9 0.8 3.8 3.1 99.0 1.6 121.6 0.8 0.6 31.5 0.3 0.3 0.1 7.8 1.3 0.5 77.4 1.6 2.3 15.3 116.8 0.4 1.4 0.3 0.1 0.2 0.7 139.5 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 4.3 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.9 0.2 0.0 0.5 0.3 0.3 0.1 0.1 1.1 0.3 0.1 62.5 40.3 0.3 0.0 0.3 0.1 0.5 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 150.5 160.0 95.7 210.0 170.3 118.2 110.5 114.0 161.9 121.6 77.4 116.8 139.5 0.1 0.0 0.6 17.3 0.0 0.3 0.3 0.0 0.0 55.4 0.2 0.3 1.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 3.9 1.3 24.4 0.2 0.3 0.2 39.0 18.7 46.1 3.1 0.0 1.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 32.0 30.4 0.5 4.1 0.3 0.5 83.4 1.5 0.3 0.0 4.7 0.1 6.5 1.0 16.1 12.5 1.0 1.2 3.4 0.0 0.4 0.0 0.8 0.0 16.8 0.0 0.8 0.5 1.4 1.3 0.0 0.4 0.1 0.1 3.0 0.1 0.3 UBTF "NOR-90, UBF, UBF1, UBF2" ENSG00000108312 "Upstream binding transcription factor" P17480 17 44205033-44221626 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004611, HPA006385" Supported Supported Enhanced "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "CAB004611: AB_671403, HPA006385: AB_1080447" "unprognostic (1.37e-3)" "unprognostic (1.12e-3)" "unprognostic (2.54e-1)" "unprognostic (1.12e-2)" "unprognostic (3.15e-1)" "unprognostic (8.54e-3)" "unprognostic (1.35e-3)" "unprognostic (4.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-1)" "unprognostic (1.96e-3)" "unprognostic (5.44e-2)" "unprognostic (9.01e-2)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" 35.0 36.8 35.5 45.2 32.7 55.4 35.7 37.4 37.4 50.1 29.8 44.5 33.9 51.2 27.7 42.1 42.3 32.8 38.5 34.7 31.9 34.0 36.4 32.6 68.1 35.9 33.8 32.0 41.9 41.7 38.5 34.1 29.4 34.3 42.0 28.5 23.3 38.0 41.2 64.3 47.8 42.8 36.6 30.9 50.2 34.9 21.0 36.1 74.3 46.8 36.9 52.1 45.5 42.2 33.0 69.1 104.3 77.3 93.2 49.6 56.5 72.3 70.6 46.7 70.1 52.0 50.7 54.8 250.0 69.3 65.3 51.9 63.6 99.1 59.2 57.9 145.3 109.5 100.5 73.8 83.7 32.5 192.1 85.7 56.9 52.2 44.6 65.6 67.2 58.9 108.8 117.4 75.9 58.9 113.7 188.3 75.0 73.7 46.6 81.6 184.0 104.3 112.0 40.4 54.5 119.5 90.3 70.4 62.2 54.2 47.9 89.9 120.8 75.5 109.9 133.1 65.1 95.0 66.6 61.7 151.1 64.8 86.0 100.1 9.6 5.7 6.1 15.5 6.3 16.7 11.7 10.8 16.2 6.7 14.1 12.2 13.1 9.7 15.7 11.6 12.7 10.0 11.3 35.5 32.7 37.4 37.4 34.7 31.9 35.9 33.8 32.0 34.3 30.9 36.1 33.0 41.4 41.7 42.1 14.7 57.5 20.5 19.6 17.9 57.5 88.8 31.0 29.6 44.5 35.8 32.2 38.6 79.2 30.9 60.3 41.7 35.2 27.2 2.3 39.3 57.7 42.7 47.3 61.2 8.5 40.8 40.7 38.9 23.9 48.1 31.7 43.1 32.5 26.5 25.9 26.9 8.2 32.5 12.2 18.4 13.3 3.6 36.7 27.4 23.2 8.4 38.1 33.9 54.6 3.5 10.6 28.1 30.7 50.8 42.2 17.4 26.7 25.4 26.5 57.6 52.6 48.5 45.9 5.3 44.0 52.1 24.3 32.7 53.1 40.2 32.8 11.8 CSF3 "C17orf33, G-CSF, GCSF, MGC45931" ENSG00000108342 "Colony stimulating factor 3" P09919 17 40015361-40017813 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 124.1;urinary bladder: 58.0" "Cell type enhanced" "Detected in some" "Adipocytes: 57.0;Alveolar cells type 2: 121.2;Basal respiratory cells: 155.9;Club cells: 85.8;Endothelial cells: 192.1;Fibroblasts: 101.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 74.8;U-87 MG: 286.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 6170 "unprognostic (3.59e-3)" "unprognostic (1.57e-2)" "unprognostic (1.73e-1)" "prognostic favorable (8.45e-4)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (1.16e-2)" "unprognostic (1.74e-1)" "unprognostic (2.26e-1)" "unprognostic (2.82e-2)" "unprognostic (7.40e-4)" "unprognostic (1.21e-1)" "unprognostic (1.96e-1)" "unprognostic (4.10e-2)" "unprognostic (4.80e-3)" 23.5 6.0 1.3 14.3 1.0 3.6 7.3 0.8 2.0 25.4 1.5 6.2 0.0 4.1 0.0 6.2 7.3 2.3 13.5 1.0 2.1 3.0 0.5 124.1 0.3 2.0 1.1 0.8 1.9 3.9 0.3 10.3 2.6 1.3 16.3 0.5 0.3 3.1 0.1 21.8 1.5 4.3 1.6 1.8 0.9 8.1 1.3 1.1 0.3 3.9 10.6 0.4 58.0 5.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 74.8 0.0 2.8 0.2 0.0 0.0 1.0 0.0 3.2 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 36.0 11.6 0.0 9.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 286.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.8 2.0 1.0 2.1 2.0 1.1 0.8 1.3 1.8 1.1 1.6 57.0 22.4 121.2 0.0 0.0 34.5 5.3 155.9 0.0 0.0 0.1 0.1 0.1 0.0 85.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 11.4 0.8 192.1 0.0 0.0 0.0 0.2 0.0 101.5 5.6 23.6 7.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 18.3 0.0 36.5 0.0 0.0 2.2 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 14.0 0.0 0.0 34.9 0.0 0.0 37.3 6.4 0.2 0.9 0.9 33.5 0.0 3.2 0.0 0.8 17.3 PSMD3 "P58, Rpn3, S3, TSTA2" ENSG00000108344 "Proteasome 26S subunit, non-ATPase 3" O43242 17 39980807-39997959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 254.6" "Cell type enhanced" "Detected in all" "Early spermatids: 247.0;Syncytiotrophoblasts: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 842.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017038, HPA048972" Approved Enhanced Nucleoplasm,Cytosol No No 3100000 Nucleoplasm Cytosol "CAB017038: , HPA048972: AB_2680579" "unprognostic (3.44e-2)" "unprognostic (3.10e-1)" "unprognostic (2.22e-2)" "unprognostic (5.21e-2)" "unprognostic (7.87e-2)" "unprognostic (8.36e-3)" "unprognostic (5.75e-3)" "unprognostic (7.46e-2)" "unprognostic (6.19e-2)" "unprognostic (1.61e-1)" "unprognostic (6.89e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (4.47e-7)" "unprognostic (1.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "unprognostic (7.45e-2)" 55.0 64.7 42.1 48.0 44.9 48.5 54.0 43.4 49.3 53.1 38.2 56.6 43.7 62.3 35.3 70.2 52.0 25.5 70.4 45.7 45.2 48.2 94.3 51.5 46.0 45.1 42.9 45.4 53.1 57.6 55.9 48.6 47.7 47.4 48.1 46.6 31.5 54.6 37.6 254.6 83.7 49.3 45.6 41.8 49.7 53.1 53.3 45.5 57.4 46.3 104.2 51.5 54.1 53.6 52.3 203.7 247.8 133.2 192.9 106.3 68.2 158.3 146.2 150.7 257.3 198.3 206.4 170.0 242.3 357.7 157.6 172.5 310.2 238.6 190.7 172.9 245.5 266.2 140.4 120.5 207.2 96.5 191.3 151.0 91.5 160.0 272.7 118.8 86.4 147.6 166.0 291.5 146.9 121.2 148.0 298.2 131.2 185.5 130.9 145.2 216.2 184.7 227.7 130.5 135.3 174.9 132.5 139.7 842.6 124.3 160.9 190.2 162.7 132.9 110.7 195.8 165.6 266.2 158.2 217.2 269.3 169.4 142.2 182.6 8.1 22.4 19.0 17.6 21.3 17.2 16.6 17.0 20.4 29.8 17.7 15.3 19.1 6.3 16.6 18.3 20.4 16.3 17.9 42.1 44.9 43.4 49.3 45.7 45.2 45.1 42.9 45.4 47.4 41.8 45.5 52.3 32.4 44.8 40.1 16.6 43.3 46.7 57.2 71.5 33.0 70.8 31.7 25.7 21.3 15.7 48.6 16.5 20.9 165.3 38.0 98.3 46.9 101.4 247.0 30.7 35.9 46.5 26.4 44.6 18.0 106.3 131.6 50.6 34.7 28.5 25.3 70.2 32.2 50.9 96.3 60.6 17.6 59.2 69.2 27.4 37.0 51.8 62.7 39.1 65.8 4.7 57.4 89.9 35.0 11.1 16.5 101.4 68.3 54.2 57.2 76.3 75.3 54.8 32.0 56.9 26.3 51.1 50.7 87.3 54.0 38.7 44.6 271.7 32.4 78.8 77.2 53.7 CASC3 "BTZ, MLN51" ENSG00000108349 "CASC3 exon junction complex subunit" O15234 17 40140318-40172171 "Cancer-related genes, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 239.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024592, HPA050262" Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA024592: AB_1846034, HPA050262: AB_2681067" "unprognostic (3.76e-2)" "unprognostic (3.18e-1)" "unprognostic (2.00e-1)" "unprognostic (1.00e-1)" "unprognostic (1.98e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-3)" "unprognostic (3.40e-3)" "unprognostic (3.38e-1)" "unprognostic (1.16e-2)" "unprognostic (3.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.48e-2)" 40.0 28.1 96.8 30.1 100.4 37.5 38.9 87.9 90.7 41.2 69.4 41.6 23.1 49.9 38.5 30.6 47.3 25.2 25.1 84.3 88.8 29.2 21.0 35.7 34.3 105.0 94.9 76.2 56.1 33.6 35.3 26.2 30.5 95.9 36.4 32.2 39.3 32.1 48.4 55.9 36.7 32.5 48.1 92.9 34.4 35.6 54.6 101.5 40.5 40.7 43.9 37.9 48.1 33.6 97.4 44.6 44.9 58.5 64.9 46.1 48.2 34.3 45.5 40.6 61.3 52.5 48.3 38.3 81.7 67.2 57.7 50.4 77.8 71.8 48.0 83.5 54.8 58.1 58.6 55.4 50.6 42.0 74.7 39.6 50.2 43.9 59.9 93.6 46.8 77.4 45.8 64.0 61.5 50.8 25.6 110.9 44.3 44.5 39.8 26.0 67.3 74.5 85.9 32.1 39.5 85.4 49.8 63.8 239.4 59.4 91.1 78.2 58.9 50.0 51.7 53.3 48.7 71.0 56.5 56.3 81.1 50.4 40.2 57.1 7.8 9.4 13.1 12.5 11.5 11.1 8.6 9.3 11.5 10.0 8.6 10.5 10.4 35.9 10.2 18.2 5.8 9.1 8.6 96.8 100.4 87.9 90.7 84.3 88.8 105.0 94.9 76.2 95.9 92.9 101.5 97.4 32.8 19.2 36.8 31.0 29.5 19.8 22.9 11.3 31.3 40.8 38.5 32.5 26.7 14.3 31.8 23.9 22.9 19.9 38.0 21.4 21.5 17.8 14.8 30.2 38.8 34.0 31.2 23.5 29.0 24.3 21.3 26.9 26.0 31.4 16.4 32.5 23.9 21.9 17.0 30.3 32.8 20.8 18.3 26.4 29.2 24.5 36.1 25.8 35.6 22.5 23.9 23.5 26.8 15.1 34.5 21.0 17.6 29.7 26.5 27.2 17.3 18.1 27.2 38.5 13.1 42.0 40.2 59.4 67.7 28.1 19.9 27.1 30.1 22.7 20.6 24.7 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 200.7;skin 1: 232.2;vagina: 114.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 6.0 4.5 40.2 6.9 36.9 4.4 9.2 12.4 60.6 26.3 2.4 51.1 48.7 4.6 9.9 200.7 6.7 8.9 5.8 58.0 19.4 3.8 10.6 8.1 2.2 15.4 12.3 42.9 3.7 7.9 1.1 14.3 2.3 19.9 17.9 44.9 6.2 27.6 7.0 12.7 232.2 40.9 4.1 4.1 7.4 32.1 10.2 14.9 3.3 4.5 2.9 20.9 22.1 114.1 31.5 5.3 2.6 13.7 10.2 1.5 3.3 6.6 1.9 1.4 2.7 3.2 6.0 7.6 4.2 1.9 2.7 2.4 92.4 2.7 3.3 3.8 7.7 6.9 2.5 3.6 6.0 1.7 5.2 8.5 3.9 45.8 2.8 1.3 4.0 4.1 13.9 1.9 2.8 2.1 14.6 4.9 6.3 4.3 26.1 2.6 8.8 1.6 2.6 1.7 27.6 26.2 5.3 3.3 31.2 1.3 11.5 80.7 3.9 7.9 3.3 6.8 3.5 3.2 4.6 4.7 3.4 7.8 3.2 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 40.2 36.9 12.4 60.6 58.0 19.4 15.4 12.3 42.9 19.9 4.1 14.9 31.5 1.9 0.0 1.1 7.5 1.0 45.5 9.7 14.0 13.1 5.7 2.6 3.7 2.4 11.5 10.9 1.8 6.2 0.2 0.7 87.7 0.0 0.9 2.7 5.9 2.1 2.2 4.9 2.7 47.8 0.8 0.3 1.4 32.6 9.4 5.7 1.7 3.9 4.4 0.5 1.7 32.1 31.9 6.1 1.2 5.2 2.2 3.4 1.9 5.4 1.0 2.4 2.9 1.0 8.0 5.0 1.6 44.6 3.8 0.1 10.9 55.3 0.1 6.5 4.4 0.0 2.1 1.9 12.0 15.0 95.4 97.0 0.7 1.1 1.8 44.1 39.2 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 325.2;Rod photoreceptor cells: 480.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 9.7;MAIT T-cell: 2.5;memory CD8 T-cell: 6.8;naive CD8 T-cell: 3.2;NK-cell: 4.0" "Group enriched" "Detected in many" 42 "NK-cells: 4.0;T-cells: 9.7" "Cell line enhanced" "Detected in some" "HDLM-2: 25.9;HEL: 11.7;hTERT-RPE1: 4.7;SuSa: 4.1" "Region enriched" "Detected in all" 9 "basal ganglia: 248.1" "Region enriched" "Detected in all" 10 "basal ganglia: 110.0" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 0.6 1.5 5.8 1.2 19.2 0.3 0.8 4.3 7.9 1.6 3.4 6.1 1.1 1.7 2.5 1.5 10.4 1.0 0.5 4.8 9.7 2.4 2.3 5.2 2.1 8.0 5.3 4.7 2.6 1.4 5.6 12.2 1.2 11.5 4.6 1.3 1.3 1.3 3.3 0.1 1.4 3.8 1.4 4.4 1.7 3.9 0.4 6.3 0.6 0.6 0.3 3.0 3.0 2.8 4.2 0.4 0.0 1.3 0.1 0.1 0.2 0.0 0.1 2.6 0.0 0.3 0.2 0.0 1.2 1.8 0.0 0.0 0.1 0.0 0.1 0.1 25.9 0.6 11.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.2 4.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 9.7 0.0 2.5 0.0 0.8 6.8 0.0 0.0 0.0 3.2 0.1 4.0 0.0 0.1 0.0 1.7 5.8 19.2 4.3 7.9 4.8 9.7 8.0 5.3 4.7 11.5 4.4 6.3 4.2 1.3 3.2 1.5 33.3 0.4 0.4 1.4 0.9 0.6 25.0 7.8 14.5 0.4 0.0 1.3 1.8 325.2 0.0 27.5 0.1 3.9 8.9 0.6 2.5 1.8 2.6 59.7 0.0 2.3 3.1 0.1 5.8 1.1 4.2 0.0 3.3 1.1 0.0 0.1 52.2 2.3 2.3 0.0 0.0 3.0 2.4 0.9 2.9 1.8 1.9 19.4 39.2 18.6 2.5 1.2 2.7 0.1 4.9 6.3 0.1 0.1 14.2 0.8 480.2 0.0 0.5 1.9 0.1 0.4 0.0 0.1 0.1 10.3 12.8 0.6 0.3 RNF43 "DKFZp781H0392, FLJ20315, URCC" ENSG00000108375 "Ring finger protein 43" Q68DV7 17 58353676-58417595 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 41.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7" HPA008079 Uncertain NA NA "HPA008079: AB_1856371" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (7.46e-2)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.33e-2)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (5.69e-2)" "unprognostic (3.79e-1)" "prognostic favorable (6.04e-9)" "unprognostic (3.61e-3)" "unprognostic (2.56e-1)" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" 0.2 11.0 2.2 2.0 2.8 0.7 5.6 9.0 2.7 2.4 1.4 13.5 22.9 1.7 4.5 10.5 4.9 2.7 2.8 2.0 3.2 4.3 9.1 3.7 0.4 1.7 3.3 1.5 0.9 8.3 5.2 4.3 4.8 3.3 9.5 19.5 1.2 9.4 4.9 0.3 11.4 17.1 0.6 1.7 0.5 5.9 3.4 3.6 3.7 1.9 0.0 1.5 2.1 5.2 1.5 1.1 17.0 2.7 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 24.7 8.2 0.0 8.5 0.0 1.9 4.6 0.6 6.8 0.0 8.6 11.3 1.9 0.8 49.4 0.0 0.2 0.1 0.0 13.4 0.0 2.1 0.0 0.0 0.2 0.2 0.4 0.0 0.2 0.1 0.2 0.4 54.7 1.0 0.3 0.0 2.2 5.9 9.0 1.6 0.1 1.6 0.7 0.5 5.4 2.0 0.1 0.0 0.0 1.8 0.0 0.0 0.6 1.4 0.1 0.3 0.0 3.8 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.2 0.0 2.2 2.8 9.0 2.7 2.0 3.2 1.7 3.3 1.5 3.3 1.7 3.6 1.5 0.3 3.2 8.9 29.0 2.5 9.6 17.5 14.1 67.7 2.5 17.3 13.6 4.0 17.2 5.8 18.4 2.1 26.0 2.2 33.0 15.6 5.3 1.2 14.6 1.1 1.8 15.5 0.8 1.8 2.7 3.1 0.7 9.7 12.7 0.0 7.2 0.7 11.9 2.6 5.0 1.3 41.6 12.2 0.8 0.9 1.5 0.3 1.3 14.2 4.7 2.8 12.0 10.3 0.0 0.7 6.2 21.1 0.4 1.0 9.9 28.7 2.9 5.6 2.8 0.0 0.5 1.1 1.0 0.8 28.4 6.1 5.9 3.1 0.4 63.6 6.3 WNT3 "INT4, MGC131950, MGC138321, MGC138323" ENSG00000108379 "Wnt family member 3" P56703 17 46762506-46833154 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 12.4;skin 1: 24.9" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 44.5;Early spermatids: 27.7;Late spermatids: 63.8;Suprabasal keratinocytes: 17.6" "Cancer enriched" "Detected in many" 6 "testis cancer: 13.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 8.5;U-698: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049893 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA049893: " "unprognostic (1.84e-1)" "unprognostic (2.90e-2)" "unprognostic (2.35e-1)" "unprognostic (6.41e-4)" "unprognostic (4.73e-2)" "unprognostic (5.26e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (4.97e-2)" "unprognostic (2.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "unprognostic (1.10e-8)" "unprognostic (1.77e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" 0.6 0.4 1.3 0.4 1.1 0.1 1.0 0.8 1.0 0.8 0.5 0.6 3.5 0.5 0.0 1.3 0.5 0.1 0.8 0.9 1.2 1.7 12.4 0.9 0.2 1.4 1.9 0.9 0.5 0.8 2.6 1.7 0.2 1.3 1.3 0.2 0.2 1.2 0.0 0.2 24.9 2.7 0.2 0.8 0.7 0.4 4.4 3.0 0.1 1.4 0.0 0.1 0.4 1.1 1.5 3.9 1.7 8.5 0.0 0.1 0.1 0.7 0.8 0.9 3.0 0.0 2.7 1.7 1.6 2.3 2.1 6.1 1.3 0.4 0.0 3.9 0.0 0.4 0.0 3.0 2.3 0.0 0.1 0.1 0.2 1.8 1.1 2.3 3.5 1.1 2.5 1.5 0.0 1.0 1.7 0.0 1.4 0.0 1.0 2.4 2.9 1.9 0.2 0.6 0.0 0.1 0.7 1.6 0.0 1.2 2.1 0.0 4.0 0.2 3.2 2.1 0.4 1.5 0.6 0.2 14.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 1.1 0.8 1.0 0.9 1.2 1.4 1.9 0.9 1.3 0.8 3.0 1.5 0.2 0.0 1.5 3.9 0.5 44.5 0.6 0.6 3.4 1.1 3.0 1.7 1.3 1.5 0.4 0.0 0.0 2.2 0.1 0.7 1.9 0.7 27.7 0.1 0.7 0.5 0.0 0.0 5.4 2.5 0.1 1.1 0.0 0.2 0.0 0.7 0.4 4.0 0.2 8.4 4.3 0.6 0.0 0.0 1.5 63.8 0.3 0.1 1.8 1.0 0.6 0.2 0.0 4.0 1.1 2.9 1.4 0.4 0.0 1.2 3.7 0.5 0.3 0.8 0.0 1.4 1.1 0.9 2.9 0.8 17.6 0.3 0.0 0.3 0.9 0.3 ASPA "ACY2, ASP" ENSG00000108381 Aspartoacylase P45381 17 3472374-3503405 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.2;kidney: 38.5" "Cell type enhanced" "Detected in many" "Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8" "Cancer enhanced" "Detected in some" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022142, HPA022145" Enhanced Supported Cytosol NA NA Cytosol "HPA022142: AB_1845102, HPA022145: AB_1845103" "unprognostic (4.42e-2)" "unprognostic (4.79e-2)" "unprognostic (2.02e-2)" "unprognostic (2.79e-3)" "unprognostic (4.36e-2)" "unprognostic (5.01e-1)" "unprognostic (1.08e-3)" "unprognostic (3.57e-1)" "unprognostic (4.17e-1)" "unprognostic (3.43e-1)" "unprognostic (5.27e-2)" "unprognostic (6.27e-2)" "unprognostic (1.25e-1)" "unprognostic (7.07e-4)" "unprognostic (2.77e-1)" "unprognostic (4.68e-1)" "unprognostic (1.49e-1)" 14.0 4.4 30.8 1.8 48.1 1.8 4.1 31.8 40.9 6.4 19.3 4.1 11.3 4.5 6.0 4.9 5.6 3.7 2.0 29.8 32.3 38.5 15.1 3.5 1.5 36.7 40.4 24.4 3.0 1.0 0.8 0.8 3.5 39.6 4.1 5.0 2.8 1.8 5.1 12.0 5.2 15.7 3.1 31.1 5.5 4.4 6.7 37.9 0.6 2.1 15.1 0.7 6.3 4.4 75.2 0.2 0.1 0.5 0.5 5.4 4.1 0.3 0.2 0.1 0.2 0.1 3.8 0.2 0.6 0.2 0.7 0.3 0.3 0.3 0.1 0.2 2.0 0.1 0.4 0.7 0.2 0.5 0.4 0.4 7.5 0.3 0.4 0.1 0.1 0.1 0.4 0.3 1.1 0.2 0.2 0.2 0.6 0.4 0.2 0.3 0.3 0.3 0.6 0.2 1.1 0.4 0.3 1.1 0.3 0.9 0.4 0.3 0.2 0.4 0.6 0.4 0.4 0.3 0.7 0.4 0.4 0.2 0.4 0.5 1.1 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.7 0.3 0.1 0.2 0.1 0.0 30.8 48.1 31.8 40.9 29.8 32.3 36.7 40.4 24.4 39.6 31.1 37.9 75.2 5.1 9.6 1.5 12.1 0.1 5.2 1.5 1.6 6.2 5.5 2.1 0.8 1.3 2.8 1.0 25.8 0.0 0.0 0.0 0.3 7.9 0.2 5.0 0.1 4.1 1.1 2.4 2.7 0.6 0.2 0.1 15.0 2.0 0.2 0.0 0.1 3.9 11.5 0.2 8.4 0.4 0.8 2.0 0.8 1.5 2.5 49.7 0.8 46.2 3.7 0.0 4.1 0.0 1.5 217.0 0.0 2.5 48.2 0.2 0.4 37.5 74.8 0.1 0.5 0.0 8.5 11.6 11.1 0.6 0.7 1.7 0.1 0.4 28.3 1.8 2.7 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 117.7;Spermatocytes: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 319.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" NA NA "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: AB_2679250" "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favorable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 10.9 20.3 15.9 10.1 16.2 23.3 15.4 18.8 18.5 10.9 13.9 11.7 7.6 12.7 22.2 13.2 11.3 11.1 25.9 16.8 15.4 13.0 13.4 8.9 22.2 15.6 14.8 15.9 12.6 10.7 20.2 10.6 15.2 16.3 17.6 14.6 13.6 10.8 12.1 18.5 10.6 8.7 13.9 13.8 12.3 11.7 20.4 15.0 21.4 12.5 17.4 19.2 11.0 8.7 18.7 63.7 72.1 43.3 48.5 22.9 19.6 100.1 34.2 14.5 43.5 55.3 31.0 39.3 37.4 48.9 23.5 58.8 23.3 59.5 46.6 81.7 91.6 123.0 53.0 84.6 119.4 23.3 69.1 45.0 12.1 42.2 47.8 38.6 24.0 50.0 60.9 83.6 48.5 37.0 319.1 96.8 95.3 12.1 42.5 66.5 62.1 69.5 69.8 26.9 39.6 54.3 49.6 27.3 12.0 53.5 11.1 39.2 71.6 16.5 37.6 100.1 34.3 42.4 44.1 187.2 111.5 38.3 67.1 42.0 27.6 9.2 12.5 15.6 14.3 15.2 18.0 16.9 17.2 15.9 17.3 18.2 17.4 5.1 15.0 12.5 14.3 27.1 11.0 15.9 16.2 18.8 18.5 16.8 15.4 15.6 14.8 15.9 16.3 13.8 15.0 18.7 20.5 19.2 13.9 10.1 20.5 11.9 18.7 42.9 15.9 15.0 25.1 34.0 63.7 7.2 20.9 16.5 6.2 67.8 15.0 7.1 58.7 25.7 117.7 17.3 13.0 19.3 6.7 43.8 21.5 18.6 94.1 19.8 7.1 13.0 22.9 23.3 15.7 15.7 33.4 16.8 17.7 11.7 32.6 16.1 47.7 65.4 17.4 21.8 24.9 13.1 18.7 31.3 21.6 23.1 22.8 13.0 10.4 15.4 28.5 17.2 5.7 24.6 14.1 26.9 32.9 14.7 23.9 140.7 98.3 15.9 10.7 36.3 20.5 28.2 15.3 13.9 SEPTIN4 "ARTS, C17orf47, CE5B3, FLJ40121, H5, hCDCREL-2, hucep-7, MART, PNUTL2, SEPT4" ENSG00000108387 "Septin 4" "O43236, Q8NEP4" 17 58520250-58544368 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 1178.0;choroid plexus: 765.5;retina: 408.1" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 52.0;Smooth muscle cells: 38.9" "Cancer enhanced" "Detected in all" "glioma: 8.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 14.0;hTERT-RPE1: 19.4;SK-MEL-30: 32.8" "CAB006855, HPA021587, HPA022905, HPA028424" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687, HPA028424: AB_10601690" "unprognostic (1.12e-1)" "unprognostic (5.54e-2)" "unprognostic (8.36e-3)" "unprognostic (8.01e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-2)" "unprognostic (6.88e-3)" "unprognostic (2.73e-2)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (1.97e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (6.40e-3)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (8.75e-3)" 41.8 166.6 1014.1 5.0 1126.4 0.5 33.8 1009.3 1142.4 13.7 765.5 13.7 5.0 12.5 7.0 5.9 14.3 17.2 46.4 925.2 957.9 31.5 57.0 40.0 14.5 1022.8 1067.4 839.2 15.9 8.8 9.5 23.3 21.1 1146.9 8.7 5.3 408.1 9.3 6.5 10.9 10.4 12.2 11.8 958.9 49.9 11.6 25.9 1037.1 4.4 23.4 13.8 7.3 12.3 12.2 1178.0 0.0 0.6 1.2 3.6 1.4 0.2 0.6 0.2 0.5 2.1 2.4 0.2 0.5 0.0 5.1 0.8 3.2 0.4 1.8 1.4 0.5 0.3 0.9 1.3 0.3 7.6 14.0 0.1 0.7 7.2 2.9 0.5 2.6 19.4 0.6 1.9 0.0 3.8 0.2 0.5 0.0 0.1 0.6 0.0 0.9 0.2 0.0 1.6 0.0 0.1 3.9 2.1 0.1 0.2 32.8 1.6 0.8 0.4 0.0 0.3 1.6 0.0 1.4 1.0 0.6 0.0 1.1 0.0 0.4 0.0 3.6 0.8 4.9 0.5 1.5 1.6 1.0 1.3 3.7 0.3 1.8 1.4 1.9 1.0 0.0 0.2 0.7 3.6 1014.1 1126.4 1009.3 1142.4 925.2 957.9 1022.8 1067.4 839.2 1146.9 958.9 1037.1 1178.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.0 0.0 0.0 0.0 0.0 6.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 5.9 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 MTMR4 "KIAA0647, ZFYVE11" ENSG00000108389 "Myotubularin related protein 4" Q9NYA4 17 58489529-58517905 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.07e-1)" "unprognostic (6.52e-2)" "unprognostic (4.87e-3)" "unprognostic (1.68e-2)" "unprognostic (1.54e-1)" "unprognostic (6.42e-2)" "unprognostic (4.97e-2)" "unprognostic (3.45e-3)" "unprognostic (6.82e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (2.13e-1)" "unprognostic (1.59e-2)" "unprognostic (2.92e-2)" 10.0 12.1 17.5 13.4 16.4 19.2 13.9 21.4 24.9 10.5 8.9 14.1 21.6 12.0 18.5 11.6 11.9 8.1 10.4 21.6 22.0 17.2 42.0 9.7 17.7 44.5 23.5 18.5 15.2 13.2 16.1 13.4 12.3 53.0 12.5 17.4 21.2 11.0 10.2 8.3 14.7 21.8 11.0 12.6 15.9 12.3 18.9 28.3 17.3 16.4 10.4 22.8 11.7 10.4 41.2 21.5 23.0 34.3 33.4 20.8 20.8 26.6 12.7 21.6 32.8 30.2 22.5 13.8 44.6 17.6 13.2 25.8 12.3 37.2 21.9 34.9 46.3 25.8 30.4 18.4 30.1 23.0 32.1 26.6 21.8 17.4 22.5 35.7 21.5 24.0 29.7 26.6 31.4 16.6 32.2 63.6 21.3 8.3 40.7 23.1 40.3 25.6 22.0 15.4 44.7 54.4 52.3 12.5 14.7 17.0 17.6 28.6 22.0 13.0 50.9 32.3 14.7 15.6 25.9 30.8 32.7 81.8 24.0 15.7 2.6 3.0 5.8 2.2 3.8 2.0 4.3 2.7 2.5 3.6 4.4 2.9 3.0 3.6 2.0 4.9 2.1 2.8 2.3 17.5 16.4 21.4 24.9 21.6 22.0 44.5 23.5 18.5 53.0 12.6 28.3 41.2 10.4 9.6 7.4 30.3 29.3 7.6 12.3 9.3 21.6 0.0 16.1 14.1 11.4 17.2 9.8 3.7 0.0 12.8 9.5 38.2 0.0 9.7 5.1 8.9 15.1 10.7 17.3 23.1 35.0 6.4 21.4 10.0 12.8 10.2 6.3 21.8 12.1 65.7 13.8 0.0 43.9 20.1 2.0 14.2 26.4 6.4 14.3 10.5 12.4 17.8 29.4 0.0 21.6 24.6 39.7 9.1 21.4 17.3 14.6 17.4 48.6 12.0 4.0 0.0 0.0 10.8 13.9 5.3 4.8 13.8 8.2 49.8 15.0 17.5 18.4 9.3 TRIM37 "KIAA0898, MUL, POB1, TEF3" ENSG00000108395 "Tripartite motif containing 37" O94972 17 58982638-59106921 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Repressor, Transferase" "Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 62.9" "Cell type enhanced" "Detected in all" "Early spermatids: 129.2;Excitatory neurons: 96.7;Inhibitory neurons: 105.2;Late spermatids: 88.8;Spermatocytes: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 30.4" "Group enriched" "Detected in all" 5 "granulocytes: 30.4;T-cells: 8.3" "Cell line enriched" "Detected in all" 4 "MCF7: 242.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021911 Uncertain NA NA "HPA021911: AB_10964487" "unprognostic (4.07e-2)" "unprognostic (1.71e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.46e-1)" "unprognostic (4.27e-2)" "unprognostic (3.04e-2)" 8.9 12.4 14.6 9.5 20.4 6.8 8.2 26.5 32.0 8.0 7.1 7.9 6.8 8.8 10.8 8.4 9.8 9.0 11.6 19.0 19.3 7.7 8.3 8.9 9.1 21.2 17.2 18.5 6.2 7.7 8.7 10.4 9.5 26.2 9.5 7.1 33.2 5.9 9.3 11.2 7.5 6.2 10.9 10.8 8.7 6.6 62.9 20.6 12.2 13.4 12.8 8.4 9.1 6.5 28.2 21.4 33.3 21.9 27.5 20.5 19.0 35.3 24.0 36.9 25.3 41.4 19.6 14.4 21.1 36.1 25.3 43.3 19.0 31.5 17.7 40.5 41.8 30.4 32.6 28.9 27.1 36.1 16.8 15.8 15.4 16.1 32.5 40.8 25.8 33.0 19.1 25.4 29.7 24.9 242.4 34.0 9.5 31.5 28.9 22.0 15.0 57.1 13.7 24.0 29.7 51.7 29.9 24.8 10.2 23.2 26.4 30.4 7.8 25.9 39.5 47.6 36.5 27.6 30.5 48.5 18.5 26.8 17.5 18.7 30.4 3.7 4.5 7.2 2.7 6.7 3.6 4.7 4.6 4.0 3.9 4.0 5.4 5.3 3.4 2.8 3.0 8.3 3.1 14.6 20.4 26.5 32.0 19.0 19.3 21.2 17.2 18.5 26.2 10.8 20.6 28.2 10.3 9.6 11.0 44.4 13.2 7.9 6.0 6.5 15.4 19.7 13.2 12.2 24.1 7.2 15.6 9.2 33.3 15.1 7.8 12.0 3.9 10.3 129.2 30.8 13.8 13.7 12.0 12.8 96.7 5.6 10.6 14.0 11.7 13.5 10.8 18.0 12.1 18.9 8.7 45.4 105.2 7.2 16.2 9.1 6.9 88.8 9.9 9.3 12.4 18.7 7.2 19.9 5.2 36.2 43.5 10.2 11.3 17.7 15.1 9.9 3.3 9.7 29.1 38.8 13.1 10.9 17.3 133.1 45.0 14.0 6.3 17.8 14.7 19.7 9.1 6.8 P2RX1 P2X1 ENSG00000108405 "Purinergic receptor P2X 1" P51575 17 3896592-3916476 "Predicted membrane proteins" "Apoptosis, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.4;pancreas: 65.7;urinary bladder: 76.1" "Cell type enriched" "Detected in some" 5 "granulocytes: 185.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 46.3" "Group enriched" "Detected in many" 30 "dendritic cells: 15.1;granulocytes: 23.5;monocytes: 46.3" "Cell line enhanced" "Detected in some" "HEL: 13.8;HMC-1: 8.4;Karpas-707: 16.8;THP-1: 14.7;U-937: 7.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "midbrain: 1.3" HPA057678 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA057678: " "unprognostic (1.27e-3)" "unprognostic (1.61e-2)" "unprognostic (2.65e-1)" "unprognostic (3.54e-2)" "unprognostic (7.34e-3)" "unprognostic (9.89e-5)" "unprognostic (1.77e-2)" "unprognostic (6.15e-3)" "unprognostic (2.98e-1)" "unprognostic (2.52e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-2)" "unprognostic (4.47e-3)" "unprognostic (2.60e-1)" "unprognostic (5.58e-2)" "unprognostic (4.29e-1)" "unprognostic (1.09e-2)" 6.4 2.0 0.7 4.4 0.8 42.4 1.5 1.1 0.8 7.7 0.8 9.6 9.3 7.4 1.8 23.2 3.9 2.0 1.6 0.7 0.8 0.9 0.7 4.8 3.0 0.9 1.0 0.6 2.1 65.7 0.1 0.3 3.9 1.0 10.8 9.3 0.1 1.6 34.4 0.5 4.2 9.1 6.1 0.8 13.1 2.8 2.6 0.8 2.0 0.4 0.3 3.2 76.1 8.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.2 0.1 1.1 1.8 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.1 3.3 0.0 0.4 0.0 2.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 7.4 0.0 0.0 10.8 11.9 0.0 20.4 0.0 0.4 0.0 0.0 5.9 0.9 0.0 0.0 23.5 0.0 46.3 15.1 0.0 8.2 0.7 0.8 1.1 0.8 0.7 0.8 0.9 1.0 0.6 1.0 0.8 0.8 1.2 0.1 3.2 4.2 0.7 15.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.1 8.9 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 18.5 0.3 2.0 0.1 0.9 0.5 0.0 185.4 0.0 0.0 0.0 3.6 0.0 0.2 0.1 0.0 5.1 2.4 0.2 0.0 22.5 0.0 1.0 7.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 36.0 0.0 0.0 0.1 0.7 0.0 0.0 0.4 3.4 0.0 0.1 0.1 0.9 0.0 1.8 0.5 0.3 0.0 DHX40 "ARG147, DDX40, FLJ22060, PAD" ENSG00000108406 "DEAH-box helicase 40" Q8IX18 17 59565558-59608345 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 103.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044350 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044350: AB_10960560" "unprognostic (1.58e-2)" "unprognostic (3.10e-1)" "prognostic favorable (4.05e-5)" "unprognostic (4.09e-2)" "unprognostic (5.23e-2)" "unprognostic (2.84e-1)" "unprognostic (4.57e-3)" "unprognostic (7.53e-3)" "unprognostic (2.86e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (3.08e-1)" "unprognostic (9.48e-3)" "unprognostic (2.22e-1)" "unprognostic (1.25e-2)" "unprognostic (1.11e-1)" "unprognostic (3.10e-1)" 18.1 22.2 16.1 13.0 16.2 26.7 27.2 17.5 16.8 22.3 23.9 15.5 14.7 25.9 21.3 17.5 27.6 17.3 18.4 14.7 21.0 33.2 15.0 18.9 16.4 16.0 17.0 14.1 32.5 21.3 58.2 21.8 19.9 16.5 21.5 17.2 21.7 17.1 21.8 17.5 21.3 14.0 21.0 16.6 15.6 16.9 30.0 16.0 25.3 30.9 22.5 18.5 19.4 13.6 21.5 28.7 51.7 64.0 42.5 39.4 39.5 36.0 25.3 48.2 37.9 42.8 20.5 28.0 37.7 69.3 37.2 40.0 20.9 46.5 36.2 58.6 29.9 68.8 34.3 35.1 23.4 30.7 42.3 15.3 31.2 33.1 32.3 31.4 62.3 42.0 36.2 29.3 33.9 26.5 53.5 51.8 26.4 24.8 36.0 37.8 48.8 45.1 42.3 39.0 22.9 45.5 113.5 45.7 18.4 48.6 31.3 58.4 24.8 34.5 45.8 56.3 16.6 25.2 41.2 47.5 23.9 53.5 28.9 32.0 9.2 6.8 11.6 7.9 6.6 10.3 4.7 5.6 5.6 7.1 4.9 5.5 6.6 19.4 4.5 4.9 3.7 6.2 7.5 16.1 16.2 17.5 16.8 14.7 21.0 16.0 17.0 14.1 16.5 16.6 16.0 21.5 27.3 9.6 20.9 10.1 19.7 19.4 10.4 16.7 26.2 12.6 31.9 26.7 24.3 28.6 25.3 47.8 18.8 8.8 35.5 14.2 11.7 18.4 43.0 68.8 37.8 22.4 18.5 29.8 10.9 16.9 9.3 21.1 20.9 41.8 3.8 41.8 27.5 25.0 9.2 50.5 14.3 19.0 8.2 21.6 14.7 16.7 25.1 18.8 19.6 3.7 14.8 21.7 14.4 7.1 14.6 13.2 11.9 26.7 18.0 13.4 12.6 46.2 57.7 14.6 32.9 17.4 22.8 103.9 51.4 15.3 22.0 12.6 19.1 36.5 17.8 10.9 KRT37 KRTHA7 ENSG00000108417 "Keratin 37" O76014 17 41420547-41424585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "skin 1: 3.4" "Cell type enhanced" "Detected in single" "Basal prostatic cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.15e-1)" "unprognostic (4.54e-1)" "unprognostic (8.63e-2)" "unprognostic (5.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859479-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 83.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 4.4 4.5 6.2 5.0 7.4 3.9 7.1 9.6 7.4 7.3 5.5 6.4 3.8 5.6 9.2 10.7 6.5 4.7 5.6 6.2 6.9 5.0 6.0 5.1 6.7 7.1 7.0 6.2 9.1 7.8 6.0 6.9 4.2 7.0 7.9 4.7 5.7 7.0 6.3 6.6 6.9 4.8 4.4 6.9 5.8 6.4 5.6 6.8 8.3 7.4 7.8 8.3 6.4 8.4 9.4 11.7 15.8 12.2 12.8 6.8 4.9 9.7 9.1 5.3 11.7 9.5 17.0 7.5 10.5 15.0 2.1 7.9 9.7 17.4 5.4 11.1 6.1 21.2 12.6 12.4 20.4 3.6 7.6 6.4 2.7 8.3 10.1 3.5 4.0 9.4 10.3 27.5 7.1 4.0 83.1 15.6 8.5 10.8 13.0 6.9 16.1 17.9 16.2 5.0 4.8 11.3 6.8 6.4 4.9 6.5 14.5 11.8 7.2 3.0 8.4 18.3 5.9 9.8 8.3 13.7 16.2 4.0 8.3 7.5 6.5 8.4 16.3 11.4 5.8 13.2 11.7 14.0 12.1 5.9 8.9 18.1 14.8 8.8 10.1 6.5 9.9 16.7 7.1 6.2 7.4 9.6 7.4 6.2 6.9 7.1 7.0 6.2 7.0 6.9 6.8 9.4 8.3 12.8 36.1 10.7 16.9 15.7 14.4 9.1 10.8 7.6 10.9 11.3 5.3 5.7 17.6 3.7 6.2 6.3 9.4 3.2 11.7 5.7 1.7 9.2 8.5 9.4 10.3 13.9 9.2 4.8 7.4 9.6 4.1 16.3 11.4 9.9 8.9 3.8 4.0 3.3 9.5 5.5 8.2 4.7 7.1 0.8 5.6 6.9 7.2 9.4 6.0 10.3 13.4 8.5 18.4 3.7 7.5 8.2 10.9 12.5 3.6 3.6 9.4 8.6 6.6 13.3 9.6 14.7 24.2 10.6 16.9 4.0 16.2 2.6 4.9 6.8 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" Yes No 1600000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079" "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavorable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 58.1 45.3 33.0 75.0 33.6 36.2 54.0 35.8 32.7 50.3 31.1 55.8 36.2 48.0 29.8 66.6 50.1 47.6 54.1 30.7 45.0 49.3 51.1 43.0 82.4 39.0 40.1 27.8 64.9 38.5 56.7 28.4 55.8 37.7 44.8 64.2 49.4 39.5 46.1 91.8 37.9 39.2 67.1 38.8 54.4 43.7 101.7 34.3 118.4 58.0 89.1 109.6 80.3 40.8 50.1 273.2 485.0 324.6 259.1 152.8 265.8 271.6 345.4 307.0 441.6 339.3 853.2 161.5 385.8 210.4 343.8 301.8 186.3 607.2 316.3 691.1 212.1 344.7 421.2 408.7 241.6 148.4 485.5 238.9 209.6 140.5 511.7 509.2 202.3 305.8 203.0 461.3 237.5 349.4 288.8 464.9 97.2 270.6 199.4 300.2 250.1 563.3 216.4 156.2 444.2 267.5 240.5 233.3 121.7 176.6 388.4 253.9 157.6 248.7 463.9 264.7 252.8 412.9 258.8 373.0 542.6 216.1 224.2 325.8 3.1 2.9 6.1 4.1 3.6 5.8 4.0 4.7 5.1 1.8 4.0 4.5 4.3 12.2 3.5 4.4 3.0 3.4 2.4 33.0 33.6 35.8 32.7 30.7 45.0 39.0 40.1 27.8 37.7 38.8 34.3 50.1 76.8 128.2 71.9 42.7 138.3 125.7 101.1 67.8 165.0 96.5 110.8 89.5 132.7 88.6 75.2 44.1 68.8 132.7 93.9 69.5 41.1 117.1 55.8 71.2 123.1 110.5 123.8 148.7 51.4 119.5 147.5 102.9 72.4 106.3 76.1 147.2 128.8 97.5 124.1 80.8 48.2 82.2 44.7 115.0 91.6 41.7 96.9 102.7 60.5 30.9 152.8 83.4 80.3 39.2 58.2 147.0 69.8 121.5 163.4 149.7 49.2 48.0 60.6 90.2 98.6 107.0 104.6 291.6 186.0 163.9 143.5 158.2 108.1 138.8 128.4 128.1 GOSR2 "Bos1, GS27" ENSG00000108433 "Golgi SNAP receptor complex member 2" O14653 17 46923075-46975524 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 303.0;Late spermatids: 796.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017456, HPA048956, HPA054472" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499" "unprognostic (3.28e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.30e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (2.41e-1)" "unprognostic (2.46e-3)" "unprognostic (4.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.84e-3)" "unprognostic (4.29e-2)" 22.5 25.8 28.0 21.9 28.1 16.5 25.0 30.9 37.9 25.0 30.7 23.0 50.3 24.0 31.9 21.6 21.5 18.4 32.8 28.9 28.7 42.6 34.1 23.8 26.6 28.0 28.9 27.6 26.3 31.6 35.8 37.4 29.0 30.1 23.3 27.6 25.2 32.8 30.8 43.4 22.1 43.5 30.1 27.1 30.3 23.3 48.7 29.5 27.4 26.8 34.6 32.1 25.5 18.8 30.4 44.6 47.2 33.5 40.3 54.9 39.3 37.8 59.7 58.5 63.5 56.7 60.1 25.7 37.7 33.1 75.4 66.5 30.1 43.4 48.5 77.8 83.0 33.3 56.8 37.4 60.1 60.3 44.9 44.1 40.8 47.1 52.2 73.2 49.0 52.6 43.7 56.5 50.9 46.2 46.8 50.0 24.2 31.1 60.1 65.8 43.5 64.0 44.5 40.7 37.7 28.8 61.5 33.3 19.2 47.9 57.1 55.1 31.3 62.1 60.0 38.8 47.4 58.9 64.6 39.4 60.1 56.1 28.6 67.1 39.5 33.1 29.2 33.9 63.2 31.3 29.8 29.7 27.8 32.7 38.6 29.1 25.4 3.6 31.2 86.0 29.7 38.8 35.2 28.0 28.1 30.9 37.9 28.9 28.7 28.0 28.9 27.6 30.1 27.1 29.5 30.4 23.7 25.6 18.7 17.9 22.0 16.6 17.3 16.7 4.6 18.5 21.1 18.0 16.2 15.7 14.5 33.1 6.2 30.2 23.8 15.9 23.5 34.5 303.0 9.1 18.0 25.2 7.2 20.6 24.2 42.7 33.1 18.4 15.3 11.0 14.5 22.7 21.8 22.4 45.1 23.5 26.3 16.8 16.2 22.0 14.7 796.1 16.8 15.0 10.6 21.5 22.0 16.4 14.4 17.1 28.4 58.1 24.2 14.3 23.5 22.1 96.5 90.0 13.7 20.4 0.0 9.3 26.8 33.1 26.7 7.4 16.9 52.7 14.9 18.4 12.6 20.5 PNPO PDXPO ENSG00000108439 "Pyridoxamine 5'-phosphate oxidase" Q9NVS9 17 47941506-47949308 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Pyridoxine biosynthesis" Oxidoreductase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023204, HPA027776" Enhanced Approved Nucleoplasm,Cytosol NA NA 450000 "Nucleoplasm, Cytosol" "HPA023204: AB_1855506, HPA027776: AB_10601246" "unprognostic (1.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.62e-1)" "unprognostic (1.97e-2)" "unprognostic (6.65e-2)" "unprognostic (8.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.47e-3)" "unprognostic (8.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.74e-1)" 6.9 15.9 17.1 6.3 16.7 3.5 10.7 17.7 22.7 7.0 13.0 8.9 10.2 5.0 11.7 10.7 10.2 6.6 13.3 16.3 22.5 35.4 89.5 6.5 7.0 19.5 22.0 14.9 5.9 11.0 26.8 9.3 7.0 20.2 8.1 8.7 5.4 10.5 7.9 21.3 6.7 9.7 6.2 16.5 7.2 8.7 6.7 19.5 5.9 18.0 19.7 7.8 6.7 7.4 21.0 37.9 30.9 2.4 5.8 15.3 11.7 0.0 12.2 7.7 14.0 11.9 51.1 27.6 35.2 57.4 12.7 5.5 22.0 19.4 34.7 20.3 43.4 16.4 24.6 13.9 53.6 16.3 22.6 16.6 15.4 26.9 25.8 32.7 13.1 18.0 26.1 24.4 12.2 16.5 28.3 25.3 7.8 4.5 37.4 37.1 18.8 10.4 26.2 40.2 19.5 12.1 9.5 11.2 18.6 10.7 8.5 32.4 9.1 19.1 22.6 12.8 22.2 26.2 27.8 34.0 19.0 18.4 19.2 11.7 2.5 12.3 2.8 7.2 17.7 8.2 6.7 6.3 7.6 13.5 5.3 8.2 8.1 1.1 7.9 11.9 9.8 7.0 10.3 17.1 16.7 17.7 22.7 16.3 22.5 19.5 22.0 14.9 20.2 16.5 19.5 21.0 7.6 12.8 13.9 7.5 3.9 1.5 6.7 5.0 5.7 1.1 16.2 14.4 1.9 18.6 6.8 12.9 4.2 8.4 7.8 7.3 62.6 18.2 0.8 11.2 6.4 5.9 3.6 7.4 4.2 15.6 1.9 5.3 4.6 13.3 12.7 8.8 6.4 53.4 17.2 3.3 6.2 11.6 2.0 11.4 2.4 0.9 9.9 10.6 1.8 2.8 8.6 7.1 3.1 2.5 3.2 15.0 8.9 6.0 4.9 9.0 20.2 86.3 5.9 1.9 0.0 4.1 3.8 0.7 1.3 7.2 2.3 6.3 4.7 19.5 15.4 5.0 RPS6KB1 "p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A" ENSG00000108443 "Ribosomal protein S6 kinase B1" P23443 17 59893046-59950574 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "MCF7: 243.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003838, CAB018346, HPA039442" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510" "unprognostic (2.25e-1)" "unprognostic (4.52e-2)" "unprognostic (1.91e-3)" "unprognostic (1.35e-2)" "unprognostic (9.81e-2)" "unprognostic (1.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.70e-1)" "unprognostic (5.86e-2)" "unprognostic (1.66e-1)" "unprognostic (3.67e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.09e-7)" "unprognostic (3.45e-1)" "unprognostic (2.09e-1)" "unprognostic (3.98e-2)" "unprognostic (1.52e-3)" 14.1 11.4 8.1 12.0 8.8 18.1 13.5 12.3 10.0 11.9 9.8 10.2 10.1 14.0 10.2 16.4 10.3 9.4 10.7 8.5 7.8 9.9 15.4 10.0 14.3 8.6 8.1 8.6 15.0 17.0 15.0 7.5 15.5 9.3 10.7 11.1 11.0 9.5 10.3 22.9 10.7 9.4 14.4 7.4 12.5 11.2 7.0 8.3 15.3 12.0 18.4 17.4 15.0 11.1 10.6 34.5 33.5 27.5 26.2 18.1 26.2 20.8 31.2 28.3 26.3 29.3 27.6 16.8 41.7 37.9 25.4 32.1 17.3 36.0 27.3 42.7 23.3 41.5 28.7 21.2 31.2 26.9 44.5 27.1 26.7 20.7 31.0 22.8 21.9 35.0 26.0 38.5 25.9 19.7 243.6 53.2 18.4 18.6 29.8 24.9 30.8 46.7 38.8 21.9 25.1 20.1 23.8 26.2 15.2 16.6 31.7 29.7 24.2 31.1 25.8 42.9 21.2 42.0 46.2 42.0 46.3 19.4 26.7 21.2 43.8 12.1 11.4 12.7 12.2 15.5 10.4 11.6 14.7 15.3 9.4 13.5 14.3 11.5 11.9 14.4 9.5 11.9 10.3 8.1 8.8 12.3 10.0 8.5 7.8 8.6 8.1 8.6 9.3 7.4 8.3 10.6 22.8 22.4 34.2 29.0 32.6 33.0 21.4 13.0 30.7 18.0 23.1 17.8 16.8 12.8 30.4 3.7 18.8 24.3 33.5 12.4 3.9 12.9 5.1 24.0 31.7 25.5 13.2 11.8 47.3 16.4 18.2 24.8 26.0 37.7 23.4 20.0 13.6 15.1 12.1 18.5 45.2 14.1 4.1 15.2 20.4 3.8 15.8 19.0 10.6 28.1 20.0 12.8 18.6 25.6 54.8 15.1 10.9 18.0 34.6 27.9 9.3 9.2 21.1 18.9 26.3 33.4 32.6 13.0 13.7 34.5 32.0 30.5 29.9 26.0 13.9 25.4 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981781 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavorable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favorable (7.31e-5)" 41.5 48.6 87.3 42.4 89.3 52.8 49.1 87.1 112.2 55.3 102.1 47.5 55.0 42.7 92.7 53.2 54.7 46.5 38.2 88.9 88.8 59.9 81.3 45.0 52.2 89.7 88.2 87.8 70.1 134.7 54.0 93.7 34.6 88.9 63.1 54.3 34.4 77.7 48.9 29.9 41.9 69.0 34.1 86.7 82.0 82.5 84.1 89.7 44.7 73.9 28.3 55.2 48.6 48.8 89.6 72.7 116.5 60.8 114.6 52.6 53.3 112.7 51.4 63.9 52.3 51.0 92.5 72.3 88.7 107.8 55.5 35.2 72.8 41.6 61.4 59.3 127.0 58.1 43.4 157.9 123.8 58.7 50.0 47.5 60.7 51.5 45.9 91.8 64.2 52.8 169.1 49.6 80.8 52.9 140.3 128.3 79.2 38.5 87.4 55.0 74.6 101.4 101.7 52.8 91.3 43.0 104.1 38.3 37.1 51.7 65.3 84.5 65.4 38.9 43.6 38.2 53.1 66.8 106.8 102.9 54.2 54.3 69.1 53.5 20.8 62.6 54.8 33.8 63.8 36.8 40.9 31.4 30.6 50.1 44.7 28.0 31.4 30.5 45.3 67.4 46.0 32.9 41.3 87.3 89.3 87.1 112.2 88.9 88.8 89.7 88.2 87.8 88.9 86.7 89.7 89.6 31.3 25.6 62.6 60.7 61.8 33.6 63.3 89.3 50.7 52.0 52.8 40.4 28.4 44.3 84.1 40.5 31.3 68.8 44.9 56.5 50.9 56.8 53.0 35.7 32.9 32.1 61.6 22.9 31.1 67.7 57.4 44.7 147.8 42.5 69.6 68.3 27.5 55.6 61.7 57.2 27.9 70.8 71.2 33.6 40.7 36.3 40.7 44.1 46.2 25.3 47.6 45.1 33.0 25.6 50.6 37.1 60.9 29.7 87.2 49.0 77.2 45.1 85.2 52.6 32.9 34.3 33.2 132.8 45.7 31.0 25.9 61.6 53.0 38.6 56.8 56.6 CBX1 "CBX, HP1-BETA, HP1Hs-beta, M31, MOD1" ENSG00000108468 "Chromobox 1" P83916 17 48070052-48101478 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 350.8;Spermatogonia: 304.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012265 Supported Supported "Nucleoplasm,Nuclear bodies" NA NA 120000 "Nucleoplasm, Nuclear bodies" "CAB012265: AB_297216" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (2.02e-1)" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (2.70e-4)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" "unprognostic (6.55e-2)" "unprognostic (2.78e-1)" "unprognostic (2.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.48e-3)" "unprognostic (3.82e-1)" "unprognostic (3.65e-1)" "unprognostic (6.73e-2)" 31.2 31.7 62.8 35.8 63.1 16.7 37.6 64.1 73.8 53.7 56.4 36.4 19.2 67.2 48.3 37.1 40.6 28.1 32.4 62.7 64.4 38.3 21.8 27.2 35.3 64.7 62.9 60.8 78.1 22.5 44.1 35.1 35.0 65.9 38.4 33.4 60.0 29.9 47.5 69.1 29.0 24.2 56.1 66.2 34.0 26.9 69.7 62.5 74.3 39.9 46.4 47.3 36.7 38.2 69.7 217.3 121.1 392.4 185.6 78.0 69.3 217.7 197.0 95.1 188.0 200.6 319.2 84.5 148.4 204.5 155.6 144.8 85.3 146.3 124.6 329.2 273.8 118.1 119.8 121.1 119.3 47.5 115.5 71.9 49.8 68.4 140.3 178.3 144.7 157.1 176.6 152.0 67.2 153.8 135.7 325.9 79.8 150.6 118.8 156.9 241.8 322.7 95.8 110.3 121.7 138.5 345.6 135.0 44.6 75.5 281.8 211.0 82.5 110.7 260.2 238.9 112.0 201.1 94.0 227.9 140.4 71.4 50.4 119.0 5.1 12.2 16.0 12.4 12.7 10.0 16.1 11.2 10.4 9.9 15.7 11.5 9.7 33.6 9.5 9.3 10.6 12.4 5.9 62.8 63.1 64.1 73.8 62.7 64.4 64.7 62.9 60.8 65.9 66.2 62.5 69.7 32.9 67.3 27.6 7.8 31.4 43.6 30.5 46.1 36.5 46.9 48.0 54.7 70.9 18.6 33.6 42.3 20.9 66.4 27.5 19.2 35.2 68.7 26.8 40.8 78.9 40.2 40.3 34.3 13.0 29.7 86.6 61.5 10.2 39.6 39.9 65.3 30.0 15.6 69.6 50.5 15.5 27.3 42.7 33.5 24.5 59.5 80.2 26.7 40.9 7.5 47.7 106.6 42.2 12.5 13.7 34.7 12.9 91.7 20.0 51.1 9.6 30.9 32.2 36.3 39.5 33.3 71.8 350.8 304.0 26.7 36.2 27.8 25.6 35.8 28.6 20.1 RECQL5 "FLJ90603, RecQ5" ENSG00000108469 "RecQ like helicase 5" O94762 17 75626845-75667189 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029971 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029971: AB_10611389" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "prognostic unfavorable (1.73e-6)" "unprognostic (8.39e-2)" "unprognostic (2.34e-2)" "unprognostic (3.57e-3)" "unprognostic (5.83e-2)" "unprognostic (3.15e-1)" "unprognostic (5.84e-2)" "prognostic favorable (4.34e-4)" "unprognostic (4.07e-2)" "unprognostic (7.01e-2)" "unprognostic (6.37e-2)" "unprognostic (1.42e-1)" "unprognostic (4.78e-1)" "unprognostic (1.81e-2)" 7.9 12.1 7.9 12.9 9.6 11.0 9.6 7.7 11.6 11.0 7.2 10.9 22.6 10.5 10.1 20.7 11.5 12.3 7.0 7.7 6.9 14.7 16.6 8.2 18.3 9.3 8.5 7.7 13.1 11.0 16.4 20.9 10.3 9.2 12.4 9.7 9.0 15.0 8.8 7.6 21.8 23.1 7.2 7.1 16.2 23.6 19.2 8.7 12.8 20.8 6.5 14.5 10.3 13.5 14.8 19.1 34.6 14.0 19.3 19.1 13.7 31.5 14.1 12.0 18.2 16.1 15.1 19.7 22.8 14.8 12.5 23.7 17.8 14.4 17.2 16.6 12.2 26.7 40.4 46.7 22.0 20.0 13.7 19.5 19.7 20.7 17.9 23.9 21.0 23.4 25.9 21.7 19.4 13.3 16.8 27.5 18.1 8.8 18.6 26.4 21.8 32.3 22.7 15.3 22.0 16.3 16.1 14.9 26.2 19.6 19.3 47.2 10.5 12.1 22.0 25.2 12.5 14.8 27.6 16.8 22.6 18.4 13.0 16.3 6.0 3.3 4.5 3.9 4.1 2.4 3.3 2.5 2.9 3.9 4.3 3.7 2.7 1.9 4.0 2.0 15.7 2.2 3.6 7.9 9.6 7.7 11.6 7.7 6.9 9.3 8.5 7.7 9.2 7.1 8.7 14.8 4.9 0.0 11.3 9.1 8.3 1.0 3.3 4.4 3.4 8.3 4.9 5.8 7.3 7.2 6.1 27.6 18.8 8.6 16.2 12.5 5.9 6.1 4.6 13.1 8.1 5.6 4.8 13.0 6.9 3.3 5.2 4.5 42.8 23.9 1.3 11.9 5.7 7.2 5.1 10.1 5.8 9.6 10.2 6.0 0.8 2.2 4.1 9.0 3.6 4.7 3.6 5.1 5.2 8.0 13.3 6.7 9.7 2.6 9.2 3.2 15.0 4.9 14.2 12.9 0.0 4.5 3.8 13.2 11.6 5.4 2.0 11.6 4.0 10.2 6.7 10.0 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease variant, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.7;Inhibitory neurons: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.57e-4)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 8.8 8.7 7.8 6.3 8.4 5.6 10.1 9.6 10.2 8.6 8.2 8.2 10.7 8.4 11.9 8.2 8.9 6.1 5.4 7.7 8.3 9.0 14.4 7.7 7.9 8.3 8.0 7.8 10.5 10.3 6.2 10.5 6.3 8.2 9.9 8.5 6.4 8.2 6.2 5.3 11.5 10.1 6.0 7.4 7.8 10.6 8.8 8.2 6.5 10.2 3.3 8.4 7.9 8.1 9.3 12.5 16.3 11.4 9.3 16.0 15.2 4.6 6.3 8.0 10.8 19.5 17.2 15.4 6.6 13.7 6.7 6.9 17.4 14.7 8.2 15.0 13.1 38.3 12.3 13.6 21.9 17.3 5.0 7.4 12.5 20.3 19.1 22.0 10.9 13.0 20.1 14.6 7.3 8.6 11.1 9.3 11.6 4.5 25.2 8.3 9.0 9.7 15.6 12.3 6.6 6.0 8.5 6.7 4.9 14.6 29.9 5.4 4.5 7.6 9.1 6.0 6.6 19.8 5.5 0.2 10.3 12.2 12.5 6.2 0.0 2.7 4.7 4.6 2.6 4.1 3.7 6.3 3.7 2.0 2.8 6.4 5.5 0.0 4.8 1.8 5.3 5.4 2.5 7.8 8.4 9.6 10.2 7.7 8.3 8.3 8.0 7.8 8.2 7.4 8.2 9.3 8.5 9.6 21.0 19.2 10.0 4.5 9.2 9.1 11.4 11.5 9.8 9.8 2.4 7.2 13.0 12.9 10.4 15.6 9.3 7.3 5.9 6.3 3.0 7.7 11.4 6.6 7.8 11.6 46.7 7.5 8.0 8.8 11.7 6.9 5.1 14.0 5.0 10.5 5.2 6.7 45.3 11.2 10.2 3.5 4.3 2.9 7.8 5.9 3.6 26.2 3.6 5.2 9.2 24.6 34.9 9.4 9.7 11.3 12.2 8.3 9.8 5.9 10.6 12.2 0.0 9.1 7.3 16.1 8.3 7.5 6.0 9.6 11.8 9.4 12.6 10.4 GALK1 GALK ENSG00000108479 "Galactokinase 1" P51570 17 75751594-75765236 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Kinase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 127.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0" "Cancer enhanced" "Detected in all" "liver cancer: 42.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007094, HPA016960" Approved Approved "Golgi apparatus,Cytosol" NA NA 57000 Cytosol "Golgi apparatus" "HPA007094: AB_1078939, HPA016960: AB_1849430" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (1.81e-2)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.04e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (3.04e-1)" "unprognostic (1.71e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.62e-5)" 17.8 12.6 4.5 7.9 5.1 5.7 17.3 5.1 8.5 17.6 4.7 12.2 20.8 16.7 1.0 24.6 15.1 4.3 17.4 4.4 5.5 31.8 127.4 18.9 7.5 6.4 4.8 4.0 13.8 31.5 10.7 5.7 5.9 5.7 13.4 2.0 0.7 20.2 5.7 8.7 20.5 18.4 3.9 5.7 24.7 17.7 16.1 5.5 6.2 11.7 3.6 3.4 13.1 17.9 6.8 20.4 65.2 4.9 20.7 6.8 16.6 16.7 16.9 14.3 16.8 15.8 35.4 4.2 31.2 19.5 9.3 12.6 11.9 5.0 4.4 1.9 14.2 39.3 20.1 25.1 62.4 22.1 13.0 41.9 15.3 6.9 8.5 3.5 8.5 39.1 16.9 15.9 21.2 11.7 77.3 38.6 44.7 4.7 9.8 32.3 43.6 50.1 50.9 9.8 7.3 9.9 26.1 14.6 35.8 35.0 3.8 29.8 20.9 33.4 24.3 22.3 21.7 14.6 44.4 12.4 8.2 26.7 30.3 18.3 7.2 77.2 23.0 23.0 67.8 20.8 27.7 18.5 21.2 70.1 18.9 10.0 14.5 53.1 16.2 55.6 93.3 23.6 40.8 4.5 5.1 5.1 8.5 4.4 5.5 6.4 4.8 4.0 5.7 5.7 5.5 6.8 42.1 16.0 12.9 3.3 17.7 8.7 10.0 4.4 7.4 7.3 22.4 20.6 22.6 22.8 10.6 12.9 0.0 48.4 16.3 8.4 68.4 28.5 1.3 4.9 24.5 23.5 8.4 9.0 1.5 55.2 100.1 25.3 10.2 8.6 27.9 16.6 29.3 116.7 56.1 3.3 1.7 20.9 22.4 49.0 25.2 5.6 31.1 33.3 39.2 0.0 42.3 19.2 20.6 2.5 1.6 19.3 49.6 24.0 29.1 5.7 139.4 122.0 4.0 6.1 6.6 19.2 20.8 1.7 22.1 16.6 12.5 42.3 14.9 6.1 28.2 9.2 INTS2 "INT2, KIAA1287" ENSG00000108506 "Integrator complex subunit 2" Q9H0H0 17 61865367-61928016 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049524 Uncertain NA NA "HPA049524: AB_2680804" "unprognostic (4.57e-3)" "unprognostic (2.11e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.72e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.52e-1)" "unprognostic (7.79e-2)" "unprognostic (5.91e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (7.03e-2)" "unprognostic (1.81e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.42e-1)" 3.1 3.0 0.7 3.6 1.1 2.5 3.0 2.3 1.4 3.0 0.2 2.8 2.8 3.3 1.0 3.6 2.9 1.5 3.1 0.4 0.6 2.1 2.7 2.6 5.4 1.2 0.4 0.1 3.1 2.3 4.0 3.1 2.5 1.1 2.4 3.3 4.3 2.9 0.8 3.1 3.6 3.2 2.0 0.1 3.5 2.8 4.7 0.4 4.9 2.7 1.8 5.4 2.8 3.3 1.9 8.9 15.4 14.8 8.2 4.5 5.2 6.8 6.2 3.6 9.1 6.9 9.1 4.9 17.7 5.0 3.2 11.4 12.7 14.3 4.1 15.2 8.2 10.5 20.7 6.1 15.8 2.8 26.0 14.3 4.0 6.0 6.9 14.2 5.0 6.6 11.5 19.0 10.6 6.4 17.2 31.0 10.5 5.5 12.7 10.4 23.3 39.6 13.9 3.5 7.9 11.3 12.6 7.7 4.2 5.9 10.3 18.1 8.7 6.6 19.8 12.9 6.8 8.9 8.4 16.2 24.3 6.0 9.6 6.2 2.1 0.3 0.2 0.9 0.6 1.4 1.5 1.0 1.3 0.8 0.4 1.1 1.4 0.4 0.4 0.9 0.7 1.2 0.4 0.7 1.1 2.3 1.4 0.4 0.6 1.2 0.4 0.1 1.1 0.1 0.4 1.9 7.3 6.4 3.1 17.3 8.3 4.6 3.3 4.7 6.8 12.9 5.9 4.6 9.1 8.6 6.1 1.8 14.6 5.5 6.7 3.3 0.0 3.3 4.5 8.4 8.4 5.8 2.4 9.4 19.8 2.6 3.9 5.9 5.1 9.3 5.1 11.1 6.1 6.4 5.3 15.2 26.4 5.7 6.1 7.9 2.2 9.6 4.4 6.0 0.0 9.4 7.4 6.0 3.1 24.1 37.3 4.7 1.7 3.4 5.4 4.9 3.1 1.7 8.4 10.9 0.0 8.0 7.3 12.4 10.9 9.1 5.4 2.2 8.7 7.1 5.8 3.8 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987675 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Late spermatids: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 15.6 15.8 9.2 13.7 12.3 10.4 15.2 4.9 35.1 14.2 0.0 19.0 10.3 17.1 4.4 14.5 14.6 8.8 16.6 23.1 6.5 16.1 13.0 18.6 9.8 8.5 4.5 13.5 15.0 17.7 19.4 26.2 7.4 12.5 15.2 10.9 10.8 14.0 11.7 38.3 17.1 19.1 14.3 0.0 21.8 18.7 14.6 8.4 10.5 17.1 27.8 9.5 16.1 13.1 16.5 13.2 23.2 4.2 6.1 27.8 19.0 8.6 12.4 13.8 11.6 10.1 5.9 3.6 15.5 11.9 19.7 9.8 13.1 16.2 19.5 6.6 21.8 20.7 9.8 13.3 6.6 15.9 5.8 40.4 13.4 24.0 10.8 17.1 14.0 19.6 11.8 16.2 13.9 11.0 8.8 10.3 3.7 0.6 15.6 9.5 8.9 4.8 6.1 13.1 13.8 5.8 5.1 7.8 14.1 3.8 7.2 12.6 5.6 25.6 9.1 5.3 9.8 20.6 6.8 8.0 5.6 22.4 11.5 9.2 0.5 1.2 0.9 1.3 1.6 1.0 0.6 0.6 1.2 0.7 0.4 0.8 1.0 3.0 0.6 4.9 1.1 0.5 1.4 9.2 12.3 4.9 35.1 23.1 6.5 8.5 4.5 13.5 12.5 0.0 8.4 16.5 15.2 3.2 11.3 11.4 9.2 6.9 3.7 11.6 8.6 14.7 11.9 8.9 8.0 12.8 6.9 11.0 10.4 5.9 9.0 16.1 1.9 7.9 30.1 5.9 12.6 10.0 11.4 7.4 17.9 11.2 9.6 12.3 20.4 11.6 13.3 14.7 16.8 15.3 8.5 35.3 15.7 13.9 20.3 16.7 10.2 54.3 10.2 13.1 3.6 4.7 14.9 6.5 12.3 9.0 9.5 10.6 13.9 9.4 9.0 6.3 20.1 15.4 6.1 11.2 13.1 7.9 14.8 7.2 6.9 8.8 10.4 12.4 11.4 14.4 12.2 4.1 MED13 "KIAA0593, THRAP1, TRAP240" ENSG00000108510 "Mediator complex subunit 13" Q9UHV7 17 61942605-62065278 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067939 Supported Nucleoplasm NA NA Nucleoplasm "HPA067939: AB_2685928" "unprognostic (7.26e-2)" "unprognostic (4.50e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.79e-2)" "unprognostic (1.69e-2)" "unprognostic (3.56e-1)" "unprognostic (1.33e-1)" "unprognostic (5.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (3.92e-2)" "unprognostic (2.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.21e-1)" "unprognostic (4.51e-3)" "unprognostic (2.30e-1)" 12.5 9.7 8.7 10.8 12.6 34.4 11.3 16.8 9.9 12.5 12.0 12.6 11.6 11.9 8.9 11.3 9.4 12.8 8.9 9.8 16.4 13.7 22.3 10.9 12.8 10.6 10.5 6.9 13.6 12.6 17.7 5.5 15.4 10.1 10.3 12.8 17.9 10.1 9.0 19.5 11.5 10.7 12.0 9.6 11.6 12.3 19.7 8.9 20.9 16.1 28.3 12.8 13.5 8.5 16.1 24.9 29.0 22.0 18.0 19.8 21.4 16.7 13.4 19.4 26.5 25.5 22.2 13.2 26.4 12.3 21.2 19.9 15.0 28.2 17.5 36.9 17.2 16.6 43.1 20.9 14.3 20.7 38.1 19.3 16.6 19.8 29.0 32.8 19.1 20.3 20.4 35.8 43.9 18.3 41.8 34.6 11.4 11.7 28.9 14.8 28.1 56.2 16.2 18.6 28.8 17.3 32.6 28.0 8.0 17.5 21.7 28.8 26.7 25.6 30.2 44.3 15.9 25.6 21.2 25.8 35.4 16.0 16.7 17.6 1.1 1.1 1.3 1.3 0.5 1.6 1.0 1.3 1.4 1.1 1.5 0.9 1.6 4.0 1.4 2.9 2.8 1.6 0.4 8.7 12.6 16.8 9.9 9.8 16.4 10.6 10.5 6.9 10.1 9.6 8.9 16.1 54.7 64.1 54.0 107.7 37.7 78.0 45.9 23.6 45.5 52.3 45.8 28.1 27.8 52.9 36.6 23.9 45.9 19.1 57.2 57.9 9.8 16.7 47.4 48.1 63.7 42.0 44.3 42.3 96.9 20.0 11.7 45.2 35.7 83.3 26.0 42.0 35.3 45.5 19.1 62.2 107.3 41.7 32.6 30.5 78.6 60.1 30.7 52.0 32.0 89.0 36.7 36.5 24.7 135.2 136.7 28.6 38.4 32.7 41.1 62.6 33.4 19.1 29.9 40.3 32.9 81.6 45.9 48.1 22.6 48.0 81.7 43.4 40.7 32.3 32.9 81.0 HOXB6 "HOX2, HOX2B" ENSG00000108511 "Homeobox B6" P17509 17 48595751-48604992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 40.7;kidney: 41.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 32.7" "Group enriched" "Detected in many" 6 "medulla oblongata: 12.6;spinal cord: 16.8;white matter: 10.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1" "Region enriched" "Detected in single" 102 "pons and medulla: 10.1" "Group enriched" "Detected in some" 168 "medulla oblongata: 8.1;spinal cord: 25.4" HPA042063 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA042063: AB_10796470" "unprognostic (5.01e-2)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.80e-3)" "unprognostic (5.64e-2)" "unprognostic (2.06e-3)" "unprognostic (3.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.97e-2)" "unprognostic (6.64e-2)" "unprognostic (2.50e-3)" "unprognostic (2.53e-3)" "unprognostic (5.76e-2)" "unprognostic (7.11e-2)" "unprognostic (4.19e-3)" 6.2 7.5 0.1 4.4 2.0 0.2 4.6 0.3 0.2 18.4 0.0 13.2 1.1 4.4 40.7 0.3 13.5 0.3 0.7 0.1 0.4 41.5 0.8 6.3 0.4 12.6 0.1 0.0 0.3 1.2 1.3 0.1 2.7 1.1 2.0 6.1 0.0 0.2 21.3 1.7 1.1 14.1 2.3 16.8 3.0 9.3 1.1 2.0 0.0 0.7 0.5 0.0 3.8 2.2 10.7 5.2 11.9 0.0 6.2 5.3 5.5 0.1 0.0 0.0 0.0 0.0 6.5 7.7 0.0 28.2 14.2 2.0 0.1 1.4 0.4 0.0 0.2 80.3 7.1 23.8 0.0 7.9 0.6 18.0 6.9 0.2 11.4 0.2 4.3 5.4 0.5 4.7 0.1 15.7 0.3 0.0 0.3 0.0 20.0 4.7 0.0 13.1 0.7 53.2 2.6 0.0 0.0 4.4 0.0 8.2 0.1 2.1 2.5 30.1 1.0 6.0 5.0 22.2 0.0 0.0 0.1 0.9 0.0 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.3 0.2 0.1 0.4 12.6 0.1 0.0 1.1 16.8 2.0 10.7 10.6 0.0 0.0 0.0 0.4 0.8 0.5 0.0 0.0 0.0 0.4 0.5 0.4 0.0 0.0 136.1 0.0 0.2 0.0 18.1 113.5 0.1 1.0 80.7 5.5 10.6 7.7 0.4 0.0 2.0 2.9 3.0 0.0 56.4 0.0 0.0 4.2 0.0 1.7 0.0 0.0 9.0 0.0 18.6 3.1 0.3 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 20.8 0.0 0.0 0.6 9.5 2.8 0.0 0.0 0.0 0.9 6.4 4.8 6.2 0.0 1.1 0.3 1.2 0.0 11.0 1.2 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 27 "skeletal muscle: 14898.9;tongue: 10866.4" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 582.2;Skeletal myocytes: 248.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" Yes No 86000000 "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119" "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.9 5.5 3.1 15.8 3.4 20.5 8.0 6.7 4.3 6.1 4.5 7.9 20.3 7.2 7.2 175.3 7.5 2.6 470.9 3.0 4.8 9.7 108.9 8.7 13.1 3.8 5.8 2.6 6.1 5.5 4.1 8.0 6.4 3.9 47.7 3.0 5.1 117.8 3.1 14898.9 7.6 15.7 2.8 3.7 17.1 10.1 9.4 3.4 5.8 10.4 10866.4 5.0 5.7 5.1 4.4 12.0 25.5 11.3 10.7 9.1 2.2 27.6 21.0 2.7 1.5 1.3 12.8 8.1 21.9 25.8 1.9 3.5 15.4 3.8 1.9 1.0 263.8 24.3 21.9 120.0 18.9 3.7 6.8 115.1 14.4 3.8 2.1 4.1 9.8 1.4 24.8 10.2 39.0 4.9 6.6 7.9 26.5 14.8 3.3 10.6 34.6 170.2 96.9 3.1 7.9 7.1 27.1 13.6 11.4 14.7 7.6 10.2 7.0 6.5 12.1 21.3 5.4 16.0 27.6 16.8 18.2 6.7 20.8 12.2 31.4 28.5 50.4 36.8 41.5 24.8 24.5 30.8 34.4 37.6 20.1 20.0 32.2 34.4 34.9 47.6 29.9 43.2 83.6 3.1 3.4 6.7 4.3 3.0 4.8 3.8 5.8 2.6 3.9 3.7 3.4 4.4 1.2 0.0 1.8 2.3 2.7 2.0 1.2 2.1 4.0 6.6 3.0 3.0 582.2 0.0 2.2 5.5 4.2 5.4 3.2 2.9 0.0 1.5 1.8 0.9 1.6 7.3 0.0 3.8 0.2 0.8 3.8 17.3 4.6 2.2 8.2 2.4 2.2 56.2 4.5 3.3 0.2 2.2 2.0 3.5 6.7 3.7 0.3 4.3 1.8 0.0 78.3 1.9 4.1 1.0 0.5 1.8 1.9 0.4 2.3 1.2 6.6 9.5 0.3 2.5 6.6 248.4 55.8 7.9 7.5 2.1 1.8 3.3 4.5 1.1 2.6 0.8 PFN1 ENSG00000108518 "Profilin 1" P07737 17 4945652-4949061 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 5241.0;monocytes: 4824.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037134, CAB037140" Enhanced Approved Cytosol NA NA 660000000 Cytosol "CAB037134: AB_1079599, CAB037140: AB_1079598" "unprognostic (1.07e-1)" "unprognostic (3.57e-1)" "unprognostic (1.60e-1)" "unprognostic (5.45e-3)" "unprognostic (1.65e-1)" "unprognostic (7.54e-2)" "unprognostic (4.01e-3)" "unprognostic (7.83e-3)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" "unprognostic (2.17e-1)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.62e-1)" "unprognostic (8.17e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" 578.3 368.8 273.3 1143.7 297.8 1627.1 400.4 314.4 335.7 391.2 299.1 979.4 770.9 740.6 349.4 587.4 505.3 376.0 327.8 272.5 369.2 455.3 667.0 564.0 1369.1 342.0 299.1 250.6 249.8 248.5 313.9 200.4 586.0 325.5 423.1 816.2 72.5 349.7 607.1 340.7 453.4 779.4 1043.7 325.5 918.9 681.1 117.3 335.4 1208.6 271.5 240.8 1451.7 850.6 428.6 345.0 3019.5 4276.8 1461.5 1205.2 778.8 977.1 1972.7 2416.8 1970.4 2568.6 1923.7 1684.1 1181.1 2476.9 1892.0 2542.0 1453.6 1825.4 1383.6 3040.5 2049.6 3560.1 2355.1 2516.6 2034.3 2225.8 2144.0 1630.4 5006.0 1152.4 1331.9 1957.6 1939.8 1477.6 2361.3 1646.4 1488.6 1736.7 3150.5 1815.0 2469.9 3448.0 2095.2 1474.7 2297.3 2451.9 2035.1 1494.6 2491.7 1909.8 564.0 1586.2 1910.5 1180.9 1679.7 1226.8 1121.0 1359.7 2731.7 2136.6 1675.1 1512.3 3969.3 931.3 1070.7 1799.3 1834.4 1949.7 3316.4 8100.1 8206.3 13914.4 9850.0 10858.8 6780.3 5722.0 8185.7 9586.6 9920.0 4970.0 5238.0 7604.7 9387.0 9112.1 13547.4 7809.7 11245.6 23570.1 273.3 297.8 314.4 335.7 272.5 369.2 342.0 299.1 250.6 325.5 325.5 335.4 345.0 561.8 112.2 176.1 12.1 1070.6 1806.0 873.2 3658.3 1003.3 25.0 767.4 914.1 147.6 457.5 1020.0 741.2 0.0 1911.0 1725.6 1733.8 992.0 1866.6 19.7 313.4 546.1 806.6 603.7 713.5 7.1 1625.2 5241.0 599.9 733.4 422.7 486.5 291.2 637.5 754.3 4094.2 38.7 6.4 1399.7 1452.6 1434.3 2934.8 31.0 263.8 1854.7 873.4 21.5 4824.7 99.8 3216.3 9.0 37.2 2933.5 1585.7 375.0 927.8 1238.2 1472.2 1671.2 559.4 17.8 506.2 282.3 1838.4 97.4 355.4 1170.1 1513.5 1682.8 1804.7 410.7 1355.5 1177.9 RNF167 DKFZP566H073 ENSG00000108523 "Ring finger protein 167" Q9H6Y7 17 4940008-4945222 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049810 Approved Approved "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes NA "Vesicles, Cytosol" "Mitotic spindle, Centriolar satellite" "HPA049810: AB_2680894" "unprognostic (1.13e-1)" "unprognostic (5.12e-2)" "unprognostic (2.29e-3)" "unprognostic (1.63e-2)" "unprognostic (3.43e-2)" "unprognostic (7.32e-2)" "unprognostic (2.18e-1)" "unprognostic (6.77e-2)" "unprognostic (7.46e-2)" "unprognostic (2.07e-2)" "prognostic favorable (2.03e-6)" "unprognostic (2.16e-1)" "prognostic favorable (4.47e-4)" "unprognostic (7.62e-2)" "unprognostic (1.93e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-1)" 70.9 111.5 142.1 53.5 145.9 69.6 73.8 144.7 181.3 90.8 137.0 107.0 67.2 95.7 77.1 123.1 85.0 45.7 115.9 140.4 144.0 107.2 185.7 78.2 65.1 147.4 144.8 137.5 88.1 116.0 106.7 97.6 51.2 146.1 95.8 66.3 99.0 93.3 71.2 154.2 125.3 101.3 53.3 142.9 114.8 112.8 111.5 148.9 99.0 94.2 95.1 72.1 107.6 91.2 151.8 102.6 143.1 61.1 73.7 132.8 68.7 92.7 63.4 76.1 119.7 93.4 96.2 43.3 71.5 120.3 93.5 63.9 147.5 103.2 114.8 86.1 74.5 166.1 121.9 164.4 94.9 100.6 59.0 245.0 79.6 176.5 129.8 116.2 74.6 77.2 101.0 49.9 237.5 96.2 66.3 92.8 70.6 75.4 102.0 86.8 62.8 61.9 91.5 137.3 77.4 49.2 61.1 56.0 92.9 81.9 83.1 87.3 55.9 49.5 76.6 48.3 66.8 119.3 79.5 88.0 23.7 98.4 80.6 77.9 108.4 88.8 236.9 195.3 94.0 153.4 100.4 148.0 195.7 73.9 98.7 103.2 152.2 219.8 118.8 117.7 75.9 153.0 177.0 142.1 145.9 144.7 181.3 140.4 144.0 147.4 144.8 137.5 146.1 142.9 148.9 151.8 36.9 0.0 3.9 12.4 54.3 68.6 44.4 65.8 51.8 43.2 56.6 44.7 15.8 77.2 38.9 49.7 20.9 120.1 64.7 65.2 56.7 78.5 59.6 29.8 25.1 36.4 31.8 60.6 11.3 66.7 139.7 36.3 36.2 32.2 14.0 26.3 45.7 95.1 58.4 18.5 11.2 45.7 65.1 41.3 43.6 86.5 48.7 36.1 39.2 6.5 53.1 46.9 114.4 10.1 17.9 60.7 44.9 53.8 59.1 32.6 108.2 64.0 31.1 32.3 39.5 28.4 35.1 127.1 106.7 61.4 83.3 125.2 82.5 37.2 59.6 48.0 SLC25A11 "OGC, SLC20A4" ENSG00000108528 "Solute carrier family 25 member 11" Q02978 17 4937130-4940053 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 235.8;skeletal muscle: 317.5;tongue: 454.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021167 Approved NA NA 25000 "HPA021167: AB_1857021" "unprognostic (8.58e-2)" "unprognostic (4.06e-3)" "unprognostic (9.43e-2)" "unprognostic (2.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (4.86e-1)" "unprognostic (9.48e-2)" "prognostic favorable (6.41e-6)" "unprognostic (2.84e-1)" "prognostic favorable (2.84e-9)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" 33.3 52.9 67.4 34.1 67.8 31.9 32.3 74.4 80.4 34.0 64.3 45.0 47.9 37.0 22.3 50.9 42.0 31.0 235.8 72.9 69.8 66.4 67.2 30.2 41.1 67.6 69.7 66.7 31.0 28.1 71.4 36.6 27.9 66.9 34.3 36.4 23.4 42.0 38.7 317.5 47.3 40.6 33.7 66.5 37.8 40.3 11.0 73.7 45.5 38.8 454.4 34.2 38.8 33.6 68.5 51.1 134.6 67.3 66.3 64.7 39.9 47.3 56.2 57.2 96.2 79.3 85.1 24.7 78.3 74.5 55.3 46.8 99.6 88.1 101.5 37.8 99.6 113.8 86.4 70.9 74.5 66.0 37.6 100.7 57.7 65.1 85.4 71.7 46.7 67.8 83.2 38.7 74.1 82.7 91.2 121.6 38.3 35.6 56.1 89.6 108.6 41.4 71.0 74.8 52.6 59.9 62.1 70.9 79.0 65.2 33.6 73.3 58.7 46.0 43.0 28.1 58.8 109.7 39.3 25.4 30.7 84.8 62.6 108.4 126.0 170.3 132.3 98.8 176.8 90.8 87.5 75.1 87.8 160.4 74.3 74.1 81.2 111.8 151.6 165.1 107.0 97.3 186.2 67.4 67.8 74.4 80.4 72.9 69.8 67.6 69.7 66.7 66.9 66.5 73.7 68.5 39.7 25.6 23.3 12.7 32.9 38.1 47.1 92.7 25.6 60.3 47.5 51.3 150.6 51.5 40.0 66.2 16.7 132.2 39.0 67.0 185.9 60.7 15.2 30.3 29.7 41.0 27.6 50.3 8.0 53.6 138.7 40.2 30.5 28.2 39.3 45.6 33.5 61.5 109.1 47.1 10.5 51.6 99.7 45.3 44.4 19.6 30.4 56.2 51.6 9.4 106.9 59.2 47.4 9.5 10.4 47.4 58.7 38.4 45.8 43.1 99.9 202.5 26.5 56.0 52.6 43.1 48.4 15.1 31.3 46.9 44.3 102.5 38.4 57.5 88.3 42.1 RASD1 "AGS1, DEXRAS1" ENSG00000108551 "Ras related dexamethasone induced 1" Q9Y272 17 17494437-17496395 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 374.8" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 425.1;Muller glia cells: 375.3;Peritubular cells: 469.8;Sertoli cells: 565.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 46 "plasmacytoid DC: 160.1" "Lineage enriched" "Detected in many" 46 "dendritic cells: 160.1" "Group enriched" "Detected in some" 4 "ASC diff: 70.2;REH: 71.0" "Group enriched" "Detected in all" 5 "basal ganglia: 75.6;hippocampal formation: 54.9;thalamus: 53.2" "Low region specificity" "Detected in all" HPA047896 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA047896: AB_10960535" "unprognostic (1.59e-1)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "unprognostic (3.31e-2)" "unprognostic (6.40e-2)" "unprognostic (8.13e-2)" "unprognostic (8.65e-2)" "unprognostic (7.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" "unprognostic (3.17e-3)" "unprognostic (2.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" 183.5 53.9 43.9 5.9 62.6 9.4 154.6 31.9 84.2 53.7 13.9 13.4 5.5 23.0 12.0 11.8 33.0 12.7 69.4 55.7 127.8 138.2 273.6 25.6 3.0 72.8 50.0 52.0 54.2 30.3 4.2 374.8 1.3 40.9 33.0 6.6 48.1 98.6 56.2 184.5 43.0 12.3 3.4 40.2 18.8 42.6 48.0 44.3 13.3 89.2 103.9 1.2 16.8 26.5 52.2 0.0 0.3 0.3 0.0 70.2 3.8 0.3 0.9 1.4 0.1 0.2 3.0 0.0 0.0 8.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 0.9 0.3 0.3 8.3 0.5 0.1 0.3 17.1 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.2 7.5 13.8 1.3 1.4 1.3 4.5 71.0 0.1 0.1 1.5 0.0 12.9 0.4 1.1 0.9 16.3 2.1 0.1 0.1 4.1 0.1 0.7 0.5 0.2 14.5 0.6 0.2 0.4 0.0 0.5 0.0 0.4 0.0 0.4 3.5 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.8 160.1 0.1 1.0 43.9 62.6 31.9 84.2 55.7 127.8 72.8 50.0 52.0 40.9 40.2 44.3 52.2 172.2 28.9 36.8 21.2 11.0 17.2 96.2 46.6 27.3 51.4 106.9 147.2 71.2 20.0 33.5 149.0 4.2 3.3 45.8 42.9 13.7 93.5 2.7 150.9 264.2 31.1 222.4 0.4 15.0 1.3 2.2 191.1 86.6 425.1 8.8 40.3 9.7 21.6 3.6 6.7 5.2 262.7 260.4 3.1 22.2 8.1 109.6 27.3 30.2 1.9 2.2 375.3 0.0 17.1 1.6 9.0 21.8 469.8 56.1 73.3 16.8 13.8 7.2 23.8 565.4 228.1 191.7 1.7 3.0 54.8 13.2 6.7 27.0 73.7 32.9 20.0 CHRNE ACHRE ENSG00000108556 "Cholinergic receptor nicotinic epsilon subunit" Q04844 17 4897771-4934438 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "heart muscle: 53.0;pituitary gland: 27.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 161.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HEL: 5.0;HMC-1: 11.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "basal ganglia: 6.3" NA NA "unprognostic (2.00e-3)" "unprognostic (1.56e-1)" "unprognostic (3.94e-2)" "unprognostic (4.35e-3)" "unprognostic (6.55e-2)" "unprognostic (2.27e-3)" "unprognostic (7.80e-4)" "unprognostic (7.75e-2)" "unprognostic (3.24e-1)" "unprognostic (1.34e-1)" "unprognostic (3.69e-2)" "unprognostic (6.58e-2)" "unprognostic (8.42e-4)" "unprognostic (1.39e-3)" "unprognostic (1.26e-1)" "unprognostic (5.83e-2)" "unprognostic (5.70e-2)" 0.6 0.4 0.1 0.4 0.1 0.7 0.7 0.5 0.5 0.7 0.0 0.3 0.3 0.4 1.3 0.5 0.6 1.1 53.0 0.2 0.1 0.8 3.5 0.8 0.5 0.2 0.1 0.0 0.8 1.7 0.2 27.8 0.6 0.2 0.6 0.0 5.2 0.8 0.2 1.8 2.1 0.8 0.2 0.0 1.8 0.5 0.8 0.1 0.1 0.5 2.1 0.2 0.3 0.5 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 5.0 0.0 0.8 0.4 0.0 11.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 1.3 2.5 0.4 0.0 0.0 0.1 0.8 0.2 0.4 0.1 0.7 1.1 0.8 0.6 0.1 0.0 0.7 0.1 0.1 0.5 0.5 0.2 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.2 4.9 0.0 0.0 0.3 4.2 1.7 1.4 0.8 1.2 5.0 1.6 2.0 6.5 1.5 0.6 1.8 4.2 0.6 10.2 0.0 1.9 0.3 27.8 0.6 1.1 3.3 0.0 0.0 0.5 0.9 7.3 2.3 1.1 0.8 8.2 1.4 2.9 7.4 3.4 3.3 0.4 0.1 2.0 1.3 13.0 161.5 0.9 9.9 0.0 2.8 5.3 1.1 8.2 0.5 0.7 0.7 0.0 0.4 3.5 1.1 0.0 2.9 0.6 10.0 0.0 0.9 1.1 5.6 8.4 0.2 1.1 11.1 3.5 6.2 0.2 0.7 RAI1 "DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS" ENSG00000108557 "Retinoic acid induced 1" Q7Z5J4 17 17681458-17811453 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023898, HPA054906" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA023898: AB_10971089, HPA054906: AB_2682637" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-2)" "unprognostic (3.85e-2)" "unprognostic (3.02e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.61e-2)" "unprognostic (5.29e-2)" "unprognostic (4.20e-2)" "unprognostic (6.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-2)" "unprognostic (8.28e-2)" 6.7 10.5 6.6 7.5 5.8 4.9 9.4 5.7 12.4 16.0 1.3 11.1 6.4 16.5 3.4 11.7 15.2 7.5 12.0 5.0 2.3 9.2 5.4 10.9 5.8 5.5 0.6 3.2 16.0 10.2 10.2 18.1 4.7 4.8 16.2 2.7 9.0 15.4 9.5 5.8 12.4 8.5 6.4 0.6 11.9 11.0 6.5 1.8 7.2 14.6 1.8 4.4 15.7 14.5 5.0 29.3 39.0 24.2 20.0 3.2 6.5 4.2 9.9 10.5 8.1 7.9 20.4 12.1 9.4 13.3 12.9 6.9 33.8 8.5 19.7 3.4 9.3 19.0 17.2 24.4 10.4 10.5 6.9 10.4 7.5 9.4 7.4 11.0 9.6 10.1 11.8 7.5 7.5 4.2 25.9 14.7 6.7 1.7 15.1 11.4 34.2 18.9 13.4 6.6 34.6 16.8 30.0 15.6 13.6 32.2 27.8 18.3 8.6 19.6 12.8 16.3 20.7 14.1 6.6 1.6 5.9 12.5 8.4 35.7 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.6 0.3 0.7 0.0 0.2 6.6 5.8 5.7 12.4 5.0 2.3 5.5 0.6 3.2 4.8 0.6 1.8 5.0 6.1 12.8 20.5 24.8 4.7 12.1 10.8 11.7 12.0 28.7 14.1 10.2 4.0 11.5 14.0 14.7 22.9 0.1 10.0 4.8 0.0 18.4 2.5 9.4 9.6 11.0 11.4 4.6 37.3 9.0 0.8 8.0 12.8 10.5 14.0 7.7 15.4 6.2 2.4 23.5 35.9 7.1 4.1 3.5 8.7 4.9 6.8 4.5 8.8 14.0 5.9 6.8 7.2 26.2 17.1 13.5 2.5 6.0 1.7 11.6 2.2 1.8 7.3 13.1 6.6 5.0 7.6 1.2 11.7 10.5 8.8 0.4 6.8 12.4 8.5 12.9 NUP88 MGC8530 ENSG00000108559 "Nucleoporin 88" Q99567 17 5360963-5419676 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 146.0;Spermatocytes: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002209, HPA021816" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB002209: AB_564128, HPA021816: AB_1854725" "unprognostic (3.46e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.83e-2)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-1)" "unprognostic (4.72e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-2)" "unprognostic (5.75e-3)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (9.03e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" 11.9 12.1 4.1 16.5 3.6 20.9 15.4 7.1 6.0 10.9 3.2 13.3 10.0 10.5 16.5 12.2 12.5 8.1 12.3 3.8 3.5 15.3 27.5 9.5 26.7 4.1 3.8 3.7 8.5 10.3 15.4 9.0 11.0 4.6 11.6 19.4 9.7 13.3 10.4 31.5 13.0 11.8 13.8 3.1 14.9 12.4 49.7 3.5 24.3 14.7 21.8 33.2 15.3 9.1 4.3 46.2 50.0 44.0 33.3 18.3 20.0 40.2 35.8 29.0 58.7 52.0 41.5 17.8 88.6 13.3 33.1 38.1 43.5 73.6 39.6 74.7 22.7 48.6 40.0 42.7 32.5 24.8 31.8 34.6 14.3 28.2 43.7 71.3 24.5 41.0 34.3 42.3 22.2 46.5 24.3 46.7 23.4 41.2 46.4 23.9 44.1 48.5 38.7 30.7 22.3 17.5 33.9 44.0 20.4 28.1 33.7 22.9 37.3 26.8 26.4 28.3 27.1 66.9 15.0 19.4 39.5 31.3 36.3 37.4 5.4 7.6 4.3 12.4 12.2 12.3 39.1 13.3 15.0 10.9 35.7 14.3 15.9 0.9 21.1 14.3 12.2 17.6 11.5 4.1 3.6 7.1 6.0 3.8 3.5 4.1 3.8 3.7 4.6 3.1 3.5 4.3 6.9 12.8 17.8 10.1 38.0 22.2 31.5 13.5 14.2 13.3 8.9 6.2 10.7 11.5 18.1 16.5 16.7 30.1 19.3 15.2 11.7 27.9 146.0 26.1 15.0 11.5 13.8 28.6 22.9 25.4 24.8 12.2 15.3 47.2 7.6 14.9 9.3 16.5 11.4 10.1 20.4 10.1 14.2 7.9 12.3 38.0 15.2 10.6 3.6 11.2 19.4 7.8 26.8 13.0 17.8 23.3 15.4 10.9 9.4 21.7 9.9 7.5 11.5 11.0 13.1 19.5 20.5 147.5 61.8 15.8 17.0 36.0 17.9 13.6 17.6 42.8 C1QBP "gC1Q-R, gC1qR, HABP1, p32, SF2p32" ENSG00000108561 "Complement C1q binding protein" Q07021 17 5432777-5448830 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation" "Cancer-related genes, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026483 Supported Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA 410000 "Plasma membrane" Mitochondria "HPA026483: AB_1847108" "unprognostic (2.18e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (6.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.76e-2)" "unprognostic (7.47e-2)" "unprognostic (4.62e-2)" "unprognostic (2.40e-3)" "unprognostic (6.03e-2)" "unprognostic (4.60e-3)" "unprognostic (3.08e-2)" "unprognostic (7.80e-3)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-1)" "unprognostic (3.97e-1)" 70.8 136.5 91.6 84.8 91.1 122.2 109.8 98.0 119.3 57.9 117.4 141.6 96.8 67.0 68.9 139.7 75.1 49.2 114.4 94.6 104.3 137.7 135.6 55.2 116.7 97.8 97.1 89.4 53.2 73.6 128.8 82.0 76.4 97.9 64.5 142.9 87.4 66.7 73.7 175.9 79.8 79.1 81.5 97.9 74.1 74.9 63.0 94.7 99.4 65.7 161.5 136.8 109.5 74.5 103.1 443.8 671.0 233.0 378.0 169.8 207.7 313.7 330.4 268.5 751.4 458.8 646.8 143.7 941.8 317.8 251.3 271.3 385.8 756.7 448.9 689.8 216.6 1300.5 433.9 312.4 762.2 269.9 535.6 331.0 231.4 404.1 414.6 593.1 181.1 390.0 548.2 526.1 234.4 296.1 308.6 766.4 385.6 525.9 497.2 396.7 601.2 329.1 515.0 440.5 328.7 186.0 348.0 271.4 344.4 483.6 232.1 218.1 267.1 231.1 240.1 219.7 275.9 729.9 122.0 201.2 415.0 229.3 506.2 376.8 68.1 197.6 49.9 217.1 212.0 283.5 330.1 239.0 215.4 389.5 289.8 289.7 245.7 15.5 240.7 166.4 325.4 203.6 432.6 91.6 91.1 98.0 119.3 94.6 104.3 97.8 97.1 89.4 97.9 97.9 94.7 103.1 101.6 28.9 30.5 10.7 153.1 243.1 229.0 283.3 165.0 70.5 157.3 209.4 84.8 102.9 107.8 82.8 27.1 323.8 115.0 105.6 313.1 248.0 75.1 106.7 149.9 108.2 79.2 183.1 10.8 205.1 457.9 101.0 94.8 85.9 62.2 131.6 75.3 128.5 202.7 60.6 11.6 190.2 154.6 85.3 129.8 89.5 119.6 101.8 156.5 10.3 170.3 105.2 93.7 11.1 16.1 199.3 128.5 98.6 197.4 255.1 78.9 444.1 65.1 79.9 85.5 101.6 189.1 79.3 237.3 284.4 255.3 179.0 105.5 354.3 364.0 253.8 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 82.4;intestine: 40.7;lung: 29.1" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enhanced" "Detected in many" "midbrain: 82.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4" "Region enriched" "Detected in some" 4 "midbrain: 58.4" "Group enriched" "Detected in some" 7 "midbrain: 38.9;pons: 29.1" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: AB_2686708" "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.1 0.1 0.3 0.0 0.1 0.2 0.2 0.2 3.0 0.1 0.0 0.5 10.4 0.0 0.0 2.8 1.7 0.0 0.9 0.1 0.3 0.2 0.0 29.1 0.1 14.4 82.4 0.1 0.1 1.4 0.2 0.0 18.6 31.8 0.1 0.1 0.1 0.7 0.2 0.1 0.6 40.7 0.0 0.0 0.1 0.9 0.3 21.6 0.0 0.5 0.0 0.2 0.1 0.3 20.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 10.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 3.0 0.1 0.3 14.4 82.4 0.1 31.8 0.0 21.6 20.8 1.1 16.0 5.0 0.3 0.0 0.1 0.4 0.1 17.1 1.2 0.1 0.0 1.0 0.0 1.9 1.8 0.0 125.4 1.5 0.2 0.0 0.0 2.8 0.2 0.6 3.2 0.0 0.0 0.9 0.0 8.6 1.3 0.0 0.5 2.5 0.2 2.2 0.3 9.5 0.0 0.6 2.3 0.0 1.0 1.2 2.2 0.3 5.9 0.0 0.0 0.1 0.5 2.1 0.5 0.5 0.4 0.0 0.4 0.1 0.3 100.9 0.4 0.7 0.8 0.0 1.3 0.5 0.5 0.9 4.8 0.3 106.4 0.5 0.2 4.1 0.3 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248203-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 131.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 42000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 20.3 13.6 13.9 18.4 15.3 18.3 20.6 16.3 17.7 18.3 15.6 18.3 12.5 21.4 21.3 28.6 14.8 18.5 14.6 14.4 15.9 22.2 14.1 16.2 26.2 16.2 14.6 13.3 14.0 27.0 21.9 9.8 27.6 15.7 14.6 15.6 14.8 15.7 14.5 29.0 131.3 18.4 22.6 15.4 20.8 16.3 16.1 15.3 36.6 16.7 19.2 27.2 18.0 21.6 16.8 40.3 62.9 61.5 41.6 40.6 43.8 27.8 36.5 24.0 59.1 50.8 93.2 11.9 119.5 63.3 31.1 26.1 27.1 135.5 52.8 50.1 31.5 101.4 73.5 54.6 80.0 58.3 136.1 43.2 50.5 3.5 46.5 26.5 47.1 87.2 98.2 157.9 47.6 24.6 31.0 168.1 98.6 57.2 0.0 29.2 143.0 154.5 78.9 46.8 35.6 135.1 48.4 32.6 63.2 42.2 106.6 42.9 68.5 54.5 35.0 69.2 16.0 66.0 55.8 124.1 159.3 26.7 0.2 47.6 0.0 8.8 1.5 15.3 6.2 25.3 6.5 18.2 20.2 10.1 7.3 16.4 17.8 1.2 16.3 3.3 10.1 20.0 9.9 13.9 15.3 16.3 17.7 14.4 15.9 16.2 14.6 13.3 15.7 15.4 15.3 16.8 21.0 3.2 12.6 13.4 8.8 15.9 16.7 10.6 19.4 20.2 10.3 6.6 17.8 12.8 4.0 11.0 12.5 49.6 15.6 7.6 7.9 17.4 8.4 7.4 28.2 24.0 18.0 22.5 19.0 14.2 38.0 18.3 11.2 7.0 43.8 30.5 25.7 6.9 25.0 13.5 20.9 8.4 6.1 18.9 7.1 6.6 16.1 13.0 10.6 18.7 12.2 9.9 22.6 29.1 22.6 7.2 9.6 24.8 20.0 13.0 11.5 20.0 5.5 15.7 6.6 12.9 19.7 14.9 29.1 24.0 12.6 27.5 20.9 34.8 11.5 7.6 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378927-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 25.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" NA NA 1700000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: AB_2681953, HPA055465: AB_2682823" "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 26.1 7.5 11.2 19.9 13.0 32.5 20.7 14.8 24.2 41.2 10.3 18.2 20.5 15.9 13.4 12.2 23.2 32.1 9.2 11.8 13.2 19.9 25.6 18.4 7.9 18.4 14.7 8.8 7.9 15.9 28.7 6.1 30.6 17.4 16.9 20.3 15.1 45.2 11.4 8.2 8.3 20.0 23.5 22.8 9.4 37.6 41.7 15.1 8.4 58.0 14.1 10.0 18.5 7.2 28.2 39.4 58.9 50.0 51.6 51.0 95.9 18.0 53.1 77.2 36.0 43.9 69.6 24.9 5.1 65.8 61.3 45.6 27.6 32.7 67.1 60.3 18.7 46.7 11.2 32.5 43.2 61.8 73.8 28.3 172.3 29.4 46.2 44.3 59.7 74.3 16.5 22.1 56.1 29.2 7.7 23.9 20.3 14.1 89.8 13.4 22.6 57.8 15.3 67.3 44.2 12.5 31.5 63.4 54.0 27.6 58.0 51.2 50.4 89.2 35.7 23.3 56.2 51.3 22.5 50.0 16.1 45.6 47.2 30.9 4.5 7.7 8.4 4.1 3.6 4.5 0.2 2.1 3.5 4.4 0.4 1.6 2.0 25.0 2.7 3.2 0.5 1.5 3.6 11.2 13.0 14.8 24.2 11.8 13.2 18.4 14.7 8.8 17.4 22.8 15.1 28.2 124.4 32.1 23.9 28.4 7.5 22.0 34.2 99.2 21.6 30.8 34.9 18.8 13.7 155.8 129.5 29.5 45.9 24.8 35.9 37.8 1.9 32.4 96.1 21.9 24.9 51.9 32.3 15.6 62.9 24.8 11.1 25.6 72.4 35.2 24.1 21.6 56.0 93.9 15.9 47.1 57.1 69.0 85.5 31.2 20.4 56.0 16.8 33.7 30.2 90.9 32.9 13.4 29.9 45.8 164.5 32.8 26.4 16.1 38.1 58.5 50.1 18.5 84.2 33.8 0.0 21.3 23.4 31.0 21.0 21.1 18.6 24.1 35.6 14.2 34.4 50.7 GOSR1 "GOLIM2, GOS-28, GOS28, GS28, P28" ENSG00000108587 "Golgi SNAP receptor complex member 1" O95249 17 30477362-30527592 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020590 Uncertain NA NA "HPA020590: AB_1850374" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.41e-1)" "unprognostic (2.83e-2)" "unprognostic (4.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-2)" "unprognostic (9.93e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" "unprognostic (8.64e-2)" "unprognostic (3.68e-1)" "unprognostic (7.56e-2)" "unprognostic (1.14e-2)" 18.4 15.3 9.6 16.2 9.7 12.7 22.5 11.6 11.1 19.1 9.8 20.0 16.1 21.2 15.5 18.2 23.7 16.1 18.1 10.1 9.6 25.2 31.1 16.7 17.8 9.8 9.7 8.9 21.0 22.2 28.4 13.2 19.6 10.0 21.2 23.6 19.6 18.7 18.0 17.3 14.7 18.1 21.0 8.6 14.7 19.6 23.0 9.8 24.4 24.4 19.6 24.8 20.0 12.5 10.6 33.7 54.9 35.5 26.1 27.6 27.1 25.2 35.2 35.2 50.1 45.0 48.8 22.8 34.0 33.6 38.9 44.8 29.8 43.1 36.2 57.0 20.3 34.6 35.0 41.4 32.3 37.5 55.5 39.6 27.6 28.8 48.8 54.3 27.2 32.8 36.0 55.4 30.9 33.9 23.1 43.8 28.9 36.3 55.5 21.9 41.0 47.6 27.2 25.7 47.0 31.7 30.3 36.6 76.2 44.8 38.5 58.9 40.6 37.0 33.6 29.9 31.4 46.2 41.0 56.3 60.6 32.4 26.7 45.1 26.0 21.6 29.5 29.8 27.8 34.8 33.8 28.5 28.2 30.0 35.8 33.7 32.8 26.2 36.1 27.4 30.6 33.6 19.3 9.6 9.7 11.6 11.1 10.1 9.6 9.8 9.7 8.9 10.0 8.6 9.8 10.6 45.9 28.9 52.9 35.3 40.6 27.0 34.9 51.3 30.1 62.4 36.0 38.7 45.9 38.6 61.2 42.3 62.6 48.0 28.2 26.7 50.9 39.8 124.3 41.5 44.2 38.4 41.9 21.7 42.8 40.1 39.6 42.5 26.0 33.5 61.4 38.0 35.3 47.7 27.8 104.3 40.8 31.4 40.7 29.4 21.6 46.7 29.5 27.6 16.0 35.6 31.6 70.2 26.8 37.7 49.5 36.9 23.8 28.2 26.2 37.8 26.2 41.9 75.3 67.5 19.7 52.9 45.3 80.2 44.3 27.4 27.1 73.1 33.0 33.4 29.9 31.0 CCDC47 GK001 ENSG00000108588 "Coiled-coil domain containing 47" Q96A33 17 63745255-63776351 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029674, HPA072573, HPA075958" Approved Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: " "unprognostic (6.33e-2)" "unprognostic (3.26e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.38e-1)" "unprognostic (3.54e-1)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (9.08e-2)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.73e-1)" "unprognostic (1.26e-1)" "unprognostic (8.35e-2)" "unprognostic (1.88e-1)" "unprognostic (6.43e-2)" "unprognostic (7.46e-2)" "unprognostic (1.16e-1)" 58.4 68.0 26.2 42.9 35.9 29.3 57.7 30.6 39.5 48.1 45.3 84.2 87.9 39.4 54.1 53.0 44.3 48.6 66.1 31.5 34.8 72.7 103.1 53.2 33.8 30.5 29.0 25.1 35.6 60.3 85.3 22.1 55.3 31.4 60.7 81.4 47.3 62.9 52.5 116.2 52.6 78.9 42.5 30.6 35.9 79.3 32.4 27.7 30.2 62.5 84.4 40.9 59.0 29.6 36.0 143.3 133.8 81.4 71.9 112.4 74.0 158.0 141.9 92.6 96.1 112.4 118.7 127.0 112.9 74.3 100.9 110.8 114.3 99.3 88.1 168.9 39.4 101.2 160.9 106.4 117.3 107.6 129.9 81.3 78.5 121.3 132.4 113.2 67.9 81.3 55.3 183.5 95.5 79.4 116.1 100.5 48.1 70.8 179.4 134.0 92.2 157.9 154.6 115.3 161.1 74.2 101.5 95.2 242.8 120.3 103.0 159.8 70.4 104.0 177.6 112.9 130.6 166.0 93.9 119.9 112.8 103.9 81.4 147.3 53.2 59.7 75.6 40.7 61.5 47.9 38.4 39.8 37.9 82.5 31.7 41.1 36.2 47.6 43.4 65.9 54.7 49.0 52.0 26.2 35.9 30.6 39.5 31.5 34.8 30.5 29.0 25.1 31.4 30.6 27.7 36.0 96.9 144.2 122.2 16.3 46.6 100.8 108.5 95.9 98.4 40.9 65.9 53.6 129.0 72.9 128.3 60.7 14.6 111.1 59.0 99.8 9.8 115.3 17.9 80.3 73.9 83.9 52.2 76.6 26.2 105.1 98.3 85.3 65.7 126.0 45.5 31.2 68.2 96.3 57.5 57.2 25.9 95.1 83.4 56.9 58.3 11.5 47.8 60.7 39.2 13.1 52.9 55.3 25.7 22.6 25.5 92.0 62.6 56.1 56.0 89.6 87.5 32.6 83.0 27.9 72.3 117.2 92.1 82.0 44.7 90.1 90.8 144.1 42.7 53.0 110.5 83.3 MED31 "CGI-125, Soh1" ENSG00000108590 "Mediator complex subunit 31" Q9Y3C7 17 6643311-6651634 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035947 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA035947: AB_10696646" "unprognostic (1.42e-1)" "unprognostic (4.39e-1)" "unprognostic (6.87e-2)" "unprognostic (4.40e-3)" "unprognostic (1.71e-1)" "unprognostic (3.99e-1)" "unprognostic (6.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.03e-2)" "unprognostic (1.39e-2)" "unprognostic (5.79e-2)" "unprognostic (6.46e-3)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" 11.4 22.6 18.9 9.4 20.7 10.0 14.6 19.2 26.6 12.5 19.3 9.7 8.7 11.3 26.7 25.2 12.9 12.6 15.4 19.9 21.4 15.2 18.3 11.1 15.0 19.0 19.3 18.9 12.9 9.8 13.2 25.5 9.8 20.0 12.6 8.6 10.9 12.9 9.0 14.5 21.3 10.4 12.5 18.7 16.7 11.0 17.6 20.9 13.8 14.8 10.7 14.8 14.3 14.5 21.4 37.7 41.2 36.4 23.2 32.5 27.4 13.1 28.8 29.5 43.6 56.6 20.6 19.2 5.0 35.6 14.3 32.3 40.5 29.2 35.7 37.7 27.1 48.9 9.3 34.5 32.3 24.4 10.5 18.8 15.2 37.8 39.6 13.4 23.2 32.8 20.0 16.5 9.4 32.2 13.7 20.2 27.4 13.0 16.9 23.5 15.0 16.2 13.6 36.7 18.4 14.5 16.0 14.8 11.8 33.1 17.2 12.3 11.5 14.8 21.3 18.6 27.1 29.2 8.5 11.9 12.8 29.4 12.4 15.4 77.7 22.6 38.6 26.0 16.4 24.7 22.7 24.2 25.7 19.9 23.7 21.5 23.1 63.3 23.7 20.0 25.6 31.2 20.2 18.9 20.7 19.2 26.6 19.9 21.4 19.0 19.3 18.9 20.0 18.7 20.9 21.4 34.1 16.0 22.9 13.4 37.0 106.9 48.3 92.3 68.3 8.4 38.0 35.3 4.8 37.1 47.6 33.1 10.4 40.8 29.1 23.1 54.8 36.4 34.2 78.8 31.9 35.7 12.6 30.5 32.7 31.5 40.3 31.5 15.3 38.6 26.6 21.4 39.3 57.1 33.7 13.5 24.6 23.1 59.0 23.9 37.9 62.5 44.4 25.1 40.9 12.2 29.3 22.9 21.6 18.1 21.9 46.4 15.3 26.4 34.4 51.0 22.4 81.8 97.2 12.8 39.5 29.7 33.7 101.9 81.3 46.6 120.2 47.9 37.5 35.6 19.3 66.6 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087892-18107970 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 18.9 19.3 13.6 12.9 13.7 16.0 19.8 13.8 14.9 21.5 12.9 18.4 15.0 22.5 13.0 21.8 20.0 12.8 19.0 13.7 14.6 18.6 16.7 15.9 18.6 14.2 13.9 13.6 22.7 19.8 15.9 17.9 12.4 14.7 20.2 10.1 5.2 17.1 15.3 36.9 20.3 17.6 13.8 14.1 20.0 18.1 9.0 14.2 16.2 18.5 16.6 15.0 20.2 18.4 16.1 37.1 51.1 17.4 17.3 31.1 31.7 33.1 24.8 24.7 40.0 37.0 55.5 21.8 35.5 31.8 29.4 21.2 38.9 28.5 35.1 27.4 32.1 74.2 16.0 26.5 31.5 33.4 14.3 24.2 36.4 30.5 39.1 33.0 22.9 38.5 46.8 27.6 13.7 23.6 42.5 38.7 25.8 12.9 51.4 36.1 41.5 41.8 66.7 24.3 21.6 9.9 28.0 25.2 15.2 31.9 102.8 30.0 21.4 29.2 19.6 18.3 23.0 42.8 15.5 19.4 20.1 27.9 26.2 36.6 17.7 21.1 23.6 24.6 23.3 20.2 14.9 17.8 20.0 24.6 17.7 16.9 18.7 2.8 28.2 30.5 13.8 24.9 19.3 13.6 13.7 13.8 14.9 13.7 14.6 14.2 13.9 13.6 14.7 14.1 14.2 16.1 23.8 0.0 12.4 8.5 19.5 16.7 19.9 21.2 11.4 14.9 18.8 23.0 3.9 24.3 13.2 7.3 2.1 37.5 26.3 20.1 29.4 29.4 7.3 12.8 19.3 20.8 21.6 10.1 11.9 27.1 40.8 19.4 17.9 12.9 12.0 32.6 16.4 19.4 32.2 6.7 10.0 19.7 16.2 21.4 12.2 14.2 21.5 18.0 12.4 8.4 23.9 19.6 23.7 4.0 8.0 24.8 16.2 24.5 22.9 17.4 31.4 31.8 9.3 13.4 6.6 22.0 21.7 12.1 13.0 18.2 11.6 39.3 21.9 33.9 24.5 14.4 FTSJ3 SPB1 ENSG00000108592 "FtsJ RNA 2'-O-methyltransferase 3" Q8IY81 17 63819433-63830012 "Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055544, HPA062628" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA055544: AB_2682843, HPA062628: AB_2684813" "unprognostic (1.33e-1)" "unprognostic (1.41e-1)" "unprognostic (6.60e-2)" "unprognostic (7.82e-2)" "unprognostic (6.45e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.85e-1)" "unprognostic (1.12e-1)" "unprognostic (4.99e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-1)" "unprognostic (3.43e-1)" 19.9 20.8 12.3 18.4 12.8 15.9 18.1 12.8 12.8 20.2 12.5 19.7 14.4 20.4 17.4 19.2 19.0 15.2 20.6 11.9 13.0 23.5 19.0 14.9 21.1 12.9 12.5 11.0 22.5 15.9 20.7 12.5 13.2 12.9 18.9 18.2 8.9 17.8 18.2 29.1 23.4 18.5 22.8 13.1 21.1 18.0 15.3 13.2 21.2 17.3 14.8 24.0 20.3 18.9 13.2 63.0 97.0 36.8 52.5 57.9 49.5 57.0 61.4 44.7 68.8 54.2 81.4 40.9 83.4 24.7 36.2 36.0 42.6 69.3 58.4 87.8 14.4 69.2 75.0 68.6 76.6 42.2 95.9 52.5 35.1 45.3 106.9 51.2 34.9 58.2 50.2 75.9 33.1 46.5 105.5 84.9 31.1 99.4 70.2 97.7 74.6 100.9 58.6 44.8 56.3 33.9 132.5 72.3 60.9 43.1 72.7 58.0 31.8 52.7 50.9 71.6 57.4 115.1 79.5 120.9 81.4 45.6 62.6 50.3 4.5 11.4 7.0 11.0 13.0 14.5 9.6 11.6 14.5 13.6 8.6 9.2 11.5 2.5 13.9 10.1 10.3 15.1 10.0 12.3 12.8 12.8 12.8 11.9 13.0 12.9 12.5 11.0 12.9 13.1 13.2 13.2 16.2 32.1 30.2 4.2 17.3 13.8 13.6 16.1 26.7 6.6 10.6 12.6 27.7 18.6 25.7 14.7 10.4 16.0 19.4 15.7 13.7 28.0 8.8 23.5 27.5 25.1 12.7 20.8 2.0 33.8 17.0 18.4 11.2 24.1 24.1 17.5 14.3 19.9 14.2 3.3 2.0 12.0 16.2 13.8 9.3 17.8 24.2 16.3 8.8 1.9 19.3 16.0 15.5 1.5 3.8 30.6 14.0 19.2 18.6 10.6 15.5 29.8 24.3 9.3 46.0 21.0 20.5 11.7 15.7 20.8 12.8 16.3 18.6 15.7 21.1 9.5 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 11.2 13.5 10.4 12.4 12.2 10.7 12.4 11.1 13.7 11.6 15.0 10.5 9.6 12.6 8.9 10.7 10.5 10.8 7.3 11.0 11.0 13.2 8.2 11.1 16.2 10.0 10.4 10.0 13.7 8.4 15.3 7.6 12.3 10.3 11.0 11.7 15.5 9.9 11.8 7.2 9.6 10.2 13.4 9.3 15.1 11.2 14.3 12.2 14.2 15.2 9.5 12.6 11.4 10.3 13.5 18.1 21.3 13.9 9.7 18.0 22.5 25.7 20.6 21.9 22.4 26.7 23.2 10.6 15.4 13.6 16.4 19.4 18.8 18.1 17.2 30.4 12.8 15.4 13.2 20.2 11.4 17.0 9.7 20.7 19.1 21.1 20.5 25.1 25.0 18.3 18.5 8.6 7.5 23.6 13.1 18.1 14.3 9.1 25.1 7.2 11.8 45.5 8.1 18.7 11.3 4.7 14.1 23.6 11.0 19.7 84.8 26.7 10.7 16.1 17.2 14.2 14.8 19.3 9.3 10.7 18.8 22.8 11.5 17.0 4.9 9.7 12.6 8.6 14.4 8.0 8.4 8.4 9.4 8.5 9.2 10.0 8.9 33.8 7.6 13.9 6.3 7.1 4.3 10.4 12.2 11.1 13.7 11.0 11.0 10.0 10.4 10.0 10.3 9.3 12.2 13.5 13.4 3.2 12.3 71.2 24.4 7.0 9.7 8.9 10.2 24.6 11.1 9.0 8.4 21.5 11.9 5.5 16.7 14.9 16.8 15.8 1.9 9.9 12.8 11.0 14.8 12.6 7.2 15.2 55.1 7.2 11.1 11.7 14.8 10.8 10.1 18.0 16.8 13.6 16.5 33.7 54.6 9.9 12.2 35.1 10.5 13.9 15.2 21.4 5.4 61.8 32.3 11.7 25.7 51.8 78.5 7.9 15.2 13.9 11.2 15.6 14.6 5.7 15.3 23.2 19.7 10.5 11.2 23.1 23.6 11.0 7.7 14.0 19.0 15.6 11.8 12.1 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 500.1;salivary gland: 129.0;stomach 1: 226.7" "Group enriched" "Detected in many" 4 "Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.4;lung cancer: 60.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "A549: 5094.7;OE19: 6071.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 52000 "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 1.6 1.0 1.2 1.3 0.7 0.1 3.3 0.7 0.5 5.9 14.2 4.5 6.2 0.4 0.2 500.1 5.6 10.4 0.3 1.0 1.7 1.2 1.9 11.0 0.5 0.5 2.8 0.2 0.4 0.5 0.0 0.9 0.0 0.8 1.9 3.3 0.1 129.0 1.5 1.4 73.1 3.6 0.4 0.9 0.9 226.7 1.6 2.1 0.6 0.5 0.3 34.0 6.2 22.5 0.9 0.1 5094.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 10.7 246.5 0.0 2.7 0.5 2.0 29.3 0.7 12.8 0.0 0.0 0.8 0.1 116.6 1.0 0.3 0.1 0.5 0.0 14.9 0.5 0.4 0.2 0.5 0.0 0.0 0.0 0.0 9.7 0.1 0.3 0.4 6071.6 19.8 0.0 0.0 0.0 0.0 87.0 0.2 0.6 24.8 0.0 0.0 0.2 0.2 0.9 0.6 0.3 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.7 0.7 0.5 1.0 1.7 0.5 2.8 0.2 0.8 0.9 2.1 0.9 0.7 3.2 5.5 0.0 0.7 44.1 46.8 389.5 274.3 0.0 0.1 1.5 0.4 2.8 150.1 0.0 0.0 0.0 0.0 5.1 0.0 1.4 1.5 12.4 0.2 1.3 1.8 0.0 0.1 0.5 0.0 1.6 437.9 0.8 2.5 0.3 1.4 3.2 0.2 0.0 0.0 4.8 83.4 0.3 1.8 5.2 0.9 1.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 9.5 4.7 1.9 3.2 5.8 3.4 5.0 412.7 0.2 0.0 1.7 20.1 1.7 8.6 342.2 32.0 0.0 0.5 0.2 8.4 64.3 SMARCD2 "BAF60B, CRACD2, PRO2451, Rsc6p" ENSG00000108604 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Q92925 17 63832081-63843065 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059934, HPA061348" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059934: AB_2684170, HPA061348: AB_2684486" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-2)" "unprognostic (7.84e-2)" "unprognostic (4.79e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.75e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (1.81e-2)" "unprognostic (1.26e-1)" "unprognostic (1.79e-3)" "unprognostic (6.80e-2)" 51.5 55.6 24.9 45.0 29.6 72.2 66.6 37.3 28.5 45.7 30.6 50.4 51.5 37.7 59.0 71.8 53.4 33.4 30.2 24.6 27.6 26.5 55.3 47.1 66.6 30.7 29.3 22.6 38.6 90.3 43.1 37.0 48.2 31.0 53.1 47.0 17.8 78.7 49.4 25.5 93.9 50.2 32.7 28.3 61.1 68.7 43.0 27.0 70.8 34.1 34.5 70.7 52.8 56.4 33.7 142.9 87.9 21.3 93.0 133.6 196.1 139.7 52.5 64.1 97.5 61.7 101.7 76.8 163.0 32.5 79.0 43.9 99.4 65.7 99.1 57.3 61.1 169.5 109.3 40.3 141.7 102.3 159.5 128.9 154.3 122.0 55.3 42.1 56.4 78.3 110.8 89.5 101.7 57.2 279.1 203.8 132.3 51.3 202.0 96.9 195.0 77.8 185.0 66.9 96.0 80.2 145.9 79.2 228.4 97.1 69.3 212.2 121.7 58.4 67.7 52.5 61.4 90.7 119.8 113.2 113.5 54.1 129.6 50.4 4.2 9.1 8.8 9.4 8.4 5.6 7.2 9.9 9.8 12.1 9.5 6.3 8.5 10.8 8.0 10.0 10.1 11.5 6.0 24.9 29.6 37.3 28.5 24.6 27.6 30.7 29.3 22.6 31.0 28.3 27.0 33.7 14.8 28.9 42.4 19.9 18.2 22.9 23.6 14.3 26.2 9.7 47.1 41.0 5.9 30.0 25.2 16.5 6.2 54.9 21.1 36.0 3.9 16.9 1.0 17.6 25.3 17.4 33.0 12.6 7.2 19.6 38.2 25.8 18.8 20.7 14.0 88.1 25.7 83.3 22.0 11.8 5.8 42.0 12.2 36.9 19.6 5.4 49.4 23.1 14.2 8.4 31.9 16.9 15.5 6.6 10.7 21.0 26.2 30.9 12.6 19.0 30.0 11.6 23.8 12.4 32.9 21.9 14.6 12.3 22.4 29.7 31.1 52.9 16.7 101.7 40.8 24.1 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 169.4" "Cell type enhanced" "Detected in many" "Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 1260.8;TIME: 319.0" "Low region specificity" "Detected in all" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 730000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 87.7 11.4 36.2 30.6 33.2 20.9 79.4 34.4 48.7 20.3 35.5 25.0 14.2 24.6 6.8 12.2 22.4 19.0 73.6 32.0 34.4 33.5 14.7 85.2 61.0 36.4 34.9 29.9 12.8 15.5 9.1 12.5 79.9 36.0 16.2 18.4 1.3 16.2 8.6 38.2 15.6 34.5 29.8 35.3 169.4 18.9 3.5 38.3 31.8 33.9 56.4 42.2 33.3 21.6 39.5 0.0 0.0 0.0 0.0 11.3 10.8 3.2 1.1 0.7 0.3 1.1 2.7 52.2 92.9 16.6 0.0 0.3 0.4 1.2 0.0 1.7 22.3 0.0 82.9 4.4 10.0 1.8 14.2 0.3 0.4 0.0 0.8 0.2 0.0 1260.8 78.8 67.7 50.5 0.3 0.0 101.8 11.8 0.1 0.7 0.0 60.3 0.2 128.7 6.7 12.8 0.0 0.8 0.0 0.2 0.0 0.1 0.0 10.3 319.0 0.2 0.8 6.2 0.0 47.6 18.7 83.4 0.1 17.7 0.0 444.8 191.8 62.1 282.8 464.6 326.0 265.6 371.2 270.7 203.6 328.9 400.3 253.3 23.1 188.5 525.8 67.2 450.8 502.0 36.2 33.2 34.4 48.7 32.0 34.4 36.4 34.9 29.9 36.0 35.3 38.3 39.5 341.8 0.0 8.4 0.0 47.8 7.4 4.0 5.2 0.6 0.1 6.1 11.3 0.5 1.5 4.5 7.3 0.0 0.5 41.7 1.7 0.0 1.2 0.6 1.2 2.4 180.8 1.2 28.2 0.1 1.4 0.3 13.8 1.1 0.8 12.0 0.7 128.5 1.9 20.0 0.0 0.0 2.2 2.0 55.6 13.4 1.3 0.3 56.9 28.4 21.5 25.7 0.4 106.1 0.5 0.2 6.8 4.7 1.9 114.4 3.8 0.6 0.5 4.1 0.5 6.6 7.4 11.6 0.2 0.3 0.7 5.4 1.0 60.1 6.5 4.2 2.8 SYNGR2 ENSG00000108639 "Synaptogyrin 2" O43760 17 78168581-78173527 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 434.8;monocytes: 836.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 672.3;OE19: 547.9;SK-BR-3: 630.6;T-47d: 502.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014742 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014742: AB_2669079" "unprognostic (2.19e-2)" "unprognostic (1.05e-3)" "unprognostic (2.84e-1)" "unprognostic (6.77e-3)" "unprognostic (9.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-3)" "unprognostic (4.98e-2)" "unprognostic (1.26e-2)" "unprognostic (1.20e-2)" "unprognostic (9.44e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (4.74e-2)" "unprognostic (5.21e-2)" "unprognostic (3.51e-2)" "unprognostic (1.78e-2)" 90.0 60.2 47.3 100.3 64.3 113.9 106.4 68.5 64.0 59.7 51.4 102.4 87.2 57.2 22.8 134.9 76.2 71.3 124.3 45.1 69.1 101.4 101.8 159.4 145.0 82.1 66.2 39.4 45.7 190.5 53.4 91.9 62.2 76.1 131.8 71.8 2.8 186.3 46.1 372.9 161.7 126.4 33.5 68.5 149.3 142.9 32.1 63.3 68.9 69.3 123.6 113.5 92.9 88.6 87.8 172.5 334.5 9.0 73.9 3.2 1.1 52.5 58.6 60.2 55.0 31.4 200.9 173.6 136.9 123.2 33.5 47.8 245.5 39.9 95.0 16.2 97.2 177.2 47.0 46.9 140.8 76.1 77.3 356.5 3.4 105.1 17.5 47.2 77.9 118.7 50.4 193.9 672.3 5.3 337.4 77.3 79.6 24.4 547.9 140.1 44.3 19.2 391.4 166.7 155.5 53.8 60.2 48.6 630.6 60.3 31.7 502.8 122.2 31.7 1.1 54.2 28.1 77.8 280.7 109.7 79.8 39.7 52.8 9.5 694.4 656.1 237.9 173.6 944.7 202.1 970.0 231.0 200.2 907.6 972.1 204.6 168.6 282.5 219.8 1139.9 530.1 314.6 837.0 47.3 64.3 68.5 64.0 45.1 69.1 82.1 66.2 39.4 76.1 68.5 63.3 87.8 56.1 128.2 113.4 3.3 226.6 124.1 136.1 170.9 79.1 3.3 126.5 84.1 63.0 68.6 153.2 171.0 6.2 169.7 63.1 125.2 9.8 313.6 3.6 41.2 9.6 83.5 72.6 70.2 2.4 434.8 59.1 27.9 104.5 89.7 103.0 25.3 56.4 46.9 255.5 5.0 1.2 327.6 193.3 137.9 330.6 4.9 22.1 150.3 74.7 16.9 836.7 5.1 24.7 2.5 31.3 286.5 160.9 17.0 159.2 282.4 77.5 36.2 63.4 3.9 39.5 26.0 46.2 13.4 12.3 120.1 163.4 179.5 58.8 11.4 212.8 216.8 B9D1 "B9, EPPB9, MKS9, MKSR-1" ENSG00000108641 "B9 domain containing 1" Q9UPM9 17 19334308-19378193 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 226.2;Endometrial ciliated cells: 99.7;Late spermatids: 171.8;Respiratory ciliated cells: 159.5;Spermatocytes: 141.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022957 Approved "Intracellular and membrane" NA NA "HPA022957: AB_1848220" "unprognostic (3.13e-2)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (3.66e-3)" "unprognostic (9.82e-3)" "unprognostic (1.37e-2)" "unprognostic (6.57e-3)" "unprognostic (1.32e-1)" "unprognostic (1.29e-1)" "unprognostic (1.46e-2)" "unprognostic (1.83e-2)" "unprognostic (2.21e-1)" "prognostic favorable (4.14e-4)" "unprognostic (3.21e-2)" "unprognostic (1.27e-1)" "unprognostic (1.23e-1)" "unprognostic (1.18e-3)" 6.5 21.1 20.7 3.9 20.7 5.8 12.4 16.1 23.2 14.0 32.1 9.0 6.1 15.5 55.2 9.4 63.2 11.2 12.9 20.2 27.5 24.5 10.4 9.6 3.9 17.1 19.1 17.8 15.9 22.3 34.5 61.3 5.1 16.6 11.4 7.6 22.0 11.5 18.2 5.9 6.8 5.4 11.9 17.0 7.5 10.5 65.8 17.4 3.7 39.8 5.4 4.5 8.2 7.9 17.1 66.7 61.2 14.9 20.9 18.8 29.2 18.6 10.9 55.8 35.4 37.5 14.1 17.6 18.0 13.9 21.3 20.6 27.3 11.2 31.6 22.1 6.2 41.0 1.1 30.8 43.8 30.6 4.3 2.9 23.4 24.4 22.2 42.0 50.3 33.2 21.5 10.5 2.0 33.2 57.6 2.1 5.3 10.7 32.0 21.3 11.6 1.6 29.9 74.9 4.5 43.6 10.8 22.8 5.7 15.5 42.7 47.1 7.2 6.4 9.4 23.2 10.4 11.7 11.6 2.3 5.5 23.0 2.4 15.7 0.0 0.6 0.0 0.7 1.8 0.9 2.2 0.5 0.6 0.2 0.4 0.6 0.4 0.0 0.8 1.6 0.3 0.2 1.0 20.7 20.7 16.1 23.2 20.2 27.5 17.1 19.1 17.8 16.6 17.0 17.4 17.1 1.5 16.0 11.9 13.4 8.1 3.8 10.7 23.0 13.1 5.8 10.5 13.6 10.9 8.6 19.9 38.6 12.5 4.4 0.7 2.6 64.6 19.8 226.2 99.7 8.1 4.9 20.4 9.0 14.5 14.6 4.8 14.6 12.2 5.9 0.0 9.5 3.3 4.6 5.4 5.0 10.6 12.8 14.2 1.0 1.7 171.8 13.1 2.3 16.0 1.9 1.3 14.0 1.0 10.1 8.2 9.6 2.9 9.8 27.2 11.1 1.3 82.6 159.5 16.6 6.6 7.3 30.8 141.5 26.8 14.2 2.0 2.6 2.1 25.2 7.3 7.0 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6 small subunit processome component" Q9NYH9 17 31860904-31901708 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA025936: AB_1845588, HPA055806: AB_2682930" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 16.7 14.5 25.4 7.8 25.5 9.6 15.9 26.0 40.1 20.7 26.5 16.2 4.5 15.4 13.0 17.9 17.2 4.3 16.0 25.4 25.3 17.3 24.6 14.6 11.4 25.1 25.0 25.1 20.7 19.2 5.1 19.9 6.4 25.3 22.5 6.5 10.3 13.2 5.8 16.3 16.6 17.2 6.9 24.8 25.9 15.2 18.9 25.3 9.2 18.1 6.4 12.6 16.9 17.2 25.9 14.4 9.0 12.3 7.4 11.9 8.0 15.3 11.8 6.7 17.6 13.6 32.8 7.8 20.9 14.0 11.3 16.7 18.6 16.7 14.1 16.0 4.6 26.4 13.1 21.2 31.6 14.1 19.8 13.5 13.2 15.1 16.7 12.5 16.3 11.4 13.2 23.1 11.9 13.8 11.6 19.4 56.4 16.9 17.2 14.6 20.6 17.8 21.4 19.0 12.9 8.4 12.8 12.5 9.3 22.7 19.4 22.7 39.0 11.5 27.8 20.5 14.3 24.3 13.0 25.9 31.8 18.9 14.4 15.4 15.5 10.6 7.4 7.1 11.3 7.0 12.6 7.7 7.7 14.7 15.2 6.6 7.7 13.7 5.9 11.1 21.3 8.1 7.8 25.4 25.5 26.0 40.1 25.4 25.3 25.1 25.0 25.1 25.3 24.8 25.3 25.9 22.5 19.2 24.3 17.9 32.7 25.7 30.7 29.1 12.5 16.7 13.5 16.3 15.6 14.3 31.7 5.5 8.4 42.4 34.3 10.6 9.8 29.7 35.6 23.4 29.0 21.1 5.4 29.5 23.0 24.0 50.3 26.2 16.3 33.5 36.2 20.5 12.1 15.6 35.8 11.8 21.4 16.3 20.3 21.0 17.6 5.4 18.6 29.4 8.8 18.7 43.4 16.4 7.2 17.6 16.2 26.3 8.4 17.0 17.4 31.9 12.7 18.5 30.3 16.4 6.6 28.2 23.7 102.9 66.2 17.2 26.0 38.3 19.9 21.0 16.7 31.2 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64498254-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 310000 "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 189.5 125.0 81.6 76.4 84.3 221.4 164.8 98.3 96.8 192.1 123.5 147.5 36.4 183.2 62.4 138.1 182.8 188.0 110.5 90.3 142.1 114.7 158.9 187.5 125.6 92.7 85.5 70.5 135.4 84.0 179.1 119.8 120.4 87.0 123.9 159.2 213.5 112.9 146.2 167.0 129.6 117.3 277.0 73.2 128.5 138.3 89.5 80.6 275.0 174.4 108.5 158.8 230.4 130.0 105.1 204.7 85.5 353.1 144.4 316.2 316.7 134.1 221.4 349.8 306.9 300.3 98.2 105.3 299.7 102.0 364.8 238.1 87.1 361.6 291.5 428.2 107.7 76.0 211.2 84.5 81.6 216.6 383.9 186.3 301.4 306.8 270.2 264.1 241.5 362.2 303.6 174.3 247.3 284.0 108.7 520.4 44.8 159.5 294.5 32.0 310.1 286.7 239.1 201.8 145.6 151.0 305.7 181.5 167.6 284.0 326.5 138.5 132.1 158.2 123.0 146.3 170.0 207.3 112.2 283.9 622.0 166.6 140.5 184.2 232.6 160.6 170.0 117.2 143.3 149.8 111.5 105.4 125.4 148.5 106.3 107.6 109.4 86.6 112.2 197.1 85.5 135.9 319.9 81.6 84.3 98.3 96.8 90.3 142.1 92.7 85.5 70.5 87.0 73.2 80.6 105.1 990.8 535.2 690.9 200.8 909.4 879.5 1536.4 837.0 618.1 403.5 433.3 393.7 249.6 346.0 855.7 369.6 335.7 439.9 1284.6 521.5 334.6 476.2 603.0 1021.9 987.2 767.7 664.1 309.7 187.9 419.2 371.3 733.5 452.1 1288.8 874.3 647.9 528.7 254.3 445.8 420.6 165.7 475.9 801.5 577.8 629.4 136.9 415.4 833.2 432.2 280.1 800.2 587.1 777.5 291.6 325.7 464.2 598.6 437.8 661.5 537.7 552.6 287.5 737.9 550.4 493.0 1437.7 961.5 407.6 399.1 466.4 746.0 887.3 1043.4 745.0 424.7 1056.4 C17orf75 "NJMU-R1, SRI2" ENSG00000108666 "Chromosome 17 open reading frame 75" Q9HAS0 17 32324565-32350023 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004061, HPA075333" Approved Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA004061: AB_1078337, HPA075333: " "unprognostic (4.21e-2)" "unprognostic (2.49e-2)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (1.51e-1)" "unprognostic (4.73e-2)" "unprognostic (1.07e-3)" "unprognostic (6.36e-2)" "unprognostic (3.29e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.92e-2)" "unprognostic (7.80e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.09e-1)" "unprognostic (1.29e-1)" "unprognostic (4.27e-2)" "unprognostic (5.60e-2)" 8.2 16.1 11.3 10.4 11.9 7.6 13.3 12.7 13.6 8.9 12.0 11.9 13.4 12.5 18.9 8.8 15.2 7.0 19.5 11.2 12.8 21.5 14.6 8.8 13.0 11.7 11.7 11.2 16.2 13.3 28.1 13.5 10.5 12.5 11.7 12.7 26.4 12.3 10.7 17.6 6.9 10.9 10.5 10.6 9.6 13.1 26.6 12.0 16.2 14.2 14.4 13.3 9.7 8.3 11.9 39.2 33.4 51.0 15.5 13.3 14.5 27.9 25.5 22.4 34.3 29.1 18.2 14.9 23.5 28.6 18.2 52.6 42.5 32.8 27.6 46.6 18.0 37.9 18.7 39.8 39.5 26.6 26.3 14.1 13.4 33.0 25.2 17.4 28.6 25.3 43.6 38.9 31.8 22.8 29.2 76.5 26.9 37.7 23.9 14.7 50.1 31.5 44.0 21.4 18.2 50.4 44.3 21.1 19.1 62.7 37.2 50.4 16.8 19.8 18.8 35.4 9.3 42.4 42.5 51.0 82.9 15.3 23.0 5.7 34.6 12.4 16.4 17.6 12.0 20.1 18.2 16.9 18.3 16.1 19.9 18.2 17.0 3.2 19.0 17.1 12.8 19.6 15.4 11.3 11.9 12.7 13.6 11.2 12.8 11.7 11.7 11.2 12.5 10.6 12.0 11.9 12.6 12.8 30.7 7.2 13.8 5.9 13.4 27.8 12.5 25.0 11.3 13.5 25.8 8.6 19.3 14.7 8.4 31.8 10.7 3.8 43.0 16.2 10.0 17.2 8.8 10.5 12.6 13.5 11.1 13.8 18.0 9.8 9.7 10.5 11.4 18.3 6.4 11.0 9.7 32.0 15.0 8.0 28.5 7.5 3.7 6.3 7.5 7.8 5.4 2.8 6.7 17.5 11.3 10.1 8.7 11.8 3.2 8.2 14.0 6.4 6.9 29.9 29.9 23.0 39.5 9.7 13.1 88.0 31.8 12.0 6.1 16.3 15.1 10.5 8.4 8.2 CYTH1 "B2-1, cytohesin-1, D17S811E, PSCD1" ENSG00000108669 "Cytohesin 1" Q15438 17 78674048-78782297 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 98.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047498 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047498: " "unprognostic (3.82e-3)" "unprognostic (5.49e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.48e-4)" "unprognostic (6.60e-2)" "unprognostic (3.47e-2)" "unprognostic (3.26e-1)" "unprognostic (9.69e-2)" "unprognostic (4.94e-2)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (4.14e-2)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" 29.9 26.4 41.3 52.8 50.7 69.6 23.6 44.1 43.4 15.4 40.7 30.4 22.9 12.7 8.7 51.3 16.5 26.0 25.5 39.4 45.5 23.0 34.1 44.9 79.5 50.2 51.2 34.7 10.2 29.6 10.8 14.9 27.4 54.7 24.8 33.2 83.6 32.3 8.1 36.1 31.0 41.7 16.8 43.9 58.0 43.4 16.0 48.1 59.4 26.4 23.1 89.8 25.3 25.8 68.5 24.6 16.9 16.6 14.3 11.2 14.1 15.9 11.4 10.0 13.6 15.9 10.7 26.8 18.2 11.1 15.0 23.3 21.2 8.1 29.6 10.9 38.4 22.5 7.4 22.9 19.8 8.0 15.3 70.5 6.9 23.9 15.5 15.9 9.3 44.4 59.9 12.4 68.1 16.3 12.5 98.7 13.6 4.2 39.7 14.9 25.9 18.4 64.3 14.8 16.9 9.5 34.6 20.0 38.2 16.6 16.7 18.8 17.7 21.2 10.7 15.6 17.1 11.8 78.5 39.0 66.0 7.9 15.1 11.4 150.2 41.6 85.6 96.5 51.5 69.1 63.6 79.6 78.5 35.9 55.4 86.4 74.7 85.9 59.0 48.8 49.3 66.2 93.6 41.3 50.7 44.1 43.4 39.4 45.5 50.2 51.2 34.7 54.7 43.9 48.1 68.5 65.9 60.9 52.1 48.3 83.4 41.2 31.0 28.1 45.5 65.5 18.4 14.9 18.8 18.6 34.5 5.5 110.5 3.0 123.6 50.4 7.9 12.1 29.6 62.6 17.4 58.9 27.6 11.2 29.9 18.5 8.3 16.5 58.6 110.3 36.0 13.7 27.8 28.7 48.9 43.7 58.9 49.3 34.6 80.2 135.1 46.1 4.4 76.8 37.4 61.8 121.7 21.1 122.6 52.3 170.9 42.7 32.8 5.3 88.6 39.0 16.3 6.9 50.5 78.3 6.6 8.6 10.4 16.0 15.6 54.8 34.4 7.3 113.1 10.6 20.6 58.4 PSMD11 "MGC3844, p44.5, Rpn6, S9" ENSG00000108671 "Proteasome 26S subunit, non-ATPase 11" O00231 17 32444379-32483319 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 308.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042275, HPA067433" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 95000 "Nucleoplasm, Golgi apparatus" "HPA042275: AB_10794793, HPA067433: AB_2685838" "unprognostic (1.16e-1)" "unprognostic (2.71e-1)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.64e-2)" "unprognostic (3.97e-1)" "unprognostic (8.10e-2)" "unprognostic (5.88e-2)" "unprognostic (9.17e-3)" "prognostic unfavorable (5.73e-6)" "unprognostic (9.39e-3)" "unprognostic (6.65e-2)" "unprognostic (2.90e-1)" "unprognostic (2.17e-2)" 27.2 26.7 25.7 29.7 26.8 34.8 22.8 25.3 30.5 21.4 21.8 27.6 27.4 29.0 23.3 36.6 22.0 22.9 35.8 28.3 27.0 30.4 38.1 24.5 30.4 28.1 26.6 27.0 20.8 26.2 35.2 18.7 34.4 28.7 25.2 32.3 24.1 23.5 22.0 96.8 33.9 23.4 35.3 26.1 24.2 23.1 34.6 27.0 38.7 21.8 59.2 39.5 34.3 25.0 32.2 127.0 136.8 98.4 106.2 65.4 48.4 103.8 71.5 90.0 151.9 122.0 139.9 111.5 99.1 110.7 77.0 145.9 143.0 114.5 98.5 147.8 50.9 81.2 81.0 68.7 108.3 63.3 95.5 81.6 43.7 51.0 134.3 91.8 49.0 108.7 87.0 155.5 110.9 90.8 78.0 143.1 57.4 134.5 67.4 68.8 89.2 127.2 132.4 75.2 92.2 86.3 58.8 89.8 63.4 71.0 100.3 154.2 45.1 77.8 84.3 99.5 105.6 166.5 62.2 105.0 129.1 122.5 74.8 145.2 48.3 41.2 26.7 40.2 41.8 44.2 36.3 39.1 40.6 46.6 34.2 34.5 36.4 19.1 47.7 45.6 38.2 51.5 45.6 25.7 26.8 25.3 30.5 28.3 27.0 28.1 26.6 27.0 28.7 26.1 27.0 32.2 62.7 48.1 31.5 36.6 56.3 126.9 108.7 116.3 44.9 44.5 47.8 40.8 71.9 41.5 78.0 25.8 31.3 178.2 57.8 87.5 80.3 117.8 205.4 45.8 46.2 69.7 48.8 100.8 36.0 107.3 146.1 63.8 43.8 59.9 45.7 79.8 55.3 107.0 92.3 37.0 36.4 58.7 77.3 48.4 72.6 48.0 49.0 61.1 26.6 15.9 77.5 63.1 40.2 33.2 55.6 117.2 48.0 48.5 79.3 131.9 66.4 120.6 52.6 43.3 52.6 68.0 189.7 152.7 98.4 85.3 117.5 308.9 54.8 52.0 67.6 109.5 LGALS3BP "90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B" ENSG00000108679 "Galectin 3 binding protein" Q08380 17 78971238-78979947 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 629.8;Paneth cells: 584.1;Proximal enterocytes: 931.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "monocytes: 27.2;T-cells: 68.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 862.9;SK-BR-3: 2270.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000410, HPA000554" Uncertain "Secreted to blood" NA NA 7100000000 "HPA000410: , HPA000554: AB_1079246" "unprognostic (1.23e-2)" "unprognostic (1.40e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.63e-3)" "unprognostic (1.62e-2)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (1.57e-2)" "unprognostic (4.55e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (1.58e-1)" "unprognostic (1.65e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" 194.5 220.4 45.0 75.7 71.6 49.1 110.4 82.3 54.0 190.4 133.8 212.7 315.7 122.4 45.6 115.2 156.9 242.9 314.3 36.1 112.4 102.9 69.1 184.4 53.1 134.2 71.2 23.9 156.9 79.8 108.7 136.0 148.2 97.4 115.3 93.4 10.1 503.0 155.6 20.2 54.4 263.0 80.9 90.2 77.5 318.4 70.7 76.3 49.2 103.0 20.6 25.5 126.2 120.0 145.9 499.0 255.3 7.2 11.2 157.3 181.4 147.9 55.7 49.0 371.3 725.7 107.5 862.9 2.8 372.7 33.5 361.7 200.1 53.6 203.7 11.5 1.2 319.0 33.8 206.0 481.0 387.7 0.4 31.6 305.8 111.5 197.5 12.6 83.8 9.9 68.7 3.4 1.5 87.7 62.8 151.2 6.0 13.0 163.7 170.7 100.1 209.9 4.8 155.5 352.6 235.1 267.4 52.7 2270.3 754.5 14.0 57.5 16.1 16.3 245.5 169.8 7.1 225.8 0.8 2.2 3.7 332.1 96.8 263.7 0.8 17.7 4.9 12.0 27.2 25.0 4.7 43.3 17.9 7.6 2.4 68.4 33.0 1.2 9.4 14.7 0.6 26.0 25.1 45.0 71.6 82.3 54.0 36.1 112.4 134.2 71.2 23.9 97.4 90.2 76.3 145.9 88.0 189.1 144.3 9.8 5.6 31.1 146.8 462.5 60.3 37.2 60.5 43.1 180.7 127.2 306.2 139.8 6.2 179.1 3.4 629.8 17.6 275.0 7.2 77.4 118.7 26.8 168.2 4.4 0.3 136.5 336.0 284.6 257.9 126.9 13.3 316.5 46.8 45.8 88.3 74.0 5.3 328.7 309.3 36.8 23.7 37.1 282.7 36.0 81.8 8.4 27.9 80.8 2.1 11.6 33.9 132.4 584.1 266.3 3.5 72.4 931.4 49.2 123.9 24.3 177.5 80.5 119.6 4.5 2.1 83.8 27.3 108.9 15.4 228.3 400.5 128.2 ASIC2 "ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG" ENSG00000108684 "Acid sensing ion channel subunit 2" Q16515 17 33013087-34174964 "Plasma proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.7;cervix: 3.1;endometrium 1: 3.4;retina: 4.6" "Group enriched" "Detected in some" 8 "Excitatory neurons: 1786.2;Inhibitory neurons: 666.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;RPTEC TERT1: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052112 Enhanced NA NA "HPA052112: AB_2681733" "unprognostic (3.40e-1)" "unprognostic (2.45e-2)" "unprognostic (8.50e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-3)" "unprognostic (5.29e-2)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" 0.0 0.6 9.2 0.0 11.6 0.0 0.1 4.7 10.4 3.1 0.1 0.1 0.4 3.4 0.0 0.0 0.6 0.0 0.0 12.7 6.6 0.5 0.0 0.0 0.0 6.8 5.1 10.1 0.0 0.0 0.0 0.5 0.0 3.0 0.1 0.1 4.6 0.0 0.5 0.0 0.1 0.3 1.4 2.9 0.0 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.1 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.6 4.7 10.4 12.7 6.6 6.8 5.1 10.1 3.0 2.9 5.5 8.7 0.0 0.0 0.0 17.0 0.0 0.3 0.0 0.0 0.0 25.7 0.0 0.0 1.3 0.0 0.0 9.2 2.1 0.0 0.0 0.1 0.0 0.1 16.3 0.1 0.8 0.1 6.0 0.0 1786.2 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 10.1 666.4 1.3 0.0 0.0 0.0 47.1 0.3 0.1 1.8 26.2 0.0 0.5 0.0 144.3 22.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.1 0.0 1.2 0.0 CCL7 "FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7" ENSG00000108688 "C-C motif chemokine ligand 7" P80098 17 34270221-34272242 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "bone marrow: 26.1" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 56.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.5;BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 2.8;HSkMC: 3.3" "Not detected" "Not detected" "Secreted to blood" NA NA 29700 "unprognostic (7.66e-2)" "unprognostic (1.05e-2)" "unprognostic (8.53e-2)" "unprognostic (4.65e-2)" "unprognostic (2.54e-2)" "unprognostic (9.54e-2)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (2.63e-2)" "unprognostic (2.27e-3)" "unprognostic (7.04e-2)" "unprognostic (1.99e-8)" "unprognostic (2.83e-1)" "unprognostic (8.74e-2)" "unprognostic (3.74e-1)" "unprognostic (1.79e-2)" 0.8 0.3 0.0 2.5 0.0 26.1 0.1 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.9 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 1.7 0.3 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.3 11.5 2.3 2.8 0.0 0.0 0.0 0.4 0.8 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 3.3 0.0 0.9 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 CCL2 "GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF" ENSG00000108691 "C-C motif chemokine ligand 2" P13500 17 34255218-34257203 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 763.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 7.5;eosinophil: 3.0" "Group enriched" "Detected in many" 6 "granulocytes: 3.0;monocytes: 7.5" "Group enriched" "Detected in many" 4 "BJ hTERT+: 1902.2;HMC-1: 2427.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "midbrain: 9.9;spinal cord: 39.4" "CAB013676, HPA019163" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 323000 "Golgi apparatus" Vesicles "CAB013676: , HPA019163: AB_1846179" "unprognostic (6.43e-2)" "unprognostic (4.14e-2)" "unprognostic (4.78e-2)" "unprognostic (5.57e-2)" "unprognostic (2.37e-3)" "unprognostic (8.64e-2)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-1)" "unprognostic (9.33e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (1.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.81e-1)" "unprognostic (4.92e-2)" 212.9 130.8 14.1 168.7 13.6 97.4 77.5 13.5 27.7 20.6 31.4 136.5 41.6 30.5 15.1 47.6 86.4 258.8 247.0 13.5 47.1 117.0 162.5 408.7 79.0 33.1 14.4 12.1 19.5 142.8 34.9 71.0 39.4 27.0 154.4 104.5 11.6 47.4 45.8 19.8 38.0 81.0 152.0 21.1 73.8 122.3 12.2 36.2 144.0 85.1 47.4 16.7 763.3 36.6 28.5 0.1 15.3 40.4 0.0 110.7 94.5 0.3 116.6 1902.2 243.3 516.8 7.1 0.2 0.3 90.4 27.6 3.8 64.0 4.3 0.1 122.9 0.6 0.9 0.2 13.5 0.0 3.5 0.4 2427.9 105.9 0.0 50.6 2.9 162.6 112.4 0.0 6.5 20.2 0.0 0.0 0.7 19.6 5.8 0.0 0.4 0.6 3.3 20.9 354.7 0.0 0.1 8.1 0.3 6.0 3.3 108.4 4.6 2.5 6.4 129.0 5.7 3.6 0.7 1.2 0.5 0.1 75.7 37.6 84.3 0.0 7.5 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.6 14.1 13.6 13.5 27.7 13.5 47.1 33.1 14.4 12.1 27.0 21.1 36.2 28.5 218.3 182.7 126.5 2.0 3.6 568.6 866.2 595.3 1152.5 0.1 23.5 50.9 29.5 92.9 120.7 138.0 0.0 2.7 2.2 0.0 0.0 3382.2 0.0 8.4 37.8 577.2 0.0 0.0 0.7 919.2 3.6 840.5 5.6 11.4 353.0 0.1 50.3 0.4 439.1 0.0 0.1 0.0 6.1 8.9 408.5 0.4 12.2 593.1 213.5 8.4 37.8 13.8 0.0 0.0 0.1 781.2 0.0 1.5 2.9 889.0 0.0 67.7 27.7 0.7 131.5 994.7 1507.0 0.4 0.3 13.0 222.8 4.5 44.3 1.7 0.1 40.6 CCL8 "HC14, MCP-2, SCYA8" ENSG00000108700 "C-C motif chemokine ligand 8" P80075 17 34319435-34321402 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Smooth muscle cells: 104.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 6 "classical monocyte: 3.4" "Lineage enriched" "Detected in single" 6 "monocytes: 3.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;EFO-21: 2.1;HSkMC: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 32000 "unprognostic (7.51e-2)" "unprognostic (3.20e-1)" "unprognostic (1.90e-2)" "unprognostic (4.03e-2)" "unprognostic (8.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.52e-1)" "unprognostic (1.65e-1)" "unprognostic (9.97e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.05e-7)" "unprognostic (1.39e-1)" "unprognostic (1.88e-2)" "unprognostic (5.65e-2)" "unprognostic (3.41e-2)" 17.7 4.7 0.4 5.1 0.4 1.8 6.2 0.4 0.9 1.5 1.1 18.3 14.2 7.3 1.9 3.5 1.4 8.8 2.7 0.4 0.6 5.1 3.2 7.2 4.0 0.7 0.4 0.4 1.4 1.1 4.9 0.5 7.2 0.4 2.3 16.6 0.0 1.9 1.4 0.4 0.5 17.1 9.4 0.4 3.0 3.0 3.2 0.9 12.6 2.3 7.1 0.5 13.8 0.3 1.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.4 0.9 0.4 0.6 0.7 0.4 0.4 0.4 0.4 0.9 1.9 21.5 0.0 0.0 0.0 0.1 4.2 0.3 0.5 0.0 0.0 0.9 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 10.5 0.9 7.5 9.6 0.0 0.0 0.0 2.0 0.0 16.4 0.0 1.6 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 3.5 18.6 2.2 0.0 12.7 5.4 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 104.3 0.0 0.0 0.0 5.4 0.1 0.8 0.7 0.0 0.1 CCL1 "I-309, P500, SCYA1, SISe, TCA3" ENSG00000108702 "C-C motif chemokine ligand 1" P22362 17 34360328-34363233 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.2;lymphoid tissue: 1.2" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;granulocytes: 8.9;Late spermatids: 1.6;T-cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 38 "HMC-1: 702.6" HPA049861 Uncertain "Secreted to blood" NA NA 84400 "HPA049861: AB_2680919" "unprognostic (6.52e-2)" "unprognostic (4.81e-3)" "unprognostic (5.84e-2)" "unprognostic (5.01e-1)" "unprognostic (6.04e-1)" "unprognostic (2.71e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 702.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.4 0.8 0.5 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 PEX12 ENSG00000108733 "Peroxisomal biogenesis factor 12" O00623 17 35574795-35578863 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 17.2;Spermatocytes: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069386 Enhanced NA NA "HPA069386: AB_2686135" "unprognostic (1.45e-1)" "unprognostic (6.06e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-1)" "unprognostic (1.72e-1)" "unprognostic (1.17e-1)" "unprognostic (1.98e-1)" "unprognostic (9.04e-2)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (5.55e-2)" "unprognostic (2.64e-2)" "prognostic favorable (3.58e-5)" "unprognostic (2.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" 3.9 6.9 6.5 3.7 7.1 1.5 5.5 7.8 9.2 5.3 6.5 3.1 3.6 4.4 10.8 3.5 5.6 3.3 9.2 6.6 6.9 8.3 9.1 3.4 4.8 6.6 6.9 6.2 8.3 4.0 7.9 4.7 4.8 6.6 5.8 2.9 4.7 5.5 7.0 10.4 4.2 3.5 3.5 7.0 3.9 4.0 6.8 6.9 3.2 7.7 10.9 4.5 3.7 2.8 8.2 2.8 3.7 5.4 4.4 11.0 9.9 3.9 7.3 8.3 6.0 6.3 3.2 3.0 6.4 11.6 4.1 4.9 7.3 6.6 4.8 5.2 2.3 8.7 4.7 3.8 5.9 12.8 6.7 1.2 9.2 9.2 3.7 10.9 7.7 4.6 5.2 7.5 6.6 7.2 2.9 7.9 3.8 2.2 6.3 5.8 3.8 9.3 6.4 7.1 4.2 4.0 4.0 4.6 3.0 9.6 6.5 7.4 3.7 3.7 5.6 3.5 6.3 4.9 13.3 9.9 7.5 6.0 5.1 5.2 2.2 1.5 3.0 1.8 1.1 3.2 2.3 3.0 1.8 1.7 2.6 4.1 3.5 1.0 2.0 1.2 1.7 2.4 1.4 6.5 7.1 7.8 9.2 6.6 6.9 6.6 6.9 6.2 6.6 7.0 6.9 8.2 2.7 3.2 0.5 6.5 3.3 0.6 1.9 1.3 1.8 2.1 2.4 2.2 6.3 0.0 2.7 3.7 0.0 6.7 1.4 1.3 3.9 3.5 17.2 1.9 2.3 3.9 1.2 0.8 1.3 1.1 4.1 2.6 2.6 1.5 2.5 2.0 3.3 5.4 2.9 1.7 1.9 1.7 2.0 2.6 0.6 3.0 3.1 1.5 1.8 1.0 0.9 8.3 1.0 4.5 2.8 2.2 1.0 1.5 0.5 2.4 2.7 3.3 1.8 2.2 0.0 2.6 3.7 21.0 10.2 1.4 1.3 5.2 2.8 3.0 2.2 1.3 KRT32 "Ha-2, KRTHA2" ENSG00000108759 "Keratin 32" Q14532 17 41459513-41467386 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 5.9;skin 1: 12.9" "Group enriched" "Detected in some" 6 "Basal squamous epithelial cells: 21.6;Squamous epithelial cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 210000000 "unprognostic (1.39e-2)" "unprognostic (3.29e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "unprognostic (2.32e-2)" "unprognostic (2.67e-3)" "unprognostic (2.72e-9)" "unprognostic (1.31e-2)" "unprognostic (1.77e-1)" 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 0.8 21.6 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.4 0.0 0.4 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112714 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "monocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favorable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 9.0 12.0 5.2 10.3 5.3 12.4 7.7 4.4 7.5 7.1 4.9 6.5 8.5 7.1 5.9 6.4 11.6 12.2 4.9 4.1 5.7 7.3 14.6 11.9 12.6 6.2 5.1 3.8 12.0 6.0 7.3 6.9 7.1 5.5 8.8 5.1 0.6 18.8 8.3 3.8 7.6 8.6 7.4 4.9 18.5 9.4 10.9 4.8 12.6 5.6 4.3 7.4 8.0 5.9 10.4 2.5 0.0 0.1 1.3 11.3 9.9 0.3 3.3 22.4 45.5 52.9 0.3 14.6 0.2 3.4 5.4 10.2 2.0 0.2 3.5 1.7 9.3 0.3 3.9 2.6 0.9 12.6 3.6 8.6 15.9 5.9 4.0 3.9 8.0 5.5 23.5 0.0 12.8 2.5 0.0 21.7 4.5 0.4 0.6 0.0 7.8 0.0 1.2 5.2 8.6 0.4 0.0 1.5 5.9 27.0 0.0 7.9 3.8 2.4 2.3 0.1 0.8 1.1 4.3 3.8 0.2 4.6 3.3 2.6 2.3 7.7 6.9 3.1 9.7 4.8 4.6 4.7 2.9 5.9 3.5 5.1 3.8 3.2 6.8 8.6 2.0 4.4 5.0 5.2 5.3 4.4 7.5 4.1 5.7 6.2 5.1 3.8 5.5 4.9 4.8 10.4 9.1 9.6 3.4 6.8 4.8 1.5 3.9 6.2 3.4 1.0 3.5 3.7 1.7 8.6 7.6 7.3 0.0 4.0 4.7 2.3 1.9 7.0 9.0 4.5 2.9 7.0 0.0 0.4 1.9 6.9 4.6 4.1 3.6 4.0 1.3 7.5 3.3 14.0 9.8 0.0 2.4 3.2 4.1 7.0 0.7 12.1 8.7 7.4 3.6 8.4 39.9 2.4 2.1 4.0 1.8 5.7 4.3 9.1 1.3 5.4 3.9 5.7 11.6 0.6 0.0 3.7 3.8 18.1 1.0 2.3 1.6 0.8 6.6 8.2 1.9 2.9 KAT2A "GCN5, GCN5L2, PCAF-b" ENSG00000108773 "Lysine acetyltransferase 2A" Q92830 17 42113111-42121367 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048958 Uncertain NA NA "HPA048958: AB_2680571" "unprognostic (1.71e-1)" "unprognostic (9.08e-2)" "unprognostic (1.66e-1)" "unprognostic (2.31e-1)" "unprognostic (3.41e-1)" "unprognostic (9.07e-2)" "unprognostic (1.91e-3)" "unprognostic (3.87e-2)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.78e-2)" "prognostic unfavorable (1.41e-8)" "unprognostic (3.97e-2)" "unprognostic (2.90e-1)" "unprognostic (1.89e-1)" "unprognostic (2.29e-3)" 12.3 21.0 11.2 6.5 9.7 4.2 13.3 6.0 19.0 19.3 2.4 14.0 6.7 17.3 1.7 14.8 21.2 3.1 9.9 9.3 8.4 12.3 15.8 9.8 5.4 9.9 8.8 7.5 28.6 17.0 5.8 14.5 4.7 13.3 17.1 4.0 1.0 10.0 4.4 11.9 14.4 13.6 3.4 3.9 17.6 13.1 10.9 13.4 4.7 14.8 2.1 4.6 15.7 16.5 14.4 24.7 46.6 6.8 25.3 9.3 7.6 29.7 15.7 8.3 34.0 16.7 31.9 19.5 48.1 38.6 12.1 25.6 36.0 27.9 25.0 12.1 27.0 58.0 12.0 29.8 28.8 9.7 32.3 30.8 9.0 20.8 19.1 11.9 9.2 13.8 11.9 30.7 8.9 9.1 26.4 77.7 23.5 14.5 60.9 0.0 18.3 13.3 31.9 9.2 24.4 32.4 14.2 16.8 36.2 13.2 5.1 26.9 15.3 10.7 17.1 17.4 25.1 28.2 23.8 24.5 26.9 12.5 27.5 9.7 0.0 0.1 0.0 0.2 0.0 0.4 0.5 0.5 0.6 0.4 0.3 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.2 11.2 9.7 6.0 19.0 9.3 8.4 9.9 8.8 7.5 13.3 3.9 13.4 14.4 21.5 12.8 11.5 84.5 19.0 12.2 12.6 6.8 26.2 16.5 18.9 22.7 7.1 18.6 6.6 18.4 10.4 25.1 10.7 7.9 3.9 9.2 1.3 5.9 11.3 18.4 15.7 6.7 39.6 8.0 20.5 12.1 17.3 8.2 11.4 25.8 22.5 20.2 12.1 10.1 41.0 10.1 6.1 10.9 6.8 3.7 32.6 9.8 7.2 32.8 5.2 3.7 5.2 41.7 28.3 6.7 7.3 29.0 7.2 10.9 4.0 4.1 5.4 7.8 13.1 15.1 10.8 5.2 18.2 18.7 13.9 11.2 7.8 26.4 20.2 9.1 RAB5C "RAB5CL, RABL" ENSG00000108774 "RAB5C, member RAS oncogene family" P51148 17 42124978-42155044 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003426, HPA004167" Approved Enhanced Endosomes NA NA 480000 Endosomes "HPA003426: AB_1079735, HPA004167: AB_2667156" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "unprognostic (6.75e-3)" "unprognostic (3.69e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.56e-3)" "unprognostic (4.85e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (6.06e-3)" "unprognostic (4.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.12e-2)" 132.9 119.0 83.7 114.7 88.9 205.3 120.4 89.1 108.7 88.5 71.6 107.9 136.9 104.0 67.9 93.1 88.1 89.4 68.8 80.0 91.4 145.3 100.5 121.2 95.4 92.4 90.3 75.0 83.1 77.0 103.5 49.0 107.7 90.3 71.2 87.1 40.9 85.2 85.1 47.1 89.6 125.1 98.4 89.3 117.3 119.0 42.1 95.5 87.9 110.7 55.1 79.8 116.2 83.7 92.6 169.5 311.3 96.2 140.1 210.7 144.8 184.7 201.6 212.5 273.9 238.1 223.5 163.5 81.5 172.9 254.4 194.8 231.8 179.1 197.9 175.7 104.9 232.6 124.8 120.6 326.1 206.4 165.8 195.6 187.3 204.7 208.1 144.6 143.1 292.6 110.2 145.8 123.6 189.7 154.7 170.3 148.6 95.2 294.7 0.9 110.0 165.2 139.4 209.0 246.1 53.6 136.2 103.7 651.5 220.6 149.5 288.7 159.9 276.6 279.8 155.0 237.9 218.5 113.0 157.1 104.1 185.1 127.6 290.4 56.9 119.7 129.5 45.7 103.4 40.6 42.8 44.5 46.2 83.4 43.6 36.5 37.2 194.5 56.8 110.0 55.1 56.0 99.2 83.7 88.9 89.1 108.7 80.0 91.4 92.4 90.3 75.0 90.3 89.3 95.5 92.6 185.1 6.4 9.7 23.5 83.7 111.3 89.6 139.6 62.0 51.0 86.8 80.0 5.4 77.2 66.3 106.7 12.5 189.6 95.3 198.8 252.4 207.0 63.7 43.5 51.3 146.6 78.6 64.6 12.0 173.8 210.6 81.8 78.0 51.1 44.4 59.1 165.2 63.9 443.6 38.7 12.6 115.2 142.4 204.1 213.8 100.4 108.7 171.2 158.3 24.4 207.5 105.7 133.9 18.6 21.2 247.2 189.9 155.7 64.3 105.0 243.3 408.8 33.7 43.1 131.5 57.5 137.3 28.9 60.8 74.8 130.8 274.9 83.0 65.0 99.9 145.1 NAGLU NAG ENSG00000108784 N-acetyl-alpha-glucosaminidase P54802 17 42536241-42544449 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038815 Supported "Intracellular and membrane" NA NA 270000000 "HPA038815: AB_10697398" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "unprognostic (6.48e-2)" "prognostic favorable (4.17e-4)" "prognostic unfavorable (6.59e-4)" "unprognostic (1.46e-1)" "unprognostic (1.75e-3)" "unprognostic (3.09e-2)" "unprognostic (2.20e-1)" "unprognostic (6.68e-2)" "prognostic favorable (6.90e-4)" "unprognostic (8.07e-2)" "prognostic favorable (2.58e-6)" "unprognostic (2.25e-1)" "unprognostic (8.74e-3)" "unprognostic (2.15e-2)" "unprognostic (1.62e-1)" 36.4 38.2 11.9 14.9 20.0 20.4 35.6 16.3 14.0 31.1 25.1 23.6 24.5 35.0 12.9 19.7 27.8 27.7 18.7 10.8 14.4 39.0 59.8 31.0 24.2 17.4 18.5 9.4 35.5 64.3 21.5 22.7 26.3 22.5 28.5 16.6 3.2 38.1 18.6 16.1 23.4 31.2 14.0 15.0 41.0 35.4 8.8 17.4 17.3 37.9 9.8 13.5 29.1 24.1 29.8 16.0 55.3 10.8 24.6 106.6 34.5 36.4 24.0 56.9 24.9 31.7 14.9 40.4 20.3 23.7 37.4 54.7 38.3 9.7 11.7 5.5 15.8 20.2 11.2 31.3 31.8 35.3 13.3 27.7 41.4 17.8 13.6 16.9 27.3 32.8 3.6 16.6 39.3 27.9 38.9 2.2 23.0 12.6 34.6 7.0 8.7 23.6 47.2 33.1 36.1 16.2 24.4 12.9 17.6 20.4 15.6 82.1 14.1 25.8 59.3 9.7 23.8 15.7 52.6 25.8 17.6 35.9 14.4 43.1 1.1 2.4 1.9 2.5 1.8 2.4 2.4 1.0 1.3 2.1 1.8 1.8 1.4 1.1 2.1 2.9 2.8 0.2 1.1 11.9 20.0 16.3 14.0 10.8 14.4 17.4 18.5 9.4 22.5 15.0 17.4 29.8 14.1 12.8 7.8 17.3 9.0 2.8 6.1 3.9 2.2 15.5 14.2 8.9 3.8 18.6 4.9 18.4 4.2 23.8 11.4 21.1 3.9 18.4 0.3 5.8 14.5 12.2 6.7 4.4 2.3 33.2 14.5 26.4 27.0 12.1 2.5 40.1 24.3 43.7 37.6 15.2 3.1 17.6 0.0 26.0 3.5 2.4 19.9 19.0 16.0 10.3 5.9 13.2 8.2 6.0 19.2 15.8 5.4 12.8 12.9 10.7 23.0 31.8 3.7 6.7 6.6 18.0 12.8 0.4 6.0 6.1 3.4 18.5 6.0 74.6 15.0 6.0 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42552922-42555214 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "placenta: 83.0" "Group enriched" "Detected in many" 4 "Granulosa cells: 1574.2;Syncytiotrophoblasts: 1495.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 399.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA 19000 Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 4.4 1.9 3.7 1.7 3.5 0.8 3.0 3.3 4.7 2.9 2.0 2.0 2.1 2.1 0.7 6.1 3.2 0.5 1.9 3.3 2.9 2.3 2.1 1.5 1.0 4.3 3.0 3.0 6.9 3.1 0.6 2.4 83.0 3.7 2.7 0.1 0.6 3.7 0.5 4.5 6.0 2.1 0.2 2.8 2.0 2.2 3.8 3.3 0.4 2.8 0.0 0.4 1.7 3.1 5.6 7.0 6.0 1.8 20.2 1.0 0.3 399.0 4.3 0.0 0.0 0.0 2.9 2.8 0.1 4.0 0.2 1.8 9.7 0.7 3.9 0.0 7.6 10.7 3.7 3.8 4.3 0.9 2.7 3.9 0.9 13.2 0.5 2.7 1.5 0.1 2.6 5.7 1.2 0.0 4.8 3.2 2.3 0.4 1.4 2.8 3.9 3.0 2.5 0.5 3.4 4.3 5.6 2.4 41.4 4.2 0.9 48.5 1.1 4.3 2.7 5.4 2.4 2.7 7.7 4.6 1.5 1.9 1.9 2.8 1.0 2.2 2.5 1.1 2.4 1.3 1.2 1.4 1.1 1.3 1.4 1.0 1.0 2.2 1.6 1.5 0.9 0.8 2.0 3.7 3.5 3.3 4.7 3.3 2.9 4.3 3.0 3.0 3.7 2.8 3.3 5.6 2.3 0.0 2.2 6.5 2.2 3.1 8.0 14.9 6.2 8.3 11.6 10.7 3.0 4.3 5.3 5.5 12.5 333.0 3.3 4.7 23.5 1.7 1.4 3.3 9.3 4.2 4.2 0.8 1.4 5.6 30.4 11.6 1.5 3.8 2.5 1574.2 3.6 6.4 29.7 10.1 1.6 2.7 8.2 0.6 1.2 1.9 1.8 3.6 1.8 1.9 1.0 11.2 2.1 2.0 3.3 2.0 2.0 3.4 1.4 11.6 2.5 20.5 4.2 8.9 0.0 6.7 29.2 0.8 2.7 14.6 7.4 1495.8 2.6 30.0 2.6 10.4 MLX "bHLHd13, MAD7, MXD7, TCFL4" ENSG00000108788 "MAX dimerization protein MLX" Q9UH92 17 42567072-42573239 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025329, HPA052766, HPA064438" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.21e-3)" "unprognostic (3.88e-1)" "unprognostic (2.46e-2)" "unprognostic (8.55e-3)" "unprognostic (2.49e-1)" "unprognostic (4.87e-2)" "unprognostic (8.66e-2)" "unprognostic (9.66e-2)" "unprognostic (2.89e-1)" "unprognostic (1.61e-2)" "unprognostic (7.43e-2)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (3.25e-1)" 31.4 28.3 16.3 21.9 16.8 16.6 26.5 16.9 18.2 19.4 19.0 38.9 47.9 15.9 16.7 29.4 17.3 20.5 48.2 16.5 17.2 28.9 51.9 28.1 27.7 17.3 16.5 15.9 14.9 33.0 19.8 19.0 21.6 17.1 18.4 39.2 9.4 24.9 18.3 75.0 24.9 42.6 20.5 17.2 24.3 35.7 8.1 17.0 30.4 25.0 87.2 29.7 28.2 20.9 17.3 36.8 41.5 32.1 33.1 48.0 55.3 22.0 53.5 47.5 57.1 51.4 38.0 37.5 43.6 36.8 46.4 51.6 54.4 59.4 34.8 50.0 35.2 55.5 45.4 27.2 43.1 56.3 61.6 63.4 47.9 38.4 45.6 41.8 38.9 42.9 52.2 50.7 38.3 66.2 49.3 87.0 31.3 22.9 90.9 37.3 39.2 66.1 47.5 46.8 44.7 49.9 24.6 23.9 31.2 61.8 42.5 63.3 72.1 30.2 50.7 32.5 55.7 80.8 38.7 47.2 41.2 56.5 39.2 60.8 43.3 64.0 91.4 34.2 80.1 37.6 35.2 35.0 34.6 66.5 30.2 30.5 31.1 82.7 33.7 90.9 35.7 48.0 68.3 16.3 16.8 16.9 18.2 16.5 17.2 17.3 16.5 15.9 17.1 17.2 17.0 17.3 31.6 67.3 69.8 9.4 35.6 41.9 28.1 41.5 33.0 29.4 39.8 30.4 24.1 40.0 47.2 27.6 25.0 37.8 35.8 97.7 60.7 48.9 19.1 30.5 29.1 28.2 25.8 42.7 8.0 68.9 49.5 26.0 55.5 26.3 46.7 18.7 27.8 49.7 68.6 25.2 8.1 46.9 30.5 63.4 62.3 24.5 35.1 59.5 32.0 7.5 58.3 13.1 51.5 5.5 7.1 77.5 86.4 31.2 61.8 24.4 132.3 62.1 30.4 31.7 52.6 22.9 31.4 9.3 41.2 45.2 49.9 44.1 38.3 48.0 54.2 36.4 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682531-42699993 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.7" "Cell type enhanced" "Detected in many" "Astrocytes: 11.4;Bipolar cells: 15.6;Endometrial stromal cells: 15.5;Excitatory neurons: 45.6;Inhibitory neurons: 37.7" "Cancer enhanced" "Detected in all" "glioma: 10.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 43.5;TIME: 68.5;U-138 MG: 76.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.5 3.7 22.9 5.6 32.3 0.6 5.0 16.0 47.7 11.9 0.0 17.7 1.8 22.0 6.2 2.3 14.1 6.4 7.8 29.2 21.7 4.7 1.5 7.0 2.5 22.0 17.8 30.5 15.8 11.6 0.6 19.4 4.5 27.8 7.2 4.0 11.4 2.9 6.5 3.7 2.1 6.1 26.2 8.7 5.0 9.9 3.4 21.6 1.2 4.9 2.5 2.4 8.1 8.6 30.8 4.1 5.4 13.2 4.2 20.0 40.4 0.8 25.6 43.5 18.2 16.5 0.5 1.0 0.1 1.3 27.7 18.6 4.8 6.4 2.0 14.2 9.0 2.1 0.0 24.0 6.4 9.8 0.2 0.4 39.7 0.1 17.5 3.5 29.1 23.3 0.2 1.2 7.6 7.1 0.7 0.1 3.8 4.7 0.3 5.5 0.7 1.4 2.0 4.8 0.0 2.4 7.7 7.6 0.1 4.7 12.0 4.1 2.3 68.5 76.2 12.5 18.0 7.0 8.5 5.7 0.2 21.4 1.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 22.9 32.3 16.0 47.7 29.2 21.7 22.0 17.8 30.5 27.8 8.7 21.6 30.8 1.0 0.0 4.1 11.4 0.5 0.5 0.2 0.4 1.2 15.6 0.2 0.1 1.3 0.0 0.7 0.0 4.2 0.0 0.1 0.1 0.0 0.0 0.9 3.2 15.5 1.2 0.0 0.0 45.6 0.0 0.0 4.2 0.5 1.0 0.0 0.1 1.8 0.0 0.1 1.7 37.7 0.1 0.0 0.0 0.8 0.3 1.5 0.2 0.0 6.5 0.8 0.9 0.0 7.5 5.2 0.1 0.1 0.7 0.4 0.3 0.0 0.1 1.6 3.0 6.6 1.1 6.3 1.4 1.1 0.3 0.3 0.3 0.6 0.2 0.1 0.2 ABI3 "NESH, SSH3BP3" ENSG00000108798 "ABI family member 3" Q9P2A4 17 49210411-49223225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.1" "Cell type enhanced" "Detected in many" "dendritic cells: 82.7;Kupffer cells: 130.7;Macrophages: 71.4;monocytes: 66.0;NK-cells: 249.3;T-cells: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 735.0;non-classical monocyte: 788.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 49.9;HDLM-2: 28.8;HUVEC TERT2: 76.0;RH-30: 18.6;TIME: 59.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA017345, HPA064805" Enhanced NA NA "HPA017345: AB_2669592, HPA064805: " "unprognostic (1.24e-1)" "unprognostic (1.23e-2)" "unprognostic (2.18e-2)" "prognostic favorable (7.13e-4)" "unprognostic (1.56e-1)" "unprognostic (1.16e-3)" "unprognostic (5.29e-1)" "unprognostic (8.25e-2)" "unprognostic (3.63e-2)" "unprognostic (1.48e-1)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (2.28e-3)" "unprognostic (1.03e-1)" "unprognostic (9.24e-3)" "unprognostic (4.16e-2)" "unprognostic (2.40e-1)" 9.3 8.2 6.3 22.1 9.1 6.5 8.1 10.4 11.3 6.6 6.8 7.5 11.0 7.3 1.9 5.2 7.5 7.7 10.4 7.5 14.2 8.3 7.0 17.4 30.3 15.2 10.7 4.0 3.1 4.2 3.6 4.2 6.4 14.7 8.1 7.4 0.7 4.5 3.6 3.9 4.6 18.2 8.1 13.6 70.1 8.5 1.2 15.6 10.1 9.0 6.8 28.8 7.9 6.2 14.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.9 1.9 3.1 5.2 0.4 0.0 49.9 0.6 0.1 0.0 0.0 0.0 0.0 4.9 28.8 0.0 0.2 0.2 0.0 0.0 0.5 0.2 0.1 0.0 1.4 0.1 0.0 76.0 2.7 0.0 0.0 0.5 0.0 10.1 7.3 3.2 0.0 0.0 8.2 18.6 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.4 59.3 0.1 11.2 0.0 0.0 0.6 2.6 8.4 0.0 0.5 0.1 1.4 117.2 3.2 290.2 735.0 141.2 36.1 51.8 189.2 248.5 27.3 31.4 141.0 17.9 110.8 788.6 9.8 33.5 234.0 6.3 9.1 10.4 11.3 7.5 14.2 15.2 10.7 4.0 14.7 13.6 15.6 14.8 25.5 0.0 6.4 1.0 20.5 1.9 0.1 0.0 0.0 0.0 0.8 1.8 1.5 2.8 0.0 0.0 0.0 0.3 82.7 0.2 50.9 0.1 0.4 0.1 0.3 39.4 1.2 6.9 0.2 0.2 0.5 2.4 2.6 0.2 7.0 0.1 39.7 1.6 45.7 0.0 0.2 0.0 0.0 130.7 21.4 0.7 0.3 71.4 1.8 2.8 66.0 0.1 249.3 0.0 0.0 0.0 0.0 0.0 14.7 0.2 0.0 0.4 0.7 0.4 0.0 0.8 2.1 0.2 0.4 0.0 4.3 0.3 58.0 0.5 0.1 0.2 EZH1 "KIAA0388, KMT6B" ENSG00000108799 "Enhancer of zeste 1 polycomb repressive complex 2 subunit" Q92800 17 42700275-42745049 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 134.6" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 258.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005478, HPA077684" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA005478: AB_1848340, HPA077684: AB_2732356" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (2.19e-2)" "unprognostic (8.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-3)" "unprognostic (1.76e-2)" "unprognostic (1.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-3)" "unprognostic (5.22e-3)" "unprognostic (4.11e-3)" "unprognostic (1.48e-2)" "unprognostic (4.60e-2)" "unprognostic (3.29e-1)" "unprognostic (5.39e-2)" "unprognostic (4.74e-2)" 35.0 18.2 35.6 14.5 38.2 15.4 34.4 43.2 41.9 40.9 30.3 27.8 13.1 31.4 26.8 21.7 35.9 12.9 29.8 35.1 35.0 28.7 13.5 25.9 20.7 39.0 38.4 35.2 48.2 18.5 25.7 26.5 12.6 40.2 26.3 15.6 134.6 20.4 24.0 44.2 25.9 30.8 20.6 34.1 38.1 20.9 12.1 36.0 23.2 28.6 33.5 20.5 29.5 31.7 42.4 8.9 9.3 12.4 8.5 48.4 29.1 10.4 14.0 12.7 11.4 11.6 4.4 10.8 13.4 8.6 15.0 11.2 19.8 8.1 9.2 16.3 15.0 14.5 4.7 19.7 5.4 16.6 10.2 10.8 16.7 16.6 8.6 20.8 20.0 9.4 13.4 12.5 18.5 10.2 3.7 16.6 12.9 3.4 8.2 4.7 10.7 12.4 14.5 11.7 9.3 8.4 6.8 7.8 3.8 9.5 17.5 13.2 6.5 9.8 12.2 5.0 14.4 8.9 19.3 10.4 8.0 8.8 10.4 6.4 14.2 5.2 7.8 6.0 5.4 8.2 5.8 5.3 6.1 2.0 6.3 7.7 5.8 19.7 5.8 3.6 6.3 6.4 2.6 35.6 38.2 43.2 41.9 35.1 35.0 39.0 38.4 35.2 40.2 34.1 36.0 42.4 34.2 9.6 20.8 41.1 23.6 5.2 14.2 6.6 8.6 71.7 8.7 13.1 39.3 20.0 14.1 12.9 66.7 7.9 24.6 9.3 9.8 11.2 0.7 21.8 23.2 20.7 13.1 36.4 36.8 7.5 3.2 25.3 8.6 25.5 20.3 19.4 15.4 7.8 9.0 47.1 34.0 4.9 12.2 17.1 7.2 2.8 31.1 14.7 1.8 15.0 24.1 30.8 33.0 20.6 58.9 12.1 7.7 34.3 15.9 9.1 12.9 10.7 28.0 258.1 52.6 32.7 24.1 10.7 10.6 6.6 6.1 10.8 21.8 26.2 7.4 9.6 DLX4 "BP1, DLX7, DLX8, DLX9" ENSG00000108813 "Distal-less homeobox 4" Q92988 17 49968970-49974959 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 3.8;skin 1: 3.0" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 77.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 22.9;CACO-2: 16.8;GAMG: 15.3;HAP1: 11.2;K-562: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA059933 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059933: AB_2684169" "unprognostic (8.12e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" "unprognostic (2.29e-3)" "unprognostic (7.49e-2)" "unprognostic (2.71e-1)" "unprognostic (9.35e-3)" "unprognostic (2.85e-2)" "unprognostic (8.73e-2)" "unprognostic (5.93e-2)" "unprognostic (1.29e-2)" "unprognostic (4.34e-2)" "unprognostic (2.88e-13)" "unprognostic (8.79e-3)" "unprognostic (2.77e-1)" "unprognostic (5.00e-2)" "unprognostic (6.86e-2)" 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.7 0.2 0.1 0.1 0.1 0.0 0.2 0.7 0.2 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.3 0.6 0.1 0.0 0.3 0.2 0.1 3.8 0.5 0.2 0.1 0.0 1.1 0.2 0.0 3.0 0.3 0.0 0.3 0.4 0.1 0.3 0.4 0.1 0.3 0.0 0.5 0.2 0.5 0.3 0.5 1.4 0.0 0.1 0.1 0.0 22.9 0.1 0.1 0.1 0.3 16.8 1.0 0.7 3.3 0.3 15.3 2.3 11.2 0.4 0.1 4.5 5.9 0.4 5.7 1.7 0.0 0.9 3.7 0.0 2.8 0.1 0.0 0.2 0.0 3.5 13.5 0.0 0.0 2.9 0.4 6.0 0.2 3.1 0.0 0.0 5.1 0.6 0.1 0.8 1.9 0.1 0.4 1.9 1.1 3.4 4.1 4.0 0.0 0.0 1.0 0.2 0.0 0.9 0.2 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.2 0.2 0.7 0.2 0.2 0.3 0.6 0.1 0.5 0.3 0.4 0.3 0.0 6.4 0.0 0.0 0.2 2.5 0.4 1.0 2.2 0.0 0.5 0.3 1.9 0.0 0.1 0.0 0.0 12.7 0.1 0.1 0.0 0.3 0.1 1.5 0.1 0.2 0.0 0.0 0.3 0.2 77.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 1.0 1.1 0.4 0.6 16.8 0.1 0.2 0.2 0.3 PPP1R9B "PPP1R6, PPP1R9, SPINO, Spn" ENSG00000108819 "Protein phosphatase 1 regulatory subunit 9B" Q96SB3 17 50133737-50150677 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 99.7" "Cell type enhanced" "Detected in many" "Kupffer cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022461 Approved NA NA 420000000 "CAB022461: " "unprognostic (4.71e-1)" "unprognostic (3.77e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.74e-3)" "unprognostic (1.99e-1)" "unprognostic (4.09e-2)" "unprognostic (2.80e-1)" "prognostic favorable (3.11e-4)" "unprognostic (8.50e-2)" "unprognostic (1.57e-2)" "unprognostic (1.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "unprognostic (4.29e-1)" 23.6 30.3 63.7 28.8 60.8 34.0 20.4 42.2 99.7 25.4 12.8 17.4 15.1 22.2 8.5 29.1 19.8 15.6 22.6 87.7 38.0 21.1 12.0 40.2 37.1 29.7 43.4 65.3 28.0 18.4 15.3 20.7 14.7 38.7 21.7 9.0 7.9 17.7 10.7 11.9 23.6 30.5 11.9 26.1 52.9 17.9 24.2 50.5 22.7 22.2 15.0 28.2 20.6 22.7 51.3 25.9 45.2 24.0 60.5 31.2 19.8 56.9 36.4 33.1 31.5 22.9 38.3 19.9 48.6 57.8 42.2 30.7 25.2 24.9 25.8 19.6 125.7 37.2 79.9 35.4 26.2 30.3 35.1 121.2 22.2 44.4 34.6 21.7 60.5 31.2 15.4 43.0 35.7 21.0 47.7 13.0 50.2 9.4 33.0 40.9 26.5 32.5 34.6 21.6 15.0 15.1 44.5 23.0 35.6 29.5 19.3 47.7 68.8 25.5 66.4 48.7 46.0 48.8 65.4 16.2 35.2 30.5 34.8 32.4 4.2 1.8 2.9 1.3 1.6 1.1 1.6 1.0 0.9 1.4 2.0 0.4 0.9 4.1 2.2 2.0 2.0 0.5 0.8 63.7 60.8 42.2 99.7 87.7 38.0 29.7 43.4 65.3 38.7 26.1 50.5 51.3 18.1 0.0 2.2 6.2 23.6 23.6 3.6 5.8 13.6 18.8 7.8 5.3 7.7 4.3 3.2 16.5 2.1 2.3 29.0 10.9 5.9 9.7 2.6 4.0 9.5 20.9 12.0 20.2 6.6 9.1 3.5 10.5 5.6 6.3 2.5 9.6 18.2 8.7 27.7 16.8 6.5 10.8 10.2 48.6 34.6 5.1 20.2 30.2 12.4 2.8 42.1 3.2 34.0 2.5 2.7 9.1 10.2 15.4 15.4 7.8 18.1 9.8 3.4 2.6 13.1 7.0 9.1 5.5 5.7 16.9 22.4 1.0 14.9 10.0 10.7 5.4 COL1A1 OI4 ENSG00000108821 "Collagen type I alpha 1 chain" P02452 17 50184101-50201632 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 1343.3;gallbladder: 1221.7" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebral cortex: 54.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 115.9" "HPA011795, HPA012111" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 80000000 "Endoplasmic reticulum" Vesicles "HPA011795: AB_1847088, HPA012111: " "unprognostic (1.61e-1)" "unprognostic (3.60e-3)" "unprognostic (8.29e-2)" "unprognostic (5.52e-2)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-2)" "unprognostic (8.53e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (7.19e-12)" "unprognostic (2.74e-2)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (3.87e-3)" 314.9 40.3 3.5 275.3 3.6 4.5 186.7 1.2 54.6 1343.3 18.4 185.5 38.1 535.8 23.6 111.3 236.2 1221.7 117.2 1.5 7.6 34.8 29.9 140.2 78.8 3.1 1.6 1.6 380.5 40.1 14.2 81.1 507.8 1.3 138.7 47.0 0.4 51.8 99.6 21.4 364.9 87.3 808.3 2.1 47.3 110.8 38.5 13.6 14.5 51.2 13.2 21.2 622.1 345.1 5.8 6.0 5.0 16.4 3.2 702.9 1689.5 29.2 3428.1 915.8 826.6 517.6 64.2 14.6 0.6 7.8 5206.1 5.7 9.1 8.3 3.4 150.1 5.2 6.1 0.4 92.2 4.2 1309.3 1.2 0.8 2490.3 45.7 1016.2 4.6 126.9 0.5 4.8 2.2 0.4 425.4 8.5 1.4 1.0 17.0 10.7 10.5 6.1 2.1 2.7 3.9 0.2 2.0 8.8 5.6 5.0 0.2 245.4 39.8 0.6 1.5 2687.4 562.6 405.0 16.2 2.8 5.9 0.7 200.1 1.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 1.2 54.6 1.5 7.6 3.1 1.6 1.6 1.3 2.1 13.6 5.8 66.9 9.6 13.8 0.0 2.1 188.0 12.4 31.6 10.8 0.2 9.1 10.0 12.5 5.7 13.2 7.3 0.0 45.7 1.7 1.4 0.0 13.3 1.9 64.6 2044.3 33.4 3.0 0.0 0.1 4.2 45.5 1944.4 17.9 49.2 2.5 8.1 378.0 3.4 67.6 0.0 0.3 5.4 6.1 0.3 318.1 18.2 556.0 13.1 188.5 12.2 0.0 2.5 0.0 0.0 0.0 23.8 0.3 268.1 1.3 10.7 0.1 0.7 9.8 0.2 78.9 74.8 1024.9 4.0 2.6 4.3 163.5 111.8 29.4 57.3 2.9 9.1 SGCA "A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1" ENSG00000108823 "Sarcoglycan alpha" Q16586 17 50164214-50175928 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 145.1;skeletal muscle: 527.4;tongue: 239.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 128.4;Early spermatids: 162.6;Late spermatids: 705.4;Skeletal myocytes: 195.2" "Cancer enhanced" "Detected in many" "prostate cancer: 4.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 1.4;memory B-cell: 3.3;myeloid DC: 2.2;naive B-cell: 3.3;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 15 "B-cells: 3.3;dendritic cells: 2.2;monocytes: 1.8" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 78.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007537 Uncertain "Intracellular and membrane" NA NA "HPA007537: AB_1079944" "unprognostic (1.34e-1)" "unprognostic (2.30e-2)" "unprognostic (1.89e-3)" "unprognostic (1.25e-1)" "unprognostic (9.87e-2)" "unprognostic (2.43e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-2)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" "unprognostic (7.01e-2)" "unprognostic (2.57e-1)" "unprognostic (2.07e-3)" "unprognostic (4.96e-2)" "unprognostic (2.16e-1)" "unprognostic (2.95e-1)" "unprognostic (1.15e-2)" 10.0 1.5 2.1 7.4 2.3 0.0 4.3 3.4 2.6 9.7 1.8 38.5 5.3 37.2 1.6 23.0 18.3 12.0 145.1 1.2 1.7 2.7 4.8 29.9 0.5 1.5 1.3 1.2 5.2 1.3 0.8 0.9 6.8 2.1 26.2 3.2 0.1 8.7 27.4 527.4 10.5 15.0 23.2 1.1 3.4 24.3 1.8 1.5 2.3 3.4 239.1 0.4 46.9 11.7 4.5 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.1 0.0 1.4 0.0 3.3 0.0 0.0 2.2 3.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.4 2.1 2.3 3.4 2.6 1.2 1.7 1.5 1.3 1.2 2.1 1.1 1.5 4.5 1.1 0.0 0.0 0.0 1.3 8.7 0.5 0.4 0.0 0.6 0.1 0.5 128.4 0.0 0.3 0.0 0.0 0.5 1.4 0.0 0.0 0.6 162.6 0.0 0.2 4.6 0.0 0.0 0.0 5.8 0.1 30.4 0.5 0.0 0.0 0.0 2.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 16.5 705.4 3.1 0.8 8.8 1.9 1.9 0.0 0.0 0.0 0.1 4.1 0.0 3.8 0.1 0.6 0.0 2.1 0.0 0.0 13.1 195.2 48.2 2.3 1.9 0.1 9.9 0.3 0.9 0.0 0.0 0.2 PTGES3L-AARSD1 ENSG00000108825 "PTGES3L-AARSD1 readthrough" Q9BTE6 17 42950526-42980528 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 17.4;tongue: 10.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;granulocytes: 3.8;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "RH-30: 4.9;THP-1: 10.8" "HPA021408, HPA022869, HPA023714" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (6.47e-2)" "unprognostic (1.25e-1)" "unprognostic (2.87e-1)" "unprognostic (5.44e-2)" "unprognostic (9.34e-4)" "unprognostic (1.56e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-2)" "unprognostic (1.82e-1)" "unprognostic (5.13e-1)" "unprognostic (3.27e-2)" "unprognostic (1.91e-4)" "unprognostic (1.83e-1)" 0.4 0.2 0.1 0.8 0.9 0.7 0.4 0.0 0.6 0.6 0.1 3.5 0.8 3.2 0.4 1.2 1.1 0.8 3.0 0.2 0.3 0.3 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.3 0.3 1.2 0.2 0.3 1.4 1.8 0.6 0.6 1.8 17.4 0.2 1.2 5.7 0.0 0.2 1.5 3.3 0.1 0.2 0.3 10.7 0.2 1.9 0.6 0.3 0.6 0.0 1.7 1.8 0.1 0.0 0.4 1.2 1.5 0.8 0.7 1.2 0.1 0.1 1.2 0.2 0.5 0.0 0.3 0.8 1.2 0.7 0.2 4.1 1.7 2.5 0.0 0.5 2.7 0.0 0.5 1.3 0.0 0.5 0.3 1.1 1.3 0.3 1.6 0.0 1.4 0.4 0.4 2.5 0.4 0.7 4.9 0.5 0.2 0.3 0.8 2.4 1.0 0.3 1.1 2.3 0.5 10.8 0.0 0.5 0.9 0.0 0.4 2.9 0.8 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.9 0.0 0.6 0.2 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 MRPL27 ENSG00000108826 "Mitochondrial ribosomal protein L27" Q9P0M9 17 50367857-50373207 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 377.6;Proximal tubular cells: 409.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021416 Approved "Intracellular and membrane" NA NA "HPA021416: AB_1854103" "unprognostic (2.09e-1)" "unprognostic (2.27e-2)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" "unprognostic (2.10e-2)" "unprognostic (2.99e-2)" "unprognostic (7.03e-2)" "unprognostic (1.42e-1)" "unprognostic (8.79e-2)" "unprognostic (1.96e-2)" "unprognostic (2.43e-2)" "unprognostic (4.27e-2)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (7.76e-3)" 48.2 93.1 110.4 37.1 111.7 36.0 55.8 116.0 130.5 47.8 110.8 74.2 54.3 46.6 116.5 73.4 44.5 30.1 97.8 108.8 112.6 86.3 110.3 37.6 45.1 113.5 112.0 107.8 46.3 59.7 76.2 52.7 57.6 114.0 58.7 85.2 33.2 50.7 45.4 142.3 58.1 52.6 51.3 113.7 46.0 91.9 42.8 115.8 61.8 50.1 141.8 65.2 58.5 51.4 115.0 160.2 231.3 105.5 69.8 66.5 98.9 154.3 117.1 111.8 216.9 195.5 535.5 82.6 139.3 143.5 146.0 168.0 97.3 160.9 177.8 176.2 142.2 273.0 145.5 199.8 393.1 123.4 121.9 125.3 114.3 242.9 172.8 103.0 94.7 149.0 75.8 157.4 81.0 153.4 304.2 135.6 154.0 76.4 279.4 252.4 74.4 143.6 114.5 187.8 213.6 108.1 130.4 55.0 71.3 104.9 140.0 171.2 100.6 89.8 145.0 110.5 109.4 192.1 97.6 120.5 127.8 97.6 101.7 76.4 212.7 175.6 124.6 99.3 209.2 82.9 211.4 117.2 104.5 177.1 186.4 113.9 99.0 27.9 108.7 153.6 193.5 159.0 179.3 110.4 111.7 116.0 130.5 108.8 112.6 113.5 112.0 107.8 114.0 113.7 115.8 115.0 33.6 38.5 43.7 12.7 50.7 60.0 97.2 220.9 56.9 35.5 50.1 65.8 180.5 88.6 111.2 90.1 14.6 240.7 36.8 179.7 377.6 136.5 27.7 60.1 61.7 58.1 103.0 55.3 10.0 146.5 181.9 70.6 99.9 63.9 29.7 52.1 57.8 221.4 150.6 15.2 12.9 193.3 132.2 52.5 33.9 31.1 83.0 52.0 69.4 12.2 88.8 72.5 42.2 15.6 14.5 153.8 139.0 83.8 58.2 83.9 199.5 409.5 73.5 42.1 72.3 57.1 85.8 88.7 74.6 81.6 75.4 273.4 36.4 97.5 155.3 102.6 VAT1 "FLJ20230, VATI" ENSG00000108828 "Vesicle amine transport 1" Q99536 17 43014607-43025123 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 133.2;Hofbauer cells: 146.4;Melanocytes: 122.7" "Cancer enhanced" "Detected in all" "melanoma: 295.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "basophil: 104.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 104.0" "Cell line enhanced" "Detected in all" "SK-MEL-30: 680.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045170 Uncertain NA NA 2700000 "HPA045170: AB_10964166" "unprognostic (2.22e-2)" "unprognostic (4.41e-3)" "unprognostic (6.86e-3)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (9.67e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.16e-2)" "unprognostic (5.56e-2)" "unprognostic (1.86e-2)" "unprognostic (1.17e-3)" "unprognostic (2.38e-1)" "prognostic favorable (5.89e-4)" "unprognostic (1.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.07e-1)" "unprognostic (3.36e-2)" 164.7 253.6 58.4 32.3 57.9 87.3 138.7 57.5 61.7 143.1 57.5 85.5 26.0 122.4 65.6 133.9 79.1 86.3 73.1 47.6 101.9 70.3 44.9 112.7 29.3 90.1 101.1 46.5 186.5 67.7 55.2 104.5 84.6 130.3 65.4 33.2 7.7 87.0 52.7 29.4 177.9 65.7 95.0 66.7 40.6 56.5 79.8 95.5 64.3 68.8 46.2 34.0 110.4 127.4 82.8 38.9 225.0 53.6 119.0 556.9 435.5 75.5 94.2 282.1 89.7 167.1 139.7 83.2 7.7 128.8 395.8 283.7 58.9 94.1 81.6 82.7 14.4 127.6 36.2 107.3 279.5 357.7 177.6 271.5 234.3 119.2 154.0 71.2 203.8 428.9 230.5 77.3 12.1 227.3 37.2 262.2 76.6 68.1 111.6 106.2 37.3 66.1 19.4 102.2 76.6 50.0 94.6 51.3 29.5 680.8 217.9 82.5 99.4 431.7 199.9 92.5 226.2 22.9 19.4 30.2 14.3 203.1 132.0 31.4 104.0 16.6 24.9 13.1 7.9 15.3 19.9 18.5 13.6 8.4 19.5 16.8 10.4 5.1 11.1 9.2 4.1 13.4 19.0 58.4 57.9 57.5 61.7 47.6 101.9 90.1 101.1 46.5 130.3 66.7 95.5 82.8 133.2 22.4 13.9 1.0 17.2 28.4 14.2 17.9 34.1 1.1 29.5 30.2 31.6 17.2 10.7 23.9 4.2 6.5 6.5 9.2 17.6 99.7 27.5 14.2 32.5 71.0 15.1 12.6 2.3 43.4 45.1 91.4 8.2 32.6 77.2 93.8 73.9 15.8 146.4 5.0 2.4 4.1 4.1 40.0 32.4 45.2 51.9 43.9 122.7 6.5 16.1 4.2 3.1 3.5 4.1 49.6 10.4 58.6 19.6 25.5 36.5 60.1 12.6 1.8 13.1 19.4 39.1 12.8 15.5 35.1 33.5 11.1 12.6 31.2 4.7 21.8 LRRC59 "FLJ21675, PRO1855" ENSG00000108829 "Leucine rich repeat containing 59" Q96AG4 17 50375059-50397523 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 272.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030827, HPA030829" Enhanced Enhanced "Endoplasmic reticulum" NA NA 740000 "Endoplasmic reticulum" "HPA030827: AB_10602704, HPA030829: AB_10670045" "unprognostic (4.73e-2)" "unprognostic (2.15e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.63e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (1.00e-5)" "prognostic unfavorable (3.12e-6)" "unprognostic (1.88e-3)" "unprognostic (9.95e-2)" "unprognostic (5.62e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.68e-2)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (1.90e-5)" 44.8 83.3 20.0 54.5 21.1 80.0 34.4 19.8 22.6 60.9 20.2 72.8 47.2 32.5 56.0 48.3 29.6 32.5 32.7 20.5 21.7 35.1 75.6 46.2 31.2 19.8 20.8 19.5 21.9 120.4 35.1 21.9 52.1 20.1 35.6 72.7 21.8 56.7 36.0 32.9 23.7 46.4 52.8 20.2 33.3 74.5 29.5 22.1 29.6 36.3 17.2 43.2 57.1 30.4 21.6 390.5 289.9 81.8 123.6 135.3 158.7 146.2 310.7 172.3 284.5 249.4 668.8 109.0 168.8 207.8 356.4 174.3 138.1 205.2 265.2 336.3 90.4 298.6 295.9 154.8 361.8 283.7 294.1 134.8 140.8 211.3 305.2 351.7 82.6 213.3 95.7 278.9 155.6 189.4 264.3 209.0 139.0 92.5 364.2 419.1 175.9 261.9 323.6 156.0 194.9 199.1 165.4 107.5 119.3 161.9 120.4 201.1 157.9 229.6 327.4 135.5 306.2 410.4 232.3 205.1 213.6 222.2 195.9 210.8 22.8 21.9 19.8 9.4 26.9 11.7 11.0 9.5 11.5 20.3 8.5 6.1 7.9 10.9 8.6 27.8 16.5 10.3 13.0 20.0 21.1 19.8 22.6 20.5 21.7 19.8 20.8 19.5 20.1 20.2 22.1 21.6 33.1 22.4 23.7 5.2 61.2 139.4 102.1 54.7 43.9 20.4 55.0 30.9 4.1 40.0 50.0 20.2 2.1 90.8 38.4 101.6 29.4 165.0 67.1 53.6 53.8 45.6 38.3 36.6 5.5 187.0 272.2 64.5 104.5 96.3 30.4 28.9 27.1 69.1 103.3 21.9 5.5 178.3 26.4 29.0 111.1 18.7 35.4 45.1 65.8 3.7 45.6 26.5 30.9 2.0 6.8 187.7 75.7 29.0 211.3 164.8 63.5 48.0 26.5 15.5 13.1 59.1 92.8 61.3 27.7 66.1 132.7 236.0 33.2 38.3 127.1 146.7 RND2 "ARHN, Rho7, RhoN" ENSG00000108830 "Rho family GTPase 2" P52198 17 43025231-43032041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 56.7;choroid plexus: 16.5;testis: 37.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 590.2" "Group enriched" "Detected in many" 5 "glioma: 44.4;testis cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;AN3-CA: 15.5;HAP1: 12.1;NTERA-2: 17.2;SH-SY5Y: 10.4;SuSa: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077757 Approved NA NA "HPA077757: AB_2732361" "unprognostic (2.19e-2)" "unprognostic (5.70e-2)" "unprognostic (1.65e-2)" "unprognostic (1.53e-1)" "unprognostic (2.02e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-3)" "unprognostic (4.55e-2)" "unprognostic (7.44e-2)" "unprognostic (3.79e-1)" "unprognostic (1.22e-4)" "unprognostic (7.85e-2)" "unprognostic (8.17e-2)" "unprognostic (6.13e-3)" "unprognostic (9.92e-2)" "unprognostic (7.52e-2)" "unprognostic (5.57e-2)" 0.6 3.1 31.2 0.2 36.8 0.2 1.0 47.1 26.1 2.1 16.5 3.0 0.4 3.7 2.6 1.1 2.0 0.8 1.4 22.6 41.7 0.8 4.1 0.5 0.2 56.7 53.9 18.4 3.8 0.6 5.6 7.0 0.1 51.3 2.7 0.4 3.9 0.8 3.7 0.5 2.0 1.2 2.4 47.0 0.1 1.4 37.5 44.2 0.4 6.6 0.2 0.3 2.1 1.6 40.2 0.0 0.3 12.0 15.5 0.9 0.6 0.3 0.5 0.7 2.1 1.6 1.9 0.2 0.1 2.8 1.6 0.7 0.1 12.1 0.2 1.8 0.0 6.2 0.0 0.2 0.2 0.9 0.1 0.1 0.8 0.1 2.4 0.1 0.3 0.2 1.3 3.1 0.1 0.0 0.5 4.9 0.2 17.2 0.0 0.1 0.9 0.0 0.1 0.2 0.0 3.3 10.4 0.0 0.2 0.1 7.9 2.3 0.0 0.1 0.3 0.4 0.1 0.0 1.1 3.3 0.2 1.9 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 31.2 36.8 47.1 26.1 22.6 41.7 56.7 53.9 18.4 51.3 47.0 44.2 40.2 1.5 0.0 1.5 2.0 0.1 1.3 4.8 0.6 6.8 2.8 2.0 3.3 2.1 1.5 2.0 3.7 0.0 2.1 0.0 0.1 5.9 1.2 136.3 1.9 12.6 1.2 0.0 0.0 2.2 0.8 1.9 3.2 0.0 1.0 1.3 10.5 1.4 3.3 0.6 5.0 7.2 0.0 0.0 0.6 0.7 590.2 5.0 0.8 1.8 1.0 0.0 27.2 1.0 11.6 1.6 0.3 0.1 4.5 0.1 1.6 0.0 2.3 6.5 3.7 0.0 6.2 2.9 38.3 6.1 0.8 1.8 1.6 0.6 2.6 0.1 1.6 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996049-7010754 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.8;vagina: 106.5" "Cell type enriched" "Detected in some" 6 "Macrophages: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "A-431: 25.5;HEL: 40.4" "Region enriched" "Detected in single" 5 "olfactory bulb: 4.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 49000 Cytosol "Nuclear speckles, Vesicles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 1.0 1.6 0.9 3.3 1.2 4.7 0.3 0.1 1.0 16.6 0.4 0.4 1.9 2.2 0.0 49.8 1.2 3.2 1.4 0.3 0.3 0.6 0.2 1.2 3.9 1.0 0.5 0.0 1.3 1.9 0.0 0.1 1.1 1.1 0.8 0.1 3.1 20.3 0.0 1.6 21.9 2.0 0.2 0.1 3.3 1.1 1.3 0.8 0.0 1.9 0.1 3.9 1.5 106.5 3.3 25.5 4.2 1.9 1.4 0.0 0.0 1.7 1.6 0.0 0.0 0.0 3.7 0.9 1.3 0.9 0.0 1.4 3.2 0.0 0.1 0.0 2.8 3.2 40.4 6.8 2.8 0.1 0.4 6.5 0.0 0.1 0.0 0.0 2.4 0.0 2.8 2.7 1.4 0.0 0.3 0.5 0.9 1.3 0.2 0.8 1.4 0.8 0.7 0.0 3.2 0.1 0.9 0.7 0.8 0.4 2.4 1.5 1.1 4.6 2.2 1.2 2.1 1.1 0.8 0.3 0.7 1.2 3.0 1.0 2.1 0.9 1.8 0.7 0.4 0.5 1.1 0.5 0.7 0.7 0.6 0.2 0.3 4.5 0.7 0.4 1.3 0.3 13.6 0.9 1.2 0.1 1.0 0.3 0.3 1.0 0.5 0.0 1.1 0.1 0.8 3.3 0.0 0.0 0.0 2.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 17.3 0.0 1.0 0.8 0.0 0.0 2.5 2.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 2.5 1.1 0.0 0.1 0.1 0.0 2.0 HDAC5 "FLJ90614, KIAA0600, NY-CO-9" ENSG00000108840 "Histone deacetylase 5" Q9UQL6 17 44076746-44123702 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 118.9;Syncytiotrophoblasts: 218.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019400, HPA030991" Approved Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Cytosol" "CAB019400: AB_2116626, HPA030991: AB_10795286" "unprognostic (1.30e-2)" "prognostic favorable (6.14e-4)" "unprognostic (6.65e-2)" "unprognostic (8.06e-2)" "unprognostic (3.49e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (8.80e-3)" "unprognostic (3.80e-2)" "unprognostic (2.37e-2)" "unprognostic (4.91e-3)" "unprognostic (4.30e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.51e-2)" "unprognostic (3.11e-1)" "unprognostic (6.00e-2)" "unprognostic (1.76e-2)" 29.6 24.9 39.6 11.0 32.3 20.9 29.0 39.9 48.9 38.5 5.2 30.3 11.7 33.5 15.7 45.5 34.4 16.1 49.0 39.2 29.6 24.8 17.6 33.9 14.1 35.5 38.7 32.4 45.3 22.7 31.8 48.5 22.8 34.4 29.4 7.4 24.5 23.1 15.2 78.1 71.0 23.1 14.9 22.2 26.6 24.2 19.9 37.5 10.5 31.0 28.9 11.7 29.4 37.4 49.5 8.7 5.5 14.9 3.5 28.2 21.7 53.6 22.8 56.1 11.3 18.1 12.3 9.1 13.5 9.0 54.4 16.5 6.9 17.6 9.8 4.7 21.2 28.7 26.3 18.6 28.6 12.2 8.7 35.7 31.2 16.5 12.8 15.8 19.0 9.3 10.6 20.0 26.5 65.5 6.7 14.3 26.2 16.4 6.7 13.0 54.7 41.6 35.4 1.2 3.8 38.6 20.3 6.7 27.6 31.2 21.8 39.3 49.6 5.1 27.8 17.5 6.6 11.7 43.6 39.7 16.2 16.0 10.7 13.4 11.6 9.2 9.7 5.4 13.5 3.8 7.2 4.3 5.4 11.1 7.5 4.5 4.0 20.9 4.5 16.8 9.7 4.1 7.3 39.6 32.3 39.9 48.9 39.2 29.6 35.5 38.7 32.4 34.4 22.2 37.5 49.5 24.0 12.8 13.7 11.1 20.4 29.2 32.3 9.0 26.2 87.8 23.8 21.3 27.1 30.0 11.9 20.2 118.9 21.9 19.6 22.4 21.5 17.2 20.2 17.1 10.7 22.1 46.0 9.3 18.9 8.7 53.1 24.1 10.2 25.1 12.6 47.0 24.3 9.3 22.7 82.4 31.0 14.9 6.1 18.5 17.8 10.0 48.4 29.8 14.2 12.2 16.5 18.9 11.3 14.1 26.2 11.5 16.5 43.6 14.2 41.2 21.5 7.3 12.4 60.4 65.7 31.8 40.1 4.2 32.7 28.1 32.8 218.1 17.0 29.9 11.3 25.3 ABCC3 "cMOAT2, EST90757, MLP2, MOAT-D, MRP3" ENSG00000108846 "ATP binding cassette subfamily C member 3" O15438 17 50634777-50692253 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 59.6;liver: 50.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 5.1;non-classical monocyte: 6.4" "Lineage enriched" "Detected in many" 5 "monocytes: 6.4" "Cell line enhanced" "Detected in many" "A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037136, HPA048483" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB037136: AB_477165, HPA048483: AB_2680414" "unprognostic (1.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.65e-2)" "unprognostic (9.67e-3)" "unprognostic (6.19e-3)" "unprognostic (7.44e-3)" "unprognostic (8.20e-2)" "unprognostic (3.18e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.60e-3)" "prognostic unfavorable (4.68e-6)" "unprognostic (3.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.44e-2)" "unprognostic (1.57e-3)" 2.6 59.6 0.0 3.4 1.7 0.8 4.2 0.1 1.3 2.0 0.0 14.7 12.1 1.1 1.8 7.6 1.0 12.0 0.7 0.0 3.7 7.9 50.8 4.8 1.9 5.4 0.4 0.0 0.7 22.7 0.8 0.8 1.1 2.5 5.9 8.8 0.4 7.1 5.6 0.2 7.1 12.0 1.3 1.7 3.4 17.3 1.0 1.6 0.3 5.6 0.0 1.7 6.4 3.6 2.4 5.7 79.4 0.0 0.3 4.4 6.9 0.1 10.4 13.1 0.7 0.7 4.2 60.6 0.0 8.0 20.6 14.5 14.5 0.0 1.0 1.0 0.0 0.0 1.7 36.9 24.2 17.2 0.0 0.0 7.5 5.6 2.9 6.2 8.5 1.4 0.0 0.2 0.0 8.0 18.9 0.0 0.0 0.1 89.7 10.1 0.1 0.0 0.3 33.4 34.2 0.1 0.6 19.2 3.1 0.0 0.1 2.6 0.0 17.3 0.5 3.4 0.2 8.5 0.1 0.0 0.0 8.2 0.0 0.9 0.2 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.3 6.4 0.1 0.5 5.4 0.0 1.7 0.1 1.3 0.0 3.7 5.4 0.4 0.0 2.5 1.7 1.6 2.4 0.7 19.2 5.5 0.0 1.8 9.4 122.2 47.1 42.7 1.6 1.9 6.9 3.1 231.6 19.5 14.7 0.0 0.4 0.0 265.1 5.9 100.1 82.9 5.9 8.8 2.7 23.5 0.0 4.3 106.1 3.7 3.6 271.7 30.5 0.0 3.1 3.9 192.9 26.1 1.7 0.9 96.2 12.2 33.0 11.4 118.6 9.0 31.6 3.6 2.8 8.7 2.9 1.0 0.5 0.5 105.9 194.7 3.0 2.1 104.6 57.2 10.8 2.7 0.3 0.0 1.9 5.6 0.9 0.8 12.7 10.5 1.0 2.6 0.1 111.0 118.4 LUC7L3 "CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18" ENSG00000108848 "LUC7 like 3 pre-mRNA splicing factor" O95232 17 50719565-50756219 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018475, HPA018484, HPA020017" Enhanced Enhanced "Nuclear speckles" NA NA 15000 "Nuclear speckles" "HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249" "unprognostic (3.90e-1)" "unprognostic (4.71e-2)" "unprognostic (2.15e-1)" "unprognostic (1.05e-1)" "unprognostic (8.47e-2)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (1.39e-2)" "unprognostic (1.24e-2)" "unprognostic (1.18e-2)" "prognostic favorable (6.07e-4)" "unprognostic (1.16e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (7.23e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "prognostic favorable (5.35e-5)" 86.5 109.2 147.6 92.0 152.3 76.6 97.3 181.6 194.7 173.2 149.8 141.2 100.3 146.2 88.9 99.1 158.8 64.4 103.5 145.3 146.2 108.1 91.6 120.1 133.5 149.9 148.6 144.0 225.4 112.6 64.1 173.3 79.2 158.1 142.5 75.8 177.3 95.6 74.1 153.4 106.1 132.3 66.4 143.8 134.7 114.7 74.3 153.0 84.9 145.2 43.6 89.1 131.2 137.7 166.8 176.7 114.3 222.8 143.1 91.5 87.9 105.5 162.8 63.0 77.0 92.1 214.5 132.4 212.5 171.1 65.2 87.5 148.8 149.4 67.5 132.2 226.6 242.5 251.5 445.3 174.9 50.5 223.4 136.0 84.2 94.5 84.2 48.7 193.7 79.9 164.9 202.9 188.0 99.1 99.1 221.4 218.0 146.2 125.3 83.4 238.2 208.4 224.0 105.5 109.8 158.1 163.2 96.8 121.5 179.3 192.6 196.3 164.9 113.7 170.9 146.3 72.8 171.5 167.8 191.7 265.1 108.1 152.5 123.9 49.1 32.3 32.6 32.0 24.0 28.2 67.3 35.7 27.6 21.2 55.4 37.1 30.5 47.8 23.3 19.8 64.7 29.6 12.1 147.6 152.3 181.6 194.7 145.3 146.2 149.9 148.6 144.0 158.1 143.8 153.0 166.8 129.7 150.6 194.2 231.8 177.8 216.2 200.9 99.4 200.3 512.3 121.1 129.5 111.5 70.1 148.3 93.8 229.4 104.8 237.1 130.8 74.3 102.6 18.9 111.1 171.8 151.9 207.8 191.2 121.5 85.3 108.5 149.8 99.4 144.8 148.0 364.8 94.2 83.1 76.4 380.2 145.9 151.8 81.4 87.4 122.5 48.4 394.5 105.1 96.0 107.7 184.2 207.8 197.8 181.5 239.1 86.5 158.0 355.0 134.5 151.2 157.8 56.2 130.1 402.2 236.7 204.5 172.3 122.2 159.3 135.7 177.0 99.9 162.8 253.1 141.7 191.7 PPY PNP ENSG00000108849 "Pancreatic polypeptide" P01298 17 43940804-43942476 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "pancreas: 175.8" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 40.5;Langerhans cells: 10.0;Pancreatic endocrine cells: 33.3" "Cancer enriched" "Detected in some" 132 "pancreatic cancer: 630.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 3.7;EFO-21: 3.2;U-2 OS: 3.9" "CAB016735, HPA032122" Enhanced "Secreted to blood" NA NA 70300 44000 "CAB016735: , HPA032122: AB_2674164" "unprognostic (5.12e-3)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.65e-2)" "unprognostic (7.56e-3)" "unprognostic (8.13e-2)" "unprognostic (1.33e-1)" "unprognostic (7.78e-3)" "unprognostic (1.42e-1)" 0.1 0.3 0.0 0.2 0.0 2.2 0.0 0.0 0.1 0.0 0.0 2.5 1.1 0.3 4.2 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 175.8 6.9 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 6.8 0.6 0.0 0.0 0.1 1.0 0.3 0.0 0.5 1.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.7 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.5 0.0 3.9 0.4 0.5 0.0 0.3 0.9 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.1 0.0 0.0 40.5 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 10.0 2.8 0.0 0.6 1.8 0.0 0.2 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.5 0.0 0.0 0.3 0.0 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 91.0;Early spermatids: 69.6;Horizontal cells: 35.3;Oligodendrocytes: 59.6;Spermatogonia: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026486, HPA073483" Enhanced Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA026486: AB_1854085, HPA073483: " "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.3 3.9 23.3 1.4 26.4 0.5 3.3 24.3 29.8 5.2 7.4 6.9 1.1 5.7 26.2 3.0 5.0 2.2 8.8 24.6 25.1 1.6 0.2 1.5 0.5 31.0 28.5 25.5 3.2 3.5 16.0 13.8 2.5 28.7 7.6 1.2 15.9 1.4 8.8 1.0 1.7 2.5 5.0 26.0 0.7 3.8 17.0 26.2 0.7 3.5 1.6 0.6 6.7 4.4 43.0 7.2 10.5 11.0 15.7 1.4 1.0 6.0 2.5 0.3 9.9 9.0 3.7 4.7 10.4 5.7 2.5 12.2 2.9 15.1 6.0 7.0 0.0 11.5 0.9 9.2 0.2 0.3 0.0 2.9 1.5 0.5 6.8 0.1 5.4 0.7 16.6 3.9 0.0 2.5 2.8 1.5 0.8 19.7 0.8 6.4 7.4 15.5 0.7 0.2 0.2 11.6 10.7 3.0 1.0 4.1 9.8 24.5 4.9 0.1 10.5 13.2 4.0 4.5 3.4 7.4 0.0 15.8 6.9 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 23.3 26.4 24.3 29.8 24.6 25.1 31.0 28.5 25.5 28.7 26.0 26.2 43.0 2.1 0.0 0.0 11.1 0.0 0.4 1.4 1.0 0.0 91.0 0.5 2.9 10.5 0.0 0.0 0.0 2.1 5.8 0.1 0.1 0.0 0.7 69.6 0.1 0.4 1.4 0.0 0.0 20.4 0.4 0.4 2.7 0.0 0.1 0.0 1.2 0.0 0.0 0.7 35.3 19.0 0.0 0.0 0.0 0.4 21.1 3.7 0.2 0.0 1.9 0.0 16.1 0.0 13.6 59.6 0.5 0.0 5.7 0.1 0.0 0.0 0.1 0.0 7.1 0.0 1.5 1.9 23.2 31.4 0.2 0.1 2.7 0.3 0.1 0.0 0.0 SMURF2 ENSG00000108854 "SMAD specific E3 ubiquitin protein ligase 2" Q9HAU4 17 64542282-64662307 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ: 221.1;HBF TERT88: 157.4;LHCN-M2: 164.1;TIME: 207.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071508 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA071508: AB_2686406" "unprognostic (1.21e-1)" "unprognostic (2.07e-2)" "unprognostic (1.59e-2)" "unprognostic (3.24e-1)" "unprognostic (6.19e-2)" "unprognostic (7.33e-2)" "unprognostic (2.67e-2)" "unprognostic (1.50e-1)" "unprognostic (7.94e-2)" "unprognostic (1.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.54e-1)" "unprognostic (5.55e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" 6.9 4.3 3.2 6.2 3.6 5.9 5.2 5.0 4.1 7.3 4.8 5.4 6.9 6.0 2.3 4.5 5.9 7.2 4.1 3.1 4.3 7.1 3.8 10.6 5.0 4.7 2.6 1.9 4.9 6.6 6.4 3.5 13.5 2.5 7.4 4.9 12.6 6.2 5.3 3.0 4.8 10.2 6.1 3.1 5.5 7.9 13.2 3.4 7.8 8.4 6.3 6.6 7.6 3.2 3.8 67.0 17.8 15.3 9.1 11.0 41.5 7.6 221.1 103.2 88.2 73.4 10.4 45.5 8.6 14.5 38.8 29.9 15.2 16.0 37.2 157.4 4.3 12.9 9.1 10.9 11.8 12.0 12.2 5.5 11.8 16.1 109.5 48.5 52.7 97.0 11.9 13.0 7.5 164.1 13.2 28.3 4.8 9.9 8.8 23.8 6.1 38.4 5.2 20.1 11.1 16.0 17.9 14.4 5.8 10.0 24.6 11.7 8.4 207.6 93.8 44.4 39.2 139.6 10.4 11.7 13.9 23.7 7.3 28.4 1.0 0.6 1.4 1.0 0.4 1.1 0.7 0.8 1.1 0.7 0.9 0.9 0.9 1.4 2.7 0.3 0.6 0.2 0.5 3.2 3.6 5.0 4.1 3.1 4.3 4.7 2.6 1.9 2.5 3.1 3.4 3.8 40.2 32.1 26.0 96.3 18.6 43.8 30.8 10.0 25.0 26.4 23.3 18.7 10.3 7.2 16.1 9.2 43.8 13.2 35.4 13.8 9.8 18.1 29.0 29.0 37.2 39.3 17.9 2.5 46.1 10.0 3.6 28.1 12.2 39.7 13.3 21.4 38.2 5.1 13.6 26.9 40.9 11.2 10.2 17.3 25.5 9.2 12.5 22.8 21.4 101.2 13.2 21.4 20.6 101.0 52.8 26.5 24.7 12.0 18.0 25.2 28.0 9.6 14.4 46.7 0.0 37.4 23.3 37.1 21.3 13.7 39.8 7.3 33.5 16.2 13.8 24.6 DUSP3 VHR ENSG00000108861 "Dual specificity phosphatase 3" P51452 17 43766125-43778977 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 264.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 274.3;Late spermatids: 160.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 9 "dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063616 Supported Nucleoplasm,Cytosol NA NA 1300000 Nucleoplasm Cytosol "HPA063616: AB_2685061" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (1.04e-3)" "prognostic unfavorable (3.00e-4)" "unprognostic (4.83e-2)" "unprognostic (8.98e-2)" "unprognostic (5.13e-1)" "unprognostic (6.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.40e-3)" "prognostic favorable (5.49e-5)" "unprognostic (2.67e-3)" "unprognostic (5.45e-2)" "unprognostic (1.94e-1)" "unprognostic (1.37e-2)" 38.9 43.6 70.5 21.8 72.0 10.0 33.0 63.3 85.8 31.9 65.8 76.1 28.1 49.6 31.4 48.8 33.9 33.7 155.5 73.7 71.4 72.3 108.9 50.6 14.4 69.3 71.3 71.7 18.4 49.0 47.4 33.4 31.7 71.3 58.2 26.3 31.0 32.1 73.6 264.4 24.2 39.0 63.5 65.6 41.1 58.0 24.7 73.2 6.3 30.8 215.6 13.1 63.6 33.9 73.4 32.3 57.1 21.5 23.1 61.1 32.7 18.3 23.8 56.4 54.4 65.1 55.4 21.1 4.9 36.7 44.7 112.4 27.3 33.7 29.3 56.9 11.1 25.6 16.2 25.9 45.4 74.5 2.0 16.1 30.5 51.5 42.0 36.2 59.0 38.5 15.9 14.7 5.4 64.2 23.1 8.5 8.4 9.9 45.5 41.1 10.5 64.5 12.1 75.8 33.3 12.0 21.6 27.9 18.3 71.8 58.8 82.2 44.7 40.4 61.1 41.5 87.9 40.1 28.5 40.4 1.2 72.4 22.6 20.8 11.0 29.3 6.4 1.5 15.0 2.7 2.6 2.4 1.9 33.5 2.4 1.9 1.7 7.0 1.7 20.6 13.8 1.6 11.4 70.5 72.0 63.3 85.8 73.7 71.4 69.3 71.3 71.7 71.3 65.6 73.2 73.4 23.1 25.6 21.2 6.5 9.2 22.4 47.6 17.6 10.8 17.2 20.3 21.3 274.3 54.3 17.9 42.3 25.0 16.3 9.5 36.9 41.1 47.8 88.6 18.8 16.6 33.8 36.4 11.6 18.1 58.9 21.8 25.9 42.8 25.0 38.7 6.1 25.4 108.8 86.6 20.2 15.5 19.9 24.4 49.1 52.0 160.5 14.6 47.2 10.6 15.9 53.9 16.8 4.1 8.5 13.8 56.5 32.3 26.4 8.0 46.2 57.7 87.6 21.1 17.3 32.9 24.1 28.4 3.3 5.0 16.0 28.8 45.0 6.3 15.1 18.0 42.6 CACNG1 CACNLG ENSG00000108878 "Calcium voltage-gated channel auxiliary subunit gamma 1" Q06432 17 67044554-67056797 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 55 "skeletal muscle: 330.4;tongue: 122.9" "Cell type enriched" "Detected in single" 27 "Skeletal myocytes: 8.1" "Cancer enhanced" "Detected in some" "breast cancer: 1.6;head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 2.9" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" NA NA "unprognostic (1.76e-1)" "unprognostic (9.83e-3)" "unprognostic (1.75e-5)" "unprognostic (2.60e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.94e-1)" 0.0 1.7 0.5 0.0 0.6 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 3.3 0.0 330.4 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.6 0.0 122.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.1 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849948-44899445 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA 94000 Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.7 31.0 26.7 31.6 27.9 37.7 22.6 25.4 28.2 17.8 27.5 26.7 21.8 19.6 18.9 33.4 25.2 16.4 31.2 27.9 27.4 21.9 26.4 22.8 35.8 26.5 26.8 27.0 17.8 24.2 28.1 13.3 28.9 27.4 18.0 29.1 15.7 22.7 18.8 66.4 28.7 23.0 23.7 25.5 30.0 22.7 27.8 27.2 41.4 21.4 38.6 46.9 29.1 20.5 27.5 88.7 173.6 82.8 134.9 61.9 60.9 97.1 68.7 91.4 169.6 146.0 134.6 73.9 152.1 79.0 87.1 130.3 98.6 181.5 120.2 196.2 153.9 150.8 150.9 100.9 144.5 68.2 179.9 107.5 66.5 67.4 157.2 85.0 65.2 149.1 134.8 189.6 57.8 98.0 88.2 182.3 118.6 85.7 206.8 143.1 126.1 168.1 132.0 97.0 97.8 135.7 81.1 67.7 49.5 73.9 120.6 131.6 112.2 91.4 126.5 97.4 77.7 176.3 60.2 81.4 150.0 101.6 98.4 132.0 42.7 84.3 85.9 37.2 81.6 41.7 32.3 32.9 36.1 82.8 31.3 28.8 32.2 13.0 44.2 85.0 35.5 35.2 70.7 26.7 27.9 25.4 28.2 27.9 27.4 26.5 26.8 27.0 27.4 25.5 27.2 27.5 11.3 0.0 14.0 11.1 18.1 11.7 12.2 15.1 13.6 14.7 14.1 11.8 21.1 22.8 15.3 18.4 33.3 34.5 14.0 15.6 3.9 29.4 12.5 17.8 17.9 21.4 10.8 24.8 17.5 26.7 30.9 14.0 18.3 18.8 19.7 22.6 21.8 22.4 38.5 26.9 17.2 13.4 16.2 30.1 17.5 6.5 12.8 26.2 5.4 12.2 46.7 12.0 21.6 6.0 15.5 27.7 12.0 9.1 20.3 14.5 15.9 13.2 17.4 18.0 19.7 14.8 14.8 28.2 43.3 16.0 14.6 27.2 16.3 21.4 22.2 12.5 HLF MGC33822 ENSG00000108924 "HLF transcription factor, PAR bZIP family member" Q16534 17 55264960-55325187 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 123.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Region enhanced" "Detected in many" "cerebral cortex: 48.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 163.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 15.2 21.7 4.9 2.0 26.2 0.4 15.6 0.0 48.8 14.5 0.0 13.1 1.4 14.5 11.1 26.5 12.3 7.9 24.4 16.0 8.2 12.9 123.4 13.5 2.2 3.8 2.3 13.0 50.4 3.0 4.0 9.9 1.0 10.8 13.3 3.4 43.5 24.3 12.5 7.8 16.9 4.4 12.4 0.0 8.2 6.1 4.1 2.0 3.5 34.6 10.0 7.8 12.4 7.9 14.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.9 0.5 0.0 0.0 0.0 0.4 0.2 0.0 27.3 0.7 0.0 0.1 163.0 0.1 0.9 0.2 0.1 0.7 0.0 0.1 0.3 0.0 1.4 0.0 0.6 0.0 0.6 1.1 0.0 0.1 0.0 2.4 0.0 0.4 0.4 13.0 0.1 11.1 0.6 0.0 7.2 0.2 0.0 0.2 0.0 0.1 0.8 0.2 0.6 0.5 5.1 4.9 0.0 0.3 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.9 26.2 0.0 48.8 16.0 8.2 3.8 2.3 13.0 10.8 0.0 2.0 14.1 13.8 3.2 42.8 22.2 0.4 22.3 4.4 1.4 56.9 120.7 5.9 16.4 38.6 12.8 6.3 7.3 10.4 0.1 0.5 0.0 11.7 1.9 1.3 0.1 6.2 19.7 3.0 0.8 77.5 0.9 0.0 17.6 0.0 0.6 0.0 0.5 6.1 156.8 0.1 92.5 36.6 0.6 0.0 3.5 4.0 4.7 28.3 0.7 10.6 74.0 0.1 60.7 0.0 24.6 6.9 0.4 0.0 39.1 1.5 1.3 2.8 23.3 1.0 15.0 13.1 4.5 7.4 0.4 5.0 33.7 27.6 1.2 3.8 0.5 0.4 0.4 SLC16A6 "MCT6, MCT7" ENSG00000108932 "Solute carrier family 16 member 6" O15403 17 68267026-68291267 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 41.7;epididymis: 33.6;retina: 31.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Glandular and luminal cells: 27.4;Kupffer cells: 16.7;Macrophages: 21.8;Rod photoreceptor cells: 45.1" "Group enriched" "Detected in many" 6 "breast cancer: 10.9;melanoma: 11.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 13 "SK-MEL-30: 481.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054459, HPA066328" Uncertain Approved Vesicles NA NA Vesicles "HPA054459: AB_2682494, HPA066328: AB_2685660" "unprognostic (2.53e-2)" "unprognostic (2.09e-3)" "unprognostic (8.41e-2)" "unprognostic (6.94e-2)" "unprognostic (3.10e-1)" "unprognostic (5.26e-3)" "unprognostic (5.08e-3)" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.44e-2)" "unprognostic (8.78e-2)" "unprognostic (2.23e-1)" "unprognostic (8.16e-3)" "unprognostic (2.09e-2)" "unprognostic (9.46e-2)" 1.5 2.7 3.3 7.3 5.3 9.8 5.9 4.0 4.3 1.6 41.7 0.7 0.5 2.6 33.6 11.0 0.9 1.4 0.8 5.1 4.0 0.7 1.4 3.1 5.3 4.4 3.5 1.8 1.5 0.5 0.1 1.7 2.4 5.3 0.6 0.8 31.2 2.2 4.2 5.1 4.5 1.2 0.8 2.2 5.7 1.0 2.3 6.8 1.6 3.5 0.7 4.8 2.1 2.6 5.2 2.1 1.8 0.6 0.8 0.4 0.6 14.2 0.8 18.0 1.7 1.2 0.7 2.5 17.6 1.4 0.0 0.2 0.6 2.5 0.0 0.7 5.4 1.3 1.4 2.2 22.3 3.2 5.7 1.1 0.8 0.2 1.0 1.0 1.7 0.8 2.5 1.1 3.8 0.0 18.1 8.5 3.6 0.2 0.1 1.0 0.1 0.4 2.4 0.8 1.5 4.2 0.3 0.8 10.7 481.5 3.8 15.0 3.5 2.7 5.9 1.1 0.5 2.0 4.2 17.5 14.6 36.0 4.6 2.6 0.8 3.1 0.2 1.8 2.7 0.8 0.4 0.6 1.4 1.9 0.0 0.4 0.8 5.4 0.4 1.4 0.3 1.5 0.9 3.3 5.3 4.0 4.3 5.1 4.0 4.4 3.5 1.8 5.3 2.2 6.8 5.2 0.6 0.0 2.5 1.6 1.8 0.3 0.2 0.1 1.2 8.2 2.5 0.9 0.8 0.0 4.0 9.2 22.9 0.4 8.4 0.0 0.0 0.0 0.7 4.7 2.5 3.2 0.0 2.7 6.7 0.0 11.5 0.9 0.5 27.4 1.3 0.1 0.7 0.3 5.6 0.0 6.2 0.0 0.0 16.7 7.0 0.3 0.0 21.8 10.6 4.7 11.1 6.2 5.2 0.5 0.8 0.0 0.0 1.9 5.0 0.2 0.0 0.3 1.6 45.1 0.0 0.8 0.3 1.7 0.7 6.7 0.4 0.4 5.3 0.4 0.1 0.2 PRKAR1A "CNC1, PRKAR1, TSE1" ENSG00000108946 "Protein kinase cAMP-dependent type I regulatory subunit alpha" P10644 17 68511780-68551319 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 606.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019378, HPA049979" Approved Approved Cytosol NA NA 1800000 Cytosol "CAB019378: , HPA049979: AB_2680980" "unprognostic (8.69e-2)" "unprognostic (6.97e-2)" "unprognostic (5.34e-2)" "unprognostic (2.04e-1)" "unprognostic (1.68e-1)" "unprognostic (4.39e-2)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (2.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (5.55e-2)" "unprognostic (8.56e-3)" "unprognostic (6.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.29e-2)" "unprognostic (1.11e-1)" 127.1 159.7 87.6 125.2 95.5 57.6 119.6 88.0 115.7 152.5 104.6 70.6 52.2 146.9 123.4 99.4 142.6 126.3 433.9 97.1 123.9 165.8 152.0 165.2 112.3 97.5 90.3 79.7 204.6 63.6 302.6 88.6 165.6 114.0 115.6 79.9 133.3 171.2 138.9 252.6 64.3 59.2 133.2 86.6 122.7 87.7 132.0 101.8 110.4 175.2 148.7 104.5 137.7 68.2 126.2 95.5 180.0 225.9 136.1 294.6 331.7 33.9 125.7 257.9 192.2 168.6 70.5 125.5 96.3 84.3 276.7 196.8 77.2 168.8 204.2 273.8 65.8 60.4 149.1 154.0 233.0 213.0 115.8 160.2 239.1 207.4 222.3 185.9 215.0 324.6 80.8 68.5 147.2 236.4 181.0 128.2 60.9 83.9 97.7 121.4 88.1 373.6 106.7 292.4 204.3 81.8 110.3 115.4 207.6 496.8 208.5 162.8 161.1 232.2 269.4 127.6 123.3 119.0 121.6 93.5 142.4 163.0 107.8 171.8 149.6 108.3 189.4 48.6 101.0 48.8 42.8 35.9 43.6 105.9 32.3 32.1 35.9 208.2 76.1 120.9 34.7 50.9 113.5 87.6 95.5 88.0 115.7 97.1 123.9 97.5 90.3 79.7 114.0 86.6 101.8 126.2 134.1 147.4 263.4 38.5 126.0 142.8 100.1 136.8 116.7 99.6 106.8 65.4 606.2 81.5 156.4 252.0 66.7 77.4 127.4 58.1 178.1 80.7 407.9 142.9 116.4 131.8 136.9 52.5 76.1 52.0 86.8 163.2 78.5 110.3 185.0 78.2 158.1 120.7 146.1 139.7 78.4 53.3 136.3 176.2 171.1 93.7 133.6 151.1 192.1 46.9 142.3 125.1 78.2 57.3 76.3 74.6 51.5 190.7 95.6 85.3 27.1 210.1 307.7 59.9 85.5 123.2 210.9 219.8 54.2 122.4 131.7 82.5 117.3 184.0 43.9 112.8 EFNB3 "EPLG8, LERK-8" ENSG00000108947 "Ephrin B3" Q15768 17 7705202-7711372 "Cancer-related genes, Predicted membrane proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 11.6;Early spermatids: 9.2;Excitatory neurons: 9.1" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.9;AN3-CA: 32.3;hTERT-RPE1: 32.6;SH-SY5Y: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001623 Approved NA NA 11000 "HPA001623: AB_1848026" "unprognostic (5.17e-2)" "unprognostic (7.15e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (3.27e-1)" "unprognostic (1.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.21e-4)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.00e-1)" "unprognostic (8.56e-2)" "unprognostic (2.20e-2)" 1.9 2.1 24.0 0.7 29.9 0.0 3.6 3.0 21.9 6.8 6.2 0.6 0.3 10.4 0.5 2.0 5.6 1.2 0.8 24.6 28.9 1.1 1.7 1.0 0.3 12.2 10.2 27.4 4.8 1.3 12.2 5.8 1.3 9.9 2.2 0.6 3.6 1.5 0.5 0.3 6.0 0.9 3.7 7.8 0.1 0.8 3.6 28.2 0.4 0.7 0.1 0.9 1.0 2.4 14.7 0.0 1.0 53.9 32.3 1.0 0.7 0.4 0.6 7.2 4.8 3.1 2.0 3.4 0.0 1.1 2.1 0.3 0.4 13.9 6.9 2.8 0.0 6.8 0.2 0.0 0.1 1.5 0.0 0.0 3.1 1.4 1.5 1.1 32.6 0.3 0.5 0.0 0.0 0.9 5.4 0.0 0.0 4.8 0.0 1.0 0.2 0.1 0.0 7.4 0.7 3.4 28.1 0.0 0.0 1.1 9.4 2.9 0.0 0.1 3.2 10.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 29.9 3.0 21.9 24.6 28.9 12.2 10.2 27.4 9.9 7.8 28.2 14.7 2.1 0.0 0.0 1.0 0.2 4.1 3.8 4.6 6.8 2.2 5.9 11.6 1.7 1.5 0.9 0.0 0.0 0.3 0.0 0.1 0.0 1.1 9.2 2.5 5.9 1.3 6.7 2.7 9.1 0.2 1.0 4.6 0.0 0.7 1.3 3.3 2.2 0.0 0.4 5.0 6.8 0.3 4.1 0.0 0.4 5.6 4.7 0.2 0.0 1.0 0.0 1.4 0.0 0.5 1.3 0.2 0.0 3.4 0.0 1.6 0.0 0.0 6.0 0.7 0.0 0.0 2.2 0.7 0.7 1.8 2.8 0.3 0.1 1.2 0.0 1.6 FAM20A DKFZp434F2322 ENSG00000108950 "FAM20A golgi associated secretory pathway pseudokinase" Q96MK3 17 68535113-68601367 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 82.4;Early spermatids: 69.0;Hepatocytes: 66.8;Hofbauer cells: 94.0;Late spermatids: 189.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "hypothalamus: 7.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;BJ hTERT+: 27.3;HSkMC: 21.8;U-2197: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048964 Approved "Secreted in other tissues" NA NA 13000000 "HPA048964: AB_2680575" "unprognostic (3.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.35e-2)" "unprognostic (4.49e-3)" "unprognostic (6.56e-2)" "unprognostic (5.29e-2)" "unprognostic (3.90e-3)" "unprognostic (2.39e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (9.16e-10)" "unprognostic (1.25e-3)" "unprognostic (1.06e-1)" "unprognostic (4.55e-2)" "unprognostic (2.39e-2)" 6.6 1.6 0.5 2.7 0.4 0.6 5.5 0.3 2.1 13.1 3.1 1.6 0.6 12.6 0.1 3.1 6.1 1.3 2.6 0.1 7.3 12.7 50.6 12.7 1.6 0.8 1.7 0.1 8.2 1.0 0.3 6.3 2.3 0.3 2.5 0.4 0.1 11.7 0.6 1.6 2.4 2.0 2.4 0.1 4.5 7.9 6.6 2.6 0.5 6.8 0.1 0.6 2.2 5.7 0.9 0.0 0.2 0.0 0.2 1.1 10.1 0.0 0.5 27.3 0.0 0.0 0.0 0.1 0.0 2.0 2.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.1 0.0 21.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.1 0.0 0.0 0.1 0.0 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.5 0.4 0.3 2.1 0.1 7.3 0.8 1.7 0.1 0.3 0.1 2.6 0.9 1.4 16.0 82.4 0.7 1.1 2.3 0.1 5.2 0.0 3.2 5.3 0.9 5.2 7.2 21.3 44.1 0.0 0.6 0.4 0.0 0.0 1.2 69.0 6.1 44.4 3.6 0.0 2.7 3.8 0.5 2.2 18.1 42.3 9.7 1.3 2.9 7.5 66.8 94.0 42.1 8.2 0.0 2.0 27.4 3.5 189.3 11.1 26.8 1.8 16.9 1.3 0.2 0.0 4.0 2.1 0.8 0.0 14.7 0.2 0.0 0.0 15.3 0.8 2.8 6.6 3.4 3.0 1.2 0.6 1.2 1.8 2.7 1.0 13.6 0.0 0.1 YWHAE FLJ45465 ENSG00000108953 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" P62258 17 1344275-1400222 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008445, CAB016200, CAB021109, CAB047350" Approved Supported Cytosol NA NA 83000000 Cytosol "CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336" "unprognostic (1.29e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-2)" "prognostic favorable (6.48e-6)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.73e-2)" "unprognostic (4.77e-3)" "unprognostic (4.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.92e-3)" "unprognostic (8.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.24e-2)" "unprognostic (8.94e-2)" 207.7 200.6 264.6 123.9 273.1 122.3 200.4 273.7 277.8 155.8 203.8 162.6 138.0 156.9 194.4 241.0 189.7 104.6 244.6 267.4 275.4 231.4 213.5 178.4 114.6 273.1 262.2 241.8 172.3 156.2 238.9 180.2 199.9 274.9 151.3 169.7 222.7 186.4 122.7 662.1 190.6 130.4 138.4 295.7 102.3 138.1 166.7 266.7 212.9 210.4 445.7 165.9 188.6 181.2 311.9 615.3 565.8 700.2 563.4 376.9 454.7 589.8 382.1 481.5 724.5 571.3 907.5 305.5 524.7 411.9 621.9 439.7 463.1 859.2 745.6 798.7 294.2 930.9 334.1 366.2 409.4 483.4 277.1 311.1 421.6 458.6 619.3 897.0 520.6 729.2 458.5 402.8 337.9 719.7 368.5 445.8 264.1 566.6 596.9 332.7 477.3 255.9 380.4 547.7 365.7 354.2 497.2 531.1 240.3 364.3 439.9 442.3 290.9 467.4 411.9 293.8 453.7 731.4 190.5 329.9 346.6 478.4 387.5 585.4 78.6 137.2 41.2 47.3 153.6 57.8 78.1 67.3 55.1 180.3 59.1 55.7 51.2 49.9 64.1 144.8 133.8 99.7 151.0 264.6 273.1 273.7 277.8 267.4 275.4 273.1 262.2 241.8 274.9 295.7 266.7 311.9 363.6 298.1 194.4 83.2 161.1 573.9 457.5 468.4 281.7 153.6 313.6 219.1 473.4 265.9 310.9 371.5 50.1 463.2 128.7 300.7 745.4 460.8 258.0 573.6 414.3 352.6 352.6 244.7 73.4 421.4 709.5 319.4 194.7 502.7 211.5 328.1 262.3 309.0 384.9 111.0 72.4 346.3 376.4 260.9 434.9 434.3 280.8 227.5 425.2 60.0 320.5 357.8 55.6 56.8 112.1 464.8 289.8 294.9 279.5 487.9 272.1 707.8 504.6 173.3 243.3 361.2 524.6 508.7 573.3 333.8 586.6 519.5 130.7 287.2 361.1 474.4 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392622-55421924 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 153.5;brain: 83.3" "Cell type enhanced" "Detected in many" "Kupffer cells: 56.4;Macrophages: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 110.0;HSkMC: 199.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles NA NA Vesicles "HPA026978: AB_2672068" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.52e-5)" "prognostic unfavorable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.12e-2)" 153.5 13.4 56.7 15.9 56.8 14.2 28.6 12.7 54.4 4.9 7.5 12.4 11.0 6.3 9.8 7.3 4.2 9.5 6.5 83.3 32.3 6.4 13.3 10.1 17.9 25.6 30.2 57.1 2.8 3.5 3.7 4.8 21.6 22.8 6.2 13.1 12.9 4.9 8.0 3.4 5.1 10.2 11.5 22.0 16.7 5.5 17.1 24.1 8.3 6.7 8.1 12.2 11.7 4.1 36.0 20.1 46.3 67.0 13.5 110.0 86.0 39.2 13.6 5.2 7.2 10.2 7.4 53.8 30.1 39.6 4.5 20.1 1.5 18.8 14.3 14.9 41.5 9.5 11.0 2.5 85.2 29.8 10.8 3.2 199.4 4.5 10.1 11.4 15.7 9.0 27.4 4.4 20.5 15.1 2.8 29.7 8.2 20.6 3.3 15.6 12.4 46.9 10.0 19.7 5.0 7.0 72.8 5.0 7.1 10.9 41.5 15.4 17.3 9.6 18.7 26.6 15.5 14.0 13.1 6.2 45.7 26.7 8.5 15.2 14.2 1.5 1.9 1.7 2.1 4.9 4.5 1.8 3.3 4.3 5.0 3.1 3.3 4.6 2.9 1.9 1.3 2.1 17.5 56.7 56.8 12.7 54.4 83.3 32.3 25.6 30.2 57.1 22.8 22.0 24.1 36.0 15.5 3.2 0.6 5.2 20.3 5.4 23.7 9.3 5.2 28.2 3.3 3.3 4.6 11.5 2.7 7.3 4.2 11.5 12.2 3.4 15.6 27.7 2.5 4.8 8.9 16.4 7.8 27.3 36.5 1.3 18.8 12.7 2.6 8.7 0.0 3.5 19.6 17.9 37.6 16.8 11.5 6.8 8.2 56.4 35.9 4.0 1.8 85.9 7.2 14.0 48.6 14.5 12.3 7.5 7.2 17.3 1.6 3.4 12.1 26.2 2.3 9.8 2.4 10.2 19.7 5.2 11.4 28.9 23.3 3.1 17.5 20.0 17.7 1.3 8.6 6.1 RANGRF "HSPC165, HSPC236, MOG1, RANGNRF" ENSG00000108961 "RAN guanine nucleotide release factor" Q9HD47 17 8288654-8290092 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 435.1;Late spermatids: 1448.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057280, HPA057888" Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA057280: AB_2683393, HPA057888: AB_2683549" "unprognostic (2.87e-2)" "unprognostic (2.93e-2)" "unprognostic (7.41e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.90e-3)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (2.01e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" 27.8 27.8 39.3 19.0 40.4 20.7 29.4 38.6 44.1 47.8 38.7 33.4 15.9 37.2 32.2 15.8 35.4 17.0 41.0 38.9 41.1 41.1 18.7 25.6 33.3 39.0 39.5 37.9 36.6 15.2 44.2 32.9 22.9 39.5 35.8 16.1 35.1 13.2 27.9 24.3 19.4 28.4 27.3 39.6 33.5 39.3 79.0 40.8 34.3 25.3 26.2 32.5 35.0 23.4 39.3 52.8 59.5 41.0 42.7 30.0 41.0 35.4 29.7 59.9 75.3 72.7 30.4 20.3 98.4 31.7 35.9 29.7 58.0 77.7 39.3 53.7 71.2 97.6 46.6 45.0 46.6 72.9 30.7 66.2 39.6 75.1 66.4 66.4 38.9 65.5 93.4 21.2 27.1 48.9 1.3 91.7 98.4 29.7 29.8 22.7 81.1 32.0 61.8 44.4 21.3 15.7 45.2 23.5 36.2 65.0 25.9 2.8 28.3 36.3 16.4 29.5 33.0 58.4 47.5 40.0 121.4 35.1 60.8 24.1 17.2 47.6 81.5 68.2 50.7 64.4 74.7 82.8 78.1 51.5 82.0 72.3 61.6 5.9 70.1 41.0 67.8 129.9 57.5 39.3 40.4 38.6 44.1 38.9 41.1 39.0 39.5 37.9 39.5 39.6 40.8 39.3 21.2 9.6 26.1 6.2 35.8 18.1 24.3 23.5 25.0 26.2 31.4 36.2 4.7 12.8 17.5 25.8 12.5 93.2 25.4 9.4 68.4 25.5 435.1 19.0 18.8 26.0 19.8 15.4 6.2 18.3 46.4 25.3 14.8 19.3 27.8 19.0 23.9 17.3 49.3 20.2 9.0 17.4 26.4 16.4 19.2 1448.8 28.3 18.9 17.8 1.9 29.5 33.6 58.7 3.0 9.5 21.1 21.2 31.6 37.5 22.9 14.3 66.7 14.3 38.4 19.7 16.3 34.0 180.6 23.0 10.6 19.6 112.9 35.6 28.1 21.8 16.1 DPH1 "DPH2L, DPH2L1, OVCA1" ENSG00000108963 "Diphthamide biosynthesis 1" Q9BZG8 17 2030137-2043898 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069750, HPA073864" Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA069750: AB_2686188, HPA073864: " "unprognostic (5.54e-2)" "unprognostic (1.99e-1)" "unprognostic (1.62e-1)" "unprognostic (1.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "prognostic favorable (1.78e-5)" "unprognostic (2.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (7.30e-2)" "unprognostic (1.41e-1)" 21.7 32.6 11.4 6.0 12.1 5.3 22.3 14.7 17.8 27.0 9.5 24.7 8.1 29.0 5.6 20.0 31.3 9.2 18.6 12.6 19.6 27.8 36.6 16.7 7.5 9.7 10.5 12.1 26.8 32.3 14.3 59.8 8.5 10.6 36.5 6.2 12.5 23.9 11.1 42.6 29.5 21.0 9.0 9.0 24.5 27.2 20.5 10.6 6.8 28.8 13.8 6.1 24.4 22.4 10.8 15.4 24.9 6.3 16.0 22.2 14.2 18.7 19.3 26.8 29.7 18.7 24.1 11.6 29.0 23.6 52.5 11.2 11.6 20.7 21.1 15.9 9.0 52.4 6.3 10.5 13.1 19.4 8.3 10.2 20.3 20.3 22.7 19.0 20.5 13.9 16.8 23.4 11.2 11.9 18.2 14.7 4.8 6.5 17.3 25.9 16.6 5.7 22.0 13.3 8.0 13.1 15.2 17.4 17.9 17.2 6.9 25.9 6.8 10.1 19.4 10.1 26.2 16.7 10.3 8.3 6.8 20.3 10.8 8.5 0.8 4.5 0.8 8.0 6.1 8.9 8.8 6.5 7.4 7.7 7.2 9.6 6.9 0.3 6.7 4.5 5.5 10.2 5.2 11.4 12.1 14.7 17.8 12.6 19.6 9.7 10.5 12.1 10.6 9.0 10.6 10.8 0.9 3.2 9.2 1.3 9.3 0.4 0.9 0.5 19.4 2.1 0.8 0.8 1.5 0.0 2.7 0.0 2.1 1.4 0.9 0.6 0.0 0.5 1.2 1.5 1.2 1.7 0.0 9.0 4.0 0.6 0.9 4.5 21.4 0.8 2.5 1.0 0.7 0.0 0.6 1.7 3.7 0.8 0.0 0.0 0.8 1.5 0.6 3.9 0.0 1.0 0.4 0.9 2.1 1.5 1.4 0.0 0.2 0.4 12.0 0.5 0.5 0.5 3.0 2.8 0.0 1.3 3.2 1.2 0.5 13.0 0.3 1.4 5.4 1.3 0.4 0.6 MAP2K6 "MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3" ENSG00000108984 "Mitogen-activated protein kinase kinase 6" P52564 17 69414697-69553865 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.9" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 8.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3" "Group enriched" "Detected in all" 9 "dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0" "Cell line enhanced" "Detected in many" "A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007744, HPA031134" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB007744: AB_562318, HPA031134: AB_10603016" "prognostic favorable (2.27e-6)" "unprognostic (2.24e-1)" "unprognostic (8.46e-2)" "unprognostic (4.10e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.61e-3)" "unprognostic (9.52e-2)" "unprognostic (3.67e-1)" "unprognostic (4.09e-3)" "prognostic favorable (7.52e-4)" "unprognostic (3.61e-2)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (9.43e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-2)" 5.3 1.3 5.0 8.4 4.2 16.0 20.6 12.1 4.2 27.2 6.8 31.0 10.4 6.1 3.2 3.2 4.5 7.3 1.4 2.9 3.9 5.6 12.3 1.8 8.0 4.4 3.9 2.4 3.2 8.4 0.3 1.6 1.7 5.1 3.4 32.0 5.9 2.5 3.1 40.9 2.1 10.9 3.3 4.6 4.1 7.5 1.3 5.0 11.6 3.3 21.3 5.9 3.3 1.2 8.2 0.1 40.0 17.6 21.4 7.4 4.0 2.5 0.3 5.8 1.6 2.4 1.2 1.7 1.1 14.2 0.8 1.3 1.9 6.1 0.8 0.5 1.3 3.2 0.1 10.3 11.4 7.4 1.7 1.3 19.0 0.5 0.3 0.0 1.4 28.4 5.3 0.1 2.5 0.0 0.3 21.6 0.7 12.5 0.9 7.3 7.7 1.8 0.5 7.8 5.4 7.8 11.8 1.7 1.3 3.9 9.3 5.4 2.3 5.1 1.9 2.3 1.6 0.5 1.7 2.2 0.5 1.6 2.5 1.5 2.5 22.0 4.0 2.8 2.6 5.0 4.1 3.1 3.5 7.1 5.2 3.6 3.4 45.9 4.7 1.1 78.3 5.0 6.2 5.0 4.2 12.1 4.2 2.9 3.9 4.4 3.9 2.4 5.1 4.6 5.0 8.2 11.2 3.2 6.7 27.7 7.7 2.7 4.1 0.8 8.6 5.2 14.3 29.1 1.3 5.7 3.6 0.0 2.1 9.7 29.2 42.3 23.5 1.9 10.2 53.9 11.5 7.9 45.6 5.0 26.0 4.1 6.6 5.0 9.2 82.7 1.3 13.4 4.2 2.5 6.2 3.3 22.4 22.9 0.0 6.8 7.4 2.9 4.4 6.9 3.6 24.4 9.6 31.8 10.3 32.6 52.5 1.1 16.7 3.8 10.7 1.3 14.5 1.5 4.2 4.2 0.0 3.9 5.7 0.1 1.8 4.8 4.3 0.8 13.3 1.4 30.6 2.8 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 18.9 18.9 19.1 8.2 19.0 3.0 19.4 19.9 28.5 17.9 19.6 15.3 15.7 11.5 25.9 12.9 16.1 12.0 21.0 19.0 19.5 23.1 20.3 13.6 7.8 19.8 19.8 18.8 8.4 20.4 33.2 8.0 13.3 19.4 15.2 15.9 10.9 18.4 10.3 31.0 18.8 14.6 9.7 19.8 9.3 18.3 24.2 19.0 6.8 16.8 19.7 9.0 12.5 11.2 21.3 17.2 19.9 7.1 15.6 18.5 12.7 12.4 16.0 8.9 11.4 20.7 25.2 17.6 7.2 23.8 13.7 9.0 23.7 10.6 26.2 16.1 13.8 33.9 9.9 13.8 21.8 10.2 5.5 7.0 10.0 17.0 14.6 22.1 5.6 11.3 12.5 6.0 8.6 13.5 35.2 6.0 21.6 9.9 55.4 8.5 10.0 18.8 12.7 39.1 20.5 3.9 8.3 19.8 17.4 17.9 56.8 11.7 11.2 5.6 9.4 6.4 28.7 18.3 4.7 7.9 13.6 14.9 20.3 14.4 19.2 34.3 29.3 6.7 33.9 6.0 7.6 6.5 4.6 21.6 5.9 7.0 6.1 25.0 8.4 40.8 9.4 10.9 14.4 19.1 19.0 19.9 28.5 19.0 19.5 19.8 19.8 18.8 19.4 19.8 19.0 21.3 31.1 16.0 18.1 29.4 11.9 16.3 26.7 59.0 11.4 21.3 19.8 17.4 14.1 25.8 38.5 29.5 31.3 52.9 11.3 25.9 17.6 47.2 69.5 38.1 13.6 23.7 7.2 21.9 32.9 39.0 31.8 18.9 14.3 22.2 8.8 13.8 27.5 20.5 29.4 18.5 37.3 28.5 48.8 17.9 15.5 24.4 22.4 14.3 19.6 14.0 20.8 27.6 22.6 36.7 36.2 30.0 24.8 35.0 10.5 29.0 44.4 25.2 50.7 40.1 6.6 15.1 18.2 71.5 22.3 10.7 18.6 51.6 11.2 27.3 22.2 25.1 WSB1 "DKFZp564A122, DKFZp564B0482, SWIP1" ENSG00000109046 "WD repeat and SOCS box containing 1" Q9Y6I7 17 27294076-27315926 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003293 Approved Approved Mitochondria NA Yes Mitochondria "HPA003293: AB_1858863" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.44e-1)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.07e-5)" "unprognostic (2.59e-2)" "unprognostic (5.40e-3)" "unprognostic (2.74e-1)" "unprognostic (9.22e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-7)" "unprognostic (1.44e-1)" "unprognostic (3.18e-1)" "unprognostic (1.62e-1)" "unprognostic (3.74e-2)" 40.4 22.2 3.9 46.3 23.4 49.2 36.0 12.4 26.8 46.9 3.6 37.2 28.9 49.8 24.9 28.0 46.3 40.0 30.3 8.8 18.0 29.1 15.7 58.8 34.8 29.2 20.7 2.1 48.1 29.8 19.2 24.0 75.7 35.0 27.9 31.2 76.7 27.6 32.5 23.2 23.3 34.0 45.2 10.4 70.5 33.0 21.8 18.8 25.0 29.1 16.2 35.5 33.1 39.4 69.2 30.8 21.3 65.3 37.5 40.3 49.7 69.7 26.6 37.9 20.6 39.6 32.0 12.2 30.6 29.6 36.6 26.2 28.4 40.0 19.6 30.9 85.3 33.1 48.7 41.9 32.7 75.7 34.1 69.2 60.2 26.3 30.1 18.4 31.5 83.1 31.7 49.8 28.6 36.9 19.4 44.4 38.4 19.4 17.1 17.3 35.5 35.9 18.5 31.1 24.6 20.9 28.8 27.8 27.3 36.7 77.8 22.1 44.5 46.5 25.3 19.2 34.8 26.4 12.8 34.9 31.2 23.9 26.8 23.4 75.0 41.1 71.5 21.6 70.3 26.1 22.1 18.1 24.2 65.5 25.3 17.0 19.7 37.1 21.4 82.5 21.5 30.2 26.4 3.9 23.4 12.4 26.8 8.8 18.0 29.2 20.7 2.1 35.0 10.4 18.8 69.2 300.4 221.2 476.1 189.7 245.4 249.2 185.6 138.4 253.8 91.9 186.7 147.7 67.5 144.4 194.2 239.1 348.2 360.7 183.2 222.7 27.4 124.9 153.0 201.2 187.6 254.9 194.4 148.1 229.5 65.1 217.2 284.6 190.6 301.5 163.5 436.3 316.6 43.3 228.2 82.4 267.8 191.5 162.8 412.6 288.9 26.6 141.4 358.9 197.5 206.1 153.2 170.5 112.3 349.3 658.2 76.7 185.4 122.6 144.9 196.3 178.7 30.7 137.5 381.4 124.9 243.8 221.9 119.6 104.8 202.2 280.3 714.5 183.9 98.5 133.6 148.9 RCVRN RCV1 ENSG00000109047 Recoverin P35243 17 9896320-9905271 "Plasma proteins, Predicted intracellular proteins, Transporters" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 338 "retina: 467.8" "Cell type enriched" "Detected in some" 4 "Rod photoreceptor cells: 1926.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "WM-115: 1.8" "Region enhanced" "Detected in single" "hippocampal formation: 1.3" "Low region specificity" "Detected in many" "HPA015783, CAB022363" Enhanced NA NA "CAB022363: , HPA015783: AB_2669298" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-2)" "unprognostic (1.32e-1)" "unprognostic (7.95e-3)" "unprognostic (4.82e-2)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (1.94e-4)" "unprognostic (1.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.41e-2)" "unprognostic (9.23e-2)" 0.1 0.0 0.5 0.0 0.8 0.0 0.0 0.2 1.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.2 0.0 0.0 0.0 0.0 0.2 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 467.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.2 1.2 1.2 0.2 0.2 1.3 0.7 0.2 0.0 0.1 0.9 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 230.5 0.0 0.0 0.5 0.0 0.0 0.0 475.4 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 11.5 0.0 0.0 1.5 0.0 0.0 2.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 107.7 0.7 0.0 0.0 0.0 0.9 0.7 2.5 0.5 1.8 0.0 0.1 393.9 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1926.6 0.0 1.7 0.3 0.1 0.5 0.0 0.3 0.1 0.1 0.0 0.0 0.0 MYH1 "MGC133384, MYHa, MyHC-2X/D, MYHSA1" ENSG00000109061 "Myosin heavy chain 1" P12882 17 10492307-10518542 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 137 "skeletal muscle: 7957.1" "Cell type enriched" "Detected in some" 10 "Skeletal myocytes: 77.4" "Cancer enriched" "Detected in single" 45 "head and neck cancer: 8.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001349, CAB010759" Enhanced Uncertain "Focal adhesion sites" NA NA 98000000 "Focal adhesion sites" "CAB010759: AB_477248, HPA001349: AB_1079437" "unprognostic (2.87e-2)" "unprognostic (3.27e-3)" "unprognostic (1.91e-1)" "unprognostic (8.95e-3)" "unprognostic (4.49e-2)" "unprognostic (7.31e-2)" "unprognostic (5.63e-3)" "unprognostic (9.85e-4)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" 2.6 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 3.5 0.1 0.1 0.5 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 1.3 0.0 0.0 9.1 0.1 7957.1 0.5 0.2 0.1 0.0 0.1 0.2 1.9 0.0 0.0 0.5 58.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.4 0.6 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SLC9A3R1 "EBP50, NHERF, NHERF1" ENSG00000109062 "SLC9A3 regulator 1" O14745 17 74748628-74769353 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Wnt signaling pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 355.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001962, HPA009672, HPA027247" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" NA Yes 940000 "Plasma membrane" "Vesicles, Centriolar satellite" "CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162" "unprognostic (1.29e-1)" "unprognostic (4.58e-2)" "unprognostic (1.73e-2)" "unprognostic (5.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (7.41e-2)" "unprognostic (5.61e-2)" "unprognostic (5.38e-2)" "unprognostic (7.53e-2)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (7.81e-3)" "unprognostic (5.53e-2)" "unprognostic (3.84e-2)" "unprognostic (2.08e-2)" 21.5 147.5 91.8 44.1 94.3 116.7 64.8 98.2 107.3 51.8 111.3 85.9 260.2 22.8 26.2 355.7 90.4 97.5 19.3 90.9 83.4 199.8 271.4 26.7 68.5 91.4 90.8 78.8 11.2 86.1 111.2 20.9 33.9 90.5 44.3 59.9 13.1 193.9 71.8 5.2 51.5 276.7 11.7 86.5 61.6 78.8 22.7 92.9 58.3 21.6 10.1 90.0 25.9 104.1 98.7 102.1 82.6 40.4 42.1 23.9 17.5 179.9 24.1 22.4 60.3 58.2 259.6 59.6 22.2 23.9 51.4 32.3 142.2 69.8 46.4 28.3 25.9 66.2 167.4 210.9 350.8 48.6 110.3 108.9 14.4 25.6 48.0 20.6 124.9 50.2 65.8 54.0 115.9 93.8 572.4 262.5 246.7 36.1 286.3 47.6 28.0 45.4 100.6 83.5 71.7 34.6 45.3 25.2 450.7 51.9 110.4 873.8 87.3 17.0 18.7 53.5 43.8 40.2 200.0 98.9 40.9 30.2 145.4 11.2 581.6 91.9 440.8 421.5 133.0 279.8 58.6 255.5 360.4 87.8 52.1 147.5 266.1 318.8 308.8 172.1 90.8 309.0 345.9 91.8 94.3 98.2 107.3 90.9 83.4 91.4 90.8 78.8 90.5 86.5 92.9 98.7 12.3 6.4 17.2 29.0 41.8 46.1 21.4 128.7 50.1 2.2 135.3 78.7 17.8 163.0 120.8 31.3 4.2 74.5 122.9 295.8 66.5 194.9 15.8 61.8 7.8 12.0 18.7 24.8 0.4 99.0 56.6 24.7 45.3 85.0 25.3 7.3 7.9 190.6 85.4 5.0 0.5 58.0 105.8 25.7 18.8 9.9 8.7 43.5 28.4 3.7 27.0 86.2 203.9 5.0 11.4 76.5 143.8 41.8 151.1 27.5 536.9 433.0 76.0 5.0 6.6 27.6 20.0 22.5 19.5 303.4 57.4 111.5 126.1 17.1 57.1 34.6 MYH3 "HEMHC, MYHC-EMB, MYHSE1, SMHCE" ENSG00000109063 "Myosin heavy chain 3" P11055 17 10628526-10657309 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 29.3;seminal vesicle: 18.5;skeletal muscle: 20.8" "Cell type enriched" "Detected in many" 7 "Early spermatids: 411.9" "Group enriched" "Detected in many" 4 "head and neck cancer: 3.3;prostate cancer: 4.6;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 26 "HSkMC: 59.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA021808 Enhanced NA NA 29000000 "HPA021808: AB_1854242" "unprognostic (1.70e-2)" "unprognostic (1.10e-3)" "unprognostic (4.19e-4)" "unprognostic (3.35e-1)" "unprognostic (7.66e-2)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (1.67e-2)" "unprognostic (3.54e-1)" "unprognostic (7.84e-4)" "unprognostic (1.29e-1)" "unprognostic (3.24e-4)" "unprognostic (1.91e-2)" "unprognostic (6.17e-3)" "unprognostic (3.40e-2)" "unprognostic (3.49e-1)" 1.4 0.9 2.0 1.1 2.0 0.8 1.5 1.7 1.8 3.0 1.7 4.8 1.1 3.4 1.2 9.2 2.6 0.5 1.0 1.8 1.7 1.8 3.4 1.2 1.3 2.0 2.1 1.6 2.3 2.5 0.3 1.5 0.4 2.1 29.3 1.0 1.8 1.5 18.5 20.8 2.4 2.5 1.7 1.6 2.7 1.7 4.6 2.0 3.1 3.5 6.1 0.6 4.5 3.8 1.9 0.2 1.1 0.8 1.1 1.0 0.3 1.0 0.8 0.4 0.5 0.5 1.0 0.1 0.7 0.3 0.4 0.2 1.1 0.5 0.2 1.0 0.7 0.9 1.0 0.3 1.6 0.3 0.6 1.4 59.6 0.4 0.6 0.8 0.1 0.1 1.3 0.4 0.1 0.2 0.7 1.0 2.3 0.9 0.3 0.6 0.8 0.8 0.3 0.3 0.3 0.0 0.4 0.4 0.0 0.3 0.7 0.3 0.3 0.3 0.1 1.0 0.3 0.1 1.3 1.1 0.3 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.0 1.7 1.8 1.8 1.7 2.0 2.1 1.6 2.1 1.6 2.0 1.9 0.5 0.0 9.8 4.6 0.7 2.9 0.9 0.1 0.6 4.9 0.7 1.8 3.6 1.5 0.7 0.0 6.2 0.4 0.8 0.9 0.0 0.6 411.9 0.5 0.8 1.4 0.0 2.7 3.9 0.6 0.8 1.1 1.1 0.5 7.6 0.8 0.4 0.6 0.1 0.0 3.4 0.5 0.0 0.8 0.3 56.0 2.8 1.2 1.8 1.9 0.2 1.8 0.0 7.5 5.4 0.7 0.2 2.6 0.0 1.5 1.8 0.3 0.3 4.6 0.0 5.5 0.8 10.7 4.2 0.3 1.6 0.5 1.4 0.2 0.8 0.3 NAT9 DKFZP564C103 ENSG00000109065 "N-acetyltransferase 9 (putative)" Q9BTE0 17 74770529-74776367 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021820, HPA057149" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021820: AB_1847958, HPA057149: AB_2683350" "unprognostic (7.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.40e-1)" "unprognostic (2.18e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.27e-1)" "unprognostic (5.77e-2)" "unprognostic (1.41e-1)" "prognostic favorable (3.21e-5)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.26e-6)" "prognostic favorable (7.80e-4)" "unprognostic (8.50e-2)" "unprognostic (8.64e-2)" "unprognostic (1.03e-3)" 17.8 58.0 24.0 11.5 24.3 13.6 18.3 25.6 27.8 23.3 24.5 17.4 8.1 18.9 23.4 16.4 21.6 9.0 19.5 23.6 24.0 24.0 30.1 17.8 13.7 25.1 25.0 23.8 31.3 25.4 18.2 29.7 14.3 25.1 27.9 9.9 11.6 17.3 12.6 16.6 16.1 15.9 11.2 24.3 21.0 19.5 21.1 25.3 13.9 24.6 11.1 11.4 21.9 18.4 25.5 20.9 30.0 18.7 17.2 29.9 37.4 22.3 39.5 34.2 40.7 35.1 51.3 22.8 57.4 14.7 31.2 26.2 22.8 25.6 42.9 25.9 12.0 37.0 37.0 24.6 46.2 34.9 19.1 22.9 34.2 31.9 40.5 61.2 33.7 44.7 36.2 46.8 17.6 30.2 19.9 38.9 15.6 14.5 40.5 42.8 25.6 55.7 33.4 29.2 33.5 27.0 35.7 16.5 48.1 78.0 25.5 44.4 24.7 26.2 47.0 37.7 20.4 37.5 24.1 9.4 32.0 19.4 12.9 30.5 20.4 16.2 7.4 9.2 24.0 18.9 20.7 16.7 13.8 19.9 30.5 28.5 21.1 4.2 16.7 13.9 15.2 9.8 12.0 24.0 24.3 25.6 27.8 23.6 24.0 25.1 25.0 23.8 25.1 24.3 25.3 25.5 15.3 6.4 14.5 15.7 22.6 35.1 41.7 25.9 12.5 39.5 24.7 18.9 5.6 5.7 16.4 18.4 47.9 23.3 20.3 14.5 7.9 14.9 5.5 7.6 13.3 14.3 26.4 10.3 24.4 19.5 19.2 17.3 17.3 13.1 1.3 33.0 9.3 9.9 18.0 45.4 20.2 17.7 20.3 14.1 21.0 4.0 29.5 16.8 10.6 5.6 20.7 11.3 18.6 15.6 16.4 18.3 17.0 17.0 15.8 43.7 11.8 14.5 13.5 46.4 6.6 15.1 16.1 20.5 26.4 9.0 29.7 22.2 14.3 23.7 20.8 39.0 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776499-74839753 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favorable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 6.3 10.7 6.6 5.7 8.3 8.5 5.4 8.5 8.0 3.9 4.9 4.7 3.5 4.7 3.8 6.7 4.3 3.5 6.7 6.1 6.7 7.7 15.0 7.8 4.6 9.2 9.0 5.3 3.8 8.2 8.2 10.0 5.1 8.8 5.6 2.9 2.1 7.6 3.8 5.5 5.0 5.3 4.3 8.4 7.0 6.1 8.5 7.6 4.3 7.8 3.9 4.4 5.2 4.3 10.4 10.8 26.0 13.4 15.4 18.9 11.7 8.1 18.2 18.1 22.8 25.1 21.1 11.2 5.6 5.8 20.9 23.4 12.0 13.8 10.2 12.0 4.2 19.5 14.1 10.5 15.0 13.8 23.5 12.6 9.3 10.9 23.1 5.0 6.8 16.5 13.6 8.4 8.5 15.6 10.3 14.1 9.3 7.5 14.2 20.6 8.7 21.3 9.4 9.9 9.3 11.4 15.1 10.1 12.9 13.6 10.0 16.5 35.8 13.2 48.0 12.1 18.4 24.0 5.9 5.5 6.5 18.5 24.0 18.6 1.4 5.0 3.7 4.7 4.1 2.4 3.3 4.5 4.4 5.3 0.8 3.7 2.6 2.1 2.8 4.6 5.5 5.0 3.6 6.6 8.3 8.5 8.0 6.1 6.7 9.2 9.0 5.3 8.8 8.4 7.6 10.4 2.3 6.4 5.8 7.8 2.2 2.5 1.1 3.4 0.6 2.7 5.6 3.3 49.5 8.6 4.6 5.5 2.1 4.1 5.2 6.0 0.0 5.0 3.0 3.3 2.7 4.8 8.3 1.7 5.6 5.6 4.3 4.6 5.6 6.4 1.3 3.2 2.9 14.2 13.3 0.0 4.4 4.7 4.1 7.3 3.8 3.5 2.8 9.5 0.0 4.7 4.7 4.1 3.1 4.0 11.1 6.2 3.4 2.2 8.2 2.5 3.4 1.9 2.0 3.1 0.0 3.3 4.2 4.4 3.8 2.8 2.3 3.8 4.3 2.5 3.6 1.6 VTN VN ENSG00000109072 Vitronectin P04004 17 28367284-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "liver: 6088.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 5507.4" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "CACO-2: 1748.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016695, CAB016765, HPA060933, HPA068011" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" NA NA 606000000000 33000000000 "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favorable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 3.2 99.8 2.3 2.5 2.5 0.3 0.9 4.8 3.7 0.9 0.3 0.7 4.7 1.5 0.9 0.5 2.2 61.8 53.6 2.4 2.1 3.6 6088.3 1.8 4.3 2.2 2.6 2.5 1.9 17.8 0.1 3.0 40.9 2.8 1.3 0.3 47.8 0.6 4.4 0.4 0.8 1.3 2.8 1.3 2.9 5.1 10.1 2.0 0.1 0.8 0.5 0.4 4.2 0.7 2.3 0.0 28.4 0.7 0.4 0.2 0.3 7.3 1.8 0.8 0.9 0.9 1748.9 0.1 1.2 0.2 0.2 0.2 0.7 0.0 0.0 0.1 0.2 0.2 1.2 1.1 86.7 2.5 6.1 0.5 0.4 0.0 0.6 0.0 3.9 0.1 0.0 1.6 0.3 0.2 0.7 0.2 0.0 0.8 0.4 0.1 0.4 3.5 0.1 0.3 0.0 1.0 1.4 115.6 8.0 0.2 4.3 0.3 0.0 1.0 0.4 0.3 0.1 0.2 1.0 0.5 1.4 0.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 2.3 2.5 4.8 3.7 2.4 2.1 2.2 2.6 2.5 2.8 1.3 2.0 2.3 0.1 0.0 1.1 2.0 21.5 0.0 0.0 0.0 0.0 13.0 0.1 0.1 18.1 1162.4 0.0 0.0 77.2 3.7 0.0 0.0 3.9 16.8 0.0 0.0 1.2 7.3 0.0 131.0 0.9 19.7 2.8 48.1 0.0 0.0 0.0 1.8 120.3 5507.4 4.7 38.7 1.0 0.1 0.0 160.3 0.3 0.2 0.0 0.3 0.0 0.0 20.1 6.9 0.0 1.0 0.5 23.5 1.2 1.5 0.0 0.0 0.1 9.5 0.0 38.3 0.0 0.4 1.5 4.2 0.6 0.0 0.0 9.6 9.0 0.7 0.0 0.0 TNFAIP1 "B12, B61, BTBD34, EDP1, MGC2317" ENSG00000109079 "TNF alpha induced protein 1" Q13829 17 28335602-28347009 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 166.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013333, HPA014641" Uncertain Approved Nucleoli NA NA Nucleoli "HPA013333: AB_1858160, HPA014641: AB_1858159" "unprognostic (4.42e-1)" "unprognostic (1.54e-2)" "unprognostic (4.32e-2)" "prognostic unfavorable (7.48e-5)" "unprognostic (2.29e-1)" "unprognostic (4.97e-3)" "unprognostic (3.21e-1)" "unprognostic (1.94e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-2)" "unprognostic (8.27e-3)" "unprognostic (1.43e-2)" "unprognostic (4.21e-3)" "unprognostic (2.49e-2)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (7.02e-2)" 32.0 30.6 32.5 19.5 30.2 8.2 30.5 28.3 31.9 22.2 36.3 19.4 17.9 21.9 15.0 39.9 19.3 29.2 38.4 30.5 33.5 32.0 55.2 41.3 17.1 30.2 30.7 28.6 17.6 37.9 23.2 17.6 45.0 28.7 20.7 17.0 26.5 24.1 20.7 23.5 28.9 17.9 31.1 29.0 50.6 25.6 17.3 34.0 22.2 24.2 24.0 19.7 35.5 23.6 29.3 43.3 61.3 40.2 28.4 34.3 30.1 39.0 50.4 62.4 60.6 47.6 166.1 25.8 8.7 34.4 67.0 29.4 49.1 22.3 86.9 46.5 24.0 28.0 7.7 66.0 24.2 45.9 13.5 12.5 38.9 99.7 47.7 37.0 56.9 71.7 17.4 20.0 12.8 28.8 25.8 25.6 7.4 9.3 36.4 22.3 11.3 50.8 15.5 89.5 45.9 29.3 31.7 62.3 102.5 25.8 55.8 42.9 11.4 76.4 44.2 43.7 34.4 39.3 20.8 18.7 9.3 34.3 9.0 28.5 1.7 7.2 9.5 6.5 7.0 7.7 5.3 4.7 5.9 9.3 3.9 4.5 5.5 2.5 9.1 8.7 4.5 4.3 5.0 32.5 30.2 28.3 31.9 30.5 33.5 30.2 30.7 28.6 28.7 29.0 34.0 29.3 66.6 38.5 12.9 5.5 4.6 24.6 47.5 32.0 12.5 25.6 18.2 11.9 21.8 20.0 17.5 22.0 16.7 31.5 6.2 14.3 23.5 60.5 40.1 23.0 13.9 62.4 17.4 7.4 11.7 82.5 34.9 13.5 12.8 30.2 7.0 14.0 60.3 29.5 11.0 11.8 7.5 11.0 10.2 12.5 12.1 6.9 7.8 7.0 0.0 9.4 30.1 10.0 4.1 7.1 7.2 112.9 15.1 7.9 7.1 46.9 13.6 16.9 20.2 9.8 13.1 10.9 22.3 5.4 5.6 15.9 28.4 69.2 5.0 18.1 9.7 43.0 IFT20 ENSG00000109083 "Intraflagellar transport 20" Q8IY31 17 28328325-28335489 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021376 Approved Approved Microtubules NA NA Microtubules "HPA021376: AB_1851460" "unprognostic (1.29e-1)" "unprognostic (2.35e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (8.65e-4)" "unprognostic (1.13e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (8.02e-2)" "unprognostic (4.86e-3)" "unprognostic (2.42e-1)" "unprognostic (2.48e-2)" "unprognostic (6.19e-3)" "prognostic unfavorable (5.09e-7)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (2.59e-2)" "unprognostic (4.71e-3)" 24.7 33.1 29.5 14.9 29.6 77.8 27.0 29.6 46.5 22.0 31.7 32.4 29.1 21.1 39.5 19.0 22.8 22.4 18.0 29.1 31.1 33.2 41.8 22.5 20.9 30.2 29.6 29.2 21.8 117.1 25.7 45.5 24.3 29.6 30.2 20.2 26.9 41.6 20.7 9.6 17.0 28.3 20.1 30.3 25.1 42.8 50.5 29.6 23.0 29.5 7.6 20.0 28.1 19.8 30.6 27.3 39.0 25.2 20.7 74.2 75.2 24.2 47.2 58.0 28.9 45.5 59.6 12.7 13.4 24.8 59.8 17.5 29.1 16.9 35.1 41.8 55.0 72.5 8.0 39.7 26.7 72.7 34.1 16.0 57.6 46.4 24.8 39.9 48.2 46.1 26.6 24.2 32.8 23.0 38.2 30.7 26.8 16.9 82.4 21.8 14.4 32.6 35.4 46.2 26.7 31.7 46.2 31.3 64.3 74.8 43.6 41.0 38.2 51.3 16.9 25.8 25.3 25.9 49.6 44.8 17.1 61.6 24.6 25.1 53.7 67.7 52.6 38.6 50.6 44.8 43.2 39.2 38.6 78.1 51.6 39.8 34.7 71.1 36.8 49.0 56.1 45.8 53.7 29.5 29.6 29.6 46.5 29.1 31.1 30.2 29.6 29.2 29.6 30.3 29.6 30.6 42.1 38.5 55.8 17.9 36.7 37.0 38.0 63.0 34.7 63.3 74.6 68.3 6.1 47.1 51.5 51.5 60.5 73.0 47.4 30.7 140.8 60.8 245.4 79.8 40.3 47.3 62.6 25.7 31.3 113.2 82.6 47.4 32.1 39.5 23.5 34.2 38.2 48.6 54.2 57.2 36.5 69.5 40.7 47.8 69.4 53.4 60.3 49.6 32.0 7.5 72.8 37.4 42.2 24.6 30.7 68.0 29.9 57.6 57.8 45.9 127.8 98.0 102.6 78.3 78.9 33.5 67.0 164.8 53.0 25.7 42.8 81.4 35.9 59.6 43.1 49.5 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319200-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 114.4;pancreas: 324.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 121.5;Exocrine glandular cells: 196.4;Granulosa cells: 212.9;Hepatocytes: 226.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 341.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 4.1 26.2 6.1 7.4 6.5 6.7 11.8 6.5 8.5 5.7 5.9 14.5 16.6 6.8 4.7 7.5 13.2 10.3 3.4 6.4 4.5 7.2 114.4 17.5 7.2 13.4 7.7 5.9 18.3 324.7 6.5 1.6 6.9 19.5 10.9 12.7 6.3 3.7 3.3 15.6 7.9 11.2 5.8 5.0 4.7 39.1 58.5 8.7 7.7 4.2 9.2 8.2 26.8 5.2 16.0 46.1 120.4 214.8 105.5 28.0 40.2 70.5 44.1 27.9 67.9 90.3 341.0 34.3 126.3 46.4 17.0 140.1 48.7 137.1 75.0 52.7 60.3 102.1 47.8 56.9 143.0 25.7 76.9 36.4 84.0 10.0 66.4 27.5 8.3 21.1 80.1 101.3 92.1 22.7 81.8 120.0 72.4 95.6 187.7 30.6 94.8 236.5 112.8 85.6 210.6 154.1 67.0 70.0 55.1 36.3 118.2 97.0 35.8 13.8 72.8 56.8 62.9 81.7 74.3 159.0 115.9 14.6 54.7 44.3 0.7 2.2 2.2 7.8 2.7 9.2 11.1 6.4 9.4 16.1 5.5 10.4 9.8 1.0 9.5 1.0 9.3 6.6 5.2 6.1 6.5 6.5 8.5 6.4 4.5 13.4 7.7 5.9 19.5 5.0 8.7 16.0 4.2 9.6 61.5 3.3 7.7 14.5 6.0 32.8 18.8 11.3 22.5 21.5 9.0 121.5 19.1 14.7 16.7 34.2 5.0 6.1 15.6 23.3 22.3 7.5 14.3 7.1 38.8 40.3 2.9 196.4 84.0 14.4 49.5 11.4 1.3 212.9 6.4 226.9 22.0 3.3 4.5 16.2 26.4 6.7 34.7 49.1 13.4 9.9 16.0 0.0 11.4 8.2 4.1 4.0 1.0 47.7 3.5 11.3 15.3 13.9 4.0 6.3 12.2 9.1 6.6 10.4 12.4 91.3 65.5 22.7 11.2 10.7 6.4 65.1 29.4 7.9 CDR2L HUMPPA ENSG00000109089 "Cerebellar degeneration related protein 2 like" Q86X02 17 74987632-75005800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 23.2;Glandular and luminal cells: 28.9;Late spermatids: 30.9;Pancreatic endocrine cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 61.8;U-138 MG: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022015 Enhanced Approved Cytosol NA NA Cytosol "HPA022015: AB_1846462" "unprognostic (4.60e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-2)" "unprognostic (3.85e-2)" "unprognostic (2.17e-1)" "unprognostic (7.36e-3)" "unprognostic (9.22e-2)" "unprognostic (1.78e-2)" "unprognostic (9.11e-2)" "unprognostic (2.11e-1)" "unprognostic (4.21e-2)" "unprognostic (1.84e-1)" "unprognostic (5.89e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" 8.0 5.9 24.1 2.7 32.2 0.1 8.1 38.5 22.7 10.1 18.9 8.4 22.6 12.8 0.9 6.7 6.8 8.9 16.3 15.7 25.2 10.7 1.6 13.0 0.9 42.1 35.4 11.4 3.2 4.4 2.6 6.0 7.0 43.5 7.4 1.4 1.7 8.4 5.1 2.1 4.4 11.6 5.5 32.4 1.8 15.2 7.9 35.8 0.5 4.7 3.2 0.7 9.6 7.0 45.1 15.0 42.1 9.2 19.3 15.8 13.8 4.2 21.3 9.4 12.2 15.5 25.1 13.5 0.0 21.9 37.3 11.0 39.2 11.0 5.2 8.0 0.3 18.6 0.1 26.2 16.3 9.1 1.7 0.7 8.1 8.1 29.0 3.0 8.7 26.5 3.2 6.5 2.1 13.0 13.5 2.0 1.6 12.0 35.3 20.6 6.9 14.0 6.5 32.5 9.3 15.8 53.4 26.8 61.8 2.0 5.5 17.1 2.8 19.0 62.4 13.1 39.7 13.6 2.0 1.3 0.0 17.3 5.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.1 32.2 38.5 22.7 15.7 25.2 42.1 35.4 11.4 43.5 32.4 35.8 45.1 9.4 16.0 0.0 0.7 0.0 6.0 2.1 2.3 4.6 3.9 7.3 5.8 4.1 11.5 3.4 5.5 0.0 2.9 0.8 0.3 15.6 12.9 7.5 23.2 12.8 12.5 4.9 0.0 2.6 6.9 0.5 6.8 14.8 28.9 0.0 0.7 7.9 0.4 1.6 0.0 5.3 4.2 2.0 0.6 4.6 30.9 2.8 1.6 1.8 5.6 0.6 0.9 0.0 2.5 16.8 26.0 0.0 2.6 0.4 8.1 19.5 2.7 4.0 2.5 0.0 4.2 6.8 3.1 1.7 2.6 2.4 2.3 0.5 1.6 2.3 14.1 PMP22 "CMT1A, GAS3, HMSNIA, HNPP, Sp110" ENSG00000109099 "Peripheral myelin protein 22" Q01453 17 15229773-15272292 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes, Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 404.1;Hofbauer cells: 558.3;Leydig cells: 324.3;Melanocytes: 343.3;Proximal enterocytes: 580.6;Skeletal myocytes: 288.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 32.2;eosinophil: 43.0;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 22 "dendritic cells: 23.8;granulocytes: 43.0" "Cell line enhanced" "Detected in many" "ASC diff: 383.5;HMC-1: 263.7;SuSa: 333.9;WM-115: 448.8" "Intracellular and membrane" NA NA "unprognostic (3.00e-1)" "unprognostic (1.65e-1)" "unprognostic (2.21e-1)" "unprognostic (4.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.28e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (3.74e-1)" "unprognostic (4.33e-2)" "unprognostic (7.70e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.83e-2)" "unprognostic (5.45e-2)" "unprognostic (2.88e-1)" "unprognostic (1.08e-2)" 237.3 45.7 110.4 55.6 152.9 5.0 186.1 146.6 136.3 187.2 82.7 171.1 42.0 143.3 36.8 68.9 164.8 107.4 166.6 109.4 125.1 33.0 11.8 210.2 28.0 150.5 144.7 95.5 103.8 23.0 10.9 26.5 203.6 153.4 81.9 75.4 6.6 78.1 81.4 254.4 101.4 241.0 123.1 140.6 28.1 97.1 20.9 132.0 17.5 96.1 128.1 22.0 211.0 158.7 215.2 7.0 44.1 61.9 62.2 383.5 167.1 12.6 60.5 68.8 58.7 38.0 48.7 1.1 0.1 7.0 172.3 22.7 0.7 74.0 1.1 15.4 0.2 13.9 4.3 76.7 17.2 201.8 0.1 263.7 126.9 1.1 32.6 1.8 72.1 66.1 2.8 24.5 0.8 33.2 6.1 0.2 2.0 3.5 4.0 74.7 22.0 39.3 0.0 44.6 4.8 0.1 40.6 16.6 0.6 134.2 333.9 0.2 0.5 81.4 12.7 45.7 216.9 62.0 0.5 0.1 0.3 84.7 0.1 448.8 32.2 1.4 43.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.1 0.2 0.1 0.2 23.8 0.0 0.9 110.4 152.9 146.6 136.3 109.4 125.1 150.5 144.7 95.5 153.4 140.6 132.0 215.2 86.6 28.9 11.5 50.9 2.8 90.1 6.7 6.1 9.6 1.4 43.0 82.7 68.4 4.3 7.4 0.0 0.0 8.8 2.5 9.1 3.9 4.5 17.7 20.1 118.6 148.0 4.8 10.1 3.7 3.3 23.1 404.1 2.6 11.0 119.7 25.0 88.5 0.9 558.3 0.0 1.8 23.8 0.0 23.4 116.8 11.0 324.3 93.0 343.3 29.0 11.8 61.6 0.0 46.8 217.1 1.7 25.2 246.4 1.9 4.9 580.6 0.7 3.0 2.2 230.1 288.8 141.1 3.0 4.8 3.0 103.0 19.0 8.7 49.2 17.9 5.2 FOXN1 "FKHL20, RONU, WHN" ENSG00000109101 "Forkhead box N1" O15353 17 28506243-28538900 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 18.6;lymphoid tissue: 10.8;skin 1: 40.5;vagina: 11.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.0;Prostatic glandular cells: 5.9;Squamous epithelial cells: 15.9;Suprabasal keratinocytes: 12.4;Urothelial cells: 15.4" "Cancer enhanced" "Detected in many" "cervical cancer: 7.0;head and neck cancer: 8.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HaCaT: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.60e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.68e-3)" "unprognostic (5.98e-6)" "prognostic favorable (5.00e-4)" "unprognostic (2.85e-1)" "unprognostic (2.56e-1)" "unprognostic (3.89e-2)" "unprognostic (7.08e-3)" "unprognostic (1.26e-2)" "unprognostic (1.90e-3)" "unprognostic (4.68e-2)" "unprognostic (3.96e-1)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 18.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.5 0.1 0.1 40.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 10.8 0.1 0.0 5.6 0.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.9 1.8 1.2 0.0 0.4 0.6 0.4 0.0 0.3 0.0 0.0 0.8 0.0 2.2 0.0 0.0 0.8 0.3 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 15.9 12.4 1.1 0.1 0.0 0.4 15.4 UNC119 "HRG4, POC7, POC7A" ENSG00000109103 "Unc-119 lipid binding chaperone" Q13432 17 28546708-28552631 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 20 "retina: 1178.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 671.1;Cone photoreceptor cells: 856.9;Muller glia cells: 301.5;Rod photoreceptor cells: 2038.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041912 Enhanced NA NA "HPA041912: AB_10795267" "unprognostic (8.93e-2)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (4.95e-3)" "unprognostic (2.10e-1)" "unprognostic (1.44e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.76e-3)" "prognostic favorable (8.09e-5)" "unprognostic (2.65e-1)" "unprognostic (8.08e-3)" "unprognostic (5.51e-3)" "unprognostic (1.87e-1)" "prognostic unfavorable (9.82e-4)" "unprognostic (1.71e-3)" 17.8 29.5 45.8 23.8 46.0 56.4 20.9 42.1 59.7 25.8 50.3 19.8 12.1 21.5 18.0 25.6 19.3 14.4 23.7 47.7 47.5 36.8 33.2 21.3 30.0 46.4 43.9 45.6 21.5 24.7 22.4 29.0 11.1 47.4 30.1 11.0 1178.8 26.9 20.3 6.1 32.5 26.2 13.8 42.0 55.9 20.5 53.5 47.6 17.7 23.3 6.3 29.9 23.1 26.1 46.1 24.9 30.7 30.0 42.0 31.1 30.2 14.7 20.0 27.4 35.7 33.4 42.7 8.1 20.2 21.2 30.9 24.5 39.7 25.6 29.8 19.0 37.6 47.8 14.0 15.5 13.2 21.3 20.9 42.1 27.8 40.4 25.7 12.7 33.4 28.9 21.5 14.6 16.3 22.1 39.1 20.8 20.8 29.3 21.0 21.9 32.8 49.2 9.0 27.2 27.2 11.7 41.1 28.8 46.4 31.1 34.5 36.7 35.7 22.1 20.4 38.5 33.3 19.8 18.6 20.7 4.6 33.7 33.5 19.1 21.6 48.7 120.2 8.9 122.1 8.9 29.1 16.9 13.7 82.3 42.6 18.7 13.4 131.5 18.2 212.4 93.4 16.5 36.3 45.8 46.0 42.1 59.7 47.7 47.5 46.4 43.9 45.6 47.4 42.0 47.6 46.1 10.4 0.0 5.4 5.2 34.5 13.4 16.3 38.8 34.1 671.1 25.2 33.8 12.6 18.6 17.9 12.9 856.9 25.3 48.7 22.9 33.2 20.4 3.0 5.5 8.4 24.0 25.3 4.8 8.8 18.3 9.0 13.6 11.2 7.8 12.7 14.1 8.9 13.8 34.6 146.4 11.3 14.3 34.6 41.0 89.8 6.6 14.6 44.6 19.6 4.7 56.8 301.5 59.8 4.5 1.2 17.8 16.4 21.4 19.6 22.1 23.8 20.6 6.7 2038.5 46.0 6.6 15.8 1.5 16.6 20.6 14.3 20.0 25.3 14.1 13.7 18.9 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28576948 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 1335.8;choroid plexus: 576.5;retina: 1193.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 250.9;U-266/70: 161.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" Yes No 150000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 87.8 24.6 928.5 12.8 927.3 23.8 42.9 1192.6 1159.0 28.8 576.5 17.9 18.9 18.0 11.0 41.1 14.4 11.0 257.9 917.3 907.7 12.2 99.1 13.8 19.5 1188.9 971.0 843.4 39.4 4.9 12.2 30.8 4.2 1335.8 19.0 14.9 1193.4 20.1 16.0 4.8 68.0 44.3 12.5 878.6 24.6 23.6 14.4 1036.4 9.7 7.5 8.2 30.7 19.1 47.4 1215.1 29.9 2.1 13.7 55.7 29.9 32.9 2.9 16.7 37.7 12.9 76.0 17.9 3.0 14.9 17.3 15.5 3.3 36.9 10.3 102.3 23.4 12.4 8.9 28.3 11.6 30.4 25.8 10.0 29.2 27.8 13.9 1.5 24.0 1.7 5.3 29.7 19.3 71.9 10.7 15.1 11.9 32.0 20.8 6.7 15.3 9.5 1.6 250.9 1.9 4.3 36.2 61.9 9.1 67.3 0.5 20.8 36.6 21.2 3.5 1.2 5.3 2.1 2.4 161.0 51.4 10.9 105.2 28.0 1.9 0.5 7.4 3.0 21.6 8.7 30.6 24.0 29.5 17.8 9.4 25.1 37.7 28.4 18.0 29.4 5.3 4.6 40.9 19.0 928.5 927.3 1192.6 1159.0 917.3 907.7 1188.9 971.0 843.4 1335.8 878.6 1036.4 1215.1 4.2 0.0 15.8 97.6 9.8 7.5 20.3 80.5 8.6 112.5 9.0 11.0 22.1 11.5 29.3 7.3 106.3 1.1 9.5 31.7 3.9 21.9 0.9 1.0 3.0 11.3 21.6 3.2 19.2 10.2 6.5 5.8 6.6 1.2 13.3 4.9 14.3 93.1 5.4 274.2 41.3 12.9 28.5 4.4 5.3 1.3 9.3 3.1 24.9 21.5 34.1 127.1 12.3 26.7 16.8 12.4 12.4 10.1 2.6 6.1 120.0 2.1 11.8 348.5 13.1 6.4 10.1 0.3 3.2 7.9 10.9 1.5 17.0 11.7 5.1 7.8 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone and transcription elongation factor" Q7KZ85 17 28662198-28702679 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 29.5 33.8 24.4 25.6 25.9 65.9 28.6 24.0 27.0 26.8 24.8 32.9 20.2 30.9 27.0 26.7 26.8 24.9 27.2 23.8 26.0 25.7 36.1 29.1 28.6 25.7 24.4 20.4 31.4 31.7 31.1 34.5 28.0 28.4 28.9 21.1 29.4 29.3 25.8 54.9 39.5 32.5 27.5 21.4 34.7 31.5 21.6 26.7 34.3 29.2 32.8 30.6 32.3 25.9 25.7 49.4 101.3 49.8 57.1 59.1 39.3 38.2 66.2 70.3 76.3 67.8 94.7 21.5 52.1 33.6 66.5 58.7 57.5 73.6 48.1 78.4 97.6 65.4 72.9 83.2 59.4 49.4 77.2 77.9 54.6 28.4 81.2 53.6 50.3 50.8 50.3 72.9 59.7 55.1 59.1 76.9 33.4 38.7 43.2 32.4 38.7 91.2 42.7 37.6 95.9 37.8 49.9 77.6 120.5 41.6 67.9 74.2 54.2 80.6 59.8 49.4 57.5 85.3 75.4 62.2 74.4 67.5 34.4 50.5 14.7 4.5 4.4 3.7 2.9 3.9 4.5 3.1 4.1 3.7 4.5 3.1 2.8 6.8 4.3 5.0 6.2 3.1 3.1 24.4 25.9 24.0 27.0 23.8 26.0 25.7 24.4 20.4 28.4 21.4 26.7 25.7 33.9 38.5 51.0 24.2 36.5 22.4 19.2 16.8 43.3 29.5 27.4 26.0 51.6 22.8 28.4 20.2 56.3 24.4 38.4 29.5 5.9 22.1 5.4 31.0 45.3 32.6 31.0 33.0 21.6 21.3 21.3 32.7 46.4 49.1 50.5 36.6 22.9 33.9 23.7 30.3 19.7 23.1 8.2 23.0 22.4 17.8 25.7 41.8 8.8 16.9 29.9 22.0 30.9 17.6 19.4 31.9 18.7 26.7 55.7 20.0 23.4 10.5 25.7 44.4 32.9 32.4 32.0 19.8 19.1 40.1 24.3 49.8 38.3 42.0 22.9 25.7 RAB34 "NARR, RAB39, RAH" ENSG00000109113 "RAB34, member RAS oncogene family" "P0DI83, Q9BZG1" 17 28714281-28718429 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Peritubular cells: 169.7;Theca cells: 182.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 51.0;intermediate monocyte: 47.2;myeloid DC: 76.3;non-classical monocyte: 23.4;plasmacytoid DC: 46.6" "Group enriched" "Detected in all" 5 "dendritic cells: 76.3;monocytes: 51.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021366 Approved NA NA 1100000 "HPA021366: AB_1856003" "unprognostic (1.29e-3)" "unprognostic (1.77e-1)" "unprognostic (7.87e-2)" "unprognostic (2.38e-1)" "unprognostic (2.35e-2)" "unprognostic (7.75e-2)" "unprognostic (1.33e-1)" "unprognostic (1.36e-3)" "unprognostic (2.21e-1)" "unprognostic (5.62e-2)" "unprognostic (8.77e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.31e-3)" "unprognostic (7.72e-2)" "prognostic favorable (1.06e-5)" "unprognostic (5.05e-2)" 48.3 87.0 24.1 25.2 22.8 21.5 45.8 24.0 26.8 92.3 32.3 59.9 13.5 81.3 60.7 32.4 75.2 54.7 39.7 22.3 32.7 59.6 7.3 44.0 26.4 25.3 23.4 21.2 105.5 7.2 66.7 31.1 33.0 25.8 71.2 21.6 3.8 28.6 78.9 11.1 36.3 31.3 75.7 23.6 30.5 37.9 11.1 24.7 26.1 53.4 17.9 23.7 79.3 61.0 23.6 143.2 203.2 109.4 314.4 129.9 206.3 38.2 184.1 299.0 200.3 166.9 1.7 51.1 0.4 171.5 310.1 69.6 87.7 1.9 104.6 159.7 10.8 94.7 99.2 141.0 11.3 152.0 1.0 0.7 187.7 63.3 151.8 127.9 237.7 138.8 0.4 0.5 1.2 201.6 0.0 0.6 0.2 108.9 0.1 53.7 20.2 261.9 0.7 189.6 73.5 26.8 0.2 134.2 0.6 227.2 93.1 79.0 55.2 31.5 144.0 192.4 132.1 181.9 0.2 0.9 1.5 158.3 0.6 144.8 7.0 51.0 3.1 3.0 47.2 0.7 11.4 5.4 4.2 76.3 11.8 11.7 10.5 1.7 1.1 23.4 46.6 5.8 21.7 24.1 22.8 24.0 26.8 22.3 32.7 25.3 23.4 21.2 25.8 23.6 24.7 23.6 37.0 35.3 44.7 42.1 9.7 52.9 105.1 145.0 33.0 2.6 31.2 65.9 8.7 10.0 56.2 57.0 0.0 49.8 12.8 0.2 95.9 3.9 1.1 49.8 79.5 29.3 0.0 12.6 0.1 3.8 102.3 124.2 2.0 34.1 71.5 84.1 25.4 0.3 41.7 1.7 1.2 0.5 59.0 60.5 82.9 5.6 148.8 43.5 65.8 5.6 40.5 25.3 1.0 6.0 0.1 2.0 0.0 169.7 4.6 82.1 0.1 44.6 45.3 2.5 32.9 81.1 98.3 1.9 4.6 20.6 35.4 58.8 10.8 182.1 0.4 59.0 PHF12 "KIAA1523, PF1" ENSG00000109118 "PHD finger protein 12" Q96QT6 17 28905250-28951771 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 40.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 40.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021410, HPA021452" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021410: AB_1855287, HPA021452: AB_2670708" "unprognostic (9.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-2)" "unprognostic (1.21e-2)" "unprognostic (2.81e-1)" "unprognostic (1.46e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-2)" "unprognostic (8.73e-2)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.16e-2)" "unprognostic (3.11e-1)" "unprognostic (3.24e-1)" "unprognostic (1.08e-3)" 12.8 11.1 11.6 15.7 11.9 40.3 14.5 13.4 12.3 17.2 6.8 16.6 11.6 18.8 14.1 10.7 17.4 11.1 10.8 10.7 9.6 12.3 14.8 16.9 18.3 13.0 11.0 8.3 18.1 19.3 13.9 17.0 10.9 10.5 22.0 11.5 15.1 15.9 17.1 15.8 15.3 17.9 14.7 7.0 23.1 14.9 10.0 13.1 25.6 17.1 14.3 17.3 16.9 13.9 13.9 15.0 24.4 33.1 19.8 18.6 13.8 15.0 14.6 22.0 23.0 21.2 16.9 14.3 17.3 17.9 17.4 19.0 15.9 21.5 13.0 21.8 27.9 22.5 18.8 27.2 13.2 16.8 20.5 22.7 15.8 13.8 20.9 19.0 21.3 16.7 23.0 16.0 18.6 14.2 16.6 38.3 26.7 19.0 33.6 10.4 38.2 26.8 17.6 15.2 19.3 22.8 18.7 22.6 35.7 17.6 17.5 19.6 26.6 9.9 18.9 16.8 18.2 18.4 21.9 19.9 20.2 14.7 15.2 19.5 25.2 4.4 7.2 6.3 3.6 6.1 4.4 4.9 6.6 2.5 6.5 4.4 5.2 40.1 6.3 4.3 8.2 3.1 2.9 11.6 11.9 13.4 12.3 10.7 9.6 13.0 11.0 8.3 10.5 7.0 13.1 13.9 13.1 16.0 8.6 27.1 24.7 15.3 8.5 7.5 26.7 22.7 17.6 15.1 6.9 8.6 12.2 3.7 14.6 7.9 24.5 12.0 1.9 9.1 9.5 17.5 16.4 14.4 10.7 27.0 16.3 10.4 7.6 11.9 12.8 23.8 14.5 14.4 14.3 11.7 9.2 25.2 18.6 16.5 12.2 15.7 18.9 7.4 17.1 16.5 12.4 27.2 20.0 12.9 17.5 30.2 31.3 9.7 6.5 16.6 31.4 27.1 8.9 5.9 8.1 21.3 26.3 11.2 17.2 13.5 12.6 22.2 16.3 6.0 35.3 11.4 10.8 14.0 PHOX2B "NBPhox, PMX2B" ENSG00000109132 "Paired like homeobox 2B" Q99453 4 41744082-41748725 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 8.7;brain: 8.8" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "medulla oblongata: 8.4;midbrain: 3.0;pons: 8.8;white matter: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 89 "SH-SY5Y: 132.7" "Region enriched" "Detected in single" 17 "pons and medulla: 5.6" "Group enriched" "Detected in some" 18 "medulla oblongata: 1.4;pons: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 8.7 0.3 0.4 1.5 0.0 0.0 0.0 1.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 3.0 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.2 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 1.0 0.0 0.0 8.4 3.0 0.0 8.8 0.2 1.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM33 "FLJ10525, Pom33" ENSG00000109133 "Transmembrane protein 33" P57088 4 41935129-41960803 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075863 Approved NA NA "HPA075863: " "unprognostic (7.14e-2)" "unprognostic (9.25e-3)" "unprognostic (1.59e-2)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (2.04e-1)" "unprognostic (3.94e-2)" "unprognostic (5.45e-2)" "unprognostic (2.09e-1)" "unprognostic (1.16e-2)" "unprognostic (3.75e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.70e-2)" "unprognostic (4.20e-1)" "unprognostic (9.35e-3)" "unprognostic (2.36e-2)" 12.5 16.2 9.1 19.5 12.5 15.0 16.2 13.6 11.8 11.5 14.9 18.9 21.3 11.2 25.7 21.4 12.4 17.4 10.5 9.9 15.1 24.4 40.2 15.2 17.1 15.3 15.4 9.4 10.6 18.4 30.4 11.1 20.1 14.8 17.4 21.5 13.2 18.0 11.9 8.5 12.0 17.1 11.4 16.1 14.1 19.2 10.0 13.5 15.0 24.0 12.5 20.3 22.0 10.9 19.4 36.9 42.4 36.7 51.3 46.7 31.8 44.9 49.5 53.9 41.5 47.5 52.4 123.4 64.8 74.7 41.5 85.5 57.4 124.4 65.0 56.1 17.1 26.2 80.7 49.7 45.9 54.4 108.7 67.6 33.4 69.0 52.5 78.3 26.5 32.7 37.3 86.8 24.7 57.4 32.6 96.5 67.9 67.2 58.1 50.0 42.7 57.8 51.6 58.2 53.5 40.8 58.4 40.5 38.0 62.4 35.3 42.9 37.4 53.0 48.3 65.0 48.9 89.5 44.5 76.9 77.4 51.7 88.4 71.2 41.2 32.1 21.7 14.9 31.0 17.6 13.0 15.3 14.2 22.9 12.0 13.6 15.0 43.2 16.5 35.2 17.9 19.0 16.4 9.1 12.5 13.6 11.8 9.9 15.1 15.3 15.4 9.4 14.8 16.1 13.5 19.4 25.1 60.9 34.3 20.9 25.0 73.3 35.7 42.4 24.5 19.2 36.9 16.4 18.0 27.1 40.5 55.2 16.7 56.3 35.2 58.9 23.5 44.6 2.9 26.9 31.2 25.9 35.0 25.0 33.6 38.1 49.3 30.5 36.2 33.4 38.7 23.1 24.7 84.4 57.3 28.6 32.8 40.4 34.6 67.5 51.0 4.7 20.2 55.7 56.9 11.2 55.9 33.9 16.5 32.6 40.3 54.1 47.4 23.3 32.5 73.7 41.6 41.1 29.7 20.4 26.3 26.5 55.6 31.0 28.7 47.5 66.9 133.1 28.3 39.7 43.0 64.5 GABRA4 ENSG00000109158 "Gamma-aminobutyric acid type A receptor subunit alpha4" P48169 4 46918900-46993581 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 7.3;heart muscle: 2.6" "Group enriched" "Detected in some" 6 "Excitatory neurons: 124.9;Inhibitory neurons: 160.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 149 "REH: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.78e-2)" "unprognostic (6.57e-3)" "unprognostic (2.46e-1)" "unprognostic (2.23e-1)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "unprognostic (6.91e-2)" 0.0 0.0 1.2 0.0 7.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.6 3.7 2.9 0.0 0.0 0.0 0.0 0.9 0.2 3.4 0.0 0.0 0.0 0.5 0.2 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.3 0.0 7.3 3.7 2.9 0.9 0.2 3.4 2.3 0.0 0.7 1.1 0.0 0.0 0.0 21.5 0.0 0.5 0.0 0.0 0.6 0.3 0.0 0.6 15.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.9 0.0 1.3 0.0 0.0 0.1 0.0 0.0 124.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 160.1 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 8.4 0.0 6.1 0.0 3.5 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.4 3.8 0.1 0.4 0.1 0.0 0.0 0.0 0.9 0.0 GNRHR "GRHR, LHRHR" ENSG00000109163 "Gonadotropin releasing hormone receptor" P30968 4 67737118-67754388 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.4;pituitary gland: 5.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.2;Inhibitory neurons: 1.3;Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013424 Enhanced NA NA "HPA013424: AB_2668840" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (4.05e-1)" "unprognostic (1.78e-1)" "unprognostic (4.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.90e-1)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.63e-1)" "unprognostic (9.03e-2)" "unprognostic (3.23e-2)" "unprognostic (9.67e-2)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" 0.0 0.8 0.3 0.1 0.7 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.8 0.1 0.1 0.0 0.3 0.9 0.8 0.2 0.1 0.1 0.0 5.5 0.0 1.2 0.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.3 2.4 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.9 0.3 0.8 0.9 0.8 0.2 1.2 0.6 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SLAIN2 "FLJ21611, KIAA1458" ENSG00000109171 "SLAIN motif family member 2" Q9P270 4 48341529-48426201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035824, HPA063599" Approved Enhanced Centrosome,Cytosol NA NA 210000 Centrosome Cytosol "HPA035824: AB_10602399, HPA063599: AB_2685056" "unprognostic (6.20e-2)" "unprognostic (1.80e-1)" "prognostic favorable (5.77e-4)" "prognostic favorable (7.98e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (1.33e-3)" "unprognostic (2.58e-1)" "unprognostic (1.59e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.50e-4)" "unprognostic (1.75e-1)" "unprognostic (5.72e-2)" "unprognostic (1.85e-1)" "unprognostic (8.00e-2)" 25.1 12.8 7.2 14.7 6.8 15.6 17.2 10.6 8.9 21.6 9.8 23.6 13.5 23.8 18.8 39.1 25.9 18.6 41.0 6.1 6.2 18.8 26.9 21.2 16.6 7.2 7.1 5.1 22.3 15.2 29.8 7.9 22.4 7.1 26.1 24.2 15.9 19.2 30.5 72.4 32.7 16.4 35.7 5.9 16.4 18.3 40.7 7.7 24.6 20.2 99.7 21.2 26.6 22.1 8.4 32.8 12.7 22.2 22.0 33.9 41.6 15.6 49.3 62.3 43.0 44.5 12.6 26.8 19.4 29.7 56.7 76.7 21.2 91.5 46.1 75.6 16.1 9.5 34.1 17.5 14.4 36.5 31.5 33.4 35.4 67.1 50.0 58.0 32.2 25.8 17.1 22.3 21.1 43.7 16.5 36.4 25.9 9.4 25.7 18.2 20.6 43.1 12.4 38.0 35.4 14.7 18.7 20.0 14.8 21.2 20.4 18.6 22.2 33.0 46.8 44.2 29.9 50.5 28.6 32.1 16.3 36.8 35.2 34.5 9.5 6.5 7.7 6.6 4.7 7.2 5.1 8.1 9.9 6.6 7.5 6.6 7.1 5.8 8.8 7.3 2.3 5.7 3.6 7.2 6.8 10.6 8.9 6.1 6.2 7.2 7.1 5.1 7.1 5.9 7.7 8.4 37.2 54.5 38.7 43.8 27.9 84.2 50.6 32.6 38.7 15.8 26.5 19.4 79.6 18.6 32.3 27.6 14.6 29.3 31.7 35.0 21.5 29.9 162.4 145.1 64.7 28.8 25.2 16.6 47.0 34.9 29.1 31.9 28.5 57.4 21.6 20.3 21.8 33.0 21.6 35.3 47.3 34.5 22.4 20.5 31.0 319.2 27.4 29.2 19.6 38.4 37.5 20.7 28.8 54.3 43.1 32.2 27.9 36.9 26.2 53.9 23.4 26.4 85.1 41.0 32.9 54.1 43.1 98.7 48.8 55.0 91.5 75.5 35.0 32.8 25.6 58.3 OCIAD1 "Asrij, FLJ20455, OCIA, TPA018" ENSG00000109180 "OCIA domain containing 1" Q9NX40 4 48805212-48861817 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044803 Approved Approved Mitochondria NA NA 21000 Mitochondria "HPA044803: AB_10961287" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" "unprognostic (4.82e-2)" "unprognostic (7.39e-2)" "unprognostic (1.69e-1)" "unprognostic (4.17e-2)" "unprognostic (2.53e-1)" "unprognostic (1.60e-1)" "unprognostic (4.10e-1)" "unprognostic (2.83e-3)" "unprognostic (1.34e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (9.23e-2)" "unprognostic (2.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" 130.7 185.7 162.0 100.4 179.3 108.7 155.4 162.6 214.7 151.5 176.7 162.7 157.2 139.3 193.9 119.2 168.7 125.7 221.3 180.3 177.2 240.3 329.2 125.2 128.4 170.0 163.2 166.4 160.5 157.4 250.7 110.7 119.4 168.6 147.2 161.5 145.0 163.3 149.4 257.4 107.9 135.8 134.4 167.0 106.0 142.6 91.8 172.6 134.8 241.5 258.1 135.0 137.6 72.9 179.3 165.2 118.2 231.7 162.8 230.8 283.0 178.6 253.1 393.8 261.1 311.3 110.6 473.2 190.4 241.5 238.0 311.4 141.7 229.4 250.4 296.2 149.4 152.7 293.4 105.7 88.1 336.5 309.1 300.9 292.0 353.5 208.3 258.4 315.4 270.0 173.9 339.8 104.1 300.0 107.7 261.4 287.6 195.2 211.7 110.4 169.6 216.9 203.1 502.9 154.5 139.8 261.0 120.4 101.1 306.5 179.8 212.8 271.5 196.9 176.1 200.7 120.7 333.1 256.3 380.4 283.1 223.2 251.0 220.2 47.8 60.2 76.5 62.6 68.0 90.8 74.1 73.1 79.2 75.4 64.9 90.2 80.5 48.3 95.4 86.5 85.2 68.5 73.5 162.0 179.3 162.6 214.7 180.3 177.2 170.0 163.2 166.4 168.6 167.0 172.6 179.3 176.7 160.3 124.5 85.8 107.1 79.7 111.3 243.3 102.4 126.6 96.7 119.6 152.3 102.9 169.4 121.4 66.7 170.5 103.1 140.0 137.0 140.0 34.3 147.3 120.5 120.2 130.1 89.8 125.1 128.3 168.8 124.4 84.1 110.5 141.8 102.6 118.9 167.3 152.7 89.2 137.2 131.3 124.1 94.0 77.2 35.5 132.3 106.1 87.2 76.8 107.2 206.1 121.5 106.1 158.1 130.7 122.5 139.2 115.3 104.2 164.1 178.9 151.2 111.6 124.9 121.3 112.7 188.3 88.3 94.1 75.9 164.7 109.8 197.2 142.7 100.4 UGT2B10 ENSG00000109181 "UDP glucuronosyltransferase family 2 member B10" P36537 4 68815994-68832023 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 149 "liver: 235.6" "Cell type enriched" "Detected in some" 11 "Hepatocytes: 245.3" "Cancer enriched" "Detected in single" 296 "liver cancer: 93.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 116 "Hep G2: 12.0" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (3.50e-3)" "unprognostic (1.92e-3)" "unprognostic (4.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 235.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.0 0.1 0.0 0.3 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 245.3 0.0 0.0 0.0 0.3 0.0 7.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 CWH43 "CWH43-C, FLJ21511, PGAP2IP" ENSG00000109182 "Cell wall biogenesis 43 C-terminal homolog" Q9H720 4 48986275-49062081 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.1;prostate: 43.2;skin 1: 25.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0" "Cancer enriched" "Detected in many" 4 "prostate cancer: 20.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA042814, HPA048140" Uncertain Uncertain "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA042814: AB_2678182, HPA048140: AB_2680280" "unprognostic (9.38e-3)" "unprognostic (6.23e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.32e-4)" "unprognostic (2.14e-1)" "unprognostic (5.00e-2)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.29e-11)" "unprognostic (5.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.82e-2)" "unprognostic (2.51e-2)" 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 3.2 0.0 17.1 0.4 0.6 0.4 21.1 14.7 0.0 0.0 0.0 0.1 9.1 0.7 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 43.2 15.7 0.0 3.0 7.8 0.0 25.7 0.0 0.8 0.1 0.0 9.7 0.0 0.0 0.1 10.3 0.0 1.5 2.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.9 0.1 0.8 0.0 0.0 0.6 0.1 0.6 0.0 2.3 7.3 0.0 0.0 0.0 10.4 1.9 0.0 0.2 41.3 2.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 10.7 21.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 15.4 0.0 0.0 7.6 0.0 2.9 29.5 0.0 0.0 0.0 0.5 0.0 0.5 3.2 9.1 0.0 0.2 0.0 15.0 0.3 DCUN1D4 KIAA0276 ENSG00000109184 "Defective in cullin neddylation 1 domain containing 4" Q92564 4 51843000-51916837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 111.9;Oligodendrocytes: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036483, HPA036484" Uncertain Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA036483: AB_10670719, HPA036484: AB_10671843" "unprognostic (3.16e-2)" "unprognostic (2.65e-1)" "unprognostic (2.77e-3)" "unprognostic (1.41e-1)" "unprognostic (5.61e-2)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (1.37e-1)" "unprognostic (8.47e-3)" "unprognostic (1.61e-3)" "unprognostic (3.88e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-3)" "unprognostic (2.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.10e-3)" "unprognostic (1.40e-1)" 14.1 17.9 17.5 7.3 16.6 2.9 9.9 17.4 21.3 13.2 11.6 13.4 6.0 13.7 11.6 10.5 12.9 11.5 12.2 16.3 20.8 15.0 29.1 9.2 7.5 18.7 19.9 13.8 16.2 9.2 9.6 15.8 7.0 19.5 12.1 8.5 15.8 13.5 17.1 11.9 7.7 9.7 17.4 17.4 9.5 13.4 17.2 19.6 6.6 13.3 11.5 6.2 17.1 11.0 19.1 10.6 18.9 25.5 36.7 25.6 27.5 9.8 31.1 23.2 18.0 15.9 11.8 12.1 8.1 20.1 35.2 23.5 11.2 31.0 19.8 27.8 4.9 9.5 13.8 14.9 28.7 54.9 20.4 17.9 25.1 23.7 19.6 17.9 27.0 19.2 7.4 15.6 5.9 35.3 15.2 24.1 13.6 14.5 21.1 15.1 11.4 12.2 4.4 23.1 12.4 14.4 15.6 13.1 17.8 28.9 13.9 18.4 12.3 28.8 24.0 19.7 19.7 25.7 11.1 18.1 7.3 16.6 18.8 14.4 6.8 3.6 8.8 5.7 3.3 8.5 3.6 6.4 6.5 2.5 2.4 6.0 6.8 1.4 3.7 2.4 1.5 3.2 4.4 17.5 16.6 17.4 21.3 16.3 20.8 18.7 19.9 13.8 19.5 17.4 19.6 19.1 13.1 6.4 14.1 86.2 9.7 37.2 19.2 16.5 16.5 23.3 18.1 11.7 40.6 14.3 13.2 16.5 16.7 5.0 9.8 14.9 13.7 10.6 76.3 10.7 16.1 17.9 6.7 11.8 90.9 12.2 8.5 23.1 21.9 10.0 13.3 18.9 17.2 35.8 8.2 30.3 88.6 7.2 12.2 7.3 18.4 111.9 14.9 7.2 32.0 51.5 5.3 14.9 15.5 69.4 131.4 13.3 10.9 25.9 6.3 17.2 8.9 24.1 18.1 17.8 0.0 13.4 20.8 24.6 25.5 17.3 33.2 3.4 11.1 12.4 8.9 15.0 USP46 FLJ12552 ENSG00000109189 "Ubiquitin specific peptidase 46" P62068 4 52590960-52659301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Behavior, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 150.8;Early spermatids: 229.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, CAB076369, CAB076370" Uncertain Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (1.31e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-3)" "unprognostic (1.59e-1)" "unprognostic (2.45e-2)" "unprognostic (1.80e-2)" "unprognostic (2.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (3.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" 4.4 8.7 32.7 3.3 34.1 2.9 6.4 30.3 32.8 7.7 23.8 3.9 4.5 6.5 5.5 11.6 7.1 5.3 28.9 32.3 35.5 10.0 2.9 4.0 3.7 31.7 35.3 29.6 11.1 5.2 10.5 4.6 5.3 29.4 7.0 4.1 11.6 8.4 6.8 14.7 7.6 4.2 5.0 31.7 3.3 6.1 12.4 33.4 3.4 9.4 12.6 5.6 6.1 7.4 29.7 8.1 5.7 18.0 13.3 19.1 23.8 19.8 13.0 10.5 9.5 7.9 11.5 6.2 5.4 14.9 13.0 13.4 4.7 31.6 15.1 17.2 4.7 11.1 8.4 5.3 12.8 19.1 11.2 9.4 20.4 13.9 9.7 9.1 18.4 14.2 7.4 8.3 7.4 20.3 7.4 4.8 5.9 13.3 9.0 6.8 12.0 13.1 1.1 20.3 14.8 10.8 12.9 6.4 21.5 12.9 17.1 7.9 8.2 13.3 9.2 20.1 10.9 19.9 7.5 3.7 4.2 14.2 6.7 11.6 0.7 0.4 0.1 0.7 0.4 0.5 0.4 1.2 0.6 0.9 0.4 0.2 0.2 0.1 0.4 0.3 1.4 0.4 0.3 32.7 34.1 30.3 32.8 32.3 35.5 31.7 35.3 29.6 29.4 31.7 33.4 29.7 10.0 6.4 7.2 24.2 6.4 5.4 11.2 15.2 26.2 150.8 13.7 11.7 44.9 14.3 16.4 14.7 4.2 12.1 10.7 5.2 21.5 10.8 229.8 18.4 34.9 12.5 4.2 6.7 32.6 12.0 12.5 17.8 17.3 15.6 0.0 22.9 13.6 6.8 5.8 35.3 24.3 5.9 10.2 8.4 4.6 34.1 28.9 7.9 8.8 21.5 12.9 30.0 5.2 30.2 12.6 12.5 9.9 36.1 9.5 21.1 3.9 17.1 23.8 8.7 6.6 16.2 15.9 3.2 14.4 25.9 8.2 7.7 8.0 18.3 7.1 17.7 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860145 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.8;liver: 37.5;skin 1: 17.8;vagina: 30.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 65.8;Glandular and luminal cells: 35.1;Hepatocytes: 51.4;Paneth cells: 66.3;Proximal enterocytes: 21.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HHSteC: 71.1;HSkMC: 32.3;hTCEpi: 27.3;HUVEC TERT2: 20.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 7.8" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.0 14.6 0.1 0.0 0.0 0.1 0.1 0.1 0.2 6.6 3.3 0.1 27.8 0.3 1.0 0.8 0.2 0.2 0.0 0.1 0.0 0.3 37.5 2.3 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.6 0.1 0.1 0.7 0.1 0.0 6.7 0.4 0.0 17.8 27.5 0.1 0.0 0.0 2.1 0.1 0.1 0.5 0.0 0.0 1.5 0.7 30.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 71.1 0.0 0.0 32.3 27.3 0.0 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 11.9 1.0 8.7 0.0 0.0 0.1 0.0 0.1 1.5 2.8 1.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 65.8 1.3 0.3 0.0 0.0 0.1 1.3 0.1 0.2 0.0 35.1 0.0 0.0 2.5 51.4 0.3 0.0 0.0 4.7 0.0 0.8 0.7 0.0 0.3 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 66.3 0.0 0.0 0.0 21.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 3.4 1.5 0.1 0.0 13.8 0.2 ODAM "APin, FLJ20513" ENSG00000109205 "Odontogenic, ameloblast associated" A1E959 4 70196496-70204576 "Cancer-related genes, Predicted intracellular proteins" Biomineralization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "salivary gland: 374.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 31.7;OE19: 21.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036279, HPA036543, HPA070297" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA036279: , HPA036543: AB_10669797, HPA070297: " "unprognostic (2.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "unprognostic (3.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.88e-2)" "unprognostic (3.47e-1)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-2)" "unprognostic (2.50e-2)" 0.0 0.8 0.0 2.9 0.4 0.0 0.7 0.0 0.0 0.2 0.0 2.8 1.0 0.1 0.6 0.2 0.1 0.5 0.0 0.0 0.6 1.2 0.0 2.5 0.3 0.8 0.7 0.0 0.0 0.5 3.6 0.5 0.3 0.1 1.8 0.8 0.0 374.5 1.4 0.0 0.0 0.7 7.4 0.0 0.0 9.9 0.0 0.2 0.0 4.1 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.8 0.7 0.0 0.1 0.0 0.2 0.1 0.1 3.2 4.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 10.3 0.4 0.0 1.5 1.3 1.8 0.0 0.4 0.0 0.0 0.0 6.5 0.0 2.3 0.9 0.1 0.0 0.0 0.0 8.2 0.0 0.0 6.6 10.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 4.2 0.5 0.4 SMR3A "PBI, PRL5, PROL5" ENSG00000109208 "Submaxillary gland androgen regulated protein 3A" Q99954 4 70360760-70367158 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "salivary gland: 60.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 0.7;liver cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044567 Enhanced "Secreted to digestive system" NA NA "HPA044567: AB_10796114" "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 60.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064605 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 348.7;Suprabasal keratinocytes: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 365.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317" "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 19.6 16.0 9.4 13.0 8.8 27.3 18.2 12.4 10.8 15.0 13.3 12.5 12.4 12.4 10.4 27.6 12.2 20.7 13.9 8.9 9.1 13.0 20.5 19.9 14.9 9.0 9.5 8.8 13.1 10.0 6.5 9.4 13.6 10.1 13.0 9.0 5.9 15.3 5.8 9.9 26.7 13.3 10.6 8.5 17.5 13.1 39.9 9.7 22.1 12.0 6.7 13.4 15.2 18.3 10.2 25.4 4.6 12.8 11.9 21.5 16.8 13.1 34.6 36.1 20.1 20.3 18.1 22.0 21.4 29.5 22.0 17.2 7.7 17.9 25.1 22.0 11.9 9.5 11.7 4.2 13.6 65.1 19.2 23.4 22.6 19.8 30.3 45.3 38.3 30.0 22.2 13.0 15.4 40.6 7.1 22.3 30.7 8.7 11.2 16.9 14.3 7.3 8.4 23.3 8.1 19.7 18.3 8.3 12.2 26.6 18.3 6.1 26.8 51.3 25.2 19.9 36.6 21.4 18.4 9.5 17.2 18.7 18.7 18.7 365.5 79.3 171.5 60.1 64.7 57.7 41.3 60.0 68.6 55.9 40.1 54.6 59.6 325.0 74.2 68.3 47.0 81.5 77.9 9.4 8.8 12.4 10.8 8.9 9.1 9.0 9.5 8.8 10.1 8.5 9.7 10.2 58.1 6.4 7.3 35.6 42.5 348.7 95.5 61.0 68.3 8.1 61.6 33.5 4.1 15.7 25.9 7.3 8.4 27.8 57.8 27.2 17.6 42.8 55.4 64.1 58.0 64.3 25.8 72.6 39.7 28.0 38.7 80.8 32.6 34.2 36.3 36.8 38.6 23.9 24.7 13.5 40.2 21.9 40.7 36.4 144.2 13.4 17.1 50.3 67.6 49.6 32.6 9.0 28.8 74.4 23.2 61.8 42.1 24.5 40.2 85.1 41.9 29.2 56.0 7.2 19.7 53.9 45.1 163.5 89.9 97.4 373.8 47.7 65.8 39.8 21.0 135.9 NMU ENSG00000109255 "Neuromedin U" P48645 4 55595229-55636698 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 101.0;skin 1: 38.8;vagina: 31.0" "Group enriched" "Detected in many" 4 "Squamous epithelial cells: 212.4;Suprabasal keratinocytes: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "MAIT T-cell: 3.6;memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "Daudi: 90.2;HaCaT: 382.6;K-562: 311.3;Karpas-707: 135.7" "Group enriched" "Detected in some" 8 "hypothalamus: 1.1;pons and medulla: 4.5" "Low region specificity" "Detected in some" HPA025926 Uncertain "Secreted in other tissues" NA NA "HPA025926: AB_1854539" "unprognostic (4.42e-2)" "unprognostic (1.00e-1)" "unprognostic (5.83e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.19e-2)" "unprognostic (7.12e-2)" "unprognostic (7.29e-3)" "unprognostic (9.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.07e-10)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (2.54e-2)" "unprognostic (5.55e-2)" 0.1 0.3 0.4 0.7 0.5 9.8 1.6 0.5 1.1 5.9 0.1 1.4 0.8 0.1 0.0 101.0 0.2 0.0 0.1 0.3 1.9 0.2 0.0 0.8 0.5 1.1 3.2 0.4 0.1 0.1 0.0 2.4 0.8 0.6 0.2 0.8 0.1 14.4 0.2 0.1 38.8 1.4 0.2 1.7 0.1 4.0 2.2 3.6 1.7 2.5 0.0 7.8 0.1 31.0 1.4 41.3 0.3 22.1 5.6 0.0 0.0 0.0 0.0 0.0 2.9 7.8 0.3 61.5 90.2 8.6 0.0 8.5 382.6 46.1 3.3 2.3 5.6 25.1 0.6 36.0 0.0 0.0 0.0 0.3 0.0 4.2 0.0 3.0 10.0 0.4 6.4 311.3 135.7 0.3 9.9 1.2 0.2 11.7 7.5 11.4 0.2 0.0 0.5 1.9 0.4 19.5 49.0 30.9 0.8 0.1 4.2 20.9 0.1 2.7 0.2 27.5 0.3 54.5 39.1 0.3 0.0 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.5 1.1 0.3 1.9 1.1 3.2 0.4 0.6 1.7 3.6 1.4 0.0 0.0 2.3 0.0 0.6 16.3 0.6 16.2 4.0 0.2 0.9 1.3 0.1 0.0 8.0 0.0 0.0 2.0 0.0 0.6 0.0 0.1 0.4 3.9 0.3 0.7 0.0 14.5 0.2 0.2 0.1 4.4 29.6 5.8 1.3 0.9 0.0 0.1 0.3 0.0 17.2 0.8 20.3 0.0 1.6 0.3 0.0 0.2 3.6 0.0 0.1 2.0 0.0 1.0 0.2 2.4 0.2 0.0 1.2 0.4 0.0 0.0 7.0 0.0 0.0 0.0 1.2 5.8 10.0 212.4 73.6 0.1 0.7 0.2 2.6 12.0 CRACD "CRAD, KIAA1211" ENSG00000109265 "Capping protein inhibiting regulator of actin dynamics" Q6ZU35 4 56049073-56328625 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;intestine: 19.8;testis: 29.8" "Cell type enriched" "Detected in single" 11 "Cardiomyocytes: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.7;SH-SY5Y: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 59000 Nucleoplasm "Golgi apparatus" "HPA043249: AB_2678388, HPA048148: AB_2680286" "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 0.5 2.3 6.7 3.1 7.8 4.0 0.3 8.8 6.9 1.6 0.0 9.5 13.9 3.5 4.2 0.5 3.0 11.4 0.7 5.3 11.2 0.7 0.7 1.0 2.2 15.7 12.0 2.6 1.2 1.8 6.4 0.9 0.6 19.3 1.7 8.2 4.2 1.0 3.6 0.0 0.5 19.8 4.4 8.6 2.6 2.7 29.8 11.0 0.6 0.1 0.2 1.9 1.3 1.2 15.6 0.0 2.9 11.2 0.9 0.3 0.0 4.1 0.1 0.4 0.5 1.2 3.4 0.4 10.2 0.3 0.0 9.1 0.0 9.6 0.2 0.3 0.9 5.6 5.7 5.1 0.5 1.6 4.8 0.8 0.4 0.2 0.0 0.1 3.6 5.3 9.1 0.0 9.8 0.1 1.4 7.1 0.4 6.0 8.7 7.2 6.8 6.1 0.2 0.1 2.6 26.7 56.7 1.0 0.3 6.9 9.4 2.4 0.5 2.1 0.3 2.8 0.7 2.6 9.7 6.9 0.1 2.8 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.8 8.8 6.9 5.3 11.2 15.7 12.0 2.6 19.3 8.6 11.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LAMTOR3 "MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3" ENSG00000109270 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3" Q9UHA4 4 99878336-99894428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026858 Supported NA NA 120000 "HPA026858: AB_1853523" "unprognostic (7.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.07e-1)" "unprognostic (5.36e-3)" "unprognostic (3.96e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.61e-2)" "unprognostic (3.20e-3)" "unprognostic (1.58e-1)" "unprognostic (5.57e-2)" "unprognostic (1.66e-1)" "prognostic favorable (1.75e-9)" "unprognostic (5.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-2)" 17.0 25.9 19.1 16.6 19.9 32.8 25.1 22.0 27.0 21.0 18.9 25.1 23.7 23.5 39.9 30.3 19.4 19.6 24.5 19.8 20.4 38.5 21.9 17.7 20.5 20.4 21.4 18.9 24.5 17.4 36.7 19.0 22.7 20.8 28.5 26.4 23.5 24.8 17.2 21.2 24.0 24.0 19.2 18.2 16.7 21.5 15.8 19.9 20.3 34.2 20.3 21.2 24.1 21.8 21.4 19.9 6.4 26.1 17.5 36.2 35.1 20.2 18.9 18.6 18.3 15.0 15.0 39.0 17.3 18.6 19.5 17.8 9.3 26.1 23.9 25.4 20.5 14.0 12.0 13.1 28.3 35.0 36.1 34.1 23.1 48.9 13.8 15.4 26.9 20.7 12.9 30.4 21.1 35.2 20.4 30.5 35.4 16.1 42.8 10.7 20.2 14.9 19.5 55.2 22.9 20.2 25.2 12.2 40.6 41.0 26.3 20.9 29.3 20.5 14.2 16.7 24.0 14.8 26.5 30.6 33.8 30.0 20.6 20.5 43.5 17.6 38.5 9.8 26.8 12.9 11.4 12.1 11.1 19.0 9.3 14.0 14.1 58.6 18.8 28.4 13.3 13.5 13.8 19.1 19.9 22.0 27.0 19.8 20.4 20.4 21.4 18.9 20.8 18.2 19.9 21.4 38.8 57.7 33.7 8.8 35.6 49.6 60.7 77.8 68.3 28.0 53.9 46.1 35.9 24.3 44.2 35.0 12.5 48.8 30.3 95.7 135.0 50.9 12.0 38.3 29.8 27.6 36.1 46.7 15.2 32.6 55.8 37.4 43.8 61.3 41.8 23.9 22.9 25.2 77.8 18.5 13.7 48.9 52.9 41.5 89.8 9.4 40.0 56.9 37.4 3.7 60.7 50.7 38.1 8.5 12.7 43.9 102.5 42.5 30.7 63.9 53.9 130.2 30.3 26.3 19.7 30.9 30.9 72.6 40.2 86.6 64.6 78.4 32.6 22.8 43.3 78.8 PF4V1 "CXCL4L1, CXCL4V1, SCYB4V1" ENSG00000109272 "Platelet factor 4 variant 1" P10720 4 73853296-73854483 "Plasma proteins, Predicted secreted proteins" "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.7;lymphoid tissue: 2.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 10.0;Club cells: 2.6;Enteroendocrine cells: 5.3;Macrophages: 6.4;Theca cells: 2.2" "Cancer enhanced" "Detected in some" "renal cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "basophil: 14.2;neutrophil: 9.9" "Lineage enriched" "Detected in single" 45 "granulocytes: 14.2" "Cell line enhanced" "Detected in single" "EFO-21: 1.7" HPA052485 Supported "Secreted to blood" NA NA "HPA052485: AB_2681847" "unprognostic (4.95e-1)" "unprognostic (5.68e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-3)" "unprognostic (9.88e-2)" "unprognostic (1.72e-2)" "unprognostic (1.68e-3)" "unprognostic (2.66e-1)" "unprognostic (6.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.95e-3)" "unprognostic (1.39e-2)" "unprognostic (2.11e-1)" 0.2 0.0 0.1 0.1 0.1 1.2 0.2 0.0 0.4 0.2 0.2 0.1 1.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.7 0.6 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.0 0.4 1.1 0.0 0.0 0.9 0.0 0.1 2.4 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 9.9 0.0 0.1 0.3 0.0 11.2 0.1 0.1 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.1 0.0 10.0 2.6 1.8 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.7 2.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 6.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.4 2.2 0.0 0.5 NFKB1 "KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50" ENSG00000109320 "Nuclear factor kappa B subunit 1" P19838 4 102501331-102617302 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 610.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004031, HPA027305" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004031: AB_330564, HPA027305: AB_1854429" "unprognostic (1.06e-1)" "unprognostic (1.61e-2)" "unprognostic (4.37e-2)" "unprognostic (2.38e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (8.98e-2)" "unprognostic (1.96e-1)" "unprognostic (9.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.71e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.84e-2)" "unprognostic (6.75e-3)" "unprognostic (1.74e-1)" "unprognostic (6.92e-3)" 24.1 16.3 5.3 30.6 6.6 34.9 20.0 6.6 9.6 21.6 8.4 19.9 15.3 19.0 2.7 23.1 19.3 21.0 14.6 4.1 8.0 14.0 16.5 25.2 33.4 7.6 6.1 2.1 19.0 16.1 11.8 7.8 21.4 7.5 17.5 19.8 4.9 19.0 18.0 21.1 23.6 20.4 17.1 6.6 23.2 17.7 7.7 6.3 37.4 16.4 10.8 35.4 49.0 20.0 10.3 36.8 19.2 11.2 13.6 27.0 28.5 10.9 20.0 64.2 27.7 27.1 21.5 40.8 58.0 17.6 32.6 39.4 29.5 22.0 34.5 35.2 53.6 10.8 22.7 14.5 15.0 20.0 44.3 44.3 19.7 20.2 22.0 34.4 15.0 34.5 18.1 25.8 34.1 17.6 17.7 4.1 9.1 5.0 24.3 15.4 33.4 25.9 24.0 15.3 38.8 7.1 11.8 38.3 37.2 16.3 8.3 8.6 24.2 40.5 32.5 16.6 14.5 26.4 17.0 13.3 52.0 20.8 19.4 44.1 0.0 2.1 2.6 0.9 3.0 1.9 1.9 3.0 1.6 4.8 1.7 4.5 3.2 1.9 3.7 3.1 1.5 0.8 1.6 5.3 6.6 6.6 9.6 4.1 8.0 7.6 6.1 2.1 7.5 6.6 6.3 10.3 32.5 41.7 49.4 42.1 90.0 165.4 91.5 57.1 31.3 6.6 41.5 32.6 19.1 24.3 40.8 20.2 6.2 14.4 119.6 41.1 3.9 28.5 7.6 82.5 62.0 47.6 33.6 13.0 78.4 37.3 16.9 63.1 29.6 207.0 111.1 19.8 23.9 23.9 24.8 20.2 77.2 43.2 18.3 56.2 610.3 2.4 23.9 178.3 55.2 59.0 207.9 9.5 23.7 66.9 127.4 46.3 27.1 34.6 56.3 78.5 21.1 24.4 31.5 6.7 0.0 73.7 41.2 2.5 8.1 35.3 150.3 14.2 88.2 16.7 35.4 90.2 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445136-74455005 "Cancer-related genes, Human disease related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 131.1;placenta: 331.5;urinary bladder: 147.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1119.1;Basal prostatic cells: 1254.3;Macrophages: 1271.1;Paneth cells: 909.8;Urothelial cells: 2102.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 67.1" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Group enriched" "Detected in some" 11 "basophil: 11.0;eosinophil: 11.8;NK-cell: 3.8" "Group enriched" "Detected in many" 10 "granulocytes: 11.8;NK-cells: 3.8" "Cell line enhanced" "Detected in many" "CACO-2: 379.0;HBEC3-KT: 648.1;hTCEpi: 644.0;hTERT-HME1: 1365.7;MCF7: 416.8" "Region enriched" "Detected in single" 4 "olfactory bulb: 1.2" "Low region specificity" "Detected in many" "HPA008720, CAB023519" Approved Approved Mitochondria NA NA 1520000 Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 35.8 4.7 0.1 37.0 0.1 131.1 62.3 0.1 1.3 19.4 1.6 18.8 3.4 3.8 0.2 43.7 13.3 74.7 17.8 0.3 2.7 2.5 4.1 36.5 1.9 0.4 0.1 0.1 12.5 4.5 1.5 9.6 331.5 1.3 6.5 19.1 0.1 11.8 0.7 18.5 12.4 10.3 6.6 0.2 10.1 20.4 9.4 0.4 7.2 5.4 0.8 3.0 147.0 13.9 0.5 15.9 107.3 0.0 0.0 0.9 1.4 0.0 3.2 5.0 0.7 2.9 379.0 59.8 0.0 8.0 0.0 0.0 17.4 0.1 648.1 6.5 0.1 0.0 0.4 2.8 18.0 191.9 2.3 0.4 5.9 644.0 37.8 1365.7 0.9 0.2 0.4 1.6 0.7 14.4 416.8 0.2 0.0 0.0 78.6 42.8 0.0 0.1 0.1 36.4 2.9 0.5 0.2 22.2 1.2 0.0 0.4 11.6 0.1 1.0 0.0 15.3 5.3 0.1 0.9 0.0 0.1 0.0 0.0 1.7 11.0 0.0 11.8 0.0 0.0 0.0 0.2 0.4 0.0 0.8 0.3 0.2 0.0 0.1 3.8 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.3 0.3 2.7 0.4 0.1 0.1 1.3 0.2 0.4 0.5 670.0 198.7 301.9 0.0 190.7 1119.1 1254.3 73.0 303.9 0.0 801.5 460.2 49.0 62.9 183.9 51.5 0.0 1.8 836.1 878.0 0.0 61.8 70.4 167.7 12.3 32.2 41.6 18.5 0.0 10.2 1.5 80.8 254.9 193.1 680.5 0.9 10.8 4.2 32.2 0.0 0.5 393.5 8.2 250.4 196.4 12.1 0.3 1271.1 33.8 0.0 1.7 0.8 20.6 0.0 0.0 497.1 909.8 1.2 352.1 115.3 55.7 0.7 53.3 0.2 19.7 10.3 20.2 68.3 51.1 194.5 342.4 1.1 473.6 1.2 308.9 2102.9 MANBA ENSG00000109323 "Mannosidase beta" O00462 4 102630770-102760994 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Macrophages: 74.0;Microglial cells: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 16.6" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1" "Cell line enhanced" "Detected in many" "ASC diff: 15.5;hTCEpi: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053478 Approved Supported Vesicles NA NA 15000000 Vesicles "HPA053478: AB_2682165" "unprognostic (2.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.80e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (1.32e-1)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (7.78e-2)" "unprognostic (1.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (7.12e-2)" "unprognostic (4.81e-2)" "unprognostic (2.13e-1)" 7.1 12.5 2.6 1.5 2.2 7.0 6.4 4.3 2.1 6.3 2.5 6.6 1.6 6.2 0.2 3.9 6.4 1.4 6.0 1.4 2.5 4.8 4.8 10.6 2.2 3.5 3.0 0.4 8.9 8.4 3.0 5.1 3.7 4.7 4.3 1.1 2.7 8.9 2.0 3.0 4.3 8.6 2.4 3.1 12.1 9.2 1.6 3.4 1.2 7.2 0.1 2.0 8.2 5.8 5.8 2.9 1.4 0.6 1.6 15.5 12.1 0.9 1.1 6.9 1.8 4.1 1.7 1.0 3.6 1.4 2.7 3.9 1.0 3.0 2.2 1.1 2.2 0.7 3.0 1.1 0.7 2.7 2.8 8.2 3.7 13.7 7.6 3.4 8.9 3.0 1.2 3.6 2.0 3.4 1.4 2.0 2.3 1.3 1.9 1.1 1.9 1.6 0.6 3.4 2.3 1.4 0.5 1.4 1.9 1.5 5.4 4.5 1.8 0.2 2.0 1.3 9.3 1.2 1.3 5.8 0.5 3.1 1.5 1.6 4.0 6.8 16.6 0.4 6.1 0.7 1.7 0.0 0.7 5.3 2.1 0.4 0.6 6.1 1.8 9.1 1.2 0.5 3.1 2.6 2.2 4.3 2.1 1.4 2.5 3.5 3.0 0.4 4.7 3.1 3.4 5.8 6.4 32.1 35.6 24.5 45.4 5.9 8.4 13.2 12.0 6.2 11.6 8.1 14.6 14.3 13.5 9.2 6.2 42.3 14.3 5.1 1.9 8.1 2.8 6.9 6.9 8.1 1.8 19.7 36.4 2.7 7.3 13.8 25.5 12.8 34.8 5.5 10.4 17.7 43.6 6.7 66.5 10.5 2.0 58.5 29.6 1.6 9.0 74.0 0.0 111.5 52.8 5.2 17.5 31.2 66.8 5.5 17.3 19.9 17.5 7.5 5.2 9.8 5.8 7.5 0.0 10.8 6.7 0.2 1.4 12.6 4.5 22.6 16.9 12.6 11.2 9.7 UBE2D3 UbcH5C ENSG00000109332 "Ubiquitin conjugating enzyme E2 D3" P61077 4 102794383-102868896 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (7.43e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-2)" "unprognostic (5.78e-2)" "unprognostic (6.44e-2)" "unprognostic (4.96e-2)" "unprognostic (1.17e-1)" "unprognostic (8.44e-3)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.75e-2)" "unprognostic (3.31e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.08e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (1.34e-2)" 168.0 173.1 87.9 173.5 95.4 482.6 143.1 100.0 119.2 121.5 99.3 156.4 155.4 126.5 114.8 175.0 127.0 143.7 150.8 93.8 136.5 173.8 253.5 176.8 191.2 103.5 105.9 81.4 132.6 155.5 134.6 99.2 160.3 101.8 107.8 145.8 130.1 117.7 103.1 245.6 136.8 159.7 131.0 103.4 150.8 145.7 128.2 101.0 200.4 160.7 199.7 198.6 187.3 129.0 119.4 301.6 169.1 275.4 223.4 286.2 408.0 235.9 301.2 395.1 260.1 243.6 257.4 416.4 319.3 190.6 304.4 336.8 168.6 294.7 400.8 352.5 299.6 149.8 292.0 165.8 209.6 300.3 415.5 240.4 314.0 247.9 288.6 398.9 334.3 343.4 258.7 372.9 316.4 350.9 243.1 613.4 235.1 200.2 341.0 167.1 318.4 269.9 231.5 261.5 283.7 275.6 232.1 183.5 464.8 349.6 318.2 193.0 241.0 318.4 270.0 231.1 179.2 276.3 277.9 389.8 491.3 288.2 227.2 297.0 614.9 253.7 394.0 163.5 256.0 216.3 165.9 203.4 194.4 217.6 139.2 205.8 190.5 817.2 215.7 271.9 149.8 229.6 422.1 87.9 95.4 100.0 119.2 93.8 136.5 103.5 105.9 81.4 101.8 103.4 101.0 119.4 303.4 166.7 193.1 98.9 291.7 844.0 693.9 408.2 233.9 133.7 251.5 166.9 229.8 193.0 242.3 139.8 125.1 311.5 317.4 336.1 547.8 361.0 779.4 257.1 246.7 344.0 240.8 348.7 159.7 382.2 561.6 286.0 202.3 371.3 224.9 154.8 193.1 235.7 392.9 122.8 145.8 283.8 303.2 403.0 825.6 635.1 164.7 415.1 357.5 111.5 399.4 160.0 280.2 104.5 185.0 454.4 347.2 149.0 296.4 612.3 335.8 428.8 242.4 170.6 105.2 270.6 531.9 217.2 180.7 258.2 813.3 638.4 382.5 172.3 268.2 784.3 MAPK10 "JNK3, p493F12, p54bSAPK, PRKM10" ENSG00000109339 "Mitogen-activated protein kinase 10" P53779 4 85990007-86594625 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 87.3" "Cell type enhanced" "Detected in many" "Astrocytes: 902.0;Excitatory neurons: 1018.9;Inhibitory neurons: 727.8;Late spermatids: 400.5;Oligodendrocyte precursor cells: 596.6;Oligodendrocytes: 302.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "AF22: 155.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022625 Approved NA NA "CAB022625: " "unprognostic (2.46e-2)" "unprognostic (4.36e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (5.17e-2)" "unprognostic (2.03e-1)" "unprognostic (4.59e-2)" "unprognostic (4.82e-2)" "unprognostic (3.81e-2)" "unprognostic (4.45e-2)" "unprognostic (1.18e-3)" "unprognostic (3.02e-2)" "prognostic favorable (3.11e-4)" "unprognostic (1.92e-2)" "unprognostic (1.44e-1)" "unprognostic (6.22e-3)" "prognostic favorable (5.57e-4)" 26.4 15.8 36.6 5.2 59.4 14.7 7.5 26.3 87.3 16.5 17.1 5.4 3.6 14.7 19.0 9.9 15.9 13.9 6.9 53.9 31.5 20.6 3.2 8.6 5.2 28.0 32.8 42.3 14.9 7.5 10.4 25.7 4.4 33.4 22.6 5.4 18.4 4.7 24.5 2.7 4.6 5.1 15.7 24.3 7.4 6.7 26.7 35.4 3.4 20.7 4.2 4.7 14.2 18.6 54.4 2.9 4.9 155.0 4.8 4.1 3.6 5.6 3.2 2.9 2.7 1.2 3.3 4.4 7.1 5.1 1.9 3.8 9.4 1.8 4.2 4.3 4.9 4.0 5.7 7.3 4.6 3.6 2.7 3.1 4.1 1.9 3.7 5.0 5.5 3.5 4.8 5.2 27.9 1.7 3.5 4.4 3.1 8.8 0.7 3.2 4.9 4.0 2.5 10.7 16.9 9.2 8.4 3.3 5.9 2.2 5.0 8.8 3.3 7.5 6.3 6.4 3.0 2.7 8.2 5.1 4.4 9.9 3.5 3.8 3.3 0.7 1.2 0.8 0.7 1.0 1.3 0.7 1.0 0.6 1.1 1.0 1.4 4.4 1.2 0.7 1.2 1.2 0.9 36.6 59.4 26.3 87.3 53.9 31.5 28.0 32.8 42.3 33.4 24.3 35.4 54.4 4.3 22.4 33.8 902.0 1.6 0.8 15.7 5.5 4.0 26.1 3.2 3.7 1.6 8.6 12.8 22.0 6.2 0.3 0.1 0.0 11.7 2.4 219.5 61.1 25.1 1.3 2.4 0.0 1018.9 0.0 0.5 16.9 2.0 7.1 2.5 6.2 1.1 0.0 0.3 38.7 727.8 0.0 4.1 0.3 0.0 400.5 26.4 1.5 1.8 185.5 0.0 15.7 0.0 596.6 302.8 2.0 0.0 54.9 0.1 7.6 0.0 22.6 68.9 10.8 6.6 7.2 18.5 10.5 5.5 1.3 1.0 0.1 0.9 28.5 0.0 22.6 ELF2 "EU32, NERF, NERF-1A, NERF-1B, NERF-2" ENSG00000109381 "E74 like ETS transcription factor 2" Q15723 4 139028112-139177218 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006057, HPA071166" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006057: AB_1078733, HPA071166: AB_2686351" "unprognostic (7.21e-2)" "unprognostic (3.84e-2)" "unprognostic (7.41e-2)" "unprognostic (3.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-2)" "unprognostic (7.05e-3)" "unprognostic (1.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.21e-2)" "unprognostic (2.48e-2)" "unprognostic (3.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.97e-3)" 22.7 14.3 12.9 15.4 17.6 47.7 24.8 20.1 16.2 21.9 11.9 21.4 15.2 25.0 18.6 17.4 20.9 18.0 20.3 12.2 15.5 15.6 20.5 19.1 20.0 16.4 15.6 11.8 28.4 16.9 20.2 22.7 27.1 17.5 21.6 19.4 30.9 21.6 21.9 36.3 23.4 17.7 23.2 14.7 19.8 17.6 37.8 15.6 33.1 23.2 33.9 21.6 19.4 18.5 21.3 15.9 11.3 27.9 21.4 28.2 31.7 26.9 18.4 31.8 19.6 21.8 22.2 31.2 32.3 18.5 25.7 10.4 16.8 41.2 26.3 20.5 20.2 18.6 28.5 26.4 20.0 20.7 32.1 22.1 31.1 24.8 19.3 23.3 25.7 29.5 18.0 46.8 18.4 17.7 27.8 37.8 28.6 17.0 36.4 13.1 36.0 36.8 30.1 25.1 27.2 28.4 32.6 23.1 28.5 17.6 32.4 19.7 38.5 25.0 18.3 15.9 16.7 12.4 40.8 48.6 28.3 13.5 32.4 17.2 13.3 8.3 14.1 12.0 7.2 13.2 17.5 11.8 10.8 9.9 19.3 14.6 13.5 9.1 12.9 7.9 18.0 9.4 5.3 12.9 17.6 20.1 16.2 12.2 15.5 16.4 15.6 11.8 17.5 14.7 15.6 21.3 103.0 48.1 22.5 64.0 57.6 53.2 41.1 36.1 120.1 42.0 50.3 40.4 37.0 40.0 39.1 40.5 75.0 32.6 71.9 31.0 43.0 26.4 26.0 60.0 54.3 67.1 47.3 43.5 73.6 24.2 32.3 63.7 35.7 56.3 34.8 44.0 53.2 46.9 22.2 67.3 75.3 38.1 42.7 52.2 40.1 24.6 52.5 59.5 30.2 98.4 49.2 37.3 77.2 83.9 279.4 24.1 33.5 38.0 51.0 52.6 35.9 23.1 48.2 57.7 39.5 81.4 59.2 59.7 42.0 79.0 47.6 23.7 50.7 33.6 27.7 39.6 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "heart muscle: 84.3;skeletal muscle: 270.8;tongue: 159.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1840.3;Distal tubular cells: 1136.7;Proximal tubular cells: 1449.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044556, HPA062427" Enhanced Approved Mitochondria No No Mitochondria "HPA044556: AB_10794402, HPA062427: " "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favorable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favorable (7.25e-4)" 9.6 15.4 18.5 8.0 19.3 9.1 11.1 21.3 28.8 7.4 19.5 18.8 24.0 8.2 14.4 10.6 10.6 5.4 84.3 18.8 19.7 26.9 24.3 8.9 10.2 19.4 19.7 17.2 10.1 14.9 23.1 15.9 5.9 20.2 9.8 19.2 23.7 19.0 14.5 270.8 13.3 18.7 7.4 18.6 10.5 17.1 12.8 19.1 8.7 15.0 159.9 11.1 8.7 8.0 21.4 21.4 5.9 19.2 30.8 17.7 22.7 20.5 20.1 13.1 11.1 10.4 13.1 23.7 7.7 7.7 15.5 14.9 10.5 38.6 18.2 15.0 13.0 13.5 11.9 13.5 23.0 18.1 11.2 10.1 24.5 18.2 14.4 21.6 16.8 17.5 17.8 25.3 33.8 11.0 17.8 17.8 32.1 16.3 44.1 11.7 14.9 10.6 52.6 24.6 14.2 14.6 14.7 13.8 23.2 10.5 15.6 23.7 23.2 8.1 24.2 6.4 13.0 13.5 23.2 49.5 18.5 18.9 26.7 13.8 26.2 10.1 13.1 8.5 10.3 11.6 7.1 11.7 11.5 8.9 15.9 10.5 11.4 3.0 10.1 14.2 16.2 18.2 10.8 18.5 19.3 21.3 28.8 18.8 19.7 19.4 19.7 17.2 20.2 18.6 19.1 21.4 201.8 89.8 145.7 15.7 95.8 140.2 173.3 402.7 185.0 120.4 240.3 349.6 1840.3 221.6 240.1 439.6 33.3 147.4 71.7 343.0 1136.7 270.3 409.9 333.5 115.5 162.7 221.4 175.2 10.9 336.9 166.2 176.9 158.0 196.8 73.3 151.2 133.5 432.9 225.1 119.5 14.3 340.5 276.7 102.0 65.7 70.9 169.3 115.6 266.8 6.5 185.5 446.6 79.3 8.0 13.3 265.3 355.8 206.5 155.6 173.7 471.7 1449.6 297.1 139.1 98.6 159.3 184.4 439.0 197.4 290.1 179.3 118.1 83.5 224.7 343.7 176.0 UCP1 "SLC25A7, UCP" ENSG00000109424 "Uncoupling protein 1" P25874 4 140559431-140568961 "Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.7;brain: 1.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.2;Syncytiotrophoblasts: 2.3" "Cancer enhanced" "Detected in single" "breast cancer: 1.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 4.7;HAP1: 3.3;JURKAT: 1.1" "Not detected" "Not detected" NA NA "unprognostic (5.08e-3)" "unprognostic (4.44e-1)" "unprognostic (2.65e-2)" "unprognostic (2.30e-1)" "unprognostic (7.17e-2)" "unprognostic (6.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (1.38e-1)" "unprognostic (4.45e-2)" "unprognostic (2.29e-1)" "unprognostic (1.40e-1)" "unprognostic (4.58e-2)" 0.4 2.7 0.1 0.0 0.1 0.0 0.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.2 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 TBC1D9 "GRAMD9, KIAA0882, MDR1" ENSG00000109436 "TBC1 domain family member 9" Q6ZT07 4 140620782-140756385 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 91.6" "Cancer enriched" "Detected in all" 7 "breast cancer: 85.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.9" "Group enriched" "Detected in many" 37 "B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000262, HPA006503" Uncertain Approved Cytosol NA NA Cytosol "HPA000262: AB_2665956, HPA006503: AB_2667604" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.22e-2)" "unprognostic (9.17e-2)" "unprognostic (2.11e-3)" "unprognostic (2.64e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-3)" "unprognostic (6.77e-2)" "prognostic favorable (1.61e-6)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.16e-2)" 18.4 9.3 6.2 15.4 8.0 2.0 49.2 23.4 9.3 13.0 29.5 7.3 8.3 8.4 7.9 9.2 10.1 13.9 8.6 8.1 12.7 15.8 12.7 16.5 15.2 7.6 11.9 8.1 16.0 9.2 9.9 6.4 20.7 12.4 14.7 6.7 21.2 8.8 21.5 2.2 3.1 12.9 7.8 5.5 33.9 17.0 3.3 11.2 5.6 5.9 6.9 19.6 15.9 7.2 16.3 0.9 11.9 10.9 9.4 26.0 24.3 22.3 15.3 16.3 10.8 13.7 2.4 10.4 0.1 9.5 19.9 13.4 2.4 13.7 10.8 10.1 0.0 7.7 7.0 8.5 10.4 9.4 0.9 1.1 20.1 17.7 9.4 37.2 31.2 30.3 3.7 0.0 0.0 10.2 12.0 1.6 0.1 1.7 12.7 10.4 7.7 17.9 18.1 12.3 22.0 16.0 11.4 15.8 27.4 10.5 18.4 6.4 0.4 47.7 28.3 8.5 18.6 13.3 0.0 0.0 0.1 17.2 1.3 15.7 0.0 1.7 0.0 0.0 1.3 0.0 5.9 0.0 0.0 2.9 2.9 0.0 0.0 0.0 0.0 0.5 3.2 0.0 0.7 6.2 8.0 23.4 9.3 8.1 12.7 7.6 11.9 8.1 12.4 5.5 11.2 16.3 49.4 54.5 9.3 4.6 42.1 4.6 10.6 21.4 4.0 35.4 91.6 39.4 8.1 17.2 15.1 55.2 4.2 14.1 14.0 8.3 7.9 13.6 0.5 49.4 20.9 32.6 7.7 0.4 54.8 17.2 4.7 15.1 8.2 61.4 0.0 8.0 17.2 23.9 18.3 10.1 66.2 6.6 24.4 39.3 30.3 1.3 13.1 44.8 8.8 78.7 39.5 43.5 1.0 27.6 2.6 12.2 5.8 26.7 25.0 16.3 6.1 5.7 15.9 7.6 0.0 2.8 11.1 0.8 1.7 10.4 3.8 43.2 3.7 16.0 3.1 16.0 ZNF330 "HSA6591, NOA36" ENSG00000109445 "Zinc finger protein 330" Q9Y3S2 4 141220887-141234697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 154.0;Early spermatids: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015705, HPA056325" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA015705: AB_1859199, HPA056325: AB_2683101" "unprognostic (1.90e-1)" "unprognostic (4.65e-2)" "unprognostic (3.66e-1)" "unprognostic (1.35e-2)" "unprognostic (4.12e-1)" "unprognostic (5.93e-2)" "unprognostic (2.37e-1)" "unprognostic (2.32e-3)" "unprognostic (4.49e-3)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.66e-6)" "prognostic favorable (7.27e-6)" "unprognostic (3.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.02e-2)" "unprognostic (1.30e-2)" 29.1 27.0 13.3 20.5 14.0 35.9 23.0 15.8 15.8 23.3 16.4 27.3 18.6 26.3 17.7 25.5 25.9 19.9 101.2 12.5 15.2 26.3 52.1 25.4 28.8 14.7 14.2 11.8 25.3 27.1 24.1 15.6 20.3 14.4 21.2 22.9 25.2 48.5 20.3 67.8 19.2 21.4 32.4 14.9 23.4 23.0 26.5 14.5 21.7 37.8 43.7 27.0 23.6 18.9 16.1 20.7 24.8 29.5 23.4 51.7 46.1 41.3 54.0 31.1 34.1 32.1 33.5 38.6 87.6 32.4 34.3 19.3 16.1 52.6 35.0 51.7 40.8 34.4 40.7 39.2 47.6 55.2 103.8 31.6 46.6 40.3 32.0 46.4 41.4 36.1 53.1 84.3 57.9 43.8 46.4 80.9 48.6 26.3 63.2 46.7 65.0 42.2 55.9 36.7 22.6 51.1 23.8 19.0 42.9 55.7 33.0 21.5 28.1 38.7 43.3 29.4 26.3 39.1 96.1 74.7 83.2 36.2 63.8 31.6 16.3 27.4 16.7 15.9 22.7 22.3 21.6 20.1 20.7 28.9 17.7 21.6 20.0 4.1 20.1 18.8 19.6 25.9 16.3 13.3 14.0 15.8 15.8 12.5 15.2 14.7 14.2 11.8 14.4 14.9 14.5 16.1 32.5 54.5 32.4 8.1 31.9 49.2 53.9 22.3 35.3 63.0 21.5 29.1 154.0 27.1 26.2 9.2 14.6 38.2 29.8 21.2 58.7 32.7 197.7 34.9 58.2 31.5 16.8 29.6 13.0 51.0 37.9 35.3 18.8 26.9 22.9 25.7 32.5 70.6 73.5 16.8 13.4 25.7 20.3 56.2 36.0 50.5 39.1 48.2 46.2 20.6 38.1 38.4 14.4 11.6 17.3 43.5 27.8 28.6 27.4 43.6 26.0 78.3 20.3 26.1 13.1 42.4 34.9 46.2 17.7 33.6 51.6 34.3 29.7 38.4 26.9 56.6 INPP4B ENSG00000109452 "Inositol polyphosphate-4-phosphatase type II B" O15327 4 142023160-142847432 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 158.7;Early spermatids: 178.1;Excitatory neurons: 196.8;Inhibitory neurons: 614.4;Late spermatids: 291.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 30.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 150.4;SK-MEL-30: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037681, HPA037682" Approved Approved Centrosome NA NA Centrosome "HPA037681: AB_10670389, HPA037682: AB_10671377" "unprognostic (9.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.25e-2)" "unprognostic (1.77e-1)" "unprognostic (8.24e-2)" "unprognostic (3.03e-3)" "unprognostic (5.76e-3)" "unprognostic (1.95e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.58e-2)" "unprognostic (1.26e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (1.39e-2)" 8.9 4.1 5.3 6.8 6.8 2.1 18.5 3.4 6.7 13.2 1.2 5.9 4.7 5.5 3.9 7.6 7.3 8.0 17.6 5.4 2.3 5.4 1.8 6.5 10.9 1.4 2.7 4.6 5.7 2.5 2.0 1.3 5.7 2.0 4.7 5.2 1.7 2.7 4.8 8.0 3.7 5.5 7.4 0.0 6.9 5.8 18.8 8.0 6.0 4.3 5.3 7.0 14.1 8.8 6.1 27.7 11.4 7.3 3.6 5.5 3.4 1.4 32.5 37.9 8.2 15.3 3.1 150.4 0.8 8.9 29.4 12.6 41.1 0.0 37.9 19.1 0.1 1.1 6.6 4.0 0.1 1.8 1.4 5.0 5.9 5.2 5.8 19.4 24.7 4.8 0.0 0.0 1.5 17.9 49.1 1.1 0.0 0.3 16.8 8.1 0.3 24.7 1.4 11.3 50.3 0.6 0.7 3.7 11.2 66.6 4.3 34.2 4.9 3.1 18.8 22.6 28.0 0.3 0.4 0.1 0.1 4.4 29.7 49.5 6.1 0.2 0.0 5.2 0.0 10.1 0.0 30.4 13.6 0.1 0.1 20.6 8.9 0.5 17.0 0.0 0.1 17.4 5.9 5.3 6.8 3.4 6.7 5.4 2.3 1.4 2.7 4.6 2.0 0.0 8.0 6.1 13.4 0.0 0.6 158.7 2.6 6.6 9.5 7.0 4.0 7.5 49.0 15.5 42.2 7.2 20.2 9.2 0.0 1.7 8.7 8.7 5.9 12.2 178.1 19.8 58.2 13.2 8.9 6.1 196.8 30.6 5.1 5.1 19.4 5.4 6.3 0.6 6.4 0.3 8.1 6.7 614.4 3.5 4.1 2.8 4.9 291.9 13.7 3.9 72.9 47.8 1.3 0.9 2.1 79.4 57.6 76.3 0.2 6.4 4.5 20.5 10.1 0.9 35.7 0.8 85.5 5.2 84.7 2.5 1.9 1.9 2.6 1.9 60.4 1.8 4.3 42.9 GAB1 DFNB26 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 5.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Nucleoli fibrillar center, Plasma membrane" Cytosol "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favorable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 8.0 8.7 27.0 6.8 61.0 11.6 10.0 31.4 38.2 10.7 1.6 19.9 12.2 18.3 14.3 20.6 9.3 12.6 30.8 17.5 24.4 14.1 9.2 18.0 6.2 48.8 42.7 7.3 19.7 8.2 11.4 4.3 21.2 51.6 8.6 23.0 6.9 9.0 14.9 13.5 10.8 12.4 17.8 34.5 7.6 11.4 9.3 38.6 5.5 7.6 16.6 8.8 7.2 9.8 114.5 6.7 1.4 16.7 12.1 8.3 7.9 22.0 4.6 15.2 5.4 9.4 12.8 11.2 0.2 1.4 6.5 3.7 3.8 16.2 5.3 6.2 1.0 3.9 12.2 3.7 6.1 5.7 1.6 2.3 9.7 9.5 6.6 4.3 11.5 7.2 0.2 4.1 21.7 3.8 9.7 0.9 0.0 4.8 3.5 5.3 74.6 8.2 8.8 8.4 8.0 3.9 11.8 3.1 13.3 5.6 11.2 8.5 1.6 5.5 6.9 5.4 3.4 3.5 34.6 18.2 26.3 4.7 4.8 5.7 4.1 0.4 0.5 0.0 0.5 0.2 0.9 0.0 0.0 0.5 1.8 0.0 0.0 2.6 5.0 1.7 2.2 0.0 0.3 27.0 61.0 31.4 38.2 17.5 24.4 48.8 42.7 7.3 51.6 34.5 38.6 114.5 13.4 28.9 19.0 89.5 13.1 20.3 8.8 3.3 12.0 2.1 11.6 8.9 34.0 8.6 5.3 12.9 0.0 23.5 10.9 26.2 0.0 6.6 0.9 8.8 9.3 16.3 22.2 40.8 162.7 2.6 10.6 14.4 11.2 21.6 2.5 9.6 13.9 7.0 6.1 3.3 62.2 27.8 4.1 11.6 10.2 3.8 20.8 8.8 16.0 192.0 5.6 15.4 1.0 288.0 1013.6 4.9 10.7 18.8 94.4 7.2 9.3 5.4 3.4 0.8 13.1 7.0 14.3 2.0 5.3 19.9 24.9 10.4 2.7 4.4 13.6 13.5 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207561-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 125.4;Oligodendrocytes: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 11.9 11.9 38.3 12.2 53.9 21.6 13.1 29.9 58.6 6.0 19.0 6.7 5.4 7.7 13.6 19.9 10.0 10.8 5.5 76.8 47.9 14.6 27.4 14.3 11.3 38.1 38.4 38.6 4.1 7.9 9.6 16.4 7.7 34.4 8.3 6.8 8.9 20.2 10.1 4.7 6.4 6.6 10.8 36.8 14.7 8.3 6.1 40.3 6.4 12.4 6.9 9.6 15.3 8.8 47.6 16.1 14.7 9.8 10.1 14.1 12.9 10.2 21.3 16.7 10.7 11.7 8.9 11.5 16.3 5.1 10.9 19.2 10.5 16.1 10.4 13.9 27.2 6.0 14.1 12.8 12.9 12.9 14.2 19.3 10.7 30.5 9.8 37.1 18.5 25.9 6.1 6.4 33.0 16.1 6.0 0.4 4.0 6.0 8.9 6.5 5.6 7.0 5.1 18.1 14.9 49.1 8.1 13.5 4.5 13.0 18.1 3.3 15.1 37.0 8.4 17.6 9.6 14.0 21.5 16.3 13.2 10.1 9.7 16.9 1.8 0.9 1.3 0.5 1.0 0.3 0.3 0.3 0.3 0.8 0.8 0.9 1.0 7.2 0.3 1.2 0.4 0.5 0.4 38.3 53.9 29.9 58.6 76.8 47.9 38.1 38.4 38.6 34.4 36.8 40.3 47.6 19.0 6.4 17.9 33.3 10.7 6.0 13.1 8.0 4.6 8.9 13.2 10.9 4.7 8.6 9.7 22.0 14.6 4.3 8.3 7.5 27.4 8.7 1.9 8.3 6.6 14.6 15.5 2.1 125.4 12.9 9.4 5.2 8.2 13.5 9.5 4.0 25.7 35.6 8.3 32.0 33.0 6.2 8.2 42.5 13.9 1.7 4.1 22.7 5.4 39.4 13.5 5.8 1.0 43.2 144.5 9.6 7.4 4.5 6.3 11.9 5.4 19.0 10.9 7.3 0.0 11.9 7.2 3.3 7.4 7.7 7.5 3.7 9.2 3.9 3.9 20.1 IL2 "IL-2, TCGF" ENSG00000109471 "Interleukin 2" P60568 4 122451470-122456725 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Cytokine, Growth factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Melanocytes: 3.6;T-cells: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB010310 Uncertain "Secreted to blood" NA NA 20300 "CAB010310: AB_649346" "unprognostic (8.87e-5)" "unprognostic (6.13e-3)" "unprognostic (1.38e-3)" "unprognostic (9.79e-3)" "unprognostic (2.56e-2)" "unprognostic (7.32e-2)" "unprognostic (2.06e-5)" "unprognostic (5.21e-3)" "unprognostic (8.01e-2)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 13.4 0.0 0.0 0.0 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498547 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 631.3;retina: 748.2" "Cell type enhanced" "Detected in many" "Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4" "Cancer enhanced" "Detected in all" "glioma: 240.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" NA NA 600000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: AB_2667054" "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.12e-4)" 139.4 153.1 550.7 20.7 531.9 1.8 98.5 553.2 609.3 50.0 314.1 45.0 22.2 68.3 408.1 75.5 89.3 66.3 96.6 577.1 631.3 50.5 26.9 50.5 37.8 448.5 478.7 491.4 104.9 171.9 90.5 331.0 7.8 448.7 297.8 37.2 748.2 105.3 85.5 56.8 36.4 30.9 84.0 423.5 11.7 80.9 147.5 520.4 69.4 181.4 47.9 35.5 34.1 74.0 468.9 0.2 8.4 54.4 10.5 41.4 4.5 2.4 0.1 21.5 8.1 16.5 0.0 0.5 0.0 15.8 0.6 1.9 1.2 20.4 4.4 4.7 0.3 78.6 0.0 21.6 311.6 3.0 0.3 0.5 102.3 21.5 0.3 0.4 104.0 0.2 0.0 0.1 2.1 11.2 15.4 0.4 2.7 34.4 0.2 12.1 0.3 0.2 1.1 0.7 3.4 418.2 138.0 629.0 77.9 0.0 342.6 46.7 1.9 0.0 16.7 42.5 1.5 1.5 23.5 0.6 2.2 15.5 0.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 550.7 531.9 553.2 609.3 577.1 631.3 448.5 478.7 491.4 448.7 423.5 520.4 468.9 87.1 0.0 5.6 727.4 0.6 26.1 81.7 10.3 66.0 569.1 25.6 52.1 54.5 54.3 5.0 22.0 621.3 0.6 1.4 2.9 0.0 19.7 6.7 2.2 12.1 130.4 587.4 2.7 234.8 1.8 0.3 249.0 31.6 1.3 0.0 8.6 274.2 15.1 1.0 70.7 129.0 16.2 38.7 5.4 41.2 23.3 500.8 6.3 87.2 94.6 1.0 530.9 0.0 211.6 23.0 12.4 3.7 621.0 0.7 434.6 10.2 12.7 1.2 803.3 854.6 14.1 519.4 19.7 13.3 14.0 20.9 0.8 5.5 15.4 4.0 18.9 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620569-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favorable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 2414.2 1604.7 1018.1 792.8 1027.5 2287.6 2754.1 1010.2 1536.9 3081.7 1010.2 1977.6 830.7 1979.9 1557.7 2159.9 2373.2 626.9 1528.6 978.8 1021.7 1766.4 1491.5 1511.2 1684.0 1031.3 1013.7 976.1 4612.5 4161.1 566.4 1628.8 722.8 1034.8 2125.6 923.5 442.8 1983.5 735.9 1806.3 2488.6 1982.1 692.3 1090.3 2241.4 2024.6 511.8 1045.8 1288.4 1714.7 746.1 1523.9 2062.1 2502.9 1077.9 825.0 541.4 1026.2 1485.8 2018.1 3044.8 1023.2 1230.1 1393.2 916.9 752.8 1358.5 1395.7 2413.4 723.7 1117.5 499.4 564.9 1064.4 1792.9 1160.3 927.5 1680.3 1034.0 1087.0 2109.6 1708.0 2628.2 1118.4 2837.7 2381.1 773.6 1701.2 1839.1 1618.7 1345.9 1731.4 1357.1 1479.3 1452.6 1625.9 3123.7 1214.4 1794.1 1095.2 1473.5 1112.4 1478.1 1929.2 1234.1 1099.4 1409.8 510.1 2915.7 1881.3 805.7 957.1 2348.2 1357.7 674.5 926.3 711.3 1121.6 1020.7 1327.3 1913.0 924.1 1533.2 859.0 1744.5 3024.8 943.1 2796.0 2242.1 4811.7 7783.4 5669.6 3854.8 3005.0 6460.3 7498.4 5716.8 610.2 3571.6 1985.1 3793.7 4557.8 12314.4 1018.1 1027.5 1010.2 1536.9 978.8 1021.7 1031.3 1013.7 976.1 1034.8 1090.3 1045.8 1077.9 3354.3 1413.4 2496.4 19.9 8040.6 12566.5 10934.5 14134.5 6505.0 343.4 12055.8 16944.0 1156.9 4838.4 5399.5 2164.7 75.0 6443.9 5150.7 1717.5 6914.3 3577.3 1527.0 2002.3 4683.1 4313.0 2720.0 3488.0 31.4 8680.5 7464.2 3471.8 2274.2 2664.1 3308.2 3093.0 5696.3 5781.3 4151.7 154.8 29.1 6030.2 3912.2 6966.0 11139.9 2023.8 7477.3 4326.2 5839.5 43.1 7738.0 1718.3 4866.1 18.1 28.5 5645.0 4899.2 4032.5 3437.1 5962.5 5302.3 9409.4 2362.8 535.0 1913.0 6558.2 3975.1 787.2 678.5 6369.9 15308.7 6380.6 7015.5 2344.3 6469.6 8608.5 WFS1 "DFNA14, DFNA38, DFNA6, DIDMOAD, WFS" ENSG00000109501 "Wolframin ER transmembrane glycoprotein" O76024 4 6269849-6303265 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 100.4;Hep G2: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029128 Approved NA NA "HPA029128: AB_10603460" "unprognostic (4.27e-2)" "unprognostic (5.05e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.13e-6)" "unprognostic (7.35e-2)" "unprognostic (1.29e-2)" "unprognostic (2.73e-2)" "unprognostic (6.97e-3)" "unprognostic (2.37e-1)" "unprognostic (1.78e-1)" "unprognostic (8.36e-3)" "unprognostic (5.33e-3)" "unprognostic (6.20e-2)" "unprognostic (5.02e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.64e-2)" 39.0 20.4 42.3 6.8 68.2 0.7 36.3 35.5 39.9 50.3 29.2 36.1 12.3 76.0 14.2 11.4 59.1 12.6 57.1 34.4 59.2 16.7 17.3 44.2 6.0 35.5 35.7 33.2 87.8 20.3 7.3 50.6 16.8 35.3 34.9 3.4 6.9 14.7 36.6 16.1 25.7 22.2 17.1 29.6 29.5 29.3 32.1 37.8 2.9 48.5 7.5 2.3 58.3 29.4 30.4 14.1 35.3 9.1 33.9 37.2 10.2 100.4 23.0 32.7 15.8 14.6 24.8 37.2 5.5 34.3 26.3 74.8 8.0 6.8 14.2 6.4 5.7 14.1 0.0 11.0 83.0 34.5 0.0 1.1 33.7 18.8 15.0 13.6 12.3 25.3 2.5 0.6 24.3 9.7 28.0 1.1 0.3 13.5 20.3 38.0 3.4 9.6 7.5 6.7 52.4 6.1 15.4 12.2 17.4 13.1 9.6 31.5 0.3 19.9 19.8 22.8 19.1 14.8 26.0 10.1 0.5 23.9 0.2 18.3 0.0 0.7 0.0 2.7 0.9 3.9 2.4 1.3 2.1 0.2 1.2 1.3 1.5 0.0 1.5 1.1 0.4 0.8 1.4 42.3 68.2 35.5 39.9 34.4 59.2 35.5 35.7 33.2 35.3 29.6 37.8 30.4 38.4 131.4 12.4 40.5 3.6 2.4 1.9 2.5 2.2 4.9 9.7 6.0 42.5 5.7 5.7 25.8 0.0 22.2 1.0 2.0 0.0 5.5 10.3 18.1 12.6 21.1 33.5 0.0 2.7 4.4 120.2 15.4 13.3 25.5 1.3 71.4 21.4 10.7 19.0 3.3 4.7 5.7 4.1 1.3 2.4 19.1 40.0 2.5 12.4 12.2 0.7 31.7 0.0 9.5 2.4 10.9 1.6 57.9 19.0 4.7 3.7 3.7 12.1 5.0 13.1 3.6 15.1 10.8 14.6 2.2 3.4 39.7 1.6 11.0 4.7 2.1 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092537-168187736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 490.8" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 172.6;Gastric mucus-secreting cells: 667.7;Pancreatic endocrine cells: 315.0" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "OE19: 284.8;PC-3: 125.5;RT4: 172.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005469, HPA074650" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849, HPA074650: " "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favorable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 19.8 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 490.8 0.9 0.1 0.0 0.0 0.0 0.0 90.4 0.1 0.1 0.0 4.6 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.5 0.0 0.1 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.4 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.4 0.1 9.7 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 284.8 125.5 0.0 0.6 0.0 0.0 172.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.5 0.0 1.5 0.0 0.5 15.5 0.0 0.4 0.1 0.0 0.2 7.2 3.2 0.0 2.1 0.0 0.0 0.1 0.0 21.1 11.0 0.1 0.1 0.3 0.0 2.7 0.2 172.6 0.0 0.4 667.7 0.1 0.0 0.0 1.8 72.6 0.0 0.0 0.2 0.5 0.0 2.8 0.0 0.8 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.5 0.0 315.0 1.1 0.0 1.4 0.6 0.0 0.2 0.3 0.6 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 14.7 GRPEL1 "FLJ25609, GrpE, hMGE" ENSG00000109519 "GrpE like 1, mitochondrial" Q9HAV7 4 7058895-7068064 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036647 Supported Supported Mitochondria NA NA 23000 Mitochondria "HPA036647: AB_10672359" "unprognostic (6.13e-3)" "unprognostic (3.66e-2)" "unprognostic (1.92e-2)" "unprognostic (6.31e-2)" "unprognostic (9.77e-2)" "unprognostic (2.12e-3)" "unprognostic (2.17e-1)" "unprognostic (2.21e-3)" "unprognostic (1.51e-1)" "unprognostic (5.53e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-2)" "prognostic favorable (2.00e-6)" "unprognostic (9.61e-2)" "unprognostic (7.18e-2)" "unprognostic (2.81e-1)" "unprognostic (7.30e-2)" 15.5 36.3 13.5 7.8 13.9 25.2 11.3 15.0 16.5 7.3 14.5 10.2 9.1 7.0 8.5 11.0 8.5 7.6 23.3 14.0 14.3 20.9 32.6 7.8 10.2 14.6 14.2 13.5 10.5 10.2 13.2 6.9 7.9 15.0 8.0 9.8 12.5 8.7 8.0 27.0 10.7 7.9 8.4 14.6 10.5 11.2 12.9 14.8 7.7 9.0 29.9 11.4 15.4 7.7 16.1 21.7 20.0 11.3 22.3 21.3 17.9 13.9 27.9 22.2 30.8 22.6 35.5 27.5 46.4 18.3 21.4 47.7 21.5 45.0 32.0 35.9 11.2 28.2 49.8 17.6 38.7 24.9 50.7 24.2 17.8 41.4 27.3 32.8 15.7 27.4 30.8 29.7 18.9 36.7 21.9 40.3 62.5 16.9 38.8 65.7 26.6 42.1 19.5 31.0 22.4 31.6 15.3 21.9 21.5 24.3 11.4 19.3 29.2 23.8 20.5 12.7 29.5 49.3 20.3 31.1 31.0 27.9 32.6 16.5 12.0 25.2 41.1 22.8 27.6 31.9 27.3 24.4 25.9 36.3 21.6 30.8 23.9 8.4 26.2 22.7 22.0 26.6 27.2 13.5 13.9 15.0 16.5 14.0 14.3 14.6 14.2 13.5 15.0 14.6 14.8 16.1 52.5 25.6 32.1 1.6 40.7 133.4 134.8 68.5 60.9 27.8 44.0 43.6 96.1 34.3 43.1 38.6 10.4 69.3 52.9 35.3 133.1 75.0 60.3 35.0 41.7 51.5 18.5 34.5 4.5 47.7 80.3 46.5 26.0 38.0 58.2 23.2 25.0 109.4 60.3 28.6 5.1 34.1 52.9 29.0 74.7 84.9 28.0 41.7 64.0 2.8 54.0 26.4 17.5 3.0 6.5 91.4 27.6 29.0 27.0 116.5 49.2 203.1 36.2 28.0 0.0 38.1 56.3 51.7 55.0 58.1 125.2 86.1 61.6 92.0 47.0 120.3 GAR1 NOLA1 ENSG00000109534 "GAR1 ribonucleoprotein" Q9NY12 4 109815510-109824740 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059098 Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA059098: AB_2683904" "unprognostic (9.72e-2)" "unprognostic (6.94e-2)" "unprognostic (3.04e-2)" "unprognostic (4.47e-2)" "unprognostic (2.40e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (4.17e-3)" "unprognostic (2.14e-2)" "unprognostic (2.45e-3)" "unprognostic (1.17e-1)" "unprognostic (5.11e-2)" "unprognostic (1.11e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-3)" 13.4 16.6 10.4 13.6 10.7 32.0 16.0 10.5 13.1 12.4 10.6 14.9 11.4 13.8 11.5 23.2 13.4 6.5 11.1 10.5 11.1 12.3 16.7 9.7 13.7 10.7 10.5 10.3 15.6 14.8 9.4 11.9 11.6 10.8 12.4 15.4 7.2 13.3 8.1 12.3 22.8 13.3 11.8 10.6 15.7 13.0 15.2 10.6 13.9 10.8 6.7 16.2 16.4 13.7 11.1 45.7 65.5 34.3 49.7 19.3 26.8 34.1 47.1 24.1 35.3 30.1 100.6 60.2 103.5 27.5 38.9 39.5 22.2 68.8 47.7 66.5 31.2 68.3 57.7 57.1 113.1 46.6 150.8 35.2 27.0 49.5 48.6 37.6 27.9 44.5 48.1 146.8 34.6 50.0 121.7 78.5 115.4 59.5 78.4 68.7 58.0 57.2 41.2 55.3 79.3 51.2 55.7 26.3 80.6 46.2 29.5 25.1 48.4 39.3 38.5 51.1 27.2 61.4 42.0 70.7 132.2 26.3 69.7 43.2 7.5 4.0 2.9 6.1 6.7 6.5 8.4 5.9 6.2 6.3 7.9 6.7 6.2 0.7 7.3 6.3 6.8 6.8 2.6 10.4 10.7 10.5 13.1 10.5 11.1 10.7 10.5 10.3 10.8 10.6 10.6 11.1 25.2 3.2 17.0 4.6 29.0 57.9 40.9 42.7 27.3 11.9 36.3 37.2 13.8 14.3 33.1 16.5 14.6 69.9 23.4 18.5 25.4 49.2 1.3 54.0 39.9 30.9 18.6 62.1 6.6 53.8 65.8 24.7 30.1 36.9 19.0 38.1 18.2 19.6 35.8 5.0 6.3 40.7 10.2 13.3 17.2 4.3 22.1 16.0 17.8 5.6 16.1 39.2 17.5 5.5 7.4 49.5 22.7 18.8 24.7 68.5 14.5 40.4 35.6 9.3 6.6 35.2 27.7 45.0 38.3 40.2 60.0 87.8 24.8 44.6 46.1 40.6 FRG1 "FRG1A, FSG1" ENSG00000109536 "FSHD region gene 1" Q14331 4 189940870-189963202 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing" "Actin-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA075683 Approved NA NA "HPA075683: " "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-1)" "unprognostic (5.56e-2)" "unprognostic (7.14e-2)" "unprognostic (5.62e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-3)" "unprognostic (2.83e-3)" "unprognostic (2.55e-1)" "unprognostic (2.42e-1)" "unprognostic (3.84e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.01e-1)" 34.1 25.9 6.7 6.4 6.8 16.7 34.2 6.8 13.1 28.8 6.8 31.9 6.7 33.2 9.7 31.0 27.9 6.0 30.6 6.7 6.8 26.3 25.0 23.7 8.0 6.8 6.8 6.7 32.2 30.9 13.2 18.6 6.0 6.8 21.9 7.8 3.6 25.1 7.6 31.4 28.7 26.9 8.7 6.7 29.2 30.2 20.0 6.9 13.1 23.6 9.5 8.5 29.0 28.5 6.9 12.2 8.5 21.5 19.0 11.0 16.4 14.6 18.0 13.4 23.3 15.6 6.1 20.1 21.9 8.5 13.5 8.8 7.3 20.3 13.8 24.6 13.3 9.6 39.4 9.3 4.3 18.8 28.9 14.9 12.1 15.5 12.9 4.2 15.8 15.5 19.1 25.4 42.4 19.0 6.9 38.6 42.7 4.4 5.4 12.8 27.2 4.9 14.4 16.3 6.9 15.8 15.7 11.4 13.0 21.1 11.8 6.7 20.3 15.4 8.8 11.6 6.5 13.4 15.4 12.8 17.6 15.7 18.7 13.1 30.7 13.4 19.7 13.6 18.0 13.8 16.9 16.0 15.1 12.1 15.4 13.6 14.8 13.3 16.9 19.1 13.4 20.1 13.6 6.7 6.8 6.8 13.1 6.7 6.8 6.8 6.8 6.7 6.8 6.7 6.9 6.9 69.3 80.1 52.9 6.5 61.9 33.4 42.5 62.9 18.2 43.1 47.6 56.9 70.6 64.3 52.9 33.1 16.7 77.0 82.2 45.6 131.0 106.0 50.4 42.4 51.4 61.1 44.9 94.1 12.5 121.9 65.2 50.9 18.8 40.9 84.2 34.8 83.6 133.8 68.1 32.0 11.6 53.9 50.8 92.6 46.7 20.4 76.1 57.4 21.4 4.7 107.6 61.1 124.6 12.5 17.0 88.4 48.9 72.6 41.9 20.7 60.8 126.2 51.7 52.0 52.6 50.7 84.6 75.9 70.6 27.5 28.1 53.5 64.6 42.8 52.9 32.4 CLCN3 "ClC-3, CLC3" ENSG00000109572 "Chloride voltage-gated channel 3" P51790 4 169612633-169723673 "Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044723 Approved Supported Vesicles NA NA Vesicles "HPA044723: AB_10959733" "unprognostic (1.92e-1)" "unprognostic (3.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.25e-1)" "unprognostic (3.32e-1)" "unprognostic (1.79e-1)" "unprognostic (5.40e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.10e-4)" "unprognostic (2.49e-2)" "unprognostic (2.49e-1)" "unprognostic (1.45e-1)" "unprognostic (6.38e-3)" 21.3 34.8 21.7 20.7 30.0 12.4 32.2 29.3 30.4 24.1 19.4 48.0 30.4 18.9 29.6 41.1 26.6 38.4 35.6 24.8 30.3 36.7 25.9 21.4 17.4 33.1 31.6 19.4 23.3 41.3 37.5 18.4 24.3 34.7 32.9 53.1 79.0 78.6 22.0 25.0 29.3 30.0 18.0 34.5 16.8 41.6 33.6 27.5 21.2 37.3 22.3 24.7 37.7 17.3 43.7 32.6 33.2 48.7 62.1 96.1 80.8 24.0 42.9 53.5 28.3 34.3 23.7 72.2 40.0 26.1 35.9 32.7 27.2 61.2 26.6 46.9 35.9 24.4 33.8 50.6 27.3 65.8 41.0 54.2 56.6 59.7 50.5 49.5 117.4 51.7 55.2 85.1 88.0 49.7 11.8 56.2 9.4 20.0 56.2 22.4 25.0 21.5 31.6 58.1 66.6 51.9 51.5 38.4 40.9 66.9 39.3 27.9 19.2 43.5 22.5 25.3 36.5 33.7 39.3 64.3 35.5 67.6 15.4 60.8 3.8 4.1 2.9 5.0 4.8 6.5 5.0 3.7 4.7 5.7 3.8 5.7 5.2 2.9 4.5 4.0 7.1 4.7 4.7 21.7 30.0 29.3 30.4 24.8 30.3 33.1 31.6 19.4 34.7 34.5 27.5 43.7 35.5 32.1 26.2 58.8 30.7 11.3 25.7 21.5 20.5 90.3 54.6 27.9 66.5 42.9 25.3 62.5 131.3 23.8 23.1 118.3 7.9 37.2 88.1 46.9 35.9 35.2 66.9 83.1 102.4 44.3 18.7 29.5 51.5 51.8 113.0 32.3 38.6 39.3 18.6 60.6 126.1 64.2 20.3 32.9 9.8 67.4 24.5 47.8 32.0 44.0 17.1 136.7 28.8 139.7 141.5 31.9 55.3 21.1 21.4 45.3 37.1 17.9 67.8 115.1 6.6 34.6 21.5 17.2 15.5 42.8 26.1 71.1 21.0 67.0 65.4 34.0 AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 67.6" "Cell type enhanced" "Detected in many" "Astrocytes: 22.2;Extravillous trophoblasts: 71.3;Hepatocytes: 29.3;Spermatogonia: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favorable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 2.9 2.8 6.4 1.9 7.3 0.3 4.8 4.5 9.9 9.8 10.3 5.2 1.6 10.6 5.9 2.6 6.4 3.9 2.7 7.1 6.4 6.8 67.6 5.0 0.7 6.7 6.7 7.3 4.7 5.7 6.0 6.1 1.9 7.4 14.6 5.1 11.9 1.7 5.4 4.0 1.4 2.3 7.4 5.4 1.7 3.6 8.2 6.9 1.5 7.6 2.5 0.9 6.4 5.7 9.1 3.5 8.5 25.0 0.0 4.9 18.9 9.0 8.7 4.2 4.9 5.0 8.4 1.0 0.1 1.4 9.8 6.5 2.9 11.3 4.1 3.4 0.0 9.7 0.0 10.0 14.0 3.9 0.1 3.8 7.7 2.5 4.0 5.1 13.5 4.7 11.4 1.5 0.1 19.0 8.9 4.3 0.1 19.0 9.6 7.6 0.0 7.8 0.0 4.4 15.3 20.1 23.5 7.0 1.7 8.5 8.0 0.1 1.7 3.2 12.5 13.4 14.3 13.9 0.1 0.0 0.1 12.5 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 7.3 4.5 9.9 7.1 6.4 6.7 6.7 7.3 7.4 5.4 6.9 9.1 0.9 0.0 5.9 22.2 0.3 0.9 2.8 0.9 6.2 6.0 3.9 1.0 1.2 1.5 2.1 0.0 2.1 2.8 0.0 0.7 0.0 1.6 0.5 3.7 7.4 0.7 6.7 0.0 15.4 2.2 71.3 3.2 3.1 6.0 0.0 6.2 0.7 29.3 1.6 0.0 13.6 2.8 0.0 0.3 0.9 1.4 1.2 0.4 1.8 5.6 0.0 2.7 0.0 17.6 14.0 1.1 1.6 2.2 0.0 4.0 0.2 8.4 8.5 9.1 6.6 3.9 4.2 14.5 27.1 3.0 0.4 5.6 0.3 3.3 3.1 1.8 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168811-173323967 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 6200000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 6.5 6.5 6.9 16.5 10.1 11.6 23.5 32.0 8.5 25.3 4.5 48.2 29.4 17.0 7.1 15.0 9.9 15.7 6.0 7.1 11.2 7.9 2.9 9.7 12.3 12.5 10.1 6.7 11.3 22.4 8.8 5.2 13.1 15.1 40.1 53.4 22.6 27.7 8.2 1.4 3.6 34.0 16.8 10.7 11.1 66.3 12.0 9.8 60.6 13.6 3.9 9.9 17.1 6.0 16.5 71.1 37.2 35.0 11.2 18.6 27.1 50.3 18.1 20.5 16.7 23.0 11.5 109.9 39.4 13.3 16.6 45.2 59.2 15.0 32.0 22.7 154.3 29.1 47.8 72.2 0.4 12.2 71.6 32.8 17.5 28.3 37.6 18.9 63.4 112.3 28.2 32.6 59.3 86.0 23.5 52.7 39.4 34.8 70.2 24.0 52.1 32.4 10.2 123.2 32.8 28.2 21.5 8.5 50.4 25.4 45.3 20.2 21.0 135.6 11.9 52.3 0.6 40.0 17.2 0.2 20.8 48.6 42.3 43.6 13.2 14.3 18.9 5.1 7.5 7.2 6.2 5.7 5.3 12.4 3.3 4.4 3.3 21.3 7.5 8.0 5.0 9.2 6.4 6.9 10.1 32.0 8.5 7.1 11.2 12.5 10.1 6.7 15.1 10.7 9.8 16.5 10.0 6.4 38.0 72.8 12.1 1.8 9.0 12.3 4.0 47.9 41.1 19.8 9.6 8.6 36.0 20.2 2.1 1.4 16.4 143.4 0.0 14.4 2.5 28.3 13.3 11.3 22.8 12.0 74.4 48.9 3.7 12.1 102.4 52.9 24.1 14.8 12.1 0.2 10.3 10.1 172.0 126.8 24.4 17.9 6.2 4.2 9.3 17.2 8.8 62.8 16.3 8.1 5.2 71.4 54.1 39.9 50.0 5.3 6.6 52.8 63.7 10.0 17.4 25.5 13.1 16.1 11.7 3.8 5.5 14.9 1.1 0.8 9.9 13.1 48.6 19.4 DHX15 "DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p" ENSG00000109606 "DEAH-box helicase 15" O43143 4 24517441-24584554 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047047 Approved Enhanced "Nuclear speckles" NA NA 130000 "Nuclear speckles" "HPA047047: AB_2679916" "unprognostic (4.46e-3)" "unprognostic (2.47e-2)" "prognostic favorable (5.74e-4)" "unprognostic (3.35e-1)" "unprognostic (5.30e-2)" "unprognostic (5.74e-2)" "unprognostic (2.06e-3)" "unprognostic (5.53e-3)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (8.68e-3)" "unprognostic (7.77e-3)" "unprognostic (2.51e-3)" "unprognostic (2.19e-1)" "unprognostic (1.59e-1)" "unprognostic (5.41e-3)" 40.2 36.0 16.9 51.7 22.8 79.2 51.2 30.4 22.8 41.6 27.7 49.2 37.1 44.9 30.5 44.3 38.8 35.9 33.6 18.5 21.5 46.1 45.1 37.4 60.6 20.6 20.3 15.9 44.2 48.1 52.5 21.7 55.5 21.5 39.9 58.5 40.4 38.0 36.2 43.4 42.1 38.2 48.5 22.0 40.4 45.1 33.8 20.1 80.5 40.3 42.6 71.5 66.2 35.0 28.9 135.0 129.1 209.4 104.6 100.6 97.4 124.7 153.0 133.9 157.8 155.5 132.0 158.5 245.4 91.8 126.2 183.7 109.8 272.1 184.1 243.7 90.6 129.0 213.3 134.7 107.3 59.2 222.3 140.9 82.2 108.4 154.3 103.1 100.8 133.9 113.4 203.4 96.2 181.3 101.3 293.7 148.2 228.4 133.4 115.8 190.4 245.3 114.6 187.1 190.2 179.0 111.9 118.7 112.8 109.1 149.0 123.8 113.7 123.5 132.8 87.5 101.6 181.4 72.1 130.2 289.3 89.1 177.9 161.8 57.5 29.6 28.5 28.8 30.8 39.7 28.7 32.0 33.7 39.0 29.9 33.2 32.2 13.9 37.1 38.5 25.8 38.6 28.5 16.9 22.8 30.4 22.8 18.5 21.5 20.6 20.3 15.9 21.5 22.0 20.1 28.9 51.2 76.9 57.4 40.1 53.4 98.7 68.3 58.0 56.3 30.2 50.1 36.7 28.1 35.8 70.6 27.6 22.9 72.7 44.9 79.8 37.2 59.3 32.6 61.7 53.2 53.6 60.5 58.9 51.4 41.8 69.7 55.5 79.5 97.3 57.0 47.4 42.8 48.4 44.7 26.9 50.8 69.3 36.7 46.9 53.2 16.5 39.4 50.2 48.0 49.6 48.0 24.4 34.0 61.3 99.1 57.1 41.2 40.3 51.0 73.1 33.2 34.8 55.6 32.1 26.3 59.6 69.4 72.9 46.3 60.4 100.0 88.2 49.3 34.0 71.2 89.4 SOD3 EC-SOD ENSG00000109610 "Superoxide dismutase 3" P08294 4 24789912-24800842 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Antioxidant, Heparin-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 368.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 498.5;Leydig cells: 424.1;Peritubular cells: 365.6;Smooth muscle cells: 428.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 66.2;BJ: 38.1;PC-3: 55.1;RPTEC TERT1: 231.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042110 Supported "Secreted to blood" NA NA 50400000 510000000 "HPA042110: AB_2677850" "unprognostic (7.67e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (8.80e-2)" "unprognostic (3.32e-2)" "unprognostic (9.66e-2)" "unprognostic (1.73e-1)" "unprognostic (4.98e-2)" "unprognostic (3.68e-1)" "unprognostic (2.39e-1)" "unprognostic (3.26e-2)" "unprognostic (1.50e-1)" "unprognostic (2.80e-2)" "unprognostic (8.80e-2)" "unprognostic (3.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.45e-2)" 182.7 20.6 12.3 26.4 15.1 0.0 135.4 13.6 24.0 188.1 368.9 109.7 18.4 152.9 10.5 62.6 179.1 22.6 120.6 44.1 26.6 123.3 16.6 156.4 10.6 19.4 22.9 7.8 60.3 87.4 2.7 19.9 40.2 18.5 132.4 13.6 2.0 71.5 23.6 22.2 82.6 65.7 37.4 15.0 25.0 103.0 74.6 17.9 5.8 178.0 23.1 7.1 179.8 171.8 15.6 0.0 0.0 0.0 0.0 66.2 17.3 2.0 38.1 16.7 2.3 1.4 0.5 0.0 0.0 11.8 8.0 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 16.8 0.0 15.8 0.0 17.9 0.1 0.0 1.1 0.0 0.0 0.1 0.3 1.1 8.0 0.0 55.1 0.0 0.0 0.6 231.3 0.8 0.2 0.2 0.0 1.2 0.0 2.1 32.8 0.0 0.0 8.7 1.0 1.6 0.4 0.1 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 15.1 13.6 24.0 44.1 26.6 19.4 22.9 7.8 18.5 15.0 17.9 15.6 46.1 12.8 18.1 7.2 1.0 90.8 65.5 0.6 10.2 0.4 21.7 22.1 23.0 144.4 7.6 90.1 0.0 211.4 1.8 25.6 15.6 63.6 18.7 81.9 45.8 21.0 34.6 0.0 0.1 1.8 17.0 498.5 5.1 80.3 0.0 0.1 15.4 0.2 17.3 0.0 0.1 51.9 0.0 0.3 115.5 33.9 424.1 3.2 80.0 3.7 0.0 20.7 0.0 0.5 0.7 3.5 89.3 365.6 1.1 80.4 0.0 142.7 0.1 1.4 197.2 6.5 428.9 73.2 4.4 6.1 70.3 190.0 7.6 6.1 51.8 9.6 SEPSECS "SLA, SLA/LP" ENSG00000109618 "Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase" Q9HD40 4 25120014-25160550 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "RNA-binding, Transferase, tRNA-binding" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070409 Approved Vesicles NA NA Vesicles "HPA070409: AB_2686265" "unprognostic (1.83e-1)" "unprognostic (4.09e-2)" "unprognostic (6.37e-3)" "unprognostic (5.86e-2)" "unprognostic (9.63e-2)" "unprognostic (4.61e-3)" "unprognostic (1.82e-3)" "unprognostic (6.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.34e-1)" "unprognostic (2.52e-1)" "unprognostic (3.56e-2)" "unprognostic (4.45e-3)" "unprognostic (4.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-3)" 4.0 3.5 2.3 1.7 2.2 0.7 4.5 2.2 3.0 4.1 1.9 4.4 4.9 3.8 2.6 3.2 3.8 2.5 2.7 2.3 2.3 8.3 26.3 3.9 2.1 2.5 2.3 2.2 4.9 7.5 3.3 3.1 2.8 2.4 3.4 2.7 1.5 3.9 2.0 3.4 5.2 7.7 1.3 2.3 5.6 5.0 4.0 2.3 5.2 4.8 2.6 2.0 3.9 3.6 2.5 1.7 1.0 3.0 1.3 3.9 4.9 2.5 1.1 1.9 2.6 2.3 0.6 2.6 2.9 1.4 1.0 2.6 1.3 3.5 1.2 2.0 1.9 1.3 2.5 1.0 1.8 4.0 2.0 3.3 4.0 4.2 1.0 3.7 3.1 2.5 4.3 7.0 2.5 1.6 0.7 4.4 6.2 2.1 1.8 2.5 1.3 4.3 1.7 3.7 0.7 1.6 2.4 1.3 1.4 4.7 1.9 1.5 5.5 1.0 1.4 0.7 0.7 1.7 2.3 6.2 1.6 1.4 5.4 1.8 0.0 0.2 0.1 0.1 0.6 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 2.3 2.2 2.2 3.0 2.3 2.3 2.5 2.3 2.2 2.4 2.3 2.3 2.5 5.7 0.0 7.2 9.4 6.6 2.4 1.7 3.9 2.8 3.0 5.5 4.3 5.3 22.8 4.3 16.5 0.0 5.5 4.1 10.2 7.9 5.4 30.0 7.3 6.2 6.1 6.1 8.2 5.3 4.7 3.5 4.8 8.2 5.4 3.8 7.9 6.1 42.6 6.1 5.0 7.2 7.7 4.1 8.1 4.5 18.1 3.4 6.6 3.6 14.0 8.0 3.2 4.1 16.1 18.5 5.4 6.0 6.4 6.9 2.7 20.0 20.9 10.2 2.4 0.0 4.9 4.4 26.0 18.3 5.3 3.3 5.9 6.2 7.6 7.8 1.1 CPZ ENSG00000109625 "Carboxypeptidase Z" Q66K79 4 8592660-8619759 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 145.5" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.5;Fibroblasts: 8.5;Microglial cells: 2.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 73.6;BJ: 39.7;BJ hTERT+: 51.7;hTERT-RPE1: 30.6;RH-30: 57.6;U-2197: 46.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA078608 Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "HPA078608: " "unprognostic (2.58e-1)" "unprognostic (7.16e-2)" "unprognostic (4.83e-2)" "unprognostic (1.42e-1)" "unprognostic (7.77e-2)" "unprognostic (2.20e-2)" "unprognostic (2.98e-1)" "unprognostic (7.77e-2)" "unprognostic (2.30e-1)" "unprognostic (1.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (7.23e-8)" "unprognostic (4.30e-3)" "unprognostic (3.58e-2)" "unprognostic (6.13e-4)" "unprognostic (5.51e-2)" 7.3 1.8 1.4 2.8 0.7 0.0 11.9 0.5 3.4 32.3 3.8 4.0 0.8 14.8 9.1 7.4 20.1 31.0 1.7 0.8 0.8 1.9 1.4 7.1 2.9 0.7 0.6 0.3 145.5 3.2 1.8 5.2 42.5 1.1 6.0 1.8 0.1 1.5 24.4 0.2 13.9 2.6 8.5 1.2 1.4 3.3 3.2 0.3 1.5 7.8 0.0 1.0 23.2 25.3 0.9 26.1 0.4 0.0 1.6 5.0 0.5 73.6 39.7 51.7 14.5 5.8 1.7 0.7 0.0 3.7 21.3 0.3 0.0 0.0 0.0 5.4 0.0 2.9 0.0 0.3 0.7 4.4 0.0 0.0 9.2 0.0 0.0 0.0 30.6 0.0 0.0 1.2 0.0 0.9 6.1 0.0 0.1 9.2 0.2 22.0 0.1 57.6 0.0 0.0 1.1 0.1 0.1 1.4 0.5 0.1 8.3 0.3 0.0 0.0 2.0 2.6 46.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.5 3.4 0.8 0.8 0.7 0.6 0.3 1.1 1.2 0.3 0.9 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.6 8.5 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 TRIM2 "CMT2R, KIAA0517, RNF86" ENSG00000109654 "Tripartite motif containing 2" Q9C040 4 153152163-153339319 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 107.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 47.0;SK-MEL-30: 46.8" "HPA035853, HPA035854" Supported Uncertain Centrosome NA NA Centrosome "HPA035853: AB_10669533, HPA035854: AB_10669659" "unprognostic (8.94e-2)" "unprognostic (7.89e-2)" "unprognostic (6.21e-3)" "unprognostic (7.51e-3)" "unprognostic (2.07e-2)" "unprognostic (2.32e-1)" "unprognostic (1.16e-2)" "unprognostic (2.30e-3)" "unprognostic (5.30e-2)" "unprognostic (6.77e-2)" "unprognostic (1.93e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.58e-14)" "unprognostic (5.89e-2)" "unprognostic (1.17e-2)" "unprognostic (4.19e-2)" "unprognostic (4.13e-2)" 5.5 11.9 17.4 4.9 49.0 0.1 11.9 26.6 44.1 23.8 0.0 21.8 17.6 10.0 8.0 10.8 15.4 12.7 8.5 43.2 26.4 21.6 8.0 7.3 2.2 33.0 30.1 23.4 13.0 12.8 1.0 21.7 2.5 47.3 13.2 19.4 19.5 43.3 13.5 2.2 6.9 17.4 7.0 34.3 10.7 27.7 2.0 29.6 3.0 51.0 3.0 4.0 12.1 11.6 107.1 10.2 0.2 47.0 24.2 22.0 27.2 0.5 12.7 15.4 3.6 4.5 4.1 0.2 0.1 7.7 21.7 8.5 6.4 24.7 4.7 3.2 0.0 5.4 0.1 4.6 0.5 24.7 0.1 0.1 13.5 2.3 5.4 4.7 12.9 3.4 0.4 0.2 0.0 4.9 0.4 2.4 0.1 37.4 27.5 8.8 1.0 9.4 0.0 37.0 11.8 14.5 27.3 4.4 2.7 46.8 6.9 1.7 0.5 2.8 12.7 3.0 10.8 3.9 0.0 0.0 0.1 20.9 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 17.4 49.0 26.6 44.1 43.2 26.4 33.0 30.1 23.4 47.3 34.3 29.6 107.1 11.2 6.4 33.7 189.0 2.6 7.0 15.3 40.2 9.1 67.7 40.5 29.1 39.6 17.2 82.1 58.8 29.2 2.0 0.7 59.4 101.8 9.6 3.3 113.3 16.3 17.3 62.3 0.4 266.4 26.1 0.5 22.0 80.0 95.6 1.3 4.8 21.0 12.4 1.4 111.0 211.2 64.1 54.9 0.8 7.7 2.4 29.5 2.2 64.0 21.5 3.2 86.9 0.0 237.2 1132.8 22.5 41.4 32.7 1.5 17.8 62.9 14.7 106.0 23.4 26.3 14.7 16.2 0.4 1.3 5.0 4.0 0.7 2.8 8.7 90.8 33.7 SLC2A9 "Glut9, GLUTX, URATv1" ENSG00000109667 "Solute carrier family 2 member 9" Q9NRM0 4 9771153-10054936 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.5;liver: 21.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 27.4;Proximal tubular cells: 72.6" "Cancer enhanced" "Detected in many" "renal cancer: 6.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 36.9;myeloid DC: 30.5" "Group enriched" "Detected in many" 30 "dendritic cells: 30.5;monocytes: 36.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA066229, HPA075669" Enhanced NA NA "HPA066229: AB_2685639, HPA075669: " "unprognostic (3.21e-1)" "unprognostic (8.99e-3)" "unprognostic (1.25e-2)" "unprognostic (2.01e-1)" "unprognostic (2.14e-2)" "unprognostic (2.56e-2)" "unprognostic (8.94e-2)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (1.28e-2)" "unprognostic (3.16e-1)" "unprognostic (2.23e-1)" "prognostic favorable (1.32e-11)" "unprognostic (1.01e-1)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.20e-1)" 1.6 2.6 1.1 2.1 1.2 2.1 4.2 1.4 1.5 2.1 2.7 1.8 10.8 1.4 2.4 5.2 3.5 2.4 1.9 1.1 2.2 29.5 21.5 4.3 2.0 2.4 1.4 0.6 1.7 1.0 2.5 1.4 7.7 2.0 3.6 1.6 1.3 16.7 19.0 0.5 2.0 8.5 2.1 1.9 1.8 1.0 0.7 1.9 4.3 2.7 0.5 1.4 6.5 4.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.1 0.0 0.3 2.4 0.0 3.5 0.7 0.0 7.3 0.0 48.1 0.0 8.2 0.3 0.0 0.0 23.6 1.6 0.1 6.3 3.4 19.9 0.0 4.8 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.3 2.4 0.0 0.4 0.1 1.5 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 20.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.5 0.1 0.0 36.9 0.9 0.3 7.6 0.3 0.3 0.3 0.1 30.5 0.1 0.2 0.1 1.1 0.2 0.9 12.2 0.2 9.1 1.1 1.2 1.4 1.5 1.1 2.2 2.4 1.4 0.6 2.0 1.9 1.9 2.9 1.4 0.0 0.0 8.1 1.3 0.9 13.4 27.4 6.2 0.0 4.6 6.1 2.4 0.0 5.7 3.7 2.1 18.7 0.5 1.7 3.9 0.5 5.1 4.1 2.1 1.5 0.0 1.3 4.4 1.1 1.8 1.6 1.1 11.5 1.3 0.5 2.2 5.2 10.3 0.0 5.6 0.9 10.2 8.7 3.7 3.4 0.0 8.8 0.0 15.9 4.4 1.2 1.0 10.6 1.1 0.6 0.5 0.4 0.3 2.0 8.1 72.6 3.0 0.4 0.0 4.6 1.6 1.1 1.9 5.4 0.6 8.5 0.9 0.7 2.5 7.7 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536092 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.4" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 201.8;Excitatory neurons: 529.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 23.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 14.3 9.6 43.2 15.1 48.0 20.0 14.3 61.6 67.4 8.5 15.8 9.6 7.9 8.7 24.5 14.4 15.7 9.3 20.0 51.1 34.0 6.3 11.3 11.5 16.2 25.2 30.1 38.1 9.2 12.9 7.9 9.3 9.5 30.9 7.8 10.4 18.2 11.9 7.6 26.2 63.7 10.5 9.1 18.6 16.3 13.1 23.0 30.3 14.9 10.4 19.9 20.5 12.0 10.8 52.9 9.8 8.0 19.1 14.2 12.2 9.4 16.2 13.4 12.9 8.5 8.1 15.7 12.0 24.7 3.9 13.7 6.5 5.2 16.9 30.9 12.1 16.2 8.0 11.9 10.7 10.9 12.7 29.2 10.6 14.8 45.7 15.2 24.4 8.4 15.2 20.5 19.2 25.7 10.8 13.7 34.9 10.6 9.7 8.0 6.1 32.2 8.0 5.3 9.8 17.0 12.7 10.2 8.5 11.3 7.5 21.6 6.4 12.6 15.6 11.3 12.6 5.4 8.2 79.0 47.5 24.4 9.4 9.2 8.3 23.5 2.7 1.6 4.0 3.0 2.7 2.8 3.1 2.7 1.6 1.8 3.4 2.5 4.8 7.1 2.2 2.1 2.9 1.3 43.2 48.0 61.6 67.4 51.1 34.0 25.2 30.1 38.1 30.9 18.6 30.3 52.9 29.5 9.6 22.9 80.0 48.1 201.8 36.5 29.9 120.1 74.9 32.1 30.9 61.8 12.8 15.1 9.2 31.3 10.9 54.7 22.2 3.9 14.3 17.4 37.7 37.3 36.1 14.5 30.1 529.6 13.5 39.9 27.2 21.4 61.6 15.8 19.1 17.9 18.3 10.5 11.8 186.5 16.4 32.6 18.8 47.0 10.2 15.2 33.7 28.4 172.4 28.0 37.0 35.0 102.5 99.8 18.7 18.2 11.3 174.5 36.3 8.9 7.5 11.9 41.4 13.1 33.2 25.5 74.1 87.2 57.0 174.9 31.2 46.2 18.7 14.9 70.5 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309874-177362936 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 6.7;lymphoid tissue: 23.8" "Cell type enhanced" "Detected in some" "Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.3" HPA065761 Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.1 0.0 0.0 1.7 0.0 6.7 0.3 0.0 0.1 0.1 0.1 1.1 1.1 0.1 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 2.3 1.3 0.5 0.0 0.4 0.6 1.5 0.1 23.8 0.0 0.0 3.5 0.4 0.4 0.3 19.3 15.8 16.4 8.2 1.8 3.3 8.0 23.4 8.6 25.3 14.9 5.8 16.5 21.2 3.4 6.2 25.1 8.8 17.4 9.3 36.6 72.1 11.4 14.7 11.9 15.2 0.5 79.1 9.7 0.3 0.5 26.2 5.6 5.2 9.9 53.9 15.3 99.1 16.7 8.4 80.7 30.2 7.5 5.7 11.5 16.2 11.2 6.8 6.8 2.6 12.8 8.9 11.7 13.4 6.3 7.2 10.9 20.4 4.7 15.2 11.8 7.8 24.0 6.8 4.8 33.5 10.1 27.8 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.9 0.1 0.4 1.2 0.0 0.2 0.1 0.4 0.0 1.3 0.0 0.0 2.6 1.6 0.5 0.0 0.0 0.1 0.1 0.6 0.3 0.0 14.7 0.1 0.2 3.3 0.9 0.0 0.5 0.0 4.8 0.4 0.0 1.5 0.0 0.1 1.0 0.0 1.3 0.4 0.2 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 6.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.5 2.7 2.4 4.5 1.3 0.3 1.0 0.5 1.2 0.2 TBC1D19 FLJ11082 ENSG00000109680 "TBC1 domain family member 19" Q8N5T2 4 26576437-26756223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 66.9;Excitatory neurons: 106.6;Inhibitory neurons: 95.3;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039592 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA039592: AB_10671043" "unprognostic (2.64e-2)" "unprognostic (2.71e-2)" "unprognostic (2.94e-1)" "unprognostic (8.65e-2)" "unprognostic (1.03e-1)" "unprognostic (1.57e-1)" "unprognostic (2.86e-1)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.90e-1)" "unprognostic (3.29e-2)" "unprognostic (4.28e-2)" "prognostic favorable (1.21e-7)" "unprognostic (1.04e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.51e-1)" 3.4 5.8 5.6 2.5 5.0 1.6 4.4 6.0 5.5 7.5 9.6 3.6 1.8 7.7 7.1 2.9 7.8 7.6 5.8 4.4 7.0 17.5 2.9 4.3 2.2 7.2 6.4 4.0 8.9 3.0 14.7 5.1 3.8 7.6 5.3 3.0 9.3 3.3 6.4 3.1 2.2 1.7 8.8 5.5 2.8 3.1 5.0 7.2 17.5 7.9 5.1 2.6 4.9 3.0 6.5 2.4 1.9 8.5 5.3 11.5 18.5 2.4 11.1 8.2 4.9 4.8 4.1 5.8 5.6 9.5 15.0 15.2 1.0 4.8 5.6 4.7 1.7 2.2 1.4 6.6 1.2 6.3 3.2 1.4 9.3 4.5 9.4 5.7 19.7 6.7 7.2 5.3 0.0 77.1 0.1 6.3 3.5 3.9 3.2 9.2 4.7 8.4 0.6 18.9 2.5 8.4 3.2 5.3 1.2 5.5 6.9 2.1 1.2 6.5 6.2 1.7 4.7 2.8 1.2 3.1 2.6 22.1 1.7 6.4 1.1 0.5 1.8 4.2 0.6 5.1 1.6 3.2 4.7 0.9 2.0 2.4 2.9 0.0 4.5 0.6 1.7 1.7 1.3 5.6 5.0 6.0 5.5 4.4 7.0 7.2 6.4 4.0 7.6 5.5 7.2 6.5 6.0 3.2 4.1 66.9 8.2 3.6 5.3 7.6 7.4 7.4 5.7 5.3 6.4 1.5 2.5 20.2 14.6 4.0 18.1 1.0 5.9 4.8 11.1 15.7 18.9 6.8 9.5 2.1 106.6 3.1 2.2 9.3 6.1 9.0 8.9 9.3 7.1 1.9 1.6 5.0 95.3 2.1 10.2 2.4 2.7 3.1 9.0 2.4 10.6 42.2 0.8 7.4 13.4 102.5 72.4 2.6 0.4 9.1 5.5 1.9 0.6 19.2 17.4 19.3 0.0 9.5 11.1 25.6 8.9 3.1 4.5 1.9 14.4 13.1 1.6 2.3 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684768 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.1" "Cell type enriched" "Detected in many" 5 "Ionocytes: 73.2" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 4.1;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035671, HPA035672" Uncertain Uncertain Vesicles NA NA Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.3 0.2 0.5 0.9 0.4 0.4 0.6 1.4 0.8 0.2 0.5 0.3 0.6 0.4 1.2 0.4 0.2 0.5 0.2 0.5 0.4 6.1 0.9 0.6 3.0 0.6 0.3 0.6 0.4 0.1 0.1 1.3 1.0 0.9 0.4 0.4 0.3 0.5 0.3 0.2 0.9 0.9 0.1 0.2 1.6 1.1 0.8 0.4 1.4 0.3 0.0 2.0 0.3 0.0 0.8 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.2 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 2.2 0.1 0.5 0.1 0.2 0.2 0.1 0.1 1.4 0.4 0.1 2.6 1.1 0.1 0.1 0.4 2.0 0.0 0.6 1.8 0.2 0.5 0.4 1.4 0.8 0.5 0.4 0.6 0.3 0.6 0.9 0.2 0.4 0.8 0.1 3.2 3.0 1.0 12.9 0.8 0.8 0.0 0.0 1.3 0.3 0.3 0.7 0.0 0.9 0.0 2.1 0.3 4.6 0.1 13.7 0.0 5.3 0.7 0.2 0.4 0.0 5.3 1.7 0.0 2.2 0.5 0.5 0.9 11.4 0.2 0.7 0.3 0.3 0.0 1.6 0.2 73.2 1.9 5.5 5.4 0.3 3.5 1.8 1.9 0.5 0.4 0.0 1.0 0.7 0.1 0.0 2.2 1.1 0.7 0.0 0.2 0.2 1.0 0.0 1.1 0.5 1.9 0.8 0.0 0.4 0.1 6.0 1.3 0.0 0.7 NSD2 "KMT3G, MMSET, WHSC1" ENSG00000109685 "Nuclear receptor binding SET domain protein 2" O96028 4 1871393-1982207 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 20.3;Granulosa cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015801, CAB068246, CAB068247" Enhanced Supported Nucleoplasm No No Nucleoplasm "CAB068246: AB_2665690, CAB068247: AB_2665689, HPA015801: AB_1858830" "unprognostic (3.70e-1)" "unprognostic (9.80e-2)" "unprognostic (3.33e-2)" "unprognostic (1.77e-1)" "unprognostic (4.01e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.24e-2)" "unprognostic (6.22e-2)" "unprognostic (7.66e-2)" "unprognostic (2.09e-1)" "unprognostic (9.25e-3)" "prognostic unfavorable (7.19e-4)" "unprognostic (3.89e-2)" "unprognostic (2.95e-1)" "unprognostic (1.31e-1)" "unprognostic (6.15e-2)" 10.0 8.5 11.8 16.7 13.5 55.4 10.0 22.2 14.5 9.1 0.8 19.8 18.8 10.8 7.3 13.7 8.5 8.4 15.9 12.0 12.4 9.3 8.4 12.7 25.6 9.8 9.2 12.1 7.7 13.7 12.1 13.9 12.3 12.6 9.8 22.7 28.7 11.7 8.5 16.9 11.7 18.5 12.6 5.3 14.2 12.6 37.6 11.8 60.3 17.6 13.8 24.5 9.8 9.2 15.4 124.0 58.6 168.3 71.2 17.5 26.5 44.2 98.2 85.4 115.2 128.8 44.6 141.4 117.5 31.4 78.0 158.5 50.2 114.4 74.3 195.0 58.3 47.7 151.3 81.7 25.5 18.6 89.5 74.9 9.9 19.8 101.2 89.9 60.1 92.2 123.4 81.7 132.2 95.8 42.1 243.3 99.7 68.8 60.1 77.1 137.8 106.7 42.9 45.4 57.4 115.6 82.7 78.4 29.2 31.7 71.4 68.9 52.2 64.9 109.0 87.4 72.8 188.1 54.1 72.9 113.7 66.0 81.9 108.0 4.0 1.1 1.3 1.0 0.8 1.1 0.9 1.5 1.2 1.2 1.7 1.1 0.8 3.4 1.2 0.5 2.1 2.9 0.7 11.8 13.5 22.2 14.5 12.0 12.4 9.8 9.2 12.1 12.6 5.3 11.8 15.4 12.6 12.8 18.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 15.3 9.1 0.0 0.0 8.1 12.9 0.0 15.7 7.2 0.0 3.9 10.4 0.0 13.0 11.7 6.3 0.0 0.0 0.0 7.1 10.0 6.0 0.0 20.3 2.5 69.3 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 5.7 0.0 0.0 0.0 0.0 11.4 0.0 0.0 4.9 0.0 0.0 4.0 7.3 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 3.4 5.2 3.7 0.0 0.0 SH3D19 "DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19" ENSG00000109686 "SH3 domain containing 19" Q5HYK7 4 151102751-151325605 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 360.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 190.3;ASC TERT1: 161.0;HSkMC: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016424, HPA058562" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016424: AB_1856814, HPA058562: AB_2683758" "unprognostic (1.09e-1)" "unprognostic (6.14e-2)" "unprognostic (1.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (5.09e-1)" "unprognostic (7.37e-2)" "unprognostic (1.48e-1)" "unprognostic (6.40e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.90e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.64e-2)" 71.4 15.9 9.6 12.9 12.9 0.2 31.8 5.4 8.7 22.7 90.4 44.6 44.8 23.4 10.8 41.1 23.9 64.2 64.7 5.8 7.2 27.5 50.3 36.5 5.1 10.8 9.8 3.5 43.3 15.3 20.1 5.0 28.2 14.1 27.4 48.8 12.9 17.5 40.9 17.9 30.2 49.4 41.8 5.4 7.5 22.8 12.5 9.9 4.0 25.4 34.1 8.0 33.7 20.8 18.4 26.3 19.2 12.1 9.5 190.3 161.0 26.0 31.8 34.0 13.9 14.4 24.9 31.6 0.0 12.5 29.9 22.7 19.2 12.8 36.6 13.5 0.1 10.1 0.0 22.2 26.7 46.0 0.1 0.1 129.1 27.6 20.9 32.0 23.9 81.9 0.0 0.0 0.1 36.9 10.9 0.0 0.4 24.3 40.3 27.6 0.0 0.9 0.4 17.3 18.3 0.9 16.3 22.7 23.0 18.5 24.7 7.5 0.1 59.9 43.6 15.6 19.5 12.9 0.1 0.0 0.1 22.6 0.1 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.6 12.9 5.4 8.7 5.8 7.2 10.8 9.8 3.5 14.1 5.4 9.9 18.4 36.7 22.4 32.5 8.1 2.9 28.6 14.1 12.3 18.8 6.6 20.5 25.0 88.5 34.3 29.2 16.5 14.6 25.9 5.0 103.5 5.9 11.9 4.4 17.6 38.1 29.1 18.6 7.0 55.8 15.4 20.7 77.9 38.7 13.7 21.5 37.5 21.8 46.4 7.4 6.7 30.0 35.6 10.2 4.6 20.2 6.7 62.1 4.8 26.6 74.0 1.2 20.8 5.2 263.9 360.1 21.3 55.9 48.2 3.2 41.5 88.2 27.2 52.4 11.0 13.1 46.0 26.3 2.9 6.0 16.7 38.5 27.2 5.5 20.3 54.0 41.2 STIM2 ENSG00000109689 "Stromal interaction molecule 2" Q9P246 4 26857601-27025381 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 70.6" "Cell type enhanced" "Detected in all" "Astrocytes: 123.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 187.7;U-698: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036933, CAB037196, HPA057511" Supported NA NA "CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453" "unprognostic (7.09e-2)" "unprognostic (8.80e-3)" "unprognostic (1.60e-3)" "unprognostic (2.58e-2)" "unprognostic (2.83e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "prognostic favorable (5.01e-4)" "unprognostic (6.81e-2)" "unprognostic (1.45e-2)" "unprognostic (2.60e-2)" "unprognostic (7.55e-2)" "unprognostic (3.17e-1)" "unprognostic (2.17e-3)" 10.6 7.6 11.6 17.1 14.1 17.5 11.7 11.3 14.2 11.1 70.6 11.6 16.8 10.9 22.7 6.2 12.4 20.0 6.7 18.0 13.7 13.1 10.0 15.3 25.6 12.8 12.4 11.7 18.9 14.3 8.4 13.8 10.4 13.5 14.0 14.6 19.0 13.0 7.3 8.3 14.1 15.1 10.2 10.2 22.3 15.0 7.4 12.4 21.0 10.7 6.6 23.6 14.0 7.7 14.3 10.0 14.1 13.9 17.5 14.7 9.2 12.7 24.0 7.7 12.6 15.1 12.4 34.4 44.5 13.6 9.4 13.1 11.9 10.4 28.3 13.4 13.4 16.2 13.0 26.3 11.9 11.7 23.3 13.5 12.1 13.7 16.9 8.8 16.3 15.4 17.7 14.1 8.8 31.0 11.9 17.2 22.9 15.2 20.8 18.9 187.7 26.0 10.9 10.6 22.3 24.3 8.8 16.9 12.3 6.6 9.9 7.6 19.8 16.3 17.1 11.1 11.8 15.7 23.7 20.8 90.6 18.4 24.8 28.0 12.9 1.7 1.4 3.9 1.4 2.6 4.1 4.2 3.3 1.3 4.8 4.5 3.5 3.0 1.8 6.5 5.0 2.2 1.3 11.6 14.1 11.3 14.2 18.0 13.7 12.8 12.4 11.7 13.5 10.2 12.4 14.3 55.8 12.8 26.9 123.7 57.1 16.4 14.1 42.4 17.6 39.0 18.7 16.3 8.8 22.8 30.6 33.1 81.3 11.9 62.7 17.3 13.7 10.5 9.8 18.0 19.9 49.3 45.7 14.9 69.9 20.1 6.9 20.2 26.0 14.7 36.8 32.4 32.2 11.2 7.4 30.3 68.1 30.8 46.8 20.4 16.2 8.3 15.2 29.2 8.8 58.1 18.9 19.2 65.9 101.0 87.5 12.7 15.9 7.2 37.1 10.9 19.4 5.1 112.4 61.1 19.7 22.5 18.3 19.9 24.0 7.8 15.5 4.9 48.3 37.0 14.4 12.9 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13544508 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 15.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.2;Cardiomyocytes: 4.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.3;NB-4: 11.3;NTERA-2: 6.2;THP-1: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 15.1 0.7 0.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.2 0.1 0.6 0.0 0.0 0.4 1.0 0.0 0.1 0.2 0.0 0.1 1.8 1.4 0.0 2.4 1.8 0.8 0.0 0.0 0.2 0.4 0.0 0.0 1.4 0.0 0.0 0.4 2.0 1.8 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.9 0.0 4.3 0.0 0.0 0.0 2.2 0.6 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.5 1.4 0.0 0.6 0.0 0.3 11.3 6.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.9 6.6 0.0 0.5 2.5 0.1 0.4 1.7 0.0 0.0 0.4 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934834 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 251.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 275.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA043209: AB_2678364" "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavorable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 32.0 20.3 13.3 10.0 13.9 66.7 30.7 11.5 24.3 40.5 15.9 29.8 12.5 35.0 3.4 27.8 37.3 12.6 25.9 13.5 15.0 32.7 10.9 37.2 13.3 13.8 11.9 13.1 42.0 29.2 3.6 28.9 11.6 13.0 34.6 3.8 1.1 30.7 11.4 14.1 21.0 31.2 7.6 11.2 36.4 31.8 15.7 15.6 6.3 37.9 3.5 6.3 34.9 33.1 14.3 50.4 46.2 13.3 33.7 21.7 15.5 36.0 45.1 21.9 21.5 24.6 24.7 117.3 8.8 23.7 28.4 40.0 45.9 12.1 65.6 5.8 56.9 40.7 19.1 39.2 25.9 36.5 59.9 27.1 23.5 37.5 24.5 15.4 33.4 24.7 20.0 26.4 18.0 16.5 53.8 16.9 275.6 43.0 38.9 54.5 20.7 6.4 41.8 32.9 30.6 34.2 40.7 10.8 31.5 49.1 13.5 82.9 112.9 37.1 17.7 30.4 22.2 36.6 12.2 5.8 13.8 50.0 153.3 27.8 64.7 55.0 117.4 73.0 71.2 62.6 45.1 46.8 82.1 57.4 35.2 23.3 41.1 44.2 45.9 95.8 45.7 34.4 42.6 13.3 13.9 11.5 24.3 13.5 15.0 13.8 11.9 13.1 13.0 11.2 15.6 14.3 64.6 38.5 29.1 17.6 41.3 31.4 78.8 251.5 28.5 9.2 56.3 68.1 5.0 28.6 123.2 46.0 8.4 67.4 71.0 37.8 3.9 96.0 11.7 41.5 33.4 41.1 28.2 13.3 21.5 45.9 93.0 42.9 33.6 44.3 32.4 50.7 45.7 3.1 69.6 15.2 14.8 37.2 93.6 49.3 36.7 18.8 36.4 45.6 42.7 9.4 62.1 11.0 64.9 9.5 8.8 86.0 51.5 22.6 28.1 92.1 60.0 17.9 104.9 10.0 92.1 27.0 56.6 15.5 16.1 26.9 26.9 83.7 62.4 44.7 49.4 100.5 GLRB ENSG00000109738 "Glycine receptor beta" P48167 4 157076125-157172090 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.2;parathyroid gland: 33.3" "Group enriched" "Detected in many" 4 "Excitatory neurons: 168.6;Inhibitory neurons: 110.7;Oligodendrocyte precursor cells: 110.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 28.6;hTERT-RPE1: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052363 Approved NA NA "HPA052363: AB_2681800" "unprognostic (7.36e-2)" "unprognostic (6.53e-2)" "unprognostic (1.44e-1)" "unprognostic (2.59e-3)" "unprognostic (5.65e-2)" "unprognostic (1.18e-1)" "unprognostic (9.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.19e-2)" "unprognostic (2.99e-2)" "unprognostic (6.81e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.89e-4)" "unprognostic (4.32e-3)" "unprognostic (1.85e-1)" "unprognostic (5.61e-2)" "unprognostic (1.66e-2)" 4.8 7.1 15.6 1.1 22.2 0.2 10.7 11.9 39.2 9.1 6.9 2.6 0.6 3.0 5.2 1.0 7.4 3.3 11.2 20.4 22.1 3.9 1.2 3.2 0.3 14.4 12.7 20.9 1.2 15.3 33.3 7.6 2.6 16.6 6.3 0.9 8.5 19.7 4.8 3.3 1.6 1.4 3.8 9.5 0.0 2.9 1.6 18.7 1.1 1.0 5.0 0.2 1.4 1.5 29.1 8.0 3.4 9.5 28.6 18.0 7.2 0.0 16.0 10.1 7.6 14.4 0.0 24.0 0.0 3.7 16.2 9.4 0.0 7.2 2.5 14.3 0.0 9.7 5.0 3.8 0.3 8.1 6.2 0.0 6.4 2.2 13.4 1.9 37.8 6.9 5.1 0.0 0.0 14.1 0.0 0.8 0.0 0.6 0.0 2.3 0.0 13.0 0.0 20.6 1.5 10.3 6.1 0.0 7.3 1.2 1.4 6.8 1.6 10.5 4.5 13.2 7.6 15.3 0.0 0.0 0.0 10.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.6 22.2 11.9 39.2 20.4 22.1 14.4 12.7 20.9 16.6 9.5 18.7 29.1 0.5 0.0 1.1 26.1 0.0 1.1 0.9 3.1 1.2 10.8 7.8 4.8 13.9 4.3 3.5 0.0 2.1 0.4 0.4 0.1 0.0 8.8 0.3 6.9 3.4 2.1 0.0 1.7 168.6 1.8 0.0 3.9 0.0 2.0 1.3 7.0 3.3 0.0 0.1 1.7 110.7 0.0 4.1 0.3 1.9 0.3 0.3 0.1 3.6 15.9 0.6 13.2 0.0 110.1 31.5 1.5 0.0 3.4 0.0 0.6 0.0 0.5 10.4 2.2 0.0 8.5 2.2 1.3 3.3 0.4 0.3 0.1 0.1 1.3 0.1 0.2 BST1 CD157 ENSG00000109743 "Bone marrow stromal cell antigen 1" Q10588 4 15703065-15738313 "CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 141.1;intestine: 49.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 40.8;Macrophages: 33.3;monocytes: 80.1;Proximal enterocytes: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "classical monocyte: 257.7;neutrophil: 292.7" "Group enriched" "Detected in many" 95 "dendritic cells: 78.9;granulocytes: 292.7;monocytes: 257.7" "Cell line enhanced" "Detected in many" "THP-1: 76.0;TIME: 40.4;U-937: 52.5;WM-115: 44.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050121 Uncertain "Intracellular and membrane" NA NA 190000000 "HPA050121: AB_2681025" "unprognostic (2.95e-1)" "unprognostic (3.61e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-2)" "unprognostic (7.49e-2)" "unprognostic (2.89e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (1.84e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-2)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (3.11e-1)" "unprognostic (1.57e-2)" "unprognostic (1.95e-1)" 17.4 2.7 1.9 13.8 2.2 141.1 9.4 2.1 4.5 11.1 2.1 8.4 49.1 6.4 2.9 4.7 8.0 18.4 12.7 2.1 2.5 17.2 8.6 12.8 7.1 2.0 1.6 1.3 9.4 3.1 1.7 1.4 13.8 2.2 3.8 9.8 1.0 3.9 4.7 2.8 4.5 29.5 9.8 0.9 18.7 3.2 2.7 2.5 4.0 4.9 6.9 3.6 17.0 7.4 3.2 0.6 10.5 1.2 1.0 28.8 7.0 1.6 21.0 2.1 20.4 22.2 0.3 12.1 0.8 1.9 12.2 0.6 0.3 3.3 0.5 17.2 0.8 0.7 5.6 0.8 0.6 6.7 7.2 15.1 5.7 1.5 12.9 1.0 0.9 3.0 5.0 0.7 0.5 12.5 0.3 2.3 4.3 2.7 0.9 2.2 0.8 1.8 0.5 0.5 0.6 1.4 4.3 0.4 0.7 14.2 1.2 0.5 76.0 40.4 0.6 1.0 7.9 1.1 0.6 0.2 0.7 2.7 52.5 44.8 41.8 257.7 20.8 1.1 97.4 1.7 2.2 0.9 0.8 78.9 0.9 1.1 0.7 292.7 0.4 73.9 26.6 1.0 109.8 1.9 2.2 2.1 4.5 2.1 2.5 2.0 1.6 1.3 2.2 0.9 2.5 3.2 5.4 3.2 3.7 1.3 0.3 4.6 0.8 0.1 1.8 0.6 1.2 2.0 1.5 2.8 1.0 1.8 0.0 16.0 5.5 3.7 1.9 4.4 4.4 8.0 9.9 3.8 1.2 2.5 0.7 2.5 24.0 22.5 0.0 16.2 15.9 20.6 6.4 2.1 40.8 0.0 0.7 8.1 0.0 26.3 11.5 1.2 3.1 33.3 14.2 3.7 80.1 0.6 3.1 0.5 3.6 1.1 11.9 2.2 0.4 0.6 79.0 9.6 3.0 0.2 6.6 3.9 15.5 2.5 1.4 1.7 3.0 7.1 1.8 1.4 23.2 3.3 RAPGEF2 "DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF" ENSG00000109756 "Rap guanine nucleotide exchange factor 2" Q9Y4G8 4 159103013-159360174 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, GTPase activation, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 456.2;Inhibitory neurons: 264.1;Microglial cells: 238.9;Oligodendrocyte precursor cells: 199.0;Oligodendrocytes: 236.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 5.9" "Group enriched" "Detected in many" 5 "granulocytes: 5.9;NK-cells: 3.3" "Cell line enhanced" "Detected in many" "HMC-1: 104.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068798 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA068798: " "unprognostic (4.88e-2)" "unprognostic (7.42e-2)" "unprognostic (1.67e-2)" "unprognostic (7.79e-3)" "unprognostic (8.16e-2)" "unprognostic (4.71e-3)" "unprognostic (4.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (9.71e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.76e-7)" "unprognostic (2.29e-1)" "unprognostic (2.07e-1)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" 22.6 9.5 8.0 13.5 21.4 88.3 24.3 4.5 27.0 16.9 0.4 22.0 16.0 16.3 9.9 14.0 14.1 20.3 22.6 23.3 9.1 22.9 30.7 26.8 12.0 2.8 2.8 14.3 13.6 19.7 23.7 15.4 38.8 6.3 12.4 21.0 35.4 25.5 12.7 21.9 17.1 17.1 19.9 0.6 30.0 19.5 9.9 3.3 17.6 39.8 31.7 11.6 14.9 11.9 18.5 8.9 11.9 55.4 17.2 21.4 23.9 84.9 17.0 21.3 15.2 10.9 36.7 19.4 50.7 6.1 17.0 22.0 8.0 19.1 21.8 18.0 8.6 13.2 79.0 25.3 21.4 15.5 9.7 104.5 14.1 12.1 36.5 12.9 32.0 44.1 20.7 17.6 46.0 19.0 15.6 24.1 1.5 23.7 10.4 11.8 19.7 14.0 2.0 13.6 20.2 15.7 21.0 24.9 12.1 20.0 26.5 6.0 6.3 47.0 23.9 25.2 30.7 14.2 51.0 32.9 0.8 28.3 4.1 14.8 2.2 1.0 0.7 0.5 0.5 0.6 0.2 0.4 0.3 0.5 0.2 0.6 0.3 5.9 3.3 0.6 1.0 1.0 0.3 8.0 21.4 4.5 27.0 23.3 9.1 2.8 2.8 14.3 6.3 0.6 3.3 18.5 66.7 57.7 30.1 110.7 12.9 20.4 11.2 7.5 9.6 19.7 23.5 11.9 39.0 11.5 13.8 7.3 41.7 11.1 20.2 24.8 0.0 9.2 5.3 43.5 19.5 49.2 14.4 38.9 456.2 12.6 9.6 16.9 7.7 59.2 51.8 22.9 32.2 30.5 10.8 33.7 264.1 12.0 2.0 24.6 20.1 5.3 7.8 29.5 33.8 238.9 15.6 30.2 2.1 199.0 236.2 22.1 17.7 8.6 40.5 17.6 7.1 8.7 18.7 22.4 52.6 28.1 37.2 3.5 8.9 10.7 20.0 5.9 12.9 7.2 7.9 15.1 HGFAC "HGFA, HGFAP" ENSG00000109758 "HGF activator" Q04756 4 3441968-3449486 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 56 "liver: 218.9" "Group enriched" "Detected in some" 5 "Early spermatids: 85.6;Hepatocytes: 72.0;Late spermatids: 165.9" "Cancer enriched" "Detected in some" 22 "liver cancer: 26.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "Hep G2: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA058279, HPA059076" Enhanced "Secreted to blood" NA NA 7590000 9300000000 "HPA058279: AB_2683665, HPA059076: AB_2683898" "unprognostic (2.70e-2)" "unprognostic (8.20e-2)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.39e-2)" "unprognostic (2.85e-3)" "unprognostic (5.37e-3)" "unprognostic (5.90e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-3)" "unprognostic (5.52e-2)" "prognostic unfavorable (9.31e-4)" "unprognostic (2.87e-1)" "unprognostic (2.24e-1)" "unprognostic (9.49e-2)" "unprognostic (3.74e-4)" 0.0 0.0 1.3 0.0 2.1 0.0 0.1 1.9 2.6 0.4 0.3 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.1 1.9 0.3 0.5 218.9 0.1 0.0 1.6 0.4 1.2 0.2 0.1 0.0 0.7 0.0 2.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.9 0.0 0.1 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.1 1.9 2.6 1.9 0.3 1.6 0.4 1.2 2.0 0.4 0.9 1.3 0.1 0.0 0.0 1.3 0.2 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 85.6 0.5 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.4 0.0 4.4 2.2 72.0 0.0 3.3 3.9 0.0 0.0 3.2 0.0 165.9 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 0.3 0.0 0.0 1.2 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.1 21.5 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 SNX25 SBBI31 ENSG00000109762 "Sorting nexin 25" Q9H3E2 4 185204237-185370185 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 128.9;Astrocytes: 50.6;Excitatory neurons: 57.7;Inhibitory neurons: 60.7;Oligodendrocyte precursor cells: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036928 Supported Vesicles NA NA Vesicles "HPA036928: AB_10669720" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (4.29e-3)" "unprognostic (8.89e-2)" "unprognostic (5.63e-2)" "unprognostic (1.43e-2)" "unprognostic (6.41e-2)" "unprognostic (5.35e-2)" "unprognostic (2.99e-2)" "unprognostic (4.03e-3)" "unprognostic (1.87e-1)" "unprognostic (3.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.57e-1)" "unprognostic (1.32e-2)" "unprognostic (8.55e-3)" 7.0 8.0 7.0 7.4 8.6 2.0 9.6 17.7 8.2 6.1 20.3 9.9 3.5 6.9 6.4 7.2 9.7 8.6 7.9 7.8 10.8 11.4 9.2 29.3 11.6 9.3 10.0 6.6 7.4 10.0 13.4 10.6 11.9 9.9 15.1 6.8 25.8 6.7 8.6 10.3 6.1 7.9 7.0 8.4 9.6 6.2 12.8 9.6 2.9 16.8 8.7 13.0 7.3 5.5 8.0 11.9 6.2 7.8 11.0 20.5 15.0 11.5 35.6 17.1 17.9 14.9 5.3 8.1 33.6 3.8 26.0 12.4 4.6 8.9 7.8 20.0 55.9 14.5 5.7 7.5 12.8 11.9 3.8 8.0 10.4 8.3 15.6 8.6 36.0 15.7 6.3 12.0 33.3 23.9 3.5 1.5 6.9 6.3 1.6 5.9 4.9 9.0 8.6 43.0 4.5 16.5 11.9 7.4 2.0 30.3 10.8 4.2 4.9 30.0 10.2 6.5 9.8 15.7 29.3 12.8 7.1 16.7 2.8 12.9 0.0 0.0 0.0 0.1 0.0 0.3 0.7 0.3 0.4 0.0 1.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 7.0 8.6 17.7 8.2 7.8 10.8 9.3 10.0 6.6 9.9 8.4 9.6 8.0 9.5 25.6 128.9 50.6 12.6 4.8 4.2 2.3 4.6 15.9 7.0 3.4 6.8 0.0 7.3 5.5 31.3 4.8 5.5 5.4 0.0 4.8 5.9 11.5 8.1 9.6 0.0 0.0 57.7 2.6 4.9 4.9 5.1 10.3 1.3 3.9 12.5 8.8 2.0 6.7 60.7 4.0 2.0 3.2 2.5 4.8 9.6 2.2 21.4 32.8 0.6 5.6 3.1 55.3 21.4 3.9 1.6 9.8 11.3 9.4 5.6 2.3 6.7 15.7 0.0 4.8 5.7 9.0 16.2 2.3 6.1 5.6 7.0 10.3 3.3 5.5 LRP2BP DKFZp761O0113 ENSG00000109771 "LRP2 binding protein" Q9P2M1 4 185363872-185395924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5;retina: 29.2" "Cell type enhanced" "Detected in many" "Astrocytes: 57.5;Cone photoreceptor cells: 33.3;Early spermatids: 62.1;Inhibitory neurons: 34.2;Late spermatids: 42.3;Oligodendrocyte precursor cells: 40.2;Oligodendrocytes: 34.9;Rod photoreceptor cells: 34.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036664, HPA036665" Approved NA NA "HPA036664: AB_10672361, HPA036665: AB_10673660" "unprognostic (2.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-3)" "unprognostic (3.15e-5)" "unprognostic (2.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (9.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.84e-2)" "unprognostic (4.35e-4)" "unprognostic (2.17e-2)" "unprognostic (9.76e-3)" "unprognostic (2.15e-1)" "unprognostic (5.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.54e-4)" 1.4 2.1 11.1 0.7 7.6 0.4 1.6 15.8 8.0 2.5 9.0 2.8 0.3 1.9 2.3 1.1 7.0 0.9 3.5 7.1 10.0 3.2 1.6 4.5 0.7 11.1 9.1 5.9 8.6 3.2 0.2 17.5 0.6 8.8 3.7 0.4 29.2 1.5 0.5 3.1 1.5 1.9 0.3 11.3 2.7 1.7 10.8 8.2 0.2 3.5 0.7 0.1 2.1 1.8 11.4 0.5 0.4 0.5 1.1 0.3 0.1 1.0 1.5 0.4 0.0 0.3 0.5 0.5 1.8 0.1 0.1 0.5 0.3 0.3 0.2 0.2 1.7 0.9 0.4 1.5 1.6 0.2 0.3 0.5 0.3 0.2 0.7 0.2 1.5 0.4 1.3 0.6 1.4 0.4 0.1 0.6 1.2 0.6 0.0 0.2 0.3 0.3 0.4 0.4 0.3 1.2 0.8 0.3 0.4 1.0 0.7 0.4 0.1 1.4 0.8 0.6 0.2 0.8 5.3 0.5 0.3 1.3 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.2 0.0 0.5 0.3 0.2 0.1 0.1 0.1 0.5 0.2 0.0 11.1 7.6 15.8 8.0 7.1 10.0 11.1 9.1 5.9 8.8 11.3 8.2 11.4 3.1 9.6 2.6 57.5 3.5 2.4 4.1 1.3 2.8 28.8 3.0 2.4 5.5 0.0 1.8 0.0 33.3 1.2 3.3 1.7 0.0 1.5 62.1 17.6 3.1 3.2 7.8 0.0 28.0 0.9 2.5 2.1 2.6 4.4 0.0 1.9 1.4 0.3 0.5 26.9 34.2 2.4 4.1 1.2 1.4 42.3 2.8 1.9 5.4 3.7 0.8 10.4 0.0 40.2 34.9 1.0 0.2 3.8 2.5 4.3 2.6 1.6 14.1 34.0 0.0 5.4 2.8 8.4 1.9 0.8 3.1 1.6 3.1 2.1 1.0 2.1 UFSP2 "C4orf20, FLJ11200" ENSG00000109775 "UFM1 specific peptidase 2" Q9NUQ7 4 185399537-185425979 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 190.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039985, HPA043298" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039985: AB_10794206, HPA043298: AB_10795037" "unprognostic (8.87e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (3.63e-2)" "unprognostic (3.19e-2)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.07e-8)" "unprognostic (1.92e-1)" "unprognostic (8.12e-2)" "unprognostic (9.36e-3)" "unprognostic (6.70e-3)" 21.4 25.1 21.2 9.6 21.5 5.8 24.5 25.3 24.3 21.8 27.3 17.2 13.1 20.1 28.4 26.1 17.9 15.8 32.4 22.1 23.5 37.6 24.3 17.3 12.0 21.0 21.1 17.7 31.6 19.8 24.0 10.1 14.1 21.1 19.9 15.4 56.9 20.4 19.4 48.9 21.8 12.1 20.4 21.1 14.7 17.7 21.2 22.1 14.4 26.1 40.9 16.2 16.3 10.2 25.5 17.5 11.9 28.8 24.3 25.8 25.6 15.3 20.3 20.5 19.3 19.3 18.4 23.2 17.9 9.0 19.7 14.7 16.1 20.4 32.2 17.4 21.8 12.4 11.8 13.0 23.3 30.2 15.3 12.3 14.7 26.8 16.5 16.7 26.7 35.7 21.9 24.8 34.3 28.2 16.3 22.0 16.4 8.7 11.8 16.7 20.2 11.5 20.4 31.9 11.4 18.6 14.8 11.3 25.6 23.1 17.6 15.4 13.6 27.3 9.5 16.8 7.5 17.2 34.6 14.8 9.5 30.5 11.0 25.3 10.8 12.3 7.6 21.2 10.4 25.7 22.0 21.7 24.1 14.1 15.4 23.2 22.9 0.7 21.5 11.1 19.9 20.6 12.5 21.2 21.5 25.3 24.3 22.1 23.5 21.0 21.1 17.7 21.1 21.1 22.1 25.5 33.8 6.4 23.9 14.7 30.1 22.0 28.7 35.1 33.0 47.6 20.9 25.5 27.0 15.7 31.1 20.2 66.7 26.0 23.4 8.3 111.6 28.3 190.5 16.4 28.9 24.1 19.3 24.0 12.2 33.1 29.7 34.2 20.4 19.2 29.7 21.9 21.8 17.3 27.2 18.5 17.8 18.6 28.5 22.1 18.8 52.9 35.4 18.5 35.6 12.2 17.3 71.8 21.6 23.6 33.2 19.7 14.6 42.2 53.0 15.4 22.2 100.9 23.7 87.9 65.7 31.8 38.9 89.3 56.7 22.6 18.9 41.9 27.1 35.6 14.8 19.6 KLF3 BKLF ENSG00000109787 "Kruppel like factor 3" P57682 4 38664197-38701517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049512, HPA065054" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049512: AB_2680799, HPA065054: AB_2685415" "unprognostic (4.20e-1)" "unprognostic (2.08e-2)" "unprognostic (4.70e-3)" "unprognostic (3.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.02e-2)" "unprognostic (3.20e-2)" "unprognostic (2.33e-1)" "unprognostic (2.57e-2)" "unprognostic (2.15e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" "prognostic favorable (4.36e-4)" "unprognostic (9.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.10e-3)" 28.2 24.1 13.3 22.3 17.6 95.8 20.9 16.6 15.0 25.4 15.8 45.0 38.3 28.3 14.2 56.7 20.3 33.8 14.8 14.9 16.0 16.2 44.5 24.1 16.5 18.7 18.2 9.9 45.0 33.7 31.2 11.4 31.8 18.1 23.6 47.8 16.7 31.5 19.9 14.6 61.6 39.0 26.0 16.4 29.5 46.4 5.3 18.2 13.2 28.4 18.1 19.8 42.6 39.5 21.6 21.1 14.1 51.8 10.6 23.3 34.5 16.8 11.3 32.5 7.4 9.2 13.3 37.3 0.0 15.7 24.4 21.6 22.3 14.9 19.8 11.9 0.3 11.5 20.1 20.7 28.5 23.8 5.0 0.2 31.3 53.3 10.8 20.0 14.0 29.0 7.6 58.0 9.7 12.0 4.7 5.4 8.8 12.2 42.6 10.1 7.2 25.2 22.8 26.4 49.1 14.9 19.4 12.3 9.6 24.4 20.8 6.0 6.9 46.2 24.6 14.4 42.2 12.4 13.7 4.6 0.1 10.2 14.9 10.7 10.8 4.4 17.0 6.3 7.6 4.5 5.3 7.0 5.7 3.4 4.2 9.7 5.6 13.4 3.0 12.5 0.8 8.3 2.4 13.3 17.6 16.6 15.0 14.9 16.0 18.7 18.2 9.9 18.1 16.4 18.2 21.6 108.7 22.4 29.5 20.9 78.6 121.5 150.9 82.2 99.0 42.8 38.5 29.7 16.2 77.2 76.6 31.3 31.3 27.4 137.3 219.5 11.7 88.3 1.1 87.3 70.8 86.7 86.5 239.3 11.6 86.2 21.8 70.0 230.4 168.2 19.7 35.0 65.7 57.2 56.3 35.3 27.9 170.3 91.6 87.9 78.6 4.1 51.9 94.9 49.8 45.0 64.4 46.7 143.2 36.2 47.8 113.6 145.5 48.2 105.2 143.9 124.6 24.3 39.4 38.1 26.3 55.5 42.6 1.1 5.0 191.6 222.5 27.4 84.3 62.4 128.4 308.7 KLHL5 ENSG00000109790 "Kelch like family member 5" Q96PQ7 4 39045039-39126857 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 186.3;Microglial cells: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 323.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013958 Approved NA NA "HPA013958: AB_1852590" "unprognostic (6.02e-2)" "unprognostic (3.94e-1)" "unprognostic (3.92e-1)" "unprognostic (7.54e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-2)" "unprognostic (3.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-1)" "unprognostic (6.04e-2)" "unprognostic (2.87e-2)" "unprognostic (1.42e-2)" "unprognostic (1.05e-2)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" "unprognostic (3.24e-3)" 41.8 22.6 58.3 32.6 56.1 9.1 18.9 50.4 51.4 17.2 35.6 31.8 12.8 19.3 13.6 32.3 9.5 23.3 14.6 53.9 52.5 25.2 42.6 20.4 34.0 59.0 54.8 43.0 18.6 11.4 13.0 7.6 28.3 56.5 36.2 16.2 11.9 10.3 66.7 10.8 6.2 13.3 46.6 60.0 21.1 13.3 11.1 60.2 14.7 21.7 19.1 39.3 35.1 9.6 55.9 56.7 78.2 40.9 30.2 22.9 58.5 59.1 44.2 323.1 36.6 35.4 64.6 40.4 86.4 52.4 45.5 192.7 3.3 50.7 112.3 46.6 8.8 10.1 36.8 71.4 46.5 195.6 10.9 11.9 74.5 61.9 55.5 137.7 134.1 73.7 13.8 28.2 17.0 87.1 23.8 11.5 19.6 12.6 14.3 75.5 20.9 53.7 2.1 31.3 23.0 2.8 29.7 25.0 8.0 21.8 49.0 19.3 22.9 94.2 96.8 65.4 25.5 53.8 19.3 18.7 79.0 78.6 28.3 22.9 5.4 2.2 0.4 0.7 3.2 1.1 5.1 1.4 0.8 2.5 3.7 1.1 0.5 2.3 1.0 1.4 0.9 0.2 0.8 58.3 56.1 50.4 51.4 53.9 52.5 59.0 54.8 43.0 56.5 60.0 60.2 55.9 74.9 16.0 1.1 45.7 38.0 3.7 9.4 22.9 7.4 18.8 16.5 11.2 4.5 17.2 33.7 11.0 4.2 1.0 6.3 0.3 17.6 39.3 2.8 4.0 11.1 43.6 1.2 10.9 46.1 21.0 57.9 12.6 3.1 5.3 2.5 9.5 22.9 35.6 13.3 70.7 186.3 0.4 12.2 25.4 25.8 6.6 8.1 28.6 17.8 190.2 27.5 12.1 7.2 69.9 79.0 24.3 0.1 13.9 43.0 31.5 2.0 21.8 32.7 3.4 0.0 14.2 17.3 9.8 5.6 3.3 3.4 5.7 10.7 32.4 0.7 14.1 FAM149A "DKFZP564J102, MST119, MSTP119" ENSG00000109794 "Family with sequence similarity 149 member A" A5PLN7 4 186104419-186172667 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Microglial cells: 41.2;Muller glia cells: 29.1;Rod photoreceptor cells: 35.5" "Cancer enhanced" "Detected in many" "renal cancer: 9.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 11.1;JURKAT: 8.3;MOLT-4: 8.5;RT4: 9.6;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044019, HPA055004" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA044019: AB_2732513, HPA055004: AB_2682667" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (4.64e-2)" "prognostic favorable (2.67e-6)" "unprognostic (7.08e-2)" "unprognostic (9.12e-2)" "unprognostic (1.41e-3)" "unprognostic (1.06e-1)" "unprognostic (2.52e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.81e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" 11.9 5.1 23.4 1.6 28.1 0.1 6.1 21.0 26.7 7.2 25.4 10.9 5.8 7.5 12.0 11.3 13.8 14.9 7.3 29.7 23.0 36.0 50.8 5.5 1.4 24.1 23.3 22.3 7.5 25.9 9.5 5.7 2.3 26.2 9.6 7.7 26.8 10.0 16.2 10.1 2.3 5.3 7.2 23.2 2.3 14.9 5.2 23.8 2.1 3.4 11.5 1.7 11.2 5.5 23.2 0.0 3.3 2.9 0.1 11.1 4.5 0.1 0.0 0.0 0.3 0.3 0.0 1.9 0.0 1.6 1.5 2.9 0.0 5.3 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.7 0.1 0.2 2.0 0.3 0.2 0.0 1.1 0.0 8.3 0.0 2.5 1.3 1.7 8.5 0.4 5.1 0.0 0.0 0.3 0.0 2.1 1.7 9.6 14.2 3.9 0.1 0.0 4.7 0.9 1.0 0.0 0.9 0.2 1.6 0.0 1.7 0.0 0.1 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.2 0.0 23.4 28.1 21.0 26.7 29.7 23.0 24.1 23.3 22.3 26.2 23.2 23.8 23.2 1.8 0.0 1.5 8.1 0.5 0.5 2.4 0.4 1.2 11.8 0.6 1.0 8.5 22.8 4.4 5.5 45.9 0.7 0.0 1.6 5.9 9.5 15.3 17.4 3.7 1.8 9.5 2.7 8.8 5.4 0.9 5.0 4.1 16.7 0.0 0.4 1.4 13.8 0.2 1.7 12.4 3.7 2.0 1.3 1.8 5.6 3.4 2.6 3.6 41.2 0.0 29.1 0.0 7.5 0.5 5.0 4.0 4.1 2.9 2.3 0.8 8.5 11.1 35.5 6.6 2.5 3.3 1.0 4.7 1.6 0.3 0.8 1.1 0.1 3.3 2.8 NCAPG "CAP-G, FLJ12450, hCAP-G, YCG1" ENSG00000109805 "Non-SMC condensin I complex subunit G" Q9BPX3 4 17810979-17844865 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.0;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.6" "Low region specificity" "Detected in all" HPA039613 Uncertain NA Yes 9500 "HPA039613: AB_10805481" "unprognostic (5.23e-2)" "unprognostic (3.37e-1)" "unprognostic (1.59e-3)" "prognostic unfavorable (8.28e-4)" "unprognostic (4.22e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (1.18e-3)" "unprognostic (1.63e-2)" "unprognostic (6.70e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.44e-2)" "unprognostic (0.00e+0)" "unprognostic (1.94e-2)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" 0.7 0.5 0.2 4.2 0.1 14.0 0.9 0.5 0.1 0.4 0.2 3.1 3.8 0.6 0.0 3.6 0.2 0.9 0.2 0.0 0.5 0.2 0.7 0.6 8.8 0.6 1.1 0.0 0.2 0.2 0.1 0.1 3.0 0.5 0.3 2.5 0.3 0.7 0.0 0.2 3.5 3.3 1.0 0.9 2.1 1.9 5.6 0.3 16.0 0.3 0.1 8.8 1.2 1.0 0.9 45.1 28.3 63.8 42.2 4.0 7.8 23.1 56.8 22.2 55.0 55.8 36.3 26.8 66.8 11.3 16.0 47.6 19.9 54.5 22.1 74.8 30.5 27.0 53.6 37.3 29.8 0.2 38.4 20.3 1.5 1.5 40.7 18.6 8.8 27.9 28.9 53.1 74.1 55.0 13.4 44.1 36.9 32.8 26.1 27.9 42.8 57.4 28.0 16.6 13.9 50.0 29.7 51.2 10.9 15.7 27.2 25.6 21.3 23.2 52.5 23.6 30.0 78.9 23.2 23.3 56.1 21.7 39.1 35.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.4 0.2 0.1 0.5 0.1 0.0 0.5 0.6 1.1 0.0 0.5 0.9 0.3 0.9 0.3 0.0 1.1 0.0 3.3 2.4 0.6 1.9 1.2 0.2 0.6 0.6 0.2 0.0 0.8 0.0 0.0 11.7 1.6 2.9 0.0 0.1 15.8 0.9 1.9 1.7 1.8 59.3 0.2 0.0 26.6 3.8 7.1 2.3 1.3 14.2 2.2 0.5 9.5 0.0 0.4 3.1 2.0 2.6 2.9 9.5 0.6 3.7 1.8 1.0 0.7 0.3 3.1 0.5 0.5 0.2 0.1 0.0 20.4 0.4 0.2 0.0 0.0 0.2 0.0 0.2 4.3 63.7 24.3 11.0 1.1 2.2 3.7 0.7 5.6 1.3 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.8" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 345.5;Hepatocytes: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 509.6;Hep G2: 595.9;U-2197: 375.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm Yes No 1300000 Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 49.0 28.0 7.2 29.8 7.5 2.5 32.4 9.6 10.6 31.7 17.3 97.4 45.7 29.4 10.7 34.4 29.9 40.9 12.7 6.2 13.5 37.8 138.8 19.2 13.4 7.5 7.3 6.0 30.3 34.0 23.3 7.8 38.7 8.1 35.9 74.0 14.5 17.0 14.1 6.8 10.0 41.5 23.7 8.4 11.6 47.8 6.9 8.5 10.4 28.1 9.6 14.6 55.0 17.2 9.9 36.0 509.6 58.4 76.2 181.5 185.3 51.3 102.7 113.8 94.5 84.8 76.2 115.5 25.4 63.0 133.3 94.5 33.5 56.0 29.5 95.8 32.1 13.0 26.2 65.4 595.9 72.7 34.1 25.3 64.4 14.9 160.2 49.8 78.9 59.3 20.9 34.1 17.3 67.9 89.8 29.4 34.4 53.1 194.0 46.4 48.3 95.0 22.0 53.7 120.0 31.2 46.7 69.2 37.9 45.3 41.4 21.0 27.0 85.9 97.9 49.1 375.8 54.2 42.1 33.3 23.3 86.9 25.8 56.6 30.0 20.9 19.7 23.2 18.4 37.8 18.8 18.8 24.9 19.0 18.4 16.1 19.4 3.8 42.3 11.2 22.5 13.5 18.8 7.2 7.5 9.6 10.6 6.2 13.5 7.5 7.3 6.0 8.1 8.4 8.5 9.9 19.1 25.6 27.6 4.6 14.1 116.1 73.4 19.5 43.9 7.5 115.8 62.0 8.9 24.3 25.4 20.2 14.6 21.3 12.9 207.8 70.5 54.7 1.1 78.3 53.8 25.4 113.3 9.1 10.6 345.5 78.8 145.7 184.0 64.8 35.5 11.1 20.7 231.3 17.8 10.1 12.6 114.5 12.2 20.2 33.3 1.6 33.2 12.7 30.2 7.5 19.9 7.3 9.2 46.3 12.8 195.8 112.2 29.0 21.3 127.3 81.4 79.6 65.7 9.2 32.9 39.0 57.5 6.5 5.5 102.2 40.1 29.0 11.7 12.4 152.4 86.4 PPARGC1A "PGC-1alpha, PGC1, PGC1A, PPARGC1" ENSG00000109819 "PPARG coactivator 1 alpha" Q9UBK2 4 23755041-23904089 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Activator, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.9" "Group enriched" "Detected in many" 5 "Excitatory neurons: 1098.2;Inhibitory neurons: 1704.4;Oligodendrocyte precursor cells: 890.2" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "A-431: 88.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063136 Supported Nucleoplasm NA NA Nucleoplasm "HPA063136: AB_2684948" "unprognostic (1.08e-1)" "unprognostic (7.47e-2)" "unprognostic (6.85e-3)" "unprognostic (2.28e-6)" "unprognostic (5.00e-2)" "unprognostic (1.15e-1)" "prognostic favorable (3.35e-6)" "unprognostic (3.04e-1)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (6.77e-2)" "unprognostic (4.58e-2)" "prognostic favorable (1.49e-14)" "unprognostic (3.62e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.07e-3)" 2.2 2.9 3.9 0.7 2.7 0.0 1.6 8.2 12.8 3.3 27.4 7.5 7.6 0.9 1.5 3.3 1.5 2.6 29.9 3.1 9.0 29.3 44.9 3.2 0.2 3.6 3.8 1.1 1.2 3.9 38.8 4.9 0.1 2.5 3.3 9.2 4.2 29.6 3.0 29.8 7.4 6.7 2.0 2.4 0.8 4.3 4.5 6.7 2.4 17.8 37.6 0.4 1.1 1.0 3.8 88.6 0.0 1.6 0.0 2.6 0.0 0.0 0.0 1.9 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.8 0.0 4.5 10.7 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.7 0.0 12.3 0.1 4.0 0.2 2.8 0.0 3.5 4.2 0.5 1.4 0.0 0.7 0.7 0.0 1.6 8.1 0.1 0.1 1.6 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.7 8.2 12.8 3.1 9.0 3.6 3.8 1.1 2.5 2.4 6.7 3.8 2.5 19.2 2.6 240.6 0.9 0.9 4.1 7.4 1.2 7.0 2.7 1.5 90.9 47.1 6.3 36.8 39.6 0.0 0.0 36.0 52.8 12.0 78.3 7.2 1.3 0.8 26.7 0.0 1098.2 0.0 0.0 2.4 4.1 9.7 1.3 0.2 1.1 88.8 0.0 0.0 1704.4 17.0 38.7 2.5 0.3 69.7 0.9 0.6 7.2 24.4 0.1 6.4 0.0 890.2 28.8 0.6 7.3 2.2 1.8 1.4 32.0 26.8 4.8 1.9 0.0 37.1 5.1 0.8 0.6 2.6 1.1 0.0 1.0 1.9 21.9 1.5 DDX25 GRTH ENSG00000109832 "DEAD-box helicase 25" Q9UHL0 11 125903348-125943702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport" "Developmental protein, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 92.2" "Group enriched" "Detected in some" 4 "Early spermatids: 332.1;Spermatocytes: 266.3" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020137 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020137: AB_1847552" "unprognostic (5.78e-3)" "unprognostic (9.75e-3)" "unprognostic (7.93e-2)" "unprognostic (5.09e-3)" "unprognostic (1.11e-2)" "unprognostic (1.78e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-3)" "unprognostic (6.24e-5)" "unprognostic (2.57e-1)" "unprognostic (2.44e-3)" "unprognostic (3.89e-1)" "unprognostic (3.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.69e-1)" 0.3 2.8 13.0 0.1 16.3 0.3 0.3 12.7 17.1 0.3 4.2 0.3 0.4 0.3 0.2 0.1 0.6 0.1 0.0 13.6 14.9 2.6 0.3 0.2 0.1 10.2 9.9 14.8 0.6 1.4 1.7 15.0 0.2 11.1 0.2 0.2 22.0 0.2 0.4 0.1 1.2 0.1 0.0 6.7 0.3 0.4 92.2 12.7 0.6 4.8 0.1 0.1 0.0 0.2 13.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.5 1.7 0.0 10.8 0.5 0.0 0.4 0.0 0.0 0.0 0.1 8.7 1.9 0.1 0.0 1.7 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 13.0 16.3 12.7 17.1 13.6 14.9 10.2 9.9 14.8 11.1 6.7 12.7 13.9 0.2 0.0 0.5 16.0 0.5 0.1 0.8 0.0 2.2 18.0 0.1 0.8 1.1 0.0 0.0 0.0 16.7 0.1 0.0 0.0 3.9 0.3 332.1 0.2 0.0 1.0 0.0 0.0 18.0 0.2 0.2 0.4 0.0 0.1 0.0 2.3 0.4 0.5 0.1 16.8 23.1 0.0 0.0 0.0 0.3 66.0 3.7 0.4 0.0 1.9 0.0 20.2 0.0 15.6 3.1 0.1 0.0 4.9 0.0 0.5 0.0 2.7 0.0 16.6 0.0 0.2 0.3 266.3 28.6 0.4 0.0 0.0 0.1 4.0 0.0 0.2 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908564-111923722 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 8710.7;skeletal muscle: 7029.4;tongue: 9490.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 2889.5;Cardiomyocytes: 6878.2;Muller glia cells: 1664.3;Proximal tubular cells: 7285.9" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "ASC diff: 2663.1;fHDF/TERT166: 775.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 370000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337" "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.70e-5)" 906.4 107.5 3002.9 114.9 3397.7 0.4 597.2 3214.1 4545.3 368.5 2373.4 510.1 24.8 354.4 180.7 315.0 205.8 72.3 8710.7 2629.7 2902.0 2092.0 37.5 255.7 15.1 3489.8 3097.9 2457.3 137.1 51.1 25.1 210.8 108.7 3406.7 320.7 79.0 482.9 432.2 361.9 7029.4 300.2 159.9 341.2 3406.7 89.2 266.0 23.7 3255.3 21.1 481.7 9490.1 34.7 494.2 481.5 4323.9 0.1 0.5 0.1 45.0 2663.1 90.9 15.0 54.5 2.5 0.8 2.5 1.7 0.2 0.0 41.7 775.8 0.2 2.0 1.8 2.3 1.4 0.3 0.0 0.0 11.9 3.9 16.9 0.4 0.7 77.1 11.1 0.6 6.2 44.3 0.2 0.0 4.6 2.5 169.5 0.1 0.1 1.1 0.5 0.0 1.0 0.2 0.0 0.6 29.8 0.8 0.1 0.4 5.3 9.1 39.8 63.5 4.9 0.0 1.7 310.1 105.0 6.5 4.1 0.5 0.1 0.6 7.1 0.4 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3002.9 3397.7 3214.1 4545.3 2629.7 2902.0 3489.8 3097.9 2457.3 3406.7 3406.7 3255.3 4323.9 38.4 83.3 4.1 96.0 51.3 174.9 2889.5 32.1 72.8 16.2 334.4 696.1 6878.2 84.4 15.2 1338.9 18.8 3.9 6.8 0.4 677.0 320.3 24.7 345.4 265.3 88.4 7.1 0.0 6.7 11.5 7.4 880.6 0.0 1008.4 0.0 16.1 35.7 0.7 5.8 10.1 12.6 2.4 8.2 0.3 85.8 12.6 228.6 67.7 483.8 11.2 3.6 1664.3 0.0 7.5 615.7 12.1 0.0 187.7 1.6 855.4 0.0 7285.9 23.2 59.4 138.1 799.9 1053.3 21.6 1.4 56.5 155.1 33.4 55.4 6.7 1.2 249.0 DBX1 ENSG00000109851 "Developing brain homeobox 1" A6NMT0 11 20156155-20160475 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NTERA-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039802 Uncertain NA NA "HPA039802: AB_10795256" "unprognostic (3.76e-1)" "unprognostic (5.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTATIP2 "CC3, FLJ26963, SDR44U1, TIP30" ENSG00000109854 "HIV-1 Tat interactive protein 2" Q9BUP3 11 20363685-20383782 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Differentiation, Host-virus interaction" "Developmental protein, Oxidoreductase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 269.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 283.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006417, HPA024321" Approved Supported Cytosol NA NA Cytosol "HPA006417: AB_1079091, HPA024321: AB_1851288" "unprognostic (8.05e-3)" "unprognostic (2.13e-1)" "unprognostic (9.31e-2)" "unprognostic (3.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.79e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.20e-3)" "unprognostic (1.05e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.20e-1)" "unprognostic (9.42e-2)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" 28.6 58.0 32.0 32.6 36.5 18.7 29.9 34.4 40.2 19.2 35.1 89.2 137.1 13.9 31.6 50.4 13.7 45.2 19.8 31.0 35.4 32.4 98.6 39.5 28.8 36.0 33.5 28.8 16.4 26.9 28.0 40.2 28.7 36.0 22.6 81.5 1.9 35.3 20.8 46.6 35.8 122.4 14.6 35.1 38.9 76.1 21.6 33.7 20.4 51.8 21.5 27.7 38.0 35.7 47.7 109.6 177.5 3.9 0.2 52.5 39.4 38.7 46.4 45.8 35.3 41.8 103.2 93.8 24.8 93.1 58.3 136.6 149.7 0.0 28.2 33.9 283.9 21.4 30.8 170.1 0.2 125.3 11.3 139.6 57.3 196.0 28.7 44.5 0.0 102.2 0.0 76.8 31.6 66.3 102.0 0.4 7.0 56.5 193.2 87.1 23.2 0.3 89.8 48.1 60.1 47.2 0.5 150.9 59.1 73.6 18.0 123.7 57.0 125.4 25.1 54.8 51.0 1.2 33.5 44.7 0.6 0.4 76.9 111.4 233.4 133.3 171.1 64.3 126.4 73.4 65.9 74.1 69.2 76.9 76.4 63.9 62.7 304.1 64.5 135.2 23.2 140.9 116.7 32.0 36.5 34.4 40.2 31.0 35.4 36.0 33.5 28.8 36.0 35.1 33.7 47.7 49.2 25.6 9.6 3.9 28.0 36.3 60.0 74.2 67.2 1.0 32.9 26.7 11.6 102.9 43.7 47.8 0.0 53.7 16.7 175.6 31.3 91.4 51.1 19.3 6.1 29.5 24.1 28.8 12.9 72.3 118.0 23.8 49.5 34.5 22.9 22.7 33.2 77.5 82.8 3.3 9.1 100.3 105.8 54.0 27.6 59.5 19.9 61.3 44.4 8.4 114.6 9.5 39.1 3.5 40.2 94.7 157.3 9.4 21.4 65.2 269.7 69.0 37.4 1.7 13.1 19.2 28.5 45.5 21.5 87.2 42.1 61.6 33.4 13.2 87.8 62.7 CTSC "DPP1, PALS, PLS" ENSG00000109861 "Cathepsin C" P53634 11 88265069-88359684 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1078.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025364, HPA066610, HPA068434" Enhanced Supported Vesicles "Intracellular and membrane" No No 19000000 Vesicles "CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989" "unprognostic (4.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (1.10e-1)" "unprognostic (3.70e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (9.30e-5)" "unprognostic (1.62e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (3.11e-2)" "unprognostic (3.35e-1)" "prognostic favorable (4.80e-4)" "unprognostic (2.93e-1)" "unprognostic (4.35e-2)" "unprognostic (8.10e-2)" "unprognostic (4.07e-2)" 174.8 61.3 8.4 186.7 9.3 72.3 64.1 10.6 25.1 78.5 15.1 144.5 122.1 44.3 28.7 63.9 54.5 183.6 36.6 8.6 31.4 236.8 82.7 275.0 245.7 11.7 9.8 8.4 22.3 52.6 42.7 39.6 255.4 11.8 26.2 193.3 3.8 132.7 29.1 19.0 29.7 129.8 89.8 12.0 198.9 74.3 23.0 15.7 64.3 43.9 32.2 141.7 177.9 43.6 16.5 80.3 75.9 27.6 69.9 103.7 286.1 218.4 626.5 1078.4 372.8 270.3 194.7 361.3 117.3 278.9 365.2 84.3 133.6 50.4 269.2 341.9 204.7 82.8 144.5 188.0 233.5 140.2 188.9 108.7 419.1 198.8 284.5 697.4 302.1 377.6 122.3 155.3 145.4 54.8 14.8 89.1 295.1 172.2 551.5 244.9 113.6 30.7 227.0 451.3 106.6 8.8 66.8 81.2 114.9 80.6 185.4 27.9 152.7 149.3 23.5 190.5 156.8 364.6 61.9 81.0 122.9 56.8 435.8 122.4 85.5 203.8 309.7 230.1 415.6 194.9 47.2 99.6 198.2 209.9 26.3 49.5 115.3 215.0 200.5 582.9 425.0 162.7 243.3 8.4 9.3 10.6 25.1 8.6 31.4 11.7 9.8 8.4 11.8 12.0 15.7 16.5 78.6 22.4 88.1 0.3 40.8 30.1 7.3 900.7 33.6 1.5 15.9 14.6 4.4 52.9 471.8 40.5 0.0 414.1 330.6 37.9 29.4 29.8 1.6 13.4 135.6 94.8 11.4 29.7 3.0 90.6 159.2 114.4 39.8 21.2 75.3 25.5 26.4 15.8 1100.6 0.0 8.2 19.4 158.7 344.7 200.7 7.9 198.5 391.7 48.0 61.8 185.4 0.5 299.7 13.6 0.4 44.8 72.3 25.6 78.5 8.5 20.2 166.4 93.7 0.8 59.2 4.4 150.8 3.0 11.1 43.3 27.1 227.3 170.6 286.7 44.9 16.1 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363234 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.3" "Cell type enhanced" "Detected in many" "Early spermatids: 383.4;Endometrial ciliated cells: 156.1;Spermatocytes: 336.8;Spermatogonia: 218.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 159.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favorable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 3.9 5.3 15.4 5.7 15.3 13.9 11.3 13.0 33.1 4.4 15.4 8.9 10.8 4.9 11.4 5.5 12.6 3.4 3.5 15.2 14.8 5.1 4.7 2.4 6.6 14.4 13.7 14.3 9.8 4.4 8.2 5.6 5.1 14.8 5.5 10.2 6.2 4.2 4.4 3.1 6.5 9.0 3.5 13.6 4.4 9.4 49.3 14.6 16.0 5.6 3.4 8.9 3.4 3.5 14.1 46.1 50.4 41.6 44.7 7.5 17.6 30.8 29.5 11.1 29.8 28.8 28.2 8.3 49.4 20.2 15.8 42.7 40.2 41.9 18.2 54.3 19.5 58.2 39.4 62.6 74.1 3.8 40.6 15.4 5.7 13.4 26.0 12.5 13.2 23.3 70.1 39.0 15.9 32.1 32.6 79.3 63.1 42.9 31.4 44.1 74.8 152.8 7.4 12.8 15.2 32.2 42.2 44.0 19.5 20.8 23.4 52.8 21.4 11.1 47.8 45.2 91.3 69.4 153.2 159.4 34.8 44.5 2.0 42.7 0.0 0.2 0.4 3.1 1.0 3.7 3.4 3.9 4.2 1.0 4.0 4.5 2.8 0.0 3.7 3.8 2.3 6.7 1.1 15.4 15.3 13.0 33.1 15.2 14.8 14.4 13.7 14.3 14.8 13.6 14.6 14.1 5.1 0.0 1.7 4.9 10.1 22.8 22.9 33.2 13.1 10.3 71.4 73.3 9.2 27.1 20.6 23.9 12.5 45.5 3.4 41.0 19.6 14.1 383.4 156.1 12.5 11.1 21.6 91.3 11.5 12.3 25.1 17.2 31.1 15.3 7.0 30.9 10.0 16.0 22.0 3.3 7.5 40.5 18.3 8.9 8.4 82.4 21.5 5.7 14.2 0.0 4.7 26.6 7.2 1.0 1.2 5.5 12.1 20.7 13.9 10.3 6.2 17.6 101.5 20.6 6.6 11.6 18.3 336.8 218.8 33.2 20.6 16.1 9.1 10.3 71.2 15.5 ZBTB16 "PLZF, ZNF145" ENSG00000109906 "Zinc finger and BTB domain containing 16" Q05516 11 114059711-114256765 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 106.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 134.8;Inhibitory neurons: 125.9;NK-cells: 119.4;Skeletal myocytes: 163.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 23.3;MAIT T-cell: 39.4;naive B-cell: 11.0;NK-cell: 10.9" "Group enriched" "Detected in many" 5 "B-cells: 11.0;NK-cells: 10.9;T-cells: 39.4" "Cell line enhanced" "Detected in some" "ASC diff: 71.5;ASC TERT1: 38.6;HEL: 40.7;HHSteC: 26.6;HSkMC: 26.7;hTCEpi: 30.6;hTERT-HME1: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001499, CAB004540" Uncertain NA NA "CAB004540: AB_2218941, HPA001499: AB_1079640" "unprognostic (2.21e-1)" "unprognostic (2.17e-1)" "unprognostic (7.30e-2)" "unprognostic (1.18e-1)" "unprognostic (2.53e-1)" "unprognostic (3.05e-1)" "unprognostic (1.25e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-4)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.57e-3)" "unprognostic (2.67e-1)" "unprognostic (1.00e-1)" "unprognostic (5.90e-2)" 56.3 21.0 4.7 3.4 12.6 7.7 32.6 10.9 21.2 23.0 14.9 18.4 0.9 29.9 4.1 28.3 31.1 13.2 28.4 10.6 13.9 10.7 14.7 27.3 8.9 20.5 9.9 2.6 51.9 62.2 34.6 6.4 9.7 21.2 15.3 3.4 2.2 13.5 7.1 89.4 28.1 16.5 16.0 5.6 13.3 18.5 4.0 7.8 6.6 29.5 106.8 2.0 29.7 19.9 16.0 0.0 0.0 13.0 0.0 71.5 38.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 40.7 0.0 0.0 26.6 0.9 0.7 26.7 30.6 0.0 25.6 0.0 4.6 5.5 0.1 0.0 0.8 0.0 2.2 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 4.2 1.2 23.3 1.2 39.4 0.4 1.2 3.5 0.1 11.0 1.3 0.6 0.3 10.9 1.2 0.0 0.4 5.7 4.7 12.6 10.9 21.2 10.6 13.9 20.5 9.9 2.6 21.2 5.6 7.8 16.0 95.3 22.4 7.7 59.1 16.3 11.1 81.7 7.7 8.6 32.6 12.6 16.8 35.1 42.9 7.1 9.2 0.0 0.1 51.2 0.7 1.9 1.9 21.1 1.7 41.3 49.5 7.2 18.1 134.8 0.9 0.2 59.8 1.1 3.8 14.5 38.2 65.7 50.9 0.8 0.0 125.9 3.7 8.2 27.0 5.3 27.7 89.8 32.1 7.2 65.6 7.6 20.2 119.4 45.8 43.4 0.3 0.1 92.2 17.7 38.6 28.8 6.6 6.8 1.9 105.2 163.9 75.3 0.4 9.9 1.8 6.8 0.3 27.8 0.2 3.5 9.4 ELP4 "C11orf19, PAXNEB" ENSG00000109911 "Elongator acetyltransferase complex subunit 4" Q96EB1 11 31509755-31790324 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.2" "Cell type enhanced" "Detected in all" "Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038572, HPA038573" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038572: AB_2676090, HPA038573: AB_2676091" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (7.81e-2)" "unprognostic (1.61e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (1.67e-2)" "unprognostic (1.87e-1)" "unprognostic (6.73e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-1)" "unprognostic (5.33e-2)" "unprognostic (1.09e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (8.38e-2)" "unprognostic (3.63e-2)" 7.2 7.3 14.7 7.5 15.9 8.6 6.8 38.2 19.2 7.4 13.6 9.1 4.7 6.9 8.4 9.8 7.4 7.3 10.3 14.5 14.2 10.3 9.6 7.3 9.8 14.5 16.5 13.8 7.5 9.5 8.2 5.4 7.8 21.4 6.8 7.8 12.8 7.0 7.5 8.3 9.7 6.6 7.7 13.8 6.5 6.6 8.4 14.7 15.2 6.6 8.4 8.5 7.8 7.4 18.6 13.2 11.2 12.0 14.4 10.9 14.9 4.6 11.5 12.3 16.7 18.4 10.4 11.5 18.0 9.7 10.3 20.9 23.3 16.5 14.4 18.3 15.1 18.3 5.9 13.2 16.0 11.2 12.6 11.2 14.9 8.7 7.2 19.5 13.2 20.4 22.9 27.4 15.7 10.7 20.3 21.4 14.9 6.9 38.9 13.7 12.8 25.7 12.0 25.6 13.0 13.8 6.4 22.3 13.4 10.0 11.7 25.4 18.2 8.2 15.3 13.5 25.3 15.2 6.1 12.9 22.0 10.8 17.6 13.4 5.9 8.0 8.1 6.7 9.2 8.3 9.1 7.6 7.9 9.3 5.9 8.5 7.4 2.1 7.5 9.5 8.3 10.1 6.6 14.7 15.9 38.2 19.2 14.5 14.2 14.5 16.5 13.8 21.4 13.8 14.7 18.6 13.9 12.8 10.5 153.5 11.4 8.3 11.0 20.2 6.8 4.9 7.7 8.5 7.7 5.7 14.5 7.3 4.2 20.2 11.4 4.3 29.4 9.1 18.0 11.0 14.0 7.5 6.7 4.6 93.6 11.3 15.6 10.5 4.1 8.3 10.8 12.8 3.9 5.5 11.5 15.2 90.2 6.0 12.2 5.7 2.4 3.6 5.0 8.5 3.6 91.8 7.7 16.5 8.2 129.2 123.4 6.1 3.9 6.4 14.3 2.9 4.0 33.1 8.6 6.1 6.6 8.3 12.9 23.5 10.2 9.4 8.2 18.9 11.4 11.6 6.4 6.9 ZPR1 ZNF259 ENSG00000109917 "ZPR1 zinc finger" O75312 11 116773799-116788039 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 228.5;Late spermatids: 418.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022596, HPA030979" Uncertain Approved Vesicles NA NA Vesicles "CAB022596: , HPA030979: AB_2673684" "unprognostic (2.12e-2)" "unprognostic (3.55e-1)" "unprognostic (6.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.01e-4)" "prognostic unfavorable (5.87e-6)" "unprognostic (1.04e-1)" "unprognostic (1.09e-1)" "unprognostic (9.42e-2)" "unprognostic (4.96e-3)" "unprognostic (4.79e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.71e-2)" "unprognostic (6.66e-2)" 19.1 12.4 11.9 14.4 13.0 35.5 16.6 11.1 13.6 13.2 8.7 13.6 10.7 14.1 13.2 16.6 13.6 11.7 13.8 13.8 13.3 13.9 24.7 14.5 15.7 12.7 12.2 11.5 15.3 21.3 9.7 11.9 12.9 12.9 13.4 12.7 5.6 12.4 12.4 28.6 15.1 14.4 15.7 13.9 14.2 16.2 27.5 13.9 14.0 14.2 14.4 18.9 20.5 13.7 13.6 23.3 33.3 19.4 36.9 29.0 30.1 25.7 39.0 30.6 34.4 36.6 84.0 41.1 53.2 67.4 39.1 61.9 31.0 53.9 35.7 48.5 34.7 26.5 112.6 18.1 45.6 57.4 51.4 45.2 28.7 49.3 65.6 105.6 23.0 38.7 33.8 54.4 35.3 50.7 28.9 42.3 64.0 35.5 63.9 49.7 32.9 29.6 58.9 33.1 40.0 25.3 43.7 32.0 42.2 28.1 33.1 28.5 34.9 33.3 44.3 22.0 26.2 55.6 24.6 19.8 64.3 24.2 89.9 43.5 12.7 20.7 16.5 15.9 22.2 18.5 28.1 21.6 20.5 22.5 22.6 21.2 19.3 3.0 24.5 18.5 16.2 23.7 20.3 11.9 13.0 11.1 13.6 13.8 13.3 12.7 12.2 11.5 12.9 13.9 13.9 13.6 23.8 9.6 15.9 0.7 37.0 0.0 66.3 0.0 32.5 8.8 21.6 20.1 11.7 20.0 9.9 20.2 0.0 34.5 36.3 13.6 45.0 45.8 228.5 18.9 20.1 22.0 23.4 14.7 1.1 40.2 58.0 21.3 18.8 24.2 28.0 29.9 13.9 19.9 36.3 5.0 1.4 19.2 0.0 19.5 0.0 418.8 19.0 25.1 0.0 1.9 36.6 7.9 26.8 1.0 2.4 62.5 20.3 12.4 29.4 83.1 42.5 28.8 2.9 6.2 6.6 29.3 23.3 75.2 33.2 30.4 0.0 45.8 34.3 27.1 25.4 84.2 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642607 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 569.2;Proximal tubular cells: 508.1;Spermatocytes: 435.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Approved Mitochondria NA NA 14000 Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 28.5 40.6 14.1 14.2 14.6 12.7 25.5 14.8 15.8 17.9 12.8 32.9 39.2 27.0 19.5 50.7 19.1 12.0 34.7 14.2 15.4 57.9 116.2 20.1 14.8 14.3 14.9 13.7 13.7 22.8 21.3 18.6 10.0 14.1 18.5 33.0 16.4 30.1 12.0 82.5 28.9 37.9 21.6 13.4 19.8 22.8 70.4 15.3 14.7 21.8 47.9 23.1 23.4 26.4 15.2 47.8 51.2 42.9 57.9 49.7 45.8 31.6 50.5 46.1 66.7 62.6 40.9 47.2 65.4 26.8 62.3 71.7 58.5 77.7 66.4 80.9 33.0 73.4 37.5 69.3 82.5 68.2 79.1 36.1 52.1 51.5 44.3 65.8 38.6 61.1 55.1 70.9 38.0 82.9 69.3 61.1 59.5 46.4 92.4 77.0 56.1 65.4 47.0 78.5 60.6 51.0 35.7 69.1 68.8 37.1 40.3 99.2 36.4 51.2 60.9 52.9 102.4 65.8 40.5 49.3 73.2 50.4 67.7 55.7 13.3 33.8 14.1 20.3 37.6 19.6 25.1 17.7 19.2 44.0 19.5 15.1 17.6 3.2 22.2 31.5 28.9 24.0 34.1 14.1 14.6 14.8 15.8 14.2 15.4 14.3 14.9 13.7 14.1 13.4 15.3 15.2 28.4 22.4 35.9 54.9 39.2 47.0 56.0 169.3 44.9 0.0 50.7 41.3 67.8 71.4 84.0 53.3 0.0 82.8 41.2 98.1 181.9 153.3 569.2 48.8 37.5 31.6 79.8 74.6 47.0 109.4 119.1 40.0 46.4 40.1 37.3 29.3 33.2 289.4 164.2 0.0 50.9 97.0 150.5 65.7 40.3 166.5 28.9 67.5 81.8 22.5 103.9 0.0 30.9 58.8 58.6 93.0 69.7 58.3 70.9 84.9 213.3 508.1 79.0 0.0 32.9 30.0 141.3 435.4 104.4 129.8 54.1 127.8 34.5 74.4 165.5 65.2 FNBP4 KIAA1014 ENSG00000109920 "Formin binding protein 4" Q8N3X1 11 47716494-47767443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039485, HPA040029" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA039485: AB_2676536, HPA040029: AB_2676808" "unprognostic (2.49e-2)" "unprognostic (3.95e-1)" "unprognostic (5.50e-2)" "unprognostic (2.78e-1)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.58e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.60e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (6.35e-4)" "prognostic unfavorable (1.91e-8)" "unprognostic (3.54e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-1)" "prognostic favorable (7.23e-5)" 35.9 34.7 6.2 12.2 6.4 19.8 36.9 10.1 7.5 46.0 8.2 33.4 9.0 39.2 9.5 34.1 41.0 8.3 28.1 6.2 6.5 26.0 31.5 39.5 16.0 6.8 6.2 6.2 49.2 39.6 7.5 29.4 9.7 7.7 36.6 8.9 15.0 32.9 8.2 51.5 40.3 43.1 9.1 5.5 51.0 31.8 16.7 6.9 14.1 43.2 7.1 14.3 34.5 40.5 8.2 10.6 8.5 17.7 12.5 10.0 11.6 12.0 12.3 12.7 11.1 12.9 8.4 14.0 23.2 6.0 14.0 9.3 21.2 15.8 10.0 16.4 18.2 24.1 17.5 28.1 14.3 14.1 19.5 16.6 14.2 16.4 9.7 22.0 16.2 13.1 14.1 19.2 19.2 10.7 9.7 30.0 22.6 16.7 9.4 7.8 21.2 16.8 12.9 10.9 12.8 7.9 13.1 18.5 15.2 10.5 13.2 12.3 9.1 14.4 13.1 13.8 19.0 17.3 18.6 13.4 26.1 9.5 11.9 9.1 3.8 2.1 3.4 3.7 1.5 2.9 5.1 2.6 2.6 1.3 5.4 2.7 2.9 2.0 1.8 2.2 5.6 3.9 0.9 6.2 6.4 10.1 7.5 6.2 6.5 6.8 6.2 6.2 7.7 5.5 6.9 8.2 65.0 51.3 71.7 82.6 114.7 70.9 112.5 45.9 112.7 95.1 57.0 49.0 38.2 27.1 63.6 25.8 108.4 48.9 122.0 46.1 5.9 39.9 5.5 94.3 121.9 59.7 36.5 59.1 86.7 37.8 37.4 70.6 89.2 165.4 57.6 95.5 48.2 27.0 28.4 67.3 93.6 46.5 34.6 37.2 58.3 8.0 89.5 59.2 39.2 71.2 62.1 28.1 83.4 100.5 108.3 50.8 39.4 62.1 102.4 120.8 36.6 11.3 60.5 103.2 46.0 70.5 61.6 37.3 28.1 96.0 69.9 82.9 105.7 93.4 42.6 168.0 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101243-121191490 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Astrocytes: 5.2;Cone photoreceptor cells: 4.2;Early spermatids: 5.6;Excitatory neurons: 9.9;Hepatic stellate cells: 8.9;Inhibitory neurons: 7.2;Oligodendrocyte precursor cells: 5.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" NA NA "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.3 0.5 1.5 0.2 1.8 0.2 0.3 0.9 1.6 0.3 1.3 0.4 0.1 0.3 0.6 0.1 0.3 0.3 0.9 1.3 1.9 0.5 0.4 0.4 0.1 1.5 1.2 1.3 0.7 0.3 0.8 1.4 0.2 1.6 0.5 0.1 1.1 0.3 0.5 0.8 0.1 0.2 0.2 0.7 0.3 0.3 0.9 1.4 0.2 0.7 0.4 0.1 0.3 0.2 1.9 0.0 0.0 1.1 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 1.7 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.9 1.6 1.3 1.9 1.5 1.2 1.3 1.6 0.7 1.4 1.9 0.5 3.2 0.5 5.2 0.1 0.0 0.1 0.0 0.0 1.8 0.2 0.3 1.9 1.5 0.6 0.0 4.2 0.0 0.2 0.0 0.0 0.2 5.6 0.6 0.3 0.5 0.0 0.0 9.9 0.4 0.1 0.4 0.0 0.3 0.0 0.6 8.9 0.6 0.1 0.0 7.2 0.0 0.0 0.3 0.0 2.7 0.3 0.2 0.0 1.0 0.2 0.9 0.0 5.0 2.8 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.2 0.7 0.0 1.9 0.4 0.9 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292681-121313410 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 396.9" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 141.0;Hepatocytes: 307.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 28.9 35.7 21.3 12.7 25.1 5.7 57.2 38.6 29.5 20.9 17.8 23.5 48.6 15.2 73.8 40.0 16.6 18.4 22.2 22.2 33.5 49.6 396.9 24.8 13.6 38.3 34.2 19.3 17.1 21.7 49.0 15.7 14.8 42.2 102.3 20.1 29.8 22.6 57.1 7.7 12.5 24.9 16.3 35.7 8.9 21.9 24.5 32.6 13.6 24.1 13.2 19.6 21.7 27.3 47.9 26.5 14.3 184.8 39.5 72.1 59.9 27.8 27.8 53.5 18.2 32.4 83.1 95.9 25.4 89.0 32.3 156.6 100.8 59.2 70.9 18.1 12.5 80.0 34.6 73.4 64.4 57.9 24.8 12.5 51.0 57.4 60.4 60.2 15.6 29.8 22.8 25.0 34.6 89.0 27.4 9.4 29.2 59.8 74.4 39.7 13.2 51.0 21.6 133.6 116.5 51.1 28.8 73.4 14.6 38.0 125.4 62.2 38.6 58.3 19.0 29.7 32.5 14.0 6.4 11.2 33.3 7.0 49.5 33.5 7.8 3.7 1.0 3.5 4.9 5.9 4.4 4.7 4.2 6.5 4.1 6.8 6.7 0.3 5.3 3.6 7.7 5.5 2.6 21.3 25.1 38.6 29.5 22.2 33.5 38.3 34.2 19.3 42.2 35.7 32.6 47.9 10.4 19.2 31.9 23.8 62.6 9.7 49.9 48.9 14.8 26.8 33.7 12.4 20.8 18.6 40.8 20.2 31.3 15.9 47.5 26.4 5.9 24.1 3.0 11.5 8.8 15.7 14.4 18.1 29.6 28.9 16.7 16.3 18.3 19.6 17.7 11.1 141.0 307.1 21.0 23.5 29.4 15.3 59.0 22.1 17.0 1.3 19.3 17.6 19.6 20.6 15.6 38.7 13.4 27.6 34.0 19.3 18.8 17.0 20.9 50.1 24.1 15.8 18.7 28.3 13.1 12.9 14.7 6.7 12.7 36.2 15.5 18.6 56.5 42.8 13.3 54.4 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872643 "CD markers, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 37.4" "Group enriched" "Detected in some" 4 "dendritic cells: 63.8;Plasma cells: 16.0;T-cells: 54.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 9 "cerebellum: 37.4;pons: 12.6" "Immune cell enhanced" "Detected in many" "NK-cell: 54.0" "Group enriched" "Detected in many" 4 "NK-cells: 54.0;T-cells: 33.3" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 12.9" "Region enriched" "Detected in some" 44 "cerebellum: 102.6" "Region enriched" "Detected in all" 7 "cerebellum: 25.7" NA NA 6800000 "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.2 0.3 0.4 2.3 0.6 1.8 0.5 37.4 1.7 0.3 0.9 0.5 0.6 0.8 0.5 0.3 0.3 1.5 0.2 0.3 0.6 0.1 1.0 1.8 8.8 1.1 2.8 0.3 0.3 0.1 0.1 0.1 0.2 12.6 0.3 0.6 0.0 0.7 0.2 0.1 0.3 1.2 0.3 0.5 3.6 0.8 0.3 0.8 4.9 0.2 0.0 3.5 0.9 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 4.6 0.6 13.0 5.6 12.9 0.1 1.5 27.0 3.6 0.2 4.3 33.3 1.2 54.0 10.5 0.2 0.1 6.0 0.4 0.6 37.4 1.7 0.3 0.6 1.1 2.8 0.3 12.6 0.5 0.8 1.6 1.1 0.0 1.1 0.3 0.8 1.5 0.4 0.1 0.0 0.0 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 63.8 0.1 0.0 0.0 1.2 0.4 0.4 0.3 0.0 0.4 0.5 0.0 0.2 1.6 2.0 0.6 1.3 0.0 0.4 0.2 5.9 0.0 0.7 0.0 0.0 8.8 8.1 1.2 0.0 10.3 3.6 0.0 9.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.6 0.3 0.5 0.0 0.9 0.1 54.1 0.0 0.0 0.5 JHY "C11orf63, FLJ23554" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882683-122963862 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favorable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favorable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (7.79e-2)" 6.1 1.8 4.5 2.2 2.8 1.1 3.6 3.5 2.4 3.2 14.5 2.8 1.6 2.1 2.7 1.8 7.5 2.6 1.5 1.9 5.8 7.9 0.4 4.5 2.2 3.6 4.3 1.6 3.3 2.8 5.7 4.9 1.3 3.6 3.6 1.7 1.7 1.5 2.6 0.2 1.9 1.9 2.0 5.0 2.6 2.0 36.0 3.1 3.3 5.1 0.8 2.1 2.6 1.8 3.8 2.8 3.9 2.2 0.1 0.6 0.4 0.7 5.9 6.8 2.5 1.1 0.3 10.3 0.1 1.5 9.1 13.6 2.4 2.7 1.4 1.1 9.5 2.8 0.1 1.8 0.1 0.9 1.7 4.7 2.8 7.4 0.4 0.6 6.3 3.8 4.1 0.0 0.1 2.0 1.8 0.1 0.6 0.3 8.2 3.5 1.0 0.0 1.3 7.0 3.2 5.8 4.2 7.1 3.9 2.6 2.8 4.7 0.6 1.2 7.9 1.0 0.2 4.8 0.1 0.0 0.1 2.1 2.1 5.3 0.5 0.3 0.1 1.3 0.1 1.8 1.1 1.3 1.7 2.4 0.6 0.9 1.0 0.4 2.4 0.1 0.6 0.3 0.5 4.5 2.8 3.5 2.4 1.9 5.8 3.6 4.3 1.6 3.6 5.0 3.1 3.8 4.4 12.8 4.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.3 3.2 0.0 0.0 7.4 5.5 0.0 0.2 2.2 0.0 3.9 5.5 0.0 41.5 3.1 1.1 0.0 0.0 0.0 1.4 0.9 2.2 0.0 8.7 0.0 2.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.0 12.0 19.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 1.8 1.3 0.0 0.0 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134412242 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 195.4" "Cell type enhanced" "Detected in some" "Astrocytes: 27.4;Bipolar cells: 37.0;Excitatory neurons: 37.2;Inhibitory neurons: 30.4;Muller glia cells: 116.2;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 77.8" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 23.1;HMC-1: 25.3;NTERA-2: 22.1;SH-SY5Y: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468, HPA074314" Enhanced Enhanced Vesicles "Secreted in brain" NA NA Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 0.2 4.2 147.5 0.4 129.4 1.0 3.9 112.4 195.4 0.3 38.4 0.7 0.5 1.4 0.2 0.2 0.4 0.3 0.2 184.7 98.8 1.8 5.9 0.6 2.1 132.8 147.9 122.8 0.2 0.4 0.0 4.5 0.1 128.7 2.8 0.1 24.0 1.2 0.4 0.1 0.4 0.6 0.1 132.3 1.4 35.2 0.9 117.4 0.4 6.3 0.2 0.4 0.7 0.3 177.1 0.0 0.0 23.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.9 0.0 0.9 1.2 1.6 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.1 0.1 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.1 22.1 1.1 0.0 0.4 0.0 1.7 0.0 0.1 3.1 8.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 2.3 0.1 0.0 0.1 0.0 0.1 0.2 0.1 5.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 147.5 129.4 112.4 195.4 184.7 98.8 132.8 147.9 122.8 128.7 132.3 117.4 177.1 0.1 0.0 0.0 27.4 0.1 0.0 0.0 0.0 0.0 37.0 1.2 0.8 1.1 2.8 0.0 0.0 4.2 0.0 14.4 0.1 0.0 0.0 1.8 0.1 0.1 0.4 1.8 0.4 37.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 4.7 0.1 23.5 30.4 0.0 0.0 0.3 0.0 3.9 0.0 0.2 0.0 3.7 0.0 116.2 15.5 33.2 77.8 0.0 0.0 0.4 7.5 0.9 0.0 1.9 0.0 8.6 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.1 3.8 0.0 0.0 0.3 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Hydrolase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 2455.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles NA Yes 140000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: AB_2681854" "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favorable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favorable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 460.8 610.7 448.1 547.0 456.7 446.2 453.5 544.4 728.8 329.4 548.1 438.7 511.4 370.3 620.1 558.6 502.8 513.1 767.0 584.2 526.9 858.4 769.5 484.2 690.6 556.5 514.0 410.3 424.9 1248.5 598.6 505.8 491.2 559.5 414.8 530.9 536.2 407.5 443.9 1533.3 207.6 457.3 512.8 512.5 524.5 682.3 398.6 583.9 634.4 426.4 1521.9 886.8 874.3 304.9 685.6 1369.6 2077.3 1370.5 1176.5 1259.4 1337.4 1775.6 2730.9 1550.4 3373.2 2004.8 3151.7 1787.3 2318.5 1614.6 1591.9 2337.3 1835.9 4091.6 1027.2 3323.5 1955.4 605.9 2570.4 881.5 1532.0 347.5 2418.0 1757.1 721.8 1594.5 1045.0 320.7 1753.4 1845.6 321.7 2727.8 1147.0 2704.5 1235.5 2507.0 1761.3 2063.2 3463.3 1874.0 2214.4 962.2 1281.3 1665.1 1008.4 1371.8 1023.9 1980.4 2110.5 763.6 1491.1 1837.1 901.9 1767.0 1621.1 1246.1 1404.5 2402.7 740.6 1985.0 1890.9 1791.1 3316.9 1970.0 517.7 592.3 587.8 1245.4 1159.8 1499.6 1009.2 1441.8 1366.1 656.1 752.2 1367.5 1326.5 201.8 1110.7 1255.0 465.5 1761.7 3439.4 448.1 456.7 544.4 728.8 584.2 526.9 556.5 514.0 410.3 559.5 512.5 583.9 685.6 795.5 192.3 228.2 72.5 576.3 282.3 2455.6 315.3 507.6 206.7 454.5 380.1 396.3 278.8 352.8 130.6 127.2 926.1 740.3 513.1 528.3 589.0 49.8 404.1 380.1 512.8 519.8 551.7 33.4 628.8 1032.6 609.7 366.0 366.5 434.8 633.8 249.9 223.9 810.9 181.7 45.6 511.1 303.2 359.8 1060.8 58.2 222.4 590.6 528.3 35.6 530.9 307.4 639.5 28.1 50.3 513.8 552.1 270.0 573.6 779.5 823.0 1002.2 465.7 278.1 243.3 416.3 893.1 248.9 419.2 590.6 284.6 1512.1 1123.5 430.3 632.0 1171.5 P2RX3 P2X3 ENSG00000109991 "Purinergic receptor P2X 3" P56373 11 57338352-57372396 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.9;liver: 1.7;testis: 5.3" "Group enriched" "Detected in some" 28 "Early spermatids: 34.5;Late spermatids: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA057776 Uncertain NA NA "HPA057776: AB_2683526" "unprognostic (5.44e-2)" "unprognostic (9.43e-2)" "unprognostic (2.84e-1)" "unprognostic (1.33e-3)" "unprognostic (2.24e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-7)" "unprognostic (1.58e-1)" "unprognostic (2.88e-1)" "unprognostic (3.00e-2)" "unprognostic (1.29e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 2.9 0.0 0.1 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.6 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115404-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "granulocytes: 563.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 57.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 57.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 14.3 25.1 20.4 13.0 16.2 3.1 24.4 13.3 18.3 22.6 13.7 38.3 26.7 14.1 25.5 15.1 15.2 31.4 5.5 17.0 40.3 16.9 6.4 31.0 12.3 21.6 20.3 16.8 10.3 20.9 4.4 37.7 10.3 25.1 18.0 43.7 12.0 30.3 19.4 4.4 28.8 36.9 16.1 16.3 8.4 28.4 9.7 37.5 8.0 11.6 12.4 14.8 23.0 12.7 22.4 0.0 0.6 7.6 0.5 7.9 7.4 2.8 1.1 0.6 0.6 0.3 0.4 59.7 0.0 7.2 1.3 10.3 0.4 1.5 13.6 0.0 20.9 0.2 44.1 10.5 1.4 32.1 0.6 19.8 21.8 1.5 1.3 4.4 2.9 39.5 5.8 2.4 7.3 2.4 0.2 0.9 0.7 11.9 0.0 1.5 0.0 26.2 0.3 43.0 0.5 6.7 0.7 1.1 0.4 2.1 17.3 5.4 1.9 1.0 0.2 5.5 0.3 0.0 2.7 2.5 0.0 24.1 0.9 0.4 57.8 7.9 0.9 4.7 5.5 1.1 7.1 5.0 2.7 8.0 3.8 6.3 4.1 0.6 8.1 9.3 4.3 12.7 6.1 20.4 16.2 13.3 18.3 17.0 40.3 21.6 20.3 16.8 25.1 16.3 37.5 22.4 5.0 9.6 28.3 4.6 1.3 17.2 14.6 14.9 4.6 3.8 12.6 8.8 2.6 5.7 33.2 33.1 2.1 7.9 2.0 25.0 9.8 27.8 50.6 11.5 4.8 4.3 15.0 3.4 4.0 28.1 2.5 11.4 17.3 7.6 563.0 3.8 3.9 3.2 35.7 32.0 17.1 22.3 30.5 6.6 7.2 6.0 2.8 6.7 5.4 1.9 3.6 14.3 3.1 8.0 2.6 17.7 16.8 0.4 2.5 6.5 50.6 15.1 59.1 1.4 0.0 9.5 5.7 0.7 4.1 4.8 12.5 1.9 9.4 5.9 23.7 13.6 DNAJC4 "HSPF2, MCG18" ENSG00000110011 "DnaJ heat shock protein family (Hsp40) member C4" Q9NNZ3 11 64230278-64234286 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 242.7" "Cell type enriched" "Detected in all" 5 "Late spermatids: 3342.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011947 Uncertain NA NA "HPA011947: AB_1847803" "unprognostic (8.99e-3)" "unprognostic (2.28e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (2.95e-2)" "unprognostic (1.15e-1)" "unprognostic (5.20e-2)" "unprognostic (8.99e-2)" "unprognostic (1.56e-2)" "unprognostic (7.69e-2)" "unprognostic (5.44e-3)" "unprognostic (1.73e-3)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.47e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (2.69e-1)" 38.6 81.2 47.6 25.2 46.3 43.5 39.1 47.7 51.4 49.8 49.8 53.3 39.3 38.2 36.0 44.4 40.5 24.1 83.7 44.0 46.6 66.7 72.4 38.9 35.3 50.0 46.7 40.1 62.0 99.3 33.6 55.1 16.6 50.1 59.0 23.1 11.4 60.4 23.4 64.7 53.6 54.1 16.3 45.9 71.0 62.8 242.7 51.8 29.3 57.7 49.6 33.6 43.4 40.7 49.8 12.4 11.6 26.9 39.9 32.0 56.0 18.8 17.9 30.2 10.9 15.0 11.6 17.6 14.9 57.6 32.1 6.4 9.7 13.5 16.2 6.3 31.6 15.9 18.5 12.2 31.8 39.0 13.9 42.3 58.4 42.9 17.3 20.2 51.5 26.1 16.4 12.7 76.2 7.1 30.4 5.6 33.2 7.8 29.1 22.3 38.7 7.1 101.1 45.4 8.2 23.4 37.9 18.0 20.2 68.8 25.6 48.8 24.6 24.3 12.6 12.6 19.4 10.2 74.8 32.8 18.6 11.1 17.3 36.8 48.2 57.6 42.7 21.9 52.2 27.7 47.6 21.8 25.6 80.4 49.1 30.9 24.8 31.2 41.6 42.7 129.8 22.4 36.4 47.6 46.3 47.7 51.4 44.0 46.6 50.0 46.7 40.1 50.1 45.9 51.8 49.8 29.8 12.8 30.5 11.4 69.5 43.7 58.2 54.5 95.0 21.1 93.8 119.9 22.3 34.3 37.8 27.6 8.4 80.1 58.1 47.6 160.4 37.6 667.3 22.1 27.3 35.1 81.3 28.2 5.0 38.5 60.2 34.4 45.9 24.9 46.3 41.6 43.2 32.4 53.0 25.2 6.9 74.1 69.2 69.5 63.8 3342.9 62.7 66.0 48.0 4.7 112.4 35.0 55.6 3.0 5.5 28.7 55.6 46.6 96.3 43.4 115.0 101.7 15.1 14.5 19.7 29.0 30.3 28.4 28.8 60.1 51.1 54.5 46.6 61.9 68.9 64.9 SIAE "CSE-C, LSE, MGC87009, YSG2" ENSG00000110013 "Sialic acid acetylesterase" Q9HAT2 11 124633113-124695707 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 105.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 58.0;Cardiomyocytes: 59.5;Distal enterocytes: 102.4;Paneth cells: 53.0;Proximal enterocytes: 51.6;Undifferentiated cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 88.6;ASC TERT1: 91.3;HSkMC: 98.9;OE19: 97.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038052, HPA038053" Approved "Intracellular and membrane" NA NA 2200000 "HPA038052: AB_10671518, HPA038053: AB_10673039" "unprognostic (9.97e-2)" "unprognostic (1.28e-2)" "unprognostic (2.48e-3)" "prognostic favorable (4.66e-5)" "unprognostic (3.30e-2)" "unprognostic (5.20e-2)" "unprognostic (4.90e-2)" "unprognostic (4.32e-2)" "unprognostic (1.18e-1)" "unprognostic (2.26e-1)" "unprognostic (2.45e-1)" "unprognostic (9.19e-2)" "prognostic favorable (4.42e-11)" "unprognostic (7.24e-2)" "unprognostic (3.22e-1)" "unprognostic (4.49e-2)" "unprognostic (1.92e-2)" 18.9 17.5 18.6 11.9 22.4 3.7 16.0 28.5 20.6 13.1 36.0 98.8 34.7 7.2 34.6 13.7 19.5 16.9 40.0 16.8 28.7 62.7 43.8 20.8 5.8 25.8 24.3 16.7 5.7 17.4 45.6 14.5 11.9 26.2 20.6 105.4 6.2 18.5 15.4 27.0 13.1 36.1 10.5 24.6 9.2 19.2 10.4 26.4 3.8 54.5 33.6 6.8 17.0 7.9 28.5 8.9 14.0 8.0 34.6 88.6 91.3 20.9 16.8 24.0 4.3 2.6 10.9 61.4 5.5 24.2 21.5 9.4 17.3 12.8 18.7 4.2 26.0 3.9 8.6 3.7 11.1 41.8 0.7 7.2 98.9 24.9 11.4 17.3 58.5 30.6 11.0 7.1 37.5 14.8 16.5 0.2 0.6 5.0 97.7 28.5 3.2 0.2 8.4 51.4 12.1 2.4 5.1 46.5 18.6 8.0 24.0 36.8 3.2 34.1 23.6 4.3 26.5 4.0 9.4 7.5 0.7 8.3 4.6 9.8 7.6 2.9 0.1 0.4 2.1 0.3 0.5 1.3 0.6 1.9 0.7 1.7 1.1 0.5 0.2 3.7 0.5 0.6 1.8 18.6 22.4 28.5 20.6 16.8 28.7 25.8 24.3 16.7 26.2 24.6 26.4 28.5 4.2 19.2 58.0 11.8 2.4 3.2 6.3 6.7 7.4 6.5 10.1 4.3 59.5 12.8 9.4 36.8 0.0 7.6 0.6 102.4 9.8 15.2 14.0 9.1 9.3 6.9 14.5 5.2 15.0 3.8 8.8 7.5 12.8 14.0 1.3 3.9 8.9 30.0 4.5 5.0 9.1 31.0 4.1 3.5 1.6 12.0 3.1 4.3 3.6 6.5 4.5 1.9 1.0 8.0 6.7 5.2 53.0 1.2 3.9 7.4 51.6 26.2 11.9 1.8 0.0 4.9 7.9 14.8 9.6 12.2 5.3 6.7 2.0 8.9 63.6 7.1 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027439-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Distal enterocytes: 5.6;Enteroendocrine cells: 7.8;granulocytes: 8.2;monocytes: 7.9;Paneth cells: 8.0;Proximal enterocytes: 6.5;Undifferentiated cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 16.3 13.5 17.2 10.3 17.8 10.6 15.4 19.4 19.4 16.1 9.5 22.0 15.5 15.9 6.5 15.0 13.0 7.5 14.0 18.3 16.4 17.0 10.2 12.0 9.4 19.6 18.2 16.4 15.0 12.8 10.8 9.5 7.4 16.8 13.0 8.9 5.9 12.4 11.0 25.9 17.5 17.0 9.0 16.9 10.9 16.5 5.3 17.7 9.5 10.7 15.6 7.5 18.2 15.0 18.4 31.1 22.3 14.7 14.2 17.3 12.4 7.9 10.0 13.6 23.3 21.3 17.6 23.7 30.7 16.7 17.4 29.3 16.8 16.8 15.2 9.8 47.0 14.0 15.8 18.2 30.2 18.3 10.7 24.5 10.6 22.2 24.7 14.5 13.0 14.1 22.6 27.0 19.6 12.5 18.8 29.2 36.8 15.5 12.0 21.9 23.7 8.4 34.0 17.6 6.7 25.6 19.2 25.3 23.0 23.2 9.7 23.4 18.6 27.5 23.5 22.9 24.1 14.7 20.9 38.3 30.3 23.2 14.5 8.4 9.2 13.6 13.6 7.6 16.2 6.2 8.9 7.8 6.8 9.4 8.7 5.6 5.1 2.1 4.3 23.6 6.4 8.3 7.3 17.2 17.8 19.4 19.4 18.3 16.4 19.6 18.2 16.4 16.8 16.9 17.7 18.4 0.3 0.0 3.3 0.0 0.8 1.0 0.1 0.4 4.0 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.4 0.1 5.6 0.0 4.8 0.0 0.1 0.2 0.9 7.8 1.3 0.0 3.1 0.6 0.4 1.1 0.1 8.2 0.4 0.7 0.1 1.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 7.9 0.2 0.0 0.0 0.0 3.9 8.0 0.4 1.1 0.0 6.5 0.6 0.7 0.4 0.0 0.7 1.0 0.0 0.0 1.5 0.4 0.4 1.1 0.2 5.6 0.1 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 119.5" "Cell type enhanced" "Detected in many" "B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" No No "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favorable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 9.5 8.4 8.5 48.7 8.5 10.3 10.3 8.6 11.9 7.9 5.6 14.7 11.0 7.4 12.0 5.2 7.7 15.3 5.4 7.7 9.5 8.7 14.1 33.8 87.8 9.7 9.7 7.4 9.6 8.6 6.5 7.2 5.3 10.7 9.5 19.8 7.1 11.1 7.2 3.8 5.4 26.4 9.8 10.0 44.5 13.1 10.3 9.5 104.3 10.3 5.2 119.5 32.7 6.1 10.5 1.7 2.1 2.0 3.9 7.4 9.3 1.4 50.5 200.7 12.4 22.0 0.4 5.1 149.8 2.0 61.9 9.2 2.0 1.7 137.7 51.4 65.4 0.9 6.8 1.3 1.0 12.8 41.1 329.3 7.2 3.2 170.8 22.0 12.0 80.9 90.0 1.9 285.0 101.5 1.1 144.8 51.6 1.6 2.3 45.8 2.1 2.5 129.2 8.3 71.2 1.0 1.6 2.2 3.2 20.1 2.8 2.7 11.7 79.8 30.8 9.5 199.5 45.9 18.4 18.9 146.5 71.6 36.8 71.6 6.3 74.3 12.2 101.3 41.8 148.9 71.9 102.9 117.6 137.5 46.2 79.6 95.9 14.1 79.2 22.2 124.4 152.1 98.8 8.5 8.5 8.6 11.9 7.7 9.5 9.7 9.7 7.4 10.7 10.0 9.5 10.5 4.1 0.0 6.7 22.9 75.9 9.7 6.6 7.2 3.4 4.1 4.0 4.7 2.3 4.3 2.8 0.0 4.2 2.8 80.7 4.2 3.9 2.5 23.0 2.8 1.9 5.9 6.1 13.3 18.2 5.6 1.3 6.6 13.3 2.3 51.5 5.4 2.5 7.6 44.0 1.7 19.8 3.1 6.1 63.7 154.6 8.7 1.8 81.7 19.6 30.0 52.9 2.8 49.4 11.6 27.3 4.1 5.2 3.8 82.2 3.6 6.9 5.7 4.3 4.4 6.6 3.6 3.8 9.2 4.2 2.6 9.7 2.5 90.3 2.9 5.2 27.6 DTX4 "KIAA0937, RNF155" ENSG00000110042 "Deltex E3 ubiquitin ligase 4" Q9Y2E6 11 59171430-59208588 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.6;Oligodendrocytes: 33.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 63.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 62.8;CACO-2: 34.5;CAPAN-2: 37.7;OE19: 35.4;RT4: 95.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056760, HPA059294" Approved Approved Vesicles NA NA Vesicles "HPA056760: AB_2683228, HPA059294: AB_2683969" "unprognostic (3.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (4.97e-2)" "unprognostic (5.03e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (5.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.57e-3)" 9.8 1.9 20.9 5.6 19.8 9.4 9.6 20.6 18.8 8.0 7.3 17.4 16.5 3.9 1.9 4.7 5.8 4.9 2.9 14.4 18.2 8.5 32.8 18.2 5.4 28.5 22.4 12.2 15.2 7.9 1.0 4.1 14.9 26.2 7.5 17.4 10.5 21.9 3.1 1.4 3.9 14.5 2.6 40.0 6.8 11.7 1.7 23.5 1.5 10.3 1.7 6.5 15.2 3.9 53.2 4.8 5.7 30.5 0.6 8.5 0.5 62.8 0.4 2.7 0.3 0.4 34.5 37.7 11.6 2.1 0.7 1.2 16.5 9.5 11.8 0.1 0.8 0.5 0.1 6.6 11.2 2.4 0.9 2.3 1.4 19.3 0.1 0.5 2.1 0.0 2.1 0.1 1.1 1.4 2.7 0.5 0.1 16.1 35.4 1.5 4.1 27.1 1.3 2.6 95.2 0.0 0.1 24.3 6.4 0.8 7.7 4.9 0.5 0.3 0.1 4.9 0.1 0.0 0.4 0.1 1.1 0.2 2.8 2.6 0.7 0.4 0.4 0.0 0.4 0.0 1.0 0.0 0.0 0.6 1.3 0.0 0.0 1.5 0.0 0.2 2.8 0.0 0.1 20.9 19.8 20.6 18.8 14.4 18.2 28.5 22.4 12.2 26.2 40.0 23.5 53.2 8.9 19.2 16.8 9.4 3.1 1.7 3.2 7.9 2.2 2.0 2.9 3.9 1.4 28.6 21.8 7.3 0.0 15.0 6.9 33.6 0.0 10.2 0.4 1.5 8.1 3.6 4.9 0.0 12.0 4.9 19.2 7.2 12.2 3.0 1.3 4.9 5.7 23.1 3.7 0.0 8.4 10.5 2.0 2.5 2.5 0.4 4.1 2.7 5.4 3.7 0.9 30.3 0.0 7.5 33.9 10.8 16.3 3.4 0.0 3.1 19.8 9.1 14.9 2.0 0.0 22.1 3.6 0.4 1.7 1.8 1.3 5.5 1.2 5.9 18.5 22.5 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917211 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 16.3 20.3 9.5 6.6 8.8 60.8 17.1 6.8 33.2 19.0 8.6 18.2 7.6 18.3 1.9 15.9 19.4 4.3 17.2 9.9 7.9 22.0 59.7 24.4 6.2 12.4 11.2 9.1 25.1 22.9 4.9 21.8 4.9 10.9 21.8 2.6 1.9 15.4 5.8 26.9 33.8 21.6 3.3 6.8 25.9 23.4 15.5 8.9 5.5 19.4 4.5 3.3 17.8 15.8 8.6 13.2 12.6 4.4 12.0 5.7 4.0 12.3 7.1 10.3 9.4 6.8 11.0 9.9 9.3 14.7 6.0 12.0 10.8 4.5 8.3 2.5 9.1 15.7 8.7 19.1 10.0 8.4 6.5 18.2 10.9 7.1 11.8 6.3 5.4 7.9 9.5 16.1 7.3 4.1 21.3 7.8 21.9 5.1 3.5 14.3 8.6 7.1 13.5 5.0 10.9 16.5 6.7 10.6 14.6 13.3 3.3 14.3 8.1 10.1 9.0 8.6 18.3 5.3 14.7 5.5 6.5 13.0 5.2 5.6 3.0 2.0 2.2 2.5 2.1 2.1 0.8 1.7 2.2 1.4 0.9 1.3 2.4 16.9 1.8 1.7 2.4 0.9 1.2 9.5 8.8 6.8 33.2 9.9 7.9 12.4 11.2 9.1 10.9 6.8 8.9 8.6 9.8 9.6 16.2 20.2 17.0 28.9 8.7 35.7 16.5 16.6 15.8 10.3 8.1 7.2 17.6 9.2 33.3 12.7 40.1 38.8 1.9 10.2 2.5 12.4 9.2 10.2 35.9 16.2 7.6 10.3 5.3 12.6 16.8 24.4 9.5 15.4 7.9 23.2 10.9 13.5 8.4 17.6 24.4 20.1 19.9 3.6 12.8 24.2 30.2 5.6 11.9 12.3 19.6 6.6 7.1 14.9 21.7 10.1 27.3 12.2 26.8 6.6 13.3 26.0 13.1 11.6 10.6 9.0 6.2 16.3 38.4 66.9 40.2 27.2 19.0 15.9 EHD1 "FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1" ENSG00000110047 "EH domain containing 1" Q9H4M9 11 64851642-64888296 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 152.9;testis: 161.2" "Group enriched" "Detected in all" 10 "Early spermatids: 1033.0;Late spermatids: 1950.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751, HPA067747" Approved Supported "Plasma membrane" NA NA 10000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (6.35e-3)" "unprognostic (2.43e-1)" "unprognostic (1.62e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.81e-5)" "unprognostic (1.46e-3)" "unprognostic (9.10e-3)" "unprognostic (9.44e-2)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (6.37e-2)" "unprognostic (9.88e-2)" "unprognostic (2.74e-1)" "unprognostic (2.59e-2)" 40.0 25.6 20.4 60.2 23.3 152.9 22.0 36.5 28.1 24.4 17.3 30.1 34.1 28.3 8.5 26.2 27.2 25.2 30.6 23.1 24.3 31.2 22.2 45.1 66.1 30.6 26.2 15.5 13.7 11.2 9.0 7.1 35.7 26.8 19.0 14.7 3.1 16.7 21.1 32.3 32.5 38.8 28.5 28.2 75.0 29.5 161.2 26.2 29.1 19.5 31.8 50.7 55.8 23.2 32.2 109.4 74.1 26.2 28.9 31.2 50.2 15.4 108.2 97.4 89.5 51.8 96.5 66.2 142.0 37.8 129.9 76.5 86.6 27.3 108.9 34.5 89.5 15.2 94.8 37.1 49.1 36.8 30.9 24.6 22.8 22.9 138.7 43.2 40.6 89.8 27.6 39.6 243.8 68.7 57.8 62.5 51.4 17.5 27.5 95.9 24.8 83.5 49.9 84.5 35.7 18.6 16.6 60.8 109.3 48.6 29.5 149.2 21.8 127.9 39.6 35.4 106.0 52.6 100.2 48.5 112.1 103.3 40.1 22.0 18.0 13.9 99.6 39.0 16.1 39.2 24.0 27.3 33.8 7.2 18.2 16.2 23.1 57.1 25.4 33.7 8.7 31.8 30.7 20.4 23.3 36.5 28.1 23.1 24.3 30.6 26.2 15.5 26.8 28.2 26.2 32.2 31.2 76.9 30.3 4.2 46.0 67.3 52.8 39.4 17.6 3.8 28.8 24.8 29.2 18.6 22.9 14.7 2.1 88.6 76.5 75.9 7.9 29.4 1033.0 41.9 24.4 29.3 6.6 19.8 1.7 40.8 24.5 32.4 25.5 54.9 93.8 37.2 10.4 10.9 32.2 5.0 3.5 27.7 12.2 37.4 61.0 1950.6 30.1 79.6 26.6 1.9 34.3 5.9 78.2 2.5 12.2 101.5 47.7 27.1 50.8 28.2 38.9 41.9 16.5 2.8 78.9 47.9 53.5 55.0 27.4 19.9 49.2 137.0 71.7 19.8 22.1 42.7 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59615774 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 70000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: AB_2676401, HPA043625: AB_2678587" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favorable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 19.8 42.1 14.4 15.7 15.4 27.4 27.6 15.7 19.0 24.9 18.5 27.1 29.7 20.2 31.9 19.8 22.6 19.6 25.8 14.9 16.1 43.2 58.1 18.7 18.0 15.6 16.1 13.9 22.6 37.7 45.3 16.2 23.1 16.5 26.1 28.6 16.1 30.4 27.3 58.2 26.1 25.8 21.4 14.9 15.7 28.0 18.1 15.8 24.2 32.6 44.2 23.9 19.8 17.2 16.2 40.9 33.6 24.7 33.2 56.5 52.4 26.8 32.9 42.3 38.4 34.4 38.1 40.2 41.1 42.7 37.9 47.2 41.4 45.4 43.5 43.0 40.0 20.9 28.1 25.1 25.8 60.2 36.2 52.9 40.4 52.8 36.2 94.4 40.0 41.7 38.3 48.6 37.3 34.5 19.0 34.0 26.2 28.0 59.5 32.7 32.5 39.8 28.6 45.6 47.0 28.5 20.3 38.6 47.7 46.0 33.6 66.9 22.7 45.8 32.7 22.8 49.5 22.3 51.9 45.2 41.4 37.0 25.6 26.8 1.7 1.6 1.5 2.8 1.4 2.6 2.2 2.9 2.3 1.6 1.6 2.6 2.1 1.5 2.2 1.3 4.0 1.3 1.1 14.4 15.4 15.7 19.0 14.9 16.1 15.6 16.1 13.9 16.5 14.9 15.8 16.2 29.2 25.6 9.0 14.7 18.9 39.6 16.4 13.7 29.6 23.8 38.0 27.1 34.1 32.9 19.0 27.6 22.9 14.2 31.1 34.0 7.9 14.0 8.8 37.9 52.7 21.8 30.0 10.5 25.6 18.6 14.7 21.1 22.4 43.8 27.9 21.8 15.4 67.1 16.0 26.9 22.9 40.0 8.2 12.9 16.9 14.5 15.8 17.9 14.2 12.2 9.6 15.7 18.6 18.1 23.3 20.2 20.5 19.9 32.2 31.2 34.6 21.0 27.8 21.7 6.6 28.4 19.3 25.1 14.5 27.0 47.3 30.8 20.0 43.5 28.4 26.4 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991100-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm No No Nucleoplasm "HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176" "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 17.8 17.8 3.9 20.1 5.4 20.1 15.6 4.4 7.6 16.6 6.0 15.4 22.7 7.8 0.8 20.6 15.8 9.9 7.3 3.9 6.7 16.3 15.5 29.8 29.8 8.0 5.2 2.6 6.2 17.3 2.7 6.8 6.5 6.1 16.5 3.1 0.1 28.1 8.9 3.5 16.4 36.1 3.1 6.8 77.3 20.8 1.7 4.9 3.5 15.0 1.5 7.3 20.8 15.1 12.1 18.9 34.1 2.5 13.8 7.2 2.7 28.2 8.3 7.7 13.0 11.8 2.8 128.9 40.9 30.8 4.0 11.0 44.9 1.0 7.0 0.4 14.1 9.3 4.2 11.1 6.4 11.2 30.0 22.7 6.0 7.6 3.8 1.5 5.0 2.6 6.4 3.0 19.3 2.0 18.7 0.2 23.9 6.2 46.8 16.7 24.5 0.0 368.2 11.8 10.7 3.9 5.5 14.0 95.6 19.3 1.0 35.4 39.0 9.2 8.6 12.2 12.8 0.8 13.2 18.8 7.0 16.0 30.7 10.5 0.1 3.8 6.6 0.1 7.2 0.2 2.5 0.2 0.2 5.1 2.7 0.0 0.0 3.2 2.1 7.7 14.8 0.0 1.2 3.9 5.4 4.4 7.6 3.9 6.7 8.0 5.2 2.6 6.1 6.8 4.9 12.1 12.5 9.6 9.1 4.6 45.3 4.0 21.9 12.5 9.1 0.0 16.4 13.1 1.8 40.0 21.0 16.5 0.0 10.3 63.3 23.2 1.9 36.8 0.8 32.0 5.9 10.0 4.2 3.0 1.1 23.4 47.8 8.0 20.9 17.2 7.0 9.3 10.0 5.4 96.2 5.0 0.1 17.2 14.2 78.3 28.4 0.1 4.4 85.3 23.2 13.1 57.5 4.7 8.2 0.0 0.7 49.7 25.6 4.1 33.8 27.0 31.7 6.9 57.3 0.5 0.0 8.3 9.8 0.2 1.1 12.9 6.5 7.3 10.5 2.1 23.1 37.7 PUS3 FKSG32 ENSG00000110060 "Pseudouridine synthase 3" Q9BZE2 11 125893485-125903221 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038040, HPA063802" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038040: AB_10697092, HPA063802: AB_2685126" "unprognostic (5.89e-2)" "unprognostic (7.24e-2)" "unprognostic (1.29e-1)" "unprognostic (4.37e-3)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (7.67e-2)" "unprognostic (1.77e-1)" "unprognostic (8.92e-3)" "unprognostic (4.47e-3)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.13e-1)" "unprognostic (2.44e-1)" 8.4 8.5 7.6 8.3 8.6 3.3 9.5 9.2 10.4 7.8 7.5 8.0 11.0 7.9 9.8 9.1 7.5 6.5 6.4 8.4 8.8 9.1 33.5 6.2 9.2 8.5 8.3 7.5 7.4 18.0 7.0 8.6 6.8 8.1 8.8 8.0 8.5 7.7 5.5 15.1 9.6 6.8 9.8 7.8 7.7 10.2 7.2 8.6 11.1 9.4 15.3 10.6 10.2 6.3 9.0 6.5 7.9 23.2 24.9 24.3 29.7 11.0 21.1 17.0 11.6 13.2 24.0 23.2 31.4 33.3 9.2 17.1 22.5 37.6 19.7 11.5 28.2 18.2 31.2 9.5 18.6 24.6 20.5 9.2 23.1 23.4 13.7 29.8 16.2 21.0 23.5 34.0 16.1 13.0 4.0 23.7 23.6 19.8 47.0 15.8 4.8 20.5 18.4 20.3 9.5 27.1 25.7 13.1 21.4 11.7 16.5 43.2 13.8 15.3 24.0 10.1 11.9 17.3 12.4 20.1 33.6 6.7 31.9 17.1 14.2 10.5 9.9 13.4 10.8 15.3 13.3 13.1 12.8 9.2 14.8 17.0 16.0 4.2 14.9 14.0 8.0 15.0 8.3 7.6 8.6 9.2 10.4 8.4 8.8 8.5 8.3 7.5 8.1 7.8 8.6 9.0 8.5 9.6 11.5 3.6 9.5 12.9 12.2 10.6 8.0 9.3 7.3 9.4 5.4 11.5 13.6 5.5 29.2 9.7 7.4 3.6 5.9 17.8 7.7 4.4 8.9 10.5 4.8 14.5 2.9 27.2 12.7 6.1 9.2 4.4 12.7 6.1 10.4 33.0 8.2 5.0 3.4 4.6 10.2 5.0 2.9 6.3 7.8 5.5 1.8 1.9 9.9 9.8 6.2 2.5 3.8 15.0 3.9 7.9 6.7 9.1 10.2 16.9 6.2 10.9 6.6 9.9 10.1 7.8 7.2 6.7 11.8 14.0 7.9 12.8 6.5 10.9 DCPS "HINT-5, HINT5, HSL1, HSPC015" ENSG00000110063 "Decapping enzyme, scavenger" Q96C86 11 126304060-126350005 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.1" "Cell type enhanced" "Detected in many" "Plasma cells: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 46.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 79.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039632, HPA058597" Supported Supported Nucleoplasm,Cytosol NA NA 1200000 Nucleoplasm Cytosol "HPA039632: AB_10794200, HPA058597: AB_2683770" "unprognostic (1.45e-1)" "unprognostic (5.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.55e-2)" "unprognostic (5.22e-2)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (5.57e-2)" "unprognostic (1.91e-2)" "unprognostic (4.83e-2)" "unprognostic (5.00e-2)" "unprognostic (5.25e-2)" "unprognostic (2.24e-2)" "unprognostic (8.04e-2)" "unprognostic (7.67e-2)" "unprognostic (3.40e-2)" 8.3 11.4 2.8 7.4 3.8 12.2 8.6 5.1 4.5 10.5 6.9 9.9 4.7 11.1 4.1 11.4 8.7 16.2 9.9 3.9 5.0 12.6 51.1 9.1 12.2 3.4 3.4 2.7 9.3 12.2 3.6 8.2 4.1 4.0 8.2 5.9 6.4 12.1 5.3 14.7 11.2 9.5 5.6 2.5 17.4 8.8 6.2 3.3 8.9 7.6 5.8 9.7 13.4 9.3 3.5 13.9 8.5 10.2 19.8 7.9 11.2 8.9 6.5 10.3 11.5 10.8 17.5 29.1 19.5 28.0 12.2 7.5 16.2 14.4 24.4 5.9 35.8 7.1 27.1 9.9 14.7 18.8 33.3 25.4 12.5 14.0 16.0 17.6 5.9 14.1 17.0 11.6 34.8 11.2 21.6 21.1 41.5 8.0 79.8 28.7 13.7 13.8 40.6 11.4 15.1 16.1 11.0 20.3 21.1 15.8 6.3 33.8 22.1 9.3 18.7 7.3 8.9 13.7 13.4 14.6 20.0 6.0 51.0 46.7 4.2 10.5 4.3 9.3 15.2 7.8 13.0 8.5 9.7 16.6 8.6 6.4 6.7 1.3 8.9 15.3 46.6 15.4 8.9 2.8 3.8 5.1 4.5 3.9 5.0 3.4 3.4 2.7 4.0 2.5 3.3 3.5 14.2 12.8 11.2 6.2 31.2 6.9 16.4 38.7 8.0 6.7 12.2 17.1 5.0 47.1 18.8 42.3 0.0 39.9 35.3 6.4 56.7 19.7 8.1 11.1 12.1 12.4 7.3 14.5 5.8 29.2 43.8 15.9 11.2 23.2 17.1 9.8 8.6 31.4 29.2 3.3 6.0 12.0 28.5 14.1 11.7 2.2 17.1 16.8 17.8 2.8 15.3 10.1 22.6 2.5 4.6 17.1 14.9 18.4 101.1 8.7 6.1 15.0 15.7 9.4 19.7 10.8 14.6 14.8 24.9 18.3 8.9 27.1 24.3 16.2 14.4 24.0 KMT5B "CGI-85, SUV420H1" ENSG00000110066 "Lysine methyltransferase 5B" Q4FZB7 11 68154863-68213828 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 128.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063648 Supported Nucleoplasm NA NA Nucleoplasm "HPA063648: AB_2685073" "unprognostic (5.82e-2)" "unprognostic (4.25e-2)" "unprognostic (2.54e-1)" "unprognostic (5.36e-3)" "unprognostic (3.52e-1)" "unprognostic (2.94e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "unprognostic (5.54e-2)" "unprognostic (1.21e-1)" "unprognostic (3.79e-3)" "unprognostic (2.62e-1)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "prognostic favorable (9.30e-4)" 18.7 16.7 16.8 15.8 18.0 28.8 27.8 26.2 17.2 20.4 16.7 22.5 23.1 26.4 19.2 17.3 18.4 15.1 15.2 16.2 15.8 19.4 22.6 18.3 19.4 17.3 16.9 14.3 22.6 23.0 20.8 15.8 22.5 18.5 22.2 21.8 33.7 23.6 16.5 17.1 21.8 22.0 20.9 15.0 17.3 20.9 20.9 16.5 27.2 31.3 16.8 20.6 16.7 17.7 21.9 25.3 18.8 37.6 24.5 8.6 21.4 40.8 17.7 12.3 21.7 12.8 59.7 39.6 20.5 30.2 24.4 21.4 13.0 26.2 20.6 31.6 23.2 15.1 19.4 21.9 24.7 31.0 27.7 25.6 21.3 41.6 26.2 27.3 20.0 21.8 20.3 29.3 23.4 18.7 52.2 19.6 28.9 40.4 50.4 13.9 31.9 29.4 55.4 16.2 24.2 32.7 39.1 27.5 27.4 128.7 20.3 35.1 17.9 23.1 29.2 38.9 22.5 18.4 29.5 13.8 43.0 18.4 17.3 31.8 10.0 3.7 16.5 4.4 5.2 3.1 3.2 4.6 5.4 3.5 3.8 5.3 4.8 10.9 9.6 5.3 5.4 4.1 2.8 16.8 18.0 26.2 17.2 16.2 15.8 17.3 16.9 14.3 18.5 15.0 16.5 21.9 39.8 60.9 61.3 0.0 32.9 0.0 42.3 0.0 50.7 50.0 45.8 34.7 0.0 25.8 25.4 25.8 12.5 27.4 37.6 32.6 21.5 27.9 22.0 42.6 46.3 31.7 25.5 31.4 0.0 32.7 29.6 26.3 37.2 44.3 22.7 40.7 30.0 37.7 17.9 63.9 0.0 26.6 0.0 32.4 0.0 21.0 28.0 27.7 0.0 0.0 38.2 29.6 43.3 0.0 0.0 37.1 25.7 31.6 34.8 43.7 36.4 22.7 32.1 39.6 32.9 44.8 28.6 45.8 58.9 38.0 0.0 51.7 30.7 31.8 25.1 53.6 FOXRED1 H17 ENSG00000110074 "FAD dependent oxidoreductase domain containing 1" Q96CU9 11 126269055-126278131 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039620, HPA046192" Uncertain Supported Mitochondria NA NA Mitochondria "HPA039620: AB_2676602, HPA046192: AB_2679580" "prognostic unfavorable (7.36e-4)" "unprognostic (4.62e-2)" "unprognostic (2.71e-1)" "unprognostic (3.47e-3)" "unprognostic (1.76e-1)" "unprognostic (1.84e-1)" "unprognostic (9.59e-2)" "unprognostic (1.43e-1)" "unprognostic (8.14e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.01e-6)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" 8.0 13.9 13.8 6.0 14.1 12.2 7.7 15.0 16.7 5.7 15.7 12.2 10.5 6.8 6.4 9.3 7.5 5.6 21.4 14.4 13.9 14.8 37.7 5.3 10.5 14.5 13.9 14.5 4.8 7.8 9.8 8.2 7.1 15.1 6.9 13.1 3.8 7.4 6.9 17.9 7.2 8.7 8.0 14.2 11.1 11.0 8.8 14.7 11.6 6.1 29.7 10.7 7.2 6.0 14.9 23.5 26.6 19.5 24.3 14.2 6.8 26.1 11.6 14.9 22.1 22.1 40.0 24.1 38.2 32.3 9.8 28.7 38.5 51.7 31.5 13.8 20.4 14.3 79.7 16.7 48.2 18.8 19.7 16.4 6.3 12.1 14.9 26.5 6.0 24.7 40.2 46.6 20.6 18.7 32.7 23.1 35.3 16.0 61.8 45.2 37.0 34.1 45.2 20.5 11.9 25.0 21.5 23.8 35.7 13.1 12.2 85.9 33.4 9.0 13.1 10.7 23.8 19.4 12.2 19.0 31.9 16.2 66.5 18.7 1.6 10.1 5.9 6.7 13.4 7.0 7.1 5.3 8.9 12.1 6.2 7.4 6.7 2.0 9.9 9.9 16.8 7.6 8.1 13.8 14.1 15.0 16.7 14.4 13.9 14.5 13.9 14.5 15.1 14.2 14.7 14.9 6.1 9.6 11.5 19.6 13.5 3.6 6.2 14.9 8.0 24.8 7.3 7.0 21.7 10.0 10.7 3.7 27.1 27.7 12.2 12.6 7.9 13.6 4.2 7.4 8.7 7.6 13.1 14.9 24.7 13.8 24.1 9.8 17.9 7.8 9.5 17.8 10.0 28.2 20.4 13.5 27.1 12.6 8.2 7.1 5.1 7.2 5.6 8.0 8.8 4.7 7.1 18.6 9.2 14.1 16.1 10.7 5.9 11.3 24.4 4.6 8.9 21.0 6.7 32.2 6.6 8.9 9.6 24.5 24.0 11.0 5.7 21.1 8.9 25.0 14.9 4.8 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 6600 "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 29.0 28.2 23.0 31.4 27.2 53.5 31.4 36.1 24.6 27.0 31.3 33.7 27.6 31.2 23.5 32.9 26.4 31.0 33.2 21.4 31.3 29.5 32.2 28.3 37.2 25.1 24.9 19.5 38.7 22.9 43.2 24.3 35.0 26.4 32.7 33.8 34.1 28.5 26.3 49.2 30.1 31.2 34.8 24.8 33.2 30.2 37.2 24.5 44.8 44.3 49.4 36.9 33.0 26.7 36.3 72.8 83.6 85.0 59.6 44.5 44.9 66.3 62.0 59.7 70.7 64.2 148.3 71.3 83.4 59.4 58.1 74.3 66.6 94.6 70.2 92.3 81.4 40.6 96.1 83.0 49.8 42.6 92.3 82.5 44.8 46.1 72.6 78.0 39.6 65.3 65.4 83.1 59.7 51.1 96.5 92.8 70.8 42.9 142.1 49.5 86.1 116.0 80.9 46.9 103.8 47.8 57.4 88.5 68.8 128.7 70.4 102.4 48.5 65.3 69.1 65.0 74.4 53.4 47.1 71.2 107.0 50.1 40.1 75.1 14.5 9.9 13.2 11.8 13.3 11.4 11.3 12.6 11.7 6.4 12.8 13.7 12.8 14.1 10.1 15.8 13.2 13.2 6.8 23.0 27.2 36.1 24.6 21.4 31.3 25.1 24.9 19.5 26.4 24.8 24.5 36.3 41.5 44.8 37.6 134.8 39.6 33.1 25.4 17.6 25.6 49.8 32.1 24.9 42.3 25.8 33.1 27.6 56.3 19.4 36.6 40.9 15.6 15.4 65.8 33.3 33.1 31.0 30.5 35.6 133.3 16.7 17.0 29.8 36.7 43.1 27.8 31.6 29.6 25.3 17.5 26.9 155.0 29.6 16.2 24.9 27.6 24.8 31.1 29.4 21.4 163.9 22.1 28.6 17.5 186.0 213.6 23.9 36.2 31.6 35.9 37.9 29.4 16.1 25.9 50.2 19.7 29.0 30.2 33.8 31.0 29.2 35.5 32.8 38.6 28.6 26.5 42.2 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723197 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.4;Horizontal cells: 149.7;Inhibitory neurons: 47.8;Late spermatids: 49.7;Muller glia cells: 60.7;Oligodendrocyte precursor cells: 47.3;Peritubular cells: 59.0" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 47.8;SCLC-21H: 22.8;SH-SY5Y: 10.5;U-2 OS: 26.1;U-87 MG: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 1000000 "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 2.7 4.7 56.4 2.0 47.3 0.5 2.6 62.8 66.5 22.6 0.0 12.5 1.0 19.2 1.1 0.4 14.7 2.3 2.7 49.3 18.3 5.7 1.0 1.5 1.0 15.0 18.3 53.5 15.7 3.0 0.1 4.3 0.7 21.8 4.9 0.6 13.2 1.6 2.9 1.1 0.9 2.7 2.4 0.5 1.5 2.4 15.4 24.2 0.8 4.1 0.3 0.4 5.9 7.5 14.2 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.3 0.3 2.5 2.0 0.1 3.3 0.0 0.0 0.3 0.4 6.5 0.0 0.0 0.0 0.0 0.5 1.2 0.0 4.5 0.0 0.0 0.0 0.1 0.0 9.0 3.1 0.0 0.7 0.3 7.6 0.0 0.0 47.8 1.4 1.9 0.0 0.0 22.8 10.5 0.1 0.0 0.0 0.1 0.0 0.0 0.3 1.1 26.1 0.5 0.0 0.0 0.0 0.0 18.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 56.4 47.3 62.8 66.5 49.3 18.3 15.0 18.3 53.5 21.8 0.5 24.2 14.2 0.5 0.0 0.0 13.1 0.0 0.5 0.1 0.0 0.0 72.4 0.2 0.6 3.2 0.0 0.0 1.8 6.2 0.1 0.6 6.3 3.9 0.0 23.6 0.9 23.5 2.5 6.7 2.1 36.0 2.7 0.2 7.3 0.0 0.6 0.0 0.7 2.9 8.6 0.2 149.7 47.8 1.1 0.0 1.2 0.7 49.7 42.6 1.2 0.0 7.5 0.7 60.7 6.2 47.3 26.0 0.4 2.5 59.0 0.0 0.1 5.1 40.9 0.0 21.7 0.0 27.3 4.0 37.5 15.2 0.0 0.1 0.3 0.7 4.9 0.9 0.0 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 580.8;Hofbauer cells: 376.8;Kupffer cells: 1649.6;Langerhans cells: 470.0;Macrophages: 675.9;monocytes: 429.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 406.4;classical monocyte: 1095.3;intermediate monocyte: 345.6;myeloid DC: 638.8;plasmacytoid DC: 454.4" "Group enriched" "Detected in all" 74 "dendritic cells: 638.8;granulocytes: 406.4;monocytes: 1095.3" "Cell line enriched" "Detected in some" 8 "THP-1: 47.9" "HPA011391, HPA076623" Approved Approved Vesicles NA NA Vesicles "HPA011391: AB_10603876, HPA076623: AB_2686809" "unprognostic (1.17e-1)" "prognostic favorable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 73.2 42.7 9.6 58.1 10.4 33.8 40.4 10.3 22.7 28.3 16.3 41.4 28.0 14.4 9.7 25.9 17.0 61.9 22.9 10.1 18.0 11.5 109.5 56.9 110.1 15.4 11.7 8.6 12.5 7.8 8.8 9.9 65.8 12.2 12.5 55.5 1.4 16.1 18.4 5.3 6.8 45.5 53.1 11.4 122.5 24.7 7.9 12.0 32.5 10.1 17.9 48.0 60.5 8.7 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 5.7 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 4.1 0.0 406.4 1095.3 8.2 1.6 345.6 3.4 9.6 2.2 1.4 638.8 1.5 1.0 1.0 72.8 2.1 24.4 454.4 1.9 752.8 9.6 10.4 10.3 22.7 10.1 18.0 15.4 11.7 8.6 12.2 11.4 12.0 15.6 5.3 6.4 22.9 0.0 16.1 9.3 0.6 0.0 1.2 0.3 2.2 8.0 3.3 17.2 2.5 3.7 0.0 2.0 220.6 0.3 0.0 0.0 2.2 0.4 0.2 12.8 0.0 43.9 0.1 0.0 2.7 4.3 2.6 0.2 13.9 0.1 580.8 20.5 376.8 0.0 0.1 0.1 0.0 1649.6 470.0 5.1 1.5 675.9 14.2 40.3 429.2 0.0 11.3 0.5 0.1 0.0 1.2 0.0 2.0 0.2 0.0 0.5 1.5 0.6 46.0 3.0 4.4 0.5 1.1 2.4 8.0 2.1 10.4 0.1 0.2 0.3 MS4A4A "CD20L1, MS4A4, MS4A7" ENSG00000110079 "Membrane spanning 4-domains A4A" Q96JQ5 11 60185657-60318080 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.7" "Group enriched" "Detected in many" 7 "Hofbauer cells: 376.8;Kupffer cells: 445.0;Macrophages: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 61.2;myeloid DC: 27.6;non-classical monocyte: 82.9;plasmacytoid DC: 27.7" "Group enriched" "Detected in many" 30 "dendritic cells: 27.7;monocytes: 82.9" "Cell line enhanced" "Detected in some" "HEL: 35.6;HMC-1: 45.8;K-562: 154.9" HPA029323 Approved NA NA "HPA029323: AB_10601866" "unprognostic (7.93e-2)" "unprognostic (2.05e-2)" "unprognostic (1.37e-3)" "unprognostic (1.98e-1)" "unprognostic (4.46e-2)" "unprognostic (2.31e-1)" "unprognostic (9.66e-2)" "unprognostic (1.59e-1)" "unprognostic (4.56e-1)" "unprognostic (6.65e-2)" "unprognostic (8.10e-2)" "unprognostic (2.11e-1)" "unprognostic (5.02e-3)" "unprognostic (3.32e-2)" "unprognostic (4.66e-2)" "unprognostic (4.89e-2)" "unprognostic (4.21e-2)" 43.2 25.0 3.5 16.6 3.7 6.2 12.4 3.6 8.6 14.2 5.4 14.1 5.3 5.0 3.5 9.0 11.7 26.1 8.4 3.5 7.6 4.9 15.5 28.2 31.6 4.1 2.8 3.0 4.2 4.1 3.3 3.3 63.7 3.9 3.5 16.2 2.1 7.7 5.0 2.3 2.7 13.6 20.2 2.3 33.6 6.6 3.0 5.0 11.6 3.8 10.5 7.5 28.3 3.3 4.9 0.3 0.1 0.1 0.6 0.0 0.2 0.7 0.6 0.0 0.2 0.4 0.3 0.9 0.8 0.4 0.0 0.4 0.3 0.5 0.1 0.6 1.6 0.0 35.6 0.7 0.6 0.1 1.2 45.8 0.4 0.3 0.2 0.8 0.2 0.0 0.4 154.9 4.2 0.6 0.7 0.6 0.9 0.7 0.3 0.1 0.7 0.0 2.5 0.1 1.5 0.5 0.5 0.3 0.3 0.1 0.7 0.7 8.9 0.8 1.5 0.6 0.4 0.2 6.0 0.7 0.5 0.2 0.8 0.2 0.1 9.9 0.0 0.1 61.2 0.2 1.0 0.1 0.1 27.6 0.3 0.2 0.1 0.9 1.8 82.9 27.7 0.1 6.0 3.5 3.7 3.6 8.6 3.5 7.6 4.1 2.8 3.0 3.9 2.3 5.0 4.9 2.3 0.0 7.9 0.0 3.0 1.8 0.1 0.0 0.6 0.0 0.3 2.2 3.4 2.8 2.5 0.0 0.0 1.8 7.5 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.0 13.0 0.1 0.0 2.0 1.6 0.0 0.0 7.6 0.0 47.5 4.6 376.8 0.0 0.1 0.0 0.0 445.0 24.9 1.0 0.9 264.6 3.6 10.3 8.3 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 13.1 1.2 1.1 0.1 0.2 0.7 1.8 3.6 1.5 0.1 0.0 0.1 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 270.0;Paneth cells: 214.3;Syncytiotrophoblasts: 962.5" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 111.9;neutrophil: 71.8;plasmacytoid DC: 93.7" "Group enriched" "Detected in many" 12 "dendritic cells: 93.7;granulocytes: 111.9" "Cell line enhanced" "Detected in all" "SK-MEL-30: 234.7;WM-115: 515.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049827 Approved "Intracellular and membrane" NA NA 15000 "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 21.2 118.1 28.4 14.5 40.0 19.2 19.7 43.8 34.4 26.2 34.4 58.7 4.2 16.4 88.4 71.3 19.4 24.1 60.6 25.4 29.2 34.4 28.7 38.5 10.0 40.2 42.2 23.2 112.2 13.8 1.7 15.8 35.6 38.6 22.8 67.1 10.9 44.6 16.1 6.1 16.4 12.4 19.2 37.8 41.9 13.4 42.5 35.8 6.4 14.8 7.8 22.9 49.7 34.1 58.1 26.4 21.4 17.0 13.6 46.8 39.4 38.5 30.2 56.6 26.5 18.2 11.4 44.5 7.0 21.9 47.0 88.0 37.1 34.0 19.2 20.0 27.7 9.7 62.8 52.7 13.4 29.9 78.8 126.1 31.5 30.7 39.9 60.9 47.7 34.6 27.5 41.4 18.8 32.2 107.3 25.7 76.5 10.2 166.2 136.6 25.8 50.3 3.3 6.0 74.1 29.5 18.4 32.8 193.5 234.7 10.6 66.3 52.2 13.2 61.7 14.2 44.1 56.2 2.0 4.3 4.0 28.5 118.7 515.8 111.9 5.3 0.7 5.2 8.7 4.8 0.4 1.7 3.3 20.6 0.1 0.6 2.6 71.8 4.7 3.8 93.7 0.3 6.4 28.4 40.0 43.8 34.4 25.4 29.2 40.2 42.2 23.2 38.6 37.8 35.8 58.1 10.3 9.6 0.6 17.0 1.9 10.6 6.6 23.0 0.6 4.0 12.8 6.7 25.9 5.7 23.1 31.3 10.4 115.9 37.5 149.2 49.0 6.1 1.5 3.2 9.8 15.0 5.3 3.4 16.3 6.6 72.3 43.2 2.0 10.2 41.9 270.0 31.8 11.9 17.8 5.0 17.5 115.7 16.2 5.9 14.9 7.2 76.1 11.2 78.2 3.7 9.5 5.4 18.6 5.0 83.3 5.3 214.3 93.6 6.7 16.5 0.0 3.9 5.5 10.0 13.1 4.3 43.1 1.5 17.4 0.7 6.7 962.5 8.4 36.8 23.2 41.1 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 110.0;Hepatocytes: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria NA NA 45000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favorable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 24.2 27.9 15.2 22.5 16.5 39.3 22.9 20.3 16.8 19.6 29.0 68.0 71.3 25.3 7.4 22.2 25.6 28.0 21.9 13.8 20.4 38.7 68.5 25.6 16.1 18.9 20.0 9.9 18.5 23.8 27.8 14.5 18.6 19.8 20.4 45.1 22.8 26.2 22.1 10.0 16.6 71.9 35.2 14.8 27.6 36.0 13.6 20.1 14.1 15.5 14.4 12.4 18.8 18.2 15.4 29.4 50.9 7.3 48.6 31.2 28.0 2.1 22.9 18.8 17.7 3.6 2.0 96.0 0.1 82.2 60.4 62.2 93.5 63.9 13.6 5.3 46.8 6.3 71.5 52.3 24.0 46.4 41.9 82.6 29.2 6.6 35.5 21.4 24.1 63.5 28.2 7.6 56.8 16.5 83.6 34.4 73.7 0.8 149.7 53.2 94.7 1.2 127.1 41.7 71.7 1.0 31.8 63.0 119.9 20.2 4.8 107.4 40.0 64.5 38.3 0.9 77.7 33.5 43.9 60.1 29.2 40.3 30.3 42.8 8.2 6.6 9.5 7.3 7.7 4.2 1.9 4.4 4.4 4.4 2.0 2.7 5.5 3.2 4.9 6.7 10.4 2.8 2.7 15.2 16.5 20.3 16.8 13.8 20.4 18.9 20.0 9.9 19.8 14.8 20.1 15.4 44.4 38.5 28.8 35.6 13.5 9.4 11.0 9.0 28.5 4.8 9.6 7.6 25.5 22.8 18.0 23.9 64.6 15.9 39.3 110.0 19.6 13.8 14.7 33.2 22.6 30.4 16.2 30.9 5.6 9.5 3.9 16.6 31.1 56.7 29.7 23.0 40.7 108.3 15.7 1.7 5.7 48.9 10.2 39.1 11.5 43.9 9.6 24.6 0.0 28.1 31.4 12.7 23.7 7.1 1.7 8.5 43.4 32.0 28.6 9.6 83.4 11.8 23.8 43.0 39.5 18.3 21.1 14.5 10.0 14.8 7.7 7.8 24.0 17.3 67.4 9.2 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641156-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 874.2;WM-115: 1239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB000024: AB_563678, HPA027802: AB_2672390" "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 56.1 29.4 14.3 10.0 12.9 1.5 40.5 14.6 12.1 17.1 30.4 20.0 22.9 14.9 27.9 73.6 31.1 19.7 65.6 10.2 22.3 32.5 108.1 61.6 10.6 17.3 14.6 7.6 4.6 87.1 83.2 25.9 64.2 17.2 53.8 17.3 3.2 30.7 50.8 3.6 121.3 16.1 23.5 16.4 37.6 53.2 3.3 20.7 10.0 45.9 5.3 19.2 29.8 44.3 19.5 467.3 183.0 59.5 1.8 178.3 186.7 127.4 717.5 264.9 82.1 47.6 206.9 349.9 0.1 317.6 375.5 137.2 332.1 6.5 195.2 146.0 1.2 36.5 0.3 46.7 211.7 43.3 3.3 6.7 106.5 37.9 116.0 44.0 192.5 142.1 0.2 0.6 1.3 654.2 197.1 0.4 26.6 109.0 190.7 198.3 1.2 187.9 11.3 379.4 282.8 10.0 231.4 9.2 167.7 458.4 143.5 102.6 9.5 600.4 399.5 111.0 176.1 496.2 874.2 559.4 1.5 341.6 5.9 1239.0 0.2 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 1.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 12.9 14.6 12.1 10.2 22.3 17.3 14.6 7.6 17.2 16.4 20.7 19.5 84.6 182.7 115.6 0.3 8.3 202.5 234.7 499.7 133.1 2.3 163.4 140.0 80.0 92.9 271.6 125.0 2.1 10.9 2.4 44.8 31.3 504.0 0.4 104.2 23.5 141.0 56.5 2.5 0.5 142.6 1.2 67.6 127.4 199.5 29.1 0.0 98.2 165.2 75.0 0.0 2.2 42.6 75.3 18.8 61.9 2.0 4.1 23.6 51.6 17.8 2.4 79.1 0.0 49.8 0.3 622.1 118.0 57.6 0.5 262.0 19.4 57.1 85.9 3.1 131.5 13.0 184.8 0.5 23.4 292.3 351.1 2.5 8.8 3.4 82.2 412.6 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842113-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 380.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 23.2 26.9 11.7 14.5 13.0 10.3 20.9 12.7 14.3 13.0 10.4 14.0 11.5 16.8 3.6 19.6 15.3 7.0 14.3 12.3 12.9 13.1 13.8 11.9 11.7 13.0 12.8 11.2 13.9 24.1 380.6 25.1 11.7 13.1 24.2 5.8 8.3 12.3 8.7 35.0 22.7 12.4 10.5 12.5 12.8 16.6 49.3 12.3 8.9 13.0 13.8 8.6 20.4 14.6 14.0 83.4 110.2 26.5 76.1 21.8 35.7 36.3 54.3 42.4 98.1 52.4 95.0 53.7 98.9 100.7 31.0 69.7 73.3 94.2 65.7 48.2 35.7 101.3 51.0 45.8 133.2 70.7 80.7 82.6 39.5 48.7 90.2 61.8 14.3 75.8 53.5 166.0 46.9 50.3 97.3 125.2 122.6 107.0 48.6 156.3 81.4 39.6 253.5 37.2 33.8 59.9 38.9 34.7 79.5 64.6 17.6 80.8 30.3 45.9 93.6 59.6 131.6 118.2 41.0 66.5 109.2 78.2 86.0 118.6 1.7 13.5 4.2 9.1 29.4 9.7 9.4 9.6 8.3 29.8 9.0 11.5 10.2 1.0 6.9 9.3 16.6 9.7 10.1 11.7 13.0 12.7 14.3 12.3 12.9 13.0 12.8 11.2 13.1 12.5 12.3 14.0 9.3 0.0 2.2 2.0 8.9 37.0 22.2 5.7 28.5 12.1 9.9 10.3 0.6 4.3 4.0 1.8 8.4 17.2 5.7 5.3 7.9 18.6 25.6 6.8 9.4 12.7 7.2 8.8 2.0 12.2 20.4 10.2 9.7 7.7 5.1 7.9 3.6 3.1 18.4 3.3 1.7 5.7 6.1 2.5 16.5 15.0 11.5 7.3 16.0 1.0 5.3 3.9 4.1 1.0 1.3 19.2 3.6 6.0 8.6 24.0 4.4 7.3 1.3 8.3 19.7 10.7 19.1 74.6 18.8 21.2 31.0 8.2 7.0 12.5 11.3 18.8 PRPF19 "hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4" ENSG00000110107 "Pre-mRNA processing factor 19" Q9UMS4 11 60890547-60906585 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012448, HPA038051, HPA059070" Supported Enhanced "Nuclear speckles" NA NA 71000 "Nuclear speckles" "CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896" "unprognostic (5.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.11e-8)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (9.37e-3)" "unprognostic (9.53e-2)" "unprognostic (1.54e-1)" "unprognostic (6.70e-2)" "unprognostic (9.62e-2)" "unprognostic (7.12e-2)" "unprognostic (9.04e-2)" "unprognostic (3.41e-3)" 44.5 71.1 89.7 50.2 96.5 67.5 49.2 82.1 108.2 55.4 67.2 55.1 43.3 55.8 34.5 82.4 57.8 29.7 43.2 96.8 100.0 39.9 77.8 34.9 64.6 99.2 87.0 96.2 67.2 70.0 80.5 79.9 43.2 102.4 62.7 52.3 46.5 57.0 48.6 75.8 80.7 49.9 48.3 80.2 54.7 54.8 30.8 88.1 79.2 43.8 39.3 74.3 59.2 56.4 115.5 197.5 147.0 161.8 116.2 92.7 80.8 155.6 102.4 137.5 200.2 149.0 162.7 141.1 280.5 145.2 98.2 120.2 179.0 229.2 184.6 153.4 207.0 153.4 232.4 111.3 184.9 134.2 308.6 161.1 86.3 137.0 154.4 171.9 58.7 158.7 167.4 248.2 155.3 99.5 270.6 328.9 249.5 292.6 150.5 197.7 285.8 165.5 227.5 101.7 127.5 142.3 172.9 126.6 208.3 178.0 73.1 225.8 170.2 101.9 89.6 147.2 161.8 171.2 147.2 223.3 287.9 111.6 208.6 138.6 4.2 7.8 2.0 2.4 3.8 1.7 0.9 1.8 1.7 3.6 2.4 2.2 2.0 0.5 1.8 2.3 3.9 1.7 1.0 89.7 96.5 82.1 108.2 96.8 100.0 99.2 87.0 96.2 102.4 80.2 88.1 115.5 15.8 19.2 23.7 10.1 26.7 42.1 35.2 40.2 33.0 32.0 24.6 19.4 17.6 20.0 28.6 27.6 10.4 94.7 16.2 20.4 27.4 48.5 21.6 21.4 19.7 27.3 39.0 45.2 19.8 51.6 90.2 24.9 23.4 28.4 22.8 25.4 20.0 46.1 46.3 62.2 22.2 40.0 32.6 23.0 21.6 3.6 37.0 19.3 26.6 11.2 41.2 25.4 21.6 10.1 11.8 33.4 27.7 38.7 31.9 40.4 27.8 27.9 17.8 25.3 46.0 22.4 22.6 25.2 38.0 37.4 41.6 40.6 24.8 24.8 55.1 26.3 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60914158-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (2.68e-4)" 79.9 46.8 20.2 44.8 20.8 27.2 72.5 21.2 25.7 78.3 38.6 64.0 26.5 98.5 26.9 94.5 74.3 36.0 80.8 17.6 30.5 47.6 32.4 72.5 48.4 24.4 22.1 16.6 82.2 46.5 67.9 41.4 47.2 22.4 52.8 27.3 14.5 82.5 61.3 100.3 66.6 48.2 70.6 23.9 58.6 58.7 14.5 24.0 41.8 57.7 77.7 50.7 71.0 80.6 22.5 111.5 103.5 63.3 102.1 169.4 77.7 51.5 107.3 100.4 118.5 99.8 94.5 115.7 131.5 190.4 130.1 69.9 143.5 73.2 48.8 72.5 102.5 97.0 96.2 44.3 21.1 50.2 188.4 77.0 54.1 61.6 92.9 46.8 41.9 148.1 104.8 48.4 330.4 85.4 217.2 139.9 80.8 104.6 62.8 111.4 132.3 123.9 183.0 56.6 63.6 25.3 44.4 86.2 196.8 102.7 44.8 110.4 35.8 143.7 136.9 65.9 174.4 95.8 108.7 89.5 69.9 121.2 82.0 159.7 39.0 76.0 56.4 188.7 69.5 193.3 116.5 108.4 161.4 227.4 140.4 97.4 124.8 8.2 121.1 52.4 470.0 91.1 139.4 20.2 20.8 21.2 25.7 17.6 30.5 24.4 22.1 16.6 22.4 23.9 24.0 22.5 118.2 70.5 23.2 5.5 60.2 50.7 43.8 30.9 63.7 13.4 39.5 45.3 34.6 25.8 23.9 25.8 0.0 120.7 83.4 6.8 25.4 76.6 20.7 18.7 25.9 91.2 7.2 33.0 5.3 80.2 116.4 75.9 10.7 27.9 50.7 22.2 71.0 18.9 66.8 30.3 3.8 10.1 22.4 21.3 69.1 11.1 89.5 43.4 51.6 11.2 45.4 30.2 68.0 3.5 5.1 53.1 14.7 97.4 38.4 36.5 10.6 17.1 18.7 34.8 39.5 45.0 67.6 5.9 7.2 55.1 50.6 53.2 52.7 25.8 16.8 33.9 CCKBR ENSG00000110148 "Cholecystokinin B receptor" P32239 11 6259806-6272127 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 14.3;pancreas: 27.3;stomach 1: 42.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 14.6;Gastric mucus-secreting cells: 14.3;Granulosa cells: 23.3" "Cancer enriched" "Detected in some" 8 "testis cancer: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 73.4" "Low region specificity" "Detected in many" NA NA "unprognostic (2.82e-1)" "unprognostic (4.62e-2)" "unprognostic (1.79e-3)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (6.34e-4)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (9.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (1.30e-2)" 0.0 0.2 8.2 0.0 13.0 0.0 0.0 6.9 14.3 0.0 1.3 0.2 0.3 0.3 0.0 0.0 0.3 0.0 0.0 11.4 5.4 0.0 0.0 0.0 0.0 4.9 3.2 12.7 0.1 27.3 0.0 0.9 0.0 6.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.0 42.3 0.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 73.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.0 6.9 14.3 11.4 5.4 4.9 3.2 12.7 6.0 1.9 3.2 8.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 14.6 1.3 0.0 0.2 14.3 0.1 0.0 23.3 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 HPX ENSG00000110169 Hemopexin P02790 11 6431049-6442617 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 908 "liver: 5485.4" "Cell type enriched" "Detected in some" 38 "Hepatocytes: 6095.8" "Cancer enriched" "Detected in many" 79 "liver cancer: 571.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016725, HPA065318, HPA068847" Approved "Secreted to blood" NA NA 425000000000 190000000000 "CAB016725: , HPA065318: , HPA068847: " "unprognostic (3.39e-2)" "unprognostic (9.26e-2)" "unprognostic (3.88e-1)" "unprognostic (6.19e-4)" "unprognostic (2.05e-2)" "unprognostic (2.41e-1)" "prognostic favorable (2.26e-4)" "unprognostic (6.33e-2)" "unprognostic (5.67e-3)" "unprognostic (3.88e-1)" "unprognostic (5.08e-3)" "unprognostic (2.78e-2)" "unprognostic (5.82e-12)" "unprognostic (2.01e-1)" "unprognostic (4.48e-1)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" 1.1 0.8 0.8 0.1 0.7 0.1 6.0 1.0 1.0 1.6 0.6 1.1 0.4 1.0 0.2 0.5 1.6 0.3 0.9 0.7 0.8 1.4 5485.4 1.2 0.3 0.7 0.7 0.8 1.6 5.6 0.1 1.2 0.3 0.8 2.4 0.6 1.7 1.1 0.6 0.3 1.6 1.1 0.3 0.7 3.9 0.9 1.1 0.8 0.1 0.9 0.0 0.1 1.1 1.2 0.7 0.2 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.3 1.3 0.0 0.8 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.6 0.2 21.3 0.0 3.0 0.0 0.8 0.6 0.1 0.0 0.5 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.0 0.3 0.9 0.0 0.1 1.3 0.2 0.0 0.1 0.2 0.0 1.0 3.0 0.2 0.2 1.1 0.0 0.5 0.3 0.2 1.0 0.1 0.4 0.2 0.9 0.2 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 1.0 1.0 0.7 0.8 0.7 0.7 0.8 0.8 0.7 0.8 0.7 0.5 3.2 0.5 0.3 15.1 0.6 0.2 0.2 0.0 1.5 19.1 7.7 0.7 80.1 0.2 0.0 2.1 0.1 0.1 0.6 0.0 0.1 2.3 0.2 0.3 6.2 0.0 157.7 0.7 0.6 0.1 0.4 0.0 1.2 0.0 1.1 132.8 6095.8 0.2 0.0 0.8 0.7 0.0 155.3 0.2 2.9 0.3 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.7 0.2 0.0 1.0 2.1 0.0 0.4 0.5 0.6 0.5 0.0 0.3 0.0 11.3 0.2 0.5 0.3 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043396: AB_2678460, HPA048233: AB_2680321" "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favorable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 9.0 4.6 3.7 4.6 5.6 1.3 10.4 10.9 7.6 11.0 0.0 12.9 17.9 13.6 1.8 4.8 10.2 4.1 7.9 5.3 4.2 6.3 6.3 9.8 2.4 7.3 3.5 6.0 8.8 6.5 2.7 5.9 4.0 8.6 9.6 4.9 4.9 9.0 5.5 11.6 8.2 15.9 5.6 1.6 5.8 10.2 3.8 6.0 1.6 6.8 4.9 1.6 11.3 9.4 8.1 7.2 12.4 4.9 8.3 8.1 7.8 6.7 10.3 6.1 7.8 8.6 7.6 5.0 3.9 3.6 7.9 9.1 5.0 5.1 7.7 3.0 4.8 7.6 1.2 13.5 5.3 5.2 0.4 4.1 6.7 3.7 6.1 3.2 3.3 8.0 2.9 1.7 4.7 7.8 15.2 0.3 1.0 3.5 15.2 10.7 2.4 4.2 4.9 1.9 3.8 5.1 7.8 5.7 54.9 6.6 2.5 20.8 1.3 13.4 20.3 9.5 15.0 6.9 5.5 3.6 0.8 11.0 1.7 7.6 0.0 1.0 0.6 0.5 1.0 0.4 0.1 0.4 0.4 1.2 0.1 0.1 0.6 0.0 0.6 0.2 0.2 0.5 0.5 3.7 5.6 10.9 7.6 5.3 4.2 7.3 3.5 6.0 8.6 1.6 6.0 8.1 8.5 6.4 0.0 9.8 2.4 4.8 2.8 2.8 3.4 8.8 8.5 6.0 2.2 2.8 2.7 0.0 10.4 1.8 3.5 16.0 0.0 3.1 3.9 2.8 4.4 6.5 4.8 0.4 13.2 3.5 2.2 6.9 5.6 7.3 1.3 3.6 4.6 2.5 4.7 8.4 12.2 11.4 4.1 0.8 6.5 5.6 5.9 3.5 7.2 11.2 3.4 2.2 3.1 5.0 10.2 3.1 5.4 5.3 2.5 3.2 28.7 3.1 8.4 9.6 13.1 5.0 11.3 3.1 6.0 3.7 5.4 0.8 3.4 3.3 6.6 2.3 CHORDC1 "CHP-1, CHP1" ENSG00000110172 "Cysteine and histidine rich domain containing 1" Q9UHD1 11 90200429-90223077 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041040 Approved Approved Cytosol NA NA 160000 Cytosol "HPA041040: AB_10794185" "unprognostic (2.29e-3)" "unprognostic (3.08e-1)" "unprognostic (5.26e-2)" "unprognostic (3.10e-2)" "unprognostic (3.27e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.84e-1)" "unprognostic (1.04e-3)" "unprognostic (5.27e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (4.23e-2)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-1)" 15.6 20.0 26.6 10.6 24.2 10.8 12.1 24.1 68.9 16.0 25.2 13.5 5.5 15.4 8.5 17.6 14.7 7.1 21.7 35.1 26.0 13.0 21.9 18.2 13.5 27.2 27.9 22.0 25.6 13.0 5.1 22.5 12.3 29.8 15.5 7.0 7.8 12.4 7.2 18.2 9.9 12.5 7.0 26.9 16.7 14.3 13.9 31.2 10.7 17.0 13.2 13.8 17.1 17.4 36.2 28.1 74.8 26.0 17.0 24.7 14.9 39.6 34.1 11.6 34.9 29.3 113.9 21.9 49.3 54.0 15.1 60.8 35.0 76.7 17.3 38.7 42.4 37.3 46.6 45.1 55.7 19.0 35.0 29.6 5.5 22.9 29.4 33.8 18.7 26.9 28.5 71.8 19.9 41.5 13.9 32.2 45.9 29.9 96.0 63.3 49.2 15.5 29.3 28.5 12.7 24.8 10.2 37.3 28.8 13.8 29.7 49.0 16.6 24.0 25.4 51.1 35.5 40.6 9.4 80.0 38.9 7.3 49.9 22.1 8.6 8.0 8.9 12.0 13.6 13.1 13.1 13.0 12.7 12.7 11.5 13.6 13.2 2.4 16.5 9.2 9.8 17.9 11.2 26.6 24.2 24.1 68.9 35.1 26.0 27.2 27.9 22.0 29.8 26.9 31.2 36.2 49.4 19.2 27.4 18.6 55.5 70.7 164.8 20.1 32.5 45.1 33.2 31.8 30.7 12.8 29.3 11.0 135.5 41.3 62.1 30.1 11.7 23.8 93.9 112.7 75.0 48.2 68.8 25.7 65.7 16.1 76.5 50.2 20.4 93.9 87.0 34.0 15.7 14.8 39.2 65.6 60.0 32.7 22.4 19.2 109.2 57.1 32.6 61.7 28.4 30.0 30.5 22.9 39.1 46.8 81.5 20.9 28.5 31.2 42.9 97.5 10.7 25.3 48.0 53.7 13.1 32.6 71.0 98.1 47.0 26.5 81.8 50.9 104.9 51.6 37.0 89.6 FOLR1 "FOLR, FRα" ENSG00000110195 "Folate receptor alpha" P15328 11 72189558-72196323 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 396.3;fallopian tube: 188.8;lung: 195.2;salivary gland: 221.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HeLa: 444.2;RPTEC TERT1: 476.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" NA NA 448000 140000 "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.1 1.8 4.3 0.2 1.8 0.1 28.6 12.4 5.7 124.5 396.3 0.5 0.3 1.9 7.6 3.5 188.8 2.4 0.4 14.9 12.1 154.4 0.2 195.2 0.0 4.8 9.0 0.8 0.7 7.2 17.7 8.2 36.5 3.4 1.5 0.4 0.5 221.4 15.4 0.1 2.1 0.4 0.2 3.4 0.2 33.3 0.2 6.8 0.2 46.4 0.0 0.4 0.1 0.1 2.5 0.2 0.2 0.0 0.2 0.0 0.0 64.7 0.1 0.1 0.1 0.1 44.5 46.0 0.0 45.5 0.8 0.0 0.9 2.4 2.1 0.2 0.1 1.4 1.0 444.2 1.3 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.5 0.1 0.1 2.2 0.7 0.0 0.5 15.1 0.0 476.5 0.0 0.1 3.0 1.4 7.1 0.1 38.5 65.7 0.5 0.0 0.0 8.4 0.3 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.8 12.4 5.7 14.9 12.1 4.8 9.0 0.8 3.4 3.4 6.8 2.5 1.0 496.8 213.3 0.0 1.3 0.9 7.9 80.3 0.0 0.0 211.3 62.9 0.2 34.3 276.3 318.2 0.0 462.2 1.1 0.0 133.1 14.3 0.1 33.6 2.3 3.4 1.8 0.0 0.0 1.4 110.9 4.3 9.7 33.7 5.1 0.0 0.0 0.0 29.5 0.0 0.0 0.1 87.5 0.0 0.4 0.0 0.6 3.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 6.3 0.0 366.0 149.1 0.1 0.0 0.1 6.3 0.0 0.5 3.2 0.1 259.0 2.2 0.3 0.3 10.4 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 28.1 44.6 50.4 30.3 50.9 96.8 30.2 50.8 61.6 23.3 48.4 60.2 31.0 43.8 38.6 53.7 30.7 18.5 58.0 50.6 50.8 47.7 44.4 30.3 43.8 50.5 50.1 50.0 22.6 39.6 25.6 33.1 19.3 51.0 52.5 41.0 43.1 40.2 39.2 96.1 39.1 40.4 32.1 49.5 41.6 46.9 72.6 49.7 73.3 45.0 64.9 44.7 42.0 29.8 52.2 74.0 109.4 87.5 55.8 25.5 41.2 41.4 77.1 70.1 121.3 80.2 128.8 78.4 98.8 72.9 110.3 59.0 122.6 133.4 144.0 113.9 64.0 63.3 113.1 124.9 84.5 30.2 110.8 101.3 43.2 56.2 68.9 91.6 45.4 80.7 136.7 83.3 66.6 80.0 127.2 214.5 102.9 70.9 155.3 62.3 89.6 217.4 67.2 106.1 50.5 61.9 53.8 79.0 76.5 127.0 46.8 89.6 58.6 73.4 55.5 72.9 110.5 82.8 68.0 71.5 125.3 34.0 87.8 31.7 29.7 168.5 136.3 73.3 114.2 78.0 94.5 93.4 86.3 148.8 71.4 110.9 101.5 68.4 72.4 107.4 119.1 153.0 124.1 50.4 50.9 50.8 61.6 50.6 50.8 50.5 50.1 50.0 51.0 49.5 49.7 52.2 20.1 16.0 16.5 2.9 36.1 41.8 71.2 83.5 44.3 32.9 43.2 55.6 3.9 12.8 50.6 23.9 27.1 84.7 40.5 82.9 123.3 49.4 15.4 38.8 21.3 22.8 49.6 34.1 7.1 102.7 78.8 18.3 36.7 27.8 30.4 27.2 15.0 44.1 82.8 13.5 7.3 66.2 61.1 48.5 47.5 13.4 6.8 48.0 26.6 1.0 58.8 44.1 36.0 5.5 5.2 53.1 61.4 23.0 47.1 43.8 56.2 123.6 45.6 43.3 19.7 16.0 35.3 115.9 139.9 53.8 41.1 46.7 41.1 32.3 71.5 61.7 FOLR3 "FR-G, FRγ" ENSG00000110203 "Folate receptor gamma" P41439 11 72114869-72139892 "Metabolic proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "bone marrow: 99.6;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 10 "Distal tubular cells: 406.9;monocytes: 103.0" "Cancer enhanced" "Detected in some" "ovarian cancer: 5.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 11 "classical monocyte: 330.8;neutrophil: 492.8" "Group enriched" "Detected in many" 11 "granulocytes: 492.8;monocytes: 330.8" "Group enriched" "Detected in some" 5 "hTERT-HME1: 72.4;U-2197: 64.7" "Secreted to blood" NA NA 12000000 "unprognostic (1.47e-2)" "unprognostic (6.26e-3)" "unprognostic (1.94e-2)" "unprognostic (8.72e-3)" "unprognostic (6.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "unprognostic (3.72e-1)" "unprognostic (1.72e-1)" "unprognostic (1.54e-1)" "unprognostic (7.35e-2)" "unprognostic (7.90e-2)" "unprognostic (8.39e-2)" "unprognostic (9.99e-4)" "unprognostic (1.96e-1)" "unprognostic (2.03e-6)" "unprognostic (4.17e-1)" 5.8 0.4 0.3 10.7 0.4 99.6 0.2 0.2 1.3 0.2 1.3 0.1 0.4 0.0 0.0 1.0 1.0 0.3 0.5 0.2 0.5 5.0 0.8 5.9 0.1 0.3 0.4 0.2 0.0 0.2 0.0 0.1 0.7 0.4 0.2 0.1 0.0 0.6 0.1 0.1 0.5 0.5 0.6 0.3 28.6 0.4 0.9 0.5 1.3 1.7 0.5 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.3 10.4 13.1 3.7 9.2 0.0 0.0 0.0 1.3 2.0 0.2 1.1 0.0 6.9 8.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 8.8 5.4 72.4 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.6 0.3 64.7 0.0 0.1 0.0 0.0 2.7 0.0 0.0 15.1 330.8 30.9 0.5 26.1 1.8 0.3 0.1 0.2 36.2 0.1 0.1 0.0 492.8 0.5 1.4 6.3 0.4 294.4 0.3 0.4 0.2 1.3 0.2 0.5 0.3 0.4 0.2 0.4 0.3 0.5 0.3 0.1 0.0 7.9 0.0 1.1 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 1.9 23.9 0.0 0.1 1.3 0.0 406.9 0.1 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.8 0.0 1.1 0.0 1.6 0.0 0.0 0.0 0.0 22.4 1.7 10.9 0.0 17.4 0.0 0.0 103.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 18.1 1.5 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 1.0 0.1 0.0 0.1 PANX1 "MRS1, PX1, UNQ2529" ENSG00000110218 "Pannexin 1" Q96RD7 11 94128841-94181968 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Oogenesis, Transport" "Calcium channel, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016930 Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA016930: AB_1854954" "unprognostic (1.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.09e-5)" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-3)" 11.5 7.2 3.2 12.2 4.6 4.1 6.5 0.7 5.3 8.0 1.9 7.2 5.5 8.5 5.2 8.0 5.3 11.6 9.8 3.9 5.7 6.9 16.9 10.3 6.4 2.2 2.4 4.3 7.1 7.5 4.5 4.7 9.8 2.3 7.8 7.3 3.1 6.0 7.1 21.0 7.9 5.8 12.9 2.1 5.9 7.5 10.0 3.5 8.2 8.8 10.8 7.1 22.1 6.5 4.6 24.6 10.2 26.2 16.0 23.9 32.3 17.1 29.8 63.0 25.1 30.7 26.2 37.6 7.8 27.3 30.5 46.1 50.5 20.9 49.2 25.2 33.6 10.9 36.0 10.2 13.5 23.1 18.7 31.0 25.7 33.9 32.8 29.2 16.1 21.2 20.1 23.8 27.5 28.3 7.8 31.3 4.4 21.0 19.7 18.2 36.7 35.0 9.7 16.3 24.0 11.0 31.9 20.9 11.9 14.4 13.3 25.2 9.5 15.4 49.5 25.5 16.4 29.9 4.5 18.2 12.6 20.6 19.0 32.2 3.2 4.0 0.3 2.1 2.2 2.4 1.3 1.7 2.3 2.7 1.2 1.6 1.7 0.2 2.6 1.4 0.4 2.9 3.2 3.2 4.6 0.7 5.3 3.9 5.7 2.2 2.4 4.3 2.3 2.1 3.5 4.6 3.8 0.0 8.7 4.6 6.6 102.0 12.3 14.9 13.6 1.3 4.5 2.0 4.7 4.3 4.7 1.8 0.0 12.8 5.3 4.7 0.0 15.7 5.3 9.1 13.0 6.8 2.4 5.2 8.9 18.2 32.4 17.5 7.1 13.9 9.5 4.0 2.2 8.1 20.5 0.0 15.4 4.1 0.0 3.1 21.6 3.9 4.4 11.5 17.8 8.4 3.7 1.1 1.0 9.5 5.8 26.1 3.4 3.8 7.4 10.2 2.6 2.1 6.2 1.1 0.0 16.9 10.6 1.7 8.2 8.3 72.2 23.8 6.6 10.1 4.2 12.7 ARHGEF17 "KIAA0337, p164-RhoGEF, TEM4" ENSG00000110237 "Rho guanine nucleotide exchange factor 17" Q96PE2 11 73308276-73369388 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Endometrial stromal cells: 40.5;Sertoli cells: 85.5;Smooth muscle cells: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007991 Uncertain Approved Cytosol NA NA Cytosol "HPA007991: AB_1845005" "unprognostic (2.36e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.27e-5)" "unprognostic (6.96e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-3)" "unprognostic (1.15e-2)" "unprognostic (2.39e-1)" "unprognostic (1.47e-1)" "unprognostic (7.54e-3)" "unprognostic (7.12e-3)" "unprognostic (6.85e-3)" "unprognostic (3.42e-3)" 29.8 12.3 32.7 9.2 35.5 3.3 24.3 22.8 46.9 33.9 15.5 29.3 5.5 40.2 15.4 10.1 30.8 17.7 31.5 29.6 31.9 25.0 5.5 31.5 6.0 37.0 31.2 29.7 24.4 8.3 19.2 15.4 23.8 37.6 25.6 5.4 7.2 11.8 27.6 11.6 9.3 16.6 22.8 18.5 12.9 20.0 7.1 32.2 3.1 36.3 12.3 2.8 27.1 20.4 31.5 9.6 11.4 24.1 28.4 18.7 15.7 14.8 26.6 38.2 25.9 16.5 30.2 8.2 0.0 18.2 50.7 11.8 14.5 8.1 10.8 10.8 16.9 2.4 0.0 21.0 11.9 21.6 0.8 0.5 27.1 12.2 15.6 9.3 16.9 19.4 1.2 0.9 0.2 14.6 13.7 0.3 17.4 3.2 6.4 2.4 4.0 27.3 0.6 16.5 6.7 15.8 12.1 22.6 26.4 31.3 22.0 43.8 8.2 12.9 12.5 25.5 5.3 8.6 1.6 0.3 0.1 4.4 1.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 32.7 35.5 22.8 46.9 29.6 31.9 37.0 31.2 29.7 37.6 18.5 32.2 31.5 13.9 16.0 16.3 38.5 0.2 3.4 2.4 6.0 5.7 12.6 11.1 12.3 25.5 8.6 7.4 7.3 0.0 7.2 0.1 1.5 0.0 6.4 1.1 10.5 40.5 10.9 1.2 1.3 29.5 0.7 5.3 10.7 2.6 8.9 0.0 13.7 10.8 0.6 2.0 23.5 24.8 0.7 0.0 0.3 4.2 2.0 10.8 1.4 1.8 8.4 1.1 11.1 0.0 10.6 2.0 2.4 0.4 20.3 1.6 4.1 0.0 4.3 5.4 2.3 85.5 5.2 67.5 1.6 8.3 1.1 2.7 6.2 0.6 2.0 1.0 1.5 APOA5 "APOA-V, RAP3" ENSG00000110243 "Apolipoprotein A5" Q6Q788 11 116789367-116792420 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 216 "liver: 586.9" "Cell type enriched" "Detected in some" 88 "Hepatocytes: 1249.5" "Cancer enriched" "Detected in single" 489 "liver cancer: 112.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 55 "Hep G2: 35.6" "Not detected" "Not detected" "Secreted to blood" NA NA 114000000 21000000 "unprognostic (1.57e-4)" "unprognostic (4.67e-3)" "unprognostic (5.57e-2)" "unprognostic (2.60e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 586.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 35.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 10.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.4 1249.5 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823304 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 3138.1" "Cell type enriched" "Detected in some" 44 "Proximal enterocytes: 10311.5" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" NA NA 61200000000 74000000000 Vesicles "CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.1 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 2224.9 1.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 259.4 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 3138.1 3.1 0.0 0.1 4.7 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 3.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 77.5 0.0 0.0 0.0 234.3 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.5 0.0 0.0 0.0 10311.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 87.7 0.0 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "liver: 27875.1" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 84691.9" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 107.3;Hep G2: 296.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 45000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 2.2 1.2 0.0 1.0 0.0 0.0 2.5 0.0 0.1 0.3 0.0 6.0 915.3 0.5 0.0 1.1 1.9 0.0 1.6 0.0 0.0 18.4 27875.1 1.4 0.9 0.0 0.0 0.0 0.8 2.4 0.0 0.8 0.9 0.0 0.6 0.0 0.0 0.6 0.0 0.6 1.0 1115.8 0.5 0.0 8.0 1.5 1.0 0.0 0.5 0.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.0 0.1 107.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 296.2 0.0 10.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 2.3 0.2 0.0 0.0 0.0 6.3 3.9 0.0 0.1 1.1 3.8 4.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.2 0.0 3.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 674.9 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 4.2 0.0 0.0 39.7 0.0 823.7 0.0 0.4 1.5 0.1 0.0 0.0 0.0 0.3 707.9 84691.9 1.1 0.0 0.0 264.5 0.0 1107.4 0.0 12.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 224.0 0.0 0.0 0.0 10473.3 121.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 39.8 0.0 135.5 0.0 CEP164 "KIAA1052, NPHP15" ENSG00000110274 "Centrosomal protein 164" Q9UPV0 11 117314557-117413266 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 454.5;Early spermatids: 241.0;Late spermatids: 291.7;Rod photoreceptor cells: 268.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037605, HPA037606" Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA037605: AB_10672908, HPA037606: AB_10672498" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (7.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.47e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (1.90e-1)" "prognostic favorable (5.93e-4)" "unprognostic (6.54e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (7.93e-2)" 6.6 5.9 8.3 9.8 7.4 7.3 6.9 10.3 7.1 10.1 9.8 6.4 4.3 10.9 8.2 8.7 11.5 8.5 3.8 5.1 7.9 5.2 7.3 6.8 7.7 10.3 8.6 4.5 12.0 26.6 5.6 11.2 4.7 8.8 7.0 5.1 26.2 5.8 5.8 3.1 8.0 6.3 10.4 4.6 8.6 5.8 24.0 7.6 7.8 8.4 1.3 8.6 7.2 7.6 13.8 13.2 18.0 13.0 25.9 12.8 21.7 4.2 25.6 14.3 18.0 17.5 22.4 20.8 25.9 18.1 15.9 17.7 17.1 14.6 15.0 15.3 25.8 12.0 7.8 18.9 7.1 18.9 11.3 16.8 15.2 12.6 27.3 26.5 16.1 23.6 12.6 21.7 16.4 14.4 11.2 10.6 10.2 9.2 8.5 19.4 14.0 15.5 10.1 7.9 11.3 15.1 21.8 20.3 12.2 14.4 14.4 16.9 13.2 25.7 21.3 13.2 20.7 23.8 5.8 7.7 15.2 10.3 12.6 14.5 96.2 34.3 23.4 35.4 30.9 22.9 38.8 44.3 40.4 13.9 41.0 41.4 32.6 82.5 29.6 42.0 49.4 52.6 10.8 8.3 7.4 10.3 7.1 5.1 7.9 10.3 8.6 4.5 8.8 4.6 7.6 13.8 21.0 6.4 13.1 28.1 15.4 7.6 10.3 13.2 10.8 97.7 14.5 23.6 5.8 15.7 10.3 11.0 454.5 4.5 14.3 9.0 1.9 11.1 241.0 26.5 30.3 18.3 15.5 8.0 19.0 14.7 6.8 17.2 17.9 14.7 19.6 17.6 13.2 9.0 12.9 74.0 26.3 10.2 10.2 11.7 11.4 291.7 23.9 14.5 5.4 8.4 21.2 23.4 15.5 21.6 28.7 11.7 5.8 17.0 11.0 9.8 5.4 6.2 31.6 268.7 0.0 30.3 21.4 37.6 17.2 11.4 8.1 2.2 16.4 45.0 11.9 5.6 RNF141 "ZFP26, ZNF230" ENSG00000110315 "Ring finger protein 141" Q8WVD5 11 10511673-10541230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 1045.8;Late spermatids: 666.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 176.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018133 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA018133: AB_1859142" "unprognostic (7.41e-2)" "unprognostic (1.16e-1)" "unprognostic (7.88e-3)" "unprognostic (8.42e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (1.44e-1)" "unprognostic (5.50e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (4.57e-2)" "prognostic favorable (2.60e-4)" "unprognostic (6.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.71e-2)" "unprognostic (1.61e-2)" 24.2 28.6 47.3 27.0 66.8 19.9 27.2 63.6 55.0 17.6 31.1 17.5 21.9 13.8 19.8 56.8 16.5 14.7 22.9 40.8 54.8 23.8 22.0 21.8 18.1 69.7 60.1 36.4 11.0 14.6 30.8 10.0 15.0 66.5 22.8 17.0 18.8 38.6 14.4 43.8 43.3 30.2 13.4 65.4 28.0 21.8 83.3 56.8 18.9 23.1 36.0 25.9 21.2 23.1 86.6 48.3 24.6 34.5 21.1 51.7 50.2 24.6 32.2 26.1 12.6 15.1 38.3 176.3 19.9 28.3 25.0 22.3 34.8 15.3 38.4 19.0 21.7 20.1 13.3 15.8 19.9 20.0 22.2 15.2 33.0 44.0 6.7 41.1 45.8 33.9 25.2 38.4 18.7 31.6 20.6 21.2 8.3 17.5 32.3 14.0 27.3 14.8 22.9 20.4 52.9 11.0 21.5 31.1 36.8 20.6 29.5 23.4 11.3 36.3 30.1 18.5 24.6 10.4 8.2 16.5 22.7 37.7 31.3 37.3 34.2 52.3 92.7 8.3 106.8 13.9 67.6 9.6 8.1 28.9 69.9 10.5 7.3 152.4 9.2 103.9 26.6 12.8 33.9 47.3 66.8 63.6 55.0 40.8 54.8 69.7 60.1 36.4 66.5 65.4 56.8 86.6 15.1 19.2 49.2 14.4 39.4 40.8 39.7 47.7 37.0 20.3 31.7 22.0 46.7 18.6 36.9 20.2 12.5 14.4 18.8 16.6 41.1 21.2 1045.8 18.5 14.0 18.4 21.0 15.4 10.7 24.7 15.1 15.9 16.8 23.0 13.3 18.8 21.0 28.0 41.6 37.0 11.8 28.2 16.2 107.4 10.5 666.5 19.6 52.6 19.6 4.7 41.7 27.8 4.1 12.1 67.9 41.6 11.2 19.5 15.2 53.3 58.8 33.5 48.0 11.0 6.6 19.1 18.6 83.4 39.4 49.1 40.1 17.9 11.7 23.3 21.1 74.8 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915010-102001062 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 143.7;Horizontal cells: 102.6;Respiratory ciliated cells: 138.5;Spermatocytes: 96.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 6.1;EFO-21: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 4.7 4.9 10.5 0.8 9.1 0.9 3.9 9.5 12.5 6.7 14.8 3.7 0.6 4.3 2.7 2.1 9.3 1.9 3.0 9.1 7.5 2.0 0.4 4.5 1.4 9.7 9.5 8.2 7.9 2.1 1.4 18.3 0.9 7.6 3.6 1.9 11.2 2.4 3.1 1.0 3.9 2.3 2.1 11.0 1.8 1.9 16.9 9.0 0.8 4.1 1.5 0.8 3.8 5.2 9.4 0.5 1.0 0.6 0.8 6.1 3.3 0.3 0.9 1.1 0.5 0.4 0.3 1.8 0.6 5.7 1.1 2.6 0.5 0.7 1.4 0.4 1.8 0.9 0.1 2.6 0.7 0.7 0.1 0.1 1.0 3.0 0.7 1.5 3.3 1.5 0.8 0.1 0.2 1.3 0.6 0.6 0.1 0.5 0.7 0.9 0.1 0.6 0.0 1.3 0.8 1.7 2.7 0.8 1.2 0.1 1.2 2.2 0.2 1.0 1.7 0.9 0.5 1.4 1.3 0.7 0.1 1.9 0.1 0.5 0.3 0.1 0.3 0.4 0.0 0.3 0.5 0.3 0.4 0.1 0.6 0.4 0.4 0.4 0.9 0.0 1.2 0.1 0.1 10.5 9.1 9.5 12.5 9.1 7.5 9.7 9.5 8.2 7.6 11.0 9.0 9.4 6.7 9.6 6.7 0.0 7.2 0.0 5.1 0.0 5.2 29.7 6.4 11.9 6.9 8.6 23.5 18.4 45.9 1.3 20.2 0.5 3.9 2.4 21.7 143.7 45.1 4.0 66.7 2.5 0.0 0.4 0.6 33.4 8.2 3.6 0.0 19.0 3.3 0.0 0.4 102.6 0.0 9.4 0.0 0.3 0.0 12.0 53.7 2.8 0.0 0.0 0.7 25.8 20.6 0.0 0.0 1.1 1.7 51.1 3.5 3.0 0.5 6.0 138.5 53.7 6.6 18.3 11.3 96.3 26.2 1.4 0.0 0.1 6.3 39.3 1.7 2.0 EIF4G2 "DAP5, NAT1, p97" ENSG00000110321 "Eukaryotic translation initiation factor 4 gamma 2" P78344 11 10797050-10808940 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005163, HPA006773, HPA016965" Approved Enhanced Cytosol NA NA 48000 Cytosol "CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100" "unprognostic (1.10e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (9.92e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.25e-1)" "unprognostic (7.84e-3)" "unprognostic (5.42e-2)" "unprognostic (7.07e-2)" "unprognostic (2.63e-1)" "prognostic favorable (1.67e-4)" "unprognostic (1.02e-2)" "unprognostic (2.08e-1)" "unprognostic (6.16e-2)" "unprognostic (2.74e-1)" 309.9 262.4 185.5 280.9 177.8 520.9 215.9 187.3 199.6 283.5 248.5 332.3 218.9 313.4 312.8 375.4 267.4 292.6 381.4 177.0 212.1 324.8 291.1 315.6 288.9 197.1 200.6 150.6 249.3 261.8 371.5 161.4 409.8 195.8 278.6 321.7 260.8 233.1 308.4 460.8 301.9 218.1 399.4 196.0 251.6 247.6 228.4 199.8 388.3 352.8 375.7 372.3 434.1 204.7 198.9 933.5 715.1 958.4 527.9 668.2 712.0 668.4 848.9 841.7 713.1 483.6 790.1 1064.3 525.7 474.1 1029.4 545.2 537.8 1048.1 781.0 970.8 820.1 489.0 676.3 427.7 607.2 580.2 1041.8 545.9 582.3 601.0 444.6 577.3 657.1 830.2 483.5 527.8 570.5 935.1 481.8 691.7 377.9 702.1 646.8 756.0 690.3 563.8 336.1 630.7 1328.3 357.9 584.6 966.5 658.7 516.7 640.7 561.1 474.5 805.5 916.1 614.8 793.4 711.4 281.5 841.5 766.9 531.5 600.2 998.7 343.1 331.3 498.6 212.1 382.2 277.0 251.3 237.3 250.1 304.6 212.9 205.8 212.9 244.6 262.4 422.3 162.3 295.9 767.1 185.5 177.8 187.3 199.6 177.0 212.1 197.1 200.6 150.6 195.8 196.0 199.8 198.9 306.7 323.7 284.4 48.6 273.6 633.2 372.0 213.4 285.1 128.1 236.0 196.0 382.6 198.8 243.4 147.1 123.0 321.8 289.0 422.3 244.6 325.2 163.7 213.4 247.1 302.9 247.8 169.1 48.1 368.1 373.7 250.1 263.5 269.3 199.5 271.3 209.9 209.0 272.2 164.9 53.8 279.7 191.2 240.1 417.9 152.0 208.8 312.7 250.8 54.4 279.7 197.3 224.6 36.7 53.3 582.5 260.6 240.7 262.0 307.1 205.6 329.5 225.3 142.8 131.5 328.1 363.1 203.6 197.6 320.3 630.1 1056.1 267.7 281.2 289.0 518.3 IL10RA "CD210, CD210a, CDW210A, HIL-10R, IL10R" ENSG00000110324 "Interleukin 10 receptor subunit alpha" Q13651 11 117986370-118003037 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 64.1;lymphoid tissue: 74.3" "Cell type enhanced" "Detected in many" "dendritic cells: 87.5;Extravillous trophoblasts: 93.0;Kupffer cells: 190.7;Langerhans cells: 145.0;Macrophages: 128.6;monocytes: 175.7;NK-cells: 110.2;Plasma cells: 129.5;T-cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 30.5;HDLM-2: 76.6;Karpas-707: 27.7;RPMI-8226: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065647, HPA069086" Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA065647: , HPA069086: " "unprognostic (1.01e-2)" "unprognostic (2.07e-3)" "unprognostic (1.58e-2)" "unprognostic (7.08e-2)" "unprognostic (8.27e-2)" "prognostic favorable (4.47e-4)" "unprognostic (5.27e-2)" "unprognostic (4.84e-2)" "unprognostic (7.70e-3)" "unprognostic (5.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.82e-1)" "unprognostic (8.43e-3)" "unprognostic (2.19e-1)" "unprognostic (1.27e-1)" 14.0 8.9 4.7 40.1 5.3 64.1 6.1 4.4 7.1 5.7 5.4 12.1 8.1 3.5 2.7 6.5 5.2 18.1 5.4 4.1 6.9 4.0 13.2 24.1 52.1 6.6 5.0 3.9 3.1 2.5 2.6 3.6 14.3 5.2 4.8 14.6 0.5 5.3 3.2 1.7 3.3 25.0 10.5 5.6 74.3 9.3 1.9 5.3 17.0 4.2 3.3 32.6 20.9 3.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.2 0.0 0.7 0.0 0.5 0.0 0.0 76.6 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.6 27.7 0.0 0.0 0.4 6.0 0.1 0.0 0.0 0.0 0.0 35.5 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 5.6 1.0 8.0 0.0 11.4 0.0 3.3 48.9 2.4 52.8 68.6 38.3 12.6 51.0 62.1 44.7 6.2 17.9 33.3 3.4 70.2 58.6 17.3 88.7 84.1 4.7 5.3 4.4 7.1 4.1 6.9 6.6 5.0 3.9 5.2 5.6 5.3 6.6 2.2 6.4 16.0 0.3 52.8 5.7 0.4 0.0 5.7 0.1 1.0 1.9 2.7 0.0 1.3 0.0 0.0 1.3 87.5 0.5 0.0 0.2 0.1 0.4 0.5 4.9 0.0 9.3 0.8 0.8 93.0 2.3 6.6 0.7 12.6 0.0 3.6 1.4 60.4 0.0 1.2 0.0 0.0 190.7 145.0 0.5 0.3 128.6 17.8 22.5 175.7 0.4 110.2 0.0 0.6 0.1 0.1 0.0 129.5 0.0 0.0 1.0 1.5 0.1 0.0 1.6 2.7 0.1 0.3 1.2 4.1 3.3 105.5 0.0 0.7 0.4 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270877-11622005 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 149.5;Excitatory neurons: 104.4;Inhibitory neurons: 156.3;Microglial cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 42.1;HaCaT: 52.4;HBEC3-KT: 36.5;PC-3: 36.4;RPMI-8226: 39.3;SK-BR-3: 47.2;U-87 MG: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012955, HPA070681" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 300000 "Golgi apparatus" "Vesicles, Cytosol" "HPA012955: AB_1849460, HPA070681: " "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.0 4.7 18.1 4.2 16.9 0.0 15.7 16.3 20.0 11.5 9.7 19.5 3.0 24.2 2.4 7.8 12.1 11.3 23.5 25.6 13.0 18.7 10.6 51.6 5.5 11.4 16.6 17.1 4.9 8.3 9.9 6.4 24.6 13.8 13.1 3.2 3.6 17.2 9.4 10.8 12.8 8.8 13.4 10.6 3.6 6.9 14.8 18.6 6.3 43.1 6.2 3.3 11.8 11.6 13.8 42.1 15.0 2.0 9.1 0.0 0.0 0.3 4.5 11.2 0.6 0.0 1.7 5.4 0.1 3.1 0.1 5.6 52.4 9.9 36.5 0.1 0.0 14.6 0.0 0.1 0.1 0.5 0.0 0.0 0.2 14.9 0.0 13.5 0.0 0.0 18.5 0.0 0.1 1.9 10.2 0.5 0.1 1.5 0.1 36.4 0.0 0.0 39.3 27.5 5.1 0.6 4.1 7.6 47.2 0.3 1.4 9.9 0.1 0.0 0.7 8.1 0.4 0.2 0.0 0.0 0.0 33.6 0.0 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 16.9 16.3 20.0 25.6 13.0 11.4 16.6 17.1 13.8 10.6 18.6 13.8 40.5 44.8 6.9 149.5 0.1 5.6 6.6 18.3 12.0 1.6 1.6 2.5 8.5 30.0 13.7 20.2 2.1 49.2 0.4 0.8 15.6 19.9 2.2 1.9 0.4 40.6 0.0 0.0 104.4 4.0 3.5 5.4 0.0 1.3 1.3 16.7 18.5 2.6 2.6 0.0 156.3 0.4 8.2 0.8 1.1 1.4 1.5 0.4 1.8 79.6 0.0 43.1 0.0 8.5 10.5 7.3 0.2 3.0 0.2 13.4 0.0 40.8 14.3 2.1 13.1 15.1 7.4 0.6 1.1 1.8 5.4 15.5 0.3 46.7 1.1 1.9 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 23.1 27.9 19.3 26.1 20.3 36.8 28.5 20.9 23.6 27.8 23.6 27.5 23.8 25.9 30.5 18.2 19.8 25.1 22.5 18.6 22.8 29.1 44.7 22.8 34.8 21.0 20.4 18.3 22.0 34.0 20.5 18.9 29.7 20.8 21.6 26.2 22.4 21.3 16.3 29.9 17.5 25.5 21.8 21.9 27.0 23.7 24.8 19.5 51.1 22.4 33.2 27.3 30.7 20.6 25.9 34.0 24.7 37.3 29.3 46.1 63.3 23.9 128.3 48.8 71.9 43.4 30.9 81.7 37.1 123.5 59.2 40.3 36.7 24.5 33.8 85.7 50.0 12.6 37.2 17.6 37.8 46.9 22.9 23.0 40.8 64.4 41.2 52.3 66.2 50.1 22.2 34.4 0.2 131.0 10.9 24.3 20.1 18.1 40.1 23.7 11.9 48.4 24.9 55.4 38.5 15.5 20.3 44.7 26.9 40.7 56.7 42.5 27.3 82.7 150.7 34.4 46.2 84.2 14.9 21.9 25.0 32.6 28.2 112.5 97.2 43.3 104.4 22.9 42.2 18.9 15.7 21.5 21.3 33.8 15.1 27.4 27.7 67.6 34.3 46.7 20.4 33.2 27.5 19.3 20.3 20.9 23.6 18.6 22.8 21.0 20.4 18.3 20.8 21.9 19.5 25.9 61.8 41.7 41.1 17.0 52.6 67.2 109.2 53.6 39.9 24.4 52.3 52.8 58.6 67.2 49.5 64.4 29.2 38.4 77.9 85.7 43.0 49.8 20.8 63.2 54.0 51.0 48.5 80.0 22.4 73.7 27.8 55.9 28.5 85.7 62.7 43.7 59.3 182.1 41.5 20.2 21.7 54.3 46.8 84.3 71.5 11.2 36.4 71.1 51.6 26.2 81.2 34.3 55.6 21.6 33.1 54.5 71.1 29.0 49.2 75.0 82.1 110.1 56.6 31.0 26.3 45.7 48.9 44.7 42.4 28.4 62.8 35.2 57.1 36.4 44.2 82.5 UBE4A "E4, KIAA0126, UBOX2, UFD2" ENSG00000110344 "Ubiquitination factor E4A" Q14139 11 118359600-118399211 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055035, HPA064010" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA055035: AB_2682679, HPA064010: AB_2685174" "unprognostic (1.32e-2)" "unprognostic (8.15e-2)" "unprognostic (5.23e-3)" "unprognostic (3.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.97e-1)" "unprognostic (7.67e-3)" "unprognostic (3.31e-1)" "unprognostic (1.30e-1)" "unprognostic (4.67e-2)" "unprognostic (6.01e-2)" "unprognostic (5.83e-2)" "unprognostic (7.73e-3)" "unprognostic (4.74e-2)" "unprognostic (5.94e-2)" "unprognostic (2.72e-1)" "unprognostic (8.86e-2)" 18.8 14.3 15.6 20.5 18.1 17.8 18.2 25.9 21.2 16.2 15.8 17.6 19.3 19.1 18.8 15.1 15.6 15.7 19.9 15.5 20.1 18.2 27.8 17.1 22.7 18.9 18.0 15.1 19.3 19.7 19.2 9.6 17.7 20.4 19.2 21.0 18.6 16.2 15.0 22.3 24.1 20.6 18.2 16.7 19.9 24.1 17.8 19.9 21.4 18.5 16.0 21.8 14.8 12.8 24.7 18.8 17.9 22.4 22.5 38.0 34.9 22.3 27.1 28.1 19.7 24.0 49.7 44.9 39.3 51.0 34.4 26.5 40.3 31.9 25.7 32.6 22.3 14.8 64.5 15.4 25.7 32.6 36.8 47.3 35.4 18.2 40.4 39.3 26.3 33.3 33.9 37.2 35.9 28.7 35.4 31.5 36.5 20.9 37.7 22.7 20.0 32.5 40.2 21.6 43.1 20.3 21.1 39.2 33.5 12.3 24.2 44.8 16.6 34.6 29.0 19.0 25.1 22.8 10.5 13.8 36.4 16.1 41.6 30.4 14.2 9.5 9.7 7.5 10.5 5.8 5.1 5.6 5.4 9.8 3.5 6.0 5.4 9.6 6.5 12.8 5.7 7.0 4.8 15.6 18.1 25.9 21.2 15.5 20.1 18.9 18.0 15.1 20.4 16.7 19.9 24.7 28.7 12.8 31.9 45.7 27.5 26.8 22.0 20.4 25.6 19.5 26.3 18.0 18.2 10.0 27.8 14.7 18.8 20.3 30.6 25.5 5.9 19.8 18.0 23.7 35.3 20.9 18.6 26.9 46.2 28.5 19.8 24.2 41.8 31.7 10.8 25.7 19.2 44.6 21.9 16.8 56.3 20.1 30.5 27.9 23.1 15.2 17.1 33.2 24.9 36.5 32.4 20.5 24.7 55.8 80.9 27.0 18.3 21.4 42.0 23.1 29.0 11.5 37.5 16.8 19.7 23.4 23.6 35.3 22.0 30.3 39.2 24.8 31.0 26.0 20.3 26.1 DDX6 "HLR2, RCK, Rck/p54" ENSG00000110367 "DEAD-box helicase 6" P26196 11 118747763-118791164 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004668, HPA024201, HPA026644" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 19000 "Cytoplasmic bodies" Cytosol "CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582" "unprognostic (1.26e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-1)" "unprognostic (3.40e-2)" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (3.43e-1)" "unprognostic (1.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (7.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.91e-3)" "unprognostic (1.88e-1)" "unprognostic (9.58e-2)" "unprognostic (4.55e-2)" 31.8 28.7 33.8 35.3 37.7 69.6 35.3 54.5 35.2 33.5 19.1 30.3 23.9 30.7 30.8 33.4 29.4 23.8 37.6 33.2 37.0 30.8 34.5 27.5 49.4 32.4 33.7 27.7 49.2 31.0 28.5 17.5 31.9 29.1 33.2 28.2 49.2 32.7 29.5 43.6 27.4 26.4 30.8 36.1 45.8 30.1 29.1 36.1 55.4 37.8 42.3 61.4 30.2 22.0 40.0 33.9 50.4 73.6 71.7 64.0 64.8 47.2 45.6 62.0 43.0 40.4 72.1 50.9 77.6 47.1 78.8 44.3 53.2 88.8 69.1 69.0 62.7 17.4 154.5 30.8 57.1 42.0 110.9 55.8 67.1 49.5 63.5 100.8 54.8 69.1 53.2 72.5 110.4 59.2 96.8 81.0 52.1 53.3 50.1 33.6 89.3 59.2 60.1 50.1 92.7 48.7 63.9 84.7 67.2 28.5 56.2 79.2 44.2 81.2 67.2 38.4 39.8 47.6 34.1 47.8 91.7 26.8 52.2 59.2 13.8 4.8 13.2 10.2 6.2 12.3 12.1 10.0 10.8 5.1 12.0 12.2 11.0 19.0 8.3 12.4 7.1 9.9 6.8 33.8 37.7 54.5 35.2 33.2 37.0 32.4 33.7 27.7 29.1 36.1 36.1 40.0 84.6 60.9 57.9 37.9 140.1 30.2 75.2 31.3 69.4 82.2 49.8 43.2 116.9 42.9 41.4 44.1 50.1 38.4 184.0 58.6 31.3 32.2 4.2 77.3 81.5 64.6 85.7 88.2 57.3 35.5 36.5 55.6 42.3 91.7 52.5 54.2 61.8 41.5 38.3 62.2 60.9 59.8 42.7 66.9 44.3 10.5 54.0 70.1 33.8 68.4 75.9 90.0 119.4 50.3 80.9 51.2 57.0 45.1 106.0 49.8 57.2 41.3 35.9 91.3 39.5 92.6 69.7 71.1 76.8 73.4 30.5 76.5 130.2 48.8 53.1 78.2 UPK2 "MGC138598, UP2, UPII" ENSG00000110375 "Uroplakin 2" O00526 11 118925164-118958559 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "urinary bladder: 70.7" "Group enriched" "Detected in some" 7 "Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9" "Cancer enriched" "Detected in many" 72 "urothelial cancer: 339.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 144.4;RT4: 160.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043312, HPA061106" Enhanced NA NA "HPA043312: AB_2678420, HPA061106: AB_2684429" "unprognostic (6.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (3.97e-2)" "unprognostic (1.21e-1)" "unprognostic (4.12e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (3.13e-3)" "unprognostic (1.37e-1)" "unprognostic (1.05e-3)" "unprognostic (6.35e-3)" "prognostic unfavorable (7.30e-7)" "unprognostic (6.69e-2)" "unprognostic (7.45e-2)" "unprognostic (2.98e-1)" "unprognostic (1.00e-1)" 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.0 0.2 70.7 2.4 0.2 4.0 0.4 0.1 0.4 0.0 0.1 26.2 0.0 0.0 0.0 0.1 0.2 9.0 0.0 0.2 0.4 0.2 6.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 144.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.1 160.9 0.0 0.1 0.3 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.9 0.0 0.4 0.6 1.0 0.0 0.0 3.2 0.0 0.0 10.5 0.4 0.0 0.0 0.1 0.5 0.3 0.1 0.5 0.0 0.0 0.1 0.2 0.8 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.0 0.0 0.6 0.9 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.5 0.1 9.6 0.1 0.4 0.0 6.9 CBL "c-Cbl, CBL2, RNF55" ENSG00000110395 "Cbl proto-oncogene" P22681 11 119206298-119313926 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004350, HPA027956" Enhanced Approved Cytosol NA NA 67000 Cytosol "CAB004350: AB_2244054, HPA027956: AB_10601094" "unprognostic (2.52e-1)" "unprognostic (1.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-2)" "unprognostic (2.92e-1)" "unprognostic (4.10e-3)" "unprognostic (9.75e-2)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.03e-2)" "unprognostic (5.23e-2)" "unprognostic (5.21e-2)" "unprognostic (5.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" 6.8 4.1 5.5 9.6 5.6 8.6 5.6 5.2 6.6 4.9 1.6 5.8 4.0 6.6 3.4 5.6 5.6 3.9 4.1 5.0 6.7 4.1 2.8 8.0 10.8 6.1 6.0 3.7 3.7 3.8 6.1 2.9 6.5 5.7 4.0 5.0 8.4 3.6 4.6 2.5 5.2 6.7 7.4 6.2 10.0 5.2 18.4 7.0 22.7 4.1 3.2 11.3 5.9 5.0 9.6 10.7 7.6 26.6 16.7 7.8 9.2 16.0 11.2 11.4 10.8 10.2 16.7 12.6 25.1 10.0 14.0 21.7 15.2 18.4 9.4 22.7 14.8 4.7 26.4 6.2 5.1 9.5 30.3 27.9 8.1 10.1 26.7 28.4 11.1 26.3 23.7 21.7 9.9 19.1 11.3 16.2 17.0 14.0 9.2 8.8 17.5 13.5 4.6 9.3 8.2 3.7 11.3 20.9 8.8 7.3 18.1 9.4 24.8 22.8 16.0 11.5 11.6 14.7 3.3 5.3 19.9 6.7 25.4 11.9 0.8 2.4 2.0 0.9 2.8 0.8 1.5 1.1 0.9 2.6 1.2 1.2 1.3 8.6 0.4 2.5 1.4 1.0 0.9 5.5 5.6 5.2 6.6 5.0 6.7 6.1 6.0 3.7 5.7 6.2 7.0 9.6 23.2 9.6 8.3 23.5 23.2 18.0 5.9 7.5 19.4 14.0 13.6 11.7 8.8 5.7 6.0 11.0 45.9 6.3 24.0 7.6 1.9 6.1 28.2 9.9 19.6 23.2 8.4 5.7 38.5 6.7 10.5 9.4 9.2 16.8 3.8 20.8 20.0 3.1 16.0 13.5 39.1 4.9 2.0 59.1 43.2 42.0 7.8 41.2 16.0 45.0 46.8 13.2 22.6 26.2 19.6 10.6 11.6 12.8 19.7 8.0 5.1 5.4 4.8 33.3 26.3 11.6 22.7 38.0 36.2 18.5 21.9 7.0 24.9 10.6 5.1 10.9 NECTIN1 "CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12" ENSG00000110400 "Nectin cell adhesion molecule 1" Q15223 11 119623408-119729200 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 129.8;skin 1: 135.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 12.1;Breast myoepithelial cells: 27.3;Exocrine glandular cells: 12.3;Granulosa cells: 68.7;Pancreatic endocrine cells: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 229.2;hTCEpi: 139.2;RT4: 157.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016135, HPA026846" Approved "Secreted in other tissues" NA NA 180000000 "CAB016135: AB_626865, HPA026846: AB_1846226" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-2)" "unprognostic (2.25e-3)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (3.42e-1)" "unprognostic (3.58e-2)" "unprognostic (3.28e-1)" "unprognostic (3.59e-3)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (9.62e-2)" 4.4 4.1 15.3 4.7 22.4 24.5 8.3 14.5 30.6 8.1 0.0 12.5 16.8 3.4 2.3 129.8 4.0 3.4 5.9 28.7 13.2 4.0 4.4 3.5 2.1 22.0 26.1 14.3 2.3 18.9 2.7 7.9 7.4 21.3 12.9 13.0 18.7 18.2 6.3 1.9 135.5 12.1 4.5 15.2 3.3 4.7 1.3 19.0 6.8 2.2 1.6 28.2 29.2 37.1 37.6 16.6 13.6 12.6 18.2 6.5 2.1 88.2 6.6 6.1 5.4 3.8 28.8 55.2 21.8 26.1 7.6 10.9 229.2 32.5 117.6 2.4 51.8 4.9 3.0 4.4 13.2 2.6 14.9 35.4 2.0 139.2 17.1 62.5 2.1 16.3 6.2 0.6 113.2 7.2 42.7 0.3 9.0 41.6 55.3 18.7 1.2 75.7 26.3 5.1 157.4 30.6 68.6 22.1 57.4 1.8 18.8 52.3 2.2 9.0 4.8 17.6 39.2 5.9 20.6 28.0 0.2 1.7 11.9 11.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 1.6 0.0 0.0 15.3 22.4 14.5 30.6 28.7 13.2 22.0 26.1 14.3 21.3 15.2 19.0 37.6 4.2 0.0 3.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 12.1 27.3 0.0 0.0 4.3 1.8 0.0 4.1 4.1 0.0 0.0 8.7 0.0 4.6 3.2 1.3 0.0 0.0 0.0 12.3 1.3 2.1 0.0 10.9 0.0 68.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 15.5 0.0 0.0 1.9 0.0 0.0 3.3 1.5 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 8.9 1.3 1.7 0.0 0.0 HIPK3 "DYRK6, FIST3, PKY, YAK1" ENSG00000110422 "Homeodomain interacting protein kinase 3" Q9H422 11 33256672-33357023 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028069 Approved Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA028069: AB_10601815" "unprognostic (2.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.61e-1)" "unprognostic (5.74e-2)" "unprognostic (2.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.63e-1)" "unprognostic (7.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.78e-1)" "unprognostic (2.18e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-3)" "unprognostic (7.89e-3)" "unprognostic (1.80e-1)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" 58.3 21.7 30.1 25.6 30.8 23.5 35.4 35.5 24.1 27.9 72.6 25.3 16.8 33.4 24.4 31.1 32.0 30.9 54.2 21.4 66.7 38.5 30.0 27.2 23.0 38.6 36.3 14.8 27.4 26.1 47.1 12.9 35.0 28.8 23.5 20.8 22.6 23.1 26.4 69.6 22.5 20.4 39.6 36.0 30.9 22.3 19.0 41.2 25.7 34.0 86.0 24.9 32.7 22.6 35.3 19.3 18.0 13.4 15.1 60.5 37.9 12.9 20.0 23.1 15.9 13.3 19.9 13.8 20.7 16.3 24.4 8.0 24.3 10.2 22.2 22.1 30.8 15.8 21.0 20.3 15.2 25.0 22.9 12.8 35.8 42.8 6.1 17.7 16.5 19.4 14.8 6.4 40.4 26.0 10.1 19.2 15.8 3.4 17.3 11.1 25.4 47.3 19.9 26.4 29.4 2.0 11.3 27.1 30.7 18.7 14.2 34.6 41.2 25.8 24.8 16.9 28.9 14.6 21.7 37.2 21.4 11.9 23.5 23.7 10.6 12.7 6.1 4.0 9.4 5.0 2.8 3.6 4.3 14.0 3.3 3.2 4.0 21.1 4.4 11.1 1.7 4.0 5.0 30.1 30.8 35.5 24.1 21.4 66.7 38.6 36.3 14.8 28.8 36.0 41.2 35.3 122.2 12.8 44.7 46.0 29.6 66.5 42.8 21.3 39.3 16.2 35.8 25.8 159.9 37.1 32.9 33.1 18.8 18.6 31.2 32.7 5.9 13.0 21.8 76.5 80.5 96.5 37.1 20.6 44.9 24.9 13.4 59.2 23.0 49.0 14.5 24.3 57.5 53.2 30.7 32.0 48.0 28.4 12.2 102.0 76.0 26.1 42.9 68.1 58.7 73.1 69.1 16.2 25.7 45.8 69.1 21.5 21.1 37.6 24.9 52.6 40.7 35.0 65.4 24.9 52.6 83.4 56.4 10.7 8.1 33.4 75.0 15.5 29.8 12.5 25.2 51.2 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376108-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 28.3;parathyroid gland: 33.7" "Group enriched" "Detected in some" 6 "Excitatory neurons: 366.9;Inhibitory neurons: 193.5" "Cancer enhanced" "Detected in many" "melanoma: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 160000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.2 0.4 5.2 0.2 15.1 0.0 0.8 0.0 28.3 0.1 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.3 0.1 11.3 10.9 0.4 0.0 0.0 0.1 1.4 0.2 14.4 0.2 0.3 33.7 0.7 1.1 8.8 0.0 0.1 1.0 0.3 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.7 0.4 0.2 9.6 0.1 1.9 6.1 0.2 1.0 6.5 0.0 24.7 14.4 3.8 2.1 0.0 0.6 18.7 0.3 21.9 19.2 1.4 0.9 7.3 5.7 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.1 6.4 11.0 13.4 16.9 0.5 0.2 20.5 15.1 0.0 0.2 0.0 1.4 0.0 9.1 0.0 1.6 0.0 0.0 9.6 2.2 2.2 0.3 0.0 6.2 0.2 0.0 0.0 42.4 53.8 11.8 1.3 19.6 0.0 0.0 0.0 14.7 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 15.1 0.0 28.3 11.3 10.9 1.4 0.2 14.4 8.8 0.0 0.0 9.6 0.2 0.0 0.0 18.3 0.1 2.0 0.6 0.6 0.0 5.6 2.2 2.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.8 1.1 0.2 0.1 0.7 0.0 0.0 366.9 0.0 0.2 1.0 0.0 0.6 0.0 0.2 5.0 0.2 0.3 3.3 193.5 0.0 0.0 0.0 0.9 1.2 0.0 0.1 17.8 18.7 0.0 0.1 0.0 40.2 7.2 1.2 0.0 0.4 0.0 1.2 0.0 0.1 0.1 0.4 0.0 0.1 1.8 0.0 1.8 0.6 0.3 0.0 0.0 0.1 0.0 0.7 FBXO3 "FBA, FBX3" ENSG00000110429 "F-box protein 3" Q9UK99 11 33740939-33774543 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002467 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002467: AB_2666602" "unprognostic (1.87e-1)" "unprognostic (2.81e-1)" "unprognostic (6.07e-2)" "unprognostic (1.25e-1)" "unprognostic (3.71e-1)" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (8.53e-2)" "unprognostic (5.21e-2)" "unprognostic (2.42e-1)" "unprognostic (1.47e-1)" "unprognostic (7.36e-2)" "prognostic favorable (2.46e-9)" "unprognostic (6.96e-2)" "unprognostic (1.92e-1)" "unprognostic (1.27e-1)" "unprognostic (3.19e-2)" 20.9 24.5 18.9 15.0 22.4 27.2 27.8 22.1 24.8 21.6 19.7 21.6 18.3 25.0 24.4 33.9 23.5 21.7 46.7 21.1 21.5 47.5 42.4 19.9 18.4 18.5 18.7 20.7 29.1 27.3 57.3 17.8 16.7 19.1 25.8 23.9 34.1 23.2 25.7 125.3 29.1 20.6 24.7 17.6 19.3 23.7 25.4 19.6 20.6 34.6 99.7 21.6 21.0 22.7 20.3 22.1 19.2 25.8 27.6 30.4 23.8 15.6 25.7 25.6 20.4 25.3 22.1 21.6 14.6 17.7 28.2 25.1 37.2 34.8 33.9 34.1 14.7 48.2 7.5 28.4 18.3 19.4 17.4 16.9 24.2 33.8 14.1 22.3 29.7 27.3 10.6 25.9 28.4 23.2 14.9 13.0 10.2 13.1 49.4 29.5 9.9 57.5 20.8 29.5 27.5 36.3 20.0 36.4 24.8 19.6 24.6 35.8 13.2 25.2 25.2 22.0 35.9 22.0 15.7 22.1 24.5 22.5 13.4 25.4 25.9 11.9 18.0 21.6 11.8 24.4 16.2 25.5 24.6 12.8 20.0 32.1 22.4 12.8 25.1 15.5 6.6 34.3 15.8 18.9 22.4 22.1 24.8 21.1 21.5 18.5 18.7 20.7 19.1 17.6 19.6 20.3 33.3 35.3 17.2 31.3 28.9 48.8 64.2 32.0 35.3 56.8 24.5 14.7 42.4 21.5 31.0 25.8 27.1 22.7 28.9 22.6 56.7 49.6 130.8 17.3 19.2 31.7 23.9 32.8 45.1 25.3 28.7 30.7 17.3 21.8 16.5 25.8 32.5 41.0 12.3 57.2 37.9 18.8 54.9 15.0 20.1 51.3 29.8 11.9 28.4 22.5 15.2 46.7 40.2 30.7 40.1 34.9 25.2 27.1 28.3 33.3 23.2 63.6 34.4 52.4 59.2 26.2 37.1 64.2 27.3 43.6 67.5 36.5 32.9 19.4 16.7 50.4 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 140.0;tongue: 126.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 23.7 21.7 18.5 12.3 22.0 7.5 16.7 23.0 22.3 13.4 10.1 23.0 20.3 14.4 13.4 17.4 10.1 12.4 78.6 22.6 16.9 21.7 31.3 12.8 12.0 17.8 18.4 17.2 11.8 21.6 21.2 15.5 24.6 20.3 19.1 20.8 27.3 20.6 16.1 140.0 14.7 15.1 17.9 13.4 11.2 23.3 28.1 21.3 13.3 14.4 126.3 15.0 15.1 11.8 22.2 20.4 54.3 29.9 11.9 20.7 25.5 28.5 38.9 30.1 40.3 38.9 69.3 18.8 27.2 24.7 31.4 49.1 39.4 58.9 31.9 41.1 25.8 47.2 26.9 54.6 82.3 45.0 50.7 30.7 25.6 37.9 23.2 31.5 23.8 31.1 23.9 57.9 25.4 33.1 35.7 32.2 29.9 25.2 54.2 30.5 27.0 53.5 23.8 62.1 54.7 32.0 23.3 33.8 48.1 52.2 29.3 54.8 29.9 21.0 30.4 35.5 32.3 42.7 24.4 53.3 35.7 23.9 24.2 32.5 14.0 19.4 17.5 15.4 21.4 14.3 18.8 14.4 12.7 27.5 16.0 17.2 12.6 3.9 22.1 34.6 7.4 22.1 14.7 18.5 22.0 23.0 22.3 22.6 16.9 17.8 18.4 17.2 20.3 13.4 21.3 22.2 9.0 35.3 24.6 34.3 14.5 26.0 21.4 26.7 15.4 25.8 15.1 11.4 115.3 20.0 26.0 5.5 29.2 62.9 9.0 14.4 64.6 21.4 52.6 15.1 12.2 13.0 9.0 13.5 85.4 14.3 34.9 20.6 16.3 16.6 5.7 16.5 11.7 23.6 26.4 20.2 80.3 17.2 42.7 18.6 13.6 54.0 10.8 14.7 21.4 24.4 23.2 21.0 9.2 40.2 53.4 16.7 15.9 13.5 14.1 22.4 15.0 30.7 19.8 26.7 0.0 14.5 18.8 57.2 36.1 17.9 25.4 83.0 13.4 27.5 20.0 19.7 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 830.5;choroid plexus: 249.5" "Cell type enriched" "Detected in many" 7 "Astrocytes: 4607.2" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172, HPA067499" Enhanced NA NA "CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: " "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 0.4 4.7 595.4 0.6 634.7 0.4 3.9 425.9 830.5 0.9 249.5 0.2 0.5 1.0 0.3 0.2 0.3 0.2 0.9 682.6 430.9 0.2 35.2 0.6 1.9 525.7 520.3 562.1 0.1 9.5 0.1 2.6 1.1 594.6 0.3 0.1 60.6 4.7 0.1 0.3 1.3 0.2 0.3 415.4 0.5 2.1 1.7 506.0 0.2 0.3 0.5 1.7 0.3 0.7 549.0 0.0 0.1 0.5 0.0 0.2 2.1 0.0 0.5 2.4 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.3 2.9 0.1 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.2 0.0 1.1 0.0 0.1 0.5 0.0 0.3 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.5 0.2 0.1 0.1 0.1 0.1 595.4 634.7 425.9 830.5 682.6 430.9 525.7 520.3 562.1 594.6 415.4 506.0 549.0 0.4 3.2 4.8 4607.2 0.4 2.9 0.0 0.0 0.0 109.9 8.1 2.4 3.1 0.0 0.0 0.0 148.0 25.6 0.3 0.1 0.0 0.1 96.6 1.8 11.7 1.6 0.0 0.0 83.7 3.4 1.0 3.1 1.1 1.5 0.0 0.7 0.0 6.7 3.3 6.7 81.5 0.0 0.0 0.0 3.0 97.9 0.0 0.6 1.8 194.9 31.6 10.1 0.0 634.9 12.3 0.4 0.0 0.0 0.1 0.3 0.0 0.1 0.8 161.2 0.0 0.3 1.8 0.5 1.3 0.0 1.1 269.4 0.2 0.0 0.0 0.1 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favorable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.5 32.4 34.5 22.0 33.8 51.2 24.5 35.5 37.0 17.3 29.8 19.8 21.3 14.2 25.3 25.1 20.5 20.7 31.4 33.5 33.4 39.1 36.9 27.1 26.2 35.0 34.6 33.4 19.5 26.6 27.7 23.3 25.0 33.8 14.1 24.5 20.5 22.1 13.4 64.8 26.8 20.3 22.1 35.7 27.0 19.9 15.1 36.5 30.9 25.4 62.3 32.3 20.8 16.7 39.8 28.8 33.4 36.1 38.2 54.5 37.8 20.0 33.6 42.6 74.7 69.8 27.3 23.9 33.0 32.5 67.1 57.5 41.4 64.0 45.2 69.6 39.9 75.2 18.2 57.6 48.0 51.0 71.6 52.3 48.0 49.5 40.9 25.0 38.5 62.2 43.3 45.7 34.7 59.4 36.9 47.9 49.6 38.5 55.6 70.3 52.1 81.7 38.9 78.6 26.6 44.1 49.2 47.9 47.1 43.6 29.2 102.7 27.0 41.9 45.0 34.4 107.9 49.8 24.3 53.2 37.2 51.8 66.4 44.0 85.6 376.6 173.7 91.4 359.0 86.8 130.7 87.5 88.4 383.6 138.3 99.8 83.4 42.7 94.8 300.9 145.8 114.5 315.2 34.5 33.8 35.5 37.0 33.5 33.4 35.0 34.6 33.4 33.8 35.7 36.5 39.8 26.9 22.4 29.4 2.6 27.0 15.3 12.7 37.4 13.1 16.6 25.6 38.7 29.9 12.8 20.2 18.4 10.4 43.2 28.3 16.9 78.2 70.1 9.5 13.2 20.3 22.8 25.7 23.1 9.4 46.4 52.9 21.2 11.7 17.0 19.0 25.6 15.4 17.1 105.1 5.0 8.7 20.4 34.6 59.5 35.6 28.9 17.7 57.5 24.9 1.9 61.3 36.3 33.0 4.5 8.8 46.5 17.7 11.7 10.4 4.9 30.3 62.5 8.5 22.9 13.1 12.3 22.8 32.8 33.3 19.6 21.6 24.9 19.2 28.4 24.6 12.0 SLC15A3 "hPTR3, PHT2" ENSG00000110446 "Solute carrier family 15 member 3" Q8IY34 11 60937060-60952653 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 90.6;Kupffer cells: 59.3;Macrophages: 65.5;monocytes: 70.9;Muller glia cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 9.0;intermediate monocyte: 12.8;memory B-cell: 4.9;myeloid DC: 6.5;neutrophil: 13.4;non-classical monocyte: 6.4;plasmacytoid DC: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.4;BJ hTERT+ SV40 Large T+: 58.0;BJ hTERT+ SV40 Large T+ RasG12V: 74.0;HHSteC: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047880, HPA057642" Approved Supported Vesicles NA NA Vesicles "HPA047880: AB_10959455, HPA057642: AB_2683487" "unprognostic (5.61e-2)" "prognostic favorable (4.07e-5)" "unprognostic (8.79e-2)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (9.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (9.78e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 26.5 12.9 11.4 31.0 10.6 35.6 18.4 10.3 15.2 19.1 12.4 30.0 12.1 14.0 3.9 9.4 18.3 19.2 23.9 9.1 14.5 14.0 15.3 52.7 40.4 12.5 10.1 7.9 29.4 6.6 4.5 8.4 27.7 12.7 16.9 9.5 17.7 10.1 8.6 6.4 7.4 28.9 15.3 12.1 64.4 18.7 5.5 13.0 13.0 10.6 10.2 15.9 15.8 17.7 14.4 4.3 0.0 2.2 0.0 12.6 9.9 23.4 1.2 21.8 58.0 74.0 0.1 1.9 9.7 0.3 8.8 14.2 1.7 0.0 0.7 3.4 9.4 0.0 0.1 0.1 0.6 34.9 0.0 0.9 6.6 0.0 15.3 0.0 0.1 2.8 0.0 0.0 0.5 3.6 0.5 0.0 1.8 9.8 0.0 0.1 3.9 0.0 3.3 0.0 1.3 0.0 0.1 2.8 9.6 0.4 0.4 4.2 5.7 0.3 0.3 1.2 1.0 0.1 0.0 0.0 3.8 3.9 0.0 13.7 0.0 9.0 1.2 0.1 12.8 0.0 4.9 0.0 0.0 6.5 1.9 0.9 0.9 13.4 0.0 6.4 10.7 0.0 2.4 11.4 10.6 10.3 15.2 9.1 14.5 12.5 10.1 7.9 12.7 12.1 13.0 14.4 19.3 9.6 13.2 0.0 7.7 1.7 0.2 4.5 2.2 1.6 0.7 1.4 2.5 1.5 3.7 0.0 0.0 3.6 9.6 1.1 0.0 0.3 7.9 0.1 2.0 12.6 0.0 0.4 0.1 2.2 15.1 5.6 1.1 0.3 15.2 3.7 20.3 3.1 90.6 5.0 0.0 1.2 2.0 59.3 35.5 3.8 8.1 65.5 1.8 4.7 70.9 211.7 1.0 0.0 0.1 2.2 2.8 4.9 2.0 0.1 0.3 0.1 3.1 5.5 13.1 3.1 3.0 4.2 0.7 0.6 1.4 2.6 1.9 4.5 1.1 0.3 CD5 "LEU1, T1" ENSG00000110448 "CD5 molecule" P06127 11 61102489-61127852 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.9" "Cell type enhanced" "Detected in some" "dendritic cells: 7.5;Langerhans cells: 9.3;Muller glia cells: 16.0;T-cells: 57.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 138.2" "Lineage enriched" "Detected in many" 33 "T-cells: 138.2" "Group enriched" "Detected in some" 66 "JURKAT: 21.0;MOLT-4: 70.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB015392, CAB020308, HPA043416, HPA060839" Enhanced NA NA "CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376" "prognostic favorable (4.05e-4)" "prognostic favorable (9.16e-5)" "unprognostic (2.33e-1)" "prognostic favorable (9.00e-5)" "unprognostic (1.02e-2)" "prognostic favorable (7.41e-6)" "unprognostic (2.45e-3)" "unprognostic (1.37e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.94e-5)" "unprognostic (4.78e-2)" "unprognostic (1.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.06e-1)" 1.4 0.9 0.4 22.9 0.4 12.4 1.0 0.1 0.5 0.9 0.1 2.9 3.1 0.8 0.4 2.3 0.8 5.0 0.9 0.6 0.3 0.7 1.5 5.8 38.3 0.3 0.1 0.3 0.8 0.4 0.2 0.4 0.3 0.6 1.0 2.7 1.8 6.5 0.3 0.6 1.4 7.2 1.2 0.0 14.3 8.0 0.8 0.2 46.9 1.0 0.3 22.4 6.2 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.1 70.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.6 45.9 0.4 32.8 1.5 108.7 72.5 3.7 3.4 88.4 69.8 1.8 0.4 3.4 4.1 138.2 61.5 0.4 0.4 0.1 0.5 0.6 0.3 0.3 0.1 0.3 0.6 0.0 0.2 0.2 0.4 0.0 1.7 0.0 4.1 0.9 0.0 0.0 0.0 0.2 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 2.7 0.0 0.1 0.2 0.0 1.3 0.3 0.0 0.0 0.9 2.6 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 9.3 0.9 0.0 1.8 3.6 0.0 2.1 16.0 1.0 0.0 0.1 0.1 0.3 0.0 6.3 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.6 0.4 0.7 0.2 0.3 0.0 57.0 0.0 0.2 0.2 ACCS "ACS, PHACS" ENSG00000110455 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive)" Q96QU6 11 44065925-44084237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018873, HPA021654" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA018873: AB_1855273, HPA021654: AB_1855274" "unprognostic (3.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.98e-1)" "unprognostic (1.86e-1)" "unprognostic (7.86e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-1)" "unprognostic (7.57e-3)" "unprognostic (1.41e-1)" "unprognostic (3.38e-2)" "prognostic favorable (4.25e-4)" "unprognostic (6.51e-2)" "unprognostic (3.07e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-1)" "unprognostic (5.63e-3)" "unprognostic (1.92e-2)" 10.5 17.2 1.4 3.7 1.3 10.1 11.3 1.1 2.0 10.9 6.3 8.3 5.5 14.3 8.2 5.6 15.5 10.2 5.4 1.6 1.8 10.5 19.1 9.8 5.5 2.7 1.5 1.1 9.9 11.1 2.9 11.0 2.7 1.8 11.0 7.0 1.0 10.4 6.4 3.1 7.8 10.3 6.3 1.2 14.1 10.5 6.5 1.7 4.1 12.8 2.4 6.5 9.1 8.3 1.9 4.0 8.8 0.0 1.0 2.3 4.1 0.0 2.1 2.7 1.9 2.0 0.7 5.6 1.5 1.6 4.7 0.0 6.7 2.4 0.5 1.0 0.5 2.6 6.3 3.3 0.1 4.4 0.0 0.0 4.6 8.2 2.4 1.1 2.6 3.5 0.0 5.0 0.0 5.8 3.0 0.0 2.5 3.4 5.1 1.3 5.5 0.0 0.0 4.8 2.6 1.1 3.5 2.1 1.1 2.5 2.2 8.6 3.8 3.8 2.2 2.3 3.5 1.1 0.0 0.0 0.2 5.3 0.0 2.3 0.9 3.1 5.6 0.8 3.1 0.7 1.1 0.7 1.3 4.4 1.4 1.1 0.7 0.0 0.9 2.5 3.3 1.2 2.0 1.4 1.3 1.1 2.0 1.6 1.8 2.7 1.5 1.1 1.8 1.2 1.7 1.9 12.2 12.8 22.7 11.8 4.6 2.7 2.7 4.0 6.8 1.9 8.6 10.2 4.0 7.2 8.9 9.2 0.0 3.1 4.0 6.4 0.0 2.3 2.1 8.6 3.9 7.0 7.2 3.4 3.4 4.2 0.4 6.9 13.7 5.0 9.5 11.0 8.2 9.7 6.1 0.0 3.3 8.2 4.1 7.0 5.5 4.4 9.6 9.0 0.0 5.6 9.4 2.6 7.2 4.5 6.6 2.9 8.0 7.5 2.5 2.1 16.6 6.5 7.4 1.0 0.0 3.7 4.7 0.7 2.4 2.4 2.3 1.9 3.3 9.2 6.4 2.1 SCGB2A2 "MGB1, MGC71974, PSBP1, UGB2" ENSG00000110484 "Secretoglobin family 2A member 2" Q13296 11 62270158-62273160 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "breast: 2835.1" "Group enriched" "Detected in some" 11 "Breast glandular cells: 2119.6;Breast myoepithelial cells: 1028.8;Melanocytes: 1762.7" "Cancer enriched" "Detected in many" 23 "breast cancer: 823.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 124 "SK-BR-3: 18.0" CAB026270 Enhanced "Secreted in female reproductive system" NA NA "CAB026270: AB_912980" "unprognostic (2.38e-1)" "unprognostic (7.28e-2)" "prognostic favorable (9.57e-8)" "unprognostic (4.17e-1)" "unprognostic (3.75e-1)" 19.3 0.2 0.0 0.0 0.0 0.0 2835.1 0.0 0.0 311.9 0.0 0.4 0.0 4.1 0.0 77.3 0.1 0.0 2.2 0.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.6 1.3 0.0 0.2 0.0 0.0 160.6 0.1 1.8 635.0 0.2 0.0 0.0 0.2 0.3 1.1 0.0 2.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 6.6 49.6 0.3 0.0 0.0 0.0 2119.6 1028.8 0.1 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 1.4 41.9 21.6 11.3 0.0 0.0 0.0 0.0 0.0 6.7 0.0 141.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 3.2 1762.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 10.9 0.0 9.2 0.0 0.0 0.0 MDK "FLJ27379, MK, NEGF2" ENSG00000110492 Midkine P21741 11 46380756-46383837 "Cancer-related genes, Predicted secreted proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 533.5" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 1010.4;Granulosa cells: 726.2;Paneth cells: 1272.7;Proximal enterocytes: 883.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.8;neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 888.4;REH: 1343.8;SH-SY5Y: 1093.6" "CAB010055, HPA057126" Uncertain Approved Vesicles "Secreted to blood" NA NA 158000 960000 Vesicles "CAB010055: AB_627949, HPA057126: AB_2683344" "unprognostic (8.87e-3)" "unprognostic (6.65e-2)" "unprognostic (4.02e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.11e-2)" "unprognostic (4.01e-2)" "unprognostic (4.15e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (8.78e-2)" "unprognostic (1.31e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" 39.7 98.8 21.0 23.1 19.5 11.8 82.9 24.4 37.3 353.1 19.9 64.6 265.7 210.0 60.9 38.5 171.8 141.2 27.2 19.2 37.0 26.2 8.5 48.9 20.5 31.0 22.3 17.8 533.5 30.8 104.8 373.3 32.3 20.5 129.8 38.4 6.0 138.6 84.9 7.7 24.7 213.1 49.9 21.0 78.8 109.3 16.9 26.2 93.7 27.0 9.8 16.1 84.9 130.4 28.0 51.1 66.5 758.4 2.5 5.2 62.2 18.6 39.2 77.0 145.6 128.8 505.2 219.5 3.4 528.6 58.5 6.3 429.6 431.8 0.7 13.3 157.0 91.6 22.5 5.6 703.6 336.2 1.7 3.5 100.0 13.2 89.2 0.5 31.0 214.3 28.9 385.2 3.5 83.3 348.6 19.8 9.4 888.4 275.9 388.0 1343.8 28.8 4.4 1.8 1.6 418.1 1093.6 128.9 11.3 11.0 665.8 347.3 349.5 59.0 221.1 526.2 3.1 27.2 2.9 11.0 5.1 6.5 13.7 197.3 0.0 0.0 0.0 0.1 0.2 0.0 1.8 0.1 0.2 0.0 0.4 0.0 0.0 2.1 0.1 0.2 0.1 0.9 0.4 21.0 19.5 24.4 37.3 19.2 37.0 31.0 22.3 17.8 20.5 21.0 26.2 28.0 108.2 0.0 5.4 5.5 9.6 11.1 162.1 392.4 12.5 1.3 245.2 218.7 7.0 34.3 393.6 47.8 0.0 162.3 5.4 499.0 1.9 286.0 26.4 134.6 490.2 115.0 1010.4 2.5 2.1 104.5 123.5 275.2 162.1 228.2 4.5 726.2 102.4 4.6 48.3 0.0 1.9 368.8 286.8 4.2 12.0 126.3 109.6 10.0 37.4 7.5 9.4 47.1 0.0 4.5 1.3 221.1 1272.7 18.8 18.6 163.6 883.4 19.6 109.5 1.1 85.5 26.1 197.0 31.8 34.3 26.2 8.1 153.1 11.4 8.9 187.6 511.1 AMBRA1 "DCAF3, FLJ20294, KIAA1736, WDR94" ENSG00000110497 "Autophagy and beclin 1 regulator 1" Q9C0C7 11 46396414-46594125 "Predicted intracellular proteins" "Autophagy, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 65.6;Excitatory neurons: 101.4;Inhibitory neurons: 101.9;Microglial cells: 84.3;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 11.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017825, HPA038535" Approved Approved Vesicles,Mitochondria NA NA Vesicles Mitochondria "CAB017825: , HPA038535: AB_2676068" "unprognostic (1.76e-3)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.56e-1)" "unprognostic (6.00e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-3)" "unprognostic (7.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.98e-2)" "unprognostic (5.53e-3)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (2.90e-1)" "unprognostic (8.17e-2)" "unprognostic (1.61e-2)" "unprognostic (7.98e-2)" 9.3 16.6 7.3 6.7 8.6 11.7 10.6 7.2 9.0 10.4 6.2 10.1 10.1 11.8 5.9 10.7 10.1 6.5 8.4 7.6 6.3 8.2 9.1 8.7 8.3 6.8 6.1 7.2 11.7 8.3 12.4 9.3 7.6 7.0 9.9 7.1 7.9 10.7 7.7 13.1 16.5 9.9 8.8 3.8 10.4 9.8 12.7 6.5 13.6 9.5 8.4 8.2 9.5 10.1 10.3 8.7 23.0 15.5 16.8 16.1 12.0 9.6 8.5 16.1 13.6 14.1 17.4 14.8 17.5 8.5 15.1 16.1 15.4 7.9 15.0 10.0 15.3 25.5 11.9 14.6 22.5 10.5 17.3 14.6 16.7 11.6 8.6 16.3 14.8 14.3 14.9 20.8 11.7 10.2 21.4 22.2 12.2 26.1 19.6 12.4 21.5 21.3 9.7 13.1 15.4 12.5 13.9 14.7 16.6 15.6 10.1 17.2 11.6 15.2 12.5 11.1 14.6 12.8 13.2 11.3 18.1 11.1 9.6 11.3 11.8 2.2 1.7 2.6 1.1 2.2 2.4 1.9 2.0 2.0 2.1 1.9 1.7 2.5 1.4 1.9 2.1 3.2 1.9 7.3 8.6 7.2 9.0 7.6 6.3 6.8 6.1 7.2 7.0 3.8 6.5 10.3 5.1 3.2 5.6 65.6 7.2 4.1 2.5 3.4 4.0 6.6 5.1 5.2 8.2 4.3 4.3 0.0 2.1 4.0 5.9 16.0 0.0 6.9 13.8 5.2 5.3 4.7 9.6 10.3 101.4 9.3 2.1 6.7 13.7 8.3 4.5 8.8 3.6 4.1 5.2 5.0 101.9 9.7 2.0 3.5 2.3 6.7 5.3 4.8 5.4 84.3 3.1 3.2 6.2 84.9 136.4 8.4 7.5 7.9 6.6 3.5 8.2 3.2 4.4 5.7 13.1 4.2 5.8 2.1 2.1 7.4 4.5 6.8 6.4 7.9 6.4 4.2 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 134.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 80.9;Cone photoreceptor cells: 125.1;Horizontal cells: 132.9;Rod photoreceptor cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 33.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 33.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favorable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favorable (8.25e-4)" 14.9 24.9 24.1 17.9 33.9 28.6 14.9 48.5 46.0 15.9 1.0 18.0 12.5 15.3 12.1 11.2 14.2 12.3 24.3 41.2 27.1 15.5 13.1 19.2 21.1 20.2 23.1 38.2 19.0 17.6 18.6 66.2 16.2 25.0 20.9 16.7 134.4 16.8 17.3 30.4 22.1 19.2 14.7 7.4 22.2 19.0 28.8 19.9 23.8 14.5 23.6 18.0 18.9 15.1 33.6 14.0 28.7 30.8 27.6 20.6 14.3 6.9 19.3 25.8 24.2 25.9 21.0 12.9 29.6 6.0 21.3 31.1 27.2 25.2 13.6 20.8 33.1 25.6 52.7 55.0 18.3 14.8 36.1 69.4 13.9 14.3 12.7 15.9 16.4 22.4 18.7 34.5 21.1 21.5 19.7 17.2 38.6 18.4 32.8 19.6 23.2 49.5 19.7 12.4 66.0 48.4 31.5 24.9 29.0 17.6 18.1 22.8 27.0 19.2 22.4 14.1 32.3 13.2 24.9 27.9 16.6 20.9 25.1 21.5 33.3 3.4 6.5 5.6 5.6 5.0 4.0 3.9 4.6 5.2 4.2 4.5 3.6 0.9 5.7 7.9 2.7 7.5 6.2 24.1 33.9 48.5 46.0 41.2 27.1 20.2 23.1 38.2 25.0 7.4 19.9 33.6 10.6 12.8 9.2 21.5 11.7 10.7 4.1 6.1 6.8 80.9 11.3 10.2 23.4 7.2 5.8 7.3 125.1 4.6 29.0 21.2 0.0 7.5 14.6 5.3 7.0 11.5 16.3 8.6 37.4 4.9 2.3 7.8 23.4 8.3 26.6 13.9 14.6 7.0 11.5 132.9 33.7 17.7 4.1 19.4 14.9 4.9 7.2 14.9 10.6 21.5 11.1 14.4 23.7 14.1 22.4 12.0 12.2 12.8 17.7 8.0 12.2 5.1 6.2 106.8 6.6 8.7 7.7 14.9 23.2 6.7 8.2 4.4 15.4 16.2 13.7 5.9 PTPMT1 "DUSP23, MOSP, PLIP" ENSG00000110536 "Protein tyrosine phosphatase mitochondrial 1" Q8WUK0 11 47565430-47573461 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 235.1;Late spermatids: 640.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043932, HPA060060" Approved Enhanced Mitochondria NA NA Mitochondria "HPA043932: AB_2678738, HPA060060: " "unprognostic (6.61e-2)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (3.29e-2)" "unprognostic (2.77e-2)" "unprognostic (1.93e-3)" "unprognostic (6.76e-2)" "unprognostic (1.72e-1)" "unprognostic (2.68e-3)" "unprognostic (1.21e-1)" "unprognostic (5.39e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 37.2 57.0 13.4 5.3 14.2 9.1 37.7 14.4 17.5 31.3 14.3 29.8 7.7 33.0 7.8 35.0 29.8 4.2 23.0 12.8 14.8 37.8 40.9 36.8 6.2 14.4 14.8 12.6 28.2 45.1 9.7 42.2 6.7 14.1 33.0 4.0 4.3 37.4 6.0 41.3 28.1 23.6 4.8 14.5 29.1 39.5 106.3 15.3 4.3 30.9 5.8 5.0 27.8 28.3 14.7 34.5 19.4 2.3 17.8 17.5 11.4 7.0 20.1 17.1 19.4 16.8 27.9 17.6 27.9 22.1 14.7 16.8 30.6 16.9 20.4 16.6 31.4 57.3 12.9 43.8 43.4 25.7 25.2 17.1 12.7 21.9 8.8 24.0 11.2 13.7 26.2 32.6 19.5 14.2 65.4 21.4 41.0 18.8 3.9 37.7 38.6 16.7 22.3 22.5 23.3 15.5 21.4 33.8 11.1 23.2 7.2 53.1 32.7 16.6 13.6 23.3 28.6 33.1 27.1 22.6 18.6 13.6 23.3 10.0 11.2 38.0 38.2 24.8 36.8 23.0 33.7 22.7 26.2 44.9 30.3 22.3 21.0 3.1 26.1 34.6 64.6 28.5 28.8 13.4 14.2 14.4 17.5 12.8 14.8 14.4 14.8 12.6 14.1 14.5 15.3 14.7 26.8 22.4 35.0 14.4 31.8 17.8 15.8 58.5 34.1 14.4 64.9 78.4 5.8 45.8 38.6 40.5 4.2 72.2 34.7 19.9 72.4 95.3 235.1 48.0 23.9 24.6 31.3 30.1 8.2 85.8 66.3 23.9 28.1 25.6 17.1 16.5 29.6 39.8 62.4 5.0 10.8 45.7 48.8 32.6 21.2 640.8 46.6 45.6 46.2 6.5 56.2 74.9 41.2 9.5 14.6 106.2 38.8 46.6 61.0 26.0 37.9 72.8 57.2 15.7 19.7 17.3 28.1 179.8 28.6 55.0 17.3 76.8 25.9 21.3 62.7 22.0 NAA40 "FLJ13848, NAT11" ENSG00000110583 "N-alpha-acetyltransferase 40, NatD catalytic subunit" Q86UY6 11 63938959-63957319 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 102.6;Late spermatids: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037816, HPA056142" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA037816: AB_10672289, HPA056142: " "unprognostic (3.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-1)" "unprognostic (6.88e-3)" "unprognostic (1.50e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (1.58e-1)" "unprognostic (7.01e-3)" "unprognostic (6.29e-3)" "unprognostic (3.42e-2)" "unprognostic (6.43e-3)" "unprognostic (2.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.25e-2)" 3.2 8.9 5.5 3.9 5.5 2.6 4.5 5.0 5.7 4.0 5.7 4.5 5.8 3.0 3.3 6.7 6.8 3.7 9.5 5.6 5.1 7.8 3.9 3.7 7.6 5.8 5.9 5.1 2.7 6.5 15.2 10.5 6.7 5.7 4.3 4.7 7.3 6.6 4.0 4.8 2.7 5.7 3.2 5.4 8.9 4.9 15.4 5.4 10.1 6.2 8.6 7.4 4.2 3.6 5.6 15.5 17.3 21.7 11.8 6.0 5.9 13.8 11.3 12.0 27.3 19.1 14.8 19.3 9.5 13.6 10.2 18.9 13.7 18.3 8.2 20.1 12.5 11.2 13.0 11.1 16.9 7.9 20.9 10.8 6.0 7.4 17.0 4.6 10.6 18.0 16.1 22.4 6.9 12.9 11.8 22.3 16.3 20.2 14.3 11.8 21.9 19.5 12.1 18.5 11.8 28.7 15.1 17.7 15.2 9.2 15.8 25.1 9.2 11.6 15.1 18.3 8.9 9.3 8.3 5.6 16.5 9.2 8.9 11.9 2.3 0.5 2.7 6.9 0.4 2.4 2.7 1.8 3.3 2.7 2.4 1.1 2.6 0.1 5.2 0.2 3.5 0.5 2.3 5.5 5.5 5.0 5.7 5.6 5.1 5.8 5.9 5.1 5.7 5.4 5.4 5.6 4.3 3.2 4.8 12.1 8.1 2.8 2.0 4.5 10.8 30.9 11.5 7.0 14.8 5.7 9.4 18.4 33.3 9.6 12.1 13.6 0.0 5.7 46.3 20.0 7.4 7.6 17.5 7.4 14.3 5.4 12.8 4.8 6.1 8.5 1.3 14.3 9.7 5.2 9.5 102.6 15.6 6.1 10.2 10.3 5.3 130.5 4.7 7.3 1.8 15.0 4.4 8.6 17.5 11.6 10.1 5.9 3.5 7.2 12.2 2.1 10.6 4.1 22.5 23.9 0.0 4.3 4.4 27.4 16.5 6.5 2.8 4.1 8.9 10.4 7.3 1.8 CARS1 CARS ENSG00000110619 "Cysteinyl-tRNA synthetase 1" P49589 11 3000922-3057613 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 10.3;Cardiomyocytes: 8.8;Cytotrophoblasts: 22.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 22.0;Syncytiotrophoblasts: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737" Enhanced Enhanced Cytosol NA NA 200000 Cytosol "CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033" "unprognostic (9.10e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-3)" "unprognostic (1.43e-1)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (8.00e-2)" "unprognostic (5.51e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "unprognostic (3.46e-1)" 21.4 17.5 15.3 12.1 8.5 7.3 20.0 8.6 16.7 13.1 7.8 20.3 12.1 16.1 7.6 19.4 12.9 10.4 12.3 11.3 9.7 13.1 21.3 17.7 12.8 14.8 9.4 8.0 8.9 33.0 9.7 18.7 10.4 13.8 12.9 12.9 5.3 20.8 6.8 32.0 23.7 17.6 16.1 9.0 17.3 23.7 16.9 13.4 14.7 17.4 14.8 17.9 18.2 15.1 17.1 29.2 14.0 17.8 55.6 67.3 61.4 16.2 70.0 78.6 46.7 84.1 34.2 64.7 43.1 20.1 88.2 0.0 68.7 58.3 78.6 64.0 123.7 13.5 24.4 23.7 25.8 161.1 50.9 50.2 102.2 64.1 40.1 46.8 0.0 62.3 103.6 42.2 147.0 47.1 41.9 35.7 0.0 65.2 97.9 25.0 17.2 29.7 54.9 0.0 46.1 39.0 49.7 17.1 48.1 80.1 13.3 0.0 0.1 21.8 19.5 18.2 48.2 0.2 107.8 106.8 27.2 0.1 26.6 40.3 16.3 18.6 13.5 20.9 15.4 17.4 10.9 18.3 18.6 19.4 8.5 9.9 16.0 25.4 23.7 37.9 7.5 27.0 19.2 15.3 8.5 8.6 16.7 11.3 9.7 14.8 9.4 8.0 13.8 9.0 13.4 17.1 10.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 22.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 40.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 32.3 1.4 0.0 0.0 0.0 SLC22A18 "BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5" ENSG00000110628 "Solute carrier family 22 member 18" Q96BI1 11 2899721-2925246 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 42.7;liver: 45.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 368.4;Late spermatids: 499.1;Paneth cells: 385.7;Proximal enterocytes: 730.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.4;Karpas-707: 29.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA067812, HPA071461" Enhanced NA NA "HPA067812: AB_2685902, HPA071461: AB_2686401" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (7.75e-2)" "unprognostic (7.92e-3)" "unprognostic (2.67e-1)" "unprognostic (8.25e-2)" "unprognostic (4.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.48e-2)" "unprognostic (9.35e-2)" "unprognostic (8.60e-2)" "unprognostic (8.36e-2)" "unprognostic (9.51e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-1)" "unprognostic (2.82e-1)" 6.1 3.0 0.1 2.2 0.0 1.6 6.7 0.0 1.2 5.7 0.9 17.3 42.7 6.9 0.2 13.4 8.2 4.0 12.6 0.1 0.7 16.4 45.6 6.9 2.3 0.5 0.4 0.2 4.9 6.4 1.7 3.2 5.4 1.0 8.0 4.2 0.0 10.4 2.8 1.7 16.0 28.3 0.9 0.2 9.2 11.4 2.1 0.7 0.8 12.1 0.0 1.1 6.5 9.8 0.5 2.3 14.1 0.0 7.2 1.3 2.0 5.8 4.4 7.4 2.5 4.2 8.0 33.4 1.0 14.1 5.8 5.6 7.3 0.4 0.7 0.5 6.8 1.3 0.3 3.3 7.4 13.5 0.1 6.2 5.7 1.3 2.1 0.4 2.2 0.0 4.5 0.3 29.1 1.4 6.8 0.2 0.8 0.7 10.6 3.3 2.6 0.0 4.7 1.1 4.2 0.3 2.5 1.8 17.6 15.7 0.1 3.6 3.8 0.5 1.9 4.2 6.1 0.3 5.5 1.4 0.3 7.7 3.9 7.5 32.1 28.7 27.4 6.8 28.2 3.7 4.2 5.1 4.8 17.9 3.0 2.7 4.0 42.3 6.3 22.9 13.2 9.4 13.5 0.1 0.0 0.0 1.2 0.1 0.7 0.5 0.4 0.2 1.0 0.2 0.7 0.5 1.6 6.4 9.6 1.6 5.6 7.4 22.5 48.8 14.2 1.2 16.8 11.0 11.2 54.3 29.0 27.6 0.0 102.6 9.0 368.4 7.9 31.4 161.7 9.3 5.3 2.7 19.8 1.3 3.0 8.7 20.9 9.4 47.9 14.1 15.9 7.6 6.4 158.6 46.3 0.0 0.6 93.2 52.9 33.0 16.7 499.1 10.5 23.5 19.6 4.7 18.8 6.9 10.3 0.5 1.6 22.5 385.7 7.5 3.1 10.2 730.9 122.1 26.6 1.1 0.0 2.7 11.2 5.8 4.1 19.2 8.8 181.3 13.7 7.3 121.3 20.3 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397397 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 148.9;naive B-cell: 137.2" "Lineage enriched" "Detected in all" 4 "B-cells: 148.9" "Cell line enhanced" "Detected in many" "ASC diff: 2960.6;fHDF/TERT166: 1752.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane,Cytosol" NA NA 400000 "Plasma membrane" Cytosol "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 892.8 301.9 498.7 273.2 517.1 78.4 780.2 579.0 594.8 958.2 452.9 783.7 152.0 1395.6 968.9 367.6 860.5 539.2 865.0 451.8 627.3 639.5 1185.3 775.0 432.6 602.7 567.7 415.7 662.3 453.3 260.3 412.3 444.6 569.4 639.4 236.6 76.6 535.5 1616.9 216.1 512.5 426.7 986.7 628.4 636.3 498.5 319.3 588.0 160.3 569.3 229.7 280.9 755.5 769.9 701.7 337.0 342.0 268.5 413.4 2960.6 1668.4 224.8 621.0 1361.6 490.3 492.2 322.8 1.8 285.4 218.3 1752.6 312.5 430.5 167.3 442.2 199.9 135.6 517.8 43.7 117.1 0.3 976.4 188.2 359.8 1222.3 619.9 201.1 302.1 757.9 476.6 204.0 198.7 484.9 696.4 257.2 160.7 239.1 324.4 304.7 274.2 324.7 135.5 183.3 529.1 223.3 288.8 319.2 198.4 514.4 383.8 214.3 171.0 337.8 641.3 249.0 181.6 471.2 216.6 356.9 88.1 529.1 361.3 111.0 435.0 0.9 3.3 22.9 21.1 5.8 34.4 148.9 14.9 33.0 2.6 137.2 9.2 16.9 1.0 14.7 7.3 7.7 12.0 10.7 498.7 517.1 579.0 594.8 451.8 627.3 602.7 567.7 415.7 569.4 628.4 588.0 701.7 1003.1 243.6 270.0 95.0 88.2 179.8 391.8 89.7 26.2 82.7 325.6 452.0 277.4 167.3 102.3 207.8 27.1 21.8 267.1 20.0 35.2 105.7 15.9 365.4 1050.9 344.5 71.9 30.7 19.0 55.1 31.7 560.4 21.4 462.7 81.7 204.0 293.4 603.9 251.5 148.0 32.4 48.2 50.8 232.7 179.7 50.2 389.2 277.6 151.2 60.0 23.0 809.2 45.3 145.8 93.6 61.3 14.7 251.3 50.7 147.6 5.0 29.9 85.8 76.1 118.3 356.9 423.6 15.6 19.4 30.6 164.9 20.1 136.8 379.0 41.5 298.1 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 37.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.0;Basal prostatic cells: 34.5;Suprabasal keratinocytes: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 188.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048185, HPA060150" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA048185: AB_2680304, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 4.1 1.3 3.6 7.3 4.2 5.2 5.5 2.6 3.6 16.4 3.5 18.1 19.2 6.4 11.7 12.3 13.6 5.2 2.3 4.0 4.6 10.1 0.5 5.8 8.0 3.5 3.4 2.6 5.0 5.5 6.1 3.5 3.3 3.6 22.5 20.6 12.8 37.7 6.2 1.1 20.7 17.9 4.7 5.0 4.1 7.0 4.6 3.5 5.6 7.2 1.5 14.0 8.0 9.6 3.8 30.8 19.8 2.3 30.1 15.2 22.6 29.0 6.8 3.9 17.3 22.7 84.2 31.4 51.2 67.7 20.1 94.1 63.1 37.3 60.5 34.2 40.3 34.8 28.5 18.1 34.1 24.8 65.0 14.2 15.7 36.9 58.3 123.1 53.2 91.7 38.3 74.0 20.7 13.0 17.0 28.3 69.7 20.5 67.5 188.4 57.7 23.9 68.9 100.1 26.7 46.6 20.1 21.9 54.8 14.8 24.7 38.1 15.2 68.0 33.4 53.9 0.8 73.5 54.6 62.5 53.9 21.4 22.0 22.4 0.3 0.2 0.0 3.1 0.1 8.2 10.6 5.3 5.4 6.9 6.5 1.9 2.7 0.6 3.7 0.0 0.3 13.5 1.8 3.6 4.2 2.6 3.6 4.0 4.6 3.5 3.4 2.6 3.6 5.0 3.5 3.8 2.7 9.6 1.5 2.0 10.3 46.0 34.5 6.4 14.8 1.1 3.7 2.3 0.6 7.2 9.6 3.7 12.5 0.9 2.5 21.5 3.9 9.5 0.3 13.6 2.8 13.7 6.0 1.7 3.9 8.2 19.1 8.3 6.1 22.9 2.5 5.0 0.7 0.0 4.8 0.0 4.4 10.1 4.1 0.3 15.0 1.0 0.9 3.6 23.2 6.5 3.7 1.2 1.0 4.0 0.4 25.9 10.0 2.6 23.6 20.6 15.1 6.4 0.1 8.0 6.6 2.8 3.1 0.3 7.5 8.6 50.3 4.5 5.7 4.9 24.7 16.6 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295628-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "bone marrow: 50.9;heart muscle: 16.4;lymphoid tissue: 15.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2" HPA037607 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.2 0.6 0.3 7.2 0.7 50.9 0.6 0.4 0.4 1.6 0.3 0.8 0.6 0.6 0.3 0.6 0.7 2.1 16.4 0.3 0.4 0.7 1.3 4.8 14.1 0.6 0.5 0.1 0.2 0.4 0.1 0.3 0.6 0.8 0.6 1.3 0.0 1.5 0.4 1.0 1.3 3.5 1.0 0.6 15.1 2.7 0.3 0.5 3.7 0.9 0.2 7.4 1.1 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 51.7 0.1 0.1 0.5 19.7 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.4 22.2 0.0 80.3 14.9 45.8 23.8 31.4 16.1 4.7 7.8 18.8 17.1 5.8 11.6 16.3 12.6 23.9 58.4 1.7 6.1 16.5 0.3 0.7 0.4 0.4 0.3 0.4 0.6 0.5 0.1 0.8 0.6 0.5 1.3 0.2 0.0 4.2 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.1 0.3 68.1 2.8 0.0 0.0 0.0 0.1 29.4 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 13.9 0.0 0.0 0.2 1.7 0.5 0.0 15.8 0.0 2.5 0.0 3.7 0.0 0.0 0.0 0.0 12.5 15.5 0.0 0.0 20.3 1.8 0.0 28.4 0.0 47.4 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.4 0.0 16.0 0.0 0.0 0.0 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 35.2;pituitary gland: 21.9;retina: 32.9;skin 1: 29.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.5;Excitatory neurons: 126.1;Horizontal cells: 37.0;Inhibitory neurons: 103.9;Oligodendrocyte precursor cells: 80.9" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 14.9;RH-30: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 0.4 2.6 14.7 0.3 28.4 0.1 2.4 16.5 35.2 0.3 0.2 0.4 0.2 0.4 0.1 0.1 2.1 0.1 3.5 26.7 21.4 3.1 0.4 0.4 0.1 17.4 28.7 19.8 0.1 0.1 0.9 21.9 0.0 14.7 0.8 0.2 32.9 0.1 0.1 2.7 29.2 0.2 0.3 13.0 0.1 0.1 1.6 24.6 0.4 0.1 1.8 0.0 0.0 0.1 30.1 0.0 0.0 5.6 0.1 0.0 0.1 0.2 0.2 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.2 4.4 0.5 2.8 0.4 0.5 0.0 2.3 0.1 0.0 0.1 1.5 0.1 0.0 0.5 0.1 0.0 0.0 0.1 14.9 1.9 0.0 0.1 1.1 0.1 0.0 0.1 0.6 0.0 2.2 0.1 33.9 0.0 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 1.6 0.0 0.9 0.2 0.0 0.0 4.5 0.0 2.7 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 14.7 28.4 16.5 35.2 26.7 21.4 17.4 28.7 19.8 14.7 13.0 24.6 30.1 0.0 0.0 3.9 24.2 0.2 0.0 0.4 0.1 0.0 33.5 0.0 0.1 12.8 0.0 1.3 0.0 16.7 0.1 0.0 0.0 0.0 0.0 11.4 2.2 1.0 1.6 0.0 0.0 126.1 0.0 0.1 0.5 0.0 0.2 0.0 0.1 0.4 1.1 0.1 37.0 103.9 0.0 0.0 0.3 2.2 13.6 0.3 0.4 0.0 7.5 0.0 10.0 0.0 80.9 5.9 0.0 0.0 0.4 0.0 0.3 0.0 4.2 4.8 18.3 0.0 0.7 0.8 5.0 1.5 0.0 3.1 0.0 0.2 0.0 0.0 0.2 CALCA "CALC1, CGRP, CGRP-alpha" ENSG00000110680 "Calcitonin related polypeptide alpha" "P01258, P06881" 11 14966668-14972351 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters" Hormone "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "parathyroid gland: 179.4;thyroid gland: 155.5" "Cell type enriched" "Detected in some" 64 "Ionocytes: 2368.1" "Cancer enriched" "Detected in many" 7 "lung cancer: 64.7" "Group enriched" "Detected in many" 4 "hypothalamus: 11.7;medulla oblongata: 14.7;pons: 34.8;white matter: 11.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "pons and medulla: 57.9" "HPA059886, HPA064453" Enhanced Supported "Secreted to blood" NA NA 51500 "HPA059886: , HPA064453: " "unprognostic (1.97e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (5.99e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" "unprognostic (3.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.74e-2)" "unprognostic (2.53e-3)" "unprognostic (1.02e-2)" 0.7 0.2 0.6 1.6 0.6 0.0 0.2 0.6 3.9 0.2 0.1 0.4 0.0 0.2 0.0 0.1 0.3 0.2 0.9 0.3 11.7 7.2 37.8 2.4 0.1 14.7 4.5 0.1 0.1 0.4 179.4 0.8 0.0 34.8 2.5 0.1 0.0 0.1 0.0 0.5 0.0 0.1 1.5 1.9 3.0 0.2 0.2 0.5 0.3 155.5 0.0 0.0 4.4 0.4 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 3.9 0.3 11.7 14.7 4.5 0.1 34.8 1.9 0.5 11.6 0.1 0.0 0.0 0.0 0.2 0.3 0.4 35.4 0.0 0.0 0.0 0.1 0.4 0.0 0.3 36.8 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.3 0.0 0.0 0.7 4.4 0.3 0.0 0.0 0.0 2368.1 0.0 4.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.2 0.0 0.0 0.4 5.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 SOX6 ENSG00000110693 "SRY-box transcription factor 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.1" "Cell type enhanced" "Detected in many" "Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.4 1.4 7.3 0.4 6.1 27.1 0.7 3.8 5.3 1.8 4.7 1.1 6.5 0.6 2.0 2.1 4.1 2.6 3.0 4.5 10.5 11.2 4.9 0.8 0.1 8.3 6.8 3.3 0.7 6.8 0.1 2.9 2.5 6.0 0.5 1.3 3.2 0.5 0.7 9.4 5.8 11.1 0.5 8.1 0.5 1.0 14.5 4.6 1.6 3.5 6.0 0.2 0.8 0.8 7.1 0.0 0.7 3.9 3.7 0.0 0.0 0.0 0.3 1.3 0.1 0.1 5.7 0.0 0.0 3.6 0.0 0.0 0.1 4.4 1.1 0.0 0.0 0.5 0.0 0.0 0.3 0.6 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 1.8 0.0 0.0 0.1 0.4 0.0 4.9 0.5 0.0 0.0 0.0 2.6 2.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 7.3 6.1 3.8 5.3 4.5 10.5 8.3 6.8 3.3 6.0 8.1 4.6 7.1 2.7 3.2 6.3 308.9 1.0 40.1 5.8 6.8 66.6 26.3 3.7 2.5 21.6 54.3 3.8 36.8 10.4 1.3 0.1 1.4 9.8 19.8 256.8 29.4 5.3 4.8 7.8 126.7 2.8 3.7 0.6 14.5 2.0 27.8 0.0 1.6 2.2 7.5 1.1 0.0 481.0 6.6 0.0 2.9 3.2 70.1 3.4 1.4 35.6 21.5 0.0 48.4 0.0 1687.9 8.9 5.5 20.3 2.2 0.1 3.2 99.8 27.1 8.3 4.3 0.0 26.2 14.6 22.1 4.5 32.7 16.1 0.5 1.1 3.0 11.8 3.7 C11orf58 SMAP ENSG00000110696 "Chromosome 11 open reading frame 58" O00193 11 16613132-16758340 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036591, HPA076406" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA 100000 "Endoplasmic reticulum" Nucleoplasm "HPA036591: AB_10669909, HPA076406: AB_2686798" "unprognostic (8.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (1.30e-1)" "unprognostic (7.84e-2)" "unprognostic (9.45e-3)" "unprognostic (1.76e-1)" "unprognostic (2.06e-1)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.50e-1)" 143.5 136.4 50.5 130.6 56.2 129.4 95.3 52.4 80.4 92.2 66.3 102.8 90.7 137.4 74.5 173.9 129.1 116.6 161.4 50.6 61.8 116.0 134.0 103.8 164.2 56.2 51.1 46.2 173.6 128.9 116.1 79.3 125.0 57.6 112.7 72.4 95.0 129.7 86.1 214.2 100.6 97.3 114.8 53.4 126.9 112.7 90.4 58.7 139.5 163.6 110.6 129.0 126.3 81.9 66.8 416.1 362.9 390.3 197.0 199.5 162.3 272.8 419.2 213.0 276.2 245.5 348.0 397.7 383.1 315.2 253.7 311.4 242.3 275.0 206.9 232.8 485.8 289.9 342.7 286.8 310.1 243.4 492.8 276.2 182.3 230.6 168.9 336.6 209.7 178.4 232.6 435.2 246.5 191.1 247.8 506.5 211.7 291.1 212.7 197.6 404.3 413.6 196.0 158.6 248.7 269.8 267.4 372.4 273.4 501.4 225.0 244.4 315.7 359.5 336.7 268.2 407.1 388.0 164.0 648.6 525.2 297.2 275.3 326.1 587.6 390.4 552.8 407.8 451.9 482.3 621.9 451.4 435.0 429.7 578.9 506.9 440.6 186.9 433.9 490.1 544.7 522.0 896.2 50.5 56.2 52.4 80.4 50.6 61.8 56.2 51.1 46.2 57.6 53.4 58.7 66.8 188.3 246.8 222.5 41.8 219.8 257.1 275.3 379.8 167.9 169.5 170.9 168.4 206.4 178.7 259.1 200.5 150.1 312.2 242.8 65.6 428.4 249.7 65.6 204.2 202.0 217.3 159.2 213.7 72.5 228.1 346.8 258.2 73.4 139.8 237.3 151.3 175.6 163.8 227.0 143.0 68.6 133.2 299.1 164.3 261.0 34.3 205.9 180.1 229.5 45.0 249.9 230.5 248.2 61.3 63.5 232.3 104.3 204.2 183.0 324.1 103.4 364.6 237.0 215.7 157.8 164.9 246.8 331.6 245.7 142.5 276.6 453.5 217.3 188.2 118.7 296.6 PITPNM1 "DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1" ENSG00000110697 "Phosphatidylinositol transfer protein membrane associated 1" O00562 11 67491768-67506263 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Distal enterocytes: 69.9;Endometrial ciliated cells: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 91.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060227 Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA060227: AB_2684226" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" "unprognostic (1.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.83e-2)" "unprognostic (8.68e-2)" "unprognostic (8.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.77e-1)" "unprognostic (2.26e-2)" "unprognostic (4.61e-1)" "unprognostic (3.27e-2)" "unprognostic (2.32e-2)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (4.62e-2)" "unprognostic (5.69e-2)" 8.2 24.7 18.5 24.6 11.6 27.0 6.5 6.5 22.3 10.1 10.2 14.6 18.9 9.3 2.4 19.7 23.3 9.1 17.9 12.4 20.7 26.5 11.1 16.4 27.8 11.5 28.2 11.9 4.0 9.9 10.4 26.9 8.0 15.5 10.5 7.6 41.1 8.8 10.4 7.0 5.0 21.3 6.0 1.1 21.8 16.1 8.9 51.2 17.5 15.8 18.5 17.3 16.3 9.4 13.3 12.7 31.2 18.8 13.9 20.3 12.1 30.5 12.2 21.5 14.8 8.4 28.5 22.6 12.5 28.7 17.5 28.4 32.4 14.5 27.0 4.8 91.0 6.0 17.0 55.8 10.8 16.0 19.4 35.3 15.0 17.0 22.4 14.7 27.4 17.9 18.7 13.2 11.0 12.5 19.1 33.2 45.6 19.3 35.9 13.5 23.7 6.0 17.3 24.4 25.1 18.1 11.5 27.3 37.6 29.6 9.0 7.4 16.9 17.7 26.5 20.1 16.9 8.9 16.0 8.3 11.2 37.1 22.7 10.6 0.0 1.4 0.9 1.1 3.3 1.0 0.7 0.8 1.0 1.0 0.5 0.3 0.8 1.4 0.1 2.7 0.4 0.7 1.1 18.5 11.6 6.5 22.3 12.4 20.7 11.5 28.2 11.9 15.5 1.1 51.2 13.3 7.5 3.2 5.8 2.0 10.8 8.2 6.3 9.3 13.6 45.7 5.4 5.2 8.4 5.7 9.7 20.2 64.6 4.6 10.6 69.9 3.9 11.3 6.1 63.3 16.5 4.9 11.4 0.4 5.1 9.3 8.9 4.2 34.7 24.6 2.5 7.1 3.3 3.4 8.4 38.7 6.6 16.8 10.2 13.2 14.0 17.0 2.1 15.2 3.6 10.3 13.5 20.7 3.1 0.5 0.5 15.9 32.7 1.2 7.5 9.8 39.0 18.9 37.8 53.7 0.0 6.3 9.8 1.4 5.5 11.2 3.3 15.2 14.9 1.4 24.0 19.4 RPS13 S13 ENSG00000110700 "Ribosomal protein S13" P62277 11 17074388-17077715 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005985 Uncertain Approved "Endoplasmic reticulum" NA NA 190000 "Endoplasmic reticulum" "HPA005985: AB_10960703" "unprognostic (7.74e-3)" "unprognostic (2.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.21e-3)" "unprognostic (2.88e-1)" "unprognostic (4.85e-2)" "unprognostic (8.68e-3)" "unprognostic (3.81e-1)" "unprognostic (1.41e-1)" "unprognostic (3.74e-2)" "unprognostic (8.20e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (5.71e-2)" "unprognostic (3.85e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" 1090.9 739.8 855.3 829.2 884.0 2425.1 2086.3 870.8 1215.0 1280.9 885.7 1146.3 862.4 1125.8 1162.6 1171.0 1296.4 958.7 1074.5 823.9 916.9 853.2 1110.6 702.7 2047.8 897.0 864.4 807.3 2693.7 1750.8 651.6 524.4 989.5 898.2 821.1 1147.0 666.6 1379.9 837.4 1952.8 1461.8 824.6 955.3 939.4 1112.3 970.5 359.8 894.1 1753.3 1005.8 1539.4 1860.6 1330.9 1079.0 939.3 2115.6 1619.7 1524.1 1279.1 2680.1 4138.4 1660.6 1430.9 1991.9 2194.7 1774.8 2580.3 2640.4 3164.1 975.4 1710.4 1405.0 1546.0 2213.2 2387.6 2309.0 1326.2 4617.5 1347.9 1531.6 2761.0 3226.4 2821.8 1400.8 3174.0 3942.6 917.4 3647.4 2486.7 2632.2 2073.1 2128.5 1736.5 2173.6 2173.4 2377.2 3920.5 1727.0 2853.9 3099.3 2189.8 2064.2 2008.3 2147.5 2483.2 1249.0 2080.7 682.1 2723.3 3495.9 1527.1 1238.1 4255.9 1550.7 997.4 1660.5 2271.0 1835.2 1186.2 2726.3 2444.2 1143.1 2407.0 1352.5 582.6 2489.7 362.9 1356.0 1807.4 2715.0 3719.8 2904.9 2027.9 3004.4 3245.9 4371.9 3365.9 232.1 1880.4 1483.8 3192.8 2173.3 6018.5 855.3 884.0 870.8 1215.0 823.9 916.9 897.0 864.4 807.3 898.2 939.4 894.1 939.3 2429.5 926.3 1565.1 24.8 4390.9 4567.0 4447.1 4666.4 4408.4 271.6 5079.9 8516.0 778.1 1998.8 2361.4 665.8 104.3 3971.3 2743.0 912.1 2915.1 2434.7 1352.5 1075.0 2375.9 2226.1 1369.9 2311.8 19.4 4554.7 5434.6 2170.0 1711.1 1305.6 1506.6 2246.3 2328.4 2036.1 2923.8 90.9 24.7 2896.7 1501.4 4367.6 4707.0 1820.3 3551.8 2950.1 2180.6 30.9 4862.5 1677.2 2326.5 18.6 33.1 2988.2 2321.6 1774.6 2669.5 4100.7 1793.2 3790.7 1206.8 482.6 874.4 3314.3 2545.4 616.6 352.4 5638.8 5447.9 4488.7 3426.6 2642.9 3153.8 4835.4 AIP "ARA9, FKBP16, FKBP37, XAP2" ENSG00000110711 "Aryl hydrocarbon receptor interacting protein" O00170 11 67483026-67491103 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cushing syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033674, HPA050217, CAB069477" Approved Supported Cytosol NA NA 13000 Cytosol "CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055" "unprognostic (2.59e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.15e-2)" "unprognostic (9.54e-2)" "unprognostic (4.02e-2)" "unprognostic (2.17e-2)" "unprognostic (1.14e-1)" "unprognostic (6.19e-3)" "unprognostic (2.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.16e-1)" "unprognostic (5.28e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (9.45e-2)" 61.8 58.6 67.7 47.8 71.0 40.8 59.1 68.7 83.0 81.4 63.3 67.9 34.0 71.6 32.7 39.3 67.5 39.8 70.7 65.0 69.5 68.1 52.0 62.9 90.3 70.6 67.3 63.8 78.6 49.2 35.7 51.4 33.8 70.5 61.4 20.3 23.1 40.9 36.4 46.8 39.2 65.3 29.1 68.2 85.8 57.5 29.9 68.7 79.4 64.1 46.2 49.5 73.7 63.1 75.1 80.8 91.1 51.6 49.9 64.8 64.2 39.3 49.7 61.2 83.6 60.9 143.7 77.9 142.2 118.1 55.3 63.5 63.9 59.2 51.9 32.1 209.3 63.5 86.5 98.7 87.0 67.1 87.5 145.1 77.8 48.3 74.6 48.4 81.4 43.0 138.6 50.0 83.6 55.5 153.7 187.7 214.6 49.0 122.0 115.7 82.2 78.5 126.5 59.5 47.2 81.4 81.3 64.4 45.5 204.3 19.9 60.9 87.2 71.5 73.4 71.1 108.9 46.3 67.4 99.8 112.7 100.4 67.4 57.7 192.5 117.9 135.6 194.3 144.6 212.0 241.6 227.4 227.6 179.8 221.5 203.4 194.7 78.2 165.3 175.0 207.9 352.4 182.4 67.7 71.0 68.7 83.0 65.0 69.5 70.6 67.3 63.8 70.5 68.2 68.7 75.1 57.2 32.1 25.6 6.8 69.4 30.3 35.8 54.2 31.9 36.8 24.6 33.1 23.1 30.0 33.7 49.7 4.2 56.4 61.9 50.1 82.2 46.8 25.3 12.7 31.0 54.0 31.8 22.5 4.0 42.2 63.5 51.0 23.4 18.0 77.3 51.7 45.7 23.3 66.7 37.0 4.9 34.7 48.8 65.0 54.6 14.2 53.1 56.1 56.9 5.6 72.5 49.6 76.2 5.0 10.5 41.2 53.5 35.3 50.2 42.7 86.1 98.3 17.4 29.4 39.5 36.4 86.5 21.7 28.4 19.4 21.2 59.5 90.6 42.0 25.4 52.2 NUP98 "NUP96, Nup98-96, Nup98-Nup96" ENSG00000110713 "Nucleoporin 98 and 96 precursor" P52948 11 3671083-3797792 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 118.7;Late spermatids: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (7.41e-2)" "unprognostic (2.13e-1)" "unprognostic (7.71e-3)" "unprognostic (3.40e-1)" "unprognostic (4.08e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (7.76e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (5.09e-1)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" 23.1 14.9 7.8 25.4 8.9 76.7 25.6 15.4 12.1 22.0 14.1 21.3 18.0 22.4 20.9 23.3 21.0 21.8 21.0 7.6 27.1 19.5 32.2 23.6 27.9 9.8 9.4 6.7 28.7 24.2 25.9 16.8 25.8 10.2 22.1 23.9 23.4 23.5 22.5 42.2 20.9 17.8 23.6 7.4 22.1 17.8 79.1 9.4 34.8 29.4 31.3 30.9 33.0 18.7 13.2 81.2 63.7 51.7 54.5 54.7 46.1 44.5 57.9 67.7 78.3 69.9 69.4 97.4 80.6 26.0 68.6 77.1 85.5 90.0 56.1 105.6 56.7 67.0 86.4 51.7 48.1 46.1 111.1 67.5 51.9 37.6 41.8 75.2 33.7 61.9 88.3 109.3 60.6 82.5 33.2 110.2 36.3 64.5 87.8 48.4 65.9 62.6 37.8 43.4 63.4 46.8 31.5 83.4 64.9 38.1 52.0 40.5 43.4 45.9 59.9 51.1 67.5 53.0 37.0 67.0 83.5 41.0 46.5 64.4 40.5 11.7 23.3 15.0 15.0 15.1 12.8 14.7 13.5 14.3 10.8 16.1 14.4 35.2 9.7 9.5 3.9 20.1 13.3 7.8 8.9 15.4 12.1 7.6 27.1 9.8 9.4 6.7 10.2 7.4 9.4 13.2 24.7 28.9 25.2 32.7 37.4 49.8 36.3 12.6 34.7 14.9 28.2 24.5 19.5 22.8 20.1 7.3 16.7 22.2 41.6 18.8 3.9 12.2 118.7 32.1 30.4 22.5 21.5 42.5 43.6 11.8 17.5 22.7 42.3 62.0 18.3 16.3 15.7 23.6 16.8 15.2 43.7 15.1 6.1 19.8 51.1 158.6 17.1 29.3 16.0 25.3 24.9 11.1 12.3 31.7 44.4 13.2 16.1 14.3 36.3 25.1 11.8 9.0 16.6 14.1 32.9 36.9 23.2 56.2 31.0 30.3 50.4 46.5 44.5 13.7 19.5 32.5 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 833.5;Late spermatids: 797.2;Proximal tubular cells: 927.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018524, HPA067429" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA018524: AB_1854355, HPA067429: " "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 90.7 310.9 133.5 39.1 140.0 56.7 88.4 148.0 181.7 72.0 152.8 129.5 82.2 90.0 27.4 116.2 82.0 29.4 400.7 135.7 142.2 189.1 153.2 73.7 42.5 140.6 135.4 131.9 68.7 98.5 75.3 131.7 33.9 137.7 119.2 37.1 49.9 97.0 67.3 410.3 91.2 85.1 39.3 133.3 77.5 138.9 105.5 144.9 40.7 102.6 277.9 30.3 95.2 76.6 139.4 152.9 366.4 94.6 137.0 70.9 63.5 132.4 102.3 88.5 155.6 118.9 338.4 159.6 118.4 186.8 85.9 134.6 181.2 108.8 128.4 53.1 139.4 264.9 107.2 217.1 186.3 171.8 99.1 112.1 80.5 126.5 111.1 124.8 82.0 106.2 159.9 110.3 121.1 99.2 358.6 219.2 216.9 125.2 377.7 308.0 154.4 95.9 384.9 192.8 123.3 125.5 102.2 75.7 171.7 392.3 66.5 245.6 105.9 84.1 155.6 133.9 224.8 148.8 165.2 188.5 99.7 252.3 121.8 111.2 84.7 220.1 124.0 182.4 232.0 170.1 183.3 154.6 165.5 309.4 156.3 146.2 164.2 20.7 309.6 131.7 324.3 202.2 232.4 133.5 140.0 148.0 181.7 135.7 142.2 140.6 135.4 131.9 137.7 133.3 144.9 139.4 88.7 89.8 90.1 18.6 92.3 85.4 95.5 284.3 104.7 83.4 147.2 156.7 301.9 143.0 164.9 213.3 54.2 279.6 97.8 301.0 833.5 200.8 225.7 101.1 74.8 85.3 205.0 149.8 13.6 199.3 165.9 109.6 147.3 79.7 95.8 156.5 73.5 231.7 276.6 50.5 19.3 277.2 240.1 124.1 108.0 797.2 100.6 128.7 163.7 13.1 187.4 143.6 128.8 12.1 15.4 173.7 194.9 108.0 157.8 118.6 337.1 927.8 120.8 118.7 59.2 81.2 208.6 105.9 72.7 209.7 116.2 172.4 102.7 278.7 318.2 139.1 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039025-68050895 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 291.6" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 135.5;Kupffer cells: 115.2;Macrophages: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 131.9;RPMI-8226: 138.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria NA NA Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favorable (9.45e-6)" 55.2 113.4 7.7 46.6 7.4 98.6 47.6 9.3 13.1 81.6 13.1 62.4 44.6 58.5 18.8 45.6 62.0 11.8 28.0 6.3 12.2 35.6 62.2 114.9 31.2 11.0 7.8 5.3 49.5 291.6 4.4 20.5 14.2 9.7 72.8 8.1 0.3 58.4 16.2 10.6 24.5 87.7 12.2 8.6 196.4 59.7 6.7 15.1 12.2 52.9 3.9 13.5 56.5 61.2 12.6 31.8 57.2 0.8 0.2 25.1 19.7 39.0 61.5 29.4 17.2 16.3 1.3 92.0 2.7 32.9 21.9 26.2 39.0 3.7 23.5 3.6 82.1 1.9 22.0 80.6 18.9 23.4 16.3 131.9 22.8 13.5 21.2 1.4 0.0 11.8 1.2 11.6 8.4 5.7 10.7 0.8 97.8 3.5 44.6 14.4 26.8 0.9 138.6 16.2 17.6 3.0 0.7 26.0 33.4 16.8 6.1 36.3 41.1 42.3 33.2 25.9 93.3 11.4 1.3 1.2 4.8 74.0 26.7 16.2 21.7 65.5 72.8 15.7 109.0 12.7 11.3 11.7 16.9 49.0 7.5 6.6 7.2 150.0 32.1 144.3 33.8 12.1 47.8 7.7 7.4 9.3 13.1 6.3 12.2 11.0 7.8 5.3 9.7 8.6 15.1 12.6 40.6 28.9 59.8 0.3 37.1 6.2 13.2 36.2 7.4 0.7 14.9 8.9 1.6 18.6 57.1 7.3 0.0 21.7 60.6 74.2 0.0 30.4 0.4 13.3 16.7 22.1 23.9 15.2 0.3 67.0 54.1 24.9 135.5 21.5 50.0 29.5 21.0 17.8 105.1 0.0 0.6 32.4 18.3 115.2 22.8 0.6 5.9 132.3 5.4 8.4 74.9 0.7 45.3 0.5 0.1 51.8 85.4 13.2 59.1 10.6 45.5 2.0 47.9 1.0 39.5 7.7 26.0 0.1 2.9 10.4 5.3 26.5 46.5 9.0 36.2 19.0 CHKA "CHK, CKI" ENSG00000110721 "Choline kinase alpha" P35790 11 68052859-68121444 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 179.6;Early spermatids: 357.3;Late spermatids: 267.3;Oligodendrocytes: 203.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 183.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024153, CAB072803" Approved Approved "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "CAB072803: , HPA024153: AB_1846664" "unprognostic (5.16e-2)" "unprognostic (1.46e-1)" "unprognostic (2.52e-1)" "unprognostic (2.51e-1)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (7.75e-4)" "unprognostic (2.36e-3)" "unprognostic (1.66e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (5.97e-3)" "unprognostic (5.00e-2)" "unprognostic (6.06e-2)" "unprognostic (1.82e-1)" "unprognostic (4.73e-2)" 16.1 36.1 49.4 7.2 53.9 34.1 21.1 52.2 58.2 16.3 51.3 22.2 21.8 12.3 20.7 6.3 13.3 10.4 13.7 48.8 52.4 18.8 43.6 18.0 9.1 56.3 54.4 48.5 20.3 38.3 8.0 21.8 5.2 60.9 31.3 12.9 21.3 45.3 16.6 8.3 8.2 23.3 5.5 53.2 30.2 40.3 76.2 53.2 5.8 43.9 4.6 5.5 19.5 9.3 71.8 25.6 21.3 24.2 24.1 8.0 6.1 24.5 7.7 13.6 22.5 14.4 92.2 70.5 18.9 27.4 12.4 23.2 16.2 34.4 5.6 18.5 8.7 12.1 23.8 29.6 106.9 22.9 25.6 12.5 11.0 9.4 10.0 4.8 12.3 12.7 11.9 23.1 34.7 12.0 19.4 14.6 68.4 40.1 83.2 14.2 21.3 26.1 54.6 18.1 27.3 17.9 19.6 14.9 74.6 183.8 19.9 31.6 34.4 7.3 14.2 16.3 32.4 10.4 37.0 42.5 34.4 14.6 32.8 13.0 0.0 0.8 6.1 0.1 1.5 0.0 0.7 0.1 0.2 0.9 0.3 0.4 0.2 0.4 1.1 0.9 0.7 0.2 0.2 49.4 53.9 52.2 58.2 48.8 52.4 56.3 54.4 48.5 60.9 53.2 53.2 71.8 27.2 44.8 36.6 179.6 10.1 15.8 16.6 6.5 18.2 10.6 49.4 35.7 3.6 35.8 20.2 3.7 33.3 8.2 14.2 48.1 13.7 9.6 357.3 42.7 16.2 13.6 28.1 6.7 89.0 19.3 3.4 9.2 37.2 59.0 19.0 23.4 11.7 19.8 17.6 57.2 63.2 16.3 0.0 28.5 19.4 267.3 6.2 31.0 23.2 59.0 8.5 21.4 2.1 100.0 203.5 18.4 18.0 2.6 10.1 17.3 21.6 4.6 23.1 28.4 0.0 9.6 9.8 121.9 20.7 9.2 10.4 13.0 8.2 16.9 31.7 39.2 EXPH5 SLAC2-B ENSG00000110723 "Exophilin 5" Q8NEV8 11 108505435-108593768 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 67.8;skin 1: 26.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Basal keratinocytes: 107.7;Glandular and luminal cells: 89.5;Respiratory ciliated cells: 98.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 7 "cerebellum: 67.8;pons: 17.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 7.9;hTERT-HME1: 11.2;RT4: 20.5;SK-BR-3: 9.7" "Group enriched" "Detected in many" 4 "cerebellum: 20.9;cerebral cortex: 6.7" "Region enriched" "Detected in many" 8 "cerebellum: 30.9" NA NA "unprognostic (1.34e-3)" "unprognostic (8.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (3.42e-6)" "unprognostic (2.91e-1)" "prognostic favorable (1.46e-4)" "unprognostic (4.57e-3)" "prognostic favorable (5.12e-4)" "unprognostic (1.26e-1)" "unprognostic (3.03e-1)" "unprognostic (5.56e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.18e-2)" "unprognostic (2.57e-1)" "unprognostic (3.36e-1)" "unprognostic (4.51e-1)" 0.4 0.1 4.9 0.5 1.6 0.2 2.9 67.8 1.9 2.2 10.0 3.9 0.7 0.7 2.7 7.5 1.7 0.3 0.2 2.1 6.0 2.4 7.8 3.9 0.1 1.5 3.8 0.2 0.3 1.0 4.7 0.5 2.8 17.8 1.5 4.4 0.3 4.4 0.3 0.1 26.1 0.8 0.4 1.1 0.2 3.2 0.7 1.7 0.8 1.0 0.2 1.5 0.7 3.8 3.3 3.9 0.4 0.2 0.1 0.0 0.1 3.2 0.2 0.1 0.0 0.6 1.0 5.9 0.0 0.2 0.2 0.9 7.9 5.7 2.1 0.2 0.1 1.7 1.6 0.8 0.0 0.5 0.8 0.1 0.1 3.3 0.0 11.2 0.5 0.0 1.3 3.0 0.0 3.1 0.6 1.0 0.0 0.2 6.4 2.4 0.0 0.1 0.0 0.6 20.5 1.4 0.8 1.0 9.7 0.2 1.1 6.4 0.1 0.1 0.0 2.3 0.0 1.1 0.1 0.0 0.0 0.1 0.4 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.5 0.5 0.8 0.9 0.1 0.2 0.0 0.1 4.9 1.6 67.8 1.9 2.1 6.0 1.5 3.8 0.2 17.8 1.1 1.7 3.3 0.6 147.4 60.0 18.6 0.9 107.7 12.9 16.6 58.6 0.6 14.1 8.6 5.7 4.3 65.3 20.2 14.6 44.5 2.4 47.9 3.9 5.4 10.3 74.8 7.8 2.5 4.9 3.2 9.0 4.9 4.9 5.6 20.9 89.5 1.3 0.9 0.7 24.2 3.8 0.0 4.9 38.6 14.2 0.6 15.2 2.3 0.6 1.8 5.4 16.9 1.3 0.5 1.0 3.0 0.6 3.6 17.5 0.0 1.5 30.4 1.9 3.7 98.5 1.4 0.0 0.3 2.1 1.1 0.5 46.9 72.2 54.6 2.8 0.4 29.1 19.3 HPS5 "AIBP63, BLOC2S2, RU2" ENSG00000110756 "HPS5 biogenesis of lysosomal organelles complex 2 subunit 2" Q9UPZ3 11 18278668-18322198 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 36.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 96.1" "Cancer enhanced" "Detected in all" "melanoma: 19.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077851 Approved Supported Cytosol NA NA Cytosol "HPA077851: " "unprognostic (2.25e-2)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "unprognostic (2.59e-1)" "unprognostic (9.85e-3)" "unprognostic (5.89e-1)" "unprognostic (1.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.06e-1)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (2.72e-1)" 6.4 8.4 4.3 5.9 5.2 3.8 10.6 4.7 4.6 5.2 5.9 4.8 6.1 5.0 2.9 7.4 5.1 4.0 5.6 3.9 7.2 5.4 36.0 8.7 9.3 5.5 4.8 3.5 7.1 6.9 3.7 8.6 7.1 5.4 4.8 3.3 9.0 16.4 3.5 5.6 6.3 8.1 4.0 5.2 9.1 4.7 14.9 5.4 5.9 6.0 3.1 8.4 4.9 5.5 7.3 5.9 8.5 9.0 9.1 11.9 6.6 9.8 15.3 12.6 9.9 10.4 5.3 1.8 14.1 5.8 13.3 12.4 8.3 10.6 10.1 12.1 11.8 7.7 6.9 7.1 6.7 11.2 15.2 12.4 10.6 9.9 6.1 12.9 10.0 8.0 9.0 9.1 8.0 16.1 4.8 8.1 11.0 4.5 6.8 9.3 11.8 12.9 6.0 9.6 5.3 3.0 5.9 19.2 6.8 22.8 8.9 5.1 8.8 5.9 11.3 6.1 14.8 7.1 3.4 12.0 16.1 6.2 7.8 32.4 12.3 3.6 2.9 2.1 5.4 2.6 5.3 2.6 2.2 8.3 4.4 2.5 2.6 1.0 2.8 6.0 3.2 2.6 2.5 4.3 5.2 4.7 4.6 3.9 7.2 5.5 4.8 3.5 5.4 5.2 5.4 7.3 17.2 96.1 14.6 13.1 30.8 15.6 14.2 16.2 12.5 17.5 17.4 23.0 18.2 17.2 14.7 7.3 31.3 22.2 16.0 4.7 5.9 5.2 50.9 20.7 11.2 13.4 10.7 11.6 16.7 8.4 10.6 11.8 18.3 30.0 14.5 17.8 7.9 45.1 18.1 10.1 21.0 5.0 12.2 22.7 45.0 18.6 8.4 35.8 28.4 11.2 32.3 16.1 0.0 21.1 24.0 6.2 8.5 13.2 17.4 15.2 27.1 6.5 21.1 26.1 6.6 17.1 13.1 16.2 12.6 19.6 15.3 17.4 17.8 10.5 6.0 21.8 GTF2H1 "BTF2, P62, TFIIH" ENSG00000110768 "General transcription factor IIH subunit 1" P32780 11 18322295-18367045 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004637, HPA046660" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004637: AB_425470, HPA046660: AB_2679743" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (9.78e-2)" "unprognostic (2.38e-1)" "unprognostic (2.63e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (5.98e-9)" "unprognostic (7.71e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (7.42e-3)" "unprognostic (8.31e-2)" "unprognostic (1.24e-1)" "unprognostic (7.90e-2)" "unprognostic (2.94e-1)" 18.9 18.4 6.3 7.7 6.8 4.8 18.3 8.1 7.3 16.2 9.7 16.5 7.5 15.8 8.2 19.6 14.7 9.4 14.4 6.9 6.7 15.0 17.4 14.0 10.9 5.9 6.1 6.6 19.3 18.1 8.2 13.9 10.0 6.5 15.9 8.3 13.2 18.8 10.1 16.8 19.9 14.8 8.5 6.0 17.3 15.3 26.7 6.4 8.9 16.1 8.4 11.2 17.9 17.1 7.7 14.7 13.3 11.0 15.5 25.1 20.1 13.7 21.8 23.6 19.0 21.9 13.9 5.6 24.9 8.4 22.4 27.2 19.8 19.1 20.1 24.1 11.0 18.5 15.9 13.4 14.1 35.8 30.7 16.5 22.4 23.8 11.7 37.3 15.7 17.3 12.8 25.2 12.6 27.7 13.6 15.6 23.3 9.8 24.7 19.8 16.1 23.4 11.3 15.3 19.6 12.5 13.5 17.8 17.1 27.0 9.4 8.8 17.5 12.6 24.9 12.2 45.3 17.8 6.3 16.0 17.7 21.5 24.0 24.4 11.0 5.0 5.4 3.8 5.0 4.2 5.4 4.8 4.3 5.4 5.7 5.8 4.7 3.5 7.5 6.0 2.9 5.2 4.2 6.3 6.8 8.1 7.3 6.9 6.7 5.9 6.1 6.6 6.5 6.0 6.4 7.7 27.8 16.0 18.2 19.2 26.1 48.3 22.7 22.2 39.9 17.3 23.4 20.6 28.3 22.8 21.9 11.0 20.9 26.1 26.8 14.7 7.9 25.2 50.2 19.0 17.7 21.6 7.7 26.1 32.1 30.5 27.5 27.1 21.4 20.2 18.3 20.0 22.1 13.9 25.2 21.9 29.9 12.9 14.2 20.8 27.2 46.1 17.1 28.8 23.2 20.6 25.9 23.4 25.7 24.1 29.4 28.8 10.5 16.1 25.7 23.4 18.6 25.1 23.6 21.2 6.6 23.4 23.2 84.8 30.1 37.6 51.7 28.2 20.4 29.2 16.8 26.8 POU2AF1 "BOB1, OBF1" ENSG00000110777 "POU class 2 homeobox associating factor 1" Q16633 11 111352255-111455630 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 38.9;lymphoid tissue: 120.4;stomach 1: 40.4" "Cell type enriched" "Detected in many" 4 "Plasma cells: 566.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 33.5;naive B-cell: 24.0" "Lineage enriched" "Detected in many" 9 "B-cells: 33.5" "Group enriched" "Detected in many" 4 "Daudi: 307.2;Karpas-707: 339.3;U-266/70: 326.6;U-266/84: 159.9;U-698: 610.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB011193 Enhanced NA NA "CAB011193: AB_532299" "prognostic favorable (1.68e-4)" "prognostic favorable (1.63e-4)" "unprognostic (1.04e-2)" "unprognostic (5.50e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.59e-4)" "unprognostic (2.09e-1)" "unprognostic (3.63e-3)" "unprognostic (7.15e-2)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" "unprognostic (4.81e-2)" "unprognostic (8.51e-8)" "unprognostic (2.35e-1)" "unprognostic (3.90e-1)" "unprognostic (7.14e-3)" "unprognostic (1.23e-1)" 2.0 1.2 6.5 49.4 5.5 8.2 5.6 4.1 7.4 1.7 16.5 15.9 22.4 1.6 1.3 2.9 1.3 4.8 1.4 5.8 2.6 1.4 1.4 3.3 100.1 7.0 5.8 4.3 1.2 0.6 0.3 0.1 2.8 7.3 1.9 13.5 6.6 13.0 1.9 1.8 1.1 38.9 1.2 2.6 80.1 40.4 1.7 5.7 9.7 2.8 0.3 120.4 9.4 1.9 7.2 0.9 0.9 0.3 0.4 5.6 5.2 1.0 0.2 0.1 0.1 0.1 1.1 0.3 307.2 0.7 0.3 0.2 0.8 0.9 0.4 0.1 0.9 0.2 0.5 1.0 1.1 0.1 0.6 1.7 0.2 0.3 0.3 0.6 0.5 0.3 3.4 11.8 339.3 0.3 0.8 1.5 1.6 0.4 0.5 0.5 65.3 0.7 83.0 0.2 0.8 0.6 6.1 0.7 0.3 0.2 2.4 1.3 0.9 2.7 0.5 3.1 0.6 0.5 326.6 159.9 610.8 0.4 0.7 0.5 3.8 0.2 0.6 0.3 0.2 0.2 33.5 0.5 0.2 0.1 24.0 0.4 0.2 1.6 0.5 0.4 0.3 1.2 1.2 6.5 5.5 4.1 7.4 5.8 2.6 7.0 5.8 4.3 7.3 2.6 5.7 7.2 0.0 0.0 3.6 0.3 131.3 0.3 7.1 12.3 0.0 0.0 0.0 0.9 1.9 10.0 20.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 8.4 24.9 0.6 0.2 3.0 6.6 0.1 5.7 0.0 0.8 4.6 0.5 0.0 0.1 0.7 2.4 0.1 0.0 0.1 0.7 2.0 0.6 0.4 10.9 0.3 0.8 8.8 1.0 0.3 0.0 1.0 0.0 4.6 0.4 1.2 0.4 566.8 1.2 0.0 0.4 65.0 0.0 0.0 0.1 1.0 6.3 1.8 0.8 0.0 0.0 4.2 0.0 0.8 8.4 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 135.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 59.0;Inhibitory neurons: 51.9" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;NTERA-2: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: AB_2686487" "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 1.5 0.5 26.6 0.2 135.1 0.1 1.1 0.3 59.3 0.5 0.0 0.8 0.1 0.8 0.0 0.5 1.1 0.3 7.4 32.1 21.6 0.3 0.0 1.5 0.1 24.9 7.2 42.7 2.1 0.4 0.2 2.2 0.0 47.2 1.0 0.3 2.0 1.2 0.6 0.7 0.5 0.6 0.4 2.3 0.4 0.9 2.9 17.4 0.0 0.7 3.3 0.0 1.0 1.1 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 135.1 0.3 59.3 32.1 21.6 24.9 7.2 42.7 47.2 2.3 17.4 33.3 0.1 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.2 6.9 0.0 0.0 59.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.3 0.0 12.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 2.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 VWF F8VWF ENSG00000110799 "Von Willebrand factor" P04275 12 5948877-6124770 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Cancer-related genes, Disease variant, FDA approved drug targets, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Adipocytes: 904.3;Endothelial cells: 737.5;Hepatic stellate cells: 424.4" "Cancer enhanced" "Detected in all" "renal cancer: 76.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 56 "HUVEC TERT2: 560.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001694, HPA001815, HPA002082, CAB072874, CAB072875" Supported "Secreted to blood" NA NA 28300000000 5600000000 "CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (2.91e-3)" "unprognostic (7.09e-2)" "unprognostic (4.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.92e-2)" "unprognostic (4.69e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.55e-1)" "unprognostic (3.12e-1)" "unprognostic (2.73e-3)" 152.3 5.9 39.0 20.4 31.8 0.8 118.3 31.1 43.1 43.9 44.4 32.6 12.9 51.6 10.7 22.1 46.1 30.4 115.2 26.0 30.3 9.5 2.2 107.1 23.0 52.1 35.9 14.8 22.2 15.1 27.5 6.3 73.3 44.4 27.6 9.3 3.0 18.3 19.4 57.5 21.3 34.7 44.6 29.1 44.4 25.9 10.9 47.8 7.1 51.2 52.1 9.6 40.1 35.8 35.6 0.0 0.0 0.0 0.0 0.7 0.6 0.5 0.0 0.6 0.2 0.4 0.0 0.3 0.0 1.2 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 560.9 0.0 0.0 0.1 0.0 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.3 0.5 0.4 0.0 0.1 10.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 39.0 31.8 31.1 43.1 26.0 30.3 52.1 35.9 14.8 44.4 29.1 47.8 35.6 904.3 12.8 25.7 3.6 1.0 6.6 0.6 1.3 4.6 0.0 4.5 4.7 112.2 1.5 1.7 11.0 0.0 1.1 2.6 0.0 0.0 0.5 6.8 2.0 1.6 737.5 0.0 2.7 2.9 0.0 0.9 21.1 0.0 2.1 5.7 0.1 424.4 3.3 0.5 0.0 2.2 0.0 4.1 5.3 3.4 15.5 5.9 2.6 5.4 75.9 0.3 0.7 0.0 1.5 4.2 0.0 0.0 0.7 0.0 1.3 0.0 0.1 1.0 1.7 0.0 12.4 34.7 2.9 5.7 4.7 4.3 1.0 2.0 10.6 0.0 1.7 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888732-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" NA NA 500000 Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 16.7 4.7 6.5 2.3 6.7 19.4 4.8 6.7 10.1 5.5 9.7 13.9 11.6 7.2 2.2 6.3 6.4 3.8 5.0 6.5 7.3 10.9 4.6 6.0 5.7 7.8 7.8 6.4 5.9 10.7 4.8 3.6 3.9 7.2 4.6 2.2 3.6 8.9 6.8 18.7 6.0 6.2 3.3 7.0 9.0 15.0 5.2 8.4 6.7 5.2 6.0 3.2 4.2 5.6 8.1 54.8 81.8 6.7 12.2 11.2 11.6 13.9 54.5 17.8 27.3 15.5 60.0 6.3 40.5 45.0 28.6 9.2 22.1 20.0 29.1 16.3 78.5 41.6 33.3 40.9 30.5 27.5 23.3 22.7 20.4 14.0 30.4 11.7 9.9 16.6 24.7 30.1 5.3 17.6 63.2 47.1 17.8 14.0 7.1 63.4 35.6 18.3 24.9 13.4 53.9 14.1 19.3 54.4 7.7 29.3 5.8 23.3 11.3 43.3 25.4 29.0 50.1 38.4 30.4 73.0 62.1 45.5 30.1 23.8 41.8 43.6 53.0 33.9 46.2 27.3 47.6 32.6 31.0 38.5 38.5 25.0 21.2 41.3 29.3 41.7 63.7 48.1 51.6 6.5 6.7 6.7 10.1 6.5 7.3 7.8 7.8 6.4 7.2 7.0 8.4 8.1 22.8 48.1 33.7 10.1 32.6 60.5 11.4 64.1 67.2 7.3 40.9 34.8 8.0 34.3 40.0 35.0 18.8 30.3 45.8 66.6 52.8 116.9 34.9 32.6 28.7 29.7 46.6 121.4 12.9 121.4 30.7 30.5 42.8 27.4 44.4 11.0 33.9 26.8 39.8 15.2 10.7 66.5 54.9 37.9 55.3 11.4 37.9 43.6 55.2 7.5 93.9 17.2 35.0 7.1 18.7 138.2 64.2 38.7 73.2 9.5 146.8 100.7 36.6 14.8 39.5 19.5 46.8 33.9 37.5 69.4 71.6 37.8 44.9 12.9 67.7 12.8 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828407-6839847 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 19.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 47.2;Cone photoreceptor cells: 100.1;Horizontal cells: 43.7;Leydig cells: 49.7;Peritubular cells: 38.4;Rod photoreceptor cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 39.6;hTERT-RPE1: 27.3;NTERA-2: 27.5;U-251 MG: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 740000 "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.4 2.7 1.1 1.5 0.9 0.3 3.9 3.8 3.1 11.2 4.8 4.5 0.8 19.4 0.5 1.6 10.0 1.7 3.4 1.4 1.1 1.9 0.6 3.7 0.3 1.4 0.9 1.3 12.5 2.9 4.5 15.5 1.3 2.2 6.0 0.3 4.1 6.6 3.7 0.8 2.8 2.8 3.8 0.0 1.3 3.8 1.2 0.8 0.1 4.3 0.3 0.3 7.9 6.4 0.9 0.0 1.6 7.1 14.0 8.4 10.2 0.3 39.6 22.4 12.2 13.5 0.6 0.0 0.0 0.5 14.9 0.5 0.0 4.4 0.4 2.7 0.1 18.8 1.0 4.2 1.9 5.9 1.0 0.0 11.1 0.4 6.0 3.3 27.3 13.1 1.2 3.7 0.0 5.7 0.0 0.1 0.4 27.5 0.0 1.1 0.0 6.9 0.2 0.6 0.0 2.8 10.5 0.1 0.0 4.8 3.4 0.2 0.2 23.2 12.0 17.5 18.6 27.7 0.1 0.3 0.3 10.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 3.8 3.1 1.4 1.1 1.4 0.9 1.3 2.2 0.0 0.8 0.9 2.3 0.0 0.0 3.3 0.5 0.0 4.9 0.0 2.2 47.2 5.3 5.5 11.1 1.5 1.8 5.5 100.1 0.5 0.1 0.1 1.9 1.4 0.9 0.9 19.6 3.9 1.2 0.0 13.1 2.7 0.5 24.1 2.0 0.4 0.0 0.8 7.9 0.0 1.4 43.7 13.7 2.7 0.0 0.0 0.0 2.2 49.7 0.5 0.0 2.8 1.1 5.3 0.0 5.5 1.3 1.3 0.1 38.4 3.1 5.1 0.4 0.4 1.5 28.8 6.6 7.8 11.9 0.7 0.8 0.8 0.0 1.0 0.9 3.2 0.6 1.5 PPFIBP1 "hSGT2, hSgt2p, L2, SGT2" ENSG00000110841 "PPFIA binding protein 1" Q86W92 12 27523431-27695564 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 201.3;Endothelial cells: 189.5;Excitatory neurons: 206.1;Oligodendrocytes: 202.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001924, HPA071162" Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA001924: AB_1079665, HPA071162: " "unprognostic (5.27e-2)" "unprognostic (5.71e-2)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.73e-2)" "unprognostic (6.94e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.11e-4)" "unprognostic (7.33e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.92e-2)" "prognostic favorable (5.11e-7)" "unprognostic (8.54e-2)" "unprognostic (7.54e-2)" "unprognostic (2.64e-1)" "unprognostic (4.09e-2)" 32.7 27.3 24.6 13.9 28.8 3.4 38.3 1.6 31.3 21.4 20.1 21.5 12.0 28.0 11.5 28.9 26.8 20.3 64.3 30.6 11.0 36.7 26.9 40.0 9.3 13.5 16.3 12.4 85.9 21.5 17.2 19.7 60.7 17.1 24.9 18.4 5.2 21.8 29.6 26.1 30.7 15.2 31.5 7.8 30.1 25.7 12.0 32.3 18.7 39.4 44.7 10.6 24.6 29.7 24.8 18.8 37.1 29.7 25.5 48.4 133.3 52.9 67.0 75.2 38.6 55.4 98.0 55.9 14.2 75.6 135.7 51.5 46.0 16.3 61.0 69.1 32.3 9.0 31.3 28.3 14.6 21.0 9.8 16.9 104.8 41.3 112.1 114.0 75.2 134.0 18.9 16.7 13.9 138.5 14.4 9.1 2.8 53.4 26.8 28.5 14.6 74.0 5.5 56.6 41.0 2.4 12.1 33.4 17.6 91.3 206.5 22.7 14.3 131.3 107.7 36.0 59.8 68.8 0.2 0.4 1.2 119.7 13.7 173.7 0.9 0.2 0.1 0.3 0.0 0.6 0.3 0.5 0.3 0.3 2.7 0.5 0.5 0.6 0.1 0.1 0.9 0.8 0.2 24.6 28.8 1.6 31.3 30.6 11.0 13.5 16.3 12.4 17.1 7.8 32.3 24.8 201.3 99.3 19.8 7.5 9.4 41.0 76.5 42.8 68.3 15.5 19.6 40.3 164.0 10.0 18.3 80.9 4.2 37.2 2.5 8.0 11.7 42.2 3.5 40.2 12.7 189.5 18.6 8.6 206.1 24.8 23.2 74.6 46.9 73.3 3.8 132.8 157.8 14.0 8.9 45.4 68.4 15.9 10.2 16.7 30.9 5.4 21.1 6.2 62.2 174.3 3.1 6.3 0.0 116.6 202.9 33.9 19.7 42.2 4.6 45.0 8.6 48.7 9.0 1.8 19.7 71.7 78.9 2.4 8.6 48.2 27.6 91.9 5.9 25.4 12.5 84.5 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Spermatocytes: 61.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 8.0 16.5 16.5 3.3 15.7 0.8 11.6 13.3 19.0 22.9 12.9 12.9 4.1 18.0 10.5 10.5 19.2 6.5 14.9 16.7 14.7 20.3 9.3 7.4 3.2 16.5 15.1 14.7 25.6 16.1 20.5 26.4 6.5 16.5 17.6 3.4 12.4 13.4 11.9 25.4 11.3 7.7 7.8 13.1 9.6 14.6 34.0 14.7 3.5 29.4 13.6 3.4 14.7 14.7 15.4 7.2 10.5 10.3 10.0 8.4 5.4 9.5 5.8 8.1 6.1 3.0 12.2 15.8 5.8 12.0 7.7 8.6 4.2 6.3 20.1 3.1 4.4 2.5 6.1 4.2 4.4 10.6 2.0 7.8 7.7 16.8 6.1 22.0 13.2 4.9 11.7 3.0 3.0 7.3 6.7 1.4 4.2 4.4 8.2 3.9 5.1 1.6 4.8 13.0 6.6 10.9 13.1 4.7 12.8 7.2 9.4 24.5 5.7 2.0 3.7 14.9 4.9 2.5 7.1 4.3 2.4 11.2 1.5 3.5 0.0 0.1 0.0 0.8 0.1 1.1 0.3 0.8 0.3 0.2 0.6 0.8 0.9 0.0 1.3 0.0 0.5 0.3 0.3 16.5 15.7 13.3 19.0 16.7 14.7 16.5 15.1 14.7 16.5 13.1 14.7 15.4 5.3 12.8 20.3 15.7 4.1 3.6 8.7 10.2 11.4 19.1 6.6 9.7 1.2 5.7 17.5 18.4 10.4 21.9 1.2 1.5 7.9 13.8 28.9 8.6 7.5 5.2 7.7 3.0 19.3 11.1 7.4 7.2 4.1 5.6 2.5 15.6 8.2 3.1 5.4 11.8 22.9 3.2 12.2 1.6 2.1 23.1 11.8 1.5 3.6 6.5 4.9 8.3 2.1 20.6 17.2 6.8 1.1 12.0 1.1 6.7 1.4 5.6 24.5 19.8 13.1 9.8 9.7 61.3 26.6 8.0 6.0 26.4 3.1 9.2 5.2 5.0 CD69 CLEC2C ENSG00000110848 "CD69 molecule" Q07108 12 9752486-9760901 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 170.6;lymphoid tissue: 95.2" "Cell type enhanced" "Detected in many" "B-cells: 1017.1;dendritic cells: 694.0;granulocytes: 1455.3;Plasma cells: 308.8;T-cells: 1185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 26.7;T-cells: 30.8" "Cell line enhanced" "Detected in some" "HL-60: 30.0;JURKAT: 19.5;K-562: 58.4;MOLT-4: 20.9;U-266/70: 22.5;U-698: 25.6;U-937: 97.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002503, HPA050525" Enhanced NA NA "CAB002503: AB_563625, HPA050525: AB_2681157" "prognostic favorable (3.31e-5)" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "unprognostic (7.10e-3)" "unprognostic (4.76e-3)" "unprognostic (9.53e-3)" "unprognostic (9.73e-3)" "unprognostic (1.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.88e-2)" "unprognostic (3.32e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" 9.4 6.3 1.0 48.5 1.0 170.6 19.1 1.3 1.3 9.3 2.0 9.0 8.2 6.1 2.9 12.0 7.7 27.6 2.4 0.8 3.5 4.9 13.0 22.8 95.2 1.8 1.4 0.5 2.7 1.7 2.0 4.0 2.6 1.6 10.5 21.5 0.2 5.1 2.9 0.7 3.8 19.7 14.4 2.0 43.9 11.9 1.3 1.0 57.6 7.0 4.6 60.6 18.1 7.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 1.1 0.0 1.5 0.0 0.0 0.0 0.0 12.1 0.0 0.0 1.5 30.0 1.3 0.1 0.0 0.0 0.0 0.0 0.5 19.5 58.4 0.0 0.0 0.0 20.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.9 8.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 22.5 2.7 25.6 0.0 97.8 0.0 1.3 0.1 5.9 22.9 0.1 30.8 6.0 14.5 16.9 0.1 6.2 20.6 15.6 0.3 26.7 0.0 0.0 7.9 7.3 1.0 1.0 1.3 1.3 0.8 3.5 1.8 1.4 0.5 1.6 2.0 1.0 2.3 13.5 41.7 116.7 0.0 1017.1 18.5 3.8 0.0 10.8 0.1 11.8 14.7 2.0 7.2 5.0 1.8 0.0 0.9 694.0 1.1 0.0 1.1 0.4 5.7 3.6 14.3 0.0 33.7 0.0 0.0 0.3 15.4 63.7 16.7 1455.3 0.0 14.6 2.4 16.6 0.0 0.0 0.2 0.0 15.4 77.1 0.3 0.0 80.1 33.8 10.3 3.2 0.1 57.7 0.0 0.1 0.0 0.1 0.0 308.8 2.2 0.4 2.1 1.5 0.6 0.0 4.3 9.2 0.1 0.3 4.2 18.2 1.9 1185.9 0.0 0.9 3.3 PRDM4 PFM1 ENSG00000110851 "PR/SET domain 4" Q9UKN5 12 107732871-107761272 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024322, HPA067437" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA024322: AB_1855691, HPA067437: AB_2685839" "unprognostic (4.64e-2)" "unprognostic (3.16e-3)" "unprognostic (1.73e-3)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.66e-4)" "unprognostic (9.64e-2)" "unprognostic (9.06e-3)" "unprognostic (5.31e-2)" "prognostic favorable (3.15e-7)" "unprognostic (9.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (2.62e-3)" 12.5 8.7 13.4 12.0 12.7 17.0 11.8 14.5 13.5 12.1 12.5 15.1 13.3 15.3 13.5 15.7 11.9 11.3 8.9 12.1 13.4 21.2 7.1 13.0 12.5 13.0 13.1 12.3 15.1 10.3 44.8 8.2 12.6 13.7 11.6 16.6 21.1 11.6 12.2 12.6 12.2 13.9 14.0 11.4 12.4 12.8 11.7 14.9 11.5 12.7 12.9 14.2 11.6 13.3 14.1 19.2 20.9 22.4 23.4 23.7 24.3 17.1 25.6 33.2 25.4 19.2 14.7 8.1 24.6 10.6 27.2 23.7 13.4 23.5 18.7 27.4 18.1 24.1 19.5 15.5 15.8 30.5 28.1 19.3 29.8 35.3 28.7 49.1 27.6 33.5 22.7 24.0 29.0 30.6 20.1 15.9 24.9 11.7 12.4 28.2 12.8 22.4 24.2 26.2 29.0 27.6 25.8 19.3 13.5 23.5 15.2 16.5 14.1 34.1 19.4 14.0 26.1 21.7 20.3 21.5 17.2 14.2 13.1 14.7 1.1 0.8 1.4 1.9 3.0 1.3 2.6 1.0 1.7 2.3 2.1 1.6 2.0 0.3 1.2 4.2 1.2 2.2 0.8 13.4 12.7 14.5 13.5 12.1 13.4 13.0 13.1 12.3 13.7 11.4 14.9 14.1 10.6 9.6 6.4 4.9 38.3 14.5 9.0 4.2 8.0 13.6 7.6 6.7 7.3 4.3 6.3 12.9 14.6 6.3 9.8 13.3 9.8 14.8 23.4 12.3 19.8 11.2 12.6 6.9 12.0 11.4 7.5 9.7 10.2 21.8 3.8 11.0 11.0 4.6 11.4 33.7 12.2 10.3 2.0 10.3 7.2 28.4 6.2 9.0 8.8 15.0 12.1 7.5 12.3 9.5 12.9 16.6 8.1 4.9 8.2 12.4 14.6 9.7 7.2 11.7 6.6 12.4 10.6 6.3 12.5 12.5 16.9 4.8 11.1 6.4 12.0 10.2 CLEC2B "AICL, CLECSF2, HP10085" ENSG00000110852 "C-type lectin domain family 2 member B" Q92478 12 9852369-9869386 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 114.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 393.1;dendritic cells: 255.7;NK-cells: 265.7;Suprabasal keratinocytes: 240.8;T-cells: 276.6" "Cancer enhanced" "Detected in all" "cervical cancer: 26.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 221.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 56.7;ASC TERT1: 87.7;fHDF/TERT166: 49.5;HSkMC: 50.3;U-937: 229.5" "Low region specificity" "Detected in all" HPA008194 Enhanced "Intracellular and membrane" NA NA "HPA008194: AB_1078533" "unprognostic (3.14e-2)" "unprognostic (4.27e-2)" "unprognostic (2.14e-2)" "unprognostic (9.69e-3)" "unprognostic (4.83e-2)" "unprognostic (2.51e-1)" "unprognostic (5.99e-2)" "unprognostic (4.45e-1)" "unprognostic (1.79e-1)" "unprognostic (3.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.50e-1)" "prognostic unfavorable (5.64e-13)" "unprognostic (8.09e-2)" "unprognostic (7.12e-3)" "unprognostic (5.70e-2)" "unprognostic (2.79e-1)" 32.3 7.5 10.2 22.1 10.0 114.0 23.7 11.9 20.2 22.8 12.0 9.5 7.2 20.1 6.6 17.6 15.6 20.6 13.4 9.7 9.8 8.1 16.5 39.7 32.5 11.5 9.6 8.8 33.4 2.5 2.9 4.2 17.8 11.3 9.9 13.7 2.4 12.8 6.1 17.3 80.6 14.1 14.6 10.0 45.0 9.2 3.0 11.8 16.4 10.5 20.8 16.1 20.0 24.1 12.4 0.3 2.6 0.0 0.2 56.7 87.7 0.4 1.6 11.0 0.8 2.9 0.1 1.8 1.2 0.9 49.5 32.8 17.4 8.0 0.1 0.2 1.8 0.1 2.3 0.1 0.1 19.9 2.0 0.4 50.3 18.1 2.2 0.4 2.9 29.1 9.0 0.1 7.4 13.0 0.1 15.2 4.1 0.3 0.0 2.0 20.9 0.4 0.1 0.1 18.3 0.1 0.0 0.8 0.2 13.9 0.2 3.6 0.6 41.8 0.4 9.2 1.6 5.3 13.2 1.2 1.7 13.5 229.5 16.8 54.8 37.8 14.6 68.2 58.1 55.4 12.6 42.3 69.7 34.5 20.0 40.2 62.2 221.4 67.2 75.6 12.6 36.0 84.4 10.2 10.0 11.9 20.2 9.7 9.8 11.5 9.6 8.8 11.3 10.0 11.8 12.4 216.3 3.2 23.1 0.0 102.0 201.6 76.4 393.1 106.4 0.1 4.4 7.7 3.6 7.2 122.3 0.0 0.0 0.9 255.7 0.5 0.0 5.1 0.3 5.8 84.2 179.5 1.8 32.8 0.0 0.8 2.0 97.1 3.6 5.5 54.4 1.3 142.8 3.6 74.4 0.0 0.0 1.0 61.1 141.5 208.2 2.4 49.7 183.2 80.0 15.0 59.2 1.1 265.7 0.0 0.2 1.9 0.0 17.7 102.8 23.9 0.3 1.1 17.4 0.7 6.6 45.8 26.4 0.3 0.5 99.9 240.8 1.9 276.6 16.7 1.1 140.9 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503279-120534434 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA049487: AB_2680789" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 23.0 30.2 23.2 16.0 26.1 11.4 24.3 25.4 29.2 18.6 26.5 24.9 23.6 18.0 23.2 20.6 22.4 14.5 34.4 23.2 25.0 39.3 61.2 15.5 23.4 25.1 25.1 22.9 20.7 20.7 21.8 18.3 23.5 25.6 19.1 24.9 26.5 22.6 16.0 99.4 17.0 20.1 18.4 24.2 21.3 19.5 24.9 25.1 22.5 25.9 69.8 23.6 17.3 17.7 30.6 35.7 56.1 49.2 14.2 63.5 48.5 33.7 42.3 27.6 42.5 26.9 22.5 29.2 35.6 48.8 44.7 29.9 37.7 44.2 47.2 43.3 45.4 26.3 47.4 35.0 37.8 51.8 52.2 28.7 46.8 50.2 40.0 46.1 66.0 38.0 67.5 47.4 25.3 49.7 46.9 30.3 60.0 43.2 25.4 43.2 55.9 49.8 52.0 55.2 26.7 37.0 29.8 30.7 15.5 58.3 51.2 77.8 42.6 37.9 29.1 33.4 21.8 28.5 53.9 48.5 40.5 33.3 48.9 35.8 28.6 44.3 32.3 39.7 44.9 39.0 45.6 42.4 43.2 61.0 52.7 56.8 45.5 9.3 60.6 43.5 40.3 57.2 54.4 23.2 26.1 25.4 29.2 23.2 25.0 25.1 25.1 22.9 25.6 24.2 25.1 30.6 14.4 12.8 12.8 7.2 15.5 7.8 11.5 33.5 10.8 12.6 17.5 15.2 30.5 18.6 18.1 14.7 14.6 73.0 12.9 16.1 46.9 32.3 59.8 17.8 12.1 15.4 15.0 17.5 5.7 20.0 45.6 16.5 11.7 11.3 17.2 24.0 15.4 42.4 46.3 5.0 7.8 17.0 22.4 12.8 10.1 23.1 16.4 13.6 23.2 3.7 29.0 18.0 23.7 6.6 17.5 11.0 23.9 18.8 11.0 11.2 35.8 66.7 22.4 15.6 6.6 16.3 14.4 34.7 14.8 14.3 8.9 58.3 15.0 32.8 28.1 10.9 SELPLG "CD162, PSGL-1" ENSG00000110876 "Selectin P ligand" Q14242 12 108621895-108633894 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 87.3" "Cell type enhanced" "Detected in many" "dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5" "Low region specificity" "Detected in all" "CAB002431, HPA011256, HPA069062" Enhanced Approved Vesicles NA NA 2700000 Vesicles "CAB002431: AB_563509, HPA011256: , HPA069062: " "unprognostic (2.32e-2)" "prognostic favorable (1.46e-4)" "unprognostic (3.64e-3)" "unprognostic (1.02e-2)" "unprognostic (6.32e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "prognostic favorable (2.92e-4)" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (5.88e-2)" "unprognostic (2.37e-2)" "prognostic favorable (2.74e-4)" "unprognostic (5.44e-2)" 17.7 9.2 10.6 47.9 10.2 21.3 7.0 11.6 12.2 9.3 8.5 9.7 8.6 3.8 2.1 8.7 7.9 17.1 5.1 11.3 12.1 4.0 6.5 41.1 62.7 15.0 12.7 6.4 2.8 3.5 4.4 3.1 13.1 16.0 3.3 8.4 0.7 7.1 3.9 2.2 4.7 15.6 11.6 18.5 87.3 11.4 2.3 15.4 52.6 3.4 7.4 30.8 21.7 3.3 20.7 0.5 0.4 1.4 0.8 0.7 1.5 0.8 4.9 4.8 1.8 1.4 0.3 1.9 0.5 1.7 7.4 2.0 0.3 0.1 0.1 1.3 136.2 0.0 45.7 0.2 0.2 0.4 35.1 130.0 1.8 0.5 2.5 0.6 5.0 0.4 102.2 0.8 195.1 6.0 0.0 28.3 18.9 0.2 0.1 1.6 0.3 0.5 286.7 2.9 0.0 0.3 0.0 0.6 0.2 2.2 3.3 0.1 42.6 1.7 2.6 0.8 3.5 1.4 326.8 214.5 6.4 1.5 74.2 1.9 1543.6 297.6 940.2 419.2 509.2 344.3 22.0 396.6 362.9 299.9 22.3 300.3 323.7 1257.2 309.2 762.7 518.3 662.2 1035.5 10.6 10.2 11.6 12.2 11.3 12.1 15.0 12.7 6.4 16.0 18.5 15.4 20.7 1.2 3.2 12.4 0.0 11.6 3.4 0.1 0.2 0.0 0.2 0.6 1.4 2.2 4.3 2.7 0.0 0.0 0.5 159.7 0.2 0.0 0.3 8.2 1.8 0.6 2.6 0.0 10.9 0.2 0.2 2.3 2.4 2.6 0.9 29.7 0.4 3.6 2.2 40.1 0.0 0.3 0.0 0.0 84.9 49.6 12.2 0.3 64.8 7.2 15.9 123.8 0.0 154.5 0.0 0.1 0.5 0.0 0.0 65.1 0.1 0.0 0.5 6.4 0.2 0.0 1.2 0.9 0.8 0.5 0.5 1.8 1.0 65.9 0.1 0.0 0.0 CORO1C "coronin-3, HCRNN4" ENSG00000110880 "Coronin 1C" Q9ULV4 12 108645109-108731526 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041737 Approved NA NA 13000000 "HPA041737: AB_10804115" "unprognostic (2.86e-1)" "unprognostic (2.82e-2)" "unprognostic (2.83e-1)" "unprognostic (3.96e-1)" "unprognostic (6.50e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.59e-5)" "unprognostic (2.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.41e-1)" "unprognostic (1.07e-2)" "unprognostic (3.96e-1)" "unprognostic (1.67e-3)" "unprognostic (2.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.39e-3)" "unprognostic (4.90e-3)" 69.1 30.9 37.6 50.2 36.4 53.0 36.9 31.0 39.3 46.7 26.8 92.8 29.2 96.9 24.3 68.4 56.4 54.9 31.9 42.4 48.0 26.0 49.5 77.1 31.9 44.9 38.0 30.4 30.6 13.1 36.7 22.2 48.6 39.2 36.1 53.8 10.6 24.8 67.9 30.3 51.6 43.3 144.1 41.0 26.4 45.4 22.7 41.4 47.8 14.3 23.8 33.9 72.1 45.1 55.8 188.2 207.2 274.3 140.8 137.3 186.5 117.3 347.8 372.0 443.2 353.6 245.8 81.5 10.6 88.8 547.9 173.2 85.4 153.3 255.1 558.1 82.8 71.4 313.8 95.3 192.7 123.8 76.6 154.1 173.7 120.3 501.0 376.9 262.3 234.1 51.8 157.0 101.0 473.6 68.4 34.7 90.5 70.5 68.7 197.9 53.3 158.6 121.9 176.0 122.5 75.0 66.3 115.6 16.0 156.6 173.0 83.0 58.0 263.7 316.1 165.1 297.7 296.8 99.4 245.7 232.8 246.3 64.0 215.5 42.3 70.7 32.0 7.4 78.1 3.5 24.6 2.9 4.5 75.7 19.1 1.0 3.3 81.9 12.6 75.2 75.9 7.5 44.7 37.6 36.4 31.0 39.3 42.4 48.0 44.9 38.0 30.4 39.2 41.0 41.4 55.8 24.5 54.5 20.7 18.3 27.8 138.0 168.2 47.7 66.0 7.1 18.2 14.1 19.0 18.6 34.6 12.9 2.1 28.4 39.1 41.3 3.9 59.7 58.9 33.6 47.2 51.9 30.9 25.5 32.8 22.7 125.3 38.4 20.4 39.1 41.8 43.3 17.2 49.8 122.2 15.2 39.7 23.4 16.2 71.0 181.4 56.4 22.4 108.8 90.7 37.5 81.7 6.7 8.2 46.3 42.6 76.9 29.8 58.6 31.6 92.8 19.0 30.1 10.5 5.3 13.1 42.8 53.2 26.8 22.9 60.6 167.8 46.8 12.0 9.9 30.7 93.2 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.6" "Cell type enhanced" "Detected in some" "Astrocytes: 31.3;Inhibitory neurons: 16.4;Oligodendrocyte precursor cells: 64.8;Oligodendrocytes: 11.2" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 34.8;SH-SY5Y: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA058870: AB_2683841" "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 1.5 0.7 16.9 0.9 17.9 0.1 1.7 12.0 17.6 3.2 3.2 4.9 0.8 1.9 0.0 2.4 3.0 2.6 1.8 15.7 16.0 0.6 0.2 0.7 0.4 16.9 22.6 13.3 1.1 0.5 5.1 0.9 0.6 16.0 2.8 1.2 1.1 3.6 1.9 0.3 0.9 2.5 2.3 9.7 0.3 2.8 0.7 20.1 1.5 0.5 0.0 0.2 2.0 1.7 14.0 3.3 7.2 8.7 19.7 2.7 4.2 4.9 2.2 6.1 4.0 4.0 4.8 2.3 2.1 4.7 1.1 2.4 3.2 8.7 7.7 2.3 1.9 25.1 6.2 9.0 3.2 3.8 9.5 22.7 10.7 3.7 0.4 1.0 34.8 0.5 22.8 4.3 0.0 3.3 4.0 8.8 18.3 3.9 6.9 12.5 9.3 8.5 4.0 2.0 0.1 13.4 27.4 5.3 1.8 3.2 1.4 11.0 6.5 0.3 4.1 12.8 2.5 1.2 0.1 0.0 0.0 5.1 7.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 17.9 12.0 17.6 15.7 16.0 16.9 22.6 13.3 16.0 9.7 20.1 14.0 0.3 0.0 0.0 31.3 0.0 0.0 0.4 0.5 0.0 2.8 2.0 2.8 0.9 0.0 2.1 1.8 0.0 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.0 7.0 0.0 0.9 3.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 3.3 16.4 0.1 0.0 0.0 0.3 0.0 1.5 0.1 0.0 1.9 0.0 1.4 0.0 64.8 11.2 0.2 0.0 1.2 0.2 0.5 0.0 3.2 6.0 0.5 0.0 1.3 0.7 0.1 0.9 2.3 0.0 0.3 0.9 0.4 0.0 0.2 DAO "DAAO, DAMOX" ENSG00000110887 "D-amino acid oxidase" P14920 12 108858932-108901043 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 64.1;kidney: 91.1;liver: 151.1" "Group enriched" "Detected in some" 8 "Hepatocytes: 46.1;Proximal tubular cells: 86.8" "Cancer enriched" "Detected in some" 9 "liver cancer: 13.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.1" "Group enriched" "Detected in some" 10 "cerebellum: 66.4;pons and medulla: 20.2" "Low region specificity" "Detected in all" "HPA038653, HPA038654" Enhanced "Intracellular and membrane" NA NA "HPA038653: AB_10673016, HPA038654: AB_10673285" "unprognostic (1.50e-1)" "unprognostic (5.61e-2)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (2.99e-2)" "unprognostic (2.31e-3)" "unprognostic (8.02e-2)" "unprognostic (2.88e-2)" "unprognostic (9.59e-2)" "unprognostic (9.07e-2)" "unprognostic (7.13e-2)" "prognostic favorable (4.11e-4)" "unprognostic (3.44e-3)" "unprognostic (8.96e-2)" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" 0.1 0.0 4.2 0.0 9.9 0.0 0.0 64.1 6.8 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.0 91.1 151.1 0.2 0.0 35.7 16.0 0.1 0.0 0.2 0.0 0.0 0.0 27.3 0.0 2.1 12.1 0.0 0.0 0.0 0.0 0.0 0.1 37.3 0.1 0.1 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 9.9 64.1 6.8 0.9 3.0 35.7 16.0 0.1 27.3 37.3 5.2 60.9 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.7 0.0 4.6 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 46.1 0.2 0.0 1.2 0.0 0.0 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.5 0.1 0.0 1.2 0.0 0.0 0.0 0.0 86.8 0.0 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.4 0.0 0.2 0.0 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.8;Inhibitory neurons: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favorable (8.36e-4)" 4.2 6.2 9.1 4.1 12.7 8.5 3.8 11.7 21.1 5.4 4.4 5.3 2.8 6.3 7.4 2.9 5.1 4.4 13.6 10.7 30.0 5.7 5.6 4.8 4.3 16.7 9.9 11.3 7.4 5.9 9.4 10.1 3.0 13.6 5.6 4.0 18.1 3.2 6.9 6.0 8.0 5.0 6.2 3.4 6.2 5.5 17.5 11.8 3.6 5.1 5.0 3.7 6.1 4.4 16.5 7.4 5.1 9.4 7.9 9.1 9.5 5.7 13.4 11.2 5.7 7.7 2.8 4.6 4.3 11.5 14.1 11.3 5.8 5.0 22.0 10.3 6.5 5.6 18.0 9.5 10.4 5.1 2.9 1.8 11.1 8.4 18.2 14.6 23.6 13.0 7.7 1.1 4.3 13.6 1.4 3.7 4.6 11.0 3.9 15.2 1.6 14.1 2.1 2.5 26.1 11.7 7.1 5.0 3.6 5.6 22.3 3.2 0.9 17.8 11.0 6.0 33.5 24.9 8.1 6.1 4.1 13.2 0.9 7.3 6.2 0.8 0.7 2.4 0.3 2.9 2.6 1.5 2.6 0.4 2.1 1.7 1.6 0.1 1.7 0.4 2.4 1.1 0.6 9.1 12.7 11.7 21.1 10.7 30.0 16.7 9.9 11.3 13.6 3.4 11.8 16.5 9.8 22.4 27.7 45.1 9.0 7.1 4.9 3.8 7.4 28.9 6.4 9.1 28.7 0.0 6.3 3.7 22.9 8.6 14.7 5.3 9.8 5.6 17.2 21.8 12.2 11.6 16.7 23.5 73.8 11.2 1.7 12.2 11.2 10.0 22.1 19.6 7.9 8.0 9.6 11.8 68.5 5.0 0.0 7.8 4.4 13.7 6.8 6.7 3.6 12.2 4.5 10.5 11.3 49.3 19.4 33.9 2.2 8.6 8.8 2.5 4.5 11.9 13.0 34.2 6.6 13.2 11.3 8.2 33.5 9.2 4.5 12.3 11.8 9.8 3.9 3.3 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996602 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 19.5" "Cell type enhanced" "Detected in some" "Hepatic stellate cells: 5.7;Inhibitory neurons: 5.7;Late spermatids: 10.6;Oligodendrocyte precursor cells: 27.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.2;HSkMC: 22.8;NTERA-2: 18.2;SCLC-21H: 9.7;SH-SY5Y: 18.6;SuSa: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066789 Approved Vesicles NA NA Vesicles "HPA066789: AB_2685723" "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favorable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 2.5 2.2 5.4 7.6 4.8 0.0 2.0 9.2 5.0 6.5 0.7 19.5 3.9 1.7 5.9 3.6 1.9 7.2 4.8 4.8 3.4 1.0 0.7 3.4 2.3 5.3 5.3 3.9 0.8 1.1 0.1 1.0 0.7 7.7 4.1 8.9 1.4 2.5 4.8 0.4 5.6 9.7 6.5 1.9 2.4 3.8 1.0 5.5 0.8 3.2 1.2 4.1 4.6 3.7 4.6 0.0 0.3 25.2 0.0 0.1 0.3 0.2 0.3 0.8 0.0 0.0 0.0 0.8 0.0 1.4 2.2 0.1 0.6 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.1 22.8 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 18.2 0.0 0.2 0.1 0.1 0.5 0.0 0.1 9.7 18.6 0.2 0.0 0.1 11.2 0.0 0.0 0.0 0.1 1.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.8 9.2 5.0 4.8 3.4 5.3 5.3 3.9 7.7 1.9 5.5 4.6 0.6 0.0 0.0 3.6 0.0 0.8 0.0 0.0 0.0 1.7 0.1 0.0 2.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.5 2.4 3.3 0.0 0.0 1.5 0.0 0.0 4.3 0.0 0.4 0.0 0.2 5.7 0.2 0.1 0.0 5.7 0.0 0.0 0.0 1.7 10.6 4.7 0.2 1.8 1.0 0.0 3.6 0.0 27.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.9 0.5 0.0 0.3 1.1 0.2 0.5 0.1 1.1 0.0 0.2 0.1 0.0 0.1 KCTD10 "BTBD28, MSTP028" ENSG00000110906 "Potassium channel tetramerization domain containing 10" Q9H3F6 12 109448655-109477359 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014273 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA014273: AB_1852159" "unprognostic (7.21e-3)" "unprognostic (3.04e-1)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.93e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.84e-2)" "unprognostic (1.85e-1)" "unprognostic (7.01e-2)" "unprognostic (9.33e-2)" "unprognostic (3.45e-1)" "unprognostic (7.72e-2)" "unprognostic (5.76e-2)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" 40.0 23.6 21.2 26.4 20.0 15.6 33.2 17.7 20.0 34.5 31.6 38.2 14.8 44.2 14.2 37.0 27.6 33.3 23.6 20.0 28.6 22.8 11.5 32.2 22.1 21.9 22.3 18.9 18.2 12.5 22.4 17.1 25.6 24.5 29.4 33.5 14.4 20.9 44.7 11.6 28.5 22.5 57.5 19.6 23.4 26.0 16.5 27.9 15.0 47.5 11.8 22.9 39.3 29.7 20.1 28.4 27.9 84.6 27.5 67.8 91.2 18.5 59.0 80.2 38.8 38.2 28.1 23.1 27.5 34.0 136.4 19.2 22.0 30.7 51.6 35.9 26.0 22.0 32.3 19.2 19.3 44.5 24.9 26.7 92.2 30.7 50.0 29.3 54.7 89.5 26.4 21.5 11.5 68.0 15.1 29.8 32.9 48.1 12.7 36.0 29.2 37.7 22.6 38.5 48.9 29.5 44.3 35.6 38.8 41.8 47.5 45.2 18.8 70.0 42.3 15.5 24.0 32.8 26.0 52.8 37.1 48.8 20.2 60.5 10.9 9.5 6.4 13.5 14.4 10.1 6.6 8.0 10.0 11.9 6.2 8.8 11.1 6.5 25.1 17.2 9.0 10.0 14.9 21.2 20.0 17.7 20.0 20.0 28.6 21.9 22.3 18.9 24.5 19.6 27.9 20.1 21.1 16.0 29.9 6.2 9.0 14.7 20.1 17.4 11.4 5.4 12.1 13.5 11.5 10.0 13.7 5.5 16.7 9.1 19.4 31.5 5.9 15.3 12.2 9.9 17.8 26.8 11.5 6.5 9.8 13.1 12.8 15.5 10.7 12.8 14.0 11.3 24.7 5.3 11.5 8.4 8.1 13.4 10.2 13.6 13.3 11.3 11.5 14.6 16.0 8.4 15.7 2.8 81.4 8.0 9.4 25.9 11.8 18.8 7.5 12.2 6.4 10.5 12.2 4.4 26.3 13.4 32.6 13.5 6.3 10.2 16.6 13.5 10.6 10.4 15.0 18.1 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria No No Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 12.2 17.2 13.3 14.1 20.3 16.0 30.6 19.2 18.2 29.5 12.7 16.5 54.3 15.9 17.7 24.1 21.6 17.8 14.9 13.2 19.5 22.7 25.8 23.5 10.4 21.1 18.3 13.4 12.9 22.8 42.9 11.0 23.9 21.6 24.6 16.3 23.3 31.5 19.5 18.6 20.4 13.9 15.5 20.8 8.8 18.0 13.4 18.7 19.4 42.0 20.5 17.4 20.6 14.0 31.0 19.0 22.4 31.4 28.7 33.5 28.6 106.3 19.7 73.9 19.0 21.8 30.6 35.3 11.8 38.8 22.8 35.7 25.3 26.6 19.2 21.9 17.1 17.4 27.4 29.2 35.5 35.7 19.0 54.5 31.6 24.3 32.7 35.1 45.6 22.8 23.6 24.4 5.6 22.4 21.7 21.8 12.9 46.6 19.8 15.5 14.7 28.6 21.1 23.4 27.7 21.6 19.0 16.3 47.1 20.9 36.2 50.8 12.6 26.8 19.2 15.8 21.5 10.9 14.1 20.4 4.7 54.1 10.2 8.3 0.6 4.7 1.9 4.2 6.8 3.7 2.6 3.3 4.3 7.0 3.3 4.6 4.3 2.3 6.0 4.8 2.9 2.9 3.4 13.3 20.3 19.2 18.2 13.2 19.5 21.1 18.3 13.4 21.6 20.8 18.7 31.0 9.8 38.5 46.1 32.7 6.9 15.4 24.8 84.0 22.2 26.6 37.6 18.5 15.5 25.8 69.4 57.0 18.8 27.0 11.9 14.0 3.9 30.6 1.5 31.7 11.6 13.1 16.4 64.8 33.6 28.3 22.5 17.3 15.3 43.6 71.4 20.1 11.4 41.3 35.2 28.6 38.1 14.3 42.7 16.9 25.4 1.7 9.6 30.1 26.6 26.2 15.7 26.5 6.2 51.8 94.5 20.6 15.0 8.6 8.2 47.8 13.2 9.0 109.6 17.8 6.6 14.2 13.2 9.0 12.2 14.3 13.4 19.4 10.7 10.4 15.0 23.1 MLEC KIAA0152 ENSG00000110917 Malectin Q14165 12 120687149-120701859 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Undifferentiated cells: 397.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 880000 "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (9.60e-6)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (5.41e-2)" "unprognostic (3.94e-1)" "unprognostic (3.39e-1)" "unprognostic (9.77e-2)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (1.15e-2)" "prognostic favorable (8.77e-4)" "unprognostic (1.98e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" 52.1 93.8 35.0 52.2 34.7 34.9 44.8 33.1 33.5 53.2 36.9 128.2 79.0 37.5 139.3 24.7 48.9 49.0 66.5 33.9 40.6 74.2 78.8 35.2 30.5 42.0 37.7 31.5 49.6 63.2 102.0 37.0 46.1 36.8 62.9 118.5 25.5 51.1 65.5 80.6 28.0 86.7 50.4 38.4 30.4 45.8 69.7 39.5 33.6 101.9 83.7 37.6 34.4 17.6 36.8 122.7 177.9 113.6 151.8 196.3 107.4 127.9 144.5 126.3 108.9 80.1 127.5 75.1 100.3 129.0 142.2 85.4 101.9 140.4 87.4 138.7 86.5 76.9 142.4 79.4 100.6 72.1 199.3 123.1 82.2 82.7 116.0 91.4 174.1 97.2 93.9 85.9 112.2 116.3 127.8 106.4 122.2 158.1 156.6 91.7 115.7 82.0 109.1 132.2 204.0 58.2 69.2 166.5 85.9 86.0 143.0 127.0 144.6 79.2 115.8 108.5 112.8 100.3 83.3 165.0 76.8 147.6 147.9 120.1 0.5 6.0 8.0 3.8 7.5 4.1 4.7 2.3 3.4 5.0 6.9 4.0 3.4 1.6 3.9 6.5 18.6 2.4 2.2 35.0 34.7 33.1 33.5 33.9 40.6 42.0 37.7 31.5 36.8 38.4 39.5 36.8 151.4 25.6 62.2 23.2 65.7 72.8 70.6 32.0 55.2 40.9 99.7 76.3 145.3 97.2 40.0 86.5 45.9 88.4 105.7 155.3 37.2 134.2 243.3 78.3 127.6 94.1 80.3 68.5 21.4 183.7 176.9 90.5 69.3 80.2 49.5 99.8 27.1 206.1 126.8 84.1 24.7 199.2 30.5 61.7 73.2 228.0 82.6 70.1 193.9 34.7 56.4 81.8 74.2 32.2 23.0 95.8 86.0 108.0 217.4 152.6 135.4 121.7 41.9 45.3 85.5 61.4 78.5 165.6 153.4 52.8 58.7 115.6 51.2 142.5 397.0 82.2 MVK "LRBP, MK" ENSG00000110921 "Mevalonate kinase" Q03426 12 109573255-109598125 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Kinase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.6" "Cell type enhanced" "Detected in all" "Early spermatids: 60.5;Horizontal cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016961, HPA044110" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA016961: AB_1854220, HPA044110: " "unprognostic (3.10e-1)" "unprognostic (2.27e-2)" "unprognostic (1.85e-1)" "unprognostic (4.43e-2)" "unprognostic (3.66e-2)" "unprognostic (2.08e-2)" "unprognostic (4.30e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-1)" "unprognostic (6.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (3.88e-1)" "unprognostic (3.28e-1)" 7.5 30.1 13.1 6.1 15.2 8.4 14.8 16.5 16.0 10.4 9.3 10.9 14.0 7.3 10.3 45.8 6.3 5.4 8.5 11.5 17.1 28.5 69.6 11.5 7.0 33.1 20.1 12.4 10.8 10.1 11.6 11.7 5.4 38.3 12.4 8.7 7.4 13.8 7.0 12.2 32.7 9.8 5.0 16.1 6.7 11.9 28.7 16.5 4.2 15.3 8.8 9.2 9.6 20.3 26.2 30.1 25.0 29.9 13.7 11.2 27.3 14.4 9.5 21.7 30.0 32.8 31.4 33.8 17.7 7.8 11.7 48.1 36.0 31.6 50.0 13.2 19.0 18.1 9.9 15.7 53.7 31.5 11.1 13.0 27.2 42.1 48.8 13.6 12.6 20.9 19.0 18.7 17.4 13.6 34.5 12.0 34.6 22.6 14.9 32.3 10.5 22.1 37.0 67.4 40.9 25.1 18.7 19.8 58.7 14.0 11.0 59.7 21.1 14.1 13.2 14.5 12.0 12.8 13.3 20.6 28.2 16.1 29.2 16.6 1.0 6.9 4.0 12.6 6.5 11.3 9.4 7.4 12.4 8.6 14.1 10.9 8.3 1.6 11.0 4.6 7.0 7.6 6.4 13.1 15.2 16.5 16.0 11.5 17.1 33.1 20.1 12.4 38.3 16.1 16.5 26.2 6.1 12.8 12.4 6.8 8.3 4.7 5.2 39.7 4.6 12.4 13.1 11.0 5.7 11.5 25.8 14.7 18.8 33.0 7.3 10.4 21.5 15.6 60.5 5.8 2.3 7.1 9.0 4.8 5.1 18.1 15.3 6.8 9.7 5.1 1.3 14.7 6.4 32.7 15.6 62.2 5.2 7.8 10.2 3.4 2.2 42.5 8.1 4.8 7.2 3.7 10.3 10.6 10.3 4.0 15.3 13.2 3.2 7.2 4.1 5.5 16.4 52.4 13.5 12.2 6.6 4.0 8.2 33.9 16.8 12.0 8.5 47.9 6.1 44.8 11.1 4.6 CSRNP2 "C12ORF2, C12orf22, FAM130A1, PPP1R72, TAIP-12" ENSG00000110925 "Cysteine and serine rich nuclear protein 2" Q9H175 12 51061205-51083664 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018503, HPA019914" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA018503: AB_1845535, HPA019914: AB_2670315" "unprognostic (8.67e-3)" "unprognostic (1.00e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-2)" "unprognostic (1.14e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.74e-2)" "prognostic favorable (2.78e-4)" 12.1 10.5 17.6 7.5 20.3 3.4 11.2 17.0 22.4 12.6 13.2 10.7 6.8 13.8 12.0 7.8 11.3 11.7 12.5 20.8 19.4 10.1 6.9 10.9 8.4 15.6 16.9 20.1 12.5 9.4 11.9 17.7 11.5 17.8 11.7 7.0 20.7 10.0 10.6 16.9 9.4 8.9 14.7 12.8 10.1 10.1 26.5 18.6 14.0 11.4 14.9 7.0 12.5 9.8 17.8 9.0 10.2 30.2 27.1 22.8 16.0 31.5 17.3 19.9 23.8 16.3 19.6 6.4 7.5 16.2 18.7 16.2 10.8 14.9 9.5 18.8 15.4 10.4 8.9 12.1 6.1 24.7 6.2 12.8 19.6 26.4 27.6 15.6 25.9 23.6 34.0 12.5 13.1 27.8 15.6 21.3 8.6 24.8 4.2 14.3 12.5 19.1 6.0 13.6 11.6 21.2 25.1 25.1 20.0 25.9 21.2 12.7 17.2 21.4 23.6 12.4 15.8 11.9 13.5 16.0 6.9 14.5 8.1 7.7 0.0 0.3 1.0 0.7 0.0 0.2 0.4 0.7 0.4 0.4 0.2 0.7 1.0 1.0 2.2 0.2 0.1 0.5 0.2 17.6 20.3 17.0 22.4 20.8 19.4 15.6 16.9 20.1 17.8 12.8 18.6 17.8 17.8 3.2 6.8 13.1 9.4 17.8 11.4 7.1 8.0 6.8 14.1 20.2 19.5 5.7 5.4 5.5 25.0 6.6 13.8 15.4 3.9 6.9 23.5 10.3 14.4 12.7 8.3 4.0 39.9 5.0 9.2 15.6 63.2 10.0 11.4 13.1 13.6 2.6 6.5 6.7 32.3 10.8 8.2 4.4 14.8 14.8 6.2 9.7 16.0 11.2 4.2 5.4 5.2 23.6 20.7 8.0 7.5 7.9 10.8 10.0 8.6 4.2 7.4 7.6 0.0 20.2 17.3 28.6 13.8 6.8 16.1 15.1 12.5 5.9 5.7 6.6 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237675-121298308 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 138.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 64.8;Horizontal cells: 62.2;Late spermatids: 89.6" "Cancer enriched" "Detected in all" 5 "prostate cancer: 56.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 32.7;eosinophil: 62.1;intermediate monocyte: 42.3;myeloid DC: 15.9;neutrophil: 39.2;non-classical monocyte: 39.5" "Group enriched" "Detected in all" 5 "dendritic cells: 15.9;granulocytes: 62.1;monocytes: 42.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol NA NA Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 25.1 16.8 41.2 17.2 50.4 31.1 22.9 138.5 61.0 21.7 20.0 22.7 25.9 23.1 10.9 17.7 27.8 13.0 17.6 43.2 31.0 16.7 31.1 23.8 15.4 26.6 29.7 50.5 27.6 17.0 12.5 11.9 15.5 63.0 29.8 19.6 7.1 18.7 24.1 11.6 18.4 26.8 20.8 20.9 39.9 24.2 7.0 26.1 13.5 17.3 11.3 15.7 26.2 21.3 44.1 27.9 20.5 16.3 30.9 46.7 43.0 22.8 22.0 23.8 19.0 17.3 21.4 12.1 43.0 18.1 48.1 14.1 22.7 20.0 25.8 15.1 29.3 35.9 22.0 14.4 21.3 31.1 50.0 20.0 28.2 37.2 18.0 41.4 26.0 45.0 33.5 25.2 23.6 18.4 27.2 55.8 40.6 11.7 24.9 22.7 35.3 18.4 37.7 18.8 32.1 60.2 22.4 31.5 16.5 19.1 12.9 39.7 62.0 32.2 14.8 11.8 13.1 13.0 84.8 55.6 32.7 27.7 34.4 16.0 2.0 32.7 62.1 4.7 42.3 4.6 4.8 3.5 4.2 15.9 2.8 3.2 3.8 39.2 8.6 39.5 3.6 3.3 15.8 41.2 50.4 138.5 61.0 43.2 31.0 26.6 29.7 50.5 63.0 20.9 26.1 44.1 25.4 9.6 5.6 9.8 5.7 7.9 6.0 8.1 8.0 22.2 11.6 10.5 8.2 12.8 8.3 9.2 2.1 9.2 10.6 18.2 3.9 9.6 16.0 6.5 19.6 21.9 34.3 12.0 64.8 10.4 8.2 18.0 13.3 10.9 6.3 23.3 15.0 19.7 7.9 62.2 21.4 16.2 8.2 14.8 15.6 89.6 20.5 16.6 8.8 12.2 36.3 5.4 12.3 10.1 19.3 8.5 10.9 31.6 11.9 16.5 26.6 9.6 7.2 7.0 19.7 7.7 20.6 0.8 2.9 13.3 6.0 3.4 7.6 32.7 17.6 6.3 BIN2 BRAP-1 ENSG00000110934 "Bridging integrator 2" Q9UBW5 12 51281038-51324668 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 102.2;lymphoid tissue: 49.1" "Cell type enhanced" "Detected in many" "dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038666, HPA038667" Enhanced Enhanced "Plasma membrane" NA NA 19000000 "Plasma membrane" "HPA038666: AB_2676139, HPA038667: AB_2676140" "unprognostic (8.44e-3)" "prognostic favorable (1.33e-4)" "unprognostic (2.48e-1)" "prognostic favorable (6.34e-4)" "unprognostic (4.63e-1)" "unprognostic (2.00e-3)" "unprognostic (1.21e-1)" "unprognostic (3.59e-2)" "unprognostic (3.72e-2)" "unprognostic (7.47e-2)" "unprognostic (5.71e-2)" "unprognostic (3.29e-1)" "unprognostic (1.65e-3)" "unprognostic (4.03e-1)" "unprognostic (3.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-1)" 7.2 3.8 3.7 32.8 4.2 102.2 3.3 4.0 4.8 3.7 6.1 9.0 6.2 2.1 1.0 3.2 3.2 9.3 2.1 3.5 7.5 3.0 7.4 16.6 42.3 5.4 4.4 3.0 1.7 1.3 1.0 1.1 19.7 5.4 2.2 9.3 0.4 3.4 2.0 1.5 1.4 10.8 6.4 5.0 49.0 7.5 8.0 5.8 49.1 2.2 4.3 36.7 10.2 2.0 7.2 0.1 0.1 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 38.3 0.1 82.6 0.0 0.0 0.0 34.7 134.9 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.1 59.1 0.0 0.5 24.2 140.8 0.1 0.1 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.2 117.4 0.1 0.0 0.1 0.1 0.1 31.5 0.1 8.0 0.1 76.8 0.0 663.7 199.8 245.9 281.0 311.8 227.7 49.2 188.9 237.2 107.2 74.0 145.4 193.5 380.1 235.6 411.7 39.7 267.1 479.5 3.7 4.2 4.0 4.8 3.5 7.5 5.4 4.4 3.0 5.4 5.0 5.8 7.2 1.5 3.2 17.6 1.3 54.0 0.6 0.1 0.0 0.0 0.1 1.3 1.5 0.6 1.5 2.6 1.8 0.0 103.9 213.6 4.5 17.6 0.1 26.5 0.1 0.2 3.5 1.2 16.2 0.7 0.0 172.1 2.7 3.1 0.2 56.3 0.1 8.2 1.2 56.9 0.0 0.6 8.5 0.0 73.0 22.3 25.7 0.6 111.2 1.8 44.0 77.6 0.0 598.3 2.0 0.6 0.0 4.6 0.4 51.3 0.1 0.1 1.6 3.7 0.1 0.0 1.0 0.9 39.6 11.3 0.4 0.6 158.6 165.7 0.1 5.4 0.1 IL23A "IL-23, IL-23A, IL23P19, P19, SGRF" ENSG00000110944 "Interleukin 23 subunit alpha" Q9NPF7 12 56334174-56340410 "FDA approved drug targets, Predicted secreted proteins" "Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "urinary bladder: 45.0" "Cell type enhanced" "Detected in many" "Ductal cells: 43.4;Ionocytes: 73.2;Langerhans cells: 151.8;Pancreatic endocrine cells: 70.5;Spermatocytes: 41.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "MAIT T-cell: 14.1;memory B-cell: 18.9;memory CD4 T-cell: 25.7;memory CD8 T-cell: 12.5;naive B-cell: 21.5;naive CD4 T-cell: 28.1;naive CD8 T-cell: 17.6;T-reg: 15.6" "Group enriched" "Detected in many" 12 "B-cells: 21.5;T-cells: 28.1" "Cell line enhanced" "Detected in some" "A-431: 15.3;CAPAN-2: 25.6;U-266/70: 42.1;U-266/84: 20.5" "Region enhanced" "Detected in some" "white matter: 3.9" "Not detected" "Not detected" HPA001554 Approved Approved Cytosol "Secreted to blood" NA NA 11000 Cytosol "HPA001554: AB_1079135" "unprognostic (2.34e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.06e-1)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (4.40e-1)" "unprognostic (1.43e-3)" "unprognostic (1.30e-1)" "unprognostic (6.79e-2)" "unprognostic (3.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-10)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.83e-1)" "unprognostic (4.50e-3)" 0.4 0.3 0.3 2.1 0.2 3.2 0.3 0.1 0.5 0.3 0.1 0.3 0.2 1.1 0.5 4.5 0.4 0.9 0.3 0.5 0.2 0.6 1.1 1.3 4.3 0.3 0.2 0.0 0.3 0.7 0.0 0.7 0.6 0.2 0.5 0.3 0.1 1.3 0.2 0.2 0.7 2.0 0.0 0.3 2.2 0.7 4.4 0.3 7.2 0.4 0.0 8.8 45.0 0.5 0.5 15.3 0.3 0.5 0.5 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.5 25.6 0.9 7.5 0.0 0.8 1.3 0.0 2.5 0.1 1.1 0.5 0.4 0.3 1.2 0.0 0.3 0.9 0.1 0.0 0.0 0.7 3.1 0.0 3.5 0.6 6.2 0.1 0.6 0.6 0.8 2.2 0.3 0.4 0.4 0.2 0.6 8.9 7.4 0.5 0.6 0.3 0.4 1.4 2.1 0.2 7.0 0.5 0.5 0.5 0.4 1.8 42.1 20.5 2.1 0.5 3.7 0.4 0.0 0.4 0.0 2.8 0.0 14.1 18.9 25.7 12.5 0.9 21.5 28.1 17.6 0.2 2.0 0.1 0.1 15.6 10.0 0.3 0.2 0.1 0.5 0.5 0.2 0.3 0.2 0.0 0.2 0.3 0.3 0.5 0.5 3.2 2.2 0.0 13.6 3.6 12.1 16.2 0.6 0.0 1.2 1.4 0.4 0.0 23.7 1.8 0.0 0.4 1.5 1.1 1.9 43.4 6.9 11.1 1.0 1.4 0.0 0.0 0.3 7.4 0.5 2.3 1.5 16.6 0.0 0.3 0.0 0.5 2.5 0.0 0.2 1.0 73.2 0.8 151.8 4.2 0.3 14.7 8.8 0.0 34.7 0.5 0.0 0.0 0.3 70.5 0.1 0.7 7.4 6.1 0.4 0.6 15.3 0.5 0.0 0.4 1.4 41.9 6.9 0.6 4.0 0.0 14.4 0.2 2.0 16.3 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56645984 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2614.9;tongue: 3233.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 821.1;Distal tubular cells: 1238.5;Extravillous trophoblasts: 592.7;Hofbauer cells: 608.9;Proximal tubular cells: 951.7;Syncytiotrophoblasts: 1138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria NA NA 19000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavorable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favorable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 436.6 560.1 230.8 303.2 235.9 469.8 304.6 282.9 304.4 243.9 399.9 748.6 695.7 237.3 225.4 531.8 280.3 227.7 2014.4 236.4 300.4 954.6 614.3 255.6 297.0 263.4 251.3 220.6 201.9 304.3 1322.9 254.6 303.9 285.2 283.4 775.0 488.4 411.3 359.7 2614.9 400.4 580.3 335.4 230.6 274.7 498.9 238.1 274.6 394.5 345.9 3233.7 462.1 407.9 313.8 335.0 693.6 834.9 632.3 1003.6 578.3 596.7 1159.8 683.2 645.6 1179.1 663.9 1375.7 755.6 1236.3 723.0 863.5 482.9 906.1 1378.1 851.5 1039.4 579.9 987.5 1333.1 726.4 872.5 716.6 1509.7 912.9 755.1 843.3 918.0 1171.2 870.2 985.8 901.7 1246.3 1363.1 992.2 671.5 1134.4 941.3 1085.9 905.6 1637.6 1079.3 711.0 1603.5 1315.6 1196.7 737.5 658.2 1042.3 1481.3 1214.0 663.4 1404.1 1151.8 657.6 454.8 507.9 671.9 751.0 659.5 865.7 1254.8 684.7 1007.8 718.4 403.5 549.4 281.8 293.5 643.6 326.3 303.2 275.4 313.6 713.4 248.4 221.0 266.8 137.1 296.9 750.6 360.9 372.9 1077.1 230.8 235.9 282.9 304.4 236.4 300.4 263.4 251.3 220.6 285.2 230.6 274.6 335.0 172.3 134.6 173.2 0.0 48.6 0.0 0.0 0.0 0.0 0.0 176.8 149.1 0.0 0.0 81.1 277.7 0.0 821.1 141.5 0.0 1238.5 517.7 0.0 194.1 169.2 115.7 0.0 0.0 0.0 367.9 592.7 115.0 0.0 163.3 145.1 267.6 0.0 0.0 608.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.3 0.0 0.0 281.2 0.0 0.0 0.0 0.0 333.3 0.0 0.0 26.8 0.0 0.0 951.7 102.7 0.0 0.0 0.0 151.1 0.0 0.0 0.0 0.0 1138.6 77.4 518.4 0.0 0.0 PTGES3 "cPGES, p23, TEBP" ENSG00000110958 "Prostaglandin E synthase 3" Q15185 12 56663341-56688408 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034319, HPA038672, HPA038673" Enhanced Approved Nucleoplasm,Cytosol NA NA 660000 Cytosol Nucleoplasm "CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786" "prognostic unfavorable (2.15e-5)" "unprognostic (2.60e-1)" "unprognostic (8.67e-3)" "unprognostic (7.07e-2)" "unprognostic (2.24e-1)" "unprognostic (2.96e-3)" "prognostic unfavorable (4.44e-6)" "unprognostic (4.33e-3)" "unprognostic (3.64e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.73e-2)" "unprognostic (2.31e-2)" "unprognostic (3.05e-3)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (2.07e-1)" 134.6 129.2 232.0 138.5 222.0 151.5 172.9 230.1 362.2 164.7 212.5 171.6 153.1 174.6 160.4 162.6 219.6 115.9 120.4 243.4 221.9 167.6 220.4 135.1 158.5 242.5 232.5 191.5 252.2 122.9 134.8 112.5 166.3 235.5 142.9 174.5 119.0 125.1 149.0 210.3 120.1 156.7 140.0 244.2 126.1 118.2 136.3 237.1 168.8 163.8 159.9 186.5 160.2 147.1 298.1 616.6 528.8 416.5 249.8 300.2 270.3 634.3 392.8 298.5 494.5 366.9 452.5 629.6 676.0 588.5 338.3 331.7 385.4 790.0 514.2 621.8 509.8 529.8 529.7 309.5 524.4 219.4 637.9 367.2 197.0 367.3 375.1 450.3 468.5 518.1 425.7 866.0 628.2 490.4 385.3 636.5 602.1 714.7 538.3 609.3 549.2 392.3 914.4 436.8 473.2 538.4 313.8 401.7 570.1 355.8 546.5 658.3 526.9 314.0 294.7 341.8 358.3 552.8 262.8 777.5 540.4 321.1 516.7 543.8 141.1 166.1 107.1 130.9 261.6 172.3 172.3 170.6 156.7 160.2 127.0 167.3 147.7 64.7 132.2 346.2 135.3 191.6 316.1 232.0 222.0 230.1 362.2 243.4 221.9 242.5 232.5 191.5 235.5 244.2 237.1 298.1 265.8 179.5 137.1 39.5 251.0 386.6 826.7 248.5 272.6 128.3 208.5 197.1 166.0 178.7 161.4 189.4 77.2 457.2 245.6 246.5 373.7 310.4 42.5 493.7 221.5 242.1 261.3 452.0 43.4 214.8 676.3 268.7 143.2 291.3 234.2 224.5 188.8 187.0 349.9 112.7 41.3 295.9 201.4 209.5 363.6 107.9 238.9 261.7 282.8 47.8 283.3 244.1 178.2 38.7 71.4 220.8 207.1 213.3 299.8 657.6 218.9 343.8 345.5 128.0 144.7 185.1 337.7 558.4 348.4 350.4 377.6 566.0 359.3 219.0 358.9 556.3 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 4.8;fallopian tube: 2.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.9;Distal tubular cells: 7.9;Excitatory neurons: 4.4;Inhibitory neurons: 15.4;Late spermatids: 16.2" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;K-562: 1.0;MCF7: 3.5;RT4: 1.3;SCLC-21H: 1.7" "Region enhanced" "Detected in all" "olfactory bulb: 49.5" "Low region specificity" "Detected in all" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.0 0.3 1.3 0.1 2.3 0.0 0.0 0.0 1.3 0.5 0.4 0.6 0.2 0.0 0.1 0.0 2.2 0.0 0.0 0.6 3.6 0.8 0.3 0.0 0.0 4.0 1.9 0.9 0.0 0.0 0.0 0.5 0.0 4.8 0.4 0.4 0.2 0.0 0.7 0.0 0.0 0.3 0.1 1.3 0.0 0.4 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.3 0.0 1.3 0.6 3.6 4.0 1.9 0.9 4.8 1.3 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.5 0.0 2.5 0.0 0.0 0.1 0.0 0.0 7.9 0.0 1.5 1.8 0.3 0.1 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.0 0.0 0.8 1.4 0.0 0.0 0.0 15.4 0.2 0.0 0.0 0.0 16.2 0.3 0.0 0.0 1.0 0.0 0.6 0.0 0.5 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.3 0.2 3.7 0.0 0.0 0.1 0.0 3.2 0.1 0.1 BCL7A BCL7 ENSG00000110987 "BAF chromatin remodeling complex subunit BCL7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 77.9;Horizontal cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 1.0;naive B-cell: 2.1;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 14 "B-cells: 2.1;dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "Daudi: 71.9;MOLT-4: 71.4;U-698: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.1 2.9 6.0 5.2 10.6 9.9 5.8 9.0 11.4 5.2 0.1 3.6 2.5 4.5 6.7 2.8 8.5 2.4 7.0 9.4 4.6 9.2 4.9 3.9 16.3 4.3 5.1 10.1 3.7 9.2 9.2 5.2 2.0 5.5 5.2 2.9 4.1 7.1 6.0 11.6 7.8 3.0 3.3 1.7 5.9 3.8 2.3 4.5 24.9 9.1 9.0 15.5 4.9 4.9 9.2 6.0 6.2 29.9 17.9 2.2 1.1 6.0 3.2 3.1 5.3 4.9 3.2 2.4 71.9 9.2 2.7 2.7 8.8 22.7 16.4 5.3 0.0 25.0 3.5 0.4 5.5 6.5 13.8 8.1 4.7 21.3 3.9 26.7 8.1 7.7 42.3 18.3 0.0 4.3 10.7 71.4 1.3 10.7 9.7 11.0 33.2 8.5 1.2 13.4 14.3 26.5 28.9 3.4 0.8 13.1 7.7 17.4 13.6 6.9 0.7 5.1 10.0 6.1 9.4 5.4 95.8 2.1 9.3 6.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 2.1 0.1 0.1 0.1 0.0 0.0 2.8 0.0 0.1 6.0 10.6 9.0 11.4 9.4 4.6 4.3 5.1 10.1 5.5 1.7 4.5 9.2 4.6 22.4 9.2 8.5 51.6 35.9 77.9 26.5 22.8 41.8 32.7 33.5 28.6 42.9 19.0 38.6 18.8 1.5 38.1 5.9 58.7 33.5 6.9 39.3 10.9 5.6 21.5 18.7 15.9 10.9 0.9 11.9 7.1 26.8 10.8 16.6 5.3 18.6 4.2 107.7 19.9 8.6 16.2 2.2 14.3 18.7 14.0 9.8 12.4 1.9 6.2 5.5 1.0 13.6 16.2 10.0 6.9 7.9 6.8 29.9 1.6 31.3 20.7 14.0 6.6 34.7 16.6 0.7 7.7 5.3 30.1 0.5 3.2 42.9 11.7 32.3 RSRC2 FLJ11021 ENSG00000111011 "Arginine and serine rich coiled-coil 2" Q7L4I2 12 122503454-122527000 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 66.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040070, HPA048183" Approved Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" No No "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA040070: AB_10673430, HPA048183: AB_2680302" "unprognostic (4.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "unprognostic (6.42e-3)" "unprognostic (6.90e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.74e-2)" "unprognostic (3.26e-1)" "unprognostic (3.19e-2)" "unprognostic (1.06e-2)" "unprognostic (2.23e-2)" "unprognostic (8.87e-2)" "unprognostic (4.84e-2)" "unprognostic (1.53e-2)" 12.7 12.3 12.9 11.1 12.2 66.3 13.3 18.0 18.5 14.6 12.6 14.0 8.7 14.2 12.6 17.5 12.4 13.7 12.8 12.8 11.7 13.0 11.5 14.0 16.9 14.8 12.0 9.9 16.6 13.9 8.1 14.7 13.4 13.3 12.8 12.1 17.3 12.7 9.6 28.8 12.8 12.6 8.9 8.8 11.7 10.9 14.1 12.8 13.3 15.5 16.2 10.8 14.2 15.1 19.3 21.4 24.8 23.2 9.5 18.4 11.2 16.9 38.8 12.0 16.0 8.7 35.5 8.6 24.4 32.0 13.3 9.7 13.3 25.9 10.8 15.7 22.8 23.9 42.1 32.0 38.3 10.1 37.0 24.8 14.5 12.3 13.6 23.2 20.1 11.6 10.7 27.8 14.6 14.1 16.3 26.8 27.8 19.6 17.8 19.6 19.6 20.9 15.9 21.1 39.8 18.4 16.7 29.6 10.0 22.0 23.1 15.9 13.4 18.1 16.5 20.3 18.4 21.7 16.7 42.8 39.5 9.8 21.6 9.4 27.5 17.7 25.4 17.2 14.7 14.3 28.3 15.3 13.9 18.0 33.4 19.3 15.4 18.7 18.3 22.2 17.0 22.4 12.3 12.9 12.2 18.0 18.5 12.8 11.7 14.8 12.0 9.9 13.3 8.8 12.8 19.3 176.8 86.6 102.0 44.7 208.7 202.3 376.1 94.0 118.4 114.3 155.6 146.0 103.3 104.4 107.1 93.8 79.2 149.1 219.3 193.5 195.6 109.3 247.3 223.6 218.6 141.7 156.3 143.1 39.1 97.2 183.8 169.3 89.7 238.0 216.5 127.5 84.9 113.7 94.3 149.7 39.9 185.7 101.7 87.6 184.9 107.1 119.9 139.0 126.3 35.6 107.0 132.9 133.9 34.2 49.6 107.3 171.0 105.7 134.2 219.0 110.1 132.7 128.5 131.0 124.9 194.8 176.7 229.2 165.3 116.0 187.0 280.1 210.3 107.6 154.8 287.1 CYP27B1 "CYP1, P450c1, PDDR, VDD1" ENSG00000111012 "Cytochrome P450 family 27 subfamily B member 1" O15528 12 57762334-57768986 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 15.4;thyroid gland: 5.8" "Group enriched" "Detected in many" 5 "Exocrine glandular cells: 22.1;monocytes: 22.8;Proximal tubular cells: 36.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 13.6;RH-30: 22.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.59e-2)" "unprognostic (1.42e-1)" "unprognostic (8.89e-2)" "unprognostic (2.77e-2)" "unprognostic (4.16e-2)" "unprognostic (1.03e-2)" "unprognostic (1.28e-2)" "unprognostic (1.44e-1)" "unprognostic (2.10e-2)" "unprognostic (4.72e-2)" "unprognostic (2.51e-1)" "unprognostic (1.17e-2)" "unprognostic (1.75e-3)" "unprognostic (4.10e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.67e-3)" 0.3 0.9 0.3 0.7 0.3 0.8 0.9 0.3 0.4 0.1 0.3 0.4 0.4 0.2 0.6 0.4 0.2 0.5 0.1 0.3 0.3 15.4 0.6 0.5 0.9 0.3 0.3 0.3 0.2 1.6 1.0 0.4 0.3 0.3 0.3 0.6 3.4 0.5 0.2 0.1 0.6 0.5 0.1 0.3 0.2 0.5 0.4 0.3 0.2 5.8 0.0 0.7 2.2 0.2 0.4 2.8 0.4 0.0 0.3 0.2 0.4 1.1 0.1 3.1 1.0 0.3 3.7 1.0 2.0 0.1 0.4 0.3 3.3 0.5 5.9 3.1 0.6 0.4 0.9 0.0 1.0 0.3 1.2 2.5 0.5 1.9 0.8 13.6 1.2 0.4 2.6 1.3 1.2 0.4 0.4 0.4 1.1 1.3 2.8 2.3 0.8 22.6 1.7 0.5 0.3 0.7 0.8 2.0 0.4 0.1 0.1 1.7 2.3 0.2 0.2 1.6 1.1 0.4 1.4 1.2 0.4 1.2 2.6 1.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.0 0.0 0.7 3.0 5.2 1.3 1.1 0.6 0.7 5.1 2.7 0.7 2.8 1.9 0.0 2.1 0.1 0.0 0.6 1.9 2.0 0.9 1.1 0.5 0.5 0.0 0.0 0.3 22.1 0.4 0.6 0.0 1.7 4.5 0.4 0.4 0.3 2.3 0.0 0.2 0.6 0.0 0.3 0.8 0.0 0.0 1.5 0.0 0.0 22.8 0.6 0.0 0.0 0.1 5.4 0.1 0.4 1.7 1.4 0.5 36.9 0.6 5.2 0.0 1.5 1.1 0.3 0.7 1.3 2.7 0.1 0.5 0.4 0.9 0.6 MYF6 "bHLHc4, MRF4" ENSG00000111046 "Myogenic factor 6" P23409 12 80707634-80709474 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "skeletal muscle: 443.6;tongue: 209.5" "Cell type enriched" "Detected in some" 39 "Skeletal myocytes: 146.1" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "LHCN-M2: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.20e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.88e-2)" "unprognostic (6.64e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 7.8 0.0 443.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 209.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 146.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYF5 bHLHc2 ENSG00000111049 "Myogenic factor 5" P13349 12 80716912-80719671 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 5.6;tongue: 8.9" "Cell type enriched" "Detected in single" 1159 "Skeletal myocytes: 347.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "LHCN-M2: 478.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA041691 Supported Nucleoplasm NA NA Nucleoplasm "HPA041691: AB_10796780" "unprognostic (2.65e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 478.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 347.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LIN7A "LIN-7A, MALS-1, TIP-33, VELI1" ENSG00000111052 "Lin-7 homolog A, crumbs cell polarity complex component" O14910 12 80792520-80937934 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.2;retina: 26.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 77.3;Early spermatids: 107.2;Excitatory neurons: 135.5;Inhibitory neurons: 93.1;Late spermatids: 76.9;Spermatocytes: 61.3" "Cancer enhanced" "Detected in many" "renal cancer: 8.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 18.8;eosinophil: 15.8;neutrophil: 29.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 29.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.3;ASC TERT1: 31.4;HAP1: 25.2;HDLM-2: 29.6;HL-60: 29.1;NB-4: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071562 Approved NA NA "HPA071562: AB_2732181" "unprognostic (7.11e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-3)" "unprognostic (3.04e-2)" "unprognostic (8.24e-2)" "unprognostic (4.24e-2)" "unprognostic (1.46e-2)" "unprognostic (8.83e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "prognostic favorable (1.63e-11)" "unprognostic (5.01e-5)" "unprognostic (7.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" 4.7 3.1 5.2 2.4 7.2 28.2 5.5 23.5 10.9 7.5 1.6 1.8 0.5 8.6 0.5 0.9 3.7 4.0 6.1 6.3 7.4 8.7 17.8 5.1 2.7 2.1 5.8 6.8 3.7 0.5 1.0 6.0 5.3 7.1 1.8 0.6 26.8 0.8 0.8 1.1 0.6 2.1 4.6 1.8 4.6 1.1 7.1 6.9 0.7 4.3 2.6 1.2 3.9 4.6 4.9 0.0 0.6 5.0 0.0 21.3 31.4 0.0 12.8 5.9 5.1 1.1 9.9 0.0 0.0 0.0 4.9 0.1 0.0 25.2 0.0 1.5 29.6 7.8 0.0 0.2 15.6 2.6 29.1 0.2 7.8 0.0 0.5 0.5 1.2 4.1 0.0 0.0 0.0 2.3 0.3 0.0 27.0 4.7 0.3 0.1 0.0 18.7 0.0 2.9 4.1 10.2 0.0 0.0 0.0 0.1 0.3 1.1 15.5 0.0 4.0 1.5 2.1 0.1 4.4 0.0 0.0 0.4 0.0 0.2 18.8 5.2 15.8 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 29.8 0.0 0.2 0.0 0.1 1.2 5.2 7.2 23.5 10.9 6.3 7.4 2.1 5.8 6.8 7.1 1.8 6.9 4.9 4.8 22.4 5.8 18.6 0.0 0.8 4.8 0.0 0.0 77.3 10.8 3.4 22.8 8.6 0.6 25.8 2.1 0.4 0.2 0.3 9.8 1.3 107.2 1.9 8.9 1.9 1.8 0.4 135.5 0.2 0.1 4.9 0.0 3.5 0.0 0.1 1.8 21.5 2.5 30.3 93.1 0.5 0.0 5.2 0.7 76.9 4.7 4.2 0.0 9.4 6.5 42.6 0.0 23.1 2.7 0.0 1.2 1.5 0.4 2.0 20.1 26.5 0.7 11.2 13.1 5.0 19.2 61.3 1.3 0.0 0.4 0.7 0.6 3.5 1.1 1.8 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952906 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "basophil: 76.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in many" "A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 12.1" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 83.9 29.2 3.3 78.2 2.8 1.5 211.9 5.5 4.6 245.5 28.8 428.1 327.2 28.1 228.0 119.4 195.1 182.1 24.4 2.1 4.6 227.6 523.8 179.3 8.7 21.9 5.6 1.1 16.5 574.9 80.1 253.9 478.4 30.8 184.9 497.1 0.6 326.2 130.7 2.1 40.9 373.8 23.7 2.3 28.7 292.4 8.4 10.3 10.4 246.2 1.4 28.0 201.6 62.7 12.7 2065.1 5639.4 1.1 7.9 0.7 1.1 3818.0 313.3 349.5 368.4 104.6 6249.4 4576.4 1.4 839.8 318.4 196.5 487.2 79.1 2228.5 217.9 2.6 138.2 19.4 865.7 1743.9 942.1 0.6 1.3 13.6 202.9 323.8 437.1 1046.9 399.0 3.4 511.4 0.2 0.3 8470.0 3.8 37.3 471.0 2740.1 457.9 3.0 0.3 236.1 1803.3 1144.9 65.6 3.7 512.7 4583.8 18.8 2696.0 2446.8 6.6 137.9 5.0 441.8 6.9 68.3 1.1 7.3 4.3 0.9 1.2 36.4 76.7 0.3 2.4 0.6 0.2 2.2 4.6 4.5 1.2 2.2 7.4 11.1 4.1 3.2 2.5 0.0 0.1 0.4 2.9 3.3 2.8 5.5 4.6 2.1 4.6 21.9 5.6 1.1 30.8 2.3 10.3 12.7 14.4 862.2 286.4 0.3 29.8 14.8 1605.7 912.1 447.3 0.1 814.6 615.6 5.3 1252.5 877.3 623.5 0.0 3698.8 14.2 1942.9 275.9 6583.8 1.0 462.3 60.3 77.8 642.3 15.4 0.0 4826.1 5496.7 203.5 971.5 742.4 48.9 51.2 57.1 610.9 308.3 1.7 0.0 2492.6 1969.3 9.8 13.8 3.8 10.5 28.3 208.1 1.0 41.5 6.2 0.0 0.0 0.0 6071.5 2164.1 0.0 13.7 1205.1 1912.3 718.5 500.8 0.6 0.0 0.6 298.6 2.7 26.0 395.7 6.7 7643.5 38.1 45.0 1635.0 1512.1 ACSS3 FLJ21963 ENSG00000111058 "Acyl-CoA synthetase short chain family member 3" Q9H6R3 12 80936414-81261210 "Enzymes, Metabolic proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "basophil: 7.0;neutrophil: 2.2" "Lineage enriched" "Detected in single" 70 "granulocytes: 7.0" "Cell line enhanced" "Detected in many" "ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039353, HPA047956, HPA061517" Approved Supported Mitochondria NA NA Mitochondria "HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549" "unprognostic (8.59e-2)" "unprognostic (9.29e-4)" "unprognostic (1.47e-1)" "unprognostic (9.37e-3)" "unprognostic (2.46e-2)" "unprognostic (2.21e-1)" "unprognostic (9.25e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (7.18e-3)" "unprognostic (1.68e-1)" "unprognostic (7.79e-2)" "prognostic favorable (0.00e+0)" "unprognostic (6.16e-4)" "unprognostic (1.63e-1)" "unprognostic (2.00e-1)" "unprognostic (2.00e-4)" 22.9 14.6 5.5 1.5 5.3 0.1 7.4 5.8 6.0 8.4 8.7 2.0 0.7 9.2 12.2 1.5 8.1 8.2 6.9 5.0 5.5 26.1 40.4 6.4 1.5 5.6 6.3 4.2 16.8 2.0 13.8 4.4 4.0 5.9 5.7 1.1 4.8 12.2 5.6 3.5 1.5 1.5 6.3 5.1 2.2 1.4 2.3 6.1 1.1 8.9 5.8 1.1 2.8 5.1 5.7 0.0 0.2 3.4 0.0 14.3 16.1 0.1 2.2 11.0 1.7 1.9 0.4 0.1 0.0 0.0 5.0 5.2 0.1 0.0 0.0 1.0 0.0 2.2 0.0 0.0 42.6 4.8 0.1 0.0 10.8 0.0 0.5 0.0 14.0 0.4 0.0 0.0 0.0 7.8 1.0 0.1 0.2 4.8 0.0 0.0 0.0 19.1 2.7 0.1 0.1 3.1 0.0 0.0 18.0 0.1 7.1 7.9 0.5 0.0 2.8 2.7 0.2 1.2 0.1 0.1 0.1 3.5 0.0 3.4 7.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 5.5 5.3 5.8 6.0 5.0 5.5 5.6 6.3 4.2 5.9 5.1 6.1 5.7 1.3 22.4 46.5 167.8 0.2 0.9 9.5 0.0 2.2 37.8 5.6 3.0 21.8 14.3 3.2 12.9 4.2 1.5 0.1 0.1 5.9 6.4 52.9 3.9 14.8 1.5 0.0 0.0 1.5 2.9 0.8 12.1 0.0 2.7 0.0 8.8 1.8 53.6 0.7 28.6 1.6 0.1 0.0 3.2 0.6 9.4 23.9 0.8 0.0 35.6 0.1 16.4 0.0 16.6 0.7 0.1 0.1 23.7 0.0 3.0 1.1 31.7 3.7 5.3 6.6 18.6 9.9 4.6 0.6 0.4 0.1 0.5 0.6 13.2 1.2 3.7 TNS2 "C1-TEN, KIAA1075, TENC1" ENSG00000111077 "Tensin 2" Q63HR2 12 53046969-53064379 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 109.3;Hepatic stellate cells: 93.1;Leydig cells: 141.7;Peritubular cells: 114.0;Sertoli cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 114.2;ASC TERT1: 78.1;HHSteC: 59.9;HSkMC: 86.2;hTERT-RPE1: 61.9;TIME: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034659 Approved NA Yes "HPA034659: AB_10603349" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (5.21e-3)" "unprognostic (1.86e-1)" "unprognostic (3.59e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-2)" "unprognostic (8.97e-3)" "prognostic favorable (1.72e-4)" "prognostic favorable (9.32e-4)" "unprognostic (4.46e-2)" "unprognostic (1.09e-2)" "unprognostic (8.46e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-2)" 147.0 67.5 53.2 14.9 55.9 0.3 122.6 41.1 58.2 117.6 33.9 67.4 14.6 99.6 14.2 28.5 122.1 32.8 90.4 37.4 39.6 67.4 67.0 84.1 15.9 62.8 57.6 30.0 105.0 34.9 17.1 43.6 33.4 70.8 66.9 11.6 6.1 36.0 41.4 69.5 38.0 57.2 28.8 44.5 80.1 58.7 16.0 52.9 7.3 81.3 59.4 6.5 83.3 81.8 46.5 2.0 21.2 2.7 2.2 114.2 78.1 0.7 11.8 27.1 6.2 3.2 1.4 5.7 0.1 25.3 32.1 2.6 1.5 0.1 7.8 2.4 0.5 0.8 0.4 25.5 11.3 59.9 0.3 0.5 86.2 0.3 7.9 4.7 61.9 36.3 0.4 0.6 0.3 24.9 5.1 0.2 0.4 1.9 1.4 5.8 0.7 6.6 0.3 8.2 0.4 1.2 2.7 4.4 2.4 8.8 1.6 26.1 0.7 52.1 12.9 14.8 4.7 2.0 0.6 0.3 0.1 20.4 0.3 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.2 55.9 41.1 58.2 37.4 39.6 62.8 57.6 30.0 70.8 44.5 52.9 46.5 109.3 3.2 25.7 33.3 0.5 0.0 6.8 0.0 5.2 21.1 15.1 13.0 7.9 10.0 2.5 5.5 0.0 0.5 0.9 0.4 3.9 5.8 2.8 4.4 41.1 69.6 1.2 2.7 3.1 4.4 0.4 40.5 2.0 14.5 0.0 7.7 93.1 37.5 2.4 30.3 7.8 3.9 0.0 4.4 0.0 7.2 141.7 2.9 0.0 31.9 0.1 29.6 0.0 46.3 35.6 2.4 9.0 114.0 1.8 4.5 2.1 2.6 1.5 11.3 151.2 51.3 64.7 4.2 4.4 1.3 0.0 0.8 1.4 2.6 1.8 2.1 GLI1 GLI ENSG00000111087 "GLI family zinc finger 1" P08151 12 57459785-57472268 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 11.2" "Cell type enhanced" "Detected in some" "Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009460, HPA065172, HPA068903" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122" "unprognostic (4.97e-4)" "unprognostic (5.53e-2)" "unprognostic (1.26e-1)" "unprognostic (5.58e-3)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.00e-2)" "unprognostic (1.88e-1)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-8)" "unprognostic (4.59e-3)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-2)" 1.5 1.2 1.4 1.7 1.6 0.5 1.5 3.8 2.0 11.2 0.8 3.0 2.6 9.6 6.7 0.6 3.8 5.5 1.6 1.2 2.0 1.4 0.8 1.6 0.7 2.0 2.2 1.2 1.5 0.8 0.0 1.0 0.5 3.8 4.2 4.1 0.0 1.6 2.9 0.6 1.5 3.3 2.4 1.8 0.9 1.9 4.8 3.3 0.3 2.3 1.8 1.0 4.5 3.2 1.3 0.1 9.8 3.2 24.2 0.7 0.1 0.3 0.9 16.9 2.1 2.3 0.3 0.7 3.1 0.0 0.5 2.3 1.7 1.8 1.1 0.4 2.7 0.3 0.1 1.2 0.2 2.7 0.7 1.4 0.8 0.4 3.1 1.0 4.2 0.3 2.2 0.4 7.8 1.0 0.0 0.7 0.5 14.0 0.8 0.9 1.2 60.6 1.7 2.7 0.0 0.1 0.1 0.2 0.1 0.4 2.4 0.0 0.3 0.1 2.2 7.7 0.6 0.3 16.7 1.0 5.7 2.0 1.3 3.8 0.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 1.9 0.0 0.0 0.1 0.2 0.0 1.4 1.6 3.8 2.0 1.2 2.0 2.0 2.2 1.2 3.8 1.8 3.3 1.3 0.4 0.0 0.0 2.0 0.7 0.1 0.4 0.3 0.0 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.1 3.5 0.5 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 2.5 29.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.9 0.1 0.2 0.0 1.3 0.0 0.0 13.1 1.9 1.6 0.3 1.1 0.2 0.6 0.1 0.5 7.8 0.1 0.1 PPM1H "ARHCL1, FLJ13253, KIAA1157, NERPP-2C" ENSG00000111110 "Protein phosphatase, Mg2+/Mn2+ dependent 1H" Q9ULR3 12 62643994-62935150 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.1;parathyroid gland: 42.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020694, HPA044244, HPA058777" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816" "unprognostic (3.41e-2)" "unprognostic (1.94e-1)" "unprognostic (9.51e-2)" "unprognostic (8.61e-3)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (5.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" "unprognostic (5.53e-3)" "unprognostic (2.19e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" "unprognostic (8.04e-3)" "unprognostic (1.14e-1)" 2.2 1.5 12.6 1.2 12.6 3.1 5.0 30.1 16.2 7.6 5.6 2.4 3.1 6.2 6.7 0.6 6.5 6.8 1.8 13.3 14.0 10.7 3.4 2.7 1.2 12.0 13.4 11.8 9.6 3.9 42.7 8.2 6.6 13.7 13.5 3.0 26.9 11.5 6.0 1.2 0.7 1.7 1.6 8.3 0.9 5.8 0.9 17.3 4.4 3.3 1.3 1.7 2.1 0.3 14.6 1.2 12.4 2.2 0.2 0.5 0.0 26.5 2.9 2.9 1.8 0.6 80.6 5.7 0.0 2.7 1.4 1.8 1.6 8.7 0.2 1.1 0.2 4.3 15.2 2.4 18.4 0.1 4.6 62.7 0.1 0.3 0.0 0.7 1.9 0.3 2.7 4.0 0.0 1.3 9.5 1.5 2.2 15.9 4.1 5.9 2.1 5.6 23.0 18.1 28.3 6.9 0.0 5.0 35.6 12.1 8.5 19.6 2.7 0.2 0.5 1.5 0.2 0.9 3.3 21.4 4.1 0.2 0.1 1.2 2.9 0.7 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.1 12.6 12.6 30.1 16.2 13.3 14.0 12.0 13.4 11.8 13.7 8.3 17.3 14.6 4.6 6.4 4.7 25.5 1.0 0.1 0.3 3.0 0.0 9.4 9.5 3.4 2.4 12.8 5.9 16.5 27.1 22.2 0.0 0.7 3.9 4.2 8.5 27.6 25.3 6.5 9.0 3.8 123.5 6.3 2.1 1.3 7.7 81.6 14.5 0.3 9.7 6.1 6.1 11.8 162.1 2.0 6.1 1.6 2.1 10.1 0.9 2.1 3.6 89.9 2.1 6.4 0.0 41.7 341.4 4.5 2.1 1.5 0.5 4.3 0.1 8.5 14.0 10.9 0.0 0.6 1.7 0.0 0.5 0.5 0.1 6.8 1.3 2.8 2.4 0.5 METAP2 "MAP2, MNPEP, p67" ENSG00000111142 "Methionyl aminopeptidase 2" P50579 12 95473520-95515839 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013025, HPA019095" Enhanced Supported "Plasma membrane,Cytosol" NA NA 70000 "Plasma membrane, Cytosol" "CAB013025: AB_2533993, HPA019095: AB_1853823" "unprognostic (1.91e-1)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.44e-1)" "unprognostic (3.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.51e-6)" "unprognostic (1.25e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-2)" "unprognostic (8.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" 53.0 58.5 42.3 52.0 46.5 103.1 55.6 47.6 53.6 46.4 42.0 51.2 37.1 54.7 53.1 55.2 43.0 47.4 66.5 42.0 50.3 56.1 85.2 49.5 78.6 47.5 45.8 36.8 61.1 53.2 52.7 36.8 51.7 50.6 43.7 51.4 31.1 41.0 101.9 120.6 58.8 38.0 55.4 45.4 40.7 37.8 62.4 46.6 69.8 52.3 79.4 126.0 62.8 41.8 52.0 192.3 157.8 163.7 129.6 98.4 156.4 125.9 186.0 127.6 177.7 125.7 228.0 88.6 542.1 113.5 133.4 101.9 120.5 187.4 142.4 203.8 131.2 161.2 244.9 113.7 165.6 104.5 313.5 117.1 137.5 148.1 164.9 164.0 210.7 192.9 184.2 321.8 60.5 135.3 125.8 230.3 213.0 204.5 109.4 233.4 179.6 141.5 178.5 123.5 198.3 127.0 165.3 166.0 132.7 169.0 140.6 159.4 146.5 165.1 100.7 98.5 115.0 195.7 87.7 246.8 585.1 58.1 173.7 129.9 77.5 70.5 32.0 60.0 52.2 74.3 114.2 66.8 67.8 66.0 101.8 79.2 74.1 3.4 72.8 65.6 85.3 71.6 46.4 42.3 46.5 47.6 53.6 42.0 50.3 47.5 45.8 36.8 50.6 45.4 46.6 52.0 87.0 282.0 238.9 22.9 101.3 233.2 130.2 141.3 97.3 70.6 119.7 95.9 143.6 100.1 133.3 290.6 66.7 146.2 87.7 96.8 164.4 115.2 189.5 114.9 260.0 110.2 91.7 278.4 35.1 145.8 161.5 112.2 53.0 153.7 122.9 140.5 112.1 314.6 98.1 75.7 49.5 119.7 73.2 141.0 89.8 123.3 100.3 83.8 92.5 20.6 103.5 72.6 81.4 26.2 41.4 130.1 105.8 106.8 87.0 108.1 93.4 186.6 92.4 83.8 98.6 137.4 133.4 378.4 207.6 95.2 215.0 172.0 80.7 101.4 144.8 110.5 LTA4H ENSG00000111144 "Leukotriene A4 hydrolase" P09960 12 96000753-96043520 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Leukotriene biosynthesis, Lipid metabolism" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008399, CAB015221, HPA017017" Supported Approved Nucleoplasm,Cytosol NA NA 86000000 "Nucleoplasm, Cytosol" "CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818" "prognostic favorable (9.79e-4)" "unprognostic (6.62e-2)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (4.25e-3)" "prognostic favorable (8.96e-4)" "unprognostic (1.72e-1)" "unprognostic (1.75e-2)" "unprognostic (3.38e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.74e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-1)" 38.4 67.6 24.9 65.1 26.1 182.0 54.1 29.5 30.9 56.1 34.4 48.6 78.8 51.6 38.8 111.0 62.3 40.6 35.8 24.8 29.8 58.7 44.3 192.5 64.6 26.2 25.5 24.0 111.5 55.3 53.8 37.7 27.6 25.2 41.5 50.1 37.3 41.6 41.3 45.4 68.3 61.0 58.9 29.2 58.3 47.0 20.1 27.2 49.6 49.8 45.4 97.2 52.4 53.2 28.2 85.2 90.4 123.5 73.4 104.2 115.1 53.8 33.7 101.8 67.5 78.1 66.6 72.0 190.0 42.0 51.9 52.8 108.3 103.4 140.1 92.3 63.3 97.0 68.5 54.3 81.8 61.8 35.7 39.4 110.1 118.4 91.9 114.5 305.3 134.9 101.1 42.9 32.5 98.7 59.2 96.7 115.0 145.8 100.7 115.5 88.9 90.5 109.7 125.7 107.7 63.9 75.5 64.2 80.4 78.3 95.1 98.7 44.7 49.0 28.3 47.6 40.2 38.2 42.8 79.4 85.4 19.1 66.2 22.3 4.4 662.9 17.7 33.4 699.2 63.4 126.1 46.6 43.4 282.3 157.5 65.0 50.5 46.0 120.4 638.8 70.4 51.2 591.5 24.9 26.1 29.5 30.9 24.8 29.8 26.2 25.5 24.0 25.2 29.2 27.2 28.2 32.8 38.5 135.0 15.3 82.8 51.9 64.8 96.6 52.3 21.4 41.8 41.1 25.3 25.8 110.2 38.6 33.3 29.3 47.9 17.6 74.3 42.9 74.3 18.4 20.8 38.2 21.6 50.5 21.3 28.0 28.2 29.7 38.2 27.3 7.6 31.5 57.8 21.7 207.2 11.8 18.5 40.4 40.7 255.8 76.6 16.4 36.7 183.3 21.4 10.3 245.5 35.5 26.8 19.6 17.5 20.8 27.1 41.0 40.1 35.4 73.2 69.3 45.0 55.6 6.6 26.7 35.4 46.9 11.6 108.0 74.9 20.8 39.1 32.9 70.4 49.7 ELK3 "ERP, NET, SAP2" ENSG00000111145 "ETS transcription factor ELK3" P41970 12 96194375-96269824 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001600 Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA001600: AB_1078752" "unprognostic (3.11e-1)" "unprognostic (8.81e-3)" "unprognostic (6.38e-2)" "unprognostic (5.77e-2)" "unprognostic (7.18e-3)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-3)" "unprognostic (7.39e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (1.20e-3)" "unprognostic (2.90e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (2.05e-2)" 37.4 14.5 5.2 34.5 5.8 18.5 28.7 13.0 5.8 28.2 11.2 14.0 9.3 35.5 9.4 38.4 17.0 30.4 24.1 4.6 10.6 11.7 10.9 27.7 38.3 8.5 7.7 3.3 10.3 9.0 11.7 5.9 27.2 9.1 13.3 14.0 2.9 15.4 15.5 11.3 12.6 13.6 38.3 7.8 42.1 14.9 8.7 9.1 19.9 22.0 22.4 37.8 29.5 24.7 6.6 50.3 29.5 29.7 15.8 73.7 137.3 7.6 62.3 118.5 48.6 37.3 1.7 36.6 8.0 20.9 70.4 36.4 17.6 3.3 99.8 85.0 21.7 11.4 2.5 12.2 11.2 22.3 24.2 5.7 81.3 18.4 100.4 75.4 98.5 117.8 6.0 6.0 32.3 166.4 7.6 4.8 16.4 36.3 7.1 38.8 39.7 49.8 9.1 41.7 13.0 1.4 31.4 20.5 9.1 32.0 44.7 5.0 13.3 73.2 132.4 52.2 82.5 54.8 61.7 55.0 1.8 47.0 28.2 94.1 7.1 23.5 0.5 11.1 13.0 42.5 23.2 25.7 15.0 17.7 19.0 15.4 11.4 7.4 20.1 12.1 7.1 45.4 12.8 5.2 5.8 13.0 5.8 4.6 10.6 8.5 7.7 3.3 9.1 7.8 9.1 6.6 170.7 6.4 22.3 3.9 22.3 32.6 44.6 15.0 10.8 0.7 7.1 8.1 6.6 2.8 39.4 5.5 4.2 1.2 27.5 2.1 5.9 21.8 1.0 49.0 19.7 148.0 1.2 12.4 4.2 15.6 3.9 35.2 3.1 44.0 17.1 1.3 160.6 4.3 24.5 0.0 1.9 3.4 2.0 32.0 39.7 2.5 11.5 31.4 12.4 39.4 23.6 5.8 9.2 5.5 5.3 56.8 3.4 10.5 29.5 45.7 0.5 0.7 103.1 0.6 13.1 27.7 19.9 0.2 12.6 24.4 27.0 1.1 32.6 10.6 3.0 79.0 SLC6A12 BGT-1 ENSG00000111181 "Solute carrier family 6 member 12" P48065 12 190077-214570 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;kidney: 28.7;liver: 82.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 46.0;Hepatocytes: 22.7;monocytes: 10.7" "Cancer enhanced" "Detected in many" "liver cancer: 8.8;renal cancer: 11.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 50 "classical monocyte: 5.7;intermediate monocyte: 5.7;myeloid DC: 2.4;neutrophil: 3.0;non-classical monocyte: 7.9" "Group enriched" "Detected in many" 45 "dendritic cells: 2.4;granulocytes: 3.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "Hep G2: 7.2;RPTEC TERT1: 13.8;SuSa: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034973 Approved Approved Vesicles NA NA Vesicles "HPA034973: AB_10610427" "unprognostic (3.48e-1)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.70e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (8.30e-2)" "unprognostic (6.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.85e-2)" "unprognostic (3.68e-1)" "prognostic favorable (2.70e-6)" "unprognostic (2.30e-1)" "unprognostic (4.92e-4)" "unprognostic (3.35e-1)" "unprognostic (4.31e-4)" 0.2 0.4 22.5 1.1 22.3 0.1 0.4 16.6 30.7 0.8 11.9 0.7 4.6 1.2 6.9 0.0 3.4 1.0 0.3 17.1 19.6 28.7 82.2 2.4 0.5 19.5 23.7 14.4 0.3 1.6 0.4 0.8 0.5 23.4 0.1 1.8 0.6 0.1 0.0 0.1 0.3 0.9 0.9 14.7 0.5 2.4 1.6 20.5 0.3 6.4 0.0 0.3 0.4 0.3 21.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.8 0.1 0.0 0.4 0.0 0.0 0.1 2.9 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 3.0 0.0 7.9 0.0 0.0 1.9 22.5 22.3 16.6 30.7 17.1 19.6 19.5 23.7 14.4 23.4 14.7 20.5 21.1 0.1 0.0 0.5 4.2 0.6 0.1 0.0 0.0 0.0 0.5 0.9 0.6 0.7 0.0 0.1 46.0 0.0 0.0 0.0 1.6 1.9 0.0 4.6 3.5 1.7 0.2 0.0 0.0 0.4 0.4 0.0 0.6 2.0 8.8 0.0 0.1 0.7 22.7 2.4 0.0 0.3 1.7 0.0 1.9 2.5 6.2 0.6 1.6 0.0 8.4 10.7 5.2 0.0 0.5 9.2 0.0 1.2 0.0 0.0 0.0 0.0 8.0 0.0 0.4 6.6 0.6 0.4 2.3 4.5 0.0 0.4 0.8 0.1 0.1 1.0 0.1 WNT5B ENSG00000111186 "Wnt family member 5B" Q9H1J7 12 1529891-1647212 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 32.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 25.6;Microglial cells: 19.7;Muller glia cells: 40.4;Urothelial cells: 16.2" "Cancer enhanced" "Detected in all" "testis cancer: 15.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.8;eosinophil: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 231.4;BJ hTERT+: 143.5;BJ hTERT+ SV40 Large T+: 165.4;BJ hTERT+ SV40 Large T+ RasG12V: 136.4;fHDF/TERT166: 162.6;HBF TERT88: 144.1;hTEC/SVTERT24-B: 144.8;U-138 MG: 142.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA061991 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA061991: " "unprognostic (7.44e-2)" "unprognostic (5.59e-2)" "unprognostic (8.14e-2)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-1)" "unprognostic (5.53e-3)" "unprognostic (1.26e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (4.08e-2)" "unprognostic (2.16e-2)" "unprognostic (1.49e-3)" "unprognostic (1.90e-1)" "unprognostic (2.93e-2)" "unprognostic (2.77e-1)" "unprognostic (2.71e-2)" 3.0 2.4 3.7 4.2 3.8 0.5 3.0 2.8 3.7 5.4 2.0 17.7 4.3 7.2 5.1 15.1 6.3 2.8 3.6 2.9 4.6 1.7 4.6 3.0 2.6 4.7 3.9 3.2 8.3 1.5 9.1 11.3 3.9 3.9 32.6 5.8 5.4 15.8 20.1 1.4 5.1 5.1 5.5 3.6 5.3 6.5 1.8 4.8 3.7 2.1 6.7 3.1 14.0 9.8 4.0 0.3 0.1 1.4 0.2 34.6 61.2 0.0 231.4 143.5 165.4 136.4 8.7 0.9 2.9 0.4 162.6 111.1 3.5 3.3 0.0 144.1 55.0 7.9 12.8 0.0 0.0 8.5 0.2 0.1 51.3 3.3 144.8 41.3 66.6 0.0 0.1 9.5 51.9 39.4 0.1 0.0 0.3 5.7 0.2 0.5 0.0 2.3 4.0 2.0 0.0 1.0 3.2 4.9 0.5 0.2 17.7 0.2 0.9 0.0 142.4 5.9 56.7 119.7 13.9 2.2 0.7 13.9 0.0 1.5 0.0 1.8 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 3.7 3.8 2.8 3.7 2.9 4.6 4.7 3.9 3.2 3.9 3.6 4.8 4.0 0.9 0.0 0.6 7.5 1.5 0.9 11.0 1.9 25.6 1.8 0.7 6.5 2.2 0.0 3.3 0.0 0.0 1.0 0.2 2.4 0.0 1.1 0.2 1.7 10.4 1.4 0.0 0.0 6.9 0.7 1.1 8.0 0.5 2.7 0.0 0.3 0.4 1.7 5.3 0.0 7.9 1.9 2.0 2.1 2.9 0.5 2.1 2.7 3.6 19.7 4.1 40.4 0.0 4.0 5.6 2.8 5.0 2.6 4.5 8.8 1.0 0.2 4.3 2.7 6.6 7.9 4.3 0.7 5.7 7.7 1.3 0.7 0.2 0.0 1.7 16.2 MAGOHB "FLJ10292, MGN2" ENSG00000111196 "Mago homolog B, exon junction complex subunit" Q96A72 12 10604193-10613609 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 119.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043036, HPA047754" Uncertain NA NA "HPA043036: AB_2678279, HPA047754: AB_2680148" "unprognostic (1.16e-2)" "unprognostic (4.94e-2)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" "unprognostic (2.50e-2)" "unprognostic (3.42e-2)" "unprognostic (6.27e-2)" "unprognostic (8.57e-2)" "prognostic favorable (5.56e-6)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.04e-8)" "prognostic favorable (6.50e-4)" "unprognostic (1.61e-1)" "unprognostic (3.33e-1)" "unprognostic (6.03e-2)" 7.8 8.3 8.6 7.2 9.0 7.2 9.3 9.4 11.2 7.6 8.8 9.0 5.3 6.6 11.8 8.0 4.3 4.7 7.8 8.6 8.6 8.4 14.6 5.1 9.4 8.5 8.5 8.1 4.0 5.9 7.1 7.4 7.5 8.6 6.9 8.9 4.1 5.1 6.3 3.2 5.7 6.3 7.7 8.8 7.2 6.0 3.4 8.5 11.2 6.4 2.4 12.2 7.1 4.5 9.0 39.4 53.0 55.7 38.7 13.0 17.7 55.0 56.0 16.7 46.0 33.3 69.4 37.4 64.5 8.7 38.1 42.0 21.3 50.2 33.1 59.2 39.4 70.0 53.6 54.4 47.4 16.9 110.0 29.2 12.6 12.5 36.7 22.7 12.9 28.9 76.5 52.7 9.9 42.0 56.9 71.9 72.2 113.7 40.8 47.2 63.1 92.6 39.4 36.7 46.5 15.2 31.3 38.9 43.0 40.6 106.7 20.9 95.8 16.5 26.1 88.3 38.2 82.0 14.2 42.5 128.1 61.3 56.9 72.0 0.5 7.8 3.0 14.2 13.6 15.3 12.1 13.6 15.9 11.6 12.7 15.3 18.7 1.4 20.1 13.1 32.9 13.4 8.3 8.6 9.0 9.4 11.2 8.6 8.6 8.5 8.5 8.1 8.6 8.8 8.5 9.0 21.8 19.2 18.8 4.2 27.1 14.1 27.8 61.4 14.8 12.2 22.3 26.8 25.5 17.2 32.7 22.0 8.4 67.5 34.8 13.3 70.5 43.8 9.9 21.1 29.8 24.4 22.7 36.4 7.6 34.3 119.6 30.4 19.4 31.4 24.1 33.6 19.2 38.5 49.6 0.0 7.9 32.7 40.7 14.5 14.1 6.5 18.0 18.5 30.2 5.6 30.8 18.4 30.9 14.1 10.3 25.3 11.3 15.4 26.4 33.5 16.2 48.3 22.3 15.1 26.3 19.7 49.1 24.7 54.3 21.6 13.2 46.8 24.1 17.8 25.5 26.4 TRPV4 "CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC" ENSG00000111199 "Transient receptor potential cation channel subfamily V member 4" Q9HBA0 12 109783087-109833406 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Charcot-Marie-Tooth disease, Disease variant, Dwarfism, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 40.9;salivary gland: 19.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 17.1;Cholangiocytes: 20.0;Cytotrophoblasts: 20.0;Kupffer cells: 19.6;Respiratory ciliated cells: 28.2;Syncytiotrophoblasts: 21.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 6 "hippocampal formation: 4.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 7.9;BJ hTERT+: 9.5;EFO-21: 7.2;HaCaT: 14.2;HUVEC TERT2: 8.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA007150 Uncertain NA NA "HPA007150: AB_1080393" "unprognostic (2.98e-2)" "unprognostic (1.12e-2)" "unprognostic (2.33e-2)" "unprognostic (4.20e-3)" "unprognostic (6.25e-3)" "unprognostic (1.09e-2)" "unprognostic (7.95e-2)" "unprognostic (2.03e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "prognostic favorable (4.12e-5)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" 0.8 0.8 0.2 1.0 0.3 0.1 1.9 0.6 0.6 2.0 40.9 0.3 0.7 0.6 0.4 10.4 4.7 1.4 0.6 4.2 0.1 14.7 8.6 2.3 0.8 0.4 0.6 0.1 0.3 4.4 0.3 2.2 5.2 0.4 6.9 0.3 0.0 19.3 0.8 0.1 7.5 0.4 0.7 0.2 2.9 0.7 0.8 0.6 0.1 0.9 0.0 1.0 1.8 2.2 0.4 2.4 0.2 0.0 0.0 2.0 1.2 7.9 4.2 9.5 1.2 0.3 0.0 6.4 0.0 7.2 5.8 0.0 14.2 1.0 0.0 0.4 0.0 1.8 0.0 0.1 3.7 0.6 0.0 0.0 3.4 2.0 2.7 0.0 0.6 8.7 0.0 0.5 0.0 0.4 5.3 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 4.9 0.0 0.0 0.3 0.6 2.6 3.5 1.1 0.2 4.5 0.0 2.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.6 4.2 0.1 0.4 0.6 0.1 0.4 0.2 0.6 0.4 0.1 0.0 0.0 0.0 0.7 3.3 8.1 17.1 7.4 0.0 5.1 5.5 1.0 20.0 12.0 11.0 0.0 20.0 0.4 0.0 3.9 2.5 0.2 3.2 1.0 1.4 0.0 0.0 0.3 9.3 5.3 1.2 2.0 1.2 0.0 0.9 0.7 7.7 4.0 0.0 0.4 0.0 6.1 19.6 0.7 0.2 0.9 2.6 7.2 1.9 0.8 0.0 0.0 1.0 0.3 2.0 0.0 0.0 0.0 4.6 0.0 12.5 28.2 0.0 0.0 0.1 1.1 0.3 1.1 4.5 3.8 21.1 0.3 0.2 0.0 3.3 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Uncertain "Endoplasmic reticulum" NA No "Endoplasmic reticulum" "HPA038664: AB_10672722, HPA038665: AB_2676138" "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.7 15.7 6.3 11.5 8.1 14.5 14.1 9.9 8.2 17.8 9.7 14.0 12.5 18.9 14.6 13.2 17.3 9.0 12.2 6.0 7.2 15.0 12.3 15.1 16.0 8.1 7.9 5.7 29.1 22.3 28.3 14.2 14.7 8.6 14.0 15.1 8.2 18.0 15.7 8.3 11.4 14.6 13.5 6.5 19.7 16.2 5.1 7.8 18.2 26.9 9.8 16.0 14.8 15.0 11.9 7.3 10.6 11.9 9.7 10.2 11.6 11.0 15.9 9.0 18.9 13.8 22.7 17.6 16.5 4.4 15.0 9.4 9.1 18.5 15.9 14.1 14.7 10.6 23.1 12.7 9.1 18.8 21.7 12.0 15.7 18.4 17.3 26.4 15.5 13.1 15.6 12.8 17.3 10.9 21.9 31.3 12.6 24.6 16.5 8.0 15.6 13.3 9.5 11.3 12.3 5.7 18.3 19.5 17.1 7.2 16.2 10.6 9.9 13.4 12.4 7.4 12.0 30.8 2.2 1.4 25.0 8.0 12.4 12.8 4.0 16.6 8.4 19.2 22.2 18.0 25.8 14.7 19.0 19.6 24.2 19.8 18.6 1.9 23.4 35.6 14.6 13.2 16.5 6.3 8.1 9.9 8.2 6.0 7.2 8.1 7.9 5.7 8.6 6.5 7.8 11.9 11.1 12.8 17.9 12.7 35.9 3.3 9.8 9.3 10.2 39.8 16.5 15.6 17.1 18.6 12.1 12.9 64.6 28.1 27.6 13.0 11.7 9.2 46.3 13.0 19.1 10.5 9.5 17.9 13.6 7.2 8.9 15.0 23.0 13.2 6.3 18.7 12.1 11.3 13.4 32.0 15.2 15.2 8.2 12.0 5.1 12.1 16.8 11.0 1.8 8.4 16.8 10.0 42.2 10.1 25.8 7.2 14.4 13.2 19.6 9.1 20.5 6.1 8.7 56.0 6.6 11.7 16.9 13.2 20.0 14.3 4.0 17.4 24.3 22.2 19.5 5.9 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857680-2877174 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 32.5;testis: 21.6" "Cell type enhanced" "Detected in many" "Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.9 1.1 0.4 9.5 0.5 25.2 1.8 0.7 0.9 1.5 0.1 10.6 9.8 1.7 0.2 11.2 0.8 1.6 0.4 0.8 0.5 0.7 1.2 1.8 11.4 0.5 0.8 0.4 0.3 0.4 0.4 0.1 6.2 0.7 0.7 12.6 1.1 1.9 0.8 0.6 6.5 8.9 7.6 0.1 3.2 5.2 21.6 0.7 32.5 0.9 0.3 15.3 3.0 3.2 2.9 133.0 129.5 101.3 92.2 14.2 19.0 129.2 84.0 80.4 165.2 147.2 166.9 114.8 84.5 17.7 119.8 188.5 100.2 153.1 76.1 160.0 159.8 80.3 94.7 121.6 71.6 2.0 79.2 75.0 9.9 8.3 154.4 106.1 39.1 117.8 96.8 55.6 184.9 130.5 122.6 108.3 36.8 225.6 136.1 95.4 77.3 149.8 44.1 38.1 82.7 56.3 89.1 106.7 90.4 46.6 189.4 87.1 87.8 48.0 134.3 200.5 160.4 300.4 24.7 44.3 122.1 63.1 74.3 147.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.7 0.9 0.8 0.5 0.5 0.8 0.4 0.7 0.1 0.7 2.9 0.1 0.0 1.3 0.7 2.4 2.9 1.3 1.0 1.2 2.0 1.7 1.3 0.5 1.5 0.8 1.8 4.2 7.1 0.8 6.6 1.9 0.2 22.4 1.2 2.1 2.5 0.0 18.7 1.1 0.0 18.2 3.2 10.2 2.4 0.0 15.4 3.6 0.8 9.1 5.0 0.6 7.5 2.0 4.2 1.2 25.5 0.9 2.4 0.0 0.0 1.1 0.6 1.0 0.5 1.0 0.3 0.3 0.7 19.9 1.0 1.4 0.4 0.2 4.0 0.0 1.2 3.0 15.0 9.9 10.2 1.4 1.9 3.3 0.9 12.9 1.9 PRR4 "LPRP, PROL4" ENSG00000111215 "Proline rich 4" Q16378 12 10845849-10849475 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 45 "salivary gland: 6671.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 92.8;Cone photoreceptor cells: 139.7;Horizontal cells: 85.8;Rod photoreceptor cells: 119.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "OE19: 2.8" HPA042133 Supported "Secreted to digestive system" NA NA 14000000 "HPA042133: AB_10793979" "unprognostic (1.34e-1)" "unprognostic (2.13e-1)" "unprognostic (1.35e-2)" "unprognostic (1.74e-2)" "unprognostic (1.99e-1)" "unprognostic (5.03e-2)" "unprognostic (3.01e-3)" "unprognostic (3.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.23e-1)" "unprognostic (3.19e-2)" "unprognostic (1.09e-2)" "unprognostic (3.57e-6)" "unprognostic (2.81e-2)" "unprognostic (9.15e-2)" "unprognostic (1.21e-1)" "unprognostic (2.15e-2)" 1.1 2.1 0.6 0.0 0.6 0.1 9.7 0.6 1.8 0.1 0.6 0.2 7.6 0.0 0.0 149.3 0.0 0.0 0.4 0.6 0.6 0.2 0.2 75.1 0.0 0.8 0.6 0.6 0.1 2.7 0.0 2.1 0.1 0.6 4.1 0.0 0.0 6671.2 0.1 0.8 52.4 0.2 0.0 0.6 0.1 66.6 0.5 0.6 0.0 0.1 0.0 0.5 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 1.8 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.6 0.6 0.3 3.2 0.0 0.0 22.0 3.1 6.8 19.9 9.6 92.8 7.5 2.8 1.8 7.2 8.2 1.8 139.7 16.4 20.1 6.3 1.9 0.1 10.2 0.1 0.2 9.6 16.2 14.1 0.0 0.4 2.5 9.3 10.7 0.1 8.9 0.4 14.6 5.9 7.7 85.8 0.0 6.4 24.4 8.7 6.0 13.9 21.8 6.1 28.4 0.0 7.9 18.2 56.7 0.0 0.0 3.4 14.4 24.5 17.1 9.3 7.9 0.2 6.8 119.2 13.1 23.0 7.1 13.5 5.7 8.1 2.3 4.0 20.1 0.5 9.6 4.0 PRMT8 "HRMT1L3, HRMT1L4" ENSG00000111218 "Protein arginine methyltransferase 8" Q9NR22 12 3381349-3593973 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.7;retina: 3.9;testis: 2.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 21.7;Cone photoreceptor cells: 16.7;Early spermatids: 22.8;Excitatory neurons: 60.5;Inhibitory neurons: 63.8;Late spermatids: 15.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "hTERT-HME1: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039747, HPA069769" Enhanced NA NA "HPA039747: AB_2732482, HPA069769: AB_2686193" "unprognostic (3.09e-1)" "unprognostic (9.47e-2)" "unprognostic (5.59e-1)" "unprognostic (3.34e-3)" "unprognostic (4.80e-3)" "unprognostic (9.41e-2)" "unprognostic (3.41e-5)" "unprognostic (5.99e-1)" "unprognostic (1.93e-1)" "unprognostic (1.50e-2)" "unprognostic (7.06e-2)" "unprognostic (2.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.64e-1)" "unprognostic (6.02e-2)" "unprognostic (5.49e-2)" 0.0 0.0 2.4 0.0 7.1 0.0 0.0 4.2 7.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.9 5.0 4.9 0.3 0.0 0.8 0.0 2.3 3.5 4.9 0.0 0.6 0.0 0.1 0.0 2.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 4.0 1.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 48.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 7.1 4.2 7.7 5.0 4.9 2.3 3.5 4.9 2.8 0.4 4.0 3.8 0.0 6.4 1.7 1.6 0.1 0.0 0.0 0.0 0.0 21.7 0.1 0.0 1.3 0.0 5.0 0.0 16.7 0.0 0.0 0.1 0.0 0.0 22.8 2.2 0.1 0.3 0.0 0.0 60.5 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 5.0 63.8 0.0 4.1 0.0 4.2 15.4 0.6 0.4 0.0 1.0 0.0 0.7 0.0 3.0 1.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 7.5 1.6 0.0 0.0 0.2 3.5 1.5 0.0 0.0 0.0 0.2 0.0 0.1 0.2 PARP11 "ARTD11, C12orf6" ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 3.5 5.0 2.6 5.1 2.9 3.3 5.3 1.9 2.8 4.3 2.5 3.6 3.7 6.5 5.4 3.1 4.1 4.1 2.4 2.4 3.3 3.9 4.5 3.8 10.3 3.4 2.6 2.6 8.2 2.5 7.8 1.8 3.2 3.0 8.7 4.2 3.3 4.1 4.2 1.9 2.3 3.8 5.2 2.6 6.2 3.3 9.4 3.2 10.5 9.2 3.0 9.5 5.1 1.9 3.5 2.7 2.3 14.0 2.3 4.4 7.2 4.1 3.3 5.5 5.6 5.7 8.7 2.2 8.0 2.0 6.4 6.6 2.2 4.8 4.8 9.0 16.1 4.9 12.0 0.0 6.5 5.1 8.1 4.4 5.9 3.8 4.4 12.4 0.0 4.4 15.3 3.1 6.5 8.1 4.0 4.2 3.1 5.2 2.9 0.3 8.3 9.8 1.8 2.6 6.3 0.9 2.9 3.1 2.8 4.2 15.1 0.5 7.1 8.5 4.9 4.8 7.3 4.4 3.1 7.3 11.7 4.6 4.4 1.2 20.3 8.9 9.2 7.4 7.4 10.0 10.0 8.3 5.5 8.9 8.8 9.2 7.5 8.5 7.7 6.1 7.8 3.7 6.2 2.6 2.9 1.9 2.8 2.4 3.3 3.4 2.6 2.6 3.0 2.6 3.2 3.5 8.6 9.6 9.5 16.0 18.3 1.9 4.4 6.7 7.4 10.6 5.7 4.1 3.8 2.8 4.5 1.8 2.1 4.2 17.7 2.6 0.0 3.4 61.5 2.1 9.6 5.3 3.6 12.0 30.8 3.1 1.6 8.4 1.1 1.9 14.7 72.0 6.8 4.1 7.1 3.3 30.8 4.7 2.0 9.8 5.8 45.1 10.5 9.7 1.8 18.7 10.3 5.4 17.5 32.6 18.8 3.3 7.6 8.6 3.7 6.6 2.6 4.1 6.0 6.4 6.6 7.0 9.8 9.9 10.9 3.6 1.8 2.6 15.0 8.9 5.0 3.4 ARPC3 "ARC21, p21-Arc" ENSG00000111229 "Actin related protein 2/3 complex subunit 3" O15145 12 110434823-110450422 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006550 Approved Uncertain Nucleoplasm NA NA 3800000 Nucleoplasm "HPA006550: AB_1854869" "unprognostic (1.83e-1)" "unprognostic (4.21e-3)" "unprognostic (4.15e-1)" "unprognostic (4.26e-3)" "unprognostic (2.89e-1)" "unprognostic (1.11e-3)" "unprognostic (1.10e-2)" "unprognostic (6.71e-2)" "unprognostic (2.89e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.22e-11)" "unprognostic (3.00e-1)" "unprognostic (5.83e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-3)" 196.0 207.2 168.4 369.0 179.6 781.3 215.6 168.6 230.0 207.2 180.8 327.1 261.8 153.1 301.0 370.1 163.6 255.3 154.4 175.1 182.5 243.8 264.6 267.1 583.5 181.4 170.2 167.5 108.1 173.1 176.3 164.9 278.9 180.0 168.4 347.5 61.0 206.7 153.6 107.6 157.2 260.3 208.4 179.6 369.5 265.7 107.9 172.7 346.4 185.9 103.4 578.4 359.1 208.2 183.9 452.0 360.8 307.0 196.4 318.3 600.2 411.5 476.0 550.1 594.6 578.6 392.9 350.1 654.7 359.3 559.7 354.4 340.1 343.9 520.7 647.7 377.7 415.6 562.1 146.6 385.1 519.7 565.6 842.4 422.6 555.3 375.3 347.8 736.2 756.3 434.5 366.2 170.3 746.3 365.6 661.6 1390.3 302.7 525.8 428.6 510.9 181.5 559.4 1050.5 581.0 346.6 342.2 334.0 464.7 427.1 453.8 757.8 933.8 630.0 350.5 195.7 312.9 349.9 332.7 507.0 914.8 458.0 568.1 425.1 1313.6 1022.6 1660.3 352.4 1182.3 322.2 692.3 361.1 398.7 987.2 604.5 267.0 349.5 1607.5 418.3 1417.4 632.7 619.8 1547.5 168.4 179.6 168.6 230.0 175.1 182.5 181.4 170.2 167.5 180.0 179.6 172.7 183.9 316.2 189.1 239.5 16.6 619.4 159.5 315.8 810.1 145.1 36.1 222.3 252.2 52.2 208.8 555.8 268.5 12.5 538.2 582.4 473.2 579.2 636.3 131.2 373.6 241.1 269.0 274.1 244.0 32.4 535.1 824.0 199.0 190.6 459.6 491.8 245.8 227.7 165.5 1432.0 53.8 25.1 538.9 537.1 918.9 781.2 45.3 172.4 935.9 240.1 45.9 1221.8 184.1 545.8 23.6 41.6 630.2 665.2 157.6 352.5 313.5 422.2 777.0 407.3 35.6 249.8 108.4 329.6 209.8 200.1 365.5 171.9 721.6 462.6 323.3 401.1 629.3 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452486-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA039764: AB_2676669, HPA047793: AB_2680157" "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavorable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favorable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 25.8 19.1 11.3 16.5 12.4 15.5 24.6 13.6 13.0 15.9 12.7 13.8 8.2 18.0 15.4 16.5 18.7 13.9 34.6 11.1 14.2 31.7 32.3 17.0 23.1 13.2 12.9 10.3 23.5 20.1 29.5 11.1 21.5 13.3 22.4 13.2 23.6 24.4 18.1 48.4 11.1 10.7 19.7 14.9 16.4 15.7 41.7 12.0 18.3 21.4 51.5 18.2 17.8 13.9 15.9 42.3 65.8 43.2 42.8 47.5 30.1 57.6 57.1 34.1 62.2 50.3 59.7 24.6 81.5 38.5 31.0 46.0 37.9 54.2 50.5 83.9 46.9 50.6 47.7 33.8 50.5 33.2 75.2 42.2 32.2 31.4 61.1 39.5 34.9 45.6 67.0 82.1 17.9 44.3 28.2 69.8 142.8 53.4 58.6 64.8 23.5 59.9 62.2 39.3 37.8 34.7 34.8 57.7 39.0 49.9 55.0 66.7 87.7 25.4 51.6 38.0 51.3 66.6 24.7 68.0 85.1 38.2 68.5 60.3 41.0 54.4 79.4 30.0 71.9 32.8 46.5 32.0 34.2 51.1 47.9 40.5 26.9 27.4 28.4 75.3 62.5 30.1 41.6 11.3 12.4 13.6 13.0 11.1 14.2 13.2 12.9 10.3 13.3 14.9 12.0 15.9 23.8 25.6 34.5 3.3 24.5 29.8 49.3 57.9 15.9 18.8 28.8 32.5 43.8 20.0 36.0 33.1 14.6 62.4 26.6 3.8 107.6 30.4 111.1 24.9 24.6 20.8 8.3 26.9 4.3 21.3 74.0 25.4 8.2 21.5 31.0 18.6 18.2 38.1 94.7 21.9 5.6 9.1 40.7 19.1 17.7 22.6 19.9 33.2 16.0 14.0 39.6 25.7 19.6 3.5 6.4 22.4 11.0 23.7 20.9 55.5 5.3 72.1 34.2 33.0 26.3 31.0 35.3 187.2 77.6 20.8 25.4 46.7 19.2 22.1 13.7 40.2 VPS29 "DC15, DC7, PEP11" ENSG00000111237 "VPS29 retromer complex component" Q9UBQ0 12 110491083-110502111 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039748 Uncertain Supported Vesicles,Cytosol NA NA 110000 "Vesicles, Cytosol" "HPA039748: AB_10674426" "unprognostic (9.46e-2)" "unprognostic (3.46e-3)" "unprognostic (2.16e-2)" "unprognostic (2.58e-1)" "unprognostic (3.08e-1)" "unprognostic (2.26e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.52e-1)" "unprognostic (3.37e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.64e-1)" "unprognostic (2.10e-3)" "unprognostic (2.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.11e-1)" "unprognostic (5.57e-2)" "unprognostic (4.29e-3)" 59.8 63.3 50.1 57.5 50.9 97.0 59.8 50.2 62.4 50.7 51.9 75.5 64.7 53.3 90.3 71.7 50.8 51.6 70.8 51.6 53.3 79.9 78.2 55.3 70.2 51.2 50.6 50.2 47.5 57.1 55.3 54.1 47.7 51.2 63.2 79.8 100.4 59.0 72.0 128.3 47.2 66.2 67.7 53.5 77.2 63.3 32.8 50.3 63.8 54.5 101.7 72.6 65.7 51.1 53.7 103.5 98.6 91.9 65.6 100.4 98.7 72.6 94.9 98.1 93.9 84.2 100.0 87.0 94.0 97.1 94.3 87.7 95.5 123.1 88.0 97.0 112.2 98.9 115.4 122.6 83.0 87.4 139.5 97.1 66.0 73.3 79.3 87.4 114.1 166.0 116.6 112.1 85.5 170.0 51.9 110.3 196.4 52.6 90.9 124.8 72.2 93.5 131.8 157.0 149.7 98.1 51.8 107.9 94.0 122.8 78.5 128.6 106.0 94.0 80.6 53.4 112.9 113.0 58.0 87.5 112.1 93.9 130.8 87.8 246.2 262.7 259.4 139.1 356.8 155.3 195.9 175.5 164.9 318.3 158.7 159.8 156.8 178.7 202.9 405.4 214.0 224.8 385.1 50.1 50.9 50.2 62.4 51.6 53.3 51.2 50.6 50.2 51.2 53.5 50.3 53.7 138.8 76.9 96.2 21.2 93.7 143.5 172.6 395.9 70.6 39.0 93.4 109.2 282.4 90.1 209.7 101.2 27.1 192.8 116.5 156.3 289.5 231.0 56.8 94.7 79.8 125.0 83.2 147.5 30.2 179.8 187.6 120.2 60.1 104.1 153.9 78.1 94.9 158.7 409.9 42.1 26.7 149.8 248.2 158.0 296.1 82.6 92.2 178.7 177.9 30.9 295.2 107.9 101.0 22.6 30.4 217.9 182.2 105.7 94.8 157.4 142.2 404.7 131.1 111.8 157.8 81.9 212.1 256.4 148.4 108.3 173.0 178.8 111.2 105.8 164.5 187.7 FGF6 ENSG00000111241 "Fibroblast growth factor 6" P10767 12 4428155-4445614 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 16.2;tongue: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;REH: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (4.29e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 2.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL2 CMH10 ENSG00000111245 "Myosin light chain 2" P10916 12 110910819-110921443 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 70 "heart muscle: 26352.1;skeletal muscle: 29242.5;tongue: 19998.9" "Cell type enriched" "Detected in some" 80 "Cardiomyocytes: 27611.5" "Group enriched" "Detected in some" 46 "head and neck cancer: 31.5;prostate cancer: 25.5" "Region enriched" "Detected in single" 8 "hypothalamus: 5.3" "Group enriched" "Detected in some" 12 "memory B-cell: 1.1;naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "EFO-21: 4.2;HSkMC: 8.8;U-2 OS: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA019763, HPA039262" Supported Uncertain Microtubules NA NA 180000 Microtubules "HPA019763: AB_1854243, HPA039262: AB_2676418" "unprognostic (2.07e-2)" "unprognostic (1.37e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.32e-1)" "unprognostic (4.05e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (3.55e-1)" 6.2 4.5 0.0 0.1 0.0 0.7 29.7 0.0 0.0 1.5 0.0 3.7 0.6 2.2 0.0 360.1 0.5 9.5 26352.1 0.0 5.3 2.9 5.5 5.1 15.3 0.6 0.5 0.0 2.4 5.8 0.0 2.5 0.1 0.2 252.0 0.1 0.0 109.6 0.2 29242.5 12.6 3.2 0.3 0.1 2.1 3.5 2.1 0.0 1.0 13.5 19998.9 1.1 2.2 4.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.2 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 17.7 0.0 0.1 0.0 0.0 1.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.6 0.5 0.0 0.2 0.1 0.0 0.1 1.1 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 27611.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 235.7 0.0 0.0 0.0 0.0 0.0 53.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 342.2 138.8 0.1 0.1 0.0 0.0 0.0 3.3 0.0 0.1 0.0 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560047 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Meiosis" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.0;lymphoid tissue: 14.5" "Cell type enhanced" "Detected in many" "Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 0.9 0.8 0.5 4.8 0.5 17.0 2.8 0.6 0.7 0.9 0.5 5.2 5.2 1.2 0.6 3.2 1.0 1.1 0.6 0.5 0.6 0.9 1.9 1.4 9.0 0.6 0.6 0.4 0.5 0.4 0.6 0.3 3.9 0.6 1.3 6.6 1.6 1.0 1.0 0.5 3.2 4.8 1.9 0.6 3.4 2.7 6.4 0.5 14.5 1.0 0.6 8.0 1.7 1.3 0.7 37.5 13.0 45.3 22.7 2.7 5.7 53.0 48.2 21.2 52.6 68.9 35.4 35.4 48.6 7.0 10.4 24.7 23.1 31.8 14.5 80.0 38.7 27.0 61.4 21.6 24.8 0.6 56.6 29.9 1.2 1.5 31.6 30.4 7.5 21.4 33.0 39.2 54.4 33.7 13.6 46.5 20.5 110.4 36.3 14.4 46.0 54.3 19.2 16.1 18.3 15.1 16.6 35.9 27.7 11.6 45.5 11.3 32.6 9.5 35.5 36.5 38.8 52.4 7.8 10.0 93.3 13.3 40.0 29.4 0.0 0.5 0.7 0.1 2.3 0.5 3.1 0.4 1.0 0.4 3.4 0.1 0.2 0.0 1.4 2.0 6.9 1.0 0.6 0.5 0.5 0.6 0.7 0.5 0.6 0.6 0.6 0.4 0.6 0.6 0.5 0.7 1.4 0.0 0.5 0.7 6.1 5.2 2.3 6.6 1.2 3.1 3.4 5.7 1.4 2.8 4.5 0.0 4.2 20.3 11.3 5.7 0.0 3.0 33.4 3.3 2.9 2.9 2.4 47.8 2.7 2.7 34.1 5.2 6.1 3.6 1.3 22.6 2.5 1.2 40.8 0.0 1.1 6.4 16.2 6.2 5.6 68.1 1.2 10.1 0.0 3.7 6.8 2.7 3.1 0.5 2.4 1.5 0.8 1.5 15.5 1.0 1.2 1.5 0.9 4.8 0.0 2.4 4.2 35.9 25.0 10.0 2.6 4.7 4.6 2.0 14.6 2.7 CUX2 "CDP2, CUTL2, KIAA0293" ENSG00000111249 "Cut like homeobox 2" O14529 12 111034165-111350554 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 21.7;choroid plexus: 21.6;liver: 20.5;prostate: 11.5" "Cell type enhanced" "Detected in some" "dendritic cells: 28.1;Excitatory neurons: 175.4;Hepatocytes: 50.9;Horizontal cells: 26.9;Inhibitory neurons: 72.5" "Group enriched" "Detected in some" 4 "liver cancer: 5.2;prostate cancer: 11.2" "Region enhanced" "Detected in many" "cerebral cortex: 21.7" "Immune cell enriched" "Detected in single" 70 "plasmacytoid DC: 6.9" "Lineage enriched" "Detected in single" 70 "dendritic cells: 6.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 6.6;HDLM-2: 2.9;hTERT-HME1: 3.5;SCLC-21H: 6.5;SH-SY5Y: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (6.98e-3)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.78e-2)" "unprognostic (1.22e-2)" "unprognostic (9.44e-2)" "unprognostic (2.33e-1)" "unprognostic (3.30e-2)" "unprognostic (7.83e-5)" "unprognostic (2.67e-1)" "unprognostic (3.54e-3)" "unprognostic (4.31e-2)" "unprognostic (9.03e-2)" "unprognostic (4.64e-2)" "unprognostic (1.90e-2)" 0.0 0.0 3.7 0.2 1.5 0.2 1.8 0.0 21.7 0.8 21.6 0.3 0.1 0.1 0.3 0.1 0.0 0.0 0.0 4.1 1.6 0.0 20.5 0.0 0.5 0.7 1.6 4.9 0.0 0.1 0.0 2.1 0.0 4.3 11.5 0.0 2.3 0.0 2.9 0.1 0.2 0.2 0.0 0.0 0.2 1.6 0.5 7.9 0.2 4.2 0.1 0.4 0.1 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.6 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.5 14.0 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 3.7 1.5 0.0 21.7 4.1 1.6 0.7 1.6 4.9 4.3 0.0 7.9 2.9 0.0 0.0 0.0 7.2 0.5 0.0 3.5 0.7 0.0 6.4 2.6 3.0 1.0 2.8 0.1 0.0 0.0 0.0 28.1 0.1 0.0 0.0 1.2 3.7 0.1 0.1 0.0 2.7 175.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 50.9 0.7 26.9 72.5 0.0 0.0 0.6 0.0 0.6 0.0 0.5 0.0 1.9 0.0 0.1 0.0 20.1 1.8 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.9 0.0 0.3 0.1 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 SH2B3 "IDDM20, LNK" ENSG00000111252 "SH2B adaptor protein 3" Q9UQQ2 12 111405923-111451623 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.3" "Cell type enhanced" "Detected in many" "Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005483 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005483: AB_1079260" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.09e-2)" "unprognostic (1.23e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.65e-2)" "unprognostic (8.17e-3)" "unprognostic (9.08e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (2.86e-1)" "unprognostic (3.89e-3)" "unprognostic (1.11e-1)" "unprognostic (2.24e-2)" 22.4 11.0 9.7 22.1 8.5 61.3 13.4 4.1 10.7 8.7 11.4 11.5 8.2 8.6 3.3 7.8 8.2 18.8 20.0 5.9 10.1 10.4 17.6 20.7 21.1 11.9 7.1 5.3 5.5 10.3 5.8 8.1 24.6 10.8 7.3 13.6 3.7 5.3 6.0 9.7 4.2 12.6 13.7 11.6 37.4 7.2 9.6 10.2 10.6 11.1 9.6 15.9 15.8 6.1 11.4 9.2 5.5 7.0 7.3 23.9 35.5 4.8 29.2 79.5 21.9 23.3 8.4 5.2 15.6 20.3 44.6 73.6 1.7 5.5 16.9 35.2 13.3 2.7 53.2 2.6 6.2 23.3 23.5 122.2 21.2 3.8 140.7 12.7 48.4 119.1 12.8 38.9 6.1 80.2 3.2 9.7 46.7 11.0 2.4 21.0 9.5 15.9 10.2 10.5 3.7 4.6 4.9 5.4 0.6 42.2 6.2 3.5 33.4 93.0 20.0 11.3 17.4 48.1 13.9 15.8 17.6 211.6 16.6 165.3 0.9 3.5 1.2 1.2 8.4 1.0 1.5 1.1 1.3 4.8 0.5 0.7 1.0 3.0 1.8 6.6 4.9 0.4 1.8 9.7 8.5 4.1 10.7 5.9 10.1 11.9 7.1 5.3 10.8 11.6 10.2 11.4 26.8 3.2 22.0 2.6 26.2 6.8 1.5 4.2 1.2 4.6 4.3 3.8 17.5 4.3 4.3 1.8 2.1 0.4 40.6 15.0 1.9 3.6 13.1 1.0 2.2 39.2 3.5 11.2 11.0 9.0 1.4 8.1 0.5 1.2 38.6 0.8 46.1 11.1 40.4 3.3 7.3 3.0 6.1 113.6 130.9 5.3 2.8 84.1 16.0 38.4 67.1 1.1 18.6 11.1 9.0 7.2 5.9 4.1 4.9 3.0 0.8 1.5 3.5 3.4 0.0 4.0 12.7 12.5 4.5 0.7 4.1 1.0 12.1 4.4 3.2 1.2 AKAP3 "AKAP110, CT82, FSP95, SOB1" ENSG00000111254 "A-kinase anchoring protein 3" O75969 12 4615508-4649051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 32 "testis: 100.9" "Group enriched" "Detected in some" 19 "Early spermatids: 818.1;Late spermatids: 356.6" "Cancer enriched" "Detected in many" 6 "testis cancer: 6.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.3;NTERA-2: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039765, HPA073296" Enhanced NA NA "HPA039765: AB_10795113, HPA073296: " "unprognostic (2.89e-2)" "unprognostic (2.89e-1)" "unprognostic (5.85e-2)" "unprognostic (2.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.66e-1)" "unprognostic (6.88e-2)" "unprognostic (7.03e-3)" "unprognostic (8.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (8.07e-6)" "unprognostic (3.22e-3)" "unprognostic (3.21e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" 0.4 0.8 1.7 0.7 2.5 0.0 0.9 2.5 1.9 0.5 1.3 0.6 0.9 0.6 2.7 0.5 2.4 0.3 2.6 1.6 2.5 2.2 1.1 0.8 0.5 2.4 2.1 1.2 0.9 2.0 0.8 1.0 0.7 2.3 0.9 0.5 0.5 1.5 0.6 0.7 0.7 0.6 0.7 2.2 0.6 0.7 100.9 2.3 0.9 1.6 0.5 0.6 0.5 0.3 3.1 0.0 0.3 1.0 0.2 2.7 0.2 0.6 0.3 0.3 0.3 0.9 0.1 2.0 0.2 0.0 0.6 2.0 0.0 1.5 0.0 0.4 1.5 1.8 0.2 0.0 0.3 0.1 0.2 0.5 0.5 0.4 0.6 0.7 0.2 0.3 3.3 0.8 2.1 0.7 0.3 0.3 0.0 4.0 0.3 0.1 0.5 0.1 0.3 1.1 0.1 0.3 0.1 0.2 0.2 0.9 2.7 0.0 0.0 0.1 0.1 0.3 0.7 0.1 0.9 1.3 0.4 1.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.4 0.0 0.4 0.5 0.7 0.0 0.5 0.0 0.0 0.0 0.1 1.7 2.5 2.5 1.9 1.6 2.5 2.4 2.1 1.2 2.3 2.2 2.3 3.1 0.1 0.0 0.5 3.9 0.4 0.0 0.2 0.2 0.0 0.2 0.5 0.6 23.7 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.3 818.1 1.4 0.1 0.5 0.0 0.0 0.7 0.4 0.3 1.7 1.5 0.3 0.0 0.2 0.4 0.1 0.2 0.0 0.7 0.7 2.0 0.0 0.0 356.6 3.7 0.4 0.0 1.9 0.0 0.7 0.0 1.5 6.3 0.1 0.0 2.2 0.5 0.2 0.5 1.5 2.4 0.3 6.6 0.4 0.4 29.6 5.8 0.5 0.0 0.3 0.2 0.1 0.4 0.2 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350242 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 70.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "neutrophil: 98.3" "Lineage enriched" "Detected in many" 39 "granulocytes: 98.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" NA NA 44000000 "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 18.3 12.2 3.8 4.3 4.1 3.5 19.7 4.1 6.6 14.8 5.6 20.3 11.8 22.3 11.6 42.6 16.8 10.3 11.2 4.3 3.3 11.9 9.7 12.4 2.3 3.4 3.5 3.9 11.4 25.4 11.4 18.1 9.5 3.8 15.2 15.9 5.5 70.5 10.9 4.1 21.7 15.4 12.2 2.7 11.4 21.7 8.5 4.1 1.4 13.9 4.4 6.4 16.4 20.8 4.2 0.3 5.7 1.8 0.1 5.6 5.5 6.2 3.9 4.6 2.0 2.5 4.8 18.2 0.0 4.2 3.9 2.1 0.8 7.1 3.3 1.5 0.0 6.9 8.3 6.4 4.2 0.9 1.4 2.3 3.5 5.3 1.3 0.9 13.8 50.7 0.1 5.6 0.1 0.6 11.0 0.0 0.6 6.5 54.3 3.0 0.2 0.0 0.1 25.9 18.8 2.6 10.3 2.1 16.9 6.0 2.8 15.4 5.0 20.5 2.8 2.3 0.7 5.5 0.4 0.2 2.8 2.0 0.0 2.1 6.6 1.2 1.0 0.1 0.9 0.0 0.2 0.3 0.0 0.6 0.4 2.5 0.4 98.3 0.6 0.4 0.1 0.0 0.6 3.8 4.1 4.1 6.6 4.3 3.3 3.4 3.5 3.9 3.8 2.7 4.1 4.2 29.0 9.6 21.2 8.8 3.3 4.0 7.1 7.2 6.2 6.1 21.2 13.5 2.6 28.6 11.9 23.9 8.4 35.4 4.5 33.6 1.9 19.0 0.9 15.1 5.2 28.8 21.7 3.6 16.6 37.9 7.4 10.4 23.0 20.5 2.5 8.6 37.1 9.8 8.0 10.1 13.5 33.4 8.2 5.5 0.7 2.2 13.7 2.0 0.0 15.0 2.7 11.4 9.2 7.5 11.4 16.3 25.2 16.6 1.0 7.4 16.7 3.0 18.1 13.1 0.0 4.8 6.5 2.1 1.5 22.1 4.7 17.0 3.0 9.7 26.5 8.8 KCNA1 "AEMK, HUK1, Kv1.1, MBK1, RBK1" ENSG00000111262 "Potassium voltage-gated channel subfamily A member 1" Q09470 12 4909905-4918256 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 49.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 15.1;Excitatory neurons: 39.6;Inhibitory neurons: 18.6;Oligodendrocyte precursor cells: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074471 Approved NA NA "HPA074471: " "unprognostic (6.39e-3)" "unprognostic (2.64e-1)" "unprognostic (1.09e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-2)" "unprognostic (4.69e-3)" "unprognostic (2.48e-1)" "unprognostic (8.77e-5)" "unprognostic (6.30e-2)" "unprognostic (1.08e-4)" 0.2 0.0 13.5 0.0 22.6 0.0 0.3 30.3 49.3 0.6 8.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.5 13.4 0.0 0.0 0.0 0.0 25.9 17.1 15.3 0.0 0.0 0.8 0.9 0.0 28.1 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.2 0.1 12.5 0.0 1.2 0.0 28.5 1.2 0.6 0.0 0.0 0.3 0.3 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 22.6 30.3 49.3 24.5 13.4 25.9 17.1 15.3 28.1 12.5 28.5 32.2 0.1 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 15.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 18.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.2 0.0 16.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP16 "KIAA1700, MKP-7, MKP7" ENSG00000111266 "Dual specificity phosphatase 16" Q9BY84 12 12473282-12562863 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 114.9;Oligodendrocytes: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.9" "Lineage enriched" "Detected in single" 5 "T-cells: 3.9" "Cell line enhanced" "Detected in many" "NTERA-2: 37.7;RT4: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020326 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020326: AB_1847890" "unprognostic (8.05e-2)" "unprognostic (9.47e-2)" "unprognostic (1.49e-3)" "unprognostic (4.14e-2)" "unprognostic (9.86e-2)" "prognostic favorable (1.01e-4)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (2.82e-1)" "unprognostic (2.34e-3)" "unprognostic (6.35e-3)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (5.76e-2)" 8.2 48.2 5.5 7.8 7.9 3.6 15.1 7.4 5.3 10.2 6.1 11.4 13.7 11.4 6.3 12.8 10.6 8.1 7.0 4.5 12.5 7.7 33.5 12.1 6.4 7.3 8.2 3.4 10.8 18.9 8.1 13.0 5.6 7.9 19.8 11.0 7.6 14.7 3.4 11.4 11.0 13.2 4.9 6.1 6.8 13.3 7.2 6.6 15.3 8.8 4.8 9.1 10.8 17.2 11.9 4.5 6.5 7.6 4.2 2.8 3.3 13.6 2.6 5.8 6.4 9.1 18.1 8.6 0.4 1.4 2.9 11.3 2.9 14.1 2.4 8.6 14.4 7.0 0.7 6.8 19.2 5.4 1.3 3.0 2.8 6.7 5.1 16.3 6.8 5.0 7.3 4.0 11.8 0.4 8.6 1.7 0.9 37.7 11.1 1.9 2.0 2.6 8.6 3.6 34.3 12.3 11.5 10.6 13.6 6.7 28.2 5.5 2.2 4.5 2.9 8.3 1.8 2.9 8.3 10.6 1.5 3.8 2.9 4.0 0.0 0.0 0.0 0.5 0.0 2.3 0.0 1.6 0.7 0.1 0.0 0.5 0.3 0.8 0.0 0.0 0.0 3.9 0.3 5.5 7.9 7.4 5.3 4.5 12.5 7.3 8.2 3.4 7.9 6.1 6.6 11.9 9.6 28.9 55.5 30.3 3.3 2.8 14.9 1.5 3.4 4.8 23.8 13.1 11.5 20.0 9.7 3.7 2.1 10.5 5.6 35.7 0.0 14.3 1.3 15.1 10.2 9.2 49.6 0.0 19.5 24.6 4.1 9.9 11.7 19.9 23.5 114.9 7.5 34.2 5.3 6.7 24.8 10.0 2.0 9.4 1.9 2.3 5.9 5.7 5.4 38.4 2.9 36.8 0.0 56.3 196.3 20.9 25.3 6.8 4.3 34.3 25.4 5.2 10.4 4.8 0.0 11.1 10.3 3.0 5.8 6.2 1.8 30.1 27.9 9.9 18.7 24.5 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 131.9" "Cell type enhanced" "Detected in all" "Kupffer cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 40.1 131.9 27.0 30.7 28.0 5.3 32.3 24.7 29.5 26.6 31.0 23.6 23.3 19.2 29.0 17.3 24.8 28.4 22.7 27.6 32.1 50.1 50.5 32.8 37.8 26.7 26.6 24.7 37.5 24.9 56.7 32.4 24.4 26.4 28.5 24.0 35.5 26.7 23.2 10.2 24.8 23.8 19.1 27.8 37.8 25.3 21.1 28.6 25.0 44.7 15.8 30.1 28.2 15.2 28.0 12.5 15.9 13.6 15.5 46.9 47.0 26.3 24.0 40.4 17.3 23.7 11.5 17.9 10.8 9.1 29.3 26.2 10.3 20.7 18.4 29.1 61.0 12.6 8.5 15.1 14.2 30.7 12.2 15.2 30.8 32.2 20.3 33.1 58.7 25.7 8.5 8.7 16.5 29.4 20.1 6.4 9.9 40.8 11.9 14.4 8.7 23.6 6.9 33.1 35.7 16.0 18.2 24.4 11.7 43.3 58.5 6.5 13.6 20.8 23.7 15.1 23.7 23.9 13.9 19.7 2.7 28.1 10.3 24.9 1.1 2.5 2.6 1.7 5.6 3.1 0.9 3.4 2.7 2.8 1.1 3.3 2.7 0.4 1.1 2.6 1.4 5.6 1.5 27.0 28.0 24.7 29.5 27.6 32.1 26.7 26.6 24.7 26.4 27.8 28.6 28.0 18.0 25.6 26.5 23.5 14.8 22.2 18.6 11.1 18.8 17.5 23.5 15.9 14.6 30.0 12.2 33.1 2.1 18.1 15.7 17.7 41.1 21.6 40.4 14.2 10.4 19.1 30.0 27.8 15.9 21.8 19.3 25.3 17.9 10.6 10.2 12.1 23.2 48.4 39.3 37.0 17.7 16.4 26.4 120.0 83.0 12.1 36.1 58.2 33.8 33.7 45.6 38.0 10.3 28.6 18.6 21.8 15.0 35.3 17.3 29.5 29.3 58.8 19.9 11.8 39.5 13.7 12.4 45.8 20.8 18.0 29.1 27.5 23.3 11.5 17.6 28.1 ACAD10 MGC5601 ENSG00000111271 "Acyl-CoA dehydrogenase family member 10" Q6JQN1 12 111686053-111757107 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA067222 Uncertain NA NA "HPA067222: AB_2685805" "unprognostic (8.45e-2)" "unprognostic (1.36e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-3)" "unprognostic (6.01e-2)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.38e-2)" "unprognostic (1.56e-2)" "unprognostic (1.68e-2)" "unprognostic (6.21e-3)" "unprognostic (6.21e-2)" "prognostic favorable (3.71e-6)" "unprognostic (2.37e-2)" "unprognostic (5.81e-2)" "unprognostic (6.45e-2)" "unprognostic (4.87e-2)" 7.5 14.8 4.0 6.7 5.0 9.2 8.3 6.1 4.9 8.3 9.6 13.5 16.2 7.7 10.9 9.1 9.8 8.0 13.0 4.1 4.4 19.5 22.9 6.4 8.7 4.6 4.3 3.7 10.4 13.5 18.8 12.2 7.5 5.1 9.8 11.2 9.1 10.7 8.1 13.1 12.0 14.9 7.8 3.2 9.4 12.6 7.7 4.2 10.1 13.0 9.1 8.6 8.6 8.4 8.2 6.8 18.7 7.9 10.3 12.2 15.9 14.2 6.0 9.5 6.5 5.0 6.9 11.2 5.0 6.3 7.0 6.1 15.8 7.4 6.4 3.4 11.8 10.4 8.0 13.7 9.1 12.4 6.7 10.0 18.3 11.5 9.4 9.3 13.7 7.3 11.6 5.6 10.1 5.9 9.5 8.1 10.6 12.4 9.7 12.7 8.7 4.0 14.3 12.6 15.1 7.5 12.0 7.0 12.5 19.1 10.6 28.7 13.0 4.5 5.9 4.5 9.3 5.8 12.8 6.4 8.6 8.8 9.4 9.2 6.9 6.2 3.6 3.6 6.9 3.9 4.0 3.6 3.6 6.1 3.3 3.5 3.5 6.7 4.8 8.6 3.5 5.0 3.6 4.0 5.0 6.1 4.9 4.1 4.4 4.6 4.3 3.7 5.1 3.2 4.2 8.2 3.7 6.4 11.6 19.6 7.2 1.9 3.4 5.6 5.7 11.7 5.5 5.5 17.1 7.2 5.7 3.7 25.0 9.4 5.2 9.3 0.0 5.0 12.2 5.7 5.6 5.1 11.4 1.3 11.8 4.7 5.2 4.1 14.3 5.1 2.5 15.0 5.0 14.8 5.7 10.1 14.7 10.6 4.1 6.7 2.3 8.7 5.9 5.8 1.8 9.4 8.0 7.0 3.1 14.1 22.9 3.7 7.8 3.0 5.4 3.4 17.1 12.1 6.1 23.7 0.0 5.5 5.5 11.3 11.7 4.5 2.8 5.6 4.8 10.2 12.9 2.1 ALDH2 ENSG00000111275 "Aldehyde dehydrogenase 2 family member" P05091 12 111766887-111817532 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 864.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0" "Cancer enhanced" "Detected in all" "liver cancer: 71.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 212.0;myeloid DC: 213.2" "Group enriched" "Detected in many" 4 "dendritic cells: 213.2;monocytes: 212.0" "Cell line enhanced" "Detected in many" "ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051065 Approved NA NA 2200000 "HPA051065: AB_2681332" "unprognostic (9.22e-3)" "unprognostic (1.20e-2)" "unprognostic (4.14e-3)" "prognostic favorable (2.63e-4)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "prognostic favorable (3.95e-7)" "unprognostic (5.62e-3)" "unprognostic (3.00e-1)" "unprognostic (1.16e-1)" "unprognostic (8.22e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.24e-6)" "unprognostic (9.70e-2)" "unprognostic (3.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (7.71e-4)" 306.5 103.3 129.6 40.1 132.7 29.4 77.8 129.1 164.8 25.2 113.0 74.0 74.3 30.4 21.5 74.3 32.5 37.8 112.4 123.8 127.2 179.4 864.8 112.6 18.9 138.5 132.2 116.2 42.4 23.5 2.7 23.5 7.0 134.3 34.9 73.0 29.4 32.7 29.7 132.1 128.9 75.4 30.5 131.7 20.8 102.4 13.1 140.1 27.3 31.1 167.1 53.4 50.5 29.2 134.4 8.8 13.1 18.7 31.9 86.8 13.0 60.9 9.3 16.8 4.3 3.1 23.5 12.1 0.5 45.3 20.8 11.9 16.2 0.1 4.6 2.7 0.6 6.1 0.7 8.4 64.7 97.0 0.9 0.9 23.9 22.6 14.8 0.3 17.7 26.9 0.9 17.9 3.0 4.1 0.5 1.0 23.4 24.8 152.2 2.1 0.6 0.4 1.9 31.4 0.6 7.5 23.1 22.8 201.0 0.2 33.7 20.3 92.1 1.1 0.4 16.5 0.6 0.4 5.5 3.0 25.7 22.0 0.8 0.4 6.5 212.0 51.1 0.7 93.0 0.9 6.2 0.3 0.7 213.2 5.2 0.7 0.5 10.7 3.4 25.4 70.6 0.5 123.5 129.6 132.7 129.1 164.8 123.8 127.2 138.5 132.2 116.2 134.3 131.7 140.1 134.4 27.7 147.4 242.7 51.2 22.6 60.0 205.2 311.1 80.8 78.7 35.0 23.7 378.9 165.8 243.1 66.2 18.8 62.4 48.6 260.3 399.2 127.5 4.3 27.8 24.5 66.2 55.2 42.1 11.7 218.0 127.5 103.1 200.3 47.7 30.9 29.0 139.6 857.0 129.2 35.3 18.2 231.0 101.7 278.5 124.1 10.6 79.9 189.3 35.6 26.2 940.8 130.2 8.2 14.1 6.8 130.2 366.5 149.0 12.5 84.4 384.3 882.0 89.4 42.6 46.0 46.0 67.6 3.0 3.9 105.1 124.7 42.1 13.1 81.0 272.6 150.4 CDKN1B "KIP1, P27KIP1" ENSG00000111276 "Cyclin dependent kinase inhibitor 1B" P46527 12 12715058-12722369 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003691, CAB021888, HPA059086" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB003691: AB_425362, CAB021888: , HPA059086: AB_2683900" "unprognostic (5.67e-2)" "unprognostic (9.76e-2)" "prognostic favorable (5.15e-4)" "unprognostic (6.90e-3)" "unprognostic (5.84e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (2.85e-3)" "unprognostic (9.23e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.23e-1)" "unprognostic (8.68e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" 48.8 45.1 59.8 40.5 74.2 68.7 50.6 79.8 76.9 50.4 51.3 40.4 44.9 41.4 24.7 29.3 47.7 24.8 33.2 55.5 65.6 30.5 35.5 39.3 55.7 65.4 65.8 51.1 66.7 24.1 34.7 24.6 41.3 70.7 36.3 32.8 55.8 36.6 33.7 82.2 44.9 41.1 25.0 64.8 55.5 30.3 26.1 64.5 72.5 33.9 64.0 40.2 32.2 44.9 98.0 37.1 16.6 94.5 16.6 32.0 18.0 46.1 31.5 53.8 46.0 56.4 47.7 40.4 0.3 12.5 19.6 16.6 34.2 44.9 16.7 41.1 62.4 31.5 28.8 46.5 53.2 42.5 24.5 18.6 19.8 35.3 15.2 44.0 107.8 27.8 54.5 31.5 101.6 16.6 45.9 32.7 35.3 38.0 32.1 16.8 25.2 30.9 63.1 22.5 38.6 35.6 58.4 48.9 34.8 65.8 33.7 18.6 54.6 19.1 22.6 34.9 20.7 33.3 86.1 59.4 33.2 28.2 36.6 22.5 6.2 3.8 8.6 5.9 3.5 6.1 6.8 7.7 7.2 3.6 5.0 8.0 6.1 20.9 7.3 5.5 3.9 12.3 4.0 59.8 74.2 79.8 76.9 55.5 65.6 65.4 65.8 51.1 70.7 64.8 64.5 98.0 64.2 44.8 29.3 6.2 126.2 52.6 20.7 21.0 115.5 45.6 39.5 30.1 39.1 21.5 27.1 9.2 27.1 42.9 92.5 32.3 15.6 10.8 70.0 31.2 35.8 51.1 45.7 70.5 8.1 9.3 47.6 39.3 25.5 34.3 31.0 21.3 47.2 30.7 26.8 10.1 13.4 41.4 24.4 55.3 66.0 67.7 55.9 65.1 74.7 23.4 31.6 182.9 60.8 6.0 29.5 10.1 21.3 26.7 121.2 30.3 33.4 16.9 36.4 29.4 92.1 20.2 53.5 7.7 10.8 102.3 52.6 39.0 166.1 20.9 41.9 22.7 GPRC5D ENSG00000111291 "G protein-coupled receptor class C group 5 member D" Q9NZD1 12 12940775-12952147 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 29.3" "Cell type enhanced" "Detected in some" "Early spermatids: 6.8;Gastric mucus-secreting cells: 5.6;Late spermatids: 6.2;Melanocytes: 5.4;Plasma cells: 16.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 21.9;naive B-cell: 7.5" "Lineage enriched" "Detected in many" 14 "B-cells: 21.9" "Group enriched" "Detected in many" 9 "Karpas-707: 84.5;RPMI-8226: 85.9;U-266/84: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA071909 Approved NA NA "HPA071909: AB_2686470" "unprognostic (4.27e-2)" "unprognostic (8.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.09e-4)" "unprognostic (3.00e-5)" "unprognostic (4.06e-2)" "unprognostic (3.06e-2)" "unprognostic (5.53e-2)" "unprognostic (7.01e-2)" "unprognostic (2.27e-2)" "unprognostic (8.33e-3)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-2)" "unprognostic (6.63e-2)" 0.9 0.6 0.2 0.4 0.3 0.6 3.0 0.1 0.3 0.7 1.6 2.7 1.8 0.2 0.0 2.5 0.3 0.8 0.7 0.2 0.4 0.6 1.1 7.3 0.7 0.9 0.9 0.1 0.5 2.1 0.0 1.5 0.3 0.5 1.2 2.3 0.3 4.5 0.0 0.2 29.3 2.7 0.0 0.3 1.6 2.3 2.7 0.4 0.1 1.2 0.0 1.1 0.7 1.0 0.5 1.3 1.4 0.0 1.5 0.0 0.0 3.3 0.4 0.0 0.0 0.3 1.3 3.2 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 7.6 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.1 84.5 0.2 3.1 0.0 0.0 0.8 3.9 0.1 0.1 0.0 85.9 0.0 3.4 2.6 0.5 1.9 1.4 0.0 3.5 0.0 0.0 2.3 0.0 3.9 0.1 0.0 4.4 25.2 1.1 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 21.9 0.2 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.2 0.3 0.1 0.3 0.2 0.4 0.9 0.9 0.1 0.5 0.3 0.4 0.5 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 5.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.3 0.0 6.2 0.0 0.1 5.4 1.9 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N-alpha-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112108796 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" No No "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 5.5 6.1 5.3 6.0 5.9 9.8 6.8 7.1 8.2 6.4 8.3 5.9 3.9 5.6 4.4 7.6 5.9 3.8 5.5 5.8 5.5 3.7 5.7 4.9 6.7 6.5 5.5 6.0 7.1 6.9 5.9 4.4 5.3 8.6 5.5 4.3 14.9 4.9 4.5 15.0 7.4 4.8 5.4 3.6 5.3 4.9 5.2 5.1 6.1 5.8 10.0 7.0 6.5 6.8 8.6 16.7 16.1 14.8 11.9 8.1 14.0 17.9 15.3 12.4 18.3 12.4 16.2 8.6 28.9 14.4 12.3 10.5 19.2 32.8 13.0 25.1 16.6 22.9 23.6 15.9 15.0 13.2 34.0 13.7 12.1 15.9 21.3 21.8 15.5 16.1 12.6 35.3 3.7 16.7 13.5 19.6 24.9 22.1 34.2 18.6 21.5 15.2 19.7 14.0 27.0 19.1 10.5 16.9 19.8 15.0 14.0 19.3 13.4 13.7 15.2 13.6 17.0 21.3 15.0 30.4 33.0 19.4 14.7 15.5 0.0 1.7 0.5 2.4 1.9 3.7 2.5 3.0 2.3 3.5 2.8 4.2 4.1 0.0 1.6 2.5 3.7 2.5 1.6 5.3 5.9 7.1 8.2 5.8 5.5 6.5 5.5 6.0 8.6 3.6 5.1 8.6 16.1 9.6 16.2 44.1 23.3 66.7 34.5 17.1 22.8 38.9 18.9 12.4 23.5 12.8 26.5 7.3 146.0 25.6 20.4 10.1 3.9 15.3 26.5 15.1 23.9 17.4 16.2 17.0 71.6 19.4 21.6 17.8 15.8 14.8 20.3 20.7 15.4 19.4 14.0 23.5 68.0 11.9 28.5 15.4 25.2 8.6 17.4 16.5 16.0 30.0 83.8 13.0 12.3 48.2 109.6 17.4 7.5 12.8 15.7 61.5 7.4 4.7 25.0 67.7 6.6 28.7 22.7 31.5 29.5 28.5 70.2 22.6 15.3 20.0 14.7 48.1 GSG1 MGC3146 ENSG00000111305 "Germ cell associated 1" Q2KHT4 12 13083532-13103683 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 433.3" "Cell type enriched" "Detected in many" 4 "Late spermatids: 10812.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.9" "Region enhanced" "Detected in some" "midbrain: 6.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 12.3;U-2 OS: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (1.50e-1)" "unprognostic (2.21e-2)" "unprognostic (6.33e-2)" "unprognostic (2.36e-2)" "unprognostic (1.34e-1)" "unprognostic (8.01e-2)" "unprognostic (1.04e-1)" "unprognostic (4.52e-1)" "unprognostic (6.85e-2)" "unprognostic (8.23e-2)" "unprognostic (5.91e-2)" "unprognostic (3.20e-3)" "unprognostic (1.48e-1)" "unprognostic (3.65e-2)" "unprognostic (1.79e-1)" "unprognostic (6.32e-3)" 0.1 0.1 0.4 0.2 0.9 0.8 0.4 1.8 1.4 0.0 1.1 0.1 1.4 0.1 0.6 0.1 0.0 0.2 0.1 0.6 0.4 0.5 0.1 0.1 0.3 0.1 6.8 0.5 0.1 4.8 0.0 0.2 0.2 0.6 0.4 0.2 30.7 0.1 0.0 0.3 0.2 0.7 0.0 0.0 0.2 0.1 433.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 1.4 0.1 0.4 0.3 0.1 2.0 1.2 0.4 0.2 0.4 0.3 0.4 0.2 0.1 0.2 0.1 8.8 0.6 0.1 0.1 0.0 0.8 0.2 0.0 0.2 0.6 0.3 0.0 0.2 0.1 0.8 0.0 1.6 0.1 0.1 0.0 0.1 0.1 1.6 9.8 0.2 0.1 1.0 2.1 0.1 0.2 0.1 3.5 0.1 12.3 0.2 0.6 0.2 0.3 0.0 0.1 0.3 0.0 1.4 0.1 0.5 5.9 0.3 0.3 0.5 0.3 0.1 2.5 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.9 1.8 1.4 0.6 0.4 0.1 6.8 0.5 0.6 0.0 0.1 1.4 0.1 3.2 1.1 0.3 0.0 0.1 0.1 0.0 0.0 134.9 0.1 0.0 0.3 1.5 0.0 0.0 6.2 0.1 0.0 0.0 1.9 0.6 2248.2 0.1 0.2 2.8 27.5 2.7 1.8 0.0 0.1 0.7 0.0 0.1 0.0 0.0 1.4 0.0 0.6 1.7 0.8 2.0 2.0 0.3 0.0 10812.1 53.4 2.9 0.0 1.0 0.1 6.7 0.0 0.0 0.1 0.0 1.2 39.9 0.0 0.1 0.1 0.0 0.0 16.1 6.6 0.4 0.1 57.0 27.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 SCNN1A "ENaCalpha, SCNN1" ENSG00000111319 "Sodium channel epithelial 1 subunit alpha" P37088 12 6346843-6377730 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 158.6" "Cell type enhanced" "Detected in many" "Collecting duct cells: 114.0;Distal enterocytes: 230.9;Glandular and luminal cells: 189.8;Intestinal goblet cells: 180.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "hippocampal formation: 7.1" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 300.5;HBEC3-KT: 202.4;hTCEpi: 85.3;RPTEC TERT1: 103.7;RT4: 114.1;SK-BR-3: 96.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012743 Enhanced NA NA "HPA012743: AB_1856627" "unprognostic (1.68e-1)" "unprognostic (4.16e-2)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (5.16e-2)" "unprognostic (6.77e-3)" "unprognostic (3.09e-2)" "unprognostic (2.62e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.86e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (5.56e-2)" "prognostic favorable (9.21e-8)" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" 2.7 12.6 0.2 5.6 0.1 0.5 20.8 1.0 1.1 65.2 91.4 65.4 18.8 7.7 43.6 141.2 58.4 17.8 0.5 7.1 0.0 136.0 8.3 63.4 0.2 0.1 0.9 0.0 3.5 40.3 0.7 16.7 0.4 0.3 44.1 66.0 0.0 158.6 50.0 0.5 53.7 26.2 2.9 0.1 0.7 64.1 4.7 1.1 1.9 95.1 0.1 12.6 21.0 58.1 0.1 21.6 4.1 0.0 1.9 0.3 0.4 17.6 0.0 0.1 0.1 0.0 6.1 300.5 0.3 0.8 0.1 0.1 14.0 0.0 202.4 0.0 0.0 0.0 0.0 17.5 3.1 20.9 0.0 0.1 5.1 85.3 0.0 61.6 0.4 0.0 0.5 0.0 0.1 0.5 1.9 0.1 0.3 17.6 38.9 0.8 0.2 0.0 0.5 103.7 114.1 1.2 0.1 2.3 96.7 0.1 17.1 22.3 0.0 0.0 0.2 0.7 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.1 1.5 0.0 0.0 1.0 0.5 0.1 0.2 0.1 1.0 1.1 7.1 0.0 0.1 0.9 0.0 0.3 0.1 1.1 0.1 1.7 73.7 75.7 0.0 1.3 1.9 25.1 17.0 10.8 0.9 17.7 21.2 0.8 54.3 52.5 114.0 4.2 1.4 1.8 230.9 5.9 45.0 0.5 85.3 17.8 3.2 27.1 0.0 0.3 33.9 0.3 2.0 97.3 189.8 2.5 1.3 1.4 3.2 0.3 1.7 0.2 180.3 63.1 1.9 3.1 0.6 1.8 2.5 0.0 0.0 1.6 0.3 1.0 0.5 0.1 39.4 95.8 1.5 0.3 30.9 12.2 6.2 36.7 1.4 0.0 5.6 4.3 1.2 3.7 48.1 8.8 1.6 3.6 0.2 31.5 42.1 LTBR "D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3" ENSG00000111321 "Lymphotoxin beta receptor" P36941 12 6375045-6391571 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 71.3;intermediate monocyte: 66.3;myeloid DC: 49.8;neutrophil: 45.0;non-classical monocyte: 50.1" "Group enriched" "Detected in many" 36 "dendritic cells: 49.8;granulocytes: 45.0;monocytes: 71.3" "Cell line enhanced" "Detected in many" "HHSteC: 393.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026202, HPA061617" Uncertain Supported "Golgi apparatus" NA Yes "Golgi apparatus" "CAB026202: , HPA061617: AB_2732666" "unprognostic (2.60e-2)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" "unprognostic (3.24e-3)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (3.66e-2)" "unprognostic (9.84e-3)" "unprognostic (6.91e-2)" "unprognostic (2.86e-1)" 66.1 64.9 14.6 36.7 13.3 11.8 60.9 13.9 16.0 61.7 17.5 67.9 49.1 68.6 20.9 81.9 50.1 48.7 35.0 12.1 19.6 55.2 137.0 66.6 14.7 18.9 15.3 11.2 46.7 79.3 55.4 26.5 49.0 16.7 62.4 34.6 2.0 62.0 44.5 26.5 71.6 51.5 63.1 16.2 45.2 68.2 13.4 16.3 11.8 57.7 23.7 18.1 66.4 65.7 20.2 98.2 130.3 0.0 41.1 245.9 183.7 89.9 67.9 153.1 98.8 101.1 62.0 148.7 0.1 39.5 145.7 0.5 112.2 0.5 140.5 38.9 0.0 0.2 58.1 53.2 36.6 393.1 4.1 94.6 270.8 255.2 70.7 197.1 102.6 91.2 0.0 55.5 0.5 115.0 93.5 0.4 29.3 1.2 155.7 74.4 0.0 6.6 0.2 149.2 112.2 0.7 0.5 63.6 122.9 143.6 5.0 20.5 105.3 58.0 34.6 39.6 129.0 72.1 0.0 0.4 0.1 14.6 35.9 129.5 5.4 71.3 0.5 0.2 66.3 0.0 0.1 0.1 0.1 49.8 0.1 0.3 0.2 45.0 1.5 50.1 11.8 0.1 27.2 14.6 13.3 13.9 16.0 12.1 19.6 18.9 15.3 11.2 16.7 16.2 16.3 20.2 47.0 60.9 68.9 2.9 3.6 39.0 87.2 46.4 72.3 4.1 33.9 35.9 15.5 45.8 60.7 31.3 0.0 31.3 12.4 78.3 9.8 52.2 0.7 23.8 48.6 49.3 52.0 15.8 0.5 99.8 43.6 50.5 89.7 45.2 29.7 30.1 50.7 66.5 48.7 0.0 0.5 57.1 34.6 77.3 34.6 5.1 52.8 50.8 23.2 14.0 43.1 9.6 11.3 5.5 1.1 69.5 82.3 39.9 3.3 110.7 136.9 30.1 42.8 1.6 26.3 33.1 42.0 1.6 0.9 78.9 61.7 37.5 4.9 28.0 63.4 97.6 OGFOD2 "FLJ13491, FLJ37501" ENSG00000111325 "2-oxoglutarate and iron dependent oxygenase domain containing 2" Q6N063 12 122974580-122980043 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 431.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039448, HPA040306" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039448: AB_10795035, HPA040306: AB_10794026" "unprognostic (2.14e-1)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" "unprognostic (3.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.57e-2)" "unprognostic (6.12e-3)" "unprognostic (1.14e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.07e-3)" "unprognostic (2.48e-3)" "unprognostic (1.13e-3)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" 6.3 15.1 10.3 7.8 10.5 8.5 7.6 10.4 14.1 8.8 11.1 9.0 13.9 6.9 5.9 10.7 10.3 4.9 9.5 9.7 10.1 14.1 21.4 7.8 11.1 11.6 10.5 9.7 9.4 21.1 6.5 13.3 5.7 11.2 12.1 5.6 4.9 14.8 7.9 11.0 12.0 12.9 3.4 10.6 14.5 13.1 29.3 10.8 9.4 11.9 4.5 6.7 7.8 8.4 12.9 11.7 18.6 7.6 12.4 5.2 5.5 20.4 6.9 7.1 9.5 8.6 17.6 10.2 13.0 14.1 6.0 5.6 16.5 5.5 9.5 3.6 9.1 12.0 20.6 17.8 18.3 11.1 20.7 15.5 8.1 14.0 8.8 7.8 13.7 10.1 24.7 24.4 9.3 4.8 22.4 17.6 39.0 4.6 8.0 23.5 19.2 7.3 23.2 7.2 10.4 9.7 8.8 9.4 13.4 13.8 5.0 34.0 17.6 6.5 13.0 13.2 15.5 7.3 23.4 15.1 12.4 17.9 10.7 12.8 18.7 11.7 18.9 9.1 12.9 7.8 15.9 7.5 9.0 13.1 11.3 8.1 7.7 9.6 9.7 18.2 7.8 16.0 9.0 10.3 10.5 10.4 14.1 9.7 10.1 11.6 10.5 9.7 11.2 10.6 10.8 12.9 4.1 0.0 7.0 4.6 10.0 2.9 6.5 10.3 8.0 3.6 9.2 8.6 0.4 10.0 8.6 12.9 2.1 25.9 5.6 9.2 9.8 11.8 97.3 13.0 5.2 5.9 2.4 17.2 3.2 15.0 14.0 5.4 8.6 5.3 0.0 8.6 7.9 21.1 12.5 11.8 3.6 8.0 16.2 11.9 3.4 431.0 8.7 6.4 7.2 1.0 7.7 7.8 10.3 3.0 2.6 12.7 7.8 4.5 18.4 4.6 32.4 34.1 30.5 6.4 13.1 4.1 5.7 36.8 16.2 7.3 4.5 16.4 7.2 11.5 10.1 4.3 CDK2AP1 "doc-1, DOC1, DORC1, p12DOC-1, ST19" ENSG00000111328 "Cyclin dependent kinase 2 associated protein 1" O14519 12 123250112-123272334 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 44.3;intermediate monocyte: 152.6;myeloid DC: 52.5;non-classical monocyte: 175.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.5;monocytes: 175.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019377, HPA057648, HPA068833" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB019377: , HPA057648: AB_2683488, HPA068833: AB_2686046" "unprognostic (1.56e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-2)" "unprognostic (3.04e-2)" "unprognostic (7.77e-2)" "unprognostic (8.89e-2)" "unprognostic (4.21e-3)" "unprognostic (2.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (3.32e-2)" "unprognostic (2.22e-1)" "prognostic unfavorable (5.27e-7)" "unprognostic (9.32e-2)" "unprognostic (6.20e-2)" "unprognostic (5.56e-2)" "unprognostic (1.18e-1)" 94.4 83.5 261.9 63.3 272.8 71.2 106.0 299.3 287.6 115.8 226.2 95.2 40.5 112.8 128.8 116.1 82.2 88.5 95.5 261.3 324.0 70.6 57.1 78.9 51.4 322.7 277.6 232.7 56.5 53.7 72.9 89.5 65.0 307.2 104.4 63.7 43.8 160.2 98.6 92.4 68.6 54.3 121.3 316.9 49.0 85.6 69.8 291.7 86.8 61.9 110.9 57.0 126.0 106.2 324.4 125.7 172.4 451.1 481.5 352.6 443.9 81.8 399.1 369.6 311.1 234.7 131.0 117.5 0.1 174.9 611.4 115.9 111.3 484.0 261.3 256.1 77.6 120.7 66.4 98.0 208.4 192.0 104.9 68.7 282.8 267.0 180.2 116.9 283.4 449.4 151.0 90.6 0.5 594.9 244.3 140.3 170.2 296.1 154.9 129.2 528.7 193.0 54.0 259.7 295.2 416.7 496.5 290.9 141.5 412.0 119.4 272.5 104.3 273.2 286.5 149.1 172.9 267.6 21.0 41.6 116.1 156.6 48.9 640.9 15.9 44.3 21.3 0.5 152.6 1.9 0.9 0.5 0.9 52.5 0.1 0.3 0.5 1.5 1.3 175.4 4.2 0.4 29.7 261.9 272.8 299.3 287.6 261.3 324.0 322.7 277.6 232.7 307.2 316.9 291.7 324.4 10.4 28.9 39.7 32.0 3.0 1.3 1.5 8.7 18.2 0.3 6.9 8.8 1.8 8.6 21.7 12.9 0.0 1.6 1.4 12.3 1.9 24.0 30.7 8.0 31.6 14.0 7.7 13.7 12.2 16.7 3.3 13.8 19.9 7.6 19.0 3.2 16.4 6.9 6.0 3.3 5.0 16.7 4.1 26.0 4.9 131.8 13.4 18.8 3.6 14.0 11.4 19.4 1.0 17.1 25.0 24.3 12.5 14.3 2.8 0.4 5.4 3.4 12.5 0.3 0.0 3.2 10.3 1.4 8.1 46.9 2.8 1.4 1.9 1.0 16.2 0.9 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938051-112976460 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "monocytes: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 15.3" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 202.5;BJ hTERT+ SV40 Large T+ RasG12V: 224.5;GAMG: 89.8;RT4: 62.6" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Yes No 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 8.2 4.2 4.1 11.6 5.4 21.1 6.1 2.2 2.8 6.7 1.2 7.2 7.1 3.9 1.5 16.0 5.2 11.4 6.0 2.1 3.7 5.6 4.5 12.7 6.0 8.1 3.4 1.5 3.8 3.8 3.2 3.5 11.2 5.0 3.5 6.3 0.6 27.9 2.7 3.0 5.4 6.6 9.4 2.7 18.0 11.1 2.3 4.0 16.2 4.2 5.9 6.5 14.5 7.8 13.8 23.2 34.4 0.3 5.5 1.0 4.6 2.1 2.6 25.3 202.5 224.5 24.1 20.5 0.7 7.3 8.1 89.8 15.7 3.3 22.7 11.2 9.7 1.2 15.9 16.3 4.0 3.9 4.5 6.6 0.9 7.2 32.8 1.3 4.0 11.7 3.9 0.5 3.1 2.0 13.3 8.0 2.7 1.4 33.7 22.8 13.5 11.6 0.1 7.0 62.6 0.6 0.1 19.8 5.5 14.8 0.2 25.7 1.1 9.5 4.6 4.0 5.5 6.5 0.8 21.0 0.2 4.9 12.9 16.7 1.0 7.8 0.8 1.4 7.4 1.7 2.3 2.0 2.3 4.1 1.0 1.8 1.7 9.7 2.7 15.3 0.3 2.6 3.5 4.1 5.4 2.2 2.8 2.1 3.7 8.1 3.4 1.5 5.0 2.7 4.0 13.8 19.9 3.2 3.9 0.7 3.8 3.4 5.6 13.5 5.2 0.4 3.1 2.7 1.7 0.0 5.1 3.7 0.0 5.4 1.8 14.7 3.9 11.2 5.9 1.8 4.1 20.8 1.8 0.8 0.3 9.8 20.9 5.5 16.3 5.6 1.3 21.9 9.3 1.7 18.7 0.0 0.4 6.8 8.2 5.8 7.0 10.8 10.2 16.7 1.8 5.6 30.2 3.0 8.2 3.5 0.0 21.2 8.2 15.1 1.4 11.8 4.5 2.0 2.3 0.5 0.0 2.5 5.0 0.8 0.7 14.4 4.7 1.9 6.5 9.2 5.4 26.8 OAS2 ENSG00000111335 "2'-5'-oligoadenylate synthetase 2" P29728 12 112978395-113011723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 67.7" "Cell type enhanced" "Detected in many" "Adipocytes: 22.8;Endothelial cells: 21.4;Macrophages: 27.6;monocytes: 26.1;NK-cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 364.3;BJ hTERT+ SV40 Large T+ RasG12V: 297.5;Daudi: 88.7;SK-MEL-30: 135.0;U-266/70: 118.4;U-266/84: 115.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003320, CAB024984" Approved Approved Centrosome NA NA Centrosome "CAB024984: , HPA003320: " "unprognostic (2.39e-1)" "unprognostic (9.51e-2)" "unprognostic (2.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.34e-1)" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (7.64e-3)" "prognostic unfavorable (4.63e-4)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.94e-2)" 12.0 4.4 6.9 25.9 7.2 15.3 7.3 5.7 7.9 9.4 5.3 8.6 9.4 6.3 2.9 13.5 6.3 17.9 8.8 5.3 6.3 5.9 19.7 26.6 38.3 9.6 6.3 4.8 2.1 1.7 2.8 2.3 23.6 7.9 7.3 9.0 1.0 67.7 3.6 2.6 2.7 9.1 13.0 6.2 43.9 18.7 3.9 7.1 37.1 5.2 7.0 33.4 23.0 5.7 13.8 3.0 0.5 0.2 0.2 1.7 12.3 0.2 0.5 41.9 364.3 297.5 0.6 5.9 88.7 8.4 6.9 71.3 3.4 0.8 0.9 12.1 22.8 0.2 0.2 0.8 0.5 2.5 0.1 0.2 0.8 6.0 19.7 0.0 0.3 5.2 4.2 0.1 42.2 0.2 1.2 2.4 4.2 0.1 0.4 12.4 20.5 0.1 13.5 0.1 31.2 0.1 0.1 3.3 0.6 135.0 0.2 2.6 5.4 8.1 0.6 0.1 1.1 0.3 118.4 115.4 13.6 2.6 4.5 2.7 3.9 35.5 2.7 25.6 55.6 33.5 24.3 30.0 29.6 26.9 15.5 28.9 21.7 3.6 32.1 60.2 11.5 35.4 30.9 6.9 7.2 5.7 7.9 5.3 6.3 9.6 6.3 4.8 7.9 6.2 7.1 13.8 22.8 3.2 6.0 0.3 16.6 2.0 1.6 4.0 2.8 0.1 2.1 1.3 1.6 0.0 5.1 1.8 0.0 0.2 15.1 1.2 0.0 1.0 0.7 3.5 3.4 21.4 0.0 4.0 0.2 1.2 2.4 4.8 6.1 1.7 1.3 2.5 12.1 2.6 16.1 0.0 0.5 3.8 0.0 19.7 4.7 1.2 0.6 27.6 5.4 10.3 26.1 0.4 26.8 2.0 0.1 3.8 1.2 3.4 15.5 2.6 0.4 0.3 12.2 0.2 0.0 1.0 2.7 0.1 0.1 7.6 1.1 0.1 15.5 6.0 0.4 10.4 ART4 "ARTC4, CD297, DO, DOK1" ENSG00000111339 "ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)" Q93070 12 14825569-14843526 "Blood group antigen proteins, CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 53.7;lymphoid tissue: 19.2" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Endothelial cells: 12.9;Erythroid cells: 51.3;Hepatic stellate cells: 66.0;Hepatocytes: 30.2" "Group enriched" "Detected in some" 5 "liver cancer: 3.8;pancreatic cancer: 1.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;HEL: 12.1;Hep G2: 7.3;HUVEC TERT2: 27.0" "Region enhanced" "Detected in single" "olfactory bulb: 1.8" "Low region specificity" "Detected in all" HPA075664 Approved "Rods & Rings" "Secreted to blood" NA NA 17000000 "Rods & Rings" "HPA075664: " "unprognostic (2.50e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.90e-2)" "unprognostic (2.62e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-3)" "unprognostic (1.05e-1)" "unprognostic (1.71e-1)" 2.3 2.8 0.3 1.1 0.4 4.6 1.9 0.2 1.3 0.9 1.8 0.7 0.0 0.8 0.3 0.9 2.1 9.0 6.1 0.3 0.5 3.7 53.7 3.2 8.7 0.5 0.4 0.2 0.5 2.3 0.3 0.1 7.0 0.6 0.3 0.5 0.3 0.7 0.4 0.3 0.3 0.6 1.1 0.2 19.2 0.3 0.2 0.4 1.9 3.7 0.2 2.4 0.6 0.5 0.6 0.0 0.0 0.2 6.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 7.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 1.3 0.3 0.5 0.5 0.4 0.2 0.6 0.2 0.4 0.6 0.7 0.0 1.1 0.7 0.2 0.3 0.8 0.0 0.0 2.4 0.2 0.1 1.5 15.7 0.0 1.8 12.5 0.9 0.1 0.0 0.0 0.9 0.4 0.2 0.1 12.9 0.0 51.3 0.2 1.9 2.5 1.9 0.0 0.1 0.0 0.0 66.0 30.2 0.1 0.0 0.2 0.0 0.0 4.7 1.3 0.3 1.8 0.1 1.8 0.0 0.0 0.3 1.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.0 11.8 6.6 0.5 1.2 0.1 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.4 MGP ENSG00000111341 "Matrix Gla protein" P08493 12 14880864-14885857 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Developmental protein" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 9375.3;Breast myoepithelial cells: 4639.0;Fibroblasts: 4233.6;Hepatic stellate cells: 1826.5;Leydig cells: 2016.2" "Cancer enriched" "Detected in all" 5 "breast cancer: 845.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 9 "dendritic cells: 1.6" "Cell line enriched" "Detected in many" 5 "AN3-CA: 9874.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013949 Approved "Secreted to blood" NA NA 29000000 "HPA013949: AB_1853599" "unprognostic (5.71e-3)" "unprognostic (5.85e-3)" "unprognostic (1.20e-3)" "unprognostic (2.83e-2)" "unprognostic (1.27e-1)" "unprognostic (1.21e-1)" "unprognostic (1.55e-2)" "unprognostic (4.17e-3)" "unprognostic (1.01e-2)" "unprognostic (6.93e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-2)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.55e-2)" "unprognostic (4.69e-2)" "unprognostic (7.50e-2)" "unprognostic (8.97e-3)" 1242.2 1522.6 48.2 189.2 48.9 1.6 3774.0 42.0 213.4 1468.1 350.3 1412.1 70.4 2060.9 759.5 220.3 2300.1 1093.0 1944.9 41.1 76.4 1325.6 58.6 1280.7 107.9 59.4 44.2 41.9 845.7 220.7 110.7 930.2 205.9 49.1 1972.2 280.0 7.6 2131.3 1151.6 178.5 340.4 826.0 1321.5 46.9 143.3 913.6 143.4 47.5 100.4 1513.2 277.5 66.4 996.2 1277.1 43.3 0.9 0.0 0.1 9874.6 1624.2 2.4 3.7 31.8 1.0 0.0 0.0 0.0 12.7 0.2 0.5 3.1 0.4 0.1 0.2 0.2 0.0 0.3 0.3 0.0 1.3 0.0 55.0 0.2 0.2 33.6 0.0 0.0 1.5 3.2 105.4 0.0 0.0 0.3 0.0 0.9 1.2 4.8 7.0 2.2 0.0 0.4 0.2 2.6 0.0 10.5 4.8 31.1 2.0 8.9 0.6 2.8 1810.9 0.1 21.7 11.1 1.2 3.6 28.7 0.5 0.1 1.1 9.0 0.6 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 48.2 48.9 42.0 213.4 41.1 76.4 59.4 44.2 41.9 49.1 46.9 47.5 43.3 451.0 19.2 72.8 1.3 29.9 149.3 220.4 0.3 19.9 0.5 9375.3 4639.0 70.2 8.6 187.5 115.8 4.2 19.0 85.7 0.1 1.9 2.3 16.9 14.7 355.8 856.1 0.0 18.7 0.2 83.4 13.5 4233.6 86.2 10.9 13.9 0.3 1826.5 6.0 30.8 0.0 0.1 0.0 0.0 9.4 219.9 67.9 2016.2 36.1 225.9 23.4 2.6 28.8 0.0 0.0 0.2 1.8 1.1 1301.8 17.0 164.3 0.0 0.7 25.8 6.8 841.5 558.8 847.0 8.2 6.1 25.8 118.5 39.5 54.5 140.6 0.0 74.6 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 60.3;salivary gland: 28.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041650 Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: AB_2677598" "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.0 15.6 9.3 1.2 12.8 0.5 1.0 0.4 19.1 2.0 1.0 1.7 0.4 0.1 0.1 22.8 1.6 0.3 0.0 21.5 3.9 9.0 0.1 0.2 1.1 4.5 4.4 16.6 0.0 1.1 60.3 5.0 0.2 4.7 0.2 1.1 0.5 28.8 4.0 0.0 10.3 0.5 0.0 0.4 0.2 10.7 0.7 6.3 0.2 10.2 0.0 2.7 0.2 5.3 12.5 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 3.9 15.3 19.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 4.3 0.0 0.0 0.6 5.5 0.0 22.3 0.0 50.0 19.0 0.0 0.5 0.0 0.0 7.2 0.0 0.1 2.9 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 42.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 12.8 0.4 19.1 21.5 3.9 4.5 4.4 16.6 4.7 0.4 6.3 12.5 0.0 0.0 0.0 1.3 0.8 0.5 0.0 0.4 0.0 0.5 2.4 2.0 4.3 2.8 1.0 36.8 0.0 1.1 0.0 1.9 0.0 1.4 0.1 1.8 0.6 0.3 1.2 0.0 14.0 0.0 0.2 0.3 57.1 4.6 2.5 0.0 0.0 0.0 0.4 0.0 1.0 4.8 0.0 0.0 5.5 0.2 0.0 1.2 1.8 0.0 1.0 2.7 0.0 0.0 46.5 5.2 3.3 0.0 0.6 0.0 0.1 5.2 0.5 0.0 0.0 0.0 0.2 0.1 0.7 4.6 1.1 1.2 0.4 0.1 3.3 0.6 ARHGDIB "GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2" ENSG00000111348 "Rho GDP dissociation inhibitor beta" P52566 12 14942031-14961728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 1593.9;lymphoid tissue: 1085.7" "Cell type enhanced" "Detected in many" "dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018584, HPA051235" Enhanced Supported Cytosol NA NA 61000000 Cytosol "CAB018584: AB_647972, HPA051235: AB_2681398" "unprognostic (2.29e-3)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (9.16e-2)" "unprognostic (1.90e-2)" "unprognostic (2.44e-1)" "unprognostic (1.47e-2)" "unprognostic (3.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (4.42e-3)" "unprognostic (4.97e-2)" "prognostic favorable (3.42e-4)" 190.5 74.8 46.5 525.8 54.8 1593.9 172.1 55.0 78.3 86.1 68.4 114.0 80.3 68.6 48.8 83.6 86.1 167.3 111.7 47.0 75.1 96.0 140.1 282.8 912.6 67.3 54.6 43.0 27.8 32.5 54.6 35.7 145.0 65.4 69.4 143.8 5.4 123.4 66.9 56.8 69.0 203.2 145.7 64.4 597.3 109.1 19.7 62.0 1085.7 111.5 79.7 1045.2 293.1 67.9 69.1 147.8 5.5 5.8 327.3 23.7 17.6 2.1 6.0 1.8 2.3 1.6 19.3 156.9 1210.9 74.3 28.0 1.9 171.1 0.0 270.8 17.9 2.3 0.0 1636.5 3.5 0.7 5.2 1927.3 2070.0 2.5 37.5 0.8 24.2 5.6 929.0 1421.7 8.7 454.5 28.8 0.8 2313.6 1382.4 7.1 3.3 1.7 1912.5 21.3 540.3 52.7 845.5 1.3 1.4 1.8 205.7 2.5 14.1 10.9 1385.1 1171.8 4.6 11.5 2.2 36.2 74.5 13.0 1750.9 5.3 1339.7 2.4 5890.8 2659.3 6464.2 2731.2 3085.1 2695.1 2676.3 3099.3 3090.3 2210.1 2532.9 2986.0 3120.5 5422.5 2408.4 3802.9 955.6 5589.7 9860.2 46.5 54.8 55.0 78.3 47.0 75.1 67.3 54.6 43.0 65.4 64.4 62.0 69.1 189.6 60.9 143.0 0.7 575.2 68.2 51.9 11.1 5.7 0.6 99.7 64.5 14.0 11.5 79.5 58.8 0.0 89.6 703.8 5.3 17.6 21.9 1.5 3.2 6.1 175.6 1.2 182.1 0.7 342.7 667.6 47.3 42.3 3.6 700.2 0.4 342.3 11.1 915.2 0.0 0.2 2.2 8.2 742.6 487.7 4.1 53.4 672.9 90.7 26.2 451.3 3.3 999.0 0.5 0.1 53.5 16.3 58.6 292.5 6.9 0.2 9.2 39.0 1.2 243.3 10.3 187.9 1.2 2.3 5.5 56.1 68.0 895.2 14.9 6.7 94.7 GTF2H3 "BTF2, P34, TFIIH" ENSG00000111358 "General transcription factor IIH subunit 3" Q13889 12 123633739-123662604 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004844, HPA053562" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004844: AB_2667265, HPA053562: AB_2682191" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.02e-2)" "unprognostic (6.13e-3)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (1.02e-1)" "unprognostic (1.22e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.10e-1)" "unprognostic (5.68e-3)" "unprognostic (4.71e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (2.80e-2)" 10.5 9.0 6.1 13.0 6.1 11.3 15.7 5.8 7.0 11.8 5.0 14.1 10.6 13.0 9.0 15.5 15.1 9.8 10.8 5.8 5.9 11.3 14.2 9.8 16.7 6.4 6.4 6.0 11.3 5.7 11.8 5.9 13.0 6.6 13.1 16.3 10.2 7.3 11.4 13.9 12.9 10.7 14.3 5.5 10.5 11.8 12.3 5.9 16.1 13.5 11.2 16.2 11.5 8.3 7.2 42.0 21.7 27.6 35.5 33.3 37.1 38.9 31.2 38.2 47.1 31.6 23.2 21.1 48.4 37.4 43.0 18.8 27.8 46.2 56.4 56.2 41.4 32.5 39.7 19.3 33.3 46.8 80.9 25.3 39.7 42.2 38.2 85.9 35.3 34.2 59.4 60.4 15.7 42.9 27.4 40.5 27.2 35.6 29.6 39.9 41.3 42.1 27.4 24.1 40.1 24.8 21.8 41.1 19.8 32.1 30.1 55.4 48.1 22.9 29.3 22.3 45.9 50.7 28.8 42.3 47.6 33.7 40.5 34.3 11.4 4.6 6.0 7.6 6.9 7.6 5.9 6.1 8.1 7.0 5.7 8.7 8.0 0.6 10.7 7.0 5.9 6.7 4.1 6.1 6.1 5.8 7.0 5.8 5.9 6.4 6.4 6.0 6.6 5.5 5.9 7.2 20.8 22.4 24.3 23.5 19.2 11.7 12.3 20.9 27.9 16.2 12.6 15.2 7.4 12.8 22.3 12.9 10.4 26.3 13.8 8.4 3.9 12.9 8.6 18.3 24.7 11.1 6.7 21.6 26.6 11.0 23.4 17.1 16.8 16.7 24.1 19.9 12.1 16.9 17.2 16.8 27.8 12.3 6.1 12.3 7.9 4.3 11.8 15.3 1.8 10.3 16.1 21.9 7.2 15.6 23.1 10.8 10.8 11.3 17.1 10.5 6.1 15.8 20.7 13.7 13.1 18.8 15.2 32.6 27.1 25.7 13.2 23.7 14.5 36.2 15.7 10.4 EIF2B1 "EIF-2B, EIF-2Balpha, EIF2B, EIF2BA" ENSG00000111361 "Eukaryotic translation initiation factor 2B subunit alpha" Q14232 12 123620406-123633766 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034258, HPA049509" Approved Approved Cytosol NA NA 16000 Cytosol "CAB034258: AB_2095995, HPA049509: AB_2680797" "unprognostic (2.14e-2)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (7.50e-2)" "unprognostic (1.22e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.65e-2)" "unprognostic (7.24e-3)" "unprognostic (1.53e-1)" "unprognostic (7.27e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (1.78e-9)" "unprognostic (2.46e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.40e-2)" 32.4 32.3 23.9 33.4 26.2 36.7 31.8 28.3 28.1 32.7 24.4 31.4 27.8 34.3 29.7 34.1 31.4 22.2 24.9 25.3 24.9 26.0 29.2 24.6 40.8 25.5 25.0 24.3 34.4 33.2 21.8 28.4 31.3 27.8 29.7 31.1 23.7 29.0 26.4 43.5 51.5 29.5 31.8 24.0 33.7 28.9 22.8 25.4 30.3 27.6 27.5 43.5 32.8 31.4 32.6 55.6 47.9 50.0 53.1 45.8 46.2 52.5 66.8 38.2 64.3 46.7 62.8 34.0 104.2 77.3 51.1 28.6 54.3 79.0 52.0 67.3 85.4 87.8 74.9 68.3 55.6 43.3 106.9 90.2 42.0 63.3 55.4 38.9 54.0 59.6 66.8 136.4 34.2 60.2 50.4 86.1 113.3 82.4 59.5 64.1 89.5 61.1 79.2 43.2 46.0 61.9 69.9 49.4 48.7 63.3 46.7 88.5 63.2 56.8 43.8 52.9 63.2 62.4 90.9 102.1 153.6 63.6 71.7 63.9 113.2 87.3 119.3 56.3 104.2 51.3 60.1 57.2 58.9 95.7 53.2 58.0 53.9 9.8 64.8 101.6 59.9 73.2 100.7 23.9 26.2 28.3 28.1 25.3 24.9 25.5 25.0 24.3 27.8 24.0 25.4 32.6 29.0 16.0 19.6 10.7 29.3 20.4 17.5 28.3 24.5 19.8 16.0 17.3 20.0 25.8 19.0 18.4 8.4 69.0 33.8 18.3 29.4 33.0 7.6 15.0 28.3 26.0 21.7 21.9 23.4 40.1 58.8 23.6 15.3 14.2 41.2 24.4 22.1 13.1 37.8 16.8 21.2 15.4 18.3 18.6 18.5 5.3 25.1 26.0 19.6 14.0 30.6 34.4 35.0 16.1 21.9 32.8 23.8 16.6 30.7 14.8 26.1 23.9 14.3 21.6 32.9 18.5 29.8 49.2 38.7 27.3 20.5 51.6 26.7 29.3 21.7 14.6 DDX55 KIAA1595 ENSG00000111364 "DEAD-box helicase 55" Q8NHQ9 12 123602077-123620943 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039962, HPA044101" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039962: AB_2676774, HPA044101: AB_2678810" "unprognostic (1.14e-1)" "unprognostic (2.30e-2)" "unprognostic (2.29e-1)" "unprognostic (3.71e-3)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.11e-9)" "unprognostic (1.60e-1)" "unprognostic (4.49e-2)" "unprognostic (7.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-3)" "prognostic unfavorable (8.97e-12)" "unprognostic (9.15e-3)" "unprognostic (2.94e-1)" "unprognostic (3.47e-2)" "unprognostic (1.23e-3)" 11.1 10.4 11.3 10.5 11.3 20.5 11.2 13.3 19.6 12.2 11.1 9.6 7.6 9.7 7.8 11.2 12.3 5.7 7.0 10.8 10.5 8.3 14.9 8.4 13.9 11.6 11.6 10.2 13.2 15.5 6.5 11.4 7.8 12.4 11.4 8.9 12.7 9.6 6.4 6.5 13.7 10.9 7.2 10.1 15.0 9.8 9.7 11.2 10.4 9.2 3.4 10.8 10.8 11.2 13.1 20.5 28.4 21.4 21.7 18.0 14.2 32.2 24.8 9.1 21.6 14.8 32.5 14.6 30.2 19.3 10.9 19.5 24.4 32.8 18.4 25.1 22.8 29.7 40.8 34.0 24.3 13.7 50.7 30.7 12.0 19.2 25.7 29.5 16.7 15.8 23.9 42.3 15.5 15.5 21.1 50.0 68.2 33.3 23.6 27.9 37.1 22.7 19.7 15.2 34.8 25.3 21.0 20.2 25.9 35.0 17.7 46.2 32.4 16.3 18.6 24.5 30.6 31.2 28.4 37.4 54.2 17.7 35.8 32.4 3.4 9.1 7.8 11.4 10.6 12.4 13.9 11.1 12.3 7.7 10.7 14.9 13.9 5.2 13.3 6.4 13.2 9.9 8.6 11.3 11.3 13.3 19.6 10.8 10.5 11.6 11.6 10.2 12.4 10.1 11.2 13.1 13.3 22.4 13.9 15.7 14.2 11.0 13.4 13.9 9.6 20.2 9.6 14.9 2.5 8.6 11.7 7.3 22.9 13.8 26.3 5.9 7.9 12.2 45.1 9.0 18.4 12.0 7.2 19.6 13.4 12.0 17.4 12.0 11.2 7.2 25.3 16.4 7.1 9.4 14.3 15.2 16.5 15.9 10.2 7.1 7.4 74.8 17.1 9.0 7.2 12.2 9.9 16.1 15.5 6.6 14.3 13.3 7.6 14.7 13.8 13.3 5.9 6.3 12.3 28.1 6.6 10.5 14.1 21.9 18.6 12.5 16.9 7.7 14.2 14.0 10.2 11.0 SLC38A1 "ATA1, NAT2, SAT1" ENSG00000111371 "Solute carrier family 38 member 1" Q9H2H9 12 46183063-46270017 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 443.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 386.1" "Low region specificity" "Detected in all" "HPA039460, HPA052272" Uncertain Supported NA NA "HPA039460: , HPA052272: AB_2681781" "unprognostic (8.92e-3)" "unprognostic (3.23e-2)" "unprognostic (9.47e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (1.00e-1)" "unprognostic (3.74e-1)" "prognostic unfavorable (6.95e-8)" "unprognostic (2.01e-3)" "unprognostic (1.38e-1)" "unprognostic (4.19e-3)" "unprognostic (2.44e-2)" "unprognostic (3.99e-2)" "unprognostic (1.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (3.00e-1)" "unprognostic (5.55e-2)" 8.3 5.3 20.9 38.9 19.0 26.2 82.6 49.1 27.8 13.7 1.1 39.7 16.9 16.6 8.8 26.9 15.7 16.7 45.0 16.5 52.2 20.5 6.4 13.4 64.9 48.0 32.9 13.8 10.0 24.0 79.3 19.4 22.7 38.7 29.8 38.8 79.7 20.7 35.9 91.4 30.7 23.1 28.1 47.2 32.2 21.5 1.1 30.4 60.0 42.9 83.1 54.8 23.6 11.3 61.0 77.6 79.2 28.2 104.9 12.4 4.5 142.8 60.6 98.2 27.3 42.7 136.6 74.9 176.3 113.0 74.7 83.6 116.5 94.8 124.5 50.4 109.6 49.8 12.3 127.4 51.2 108.3 126.1 4.5 21.7 186.7 8.2 325.1 67.5 61.6 112.0 65.2 144.2 86.5 96.5 112.7 22.0 104.1 0.1 122.7 99.8 6.9 124.6 105.4 109.8 111.6 77.2 126.2 152.9 71.7 108.0 88.9 91.1 129.8 21.2 19.7 0.6 62.7 136.2 126.5 386.1 67.9 242.2 18.6 1.0 0.8 26.3 51.8 0.2 71.0 50.4 54.1 61.0 34.9 57.8 62.6 57.1 2.4 68.3 0.4 44.3 63.5 46.4 20.9 19.0 49.1 27.8 16.5 52.2 48.0 32.9 13.8 38.7 47.2 30.4 61.0 10.3 35.3 44.7 75.4 150.0 97.8 73.8 103.8 30.1 443.5 136.5 64.8 207.5 38.6 61.8 213.3 141.8 106.9 216.3 99.3 3.9 56.3 0.2 78.1 9.8 26.7 40.6 25.6 104.7 46.4 79.3 14.6 19.4 123.7 3.8 30.9 5.7 6.1 12.2 8.4 157.8 73.6 79.3 12.9 76.1 0.3 2.1 23.3 26.6 30.9 13.6 51.4 107.1 94.5 59.7 53.5 52.8 0.7 138.8 66.5 23.6 1.1 29.7 54.2 0.0 62.9 34.5 0.1 0.4 70.3 122.7 185.7 167.9 1.6 93.6 75.4 RERGL FLJ22655 ENSG00000111404 "RERG like" Q9H628 12 18080869-18320107 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 37 "Sertoli cells: 164.3;Smooth muscle cells: 381.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 719 "REH: 230.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA041740 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041740: AB_10795694" "unprognostic (3.53e-2)" "unprognostic (7.03e-4)" "unprognostic (6.29e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-2)" "unprognostic (4.39e-2)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (5.51e-2)" "unprognostic (7.26e-2)" "unprognostic (8.47e-2)" "unprognostic (1.25e-1)" "unprognostic (6.76e-3)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "unprognostic (1.66e-2)" 35.5 5.5 15.0 2.5 15.4 0.0 29.4 15.3 30.7 21.8 15.4 14.6 3.0 25.5 38.2 7.3 26.1 10.3 6.6 14.9 16.4 16.0 2.1 4.5 1.3 15.7 15.7 14.2 20.0 1.8 1.1 1.6 0.0 16.2 7.2 17.0 0.2 3.8 19.6 6.1 9.2 13.5 16.1 15.2 2.7 7.9 2.9 16.0 1.2 13.5 30.5 1.4 11.3 14.8 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 230.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 15.4 15.3 30.7 14.9 16.4 15.7 15.7 14.2 16.2 15.2 16.0 15.5 6.9 0.0 0.0 2.0 0.1 4.5 0.3 0.0 4.0 0.0 2.8 5.2 4.1 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.7 7.2 0.0 0.0 0.1 0.0 0.5 2.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.4 0.3 0.6 5.4 3.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.5 0.0 0.3 0.0 0.6 0.0 0.1 164.3 0.6 381.7 0.1 1.1 0.8 2.4 0.1 0.9 0.3 0.1 0.4 ENDOU "P11, PP11, PRSS26" ENSG00000111405 "Endonuclease, poly(U) specific" P21128 12 47709734-47725567 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 83.5;salivary gland: 23.4;skin 1: 21.3;vagina: 31.2" "Cell type enhanced" "Detected in some" "Adipocytes: 6.9;Glandular and luminal cells: 9.6;Squamous epithelial cells: 5.2;Suprabasal keratinocytes: 9.1;Syncytiotrophoblasts: 34.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;SK-BR-3: 4.9;SuSa: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012388, HPA067448" Enhanced "Secreted in other tissues" NA NA 14000 "HPA012388: AB_1854860, HPA067448: AB_2685843" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.29e-4)" "unprognostic (6.50e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" 1.7 0.1 2.4 0.1 2.6 0.2 1.7 2.7 3.1 9.6 1.9 0.5 0.1 0.5 1.0 83.5 0.9 0.5 0.6 2.7 2.1 1.1 0.1 0.7 0.3 2.7 2.6 2.0 1.9 0.2 0.0 0.5 2.5 2.7 0.4 0.1 0.1 23.4 0.2 0.5 21.3 0.4 0.5 2.2 0.3 0.6 0.3 2.8 0.1 0.9 0.1 8.8 0.7 31.2 2.3 0.0 0.0 0.0 0.0 0.3 1.1 0.7 0.2 0.9 0.8 0.7 0.1 0.0 2.2 0.5 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 4.6 0.1 0.0 0.1 0.2 0.0 0.6 0.1 1.2 1.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.6 2.7 3.1 2.7 2.1 2.7 2.6 2.0 2.7 2.2 2.8 2.3 6.9 0.0 0.0 2.0 0.1 1.7 0.2 0.0 0.0 0.2 0.4 0.4 1.2 0.0 0.7 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.1 2.4 0.8 3.5 0.0 0.0 0.1 0.0 1.0 0.8 0.0 9.6 0.0 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.1 1.5 0.1 3.6 1.0 0.1 0.1 0.0 0.5 0.5 0.1 0.0 1.2 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.2 0.0 0.0 5.2 9.1 34.3 0.0 0.2 0.0 0.1 SPRING1 "C12orf49, FLJ21415, LUR1, POST1, SPRING" ENSG00000111412 "SREBF pathway regulator in golgi 1" Q9H741 12 116710171-116738070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 37.8" "Cell type enhanced" "Detected in some" "Adipocytes: 10.5;Cytotrophoblasts: 11.5;dendritic cells: 9.8;Extravillous trophoblasts: 37.5;Hofbauer cells: 40.9;Syncytiotrophoblasts: 17.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 35.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026905 Uncertain "Intracellular and membrane" NA NA 330000 "HPA026905: AB_10603446" "unprognostic (2.74e-3)" "unprognostic (1.41e-1)" "unprognostic (3.66e-2)" "unprognostic (9.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.76e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (2.56e-1)" "unprognostic (4.78e-2)" "unprognostic (2.62e-2)" "unprognostic (3.72e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.91e-11)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (8.46e-2)" "unprognostic (1.73e-1)" 5.5 8.2 12.9 8.0 13.3 6.3 6.0 13.5 12.5 3.5 7.2 11.3 6.6 4.3 8.6 7.9 3.5 5.8 6.6 10.6 14.9 14.7 8.8 18.6 8.6 17.3 15.5 10.4 3.5 6.9 7.1 6.9 4.4 15.3 4.6 8.4 5.7 13.8 4.2 3.1 6.3 6.5 3.9 13.3 7.2 11.4 9.3 17.5 9.9 37.8 2.4 8.8 5.4 4.2 14.4 12.6 16.7 15.2 15.2 17.4 13.8 19.0 8.6 11.5 9.5 8.2 32.9 9.3 32.3 16.6 11.9 14.1 16.0 21.3 13.2 10.6 26.0 17.1 9.2 8.5 31.6 12.2 17.8 27.3 16.8 16.3 12.4 14.0 16.1 14.5 21.3 10.0 7.3 15.3 18.9 16.2 16.5 24.4 19.2 19.4 24.0 10.3 14.0 24.1 33.7 14.0 17.4 14.0 14.0 25.9 17.1 16.9 18.3 18.9 14.1 19.4 20.0 17.1 15.0 48.7 45.6 22.9 18.2 16.9 3.1 2.4 4.1 4.5 3.3 4.6 5.6 3.5 3.7 2.2 4.9 3.0 4.1 1.7 2.9 2.3 4.3 3.9 1.7 12.9 13.3 13.5 12.5 10.6 14.9 17.3 15.5 10.4 15.3 13.3 17.5 14.4 10.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 11.5 9.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 37.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 17.9 1.6 0.0 0.0 0.0 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 237.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 7 "classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7" "Group enriched" "Detected in many" 8 "dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3" "Region enhanced" "Detected in single" "olfactory bulb: 2.1" "Region enhanced" "Detected in some" "spinal cord: 4.3" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.6 13.8 0.2 13.4 0.3 8.3 11.4 0.3 0.5 3.4 0.9 40.8 56.5 1.6 0.4 13.7 1.8 8.6 0.9 0.3 1.4 21.2 1.1 7.8 5.4 0.8 0.4 0.2 0.5 2.1 237.9 11.2 3.0 0.8 1.9 35.7 0.2 6.1 1.8 2.9 20.7 55.4 3.9 0.3 2.6 7.5 1.0 1.2 1.6 2.3 0.6 7.3 10.5 7.7 0.8 15.0 2.6 0.1 0.1 12.0 16.4 0.2 17.7 8.6 15.0 12.9 10.6 12.1 3.5 17.4 13.6 10.7 27.1 0.5 55.5 6.4 80.0 4.0 6.3 3.1 0.9 8.1 12.2 20.3 23.6 30.5 16.4 26.0 22.3 1.2 1.3 1.8 3.9 7.0 9.2 0.3 6.0 0.2 34.8 19.1 0.3 0.0 9.9 13.3 13.5 6.2 0.2 14.7 42.6 5.9 0.1 47.6 6.7 1.0 28.8 7.3 8.2 10.2 2.2 0.1 3.0 8.6 85.3 7.7 0.1 3.5 1.9 0.0 6.5 0.1 0.5 0.3 0.0 5.1 0.0 0.1 0.0 6.5 0.2 6.7 0.4 0.7 1.5 0.2 0.3 0.3 0.5 0.3 1.4 0.8 0.4 0.2 0.8 0.3 1.2 0.8 0.4 12.8 20.1 0.3 1.4 36.1 9.0 8.5 24.5 0.5 21.2 13.7 1.7 0.0 9.2 7.3 0.0 0.2 0.9 141.7 7.9 3.5 0.2 11.9 0.5 1.3 21.7 0.0 0.4 10.9 0.1 5.3 14.3 4.7 7.0 0.2 0.0 0.3 3.4 0.0 0.3 32.8 2.0 7.3 43.4 0.0 0.0 21.2 8.8 1.0 10.4 0.2 0.0 0.5 0.1 22.4 43.3 0.4 10.9 8.3 88.7 32.0 9.0 0.2 0.0 1.1 2.2 0.7 0.3 23.4 40.6 0.3 2.8 0.0 72.4 11.6 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 16.9;skin 1: 8.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 13.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2" "Region enhanced" "Detected in many" "thalamus: 6.9" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 0.7 0.1 0.9 0.1 0.6 0.0 0.8 1.3 0.6 6.5 0.3 0.3 0.1 2.8 0.9 16.9 1.4 1.6 0.2 0.7 0.7 0.1 0.0 0.8 0.4 1.3 1.0 0.3 2.9 0.1 0.0 0.9 2.4 1.0 2.9 0.2 0.4 4.2 1.5 1.0 8.7 0.4 0.4 0.8 0.0 0.4 0.1 2.7 0.3 1.0 0.8 0.7 2.6 6.9 1.1 0.0 0.0 5.5 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.0 0.5 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 3.2 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 1.3 0.6 0.7 0.7 1.3 1.0 0.3 1.0 0.8 2.7 1.1 0.4 0.0 0.5 0.0 0.0 8.4 4.7 0.1 12.5 0.1 0.6 0.8 0.6 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.5 2.1 2.1 0.0 0.0 0.0 0.2 0.6 8.4 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 13.1 9.3 0.0 0.4 25.5 8.5 0.8 0.1 0.0 0.0 1.8 RFC5 RFC36 ENSG00000111445 "Replication factor C subunit 5" P40937 12 118013588-118033130 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041037 Supported Approved Nucleoplasm NA NA 6500 Nucleoplasm "HPA041037: AB_10805834" "unprognostic (9.63e-2)" "prognostic favorable (8.05e-5)" "unprognostic (5.12e-3)" "unprognostic (2.25e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.44e-1)" "unprognostic (2.15e-1)" "unprognostic (2.70e-1)" "unprognostic (5.06e-1)" 5.6 5.8 4.5 10.6 4.9 34.1 10.9 5.9 5.1 8.4 4.1 10.4 9.9 11.2 5.5 9.4 9.6 6.8 5.5 6.2 3.5 8.8 13.1 6.8 16.6 4.2 3.7 4.0 15.7 7.7 7.1 4.7 7.4 4.0 7.9 12.7 11.6 5.9 8.0 5.7 13.0 9.2 7.8 4.7 8.1 7.3 8.4 3.6 23.6 10.4 4.8 16.2 6.4 7.1 5.1 52.8 49.3 49.1 28.1 12.2 14.7 58.3 38.4 24.0 66.6 49.9 50.2 21.4 56.4 25.9 18.1 42.0 47.2 66.9 34.0 63.2 42.1 58.1 43.9 40.7 36.5 7.6 70.7 38.1 7.8 12.2 50.0 16.8 30.4 28.6 70.3 62.6 21.6 33.3 50.3 93.2 59.2 40.5 29.8 46.1 68.1 61.2 55.3 30.7 47.7 67.5 30.7 62.2 18.2 24.1 30.4 64.4 30.0 13.7 36.9 42.5 50.4 69.5 36.2 51.7 76.9 36.4 51.7 66.1 16.6 5.0 3.6 8.6 8.4 7.6 10.7 10.3 7.4 7.2 9.1 8.0 6.9 5.6 7.9 4.9 6.0 11.4 6.5 4.5 4.9 5.9 5.1 6.2 3.5 4.2 3.7 4.0 4.0 4.7 3.6 5.1 4.0 0.0 3.3 4.6 5.6 8.4 6.9 7.1 4.0 4.2 5.2 4.7 3.1 4.3 4.6 9.2 2.1 21.0 4.7 3.6 9.8 8.9 3.0 6.0 6.3 4.3 4.2 45.7 11.8 6.3 25.2 6.4 4.1 6.5 5.7 14.0 3.3 6.0 9.1 1.7 7.3 6.9 4.1 3.2 3.1 2.7 4.1 4.9 0.0 3.7 3.8 9.5 2.1 2.5 5.5 4.1 4.0 8.2 16.4 2.3 3.2 6.6 11.0 6.0 0.0 5.3 8.4 13.4 9.1 9.5 5.4 8.9 7.9 18.7 10.6 4.2 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 152.2;Endometrial ciliated cells: 86.4;Late spermatids: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079007" Uncertain Supported Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079007: , HPA069176: AB_2686098" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 16.9 11.1 12.5 9.2 12.6 6.5 12.1 13.6 13.5 15.2 23.1 16.7 4.2 14.5 9.9 6.0 16.4 10.0 14.7 13.0 13.4 12.7 13.4 17.9 8.7 16.2 13.3 11.9 15.4 11.0 6.0 14.8 13.3 14.9 8.5 6.9 16.9 5.1 10.7 6.7 5.0 11.5 17.3 14.5 12.5 11.5 17.1 12.8 7.0 12.5 8.0 6.2 14.6 10.8 17.9 9.6 18.3 26.8 22.4 27.8 63.2 2.8 44.2 35.8 50.8 35.7 5.5 6.6 11.7 6.6 50.5 16.4 2.8 24.4 6.6 54.9 18.7 9.2 6.4 15.9 15.7 30.6 9.2 15.5 23.4 8.3 24.9 20.1 48.2 27.6 12.7 25.7 11.2 46.2 5.6 13.3 10.6 17.9 2.9 28.2 13.7 18.9 7.0 28.7 2.1 24.3 25.4 20.4 1.8 18.1 23.4 6.1 6.4 36.5 30.1 20.3 33.1 19.6 8.1 6.7 7.9 35.0 10.8 24.4 1.0 0.4 0.6 0.5 0.5 0.5 0.5 0.6 0.5 0.3 0.3 0.6 0.6 0.4 0.2 0.2 0.3 0.4 0.2 12.5 12.6 13.6 13.5 13.0 13.4 16.2 13.3 11.9 14.9 14.5 12.8 17.9 35.3 22.4 14.8 20.5 6.2 3.4 1.2 2.1 3.4 5.6 2.1 3.0 17.2 11.5 6.9 29.5 0.0 1.8 12.3 0.4 9.8 19.1 152.2 86.4 40.0 22.4 6.7 32.4 33.6 7.4 7.1 26.5 2.6 7.6 1.3 10.9 17.9 19.0 11.5 0.0 17.6 0.7 2.0 11.5 12.3 114.4 28.0 15.1 14.2 23.4 10.3 12.3 6.2 15.1 24.3 14.5 0.1 24.5 10.2 2.0 0.1 17.6 33.9 31.4 13.1 26.1 29.6 42.0 34.2 1.7 1.4 0.8 14.2 11.7 0.6 0.5 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 51.4" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.5;Cardiomyocytes: 47.0;Early spermatids: 16.2;Endometrial stromal cells: 50.2;Fibroblasts: 32.7;Late spermatids: 21.4;Leydig cells: 13.7;Microglial cells: 25.3;Peritubular cells: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.0;intermediate monocyte: 2.3;myeloid DC: 1.1;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;monocytes: 2.3" "Cell line enhanced" "Detected in some" "BJ: 4.1;fHDF/TERT166: 4.7;HeLa: 7.6;HHSteC: 4.9;HMC-1: 13.0;U-2 OS: 6.1" "Region enhanced" "Detected in some" "basal ganglia: 5.1" "Low region specificity" "Detected in all" "HPA042395, HPA076279" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "HPA042395: AB_10796906, HPA076279: " "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 20.8 1.9 2.0 1.4 2.5 0.3 10.4 1.4 2.5 19.9 1.4 10.2 2.0 15.6 7.4 7.0 17.9 13.0 51.4 1.4 3.1 2.2 10.3 36.0 0.4 2.0 2.6 1.1 18.1 12.1 0.3 6.4 25.9 2.0 15.5 1.8 0.8 2.9 1.0 7.3 6.6 12.2 7.1 2.2 2.3 20.8 7.6 3.5 0.4 11.3 8.6 1.0 40.6 16.4 4.4 0.0 0.7 0.0 2.0 0.0 0.0 0.1 4.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.6 0.0 4.9 0.0 13.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.8 0.0 0.1 0.2 2.1 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.4 6.1 1.5 0.1 0.1 1.7 0.8 0.1 0.0 0.0 0.0 2.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 2.0 2.5 1.4 2.5 1.4 3.1 2.0 2.6 1.1 2.0 2.2 3.5 4.4 2.0 22.4 30.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 47.0 0.0 5.0 1.8 0.0 1.3 0.0 0.0 0.0 0.0 16.2 1.3 50.2 3.4 0.0 0.0 1.1 0.4 0.6 32.7 0.5 1.0 1.3 0.3 1.8 3.6 2.3 0.0 1.4 0.0 0.0 1.5 0.0 21.4 13.7 1.5 0.0 25.3 3.5 0.0 0.0 0.0 0.1 0.3 0.0 15.8 0.0 0.0 0.0 0.1 2.2 0.7 6.6 2.2 3.5 4.3 6.5 0.1 0.0 1.0 0.6 0.2 0.1 0.3 COPZ1 "CGI-120, COPZ" ENSG00000111481 "COPI coat complex subunit zeta 1" P61923 12 54301202-54351846 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 70000 "prognostic unfavorable (7.84e-4)" "unprognostic (2.79e-1)" "unprognostic (4.51e-1)" "unprognostic (7.54e-3)" "unprognostic (1.46e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (6.40e-5)" "unprognostic (1.02e-2)" "unprognostic (3.56e-2)" "unprognostic (7.44e-3)" "unprognostic (1.18e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (2.16e-1)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (3.41e-2)" 70.3 102.0 69.8 51.5 69.7 58.7 96.3 69.6 87.1 86.5 79.9 84.5 74.8 73.7 126.4 107.9 91.0 56.3 98.0 69.4 70.5 96.5 116.4 74.7 69.0 68.9 69.4 67.8 73.6 152.5 107.3 106.5 84.2 68.6 76.8 103.6 105.1 105.8 69.3 105.3 75.8 69.1 79.9 69.6 75.5 90.1 36.1 69.8 97.1 116.3 91.1 94.6 73.9 69.3 71.9 135.4 212.1 149.8 133.2 179.8 234.7 96.5 109.3 166.9 149.9 110.6 122.9 185.5 103.1 180.6 165.9 96.3 102.0 265.0 183.7 181.1 137.0 153.5 99.8 181.8 190.6 183.9 133.3 89.9 172.8 250.0 183.2 294.8 257.5 206.8 103.2 221.7 202.1 199.7 177.3 158.7 141.5 109.2 204.2 160.0 121.8 96.4 145.8 225.7 123.5 140.3 112.5 113.2 197.7 147.2 139.6 274.7 210.0 131.7 92.0 96.8 90.7 108.0 82.6 112.1 100.7 172.5 110.4 164.9 97.5 127.3 95.0 93.6 117.7 100.3 86.4 86.2 84.8 128.0 86.2 69.9 75.2 42.9 114.7 134.6 151.6 116.7 134.7 69.8 69.7 69.6 87.1 69.4 70.5 68.9 69.4 67.8 68.6 69.6 69.8 71.9 54.3 57.7 73.3 15.3 64.4 28.7 71.9 137.9 47.8 51.0 91.6 72.0 77.2 68.6 105.7 68.0 22.9 175.3 73.3 62.5 273.9 152.2 19.8 66.8 73.6 58.1 66.9 58.5 13.5 115.6 273.9 73.8 63.7 74.5 87.5 100.9 50.7 95.1 173.1 48.8 15.4 141.4 85.5 64.3 42.6 25.4 62.7 78.8 53.4 7.5 150.5 86.3 76.2 14.6 13.7 113.9 74.0 57.2 132.5 100.9 118.0 208.0 92.8 75.4 19.7 35.8 57.1 64.2 60.2 66.6 35.9 202.2 62.0 99.8 87.5 95.3 TBC1D30 KIAA0984 ENSG00000111490 "TBC1 domain family member 30" Q9Y2I9 12 64759484-64881033 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;pancreas: 12.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 30.9;Inhibitory neurons: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 25.9;OE19: 11.9;RPMI-8226: 12.6;RT4: 12.8;SCLC-21H: 26.5;SK-BR-3: 16.7;T-47d: 14.5" "HPA039772, HPA040043" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA039772: AB_10795409, HPA040043: AB_10795411" "unprognostic (1.85e-1)" "unprognostic (6.95e-2)" "unprognostic (2.66e-1)" "prognostic favorable (3.61e-5)" "unprognostic (9.35e-2)" "unprognostic (2.09e-1)" "unprognostic (2.65e-5)" "prognostic favorable (5.08e-4)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.44e-1)" "unprognostic (9.72e-2)" "unprognostic (7.32e-2)" "unprognostic (7.62e-3)" "unprognostic (8.72e-2)" "unprognostic (2.67e-3)" "unprognostic (7.80e-3)" 1.5 1.1 1.0 1.0 2.7 0.3 2.3 4.9 10.2 3.0 1.1 1.4 1.8 1.4 1.8 0.6 1.5 1.8 0.5 5.5 2.8 1.7 1.2 2.3 0.4 6.1 1.8 2.3 0.9 12.1 2.4 6.4 0.6 7.1 3.0 1.5 2.2 6.9 2.7 0.3 0.7 1.6 0.9 0.9 2.0 3.9 1.9 2.9 0.3 1.5 0.3 0.3 3.3 1.3 8.6 5.1 1.0 0.5 0.3 0.1 0.6 0.7 0.0 0.0 0.1 0.0 4.3 1.8 0.1 0.9 0.1 0.3 0.1 5.3 0.2 0.0 0.0 3.8 0.3 1.4 0.1 0.0 4.0 0.8 0.3 0.1 0.0 0.0 0.6 3.8 1.2 0.0 2.0 0.3 25.9 0.0 0.6 1.1 11.9 5.2 0.2 0.1 12.6 0.9 12.8 26.5 1.8 1.4 16.7 0.3 0.3 14.5 1.4 4.2 0.0 0.9 0.9 2.5 0.0 0.0 0.1 0.1 0.4 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 2.7 4.9 10.2 5.5 2.8 6.1 1.8 2.3 7.1 0.9 2.9 8.6 5.1 0.0 6.3 4.9 0.6 0.9 4.6 0.9 0.0 9.3 7.2 3.8 0.6 5.7 4.5 3.7 8.4 0.7 1.5 2.5 9.8 3.9 14.2 2.2 0.8 6.5 0.0 0.0 30.9 4.9 0.3 0.7 3.6 4.2 8.9 0.8 1.8 0.3 1.6 0.0 42.8 6.4 6.1 4.0 6.2 1.9 0.3 3.0 5.4 12.2 1.2 2.6 0.0 1.5 2.0 2.7 4.9 0.0 0.6 9.1 3.9 2.3 1.8 0.6 0.0 0.6 1.0 3.7 3.0 0.3 1.4 0.1 0.8 0.4 4.4 8.7 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269358-67319953 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 5900000 "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 18.5 23.3 19.9 20.0 23.2 22.8 26.2 27.2 23.4 21.6 17.4 20.0 19.7 21.4 28.1 22.6 19.4 18.5 11.8 22.2 23.2 24.5 27.6 16.9 27.7 21.1 21.9 20.9 25.2 18.9 28.6 19.5 23.4 21.5 22.6 20.8 37.9 16.7 20.2 10.0 29.5 18.7 21.8 19.7 19.3 18.3 28.0 20.7 39.1 26.3 11.5 31.1 23.6 19.4 25.5 62.1 62.6 93.1 66.6 69.7 54.3 62.4 60.2 51.6 62.0 54.2 58.4 34.5 132.9 51.0 60.6 38.9 57.8 101.1 68.3 70.6 50.8 60.5 75.1 46.5 55.7 45.7 89.5 40.9 51.5 51.0 56.8 51.9 75.8 58.7 63.9 60.4 72.3 67.7 61.0 81.6 60.3 98.8 47.4 43.1 78.4 79.8 56.3 57.3 103.9 95.2 47.3 74.9 68.0 49.9 77.8 73.2 40.7 50.3 49.0 31.5 34.1 46.1 23.5 31.1 111.5 58.3 52.2 51.4 9.3 6.4 7.4 14.0 7.4 17.0 10.9 16.8 15.3 10.0 14.7 17.7 14.9 2.7 19.0 14.0 8.6 19.3 5.7 19.9 23.2 27.2 23.4 22.2 23.2 21.1 21.9 20.9 21.5 19.7 20.7 25.5 37.6 60.9 36.3 38.5 61.2 58.1 50.2 51.6 57.5 92.4 51.4 40.6 17.0 42.9 42.0 44.1 116.7 37.4 61.5 47.3 13.7 30.7 3.9 45.2 53.9 44.6 45.4 34.9 48.8 28.6 42.7 47.7 41.3 51.1 7.6 71.0 40.4 49.8 31.3 87.5 61.7 50.4 34.6 42.4 52.4 11.0 69.0 35.9 33.8 32.8 54.6 53.8 48.4 49.8 63.5 35.2 28.6 60.9 55.1 56.6 59.8 32.3 55.3 115.3 26.3 52.1 50.7 82.5 47.7 47.1 63.9 44.6 59.3 66.4 46.5 64.2 IL26 "AK155, IL-26" ENSG00000111536 "Interleukin 26" Q9NPH9 12 68201349-68225810 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.6;T-cells: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 35700 "unprognostic (2.71e-1)" "unprognostic (8.87e-2)" "unprognostic (3.26e-5)" "unprognostic (7.10e-2)" "unprognostic (5.90e-2)" "unprognostic (2.96e-1)" "unprognostic (3.69e-5)" "unprognostic (3.80e-1)" "unprognostic (5.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.79e-2)" 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 3.8 0.1 0.0 0.0 IFNG ENSG00000111537 "Interferon gamma" P01579 12 68154768-68159740 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense, Growth regulation" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 11.6;lymphoid tissue: 7.5" "Group enriched" "Detected in many" 12 "dendritic cells: 283.2;T-cells: 200.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 7 "T-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB010344 Approved "Secreted to blood" NA NA 1470 "CAB010344: AB_2123447" "unprognostic (2.16e-4)" "unprognostic (1.93e-3)" "unprognostic (9.21e-2)" "unprognostic (1.04e-4)" "unprognostic (5.14e-1)" "unprognostic (3.96e-3)" "unprognostic (1.33e-1)" "unprognostic (3.17e-4)" "unprognostic (7.79e-2)" "unprognostic (7.97e-3)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (7.62e-9)" "unprognostic (3.54e-2)" "unprognostic (5.36e-1)" "unprognostic (6.32e-2)" "unprognostic (7.38e-3)" 0.3 0.7 0.0 3.5 0.1 11.6 0.3 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.5 0.1 0.0 0.0 0.2 1.5 1.8 7.5 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.9 0.2 0.0 0.0 0.3 0.2 0.0 1.3 0.4 0.1 0.1 0.5 0.3 0.0 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 2.4 6.6 0.0 0.4 0.5 3.7 0.1 0.9 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.0 0.0 0.0 3.1 3.2 1.3 0.0 0.0 0.0 4.8 5.5 0.2 1.5 0.0 0.0 0.0 0.0 283.2 0.1 0.0 0.0 0.2 1.0 1.1 1.3 0.0 0.4 0.0 0.0 0.0 1.5 6.1 1.1 0.0 0.0 1.4 1.2 0.1 0.0 0.0 0.5 0.0 4.4 5.5 0.0 0.0 10.4 7.2 0.0 0.0 0.0 19.6 0.0 0.1 0.0 1.1 0.0 10.9 0.2 0.0 0.3 0.0 0.0 0.0 1.0 2.9 0.0 0.0 0.8 4.0 0.0 200.1 0.0 0.2 0.2 RAB5B ENSG00000111540 "RAB5B, member RAS oncogene family" P61020 12 55973913-55996683 "Predicted intracellular proteins, RAS pathway related proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010224, HPA068337" Approved Supported Vesicles NA NA Vesicles "CAB010224: AB_2175453, HPA068337: AB_2685974" "prognostic unfavorable (2.24e-5)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (7.66e-3)" "unprognostic (2.09e-1)" "unprognostic (8.42e-2)" "unprognostic (9.16e-3)" "unprognostic (3.09e-1)" "unprognostic (3.13e-1)" "unprognostic (8.31e-3)" "unprognostic (8.64e-2)" "unprognostic (2.26e-1)" "unprognostic (2.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.74e-1)" "unprognostic (2.85e-1)" "unprognostic (2.49e-1)" 50.2 55.0 96.6 39.8 99.7 35.3 68.9 105.3 97.6 77.5 76.6 72.3 52.9 74.5 93.3 100.7 76.4 56.3 88.0 93.8 99.4 70.7 69.4 73.6 44.8 106.3 107.0 91.3 86.2 48.3 113.0 31.7 64.0 105.2 75.2 81.4 73.5 62.2 95.5 101.5 88.3 50.8 80.6 108.0 48.5 67.6 57.6 101.9 64.6 65.2 128.8 76.7 66.2 70.2 113.3 62.3 39.1 80.2 59.4 128.5 115.9 72.1 56.1 102.3 68.3 57.5 67.5 76.7 34.7 65.5 107.6 50.3 44.8 51.4 77.8 63.3 44.1 39.5 39.3 53.1 38.6 94.5 33.2 61.6 94.9 142.7 64.2 54.2 153.0 87.0 42.2 36.2 99.3 87.3 42.3 42.6 51.9 35.8 51.5 35.2 36.5 49.9 45.1 128.2 100.7 40.0 35.6 73.1 72.4 89.0 88.3 104.6 102.5 72.3 44.5 32.5 32.8 22.2 56.4 46.9 21.8 71.5 30.7 38.4 18.5 10.1 32.6 11.1 9.3 10.3 8.9 9.0 9.9 8.0 6.9 10.2 8.0 27.4 7.6 10.6 8.0 7.6 8.9 96.6 99.7 105.3 97.6 93.8 99.4 106.3 107.0 91.3 105.2 108.0 101.9 113.3 24.4 57.7 37.1 13.1 26.7 51.7 26.5 34.0 35.3 33.3 54.4 38.2 53.2 55.8 34.0 42.3 52.1 44.0 29.1 88.1 35.2 49.4 11.1 24.1 22.8 30.8 38.9 29.8 21.4 37.1 42.8 33.1 37.2 33.9 19.7 34.1 42.1 86.0 31.1 16.8 23.4 51.1 16.2 46.4 52.3 27.7 53.4 25.4 35.6 11.2 64.7 41.6 32.0 11.1 26.3 71.3 44.4 59.5 27.1 57.0 44.7 35.9 23.9 31.6 59.2 31.9 33.2 36.8 25.6 64.7 89.2 88.0 25.0 23.4 42.7 65.8 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 44.0;Spermatocytes: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040411, HPA041594" Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 5.0 5.7 7.9 9.6 7.4 16.6 9.2 7.9 7.3 8.5 12.4 18.6 4.8 14.1 11.3 4.3 18.4 5.9 4.8 6.0 11.4 8.2 4.7 6.4 13.1 8.5 8.6 5.2 9.7 5.3 7.1 9.5 5.7 8.3 9.4 9.9 29.5 6.4 14.0 3.1 3.7 7.1 13.1 10.2 9.4 6.7 20.8 6.9 15.4 10.1 3.3 13.1 11.0 6.4 8.9 8.4 6.9 13.0 12.7 6.3 8.5 10.0 11.0 6.1 17.2 15.7 8.3 3.8 19.3 7.1 5.0 8.4 8.6 9.0 5.9 19.4 25.4 8.6 42.5 9.1 5.7 9.8 23.8 16.1 3.9 7.6 11.6 11.2 9.3 9.9 21.9 8.2 21.1 10.0 6.1 33.7 16.7 6.9 8.3 8.4 32.8 11.7 5.7 8.2 7.3 11.8 6.3 10.6 6.3 11.1 10.3 15.1 16.9 5.2 13.7 6.0 8.7 10.3 10.9 34.0 13.3 7.2 15.3 8.9 9.9 5.1 15.0 5.0 12.0 8.1 7.5 6.5 5.2 4.4 6.9 7.6 6.2 3.3 7.2 19.4 2.5 6.7 5.7 7.9 7.4 7.9 7.3 6.0 11.4 8.5 8.6 5.2 8.3 10.2 6.9 8.9 8.3 3.2 4.6 14.0 12.9 4.8 3.9 5.3 5.2 16.0 8.0 9.0 10.8 2.8 6.8 7.3 0.0 4.7 13.2 2.8 9.8 4.8 26.0 35.4 16.0 6.6 2.4 25.2 12.5 3.5 4.2 5.7 5.6 5.3 7.0 12.0 6.1 4.9 6.3 8.4 11.7 2.8 10.2 4.7 5.1 13.5 9.0 14.5 16.0 8.4 7.3 25.7 18.6 9.5 18.7 3.0 4.7 13.5 9.3 1.8 1.8 10.4 44.0 34.6 6.6 7.4 8.2 56.3 22.3 6.3 4.1 0.3 13.9 8.6 4.9 1.7 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686951-68745809 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 14.0 11.2 4.8 18.0 6.3 24.2 18.0 8.2 6.0 12.9 6.3 13.1 10.4 16.8 14.4 10.8 13.7 9.4 11.5 4.6 5.4 10.7 11.9 12.9 26.0 5.3 5.7 4.3 16.5 9.4 11.9 6.8 13.9 5.9 12.1 16.4 14.9 10.4 12.3 11.8 15.9 13.0 14.2 5.6 15.9 11.1 21.1 5.4 25.8 10.4 12.2 25.7 12.5 10.8 7.7 53.1 66.8 77.8 56.7 22.6 28.6 84.1 56.6 32.4 83.0 68.9 67.6 43.7 96.3 53.7 27.2 36.9 59.4 88.4 41.7 109.8 90.8 65.6 110.1 46.2 57.4 14.2 97.9 35.6 15.2 19.4 66.5 43.2 29.0 50.3 54.9 133.7 67.3 52.8 64.3 81.3 85.2 85.8 20.3 64.6 81.9 93.6 57.8 36.1 55.3 45.7 46.9 62.7 46.5 34.4 60.4 69.8 46.7 31.1 45.0 45.8 53.0 69.9 29.2 62.2 115.2 34.7 70.2 54.2 10.5 9.2 14.4 17.7 12.5 23.4 18.7 17.5 19.3 10.2 18.7 21.5 19.5 2.4 30.5 23.2 8.1 20.0 11.8 4.8 6.3 8.2 6.0 4.6 5.4 5.3 5.7 4.3 5.9 5.6 5.4 7.7 18.3 12.8 17.7 13.7 38.1 17.3 18.4 28.1 25.0 23.8 12.5 11.4 13.5 12.8 18.9 9.2 18.8 30.7 30.3 12.2 11.7 22.8 45.3 12.6 18.2 20.6 8.5 64.4 23.8 17.6 30.8 19.6 16.3 10.2 15.8 35.6 15.4 7.0 17.5 13.5 20.1 12.6 42.7 13.9 16.2 9.6 38.8 18.3 19.6 15.9 27.0 16.7 36.0 21.6 34.3 22.1 9.9 21.8 22.9 19.4 10.5 6.4 21.9 29.6 13.1 18.4 18.2 89.4 51.9 18.7 17.6 14.1 27.0 24.5 16.8 12.5 CNOT2 "CDC36, NOT2, NOT2H" ENSG00000111596 "CCR4-NOT transcription complex subunit 2" Q9NZN8 12 70243002-70354993 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067711 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067711: AB_2685893" "unprognostic (5.00e-2)" "unprognostic (2.12e-1)" "unprognostic (6.95e-2)" "unprognostic (3.60e-2)" "unprognostic (3.48e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.36e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.32e-1)" "unprognostic (9.70e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.28e-1)" "unprognostic (5.58e-2)" "unprognostic (5.97e-2)" "unprognostic (6.23e-2)" 30.1 25.9 25.7 31.5 34.1 79.2 35.3 68.0 31.0 29.5 28.0 31.9 30.4 34.6 34.8 24.6 29.3 27.5 24.2 26.6 49.3 29.0 35.1 29.7 40.8 35.6 30.7 25.0 35.5 24.3 32.7 23.6 32.3 39.6 28.0 34.8 46.6 26.2 27.3 33.7 50.7 31.1 30.7 31.2 36.1 25.9 26.4 33.3 50.5 31.0 34.1 43.1 33.1 28.2 45.7 46.2 44.5 70.7 45.3 38.5 42.8 60.1 49.2 59.5 53.8 46.1 55.8 42.1 100.2 45.1 57.4 33.8 43.9 50.2 49.1 59.7 47.1 50.2 66.4 38.8 55.7 40.7 84.3 54.6 50.1 52.4 50.5 59.1 78.7 59.0 61.5 61.9 55.4 47.2 52.4 95.7 61.0 61.0 46.1 46.4 75.1 59.9 61.1 50.7 93.2 50.6 55.7 59.1 46.4 45.6 60.5 59.1 68.4 44.7 50.2 33.6 45.8 40.7 50.3 59.5 77.3 52.5 42.3 41.9 92.8 49.2 57.6 50.1 69.4 56.6 54.0 54.7 58.9 60.3 51.5 62.6 67.6 30.3 62.6 58.5 44.4 55.8 56.3 25.7 34.1 68.0 31.0 26.6 49.3 35.6 30.7 25.0 39.6 31.2 33.3 45.7 71.1 41.7 43.2 76.7 79.8 51.1 37.7 45.4 47.3 64.4 40.9 38.0 30.1 58.6 45.6 36.8 56.3 45.3 144.3 50.2 33.2 49.5 44.5 47.8 55.8 55.4 58.0 49.2 110.9 44.7 47.4 57.4 41.3 62.2 76.5 60.1 46.4 34.6 40.3 52.2 115.8 39.0 44.7 55.1 46.7 12.6 45.7 62.7 32.0 86.2 46.3 54.3 56.7 123.6 204.0 45.8 44.4 46.6 77.9 45.4 45.2 30.3 44.7 54.8 39.5 72.3 64.5 53.8 44.7 46.7 64.1 35.4 94.2 50.4 39.2 48.9 TIMELESS "hTIM, TIM, TIM1" ENSG00000111602 "Timeless circadian regulator" Q9UNS1 12 56416363-56449426 "Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 57.5;Spermatogonia: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA060655 Enhanced Supported Nucleoplasm No No Nucleoplasm "HPA060655: AB_2684338" "unprognostic (3.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-2)" "unprognostic (2.18e-2)" "unprognostic (2.36e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.06e-5)" "unprognostic (7.03e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (9.47e-3)" "unprognostic (1.72e-1)" "unprognostic (1.92e-2)" "unprognostic (5.01e-2)" 3.4 3.5 1.7 11.1 2.1 22.2 4.6 2.1 2.1 4.1 2.5 6.8 6.1 4.4 2.5 6.9 3.1 3.4 1.8 1.4 2.3 3.8 9.9 4.1 15.4 2.3 2.3 1.3 2.0 5.1 6.0 5.4 8.7 2.5 3.2 8.6 13.8 3.9 3.4 3.4 5.5 6.3 5.6 2.0 6.8 5.5 6.3 2.4 20.0 4.7 1.7 18.0 4.7 4.0 2.4 39.4 89.1 111.4 51.9 9.9 9.9 62.8 41.9 25.3 58.3 46.0 45.6 56.5 113.3 41.5 24.5 29.4 32.8 82.0 32.7 53.5 54.2 45.7 86.9 47.6 33.6 5.1 66.2 62.2 6.9 10.3 41.9 25.2 16.0 31.5 67.3 82.7 99.5 49.8 77.2 94.7 51.2 79.2 49.5 36.8 93.5 56.7 55.5 22.7 49.5 85.4 58.9 78.2 43.9 12.2 45.6 77.4 51.8 18.9 45.3 45.1 41.8 35.0 37.3 50.9 62.8 21.1 39.9 55.5 0.1 0.6 0.4 1.8 1.5 0.3 3.3 1.1 1.2 1.0 4.9 0.8 0.3 0.2 1.5 1.1 1.2 1.5 1.1 1.7 2.1 2.1 2.1 1.4 2.3 2.3 2.3 1.3 2.5 2.0 2.4 2.4 2.6 0.0 5.0 2.3 8.2 3.3 3.0 3.0 6.8 57.5 3.1 3.4 2.1 2.8 6.8 7.3 2.1 15.9 1.8 2.7 0.0 4.8 6.9 2.5 3.9 5.0 1.8 16.6 0.9 5.7 20.9 3.7 6.6 4.8 5.7 15.5 4.6 10.6 8.5 6.7 1.3 5.2 4.1 2.6 3.7 2.9 1.2 4.6 0.0 1.9 4.2 4.8 4.1 0.5 3.2 3.7 0.6 1.2 18.2 4.2 1.1 2.0 3.4 17.8 0.0 2.7 7.0 1.6 24.5 12.1 1.4 9.2 6.1 3.2 8.5 3.0 CPSF6 "CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7" ENSG00000111605 "Cleavage and polyadenylation specific factor 6" Q16630 12 69239569-69274358 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039973 Supported Enhanced "Nucleoplasm,Nuclear speckles" No No "Nucleoplasm, Nuclear speckles" "HPA039973: AB_10795242" "unprognostic (1.50e-1)" "unprognostic (3.33e-2)" "unprognostic (4.37e-3)" "unprognostic (5.47e-2)" "unprognostic (4.24e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.91e-6)" "unprognostic (6.82e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.20e-1)" "unprognostic (7.63e-2)" "unprognostic (2.05e-1)" "unprognostic (7.41e-2)" 23.6 26.5 15.7 36.1 14.1 72.6 24.0 32.2 17.0 26.8 2.1 24.1 26.4 28.6 38.9 28.0 25.6 18.5 21.2 15.8 9.6 19.4 20.8 22.7 47.3 8.6 7.7 11.0 40.8 24.1 28.5 26.7 25.2 13.6 23.3 25.1 43.9 26.2 20.4 28.1 24.7 25.6 23.9 6.6 27.4 26.9 22.5 10.3 44.0 26.8 17.2 41.1 25.9 25.5 13.5 97.5 80.3 115.7 81.7 43.8 49.7 87.1 62.7 74.1 87.3 82.0 83.8 64.8 153.6 62.6 63.9 48.5 89.2 114.5 73.7 92.3 101.4 78.1 124.3 85.7 97.1 65.4 170.1 87.1 60.0 57.2 70.4 28.7 58.2 68.3 90.6 130.1 159.6 73.3 112.9 159.9 110.3 112.3 80.4 67.8 159.9 91.6 108.2 68.9 113.4 97.0 85.4 83.7 77.7 88.9 68.8 93.2 118.5 79.1 65.4 80.0 62.6 104.5 101.9 88.5 190.9 53.1 97.5 85.9 44.3 26.0 29.9 27.9 32.6 29.5 32.8 30.8 29.1 39.0 28.9 23.4 28.2 7.7 30.2 28.7 27.8 47.2 19.7 15.7 14.1 32.2 17.0 15.8 9.6 8.6 7.7 11.0 13.6 6.6 10.3 13.5 29.1 12.8 24.9 53.2 49.9 76.0 46.7 55.7 43.3 56.5 30.0 24.5 31.7 30.0 39.9 18.4 37.5 64.6 51.1 22.5 37.2 59.6 18.7 35.6 40.2 35.0 52.5 47.1 97.6 56.8 85.7 36.6 33.6 37.9 34.9 54.0 23.6 23.0 39.5 89.2 115.4 32.6 75.3 29.3 39.7 19.8 56.8 37.1 24.9 53.4 53.5 37.8 45.3 137.2 126.0 61.1 23.3 53.0 56.3 37.4 25.4 26.6 28.0 45.8 39.5 37.4 56.0 68.1 69.4 43.9 59.1 51.2 38.5 54.1 36.2 51.5 KRR1 "HRB2, RIP-1" ENSG00000111615 "KRR1 small subunit processome component homolog" Q13601 12 75490863-75511636 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043433, HPA051690" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA043433: AB_10960988, HPA051690: AB_2681574" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (8.21e-2)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" "unprognostic (4.71e-2)" "unprognostic (6.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.38e-1)" "unprognostic (5.85e-2)" "unprognostic (1.88e-1)" "unprognostic (2.32e-2)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-2)" 15.4 14.4 6.0 15.8 6.1 44.3 16.9 8.5 10.5 11.7 7.1 12.6 12.2 15.1 9.0 16.2 9.9 10.1 11.9 6.1 7.5 16.3 20.6 11.6 19.1 5.7 6.2 5.4 15.1 10.8 20.5 8.1 14.6 6.3 13.3 11.0 16.1 19.5 9.9 23.8 12.8 10.4 11.0 6.4 12.7 12.8 12.1 6.4 18.0 15.0 22.9 18.1 16.0 9.9 7.4 59.4 48.1 29.2 27.1 21.8 20.1 54.1 51.0 31.7 38.5 24.8 35.7 30.7 62.2 40.3 23.9 39.0 30.5 39.1 43.0 42.4 52.0 39.9 60.9 25.0 41.8 26.4 107.0 37.1 21.3 35.8 44.8 41.7 39.1 26.6 57.4 67.7 19.8 38.2 39.2 63.1 30.8 43.6 32.4 42.4 49.9 56.1 37.4 42.6 73.6 35.4 29.6 48.0 33.7 59.5 27.9 56.2 42.9 34.4 36.2 24.1 37.7 53.2 38.8 52.3 39.0 19.6 37.0 66.2 13.3 3.2 13.2 13.1 6.5 16.4 23.0 18.3 15.0 5.5 20.6 18.6 17.9 1.5 12.9 5.5 15.3 18.2 7.6 6.0 6.1 8.5 10.5 6.1 7.5 5.7 6.2 5.4 6.3 6.4 6.4 7.4 62.9 70.5 49.2 13.4 64.0 49.1 104.3 70.3 48.9 56.4 41.1 50.5 25.6 24.3 55.7 40.5 33.3 68.5 86.4 18.7 58.7 50.9 5.4 52.5 63.8 46.7 18.0 55.8 25.3 49.0 55.7 48.2 21.4 62.6 38.0 41.3 31.1 40.9 29.5 74.0 24.3 25.7 46.8 24.2 21.3 7.6 52.5 30.0 12.4 6.5 42.4 66.4 66.9 19.1 16.3 42.8 28.1 53.4 37.9 45.6 19.2 47.0 42.3 55.5 13.1 79.2 50.2 72.6 61.1 46.8 44.3 70.5 65.4 59.6 29.3 63.2 MRPL51 "bMRP64, CDA09, HSPC241, MRP64" ENSG00000111639 "Mitochondrial ribosomal protein L51" Q4U2R6 12 6491886-6493841 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 950.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039923 Approved Supported Mitochondria NA NA Mitochondria "HPA039923: AB_10795373" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (3.81e-3)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.62e-1)" "unprognostic (1.17e-1)" "unprognostic (8.33e-2)" 85.7 129.2 158.3 77.8 164.3 88.8 83.9 168.4 241.8 82.4 159.3 112.9 66.1 80.9 100.2 147.3 83.1 49.8 215.5 157.8 165.7 133.7 159.8 76.5 105.4 165.7 161.8 154.0 79.6 120.7 129.3 110.1 70.6 165.7 106.7 92.3 65.0 87.7 64.3 265.2 88.6 86.6 71.6 166.3 100.4 113.2 235.1 162.3 132.6 91.4 242.6 127.7 105.1 91.5 172.8 263.4 286.8 334.5 244.1 235.8 212.8 390.6 187.7 222.5 277.1 258.1 398.4 325.4 376.3 124.4 278.2 330.2 220.8 272.4 298.1 409.8 456.3 294.7 256.3 415.2 340.8 217.7 352.4 206.2 205.7 237.2 251.1 331.4 357.9 265.4 291.0 186.1 114.0 356.2 374.3 356.7 463.3 707.1 471.1 287.1 248.2 384.5 264.8 232.6 319.7 126.4 222.2 320.9 355.8 305.4 662.7 107.6 323.7 218.1 226.0 318.5 188.8 406.3 109.0 177.7 850.0 279.8 243.3 305.6 224.5 202.0 231.8 181.6 196.4 206.8 229.3 193.2 201.4 234.6 211.9 196.4 201.4 77.5 203.3 197.8 318.4 234.4 294.0 158.3 164.3 168.4 241.8 157.8 165.7 165.7 161.8 154.0 165.7 166.3 162.3 172.8 98.5 105.8 77.4 11.4 113.8 136.1 167.4 410.5 131.5 47.1 180.4 265.8 302.6 178.7 195.4 171.0 12.5 277.1 111.8 126.2 469.5 239.1 950.6 159.7 159.1 129.5 149.9 152.5 9.6 277.8 404.4 146.6 65.7 122.2 92.6 202.3 144.2 374.1 263.9 43.7 10.0 188.3 244.1 147.6 117.9 523.6 153.1 109.4 193.9 10.3 301.6 133.8 121.5 7.1 16.1 247.4 160.3 147.8 171.9 250.0 153.9 538.2 157.5 47.5 111.7 132.7 155.7 534.2 195.4 188.4 157.0 215.5 98.1 244.4 221.2 182.8 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6534512-6538374 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 27843.4;tongue: 19060.0" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 10357.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "CAB005197, CAB016392, HPA040067, HPA061280, CAB079968" Supported Enhanced "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" No No 1400000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavorable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 1223.3 1830.7 2425.0 1202.0 2429.9 4649.7 1051.3 2633.9 3091.6 1047.4 2181.4 1707.6 1494.2 1090.0 776.7 2997.7 1051.9 1171.9 5061.7 2400.7 2602.7 2316.2 2578.9 1147.8 1399.6 2614.1 2544.6 2305.0 1096.1 657.5 1629.3 1349.1 1200.5 2610.7 1251.6 1601.8 2407.5 1850.8 1250.2 27843.4 1693.2 1469.7 1436.8 2486.7 1218.2 1225.6 698.4 2836.9 1585.4 1030.5 19060.0 1876.1 1905.1 1686.9 2649.4 6063.0 10247.9 3109.5 4709.2 3026.2 5018.7 6516.0 4716.2 7218.1 7172.8 7491.2 7211.3 4091.6 7540.8 878.2 5947.4 4904.2 3359.8 3372.7 10829.1 5432.4 6263.1 3229.5 4224.9 5857.5 6279.2 3890.9 6710.2 3046.1 4089.0 3521.7 6553.0 7609.7 15565.8 7762.7 5052.4 2215.9 1484.1 8670.0 11849.8 7303.1 3247.3 10995.7 7254.7 3950.7 5849.8 5505.7 3512.8 7909.6 7115.9 2088.3 3331.0 4243.1 10206.4 5984.0 8874.7 1657.2 4311.2 4794.3 5049.0 5907.2 2717.1 7931.5 3178.4 2544.6 9374.4 10632.2 4050.5 8040.5 2575.4 4295.8 737.9 1325.8 2011.2 1171.4 1046.9 1364.8 1333.1 3253.6 652.5 757.6 886.9 1981.4 1227.8 1900.6 474.6 2126.1 6812.0 2425.0 2429.9 2633.9 3091.6 2400.7 2602.7 2614.1 2544.6 2305.0 2610.7 2486.7 2836.9 2649.4 1036.7 237.2 259.5 228.2 1086.9 1818.8 2223.4 7367.5 4070.9 1157.6 1794.6 3689.2 40.4 1263.9 2213.7 1022.5 417.0 4237.7 1032.7 2579.6 3463.0 5198.9 759.8 770.1 702.4 1597.4 1324.3 1180.6 112.1 3794.5 10357.8 1127.1 1068.8 1021.8 562.3 2063.7 1242.9 1742.3 3895.3 2348.7 145.8 2351.2 2543.1 2586.7 2494.4 2257.7 889.4 2134.0 4220.8 86.2 3422.3 6177.9 1045.4 98.5 196.2 5681.8 3001.4 1026.9 2668.2 1714.0 5714.0 7286.7 864.3 1435.2 1150.4 1744.7 2827.8 429.9 476.2 3605.2 1600.7 4694.0 1514.9 1839.0 3140.9 2882.4 NOP2 "NOL1, NOP120, NSUN1, p120" ENSG00000111641 "NOP2 nucleolar protein" P46087 12 6556863-6568691 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040119 Supported Enhanced Nucleoli No No Nucleoli "HPA040119: AB_10965321" "unprognostic (2.88e-1)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (7.15e-2)" "unprognostic (8.74e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (6.38e-2)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (2.53e-1)" "prognostic unfavorable (2.35e-10)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-3)" 23.8 22.8 15.5 22.8 15.8 35.0 20.0 16.0 18.6 20.0 15.3 19.8 14.3 21.0 10.3 28.9 21.4 11.0 17.6 15.8 16.5 16.7 27.0 20.8 28.5 15.6 15.0 15.7 20.4 21.8 10.0 21.4 12.3 15.7 25.3 14.3 6.7 19.3 8.7 42.5 24.5 24.7 14.9 15.4 32.6 20.7 23.3 16.0 23.0 23.7 12.4 29.0 21.9 21.2 15.9 69.0 107.2 29.5 101.8 37.4 32.1 159.8 61.4 40.4 71.8 61.6 130.5 69.0 144.7 16.7 30.8 75.5 84.9 113.9 69.6 68.0 175.3 105.2 143.7 110.8 78.5 49.0 141.2 79.9 33.0 67.3 87.9 135.8 31.3 50.2 76.9 102.7 22.8 58.1 83.7 77.1 124.7 247.6 93.6 59.9 108.4 84.1 72.8 53.1 92.1 22.7 44.5 94.1 102.5 50.2 116.2 17.1 70.4 47.6 49.1 64.1 63.7 143.2 31.2 49.7 217.9 45.0 81.3 88.6 2.4 14.0 1.5 23.6 19.5 32.7 21.0 22.4 27.1 28.7 15.8 27.2 28.2 5.1 22.2 19.0 24.8 16.8 19.9 15.5 15.8 16.0 18.6 15.8 16.5 15.6 15.0 15.7 15.7 15.4 16.0 15.9 3.9 12.8 6.8 7.8 20.5 23.8 17.7 12.9 47.8 5.8 6.0 4.4 6.8 5.7 6.4 3.7 2.1 12.6 6.6 13.1 1.9 12.0 17.9 4.2 4.4 11.4 7.2 19.4 9.1 11.8 13.4 10.3 26.0 4.3 7.6 1.4 7.9 8.3 11.8 6.7 7.3 11.1 16.2 7.7 15.7 7.3 9.3 11.7 8.8 2.8 7.7 3.0 18.6 5.5 5.7 13.5 5.3 4.9 19.2 19.2 2.1 1.3 5.2 2.9 13.1 22.7 9.7 11.3 21.4 43.4 21.3 7.3 16.2 1.2 16.4 16.7 CHD4 "Mi-2b, Mi2-BETA" ENSG00000111642 "Chromodomain helicase DNA binding protein 4" Q14839 12 6570082-6614524 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA012008 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012008: AB_1846633" "unprognostic (6.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.71e-2)" "unprognostic (6.40e-3)" "unprognostic (8.99e-2)" "unprognostic (3.36e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (9.84e-2)" "unprognostic (1.66e-1)" 33.8 46.0 22.3 38.9 29.3 44.8 32.2 25.2 30.4 39.5 20.4 41.4 26.7 48.2 45.3 35.7 38.0 31.4 39.6 19.3 25.4 39.6 31.9 35.6 46.7 28.9 29.6 12.4 41.2 38.0 58.8 33.8 42.5 35.0 28.6 35.7 45.3 34.1 44.5 50.4 44.6 35.8 50.4 23.7 39.3 38.8 34.5 27.9 91.5 55.1 39.0 57.0 42.6 34.6 27.8 86.7 79.7 187.6 72.1 76.6 84.7 110.4 92.9 93.4 102.3 93.5 130.6 66.6 184.9 36.0 107.5 66.1 76.0 179.1 104.5 135.7 139.9 92.7 258.5 122.0 83.3 67.1 207.2 119.1 82.9 51.7 99.1 68.7 128.2 122.2 101.6 209.0 91.0 98.7 111.8 196.6 67.8 184.7 82.5 72.7 166.4 114.9 103.6 64.2 101.6 88.8 114.6 121.1 136.0 92.9 205.4 61.3 121.3 114.4 103.4 217.4 76.3 111.5 144.0 91.8 230.2 68.7 125.8 79.5 12.3 6.8 8.7 9.3 7.7 9.6 8.8 8.4 9.3 6.9 11.3 10.6 10.3 10.8 12.2 8.0 14.4 15.9 5.6 22.3 29.3 25.2 30.4 19.3 25.4 28.9 29.6 12.4 35.0 23.7 27.9 27.8 68.2 60.9 119.7 56.2 82.8 68.6 47.4 42.4 76.2 109.9 77.5 61.2 132.9 58.6 67.2 88.3 70.9 48.2 106.0 58.1 13.7 84.6 76.4 128.1 153.3 78.9 97.1 64.4 26.1 71.9 46.1 67.7 47.9 123.7 85.9 73.0 56.0 69.2 69.0 139.7 21.4 66.6 54.9 51.9 78.3 59.1 65.9 68.9 48.0 25.3 66.7 71.4 56.7 24.6 55.5 95.8 36.4 74.4 69.0 49.4 45.8 38.3 82.1 57.8 52.6 112.1 98.1 102.6 111.6 78.9 67.6 68.0 85.1 83.7 72.1 47.4 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "testis: 285.8" "Cell type enhanced" "Detected in many" "Early spermatids: 1097.8;Late spermatids: 723.5;Macrophages: 220.0;Spermatocytes: 387.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;intermediate monocyte: 15.8;myeloid DC: 17.7;non-classical monocyte: 31.0" "Group enriched" "Detected in many" 9 "dendritic cells: 17.7;monocytes: 31.0" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 6.7;U-266/70: 15.0;U-266/84: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Secreted in male reproductive system" NA NA "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 2.2 0.9 1.2 3.9 1.3 10.8 1.1 2.0 1.6 1.9 1.4 2.9 8.5 1.4 14.3 0.9 2.1 4.1 0.6 1.0 1.3 1.8 2.2 2.9 5.5 1.5 1.1 0.8 0.7 2.9 0.3 0.9 2.3 1.3 2.0 2.1 1.8 1.3 1.1 0.4 1.7 8.2 2.2 1.1 9.2 1.9 285.8 1.2 3.1 13.9 0.4 3.6 2.4 0.9 2.4 0.2 0.1 0.8 2.5 0.8 1.2 1.3 0.0 0.0 0.1 0.1 0.0 1.8 0.3 0.8 0.2 0.1 0.0 0.4 0.0 0.2 0.8 0.0 5.3 0.6 0.0 1.8 0.1 6.7 0.1 3.3 0.9 0.1 0.6 0.6 1.7 3.5 0.0 0.1 0.3 0.2 1.9 1.5 4.3 0.0 0.3 0.1 0.3 0.5 0.1 1.0 0.3 0.0 0.7 1.1 1.2 0.0 1.9 0.7 0.1 0.8 0.5 0.0 15.0 10.5 0.5 0.5 2.0 0.0 1.5 12.5 1.2 0.2 15.8 0.0 1.3 0.0 0.0 17.7 1.9 0.2 0.1 2.6 0.7 31.0 4.5 0.0 10.6 1.2 1.3 2.0 1.6 1.0 1.3 1.5 1.1 0.8 1.3 1.1 1.2 2.4 0.3 0.0 1.3 0.7 1.5 0.1 0.1 0.0 1.2 1.7 0.5 0.5 1.0 0.0 0.1 0.0 0.0 0.1 1.9 0.9 0.0 0.2 1097.8 0.7 0.5 1.5 0.0 5.7 0.2 0.5 0.3 0.5 0.0 0.8 6.3 0.4 1.8 0.3 9.8 0.0 0.3 0.8 0.0 20.5 3.4 723.5 8.1 220.0 0.0 1.0 7.6 1.1 10.3 0.0 0.4 0.1 1.6 4.5 0.5 0.0 7.6 1.1 0.2 1.3 6.6 0.3 0.2 387.5 7.5 0.3 0.0 0.1 1.0 0.4 1.1 0.1 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142874 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 8.7 11.0 4.4 10.2 7.3 33.2 8.9 10.9 11.6 7.2 8.3 8.4 8.5 7.6 7.0 7.1 6.4 8.9 8.0 12.9 5.7 12.4 24.8 7.8 9.3 4.7 5.4 5.7 7.6 3.8 13.7 5.3 9.1 5.8 9.0 7.9 14.7 6.4 8.1 20.0 5.9 7.1 8.9 4.1 9.3 6.1 14.2 3.9 8.5 11.0 14.7 7.0 10.2 5.2 8.6 18.6 19.7 10.8 11.2 16.4 23.1 21.6 28.3 28.4 22.4 16.3 14.8 6.2 16.0 7.2 29.1 13.1 6.9 20.4 9.7 21.5 42.7 10.0 10.7 14.1 17.3 15.1 20.4 16.8 13.1 8.0 27.0 18.6 20.7 16.0 11.0 8.6 16.2 22.1 10.3 13.1 17.5 18.7 6.3 17.7 14.7 19.2 15.7 11.4 32.2 18.3 11.4 21.4 24.5 8.5 9.2 21.9 23.0 12.7 24.6 13.2 21.5 20.1 19.1 35.2 22.3 12.4 15.1 15.2 21.6 11.4 7.8 3.6 12.3 5.3 5.5 4.0 4.1 12.8 4.5 3.4 4.2 33.9 5.9 10.9 7.6 5.2 5.4 4.4 7.3 10.9 11.6 12.9 5.7 4.7 5.4 5.7 5.8 4.1 3.9 8.6 10.6 28.9 8.7 27.1 18.2 12.7 17.2 5.0 19.9 11.9 9.3 7.5 15.7 1.5 12.6 9.2 4.2 4.7 15.0 10.9 5.9 6.0 35.1 15.7 23.7 8.6 5.4 9.4 75.2 5.9 8.9 24.7 7.7 9.9 24.1 6.3 5.3 18.5 11.2 15.2 54.2 2.1 4.1 23.3 21.4 5.3 7.2 29.5 10.6 45.0 25.7 8.3 8.2 37.2 29.5 5.9 7.4 7.9 12.5 18.5 8.9 14.9 21.8 12.0 0.0 23.3 15.1 24.1 19.1 14.9 11.6 10.9 15.7 8.3 5.7 11.9 COPS7A CSN7A ENSG00000111652 "COP9 signalosome subunit 7A" Q9UBW8 12 6724014-6731875 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026915 Supported Supported Nucleoplasm,Cytosol NA NA 54000 Nucleoplasm Cytosol "HPA026915: AB_1847156" "unprognostic (3.50e-1)" "unprognostic (1.33e-2)" "unprognostic (3.95e-3)" "unprognostic (3.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.96e-3)" "unprognostic (3.91e-2)" "unprognostic (4.26e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" 45.4 53.2 69.8 33.2 68.8 19.9 36.4 69.6 72.3 33.2 63.6 39.9 30.2 39.5 47.1 55.7 45.1 33.0 79.8 70.0 69.0 48.6 53.7 35.0 30.1 72.7 71.2 68.1 35.1 40.6 72.5 51.5 43.1 71.6 43.2 30.4 47.2 44.9 40.5 104.6 39.6 29.3 43.5 65.5 33.6 41.6 24.2 77.7 23.0 46.2 99.0 30.7 46.2 38.8 74.5 73.3 78.8 34.0 33.3 96.3 114.0 84.9 93.2 107.8 87.6 86.7 54.3 95.0 47.1 37.1 111.2 49.9 55.9 45.7 86.6 75.5 70.3 57.8 47.0 50.1 63.9 84.6 47.1 28.3 106.7 80.6 97.5 183.4 100.1 61.8 29.2 33.3 18.1 116.0 58.7 29.5 30.3 92.9 91.4 64.1 18.8 71.9 47.2 69.0 69.0 19.4 47.2 58.4 67.5 97.2 79.5 29.9 68.0 70.1 90.8 48.4 82.3 85.6 21.0 24.7 38.4 150.6 60.0 104.7 85.9 56.4 86.1 36.3 73.2 35.8 26.2 30.7 32.2 65.3 36.0 30.2 29.8 43.7 31.0 58.9 41.3 30.9 49.9 69.8 68.8 69.6 72.3 70.0 69.0 72.7 71.2 68.1 71.6 65.5 77.7 74.5 23.7 16.0 17.5 17.0 14.7 13.9 31.4 39.8 25.0 37.0 29.1 27.6 36.7 22.8 28.0 23.9 6.2 72.6 11.7 15.7 66.5 47.8 4.3 21.4 28.0 23.4 12.6 17.0 13.0 49.7 58.2 34.8 13.7 22.9 16.5 13.0 22.9 26.3 63.2 30.3 15.3 18.6 69.2 24.2 14.4 6.5 23.0 26.1 12.4 5.6 50.0 51.4 13.4 11.1 11.9 49.8 18.6 25.6 16.2 34.3 22.3 47.3 23.8 23.8 39.5 21.7 33.2 16.9 40.6 39.2 13.9 59.1 12.6 40.6 17.1 30.7 ING4 "my036, p29ING4" ENSG00000111653 "Inhibitor of growth family member 4" Q9UNL4 12 6650301-6663142 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Chromatin regulator" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031817, HPA057338" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA031817: AB_2674056, HPA057338: AB_2683412" "unprognostic (2.95e-1)" "unprognostic (1.92e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (9.44e-2)" "unprognostic (5.76e-3)" "unprognostic (1.65e-2)" "prognostic favorable (5.16e-4)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (7.66e-3)" "unprognostic (1.52e-1)" "unprognostic (4.32e-2)" "unprognostic (1.31e-1)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (1.42e-2)" 20.9 26.6 45.1 15.7 45.9 11.7 28.2 47.3 52.2 34.1 42.2 30.2 18.1 27.6 31.0 23.0 27.6 18.2 21.7 45.6 45.6 28.9 26.0 18.8 27.8 46.4 45.5 44.7 31.5 19.8 32.2 27.9 21.8 46.2 33.3 22.0 22.5 26.1 23.3 19.5 31.1 27.0 22.7 46.4 38.0 27.1 20.6 45.9 38.9 35.2 24.1 24.7 29.7 27.4 50.7 9.2 12.3 35.8 17.0 27.3 26.9 22.9 12.0 19.4 19.6 23.4 5.6 41.1 15.9 7.8 16.8 15.6 14.3 17.8 14.1 21.7 31.1 26.4 22.9 22.5 11.5 16.0 9.1 10.4 27.3 32.3 10.4 13.3 63.4 29.8 30.6 10.9 8.9 19.0 6.6 33.2 13.9 52.8 20.3 11.7 30.9 18.8 17.0 24.7 10.4 14.7 38.3 18.6 6.2 23.2 51.5 8.2 25.0 22.7 8.1 16.1 9.1 7.9 10.7 15.6 21.6 21.6 14.0 8.3 32.2 31.1 26.8 33.5 43.5 31.2 30.9 27.8 28.7 34.3 48.2 37.9 32.9 20.1 38.0 51.0 26.5 30.9 37.9 45.1 45.9 47.3 52.2 45.6 45.6 46.4 45.5 44.7 46.2 46.4 45.9 50.7 20.5 22.4 19.0 15.0 26.8 8.2 11.1 19.1 13.6 31.2 22.2 27.6 10.9 17.2 17.9 18.4 18.8 43.3 37.0 14.4 29.4 25.0 2.0 17.1 21.6 22.4 25.2 18.1 23.1 8.1 11.7 21.8 10.2 14.8 27.9 40.7 20.0 8.9 24.6 35.3 23.0 18.6 30.5 16.6 12.4 6.7 34.5 27.0 10.6 13.1 32.6 34.6 52.5 18.6 20.7 11.9 16.9 37.6 11.7 11.8 21.3 24.4 12.5 26.4 32.9 13.6 21.2 20.7 19.1 9.9 10.1 30.6 22.3 31.8 14.6 9.7 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "retina: 430.2" "Group enriched" "Detected in many" 7 "Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 5.1" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.9 1.4 5.6 1.6 5.7 1.0 0.6 6.3 9.6 2.1 6.2 1.2 1.7 2.2 0.7 0.4 1.6 1.1 4.4 5.7 6.1 0.8 0.2 0.7 1.6 5.4 14.2 5.6 2.8 0.7 1.5 36.4 0.4 5.5 2.1 0.6 430.2 2.1 1.4 1.3 0.8 1.5 3.3 4.6 0.9 1.0 0.6 5.2 0.3 1.6 0.3 1.6 1.6 1.1 6.1 0.4 1.2 9.4 3.1 1.3 2.0 0.9 4.8 0.8 2.5 2.1 1.9 0.5 14.1 0.1 5.1 0.1 0.5 9.2 0.3 2.3 1.2 2.1 3.4 6.8 1.5 0.9 1.1 2.3 2.4 0.5 2.4 2.7 9.6 2.5 1.8 1.5 1.3 1.2 0.7 0.7 0.8 17.0 0.1 0.5 0.7 2.8 0.9 0.5 0.4 1.1 2.2 0.4 0.1 1.0 2.5 0.1 0.6 4.0 3.2 3.8 4.8 6.7 1.4 1.0 40.9 1.3 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 5.7 6.3 9.6 5.7 6.1 5.4 14.2 5.6 5.5 4.6 5.2 6.1 0.3 0.0 0.0 5.2 1.3 0.4 0.4 0.2 1.2 471.3 0.8 1.3 6.1 0.0 0.1 0.0 932.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 3.3 0.0 1.3 12.3 0.0 0.0 2.3 2.0 0.1 0.0 0.1 1.1 0.0 0.1 74.0 12.4 0.0 4.1 0.3 0.4 0.0 3.7 0.1 1.8 3.7 0.1 86.7 0.0 6.0 1.2 0.1 0.0 3.4 3.2 0.8 0.0 0.1 0.6 462.8 0.0 0.3 1.4 0.1 0.5 0.0 0.0 0.0 0.4 0.2 0.1 0.2 CDCA3 "GRCC8, TOME-1" ENSG00000111665 "Cell division cycle associated 3" Q99618 12 6844793-6851292 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.8;retina: 66.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Erythroid cells: 46.5;Extravillous trophoblasts: 74.1;Proximal enterocytes: 65.5;Spermatocytes: 71.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA026587 Approved Cytosol NA Yes Cytosol "HPA026587: AB_1846386" "unprognostic (3.05e-1)" "unprognostic (1.32e-1)" "unprognostic (9.85e-2)" "unprognostic (1.63e-2)" "unprognostic (2.42e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.51e-5)" "prognostic unfavorable (9.77e-5)" "unprognostic (3.88e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-3)" "unprognostic (8.81e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.11e-1)" "unprognostic (4.94e-2)" 1.2 2.6 0.7 7.4 0.7 16.2 1.2 1.1 1.0 3.7 0.5 6.2 20.9 3.0 0.4 9.0 1.9 1.2 2.8 0.8 0.8 1.5 1.6 1.7 17.3 0.8 0.9 0.7 4.6 1.1 0.4 8.7 4.7 0.8 3.1 7.9 66.9 2.5 0.3 0.5 6.3 18.7 3.0 0.5 4.6 3.2 21.5 0.7 30.8 1.8 0.2 23.6 2.2 4.0 1.6 106.8 88.8 81.0 45.1 4.3 6.8 95.0 71.7 46.4 119.5 83.3 142.7 86.9 64.9 8.6 54.9 86.9 71.0 53.3 55.0 117.0 97.2 60.9 56.8 58.9 81.7 0.5 41.3 47.2 3.1 3.9 63.0 34.6 27.9 50.9 44.2 47.8 36.4 116.7 94.1 60.0 46.0 86.2 75.8 62.3 57.6 68.5 34.3 40.2 36.4 12.2 23.6 61.8 53.5 18.7 87.0 21.9 38.6 22.3 52.6 67.2 35.0 117.2 19.7 21.5 104.2 25.4 53.6 92.0 0.0 0.2 0.0 0.1 0.1 0.3 0.7 0.7 0.8 0.2 0.2 0.2 0.4 0.2 0.4 0.3 1.1 4.3 0.5 0.7 0.7 1.1 1.0 0.8 0.8 0.8 0.9 0.7 0.8 0.5 0.7 1.6 0.7 0.0 0.5 0.7 4.1 2.9 1.7 5.0 2.2 12.3 1.9 2.5 1.2 1.5 1.1 0.0 56.3 29.5 0.9 6.9 0.0 1.1 12.4 1.8 2.3 1.7 1.2 46.5 0.5 0.4 74.1 5.2 4.6 2.3 4.5 15.2 3.9 1.6 19.3 6.7 0.6 11.9 4.1 4.0 3.1 6.8 1.8 3.5 0.0 1.0 1.1 1.1 1.0 0.5 0.5 0.4 4.0 0.4 19.2 1.4 65.5 0.9 0.4 18.0 6.6 0.5 8.3 71.5 14.8 12.6 1.8 8.5 4.6 1.4 17.4 2.6 CHPT1 CPT1 ENSG00000111666 "Choline phosphotransferase 1" Q8WUD6 12 101696947-101744140 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 344.4;Late spermatids: 650.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 36.9;eosinophil: 14.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 36.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067643 Approved Supported Vesicles NA NA Vesicles "HPA067643: " "unprognostic (1.59e-3)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.48e-2)" "unprognostic (3.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.79e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-1)" "unprognostic (4.70e-1)" "unprognostic (5.27e-2)" "unprognostic (1.16e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.72e-1)" "prognostic favorable (7.41e-4)" "unprognostic (1.79e-1)" 38.6 48.1 46.7 17.9 47.4 62.5 103.9 43.6 66.1 50.9 40.2 49.9 88.9 19.4 56.6 25.2 33.7 40.6 87.2 44.3 48.1 74.2 158.7 38.7 20.2 48.2 48.6 42.6 18.9 25.2 93.2 12.5 23.0 44.2 35.3 49.4 4.8 131.2 50.4 28.1 27.1 76.3 19.0 47.9 23.7 56.5 28.4 50.2 9.1 38.3 28.6 21.4 32.7 26.4 47.7 11.3 51.2 13.7 29.3 106.6 35.7 38.9 40.2 46.2 39.7 25.5 19.3 7.7 17.3 22.1 55.1 54.3 16.9 83.8 14.2 37.3 26.2 70.1 69.7 25.7 112.6 59.4 34.8 13.5 33.6 4.1 18.0 32.7 59.0 20.0 36.4 102.8 43.1 39.4 27.6 20.8 118.5 36.2 53.8 67.4 15.9 26.8 12.4 17.9 43.4 13.8 10.4 37.2 52.3 103.2 21.4 53.8 23.6 14.7 36.1 18.7 28.5 39.9 24.3 7.9 21.2 28.4 39.7 53.4 36.9 2.2 14.6 0.6 1.7 0.6 4.4 1.2 0.9 2.9 2.6 0.4 0.6 3.1 4.6 2.2 3.7 0.6 0.5 46.7 47.4 43.6 66.1 44.3 48.1 48.2 48.6 42.6 44.2 47.9 50.2 47.7 27.1 48.1 27.6 159.6 135.1 37.5 313.3 4.2 21.6 19.3 243.8 76.7 45.3 102.9 13.1 64.4 29.2 123.9 32.6 61.7 70.5 8.1 344.4 17.1 50.2 22.5 21.1 168.6 95.8 13.8 56.1 75.4 69.8 21.0 10.8 15.3 31.1 189.7 56.4 35.3 95.6 53.4 2.0 102.9 55.7 650.9 85.4 81.2 145.9 36.5 27.0 68.1 5.2 65.9 10.2 9.6 113.3 89.1 55.4 172.1 174.1 183.7 4.3 16.0 19.7 88.2 37.8 193.8 43.2 43.1 43.2 60.3 41.3 3.4 90.7 291.6 USP5 IsoT ENSG00000111667 "Ubiquitin specific peptidase 5" P45974 12 6852148-6866632 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006756 Uncertain Approved Nucleoplasm,Cytosol NA NA 1200000 "Nucleoplasm, Cytosol" "HPA006756: AB_1080534" "unprognostic (2.19e-1)" "unprognostic (5.83e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-1)" "unprognostic (7.60e-2)" "unprognostic (2.21e-2)" "unprognostic (4.02e-2)" "unprognostic (3.93e-2)" "unprognostic (2.57e-1)" "unprognostic (4.71e-2)" "unprognostic (8.90e-3)" "unprognostic (4.69e-2)" "unprognostic (1.17e-2)" "unprognostic (2.65e-2)" "unprognostic (3.56e-1)" "unprognostic (3.23e-1)" "unprognostic (2.02e-3)" 27.3 38.2 19.4 26.9 26.3 23.0 19.6 15.0 38.2 22.6 2.7 31.6 25.5 31.8 17.6 38.6 26.2 18.6 33.3 23.7 25.9 20.3 23.3 20.7 29.5 28.4 24.3 21.9 19.5 17.9 41.7 28.0 25.6 33.5 26.7 22.4 15.8 20.2 29.9 67.2 48.5 26.3 35.8 14.7 21.4 23.1 41.3 29.5 36.9 26.9 42.9 29.7 30.1 24.4 39.0 88.1 135.7 88.4 100.4 59.0 53.9 113.4 93.0 70.9 109.2 78.8 129.4 84.9 105.7 47.6 98.5 86.5 75.2 98.6 92.7 69.5 198.6 84.0 97.1 105.5 71.0 45.8 88.5 97.2 55.6 52.9 94.8 64.9 72.9 94.8 41.7 85.4 40.9 91.1 97.4 132.9 44.4 172.8 89.3 56.5 103.4 115.5 73.5 62.9 84.5 48.5 97.4 63.5 96.3 41.1 110.6 38.3 72.4 92.4 91.5 109.1 70.4 117.6 49.0 124.5 163.8 102.1 55.3 91.3 5.4 19.3 8.3 24.3 25.1 23.1 15.0 21.7 20.8 28.4 13.9 20.1 20.9 1.3 17.6 24.4 20.5 19.9 27.7 19.4 26.3 15.0 38.2 23.7 25.9 28.4 24.3 21.9 33.5 14.7 29.5 39.0 11.3 9.6 13.1 7.5 14.0 11.6 11.4 18.0 8.6 18.7 13.1 10.8 9.5 17.2 11.5 22.0 60.5 45.9 14.8 21.5 11.7 28.1 14.7 10.6 14.7 15.3 16.7 19.4 11.5 20.5 30.7 16.6 10.2 13.7 14.7 29.6 11.4 22.2 28.4 40.4 11.9 19.3 14.2 13.0 7.4 19.2 23.0 10.9 16.0 9.4 32.4 16.0 13.4 6.0 11.9 20.2 17.4 33.8 14.1 10.3 22.5 18.5 7.9 16.2 32.9 13.3 17.2 51.7 25.6 17.6 15.5 52.8 15.4 27.6 27.5 7.9 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2494.5;tongue: 2023.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles NA NA 170000000 Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 314.7 593.5 487.4 272.1 508.7 337.7 276.9 501.4 555.9 276.2 461.7 411.3 424.8 242.5 222.2 770.6 250.3 218.7 790.7 509.7 485.2 613.4 540.5 311.2 255.9 482.4 491.7 489.8 272.2 240.1 500.6 238.6 289.6 489.4 274.5 439.4 630.5 380.7 275.8 2494.5 405.5 407.9 304.1 458.1 293.8 331.7 241.7 532.8 202.2 271.3 2023.6 413.8 366.9 444.3 546.2 1556.8 1350.5 706.1 1094.6 666.5 696.6 1236.3 1097.5 1184.9 1999.1 2407.5 1409.9 823.0 903.4 212.7 1069.7 1042.4 748.8 1671.0 1812.3 2189.4 1196.4 1265.1 1172.0 924.4 926.2 496.8 1351.5 924.0 764.0 739.7 1537.8 1305.0 2816.1 1233.3 451.0 615.0 336.5 1554.5 1130.0 709.6 1119.5 1741.0 1302.3 855.9 413.5 1156.1 930.7 1261.4 1061.1 497.2 830.0 953.3 977.8 542.7 1452.6 224.4 1003.2 778.2 1068.0 914.6 703.1 1631.7 653.4 285.7 1327.8 2153.1 821.2 784.9 1708.8 2304.1 2375.2 824.6 2402.3 845.7 863.3 820.0 808.0 2656.1 800.9 570.5 703.0 934.3 1387.7 2165.7 482.0 1106.3 4679.5 487.4 508.7 501.4 555.9 509.7 485.2 482.4 491.7 489.8 489.4 458.1 532.8 546.2 311.5 134.6 204.2 34.6 290.6 684.8 553.8 1756.4 414.9 284.6 294.3 303.3 552.5 391.7 673.0 389.9 110.5 1017.0 278.2 850.3 1508.5 1361.5 203.0 280.8 307.0 352.0 425.5 243.3 38.4 786.5 1824.0 386.5 408.3 343.9 362.8 364.8 276.6 547.3 937.3 297.8 33.7 567.2 1151.5 386.7 750.4 683.5 279.0 482.8 674.1 18.7 1129.8 739.6 312.0 17.1 26.7 1081.5 889.4 263.3 427.9 556.2 1595.9 1642.7 401.2 298.0 197.2 270.5 551.3 14.9 79.0 690.4 615.9 1530.4 352.9 869.2 827.0 652.5 GNPTAB "GNPTA, KIAA1208, MGC4170" ENSG00000111670 "N-acetylglucosamine-1-phosphate transferase subunits alpha and beta" Q3T906 12 101745499-101830959 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cancer-related genes, Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014558, HPA042343" Approved Supported "Golgi apparatus" NA NA 160000 "Golgi apparatus" "HPA014558: AB_2732409, HPA042343: " "unprognostic (6.72e-2)" "unprognostic (1.66e-1)" "unprognostic (8.71e-3)" "prognostic favorable (8.48e-4)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (2.73e-1)" "unprognostic (8.57e-2)" "unprognostic (3.73e-2)" "unprognostic (1.09e-2)" "unprognostic (2.28e-2)" "unprognostic (2.00e-1)" "unprognostic (6.86e-2)" "unprognostic (3.44e-1)" "unprognostic (1.02e-1)" "unprognostic (5.44e-2)" "unprognostic (4.98e-2)" 11.9 7.9 19.5 16.4 22.7 24.2 16.5 15.2 20.4 17.5 5.5 29.8 14.3 11.9 6.3 15.7 8.9 14.9 21.7 22.2 13.2 14.6 9.5 27.2 20.8 10.8 12.6 19.8 7.3 11.4 23.1 8.4 15.0 14.0 20.3 30.6 13.2 54.8 13.1 16.6 25.3 16.3 16.0 10.1 19.2 21.5 10.5 12.2 34.4 14.1 26.1 18.0 19.5 12.1 16.8 18.2 17.5 6.4 10.9 52.3 24.8 19.6 25.4 52.3 24.7 32.2 13.5 12.4 38.1 17.9 35.1 20.1 23.2 29.8 32.8 38.4 18.1 15.6 16.3 15.4 19.3 9.7 15.0 31.7 19.3 17.7 23.5 13.8 61.4 44.0 30.0 25.9 11.0 23.4 27.8 45.6 21.0 22.0 22.6 12.5 10.6 32.6 51.2 39.5 46.8 13.6 11.2 42.3 29.7 60.7 23.5 30.6 9.8 43.6 23.1 12.5 19.6 14.4 30.0 32.9 21.5 26.4 21.8 14.6 8.6 3.8 4.4 18.8 3.6 6.2 3.0 4.0 10.3 7.1 4.9 5.1 7.9 1.4 17.0 4.6 6.9 3.3 3.7 19.5 22.7 15.2 20.4 22.2 13.2 10.8 12.6 19.8 14.0 10.1 12.2 16.8 25.3 60.9 65.0 35.9 42.1 16.8 32.9 16.2 17.1 23.6 25.2 18.9 43.5 18.6 27.8 22.0 25.0 25.7 107.3 68.3 7.9 10.3 0.6 25.3 23.7 21.1 18.0 19.5 84.5 15.1 15.0 18.9 33.1 61.6 122.8 24.6 10.4 9.7 46.7 8.4 83.8 29.6 24.4 46.7 17.6 3.8 17.1 41.2 42.7 30.0 43.5 26.9 192.6 135.2 19.8 15.7 129.3 12.8 63.9 28.1 17.7 13.8 10.0 37.0 0.0 18.6 14.9 12.4 33.0 26.7 14.3 8.8 63.4 30.6 49.7 46.5 SPSB2 "GRCC9, SSB-2" ENSG00000111671 "SplA/ryanodine receptor domain and SOCS box containing 2" Q99619 12 6870935-6889358 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 40.2" "Cancer enriched" "Detected in all" 5 "testis cancer: 38.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055225 Approved NA NA "HPA055225: AB_2682746" "unprognostic (1.13e-1)" "unprognostic (3.66e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (3.05e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.42e-1)" "unprognostic (2.13e-2)" "unprognostic (4.83e-2)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (9.05e-2)" "unprognostic (2.39e-2)" 5.3 11.3 6.7 5.9 6.5 6.2 5.9 9.6 9.9 7.7 6.0 6.9 5.0 8.0 3.4 7.3 7.7 6.4 4.5 6.0 7.2 13.5 6.8 12.5 7.4 6.7 6.5 5.4 5.1 8.7 4.6 7.6 2.4 7.0 7.2 2.3 4.3 7.8 6.2 5.2 8.2 7.5 3.0 6.6 9.4 7.7 9.8 6.3 8.5 12.2 1.7 3.6 7.5 6.6 7.8 9.4 43.6 4.2 6.5 9.7 4.6 8.3 9.7 11.0 8.4 4.0 19.9 35.8 3.2 4.5 8.4 6.1 8.8 10.3 5.5 1.2 21.4 3.5 11.0 13.7 7.8 14.7 5.0 10.5 4.9 7.8 11.1 9.8 6.9 5.7 12.6 7.1 4.3 8.7 13.7 10.0 5.8 17.1 12.6 13.2 9.3 5.5 6.4 16.7 6.4 1.8 5.3 6.7 13.0 10.4 12.3 3.9 8.5 4.8 8.4 13.2 8.8 10.3 5.7 9.2 4.1 9.3 9.6 12.0 0.1 8.4 24.0 12.1 9.9 14.2 11.8 11.9 9.9 9.3 13.2 13.5 12.1 6.8 7.0 12.1 17.3 13.6 8.3 6.7 6.5 9.6 9.9 6.0 7.2 6.7 6.5 5.4 7.0 6.6 6.3 7.8 4.2 28.9 19.9 2.0 7.1 2.5 3.7 7.5 2.2 5.3 8.5 4.4 3.3 7.2 9.4 20.2 2.1 5.8 4.4 11.1 33.2 13.3 16.8 18.6 5.3 5.5 9.5 6.6 0.5 10.7 4.5 5.8 3.6 8.9 8.2 2.5 7.5 4.7 11.5 6.7 0.9 10.8 0.0 7.6 3.9 8.9 9.6 8.1 0.0 1.9 13.4 9.4 17.5 1.0 1.8 9.0 6.6 9.1 2.2 7.6 15.6 40.2 19.5 14.3 6.6 6.5 6.3 29.0 9.2 4.1 4.8 7.7 8.5 10.2 7.8 3.4 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "brain: 457.3;retina: 1710.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 318.2;Cone photoreceptor cells: 312.8;Horizontal cells: 429.0;Rod photoreceptor cells: 787.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 11.3;memory B-cell: 6.8;memory CD4 T-cell: 13.1;memory CD8 T-cell: 11.4;naive B-cell: 4.4;naive CD4 T-cell: 8.2;naive CD8 T-cell: 8.6;neutrophil: 7.0;T-reg: 7.5" "Group enriched" "Detected in many" 7 "B-cells: 6.8;granulocytes: 7.0;T-cells: 13.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 537.4;U-87 MG: 398.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 55000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119" "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 23.0 47.2 256.8 20.2 316.4 9.6 20.4 321.3 421.6 53.9 126.6 57.3 10.3 40.4 12.7 15.4 40.5 18.1 39.6 300.3 327.5 23.6 7.8 34.1 26.5 308.3 260.6 331.0 30.0 9.0 44.0 125.4 10.5 324.7 35.2 15.7 1710.3 13.9 34.7 7.5 19.4 37.5 35.3 187.3 26.6 30.7 9.7 303.9 27.0 42.4 6.4 24.6 57.9 44.5 457.3 74.3 45.3 16.2 0.5 23.7 26.0 1.5 56.5 37.3 82.0 125.9 8.6 5.8 103.9 9.5 24.3 108.8 11.0 173.0 15.4 116.1 211.9 16.6 141.0 47.7 60.3 17.4 8.3 161.2 13.0 0.7 61.1 11.5 537.4 17.5 137.9 9.5 1.1 56.3 10.3 66.9 8.8 84.9 31.7 27.2 75.0 13.9 22.9 38.5 9.8 128.3 94.0 14.3 1.0 96.3 76.4 4.5 3.9 20.9 69.4 73.7 95.7 73.0 73.3 79.5 15.4 398.4 0.3 15.2 2.1 0.0 0.2 9.9 0.0 11.3 6.8 13.1 11.4 0.1 4.4 8.2 8.6 7.0 0.4 0.3 1.2 7.5 6.1 256.8 316.4 321.3 421.6 300.3 327.5 308.3 260.6 331.0 324.7 187.3 303.9 457.3 3.2 35.3 27.4 54.2 11.2 6.2 2.3 45.2 1.8 318.2 5.2 4.3 16.1 1.5 17.2 12.9 312.8 0.3 7.5 0.3 0.0 17.0 0.5 9.6 2.1 9.9 23.9 7.0 96.2 1.8 1.1 8.3 2.0 2.7 67.2 1.0 5.3 0.2 1.7 429.0 89.4 0.5 18.3 0.6 6.9 0.3 5.6 5.9 12.4 25.3 3.5 146.1 0.0 23.6 31.5 9.3 1.2 9.8 9.2 2.5 0.1 0.2 32.2 787.2 13.1 8.1 20.2 1.5 2.5 1.1 2.3 0.3 17.1 0.3 0.4 2.2 ATN1 "B37, D12S755E, DRPLA" ENSG00000111676 "Atrophin 1" P54259 12 6924463-6942321 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031619 Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031619: AB_10601667" "unprognostic (3.86e-3)" "unprognostic (2.07e-1)" "unprognostic (1.80e-3)" "unprognostic (5.82e-2)" "unprognostic (1.37e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (1.44e-1)" "unprognostic (6.90e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-2)" "unprognostic (3.19e-1)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-1)" "unprognostic (7.35e-2)" 119.5 149.5 60.7 34.0 50.1 7.0 121.7 78.8 120.9 139.5 11.1 127.5 36.6 147.6 25.7 72.5 150.2 43.6 93.4 57.1 38.5 96.1 43.0 109.9 20.6 79.1 55.9 38.5 236.6 80.3 57.2 190.4 44.2 56.7 118.6 21.3 59.4 90.5 60.1 82.6 79.4 82.7 49.9 26.0 74.8 101.2 33.5 61.3 16.5 190.6 34.7 14.1 123.2 109.7 57.9 56.4 72.1 75.9 154.7 69.6 61.7 126.3 65.5 55.4 65.1 45.8 73.6 65.6 15.2 20.4 80.8 54.1 36.8 46.2 63.8 33.3 178.0 46.3 70.6 71.7 35.6 108.3 14.6 103.8 101.8 46.1 82.4 63.6 112.5 64.4 22.4 61.1 29.9 58.2 81.2 31.9 13.5 156.0 26.2 30.1 65.9 40.6 11.2 48.3 78.3 23.4 75.3 66.5 77.2 47.1 73.6 29.5 40.3 85.2 76.7 97.9 61.1 102.2 22.7 8.1 10.7 60.1 18.7 82.3 0.5 0.1 0.7 0.6 0.0 0.5 0.7 0.2 0.3 0.1 0.5 0.3 0.4 0.0 0.1 0.0 0.5 0.3 0.2 60.7 50.1 78.8 120.9 57.1 38.5 79.1 55.9 38.5 56.7 26.0 61.3 57.9 66.3 16.0 17.2 76.4 9.1 30.2 13.5 22.9 30.1 26.6 51.5 57.4 16.4 24.3 20.4 29.5 18.8 27.4 11.4 37.4 15.6 20.5 2.3 39.9 61.2 40.7 21.7 4.8 23.8 30.3 15.3 30.9 34.7 51.7 10.1 37.1 39.7 8.0 11.9 25.2 29.7 23.0 8.2 10.9 21.0 3.5 63.6 13.7 21.4 23.4 4.8 17.3 3.1 17.6 18.2 29.9 25.3 52.6 9.5 17.4 24.2 12.1 15.4 23.9 19.7 29.4 39.5 9.7 7.7 22.1 24.9 37.1 10.9 26.2 20.4 17.9 C12orf57 "C10, GRCC10" ENSG00000111678 "Chromosome 12 open reading frame 57" Q99622 12 6942978-6946003 "Disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046182, HPA059163, HPA066043" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603" "unprognostic (5.89e-2)" "unprognostic (1.56e-2)" "unprognostic (2.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.24e-2)" "unprognostic (2.56e-1)" "unprognostic (5.20e-3)" "unprognostic (8.27e-2)" "unprognostic (1.11e-1)" "unprognostic (3.48e-2)" "prognostic favorable (8.74e-4)" "unprognostic (4.25e-2)" "prognostic unfavorable (2.32e-7)" "unprognostic (1.47e-2)" "unprognostic (3.26e-1)" "unprognostic (6.81e-2)" "unprognostic (8.39e-3)" 249.7 201.5 189.8 76.8 186.2 129.5 285.1 192.3 331.9 414.4 195.4 222.0 77.2 298.5 86.7 145.1 330.9 135.4 297.2 179.7 198.5 214.1 207.2 219.8 185.0 190.7 194.3 176.7 578.8 303.3 118.2 335.0 75.8 188.9 299.6 70.1 37.4 174.6 158.6 195.8 295.4 164.7 86.0 185.8 162.0 222.1 82.8 201.6 265.0 216.0 181.4 77.6 266.2 272.3 190.5 88.3 253.6 291.0 288.0 196.6 233.8 96.1 113.7 277.0 96.4 153.0 101.4 146.8 27.0 88.1 178.1 124.4 83.6 111.2 140.6 23.1 158.1 232.8 234.8 191.4 145.2 372.3 96.9 220.7 281.9 164.7 74.6 101.7 188.8 164.2 216.5 82.2 230.3 90.5 264.3 204.6 124.8 522.0 146.3 92.2 224.4 259.7 404.8 131.2 218.8 128.9 377.5 182.8 184.3 242.6 136.7 46.8 501.1 174.3 192.7 181.8 77.9 173.0 169.8 150.0 149.8 198.6 2.4 132.2 75.7 20.0 19.3 187.8 34.2 123.6 133.2 208.5 199.6 29.5 163.8 248.0 203.7 7.9 99.9 87.0 225.2 204.5 160.1 189.8 186.2 192.3 331.9 179.7 198.5 190.7 194.3 176.7 188.9 185.8 201.6 190.5 260.9 64.1 129.2 11.1 256.4 264.5 285.2 255.3 546.9 90.6 284.2 624.3 219.4 211.6 146.0 123.2 25.0 131.4 216.3 262.8 365.9 191.9 175.7 122.1 336.7 206.8 312.1 81.6 7.4 423.9 219.4 340.3 179.4 146.9 148.9 86.2 204.9 307.0 67.2 37.0 11.0 686.2 162.8 88.9 138.1 299.5 453.3 120.2 231.3 15.0 58.4 197.5 200.8 7.1 8.9 205.5 240.0 377.3 216.6 279.5 146.8 244.4 89.0 94.9 289.3 389.2 473.4 75.1 86.0 301.7 215.0 154.2 328.2 157.0 349.5 215.6 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 133.0;lymphoid tissue: 154.8" "Cell type enhanced" "Detected in many" "B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli NA NA 6000000 Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favorable (1.87e-4)" "prognostic unfavorable (5.42e-4)" "prognostic favorable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favorable (2.64e-8)" 14.5 15.7 3.3 103.4 3.9 133.0 11.1 4.4 5.9 11.2 6.4 22.2 30.7 6.2 10.3 12.9 14.0 20.5 4.9 3.4 7.4 11.5 19.4 50.1 154.8 6.3 4.1 2.3 3.0 12.0 13.8 10.1 20.0 6.0 11.8 21.6 0.7 17.2 9.1 2.0 19.0 42.3 12.5 7.1 129.1 28.3 3.1 5.5 72.0 12.7 4.5 128.3 27.2 7.6 7.3 16.4 30.8 0.2 0.1 0.1 0.0 28.5 0.0 0.0 0.0 0.0 16.5 36.0 11.9 8.4 0.0 0.0 18.3 0.3 21.6 0.0 7.3 6.5 170.9 3.4 13.9 0.0 154.3 648.7 0.1 15.4 0.0 6.5 0.0 0.0 60.0 0.3 1.3 0.0 34.5 55.4 92.2 8.3 38.0 5.1 50.4 0.2 86.5 16.7 30.2 2.7 0.0 5.2 24.9 0.2 20.9 7.7 259.8 0.4 0.0 0.2 0.1 0.2 0.4 0.2 5.5 0.4 66.3 0.5 676.7 368.3 1112.5 263.4 728.6 169.3 595.0 125.3 195.9 377.0 650.0 142.7 182.6 674.8 238.6 1117.7 98.7 146.8 789.3 3.3 3.9 4.4 5.9 3.4 7.4 6.3 4.1 2.3 6.0 7.1 5.5 7.3 10.5 6.4 13.8 0.7 214.6 9.1 8.2 18.8 29.6 0.0 8.6 10.0 2.1 11.5 15.3 5.5 0.0 25.6 77.7 16.0 15.6 15.8 50.4 12.1 1.5 7.5 24.7 22.9 0.9 15.4 18.3 3.0 25.0 11.8 137.3 10.9 8.9 11.6 191.6 0.0 0.9 13.2 18.3 146.5 118.2 10.5 0.9 152.1 14.2 3.7 99.7 0.5 154.5 2.0 0.1 12.6 16.9 0.0 53.5 3.9 22.8 14.3 17.2 0.5 6.6 1.6 4.0 0.3 1.3 14.6 8.7 18.5 86.2 24.5 15.6 7.8 LPCAT3 "C3F, MBOAT5, nessy, OACT5" ENSG00000111684 "Lysophosphatidylcholine acyltransferase 3" Q6P1A2 12 6976185-7018477 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 103.5;Proximal enterocytes: 121.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 156.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (3.33e-2)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" "unprognostic (3.86e-1)" "unprognostic (2.40e-2)" "unprognostic (6.90e-2)" "unprognostic (1.88e-1)" "unprognostic (5.00e-3)" "unprognostic (2.06e-1)" "unprognostic (2.58e-2)" "prognostic favorable (4.89e-5)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (6.49e-3)" "unprognostic (1.23e-1)" 33.8 52.5 9.2 21.8 9.7 28.6 36.6 11.7 9.6 20.4 10.8 51.9 124.1 18.9 21.7 32.2 21.4 18.7 27.8 9.0 10.3 44.8 110.1 46.4 17.1 11.5 10.0 8.7 17.8 51.2 19.7 15.3 38.3 10.3 36.3 48.4 4.1 37.6 16.5 46.0 31.1 100.6 21.9 9.9 20.2 59.2 11.3 9.9 21.7 27.9 58.0 21.4 35.6 21.9 11.0 20.2 34.0 15.8 44.3 109.4 51.2 32.9 11.8 49.5 31.7 53.4 78.6 103.9 21.9 6.5 19.1 65.7 50.8 19.2 43.0 24.3 52.7 21.3 44.7 28.2 71.5 23.6 23.3 45.8 81.2 24.7 30.2 15.1 20.1 30.0 33.0 24.4 15.4 20.9 30.0 29.1 28.7 53.1 73.1 20.2 29.9 21.5 22.4 38.7 156.0 13.6 12.5 68.5 107.3 7.9 49.5 10.9 31.4 12.0 19.2 27.8 34.1 8.3 19.1 14.5 30.9 24.0 23.5 17.0 44.4 55.7 91.0 21.5 80.5 25.4 12.3 22.3 24.8 37.2 12.3 20.1 21.3 53.7 32.3 98.7 21.1 29.7 38.3 9.2 9.7 11.7 9.6 9.0 10.3 11.5 10.0 8.7 10.3 9.9 9.9 11.0 17.9 70.5 38.5 15.7 13.1 23.6 39.4 35.8 36.5 5.2 19.8 13.8 0.6 12.8 30.3 20.2 0.0 103.5 11.6 47.0 11.7 29.9 2.5 18.8 21.4 13.1 43.2 57.7 20.7 33.0 51.7 14.3 49.5 26.6 14.0 10.6 15.0 62.9 41.6 11.8 16.7 26.8 26.4 21.9 9.6 1.7 18.3 15.2 7.2 6.5 15.8 12.2 15.5 25.6 22.4 18.1 27.1 6.4 17.5 24.7 121.9 37.2 16.4 4.0 19.7 6.0 18.2 24.3 35.3 17.7 22.3 66.4 18.9 17.0 41.2 25.9 NT5DC3 "FLJ11266, TU12B1-TY" ENSG00000111696 "5'-nucleotidase domain containing 3" Q86UY8 12 103770453-103841234 "Metabolic proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 41.2;Excitatory neurons: 36.6;Oligodendrocyte precursor cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041634 Approved Mitochondria,Cytosol "Secreted - unknown location" NA NA Mitochondria Cytosol "HPA041634: AB_10795597" "unprognostic (2.61e-2)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (2.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.57e-1)" "unprognostic (2.19e-1)" "unprognostic (2.45e-2)" "unprognostic (5.43e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.60e-3)" "unprognostic (7.42e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.11e-4)" 2.7 4.1 14.5 1.9 12.7 17.7 3.3 0.3 11.8 8.9 0.0 57.6 1.0 23.3 5.0 5.2 3.7 1.4 1.9 21.4 6.8 2.0 5.0 2.8 1.3 1.9 2.7 12.0 2.9 3.5 0.8 4.5 1.5 2.1 7.6 7.8 2.4 4.1 5.5 7.8 2.4 4.7 6.9 0.3 1.6 6.7 3.2 6.6 0.6 1.9 3.3 1.3 21.8 5.7 9.2 3.6 6.5 3.6 4.2 5.1 4.0 6.8 5.9 3.5 4.1 2.6 4.4 0.9 6.1 1.1 7.0 4.5 4.1 5.2 11.7 5.9 4.5 4.2 7.6 2.5 5.2 2.8 4.1 1.9 3.5 2.5 5.3 22.7 8.3 2.4 3.0 12.2 3.0 9.2 3.3 3.6 6.6 4.5 5.2 6.9 4.9 6.3 2.3 6.5 2.4 4.9 2.0 4.9 5.4 7.1 3.3 3.1 3.8 3.2 4.0 4.8 5.5 11.9 2.7 3.5 4.4 3.8 6.2 6.0 0.4 0.5 0.0 0.6 0.6 1.2 1.3 0.9 0.5 1.5 1.4 0.7 0.6 0.9 0.6 0.4 1.9 0.2 0.3 14.5 12.7 0.3 11.8 21.4 6.8 1.9 2.7 12.0 2.1 0.3 6.6 9.2 1.4 0.0 2.3 3.9 2.7 4.5 21.9 3.0 21.6 2.0 5.6 7.4 3.8 2.8 2.1 1.8 0.0 5.2 2.7 5.8 0.0 2.1 12.1 14.0 11.9 1.7 41.2 1.3 36.6 2.0 4.7 3.8 7.7 19.4 0.0 3.7 0.7 5.3 1.8 10.1 24.4 11.4 10.2 4.1 6.5 10.5 5.0 2.8 0.0 6.5 2.9 0.8 1.0 29.1 2.7 2.7 2.2 8.2 2.7 13.0 1.1 2.1 6.9 5.0 0.0 5.6 5.7 0.4 3.1 9.0 4.4 4.1 2.5 4.1 9.2 9.8 SLCO1B3 "OATP1B3, OATP8, SLC21A8" ENSG00000111700 "Solute carrier organic anion transporter family member 1B3" Q9NPD5 12 20810702-20916911 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 267.3" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 203.4" "Cancer enriched" "Detected in many" 4 "liver cancer: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7" "HPA004943, HPA050892" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004943: AB_1854758, HPA050892: AB_2681265" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (6.95e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-2)" "unprognostic (7.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.54e-2)" "unprognostic (7.37e-2)" "unprognostic (1.50e-1)" "unprognostic (6.61e-3)" "unprognostic (2.36e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 13.1 13.1 0.3 0.2 0.1 0.4 0.3 0.0 0.3 0.0 0.5 0.0 0.0 267.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 65.3 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 12.6 0.0 4.3 0.0 13.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 14.7 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 203.4 0.0 0.0 0.5 0.0 0.0 1.6 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 APOBEC1 "APOBEC-1, BEDP, CDAR1, HEPR" ENSG00000111701 "Apolipoprotein B mRNA editing enzyme catalytic subunit 1" P41238 12 7649400-7665908 "Enzymes, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "intestine: 29.3" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 153.8" "Group enriched" "Detected in some" 9 "colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "CAPAN-2: 1.7;OE19: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.35e-1)" "unprognostic (3.80e-4)" "unprognostic (7.96e-3)" "unprognostic (1.79e-1)" "unprognostic (4.38e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 28.2 0.0 0.0 0.0 153.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 NANOG "FLJ12581, FLJ40451" ENSG00000111704 "Nanog homeobox" Q9H9S0 12 7787794-7799146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Spermatocytes: 5.5" "Cancer enriched" "Detected in single" 1164 "testis cancer: 58.1" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;granulocytes: 1.5" "Cell line enriched" "Detected in some" 5 "NTERA-2: 125.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB019380, HPA072117" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB019380: , HPA072117: " "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (8.59e-3)" "unprognostic (3.50e-1)" "unprognostic (3.46e-2)" "unprognostic (6.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.87e-1)" "unprognostic (4.51e-7)" "unprognostic (3.46e-2)" "unprognostic (2.09e-1)" "unprognostic (1.51e-1)" "unprognostic (3.85e-2)" 0.0 0.1 0.3 0.1 0.6 0.4 0.1 1.8 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.4 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 125.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.7 0.3 0.2 1.7 0.1 0.0 0.3 0.6 1.8 0.5 0.3 0.2 0.2 0.1 0.3 0.8 0.1 0.3 0.7 0.4 0.0 0.0 0.0 0.2 1.7 1.8 0.8 0.0 2.2 0.3 0.1 0.8 0.0 0.3 0.0 8.4 1.6 1.4 0.1 0.0 0.4 1.0 0.3 0.5 0.6 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.3 0.0 2.1 0.7 0.6 0.5 0.0 0.0 0.3 2.0 0.3 0.0 0.3 1.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.4 1.5 0.0 0.9 0.0 0.3 0.9 1.0 0.0 1.7 0.4 5.5 0.6 0.0 0.6 0.7 0.7 0.7 0.4 1.8 SUDS3 "FLJ00052, SAP45, SDS3" ENSG00000111707 "SDS3 homolog, SIN3A corepressor complex component" Q9H7L9 12 118376555-118418033 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 271.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040402, HPA041972" Approved Supported "Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nuclear bodies, Cytosol" "HPA040402: , HPA041972: AB_2677776" "unprognostic (1.49e-1)" "unprognostic (4.08e-3)" "unprognostic (1.09e-1)" "unprognostic (6.60e-2)" "unprognostic (7.39e-2)" "unprognostic (1.45e-1)" "unprognostic (3.05e-3)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.70e-1)" "unprognostic (8.71e-2)" "unprognostic (3.03e-1)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "unprognostic (2.37e-1)" 10.5 12.4 13.7 12.1 14.6 17.1 18.9 10.3 15.6 16.7 12.1 16.1 14.4 15.1 16.2 20.1 18.3 11.8 12.9 15.6 13.8 16.3 14.1 12.0 14.8 12.6 15.1 14.5 15.1 17.5 25.5 11.7 11.6 13.6 16.4 18.5 16.4 19.3 15.8 11.4 20.2 14.2 13.9 11.0 13.8 16.3 16.5 13.2 18.1 21.9 12.1 19.7 14.5 15.3 14.3 29.4 21.9 29.4 29.4 16.1 21.1 31.5 22.5 23.2 25.8 20.4 24.1 18.6 39.8 23.5 21.8 16.0 34.3 35.3 23.8 30.3 35.3 20.9 27.7 18.4 21.6 18.4 30.9 20.5 14.6 25.0 12.8 22.7 33.5 22.2 36.9 30.8 14.1 23.9 20.2 36.7 40.2 30.5 38.8 17.0 32.9 26.4 28.3 23.7 42.7 22.9 22.7 31.9 18.7 19.9 36.7 61.1 24.9 18.7 17.5 16.6 19.7 15.5 26.2 31.4 29.2 19.4 19.4 21.4 1.8 4.3 5.9 5.0 2.8 6.1 8.8 5.4 5.7 4.7 8.4 6.4 4.4 12.6 4.3 2.8 6.8 5.5 3.9 13.7 14.6 10.3 15.6 15.6 13.8 12.6 15.1 14.5 13.6 11.0 13.2 14.3 25.5 28.9 15.9 19.6 37.8 64.7 44.7 55.0 46.1 75.4 85.6 63.0 37.5 41.5 37.1 47.8 77.2 34.6 26.9 75.1 80.3 41.5 271.9 87.6 54.4 24.6 37.3 30.3 22.4 19.3 54.5 31.5 36.7 73.2 8.2 37.5 21.0 34.1 25.0 107.7 29.1 60.2 59.0 18.2 36.1 59.4 38.5 20.8 28.4 13.1 30.5 30.0 29.9 30.2 21.6 26.4 52.6 41.0 49.1 60.5 38.3 45.7 61.9 57.3 26.3 42.8 48.5 62.6 53.4 74.1 78.7 49.1 32.9 41.6 56.8 61.9 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055909: AB_2682967, HPA066383: AB_2685667" "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavorable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 17.6 22.3 15.4 17.1 16.1 26.0 18.7 15.8 19.1 18.1 15.0 13.5 10.6 14.8 15.7 13.8 12.6 14.0 15.0 15.9 16.9 15.6 18.9 17.8 15.1 15.8 16.4 15.5 11.0 21.8 12.0 19.2 29.2 16.3 16.2 15.0 14.2 16.3 13.3 15.7 13.0 11.4 17.9 16.1 12.5 14.4 10.7 16.7 11.3 16.1 12.0 14.2 17.9 12.3 18.6 31.2 30.0 28.5 36.5 56.5 83.2 46.1 126.5 48.2 40.4 63.3 45.4 48.1 19.4 29.8 66.6 71.0 30.1 23.4 27.2 69.5 29.4 22.8 29.7 19.6 32.8 61.0 37.0 36.8 44.2 50.1 44.9 85.6 67.7 35.8 24.4 18.6 21.1 59.2 30.7 17.3 62.1 75.7 27.8 23.5 14.0 65.0 39.4 32.2 18.7 7.2 23.1 49.0 20.6 70.4 90.2 28.2 39.4 40.6 46.5 49.5 57.1 67.2 20.3 45.9 51.8 63.6 35.5 64.2 48.0 26.6 20.8 22.1 31.4 26.6 22.7 25.8 24.4 27.0 25.9 23.3 23.8 7.2 21.6 29.4 29.4 28.0 27.6 15.4 16.1 15.8 19.1 15.9 16.9 15.8 16.4 15.5 16.3 16.1 16.7 18.6 23.4 9.6 15.6 15.0 38.9 46.7 23.4 42.7 27.3 27.6 20.4 11.2 18.9 22.8 36.8 16.5 10.4 29.0 34.9 13.8 27.4 31.6 3.4 10.9 26.3 28.7 13.1 22.9 70.4 33.4 72.4 45.7 15.3 21.7 21.5 10.3 16.8 23.2 41.0 18.5 49.3 31.7 38.7 23.6 65.1 5.2 17.4 35.4 53.4 14.0 26.0 17.5 18.6 25.1 25.4 38.6 15.4 19.9 75.8 49.0 8.7 21.7 18.2 7.7 13.1 24.6 39.3 23.7 32.4 22.8 63.9 64.0 39.1 9.6 14.6 44.9 GYS2 ENSG00000111713 "Glycogen synthase 2" P54840 12 21536107-21604847 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "liver: 175.3" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 63.6" "Cancer enriched" "Detected in single" 29 "liver cancer: 12.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039482 Approved NA NA "HPA039482: AB_10795107" "unprognostic (7.22e-3)" "unprognostic (2.85e-2)" "unprognostic (8.88e-2)" "unprognostic (1.78e-2)" "unprognostic (5.68e-2)" "unprognostic (3.16e-1)" "prognostic favorable (7.62e-5)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (4.68e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.85e-1)" "unprognostic (2.66e-4)" 2.7 0.0 0.1 0.0 0.1 0.0 1.0 0.1 0.1 1.2 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.1 0.1 0.0 0.2 175.3 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.4 63.6 0.0 0.0 7.7 0.0 6.1 1.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 5.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 LDHB ENSG00000111716 "Lactate dehydrogenase B" P07195 12 21635342-21757857 "Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1965.9;kidney: 1742.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 2502.3;Cytotrophoblasts: 1693.0;Distal tubular cells: 3306.5;Proximal tubular cells: 3483.9;Syncytiotrophoblasts: 1639.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 6021.8" "CAB004641, HPA019007" Enhanced Supported Cytosol No No 560000000 Cytosol "CAB004641: AB_425525, HPA019007: AB_2670008" "unprognostic (2.93e-1)" "unprognostic (9.20e-3)" "unprognostic (6.10e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-3)" "unprognostic (1.36e-3)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (5.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.91e-1)" "unprognostic (6.41e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (2.55e-1)" "unprognostic (9.32e-2)" 554.8 428.3 490.5 261.5 504.1 355.8 323.8 578.8 622.3 232.9 511.6 279.1 85.2 275.6 170.5 168.1 255.1 235.0 1965.9 460.0 541.2 1742.6 71.1 222.3 429.3 543.1 543.4 445.0 476.6 373.4 451.1 162.6 300.7 533.2 243.0 279.7 292.5 163.7 289.9 311.9 78.6 172.7 312.4 514.9 183.5 462.8 120.6 551.5 539.4 351.6 958.8 453.1 421.8 172.6 518.1 647.2 1697.3 1457.5 966.0 1021.7 1126.6 1689.4 879.8 873.0 1201.5 1179.4 2712.9 3.6 2268.6 561.5 597.3 1170.1 315.8 2031.4 1631.4 1518.4 586.5 1413.1 2339.5 1619.0 3.0 975.0 2212.8 967.9 1300.5 572.1 1056.8 1423.4 1416.9 1395.2 1610.8 1304.6 332.6 1342.7 3.2 1895.9 2665.6 4216.4 1051.1 727.7 1681.3 2032.0 1838.7 6021.8 2832.7 467.2 1077.8 403.6 618.1 1586.1 3842.2 5.3 1704.6 548.3 803.7 1048.1 578.5 1684.5 291.0 420.9 2953.4 891.8 1037.5 978.2 540.8 201.9 25.1 346.8 124.7 583.1 349.4 1341.5 723.8 367.2 250.9 1722.4 1124.1 31.7 459.0 95.2 427.7 1405.8 1431.2 490.5 504.1 578.8 622.3 460.0 541.2 543.1 543.4 445.0 533.2 514.9 551.5 518.1 89.8 141.1 316.4 68.2 242.2 73.0 439.5 1103.1 221.4 151.5 332.4 325.0 2502.3 298.8 433.9 474.5 68.8 1693.0 208.0 69.6 3306.5 18.4 10.5 224.3 325.0 227.3 92.4 361.2 39.4 314.9 870.1 299.4 222.8 309.4 268.6 412.6 155.7 11.2 612.9 141.3 55.6 152.2 956.2 189.8 104.3 34.3 274.6 174.8 179.7 33.7 197.3 277.6 159.6 47.7 40.3 99.7 84.3 415.2 303.1 310.6 0.2 3483.9 363.0 118.1 236.7 195.2 363.7 21.5 124.3 216.3 64.2 1639.5 398.1 1105.3 257.0 344.9 PRKAB1 ENSG00000111725 "Protein kinase AMP-activated non-catalytic subunit beta 1" Q9Y478 12 119667864-119681624 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004247, CAB005058" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005058: AB_562038, HPA004247: AB_1078149" "unprognostic (1.20e-1)" "unprognostic (3.08e-2)" "unprognostic (7.42e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.33e-1)" "unprognostic (2.89e-2)" "unprognostic (8.97e-3)" "unprognostic (1.46e-2)" "unprognostic (6.26e-2)" "unprognostic (3.63e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "prognostic favorable (5.40e-9)" "unprognostic (5.60e-2)" "unprognostic (2.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.32e-2)" 17.0 17.0 10.7 14.0 12.3 44.4 15.5 11.9 13.3 25.5 11.5 35.1 32.8 17.0 16.4 21.6 17.4 14.7 12.3 10.9 13.6 53.8 17.5 25.5 18.2 13.3 12.7 10.6 14.4 33.7 19.1 10.8 27.8 13.6 12.0 33.7 19.6 16.1 15.8 12.7 10.2 22.9 17.2 11.9 24.3 29.3 21.6 11.9 19.9 21.0 10.6 24.1 15.2 10.8 14.7 11.4 30.8 22.1 21.5 17.8 16.7 29.7 18.3 22.7 28.2 20.4 39.9 24.0 36.6 21.8 23.6 12.6 15.2 22.6 32.1 24.9 22.4 36.5 57.8 17.1 51.5 35.6 26.7 66.0 22.4 29.9 24.4 29.7 30.0 21.2 54.5 89.4 13.5 21.6 33.0 60.4 35.4 32.3 16.5 50.1 33.9 20.8 22.7 32.7 33.7 18.7 31.8 22.1 8.6 25.3 26.7 27.2 34.1 25.0 16.9 20.2 13.3 17.8 45.8 45.7 26.8 16.5 19.7 25.5 50.6 28.5 70.3 28.5 32.6 34.4 47.1 30.0 31.0 30.8 39.5 32.3 29.7 34.7 42.0 38.6 27.8 36.1 36.4 10.7 12.3 11.9 13.3 10.9 13.6 13.3 12.7 10.6 13.6 11.9 11.9 14.7 20.6 48.1 49.7 3.3 11.9 3.3 6.5 15.3 15.4 16.2 10.0 6.3 5.3 8.6 16.6 22.0 4.2 18.4 7.5 27.0 46.9 8.3 1.2 12.7 7.7 13.2 19.7 34.5 7.1 30.2 10.9 8.6 12.8 15.4 12.0 18.5 5.3 7.1 12.3 21.9 6.2 15.3 14.2 7.0 5.2 2.2 5.6 9.6 3.6 8.4 10.3 13.4 11.3 7.5 7.6 11.7 17.9 6.4 6.4 5.2 16.2 38.2 12.7 17.9 6.6 4.8 8.2 25.6 13.2 13.7 4.3 15.1 9.9 26.3 23.7 8.3 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046218-22065674 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 532.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 19.3 57.5 50.2 23.4 58.8 48.3 33.2 47.5 56.0 23.6 42.9 78.5 66.8 23.7 69.6 72.3 22.0 24.6 43.0 56.5 60.0 29.2 72.8 18.3 24.4 51.3 63.2 52.7 25.5 42.9 80.1 30.2 34.3 59.9 37.1 72.6 25.0 32.8 27.0 44.4 29.6 64.1 28.0 49.6 20.3 30.0 70.5 56.8 20.0 24.0 41.5 26.3 24.5 40.6 60.7 63.4 50.2 59.5 29.3 47.0 57.5 88.8 43.2 46.2 45.0 47.2 114.1 72.0 56.5 41.3 37.3 83.9 50.9 35.8 60.1 60.7 75.0 45.4 169.1 38.8 57.2 43.2 45.4 85.5 38.5 56.4 58.1 86.3 61.5 61.3 58.7 108.8 28.1 80.9 83.8 52.0 105.3 147.5 69.4 69.5 36.2 63.6 53.7 56.0 67.8 23.8 42.0 34.2 59.6 51.9 120.2 82.3 62.0 45.5 51.2 42.4 46.2 81.1 19.4 26.0 74.9 83.6 34.6 54.3 22.7 27.3 32.1 20.4 29.7 26.1 19.0 26.9 27.0 31.5 18.2 24.2 24.6 2.8 36.9 27.4 20.2 33.8 25.5 50.2 58.8 47.5 56.0 56.5 60.0 51.3 63.2 52.7 59.9 49.6 56.8 60.7 21.5 12.8 17.5 12.4 19.2 29.2 76.8 117.2 14.8 38.3 31.9 21.2 72.7 41.5 102.3 23.9 4.2 175.2 17.8 158.1 76.3 56.6 12.4 17.2 19.6 36.8 41.6 153.9 38.7 83.6 141.3 41.7 21.9 20.0 22.8 28.2 34.2 63.6 66.2 35.3 29.2 118.2 93.6 29.8 22.0 19.0 25.4 32.5 44.4 8.4 45.3 33.4 26.8 16.6 25.5 79.7 156.2 27.8 16.7 112.3 133.6 87.0 82.5 20.4 19.7 30.4 42.3 112.2 97.1 52.3 44.5 532.6 24.6 63.0 90.8 190.6 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064531-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 250.3;Spermatocytes: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 5.7 6.8 4.3 3.6 5.6 2.7 5.2 4.8 5.5 7.4 2.6 7.3 5.2 7.9 5.0 6.3 5.4 5.7 5.1 4.1 4.6 5.8 7.3 4.7 4.6 5.5 5.6 3.9 7.8 6.0 6.7 4.2 6.5 5.4 7.2 4.3 8.1 4.5 9.5 9.8 4.5 5.0 7.3 5.2 5.1 5.2 9.6 5.2 5.2 7.0 11.3 3.7 6.0 6.0 7.3 2.0 2.3 2.3 2.0 12.7 12.5 1.7 9.1 4.1 6.8 3.9 1.1 0.9 2.1 3.1 7.1 2.5 2.2 2.9 1.6 7.3 3.5 2.8 2.1 2.3 1.0 8.5 1.7 3.3 7.8 4.3 4.2 3.5 9.8 5.3 3.1 2.5 4.2 12.3 1.8 3.1 4.0 0.5 1.3 4.7 2.5 7.6 1.3 3.1 1.4 3.3 2.5 4.4 3.2 3.5 1.5 5.0 1.9 8.0 10.7 1.4 5.6 3.1 5.3 1.7 1.8 5.1 2.3 4.4 0.4 0.6 0.9 0.8 1.1 0.9 0.5 0.7 0.9 0.7 0.5 0.8 0.9 0.1 0.8 1.8 0.4 0.9 0.5 4.3 5.6 4.8 5.5 4.1 4.6 5.5 5.6 3.9 5.4 5.2 5.2 7.3 19.3 12.8 14.1 18.9 10.0 8.0 6.6 5.4 8.6 19.6 6.1 5.0 12.5 1.5 9.6 5.5 20.9 5.0 8.8 7.4 9.8 6.2 250.3 7.9 18.5 14.4 8.4 7.4 31.8 3.3 5.0 16.0 6.6 6.5 17.1 9.8 15.7 11.5 7.4 23.5 33.9 4.7 8.2 11.4 5.7 59.4 21.8 8.6 7.2 16.9 9.3 13.7 7.2 30.7 45.6 3.1 6.0 27.8 12.2 2.7 7.7 8.6 10.4 22.2 13.1 18.7 17.4 130.9 16.4 8.5 7.2 10.8 11.3 17.9 3.8 3.3 ST8SIA1 "SIAT8, SIAT8A" ENSG00000111728 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1" Q92185 12 22063773-22437041 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 133.2;Inhibitory neurons: 152.0;Oligodendrocyte precursor cells: 198.0" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.5;ASC TERT1: 4.2;hTERT-RPE1: 3.0;RPTEC TERT1: 3.3;SK-MEL-30: 6.2;WM-115: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026775 Approved NA NA "HPA026775: AB_1857534" "unprognostic (1.98e-1)" "unprognostic (5.76e-3)" "unprognostic (1.79e-1)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-3)" "unprognostic (1.76e-2)" "unprognostic (1.07e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "unprognostic (6.37e-3)" "unprognostic (2.80e-2)" "unprognostic (1.07e-8)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (5.28e-2)" "unprognostic (3.16e-2)" 0.9 3.6 9.3 2.5 7.5 1.3 2.9 15.0 6.6 2.3 0.0 2.6 0.1 2.3 0.6 1.3 1.3 1.0 2.3 6.7 8.8 0.4 0.2 2.0 4.6 12.1 10.5 4.5 1.2 0.6 6.4 0.2 0.1 13.0 3.1 1.6 6.1 1.4 2.0 0.4 2.1 1.3 2.2 8.5 1.4 1.1 0.4 7.3 0.9 0.7 0.4 4.8 4.1 1.8 7.6 0.0 0.3 6.5 0.0 1.0 4.2 0.6 0.0 0.0 0.1 0.3 0.2 0.1 0.8 0.0 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.4 0.7 0.1 0.6 3.0 0.1 0.0 0.0 0.4 0.2 0.0 0.9 0.2 1.6 2.6 0.0 0.0 0.1 0.1 3.3 0.0 0.0 0.1 0.0 0.1 6.2 0.2 0.5 0.0 0.0 0.5 0.6 0.0 1.0 0.5 0.4 0.5 1.0 0.0 6.5 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.1 9.3 7.5 15.0 6.6 6.7 8.8 12.1 10.5 4.5 13.0 8.5 7.3 7.6 0.6 0.0 1.8 43.1 0.4 4.5 0.4 1.4 0.0 9.6 7.2 5.8 4.1 0.0 1.6 0.0 45.9 3.6 1.7 0.1 1.9 0.0 12.8 8.7 2.9 1.3 0.0 3.2 133.2 0.0 13.8 8.3 0.0 0.3 34.1 2.6 1.8 0.0 0.9 5.0 152.0 0.0 0.0 0.0 2.7 5.0 0.3 0.5 12.4 17.8 0.2 46.2 0.0 198.0 4.7 0.0 0.0 0.0 0.7 3.5 0.0 0.5 9.4 4.2 0.0 43.9 2.3 6.3 6.3 0.0 2.4 3.7 5.9 31.3 0.0 0.2 CLEC4A "CD367, CLECSF6, DCIR, DDB27" ENSG00000111729 "C-type lectin domain family 4 member A" Q9UMR7 12 8123617-8138607 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 21.8;lymphoid tissue: 27.1" "Group enriched" "Detected in many" 4 "Kupffer cells: 79.9;Langerhans cells: 119.3;Macrophages: 88.5;monocytes: 98.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 226.8;classical monocyte: 331.7;intermediate monocyte: 198.1;myeloid DC: 327.4;neutrophil: 298.3;non-classical monocyte: 130.0" "Group enriched" "Detected in all" 13 "dendritic cells: 327.4;granulocytes: 298.3;monocytes: 331.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA007842 Uncertain NA NA "HPA007842: AB_1078534" "unprognostic (9.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.41e-2)" "unprognostic (3.13e-2)" "unprognostic (2.69e-1)" "unprognostic (9.34e-2)" "unprognostic (5.49e-2)" "unprognostic (8.22e-2)" "unprognostic (1.62e-1)" "unprognostic (7.84e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.42e-3)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (3.05e-1)" "unprognostic (9.79e-2)" 4.1 2.5 3.1 27.1 3.2 21.8 4.6 3.2 5.4 3.2 3.1 4.6 5.1 3.9 4.4 2.6 2.6 7.4 2.0 3.0 3.9 1.7 4.2 11.2 9.5 4.2 3.3 2.7 4.4 1.9 1.0 2.0 5.0 3.2 2.3 6.1 3.5 2.8 3.0 1.6 5.4 4.7 4.7 3.6 15.5 2.5 2.4 2.7 6.3 1.7 2.7 8.9 7.7 1.8 3.5 0.2 0.0 0.3 0.9 1.7 4.2 0.5 1.2 0.5 0.9 1.3 1.6 0.7 0.7 0.1 0.6 0.3 0.2 0.9 0.2 0.6 1.2 1.2 0.7 0.7 0.4 2.1 2.3 2.9 2.1 0.9 0.4 1.2 2.7 0.2 1.6 0.4 0.6 1.2 0.6 0.6 1.7 0.6 0.6 0.4 0.4 0.7 1.1 0.6 1.1 0.2 0.4 0.2 0.8 0.0 1.4 0.1 0.1 0.2 1.6 1.0 0.6 0.8 0.7 0.1 0.9 0.2 0.8 0.0 226.8 331.7 1.1 0.5 198.1 0.6 14.1 0.9 1.3 327.4 25.0 0.6 0.6 298.3 3.3 130.0 44.4 0.6 168.9 3.1 3.2 3.2 5.4 3.0 3.9 4.2 3.3 2.7 3.2 3.6 2.7 3.5 1.1 0.0 4.6 3.9 8.6 4.2 0.8 0.6 0.0 0.6 0.7 2.0 0.8 0.0 2.0 0.0 4.2 0.3 8.9 0.4 1.9 0.1 5.5 0.2 0.6 1.5 1.8 2.7 2.2 0.5 0.2 1.4 0.5 0.3 2.5 1.5 0.7 1.3 23.8 0.0 2.4 0.3 0.0 79.9 119.3 1.5 2.5 88.5 7.2 3.7 98.8 1.0 6.2 4.5 2.9 0.6 1.2 1.5 0.7 0.8 0.0 0.3 2.3 1.1 0.0 1.1 1.1 0.6 0.4 0.3 3.3 0.3 2.1 0.7 0.2 0.9 C2CD5 "CDP138, KIAA0528" ENSG00000111731 "C2 calcium dependent domain containing 5" Q86YS7 12 22448583-22544546 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 244.6;Inhibitory neurons: 253.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 103.0" "Cancer enriched" "Detected in all" 5 "testis cancer: 39.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046194 Approved Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA046194: AB_10965327" "unprognostic (2.59e-1)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.17e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-3)" "unprognostic (1.17e-2)" "unprognostic (8.47e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-3)" 13.4 16.0 12.3 17.3 20.3 20.4 19.8 35.6 25.0 18.0 5.9 27.6 26.6 22.6 17.4 13.6 22.3 22.7 11.8 17.6 15.3 22.5 12.1 16.8 22.9 12.9 13.2 17.4 24.2 16.9 28.2 20.9 14.2 15.1 14.7 28.8 56.7 15.6 13.9 10.2 17.7 22.5 18.5 3.9 19.4 28.1 20.1 10.3 27.2 22.5 16.5 21.9 13.2 13.9 22.1 18.6 18.0 39.2 21.4 25.3 33.4 24.9 20.1 21.4 36.6 43.3 19.9 24.0 20.9 8.7 18.9 20.4 16.2 25.2 16.4 50.7 34.2 26.3 25.9 19.8 17.9 23.3 35.4 29.9 19.3 11.7 23.6 41.1 34.6 26.9 28.5 17.2 13.2 23.9 19.8 33.5 53.9 78.3 36.0 13.5 28.9 43.3 28.5 21.7 14.9 18.1 15.7 18.1 17.5 19.3 57.5 23.2 23.4 23.4 21.9 17.5 19.9 21.5 10.6 8.8 33.4 13.5 26.4 16.4 23.2 6.7 3.3 5.6 14.9 7.6 7.6 8.4 5.6 6.8 5.1 7.3 5.9 6.9 14.2 17.1 3.9 9.1 4.9 12.3 20.3 35.6 25.0 17.6 15.3 12.9 13.2 17.4 15.1 3.9 10.3 22.1 12.4 9.6 19.6 41.1 14.8 6.9 4.3 4.1 10.2 30.4 8.0 6.6 16.2 14.3 16.3 5.5 52.1 3.9 13.6 16.9 5.9 3.5 72.2 14.3 13.2 11.2 16.2 17.1 244.6 4.6 2.6 11.5 30.1 11.7 17.7 18.8 16.8 6.7 8.3 18.5 253.4 20.4 6.1 33.8 6.7 17.6 8.7 17.3 7.2 84.3 9.1 6.4 10.3 149.3 103.0 3.4 11.4 7.9 12.0 3.9 13.6 6.4 17.4 42.9 6.6 12.0 11.7 14.1 7.8 13.3 5.5 2.6 11.5 9.4 16.5 4.6 AICDA "AID, ARP2, CDA2, HIGM2" ENSG00000111732 "Activation induced cytidine deaminase" Q9GZX7 12 8602170-8612867 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 15.5" "Cell type enhanced" "Detected in single" "Proximal enterocytes: 2.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "memory B-cell: 1.9;naive B-cell: 3.8" "Lineage enriched" "Detected in single" 6 "B-cells: 3.8" "Group enriched" "Detected in some" 7 "Daudi: 142.5;U-698: 118.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (2.71e-2)" "unprognostic (1.39e-2)" "unprognostic (7.76e-2)" "unprognostic (1.68e-1)" "unprognostic (8.73e-3)" "unprognostic (1.11e-1)" "unprognostic (4.05e-2)" "unprognostic (9.69e-2)" "unprognostic (1.96e-2)" "unprognostic (4.04e-6)" "unprognostic (8.82e-2)" "unprognostic (1.28e-1)" "unprognostic (4.21e-1)" "unprognostic (4.65e-1)" 0.1 0.1 0.4 3.7 0.3 0.6 0.0 1.1 0.6 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.5 0.3 0.3 0.1 0.0 0.1 0.2 15.5 0.3 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.2 0.3 0.0 1.4 0.3 0.8 0.0 0.1 0.7 0.2 0.2 0.2 0.4 0.2 0.0 12.1 0.1 0.1 0.5 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 142.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 5.3 0.2 0.1 0.0 2.0 19.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.5 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 1.3 0.1 0.1 0.6 0.1 0.4 0.5 0.1 0.0 0.1 118.4 0.0 0.3 0.1 0.5 0.2 0.1 0.1 0.1 0.0 1.9 0.1 0.0 0.1 3.8 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.2 0.4 0.3 1.1 0.6 0.3 0.1 0.3 0.2 0.4 0.6 0.1 0.2 0.5 0.2 0.0 0.6 0.0 0.9 0.3 0.6 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.6 0.2 0.0 0.7 0.0 0.8 0.1 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.1 0.3 RAB35 H-ray ENSG00000111737 "RAB35, member RAS oncogene family" Q15286 12 120095099-120117502 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054146 Approved NA NA "HPA054146: AB_2682399" "unprognostic (3.15e-2)" "unprognostic (1.94e-2)" "unprognostic (2.74e-2)" "unprognostic (2.47e-1)" "unprognostic (1.91e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (6.46e-6)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.16e-1)" "unprognostic (5.84e-2)" "unprognostic (4.50e-2)" "unprognostic (2.24e-1)" "unprognostic (5.13e-2)" "unprognostic (4.84e-2)" "unprognostic (6.60e-2)" "unprognostic (1.44e-1)" "unprognostic (1.49e-1)" 27.7 18.6 15.7 28.1 17.0 36.5 24.0 14.6 20.0 24.3 11.7 24.7 21.3 27.3 8.5 40.0 24.2 17.9 20.0 17.0 15.3 19.5 19.3 22.1 28.5 15.7 16.0 15.2 20.5 16.3 13.7 17.1 21.7 15.8 19.7 14.9 9.7 21.9 14.7 22.2 35.8 23.1 20.3 14.3 31.6 22.6 11.0 16.9 27.0 15.1 17.7 25.3 25.7 28.7 16.2 52.8 58.8 33.8 34.1 33.6 34.7 44.3 47.0 33.8 46.1 29.7 64.7 26.2 40.2 58.6 60.9 35.2 46.0 45.9 50.0 29.6 66.0 50.7 74.2 33.4 44.2 34.2 52.3 67.3 38.2 38.7 61.7 42.7 42.4 50.3 23.8 62.5 25.4 33.0 54.8 54.6 68.3 38.0 31.4 56.9 42.4 28.3 52.5 28.3 61.2 35.8 41.4 55.9 28.3 34.1 33.0 63.0 45.3 62.2 44.7 47.3 45.5 61.9 51.1 62.7 70.3 45.4 45.6 40.2 3.0 7.3 14.6 6.9 8.2 5.8 3.9 4.6 7.2 6.7 3.9 2.5 3.8 14.1 6.5 11.8 3.8 6.9 6.6 15.7 17.0 14.6 20.0 17.0 15.3 15.7 16.0 15.2 15.8 14.3 16.9 16.2 22.1 19.2 17.1 5.9 15.1 29.7 18.9 11.4 8.0 9.3 13.0 8.4 6.6 14.3 10.5 9.2 0.0 28.1 28.6 23.7 37.2 21.6 8.6 11.3 14.9 22.7 12.6 10.5 6.5 18.3 25.7 15.6 22.4 17.2 19.6 9.1 22.5 8.7 36.6 15.2 6.0 19.3 2.0 21.8 28.1 3.4 11.5 21.5 12.4 5.6 24.8 10.8 27.8 1.0 5.9 27.9 20.6 15.4 12.6 20.0 17.1 12.9 10.3 7.1 6.6 9.5 15.3 7.3 8.0 16.0 34.7 48.2 23.5 13.4 15.7 20.2 PHC1 "EDR1, HPH1, RAE28" ENSG00000111752 "Polyhomeotic homolog 1" P78364 12 8913896-8941467 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein, DNA-binding" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3" "Cancer enriched" "Detected in many" 7 "testis cancer: 32.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "BEWO: 141.8;NTERA-2: 492.6;SuSa: 178.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006973 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006973: AB_1855278" "unprognostic (4.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.73e-1)" "unprognostic (4.21e-3)" "unprognostic (7.46e-2)" "unprognostic (1.33e-1)" "unprognostic (1.59e-1)" "unprognostic (2.52e-1)" "unprognostic (1.47e-1)" "unprognostic (4.79e-3)" "unprognostic (1.69e-1)" "unprognostic (1.34e-2)" "unprognostic (7.55e-2)" "unprognostic (2.47e-1)" "unprognostic (9.27e-2)" "unprognostic (3.63e-2)" 20.0 18.3 22.9 17.9 20.8 7.6 23.3 24.8 22.0 45.4 28.5 25.8 6.9 42.3 13.4 20.9 45.0 15.9 20.0 21.6 26.8 25.1 7.0 21.6 16.2 19.6 20.8 18.7 47.6 25.7 26.6 76.3 14.3 21.7 32.0 9.5 40.3 23.8 20.4 16.3 10.5 21.2 22.6 18.8 22.4 22.5 43.7 18.7 28.3 44.6 10.4 14.7 28.2 27.1 19.5 6.6 11.1 46.5 43.0 13.8 14.5 141.8 6.6 13.7 11.3 14.7 7.4 10.5 17.4 5.7 11.3 17.4 5.8 12.9 15.4 15.2 60.8 7.5 22.8 14.5 7.5 15.0 12.4 38.5 18.0 8.0 18.1 18.1 36.2 13.7 19.8 4.6 6.4 11.5 8.2 15.8 22.1 492.6 2.5 3.7 25.1 31.3 0.9 12.3 29.0 9.0 32.1 10.4 23.4 17.4 178.3 3.4 12.4 7.8 20.8 34.5 13.2 9.6 12.8 8.9 24.9 9.3 6.7 14.4 0.6 0.2 0.0 0.8 1.1 0.5 1.1 1.2 1.5 0.1 0.9 1.2 0.9 0.0 0.8 2.8 1.2 0.8 0.8 22.9 20.8 24.8 22.0 21.6 26.8 19.6 20.8 18.7 21.7 18.8 18.7 19.5 11.9 16.0 19.8 48.3 7.7 2.4 5.5 4.6 9.1 24.2 10.8 11.2 0.5 11.5 13.1 9.2 27.1 5.9 10.1 0.8 1.9 5.4 26.4 20.0 17.4 11.0 11.4 9.5 36.4 5.2 11.5 11.8 5.1 10.6 19.0 15.5 8.6 2.0 4.4 16.8 44.0 2.7 4.1 5.4 3.9 17.6 14.3 6.0 7.2 12.2 3.2 17.7 7.2 23.1 13.0 4.6 1.9 12.0 3.0 4.5 0.7 5.3 19.2 36.8 0.0 15.8 12.2 17.7 25.1 10.2 2.4 5.1 11.2 8.7 2.0 4.9 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440737 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria NA NA 85000 Mitochondria "HPA062394: AB_2684749" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favorable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 327.2 399.7 957.4 205.2 957.6 371.2 324.1 984.7 1315.9 251.2 879.2 602.7 617.0 250.2 276.3 586.9 250.8 233.4 266.4 956.4 1004.9 668.7 712.9 271.3 275.5 998.5 992.6 939.9 209.1 376.2 994.9 346.9 195.1 1013.2 285.1 447.3 395.8 376.6 246.6 60.2 374.3 485.2 232.5 937.1 264.4 498.0 226.1 985.3 330.9 318.7 89.3 257.4 322.6 351.7 977.2 532.7 1142.5 627.4 653.5 475.4 403.9 755.8 327.1 447.7 585.1 497.2 1388.3 528.9 1115.9 955.5 477.1 442.6 865.0 624.6 737.3 382.3 663.5 1314.3 596.5 594.9 1036.8 434.6 661.9 405.9 487.3 895.5 531.3 632.3 477.0 505.0 801.0 602.9 337.1 494.2 1528.7 965.1 1667.1 566.1 1034.6 1627.5 644.7 414.7 1044.5 945.3 1302.6 822.4 708.6 595.6 589.9 803.5 347.1 1051.4 742.9 373.0 355.0 431.9 370.9 466.8 513.0 791.3 897.5 558.7 643.2 484.9 225.6 347.3 316.4 258.9 353.6 278.9 377.1 305.3 287.3 486.9 296.9 279.3 287.3 297.9 253.7 374.0 516.7 460.6 534.3 957.4 957.6 984.7 1315.9 956.4 1004.9 998.5 992.6 939.9 1013.2 937.1 985.3 977.2 346.4 397.4 312.4 41.1 355.0 383.3 526.3 1145.7 508.2 238.3 411.3 426.7 124.4 543.3 683.0 774.3 577.6 774.8 289.0 1306.7 1481.1 659.4 207.3 487.3 239.6 311.2 515.7 348.0 26.3 661.9 701.5 304.0 437.3 425.9 272.2 263.9 266.0 971.0 779.3 146.4 38.1 861.7 980.6 376.6 426.0 136.4 302.0 377.7 524.7 19.7 583.9 440.8 332.7 23.6 56.9 726.1 1417.1 265.5 565.2 506.1 1857.6 1701.6 718.9 414.2 341.8 259.0 508.6 455.8 373.7 1155.8 388.0 927.2 341.0 399.5 1049.7 778.9 AL021546.1 ENSG00000111780 "Novel protein" 12 120438198-120460006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 8.9;HEK 293: 11.5;U-266/84: 10.4" HPA062394 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (3.79e-2)" "unprognostic (1.74e-1)" "unprognostic (2.79e-1)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-1)" "unprognostic (9.54e-4)" "unprognostic (2.04e-1)" 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.4 0.5 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.3 2.0 2.6 0.0 0.6 0.0 0.0 0.0 1.8 0.3 0.5 0.0 8.9 0.0 0.5 3.2 0.0 0.8 0.9 0.0 0.5 0.0 1.6 11.5 0.7 0.0 0.0 0.0 4.1 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.9 0.2 0.0 0.0 3.2 0.4 0.2 0.0 4.6 1.8 1.2 1.0 0.0 0.0 4.5 0.3 2.9 0.7 0.0 0.0 0.8 0.4 2.4 1.5 0.4 0.0 1.2 0.9 10.4 3.8 0.6 1.3 0.0 1.6 6.1 5.6 5.0 8.9 5.6 4.9 3.0 5.7 11.0 3.8 3.3 3.1 1.3 2.2 6.9 7.9 5.4 4.2 0.2 0.2 0.2 0.4 0.2 0.3 0.4 0.3 0.1 0.3 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFX4 ENSG00000111783 "Regulatory factor X4" Q33E94 12 106583004-106762803 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 52.3;testis: 75.7" "Group enriched" "Detected in some" 5 "Astrocytes: 346.7;Spermatocytes: 98.7" "Cancer enriched" "Detected in single" 54 "glioma: 15.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "AF22: 48.0" "Low region specificity" "Detected in all" HPA050527 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA050527: AB_2681158" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-2)" "unprognostic (1.09e-1)" "unprognostic (6.97e-2)" "unprognostic (7.97e-2)" "unprognostic (3.04e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-3)" "unprognostic (1.66e-3)" "unprognostic (1.15e-2)" "unprognostic (1.30e-2)" "unprognostic (5.46e-2)" 0.1 0.0 34.3 0.0 33.1 0.0 0.0 35.3 29.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.8 49.7 0.0 0.0 0.0 0.0 52.3 38.0 21.0 0.0 0.1 0.0 10.0 0.0 39.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 75.7 37.2 0.0 0.1 0.0 0.0 0.0 0.0 32.6 0.0 0.3 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.3 33.1 35.3 29.5 28.8 49.7 52.3 38.0 21.0 39.1 39.0 37.2 32.6 0.0 0.0 0.0 346.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 41.8 0.0 0.1 0.2 0.0 0.0 13.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 13.4 0.0 0.0 0.0 0.0 29.2 2.1 0.0 0.0 7.5 0.1 0.1 0.0 27.6 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.1 98.7 2.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 RIC8B "FLJ10620, hSyn, RIC8" ENSG00000111785 "RIC8 guanine nucleotide exchange factor B" Q9NVN3 12 106774621-106889316 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 96.4;Inhibitory neurons: 93.9;Microglial cells: 58.1;Oligodendrocyte precursor cells: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039970, HPA042746" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039970: , HPA042746: AB_2678143" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (9.87e-3)" "unprognostic (5.43e-2)" "unprognostic (3.28e-2)" "unprognostic (8.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.60e-1)" "unprognostic (1.99e-2)" "unprognostic (3.83e-1)" "unprognostic (1.10e-3)" "unprognostic (5.13e-2)" "unprognostic (3.65e-3)" "unprognostic (2.21e-1)" "unprognostic (3.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-2)" 5.5 5.4 7.1 3.3 21.8 1.3 5.0 8.4 9.2 5.5 6.2 5.7 3.2 7.1 4.4 3.1 6.4 5.6 7.5 6.8 9.5 7.3 5.8 3.7 2.6 9.1 11.3 7.4 5.8 6.2 11.6 7.9 3.8 9.9 4.5 3.9 12.8 3.5 8.3 7.4 2.7 4.1 6.4 5.5 4.7 4.1 4.4 9.8 6.6 9.4 8.3 2.4 5.9 4.3 8.7 3.6 11.0 20.7 8.3 9.7 11.7 2.5 11.7 9.3 10.3 9.6 3.7 3.1 2.2 8.0 6.7 4.1 6.2 7.5 4.1 12.3 25.0 10.0 7.5 5.2 4.7 7.5 7.2 4.9 6.8 5.2 6.7 3.4 12.2 9.6 7.7 4.7 0.1 9.4 2.9 8.2 7.8 10.4 5.6 11.0 7.1 12.0 7.2 8.7 3.2 15.1 9.7 8.5 5.3 5.9 7.8 4.7 4.9 9.3 8.3 4.6 5.6 8.5 6.1 13.7 0.1 4.0 4.9 12.4 0.9 1.4 1.2 1.9 0.8 2.2 0.4 1.0 0.9 1.3 0.2 0.8 0.8 0.6 0.9 0.7 0.8 1.1 1.0 7.1 21.8 8.4 9.2 6.8 9.5 9.1 11.3 7.4 9.9 5.5 9.8 8.7 10.0 6.4 7.8 47.7 5.9 3.3 3.9 5.5 5.2 14.4 8.5 7.4 33.9 25.8 5.8 3.7 10.4 7.1 5.0 10.9 7.9 21.7 5.7 12.7 17.5 11.2 18.6 5.5 96.4 4.0 3.7 10.5 7.7 7.3 8.2 10.4 15.0 9.2 3.6 6.7 93.9 7.8 8.2 6.6 3.9 5.0 12.8 4.6 7.2 58.1 3.8 5.5 14.4 76.9 52.9 6.6 4.8 19.2 2.6 1.7 7.2 6.7 10.8 45.0 13.1 18.6 9.3 18.4 8.8 2.6 2.8 1.4 7.6 10.6 6.7 1.5 SRSF9 "SFRS9, SRp30c" ENSG00000111786 "Serine and arginine rich splicing factor 9" Q13242 12 120461672-120469748 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049849 Supported Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA049849: AB_2680911" "unprognostic (3.80e-1)" "unprognostic (3.84e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (2.50e-3)" "prognostic unfavorable (9.85e-7)" "unprognostic (9.65e-3)" "prognostic unfavorable (7.80e-4)" "unprognostic (2.31e-2)" "unprognostic (4.35e-1)" "unprognostic (1.19e-2)" "unprognostic (1.19e-3)" "unprognostic (9.57e-2)" "unprognostic (3.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" 62.5 113.0 74.2 76.2 75.1 95.8 72.8 76.7 74.6 70.9 81.4 89.5 73.7 58.0 86.3 127.6 76.8 49.1 38.4 73.4 78.2 89.0 92.8 62.6 100.1 77.1 78.6 69.6 71.8 114.8 95.0 78.8 85.9 76.4 77.5 85.0 22.0 77.7 57.9 30.2 79.0 64.0 59.4 76.9 87.4 83.3 94.0 82.2 111.3 81.4 27.8 130.1 83.7 76.3 75.0 334.7 229.2 344.3 222.7 153.6 153.7 365.3 224.3 200.7 281.5 240.2 276.9 153.1 323.6 254.7 189.4 152.7 194.9 312.0 318.9 308.5 244.7 321.9 276.3 152.8 273.5 197.7 344.7 241.8 163.4 201.8 244.6 211.0 301.2 260.4 207.0 353.6 95.3 245.9 466.8 339.7 668.7 429.6 224.8 198.2 374.2 144.1 312.9 246.4 420.4 303.9 217.3 262.5 137.3 276.2 222.4 415.9 299.4 229.1 207.8 247.0 157.8 246.3 288.6 234.5 404.9 218.8 255.7 221.5 28.7 16.9 49.3 22.5 19.8 17.5 41.2 17.4 19.9 22.5 36.7 17.3 19.1 19.7 26.5 27.7 30.7 20.1 8.7 74.2 75.1 76.7 74.6 73.4 78.2 77.1 78.6 69.6 76.4 76.9 82.2 75.0 172.6 25.6 37.2 17.3 190.1 264.9 269.7 81.2 140.0 74.5 235.6 174.4 1.7 157.3 60.4 161.8 29.2 339.2 204.5 119.5 489.1 200.6 68.5 179.1 149.9 143.8 144.7 141.9 24.1 155.1 469.4 148.9 105.5 143.9 33.7 321.3 132.8 150.0 202.9 72.3 23.6 160.5 63.1 136.3 322.0 28.5 124.5 171.3 200.9 11.2 192.7 134.4 129.8 14.1 24.1 152.4 102.2 155.0 317.8 336.8 89.8 404.3 63.6 55.3 52.6 128.1 165.5 288.5 248.8 218.2 313.4 475.4 158.1 433.1 160.6 392.2 FGFR1OP2 DKFZp564O1863 ENSG00000111790 "FGFR1 oncogene partner 2" Q9NVK5 12 26938470-26966650 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038308, HPA038696" Supported Approved Mitochondria NA NA Mitochondria "HPA038308: AB_10672524, HPA038696: AB_10675948" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (1.95e-1)" "unprognostic (2.34e-1)" "unprognostic (4.01e-2)" "unprognostic (1.19e-1)" "unprognostic (4.37e-3)" "unprognostic (1.72e-1)" "unprognostic (8.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (1.55e-2)" "unprognostic (6.82e-2)" "unprognostic (1.40e-1)" "unprognostic (5.33e-2)" "unprognostic (1.36e-2)" 25.9 42.0 34.0 30.9 38.7 62.1 26.6 33.5 44.3 24.0 28.8 20.7 23.3 31.9 29.2 23.3 23.9 28.9 28.8 38.9 34.2 31.2 28.0 26.0 42.7 34.1 34.7 34.4 60.1 15.2 19.4 18.0 27.3 35.2 20.1 20.2 31.0 18.4 18.8 23.5 23.7 23.0 26.8 37.6 33.5 20.7 23.2 34.3 36.5 24.4 33.0 31.2 25.4 21.3 49.7 30.3 36.9 30.5 41.1 51.9 37.4 44.2 51.6 60.1 39.1 42.5 57.3 34.4 44.3 24.8 45.9 37.4 31.4 21.3 38.8 55.5 33.6 31.1 75.0 39.4 38.4 61.3 43.5 54.9 27.3 24.8 47.7 61.6 53.3 56.8 39.6 45.3 33.0 46.2 36.3 58.0 103.3 50.4 39.1 59.9 34.6 84.2 37.1 34.8 36.5 9.3 18.5 58.9 21.5 52.1 69.9 38.5 65.3 61.7 51.6 52.0 95.9 48.5 23.1 25.2 93.4 43.2 50.2 42.7 81.1 31.5 40.6 31.6 31.4 28.3 22.3 33.0 30.7 25.2 19.7 29.8 33.3 32.0 25.9 31.3 20.6 61.3 23.7 34.0 38.7 33.5 44.3 38.9 34.2 34.1 34.7 34.4 35.2 37.6 34.3 49.7 70.8 38.5 37.2 39.2 97.1 140.3 62.3 30.6 86.0 52.7 45.4 39.6 45.4 24.3 41.2 27.6 77.2 41.5 114.1 19.9 72.4 28.9 17.9 28.9 47.8 70.1 26.9 249.0 79.4 23.1 37.8 86.5 23.0 30.8 59.5 77.9 70.6 30.7 60.6 58.9 30.6 22.0 26.4 64.7 96.2 18.8 105.3 74.6 88.9 47.8 49.6 64.3 83.4 63.8 128.5 29.7 29.0 170.8 138.2 56.7 27.2 70.0 20.8 48.0 46.0 69.6 81.4 32.9 70.1 57.4 119.8 59.5 141.2 42.9 20.0 63.5 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607916 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.8;lymphoid tissue: 36.7" "Group enriched" "Detected in many" 9 "dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in all" "MAIT T-cell: 2177.1" "Group enriched" "Detected in all" 140 "NK-cells: 756.7;T-cells: 2177.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 2.4 1.7 0.6 18.0 0.7 47.8 5.1 0.3 0.8 4.2 0.4 7.8 10.8 1.6 1.4 3.2 1.6 10.8 0.7 0.6 0.6 1.4 11.4 6.8 20.2 0.6 0.6 0.5 1.0 0.4 0.2 0.3 1.4 0.6 2.1 8.2 0.1 0.8 1.0 0.7 0.8 20.2 1.6 0.4 29.2 10.1 0.6 0.6 5.7 1.3 0.9 36.7 10.7 1.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.4 0.2 9.5 2.2 1.1 519.7 2.1 2177.1 1.6 307.4 346.1 1.9 1.5 17.1 98.0 10.5 756.7 3.6 3.9 77.9 285.3 0.6 0.7 0.3 0.8 0.6 0.6 0.6 0.6 0.5 0.6 0.4 0.6 0.8 6.1 0.0 8.9 0.0 19.0 9.7 0.9 0.0 1.2 0.0 5.2 2.5 1.0 4.3 1.3 0.0 0.0 0.4 642.3 1.7 0.0 0.6 0.0 1.9 1.5 6.2 0.0 118.1 0.4 0.0 0.1 7.9 12.2 2.4 0.0 0.0 45.3 10.1 0.9 0.0 0.6 1.0 0.0 36.2 15.8 0.0 0.0 13.2 24.9 0.0 28.1 0.0 1855.8 2.5 0.1 0.0 3.3 0.0 23.0 1.1 0.9 2.0 0.0 0.0 0.0 1.6 4.1 0.0 0.1 1.2 8.8 1.0 790.5 0.0 2.0 1.3 COL12A1 COL12A1L ENSG00000111799 "Collagen type XII alpha 1 chain" Q99715 6 75084326-75206267 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 125.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "fHDF/TERT166: 1432.1;SiHa: 846.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 29.1" "HPA009143, HPA010021" Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 9100000 Vesicles Cytosol "HPA009143: AB_1847095, HPA010021: " "unprognostic (2.60e-2)" "unprognostic (2.80e-3)" "unprognostic (7.92e-2)" "unprognostic (8.27e-3)" "unprognostic (1.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (3.47e-3)" "unprognostic (1.38e-1)" "unprognostic (4.30e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "prognostic unfavorable (1.69e-9)" "unprognostic (1.03e-3)" "unprognostic (1.81e-1)" "unprognostic (3.16e-3)" "unprognostic (1.92e-2)" 82.9 15.9 1.5 16.1 2.0 0.0 65.9 1.0 2.9 101.7 1.2 58.2 8.8 125.6 5.5 36.6 42.6 21.0 25.6 1.3 1.2 19.6 3.5 24.9 7.3 2.0 4.7 1.0 124.2 5.9 5.0 4.9 1.8 1.1 21.0 17.4 0.4 16.2 42.8 14.5 39.8 41.0 72.7 0.7 11.5 18.2 4.6 1.7 5.6 19.4 12.7 4.2 26.5 46.2 1.4 0.2 2.2 11.5 0.2 270.2 162.0 28.3 275.4 229.3 186.2 257.3 27.5 0.7 0.0 27.7 1432.1 3.9 59.2 0.5 28.7 174.6 0.2 1.4 0.2 101.1 0.1 97.9 0.3 0.2 234.9 5.0 42.2 50.6 173.6 32.0 0.1 0.0 0.0 29.4 0.2 0.1 0.2 6.4 0.0 15.3 0.1 23.1 0.2 8.9 14.4 0.0 0.0 846.1 21.2 0.3 15.5 131.8 0.5 0.2 78.5 97.0 41.5 91.4 0.1 0.1 0.4 26.4 0.3 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 1.0 2.9 1.3 1.2 2.0 4.7 1.0 1.1 0.7 1.7 1.4 14.2 76.9 5.1 2.3 0.0 20.6 0.6 12.7 5.2 0.4 4.7 7.1 4.1 0.0 4.7 3.7 0.0 0.6 0.0 0.0 0.0 1.4 24.1 6.3 44.3 11.0 0.0 0.0 52.9 4.6 1.3 99.7 2.6 14.1 1.3 0.1 3.3 0.0 0.8 0.0 32.4 0.0 0.0 0.3 18.4 14.7 60.3 1.8 21.4 38.4 0.0 0.0 0.0 19.6 1.2 6.7 0.0 13.2 0.1 1.7 0.0 0.9 1.7 0.0 46.0 20.0 48.6 0.3 0.6 0.6 13.1 0.7 2.5 1.4 0.1 0.3 BTN3A3 "BTF3, BTN3.3" ENSG00000111801 "Butyrophilin subfamily 3 member A3" O00478 6 26440472-26453415 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 26.9;NK-cells: 33.0;Plasma cells: 30.5;T-cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 62.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.8" "HPA007904, HPA011871" Enhanced NA NA "HPA007904: AB_1078307, HPA011871: AB_1845496" "unprognostic (1.18e-2)" "unprognostic (6.54e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-2)" "unprognostic (2.30e-2)" "unprognostic (8.60e-2)" "unprognostic (5.13e-3)" "unprognostic (8.08e-2)" "unprognostic (7.88e-2)" "prognostic favorable (1.80e-4)" "unprognostic (4.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (3.49e-2)" "unprognostic (2.14e-2)" "unprognostic (5.26e-2)" "unprognostic (4.54e-3)" 15.1 19.8 7.0 20.2 7.6 5.6 12.1 6.4 7.9 16.8 8.2 15.1 17.7 16.9 18.8 8.4 20.5 20.5 9.0 7.2 8.3 9.0 20.7 34.0 29.5 8.7 7.1 5.9 19.7 4.9 5.1 12.3 10.2 7.5 9.5 14.8 1.8 12.4 11.3 5.9 11.7 16.9 17.2 7.4 47.6 16.4 3.4 7.7 21.7 9.2 14.5 23.0 16.8 9.6 8.6 4.1 1.8 1.8 1.6 33.2 62.8 0.5 5.4 29.7 12.0 43.8 0.0 12.3 25.0 24.5 9.0 11.1 2.9 2.6 9.7 5.8 21.4 4.2 11.5 11.8 1.3 24.2 6.4 2.1 33.4 3.8 10.5 3.9 19.3 24.1 9.4 0.5 3.7 6.7 0.0 16.7 5.3 0.1 0.0 2.9 16.7 3.3 24.9 9.4 3.3 2.2 3.9 3.3 3.1 6.2 0.4 0.8 3.5 15.0 5.8 1.3 6.5 3.8 4.1 1.0 2.5 15.4 12.0 6.2 49.0 15.7 13.4 54.7 23.2 43.7 19.3 37.6 55.5 12.4 14.0 36.3 49.0 11.6 45.9 24.6 6.4 46.2 33.3 7.0 7.6 6.4 7.9 7.2 8.3 8.7 7.1 5.9 7.5 7.4 7.7 8.6 20.3 9.6 7.7 0.3 15.9 1.8 1.9 2.8 8.0 0.2 3.6 2.8 4.9 0.0 5.2 0.0 0.0 2.5 26.9 6.4 1.9 5.3 4.6 4.2 9.4 22.1 1.2 9.9 1.4 2.3 1.6 11.1 7.1 4.3 3.8 8.7 15.7 4.0 4.3 0.0 2.1 8.9 0.0 20.8 4.0 18.0 4.1 12.4 3.6 2.8 12.6 2.3 33.0 1.5 0.4 2.4 3.9 2.2 30.5 2.0 12.8 1.1 3.3 0.0 6.6 4.9 4.0 0.4 0.3 3.1 2.0 0.5 27.1 12.3 6.2 1.9 TDP2 TTRAP ENSG00000111802 "Tyrosyl-DNA phosphodiesterase 2" O95551 6 24649979-24666930 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Hydrolase, Nuclease" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 184.7" "Cell type enhanced" "Detected in all" "Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 75.6;neutrophil: 228.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 228.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB073398, HPA074011" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" No No "Nucleoplasm, Nuclear bodies" "CAB073398: , HPA074011: AB_2686651" "unprognostic (2.46e-2)" "unprognostic (2.10e-3)" "unprognostic (1.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.58e-1)" "unprognostic (4.66e-3)" "unprognostic (4.13e-3)" "unprognostic (3.24e-1)" "unprognostic (5.78e-3)" "prognostic favorable (2.53e-7)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.70e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.47e-5)" 24.6 23.9 30.1 34.7 30.7 22.0 27.6 33.0 36.7 20.8 33.1 142.9 121.2 19.9 25.5 18.8 22.8 28.9 28.5 30.2 31.7 78.6 51.6 24.7 39.2 31.0 32.0 29.2 21.5 29.7 25.9 20.4 20.3 31.1 57.0 128.5 19.0 22.1 22.0 22.0 21.3 184.7 24.8 31.3 28.2 26.4 25.5 33.6 37.8 21.9 26.5 38.0 27.5 16.6 32.5 47.7 37.1 41.5 48.1 63.0 64.0 32.4 41.4 53.1 38.9 51.9 50.8 26.3 57.0 70.1 43.8 90.0 34.2 51.2 47.3 52.9 73.6 53.1 53.4 37.7 84.2 40.1 82.8 49.5 43.1 43.7 40.7 36.5 46.0 63.9 54.1 48.8 23.7 59.2 34.1 64.7 52.8 37.1 54.7 31.8 55.5 43.7 61.6 67.0 66.5 52.2 29.8 33.6 84.5 71.0 42.2 38.9 47.4 48.0 37.6 31.3 28.3 61.4 33.7 107.9 77.1 26.0 107.5 61.3 75.6 13.9 29.4 25.0 14.8 30.8 20.0 28.8 27.9 13.2 14.5 24.0 26.2 228.9 29.0 16.5 12.4 31.9 22.7 30.1 30.7 33.0 36.7 30.2 31.7 31.0 32.0 29.2 31.1 31.3 33.6 32.5 24.0 6.4 16.7 23.5 24.1 14.1 25.1 37.0 18.8 12.7 19.8 20.2 23.4 37.1 29.6 22.0 6.2 18.4 23.0 530.9 49.0 35.4 140.6 19.4 16.6 22.5 52.7 20.8 25.9 36.0 23.6 18.3 14.3 19.7 24.1 15.7 27.5 31.4 68.4 6.7 25.8 168.9 30.5 28.9 20.0 80.2 18.0 33.5 12.4 15.0 61.7 19.5 38.1 11.6 21.2 21.4 428.1 23.3 10.7 37.0 637.5 175.8 30.5 15.8 32.9 19.1 20.4 9.0 32.7 10.4 16.6 44.3 28.5 15.7 119.3 31.9 FRK "GTK, PTK5, RAK" ENSG00000111816 "Fyn related Src family tyrosine kinase" P42685 6 115931149-116060891 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 11.4" "Cell type enhanced" "Detected in many" "Early spermatids: 89.4;Oligodendrocytes: 97.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 18.3;RT4: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025217, HPA030479, HPA072590" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025217: , HPA030479: AB_2732457, HPA072590: " "unprognostic (7.70e-3)" "unprognostic (1.99e-2)" "unprognostic (1.11e-1)" "unprognostic (4.68e-3)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (4.23e-2)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (7.54e-2)" "prognostic favorable (9.66e-7)" "unprognostic (1.52e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.10e-1)" 0.8 1.1 1.6 1.2 2.6 1.5 2.4 6.3 5.5 1.8 11.4 4.6 6.2 1.0 2.5 2.9 2.6 2.6 1.6 2.3 0.6 9.1 6.8 1.8 0.7 1.4 1.6 1.0 0.9 2.8 1.0 0.4 0.9 2.5 2.3 4.9 2.9 4.0 2.4 2.2 1.9 6.3 0.8 0.3 0.9 5.0 1.9 0.4 1.2 1.0 0.8 1.6 2.1 1.0 6.0 2.5 4.0 0.5 0.9 0.2 0.2 0.6 0.5 0.1 0.0 0.1 3.1 3.8 0.9 3.5 0.5 0.5 5.8 0.2 1.1 0.1 3.3 0.3 1.3 3.3 2.7 0.2 0.9 0.7 0.2 1.5 0.3 0.4 0.4 0.2 0.6 0.6 2.3 1.0 1.3 0.7 0.5 1.0 18.3 0.7 1.1 3.3 1.2 4.8 7.6 0.7 0.8 0.7 5.1 0.5 0.9 1.5 0.7 0.8 1.0 1.0 0.7 0.5 3.6 2.7 1.6 1.1 0.6 0.6 0.9 0.2 0.2 0.4 0.1 0.5 0.2 0.3 0.4 0.1 0.4 0.2 0.3 0.8 0.3 0.2 0.3 0.2 0.0 1.6 2.6 6.3 5.5 2.3 0.6 1.4 1.6 1.0 2.5 0.3 0.4 6.0 0.4 0.0 10.3 10.4 0.5 2.7 20.8 23.3 6.8 0.6 7.3 2.9 9.2 11.5 22.6 23.9 0.0 4.4 0.1 34.9 11.7 20.3 89.4 28.1 1.7 0.7 19.8 0.0 12.2 16.4 4.3 3.5 29.0 30.4 3.8 0.2 1.4 21.9 0.9 6.7 7.7 14.5 34.6 0.6 0.4 38.1 0.6 0.6 0.0 1.0 1.0 0.2 0.0 2.5 97.8 21.9 23.3 1.2 0.5 23.4 49.3 28.4 36.6 0.3 13.1 9.9 16.2 4.6 1.0 16.4 3.1 0.8 1.0 2.3 19.1 46.2 DSE "DS-Epi1, DSEPI, SART2" ENSG00000111817 "Dermatan sulfate epimerase" Q9UL01 6 116254173-116444861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 112.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014764 Uncertain "Intracellular and membrane" NA NA "HPA014764: AB_1856587" "unprognostic (1.28e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-3)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.02e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.34e-4)" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.19e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "unprognostic (1.10e-2)" 27.3 10.8 4.0 27.0 4.3 18.5 18.5 4.1 5.5 13.2 10.4 7.8 6.4 10.6 8.3 13.8 14.8 15.0 8.9 3.0 7.8 8.7 11.4 15.4 16.5 6.4 4.8 2.6 13.9 3.8 11.2 6.0 23.3 5.6 8.6 8.1 3.5 7.0 10.3 6.9 13.3 9.1 15.1 4.6 18.8 6.5 6.2 7.0 10.3 6.6 10.8 9.8 19.8 14.4 5.7 32.7 7.0 23.6 22.2 62.0 40.7 26.5 37.6 88.2 46.4 67.4 0.2 8.9 0.9 3.3 66.3 46.4 60.8 3.3 88.7 60.1 33.9 14.6 2.2 9.8 0.3 69.0 1.5 1.7 86.8 37.4 51.5 50.0 24.0 27.7 8.3 0.8 14.4 22.4 1.0 4.4 1.8 12.7 0.2 1.8 5.6 21.6 15.6 30.4 2.2 7.8 5.9 36.4 0.1 0.8 16.2 0.3 3.9 10.5 46.4 13.4 11.8 30.6 3.1 1.1 1.6 24.6 4.0 5.5 0.4 2.0 0.1 0.6 2.5 0.3 2.0 0.5 0.3 5.9 2.1 0.6 0.3 1.6 0.1 1.6 2.7 0.1 0.8 4.0 4.3 4.1 5.5 3.0 7.8 6.4 4.8 2.6 5.6 4.6 7.0 5.7 9.4 16.0 4.1 64.9 15.4 52.0 26.4 42.2 78.6 6.3 7.4 10.7 8.3 2.8 20.7 3.7 0.0 2.9 16.5 0.3 7.9 4.8 52.2 11.0 21.9 15.4 1.2 11.4 46.8 8.5 7.0 73.7 3.6 3.1 22.8 100.9 56.4 5.7 39.8 1.7 48.9 0.6 8.2 83.6 77.1 24.9 55.0 112.2 10.6 51.5 79.4 3.4 5.2 73.4 86.4 13.6 0.4 30.1 8.9 32.0 0.4 7.7 30.3 3.0 32.9 16.4 33.4 6.1 5.5 76.6 39.9 4.9 14.0 17.2 1.0 51.0 RWDD1 PTD013 ENSG00000111832 "RWD domain containing 1" Q9H446 6 116571409-116597675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028712, HPA028713" Approved NA NA "HPA028712: AB_10602793, HPA028713: AB_10601485" "unprognostic (1.44e-2)" "unprognostic (4.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.46e-1)" "unprognostic (7.36e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.64e-1)" "unprognostic (6.37e-2)" "unprognostic (4.30e-2)" "unprognostic (9.24e-2)" "unprognostic (9.58e-2)" "unprognostic (9.60e-2)" "unprognostic (4.83e-3)" "unprognostic (1.63e-1)" 56.9 47.9 45.5 31.3 47.8 60.4 52.0 50.9 48.7 50.6 42.9 58.7 36.5 47.6 37.6 41.4 47.7 35.1 63.8 42.8 49.9 45.0 45.5 41.7 41.1 48.5 47.1 39.6 54.5 72.6 47.5 32.6 31.6 49.0 45.9 34.0 61.1 59.6 37.4 129.8 34.8 35.8 36.3 52.0 33.2 50.3 24.1 47.4 35.4 36.4 97.5 39.1 55.7 45.7 54.0 48.4 30.1 65.5 142.2 102.8 127.3 41.4 111.7 69.8 66.3 74.5 53.8 27.9 70.5 68.2 74.7 78.6 37.7 52.6 70.1 90.7 84.6 81.5 62.4 45.8 77.7 81.4 102.7 51.2 79.3 81.3 44.8 77.0 95.4 78.1 69.9 99.8 96.9 101.2 44.1 97.9 136.0 32.9 82.2 58.4 82.0 43.0 63.3 84.9 38.2 57.1 56.5 35.1 70.1 133.7 64.5 46.6 93.3 57.9 78.1 42.1 74.6 120.9 70.3 86.6 133.3 69.9 79.4 84.7 63.9 42.2 44.7 64.7 55.0 83.2 69.7 85.3 74.6 51.0 57.7 78.0 78.3 16.7 89.0 73.4 75.5 118.0 51.9 45.5 47.8 50.9 48.7 42.8 49.9 48.5 47.1 39.6 49.0 52.0 47.4 54.0 139.4 70.5 75.9 14.4 118.0 206.5 166.2 212.3 135.5 133.5 153.3 211.5 205.0 134.4 120.1 130.6 116.7 106.5 130.5 105.1 440.3 130.2 191.5 68.0 120.8 148.5 90.3 108.2 15.5 184.4 147.0 151.9 67.2 76.3 107.2 100.8 172.1 209.3 162.1 106.0 17.6 131.2 150.5 194.0 173.3 149.3 220.3 121.0 209.9 2.8 146.9 169.7 196.7 7.5 19.4 145.4 114.1 222.3 145.1 226.5 183.5 479.7 75.9 179.2 170.9 176.9 188.4 164.4 119.5 164.1 213.5 97.4 144.8 166.2 138.5 159.3 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head component 4A" Q5TD94 6 116616479-116632985 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 17.6;fallopian tube: 37.5" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 3.3;U-266/84: 2.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 14.5" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.5 0.5 6.3 0.3 1.6 0.9 0.6 2.0 1.3 1.2 17.6 0.3 0.3 1.6 0.5 0.2 37.5 0.5 0.4 1.3 4.4 0.5 0.5 4.6 0.3 5.2 4.9 0.4 0.8 0.8 2.0 4.3 0.1 3.8 0.5 0.2 6.1 0.4 0.2 0.9 0.5 0.5 0.4 6.1 0.9 0.5 2.8 2.1 0.5 0.9 0.2 0.3 0.3 0.3 2.9 0.0 0.1 0.6 1.4 0.0 0.0 0.1 0.1 0.3 0.2 0.3 0.3 0.5 0.4 0.1 0.0 0.5 0.1 0.1 0.2 0.2 0.3 0.5 0.2 0.2 0.5 0.0 0.3 0.4 0.1 0.1 0.4 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.3 0.7 3.3 1.3 0.2 1.2 0.5 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 2.4 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.6 2.0 1.3 1.3 4.4 5.2 4.9 0.4 3.8 6.1 2.1 2.9 0.8 3.2 3.4 7.2 0.3 0.0 0.1 4.9 0.0 3.3 0.4 0.8 0.6 0.0 22.9 0.0 2.1 0.0 0.1 0.1 1.9 0.4 33.1 92.4 1.6 2.2 0.0 0.0 10.6 0.4 0.1 1.1 0.5 1.4 2.5 0.7 1.8 0.0 0.1 1.7 12.9 0.0 10.2 0.0 0.0 9.3 0.3 0.4 1.8 0.0 0.0 2.0 0.0 3.5 5.0 0.2 0.0 0.0 0.2 0.3 0.0 0.1 260.6 3.7 0.0 2.0 2.4 9.3 1.6 0.0 0.1 0.3 0.5 5.7 0.0 0.1 MAK "dJ417M14.2, RP62" ENSG00000111837 "Male germ cell associated kinase" P20794 6 10762723-10838553 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "retina: 120.0" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 369.1;Early spermatids: 119.7;Rod photoreceptor cells: 330.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 9 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.3" "Cell line enhanced" "Detected in single" "HDLM-2: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.23e-3)" "unprognostic (8.77e-3)" "unprognostic (2.44e-1)" "unprognostic (3.81e-2)" "unprognostic (6.62e-2)" "unprognostic (1.35e-3)" "unprognostic (1.97e-2)" "unprognostic (2.53e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (6.73e-2)" "unprognostic (6.59e-5)" "unprognostic (1.55e-1)" "unprognostic (8.40e-2)" "unprognostic (7.71e-3)" "unprognostic (4.59e-2)" 0.2 0.1 1.0 0.6 0.1 0.6 0.4 1.5 0.4 0.3 4.4 0.0 0.1 0.4 0.0 0.2 5.4 0.4 0.1 0.1 0.0 0.1 0.0 0.8 0.1 0.6 0.6 0.0 0.1 0.2 4.7 0.8 0.1 0.6 0.2 0.0 120.0 0.2 0.0 0.1 0.3 0.1 0.0 0.4 0.7 0.3 4.7 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.7 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.1 1.3 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.4 0.6 0.3 0.3 0.3 0.3 0.1 0.3 0.2 0.3 0.4 0.3 0.5 6.3 0.2 0.6 0.3 0.1 0.1 1.0 0.1 1.5 0.4 0.1 0.0 0.6 0.6 0.0 0.6 0.4 0.3 0.3 2.1 0.0 6.4 16.3 1.5 0.4 2.3 0.8 2.8 14.6 4.0 3.9 0.9 0.0 5.3 3.7 369.1 0.5 0.5 0.1 0.0 0.4 119.7 43.3 1.7 1.8 0.0 1.3 45.6 0.2 1.0 2.2 1.1 3.8 2.5 0.3 1.1 0.1 0.2 5.0 39.4 0.0 2.0 0.6 0.7 47.1 0.6 1.3 1.8 12.2 1.3 23.6 0.0 30.7 21.5 0.1 0.0 0.4 1.0 1.1 0.0 0.1 48.9 330.1 0.0 5.4 1.5 15.2 5.5 0.7 0.4 0.8 0.8 0.3 0.0 0.8 TMEM14C "bA421M1.6, C6orf53, HSPC194, NET26" ENSG00000111843 "Transmembrane protein 14C" Q9P0S9 6 10722915-10731129 "Predicted membrane proteins" "Heme biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.08e-3)" "unprognostic (1.10e-1)" "unprognostic (2.82e-2)" "unprognostic (3.53e-2)" "unprognostic (3.77e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.66e-4)" "unprognostic (2.83e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (5.93e-2)" "unprognostic (3.39e-3)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (2.34e-1)" 94.5 125.6 28.3 22.8 29.1 60.3 88.0 32.0 37.8 89.9 37.7 87.2 42.9 94.8 43.1 64.5 85.5 40.6 102.6 26.0 34.1 93.8 70.9 67.6 29.9 29.8 29.2 25.4 88.8 67.3 60.8 52.9 37.6 30.6 87.5 37.9 26.0 81.0 42.2 124.8 60.5 63.9 34.5 31.5 51.8 82.0 32.9 30.2 34.0 79.8 71.3 26.8 80.9 74.0 32.7 123.7 70.1 53.7 80.4 103.4 115.5 52.4 70.8 114.5 80.5 89.5 71.6 88.2 81.8 151.8 81.6 159.5 57.3 30.1 85.1 62.4 53.7 51.0 52.4 67.8 109.4 127.3 41.0 36.6 103.5 91.1 60.6 98.7 88.6 42.8 21.4 130.4 29.8 110.3 67.2 27.8 114.4 64.4 59.0 73.6 51.4 71.5 132.7 113.0 51.3 44.8 58.5 70.3 109.8 134.4 105.7 68.3 49.0 102.3 106.6 64.7 44.4 109.5 69.3 132.7 38.6 61.4 52.8 114.2 48.2 39.2 68.2 10.9 39.4 32.1 31.2 27.0 16.3 70.5 23.7 26.2 22.2 4.0 32.0 35.6 66.1 32.2 31.6 28.3 29.1 32.0 37.8 26.0 34.1 29.8 29.2 25.4 30.6 31.5 30.2 32.7 163.2 115.4 77.3 15.7 59.1 99.4 135.2 318.8 99.6 41.0 167.4 219.2 129.3 151.5 171.0 156.3 8.4 239.7 60.3 148.4 270.1 200.0 4.8 132.3 159.6 122.7 122.4 472.5 10.0 138.6 275.2 158.9 66.3 128.2 137.1 104.4 124.2 142.5 390.8 16.8 14.6 177.6 189.2 151.5 228.0 15.0 179.3 146.3 193.9 9.4 288.6 199.5 8.2 7.1 18.0 206.3 192.6 190.7 90.8 163.9 274.4 310.4 128.3 51.5 177.5 114.3 160.3 41.5 99.0 134.2 115.5 195.2 56.7 176.2 204.5 141.8 PAK1IP1 "bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84" ENSG00000111845 "PAK1 interacting protein 1" Q9NWT1 6 10694972-10709782 "Predicted intracellular proteins" "Ribosome biogenesis" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030111, HPA030112" Supported Supported Nucleoli NA NA Nucleoli "HPA030111: AB_2732454, HPA030112: AB_10603125" "unprognostic (9.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.67e-2)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (7.23e-2)" "unprognostic (9.29e-3)" "unprognostic (1.06e-3)" "unprognostic (2.14e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.02e-8)" "unprognostic (8.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.11e-1)" "unprognostic (2.10e-1)" 11.6 10.4 6.3 7.7 6.3 10.7 12.5 6.3 8.1 9.4 6.1 8.4 4.2 10.4 7.3 16.4 8.5 5.3 9.2 6.3 6.6 6.7 11.4 7.3 7.9 6.4 6.3 6.2 8.1 9.7 5.8 6.7 7.1 6.5 38.1 7.4 4.9 9.3 5.7 15.4 8.4 7.2 8.1 6.5 8.3 7.8 5.8 6.5 7.1 7.5 9.8 9.7 11.6 10.0 7.5 35.3 13.7 17.2 29.9 21.3 19.4 24.9 22.4 18.7 33.7 32.9 30.2 15.4 35.6 54.9 19.4 41.4 18.4 35.8 29.2 48.1 20.9 23.3 19.4 12.4 35.2 31.1 54.5 24.3 17.9 25.2 32.6 55.3 11.1 22.9 19.2 60.2 10.0 28.3 21.2 27.4 49.5 37.4 32.7 24.1 27.9 22.4 55.0 24.4 21.0 25.7 22.4 16.8 42.7 51.1 28.9 18.9 19.6 19.6 26.9 19.5 29.2 56.4 23.3 68.7 38.9 11.0 36.3 51.7 2.0 8.1 2.9 9.4 12.4 9.6 10.0 8.3 9.4 11.7 7.2 11.1 13.5 0.4 9.9 10.3 13.7 5.9 6.8 6.3 6.3 6.3 8.1 6.3 6.6 6.4 6.3 6.2 6.5 6.5 6.5 7.5 22.6 19.2 12.3 8.8 18.5 66.4 54.2 47.3 30.1 13.2 18.6 28.3 18.6 17.2 35.0 11.0 4.2 24.9 24.8 10.3 19.6 43.3 12.4 26.0 35.0 24.1 5.4 31.1 9.9 26.9 32.0 32.0 14.8 34.3 35.5 16.6 15.0 21.7 36.6 13.5 10.9 12.7 42.7 16.1 12.6 8.4 21.5 18.2 12.4 6.5 22.1 12.0 12.3 9.5 12.5 31.3 7.7 20.7 18.2 56.5 5.1 27.0 17.7 11.8 6.6 40.9 31.4 27.3 44.2 29.3 49.9 17.5 16.3 23.1 24.0 28.6 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2 (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4" "Region enriched" "Detected in all" 4 "basal ganglia: 61.1" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 750000 "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 0.6 0.3 0.8 1.0 0.7 0.3 10.2 2.5 1.1 4.2 3.6 3.3 5.2 1.4 0.2 1.4 0.8 1.5 4.4 0.7 0.9 5.7 5.2 3.9 1.8 1.0 0.8 0.5 0.3 1.3 0.4 1.4 2.6 1.2 13.6 2.0 0.3 4.3 0.3 0.7 1.4 5.8 1.6 0.9 1.5 6.0 2.5 0.8 0.5 1.2 1.8 2.4 1.0 0.7 1.0 6.3 4.9 1.5 4.8 0.0 0.0 9.6 0.0 4.1 1.1 0.5 11.0 5.2 3.5 44.2 0.0 3.2 0.3 0.4 5.1 2.9 3.1 1.8 0.5 2.6 19.7 0.0 1.7 4.7 0.0 0.0 0.5 0.0 2.4 9.1 0.0 0.4 0.0 0.4 0.0 0.0 4.0 4.4 0.0 3.6 0.2 3.8 6.0 16.0 2.9 4.0 1.2 0.0 14.4 17.1 21.4 0.3 0.8 6.4 0.8 0.5 0.0 5.0 0.1 0.0 2.4 0.8 0.3 2.3 1.9 1.1 0.5 0.1 0.8 0.0 0.7 0.1 0.1 0.8 0.4 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.3 0.8 0.7 2.5 1.1 0.7 0.9 1.0 0.8 0.5 1.2 0.9 0.8 1.0 1.4 76.9 32.4 1.0 9.5 4.6 6.6 15.5 9.6 5.1 30.5 16.1 18.4 2.8 28.6 7.3 0.0 27.9 6.4 15.5 11.7 2.9 4.3 79.1 5.5 11.0 2.4 25.9 0.7 24.7 2.1 2.0 16.8 105.5 2.5 0.0 12.8 32.0 15.8 3.3 11.8 5.6 6.1 7.7 9.4 8.2 0.3 7.8 49.8 52.5 11.1 2.4 0.0 18.6 1.1 12.0 11.9 0.0 1.0 16.6 44.3 13.4 27.9 0.6 0.0 0.7 2.2 6.2 27.6 11.2 1.7 10.9 3.1 0.0 16.3 8.1 SMIM8 "C6orf162, dJ102H19.2, DKFZP586E1923" ENSG00000111850 "Small integral membrane protein 8" Q96KF7 6 87322583-87399749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007401, HPA067453" Approved Approved Vesicles NA NA Vesicles "HPA007401: AB_1078357, HPA067453: AB_2685844" "unprognostic (2.54e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.90e-1)" "unprognostic (1.56e-2)" "unprognostic (3.16e-2)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (5.31e-2)" "unprognostic (6.12e-3)" "unprognostic (1.86e-5)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (4.01e-1)" 5.0 5.1 8.2 3.8 8.5 6.1 5.3 9.0 9.5 6.4 8.3 5.6 5.2 6.6 6.8 4.2 5.5 2.7 6.9 8.5 8.7 5.9 7.1 3.9 5.0 8.6 8.6 8.4 6.5 4.7 6.3 7.3 3.4 8.7 4.8 4.6 8.8 4.0 4.0 10.7 4.2 4.8 4.1 8.2 4.1 4.1 5.0 8.8 6.8 4.9 8.8 4.0 5.3 5.6 8.8 5.3 4.6 9.3 16.2 5.3 6.0 4.1 5.8 4.5 4.8 9.2 3.2 4.8 10.8 6.8 5.8 8.4 6.5 7.6 4.4 9.1 9.6 8.2 15.9 5.2 6.4 5.0 16.8 5.5 5.7 5.9 4.9 5.2 5.4 7.0 13.8 18.1 17.7 5.5 4.0 10.1 13.3 5.7 7.9 7.1 16.1 13.8 6.2 6.2 5.2 15.9 6.5 8.5 5.0 10.1 8.4 4.6 16.5 6.8 2.5 7.2 10.8 5.7 7.8 13.6 7.2 8.1 7.9 7.6 5.8 8.8 15.7 11.2 8.6 11.4 18.5 13.2 13.6 10.1 11.4 19.3 16.9 14.7 9.7 10.3 8.5 18.4 9.1 8.2 8.5 9.0 9.5 8.5 8.7 8.6 8.6 8.4 8.7 8.2 8.8 8.8 19.4 12.8 5.8 18.9 17.6 13.8 20.6 29.7 8.6 24.4 12.8 16.0 47.3 17.2 16.6 23.9 37.5 17.7 8.7 8.0 45.0 10.7 18.7 32.1 19.0 15.0 8.5 17.1 21.7 10.3 12.3 17.8 12.8 9.6 5.1 31.4 22.5 13.8 14.9 37.0 19.8 9.4 36.7 12.3 11.5 14.5 15.8 11.1 8.8 8.4 11.0 28.4 13.4 8.0 13.3 8.1 11.6 20.7 14.0 10.1 15.5 23.0 17.5 22.9 26.3 21.1 17.9 23.9 28.4 10.7 14.8 14.9 14.8 30.7 16.5 13.4 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 137.3;HSkMC: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 82.5 8.7 10.1 23.5 8.7 8.6 64.8 6.9 11.9 26.8 13.9 31.0 15.6 19.4 17.6 14.6 22.9 31.6 31.1 8.2 31.3 34.1 20.9 92.7 26.0 8.8 7.9 6.3 8.3 17.2 9.6 8.2 69.8 9.5 22.6 30.5 9.9 26.9 30.1 27.5 17.9 38.4 26.0 7.3 25.4 23.7 7.0 9.5 22.4 25.8 12.1 22.4 34.9 15.4 10.1 4.4 29.0 26.4 0.4 17.7 2.3 27.7 6.6 8.2 12.2 22.4 9.3 1.9 9.2 137.3 14.7 1.5 12.6 36.0 13.5 15.8 4.1 1.0 0.8 4.4 62.3 8.3 10.1 0.4 67.7 4.0 7.9 1.3 4.4 21.0 0.8 0.1 7.6 27.7 1.3 5.8 4.0 4.1 34.6 2.9 1.6 0.7 5.4 6.1 39.8 0.6 4.8 1.1 31.2 55.5 29.3 2.3 7.7 53.8 8.2 14.3 0.8 16.5 7.8 34.8 11.4 0.2 7.9 36.6 24.2 13.3 37.3 18.3 28.5 14.7 10.9 12.2 17.5 14.1 12.3 6.4 9.9 80.9 12.3 50.6 8.7 12.1 17.1 10.1 8.7 6.9 11.9 8.2 31.3 8.8 7.9 6.3 9.5 7.3 9.5 10.1 323.2 471.1 135.1 11.1 34.9 60.5 235.6 83.5 98.4 4.7 43.1 38.0 14.2 50.1 89.0 44.1 25.0 56.3 45.9 103.4 9.8 62.0 8.2 244.8 24.8 148.1 108.3 2.5 18.2 19.8 42.6 37.2 107.6 337.0 64.5 15.7 86.7 21.6 14.7 10.1 11.3 108.4 12.2 29.8 28.9 4.3 7.5 51.4 24.9 34.7 15.4 84.1 64.9 8.0 4.9 69.1 43.6 29.0 34.8 66.1 100.5 26.7 64.4 12.4 26.3 8.8 30.0 2.1 1.1 11.4 20.6 42.8 59.4 37.2 46.6 90.3 CEP85L "bA57K17.2, C6orf204, NY-BR-15" ENSG00000111860 "Centrosomal protein 85 like" Q5SZL2 6 118460772-118710075 "Disease related genes, Predicted intracellular proteins" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.2" "Cell type enhanced" "Detected in many" "Astrocytes: 266.1;Early spermatids: 445.2;Late spermatids: 742.5;Oligodendrocyte precursor cells: 251.9;Oligodendrocytes: 189.4" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029137, HPA029138, HPA029139" Uncertain NA NA "HPA029137: AB_10600657, HPA029138: AB_10600874, HPA029139: AB_10601220" "unprognostic (3.25e-2)" "unprognostic (1.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (2.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.01e-2)" "unprognostic (8.37e-2)" "unprognostic (2.03e-1)" "unprognostic (1.39e-3)" "unprognostic (8.45e-2)" "unprognostic (2.87e-5)" "unprognostic (2.72e-3)" "unprognostic (2.44e-1)" "unprognostic (1.64e-1)" "unprognostic (1.85e-2)" 3.2 5.2 4.0 7.2 5.5 11.6 2.5 12.0 5.6 3.9 0.2 2.4 1.8 4.2 2.1 3.0 3.8 3.3 3.7 3.9 5.9 1.4 2.2 3.3 13.6 5.5 7.3 2.3 7.6 2.6 3.5 5.1 4.2 6.8 2.2 2.4 3.4 4.6 2.0 8.6 1.3 4.1 3.1 4.5 7.7 8.1 30.2 7.3 19.2 2.2 11.9 9.8 5.3 2.6 5.8 1.3 1.1 6.5 3.7 3.5 6.5 25.7 3.4 5.1 3.0 3.4 0.2 0.3 6.6 1.0 5.0 2.5 1.7 2.9 4.9 5.5 3.6 3.4 8.8 2.0 0.8 2.8 0.6 2.5 3.8 2.6 3.7 4.0 6.0 4.4 9.5 8.7 6.1 5.0 1.0 16.0 4.0 2.0 0.2 1.8 3.8 5.1 1.5 3.6 2.9 4.0 2.3 2.6 0.1 5.0 5.2 0.8 3.3 3.6 4.8 2.7 4.2 5.6 7.8 6.1 6.0 4.0 2.9 5.0 1.5 10.7 9.0 6.6 11.6 6.7 3.4 5.4 5.4 5.5 4.6 7.1 5.9 15.7 6.9 11.2 2.6 4.7 4.0 4.0 5.5 12.0 5.6 3.9 5.9 5.5 7.3 2.3 6.8 4.5 7.3 5.8 24.1 6.4 4.6 266.1 26.3 6.9 10.7 10.6 9.6 31.6 4.5 7.1 33.9 0.0 3.5 3.7 10.4 26.7 35.5 0.2 1.9 3.7 445.2 7.5 43.2 25.8 3.0 2.5 156.1 4.3 5.9 23.4 33.1 16.6 8.8 12.5 14.6 6.5 8.4 33.7 147.1 0.6 2.0 25.7 16.7 742.5 32.0 24.0 23.2 80.6 22.9 4.7 19.6 251.9 189.4 9.4 1.2 29.0 28.7 7.1 0.0 2.1 5.2 9.8 19.7 53.4 32.2 38.2 49.7 3.5 4.8 22.2 48.3 48.3 0.6 8.1 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 99.3;parathyroid gland: 93.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 116.4;Distal tubular cells: 52.8;Early spermatids: 141.6;Late spermatids: 168.0;Paneth cells: 87.0;Proximal enterocytes: 127.0;Undifferentiated cells: 52.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 14.8;T-reg: 13.5" "Lineage enriched" "Detected in many" 5 "T-cells: 14.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 93.9;RPMI-8226: 41.2;TIME: 57.7;U-138 MG: 42.4;U-266/84: 47.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA048113: AB_2680268" "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.5 0.2 1.3 14.3 2.3 1.2 3.4 0.9 4.0 0.4 28.9 81.5 83.1 0.3 13.8 1.5 0.6 1.6 0.3 2.2 0.8 9.9 1.4 11.2 9.5 0.4 0.2 1.9 0.2 0.8 93.7 0.0 2.4 0.8 0.4 59.1 0.6 0.8 24.6 1.0 19.1 99.3 2.6 0.2 1.4 38.5 22.8 0.5 2.6 0.5 0.1 12.8 10.3 0.3 3.8 4.1 0.0 0.0 0.0 0.5 0.9 0.1 1.5 0.8 1.0 0.7 3.6 1.9 0.1 1.7 0.7 2.4 1.9 0.0 11.2 1.4 0.1 0.0 0.3 0.8 0.1 0.3 0.1 0.2 0.0 20.4 10.4 23.6 17.5 93.9 0.7 23.0 0.0 3.1 0.1 0.2 0.6 0.3 0.1 5.8 0.0 0.3 41.2 1.7 0.2 0.1 0.2 1.5 0.0 0.8 2.8 0.0 0.8 57.7 42.4 2.0 0.7 2.6 1.2 47.1 0.0 7.9 1.3 0.2 2.7 0.0 0.0 0.0 0.3 2.6 0.2 3.7 0.3 0.1 0.2 14.8 1.3 0.3 0.1 0.2 0.2 13.5 1.7 1.3 2.3 0.9 4.0 2.2 0.8 0.4 0.2 1.9 0.8 0.2 0.5 3.8 0.2 0.0 1.1 0.7 4.0 5.1 0.3 3.9 0.6 0.0 0.1 1.9 0.1 0.0 2.6 5.5 0.0 0.2 0.1 116.4 52.8 0.7 141.6 0.2 0.0 0.3 5.4 2.7 13.1 2.4 0.2 1.1 32.1 0.1 5.7 0.0 0.0 0.2 11.4 0.0 0.4 40.7 2.0 0.8 1.5 168.0 1.8 3.1 1.8 0.0 27.9 0.0 1.0 1.0 0.1 7.9 87.0 0.7 7.8 0.6 127.0 0.7 0.8 0.0 0.0 0.2 1.2 1.6 0.7 0.4 5.7 0.1 6.2 0.0 52.3 0.5 ASF1A "CIA, DKFZP547E2110" ENSG00000111875 "Anti-silencing function 1A histone chaperone" Q9Y294 6 118894152-118909171 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030502, HPA071495" Enhanced Nucleoplasm No No Nucleoplasm "HPA030502: AB_2673504, HPA071495: AB_2686404" "unprognostic (7.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.78e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (5.02e-7)" "unprognostic (8.28e-2)" "unprognostic (8.42e-2)" "unprognostic (8.37e-3)" "unprognostic (3.28e-2)" "unprognostic (4.95e-1)" "unprognostic (9.07e-3)" "unprognostic (2.90e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (5.09e-3)" 7.5 10.3 13.8 8.8 15.1 8.4 12.6 15.7 17.3 8.6 12.4 9.5 7.8 10.7 13.1 8.9 10.6 8.0 13.5 13.3 16.4 12.7 12.1 13.5 16.1 14.5 15.4 12.7 17.6 9.5 15.9 6.3 8.3 14.8 9.9 11.0 11.6 10.8 11.1 16.8 11.7 8.9 7.4 15.0 11.6 11.0 9.8 15.0 24.6 15.2 16.3 15.2 9.5 6.8 16.6 14.7 9.2 31.2 21.2 26.0 15.2 25.3 19.3 18.8 24.3 27.2 11.7 12.2 24.0 30.8 13.7 21.5 15.3 27.2 24.7 30.8 17.5 25.4 35.1 20.7 72.9 18.5 60.6 17.4 13.8 24.3 21.2 32.0 32.6 32.9 75.2 55.2 61.9 28.9 15.7 70.8 47.4 12.9 21.6 30.5 38.7 13.1 30.1 32.7 18.4 20.1 15.8 19.6 19.4 23.3 9.8 11.4 55.3 29.1 11.3 17.0 16.1 30.1 19.4 34.5 35.6 29.7 47.5 25.0 18.8 15.4 32.9 40.3 17.1 56.5 35.7 64.0 51.8 34.1 24.7 69.0 56.8 2.7 34.3 23.1 26.1 83.9 47.4 13.8 15.1 15.7 17.3 13.3 16.4 14.5 15.4 12.7 14.8 15.0 15.0 16.6 16.0 16.0 22.6 11.1 24.7 29.4 14.8 36.7 28.5 16.7 14.0 19.2 27.1 18.6 23.0 9.2 4.2 67.5 19.8 11.6 62.6 33.9 40.9 10.2 13.9 23.3 29.5 82.1 5.8 23.5 71.5 24.0 17.9 9.1 22.8 39.9 17.2 15.1 24.6 25.2 6.3 12.4 10.2 16.3 16.7 10.8 25.4 16.5 16.0 9.4 24.9 27.8 24.7 9.0 10.0 20.7 10.1 23.3 22.7 10.9 11.5 27.2 21.2 13.7 13.1 17.0 37.2 32.7 48.0 20.8 33.0 46.7 49.1 28.1 17.5 12.5 MCM9 "C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304" ENSG00000111877 "Minichromosome maintenance 9 homologous recombination repair factor" Q9NXL9 6 118813442-118935162 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031137 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031137: AB_10602027" "unprognostic (3.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.33e-3)" "unprognostic (2.90e-1)" "unprognostic (2.78e-2)" "unprognostic (2.82e-1)" "unprognostic (3.00e-2)" "unprognostic (2.29e-1)" "unprognostic (3.61e-2)" "unprognostic (7.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (8.30e-2)" "unprognostic (2.16e-1)" "unprognostic (3.95e-1)" "unprognostic (2.26e-1)" "unprognostic (8.79e-2)" 5.2 4.4 2.5 5.7 3.3 12.8 7.0 2.4 2.9 6.6 3.2 5.0 5.0 5.3 10.2 6.5 5.9 3.8 3.4 2.2 2.4 6.0 5.1 5.3 7.6 3.0 3.0 2.0 5.2 6.9 5.3 4.6 7.0 3.1 6.8 5.7 4.1 7.5 4.8 2.6 6.5 5.9 4.2 2.8 6.4 4.9 5.8 2.8 8.1 8.1 2.2 7.2 5.8 7.0 3.6 4.2 6.5 10.3 11.8 4.2 4.8 7.3 3.9 7.1 5.4 6.8 5.2 6.7 12.1 4.5 6.2 3.9 12.5 7.1 4.7 7.2 7.5 10.1 11.4 9.5 5.5 3.0 11.7 7.3 5.2 5.7 6.0 7.3 3.7 5.5 8.0 12.9 6.3 4.2 9.4 10.0 9.4 4.7 7.3 3.1 8.3 7.0 4.2 5.4 7.9 8.5 6.0 6.9 5.7 3.7 2.9 7.3 15.8 6.0 4.3 3.7 2.9 5.7 7.8 7.2 13.9 5.5 8.7 5.6 4.3 2.6 4.4 2.2 2.7 1.8 1.5 1.4 2.3 2.9 1.4 1.7 1.6 2.9 4.8 1.7 2.1 3.5 2.1 2.5 3.3 2.4 2.9 2.2 2.4 3.0 3.0 2.0 3.1 2.8 2.8 3.6 6.6 6.4 6.7 32.0 10.8 2.9 3.8 2.9 7.4 3.5 6.4 4.1 6.0 2.8 4.4 7.3 10.4 11.8 7.6 7.2 3.9 3.0 2.9 7.4 6.0 6.3 7.2 4.6 16.8 2.8 3.4 5.0 9.2 6.9 7.0 8.1 2.9 3.9 3.5 1.7 15.2 6.0 6.1 5.5 2.8 2.6 3.7 7.4 0.0 40.3 6.3 1.6 11.3 35.7 39.7 2.7 5.6 4.1 10.9 3.9 6.8 3.3 10.6 5.6 0.0 5.7 5.8 6.3 4.6 8.6 2.0 7.3 9.8 4.7 4.1 4.3 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3;choroid plexus: 31.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 3.1 1.6 35.5 1.3 36.1 0.2 4.7 39.2 43.7 3.3 31.4 2.7 3.1 2.6 3.1 1.4 3.2 1.8 1.9 36.2 51.3 4.4 6.4 10.0 3.5 34.9 33.2 35.4 4.5 3.2 4.8 11.1 23.1 34.4 3.9 0.9 16.4 3.3 2.8 0.9 1.7 1.6 1.6 30.8 0.6 1.7 17.1 33.4 0.6 7.0 2.2 3.5 2.4 2.1 36.4 0.1 0.3 11.8 0.9 0.3 0.3 0.0 0.6 0.4 0.5 0.9 2.0 1.1 0.9 0.0 0.2 5.3 0.0 3.4 0.0 0.2 1.3 11.1 0.1 0.9 7.9 0.2 0.0 0.6 0.4 0.1 0.1 0.0 0.3 0.0 11.6 10.4 0.7 0.3 0.3 0.4 0.1 6.0 0.6 1.3 0.0 0.1 0.0 0.1 0.1 8.5 8.0 0.7 0.6 1.8 2.2 2.1 1.4 0.3 0.8 0.5 0.2 2.9 4.9 3.3 0.3 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 35.5 36.1 39.2 43.7 36.2 51.3 34.9 33.2 35.4 34.4 30.8 33.4 36.4 21.0 48.1 103.0 261.2 0.7 2.4 5.9 0.4 11.4 35.2 3.8 8.8 6.4 2.8 17.7 3.7 29.2 61.4 0.6 0.4 17.6 1.0 22.9 2.0 2.0 5.3 6.0 0.4 66.9 1.1 18.9 11.8 1.5 0.8 6.3 8.9 1.8 4.0 5.6 13.5 55.5 0.6 0.0 0.3 1.8 9.2 3.7 1.0 0.0 34.7 0.0 11.1 0.0 88.4 20.6 0.3 1.2 7.2 2.7 1.6 0.4 3.1 37.3 28.4 6.6 45.2 4.1 61.8 16.0 4.2 3.4 266.4 5.8 1.4 0.7 2.0 RNGTT "hCAP, HCE, HCE1" ENSG00000111880 "RNA guanylyltransferase and 5'-phosphatase" O60942 6 88609897-88963618 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA capping, mRNA processing" "Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003750 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003750: AB_1856383" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (2.82e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.48e-3)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-3)" "unprognostic (9.83e-2)" "unprognostic (6.55e-2)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" 5.4 6.8 5.4 8.3 5.4 9.6 5.6 9.7 5.8 5.3 3.3 4.7 4.2 5.3 3.6 7.2 4.2 3.7 5.4 5.2 7.0 5.4 7.0 4.5 17.4 5.1 5.3 4.4 4.9 2.9 6.4 5.0 5.0 5.7 5.3 5.5 10.7 3.6 4.9 5.3 4.4 5.2 6.1 4.7 7.7 4.2 9.4 7.0 14.8 5.7 6.4 17.4 6.3 4.8 5.8 9.2 14.0 21.1 26.2 12.0 12.6 12.4 20.2 13.4 16.4 20.4 15.9 6.8 23.1 16.2 14.9 21.5 11.1 24.7 16.5 29.7 31.8 19.0 30.5 11.4 12.2 9.5 33.2 16.6 7.7 13.8 16.8 15.9 13.6 14.7 12.7 30.9 18.1 23.8 12.0 14.6 22.8 12.5 15.0 11.7 28.6 32.0 13.3 14.0 14.2 12.3 17.3 16.8 9.8 11.1 19.7 10.8 31.8 11.5 13.0 12.0 14.7 27.9 16.1 31.6 13.2 18.9 23.8 24.1 5.2 4.1 7.6 7.8 5.9 7.8 22.9 8.6 9.7 5.8 22.8 9.7 10.1 3.4 10.9 5.5 4.0 9.0 5.4 5.4 5.4 9.7 5.8 5.2 7.0 5.1 5.3 4.4 5.7 4.7 7.0 5.8 8.9 0.0 16.2 54.5 60.4 8.3 10.7 6.0 10.8 22.4 6.5 6.1 10.7 7.2 12.9 12.9 39.6 10.4 19.7 8.0 0.0 6.3 17.9 7.9 12.1 7.0 9.1 7.6 108.6 4.9 9.9 9.7 15.8 12.4 8.8 11.0 7.5 10.3 7.8 15.2 110.2 7.0 4.1 9.1 7.3 5.2 5.9 13.6 3.6 69.3 9.8 7.2 18.6 96.5 94.3 7.2 5.1 7.9 42.3 8.6 4.6 6.3 10.1 43.4 6.6 15.8 9.5 23.3 20.1 10.7 8.7 11.8 24.6 8.0 6.7 7.4 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177205-119349761 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 155.9" "Cell type enhanced" "Detected in many" "Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" NA NA 460000000 "Golgi apparatus" "CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042" "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 103.1 48.9 4.6 33.1 13.6 29.2 34.6 2.2 9.4 26.1 7.4 36.5 53.2 24.0 8.8 22.9 16.1 47.5 14.1 8.7 5.9 67.2 155.9 36.1 35.0 5.3 5.2 6.7 20.3 33.0 26.0 4.6 80.1 3.6 18.2 29.6 6.3 43.1 15.2 7.6 14.0 70.4 27.4 4.2 36.8 26.2 7.1 7.2 19.1 22.8 31.3 26.2 56.5 17.3 5.0 0.2 0.0 3.4 0.0 273.1 119.9 6.6 6.9 41.4 5.1 12.5 19.8 2.6 43.2 0.3 26.5 65.7 0.4 7.6 0.1 6.4 64.5 19.4 36.3 3.9 204.0 27.2 0.1 17.7 82.4 5.3 41.6 25.3 22.1 3.4 12.6 128.1 219.6 39.7 6.1 1.7 0.3 2.3 20.0 10.0 12.1 4.2 66.6 13.4 35.4 14.1 21.0 0.1 0.6 0.0 8.3 10.4 4.8 24.8 16.9 15.4 32.0 15.8 294.5 44.6 84.8 50.2 0.7 10.4 4.3 0.3 1.1 1.1 0.5 2.3 0.7 0.6 0.6 0.3 0.4 0.3 0.9 1.9 0.9 0.5 2.8 0.7 0.3 4.6 13.6 2.2 9.4 8.7 5.9 5.3 5.2 6.7 3.6 4.2 7.2 5.0 37.1 9.6 46.1 19.9 31.0 31.7 5.7 1.2 5.2 28.1 18.8 5.8 4.4 44.3 6.9 106.7 0.0 6.8 40.6 23.3 5.9 9.4 232.5 5.9 63.9 42.1 48.0 40.4 165.0 37.8 12.4 98.4 18.8 10.7 3.8 24.0 97.5 270.5 101.1 0.0 79.4 61.1 0.0 84.6 91.2 39.3 26.4 98.0 28.4 128.4 13.5 1.7 42.2 4.5 3.7 14.8 18.9 4.1 147.5 5.3 92.2 33.5 4.6 5.0 6.6 12.9 27.8 2.8 3.9 3.4 27.8 6.2 24.3 14.6 18.9 9.7 GABRR2 ENSG00000111886 "Gamma-aminobutyric acid type A receptor subunit rho2" P28476 6 89254464-89315299 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "retina: 31.7" "Cell type enriched" "Detected in some" 18 "Bipolar cells: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2;U-266/70: 5.1;U-266/84: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-2)" "unprognostic (1.47e-4)" "unprognostic (1.56e-1)" "unprognostic (1.88e-4)" "unprognostic (4.19e-1)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (9.13e-2)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-1)" "unprognostic (1.41e-1)" "unprognostic (1.54e-6)" "unprognostic (3.69e-2)" "unprognostic (7.81e-2)" "unprognostic (5.79e-2)" "unprognostic (7.15e-3)" 0.5 0.3 0.6 1.2 0.5 0.7 0.2 0.8 0.7 0.3 0.4 0.3 0.7 0.5 0.4 0.1 0.1 0.3 0.2 0.5 0.4 0.4 0.1 0.3 0.8 0.6 0.6 0.4 0.2 0.1 0.0 0.0 0.3 0.6 0.3 0.4 31.7 0.3 0.2 0.8 0.4 0.7 0.3 0.3 0.8 0.3 0.2 0.6 1.2 0.3 0.2 0.6 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 2.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.1 0.8 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.6 0.0 0.7 0.1 0.2 0.1 0.0 0.3 5.1 1.4 0.2 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.5 0.8 0.7 0.5 0.4 0.6 0.6 0.4 0.6 0.3 0.6 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.3 0.0 1.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERINC1 "KIAA1253, TDE1L, TDE2, TMS-2" ENSG00000111897 "Serine incorporator 1" Q9NRX5 6 122443351-122471807 "Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035738, HPA035739" Uncertain Approved Cytosol NA NA Cytosol "HPA035738: AB_10672990, HPA035739: AB_10669536" "unprognostic (2.83e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.65e-1)" "unprognostic (2.84e-2)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.27e-2)" "unprognostic (9.07e-3)" "unprognostic (2.84e-1)" "unprognostic (5.50e-3)" "unprognostic (1.80e-3)" "unprognostic (9.22e-2)" "unprognostic (3.58e-1)" "unprognostic (1.00e-2)" 215.5 245.1 261.8 94.1 286.5 149.5 159.4 268.5 316.3 152.7 217.4 95.6 100.3 148.0 109.0 95.8 105.3 129.2 165.2 276.0 292.0 195.9 243.3 161.9 97.6 287.3 288.0 253.0 165.9 101.2 245.3 72.3 196.7 311.5 140.8 101.1 227.5 98.0 144.7 153.9 76.7 115.3 143.0 318.2 124.7 97.4 66.2 270.6 90.6 205.0 196.5 80.2 122.8 85.6 346.4 40.5 49.1 121.7 111.8 450.2 245.1 64.5 208.4 259.8 111.6 171.6 57.8 106.9 27.1 159.7 236.5 127.9 78.7 72.6 90.2 166.1 87.1 86.0 76.9 79.0 105.9 201.3 77.5 146.3 256.7 173.0 139.0 190.8 256.4 98.1 69.9 77.4 149.3 233.8 46.8 35.1 51.4 39.7 63.5 61.9 42.5 60.0 66.5 240.3 70.1 63.6 114.5 92.3 101.2 146.8 107.4 70.0 107.1 201.3 133.7 57.9 110.8 109.9 112.4 134.4 35.9 176.8 62.1 159.5 158.3 43.0 92.6 44.7 53.2 48.1 27.7 45.9 43.3 35.9 23.7 53.2 46.9 108.7 51.7 62.0 28.0 54.2 56.0 261.8 286.5 268.5 316.3 276.0 292.0 287.3 288.0 253.0 311.5 318.2 270.6 346.4 167.8 150.6 99.2 44.4 73.9 66.2 81.1 55.7 61.5 114.4 71.7 57.1 156.2 87.2 58.9 77.3 70.9 53.8 80.9 88.8 9.8 63.0 3.2 54.9 103.3 130.0 84.5 81.5 92.5 48.7 57.7 131.4 39.8 106.8 124.0 58.1 127.8 132.1 73.1 138.0 145.7 41.8 36.7 158.2 86.4 10.0 126.8 107.4 94.3 65.6 58.1 97.2 58.7 48.2 134.0 78.4 43.6 131.3 80.0 86.1 80.1 44.0 56.1 70.6 59.2 105.1 110.6 25.7 17.0 39.0 74.9 119.7 100.7 99.8 32.7 97.1 HDDC2 "C6orf74, CGI-130, dJ167O5.2" ENSG00000111906 "HD domain containing 2" Q7Z4H3 6 125219962-125302078 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035677 Approved Approved Nucleoplasm,Nucleoli NA NA 44000 Nucleoli Nucleoplasm "HPA035677: AB_10603768" "unprognostic (8.34e-2)" "unprognostic (5.41e-2)" "unprognostic (6.52e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (6.39e-3)" "unprognostic (1.04e-3)" "unprognostic (1.76e-1)" "unprognostic (2.18e-1)" "unprognostic (2.38e-2)" "unprognostic (8.59e-3)" "unprognostic (5.13e-2)" "unprognostic (4.56e-2)" "unprognostic (2.54e-1)" "unprognostic (3.68e-2)" "unprognostic (1.80e-2)" "unprognostic (9.54e-2)" 44.3 85.1 61.9 20.3 64.2 19.9 42.5 60.7 99.3 43.9 75.5 37.1 20.5 36.5 29.9 50.1 37.4 15.2 76.0 61.8 64.6 61.6 23.1 32.2 27.3 67.2 64.5 57.0 41.4 44.9 49.9 50.4 15.9 65.4 38.8 22.3 31.8 46.2 24.1 119.0 38.0 30.9 13.7 63.1 27.8 44.0 59.2 64.0 22.4 40.6 61.2 25.0 39.5 39.8 62.6 29.7 81.2 46.2 191.3 23.0 30.8 59.7 36.4 41.4 30.9 33.1 122.7 30.4 119.9 80.8 57.4 89.0 26.5 53.1 41.1 36.5 46.7 166.8 55.2 43.6 125.1 65.0 76.6 45.3 56.0 61.8 49.6 104.6 44.6 20.2 67.8 205.1 51.4 59.5 162.7 61.2 73.8 57.7 79.9 58.8 92.8 37.2 25.2 68.7 34.1 84.0 44.5 43.9 84.8 88.8 35.4 50.2 126.6 18.2 37.7 44.5 58.8 75.8 72.1 48.2 110.1 56.0 122.6 80.4 13.8 33.4 6.7 53.3 30.6 43.8 71.2 57.7 72.6 36.1 59.4 71.3 78.2 7.3 62.1 29.0 38.3 55.7 44.0 61.9 64.2 60.7 99.3 61.8 64.6 67.2 64.5 57.0 65.4 63.1 64.0 62.6 23.0 25.6 41.2 22.5 39.3 44.6 64.3 114.9 70.6 62.6 73.5 114.4 119.9 37.1 55.3 62.5 14.6 86.6 56.0 35.0 338.5 86.0 61.3 50.9 60.7 24.2 64.5 33.4 17.1 98.0 156.4 67.5 33.6 37.5 38.0 84.8 9.3 21.3 112.2 69.0 17.9 76.4 77.3 54.2 20.4 42.1 91.0 34.6 80.0 15.0 31.7 90.5 155.5 19.1 10.6 58.5 45.3 114.7 47.4 101.9 72.3 254.8 38.9 25.0 39.5 83.9 72.6 124.5 74.6 88.6 43.0 45.7 47.6 145.8 84.1 57.9 TPD52L1 "D53, hD53, TPD53" ENSG00000111907 "TPD52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 260.5;salivary gland: 300.9" "Cell type enhanced" "Detected in many" "Astrocytes: 390.1;Squamous epithelial cells: 272.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 35.8 260.5 78.1 10.2 87.1 0.8 67.6 66.8 98.2 25.8 91.8 27.0 9.8 15.3 69.4 153.6 34.9 27.6 72.0 72.8 83.8 39.8 58.9 11.0 6.7 75.8 69.6 70.0 20.9 47.5 67.9 25.0 9.0 74.7 41.3 13.1 1.9 300.9 79.8 112.8 48.0 10.7 12.4 63.3 2.0 43.4 5.1 71.8 3.5 61.3 127.4 12.4 60.1 61.3 70.9 37.7 42.0 0.5 269.1 2.4 0.6 63.3 6.2 5.9 0.0 0.7 67.3 46.9 0.1 136.2 31.2 9.1 83.8 8.4 58.2 0.2 0.8 58.0 0.8 58.0 0.5 5.7 0.2 0.1 7.4 234.3 0.1 30.7 82.5 0.0 0.0 30.5 0.6 4.7 365.5 0.0 0.7 4.4 36.8 22.7 0.4 0.1 0.0 271.4 9.8 9.1 0.2 70.5 189.4 4.6 9.6 162.3 0.8 0.2 1.8 5.9 0.5 2.0 0.1 0.1 0.2 1.0 0.3 0.7 1.8 0.5 0.3 0.3 0.2 0.3 0.3 0.6 0.2 0.2 0.4 0.7 0.5 2.7 2.6 0.1 0.4 0.2 0.4 78.1 87.1 66.8 98.2 72.8 83.8 75.8 69.6 70.0 74.7 63.3 71.8 70.9 141.6 0.0 28.3 390.1 2.2 19.6 44.6 70.2 128.1 3.8 164.4 154.9 45.8 25.8 51.7 125.0 4.2 32.7 3.2 3.9 176.1 30.7 6.9 71.7 21.1 87.2 16.2 0.0 16.4 110.8 140.2 18.8 13.7 184.5 2.5 29.5 15.4 59.9 10.9 0.0 48.2 11.3 83.4 2.1 5.2 4.9 17.4 3.4 131.6 28.1 0.6 3.9 1.0 11.6 2.9 35.3 2.3 36.5 2.6 37.1 10.9 45.4 15.7 1.3 0.0 177.1 10.1 5.7 9.2 272.2 37.2 14.4 3.5 53.8 17.8 19.2 HINT3 "FLJ33126, HINT4" ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956770-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.8" "Cell type enhanced" "Detected in all" "Early spermatids: 352.2;Spermatocytes: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavorable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favorable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 18.2 23.6 37.0 12.7 37.9 12.4 23.2 35.8 39.5 18.5 28.1 18.9 15.9 16.8 18.0 22.5 16.5 16.3 28.7 34.7 36.7 22.4 28.5 21.2 11.4 39.1 37.4 32.1 14.8 19.5 30.9 14.5 14.6 39.3 30.0 17.7 15.4 25.8 22.7 113.8 17.6 16.2 17.5 42.9 10.6 25.1 12.4 37.5 13.8 23.7 85.3 11.5 18.6 10.9 43.8 13.2 10.3 14.1 29.5 5.5 14.8 17.5 14.1 20.2 10.6 11.0 25.6 7.2 28.4 25.5 9.4 23.7 19.5 18.2 11.9 12.3 27.4 23.5 12.0 15.1 21.6 25.4 19.2 19.6 11.8 25.9 10.7 27.0 27.3 16.1 21.0 38.3 18.7 10.6 20.1 15.5 13.7 4.8 27.1 9.9 12.8 9.7 9.7 21.8 24.0 28.2 17.4 12.9 18.0 67.8 10.2 18.4 28.9 11.4 7.2 10.1 34.8 20.3 27.1 33.3 18.2 20.4 18.1 9.5 12.5 9.3 8.9 4.4 5.9 4.6 7.0 5.9 4.8 7.7 6.3 6.0 5.3 11.2 5.9 8.6 4.3 6.3 5.3 37.0 37.9 35.8 39.5 34.7 36.7 39.1 37.4 32.1 39.3 42.9 37.5 43.8 11.7 80.1 61.2 11.8 16.7 18.1 10.2 22.1 24.5 21.8 26.5 18.4 38.7 10.0 29.8 16.5 8.4 19.2 13.4 17.2 33.2 29.3 352.2 23.6 11.5 12.3 16.3 6.9 27.0 20.2 6.4 13.7 19.4 25.8 9.5 15.2 10.4 17.5 27.2 6.7 29.8 25.1 20.3 15.3 14.6 78.3 9.9 19.3 21.4 5.6 17.3 43.4 11.3 21.6 40.0 21.4 28.7 17.3 8.1 20.9 15.3 28.0 25.7 25.4 6.6 18.3 15.1 110.7 40.2 21.5 17.3 26.4 11.3 14.6 18.5 19.9 NCOA7 "dJ187J11.3, ERAP140, TLDC4" ENSG00000111912 "Nuclear receptor coactivator 7" Q8NI08 6 125781161-125932034 "Predicted intracellular proteins, Transporters" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030289, HPA030290, HPA030291, HPA030292" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834" "unprognostic (1.01e-2)" "unprognostic (3.21e-2)" "unprognostic (7.32e-3)" "unprognostic (7.27e-3)" "unprognostic (1.54e-1)" "unprognostic (4.67e-2)" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (2.73e-1)" "unprognostic (2.14e-1)" "unprognostic (6.08e-2)" "unprognostic (4.37e-2)" "prognostic favorable (1.78e-6)" "unprognostic (2.10e-1)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (8.10e-2)" 54.4 61.0 9.7 46.2 22.0 43.1 27.7 13.5 44.4 29.2 0.0 30.4 33.3 22.5 5.3 30.7 16.1 47.0 11.7 21.4 20.1 57.2 33.2 52.6 30.3 34.6 17.5 15.4 14.9 20.0 8.8 30.0 13.0 41.2 18.8 29.5 18.4 38.5 13.0 6.9 10.9 39.5 28.5 14.4 24.6 31.0 7.9 27.5 21.9 25.3 9.2 28.7 102.8 19.9 66.2 13.7 36.6 2.2 16.0 78.2 46.3 23.7 18.2 71.9 22.1 30.1 34.3 12.7 55.2 96.5 10.0 108.0 78.7 12.6 12.4 13.3 120.2 16.5 28.0 43.7 12.3 44.5 16.4 25.4 33.3 29.4 21.1 16.3 39.1 46.7 18.0 38.7 30.6 13.9 13.7 16.1 16.2 2.7 33.8 7.6 12.3 5.7 10.3 39.1 90.4 36.9 33.5 93.7 22.6 42.1 6.5 3.8 19.3 27.7 5.1 10.9 26.3 14.1 39.9 34.1 28.8 11.5 21.2 18.7 17.0 11.4 4.0 19.2 9.1 24.1 17.7 18.1 15.6 10.0 11.1 9.6 9.4 6.4 13.6 14.2 34.1 8.1 5.1 9.7 22.0 13.5 44.4 21.4 20.1 34.6 17.5 15.4 41.2 14.4 27.5 66.2 144.6 314.1 371.9 27.7 33.7 98.1 270.8 311.2 709.7 50.2 94.2 47.9 11.4 98.7 324.1 62.5 43.8 9.3 84.6 113.2 80.3 241.7 0.9 160.1 90.2 130.2 35.8 29.8 144.9 139.2 8.9 94.8 142.8 298.2 37.3 18.5 106.7 23.2 13.6 37.0 89.5 119.3 288.9 33.8 57.4 6.8 42.3 41.9 51.6 75.9 33.4 76.8 59.8 34.2 303.9 108.7 160.1 29.3 44.1 129.5 24.3 103.2 335.8 53.3 13.1 33.8 49.3 11.2 33.9 515.9 59.2 3.8 63.5 36.5 130.6 294.4 RIPOR2 "C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP" ENSG00000111913 "RHO family interacting cell polarization regulator 2" Q9Y4F9 6 24804282-25042170 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Differentiation, Hearing, Myogenesis" "Developmental protein, Signal transduction inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 83.3" "Cell type enhanced" "Detected in many" "B-cells: 57.4;dendritic cells: 98.4;Respiratory ciliated cells: 83.1;Syncytiotrophoblasts: 82.8;T-cells: 38.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 951.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 951.9" "Cell line enhanced" "Detected in many" "AF22: 30.9;Daudi: 73.5;fHDF/TERT166: 73.2;U-266/70: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.05e-3)" "unprognostic (1.34e-3)" "unprognostic (3.55e-2)" "unprognostic (1.91e-2)" "unprognostic (1.47e-2)" "unprognostic (1.75e-2)" "unprognostic (5.89e-4)" "unprognostic (2.62e-2)" "unprognostic (1.54e-1)" "unprognostic (4.40e-3)" "unprognostic (1.64e-1)" "unprognostic (1.74e-2)" "unprognostic (8.55e-2)" "unprognostic (3.33e-2)" "unprognostic (2.30e-2)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" 13.2 3.7 14.4 49.6 24.3 27.9 6.1 2.1 13.0 13.6 5.1 3.7 2.7 46.7 2.7 3.3 14.9 8.7 2.7 13.7 11.0 3.0 4.4 20.9 83.3 7.0 7.6 17.2 2.7 2.5 0.9 13.1 6.1 5.0 6.1 3.8 3.7 8.3 4.6 19.7 4.5 17.6 17.8 2.4 56.4 6.7 6.4 7.4 41.4 2.9 7.6 71.6 10.3 7.5 8.4 1.1 0.1 30.9 0.6 0.3 0.2 11.3 8.8 15.5 3.7 5.4 0.4 0.5 73.5 2.0 73.2 0.5 0.9 0.0 0.0 0.7 7.3 0.4 17.8 1.2 0.3 0.6 0.4 1.3 3.2 0.3 0.0 0.4 0.2 0.0 3.2 1.0 12.2 0.2 0.2 17.0 0.8 2.3 1.2 2.1 18.5 3.0 0.7 0.1 0.4 1.5 0.3 0.6 0.3 5.7 10.3 0.3 0.5 0.3 0.7 3.3 0.8 0.9 25.4 0.6 2.4 0.8 1.0 5.1 414.0 100.8 334.5 128.6 127.3 134.8 188.3 131.8 136.6 68.7 176.3 171.6 136.8 951.9 125.7 173.8 57.7 124.9 168.1 14.4 24.3 2.1 13.0 13.7 11.0 7.0 7.6 17.2 5.0 2.4 7.4 8.4 7.3 3.2 14.6 0.0 57.4 0.0 0.0 0.0 0.0 0.0 3.3 1.7 0.0 0.0 18.6 5.5 0.0 4.1 98.4 0.0 1.9 0.1 0.0 16.4 10.5 2.8 0.0 0.0 0.0 0.2 1.9 2.7 0.0 10.7 12.6 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 15.6 0.0 0.0 3.1 83.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 82.8 38.0 1.7 0.0 0.0 SASH1 "dJ323M4.1, KIAA0790, SH3D6A" ENSG00000111961 "SAM and SH3 domain containing 1" O94885 6 148272304-148552048 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 194.8;Astrocytes: 426.7;Microglial cells: 179.9;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 328.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "classical monocyte: 1.2;intermediate monocyte: 2.6;non-classical monocyte: 1.3" "Lineage enriched" "Detected in single" 26 "monocytes: 2.6" "Cell line enhanced" "Detected in many" "ASC diff: 198.0;ASC TERT1: 74.7;fHDF/TERT166: 73.4;HUVEC TERT2: 75.0;WM-115: 95.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029947, HPA029949" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029947: AB_10598915, HPA029949: AB_10602280" "unprognostic (9.71e-2)" "unprognostic (4.74e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.55e-2)" "unprognostic (4.79e-3)" "unprognostic (6.69e-2)" "unprognostic (4.76e-2)" "unprognostic (2.06e-1)" "unprognostic (8.65e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-1)" "unprognostic (2.13e-3)" "unprognostic (5.45e-2)" "unprognostic (3.53e-1)" "unprognostic (8.04e-3)" "unprognostic (1.54e-1)" 65.1 6.1 50.6 6.7 58.8 0.3 48.0 59.5 36.0 19.4 14.2 15.6 6.8 13.7 5.2 45.6 16.0 19.8 17.2 38.9 40.7 13.8 9.4 26.7 6.2 67.2 58.9 27.1 6.6 9.6 14.4 5.1 30.5 60.4 11.7 9.9 15.5 20.0 9.3 18.1 28.6 11.9 16.3 55.6 13.8 9.6 4.6 61.7 5.1 39.4 22.7 7.8 14.0 28.1 64.6 4.8 2.9 23.6 7.9 198.0 74.7 3.9 27.3 65.6 20.2 30.7 6.2 5.7 0.0 14.1 73.4 10.1 5.7 7.3 6.7 16.9 0.0 5.3 0.0 13.6 5.7 6.1 0.0 1.3 35.1 6.8 30.6 8.3 8.3 75.0 0.0 0.4 0.1 19.1 5.5 0.0 0.0 6.9 2.6 3.8 0.0 16.8 0.2 15.1 15.1 0.9 0.0 8.4 30.8 21.5 6.1 2.4 14.0 65.6 19.7 4.0 63.1 5.9 0.0 0.0 0.0 31.6 0.0 95.6 0.0 1.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 50.6 58.8 59.5 36.0 38.9 40.7 67.2 58.9 27.1 60.4 55.6 61.7 64.6 194.8 16.0 21.7 426.7 0.6 41.0 6.2 5.1 29.6 21.9 17.7 24.0 18.5 5.7 18.3 46.0 6.2 20.6 0.8 4.4 7.9 3.1 0.8 45.3 36.2 104.7 4.8 0.0 16.4 2.4 59.5 66.5 8.2 40.1 2.5 2.3 60.3 8.1 8.8 3.3 120.7 5.3 10.2 42.4 18.5 1.6 18.3 15.6 42.7 179.9 4.9 100.4 0.0 186.5 328.6 1.5 2.9 28.2 1.3 6.4 2.3 15.0 15.5 4.7 78.9 49.9 73.2 0.5 3.7 46.3 33.0 32.7 1.6 3.1 7.2 7.4 UST 2OST ENSG00000111962 "Uronyl 2-sulfotransferase" Q9Y2C2 6 148747030-149076990 "Metabolic proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 339.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 15.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 2.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032022 Approved NA NA "HPA032022: AB_10603326" "unprognostic (3.43e-1)" "unprognostic (1.90e-1)" "unprognostic (7.87e-3)" "unprognostic (3.22e-5)" "unprognostic (1.83e-3)" "unprognostic (1.50e-1)" "unprognostic (5.71e-2)" "unprognostic (1.96e-2)" "unprognostic (8.31e-3)" "unprognostic (2.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.11e-1)" "unprognostic (9.25e-3)" "unprognostic (9.48e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (3.02e-2)" 6.0 12.3 8.2 3.0 7.2 0.2 6.2 11.9 6.8 7.2 6.8 7.4 1.7 6.9 5.7 4.7 9.2 6.1 3.2 5.8 15.6 3.6 1.4 5.2 3.9 29.2 15.7 4.4 11.7 13.2 4.6 1.9 4.6 15.7 6.4 2.7 6.8 3.2 4.9 1.7 6.6 5.7 8.9 13.0 6.6 5.0 6.8 19.2 6.6 27.7 5.8 3.7 8.9 7.7 15.9 0.1 3.2 18.2 14.0 21.5 17.8 0.1 7.9 20.5 3.8 9.8 0.0 1.2 6.7 1.7 12.3 9.5 5.7 13.0 6.6 7.6 9.1 9.9 0.2 10.0 0.1 7.9 0.3 2.8 9.2 14.6 9.8 18.1 7.6 0.2 11.1 0.0 0.0 3.0 8.3 0.1 0.0 10.7 32.4 4.2 3.3 2.5 7.7 0.1 14.8 9.4 0.0 26.4 6.3 5.0 13.0 4.7 0.3 0.4 10.9 1.3 2.5 7.4 0.0 0.0 0.0 12.1 5.4 6.3 0.0 0.0 0.0 0.6 0.2 0.4 0.3 0.4 0.5 0.4 0.5 0.0 0.2 0.0 2.5 0.3 0.4 0.1 0.1 8.2 7.2 11.9 6.8 5.8 15.6 29.2 15.7 4.4 15.7 13.0 19.2 15.9 0.9 3.2 3.2 70.2 4.5 9.4 5.4 2.6 3.4 0.1 1.7 1.5 1.7 0.0 2.7 1.8 0.0 2.0 8.9 0.2 0.0 0.1 1.1 0.3 8.7 0.6 0.0 0.0 36.3 2.0 0.3 16.3 7.1 0.4 0.0 12.3 1.4 0.3 1.7 0.0 39.7 1.8 10.2 1.0 20.9 3.4 18.3 2.8 5.4 80.6 1.0 14.6 5.2 339.8 3.2 1.1 0.3 11.3 0.4 5.9 0.0 0.6 2.3 0.8 0.0 6.8 3.5 2.9 5.7 1.9 11.6 1.4 2.0 10.2 0.5 6.8 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149963943-149973715 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.7;lung: 1.7;testis: 3.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.2;Breast myoepithelial cells: 3.0;Respiratory ciliated cells: 2.2;Squamous epithelial cells: 2.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.5;HAP1: 29.3;HDLM-2: 17.1;HHSteC: 18.0;JURKAT: 26.1" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.1 0.1 0.1 0.2 0.1 0.3 0.0 3.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.7 0.1 0.2 0.1 1.7 0.1 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 3.4 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.3 2.1 1.0 1.6 0.0 3.3 6.8 3.2 3.0 0.9 0.6 2.0 0.2 3.1 3.5 0.7 16.5 6.9 0.7 29.3 1.4 2.7 17.1 3.8 0.3 0.6 0.0 18.0 0.1 1.2 9.1 6.8 13.6 2.5 0.0 1.1 26.1 3.3 0.0 3.5 2.7 4.3 0.0 0.5 1.4 2.3 0.0 1.3 0.5 0.0 0.4 1.0 0.4 4.4 2.0 0.0 1.3 2.9 6.4 0.3 1.6 0.0 1.4 0.0 0.5 0.7 2.3 8.7 5.0 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.1 3.7 1.9 1.7 0.1 0.1 0.3 0.2 0.8 0.1 0.1 0.3 1.6 6.4 2.2 0.0 0.5 0.1 0.5 0.0 0.6 0.0 1.0 3.0 0.9 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.1 0.2 0.6 1.1 0.0 0.0 0.1 0.6 0.0 1.6 0.0 0.7 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.3 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.0 0.0 1.6 1.3 0.2 0.2 2.5 0.6 0.0 0.7 0.2 0.3 0.1 FBXO5 "EMI1, FBX5, Fbxo31" ENSG00000112029 "F-box protein 5" Q9UKT4 6 152970519-152983579 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 44.4;lymphoid tissue: 27.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008106, HPA029048" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB008106: AB_828450, HPA029048: AB_10602132" "unprognostic (1.22e-2)" "unprognostic (7.21e-2)" "unprognostic (4.61e-3)" "unprognostic (1.24e-2)" "unprognostic (5.92e-2)" "unprognostic (2.94e-2)" "unprognostic (2.43e-8)" "unprognostic (2.46e-2)" "unprognostic (1.55e-2)" "unprognostic (7.32e-2)" "unprognostic (2.89e-1)" "unprognostic (5.86e-2)" "unprognostic (1.25e-9)" "prognostic favorable (8.65e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-1)" 3.2 3.2 1.7 7.3 1.9 44.4 4.6 2.9 2.0 4.0 2.2 5.0 4.7 5.3 4.5 3.7 3.1 2.7 1.8 1.7 1.9 3.1 4.5 3.4 15.0 1.9 1.9 1.6 4.1 3.0 2.3 2.1 6.4 2.1 3.0 5.2 3.3 2.7 2.9 0.9 4.4 4.3 5.0 1.9 5.6 4.6 4.0 1.9 27.6 4.4 2.6 14.7 4.0 3.0 2.2 33.7 17.2 70.8 48.1 5.3 10.8 22.6 79.9 35.5 58.7 65.6 35.6 19.8 81.6 23.9 21.3 39.7 31.4 56.4 26.7 70.0 44.2 50.6 82.3 24.1 38.7 10.2 74.4 48.6 7.7 4.9 39.8 30.9 14.3 27.3 42.3 88.2 74.5 53.9 25.7 85.2 47.6 41.5 25.8 25.0 71.0 56.8 52.8 20.8 18.0 46.1 47.9 56.6 30.2 15.6 24.7 21.8 68.7 20.6 43.9 57.4 51.1 94.8 24.9 29.5 120.4 31.9 54.3 54.2 0.0 1.9 0.0 2.8 2.5 4.0 5.1 4.7 5.2 3.7 5.0 4.6 4.8 0.0 7.1 3.2 4.3 6.6 2.5 1.7 1.9 2.9 2.0 1.7 1.9 1.9 1.9 1.6 2.1 1.9 1.9 2.2 6.0 0.0 1.1 1.3 9.8 9.9 3.7 4.0 7.4 3.2 5.7 5.2 1.8 2.8 3.9 1.8 6.2 15.2 13.5 2.6 3.9 3.0 0.4 2.3 10.5 5.7 4.8 36.0 1.0 1.6 30.5 9.1 7.7 4.0 2.5 16.6 5.0 1.9 7.9 1.7 0.9 6.1 2.0 3.2 6.1 0.1 4.4 5.3 1.8 1.9 4.2 4.1 9.2 1.5 2.1 1.5 0.5 6.0 24.7 3.6 1.5 3.6 1.9 3.6 13.1 8.6 8.9 32.3 26.1 10.2 5.3 5.9 7.9 8.0 6.3 2.0 MTRF1L "HMRF1L, mtRF1a" ENSG00000112031 "Mitochondrial translational release factor 1 like" Q9UGC7 6 152987362-153002709 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036367 Uncertain NA NA "HPA036367: AB_10670715" "prognostic unfavorable (4.82e-4)" "unprognostic (4.64e-2)" "unprognostic (1.65e-2)" "unprognostic (3.56e-3)" "unprognostic (4.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.01e-3)" "unprognostic (4.80e-3)" "unprognostic (2.88e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (3.61e-2)" "unprognostic (1.97e-1)" "unprognostic (7.46e-3)" "unprognostic (1.91e-1)" "unprognostic (2.61e-2)" "unprognostic (4.84e-1)" 6.8 6.3 8.8 5.9 10.4 7.1 4.7 12.6 10.3 4.8 12.1 7.7 8.3 4.0 5.9 5.5 3.6 5.1 11.5 8.3 11.7 10.2 7.7 4.7 6.6 10.1 9.9 7.8 4.3 6.3 8.6 3.9 5.6 11.3 5.1 6.3 10.4 5.5 5.5 18.0 7.8 6.3 6.8 10.8 5.4 5.7 4.6 9.9 4.9 7.6 22.1 5.8 6.1 3.6 11.1 7.8 8.9 14.8 20.4 16.1 8.5 14.7 13.9 13.4 12.8 18.6 15.4 6.1 14.0 10.7 14.3 22.0 11.7 21.3 12.3 18.5 16.0 14.7 14.0 12.8 20.9 13.9 14.3 14.4 13.4 14.1 16.2 17.9 12.4 18.4 15.3 22.4 8.8 15.4 12.8 10.8 12.1 8.9 17.2 13.1 10.3 11.0 11.2 19.2 13.7 15.6 19.6 18.1 12.9 10.3 16.4 8.6 15.6 12.8 10.2 16.3 17.3 18.2 15.6 15.7 14.8 19.6 10.7 13.1 10.3 3.5 7.1 3.2 5.2 2.8 3.3 3.4 2.9 3.7 2.4 3.1 3.5 3.4 3.3 6.9 2.7 4.0 4.0 8.8 10.4 12.6 10.3 8.3 11.7 10.1 9.9 7.8 11.3 10.8 9.9 11.1 29.9 12.8 16.4 11.8 19.9 33.9 24.2 14.5 20.5 0.0 13.8 11.4 28.0 8.6 13.7 18.4 0.0 15.7 15.7 26.3 25.4 34.1 59.8 15.2 22.8 34.5 17.3 14.9 13.0 26.7 24.3 23.6 14.3 20.3 18.4 17.7 62.8 17.6 17.1 0.0 13.2 12.9 12.2 21.2 15.4 54.5 20.2 23.5 16.0 9.4 31.2 0.0 21.6 11.1 11.8 34.0 22.9 25.6 24.0 21.2 27.9 39.2 6.8 0.0 39.5 23.7 30.0 43.4 13.8 29.1 32.7 19.7 16.5 33.8 17.9 23.4 PPARD "FAAR, NR1C2, NUC1, NUCII" ENSG00000112033 "Peroxisome proliferator activated receptor delta" Q03181 6 35342558-35428191 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 67.7;Pancreatic endocrine cells: 102.5;Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017635 Approved NA NA "CAB017635: AB_1128605" "unprognostic (3.70e-2)" "unprognostic (8.75e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (8.68e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (4.59e-3)" "unprognostic (4.34e-1)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-3)" "unprognostic (7.27e-3)" "unprognostic (1.43e-1)" "unprognostic (9.42e-2)" "unprognostic (5.95e-2)" "unprognostic (2.00e-2)" 18.9 20.8 28.0 18.8 26.2 9.2 18.6 23.4 35.5 23.4 18.4 23.7 11.7 19.2 18.5 46.2 19.8 15.1 20.9 31.6 28.0 21.1 32.1 31.8 15.6 27.1 27.2 20.5 32.3 12.3 14.3 24.8 28.6 26.9 28.4 12.5 11.0 20.6 17.3 29.7 28.7 27.6 11.4 23.4 30.9 30.0 14.2 30.6 7.7 41.2 13.5 13.9 23.7 34.0 27.0 51.0 8.9 13.7 29.3 20.0 34.9 74.3 40.6 36.1 34.2 28.4 12.0 9.4 8.1 11.6 29.1 19.4 17.8 13.0 39.4 23.8 11.8 11.8 7.7 12.2 17.9 35.0 1.9 8.3 59.7 13.0 50.7 25.9 39.0 16.2 9.9 8.1 8.9 29.1 16.1 5.6 8.2 6.7 19.1 23.9 7.9 23.5 8.2 8.5 44.7 7.7 21.4 16.3 27.9 34.5 9.4 10.4 28.1 35.1 46.3 17.5 28.1 49.1 7.5 11.2 8.7 15.2 16.3 21.2 0.5 1.5 3.3 1.2 1.3 0.9 1.3 1.3 1.2 1.3 1.7 2.2 2.1 2.3 1.0 0.9 0.8 1.4 1.1 28.0 26.2 23.4 35.5 31.6 28.0 27.1 27.2 20.5 26.9 23.4 30.6 27.0 14.8 9.6 7.8 11.8 8.8 18.7 19.5 7.5 5.7 7.6 6.6 6.2 11.0 10.0 11.6 1.8 2.1 35.6 3.2 67.7 3.9 30.9 3.0 9.7 8.5 11.9 6.6 1.7 24.4 24.1 32.1 8.0 31.6 18.3 22.9 5.5 6.1 5.6 14.9 5.0 18.7 9.2 10.2 6.6 18.3 3.6 5.9 17.0 12.4 59.0 4.3 8.0 6.2 23.1 42.8 102.5 38.6 8.2 6.1 18.5 22.6 6.3 5.1 7.5 13.1 9.6 10.2 6.2 7.7 7.2 12.8 98.1 7.1 18.8 8.1 51.4 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.4;testis: 2.9" "Group enriched" "Detected in some" 13 "Early spermatids: 29.2;Excitatory neurons: 41.1;Inhibitory neurons: 23.5;Late spermatids: 29.7;Microglial cells: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 11 "SH-SY5Y: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported NA NA "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.1 0.8 1.7 0.3 2.6 0.7 0.4 8.4 3.1 0.2 0.0 0.2 0.2 0.3 0.6 1.1 0.2 0.3 0.1 1.2 2.4 0.2 0.2 0.2 0.4 2.1 5.8 2.7 0.4 0.2 0.2 0.0 0.2 1.9 0.3 0.2 0.9 0.3 0.2 0.4 0.6 0.2 0.2 0.7 0.4 0.4 2.9 8.2 0.2 0.5 0.1 0.3 0.1 0.0 4.5 0.1 0.0 0.3 0.3 0.1 0.3 0.2 0.3 0.2 0.2 0.1 0.2 0.5 0.4 0.2 0.1 0.4 0.2 0.4 0.4 0.2 0.3 0.2 0.3 0.5 0.2 0.3 0.4 0.3 0.2 0.6 0.2 0.5 0.2 0.2 0.3 0.3 0.6 0.4 0.2 0.2 0.4 0.1 0.2 0.1 0.3 0.2 0.2 0.3 0.4 0.4 6.8 0.1 0.2 0.4 0.4 0.3 0.2 0.1 0.4 0.2 0.3 0.1 0.5 0.2 0.3 0.3 0.3 0.2 1.1 0.1 0.3 0.2 0.1 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.7 0.4 0.2 0.4 0.2 0.1 1.7 2.6 8.4 3.1 1.2 2.4 2.1 5.8 2.7 1.9 0.7 8.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 29.7 0.0 0.2 0.0 10.3 0.0 0.0 0.0 1.5 2.0 0.0 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.2 FANCE "FACE, FAE" ENSG00000112039 "FA complementation group E" Q9HB96 6 35452338-35467102 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB014893 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB014893: " "unprognostic (2.66e-1)" "unprognostic (8.01e-3)" "unprognostic (7.73e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.80e-3)" "prognostic unfavorable (2.08e-9)" "unprognostic (8.90e-2)" "unprognostic (5.70e-3)" "unprognostic (8.41e-2)" "unprognostic (1.52e-1)" "unprognostic (2.91e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.14e-2)" 4.3 1.6 2.6 3.2 2.4 5.8 5.0 2.8 3.1 6.2 2.1 3.1 2.2 3.8 3.4 8.7 4.9 1.5 3.4 2.3 2.9 1.7 1.4 4.1 4.5 2.7 2.5 2.2 7.9 3.5 4.0 3.2 9.3 2.6 3.8 3.0 1.8 4.3 2.7 11.1 13.6 3.6 3.1 2.5 3.8 3.4 8.8 2.7 2.6 3.0 3.2 5.8 4.0 7.7 2.6 9.9 4.2 12.8 27.6 9.2 15.9 34.6 11.4 9.6 14.8 12.1 11.1 5.3 33.0 7.5 6.7 11.2 7.2 13.7 9.8 13.9 11.0 11.9 23.8 11.7 6.8 4.8 12.6 8.2 10.1 28.6 17.7 27.7 3.9 8.7 12.6 21.3 11.6 12.2 11.4 5.8 16.6 4.7 10.6 7.0 18.8 12.3 12.1 3.1 10.0 12.1 11.4 6.4 9.1 10.0 11.9 8.8 43.7 5.6 16.7 14.5 10.9 18.1 7.4 29.3 11.6 3.9 24.3 16.8 0.0 0.2 0.2 0.4 0.1 0.7 0.1 0.6 0.9 0.1 0.5 0.3 0.3 0.0 0.5 0.1 0.4 0.3 0.2 2.6 2.4 2.8 3.1 2.3 2.9 2.7 2.5 2.2 2.6 2.5 2.7 2.6 7.0 6.4 0.0 1.0 2.4 8.8 4.1 4.7 1.8 1.1 2.0 2.8 2.7 0.0 1.6 0.0 0.0 22.1 2.0 1.6 0.0 1.7 0.3 1.9 2.4 3.7 1.2 2.5 0.4 0.8 104.8 2.8 1.1 3.4 0.0 5.2 1.4 0.7 6.0 0.0 0.9 3.6 0.0 0.8 1.3 0.6 1.5 1.4 1.8 2.8 0.5 1.9 1.0 0.5 1.0 1.1 0.4 0.7 3.1 5.8 1.1 0.3 0.1 2.0 0.0 4.0 3.4 8.2 13.2 4.6 7.1 46.7 2.2 3.4 4.4 3.5 TULP1 "LCA15, RP14, TUBL1" ENSG00000112041 "TUB like protein 1" O00294 6 35497874-35512896 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction, Vision" "Disease variant, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 285 "retina: 211.0" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 266.9;Rod photoreceptor cells: 393.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;MCF7: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (7.98e-2)" "unprognostic (2.33e-2)" "unprognostic (4.38e-2)" "unprognostic (4.60e-5)" "unprognostic (2.28e-2)" "unprognostic (3.12e-3)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.85e-1)" "unprognostic (2.66e-2)" "unprognostic (7.42e-2)" "unprognostic (1.66e-6)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (5.42e-2)" "unprognostic (4.11e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.4 0.2 0.1 0.0 0.3 0.4 0.2 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.7 0.0 211.0 0.2 0.3 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 64.2 0.0 0.0 0.7 0.0 0.0 0.0 266.9 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.3 2.6 0.0 0.0 0.1 0.0 2.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 18.5 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 393.2 0.0 0.4 0.2 0.1 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.4 SLC26A8 ENSG00000112053 "Solute carrier family 26 member 8" Q96RN1 6 35943516-36024868 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 44.4" "Cell type enhanced" "Detected in some" "Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 11 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038081 Enhanced NA NA "HPA038081: AB_10670653" "unprognostic (8.18e-2)" "unprognostic (1.74e-1)" "unprognostic (6.71e-2)" "unprognostic (1.31e-2)" "unprognostic (2.46e-1)" "unprognostic (7.07e-3)" "unprognostic (2.93e-1)" "unprognostic (6.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.85e-1)" "unprognostic (3.78e-1)" "unprognostic (4.63e-6)" "unprognostic (7.14e-2)" "unprognostic (4.24e-1)" "unprognostic (2.31e-1)" "unprognostic (5.24e-8)" 0.1 0.1 0.7 0.3 0.6 4.8 0.1 0.9 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 1.2 0.0 0.1 0.3 0.0 1.0 0.8 0.9 0.0 0.1 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 1.0 0.0 44.4 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.7 0.6 0.9 0.8 0.5 1.2 1.0 0.8 0.9 1.3 0.3 1.0 0.9 0.1 3.2 1.1 2.0 0.0 0.4 0.4 0.1 0.0 0.3 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 54.1 0.4 0.2 0.3 0.0 0.0 15.8 0.0 0.0 0.3 0.0 0.8 0.0 0.1 0.4 0.8 0.1 0.0 12.1 0.0 0.0 1.2 0.4 12.0 0.9 0.5 1.8 1.0 0.9 0.0 0.0 0.5 1.0 0.1 0.0 0.4 0.1 0.4 0.3 0.1 0.3 0.3 0.0 0.7 0.1 64.8 0.8 0.0 0.1 0.3 0.3 0.0 0.0 0.2 MAPK14 "CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15" ENSG00000112062 "Mitogen-activated protein kinase 14" Q16539 6 36027677-36111236 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 79.0;neutrophil: 24.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 79.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010285, CAB040578, HPA051825" Approved Supported "Nuclear speckles,Cytosol" NA NA 970000 "Nuclear speckles" Cytosol "CAB010285: AB_632140, CAB040578: , HPA051825: " "unprognostic (6.76e-3)" "unprognostic (6.28e-2)" "unprognostic (6.30e-3)" "unprognostic (3.30e-3)" "unprognostic (6.98e-2)" "unprognostic (4.04e-2)" "unprognostic (8.10e-2)" "unprognostic (1.93e-1)" "unprognostic (2.20e-3)" "unprognostic (8.39e-2)" "unprognostic (6.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.47e-2)" "unprognostic (3.66e-3)" "unprognostic (6.66e-2)" "unprognostic (3.25e-1)" "unprognostic (1.58e-1)" 29.4 26.3 13.5 31.8 16.8 90.1 24.0 19.5 17.8 29.6 21.8 26.9 28.2 37.5 16.0 32.6 25.9 23.7 26.0 16.5 16.3 24.1 41.7 28.5 28.2 11.6 12.6 16.2 22.4 18.5 20.7 19.5 45.0 14.2 19.8 29.3 14.9 21.2 24.6 33.8 33.2 26.5 39.4 12.7 45.3 22.7 9.2 16.4 38.9 31.4 32.2 33.6 32.6 29.5 15.2 49.7 26.7 28.3 44.9 60.0 59.8 62.2 50.2 64.8 58.7 60.3 67.3 24.8 40.4 49.6 54.9 28.0 34.8 47.2 43.7 60.9 47.3 37.6 94.9 37.2 53.1 33.2 60.3 54.9 43.1 40.5 42.2 40.9 47.6 67.1 67.2 52.4 49.1 40.3 21.1 62.2 62.5 17.0 29.9 26.2 71.7 45.5 37.5 38.5 67.6 21.8 17.2 46.0 33.5 50.3 34.1 40.8 99.9 47.9 52.5 29.8 33.6 47.7 24.3 59.8 39.5 23.2 112.1 43.9 79.0 10.3 6.3 4.5 7.2 5.5 3.1 4.4 5.1 8.2 5.3 4.6 4.7 24.9 6.1 10.8 4.0 5.8 5.1 13.5 16.8 19.5 17.8 16.5 16.3 11.6 12.6 16.2 14.2 12.7 16.4 15.2 24.4 32.1 13.9 37.2 22.6 15.9 11.0 13.9 28.5 18.9 14.0 11.7 25.0 14.3 18.5 18.4 31.3 45.4 26.8 29.0 1.9 13.9 3.6 18.7 25.8 22.6 16.8 47.1 104.9 11.3 18.7 25.9 21.9 30.7 21.0 17.7 28.9 52.9 25.3 11.8 79.2 25.4 10.2 51.7 24.9 5.2 24.5 38.5 10.6 52.5 58.7 10.9 39.1 46.8 69.6 22.8 16.2 26.7 27.7 10.3 33.7 17.2 20.9 22.5 13.1 20.4 15.7 9.9 8.5 27.1 19.0 23.9 28.0 12.3 18.8 10.7 RHAG "CD241, RH50A, SLC42A1" ENSG00000112077 "Rh associated glycoprotein" Q02094 6 49605175-49636839 "CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "bone marrow: 120.5" "Cell type enriched" "Detected in some" 170 "Erythroid cells: 494.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 202 "HEL: 506.0;K-562: 491.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA046051, HPA055331" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA046051: , HPA055331: AB_2682785" "unprognostic (8.16e-2)" "unprognostic (6.86e-2)" "unprognostic (1.25e-3)" "unprognostic (1.65e-1)" 0.2 0.1 0.0 0.0 0.0 120.5 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.1 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.4 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 506.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 491.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.4 0.1 0.3 0.0 494.2 0.2 0.2 0.6 0.3 0.0 0.6 2.5 0.0 1.1 0.1 0.5 0.0 0.1 0.0 0.0 0.6 0.3 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.1 0.0 0.0 KCTD20 "C6orf69, dJ108K11.3, MGC14254" ENSG00000112078 "Potassium channel tetramerization domain containing 20" Q7Z5Y7 6 36442767-36491143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030092 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear speckles" "HPA030092: AB_10601437" "unprognostic (2.17e-1)" "unprognostic (2.02e-1)" "unprognostic (5.20e-3)" "unprognostic (2.43e-2)" "unprognostic (1.00e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.63e-1)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (9.31e-4)" "unprognostic (2.94e-2)" 42.0 26.1 15.1 28.3 15.8 27.9 21.5 15.7 16.5 23.9 15.0 18.9 14.4 25.9 15.5 28.3 19.7 29.1 18.1 15.2 36.4 16.2 31.5 22.1 27.9 18.5 18.3 14.5 23.0 12.9 14.7 12.0 26.3 17.4 19.5 18.3 11.0 14.7 21.2 20.9 29.8 15.8 31.8 16.9 25.5 14.8 10.4 17.2 35.1 14.4 19.1 29.7 28.9 17.7 17.5 36.7 16.9 47.0 90.4 62.8 41.3 23.4 43.7 60.4 46.9 52.2 43.6 20.8 124.3 38.2 72.4 26.8 33.3 62.3 31.4 77.3 90.3 34.9 70.3 26.0 46.5 29.9 68.9 46.8 41.1 32.5 36.1 23.0 31.2 48.7 64.1 112.8 68.2 44.9 33.1 78.5 26.6 17.5 29.1 15.3 78.0 53.4 68.8 25.5 40.6 11.4 65.9 38.4 38.6 116.6 46.6 53.5 68.1 56.4 126.2 43.4 37.5 55.0 53.0 132.9 87.8 21.7 93.7 131.4 29.7 17.4 11.4 8.1 15.1 9.4 6.8 6.5 6.8 16.3 5.6 6.5 6.6 12.5 7.8 8.9 9.0 8.6 13.9 15.1 15.8 15.7 16.5 15.2 36.4 18.5 18.3 14.5 17.4 16.9 17.2 17.5 38.3 38.5 23.7 21.9 28.6 50.1 19.6 15.2 24.5 22.4 23.7 23.9 15.9 28.6 22.2 16.5 10.4 26.3 45.4 14.0 1.9 18.2 0.7 20.0 33.8 38.3 15.1 64.6 23.3 14.2 18.9 38.9 23.9 24.6 53.8 40.8 44.6 45.6 26.7 15.2 23.3 15.5 12.2 51.3 126.3 2.3 31.7 61.4 33.8 27.2 58.4 18.1 30.9 22.6 26.5 19.5 16.3 53.4 48.7 18.9 18.8 19.0 22.5 10.5 19.7 35.8 42.7 8.1 27.2 27.6 63.4 23.0 39.6 23.8 16.1 32.2 STK38 "NDR, NDR1" ENSG00000112079 "Serine/threonine kinase 38" Q15208 6 36493892-36547479 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004673, HPA038623, HPA051324" Uncertain Approved Cytosol NA NA Cytosol "CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (3.58e-3)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (6.76e-3)" "unprognostic (8.25e-2)" "unprognostic (1.47e-2)" "unprognostic (2.88e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (1.98e-2)" "unprognostic (3.80e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-3)" 26.6 11.6 13.7 29.2 14.2 30.9 23.4 16.3 18.2 23.0 16.4 37.2 24.2 21.5 12.6 39.9 21.6 20.9 22.7 14.6 15.9 22.0 24.9 25.1 34.8 15.1 13.8 13.8 16.1 12.6 8.4 14.5 21.9 15.1 24.0 36.8 11.4 33.8 16.1 16.3 30.8 41.9 27.6 13.7 34.8 23.4 13.9 15.0 28.2 14.1 16.4 34.1 30.2 28.7 15.4 43.0 31.1 32.1 34.8 63.4 47.9 27.9 46.7 37.6 47.6 47.4 24.0 28.7 57.3 35.3 70.0 39.5 44.7 26.9 19.6 55.7 23.6 23.0 41.1 40.8 21.9 31.2 15.8 21.7 31.9 50.0 36.9 23.6 54.5 30.1 28.7 34.0 32.4 68.5 25.7 25.5 40.8 13.4 50.5 27.3 97.7 38.9 15.3 45.0 52.9 37.4 17.7 57.0 25.9 34.0 35.7 27.8 40.8 29.4 38.4 33.6 30.9 30.7 27.1 51.4 39.9 8.7 60.1 37.8 91.2 45.2 34.6 57.0 49.5 44.1 22.4 46.9 50.4 29.1 16.2 41.1 45.8 59.4 59.3 73.3 14.4 48.7 58.3 13.7 14.2 16.3 18.2 14.6 15.9 15.1 13.8 13.8 15.1 13.7 15.0 15.4 29.7 19.2 16.0 27.4 25.7 13.5 9.6 21.5 21.1 3.0 16.0 14.5 15.5 18.6 47.9 7.3 0.0 13.8 59.5 47.1 1.9 18.9 9.0 15.3 16.0 18.4 14.4 16.6 46.5 12.7 17.8 22.2 34.7 20.4 13.3 13.5 12.1 15.0 13.2 5.0 34.2 25.4 22.4 38.2 20.3 5.3 27.1 40.1 17.8 57.1 48.7 7.6 101.0 38.2 36.8 27.8 30.8 30.1 39.6 12.8 32.8 16.6 40.4 7.7 13.1 8.3 14.0 26.5 10.3 31.5 21.2 15.3 45.5 10.1 28.4 27.9 SRSF3 "SFRS3, SRp20" ENSG00000112081 "Serine and arginine rich splicing factor 3" P84103 6 36594353-36605600 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012986, HPA056981" Supported Supported Nucleoplasm NA NA 1600000 Nucleoplasm "CAB012986: AB_2533150, HPA056981: AB_2683299" "unprognostic (3.25e-1)" "unprognostic (1.08e-3)" "prognostic favorable (2.56e-4)" "unprognostic (8.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.22e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (1.95e-4)" "prognostic favorable (1.37e-4)" "unprognostic (9.61e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (9.88e-2)" "unprognostic (3.33e-2)" "unprognostic (8.33e-2)" "unprognostic (1.06e-2)" 83.8 63.0 39.7 94.4 41.5 173.8 91.1 44.0 44.3 69.3 42.4 90.4 54.5 76.8 63.1 98.6 78.7 40.9 68.1 40.5 49.1 64.8 76.0 69.4 119.9 41.5 41.9 38.3 84.7 58.4 62.8 49.5 75.2 41.0 59.2 96.2 45.6 58.3 65.2 76.6 63.6 73.8 90.7 44.3 67.8 75.5 60.4 44.0 165.8 61.2 48.9 149.1 98.6 72.6 45.5 357.2 232.3 401.4 308.9 151.9 117.9 247.2 248.4 206.5 408.6 312.2 275.1 248.2 593.4 174.3 273.3 266.8 275.1 533.1 395.4 433.2 279.3 327.3 357.0 175.5 312.3 184.9 485.2 289.6 105.8 131.6 267.4 295.6 130.3 315.2 354.4 438.7 244.1 300.8 277.4 601.0 457.0 424.5 414.5 241.5 527.3 384.2 355.9 292.2 291.1 308.7 291.8 276.1 267.4 385.4 284.9 271.2 513.1 207.9 208.1 303.9 211.0 380.1 238.6 381.4 822.9 178.4 443.7 295.5 85.6 179.0 57.9 145.8 176.6 166.0 129.0 136.8 154.7 350.7 113.5 136.1 140.8 17.1 190.5 125.1 206.8 184.2 305.6 39.7 41.5 44.0 44.3 40.5 49.1 41.5 41.9 38.3 41.0 44.3 44.0 45.5 648.3 201.9 238.6 47.3 337.6 469.6 425.1 308.4 225.9 146.2 371.3 388.4 227.9 198.8 258.0 125.0 54.2 495.6 574.3 245.3 363.9 357.3 176.1 216.0 295.7 346.9 332.9 345.9 24.0 324.9 816.9 373.6 226.8 251.1 396.8 275.2 243.8 182.7 359.3 99.3 23.8 409.9 191.2 262.9 559.3 321.2 211.9 356.5 334.4 45.9 366.3 368.8 334.8 38.2 51.1 290.1 301.9 172.3 256.3 401.7 259.2 274.7 164.8 154.5 203.8 497.3 448.2 374.2 290.8 312.2 445.8 526.1 415.2 184.1 427.4 285.1 SOD2 GClnc1 ENSG00000112096 "Superoxide dismutase 2" P04179 6 159669069-159762529 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 1093.7;skeletal muscle: 3256.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "neutrophil: 4470.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 4470.5" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001814, CAB002013" Supported Enhanced Mitochondria NA NA 55000000 Mitochondria "CAB002013: , HPA001814: AB_1080134" "unprognostic (2.47e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "unprognostic (1.37e-1)" "unprognostic (6.67e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.99e-2)" "unprognostic (1.82e-1)" 249.9 247.9 65.8 527.4 43.1 1093.7 170.5 40.2 113.9 92.6 107.6 114.6 61.1 106.3 7.3 137.6 119.6 122.9 180.1 35.2 399.6 252.8 463.6 268.9 65.3 254.7 76.0 30.8 56.3 214.1 69.7 43.0 63.4 136.1 132.0 38.3 25.3 331.5 44.3 3256.5 84.5 84.4 109.4 66.3 82.1 121.4 39.9 130.5 38.6 67.7 315.4 65.5 519.8 98.7 180.0 35.8 46.3 37.3 85.1 229.0 378.7 20.5 52.7 1611.9 57.7 131.1 91.3 19.4 70.7 144.5 54.1 614.3 58.9 39.1 42.5 42.4 71.2 87.2 74.5 71.8 152.3 169.5 74.0 31.9 688.9 68.5 180.9 133.6 40.7 30.0 44.9 106.7 82.2 55.4 37.6 60.3 46.6 63.3 41.5 55.4 79.6 50.3 63.9 106.2 56.6 71.5 29.5 105.1 52.4 21.4 14.1 33.1 33.7 30.4 168.6 62.1 92.5 87.9 37.8 100.2 86.5 186.7 57.4 23.6 146.3 364.4 181.1 38.8 273.9 43.4 43.4 54.9 38.5 105.2 38.3 45.0 36.9 4470.5 19.1 445.3 14.8 87.9 340.0 65.8 43.1 40.2 113.9 35.2 399.6 254.7 76.0 30.8 136.1 66.3 130.5 180.0 303.2 201.9 746.1 13.4 99.0 684.7 1144.9 2508.2 114.4 45.6 150.2 96.6 0.0 287.4 613.3 237.3 45.9 18.3 43.8 153.9 86.1 1400.2 318.2 281.7 649.8 593.0 79.6 101.2 31.1 1389.7 51.2 1098.4 103.5 1080.1 112.3 23.1 58.9 395.0 292.0 32.0 30.1 92.7 339.7 333.3 1425.8 111.5 58.1 1031.2 521.2 15.9 339.9 50.4 35.0 8.5 12.2 581.6 111.3 65.1 101.2 3524.0 128.6 530.1 269.6 61.8 39.5 1164.0 407.3 91.7 51.4 258.7 681.8 27.2 119.4 38.3 148.1 1195.7 MRPL18 HSPC071 ENSG00000112110 "Mitochondrial ribosomal protein L18" Q9H0U6 6 159789812-159798436 "Predicted intracellular proteins, Ribosomal proteins" Transport "Chaperone, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028774, HPA028775" Enhanced NA NA "HPA028774: AB_10600113, HPA028775: AB_10601440" "unprognostic (4.73e-3)" "unprognostic (9.67e-2)" "unprognostic (5.90e-2)" "unprognostic (1.79e-1)" "unprognostic (1.07e-1)" "unprognostic (3.34e-3)" "prognostic unfavorable (3.61e-4)" "unprognostic (3.44e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (3.56e-1)" "unprognostic (7.91e-2)" "prognostic unfavorable (9.02e-5)" "unprognostic (3.51e-1)" "unprognostic (7.14e-2)" "unprognostic (1.35e-2)" "unprognostic (5.22e-2)" 42.5 56.3 76.7 42.4 78.4 46.2 39.4 79.6 105.4 41.1 80.4 52.8 43.4 46.2 51.8 52.4 54.2 36.2 65.2 80.5 78.6 53.0 65.8 37.1 55.3 79.4 78.4 76.3 43.2 40.9 43.9 38.7 41.5 79.4 42.8 46.9 28.4 44.9 44.3 78.1 41.2 39.2 49.1 80.0 35.3 45.4 30.4 79.4 50.7 35.2 74.7 49.0 50.5 43.1 83.6 77.5 148.5 55.1 140.1 78.4 86.7 109.7 105.6 89.7 124.1 128.8 172.4 68.5 118.1 88.5 88.8 185.9 107.4 205.1 129.9 118.4 81.4 166.7 117.9 119.8 303.1 87.6 117.6 100.4 67.9 113.0 132.5 97.1 80.0 110.3 121.4 172.4 120.2 115.1 119.5 155.4 256.2 77.2 149.2 143.6 106.6 54.6 196.1 140.3 49.6 92.2 59.1 102.6 165.9 65.7 56.0 102.3 283.7 70.5 93.8 106.0 159.8 212.8 98.5 196.7 139.8 142.7 245.1 116.6 130.6 116.3 108.9 92.6 152.9 107.6 154.3 118.2 103.9 134.4 132.2 131.4 117.6 23.2 110.8 175.9 167.9 137.5 193.0 76.7 78.4 79.6 105.4 80.5 78.6 79.4 78.4 76.3 79.4 80.0 79.4 83.6 93.8 51.3 30.5 9.1 62.2 127.3 271.8 170.1 63.2 29.8 98.3 127.6 61.4 108.7 98.6 53.3 16.7 103.8 66.1 94.9 211.3 125.4 226.8 95.9 74.2 73.6 143.5 49.2 11.8 110.9 194.2 77.5 44.9 74.0 93.4 56.0 41.4 86.7 126.8 23.5 12.7 131.5 124.1 48.9 170.4 58.8 90.4 106.1 106.7 11.2 81.7 92.1 75.2 8.5 15.6 126.7 116.2 83.1 54.5 210.4 75.6 192.5 120.4 42.4 85.5 51.1 106.3 258.2 125.8 72.8 119.2 74.8 90.1 108.9 138.7 172.6 IL17A "CTLA8, IL-17, IL-17A, IL17" ENSG00000112115 "Interleukin 17A" Q16552 6 52186375-52190638 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Cell type enriched" "Detected in single" 14 "T-cells: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "Karpas-707: 2.7;U-266/84: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA052258 Uncertain "Secreted to blood" NA NA 9920 "HPA052258: " "unprognostic (5.55e-1)" "unprognostic (2.18e-4)" "unprognostic (3.05e-4)" "unprognostic (1.41e-2)" "unprognostic (2.22e-2)" 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 IL17F "IL-17F, ML-1, ML1" ENSG00000112116 "Interleukin 17F" Q96PD4 6 52236681-52244500 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 30000 "unprognostic (1.40e-1)" "unprognostic (1.20e-1)" "unprognostic (3.02e-1)" "unprognostic (2.52e-1)" 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 MCM3 ENSG00000112118 "Minichromosome maintenance complex component 3" P25205 6 52264014-52284881 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 122.7;Erythroid cells: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002162, HPA004789, HPA004790" Supported Supported Nucleoplasm NA Yes 150000 Nucleoplasm "CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335" "unprognostic (9.14e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.37e-1)" "unprognostic (1.53e-2)" "unprognostic (2.14e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (1.16e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.34e-2)" 23.3 16.1 12.9 41.9 13.4 56.0 29.4 13.8 13.9 26.1 13.6 33.2 19.8 31.1 24.0 33.7 29.4 16.6 25.6 11.9 14.0 19.7 19.0 21.6 69.3 14.1 13.6 11.4 32.1 17.2 29.2 10.9 40.4 14.1 19.9 39.7 19.5 19.3 31.0 16.1 32.5 29.6 37.3 14.0 31.5 24.4 21.3 14.9 81.8 18.5 17.8 79.2 28.3 24.7 14.1 187.9 121.7 208.0 196.9 43.9 39.4 136.1 135.8 103.7 226.6 230.3 251.6 99.2 202.8 132.5 79.7 147.8 145.4 277.4 165.9 226.9 230.0 261.4 383.6 233.2 358.2 11.8 381.7 150.8 23.7 38.1 166.6 46.2 55.6 117.3 240.4 318.1 452.9 118.3 123.8 386.9 293.5 173.1 369.8 84.8 338.3 317.0 271.2 101.1 195.8 210.3 160.5 142.2 81.1 125.3 289.4 159.7 266.9 60.5 153.5 163.6 160.8 206.4 132.9 163.5 356.4 132.2 323.8 184.0 30.5 18.3 27.3 50.0 31.3 42.8 47.7 49.9 50.3 30.0 41.2 47.6 51.2 2.6 55.0 18.3 19.0 71.6 46.9 12.9 13.4 13.8 13.9 11.9 14.0 14.1 13.6 11.4 14.1 14.0 14.9 14.1 24.3 22.4 12.3 3.3 26.4 19.2 20.0 24.9 12.5 16.1 14.1 17.1 19.9 7.2 19.2 22.0 4.2 122.7 18.6 10.9 13.7 30.9 1.1 9.6 16.7 30.9 7.3 92.6 2.5 20.2 63.6 22.3 15.8 15.1 37.4 48.3 15.0 10.5 36.0 0.0 2.1 20.4 8.2 10.1 7.5 3.6 27.1 12.1 7.2 8.4 12.5 17.8 34.0 2.5 6.1 17.3 10.5 21.1 37.6 10.9 7.3 7.5 17.0 16.0 6.6 16.8 27.9 22.5 64.0 24.5 10.1 27.4 26.0 19.0 37.1 13.9 RNF8 KIAA0646 ENSG00000112130 "Ring finger protein 8" O76064 6 37353979-37394734 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 76.0" "Not detected" "Not detected" "HPA050731, HPA064925" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050731: AB_2681222, HPA064925: AB_2685385" "unprognostic (1.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.39e-2)" "unprognostic (8.20e-2)" "unprognostic (5.17e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (3.33e-5)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (2.26e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (3.41e-2)" "unprognostic (3.66e-3)" "unprognostic (1.09e-1)" 5.1 7.8 10.4 3.6 10.6 4.6 5.3 12.3 14.5 7.1 9.6 5.8 3.1 7.1 2.1 10.7 6.0 4.0 8.7 10.5 11.0 6.6 4.8 6.0 4.2 10.8 11.1 10.0 7.7 4.6 7.5 6.6 4.8 10.8 6.1 3.7 9.1 6.2 5.3 8.2 7.3 5.0 4.9 9.7 4.8 5.2 11.3 12.7 5.9 4.6 10.7 6.6 6.6 7.9 11.4 12.5 7.3 17.3 20.7 13.7 19.6 4.9 12.6 15.5 23.4 25.6 11.0 6.8 15.3 7.5 12.4 20.1 11.4 24.4 16.0 24.4 16.2 23.7 26.5 12.0 16.6 7.8 14.3 18.7 9.8 15.2 14.0 16.2 14.3 22.9 17.9 18.1 5.2 13.6 8.3 17.4 17.5 12.1 6.3 9.4 13.5 16.0 10.6 12.1 8.7 34.0 11.4 9.5 10.6 18.0 11.3 9.5 13.6 10.4 15.4 13.5 14.7 18.8 15.2 21.8 76.0 7.5 20.1 18.0 1.0 4.3 2.5 9.5 5.8 8.8 8.1 7.0 9.2 7.8 4.9 6.1 8.1 0.5 7.9 8.8 3.3 9.1 5.2 10.4 10.6 12.3 14.5 10.5 11.0 10.8 11.1 10.0 10.8 9.7 12.7 11.4 21.0 19.2 25.9 13.4 15.0 18.2 22.2 26.0 26.2 26.7 16.5 20.4 31.1 12.8 18.5 25.8 39.6 24.8 18.2 10.3 15.6 24.7 41.1 68.5 32.2 19.2 22.2 18.7 17.0 18.9 25.8 28.0 16.3 52.3 28.5 37.0 27.8 16.5 17.5 50.5 15.9 16.5 14.2 13.9 17.7 30.2 26.8 24.0 10.6 11.2 19.6 25.4 37.0 12.5 20.5 28.8 18.1 30.9 13.7 31.8 11.8 20.6 23.8 32.3 13.1 23.2 20.8 46.5 34.5 34.2 22.0 5.9 19.3 22.0 18.0 21.9 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716554-13287843 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.3;brain: 44.0;lymphoid tissue: 24.1" "Group enriched" "Detected in many" 4 "Excitatory neurons: 1954.8;Inhibitory neurons: 523.7" "Cancer enriched" "Detected in many" 5 "melanoma: 10.2" "Region enhanced" "Detected in many" "basal ganglia: 44.0" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 37.8" "Group enriched" "Detected in many" 18 "B-cells: 13.6;dendritic cells: 37.8;granulocytes: 18.7" "Cell line enhanced" "Detected in many" "HMC-1: 74.6;SK-MEL-30: 79.5;U-266/70: 176.1;U-266/84: 133.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 5.2 2.0 2.6 12.7 44.0 38.3 1.5 0.0 26.3 1.1 0.0 2.0 2.8 1.1 2.5 1.7 2.5 6.1 15.1 12.5 15.8 5.4 2.6 14.0 15.0 5.6 0.8 7.8 1.6 6.1 0.5 4.1 2.6 15.5 1.1 2.0 7.9 1.0 0.7 0.5 3.3 3.0 2.5 0.0 11.3 3.7 1.9 5.0 3.6 1.1 0.7 24.1 4.1 1.0 4.5 0.2 0.3 4.5 0.3 0.0 0.1 14.7 1.5 5.0 4.1 7.7 0.3 0.3 0.9 1.2 0.6 6.4 0.3 0.0 0.2 5.3 17.3 0.6 39.5 0.6 0.2 0.5 38.1 74.6 1.7 0.1 0.0 0.7 0.3 6.2 2.1 18.6 31.1 4.1 0.0 0.4 22.4 5.1 0.0 0.0 17.7 10.2 2.9 2.9 0.5 18.3 5.8 0.1 9.9 79.5 6.1 21.2 8.6 6.8 0.6 1.1 0.0 0.4 176.1 133.7 33.5 2.3 9.8 26.0 0.2 1.3 1.5 0.1 1.1 0.1 9.9 0.1 0.0 6.7 13.6 0.0 0.1 18.7 0.1 0.9 37.8 0.0 0.9 2.6 44.0 0.0 26.3 12.5 15.8 5.6 0.8 7.8 15.5 0.0 5.0 4.5 12.6 67.3 48.5 265.1 131.6 3.7 1.4 0.8 1.2 43.5 2.1 3.9 10.4 4.3 8.3 62.5 4.2 1.4 79.4 0.7 31.3 0.7 59.9 5.5 2.8 12.9 1.8 13.7 1954.8 2.9 2.3 8.6 0.5 15.0 81.2 2.7 13.6 1.1 83.1 180.0 523.7 0.2 0.0 138.2 91.5 79.8 4.7 188.5 48.0 114.3 20.5 28.4 6.2 186.5 247.8 0.8 0.2 6.4 59.6 1.0 0.3 1.0 5.1 14.0 0.0 4.0 4.3 2.0 4.8 2.1 3.1 1.9 8.6 6.6 1.0 0.8 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 72.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 34.0;Cone photoreceptor cells: 50.1;Horizontal cells: 57.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 7 "cerebellum: 72.3;pons: 29.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031235, HPA050382" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1200000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: AB_2681108" "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 2.2 3.0 4.2 2.6 3.4 0.3 1.6 72.3 4.5 5.3 0.0 2.2 0.5 3.4 1.8 3.7 2.8 3.3 2.2 7.4 4.6 1.0 0.6 3.1 2.7 3.9 6.9 2.7 6.5 2.5 4.1 4.8 0.3 29.1 2.1 1.2 4.1 1.1 1.3 1.1 4.9 2.8 2.6 0.9 3.1 2.0 1.5 1.7 0.8 1.4 1.7 2.1 1.9 4.5 3.4 0.2 3.5 4.8 2.4 12.3 4.3 2.2 2.8 2.2 3.5 3.2 0.0 0.0 0.7 0.5 1.7 3.0 5.4 0.5 0.0 1.0 4.9 3.4 0.0 0.3 0.0 0.5 0.0 1.1 1.0 0.0 1.4 0.0 6.8 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.1 0.4 5.9 1.7 0.0 0.8 3.7 4.3 0.0 1.5 0.3 2.6 0.2 3.1 0.6 0.3 3.4 1.4 1.2 4.3 0.0 0.1 0.0 4.2 1.0 2.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.1 4.2 3.4 72.3 4.5 7.4 4.6 3.9 6.9 2.7 29.1 0.9 1.7 3.4 3.0 9.6 0.5 12.7 2.0 2.3 2.4 0.7 1.2 34.0 0.4 0.6 5.7 1.5 0.8 3.7 50.1 0.2 3.1 0.0 0.0 0.5 2.6 0.6 1.8 1.6 1.8 0.0 4.9 0.0 1.4 4.4 0.5 0.5 0.0 1.1 1.4 0.0 0.1 57.2 4.9 0.0 0.0 0.3 1.1 0.2 10.2 0.3 1.8 1.9 0.0 2.6 4.1 4.0 2.1 0.6 0.0 4.9 1.7 2.0 0.0 0.5 1.9 2.0 0.0 2.6 3.0 2.1 1.3 2.8 3.0 0.7 2.9 0.2 0.0 5.1 CILK1 "ICK, KIAA0936, LCK2, MGC46090, MRK" ENSG00000112144 "Ciliogenesis associated kinase 1" Q9UPZ9 6 53001279-53061824 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000791, HPA001113" Approved Supported "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA000791: AB_2732392, HPA001113: AB_1851385" "unprognostic (1.75e-2)" "unprognostic (1.02e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (2.32e-1)" "unprognostic (1.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.82e-2)" "unprognostic (1.17e-3)" "unprognostic (5.11e-2)" "unprognostic (1.18e-1)" "unprognostic (8.28e-2)" "unprognostic (8.12e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (2.26e-1)" 8.0 18.1 10.2 4.9 11.3 2.7 10.8 9.3 9.2 9.0 5.8 8.8 9.9 8.1 5.5 8.6 7.5 7.0 8.6 7.4 8.7 4.5 7.6 6.3 5.2 10.1 12.6 6.1 9.5 5.0 7.4 1.7 12.2 11.0 10.0 10.8 17.6 18.1 7.4 4.1 8.7 10.5 7.4 10.9 5.6 13.0 4.5 15.7 10.2 6.3 5.1 6.2 6.6 5.8 13.8 7.8 2.9 14.6 10.0 8.9 14.0 17.0 6.9 12.4 10.8 12.3 4.1 2.4 5.7 4.0 21.0 3.5 5.0 17.6 7.1 14.2 19.9 7.0 4.2 3.3 22.3 4.5 5.2 5.4 12.5 7.6 4.6 5.3 7.7 10.2 12.1 8.1 22.6 24.9 6.7 5.6 6.4 5.6 27.0 6.3 8.8 6.5 7.5 4.5 5.6 23.6 10.6 6.7 16.3 9.6 14.2 9.5 10.9 8.5 17.2 8.0 6.5 17.1 6.3 4.8 2.2 3.5 5.0 8.5 2.8 1.0 2.2 1.7 0.8 1.5 1.2 1.2 1.4 1.0 1.5 1.4 1.2 0.5 1.1 0.9 1.4 1.7 0.8 10.2 11.3 9.3 9.2 7.4 8.7 10.1 12.6 6.1 11.0 10.9 15.7 13.8 6.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 20.6 5.7 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 33.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 58.1 0.8 0.0 0.0 0.0 FBXO9 "FBX9, NY-REN-57" ENSG00000112146 "F-box protein 9" Q9UK97 6 53051991-53100873 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064246 Approved Centrosome NA NA Centrosome "HPA064246: AB_2685225" "unprognostic (6.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.71e-1)" "unprognostic (9.38e-2)" "unprognostic (3.38e-2)" "unprognostic (3.06e-3)" "unprognostic (6.73e-2)" "unprognostic (1.40e-3)" "unprognostic (2.89e-3)" "prognostic favorable (1.51e-4)" "prognostic favorable (1.82e-4)" "unprognostic (2.50e-1)" "unprognostic (3.41e-1)" "unprognostic (2.29e-1)" "unprognostic (8.73e-2)" "unprognostic (1.56e-2)" "unprognostic (6.64e-3)" 46.2 127.4 27.5 30.7 27.2 103.8 38.8 32.2 40.1 34.8 36.4 38.8 34.7 39.0 42.2 45.8 37.9 30.3 56.7 25.8 27.6 52.1 64.6 35.5 33.5 27.8 30.6 24.4 37.6 57.2 65.2 36.8 35.0 28.4 39.6 33.6 61.6 49.8 45.2 72.5 41.2 34.8 50.9 22.9 37.9 48.3 36.7 29.5 27.1 46.6 49.1 36.7 34.8 31.0 33.4 74.2 29.4 26.6 81.2 53.4 42.9 61.7 68.2 68.8 61.4 61.0 56.6 31.6 36.6 46.3 67.7 39.2 44.8 58.2 54.5 78.4 45.7 57.9 87.8 56.5 83.4 44.4 84.6 53.2 56.1 58.9 42.5 43.5 61.9 52.9 37.6 88.5 56.4 65.4 47.4 36.9 57.3 24.1 70.1 41.5 43.8 71.0 44.9 68.4 54.3 94.9 36.5 69.2 50.0 96.5 53.6 76.8 83.6 45.2 87.6 60.8 97.3 80.8 59.9 80.6 57.3 43.0 58.1 50.3 14.5 21.8 13.2 10.9 11.7 12.6 13.5 11.3 11.2 14.5 13.7 12.5 9.6 13.5 14.6 11.6 11.6 13.1 8.2 27.5 27.2 32.2 40.1 25.8 27.6 27.8 30.6 24.4 28.4 22.9 29.5 33.4 36.4 76.9 91.5 44.1 34.0 14.1 20.7 35.2 54.1 82.1 43.6 42.2 42.2 40.0 47.0 20.2 66.7 41.0 47.7 26.2 39.2 68.7 135.1 23.8 40.5 32.6 29.9 166.1 57.8 76.3 44.1 31.7 50.4 21.5 32.2 43.9 28.9 60.6 24.9 77.4 48.9 28.0 28.5 41.2 15.7 116.8 38.5 36.9 19.6 30.0 52.8 71.6 63.8 53.3 58.6 57.4 18.8 32.4 41.5 33.2 28.5 66.9 31.7 81.9 19.7 43.2 39.1 40.7 24.1 60.4 16.2 75.4 38.1 60.5 23.9 18.2 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 211.5" "Cell type enhanced" "Detected in many" "B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454, HPA073595" Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: " "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 10.3 20.1 20.1 35.2 16.4 211.5 7.1 18.7 22.1 24.8 27.0 5.2 4.6 7.3 4.0 4.6 5.2 17.1 4.2 18.4 21.5 18.9 15.0 40.2 51.7 21.8 18.0 15.1 16.6 4.3 6.6 7.2 9.3 23.8 8.4 9.3 5.1 19.7 14.0 1.3 4.7 11.6 7.0 27.3 20.3 5.8 5.3 23.3 38.3 5.4 2.9 70.8 15.7 15.6 26.7 18.1 0.8 12.7 17.7 18.2 4.2 0.4 5.1 17.6 8.3 14.4 1.3 11.6 79.1 14.6 1.3 16.8 2.0 4.8 5.5 27.0 71.9 7.6 10.6 21.4 2.1 0.6 15.8 16.5 4.8 2.3 8.0 2.6 2.5 0.2 26.4 2.4 0.0 0.8 6.5 12.6 29.7 5.3 3.2 3.7 12.1 28.1 10.9 6.0 17.2 2.8 5.2 1.0 0.6 13.5 7.3 3.0 12.3 0.4 12.8 8.1 1.9 12.0 0.7 0.2 121.5 2.8 21.6 19.7 0.0 3.1 2.0 4.4 19.0 4.8 19.7 4.0 3.7 9.0 31.0 2.8 3.3 2.2 5.0 29.3 3.2 6.2 4.4 20.1 16.4 18.7 22.1 18.4 21.5 21.8 18.0 15.1 23.8 27.3 23.3 26.7 41.3 19.2 77.9 5.2 668.5 49.5 16.0 10.0 41.5 4.2 26.5 46.4 30.9 2.8 8.2 11.0 6.2 1.5 100.4 5.4 3.9 0.9 0.9 29.0 24.1 39.1 24.0 3.0 5.6 1.6 2.4 31.1 11.2 74.8 238.8 8.1 2.9 1.1 145.6 1.7 6.1 7.3 4.1 83.0 1390.2 1.9 0.3 539.4 44.4 13.1 513.6 3.5 1.0 2.5 1.3 2.1 0.4 0.0 20.4 26.2 1.7 17.7 4.9 2.7 0.0 17.2 17.0 2.1 10.2 17.2 38.5 2.7 69.2 21.0 11.6 3.5 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642498-89819794 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.5;Inhibitory neurons: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 24.7;NTERA-2: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 4.1 4.6 3.0 1.9 3.8 4.3 4.3 4.3 3.8 4.4 1.7 4.2 1.2 5.6 2.1 5.0 5.0 1.2 4.8 3.1 3.2 3.2 9.1 4.0 2.6 3.8 3.4 2.8 7.7 5.9 3.0 4.7 1.2 3.8 3.6 1.8 3.0 3.9 1.5 8.4 6.9 5.0 1.8 2.3 4.5 4.6 6.5 3.5 2.8 6.0 3.5 2.5 4.3 4.4 5.8 4.2 4.1 4.1 3.8 6.6 6.3 4.1 2.8 2.1 3.1 3.8 9.4 1.5 12.5 3.1 2.9 3.3 3.6 10.7 3.8 5.5 4.9 7.1 13.5 5.6 6.1 2.5 17.7 3.2 3.9 3.1 8.3 7.6 1.9 5.6 5.6 24.7 2.9 3.1 5.0 2.8 6.6 22.7 3.4 3.5 5.5 7.8 3.1 2.7 5.8 7.5 3.3 3.9 2.3 2.5 5.4 1.6 7.7 7.2 2.1 3.8 2.8 6.5 3.3 3.9 5.9 2.8 9.8 3.7 3.2 0.3 0.6 0.7 0.2 0.6 1.0 1.0 0.8 0.2 1.3 1.3 1.0 0.0 1.1 0.3 3.0 0.4 0.1 3.0 3.8 4.3 3.8 3.1 3.2 3.8 3.4 2.8 3.8 2.3 3.5 5.8 13.2 28.9 19.1 55.2 19.2 29.3 8.2 6.0 30.7 24.4 14.0 11.0 39.2 11.5 16.9 14.7 25.0 5.5 25.2 6.6 0.0 6.3 7.5 20.1 21.9 15.0 7.7 58.5 82.5 8.1 7.2 13.3 19.4 25.2 6.3 26.4 6.4 48.5 6.6 18.5 79.5 7.7 6.1 6.3 9.5 4.3 7.2 8.6 12.4 33.7 6.6 8.0 9.2 35.7 74.8 6.9 3.7 8.6 26.0 18.1 4.7 2.5 12.9 18.7 0.0 33.1 12.7 37.5 50.1 26.1 30.1 3.4 19.4 17.4 10.3 8.5 GLP1R GLP-1R ENSG00000112164 "Glucagon like peptide 1 receptor" P43220 6 39048781-39091303 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;heart muscle: 2.7;pancreas: 7.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.2;Early spermatids: 1.0;Inhibitory neurons: 1.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "hypothalamus: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;SCLC-21H: 2.7" "Region enriched" "Detected in many" 4 "basal ganglia: 20.7" "Low region specificity" "Detected in some" NA NA "unprognostic (4.06e-3)" "unprognostic (5.38e-6)" "unprognostic (1.80e-2)" "unprognostic (4.16e-2)" "unprognostic (4.98e-2)" "unprognostic (3.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (9.76e-2)" "unprognostic (3.29e-1)" "unprognostic (1.73e-1)" "unprognostic (8.60e-3)" "unprognostic (2.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.42e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.6 0.3 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.7 0.5 3.4 0.1 0.0 0.3 0.1 1.0 0.4 0.2 0.0 7.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.9 0.2 1.2 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 0.4 0.5 3.4 1.0 0.4 0.2 1.0 0.6 1.2 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104063-39115186 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.9" "Group enriched" "Detected in many" 4 "Early spermatids: 136.1;Late spermatids: 63.2;Spermatocytes: 223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles NA NA Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.4 8.0 8.7 6.6 9.1 7.6 10.6 8.9 10.4 8.4 8.5 8.5 10.0 8.5 11.2 7.5 8.7 7.0 7.9 8.7 9.1 9.5 10.2 7.1 10.4 8.5 8.8 8.2 8.8 11.2 7.7 6.4 6.8 8.7 9.3 7.8 6.9 12.7 8.2 7.1 7.5 9.5 6.9 8.3 7.6 7.8 55.9 8.7 17.2 8.8 7.1 9.5 7.3 6.9 10.1 14.8 9.4 8.3 9.9 13.4 17.7 8.6 6.7 7.3 7.9 8.3 13.6 10.2 13.4 9.4 8.8 11.2 9.9 7.3 6.3 8.3 8.5 13.2 8.8 5.5 11.9 10.9 10.1 12.7 12.3 15.4 3.1 7.8 5.6 7.4 19.9 15.1 7.9 9.0 20.4 16.1 16.6 7.2 9.7 4.8 2.3 10.1 5.4 16.7 10.3 23.3 9.4 11.6 10.0 10.9 6.6 16.4 13.1 9.7 10.4 7.5 3.2 8.8 0.2 4.3 16.2 6.0 14.4 7.8 10.6 10.8 24.9 14.0 15.1 16.0 16.4 15.2 12.8 11.4 18.5 21.0 17.9 5.2 15.8 15.8 9.0 22.2 12.1 8.7 9.1 8.9 10.4 8.7 9.1 8.5 8.8 8.2 8.7 8.3 8.7 10.1 19.3 3.2 6.0 4.6 11.4 15.4 13.2 29.1 8.6 6.4 26.4 21.8 18.8 21.5 17.0 18.4 8.4 33.1 8.3 10.5 17.6 22.9 136.1 22.8 14.0 11.2 8.4 13.5 3.2 21.8 32.7 16.8 4.6 19.0 8.2 13.8 6.4 23.3 26.8 6.7 4.2 16.5 2.0 13.9 15.7 63.2 20.5 13.2 12.4 0.0 11.9 15.5 12.3 9.0 6.3 15.9 9.7 19.2 5.3 22.6 21.8 28.3 19.2 4.1 6.6 13.1 17.3 223.6 14.5 11.6 16.6 12.3 12.8 10.2 20.1 14.9 BMP5 ENSG00000112175 "Bone morphogenetic protein 5" P22003 6 55753653-55875590 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 71.9" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 17.7;Fibroblasts: 28.9;Microglial cells: 26.2;Smooth muscle cells: 26.3" "Cancer enhanced" "Detected in many" "lung cancer: 2.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 27.6;U-2 OS: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (2.84e-4)" "unprognostic (9.07e-4)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.21e-2)" "unprognostic (1.58e-1)" "unprognostic (2.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (6.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-1)" "unprognostic (4.76e-2)" 1.6 1.0 0.2 1.0 0.2 0.2 1.1 0.6 0.7 0.0 2.5 6.2 8.4 0.0 0.0 0.9 0.0 2.3 3.3 0.1 0.2 2.4 3.2 13.0 0.4 2.0 0.9 0.2 0.0 1.6 1.1 3.6 71.9 3.0 14.2 7.5 0.0 1.2 0.0 4.5 0.0 9.8 0.3 0.0 0.0 3.3 0.0 0.2 0.3 1.0 12.4 0.2 9.4 0.3 1.1 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.7 0.1 0.2 2.0 0.9 0.2 3.0 0.0 0.2 1.1 1.8 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.0 17.7 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 2.7 0.4 0.0 0.8 28.9 0.0 0.0 0.0 0.0 2.2 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 26.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 26.3 0.0 0.1 0.3 0.0 1.9 0.6 0.0 0.0 0.1 BACH2 BTBD25 ENSG00000112182 "BTB domain and CNC homolog 2" Q9BYV9 6 89926528-90296908 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.8;lymphoid tissue: 17.1" "Group enriched" "Detected in many" 4 "Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 14.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Daudi: 139.5;U-698: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051384, HPA058384" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051384: AB_2681462, HPA058384: AB_2683700" "unprognostic (4.00e-3)" "unprognostic (3.17e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-4)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.42e-2)" "unprognostic (8.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (3.12e-3)" "unprognostic (4.22e-1)" "unprognostic (9.87e-3)" "unprognostic (2.10e-2)" "unprognostic (1.83e-1)" "unprognostic (2.03e-1)" "unprognostic (3.87e-4)" 1.3 0.8 1.8 4.9 3.3 11.8 1.7 2.6 3.7 1.6 0.1 0.8 0.3 2.6 0.6 0.6 1.1 0.9 1.2 2.0 2.9 0.6 2.5 2.5 17.1 4.9 2.7 1.6 3.3 1.6 1.6 0.6 1.0 3.9 1.3 0.5 1.3 1.4 0.8 3.2 2.1 2.7 1.2 1.9 4.4 0.7 1.7 2.4 12.4 0.7 2.3 12.9 1.4 1.3 7.6 1.0 0.1 5.1 0.5 0.2 0.0 0.8 0.0 0.2 0.1 0.6 0.0 0.2 139.5 0.2 0.0 0.1 0.1 0.8 1.7 0.4 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.4 1.1 0.4 0.1 3.0 0.0 0.1 8.6 5.8 11.6 0.0 0.4 3.0 0.0 1.4 0.0 1.1 19.3 3.6 2.5 0.0 0.3 4.5 12.8 0.5 0.1 0.9 1.7 0.2 0.1 0.4 0.0 1.9 0.0 0.1 8.9 0.4 78.8 0.6 1.4 1.0 2.4 0.0 0.8 0.3 0.0 0.8 2.5 0.8 0.7 0.2 14.1 3.6 2.5 0.0 1.7 0.0 0.2 0.1 0.5 1.8 3.3 2.6 3.7 2.0 2.9 4.9 2.7 1.6 3.9 1.9 2.4 7.6 4.0 0.0 0.5 81.3 93.1 7.5 11.4 1.7 15.9 5.9 5.4 7.7 2.2 0.0 2.2 3.7 41.7 0.2 10.2 0.1 0.0 6.2 19.9 2.9 7.2 2.9 0.0 2.5 95.2 2.8 0.3 8.4 1.5 11.4 0.0 0.7 2.2 3.1 0.5 198.5 293.9 0.2 0.0 0.3 11.8 10.6 5.9 3.0 3.6 38.4 2.5 0.7 20.6 169.9 253.9 3.4 0.0 4.5 7.6 20.0 0.0 0.3 0.7 1.8 0.0 13.5 4.2 0.1 2.4 3.8 7.7 0.0 23.6 0.5 0.1 3.5 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281361-17293871 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 143.4;skeletal muscle: 316.0;tongue: 106.6" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 193.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066927: AB_2685750, HPA067231: AB_2685808" "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 4.3 0.5 4.4 1.8 5.0 0.1 3.8 0.6 6.1 12.4 2.7 6.8 1.6 31.5 16.9 7.4 24.2 2.7 143.4 4.6 5.0 0.7 1.2 1.3 0.5 3.0 1.7 5.0 2.2 0.2 2.1 5.6 0.6 1.5 10.0 7.5 0.4 4.1 5.8 316.0 1.2 3.7 29.5 1.4 1.2 2.2 4.2 2.8 0.8 2.1 106.6 0.3 8.8 3.6 3.0 1.5 9.3 12.0 0.0 0.0 0.0 0.0 18.7 6.8 12.4 13.0 0.0 1.1 0.0 5.7 13.4 19.5 0.0 11.5 0.4 22.3 0.0 0.4 0.0 1.0 6.4 0.5 0.0 1.1 6.4 0.0 2.4 0.5 15.8 1.6 0.0 0.0 0.0 58.7 2.8 0.0 0.2 4.1 0.0 1.4 0.1 59.7 0.0 0.0 0.0 7.8 0.9 0.2 0.0 0.2 9.3 28.2 0.4 0.0 4.2 10.0 0.0 16.2 0.0 0.0 0.1 0.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 0.6 6.1 4.6 5.0 3.0 1.7 5.0 1.5 1.4 2.8 3.0 1.1 0.0 0.0 0.0 0.0 1.1 0.2 1.1 0.0 2.3 3.2 0.8 193.2 0.0 1.8 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.6 33.5 13.6 1.5 4.8 0.0 11.6 0.0 13.4 6.4 0.0 9.9 1.3 0.5 0.4 0.0 0.3 1.7 6.6 4.5 0.0 0.0 0.7 1.9 0.0 0.3 1.8 1.9 0.0 0.7 0.0 0.5 0.4 0.3 2.2 0.7 0.0 0.3 0.0 0.6 21.9 0.0 6.6 23.9 19.7 0.4 7.3 0.2 1.0 0.8 0.5 0.0 3.0 0.1 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393505-17557790 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 582.6;tongue: 315.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 101.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 18.0 11.7 22.4 7.6 47.3 0.0 10.8 5.2 74.1 15.5 7.2 22.9 4.1 28.7 18.0 21.9 17.0 11.5 114.7 57.3 39.6 8.7 4.6 4.8 1.8 9.6 9.0 44.5 4.5 4.3 7.5 5.2 8.8 18.5 25.3 9.7 9.2 7.7 30.9 582.6 2.2 9.0 43.1 1.6 3.1 9.9 1.5 18.3 3.1 5.6 315.7 2.4 14.6 6.4 37.8 15.5 24.6 44.4 55.1 0.3 0.1 10.4 52.3 42.7 46.6 43.0 8.1 6.9 0.0 48.9 62.1 60.5 8.2 21.3 20.9 66.8 0.1 7.9 0.0 15.4 26.5 4.3 0.0 0.0 3.5 9.9 23.1 10.3 72.3 2.2 0.0 0.0 0.1 101.6 25.2 0.0 0.0 17.0 0.8 15.6 5.2 59.1 1.1 23.6 6.4 6.1 10.9 19.0 59.2 31.3 82.8 65.0 11.2 0.2 36.6 31.6 1.0 47.6 0.0 0.0 0.2 11.7 0.1 48.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 47.3 5.2 74.1 57.3 39.6 9.6 9.0 44.5 18.5 1.6 18.3 37.8 2.0 3.2 1.5 9.8 0.0 1.9 4.3 6.2 5.7 16.4 10.2 8.4 126.5 4.3 5.4 1.8 4.2 16.5 0.0 1.9 3.9 2.7 0.1 13.9 13.7 2.7 6.0 0.0 158.1 0.7 12.2 7.9 0.0 5.8 0.0 22.8 3.9 2.4 2.2 8.4 137.2 1.3 2.0 0.0 2.2 0.0 0.6 0.3 0.0 10.3 0.0 6.3 0.0 16.6 7.2 3.7 1.9 4.9 0.0 1.9 0.0 16.7 33.9 2.2 32.9 25.5 43.4 0.1 3.2 2.1 0.9 37.5 0.3 0.3 1.6 0.6 TREML2 "C6orf76, dJ238O23.1, FLJ13693, TLT2" ENSG00000112195 "Triggering receptor expressed on myeloid cells like 2" Q5T2D2 6 41189749-41201149 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 14.5;lymphoid tissue: 9.6" "Cell type enhanced" "Detected in some" "B-cells: 5.3;Early spermatids: 19.1;Late spermatids: 37.3;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive B-cell: 23.3;neutrophil: 33.3" "Group enriched" "Detected in many" 15 "B-cells: 23.3;dendritic cells: 9.3;granulocytes: 33.3" "Cell line enhanced" "Detected in some" "HEL: 27.9;HL-60: 6.9;JURKAT: 7.9;SuSa: 4.5;U-698: 8.0;U-937: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 3400000 "unprognostic (3.76e-3)" "unprognostic (2.39e-1)" "unprognostic (9.05e-3)" "unprognostic (1.30e-3)" "unprognostic (3.22e-3)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-1)" "unprognostic (7.46e-2)" "unprognostic (2.51e-1)" "unprognostic (2.40e-3)" "unprognostic (2.46e-1)" "unprognostic (2.02e-2)" "unprognostic (7.45e-2)" "unprognostic (1.54e-2)" "unprognostic (6.23e-2)" "unprognostic (6.71e-2)" 1.7 0.0 0.1 6.5 0.1 14.5 0.2 0.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.3 0.5 0.1 0.1 0.2 0.0 0.2 0.7 9.6 0.1 0.0 0.1 0.0 0.2 0.4 0.0 3.1 0.2 0.0 0.3 0.1 0.3 0.0 0.8 0.1 1.1 0.3 0.0 6.6 0.3 3.8 0.1 7.0 0.1 0.8 7.6 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.1 0.4 0.0 0.0 1.5 2.2 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 5.2 0.0 2.6 0.6 13.4 0.4 1.2 0.5 6.0 1.0 0.2 2.2 23.3 1.3 0.4 33.3 0.7 1.4 9.3 0.7 2.0 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 1.1 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.4 37.3 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 8.8 0.2 0.0 0.0 0.0 ZNF451 "COASTER, dJ417I1.1, KIAA0576, KIAA1702" ENSG00000112200 "Zinc finger protein 451" Q9Y4E5 6 57086844-57170305 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.9" "Cell type enhanced" "Detected in all" "Early spermatids: 247.3;Late spermatids: 412.7;Oligodendrocytes: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028838 Approved Nucleoplasm NA NA Nucleoplasm "HPA028838: AB_10603330" "unprognostic (5.95e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "unprognostic (9.00e-3)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "unprognostic (1.38e-2)" "unprognostic (1.27e-3)" "unprognostic (9.09e-2)" "unprognostic (6.42e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (2.50e-1)" "unprognostic (2.13e-3)" "unprognostic (6.17e-2)" 12.3 15.2 12.5 10.9 19.6 70.9 13.6 30.7 18.6 12.0 7.5 10.0 8.3 13.0 15.0 10.8 9.7 10.4 9.3 12.1 14.6 11.2 13.0 12.7 16.1 14.4 14.7 11.9 12.4 9.0 14.3 10.1 15.1 16.3 13.8 9.9 17.4 10.7 10.3 8.9 11.8 9.5 11.6 13.9 14.9 11.9 29.3 14.7 16.5 15.7 11.4 14.0 10.8 9.5 25.6 17.8 10.6 23.0 14.4 21.6 27.3 22.1 19.5 23.8 22.3 24.0 20.9 8.5 19.1 12.7 20.8 26.4 16.6 22.6 21.9 36.3 15.5 16.7 50.5 17.6 20.3 16.5 28.3 20.7 19.3 21.0 24.7 31.1 16.7 22.6 26.8 69.6 17.9 19.4 12.5 34.5 24.1 12.6 13.3 10.6 23.5 29.1 17.9 15.1 29.0 27.3 18.4 20.7 13.6 22.7 27.1 16.4 26.4 14.7 22.5 23.2 29.5 22.5 17.7 32.2 39.1 19.7 34.1 11.4 33.5 10.1 10.5 11.0 8.9 11.1 10.7 9.1 6.8 11.1 14.8 12.3 9.6 5.0 8.8 9.7 14.6 7.9 7.8 12.5 19.6 30.7 18.6 12.1 14.6 14.4 14.7 11.9 16.3 13.9 14.7 25.6 47.6 25.6 34.5 67.6 40.6 56.3 14.9 19.3 40.5 55.7 31.7 25.1 25.1 25.8 24.5 31.3 75.0 40.8 62.0 21.1 9.8 15.1 247.3 33.4 51.3 37.0 36.7 124.6 87.6 14.0 30.5 44.5 34.1 35.1 43.0 71.3 45.0 32.6 18.3 48.8 84.8 23.4 14.2 36.0 43.4 412.7 37.6 33.4 33.8 47.8 28.7 26.5 24.7 82.0 212.2 18.9 13.0 41.3 38.2 25.9 19.8 14.6 35.2 68.6 6.6 37.6 36.8 48.0 32.0 32.7 42.8 13.1 40.6 44.9 23.1 22.8 BAG2 ENSG00000112208 "BAG cochaperone 2" O95816 6 57172326-57189833 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018862, HPA019918" Enhanced Supported "Intermediate filaments,Cytosol" NA NA Cytosol "Intermediate filaments" "HPA018862: AB_2669957, HPA019918: AB_2670317" "unprognostic (3.93e-1)" "unprognostic (1.62e-1)" "unprognostic (2.60e-1)" "unprognostic (1.33e-1)" "unprognostic (5.63e-2)" "unprognostic (8.32e-3)" "prognostic unfavorable (6.72e-6)" "unprognostic (1.10e-1)" "unprognostic (7.79e-5)" "unprognostic (6.20e-3)" "unprognostic (4.71e-2)" "unprognostic (6.56e-2)" "unprognostic (6.07e-3)" "unprognostic (5.97e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (1.26e-4)" "unprognostic (6.24e-3)" 3.5 4.4 3.2 6.7 2.9 1.5 1.7 3.1 3.5 11.5 3.3 23.8 2.1 25.3 4.0 7.2 9.2 7.4 9.2 3.1 3.0 2.8 4.2 5.1 2.7 2.9 2.7 2.7 8.6 1.6 0.4 2.0 7.6 3.1 11.3 4.5 5.0 1.0 16.1 9.3 1.2 6.6 29.3 2.7 1.2 7.9 6.4 2.8 1.3 4.7 6.6 2.1 22.7 6.0 3.2 17.2 9.3 3.9 13.8 9.4 26.9 10.9 27.2 25.8 19.2 18.2 12.1 8.6 5.7 25.3 43.2 15.7 3.1 22.5 2.4 18.3 18.3 16.4 16.7 13.3 27.5 14.5 14.8 3.7 13.1 1.2 15.8 14.6 11.4 15.2 13.0 34.1 7.9 19.1 1.3 10.5 12.4 14.8 0.3 9.6 9.5 10.9 11.4 23.2 2.8 4.9 4.4 12.2 0.9 10.1 17.8 2.1 12.7 20.8 10.9 17.9 23.2 27.4 5.3 5.5 12.5 9.7 5.8 1.0 0.1 0.2 0.5 1.9 0.2 2.2 3.5 1.7 1.9 0.9 3.0 3.4 2.9 0.1 2.1 0.0 0.3 2.0 1.1 3.2 2.9 3.1 3.5 3.1 3.0 2.9 2.7 2.7 3.1 2.7 2.8 3.2 2.4 3.2 3.7 4.6 16.7 2.4 4.6 5.0 1.8 6.9 4.1 2.7 40.0 0.0 3.8 3.7 12.5 73.3 8.0 0.6 1.9 11.6 152.3 11.0 35.5 3.1 1.8 12.2 8.1 3.7 18.2 46.2 3.1 4.2 4.5 25.6 2.2 15.8 15.8 10.1 10.0 0.3 14.2 2.6 6.6 35.9 31.1 5.1 7.2 5.6 9.1 8.2 3.1 10.6 10.6 5.4 1.3 38.7 13.0 6.2 0.4 33.9 9.1 16.9 6.6 32.1 31.0 93.5 9.8 1.3 3.8 18.9 12.2 30.6 1.3 2.1 RAB23 ENSG00000112210 "RAB23, member RAS oncogene family" Q9ULC3 6 57186992-57222307 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Developmental protein" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 75.7" "Cell type enhanced" "Detected in many" "Fibroblasts: 22.3;Peritubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "ASC TERT1: 97.2;U-2197: 177.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029135, HPA029136" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA029135: AB_10602070, HPA029136: AB_10601794" "unprognostic (8.78e-2)" "unprognostic (6.55e-2)" "unprognostic (7.17e-2)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (2.28e-2)" "unprognostic (2.55e-2)" "unprognostic (5.33e-3)" "unprognostic (6.41e-2)" "unprognostic (6.55e-2)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "unprognostic (9.12e-3)" "unprognostic (1.36e-2)" "unprognostic (2.38e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-3)" 9.7 6.2 9.1 13.3 9.6 0.8 7.8 11.6 9.7 46.3 7.2 44.6 7.1 53.1 14.3 20.0 14.6 27.2 12.4 8.9 16.4 7.3 4.2 10.7 4.5 9.4 9.1 7.9 10.9 2.9 5.8 3.4 27.9 9.8 39.1 16.1 4.0 3.9 56.2 6.1 4.8 10.9 75.7 10.0 2.2 11.7 5.1 9.4 3.2 32.9 10.5 4.1 47.2 14.8 12.1 15.6 6.1 21.6 15.3 32.3 97.2 19.8 44.9 77.4 38.6 39.7 13.4 7.3 3.1 13.6 72.3 19.3 5.5 22.7 16.4 45.6 11.6 10.5 11.3 9.4 10.6 19.8 5.9 1.6 36.5 18.6 48.1 44.7 18.7 20.3 6.6 17.6 9.3 43.4 13.2 5.2 6.3 8.1 10.3 8.2 5.7 31.7 4.7 26.8 10.7 11.2 7.6 22.5 10.6 11.6 26.8 9.7 6.8 27.4 59.6 18.5 177.4 26.6 8.0 9.3 7.6 33.5 12.5 30.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.0 0.0 9.1 9.6 11.6 9.7 8.9 16.4 9.4 9.1 7.9 9.8 10.0 9.4 12.1 2.9 12.8 5.0 6.8 0.7 4.1 1.6 2.0 5.7 2.5 4.0 3.0 3.4 1.5 1.6 0.0 2.1 11.5 1.7 2.4 0.0 3.4 2.4 6.5 15.5 2.6 1.2 4.8 13.0 2.9 10.7 22.3 1.1 6.2 0.0 3.7 4.6 3.4 4.2 1.7 12.3 1.4 2.0 0.8 3.1 2.5 19.9 1.4 5.4 11.2 7.7 4.4 0.0 8.0 5.3 2.6 0.1 30.5 0.5 3.5 0.6 6.1 5.3 0.9 0.0 17.2 14.5 6.6 7.8 4.1 5.1 13.7 0.8 4.0 1.6 1.8 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042467-41044337 "Predicted membrane proteins, Transporters" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "bone marrow: 50.6" "Cell type enriched" "Detected in some" 115 "Erythroid cells: 253.9" "Cancer enhanced" "Detected in some" "liver cancer: 0.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA060691, HPA066996" Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA060691: , HPA066996: AB_2685761" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.0 0.0 0.2 0.1 0.5 50.6 0.0 0.0 0.5 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.5 0.6 0.2 0.1 0.5 0.2 0.0 0.1 0.1 0.0 0.0 1.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.7 0.0 0.1 1.3 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.4 0.0 11.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 0.5 0.2 0.0 1.3 0.1 0.7 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.1 0.0 0.0 0.0 253.9 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 FHL5 "ACT, dJ393D12.2, FLJ33049" ENSG00000112214 "Four and a half LIM domains 5" Q5TD97 6 96562548-96616636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 66.1" "Group enriched" "Detected in some" 20 "Early spermatids: 1160.3;Late spermatids: 1540.1" "Cancer enhanced" "Detected in many" "renal cancer: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "ASC diff: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "prognostic favorable (4.81e-4)" "unprognostic (4.93e-2)" "unprognostic (1.91e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (6.56e-2)" "unprognostic (1.84e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.22e-1)" "unprognostic (3.48e-3)" 36.1 10.4 5.0 4.5 6.5 0.0 16.1 5.4 8.2 28.1 8.6 5.7 2.5 15.1 17.8 9.6 21.7 13.1 5.6 4.6 4.7 6.5 0.4 14.1 1.9 6.0 5.6 3.6 11.5 4.7 3.3 1.2 0.6 6.5 4.9 5.1 0.4 2.1 11.2 9.0 4.1 5.2 9.6 4.8 3.5 4.0 66.1 5.9 1.2 9.0 14.7 0.8 6.9 10.4 5.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 6.5 5.4 8.2 4.6 4.7 6.0 5.6 3.6 6.5 4.8 5.9 5.6 5.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1160.3 0.0 0.1 3.8 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1540.1 52.5 1.1 5.4 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.2 0.0 0.0 0.0 0.0 52.6 1.9 67.4 13.2 4.4 0.0 0.3 0.0 0.6 0.1 0.0 0.2 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794125-96837477 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 0.4 0.9 0.9 0.7 3.0 0.1 0.4 1.0 2.8 1.1 2.3 1.1 1.5 0.5 0.3 0.5 0.7 0.7 0.5 1.5 0.9 0.3 0.0 0.3 0.2 1.6 0.8 1.9 1.1 1.4 1.0 0.9 0.7 2.4 0.9 1.8 0.2 0.4 0.5 0.2 0.4 1.1 0.6 0.0 0.3 1.1 2.5 1.2 0.6 0.6 0.1 0.2 0.8 1.5 2.0 0.0 0.1 1.6 0.4 2.3 0.8 0.4 1.0 0.0 0.0 0.2 0.2 1.2 0.1 0.0 0.1 1.3 1.2 5.4 2.5 0.0 8.8 4.1 5.2 0.4 0.0 13.5 3.3 0.6 2.5 0.4 0.0 3.7 0.3 0.0 7.6 3.8 20.8 0.5 0.4 2.5 0.0 5.4 0.0 0.7 0.0 1.9 4.3 0.3 0.2 2.4 1.5 0.3 3.3 0.6 1.7 1.3 0.7 0.0 1.4 2.1 0.2 2.0 1.6 0.9 0.1 0.8 2.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.9 3.0 1.0 2.8 1.5 0.9 1.6 0.8 1.9 2.4 0.0 1.2 2.0 0.6 0.0 0.0 2.3 0.2 1.9 0.7 0.3 4.0 1.5 0.6 0.9 0.7 2.8 0.1 1.8 0.0 0.2 0.3 0.1 0.0 0.4 31.4 0.1 0.5 0.7 3.0 0.4 46.2 0.9 0.7 2.5 1.1 0.1 0.0 31.2 1.1 0.0 0.2 0.0 20.3 0.5 0.0 0.0 8.9 35.2 3.4 0.4 1.8 9.4 0.1 0.2 0.0 11.6 4.8 0.4 0.1 4.9 1.0 1.1 0.1 0.2 0.0 0.2 0.0 0.4 2.2 24.6 10.5 1.9 0.3 0.1 0.4 2.1 0.5 0.3 KHDRBS2 "MGC26664, SLM-1, SLM1" ENSG00000112232 "KH RNA binding domain containing, signal transduction associated 2" Q5VWX1 6 61679961-62286225 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4;retina: 4.1;thyroid gland: 4.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 1423.1;Inhibitory neurons: 720.1" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.6" "Region enhanced" "Detected in many" "cerebral cortex: 6.4" "Group enriched" "Detected in some" 13 "memory B-cell: 5.9;naive B-cell: 6.9;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 12 "B-cells: 6.9;dendritic cells: 1.9" "Group enriched" "Detected in some" 7 "AF22: 4.7;NTERA-2: 1.6;THP-1: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000500, HPA029392" Supported NA NA "HPA000500: AB_1079184, HPA029392: AB_10600816" "unprognostic (6.98e-2)" "unprognostic (1.21e-1)" "unprognostic (3.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-3)" "unprognostic (4.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.25e-4)" "unprognostic (1.45e-2)" "unprognostic (2.19e-5)" "unprognostic (5.52e-2)" "unprognostic (4.54e-2)" "unprognostic (6.24e-3)" "unprognostic (1.15e-1)" 0.1 0.9 0.8 0.3 2.3 0.1 0.0 0.0 6.4 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.3 0.0 2.3 0.4 0.0 0.0 2.1 0.1 0.0 0.0 1.2 0.4 0.7 0.1 0.1 4.1 0.0 0.1 0.2 0.0 0.7 0.0 0.0 1.0 0.1 0.1 0.4 0.6 4.1 0.0 0.5 0.2 0.0 2.6 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.1 0.3 1.9 0.0 0.3 0.8 2.3 0.0 6.4 1.3 0.7 0.0 0.0 2.1 0.7 0.0 0.4 2.6 0.0 38.5 3.3 17.6 24.3 0.0 0.0 0.0 0.6 41.4 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.8 0.0 1.7 1423.1 0.0 0.0 0.4 0.0 0.3 0.0 0.6 0.4 0.0 0.1 35.3 720.1 0.0 0.0 0.3 0.0 0.0 0.3 1.4 0.0 117.1 0.3 30.5 0.0 238.8 99.4 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.0 3.1 0.0 0.3 0.3 0.1 1.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 FBXL4 "FBL4, FBL5" ENSG00000112234 "F-box and leucine rich repeat protein 4" Q9UKA2 6 98868535-98948006 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029140, CAB033362" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB033362: AB_2103974, HPA029140: AB_10611967" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-2)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (3.10e-1)" "unprognostic (2.79e-1)" "unprognostic (2.68e-1)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-1)" "unprognostic (2.62e-1)" 5.8 8.0 5.7 5.4 7.8 5.1 7.8 7.3 5.6 7.1 5.0 6.3 6.0 7.0 11.3 5.4 7.8 6.7 5.9 4.4 6.8 13.2 15.8 5.9 6.1 7.4 7.5 3.2 8.3 9.5 12.8 4.8 6.9 7.6 8.1 7.0 5.1 10.0 6.7 9.4 5.7 5.9 6.3 7.8 5.4 7.5 4.2 7.4 9.0 12.3 7.3 6.4 5.8 5.3 10.7 5.7 9.0 7.6 10.2 12.5 22.8 8.2 12.7 10.7 7.3 10.3 4.1 10.7 13.1 11.5 10.6 12.8 8.1 8.8 9.2 11.1 21.4 7.2 9.3 6.2 9.4 9.7 11.5 8.9 13.0 16.4 6.6 18.4 20.4 9.5 10.2 12.6 10.1 13.4 5.6 4.3 5.5 4.0 7.5 5.5 14.6 5.2 10.7 13.9 8.2 9.5 7.7 6.7 8.9 12.2 9.2 6.6 8.2 13.3 8.4 3.7 11.9 9.3 3.4 3.4 5.5 10.5 10.4 10.2 18.4 4.7 13.0 4.6 4.5 6.1 7.1 4.6 4.6 3.8 5.7 5.9 5.6 5.9 4.3 6.0 2.5 6.1 3.9 5.7 7.8 7.3 5.6 4.4 6.8 7.4 7.5 3.2 7.6 7.8 7.4 10.7 12.2 19.2 11.9 42.7 14.2 9.7 8.2 9.0 12.0 14.9 9.1 8.3 16.2 5.7 8.8 36.8 22.9 10.1 9.5 9.8 19.6 9.7 5.4 10.6 14.5 10.8 7.2 20.2 46.9 11.0 10.7 13.7 14.3 7.9 8.9 20.8 11.4 19.4 8.9 10.1 58.3 13.7 8.2 12.3 6.4 2.1 19.0 11.8 5.4 41.2 14.9 10.6 12.3 97.0 94.4 7.5 9.8 12.8 8.8 13.9 12.5 11.8 11.3 13.3 13.1 12.7 10.0 4.1 6.4 12.4 8.5 9.9 9.3 16.9 10.4 8.2 CCNC CycC ENSG00000112237 "Cyclin C" P24863 6 99542387-99568825 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Cyclin, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010499, HPA069322" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010499: AB_2244021, HPA069322: AB_2686120" "unprognostic (1.48e-2)" "unprognostic (1.21e-2)" "unprognostic (1.85e-3)" "unprognostic (6.34e-2)" "unprognostic (1.92e-2)" "unprognostic (1.95e-3)" "unprognostic (2.09e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-2)" "unprognostic (1.92e-1)" "unprognostic (7.10e-2)" "prognostic favorable (8.12e-4)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (3.83e-2)" 31.6 32.8 17.7 27.6 18.6 33.3 47.8 27.5 19.6 30.0 26.4 31.2 43.1 22.1 59.2 41.6 19.1 42.5 23.8 18.3 20.6 54.8 75.2 25.3 40.0 18.4 18.5 17.8 16.9 63.1 47.7 22.4 36.0 20.3 34.9 30.6 27.2 71.1 23.4 22.3 32.8 35.3 22.1 18.2 24.3 42.0 17.2 19.3 32.4 61.1 17.8 43.6 34.9 19.8 19.5 86.9 29.8 45.8 99.2 39.3 53.7 126.9 61.4 78.3 75.9 97.9 118.2 53.2 177.2 69.1 51.5 69.8 60.5 72.2 91.1 109.7 45.1 91.2 101.6 44.4 97.7 67.6 118.6 35.3 51.5 55.4 55.9 67.3 52.0 82.2 102.3 151.6 62.9 68.3 53.8 43.7 98.5 64.1 53.5 47.4 75.8 76.7 71.2 105.3 101.2 72.5 43.8 35.6 67.1 69.5 65.5 46.5 117.8 60.6 38.4 51.2 47.0 92.8 42.9 69.7 134.1 69.0 87.9 55.8 40.9 20.7 16.2 21.2 22.1 39.8 29.7 25.5 20.9 23.4 25.3 27.4 21.7 3.3 28.2 16.7 23.0 29.6 30.7 17.7 18.6 27.5 19.6 18.3 20.6 18.4 18.5 17.8 20.3 18.2 19.3 19.5 37.1 44.8 32.8 25.5 58.3 75.1 99.3 58.0 50.7 42.8 60.0 31.0 16.1 81.5 57.5 23.9 22.9 110.3 45.0 32.2 84.1 127.2 45.1 36.7 27.3 46.3 43.6 23.3 64.2 186.9 93.3 33.2 38.2 43.1 32.4 31.1 36.4 53.0 41.1 25.2 56.6 38.2 67.1 37.0 52.8 45.5 22.4 32.8 58.7 24.4 41.2 64.6 40.2 52.8 40.5 133.7 27.1 25.2 120.5 158.8 37.8 128.4 37.4 42.2 19.7 26.9 40.2 62.3 21.4 60.0 67.5 176.4 38.7 42.8 46.3 147.0 PRDM13 PFM10 ENSG00000112238 "PR/SET domain 13" Q9H4Q3 6 99606774-99615578 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 4.8;Horizontal cells: 1.7;Spermatogonia: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;HMC-1: 1.1;JURKAT: 2.7;RPMI-8226: 2.0;SCLC-21H: 2.3;U-266/70: 2.7;U-266/84: 1.4;WM-115: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA070592 Uncertain NA NA "HPA070592: AB_2686283" "unprognostic (4.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.30e-1)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (3.16e-2)" "unprognostic (1.24e-2)" "unprognostic (2.93e-1)" "unprognostic (1.86e-2)" "unprognostic (7.54e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.3 0.0 1.1 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.7 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 E2F3 ENSG00000112242 "E2F transcription factor 3" O00716 6 20401879-20493714 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029779, HPA065012" Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA029779: AB_2732448, HPA065012: AB_2685403" "unprognostic (4.10e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-3)" "unprognostic (2.96e-1)" "unprognostic (9.14e-2)" "unprognostic (8.99e-3)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.63e-8)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (3.50e-1)" "unprognostic (5.99e-3)" 6.5 5.0 5.3 9.8 5.7 20.0 4.2 3.5 6.2 3.3 4.0 5.5 5.2 3.7 3.9 4.9 2.6 6.5 5.2 6.6 4.9 5.8 4.4 4.9 11.1 4.4 5.0 5.4 1.4 2.1 3.1 1.8 5.6 4.2 3.3 6.4 6.1 2.7 3.2 10.1 2.5 5.8 6.0 4.0 8.5 3.6 3.4 5.1 8.7 8.6 9.4 9.5 8.6 2.8 4.3 14.3 11.6 32.2 35.1 10.9 11.9 22.0 18.9 16.8 18.2 19.9 14.3 8.8 32.3 35.2 18.2 16.9 14.6 37.8 17.4 30.3 12.2 25.3 58.1 20.4 16.3 11.6 38.6 33.0 9.7 12.6 17.7 21.6 18.8 12.7 29.8 65.3 19.4 20.9 15.0 43.6 43.2 24.2 11.0 11.9 46.5 27.8 36.5 21.8 25.1 22.9 42.2 17.3 24.1 26.3 20.0 12.4 23.4 17.2 28.6 17.4 14.2 30.5 12.1 40.1 38.3 7.1 23.2 41.3 5.6 2.3 1.1 1.6 1.6 2.0 0.4 1.0 2.4 2.6 0.4 0.8 1.8 7.2 3.5 1.1 1.1 1.6 1.1 5.3 5.7 3.5 6.2 6.6 4.9 4.4 5.0 5.4 4.2 4.0 5.1 4.3 4.8 0.0 2.6 53.8 10.6 9.2 12.3 7.0 7.4 34.1 11.9 7.2 10.6 4.3 10.6 7.3 22.9 8.3 15.0 12.0 9.8 7.6 12.2 3.9 14.1 8.5 12.0 17.2 67.7 6.9 13.8 9.2 12.8 10.6 20.3 32.3 14.6 4.7 17.1 32.0 31.9 11.7 4.1 47.2 17.7 5.7 2.8 28.7 5.4 27.2 23.8 2.9 15.5 37.7 2.9 14.8 10.3 3.0 19.1 22.1 4.5 25.1 2.2 9.0 0.0 9.0 11.5 3.0 4.7 16.5 8.9 3.1 15.3 5.7 13.8 18.4 PTP4A1 "PRL-1, PRL1, PTPCAAX1" ENSG00000112245 "Protein tyrosine phosphatase 4A1" Q93096 6 63521746-63583436 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 497.8" "Cell type enriched" "Detected in all" 4 "Late spermatids: 3071.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 533.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003281 Approved NA NA "HPA003281: AB_1855903" "unprognostic (8.63e-2)" "prognostic unfavorable (5.53e-4)" "unprognostic (9.05e-2)" "unprognostic (7.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.71e-2)" "unprognostic (6.12e-2)" "unprognostic (1.96e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.23e-2)" "unprognostic (1.07e-2)" "unprognostic (6.64e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (1.11e-2)" 32.6 141.9 29.2 37.8 33.5 229.4 31.7 34.9 36.3 41.8 32.8 108.9 55.6 44.2 15.4 53.9 34.9 59.4 28.8 29.7 96.0 51.0 497.8 55.3 24.6 37.7 36.8 27.3 55.2 70.0 16.2 41.4 73.1 37.1 44.6 111.1 22.7 68.8 21.2 302.4 54.9 51.2 57.1 40.7 19.6 55.7 62.9 32.5 26.4 39.6 114.0 24.8 52.1 33.8 49.7 71.5 122.9 106.2 128.3 85.8 77.2 239.1 113.9 97.6 58.4 79.2 103.5 45.4 65.1 50.6 88.7 95.7 41.8 97.0 197.9 94.3 61.0 51.6 43.8 320.2 533.9 175.7 118.6 57.7 91.3 383.6 124.7 320.5 63.5 80.3 65.0 106.1 148.7 151.5 140.9 52.4 69.1 50.6 91.0 53.7 70.9 53.4 60.5 132.4 120.6 44.7 62.5 278.5 71.8 140.1 156.9 59.8 122.0 77.5 132.9 130.6 89.5 122.3 90.7 94.9 121.7 60.9 72.5 154.1 45.4 20.4 15.1 12.8 21.3 20.1 12.9 14.5 14.3 17.2 10.7 12.8 12.9 48.4 16.3 16.6 9.1 18.8 15.4 29.2 33.5 34.9 36.3 29.7 96.0 37.7 36.8 27.3 37.1 40.7 32.5 49.7 33.3 22.4 90.3 4.6 105.4 681.3 268.7 94.1 261.8 22.3 98.4 55.4 78.5 207.3 83.0 75.4 16.7 248.7 99.8 336.5 80.3 186.9 716.1 189.8 68.8 47.0 129.6 30.9 11.7 193.9 215.1 90.8 178.4 279.5 63.0 41.2 41.4 528.8 98.6 11.8 9.9 253.4 63.1 71.6 236.5 3071.4 28.6 99.7 170.7 5.6 47.4 22.0 15.5 9.5 20.4 151.8 196.9 24.0 110.6 166.4 181.3 112.1 61.2 24.6 6.6 44.4 110.2 47.2 26.3 181.8 641.0 459.6 123.4 79.1 214.6 164.1 SIM1 bHLHe14 ENSG00000112246 "SIM bHLH transcription factor 1" P81133 6 100385009-100464921 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;kidney: 10.0;skeletal muscle: 3.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 20.2;Distal tubular cells: 7.9;Ductal cells: 4.5;Skeletal myocytes: 7.6" "Cancer enhanced" "Detected in single" "renal cancer: 1.8" "Region enhanced" "Detected in some" "hypothalamus: 3.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.7;BJ: 16.4;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 7.2;HDLM-2: 7.3;RPTEC TERT1: 18.4" "Region enriched" "Detected in single" 8 "hypothalamus: 5.2" "Region enhanced" "Detected in some" "hypothalamus: 3.1" HPA024385 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024385: AB_1856879" "unprognostic (1.04e-1)" "unprognostic (4.34e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-1)" "unprognostic (4.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (4.64e-2)" "unprognostic (3.76e-2)" "prognostic favorable (5.32e-7)" "unprognostic (1.00e-1)" "unprognostic (1.19e-1)" 0.9 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 3.0 10.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 9.7 0.0 16.4 23.7 7.2 6.7 0.0 0.0 0.0 0.0 5.2 1.5 0.0 0.0 0.0 6.1 7.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.0 0.0 1.2 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 20.2 0.0 0.1 0.0 0.0 7.9 4.5 1.8 0.1 0.1 0.1 1.8 0.0 0.1 1.2 0.1 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 7.6 0.3 1.5 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 ASCC3 "ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH" ENSG00000112249 "Activating signal cointegrator 1 complex subunit 3" Q8N3C0 6 100508194-100881372 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031608, HPA031609, HPA031610" Enhanced Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526" "unprognostic (6.79e-2)" "unprognostic (1.46e-2)" "unprognostic (2.96e-3)" "unprognostic (1.12e-1)" "unprognostic (9.70e-3)" "unprognostic (4.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.14e-2)" "unprognostic (4.02e-1)" "unprognostic (3.34e-1)" "unprognostic (5.08e-3)" "unprognostic (1.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" 6.0 6.7 4.1 10.1 5.4 11.3 9.3 6.7 4.3 10.3 7.4 9.4 8.3 7.9 8.6 8.4 5.9 7.6 6.6 3.9 5.1 5.0 12.6 7.1 10.1 4.8 4.5 3.4 5.9 6.5 10.8 6.2 13.0 5.1 9.3 11.5 5.7 6.4 8.2 6.0 7.1 8.6 8.6 4.3 8.4 8.6 8.7 4.6 12.8 7.3 5.5 11.1 14.9 7.5 6.2 16.8 21.1 30.1 18.6 32.9 41.7 48.0 71.5 45.5 24.1 27.6 43.3 13.0 52.1 14.4 48.3 19.0 37.6 26.2 63.5 38.7 35.2 23.2 38.7 36.0 27.8 30.1 41.0 28.5 38.1 31.7 35.4 44.2 22.6 45.1 20.5 47.1 23.0 67.3 16.5 21.1 12.7 15.9 31.8 16.4 24.7 23.3 18.7 23.7 46.6 20.2 15.3 30.1 26.7 12.5 53.3 14.7 23.2 64.2 26.9 20.6 23.3 30.4 9.9 11.3 46.4 19.4 30.6 29.0 6.2 2.7 1.8 4.3 4.3 5.2 4.2 3.8 4.0 2.9 5.7 4.3 4.2 0.2 4.4 3.8 6.4 3.1 1.4 4.1 5.4 6.7 4.3 3.9 5.1 4.8 4.5 3.4 5.1 4.3 4.6 6.2 32.7 32.1 24.9 58.1 45.4 25.5 41.3 33.3 19.4 27.0 24.1 24.0 32.0 20.0 37.7 3.7 22.9 24.4 49.0 17.3 11.7 23.1 11.3 30.1 77.3 25.2 13.8 20.8 166.0 25.1 66.3 32.2 46.9 35.0 22.1 29.9 10.4 30.3 17.7 28.6 166.2 22.8 22.4 17.2 12.5 3.7 23.0 27.5 5.4 103.0 26.2 14.6 29.9 150.8 132.3 28.6 14.4 17.3 66.4 66.9 17.5 10.6 32.0 31.1 6.6 39.6 30.0 50.2 30.3 38.2 27.4 38.0 43.7 42.6 23.5 65.4 HDGFL1 "dJ309H15.1, Hdgfrp1, HRP-1, PWWP1" ENSG00000112273 "HDGF like 1" Q5TGJ6 6 22569566-22571666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 215 "testis: 91.8" "Group enriched" "Detected in some" 5 "Early spermatids: 130.5;Late spermatids: 120.2;Spermatocytes: 165.6" "Cancer enriched" "Detected in some" 41 "testis cancer: 21.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045679, HPA063707" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA045679: AB_2679415, HPA063707: AB_2685099" "unprognostic (1.55e-1)" "unprognostic (6.18e-2)" "unprognostic (4.03e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.2 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 165.6 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BVES "HBVES, POP1, POPDC1" ENSG00000112276 "Blood vessel epicardial substance" Q8NE79 6 105096822-105137157 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion" "Developmental protein" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.0;skeletal muscle: 44.3;tongue: 29.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 29.7;WM-115: 30.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA014788, HPA018176" Enhanced Supported "Plasma membrane,Cell Junctions" Yes NA "Plasma membrane, Cell Junctions" "HPA014788: AB_1845504, HPA018176: AB_1845503" "unprognostic (2.91e-1)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.73e-2)" "unprognostic (5.46e-2)" "unprognostic (3.66e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-2)" "unprognostic (8.37e-2)" "unprognostic (4.49e-2)" "unprognostic (2.29e-2)" "unprognostic (8.92e-2)" "unprognostic (5.84e-3)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "unprognostic (2.02e-2)" "unprognostic (3.24e-4)" 2.9 0.7 2.6 2.3 6.4 0.2 1.5 5.6 3.7 2.2 4.3 10.7 1.4 5.9 1.8 5.3 2.8 1.9 28.0 2.6 5.9 1.1 0.3 1.9 0.6 7.2 5.6 1.7 1.0 0.6 0.7 2.4 3.5 6.7 5.2 3.3 0.2 1.5 10.0 44.3 0.6 3.0 17.8 5.8 0.3 6.9 11.6 5.1 0.2 1.3 29.6 0.4 9.3 2.2 10.9 1.3 2.0 7.6 1.3 10.9 14.9 3.3 5.8 4.1 8.8 11.6 0.5 0.0 0.0 0.0 10.9 14.7 0.1 3.3 2.0 8.1 0.0 2.8 0.0 1.0 0.3 2.4 0.0 0.6 8.7 6.9 13.6 1.1 6.6 4.0 3.3 0.1 19.3 19.7 0.1 0.2 1.0 1.6 0.0 0.0 5.7 29.7 0.0 0.0 0.0 9.9 17.1 3.7 0.1 7.7 5.5 0.0 20.0 8.9 14.0 0.0 0.0 15.3 1.8 0.8 0.0 8.3 0.0 30.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.6 6.4 5.6 3.7 2.6 5.9 7.2 5.6 1.7 6.7 5.8 5.1 10.9 2.1 0.0 0.0 1.6 0.0 0.3 0.4 0.1 0.6 0.0 0.4 1.0 34.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 36.1 1.9 4.4 3.1 0.0 0.0 3.3 0.0 0.2 2.6 0.0 6.0 0.0 0.9 2.2 0.1 2.3 0.0 0.6 0.0 0.0 0.0 1.9 55.3 1.2 0.5 0.0 3.7 1.0 0.0 0.0 5.0 17.8 0.1 0.0 3.4 0.0 0.5 0.1 0.1 0.1 0.0 13.1 11.8 4.4 24.4 5.4 0.1 0.9 0.1 0.2 1.3 0.0 0.3 COL9A1 ENSG00000112280 "Collagen type IX alpha 1 chain" P20849 6 70216040-70303084 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Deafness, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 57.0;prostate: 15.4" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 310.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 25.7;NTERA-2: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074749 Enhanced "Secreted to extracellular matrix" NA NA 120000 "HPA074749: AB_2732266" "unprognostic (2.18e-2)" "unprognostic (2.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.48e-3)" "unprognostic (5.72e-2)" "unprognostic (5.32e-4)" "unprognostic (3.24e-3)" "unprognostic (8.79e-2)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "unprognostic (1.54e-1)" "unprognostic (2.09e-1)" "unprognostic (2.78e-1)" "unprognostic (3.62e-2)" 0.1 0.0 5.1 0.1 5.0 0.0 0.1 4.4 5.6 0.4 57.0 1.0 0.8 0.3 0.1 0.1 0.2 0.4 5.0 5.5 4.9 0.3 0.0 0.0 0.0 6.8 5.3 3.8 0.0 0.3 0.1 5.2 0.0 6.1 15.4 0.5 9.6 1.5 0.3 0.0 0.0 0.9 0.2 4.8 0.0 1.5 4.1 5.2 0.1 0.4 0.3 0.0 1.3 2.9 6.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.0 4.4 5.6 5.5 4.9 6.8 5.3 3.8 6.1 4.8 5.2 6.0 0.6 0.0 0.0 2.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 3.7 0.0 0.0 0.0 4.2 0.0 0.0 1.0 1.9 0.0 21.4 1.2 0.1 0.8 1.2 0.0 1.4 0.2 0.0 0.5 0.0 1.7 0.0 1.0 0.0 0.0 0.1 35.3 6.7 0.5 0.0 0.0 0.0 11.6 0.0 0.1 0.0 2.8 0.1 68.5 0.0 310.1 0.6 0.0 0.8 0.4 0.0 2.3 0.0 0.1 0.0 3.2 0.0 0.3 4.2 0.6 2.3 0.1 0.0 0.0 0.0 0.1 0.8 0.1 MED23 "CRSP130, CRSP3, DRIP130, MRT18, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628242 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 72.0;Inhibitory neurons: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA070341: AB_2686257" "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 7.7 10.6 2.9 11.6 3.6 22.2 14.4 9.7 4.4 12.1 3.5 10.7 11.5 13.4 10.7 8.6 11.1 9.0 6.6 3.1 3.2 10.4 8.0 10.0 14.9 2.6 3.2 3.0 14.4 10.8 18.5 6.1 11.1 4.6 11.8 12.6 11.6 12.8 11.7 7.5 11.5 10.7 10.5 2.0 12.9 11.7 10.6 3.0 18.2 14.5 10.2 15.4 10.2 7.8 6.2 7.2 7.8 18.2 23.0 22.1 16.8 16.7 17.6 19.8 16.0 23.0 8.2 9.8 15.9 12.5 18.2 15.4 12.6 9.9 11.4 24.7 18.1 13.8 16.6 14.9 14.0 16.0 27.8 27.1 14.9 13.3 17.7 17.8 18.6 20.1 16.9 21.7 16.2 17.0 11.0 21.3 17.4 8.7 12.3 7.8 18.9 11.4 9.6 12.2 10.4 13.6 12.3 12.6 17.4 11.6 20.9 4.8 19.3 20.4 11.8 13.3 19.0 16.2 17.0 12.3 22.6 14.5 12.6 16.1 4.9 4.5 7.6 5.5 4.6 8.3 4.7 5.5 6.2 5.6 4.2 5.5 5.1 3.6 12.9 3.3 2.9 6.6 3.9 2.9 3.6 9.7 4.4 3.1 3.2 2.6 3.2 3.0 4.6 2.0 3.0 6.2 16.3 19.2 9.6 24.8 21.5 9.2 6.3 11.9 13.6 23.7 15.5 10.9 6.5 8.6 15.7 23.9 16.7 8.7 23.7 15.5 3.9 7.6 2.1 14.8 14.7 13.9 14.4 12.0 72.0 7.7 6.8 12.5 14.3 16.6 14.0 18.3 14.3 12.4 8.1 11.8 67.1 17.4 6.1 17.6 9.5 3.2 14.3 12.8 5.4 36.5 16.9 7.7 21.6 42.3 60.8 9.1 14.9 10.1 19.4 10.7 14.7 8.5 13.4 24.4 13.1 13.8 10.2 13.5 5.3 12.0 8.7 7.8 20.7 14.6 14.3 12.8 WASF1 "KIAA0269, SCAR1, WAVE, WAVE1" ENSG00000112290 "WASP family member 1" Q92558 6 110099819-110180004 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.5;testis: 79.3" "Cell type enhanced" "Detected in many" "Early spermatids: 192.5;Excitatory neurons: 220.2;Late spermatids: 476.1;Oligodendrocytes: 106.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "memory B-cell: 3.3;naive B-cell: 4.2;plasmacytoid DC: 8.4" "Group enriched" "Detected in many" 9 "B-cells: 4.2;dendritic cells: 8.4" "Cell line enhanced" "Detected in many" "hTERT-HME1: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004105, CAB022161" Approved Supported NA NA "CAB022161: , HPA004105: AB_1080583" "unprognostic (8.22e-2)" "unprognostic (1.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.30e-3)" "unprognostic (5.50e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.82e-8)" "unprognostic (9.20e-2)" "unprognostic (5.06e-2)" "unprognostic (2.52e-1)" "unprognostic (3.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.95e-2)" "unprognostic (3.09e-2)" "unprognostic (9.03e-2)" "unprognostic (3.38e-1)" 8.2 9.2 30.3 3.8 51.9 9.7 7.7 21.1 76.5 9.9 0.4 10.6 2.1 12.5 5.7 13.0 11.7 8.0 2.8 73.2 24.4 7.9 7.6 4.8 3.6 21.4 15.7 52.6 22.7 5.3 3.0 13.5 2.8 25.7 5.5 3.7 16.6 6.8 4.5 1.6 6.0 6.3 13.5 10.0 2.5 8.5 79.3 16.5 8.2 4.0 2.4 3.7 6.6 9.0 51.8 10.3 11.1 60.1 48.9 25.4 32.2 6.6 21.9 24.8 18.2 31.5 19.8 9.9 59.9 13.9 34.3 27.1 11.7 94.7 29.2 31.1 0.9 43.1 116.3 22.9 17.8 45.3 6.4 17.2 25.5 41.4 24.9 124.2 26.4 27.7 29.3 42.6 13.6 21.3 8.2 60.7 2.0 54.3 7.9 15.0 56.3 21.9 2.4 29.4 11.8 46.8 73.9 15.6 11.3 14.0 62.0 13.6 30.2 21.1 16.8 17.0 48.1 28.6 0.4 9.4 53.0 18.4 50.5 12.7 0.0 0.6 0.0 0.0 0.2 0.2 3.3 0.2 0.0 0.6 4.2 0.1 0.1 0.1 0.6 0.6 8.4 0.0 0.4 30.3 51.9 21.1 76.5 73.2 24.4 21.4 15.7 52.6 25.7 10.0 16.5 51.8 1.5 0.0 0.0 16.0 2.6 14.8 2.1 7.4 22.8 14.4 5.1 4.7 1.7 1.5 2.3 0.0 6.2 3.8 2.8 0.0 1.9 4.8 192.5 2.9 15.3 2.9 12.6 10.3 220.2 0.9 3.1 11.8 3.1 7.0 0.0 57.5 6.4 6.1 1.1 10.1 63.1 2.1 2.0 1.8 4.4 476.1 18.0 1.6 3.6 12.2 0.8 4.4 0.0 67.3 106.5 1.2 2.8 9.4 1.8 3.0 0.2 12.6 0.5 7.1 6.6 2.6 9.8 85.0 38.5 33.5 8.8 1.8 0.7 26.3 1.2 1.9 GPLD1 ENSG00000112293 "Glycosylphosphatidylinositol specific phospholipase D1" P80108 6 24424565-24495205 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 46.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2" "Cancer enriched" "Detected in some" 11 "liver cancer: 6.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 7.6;U-698: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008625, HPA012500" Uncertain "Secreted to blood" NA NA 103000000000 3100000000 "CAB008625: AB_1621070, HPA012500: AB_1849931" "unprognostic (6.80e-3)" "unprognostic (2.27e-1)" "unprognostic (1.59e-1)" "unprognostic (4.81e-5)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.12e-4)" "unprognostic (6.37e-4)" "unprognostic (7.93e-2)" "unprognostic (2.86e-2)" "unprognostic (6.07e-4)" "unprognostic (2.68e-1)" "unprognostic (5.28e-4)" "unprognostic (2.20e-1)" "unprognostic (9.98e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" 4.3 0.9 1.5 0.6 1.7 0.9 1.4 7.7 4.7 0.9 0.1 0.8 0.5 1.6 1.7 1.1 0.9 0.6 0.5 1.4 1.8 0.6 46.5 0.9 0.9 1.8 2.4 1.4 1.2 0.6 2.5 1.7 0.2 3.3 1.8 0.6 6.2 0.4 4.8 1.7 8.6 0.5 1.5 0.2 0.6 0.7 1.4 1.4 5.2 2.5 0.6 1.3 1.1 1.5 3.2 0.5 0.7 0.8 1.2 0.0 0.0 2.0 0.1 0.2 0.2 0.1 3.5 0.1 7.6 0.8 0.1 0.2 0.1 1.2 0.2 0.1 0.9 2.1 1.1 0.9 3.2 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.8 0.0 1.8 0.5 0.3 0.1 0.5 0.7 0.5 2.9 0.5 0.3 1.4 0.2 0.1 0.4 3.4 2.0 2.3 0.9 0.1 0.4 0.6 0.4 0.3 0.1 0.7 0.9 0.1 1.0 2.4 3.4 8.1 0.1 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.0 1.5 1.7 7.7 4.7 1.4 1.8 1.8 2.4 1.4 3.3 0.2 1.4 3.2 0.4 0.0 3.7 24.8 1.1 0.0 0.7 2.8 0.6 19.6 0.7 0.4 11.6 0.0 1.7 1.8 68.8 0.3 1.6 0.1 0.0 0.4 3.5 0.5 0.6 1.2 1.8 7.4 62.4 0.4 0.3 1.3 0.0 0.3 0.0 2.1 1.4 66.8 0.1 15.2 78.3 0.3 0.0 1.3 0.0 3.4 3.1 0.1 0.0 9.4 0.1 4.0 3.1 33.2 3.1 0.1 0.1 3.4 3.1 0.3 0.1 0.5 1.1 10.9 0.0 3.6 1.4 0.5 5.8 0.3 0.6 0.0 0.5 0.9 0.5 2.6 ALDH5A1 "SSADH, SSDH" ENSG00000112294 "Aldehyde dehydrogenase 5 family member A1" P51649 6 24494867-24537207 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 136.6;U-698: 173.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029715, HPA029716" Enhanced Supported Mitochondria NA NA 50000 Mitochondria "HPA029715: AB_10599994, HPA029716: AB_10601876" "unprognostic (7.43e-2)" "unprognostic (1.12e-3)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "prognostic favorable (7.61e-6)" "unprognostic (2.38e-2)" "unprognostic (2.17e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.43e-2)" "unprognostic (1.21e-1)" "prognostic favorable (3.68e-4)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.00e-2)" "unprognostic (1.08e-2)" 9.5 6.2 27.9 6.0 29.8 4.5 5.2 26.7 33.6 4.9 17.7 8.6 12.0 4.9 3.7 7.4 19.1 5.2 14.6 26.8 32.1 28.1 99.6 6.5 13.7 28.2 31.7 26.2 7.4 8.3 19.5 5.9 2.5 26.5 8.3 7.2 11.1 5.3 5.2 58.5 9.6 8.0 3.2 26.7 6.9 7.8 4.6 31.9 27.0 17.1 34.1 13.0 6.7 8.5 27.2 11.5 9.3 6.5 10.1 0.1 0.0 11.7 0.8 2.0 2.4 1.6 35.1 2.5 136.6 21.1 1.0 2.2 0.1 10.5 1.3 1.5 14.7 20.2 20.7 5.9 42.4 1.6 32.2 2.7 1.0 4.4 0.2 0.0 7.1 0.1 34.7 10.4 0.0 1.8 23.3 40.4 19.0 2.7 18.4 5.5 46.1 1.4 1.3 7.7 19.6 11.7 10.5 12.1 1.2 13.2 2.8 19.4 17.5 0.2 1.1 6.7 0.3 7.1 19.4 32.2 173.7 0.2 9.8 1.4 0.3 0.0 0.1 1.0 0.0 1.9 2.2 1.4 1.5 0.1 2.0 3.8 3.4 0.2 0.8 0.1 2.4 0.9 0.7 27.9 29.8 26.7 33.6 26.8 32.1 28.2 31.7 26.2 26.5 26.7 31.9 27.2 2.9 16.0 25.3 14.0 9.7 1.7 5.6 8.2 2.2 12.9 7.5 3.4 34.8 11.5 9.4 7.3 16.7 6.1 7.4 6.1 1.9 1.6 0.8 15.2 5.0 3.7 8.4 16.0 18.1 1.0 5.2 3.5 5.6 5.4 7.0 13.5 6.8 90.7 3.9 16.8 32.4 11.7 2.0 3.8 1.8 0.3 3.4 1.7 1.8 8.4 0.2 11.8 3.1 11.6 2.4 1.3 7.7 4.5 12.2 4.1 13.4 26.8 12.8 6.9 0.0 6.9 2.3 1.7 6.6 8.7 3.0 1.9 5.4 8.0 17.0 13.1 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" 6 106360717-106572017 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.5;placenta: 72.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8" "Region enriched" "Detected in single" 5 "olfactory bulb: 4.2" "Low region specificity" "Detected in many" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 17.1 1.2 0.5 22.1 0.5 24.3 17.4 0.7 1.0 4.3 33.4 25.2 25.6 2.4 6.3 62.5 6.8 8.1 1.0 1.9 1.0 15.4 11.9 9.9 20.6 0.9 0.7 0.3 2.3 4.9 5.9 0.4 72.6 0.6 25.4 19.4 0.8 9.4 5.4 1.1 42.4 23.9 4.9 0.4 12.7 10.4 5.1 1.3 9.8 2.6 1.2 33.8 19.2 14.1 0.9 34.7 0.2 0.0 0.1 25.5 93.7 9.9 4.9 33.5 10.8 10.0 2.4 11.5 54.0 2.3 21.7 14.6 54.5 0.2 124.1 5.3 74.0 2.3 0.0 1.5 16.9 12.1 33.4 0.2 44.9 66.7 19.7 95.8 0.1 46.5 41.9 1.7 7.3 28.5 3.5 9.7 10.7 0.4 0.2 21.2 16.4 0.4 0.4 14.9 80.0 2.2 0.2 20.3 31.9 0.3 3.0 16.4 24.3 13.5 11.6 1.5 0.2 34.4 5.7 4.7 57.7 56.0 39.3 26.3 0.3 3.4 0.4 7.4 3.6 10.1 6.6 9.8 8.5 8.6 2.9 5.8 5.7 2.4 4.8 4.1 1.0 9.9 4.0 0.5 0.5 0.7 1.0 1.9 1.0 0.9 0.7 0.3 0.6 0.4 1.3 0.9 13.4 12.8 11.9 0.0 24.2 0.0 0.0 0.0 0.0 0.0 31.2 14.1 0.0 0.0 13.0 33.1 0.0 219.4 153.6 0.0 3.9 10.9 0.0 20.2 2.7 4.4 0.0 0.0 0.0 12.5 15.3 2.5 0.0 31.6 1.3 0.1 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.0 5.7 0.0 0.0 0.0 0.0 26.4 0.0 0.0 89.9 0.0 0.0 15.0 8.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 600.1 76.7 0.1 0.0 0.0 VNN1 Tiff66 ENSG00000112299 "Vanin 1" O95497 6 132680849-132714055 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "gallbladder: 90.0;intestine: 137.5;liver: 220.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7" "Cancer enhanced" "Detected in many" "liver cancer: 41.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "classical monocyte: 13.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 80 "dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7" "Cell line enhanced" "Detected in some" "A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5" "Region enhanced" "Detected in single" "white matter: 2.4" "Not detected" "Not detected" "HPA046103, HPA064145" Approved Approved Vesicles "Intracellular and membrane" NA NA 980000000 Vesicles "HPA046103: , HPA064145: AB_2685197" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (9.95e-2)" "unprognostic (1.35e-3)" "unprognostic (6.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.20e-1)" "unprognostic (4.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (4.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (2.26e-2)" "unprognostic (4.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.34e-1)" 2.4 0.6 0.3 3.2 0.6 9.5 1.1 0.5 1.3 1.0 0.5 6.2 137.5 8.9 0.2 0.6 2.6 90.0 0.6 0.3 0.4 21.9 220.5 4.7 2.5 0.6 0.4 0.3 0.3 1.4 0.1 0.1 2.7 1.2 0.3 1.8 1.0 2.3 0.2 0.3 0.9 80.2 0.9 0.2 10.2 1.5 0.5 0.5 0.6 0.4 1.1 2.5 1.7 0.7 1.0 2.5 0.0 0.3 0.1 0.0 0.7 0.5 0.2 0.2 0.0 0.0 0.0 2.5 0.1 8.7 0.0 0.4 0.0 0.0 2.3 0.6 0.0 0.0 0.1 0.1 1.4 1.3 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.5 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.3 3.0 13.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 8.5 0.0 11.9 0.2 0.0 3.8 0.3 0.6 0.5 1.3 0.3 0.4 0.6 0.4 0.3 1.2 0.2 0.5 1.0 0.0 0.0 3.0 0.0 0.3 1.3 0.2 14.9 0.0 0.0 1.2 0.4 0.2 50.1 11.4 1.8 0.0 0.1 0.2 12.5 0.0 244.2 0.0 7.6 4.1 0.2 0.0 0.0 0.0 19.4 0.1 0.3 4.6 39.6 0.0 0.0 1.1 70.6 18.1 0.0 0.0 11.2 22.4 12.0 3.9 0.0 0.0 23.1 0.0 0.0 17.6 0.0 0.0 0.0 0.0 98.0 1.6 0.0 0.5 6.6 61.7 21.9 16.0 0.0 0.0 0.4 1.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.0 14.7 VNN2 "FOAP-4, GPI-80" ENSG00000112303 "Vanin 2" O95498 6 132743870-132763459 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.9;lymphoid tissue: 57.0" "Cell type enhanced" "Detected in many" "Ductal cells: 63.6;Ionocytes: 22.4;Macrophages: 41.1;monocytes: 57.5;Respiratory ciliated cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "neutrophil: 477.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 477.4" "Cell line enriched" "Detected in some" 7 "Daudi: 59.7" "Low region specificity" "Detected in some" NA NA 240000 "unprognostic (2.13e-1)" "unprognostic (1.15e-1)" "unprognostic (9.60e-3)" "unprognostic (5.71e-2)" "unprognostic (2.14e-1)" "unprognostic (5.61e-3)" "unprognostic (1.98e-3)" "unprognostic (4.38e-1)" "unprognostic (3.07e-1)" "unprognostic (3.46e-1)" "unprognostic (2.84e-1)" "unprognostic (8.30e-2)" "prognostic unfavorable (2.72e-7)" "unprognostic (1.62e-1)" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (5.45e-2)" 21.9 2.7 0.6 24.1 0.8 31.9 1.3 0.8 2.6 4.3 2.5 3.8 2.5 1.3 0.4 4.1 5.3 22.7 2.3 0.5 1.7 2.4 10.2 22.7 39.3 1.5 0.8 0.4 1.6 4.3 0.7 0.9 20.8 1.8 1.8 3.1 0.1 1.5 0.9 0.6 0.3 4.6 6.4 0.8 57.0 7.4 0.7 0.8 11.8 1.2 8.0 42.3 18.0 1.2 2.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 59.7 1.1 0.0 1.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.1 1.4 0.0 0.0 11.6 65.2 0.3 24.6 14.5 10.3 40.3 8.4 29.0 14.1 32.2 27.0 39.4 477.4 36.1 9.9 2.6 6.1 40.4 0.6 0.8 0.8 2.6 0.5 1.7 1.5 0.8 0.4 1.8 0.8 0.8 2.0 0.2 0.0 6.7 0.0 11.0 0.0 0.5 4.3 0.0 0.0 0.2 0.0 1.5 7.2 11.8 0.0 0.0 0.8 10.9 0.1 0.0 63.6 0.0 0.3 0.0 1.4 0.0 1.3 0.2 0.4 0.2 1.9 13.3 0.2 5.1 0.1 3.3 1.0 13.9 0.0 0.0 0.0 22.4 18.6 1.0 0.0 0.0 41.1 0.0 1.9 57.5 0.3 20.6 0.0 0.1 3.6 0.0 0.0 2.7 8.0 0.0 0.6 25.4 0.1 6.6 2.5 1.2 0.1 0.0 0.1 0.0 1.4 10.9 6.5 0.2 14.5 ACOT13 "HT012, THEM2" ENSG00000112304 "Acyl-CoA thioesterase 13" Q9NPJ3 6 24667035-24705065 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.9" "Cell type enhanced" "Detected in all" "Early spermatids: 847.1;Proximal tubular cells: 525.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019881, HPA057134" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA019881: AB_1857978, HPA057134: " "unprognostic (3.61e-1)" "unprognostic (1.62e-1)" "unprognostic (6.02e-2)" "unprognostic (1.80e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.53e-6)" "unprognostic (3.67e-2)" "unprognostic (1.64e-2)" "unprognostic (7.16e-2)" "unprognostic (5.97e-2)" "unprognostic (4.86e-2)" "unprognostic (1.50e-1)" "unprognostic (2.13e-2)" 6.4 6.1 6.6 4.9 7.1 3.4 3.8 7.5 7.3 3.5 5.6 9.2 6.5 3.2 3.8 3.5 3.6 5.0 12.2 6.2 7.2 19.4 30.9 4.6 5.2 6.9 7.3 5.9 3.9 6.7 7.3 5.1 3.0 6.9 6.5 7.4 9.7 5.0 3.3 12.3 5.5 6.2 3.1 6.8 4.8 5.5 7.0 7.7 5.1 5.8 10.4 3.4 3.5 3.1 7.1 5.9 7.6 7.6 13.6 10.5 13.1 4.2 4.8 5.8 3.5 5.4 10.1 7.5 11.1 16.2 5.5 18.4 6.4 6.7 9.7 5.4 17.4 6.2 10.4 7.7 7.0 5.3 6.7 4.6 7.6 9.4 4.7 9.0 8.5 8.3 11.3 17.0 5.7 7.0 6.1 12.1 12.9 5.1 11.7 5.9 10.4 6.6 14.0 11.7 5.4 15.0 5.2 5.7 19.1 14.1 8.8 13.2 5.5 9.7 6.2 3.5 1.7 4.6 10.7 29.3 11.1 6.5 23.8 19.1 4.8 5.3 3.6 4.4 5.7 6.1 6.9 4.9 5.0 4.7 4.9 5.7 5.1 6.2 4.6 5.8 3.7 5.3 4.8 6.6 7.1 7.5 7.3 6.2 7.2 6.9 7.3 5.9 6.9 6.8 7.7 7.1 27.9 67.3 41.7 19.6 19.7 17.2 26.6 66.4 18.8 18.7 29.4 32.3 94.6 45.8 46.9 31.3 16.7 56.8 22.6 88.4 158.5 43.2 847.1 34.0 31.3 24.0 54.7 37.2 12.1 40.2 31.1 26.2 23.9 31.8 14.5 30.3 21.4 215.5 86.7 5.0 14.3 85.8 67.1 24.5 23.7 131.5 19.6 35.0 26.6 14.0 68.9 41.7 18.6 15.6 18.7 29.2 130.7 24.0 25.4 23.2 47.1 525.2 56.8 31.8 26.3 50.6 64.2 117.1 27.3 19.5 23.4 40.0 20.5 43.4 69.4 28.6 SMAP1 "FLJ13159, SMAP-1" ENSG00000112305 "Small ArfGAP 1" Q8IYB5 6 70667776-70862011 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 325.7;Late spermatids: 281.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030574 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "HPA030574: AB_10601589" "unprognostic (1.55e-1)" "unprognostic (2.66e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-3)" "unprognostic (7.06e-2)" "unprognostic (2.90e-2)" "unprognostic (1.66e-3)" "unprognostic (3.46e-1)" "unprognostic (6.50e-2)" "unprognostic (3.75e-2)" "unprognostic (7.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-1)" "unprognostic (4.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.85e-1)" "unprognostic (1.22e-1)" 15.8 12.9 19.4 16.2 26.2 18.8 13.7 17.8 45.2 13.6 11.8 27.8 27.1 14.2 18.1 28.7 10.3 17.5 23.3 26.9 20.4 14.2 16.8 15.0 15.5 21.2 21.9 24.2 11.2 37.5 28.7 8.6 16.3 21.9 17.8 28.5 25.0 18.1 15.3 33.2 19.7 27.0 19.9 17.8 13.9 21.0 31.1 23.5 25.1 21.3 20.2 22.6 18.3 16.2 27.5 60.3 18.6 28.5 35.3 26.0 33.9 46.4 26.6 29.5 21.4 20.9 27.9 17.4 31.4 28.1 32.0 30.5 18.5 27.4 28.1 35.5 36.3 39.4 34.7 16.5 23.6 17.2 25.5 28.0 22.3 31.3 24.2 29.2 39.6 34.2 16.1 33.8 36.9 33.8 35.0 19.2 31.4 21.3 30.9 21.9 36.0 107.9 51.8 38.1 36.0 40.7 28.7 16.9 23.3 17.1 24.2 31.0 37.3 33.6 17.2 29.7 11.4 23.5 34.3 32.9 16.0 13.0 29.4 24.2 35.0 16.4 18.4 18.2 18.3 20.7 14.8 24.3 21.0 14.0 12.7 12.1 15.7 22.6 25.6 20.0 13.7 25.3 23.4 19.4 26.2 17.8 45.2 26.9 20.4 21.2 21.9 24.2 21.9 17.8 23.5 27.5 45.0 38.5 39.4 58.1 39.3 66.9 37.7 66.9 33.0 51.8 39.6 47.2 38.8 52.9 46.0 38.6 37.5 26.2 47.6 111.3 54.8 78.9 325.7 26.1 46.8 43.2 41.9 28.8 120.1 151.0 48.8 40.3 64.7 52.1 48.2 42.9 58.5 41.3 56.6 55.5 104.3 82.3 61.1 61.2 59.8 281.1 50.7 53.0 32.0 60.0 64.1 69.7 64.9 115.6 72.7 108.2 99.5 67.0 51.8 76.3 92.6 69.6 21.1 38.6 65.7 36.3 53.3 105.2 84.2 89.3 77.3 31.7 64.9 44.1 75.8 51.6 RPS12 S12 ENSG00000112306 "Ribosomal protein S12" P25398 6 132814569-132817564 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006124, HPA006365" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 450000 Cytosol "Golgi apparatus, Vesicles" "HPA006124: AB_1856460, HPA006365: AB_2667570" "unprognostic (6.58e-2)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (6.37e-2)" "unprognostic (4.95e-3)" "unprognostic (1.46e-1)" "unprognostic (3.95e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-1)" "unprognostic (5.66e-2)" 2093.4 1336.1 1396.7 1783.4 1421.8 5434.0 3587.1 1379.8 2044.2 2253.8 1394.4 1866.9 1612.3 1764.1 1679.2 2470.6 2168.0 1428.4 1293.3 1338.3 1421.8 1506.1 1455.5 1579.0 3980.4 1418.8 1394.0 1317.5 4927.9 3691.3 1008.6 878.0 1647.3 1426.5 1710.5 1923.3 613.6 2186.5 1227.8 1984.5 3379.7 1706.9 1368.8 1492.4 2127.3 1732.5 688.2 1454.7 2557.4 1976.6 1389.1 3079.0 2030.2 2126.1 1475.9 1993.8 1568.3 2260.4 3581.3 4521.2 5855.0 2728.8 2502.9 3598.4 2772.7 2665.2 3294.5 1880.3 4497.8 3443.9 3368.1 1338.8 1900.3 2613.1 4373.5 2576.9 2895.0 3346.5 3013.3 1944.0 4743.1 5047.1 8481.4 2221.0 6167.0 7332.7 2340.5 8322.4 4658.3 3754.7 3556.4 5166.0 2858.9 3487.9 4342.3 3620.8 5030.3 2772.9 3420.0 2533.0 3993.0 1799.7 2884.6 3698.6 2185.9 1991.3 1573.0 833.4 5314.3 7184.2 2173.7 2276.5 8489.5 3027.8 1121.1 3111.7 3721.2 4696.8 4153.6 4104.8 3493.8 3635.1 5063.0 1621.7 599.0 1545.5 220.8 2412.5 1426.7 3728.9 4156.1 4210.9 3131.6 1971.7 3564.5 5201.1 4454.7 151.1 2031.9 1170.8 2722.3 2519.7 7450.3 1396.7 1421.8 1379.8 2044.2 1338.3 1421.8 1418.8 1394.0 1317.5 1426.5 1492.4 1454.7 1475.9 3755.5 1660.2 3063.5 22.9 9470.7 8277.4 8259.7 3758.1 8926.6 531.5 10637.2 15674.0 827.7 3777.4 2693.4 1237.8 179.3 7566.9 6150.1 1808.1 4574.3 4058.0 792.6 1406.5 4602.8 3829.0 2863.4 5499.5 18.9 8085.7 9433.9 3353.4 3537.2 2309.6 1773.2 3890.7 4755.4 5136.7 5871.9 212.0 17.7 6806.4 1116.9 6161.6 5357.0 2335.6 6075.0 4790.9 3938.0 20.6 6667.5 2216.0 5160.7 10.1 25.0 6009.9 4480.8 2990.3 4762.0 10484.3 3517.1 5647.3 792.4 713.1 1617.2 5397.5 3117.8 1035.0 3063.2 11325.5 10512.6 7894.9 7990.4 4517.7 6783.0 9815.1 C6orf62 "DKFZP564G182, FLJ12619, XTP12" ENSG00000112308 "Chromosome 6 open reading frame 62" Q9GZU0 6 24704861-24719998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 354.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030564, HPA030566" Supported Approved Cytosol NA NA Cytosol "HPA030564: AB_10600000, HPA030566: AB_10599425" "unprognostic (2.07e-2)" "unprognostic (2.92e-1)" "unprognostic (7.10e-2)" "unprognostic (6.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.18e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.04e-4)" "unprognostic (4.16e-3)" "unprognostic (3.94e-2)" "unprognostic (3.08e-2)" "unprognostic (9.01e-2)" "unprognostic (4.03e-1)" "unprognostic (1.93e-2)" "prognostic favorable (3.62e-6)" 111.0 83.4 107.6 116.1 110.4 119.0 88.2 109.0 113.5 61.2 97.4 77.2 91.2 71.3 101.5 57.1 77.3 63.3 60.3 98.8 132.8 93.8 108.4 97.4 145.5 124.4 121.4 89.7 94.6 122.9 71.8 45.8 88.2 110.7 84.9 77.5 152.3 94.8 76.1 84.9 94.3 93.8 69.8 111.7 157.6 111.3 126.1 118.7 134.3 86.3 58.8 144.1 74.4 37.2 113.8 154.6 73.9 108.2 169.8 106.6 142.2 118.5 178.0 172.6 204.4 211.2 91.8 116.7 177.9 258.3 172.0 230.8 114.5 103.7 137.1 221.0 301.2 61.9 194.0 104.8 112.7 191.0 235.0 201.4 106.0 267.6 138.6 182.8 152.2 162.0 97.8 160.6 121.6 199.3 96.3 160.4 325.9 118.0 79.9 86.0 127.8 126.0 164.7 131.2 165.5 170.9 99.5 219.8 239.4 349.4 105.4 197.1 174.2 192.7 214.7 108.8 83.7 239.4 289.6 494.0 213.6 75.9 294.8 209.8 214.5 246.5 271.9 211.0 253.7 227.1 204.4 215.0 229.7 192.9 170.8 216.6 241.0 177.8 223.4 277.4 198.1 226.3 522.4 107.6 110.4 109.0 113.5 98.8 132.8 124.4 121.4 89.7 110.7 111.7 118.7 113.8 136.4 83.3 76.7 67.3 91.1 57.5 53.0 56.7 58.6 56.6 107.7 86.7 36.6 94.4 56.3 93.8 50.1 50.8 147.9 105.8 37.2 63.4 147.2 83.1 92.0 85.9 95.9 128.6 50.9 74.0 62.2 78.0 86.6 112.8 55.2 122.8 86.7 132.8 90.1 42.1 39.4 89.3 48.8 354.8 105.3 53.9 54.0 138.8 49.8 94.6 120.8 43.6 96.8 35.2 53.1 83.2 84.9 47.4 54.3 98.3 90.2 71.5 80.5 63.3 52.6 120.5 64.9 98.9 101.6 103.2 56.0 75.2 95.7 61.6 98.8 63.3 B3GAT2 GlcAT-S ENSG00000112309 "Beta-1,3-glucuronyltransferase 2" Q9NPZ5 6 70856679-70957060 "Enzymes, Metabolic proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 18.5" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 319.7" "Group enriched" "Detected in some" 20 "glioma: 4.7;testis cancer: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012059 Uncertain NA NA "HPA012059: AB_2061050" "unprognostic (7.10e-3)" "unprognostic (7.81e-2)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.96e-2)" "unprognostic (4.88e-2)" "unprognostic (4.22e-2)" "unprognostic (9.16e-4)" "unprognostic (8.09e-2)" "unprognostic (7.43e-3)" "unprognostic (6.88e-7)" "unprognostic (2.72e-2)" "unprognostic (3.35e-2)" "unprognostic (2.53e-2)" "unprognostic (3.45e-3)" 1.2 0.4 15.9 0.5 18.3 0.4 1.1 13.4 14.7 1.2 6.2 0.8 0.7 0.7 0.1 1.0 0.7 0.2 0.8 26.1 14.1 0.6 0.9 1.0 0.5 19.8 18.4 11.5 0.8 1.5 0.0 0.8 0.1 23.8 0.9 0.0 18.5 1.2 0.0 0.8 1.5 1.0 0.1 22.3 0.7 1.1 1.0 15.3 0.6 1.0 0.0 0.0 1.1 1.4 30.2 0.3 0.0 0.6 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.1 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.5 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.1 0.2 0.2 0.0 0.2 21.8 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.3 0.0 15.9 18.3 13.4 14.7 26.1 14.1 19.8 18.4 11.5 23.8 22.3 15.3 30.2 4.5 0.0 2.2 23.8 9.7 25.5 11.9 19.4 0.0 16.5 7.2 1.7 1.0 11.5 9.0 16.5 22.9 6.0 10.0 13.0 0.0 5.6 9.7 3.6 5.4 7.7 0.0 3.2 2.5 3.9 3.9 6.9 2.0 6.0 0.0 2.5 9.3 10.7 7.5 319.7 8.2 4.9 16.2 10.0 27.0 6.0 19.9 5.1 14.2 0.0 11.6 15.2 30.9 32.2 0.2 9.1 15.5 13.5 3.7 16.9 23.3 1.4 3.4 22.5 13.1 5.8 5.8 18.7 36.7 1.2 19.9 7.1 15.1 2.1 6.2 12.2 GMNN Gem ENSG00000112312 "Geminin DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 233.4" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 184.8;Paneth cells: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538" "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favorable (4.13e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 9.2 7.7 17.0 17.3 18.6 69.5 24.4 19.8 23.9 10.2 13.8 42.0 17.9 10.7 5.9 16.8 16.6 8.0 7.2 15.0 34.9 24.8 18.3 9.0 30.6 18.9 18.9 15.3 14.7 233.4 8.5 11.2 16.6 18.3 41.8 44.8 16.4 8.7 25.2 7.5 33.5 16.3 12.6 16.2 19.2 22.8 37.7 20.9 37.7 10.9 14.4 23.9 28.6 14.0 18.0 110.9 64.2 159.2 66.2 22.2 23.5 106.0 106.0 55.9 124.4 135.5 125.1 38.8 110.1 131.3 34.4 91.3 63.3 139.4 78.1 133.0 41.2 145.4 151.5 109.3 207.4 20.7 119.1 53.1 19.1 25.1 75.9 29.5 25.8 62.2 84.6 193.9 56.9 88.9 86.3 224.9 128.2 87.3 89.6 50.2 128.9 124.4 141.2 53.5 94.6 127.3 78.3 47.5 77.4 95.2 89.1 81.3 72.0 30.9 75.7 76.8 88.3 182.6 62.8 207.6 210.3 23.1 220.9 111.2 5.5 5.2 17.1 4.4 6.9 5.6 9.2 8.5 6.9 7.6 4.6 6.1 6.9 3.0 5.9 5.0 9.4 15.9 5.6 17.0 18.6 19.8 23.9 15.0 34.9 18.9 18.9 15.3 18.3 16.2 20.9 18.0 24.0 6.4 15.6 8.8 17.0 33.0 28.4 57.4 18.8 9.5 51.0 52.5 12.1 18.6 68.1 44.1 2.1 83.2 19.9 72.6 9.8 113.6 94.8 84.8 30.6 18.4 25.9 66.2 3.5 112.3 136.3 17.7 12.2 184.8 13.3 36.4 13.9 17.4 54.0 11.8 5.3 66.3 10.2 10.7 13.2 28.0 9.6 15.2 23.2 5.6 12.6 30.9 6.2 5.5 3.2 31.8 300.5 10.9 41.6 25.6 20.8 20.6 25.2 13.7 19.7 8.0 21.9 158.8 58.8 26.8 63.5 48.7 19.1 30.4 156.5 30.1 EYA4 "CMD1J, DFNA10" ENSG00000112319 "EYA transcriptional coactivator and phosphatase 4" O95677 6 133240598-133532128 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.9;tongue: 21.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004805, HPA038771, HPA038772" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-9)" "unprognostic (1.64e-1)" "unprognostic (3.08e-2)" "unprognostic (3.44e-2)" "unprognostic (7.21e-2)" "unprognostic (9.07e-2)" "unprognostic (2.04e-2)" "unprognostic (2.80e-1)" "unprognostic (2.29e-1)" "unprognostic (8.27e-4)" "unprognostic (1.82e-3)" "unprognostic (6.67e-2)" "unprognostic (9.55e-2)" "unprognostic (2.51e-2)" 1.1 2.6 2.3 0.1 1.7 0.0 0.5 3.5 2.0 2.6 10.8 0.2 0.2 0.5 1.2 0.4 7.5 0.5 5.9 2.4 1.3 5.1 0.0 1.8 0.1 4.6 5.2 0.2 1.2 0.2 0.0 0.8 0.0 4.3 5.7 0.2 0.1 0.2 11.9 27.9 0.0 0.1 0.3 5.6 0.4 0.4 3.1 3.6 6.7 2.1 21.5 0.5 2.3 2.3 5.1 0.0 25.4 2.4 0.0 0.0 0.0 0.0 0.0 20.4 0.5 2.9 0.1 0.1 0.1 19.6 0.0 25.6 0.0 15.4 6.7 0.0 0.0 20.2 2.8 74.3 0.0 0.6 0.0 6.8 5.1 0.0 14.4 4.5 3.4 0.0 0.0 0.0 10.7 8.1 0.0 0.0 0.0 0.0 0.3 1.6 0.3 23.8 0.0 0.0 3.9 3.7 4.1 0.2 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 18.4 7.2 3.4 0.0 24.6 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.7 3.5 2.0 2.4 1.3 4.6 5.2 0.2 4.3 5.6 3.6 5.1 0.3 12.8 1.8 2.6 0.0 0.1 0.1 13.3 0.0 0.0 0.0 0.0 14.4 0.0 6.7 46.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.1 0.1 0.5 1.8 0.0 4.8 0.2 0.0 2.9 0.0 0.1 0.0 1.5 0.4 0.1 0.0 0.0 139.0 0.0 8.2 1.0 0.0 2.6 0.6 0.2 0.0 2.8 7.2 0.0 0.0 1.5 79.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 4.8 0.0 0.0 26.2 3.3 7.9 7.1 0.0 0.0 0.0 0.1 1.5 0.0 0.2 SOBP FLJ10159 ENSG00000112320 "Sine oculis binding protein homolog" A7XYQ1 6 107490106-107661306 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 175.3;Excitatory neurons: 260.1;Granulosa cells: 149.3;Inhibitory neurons: 287.7;Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 278.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 10.5;AN3-CA: 13.9;ASC diff: 12.9;HDLM-2: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029242 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029242: AB_10603340" "unprognostic (7.11e-2)" "unprognostic (1.35e-3)" "unprognostic (9.01e-2)" "unprognostic (2.04e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "unprognostic (5.63e-2)" "unprognostic (9.84e-2)" "unprognostic (5.35e-3)" "prognostic favorable (1.55e-5)" "unprognostic (6.64e-2)" "unprognostic (2.00e-3)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-3)" 4.3 6.7 13.0 1.7 15.5 0.0 3.4 9.7 17.1 6.1 1.2 10.5 1.2 5.7 2.0 2.0 4.3 2.7 10.2 16.0 9.1 3.4 1.7 2.4 0.9 8.7 8.5 13.4 10.9 1.4 3.2 9.5 2.4 7.9 8.3 1.3 5.4 10.5 2.6 16.9 1.0 3.2 4.0 6.7 2.0 4.8 4.2 9.1 2.7 4.3 5.9 1.1 12.0 4.4 12.1 0.0 0.3 10.5 13.9 12.9 4.9 1.2 0.0 0.0 0.3 0.6 0.0 0.0 5.7 0.3 0.0 0.9 0.0 7.0 0.2 0.2 9.0 6.8 0.6 0.0 6.8 1.6 3.0 0.5 5.2 0.0 5.1 0.0 1.1 4.2 2.6 0.0 0.3 0.0 2.9 1.3 0.3 2.5 0.3 0.9 3.1 1.3 0.0 0.0 0.2 3.3 5.6 1.2 0.0 0.1 0.4 0.4 2.0 0.0 3.3 1.1 5.7 0.5 2.6 0.5 3.5 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 15.5 9.7 17.1 16.0 9.1 8.7 8.5 13.4 7.9 6.7 9.1 12.1 6.0 3.2 9.8 175.3 9.2 0.5 10.3 11.4 3.4 40.4 0.5 7.4 19.4 17.2 6.1 23.9 0.0 0.2 1.8 0.2 0.0 2.5 96.2 0.6 15.8 4.4 10.8 5.3 260.1 0.2 0.7 23.6 3.1 0.4 0.0 149.3 5.3 1.4 3.0 92.5 287.7 0.1 4.1 9.6 4.1 61.4 45.1 1.8 3.6 51.5 0.1 7.6 0.0 263.9 278.8 0.4 0.0 48.9 0.2 9.3 0.0 11.9 10.9 10.1 26.3 42.8 21.0 61.2 5.6 0.6 0.9 0.1 1.3 13.3 0.2 1.0 NR2E1 "TLL, TLX, XTLL" ENSG00000112333 "Nuclear receptor subfamily 2 group E member 1" Q9Y466 6 108166022-108188805 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 55 "brain: 18.7;choroid plexus: 12.8;retina: 30.8" "Cell type enhanced" "Detected in some" "Astrocytes: 22.2;Inhibitory neurons: 8.5;Muller glia cells: 44.9;Oligodendrocyte precursor cells: 4.5" "Cancer enriched" "Detected in single" 14 "glioma: 6.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;GAMG: 1.4;HEK 293: 1.0;U-251 MG: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036954, HPA055642" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA036954: AB_10670958, HPA055642: AB_2682871" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.00e-1)" "unprognostic (1.78e-2)" "unprognostic (7.31e-2)" "unprognostic (8.64e-2)" "unprognostic (9.59e-8)" "unprognostic (2.87e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" 0.0 0.3 16.0 0.0 14.8 0.0 0.0 6.5 18.7 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 13.3 0.1 0.0 0.0 0.0 9.1 10.7 14.0 0.0 0.0 0.0 0.2 0.0 11.0 0.0 0.0 30.8 0.1 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 14.8 6.5 18.7 15.8 13.3 9.1 10.7 14.0 11.0 5.8 16.7 13.1 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNX3 Grd19 ENSG00000112335 "Sorting nexin 3" O60493 6 108211222-108261246 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Microphthalmia "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 270000 "prognostic unfavorable (4.37e-5)" "unprognostic (1.70e-2)" "unprognostic (2.44e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.82e-2)" "unprognostic (7.74e-3)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (5.76e-2)" "unprognostic (1.87e-1)" "unprognostic (7.66e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (2.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.50e-1)" "unprognostic (1.67e-1)" 223.4 222.9 214.0 132.5 216.9 298.9 184.1 213.3 270.3 165.0 212.2 150.5 120.5 139.1 154.1 173.7 145.8 133.2 269.0 217.1 233.3 170.1 200.7 148.6 185.5 213.7 213.6 207.9 189.1 124.7 125.4 96.2 201.0 216.2 105.5 113.9 89.1 135.6 120.5 326.1 128.6 126.2 158.4 227.8 146.3 123.0 110.7 231.8 124.5 124.2 287.9 164.9 167.9 149.1 242.9 164.9 98.2 94.9 314.3 505.0 377.9 147.6 241.3 240.3 187.5 231.2 155.0 118.8 138.5 232.8 315.3 328.8 128.6 212.5 207.9 254.6 161.2 136.7 268.1 110.2 182.6 272.9 183.9 175.3 324.4 279.9 180.1 202.1 296.9 312.9 131.0 261.6 161.1 263.1 156.6 70.4 403.7 80.1 199.1 166.2 76.2 229.7 145.4 300.0 225.1 111.0 154.9 155.5 197.7 260.4 212.2 100.6 623.8 235.8 161.0 108.2 218.0 319.7 65.0 90.7 148.9 284.2 332.5 197.2 118.5 75.9 169.1 37.4 70.5 48.2 215.3 43.8 39.5 109.8 181.6 44.6 37.0 48.4 64.5 68.6 132.1 48.8 70.4 214.0 216.9 213.3 270.3 217.1 233.3 213.7 213.6 207.9 216.2 227.8 231.8 242.9 329.6 105.8 70.0 39.2 332.6 378.9 328.7 264.3 231.1 44.6 254.0 244.3 395.2 161.5 160.3 191.3 16.7 685.3 219.3 199.1 643.7 307.1 387.8 144.6 161.1 352.6 128.0 611.8 55.7 253.8 581.2 323.0 101.9 120.0 167.1 127.2 275.9 240.6 974.2 43.7 43.1 154.7 189.2 451.6 786.3 496.6 288.6 415.7 368.2 31.9 409.1 325.7 209.1 27.2 39.7 260.1 200.9 266.7 187.1 247.7 321.4 697.8 198.8 53.7 256.4 186.0 304.1 316.5 173.3 354.5 440.8 618.3 181.0 259.4 180.6 337.9 SLC17A2 NPT3 ENSG00000112337 "Solute carrier family 17 member 2" O00624 6 25912754-25930691 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 165 "liver: 80.2" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 30.9" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "Hep G2: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038270 Uncertain NA NA "HPA038270: AB_10672511" "prognostic favorable (8.54e-4)" "unprognostic (1.90e-2)" "unprognostic (4.14e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 30.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBS1L "DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038" ENSG00000112339 "HBS1 like translational GTPase" Q9Y450 6 134960378-135103056 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis, Translation regulation" "Elongation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 198.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029728, HPA029729" Approved Approved "Nuclear bodies,Cytosol" NA NA 9200 "Nuclear bodies, Cytosol" "HPA029728: AB_10611112, HPA029729: AB_10601228" "unprognostic (3.68e-3)" "unprognostic (6.39e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.26e-1)" "unprognostic (2.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (8.66e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (7.73e-2)" "unprognostic (3.84e-1)" "unprognostic (4.98e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-2)" 35.7 32.8 29.5 31.5 51.4 83.2 40.1 37.1 45.0 32.1 27.0 30.2 23.2 32.1 23.2 44.3 30.1 26.8 51.4 30.3 41.1 37.3 63.6 24.8 40.6 43.4 44.6 26.3 32.9 39.8 47.5 17.3 35.7 47.9 29.0 29.8 45.2 42.7 29.7 168.8 27.1 27.2 38.8 37.3 23.8 29.9 33.0 38.3 66.1 38.9 124.5 43.8 34.3 20.2 89.8 63.9 41.9 85.7 124.8 76.7 67.9 65.4 125.5 107.7 116.7 143.6 70.7 46.8 109.5 55.3 111.9 84.3 46.6 121.1 92.4 181.2 111.8 82.9 335.3 113.6 95.5 91.9 209.5 87.9 67.8 68.7 111.0 135.0 87.2 98.5 128.2 182.7 89.4 125.1 60.0 129.6 53.0 55.4 75.6 45.3 120.0 95.3 74.9 72.3 59.7 84.2 57.4 85.6 88.7 88.4 67.4 74.1 124.6 93.6 82.4 85.5 103.3 134.8 202.5 158.3 184.8 125.5 106.8 104.9 108.7 47.8 52.0 44.0 44.9 48.9 49.3 51.2 44.2 55.9 42.7 68.9 57.0 22.0 66.4 44.9 44.6 67.5 57.7 29.5 51.4 37.1 45.0 30.3 41.1 43.4 44.6 26.3 47.9 37.3 38.3 89.8 25.9 25.6 25.7 27.1 32.0 27.3 26.9 23.2 31.3 42.7 22.1 17.8 56.0 17.2 30.4 11.0 14.6 32.2 36.8 11.1 25.4 25.2 36.3 27.1 28.9 24.4 16.3 58.0 61.4 20.4 33.7 26.2 20.4 27.1 60.0 23.9 18.2 39.3 13.5 21.9 56.2 11.1 16.2 18.0 18.9 12.6 18.6 17.6 30.2 29.0 28.0 26.5 19.6 47.3 198.7 18.7 12.3 22.2 53.7 21.6 13.9 23.5 24.0 26.6 39.5 36.6 25.9 28.3 25.8 24.9 18.6 40.5 34.5 27.5 14.6 25.7 TRIM38 "RNF15, RORET" ENSG00000112343 "Tripartite motif containing 38" O00635 6 25962802-25991231 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031685 Approved Approved "Plasma membrane,Cell Junctions,Centrosome" NA NA Centrosome "Plasma membrane, Cell Junctions" "HPA031685: AB_10603218" "unprognostic (6.62e-2)" "unprognostic (1.65e-3)" "unprognostic (3.34e-1)" "unprognostic (2.72e-2)" "unprognostic (1.25e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (3.27e-2)" "unprognostic (2.78e-2)" "prognostic favorable (8.95e-5)" "unprognostic (2.81e-2)" "unprognostic (6.28e-2)" "unprognostic (2.73e-1)" "unprognostic (3.36e-1)" "unprognostic (4.49e-2)" "prognostic favorable (8.20e-5)" "prognostic favorable (4.94e-9)" 7.1 6.0 1.8 10.9 1.9 13.1 6.2 1.6 2.4 6.9 3.6 5.9 6.7 7.4 9.7 7.9 7.4 6.7 3.5 1.6 2.3 9.9 5.6 9.4 13.7 2.5 2.0 1.2 4.6 3.2 2.9 2.0 6.3 2.6 7.0 7.4 0.4 6.2 6.2 7.6 5.3 8.9 6.2 2.2 14.4 5.9 2.1 2.5 7.8 5.5 3.0 14.7 7.0 7.1 2.7 4.8 2.6 0.4 5.6 13.0 17.3 4.6 5.9 11.7 11.2 18.5 2.0 5.0 10.5 9.4 7.3 10.8 7.3 3.6 5.8 6.6 10.7 2.3 4.8 4.6 2.0 17.2 5.7 9.4 17.4 4.2 6.9 2.5 9.2 9.8 5.0 3.2 5.7 13.5 2.3 5.5 6.4 1.8 0.0 3.5 8.3 5.4 11.2 13.3 9.3 0.1 0.1 4.4 9.1 16.2 0.6 1.3 7.3 10.1 2.0 3.4 3.5 4.0 6.5 5.1 11.7 5.4 6.9 12.6 12.1 10.2 4.7 6.9 12.5 6.6 13.1 5.8 6.2 9.8 15.1 5.4 6.0 11.4 6.5 11.7 9.0 7.9 7.1 1.8 1.9 1.6 2.4 1.6 2.3 2.5 2.0 1.2 2.6 2.2 2.5 2.7 37.6 25.6 47.1 0.3 120.2 14.9 56.9 16.1 24.5 0.6 20.1 12.8 6.0 18.6 32.4 46.0 0.0 23.5 88.5 48.3 17.6 28.5 1.1 48.4 28.1 39.9 18.1 10.3 0.1 14.9 23.5 25.5 24.5 69.4 35.5 52.4 35.0 17.5 32.6 0.0 0.1 33.3 16.2 94.0 32.7 2.8 19.9 81.3 10.6 34.7 113.2 0.2 107.1 0.0 0.2 20.4 47.4 18.8 34.3 39.7 48.3 69.5 22.7 1.1 6.6 23.1 28.2 0.3 0.5 42.7 9.2 21.2 53.1 23.0 25.6 94.7 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913934 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA049202: AB_2680674" "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favorable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favorable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 4.8 14.9 4.2 2.1 4.5 3.9 12.1 5.7 5.3 6.8 4.7 8.0 5.3 4.2 17.4 7.4 8.8 4.5 11.8 3.9 4.0 15.7 9.2 5.0 3.2 4.4 4.2 4.3 5.0 27.2 17.3 6.0 4.1 4.3 10.5 8.5 7.0 10.7 6.5 10.8 11.3 4.7 3.3 4.3 3.3 15.7 10.1 4.7 3.8 11.1 9.9 3.3 5.5 6.7 5.4 4.4 4.3 4.4 6.2 6.6 9.8 2.4 6.1 8.9 7.5 7.4 4.9 6.0 1.5 11.3 8.3 8.5 5.3 3.3 13.8 9.8 5.7 7.5 6.4 4.3 0.9 13.9 8.1 5.3 9.6 13.1 5.4 7.9 8.7 5.4 12.0 13.0 5.2 10.6 13.4 3.5 7.9 5.0 13.9 8.3 4.8 3.4 5.7 17.4 6.4 8.3 10.6 6.5 9.0 8.4 4.9 5.8 7.7 2.5 4.8 1.7 7.3 5.3 6.9 5.1 0.0 4.2 6.4 4.9 2.9 1.3 2.2 0.7 1.0 0.7 1.5 1.3 1.6 2.3 1.0 2.4 1.5 0.9 1.6 1.9 1.8 2.3 0.9 4.2 4.5 5.7 5.3 3.9 4.0 4.4 4.2 4.3 4.3 4.3 4.7 5.4 4.9 3.2 9.4 10.7 6.3 12.1 14.9 16.5 9.1 9.1 19.5 13.8 18.7 11.5 14.7 11.0 8.4 19.6 2.3 11.6 60.7 16.5 12.5 18.7 6.4 5.6 10.3 15.8 12.4 22.7 21.0 6.8 10.2 11.1 14.0 7.9 6.1 7.0 12.4 0.0 14.7 21.8 30.5 5.7 6.2 10.2 9.0 6.4 14.2 5.6 11.9 20.8 4.1 17.6 19.9 16.7 13.2 9.8 3.7 16.0 15.0 38.3 16.1 9.9 6.6 5.7 8.2 30.6 16.7 15.4 18.2 17.1 6.6 24.3 17.2 17.4 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483219 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Yes No Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: AB_2669673, HPA049003: AB_2680596" "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 2.8 2.3 1.4 5.5 2.4 9.0 4.6 2.5 2.4 4.0 1.0 3.5 3.6 3.1 3.2 3.0 2.9 2.6 2.2 1.6 1.7 3.9 2.6 4.0 8.8 1.7 1.5 1.5 3.4 3.5 7.5 1.8 3.2 1.7 3.5 3.8 10.2 4.4 3.3 3.2 4.7 3.7 2.8 1.3 5.6 4.1 4.3 1.7 7.0 4.9 2.9 7.3 3.5 2.8 3.0 4.7 4.8 4.3 10.8 6.8 6.9 7.0 5.3 7.3 6.5 7.4 6.7 3.6 20.0 6.7 6.7 7.8 6.0 10.9 8.3 9.8 12.4 10.7 16.2 6.5 5.1 5.0 13.3 8.0 7.0 6.7 6.6 11.4 4.6 5.5 9.3 13.8 11.0 6.8 8.0 19.2 9.0 10.7 4.7 5.3 11.9 6.1 8.3 8.0 8.0 7.3 6.4 6.8 7.1 16.9 5.9 5.0 14.5 5.4 5.3 5.3 4.4 11.5 5.3 4.4 20.2 7.0 10.4 9.0 0.1 0.6 0.9 0.7 0.6 0.4 3.4 1.5 0.9 0.7 2.8 1.9 1.1 0.4 1.3 0.8 1.1 2.9 0.5 1.4 2.4 2.5 2.4 1.6 1.7 1.7 1.5 1.5 1.7 1.3 1.7 3.0 8.4 12.8 9.1 2.6 32.8 10.1 11.2 5.3 7.4 21.7 8.6 7.4 3.8 7.2 5.2 3.7 31.3 8.5 16.8 4.5 3.9 6.6 1.4 7.3 14.3 6.6 9.6 12.0 3.3 9.1 9.9 8.6 12.8 10.7 9.5 14.1 3.6 7.3 7.7 10.1 2.8 11.0 6.1 12.5 12.1 1.8 7.2 10.3 8.8 5.6 20.5 10.0 14.4 1.0 5.4 6.4 5.1 6.4 16.8 8.2 7.4 6.4 6.0 65.2 0.0 13.2 7.4 6.2 27.8 9.3 9.7 7.8 17.8 15.0 8.5 7.3 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109690609-109878098 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Supported "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "CAB017823: , HPA068859: AB_2686049" "prognostic unfavorable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favorable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favorable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 8.6 10.3 5.9 7.1 7.4 5.7 8.2 6.2 7.7 8.2 11.7 9.8 5.0 8.6 7.8 9.5 7.3 7.6 7.7 6.1 9.0 9.6 6.1 13.6 10.2 6.6 7.8 5.8 8.3 7.6 17.6 12.0 8.8 8.6 7.8 9.6 10.9 10.8 7.9 10.7 7.6 9.2 10.4 6.1 13.9 8.7 8.3 6.2 12.4 9.4 8.4 10.2 9.3 8.4 7.3 8.3 8.4 11.7 14.9 11.8 17.2 7.8 9.9 14.1 8.3 23.2 4.6 7.2 23.2 5.8 18.9 14.9 5.2 12.6 8.5 20.7 13.3 16.5 10.9 5.9 5.5 11.4 9.5 10.0 8.8 9.9 12.8 10.6 22.8 18.3 13.9 6.8 8.8 12.7 6.8 12.0 8.4 5.9 12.0 4.7 7.9 6.1 7.3 13.3 18.4 12.8 11.7 7.1 10.7 21.1 15.6 6.0 23.1 11.2 4.2 3.8 5.4 9.5 3.4 2.6 7.9 27.3 8.5 4.6 15.4 24.9 14.2 8.8 24.5 7.7 18.9 6.3 8.5 19.2 21.2 7.5 7.5 7.4 10.0 15.2 8.1 9.4 11.7 5.9 7.4 6.2 7.7 6.1 9.0 6.6 7.8 5.8 8.6 6.1 6.2 7.3 4.9 16.0 9.0 24.5 15.7 4.6 7.1 7.3 5.2 8.8 5.4 3.3 6.7 2.8 6.9 9.2 2.1 13.4 9.5 7.0 5.9 9.8 18.0 7.5 5.3 5.2 10.2 3.0 49.5 11.4 7.0 6.0 8.2 7.9 8.8 8.6 7.1 4.1 23.3 1.7 32.4 8.6 8.2 19.2 6.8 17.7 3.4 17.3 8.8 29.0 16.4 8.5 11.3 46.8 37.4 7.6 6.3 6.8 6.5 4.0 6.3 8.2 9.1 7.6 0.0 5.1 6.6 5.5 12.1 8.3 4.4 12.3 9.3 5.6 6.4 8.9 PERP "dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW" ENSG00000112378 "P53 apoptosis effector related to PMP22" Q96FX8 6 138088505-138107419 "Predicted membrane proteins" "Apoptosis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "esophagus: 789.1;salivary gland: 298.3;skin 1: 1106.3;vagina: 429.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 3312.8;Squamous epithelial cells: 3451.4;Suprabasal keratinocytes: 5828.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 555.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 39.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 39.8" "Cell line enhanced" "Detected in many" "hTCEpi: 1024.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022269 Enhanced NA NA "HPA022269: AB_1855219" "prognostic unfavorable (5.46e-4)" "unprognostic (2.90e-1)" "unprognostic (1.94e-1)" "unprognostic (5.18e-2)" "unprognostic (2.82e-2)" "unprognostic (1.27e-1)" "unprognostic (6.28e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.92e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (4.02e-2)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.51e-2)" 21.9 9.4 7.0 10.0 6.2 1.5 132.4 7.2 8.7 104.7 12.3 41.3 50.6 23.4 48.3 789.1 61.8 38.2 54.4 6.3 7.5 20.3 94.5 27.3 3.3 8.2 6.8 5.3 6.4 33.3 40.9 13.2 39.0 7.6 61.2 38.8 8.8 298.3 47.3 5.7 1106.3 52.5 20.0 6.9 1.4 65.7 3.1 8.2 23.5 24.8 16.4 150.7 60.7 429.9 6.8 81.5 80.3 3.7 11.3 60.0 63.1 172.7 115.5 129.8 17.6 12.9 64.8 143.1 1.5 45.5 37.5 144.0 268.4 15.6 207.6 4.5 126.9 64.6 1.5 70.7 69.8 42.6 1.7 1.0 44.3 1024.8 2.2 111.8 91.7 71.3 5.8 2.4 31.3 3.0 53.4 1.5 4.6 34.4 174.6 47.1 1.5 28.6 0.9 108.2 94.0 29.3 3.7 141.2 68.7 59.6 90.7 36.4 18.4 82.6 29.4 12.1 31.7 2.1 11.1 17.4 1.3 23.0 1.5 65.5 39.8 0.0 0.0 4.3 0.0 7.6 2.0 5.3 3.8 0.0 1.0 0.6 2.3 0.3 0.1 0.0 0.0 8.9 1.3 7.0 6.2 7.2 8.7 6.3 7.5 8.2 6.8 5.3 7.6 6.9 8.2 6.8 13.9 211.5 84.2 0.7 8.1 3312.8 1415.8 1383.2 1110.4 3.3 371.4 305.0 137.7 260.2 728.5 154.5 16.7 994.5 17.6 374.8 62.6 588.0 2.1 1013.4 78.1 71.8 147.2 13.9 1.2 305.1 990.1 83.8 197.2 777.1 10.8 0.5 21.4 171.3 82.0 3.3 2.1 185.0 736.5 3.8 259.2 2.7 10.5 12.8 350.4 12.2 10.3 29.1 3.1 2.0 0.5 655.0 316.7 2.6 43.2 789.2 355.0 10.6 743.5 28.3 6.6 15.4 82.6 2.4 1.4 3451.4 5828.3 824.0 67.2 73.5 218.6 1546.6 ARFGEF3 "BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33" ENSG00000112379 "ARFGEF family member 3" Q5TH69 6 138161939-138344663 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2;salivary gland: 18.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036350 Uncertain NA NA "HPA036350: AB_10672084" "prognostic unfavorable (8.20e-4)" "unprognostic (4.31e-2)" "unprognostic (9.91e-3)" "unprognostic (5.91e-2)" "unprognostic (2.20e-2)" "unprognostic (4.53e-2)" "unprognostic (4.30e-3)" "unprognostic (1.21e-2)" "unprognostic (7.41e-2)" "unprognostic (7.82e-2)" "unprognostic (3.46e-2)" "unprognostic (4.93e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (2.38e-1)" "unprognostic (8.87e-2)" "unprognostic (1.69e-2)" 0.9 3.8 13.0 0.7 15.3 0.4 8.0 19.6 14.8 5.0 0.0 4.3 2.2 0.7 0.9 0.4 2.2 1.7 1.0 15.5 12.8 2.1 0.1 6.4 0.2 11.8 9.7 16.3 0.1 8.7 16.0 7.0 1.5 12.6 12.1 4.8 2.8 18.2 1.0 0.2 1.1 1.9 0.7 7.3 0.4 10.1 0.6 12.2 0.1 1.9 0.7 0.2 3.4 0.5 28.2 8.0 3.1 0.0 0.6 0.0 0.0 4.7 0.3 0.2 0.2 0.0 0.1 0.4 0.0 3.1 0.3 2.7 2.6 3.8 2.0 0.0 0.0 4.9 0.0 1.5 0.9 0.0 3.0 0.0 0.0 0.9 0.0 0.9 3.5 4.1 2.7 0.0 4.9 0.0 14.8 0.0 0.0 2.7 8.5 3.4 0.6 13.4 2.6 2.6 19.4 6.9 0.0 7.8 22.2 0.9 0.3 4.4 0.0 0.4 0.2 2.2 0.0 7.9 1.7 6.7 0.0 3.2 1.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 15.3 19.6 14.8 15.5 12.8 11.8 9.7 16.3 12.6 7.3 12.2 28.2 9.4 16.0 114.6 34.3 0.5 0.0 18.8 0.0 6.2 19.0 39.9 12.6 6.4 14.3 44.6 3.7 0.0 16.5 0.8 2.5 3.9 11.4 83.0 8.6 1.4 11.9 66.7 2.7 200.9 24.7 2.4 4.1 41.3 17.7 2.5 0.1 8.2 0.3 1.4 11.8 207.8 44.2 0.0 0.0 0.0 22.0 0.0 0.5 0.0 36.5 2.0 0.9 0.0 173.9 378.1 14.2 8.4 0.0 0.9 67.6 2.5 0.3 37.2 3.3 0.0 3.5 0.9 4.1 1.1 3.0 0.0 6.2 0.8 0.1 13.2 42.7 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 44.7;pancreas: 30.0;skeletal muscle: 41.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.7;T-reg: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016860 Approved Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 2.9 5.5 1.4 3.0 7.6 0.8 0.8 4.4 3.2 0.6 44.7 1.2 8.5 0.5 1.4 0.8 0.8 1.5 2.2 2.1 6.1 10.1 13.6 4.6 1.0 1.7 4.4 1.4 1.0 30.0 7.9 1.1 23.9 1.9 1.3 1.8 0.7 3.2 0.2 41.5 15.4 5.0 0.3 0.2 1.8 5.3 4.3 8.3 11.0 2.7 6.0 1.3 1.9 1.3 3.0 0.9 1.0 0.4 2.2 0.1 0.1 3.1 0.0 0.2 0.8 1.2 9.0 0.4 5.2 1.4 0.3 2.5 0.1 49.4 0.1 1.0 0.1 20.2 8.2 0.7 7.4 0.1 7.6 7.4 0.0 0.0 0.1 0.0 0.2 0.0 10.9 1.4 0.2 0.1 3.6 9.8 0.8 14.6 0.2 3.2 5.4 6.8 37.2 0.0 0.5 10.7 3.3 0.2 0.7 1.8 3.6 1.8 0.9 0.1 0.1 1.8 0.5 2.5 2.6 0.1 1.5 0.3 5.8 0.8 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.2 1.7 1.5 0.3 0.1 0.0 0.1 1.6 0.1 1.4 7.6 4.4 3.2 2.1 6.1 1.7 4.4 1.4 1.9 0.2 8.3 3.0 0.4 9.6 32.8 2.0 1.5 9.7 10.7 0.0 4.6 6.9 2.0 1.3 9.1 0.0 3.1 5.5 2.1 1.9 0.7 2.1 1.9 0.2 9.0 0.4 0.8 1.4 6.6 1.7 33.9 12.5 1.8 8.9 3.6 1.3 1.3 2.5 4.2 25.4 21.4 1.7 47.8 4.8 0.0 12.4 12.4 8.2 0.0 33.8 44.4 0.0 0.7 1.6 0.0 16.6 0.3 2.0 0.9 0.0 4.8 3.9 10.9 17.7 0.7 0.7 0.0 18.5 1.0 11.6 11.2 1.2 14.8 1.2 5.8 9.2 8.5 1.2 HECA "dJ225E12.1, HDC, HDCL, hHDC" ENSG00000112406 "Hdc homolog, cell cycle regulator" Q9UBI9 6 139135080-139180802 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 125.8;Langerhans cells: 153.3;Suprabasal keratinocytes: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012581, HPA042313" Uncertain Approved Cytosol NA NA Cytosol "HPA012581: , HPA042313: AB_10796903" "unprognostic (2.98e-2)" "unprognostic (2.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (7.31e-2)" "unprognostic (3.38e-3)" "unprognostic (4.29e-2)" "unprognostic (3.27e-1)" "unprognostic (7.39e-2)" "unprognostic (2.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.09e-4)" "unprognostic (3.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.72e-3)" "unprognostic (5.77e-2)" 17.3 8.7 12.8 21.7 11.1 39.5 14.3 11.4 15.1 12.2 10.9 12.9 16.7 13.5 6.4 19.5 12.7 13.2 17.0 13.1 12.5 6.4 10.9 19.4 29.0 11.6 12.2 9.2 16.9 10.0 9.8 7.1 11.0 12.7 9.6 12.5 3.9 18.1 8.2 20.4 26.3 17.7 13.9 13.8 27.7 12.1 9.6 13.4 31.9 9.7 16.0 26.0 14.3 16.0 15.2 4.8 1.0 9.2 10.5 20.8 19.0 6.8 8.6 14.4 3.8 8.8 1.9 5.3 20.9 12.2 17.9 9.1 7.9 5.6 7.8 7.0 32.9 11.9 10.5 4.6 0.3 6.5 18.6 9.2 21.7 18.8 8.3 10.1 10.4 12.9 13.8 4.5 27.5 7.1 4.9 9.0 15.1 1.7 4.2 1.7 14.0 9.3 10.6 3.3 15.2 8.8 2.6 7.1 19.1 5.5 10.2 4.4 24.4 16.4 6.7 6.3 15.2 7.5 16.4 13.1 18.8 2.4 10.7 3.8 7.0 1.3 2.0 2.8 1.8 3.5 1.5 4.3 3.8 1.0 1.9 4.1 4.1 5.0 1.5 5.5 1.1 3.9 1.4 12.8 11.1 11.4 15.1 13.1 12.5 11.6 12.2 9.2 12.7 13.8 13.4 15.2 35.6 6.4 13.9 10.1 38.2 125.8 22.4 15.9 38.7 1.8 29.1 14.4 41.9 8.6 11.6 11.0 2.1 7.3 70.2 53.4 0.0 7.0 12.0 37.8 18.5 34.9 13.1 22.5 20.4 9.8 6.2 22.3 11.7 53.4 13.3 11.7 36.8 13.0 19.1 1.7 23.2 25.5 16.2 84.3 153.3 12.4 15.5 65.7 44.4 38.4 25.7 6.6 29.9 13.0 10.9 14.7 28.4 19.5 48.8 42.4 34.8 4.7 12.3 2.7 52.6 26.4 23.7 12.6 6.7 33.7 142.2 17.4 76.7 10.8 17.2 59.1 ADGRG6 "FLJ14937, GPR126" ENSG00000112414 "Adhesion G protein-coupled receptor G6" Q86SQ4 6 142301854-142446266 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 72.5;placenta: 47.8" "Cell type enhanced" "Detected in many" "Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017346 Approved NA NA 110000000 "HPA017346: AB_1849260" "unprognostic (1.04e-2)" "unprognostic (2.72e-2)" "unprognostic (7.37e-2)" "unprognostic (3.00e-2)" "unprognostic (8.64e-4)" "unprognostic (1.67e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.46e-1)" "unprognostic (6.49e-2)" "unprognostic (2.15e-1)" "unprognostic (1.36e-2)" "unprognostic (2.97e-2)" "unprognostic (4.59e-2)" 4.3 2.8 2.5 4.2 1.8 0.4 5.3 1.7 4.8 2.2 2.8 6.3 17.7 1.1 1.3 11.7 5.2 8.4 3.4 2.8 1.7 7.2 72.5 15.4 1.7 2.3 2.7 0.8 1.4 3.2 1.3 0.3 47.8 2.2 3.2 6.4 0.2 9.1 6.5 0.5 14.6 10.3 2.2 2.5 7.6 12.4 2.1 4.9 4.6 1.6 1.3 4.0 15.3 5.6 2.2 17.0 88.6 1.9 9.4 0.5 0.0 0.2 23.1 4.3 17.2 10.7 71.3 51.0 0.0 20.3 13.4 4.9 41.3 2.6 22.1 28.3 0.0 6.8 3.6 14.5 84.8 16.7 14.6 0.0 0.1 34.9 0.4 81.5 10.0 161.4 0.4 0.6 0.1 6.9 155.6 0.3 0.0 0.7 6.2 20.0 0.0 7.7 17.7 9.0 37.9 0.1 0.1 6.8 30.8 14.5 14.1 16.7 0.3 5.6 0.1 7.6 7.7 11.5 0.0 0.1 0.0 0.1 0.1 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.8 1.7 4.8 2.8 1.7 2.3 2.7 0.8 2.2 2.5 4.9 2.2 5.1 6.4 5.9 0.0 0.3 0.0 21.9 0.0 18.8 0.0 5.3 2.7 1.9 24.3 8.1 9.2 0.0 5.3 0.0 0.6 0.0 13.2 0.1 0.1 0.5 41.7 0.0 17.0 1.6 5.4 33.5 14.5 32.1 0.5 0.0 0.0 27.1 143.8 2.2 0.0 12.7 3.5 0.0 40.5 0.0 0.6 0.6 8.1 0.0 15.0 0.9 0.0 0.0 0.5 0.3 37.9 8.8 0.4 0.1 18.7 9.5 11.8 2.9 0.0 6.6 0.4 1.3 2.6 5.3 30.2 0.0 13.5 1.6 0.0 1.7 25.0 PHACTR2 "C6orf56, KIAA0680" ENSG00000112419 "Phosphatase and actin regulator 2" O75167 6 143536845-143831185 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "choroid plexus: 134.7;placenta: 84.5" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 214.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 82.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031719, HPA031720, HPA031725" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279" "unprognostic (3.25e-3)" "unprognostic (1.07e-1)" "unprognostic (4.39e-2)" "unprognostic (5.25e-2)" "unprognostic (1.90e-2)" "unprognostic (8.38e-2)" "unprognostic (3.19e-2)" "unprognostic (9.92e-2)" "unprognostic (7.46e-2)" "unprognostic (3.61e-2)" "unprognostic (2.49e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.99e-4)" "unprognostic (3.60e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" 11.7 25.6 7.2 7.8 9.0 7.6 5.6 4.4 5.3 8.2 134.7 8.5 7.5 10.0 3.6 22.2 5.7 8.4 12.5 10.0 4.8 6.0 7.9 15.9 7.9 10.4 9.6 2.2 6.6 4.9 13.2 4.0 84.5 15.0 10.4 8.5 2.8 6.1 7.0 4.6 2.8 6.1 9.9 3.2 13.6 12.1 6.5 15.2 2.7 15.6 7.4 6.7 7.7 6.4 8.9 21.9 13.5 3.6 26.6 3.7 8.0 15.3 18.0 27.2 7.7 9.6 23.9 9.5 1.2 47.5 51.7 5.4 6.5 2.0 17.9 9.1 18.1 8.5 35.5 14.7 14.0 6.1 9.1 10.5 11.2 9.8 7.7 24.9 11.8 47.0 6.7 10.2 0.1 12.4 24.0 1.3 2.1 26.8 7.7 3.8 3.3 26.3 0.2 9.3 19.2 5.2 5.2 20.0 26.1 0.3 13.4 9.8 13.1 82.2 34.9 18.2 15.2 11.8 0.2 0.1 0.3 8.6 9.5 3.2 6.0 3.5 6.7 3.3 2.5 12.3 0.4 4.0 4.4 3.3 0.2 2.4 1.6 1.8 3.5 2.7 3.2 5.5 1.9 7.2 9.0 4.4 5.3 10.0 4.8 10.4 9.6 2.2 15.0 3.2 15.2 8.9 160.9 214.7 94.5 41.4 11.7 24.2 16.0 19.5 47.3 37.0 14.2 13.8 71.8 32.9 73.2 22.0 2.1 84.7 27.5 58.9 13.7 30.5 10.1 49.6 43.7 158.6 21.6 32.8 55.2 22.5 49.8 144.8 54.6 64.7 38.7 34.9 157.1 27.6 35.4 101.0 133.8 19.2 24.4 121.1 40.2 23.2 103.2 52.5 24.9 77.8 71.7 10.3 15.5 5.5 20.9 49.4 22.3 120.0 10.6 63.3 20.2 24.8 51.1 3.0 98.6 95.9 83.5 3.1 2.3 33.0 17.2 52.5 51.3 127.9 26.3 30.9 EPM2A "LD, LDE" ENSG00000112425 "EPM2A glucan phosphatase, laforin" O95278 6 145382535-145736023 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.5;tongue: 80.2" "Cell type enhanced" "Detected in many" "Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 23.2" "Low region specificity" "Detected in all" "HPA053643, HPA055468" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053643: AB_2797247, HPA055468: AB_2797252" "unprognostic (2.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.34e-3)" "unprognostic (2.92e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (1.52e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.08e-7)" "unprognostic (4.12e-4)" "unprognostic (2.17e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" 5.8 6.0 13.8 1.5 14.1 1.8 3.3 14.5 16.3 3.1 9.3 12.4 3.2 6.0 4.3 9.4 4.5 3.6 24.6 14.2 13.2 8.6 5.7 3.0 3.3 14.2 13.4 13.0 5.8 2.4 5.2 3.9 1.5 13.7 6.2 2.9 12.2 3.2 8.8 77.5 2.1 3.8 6.4 12.5 2.1 5.3 3.0 13.5 4.9 4.0 80.2 2.6 9.8 2.7 15.7 1.3 2.1 3.4 6.6 8.6 2.3 1.6 3.1 3.8 2.9 3.5 1.7 1.7 23.2 2.7 3.8 3.5 1.8 1.3 1.6 2.6 9.3 1.9 3.6 2.5 2.7 4.8 12.7 2.4 2.0 7.0 1.7 0.7 3.8 2.0 5.0 1.8 5.4 3.8 3.1 8.4 3.2 3.9 3.2 1.9 4.8 3.1 6.7 2.5 1.8 6.3 6.4 5.5 3.3 7.8 3.1 1.9 7.3 4.6 2.9 1.1 2.7 2.6 4.1 4.6 8.6 2.6 2.8 4.8 0.0 0.0 0.0 0.1 0.5 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.9 0.1 1.9 0.1 0.3 0.0 0.3 13.8 14.1 14.5 16.3 14.2 13.2 14.2 13.4 13.0 13.7 12.5 13.5 15.7 3.9 6.4 1.5 66.9 4.4 0.9 1.0 0.8 0.6 8.4 3.5 2.2 27.8 2.8 2.2 1.8 6.2 1.0 1.9 0.2 11.7 1.0 33.0 1.9 3.6 2.2 1.2 4.4 30.4 2.3 0.7 2.3 1.1 1.4 2.5 6.0 1.4 6.6 2.3 30.3 50.7 1.5 2.0 3.3 1.4 19.8 3.1 3.1 7.2 15.9 1.7 7.9 2.1 56.8 60.1 1.2 1.7 2.2 1.7 1.5 0.5 7.1 2.2 6.3 0.0 6.2 2.4 4.9 1.6 0.8 0.4 0.4 1.8 5.1 1.2 0.3 OR12D3 hs6M1-27 ENSG00000112462 "Olfactory receptor family 12 subfamily D member 3" Q9UGF7 6 29373423-29375291 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC39A7 "D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7" ENSG00000112473 "Solute carrier family 39 member 7" Q92504 6 33200445-33204439 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053999 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053999: AB_2682338" "unprognostic (3.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (3.24e-2)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (4.87e-2)" "unprognostic (9.92e-2)" "unprognostic (7.20e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.80e-1)" "unprognostic (1.50e-1)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" 51.6 74.3 2.0 3.6 2.1 2.4 51.6 2.3 2.3 49.1 4.5 56.6 7.2 61.3 8.7 47.4 44.8 5.8 56.8 1.8 2.5 45.4 75.6 65.5 3.0 3.0 2.2 1.7 41.2 99.5 12.9 74.7 8.3 2.9 56.3 8.8 1.9 91.7 7.5 31.7 37.4 59.0 8.4 2.5 48.1 71.9 29.2 2.7 2.8 67.7 2.9 4.4 42.7 41.6 4.5 10.7 9.6 8.6 8.2 25.8 15.9 13.2 17.8 25.3 23.1 23.1 16.7 6.6 5.1 11.9 22.9 12.4 7.5 8.3 14.5 9.7 16.6 10.1 9.4 10.0 25.1 18.2 10.0 30.7 16.0 13.6 15.1 20.6 13.5 11.7 8.3 15.5 7.7 10.2 9.8 4.3 7.4 8.1 23.2 9.9 5.7 6.8 12.2 14.0 5.8 6.8 5.1 8.6 37.2 13.2 5.4 25.0 10.3 10.9 13.1 17.4 8.2 9.8 18.3 15.1 3.9 7.5 8.7 15.0 2.2 1.8 2.0 3.3 1.1 4.4 1.2 2.0 1.2 0.7 1.2 1.8 1.7 0.8 2.1 1.0 1.3 1.0 1.5 2.0 2.1 2.3 2.3 1.8 2.5 3.0 2.2 1.7 2.9 2.5 2.7 4.5 40.0 25.6 34.8 7.2 23.4 36.1 29.4 53.6 19.4 27.4 36.7 18.5 33.1 34.3 54.7 25.8 29.2 103.0 22.9 75.5 5.9 73.8 0.8 26.9 47.3 40.9 25.3 28.4 4.3 86.1 129.1 64.4 66.8 53.7 20.8 29.5 28.2 34.4 42.9 11.8 5.9 135.1 48.8 14.8 35.3 2.7 46.0 22.1 40.9 5.6 23.7 42.9 24.7 8.5 8.3 67.8 54.9 42.9 91.6 60.2 56.0 25.9 28.3 26.8 19.7 35.4 43.0 9.4 11.5 26.0 40.9 168.7 23.1 69.2 61.7 51.3 CCR6 "BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22" ENSG00000112486 "C-C motif chemokine receptor 6" P51684 6 167111807-167139696 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.1" "Group enriched" "Detected in many" 4 "B-cells: 44.0;Late spermatids: 26.4;T-cells: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 77.4;T-cells: 74.5" "Group enriched" "Detected in some" 6 "Hep G2: 9.4;OE19: 3.2" "Region enriched" "Detected in single" 7 "basal ganglia: 1.8" "Not detected" "Not detected" "CAB006820, HPA014488" Approved NA NA "CAB006820: , HPA014488: AB_1846639" "unprognostic (1.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.07e-3)" "unprognostic (2.08e-1)" "unprognostic (8.43e-2)" "unprognostic (2.05e-4)" "unprognostic (2.39e-1)" "unprognostic (4.98e-3)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (4.19e-2)" "unprognostic (4.26e-2)" "unprognostic (2.68e-4)" "unprognostic (3.74e-2)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" 0.5 0.2 0.5 11.5 0.6 2.5 2.2 0.2 0.7 0.9 0.2 1.9 2.8 0.4 0.6 1.4 0.6 2.1 0.1 0.6 0.3 0.5 0.6 1.2 18.2 0.4 0.3 0.7 0.2 0.1 0.1 0.0 0.1 0.4 1.0 2.2 1.4 0.6 0.3 0.1 2.4 6.7 0.4 0.2 12.6 3.7 2.7 0.5 3.6 0.6 0.1 36.1 4.4 0.0 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.8 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.3 0.0 0.2 9.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.2 0.0 0.1 0.1 0.1 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.0 0.1 0.4 0.3 0.2 0.4 4.5 0.0 74.5 69.0 30.7 11.6 17.5 77.4 0.3 0.2 0.7 1.5 0.1 2.1 58.7 6.9 0.5 0.6 0.2 0.7 0.6 0.3 0.4 0.3 0.7 0.4 0.2 0.5 0.5 0.7 0.0 4.2 1.0 44.0 1.0 0.3 0.0 0.0 0.8 2.1 1.1 0.0 0.0 1.9 0.0 2.1 0.1 3.0 0.0 1.9 0.2 8.6 0.8 0.3 1.0 0.0 0.4 1.8 0.2 0.0 0.9 4.1 0.3 2.5 0.2 1.1 0.8 0.1 0.0 1.1 2.0 0.0 0.0 7.3 26.4 0.0 5.5 1.8 0.0 3.7 0.5 0.0 1.0 0.3 0.1 0.1 0.4 5.5 0.2 4.6 0.4 0.9 3.8 0.0 0.7 0.5 2.2 0.4 0.1 0.4 0.1 40.1 0.1 0.8 0.1 UNC93A "dJ366N23.1, dJ366N23.2" ENSG00000112494 "Unc-93 homolog A" Q86WB7 6 167271169-167316014 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "esophagus: 5.1;intestine: 9.7;liver: 14.2;skin 1: 17.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 11.0;Endometrial ciliated cells: 2.5;Erythroid cells: 2.7;Hepatocytes: 6.9;Intestinal goblet cells: 2.4;Proximal enterocytes: 3.4" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 7.4;Hep G2: 3.1;OE19: 7.5;SCLC-21H: 3.1" "Not detected" "Not detected" HPA035729 Uncertain NA NA "HPA035729: AB_10696508" "unprognostic (2.49e-1)" "unprognostic (2.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.28e-1)" "unprognostic (2.28e-1)" "unprognostic (2.26e-1)" "unprognostic (2.32e-1)" "unprognostic (2.10e-1)" "unprognostic (3.32e-3)" "unprognostic (2.99e-2)" "unprognostic (5.97e-3)" "unprognostic (1.85e-1)" "unprognostic (4.92e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.2 9.7 0.2 0.5 5.1 1.1 0.9 0.0 0.0 0.0 1.1 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 17.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.4 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 6.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 SLC22A2 OCT2 ENSG00000112499 "Solute carrier family 22 member 2" O15244 6 160171061-160277638 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "kidney: 155.3" "Group enriched" "Detected in some" 13 "Distal tubular cells: 92.0;Proximal tubular cells: 198.3" "Cancer enriched" "Detected in single" 493 "renal cancer: 30.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 1.9" "HPA008549, CAB068236, CAB068237" Enhanced NA NA "CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: " "unprognostic (1.01e-1)" "unprognostic (3.67e-1)" "unprognostic (2.26e-1)" "unprognostic (3.67e-2)" "unprognostic (4.24e-1)" "unprognostic (3.33e-1)" "unprognostic (2.51e-2)" "unprognostic (3.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.15e-4)" "unprognostic (1.41e-1)" "unprognostic (3.68e-1)" "prognostic favorable (1.85e-7)" "unprognostic (1.65e-2)" "unprognostic (8.20e-2)" "unprognostic (4.11e-1)" "unprognostic (2.45e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.3 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 155.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.0 0.0 0.1 1.4 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.0 0.0 0.0 0.0 0.1 92.0 0.6 7.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 198.3 0.0 0.0 0.0 1.0 0.6 0.1 0.3 0.0 0.3 0.1 1.4 0.0 0.0 0.0 PHF1 "MTF2L2, PCL1, TDRD19C" ENSG00000112511 "PHD finger protein 1" O43189 6 33410399-33416453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 25.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031038 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031038: AB_10671365" "unprognostic (1.96e-3)" "unprognostic (4.77e-2)" "prognostic unfavorable (9.64e-5)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (2.43e-3)" "unprognostic (2.31e-2)" "unprognostic (8.87e-3)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (2.42e-3)" "unprognostic (4.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "prognostic favorable (1.72e-4)" 34.1 32.1 0.4 4.7 0.3 11.3 37.9 0.3 1.1 63.4 0.5 41.6 5.9 52.2 18.3 19.6 58.3 4.2 39.5 0.4 1.0 38.4 22.9 41.5 6.4 0.7 0.3 0.2 90.4 41.8 2.1 77.2 1.8 0.4 50.3 2.3 6.1 33.1 4.2 42.5 25.1 38.9 2.6 0.4 47.7 40.0 70.8 2.1 5.5 58.9 13.2 10.4 49.5 41.0 0.7 1.4 2.0 4.5 2.8 1.9 1.1 10.3 3.1 4.8 2.5 2.6 2.8 1.3 0.5 2.0 7.4 25.9 0.4 0.9 1.6 0.6 1.8 0.9 4.3 3.6 1.2 0.3 2.5 20.0 2.2 2.0 4.6 4.0 3.3 1.5 1.4 1.7 3.6 1.9 1.1 0.8 1.5 1.9 0.4 1.4 1.8 0.6 1.5 0.3 1.9 2.9 3.3 1.6 1.6 2.6 1.0 1.2 3.0 3.0 4.5 1.2 2.7 3.4 2.9 4.5 8.3 3.3 2.6 2.7 0.2 0.2 1.0 0.7 0.2 2.1 0.6 1.6 1.9 0.3 0.9 1.6 0.9 1.5 0.7 0.2 0.1 0.6 0.7 0.4 0.3 0.3 1.1 0.4 1.0 0.7 0.3 0.2 0.4 0.4 2.1 0.7 32.9 19.2 24.8 19.2 70.5 33.9 89.0 26.8 34.1 74.4 36.0 37.1 19.6 15.7 20.5 23.9 37.5 16.9 53.3 16.7 35.2 13.1 153.8 14.9 15.3 29.9 12.0 3.8 19.1 17.9 16.3 32.6 15.3 20.3 69.2 21.4 33.2 7.6 11.8 45.4 30.3 16.0 34.6 14.1 43.1 88.6 43.2 20.9 37.4 13.1 11.4 34.7 27.8 26.2 18.0 17.9 14.5 41.0 54.8 59.0 29.6 22.9 22.1 73.6 78.9 28.9 42.3 80.9 51.2 15.9 24.0 37.5 71.4 19.1 10.1 75.1 CUTA "ACHAP, C6orf82" ENSG00000112514 "CutA divalent cation tolerance homolog" O60888 6 33416442-33418317 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016787, HPA064369" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 26000000 "Plasma membrane, Focal adhesion sites" "CAB016787: , HPA064369: AB_2685248" "unprognostic (7.03e-2)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (8.91e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.98e-2)" "prognostic favorable (8.50e-4)" "unprognostic (1.87e-1)" "unprognostic (2.78e-2)" "unprognostic (1.27e-3)" "unprognostic (1.91e-1)" "unprognostic (5.55e-2)" "unprognostic (9.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (2.74e-1)" 121.3 270.2 155.9 60.9 166.9 94.7 133.5 164.7 178.6 158.5 185.3 155.0 105.4 160.1 186.4 107.3 145.6 95.9 149.3 161.0 170.6 201.8 219.6 119.3 99.8 165.3 157.5 156.7 195.4 187.9 178.7 349.3 82.2 169.7 155.1 71.9 60.8 180.7 114.0 143.9 148.2 130.2 80.8 162.7 148.3 179.0 74.8 160.2 83.5 203.3 90.0 83.2 129.2 123.0 174.3 244.5 142.0 242.7 293.8 177.6 173.9 109.7 224.0 430.1 433.1 462.7 147.5 154.1 166.1 162.2 269.1 316.0 152.4 154.5 231.3 248.9 153.2 295.1 171.8 228.9 397.0 226.3 134.2 135.9 224.7 195.8 209.8 179.8 303.7 118.8 180.9 212.9 348.7 325.1 187.2 222.0 305.1 213.8 222.6 187.5 235.9 141.8 456.4 310.1 112.3 451.7 225.4 136.2 231.3 425.8 135.5 170.8 308.7 121.3 222.6 190.0 166.5 229.8 341.7 363.9 189.5 202.9 304.9 189.3 207.8 179.2 103.6 225.8 138.1 335.1 315.7 360.7 274.6 163.6 266.5 366.5 279.2 25.6 306.9 97.2 120.0 421.9 400.4 155.9 166.9 164.7 178.6 161.0 170.6 165.3 157.5 156.7 169.7 162.7 160.2 174.3 109.5 131.4 119.3 14.0 209.5 230.6 287.9 424.5 266.9 92.6 401.0 488.6 138.2 237.4 239.7 316.3 68.8 361.6 186.2 154.0 283.7 188.3 85.4 181.8 177.9 114.7 292.1 111.7 13.0 141.0 235.5 181.4 105.5 156.8 169.9 122.6 134.2 340.1 328.6 77.4 17.4 320.1 360.1 167.1 197.1 345.2 200.0 139.2 316.6 10.3 140.0 179.7 216.3 14.1 31.2 113.3 223.9 191.5 375.7 243.3 306.6 559.1 229.5 85.9 92.1 131.1 226.7 111.0 106.4 203.5 230.4 242.9 242.4 217.8 341.3 268.4 PACRG "FLJ32724, Glup, HAK005771, PARK2CRG" ENSG00000112530 "Parkin coregulated" Q96M98 6 162727132-163315492 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.1;testis: 29.7" "Cell type enhanced" "Detected in many" "Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066293 Enhanced NA NA "HPA066293: AB_2685652" "unprognostic (3.06e-2)" "unprognostic (1.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.34e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (8.35e-2)" "unprognostic (2.93e-3)" 0.8 2.6 15.7 1.1 14.7 5.8 2.0 5.5 13.1 2.4 11.0 1.2 1.4 5.4 9.8 3.0 36.1 5.1 13.1 11.5 17.0 10.0 4.8 3.8 1.4 13.3 11.2 10.5 4.2 4.3 2.0 23.8 0.4 11.0 3.5 2.5 7.6 2.2 3.6 2.2 4.7 0.8 2.1 9.1 1.8 2.3 29.7 11.8 0.7 4.1 1.3 1.0 4.5 0.9 23.3 0.5 1.7 0.7 1.0 0.0 0.6 1.2 0.4 1.6 0.0 0.3 3.5 0.4 3.2 0.4 0.0 0.3 1.4 0.8 0.0 1.7 0.0 1.1 0.0 1.9 0.0 0.0 0.4 0.5 1.0 0.0 0.5 0.0 0.6 0.0 1.1 0.5 0.7 0.3 0.1 0.2 1.2 0.0 2.8 2.9 0.6 0.0 0.0 3.6 3.6 6.9 3.1 0.0 0.0 0.0 0.2 0.0 1.1 1.2 0.7 0.3 0.0 0.2 1.3 0.5 1.2 0.3 0.8 1.3 2.3 0.7 0.7 0.7 0.2 0.5 0.3 1.1 0.4 0.1 0.6 1.4 0.6 2.5 0.0 0.1 0.5 0.5 0.2 15.7 14.7 5.5 13.1 11.5 17.0 13.3 11.2 10.5 11.0 9.1 11.8 23.3 0.3 0.0 1.7 61.0 0.1 0.3 4.2 8.7 2.8 1.3 1.3 3.0 41.0 0.0 8.9 5.5 8.4 0.1 0.0 0.1 54.8 3.4 310.9 67.0 3.1 1.2 6.6 0.0 124.3 7.1 0.1 1.2 0.0 1.9 0.0 0.7 0.7 3.9 0.1 0.0 174.9 0.3 10.2 0.6 0.3 369.8 3.7 0.4 0.0 11.2 0.0 6.0 0.0 59.3 20.0 1.6 1.2 2.6 0.1 3.2 0.0 6.3 118.4 8.1 0.0 1.1 2.2 53.4 6.1 1.1 0.3 0.3 0.3 2.9 0.4 2.7 QKI QK3 ENSG00000112531 "QKI, KH domain containing RNA binding" Q96PU8 6 163414000-163578592 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport" "Developmental protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 640.9" "Cell type enhanced" "Detected in many" "Astrocytes: 1140.0;Microglial cells: 713.0;Oligodendrocyte precursor cells: 1421.0;Oligodendrocytes: 4573.8" "Cancer enriched" "Detected in all" 6 "glioma: 42.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 250.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019123, CAB022602" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022602: , HPA019123: AB_1855980" "unprognostic (2.42e-1)" "unprognostic (5.81e-2)" "unprognostic (1.31e-1)" "unprognostic (1.06e-2)" "unprognostic (8.57e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.34e-1)" "unprognostic (7.06e-2)" "unprognostic (1.76e-3)" "unprognostic (1.08e-1)" "unprognostic (5.15e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.16e-1)" "unprognostic (3.86e-1)" "unprognostic (4.09e-2)" 77.0 24.5 190.7 37.1 407.8 70.4 28.0 345.6 246.1 29.4 18.5 17.9 7.9 28.7 8.8 34.7 25.6 34.1 150.7 191.7 277.3 22.9 41.5 56.4 27.7 384.8 368.0 97.7 38.5 16.2 15.1 6.9 53.5 419.8 15.5 16.8 27.2 15.4 22.5 158.5 18.8 12.0 46.7 347.2 40.2 12.2 47.7 331.6 28.8 22.3 224.1 25.5 38.6 16.5 640.9 17.8 72.0 250.8 83.7 74.3 81.9 58.4 46.8 109.0 74.5 89.4 49.3 15.8 21.3 38.6 117.2 50.8 25.9 134.4 48.4 120.2 43.7 43.3 83.4 38.4 55.3 90.4 44.8 24.9 96.8 19.5 80.0 125.8 72.4 104.4 30.9 124.3 48.2 48.6 32.8 30.1 9.5 32.4 17.3 36.0 45.9 156.5 42.3 40.5 54.4 5.2 28.7 49.9 26.7 19.2 101.2 10.5 71.8 107.2 51.3 42.7 55.9 86.1 30.9 40.9 26.3 44.2 38.7 122.8 3.6 7.1 3.4 1.8 4.7 3.0 1.2 1.3 1.6 3.7 1.2 1.1 2.0 9.2 6.3 5.1 6.2 1.0 1.1 190.7 407.8 345.6 246.1 191.7 277.3 384.8 368.0 97.7 419.8 347.2 331.6 640.9 180.6 150.6 51.5 1140.0 35.4 153.7 34.1 25.3 43.9 60.4 42.8 47.2 355.5 37.1 30.5 20.2 58.4 51.1 77.7 0.2 21.5 21.8 53.0 60.7 156.7 130.0 0.0 40.4 58.4 12.0 51.3 92.2 10.2 71.1 60.9 64.8 131.0 72.9 86.8 32.0 471.4 0.0 14.2 221.9 188.0 102.5 86.6 165.7 113.8 713.0 107.9 113.5 32.0 1421.0 4573.8 19.8 0.1 98.6 34.4 46.5 0.0 33.2 23.7 31.5 46.0 197.7 83.5 46.1 19.7 47.4 136.1 55.1 32.2 69.9 0.2 46.4 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309605 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 9.1;choroid plexus: 25.4;fallopian tube: 16.6;testis: 7.1" "Cell type enhanced" "Detected in some" "Early spermatids: 145.5;Endometrial ciliated cells: 140.4;Late spermatids: 57.6;Respiratory ciliated cells: 243.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 2.7;SCLC-21H: 1.6" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria NA NA Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.0 0.0 8.7 0.0 2.5 0.0 0.0 3.0 1.2 0.4 25.4 0.0 0.0 0.5 0.0 0.0 16.6 0.0 0.0 4.5 7.1 0.0 0.0 2.1 0.0 6.6 8.8 0.6 0.0 0.0 0.0 1.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 7.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.2 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.5 3.0 1.2 4.5 7.1 6.6 8.8 0.6 5.3 9.1 3.5 4.1 0.0 0.0 1.5 0.3 0.0 0.0 0.2 6.6 0.0 0.0 0.0 0.1 0.4 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.5 140.4 1.4 0.1 0.0 0.0 0.4 0.0 0.0 1.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 10.2 0.0 0.0 57.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 243.9 0.0 0.0 0.0 1.8 16.8 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 PDE10A ENSG00000112541 "Phosphodiesterase 10A" Q9Y233 6 165327287-165988078 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 51.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 204.7;Inhibitory neurons: 209.6;Microglial cells: 89.0;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 51.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 51.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 9.0;LHCN-M2: 12.5;RT4: 6.9;SH-SY5Y: 8.1;TIME: 11.3;U-2 OS: 7.0" "Region enriched" "Detected in all" 11 "basal ganglia: 350.1" "Region enriched" "Detected in all" 5 "basal ganglia: 194.1" "CAB045998, HPA047200" Supported NA NA "CAB045998: AB_2162589, HPA047200: AB_2679981" "unprognostic (1.02e-1)" "unprognostic (3.63e-2)" "unprognostic (3.58e-2)" "unprognostic (2.91e-1)" "unprognostic (1.20e-1)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (6.03e-2)" "unprognostic (3.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (4.44e-7)" "unprognostic (3.59e-3)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (5.90e-3)" 2.1 1.3 2.9 0.8 51.3 0.0 2.3 5.5 8.5 1.3 0.0 0.8 0.2 2.0 2.4 0.4 2.4 1.5 2.7 1.9 7.7 3.8 0.3 1.0 0.5 10.7 2.7 1.9 2.3 0.5 0.5 2.7 2.5 13.4 1.7 0.2 1.9 0.4 1.7 0.4 0.3 0.7 2.1 0.5 1.4 1.2 3.4 8.5 0.3 6.1 0.5 0.4 3.2 0.9 2.0 0.0 2.4 5.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.8 0.0 0.0 0.0 3.8 0.1 2.2 0.0 0.0 0.1 3.9 0.0 9.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.5 0.0 0.0 0.0 12.5 0.3 0.9 0.0 1.1 0.0 4.7 1.5 5.8 0.0 5.9 6.9 1.8 8.1 0.0 0.0 0.4 0.7 0.0 0.0 11.3 0.1 7.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 51.3 5.5 8.5 1.9 7.7 10.7 2.7 1.9 13.4 0.5 8.5 2.0 13.8 0.0 0.0 10.4 0.1 0.4 3.3 0.4 0.0 7.2 0.3 0.3 7.3 0.0 1.2 5.5 2.1 7.8 0.0 0.0 3.9 2.0 14.3 0.2 1.7 13.4 0.0 0.0 204.7 0.0 6.1 6.6 1.1 0.4 1.3 0.1 7.9 0.0 0.8 16.8 209.6 0.0 0.0 0.0 0.0 14.9 0.0 0.2 1.8 89.0 0.0 12.6 0.0 48.7 51.8 0.1 0.0 0.4 0.0 17.9 0.0 7.2 0.9 1.1 0.0 12.4 5.0 8.8 2.1 0.1 0.3 2.9 0.1 1.6 0.1 6.9 MDFI I-mfa ENSG00000112559 "MyoD family inhibitor" Q99750 6 41636882-41654244 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 221.7;Extravillous trophoblasts: 113.7;Pancreatic endocrine cells: 134.9;Syncytiotrophoblasts: 138.7;Urothelial cells: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 80.5;HBEC3-KT: 117.2;OE19: 100.0;REH: 315.3" "Region enriched" "Detected in many" 7 "cerebellum: 17.0" "Low region specificity" "Detected in all" HPA049973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA049973: AB_2680975" "unprognostic (9.74e-3)" "unprognostic (4.25e-2)" "unprognostic (6.82e-2)" "unprognostic (6.26e-3)" "unprognostic (9.18e-2)" "unprognostic (1.07e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.32e-5)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.66e-1)" "unprognostic (3.27e-2)" "unprognostic (4.04e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.66e-2)" "unprognostic (6.06e-2)" "unprognostic (1.57e-1)" "unprognostic (8.22e-2)" 33.1 4.3 4.5 5.7 4.4 0.2 23.3 3.7 5.9 20.0 5.0 2.4 1.8 5.9 1.2 45.0 10.1 12.9 5.4 3.3 3.6 5.1 1.5 18.8 1.7 8.0 4.8 2.7 15.7 3.3 1.6 9.2 11.1 5.4 14.5 0.4 0.1 22.5 2.2 0.9 15.1 3.2 2.6 3.4 0.3 4.6 5.0 4.2 1.5 4.6 1.1 2.5 13.7 27.3 4.3 60.1 0.2 50.4 0.1 0.1 0.0 80.5 0.0 0.0 0.0 0.0 0.0 28.2 0.1 18.2 0.0 0.3 48.4 13.8 117.2 0.0 0.0 0.0 0.4 0.0 2.5 2.2 0.0 0.3 3.6 53.3 0.6 24.6 0.0 38.4 16.1 0.2 0.3 0.0 0.0 41.8 0.4 34.4 100.0 1.6 315.3 29.6 0.5 3.3 9.2 9.4 23.2 0.6 43.1 0.0 34.5 0.2 4.0 40.3 0.1 44.1 0.5 1.7 0.1 0.3 0.1 0.3 2.8 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.4 3.7 5.9 3.3 3.6 8.0 4.8 2.7 5.4 3.4 4.2 4.3 1.8 0.0 0.0 0.0 0.0 24.5 48.6 36.8 12.0 0.5 18.9 16.9 0.9 0.0 8.2 5.5 0.0 221.7 0.2 0.4 0.0 33.8 0.5 0.5 1.7 12.7 0.0 0.0 0.1 51.2 113.7 12.8 0.0 0.7 0.0 10.0 7.9 0.1 19.6 0.0 0.3 1.2 6.1 0.0 4.5 0.5 39.1 0.4 0.0 2.8 0.6 0.0 0.0 4.5 0.2 134.9 0.0 6.0 0.0 55.6 0.0 0.0 3.5 0.0 0.0 19.7 9.1 0.1 7.9 10.7 9.1 138.7 0.6 2.7 0.3 73.5 TFEB "bHLHe35, TCFEB" ENSG00000112561 "Transcription factor EB" P19484 6 41683978-41736259 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.6" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 97.4;Syncytiotrophoblasts: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 16.1;eosinophil: 16.9;intermediate monocyte: 16.3;memory B-cell: 34.2;myeloid DC: 14.7;naive B-cell: 22.6;neutrophil: 47.4;non-classical monocyte: 14.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 60.3;Daudi: 35.8;OE19: 53.1;U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067082 Supported Cytosol NA NA Cytosol "HPA067082: " "unprognostic (3.63e-3)" "unprognostic (1.51e-3)" "unprognostic (1.75e-2)" "unprognostic (4.48e-3)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (4.22e-3)" "unprognostic (1.39e-2)" "unprognostic (4.13e-2)" "prognostic favorable (4.77e-4)" "unprognostic (2.12e-2)" "prognostic favorable (1.06e-5)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (2.46e-1)" "unprognostic (1.31e-2)" 14.1 10.8 17.7 16.9 26.5 8.4 15.2 21.9 20.6 13.5 9.0 22.8 5.9 11.2 1.5 14.9 13.0 7.8 33.9 15.6 19.2 26.8 11.7 18.3 26.3 26.5 26.4 11.4 6.6 13.0 17.9 31.6 14.7 29.1 23.6 4.3 2.3 21.3 7.0 90.6 17.2 34.9 5.7 21.9 57.6 14.5 2.7 22.5 5.0 23.1 41.9 17.3 19.7 15.8 38.5 3.5 3.2 0.6 12.3 3.8 2.5 60.3 5.3 6.9 3.4 2.7 6.9 2.7 35.8 6.8 3.5 2.9 8.7 2.4 4.9 1.0 28.3 4.1 0.1 8.8 12.8 6.8 1.0 4.3 0.7 9.8 4.9 2.6 6.9 4.1 3.3 4.1 7.4 1.0 1.8 2.3 1.2 0.1 53.1 1.6 24.3 0.1 5.0 7.5 2.6 12.8 4.3 4.7 10.5 1.0 3.4 2.3 19.5 7.1 1.5 3.1 0.1 3.0 15.7 2.3 42.1 2.6 15.3 0.9 0.3 16.1 16.9 3.8 16.3 0.9 34.2 1.5 1.8 14.7 22.6 0.4 1.5 47.4 1.7 14.1 2.9 0.6 8.7 17.7 26.5 21.9 20.6 15.6 19.2 26.5 26.4 11.4 29.1 21.9 22.5 38.5 14.5 9.6 9.3 10.1 36.7 14.1 8.2 14.8 5.2 6.1 5.7 5.6 19.2 10.0 6.0 12.9 12.5 50.7 13.8 16.3 21.5 3.7 1.1 11.4 2.6 12.2 13.2 3.2 6.3 6.9 8.3 6.9 6.1 8.0 1.3 0.5 6.4 4.2 26.8 26.9 7.9 10.2 26.4 22.8 13.3 4.2 3.4 19.6 0.0 17.8 20.0 18.4 22.6 11.1 97.4 10.6 18.0 10.9 16.0 7.1 14.1 3.7 7.4 5.2 6.6 13.1 7.8 0.9 1.0 6.4 14.5 120.4 9.1 0.8 8.8 6.3 SMOC2 SMAP2 ENSG00000112562 "SPARC related modular calcium binding 2" Q9H3U7 6 168441151-168673445 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 149.8;Leydig cells: 321.8;Peritubular cells: 769.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.1;EFO-21: 2.8;RPMI-8226: 11.3;RPTEC TERT1: 3.8;SuSa: 9.1" "Region enhanced" "Detected in many" "hippocampal formation: 25.7" "Region enhanced" "Detected in single" "spinal cord: 1.4" "Secreted to extracellular matrix" NA NA 120000 "unprognostic (3.23e-1)" "unprognostic (5.29e-2)" "unprognostic (3.70e-2)" "unprognostic (1.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (4.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.16e-6)" "unprognostic (3.50e-2)" "unprognostic (2.68e-1)" "unprognostic (6.35e-2)" "unprognostic (6.20e-3)" 66.9 14.1 11.5 13.1 12.5 0.0 61.6 10.9 16.3 74.8 38.9 36.1 21.6 165.4 148.5 53.6 120.6 101.7 55.9 10.7 11.2 10.0 4.0 14.8 14.8 11.5 11.7 9.1 125.1 25.4 12.3 4.5 19.0 12.7 31.3 25.2 2.8 17.3 55.1 42.5 24.1 28.0 77.2 10.2 4.5 145.9 44.6 11.8 11.0 43.9 55.3 11.2 69.3 22.0 13.1 2.4 0.0 8.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 1.0 0.0 0.0 0.0 0.0 11.3 3.8 0.0 1.7 0.3 0.0 0.3 0.1 9.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.5 12.5 10.9 16.3 10.7 11.2 11.5 11.7 9.1 12.7 10.2 11.8 13.1 8.1 0.0 1.7 0.7 0.0 11.1 8.0 0.0 1.2 7.1 12.5 12.1 7.7 0.0 1.8 11.0 0.0 2.5 0.0 3.6 0.0 0.0 2.6 40.3 42.3 11.0 19.7 0.0 0.5 0.0 1.7 149.8 1.1 58.4 0.0 17.2 3.3 0.0 1.2 0.0 9.7 4.5 0.0 0.0 3.9 17.2 321.8 2.9 3.6 6.5 0.0 0.4 0.0 2.0 0.1 0.1 0.4 769.2 0.1 6.7 2.0 0.0 2.2 0.8 46.0 14.7 63.3 3.9 5.1 0.8 2.7 2.6 1.7 17.3 47.4 1.1 CCND3 ENSG00000112576 "Cyclin D3" P30281 6 41934934-42050357 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 259.0" "Cell type enhanced" "Detected in all" "NK-cells: 555.1;Syncytiotrophoblasts: 236.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 696.3;REH: 651.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000116, HPA042871" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB000116: , HPA042871: " "unprognostic (4.53e-2)" "unprognostic (4.45e-2)" "unprognostic (2.45e-1)" "unprognostic (4.40e-3)" "unprognostic (1.01e-1)" "unprognostic (9.80e-2)" "unprognostic (3.40e-2)" "unprognostic (5.25e-2)" "unprognostic (7.76e-2)" "unprognostic (3.45e-1)" "unprognostic (9.17e-2)" "unprognostic (6.39e-2)" "unprognostic (2.45e-3)" "unprognostic (9.12e-2)" "unprognostic (1.71e-1)" "prognostic favorable (8.08e-6)" "unprognostic (2.11e-1)" 66.9 138.7 79.3 63.7 78.7 222.1 65.3 74.3 95.3 37.2 71.7 45.7 40.9 35.7 15.4 39.9 43.6 34.8 60.7 80.2 80.4 42.4 22.3 103.3 144.5 82.1 76.3 73.5 36.3 31.9 23.9 33.6 55.9 75.1 50.8 27.2 10.4 50.8 25.8 18.4 49.9 79.1 28.8 72.5 171.7 66.6 11.2 77.9 259.0 59.1 32.8 84.2 45.8 44.7 74.9 67.7 242.2 24.6 54.8 43.7 88.6 286.1 77.1 43.7 77.7 57.1 45.9 29.7 288.9 127.8 51.9 68.9 40.5 65.8 93.4 39.2 49.2 43.4 458.8 106.6 37.3 94.9 75.9 385.2 84.7 59.8 76.0 27.9 23.5 96.6 188.3 236.7 27.2 111.6 92.0 696.3 354.6 10.9 202.8 51.5 651.8 96.3 32.2 179.1 44.9 83.8 21.8 65.8 83.3 38.6 30.6 51.5 288.4 162.9 86.2 47.9 74.7 88.1 17.9 15.2 458.5 50.4 157.6 53.3 1281.3 246.3 725.1 390.4 294.4 276.5 127.1 266.4 318.1 343.3 180.8 306.4 328.3 339.3 333.2 405.6 221.4 193.0 635.4 79.3 78.7 74.3 95.3 80.2 80.4 82.1 76.3 73.5 75.1 72.5 77.9 74.9 102.2 60.9 67.9 31.0 102.9 27.0 95.8 52.3 48.9 19.6 49.9 45.1 26.2 64.3 27.8 20.2 6.2 201.0 227.3 66.4 29.4 20.3 12.8 12.1 10.8 68.3 9.6 133.6 37.1 24.3 82.4 32.3 19.9 11.2 26.6 7.7 70.6 7.2 45.3 11.8 23.7 19.5 50.8 115.7 51.7 9.4 41.3 152.2 37.4 47.8 79.0 40.8 555.1 18.1 9.3 29.9 30.5 51.9 48.7 40.3 18.6 19.8 22.5 16.2 46.0 19.2 31.9 4.3 6.3 21.7 22.6 236.6 195.0 141.6 32.7 52.8 BYSL Enp1 ENSG00000112578 "Bystin like" Q13895 6 41921499-41933046 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031217, HPA031219" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA031217: AB_10599488, HPA031219: AB_10601989" "unprognostic (6.12e-3)" "unprognostic (6.97e-2)" "unprognostic (2.90e-1)" "unprognostic (2.33e-3)" "unprognostic (4.38e-2)" "unprognostic (2.73e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.09e-2)" "unprognostic (2.51e-1)" "unprognostic (6.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.15e-8)" "unprognostic (4.39e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-3)" "unprognostic (5.99e-2)" 10.8 10.2 6.2 8.3 6.2 7.5 8.9 5.8 6.2 6.4 5.8 6.9 4.7 8.3 5.5 9.3 8.6 5.5 7.0 6.1 6.8 5.2 10.8 5.1 8.5 6.3 6.4 6.2 8.1 11.7 6.6 3.6 10.1 6.7 6.9 7.1 2.6 4.9 6.6 20.3 8.0 4.0 12.0 6.2 5.8 5.6 8.0 6.7 12.3 5.3 10.9 13.3 15.6 5.9 6.5 50.6 52.1 30.2 54.2 21.8 25.5 59.7 44.0 21.6 66.7 48.9 72.1 15.7 78.2 43.9 32.9 51.9 34.3 91.6 61.0 58.0 30.1 89.2 72.7 37.3 81.5 38.6 58.8 36.0 30.1 39.5 67.2 62.1 16.9 50.5 47.3 96.1 26.0 48.7 70.8 74.2 68.3 29.0 162.4 50.9 77.9 38.2 57.3 45.2 37.9 65.6 37.4 30.0 37.8 58.2 26.3 38.0 58.6 39.3 49.0 53.5 31.4 77.2 24.6 33.0 185.8 14.5 57.9 49.9 0.0 3.8 0.7 4.3 3.9 5.9 3.8 2.5 3.5 6.0 5.5 1.6 3.3 0.5 6.1 3.0 9.2 3.3 2.3 6.2 6.2 5.8 6.2 6.1 6.8 6.3 6.4 6.2 6.7 6.2 6.7 6.5 6.4 0.0 3.9 0.7 6.7 31.0 34.5 19.2 8.6 2.8 8.6 8.5 2.8 5.7 9.5 1.8 4.2 22.1 4.8 4.6 3.9 21.4 10.4 7.9 12.1 10.9 5.4 6.3 2.8 17.5 24.4 11.4 4.6 9.8 2.5 11.4 3.9 6.8 12.0 0.0 2.5 6.5 12.2 1.0 7.3 6.8 8.1 5.1 8.8 1.9 6.6 4.4 9.2 4.0 2.8 23.5 2.9 7.2 4.9 26.2 2.2 10.5 5.1 3.4 6.6 16.1 13.8 10.8 25.7 14.0 25.3 29.1 4.1 18.2 11.4 32.2 FAM120B "CCPG, KIAA1838, PGCC1, SAN1" ENSG00000112584 "Family with sequence similarity 120B" Q96EK7 6 170290703-170407067 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 556.1;Late spermatids: 1847.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037518, HPA037519" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037518: AB_10671626, HPA037519: AB_10696935" "unprognostic (7.99e-3)" "unprognostic (7.81e-2)" "unprognostic (2.01e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (6.02e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-1)" "unprognostic (9.87e-2)" "prognostic unfavorable (1.60e-4)" "prognostic favorable (2.70e-4)" "unprognostic (1.41e-1)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (2.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" 11.9 12.3 8.6 5.7 8.5 4.5 12.6 10.8 10.9 11.5 9.1 11.1 6.2 12.2 9.0 10.1 12.3 6.1 10.7 7.4 8.2 8.1 8.9 9.4 7.2 9.7 9.7 7.6 11.1 9.7 7.2 11.5 6.7 10.0 11.1 8.7 9.3 13.9 6.3 17.6 12.1 10.2 7.7 7.0 10.2 10.3 14.6 8.4 7.5 9.8 6.9 6.7 11.0 10.5 10.3 7.0 7.1 8.7 12.7 15.4 14.2 6.2 6.4 13.4 8.5 7.2 6.4 5.2 8.0 5.2 14.2 9.2 8.2 11.0 13.1 13.0 9.0 5.2 10.5 6.5 8.4 10.5 10.5 6.5 14.0 11.2 9.2 12.2 14.6 15.7 6.3 9.5 7.8 17.0 13.7 6.3 11.8 5.3 12.5 4.8 6.5 9.8 10.3 10.3 6.2 6.0 9.6 6.2 8.7 2.9 13.0 7.0 20.6 13.4 4.2 6.3 11.3 6.4 6.6 7.3 9.9 11.6 7.4 15.9 16.5 5.9 7.5 5.4 6.4 6.3 4.4 5.1 6.1 6.4 5.3 6.4 5.3 10.0 11.9 10.1 3.5 6.6 6.7 8.6 8.5 10.8 10.9 7.4 8.2 9.7 9.7 7.6 10.0 7.0 8.4 10.3 17.8 22.4 17.6 36.9 13.2 3.6 5.2 11.1 16.5 16.7 13.7 13.6 15.7 11.5 13.0 14.7 33.3 10.5 7.3 11.8 0.0 8.4 556.1 18.8 16.7 15.4 9.6 11.1 48.8 9.1 7.6 13.1 14.3 22.5 10.1 14.1 10.4 10.7 11.0 6.7 53.2 12.5 12.2 9.8 5.6 1847.0 19.3 10.2 19.6 40.3 8.8 7.7 8.2 50.3 62.6 9.2 6.5 14.3 12.0 9.3 10.1 5.4 19.9 14.2 32.9 12.9 10.1 18.4 12.7 10.8 5.8 13.4 13.9 11.2 8.8 6.4 TBP "GTF2D1, SCA17, TFIID" ENSG00000112592 "TATA-box binding protein" P20226 6 170554302-170572870 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009442, HPA049805" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009442: AB_632480, HPA049805: AB_2680890" "unprognostic (2.86e-3)" "unprognostic (1.73e-2)" "unprognostic (3.90e-2)" "unprognostic (4.55e-3)" "unprognostic (7.10e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (1.46e-1)" "unprognostic (4.28e-1)" "unprognostic (1.17e-2)" "unprognostic (1.06e-2)" "unprognostic (1.34e-2)" "unprognostic (1.54e-2)" "unprognostic (8.13e-2)" "unprognostic (2.62e-1)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" 10.1 10.6 10.2 9.7 10.4 15.7 10.5 11.5 15.2 10.3 9.6 11.5 8.6 12.7 8.2 11.4 11.8 8.3 9.0 11.2 10.3 10.3 11.6 9.8 14.1 11.7 10.3 9.3 12.9 11.8 9.4 9.3 10.9 11.1 10.6 8.6 9.0 10.3 7.7 12.9 10.8 12.0 9.7 9.5 15.0 11.8 34.9 10.4 12.0 10.6 10.7 12.3 10.7 10.8 13.0 12.9 14.0 24.4 31.2 12.5 14.2 23.0 20.5 15.6 19.9 21.1 28.9 12.7 27.1 16.4 16.7 28.6 18.9 31.6 16.8 21.2 31.5 23.2 27.6 16.6 26.1 18.1 32.7 23.1 13.8 19.2 22.9 25.8 16.3 15.9 37.2 49.7 16.5 18.3 19.3 32.8 31.8 24.5 27.3 11.0 28.6 20.0 23.8 14.5 6.5 10.4 24.9 24.1 17.8 16.0 20.7 12.4 40.7 17.6 13.5 19.1 22.2 32.0 24.4 35.1 42.3 18.5 27.0 21.9 67.4 30.8 39.8 37.8 32.2 44.4 52.9 36.7 38.6 30.2 49.9 47.3 40.0 44.4 35.0 45.4 42.6 37.2 21.8 10.2 10.4 11.5 15.2 11.2 10.3 11.7 10.3 9.3 11.1 9.5 10.4 13.0 8.4 9.6 6.9 6.8 16.5 5.5 5.3 11.6 20.5 7.5 8.3 7.4 9.9 15.7 10.0 12.9 8.4 15.8 10.5 6.2 3.9 6.6 26.9 7.8 9.3 9.5 7.2 17.5 13.7 4.7 13.5 9.2 7.7 10.7 1.3 13.0 13.2 8.0 10.1 0.0 12.8 7.5 22.4 14.0 5.3 7.7 10.8 9.8 1.8 10.3 8.5 5.4 6.2 11.1 16.2 6.6 7.9 10.5 18.7 8.5 8.2 8.9 7.2 6.7 13.1 6.6 11.1 88.1 17.4 18.3 6.7 13.5 11.1 10.1 8.0 6.7 GUCA1B "GCAP2, RP48" ENSG00000112599 "Guanylate cyclase activator 1B" Q9UMX6 6 42183284-42194956 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 96 "retina: 470.1" "Group enriched" "Detected in some" 4 "Astrocytes: 23.2;Cone photoreceptor cells: 83.4;Oligodendrocytes: 28.2;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 4.3;U-698: 3.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055479 Enhanced NA NA "HPA055479: AB_2732598" "unprognostic (1.61e-1)" "unprognostic (3.28e-1)" "unprognostic (1.14e-6)" "unprognostic (5.39e-2)" "unprognostic (1.73e-2)" "unprognostic (2.87e-3)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (5.57e-1)" "unprognostic (1.66e-1)" "unprognostic (1.72e-2)" "unprognostic (3.28e-7)" "unprognostic (4.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-2)" "unprognostic (2.59e-3)" 1.2 0.9 3.6 0.8 3.8 1.3 1.4 4.0 3.9 2.2 2.5 1.2 0.4 1.9 1.0 0.8 2.3 0.2 1.4 3.4 3.2 1.0 1.9 1.1 0.7 3.5 3.5 3.5 2.7 0.9 0.2 1.1 0.4 3.8 1.5 0.5 470.1 1.1 0.5 2.6 2.8 1.4 1.0 3.3 2.1 0.8 2.6 3.6 1.0 1.0 0.9 0.9 1.1 1.4 4.9 0.1 0.6 1.3 0.5 1.0 0.9 0.3 0.5 0.8 0.8 0.7 1.1 0.4 1.6 0.8 0.1 0.2 0.4 1.4 0.2 1.4 1.3 0.6 0.4 0.1 0.2 0.4 1.5 0.5 0.3 4.3 0.8 1.1 0.4 0.1 1.2 1.0 1.5 0.2 1.3 0.6 1.0 0.0 0.3 0.3 0.2 0.8 0.1 0.8 0.5 0.6 0.9 0.0 0.2 0.1 0.2 0.1 0.9 0.0 0.2 1.7 0.6 0.7 2.7 1.3 3.9 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 3.6 3.8 4.0 3.9 3.4 3.2 3.5 3.5 3.5 3.8 3.3 3.6 4.9 0.2 0.0 0.0 23.2 0.0 0.3 0.1 0.0 0.0 4.0 0.2 0.1 0.3 0.0 0.0 0.0 83.4 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.3 0.3 0.0 0.0 8.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 6.7 11.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.8 2.8 0.1 8.1 0.0 11.6 28.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 53.0 0.0 0.5 0.4 0.5 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 PRPH2 "CACD2, rd2, RDS, RP7, TSPAN22" ENSG00000112619 "Peripherin 2" P23942 6 42696598-42722597 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Cone-rod dystrophy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "retina: 647.0" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5" "Region enriched" "Detected in single" 7 "hippocampal formation: 2.4" "Not detected" "Not detected" HPA029458 Enhanced NA NA "HPA029458: AB_10602193" "unprognostic (2.37e-1)" "unprognostic (4.88e-2)" "unprognostic (6.67e-2)" "unprognostic (8.43e-2)" "unprognostic (1.15e-1)" "unprognostic (2.87e-3)" "unprognostic (4.73e-1)" "unprognostic (1.85e-1)" "unprognostic (6.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.18e-2)" "unprognostic (7.07e-4)" "unprognostic (1.13e-3)" "unprognostic (1.59e-1)" "unprognostic (8.42e-2)" "unprognostic (8.96e-3)" 0.8 0.8 1.7 0.5 1.6 0.0 0.5 0.6 1.7 1.9 0.2 2.0 0.4 2.1 1.9 0.7 1.3 1.1 1.2 3.3 2.0 0.7 0.2 1.5 0.1 1.0 3.6 1.9 3.1 2.3 4.3 2.5 0.9 1.5 1.6 0.8 647.0 0.7 1.1 13.4 0.3 1.5 1.9 0.5 0.8 1.3 3.7 2.0 0.2 4.1 2.9 0.1 1.2 1.1 2.4 0.0 0.0 0.0 0.0 3.0 3.4 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 7.8 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.2 0.0 0.1 0.0 1.7 1.6 0.6 1.7 3.3 2.0 1.0 3.6 1.9 1.5 0.5 2.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 39.3 0.1 0.0 0.9 0.0 0.1 0.0 260.6 0.1 0.0 0.0 3.9 0.3 0.2 0.1 0.9 2.3 0.0 0.0 2.3 0.2 0.0 1.3 0.0 0.1 0.0 0.2 0.4 0.2 0.0 11.8 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.9 0.0 42.6 1.0 0.5 0.6 0.5 0.0 1.9 0.0 0.2 0.0 0.2 0.0 482.7 0.0 0.9 0.8 2.3 0.5 0.1 0.3 0.1 0.0 1.3 0.0 0.1 BICRAL "GLTSCR1L, KIAA0240" ENSG00000112624 "BRD4 interacting chromatin remodeling complex associated protein like" Q6AI39 6 42746958-42868560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029390, HPA029391" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA029390: AB_10599730, HPA029391: AB_10599949" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (2.15e-2)" "unprognostic (3.46e-2)" "unprognostic (9.25e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.74e-1)" "unprognostic (6.17e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-2)" "unprognostic (1.55e-1)" "unprognostic (7.24e-2)" "unprognostic (1.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.29e-1)" "unprognostic (6.54e-2)" 7.7 5.7 4.1 8.4 4.5 7.8 9.6 16.0 7.0 9.4 1.6 7.6 6.1 11.4 7.7 6.6 10.3 7.3 7.1 4.2 4.4 6.1 5.7 7.8 12.3 5.1 4.6 3.7 16.4 7.0 10.5 5.9 5.2 6.9 9.3 9.6 14.4 8.4 8.2 8.1 8.5 6.7 9.7 3.2 9.9 7.6 5.0 4.2 11.7 11.4 9.5 12.3 7.8 7.3 7.6 6.2 4.9 4.3 6.9 8.7 10.0 3.7 5.4 5.6 4.7 3.6 2.2 4.4 14.4 4.8 9.1 7.2 4.8 4.2 5.6 7.7 10.8 2.7 10.1 4.9 6.3 4.6 8.6 8.8 6.2 10.6 4.6 8.4 8.9 4.9 8.4 9.8 12.5 5.6 7.4 1.4 4.9 4.8 24.3 3.0 8.9 2.5 14.3 4.8 4.0 14.6 7.8 6.1 8.7 6.1 4.1 7.6 10.0 5.7 6.5 6.4 4.3 5.4 11.3 7.0 21.6 3.9 10.8 4.7 2.3 0.5 2.8 2.2 0.4 1.9 1.2 1.3 2.1 0.4 1.3 1.2 1.6 3.7 1.6 0.8 0.7 1.6 0.6 4.1 4.5 16.0 7.0 4.2 4.4 5.1 4.6 3.7 6.9 3.2 4.2 7.6 10.3 9.6 9.4 0.0 4.2 0.0 0.0 0.0 0.0 0.0 10.2 9.1 0.0 0.0 4.3 3.7 0.0 2.3 11.6 0.0 0.0 3.8 0.0 6.2 9.6 3.1 0.0 0.0 0.0 3.8 2.1 3.9 0.0 9.8 1.3 8.4 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 3.5 0.0 0.0 4.3 2.9 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.4 5.0 5.2 0.0 0.0 PPP2R5D "B56D, B56delta" ENSG00000112640 "Protein phosphatase 2 regulatory subunit B'delta" Q14738 6 42984553-43012342 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029045, HPA029046" Approved Approved Nucleoplasm,Cytosol NA NA 29000 "Nucleoplasm, Cytosol" "HPA029045: AB_10598912, HPA029046: AB_10600988" "unprognostic (2.25e-1)" "unprognostic (7.14e-2)" "unprognostic (4.73e-2)" "unprognostic (6.89e-2)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (9.44e-2)" "unprognostic (2.59e-1)" "unprognostic (2.71e-1)" "unprognostic (1.21e-1)" "unprognostic (9.96e-2)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (6.05e-2)" 22.2 20.4 25.8 17.7 31.3 18.5 20.4 24.8 36.9 30.4 16.1 26.5 30.0 29.0 4.4 24.5 28.7 15.4 28.4 30.6 27.3 18.3 20.9 18.8 20.1 29.2 26.3 28.7 28.8 19.2 24.7 16.0 18.3 31.0 25.0 23.8 29.9 20.0 21.4 40.9 27.7 36.1 30.8 18.6 18.8 22.5 28.9 29.4 44.8 18.5 41.6 24.2 24.9 27.6 31.4 71.3 38.0 72.6 88.2 61.0 63.6 32.6 38.3 39.9 108.5 86.6 58.7 24.9 55.8 36.3 71.8 67.3 38.6 108.6 66.4 94.6 45.3 67.5 62.9 51.2 81.8 33.5 51.4 43.6 45.6 47.3 88.5 35.1 54.1 87.2 68.7 67.4 41.1 63.0 44.0 114.9 40.0 26.2 228.1 36.3 86.3 73.8 37.3 45.3 39.0 77.9 45.7 56.2 38.7 47.3 63.2 47.9 55.5 57.1 57.2 50.9 55.8 61.4 39.6 54.6 109.0 21.2 48.0 51.6 18.4 13.8 21.9 18.4 11.6 19.2 10.1 16.9 21.2 13.7 9.2 12.8 15.6 8.1 14.3 8.9 14.4 23.9 20.1 25.8 31.3 24.8 36.9 30.6 27.3 29.2 26.3 28.7 31.0 18.6 29.4 31.4 6.2 9.6 6.7 6.8 7.6 8.4 2.9 5.1 13.1 12.9 6.9 6.6 4.9 4.3 6.3 7.3 10.4 7.5 10.1 15.7 5.9 6.9 6.4 7.7 19.9 7.4 9.0 12.4 10.5 7.8 11.0 9.7 7.1 9.5 8.2 10.8 6.4 11.3 9.2 3.3 10.3 8.3 8.2 6.2 5.2 7.0 9.6 6.9 10.6 3.7 6.8 8.1 3.1 3.0 5.3 9.8 9.0 14.7 7.7 3.7 35.7 5.2 5.1 7.5 6.6 8.7 10.8 8.3 10.2 13.3 9.5 4.5 11.1 6.1 13.0 2.5 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059438 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: AB_2685358" "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favorable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 25.9 32.6 25.9 12.7 27.1 20.2 26.2 29.1 37.9 23.0 25.5 27.5 25.8 23.7 13.8 24.8 22.4 10.1 45.6 26.6 29.3 33.9 51.6 18.8 13.5 27.6 26.8 26.0 24.7 27.3 29.8 29.7 13.4 28.5 22.1 16.9 11.0 22.8 17.8 75.8 25.0 20.5 12.1 25.2 20.0 23.8 19.9 26.9 17.9 26.9 57.2 14.5 22.8 21.6 28.0 47.9 43.1 20.3 39.3 28.4 20.7 38.9 20.4 24.8 47.3 41.3 109.0 15.4 61.8 42.3 24.6 36.2 49.9 50.5 48.7 27.8 30.4 90.9 46.8 34.9 109.5 57.2 43.5 21.0 27.6 51.4 52.5 82.8 22.6 32.6 68.7 84.6 36.6 23.6 84.0 48.1 127.1 22.7 175.7 49.5 59.0 25.1 77.3 38.2 26.3 51.3 27.4 18.2 39.4 73.4 18.6 41.4 73.9 27.3 27.6 40.0 35.7 58.7 47.7 44.9 115.2 21.5 65.2 27.8 17.5 37.8 30.2 28.4 40.9 36.5 46.5 31.8 33.6 54.3 48.6 32.7 32.3 9.8 38.5 33.7 56.1 39.2 31.3 25.9 27.1 29.1 37.9 26.6 29.3 27.6 26.8 26.0 28.5 25.2 26.9 28.0 36.8 22.4 18.6 5.5 27.5 24.3 32.0 86.5 19.4 22.7 25.9 30.0 37.5 38.6 48.9 60.7 27.1 74.0 21.3 43.1 185.9 59.1 94.0 30.6 34.1 32.1 30.6 35.3 5.3 53.7 53.1 31.1 30.1 32.5 28.5 43.1 33.2 75.9 49.3 5.0 5.8 44.2 69.2 23.7 26.6 37.0 55.0 22.9 53.4 2.8 41.3 44.7 43.3 2.0 5.5 44.2 51.3 51.6 35.6 31.6 77.6 159.4 40.4 23.4 26.3 32.5 82.7 53.1 41.7 35.7 27.1 63.5 27.2 59.0 65.7 28.7 PTK7 CCK4 ENSG00000112655 "Protein tyrosine kinase 7 (inactive)" Q13308 6 43076307-43161719 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Wnt signaling pathway" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 317.3;Endometrial stromal cells: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 13.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 13.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003222 Approved "Secreted to blood" NA NA 12000000 "HPA003222: AB_1079713" "unprognostic (1.80e-1)" "unprognostic (7.49e-3)" "unprognostic (6.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.15e-2)" "unprognostic (5.85e-3)" "unprognostic (9.81e-3)" "unprognostic (1.47e-3)" "unprognostic (7.15e-2)" "unprognostic (5.11e-3)" "unprognostic (8.17e-2)" "unprognostic (3.37e-2)" "unprognostic (1.73e-1)" "unprognostic (3.61e-1)" "unprognostic (9.12e-2)" "unprognostic (5.70e-3)" 9.6 5.0 11.3 6.8 8.4 2.9 17.7 8.6 9.1 65.3 31.3 8.9 6.5 88.1 87.9 30.3 38.6 24.9 6.5 8.7 15.5 21.3 1.6 34.2 4.0 9.3 11.4 7.5 86.1 16.6 13.0 21.3 49.2 8.5 38.2 8.6 6.1 37.0 25.7 0.6 34.9 9.6 39.0 9.8 28.0 12.3 42.0 9.9 30.7 23.2 1.5 6.5 22.5 44.0 9.2 9.1 2.5 83.6 141.6 88.0 89.9 119.4 94.2 145.5 77.0 99.4 77.0 31.0 0.2 74.0 107.3 56.4 99.5 38.0 87.5 49.3 0.7 52.0 8.5 17.1 105.2 132.5 0.3 0.4 129.1 77.4 103.2 32.6 135.8 10.1 35.0 6.2 0.2 36.4 7.0 32.5 12.6 39.1 0.8 7.0 33.3 119.0 0.3 61.0 42.4 48.3 91.6 14.8 1.5 50.0 87.8 51.9 19.5 6.8 84.1 53.1 0.4 51.0 0.5 0.9 3.2 19.1 0.3 14.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 1.4 0.2 0.7 0.0 13.5 0.0 0.8 11.3 8.4 8.6 9.1 8.7 15.5 9.3 11.4 7.5 8.5 9.8 9.9 9.2 3.0 16.0 13.1 10.7 0.8 17.3 19.9 40.4 27.9 4.3 23.5 32.5 1.6 5.7 14.6 12.9 56.3 19.1 6.3 1.7 1.9 21.0 317.3 23.5 84.7 8.7 21.6 4.0 8.7 6.9 2.2 30.0 8.6 25.2 1.3 25.3 2.2 0.0 3.5 0.0 5.3 3.9 42.7 0.0 9.8 48.9 18.3 4.1 16.0 1.0 1.0 20.1 0.0 3.5 1.4 10.5 4.1 18.4 1.4 11.8 0.6 0.6 15.4 2.2 13.1 8.7 27.9 2.8 21.2 13.7 10.4 8.2 3.0 17.7 6.3 11.8 SRF MCM1 ENSG00000112658 "Serum response factor" P11831 6 43171269-43181506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001819, CAB005416" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005416: AB_2255249, HPA001819: AB_1079928" "unprognostic (1.44e-3)" "unprognostic (1.09e-1)" "unprognostic (5.39e-3)" "unprognostic (2.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (4.60e-2)" "unprognostic (9.84e-2)" "unprognostic (4.28e-2)" "unprognostic (2.21e-2)" "unprognostic (6.72e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.31e-2)" "unprognostic (1.59e-1)" "unprognostic (5.10e-2)" "unprognostic (1.97e-2)" 28.6 16.9 16.0 27.2 14.9 27.5 24.9 12.6 18.9 31.5 12.5 62.9 13.5 69.8 12.5 33.6 49.6 26.8 60.1 17.7 13.0 17.2 20.3 28.9 21.5 14.4 12.9 14.4 27.9 22.0 18.6 18.9 17.5 13.1 39.1 15.0 8.8 16.9 45.9 55.9 21.0 29.5 48.6 11.6 22.4 37.3 12.7 13.8 21.6 24.1 33.0 16.6 55.0 25.9 16.8 38.4 15.0 34.2 22.6 19.8 16.2 50.2 34.2 28.0 29.0 17.9 40.4 11.1 48.1 30.5 36.7 36.7 30.4 35.0 30.2 25.5 53.5 34.4 43.6 30.7 40.2 37.7 41.2 50.9 27.8 32.3 44.8 32.7 27.4 24.5 41.0 31.6 36.8 22.2 41.1 51.2 35.9 23.8 85.7 18.3 38.7 34.9 17.3 21.3 24.5 20.0 18.1 28.0 21.1 34.2 26.2 21.7 75.6 29.9 34.2 26.4 33.4 59.5 25.4 22.6 80.6 21.4 29.2 23.5 0.4 0.4 0.8 0.8 0.8 0.6 0.5 0.4 0.6 0.5 0.5 0.3 0.6 1.2 0.3 0.6 1.0 0.6 0.3 16.0 14.9 12.6 18.9 17.7 13.0 14.4 12.9 14.4 13.1 11.6 13.8 16.8 17.1 38.5 22.5 3.9 8.8 78.0 64.3 22.6 38.1 5.7 64.0 52.1 89.6 18.6 21.7 11.0 20.9 9.7 9.4 29.8 0.0 13.6 4.7 23.8 24.6 17.5 102.2 20.2 4.9 20.0 22.6 17.0 18.3 29.5 7.6 20.6 17.2 50.6 12.7 10.1 3.5 39.1 8.2 11.3 18.8 1.1 12.5 11.6 24.9 0.0 8.0 12.5 5.2 1.5 2.8 21.5 19.6 29.0 6.5 17.8 11.1 3.8 20.3 7.5 13.1 23.6 21.8 5.2 3.3 28.7 66.9 12.2 10.5 8.9 25.6 30.2 CUL9 "H7AP1, KIAA0708, PARC" ENSG00000112659 "Cullin 9" Q8IWT3 6 43182184-43224587 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 53 "Early spermatids: 513.7;Late spermatids: 1508.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016434, HPA052004" Approved Approved Cytosol No No Cytosol "HPA016434: AB_1848125, HPA052004: AB_2681690" "prognostic favorable (5.28e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.20e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.37e-5)" "unprognostic (3.05e-3)" "unprognostic (1.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.29e-1)" "prognostic favorable (8.07e-4)" "unprognostic (8.22e-3)" "unprognostic (2.03e-1)" "unprognostic (2.68e-1)" "unprognostic (2.31e-1)" "unprognostic (9.94e-2)" "prognostic favorable (4.87e-4)" 2.9 3.1 2.8 4.9 3.7 7.0 2.9 1.1 3.1 3.2 2.7 3.5 4.0 3.3 1.7 5.5 5.0 3.6 2.6 2.9 1.6 3.2 2.1 3.6 6.3 2.1 2.6 3.0 4.3 4.2 5.5 2.9 2.4 2.4 3.4 2.4 3.2 4.0 4.1 2.9 8.1 4.2 2.8 1.1 5.0 4.3 5.3 2.3 7.7 5.2 3.0 4.7 3.8 2.8 2.4 8.2 6.0 3.2 7.7 8.8 5.2 4.4 3.2 5.6 5.0 4.6 1.9 3.4 6.8 6.0 5.1 4.5 5.8 2.7 6.7 2.3 8.3 2.5 7.4 6.8 3.0 5.8 4.7 11.6 7.1 13.8 4.1 3.7 4.4 7.4 11.5 3.9 8.7 4.5 7.2 9.6 6.8 0.6 15.7 3.6 13.9 2.2 6.6 3.8 8.4 5.5 7.8 4.2 5.0 7.2 2.7 8.6 10.4 6.9 12.5 8.6 3.7 6.1 8.3 8.3 5.5 3.2 8.2 5.7 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 0.5 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 2.8 3.7 1.1 3.1 2.9 1.6 2.1 2.6 3.0 2.4 1.1 2.3 2.4 6.6 0.0 8.2 16.3 7.5 6.4 2.7 9.3 16.5 10.2 8.0 6.1 6.9 8.6 5.9 3.7 12.5 3.4 6.5 8.8 3.9 4.2 513.7 7.5 5.5 6.8 6.0 3.4 15.8 6.2 1.7 5.3 18.8 6.4 2.5 14.6 9.3 6.4 11.6 11.8 11.9 7.9 6.1 9.6 5.0 1508.3 11.1 8.5 3.6 9.4 6.3 9.6 5.2 11.6 11.2 6.5 2.1 8.2 4.1 2.3 8.5 6.7 8.5 10.0 13.1 6.4 3.6 14.5 10.1 14.2 5.5 2.6 7.1 5.6 7.2 2.9 DNPH1 "C6orf108, dJ330M21.3, rcl" ENSG00000112667 "2'-deoxynucleoside 5'-phosphate N-hydrolase 1" O43598 6 43225629-43229481 "Predicted intracellular proteins" "Nucleotide metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 547.1;RPMI-8226: 347.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029675, HPA029676" Enhanced Approved Nucleoplasm,Cytosol No No 540000 Nucleoplasm Cytosol "HPA029675: AB_10599998, HPA029676: AB_10599424" "unprognostic (1.12e-2)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (8.24e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (2.61e-1)" "unprognostic (7.72e-2)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (2.25e-2)" "unprognostic (1.49e-1)" "unprognostic (1.74e-1)" "unprognostic (5.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (5.10e-2)" 37.4 104.1 35.8 29.3 37.2 23.4 37.5 34.2 66.7 43.3 53.7 60.9 105.0 50.7 8.4 62.8 58.3 13.3 44.9 34.3 40.5 171.1 137.9 32.1 33.3 32.5 34.2 34.3 40.7 101.5 76.5 37.5 9.3 33.7 42.4 18.1 6.1 46.1 18.9 90.4 39.4 89.0 11.5 36.4 62.1 57.9 10.3 36.6 17.2 36.0 45.1 19.0 39.4 40.1 34.8 189.4 135.3 20.7 86.2 14.4 44.5 64.1 44.9 16.1 29.8 38.9 55.8 67.2 134.9 69.4 15.3 1.5 95.1 16.2 35.7 8.6 72.4 318.7 63.7 127.4 161.2 34.1 54.3 40.3 28.1 44.3 9.0 26.7 12.0 39.6 96.8 147.1 232.0 24.5 311.8 52.3 135.3 41.5 547.1 81.5 87.0 27.7 347.3 52.1 63.6 79.8 96.2 41.4 108.5 95.7 6.6 149.2 177.9 49.7 22.6 39.2 51.6 90.2 160.7 79.6 109.5 14.3 71.6 36.0 1.2 109.7 4.8 42.4 237.9 78.5 219.8 138.8 74.6 178.2 194.6 122.2 83.8 4.1 42.0 176.6 135.3 269.7 92.3 35.8 37.2 34.2 66.7 34.3 40.5 32.5 34.2 34.3 33.7 36.4 36.6 34.8 16.4 28.9 38.2 5.5 73.9 61.3 91.3 147.6 68.3 11.9 138.4 181.0 91.0 163.0 80.9 115.8 2.1 53.4 12.9 164.0 450.0 201.6 0.6 159.5 66.4 30.8 64.8 78.8 4.1 107.2 66.5 60.1 88.7 39.1 33.7 108.4 28.5 231.2 308.3 6.7 4.9 216.6 93.6 75.8 62.3 3.1 67.1 63.4 110.3 1.0 36.7 78.4 10.3 5.5 5.1 157.2 155.3 59.8 81.8 112.6 818.0 1091.6 260.3 23.5 0.0 39.4 57.9 8.9 38.1 131.5 73.6 32.3 44.5 82.2 288.9 101.4 DUSP22 "JKAP, JSP1, MKPX, VHX" ENSG00000112679 "Dual specificity phosphatase 22" Q9NRW4 6 291630-351355 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 270.6;U-266/70: 130.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031394 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031394: AB_10604114" "unprognostic (7.34e-3)" "unprognostic (7.94e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (9.08e-3)" "unprognostic (2.48e-1)" "unprognostic (9.06e-2)" "unprognostic (5.56e-3)" "unprognostic (3.10e-2)" "unprognostic (3.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.97e-2)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" 36.7 16.5 27.9 28.0 29.6 23.9 33.3 28.4 28.4 30.0 23.3 40.9 22.7 29.2 12.3 46.1 26.1 21.5 40.6 26.1 30.9 25.9 32.9 38.8 32.6 33.5 29.6 23.1 19.8 41.1 13.3 21.4 27.5 33.6 23.4 16.3 7.8 30.7 15.3 52.7 41.5 34.0 22.2 30.7 44.2 33.0 45.3 30.2 15.2 28.4 38.1 30.8 30.6 37.2 43.7 13.7 8.3 17.3 25.9 19.5 21.5 22.8 9.9 8.0 8.6 10.3 8.8 15.1 28.4 23.3 10.3 18.3 9.4 21.9 18.3 6.1 68.6 25.1 19.3 7.1 24.7 9.9 7.0 24.4 16.2 54.1 6.2 11.3 14.1 24.8 24.0 18.3 92.2 7.2 8.2 10.3 25.1 10.4 10.0 18.7 20.2 11.7 270.6 16.2 5.8 29.7 11.6 8.5 3.4 29.6 37.4 17.6 8.9 34.2 7.7 10.1 7.8 6.0 130.0 98.6 40.0 3.0 19.0 17.7 36.4 32.5 13.6 8.6 26.5 6.2 40.4 6.7 9.1 33.5 33.3 6.1 8.8 21.8 5.9 25.1 28.8 15.9 19.6 27.9 29.6 28.4 28.4 26.1 30.9 33.5 29.6 23.1 33.6 30.7 30.2 43.7 45.5 16.0 21.3 5.5 53.7 26.5 22.0 33.3 14.2 5.7 19.4 17.5 40.8 10.0 30.7 5.5 0.0 10.8 51.1 11.7 21.5 24.2 13.4 18.6 8.2 33.4 9.5 8.2 8.5 51.4 7.7 21.9 15.3 12.9 33.0 8.8 21.8 25.0 30.1 0.0 6.1 14.7 32.6 38.6 43.0 20.5 15.5 47.1 46.2 21.5 78.4 14.9 36.0 7.1 25.9 29.2 12.4 9.4 59.7 16.5 23.2 18.2 39.7 3.2 26.3 11.6 22.8 34.5 73.8 42.5 37.1 6.6 21.3 6.8 15.4 27.9 EXOC2 "FLJ11026, SEC5L1, Sec5p" ENSG00000112685 "Exocyst complex component 2" Q96KP1 6 485154-693139 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.8;Inhibitory neurons: 80.1;Microglial cells: 68.4;Oligodendrocytes: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032093 Approved Vesicles NA NA Vesicles "HPA032093: AB_10611964" "unprognostic (1.61e-1)" "unprognostic (4.69e-1)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-2)" "unprognostic (2.48e-1)" "unprognostic (1.82e-3)" "unprognostic (1.34e-1)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (5.32e-2)" "unprognostic (2.02e-1)" "unprognostic (8.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (2.20e-1)" 9.5 8.4 10.6 11.6 11.8 6.6 11.0 11.3 11.8 10.1 11.5 9.2 8.7 8.7 5.3 12.3 6.6 9.0 11.7 11.1 11.6 9.4 10.4 11.5 13.5 11.9 11.8 10.4 7.9 6.7 11.7 8.3 18.1 12.6 8.0 10.1 13.5 8.1 8.0 10.2 11.9 9.4 9.3 11.9 13.2 9.0 16.3 11.6 18.7 14.3 10.5 14.2 10.9 9.2 14.6 21.0 15.2 26.0 28.5 23.2 20.8 15.7 18.5 21.5 21.7 25.8 20.4 11.0 15.5 44.0 22.3 32.7 17.7 29.2 32.2 25.7 48.4 30.9 19.8 18.5 20.4 29.1 21.2 18.8 18.1 25.9 15.5 18.0 21.4 36.9 30.0 39.4 11.1 27.3 18.1 28.6 20.6 26.4 18.6 15.1 26.6 22.5 31.3 19.5 22.4 25.4 14.9 14.8 9.0 29.1 48.4 23.2 12.9 54.1 19.6 14.1 24.6 17.4 27.2 56.8 16.4 19.8 17.4 61.0 11.6 9.0 10.2 17.1 11.0 20.9 13.5 17.2 18.3 14.1 14.5 16.2 15.7 2.8 14.8 17.7 11.1 21.1 14.4 10.6 11.8 11.3 11.8 11.1 11.6 11.9 11.8 10.4 12.6 11.9 11.6 14.6 12.6 3.2 14.5 35.6 15.9 4.8 3.8 6.2 6.2 9.0 10.1 9.3 8.6 2.8 6.5 5.5 8.4 16.0 18.5 6.1 7.9 6.2 11.0 7.3 7.0 11.1 2.4 8.2 75.8 5.1 7.1 7.6 6.1 8.2 5.1 11.8 8.6 8.2 10.0 8.4 80.1 6.8 12.2 9.0 5.8 3.8 6.8 8.7 5.4 68.4 10.8 4.6 13.4 49.3 73.4 6.9 5.1 9.1 11.3 6.4 4.1 8.2 9.0 9.3 0.0 7.3 8.9 21.8 17.5 9.9 7.7 12.9 18.3 7.4 5.9 6.0 COX7A2 "COX7AL, COXVIIa-L" ENSG00000112695 "Cytochrome c oxidase subunit 7A2" 6 75237675-75250323 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 4705.1;Late spermatids: 3873.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.98e-2)" "unprognostic (2.15e-2)" "unprognostic (1.34e-1)" "unprognostic (5.67e-3)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (7.70e-2)" "unprognostic (2.73e-3)" "unprognostic (7.44e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" 167.8 205.9 353.3 95.4 356.4 173.3 167.7 373.9 584.1 126.7 374.1 317.4 198.1 129.5 216.9 255.0 136.9 106.4 521.6 354.9 398.6 316.2 310.1 147.4 118.3 351.3 355.5 347.7 104.7 155.4 411.5 234.4 93.2 355.4 164.8 331.0 335.1 161.7 125.2 186.8 160.5 202.6 159.9 362.6 139.7 288.7 501.6 357.1 168.1 148.0 296.4 157.9 162.0 155.4 374.7 116.5 260.5 334.6 276.7 195.9 220.0 242.3 276.9 252.7 270.3 291.3 471.1 172.9 188.1 239.0 251.9 363.1 247.1 236.1 299.9 336.8 347.8 482.6 283.6 842.1 630.6 200.8 305.6 319.9 240.7 392.7 250.9 163.2 283.4 318.7 420.8 255.2 266.0 370.4 536.6 130.7 329.7 210.9 569.4 472.5 210.2 169.0 500.7 436.3 745.0 228.2 275.3 172.4 312.0 301.7 273.2 190.9 843.6 156.4 118.8 218.2 95.9 319.5 373.2 444.7 221.4 135.7 342.5 237.3 693.0 582.0 585.0 435.6 663.4 468.5 659.6 563.3 527.9 619.7 559.7 551.1 511.9 437.7 496.6 696.0 781.4 680.8 1055.8 353.3 356.4 373.9 584.1 354.9 398.6 351.3 355.5 347.7 355.4 362.6 357.1 374.7 370.9 304.5 371.3 15.0 391.8 553.7 624.1 2000.6 268.6 251.0 584.8 693.0 2518.6 630.5 1019.4 503.9 120.9 686.3 348.5 1504.8 2602.2 800.4 4705.1 460.2 288.0 382.5 663.0 354.3 18.9 1007.3 787.6 367.5 414.9 451.7 300.1 269.4 385.8 1485.8 870.3 154.8 22.4 1283.5 1468.9 484.8 499.6 3873.2 355.7 420.2 846.6 10.3 715.3 390.3 396.5 14.1 20.9 1157.5 1498.6 339.3 593.7 848.5 1790.7 2008.3 772.8 359.9 407.6 303.7 587.8 2905.4 230.0 627.9 626.4 818.3 381.9 336.4 1242.8 994.8 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284948 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved NA NA "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 63.5 57.5 69.2 59.7 78.4 54.2 54.5 72.6 74.0 61.8 77.2 65.3 44.3 62.6 50.7 58.6 47.9 60.6 45.7 74.2 78.6 78.1 100.5 92.5 53.9 74.3 75.0 68.7 48.0 71.4 96.9 47.9 48.9 71.8 65.3 71.5 57.5 55.7 59.1 29.5 38.6 46.7 79.8 78.2 62.7 60.0 29.1 76.8 48.0 85.3 40.8 61.4 67.0 35.1 89.3 54.2 60.6 91.5 77.6 228.2 212.0 76.3 217.9 171.3 82.3 128.2 56.3 129.1 61.9 148.3 194.8 82.7 62.4 41.5 120.4 211.5 84.9 63.8 60.4 55.1 56.7 129.2 73.7 104.6 197.2 116.5 116.9 63.7 175.2 262.4 59.1 59.4 107.8 158.4 37.2 27.1 54.2 32.7 46.1 46.7 44.4 65.6 78.5 315.3 131.1 64.9 62.9 111.9 52.8 74.9 105.8 58.6 224.8 234.5 103.8 116.9 65.6 153.3 90.3 136.1 27.9 81.7 137.2 165.7 44.5 85.8 59.0 37.1 84.7 44.8 27.1 37.3 36.7 78.6 22.6 34.8 34.5 138.3 42.5 87.5 33.2 53.0 61.5 69.2 78.4 72.6 74.0 74.2 78.6 74.3 75.0 68.7 71.8 78.2 76.8 89.3 73.2 163.5 132.5 7.5 38.8 71.2 33.7 67.6 42.1 24.5 53.1 27.6 43.8 40.0 96.1 66.2 45.9 39.6 51.0 67.6 11.7 51.0 11.1 46.7 57.0 68.0 36.2 20.8 15.8 111.2 52.1 65.7 43.3 76.0 39.8 31.4 66.0 79.1 54.3 20.2 14.5 44.3 54.9 89.3 79.1 9.5 45.4 57.8 48.0 10.3 62.4 40.7 35.0 17.1 15.6 101.6 38.5 62.4 55.8 80.9 31.1 33.2 95.2 24.0 32.9 56.1 77.2 45.0 21.2 41.8 78.3 94.4 43.3 62.5 28.8 65.9 GMDS "GMD, SDR3E1" ENSG00000112699 "GDP-mannose 4,6-dehydratase" O60547 6 1623806-2245605 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 107.0;salivary gland: 106.4;stomach 1: 98.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 208.5;Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 367.6;Proximal enterocytes: 190.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 246.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031528 Enhanced NA NA 72000 "HPA031528: AB_10601016" "unprognostic (5.94e-2)" "unprognostic (3.92e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.89e-4)" "unprognostic (4.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-3)" "unprognostic (7.15e-2)" "unprognostic (2.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-1)" "prognostic favorable (5.93e-4)" "unprognostic (2.45e-1)" "unprognostic (2.84e-1)" "unprognostic (6.68e-2)" "unprognostic (1.12e-1)" 10.2 7.6 8.6 30.4 7.0 9.2 14.7 5.6 7.1 29.7 9.7 88.5 107.0 7.8 10.5 66.4 11.6 20.7 8.5 7.5 6.6 19.7 31.3 9.1 14.3 6.6 6.2 6.6 6.7 44.2 20.6 13.0 7.1 6.3 18.5 83.2 1.5 106.4 8.1 5.1 10.3 88.0 10.4 5.7 11.5 98.0 9.3 6.8 14.0 12.1 4.9 21.0 13.9 14.3 6.3 45.9 10.6 7.4 52.6 11.8 32.0 17.9 12.5 25.7 22.7 21.2 23.1 26.1 21.7 37.3 13.6 22.4 18.3 22.9 43.8 26.2 30.0 28.8 21.0 11.2 110.3 13.2 34.2 22.5 35.6 14.9 18.0 37.2 21.9 26.9 73.0 13.9 9.8 14.7 26.3 49.0 40.1 11.4 246.4 36.0 24.8 16.8 112.4 55.4 59.5 41.4 9.9 11.5 17.7 28.8 33.6 16.4 21.4 11.7 17.4 13.1 17.7 22.5 22.1 33.6 23.1 11.4 23.6 23.4 7.0 12.9 1.5 7.8 8.3 10.3 10.5 9.4 7.5 14.5 5.0 7.6 10.8 3.8 13.1 6.8 6.1 13.2 8.3 8.6 7.0 5.6 7.1 7.5 6.6 6.6 6.2 6.6 6.3 5.7 6.8 6.3 19.7 0.0 4.5 40.8 19.8 4.2 20.1 38.3 27.3 3.7 33.1 19.3 2.9 12.8 40.5 38.6 0.0 18.7 6.5 104.1 119.3 36.5 5.7 7.8 7.3 23.0 111.7 9.7 208.5 69.7 30.8 12.4 276.8 11.9 4.5 13.2 18.2 19.6 13.5 8.4 167.5 367.6 50.8 10.9 7.6 4.6 12.2 11.0 23.2 143.4 14.7 3.3 9.2 83.9 50.2 47.0 85.5 16.6 53.1 40.7 190.7 38.1 38.3 0.7 13.1 5.8 16.6 6.5 33.1 20.1 6.1 16.7 18.6 13.4 165.1 43.5 SENP6 "KIAA0797, SUSP1" ENSG00000112701 "SUMO specific peptidase 6" Q9GZR1 6 75601509-75718281 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024376 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024376: AB_1856678" "unprognostic (9.86e-2)" "unprognostic (1.20e-2)" "unprognostic (4.84e-2)" "unprognostic (1.87e-2)" "unprognostic (6.38e-3)" "unprognostic (7.33e-2)" "unprognostic (1.13e-2)" "unprognostic (2.97e-1)" "unprognostic (3.93e-2)" "unprognostic (5.32e-3)" "unprognostic (7.81e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.78e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.83e-5)" "unprognostic (1.72e-1)" 25.3 22.8 13.1 24.8 16.9 38.2 31.7 48.6 17.1 28.8 8.4 23.9 21.1 33.3 22.3 25.5 27.1 26.2 22.8 10.6 13.4 28.8 28.2 26.7 28.8 11.3 12.8 7.3 40.9 27.3 39.7 22.5 33.7 17.2 29.6 26.3 31.7 22.0 29.2 25.8 25.4 20.6 32.2 13.2 29.1 25.2 34.1 13.1 32.7 42.3 30.3 30.6 30.0 21.3 23.0 23.8 24.5 54.3 39.1 41.3 54.6 40.3 41.9 46.5 34.6 43.1 33.9 22.4 40.1 38.6 48.7 40.9 29.8 51.6 28.0 53.1 59.2 44.2 60.8 28.9 31.7 57.3 53.5 42.8 42.6 45.6 32.6 71.8 41.9 58.2 32.8 74.9 43.2 43.0 29.0 21.4 28.6 33.1 31.9 20.4 39.7 28.7 59.0 36.7 35.0 47.2 48.7 35.8 31.3 36.4 43.5 28.2 50.1 49.0 30.8 33.4 15.9 43.8 48.9 52.4 31.4 15.4 49.8 33.1 7.5 8.0 20.8 7.3 8.4 10.5 9.1 7.4 9.9 8.9 10.5 10.5 9.6 14.9 10.1 14.7 11.0 6.9 6.3 13.1 16.9 48.6 17.1 10.6 13.4 11.3 12.8 7.3 17.2 13.2 13.1 23.0 76.7 67.3 128.3 158.0 74.0 46.5 65.0 27.6 78.6 58.8 53.0 59.6 76.7 31.5 70.9 29.5 91.8 33.0 73.8 43.2 17.6 33.7 40.4 62.9 78.1 57.9 27.6 50.5 152.6 33.7 29.4 69.3 51.0 62.9 65.1 74.2 42.1 32.0 29.5 60.6 177.3 35.6 24.4 43.2 41.5 35.6 70.8 57.7 35.6 149.9 68.4 56.6 50.4 218.1 228.9 32.1 29.9 63.2 62.8 63.4 32.6 26.8 47.2 65.7 26.3 98.9 73.7 107.7 61.7 61.4 48.4 41.2 67.2 66.0 46.3 66.8 IMPG1 "GP147, IPM150, SPACR" ENSG00000112706 "Interphotoreceptor matrix proteoglycan 1" Q17R60 6 75921114-76072678 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Heparin-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 259 "retina: 676.5" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 673.5;Rod photoreceptor cells: 694.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" "Region enriched" "Detected in single" 4 "basal ganglia: 3.3" "Not detected" "Not detected" "HPA027142, HPA030332, HPA030333" Enhanced "Secreted in other tissues" NA NA "HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433" "unprognostic (6.65e-2)" "unprognostic (4.13e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.49e-3)" "unprognostic (5.97e-2)" "unprognostic (3.56e-3)" "unprognostic (1.89e-2)" "unprognostic (2.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-3)" "unprognostic (2.84e-1)" "unprognostic (1.73e-2)" "unprognostic (2.09e-1)" "unprognostic (6.01e-2)" "unprognostic (1.96e-2)" 0.2 0.1 0.7 0.0 2.6 0.0 0.5 1.2 1.4 0.3 0.8 0.2 1.0 0.2 0.0 0.2 0.1 0.4 0.2 0.8 0.7 0.6 0.2 0.6 0.1 0.8 0.7 0.6 0.1 1.8 0.0 0.3 0.2 0.9 0.2 0.0 676.5 0.5 0.0 0.2 1.4 0.8 0.0 0.3 0.2 0.3 0.3 0.7 0.1 0.4 0.0 0.0 0.2 0.3 1.6 0.6 0.0 0.8 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 1.2 1.4 0.8 0.7 0.8 0.7 0.6 0.9 0.3 0.7 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 53.2 0.0 0.0 0.2 0.0 0.0 0.0 673.5 0.2 0.0 0.0 3.9 0.0 1.9 0.2 0.0 3.0 0.0 0.0 1.6 0.0 9.4 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 30.3 0.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 85.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 694.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 VEGFA "VEGF, VEGF-A, VPF" ENSG00000112715 "Vascular endothelial growth factor A" P15692 6 43770184-43786487 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 349.4;Muller glia cells: 265.8" "Cancer enhanced" "Detected in all" "renal cancer: 79.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 398.9;U-87 MG: 628.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005429, CAB039240, HPA069116, CAB069907" Supported "Secreted to blood" NA NA 562000 57000 "CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089" "unprognostic (1.12e-1)" "prognostic unfavorable (4.50e-4)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (4.35e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.34e-5)" "unprognostic (5.10e-2)" "unprognostic (5.27e-3)" "unprognostic (2.30e-2)" "unprognostic (1.40e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (1.76e-5)" "unprognostic (2.20e-1)" "unprognostic (1.80e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.73e-4)" 120.9 53.2 18.6 36.9 18.3 46.0 93.2 31.7 27.3 39.4 37.2 29.9 51.3 104.9 10.6 61.8 41.3 80.8 165.1 21.0 31.3 115.1 219.1 94.9 9.4 27.0 21.8 11.5 25.2 68.6 105.9 22.4 46.6 26.3 121.4 21.6 231.1 32.4 17.9 223.1 42.9 45.0 57.6 18.1 70.6 64.5 5.3 40.2 5.6 273.3 152.3 9.6 123.5 62.2 26.7 76.5 13.4 12.5 71.8 21.0 32.9 84.2 45.6 81.1 29.7 58.4 43.1 9.9 24.9 35.5 27.7 305.4 30.6 34.0 92.0 52.0 27.4 10.4 19.0 17.8 29.2 220.3 20.8 40.4 58.0 178.6 290.6 286.2 398.9 7.7 21.0 35.7 121.7 109.4 31.3 2.3 28.3 7.9 221.2 19.2 2.3 12.0 60.5 114.8 62.9 22.3 46.8 65.6 44.4 162.0 16.1 17.3 75.1 10.4 122.6 32.9 179.2 76.1 68.8 43.6 49.1 628.6 47.9 43.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 18.3 31.7 27.3 21.0 31.3 27.0 21.8 11.5 26.3 18.1 40.2 26.7 63.6 349.4 84.7 121.5 9.8 70.5 51.2 76.8 60.3 37.8 67.0 57.1 164.7 77.2 85.7 22.0 31.3 1.3 11.6 92.9 1.9 54.7 0.0 38.4 59.1 29.0 27.4 21.3 12.1 40.8 6.3 69.7 124.4 121.2 112.0 111.7 17.5 116.0 13.9 180.0 17.0 71.8 12.2 16.2 199.0 0.3 1.8 144.1 28.4 10.3 11.3 265.8 0.0 124.1 1.8 86.0 47.1 3.4 15.9 119.4 61.9 20.5 11.4 43.9 0.0 42.1 79.1 1.1 1.9 82.0 78.3 7.9 11.4 17.4 51.0 137.5 PRPF4B "KIAA0536, PR4H, Prp4" ENSG00000112739 "Pre-mRNA processing factor 4B" Q13523 6 4021267-4064983 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020638 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA020638: AB_1855774" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (4.95e-2)" "unprognostic (2.20e-1)" "unprognostic (3.59e-3)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (8.68e-3)" "unprognostic (3.41e-2)" "unprognostic (4.45e-3)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.50e-3)" "unprognostic (8.90e-2)" "unprognostic (2.34e-1)" "unprognostic (7.63e-3)" "prognostic favorable (6.82e-5)" 8.3 7.2 5.3 11.4 5.9 27.5 8.1 7.9 6.8 5.8 5.6 7.0 10.3 10.0 10.2 8.5 4.5 6.2 4.7 5.2 6.6 4.2 4.3 6.8 14.3 5.7 6.0 4.6 8.5 6.9 4.3 3.4 7.6 5.8 6.4 8.7 16.1 8.4 5.6 16.5 13.4 9.0 5.6 5.7 11.3 8.2 3.9 5.9 8.9 6.6 4.5 10.1 6.7 7.1 7.2 6.0 3.9 14.4 12.1 8.3 7.3 12.3 7.7 3.4 4.7 5.2 6.9 7.1 8.1 5.7 5.1 4.8 12.8 10.1 6.8 7.1 4.4 11.1 6.7 19.1 11.5 3.6 11.2 10.6 5.7 6.9 5.4 6.6 11.0 5.1 6.5 11.6 3.1 7.4 2.7 7.2 26.3 6.0 3.8 4.3 9.9 6.1 11.2 8.4 10.2 7.9 7.3 4.7 3.9 5.5 16.9 9.6 7.9 7.3 11.2 6.5 4.3 8.2 7.5 7.9 6.9 3.2 7.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.9 7.9 6.8 5.2 6.6 5.7 6.0 4.6 5.8 5.7 5.9 7.2 122.4 109.0 103.2 35.6 110.5 83.5 64.0 43.1 69.4 88.6 80.4 49.5 79.1 61.5 75.1 97.5 89.6 61.8 151.3 94.9 72.4 64.4 15.6 115.9 143.5 85.8 75.3 79.1 42.8 56.8 49.9 78.7 88.2 113.4 90.5 96.2 61.1 85.8 41.1 106.0 49.8 88.8 50.8 71.6 49.4 20.6 98.8 71.4 35.6 49.6 97.4 81.2 118.4 50.8 68.1 62.8 61.5 89.1 101.9 62.8 55.5 89.5 71.7 184.0 59.2 105.3 85.8 66.1 76.5 66.7 91.4 63.6 106.2 93.1 87.7 65.2 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 25.6;lymphoid tissue: 47.1;testis: 34.6" "Cell type enhanced" "Detected in many" "Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 0.7 0.8 0.0 4.2 0.1 25.6 2.2 0.1 0.3 0.7 0.0 4.9 4.0 1.0 0.1 4.8 0.6 0.5 0.1 0.1 0.1 0.2 0.5 0.8 8.2 0.1 0.2 0.0 0.2 0.2 0.3 0.0 3.9 0.2 0.8 5.9 1.8 0.7 0.1 0.0 3.7 4.1 1.7 0.1 1.4 3.4 34.6 0.1 47.1 0.4 0.1 9.1 1.2 1.4 0.4 39.9 23.4 68.2 56.4 3.1 9.5 38.5 44.9 27.4 64.2 77.8 32.1 29.6 58.5 34.1 19.5 66.9 50.0 60.7 27.6 88.6 53.4 49.3 54.1 29.4 26.5 0.2 64.4 33.9 1.2 2.8 45.0 28.6 9.6 36.9 80.6 60.2 58.5 55.2 29.5 37.0 46.4 40.4 35.4 27.9 32.7 124.4 24.4 16.3 25.2 46.8 27.4 26.6 28.3 16.3 36.6 26.6 48.3 15.4 28.8 28.5 18.8 72.9 13.1 47.1 32.4 10.3 58.9 25.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.4 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.4 0.3 3.2 1.1 0.0 1.4 1.3 0.6 2.6 0.0 0.2 0.9 0.5 0.6 0.0 2.3 0.0 2.1 9.8 0.8 2.2 3.9 0.4 43.3 3.1 1.6 1.1 1.8 23.1 0.2 0.2 15.0 2.1 2.6 2.3 1.3 13.9 0.7 0.2 6.5 0.0 0.2 3.0 4.1 2.6 1.2 21.4 0.9 1.9 0.0 0.0 5.2 0.2 1.0 0.0 0.1 0.6 0.2 0.7 5.1 0.4 0.3 0.1 3.0 1.6 6.6 0.1 1.7 130.5 33.0 8.5 0.3 3.7 1.1 0.5 5.6 1.6 SLC29A1 ENT1 ENSG00000112759 "Solute carrier family 29 member 1 (Augustine blood group)" Q99808 6 44219553-44234142 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 216.6;Extravillous trophoblasts: 224.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 26 "eosinophil: 1046.6" "Lineage enriched" "Detected in all" 26 "granulocytes: 1046.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012384 Approved NA NA "HPA012384: AB_1857073" "unprognostic (1.82e-2)" "unprognostic (1.41e-2)" "unprognostic (1.81e-1)" "unprognostic (2.49e-3)" "unprognostic (2.76e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (1.38e-2)" "unprognostic (4.60e-2)" "unprognostic (9.02e-2)" "unprognostic (1.34e-1)" 77.1 96.7 8.3 22.5 10.6 53.8 50.9 14.3 15.1 25.6 7.1 44.8 13.2 37.6 16.1 25.5 34.8 44.6 120.8 9.8 11.5 17.9 58.3 33.4 26.1 11.9 11.8 9.2 13.0 92.0 23.0 22.8 59.3 15.3 16.7 18.0 21.3 35.9 19.5 145.8 53.5 17.4 46.6 9.3 14.6 54.2 15.1 11.6 82.1 31.0 101.6 17.2 33.1 17.8 15.5 85.3 84.2 58.5 95.1 87.8 8.1 347.1 61.2 24.0 83.6 57.4 91.8 34.8 171.2 60.8 18.5 51.7 103.8 105.2 72.8 51.9 97.6 97.2 150.5 57.8 122.5 14.1 170.3 139.7 10.9 18.4 123.0 42.7 171.6 216.0 137.2 205.4 100.1 46.9 94.0 142.0 114.4 89.0 218.4 55.4 94.0 117.8 208.9 49.1 49.5 75.0 97.0 18.4 58.9 43.9 61.5 80.7 107.1 333.1 46.4 74.8 62.6 117.7 67.0 93.8 221.9 28.8 136.8 57.1 21.9 12.1 1046.6 5.1 38.8 4.2 4.4 2.7 3.9 6.8 2.4 1.1 2.4 1.8 3.1 32.5 40.0 8.2 6.6 8.3 10.6 14.3 15.1 9.8 11.5 11.9 11.8 9.2 15.3 9.3 11.6 15.5 64.2 0.0 10.5 1.3 4.0 10.7 9.0 4.1 2.2 10.9 20.2 30.1 46.4 17.2 6.0 7.3 14.6 216.6 5.7 3.0 3.9 24.2 0.5 4.3 3.5 31.7 31.2 49.2 18.4 56.7 224.6 40.0 26.5 11.2 8.2 25.4 25.7 16.7 63.6 5.0 25.4 2.9 79.3 37.0 13.3 2.8 32.9 19.2 35.6 16.9 8.3 4.3 0.0 5.0 2.6 61.9 3.4 53.8 14.2 18.2 0.7 0.9 6.9 11.9 92.1 21.0 22.5 0.4 11.0 4.6 15.6 42.0 3.2 4.1 6.2 9.8 CCN6 "WISP-3, WISP3" ENSG00000112761 "Cellular communication network factor 6" O95389 6 112054075-112069686 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 10.3" "Cell type enriched" "Detected in single" 7 "Cardiomyocytes: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "RT4: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA064196 Supported Mitochondria "Secreted to extracellular matrix" NA NA Mitochondria "HPA064196: AB_2685209" "unprognostic (2.13e-2)" "unprognostic (7.90e-3)" "unprognostic (5.00e-2)" "unprognostic (2.22e-2)" "unprognostic (3.76e-1)" "unprognostic (6.52e-2)" "unprognostic (1.98e-3)" "unprognostic (4.07e-3)" "unprognostic (1.82e-1)" "unprognostic (3.90e-1)" "unprognostic (1.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "unprognostic (3.11e-1)" "unprognostic (4.91e-2)" "unprognostic (2.93e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 10.3 0.0 2.3 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019208 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favorable (4.52e-5)" 15.8 17.4 11.4 11.5 11.0 16.9 13.4 20.1 13.2 15.0 11.5 16.3 9.9 16.9 8.4 9.0 16.2 10.3 15.1 11.4 13.0 13.6 9.2 18.5 14.0 12.2 12.1 10.4 15.3 9.0 4.9 12.0 19.2 13.1 13.4 11.1 4.6 9.6 14.5 11.8 8.1 15.2 17.1 12.0 26.0 12.3 11.8 13.6 10.7 10.6 10.2 11.5 17.4 13.4 12.5 16.4 14.5 28.9 18.3 12.7 10.2 1.4 36.1 30.1 42.3 38.7 13.5 11.0 13.3 47.3 24.5 54.9 7.0 22.1 8.9 40.2 18.4 21.6 7.9 15.3 16.0 19.9 11.8 21.2 13.9 8.2 47.1 15.2 25.1 15.3 25.4 13.5 20.6 35.7 6.7 19.9 18.2 9.7 4.8 11.9 17.0 27.3 13.6 16.5 7.3 28.9 16.4 11.2 14.8 26.4 17.8 4.3 9.9 21.3 32.1 16.6 28.1 40.8 16.1 40.4 11.1 12.8 22.0 52.1 43.6 9.0 30.2 11.1 5.2 9.8 8.6 9.3 12.4 8.4 6.2 8.6 11.0 51.7 9.9 8.8 8.9 16.0 7.2 11.4 11.0 20.1 13.2 11.4 13.0 12.2 12.1 10.4 13.1 12.0 13.6 12.5 21.2 16.0 14.7 7.5 20.0 8.0 8.0 8.5 9.1 8.0 11.8 10.9 17.6 7.2 11.7 9.2 6.2 6.1 35.4 16.0 3.9 10.9 3.2 18.1 17.7 22.1 9.0 4.6 8.9 12.8 11.2 14.7 18.8 20.8 24.6 13.3 21.8 6.2 11.6 3.3 10.2 14.8 12.2 17.9 16.7 6.2 12.8 18.4 10.6 10.3 21.9 6.0 25.7 10.6 7.8 16.4 10.2 12.8 18.9 13.1 11.4 4.7 26.9 2.3 39.5 12.4 24.4 8.7 12.9 7.3 8.1 11.8 25.0 14.9 12.9 17.9 LAMA4 LAMA3 ENSG00000112769 "Laminin subunit alpha 4" Q16363 6 112107931-112254939 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015693, CAB078156" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 320000 "Plasma membrane, Cytosol" "CAB078156: AB_2665814, HPA015693: AB_1852687" "unprognostic (1.87e-2)" "unprognostic (6.48e-2)" "unprognostic (8.37e-2)" "unprognostic (2.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.52e-2)" "unprognostic (5.07e-2)" "unprognostic (4.59e-2)" "unprognostic (2.93e-2)" "unprognostic (9.06e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (4.40e-3)" "unprognostic (1.85e-1)" "unprognostic (2.80e-2)" "unprognostic (1.15e-2)" 116.2 9.5 18.5 34.3 14.7 0.5 60.4 11.1 14.1 72.9 14.4 63.4 17.3 78.2 18.7 36.0 116.3 37.7 44.5 12.1 26.6 10.0 4.4 81.5 11.6 13.9 14.7 8.6 23.4 5.0 8.7 13.7 68.6 15.5 35.7 34.3 1.3 38.7 41.1 10.7 17.0 34.8 108.8 9.7 1.5 37.0 18.8 19.9 5.1 23.4 18.8 9.0 65.7 40.7 32.2 0.3 0.1 18.8 0.6 330.5 512.5 0.3 91.4 55.8 8.9 1.4 0.0 36.1 0.0 58.0 154.9 19.8 0.3 4.0 0.6 1.5 0.3 46.4 0.0 44.4 0.0 69.6 0.1 0.3 405.5 0.1 64.9 0.2 256.0 441.3 0.0 0.4 0.4 1.7 0.0 0.1 0.3 1.1 0.0 15.1 0.2 0.2 0.3 134.0 2.8 0.4 2.1 14.2 0.4 68.5 1.5 0.4 0.2 404.9 145.1 7.6 160.6 29.1 0.0 0.3 0.3 33.5 0.2 191.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 14.7 11.1 14.1 12.1 26.6 13.9 14.7 8.6 15.5 9.7 19.9 32.2 115.7 3.2 4.5 45.4 0.1 22.7 1.4 2.9 8.6 1.6 5.4 9.4 53.3 2.8 10.4 3.7 0.0 1.0 0.6 0.0 3.9 0.7 114.7 6.2 24.8 103.5 0.0 2.7 27.4 0.7 119.1 149.2 3.6 10.5 1.3 3.5 36.0 35.3 3.0 0.0 6.3 0.8 20.3 1.6 20.8 47.0 166.5 2.0 56.9 124.6 0.6 0.0 0.0 160.4 2.0 0.7 0.0 81.3 1.5 1.5 0.0 0.1 1.7 0.5 65.7 5.4 98.2 1.3 1.2 5.0 18.6 3.0 2.7 117.4 0.0 12.9 TENT5A "C6orf37, FAM46A, FLJ20037" ENSG00000112773 "Terminal nucleotidyltransferase 5A" Q96IP4 6 81491439-81752774 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 228.0;salivary gland: 105.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 13.6 21.5 5.2 8.0 4.4 228.0 12.3 8.2 11.3 21.5 9.9 17.3 16.5 10.3 19.9 4.5 12.1 32.6 20.4 5.7 22.7 6.5 36.2 9.1 5.3 6.6 6.8 2.8 23.8 8.3 9.5 17.5 18.9 5.8 10.0 17.0 8.8 105.2 25.1 2.1 18.8 22.4 11.2 4.9 10.0 38.2 3.7 6.5 3.0 8.8 5.1 4.3 16.7 8.9 7.4 3.5 5.0 3.3 0.2 67.9 29.8 6.2 27.0 19.2 15.7 23.5 51.0 2.6 0.3 1.0 81.9 10.0 2.9 2.4 4.2 11.5 0.0 6.2 0.1 86.1 8.0 21.2 95.6 7.1 13.2 2.4 12.3 2.1 51.2 2.0 0.8 1.4 0.0 10.6 14.7 0.0 67.2 0.9 29.2 3.8 0.0 28.8 0.1 2.1 6.2 3.3 4.4 12.1 5.2 8.3 9.9 1.2 162.0 4.5 17.9 3.8 7.6 7.6 0.4 0.3 0.3 25.3 72.7 7.8 37.3 29.9 46.3 11.5 29.6 6.8 18.2 4.3 5.7 24.2 21.0 8.1 8.0 13.8 16.9 47.3 8.5 5.6 14.0 5.2 4.4 8.2 11.3 5.7 22.7 6.6 6.8 2.8 5.8 4.9 6.5 7.4 22.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 40.8 44.2 0.0 0.0 0.0 5.5 0.0 39.9 43.1 0.0 3.9 30.5 0.0 73.1 70.6 2.9 0.0 0.0 0.0 23.4 115.4 32.7 0.0 176.7 0.0 40.9 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 26.7 0.0 0.0 5.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 162.0 9.4 12.6 0.0 0.0 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.7;skeletal muscle: 292.4;tongue: 99.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 5.1" "Lineage enriched" "Detected in single" 17 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 400000 "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 12.5 1.5 3.0 4.3 4.4 0.2 6.6 1.6 2.9 19.1 0.6 28.9 21.0 2.1 0.9 2.9 4.5 3.0 103.7 2.1 5.5 53.2 0.3 71.4 1.7 2.3 2.4 1.5 0.5 1.1 1.7 3.0 16.6 3.0 2.6 26.0 17.1 2.7 1.4 292.4 1.1 36.9 2.3 1.5 44.9 1.7 1.4 4.0 1.0 7.4 99.2 1.9 2.0 2.7 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.5 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.4 1.6 0.0 11.9 0.3 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.1 0.1 2.0 1.3 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 1.0 0.5 3.0 4.4 1.6 2.9 2.1 5.5 2.3 2.4 1.5 3.0 1.5 4.0 1.9 59.6 509.6 30.0 4.6 1.4 0.1 0.1 0.0 1.2 0.3 0.5 0.4 285.7 5.7 26.9 14.7 0.0 0.2 0.7 164.2 0.0 1.7 52.9 4.6 0.5 29.8 13.1 0.4 8.6 0.2 0.1 7.9 0.5 5.7 1.3 0.0 0.7 0.0 0.0 0.0 5.4 23.5 0.0 0.0 0.0 93.8 0.9 0.7 0.0 34.7 0.6 53.8 0.0 0.5 2.9 2.9 51.1 0.7 3.4 3.2 126.0 2.9 11.4 1.8 0.0 6.1 4.3 1.0 0.1 0.1 0.1 2.2 5.8 0.1 13.5 4.3 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 12.1 19.4 15.6 8.8 11.6 10.2 13.3 19.5 21.4 17.4 6.0 20.1 11.3 18.8 7.8 15.7 18.8 4.1 27.0 15.4 6.1 19.2 27.0 16.3 8.6 9.2 7.2 11.3 22.5 39.5 7.3 28.9 5.8 12.3 22.1 3.6 5.9 14.9 7.3 32.2 19.1 23.5 4.1 3.2 28.5 21.5 29.3 8.1 6.3 15.8 9.5 4.8 18.0 15.8 9.7 11.7 18.5 8.7 14.8 3.7 4.5 64.4 10.9 3.1 7.1 4.3 32.7 6.9 19.0 18.4 3.6 6.1 22.6 9.3 6.1 2.3 14.7 47.6 23.2 11.0 25.0 8.0 24.7 23.4 4.1 10.7 6.6 4.8 6.5 7.0 15.9 49.9 3.8 3.1 29.8 33.7 90.0 22.7 8.4 33.4 50.9 9.3 13.2 6.2 11.2 33.4 28.0 10.2 15.8 14.1 3.6 18.6 23.7 11.1 7.6 18.5 13.7 13.9 24.6 13.0 12.0 8.8 23.8 9.4 1.2 0.4 1.2 0.3 0.3 0.3 0.8 0.3 0.3 0.3 0.6 0.3 0.4 0.5 0.2 0.7 1.0 0.6 0.3 15.6 11.6 19.5 21.4 15.4 6.1 9.2 7.2 11.3 12.3 3.2 8.1 9.7 14.9 3.2 5.2 24.2 12.8 9.2 7.1 3.3 11.4 28.9 20.7 18.5 13.7 4.3 4.0 11.0 41.7 6.9 19.8 24.0 7.9 6.2 1.4 16.8 17.9 8.8 31.0 12.0 17.0 7.6 5.8 11.8 15.3 22.0 1.3 22.6 7.5 22.2 6.9 11.8 17.1 21.7 0.0 11.6 11.1 2.0 16.1 16.4 5.4 15.0 7.7 9.3 6.2 12.5 16.8 9.0 15.0 15.4 11.9 16.0 13.3 6.4 6.4 22.7 6.6 12.7 11.5 5.7 8.0 10.8 10.4 11.5 10.9 12.7 18.7 10.4 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase family member 5" Q9UJA9 6 46159185-46170980 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 245.8" "Cell type enhanced" "Detected in many" "Muller glia cells: 100.1;Respiratory ciliated cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.9" "Lineage enriched" "Detected in many" 5 "T-cells: 14.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 620000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 8.7 7.1 1.2 8.3 0.2 13.5 7.6 12.9 12.9 3.7 2.6 1.6 1.8 245.8 1.8 15.5 7.1 4.5 6.9 21.7 24.5 0.5 8.9 1.2 6.4 12.1 6.0 9.8 9.8 46.7 20.0 1.7 7.4 29.6 3.2 30.9 14.5 31.2 10.8 1.4 1.9 0.9 3.8 5.7 6.8 35.8 14.1 8.2 51.5 10.4 1.4 5.6 1.8 10.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.5 0.1 0.3 11.1 1.8 3.6 0.2 3.7 0.0 0.6 1.5 0.1 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 1.9 0.0 0.5 2.3 5.4 0.0 0.0 0.2 0.2 4.5 0.6 4.7 0.2 0.0 4.6 0.0 6.2 8.7 0.0 0.0 0.0 1.2 0.0 0.1 5.3 7.9 0.0 2.8 0.0 0.1 0.0 0.0 0.0 14.9 0.1 8.0 0.5 3.0 9.7 0.0 0.8 0.9 8.7 1.1 2.8 0.0 0.0 0.0 3.2 7.1 8.3 7.6 12.9 6.9 21.7 6.4 12.1 6.0 7.4 3.8 14.1 10.1 0.4 12.8 12.2 16.3 1.6 0.9 4.8 0.5 1.2 10.6 18.1 10.8 7.5 8.6 6.1 23.9 4.2 4.9 4.2 1.9 1.9 11.6 0.7 15.3 0.8 0.4 8.3 0.0 24.6 7.5 2.9 4.2 2.0 5.4 4.5 4.0 0.4 0.1 0.4 10.1 14.5 2.8 2.0 0.0 0.4 3.8 2.8 0.5 0.0 1.9 0.6 100.1 23.7 9.0 10.5 2.2 2.3 12.0 0.1 12.0 1.7 16.3 47.3 3.4 6.6 25.7 1.8 0.5 2.4 1.1 0.6 0.3 3.2 21.2 2.9 3.3 LY86 "dJ80N2.1, MD-1" ENSG00000112799 "Lymphocyte antigen 86" O95711 6 6588108-6654983 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.0" "Group enriched" "Detected in many" 9 "B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6" "Cancer enhanced" "Detected in all" "glioma: 22.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 426.6;myeloid DC: 426.1" "Group enriched" "Detected in all" 43 "B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6" "Cell line enhanced" "Detected in some" "Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025000, HPA044895" Approved "Secreted to blood" NA NA 77000 "CAB025000: , HPA044895: AB_2679138" "unprognostic (1.82e-1)" "unprognostic (2.49e-3)" "unprognostic (2.01e-2)" "unprognostic (7.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.93e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-3)" "unprognostic (3.52e-2)" "unprognostic (3.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" 9.8 10.4 13.6 31.2 14.9 29.5 7.5 14.9 22.2 8.3 15.1 7.7 5.0 3.8 2.8 3.1 4.3 14.7 2.9 13.3 19.2 3.1 13.4 30.0 72.7 17.8 14.7 12.6 3.3 3.1 3.4 2.3 14.6 18.2 3.9 11.2 1.2 5.5 6.2 0.7 3.4 17.0 11.2 19.3 53.2 6.3 1.8 17.5 15.3 1.5 1.1 79.0 15.8 1.1 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 44.7 0.0 0.0 0.0 8.0 0.0 245.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 103.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 30.3 0.0 45.8 0.0 4.1 426.6 3.5 1.0 234.9 0.7 335.1 1.1 1.1 426.1 248.8 4.7 2.7 9.1 5.3 88.3 16.3 1.8 221.1 13.6 14.9 14.9 22.2 13.3 19.2 17.8 14.7 12.6 18.2 19.3 17.5 22.0 1.2 0.0 15.0 1.6 124.9 2.0 0.0 0.0 0.0 0.0 0.9 3.7 1.5 1.5 1.3 0.0 0.0 1.4 9.8 0.0 0.0 0.0 3.4 0.4 0.1 5.4 0.0 3.8 3.8 0.0 1.8 2.1 0.0 0.0 1.3 0.0 4.2 1.3 191.7 0.0 0.6 0.3 0.0 199.1 118.6 15.4 0.3 149.8 0.0 105.9 155.6 0.0 4.1 0.5 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.7 0.4 6.6 0.4 0.2 5.3 0.2 0.3 2.4 1.9 3.6 0.0 0.2 0.2 PRSS16 TSSP ENSG00000112812 "Serine protease 16" Q9NQE7 6 27247701-27256624 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 58 "lymphoid tissue: 834.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 42.1;Extravillous trophoblasts: 25.4;Syncytiotrophoblasts: 31.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "memory B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in many" "hTCEpi: 20.4;RPMI-8226: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (9.21e-3)" "unprognostic (1.57e-1)" "unprognostic (7.89e-2)" "prognostic favorable (6.46e-5)" "unprognostic (1.57e-1)" "unprognostic (3.49e-2)" "unprognostic (5.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.62e-2)" 0.1 0.4 0.0 0.3 0.1 0.0 6.0 0.1 0.4 3.7 0.0 5.8 4.5 0.7 13.6 3.0 5.7 4.0 0.0 0.1 0.0 1.8 0.0 3.8 0.1 0.0 0.0 0.0 2.5 14.2 7.8 1.4 4.1 0.1 3.2 6.8 0.1 7.6 4.2 0.0 5.2 3.4 0.2 0.0 0.3 4.8 1.0 0.0 834.3 13.2 0.0 1.5 2.5 1.0 0.1 3.2 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.1 3.8 4.7 0.0 0.7 0.0 0.0 1.5 2.7 3.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.1 0.5 0.0 20.4 0.0 4.1 0.5 0.0 1.7 2.5 1.9 0.0 1.2 0.5 0.0 0.7 2.1 0.5 0.0 0.0 11.5 2.4 3.6 0.0 0.0 1.4 3.2 0.0 4.5 2.0 0.9 0.0 0.0 0.7 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.7 2.1 0.9 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 9.6 7.7 0.0 2.6 6.4 10.8 4.6 8.6 0.0 16.6 9.5 0.4 15.7 4.6 14.7 0.0 42.1 0.2 22.9 1.9 10.0 0.6 2.5 0.8 0.4 4.2 0.0 0.7 17.6 25.4 0.7 12.8 8.0 5.7 0.1 0.0 0.0 4.0 0.0 0.2 20.0 14.2 0.3 0.4 0.5 0.6 0.3 5.4 0.0 0.2 1.2 0.0 0.0 0.1 9.4 18.7 0.0 13.7 6.9 16.5 0.7 3.4 0.0 0.0 0.0 1.2 2.0 6.1 8.6 6.5 31.7 1.1 0.0 14.9 8.5 MEP1A PPHA ENSG00000112818 "Meprin A subunit alpha" Q16819 6 46793389-46839778 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 101 "intestine: 471.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 309.4;Intestinal goblet cells: 87.0;Paneth cells: 156.9;Proximal enterocytes: 902.8" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 38.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;CACO-2: 2.9;RPMI-8226: 1.2" "CAB025163, HPA029416" Enhanced NA NA 2100000 "CAB025163: , HPA029416: AB_10600823" "unprognostic (1.83e-1)" "unprognostic (2.81e-4)" "unprognostic (2.03e-1)" "unprognostic (8.53e-2)" "unprognostic (8.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-2)" "unprognostic (5.27e-4)" "unprognostic (2.05e-1)" "unprognostic (2.35e-2)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.45e-1)" "unprognostic (1.91e-2)" "unprognostic (4.70e-3)" "unprognostic (1.68e-1)" 0.2 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 116.7 272.3 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 4.2 0.0 0.0 0.5 0.1 0.1 103.5 0.0 0.0 0.2 0.0 0.0 471.7 2.6 0.1 0.1 0.6 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 309.4 0.0 0.0 7.7 0.1 0.0 0.0 15.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 87.0 0.0 0.0 0.0 6.9 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.5 0.3 0.0 156.9 0.4 0.0 0.0 902.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 45.8 0.0 TBX18 ENSG00000112837 "T-box transcription factor 18" O95935 6 84687351-84764598 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "Microglial cells: 91.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006807 Supported Nucleoplasm NA NA Nucleoplasm "HPA006807: " "unprognostic (8.04e-2)" "unprognostic (7.06e-3)" "unprognostic (9.71e-2)" "unprognostic (2.31e-1)" "unprognostic (4.00e-1)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-1)" "unprognostic (2.57e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.88e-14)" "unprognostic (4.81e-5)" "unprognostic (1.86e-1)" "unprognostic (3.07e-3)" "unprognostic (1.78e-1)" 6.9 2.0 1.9 0.9 2.3 0.0 6.1 1.1 4.0 1.8 7.0 0.7 0.1 1.4 0.4 3.1 1.9 1.5 5.0 1.3 1.5 0.3 0.3 0.3 1.8 2.1 1.6 0.6 2.7 0.5 0.4 1.6 1.8 1.6 0.6 0.4 0.1 1.6 1.1 1.3 4.1 1.1 0.5 1.5 0.0 0.4 1.0 1.9 0.6 1.7 1.4 0.2 4.6 2.9 1.7 0.0 57.4 0.0 0.0 39.0 40.4 0.0 23.5 11.5 17.4 16.5 0.4 0.0 0.1 0.0 9.8 0.0 3.0 0.0 13.8 14.0 0.0 23.2 0.0 0.0 0.0 5.0 0.0 23.1 17.1 1.3 12.1 25.8 0.0 20.2 0.0 30.7 0.2 12.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 37.3 0.0 0.3 0.0 0.2 1.2 0.0 1.0 9.0 1.4 0.0 31.0 18.2 0.0 4.8 17.6 0.0 0.3 0.0 0.0 10.9 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.3 1.1 4.0 1.3 1.5 2.1 1.6 0.6 1.6 1.5 1.9 1.7 1.6 0.0 0.0 0.3 0.0 5.5 0.0 0.4 0.0 0.0 0.2 0.3 2.3 0.0 0.3 0.0 0.0 0.1 0.1 0.2 0.0 0.0 6.9 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.4 0.0 2.1 6.1 2.3 1.2 0.1 8.8 91.8 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 1.0 0.1 0.2 0.1 0.0 1.6 16.9 0.4 3.1 0.1 4.4 0.1 0.8 0.8 0.3 0.0 ERBIN "ERBB2IP, LAP2" ENSG00000112851 "Erbb2 interacting protein" Q96RT1 5 65926556-66082546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 123.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;dendritic cells: 61.3;Endometrial ciliated cells: 62.3;Glandular and luminal cells: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048606, HPA059863" Approved Supported "Nuclear speckles,Plasma membrane" NA NA 39000 "Nuclear speckles, Plasma membrane" "HPA048606: AB_2680461, HPA059863: AB_2684146" "unprognostic (4.34e-1)" "unprognostic (5.56e-2)" "unprognostic (9.88e-2)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (4.23e-3)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" "unprognostic (6.52e-2)" "unprognostic (5.45e-3)" "unprognostic (7.98e-2)" "unprognostic (5.62e-3)" "unprognostic (7.21e-3)" "unprognostic (3.08e-1)" "unprognostic (6.86e-2)" "unprognostic (7.81e-2)" 15.9 14.6 70.0 29.8 104.8 30.2 24.9 68.1 64.5 23.4 26.6 28.1 24.7 22.8 27.2 20.3 20.2 28.7 17.0 56.7 96.3 29.8 33.6 21.7 41.0 94.3 89.9 45.4 20.2 19.0 22.8 8.3 16.5 105.0 26.6 26.6 28.4 22.0 20.4 20.0 33.1 44.4 19.9 72.8 31.7 40.7 27.7 93.3 49.2 30.2 20.8 39.3 28.8 13.1 123.9 97.8 32.2 41.5 49.6 30.0 36.0 31.5 61.5 62.6 85.3 94.3 31.5 113.8 82.2 58.8 95.3 67.2 31.7 26.5 45.1 149.4 36.3 12.0 28.3 41.3 24.7 39.5 22.0 26.3 39.4 29.2 47.2 67.5 50.0 32.1 37.1 29.4 54.6 58.1 33.5 59.0 25.1 10.1 9.7 9.5 53.7 33.0 45.8 49.9 65.6 20.0 18.7 65.0 21.7 46.4 30.9 38.4 53.8 29.8 48.3 85.9 29.8 80.8 47.2 31.7 69.8 31.6 35.9 28.1 13.1 4.1 5.5 5.2 5.8 4.8 4.7 3.9 4.6 3.5 3.7 4.5 4.8 9.2 3.9 5.1 2.2 3.8 2.8 70.0 104.8 68.1 64.5 56.7 96.3 94.3 89.9 45.4 105.0 72.8 93.3 123.9 53.0 70.5 57.5 0.0 13.2 0.0 0.0 0.0 0.0 0.0 39.4 24.8 0.0 0.0 31.6 53.3 0.0 6.5 61.3 0.0 11.7 26.7 0.0 62.3 50.0 26.1 0.0 0.0 0.0 24.9 11.2 16.2 0.0 101.9 27.8 47.8 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 50.3 0.0 0.0 13.3 0.0 0.0 41.7 24.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 8.9 20.0 51.4 0.0 0.0 PCDHB2 PCDH-BETA2 ENSG00000112852 "Protocadherin beta 2" Q9Y5E7 5 141094606-141098703 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 5.1;Endometrial stromal cells: 7.2;Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 23.7;AN3-CA: 51.0;EFO-21: 28.7;U-138 MG: 22.2" "Low region specificity" "Detected in many" HPA007548 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA007548: AB_2667859" "unprognostic (2.94e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-4)" "unprognostic (1.31e-1)" "unprognostic (3.03e-3)" "unprognostic (7.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.24e-1)" "unprognostic (3.99e-1)" "unprognostic (2.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.84e-4)" 2.7 0.9 0.6 0.4 1.2 0.1 2.7 0.9 2.5 1.7 0.0 1.9 0.6 2.3 0.6 1.0 1.3 1.4 1.8 2.3 1.1 1.0 0.2 2.2 0.2 0.7 0.8 0.5 1.8 1.0 0.1 1.8 0.7 0.7 1.5 0.9 1.4 1.7 0.4 1.0 1.9 1.0 1.4 0.9 0.6 0.9 5.6 0.8 0.2 1.3 1.3 0.1 1.2 1.3 1.7 0.4 3.4 23.7 51.0 6.7 3.1 10.8 0.9 3.7 0.0 0.0 0.6 0.2 0.9 28.7 1.7 5.6 0.0 1.2 0.3 0.0 0.3 0.8 0.0 0.1 6.9 0.0 0.0 2.4 1.6 0.0 0.0 0.4 1.0 0.5 2.9 0.8 0.7 7.1 0.2 6.9 0.0 10.5 0.3 6.7 0.0 17.6 0.2 2.6 0.0 13.1 3.6 0.0 3.4 7.6 13.2 14.6 4.3 2.8 22.2 6.6 10.5 3.4 0.3 0.1 0.2 4.8 0.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.9 2.5 2.3 1.1 0.7 0.8 0.5 0.7 0.9 0.8 1.7 5.1 0.0 0.5 0.0 0.0 0.8 1.1 0.6 4.0 3.1 1.8 1.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.6 2.1 7.2 2.5 1.2 0.0 0.0 0.4 0.0 3.7 0.5 1.3 0.0 0.7 0.0 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.3 1.0 1.2 0.1 3.6 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.1 1.5 0.0 0.8 0.0 0.3 0.8 1.4 0.0 3.0 1.9 9.9 4.0 0.7 0.4 0.0 0.1 0.1 0.1 0.7 HARS2 "HARSL, HARSR, HO3" ENSG00000112855 "Histidyl-tRNA synthetase 2, mitochondrial" P49590 5 140691430-140699305 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035941, HPA075303" Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035941: AB_10671237, HPA075303: " "prognostic unfavorable (6.49e-4)" "unprognostic (3.15e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.79e-2)" "unprognostic (1.78e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (2.92e-4)" "unprognostic (7.77e-2)" "unprognostic (1.88e-1)" "unprognostic (5.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.68e-2)" "unprognostic (1.85e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (1.31e-2)" 18.2 24.8 13.5 13.9 13.8 14.5 19.1 13.5 13.8 21.9 16.0 21.9 16.7 19.7 15.2 20.2 18.6 9.8 23.6 13.7 14.5 21.5 19.4 16.1 15.2 14.0 13.7 13.3 21.3 15.8 20.9 20.9 14.3 14.0 20.4 22.6 11.6 17.7 13.6 35.3 21.2 21.1 14.2 13.0 27.1 20.5 14.9 14.1 15.3 19.2 28.6 16.2 21.3 20.8 15.4 20.9 46.2 19.6 50.6 21.9 28.6 32.3 26.3 29.8 36.1 31.4 42.7 25.5 26.3 41.3 29.3 35.5 25.9 27.3 49.4 33.2 26.6 22.4 19.1 45.3 28.6 20.9 26.1 27.1 27.0 32.9 35.3 39.7 29.4 26.5 27.4 18.0 24.1 35.6 26.6 25.7 32.1 22.6 15.7 28.9 25.8 19.9 26.8 33.9 48.1 27.0 38.9 38.1 61.0 54.2 28.5 54.0 25.5 32.5 32.4 17.8 18.2 35.2 23.6 37.0 25.2 25.4 29.5 32.9 37.7 13.1 28.6 19.1 18.9 21.1 16.9 18.4 19.2 14.9 14.8 19.0 20.6 15.1 29.3 15.0 12.1 20.1 13.3 13.5 13.8 13.5 13.8 13.7 14.5 14.0 13.7 13.3 14.0 13.0 14.1 15.4 8.6 3.2 5.8 2.6 12.3 3.4 3.7 7.8 9.6 5.5 5.9 5.5 20.4 7.2 7.8 5.5 0.0 20.3 6.6 8.5 13.7 14.9 1.1 5.3 8.0 9.7 7.7 9.9 5.5 16.1 18.7 6.3 13.3 6.4 2.5 11.8 9.7 7.2 10.0 0.0 4.8 8.7 18.3 8.2 6.2 2.3 9.3 7.4 3.6 2.8 12.8 8.3 3.1 6.0 6.2 18.3 12.1 10.5 9.6 4.1 7.2 9.0 8.6 5.6 0.0 4.4 7.0 8.9 14.4 9.5 4.0 14.4 8.0 11.2 11.7 4.4 NUDT12 DKFZP761I172 ENSG00000112874 "Nudix hydrolase 12" Q9BQG2 5 103548855-103562790 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Distal tubular cells: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045449 Supported NA NA "HPA045449: AB_2679327" "unprognostic (1.94e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.44e-1)" "unprognostic (7.53e-2)" "unprognostic (1.10e-1)" "unprognostic (2.61e-1)" "unprognostic (8.79e-2)" "unprognostic (9.16e-2)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.92e-1)" "prognostic favorable (2.86e-5)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (2.67e-1)" "unprognostic (5.92e-2)" 5.8 12.2 5.8 3.7 7.7 0.9 12.1 7.6 7.2 9.3 6.9 13.4 17.1 6.4 12.1 7.7 8.6 7.4 10.4 5.2 6.6 26.9 28.6 6.5 2.7 7.8 7.3 4.8 6.7 12.4 24.6 4.0 5.0 7.6 14.7 14.5 12.6 13.1 7.9 13.5 7.4 14.4 6.1 7.1 4.4 14.3 5.1 6.6 4.7 16.2 8.9 3.6 6.1 4.0 9.8 6.2 2.7 14.6 5.5 9.8 20.3 0.0 10.7 10.1 9.5 12.2 5.3 22.0 0.0 6.9 6.2 10.6 9.9 13.8 22.3 13.2 0.0 8.3 6.4 10.1 2.8 10.1 0.0 0.0 9.7 19.1 6.3 16.3 11.2 6.6 0.0 10.5 0.0 16.8 11.5 0.5 0.3 7.5 0.0 8.4 0.0 12.9 5.0 15.9 10.7 11.0 11.4 6.9 10.3 16.5 11.5 22.6 6.4 8.0 12.0 4.3 10.5 8.7 7.2 11.6 0.0 12.3 0.0 8.9 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.9 0.4 0.6 0.3 0.0 0.5 0.3 1.1 0.1 0.2 5.8 7.7 7.6 7.2 5.2 6.6 7.8 7.3 4.8 7.6 7.1 6.6 9.8 5.8 9.6 9.0 10.4 1.6 3.3 6.3 13.8 12.5 10.4 9.2 5.1 11.9 15.7 9.0 12.9 2.1 5.9 2.3 15.4 58.7 11.2 7.1 9.5 7.9 4.6 4.2 4.2 8.3 14.2 4.6 7.0 13.3 5.8 1.3 9.4 3.3 14.7 6.1 11.8 9.0 17.5 14.2 4.6 1.9 4.9 13.4 4.6 8.8 2.8 3.0 13.1 1.0 14.6 23.7 10.6 15.7 10.5 1.2 7.6 21.1 34.0 15.8 17.7 6.6 8.5 6.2 11.0 7.6 10.9 3.1 3.0 1.1 11.7 14.1 7.7 CEP72 "FLJ10565, KIAA1519" ENSG00000112877 "Centrosomal protein 72" Q9P209 5 612340-667168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 7.3" "Cell type enriched" "Detected in many" 4 "Melanocytes: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 4.5" "Group enriched" "Detected in many" 4 "B-cells: 1.6;NK-cells: 4.5;T-cells: 1.7" "Cell line enhanced" "Detected in many" "HDLM-2: 46.0;HeLa: 40.0" "Region enriched" "Detected in many" 8 "cerebellum: 14.1" "Not detected" "Not detected" "HPA058235, HPA074879" Approved Approved Nucleoplasm,Centrosome,Mitochondria NA NA Centrosome "Nucleoplasm, Mitochondria" "HPA058235: AB_2683649, HPA074879: AB_2686720" "unprognostic (2.06e-1)" "unprognostic (3.15e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (8.50e-2)" "unprognostic (9.74e-2)" "unprognostic (2.94e-3)" "unprognostic (3.20e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.38e-2)" "unprognostic (4.38e-3)" "unprognostic (1.81e-3)" "unprognostic (3.60e-2)" "unprognostic (2.93e-1)" "unprognostic (4.68e-2)" "unprognostic (1.24e-2)" 1.1 0.9 1.1 1.9 1.1 3.1 1.4 1.3 1.3 1.6 0.8 1.1 1.4 1.3 1.0 2.2 1.6 1.5 0.8 1.4 0.9 1.1 2.1 1.4 2.7 0.9 0.8 1.0 2.8 2.0 1.2 1.5 0.7 1.0 1.3 0.9 1.1 1.7 0.8 0.7 2.4 1.6 0.9 0.5 1.8 1.9 7.3 0.9 3.1 1.8 0.6 1.4 1.3 1.7 1.8 7.5 11.9 10.6 15.0 0.9 1.0 19.1 3.2 1.4 7.1 6.2 10.8 11.2 8.8 8.2 1.4 13.2 7.1 7.5 5.4 2.8 46.0 11.8 9.7 40.0 4.3 1.3 11.3 6.3 1.1 2.3 6.1 4.1 1.4 2.8 17.0 10.1 10.1 3.5 5.7 17.1 9.8 7.0 6.4 11.1 12.8 6.1 12.2 2.3 5.8 8.1 6.2 23.3 7.6 2.0 3.3 7.6 8.7 0.9 6.8 9.9 6.5 4.6 6.3 6.4 8.8 4.2 15.7 7.3 0.0 0.3 0.3 1.3 0.1 1.7 1.4 1.1 1.2 0.1 1.6 1.6 1.6 0.0 4.5 0.6 0.4 1.5 0.8 1.1 1.1 1.3 1.3 1.4 0.9 0.9 0.8 1.0 1.0 0.5 0.9 1.8 0.7 3.2 1.5 1.3 2.9 5.7 0.9 2.4 0.6 2.5 1.1 1.8 2.2 2.8 1.0 0.0 0.0 1.2 1.1 1.1 0.0 2.5 4.0 2.4 1.5 1.1 0.0 4.2 2.5 0.9 5.1 1.0 3.6 1.9 0.0 3.8 0.4 1.7 1.4 3.3 1.3 0.7 4.1 0.8 2.9 2.2 1.2 0.7 135.2 1.0 1.4 0.9 2.1 2.0 3.9 2.3 0.5 2.6 4.7 1.1 0.1 0.5 3.4 2.0 0.0 1.3 1.1 30.7 10.1 2.8 3.7 1.6 1.9 0.9 1.3 2.5 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689927-109869625 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 107.9" "Cell type enriched" "Detected in many" 9 "Oligodendrocytes: 2117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" NA NA 110000000 "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 11.3 17.1 33.2 14.0 57.4 12.8 11.4 38.6 29.2 13.9 2.9 20.9 30.4 12.1 4.3 8.6 9.1 18.2 3.8 18.3 29.7 17.6 42.8 10.2 15.9 54.5 47.9 8.9 9.8 22.4 20.9 0.9 15.5 64.2 9.2 21.0 1.7 6.6 10.2 6.0 7.5 26.0 18.5 46.1 14.2 15.8 9.6 44.1 22.9 14.9 11.6 14.8 16.3 2.7 107.9 23.1 18.6 26.5 11.0 56.2 42.2 97.5 49.3 78.0 26.1 46.7 23.2 37.0 17.4 30.7 63.3 18.5 26.5 14.5 56.0 59.7 16.3 9.7 32.6 13.5 30.7 34.6 15.9 15.5 39.7 25.0 43.4 61.4 37.3 54.5 16.9 8.8 87.0 70.5 13.8 27.6 9.1 20.4 17.9 7.3 10.8 40.0 78.5 34.1 32.8 3.7 3.3 22.6 24.9 16.1 29.1 20.5 17.1 56.4 53.7 21.3 30.1 32.9 48.7 58.7 13.6 41.8 22.4 30.3 4.1 2.0 0.6 1.6 2.8 1.3 1.9 2.8 2.8 1.8 1.6 3.3 2.7 1.6 0.5 4.4 2.0 2.8 1.1 33.2 57.4 38.6 29.2 18.3 29.7 54.5 47.9 8.9 64.2 46.1 44.1 107.9 20.9 6.4 8.4 100.9 41.1 17.8 15.8 12.7 29.6 0.6 20.0 9.5 7.6 34.3 14.7 31.3 0.0 19.4 28.9 65.8 1.9 27.1 13.7 10.2 35.8 21.6 24.7 29.2 220.8 35.3 98.0 32.3 45.3 33.3 15.2 19.2 36.8 130.3 18.0 0.0 115.2 35.2 22.4 74.8 24.6 8.3 9.9 47.4 26.6 102.1 39.6 5.9 13.4 46.8 2117.7 28.8 28.4 6.8 84.0 39.8 60.6 24.7 12.1 0.2 19.7 52.6 16.5 16.5 19.9 33.6 23.7 23.7 34.7 14.2 49.6 24.2 SEMA5A "SEMAF, semF" ENSG00000112902 "Semaphorin 5A" Q13591 5 9035033-9546075 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 1189.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 64.2;fHDF/TERT166: 37.1;RT4: 66.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004632 Approved NA NA 13000 "HPA004632: AB_1079905" "unprognostic (1.48e-1)" "unprognostic (1.68e-2)" "unprognostic (1.40e-2)" "unprognostic (6.67e-2)" "unprognostic (3.65e-1)" "prognostic favorable (2.45e-4)" "unprognostic (7.02e-2)" "unprognostic (1.75e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.10e-2)" "unprognostic (8.15e-2)" "prognostic favorable (3.66e-8)" "unprognostic (8.51e-3)" "unprognostic (1.27e-2)" "unprognostic (3.57e-1)" "unprognostic (3.01e-2)" 4.6 1.2 8.3 2.7 8.9 0.0 6.9 5.2 24.0 13.1 3.5 9.6 3.0 9.0 2.2 3.1 2.9 5.5 9.5 30.1 12.1 11.7 4.9 11.2 4.7 10.5 11.1 6.9 1.7 4.5 1.9 2.3 7.0 10.3 3.0 7.6 7.1 2.1 5.0 1.4 4.4 5.4 2.5 8.5 6.3 2.0 1.6 14.4 1.8 1.9 3.1 3.7 5.8 3.9 14.0 0.0 0.0 15.0 0.0 10.1 14.1 0.0 24.2 64.2 4.7 2.5 0.0 0.1 0.0 0.0 37.1 0.3 21.6 0.0 1.4 2.4 0.0 0.2 0.0 0.1 0.0 1.4 0.0 0.1 3.6 0.7 5.3 21.6 10.5 0.0 0.0 0.0 0.0 5.7 0.7 0.0 0.0 1.5 13.2 1.1 0.0 0.0 0.9 1.8 66.7 3.1 0.3 0.2 0.0 19.9 5.1 0.0 0.0 0.0 23.0 0.5 0.0 0.5 0.0 0.0 0.0 21.4 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 8.3 8.9 5.2 24.0 30.1 12.1 10.5 11.1 6.9 10.3 8.5 14.4 14.0 8.0 150.6 5.6 63.6 0.3 9.2 6.4 30.8 8.0 2.8 1.6 49.0 37.0 22.8 14.3 1.8 0.0 1.8 9.6 23.9 0.0 3.4 32.6 6.3 151.5 6.4 5.4 0.0 60.6 2.3 1.2 27.8 0.5 9.3 1.3 1.8 5.3 4.3 1.3 247.3 53.1 10.9 0.0 0.0 5.2 50.5 10.2 0.8 33.8 134.9 0.1 44.8 0.0 1189.7 152.3 1.2 8.0 14.7 0.0 8.2 16.9 14.4 2.0 3.6 39.5 4.3 40.5 0.6 0.5 11.4 4.8 1.9 1.4 29.0 20.5 14.1 C7 ENSG00000112936 "Complement C7" P10643 5 40909497-40984643 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 741.6" "Group enriched" "Detected in many" 4 "Fibroblasts: 578.4;Hepatic stellate cells: 662.5;Leydig cells: 1058.5;Sertoli cells: 309.0;Theca cells: 503.1" "Cancer enriched" "Detected in all" 4 "pancreatic cancer: 73.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 116.5;HHSteC: 155.1;HSkMC: 212.1;SH-SY5Y: 146.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "spinal cord: 13.7" HPA001465 Approved "Secreted to blood" NA NA 48000000000 "HPA001465: AB_1078554" "unprognostic (5.01e-2)" "unprognostic (3.74e-2)" "unprognostic (7.40e-2)" "unprognostic (4.68e-3)" "unprognostic (5.35e-2)" "unprognostic (1.43e-3)" "prognostic favorable (5.89e-4)" "unprognostic (6.67e-2)" "unprognostic (3.45e-1)" "unprognostic (2.21e-2)" "unprognostic (1.33e-1)" "unprognostic (1.93e-3)" "unprognostic (2.24e-2)" "unprognostic (6.10e-3)" "unprognostic (1.12e-1)" "unprognostic (2.14e-1)" "unprognostic (2.06e-3)" 253.7 613.5 2.8 21.9 3.0 0.2 46.8 2.4 11.4 91.6 21.8 132.8 19.5 125.6 165.0 53.4 380.7 213.6 367.5 2.5 3.0 295.0 111.5 208.6 100.0 4.4 2.6 2.4 741.6 151.1 15.2 23.3 362.3 3.4 102.5 32.8 1.5 18.2 106.7 4.3 10.5 140.9 258.3 4.2 139.3 121.2 28.2 2.7 32.5 106.0 1.6 22.7 123.1 119.3 3.4 0.0 0.0 0.0 0.0 116.5 16.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 155.1 0.0 0.0 212.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 146.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.8 3.0 2.4 11.4 2.5 3.0 4.4 2.6 2.4 3.4 4.2 2.7 3.4 7.9 6.4 4.1 0.0 1.4 0.6 0.5 0.0 1.8 2.1 1.2 0.3 56.7 7.2 2.5 0.0 0.0 0.2 0.1 0.4 0.0 0.2 4.7 0.5 7.9 127.6 54.8 26.7 0.1 1.3 0.1 578.4 0.0 0.2 1.3 2.7 662.5 8.3 0.5 43.7 0.3 1.3 0.0 14.5 4.2 29.8 1058.5 1.5 0.0 58.1 0.6 3.7 0.0 0.0 0.0 0.9 0.9 18.0 1.0 1.3 0.2 0.1 0.0 0.9 309.0 2.2 23.7 2.6 2.5 6.5 0.6 0.3 1.2 503.1 3.0 0.8 TENT4A "LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Terminal nucleotidyltransferase 4A" Q5XG87 5 6713432-6757044 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.2 8.2 7.3 9.6 8.3 27.8 11.1 15.8 9.8 12.4 5.8 9.9 8.8 11.2 6.5 10.8 11.6 10.1 8.3 8.5 7.5 9.0 20.6 12.9 13.1 6.5 7.2 8.0 15.8 12.1 10.1 11.2 9.2 10.4 11.2 7.3 12.6 8.3 8.9 9.3 15.8 12.5 12.3 5.9 13.8 9.7 10.2 7.5 14.8 10.3 12.2 10.5 10.2 11.9 8.7 31.7 20.9 25.4 31.6 17.7 15.6 37.0 21.0 25.7 25.1 28.2 21.9 17.3 23.1 16.1 25.5 28.5 22.9 20.7 16.4 23.1 26.1 14.0 12.0 72.5 12.4 11.0 18.0 17.3 10.7 13.8 28.7 18.4 18.6 15.0 16.9 16.3 29.8 20.8 17.6 24.4 25.3 13.6 9.7 16.6 21.8 21.2 6.0 10.5 17.5 25.1 19.3 50.7 24.1 14.5 13.4 14.5 9.9 13.6 30.6 32.7 27.2 29.8 28.6 12.6 20.4 19.6 16.4 19.2 0.0 0.2 0.2 0.6 0.1 0.6 0.5 0.4 0.4 0.3 0.4 0.5 0.5 0.1 0.1 0.2 1.1 0.6 0.2 7.3 8.3 15.8 9.8 8.5 7.5 6.5 7.2 8.0 10.4 5.9 7.5 8.7 19.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 13.4 13.2 0.0 0.0 0.0 5.5 0.0 5.3 12.3 0.0 1.9 4.9 0.0 10.7 15.4 4.8 0.0 0.0 0.0 4.4 4.0 4.0 0.0 14.0 0.0 14.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 4.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 5.6 4.8 10.7 0.0 0.0 GHR GHBP ENSG00000112964 "Growth hormone receptor" P10912 5 42423439-42721878 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 85.5;liver: 215.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0" "Group enriched" "Detected in many" 4 "breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 21.2;T-47d: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045339, HPA057705" Enhanced Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 2200000 24000000 "Plasma membrane, Cytosol, Cytoplasmic bodies" "HPA045339: AB_2679294, HPA057705: AB_2683507" "unprognostic (2.18e-2)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.96e-2)" "unprognostic (3.12e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.73e-6)" "unprognostic (1.06e-1)" "unprognostic (3.92e-2)" "unprognostic (3.73e-2)" "unprognostic (6.15e-3)" "unprognostic (2.67e-2)" "unprognostic (1.67e-3)" "unprognostic (4.29e-4)" "unprognostic (7.82e-2)" "unprognostic (7.33e-4)" "unprognostic (8.35e-6)" 85.5 5.6 1.6 1.7 2.3 0.2 30.3 1.9 1.7 5.1 2.4 5.3 1.1 4.5 4.6 3.9 5.4 5.2 9.0 1.8 4.2 11.9 215.0 4.0 1.3 1.1 1.9 1.5 7.6 2.2 5.5 1.2 4.9 1.4 11.2 5.7 0.4 3.8 4.7 46.1 5.6 4.3 4.0 1.1 4.1 6.1 1.7 2.6 2.3 4.7 11.7 0.9 5.0 5.9 1.5 0.0 0.0 0.6 5.0 3.3 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.3 4.3 0.0 0.0 2.6 0.0 0.1 0.0 0.6 0.0 0.0 21.2 7.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.3 0.0 0.7 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.3 0.1 3.5 0.6 56.0 0.1 3.0 4.8 2.1 2.6 0.5 0.5 0.0 0.0 0.5 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 2.3 1.9 1.7 1.8 4.2 1.1 1.9 1.5 1.4 1.1 2.6 1.5 17.2 0.0 0.5 14.7 0.4 4.7 4.5 17.8 10.2 0.6 9.7 16.0 18.6 1.5 1.9 1.8 0.0 17.4 0.5 2.8 1.9 0.0 5.1 0.5 9.4 4.8 3.0 5.3 53.3 0.2 2.2 23.8 0.5 0.3 0.0 1.1 6.1 141.3 1.9 0.0 115.7 1.9 0.0 3.0 1.8 2.8 18.6 0.7 1.8 36.5 0.0 0.7 0.0 181.0 3.6 0.2 1.7 12.0 0.0 5.2 0.0 9.6 0.6 0.4 13.1 18.7 15.1 0.7 0.3 2.9 3.7 40.2 0.5 49.4 2.2 0.9 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43287470-43313512 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 393.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 511.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 797.7;GAMG: 523.5;HBEC3-KT: 467.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 470000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favorable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 19.3 55.6 24.7 27.4 35.5 15.9 40.5 25.8 41.0 33.6 18.5 50.7 94.5 20.0 36.4 138.6 12.5 23.5 16.2 39.6 34.0 33.1 393.6 51.8 21.7 41.0 41.2 29.5 21.8 26.8 32.0 15.1 22.7 52.9 40.9 45.9 34.5 53.6 15.9 18.0 70.8 47.6 20.1 24.9 14.9 43.8 33.5 40.5 19.3 23.8 16.9 31.7 18.5 70.0 58.1 103.4 48.8 797.7 93.0 45.8 178.4 54.1 16.2 63.8 22.8 45.2 86.6 146.6 108.4 35.6 23.3 523.5 80.2 199.7 467.2 24.1 23.5 240.7 40.1 45.3 119.3 71.3 88.0 28.0 98.5 56.2 119.5 47.9 14.0 23.7 98.4 73.1 291.7 19.4 48.9 81.3 111.9 143.1 41.7 25.9 57.5 111.9 121.8 357.7 158.2 68.2 33.0 83.6 41.4 25.9 114.5 63.6 116.7 28.3 17.1 85.7 18.0 15.5 38.8 64.0 148.3 15.0 106.2 15.5 3.3 1.8 1.9 2.4 3.3 2.4 3.8 2.6 3.4 3.5 2.9 2.2 3.1 3.0 3.2 3.6 2.9 2.6 1.6 24.7 35.5 25.8 41.0 39.6 34.0 41.0 41.2 29.5 52.9 24.9 40.5 58.1 27.8 67.3 172.6 70.5 44.8 108.3 42.3 93.8 68.3 43.6 46.3 30.0 8.9 47.1 79.2 47.8 52.1 22.3 43.3 211.2 13.7 43.0 9.0 47.1 20.2 31.3 92.1 22.3 44.9 59.8 41.1 32.3 100.4 98.6 58.5 56.6 22.1 511.7 25.5 48.8 42.6 101.9 75.3 21.9 38.2 3.2 12.8 27.5 26.6 15.0 49.1 26.4 14.4 53.3 41.8 50.4 132.3 14.3 38.1 149.2 56.8 21.4 51.1 50.1 0.0 40.1 32.8 20.0 8.7 197.9 236.4 44.5 36.4 129.4 62.9 74.5 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761234 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 52.5 104.5 32.2 47.5 31.1 44.9 69.7 29.2 39.1 75.7 82.3 66.4 94.7 59.5 69.2 39.3 63.7 84.0 54.1 33.4 38.1 99.8 163.1 65.5 46.0 37.8 33.9 28.7 75.7 243.4 83.5 81.6 64.6 31.0 77.4 69.8 13.9 130.6 93.0 9.5 45.0 87.8 64.1 31.5 46.7 107.2 27.5 35.4 41.6 93.8 14.8 51.3 88.7 49.4 31.3 107.3 76.3 92.6 86.3 169.6 203.6 102.8 255.3 394.4 189.5 217.8 54.7 88.9 46.3 163.8 318.4 119.6 20.6 58.3 151.7 205.1 245.3 42.5 62.2 137.9 136.0 159.7 117.7 44.6 105.4 51.9 124.5 223.3 109.1 358.4 51.1 73.5 152.5 188.2 85.0 63.1 74.9 33.7 143.9 172.9 86.0 40.9 76.8 250.1 195.2 62.7 84.3 261.2 105.2 69.6 70.6 83.4 170.4 177.4 116.8 125.9 78.1 137.6 85.1 118.6 68.3 115.4 225.3 179.3 40.7 78.0 45.0 32.7 70.7 38.5 39.8 33.6 29.0 76.8 25.9 24.4 24.4 63.4 33.1 72.1 62.3 39.3 62.2 32.2 31.1 29.2 39.1 33.4 38.1 37.8 33.9 28.7 31.0 31.5 35.4 31.3 29.0 16.0 44.7 8.5 36.7 19.2 62.6 14.1 19.9 8.9 90.4 39.2 12.3 72.9 27.3 53.3 6.2 66.2 42.3 75.6 133.1 97.3 13.3 45.0 31.7 38.4 44.3 23.4 5.5 193.0 98.5 45.1 61.7 58.1 35.0 68.9 41.0 109.1 52.3 5.0 7.8 115.3 10.2 49.9 34.2 33.4 29.8 56.5 28.4 35.6 44.2 29.8 32.0 22.6 6.2 124.8 69.0 34.3 74.8 78.6 133.5 100.5 15.1 8.1 0.0 18.6 41.8 30.7 7.1 15.7 18.2 101.0 24.1 43.0 70.4 108.8 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115175-138139443 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 37.6;testis: 53.8" "Group enriched" "Detected in many" 4 "Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555, HPA058103" Enhanced Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: " "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favorable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.5 6.6 10.2 0.5 10.7 0.0 4.6 10.5 11.8 8.7 17.0 1.6 0.2 5.0 23.3 1.0 37.6 8.8 3.6 10.5 12.2 20.6 0.5 4.5 0.4 10.9 11.2 10.2 5.4 4.4 24.5 8.9 0.1 11.9 5.1 1.1 13.0 3.7 4.5 0.4 0.3 0.6 3.1 10.3 0.2 2.8 53.8 10.5 0.7 12.5 0.6 0.2 2.1 0.6 10.0 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.7 0.4 0.7 0.3 0.1 1.8 0.0 1.1 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 1.7 0.0 0.0 2.1 0.0 0.9 0.0 3.8 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 29.9 0.0 6.7 2.5 0.0 0.8 4.9 1.7 0.5 1.6 0.0 0.7 0.0 0.0 0.9 0.4 0.8 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 10.7 10.5 11.8 10.5 12.2 10.9 11.2 10.2 11.9 10.3 10.5 10.0 1.0 6.4 7.5 26.8 0.3 0.6 8.5 41.1 0.0 11.7 9.0 7.9 4.3 8.6 38.1 33.1 14.6 0.5 0.1 0.3 86.1 23.8 704.9 205.8 9.2 3.5 5.4 0.0 57.9 4.0 0.0 4.2 2.6 12.7 0.0 7.7 3.6 0.6 0.1 6.7 42.2 3.3 44.7 0.0 0.3 256.5 9.0 1.4 10.6 3.7 0.6 19.1 0.0 11.1 8.1 4.2 0.3 13.9 0.0 4.8 0.2 92.3 431.9 25.8 0.0 0.5 12.6 326.8 24.7 0.0 0.3 0.0 0.8 10.9 1.7 5.9 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139770-138178953 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 120.8;Spermatocytes: 226.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 21.2 21.7 25.7 15.5 25.9 22.6 25.4 29.1 28.8 29.5 22.6 28.2 15.6 28.6 41.7 23.7 26.8 16.5 19.2 23.9 25.8 25.2 25.6 19.6 20.8 23.6 23.5 23.4 33.0 30.8 26.4 47.0 25.1 24.6 27.5 25.1 39.0 25.3 24.1 28.0 23.8 23.5 25.3 22.8 27.8 25.1 83.8 24.4 38.3 34.6 25.3 22.3 24.5 25.0 31.3 28.7 36.8 63.1 101.8 45.0 42.0 57.0 43.4 47.9 61.6 64.4 55.4 62.6 28.6 42.2 40.3 62.9 32.9 67.4 41.5 65.9 50.3 50.1 38.5 93.6 38.0 25.0 23.6 39.2 31.4 27.2 48.7 44.1 49.3 39.7 52.2 35.2 35.8 41.3 31.8 48.4 37.6 28.6 32.9 18.8 46.4 52.2 35.1 41.4 41.3 55.7 27.9 51.9 22.4 40.1 85.0 38.5 43.2 25.0 30.2 34.7 21.2 38.1 31.5 37.9 39.1 23.1 34.7 28.5 16.2 10.8 14.1 14.6 8.0 15.8 10.7 12.7 13.2 12.0 11.0 15.9 16.0 20.2 23.8 8.8 8.4 13.0 9.8 25.7 25.9 29.1 28.8 23.9 25.8 23.6 23.5 23.4 24.6 22.8 24.4 31.3 21.0 25.6 38.3 28.1 17.8 6.9 10.6 16.4 31.9 33.7 19.8 20.3 44.8 14.3 27.0 27.6 37.5 27.7 19.0 17.0 19.6 19.5 120.8 30.1 51.1 24.3 31.2 26.5 26.2 12.4 13.2 32.5 20.9 29.7 24.0 43.2 13.6 17.2 11.9 30.3 23.7 23.3 14.2 14.8 9.8 43.9 31.4 14.3 24.9 12.2 31.3 27.1 19.6 27.6 30.8 16.0 16.8 24.0 21.8 18.1 15.4 22.4 29.0 34.9 26.3 23.2 31.7 226.9 65.0 23.2 7.0 25.3 19.1 41.9 18.6 10.1 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187723 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 24.8;testis: 11.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.0;Erythroid cells: 24.6;Extravillous trophoblasts: 13.1;Granulosa cells: 11.1;Spermatocytes: 21.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 6.6;T-reg: 2.5" "Group enriched" "Detected in many" 46 "NK-cells: 6.6;T-cells: 2.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036909, HPA036910" Approved Uncertain "Nucleoplasm,Cytokinetic bridge" Yes Yes "Nucleoplasm, Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 0.7 0.8 0.1 4.6 0.1 14.2 1.3 0.1 0.1 1.0 0.2 3.4 3.6 1.4 0.0 6.6 0.4 0.8 0.5 0.1 0.3 0.4 0.9 0.9 8.7 0.1 0.2 0.0 0.2 0.2 0.1 0.0 5.4 0.1 0.2 5.2 0.0 1.0 0.1 0.1 4.5 2.8 5.8 0.1 1.9 2.2 11.8 0.4 24.8 0.5 0.1 13.2 1.6 2.0 0.9 87.8 59.5 127.8 84.4 6.7 12.3 53.9 75.0 68.9 162.3 121.4 111.9 80.5 38.8 39.2 96.5 60.6 85.9 121.7 142.5 160.9 56.4 57.4 57.2 101.1 70.7 0.3 28.2 25.1 4.8 2.3 86.2 49.5 27.1 106.7 53.9 24.4 70.4 113.9 81.5 47.6 26.7 80.6 51.8 63.7 51.2 128.5 39.5 43.9 42.3 37.8 37.5 144.1 47.9 30.9 161.6 60.8 28.5 51.1 41.6 60.5 38.0 126.4 36.0 37.5 42.0 26.7 81.1 82.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 2.5 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.9 0.3 0.0 1.7 0.0 0.8 0.4 0.4 2.9 0.0 0.0 1.1 1.3 0.3 0.0 0.7 0.0 0.0 11.0 0.1 2.8 0.0 0.1 1.0 1.0 1.9 1.7 0.0 24.6 0.0 0.0 13.1 3.1 2.6 1.3 4.5 11.1 3.3 0.4 6.1 0.0 0.0 1.6 6.1 2.2 0.4 2.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.4 3.0 0.3 1.2 0.0 0.9 0.0 0.0 0.5 4.4 21.7 7.5 5.3 0.4 1.0 0.7 0.8 3.4 0.6 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 241.3;tongue: 387.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 344.3;Hepatocytes: 314.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004829, CAB004975" Enhanced Approved Mitochondria,Cytosol NA NA 110000 Mitochondria Cytosol "CAB004975: AB_425908, HPA004829: AB_1079495" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favorable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 26.2 16.6 13.9 11.9 17.6 15.1 13.8 12.7 23.1 16.5 31.3 26.2 17.3 11.0 16.8 17.0 10.8 15.2 139.0 16.7 13.7 57.5 117.3 13.3 16.7 11.4 13.8 15.3 10.2 17.9 56.0 9.7 12.8 13.3 18.4 28.1 13.0 26.8 18.3 241.3 10.4 16.3 20.8 10.2 11.6 31.5 6.3 16.8 27.1 31.4 387.4 17.3 17.5 9.4 17.2 15.4 12.6 30.5 59.6 44.0 50.3 9.9 17.5 39.8 24.8 20.8 19.0 30.4 18.5 21.5 43.9 22.3 16.6 120.5 5.4 27.4 31.1 33.6 24.0 70.7 23.8 27.5 50.2 43.1 37.9 17.5 16.3 18.6 42.6 56.3 22.7 21.4 81.3 60.0 15.1 55.8 35.8 6.4 0.1 15.2 54.7 73.8 70.8 58.0 15.5 44.2 37.7 62.9 1.4 46.7 6.9 47.7 58.3 23.2 29.5 28.3 12.0 8.3 36.1 45.1 26.5 7.1 68.8 22.1 12.5 18.2 16.0 16.7 23.0 17.1 12.0 17.1 15.5 32.0 12.0 15.5 14.7 2.9 23.2 24.7 9.1 22.2 19.3 13.9 17.6 12.7 23.1 16.7 13.7 11.4 13.8 15.3 13.3 10.2 16.8 17.2 12.0 54.5 37.8 60.7 19.6 11.5 9.5 19.0 13.1 17.9 9.6 6.3 344.3 38.6 27.0 27.6 35.5 8.7 20.4 34.4 27.4 14.4 16.7 18.5 16.6 19.2 19.9 34.9 124.8 10.7 2.3 27.2 23.9 25.1 25.2 26.8 21.0 314.3 25.0 6.7 110.6 22.6 20.3 40.6 11.9 4.6 14.9 19.8 14.2 45.9 25.9 12.5 35.0 77.9 63.4 9.5 16.7 19.2 20.0 11.7 23.6 21.7 18.1 12.8 0.0 14.0 20.1 4.0 1.4 17.6 8.1 2.1 20.9 18.8 28.9 9.9 MRPS30 "PAP, PDCD9" ENSG00000112996 "Mitochondrial ribosomal protein S30" Q9NP92 5 44808947-44820428 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018686, HPA021149" Approved NA NA "HPA018686: AB_1854127, HPA021149: AB_1854128" "unprognostic (1.56e-1)" "unprognostic (1.23e-1)" "unprognostic (4.48e-1)" "unprognostic (2.94e-2)" "unprognostic (5.47e-2)" "unprognostic (3.54e-2)" "prognostic unfavorable (5.91e-4)" "unprognostic (1.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.15e-1)" "unprognostic (1.05e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.87e-9)" "unprognostic (2.20e-2)" "unprognostic (5.04e-1)" "unprognostic (7.01e-2)" "unprognostic (8.70e-3)" 13.1 13.5 4.1 8.6 6.2 25.6 14.3 7.8 9.1 9.5 2.4 12.4 13.5 10.3 6.0 16.8 10.5 5.9 22.5 5.9 3.0 15.3 21.6 8.6 11.8 1.4 2.5 4.5 9.5 13.0 12.8 6.4 7.5 2.8 8.8 10.9 6.4 11.7 6.4 35.9 19.6 12.1 7.4 2.3 11.4 12.1 11.6 3.4 10.2 12.1 27.0 9.7 11.5 11.0 5.9 33.2 32.5 19.2 36.9 14.0 16.3 61.9 16.2 17.4 22.8 16.1 51.9 40.5 50.4 55.1 10.7 52.6 30.6 37.7 24.2 20.3 32.7 64.5 37.5 67.8 40.8 31.1 51.5 29.8 16.2 24.4 23.9 29.4 17.2 21.7 27.4 58.5 45.6 21.4 28.3 33.3 67.7 32.4 26.0 57.6 31.3 32.1 67.6 34.6 24.1 29.3 22.9 75.1 40.1 52.2 14.5 36.2 38.0 21.4 26.8 39.6 22.3 51.0 24.4 31.0 41.0 22.6 68.4 27.7 26.0 24.0 18.7 30.9 27.2 32.3 37.8 34.2 34.2 25.6 31.7 40.0 33.9 4.4 35.2 33.3 19.4 46.1 33.6 4.1 6.2 7.8 9.1 5.9 3.0 1.4 2.5 4.5 2.8 2.3 3.4 5.9 22.1 25.6 16.5 4.6 31.7 48.8 38.8 63.3 26.7 31.3 23.6 21.1 60.2 17.2 31.5 5.5 18.8 40.0 37.6 21.4 33.2 36.5 105.1 21.3 29.4 23.9 28.7 18.7 14.4 33.1 38.0 24.1 21.4 22.5 19.0 24.1 17.9 26.9 32.5 32.0 8.0 24.5 30.5 16.6 15.7 14.3 20.8 18.9 17.8 3.7 26.3 20.4 26.8 3.5 6.9 29.6 22.8 18.0 20.1 27.6 25.6 35.4 21.9 26.3 13.1 24.9 28.7 43.4 26.4 28.6 75.0 18.6 32.6 32.6 37.0 42.3 HSPA9 "GRP75, HSPA9B, mot-2, mthsp75, PBP74" ENSG00000113013 "Heat shock protein family A (Hsp70) member 9" P38646 5 138553756-138575675 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000898, CAB005219" Supported Supported Mitochondria NA NA 3600000 Mitochondria "CAB005219: AB_647720, HPA000898: AB_1079032" "prognostic unfavorable (2.93e-4)" "unprognostic (1.86e-1)" "prognostic favorable (4.53e-4)" "unprognostic (3.73e-2)" "unprognostic (2.33e-1)" "unprognostic (9.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (9.85e-2)" "unprognostic (2.53e-1)" "unprognostic (2.74e-1)" "unprognostic (1.31e-1)" "unprognostic (8.78e-3)" "unprognostic (1.02e-1)" "unprognostic (2.15e-1)" "unprognostic (3.27e-2)" "unprognostic (2.29e-1)" 79.6 228.2 14.9 52.0 13.9 99.6 73.0 24.5 26.2 57.4 24.2 74.5 61.7 67.6 34.2 88.5 57.0 38.7 155.4 10.3 23.6 113.1 195.8 63.0 44.0 18.7 20.1 6.7 80.7 80.5 170.8 72.0 46.8 21.6 56.9 57.0 49.2 79.5 47.1 291.2 78.1 64.8 44.6 16.8 55.2 92.5 50.5 17.8 45.0 92.1 195.3 56.1 74.4 66.1 29.8 196.0 276.6 111.4 231.0 138.1 94.3 274.7 198.3 196.7 255.4 268.6 579.4 194.4 419.3 263.7 150.8 382.0 158.6 334.0 314.1 298.2 219.7 177.9 230.5 209.0 270.4 360.4 229.0 201.3 142.6 317.7 299.5 494.8 78.7 128.0 167.8 280.4 297.5 134.7 220.6 206.7 82.9 182.5 191.6 173.3 252.1 188.8 302.4 192.8 267.4 150.1 112.4 242.5 338.5 630.7 269.0 230.5 200.5 117.7 204.1 126.5 174.9 313.5 324.6 300.5 378.6 249.6 301.4 202.6 11.8 31.3 10.7 39.8 34.9 46.2 31.7 30.6 36.8 42.0 22.4 34.1 33.9 4.3 28.3 38.8 17.9 31.3 53.6 14.9 13.9 24.5 26.2 10.3 23.6 18.7 20.1 6.7 21.6 16.8 17.8 29.8 63.0 99.3 123.8 43.1 101.7 87.8 228.6 157.2 84.8 88.2 83.4 63.8 337.3 70.1 153.8 99.3 83.4 194.7 114.7 80.8 223.0 151.4 12.1 90.1 98.4 83.1 73.0 75.1 41.1 106.1 132.9 109.6 73.9 126.6 167.8 86.1 43.5 175.9 133.9 99.3 48.4 95.4 148.5 54.1 76.4 12.6 67.4 100.1 83.6 25.3 92.3 92.5 43.3 27.6 43.3 93.8 66.0 72.6 102.3 131.1 85.8 231.3 119.7 89.3 46.0 134.3 136.2 52.5 91.4 93.2 73.9 175.5 130.7 157.9 150.7 141.2 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219403-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA071751: AB_2686442" "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 25.2 36.4 24.8 22.0 26.1 19.1 32.2 24.3 28.0 25.9 32.5 26.4 20.6 26.0 27.8 32.7 31.6 19.2 56.0 25.3 24.0 30.8 38.8 17.6 37.2 25.0 25.4 23.9 39.9 27.3 33.0 21.0 21.4 25.6 25.4 31.8 17.8 22.6 30.6 59.2 31.0 22.2 27.1 25.0 26.1 25.9 15.3 25.4 31.0 35.9 89.9 42.2 29.9 26.2 25.5 49.7 65.2 56.8 94.4 73.1 93.5 73.0 46.7 66.4 86.9 69.7 81.9 68.5 128.2 63.8 54.8 94.9 54.0 111.8 166.1 93.6 48.6 69.2 66.0 71.3 91.1 72.7 58.4 49.0 88.1 68.7 91.3 101.5 79.0 94.2 92.2 67.2 37.5 73.0 59.7 87.8 70.4 65.7 35.8 40.4 92.0 94.4 131.5 80.7 52.4 87.5 46.7 78.5 63.8 58.5 52.2 97.8 69.9 54.1 35.3 51.8 50.3 85.2 37.7 61.0 89.1 60.9 94.6 57.0 15.5 23.4 8.1 24.9 27.5 37.1 36.1 30.6 30.4 44.2 32.1 35.2 37.9 3.2 43.3 23.0 16.6 34.6 31.5 24.8 26.1 24.3 28.0 25.3 24.0 25.0 25.4 23.9 25.6 25.0 25.4 25.5 13.9 9.6 11.7 32.7 27.6 20.4 22.3 21.6 23.3 11.4 26.5 22.2 101.9 7.2 15.6 11.0 16.7 41.5 18.6 9.1 25.4 20.5 2.2 16.1 21.8 17.2 16.2 36.8 43.9 17.3 48.2 18.8 17.9 12.1 7.6 29.3 15.7 34.8 24.8 10.1 38.4 21.0 8.2 28.6 13.3 4.4 19.0 15.0 10.6 30.0 31.4 15.3 17.5 38.7 51.1 14.9 15.3 25.2 16.8 13.5 10.7 28.8 12.6 13.2 13.1 18.2 17.6 10.3 18.7 32.3 17.6 28.9 21.2 30.4 31.4 14.8 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245035-140303113 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 74.8 51.3 75.8 38.1 76.8 60.7 50.4 83.0 89.1 41.8 72.3 53.7 40.6 51.2 54.7 52.7 42.2 36.0 94.2 77.2 80.1 62.1 38.8 47.3 46.5 82.6 78.5 76.3 37.5 35.0 53.2 39.8 51.3 82.7 45.2 43.4 35.4 45.8 44.1 150.4 45.9 40.2 61.9 81.4 36.9 41.0 30.2 79.5 52.0 42.8 87.2 52.0 46.3 41.2 82.7 172.4 79.6 137.7 80.9 89.7 91.8 133.8 229.6 114.9 174.6 192.6 172.1 107.9 114.9 224.1 124.3 180.0 62.6 102.0 228.7 204.2 122.6 102.9 102.4 76.5 113.0 105.1 213.5 76.4 98.2 119.8 148.5 156.3 112.6 196.0 132.8 93.7 73.1 149.8 78.5 146.0 147.6 92.0 70.3 119.2 101.3 195.9 86.3 197.1 77.9 78.2 81.8 172.1 148.6 136.8 128.5 102.1 122.3 249.1 121.8 119.6 71.9 208.0 70.3 198.6 299.2 122.5 138.5 144.1 149.5 84.7 130.3 86.2 131.1 91.8 106.0 98.6 100.4 100.5 97.9 97.3 88.4 14.0 114.7 130.3 93.0 129.3 115.5 75.8 76.8 83.0 89.1 77.2 80.1 82.6 78.5 76.3 82.7 81.4 79.5 82.7 87.9 67.3 33.0 16.3 57.4 38.0 65.9 96.2 30.7 42.5 50.1 57.3 81.3 52.9 62.1 66.2 45.9 116.1 53.1 56.6 123.3 121.9 3.9 58.0 56.6 73.8 46.6 62.9 31.2 101.7 86.6 55.4 35.2 70.9 54.4 53.6 72.1 56.9 85.4 25.2 29.3 43.6 48.8 61.1 37.7 12.9 52.2 63.4 74.7 37.5 90.4 84.9 71.1 24.1 39.3 128.9 55.1 52.3 35.5 45.4 80.9 147.3 45.3 42.9 65.7 39.6 63.7 23.7 61.8 40.8 34.9 85.6 45.2 42.9 47.3 63.6 HBEGF "DTR, DTS, HEGFL" ENSG00000113070 "Heparin binding EGF like growth factor" Q99075 5 140332843-140346603 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor, Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 129.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 818.1;Squamous epithelial cells: 281.8;Urothelial cells: 548.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 1.6" "Group enriched" "Detected in many" 6 "dendritic cells: 1.6;monocytes: 2.2" "Cell line enhanced" "Detected in many" "HBF TERT88: 61.2;JURKAT: 81.5;TIME: 68.9;U-698: 93.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053243 Uncertain "Secreted to blood" NA NA 118000 "HPA053243: AB_2682086" "unprognostic (3.64e-1)" "unprognostic (3.05e-1)" "unprognostic (4.31e-2)" "unprognostic (5.09e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (8.44e-3)" "unprognostic (3.51e-2)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (6.00e-4)" "unprognostic (2.20e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 51.4 11.7 14.2 32.6 14.4 36.7 28.9 14.2 14.6 12.5 13.3 19.8 4.7 12.2 2.3 42.7 14.4 57.1 36.7 12.1 66.2 12.9 9.7 45.3 3.2 16.1 14.8 11.1 5.2 6.6 5.6 13.2 16.1 15.1 12.9 15.6 12.2 12.1 4.9 28.2 16.2 14.4 36.9 15.8 6.3 31.6 5.4 14.9 4.8 16.0 20.3 4.6 129.9 19.0 17.9 23.2 1.6 3.4 8.1 1.6 0.6 2.7 21.8 8.5 40.5 33.2 13.0 24.4 0.3 16.9 5.4 14.1 7.1 4.2 37.0 61.2 1.3 3.8 0.5 4.9 1.8 1.2 1.5 1.0 0.9 45.7 44.4 17.8 12.0 20.5 81.5 0.2 3.6 8.7 1.6 2.0 10.8 2.9 9.2 6.0 4.0 13.1 0.7 25.0 3.0 1.2 1.3 6.4 0.8 7.8 22.8 1.4 5.9 68.9 23.1 19.5 7.4 49.5 0.5 1.8 93.6 29.1 11.0 30.3 0.0 0.3 0.0 0.0 2.2 0.0 0.3 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.2 14.2 14.4 14.2 14.6 12.1 66.2 16.1 14.8 11.1 15.1 15.8 14.9 17.9 186.2 221.2 69.3 1.3 5.7 214.6 818.1 161.9 95.6 2.8 37.9 77.8 80.8 24.3 58.0 11.0 0.0 2.5 5.4 199.2 0.0 37.6 0.5 23.6 22.9 94.7 88.3 0.0 2.1 10.7 1.8 35.2 62.7 74.0 21.5 0.6 22.5 3.4 73.2 5.0 2.9 105.1 18.3 39.7 36.2 0.7 0.3 210.2 32.0 4.7 2.1 7.4 0.0 1.0 8.8 89.5 130.6 0.7 3.1 153.2 181.9 1.0 16.4 1.0 0.0 50.5 33.1 2.0 7.4 281.8 125.2 2.6 12.7 1.0 97.7 548.7 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360194-140375141 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "kidney: 34.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051307 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA051307: AB_2681434" "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.5 34.8 0.0 0.1 0.0 0.8 0.6 0.2 0.0 0.1 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.4 0.6 0.3 0.5 0.8 0.6 0.2 1.0 0.3 0.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.4 1.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 6.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.7 1.9 0.0 0.1 0.0 0.1 0.1 0.1 0.2 LOX ENSG00000113083 "Lysyl oxidase" P28300 5 122063195-122078413 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 67.1;Club cells: 38.4;Early spermatids: 41.9;Endometrial stromal cells: 34.0;Extravillous trophoblasts: 44.2;Fibroblasts: 79.1;Peritubular cells: 39.1;Smooth muscle cells: 32.7" "Cancer enhanced" "Detected in all" "renal cancer: 39.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 777.3;fHDF/TERT166: 1790.7;HSkMC: 356.3;U-138 MG: 475.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043930 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 550000 "Endoplasmic reticulum" "HPA043930: AB_2678736" "unprognostic (5.10e-2)" "unprognostic (1.03e-2)" "unprognostic (6.99e-3)" "unprognostic (3.64e-2)" "unprognostic (9.86e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.42e-3)" "unprognostic (3.06e-3)" "unprognostic (8.92e-2)" "unprognostic (3.21e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (3.93e-8)" "unprognostic (1.11e-3)" "unprognostic (9.92e-2)" "unprognostic (4.31e-2)" "prognostic unfavorable (3.32e-4)" 28.2 2.4 0.9 6.9 0.4 0.2 17.8 0.5 1.0 10.9 1.4 4.1 3.9 6.2 1.7 5.6 9.0 18.9 14.2 0.2 0.4 4.5 2.1 13.7 3.3 1.1 1.1 0.3 5.4 3.3 0.9 1.2 8.1 0.7 4.1 4.6 1.1 3.2 2.7 2.0 10.4 3.8 10.1 1.4 2.7 4.4 1.4 0.8 0.9 6.9 2.1 1.4 14.2 4.8 1.0 0.8 0.2 2.0 0.9 168.7 185.2 0.1 777.3 205.3 73.2 246.4 0.5 0.3 0.1 16.5 1790.7 3.7 0.2 4.5 3.5 196.4 0.1 2.0 0.0 16.3 9.3 203.4 0.4 0.1 356.3 4.4 137.6 7.4 329.3 95.3 0.1 0.0 0.1 83.6 0.0 0.1 0.3 6.4 0.1 1.9 0.1 7.4 0.9 4.9 0.5 0.5 4.2 72.1 0.1 12.9 29.8 0.6 0.6 6.8 475.5 23.2 272.8 9.3 0.0 0.1 0.2 207.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.5 1.0 0.2 0.4 1.1 1.1 0.3 0.7 1.4 0.8 1.0 20.0 9.6 1.1 0.0 0.2 7.8 1.9 67.1 0.0 0.6 1.3 1.1 2.1 0.0 38.4 0.0 0.0 0.8 0.1 0.0 0.0 7.2 41.9 8.4 34.0 9.4 0.0 0.0 0.3 0.6 44.2 79.1 0.0 6.6 0.0 0.1 10.8 0.5 2.2 1.7 2.0 0.0 2.0 0.8 21.6 5.0 14.0 1.3 5.4 1.9 0.6 0.0 0.0 0.0 0.0 1.3 0.0 39.1 0.3 2.8 0.0 0.1 8.3 1.7 19.7 1.1 32.7 0.8 0.6 1.8 10.7 4.8 1.1 0.4 0.1 0.9 GZMK "PRSS, TRYP2" ENSG00000113088 "Granzyme K" P49863 5 55024256-55034570 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 100.4" "Group enriched" "Detected in many" 4 "dendritic cells: 136.3;T-cells: 301.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 741.6;NK-cell: 505.5" "Group enriched" "Detected in many" 199 "NK-cells: 505.5;T-cells: 741.6" "Cell line enriched" "Detected in single" 10 "JURKAT: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA063181, HPA065895" Enhanced "Secreted to blood" NA NA "HPA063181: AB_2684955, HPA065895: " "prognostic favorable (8.68e-4)" "unprognostic (3.26e-3)" "unprognostic (2.23e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-2)" "unprognostic (1.12e-3)" "unprognostic (1.03e-3)" "unprognostic (8.13e-3)" "unprognostic (3.50e-2)" "unprognostic (4.53e-2)" "unprognostic (9.74e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" 2.2 3.9 0.2 19.6 0.3 10.6 5.0 0.2 0.4 4.4 0.5 3.4 1.7 4.1 4.5 3.1 2.0 11.7 2.0 0.2 0.3 1.7 10.8 5.9 100.4 0.5 0.3 0.2 2.8 1.0 0.8 0.5 0.5 0.4 3.3 4.6 0.0 4.7 1.0 0.2 0.6 7.4 2.2 0.3 30.6 6.6 1.2 0.5 12.1 2.4 0.3 28.0 8.1 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 1.1 164.3 1.0 741.6 0.5 100.2 457.3 0.5 0.5 4.9 77.4 3.1 505.5 0.9 0.9 7.0 95.5 0.2 0.3 0.2 0.4 0.2 0.3 0.5 0.3 0.2 0.4 0.3 0.5 0.6 3.8 3.2 7.0 0.0 10.7 1.5 0.1 0.0 1.8 0.0 1.5 1.7 0.1 2.8 0.6 0.0 0.0 0.0 136.3 0.1 0.0 0.0 1.3 0.8 0.4 0.8 0.0 4.4 0.0 0.0 0.0 1.2 4.1 0.8 2.5 0.0 8.6 1.5 0.2 0.0 0.0 0.0 0.0 10.3 2.5 1.2 0.0 6.4 1.8 0.0 5.1 0.0 29.9 0.0 0.1 0.0 0.0 0.0 45.1 0.1 0.2 0.8 0.0 0.0 0.0 1.8 1.7 0.0 0.3 0.2 0.6 0.3 301.9 0.0 0.0 0.1 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880597-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.4;kidney: 5.8" "Group enriched" "Detected in some" 33 "Excitatory neurons: 307.2;Inhibitory neurons: 459.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 4.9" "Cell line enhanced" "Detected in some" "K-562: 7.3;NTERA-2: 10.1;U-698: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.3 0.2 7.4 0.6 4.9 1.9 0.3 0.0 6.4 0.0 0.0 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.1 5.7 2.1 5.8 0.1 0.3 1.0 0.0 0.0 6.3 0.3 0.6 0.1 0.0 0.4 0.8 0.5 0.6 1.3 0.2 0.1 0.1 1.0 0.8 0.4 0.0 0.4 0.5 2.2 0.2 0.2 1.1 0.1 1.0 0.3 0.0 1.6 1.9 0.7 0.4 0.6 0.2 0.0 1.2 0.0 0.3 0.1 0.2 0.0 0.7 1.0 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.4 0.6 2.2 0.0 0.0 1.2 0.2 0.3 0.0 0.0 0.0 0.1 0.6 7.3 1.8 0.0 1.3 0.6 0.4 10.1 0.2 0.4 0.2 0.2 0.3 0.3 0.4 2.2 0.2 0.0 0.3 0.3 1.8 0.3 0.7 1.3 0.1 0.7 0.6 0.2 2.0 0.8 4.6 0.6 0.8 0.6 1.2 0.1 0.2 0.1 0.4 0.3 2.3 0.1 0.1 0.1 1.6 0.1 0.3 4.9 0.0 0.7 0.5 0.5 0.6 7.4 4.9 0.0 6.4 5.7 2.1 0.0 0.0 6.3 0.8 0.0 0.2 1.6 0.0 0.0 0.0 10.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 459.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 11.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APBB3 FE65L2 ENSG00000113108 "Amyloid beta precursor protein binding family B member 3" O95704 5 140558268-140564781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" "Early spermatids: 63.1;Late spermatids: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005571, HPA076196" Approved Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA005571: AB_1844912, HPA076196: " "unprognostic (7.63e-2)" "unprognostic (4.58e-2)" "unprognostic (1.13e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-3)" "unprognostic (1.44e-1)" "unprognostic (5.06e-2)" "unprognostic (7.22e-2)" "unprognostic (1.98e-1)" "prognostic favorable (6.79e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.06e-6)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.38e-2)" "unprognostic (4.67e-2)" 2.1 3.9 7.0 0.0 8.6 0.7 2.3 8.4 11.1 1.9 4.5 2.0 0.2 2.5 1.5 1.5 2.6 0.6 2.3 8.4 8.4 2.5 3.1 1.4 0.5 8.7 7.7 9.3 2.5 2.6 1.6 10.0 1.4 10.0 1.9 0.7 6.4 2.5 1.7 2.3 2.0 2.1 0.9 5.6 2.2 2.6 8.6 9.0 0.6 3.2 1.2 0.7 2.2 1.8 12.6 0.4 0.4 0.2 2.0 0.0 0.8 3.3 1.0 1.2 1.3 2.6 1.0 1.1 1.3 2.0 1.7 0.8 0.7 0.0 1.4 0.4 1.6 0.6 0.6 4.0 0.1 2.2 0.7 0.8 5.0 0.6 1.2 1.0 0.3 0.8 3.6 0.1 4.4 1.5 0.9 0.2 1.3 0.8 0.5 2.5 0.3 0.4 1.1 1.2 1.0 6.4 3.0 2.8 0.9 3.7 0.2 2.7 2.8 0.7 0.3 0.6 0.0 0.2 1.7 1.3 0.1 0.8 0.4 0.5 5.6 0.7 0.0 0.7 1.8 0.4 0.2 0.4 0.6 0.6 0.6 0.3 0.6 1.9 0.4 0.3 1.0 0.5 0.6 7.0 8.6 8.4 11.1 8.4 8.4 8.7 7.7 9.3 10.0 5.6 9.0 12.6 8.3 3.2 9.3 25.8 6.8 2.8 3.4 5.7 4.0 29.4 9.4 8.3 2.1 14.3 10.1 5.5 0.0 11.7 6.3 5.4 5.9 3.9 63.1 3.9 6.8 6.1 5.4 5.2 13.1 1.5 11.9 7.8 15.3 5.3 10.8 6.2 7.1 17.0 14.5 18.5 13.5 2.8 14.2 18.0 14.2 43.6 5.6 13.8 7.2 8.4 12.6 13.5 5.2 8.5 15.6 2.4 3.7 4.9 3.9 2.3 8.6 3.3 5.6 16.5 0.0 6.4 7.2 19.2 6.9 2.9 2.8 11.8 5.2 4.9 3.6 3.1 TMCO6 "FLJ39769, PRO1580" ENSG00000113119 "Transmembrane and coiled-coil domains 6" Q96DC7 5 140639435-140645408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037473, HPA037474" Uncertain Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA037473: AB_10671049, HPA037474: AB_10671050" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (3.95e-2)" "unprognostic (1.38e-2)" "unprognostic (6.10e-3)" "unprognostic (1.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.11e-1)" "unprognostic (4.89e-2)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (7.21e-2)" "unprognostic (1.77e-1)" "unprognostic (1.96e-2)" "unprognostic (1.20e-2)" 6.1 10.6 4.8 3.9 4.7 2.9 6.6 4.8 5.9 6.0 5.0 4.4 3.0 4.8 3.4 7.2 7.0 2.9 3.0 4.6 5.3 4.7 13.4 3.7 4.6 5.2 4.6 4.1 7.2 6.6 4.1 4.9 5.6 5.1 4.8 2.5 0.7 9.9 2.9 3.6 5.1 4.8 3.0 5.3 7.3 5.2 10.5 4.9 7.8 5.4 2.6 4.0 5.4 5.7 5.7 3.9 7.5 5.0 7.4 4.9 5.2 18.1 3.0 3.4 3.8 4.1 11.6 7.2 15.6 7.8 2.3 4.4 7.7 4.2 8.8 2.0 5.5 13.7 11.9 3.7 8.3 6.5 6.7 4.4 8.6 2.3 4.6 7.7 2.9 8.9 12.6 5.1 5.0 4.7 7.5 15.3 15.5 5.7 9.2 11.3 13.1 10.3 15.5 4.6 3.5 8.6 3.7 8.6 16.6 8.0 3.4 13.6 7.9 4.2 0.1 3.7 1.4 1.3 8.4 5.7 7.4 2.4 10.7 4.6 11.6 6.5 5.7 5.2 9.1 5.7 7.8 6.9 5.1 6.9 6.1 9.5 3.9 12.7 4.4 10.3 1.9 8.2 4.1 4.8 4.7 4.8 5.9 4.6 5.3 5.2 4.6 4.1 5.1 5.3 4.9 5.7 4.0 6.4 2.0 1.3 7.5 1.9 7.3 3.4 6.8 5.2 4.6 4.3 0.6 5.7 2.4 11.0 6.2 7.7 4.2 3.9 0.0 3.8 4.1 2.2 4.0 6.3 7.3 10.3 3.8 2.4 7.4 4.6 6.6 2.5 0.0 4.6 10.0 9.7 4.8 0.0 3.3 5.0 4.1 5.1 2.7 1.5 4.1 4.1 1.8 9.4 6.6 3.3 16.5 1.0 3.9 4.5 5.2 4.9 7.3 7.4 6.2 2.4 6.2 4.3 6.6 3.9 3.4 19.2 15.8 10.3 2.3 6.3 8.2 7.7 7.7 6.9 SPARC "BM-40, ON, ONT" ENSG00000113140 "Secreted protein acidic and cysteine rich" P09486 5 151661096-151686975 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 2202.9" "Cell type enhanced" "Detected in many" "Adipocytes: 737.1;Endometrial stromal cells: 1209.0;Endothelial cells: 781.9;Fibroblasts: 1032.1;Peritubular cells: 1111.1;Sertoli cells: 2353.5;Smooth muscle cells: 1527.3;Theca cells: 987.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 10.4;classical monocyte: 8.7;neutrophil: 24.3" "Group enriched" "Detected in many" 7 "granulocytes: 24.3;monocytes: 8.7" "Cell line enhanced" "Detected in many" "ASC diff: 4911.5;BJ: 4101.8;fHDF/TERT166: 6492.5;WM-115: 4789.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002306, HPA002989, HPA003020" Supported Approved Vesicles "Secreted to blood" NA NA 8300000 130000000 Vesicles "CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531" "unprognostic (3.34e-2)" "unprognostic (8.57e-2)" "unprognostic (1.31e-1)" "unprognostic (3.97e-1)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (8.36e-3)" "unprognostic (5.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.53e-5)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.53e-1)" "unprognostic (4.93e-3)" 1676.0 410.3 601.5 440.4 848.1 32.7 533.1 805.2 369.5 844.4 311.6 287.5 111.5 543.4 113.7 310.5 273.8 1540.0 568.5 386.6 1489.6 177.7 159.9 502.3 234.0 1205.3 1065.3 151.9 351.4 120.2 275.3 112.2 2202.9 1381.1 229.1 187.1 36.7 114.0 381.6 260.7 262.7 158.7 1262.5 991.0 263.1 144.5 410.4 1349.8 71.6 296.7 477.7 132.7 837.4 251.1 1178.8 5.9 5.0 1196.5 57.5 4911.5 1596.0 112.6 4101.8 1336.6 1649.3 1693.8 5.5 4.2 2.0 953.7 6492.5 272.0 56.7 153.4 316.2 555.0 4.8 57.1 56.7 0.4 116.8 1441.6 2.9 5.4 2567.2 436.9 1233.8 170.8 1903.1 2315.1 13.5 53.7 44.6 944.1 0.4 4.7 35.5 556.2 0.4 4.4 2.9 1192.9 4.3 0.5 0.5 45.5 88.4 2.8 1.4 534.9 1922.1 4.7 138.2 2759.9 771.0 1195.2 350.2 1304.4 3.7 6.0 7.6 648.4 3.7 4789.0 10.4 8.7 2.7 1.0 0.3 0.0 0.1 0.0 0.1 2.3 0.2 0.3 0.0 24.3 0.0 0.1 1.9 0.0 123.9 601.5 848.1 805.2 369.5 386.6 1489.6 1205.3 1065.3 151.9 1381.1 991.0 1349.8 1178.8 737.1 83.3 27.5 7.2 6.8 164.8 25.7 23.8 28.5 85.7 11.2 100.5 43.6 5.7 18.8 16.5 2.1 115.4 2.8 0.1 0.0 4.6 14.2 41.6 1209.0 781.9 0.0 15.1 4.3 0.4 354.3 1032.1 9.7 31.5 12.0 146.5 668.6 9.9 108.2 1.7 2.9 0.0 0.0 50.0 175.7 46.8 319.3 92.0 234.7 38.4 10.7 13.6 3.1 21.6 37.3 5.5 0.0 1111.1 4.1 7.7 0.0 42.0 7.8 72.7 2353.5 510.4 1527.3 14.2 10.9 4.8 108.3 147.4 21.1 987.4 0.0 5.3 IK "RED, RER" ENSG00000113141 "IK cytokine" Q13123 5 140647058-140662480 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 438.7;Endometrial ciliated cells: 510.8;Respiratory ciliated cells: 732.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048798 Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA048798: AB_2680525" "unprognostic (9.90e-2)" "prognostic favorable (1.29e-4)" "unprognostic (6.99e-2)" "unprognostic (1.49e-2)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (2.32e-7)" "unprognostic (1.19e-1)" "unprognostic (4.87e-2)" "unprognostic (4.37e-2)" "unprognostic (8.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-3)" "unprognostic (3.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.26e-2)" "unprognostic (2.83e-1)" 69.1 64.6 57.1 69.4 58.8 136.6 67.5 65.8 71.4 69.8 65.8 72.6 55.9 74.6 75.1 77.6 144.7 53.8 74.9 56.2 62.7 67.7 69.1 70.2 90.6 63.0 59.7 49.6 79.5 48.7 74.9 56.3 65.4 62.5 60.8 71.0 91.2 65.8 66.8 137.6 72.4 68.5 65.1 60.4 72.2 61.0 108.7 59.1 115.1 73.2 83.7 96.8 70.2 68.6 64.3 119.1 132.5 114.4 163.2 125.7 106.4 133.4 139.0 146.7 151.6 153.2 184.1 133.4 138.9 167.4 145.4 172.3 120.9 168.2 190.1 175.4 198.1 136.6 130.4 213.2 117.8 129.6 214.6 136.9 117.2 124.4 151.5 136.8 112.0 132.7 114.9 144.3 121.1 137.3 110.0 184.1 216.8 74.5 100.3 134.2 145.5 160.7 141.4 117.7 109.2 103.6 112.3 171.5 155.6 172.9 97.9 181.3 171.8 141.2 126.2 87.9 106.2 167.8 181.8 294.1 188.4 141.8 162.4 94.5 353.1 136.5 240.3 188.3 157.1 168.9 197.4 202.7 194.3 139.0 191.5 212.7 199.1 229.4 198.8 193.0 131.2 284.4 247.0 57.1 58.8 65.8 71.4 56.2 62.7 63.0 59.7 49.6 62.5 60.4 59.1 64.3 110.7 163.5 134.9 10.1 102.8 46.1 86.4 127.5 61.5 75.3 40.0 57.7 126.7 80.1 177.1 86.5 29.2 115.2 139.9 69.2 121.3 106.4 438.7 510.8 124.9 91.4 34.1 137.6 7.6 99.6 99.6 82.6 50.0 107.2 132.2 68.0 54.3 74.7 70.6 53.8 8.2 66.4 97.6 56.8 58.8 55.0 98.2 80.2 56.9 8.4 107.4 116.1 151.4 8.5 7.4 110.1 67.3 83.8 76.9 50.5 80.4 120.8 732.0 97.3 72.3 96.0 115.7 311.3 145.0 65.3 45.5 132.8 128.5 93.0 65.5 66.9 HMGCR ENSG00000113161 "3-hydroxy-3-methylglutaryl-CoA reductase" P04035 5 75336329-75364001 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 106.6" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 239.5;Theca cells: 148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008338, CAB016797, CAB078688" Supported NA NA "CAB016797: , CAB078688: AB_2665607, HPA008338: AB_10960401" "unprognostic (5.07e-2)" "unprognostic (1.65e-2)" "unprognostic (3.65e-3)" "unprognostic (1.02e-2)" "unprognostic (1.65e-3)" "unprognostic (1.02e-1)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "unprognostic (1.90e-2)" "unprognostic (1.41e-1)" "unprognostic (3.99e-2)" "prognostic favorable (9.42e-6)" "unprognostic (2.44e-1)" "unprognostic (2.55e-2)" "unprognostic (3.64e-3)" "unprognostic (4.37e-2)" 10.9 39.8 17.6 18.3 21.8 24.9 31.1 16.1 23.3 16.2 16.2 45.6 38.4 17.0 25.5 49.5 12.3 15.4 7.5 23.7 22.0 21.3 106.6 24.4 14.8 25.5 21.8 22.5 9.8 16.6 25.0 8.3 17.9 29.0 23.5 37.7 18.9 15.7 8.2 6.5 51.2 26.7 13.0 14.9 15.0 27.8 23.5 22.2 17.9 23.6 7.2 18.7 14.3 26.9 39.2 68.5 25.6 260.7 89.2 54.9 103.4 65.5 19.3 53.6 38.6 85.0 95.8 163.7 60.3 68.7 31.7 245.2 84.5 136.4 225.9 39.4 20.8 50.8 47.0 36.7 78.6 80.8 39.8 32.9 66.8 130.7 133.6 65.6 19.2 31.5 84.8 50.4 86.4 61.0 45.2 72.7 39.9 112.5 17.7 19.7 50.7 78.7 86.5 155.2 154.5 91.0 41.3 41.4 43.7 38.3 89.6 43.1 102.4 37.2 20.5 30.0 22.4 32.8 28.1 38.1 83.2 29.7 75.2 43.7 10.0 14.8 8.8 7.7 8.9 6.2 5.1 5.2 7.8 16.9 5.2 5.3 7.2 28.8 12.5 10.5 4.9 9.0 7.5 17.6 21.8 16.1 23.3 23.7 22.0 25.5 21.8 22.5 29.0 14.9 22.2 39.2 11.6 19.2 43.3 23.2 14.9 41.4 10.1 37.6 43.3 23.5 19.0 12.1 7.0 12.8 33.3 27.6 18.8 19.7 25.7 80.4 3.9 13.5 46.6 124.4 34.3 13.4 43.0 11.6 49.9 22.0 24.0 13.7 28.5 239.5 24.1 71.3 7.9 97.5 13.1 40.4 35.8 56.0 28.5 14.8 11.8 22.2 9.3 19.5 16.0 15.0 12.1 9.7 7.2 28.1 24.7 15.0 40.0 6.0 14.4 18.4 15.5 6.9 31.6 15.2 13.1 7.0 20.2 23.4 12.0 69.8 91.6 46.7 19.2 148.7 30.4 18.8 CERT1 "CERT, COL4A3BP, GPBP, STARD11" ENSG00000113163 "Ceramide transporter 1" Q9Y5P4 5 75356345-75512138 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 132.3;WM-115: 118.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035645, HPA042608" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035645: AB_10600700, HPA042608: AB_2678075" "unprognostic (2.45e-1)" "unprognostic (7.16e-2)" "unprognostic (6.56e-3)" "unprognostic (1.53e-2)" "unprognostic (2.44e-1)" "unprognostic (9.29e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-1)" "unprognostic (2.51e-1)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.29e-2)" "prognostic favorable (1.24e-5)" "unprognostic (9.12e-2)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (2.91e-1)" 38.4 26.4 14.1 16.7 17.6 27.5 17.8 19.5 15.6 34.2 15.9 21.0 18.8 20.8 15.2 25.1 22.6 23.5 21.0 15.6 16.9 28.1 31.5 24.6 20.5 16.3 18.8 13.5 23.4 16.5 26.3 8.1 23.1 18.2 24.5 19.7 18.4 14.1 20.1 29.1 18.9 21.3 18.4 16.9 25.5 23.7 29.1 15.9 21.4 50.4 28.5 22.9 23.9 16.1 18.7 44.9 22.7 21.6 19.0 132.3 36.6 29.0 24.8 30.8 18.8 24.8 34.4 25.3 21.5 52.3 26.9 25.8 26.7 33.4 34.4 28.6 27.1 15.2 18.2 24.4 18.4 33.6 18.2 20.1 27.9 23.8 22.3 24.9 30.5 22.1 28.3 33.0 32.0 25.0 23.0 21.6 13.2 27.9 10.2 16.8 18.0 28.5 20.2 30.5 54.0 16.4 16.5 31.6 21.6 31.8 45.4 21.3 30.5 30.1 12.6 15.1 22.8 20.3 29.1 41.6 24.8 21.4 30.7 118.2 9.6 19.8 16.0 8.2 22.4 7.8 9.1 8.3 7.7 14.5 9.1 7.7 7.8 29.6 7.8 25.4 8.3 13.0 9.0 14.1 17.6 19.5 15.6 15.6 16.9 16.3 18.8 13.5 18.2 16.9 15.9 18.7 23.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 17.7 20.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 16.8 10.5 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 27.8 3.8 0.0 0.0 0.0 FAF2 "ETEA, KIAA0887, UBXD8, UBXN3B" ENSG00000113194 "Fas associated factor family member 2" Q96CS3 5 176447628-176510074 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065968, HPA071246, HPA073828" Approved Enhanced "Endoplasmic reticulum,Lipid droplets" NA NA 12000 "Lipid droplets" "Endoplasmic reticulum" "HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636" "unprognostic (6.25e-3)" "unprognostic (9.61e-2)" "unprognostic (3.52e-3)" "unprognostic (1.02e-3)" "unprognostic (4.74e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (6.02e-2)" "unprognostic (2.68e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (2.74e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.56e-3)" "unprognostic (1.48e-1)" 15.6 19.9 14.0 15.1 14.6 21.9 17.7 15.5 17.2 17.1 17.4 16.9 15.2 18.8 17.7 16.9 17.4 14.8 11.5 14.2 15.9 14.8 21.2 15.6 16.5 14.0 14.8 14.0 20.2 16.3 25.1 14.8 16.9 14.5 18.4 19.4 22.8 16.6 14.9 11.7 19.4 14.8 19.0 13.6 15.0 14.6 21.2 14.6 23.3 19.6 12.9 18.9 18.2 13.2 14.6 36.9 41.1 39.9 44.4 55.4 43.9 54.6 47.2 53.8 52.7 56.6 53.9 64.9 32.1 52.0 50.2 95.6 55.5 57.8 119.6 72.3 128.7 31.8 21.1 40.7 26.4 56.3 46.2 26.4 58.1 51.6 64.5 53.2 34.0 44.3 35.8 30.7 42.6 50.8 61.2 40.6 24.2 32.4 39.8 34.4 39.5 34.7 35.9 44.7 48.0 35.3 37.7 57.5 49.4 52.9 34.1 58.1 36.2 49.9 71.9 38.8 40.1 63.8 36.2 41.6 41.2 45.4 32.5 64.2 9.0 6.8 4.7 6.8 5.6 8.3 4.9 5.6 7.3 8.0 4.8 7.1 6.4 5.6 9.2 12.1 5.3 9.8 5.7 14.0 14.6 15.5 17.2 14.2 15.9 14.0 14.8 14.0 14.5 13.6 14.6 14.6 26.4 28.9 54.5 26.8 19.6 5.4 34.4 49.7 16.5 46.3 18.6 18.7 13.4 15.7 44.9 18.4 45.9 34.8 19.2 17.6 11.7 34.0 12.1 24.6 41.0 29.0 19.9 17.5 29.0 37.2 40.8 32.6 23.4 27.6 32.2 32.6 28.2 24.3 22.5 15.2 34.2 15.1 34.6 16.1 8.0 5.6 30.4 17.9 12.4 14.0 23.3 39.6 26.8 31.7 36.1 59.1 12.0 31.2 22.0 32.3 17.3 9.3 41.3 29.9 26.3 36.3 36.6 59.8 51.3 16.6 8.5 57.9 18.4 43.2 17.1 29.0 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478227 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 13.9;intestine: 46.0;smooth muscle: 12.4" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 15.2" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.8" "Region enhanced" "Detected in single" "thalamus: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "SH-SY5Y: 119.5;SuSa: 212.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040925, HPA075313" Uncertain Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA040925: AB_10796563, HPA075313: " "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.1 4.8 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 46.0 3.7 0.0 0.0 0.0 0.0 0.5 13.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 14.5 12.4 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 119.5 0.0 0.0 0.0 212.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 15.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.8;Cone photoreceptor cells: 2.1;Endometrial stromal cells: 2.6;Horizontal cells: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 11.3;HAP1: 3.5;SH-SY5Y: 15.2;U-138 MG: 5.3" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 1.8 1.2 0.4 0.7 1.2 0.0 1.7 0.6 1.6 1.2 0.0 0.7 0.3 1.5 0.7 0.3 0.9 0.8 1.0 1.0 0.3 1.1 0.1 1.1 0.1 0.3 0.5 0.4 1.6 1.2 1.7 1.8 0.4 0.4 1.5 0.5 1.0 0.7 0.5 0.7 0.6 0.5 1.0 0.2 0.4 0.6 3.7 0.6 0.0 0.7 0.9 0.1 0.8 0.9 0.8 0.0 0.0 1.1 3.1 1.9 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.2 1.7 0.0 3.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.6 15.2 0.0 0.1 0.0 0.5 1.9 0.1 0.0 5.3 0.7 0.5 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.6 1.6 1.0 0.3 0.3 0.5 0.4 0.4 0.2 0.6 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.9 0.8 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.3 0.8 0.4 2.6 1.1 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 1.8 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.5 0.0 0.1 0.0 0.3 0.0 1.7 1.1 1.8 0.7 0.1 0.3 0.0 0.0 0.4 0.0 0.3 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135206-141138615 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.2;Early spermatids: 8.2;Muller glia cells: 5.0;Spermatocytes: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;GAMG: 13.9;NTERA-2: 17.7;RH-30: 14.0;SCLC-21H: 16.4;SuSa: 21.7;T-47d: 17.6;U-138 MG: 32.4;U-2 OS: 14.1;WM-115: 14.7" "Low region specificity" "Detected in many" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 1.5 1.6 2.3 0.4 1.7 0.0 1.6 1.3 3.3 3.4 0.0 1.1 0.2 4.2 3.6 0.8 2.9 1.8 1.8 2.8 1.8 2.4 0.7 1.7 0.2 2.5 1.3 1.3 5.9 4.7 2.7 3.2 0.4 1.5 2.9 0.3 2.4 2.2 2.1 1.1 0.6 0.6 2.2 1.5 0.7 1.0 3.2 1.6 0.4 2.6 0.6 0.1 1.6 1.3 2.3 0.0 1.0 18.7 0.3 1.3 0.8 0.2 0.4 0.1 0.3 0.3 0.0 0.0 0.0 9.6 0.0 13.9 0.0 9.8 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.1 3.8 0.9 0.0 0.7 0.1 0.0 0.0 0.1 0.0 17.7 0.0 0.0 0.0 14.0 0.0 0.0 0.0 16.4 0.5 0.0 0.2 6.1 21.7 17.6 4.3 0.0 32.4 14.1 5.3 0.0 0.0 0.0 0.0 1.7 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.7 1.3 3.3 2.8 1.8 2.5 1.3 1.3 1.5 1.5 1.6 2.3 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.6 5.2 0.9 2.2 1.1 1.5 1.8 1.8 0.0 0.0 0.0 0.0 0.0 2.5 8.2 0.5 4.3 1.1 0.0 0.0 0.0 3.6 0.0 1.5 0.0 0.2 0.0 0.5 0.4 0.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.8 3.1 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.2 0.0 4.5 0.0 1.1 0.0 0.5 0.1 0.7 0.0 2.1 2.7 13.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.6 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150057-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 0.7 0.7 0.9 0.2 0.9 0.0 1.1 0.5 1.6 1.1 0.0 0.6 0.0 1.9 1.1 0.2 1.0 0.3 0.7 1.5 0.4 0.4 0.1 0.7 0.1 0.8 0.6 0.8 1.3 0.5 1.9 1.0 0.4 0.8 0.5 0.1 0.9 0.7 0.3 0.4 0.7 0.3 0.9 0.6 0.2 0.4 1.9 0.7 0.1 0.4 0.3 0.1 0.7 0.7 1.3 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.6 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.1 0.0 0.1 3.7 0.4 5.4 2.3 0.0 0.6 1.2 7.6 0.0 0.0 0.0 0.0 3.8 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.5 1.6 1.5 0.4 0.8 0.6 0.8 0.8 0.6 0.7 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.4 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 1.0 0.7 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 1.5 0.8 7.6 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 PCDHB7 PCDH-BETA7 ENSG00000113212 "Protocadherin beta 7" Q9Y5E2 5 141172644-141176383 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 38.4;Late spermatids: 27.3;Spermatocytes: 24.5" "Cancer enriched" "Detected in many" 5 "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.9;EFO-21: 4.8;U-138 MG: 3.2;U-2197: 9.6;U-87 MG: 3.3;WM-115: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059271 Approved NA NA "HPA059271: AB_2683962" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.97e-1)" "unprognostic (5.95e-2)" "unprognostic (3.69e-4)" "unprognostic (1.04e-2)" "unprognostic (2.78e-2)" "unprognostic (8.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.57e-3)" "unprognostic (2.29e-1)" "unprognostic (1.83e-3)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.48e-1)" "unprognostic (5.78e-4)" 1.7 0.7 0.5 0.9 0.6 0.0 2.0 0.8 1.7 2.9 0.0 1.3 0.4 4.6 1.6 0.3 2.6 1.5 1.4 1.0 2.1 0.9 0.3 2.1 0.2 1.7 0.8 0.3 2.3 0.4 0.3 2.4 0.2 1.1 1.1 0.4 1.4 0.6 1.0 0.4 0.6 0.8 3.1 0.8 0.7 0.7 2.0 0.4 0.2 1.0 0.6 0.2 1.3 1.5 1.0 0.0 0.0 0.4 0.4 3.9 1.9 0.0 0.2 0.5 0.1 0.1 0.0 0.1 0.0 4.8 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 1.4 1.0 0.3 0.0 0.8 0.0 2.1 0.0 0.7 3.2 0.6 9.6 0.1 0.0 0.0 0.0 3.3 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.8 1.7 1.0 2.1 1.7 0.8 0.3 1.1 0.8 0.4 1.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 4.9 0.2 0.5 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 38.4 0.3 2.4 1.1 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.1 0.0 0.0 1.8 0.0 0.1 1.7 0.0 0.0 6.1 0.0 0.0 27.3 0.9 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.3 6.6 3.4 2.1 24.5 0.7 0.0 0.9 0.1 0.0 0.3 0.0 0.0 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77428256 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.8" "Cell type enhanced" "Detected in many" "Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036911: AB_2675378, HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 19.6 4.9 26.2 1.0 26.9 0.4 14.1 7.4 26.6 16.2 0.8 4.5 2.0 26.6 6.3 2.1 29.0 4.3 14.5 28.0 36.4 5.8 2.3 5.2 1.2 23.5 18.2 28.1 4.2 7.9 0.8 12.6 24.0 18.9 19.2 1.2 22.7 10.6 12.1 0.8 1.8 3.3 17.9 11.3 0.8 5.6 3.0 29.4 0.3 125.8 0.8 1.0 4.0 5.0 22.6 0.1 4.9 0.8 0.3 1.5 0.0 0.5 1.5 13.6 0.2 0.1 1.4 0.1 0.3 0.1 0.1 0.2 0.6 0.2 0.0 0.2 0.2 0.7 0.4 34.8 0.3 0.0 0.4 0.5 0.8 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.2 0.0 0.2 0.5 0.8 0.8 0.2 0.1 0.6 0.9 0.4 0.0 0.2 5.4 1.0 2.3 11.1 0.7 0.7 1.8 0.9 0.5 0.3 0.3 0.2 0.5 0.7 0.5 0.4 1.2 0.5 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 26.2 26.9 7.4 26.6 28.0 36.4 23.5 18.2 28.1 18.9 11.3 29.4 22.6 0.8 3.2 2.8 64.9 0.3 0.4 2.0 0.1 0.0 10.8 5.8 3.0 28.0 2.8 1.6 1.8 54.2 0.0 0.2 0.1 0.0 2.3 6.8 15.3 2.1 4.5 4.9 0.0 183.1 0.0 0.1 3.8 0.0 7.9 1.3 1.8 2.9 0.1 0.4 69.0 276.5 1.0 0.0 1.0 1.6 5.1 5.9 0.9 1.8 10.3 0.1 86.5 0.0 190.5 45.5 0.2 0.4 0.0 0.3 29.1 0.2 0.7 0.7 5.8 6.6 1.8 7.7 1.1 2.6 0.5 1.1 0.0 0.1 8.8 1.2 4.2 CLK4 ENSG00000113240 "CDC like kinase 4" Q9HAZ1 5 178602664-178630615 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 297.5;Late spermatids: 518.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043746 Approved Approved "Actin filaments" No No "Actin filaments" "HPA043746: AB_2678650" "unprognostic (9.46e-2)" "unprognostic (2.24e-2)" "unprognostic (1.48e-1)" "unprognostic (3.44e-2)" "unprognostic (1.59e-1)" "unprognostic (7.16e-3)" "unprognostic (2.67e-1)" "unprognostic (2.04e-2)" "unprognostic (4.37e-2)" "unprognostic (5.92e-2)" "unprognostic (2.90e-3)" "unprognostic (9.62e-3)" "unprognostic (1.13e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-1)" "unprognostic (1.20e-1)" "unprognostic (1.14e-3)" 13.6 12.1 15.4 7.9 16.3 10.5 13.7 24.4 20.3 19.5 16.0 13.0 9.4 12.9 12.0 10.2 13.9 9.9 12.8 15.4 16.4 12.5 13.8 10.9 17.8 16.4 15.7 14.9 18.4 17.7 8.0 10.4 10.9 18.2 16.8 6.6 34.8 13.1 8.4 18.0 15.2 12.7 5.5 15.8 18.8 12.6 15.4 15.9 16.8 16.7 21.3 10.1 12.6 21.2 20.8 8.1 7.2 6.8 10.0 19.9 15.9 11.2 7.6 8.8 4.5 8.4 7.7 6.6 4.6 6.0 3.2 5.2 10.4 8.9 6.0 7.5 16.8 6.8 1.8 15.2 8.8 7.4 3.8 5.7 7.2 8.8 7.6 9.6 15.1 3.2 3.1 4.1 13.4 5.5 3.3 5.2 13.8 3.4 5.4 4.5 4.8 6.0 6.7 4.2 2.3 7.4 5.0 8.4 4.7 8.4 3.8 5.1 8.0 6.9 9.5 3.4 4.9 8.4 8.4 3.5 3.5 6.8 9.0 5.0 7.7 5.9 12.7 8.9 4.1 12.6 12.8 9.5 8.4 5.9 10.2 12.2 9.5 16.1 8.4 4.3 7.4 9.6 4.9 15.4 16.3 24.4 20.3 15.4 16.4 16.4 15.7 14.9 18.2 15.8 15.9 20.8 31.9 16.0 27.8 45.7 57.8 31.9 44.5 18.4 40.9 70.8 23.5 21.6 22.9 11.5 23.7 14.7 39.6 20.1 52.1 12.2 5.9 9.4 297.5 22.8 30.1 25.4 6.0 38.7 79.6 4.7 18.4 29.2 20.4 19.8 27.9 36.1 18.9 13.0 10.1 28.6 40.5 10.7 14.2 13.9 24.7 518.3 30.7 21.4 16.0 43.1 18.3 29.6 27.8 61.9 60.6 7.2 16.5 29.3 36.5 23.9 25.0 10.1 26.8 81.3 19.7 17.1 30.9 30.3 18.4 19.7 24.6 15.9 42.0 24.1 10.2 26.9 PCDHB15 PCDH-BETA15 ENSG00000113248 "Protocadherin beta 15" Q9Y5E8 5 141245395-141249365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 4.3;Bipolar cells: 4.4;Early spermatids: 7.5;Endometrial stromal cells: 4.4;Fibroblasts: 3.7;Horizontal cells: 5.0;Skeletal myocytes: 4.2;Smooth muscle cells: 4.1;Spermatocytes: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.2;LHCN-M2: 4.9;WM-115: 4.9" "Low region specificity" "Detected in all" "HPA007172, CAB026471, HPA074676" Uncertain Approved Mitochondria NA NA 250000 Mitochondria "CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (7.37e-3)" "unprognostic (1.75e-1)" "unprognostic (2.06e-2)" "unprognostic (6.19e-2)" "unprognostic (1.60e-1)" "unprognostic (4.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.58e-2)" "unprognostic (7.01e-2)" "unprognostic (6.00e-2)" "unprognostic (9.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 3.0 1.4 1.8 2.6 2.1 0.0 2.6 4.3 2.5 5.7 0.3 3.0 0.5 6.9 2.5 1.4 5.0 2.1 4.2 1.9 1.7 2.0 1.1 3.8 0.7 3.0 2.3 2.0 7.4 3.4 0.9 3.6 1.5 2.5 2.4 0.9 2.0 1.7 2.1 1.3 1.2 1.8 4.1 2.1 2.5 2.1 5.4 2.3 0.3 2.8 1.4 0.5 3.6 3.2 2.4 0.2 0.0 6.2 0.7 1.5 1.6 0.1 0.4 1.2 0.1 0.3 0.0 0.3 0.0 1.2 0.9 1.6 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.0 0.7 1.3 0.0 0.2 1.6 0.3 0.0 0.0 1.0 4.9 0.0 0.0 0.1 1.5 0.0 0.0 0.2 0.7 0.0 0.4 0.1 0.3 0.8 0.3 0.3 1.6 0.8 0.3 0.0 0.0 0.6 0.6 2.2 0.0 0.1 0.8 0.0 0.8 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 4.3 2.5 1.9 1.7 3.0 2.3 2.0 2.5 2.1 2.3 2.4 4.3 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 4.4 0.2 0.3 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 7.5 0.2 4.4 2.4 0.0 0.0 0.0 1.5 0.0 3.7 0.5 0.2 0.0 0.6 1.4 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.0 0.9 0.1 3.4 0.0 0.1 0.0 0.7 0.1 0.8 0.0 4.2 4.1 4.8 0.7 0.2 0.6 0.0 0.1 0.5 0.1 0.3 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 4.6;kidney: 7.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.9;Inhibitory neurons: 1.3;Microglial cells: 5.6;Oligodendrocytes: 1.8;Proximal tubular cells: 2.3" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 93.0;CACO-2: 113.9;RPTEC TERT1: 43.5" "Low region specificity" "Detected in many" "HPA007173, CAB075697" Uncertain Approved Vesicles NA NA 155000 Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavorable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favorable (1.32e-4)" 0.3 0.0 0.3 0.4 0.5 0.9 0.1 0.6 0.4 0.1 0.4 4.6 0.2 0.1 0.2 0.0 0.1 0.5 0.0 0.4 0.3 7.6 0.3 0.3 0.6 0.7 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 3.5 0.3 0.1 0.0 0.0 0.2 0.1 0.2 0.5 0.3 0.3 0.9 0.5 0.1 0.1 0.0 0.3 0.1 0.0 0.7 0.0 93.0 0.2 0.0 0.3 0.0 13.8 0.0 0.0 0.0 0.0 113.9 0.0 0.0 14.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 43.5 3.4 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.2 0.2 0.3 0.1 0.1 0.2 0.6 0.5 0.2 0.4 0.1 0.1 0.6 0.4 0.3 0.5 0.6 0.4 0.4 0.3 0.7 0.3 0.1 0.8 0.5 0.5 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 5.6 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.0 GRM6 "CSNB1B, GPRC1F, mGlu6, MGLUR6" ENSG00000113262 "Glutamate metabotropic receptor 6" O15303 5 178977587-178996206 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Receptor, Transducer" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "retina: 43.0" "Cell type enriched" "Detected in some" 31 "Bipolar cells: 440.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014511 Enhanced NA NA "HPA014511: AB_2669025" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (8.41e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-1)" "unprognostic (2.25e-3)" "unprognostic (7.72e-2)" "unprognostic (2.32e-2)" "unprognostic (2.12e-3)" "unprognostic (6.27e-2)" "unprognostic (3.34e-4)" "unprognostic (2.58e-1)" "unprognostic (3.36e-4)" "unprognostic (1.23e-1)" "unprognostic (6.45e-2)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.3 0.0 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.4 0.3 0.1 0.0 440.5 0.1 0.0 1.9 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 1.0 0.2 0.4 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 3.3 0.4 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.0 0.0 0.6 4.2 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 14.2 0.0 0.3 0.2 0.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 ITK "EMT, LYK, PSCTK2" ENSG00000113263 "IL2 inducible T cell kinase" Q08881 5 157142933-157255185 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 58.5" "Group enriched" "Detected in some" 6 "dendritic cells: 51.7;granulocytes: 31.8;NK-cells: 42.2;Plasma cells: 34.0;T-cells: 115.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 23 "gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2" "Group enriched" "Detected in many" 23 "NK-cells: 29.3;T-cells: 78.2" "Group enriched" "Detected in some" 10 "JURKAT: 62.2;MOLT-4: 23.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043670 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043670: " "unprognostic (2.08e-3)" "unprognostic (6.57e-4)" "unprognostic (5.06e-3)" "unprognostic (4.96e-5)" "unprognostic (1.52e-2)" "unprognostic (1.12e-4)" "unprognostic (8.45e-4)" "unprognostic (1.56e-2)" "unprognostic (1.87e-2)" "unprognostic (5.99e-3)" "unprognostic (1.76e-1)" "unprognostic (2.52e-1)" "unprognostic (4.52e-6)" "unprognostic (3.64e-1)" "unprognostic (4.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.26e-2)" 1.0 0.3 0.0 16.1 0.0 3.7 0.9 0.0 0.0 1.0 0.0 1.4 0.7 0.4 0.0 1.4 0.4 4.3 0.1 0.0 0.0 0.3 1.6 3.2 29.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.4 1.5 0.0 0.3 0.1 0.0 0.2 4.0 0.5 0.0 10.6 3.1 0.5 0.0 58.5 0.5 0.0 24.8 3.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 3.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 62.2 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 39.6 0.0 26.4 0.0 55.6 54.9 0.1 0.0 78.2 65.0 1.3 29.3 2.3 0.1 73.2 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 6.2 0.0 4.0 2.7 0.6 0.0 0.0 0.0 0.4 0.4 0.9 0.0 0.6 1.8 0.0 0.1 51.7 0.1 0.0 0.1 8.5 0.2 0.3 0.8 0.0 1.7 0.2 0.0 0.0 1.1 7.7 0.4 31.8 0.1 1.8 1.0 0.0 0.0 0.2 0.0 0.0 1.6 5.1 6.7 0.0 2.9 1.8 1.0 2.8 0.0 42.2 0.0 0.1 0.0 0.0 0.0 34.0 0.3 0.0 0.4 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.2 3.4 0.1 115.7 0.0 0.1 0.6 RNF130 "G1RZFP, GOLIATH, GP" ENSG00000113269 "Ring finger protein 130" Q86XS8 5 179911651-180072113 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 295.7;Kupffer cells: 393.7;Macrophages: 283.0;monocytes: 276.4;Oligodendrocytes: 514.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 261.6;classical monocyte: 513.2;eosinophil: 331.3;intermediate monocyte: 355.0;myeloid DC: 407.4;neutrophil: 890.5;non-classical monocyte: 328.7;plasmacytoid DC: 317.2" "Group enriched" "Detected in all" 11 "dendritic cells: 407.4;granulocytes: 890.5;monocytes: 513.2" "Cell line enhanced" "Detected in many" "HMC-1: 179.3" "Low region specificity" "Detected in all" HPA014499 Approved NA NA "HPA014499: AB_1856328" "unprognostic (2.01e-1)" "prognostic favorable (6.32e-4)" "unprognostic (2.43e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-2)" "unprognostic (2.83e-1)" "unprognostic (2.02e-3)" "unprognostic (2.93e-2)" "unprognostic (1.78e-1)" "unprognostic (4.00e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (8.41e-2)" "unprognostic (4.17e-2)" "unprognostic (4.32e-1)" "unprognostic (1.38e-2)" 95.1 43.9 86.1 48.1 105.8 94.9 50.7 106.7 115.1 55.9 82.4 40.5 28.4 42.5 35.9 26.7 47.2 56.4 36.5 88.1 101.9 49.9 168.5 63.2 39.5 119.6 101.5 83.9 52.6 64.7 28.2 16.8 48.8 112.9 35.4 42.3 14.4 85.4 60.7 33.5 14.7 32.9 53.1 112.1 52.3 35.0 17.6 100.5 17.9 32.6 54.2 26.0 52.1 19.5 144.4 32.7 26.8 125.5 110.9 117.4 54.5 21.9 20.9 29.1 24.1 25.3 8.4 31.8 0.1 69.6 47.5 47.7 3.0 81.5 49.7 26.0 0.3 54.6 57.7 11.8 25.4 27.3 14.9 179.3 52.2 25.9 2.3 15.3 65.6 42.3 57.3 9.7 0.4 27.0 71.0 28.7 68.8 32.7 6.7 33.8 65.9 27.9 0.1 38.7 7.4 68.4 28.8 43.2 34.4 126.5 45.7 40.8 38.6 36.6 50.6 18.9 38.8 27.1 0.4 24.1 6.2 7.7 132.0 41.2 261.6 513.2 331.3 25.4 355.0 21.7 15.8 10.9 12.3 407.4 15.8 12.4 13.6 890.5 53.6 328.7 317.2 1.6 323.8 86.1 105.8 106.7 115.1 88.1 101.9 119.6 101.5 83.9 112.9 112.1 100.5 144.4 75.0 19.2 21.4 119.1 22.4 14.1 22.6 27.0 12.5 26.9 55.0 45.5 35.1 81.5 34.7 42.3 52.1 11.2 123.7 26.9 23.5 56.8 11.8 49.0 38.8 48.3 16.3 69.2 119.0 76.5 16.6 57.9 25.5 38.3 82.9 28.9 47.5 147.0 295.7 6.7 144.0 36.1 36.7 393.7 170.7 24.2 36.7 283.0 32.0 141.5 276.4 21.8 28.8 242.8 514.2 41.6 32.1 48.2 11.7 27.2 32.6 52.0 56.3 20.3 46.0 32.4 48.5 13.2 32.9 10.9 12.9 8.8 26.2 33.7 52.9 23.3 THG1L "FLJ11601, FLJ20546, hTHG1, ICF45, IHG-1" ENSG00000113272 "TRNA-histidine guanylyltransferase 1 like" Q9NWX6 5 157731420-157741449 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035877, HPA035878" Approved NA NA "HPA035877: AB_10669979, HPA035878: AB_10672993" "unprognostic (4.30e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (4.37e-2)" "unprognostic (5.74e-3)" "unprognostic (4.08e-2)" "unprognostic (1.72e-1)" "unprognostic (7.16e-2)" "unprognostic (1.34e-1)" "unprognostic (4.05e-1)" "prognostic unfavorable (3.93e-6)" "unprognostic (1.48e-1)" "unprognostic (1.47e-1)" "unprognostic (3.09e-1)" "unprognostic (1.69e-1)" 3.7 4.9 2.7 4.0 2.8 5.9 5.3 2.9 3.0 5.2 2.7 6.8 5.5 6.9 6.0 5.1 6.4 4.7 3.4 2.5 2.9 3.5 5.2 3.0 5.5 2.8 2.6 2.6 7.7 4.8 3.1 3.3 4.4 2.8 4.1 7.8 3.5 3.2 5.3 4.0 5.5 4.9 5.7 2.4 4.1 5.5 4.9 2.7 5.4 6.8 2.8 6.0 6.5 4.6 3.2 8.8 15.4 7.2 13.8 6.7 19.6 5.5 6.8 12.6 13.7 18.1 21.4 8.7 21.8 5.7 6.0 8.3 9.1 9.0 13.1 15.2 8.9 12.0 7.7 10.2 9.1 7.6 16.6 8.0 17.8 15.4 12.1 16.6 13.0 5.1 3.4 13.8 6.9 8.2 12.1 2.0 11.3 6.9 3.9 14.8 3.3 13.8 12.6 8.5 11.0 9.1 12.8 5.5 8.2 11.3 5.2 13.9 9.5 5.8 10.9 7.2 9.2 18.5 6.0 7.1 14.0 4.8 15.9 6.9 3.9 7.8 0.1 3.3 8.7 3.9 5.7 4.3 3.4 7.0 4.6 6.3 5.3 0.7 6.7 8.7 4.5 5.0 3.9 2.7 2.8 2.9 3.0 2.5 2.9 2.8 2.6 2.6 2.8 2.4 2.7 3.2 6.0 3.2 8.6 1.3 14.7 20.6 27.7 27.1 27.9 2.6 14.2 15.4 6.2 11.5 11.5 3.7 4.2 17.6 10.2 6.9 9.8 17.1 19.2 8.8 20.8 9.0 7.2 23.5 1.8 26.4 12.8 15.4 12.2 7.2 2.5 17.3 6.8 8.6 19.1 0.0 1.4 14.3 8.2 15.7 17.9 8.6 14.3 16.2 5.4 1.9 21.2 2.0 7.2 0.5 1.9 12.1 19.6 15.4 13.7 21.2 9.7 14.7 5.8 4.6 6.6 17.1 12.4 19.8 8.9 24.0 15.3 13.8 11.2 38.0 24.1 28.4 ARSB ENSG00000113273 "Arylsulfatase B" P15848 5 78777209-78986087 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 25.6" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037770, HPA037771" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA037770: AB_10671719, HPA037771: AB_10671720" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-2)" "unprognostic (7.34e-2)" "unprognostic (2.65e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (7.20e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-2)" "unprognostic (2.48e-2)" "unprognostic (9.57e-3)" "unprognostic (9.88e-2)" "unprognostic (6.54e-3)" "prognostic unfavorable (3.42e-4)" 7.0 4.5 3.8 8.1 3.7 8.2 2.6 2.9 4.1 5.3 4.0 5.6 3.1 6.4 3.5 4.8 2.9 7.4 8.4 4.5 5.1 21.5 7.7 7.1 5.4 4.6 4.9 3.4 2.3 4.6 6.6 2.5 11.6 4.3 5.0 8.2 6.7 3.2 6.6 3.8 2.1 3.6 14.2 4.1 5.3 3.9 2.7 4.5 2.6 4.2 4.3 4.9 8.0 2.3 5.2 5.0 11.3 18.6 6.3 41.9 16.4 16.7 29.2 23.0 18.9 23.0 9.9 8.4 6.5 31.5 25.5 29.0 3.9 7.0 7.4 18.5 55.6 6.2 9.2 11.2 40.1 9.7 10.5 10.4 19.4 2.4 19.7 6.5 15.6 22.4 3.9 2.0 12.9 19.6 9.2 5.8 19.3 5.6 1.1 6.7 7.7 10.9 5.9 12.0 6.2 6.8 15.9 20.3 6.2 12.1 12.7 6.9 26.2 16.2 17.5 10.4 7.6 26.4 14.8 28.0 7.2 21.6 21.4 40.3 19.0 8.3 25.6 1.0 6.7 0.6 2.0 0.4 0.4 7.8 1.3 0.3 0.5 4.6 0.2 5.6 5.7 0.7 2.7 3.8 3.7 2.9 4.1 4.5 5.1 4.6 4.9 3.4 4.3 4.1 4.5 5.2 3.9 0.0 2.0 40.8 5.1 0.8 1.4 1.3 0.6 3.7 1.6 1.0 7.2 1.5 0.7 3.7 6.2 2.2 5.5 1.4 3.9 3.7 0.5 1.9 7.2 4.5 1.2 16.2 37.4 9.2 5.1 6.6 2.6 9.0 0.0 6.3 13.6 3.8 16.7 6.7 42.5 6.0 0.0 25.2 14.3 0.5 4.4 15.9 14.2 40.3 16.1 3.6 2.1 71.4 56.2 4.0 3.0 3.8 8.1 2.2 0.5 18.8 2.5 2.7 6.6 5.0 4.4 2.2 3.1 0.7 1.3 2.6 3.4 1.6 2.2 1.3 CLINT1 "CLINT, ENTH, EPNR, KIAA0171" ENSG00000113282 "Clathrin interactor 1" Q14677 5 157785743-157859145 "Plasma proteins, Predicted intracellular proteins, Transporters" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "basophil: 749.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 749.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043280, HPA056947" Supported Supported Nucleoplasm,Vesicles NA NA 540000 Vesicles Nucleoplasm "HPA043280: AB_10793944, HPA056947: AB_2683283" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.95e-4)" "unprognostic (7.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (2.53e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.88e-5)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.56e-1)" 28.9 34.7 10.6 43.2 11.9 102.0 31.7 10.7 14.6 36.7 16.6 54.4 68.9 26.7 54.6 72.7 38.2 61.9 34.6 11.8 11.7 71.0 90.2 36.6 49.8 11.6 11.1 9.9 27.1 49.7 114.1 17.9 47.5 11.5 29.8 53.9 16.2 51.2 42.8 53.6 40.0 56.1 32.1 11.1 31.2 69.8 20.4 12.3 51.2 56.5 41.3 74.4 65.1 39.1 11.4 65.6 91.7 64.3 59.8 86.3 71.0 91.6 89.7 87.5 83.4 115.9 128.7 100.0 121.3 100.3 82.6 112.0 95.8 87.1 100.4 120.7 57.9 70.4 80.6 80.4 65.2 85.5 112.9 105.6 52.5 75.6 94.7 105.6 53.6 80.0 69.6 70.6 66.1 69.9 56.7 88.7 60.5 67.8 63.6 93.9 78.8 96.9 103.0 84.8 115.4 56.6 62.1 64.5 111.7 87.4 81.2 76.4 78.0 83.7 74.6 56.3 69.5 89.4 76.1 77.9 154.4 61.0 126.2 67.5 749.5 46.5 179.7 43.6 49.2 75.2 47.5 41.4 43.7 62.7 46.2 35.9 38.8 17.6 58.6 53.4 48.5 66.2 53.1 10.6 11.9 10.7 14.6 11.8 11.7 11.6 11.1 9.9 11.5 11.1 12.3 11.4 68.6 60.9 132.9 25.1 76.0 57.1 83.7 69.4 80.2 21.6 74.4 44.2 103.9 105.8 137.8 68.0 8.4 45.1 73.8 73.5 95.9 93.4 4.1 116.5 82.4 52.8 54.5 54.9 31.9 64.0 71.9 71.8 119.3 141.9 84.7 40.2 21.0 86.8 30.5 11.8 29.0 78.9 38.7 42.9 87.8 5.6 47.2 73.0 35.6 28.1 94.1 25.5 73.2 39.2 31.4 53.7 62.6 28.6 158.3 92.5 50.3 94.5 148.5 19.0 39.5 67.2 61.9 44.2 40.2 156.3 78.3 68.3 65.5 82.0 99.0 271.5 THBS4 ENSG00000113296 "Thrombospondin 4" P35443 5 79991311-80083287 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Tissue remodeling, Unfolded protein response" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 218.6;heart muscle: 169.5;smooth muscle: 253.8;tongue: 216.5" "Cell type enriched" "Detected in many" 4 "Sertoli cells: 493.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 46 "eosinophil: 4.5" "Lineage enriched" "Detected in single" 46 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6" "Region enriched" "Detected in many" 8 "white matter: 85.7" "Region enriched" "Detected in many" 27 "spinal cord: 89.3" "CAB004597, HPA042426" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 510000000 Vesicles "CAB004597: AB_628352, HPA042426: AB_2677992" "unprognostic (1.41e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-3)" "unprognostic (3.64e-2)" "unprognostic (9.94e-2)" "unprognostic (8.10e-2)" "unprognostic (5.64e-2)" "unprognostic (7.12e-2)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-3)" "unprognostic (2.74e-2)" "unprognostic (3.98e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.33e-4)" 218.6 1.2 15.4 5.2 18.8 10.7 27.0 14.2 12.8 1.6 4.8 38.6 2.2 27.1 1.6 6.1 2.5 10.5 169.5 12.4 23.3 0.7 0.3 1.3 1.1 22.2 22.9 12.6 4.2 23.0 36.0 14.4 0.2 18.1 9.1 8.8 7.6 46.8 5.8 77.9 3.0 3.4 253.8 21.1 0.3 8.6 8.8 23.0 3.6 27.3 216.5 4.0 3.5 5.8 20.8 0.1 0.0 3.1 0.2 0.2 1.3 0.3 0.1 0.1 0.9 0.3 0.1 0.4 0.1 0.1 0.2 0.8 0.1 0.1 0.4 0.8 0.1 0.4 0.3 0.0 0.2 1.7 0.0 0.0 0.9 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 2.5 0.7 0.0 0.0 0.2 1.3 0.0 7.0 0.0 0.0 2.8 0.2 0.2 2.6 0.1 0.4 1.1 2.2 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 18.8 14.2 12.8 12.4 23.3 22.2 22.9 12.6 18.1 21.1 23.0 20.8 57.0 0.0 1.1 37.2 0.7 0.3 0.1 0.2 2.2 1.3 0.8 1.8 9.1 0.0 0.7 3.7 56.3 0.1 0.5 0.0 0.0 0.2 40.8 0.3 0.8 9.4 9.0 0.0 9.7 0.0 0.0 84.2 0.5 0.3 0.0 5.9 0.4 0.2 0.1 1.7 12.7 0.0 0.0 0.0 0.3 7.2 0.9 2.7 1.8 6.5 0.0 2.2 0.0 60.3 24.0 0.0 0.0 43.6 0.3 1.0 0.0 0.8 0.2 1.9 493.0 78.9 116.9 14.5 2.1 0.6 1.0 0.0 2.1 1.2 0.0 0.0 CNOT6 "CCR4, Ccr4a, KIAA1194" ENSG00000113300 "CCR4-NOT transcription complex subunit 6" Q9ULM6 5 180494379-180578358 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044568 Approved Approved Cytosol NA NA Cytosol "HPA044568: AB_10797257" "unprognostic (9.41e-3)" "unprognostic (1.40e-1)" "unprognostic (2.03e-3)" "unprognostic (2.55e-1)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (3.57e-2)" 6.7 6.5 8.8 12.1 9.6 12.1 9.6 16.7 8.8 8.1 10.1 10.1 12.2 9.3 8.7 11.6 9.5 7.4 6.3 8.1 10.8 10.1 5.1 9.7 11.5 9.7 9.3 7.6 9.5 6.7 8.8 5.6 11.9 10.1 9.5 11.7 17.7 7.2 7.5 5.2 9.4 12.0 8.2 9.0 10.1 10.2 13.6 9.4 19.9 9.1 7.4 14.1 11.5 8.0 9.8 24.9 29.6 59.2 47.5 9.6 10.9 61.0 17.9 12.0 23.2 27.5 36.1 35.7 26.2 26.5 11.8 32.2 25.5 50.0 59.4 27.1 77.5 25.2 28.6 38.4 23.4 14.3 33.6 20.1 9.3 28.1 17.1 36.1 21.6 28.6 30.2 30.9 24.5 21.8 51.1 43.0 20.2 17.5 25.0 13.9 39.1 29.6 18.6 25.6 48.5 43.0 36.4 30.1 39.7 26.2 28.7 49.9 33.5 31.4 24.5 28.1 18.0 32.0 16.0 30.9 27.4 23.4 45.3 20.6 0.7 0.8 1.2 1.2 1.4 1.3 0.6 1.0 0.7 0.8 0.7 1.4 1.4 0.8 0.7 2.3 0.8 0.8 0.6 8.8 9.6 16.7 8.8 8.1 10.8 9.7 9.3 7.6 10.1 9.0 9.4 9.8 12.4 28.9 13.4 16.3 11.9 21.7 6.4 12.9 15.9 18.0 19.5 11.7 11.4 14.3 12.4 11.0 22.9 9.4 21.9 17.1 1.9 11.0 6.4 32.3 22.3 13.2 14.5 27.8 27.2 9.3 12.8 11.8 11.2 21.1 2.5 29.7 13.6 5.7 12.5 18.5 24.9 13.8 6.1 16.2 15.4 9.3 13.1 14.4 10.6 18.7 20.1 13.5 26.8 30.2 33.4 17.6 8.4 18.8 15.5 17.3 12.1 13.1 20.2 17.5 26.3 11.7 13.1 38.6 48.7 23.2 22.3 11.5 16.2 12.8 16.5 19.9 IL12B "CLMF, CLMF2, IL-12B, NKSF, NKSF2" ENSG00000113302 "Interleukin 12B" P29460 5 159314780-159330487 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Cell type enriched" "Detected in some" 4 "monocytes: 6.7" "Cancer enriched" "Detected in single" 20 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040970 Supported "Secreted to blood" NA NA 140000 "HPA040970: AB_10796234" "unprognostic (5.96e-5)" "unprognostic (4.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.40e-1)" "unprognostic (9.13e-4)" "unprognostic (6.89e-2)" "unprognostic (2.58e-4)" "unprognostic (6.69e-3)" "unprognostic (3.83e-2)" "unprognostic (4.50e-2)" "unprognostic (2.53e-1)" "unprognostic (7.15e-3)" "unprognostic (9.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-2)" 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.4 0.2 0.1 0.0 1.4 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTNL8 "BTN9.2, FLJ21458" ENSG00000113303 "Butyrophilin like 8" Q6UX41 5 180899077-180950906 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "intestine: 120.1" "Group enriched" "Detected in some" 4 "Distal enterocytes: 79.6;Proximal enterocytes: 178.9" "Group enriched" "Detected in some" 12 "colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 12 "neutrophil: 233.4" "Lineage enriched" "Detected in many" 221 "granulocytes: 233.4" "Group enriched" "Detected in some" 28 "CACO-2: 39.3;OE19: 56.2" HPA039738 Enhanced NA NA "HPA039738: AB_2676656" "unprognostic (4.31e-1)" "unprognostic (6.85e-6)" "unprognostic (6.99e-2)" "unprognostic (1.48e-1)" "unprognostic (6.33e-2)" "unprognostic (1.91e-1)" "unprognostic (6.27e-3)" "unprognostic (6.07e-2)" "unprognostic (3.08e-3)" "unprognostic (3.28e-1)" "unprognostic (1.67e-1)" "unprognostic (9.02e-2)" "unprognostic (4.96e-3)" "unprognostic (2.93e-1)" "unprognostic (1.42e-1)" "unprognostic (4.43e-1)" "unprognostic (1.17e-2)" 1.1 0.3 0.2 2.1 0.2 7.3 0.5 0.2 0.4 0.0 0.2 26.9 120.1 0.1 0.0 0.2 1.4 7.0 0.3 0.2 0.6 0.6 0.6 2.6 0.3 0.4 0.3 0.1 0.1 1.7 0.2 0.2 0.2 0.3 0.1 26.0 0.0 0.1 0.0 0.3 0.0 87.2 0.6 0.2 3.1 7.2 5.5 0.3 0.2 1.1 0.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.4 56.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.0 1.6 0.0 0.2 0.4 0.0 0.1 1.0 20.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.4 0.0 0.5 0.0 0.4 0.3 0.2 0.2 0.2 0.4 0.2 0.6 0.4 0.3 0.1 0.3 0.2 0.3 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 8.6 0.1 0.0 0.0 0.0 0.0 79.6 0.0 0.2 0.3 0.0 0.0 0.6 3.6 0.0 0.3 2.6 0.0 0.2 12.2 0.0 0.0 0.0 11.7 0.1 0.8 0.0 0.1 29.6 0.0 4.5 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 26.3 0.0 0.0 0.0 178.9 0.1 0.8 0.0 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 15.6 0.1 TTC1 TPR1 ENSG00000113312 "Tetratricopeptide repeat domain 1" Q99614 5 160009113-160065543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036557, HPA057502" Approved Enhanced Cytosol NA NA 17000 Cytosol "HPA036557: AB_10670112, HPA057502: AB_2683450" "unprognostic (4.34e-3)" "unprognostic (2.26e-2)" "unprognostic (3.05e-2)" "unprognostic (7.38e-2)" "unprognostic (6.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.29e-2)" "unprognostic (2.38e-1)" "unprognostic (5.50e-2)" "unprognostic (2.31e-1)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (6.16e-2)" 37.4 46.8 84.0 35.9 84.6 26.4 39.9 88.6 112.6 31.8 76.9 41.2 27.5 32.5 58.6 37.7 32.5 26.4 57.2 84.9 87.2 50.0 45.9 33.3 48.2 94.1 90.6 82.1 32.9 27.6 45.4 30.1 35.8 94.5 33.7 45.8 43.3 39.7 37.5 92.1 35.1 31.2 42.1 87.0 36.9 34.9 34.2 87.4 49.1 36.1 77.7 56.4 36.0 27.8 95.8 83.2 85.1 62.2 104.4 71.9 51.6 70.5 90.8 80.4 97.7 115.6 120.2 94.0 84.5 172.7 78.2 132.9 63.9 83.5 124.7 156.6 157.7 88.4 75.9 63.0 87.3 102.0 127.2 61.2 48.7 81.0 86.5 71.8 71.8 118.8 74.2 73.6 81.7 112.3 65.0 92.8 99.8 70.7 67.3 85.8 88.4 87.0 93.6 124.2 76.8 51.2 57.7 63.1 74.4 175.1 58.3 117.6 121.5 84.4 64.8 55.8 58.5 141.9 58.4 114.8 82.3 89.6 143.3 85.9 109.8 72.8 105.7 57.6 80.9 73.4 92.6 68.3 68.0 73.5 86.0 62.5 69.1 103.0 87.7 80.6 65.4 90.2 113.1 84.0 84.6 88.6 112.6 84.9 87.2 94.1 90.6 82.1 94.5 87.0 87.4 95.8 48.6 67.3 50.8 20.9 55.0 47.0 33.6 89.2 28.5 38.4 40.4 47.0 237.0 40.0 67.4 46.0 20.9 108.7 36.0 58.0 162.4 114.2 115.3 62.8 46.5 61.3 35.3 89.2 54.0 106.5 77.9 57.4 23.4 54.8 83.4 41.3 52.1 72.8 90.0 35.3 47.6 51.4 83.4 48.1 34.7 39.9 46.9 52.4 28.4 23.4 70.1 99.1 68.0 43.7 57.0 98.5 54.7 63.9 42.9 37.6 53.7 144.9 89.4 50.2 59.2 55.7 59.2 142.9 101.5 37.8 47.3 99.9 50.8 53.6 53.7 21.9 MSH3 "DUP, MRP1" ENSG00000113318 "MutS homolog 3" P20585 5 80654652-80876815 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036081 Approved "Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" "HPA036081: AB_10673229" "unprognostic (1.91e-1)" "unprognostic (7.61e-2)" "prognostic favorable (5.90e-5)" "unprognostic (2.95e-2)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (1.81e-1)" "unprognostic (8.70e-2)" "unprognostic (3.17e-2)" "unprognostic (2.62e-2)" "unprognostic (2.63e-1)" "unprognostic (3.91e-1)" "prognostic favorable (1.77e-4)" "unprognostic (5.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 9.5 4.6 1.9 4.4 2.5 5.1 5.6 1.7 2.1 6.6 1.7 6.0 6.0 5.3 5.3 5.1 7.1 5.8 5.0 1.7 2.1 12.6 11.5 4.3 4.9 2.0 2.0 1.5 5.3 5.2 8.9 3.3 4.4 1.9 5.3 6.2 3.8 4.5 5.3 5.1 5.1 5.7 5.1 2.3 4.1 5.0 4.0 2.5 7.1 10.9 4.7 6.2 6.3 4.0 2.1 12.4 15.0 11.7 13.1 6.6 12.3 16.6 12.2 11.8 13.6 16.7 10.0 15.6 22.2 14.0 15.3 12.8 10.4 15.6 20.5 17.3 14.2 13.9 8.4 13.4 9.9 6.8 9.9 8.5 10.9 9.5 15.8 16.6 13.8 12.9 7.9 12.1 12.9 16.1 11.9 19.0 4.7 9.0 4.8 7.7 13.2 24.2 16.4 15.2 13.0 11.6 13.9 10.4 11.5 13.0 14.4 15.2 9.4 12.4 7.8 9.5 6.2 23.0 8.7 15.6 21.6 12.2 16.8 10.2 0.7 2.9 1.9 3.3 3.4 3.8 3.4 3.5 3.6 3.3 2.2 2.6 2.6 1.7 3.1 4.6 2.8 4.8 2.4 1.9 2.5 1.7 2.1 1.7 2.1 2.0 2.0 1.5 1.9 2.3 2.5 2.1 16.7 35.3 9.3 66.9 18.1 10.5 12.3 12.4 12.5 25.8 19.4 12.8 17.6 8.6 14.3 14.7 14.6 18.9 18.7 18.2 15.6 12.4 14.6 28.4 20.2 12.0 14.5 17.0 95.1 10.3 12.9 15.9 31.6 18.9 8.2 19.9 10.0 20.1 11.5 21.9 98.9 13.2 8.2 13.0 7.0 17.2 13.7 16.3 3.6 72.1 19.9 22.5 19.6 71.9 92.3 10.6 9.6 25.9 22.0 6.5 16.8 43.6 65.4 28.3 19.7 20.2 14.7 24.7 25.5 22.3 10.1 13.1 25.4 14.7 17.4 10.7 RASGRF2 "GRF2, Ras-GRF2" ENSG00000113319 "Ras protein specific guanine nucleotide releasing factor 2" O14827 5 80960363-81230162 "Predicted intracellular proteins, RAS pathway related proteins" "Calmodulin-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 23.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 220.6;Inhibitory neurons: 407.6;Microglial cells: 89.0;Oligodendrocytes: 395.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.9;MAIT T-cell: 5.2;memory CD4 T-cell: 2.6;memory CD8 T-cell: 1.5;naive CD4 T-cell: 4.2;naive CD8 T-cell: 3.0" "Lineage enriched" "Detected in single" 52 "T-cells: 5.2" "Cell line enhanced" "Detected in some" "BEWO: 37.8;CACO-2: 23.3;Hep G2: 31.8;HHSteC: 20.8;hTERT-RPE1: 15.3;SuSa: 16.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 24.5;cerebral cortex: 77.3;hippocampal formation: 46.6;olfactory bulb: 27.0" HPA018679 Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA018679: AB_1856089" "unprognostic (1.32e-1)" "unprognostic (6.96e-2)" "unprognostic (7.27e-2)" "unprognostic (7.80e-2)" "unprognostic (3.62e-1)" "unprognostic (1.00e-1)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (4.02e-1)" "unprognostic (8.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.34e-1)" "unprognostic (1.47e-3)" "unprognostic (1.37e-3)" "unprognostic (2.13e-2)" "unprognostic (5.01e-2)" "unprognostic (1.12e-1)" 11.3 0.9 11.5 3.4 10.9 1.0 7.4 2.2 15.0 3.3 15.7 2.4 1.8 2.4 0.8 1.3 2.2 5.3 4.1 11.6 5.6 4.9 0.5 3.3 3.5 4.1 3.8 11.0 17.7 1.0 2.3 4.2 10.3 4.6 3.6 1.4 23.1 1.5 1.5 2.7 1.0 2.5 2.6 4.7 2.2 1.9 2.1 12.9 1.5 4.7 6.9 2.8 3.4 2.4 11.1 0.0 2.1 0.5 0.3 0.0 0.0 37.8 0.7 9.3 0.4 0.4 23.3 0.0 0.4 11.9 0.0 0.2 0.6 0.0 0.0 1.2 0.6 4.0 0.2 0.3 31.8 20.8 0.0 0.0 1.0 0.1 8.8 0.1 15.3 0.2 0.5 0.0 0.1 0.0 0.3 0.3 0.2 4.5 0.0 0.1 0.2 4.5 0.1 1.4 0.0 0.4 0.5 0.1 0.0 0.3 16.2 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.4 0.0 0.0 0.0 1.9 0.0 5.2 0.0 2.6 1.5 0.0 0.0 4.2 3.0 0.0 0.0 0.0 0.0 0.7 1.0 11.5 10.9 2.2 15.0 11.6 5.6 4.1 3.8 11.0 4.6 4.7 12.9 11.1 45.3 0.0 1.1 10.1 0.6 1.7 0.3 0.1 0.0 15.9 0.2 0.3 5.2 0.0 0.6 9.2 58.4 1.1 2.2 0.2 0.0 0.4 10.2 1.3 0.3 23.7 0.0 0.0 220.6 0.0 26.9 2.5 0.5 1.1 0.0 0.2 5.3 0.1 1.1 1.7 407.6 0.5 0.0 0.3 0.8 3.0 0.9 0.5 1.8 89.0 0.2 3.7 6.2 8.5 395.6 0.7 1.2 9.1 0.9 0.3 1.0 2.1 0.0 42.1 0.0 1.5 0.9 6.7 1.6 0.3 0.6 0.8 7.5 4.1 1.3 0.5 GABRG2 ENSG00000113327 "Gamma-aminobutyric acid type A receptor subunit gamma2" P18507 5 162000057-162162977 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;retina: 11.0" "Group enriched" "Detected in some" 7 "Bipolar cells: 119.0;Excitatory neurons: 239.9;Inhibitory neurons: 167.8" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 4.5" "Group enriched" "Detected in many" 5 "B-cells: 1.6;granulocytes: 4.5;T-cells: 1.5" "Cell line enhanced" "Detected in many" "CACO-2: 10.3;Karpas-707: 10.2;RPMI-8226: 13.4;SuSa: 13.0;U-266/70: 20.1;U-266/84: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079060 Supported NA NA "CAB079060: " "unprognostic (2.88e-2)" "unprognostic (1.56e-2)" "unprognostic (6.31e-3)" "unprognostic (3.07e-3)" "unprognostic (1.52e-1)" 0.3 4.8 6.2 0.4 9.9 2.3 0.1 8.3 23.0 0.0 0.0 0.7 1.2 0.3 0.4 0.4 0.5 2.6 0.8 9.1 10.3 0.2 0.4 0.9 0.4 5.9 5.3 9.1 0.7 0.1 0.0 1.2 1.9 9.3 0.1 0.5 11.0 0.5 0.1 0.5 2.2 1.0 0.8 0.5 0.4 1.9 0.8 8.4 1.7 0.5 0.5 0.5 0.2 0.0 16.1 3.9 1.7 2.3 0.2 0.0 0.1 1.9 0.7 0.0 0.0 0.0 10.3 5.5 0.5 5.9 0.0 0.2 1.1 1.6 0.0 0.0 1.0 1.0 0.0 1.7 1.2 0.0 0.0 0.6 0.4 0.3 0.0 0.0 0.1 0.0 1.0 2.4 10.2 0.0 2.8 0.5 0.1 7.4 3.1 3.6 0.5 0.1 13.4 0.0 3.1 1.1 0.9 0.3 0.5 4.1 13.0 6.7 6.9 0.1 0.3 5.2 0.4 0.5 20.1 18.7 0.1 0.1 0.5 0.3 4.5 0.1 0.3 0.2 0.1 1.2 1.6 0.3 0.3 0.0 1.4 1.5 0.3 0.7 0.4 0.1 0.3 0.4 0.1 6.2 9.9 8.3 23.0 9.1 10.3 5.9 5.3 9.1 9.3 0.5 8.4 16.1 0.0 19.2 23.5 15.3 0.0 0.0 0.0 0.0 0.0 119.0 0.1 0.0 0.4 0.0 10.5 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 239.9 0.0 0.1 1.4 0.0 0.0 8.8 0.0 0.0 0.0 0.1 16.8 167.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 12.2 0.0 2.6 0.0 12.1 15.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 6.6 9.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CCNG1 CCNG ENSG00000113328 "Cyclin G1" P51959 5 163437569-163446151 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 265.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB000350 Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000350: " "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "prognostic favorable (7.00e-4)" "unprognostic (2.92e-2)" "unprognostic (9.04e-2)" "unprognostic (2.26e-1)" "unprognostic (6.25e-2)" "unprognostic (1.58e-1)" "unprognostic (6.15e-2)" "unprognostic (1.45e-2)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.38e-3)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (7.89e-2)" 51.7 49.2 23.2 30.7 24.5 38.7 67.9 25.0 26.0 64.0 29.2 68.6 138.5 50.9 74.1 48.3 62.4 57.2 50.8 21.3 28.9 124.6 130.7 33.7 49.4 26.2 25.7 19.6 113.0 75.0 40.0 14.7 54.5 26.7 72.0 87.8 21.5 56.8 56.2 165.2 23.7 110.0 52.7 27.7 35.8 57.8 20.9 24.7 50.8 63.0 121.7 47.4 60.2 34.1 30.8 54.9 59.8 246.6 138.8 207.9 397.3 258.2 74.1 181.2 73.8 165.2 130.4 109.4 134.1 73.7 100.1 121.7 22.2 137.2 185.0 107.9 63.7 171.9 106.6 71.7 230.0 226.4 49.9 68.9 433.8 105.6 73.3 75.1 221.5 241.1 88.3 92.3 92.8 253.4 33.8 89.6 66.5 113.3 40.1 52.7 74.6 120.7 75.2 179.5 209.4 57.6 65.6 0.4 30.5 154.0 155.2 115.5 155.8 140.5 47.6 101.0 40.8 66.2 81.5 34.2 87.7 84.3 81.4 80.6 44.5 25.6 31.0 35.8 36.1 53.9 55.4 63.2 49.3 59.6 33.9 84.5 72.0 10.9 40.7 36.7 22.6 80.9 63.9 23.2 24.5 25.0 26.0 21.3 28.9 26.2 25.7 19.6 26.7 27.7 24.7 30.8 20.8 25.6 20.0 7.5 67.3 57.2 94.7 64.7 103.0 12.4 64.4 33.0 52.9 77.2 39.7 36.8 0.0 138.7 49.8 48.2 162.4 73.0 8.1 30.6 27.5 43.5 71.0 96.3 8.4 119.0 107.7 57.1 110.6 46.1 43.7 108.8 61.1 51.7 60.0 15.2 8.8 113.2 44.7 74.8 70.5 6.1 75.8 60.8 37.4 15.0 52.0 29.9 54.6 4.5 12.7 91.1 80.2 72.2 63.5 107.2 223.4 265.9 11.2 10.8 39.5 42.4 73.4 8.8 12.1 61.5 44.2 97.3 76.4 81.5 182.7 104.3 POLR3G "C31, RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514557 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 84.5" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 1.8 0.6 4.0 2.4 4.6 3.0 2.0 6.7 6.4 1.2 0.9 1.6 1.8 1.5 4.7 4.3 1.2 1.4 1.8 4.1 3.8 0.9 2.2 1.6 4.7 5.8 5.1 3.6 1.9 2.5 2.0 0.9 1.9 7.3 1.7 1.5 3.3 2.3 0.5 3.1 4.4 1.4 0.8 2.7 1.8 1.2 4.6 3.7 0.9 3.3 0.8 2.0 2.0 1.7 6.8 24.1 13.0 18.8 5.3 5.9 8.2 7.7 11.9 4.3 19.8 16.8 9.0 18.8 63.7 4.2 5.3 20.0 11.6 20.8 23.2 69.2 29.6 19.6 26.2 8.1 15.1 9.5 19.4 6.2 6.7 8.1 32.7 25.8 4.6 27.2 26.5 35.8 6.4 8.3 13.2 19.1 14.1 78.1 4.0 63.2 16.5 7.4 40.2 5.9 3.2 22.0 6.4 3.7 9.6 35.1 7.7 5.4 6.2 29.1 10.3 21.2 13.2 48.3 13.5 36.7 50.0 22.1 23.7 84.5 3.3 0.2 0.2 1.5 0.4 0.7 1.7 0.5 0.9 0.4 0.9 1.1 1.2 0.7 2.9 1.5 1.0 0.2 0.3 4.0 4.6 6.7 6.4 4.1 3.8 5.8 5.1 3.6 7.3 2.7 3.7 6.8 3.2 6.4 2.2 11.8 2.8 3.6 1.6 1.5 1.8 3.0 2.8 3.7 5.2 0.0 0.7 1.8 8.4 0.8 0.7 0.9 3.9 2.4 4.5 1.6 2.3 2.0 6.7 8.8 24.8 4.4 5.4 3.8 0.5 1.2 7.0 1.6 4.6 2.6 1.7 3.3 21.2 1.4 0.0 0.3 0.3 1.0 0.3 1.2 1.8 5.6 0.0 1.1 1.0 14.6 70.8 4.1 3.0 1.2 5.4 6.1 0.4 1.5 3.0 0.8 0.0 1.1 1.8 7.2 26.6 6.3 8.5 0.8 1.7 6.5 2.0 0.8 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400494-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 12.4 11.4 2.7 16.0 2.4 11.7 11.7 10.1 8.1 13.4 3.4 13.9 13.7 16.0 20.6 11.5 14.7 11.8 13.1 2.5 3.8 12.4 9.8 11.0 16.1 4.4 2.0 1.2 20.7 14.5 15.3 4.5 13.9 4.6 13.8 15.8 27.4 12.6 13.3 22.4 13.6 12.3 13.9 0.1 12.6 13.3 11.2 2.3 24.7 15.6 19.7 17.3 12.3 3.9 4.7 38.7 47.3 51.8 70.8 27.0 32.8 74.2 50.0 24.4 45.6 33.9 50.6 49.0 43.3 55.9 36.9 52.7 33.0 63.5 37.8 50.4 40.9 44.6 52.9 157.8 37.0 24.3 59.2 151.6 25.8 26.0 50.7 24.2 34.6 39.5 45.3 68.9 19.7 40.5 38.5 58.3 44.8 49.1 31.2 37.9 52.2 98.9 31.1 25.7 43.2 26.9 35.6 127.1 51.4 30.0 46.0 47.4 34.1 33.9 43.7 50.3 39.0 48.0 35.8 63.5 47.1 30.3 65.9 42.9 0.9 1.2 1.5 2.2 1.3 2.4 1.8 2.4 2.7 2.5 2.0 2.7 2.0 0.3 2.5 2.5 3.0 2.5 1.6 2.7 2.4 10.1 8.1 2.5 3.8 4.4 2.0 1.2 4.6 0.1 2.3 4.7 6.2 12.8 14.3 45.4 7.1 3.6 5.0 7.0 10.8 19.4 7.1 6.0 23.4 5.7 12.8 5.5 0.0 8.5 11.4 12.9 3.9 7.8 3.5 12.3 11.6 9.0 11.4 8.0 43.4 8.1 7.6 12.7 8.6 13.6 9.5 20.4 10.0 7.2 7.8 6.7 45.8 8.5 14.2 6.3 3.0 8.2 10.8 6.0 1.8 34.7 8.4 10.2 9.2 74.9 43.9 9.3 10.2 13.2 8.8 6.1 7.3 5.1 16.8 18.8 6.6 10.4 11.6 7.1 10.9 8.8 3.4 4.9 8.3 13.9 11.7 5.9 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193686-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 14.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 477.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 9600000 "Plasma membrane, Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 5.0 1.1 3.6 1.4 7.2 0.2 2.6 2.4 3.6 4.3 1.9 1.1 1.3 2.3 1.8 2.5 6.9 9.3 2.0 1.9 6.8 14.9 0.8 4.6 0.6 4.8 5.7 1.8 0.7 0.7 1.1 1.0 3.6 4.5 1.1 0.9 1.6 0.7 1.8 1.2 0.8 1.2 2.6 3.4 0.8 1.1 0.3 11.2 0.4 2.3 1.6 0.7 2.4 1.9 4.5 0.1 1.9 62.2 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.0 0.2 0.0 0.1 477.1 0.3 0.0 0.0 49.6 0.1 0.0 0.6 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 17.5 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 9.4 0.0 0.2 0.0 10.9 0.1 14.0 0.0 1.8 0.0 0.0 0.1 0.2 19.3 0.1 0.2 0.0 0.1 1.8 5.9 1.5 0.1 0.4 1.1 0.1 0.1 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 7.2 2.4 3.6 1.9 6.8 4.8 5.7 1.8 4.5 3.4 11.2 4.5 5.7 0.0 0.5 7.2 2.4 0.9 0.1 36.5 0.0 10.8 0.1 0.4 3.1 48.6 7.0 11.0 0.0 0.0 0.0 0.0 27.4 37.2 0.2 2.9 0.6 5.3 0.0 0.0 67.1 3.0 0.0 2.9 0.0 2.9 0.0 4.1 0.0 0.1 0.1 0.0 33.6 0.0 0.0 0.0 2.5 0.1 0.3 1.3 0.0 39.4 1.0 0.3 0.0 60.8 5.5 63.8 0.0 0.4 0.0 1.2 0.0 171.1 1.1 0.8 46.0 0.6 69.5 0.0 0.4 0.1 1.0 0.0 1.8 0.2 0.0 0.1 LMNB1 ENSG00000113368 "Lamin B1" P20700 5 126776623-126837020 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in many" "Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005269, HPA050524, CAB079757, CAB079954" Supported Supported "Nuclear membrane" NA NA 2100000 "Nuclear membrane" "CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "unprognostic (4.96e-3)" "unprognostic (3.70e-2)" "unprognostic (1.61e-1)" "unprognostic (8.65e-3)" "prognostic unfavorable (3.08e-6)" "unprognostic (2.06e-2)" "unprognostic (6.62e-3)" "unprognostic (5.28e-2)" "unprognostic (2.13e-3)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.33e-2)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" 4.2 1.6 1.8 26.9 2.0 34.3 2.9 9.4 2.1 3.7 0.8 15.1 11.3 2.8 0.5 14.3 1.9 3.4 1.4 1.7 2.8 1.7 4.9 6.0 35.1 3.0 2.2 1.6 2.2 2.4 0.7 2.0 6.8 4.4 1.6 13.2 6.4 3.4 1.6 1.0 8.6 14.4 3.5 2.1 13.5 7.9 2.2 2.1 49.7 1.6 1.4 29.4 6.8 4.9 2.9 132.7 43.4 131.6 126.6 3.3 9.3 170.6 60.6 17.8 66.1 71.3 113.4 107.2 229.4 103.2 21.4 31.5 72.4 90.9 42.1 72.2 162.9 112.1 147.5 49.1 67.2 1.4 176.6 95.6 3.0 0.9 35.2 16.0 12.8 54.9 92.0 87.1 86.3 46.6 109.7 322.8 347.5 99.0 54.1 60.0 152.6 259.4 93.1 36.6 59.6 151.4 80.3 98.4 41.7 36.6 45.2 76.2 202.0 46.9 48.7 132.0 36.6 131.3 56.8 46.4 197.3 25.0 247.1 73.8 1.4 14.4 4.8 2.1 5.6 1.6 4.2 4.3 2.8 15.3 2.9 3.1 2.8 9.3 2.4 1.5 4.6 12.4 6.4 1.8 2.0 9.4 2.1 1.7 2.8 3.0 2.2 1.6 4.4 2.1 2.1 2.9 3.4 0.0 4.3 0.3 20.1 5.0 1.9 2.0 8.0 6.4 4.3 5.1 1.6 4.3 3.3 0.0 8.4 39.4 56.0 7.7 1.9 1.8 92.5 3.9 4.8 8.8 6.1 67.3 6.8 0.8 68.2 8.1 11.7 7.6 93.6 23.9 3.6 3.1 21.8 5.0 9.1 19.3 0.0 13.1 17.9 72.1 2.1 27.9 1.8 1.9 59.5 3.8 13.4 5.5 1.1 1.1 8.4 0.4 50.6 1.1 3.8 2.1 1.9 17.5 0.0 2.5 7.3 3.4 8.9 27.3 5.4 4.7 34.2 3.0 35.8 1.4 ARRDC3 "KIAA1376, TLIMP" ENSG00000113369 "Arrestin domain containing 3" Q96B67 5 91368631-91383317 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 394.2;Syncytiotrophoblasts: 339.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 115.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes "unprognostic (2.28e-1)" "unprognostic (2.24e-1)" "unprognostic (9.42e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (7.36e-2)" "unprognostic (1.57e-3)" "unprognostic (4.91e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.25e-8)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.34e-1)" "unprognostic (5.74e-2)" "unprognostic (2.15e-1)" 35.8 80.9 20.6 27.1 22.9 168.8 95.6 26.1 25.2 45.1 23.9 19.5 10.0 40.9 27.3 39.1 25.1 39.4 17.9 18.3 43.1 53.2 76.5 44.9 29.6 30.5 20.4 14.2 94.0 21.0 54.7 21.6 77.4 23.2 30.6 27.8 75.8 64.4 24.5 34.5 39.9 16.9 33.3 27.1 37.4 26.0 16.7 24.2 28.3 84.8 45.3 28.4 57.6 42.4 47.9 6.6 10.7 12.1 16.6 18.4 31.0 40.2 15.8 14.7 9.3 16.2 5.2 26.9 7.9 13.0 16.2 26.1 14.6 13.4 13.3 8.5 8.2 1.4 3.9 43.3 8.5 14.3 27.9 1.6 13.3 21.2 8.1 20.9 56.4 26.1 7.6 11.5 37.7 14.4 3.7 29.9 4.1 4.3 2.8 11.3 24.8 15.2 41.5 60.4 11.9 21.1 14.0 48.2 3.7 2.9 30.2 17.9 13.1 28.3 7.7 11.2 12.4 9.6 28.6 40.9 16.1 45.8 16.4 8.7 28.7 15.2 20.4 29.1 13.1 21.1 12.3 18.3 22.8 9.3 9.4 24.0 37.7 115.3 14.9 22.2 2.2 21.9 19.9 20.6 22.9 26.1 25.2 18.3 43.1 30.5 20.4 14.2 23.2 27.1 24.2 47.9 53.8 51.3 166.5 6.5 47.0 112.0 17.6 51.2 9.1 30.9 89.5 48.5 34.5 20.0 72.4 97.5 31.3 89.9 110.2 21.2 154.6 72.6 27.1 28.9 43.1 143.3 73.0 37.1 10.5 79.5 81.6 95.7 38.7 51.4 37.3 36.4 37.5 155.1 48.7 32.0 15.5 32.4 10.2 106.9 394.2 22.3 21.1 100.3 120.9 14.0 56.6 97.0 50.4 13.6 28.3 41.2 16.1 15.1 58.8 31.2 9.3 57.3 28.5 67.2 19.7 32.1 54.9 8.1 9.6 55.6 118.3 339.4 66.3 23.4 20.2 22.7 GOLPH3 "GOPP1, GPP34, MIDAS, Vps74" ENSG00000113384 "Golgi phosphoprotein 3" Q9H4A6 5 32124716-32174319 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044564, HPA055841" Approved Supported "Golgi apparatus,Vesicles" NA NA 23000 "Golgi apparatus, Vesicles" "HPA044564: AB_10795169, HPA055841: AB_2682940" "unprognostic (1.64e-2)" "unprognostic (1.66e-1)" "unprognostic (9.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-2)" "unprognostic (1.89e-2)" "unprognostic (8.19e-2)" "unprognostic (2.95e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" 50.6 38.7 30.9 42.3 31.6 21.0 50.5 32.6 34.8 56.7 35.2 66.7 46.8 42.0 59.2 43.5 41.4 78.4 38.1 29.1 34.6 62.0 111.0 51.1 49.6 33.0 31.8 27.6 51.9 63.2 55.3 30.0 68.9 32.4 75.9 60.8 20.0 65.3 50.8 37.6 33.0 49.7 52.8 32.4 39.8 53.4 27.2 32.2 44.3 48.5 57.5 52.8 61.1 41.6 34.6 57.7 37.9 59.9 65.5 111.3 106.1 171.6 77.8 103.3 71.5 67.7 51.9 101.3 51.7 75.0 105.7 69.3 52.8 75.1 54.9 89.7 67.7 44.9 56.9 119.9 99.4 89.4 88.8 64.0 81.3 77.1 70.3 80.1 65.8 57.9 33.6 60.5 121.8 80.4 58.0 57.1 115.3 51.8 78.0 38.5 52.8 86.4 53.8 89.9 72.1 45.6 51.0 180.8 186.9 79.4 75.6 76.4 97.1 56.5 62.7 58.5 49.7 55.6 136.1 179.3 62.5 56.3 125.8 76.4 6.8 8.0 19.2 7.8 10.6 6.8 11.5 8.4 10.1 8.9 16.0 9.9 7.2 7.9 8.5 10.5 6.9 13.2 4.2 30.9 31.6 32.6 34.8 29.1 34.6 33.0 31.8 27.6 32.4 32.4 32.2 34.6 33.9 60.9 49.2 26.8 53.3 70.0 44.5 30.0 51.2 13.5 59.6 30.7 31.7 88.6 42.8 44.1 10.4 67.3 52.0 72.6 52.8 58.0 5.2 46.3 35.8 46.2 52.0 50.5 47.9 44.1 111.6 51.7 57.6 71.3 14.5 16.8 59.3 153.6 54.4 13.5 45.8 86.3 40.7 63.7 56.2 16.1 50.7 49.1 44.4 43.1 48.7 20.2 36.0 53.8 60.1 49.7 35.1 57.2 120.0 83.9 59.8 59.8 49.1 10.0 39.5 30.8 52.1 15.4 25.1 68.2 73.6 110.0 45.6 50.4 50.2 80.7 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 regulator of transcription" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 1838.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 1427.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli NA NA 120000 "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 143.2 99.5 95.6 131.5 108.3 253.9 123.4 80.1 153.7 110.6 80.0 111.0 89.5 86.2 84.0 109.8 66.6 74.7 114.3 109.9 100.9 113.9 136.4 92.0 161.1 89.9 92.3 97.6 68.9 62.5 108.2 89.1 104.1 95.2 73.8 108.2 84.3 77.2 66.0 106.1 65.7 84.4 80.1 89.8 146.0 98.2 71.7 96.2 206.0 69.8 109.9 138.4 125.2 73.8 93.9 199.9 161.8 315.3 295.8 187.5 329.1 197.7 340.3 245.4 300.8 275.4 236.9 307.3 101.2 231.0 236.5 307.3 132.4 266.9 278.9 402.9 420.2 244.1 337.8 365.8 450.5 264.4 594.6 441.4 233.3 235.6 321.0 228.0 166.0 228.9 378.5 399.4 1427.8 269.5 178.6 566.8 942.9 207.8 235.9 326.9 247.8 409.9 645.7 303.0 178.2 170.4 141.1 526.9 244.9 251.9 198.2 272.0 544.9 238.7 324.7 351.5 275.8 261.0 556.0 1035.0 180.5 297.7 634.9 202.4 650.7 135.8 326.2 164.7 142.3 151.4 330.4 215.9 219.8 265.1 214.8 168.2 195.2 163.7 155.2 133.4 390.1 344.6 326.1 95.6 108.3 80.1 153.7 109.9 100.9 89.9 92.3 97.6 95.2 89.8 96.2 93.9 298.9 144.2 163.4 27.1 638.2 584.9 588.7 709.9 324.4 118.1 459.2 383.9 196.7 244.5 320.1 310.8 43.8 493.0 613.5 342.1 1009.5 711.4 131.6 319.0 263.7 280.2 281.4 379.5 71.5 327.2 785.0 323.6 227.9 329.9 307.5 188.6 223.1 375.4 500.5 85.8 60.9 362.9 484.2 319.0 721.3 68.1 239.9 422.5 528.3 37.5 587.5 223.7 500.5 64.3 50.4 416.3 516.6 344.6 1838.8 536.0 342.4 921.2 291.9 79.7 203.8 224.0 468.5 447.2 439.9 411.8 565.4 836.8 575.5 357.7 394.6 645.5 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 108.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 52.8;Granulosa cells: 97.9;Proximal tubular cells: 143.4" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 35.3;fHDF/TERT166: 22.8;HeLa: 81.4;HSkMC: 50.0;U-138 MG: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 21.5 3.4 1.4 0.8 1.1 4.5 3.8 0.9 1.7 8.0 5.0 4.8 0.7 4.2 2.0 5.3 4.8 4.3 27.6 1.2 1.7 108.8 4.8 11.2 0.9 1.5 1.3 1.0 1.7 1.4 1.4 0.6 9.6 1.4 6.3 1.1 2.7 1.1 9.0 5.9 4.1 1.4 3.0 1.2 9.7 1.0 1.7 1.3 4.9 13.1 9.6 2.0 1.8 4.5 1.8 0.3 4.3 0.2 0.4 2.4 35.3 0.1 10.0 1.9 0.6 0.6 0.0 0.2 0.0 0.2 22.8 0.7 0.0 4.9 0.1 1.2 0.1 0.0 0.4 81.4 0.0 7.1 0.1 0.2 50.0 0.6 2.6 6.9 2.3 0.3 0.1 0.1 0.6 3.3 0.6 0.0 0.5 0.1 0.0 11.9 0.1 0.0 0.0 0.0 0.2 0.2 0.0 3.5 13.3 0.1 0.3 0.2 0.0 0.3 21.5 0.3 1.8 0.3 0.2 0.1 0.0 3.5 0.1 0.3 0.1 0.3 0.2 0.3 0.1 0.2 0.4 0.3 0.2 0.0 0.5 0.4 0.5 3.3 0.4 0.0 0.4 0.1 0.1 1.4 1.1 0.9 1.7 1.2 1.7 1.5 1.3 1.0 1.4 1.2 1.3 1.8 3.9 16.0 4.9 1.0 0.8 5.4 0.1 1.6 24.5 11.6 0.2 1.1 27.3 0.0 1.7 9.2 0.0 0.0 0.2 0.1 52.8 0.1 1.4 4.5 8.5 11.9 0.0 13.9 0.4 0.0 0.1 2.6 0.0 16.5 3.8 97.9 15.7 1.6 0.1 3.3 11.4 0.0 0.0 0.3 0.0 3.2 11.1 1.3 0.0 0.0 0.2 1.7 0.0 1.0 0.3 0.0 0.1 12.8 1.4 1.9 0.0 143.4 3.7 1.5 6.6 0.3 6.6 0.1 1.2 23.0 1.3 0.1 1.3 16.5 0.0 0.3 FAM172A "C5orf21, DKFZP564D172, Toupee" ENSG00000113391 "Family with sequence similarity 172 member A" Q8WUF8 5 93617725-94111699 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 174.3;Excitatory neurons: 259.9;Inhibitory neurons: 297.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 343.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012299, HPA045505" Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA012299: AB_1845724, HPA045505: AB_2679354" "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (3.10e-2)" "unprognostic (7.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (1.51e-1)" "unprognostic (1.57e-2)" "unprognostic (2.52e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.38e-1)" "unprognostic (6.56e-2)" "unprognostic (1.72e-2)" "unprognostic (1.03e-2)" 13.7 9.8 11.0 8.2 11.3 7.7 13.1 13.8 11.0 12.8 8.4 7.8 7.5 12.8 10.1 11.7 12.3 9.4 9.4 11.0 11.5 12.4 5.3 9.2 9.3 11.7 10.6 9.3 15.2 9.7 12.5 7.2 8.4 11.1 12.5 8.2 14.9 11.0 14.5 3.1 7.8 9.0 11.6 11.4 9.9 8.8 5.7 11.8 9.9 15.6 6.7 9.1 9.5 7.5 12.4 7.5 8.8 20.4 23.1 24.0 29.3 10.7 16.4 12.1 6.7 6.5 6.0 10.1 10.7 11.6 18.7 11.8 6.3 6.3 22.2 15.4 7.4 7.7 14.2 17.0 3.6 10.0 11.5 15.8 25.3 12.2 6.2 11.8 23.7 15.0 10.1 3.0 3.3 27.3 8.3 9.3 8.1 3.1 13.8 7.0 10.3 21.7 10.3 10.1 14.5 17.5 32.1 12.4 5.0 11.6 12.8 12.8 12.9 14.8 15.6 14.1 10.3 18.7 13.4 20.8 11.9 24.0 11.9 29.1 12.4 4.0 5.4 8.2 5.4 8.4 6.7 6.1 6.2 5.3 6.3 6.8 6.9 9.3 9.7 4.1 5.0 6.9 4.8 11.0 11.3 13.8 11.0 11.0 11.5 11.7 10.6 9.3 11.1 11.4 11.8 12.4 27.8 54.5 26.4 174.3 40.0 12.2 25.0 26.4 23.3 49.5 31.4 28.2 21.5 22.8 23.4 11.0 31.3 13.0 47.4 14.3 60.7 19.9 47.7 29.2 34.9 25.4 16.9 10.3 259.9 21.2 13.7 32.6 21.9 21.9 25.3 22.7 21.8 14.9 11.3 42.1 297.7 13.9 22.4 21.3 12.1 34.2 38.5 18.0 21.4 227.7 27.9 37.4 58.7 264.9 343.8 20.1 14.7 36.5 17.3 19.7 27.7 35.2 47.5 54.5 13.1 39.5 30.7 22.4 26.1 25.8 10.1 10.9 37.4 30.7 16.4 24.4 SLC27A6 "ACSVL2, FACVL2, FATP6, VLCS-H1" ENSG00000113396 "Solute carrier family 27 member 6" Q9Y2P4 5 128538013-129033642 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 24.6;brain: 26.5;fallopian tube: 21.4;heart muscle: 23.7" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 19.7" "Region enhanced" "Detected in many" "hypothalamus: 26.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "BEWO: 43.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA008987 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA008987: AB_1857065" "unprognostic (5.39e-5)" "unprognostic (4.79e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-1)" "unprognostic (3.55e-1)" "unprognostic (1.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" "unprognostic (2.14e-1)" "unprognostic (2.54e-2)" "unprognostic (9.66e-4)" 0.4 24.6 3.7 0.3 2.3 0.1 3.0 3.7 2.4 4.0 0.6 0.9 0.4 4.3 0.2 4.3 21.4 2.8 23.7 1.2 26.5 0.0 0.1 0.8 0.2 8.2 4.5 0.8 9.8 0.1 0.0 6.1 6.8 7.1 3.7 1.7 7.5 3.5 0.3 0.4 1.3 1.1 0.8 6.5 0.1 0.5 13.1 4.6 9.7 1.8 0.9 5.7 1.1 2.9 7.9 0.0 0.0 0.1 0.0 0.0 0.0 43.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.9 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 3.5 0.0 3.3 2.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.3 4.4 0.0 5.1 0.0 3.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.3 3.7 2.4 1.2 26.5 8.2 4.5 0.8 7.1 6.5 4.6 7.9 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 25.0 0.6 0.2 5.5 29.6 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 13.2 3.8 1.0 0.3 0.0 0.0 0.4 0.0 37.3 2.7 0.0 1.9 0.0 1.7 0.0 0.0 3.8 3.3 4.6 0.0 0.0 0.0 0.4 2.8 0.3 0.2 0.0 0.0 0.0 33.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 18.0 0.3 1.1 1.0 1.8 0.9 27.5 0.0 2.3 0.1 0.1 TARS1 TARS ENSG00000113407 "Threonyl-tRNA synthetase 1" P26639 5 33440696-33468091 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037425 Approved Approved "Actin filaments,Cytosol" NA NA 580000 Cytosol "Actin filaments" "HPA037425: AB_10672279" "prognostic unfavorable (6.14e-5)" "unprognostic (5.13e-2)" "unprognostic (9.04e-2)" "prognostic unfavorable (5.17e-4)" "unprognostic (9.10e-2)" "unprognostic (1.07e-3)" "prognostic unfavorable (9.88e-7)" "unprognostic (1.43e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-3)" "unprognostic (5.97e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (1.37e-1)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (7.25e-2)" 29.2 32.5 14.8 34.1 15.7 45.4 27.1 19.7 19.9 24.2 16.2 43.0 30.9 24.9 36.1 41.3 17.6 20.0 39.1 15.6 20.7 32.7 69.2 24.3 30.2 21.3 15.7 10.5 18.1 68.7 34.1 10.0 37.4 18.6 27.8 43.2 41.0 37.1 26.6 38.8 19.3 30.1 37.5 20.4 21.9 40.4 18.8 18.3 32.0 37.9 28.6 40.4 43.4 10.9 23.7 253.0 136.1 132.7 189.5 80.2 129.9 230.1 237.5 172.9 152.5 163.7 176.6 128.7 96.0 84.8 176.5 271.8 151.1 261.1 207.1 267.4 158.9 140.5 151.1 332.9 108.5 256.7 225.6 141.0 133.7 287.7 217.5 273.9 102.4 144.3 191.8 236.3 204.6 191.5 105.7 166.3 104.7 159.2 181.5 168.4 137.1 237.9 123.4 170.8 119.8 81.0 102.7 245.6 175.8 195.5 103.8 85.9 236.3 123.0 132.8 211.9 102.5 196.3 135.4 258.4 132.6 156.2 302.6 148.3 34.2 22.0 22.6 27.4 24.5 27.6 28.7 25.2 26.6 32.6 23.9 21.5 27.5 2.6 46.2 18.3 18.3 24.2 20.6 14.8 15.7 19.7 19.9 15.6 20.7 21.3 15.7 10.5 18.6 20.4 18.3 23.7 12.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 36.6 15.9 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 42.1 11.7 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 52.1 2.6 0.0 0.0 0.0 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 16.0;prostate: 10.0;salivary gland: 9.5;skin 1: 20.2;vagina: 12.3" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2" "Group enriched" "Detected in many" 5 "cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "medulla oblongata: 1.2;pons: 1.5" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.1 0.0 0.4 0.0 0.0 0.1 3.2 0.7 0.2 1.7 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.9 10.0 0.0 0.0 9.5 0.0 0.6 20.2 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 12.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 16.3 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 8.3 1.1 0.1 0.1 4.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.2 0.0 0.0 0.7 0.6 0.0 0.9 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 48.6 2.8 0.1 50.7 0.0 1.4 15.6 6.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 1.1 26.5 20.2 3.7 0.0 0.0 0.0 1.7 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037513 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 257.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" NA NA 9800000 "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 11.5 4.5 7.8 12.3 9.6 16.4 8.3 18.3 9.2 6.9 4.9 7.3 5.2 6.5 5.1 9.1 5.8 5.2 12.1 8.3 8.4 8.4 4.3 7.8 19.6 10.1 9.8 6.6 8.8 4.9 15.4 5.8 9.2 11.2 8.9 7.9 9.5 6.0 8.5 11.3 16.6 8.3 7.8 8.9 12.6 8.0 4.2 9.4 17.9 8.5 12.8 18.8 7.0 7.1 10.7 10.7 11.9 5.4 5.6 32.5 15.4 6.2 10.5 13.8 12.0 18.1 9.9 16.4 52.2 19.1 14.1 33.7 13.4 6.8 20.1 12.5 18.2 3.8 12.9 8.2 7.3 8.4 15.5 16.9 12.0 12.5 17.5 13.3 13.6 12.8 11.6 5.6 32.7 13.9 9.6 18.1 10.9 1.1 3.4 6.2 12.7 19.8 7.9 44.9 21.2 10.2 2.7 12.8 11.4 6.4 5.2 34.1 20.2 26.6 17.6 9.6 13.9 16.3 7.3 17.4 45.6 16.1 14.5 8.2 4.3 2.6 3.6 5.9 4.2 5.0 2.3 4.4 4.6 2.8 3.1 4.2 4.7 3.1 9.0 11.2 2.6 4.2 3.6 7.8 9.6 18.3 9.2 8.3 8.4 10.1 9.8 6.6 11.2 8.9 9.4 10.7 43.4 35.3 41.3 52.2 91.0 59.4 21.3 28.4 37.5 58.9 24.9 18.8 80.8 22.8 27.2 36.8 125.1 12.3 108.4 20.7 5.9 15.4 3.6 21.4 28.9 33.6 25.7 38.9 47.5 14.4 24.3 36.6 30.1 28.9 25.9 29.3 30.7 16.7 16.2 23.5 50.9 29.6 22.4 49.3 35.9 5.3 32.9 52.0 21.4 45.9 59.7 33.6 257.5 49.3 73.9 21.5 17.5 46.6 44.9 27.4 16.6 10.7 25.8 38.4 26.3 46.8 36.6 29.4 27.5 44.4 47.2 27.4 97.3 31.1 25.6 23.2 PDE4D DPDE3 ENSG00000113448 "Phosphodiesterase 4D" Q08499 5 58969038-60522120 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.6;skeletal muscle: 71.0" "Cell type enhanced" "Detected in many" "Astrocytes: 619.3;Excitatory neurons: 2969.7;Inhibitory neurons: 1116.9;Oligodendrocyte precursor cells: 848.0;Oligodendrocytes: 443.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 30.7" "Immune cell enriched" "Detected in many" 5 "eosinophil: 57.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 57.9" "Cell line enhanced" "Detected in many" "A549: 62.2;AN3-CA: 70.4;HeLa: 104.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045895 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA045895: AB_10960275" "unprognostic (1.14e-1)" "unprognostic (8.73e-3)" "unprognostic (4.35e-2)" "unprognostic (7.87e-2)" "unprognostic (5.97e-2)" "unprognostic (2.03e-1)" "unprognostic (8.10e-4)" "unprognostic (1.17e-1)" "unprognostic (6.59e-2)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "prognostic favorable (4.00e-5)" "unprognostic (1.51e-1)" "unprognostic (8.20e-2)" "unprognostic (1.77e-2)" "unprognostic (2.56e-2)" 9.0 1.3 2.3 9.9 10.9 75.6 4.7 0.0 12.7 5.1 1.7 16.1 5.5 7.5 18.6 13.9 7.4 9.2 13.2 4.7 30.7 17.3 2.8 13.4 5.4 7.6 2.4 5.2 3.1 3.8 5.5 6.8 16.7 3.0 20.0 15.2 21.6 7.5 21.4 71.0 4.2 7.1 15.4 0.8 4.1 10.4 3.4 3.0 8.7 7.4 34.7 5.7 22.2 8.3 7.3 0.1 62.2 12.8 70.4 2.3 4.4 10.1 1.6 1.8 3.4 4.9 24.5 2.0 4.8 0.2 0.5 10.3 10.6 0.0 2.8 5.9 2.9 7.0 9.2 104.6 5.3 9.1 4.4 0.7 9.3 2.3 9.6 1.7 1.1 7.3 0.3 0.0 1.6 5.9 4.5 3.6 10.3 2.4 1.8 3.2 1.2 16.0 10.5 15.9 23.5 2.3 8.0 16.4 27.1 14.2 11.4 1.9 9.3 8.5 0.9 0.2 12.0 3.3 3.5 0.1 0.5 10.3 17.3 2.7 4.2 2.0 57.9 1.5 0.1 1.5 11.0 1.4 0.7 1.4 11.3 0.9 0.7 3.1 0.4 0.2 0.0 0.8 1.1 2.3 10.9 0.0 12.7 4.7 30.7 7.6 2.4 5.2 3.0 0.8 3.0 7.3 22.5 32.1 110.0 619.3 32.3 10.6 30.1 6.6 35.3 20.2 5.1 2.7 35.7 8.6 30.2 42.3 73.0 11.3 118.6 28.1 11.7 0.6 21.4 19.0 8.6 16.9 33.4 2.1 2969.7 1.8 25.7 27.5 40.2 21.9 22.2 0.3 17.2 0.8 5.2 1.7 1116.9 18.2 6.1 4.8 11.1 36.6 1.5 29.5 10.6 407.5 6.0 12.0 29.9 848.0 443.3 8.2 11.9 4.9 44.4 43.3 8.9 27.5 19.4 52.8 0.0 64.0 6.3 1.1 7.7 40.6 8.8 3.1 94.3 1.1 11.7 26.5 RAD1 "HRAD1, REC1" ENSG00000113456 "RAD1 checkpoint DNA exonuclease" O60671 5 34905260-34918989 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006692 Approved Approved Nucleoplasm,Vesicles NA Yes "Nucleoplasm, Vesicles" "HPA006692: AB_2667645" "prognostic unfavorable (6.30e-4)" "unprognostic (1.85e-2)" "unprognostic (9.40e-2)" "unprognostic (1.98e-3)" "unprognostic (2.00e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.06e-5)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.61e-3)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (3.12e-3)" 3.5 8.2 3.3 4.9 3.6 8.5 5.9 4.0 4.6 6.9 4.8 4.1 4.9 5.7 5.4 4.9 4.0 4.7 8.9 3.6 4.0 5.1 4.3 7.6 9.0 3.7 2.9 3.6 5.7 4.4 5.1 3.5 8.2 4.0 6.9 4.3 8.8 4.9 4.8 11.0 6.7 4.8 4.7 1.9 4.9 4.9 8.0 3.8 6.4 6.3 8.7 6.3 5.2 4.7 4.9 8.5 10.2 12.3 20.5 7.9 9.4 17.2 15.1 12.0 13.0 10.6 12.2 12.3 25.0 5.2 11.2 15.7 8.4 12.6 7.6 14.4 10.1 12.7 12.9 34.0 8.0 11.9 16.5 11.9 7.8 7.3 13.9 9.3 6.1 6.2 11.0 22.7 13.2 11.2 10.2 19.6 13.9 15.4 6.0 15.7 17.1 24.0 8.6 6.7 9.0 12.4 13.3 30.0 19.9 13.3 7.6 12.5 14.8 6.2 17.9 13.3 9.7 14.4 7.9 13.8 20.3 11.1 28.6 12.5 7.4 2.9 6.5 5.3 2.8 6.9 8.6 5.8 7.6 3.1 9.1 8.2 6.8 1.6 4.5 2.8 6.9 4.9 2.6 3.3 3.6 4.0 4.6 3.6 4.0 3.7 2.9 3.6 4.0 1.9 3.8 4.9 11.5 22.4 43.2 5.9 18.3 29.2 20.2 29.3 13.1 25.3 23.9 18.4 25.7 14.3 21.3 20.2 27.1 82.3 20.4 11.9 19.6 18.1 22.0 13.1 16.6 14.1 13.1 28.2 6.6 22.5 54.4 18.7 6.1 12.0 21.5 39.1 10.0 14.8 23.4 23.5 9.0 12.7 30.5 12.0 19.3 16.8 25.1 13.1 17.8 6.5 12.7 23.9 9.2 7.5 9.1 17.8 13.8 21.8 18.0 21.9 13.4 16.4 14.6 35.6 13.1 19.6 19.4 72.5 58.6 15.6 28.6 80.6 22.3 27.4 13.0 25.8 BRIX1 "BRIX, BXDC2, FLJ11100" ENSG00000113460 "Biogenesis of ribosomes BRX1" Q8TDN6 5 34915677-34925996 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039614 Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA039614: AB_10963698" "prognostic unfavorable (2.18e-4)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.10e-5)" "unprognostic (1.82e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (4.11e-8)" "unprognostic (3.37e-2)" "unprognostic (3.84e-3)" "prognostic favorable (6.34e-4)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.07e-9)" "unprognostic (1.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (2.09e-2)" 18.8 17.3 14.7 17.7 15.2 37.4 24.9 16.5 18.9 15.2 14.2 15.8 13.0 17.6 17.9 17.9 16.2 12.3 14.8 14.4 15.5 15.2 18.7 13.1 26.7 15.2 15.0 14.0 18.7 13.9 18.4 9.6 25.9 15.1 15.8 17.2 11.7 13.0 14.6 10.5 14.7 12.9 16.2 15.3 14.4 13.2 14.0 14.8 20.9 16.0 12.3 26.0 30.4 12.4 16.5 66.1 57.0 64.2 87.1 26.0 37.8 121.6 74.9 52.7 100.0 63.5 74.5 81.0 138.8 38.7 45.5 113.5 52.1 108.5 79.8 117.3 75.1 101.3 93.9 125.7 71.9 67.4 150.8 63.8 44.4 49.8 93.3 85.9 31.0 48.5 72.9 158.4 43.8 66.2 63.6 108.3 163.9 101.0 75.2 86.8 94.6 112.5 60.5 59.3 70.7 75.1 68.8 157.6 109.7 76.1 50.0 66.4 92.7 28.4 78.7 87.5 58.1 151.0 39.3 87.7 177.6 66.3 171.3 100.3 15.0 21.4 10.0 34.5 21.0 50.1 63.7 43.2 44.3 27.8 49.9 53.3 46.6 1.2 43.7 30.6 37.5 43.5 44.6 14.7 15.2 16.5 18.9 14.4 15.5 15.2 15.0 14.0 15.1 15.3 14.8 16.5 35.5 28.9 30.7 8.5 40.0 108.7 114.3 110.2 55.2 20.8 27.3 41.3 23.2 25.8 63.0 23.9 12.5 127.1 37.0 13.5 49.0 52.5 24.8 29.9 45.1 40.6 21.0 45.2 11.9 42.7 100.6 44.4 19.4 31.6 20.2 30.0 20.0 11.9 42.7 21.9 13.4 19.0 63.1 10.7 20.1 8.4 39.4 18.4 32.0 4.7 31.1 22.3 21.6 10.6 13.6 44.7 13.1 29.0 21.4 70.9 9.9 37.9 45.8 37.2 6.6 54.3 55.7 59.9 77.6 46.0 95.8 126.1 37.1 31.7 31.9 85.1 AGXT2 AGT2 ENSG00000113492 "Alanine--glyoxylate aminotransferase 2" Q9BYV1 5 34998101-35048135 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "kidney: 209.8;liver: 124.5" "Group enriched" "Detected in some" 5 "Hepatocytes: 105.9;Proximal tubular cells: 359.5" "Group enriched" "Detected in some" 112 "liver cancer: 9.2;renal cancer: 12.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037382 Enhanced NA NA 13000 "HPA037382: AB_10670851" "unprognostic (2.61e-1)" "unprognostic (1.40e-2)" "prognostic favorable (7.47e-4)" "unprognostic (8.24e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 209.8 124.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 2.8 0.0 9.2 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 105.9 0.0 0.0 0.2 0.6 0.0 2.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 1.2 0.4 0.0 0.0 6.7 359.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.3 0.0 PRLR ENSG00000113494 "Prolactin receptor" P16471 5 35048756-35230487 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "choroid plexus: 654.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 78.3;Endometrial stromal cells: 113.8;Granulosa cells: 96.4;Proximal tubular cells: 53.0;Syncytiotrophoblasts: 48.3" "Cancer enriched" "Detected in many" 9 "breast cancer: 20.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "T-47d: 382.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (3.81e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-2)" "unprognostic (6.04e-2)" "unprognostic (5.05e-2)" "unprognostic (8.21e-2)" "unprognostic (3.99e-2)" "unprognostic (7.94e-2)" "unprognostic (4.89e-2)" "unprognostic (1.67e-3)" "unprognostic (4.84e-4)" "unprognostic (2.50e-3)" "unprognostic (4.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (9.84e-5)" "unprognostic (1.24e-1)" 0.6 12.3 9.4 0.5 13.0 1.1 23.4 5.3 3.2 19.6 654.4 5.5 6.7 20.2 9.4 0.7 2.2 0.8 0.2 30.2 17.5 31.0 11.0 0.6 0.1 3.1 9.1 0.7 2.3 5.5 83.3 4.3 50.7 2.3 1.1 5.8 0.1 1.7 8.2 0.1 3.2 8.2 10.9 2.1 0.2 6.3 0.6 25.6 0.2 0.1 0.7 0.1 0.8 4.8 3.1 0.0 0.0 0.7 3.1 0.0 2.7 0.6 1.7 1.5 3.2 1.2 0.4 0.2 0.0 0.0 1.9 1.2 0.0 4.3 0.0 3.3 0.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.2 0.7 10.4 0.3 0.0 0.7 0.8 0.0 0.1 0.0 0.1 0.3 0.7 0.1 0.2 0.0 21.1 0.0 0.7 382.8 3.0 0.0 1.9 2.2 0.6 1.4 0.0 0.0 0.0 3.7 0.2 1.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.4 13.0 5.3 3.2 30.2 17.5 3.1 9.1 0.7 2.3 2.1 25.6 3.1 0.2 0.0 2.0 0.7 0.2 2.9 0.3 0.0 3.4 0.0 78.3 31.8 0.8 4.3 0.0 3.7 0.0 32.9 0.5 13.1 7.9 1.3 0.0 7.1 113.8 1.1 8.5 0.0 2.0 5.3 2.4 13.8 11.2 10.5 0.0 96.4 0.7 11.4 8.9 0.0 1.9 16.1 0.0 1.9 0.7 0.2 8.7 3.4 0.0 1.0 7.6 0.0 0.0 0.0 0.6 1.8 15.2 12.8 0.0 1.4 26.4 53.0 0.0 0.0 0.0 0.5 4.6 0.1 0.5 2.2 5.1 48.3 0.7 6.0 23.8 0.1 SLC12A7 "DKFZP434F076, KCC4" ENSG00000113504 "Solute carrier family 12 member 7" Q9Y666 5 1050384-1112063 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041652 Approved Uncertain Cytosol NA NA Cytosol "HPA041652: AB_10793971" "unprognostic (2.22e-2)" "unprognostic (1.56e-1)" "unprognostic (8.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.67e-1)" "unprognostic (1.71e-3)" "unprognostic (4.40e-2)" "unprognostic (4.50e-2)" "unprognostic (3.44e-2)" "unprognostic (1.65e-3)" "unprognostic (1.17e-3)" "unprognostic (1.26e-1)" "unprognostic (3.93e-2)" "prognostic favorable (3.16e-5)" 18.1 14.7 7.7 7.3 7.6 4.1 18.9 6.6 10.5 14.3 11.6 21.3 24.2 13.9 1.0 8.0 16.7 12.1 57.9 7.2 10.4 45.0 73.0 23.3 5.8 7.0 9.1 4.7 12.4 27.8 4.5 20.7 2.9 6.7 20.9 5.4 5.6 19.1 3.0 6.4 15.5 32.2 3.4 6.1 35.2 28.3 30.1 8.8 7.9 24.9 3.1 2.2 14.6 10.9 8.1 3.8 10.0 5.5 17.3 0.8 0.9 8.7 0.2 1.1 0.8 0.0 24.5 6.4 0.0 20.0 0.3 6.8 7.6 4.6 6.1 0.0 23.0 6.1 4.8 13.4 8.6 12.2 0.0 10.4 1.8 0.8 0.0 1.8 0.3 5.5 2.2 7.6 0.2 0.0 12.0 14.8 0.1 11.9 14.4 16.3 43.9 24.0 20.5 6.5 14.8 3.1 3.8 5.6 0.1 6.0 3.3 9.7 2.7 4.8 0.0 5.7 0.0 0.0 0.3 0.0 2.5 0.0 0.6 2.8 0.2 1.8 0.0 1.1 2.7 1.2 0.6 1.1 1.3 2.1 0.6 1.2 1.2 0.0 1.4 3.8 0.9 1.1 1.3 7.7 7.6 6.6 10.5 7.2 10.4 7.0 9.1 4.7 6.7 6.1 8.8 8.1 21.3 9.6 15.2 8.5 7.3 7.0 6.3 8.9 6.8 25.3 18.4 13.8 35.8 31.5 13.6 29.5 2.1 0.2 14.2 42.0 1.9 23.5 0.4 40.9 11.0 27.9 13.2 19.1 0.3 18.1 0.4 11.6 39.8 63.4 8.2 16.6 11.7 34.5 19.8 281.0 0.5 19.4 18.3 28.0 19.8 1.9 3.7 29.0 16.0 14.0 9.1 5.2 5.2 1.5 0.0 28.8 35.8 5.7 5.3 15.7 27.3 23.2 23.1 3.6 19.7 5.2 8.4 1.0 3.4 3.5 6.8 0.3 9.8 5.4 19.3 15.2 IL4 "BCGF-1, BCGF1, BSF1, IL-4, MGC79402" ENSG00000113520 "Interleukin 4" P05112 5 132673986-132682678 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "B-cell activation" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "T-cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 861 "basophil: 474.9" "Lineage enriched" "Detected in single" 861 "granulocytes: 474.9" "Cell line enriched" "Detected in some" 5 "MOLT-4: 21.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA072995, CAB078477" Approved "Secreted to blood" NA NA 13600 "CAB078477: AB_417057, HPA072995: AB_2732215" "unprognostic (3.40e-2)" "unprognostic (9.19e-2)" "unprognostic (1.41e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.69e-1)" "unprognostic (7.33e-2)" "unprognostic (2.26e-2)" "unprognostic (1.96e-1)" "unprognostic (1.47e-10)" "unprognostic (9.21e-3)" "unprognostic (2.88e-1)" "unprognostic (4.93e-2)" "unprognostic (1.24e-2)" 0.1 0.3 0.2 0.4 0.1 0.3 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.5 0.3 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 474.9 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 RAD50 "hRad50, RAD50-2" ENSG00000113522 "RAD50 double strand break repair protein" Q92878 5 132556019-132646349 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022103, CAB024979, HPA052291" Supported Supported Nucleoplasm NA NA 12000 Nucleoplasm "CAB022103: , CAB024979: , HPA052291: AB_2681786" "unprognostic (3.46e-3)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.50e-3)" "unprognostic (4.22e-3)" "unprognostic (6.71e-2)" "unprognostic (5.98e-2)" "unprognostic (2.76e-2)" "unprognostic (1.06e-1)" "unprognostic (6.84e-2)" "unprognostic (2.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.62e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "unprognostic (2.40e-1)" 6.2 8.1 4.5 2.8 6.7 6.0 6.6 7.5 8.7 7.0 3.3 8.5 2.5 8.1 10.4 7.7 7.4 3.5 6.8 5.9 4.8 6.0 6.2 5.0 2.5 5.2 4.6 6.1 9.3 9.3 8.9 8.2 3.6 5.8 6.3 4.6 8.6 7.1 4.3 11.4 10.4 8.1 3.8 3.0 5.5 8.6 5.6 5.1 4.1 6.1 4.7 3.5 8.0 7.0 8.3 9.1 22.8 2.1 12.1 13.3 20.0 9.8 6.3 11.2 11.0 12.8 20.4 14.8 20.6 3.7 10.3 19.7 8.8 17.6 14.2 16.5 11.7 13.4 9.5 13.3 12.5 10.8 10.2 7.6 10.8 24.1 13.4 36.7 7.2 5.4 6.5 17.9 3.2 10.1 8.6 7.7 13.9 11.7 9.0 6.8 7.2 3.7 10.1 8.8 16.9 11.5 14.9 11.7 4.7 2.8 5.6 11.5 7.0 9.5 4.7 5.5 14.5 8.3 5.7 7.7 24.2 8.4 12.5 6.7 7.0 3.3 1.1 4.1 3.8 5.6 7.0 5.4 5.4 3.6 5.8 4.9 4.5 0.3 9.3 4.8 2.5 4.0 2.7 4.5 6.7 7.5 8.7 5.9 4.8 5.2 4.6 6.1 5.8 3.0 5.1 8.3 3.5 38.5 27.1 65.6 34.6 26.0 37.3 33.7 31.9 56.8 6.6 4.8 130.0 44.3 31.6 7.3 89.6 69.6 22.9 31.0 1.9 6.3 26.4 8.2 15.8 16.6 37.1 38.5 65.9 6.0 49.2 37.6 37.2 7.6 30.4 8.5 22.1 38.5 37.4 37.0 79.7 44.1 18.3 27.2 12.2 12.6 60.6 16.5 16.0 49.6 22.4 38.0 48.4 65.9 92.4 4.8 35.6 53.4 33.0 32.1 53.7 4.4 40.8 60.8 32.9 50.9 39.9 108.4 87.2 39.2 26.7 33.1 25.2 11.5 52.3 25.1 IL5 "EDF, IL-5, TRF" ENSG00000113525 "Interleukin 5" P05113 5 132541445-132556838 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.4;testis: 5.1" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 8 "memory B-cell: 1.4" "Lineage enriched" "Detected in single" 8 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "Hep G2: 2.8;TIME: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB010304 Approved "Secreted to blood" NA NA 4130 "CAB010304: AB_2296159" "unprognostic (1.66e-1)" "unprognostic (4.76e-2)" "unprognostic (5.30e-3)" "unprognostic (2.35e-1)" "unprognostic (9.07e-2)" "unprognostic (7.98e-2)" "unprognostic (2.03e-2)" "unprognostic (3.51e-2)" "unprognostic (1.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (2.09e-1)" "unprognostic (5.27e-2)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" 0.1 0.0 0.4 0.1 0.1 0.0 0.0 1.3 1.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 0.5 0.2 1.4 0.0 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.2 5.1 0.2 0.0 0.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 1.3 1.1 1.4 0.0 0.9 0.5 0.0 0.7 0.1 0.2 1.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.7 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 19.5 1.2 0.0 0.1 0.0 1.6 0.0 0.0 0.0 ST8SIA4 "PST, PST1, SIAT8D" ENSG00000113532 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4" Q92187 5 100806933-100903282 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.1" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 91.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051126, HPA053995" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 980000 "Golgi apparatus" "HPA051126: AB_2681352, HPA053995: AB_2682336" "unprognostic (2.25e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.14e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-1)" "unprognostic (5.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.49e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.80e-7)" "unprognostic (6.07e-2)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" 5.9 1.9 2.5 14.1 2.6 7.7 2.2 1.8 3.2 1.9 2.7 3.3 3.2 1.6 0.6 1.2 1.8 5.1 2.3 2.0 4.6 0.7 2.6 5.8 12.4 4.2 3.6 1.8 0.5 0.8 1.0 0.6 11.2 5.4 1.3 4.3 0.6 1.2 0.8 0.9 0.8 4.6 2.8 3.3 11.9 3.0 0.4 4.1 9.6 2.1 1.7 10.4 5.6 1.1 5.3 0.0 6.1 41.1 0.0 2.6 3.9 1.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.1 0.0 1.0 0.1 1.0 0.1 0.1 69.3 0.0 2.5 0.4 0.0 0.0 13.0 5.0 3.2 0.0 0.1 0.1 5.3 7.7 10.1 0.0 57.2 2.4 0.6 18.6 27.9 0.3 0.0 0.3 10.3 0.7 44.8 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.0 11.6 2.7 0.4 0.2 0.0 0.6 18.6 20.3 3.9 1.0 15.8 5.1 58.0 18.5 22.9 13.1 21.7 9.9 11.1 8.7 11.1 12.2 9.9 5.4 10.1 91.7 10.6 24.0 3.7 17.4 12.2 2.5 2.6 1.8 3.2 2.0 4.6 4.2 3.6 1.8 5.4 3.3 4.1 5.3 35.8 6.4 14.1 1.6 49.7 8.3 0.4 2.1 2.2 0.6 0.9 0.9 2.3 1.5 10.1 0.0 0.0 9.4 44.0 0.0 1.9 0.2 0.2 0.9 1.6 28.4 0.0 8.2 6.8 0.0 42.4 5.0 1.1 0.3 24.1 0.1 7.1 0.1 22.6 0.0 73.3 0.2 4.1 92.4 149.3 0.7 0.0 57.5 14.2 101.2 97.5 3.2 34.0 4.5 1.6 0.0 0.0 0.4 73.8 0.2 0.0 0.3 16.6 0.9 13.1 1.2 3.7 0.5 0.8 0.4 5.5 19.2 37.7 0.7 0.0 0.5 GNPDA1 "GNPDA, GNPI, GPI, HLN, KIAA0060" ENSG00000113552 "Glucosamine-6-phosphate deaminase 1" P46926 5 141991749-142013041 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 127.2;Proximal tubular cells: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 382.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 930000 Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (6.79e-2)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.09e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (9.66e-2)" "unprognostic (2.05e-3)" 19.0 38.7 27.7 17.4 28.8 8.2 21.1 26.5 35.5 26.8 28.0 19.9 29.8 29.0 52.3 13.7 18.6 22.5 17.4 27.9 29.9 77.1 16.8 17.8 22.9 27.5 28.0 27.7 32.1 11.4 28.2 20.7 22.4 28.3 22.4 22.1 17.8 14.7 28.6 26.7 14.4 22.7 29.5 28.6 31.2 14.6 19.0 29.5 25.2 28.1 26.0 19.9 33.6 17.2 30.5 42.6 61.0 23.2 115.8 77.1 51.9 54.6 32.6 78.7 84.7 95.8 91.3 49.2 0.2 72.9 23.6 382.3 44.0 109.9 98.0 74.8 32.9 46.5 31.3 33.1 65.5 137.2 86.4 39.2 63.5 56.9 54.5 144.8 63.2 91.6 80.6 37.3 110.1 93.0 27.2 66.8 9.8 88.0 62.8 121.4 25.5 76.3 94.3 81.8 114.8 20.6 54.0 65.0 67.8 127.9 67.5 54.6 26.5 43.3 50.9 33.3 76.9 47.5 61.2 126.9 47.1 74.2 29.3 45.0 0.3 48.6 7.1 37.2 59.1 77.9 19.4 30.0 34.2 51.7 11.1 35.3 38.8 12.7 15.8 56.3 29.6 27.6 40.2 27.7 28.8 26.5 35.5 27.9 29.9 27.5 28.0 27.7 28.3 28.6 29.5 30.5 10.5 9.6 14.9 10.7 8.2 6.0 40.8 20.9 21.1 11.6 12.6 17.8 12.6 12.8 20.1 18.4 8.4 26.7 11.1 6.9 35.2 29.3 1.1 5.8 19.8 14.6 15.0 9.9 11.5 14.2 48.6 22.8 7.7 9.6 12.0 30.8 15.4 7.4 127.2 6.7 12.7 6.2 12.2 60.2 10.7 3.6 19.9 48.5 14.2 12.2 23.5 40.5 15.5 7.1 11.5 21.6 7.1 26.7 7.8 32.9 19.4 102.3 8.0 7.9 0.0 10.4 11.7 10.4 17.0 17.6 7.4 29.7 16.6 64.8 9.1 34.7 PCDH12 VE-cadherin-2 ENSG00000113555 "Protocadherin 12" Q9NPG4 5 141943581-141969741 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.5" "Group enriched" "Detected in some" 4 "Adipocytes: 38.5;Endothelial cells: 40.0;Hepatic stellate cells: 41.0;Hofbauer cells: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 8 "non-classical monocyte: 4.6" "Lineage enriched" "Detected in single" 41 "monocytes: 4.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 25.9;Karpas-707: 66.5;U-937: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051242 Uncertain "Secreted to blood" NA NA 14000000 "HPA051242: AB_2681402" "unprognostic (6.62e-2)" "unprognostic (6.94e-2)" "unprognostic (4.74e-3)" "unprognostic (4.12e-2)" "unprognostic (3.99e-1)" "unprognostic (3.25e-1)" "unprognostic (4.35e-1)" "unprognostic (1.88e-2)" "unprognostic (4.29e-2)" "unprognostic (2.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.11e-2)" "unprognostic (5.21e-2)" "unprognostic (9.37e-2)" "unprognostic (9.33e-2)" 13.5 5.0 0.9 2.5 0.8 0.5 4.9 2.3 2.0 2.7 2.4 2.0 2.0 2.8 0.4 2.1 2.1 4.0 9.3 0.7 0.9 5.9 4.0 15.6 2.7 0.6 0.4 0.5 1.7 1.4 2.9 3.6 30.5 1.2 2.0 1.3 1.6 1.4 2.3 4.0 1.7 2.1 5.3 0.2 18.8 2.0 1.1 1.7 0.8 6.5 5.2 1.0 3.3 2.0 0.7 0.1 0.1 1.9 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 5.0 0.1 0.6 0.1 0.0 0.0 0.0 0.4 0.6 1.4 0.2 0.1 0.2 0.5 0.2 0.0 0.0 0.4 0.0 0.4 25.9 0.3 0.0 66.5 0.0 0.4 0.1 0.3 0.5 0.0 0.3 0.5 0.2 3.0 0.0 0.1 0.3 0.7 0.1 0.1 0.3 0.2 0.0 1.8 1.8 0.6 0.1 0.9 0.1 0.4 0.4 0.1 0.4 11.7 2.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.9 0.8 2.3 2.0 0.7 0.9 0.6 0.4 0.5 1.2 0.2 1.7 0.7 38.5 0.0 1.1 0.0 0.5 0.6 0.0 0.0 1.2 1.3 0.1 0.1 4.0 0.0 0.0 0.0 2.1 0.3 0.3 0.0 3.9 0.1 1.7 0.1 0.1 40.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.1 1.3 0.0 41.0 0.5 34.6 0.0 0.2 0.0 0.0 8.5 0.3 2.5 0.0 1.5 1.8 6.5 0.3 0.5 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.4 0.0 0.7 1.0 0.0 0.2 0.2 0.3 0.5 0.2 1.4 0.0 0.2 SKP1 "EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L" ENSG00000113558 "S-phase kinase associated protein 1" P63208 5 134148935-134176964 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012982, HPA053745, HPA058134" Approved Supported Nucleoplasm,Cytosol No No 880000 Nucleoplasm Cytosol "CAB012982: AB_2533076, HPA053745: AB_2682245, HPA058134: AB_2683617" "prognostic unfavorable (7.53e-4)" "unprognostic (1.97e-1)" "unprognostic (9.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (4.47e-2)" "unprognostic (1.33e-1)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (3.07e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (8.26e-2)" "unprognostic (2.40e-1)" 425.7 571.3 465.4 196.6 478.8 366.8 564.6 485.1 653.9 459.2 494.2 474.1 232.2 445.0 495.0 405.2 441.6 333.0 655.2 481.3 521.4 592.3 446.5 349.6 308.4 482.5 484.0 451.9 529.8 268.8 782.6 504.9 398.0 488.8 424.6 353.6 488.6 369.9 556.1 1065.5 422.9 357.9 426.3 502.7 307.3 389.1 383.8 476.3 460.3 556.5 821.3 334.8 456.8 394.9 531.5 657.0 500.1 730.3 986.5 1103.6 891.8 519.2 744.6 939.1 854.0 877.1 773.0 620.0 481.9 1084.9 1009.8 974.9 356.6 738.2 1124.1 988.3 442.6 519.5 380.7 724.0 555.8 518.7 296.3 452.0 771.1 886.2 750.1 588.7 1060.4 928.4 611.2 467.4 411.8 1295.2 515.6 642.0 314.8 423.9 619.6 530.7 349.2 780.7 591.7 952.3 724.6 594.6 463.8 1010.2 254.4 726.9 942.4 738.5 454.6 705.3 547.5 338.4 578.2 766.4 254.7 459.1 717.8 762.3 555.5 608.0 1745.5 851.4 1484.9 884.6 841.7 1011.4 1202.8 1264.6 1099.9 817.8 1094.4 1495.5 1174.8 811.4 1096.1 1027.0 728.1 1416.7 2538.6 465.4 478.8 485.1 653.9 481.3 521.4 482.5 484.0 451.9 488.8 502.7 476.3 531.5 430.1 285.2 306.3 64.0 403.6 674.3 1025.7 1354.7 380.1 230.0 539.8 558.4 700.9 497.6 767.4 594.1 73.0 881.0 417.7 441.8 1696.3 644.9 593.3 511.9 405.3 410.1 356.0 617.8 66.5 376.9 749.4 561.5 270.1 439.0 336.9 433.9 340.2 376.9 471.6 223.8 65.8 402.2 1192.2 296.1 505.1 1048.6 601.4 344.8 718.6 33.7 565.4 792.8 338.8 43.7 87.0 378.1 564.0 712.8 278.2 744.7 630.0 1577.8 965.7 217.5 506.2 480.4 668.1 753.5 652.7 349.0 645.6 1347.0 511.1 500.4 410.4 837.6 NUP155 "KIAA0791, N155" ENSG00000113569 "Nucleoporin 155" O75694 5 37288137-37371106 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Atrial fibrillation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 71.4" "Cell type enhanced" "Detected in many" "Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037775 Enhanced Enhanced "Nuclear membrane" "Intracellular and membrane" NA NA 28000 "Nuclear membrane" "HPA037775: AB_10671885" "unprognostic (1.10e-2)" "unprognostic (7.94e-2)" "unprognostic (1.28e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (2.18e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "unprognostic (9.49e-2)" "unprognostic (1.49e-2)" "unprognostic (6.80e-2)" "unprognostic (2.27e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" 5.3 3.5 2.0 6.7 2.6 15.3 7.5 5.2 2.8 5.3 3.2 5.7 5.0 6.0 2.7 6.5 5.3 4.0 4.0 2.0 2.5 4.6 5.7 4.3 8.3 2.5 2.6 1.9 6.3 4.9 8.2 2.1 8.1 2.9 5.3 7.0 6.6 4.4 4.2 4.3 5.2 4.6 6.7 2.4 5.7 5.0 71.4 2.9 12.7 6.1 6.0 9.9 5.7 3.5 4.1 40.6 31.7 33.7 50.0 10.3 15.1 120.8 32.2 16.9 43.1 31.4 46.9 32.5 46.0 14.4 20.9 46.7 32.2 57.5 31.7 67.0 30.4 32.3 35.8 109.6 21.9 13.0 60.0 24.0 11.1 13.0 66.5 33.5 11.8 23.2 20.4 65.8 23.8 29.0 19.9 32.4 16.3 32.0 24.8 28.4 38.3 106.1 36.5 9.7 38.5 40.6 27.8 74.0 31.4 18.1 23.8 38.8 23.5 20.2 51.5 42.9 39.3 49.5 26.8 47.9 60.0 24.1 53.0 39.9 4.3 2.0 3.5 3.3 4.2 5.6 3.9 3.1 2.9 2.9 2.9 3.0 3.5 0.6 4.5 3.1 2.0 2.4 2.7 2.0 2.6 5.2 2.8 2.0 2.5 2.5 2.6 1.9 2.9 2.4 2.9 4.1 11.1 3.2 6.8 11.8 15.5 10.5 6.5 6.5 10.8 8.0 8.0 5.0 11.0 2.8 9.6 3.7 6.2 14.3 9.8 5.2 0.0 6.0 64.6 6.9 11.0 9.6 1.2 10.7 12.4 6.1 20.4 9.0 9.2 7.1 5.1 15.1 13.9 9.7 7.9 5.0 12.6 8.7 12.2 8.9 8.0 104.5 11.1 7.0 0.0 7.5 5.7 3.9 8.2 15.1 16.7 8.2 3.8 10.1 12.7 7.6 3.9 4.1 11.4 14.5 0.0 11.5 10.5 48.2 21.1 10.8 11.6 7.5 9.9 10.6 11.3 4.9 PPP2CA "PP2AC, PP2Calpha" ENSG00000113575 "Protein phosphatase 2 catalytic subunit alpha" P67775 5 134194332-134226073 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Meiosis "Hydrolase, Protein phosphatase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003848, HPA043236" Approved NA NA "CAB003848: AB_562203, HPA043236: AB_2678379" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.60e-2)" "unprognostic (3.35e-3)" "unprognostic (1.26e-1)" "unprognostic (3.21e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.59e-3)" "unprognostic (1.57e-1)" "unprognostic (2.02e-1)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (5.24e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" 48.3 53.6 56.5 43.3 62.2 125.9 47.1 67.5 66.4 39.2 52.8 51.9 46.6 47.0 36.4 72.2 39.4 45.0 90.9 62.7 63.1 57.9 62.6 39.8 59.1 56.8 59.7 60.3 30.2 44.6 87.8 26.3 52.6 59.8 38.1 47.5 59.1 36.8 40.8 75.9 54.4 44.9 58.3 61.0 40.4 41.7 35.0 61.1 93.3 48.5 73.8 77.3 76.2 41.3 68.6 157.0 128.8 180.8 97.9 92.1 98.2 126.2 144.1 123.3 214.8 215.4 249.1 119.6 136.5 131.7 134.4 242.9 79.7 175.6 208.6 250.2 123.9 100.1 96.9 142.4 156.5 136.3 97.1 84.2 91.7 141.5 169.0 166.6 107.0 153.5 135.1 97.2 99.1 165.1 112.5 154.9 95.0 98.9 123.6 77.3 136.5 179.6 132.6 130.0 173.4 142.9 99.6 148.9 55.1 166.9 179.7 112.2 112.3 109.2 123.3 69.1 99.6 206.5 88.5 171.6 217.0 83.2 125.9 130.3 43.0 64.7 75.6 46.8 63.1 59.2 53.1 53.2 62.5 77.3 54.7 60.6 57.2 71.3 75.5 67.0 41.5 72.4 95.8 56.5 62.2 67.5 66.4 62.7 63.1 56.8 59.7 60.3 59.8 61.0 61.1 68.6 58.7 51.3 47.6 27.1 103.3 239.0 187.4 90.1 121.8 43.9 93.6 53.0 111.2 55.8 63.1 57.0 22.9 152.1 89.0 68.7 107.6 109.7 34.6 85.8 83.2 81.1 87.1 89.0 36.6 87.6 171.3 78.0 77.5 106.1 62.2 44.6 51.8 65.9 111.4 50.5 35.7 62.0 69.2 88.2 194.6 29.8 38.5 95.8 104.9 24.4 115.6 62.9 51.5 36.7 48.9 101.7 56.6 45.5 120.9 143.3 64.9 114.8 53.0 31.4 19.7 76.8 97.6 91.4 85.8 112.4 234.4 309.8 110.6 53.3 69.7 176.7 FGF1 "AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1" ENSG00000113578 "Fibroblast growth factor 1" P05230 5 142592178-142698070 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 312.9;choroid plexus: 164.4" "Cell type enhanced" "Detected in many" "Astrocytes: 75.1;Cardiomyocytes: 62.4;Muller glia cells: 69.4;Oligodendrocytes: 119.8" "Cancer enriched" "Detected in many" 12 "glioma: 33.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 44.6;BJ hTERT+: 33.0;BJ hTERT+ SV40 Large T+: 35.9;BJ hTERT+ SV40 Large T+ RasG12V: 45.0;HBF TERT88: 64.3;hTEC/SVTERT24-B: 45.4;LHCN-M2: 30.6;U-2 OS: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003265, CAB017519" Enhanced Supported Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "CAB017519: AB_629473, HPA003265: AB_1848522" "unprognostic (1.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (2.55e-2)" "unprognostic (3.52e-1)" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.63e-1)" "unprognostic (1.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.54e-1)" "prognostic favorable (2.59e-5)" "unprognostic (3.72e-4)" "unprognostic (2.49e-1)" "prognostic favorable (3.45e-5)" "unprognostic (3.01e-4)" 10.5 3.3 249.8 1.6 286.3 1.1 12.6 250.8 257.5 1.3 164.4 1.8 1.0 3.1 8.0 2.0 1.7 2.6 50.7 217.2 261.1 64.9 1.7 2.8 1.2 277.8 272.5 190.8 0.9 0.8 4.3 6.5 2.1 312.9 1.8 1.4 19.0 7.3 2.3 2.3 1.7 1.2 2.5 262.2 7.0 0.8 2.1 267.9 1.5 5.6 7.9 2.0 1.2 1.0 310.7 5.6 0.3 0.3 1.5 1.1 3.3 1.8 44.6 33.0 35.9 45.0 0.2 0.2 1.3 3.1 15.4 2.1 0.7 0.0 3.5 64.3 0.2 0.0 0.0 0.8 0.4 0.6 0.0 0.4 1.6 1.1 45.4 2.7 9.7 0.0 0.2 0.0 1.6 30.6 0.7 0.1 0.9 1.4 0.1 1.4 0.2 1.5 0.6 1.5 0.2 1.1 2.3 0.1 0.9 0.6 8.0 0.0 0.2 1.1 5.8 33.0 0.8 21.3 0.8 0.4 0.3 8.2 0.3 1.6 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.3 0.0 0.1 0.2 0.1 0.0 249.8 286.3 250.8 257.5 217.2 261.1 277.8 272.5 190.8 312.9 262.2 267.9 310.7 1.4 0.0 0.0 75.1 0.1 0.4 5.0 5.7 7.4 3.5 1.2 25.4 62.4 0.0 2.1 20.2 16.7 1.1 0.1 0.0 0.0 1.1 0.4 0.0 0.7 4.8 0.0 0.0 13.0 0.0 0.5 4.7 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 14.6 0.0 12.2 0.0 0.0 1.4 0.0 0.2 3.6 29.0 0.0 69.4 0.0 15.1 119.8 0.6 0.0 0.4 0.0 5.3 0.0 0.3 0.1 11.6 6.6 0.5 23.4 0.1 0.1 0.6 0.0 0.8 0.4 0.0 0.0 0.7 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease variant, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 411.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 35.7 11.9 17.4 22.8 19.6 49.8 25.8 33.8 26.1 19.9 22.3 13.7 19.4 19.0 13.8 25.9 19.0 21.3 24.4 16.1 21.5 19.3 40.1 32.2 25.8 20.0 17.7 13.7 21.3 14.8 34.1 16.3 47.3 19.2 19.9 14.7 9.6 16.3 20.2 45.4 20.6 18.2 24.0 18.5 24.7 16.2 11.2 21.6 40.4 25.8 40.5 27.5 18.4 16.1 29.9 30.4 60.6 4.4 0.1 38.2 42.3 5.2 46.5 55.3 39.3 45.1 4.5 39.7 26.8 20.8 68.6 46.0 28.1 0.3 36.6 48.3 15.2 21.0 6.9 77.0 13.5 35.7 28.1 20.6 30.8 46.3 64.7 62.5 49.0 15.0 12.1 10.3 98.8 35.1 10.9 16.7 20.0 11.9 5.1 13.0 6.0 41.4 58.0 11.5 2.1 8.0 6.1 81.3 11.7 19.4 4.9 5.3 39.8 35.8 94.7 18.7 45.7 35.9 20.1 19.7 41.5 49.7 28.5 33.6 67.4 21.3 38.9 18.3 24.2 15.1 15.9 18.6 17.9 28.5 22.3 17.8 17.2 68.4 23.1 23.6 25.9 12.8 17.3 17.4 19.6 33.8 26.1 16.1 21.5 20.0 17.7 13.7 19.2 18.5 21.6 29.9 152.3 67.3 69.1 71.2 134.1 58.8 35.9 37.9 79.6 13.1 39.0 55.8 43.4 57.2 41.2 25.8 16.7 48.9 158.3 22.9 17.6 30.8 165.6 8.1 30.1 82.3 28.1 55.9 411.4 33.3 39.5 112.2 23.9 10.4 89.3 7.5 63.5 193.9 53.2 37.0 169.5 4.1 10.2 66.3 99.2 144.1 63.0 97.4 53.4 241.7 87.6 34.6 83.4 240.3 237.5 35.9 17.9 71.5 115.1 46.2 25.3 67.9 37.9 65.0 151.2 181.9 105.0 24.5 40.1 57.4 56.3 36.5 204.5 12.6 12.9 14.3 C5orf15 "HTGN29, KCT2" ENSG00000113583 "Chromosome 5 open reading frame 15" Q8NC54 5 133955510-133968674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011951, HPA039165" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA011951: AB_2668584, HPA039165: AB_10795580" "unprognostic (2.25e-1)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (4.91e-2)" "unprognostic (1.81e-1)" "unprognostic (2.26e-3)" "unprognostic (1.01e-2)" "unprognostic (7.72e-2)" "unprognostic (2.62e-2)" "unprognostic (7.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (9.07e-3)" "unprognostic (5.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-2)" 35.7 50.0 17.6 36.0 18.2 18.8 45.2 18.9 23.1 38.8 25.2 32.7 49.1 35.7 34.7 24.3 48.4 41.6 41.1 17.6 22.2 74.2 80.9 40.2 47.9 18.9 18.7 16.1 37.0 26.5 45.1 20.0 59.4 19.5 40.0 33.5 24.7 31.1 25.3 22.5 30.9 49.0 30.8 18.9 37.7 49.2 26.8 18.0 34.2 53.6 22.8 37.3 46.9 19.2 23.4 70.4 51.5 70.5 81.3 101.9 115.9 85.9 71.3 95.4 107.2 178.7 49.9 204.1 49.5 127.4 87.3 108.4 51.1 57.7 104.0 125.6 56.3 87.7 18.7 34.2 63.9 96.1 30.8 79.8 102.2 62.7 84.7 44.7 152.5 45.9 31.3 39.7 57.4 86.7 44.7 35.9 57.9 39.0 34.1 30.8 34.0 72.3 73.8 175.0 53.9 62.8 47.0 71.9 24.2 117.1 126.0 74.9 91.7 42.4 95.6 88.4 39.2 71.8 42.9 44.1 30.3 113.3 72.9 143.6 19.5 31.6 16.8 14.6 34.6 13.7 22.8 16.6 16.0 37.0 24.3 21.1 17.1 16.3 22.0 34.2 26.7 17.3 29.4 17.6 18.2 18.9 23.1 17.6 22.2 18.9 18.7 16.1 19.5 18.9 18.0 23.4 18.6 25.6 33.2 12.7 32.3 30.7 39.8 85.7 33.6 22.0 41.3 22.1 17.9 51.5 54.1 49.7 10.4 83.6 19.6 27.1 17.6 73.7 45.6 68.4 34.2 21.2 37.2 17.1 17.1 46.8 71.9 61.1 25.0 32.2 15.2 31.5 23.9 48.5 55.7 5.0 15.6 30.4 81.4 32.8 57.7 7.0 51.3 34.0 64.0 21.5 97.1 27.6 19.6 37.2 35.3 47.9 24.1 39.1 28.8 33.5 51.5 71.8 125.5 26.9 26.3 30.6 36.3 46.8 29.1 23.3 32.5 58.0 21.5 80.6 21.2 22.8 PPWD1 KIAA0073 ENSG00000113593 "Peptidylprolyl isomerase domain and WD repeat containing 1" Q96BP3 5 65563236-65587549 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019353, HPA019360" Enhanced Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA019353: AB_1855668, HPA019360: AB_1855669" "unprognostic (3.31e-2)" "unprognostic (2.07e-2)" "unprognostic (6.78e-2)" "unprognostic (2.85e-1)" "unprognostic (9.61e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.37e-1)" "unprognostic (4.97e-2)" "unprognostic (1.09e-1)" "unprognostic (7.84e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.72e-4)" "unprognostic (2.40e-1)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" 15.1 12.3 13.4 18.3 15.6 27.9 17.4 17.7 16.6 17.4 15.1 14.8 13.6 19.2 18.0 13.6 16.3 15.8 13.6 13.6 14.6 11.2 15.6 15.0 30.2 14.5 14.6 13.3 23.1 14.1 15.6 14.8 19.8 15.3 15.1 19.4 14.9 12.8 13.8 13.4 22.3 17.2 13.3 14.3 22.8 14.5 18.3 14.3 33.2 16.5 15.7 26.2 13.8 15.3 19.6 36.5 23.6 35.1 35.2 30.6 36.9 38.8 34.5 25.3 36.5 45.5 37.8 35.4 41.5 28.5 24.3 49.1 32.3 38.4 35.5 49.8 35.7 32.3 26.0 40.0 31.1 25.9 23.9 26.4 29.2 15.3 35.5 25.5 27.0 32.3 31.6 35.3 28.8 28.8 35.8 40.0 31.6 24.7 15.2 13.3 35.4 46.7 35.1 21.2 29.5 18.1 14.8 34.8 14.5 33.1 26.8 21.5 30.8 24.9 20.2 29.2 22.4 52.9 17.1 26.3 45.5 22.3 35.8 21.4 35.0 15.1 31.6 26.1 19.3 32.0 25.8 29.1 29.9 21.2 19.1 36.1 31.0 14.3 26.5 24.0 11.8 38.1 23.4 13.4 15.6 17.7 16.6 13.6 14.6 14.5 14.6 13.3 15.3 14.3 14.3 19.6 25.1 28.9 22.4 28.1 36.0 12.4 14.9 15.4 18.2 14.2 9.1 12.8 19.8 7.2 22.1 11.0 8.4 27.7 27.0 6.9 9.8 8.7 76.8 16.4 28.7 20.7 9.6 21.5 37.2 7.7 14.4 21.1 15.8 13.8 11.4 32.6 18.9 6.0 11.8 6.7 46.8 14.9 8.2 16.4 11.9 41.7 20.2 15.2 14.2 23.4 22.6 11.8 23.7 42.3 67.1 8.9 14.7 18.8 29.4 6.6 10.0 7.9 17.8 20.9 6.6 19.9 17.8 32.5 33.7 13.2 11.8 25.2 35.4 15.8 11.4 9.0 LIFR CD118 ENSG00000113594 "LIF receptor subunit alpha" P42702 5 38474668-38608354 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 318.9;Astrocytes: 376.8;Endothelial cells: 279.5;Hepatic stellate cells: 809.2;Oligodendrocytes: 275.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 88.0;HHSteC: 38.7;SCLC-21H: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 260000 "unprognostic (6.00e-3)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-3)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.92e-4)" "unprognostic (1.78e-1)" "unprognostic (9.80e-2)" "unprognostic (2.73e-3)" "unprognostic (1.06e-1)" "prognostic favorable (1.40e-7)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" "unprognostic (1.65e-1)" 50.4 18.3 40.5 6.3 51.9 0.1 42.2 47.3 25.5 33.7 4.3 9.4 5.9 33.4 16.6 12.2 31.2 12.5 20.0 22.8 43.1 24.1 31.2 24.0 21.2 51.5 48.8 18.5 18.8 22.5 13.6 5.0 36.2 66.3 29.1 8.9 17.5 34.4 17.0 23.6 9.1 11.1 33.7 40.4 30.1 22.1 10.1 55.8 21.5 38.9 43.2 10.3 11.8 14.7 49.1 1.3 4.3 88.0 6.8 25.4 27.0 0.6 6.7 3.8 4.7 2.9 0.9 4.6 0.0 1.2 10.1 12.4 0.7 5.5 2.1 9.0 0.0 7.0 0.0 8.7 3.7 38.7 0.0 0.5 23.5 1.6 12.0 1.5 6.1 8.6 0.9 2.3 12.3 7.3 1.3 0.0 0.2 2.1 0.0 14.8 0.1 18.4 0.0 6.0 2.0 56.6 7.2 28.3 1.6 0.0 11.7 1.9 0.0 1.5 9.0 15.7 21.0 4.3 0.0 0.0 0.0 15.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.5 51.9 47.3 25.5 22.8 43.1 51.5 48.8 18.5 66.3 40.4 55.8 49.1 318.9 12.8 39.7 376.8 2.6 23.2 6.3 1.2 10.8 6.4 16.8 22.1 33.1 8.6 7.3 14.7 8.4 12.1 0.6 0.0 5.9 2.0 15.0 11.0 12.4 279.5 0.0 13.5 33.7 9.3 28.0 62.9 14.3 16.9 1.3 29.6 809.2 11.8 3.5 1.7 54.2 0.0 6.1 50.3 17.7 29.7 113.7 2.3 17.8 45.0 0.0 6.2 0.0 111.6 275.5 7.0 0.0 19.9 0.0 18.5 0.0 12.3 8.3 37.3 39.5 65.9 30.8 9.6 7.3 2.0 18.2 28.6 3.7 15.8 0.0 5.5 TRIM23 "ARD1, ARFD1, RNF46" ENSG00000113595 "Tripartite motif containing 23" P36406 5 65589690-65625975 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039605 Approved NA NA "HPA039605: AB_10673146" "unprognostic (4.06e-1)" "unprognostic (1.07e-1)" "unprognostic (5.11e-2)" "unprognostic (3.63e-1)" "unprognostic (7.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.02e-1)" "unprognostic (5.00e-3)" "unprognostic (6.51e-2)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-2)" "unprognostic (1.06e-2)" "unprognostic (2.62e-1)" "unprognostic (6.55e-3)" "unprognostic (2.70e-1)" 8.1 10.9 12.6 6.1 15.8 7.7 8.3 20.0 17.7 9.2 7.6 5.1 3.9 9.3 6.1 7.5 7.1 5.3 11.1 15.4 14.5 8.8 10.9 5.8 7.5 13.2 13.1 15.1 13.3 5.5 8.5 4.7 7.1 14.3 11.5 4.4 14.7 5.6 7.6 13.3 6.3 4.6 7.9 13.1 7.7 4.4 10.5 13.3 8.7 10.7 17.6 6.7 6.4 5.3 20.9 8.5 11.8 12.6 18.2 17.9 17.9 9.1 16.7 15.2 13.3 16.4 12.2 8.2 6.7 18.8 11.0 13.8 7.3 11.7 9.4 20.1 6.7 15.0 5.8 15.7 6.6 16.8 3.8 7.2 14.0 8.1 14.9 13.5 12.7 6.4 8.0 6.4 9.2 16.5 7.8 7.4 4.0 6.6 1.5 4.7 6.6 21.9 9.7 7.3 8.6 7.5 10.2 15.9 4.4 13.2 10.3 10.3 4.6 11.0 10.5 11.4 13.2 12.3 11.3 12.2 8.8 12.1 6.6 10.4 19.9 3.5 8.9 4.7 2.8 5.9 3.9 5.1 4.0 3.2 4.7 8.0 6.1 9.2 5.1 4.4 3.5 6.4 3.9 12.6 15.8 20.0 17.7 15.4 14.5 13.2 13.1 15.1 14.3 13.1 13.3 20.9 13.8 19.2 7.8 28.1 13.1 6.9 2.3 4.4 7.4 28.2 7.0 7.1 22.3 10.0 6.8 5.5 16.7 3.8 12.5 4.7 5.9 4.9 7.0 9.4 21.3 11.1 6.6 21.0 49.1 3.1 2.6 17.1 5.6 7.6 3.8 19.7 13.9 13.0 3.9 45.4 49.3 4.4 2.0 10.0 3.5 4.2 20.8 7.4 10.6 24.4 6.8 27.2 8.2 39.7 49.7 5.8 4.3 17.0 11.4 9.1 6.0 10.1 11.8 24.8 32.9 16.0 12.9 27.2 16.9 5.0 6.3 7.0 13.1 16.0 3.8 6.9 TRAPPC13 "C5orf44, FLJ13611, MGC48585" ENSG00000113597 "Trafficking protein particle complex 13" A5PLN9 5 65625004-65666233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037777 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037777: AB_10672464" "unprognostic (3.66e-2)" "unprognostic (3.27e-1)" "unprognostic (1.54e-2)" "unprognostic (7.22e-2)" "unprognostic (4.79e-2)" "unprognostic (1.16e-2)" "unprognostic (2.55e-2)" "unprognostic (2.49e-2)" "unprognostic (5.70e-2)" "unprognostic (5.75e-2)" "unprognostic (3.49e-2)" "unprognostic (1.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (2.89e-1)" "unprognostic (2.58e-2)" "unprognostic (2.53e-2)" "unprognostic (6.25e-2)" 10.1 11.7 8.9 9.0 9.2 8.0 12.9 9.9 9.9 10.7 8.2 10.9 9.4 10.9 9.1 12.5 9.0 9.4 17.0 9.4 10.4 20.2 14.9 10.6 10.9 9.6 9.7 8.8 7.7 7.4 22.9 8.9 10.5 9.7 18.8 13.4 16.7 9.2 11.0 13.5 5.8 9.1 13.0 9.8 10.0 10.1 10.7 9.4 16.8 17.5 17.0 10.9 12.2 7.0 12.0 20.7 13.6 21.0 38.2 15.8 20.2 20.7 23.8 21.2 29.1 31.2 11.8 28.7 21.3 25.5 19.5 31.0 18.8 24.0 25.0 33.9 14.6 17.8 13.4 15.3 11.1 21.7 16.6 19.3 14.5 19.2 22.7 28.8 17.5 25.8 30.0 16.2 19.1 26.3 21.9 27.3 6.4 9.5 11.9 7.4 23.7 26.9 24.0 20.8 23.2 25.4 19.2 29.3 17.4 22.2 11.6 25.7 20.8 17.8 10.2 14.0 22.6 24.4 12.6 26.3 34.0 21.3 28.9 19.8 17.6 8.3 3.6 8.4 9.3 11.0 5.8 8.1 7.0 9.0 4.7 7.9 7.9 3.1 8.9 13.4 6.7 9.3 9.1 8.9 9.2 9.9 9.9 9.4 10.4 9.6 9.7 8.8 9.7 9.8 9.4 12.0 10.4 19.2 10.5 27.1 7.4 5.7 6.8 17.3 6.2 13.3 8.5 5.5 7.1 12.8 13.1 7.3 10.4 12.1 13.0 7.6 15.6 12.9 24.6 7.9 7.6 11.9 15.5 12.0 54.7 10.8 9.6 9.1 11.2 7.6 3.8 9.8 8.2 11.2 12.4 13.5 44.2 8.9 26.4 13.9 7.7 10.2 7.5 9.6 7.2 28.1 11.1 14.8 11.3 46.3 66.5 10.3 6.3 13.2 8.9 11.8 11.0 25.2 13.4 16.2 6.6 8.7 8.3 16.4 8.6 9.1 6.8 15.2 12.0 10.2 8.7 11.9 C9 ENSG00000113600 "Complement C9" P02748 5 39284140-39424868 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 287 "liver: 1408.7" "Cell type enriched" "Detected in some" 37 "Hepatocytes: 1962.3" "Cancer enriched" "Detected in single" 244 "liver cancer: 90.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "JURKAT: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002151, HPA029577" Uncertain "Secreted to blood" NA NA 69600000000 64000000000 "CAB002151: AB_563670, HPA029577: AB_10603779" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (1.50e-1)" "unprognostic (2.01e-1)" "unprognostic (6.58e-2)" "unprognostic (1.30e-1)" "unprognostic (2.91e-1)" "unprognostic (5.49e-3)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (2.19e-2)" "unprognostic (9.43e-5)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1408.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 20.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.8 2.0 0.0 18.7 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 42.5 1962.3 1.2 0.0 0.1 0.2 0.0 52.6 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.1 3.7 1.7 0.0 0.0 0.3 3.0 0.0 0.0 0.1 SEC24A ENSG00000113615 "SEC24 homolog A, COPII coat complex component" O95486 5 134648785-134727909 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 89.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038901, HPA056825" Approved Approved "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center, Vesicles" "HPA038901: AB_10674843, HPA056825: AB_2683249" "unprognostic (9.10e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.76e-2)" "unprognostic (4.98e-2)" "unprognostic (2.08e-1)" "unprognostic (4.53e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-2)" "unprognostic (2.41e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-2)" "unprognostic (3.54e-1)" "unprognostic (1.18e-3)" "unprognostic (4.77e-2)" "unprognostic (3.00e-2)" "unprognostic (9.37e-3)" "unprognostic (8.97e-2)" 9.8 13.4 2.7 13.5 2.7 17.7 10.1 4.0 3.9 11.8 11.9 11.8 21.5 8.8 8.2 10.6 5.4 10.6 5.6 3.0 7.0 9.1 34.8 7.7 10.7 3.1 2.4 2.3 6.5 15.7 11.9 8.0 15.6 3.1 10.1 13.1 6.9 17.1 8.2 12.0 5.7 22.2 10.8 2.5 9.7 14.7 6.0 3.4 9.1 11.6 7.3 14.3 13.5 7.3 3.5 21.6 12.1 22.3 17.1 32.4 32.6 24.1 32.6 40.2 25.7 44.1 45.0 12.9 16.1 21.6 38.1 27.3 12.0 28.2 25.3 44.4 19.8 13.3 13.7 18.6 33.5 23.0 16.3 26.4 20.5 14.1 24.8 18.1 22.4 23.7 11.2 18.9 24.3 25.9 11.7 15.6 11.9 14.6 19.7 7.6 15.7 19.8 18.9 16.8 16.9 9.4 9.7 21.2 10.1 26.8 38.6 17.8 13.4 26.0 21.2 8.0 27.0 19.8 42.7 40.6 26.5 24.9 17.0 41.2 3.3 2.1 1.5 1.6 2.3 2.7 2.1 1.7 1.6 2.5 1.3 1.6 1.9 1.2 2.0 2.5 1.6 1.7 1.2 2.7 2.7 4.0 3.9 3.0 7.0 3.1 2.4 2.3 3.1 2.5 3.4 3.5 14.4 6.4 8.4 15.3 15.2 31.9 14.0 10.7 8.0 7.8 20.6 9.1 6.3 11.5 18.6 3.7 12.5 10.3 14.6 22.1 5.9 6.3 12.0 25.6 33.4 12.2 9.5 6.7 29.6 13.6 17.2 18.1 32.6 70.1 12.7 8.3 15.7 54.8 11.5 13.5 25.7 19.9 8.2 16.2 32.0 5.7 8.4 20.7 14.2 15.0 9.8 6.6 6.2 35.2 23.2 15.0 11.5 13.5 89.1 22.0 42.6 12.3 13.8 7.7 6.6 19.6 12.8 15.2 8.2 17.0 32.4 22.7 13.1 8.0 15.2 36.0 TXNDC15 "2310047H23Rik, C5orf14, FLJ22625" ENSG00000113621 "Thioredoxin domain containing 15" Q96J42 5 134874371-134901635 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015483 Approved Approved "Golgi apparatus" NA NA 49000000 "Golgi apparatus" "HPA015483: AB_1845722" "unprognostic (1.56e-1)" "unprognostic (1.22e-2)" "unprognostic (2.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.68e-2)" "unprognostic (9.71e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.36e-1)" "unprognostic (4.37e-1)" "unprognostic (1.41e-3)" "unprognostic (1.50e-1)" 34.4 45.1 19.9 35.3 22.5 9.0 34.2 22.3 22.2 42.9 34.9 37.6 23.9 35.4 56.6 22.5 29.8 32.8 36.1 21.2 25.1 29.3 34.0 30.8 25.6 25.4 22.2 19.8 31.7 50.1 44.1 43.3 37.4 21.2 38.5 26.4 36.8 47.2 44.4 42.3 18.8 21.9 44.1 19.7 36.2 32.6 19.0 21.9 20.5 60.4 30.7 31.3 36.2 24.9 23.7 28.8 77.8 47.8 76.9 75.8 102.7 5.5 117.7 135.1 42.3 93.7 56.8 38.5 38.1 64.3 108.6 78.8 21.0 33.0 48.6 38.6 81.5 36.6 20.0 46.7 46.1 58.7 13.6 51.2 61.7 39.6 56.0 35.2 70.6 65.8 18.0 10.1 106.8 65.6 36.5 20.8 30.7 21.4 31.3 31.7 30.0 58.1 117.7 35.5 29.4 27.7 35.6 70.3 19.4 63.9 22.7 27.3 19.8 83.0 62.5 35.3 62.0 42.7 70.7 120.3 31.8 93.0 28.5 41.3 32.7 34.3 19.8 31.0 33.7 32.7 32.3 25.2 32.8 31.0 23.8 20.8 24.5 9.3 29.5 33.8 30.1 29.8 32.7 19.9 22.5 22.3 22.2 21.2 25.1 25.4 22.2 19.8 21.2 19.7 21.9 23.7 47.8 60.9 31.9 11.8 49.9 25.4 30.5 41.5 22.8 37.6 25.1 29.0 36.4 27.1 36.3 23.9 20.9 32.4 31.9 10.0 13.7 33.5 4.2 12.1 49.4 38.7 12.6 6.7 13.7 33.1 54.3 65.7 12.8 19.2 30.4 33.1 45.3 29.7 33.9 63.9 19.7 17.0 44.7 31.3 32.3 6.7 63.3 27.3 69.4 19.7 39.2 43.0 29.9 19.6 20.1 19.2 14.0 45.5 203.2 25.1 17.4 28.3 26.7 36.6 46.0 45.2 44.1 36.5 61.6 17.4 23.4 30.0 36.3 45.1 13.3 21.5 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755963 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 6.3 5.9 7.0 3.3 8.4 0.8 5.7 11.2 10.2 5.7 6.3 5.9 4.4 6.2 4.8 4.2 5.7 4.7 6.3 8.2 8.2 7.6 7.7 5.1 4.3 7.4 8.3 7.3 6.8 4.8 9.0 4.4 4.1 7.6 5.9 4.3 11.7 5.3 5.7 15.6 3.8 4.9 5.0 6.7 4.6 5.2 4.5 7.9 6.8 6.0 14.9 4.1 5.4 5.3 8.1 3.6 3.2 6.1 6.8 5.0 7.1 2.9 4.7 5.6 4.8 5.1 1.7 3.5 11.0 2.8 4.3 5.2 1.6 5.2 2.7 8.5 10.3 4.9 2.4 13.5 4.3 5.5 6.5 3.1 4.4 5.6 4.8 5.0 8.4 7.2 7.3 5.8 8.3 6.4 1.0 12.5 9.3 1.9 2.8 3.5 11.1 11.5 7.9 8.2 2.1 4.5 6.2 11.0 6.4 8.1 5.0 4.3 8.7 5.5 5.5 4.6 4.3 4.6 6.0 6.7 5.8 5.1 10.1 4.9 7.1 1.8 3.2 2.0 4.4 2.2 2.1 2.3 2.1 1.9 2.2 2.5 2.2 2.5 2.3 6.6 1.0 2.2 1.9 7.0 8.4 11.2 10.2 8.2 8.2 7.4 8.3 7.3 7.6 6.7 7.9 8.1 12.9 16.0 7.4 9.8 13.1 14.4 5.6 8.6 11.4 12.3 8.6 6.0 18.2 7.2 6.2 7.3 6.2 5.9 8.8 6.9 19.6 8.2 22.4 9.1 11.5 11.0 3.0 9.5 23.7 6.3 4.2 12.6 6.1 6.8 12.7 8.9 13.9 9.4 5.1 5.0 27.5 8.0 10.2 7.5 15.4 8.4 14.0 7.5 10.6 15.9 14.3 19.2 2.1 23.6 35.1 8.0 8.4 13.9 11.8 6.8 6.8 12.6 13.7 23.5 13.1 9.9 13.4 28.1 22.1 6.3 18.3 2.6 14.6 5.0 6.2 4.5 RARS1 "DALRD1, RARS" ENSG00000113643 "Arginyl-tRNA synthetase 1" P54136 5 168486451-168519301 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003979, HPA004130" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 74000 Cytosol "Nucleoplasm, Nucleoli" "HPA003979: AB_1856083, HPA004130: AB_1856084" "unprognostic (1.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-3)" "unprognostic (2.82e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.59e-5)" "prognostic unfavorable (1.10e-8)" "unprognostic (3.26e-3)" "unprognostic (5.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.92e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.43e-2)" "unprognostic (2.35e-1)" "unprognostic (2.39e-1)" "unprognostic (1.33e-2)" 27.8 25.9 14.0 31.8 13.6 12.9 36.7 21.2 16.9 23.1 11.1 37.9 55.3 26.9 33.8 38.6 26.0 23.6 29.7 14.2 14.7 33.5 43.9 22.2 31.3 10.6 12.3 12.3 23.2 34.7 33.0 16.8 36.8 11.4 28.1 43.4 17.3 33.2 23.8 31.4 42.1 49.1 33.1 7.9 22.0 33.1 23.4 13.1 23.7 30.5 34.9 40.9 41.5 25.5 22.7 100.2 115.6 82.5 94.2 113.4 128.9 143.9 143.4 122.3 145.7 168.7 198.4 105.6 104.3 114.2 137.2 149.3 93.9 111.0 192.7 188.5 110.1 76.5 71.2 103.1 126.5 96.8 169.2 72.6 99.7 100.8 159.0 76.0 89.3 118.5 56.4 107.7 51.9 158.1 92.4 70.7 68.7 138.1 86.7 77.8 30.3 122.0 99.7 129.7 110.8 79.6 97.7 109.1 124.7 152.7 101.1 113.4 69.9 118.7 104.7 96.3 81.9 169.4 51.8 100.3 105.7 114.3 118.0 101.9 5.2 21.5 8.2 17.4 27.3 20.2 15.5 17.2 18.8 32.1 9.5 21.2 22.6 5.8 26.6 26.7 14.7 19.3 18.2 14.0 13.6 21.2 16.9 14.2 14.7 10.6 12.3 12.3 11.4 7.9 13.1 22.7 10.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 104.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 96.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 84.3 1.4 0.0 0.0 0.0 WWC1 "KIAA0869, KIBRA, PPP1R168" ENSG00000113645 "WW and C2 domain containing 1" Q8IX03 5 168291645-168472303 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 143.5" "Cell type enhanced" "Detected in many" "Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038016, HPA038017" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA038016: AB_10697091, HPA038017: AB_10669513" "unprognostic (3.60e-1)" "unprognostic (2.24e-2)" "unprognostic (1.08e-1)" "unprognostic (9.92e-2)" "unprognostic (1.51e-1)" "unprognostic (6.77e-3)" "unprognostic (2.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.31e-2)" "unprognostic (7.38e-2)" "prognostic favorable (1.95e-8)" "unprognostic (2.81e-3)" "unprognostic (1.80e-1)" "unprognostic (2.77e-1)" "unprognostic (1.50e-1)" 3.8 0.6 39.5 3.0 42.1 0.1 21.5 40.7 40.0 6.1 43.8 6.5 24.5 2.8 6.9 23.1 17.4 8.7 1.4 37.6 39.7 55.8 38.5 20.4 3.0 54.6 44.0 33.3 0.8 28.5 23.7 7.9 10.3 41.3 16.5 6.2 18.0 143.5 11.9 0.0 19.8 20.4 1.1 44.4 0.7 23.1 1.7 50.0 1.3 29.9 0.0 7.0 9.4 10.2 38.1 50.6 56.4 9.2 0.4 0.0 0.0 96.8 3.7 0.9 17.1 15.3 120.2 73.6 0.0 58.6 1.2 47.4 35.0 18.9 46.1 20.1 0.1 18.6 0.0 28.6 29.9 0.9 4.4 0.0 6.0 13.9 32.3 28.5 13.2 0.0 3.0 0.0 7.2 1.3 56.4 0.0 0.1 13.3 60.8 8.2 0.0 0.4 29.1 260.4 68.8 30.7 11.4 66.5 136.4 17.1 11.6 67.8 4.3 0.0 3.0 34.2 0.4 36.9 0.8 0.4 0.2 3.4 0.1 8.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 39.5 42.1 40.7 40.0 37.6 39.7 54.6 44.0 33.3 41.3 44.4 50.0 38.1 0.3 64.1 72.3 162.2 1.3 11.9 14.7 6.0 1.8 1.4 35.7 25.7 1.8 34.3 42.1 58.8 91.8 11.6 0.6 17.9 13.7 44.9 0.4 81.8 10.8 1.3 7.8 0.0 50.1 40.5 2.3 5.3 15.3 149.2 1.3 5.6 1.1 16.9 1.3 0.0 27.9 7.8 6.1 0.6 1.1 0.1 1.2 4.2 10.6 8.4 1.1 18.1 0.0 17.6 1.9 73.1 10.9 0.7 0.1 38.8 18.9 61.8 36.7 9.1 0.0 0.2 5.6 0.3 5.0 7.3 13.9 18.2 2.1 2.5 12.2 16.5 MACROH2A1 "H2AFY, macroH2A1.2" ENSG00000113648 "MacroH2A.1 histone" O75367 5 135333900-135399914 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041189, HPA050962" Supported Supported Nucleoplasm NA NA 2700000 Nucleoplasm "HPA041189: AB_2677357, HPA050962: AB_2681292" "unprognostic (1.05e-1)" "unprognostic (3.63e-2)" "unprognostic (1.60e-3)" "unprognostic (2.78e-2)" "unprognostic (1.27e-1)" "unprognostic (7.88e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (3.17e-1)" "unprognostic (3.34e-2)" "unprognostic (2.53e-3)" "unprognostic (9.43e-2)" "unprognostic (2.21e-1)" "unprognostic (8.89e-3)" "unprognostic (8.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" 60.2 59.2 45.0 97.9 46.4 250.0 56.2 48.0 49.4 59.1 52.6 112.5 116.0 48.5 49.5 147.3 62.0 71.3 56.2 45.9 51.2 50.0 50.9 73.3 127.1 46.2 48.2 44.1 39.6 31.5 86.3 57.7 79.4 48.9 54.6 119.8 115.1 65.1 36.6 91.5 96.4 118.4 61.9 49.9 75.8 82.0 26.2 48.6 221.4 53.7 74.0 132.0 100.5 76.8 52.5 303.5 208.8 314.9 217.5 144.5 85.6 282.8 124.2 133.1 215.8 151.8 331.3 295.6 356.5 206.5 101.2 182.8 200.7 239.2 526.1 160.8 194.4 237.7 426.3 227.7 226.0 105.7 205.0 179.7 91.3 140.0 180.5 192.3 132.0 140.6 239.0 150.9 142.4 124.4 264.5 594.1 388.7 123.7 359.4 110.5 528.3 179.2 252.5 270.7 339.4 441.1 277.6 241.8 232.2 204.4 164.2 275.8 558.0 114.7 188.1 158.2 140.1 259.1 67.9 296.2 334.5 157.0 455.0 135.5 16.1 178.7 84.3 40.3 122.6 34.0 47.2 51.1 49.8 203.0 67.8 49.2 40.4 93.2 87.8 80.1 147.2 65.3 138.4 45.0 46.4 48.0 49.4 45.9 51.2 46.2 48.2 44.1 48.9 49.9 48.6 52.5 57.6 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.0 151.6 38.3 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 148.8 30.4 0.0 0.0 0.0 0.0 0.0 0.0 419.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 183.5 5.8 0.0 0.0 0.0 TCERG1 "CA150, TAF2S, Urn1" ENSG00000113649 "Transcription elongation regulator 1" O14776 5 146447311-146511961 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064854, HPA069752, HPA069808" Supported Enhanced Nucleoplasm NA NA 17000 Nucleoplasm "HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204" "unprognostic (2.73e-1)" "unprognostic (5.11e-2)" "unprognostic (1.27e-3)" "unprognostic (8.58e-2)" "unprognostic (1.32e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (1.07e-1)" "unprognostic (3.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (4.70e-11)" "unprognostic (1.52e-2)" "unprognostic (7.76e-2)" "unprognostic (3.98e-2)" "unprognostic (1.24e-3)" 11.7 8.7 7.0 15.6 6.4 28.3 12.1 8.3 10.3 11.5 4.7 12.1 10.6 13.4 6.4 13.2 12.6 7.3 9.9 6.4 5.1 7.0 6.8 10.6 17.8 6.0 5.7 5.4 13.9 9.1 8.9 11.4 12.5 6.1 10.5 10.9 17.0 11.0 8.5 23.8 13.2 11.3 10.5 4.4 12.1 11.8 10.4 5.7 19.2 10.1 13.8 17.2 12.5 12.4 9.2 51.7 37.6 56.6 39.1 15.2 23.9 72.0 38.0 30.6 42.1 48.8 61.0 53.8 89.0 27.8 31.7 30.0 44.6 70.1 48.1 63.8 52.6 56.3 58.1 43.4 37.4 16.3 87.8 43.5 16.8 28.0 40.8 43.7 23.0 37.3 73.5 69.4 31.9 32.2 36.8 76.8 49.3 56.3 29.2 42.3 74.3 66.9 58.7 26.3 40.2 36.8 45.6 42.7 44.6 28.3 34.1 47.5 43.9 42.2 36.3 42.1 31.0 60.2 32.4 38.3 116.8 33.7 73.0 41.3 0.9 5.7 2.5 5.7 8.8 6.9 5.5 6.6 7.2 9.7 5.5 6.8 6.8 0.5 9.5 11.9 4.9 6.5 5.3 7.0 6.4 8.3 10.3 6.4 5.1 6.0 5.7 5.4 6.1 4.4 5.7 9.2 35.8 54.5 49.8 50.6 49.5 44.9 49.5 35.6 54.7 54.1 32.4 33.1 35.6 14.3 39.9 23.9 62.6 48.6 42.9 20.8 1.9 31.9 3.2 23.8 62.1 37.6 28.2 77.0 100.9 33.4 60.7 43.3 56.6 44.1 37.9 57.4 21.4 17.6 30.8 35.3 91.0 36.9 24.4 28.9 30.4 7.4 28.6 36.5 24.9 42.2 33.1 20.8 35.0 73.4 76.3 44.9 25.3 24.5 61.9 60.7 13.8 7.6 33.8 38.4 19.7 53.2 51.1 73.3 60.8 66.6 45.7 43.9 42.8 43.7 47.5 62.2 DPYSL3 "CRMP4, DRP-3, ULIP" ENSG00000113657 "Dihydropyrimidinase like 3" Q14195 5 147390808-147510068 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0" "Cancer enhanced" "Detected in all" "glioma: 109.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 685.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010948 Approved Approved Cytosol NA NA 740000 Cytosol "HPA010948: AB_1847245" "unprognostic (3.92e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-3)" "unprognostic (1.39e-1)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (5.99e-2)" "unprognostic (6.92e-2)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.87e-9)" "unprognostic (1.14e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.23e-4)" 58.9 18.8 75.3 54.8 63.9 0.8 37.9 66.3 55.7 65.7 32.2 104.1 18.6 120.9 74.6 69.6 64.0 65.7 45.7 59.2 122.6 7.6 4.4 45.6 18.3 126.2 74.3 53.7 88.7 5.5 2.7 12.8 19.9 81.5 105.5 38.0 165.2 24.7 163.6 69.3 21.7 43.6 219.6 114.2 26.6 41.2 20.1 84.3 7.1 22.6 36.3 27.2 119.0 51.0 111.4 0.5 36.1 63.9 0.1 2.3 63.3 1.6 34.1 163.0 71.4 94.4 114.5 3.1 0.0 9.6 100.1 37.4 3.7 13.1 1.4 79.1 16.3 29.2 0.1 30.0 0.2 63.1 0.3 0.2 12.2 0.6 153.8 60.3 178.7 206.9 0.0 0.0 1.3 41.1 0.3 0.2 0.6 135.9 0.2 53.7 0.2 135.1 0.5 63.0 14.2 47.1 685.4 0.3 0.3 10.8 87.9 0.5 1.0 91.1 51.6 38.5 127.0 127.3 113.9 21.7 0.2 47.5 1.4 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.3 63.9 66.3 55.7 59.2 122.6 126.2 74.3 53.7 81.5 114.2 84.3 111.4 59.9 0.0 2.8 101.5 0.0 9.4 3.4 1.5 2.2 14.2 8.1 6.6 7.8 1.5 4.0 0.0 331.5 0.1 0.0 0.2 0.0 9.1 16.8 0.3 4.6 62.6 6.6 0.0 11.3 8.4 0.3 79.8 3.1 1.2 1.3 261.9 57.8 0.4 1.6 5.0 12.9 0.2 24.4 1.2 11.9 19.2 42.9 3.1 19.6 5.6 0.0 28.3 0.0 83.9 0.7 13.7 0.0 205.7 0.3 10.1 0.0 0.1 2.8 125.0 0.0 23.6 40.9 1.8 3.2 3.7 8.2 0.4 1.5 49.6 0.3 4.5 SMAD5 "Dwfc, JV5-1, MADH5" ENSG00000113658 "SMAD family member 5" Q99717 5 136132845-136188747 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 91.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 91.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058931 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058931: AB_2683856" "unprognostic (6.04e-2)" "unprognostic (4.16e-2)" "unprognostic (9.99e-3)" "unprognostic (3.23e-1)" "unprognostic (5.98e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (9.49e-2)" "unprognostic (4.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-1)" "unprognostic (3.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.40e-3)" "unprognostic (3.22e-1)" "unprognostic (5.95e-2)" "unprognostic (2.15e-1)" 18.2 13.8 10.6 11.0 16.0 10.2 17.8 34.1 14.3 18.7 10.4 14.3 12.9 26.0 14.5 17.0 16.7 14.3 15.1 7.8 13.5 15.5 20.5 13.1 11.7 13.2 13.6 5.6 30.0 13.4 21.3 7.3 25.1 15.2 17.5 16.9 15.8 13.3 16.5 15.0 27.5 11.9 20.3 13.1 15.0 14.3 11.8 12.7 11.4 17.5 21.8 13.6 14.4 15.7 18.9 36.1 30.0 35.3 31.4 37.3 57.2 37.4 48.2 34.0 32.7 48.3 134.1 25.4 39.1 39.8 38.1 33.5 32.0 42.0 56.0 51.9 16.8 26.6 25.7 32.8 24.4 31.0 15.9 26.9 43.2 32.6 50.8 34.2 32.9 40.2 19.3 25.6 26.1 35.0 14.1 13.2 16.2 21.1 12.5 14.8 27.2 68.2 23.1 18.9 37.2 31.8 33.1 42.3 11.0 41.2 42.3 24.6 19.2 46.3 48.1 30.0 35.5 48.5 29.8 37.9 48.3 31.0 19.9 37.6 91.6 12.8 29.3 14.4 8.4 11.2 14.2 8.4 9.7 13.3 14.8 2.6 8.6 2.1 20.8 10.1 15.5 2.6 5.8 10.6 16.0 34.1 14.3 7.8 13.5 13.2 13.6 5.6 15.2 13.1 12.7 18.9 95.8 41.7 32.4 34.3 24.1 46.4 38.6 31.1 79.6 29.2 36.1 46.9 38.3 42.9 36.3 31.3 20.9 19.8 25.8 19.7 23.5 24.5 25.7 32.7 80.9 57.5 99.8 17.2 27.2 26.6 12.1 63.9 41.8 38.5 8.8 62.1 53.9 61.3 14.0 52.2 36.3 36.6 22.4 33.7 21.7 24.1 70.8 21.6 21.4 52.5 20.2 50.1 25.7 45.2 57.1 31.5 21.7 72.6 40.5 48.1 10.3 43.9 32.2 27.7 46.0 87.4 58.2 23.3 23.6 66.4 50.6 11.8 18.2 68.7 30.6 35.9 CSNK1A1 "CK1, CK1a, CK1alpha, CKIa, CKIalpha" ENSG00000113712 "Casein kinase 1 alpha 1" P48729 5 149492982-149551471 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 847.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016680, HPA051334" Uncertain Approved Cytosol NA NA Cytosol "CAB016680: AB_1614518, HPA051334: AB_2681446" "unprognostic (4.27e-3)" "unprognostic (5.85e-3)" "prognostic favorable (1.15e-4)" "unprognostic (7.39e-2)" "unprognostic (2.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.27e-2)" "unprognostic (5.56e-2)" "unprognostic (4.38e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (5.47e-2)" "unprognostic (1.56e-1)" "unprognostic (7.92e-2)" "unprognostic (4.41e-2)" "unprognostic (6.28e-3)" "unprognostic (6.92e-2)" 77.7 68.3 56.0 67.9 54.6 212.7 98.8 63.5 52.8 68.5 63.3 74.8 57.1 74.3 60.7 143.7 57.1 80.4 88.4 50.8 113.6 50.7 68.7 70.2 60.5 63.4 58.0 43.4 53.7 55.5 100.2 49.2 72.3 57.8 89.1 68.9 58.2 71.9 69.9 105.0 122.4 63.6 83.7 64.3 61.2 74.2 46.0 58.9 81.8 77.5 60.0 82.5 95.7 83.0 70.0 154.4 106.4 151.0 144.1 143.6 191.4 185.0 189.7 176.8 146.0 153.5 194.1 187.0 71.6 221.3 183.3 140.7 153.9 101.2 292.5 184.1 124.6 78.0 96.9 96.6 87.8 143.1 163.9 148.4 158.5 313.4 148.1 269.0 163.9 184.7 137.2 102.2 116.0 140.7 104.4 152.2 66.6 71.4 167.6 247.3 129.0 96.1 98.9 112.3 248.3 123.5 110.5 151.1 193.3 200.8 135.6 194.1 134.4 164.6 168.6 83.6 118.2 197.1 117.0 149.2 100.6 169.2 95.6 216.9 106.0 72.6 66.6 47.5 68.9 51.6 50.2 58.1 49.7 80.0 39.9 61.4 55.2 61.1 63.7 67.8 47.4 76.7 94.7 56.0 54.6 63.5 52.8 50.8 113.6 63.4 58.0 43.4 57.8 64.3 58.9 70.0 169.7 147.4 176.7 137.1 101.8 684.5 583.1 270.0 187.8 135.8 257.0 158.4 63.5 90.1 298.1 115.8 64.6 171.2 135.6 126.8 92.0 167.1 95.7 195.8 193.5 191.1 129.9 146.7 108.4 184.1 223.7 159.8 124.4 285.2 117.6 114.0 216.4 108.9 136.1 151.4 115.4 141.9 154.6 167.8 311.5 87.5 104.1 183.8 152.9 119.0 156.6 156.9 108.1 168.4 198.1 197.2 113.9 111.7 105.4 368.6 120.4 102.8 276.7 109.6 157.8 190.2 216.1 181.9 88.9 272.4 847.7 350.9 133.5 177.0 115.7 485.2 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "parathyroid gland: 117.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli NA NA Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 13.8 17.1 10.1 9.6 11.2 20.1 17.5 9.8 11.9 14.2 12.8 10.9 8.0 14.3 15.4 10.7 14.7 12.5 11.8 10.7 13.0 13.5 13.6 16.7 11.9 10.1 11.2 10.2 15.4 13.7 117.9 17.2 12.6 10.5 20.4 11.1 11.7 13.4 12.6 14.7 14.9 11.7 11.5 10.1 16.2 14.2 14.4 12.2 15.1 16.1 13.4 12.1 12.5 11.9 11.9 23.5 27.2 19.4 30.6 27.2 22.6 32.8 22.2 41.1 33.0 41.7 39.7 28.5 22.3 25.4 31.3 70.7 17.0 36.9 39.9 29.0 20.9 26.0 19.4 30.8 20.1 38.3 38.0 42.8 30.1 29.3 48.9 39.1 42.6 24.5 17.8 26.2 23.2 36.4 19.5 23.5 20.9 14.4 16.1 41.2 20.6 26.1 21.9 20.8 29.6 24.1 24.6 19.3 48.2 51.4 16.8 22.3 25.6 20.5 49.3 21.0 24.2 42.2 27.0 27.0 31.5 57.2 29.2 26.0 3.5 2.5 2.3 3.3 3.1 2.6 3.0 2.8 2.4 3.2 2.6 2.1 2.4 0.2 1.2 2.1 2.5 4.4 2.1 10.1 11.2 9.8 11.9 10.7 13.0 10.1 11.2 10.2 10.5 10.1 12.2 11.9 34.8 9.6 12.8 14.0 22.0 11.3 27.0 14.2 17.6 29.5 33.2 26.7 8.0 11.5 17.0 9.2 35.5 16.3 36.1 13.3 21.5 22.2 6.2 47.7 37.5 24.7 15.5 12.8 20.4 21.9 12.6 23.9 30.1 47.5 18.3 36.7 15.0 12.6 27.9 72.3 20.0 12.8 6.1 11.9 13.7 3.1 13.4 18.9 3.6 16.9 23.5 19.8 29.9 15.1 18.5 34.3 8.4 12.4 29.5 41.1 7.4 13.8 24.7 43.1 13.1 23.5 19.5 28.9 24.4 15.6 12.1 15.5 23.3 42.8 15.6 29.4 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834251-172952683 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 247.8;Intestinal goblet cells: 202.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 67.5 149.0 34.3 49.6 32.7 45.3 60.9 44.9 35.2 128.2 28.3 98.6 80.2 68.0 75.9 55.4 73.0 50.6 61.5 36.2 42.5 65.6 194.7 78.5 41.1 43.7 36.8 30.2 57.4 81.3 51.1 48.9 48.3 38.4 148.1 103.7 21.8 98.4 70.5 93.1 45.9 80.1 64.6 33.2 69.8 108.0 25.5 41.0 83.9 75.9 92.7 55.4 58.9 54.7 40.6 120.2 112.8 95.0 211.6 353.3 262.0 51.9 239.5 179.3 105.5 97.4 159.5 120.4 114.8 166.9 406.4 181.7 43.2 68.5 316.8 123.3 92.0 67.5 70.7 156.1 86.1 258.9 33.3 21.6 223.8 128.6 155.8 143.8 173.8 171.0 117.8 42.6 156.8 177.1 150.4 96.5 57.6 56.0 283.7 101.4 327.4 62.9 358.5 245.2 68.6 52.9 96.0 82.7 234.7 120.6 91.1 98.0 37.4 132.4 171.3 69.1 165.9 99.2 246.8 294.0 47.5 236.9 78.3 76.2 3.7 7.5 19.2 3.1 10.5 5.2 9.3 1.6 2.1 6.1 6.2 1.0 2.3 30.6 14.3 14.3 3.1 1.0 5.1 34.3 32.7 44.9 35.2 36.2 42.5 43.7 36.8 30.2 38.4 33.2 41.0 40.6 41.9 57.7 29.5 22.9 62.0 22.8 32.1 22.7 14.8 37.2 51.2 35.1 32.9 68.6 29.4 49.7 16.7 20.7 44.3 83.6 21.5 101.9 11.5 36.2 48.0 33.5 26.0 25.9 35.4 60.8 90.3 47.2 49.5 77.9 23.5 64.4 37.5 247.8 41.1 21.9 41.8 202.9 36.7 77.0 105.2 33.8 65.0 54.8 7.2 30.0 91.1 39.0 36.0 47.7 30.6 86.9 59.3 58.3 96.2 74.2 95.0 38.5 28.4 12.6 39.5 56.1 41.1 1.9 10.5 27.2 26.9 9.0 25.1 103.5 73.3 47.8 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113839-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Sertoli cells: 1288.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "ASC diff: 1350.1;ASC TERT1: 462.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 39000000 Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (8.11e-4)" 149.7 25.3 23.0 27.7 26.1 0.7 107.2 19.3 33.5 153.8 43.1 38.1 12.0 101.9 24.4 24.3 90.4 125.6 66.9 20.9 20.8 49.5 13.5 99.1 27.7 23.1 22.9 19.6 106.4 21.0 22.1 23.1 114.2 25.2 56.7 14.3 6.3 34.8 43.7 38.4 53.4 38.2 69.5 17.3 41.8 28.1 18.6 24.2 8.8 67.0 44.5 13.9 58.8 99.5 20.9 0.1 0.3 8.3 0.4 1350.1 462.7 3.0 48.9 202.3 33.5 56.4 5.4 0.0 0.0 6.4 142.0 19.0 0.1 0.1 0.4 15.8 0.0 0.0 0.1 3.3 3.5 190.7 0.0 0.4 210.0 0.0 46.3 0.6 106.6 0.1 0.1 0.1 5.5 5.5 0.0 0.1 0.6 9.0 0.2 0.2 3.7 2.5 0.2 0.0 0.0 0.1 24.8 0.5 0.1 0.0 38.2 0.1 0.6 0.4 53.7 17.2 23.1 2.8 0.4 0.0 0.3 33.4 0.1 1.5 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.2 23.0 26.1 19.3 33.5 20.9 20.8 23.1 22.9 19.6 25.2 17.3 24.2 20.9 50.8 0.0 1.1 81.9 0.5 24.0 0.5 0.0 2.2 6.6 1.4 3.3 17.3 1.5 0.0 1.8 4.2 0.6 6.0 0.3 0.0 0.8 1.6 2.8 99.5 32.2 0.0 0.0 7.9 0.0 1.1 123.5 2.0 2.3 0.0 2.5 6.4 1.9 1.5 0.0 1.3 0.7 0.0 0.0 35.6 10.9 165.3 3.1 24.9 45.0 0.7 50.7 23.7 10.1 3.3 0.1 0.1 203.8 2.3 0.7 0.3 0.1 0.7 2.9 1288.5 6.6 288.3 1.9 1.6 0.8 15.3 0.8 4.8 4.0 0.4 1.1 CDX1 ENSG00000113722 "Caudal type homeobox 1" P47902 5 150166778-150184558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 132.5" "Group enriched" "Detected in some" 4 "Distal enterocytes: 349.6;Intestinal goblet cells: 193.4;Paneth cells: 295.0;Proximal enterocytes: 196.8;Undifferentiated cells: 312.5" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 125.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+: 6.7;SuSa: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA055196 Enhanced NA NA "HPA055196: AB_2682734" "unprognostic (2.50e-3)" "unprognostic (3.90e-1)" "unprognostic (1.65e-2)" "unprognostic (1.09e-2)" "unprognostic (5.89e-2)" "unprognostic (1.54e-2)" "unprognostic (2.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.59e-1)" "unprognostic (2.96e-1)" "unprognostic (1.83e-7)" "unprognostic (2.10e-1)" "unprognostic (4.25e-1)" "unprognostic (5.42e-3)" "unprognostic (2.16e-3)" 0.3 0.0 0.2 9.7 0.1 0.0 0.7 0.1 0.4 0.6 0.1 132.5 64.5 0.5 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.2 0.1 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 125.5 0.0 0.1 0.6 0.0 0.2 95.3 5.3 0.1 0.1 0.5 2.4 0.2 0.1 0.1 0.0 1.7 0.2 0.4 0.2 0.0 0.0 0.0 0.0 1.0 0.5 0.2 0.0 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 349.6 0.0 0.0 0.1 0.0 0.5 0.1 59.5 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.4 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 295.0 1.5 0.0 0.0 196.8 0.2 0.0 0.0 0.0 0.0 1.6 2.8 15.3 0.0 0.3 0.1 0.8 0.1 312.5 0.0 ATP6V0E1 "ATP6H, ATP6V0E, M9.2" ENSG00000113732 "ATPase H+ transporting V0 subunit e1" O15342 5 172983771-173035445 "Metabolic proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.24e-1)" "unprognostic (3.08e-1)" "unprognostic (3.61e-1)" "unprognostic (1.51e-1)" "unprognostic (5.34e-2)" "unprognostic (1.54e-3)" "unprognostic (2.25e-3)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (6.63e-2)" "unprognostic (1.47e-1)" "unprognostic (8.33e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-1)" "unprognostic (2.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.02e-1)" 243.9 270.1 134.1 160.2 140.8 90.5 225.2 145.7 193.6 215.6 175.9 197.3 128.2 200.8 639.5 230.7 195.0 164.7 263.4 132.4 173.1 340.7 238.9 255.5 193.0 156.3 142.6 126.7 190.9 180.9 147.2 316.6 173.1 152.9 234.2 156.0 46.3 247.0 155.5 226.8 179.5 191.1 159.3 151.6 272.2 235.3 94.1 145.3 131.3 243.2 138.8 189.9 229.1 200.8 157.3 249.4 263.6 85.5 259.5 777.8 310.6 200.6 475.7 444.6 235.3 361.6 299.2 376.6 107.0 663.0 567.4 622.2 174.6 173.4 342.2 260.6 741.8 170.9 100.8 242.1 287.3 379.5 192.9 340.6 413.0 413.3 270.7 149.1 284.0 287.0 116.9 67.3 306.3 519.3 487.6 121.7 278.0 99.2 195.8 228.5 128.8 121.9 193.0 471.5 312.4 123.9 82.8 208.6 255.7 400.5 235.1 282.5 265.5 430.2 553.0 125.9 397.8 405.3 263.2 587.5 120.2 299.5 318.6 185.2 2395.6 1150.2 1781.5 671.3 865.7 620.8 1088.5 761.2 706.6 734.6 951.6 734.7 761.7 2193.1 655.2 852.2 1099.7 853.8 2168.0 134.1 140.8 145.7 193.6 132.4 173.1 156.3 142.6 126.7 152.9 151.6 145.3 157.3 226.2 131.4 226.0 23.5 271.9 293.2 327.6 796.7 177.0 17.7 261.1 275.0 199.9 248.8 444.4 518.6 6.2 492.6 279.9 279.8 324.8 619.5 24.0 296.8 188.8 269.7 213.1 138.2 22.9 366.4 553.7 308.2 112.7 394.7 254.1 217.1 258.5 373.6 720.3 37.0 21.6 206.2 565.6 452.1 606.7 40.8 342.3 439.7 368.2 37.5 897.8 295.3 409.9 22.6 44.8 555.1 375.0 335.9 185.1 463.0 362.9 687.5 332.6 21.5 243.3 110.2 238.4 124.6 138.2 219.4 284.6 842.7 275.9 214.7 205.2 405.9 BNIP1 "Nip1, SEC20" ENSG00000113734 "BCL2 interacting protein 1" Q12981 5 173144442-173164387 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008009, HPA008149" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA008009: AB_1078291, HPA008149: AB_2667993" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (5.89e-2)" "unprognostic (3.08e-1)" "unprognostic (2.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.71e-2)" "unprognostic (1.50e-1)" "unprognostic (7.38e-2)" "unprognostic (2.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.28e-1)" "unprognostic (4.40e-3)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" "unprognostic (5.61e-2)" "unprognostic (3.07e-2)" 8.9 13.1 14.0 6.7 14.0 34.5 11.4 14.3 16.7 8.4 13.3 9.6 8.8 8.4 12.1 10.3 8.9 7.8 11.5 13.9 14.9 12.5 12.7 9.0 10.3 14.5 14.4 13.9 8.7 19.5 11.0 12.4 11.4 14.9 9.2 11.1 12.5 8.9 7.0 13.6 8.3 8.0 9.2 14.0 10.2 10.8 15.1 15.1 12.0 11.0 15.9 9.8 10.4 7.9 14.8 18.2 15.9 18.6 23.2 11.2 26.1 20.7 15.0 23.5 31.4 31.3 27.6 24.3 19.4 17.3 22.5 32.7 14.0 24.4 42.6 31.7 31.8 19.5 17.4 10.6 14.6 29.7 28.1 20.9 14.7 21.1 29.0 36.3 14.8 24.2 27.8 17.1 22.8 25.8 42.3 31.3 24.7 8.2 22.0 18.8 20.4 15.0 23.8 18.0 10.9 23.5 14.6 13.3 16.7 33.5 12.9 28.3 22.1 19.4 26.8 20.0 23.4 30.7 17.3 21.8 30.1 24.8 28.5 17.8 0.1 10.1 4.4 16.9 11.4 14.2 10.5 14.5 12.2 12.6 11.6 12.1 11.9 0.4 11.9 9.8 15.6 14.0 10.1 14.0 14.0 14.3 16.7 13.9 14.9 14.5 14.4 13.9 14.9 14.0 15.1 14.8 9.3 3.2 11.4 2.9 10.9 11.6 10.0 13.4 5.2 13.5 9.4 9.5 5.8 7.2 9.7 5.5 4.2 24.2 15.4 7.4 27.4 14.7 3.4 11.5 11.6 9.1 7.2 2.5 3.9 12.3 20.2 9.0 10.7 14.0 1.3 12.6 6.1 6.7 15.6 10.1 4.7 13.7 2.0 7.1 4.9 6.6 8.7 7.9 3.6 4.7 10.1 12.4 13.4 5.5 8.3 8.8 7.4 11.7 10.8 12.4 9.5 15.7 9.8 11.2 0.0 6.1 9.0 32.4 11.3 10.8 10.9 30.1 11.5 14.0 11.5 9.4 STC2 STC-2 ENSG00000113739 "Stanniocalcin 2" O76061 5 173314723-173328447 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "breast: 145.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 278.3;Breast myoepithelial cells: 119.6;Extravillous trophoblasts: 59.5" "Cancer enriched" "Detected in all" 6 "breast cancer: 91.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 1019.9;T-47d: 940.0;U-138 MG: 382.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA045372 Approved Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA 19000000 "Endoplasmic reticulum" "HPA045372: AB_10961040" "prognostic favorable (7.40e-5)" "unprognostic (2.40e-2)" "unprognostic (9.03e-3)" "unprognostic (1.21e-1)" "unprognostic (1.89e-3)" "prognostic unfavorable (1.76e-6)" "prognostic unfavorable (3.07e-5)" "unprognostic (5.28e-3)" "unprognostic (6.12e-3)" "unprognostic (1.53e-1)" "unprognostic (2.13e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.17e-8)" "prognostic unfavorable (7.57e-4)" "unprognostic (8.56e-2)" "unprognostic (5.06e-2)" "unprognostic (7.93e-3)" 6.4 1.8 1.9 2.4 1.1 0.0 145.1 2.0 3.0 13.3 1.5 4.0 0.6 3.1 0.3 2.0 2.0 6.4 7.7 2.7 1.9 3.6 0.8 11.4 1.1 4.9 2.0 0.4 0.7 32.8 3.4 1.7 28.2 3.7 4.9 0.6 7.7 1.1 6.8 4.4 9.5 2.7 21.4 1.8 11.6 3.4 0.7 4.4 0.2 9.1 4.9 0.3 4.8 3.0 2.8 52.5 15.3 2.7 13.0 47.9 20.5 133.8 234.5 239.4 59.1 115.0 74.4 36.7 0.0 33.4 139.8 298.2 21.5 33.8 72.0 102.5 0.1 18.9 0.0 26.7 50.2 311.3 15.8 4.3 43.6 117.9 133.3 7.9 274.4 16.7 42.4 2.4 0.1 1019.9 41.6 0.7 0.7 7.9 23.4 73.2 0.3 36.5 27.4 0.0 3.9 35.6 9.6 10.3 1.1 42.5 10.4 940.0 15.9 151.5 382.8 1.3 229.1 49.2 42.0 24.3 10.5 74.6 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 2.0 3.0 2.7 1.9 4.9 2.0 0.4 3.7 1.8 4.4 2.8 6.9 0.0 0.0 0.0 0.4 5.0 0.2 4.9 0.6 11.1 278.3 119.6 27.1 0.0 0.6 0.0 0.0 37.0 2.4 0.4 0.0 31.6 0.6 9.5 1.0 25.3 7.2 0.0 0.2 13.1 59.5 16.7 0.0 16.1 0.0 0.0 3.6 0.0 5.2 0.0 0.2 0.2 0.0 0.0 4.8 1.0 23.0 0.5 10.6 1.0 0.0 0.9 0.0 0.0 0.1 7.8 0.0 0.4 0.0 0.8 0.0 4.5 0.2 2.4 0.0 2.3 24.6 0.7 0.8 0.5 6.3 21.9 1.0 0.9 0.4 0.5 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888349-173961980 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 112.1;U-266/84: 173.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favorable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 20.2 66.8 24.3 17.9 30.2 72.7 17.4 45.9 33.7 17.5 39.2 13.0 13.8 12.8 7.0 31.1 10.5 20.2 47.0 24.8 25.0 51.2 79.8 16.7 12.6 26.2 30.1 22.5 10.8 36.9 73.7 12.3 18.4 23.2 12.3 13.2 42.0 23.2 15.5 62.7 11.9 15.3 16.4 24.4 14.8 19.4 15.9 28.7 9.5 33.7 63.0 16.4 22.4 8.9 33.9 12.6 18.4 9.2 5.4 14.0 8.5 16.0 21.5 20.2 7.6 9.3 16.1 8.5 15.9 16.0 12.0 24.5 1.0 7.4 12.6 12.0 32.3 8.4 11.0 42.2 10.9 30.5 4.5 19.4 13.2 24.9 19.6 29.3 32.5 8.5 6.7 33.8 35.5 17.6 8.8 3.7 3.5 4.8 5.3 17.9 3.5 8.5 50.7 10.8 21.6 9.8 10.6 2.5 29.6 39.0 13.7 20.9 7.7 22.6 12.8 6.9 6.5 15.1 112.1 173.8 8.6 28.8 8.1 15.9 0.4 1.1 1.2 0.7 1.1 1.0 1.2 0.9 0.6 0.5 0.9 0.9 0.5 5.7 0.5 1.5 0.5 0.9 0.6 24.3 30.2 45.9 33.7 24.8 25.0 26.2 30.1 22.5 23.2 24.4 28.7 33.9 66.1 76.9 34.3 270.3 39.6 42.4 14.0 23.0 23.3 163.8 80.2 30.0 221.8 97.2 55.2 53.3 135.5 11.5 36.9 68.2 23.5 31.5 67.6 104.4 38.6 54.3 62.7 244.4 190.4 26.5 5.8 26.1 59.1 133.7 90.0 7.6 59.6 144.1 69.2 146.4 163.2 26.8 52.9 109.9 95.8 47.8 8.7 87.5 74.7 61.8 50.8 108.6 18.6 322.2 237.5 43.8 59.4 21.4 174.8 43.3 39.4 81.5 74.9 131.3 0.0 49.2 47.7 55.9 19.9 45.6 51.3 62.0 26.9 36.6 21.3 64.4 HRH2 ENSG00000113749 "Histamine receptor H2" P25021 5 175658030-175710756 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 26.2;Excitatory neurons: 62.2;Inhibitory neurons: 19.1;Kupffer cells: 29.4;Macrophages: 36.2;monocytes: 24.3;Smooth muscle cells: 33.6" "Group enriched" "Detected in many" 5 "melanoma: 2.9;renal cancer: 4.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 134.4;neutrophil: 161.7" "Group enriched" "Detected in many" 5 "granulocytes: 161.7;monocytes: 51.6" "Group enriched" "Detected in some" 4 "RPMI-8226: 65.6;SK-MEL-30: 19.2;THP-1: 18.0;U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013770 Approved NA NA "HPA013770: AB_1851086" "unprognostic (8.56e-3)" "unprognostic (1.62e-1)" "unprognostic (6.66e-2)" "unprognostic (5.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (9.93e-2)" "unprognostic (5.76e-2)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (3.71e-3)" "unprognostic (2.01e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-3)" "unprognostic (1.77e-2)" 7.7 1.6 3.3 12.1 11.4 37.4 3.0 1.2 7.6 3.9 1.0 1.3 6.2 2.2 0.9 1.4 2.9 2.5 21.1 5.0 3.2 2.3 1.0 7.2 3.9 5.3 1.7 6.3 1.1 1.5 1.3 0.8 10.3 3.8 4.8 1.1 0.3 1.4 4.7 0.8 1.8 6.4 3.6 1.3 18.1 19.6 0.5 2.2 8.6 1.5 1.5 3.1 4.2 2.0 5.1 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 5.0 2.9 0.0 0.0 7.1 0.0 65.6 0.0 0.3 0.5 0.0 0.0 0.0 19.2 1.7 0.1 18.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.6 4.3 134.4 45.8 52.8 0.2 44.9 0.3 0.0 3.8 1.0 23.5 0.1 7.9 4.8 161.7 2.1 51.6 18.3 3.3 15.3 3.3 11.4 1.2 7.6 5.0 3.2 5.3 1.7 6.3 3.8 1.3 2.2 5.1 1.1 0.0 2.5 1.0 1.0 0.8 0.1 0.0 0.6 9.3 3.7 0.9 26.2 0.0 2.5 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.6 0.1 0.8 1.9 0.0 3.0 62.2 2.4 0.2 3.3 7.1 0.1 2.5 3.0 0.0 0.2 11.8 1.7 19.1 0.6 0.0 29.4 8.5 1.0 0.0 36.2 0.0 10.3 24.3 0.1 0.0 1.5 1.7 0.3 0.0 0.4 0.3 0.2 0.6 0.3 0.7 0.2 0.0 0.1 33.6 0.2 0.9 0.1 0.3 0.0 4.7 0.1 0.5 0.0 DBN1 D0S117E ENSG00000113758 "Drebrin 1" Q16643 5 177456608-177474401 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 87.1;Pancreatic endocrine cells: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051452, HPA056940" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA 2000000 "Plasma membrane, Actin filaments" "HPA051452: AB_2681489, HPA056940: AB_2683279" "unprognostic (3.81e-2)" "unprognostic (6.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.57e-3)" "unprognostic (9.32e-2)" "unprognostic (5.68e-2)" "unprognostic (2.01e-3)" "unprognostic (4.29e-2)" "unprognostic (1.73e-2)" "unprognostic (7.92e-2)" "unprognostic (2.94e-2)" "unprognostic (3.64e-1)" "prognostic favorable (8.28e-4)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-3)" 50.5 9.4 43.1 17.8 44.4 6.4 36.9 18.7 70.2 59.6 17.5 52.2 9.6 85.1 10.3 31.2 45.1 24.6 37.4 68.9 39.6 35.9 4.0 24.9 9.1 31.5 23.3 44.6 35.1 17.1 17.3 46.1 7.1 33.1 30.0 5.9 5.5 33.4 24.1 27.8 31.6 25.2 28.9 20.4 14.3 47.8 27.2 31.2 14.8 33.7 9.1 4.5 61.5 33.4 34.1 17.4 56.1 182.0 319.1 42.4 66.2 56.5 198.6 50.3 113.4 94.5 193.9 59.0 0.3 139.5 155.1 39.0 27.0 80.9 144.0 53.6 5.2 70.4 111.6 72.9 82.0 149.3 43.0 20.5 87.1 37.1 127.3 38.0 113.3 189.4 131.4 54.0 26.0 84.2 25.1 115.1 63.8 264.1 5.7 123.4 338.1 197.2 34.5 85.3 23.7 213.7 289.8 67.0 28.8 111.5 58.4 78.7 42.6 298.6 126.7 169.3 28.2 94.9 6.3 3.1 177.5 53.2 40.5 80.5 9.4 1.4 1.1 10.3 0.8 14.0 0.3 0.3 7.2 1.8 0.4 0.4 5.2 3.2 0.3 0.8 5.8 0.2 2.2 43.1 44.4 18.7 70.2 68.9 39.6 31.5 23.3 44.6 33.1 20.4 31.2 34.1 44.2 3.2 1.5 8.1 1.2 10.3 13.7 24.6 9.1 7.0 7.6 9.1 5.1 2.8 11.1 9.2 4.2 1.0 4.5 1.4 1.9 87.1 16.9 8.4 44.0 43.2 40.7 4.8 15.7 43.4 2.8 56.1 11.7 18.4 10.8 49.4 20.7 0.0 1.7 42.1 13.0 2.4 40.7 1.8 8.9 41.6 50.1 6.1 8.8 2.8 2.4 13.4 1.0 5.0 1.0 64.5 0.6 41.0 4.0 16.9 0.6 6.3 5.2 4.5 19.7 10.8 43.4 6.5 26.7 20.1 7.2 0.8 10.4 8.1 3.9 7.5 ZNF346 "JAZ, Zfp346" ENSG00000113761 "Zinc finger protein 346" Q9UL40 5 177022696-177081189 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 31.0;Excitatory neurons: 36.7;Inhibitory neurons: 35.1;Oligodendrocyte precursor cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018485 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018485: AB_1859213" "unprognostic (1.89e-1)" "unprognostic (4.25e-2)" "unprognostic (5.71e-3)" "prognostic unfavorable (9.54e-5)" "unprognostic (9.85e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.88e-7)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (2.13e-1)" "prognostic favorable (1.20e-4)" "unprognostic (5.11e-2)" "unprognostic (7.86e-2)" "unprognostic (8.60e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (1.44e-2)" 5.9 8.2 8.2 5.0 8.1 6.4 6.4 12.7 10.1 9.7 5.7 6.7 4.7 8.5 7.8 8.6 8.5 4.6 7.0 7.9 6.5 7.4 7.3 5.4 7.9 6.0 5.5 7.6 13.5 8.0 7.3 10.5 5.1 8.1 8.4 5.2 11.2 6.5 7.2 8.1 7.8 6.2 9.1 3.8 8.1 6.2 9.7 7.1 10.2 10.5 6.5 9.6 7.4 7.8 6.9 6.5 11.7 18.7 25.4 9.6 8.7 16.1 11.3 11.5 17.8 19.7 14.8 9.8 17.1 12.5 10.8 15.3 8.5 17.7 18.0 16.9 54.3 14.1 11.1 13.7 13.2 11.5 18.0 10.2 9.7 10.1 16.9 12.3 10.5 20.8 18.4 13.4 10.2 8.2 21.8 25.2 9.6 8.2 8.1 19.0 25.6 12.9 7.8 12.4 7.6 24.0 10.3 13.9 10.3 8.9 9.0 14.5 10.0 11.0 14.4 11.5 10.0 12.3 9.6 10.6 18.5 5.7 16.1 11.8 0.8 4.0 6.6 8.2 4.0 5.3 5.3 5.8 5.4 4.2 8.4 7.2 7.4 4.2 18.3 4.0 3.9 6.4 4.9 8.2 8.1 12.7 10.1 7.9 6.5 6.0 5.5 7.6 8.1 3.8 7.1 6.9 5.2 0.0 6.0 31.0 7.1 2.9 2.9 4.3 8.0 11.4 4.3 5.3 4.1 7.2 3.2 5.5 6.2 9.5 3.3 2.6 9.8 6.0 2.4 3.6 7.5 7.7 4.8 15.2 36.7 5.8 5.8 5.9 1.5 3.2 2.5 9.6 4.2 2.9 5.7 8.4 35.1 4.1 8.2 2.9 1.7 5.4 5.0 3.1 3.6 12.2 3.5 7.8 1.0 29.1 20.9 4.0 2.2 6.4 8.6 1.0 4.7 4.1 1.1 6.0 0.0 6.1 5.8 12.9 10.9 5.5 4.8 3.3 6.7 10.1 3.2 1.4 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810519-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.6;pituitary gland: 14.8" "Group enriched" "Detected in some" 4 "Excitatory neurons: 54.4;Inhibitory neurons: 19.4;Muller glia cells: 13.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 86.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA071450: AB_2686397" "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.4 7.6 10.2 0.3 13.5 0.5 0.8 2.1 30.6 0.3 0.0 0.1 0.4 0.4 0.2 0.1 0.6 0.2 0.2 16.0 2.3 0.1 0.1 0.3 0.9 2.6 0.8 12.8 0.1 1.8 0.0 14.8 0.0 4.1 0.2 0.0 3.1 2.6 0.0 0.0 0.4 0.1 0.1 0.0 0.1 1.0 0.7 1.2 0.1 0.5 0.0 0.0 0.2 0.1 11.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.1 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.4 3.5 0.0 0.0 0.0 2.5 10.1 0.0 86.4 3.9 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.2 13.5 2.1 30.6 16.0 2.3 2.6 0.8 12.8 4.1 0.0 1.2 11.1 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.7 0.6 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.1 0.9 0.0 0.0 54.4 0.0 0.0 0.0 0.0 1.6 0.0 2.0 0.0 0.0 0.0 5.0 19.4 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 4.7 0.0 13.9 0.0 7.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EHHADH ECHD ENSG00000113790 "Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase" Q08426 3 185190624-185281990 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 11 "kidney: 145.7;liver: 347.3" "Group enriched" "Detected in many" 10 "Hepatocytes: 289.0;Proximal tubular cells: 147.1" "Group enriched" "Detected in all" 7 "liver cancer: 42.2;renal cancer: 25.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036401, HPA042021" Enhanced NA NA "HPA036401: AB_10670165, HPA042021: AB_2677801" "unprognostic (1.20e-1)" "unprognostic (5.99e-2)" "unprognostic (2.17e-3)" "unprognostic (2.69e-2)" "unprognostic (6.82e-2)" "unprognostic (1.48e-1)" "unprognostic (4.79e-3)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (3.89e-2)" "unprognostic (3.19e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-5)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.96e-2)" "unprognostic (2.80e-1)" 10.9 4.3 2.1 3.0 2.9 1.2 4.2 4.1 2.7 3.6 8.0 14.3 21.7 2.8 3.5 5.6 3.6 4.5 10.8 2.1 3.8 145.7 347.3 4.4 2.1 3.1 3.7 1.7 2.7 10.0 7.8 1.5 3.2 2.9 6.3 10.9 1.6 5.8 2.2 1.7 4.6 13.0 3.7 2.5 3.7 10.5 2.8 3.2 2.1 6.5 5.7 2.9 3.6 2.1 3.0 12.3 5.0 1.4 0.0 7.3 6.1 1.5 5.7 1.8 3.7 4.1 21.9 7.5 0.0 22.1 5.7 1.4 5.8 0.0 4.8 7.6 16.2 5.2 8.6 1.3 22.5 4.7 1.0 0.2 8.7 6.0 3.7 3.4 5.0 5.5 0.0 5.7 6.1 7.2 6.4 0.2 5.1 3.0 4.3 6.3 0.0 9.9 0.5 15.4 6.8 4.4 6.4 11.2 6.4 10.5 12.1 23.7 10.1 2.6 2.4 3.6 1.9 0.5 1.7 5.6 0.5 0.8 3.9 4.0 0.1 0.9 0.0 0.6 0.8 0.4 0.5 0.4 0.9 2.4 0.0 0.6 1.0 0.0 1.2 0.8 1.0 0.6 0.4 2.1 2.9 4.1 2.7 2.1 3.8 3.1 3.7 1.7 2.9 2.5 3.2 3.0 4.9 16.0 10.9 20.9 4.5 1.5 1.4 1.9 1.2 0.7 3.2 2.3 19.2 17.2 3.9 20.2 4.2 8.9 0.4 17.8 19.6 2.1 0.2 6.5 5.1 3.9 7.7 9.7 4.9 6.8 2.9 1.6 8.6 3.1 0.0 6.1 13.6 289.0 4.4 0.0 5.7 12.8 0.0 10.5 1.0 0.7 0.6 2.7 3.6 4.7 9.4 1.9 0.0 3.5 8.0 3.7 9.3 0.4 0.8 2.5 15.0 147.1 4.0 1.2 0.0 1.1 2.4 3.7 4.2 4.9 0.4 1.4 2.2 3.6 10.8 1.8 CNTN3 "BIG-1, PANG" ENSG00000113805 "Contactin 3" Q9P232 3 74262568-74521140 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.1" "Group enriched" "Detected in many" 7 "Excitatory neurons: 274.0;Inhibitory neurons: 195.1;Oligodendrocyte precursor cells: 228.7" "Cancer enhanced" "Detected in many" "prostate cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BJ: 7.1;fHDF/TERT166: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003341 Approved "Intracellular and membrane" NA NA 130000000 "HPA003341: AB_1078556" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (2.35e-3)" "unprognostic (9.86e-2)" "unprognostic (1.82e-2)" "unprognostic (1.94e-5)" "unprognostic (4.25e-2)" "unprognostic (2.13e-3)" "unprognostic (8.42e-2)" "unprognostic (3.85e-2)" "unprognostic (1.50e-1)" "unprognostic (7.25e-2)" "unprognostic (9.30e-7)" "unprognostic (4.23e-2)" "unprognostic (1.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" 1.8 3.0 6.7 0.4 8.4 0.0 1.4 0.5 11.1 2.4 0.8 3.2 0.4 0.9 1.7 0.4 7.6 2.1 1.6 7.1 3.5 3.7 3.1 0.8 0.1 2.7 1.9 10.4 1.3 2.0 0.2 4.0 0.1 3.0 5.8 2.8 1.3 0.8 4.3 0.2 0.6 0.5 0.4 0.0 1.9 1.4 0.7 2.1 0.9 1.6 0.2 0.5 4.3 0.5 6.9 0.0 0.0 0.6 0.0 0.0 0.1 0.0 7.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.4 0.0 1.4 0.0 0.1 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.4 0.5 11.1 7.1 3.5 2.7 1.9 10.4 3.0 0.0 2.1 6.9 0.2 3.2 1.7 21.9 0.0 0.6 0.8 0.3 0.0 6.2 2.2 1.3 3.5 10.0 4.2 9.2 0.0 0.0 0.0 3.3 1.9 1.9 2.9 32.7 1.8 0.7 1.2 0.0 274.0 0.5 0.0 4.5 0.0 10.8 0.0 0.4 5.7 6.6 0.1 21.9 195.1 6.4 0.0 0.0 2.1 1.8 0.0 0.1 0.0 3.7 0.0 0.2 0.0 228.7 9.8 0.9 3.9 0.0 0.0 4.0 0.6 7.4 4.8 0.9 0.0 2.3 0.9 0.1 1.1 0.0 0.3 0.0 0.5 0.1 7.1 1.9 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434954 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 61.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 305.8;Spermatocytes: 339.8;Spermatogonia: 239.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 74.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" NA Yes 25000 "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (4.20e-5)" "prognostic unfavorable (9.00e-4)" "prognostic unfavorable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 6.8 6.6 1.1 21.4 1.9 36.6 6.9 1.2 1.4 6.4 1.9 13.3 14.2 7.5 2.3 23.7 4.6 7.7 7.3 0.8 2.4 5.9 7.8 11.9 37.4 1.9 1.4 0.9 5.9 7.9 3.8 2.0 16.3 1.8 5.9 15.0 7.7 4.6 5.1 3.7 11.1 15.5 10.2 1.3 14.8 11.9 32.8 1.7 61.1 9.1 6.8 31.9 9.7 4.3 3.2 386.3 72.8 155.0 73.0 31.5 30.9 72.1 181.2 88.8 206.0 176.8 94.4 209.7 236.6 101.9 81.1 140.0 212.5 183.0 95.0 332.4 297.9 113.8 234.7 123.3 33.6 17.3 158.3 182.6 14.6 13.3 114.4 96.5 78.5 94.8 103.2 130.3 272.2 133.9 78.3 183.2 44.4 91.8 106.7 149.3 180.1 238.8 177.3 43.4 54.8 93.7 94.0 141.4 135.1 65.5 76.6 156.9 128.6 84.8 132.2 105.2 119.9 349.8 181.1 192.2 412.0 96.7 166.9 151.9 74.4 6.0 23.6 11.5 8.9 11.4 17.2 18.2 14.3 6.6 15.0 11.4 10.2 10.8 15.3 15.9 11.7 30.3 9.5 1.1 1.9 1.2 1.4 0.8 2.4 1.9 1.4 0.9 1.8 1.3 1.7 3.2 24.6 105.8 174.0 3.9 43.7 40.8 18.2 33.1 30.7 14.9 21.5 21.0 41.3 25.8 35.0 35.0 8.4 74.6 54.4 41.4 3.9 20.9 48.6 35.2 27.0 44.8 30.1 305.8 3.5 14.7 138.1 50.7 32.6 36.1 79.1 77.3 38.2 20.4 61.3 0.0 2.9 44.5 24.4 29.7 43.5 28.3 25.1 36.4 17.8 17.8 39.3 9.3 46.4 3.5 30.1 13.5 26.5 48.2 95.9 14.1 25.9 8.6 25.4 25.8 131.5 21.7 73.2 339.8 239.4 58.1 35.7 34.1 58.4 34.6 69.7 19.1 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884417-53891962 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "basophil: 471.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 471.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 36.8 52.3 54.2 27.2 55.9 70.7 36.2 57.2 68.4 30.0 55.0 35.7 23.5 29.4 65.0 28.0 34.2 23.6 79.8 53.9 57.5 42.1 74.8 38.7 23.9 57.1 56.2 53.2 49.0 52.2 56.2 63.3 26.7 57.1 34.9 29.6 87.3 30.0 28.8 87.4 23.7 30.6 18.9 58.1 32.5 39.9 32.2 55.8 26.9 43.4 61.8 29.6 35.8 26.3 60.5 22.4 14.9 34.3 23.3 52.1 32.8 36.8 32.0 40.5 43.4 48.9 33.4 33.1 33.8 13.8 23.4 48.7 13.8 40.7 24.5 37.8 59.6 50.3 21.1 61.4 77.6 49.1 28.3 48.6 19.8 40.3 30.1 39.4 25.2 35.3 25.1 20.1 86.3 38.5 24.7 18.5 33.5 33.4 27.5 55.1 11.5 20.9 61.9 51.3 37.1 17.5 49.5 21.9 29.4 32.7 37.5 19.6 44.0 20.6 24.4 28.7 62.2 45.7 62.8 76.3 31.4 36.8 37.3 38.2 471.4 41.7 110.7 69.5 47.2 67.5 60.3 63.0 70.0 36.6 49.0 55.0 63.0 94.1 52.2 56.6 66.3 72.1 82.6 54.2 55.9 57.2 68.4 53.9 57.5 57.1 56.2 53.2 57.1 58.1 55.8 60.5 223.1 134.6 103.9 0.0 173.5 0.0 0.0 0.0 0.0 0.0 233.7 237.5 0.0 0.0 53.9 149.0 0.0 162.3 373.5 0.0 189.8 258.5 0.0 150.1 113.5 62.7 0.0 0.0 0.0 199.6 239.6 86.9 0.0 237.9 237.1 59.1 0.0 0.0 162.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.6 0.0 0.0 74.9 0.0 0.0 0.0 0.0 282.5 0.0 0.0 110.6 0.0 0.0 415.0 53.9 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 350.1 155.9 94.7 0.0 0.0 ACTR8 "ARP8, INO80N" ENSG00000113812 "Actin related protein 8" Q9H981 3 53867066-53882152 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.3;Late spermatids: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 56.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065236 Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA065236: AB_2685442" "unprognostic (9.05e-2)" "unprognostic (2.06e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.97e-1)" "unprognostic (5.67e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (2.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.82e-1)" "unprognostic (5.68e-2)" "prognostic favorable (7.88e-9)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.84e-1)" "unprognostic (1.15e-1)" 8.4 6.9 8.1 9.9 8.9 9.5 9.4 10.8 9.2 9.3 12.2 9.4 7.4 9.9 9.1 9.3 9.0 8.2 18.7 8.4 9.9 13.1 8.8 9.3 14.0 9.6 9.7 7.5 10.4 9.5 14.8 7.3 11.1 9.0 9.1 12.1 7.7 8.8 8.7 9.1 8.8 7.3 11.1 9.3 9.5 9.7 21.7 9.3 13.5 12.2 12.8 14.9 11.6 7.3 10.5 11.9 14.4 27.5 22.9 22.2 27.6 20.6 27.4 34.8 36.3 28.7 22.6 14.1 36.1 7.9 37.9 26.7 9.9 21.0 18.8 34.1 14.7 8.7 35.2 21.9 24.3 26.1 38.6 30.8 21.8 19.1 37.6 23.4 28.0 28.4 18.9 16.4 12.2 37.0 13.8 12.9 23.0 25.7 17.0 22.7 16.8 17.3 21.8 27.5 32.7 8.1 23.5 17.8 15.4 16.1 25.9 9.9 21.1 19.7 27.5 17.8 25.6 25.2 33.9 46.4 36.3 20.4 27.7 17.6 56.2 8.2 10.5 9.2 12.0 9.2 9.8 8.5 8.8 10.7 6.1 8.9 9.6 4.3 15.1 7.4 7.8 15.0 8.0 8.1 8.9 10.8 9.2 8.4 9.9 9.6 9.7 7.5 9.0 9.3 9.3 10.5 6.3 3.2 7.7 6.5 9.4 7.8 6.0 12.3 5.7 6.8 5.4 5.1 19.5 10.0 8.6 3.7 4.2 12.7 11.6 5.7 21.5 15.1 44.3 5.9 12.0 8.8 10.8 7.8 7.1 15.6 11.3 7.8 12.2 7.6 5.7 10.9 8.2 5.4 11.5 1.7 8.5 10.6 12.2 7.6 6.9 85.9 10.8 10.0 5.4 4.7 11.9 7.6 13.4 8.0 6.2 15.5 3.5 9.8 13.6 6.3 5.9 24.1 5.0 5.3 0.0 5.5 20.8 27.6 20.3 7.3 6.5 10.3 11.5 13.5 6.3 6.5 TBCCD1 FLJ10560 ENSG00000113838 "TBCC domain containing 1" Q9NVR7 3 186546067-186570543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.15e-1)" "unprognostic (7.41e-3)" "unprognostic (6.36e-2)" "unprognostic (2.62e-2)" "unprognostic (8.79e-2)" "unprognostic (7.14e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.10e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-3)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (2.27e-1)" 6.7 5.9 5.0 7.6 5.5 7.5 6.7 6.4 5.3 6.3 6.5 6.5 6.5 7.1 7.6 7.8 5.8 6.2 5.4 4.6 5.6 6.2 9.6 5.5 9.5 5.4 5.3 4.5 6.4 7.5 8.6 4.2 7.7 5.8 5.3 7.4 12.6 6.4 5.3 6.1 6.9 6.1 6.4 5.5 6.7 6.2 19.4 5.3 11.0 8.5 7.5 9.3 6.7 6.6 6.9 12.5 8.7 13.8 13.7 11.6 12.4 9.8 9.5 6.9 12.2 12.9 15.3 9.6 15.3 24.5 6.9 9.5 13.2 21.3 9.0 15.6 22.2 10.9 19.5 7.7 9.5 6.6 18.4 12.7 7.4 9.5 10.8 12.5 8.0 17.3 19.9 15.9 14.3 10.8 15.0 17.9 10.6 8.6 28.4 15.1 20.3 13.8 17.1 8.0 7.7 16.2 10.4 17.0 18.9 10.1 10.8 24.7 11.6 10.7 8.4 10.7 10.5 15.0 19.8 36.9 37.0 9.0 16.4 16.5 17.3 9.7 11.7 11.7 9.7 15.3 11.8 12.9 13.2 12.8 11.3 10.2 13.0 4.2 14.6 11.3 7.5 18.0 9.1 5.0 5.5 6.4 5.3 4.6 5.6 5.4 5.3 4.5 5.8 5.5 5.3 6.9 5.6 16.0 3.7 8.5 8.8 6.4 2.8 2.6 9.1 6.5 3.2 2.4 2.6 4.3 1.9 1.8 2.1 4.0 2.9 4.1 11.7 7.1 3.0 3.7 4.9 5.3 3.6 5.9 11.5 6.5 6.0 4.7 12.2 3.5 12.0 4.2 6.8 5.2 4.7 0.0 13.2 6.6 0.0 3.8 6.4 2.8 5.9 4.2 5.4 7.5 4.6 5.2 9.2 12.5 14.1 4.8 5.0 3.8 11.5 2.2 5.4 3.5 7.0 6.7 6.6 4.2 4.8 42.1 20.8 9.7 4.1 4.1 7.2 3.3 5.5 1.9 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498547-119525090 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053214: AB_2682081, HPA055846: AB_2682941" "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 10.6 12.1 14.2 10.8 14.9 6.4 13.2 15.1 15.5 15.1 13.8 11.4 9.0 9.4 18.1 16.1 12.9 14.6 44.4 13.5 15.0 17.9 14.3 11.1 17.8 14.9 14.5 13.2 11.0 11.2 23.3 7.1 17.2 14.6 13.1 13.8 4.2 14.7 19.9 27.5 15.9 7.8 12.2 15.0 10.0 8.5 10.7 15.0 11.5 19.2 49.7 14.9 14.3 7.1 15.5 26.9 24.5 12.4 10.4 45.5 30.6 27.0 7.7 25.3 21.7 24.7 16.7 16.0 19.5 13.7 27.1 15.1 12.2 30.8 24.8 35.0 16.4 10.9 14.4 10.7 18.8 23.9 11.3 9.1 28.0 37.4 18.4 22.4 13.9 31.5 18.5 19.8 18.1 40.3 33.2 12.0 23.7 16.2 22.4 30.1 10.0 8.4 25.4 32.0 13.1 15.8 29.4 7.8 11.8 28.0 16.2 19.5 30.4 16.1 12.2 9.3 11.3 13.8 12.1 11.8 28.3 20.7 28.5 19.6 11.1 17.6 21.3 10.8 17.6 12.5 16.2 10.4 12.0 17.4 17.6 12.2 10.9 4.3 13.1 20.9 15.1 20.7 22.1 14.2 14.9 15.1 15.5 13.5 15.0 14.9 14.5 13.2 14.6 15.0 15.0 15.5 61.2 25.6 39.3 18.6 24.0 37.5 50.4 110.2 31.3 25.0 44.8 55.0 165.3 41.5 63.7 40.5 14.6 157.5 28.9 44.0 150.6 73.2 12.2 39.9 41.1 56.0 28.8 43.1 17.4 62.7 112.7 48.2 29.0 31.1 41.2 34.1 31.8 52.4 86.3 21.9 23.9 43.5 87.5 32.7 40.4 10.0 47.2 39.4 44.4 15.0 65.7 73.6 18.6 22.6 35.6 52.7 40.9 54.5 30.2 43.5 50.5 146.5 63.0 35.4 72.3 43.9 52.5 111.1 58.2 45.9 42.1 177.5 29.7 48.0 45.7 46.7 CRBN "MRT2, MRT2A" ENSG00000113851 Cereblon Q96SW2 3 3144628-3179727 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 314.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045910 Approved NA NA "HPA045910: AB_10960409" "unprognostic (1.26e-1)" "unprognostic (4.14e-2)" "unprognostic (4.27e-2)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (3.31e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" "unprognostic (4.79e-2)" "unprognostic (2.17e-3)" "unprognostic (1.70e-1)" "unprognostic (5.95e-2)" "unprognostic (2.28e-2)" "unprognostic (1.47e-2)" 25.3 21.1 26.9 17.3 30.2 44.4 34.2 34.9 42.8 23.1 43.1 20.5 22.0 26.4 24.1 20.8 21.9 21.2 31.2 30.9 29.8 31.3 35.6 24.7 28.8 33.0 34.3 35.1 32.4 22.1 30.1 11.2 29.7 37.5 23.7 23.2 27.0 36.6 23.8 42.2 25.0 23.0 25.0 31.9 30.8 23.1 48.6 31.6 23.7 32.2 38.8 21.8 20.2 14.7 49.6 12.9 10.5 32.5 14.4 38.8 37.3 13.6 14.3 23.9 18.4 24.6 15.6 18.7 13.9 19.4 17.8 22.3 12.2 19.9 24.1 20.0 24.0 30.9 35.9 20.1 19.4 26.0 32.5 22.4 28.7 31.1 19.9 15.1 36.1 25.2 29.9 21.5 29.4 16.1 18.7 28.6 32.5 27.3 17.8 24.8 25.9 19.5 30.5 21.8 20.0 16.3 23.7 15.9 21.6 35.7 24.1 28.9 24.0 16.3 18.8 9.8 30.0 18.6 33.2 55.8 35.2 29.2 29.5 23.5 314.2 44.3 99.3 61.6 53.6 65.2 46.4 82.6 66.8 39.8 36.9 84.3 72.4 28.1 103.6 58.1 21.4 63.0 96.1 26.9 30.2 34.9 42.8 30.9 29.8 33.0 34.3 35.1 37.5 31.9 31.6 49.6 89.7 44.8 39.1 30.3 46.5 36.1 35.5 70.9 33.0 61.5 30.6 43.4 73.5 38.6 45.2 38.6 27.1 52.6 81.2 21.4 72.4 33.3 184.2 23.9 31.7 72.0 15.6 54.5 72.6 21.2 35.3 47.9 17.3 22.3 140.4 50.2 68.6 35.0 36.0 43.7 74.1 24.6 54.9 52.7 33.4 56.6 62.7 54.8 33.8 28.1 68.8 66.4 121.5 42.7 74.0 20.4 33.5 66.5 34.1 26.0 53.4 73.2 36.4 64.5 59.2 58.0 46.2 206.2 96.2 19.2 38.5 50.2 70.9 49.4 30.5 24.7 KNG1 "BDK, BK, KNG" ENSG00000113889 "Kininogen 1" P01042 3 186717348-186744410 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis, Inflammatory response" "Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 3221.7" "Group enriched" "Detected in some" 25 "Distal tubular cells: 655.4;Hepatocytes: 1816.9" "Cancer enriched" "Detected in some" 126 "liver cancer: 608.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001616, HPA001645, CAB009809" Enhanced "Secreted to blood" NA NA 90000000000 47000000000 "CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215" "unprognostic (3.88e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-1)" "unprognostic (3.27e-1)" "unprognostic (8.30e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.28e-6)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (9.96e-2)" "unprognostic (1.65e-1)" "unprognostic (3.45e-3)" "unprognostic (5.20e-2)" "unprognostic (2.46e-1)" "unprognostic (4.52e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 468.4 3221.7 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.7 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 48.6 0.0 33.1 0.0 0.0 0.0 1.8 655.4 0.0 0.4 0.0 0.0 1.5 0.0 40.2 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 30.0 1816.9 0.1 0.0 0.8 0.1 0.0 47.2 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.5 0.1 1.1 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 2.7 0.0 0.1 0.1 HRG "HPRG, HRGP" ENSG00000113905 "Histidine rich glycoprotein" P04196 3 186660216-186678234 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis" Heparin-binding "Disease variant, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 173 "liver: 5478.2" "Cell type enriched" "Detected in some" 29 "Hepatocytes: 479.7" "Cancer enriched" "Detected in some" 262 "liver cancer: 406.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 2.7;RH-30: 3.0;SiHa: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050269, HPA054598" Supported "Secreted to blood" NA NA 120000000000 28000000000 "HPA050269: AB_2681068, HPA054598: AB_2682539" "unprognostic (2.67e-1)" "unprognostic (1.74e-2)" "unprognostic (7.58e-5)" "prognostic favorable (9.64e-5)" "unprognostic (1.44e-1)" "unprognostic (2.98e-3)" "unprognostic (2.22e-1)" "unprognostic (1.55e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.7 5478.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 3.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 3.7 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.6 0.0 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 479.7 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 BCL6 "BCL5, BCL6A, LAZ3, ZBTB27, ZNF51" ENSG00000113916 "BCL6 transcription repressor" P41182 3 187721377-187745725 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Immunity, Inflammatory response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 489.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "neutrophil: 269.1;non-classical monocyte: 76.4" "Group enriched" "Detected in all" 7 "granulocytes: 269.1;monocytes: 76.4" "Cell line enhanced" "Detected in many" "Daudi: 166.4;HSkMC: 113.9;U-698: 231.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000307, HPA004899, HPA050645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199" "unprognostic (5.36e-2)" "unprognostic (3.29e-2)" "unprognostic (1.63e-3)" "unprognostic (2.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.34e-3)" "unprognostic (2.62e-2)" "unprognostic (3.33e-3)" "unprognostic (8.75e-2)" "unprognostic (2.04e-2)" "unprognostic (1.63e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.27e-9)" "unprognostic (5.22e-2)" "unprognostic (7.82e-2)" "unprognostic (5.67e-2)" "unprognostic (2.58e-2)" 136.0 49.9 53.6 54.4 50.8 124.9 128.0 78.1 55.8 97.6 38.6 66.1 7.6 68.6 16.6 45.0 141.9 46.0 65.6 47.3 99.1 35.6 65.9 111.5 56.4 103.7 55.2 45.0 66.1 49.6 11.4 45.1 15.5 76.0 57.9 10.4 34.5 70.9 22.4 489.9 159.4 34.7 43.4 57.3 107.2 58.9 18.7 65.3 43.6 50.8 97.5 48.1 91.4 82.2 106.9 5.1 13.8 14.4 3.2 98.1 78.0 14.9 16.5 39.2 18.4 19.4 9.4 7.6 166.4 11.5 21.0 11.7 7.7 4.4 10.6 15.3 33.8 5.1 0.2 6.7 22.5 51.5 2.1 0.9 113.9 68.8 22.7 32.9 60.1 10.2 4.2 1.6 27.6 18.2 5.7 5.5 1.3 1.4 3.0 10.3 45.4 7.0 0.8 13.6 23.2 3.1 0.2 18.8 8.1 11.0 30.2 35.3 5.9 21.2 43.7 7.1 16.6 7.5 21.2 7.2 231.6 24.2 6.0 31.7 8.8 33.0 18.9 5.5 37.3 5.4 6.6 3.4 5.0 24.6 15.3 2.1 2.3 269.1 3.9 76.4 4.0 3.1 30.7 53.6 50.8 78.1 55.8 47.3 99.1 103.7 55.2 45.0 76.0 57.3 65.3 106.9 35.7 19.2 67.4 66.0 22.7 47.3 14.7 18.8 205.5 10.9 55.3 54.6 71.4 14.3 28.9 16.5 20.9 1.4 36.0 3.5 0.0 12.2 13.3 36.2 26.7 25.0 4.8 3.2 7.6 12.5 2.7 57.3 12.2 51.4 11.4 9.4 15.0 51.2 11.9 0.0 19.6 2.3 16.2 67.5 74.4 8.6 28.9 48.1 35.6 7.5 16.8 39.1 1.0 50.8 7.8 7.9 0.3 18.8 14.2 27.9 1.2 1.5 29.5 9.7 32.9 77.0 84.9 0.4 1.2 72.4 61.5 4.1 30.0 10.3 2.8 29.7 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628172-120682269 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "kidney: 202.2;liver: 758.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5" "Cancer enriched" "Detected in many" 4 "liver cancer: 119.8" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" NA NA 700000 "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.4 0.3 0.4 2.5 1.2 0.5 12.6 0.5 0.8 27.6 1.2 16.9 31.9 3.2 13.2 0.4 4.2 62.3 0.3 0.5 0.4 202.2 758.9 0.8 0.4 1.1 0.4 0.5 0.2 31.4 7.1 0.2 0.2 0.4 44.9 20.5 0.7 4.3 4.3 0.1 0.6 25.8 0.5 0.4 0.6 25.7 0.1 0.4 0.7 55.6 0.2 0.1 0.2 0.1 0.6 0.0 12.3 4.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 55.8 10.7 0.1 82.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 186.6 0.0 0.4 1.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.3 328.0 0.0 0.1 0.3 0.1 212.2 0.0 0.2 0.2 0.2 0.9 0.0 0.0 0.2 1.0 0.6 0.1 0.9 0.2 0.1 0.0 0.3 0.5 0.2 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.4 1.2 0.5 0.8 0.5 0.4 1.1 0.4 0.5 0.4 0.4 0.4 0.6 0.1 0.0 2.0 0.3 5.9 0.0 0.4 0.6 0.0 0.3 7.5 1.7 0.3 81.5 4.9 27.6 2.1 0.0 0.3 18.5 103.7 7.2 0.2 113.9 17.1 1.2 43.8 24.0 3.2 17.8 0.0 0.4 19.4 127.8 1.3 0.0 16.4 534.7 0.2 0.0 0.6 16.0 2.0 16.1 0.0 0.0 0.0 21.3 0.0 1.9 2.0 4.2 0.0 0.0 0.5 12.1 35.6 0.0 0.0 12.9 54.6 477.5 4.1 0.2 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 3.8 0.4 9.1 0.4 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412138 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 64.2" "Cell type enriched" "Detected in some" 8 "Distal tubular cells: 187.9" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 153 "EFO-21: 691.6;RPTEC TERT1: 233.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.1 0.7 0.3 0.2 0.4 0.0 0.2 0.0 0.5 0.0 1.3 0.0 0.0 0.3 0.6 0.5 2.9 0.7 0.0 0.2 0.3 64.2 2.2 0.4 1.5 0.2 0.2 0.3 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.4 0.9 0.0 3.2 0.0 0.4 0.0 0.1 0.1 0.1 0.2 0.3 9.8 0.0 1.0 0.3 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 691.6 0.0 0.3 0.7 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 233.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 2.2 0.0 0.3 1.4 1.2 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.5 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.2 0.5 0.1 0.0 0.0 0.3 0.0 7.0 5.8 2.6 0.6 0.3 0.8 0.3 0.4 4.3 1.6 9.2 0.0 0.4 0.0 0.0 187.9 3.4 2.0 3.0 0.1 0.2 0.0 0.0 5.0 0.4 0.2 0.9 0.0 0.5 1.3 0.3 0.0 1.6 0.1 3.3 3.6 0.0 0.0 0.3 1.2 0.2 0.0 0.4 5.4 2.8 0.0 0.2 0.0 4.0 0.1 0.5 0.0 0.4 0.0 6.7 0.0 0.9 22.1 0.2 0.0 0.8 0.6 0.3 0.3 0.9 12.6 6.2 0.2 0.2 0.0 3.1 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801229 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 55.0;Inhibitory neurons: 51.5;Rod photoreceptor cells: 57.4;Spermatocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Microtubules NA NA Microtubules "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 3.6 5.3 4.3 2.2 5.4 0.8 3.4 4.8 5.6 3.4 4.0 2.3 1.5 4.5 3.9 3.1 7.3 3.7 3.7 5.8 6.2 7.5 2.6 5.1 2.5 4.3 4.6 4.8 3.5 2.9 12.9 4.1 2.9 4.3 4.0 2.6 46.7 5.9 3.6 1.6 3.1 1.8 4.3 3.9 3.0 2.9 6.7 4.5 2.4 5.6 2.2 2.2 3.2 2.1 5.3 10.1 5.2 4.9 4.1 11.5 7.6 1.3 6.2 5.5 5.6 6.7 2.2 3.6 5.8 6.1 3.1 8.5 4.6 6.1 6.8 10.4 6.3 3.7 1.5 3.9 2.2 5.4 7.6 3.5 4.1 4.9 7.4 1.7 4.5 6.1 7.0 1.8 1.1 8.1 3.1 4.1 3.2 6.1 4.9 7.5 1.9 5.9 4.0 6.5 2.8 26.0 14.4 5.4 3.4 11.2 3.1 4.3 2.4 5.3 5.2 4.7 4.5 8.7 4.2 5.3 6.4 9.5 4.0 6.4 0.2 0.2 0.1 1.0 0.4 2.1 0.8 0.9 1.1 0.4 1.6 1.6 1.3 0.0 1.8 0.5 0.4 1.7 0.7 4.3 5.4 4.8 5.6 5.8 6.2 4.3 4.6 4.8 4.3 3.9 4.5 5.3 3.2 3.2 3.6 31.6 2.2 3.2 3.2 4.8 5.2 12.7 3.2 3.0 2.4 1.5 5.0 9.2 27.1 1.2 0.8 0.6 3.9 3.4 25.7 20.3 4.4 3.7 2.4 2.1 55.0 2.5 2.3 5.1 4.6 2.2 0.0 2.4 4.6 2.9 1.8 5.0 51.5 1.0 6.1 1.3 1.1 5.6 4.1 1.5 1.8 15.0 0.4 8.2 2.1 15.1 27.6 1.7 2.0 4.1 3.7 1.3 0.2 10.1 27.2 57.4 6.6 3.3 4.6 39.6 6.7 4.4 2.0 0.7 2.7 4.6 1.3 2.0 NPHP3 "CFAP31, FLJ30691, FLJ36696, KIAA2000, MKS7, NPH3, SLSN3" ENSG00000113971 "Nephrocystin 3" Q7Z494 3 132680609-132722414 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Ciliopathy, Disease variant, Meckel syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009150 Uncertain NA NA "HPA009150: AB_1078086" "unprognostic (1.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.56e-2)" "unprognostic (2.79e-1)" "unprognostic (2.22e-1)" "unprognostic (8.24e-3)" "unprognostic (2.36e-5)" "unprognostic (8.02e-3)" "unprognostic (6.51e-2)" "unprognostic (1.96e-2)" "unprognostic (9.42e-3)" "unprognostic (2.92e-2)" "prognostic unfavorable (8.28e-9)" "unprognostic (2.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" 7.1 6.1 3.9 4.1 5.6 2.9 7.7 4.0 4.7 8.9 4.7 4.9 3.3 13.0 10.9 4.1 8.2 7.4 5.7 3.6 6.0 4.5 3.0 7.2 5.0 5.2 5.0 3.2 16.1 4.6 3.6 3.6 7.4 5.3 6.9 4.2 3.1 5.3 6.1 3.8 8.0 4.1 7.9 4.4 6.3 4.0 3.4 4.8 3.7 6.5 5.3 2.8 5.4 5.5 8.1 4.7 2.5 12.2 8.3 9.0 15.1 5.6 13.9 11.3 6.3 7.6 3.6 2.1 0.6 6.0 13.9 5.4 4.2 5.1 6.3 7.2 2.6 3.5 3.8 2.9 4.0 9.1 0.7 4.1 12.2 3.8 7.2 10.2 13.5 9.5 2.9 1.8 3.8 18.0 4.4 0.6 4.6 5.9 3.0 3.8 1.5 11.3 5.2 7.9 3.2 0.3 9.3 9.1 2.5 10.5 10.5 3.9 2.2 11.5 9.6 6.2 11.7 5.8 3.1 1.2 1.2 10.7 1.1 9.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.5 0.3 0.1 0.5 0.0 0.7 0.2 0.3 0.0 3.9 5.6 4.0 4.7 3.6 6.0 5.2 5.0 3.2 5.3 4.4 4.8 8.1 25.5 28.9 18.6 0.0 12.4 19.1 15.9 10.5 7.4 20.8 21.5 27.6 20.9 12.8 8.9 16.5 56.3 18.7 13.5 9.4 0.0 6.8 2.4 14.0 20.1 24.7 12.7 7.4 0.0 4.9 11.7 25.2 4.1 11.0 7.6 25.6 52.1 14.6 9.7 26.9 0.0 11.6 4.1 18.5 17.2 4.3 60.0 9.8 14.2 0.0 13.2 13.2 10.3 0.0 0.0 8.1 5.4 40.3 5.6 15.8 14.8 5.2 14.3 34.1 32.9 26.6 20.6 14.1 5.5 6.9 18.8 9.2 14.0 15.1 13.4 9.1 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055362-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2" "Group enriched" "Detected in many" 18 "B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2" "Cell line enriched" "Detected in some" 7 "HDLM-2: 296.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004319, HPA026802" Approved Supported "Plasma membrane,Centriolar satellite" NA NA 160000 "Plasma membrane" "Centriolar satellite" "CAB004319: AB_627200, HPA026802: " "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 7.8 5.4 3.1 34.8 3.7 10.3 4.5 4.0 3.8 3.5 5.7 6.4 3.7 2.4 1.0 4.0 2.1 14.4 2.7 3.0 6.9 2.0 11.3 18.8 29.1 7.1 3.9 2.3 2.1 2.6 2.9 1.2 15.1 6.5 2.4 7.7 0.9 2.3 2.5 0.8 2.0 6.8 7.4 6.0 23.6 5.3 3.1 4.2 10.7 1.3 0.8 22.2 15.0 1.0 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 296.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.2 0.0 32.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.4 0.0 0.1 0.0 0.1 15.1 0.6 35.1 0.0 0.9 0.0 0.1 79.9 0.8 0.0 79.0 0.0 41.0 0.2 0.3 78.8 28.5 0.2 0.1 0.9 3.7 85.2 8.3 1.6 33.4 3.1 3.7 4.0 3.8 3.0 6.9 7.1 3.9 2.3 6.5 6.0 4.2 8.5 0.9 0.0 7.7 0.3 36.5 3.6 0.1 1.3 0.0 0.0 0.4 1.3 0.3 1.5 3.2 1.8 0.0 1.8 3.3 0.0 0.0 0.2 3.7 0.1 0.0 2.6 0.0 1.3 0.2 3.5 0.8 0.8 0.5 0.0 2.5 0.1 1.8 0.8 121.3 0.0 0.3 0.0 0.0 107.8 148.3 2.7 0.0 151.8 7.2 78.7 489.4 0.0 0.0 0.5 0.1 0.3 0.0 0.0 20.6 0.3 0.0 0.1 0.1 0.4 0.0 0.3 0.7 0.2 0.3 0.2 4.0 1.9 2.1 0.1 0.0 0.3 AMOTL2 LCCP ENSG00000114019 "Angiomotin like 2" Q9Y2J4 3 134355347-134375479 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 89.2;Suprabasal keratinocytes: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 259.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063027 Approved "Cell Junctions" NA NA "Cell Junctions" "HPA063027: AB_2684924" "unprognostic (2.23e-1)" "unprognostic (2.55e-2)" "unprognostic (7.01e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (6.09e-2)" "unprognostic (1.57e-2)" "unprognostic (9.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.32e-1)" "unprognostic (3.02e-1)" "unprognostic (2.85e-2)" "unprognostic (1.49e-1)" "unprognostic (8.09e-2)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (3.85e-1)" "unprognostic (1.17e-2)" 72.3 11.2 23.6 7.2 40.7 0.2 56.3 26.4 29.2 30.6 33.8 23.4 7.7 44.6 9.2 37.4 37.8 23.0 24.4 18.5 25.6 25.9 17.3 33.7 12.0 40.4 35.9 14.2 21.7 27.4 9.7 5.8 33.9 43.4 24.8 5.6 5.4 25.3 15.9 17.0 36.9 15.9 16.8 25.5 20.7 23.3 4.2 35.1 4.3 29.7 16.0 7.3 29.3 33.6 72.1 99.1 43.1 29.6 30.9 30.3 37.3 259.9 97.5 54.8 87.6 43.0 132.5 30.3 0.0 119.9 69.4 50.0 72.2 19.4 26.3 39.9 0.2 2.2 0.2 22.7 14.4 56.8 0.2 0.2 53.7 79.5 34.5 39.7 35.1 42.3 0.9 0.7 0.2 59.2 31.7 0.3 0.3 37.9 21.4 16.3 0.2 37.4 0.3 56.4 22.7 4.5 11.7 73.8 94.3 68.8 66.8 88.2 0.8 72.4 59.5 53.2 41.7 59.7 0.1 0.3 0.4 22.1 0.1 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 40.7 26.4 29.2 18.5 25.6 40.4 35.9 14.2 43.4 25.5 35.1 72.1 24.0 60.9 17.3 2.6 0.2 72.9 18.4 15.4 30.1 10.4 29.2 21.5 15.6 52.9 16.4 18.4 18.8 30.4 1.1 6.5 17.6 27.5 4.0 59.7 29.1 30.1 12.5 0.0 4.5 13.1 29.9 30.3 20.4 89.2 1.3 34.1 51.8 25.8 3.0 1.7 5.8 3.6 6.1 1.6 7.8 10.9 35.8 1.7 14.2 9.4 0.0 12.1 0.0 18.6 56.9 52.8 4.2 19.9 0.0 30.0 10.6 19.3 16.2 5.1 13.1 12.1 46.1 0.2 0.6 25.3 130.1 24.8 2.6 8.7 4.5 37.3 NIT2 ENSG00000114021 "Nitrilase family member 2" Q9NQR4 3 100334739-100361635 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 26.6" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 705.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036999, HPA041289" Approved Supported Centrosome,Cytosol NA NA 1700000 Cytosol Centrosome "HPA036999: AB_10672105, HPA041289: " "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.06e-3)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.28e-2)" "unprognostic (2.10e-1)" "unprognostic (4.56e-1)" "unprognostic (1.12e-1)" "unprognostic (6.60e-3)" "unprognostic (2.21e-1)" "unprognostic (6.68e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (8.26e-2)" "unprognostic (1.47e-3)" 4.9 4.0 1.4 1.4 2.4 3.6 6.9 1.5 2.0 3.3 1.5 3.8 2.8 4.1 5.6 4.4 4.1 3.5 4.8 1.6 1.5 18.7 26.6 3.2 2.5 1.0 0.9 1.5 3.3 3.8 3.9 2.7 2.4 1.4 3.6 3.4 3.6 3.8 5.0 10.1 4.9 2.8 3.1 0.9 2.2 4.1 1.2 1.1 2.6 5.9 7.6 3.7 5.2 3.6 1.8 12.3 12.1 1.4 6.2 10.3 14.1 7.4 4.9 7.3 11.5 10.9 10.4 13.7 12.3 7.4 7.2 4.9 9.1 5.4 13.2 13.7 3.8 2.8 9.0 4.1 5.3 12.6 5.9 5.8 8.8 19.9 6.1 10.1 6.0 7.4 6.9 4.2 9.8 14.2 11.9 3.9 5.3 5.4 15.3 18.0 4.3 5.0 12.0 19.4 7.7 8.2 3.8 6.8 11.6 7.3 3.7 8.6 5.4 5.5 7.2 2.9 3.5 4.4 5.9 7.0 10.6 11.4 9.9 9.3 0.2 0.7 0.4 1.0 0.7 1.4 1.5 1.0 0.8 2.0 1.5 1.2 1.1 0.4 1.1 0.5 0.6 1.2 0.3 1.4 2.4 1.5 2.0 1.6 1.5 1.0 0.9 1.5 1.4 0.9 1.1 1.8 22.3 12.8 17.2 8.5 31.5 32.6 51.7 92.0 37.0 12.8 43.7 56.1 56.4 45.8 53.5 58.8 16.7 92.5 26.1 14.6 187.9 73.6 3.1 53.6 47.2 16.7 24.0 17.0 12.0 52.7 73.7 38.0 29.6 42.3 21.0 55.3 15.0 183.6 63.5 13.5 8.8 22.0 65.1 23.5 39.9 4.1 44.1 26.9 49.8 4.7 89.9 15.4 22.6 12.1 8.0 62.1 20.6 37.6 20.8 54.3 24.1 705.6 60.5 24.9 39.5 23.9 51.6 2.7 17.5 53.7 41.6 59.2 27.7 118.1 36.7 53.0 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 625.3;Distal tubular cells: 540.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA075611" Approved Supported Mitochondria NA NA 19000 Mitochondria "HPA035856: AB_10611965, HPA075611: " "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favorable (3.93e-4)" 46.9 106.6 57.6 31.6 63.5 40.2 44.4 60.8 82.9 64.3 60.2 147.3 56.6 49.9 59.9 209.2 50.1 46.6 171.5 60.4 61.4 98.0 201.9 32.3 33.2 59.5 59.4 58.3 85.0 135.0 117.6 51.4 17.8 59.4 75.2 150.4 84.3 60.3 49.6 142.3 89.5 56.8 45.0 58.5 32.0 93.9 44.0 67.3 35.0 44.4 143.9 43.1 77.6 132.6 61.0 132.0 27.7 40.4 75.6 72.1 66.4 20.7 52.9 46.8 49.0 123.9 69.4 58.7 142.1 89.2 18.2 40.3 89.8 73.5 128.1 130.0 74.0 55.1 115.6 44.0 125.8 47.4 114.0 39.6 77.3 65.5 46.7 97.9 164.3 66.0 137.7 79.2 55.6 71.1 52.0 116.9 137.9 59.5 294.9 144.4 69.5 57.8 186.9 144.3 314.9 60.1 48.1 39.4 92.4 114.3 59.9 57.9 55.7 47.0 48.4 34.6 28.7 55.6 108.8 39.9 144.8 143.3 109.7 22.8 9.9 25.8 75.7 58.3 68.2 86.9 75.3 79.5 74.0 84.6 68.1 85.1 88.6 8.5 50.6 75.9 70.4 80.4 38.8 57.6 63.5 60.8 82.9 60.4 61.4 59.5 59.4 58.3 59.4 58.5 67.3 61.0 55.7 28.9 46.0 41.1 68.2 128.1 155.3 625.3 82.0 31.5 80.6 109.5 338.4 84.4 188.6 130.6 47.9 51.4 47.9 477.5 540.0 148.2 102.5 82.0 30.1 49.8 106.9 47.7 33.0 177.6 47.8 78.7 84.6 79.2 85.7 59.3 44.6 280.4 92.7 38.7 30.4 374.3 240.1 66.7 108.9 33.1 134.5 61.2 104.9 7.5 108.9 79.7 45.3 22.1 21.6 141.6 313.2 148.6 61.2 121.4 186.2 466.2 95.5 29.9 105.2 83.2 315.3 146.4 68.3 315.1 132.8 47.2 66.0 121.1 358.4 210.9 OGG1 "HMMH, HOGG1, MUTM, OGH1" ENSG00000114026 "8-oxoguanine DNA glycosylase" O15527 3 9749944-9788219 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027514, CAB047301" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB047301: , HPA027514: AB_10602189" "unprognostic (6.95e-2)" "unprognostic (7.82e-3)" "unprognostic (7.19e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (7.83e-2)" "unprognostic (2.45e-2)" "unprognostic (3.43e-3)" "unprognostic (9.66e-3)" "unprognostic (4.23e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.06e-2)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.59e-1)" 12.5 14.0 17.6 13.3 17.8 12.3 12.9 18.6 19.2 18.4 11.4 14.7 19.1 17.2 10.4 9.7 17.1 8.5 11.5 18.1 15.2 30.0 20.9 10.8 26.4 17.8 15.7 16.1 22.7 10.7 6.7 10.8 8.6 16.9 15.8 8.2 12.2 12.3 10.2 7.2 9.7 17.4 9.9 15.1 15.3 12.5 8.7 15.6 13.6 13.2 8.0 21.4 15.5 14.4 16.5 11.3 20.7 20.3 13.1 19.9 22.3 38.4 14.5 14.8 21.6 25.6 19.9 10.8 68.5 9.5 18.3 34.1 10.8 12.1 15.9 9.0 25.1 17.6 33.9 32.5 29.3 20.7 13.3 20.9 22.3 20.0 37.4 16.0 17.4 27.3 9.6 11.0 10.9 20.9 21.3 10.7 13.2 11.0 10.3 29.3 7.8 13.7 22.4 12.4 5.7 9.0 15.9 18.4 15.2 11.5 10.4 23.7 22.9 17.5 21.9 22.7 17.2 24.0 10.7 16.9 35.9 17.4 37.9 13.7 15.1 10.9 20.7 18.7 9.0 18.4 13.9 15.8 15.3 9.8 16.5 12.1 11.5 2.9 27.0 7.3 15.9 21.0 10.9 17.6 17.8 18.6 19.2 18.1 15.2 17.8 15.7 16.1 16.9 15.1 15.6 16.5 9.5 0.0 3.4 15.3 16.7 5.5 8.9 8.3 9.1 20.9 6.7 7.4 2.3 10.0 4.9 9.2 35.5 6.4 16.5 9.0 11.7 7.7 0.9 5.0 12.2 10.4 18.0 22.3 11.2 6.7 10.1 11.7 6.1 4.4 2.5 10.0 10.0 11.8 18.0 8.4 9.2 8.8 6.1 9.0 5.8 1.8 14.3 9.3 7.2 10.3 15.8 11.3 27.8 13.0 9.9 8.8 11.0 13.5 10.0 5.2 47.1 86.3 4.1 34.7 26.3 11.1 10.3 10.2 21.5 5.0 4.5 4.0 12.9 12.0 14.0 5.4 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421902-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 20.4 18.6 11.1 19.9 11.7 11.5 12.0 11.3 16.1 14.2 8.3 15.6 13.1 13.7 15.2 22.0 13.0 12.2 20.5 12.1 11.8 16.3 32.2 13.1 15.8 12.0 11.3 11.5 10.7 19.0 19.4 9.1 16.1 12.1 15.3 15.6 28.9 12.5 16.4 75.0 12.8 13.7 23.2 11.6 12.4 14.7 20.8 10.7 15.6 18.1 41.4 20.8 22.3 11.5 15.4 75.1 43.4 73.2 37.2 46.6 51.2 23.2 56.5 47.5 60.4 54.4 52.6 35.6 54.1 50.6 62.4 47.8 38.3 58.2 48.2 88.9 14.8 22.1 66.6 37.1 29.5 27.3 59.8 29.5 35.7 61.0 43.7 60.9 29.5 67.3 28.8 47.6 30.5 55.8 34.6 43.7 14.1 31.8 52.5 46.2 44.1 60.8 34.8 26.2 51.8 50.4 30.3 60.5 32.6 50.1 56.9 43.2 34.8 57.9 37.7 41.2 18.7 44.1 29.1 31.8 99.9 52.7 40.9 39.1 27.1 19.3 18.8 17.4 19.5 18.6 15.8 15.2 19.3 25.4 12.7 15.4 15.8 41.5 21.2 29.3 7.9 17.6 18.2 11.1 11.7 11.3 16.1 12.1 11.8 12.0 11.3 11.5 12.1 11.6 10.7 15.4 27.9 16.0 31.8 53.5 31.9 41.4 22.2 15.8 28.5 30.1 24.2 12.3 31.1 22.8 32.9 14.7 31.3 21.2 31.5 18.6 13.7 23.2 120.1 35.0 26.1 27.6 16.3 49.2 107.2 33.4 25.9 26.1 19.4 29.5 38.7 18.6 22.5 50.2 23.3 20.2 81.7 19.7 18.3 27.9 47.4 221.8 22.4 30.0 17.8 61.8 31.5 22.2 26.8 59.8 91.7 35.1 19.8 24.8 36.6 34.5 18.6 23.1 44.8 47.4 13.1 25.4 32.1 42.1 18.0 27.1 45.5 24.9 31.3 19.6 14.0 27.5 PCCB ENSG00000114054 "Propionyl-CoA carboxylase subunit beta" P05166 3 136250340-136337896 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 203.7" "Cell type enhanced" "Detected in all" "Early spermatids: 316.7;Late spermatids: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036939, HPA036940" Enhanced "Intracellular and membrane" NA NA 120000 "HPA036939: AB_10671366, HPA036940: AB_10669779" "unprognostic (2.74e-1)" "unprognostic (7.88e-3)" "unprognostic (3.99e-2)" "unprognostic (2.89e-2)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.05e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-2)" "unprognostic (2.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.47e-7)" "unprognostic (2.43e-2)" "unprognostic (2.64e-1)" "unprognostic (3.50e-1)" "unprognostic (4.13e-1)" 34.7 75.7 22.6 15.3 32.3 38.3 27.8 30.2 30.1 17.7 31.1 44.0 38.4 13.9 14.0 26.5 19.3 17.2 95.5 23.1 27.4 89.7 203.7 14.9 16.4 31.3 29.1 23.0 12.2 32.3 57.5 15.8 19.8 31.8 23.9 42.3 17.3 23.8 21.9 84.6 14.7 27.7 22.8 27.2 12.9 26.3 39.2 29.0 21.3 38.3 92.2 20.8 20.7 11.5 47.5 64.8 45.8 42.4 64.4 30.2 34.5 75.4 33.0 35.5 49.1 69.6 67.9 44.7 80.3 89.4 46.6 44.0 35.1 50.3 44.0 69.4 47.8 43.0 140.8 49.5 101.4 66.4 107.3 60.2 40.8 41.4 31.0 69.4 30.5 56.1 131.6 104.5 41.0 38.0 123.1 109.3 63.1 36.0 96.8 40.9 29.3 34.6 116.6 89.9 69.4 84.0 62.9 84.4 48.9 77.5 35.2 98.3 62.9 42.0 24.5 26.0 69.2 29.6 78.3 70.0 66.9 34.9 41.7 29.9 7.3 29.5 7.5 22.6 30.8 25.4 21.7 14.7 23.2 44.6 19.8 15.1 18.7 2.7 25.9 28.7 38.5 14.8 22.6 22.6 32.3 30.2 30.1 23.1 27.4 31.3 29.1 23.0 31.8 27.2 29.0 47.5 5.6 9.6 14.0 16.0 9.2 4.1 9.4 37.9 3.4 16.0 12.5 5.3 51.1 8.6 28.4 20.2 10.4 57.1 8.0 15.1 39.2 24.6 316.7 14.1 9.5 8.1 9.1 53.2 16.5 14.0 27.1 13.6 14.8 14.1 29.2 18.1 9.3 76.3 35.1 11.8 22.7 15.1 24.4 11.7 5.2 159.0 13.7 11.4 19.6 16.9 16.5 11.8 10.3 22.1 50.9 14.4 16.7 10.9 22.6 10.4 19.2 97.3 23.6 13.2 13.1 13.6 13.1 11.3 29.0 16.2 3.3 50.9 9.9 52.8 25.1 12.2 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439051 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 29.4 29.2 28.8 27.9 32.2 32.7 32.9 45.4 42.0 33.8 16.9 33.8 23.2 33.2 29.7 33.2 30.2 24.7 41.0 32.2 31.9 32.9 42.6 25.1 33.6 24.8 28.3 27.7 37.4 27.4 38.7 15.4 28.6 29.6 32.1 29.2 33.1 23.5 28.7 110.2 27.1 29.7 31.2 20.6 27.2 26.4 46.0 27.5 42.1 41.9 92.8 34.5 33.1 20.2 32.9 55.9 33.6 77.7 46.1 45.0 56.4 38.4 84.8 54.8 59.9 55.6 76.0 27.6 103.4 61.2 68.2 57.8 51.2 106.8 62.2 75.2 54.1 32.7 85.8 49.0 43.1 65.5 107.0 60.2 60.6 56.2 58.3 71.6 60.0 47.6 87.0 89.0 71.1 95.1 32.3 84.0 29.1 50.3 62.1 46.6 88.6 117.8 45.6 51.7 91.1 80.0 59.6 72.1 72.1 102.1 51.3 57.9 56.7 59.2 102.1 84.7 52.1 64.5 77.5 103.4 139.5 60.4 56.6 55.3 14.4 12.7 17.2 17.0 11.2 19.9 17.3 18.5 20.8 16.7 22.8 20.8 18.7 2.2 29.6 22.3 15.2 15.8 9.7 28.8 32.2 45.4 42.0 32.2 31.9 24.8 28.3 27.7 29.6 20.6 27.5 32.9 56.6 96.1 80.5 112.6 74.7 71.1 83.8 40.6 84.2 82.7 59.5 42.3 175.3 42.9 58.7 38.6 56.3 52.3 74.3 43.3 19.6 51.6 139.4 53.6 75.2 58.7 68.7 64.3 187.7 49.6 49.6 64.1 52.5 63.8 62.8 84.1 44.3 58.6 46.0 80.8 196.3 55.0 12.2 60.9 41.1 61.6 56.8 64.4 53.4 87.1 53.3 54.5 54.6 126.2 124.4 59.8 41.5 64.7 95.7 102.8 51.4 50.3 59.4 59.2 78.9 119.0 80.5 146.1 88.3 78.3 90.6 74.0 63.3 65.7 52.6 98.6 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 128.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 21.0 14.5 16.2 18.1 18.2 61.1 16.6 42.8 18.1 14.8 24.0 16.0 12.1 17.8 12.3 21.2 15.9 15.4 17.6 15.1 18.0 19.1 17.0 16.4 21.4 16.8 18.1 14.1 16.2 14.3 21.4 12.4 19.9 23.7 16.6 18.5 26.5 12.7 17.7 39.1 12.9 13.6 24.6 16.6 16.0 15.5 18.6 18.4 22.4 21.5 35.1 23.1 22.5 13.5 20.9 46.2 22.0 28.5 23.2 35.2 30.7 37.9 34.8 33.4 46.7 45.3 34.3 23.7 43.2 35.0 30.2 54.6 23.5 37.1 33.9 57.4 29.3 25.7 77.2 14.3 23.9 44.3 60.6 82.5 46.2 21.2 30.0 42.9 25.4 37.0 37.0 29.3 23.8 58.6 40.5 42.7 28.6 39.2 34.8 19.1 33.0 45.7 34.6 30.7 42.3 33.0 24.0 50.0 17.2 29.1 36.8 33.8 31.6 40.4 24.8 20.2 33.1 25.9 45.0 37.5 65.2 22.4 28.4 25.2 79.7 39.7 74.8 38.6 43.5 44.6 48.8 35.2 41.1 45.9 43.3 41.1 40.6 27.9 48.8 46.0 20.3 50.4 37.4 16.2 18.2 42.8 18.1 15.1 18.0 16.8 18.1 14.1 23.7 16.6 18.4 20.9 25.0 28.9 14.1 56.2 38.2 31.0 31.9 29.0 25.0 34.9 17.7 14.9 23.1 24.3 27.2 12.9 33.3 29.9 35.6 25.1 11.7 20.2 7.3 16.2 22.3 23.4 23.4 59.6 101.9 14.6 27.6 23.4 31.1 19.5 35.4 24.1 24.3 24.6 22.5 43.7 93.6 16.9 30.5 32.7 39.2 7.3 30.4 35.2 19.6 70.3 27.2 25.0 39.1 128.2 120.8 14.8 17.2 22.2 26.8 28.1 17.0 26.1 17.4 47.0 13.1 30.2 31.5 43.4 32.2 22.3 28.4 34.1 30.9 19.6 17.4 28.3 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3" "Group enriched" "Detected in many" 10 "B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 7.6 12.1 20.6 6.4 22.3 6.0 13.4 25.6 22.5 30.8 16.7 17.8 56.7 21.1 21.8 12.1 30.8 13.2 16.0 19.3 37.1 21.6 29.6 14.8 5.5 24.8 22.4 18.1 18.7 24.3 21.9 15.7 4.0 22.6 21.2 18.3 36.1 8.8 21.9 18.2 6.9 19.1 11.8 21.3 6.2 13.2 69.6 23.7 42.8 39.5 20.9 7.0 12.2 11.8 24.2 53.7 11.1 25.3 30.8 15.2 16.9 23.5 10.4 19.4 14.0 20.5 15.5 27.9 12.5 24.0 19.2 53.1 23.0 23.2 20.6 31.1 22.2 15.3 35.7 26.0 20.1 24.2 1.6 12.5 92.3 11.7 10.6 26.2 37.0 20.5 40.1 26.6 40.5 23.1 20.1 38.4 2.1 15.0 13.9 24.6 41.7 32.9 32.3 26.9 23.8 30.7 19.8 54.5 12.7 60.8 28.4 64.3 17.7 12.1 10.3 19.0 21.3 12.9 37.2 22.1 42.6 22.9 3.3 35.7 0.2 0.0 0.1 2.8 0.1 3.3 1.7 2.1 2.3 0.0 1.4 4.1 4.0 0.2 2.3 0.0 0.1 1.3 1.2 20.6 22.3 25.6 22.5 19.3 37.1 24.8 22.4 18.1 22.6 21.3 23.7 24.2 7.0 32.1 69.3 44.1 4.8 9.7 46.3 14.0 22.2 15.8 11.8 9.8 34.3 22.8 27.4 20.2 35.5 8.1 4.6 10.5 72.4 24.9 222.5 114.0 14.9 7.7 15.6 13.7 51.8 17.6 4.4 11.8 16.3 52.6 20.8 21.9 6.1 14.7 2.4 21.9 48.5 11.1 8.2 0.3 3.0 299.3 9.9 2.3 10.6 19.7 0.6 26.4 2.1 60.8 30.5 12.7 8.1 12.8 9.2 29.5 3.3 21.1 34.5 31.1 6.6 17.5 12.4 163.6 9.5 18.6 8.1 9.6 8.9 9.5 23.9 28.6 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 357 "intestine: 2738.0" "Cell type enriched" "Detected in some" 26 "Proximal enterocytes: 6095.4" "Group enriched" "Detected in many" 4 "colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CACO-2: 78.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" NA NA 140000 "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.4 1.1 5.2 1.2 3.3 0.7 0.5 1.3 3.8 0.1 0.0 2.7 2738.0 2.1 0.0 0.2 0.3 1.8 0.2 3.2 6.5 2.6 0.0 7.6 2.2 6.9 6.5 3.5 0.3 3.1 0.0 0.1 0.1 3.6 0.4 2.4 2.2 0.1 0.0 0.2 1.1 1902.4 1.0 5.1 0.1 3.7 1.0 7.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.2 0.2 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 78.8 0.1 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.1 0.2 0.1 0.1 0.0 11.7 0.0 0.0 4.0 10.1 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.3 1.3 3.8 3.2 6.5 6.9 6.5 3.5 3.6 5.1 7.0 5.1 0.0 9.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 12.9 8.4 0.0 0.0 14.0 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 1.0 6.1 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 185.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.5 0.9 6.1 226.3 0.0 0.0 0.0 6095.4 0.0 0.7 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 142.6 0.1 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 1378.1;pancreas: 638.0" "Group enriched" "Detected in many" 4 "Granulosa cells: 5988.6;Theca cells: 3228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SH-SY5Y: 835.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 64.4" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA 41000 Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 13.5 380.2 71.6 18.6 72.9 1.3 50.0 75.2 71.5 54.2 227.6 27.5 32.5 181.9 64.8 35.7 393.7 184.5 45.7 74.2 103.3 35.2 141.9 27.0 18.7 91.8 78.2 61.0 1378.1 638.0 47.2 259.8 64.1 76.1 45.2 14.4 23.4 50.6 41.7 15.4 24.9 26.5 120.3 76.8 47.4 29.5 56.6 78.9 9.5 23.2 15.6 12.1 66.3 24.5 75.6 7.8 2.9 7.4 164.2 0.3 0.0 0.9 0.1 0.0 0.0 0.1 0.4 76.1 0.0 53.8 0.1 2.6 0.1 38.2 0.5 0.0 0.1 5.3 0.1 2.7 75.5 155.1 0.2 0.1 3.0 0.0 0.1 0.0 160.9 0.0 0.0 0.2 29.9 0.2 0.0 0.2 0.5 18.4 0.2 0.0 0.1 32.0 0.5 0.1 0.1 19.6 835.4 35.3 0.1 0.1 13.9 3.2 1.1 0.0 0.3 120.0 0.2 0.3 0.6 0.5 0.5 1.3 0.0 2.3 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 71.6 72.9 75.2 71.5 74.2 103.3 91.8 78.2 61.0 76.1 76.8 78.9 75.6 24.8 32.1 5.9 8.8 3.5 17.6 53.5 91.9 2.8 26.3 70.4 47.8 21.4 77.2 30.3 23.9 2.1 3.2 1.0 0.1 13.7 1013.0 4.8 199.6 961.4 103.8 43.1 13.5 0.5 1042.7 6.2 158.8 19.9 58.1 0.0 5988.6 343.7 6.9 16.5 3.3 0.3 2.3 42.7 10.6 3.4 16.2 27.1 25.1 8.8 5.6 13.5 159.9 0.0 4.0 16.0 563.0 0.0 4.5 2.9 56.6 2.6 4.7 10.3 7.2 26.3 220.9 534.7 11.6 4.9 6.2 34.9 3.8 10.2 3228.5 2.7 32.7 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140980995 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 24.2 22.4 19.3 14.4 19.4 62.2 33.8 19.4 22.4 30.2 16.8 23.7 31.2 34.8 48.1 15.1 32.9 18.6 39.5 18.8 22.7 39.0 4.2 27.7 21.5 20.0 19.9 18.0 39.3 45.6 29.1 27.1 26.6 20.9 27.4 19.7 43.0 23.5 21.0 38.8 21.8 23.1 19.3 19.6 20.3 34.3 24.1 20.4 20.8 32.1 21.0 17.8 23.2 24.1 24.6 52.3 11.5 36.0 30.8 33.0 40.7 46.2 19.4 23.6 18.2 27.3 28.6 24.0 42.1 46.9 17.3 31.2 34.9 40.1 15.2 40.6 33.8 36.5 33.9 29.8 20.9 45.9 48.8 21.3 44.1 61.1 15.4 45.8 44.4 22.0 32.0 17.6 27.4 29.2 22.8 30.6 34.1 37.8 12.8 18.4 34.2 32.0 59.6 23.5 17.7 22.4 38.2 26.7 45.1 80.9 30.3 32.6 29.2 24.1 29.5 17.1 52.2 19.0 56.4 36.8 51.2 36.0 21.1 15.0 10.7 9.2 15.1 9.6 11.5 11.8 16.3 9.6 10.2 14.0 15.1 13.5 12.6 1.7 18.3 13.5 9.7 9.9 9.8 19.3 19.4 19.4 22.4 18.8 22.7 20.0 19.9 18.0 20.9 19.6 20.4 24.6 60.3 99.3 143.0 85.5 47.6 68.2 68.0 38.1 116.7 106.0 72.2 77.5 90.3 38.6 52.0 71.7 133.5 58.8 58.2 22.7 64.6 26.4 10.6 113.4 78.0 45.8 59.3 27.3 127.7 38.3 38.0 73.9 58.1 106.3 65.9 92.8 35.7 0.5 26.5 92.5 115.6 32.5 30.5 38.2 45.8 16.0 59.7 38.4 56.9 46.9 36.9 68.2 25.7 108.6 109.1 29.3 22.8 59.5 48.2 88.9 44.9 57.5 98.8 121.8 59.2 80.0 59.2 59.4 68.8 61.3 54.4 49.4 49.1 83.2 46.8 78.9 GRK7 GPRK7 ENSG00000114124 "G protein-coupled receptor kinase 7" Q8WTQ7 3 141778148-141818490 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "retina: 11.4" "Cell type enriched" "Detected in some" 73 "Cone photoreceptor cells: 329.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA075093, HPA078232" Enhanced Approved Mitochondria NA NA Mitochondria "HPA075093: , HPA078232: " "unprognostic (1.11e-1)" "unprognostic (1.70e-2)" "unprognostic (3.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-2)" "unprognostic (5.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.53e-8)" "unprognostic (3.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.91e-1)" 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.0 3.9 0.1 0.4 0.2 0.0 0.6 1.0 0.1 0.1 0.2 0.0 0.0 0.0 329.4 0.0 0.2 0.0 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.4 2.4 0.0 0.1 0.0 1.9 0.1 1.1 0.0 4.5 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.5 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.3 0.1 0.0 RNF7 "CKBBP1, ROC2, SAG" ENSG00000114125 "Ring finger protein 7" Q9UBF6 3 141738249-141747560 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 898.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036995 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036995: AB_10673627" "unprognostic (5.68e-2)" "unprognostic (4.94e-3)" "unprognostic (1.83e-1)" "unprognostic (3.24e-1)" "unprognostic (9.11e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (4.53e-2)" "unprognostic (1.24e-2)" "unprognostic (3.98e-3)" "unprognostic (5.17e-3)" "unprognostic (8.58e-3)" "prognostic unfavorable (1.54e-9)" "unprognostic (4.60e-1)" "unprognostic (2.20e-1)" "unprognostic (3.69e-2)" "unprognostic (2.36e-2)" 64.7 115.4 64.3 41.1 66.6 65.6 64.0 65.3 80.6 66.1 72.8 90.6 70.4 59.2 71.4 87.2 61.5 46.5 91.3 65.2 72.0 84.9 84.6 58.9 44.9 65.5 65.8 63.3 74.4 81.0 44.4 82.1 51.6 66.3 78.3 60.4 38.0 60.3 44.2 143.3 69.7 64.7 48.3 67.5 59.2 68.8 71.7 66.6 45.9 53.1 114.1 44.5 78.6 72.5 67.8 172.6 67.4 98.1 80.0 91.6 125.7 65.5 94.6 87.5 78.2 82.6 79.4 82.5 57.7 214.5 104.7 192.7 80.8 61.5 88.1 98.3 56.0 119.1 56.6 64.8 116.4 122.6 89.7 52.9 118.2 96.9 63.4 105.5 104.3 112.3 96.1 61.6 77.0 117.2 131.0 56.6 100.1 105.1 170.7 113.3 61.1 63.1 124.0 169.2 74.0 54.8 68.1 108.7 108.8 161.4 126.4 102.4 114.8 86.2 78.1 75.6 139.2 80.5 73.7 66.5 121.2 122.4 98.4 90.3 119.0 128.2 87.7 78.0 116.4 77.7 82.6 82.8 83.2 112.9 74.1 79.6 83.7 45.5 61.8 125.7 103.4 108.8 121.6 64.3 66.6 65.3 80.6 65.2 72.0 65.5 65.8 63.3 66.3 67.5 66.6 67.8 128.7 60.9 55.2 7.5 81.4 132.4 143.0 290.5 150.2 34.3 159.7 207.3 104.1 105.8 151.1 101.2 27.1 183.8 133.2 262.0 254.3 225.1 348.9 99.3 112.0 134.9 125.7 41.4 12.9 247.3 249.1 114.2 73.9 100.0 72.9 206.4 129.9 132.0 214.4 28.6 12.6 195.2 134.3 126.7 123.5 898.4 117.8 137.6 144.1 18.7 174.1 111.7 140.1 10.6 19.6 233.2 261.4 121.9 102.0 181.8 295.1 324.1 105.7 56.7 85.5 84.3 126.2 212.2 129.1 183.7 144.6 129.8 112.7 281.4 174.5 185.9 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 171.3" "Cell type enhanced" "Detected in all" "Early spermatids: 986.1;Late spermatids: 397.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 19.0 15.2 8.9 9.3 9.7 50.7 19.1 21.7 13.9 12.2 9.0 14.9 22.9 15.4 16.0 13.8 14.8 19.6 26.3 10.5 7.6 29.8 17.5 11.9 10.6 13.0 10.0 7.9 23.5 12.5 16.9 13.1 28.6 13.4 19.6 14.2 13.3 12.5 13.9 28.7 12.0 21.5 14.5 8.8 9.6 12.5 70.6 11.8 171.3 21.7 21.5 10.7 11.3 10.3 12.4 32.8 14.7 61.6 49.4 20.3 21.9 134.0 16.3 18.8 25.5 40.2 19.2 32.2 115.8 73.7 18.7 44.6 19.5 15.8 31.2 35.8 46.9 28.5 140.4 21.5 26.0 19.6 43.1 47.8 20.6 22.8 27.8 26.9 23.5 18.3 216.4 53.5 6.8 44.3 25.4 423.3 16.1 49.6 17.2 20.0 222.7 42.2 27.0 29.4 16.5 26.9 25.0 54.5 19.5 29.0 45.3 46.7 21.9 12.0 24.2 21.9 19.8 20.7 20.7 20.5 366.5 19.4 11.4 11.6 69.3 4.0 48.0 28.0 6.9 10.9 14.7 12.8 14.9 9.8 18.7 18.6 22.2 4.4 37.4 10.0 33.7 12.8 12.5 8.9 9.7 21.7 13.9 10.5 7.6 13.0 10.0 7.9 13.4 8.8 11.8 12.4 29.7 32.1 30.6 64.0 24.2 25.1 52.1 30.4 43.3 33.0 45.1 36.8 87.6 45.8 30.7 47.8 33.3 235.4 98.5 23.1 93.9 36.8 986.1 63.9 51.1 26.8 38.6 171.9 194.6 26.4 125.2 44.0 15.8 35.8 33.5 84.8 27.8 39.8 27.8 37.0 166.7 27.1 40.7 13.5 15.4 397.5 77.0 27.0 5.4 51.5 14.9 26.1 128.8 61.9 116.6 27.2 25.7 75.2 25.2 36.3 87.5 98.4 43.1 34.5 26.3 96.7 38.6 75.4 75.6 31.3 20.0 99.2 42.9 72.4 42.0 36.0 XRN1 SEP1 ENSG00000114127 "5'-3' exoribonuclease 1" Q8IZH2 3 142306607-142448062 "Predicted intracellular proteins" "DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 119.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035005, HPA035006" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035005: AB_10670695, HPA035006: AB_10672750" "unprognostic (3.52e-1)" "unprognostic (2.35e-2)" "unprognostic (2.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-2)" "unprognostic (6.32e-2)" 8.0 6.8 3.4 12.3 5.4 21.4 10.8 11.9 6.0 7.7 6.6 8.3 11.1 9.9 7.9 7.1 6.3 8.1 5.6 3.5 5.0 6.9 16.3 8.7 13.2 4.3 4.1 3.0 10.2 8.2 8.9 6.0 10.6 4.8 8.9 9.5 14.7 7.5 6.1 11.8 9.2 12.5 6.6 3.4 12.9 9.1 9.4 4.4 14.5 8.8 9.7 11.4 7.8 8.3 7.1 22.1 3.9 9.6 8.6 11.1 17.0 5.9 9.9 12.9 12.3 15.2 3.6 6.1 8.9 10.3 13.3 10.0 8.6 8.6 5.2 19.2 21.4 6.5 12.7 7.3 3.5 9.6 12.8 12.7 14.0 6.1 8.8 11.7 12.1 11.4 9.7 8.0 20.4 11.7 4.5 11.2 7.6 3.0 3.4 4.4 9.0 119.2 11.4 6.5 10.8 5.7 7.3 17.3 10.4 8.2 5.9 11.9 10.8 16.0 9.0 4.7 10.3 8.7 29.1 14.2 13.7 8.4 7.2 7.9 31.0 5.8 17.2 10.0 5.4 7.1 9.8 7.7 9.1 2.9 7.2 10.1 7.0 21.2 5.9 5.0 8.0 6.2 3.1 3.4 5.4 11.9 6.0 3.5 5.0 4.3 4.1 3.0 4.8 3.4 4.4 7.1 66.1 54.5 33.3 74.7 55.9 25.6 33.7 22.7 33.6 33.7 27.2 21.0 26.5 18.6 30.2 46.0 50.1 22.9 80.8 46.5 11.7 16.5 49.9 31.9 50.7 40.6 28.2 43.6 101.6 12.5 7.8 41.8 48.4 29.0 21.5 33.7 33.9 48.0 16.3 26.9 114.2 22.5 14.2 28.9 23.0 19.1 24.8 38.8 14.2 81.5 41.4 21.0 50.4 126.7 120.4 18.6 41.9 29.0 111.7 44.0 43.4 13.2 34.2 53.9 6.6 56.0 39.9 61.8 20.5 27.6 28.3 53.5 69.8 37.1 15.0 43.8 KAT2B "GCN5, GCN5L, P/CAF, PCAF" ENSG00000114166 "Lysine acetyltransferase 2B" Q92831 3 20040446-20154404 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002470, CAB004526, HPA055839, HPA073897" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: " "unprognostic (2.91e-2)" "unprognostic (6.85e-3)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (2.66e-2)" "unprognostic (3.01e-3)" "unprognostic (2.44e-1)" "unprognostic (3.83e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-3)" "unprognostic (7.13e-2)" "unprognostic (7.03e-2)" "unprognostic (2.26e-2)" "unprognostic (1.59e-1)" "unprognostic (5.16e-2)" "unprognostic (4.63e-2)" 18.0 10.0 38.5 15.6 46.0 48.4 10.4 40.2 40.7 15.0 33.7 12.0 17.8 12.5 8.2 27.7 11.8 12.7 36.3 34.3 51.1 16.8 39.6 16.4 22.6 44.2 45.4 30.9 28.0 18.9 51.4 10.3 13.8 46.4 14.6 12.6 34.2 37.9 13.1 60.8 14.4 21.6 13.7 37.5 20.0 14.0 2.8 42.4 23.9 14.5 56.6 20.3 12.0 15.3 46.2 2.7 6.9 3.8 6.2 15.1 14.2 8.8 8.8 13.0 9.1 13.3 2.1 4.5 24.0 3.6 16.7 11.5 2.0 9.4 2.8 7.6 21.8 9.0 21.0 10.7 0.7 7.1 3.2 26.2 6.1 5.0 7.9 5.1 16.0 8.8 5.8 13.7 32.9 13.0 3.3 7.0 6.4 1.6 6.7 6.8 9.1 7.1 5.1 12.4 14.2 1.9 4.1 4.9 7.9 30.5 5.9 8.2 14.2 8.5 15.3 6.1 5.8 10.1 12.3 27.6 5.7 13.9 13.8 33.0 0.6 0.4 1.3 1.5 0.7 1.5 0.4 1.3 1.1 0.4 0.8 0.4 0.8 2.4 0.5 0.5 1.2 2.2 0.3 38.5 46.0 40.2 40.7 34.3 51.1 44.2 45.4 30.9 46.4 37.5 42.4 46.2 15.5 32.1 20.8 165.2 11.9 8.5 11.3 2.2 3.4 14.6 5.5 5.0 64.1 4.3 10.4 5.5 4.2 7.3 19.5 16.6 11.7 3.8 3.8 6.4 5.7 14.6 11.5 52.2 22.4 4.4 1.1 11.7 3.6 13.1 10.8 12.3 20.7 33.6 7.7 15.2 32.1 7.3 4.1 22.8 23.3 1.8 6.5 16.0 17.8 52.5 11.1 14.8 14.4 418.2 175.4 3.3 2.4 5.3 19.9 7.1 24.7 6.2 12.7 11.9 6.6 25.2 9.0 0.8 1.4 10.0 12.9 9.9 23.5 2.9 3.8 8.0 BCHE "CHE1, CHE2, E1" ENSG00000114200 Butyrylcholinesterase P06276 3 165772904-165837462 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "liver: 529.4" "Group enriched" "Detected in many" 9 "Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1" "Group enriched" "Detected in many" 6 "glioma: 24.0;liver cancer: 13.7;melanoma: 18.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "Karpas-707: 785.6" "Low region specificity" "Detected in all" HPA001560 Approved "Secreted to blood" NA NA 9400000000 "HPA001560: AB_1078271" "unprognostic (4.74e-2)" "unprognostic (2.00e-1)" "unprognostic (9.21e-4)" "unprognostic (8.19e-8)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (5.04e-2)" "unprognostic (6.15e-2)" "unprognostic (9.59e-2)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" "unprognostic (3.18e-3)" "unprognostic (4.46e-5)" "unprognostic (2.17e-2)" "unprognostic (5.92e-2)" "unprognostic (4.26e-4)" 14.6 11.7 9.2 2.7 7.8 0.0 4.7 7.9 12.1 22.2 5.5 25.3 4.7 41.4 24.5 26.0 36.5 6.1 7.9 8.1 7.6 4.9 529.4 11.0 0.2 8.3 9.6 7.4 3.8 2.4 0.1 1.8 0.0 8.1 12.6 16.3 8.9 1.9 32.6 2.8 8.8 10.7 29.9 7.7 6.0 3.6 1.3 12.7 2.9 1.4 5.2 0.1 11.4 5.1 9.8 0.0 2.1 82.1 0.1 0.2 0.0 0.1 0.0 1.5 0.6 7.3 0.0 0.1 0.3 30.7 0.0 0.0 0.5 5.7 0.4 5.8 0.4 0.8 0.0 0.0 0.0 6.3 0.2 0.4 23.5 1.4 0.0 8.1 25.3 3.6 30.0 0.0 785.6 0.0 0.0 0.0 0.1 2.1 0.0 0.8 0.0 28.4 67.3 0.7 0.0 0.0 0.8 0.1 0.0 46.5 0.0 34.0 0.2 0.0 19.3 0.5 0.0 8.3 3.5 0.0 1.6 8.2 0.2 84.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 7.8 7.9 12.1 8.1 7.6 8.3 9.6 7.4 8.1 7.7 12.7 9.8 5.8 0.0 0.0 1.0 0.7 5.5 0.9 0.0 1.8 1.4 0.0 0.1 9.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.7 3.4 0.0 8.0 3.0 0.0 0.0 22.0 0.5 0.0 0.0 0.2 8.9 420.3 0.1 1.7 10.5 0.4 0.0 4.7 1.5 8.7 2.1 0.3 19.6 3.7 0.0 31.7 0.0 210.1 16.1 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.2 0.0 0.8 6.5 0.3 0.3 0.6 3.4 0.0 1.1 0.1 0.0 0.1 SERPINI2 "MEPI, PANCPIN, PI14, TSA2004" ENSG00000114204 "Serpin family I member 2" O75830 3 167441789-167479004 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 107 "pancreas: 1381.7" "Cell type enhanced" "Detected in some" "Astrocytes: 37.5;Exocrine glandular cells: 93.4;Respiratory ciliated cells: 22.9" "Cancer enriched" "Detected in some" 6 "pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "THP-1: 9.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.7" "Secreted to digestive system" NA NA "unprognostic (1.88e-2)" "unprognostic (2.23e-3)" "unprognostic (1.14e-1)" "unprognostic (5.27e-2)" "unprognostic (1.17e-2)" "unprognostic (1.29e-2)" "unprognostic (1.11e-2)" "unprognostic (2.04e-1)" "unprognostic (3.13e-1)" "unprognostic (1.76e-5)" "unprognostic (5.35e-2)" "unprognostic (4.16e-2)" 0.1 0.1 7.1 0.0 3.4 0.4 0.1 6.1 2.5 0.1 8.9 0.1 1.0 0.2 0.2 0.2 3.9 0.0 0.3 2.6 8.4 0.2 0.0 1.0 0.1 8.9 6.3 1.0 0.5 1381.7 0.0 0.4 0.0 6.8 0.2 0.0 0.0 0.4 0.0 0.0 0.1 1.9 0.1 12.8 0.2 0.3 0.1 4.1 0.0 0.0 0.2 0.1 0.1 0.1 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.1 3.4 6.1 2.5 2.6 8.4 8.9 6.3 1.0 6.8 12.8 4.1 5.8 0.0 0.0 1.1 37.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.9 0.1 0.1 0.0 0.0 3.6 93.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 2.0 0.9 4.8 0.0 0.0 0.0 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 PDCD10 "CCM3, TFAR15" ENSG00000114209 "Programmed cell death 10" Q9BUL8 3 167683298-167734939 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027095 Approved NA NA 190000 "HPA027095: AB_1855101" "unprognostic (3.39e-2)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.98e-3)" "unprognostic (2.41e-2)" "unprognostic (9.95e-3)" "prognostic unfavorable (5.22e-5)" "unprognostic (3.08e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.98e-1)" "unprognostic (2.45e-1)" "unprognostic (3.14e-1)" "unprognostic (5.58e-2)" 33.1 30.7 24.0 39.6 27.3 62.2 41.7 27.8 34.6 24.7 23.6 51.4 49.2 27.5 29.4 50.8 24.6 29.7 36.3 25.6 28.6 43.9 36.7 31.7 53.4 26.9 26.1 23.0 25.8 25.9 41.8 22.1 44.8 27.9 31.3 49.1 20.5 31.6 24.9 22.0 27.8 43.7 30.5 26.9 33.3 41.7 44.5 25.9 51.4 38.2 29.9 53.1 50.6 32.5 32.2 133.1 49.3 61.6 39.6 56.7 62.1 67.7 78.5 82.7 89.8 89.9 92.3 153.3 107.5 150.0 73.2 156.5 86.0 73.1 91.1 108.0 172.2 52.9 164.8 59.3 61.1 80.3 109.8 93.0 47.9 92.7 56.9 92.6 64.3 73.3 89.1 129.6 105.2 82.1 117.2 88.4 67.7 79.3 119.3 67.9 51.3 46.9 157.9 112.7 53.5 58.9 52.1 75.2 80.8 148.5 76.8 149.0 92.4 70.5 63.5 41.2 68.9 113.5 113.4 170.9 187.6 75.3 114.6 53.2 224.8 81.7 196.5 82.4 107.0 100.1 136.2 111.2 100.2 79.4 136.4 92.0 95.3 175.0 107.1 138.9 73.2 181.9 133.8 24.0 27.3 27.8 34.6 25.6 28.6 26.9 26.1 23.0 27.9 26.9 25.9 32.2 103.3 44.8 42.6 18.6 74.8 108.1 91.0 227.1 69.4 20.2 49.1 57.4 71.1 32.9 120.9 33.1 6.2 106.2 76.9 100.1 105.7 101.4 76.0 58.8 48.3 69.8 34.6 123.3 48.0 122.0 112.3 52.9 62.7 61.4 62.7 34.8 45.3 41.5 91.2 20.2 33.8 75.4 120.1 53.8 73.6 33.5 49.7 89.0 49.8 27.2 100.5 52.9 88.6 19.1 49.7 121.7 103.0 39.5 51.2 97.2 72.0 123.5 92.8 24.1 32.9 37.9 128.4 119.5 103.7 66.6 129.0 103.0 77.9 38.9 55.9 122.7 LRRC31 FLJ23259 ENSG00000114248 "Leucine rich repeat containing 31" Q6UY01 3 169839172-169869935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 21.9;salivary gland: 6.5;stomach 1: 10.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 8.9;Enteroendocrine cells: 10.3;Intestinal goblet cells: 23.5;Paneth cells: 6.0;Undifferentiated cells: 5.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;HAP1: 1.4;OE19: 8.8;RPTEC TERT1: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA058013 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058013: " "unprognostic (5.15e-2)" "unprognostic (5.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.90e-2)" "unprognostic (4.40e-2)" "unprognostic (7.90e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-4)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (2.27e-1)" "unprognostic (5.96e-3)" 0.0 0.0 0.1 1.1 0.0 0.0 0.5 0.0 0.0 1.4 0.0 17.6 8.5 0.1 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 5.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 21.9 0.1 6.5 0.0 0.0 0.0 9.7 0.4 0.0 0.1 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.8 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.0 0.3 0.0 10.3 0.0 0.3 0.0 0.0 0.0 3.1 3.0 0.0 0.0 0.0 2.4 0.1 0.0 0.2 23.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.1 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.4 WNT5A hWNT5A ENSG00000114251 "Wnt family member 5A" P41221 3 55465715-55490539 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Wnt signaling pathway" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.7;salivary gland: 34.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Basal squamous epithelial cells: 34.7;Club cells: 31.3;Endometrial stromal cells: 101.6;Oligodendrocyte precursor cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 227.2;BJ hTERT+: 315.4;HeLa: 242.1;SiHa: 354.2;U-87 MG: 248.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (2.34e-3)" "unprognostic (1.35e-1)" "prognostic favorable (2.94e-5)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-2)" "unprognostic (3.91e-2)" "unprognostic (5.89e-2)" "unprognostic (9.58e-2)" "unprognostic (8.34e-3)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (9.70e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-3)" "unprognostic (3.63e-2)" 2.3 0.8 2.0 3.1 2.1 0.1 4.9 2.1 2.5 5.7 1.0 3.1 3.5 27.7 3.2 17.1 6.8 7.3 1.3 2.6 3.1 2.7 2.6 4.9 2.2 4.1 3.6 1.6 9.2 4.3 1.0 1.8 10.9 3.2 4.7 3.2 1.2 34.7 8.4 2.0 2.3 3.8 5.9 4.0 4.0 3.5 1.8 3.0 2.4 2.8 1.7 5.2 18.8 12.2 5.3 0.0 0.4 20.8 0.2 15.8 37.7 0.0 227.2 315.4 46.3 80.4 1.3 0.0 6.6 0.6 132.2 19.5 0.2 10.0 0.2 48.2 0.0 6.2 6.4 242.1 0.1 35.1 0.0 0.4 25.0 5.9 139.2 7.6 22.5 0.1 0.2 0.0 109.5 113.3 0.0 0.1 0.1 11.1 0.5 13.6 0.0 14.1 1.0 6.2 7.6 0.0 1.0 354.2 43.1 0.0 18.0 0.1 0.0 0.0 76.1 13.2 70.0 18.2 25.8 0.0 2.4 248.5 0.3 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.1 2.1 2.5 2.6 3.1 4.1 3.6 1.6 3.2 4.0 3.0 5.3 1.1 51.3 23.2 4.2 0.0 1.5 1.6 1.4 34.7 13.2 12.1 4.4 4.3 0.0 31.3 12.9 0.0 3.0 0.0 0.2 0.0 0.2 15.8 13.3 101.6 4.3 0.0 0.0 3.0 0.2 0.6 19.9 0.0 13.9 2.5 8.5 1.1 2.6 1.3 0.0 9.0 0.3 10.2 2.4 1.3 4.2 19.6 2.6 0.0 5.6 4.2 1.6 0.0 31.2 0.1 0.4 2.5 30.1 0.1 0.9 2.3 1.0 1.9 1.4 0.0 1.6 7.7 0.1 1.1 17.5 1.6 1.5 1.5 6.5 1.6 9.6 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 24.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1" "Group enriched" "Detected in many" 6 "granulocytes: 40.4;monocytes: 25.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 1.9 2.5 5.3 4.1 5.3 15.0 1.9 5.9 5.8 2.5 3.6 3.3 18.6 2.0 18.1 7.3 1.6 1.7 1.3 4.9 6.2 3.5 1.7 4.2 1.5 6.8 6.0 4.5 3.3 11.3 3.2 5.2 10.3 6.9 3.6 3.4 16.3 2.8 1.4 5.5 3.4 21.0 2.4 5.9 10.4 1.3 24.1 8.5 1.3 1.6 3.4 1.1 2.0 5.9 6.5 12.0 3.9 8.3 8.1 2.8 4.0 16.6 6.1 10.4 11.9 29.3 6.0 4.2 5.5 5.8 4.6 28.4 3.5 3.6 10.6 10.6 3.5 2.9 12.3 9.3 6.7 2.5 2.3 5.1 4.2 15.6 19.4 1.9 52.5 2.9 6.7 4.4 4.5 9.7 2.8 0.8 17.3 5.0 2.3 8.0 0.9 4.1 5.9 4.5 11.4 2.5 5.4 6.6 3.0 23.6 8.2 6.3 5.3 0.9 12.0 4.7 1.6 36.7 21.6 4.4 3.2 83.9 4.3 74.8 0.0 12.5 21.9 0.4 13.8 0.1 0.3 0.6 0.1 5.1 0.2 1.0 0.3 40.4 0.5 25.1 0.6 0.0 4.9 5.3 5.3 5.9 5.8 4.9 6.2 6.8 6.0 4.5 6.9 5.9 8.5 6.5 0.1 0.0 1.3 13.1 0.3 3.2 0.3 7.0 1.8 6.3 1.6 1.3 1.0 2.8 2.1 0.0 2.1 13.8 0.2 1.3 0.0 2.9 2.8 1.9 2.4 0.8 4.2 0.4 4.5 1.5 40.3 1.2 0.5 3.3 1.3 2.0 1.1 1.0 6.0 6.7 7.3 13.0 2.0 7.8 0.5 2.6 0.9 7.3 1.8 3.7 3.5 3.3 1.0 6.0 13.9 2.9 1.4 0.7 1.8 0.4 43.6 0.2 2.7 4.4 0.0 0.1 1.5 0.5 0.8 2.5 1.7 5.5 0.9 1.3 3.7 0.1 COL7A1 "EBD1, EBDCT, EBR1" ENSG00000114270 "Collagen type VII alpha 1 chain" Q02388 3 48564073-48595329 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 99.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 72.5;Basal respiratory cells: 59.3;Basal squamous epithelial cells: 67.2;Endometrial stromal cells: 45.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 41.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 65.7;HaCaT: 63.5;HBEC3-KT: 100.6;HDLM-2: 97.8;HeLa: 146.2;SiHa: 82.8" "CAB016357, HPA018877, HPA042420" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 6000 "Endoplasmic reticulum" Vesicles "CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990" "unprognostic (2.69e-2)" "unprognostic (4.11e-1)" "unprognostic (1.35e-1)" "unprognostic (3.47e-1)" "unprognostic (4.93e-2)" "prognostic favorable (6.31e-4)" "unprognostic (7.56e-2)" "unprognostic (1.25e-2)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.74e-2)" "unprognostic (0.00e+0)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.86e-2)" 0.7 1.1 1.7 3.8 1.7 0.1 4.9 2.7 2.3 24.3 0.6 2.7 1.7 12.2 6.7 22.0 6.5 4.1 2.7 0.4 5.9 7.4 1.3 1.7 1.2 6.7 2.9 0.4 3.4 0.4 0.0 2.5 1.6 2.6 34.5 1.0 1.4 11.6 12.4 3.5 99.0 4.2 2.5 2.0 6.6 2.2 3.6 5.4 1.2 0.6 0.6 1.3 6.6 29.5 1.6 0.2 25.4 1.2 0.5 9.2 12.3 31.0 65.7 40.8 16.9 10.0 0.4 0.5 0.1 2.0 15.0 15.4 63.5 0.0 100.6 3.1 97.8 0.5 0.2 146.2 4.3 25.6 0.0 0.4 19.9 58.8 34.4 26.8 23.1 0.0 0.7 0.5 0.7 2.0 0.3 0.0 0.9 3.1 1.3 1.3 0.5 2.2 0.2 9.2 0.2 0.2 0.2 82.8 0.1 0.8 3.7 1.3 0.3 0.0 5.6 3.2 3.2 50.1 1.8 1.8 0.1 49.0 0.4 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.7 2.7 2.3 0.4 5.9 6.7 2.9 0.4 2.6 2.0 5.4 1.6 0.4 0.0 0.0 10.7 0.2 72.5 24.1 59.3 67.2 17.7 1.0 10.2 6.6 0.0 10.6 11.0 10.4 1.4 0.1 0.6 0.0 0.9 11.8 3.1 45.3 1.4 1.8 0.0 6.8 0.7 1.0 8.3 1.1 4.0 0.0 0.8 0.4 0.7 1.6 8.4 11.6 0.7 0.0 0.3 4.2 6.3 5.0 0.8 8.8 8.4 0.1 2.6 0.0 4.0 4.4 15.6 0.1 5.7 0.0 5.7 0.2 0.3 2.5 12.9 0.0 2.0 13.4 2.6 1.5 11.3 24.2 1.2 0.8 5.0 0.2 5.8 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139390-192767764 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Growth factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 36.1;heart muscle: 132.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 413.7;Excitatory neurons: 1213.5;Inhibitory neurons: 1925.1;Oligodendrocyte precursor cells: 1668.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;NTERA-2: 10.3;SCLC-21H: 23.9;U-251 MG: 14.7;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071557: AB_2686417" "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.9 36.1 5.2 0.2 14.9 0.1 1.3 0.6 21.8 0.5 0.0 0.9 0.7 1.0 0.2 1.7 1.6 0.5 132.5 16.3 18.1 2.5 0.6 1.1 0.2 11.9 3.1 11.8 0.8 7.7 1.6 5.3 0.4 15.9 1.3 0.3 15.5 6.0 6.0 1.1 0.3 0.3 0.7 0.0 11.7 0.6 2.2 7.3 0.1 1.5 0.8 0.2 0.5 0.7 28.0 0.1 1.1 15.1 0.0 0.0 0.0 0.1 0.0 0.1 1.4 1.7 0.0 0.1 0.8 7.2 0.3 0.3 0.2 0.0 0.0 1.6 0.1 0.2 3.2 6.3 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 3.7 0.2 0.0 0.1 0.1 0.0 4.4 0.0 0.0 10.3 7.1 0.3 0.0 0.1 0.0 4.7 1.8 23.9 0.0 0.0 0.6 0.0 1.7 1.1 0.2 0.4 6.2 3.2 0.0 14.7 0.2 2.5 0.0 1.3 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 14.9 0.6 21.8 16.3 18.1 11.9 3.1 11.8 15.9 0.0 7.3 28.0 17.8 0.0 0.0 42.7 0.1 0.6 4.2 0.0 0.6 100.2 0.9 1.7 413.7 0.0 1.9 5.5 4.2 0.2 0.0 0.0 7.9 0.7 20.9 1.6 1.6 13.2 0.0 0.0 1213.5 13.1 0.4 18.6 0.5 0.5 0.0 9.0 16.4 0.0 0.1 33.7 1925.1 0.0 0.0 0.3 0.3 38.5 6.8 0.1 1.8 46.9 0.0 3.8 0.0 1668.3 28.2 2.7 1.2 1.2 0.5 1.1 0.0 0.4 0.8 14.2 0.0 0.7 4.8 4.0 8.0 0.4 0.1 0.0 0.1 38.7 0.1 1.7 PRKAR2A PRKAR2 ENSG00000114302 "Protein kinase cAMP-dependent type II regulatory subunit alpha" P13861 3 48744597-48847874 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.5;testis: 83.1" "Group enriched" "Detected in all" 8 "Early spermatids: 788.7;Late spermatids: 1370.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005023, HPA038268" Uncertain NA NA 210000 "CAB005023: AB_562330, HPA038268: AB_2675921" "unprognostic (2.81e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.01e-2)" "unprognostic (6.17e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (4.77e-2)" "unprognostic (2.65e-1)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (9.18e-2)" "prognostic favorable (2.07e-4)" "unprognostic (3.59e-2)" "unprognostic (3.54e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-2)" 19.2 15.0 8.5 11.7 7.4 18.7 13.1 8.0 9.5 10.5 10.7 23.7 13.0 10.0 9.4 18.7 17.7 8.3 17.4 8.1 12.2 18.2 16.0 12.6 9.0 12.5 9.1 6.5 10.8 12.6 16.6 6.9 11.5 11.3 14.4 19.8 15.9 17.2 14.6 83.5 14.0 14.0 16.4 11.7 9.4 14.3 83.1 10.7 4.9 17.4 39.7 12.6 11.9 10.1 12.4 39.2 25.9 21.2 16.4 31.1 31.4 23.8 44.0 21.8 37.7 23.7 34.4 17.1 34.3 30.1 45.7 24.4 17.6 61.0 38.4 50.4 28.3 22.6 45.8 44.7 25.4 22.8 48.6 28.3 26.2 29.5 48.5 35.4 14.1 40.2 11.5 52.3 21.4 35.9 15.2 0.4 15.7 15.1 28.6 28.4 14.7 26.9 43.6 24.2 42.4 21.0 21.6 43.2 50.8 29.1 22.8 34.2 37.1 51.5 33.0 26.3 54.2 61.0 36.2 76.4 32.5 44.5 52.5 25.4 8.0 6.5 8.0 6.7 6.1 6.6 6.0 5.8 5.8 6.3 5.0 3.9 4.0 9.2 7.0 12.0 3.9 5.5 5.2 8.5 7.4 8.0 9.5 8.1 12.2 12.5 9.1 6.5 11.3 11.7 10.7 12.4 61.5 19.2 62.2 42.1 36.5 41.9 25.5 26.9 48.9 44.2 51.0 34.9 70.8 50.1 33.1 46.0 68.8 25.0 61.2 92.3 21.5 41.3 788.7 64.2 60.4 48.8 42.0 22.9 62.4 60.3 34.6 37.6 43.8 41.3 13.3 29.4 55.0 121.4 48.8 62.2 73.1 42.5 34.6 52.2 45.3 1370.7 55.0 48.0 30.2 38.4 48.3 24.8 39.1 42.7 90.9 66.4 46.9 55.7 48.6 34.0 45.2 41.2 50.3 46.2 52.6 51.8 46.6 82.1 61.0 79.0 62.8 23.5 54.1 32.8 87.9 26.6 HES1 "bHLHb39, FLJ20408, HES-1, HRY" ENSG00000114315 "Hes family bHLH transcription factor 1" Q14469 3 194136148-194138732 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "eosinophil: 15.6" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.6" "Cell line enhanced" "Detected in many" "hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066929 Supported Nucleoplasm NA NA Nucleoplasm "HPA066929: AB_2732753" "unprognostic (1.79e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.01e-2)" "unprognostic (1.05e-1)" "unprognostic (4.64e-1)" "unprognostic (2.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.40e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.04e-5)" 58.6 32.5 14.4 8.0 15.0 0.9 87.8 13.6 15.5 47.0 14.1 35.8 31.5 22.7 9.1 128.8 22.6 17.9 54.2 14.7 35.3 84.1 69.2 47.5 7.1 15.3 17.1 10.5 25.5 35.1 22.8 43.1 27.7 14.5 90.8 36.1 67.1 80.6 31.8 70.4 179.4 24.1 9.9 13.1 23.6 42.5 12.9 15.3 12.0 93.9 22.6 11.9 60.3 137.7 15.6 9.3 2.6 20.8 27.1 6.1 0.0 5.2 4.3 12.2 0.9 0.5 36.4 26.1 1.3 74.6 1.6 12.6 51.4 3.9 24.2 0.3 7.7 44.0 33.1 3.5 9.4 0.1 0.2 30.1 2.2 94.1 0.8 10.9 14.3 28.6 1.7 16.1 1.2 0.0 43.9 47.5 45.7 19.4 95.8 17.8 0.1 1.5 1.0 28.0 71.2 1.2 1.6 21.0 78.9 38.9 23.6 22.2 2.6 22.3 2.3 21.8 0.3 31.3 0.2 0.1 0.2 1.6 0.1 43.7 0.0 0.0 15.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 14.4 15.0 13.6 15.5 14.7 35.3 15.3 17.1 10.5 14.5 13.1 15.3 15.6 684.0 25.6 96.0 70.2 54.2 122.9 498.5 736.7 159.4 15.9 352.0 164.1 128.8 517.6 355.1 196.8 16.7 41.1 4.7 696.8 189.8 268.9 2.2 231.9 37.6 401.8 160.1 19.2 1.2 199.1 6.0 274.1 105.0 257.4 303.4 16.1 850.6 163.1 24.4 10.1 0.4 579.7 213.6 95.3 76.2 8.7 58.7 74.6 80.0 5.6 22.8 1146.0 0.0 4.5 0.1 227.1 1137.2 18.8 5.0 231.1 297.5 126.6 190.2 54.9 164.3 76.8 291.7 1.2 13.2 367.8 296.5 209.2 24.1 31.4 882.7 358.1 USP4 "UNP, Unph" ENSG00000114316 "Ubiquitin specific peptidase 4" Q13107 3 49277144-49340712 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 131.8;Late spermatids: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018499 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA018499: AB_1858689" "unprognostic (2.34e-3)" "unprognostic (1.52e-1)" "unprognostic (2.22e-3)" "unprognostic (6.12e-2)" "unprognostic (3.51e-1)" "unprognostic (4.33e-2)" "unprognostic (9.42e-2)" "prognostic favorable (4.46e-5)" "unprognostic (3.54e-1)" "unprognostic (9.07e-3)" "unprognostic (2.78e-2)" "unprognostic (1.70e-3)" "prognostic favorable (4.29e-5)" "unprognostic (7.30e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 25.4 20.5 24.2 26.8 27.0 54.2 25.2 24.5 28.4 26.2 27.1 23.9 18.5 24.6 21.8 26.2 22.6 18.5 26.2 23.5 24.3 21.8 20.4 29.8 31.1 23.9 24.7 23.1 24.7 19.1 24.3 16.5 23.5 24.5 23.9 23.6 27.2 21.1 21.9 31.9 31.6 22.7 24.3 22.8 33.9 20.3 28.2 24.1 37.3 23.2 29.1 34.0 26.1 25.2 26.2 14.2 15.8 21.6 28.8 38.7 40.1 14.7 36.4 32.9 46.7 41.3 16.8 34.8 27.1 14.4 53.9 27.4 18.9 28.6 52.6 42.5 42.1 8.4 60.3 31.9 19.6 57.0 32.5 34.0 42.8 23.3 51.0 41.5 34.3 55.0 29.9 21.6 41.6 42.1 24.5 38.3 55.8 18.7 17.7 26.9 15.6 13.3 23.9 37.5 29.2 17.5 24.0 27.2 19.3 14.0 21.6 13.5 51.2 50.1 31.1 17.2 39.6 22.5 33.6 17.3 38.6 28.6 50.1 36.5 70.1 83.6 94.8 48.1 69.2 53.7 51.0 50.2 48.9 74.6 41.4 47.7 42.2 179.2 72.4 81.2 28.4 59.7 78.0 24.2 27.0 24.5 28.4 23.5 24.3 23.9 24.7 23.1 24.5 22.8 24.1 26.2 24.3 41.7 25.1 28.1 24.7 18.7 17.9 17.2 22.2 17.5 10.9 10.3 17.9 10.0 23.2 20.2 20.9 22.7 27.9 13.6 21.5 16.5 131.8 17.3 18.3 22.1 10.7 31.6 30.8 13.6 14.3 17.9 27.5 21.1 33.6 21.4 17.5 14.6 24.0 11.8 26.4 13.8 16.2 38.6 21.0 104.9 15.5 34.2 16.0 16.9 36.0 13.9 23.7 25.6 20.2 18.9 7.6 19.2 29.2 17.6 14.5 13.4 28.6 20.5 13.1 18.4 17.0 35.3 14.5 17.9 18.5 24.2 29.4 17.0 13.9 14.5 ACAP2 "CENTB2, CNT-B2, KIAA0041" ENSG00000114331 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 2" Q15057 3 195274745-195443044 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 215.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034807, HPA034808" Supported Approved Endosomes NA NA Endosomes "HPA034807: AB_10669896, HPA034808: AB_10673103" "unprognostic (9.13e-2)" "unprognostic (1.75e-3)" "unprognostic (7.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.90e-2)" "unprognostic (5.64e-2)" "unprognostic (3.08e-3)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (3.77e-2)" "unprognostic (8.54e-2)" 16.0 10.3 12.2 22.4 11.4 39.9 13.6 23.0 15.8 14.4 4.0 17.1 14.1 14.6 11.0 21.9 12.3 14.3 8.3 13.4 15.8 10.4 11.9 15.8 27.1 4.0 7.1 10.2 19.1 9.1 13.3 8.5 15.7 9.0 10.8 17.5 29.7 9.6 10.5 5.3 15.6 15.4 14.6 4.2 23.8 14.1 15.3 5.8 21.2 21.9 9.8 28.1 13.6 11.6 9.1 34.6 13.5 21.5 21.1 34.3 41.9 31.6 28.0 37.2 20.5 21.4 18.5 19.8 38.7 65.7 25.8 20.0 21.6 16.5 14.0 29.4 43.4 9.7 38.5 14.2 7.6 33.5 52.5 26.7 32.3 24.0 20.4 46.1 17.6 22.7 21.4 19.1 37.0 30.3 20.3 33.7 19.1 13.0 19.8 18.1 39.7 24.8 27.8 14.1 32.2 23.8 11.5 30.7 27.4 32.9 18.2 51.7 30.6 40.3 25.9 14.7 34.6 32.7 21.8 50.2 84.0 19.1 56.2 27.5 62.8 55.2 55.3 27.5 49.0 21.2 39.3 26.1 21.3 32.9 45.6 22.0 22.4 215.8 17.6 59.0 34.4 26.2 25.4 12.2 11.4 23.0 15.8 13.4 15.8 4.0 7.1 10.2 9.0 4.2 5.8 9.1 110.7 44.8 40.9 103.8 103.1 44.5 28.8 45.1 88.2 58.7 43.1 50.3 17.9 22.8 43.4 31.3 77.2 20.2 101.9 75.8 19.6 24.1 11.1 49.7 60.4 74.1 51.6 50.1 141.2 24.3 22.2 62.2 44.4 49.7 39.9 33.5 57.5 32.5 65.4 121.1 143.1 44.4 22.4 115.7 67.5 9.7 46.6 110.8 35.6 143.4 122.3 29.1 68.0 132.7 130.1 31.7 70.7 37.6 67.6 41.5 39.3 28.6 45.1 92.6 59.2 43.8 61.4 39.6 26.7 143.7 51.7 29.0 85.1 43.0 37.6 38.6 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Spermatocytes: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 3.7 3.3 2.2 8.3 1.9 20.0 7.5 3.3 3.4 8.2 1.4 11.6 9.4 4.5 1.8 9.0 3.3 5.3 3.2 2.6 2.0 4.4 2.7 5.2 10.6 2.4 1.9 1.8 1.3 3.0 3.6 1.2 8.8 2.9 3.3 15.9 12.6 5.7 2.6 2.1 7.1 7.6 7.5 0.5 4.4 9.5 16.0 2.2 23.5 3.9 2.7 11.5 6.9 4.3 3.6 192.0 133.6 103.2 54.0 10.6 21.8 51.6 81.5 67.5 121.4 116.9 74.7 196.9 47.2 122.1 48.8 116.0 81.8 84.2 53.1 164.3 67.8 46.6 29.6 70.0 38.5 4.6 46.2 32.8 7.1 9.0 72.2 73.2 34.0 53.0 68.6 31.3 67.2 97.2 67.6 47.5 34.6 84.4 156.7 72.0 33.7 101.1 60.7 92.2 43.7 68.6 44.1 104.5 117.4 42.2 51.5 195.4 34.1 46.5 58.5 55.7 79.6 174.9 32.8 47.2 88.2 51.6 39.7 78.0 6.0 2.0 0.7 1.0 1.7 1.1 1.4 1.4 0.9 1.6 1.3 0.6 0.9 6.3 0.7 0.7 1.6 2.5 0.7 2.2 1.9 3.3 3.4 2.6 2.0 2.4 1.9 1.8 2.9 0.5 2.2 3.6 6.7 6.4 3.2 4.2 3.8 19.5 4.9 6.2 9.1 3.4 10.1 6.5 3.6 5.7 5.7 3.7 64.6 12.0 2.9 10.7 0.0 9.5 3.3 20.1 6.6 7.7 4.8 25.2 6.5 9.2 14.9 6.0 17.9 20.5 0.0 17.9 5.3 2.9 7.3 0.0 2.5 13.5 10.2 4.7 6.3 2.8 0.9 5.1 7.2 15.0 2.8 3.1 2.1 3.0 4.9 20.7 3.8 1.5 9.6 12.8 1.5 3.7 11.0 16.3 0.0 2.9 5.2 42.6 30.4 16.9 12.8 3.8 4.1 3.3 13.5 8.8 GNAT1 CSNBAD3 ENSG00000114349 "G protein subunit alpha transducin 1" P11488 3 50191610-50197696 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 905 "retina: 1129.9" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 2275.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "hippocampal formation: 6.5" "Not detected" "Not detected" HPA045393 Enhanced NA NA "HPA045393: AB_2679310" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (8.56e-3)" "unprognostic (3.32e-2)" "unprognostic (2.13e-1)" "unprognostic (7.72e-2)" "unprognostic (2.82e-3)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.87e-1)" "unprognostic (3.02e-1)" "unprognostic (9.48e-3)" 0.1 0.1 0.4 0.1 0.3 0.7 0.2 0.9 0.5 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.2 1129.9 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.9 0.5 0.3 0.2 0.2 0.2 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 222.9 0.1 0.1 0.4 0.0 0.0 0.0 241.8 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.1 13.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 90.9 0.0 0.0 0.0 0.0 0.0 38.2 0.6 0.0 0.0 0.0 0.0 397.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2275.4 0.0 0.0 0.0 4.7 2.1 0.7 0.0 0.1 0.0 0.1 0.1 0.1 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259362 "Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 656.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 4000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 212.1 101.2 141.3 219.9 148.3 370.4 154.1 155.3 183.0 147.2 120.5 119.8 70.5 142.8 67.5 125.5 138.1 153.8 158.6 131.3 182.7 78.6 127.5 216.4 253.4 187.7 149.8 123.1 149.1 64.6 67.4 100.0 243.8 178.1 104.6 65.0 35.9 72.5 158.4 70.0 87.7 103.9 155.3 162.4 264.4 74.2 70.1 167.3 161.8 102.1 90.2 171.8 171.2 109.3 185.3 128.2 63.0 186.3 197.6 220.7 277.5 35.5 271.1 399.6 354.9 361.1 70.4 173.2 149.1 119.2 567.0 193.4 100.1 132.8 350.3 222.8 331.2 50.9 364.8 158.0 110.2 219.8 329.2 479.8 270.3 152.9 319.1 129.8 289.6 837.8 124.1 26.1 307.1 357.5 155.7 313.6 433.0 109.7 59.0 302.4 185.0 89.8 219.7 232.6 130.9 48.4 86.1 189.5 57.1 124.4 150.4 94.3 346.1 792.3 330.9 187.5 309.2 274.7 199.4 278.3 127.0 373.6 466.9 398.1 16.6 59.3 113.7 33.7 80.9 20.2 28.8 26.8 34.3 57.3 26.1 20.2 25.8 145.2 23.5 74.5 47.2 34.0 27.3 141.3 148.3 155.3 183.0 131.3 182.7 187.7 149.8 123.1 178.1 162.4 167.3 185.3 656.8 41.7 32.1 25.1 119.5 56.7 59.7 32.3 45.5 29.0 61.6 83.8 22.9 55.8 26.6 44.1 14.6 79.5 311.4 11.7 5.9 124.3 203.3 57.8 115.7 340.3 92.2 52.1 12.4 60.5 84.4 101.9 21.9 71.8 89.9 150.0 221.3 79.7 336.0 6.7 14.8 24.6 18.3 342.7 291.7 302.0 90.7 386.1 83.6 58.1 356.6 292.6 151.4 26.7 45.4 160.3 40.9 95.5 104.8 46.1 30.3 24.5 24.4 21.9 52.6 85.3 163.1 16.6 22.6 37.6 62.9 116.4 164.9 156.3 20.5 70.1 TFG "FLJ36137, SPG57, TF6" ENSG00000114354 "Trafficking from ER to golgi regulator" Q92734 3 100709295-100748964 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019473, HPA052206" Approved Supported Vesicles,Cytosol No No 320000 Vesicles Cytosol "HPA019473: AB_1857936, HPA052206: AB_2681760" "unprognostic (1.14e-1)" "unprognostic (3.58e-2)" "unprognostic (1.46e-1)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.31e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.82e-1)" "unprognostic (8.55e-2)" "unprognostic (3.33e-1)" "unprognostic (8.45e-2)" 59.2 73.6 42.0 37.5 42.7 37.7 52.9 44.5 46.8 53.3 46.5 64.4 90.6 52.4 79.2 86.4 51.7 56.9 83.1 42.3 47.6 63.5 114.8 56.0 29.6 45.5 43.1 39.9 48.6 67.3 89.7 64.6 79.8 45.0 48.3 70.3 41.2 61.1 61.8 76.1 58.9 77.2 67.0 43.3 43.0 54.9 48.1 43.4 41.0 64.7 58.7 55.4 62.2 57.8 45.4 203.8 107.5 126.7 79.0 160.1 176.4 163.9 141.1 190.4 182.5 213.0 136.0 96.1 24.7 103.3 180.4 141.3 143.1 143.4 161.5 216.2 123.8 87.4 99.7 69.3 130.0 183.3 70.2 51.8 149.3 216.6 108.4 190.8 165.1 165.5 44.5 73.1 63.5 191.9 143.9 63.3 56.7 122.5 193.8 169.3 55.5 77.8 89.0 226.5 125.9 96.4 93.1 95.0 118.2 175.8 103.4 141.7 103.1 113.1 103.0 130.8 48.4 104.4 56.2 65.8 92.1 171.2 79.7 130.7 84.3 43.6 42.8 30.8 45.2 37.4 37.4 31.6 34.5 43.1 35.9 29.4 29.7 26.1 43.1 44.8 29.3 41.0 37.0 42.0 42.7 44.5 46.8 42.3 47.6 45.5 43.1 39.9 45.0 43.3 43.4 45.4 67.9 60.9 36.9 46.4 43.3 136.6 105.9 183.6 69.4 46.8 58.0 50.2 83.5 48.6 93.1 36.8 25.0 211.6 43.1 111.8 137.0 190.3 101.5 70.8 70.4 70.2 52.6 27.1 54.8 107.7 201.5 97.8 47.4 79.0 76.8 62.9 53.9 68.4 86.2 57.2 59.2 128.5 122.1 27.3 84.9 45.5 70.8 43.6 64.0 38.4 98.5 88.0 28.8 49.3 55.0 130.5 91.0 74.1 75.8 133.5 202.5 106.4 63.9 60.3 39.5 81.3 87.2 79.2 51.5 68.0 118.9 284.4 43.2 90.0 97.2 123.0 USP9Y "AZFA, DFFRY" ENSG00000114374 "Ubiquitin specific peptidase 9 Y-linked" O00507 Y 12537650-12860839 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Excitatory neurons: 89.5;Inhibitory neurons: 69.5" "Cancer enhanced" "Detected in many" "prostate cancer: 5.7" "Region enhanced" "Detected in many" "white matter: 18.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 21.5;RT4: 17.4" "Not detected" "Not detected" HPA057687 Uncertain Vesicles NA NA Vesicles "HPA057687: " "unprognostic (2.63e-1)" "unprognostic (8.97e-2)" "unprognostic (1.10e-5)" "unprognostic (8.46e-3)" "unprognostic (4.93e-2)" "unprognostic (2.53e-2)" "unprognostic (2.77e-1)" "unprognostic (3.17e-2)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-4)" "unprognostic (2.28e-1)" "unprognostic (1.19e-2)" "unprognostic (1.42e-1)" 3.6 5.2 2.7 1.7 1.8 2.6 3.4 0.5 11.6 0.0 0.0 4.0 1.8 0.0 7.2 5.2 0.0 4.6 5.4 4.9 0.0 5.6 3.1 5.3 2.2 2.9 0.0 0.0 0.0 6.1 3.5 8.9 2.3 5.1 9.8 4.9 13.0 4.9 7.1 5.2 3.0 4.5 0.0 0.0 5.1 3.9 4.2 6.6 0.0 5.8 9.8 5.7 4.6 0.0 18.0 0.0 4.7 0.0 0.0 0.0 0.0 5.3 14.2 14.6 7.2 8.5 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 8.6 8.1 0.0 7.3 0.0 9.5 5.8 0.0 0.0 9.7 8.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 12.2 0.0 9.8 0.0 4.6 0.0 0.0 0.0 3.5 2.1 21.5 17.4 7.2 0.0 0.0 0.0 4.4 12.5 0.0 0.2 10.6 9.5 0.0 0.0 7.0 0.0 9.7 15.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.4 0.7 0.5 0.1 0.7 0.8 0.5 0.0 0.1 0.0 0.6 0.6 0.0 2.7 1.8 0.5 11.6 4.9 0.0 2.9 0.0 0.0 5.1 0.0 6.6 18.0 0.0 25.6 23.5 29.4 11.0 11.7 8.5 9.5 18.2 23.6 0.0 0.0 26.5 7.2 12.6 20.2 64.6 6.3 5.3 0.3 1.9 6.9 0.5 0.0 0.0 5.8 0.0 5.9 89.5 0.0 1.7 8.1 6.6 0.0 2.5 0.0 6.1 2.3 3.1 26.9 69.5 1.1 8.2 5.6 9.3 1.1 12.5 3.6 3.6 31.9 3.6 8.8 14.4 28.6 17.4 2.3 0.0 15.4 4.1 13.2 0.7 6.3 19.9 23.1 0.0 5.2 4.4 2.8 2.6 20.6 11.6 3.4 14.7 0.0 1.5 11.9 HYAL1 "HYAL-1, LUCA1" ENSG00000114378 "Hyaluronidase 1" Q12794 3 50299890-50312381 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 203.2;lymphoid tissue: 95.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2" "Cancer enhanced" "Detected in all" "liver cancer: 37.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 100.9;SK-BR-3: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002112 Uncertain "Secreted to blood" NA NA 590000 "HPA002112: AB_1857412" "unprognostic (1.39e-1)" "unprognostic (8.68e-2)" "prognostic favorable (2.07e-4)" "unprognostic (5.23e-2)" "unprognostic (3.18e-1)" "unprognostic (8.71e-2)" "unprognostic (9.35e-2)" "unprognostic (3.59e-2)" "unprognostic (6.56e-2)" "unprognostic (1.31e-1)" "unprognostic (6.65e-3)" "unprognostic (1.16e-1)" "prognostic favorable (1.56e-11)" "unprognostic (4.51e-2)" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.90e-2)" 9.5 21.7 4.7 2.9 4.4 0.3 9.2 6.2 6.3 8.5 15.8 5.5 3.5 8.2 0.8 5.6 7.4 13.4 43.8 4.3 3.8 49.4 203.2 31.0 1.8 5.2 4.6 3.7 3.0 9.5 20.0 3.3 2.5 5.0 4.6 2.9 3.1 7.4 2.9 15.2 20.3 6.0 6.0 3.1 95.9 19.6 1.7 5.1 0.8 8.3 19.2 1.3 4.9 12.4 4.5 2.9 1.8 0.4 0.9 0.6 0.7 0.5 0.1 0.3 0.1 0.4 11.4 3.1 0.0 0.8 0.6 0.6 6.6 0.2 0.4 0.0 0.1 0.0 0.3 8.6 100.9 4.4 0.7 0.7 3.9 13.8 0.1 0.4 0.8 2.9 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.6 7.1 0.6 0.0 0.2 0.3 5.9 0.4 0.2 2.1 0.2 28.0 0.3 2.4 2.0 0.3 1.9 0.6 0.6 0.6 0.3 0.2 0.3 0.4 0.4 0.6 0.3 1.3 0.4 1.5 0.3 0.1 0.8 0.4 0.3 0.4 0.2 0.5 0.6 0.4 3.1 0.3 0.3 0.5 0.4 0.1 4.7 4.4 6.2 6.3 4.3 3.8 5.2 4.6 3.7 5.0 3.1 5.1 4.5 18.1 19.2 18.5 1.6 0.3 2.9 0.4 3.3 0.0 1.0 0.3 0.1 20.8 30.0 2.0 11.0 4.2 0.1 0.0 2.5 23.5 16.5 8.2 0.2 0.9 25.8 1.8 2.7 3.1 14.4 0.1 3.3 19.4 0.2 0.0 0.6 33.2 137.1 0.1 0.0 3.1 1.4 0.0 4.4 0.9 7.7 2.1 0.9 0.0 7.5 0.0 0.4 0.0 1.5 1.6 12.1 0.3 1.2 0.0 0.2 0.4 58.2 0.9 0.5 6.6 1.2 4.3 0.4 1.1 0.9 3.1 0.7 0.9 7.4 0.9 1.7 TUSC2 "C3orf11, FUS1, PAP, PDAP2" ENSG00000114383 "Tumor suppressor 2, mitochondrial calcium regulator" O75896 3 50320027-50328251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 351.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030116 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA030116: AB_10602253" "unprognostic (1.58e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (8.46e-2)" "unprognostic (2.73e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (2.53e-3)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.47e-2)" "unprognostic (1.99e-2)" "prognostic favorable (8.70e-7)" "unprognostic (9.22e-3)" "unprognostic (1.98e-1)" "unprognostic (3.15e-1)" "unprognostic (6.34e-3)" 16.8 25.6 56.4 15.1 57.3 12.5 17.2 54.3 58.5 15.6 47.0 24.2 12.9 17.9 28.4 19.1 20.7 11.6 30.8 56.8 57.5 28.9 26.1 18.6 17.2 56.3 59.1 56.3 16.0 27.6 35.0 21.7 17.4 59.9 22.3 16.7 36.3 18.6 18.0 51.3 13.5 20.5 13.8 52.5 23.9 27.1 22.7 58.1 20.6 23.3 36.7 20.7 20.7 14.3 58.9 24.7 20.2 27.5 30.1 29.8 15.4 30.1 19.3 26.5 36.3 30.7 35.6 22.0 41.8 21.0 18.3 37.4 15.5 33.9 25.7 31.7 24.8 31.2 20.6 18.6 38.7 26.1 36.7 34.8 16.8 40.7 36.5 18.1 25.5 38.0 32.8 25.4 19.6 21.1 18.8 38.7 46.5 37.6 30.4 28.9 13.3 13.4 34.4 36.9 26.4 14.7 30.3 14.4 25.4 29.9 27.2 24.2 44.3 30.3 10.8 26.6 24.8 40.2 47.6 79.7 29.4 24.2 24.1 17.4 16.7 21.2 34.6 24.0 19.6 24.3 23.0 20.8 25.2 14.2 24.6 23.5 25.2 30.2 22.4 18.1 26.3 25.2 32.3 56.4 57.3 54.3 58.5 56.8 57.5 56.3 59.1 56.3 59.9 52.5 58.1 58.9 39.8 12.8 17.0 3.9 41.7 57.5 36.8 60.7 37.0 55.5 61.0 44.2 39.6 55.8 37.9 57.0 22.9 62.9 54.4 46.5 115.4 73.9 123.1 55.6 15.8 39.2 50.4 40.4 12.9 74.1 55.5 24.9 25.0 28.4 29.9 16.4 40.4 72.7 76.6 74.0 11.4 46.1 73.2 46.1 51.1 351.8 27.1 37.7 55.2 5.6 57.6 69.0 59.8 4.0 7.8 74.0 61.0 24.8 45.8 67.8 72.0 178.6 71.5 45.5 13.1 18.0 38.5 54.1 49.2 47.4 91.2 69.6 38.7 28.9 46.1 63.7 NPRL2 "NPR2, NPR2L, TUSC4" ENSG00000114388 "NPR2 like, GATOR1 complex subunit" Q8WTW4 3 50347330-50350826 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038196, HPA038197" Approved NA NA "HPA038196: AB_10675631, HPA038197: AB_10671523" "unprognostic (7.25e-3)" "unprognostic (2.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-2)" "unprognostic (3.06e-3)" "prognostic favorable (1.59e-4)" "unprognostic (7.86e-2)" "unprognostic (1.22e-2)" "unprognostic (1.60e-3)" "unprognostic (5.69e-2)" "unprognostic (4.28e-2)" "unprognostic (4.55e-2)" "unprognostic (3.14e-1)" "unprognostic (4.49e-1)" "unprognostic (3.06e-2)" 4.8 9.3 9.8 5.0 10.3 5.1 7.5 10.4 11.1 9.1 9.8 8.4 5.4 5.4 11.2 6.9 8.9 6.3 10.4 10.3 11.3 9.4 13.0 5.1 8.1 10.4 10.7 9.8 7.9 16.5 12.2 9.0 5.7 10.6 7.8 8.6 5.7 12.2 8.2 14.9 7.6 5.6 7.0 10.6 6.9 7.3 7.8 10.4 9.7 8.3 18.2 9.3 5.9 5.4 11.5 12.2 11.9 7.9 14.5 22.5 11.8 8.2 6.4 16.5 17.1 16.8 9.3 11.0 13.9 9.5 11.9 8.6 6.7 18.1 18.5 12.3 10.0 12.9 16.6 10.0 18.2 20.2 20.7 21.9 14.3 19.3 21.8 15.0 11.5 16.8 20.2 9.5 13.6 14.7 2.4 19.3 14.8 8.7 37.2 33.4 7.1 5.0 34.5 19.7 12.1 6.0 14.1 7.3 11.1 12.5 8.2 17.5 10.4 6.0 7.2 9.2 13.8 11.7 16.8 22.0 11.8 14.6 25.5 7.3 40.6 17.4 46.7 72.7 18.1 63.4 23.2 36.4 62.7 20.6 21.1 30.8 48.5 22.9 64.1 20.8 16.6 49.8 50.7 9.8 10.3 10.4 11.1 10.3 11.3 10.4 10.7 9.8 10.6 10.6 10.4 11.5 13.4 9.6 11.9 7.8 19.0 12.0 9.8 26.7 14.8 18.4 18.2 19.9 13.2 15.7 16.3 14.7 20.9 27.4 31.4 15.8 37.2 15.9 94.6 8.1 9.4 11.3 11.9 30.3 7.2 15.0 21.5 12.9 18.3 7.1 19.0 12.6 11.7 14.8 14.7 25.2 7.9 20.9 38.7 13.2 10.3 66.6 19.3 7.4 12.4 2.8 15.0 15.0 68.0 5.0 6.5 12.2 12.8 15.1 19.4 7.7 30.7 30.0 15.6 26.4 6.6 11.1 22.1 16.8 14.9 15.4 12.5 9.0 29.3 16.0 18.8 7.7 RPL24 L24 ENSG00000114391 "Ribosomal protein L24" P83731 3 101681091-101686718 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051653 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 44000 "Endoplasmic reticulum, Cytosol" "HPA051653: AB_2681564" "unprognostic (7.32e-2)" "unprognostic (2.11e-1)" "unprognostic (9.46e-2)" "unprognostic (1.78e-2)" "unprognostic (2.95e-3)" "unprognostic (1.22e-1)" "unprognostic (1.79e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.29e-2)" "unprognostic (1.55e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (4.98e-2)" "unprognostic (4.08e-1)" "prognostic favorable (8.25e-4)" "unprognostic (5.37e-2)" 1204.7 972.8 1202.3 803.2 1218.8 1829.1 2037.0 1231.8 1817.5 1706.0 1215.2 1143.2 851.4 1284.6 1672.6 1164.4 1374.9 715.8 1141.7 1176.2 1253.0 1075.1 1205.1 890.0 1527.1 1215.3 1197.6 1166.6 2912.8 2006.4 976.2 1110.2 897.2 1215.5 1134.5 946.9 593.4 1619.3 803.1 1515.7 1248.3 873.5 829.6 1252.7 925.0 1126.6 326.9 1220.4 1572.7 1228.0 1359.0 1349.6 1233.6 1293.3 1252.1 3341.0 1122.5 1638.4 1892.9 1823.4 3249.1 2499.1 1832.0 2161.4 2560.1 1868.3 2262.4 1480.2 3669.7 2253.5 1494.6 1002.0 1749.4 1967.8 2398.5 2584.5 1982.6 1939.0 2147.6 857.8 1715.0 1772.2 2451.8 1122.7 3142.6 3062.3 1585.9 2863.5 2474.3 2226.2 1741.3 2028.0 1830.4 2427.7 2323.0 2566.8 3835.9 2991.2 3052.1 2372.1 2332.6 1598.0 3622.8 2686.7 1508.6 3587.0 1629.7 966.3 1775.0 4454.7 1413.3 2184.7 4483.3 1579.9 1138.3 2019.4 613.4 2332.7 1512.4 2049.7 6425.0 1484.6 2643.4 1919.2 668.3 1239.3 311.8 1468.5 1083.5 2151.6 2246.8 2305.6 1787.9 1641.5 2185.0 2880.6 2249.1 194.6 1677.3 1115.5 1957.8 2261.4 4700.1 1202.3 1218.8 1231.8 1817.5 1176.2 1253.0 1215.3 1197.6 1166.6 1215.5 1252.7 1220.4 1252.1 1628.0 948.7 1279.6 15.7 2074.3 2283.7 3314.0 1938.2 2129.6 268.3 2541.6 4149.7 333.2 1313.9 1327.7 610.6 85.5 2064.2 1870.1 882.2 2267.6 1579.1 885.8 1200.6 2281.6 1502.9 1364.3 1421.6 22.5 2930.3 3255.0 1518.4 813.5 1574.5 1350.0 1547.4 1509.5 1509.9 1594.8 117.8 22.0 2147.0 708.0 1759.2 2028.7 689.6 3003.4 1452.0 1378.5 30.0 2166.2 1045.3 1578.8 20.1 26.8 2412.1 1728.7 1501.5 1499.8 3372.3 1679.5 2895.9 676.1 432.6 874.4 2783.8 2675.9 498.4 345.7 2210.2 2326.7 2341.6 1952.8 2206.1 2242.3 3363.9 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350845-50358460 "Enzymes, Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071862 Approved NA NA "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 12.5 20.9 8.6 16.8 10.2 22.2 14.1 10.1 9.3 10.7 10.6 19.9 22.2 7.7 26.0 14.7 9.8 14.8 9.9 8.6 10.2 19.9 34.6 14.2 22.4 10.3 10.3 8.3 7.0 19.6 18.3 13.9 11.2 10.0 16.5 18.2 3.1 20.5 11.6 10.1 9.4 22.9 7.2 10.1 24.9 21.9 10.6 9.5 13.3 20.5 3.6 15.4 12.4 9.4 12.2 16.2 33.5 8.4 15.8 17.2 14.7 19.2 27.4 20.4 24.5 28.0 24.1 25.3 25.3 29.3 33.8 29.8 16.5 12.8 25.2 10.7 38.5 31.9 23.7 40.7 22.5 24.2 26.3 52.3 23.0 11.3 29.3 13.5 12.4 21.1 19.1 10.5 32.3 19.7 30.3 17.0 22.9 13.4 24.6 52.1 11.6 5.8 50.2 26.3 27.0 8.4 23.7 13.7 56.1 17.5 8.4 19.8 30.9 23.1 22.5 18.9 37.6 35.8 24.6 26.2 16.8 30.2 32.1 24.4 145.8 113.9 176.1 144.3 140.1 95.6 88.4 96.1 115.7 86.3 79.3 67.1 99.6 110.8 109.3 136.2 89.0 114.7 112.4 8.6 10.2 10.1 9.3 8.6 10.2 10.3 10.3 8.3 10.0 10.1 9.5 12.2 13.3 6.4 21.7 5.5 24.4 5.0 12.0 37.4 8.6 6.8 26.5 12.3 0.0 0.0 30.9 25.8 6.2 35.0 40.2 47.1 11.7 44.9 19.9 19.7 14.7 9.1 31.8 6.7 6.7 68.1 46.0 13.0 31.1 18.4 21.5 8.4 0.0 0.0 57.3 8.4 5.8 47.0 46.8 0.0 12.3 9.1 8.7 29.1 19.6 6.5 36.2 22.2 45.3 6.0 13.3 43.3 49.4 7.9 36.7 17.9 55.6 22.3 38.4 8.2 13.1 8.0 15.6 6.1 14.1 14.0 7.4 55.1 32.9 15.9 28.1 18.4 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62319015-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 159.7;Spermatocytes: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 28.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 408.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 7.4 16.1 33.5 6.0 38.1 1.3 36.0 33.1 44.9 6.6 24.4 7.3 3.5 7.8 8.2 18.9 4.2 6.5 8.2 36.9 37.4 13.8 3.4 6.9 5.8 33.7 32.2 35.4 9.2 12.7 3.8 31.2 5.0 33.7 18.0 4.3 27.4 12.5 5.5 1.3 16.3 4.9 7.1 33.1 4.3 6.2 33.0 34.0 3.8 9.2 1.3 9.2 12.9 9.4 35.9 0.1 22.1 27.2 0.0 18.9 24.8 19.3 33.6 21.2 41.7 41.0 0.3 36.8 0.0 0.1 20.4 84.6 6.7 0.0 21.4 32.1 0.0 14.5 20.5 0.0 0.0 12.0 0.3 45.2 11.3 28.9 47.8 39.6 0.9 21.0 0.0 2.4 0.3 43.0 408.7 0.0 0.0 33.4 31.9 41.9 0.1 0.0 11.8 37.0 64.3 45.9 40.8 21.3 90.0 38.7 20.5 34.0 25.1 0.5 22.2 0.2 105.1 34.8 24.1 0.0 0.0 22.1 0.0 78.4 9.2 4.7 0.7 0.2 17.9 0.0 4.1 3.9 3.3 5.4 1.4 1.1 0.8 0.5 0.9 28.1 7.6 7.9 2.4 33.5 38.1 33.1 44.9 36.9 37.4 33.7 32.2 35.4 33.7 33.1 34.0 35.9 8.7 22.4 11.8 11.8 3.3 36.8 23.6 41.5 31.3 34.7 90.2 77.0 7.7 11.5 38.1 22.0 4.2 21.4 8.0 2.6 60.7 35.7 159.7 11.3 14.8 12.1 87.4 2.1 34.8 55.1 19.6 20.9 4.1 12.6 1.3 7.9 5.7 3.1 32.0 37.0 33.4 3.8 44.7 10.0 27.2 62.9 14.0 13.4 46.2 3.7 56.6 35.4 0.0 13.0 15.8 35.8 0.8 10.5 0.5 21.8 2.7 41.5 12.3 28.0 0.0 15.8 21.6 173.2 53.5 30.8 28.7 9.9 5.0 20.6 3.9 23.3 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 796.2;tongue: 455.3" "Group enriched" "Detected in all" 4 "Early spermatids: 986.2;Late spermatids: 1759.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol NA NA 15000 Cytosol "HPA018246: AB_1849204, HPA055475: AB_2682828" "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavorable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 36.1 40.5 63.6 22.7 66.7 48.5 32.2 65.2 81.2 35.6 60.7 39.0 21.4 41.8 26.6 40.3 33.6 25.9 120.0 65.0 61.7 27.1 34.1 24.8 30.3 67.2 69.4 50.6 49.7 34.6 32.8 25.7 39.3 69.6 38.3 20.3 42.5 30.0 32.9 796.2 22.1 22.6 36.5 66.7 23.3 32.5 133.6 72.7 51.0 31.7 455.3 30.8 38.9 28.6 97.2 144.2 65.8 138.8 108.5 104.6 118.4 62.7 111.9 114.0 123.1 120.5 97.5 70.9 73.3 179.8 77.7 193.9 67.6 113.3 68.8 171.0 97.4 76.1 74.3 88.9 112.7 110.8 46.6 58.5 125.7 77.0 62.3 147.8 183.7 126.1 70.5 60.7 86.0 157.1 52.2 89.4 78.3 156.8 88.8 71.2 61.0 177.5 78.6 95.4 44.6 58.4 74.6 96.8 110.9 149.9 193.7 154.7 88.5 101.3 92.0 102.3 58.1 223.3 79.0 108.9 86.9 96.0 65.9 120.2 9.4 12.6 10.0 11.7 13.7 12.2 12.9 12.3 10.6 14.4 9.1 15.5 12.9 10.9 11.6 10.4 10.2 22.2 9.6 63.6 66.7 65.2 81.2 65.0 61.7 67.2 69.4 50.6 69.6 66.7 72.7 97.2 89.1 64.1 75.0 58.1 81.1 78.4 97.6 68.5 78.6 72.6 67.7 72.3 224.6 48.6 74.8 35.0 56.3 96.8 93.5 28.9 58.7 84.5 986.2 158.2 132.1 78.1 53.8 105.6 75.6 75.8 99.5 78.6 33.6 114.8 126.6 106.3 62.4 70.2 67.9 87.5 87.8 36.1 40.7 76.6 58.7 1759.0 84.2 73.2 49.8 48.7 138.5 97.5 52.5 86.5 137.5 73.3 39.2 76.0 74.3 68.8 62.1 106.8 104.1 86.5 32.9 116.3 89.1 318.6 113.5 57.9 70.6 61.2 87.3 97.4 42.8 67.1 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 16.1 5.8 5.6 6.8 4.5 12.0 11.1 17.3 6.0 6.7 5.3 6.3 6.3 6.4 4.3 3.6 8.8 8.5 11.8 5.1 6.5 4.3 4.5 10.0 14.6 4.6 5.7 6.0 10.1 3.6 2.3 3.8 6.5 6.9 4.7 5.2 9.3 6.7 2.4 7.9 6.0 8.3 3.0 2.1 8.5 8.4 6.5 5.2 4.4 9.2 5.1 6.9 10.1 6.6 5.3 2.4 3.2 10.7 5.4 11.8 12.1 6.8 7.6 4.0 2.3 3.7 4.1 2.6 5.2 5.4 4.2 3.6 3.9 1.5 1.4 2.8 3.8 4.0 2.8 16.1 2.7 17.7 2.0 2.0 11.9 4.3 6.2 16.7 8.5 7.9 5.2 3.0 15.5 5.0 2.8 2.9 1.3 3.6 2.9 4.4 6.1 3.1 0.9 5.9 10.2 8.2 8.9 9.5 1.1 11.9 7.3 2.4 4.3 4.8 32.0 2.6 4.5 2.0 8.8 0.7 8.3 8.6 1.7 2.1 0.7 1.4 2.8 8.9 0.9 7.9 2.1 4.6 5.1 1.3 4.8 3.9 7.0 1.0 10.2 2.0 3.1 5.7 1.7 5.6 4.5 17.3 6.0 5.1 6.5 4.6 5.7 6.0 6.9 2.1 5.2 5.3 26.0 16.0 6.1 57.8 43.1 10.8 6.9 35.6 25.6 42.6 12.0 9.7 43.7 2.8 13.7 12.9 27.1 10.1 113.7 12.8 5.9 8.4 34.1 20.9 47.0 34.0 12.6 10.8 48.9 7.8 83.2 55.2 43.8 26.4 8.8 21.3 33.2 8.1 13.9 3.3 112.5 18.8 6.1 13.5 17.1 14.4 7.5 14.6 16.0 74.9 9.0 7.5 59.8 123.1 100.3 15.5 8.6 10.9 53.1 8.9 17.6 3.9 20.2 28.9 6.6 23.6 28.9 11.1 13.3 10.3 7.0 45.4 111.5 5.5 9.9 7.0 BBX "HBP2, HSPC339, MDS001" ENSG00000114439 "BBX high mobility group box domain containing" Q8WY36 3 107522936-107811339 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1071.7;Late spermatids: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006049, HPA050646" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006049: AB_2667504, HPA050646: AB_2681200" "unprognostic (7.57e-3)" "unprognostic (1.49e-2)" "unprognostic (8.73e-2)" "unprognostic (3.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.49e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (9.84e-2)" "unprognostic (4.81e-2)" "unprognostic (8.62e-2)" "unprognostic (1.11e-3)" "unprognostic (7.22e-2)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" 14.1 25.2 21.1 12.9 37.7 18.6 14.6 23.5 25.0 17.4 18.8 10.3 9.6 19.1 38.9 13.0 17.0 16.9 16.6 16.2 26.3 19.7 10.3 13.4 14.0 30.7 26.3 10.1 27.3 12.4 46.8 10.3 24.4 32.0 22.9 9.4 20.2 13.5 31.9 6.8 8.1 9.2 16.7 25.1 19.0 12.2 58.6 26.2 16.5 26.4 16.3 13.8 14.7 8.8 61.5 40.0 39.7 31.1 47.0 26.5 35.1 25.5 38.6 36.5 33.2 35.4 4.4 31.4 20.2 46.5 23.4 37.5 26.9 34.4 44.2 45.7 29.0 16.3 31.9 30.0 9.4 31.1 43.3 18.2 31.6 31.3 32.5 62.4 44.5 26.2 23.8 14.9 29.6 27.7 13.5 25.2 4.6 15.5 0.4 30.2 35.8 30.1 22.9 20.8 32.2 22.5 22.0 69.0 6.3 31.5 30.7 25.4 8.6 38.3 38.7 30.7 15.3 26.8 12.9 10.3 25.0 36.9 21.4 23.2 76.0 19.9 50.4 47.0 20.8 54.4 75.9 42.2 48.3 28.3 75.0 52.5 43.3 32.0 58.0 42.7 36.2 30.8 27.7 21.1 37.7 23.5 25.0 16.2 26.3 30.7 26.3 10.1 32.0 25.1 26.2 61.5 76.9 64.1 84.1 106.7 123.0 85.1 145.6 103.3 80.8 92.8 72.7 79.4 112.7 85.8 72.5 95.6 64.6 208.2 87.7 18.1 49.0 92.9 1071.7 76.8 62.1 78.4 66.4 51.7 96.3 73.8 92.1 86.2 40.8 88.0 32.3 151.7 66.4 30.8 47.9 171.6 78.4 41.4 114.0 62.2 73.0 571.4 156.3 70.7 67.6 112.4 48.2 149.9 101.0 163.3 323.2 65.4 37.8 206.1 66.4 115.7 19.7 112.8 60.9 64.5 144.7 108.5 114.9 94.1 159.0 59.0 75.6 198.4 100.8 107.1 39.3 128.9 IFT57 "ESRRBL1, FLJ10147, HIPPI, MHS4R2" ENSG00000114446 "Intraflagellar transport 57" Q9NWB7 3 108160812-108222435 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 1675.3;Late spermatids: 2795.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 41.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035514, HPA035515" Supported Approved "Nuclear speckles,Mitochondria,Cytosol" NA NA "Nuclear speckles" "Mitochondria, Cytosol" "HPA035514: AB_10601757, HPA035515: AB_10696505" "unprognostic (1.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (6.96e-5)" "unprognostic (2.98e-2)" "unprognostic (5.46e-3)" "unprognostic (1.02e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (3.59e-2)" "prognostic favorable (7.63e-4)" "unprognostic (5.04e-2)" "unprognostic (2.78e-1)" "unprognostic (1.68e-3)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (8.67e-3)" "unprognostic (6.12e-2)" 8.5 15.4 12.3 8.7 12.3 13.3 13.2 11.2 15.6 11.8 14.6 13.4 6.1 13.4 45.5 8.6 32.3 13.5 10.5 11.8 13.9 21.5 4.5 41.0 17.5 12.7 12.9 11.8 14.2 13.9 23.2 16.5 7.9 12.0 27.8 14.8 24.2 9.1 17.6 4.3 8.7 9.1 10.7 12.8 12.2 9.9 43.1 12.8 8.3 26.4 4.5 16.6 14.0 8.4 12.3 35.5 17.2 12.8 23.1 26.1 26.9 7.1 10.6 25.8 15.3 13.6 12.4 6.1 39.5 13.3 17.8 22.0 13.9 11.5 17.8 25.8 6.2 12.2 13.6 8.0 3.3 19.4 28.5 30.2 16.3 16.1 19.9 34.2 24.4 17.5 6.6 6.4 6.9 17.8 18.9 9.5 25.8 13.6 2.7 21.0 6.1 11.5 6.3 31.6 12.3 21.1 14.7 15.9 5.2 9.9 7.1 11.0 8.3 7.5 19.6 10.2 10.5 12.6 8.1 6.2 20.7 28.4 2.7 7.3 0.2 3.5 3.1 3.6 6.5 5.8 41.9 7.4 4.5 10.2 34.9 6.2 3.7 1.8 6.8 12.8 2.0 5.1 4.9 12.3 12.3 11.2 15.6 11.8 13.9 12.7 12.9 11.8 12.0 12.8 12.8 12.3 36.6 471.1 291.2 18.6 98.4 41.0 114.1 72.9 34.7 25.6 42.2 50.9 33.8 58.6 201.9 51.5 68.8 22.3 16.9 51.1 117.4 158.8 1675.3 266.3 57.8 38.2 57.2 13.7 52.6 134.1 19.3 78.9 25.5 37.0 44.3 57.1 25.7 5.9 14.5 28.6 20.3 35.7 42.7 8.1 27.7 2795.4 65.3 19.3 46.2 4.7 13.1 56.8 8.2 13.0 13.5 79.4 36.6 64.3 40.2 151.4 24.3 124.5 528.7 72.7 52.6 61.7 61.3 242.2 43.6 25.4 37.2 14.9 30.2 104.9 52.3 93.0 GNB4 ENSG00000114450 "G protein subunit beta 4" Q9HAV0 3 179396088-179451476 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 81.1;Kupffer cells: 98.1;Macrophages: 66.8;Microglial cells: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 143.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018383, CAB018737, HPA040736" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106" "unprognostic (2.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.01e-1)" "unprognostic (5.97e-3)" "unprognostic (2.12e-1)" "unprognostic (1.44e-2)" "unprognostic (8.28e-2)" "unprognostic (1.16e-1)" "unprognostic (3.44e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (1.90e-3)" "unprognostic (3.13e-2)" "unprognostic (8.90e-2)" "unprognostic (2.80e-3)" 15.1 6.4 8.9 22.1 18.9 34.0 12.5 7.7 13.8 11.6 5.9 8.0 6.0 9.2 3.7 22.1 7.1 15.3 14.0 10.1 14.3 5.9 7.8 16.2 17.8 14.1 8.5 10.1 5.8 2.9 2.8 3.0 22.0 13.7 4.5 8.7 2.0 4.7 4.0 3.2 34.4 6.5 23.7 12.8 18.2 7.5 4.3 10.3 8.0 6.4 5.8 11.6 13.4 6.8 19.7 33.4 15.4 37.7 0.8 23.8 41.5 44.1 46.7 33.1 54.1 61.3 0.8 3.7 61.6 9.9 54.3 49.7 0.6 36.4 43.1 56.7 143.6 29.2 71.3 54.9 0.7 23.4 62.3 16.2 32.9 6.6 42.4 21.6 12.0 59.3 13.7 18.7 0.8 42.8 1.3 32.8 24.3 18.9 0.2 19.3 61.4 49.2 25.3 34.9 1.9 7.0 20.5 37.5 33.0 61.1 23.0 67.5 26.1 45.3 45.1 27.4 13.6 61.6 0.3 0.9 0.8 24.7 52.8 35.4 5.6 21.3 11.0 0.2 27.8 0.1 6.7 0.4 0.3 24.9 13.6 0.4 0.3 14.5 3.4 23.5 12.8 0.6 8.8 8.9 18.9 7.7 13.8 10.1 14.3 14.1 8.5 10.1 13.7 12.8 10.3 19.7 40.0 25.6 12.8 17.9 20.1 18.7 1.8 2.5 13.6 1.7 14.3 12.3 15.6 0.0 12.3 3.7 6.2 13.8 11.5 0.1 3.9 1.1 1.2 15.6 22.9 42.9 0.0 22.9 18.6 1.6 18.7 26.6 3.6 10.8 10.8 16.2 53.2 0.9 81.1 1.7 18.4 0.0 2.0 98.1 17.4 1.4 10.2 66.8 14.2 91.8 59.9 0.8 2.1 11.6 7.7 2.8 0.0 15.8 8.1 2.6 0.2 0.2 11.3 4.0 26.3 9.9 41.8 2.3 16.8 23.4 25.4 4.1 2.9 14.7 0.0 1.3 HHLA2 "B7-H5, B7-H7, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 131.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8" "Low region specificity" "Detected in all" HPA055478 Enhanced NA NA "HPA055478: AB_2682830" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.4 0.2 0.6 5.7 0.5 1.2 0.2 0.8 1.3 0.0 0.0 88.7 87.6 0.3 0.8 0.5 3.7 29.5 0.2 0.7 0.5 7.7 0.1 5.8 0.6 0.7 0.4 0.3 0.1 3.0 0.1 0.2 0.1 0.8 0.2 83.8 1.2 0.2 0.3 0.5 0.3 131.0 2.1 0.2 0.3 9.4 3.3 0.4 0.4 0.2 0.0 0.3 0.0 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.7 0.2 0.1 0.1 0.0 0.1 0.2 0.6 0.0 0.0 4.0 0.1 0.1 1.4 0.2 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.8 0.0 0.2 0.4 1.5 0.5 0.2 0.3 0.3 0.1 0.8 0.0 0.1 0.7 0.7 0.7 0.0 0.1 0.5 0.1 0.2 0.1 0.1 0.7 0.2 0.2 1.3 0.7 0.3 0.0 0.4 0.1 0.5 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.6 0.5 0.8 1.3 0.7 0.5 0.7 0.4 0.3 0.8 0.2 0.4 0.8 0.0 0.0 2.0 0.7 0.4 0.0 0.1 0.7 0.0 0.0 0.7 0.3 0.2 27.1 1.6 0.0 0.0 0.0 0.0 274.7 0.0 8.5 3.3 3.2 0.0 0.3 1.8 0.0 1.3 37.6 0.1 0.3 2.6 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.5 12.5 2.0 0.0 0.7 4.2 0.3 0.3 0.0 0.0 1.1 0.0 0.0 0.5 0.9 35.7 64.2 0.0 0.0 0.1 186.8 20.4 19.4 0.0 0.0 0.1 0.1 0.7 0.3 0.0 0.0 0.1 0.5 0.0 17.7 0.1 IQCG "CFAP122, DKFZp434B227, DRC9" ENSG00000114473 "IQ motif containing G" Q9H095 3 197889077-197960142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 53.3;testis: 44.3" "Cell type enhanced" "Detected in all" "Early spermatids: 255.0;Endometrial ciliated cells: 176.3;Late spermatids: 489.4;Respiratory ciliated cells: 322.2;Spermatocytes: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042787, HPA051981" Enhanced Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA042787: AB_10797021, HPA051981: AB_2732572" "unprognostic (1.50e-2)" "unprognostic (6.20e-3)" "unprognostic (6.20e-2)" "unprognostic (1.10e-2)" "unprognostic (2.51e-2)" "unprognostic (9.20e-2)" "unprognostic (1.05e-1)" "unprognostic (4.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (7.54e-2)" "unprognostic (1.79e-1)" "unprognostic (2.94e-2)" "unprognostic (9.15e-2)" "unprognostic (1.73e-1)" "unprognostic (2.72e-3)" "unprognostic (7.75e-2)" 6.0 5.3 12.1 3.4 9.7 3.3 5.8 10.8 9.6 5.9 22.2 3.1 2.6 4.7 10.1 4.1 53.3 4.7 4.5 8.3 19.0 6.5 3.8 9.2 3.9 13.8 14.8 6.8 3.6 2.0 4.4 6.2 3.5 13.5 3.9 3.7 18.3 2.5 4.6 2.0 2.8 2.7 4.4 16.5 3.4 3.7 44.3 10.7 2.9 8.2 2.1 4.2 3.6 2.2 14.9 5.3 5.8 7.3 7.1 15.6 15.7 2.9 6.4 7.1 7.5 7.6 1.2 5.0 1.9 7.0 5.2 9.6 4.9 5.4 5.0 12.0 4.4 3.8 3.2 3.3 2.9 3.6 4.4 5.0 8.1 6.1 8.1 2.6 6.1 3.6 8.8 3.5 7.2 5.8 12.2 2.4 2.1 4.6 7.8 7.6 6.8 4.8 2.6 7.2 2.2 6.4 7.7 10.6 4.3 4.4 6.4 32.2 3.0 3.7 4.8 3.3 14.5 6.7 6.2 18.4 3.1 18.1 6.1 7.8 2.0 3.8 4.3 3.4 2.7 2.2 4.3 2.9 2.3 3.3 1.6 2.7 3.7 2.3 3.3 2.6 2.9 3.1 2.3 12.1 9.7 10.8 9.6 8.3 19.0 13.8 14.8 6.8 13.5 16.5 10.7 14.9 7.4 6.4 7.7 16.6 8.5 9.3 3.3 14.8 2.2 13.1 27.9 15.2 11.0 5.7 31.8 5.5 75.0 6.4 10.1 3.1 15.6 7.1 255.0 176.3 15.0 8.2 4.2 4.8 10.1 4.2 5.8 13.1 5.6 16.3 8.8 30.9 5.3 4.2 6.6 10.1 8.8 2.9 26.4 6.0 24.9 489.4 22.7 10.3 14.2 14.0 2.9 13.5 11.3 10.6 13.2 11.9 1.9 23.7 5.7 2.2 1.4 10.4 322.2 43.8 6.6 6.8 18.7 122.7 31.6 5.9 8.9 5.2 10.8 46.5 2.9 2.5 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489703-81761645 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 287.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Cytosol NA NA 6500000 Cytosol "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 74.5 54.3 5.4 15.0 6.3 19.9 38.9 7.3 7.8 14.3 14.5 12.0 13.3 17.4 14.4 18.2 13.9 13.1 56.1 6.3 10.4 41.8 109.5 17.4 8.6 9.9 17.4 4.4 14.3 14.3 19.2 10.5 25.8 10.6 13.3 13.9 22.2 15.7 15.1 150.3 14.2 11.6 22.0 7.8 12.1 11.2 8.0 8.1 11.5 19.8 57.1 13.3 19.4 14.0 9.4 61.3 36.2 11.9 168.7 287.6 216.8 21.5 99.1 140.1 58.1 97.6 7.1 15.6 67.9 42.7 122.5 34.5 7.1 9.9 45.7 135.4 32.3 6.4 21.2 70.0 22.8 197.5 72.2 17.8 161.2 33.2 93.5 95.5 144.9 130.5 8.0 17.0 38.0 191.1 17.8 12.5 92.7 12.0 16.8 58.0 22.9 53.6 81.1 41.4 20.5 6.0 7.9 64.6 18.7 20.9 17.2 13.3 58.9 183.4 118.9 28.1 84.7 92.8 174.8 21.4 24.6 194.1 47.8 49.8 7.5 11.8 15.6 5.2 10.8 5.1 11.6 5.6 5.7 13.8 12.5 6.4 6.6 11.4 13.5 11.8 4.8 5.1 6.5 5.4 6.3 7.3 7.8 6.3 10.4 9.9 17.4 4.4 10.6 7.8 8.1 9.4 49.7 16.0 12.4 31.3 14.9 30.7 22.2 36.8 27.3 18.6 7.5 5.5 60.2 15.7 21.9 31.3 0.0 30.3 8.4 9.5 41.1 32.1 36.2 16.3 15.2 32.0 22.1 4.6 52.4 25.4 74.0 34.9 6.6 14.7 43.1 16.0 15.4 75.2 26.3 30.3 47.4 8.7 12.2 12.9 21.3 16.9 17.4 17.3 24.9 87.1 16.3 10.4 7.2 49.3 63.0 37.8 5.8 13.2 12.8 17.7 11.3 50.8 25.0 17.8 32.9 45.8 26.7 6.9 7.3 20.6 21.3 54.9 8.7 34.2 8.3 14.5 MORC1 "CT33, MORC, ZCW6" ENSG00000114487 "MORC family CW-type zinc finger 1" Q86VD1 3 108958248-109118134 "Predicted intracellular proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 16.1" "Group enriched" "Detected in some" 6 "Early spermatids: 46.8;Late spermatids: 30.4;Microglial cells: 17.8;Spermatocytes: 51.4;Spermatogonia: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "Karpas-707: 2.5;RPMI-8226: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036413 Enhanced NA NA "HPA036413: AB_10669989" "unprognostic (1.66e-1)" "unprognostic (4.30e-2)" "unprognostic (2.17e-2)" "unprognostic (2.63e-1)" "unprognostic (7.45e-6)" "unprognostic (4.80e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.6 0.0 0.0 3.2 0.0 30.4 0.9 0.3 0.0 17.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.4 49.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 UMPS ENSG00000114491 "Uridine monophosphate synthetase" P11172 3 124730433-124749273 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036178, HPA036179" Uncertain Approved Cytosol NA NA 9200 Cytosol "HPA036178: AB_10673002, HPA036179: AB_10673615" "unprognostic (6.41e-2)" "unprognostic (6.70e-2)" "unprognostic (1.79e-2)" "unprognostic (1.13e-3)" "unprognostic (2.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.15e-3)" "unprognostic (5.51e-2)" "unprognostic (4.85e-3)" "unprognostic (1.43e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.18e-2)" "unprognostic (1.58e-2)" "unprognostic (1.91e-1)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 1.3 1.4 2.7 1.2 2.6 1.3 1.9 2.9 3.0 0.9 1.2 2.4 2.0 1.3 1.0 2.0 1.8 0.7 0.7 2.8 1.9 1.8 2.6 0.9 1.4 3.0 2.3 2.5 1.9 2.1 1.5 0.8 0.7 2.6 1.4 1.6 1.9 1.3 0.8 3.2 2.3 2.1 1.1 2.2 2.6 1.8 0.9 2.3 1.9 1.1 0.7 1.7 0.8 1.1 3.7 1.4 4.4 5.1 2.1 2.9 3.4 5.4 7.9 2.4 3.1 2.6 3.8 2.1 4.0 8.2 3.0 7.9 9.0 7.1 2.4 5.0 4.4 4.2 8.2 3.0 2.7 2.6 8.7 6.0 3.8 2.3 1.8 3.9 1.9 1.2 8.2 3.7 1.9 2.3 3.5 10.8 1.7 12.1 3.9 2.7 7.4 6.0 3.3 2.4 2.5 4.0 2.6 11.3 4.2 4.3 3.7 4.1 3.1 15.4 2.5 5.2 7.4 3.2 8.0 12.5 12.1 2.8 3.4 2.6 5.9 10.3 5.5 14.0 11.3 12.4 17.0 9.2 12.1 14.6 24.3 13.9 10.8 0.7 12.8 9.3 11.0 12.4 11.9 2.7 2.6 2.9 3.0 2.8 1.9 3.0 2.3 2.5 2.6 2.2 2.3 3.7 9.6 6.4 11.5 6.5 11.2 15.8 24.5 41.3 18.8 8.3 8.9 12.3 6.2 20.0 22.8 9.2 4.2 66.8 13.2 9.0 29.4 29.8 3.2 10.9 18.2 15.2 9.6 16.2 11.0 30.5 35.0 12.7 14.3 12.1 12.0 22.8 7.9 31.4 22.0 5.0 12.0 10.3 20.3 7.0 5.9 4.4 13.7 8.3 3.6 10.3 18.0 11.0 13.4 15.6 12.2 23.4 8.6 13.9 10.4 14.6 14.0 25.9 22.1 9.1 13.1 13.3 17.1 23.2 32.1 20.6 19.0 109.2 11.0 29.5 17.8 21.1 NCBP2 "Cbc2, CBP20, NIP1" ENSG00000114503 "Nuclear cap binding protein subunit 2" P52298 3 196935402-196942594 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044850, HPA062483" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044850: AB_10961012, HPA062483: AB_2684779" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (4.04e-2)" "unprognostic (5.12e-3)" "unprognostic (3.17e-1)" "unprognostic (5.13e-3)" "prognostic unfavorable (2.37e-7)" "unprognostic (2.86e-2)" "unprognostic (9.63e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.28e-3)" "unprognostic (6.38e-2)" "unprognostic (1.97e-1)" "unprognostic (4.30e-2)" "unprognostic (5.04e-3)" 38.6 44.4 42.6 39.1 43.9 17.4 36.3 42.7 47.0 34.7 40.6 35.8 29.6 32.9 41.5 29.3 30.3 29.0 31.6 43.2 50.3 42.1 30.4 27.4 43.8 44.7 43.9 39.9 36.0 25.9 38.5 26.2 34.1 44.4 36.7 35.5 46.6 24.6 35.9 38.9 27.4 28.0 34.1 45.2 34.5 29.9 26.0 45.4 50.3 38.0 38.9 42.6 46.1 26.3 45.6 144.3 44.6 105.5 131.8 118.6 102.8 74.1 106.1 80.9 66.4 69.7 99.5 51.2 97.0 229.7 76.3 85.4 84.6 136.1 113.0 104.7 50.8 85.0 125.2 55.3 87.5 103.9 146.4 85.3 84.1 101.2 48.7 134.1 99.5 104.3 103.2 71.6 99.7 113.7 165.5 111.3 88.4 134.5 137.2 139.5 86.9 78.6 92.9 99.3 101.9 57.3 153.1 63.8 126.4 189.4 85.4 279.1 112.4 97.5 67.1 71.4 85.0 193.0 155.6 149.4 162.1 93.8 162.5 103.2 9.9 37.7 20.9 37.5 44.5 56.6 53.2 46.2 44.8 40.1 43.5 52.8 48.1 4.0 43.1 47.0 32.2 45.0 40.4 42.6 43.9 42.7 47.0 43.2 50.3 44.7 43.9 39.9 44.4 45.2 45.4 45.6 38.5 25.6 43.5 9.1 71.1 52.5 83.6 55.9 36.5 55.7 48.9 36.8 40.5 25.8 51.6 42.3 58.4 59.1 58.9 44.0 97.8 64.3 116.2 39.5 66.6 50.2 45.0 35.1 12.8 49.8 81.8 47.1 30.5 35.9 52.6 54.7 30.0 31.1 65.4 45.4 14.0 44.9 54.9 54.1 60.7 66.2 37.6 38.6 32.0 2.8 68.2 91.0 51.5 10.6 10.4 69.1 45.9 51.6 42.0 81.9 37.0 82.5 44.6 60.3 26.3 40.9 51.3 52.9 59.5 33.5 44.8 53.2 49.8 58.8 52.1 84.2 SNX4 ATG24B ENSG00000114520 "Sorting nexin 4" O95219 3 125446650-125520202 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 163.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005709 Uncertain NA NA "HPA005709: AB_1080049" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (1.91e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (1.19e-2)" "unprognostic (6.33e-2)" "unprognostic (4.93e-2)" "unprognostic (4.06e-1)" "unprognostic (3.42e-1)" "unprognostic (6.99e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" 16.9 22.3 14.1 12.8 14.2 16.5 25.6 14.5 16.1 20.1 15.1 25.1 36.1 14.3 13.8 15.0 14.3 19.9 16.7 13.9 15.2 54.3 57.0 18.3 16.4 14.9 14.8 13.2 15.0 19.7 18.1 14.5 31.9 15.0 22.9 27.9 9.2 22.6 11.5 19.1 10.3 34.5 13.5 14.7 13.1 21.8 16.2 14.2 21.3 45.3 23.5 17.2 17.0 11.4 16.9 34.8 10.9 34.5 21.8 20.9 17.4 39.1 18.5 17.5 35.9 32.1 23.7 15.5 22.0 21.4 22.5 15.5 18.0 32.4 15.6 42.9 20.6 23.8 35.6 14.5 36.0 24.5 37.8 22.1 22.7 17.0 18.2 14.5 20.0 34.1 31.8 38.6 10.9 27.6 26.2 41.8 25.4 20.2 37.6 13.0 38.2 42.0 40.3 33.0 30.6 36.1 50.9 29.8 38.3 47.4 32.0 37.7 61.3 22.3 18.0 22.9 23.4 21.9 22.1 20.1 60.2 22.0 23.8 27.8 12.4 14.0 25.8 9.7 18.8 13.0 13.8 12.4 11.2 18.3 10.3 15.8 13.8 2.6 17.4 19.1 16.1 15.1 12.0 14.1 14.2 14.5 16.1 13.9 15.2 14.9 14.8 13.2 15.0 14.7 14.2 16.9 27.1 28.9 39.4 33.6 24.5 12.1 17.9 21.3 12.5 13.4 27.2 17.1 17.7 37.1 34.1 22.0 0.0 87.2 20.6 39.9 60.7 45.4 21.6 23.8 22.1 24.7 30.0 22.7 46.7 36.6 57.8 26.9 26.0 20.9 31.0 30.9 24.7 75.8 50.9 18.5 44.9 37.0 46.8 27.0 22.6 31.5 22.1 28.3 30.2 31.9 45.7 21.3 34.0 37.7 47.8 42.9 37.9 18.0 26.2 22.5 48.8 163.4 37.1 12.0 13.1 27.8 30.3 33.0 29.8 23.0 11.8 41.2 22.9 27.2 29.6 15.7 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 17.6;skin 1: 25.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 26.4;U-698: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 0.8 1.0 0.1 1.2 0.2 0.7 2.7 0.1 0.2 0.5 0.3 7.6 3.3 0.9 0.0 2.6 0.7 5.0 2.5 0.2 0.1 4.3 0.3 3.8 1.2 0.1 0.1 0.1 0.2 17.6 0.0 2.0 3.3 0.1 1.7 13.8 0.1 3.9 3.4 0.5 25.8 5.3 0.9 0.0 0.7 13.8 0.9 0.2 6.6 7.7 0.1 2.0 5.9 1.6 0.2 11.0 2.0 4.2 0.0 0.6 0.0 1.8 15.5 6.7 10.1 11.3 26.4 10.1 0.4 1.9 3.1 4.4 8.7 6.1 0.3 19.4 0.0 2.8 7.9 1.8 1.9 4.6 0.0 0.1 0.6 8.7 5.2 15.0 5.4 2.2 0.0 2.8 2.8 7.5 1.7 0.3 0.0 12.3 7.9 0.6 0.3 13.2 0.0 18.1 16.5 0.5 0.9 2.4 5.2 6.3 6.8 9.5 0.0 5.8 3.6 5.5 0.0 0.0 3.9 0.0 30.1 2.7 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.8 16.0 10.0 0.3 1.6 32.5 129.6 10.0 45.5 0.0 14.8 3.3 2.1 4.3 19.3 18.4 0.0 18.1 0.7 30.4 0.0 26.3 24.2 24.8 3.1 3.5 11.9 0.0 3.2 35.9 25.6 4.7 64.2 44.1 0.0 0.4 0.4 0.0 1.9 0.0 0.6 56.6 8.2 0.3 2.7 23.3 0.3 1.0 1.8 1.0 2.6 0.0 0.0 0.5 0.3 82.8 30.7 0.4 4.6 75.6 7.8 2.1 14.8 0.0 0.0 4.6 4.7 3.2 5.3 44.0 33.5 75.0 2.0 3.0 8.9 132.5 FRMD4B "GRSP1, KIAA1013" ENSG00000114541 "FERM domain containing 4B" Q9Y2L6 3 69168782-69542583 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.2" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1209.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009705 Uncertain Supported Approved "Nucleoplasm,Golgi apparatus,Centriolar satellite" NA NA 17000 "Centriolar satellite" "Nucleoplasm, Golgi apparatus" "HPA009705: AB_1849147" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (4.59e-2)" "unprognostic (9.73e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (2.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.09e-2)" "unprognostic (8.23e-2)" "prognostic favorable (5.01e-4)" "unprognostic (1.49e-1)" "unprognostic (7.54e-2)" "unprognostic (2.79e-1)" "unprognostic (4.39e-3)" 11.1 4.8 15.7 12.4 42.2 15.7 16.3 23.3 28.2 25.1 10.1 12.9 9.2 11.5 9.4 27.0 13.3 19.3 17.5 16.5 27.1 16.4 34.8 25.1 11.0 33.6 34.9 8.0 11.0 8.3 3.7 4.0 25.7 38.0 17.0 13.0 22.1 37.5 10.6 2.3 22.1 12.6 10.6 20.1 32.6 15.2 4.7 33.5 14.2 27.3 4.7 11.3 13.8 16.0 83.2 6.7 1.8 10.4 0.3 0.2 1.5 11.3 0.5 1.7 0.8 0.5 39.8 11.3 0.8 3.5 0.5 1.0 25.9 4.9 35.3 1.2 2.2 3.3 20.4 2.6 2.3 0.7 5.2 10.2 1.7 35.2 1.0 52.7 1.6 55.1 4.7 1.6 5.8 3.0 7.7 0.5 0.8 5.6 8.9 8.5 32.2 2.8 1.0 14.8 4.6 12.1 15.6 1.7 12.2 35.5 9.3 4.6 6.8 47.1 0.6 4.3 0.4 1.8 0.6 0.3 1.2 0.4 13.5 13.5 18.3 27.6 2.3 1.9 13.8 7.0 1.6 6.3 2.8 16.9 2.0 1.9 1.8 7.1 3.8 2.3 16.8 15.4 7.7 15.7 42.2 23.3 28.2 16.5 27.1 33.6 34.9 8.0 38.0 20.1 33.5 83.2 20.6 41.7 83.6 2.9 3.6 60.7 33.4 57.8 69.4 13.8 34.4 21.7 33.4 41.5 58.5 14.7 218.9 49.9 20.3 74.4 33.2 32.6 18.9 207.9 49.3 64.3 24.5 8.6 4.2 17.3 19.7 32.1 75.4 282.6 34.7 97.5 89.3 53.6 92.6 0.0 92.7 42.1 36.7 138.7 112.7 4.0 6.5 105.2 28.4 93.7 26.3 13.5 1.0 129.2 1209.1 24.5 67.0 18.4 6.9 61.1 10.7 55.6 38.2 109.2 6.6 11.8 21.0 0.0 3.5 79.9 51.4 58.3 44.6 32.1 32.2 172.8 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006357-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045847: AB_2679472" "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favorable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 28.5 47.6 49.7 13.5 53.3 11.4 29.7 53.0 55.7 40.0 49.7 23.6 18.3 44.7 55.5 22.4 40.6 28.8 32.1 53.6 53.6 25.7 14.4 21.6 18.3 53.5 53.2 52.3 55.0 33.0 35.1 40.3 19.9 55.6 23.3 19.3 25.9 31.4 23.9 62.3 24.6 24.0 29.7 46.6 19.8 28.0 45.0 51.7 34.7 32.2 48.3 19.5 29.1 29.9 52.7 43.7 17.4 28.5 24.1 78.7 45.3 42.4 24.4 42.1 32.9 39.0 23.3 38.7 31.4 44.8 48.9 35.7 33.3 10.8 42.1 29.0 31.1 32.0 17.2 32.1 34.2 65.3 31.4 18.4 44.0 50.8 20.0 41.1 48.7 46.5 38.2 14.7 26.2 44.0 22.2 35.1 25.7 21.7 57.4 26.3 18.6 29.3 43.5 39.6 31.6 22.1 23.8 37.8 12.3 104.0 26.6 12.2 41.9 32.2 30.8 23.2 47.1 28.0 19.4 17.2 15.8 27.7 14.0 28.9 13.0 6.3 4.6 12.0 9.4 9.6 9.4 11.1 12.2 9.8 9.0 9.6 9.1 1.2 14.9 6.1 9.6 21.8 6.1 49.7 53.3 53.0 55.7 53.6 53.6 53.5 53.2 52.3 55.6 46.6 51.7 52.7 25.6 16.0 10.9 9.8 13.5 13.8 22.3 24.9 20.5 15.4 22.9 23.5 14.4 32.9 20.5 22.0 4.2 34.6 14.6 7.5 3.9 35.8 36.7 34.1 15.3 28.5 21.1 5.0 17.0 24.7 36.1 19.7 11.7 17.9 5.7 21.2 35.0 7.2 16.1 28.6 20.7 12.1 30.5 12.8 10.3 14.7 37.6 8.6 14.2 15.0 13.5 25.9 7.2 11.6 8.0 24.3 6.8 54.9 10.3 15.3 14.7 12.6 14.8 12.1 26.3 23.1 20.7 16.7 45.4 18.2 15.3 25.3 17.7 42.4 15.6 19.0 ROPN1B ENSG00000114547 "Rhophilin associated tail protein 1B" Q9BZX4 3 125969160-125983454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 215.9" "Group enriched" "Detected in many" 4 "Early spermatids: 2012.7;Late spermatids: 1967.9" "Group enriched" "Detected in some" 5 "breast cancer: 1.3;melanoma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SK-MEL-30: 54.6;WM-115: 18.5" HPA052530 Supported NA NA "HPA052530: AB_2681861" "unprognostic (7.73e-3)" "unprognostic (1.35e-2)" "unprognostic (2.22e-3)" "unprognostic (2.76e-2)" "unprognostic (7.19e-2)" "unprognostic (3.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (1.96e-2)" "unprognostic (1.09e-2)" "unprognostic (8.18e-2)" "unprognostic (5.91e-2)" "unprognostic (5.01e-2)" "unprognostic (1.74e-2)" "unprognostic (6.89e-3)" "unprognostic (3.78e-2)" 0.2 0.5 1.2 0.2 1.5 0.1 38.5 1.9 1.8 0.2 0.0 0.1 0.1 0.3 22.3 0.1 0.5 0.0 2.7 1.2 1.0 0.1 1.2 0.3 0.6 0.9 1.1 0.9 0.3 0.3 0.0 3.0 0.2 1.0 0.7 0.0 1.8 14.7 0.2 0.5 6.7 0.1 0.0 0.3 0.1 0.1 215.9 0.6 0.0 0.7 0.8 0.3 0.4 0.1 1.9 0.0 0.0 0.3 0.2 0.0 0.0 2.9 0.0 0.3 0.2 0.2 0.2 2.4 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.1 1.1 0.2 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.3 0.9 0.3 0.1 0.0 54.6 0.1 0.7 0.7 0.0 0.0 0.5 0.2 0.2 5.4 1.1 0.3 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 1.5 1.9 1.8 1.2 1.0 0.9 1.1 0.9 1.0 0.3 0.6 1.9 0.6 0.0 0.0 1.3 0.3 3.7 0.1 1.4 0.0 0.2 60.1 86.2 18.8 0.0 3.9 0.0 0.0 0.3 2.0 0.0 0.0 0.2 2012.7 3.1 0.1 1.6 0.0 0.0 0.5 0.2 2.5 1.3 0.0 0.1 0.0 0.2 0.0 0.5 0.1 3.3 0.4 0.0 2.0 0.0 2.0 1967.9 19.0 1.5 149.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 9.8 0.0 0.6 0.0 0.1 17.8 0.2 19.7 0.0 1.0 493.4 11.8 0.0 0.6 0.1 0.5 0.0 0.0 1.2 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol NA NA 10000000 Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 10.1 7.6 11.3 7.0 12.9 1.0 9.7 0.6 16.6 11.0 1.5 8.4 3.4 11.0 2.3 11.4 10.3 4.9 13.6 13.0 6.8 7.2 3.2 14.8 6.4 4.9 4.9 13.6 14.0 9.4 24.2 5.5 8.3 11.4 9.4 1.9 1.8 13.0 6.4 11.0 14.7 7.9 5.3 2.4 13.3 8.0 9.1 9.7 6.3 9.7 6.1 4.2 9.8 10.1 12.6 45.3 21.1 22.8 18.1 29.3 32.7 36.3 26.3 22.2 14.8 14.7 70.2 20.6 5.0 38.6 28.4 20.0 68.2 11.7 51.6 6.1 7.2 18.6 0.7 13.4 18.3 19.2 5.4 3.6 32.8 35.4 27.4 21.2 14.9 7.5 14.7 26.3 9.1 16.1 26.3 10.6 9.9 22.0 14.2 18.5 14.0 58.0 14.1 12.9 89.4 20.2 22.1 19.1 17.9 24.7 14.7 28.8 33.9 28.0 23.6 30.0 43.4 28.1 5.5 3.9 9.8 33.9 10.2 25.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.3 12.9 0.6 16.6 13.0 6.8 4.9 4.9 13.6 11.4 2.4 9.7 12.6 1.9 48.1 4.1 8.8 1.8 15.8 5.6 23.4 6.2 6.7 6.6 7.4 13.0 1.5 18.6 12.9 4.2 21.8 0.8 3.6 0.0 8.9 4.4 5.0 10.0 3.8 9.6 0.4 22.1 6.9 2.5 13.8 7.1 5.6 0.0 20.8 2.2 0.9 13.1 20.2 11.3 4.0 0.0 7.4 12.8 1.0 7.8 7.4 8.8 5.6 1.0 2.5 1.0 13.6 3.6 17.0 2.3 6.4 3.1 21.3 7.4 1.5 11.2 3.3 6.6 6.4 9.9 5.3 9.5 6.7 16.1 7.3 2.2 4.7 5.1 9.5 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747033-113812056 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Translocase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 463.7;Late spermatids: 870.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 79.2" "Group enriched" "Detected in all" 6 "dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 700000 "Vesicles, Cytosol" Nucleoplasm "CAB006910: , HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favorable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 18.2 32.5 30.4 21.8 51.1 16.8 24.8 17.0 53.7 25.5 54.4 22.3 18.7 14.3 15.3 22.9 19.1 21.1 9.1 44.3 56.3 93.5 36.8 24.7 25.3 40.4 33.8 39.6 11.4 21.0 60.5 17.3 24.7 45.6 21.1 22.7 59.3 37.8 15.1 8.0 25.2 16.0 15.9 19.3 26.8 22.3 18.2 35.9 23.1 41.1 11.1 28.2 19.8 14.3 88.4 61.7 27.4 33.9 29.7 70.0 30.9 36.0 32.7 49.4 33.7 46.1 52.4 48.3 50.4 75.5 48.0 37.3 39.1 77.5 43.2 43.8 23.1 21.4 44.8 39.3 40.6 57.6 33.2 50.0 42.0 29.1 43.7 30.2 52.0 55.7 25.1 52.0 37.0 50.5 40.5 24.4 14.9 42.8 42.9 34.3 20.8 24.6 57.4 92.5 58.0 65.4 24.1 57.3 38.6 44.9 46.4 58.5 26.6 51.4 31.1 23.1 21.7 19.8 38.4 44.5 46.2 61.1 41.2 35.3 26.8 37.0 12.8 6.3 27.7 5.9 8.2 5.6 6.0 38.8 6.8 5.4 6.2 79.2 9.2 23.9 10.8 8.1 16.7 30.4 51.1 17.0 53.7 44.3 56.3 40.4 33.8 39.6 45.6 19.3 35.9 88.4 18.8 28.9 35.0 43.4 24.2 30.3 15.9 30.3 23.9 94.1 27.9 17.1 10.4 31.5 32.9 99.3 41.7 22.0 20.8 38.3 82.2 29.5 463.7 41.7 24.5 26.8 55.8 49.6 119.4 27.5 22.6 17.9 20.9 100.6 10.8 19.4 36.0 74.3 74.3 101.0 107.7 25.4 197.4 104.7 73.3 870.3 18.0 70.9 46.2 34.7 82.8 45.6 11.3 54.3 53.2 27.1 30.5 23.0 23.6 25.6 24.1 80.8 38.3 44.4 6.6 15.3 21.6 28.7 15.7 40.8 47.9 43.9 19.0 25.8 27.2 26.8 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680926 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 822.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 822.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 37.8 18.8 26.1 19.0 31.4 51.6 33.7 34.1 42.7 40.2 26.0 33.2 12.4 29.9 5.3 13.5 37.6 18.2 35.9 29.5 23.3 25.4 17.5 32.3 22.2 25.7 25.0 28.0 30.6 17.9 9.0 31.6 12.3 25.8 31.3 4.6 8.7 24.7 13.7 45.1 24.8 32.0 7.7 21.4 90.4 27.7 8.2 26.5 21.7 22.0 26.4 7.5 33.2 31.4 28.6 4.3 10.7 0.9 2.0 10.0 8.7 7.8 6.8 12.2 4.5 6.5 0.3 8.9 1.9 11.9 5.1 6.0 2.2 0.2 5.1 1.0 20.7 2.5 3.1 19.4 2.5 7.5 0.5 9.5 12.0 5.6 4.5 1.5 15.2 4.8 8.3 0.1 13.5 4.9 6.6 4.9 13.4 0.9 4.9 11.7 3.0 5.6 13.8 6.7 3.3 9.5 6.0 4.8 6.6 25.0 2.6 1.4 3.7 9.1 4.8 4.0 8.5 2.3 11.5 3.8 0.6 11.1 4.0 7.8 40.7 64.5 161.8 17.0 48.2 16.6 17.8 19.0 17.1 28.6 21.1 16.6 14.3 822.3 25.2 44.5 18.1 46.3 46.2 26.1 31.4 34.1 42.7 29.5 23.3 25.7 25.0 28.0 25.8 21.4 26.5 28.6 45.3 19.2 13.0 10.7 31.7 11.7 15.6 14.2 7.4 10.4 9.9 15.6 8.1 22.8 5.3 7.3 18.8 8.1 34.2 11.3 15.6 15.1 0.5 9.9 11.1 20.8 23.9 58.7 26.1 16.8 22.3 21.0 23.0 10.1 14.7 10.1 27.5 8.9 21.3 3.3 12.2 15.0 12.2 64.7 16.4 1.7 33.8 37.4 10.6 18.7 74.3 18.0 35.0 6.6 12.8 25.9 21.4 22.6 25.2 12.8 26.3 23.0 6.9 31.1 65.7 16.1 36.8 1.0 8.6 4.2 9.2 15.9 38.6 10.6 10.3 11.8 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629185-127672802 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;pituitary gland: 59.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 118.1;SCLC-21H: 167.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.2 17.5 38.0 2.7 37.3 1.8 8.8 31.2 51.3 2.8 0.9 9.5 7.2 4.4 2.3 4.2 4.3 4.6 3.2 41.5 54.2 7.2 1.7 2.0 2.2 44.2 49.3 34.8 11.3 13.6 5.3 59.4 1.0 48.8 13.2 8.2 21.8 25.1 2.0 3.2 7.5 6.8 1.8 28.0 2.0 14.3 31.0 47.4 1.9 5.5 1.8 2.7 3.2 2.9 62.2 0.3 13.8 37.5 89.2 0.0 0.0 55.2 4.3 0.2 7.9 1.6 28.7 1.5 34.0 33.3 0.6 12.1 0.2 30.9 0.0 0.7 0.2 63.3 0.7 30.9 29.3 1.2 78.1 75.7 1.5 6.6 0.2 0.0 20.9 2.2 0.2 45.6 0.2 2.9 17.6 0.3 0.3 56.2 7.9 66.6 0.2 1.0 118.1 10.9 3.9 167.0 94.0 40.9 86.3 77.2 3.7 22.0 39.2 0.4 0.2 17.2 1.5 27.3 0.2 0.0 26.9 0.9 50.1 25.1 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.6 0.5 0.1 38.0 37.3 31.2 51.3 41.5 54.2 44.2 49.3 34.8 48.8 28.0 47.4 62.2 1.6 0.0 1.1 10.4 3.4 5.5 3.7 1.3 9.1 96.3 17.5 18.4 0.5 4.3 1.7 9.2 31.3 2.2 4.4 14.3 1.9 6.8 73.5 8.7 2.5 2.2 63.5 5.5 21.3 20.1 5.9 8.2 25.0 12.3 1.3 9.5 0.7 0.7 1.3 82.4 57.7 23.2 4.1 1.3 2.8 153.1 8.7 1.6 21.4 5.6 8.1 19.0 6.2 29.1 12.5 12.9 16.7 5.7 10.4 9.9 10.8 2.9 1.7 49.9 6.6 3.8 9.8 20.4 80.4 10.0 5.5 1.5 3.3 7.5 21.8 3.1 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205143 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 34.1;urinary bladder: 89.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 32.2;Club cells: 198.3;Glandular and luminal cells: 80.9;Urothelial cells: 46.3" "Cancer enriched" "Detected in many" 4 "urothelial cancer: 147.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.7;CACO-2: 40.6;RPTEC TERT1: 36.5;RT4: 147.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA031799, HPA031800" Enhanced NA NA "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favorable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 4.9 0.0 0.5 0.1 1.5 0.2 0.2 0.3 0.5 4.9 0.0 0.0 0.1 0.6 0.0 3.5 7.9 8.0 1.0 0.3 0.0 10.3 0.1 1.3 0.0 0.6 0.1 0.5 0.0 6.5 0.0 0.2 7.7 1.3 0.4 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 34.1 0.6 0.4 3.8 0.0 0.2 17.1 89.7 1.4 2.1 0.1 17.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 40.6 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.5 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 36.5 147.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.5 1.5 0.3 0.5 0.3 0.0 0.6 0.1 0.5 1.3 0.0 0.4 2.1 0.2 0.0 1.5 0.0 0.2 0.3 0.6 32.2 0.0 0.5 0.2 0.4 0.5 24.3 198.3 0.0 0.0 3.5 0.4 0.1 0.0 15.6 3.5 25.1 9.4 0.9 0.0 0.0 1.9 0.7 11.1 4.0 11.2 80.9 2.5 0.5 0.0 0.5 0.5 1.7 1.2 0.2 24.4 0.3 3.1 1.5 0.0 1.1 1.8 0.0 1.1 0.2 0.0 0.5 0.5 0.8 0.2 0.0 0.4 0.9 0.2 10.9 27.8 1.2 0.0 0.5 4.6 0.2 0.5 0.3 0.0 1.5 0.7 0.1 0.0 46.3 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562238-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "brain: 83.9;choroid plexus: 60.6;retina: 28.6" "Group enriched" "Detected in some" 4 "Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 32.6;HEK 293: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446" "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favorable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.0 0.8 59.6 0.2 64.3 0.1 0.6 34.8 83.9 0.3 60.6 0.8 0.0 0.3 0.1 0.3 0.3 0.1 0.4 64.4 50.9 0.2 0.2 3.2 0.2 44.1 47.9 60.3 0.2 0.3 0.3 1.7 0.8 48.9 0.4 0.2 28.6 0.3 0.0 0.5 0.9 0.3 0.4 35.5 0.0 0.4 1.9 47.6 0.1 0.4 0.0 0.1 0.1 0.2 52.0 0.3 1.7 32.6 5.7 0.6 0.0 0.9 0.6 0.1 1.2 0.3 0.3 2.0 0.1 2.5 0.1 2.4 0.5 2.7 0.3 0.3 0.0 8.8 0.5 1.4 0.0 0.0 0.4 1.4 0.0 1.1 0.1 0.0 0.9 0.1 1.1 6.6 0.3 0.1 1.5 0.2 0.4 3.1 2.4 3.3 0.5 0.2 0.7 1.4 1.1 3.4 1.5 2.1 4.1 0.1 0.9 1.6 3.1 0.3 0.1 6.5 0.1 1.9 0.8 0.8 0.0 0.5 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.6 64.3 34.8 83.9 64.4 50.9 44.1 47.9 60.3 48.9 35.5 47.6 52.0 0.7 3.2 2.0 67.6 0.1 0.8 0.1 0.0 0.0 28.6 2.2 1.8 1.3 0.0 0.0 0.0 6.2 0.2 0.0 0.5 0.0 0.2 2.0 0.6 0.6 0.3 1.8 0.0 18.6 0.0 0.2 0.5 0.0 2.0 0.0 6.1 0.0 0.5 0.2 6.7 25.0 0.3 0.0 0.0 0.2 0.6 0.3 0.2 0.0 7.5 0.0 94.7 0.0 233.7 9.9 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 22.7 0.0 0.8 0.8 13.5 3.3 0.0 0.6 0.1 0.2 0.2 0.4 0.1 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 5.9 6.3 5.9 6.3 7.1 16.0 4.7 6.0 7.5 5.3 4.2 5.4 4.5 5.4 5.1 8.8 4.6 5.4 6.2 6.7 6.7 4.7 3.7 6.3 6.9 5.2 6.1 7.1 3.9 5.6 7.3 6.1 5.6 5.7 5.2 4.6 20.4 4.4 6.3 6.7 13.0 5.6 6.6 5.4 8.9 4.9 6.3 6.4 5.1 7.0 5.6 7.6 6.8 6.8 7.0 11.6 14.6 11.1 16.5 12.0 8.6 7.9 15.6 8.1 15.5 12.6 15.6 7.0 22.6 8.6 13.1 14.2 7.0 33.7 16.5 15.9 18.0 11.3 33.3 20.9 14.3 12.3 17.9 14.7 10.0 12.5 22.4 20.8 8.7 17.5 12.1 41.0 9.2 12.6 9.6 13.7 10.3 20.4 9.4 29.2 9.4 7.3 13.2 14.6 21.6 7.6 10.1 10.9 13.2 7.9 11.3 7.8 9.7 18.4 14.3 14.8 16.6 19.9 10.3 21.9 19.5 9.2 20.5 15.4 6.1 12.1 3.7 2.0 10.7 2.9 3.8 1.6 3.9 7.8 2.4 1.3 2.0 4.9 1.3 18.6 2.0 1.7 5.7 5.9 7.1 6.0 7.5 6.7 6.7 5.2 6.1 7.1 5.7 5.4 6.4 7.0 19.6 12.8 13.7 13.1 24.4 11.3 10.6 8.1 12.0 65.2 17.4 13.0 62.1 4.3 7.5 3.7 20.9 10.6 26.1 15.2 21.5 15.5 3.0 15.5 24.8 16.1 9.5 21.7 24.2 14.8 11.9 9.3 12.2 27.5 36.1 11.0 14.3 19.7 29.6 13.5 23.0 11.1 4.1 28.8 14.9 3.5 5.9 26.7 0.0 18.7 22.4 13.9 8.2 15.1 17.4 17.7 10.6 8.2 12.0 9.3 9.8 28.2 6.3 54.2 6.6 19.5 13.5 13.9 14.8 14.8 21.0 14.1 20.8 15.4 10.3 13.0 SCAP KIAA0199 ENSG00000114650 "SREBF chaperone" Q12770 3 47413681-47477126 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 136.3" "Cell type enhanced" "Detected in many" "Theca cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004713 Approved NA NA "HPA004713: AB_1079868" "unprognostic (4.02e-2)" "unprognostic (2.56e-1)" "unprognostic (1.91e-1)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (8.74e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-2)" "unprognostic (7.10e-2)" "prognostic favorable (7.14e-4)" "unprognostic (4.07e-2)" "prognostic favorable (4.33e-5)" "unprognostic (3.15e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (7.06e-3)" 23.0 136.3 28.3 15.9 25.3 17.2 26.0 32.2 37.8 28.9 29.6 32.7 24.7 31.7 17.5 37.8 28.5 14.6 26.6 25.5 21.5 33.4 74.3 22.4 16.1 28.2 24.8 23.3 35.7 34.3 28.6 34.3 18.3 28.6 29.4 22.0 27.7 25.3 18.8 27.8 45.2 34.6 20.6 16.3 37.4 32.6 39.5 27.0 18.8 30.9 19.4 15.7 32.0 29.5 32.1 19.7 28.2 28.8 45.6 51.6 26.4 51.3 18.8 27.9 30.0 28.3 38.0 31.9 31.5 26.7 30.4 30.7 20.3 41.1 38.8 31.7 23.6 29.0 54.1 37.7 40.9 51.4 33.4 32.5 33.2 40.1 36.4 42.2 24.9 26.1 32.0 38.5 21.4 24.8 28.9 37.1 49.2 30.7 39.7 40.1 20.1 25.9 37.5 24.4 37.1 19.0 35.1 27.1 33.8 18.8 36.8 29.5 37.6 22.0 27.2 33.1 39.7 26.8 21.2 24.6 18.3 27.6 30.2 20.9 6.0 5.9 6.5 6.6 4.9 8.7 5.5 5.4 6.0 7.0 5.3 6.1 6.1 15.8 6.7 4.2 5.4 7.3 5.0 28.3 25.3 32.2 37.8 25.5 21.5 28.2 24.8 23.3 28.6 16.3 27.0 32.1 15.0 0.0 16.0 34.0 11.6 11.6 9.8 14.5 19.9 23.2 20.2 18.9 14.6 11.5 16.2 20.2 29.2 27.6 9.8 55.3 0.0 13.9 13.0 11.5 12.8 12.9 12.0 10.1 39.3 15.1 15.8 16.9 26.5 16.3 7.0 53.5 7.9 46.0 16.3 53.8 39.7 20.7 10.2 13.4 8.3 28.6 19.6 10.4 24.9 15.0 7.7 18.6 14.4 27.6 30.2 10.6 33.8 21.4 18.5 10.2 40.6 9.7 17.9 34.7 32.9 14.0 22.3 14.6 25.0 19.6 11.6 79.1 12.1 100.1 31.4 9.0 EFCC1 "C3orf73, CCDC48, FLJ12057" ENSG00000114654 "EF-hand and coiled-coil domain containing 1" Q9HA90 3 129001629-129040742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.6" "Cell type enhanced" "Detected in some" "Adipocytes: 7.1;Endothelial cells: 6.5;Enteroendocrine cells: 9.5;Fibroblasts: 10.7;Microglial cells: 9.4;Peritubular cells: 7.5;Sertoli cells: 6.6;Theca cells: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 1.3;HL-60: 3.7;U-266/84: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042798, HPA050888" Uncertain NA NA "HPA042798: AB_2678173, HPA050888: AB_2681263" "unprognostic (1.74e-1)" "unprognostic (5.16e-3)" "unprognostic (1.65e-1)" "unprognostic (1.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.54e-2)" "unprognostic (1.66e-3)" "unprognostic (7.23e-3)" "unprognostic (1.57e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.70e-4)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.82e-1)" "unprognostic (2.20e-1)" 1.7 0.4 1.0 0.4 0.2 0.1 1.8 2.0 1.0 1.2 0.0 3.0 1.9 1.9 0.1 0.9 1.6 0.5 1.6 2.2 1.0 1.1 0.5 5.6 0.1 1.5 0.9 0.1 3.5 0.5 0.1 1.4 0.3 2.0 2.0 0.4 0.0 0.7 0.2 1.0 1.1 2.5 0.1 0.6 2.7 2.2 0.4 0.9 0.2 2.2 0.5 0.0 2.0 1.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 2.0 1.0 2.2 1.0 1.5 0.9 0.1 2.0 0.6 0.9 1.1 7.1 0.0 1.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 1.3 1.0 1.5 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.1 1.4 0.2 0.3 6.5 9.5 3.6 1.3 0.6 0.0 10.7 0.0 0.2 0.0 0.4 3.6 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.8 5.3 4.7 0.1 1.8 9.4 0.0 0.0 2.1 0.0 0.1 0.1 0.0 7.5 0.0 0.1 0.0 0.2 0.0 0.0 6.6 1.1 2.4 0.2 0.4 0.0 0.4 0.1 0.3 22.0 0.2 0.1 CFAP92 "FAP92, FLJ43738, KIAA1257" ENSG00000114656 "Cilia and flagella associated protein 92 (putative)" Q9ULG3 3 128909866-129002690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 22.3" "Group enriched" "Detected in some" 4 "Adipocytes: 1.3;Cardiomyocytes: 1.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "neutrophil: 34.0" "Lineage enriched" "Detected in single" 48 "granulocytes: 34.0" "Cell line enhanced" "Detected in many" "AF22: 7.6;HL-60: 13.5;THP-1: 9.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042811, HPA048445" Uncertain NA NA "HPA042811: AB_2678180, HPA048445: AB_2680397" "unprognostic (4.17e-2)" "unprognostic (5.16e-2)" "unprognostic (2.46e-1)" "unprognostic (2.67e-1)" "unprognostic (9.41e-3)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (4.22e-2)" "unprognostic (6.48e-3)" "unprognostic (7.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.88e-2)" "unprognostic (1.42e-2)" "unprognostic (3.38e-1)" "unprognostic (4.69e-2)" "unprognostic (2.52e-1)" "unprognostic (5.50e-2)" 0.4 0.7 4.2 1.0 2.0 2.1 0.8 4.1 2.4 0.4 3.6 0.7 0.8 0.7 0.5 1.2 3.3 1.4 0.6 3.8 1.6 0.5 0.2 1.1 1.0 2.8 3.2 1.9 1.2 0.9 1.7 1.8 1.1 3.3 1.0 0.8 2.8 0.7 0.3 0.7 4.3 0.9 0.2 1.7 1.0 1.1 22.3 2.2 4.2 0.8 0.5 0.3 0.4 0.1 1.8 1.0 1.4 7.6 1.6 0.1 0.2 2.4 0.3 0.3 0.1 0.0 1.2 1.0 1.5 0.3 0.0 0.7 1.1 2.3 0.1 0.0 0.6 1.1 3.3 1.9 1.0 0.0 13.5 0.7 0.0 1.4 0.0 0.1 0.5 0.1 2.9 0.9 1.7 0.2 1.5 1.3 2.5 1.4 2.6 1.4 1.1 0.8 0.9 0.0 1.5 1.5 0.7 0.4 0.5 0.6 1.0 2.6 9.2 0.4 0.8 1.2 0.8 0.5 2.2 2.0 2.5 0.6 5.0 0.6 0.8 0.7 2.9 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.5 34.0 0.3 0.3 0.3 0.2 0.2 4.2 2.0 4.1 2.4 3.8 1.6 2.8 3.2 1.9 3.3 1.7 2.2 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEK11 FLJ23495 ENSG00000114670 "NIMA related kinase 11" Q8NG66 3 131026850-131350465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.3;fallopian tube: 21.6" "Cell type enhanced" "Detected in many" "Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016908 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016908: AB_1854364" "unprognostic (9.15e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (4.85e-3)" "unprognostic (2.48e-5)" "unprognostic (5.38e-2)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "prognostic favorable (5.92e-6)" "unprognostic (2.46e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" 3.2 4.3 11.8 0.6 7.9 0.1 6.7 8.6 7.8 5.4 22.3 2.1 1.4 4.9 7.1 2.3 21.6 4.7 2.1 6.7 15.7 6.3 0.6 4.3 1.0 12.8 12.0 5.7 6.5 2.2 4.9 5.6 2.2 11.4 2.9 2.4 5.7 2.9 3.7 1.1 2.1 1.8 2.7 13.9 1.2 1.6 15.6 8.3 0.9 9.7 0.8 1.2 2.8 2.5 12.7 5.7 2.2 1.6 4.8 6.2 9.3 0.9 2.7 5.0 4.1 3.1 2.1 7.7 0.2 1.9 4.8 3.9 3.0 0.4 4.6 5.6 0.5 0.6 0.8 0.3 1.0 2.1 0.6 1.3 3.9 7.7 4.2 1.9 4.3 0.8 2.4 0.2 0.8 6.9 3.9 0.1 0.4 0.5 0.9 2.1 0.0 0.1 0.1 9.3 2.2 2.0 2.2 1.3 0.1 1.9 0.7 4.4 0.1 0.9 4.1 2.0 3.3 1.3 1.2 2.2 0.1 2.9 0.2 0.7 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.3 0.0 11.8 7.9 8.6 7.8 6.7 15.7 12.8 12.0 5.7 11.4 13.9 8.3 12.7 2.5 16.0 3.2 60.7 1.5 4.2 3.4 4.5 4.6 2.6 7.3 7.5 1.6 4.3 18.8 1.8 6.2 1.0 1.4 3.3 5.9 6.4 156.4 69.2 6.1 3.5 2.4 0.4 91.0 2.5 1.1 7.7 2.6 6.6 0.0 8.1 5.7 0.6 2.0 0.0 42.0 3.5 6.1 0.3 1.7 109.2 6.8 2.0 0.0 21.5 0.8 6.4 1.0 38.7 38.9 3.7 3.9 6.0 0.8 1.6 1.7 10.6 102.7 7.3 6.6 7.2 3.7 33.4 5.2 2.6 2.0 1.6 1.4 11.5 2.4 2.7 MRPL3 "MRL3, RPML3" ENSG00000114686 "Mitochondrial ribosomal protein L3" P09001 3 131462212-131502983 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043665, HPA060132" Approved NA NA "HPA043665: AB_2678606, HPA060132: AB_2684209" "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.61e-2)" "unprognostic (1.61e-3)" "unprognostic (7.83e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.33e-7)" "unprognostic (1.54e-1)" "unprognostic (8.23e-2)" "prognostic favorable (1.36e-4)" "prognostic unfavorable (3.51e-6)" "unprognostic (2.05e-3)" "unprognostic (6.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (3.29e-1)" 46.7 44.7 24.9 45.5 26.5 32.2 66.1 25.3 29.0 47.4 30.5 61.4 49.1 41.2 72.3 51.5 59.9 35.2 49.1 26.5 34.8 75.9 66.1 30.1 51.8 25.3 26.1 24.7 48.4 61.6 81.6 38.5 39.9 26.4 46.1 66.6 34.1 58.0 48.5 79.2 34.7 41.7 50.8 26.5 30.1 47.1 51.6 27.4 53.6 64.8 78.7 61.4 66.4 35.3 29.0 263.1 108.9 119.8 135.0 110.5 142.4 216.4 139.7 122.6 177.0 156.7 241.4 148.5 212.3 184.3 140.8 138.9 168.5 205.9 200.8 269.6 138.4 160.1 197.2 112.3 204.8 129.2 399.8 121.7 112.7 163.6 136.4 241.0 96.1 116.4 159.7 183.3 113.0 148.2 200.1 201.3 199.6 255.2 278.6 193.7 79.4 153.8 326.3 176.3 182.1 194.1 130.5 125.4 141.4 206.3 100.0 165.5 211.6 105.8 127.2 132.5 181.6 196.8 107.0 116.0 380.4 135.6 189.6 178.6 12.8 79.0 19.7 58.7 105.9 91.2 71.9 71.9 70.2 147.5 76.3 82.7 75.1 4.5 98.3 80.5 51.5 77.1 124.6 24.9 26.5 25.3 29.0 26.5 34.8 25.3 26.1 24.7 26.4 26.5 27.4 29.0 32.5 25.6 26.9 22.5 54.4 45.9 89.0 106.8 49.5 28.3 54.2 52.8 35.7 37.1 63.8 31.3 8.4 100.2 37.6 26.6 152.6 115.7 86.4 39.0 58.6 31.6 30.1 57.2 38.3 101.9 135.4 53.3 42.8 65.2 28.6 55.1 31.1 50.7 65.9 30.3 30.3 76.2 67.1 54.1 37.3 24.2 55.6 51.5 42.7 19.7 55.5 35.6 49.4 33.7 30.3 92.4 31.9 51.6 72.9 97.8 47.4 167.2 38.9 21.9 32.9 59.8 54.2 149.3 85.4 67.6 47.5 63.9 42.5 95.0 81.3 84.0 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192335-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 57.5 44.3 30.6 9.4 28.9 2.3 42.2 34.6 32.7 29.1 17.5 24.7 6.8 30.3 15.8 23.4 41.6 46.0 24.2 30.4 49.7 25.5 69.6 37.7 10.5 41.1 39.9 22.6 36.7 20.7 4.3 11.3 56.9 32.1 13.9 25.5 13.9 23.9 26.0 7.4 14.2 13.8 34.0 35.5 30.3 14.5 21.8 44.9 6.7 31.5 19.0 6.7 20.0 25.7 33.9 0.0 9.9 1.7 0.0 60.5 48.2 0.3 11.5 15.7 5.0 10.9 1.0 12.6 0.0 12.3 21.0 5.0 1.4 2.4 1.1 2.8 0.1 0.1 5.0 7.9 1.3 28.1 0.1 1.3 29.6 1.6 10.4 3.0 62.1 50.8 0.0 0.2 0.9 7.4 0.3 0.0 0.1 2.1 5.1 3.4 0.0 0.8 0.0 0.1 0.0 0.6 0.0 20.1 0.1 3.9 2.5 0.7 0.6 106.4 10.4 2.6 23.6 2.1 0.3 0.0 0.0 2.6 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.6 28.9 34.6 32.7 30.4 49.7 41.1 39.9 22.6 32.1 35.5 44.9 33.9 77.3 3.2 10.3 151.1 1.0 10.8 5.6 0.8 12.0 0.6 10.2 8.6 4.1 25.8 6.0 3.7 0.0 0.7 0.3 27.4 0.0 8.2 1.1 3.6 11.6 63.4 10.3 15.6 1.7 11.6 0.5 57.1 2.0 1.5 1.3 7.0 110.3 44.1 0.8 0.0 0.6 11.7 0.0 7.1 11.8 3.8 42.9 1.1 3.6 40.3 0.1 51.4 0.0 61.3 0.6 4.7 13.3 32.4 2.8 2.6 6.4 28.3 6.4 1.5 0.0 18.9 23.6 1.2 0.9 4.8 8.7 0.8 1.8 20.0 8.1 2.7 HEMK1 MTQ1 ENSG00000114735 "HemK methyltransferase family member 1" Q9Y5R4 3 50569152-50596168 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 149.9;Late spermatids: 151.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034701, HPA034702" Uncertain NA NA "HPA034701: AB_10601429, HPA034702: AB_10673101" "unprognostic (1.27e-2)" "unprognostic (6.96e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (2.43e-1)" "unprognostic (7.95e-3)" "unprognostic (9.39e-2)" "unprognostic (3.51e-3)" "unprognostic (1.45e-1)" "unprognostic (3.04e-1)" "unprognostic (5.33e-3)" "unprognostic (2.54e-3)" "unprognostic (1.58e-2)" "unprognostic (4.16e-2)" "unprognostic (4.53e-2)" "unprognostic (6.23e-2)" "unprognostic (2.44e-3)" 10.7 18.8 13.1 11.4 13.2 9.2 13.2 13.4 17.3 18.7 17.3 16.2 11.7 14.6 10.9 14.8 17.5 8.7 16.3 12.4 13.9 21.8 30.0 14.0 15.1 13.7 13.5 12.5 21.9 22.5 15.5 19.5 10.6 13.4 23.0 10.8 5.8 21.4 11.8 9.9 9.4 15.1 11.1 13.5 19.5 19.0 27.2 13.2 15.5 25.4 12.6 11.6 17.5 15.3 14.6 11.8 7.0 10.5 10.2 23.6 18.3 14.8 13.6 11.1 13.0 16.1 6.0 18.7 11.7 10.6 18.9 13.8 13.3 8.0 31.2 5.6 58.4 6.5 13.4 11.7 8.1 19.9 14.1 9.2 13.9 24.1 13.8 15.8 22.9 15.9 22.3 11.9 11.9 12.4 10.4 24.1 14.9 4.6 13.5 18.6 7.9 5.2 23.2 15.5 13.9 3.8 11.9 5.1 15.1 15.6 13.8 12.1 21.2 7.2 13.8 11.9 11.0 17.2 10.6 5.7 6.6 20.6 18.0 8.1 24.5 12.4 12.3 18.7 9.0 16.8 19.8 14.8 15.6 17.1 17.5 16.1 17.2 2.0 16.1 5.7 22.0 10.8 13.3 13.1 13.2 13.4 17.3 12.4 13.9 13.7 13.5 12.5 13.4 13.5 13.2 14.6 5.9 12.8 13.4 9.4 14.0 4.5 13.2 11.1 6.2 11.2 12.5 10.0 14.8 8.6 14.8 7.3 0.0 25.7 14.9 11.3 11.7 13.5 149.9 10.3 7.6 6.4 0.0 8.6 2.1 8.2 18.9 12.3 11.2 8.0 17.1 16.0 16.1 15.2 19.9 6.7 2.6 19.7 12.2 8.1 4.6 151.1 11.5 9.1 8.8 4.7 17.4 12.7 16.5 2.0 4.1 9.7 10.3 8.2 12.5 8.2 19.2 20.0 22.0 20.0 19.7 10.8 8.3 27.3 8.7 9.1 3.4 13.7 13.8 7.8 16.0 10.0 CISH "CIS, CIS-1, G18, SOCS" ENSG00000114737 "Cytokine inducible SH2 containing protein" Q9NSE2 3 50606489-50611774 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 61.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 38.5;Distal tubular cells: 58.7;Proximal tubular cells: 58.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "hypothalamus: 13.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "HDLM-2: 316.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034039, HPA040812" Approved Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "CAB034039: AB_2080282, HPA040812: AB_2677148" "unprognostic (2.36e-3)" "unprognostic (7.60e-3)" "unprognostic (2.89e-2)" "prognostic favorable (1.13e-5)" "unprognostic (8.54e-2)" "unprognostic (9.38e-2)" "prognostic favorable (6.98e-4)" "unprognostic (6.97e-3)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.65e-4)" "unprognostic (1.30e-2)" "prognostic favorable (3.53e-12)" "unprognostic (2.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" 15.6 4.8 0.9 8.7 1.3 7.7 24.7 1.1 1.9 9.7 1.8 8.4 10.3 9.5 3.1 9.7 9.9 4.5 20.9 0.9 13.0 47.2 61.2 28.2 8.6 2.8 1.6 0.8 14.6 20.3 22.3 14.4 23.4 2.1 7.5 9.0 0.3 13.3 8.9 40.3 12.2 8.9 4.9 1.6 10.0 10.5 2.3 1.8 9.8 36.7 5.3 6.8 6.0 10.1 1.6 2.4 0.8 2.8 5.9 0.7 3.4 2.5 0.6 0.6 0.3 0.4 2.3 0.6 0.0 2.0 0.9 1.3 2.8 4.7 3.8 0.3 316.3 0.8 18.7 1.8 2.5 2.1 2.5 22.0 14.2 1.6 0.7 1.3 0.2 0.6 2.0 75.6 0.6 0.6 14.8 4.1 17.4 2.7 8.7 2.9 1.8 1.2 19.4 6.3 2.7 1.4 4.7 1.0 37.7 0.7 0.8 20.9 15.4 0.5 0.8 2.2 2.8 1.4 0.3 0.4 0.0 0.5 22.7 0.4 21.3 10.2 13.7 33.8 6.2 51.1 0.9 54.0 41.6 7.0 0.4 40.5 40.6 8.6 2.0 3.9 4.6 35.3 19.6 0.9 1.3 1.1 1.9 0.9 13.0 2.8 1.6 0.8 2.1 1.6 1.8 1.6 7.1 3.2 38.5 0.0 1.8 8.0 7.4 1.9 10.2 0.7 18.3 12.1 14.3 0.0 6.7 18.4 0.0 9.1 14.1 8.9 58.7 11.7 2.6 6.6 4.3 3.5 2.4 11.6 0.1 16.4 4.0 11.6 3.6 8.5 1.3 16.9 2.2 7.0 12.7 0.0 0.0 9.6 2.0 8.4 10.0 0.6 8.4 12.8 1.8 1.0 17.3 0.1 14.4 0.0 0.0 7.2 6.7 3.8 4.0 3.0 6.5 58.2 0.8 0.2 13.1 7.6 8.8 1.0 1.3 7.3 8.9 15.9 31.0 3.4 12.1 3.6 MAPKAPK3 "3pK, MAPKAP3, MK-3, MK3" ENSG00000114738 "MAPK activated protein kinase 3" Q16644 3 50611520-50649291 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 191.1;skeletal muscle: 226.0;tongue: 286.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 226.6;Hofbauer cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 142.8;granulocytes: 126.3;monocytes: 341.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058275 Supported Nucleoplasm NA NA Nucleoplasm "HPA058275: AB_2683663" "unprognostic (6.46e-3)" "unprognostic (1.84e-1)" "prognostic favorable (8.08e-5)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (9.96e-2)" "unprognostic (8.77e-3)" "unprognostic (7.68e-3)" "unprognostic (1.11e-1)" "unprognostic (5.87e-2)" "unprognostic (2.19e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.90e-8)" "unprognostic (2.15e-2)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.69e-1)" 15.4 43.7 17.5 30.0 18.7 107.4 16.0 19.7 19.4 12.7 20.5 19.9 30.5 11.4 10.4 50.0 15.2 12.2 191.1 17.7 26.2 33.4 18.8 28.4 21.9 24.4 19.6 13.7 14.3 36.5 47.6 23.7 14.0 21.3 18.6 20.2 4.8 27.9 12.8 226.0 53.4 24.4 16.0 21.4 25.5 27.8 9.2 21.0 42.4 41.5 286.8 24.5 20.5 22.4 20.7 99.6 30.3 12.4 35.9 18.4 45.7 27.9 23.8 33.7 35.7 30.3 47.1 90.2 39.8 23.5 79.5 88.5 34.6 85.9 92.7 31.9 88.3 22.3 209.5 40.6 43.5 36.8 152.1 106.4 36.9 57.0 83.1 112.2 35.6 31.9 70.2 59.7 25.4 76.1 40.5 65.3 153.3 46.4 34.6 127.0 28.5 29.9 60.1 165.5 56.2 23.0 16.5 21.3 58.9 27.7 20.6 37.8 93.4 23.8 28.1 64.5 146.4 59.5 17.2 33.7 33.1 148.3 234.7 11.8 45.3 169.5 126.3 27.6 271.6 27.3 15.1 30.9 32.1 142.8 8.8 23.9 27.8 104.4 42.1 341.5 91.2 28.0 132.6 17.5 18.7 19.7 19.4 17.7 26.2 24.4 19.6 13.7 21.3 21.4 21.0 20.7 3.5 9.6 14.0 8.5 8.6 11.3 26.9 14.0 19.4 1.1 15.3 12.3 226.6 15.7 10.4 11.0 0.0 6.0 38.1 16.2 64.6 45.6 34.5 3.4 2.7 7.1 6.0 19.1 0.3 30.4 7.4 14.9 11.7 5.4 36.2 8.3 5.3 14.2 102.1 0.0 0.7 15.4 10.2 68.0 23.9 86.2 7.2 59.4 7.2 0.0 76.6 17.1 41.2 0.5 2.0 76.2 15.6 3.4 12.7 30.9 30.7 35.4 5.7 2.3 26.3 9.7 12.0 4.1 4.6 34.2 20.2 5.1 24.3 22.0 28.2 33.5 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453890-38493142 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.9;NTERA-2: 25.9;SuSa: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025115, HPA040384" Approved NA No "CAB025115: , HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 1.0 2.9 3.0 0.6 3.0 0.2 1.7 5.3 2.8 1.7 0.9 1.4 0.9 1.7 1.7 0.7 1.9 0.6 1.4 2.6 2.8 1.8 2.2 1.3 0.7 2.6 3.1 2.7 2.9 2.5 3.3 2.0 2.6 3.3 1.3 1.1 6.6 1.7 1.3 6.1 0.7 1.1 0.9 2.4 1.1 1.5 2.6 2.8 4.1 1.6 2.8 0.6 1.5 1.4 3.7 1.1 1.8 20.9 1.8 0.8 0.5 11.2 0.4 0.7 0.4 0.9 3.1 1.4 0.1 1.6 0.5 0.6 1.3 8.1 1.3 1.1 3.2 5.2 5.6 3.5 4.6 1.0 4.0 2.0 0.8 1.2 0.6 2.3 1.3 1.4 8.0 9.4 1.8 0.4 1.7 6.9 2.5 25.9 1.1 0.9 2.2 7.0 1.4 1.3 2.6 4.9 8.5 0.6 3.2 3.0 14.7 1.7 5.2 1.2 0.7 3.3 0.5 1.8 5.0 7.3 1.2 0.7 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.0 3.0 5.3 2.8 2.6 2.8 2.6 3.1 2.7 3.3 2.4 2.8 3.7 7.0 6.4 6.1 9.4 0.7 4.0 4.6 2.1 4.0 23.0 5.2 5.0 15.0 2.8 3.6 0.0 22.9 8.5 1.3 3.1 0.0 3.6 11.3 8.7 7.0 7.5 7.2 0.4 12.6 3.8 7.6 3.8 2.6 5.3 1.3 17.9 7.9 8.7 2.6 21.9 17.0 4.1 0.0 2.2 6.4 15.8 11.8 2.4 7.2 5.6 0.7 7.6 0.0 15.1 17.2 3.2 5.3 7.9 1.4 5.2 4.8 3.1 7.1 25.4 0.0 9.7 7.7 11.4 17.9 1.8 4.0 6.2 2.6 7.4 4.4 3.9 WDR48 "KIAA1449, P80, SPG60" ENSG00000114742 "WD repeat domain 48" Q8TAF3 3 39052013-39096671 "Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038421, HPA058015" Approved Supported Vesicles NA NA Vesicles "HPA038421: AB_10670780, HPA058015: AB_2683580" "unprognostic (1.95e-1)" "unprognostic (2.14e-1)" "unprognostic (2.99e-2)" "unprognostic (3.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.34e-3)" "unprognostic (6.14e-3)" "unprognostic (9.87e-3)" "unprognostic (8.02e-2)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-2)" "prognostic favorable (1.63e-7)" "unprognostic (2.41e-1)" "unprognostic (2.94e-2)" "unprognostic (1.43e-1)" "unprognostic (1.69e-2)" 14.2 15.6 21.1 13.5 22.5 35.4 17.8 20.5 25.9 17.8 17.7 14.5 15.3 20.2 14.2 14.1 15.8 13.3 16.4 21.6 22.2 21.6 16.2 14.0 17.8 21.2 21.2 20.8 21.3 16.3 22.2 4.5 20.9 21.4 16.1 15.3 18.0 15.5 21.1 11.6 14.2 15.3 17.1 21.6 16.3 14.3 48.3 22.2 27.0 25.1 17.3 19.6 17.0 6.4 24.3 11.6 16.4 32.9 23.6 23.8 27.2 14.4 14.4 20.6 17.6 22.5 11.5 12.7 27.8 10.0 20.2 15.7 13.8 30.3 18.7 20.5 70.3 38.8 26.1 22.8 19.0 10.8 18.8 13.7 18.1 21.2 19.0 21.9 31.9 21.8 20.1 30.7 27.8 16.3 9.9 24.6 20.1 36.3 16.8 19.8 9.6 17.3 24.1 21.9 24.2 24.1 29.0 14.7 29.8 25.4 29.0 15.6 26.7 18.8 15.9 12.0 14.7 16.2 30.2 48.6 22.7 18.5 16.9 15.5 13.3 6.0 7.5 9.2 7.9 9.1 9.4 10.6 10.7 8.7 10.9 10.7 9.3 8.0 15.1 13.0 7.2 12.6 8.9 21.1 22.5 20.5 25.9 21.6 22.2 21.2 21.2 20.8 21.4 21.6 22.2 24.3 27.0 16.0 22.0 45.4 26.6 17.6 13.3 9.2 20.5 21.6 18.1 16.6 23.2 7.2 15.5 11.0 16.7 15.9 26.0 14.4 17.6 13.9 77.2 20.2 28.5 20.6 22.1 17.9 35.3 12.4 12.2 18.0 9.7 29.7 24.1 25.5 16.1 13.0 8.6 21.9 37.0 13.7 4.1 11.4 15.9 71.9 18.6 16.2 14.2 26.2 19.8 23.6 13.4 38.7 41.1 12.0 12.9 16.6 20.9 21.9 17.3 13.4 17.8 17.9 26.3 21.9 19.2 104.5 59.9 16.7 21.2 21.5 25.7 23.0 12.3 19.5 COMMD2 HSPC042 ENSG00000114744 "COMM domain containing 2" Q86X83 3 149738472-149752495 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044190 Uncertain NA NA "HPA044190: AB_10966289" "unprognostic (2.17e-1)" "unprognostic (8.34e-3)" "unprognostic (6.28e-2)" "unprognostic (1.55e-3)" "unprognostic (1.53e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" "unprognostic (4.93e-2)" "prognostic unfavorable (3.69e-6)" "unprognostic (1.31e-1)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.89e-1)" "unprognostic (6.25e-2)" "unprognostic (4.86e-2)" 8.0 7.5 9.4 7.6 10.0 8.9 15.4 10.2 10.6 11.7 9.0 7.4 8.0 13.6 7.4 9.0 8.3 7.7 8.6 9.2 9.3 10.6 9.2 12.7 10.9 10.1 9.9 9.0 12.5 6.5 10.4 4.4 13.9 10.0 9.4 8.5 10.7 8.4 8.5 6.4 9.7 6.8 12.4 10.0 10.2 7.3 5.2 9.6 12.4 14.1 8.1 10.5 7.6 7.5 11.1 27.4 7.8 25.2 14.7 21.6 24.7 16.6 16.8 17.6 25.6 25.6 13.9 16.6 22.0 18.6 16.5 16.0 17.1 24.4 20.6 29.7 16.2 22.9 19.8 9.8 9.4 22.9 28.6 8.6 18.8 22.3 12.7 22.5 17.3 18.3 13.6 9.8 12.0 18.5 8.6 20.0 14.0 27.9 16.6 10.4 18.2 25.6 29.6 24.5 7.2 11.5 17.6 19.7 15.6 37.0 20.0 28.9 18.7 16.0 14.9 5.9 15.1 20.2 21.5 9.0 35.8 14.6 25.5 6.3 16.9 6.3 11.2 5.8 9.6 8.5 6.6 7.1 7.1 8.0 6.1 7.4 7.9 4.7 9.7 12.5 4.9 6.3 7.3 9.4 10.0 10.2 10.6 9.2 9.3 10.1 9.9 9.0 10.0 10.0 9.6 11.1 48.5 64.1 25.7 11.8 41.8 20.9 37.0 60.9 26.7 55.5 39.1 47.9 16.5 31.5 58.7 22.0 187.7 55.2 41.9 18.6 43.0 55.4 3.2 26.1 37.7 42.7 24.6 26.9 21.6 39.7 60.8 36.8 25.5 23.9 46.3 35.3 40.7 16.9 45.5 28.6 16.2 17.5 52.9 29.2 52.8 4.8 36.4 30.1 33.8 16.9 91.0 33.0 36.0 21.1 25.4 55.0 22.2 36.1 32.0 28.7 26.5 31.7 33.0 116.8 52.6 29.3 35.3 65.2 47.9 35.9 21.6 31.9 37.2 45.7 20.8 23.9 GORASP1 "FLJ23443, GOLPH5, GRASP65, P65" ENSG00000114745 "Golgi reassembly stacking protein 1" Q9BQQ3 3 39096599-39107863 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 98.9;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056283 Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA056283: AB_2683085" "unprognostic (1.06e-1)" "unprognostic (8.31e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.92e-6)" "unprognostic (2.77e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.13e-2)" "unprognostic (8.79e-3)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.73e-3)" "prognostic favorable (1.91e-6)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.44e-1)" "unprognostic (3.24e-3)" 17.1 13.6 35.8 12.9 36.4 11.6 18.8 39.6 36.0 25.4 30.4 23.8 13.7 19.0 16.7 20.2 22.4 15.8 18.6 34.3 36.5 19.7 26.6 19.7 13.5 41.4 37.3 32.2 13.4 24.7 22.7 15.6 21.2 37.7 22.3 26.3 20.8 26.4 31.0 16.5 16.6 18.6 24.2 41.8 21.6 19.2 10.5 39.1 11.9 18.6 19.2 17.5 18.1 14.9 47.1 15.6 19.0 18.0 17.8 42.8 28.1 16.6 27.1 31.1 27.5 24.6 11.3 18.4 16.8 15.7 41.4 17.2 24.7 20.7 32.2 19.3 22.4 14.3 23.8 18.7 16.0 19.3 20.0 25.8 22.0 43.8 28.5 28.0 30.6 38.2 6.0 19.8 20.3 26.3 22.6 5.6 18.9 13.1 35.7 23.1 6.0 10.7 23.8 27.4 28.1 7.1 14.0 25.7 51.4 16.1 24.4 33.2 20.7 29.0 15.4 14.3 37.0 15.0 14.1 14.8 4.1 18.3 16.7 23.0 6.5 12.0 7.0 3.3 12.7 4.5 11.7 4.1 3.1 12.8 9.3 4.7 3.4 6.9 2.8 17.2 7.2 6.7 8.0 35.8 36.4 39.6 36.0 34.3 36.5 41.4 37.3 32.2 37.7 41.8 39.1 47.1 21.1 3.2 9.8 23.2 8.7 4.1 10.6 6.5 8.0 8.5 12.9 9.7 8.7 12.8 7.2 12.9 0.0 14.0 3.4 21.4 11.7 10.7 98.9 15.5 11.4 13.4 11.4 5.5 7.7 8.7 11.1 8.9 24.5 16.3 1.3 8.8 8.9 11.4 9.5 8.4 9.2 15.3 8.2 7.2 9.8 56.1 7.2 9.5 12.4 9.4 7.0 7.3 0.0 9.0 9.6 11.0 8.0 6.4 5.7 11.4 14.2 6.0 10.7 11.1 0.0 8.8 10.0 10.1 6.8 8.0 5.8 19.8 4.4 6.5 15.1 12.6 PEX5L "PEX5R, PXR2, TRIP8b" ENSG00000114757 "Peroxisomal biogenesis factor 5 like" Q8IYB4 3 179794958-180037053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 185.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 252.3;Excitatory neurons: 848.2;Inhibitory neurons: 475.2;Oligodendrocyte precursor cells: 215.1;Oligodendrocytes: 2006.1" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 7.8;MOLT-4: 27.9;RPMI-8226: 21.8;SCLC-21H: 12.8;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058026 Enhanced NA NA "HPA058026: AB_2683582" "unprognostic (5.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.93e-1)" "unprognostic (1.82e-3)" "unprognostic (2.68e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-4)" "unprognostic (9.67e-5)" "unprognostic (3.84e-1)" "unprognostic (2.66e-10)" "unprognostic (2.27e-3)" "unprognostic (1.45e-2)" "unprognostic (1.69e-2)" "unprognostic (4.03e-3)" 0.4 0.3 22.8 0.1 76.0 0.0 0.1 53.0 73.1 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.0 0.1 33.1 40.7 0.1 0.0 0.2 0.0 63.9 63.3 19.2 1.8 10.3 30.4 5.3 0.0 83.1 0.2 0.0 15.4 0.2 0.0 1.3 0.1 0.1 0.0 53.4 0.0 0.1 4.9 52.3 2.7 0.2 0.4 0.0 0.0 0.0 185.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 7.8 0.1 0.0 0.2 0.0 0.0 1.5 0.1 0.1 0.0 0.0 1.3 0.7 0.0 0.7 0.0 3.8 0.0 0.0 27.9 0.0 1.6 0.0 0.3 0.2 0.0 21.8 0.0 0.0 12.8 0.7 0.0 0.0 0.0 0.0 0.1 2.1 0.0 2.7 0.1 0.0 0.7 16.7 0.5 0.1 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 76.0 53.0 73.1 33.1 40.7 63.9 63.3 19.2 83.1 53.4 52.3 185.7 0.0 0.0 0.0 65.6 0.0 0.0 0.2 0.0 0.0 11.3 0.1 0.1 3.2 0.0 0.0 0.0 252.3 0.1 0.0 0.0 0.0 0.0 29.6 0.2 0.6 0.4 0.0 0.0 848.2 0.6 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 10.1 475.2 0.2 0.0 0.0 0.4 18.0 0.3 0.1 0.0 35.6 0.7 2.3 0.0 215.1 2006.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 9.5 0.0 2.4 0.2 0.7 1.1 0.0 0.3 0.0 0.1 1.9 0.0 0.1 RRP9 "RNU3IP2, U3-55K" ENSG00000114767 "Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein" O43818 3 51933429-51941904 "Predicted intracellular proteins" "rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038798 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038798: AB_10672653" "unprognostic (5.57e-2)" "unprognostic (9.47e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" "unprognostic (4.18e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.24e-1)" "unprognostic (2.00e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-2)" "unprognostic (8.25e-3)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.15e-2)" "unprognostic (5.92e-2)" 18.1 20.3 9.5 13.9 10.3 12.5 17.5 9.5 12.2 16.2 7.8 13.0 11.0 16.6 5.4 17.8 16.0 6.8 13.9 10.1 9.5 12.8 16.4 14.0 15.8 9.8 9.6 9.4 15.9 14.3 10.5 10.6 9.2 9.3 14.7 7.7 5.6 11.7 9.1 29.1 17.3 12.6 9.2 9.0 14.7 13.2 10.9 10.2 9.3 12.8 13.4 10.6 19.3 15.6 10.3 35.8 50.0 23.5 56.2 33.8 18.8 59.5 38.4 20.9 63.7 40.3 85.5 39.6 102.7 15.9 27.3 86.5 32.3 81.9 59.4 25.5 47.1 35.8 69.5 30.6 77.5 67.9 76.6 55.6 39.0 43.0 80.1 75.3 15.5 24.9 35.8 67.0 25.2 28.5 56.7 65.3 76.2 92.6 54.7 126.9 39.7 26.7 78.6 31.4 52.1 28.9 34.1 34.8 38.5 38.8 20.0 20.1 49.2 24.1 44.3 59.4 111.0 160.8 43.0 75.6 96.2 39.5 94.2 71.4 2.1 9.1 0.5 16.4 13.2 17.5 16.4 14.1 14.5 17.0 13.5 10.9 13.2 0.6 18.8 6.5 18.0 12.5 10.0 9.5 10.3 9.5 12.2 10.1 9.5 9.8 9.6 9.4 9.3 9.0 10.2 10.3 9.2 0.0 10.5 3.6 15.2 66.8 27.1 29.7 13.1 12.9 11.2 10.3 4.1 10.0 14.0 5.5 4.2 26.8 14.8 8.3 15.6 24.3 8.1 11.2 12.7 12.7 8.4 7.2 1.9 13.4 40.5 12.6 9.7 9.3 15.2 14.4 5.0 7.0 23.4 16.8 1.3 7.2 22.4 5.3 13.4 6.6 8.7 8.7 21.4 1.0 12.9 10.6 16.5 2.0 1.6 20.0 10.3 9.1 11.6 34.2 6.2 22.2 11.9 10.7 6.6 15.6 36.7 8.0 23.8 15.0 50.4 16.7 12.5 16.4 18.9 14.6 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184017939 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 143.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 136.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 14.4 23.4 43.1 16.5 47.1 22.6 13.2 51.1 52.8 27.9 143.7 22.4 10.9 21.8 10.5 44.9 16.2 18.1 44.8 48.2 44.0 37.2 8.0 15.8 13.2 46.4 42.1 47.0 23.6 13.1 24.2 42.0 17.4 50.4 28.1 22.3 127.3 18.5 13.8 118.5 24.3 23.4 16.2 37.8 37.4 83.1 16.7 46.5 15.4 13.9 40.6 11.9 35.1 35.5 50.7 21.5 11.5 25.9 30.8 25.7 28.3 40.0 16.8 13.3 14.8 16.2 17.9 15.8 22.5 38.6 16.2 22.6 83.3 32.1 18.6 19.3 24.4 31.1 48.1 32.5 18.0 10.3 14.8 36.5 45.6 18.3 15.9 10.6 30.3 17.8 65.6 45.6 30.8 25.7 56.7 40.7 17.1 26.7 38.4 21.7 28.1 8.7 13.4 54.4 136.4 46.6 27.8 17.1 93.5 29.3 33.3 56.6 4.9 20.4 17.4 16.6 22.3 23.8 11.7 24.3 21.1 12.5 29.2 17.9 11.7 4.6 8.3 6.9 2.2 4.4 3.1 3.8 3.1 3.6 4.5 4.3 6.0 16.4 5.6 4.2 1.3 5.7 4.5 43.1 47.1 51.1 52.8 48.2 44.0 46.4 42.1 47.0 50.4 37.8 46.5 50.7 8.3 9.6 5.3 39.2 6.4 8.9 14.4 18.3 35.3 39.1 10.5 11.3 37.2 2.8 37.2 44.1 196.0 3.2 7.7 23.3 7.9 5.7 6.0 10.4 18.0 9.5 59.3 21.2 101.3 4.5 5.0 12.5 91.3 20.8 5.1 31.0 6.8 3.3 49.7 33.7 122.8 6.4 20.3 32.7 6.5 3.5 8.1 29.3 12.4 32.8 8.3 13.8 9.2 82.4 62.7 7.9 20.2 7.9 7.5 9.3 5.1 4.8 44.9 121.1 0.0 27.4 15.4 6.8 18.8 41.3 12.1 4.5 8.6 14.9 7.5 61.5 AADAC "CES5A1, DAC" ENSG00000114771 "Arylacetamide deacetylase" P22760 3 151814073-151828488 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 226.8;intestine: 243.7;liver: 954.5" "Group enriched" "Detected in some" 8 "Hepatocytes: 687.7;Proximal enterocytes: 460.5" "Cancer enriched" "Detected in many" 22 "liver cancer: 153.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA002911 Approved NA NA "HPA002911: AB_1078074" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.11e-2)" "unprognostic (4.41e-2)" "unprognostic (9.23e-2)" "unprognostic (7.82e-2)" "unprognostic (2.15e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.58e-6)" "prognostic unfavorable (5.02e-4)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" 6.0 226.8 0.3 0.4 0.0 0.0 5.0 0.0 0.1 0.1 0.1 0.2 222.9 0.2 0.0 2.7 0.6 27.7 0.4 0.0 0.0 0.2 954.5 9.1 0.3 0.0 0.0 0.0 0.1 37.0 0.0 0.1 1.5 0.0 0.1 0.2 0.0 1.3 0.0 0.0 13.9 243.7 0.0 0.0 0.2 52.8 0.8 0.0 0.4 0.3 0.0 2.5 0.7 0.4 0.2 0.0 9.5 0.0 0.0 4.2 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 4.6 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 1.0 0.4 0.1 0.3 1.7 0.0 1.7 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.0 0.9 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 0.0 14.3 0.0 0.7 0.3 0.0 4.4 0.0 0.0 0.0 0.0 1.1 71.4 8.7 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.3 1.8 0.1 0.7 0.0 2.7 0.0 51.9 0.0 39.3 53.5 0.2 0.0 0.0 5.0 687.7 0.2 0.0 0.0 9.6 0.0 14.8 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 10.0 0.0 0.1 0.2 460.5 0.0 2.9 0.0 0.0 0.0 3.4 0.0 0.1 1.4 3.4 0.3 0.7 0.3 18.4 0.2 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 313.2;Proximal tubular cells: 265.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 190.8" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2100000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 69.8 82.5 21.4 26.3 22.3 37.7 66.6 21.4 25.5 50.1 29.9 56.5 82.3 39.6 45.0 46.5 58.8 35.5 29.6 20.5 23.5 97.1 156.9 38.1 48.7 22.9 22.4 19.7 51.7 65.7 51.8 36.8 15.6 22.5 49.0 55.9 40.7 65.4 36.9 25.3 42.8 75.4 27.1 22.3 47.5 51.4 9.7 22.9 39.4 57.6 22.8 43.4 48.3 43.2 22.9 37.6 32.9 2.7 37.3 100.6 91.3 9.2 14.5 18.4 27.2 32.5 25.3 72.6 41.7 11.4 54.2 12.6 18.5 23.5 22.2 21.0 57.6 27.2 66.6 30.6 106.6 55.3 37.8 64.9 115.1 74.4 27.8 36.9 41.9 34.0 64.2 39.1 66.8 55.8 40.5 16.8 29.9 3.5 43.6 88.5 42.1 5.2 190.8 51.8 16.7 15.2 16.6 37.3 68.0 121.8 5.7 97.7 25.8 31.5 13.8 64.8 32.3 8.7 82.1 41.6 17.4 30.4 118.9 24.8 41.7 24.3 10.9 42.2 19.9 63.3 58.3 53.0 52.0 38.1 42.9 52.4 49.2 1.9 24.5 12.9 28.4 42.4 37.5 21.4 22.3 21.4 25.5 20.5 23.5 22.9 22.4 19.7 22.5 22.3 22.9 22.9 40.4 6.4 26.2 7.8 69.4 30.2 62.4 68.5 38.1 12.7 88.1 81.0 4.7 72.9 28.7 69.9 14.6 16.7 50.7 79.6 146.8 34.8 1.4 19.6 22.4 36.8 75.9 41.2 10.1 46.8 19.0 43.4 35.2 20.9 50.8 14.8 39.7 122.1 55.4 8.4 10.8 97.1 42.7 60.7 36.3 2.4 65.0 39.0 55.2 14.0 37.7 14.8 50.4 4.5 9.4 30.0 74.5 46.6 37.4 39.6 313.2 265.3 25.2 39.9 39.5 34.7 35.6 0.4 3.9 57.1 30.4 11.8 63.9 47.7 127.9 64.4 EIF1B GC20 ENSG00000114784 "Eukaryotic translation initiation factor 1B" O60739 3 40309707-40312424 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 366.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.54e-1)" "unprognostic (1.06e-2)" "unprognostic (1.31e-2)" "unprognostic (3.20e-3)" "unprognostic (7.64e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.02e-2)" "unprognostic (1.13e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.33e-1)" "unprognostic (1.23e-1)" "unprognostic (1.82e-1)" "unprognostic (8.87e-2)" 74.9 92.9 96.9 48.2 102.8 223.7 67.3 105.4 127.7 64.6 88.5 69.2 41.6 67.4 60.5 42.3 75.8 61.9 366.0 100.8 123.7 97.7 93.2 74.6 68.3 119.1 114.0 95.5 104.1 60.8 77.8 91.7 53.5 121.6 52.7 42.6 95.3 48.3 57.0 158.9 47.4 56.0 59.6 111.7 63.1 71.5 84.0 110.8 63.3 59.7 147.8 60.3 90.8 54.1 145.3 41.1 33.1 110.0 62.9 130.2 127.0 65.6 82.1 107.6 79.8 103.0 52.1 54.1 83.7 44.5 56.4 47.8 27.3 75.9 40.4 80.8 127.6 76.9 135.5 33.4 120.4 206.3 82.4 66.8 93.0 121.8 70.2 119.2 112.5 85.2 55.9 115.5 100.5 93.2 26.1 66.7 89.2 149.5 36.3 87.0 45.4 61.4 68.1 78.3 51.6 46.7 76.5 59.4 34.1 238.6 103.4 43.6 82.8 65.8 45.8 47.3 93.6 58.5 92.5 177.2 121.4 57.3 89.7 66.6 93.0 48.5 138.1 36.4 57.8 43.6 95.1 44.4 47.0 45.3 83.8 51.8 45.8 133.2 40.9 55.7 73.2 58.4 41.0 96.9 102.8 105.4 127.7 100.8 123.7 119.1 114.0 95.5 121.6 111.7 110.8 145.3 178.9 93.0 63.1 15.7 216.5 190.0 226.5 133.8 227.1 108.6 94.7 119.0 454.8 81.5 83.3 88.3 54.2 113.9 125.0 114.3 293.5 97.2 167.3 139.6 146.0 115.5 117.5 294.1 45.2 114.6 120.2 207.4 69.8 141.5 130.0 104.3 102.1 75.1 128.5 149.7 50.9 82.1 99.7 172.0 135.4 71.5 109.0 192.1 149.4 20.6 138.0 157.5 118.4 23.1 33.4 85.0 183.6 91.7 76.9 119.8 138.7 292.1 81.5 189.8 92.1 161.7 187.6 493.0 268.2 137.8 147.8 115.6 143.4 80.9 88.7 206.7 ABHD14A-ACY1 ENSG00000114786 "ABHD14A-ACY1 readthrough" 3 51974706-51989183 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 4.8;Collecting duct cells: 5.5;Distal tubular cells: 3.9;Proximal tubular cells: 16.8;Theca cells: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA036174, HPA036175, HPA038153" Approved Uncertain Vesicles NA NA Vesicles "HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "unprognostic (4.90e-2)" "unprognostic (7.22e-3)" "unprognostic (3.83e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (6.23e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (1.29e-2)" "unprognostic (9.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (7.11e-4)" 0.5 0.8 0.0 0.1 0.1 0.0 0.4 0.5 0.4 0.2 0.1 0.2 0.0 0.6 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.0 0.2 0.1 0.1 0.2 0.3 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.7 0.1 0.3 0.0 0.1 0.2 0.4 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.4 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.4 0.5 1.2 0.9 0.8 0.6 0.7 1.1 1.0 0.5 0.7 1.0 0.0 1.1 0.6 0.6 1.0 0.5 0.0 0.1 0.5 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 1.4 0.0 4.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.2 3.2 0.0 0.0 1.8 5.5 0.0 0.0 0.9 0.1 3.9 1.5 0.0 0.4 1.4 0.6 0.0 0.8 1.0 1.2 0.0 1.0 2.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.5 1.2 2.0 0.0 0.0 0.0 0.0 0.2 16.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 6.3 0.0 0.0 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 339.7;Astrocytes: 248.8" "Cancer enhanced" "Detected in all" "prostate cancer: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: AB_2680671" "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favorable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 8.1 2.1 5.4 1.8 5.1 0.3 6.1 4.7 5.2 4.9 6.6 13.7 7.4 4.4 1.2 7.5 6.2 5.5 2.1 4.8 5.0 1.7 15.6 16.5 0.3 6.0 5.8 3.4 4.0 6.0 10.0 1.7 3.5 5.4 3.4 2.6 7.2 3.1 4.9 0.4 6.1 6.7 7.2 5.2 0.8 8.8 5.1 5.8 0.8 3.1 1.4 0.9 5.1 6.4 4.9 8.5 3.7 10.6 6.8 5.1 1.4 0.3 0.3 0.0 3.1 4.3 6.5 0.8 5.0 0.5 0.6 4.9 8.9 6.7 4.4 3.9 0.0 8.8 0.1 2.6 1.5 4.7 1.6 0.2 1.3 0.4 4.0 0.5 1.8 0.6 5.4 0.0 0.0 2.0 8.1 2.0 0.1 6.7 2.4 3.0 0.0 12.9 0.0 0.7 4.1 3.2 1.1 1.7 14.4 1.5 4.6 10.1 0.5 0.0 1.1 5.3 0.1 26.6 4.5 0.7 0.0 2.5 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.1 4.7 5.2 4.8 5.0 6.0 5.8 3.4 5.4 5.2 5.8 4.9 5.0 339.7 26.8 248.8 1.7 19.5 9.0 2.7 17.6 11.6 54.2 6.6 1.8 20.0 10.8 3.7 4.2 1.8 4.3 1.5 0.0 2.2 11.9 4.7 4.5 4.3 0.0 2.7 4.2 2.5 1.1 12.0 14.3 2.1 5.1 3.6 8.6 60.8 0.6 5.0 10.1 7.9 6.1 2.5 3.4 3.4 10.5 1.3 3.6 7.5 2.7 58.1 12.3 41.7 5.1 2.0 6.9 18.8 0.7 7.5 21.4 0.1 14.9 47.8 0.0 14.1 3.7 4.7 37.0 11.7 23.7 6.2 4.7 2.5 8.1 5.7 KLHL24 "DRE1, FLJ20059" ENSG00000114796 "Kelch like family member 24" Q6TFL4 3 183635610-183684519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 185.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 64.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056337 Uncertain NA NA "HPA056337: AB_2683103" "unprognostic (3.68e-1)" "unprognostic (1.37e-3)" "unprognostic (1.62e-1)" "unprognostic (1.53e-3)" "unprognostic (8.56e-3)" "unprognostic (3.85e-1)" "unprognostic (2.09e-1)" "unprognostic (1.02e-2)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "unprognostic (3.31e-1)" "unprognostic (1.39e-3)" "unprognostic (1.08e-1)" "unprognostic (7.85e-2)" "unprognostic (8.40e-2)" "unprognostic (1.02e-2)" 16.3 13.2 4.4 10.6 14.8 41.4 16.2 64.8 25.0 13.8 0.0 13.7 16.2 15.5 10.4 11.6 10.4 13.5 41.7 3.5 6.3 18.7 20.5 18.9 15.9 11.6 11.2 0.1 20.2 15.4 42.0 10.5 14.0 11.2 14.0 14.1 16.2 17.9 11.6 48.9 11.2 14.7 11.4 1.7 16.3 15.3 9.1 8.2 18.0 23.5 46.9 14.8 14.1 12.0 20.2 4.4 4.3 9.9 10.5 22.1 12.0 20.6 2.2 16.9 2.7 4.8 2.8 8.0 8.9 30.1 6.1 25.2 6.2 5.7 2.6 4.8 10.1 7.9 5.4 6.9 2.9 18.9 4.7 7.1 24.7 14.0 2.9 9.2 16.7 14.4 13.8 3.5 28.5 3.7 2.1 7.9 6.0 6.4 6.7 6.5 10.0 7.5 28.7 7.8 13.6 17.5 24.5 10.3 32.1 23.5 14.4 11.8 10.4 12.5 3.4 4.4 5.4 2.9 54.1 38.4 37.7 6.0 7.5 2.2 43.1 20.3 25.0 17.3 22.7 14.7 25.7 14.3 15.8 13.8 27.7 20.7 14.8 40.9 16.3 22.5 10.7 20.5 15.3 4.4 14.8 64.8 25.0 3.5 6.3 11.6 11.2 0.1 11.2 1.7 8.2 20.2 44.5 112.2 72.3 88.8 73.4 43.6 30.7 21.8 77.4 39.8 33.2 24.8 137.8 27.1 33.4 31.3 70.9 12.1 63.2 32.0 13.7 28.1 16.1 35.5 42.0 39.5 42.3 26.1 99.5 18.9 18.0 44.5 29.6 49.3 26.0 110.1 33.2 47.7 27.1 60.6 104.3 28.5 46.8 51.9 31.4 7.0 30.7 46.5 35.6 68.4 31.3 24.4 41.2 92.0 185.2 18.1 29.3 24.5 48.5 51.9 52.3 27.7 35.8 45.8 32.9 59.7 48.8 27.9 12.4 46.1 43.9 43.8 49.5 45.1 26.0 44.8 PLCH1 "DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3" ENSG00000114805 "Phospholipase C eta 1" Q4KWH8 3 155375580-155745071 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.8;retina: 12.5" "Group enriched" "Detected in many" 4 "Astrocytes: 93.7;Early spermatids: 206.2;Excitatory neurons: 126.0;Inhibitory neurons: 131.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 12.3;AF22: 39.0;HEL: 10.1;NTERA-2: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036176, HPA057978" Uncertain Enhanced Vesicles NA NA Vesicles "HPA036176: AB_10671837, HPA057978: AB_2683569" "unprognostic (1.08e-2)" "unprognostic (3.68e-1)" "unprognostic (2.17e-2)" "unprognostic (1.55e-2)" "unprognostic (3.50e-4)" "unprognostic (6.41e-2)" "unprognostic (2.94e-5)" "unprognostic (5.04e-2)" "unprognostic (2.41e-1)" "unprognostic (2.24e-3)" "unprognostic (4.84e-2)" "unprognostic (1.76e-2)" "prognostic favorable (3.03e-5)" "unprognostic (3.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-2)" 0.0 0.0 5.4 0.3 5.0 0.2 2.6 5.1 6.4 1.2 7.8 2.5 2.5 0.7 8.3 0.1 8.2 1.5 1.1 3.4 4.4 1.2 0.1 4.1 0.0 1.4 4.5 3.7 0.1 1.4 0.4 1.5 0.4 2.2 0.3 2.4 12.5 1.3 1.9 0.3 0.1 2.6 0.1 1.0 0.0 3.9 11.4 1.4 16.8 5.7 0.0 0.0 0.4 0.1 3.9 0.0 12.3 39.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.4 9.8 0.0 0.8 0.0 0.1 0.0 7.0 0.0 0.0 0.0 3.6 10.1 0.0 1.4 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.3 0.0 0.0 4.4 2.4 9.4 20.8 1.3 1.6 0.9 0.0 0.0 2.4 0.2 3.6 0.9 0.0 9.4 0.0 5.7 4.2 0.0 0.0 0.0 0.2 0.0 1.7 0.4 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 5.0 5.1 6.4 3.4 4.4 1.4 4.5 3.7 2.2 1.0 1.4 3.9 0.0 3.2 13.6 93.7 0.3 0.0 0.4 0.5 0.6 10.5 4.0 5.0 0.8 4.3 2.3 1.8 4.2 0.0 0.1 2.7 0.0 2.2 206.2 34.6 1.3 0.6 3.0 0.0 126.0 2.3 0.3 0.3 15.3 13.6 0.0 0.1 0.0 0.0 0.2 25.2 131.5 4.0 0.0 0.3 0.4 21.4 1.2 0.4 0.0 12.2 0.1 16.1 0.0 5.5 5.7 1.5 4.6 0.4 0.0 0.4 2.8 2.1 23.4 3.0 0.0 0.0 0.2 2.4 1.2 0.7 0.1 0.0 0.3 0.1 4.4 0.4 VIPR1 "HVR1, RDC1, VPAC1, VPAC1R" ENSG00000114812 "Vasoactive intestinal peptide receptor 1" P32241 3 42489299-42537573 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 133.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 71.8;Intestinal goblet cells: 48.6;Paneth cells: 96.2;Proximal enterocytes: 58.6" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 22 "dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 60.8;OE19: 36.2;RT4: 44.0;SK-BR-3: 24.7;WM-115: 79.0" "Group enriched" "Detected in many" 4 "amygdala: 6.3;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5" "Low region specificity" "Detected in all" HPA026777 Approved NA NA "HPA026777: AB_10604003" "unprognostic (9.02e-2)" "unprognostic (9.34e-3)" "unprognostic (3.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-1)" "unprognostic (1.47e-2)" "unprognostic (8.89e-4)" "unprognostic (4.00e-3)" "unprognostic (1.03e-1)" "unprognostic (2.95e-2)" "unprognostic (1.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-3)" "unprognostic (7.70e-2)" "unprognostic (1.69e-1)" "unprognostic (1.03e-2)" "unprognostic (1.05e-2)" 14.3 2.7 8.4 3.4 12.4 2.3 17.0 13.3 15.4 2.9 5.4 28.3 34.8 1.2 6.7 5.3 1.3 6.1 5.5 12.7 6.9 2.6 32.7 133.2 4.6 5.9 5.9 12.0 0.6 2.5 4.2 1.9 2.9 9.2 25.3 28.0 4.3 22.9 9.0 1.2 28.6 30.2 1.3 4.4 5.7 6.2 1.4 5.0 1.9 15.2 4.9 2.4 8.8 5.0 11.9 0.1 2.4 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.4 2.2 60.8 0.2 3.1 0.0 0.0 2.4 0.0 1.6 0.1 0.0 5.2 3.8 1.8 0.0 0.3 0.0 0.5 0.0 3.8 0.2 1.2 0.0 0.7 0.6 0.0 0.0 0.0 5.2 0.0 0.3 3.8 36.2 0.2 0.5 0.0 2.8 0.0 44.0 1.3 0.0 0.0 24.7 0.0 7.1 15.2 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.0 1.8 0.0 0.2 1.5 1.0 0.0 2.4 1.0 2.1 0.0 2.7 0.8 0.0 0.0 1.3 0.0 0.4 0.9 8.4 12.4 13.3 15.4 12.7 6.9 5.9 5.9 12.0 9.2 4.4 5.0 11.9 16.0 3.2 6.0 3.3 1.3 7.6 4.5 2.2 22.2 0.2 19.2 21.5 2.6 5.7 2.1 1.8 8.4 0.1 0.4 71.8 0.0 0.3 3.0 0.2 0.1 2.8 4.8 0.0 26.9 0.9 1.0 1.0 16.3 0.6 0.0 0.3 19.6 0.4 0.7 0.0 1.5 48.6 0.0 8.7 4.0 0.6 0.0 5.9 0.0 3.7 8.9 1.4 0.0 3.0 1.7 1.2 96.2 0.0 1.5 6.3 58.6 0.1 1.0 5.4 32.9 0.2 20.8 0.1 0.1 4.1 7.7 0.3 2.9 0.1 24.0 3.9 DNAH1 "DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1" ENSG00000114841 "Dynein axonemal heavy chain 1" Q9P2D7 3 52316319-52400491 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 21.5;Respiratory ciliated cells: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "midbrain: 3.4" "HPA036805, HPA036806" Uncertain NA NA "HPA036805: AB_10670924, HPA036806: AB_10670849" "unprognostic (8.34e-3)" "unprognostic (3.60e-2)" "unprognostic (9.60e-4)" "unprognostic (1.54e-2)" "unprognostic (2.99e-1)" "unprognostic (6.59e-4)" "unprognostic (1.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-2)" "unprognostic (4.98e-4)" "unprognostic (1.84e-3)" "unprognostic (8.66e-3)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (9.80e-5)" 1.9 1.4 0.7 2.1 0.4 6.2 1.7 0.0 1.3 1.4 1.8 1.4 1.3 1.5 1.3 1.3 4.0 1.6 1.0 0.4 0.1 1.5 2.5 2.4 3.2 1.1 0.7 0.0 1.9 1.6 1.4 1.8 1.0 0.8 1.6 1.3 2.5 1.5 0.8 1.1 1.7 2.9 1.7 0.7 3.0 1.7 4.2 0.6 1.9 1.6 0.5 2.5 1.1 1.2 1.8 0.1 0.7 1.0 1.0 1.2 4.6 0.5 0.6 1.0 0.2 0.2 0.0 0.6 0.3 0.6 0.8 0.1 0.1 0.0 0.2 0.4 0.8 1.4 2.0 0.1 0.2 0.6 1.5 1.3 2.0 0.3 0.8 1.0 2.1 0.8 0.8 0.2 1.7 0.8 0.2 0.4 1.4 0.5 0.1 0.9 0.7 0.0 0.6 0.3 0.8 0.1 0.5 1.0 0.1 0.7 0.3 0.2 2.4 1.0 0.3 0.2 0.9 0.2 1.8 1.8 0.5 0.3 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 1.3 0.4 0.1 1.1 0.7 0.0 0.8 0.7 0.6 1.8 2.2 6.4 3.7 9.1 3.2 0.5 0.4 2.0 0.6 1.8 1.7 1.8 4.4 0.0 2.7 0.0 4.2 0.6 3.1 2.3 0.0 0.3 9.7 6.9 1.6 2.1 5.4 2.7 13.8 0.6 0.2 1.2 8.2 3.8 3.8 3.2 2.2 3.9 1.2 5.0 10.0 2.6 8.2 3.5 1.6 21.5 1.2 3.2 1.8 3.7 3.4 0.9 4.1 2.5 10.7 0.3 2.1 0.4 2.4 0.9 4.8 0.9 35.5 5.2 0.0 1.4 1.9 6.9 1.5 1.1 0.3 0.8 3.3 1.7 2.2 0.6 SSR3 TRAPG ENSG00000114850 "Signal sequence receptor subunit 3" Q9UNL2 3 156539553-156555149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 894.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014906 Approved NA NA "HPA014906: AB_2195736" "unprognostic (4.11e-1)" "unprognostic (3.50e-1)" "unprognostic (5.49e-2)" "unprognostic (5.46e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (3.43e-4)" "prognostic unfavorable (4.46e-7)" "unprognostic (1.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-3)" "unprognostic (6.68e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.23e-2)" "unprognostic (2.92e-2)" "unprognostic (1.39e-2)" "unprognostic (8.29e-2)" 85.6 72.6 32.9 74.8 35.2 53.4 107.3 37.2 45.2 145.7 33.9 85.6 62.3 85.3 174.5 52.3 107.7 59.6 117.1 31.1 51.7 76.0 101.7 60.8 64.6 41.6 36.4 29.8 94.7 196.9 72.7 59.2 60.9 41.2 74.5 92.0 29.2 182.8 138.4 62.2 33.7 57.0 114.6 42.0 62.4 83.3 58.5 43.4 49.2 114.9 45.4 88.6 74.2 53.5 48.0 449.0 92.9 113.3 143.4 377.4 354.9 118.1 641.9 363.2 320.6 444.6 184.9 209.1 148.4 277.3 432.9 290.1 203.4 192.5 760.2 762.3 178.7 91.9 264.4 58.5 185.9 402.2 279.9 122.0 318.1 278.3 545.3 1081.7 309.6 400.6 129.0 151.9 528.2 930.8 131.1 96.8 63.1 138.7 253.6 181.5 136.1 185.7 969.9 300.6 105.2 91.2 76.8 166.0 246.3 358.9 176.4 252.3 143.2 508.5 424.0 204.9 325.3 721.8 485.5 207.3 249.0 254.0 231.9 248.1 111.1 88.7 71.6 60.6 104.1 95.7 76.1 64.0 75.4 115.5 46.8 42.6 52.0 30.5 66.7 136.0 162.1 81.1 72.4 32.9 35.2 37.2 45.2 31.1 51.7 41.6 36.4 29.8 41.2 42.0 43.4 48.0 103.4 109.0 167.3 22.2 205.3 83.7 132.7 182.6 41.5 33.7 157.8 263.4 153.4 117.2 151.1 73.5 31.3 113.1 142.1 85.1 109.5 238.4 98.1 89.7 281.2 124.9 71.1 91.9 10.7 229.8 470.0 174.0 103.0 160.0 95.7 145.4 123.5 219.0 388.2 25.2 14.3 247.0 69.2 218.1 224.3 38.0 214.9 196.2 145.9 10.3 241.5 89.6 73.2 17.1 18.5 233.2 81.5 223.0 894.2 257.5 90.3 214.7 81.0 37.1 72.3 96.3 178.4 177.1 69.0 74.0 78.7 188.9 109.8 119.5 148.9 157.8 ZBTB47 "DKFZp434N0615, KIAA1190, ZNF651" ENSG00000114853 "Zinc finger and BTB domain containing 47" Q9UFB7 3 42653697-42667580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.4" "Cell type enhanced" "Detected in many" "Astrocytes: 21.9;Inhibitory neurons: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 55.5;fHDF/TERT166: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074057 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA074057: AB_2686657" "unprognostic (1.03e-1)" "unprognostic (1.15e-2)" "unprognostic (8.23e-2)" "unprognostic (3.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" "unprognostic (2.74e-1)" "unprognostic (2.00e-2)" "unprognostic (4.86e-2)" "unprognostic (8.99e-2)" "prognostic favorable (7.96e-5)" "unprognostic (5.77e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (7.10e-2)" 21.8 13.8 75.9 9.4 70.0 2.8 18.1 56.9 65.9 21.6 36.6 22.7 3.9 23.2 4.5 11.6 15.4 11.5 70.9 64.2 56.1 9.5 6.3 14.1 2.7 73.3 66.6 53.9 15.4 13.5 10.0 12.4 6.3 79.1 23.7 3.4 6.5 17.5 14.6 113.4 14.4 11.3 14.9 63.2 7.2 18.8 9.2 68.7 2.0 19.6 63.6 1.8 23.9 16.0 76.3 6.7 5.9 3.6 2.4 55.5 20.7 1.2 15.1 12.7 6.5 4.7 1.3 2.7 0.1 6.4 30.9 2.5 1.6 0.9 5.9 1.2 0.0 7.2 3.7 18.9 1.6 17.5 0.1 5.3 23.5 10.4 8.5 7.1 17.0 7.3 0.0 3.9 4.8 12.9 1.7 0.2 0.5 2.1 0.2 3.5 5.0 6.7 1.9 3.4 1.3 4.0 6.7 7.3 1.2 6.0 1.5 8.3 8.6 17.3 14.1 8.2 13.9 6.4 0.2 0.0 0.0 13.1 4.8 4.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 75.9 70.0 56.9 65.9 64.2 56.1 73.3 66.6 53.9 79.1 63.2 68.7 76.3 1.8 0.0 1.1 21.9 0.0 4.0 1.5 3.6 3.4 6.4 0.8 0.9 10.5 0.0 1.8 1.8 0.0 0.1 1.6 0.1 0.0 0.7 10.0 0.5 4.5 2.1 0.0 0.0 7.8 1.3 0.2 6.4 4.6 1.2 4.5 2.9 2.2 0.7 1.4 0.0 11.8 0.3 2.0 1.9 4.1 2.5 3.4 2.0 8.8 8.4 0.8 7.7 0.0 9.0 11.5 0.6 1.2 3.0 1.9 2.0 0.0 0.6 1.1 1.9 0.0 7.8 4.4 0.0 0.2 1.3 3.1 0.1 0.4 5.9 0.0 1.1 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451100-52454041 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 36 "heart muscle: 8240.1;skeletal muscle: 21280.3;tongue: 12513.9" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 3550.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 27.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 6 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7" "Region enriched" "Detected in all" 4 "cerebral cortex: 87.0" "Group enriched" "Detected in some" 6 "midbrain: 7.6;spinal cord: 7.1" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 990000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 6.5 11.0 0.8 0.8 0.8 0.7 19.3 3.1 1.1 7.7 6.4 3.9 1.1 2.8 42.1 390.7 2.8 3.3 8240.1 1.4 1.2 19.1 4.1 79.2 3.9 0.9 0.9 0.7 2.5 6.8 1.6 17.7 5.3 1.0 171.6 4.2 0.4 121.8 2.3 21280.3 16.3 3.3 0.8 0.9 2.8 5.7 10.7 1.0 4.4 14.5 12513.9 1.6 5.4 5.4 0.8 0.7 5.2 3.6 0.6 0.2 0.5 8.0 0.4 0.3 0.3 0.4 68.2 33.5 0.5 65.2 9.9 0.1 0.4 0.1 0.3 0.0 1.2 1.6 0.5 49.1 46.1 0.3 0.3 0.1 67.2 1.2 0.0 0.7 0.6 0.0 2.0 0.2 5.1 2.0 0.1 0.2 0.8 0.5 15.1 0.7 0.1 2.9 2.3 3.3 13.0 0.2 0.0 0.5 6.7 0.1 3.9 26.7 0.5 0.0 0.1 97.7 0.8 0.2 2.8 1.3 0.9 0.3 0.7 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.8 0.8 3.1 1.1 1.4 1.2 0.9 0.9 0.7 1.0 0.9 1.0 0.8 0.2 125.0 12.6 0.0 0.3 1.5 1.7 4.0 0.6 0.2 0.5 0.3 3550.1 5.7 7.9 3.7 2.1 59.0 0.1 1.6 27.4 11.8 0.7 66.4 6.7 39.8 330.7 0.4 0.0 13.0 5.1 52.7 0.5 98.8 0.0 0.8 0.7 0.7 4.9 0.0 0.0 1.7 2.0 0.0 1.4 5.8 22.4 2.6 5.4 0.0 0.1 1.2 0.0 0.0 0.0 6.5 0.3 177.6 0.1 0.8 0.5 1.3 2.8 0.1 0.0 241.8 36.0 2.1 1.0 0.1 0.9 31.1 2.8 1.3 2.0 6.8 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600655-42648735 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: AB_2681540" "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favorable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.01e-4)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.05e-5)" 17.2 19.4 17.8 17.7 20.6 46.9 19.4 23.0 18.6 28.6 18.2 17.3 13.3 18.6 22.6 17.1 23.2 11.5 16.2 16.1 18.9 17.1 21.2 24.1 22.3 19.5 17.5 14.6 29.2 22.3 10.6 36.8 11.2 19.6 23.4 13.5 41.7 17.6 10.6 19.7 32.8 25.6 10.8 16.0 37.0 16.4 18.2 18.9 15.5 25.6 10.5 20.2 18.4 22.8 29.3 15.1 7.7 32.3 15.6 16.6 19.3 14.9 22.8 6.8 9.9 12.9 14.7 13.3 25.9 10.7 9.1 9.0 12.6 16.1 8.4 19.2 11.0 13.1 31.4 30.5 24.6 7.3 25.4 19.9 9.6 12.2 18.4 10.5 19.1 17.4 7.1 30.3 20.2 18.6 6.9 17.8 35.5 23.1 7.6 12.3 17.3 12.0 10.5 15.7 12.7 9.4 8.5 24.1 11.1 4.8 16.3 17.5 17.8 28.0 18.0 13.1 21.4 23.2 17.2 21.7 17.7 10.1 30.0 11.3 7.8 3.6 7.5 5.7 4.6 5.3 5.5 5.6 4.9 2.9 5.3 5.6 4.9 5.3 7.0 6.8 5.1 5.3 2.3 17.8 20.6 23.0 18.6 16.1 18.9 19.5 17.5 14.6 19.6 16.0 18.9 29.3 221.8 109.0 141.4 169.4 129.5 59.0 60.3 57.8 66.0 200.0 76.3 69.8 68.7 65.8 73.2 88.3 246.0 72.5 156.0 60.3 17.6 47.3 23.9 114.4 125.5 166.2 71.8 76.6 143.5 38.8 51.1 83.3 86.6 132.4 96.8 210.0 110.7 58.6 45.9 132.9 170.0 70.2 61.1 53.8 70.2 21.8 167.7 78.9 51.6 194.9 97.4 101.9 163.7 180.0 267.2 47.6 59.2 134.3 131.3 77.5 106.8 17.0 53.3 279.9 92.1 103.5 88.9 246.2 186.1 42.4 57.3 31.3 164.4 104.5 75.0 54.2 CLCN2 "ClC-2, CLC2, EJM6" ENSG00000114859 "Chloride voltage-gated channel 2" P51788 3 184346185-184361650 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 16.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.7;Proximal enterocytes: 27.4;Theca cells: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009397, HPA014545, HPA024108" Approved Approved Cytosol NA NA Cytosol "CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883" "unprognostic (1.13e-1)" "unprognostic (4.01e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (4.67e-8)" "unprognostic (1.72e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.19e-1)" "unprognostic (4.40e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (1.35e-1)" 1.4 5.2 2.4 1.8 3.0 1.1 1.6 3.3 3.0 2.8 1.6 16.4 9.3 3.7 3.8 1.7 2.5 7.6 1.2 2.2 2.8 3.0 1.8 1.2 0.7 3.7 3.2 1.8 4.0 4.5 3.4 2.8 1.0 3.1 2.3 10.9 0.6 2.8 2.9 0.9 1.6 8.5 1.6 3.1 1.5 2.2 10.7 2.8 1.3 2.7 0.5 0.9 2.1 2.0 4.4 8.9 3.2 2.5 6.9 2.2 1.8 5.8 2.9 1.7 3.1 2.0 16.8 3.0 3.0 8.2 1.6 8.0 15.1 3.6 3.5 0.9 2.8 4.2 2.7 7.0 7.7 1.3 1.2 2.6 3.6 2.7 2.6 3.0 1.5 2.9 3.3 1.0 1.6 1.1 5.9 0.8 1.6 3.7 7.6 4.4 5.4 2.3 10.7 3.8 6.9 4.0 2.4 3.3 11.4 5.2 1.6 9.4 1.2 1.4 1.5 4.5 7.7 7.7 3.6 5.5 2.1 2.7 5.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.0 3.3 3.0 2.2 2.8 3.7 3.2 1.8 3.1 3.1 2.8 4.4 2.2 3.2 4.1 16.6 0.4 1.0 0.9 0.8 1.2 2.1 2.5 2.8 1.2 14.3 1.1 0.0 0.0 1.0 1.9 81.7 0.0 3.7 2.3 2.5 4.5 1.9 3.0 0.8 4.1 2.0 0.6 2.6 2.6 4.4 1.3 11.3 2.5 0.6 0.7 1.7 8.1 3.7 0.0 1.0 0.3 2.7 5.3 1.1 0.0 1.9 0.6 1.7 0.0 6.0 15.1 2.2 16.0 4.9 0.8 0.6 27.4 2.3 2.6 2.5 0.0 0.9 2.1 3.3 1.7 1.1 0.4 1.5 1.2 62.5 9.0 0.5 FOXP1 "12CC4, hFKH1B, HSPC215, QRF1" ENSG00000114861 "Forkhead box P1" Q9H334 3 70954708-71583989 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTEC/SVTERT24-B: 95.0" "Low region specificity" "Detected in all" "HPA003876, CAB011501" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011501: AB_732428, HPA003876: AB_1078907" "unprognostic (2.31e-1)" "unprognostic (4.35e-3)" "unprognostic (2.09e-2)" "unprognostic (3.54e-2)" "unprognostic (2.69e-1)" "unprognostic (2.81e-3)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (2.03e-1)" "unprognostic (4.38e-3)" "unprognostic (3.40e-1)" "unprognostic (6.14e-2)" "unprognostic (1.05e-1)" "unprognostic (8.65e-2)" "unprognostic (1.27e-1)" "unprognostic (6.05e-2)" 15.6 3.8 5.0 20.5 35.1 38.9 14.6 0.3 14.8 11.1 13.8 23.7 12.3 15.5 6.5 23.2 14.4 21.1 12.9 8.1 6.3 6.7 13.1 23.1 22.4 15.0 7.5 4.1 32.7 17.0 6.5 9.1 13.8 11.2 21.4 23.6 2.6 30.0 9.7 8.3 10.5 15.4 22.9 0.3 18.0 20.8 14.5 9.2 26.5 14.7 11.2 25.6 21.8 14.4 6.2 9.6 8.0 16.8 13.2 8.4 21.3 8.2 26.3 30.9 22.0 17.4 51.9 11.2 31.1 4.3 12.9 17.6 6.9 31.0 22.8 40.3 7.8 11.7 13.0 17.0 52.7 20.5 25.7 31.6 21.7 10.3 95.0 42.1 18.3 36.6 15.4 13.6 36.7 10.8 42.6 11.9 9.3 19.7 7.2 39.9 38.0 30.7 4.7 18.8 30.1 14.5 27.6 32.6 7.7 1.9 15.9 5.6 21.9 47.7 34.9 14.3 48.9 42.2 9.0 7.1 41.8 22.5 35.7 7.5 46.9 15.3 15.2 18.3 13.1 19.4 58.1 38.7 22.6 13.0 62.2 60.8 40.0 27.0 22.2 25.3 21.7 35.9 28.8 5.0 35.1 0.3 14.8 8.1 6.3 15.0 7.5 4.1 11.2 0.3 9.2 6.2 158.8 73.7 121.3 130.9 266.5 183.0 170.6 58.2 176.4 30.3 98.5 115.1 42.1 148.7 72.0 33.1 18.8 47.2 122.9 118.1 31.3 79.0 156.0 116.3 48.2 184.9 271.6 111.5 391.0 95.1 12.6 90.4 95.8 128.0 219.8 117.7 184.9 72.3 49.5 6.7 139.9 231.2 154.6 117.6 209.0 89.6 42.0 101.3 37.4 414.1 120.3 15.5 116.4 184.5 286.4 124.8 102.8 24.8 66.0 178.8 91.7 19.4 83.7 42.8 92.1 102.9 119.4 13.7 33.6 111.5 101.4 52.4 168.1 33.1 157.2 146.3 EIF4G1 "EIF4F, EIF4G, p220, PARK18" ENSG00000114867 "Eukaryotic translation initiation factor 4 gamma 1" Q04637 3 184314495-184335358 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding, Translational shunt" "Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 351.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014774, HPA028487, HPA043866" Approved Enhanced Cytosol NA NA 330000 Cytosol "CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705" "unprognostic (4.14e-3)" "unprognostic (2.10e-2)" "unprognostic (6.01e-2)" "unprognostic (3.01e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (4.27e-3)" "unprognostic (2.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.55e-3)" "unprognostic (7.06e-3)" "unprognostic (2.42e-1)" "unprognostic (7.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.33e-3)" 87.0 92.6 22.1 76.4 16.5 84.7 69.6 15.4 21.7 58.9 25.1 79.2 62.6 71.9 33.0 127.8 60.1 51.4 86.7 20.5 32.6 54.3 113.9 74.8 56.1 40.6 30.8 10.4 58.0 97.0 100.1 57.8 59.9 24.6 62.8 57.0 22.5 93.9 59.8 351.2 115.8 67.7 75.4 17.2 58.6 80.6 65.3 30.8 49.5 71.9 178.5 63.7 76.7 86.0 19.9 559.0 232.3 173.1 205.7 196.9 192.5 322.5 298.6 204.1 315.4 238.8 486.5 173.7 348.4 381.9 367.6 358.5 292.7 322.6 365.8 230.5 375.1 345.8 321.3 226.1 206.4 173.4 321.4 212.2 199.6 206.8 292.4 268.8 152.8 278.3 128.8 239.6 267.2 205.7 403.4 219.7 105.3 368.9 241.3 180.8 221.7 183.4 281.9 156.8 331.8 197.7 174.6 258.1 415.6 187.6 144.6 445.2 206.5 364.1 227.2 228.9 297.3 567.9 203.8 263.2 629.0 260.5 271.4 258.3 8.3 16.0 6.7 11.7 14.4 10.8 7.7 7.8 9.6 12.8 9.2 6.9 7.6 5.6 8.7 21.0 18.1 6.0 12.7 22.1 16.5 15.4 21.7 20.5 32.6 40.6 30.8 10.4 24.6 17.2 30.8 19.9 63.9 76.9 72.6 23.8 41.7 59.1 78.2 58.0 70.6 24.2 69.3 46.2 109.4 50.1 72.3 62.5 14.6 64.0 37.6 135.5 13.7 98.8 151.6 53.0 67.1 69.3 55.7 82.7 10.8 135.3 74.8 64.5 75.4 85.6 48.0 163.8 43.5 152.8 66.8 21.9 12.9 97.2 50.8 40.8 39.9 202.7 73.0 48.9 33.8 14.0 53.0 23.2 30.9 4.0 10.1 149.0 69.0 56.1 112.9 96.8 77.0 45.4 51.4 23.2 78.9 81.6 78.9 24.8 41.4 120.7 91.8 79.6 46.0 94.8 108.4 95.6 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711148 "Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: AB_2682768" "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favorable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 94.4 156.0 78.3 64.7 81.9 61.8 101.4 83.5 101.9 96.9 87.5 102.1 95.7 101.8 111.7 117.9 92.9 48.8 117.9 78.3 87.1 138.1 174.3 88.5 71.8 84.7 83.1 74.5 91.9 233.1 90.3 142.2 59.9 85.6 97.1 85.5 125.7 146.4 79.8 143.4 109.4 104.8 53.4 83.4 106.4 152.3 154.4 82.9 67.3 114.2 50.1 87.8 103.9 95.5 88.3 114.6 102.2 113.4 139.3 164.9 134.4 157.2 157.6 144.5 139.4 128.4 108.1 171.0 114.6 65.7 145.4 142.5 110.2 109.9 142.5 149.1 154.3 115.8 138.6 169.2 164.6 175.1 213.3 229.1 104.7 190.5 148.5 174.4 130.5 117.4 147.5 118.8 418.0 151.8 105.5 168.8 207.2 195.8 317.2 203.9 67.9 95.7 608.6 232.7 148.3 73.6 157.4 148.7 178.1 224.2 102.4 188.1 248.1 106.2 127.3 119.1 226.3 192.1 406.2 654.1 169.8 196.5 209.4 169.8 292.7 129.9 258.2 131.1 137.0 155.1 202.0 158.5 144.2 143.9 149.3 146.8 152.1 100.1 119.6 152.5 620.5 177.1 253.8 78.3 81.9 83.5 101.9 78.3 87.1 84.7 83.1 74.5 85.6 83.4 82.9 88.3 172.5 64.1 104.2 23.8 282.3 156.5 227.9 470.7 136.1 465.4 289.0 351.0 148.7 221.6 283.6 310.8 118.9 373.5 488.1 195.2 361.9 353.8 597.8 286.4 180.8 157.6 167.7 143.9 27.1 339.4 399.8 181.9 119.8 181.5 211.6 138.7 131.4 301.8 311.0 102.6 34.4 291.3 325.5 202.9 189.9 1177.6 216.3 192.5 380.6 13.1 321.9 296.9 213.1 21.1 53.2 274.8 274.1 191.8 888.8 295.0 405.5 665.1 374.1 251.3 164.3 152.6 335.5 746.4 504.5 195.8 184.4 351.2 220.8 283.6 267.7 285.3 NEK4 "NRK2, pp12301, STK2" ENSG00000114904 "NIMA related kinase 4" P51957 3 52708444-52770946 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell type enhanced" "Detected in all" "Spermatocytes: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015750, HPA058543" Enhanced Supported Cytosol NA NA Cytosol "HPA015750: AB_1854367, HPA058543: AB_2732623" "unprognostic (1.32e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.69e-5)" "unprognostic (9.65e-3)" "unprognostic (3.42e-1)" "unprognostic (6.64e-2)" "unprognostic (8.75e-3)" "unprognostic (2.27e-1)" "unprognostic (7.85e-2)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.74e-3)" "unprognostic (5.11e-2)" "unprognostic (2.85e-1)" "unprognostic (1.51e-2)" "unprognostic (8.39e-2)" 6.4 8.2 7.6 7.5 7.2 7.0 9.5 9.7 7.4 8.6 7.9 7.4 6.6 8.8 8.9 6.8 13.8 6.3 6.2 6.1 9.0 9.8 10.9 6.7 8.4 7.5 8.9 5.9 13.4 8.2 11.6 7.4 7.6 6.5 7.8 8.3 17.0 7.4 9.1 8.0 3.5 5.7 8.2 7.6 7.3 9.7 46.4 6.9 9.5 13.6 6.1 9.5 8.0 5.0 6.5 19.9 15.2 20.5 16.2 18.2 13.1 22.1 13.9 18.6 25.3 25.4 13.5 14.4 20.4 6.4 13.6 27.9 9.2 25.2 16.3 33.8 20.4 10.6 16.0 18.4 17.3 11.4 39.4 15.4 8.1 14.8 32.5 21.5 13.5 9.6 17.4 20.2 16.1 16.1 17.1 21.4 14.4 17.7 20.9 14.9 18.5 17.8 15.1 14.3 28.3 15.0 9.0 29.1 17.7 14.1 15.7 16.5 23.4 8.9 16.9 17.1 27.3 26.0 17.8 27.9 19.7 19.3 18.2 18.7 13.6 9.8 5.0 3.5 6.1 3.7 2.8 3.0 3.6 5.2 3.5 3.6 3.1 1.4 4.0 4.2 2.6 2.6 5.2 7.6 7.2 9.7 7.4 6.1 9.0 7.5 8.9 5.9 6.5 7.6 6.9 6.5 6.2 12.8 8.2 19.2 11.8 4.1 5.3 3.4 4.6 14.1 10.6 6.2 4.6 2.8 11.6 5.5 12.5 7.0 4.8 6.5 9.8 7.0 20.7 24.0 10.6 7.3 4.8 13.3 30.5 9.6 8.1 7.8 12.8 9.9 7.6 14.0 6.8 14.5 8.2 6.7 29.4 9.3 6.1 16.8 4.6 19.5 14.6 10.4 1.8 7.5 14.0 19.4 10.3 16.6 19.3 8.5 2.9 12.4 10.6 5.3 5.4 17.1 22.4 18.9 6.6 12.6 7.3 75.9 27.9 6.9 4.1 6.7 5.8 11.8 9.1 5.2 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627394-219641980 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 252.7;ovary: 125.1" "Group enriched" "Detected in many" 9 "Cardiomyocytes: 207.1;Horizontal cells: 558.6" "Cancer enhanced" "Detected in all" "glioma: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "myeloid DC: 1.4;plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 54 "dendritic cells: 5.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 3.7 16.9 35.6 1.1 32.6 0.4 4.0 20.2 32.4 10.1 4.3 2.3 0.7 15.5 2.7 3.3 9.4 2.4 252.7 31.4 31.2 4.8 0.3 1.6 0.9 37.9 22.1 29.0 125.1 4.0 7.7 41.7 2.7 42.3 10.5 0.3 13.1 3.8 5.3 0.9 1.7 1.1 3.8 7.6 3.3 2.7 14.3 32.9 1.0 2.5 0.6 0.6 2.6 4.8 40.4 6.9 0.2 2.3 6.8 0.4 0.4 4.9 4.1 4.2 5.4 3.8 4.8 3.8 0.0 1.6 1.5 9.3 3.8 1.2 7.3 1.6 0.0 1.0 0.0 0.1 0.1 1.1 0.1 0.3 3.1 7.0 0.0 2.1 13.4 0.0 0.0 0.3 0.0 1.6 2.3 0.0 0.0 3.8 0.2 5.5 0.0 0.0 0.0 3.7 1.5 1.3 6.7 2.7 6.9 3.7 7.2 0.7 1.7 0.0 3.4 6.0 0.0 3.3 0.0 0.0 0.0 2.7 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 35.6 32.6 20.2 32.4 31.4 31.2 37.9 22.1 29.0 42.3 7.6 32.9 40.4 0.3 0.0 0.0 19.2 0.2 0.3 0.7 1.5 0.0 14.4 2.2 4.8 207.1 0.0 0.8 1.8 0.0 11.4 13.5 0.0 1.9 3.0 2.3 0.9 3.5 1.8 0.0 0.0 11.5 1.7 3.0 10.4 0.0 1.4 0.0 38.3 0.0 0.0 1.8 558.6 32.7 0.0 0.0 0.3 5.6 25.6 15.2 1.1 0.0 3.7 1.3 7.6 0.0 3.5 0.6 1.1 0.0 22.6 0.0 0.4 0.0 0.3 0.2 7.5 6.6 3.9 3.5 0.6 1.2 0.0 0.9 13.8 0.1 8.7 0.0 0.1 INO80D FLJ20309 ENSG00000114933 "INO80 complex subunit D" Q53TQ3 2 205993721-206086303 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.1" "Cell type enhanced" "Detected in all" "Astrocytes: 158.7;Excitatory neurons: 127.7;Inhibitory neurons: 129.0;Oligodendrocytes: 188.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043976 Approved NA NA "HPA043976: AB_10960835" "unprognostic (6.79e-2)" "unprognostic (9.77e-2)" "unprognostic (1.34e-1)" "unprognostic (2.43e-1)" "unprognostic (4.81e-2)" "prognostic favorable (5.53e-4)" "unprognostic (4.83e-3)" "unprognostic (3.00e-1)" "unprognostic (8.10e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" "unprognostic (1.39e-2)" "unprognostic (4.05e-3)" "unprognostic (1.30e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (3.03e-2)" 4.3 3.0 0.9 2.3 1.2 18.1 4.3 4.8 1.9 4.0 1.0 3.9 3.5 4.0 1.4 4.5 3.9 3.0 3.7 0.6 0.6 3.1 3.7 4.2 4.4 1.5 0.6 0.5 5.1 4.1 1.4 4.0 2.5 1.5 3.4 1.5 5.1 4.2 0.9 5.8 6.0 4.7 1.0 0.1 3.9 3.8 5.6 0.9 1.7 5.3 1.8 1.7 3.6 4.5 3.1 2.4 1.8 4.5 3.6 1.3 1.6 3.3 1.8 0.9 1.3 1.0 3.6 4.7 2.4 2.9 1.1 4.5 3.2 1.7 1.2 1.5 2.1 3.3 5.2 4.2 4.4 0.8 4.5 3.3 1.0 1.6 1.6 2.1 3.5 1.7 2.9 5.1 5.6 1.4 3.2 2.5 14.8 6.0 1.4 2.6 3.1 2.8 2.6 1.3 4.1 4.1 3.9 3.3 2.1 3.5 3.6 2.9 4.4 4.7 3.7 3.6 1.6 2.2 7.0 5.7 6.1 2.9 3.9 2.8 4.1 2.2 2.0 3.0 1.2 2.5 4.1 2.2 1.4 1.6 5.2 2.5 1.9 5.1 2.0 3.4 4.5 2.6 0.9 0.9 1.2 4.8 1.9 0.6 0.6 1.5 0.6 0.5 1.5 0.1 0.9 3.1 31.5 22.4 34.7 158.7 35.5 30.8 18.2 9.8 25.6 39.5 19.9 13.8 17.5 31.5 18.6 18.4 39.6 8.4 43.0 27.3 5.9 13.5 3.7 25.3 31.4 27.8 25.2 29.9 127.7 13.1 5.9 29.4 26.5 41.2 32.4 24.1 17.2 16.3 11.7 11.8 129.0 20.3 4.1 21.7 28.9 5.4 20.2 23.1 17.8 117.1 25.9 16.8 26.8 126.2 188.3 17.8 19.9 15.4 33.2 26.1 24.3 12.8 16.2 39.9 13.1 55.6 29.3 11.3 5.7 31.2 29.1 15.5 33.6 16.4 17.8 25.7 EEF1B2 ENSG00000114942 "Eukaryotic translation elongation factor 1 beta 2" P24534 2 206159585-206162928 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012477, HPA035029" Supported Approved "Nucleoli fibrillar center,Cytosol" NA NA 840000 "Nucleoli fibrillar center, Cytosol" "CAB012477: AB_732078, HPA035029: AB_2674422" "prognostic favorable (2.60e-4)" "unprognostic (3.12e-1)" "unprognostic (4.22e-2)" "unprognostic (6.44e-2)" "unprognostic (4.74e-2)" "unprognostic (2.70e-1)" "unprognostic (1.49e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (9.95e-4)" "unprognostic (2.70e-1)" "unprognostic (5.37e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.62e-6)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-2)" 525.9 406.1 191.5 257.7 195.6 691.7 572.0 187.3 264.8 570.2 238.5 488.4 344.3 457.7 132.4 774.4 520.1 145.3 353.3 181.5 196.3 419.0 449.5 360.4 463.9 195.1 190.8 178.5 814.7 1600.2 96.4 221.5 140.7 197.3 360.5 295.1 53.4 471.8 148.9 1046.9 713.5 578.8 193.8 204.7 580.8 495.1 164.6 198.4 349.5 268.8 375.5 448.4 491.9 577.3 200.0 278.2 330.0 377.0 357.3 542.8 914.1 816.4 584.5 556.7 560.1 367.4 733.1 454.2 792.3 358.8 648.9 310.4 352.7 520.1 647.3 509.3 245.8 469.2 562.2 442.9 998.5 719.8 1189.2 483.1 932.9 755.6 418.1 939.0 545.0 605.2 629.9 782.8 644.2 628.0 568.2 946.5 916.2 552.5 628.0 565.3 731.7 796.0 1007.4 606.0 521.8 384.1 395.2 211.1 461.8 588.8 439.8 283.3 1349.0 431.1 290.9 403.6 391.7 529.1 681.5 631.0 918.3 338.7 751.5 224.1 93.9 357.8 44.1 432.5 370.9 794.4 1075.6 761.7 576.5 676.4 848.7 1075.2 897.6 47.9 609.1 298.1 650.3 448.7 1770.3 191.5 195.6 187.3 264.8 181.5 196.3 195.1 190.8 178.5 197.3 204.7 198.4 200.0 614.8 198.7 346.8 9.4 2022.8 1142.4 1787.7 737.1 1367.0 114.5 1353.8 2138.0 164.5 619.1 474.5 163.7 27.1 853.8 1097.6 591.9 688.7 756.0 187.8 284.9 1021.6 596.6 445.0 1188.1 13.0 1883.8 1657.1 597.5 575.4 403.4 547.2 1584.1 461.2 682.3 823.0 52.2 12.6 1316.9 270.6 826.2 1008.4 463.5 866.7 868.0 533.6 11.2 1049.6 193.2 924.8 6.0 15.4 890.3 990.9 483.7 1393.5 1529.4 1952.4 1222.5 228.5 117.9 269.5 615.5 748.0 153.7 287.4 2237.4 1259.6 950.5 1228.8 1381.0 1734.8 1525.9 ADAM23 MDC3 ENSG00000114948 "ADAM metallopeptidase domain 23" O75077 2 206443532-206621127 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3;parathyroid gland: 83.6" "Group enriched" "Detected in many" 4 "Excitatory neurons: 410.0;Inhibitory neurons: 236.6;Oligodendrocyte precursor cells: 127.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 16 "memory CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 16 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 54.4;RH-30: 63.8;RPMI-8226: 172.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033276 Approved "Secreted in brain" NA NA 890000 "CAB033276: AB_2305247" "unprognostic (7.33e-2)" "unprognostic (7.80e-2)" "unprognostic (4.60e-1)" "unprognostic (5.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.59e-2)" "unprognostic (4.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (6.84e-2)" "unprognostic (1.09e-2)" "unprognostic (2.64e-2)" "unprognostic (9.75e-6)" "unprognostic (3.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-3)" "unprognostic (1.03e-3)" 1.6 7.6 12.0 2.4 22.3 2.1 1.1 5.0 46.3 3.2 0.1 2.7 1.5 2.3 3.8 4.0 0.8 4.2 24.5 19.8 16.1 0.9 0.3 1.6 2.1 14.4 12.2 23.3 2.0 1.2 83.6 6.5 0.2 17.5 1.7 2.2 17.6 1.5 2.5 11.2 1.1 3.2 4.5 2.6 0.8 1.7 8.1 23.8 5.0 1.0 8.8 2.7 3.1 4.2 27.1 0.1 0.9 22.3 0.0 11.9 17.2 0.9 2.4 2.9 3.2 0.6 26.8 0.5 3.3 0.0 3.8 39.5 33.9 14.5 0.7 0.3 13.2 12.4 0.0 2.1 0.3 11.4 0.3 1.4 6.5 0.1 0.1 0.0 54.4 39.4 1.2 0.0 0.1 8.2 0.4 0.3 0.0 43.9 0.4 4.6 0.1 63.8 172.6 0.0 16.6 17.4 7.0 0.0 0.0 12.9 10.9 0.1 0.0 34.3 11.1 10.2 6.0 5.3 45.2 0.1 0.0 21.1 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.0 22.3 5.0 46.3 19.8 16.1 14.4 12.2 23.3 17.5 2.6 23.8 27.1 1.6 0.0 0.0 41.8 0.4 0.4 0.9 0.1 0.6 39.3 0.0 0.1 62.8 0.0 0.0 1.8 2.1 0.0 0.1 0.0 0.0 0.0 17.6 0.3 7.7 2.7 1.8 0.0 410.0 0.0 0.0 4.3 0.0 0.2 0.0 15.0 0.0 0.1 0.0 3.3 236.6 0.0 0.0 0.0 0.3 57.7 0.6 0.1 3.6 10.3 0.0 4.1 0.0 127.2 22.3 0.1 1.1 3.0 0.0 0.5 0.0 0.0 0.7 6.8 0.0 14.2 2.2 5.1 4.7 1.5 0.4 0.1 2.0 45.2 0.0 0.1 DGUOK dGK ENSG00000114956 "Deoxyguanosine kinase" Q16854 2 73926826-73958961 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034766, HPA057246" Approved NA NA "HPA034766: AB_10669850, HPA057246: AB_2683381" "unprognostic (3.40e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-2)" "unprognostic (2.94e-2)" "unprognostic (1.20e-1)" "unprognostic (4.17e-2)" "unprognostic (2.14e-2)" "unprognostic (1.37e-2)" "unprognostic (4.10e-3)" "unprognostic (5.07e-2)" "unprognostic (1.41e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (8.69e-7)" "unprognostic (3.86e-1)" "unprognostic (2.21e-2)" "unprognostic (5.98e-2)" "prognostic favorable (7.47e-4)" 20.6 30.3 38.8 20.5 41.3 27.3 28.4 38.4 48.7 22.9 38.1 25.2 17.8 23.4 34.7 21.9 31.6 19.5 23.2 40.1 43.2 20.3 30.7 17.9 37.1 39.9 39.5 39.2 30.2 16.4 11.1 41.7 21.7 40.5 24.7 29.4 34.8 20.0 22.7 17.2 26.7 20.4 22.1 39.2 26.1 21.2 33.0 40.9 36.6 22.8 17.8 41.2 22.4 21.0 41.2 45.1 72.5 74.4 67.9 47.8 53.8 37.1 29.3 56.0 66.7 61.1 91.2 51.5 83.0 27.4 42.1 74.1 34.7 85.4 57.1 79.3 47.1 53.6 65.8 25.4 107.5 70.5 62.1 66.0 49.7 51.3 50.4 58.9 48.6 48.3 91.4 67.2 37.0 78.8 54.4 59.6 101.2 76.7 60.5 53.9 73.8 73.1 59.7 55.8 49.6 85.0 82.6 27.9 28.2 77.1 35.5 34.0 34.8 45.3 43.3 68.8 37.8 52.6 32.3 31.4 86.1 62.2 65.9 95.1 129.8 70.9 138.7 62.3 87.3 72.4 108.5 77.0 69.6 81.6 114.5 98.6 79.6 56.4 79.4 84.7 91.3 79.9 91.3 38.8 41.3 38.4 48.7 40.1 43.2 39.9 39.5 39.2 40.5 39.2 40.9 41.2 72.5 32.1 42.8 14.7 103.4 74.2 138.7 249.6 88.2 52.3 85.0 128.1 19.1 78.6 108.6 60.7 6.2 159.4 89.7 58.9 84.1 102.6 12.3 82.3 69.1 74.1 113.1 67.1 17.5 149.1 165.4 88.3 40.2 82.6 57.6 87.4 76.1 69.9 90.9 52.2 21.1 100.1 158.7 88.3 112.3 15.1 93.5 80.2 110.3 15.9 151.9 89.5 118.4 12.5 27.2 173.0 88.1 86.9 70.2 146.2 88.2 119.7 87.2 40.4 92.1 55.3 89.3 105.3 129.4 88.3 83.3 124.5 101.4 124.5 104.9 142.9 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 350.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 36.9 24.9 12.3 64.8 13.0 91.3 31.7 13.6 13.6 36.8 18.8 41.4 42.7 35.3 25.7 40.6 33.5 35.8 25.5 11.4 20.0 48.5 30.9 39.2 92.6 16.0 13.6 9.8 32.1 16.2 28.8 9.2 36.1 16.3 30.6 43.1 10.3 19.6 29.7 13.3 39.2 42.0 40.8 17.4 61.6 34.6 19.9 14.4 56.7 33.9 19.6 93.9 47.0 26.2 16.5 78.2 43.9 53.9 58.5 86.9 94.0 63.5 61.3 82.0 78.1 76.6 60.2 55.4 159.0 51.3 77.4 58.2 63.7 69.6 70.2 117.7 113.0 41.5 143.7 28.0 64.3 69.1 126.1 222.1 80.2 67.1 62.6 52.5 58.6 83.3 60.4 62.5 57.2 76.8 42.1 159.4 106.9 50.3 66.4 35.6 108.2 185.2 85.2 67.3 96.1 27.3 35.6 87.1 63.6 56.4 40.4 51.0 59.1 79.6 100.9 53.0 71.4 98.7 42.2 40.5 119.5 68.0 105.3 55.3 103.7 65.3 91.5 37.3 106.1 40.3 57.8 33.3 40.3 60.5 46.1 30.2 36.4 65.6 56.4 126.0 42.1 37.2 79.7 12.3 13.0 13.6 13.6 11.4 20.0 16.0 13.6 9.8 16.3 17.4 14.4 16.5 82.6 51.3 58.0 3.9 173.0 136.9 96.5 107.4 60.9 13.3 66.8 45.1 40.0 35.8 79.5 82.8 6.2 63.8 170.1 114.1 92.0 60.9 11.1 88.3 91.3 73.1 37.7 48.8 7.4 52.6 101.9 67.2 55.0 102.2 110.4 58.5 61.1 43.0 169.5 26.9 7.9 67.4 65.1 196.6 246.9 11.8 62.4 226.1 67.6 14.0 350.8 25.2 117.4 6.0 10.1 83.4 85.7 68.4 106.4 127.8 80.4 170.2 116.6 14.5 72.3 60.6 75.3 99.5 44.6 86.6 132.0 66.4 124.4 79.3 74.0 155.3 KANSL3 "FLJ10081, KIAA1310, NSL3, Rcd1" ENSG00000114982 "KAT8 regulatory NSL complex subunit 3" Q9P2N6 2 96593170-96642787 "Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035017, HPA035018" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035017: AB_2674414, HPA035018: AB_10601763" "unprognostic (2.19e-1)" "unprognostic (6.94e-2)" "unprognostic (5.62e-2)" "unprognostic (8.72e-3)" "unprognostic (3.28e-1)" "unprognostic (4.35e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (6.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.01e-2)" "unprognostic (2.99e-2)" "unprognostic (2.04e-3)" "unprognostic (3.28e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-3)" "unprognostic (4.99e-3)" 10.5 10.0 1.5 8.6 1.9 15.0 12.4 1.5 3.1 12.3 6.4 11.8 7.3 15.1 7.7 8.9 12.6 7.0 10.8 2.2 5.1 8.9 6.5 10.0 8.3 2.7 2.4 0.9 15.2 9.8 15.2 8.8 9.1 2.3 11.3 6.9 6.3 12.6 14.9 34.2 10.4 12.1 10.7 2.5 10.2 9.9 12.9 2.4 13.2 13.0 21.3 9.0 13.1 10.9 1.9 13.1 7.9 26.0 19.4 10.6 6.4 11.4 9.7 15.2 20.1 21.4 15.1 7.8 18.1 14.6 16.2 14.7 8.2 18.8 9.4 17.5 12.8 14.8 26.0 8.1 16.2 15.0 17.4 9.0 15.0 5.8 12.8 11.4 12.0 11.0 21.0 18.6 12.8 12.8 6.9 32.3 13.5 12.5 6.7 12.8 26.2 16.5 10.6 12.4 12.7 26.8 16.9 12.3 11.8 11.8 14.7 11.4 5.5 15.9 13.5 11.8 9.8 8.9 10.1 6.7 15.7 7.0 19.9 12.2 2.4 1.3 0.5 2.8 1.5 2.1 1.6 1.7 2.9 0.7 1.5 1.2 2.3 0.2 3.1 1.3 0.7 1.1 1.7 1.5 1.9 1.5 3.1 2.2 5.1 2.7 2.4 0.9 2.3 2.5 2.4 1.9 11.6 44.8 30.8 29.0 10.5 4.6 9.9 8.1 9.1 15.0 14.8 12.2 23.8 10.0 18.8 11.0 43.8 8.1 10.0 15.0 3.9 10.5 13.4 13.0 13.7 12.1 13.1 6.7 35.6 9.6 4.3 12.7 17.3 13.5 18.3 33.1 15.7 12.7 8.1 15.2 36.2 18.4 10.2 12.5 5.6 28.6 9.9 11.2 7.2 16.9 13.7 10.2 9.2 29.7 37.3 13.2 7.9 12.8 10.6 10.3 10.7 5.8 13.1 29.5 13.1 16.0 13.6 23.3 9.7 11.3 6.5 11.1 14.2 18.3 15.6 10.1 LMAN2L "DKFZp564L2423, VIPL" ENSG00000114988 "Lectin, mannose binding 2 like" Q9H0V9 2 96705929-96740064 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026600 Approved NA NA "HPA026600: AB_1852939" "unprognostic (3.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-2)" "unprognostic (4.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.80e-1)" "unprognostic (6.91e-3)" "unprognostic (1.16e-1)" "unprognostic (5.30e-2)" "unprognostic (8.14e-2)" "unprognostic (2.17e-1)" "unprognostic (1.52e-1)" "unprognostic (3.29e-1)" 9.8 11.1 16.9 5.0 17.0 1.3 12.4 16.4 20.2 15.8 15.9 13.0 5.7 13.9 17.4 9.6 17.2 6.7 16.9 17.2 20.3 18.0 18.2 9.8 5.9 18.2 16.9 16.2 21.3 12.0 13.9 17.4 11.7 17.7 15.2 10.7 7.8 11.0 13.7 16.8 11.0 8.3 15.8 16.8 8.7 10.9 11.3 20.7 9.2 15.7 19.3 7.2 13.3 12.6 19.7 21.1 33.3 25.6 26.6 31.9 15.1 23.4 19.3 23.9 39.9 43.5 57.4 15.7 10.2 71.4 47.8 99.2 25.1 36.9 30.2 50.2 27.1 20.4 8.9 21.4 49.0 20.1 15.3 14.3 17.4 28.2 30.5 9.6 34.7 23.7 17.2 20.3 20.5 25.5 14.5 11.0 14.5 13.9 14.9 36.0 23.1 21.1 11.6 32.9 10.9 16.2 8.5 21.8 16.6 20.1 46.8 19.8 26.4 17.3 31.8 22.7 25.1 25.9 13.3 46.1 8.6 18.8 18.1 26.3 37.8 17.5 22.4 14.0 10.6 32.0 20.0 16.2 18.9 14.5 16.9 19.6 16.6 9.5 15.9 16.0 20.8 14.8 18.5 16.9 17.0 16.4 20.2 17.2 20.3 18.2 16.9 16.2 17.7 16.8 20.7 19.7 4.7 12.8 6.8 12.4 3.2 3.4 5.4 11.1 2.2 3.1 10.5 7.6 12.2 5.7 6.3 12.9 6.2 17.9 5.2 5.4 9.8 13.7 20.6 4.6 6.9 6.1 9.5 6.5 13.4 7.8 10.4 11.8 2.0 5.6 5.1 16.8 9.3 10.7 9.9 1.7 13.4 5.0 0.0 5.6 1.4 18.0 6.8 2.7 3.6 7.5 12.3 12.2 6.2 11.1 11.0 7.5 3.8 8.6 3.1 4.5 4.6 10.1 6.3 5.1 13.1 4.4 8.1 13.3 14.0 2.5 2.7 13.4 4.0 8.6 6.5 2.1 RTKN B5 ENSG00000114993 Rhotekin Q9BST9 2 74425835-74442422 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 150.8;liver: 125.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "NK-cell: 2.3;plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 4 "dendritic cells: 6.6;NK-cells: 2.3" "Cell line enhanced" "Detected in many" "Hep G2: 96.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030259 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA030259: AB_10601484" "unprognostic (4.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.20e-2)" "unprognostic (2.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-3)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (2.57e-2)" "unprognostic (9.43e-3)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (2.96e-2)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.23e-3)" 7.9 8.3 70.4 5.1 98.4 0.6 11.4 83.5 87.2 12.9 51.4 17.6 32.1 8.8 3.5 21.0 12.8 14.4 16.7 69.7 80.3 54.4 125.7 10.4 3.2 102.8 96.1 56.5 7.7 31.1 20.9 14.8 11.9 108.7 19.2 12.7 1.9 26.2 9.6 13.0 32.3 25.5 6.4 79.5 5.2 15.5 3.3 90.2 6.3 19.7 7.6 5.3 8.4 16.7 150.8 50.4 15.5 19.5 56.3 11.8 13.7 82.1 7.6 9.9 11.0 8.0 76.3 26.8 0.3 21.2 7.4 13.6 67.2 7.3 48.6 5.3 9.9 31.3 12.0 2.8 96.7 7.2 0.0 0.1 8.4 37.7 9.5 30.0 20.2 5.5 0.7 6.2 0.3 16.5 35.8 1.9 10.1 20.9 70.9 30.3 11.1 60.6 7.6 52.4 0.3 19.0 18.8 20.7 79.3 45.2 17.5 44.6 4.4 0.6 20.5 14.0 9.3 10.6 4.8 3.7 1.8 19.6 0.1 19.5 0.0 0.0 0.0 0.2 0.0 0.2 0.7 0.1 0.2 0.6 1.0 0.0 0.1 0.0 2.3 0.0 6.6 0.0 0.4 70.4 98.4 83.5 87.2 69.7 80.3 102.8 96.1 56.5 108.7 79.5 90.2 150.8 4.3 9.6 11.8 4.9 2.0 20.0 22.1 37.2 19.4 0.1 14.4 12.2 3.1 28.6 18.3 11.0 2.1 46.7 4.5 21.7 21.5 43.0 0.7 12.6 6.1 8.8 30.7 1.3 0.5 20.1 8.3 8.9 15.8 26.0 1.3 4.9 5.3 40.1 10.1 0.0 0.9 20.1 18.3 2.2 3.8 1.5 12.8 1.1 28.4 3.7 0.7 6.9 5.2 34.7 48.2 30.5 31.0 8.6 1.4 35.4 44.7 54.7 5.8 0.4 6.6 36.9 3.9 1.1 5.6 12.9 21.6 33.4 2.5 3.1 30.5 15.6 TTL MGC46235 ENSG00000114999 "Tubulin tyrosine ligase" Q8NG68 2 112482156-112541739 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066819 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA066819: AB_2685728" "unprognostic (1.05e-2)" "unprognostic (3.90e-3)" "unprognostic (2.25e-1)" "unprognostic (3.95e-3)" "unprognostic (9.75e-2)" "unprognostic (1.81e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.95e-1)" "unprognostic (3.65e-1)" "unprognostic (2.10e-1)" "unprognostic (5.48e-2)" "unprognostic (7.19e-2)" "unprognostic (6.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.45e-1)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" 1.0 0.8 2.4 0.9 2.9 1.8 0.6 1.7 3.1 0.6 0.2 0.7 0.6 1.0 0.8 1.1 0.5 1.1 1.6 2.5 1.7 0.8 0.6 1.4 1.0 2.2 2.1 2.5 0.6 0.8 0.8 0.3 1.2 2.9 0.6 0.8 1.4 0.4 0.7 3.8 1.4 0.6 1.3 0.9 0.9 0.6 0.6 2.0 1.0 0.9 3.8 0.8 1.0 0.4 3.9 2.9 2.2 2.7 6.2 3.2 4.6 1.1 4.9 4.0 5.1 4.4 2.7 1.0 2.7 2.7 4.2 3.3 2.0 4.8 2.5 6.2 1.9 2.7 2.3 3.1 3.4 1.4 3.2 1.1 2.1 1.7 7.5 4.0 2.3 4.4 1.8 3.8 2.1 4.1 1.5 2.8 1.8 2.4 0.8 4.4 3.0 3.1 1.5 1.6 2.2 5.8 4.0 3.8 1.2 6.7 1.8 1.3 1.8 4.4 6.0 4.4 4.8 3.7 1.1 2.5 2.2 6.7 2.4 2.6 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.0 2.4 2.9 1.7 3.1 2.5 1.7 2.2 2.1 2.5 2.9 0.9 2.0 3.9 14.0 12.8 6.4 19.2 7.0 20.3 4.9 8.3 4.6 15.6 6.4 6.0 39.1 2.8 6.7 12.9 12.5 3.2 10.6 8.0 0.0 7.2 12.2 8.3 28.3 18.5 11.3 16.2 34.1 9.6 2.4 12.6 2.6 10.8 0.0 11.7 15.7 10.4 11.4 8.4 24.0 5.8 16.2 24.2 19.2 5.1 3.1 17.0 7.2 20.6 17.2 9.8 8.2 24.6 72.8 9.4 5.2 5.7 9.1 6.6 2.4 6.0 4.2 20.2 6.6 15.4 12.2 4.5 5.0 6.5 18.0 1.2 7.6 7.7 6.1 4.1 IL1A "IL-1A, IL1, IL1-ALPHA, IL1F1" ENSG00000115008 "Interleukin 1 alpha" P01583 2 112773925-112784493 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cytokine, Mitogen, Pyrogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.4;testis: 10.5;urinary bladder: 26.2" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 22.6;Club cells: 9.8;Endometrial ciliated cells: 11.5;Glandular and luminal cells: 29.4;Macrophages: 30.6;Squamous epithelial cells: 9.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 22.3;urothelial cancer: 17.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 447.6;hTCEpi: 216.2;hTERT-HME1: 283.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 10800 "unprognostic (3.41e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.99e-2)" "unprognostic (4.28e-2)" "unprognostic (2.08e-1)" "unprognostic (8.03e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-3)" "unprognostic (1.22e-1)" "unprognostic (4.30e-3)" "prognostic unfavorable (4.03e-4)" "unprognostic (1.66e-1)" "unprognostic (2.44e-1)" "unprognostic (8.62e-2)" 0.2 0.0 0.5 1.3 0.4 1.0 0.4 0.5 0.4 4.9 0.2 0.3 0.1 2.5 0.8 13.4 0.1 2.3 0.0 0.4 0.6 0.0 0.0 2.4 0.3 0.9 0.4 0.2 0.0 0.0 0.4 0.2 1.5 0.9 0.1 0.2 0.1 1.2 0.4 0.0 0.8 0.1 0.0 1.0 0.3 0.1 10.5 0.5 0.3 0.2 0.0 8.7 26.2 1.3 0.9 12.5 0.0 0.5 0.0 0.1 0.0 0.2 0.4 13.5 0.0 0.2 0.5 0.8 0.0 52.5 0.0 65.9 3.6 0.0 447.6 1.7 0.1 0.1 0.1 0.7 0.2 1.0 0.2 0.1 0.0 216.2 3.8 283.4 3.4 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 4.2 0.2 0.5 0.0 0.0 0.0 0.1 55.0 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.1 1.7 1.3 0.6 0.3 0.3 0.0 0.1 0.2 5.2 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.4 0.4 0.6 0.9 0.4 0.2 0.9 1.0 0.5 0.9 0.9 6.4 1.1 0.0 2.2 1.5 0.7 22.6 1.2 0.0 0.5 0.3 0.2 0.0 9.8 0.0 0.0 0.3 0.3 0.6 0.0 4.6 8.3 11.5 2.8 0.2 0.0 0.0 0.0 0.9 0.1 0.1 0.0 29.4 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.0 0.0 4.8 3.8 0.0 30.6 0.0 5.6 0.0 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.4 0.3 0.0 0.0 1.9 0.0 0.0 0.0 1.1 0.1 0.1 9.4 1.0 0.0 0.4 0.1 0.2 2.4 CCL20 "CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38" ENSG00000115009 "C-C motif chemokine ligand 20" P78556 2 227805739-227817564 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Antibiotic, Antimicrobial, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 164.1;lymphoid tissue: 166.9;urinary bladder: 194.6" "Group enriched" "Detected in many" 7 "Basal respiratory cells: 25281.7;Club cells: 7424.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 9 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "GAMG: 63.1;Hep G2: 35.7;NB-4: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 28000 "unprognostic (2.40e-1)" "unprognostic (1.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (7.06e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.53e-3)" "unprognostic (1.37e-1)" "unprognostic (5.21e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.19e-8)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (1.63e-1)" "unprognostic (1.82e-1)" 5.4 0.3 2.4 32.1 3.0 7.3 0.7 3.9 2.9 24.1 0.5 19.9 16.6 13.8 0.8 12.3 2.8 164.1 1.2 2.9 1.8 8.8 20.3 35.7 6.3 2.7 2.0 2.1 0.9 1.8 0.2 0.3 1.3 2.9 2.9 27.3 1.8 5.0 0.5 0.6 6.5 26.8 4.8 2.4 0.4 11.3 2.1 2.5 2.6 0.6 0.2 166.9 194.6 4.6 4.1 0.5 1.4 0.7 0.9 3.2 6.0 0.9 0.4 2.1 0.2 0.8 3.9 0.6 1.3 4.4 0.0 63.1 0.7 0.2 8.7 1.4 0.9 1.5 0.2 3.3 35.7 2.4 4.7 0.4 10.1 1.8 2.0 2.4 1.0 0.0 1.2 0.3 5.1 0.5 0.4 0.3 25.7 1.8 5.3 0.8 0.7 8.6 1.0 0.3 15.4 0.6 0.5 0.3 1.5 0.9 0.8 1.4 5.7 2.3 3.3 4.1 7.2 0.7 1.0 3.2 2.1 5.0 3.5 6.6 0.0 0.1 0.0 0.0 0.0 2.7 0.1 1.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.4 0.1 2.4 3.0 3.9 2.9 2.9 1.8 2.7 2.0 2.1 2.9 2.4 2.5 4.1 2.8 48.1 108.5 0.0 5.6 118.8 554.4 25281.7 21.6 0.6 1.9 1.9 0.9 65.8 7424.9 18.4 0.0 0.5 2.4 135.0 0.0 310.9 16.0 51.9 44.4 5.1 57.9 0.0 0.0 2.9 0.5 9.2 50.4 517.8 5.7 0.0 0.0 1.7 29.1 1.7 0.0 161.0 2203.3 4.0 149.2 1.2 0.0 333.0 1.8 0.0 9.4 0.0 0.0 0.0 0.0 24.1 459.7 0.0 4.5 259.5 331.0 9.3 1477.8 0.2 0.0 0.7 115.1 1.2 1.2 224.9 64.8 0.8 68.2 0.0 121.9 1062.1 PIKFYVE "FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29" ENSG00000115020 "Phosphoinositide kinase, FYVE-type zinc finger containing" Q9Y2I7 2 208266255-208358746 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 82.0;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042604 Uncertain NA NA "HPA042604: AB_10796580" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.88e-1)" "unprognostic (3.03e-1)" "unprognostic (2.04e-2)" "prognostic favorable (6.81e-4)" "unprognostic (6.82e-3)" "unprognostic (6.45e-2)" "unprognostic (1.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-2)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" 10.5 7.9 7.2 12.1 8.4 29.1 8.1 14.6 10.0 9.2 10.5 6.2 6.1 9.3 12.0 6.4 6.4 7.3 7.4 7.8 8.1 10.7 10.6 7.9 17.5 7.7 9.0 8.0 10.0 22.4 11.2 6.0 9.8 8.3 11.6 7.5 17.5 6.5 8.1 6.6 8.2 7.4 9.0 6.6 15.2 8.1 14.1 9.3 19.5 12.4 9.0 16.2 8.3 5.9 11.7 8.0 7.9 18.3 14.3 18.1 21.4 8.5 9.6 19.5 11.1 15.0 11.3 6.6 9.2 9.8 16.6 21.7 8.0 16.1 10.8 18.8 7.9 10.1 33.0 15.6 10.2 13.7 29.5 28.5 16.0 11.5 13.0 24.1 18.5 18.3 24.1 22.7 16.1 14.0 3.4 26.9 22.1 15.2 6.1 5.9 9.9 14.2 12.7 14.2 11.5 5.8 13.8 10.6 6.8 19.2 21.4 4.3 31.3 21.2 13.8 9.2 9.4 9.0 11.2 14.2 19.2 11.1 25.2 13.9 0.9 0.5 0.4 0.9 0.4 0.5 4.4 1.2 1.4 0.5 3.2 0.9 1.1 0.7 3.2 0.7 1.2 0.9 0.3 7.2 8.4 14.6 10.0 7.8 8.1 7.7 9.0 8.0 8.3 6.6 9.3 11.7 18.8 25.6 16.2 58.8 82.0 15.3 6.7 7.8 25.6 21.9 10.5 6.6 17.5 11.5 10.6 11.0 16.7 8.1 14.4 8.1 5.9 5.4 10.4 11.3 19.4 18.8 18.6 25.5 72.6 4.3 5.7 15.7 16.3 21.7 36.1 18.0 18.2 19.4 14.4 10.1 67.9 9.6 4.1 29.9 32.5 8.3 18.6 28.5 10.6 48.7 19.1 13.5 16.5 80.9 81.7 8.5 5.9 13.5 10.3 18.1 14.3 9.9 9.2 19.7 13.1 15.4 18.9 30.5 23.0 14.8 15.3 7.3 21.5 13.3 8.8 11.4 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297327-95386077 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 39.0;Leydig cells: 25.4;Oligodendrocyte precursor cells: 54.8;Peritubular cells: 42.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.8;BJ hTERT+: 18.0;hTERT-RPE1: 23.2;RPTEC TERT1: 35.2;U-138 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA066717: , HPA069797: AB_2686199" "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavorable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 6.3 1.5 19.6 0.8 19.2 0.0 5.5 14.8 31.5 10.5 11.0 7.4 1.2 10.7 3.6 2.5 10.2 1.5 6.0 21.2 15.6 8.4 2.0 2.4 0.4 16.2 16.7 19.1 10.2 2.5 27.2 6.4 5.3 17.9 9.4 0.9 0.5 5.6 14.8 1.6 5.6 3.7 5.1 14.0 2.6 5.6 12.3 16.6 24.6 19.9 1.8 0.5 9.1 10.7 19.2 13.8 0.0 0.8 6.1 5.3 4.2 0.0 6.3 18.0 10.1 9.3 0.0 0.0 0.0 0.6 8.3 5.5 0.2 4.0 1.1 4.3 0.0 1.4 0.0 1.8 0.0 2.2 0.0 0.0 2.9 3.6 2.2 10.0 23.2 0.0 1.0 0.0 0.0 0.8 8.0 0.1 0.0 0.1 0.0 3.7 0.0 0.0 0.0 35.2 0.0 0.7 0.2 0.3 0.3 6.8 0.0 0.3 0.1 0.3 16.3 3.8 0.0 4.9 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 19.2 14.8 31.5 21.2 15.6 16.2 16.7 19.1 17.9 14.0 16.6 19.2 0.4 0.0 1.1 13.4 0.5 0.4 0.8 0.0 1.2 8.1 1.0 1.0 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.2 7.9 0.2 0.6 0.3 3.7 1.0 4.2 0.0 39.0 0.0 0.1 3.5 0.0 0.3 0.0 7.5 0.0 0.5 0.1 0.0 5.1 0.1 0.0 0.0 0.4 1.3 25.4 0.1 7.2 1.9 0.6 0.5 0.0 54.8 3.0 0.2 0.0 42.9 0.0 0.5 1.0 1.5 0.0 0.0 0.0 8.3 3.7 0.1 0.9 0.2 0.9 0.0 0.0 1.5 0.3 0.1 FAHD2A CGI-105 ENSG00000115042 "Fumarylacetoacetate hydrolase domain containing 2A" Q96GK7 2 95402708-95416616 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.7" "Cell type enhanced" "Detected in all" "Early spermatids: 101.7;Hepatocytes: 99.3;Proximal enterocytes: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042145, HPA044987, CAB045971, CAB045972" Enhanced NA NA "CAB045971: AB_11126570, CAB045972: AB_11140511, HPA042145: AB_2677873, HPA044987: AB_2679170" "unprognostic (6.52e-2)" "unprognostic (1.25e-3)" "unprognostic (9.36e-2)" "unprognostic (1.27e-2)" "unprognostic (7.77e-3)" "unprognostic (6.82e-2)" "unprognostic (2.80e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (4.58e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-2)" "unprognostic (1.17e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-2)" "unprognostic (1.55e-2)" 21.1 22.2 22.0 8.7 24.5 14.8 22.0 25.5 29.9 18.5 18.7 16.9 32.7 19.2 5.4 13.5 17.9 11.0 34.7 23.6 22.4 28.8 115.7 14.0 11.0 22.5 22.8 22.9 22.8 30.3 18.2 12.4 10.9 23.6 15.6 14.1 5.9 87.0 12.3 38.1 18.5 25.6 15.4 20.8 14.8 26.4 30.2 22.6 18.8 38.1 58.4 12.3 14.5 15.8 27.6 30.2 27.9 31.7 20.4 34.4 31.1 22.4 28.2 47.5 32.5 51.6 17.6 12.9 18.5 12.1 29.1 41.0 16.2 22.8 25.7 32.3 16.0 27.9 14.9 13.2 29.1 44.3 22.8 8.2 29.9 28.6 30.0 37.9 51.6 43.2 35.6 21.6 41.1 41.6 36.6 40.6 31.1 10.2 17.6 27.2 29.9 20.0 52.0 36.3 12.1 18.9 9.3 16.8 27.0 33.2 39.3 16.9 9.0 20.4 41.2 28.3 17.6 19.6 44.0 20.3 18.8 28.0 20.5 20.9 3.3 15.7 8.1 18.2 17.8 20.7 15.5 16.7 17.6 23.3 10.4 16.8 14.2 1.0 12.3 9.0 27.3 19.6 14.4 22.0 24.5 25.5 29.9 23.6 22.4 22.5 22.8 22.9 23.6 20.8 22.6 27.6 14.6 9.6 12.5 10.7 13.8 9.8 13.8 14.6 21.1 17.6 26.6 26.4 36.8 28.6 16.8 29.5 10.4 30.3 16.6 14.4 70.5 29.5 101.7 11.2 10.5 13.9 4.9 14.5 15.2 23.1 14.7 21.4 21.9 7.7 4.5 32.7 16.4 99.3 26.0 16.8 13.2 17.3 10.2 12.0 8.3 87.1 37.0 11.0 17.8 2.8 19.8 22.2 13.4 3.5 10.8 18.7 17.3 52.3 23.9 15.4 104.6 52.7 15.0 18.8 13.1 15.3 21.3 49.1 19.1 19.0 7.7 17.1 12.4 36.5 23.9 12.1 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 1400000 "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 213.9 194.7 144.5 228.1 153.3 303.9 231.0 140.3 150.0 181.6 125.7 185.3 162.2 207.1 151.5 230.6 174.7 133.3 165.8 128.2 138.3 167.7 220.4 148.6 292.0 161.8 151.9 115.1 260.5 210.8 260.9 116.8 205.1 170.4 156.8 221.3 148.4 158.4 162.4 353.8 198.2 158.7 202.7 152.0 177.8 166.0 127.3 160.5 350.2 200.2 230.2 331.7 273.7 170.5 155.5 718.3 691.8 715.7 640.1 485.7 592.0 823.0 790.4 497.2 690.8 628.2 1227.4 521.4 1083.7 608.6 651.0 892.6 719.5 1614.4 1059.9 1284.7 554.6 644.0 1587.3 605.9 1749.5 544.0 1930.4 632.7 513.5 613.2 872.3 1019.6 394.9 834.2 770.5 1745.4 378.6 760.5 1176.4 1443.2 1086.7 1202.0 728.7 435.9 1290.8 1452.0 918.4 583.8 959.9 749.0 502.0 555.8 704.5 706.9 625.7 476.8 985.3 686.3 611.4 626.7 714.5 1063.7 624.3 554.5 1885.9 467.2 1173.1 685.2 27.3 95.6 62.5 136.5 100.3 152.8 113.5 118.4 121.9 130.6 111.9 130.3 114.2 16.8 177.8 121.7 102.0 102.3 151.0 144.5 153.3 140.3 150.0 128.2 138.3 161.8 151.9 115.1 170.4 152.0 160.5 155.5 286.2 291.7 411.7 8.1 468.9 459.9 633.8 241.0 644.9 145.0 315.2 303.8 320.9 147.3 401.6 195.0 47.9 386.9 596.2 215.0 230.9 294.4 20.6 348.7 669.8 291.1 200.0 419.2 9.3 254.4 444.6 370.9 292.0 421.8 451.7 262.7 130.6 242.0 239.5 80.8 10.4 319.6 156.6 133.7 231.1 32.2 217.2 281.8 165.4 10.3 268.9 199.6 346.1 14.1 14.9 268.0 153.9 159.9 543.5 651.1 120.1 277.6 250.3 141.0 151.2 548.9 442.0 433.3 532.4 707.9 441.4 379.0 454.0 442.6 380.6 449.1 ACTR1B "Arp1B, CTRN2" ENSG00000115073 "Actin related protein 1B" P42025 2 97655939-97664044 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047443 Approved Microtubules NA NA 49000 Microtubules "HPA047443: AB_2680049" "unprognostic (5.26e-2)" "unprognostic (8.91e-3)" "unprognostic (2.83e-3)" "unprognostic (2.67e-1)" "unprognostic (2.96e-1)" "unprognostic (2.82e-1)" "unprognostic (3.68e-3)" "unprognostic (1.37e-2)" "unprognostic (1.60e-2)" "unprognostic (7.84e-2)" "unprognostic (8.21e-2)" "unprognostic (6.29e-2)" "unprognostic (3.42e-2)" "unprognostic (2.78e-1)" "unprognostic (2.89e-2)" "unprognostic (4.58e-2)" "prognostic favorable (4.69e-4)" 37.7 68.9 57.4 25.1 58.8 39.2 42.3 52.8 66.9 40.1 56.3 49.0 36.5 48.5 21.7 37.8 43.8 26.2 59.3 58.6 56.2 47.2 54.8 37.0 31.1 57.7 55.0 59.4 47.5 73.5 51.5 41.8 20.7 58.3 44.0 22.3 22.2 45.8 37.7 87.8 39.3 43.6 26.7 54.4 58.3 52.5 20.9 57.0 33.5 46.1 69.4 25.0 44.4 36.7 58.5 52.8 28.5 27.1 35.8 49.1 39.8 78.1 49.2 74.2 34.6 28.9 22.5 28.1 38.0 45.3 50.5 37.1 28.4 21.9 56.5 14.6 76.6 36.8 28.2 28.3 62.1 38.3 22.8 43.1 39.7 41.5 22.0 67.7 51.8 39.0 46.8 20.1 44.8 52.1 58.5 44.2 28.6 27.5 40.1 38.1 24.7 39.6 63.2 55.0 41.1 31.7 23.8 23.7 48.1 36.2 34.8 38.1 35.9 41.1 23.0 35.6 24.7 20.8 57.7 27.0 13.7 68.8 32.5 21.1 11.7 15.0 19.2 19.1 13.5 14.6 14.6 20.9 19.2 21.1 14.7 17.2 18.8 5.7 14.9 20.5 8.5 29.7 16.4 57.4 58.8 52.8 66.9 58.6 56.2 57.7 55.0 59.4 58.3 54.4 57.0 58.5 43.8 19.2 18.2 15.0 30.4 13.6 30.9 28.4 16.5 38.5 24.9 20.8 32.8 22.8 22.2 22.0 12.5 29.0 26.1 26.5 35.2 69.2 13.2 16.2 16.4 30.9 25.8 24.6 33.4 58.0 57.7 24.3 23.4 13.1 29.9 20.4 28.2 18.7 29.1 55.5 26.4 31.7 36.7 18.5 20.0 10.0 24.2 17.4 23.2 12.2 57.3 29.5 43.3 17.1 26.1 42.8 32.8 26.7 21.9 55.5 59.9 40.5 22.2 30.0 39.5 25.3 28.5 13.1 31.7 29.9 16.3 16.3 31.4 47.7 36.4 39.8 SLC35F5 FLJ22004 ENSG00000115084 "Solute carrier family 35 member F5" Q8WV83 2 113705011-113756693 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034828, HPA049229" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA034828: AB_2674350, HPA049229: AB_2680682" "unprognostic (1.59e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (8.37e-2)" "unprognostic (3.87e-3)" "unprognostic (5.62e-2)" "unprognostic (4.73e-3)" "unprognostic (3.94e-2)" "unprognostic (5.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.71e-5)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (4.83e-2)" 9.9 23.0 4.7 6.0 6.5 8.1 14.5 12.5 6.7 9.4 26.4 14.8 13.9 10.4 11.6 11.2 8.1 11.2 9.8 6.5 10.2 18.2 14.7 10.0 9.1 7.1 5.9 5.1 12.5 15.2 17.5 5.2 11.2 6.9 11.3 13.8 14.2 9.9 6.9 12.4 20.4 13.1 9.0 5.5 10.2 13.1 7.2 5.6 5.7 23.9 11.3 10.1 8.1 6.3 12.1 9.7 9.6 7.7 4.9 48.6 36.8 14.0 15.9 13.2 7.7 12.9 24.3 18.9 18.5 22.1 21.9 21.3 8.7 12.2 12.5 17.9 5.7 4.9 9.7 9.6 19.7 20.8 12.8 24.0 46.8 17.4 17.9 25.9 22.1 15.2 4.6 7.7 11.2 19.1 8.5 5.6 14.0 3.6 15.0 5.2 6.5 13.1 9.7 52.5 15.8 2.1 6.0 12.9 14.5 11.5 12.8 9.4 12.6 12.7 14.3 6.3 9.2 6.7 9.7 8.7 8.2 16.8 8.9 13.6 2.9 0.7 0.6 0.5 0.8 0.6 0.9 0.5 0.4 0.6 1.2 0.6 0.6 2.1 1.0 1.2 0.9 0.9 0.6 4.7 6.5 12.5 6.7 6.5 10.2 7.1 5.9 5.1 6.9 5.5 5.6 12.1 18.9 22.4 19.8 39.5 18.0 25.4 31.1 20.0 31.9 10.3 20.4 9.8 25.4 21.5 30.4 73.5 22.9 46.3 11.6 44.1 11.7 28.7 28.3 32.4 21.9 15.4 14.5 9.9 43.4 28.5 72.0 24.8 28.5 38.6 24.1 14.4 12.5 20.8 28.3 5.0 47.0 25.6 12.2 13.4 17.2 15.6 12.5 14.6 8.8 39.4 15.5 21.0 7.2 65.4 83.2 23.1 29.7 13.9 37.5 35.3 47.9 45.1 26.3 19.6 0.0 14.2 22.7 60.0 20.5 32.7 34.0 66.4 10.8 41.0 24.8 35.1 ZAP70 "SRK, STD, ZAP-70" ENSG00000115085 "Zeta chain of T cell receptor associated protein kinase 70" P43403 2 97713576-97739862 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.0;lymphoid tissue: 80.6" "Group enriched" "Detected in many" 4 "dendritic cells: 101.0;NK-cells: 155.5;T-cells: 105.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 41 "gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1" "Group enriched" "Detected in many" 56 "NK-cells: 112.2;T-cells: 137.4" "Group enriched" "Detected in some" 11 "JURKAT: 121.0;MOLT-4: 183.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002625, HPA003134" Enhanced NA NA 14000 "CAB002625: , HPA003134: AB_1080629" "unprognostic (4.11e-3)" "prognostic favorable (6.89e-5)" "unprognostic (3.82e-3)" "prognostic favorable (9.66e-8)" "unprognostic (5.78e-2)" "prognostic favorable (3.93e-6)" "unprognostic (2.30e-3)" "unprognostic (1.09e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-2)" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.02e-8)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (6.40e-2)" "unprognostic (5.83e-3)" 2.6 1.3 0.5 28.3 0.5 25.0 1.9 0.5 0.9 1.7 1.1 2.7 5.8 1.4 0.5 2.4 2.2 5.5 1.2 0.4 0.8 2.7 3.9 8.8 57.5 0.7 1.3 0.4 0.8 1.0 0.4 1.1 0.9 0.6 2.5 1.5 0.0 2.3 0.8 2.0 2.5 18.6 0.5 0.6 35.8 6.8 2.7 1.1 80.6 3.6 2.8 17.8 5.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 121.0 0.0 0.7 0.0 0.0 183.4 0.5 0.1 0.0 0.0 7.2 0.1 9.1 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 14.1 0.1 0.0 0.0 0.3 0.3 0.5 137.4 0.4 93.2 0.2 71.7 108.3 0.3 1.6 50.8 79.8 2.2 112.2 1.0 0.9 80.1 64.2 0.5 0.5 0.5 0.9 0.4 0.8 0.7 1.3 0.4 0.6 0.6 1.1 0.6 0.8 9.6 13.6 0.3 3.9 1.5 0.0 0.0 0.0 0.0 0.8 0.5 3.0 0.0 0.0 0.0 0.0 0.1 101.0 0.2 1.9 0.2 1.0 1.6 0.5 0.8 0.0 8.8 0.2 0.0 0.0 1.8 4.6 0.4 2.5 0.1 2.5 0.7 2.2 0.0 0.2 0.0 0.0 2.8 2.2 0.7 0.0 3.4 1.8 2.8 5.0 0.0 155.5 0.0 0.1 0.0 0.0 0.0 28.0 0.1 0.0 0.5 0.0 0.0 0.0 14.3 0.6 1.3 2.1 0.2 1.4 0.0 105.6 0.1 0.1 0.2 ACTR3 ARP3 ENSG00000115091 "Actin related protein 3" P61158 2 113890063-113962596 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005085, HPA047016, HPA051683" Approved NA NA 25000000 "CAB005085: AB_2289106, HPA047016: AB_2679903, HPA051683: AB_2681573" "unprognostic (7.28e-2)" "prognostic unfavorable (6.52e-5)" "unprognostic (2.03e-2)" "unprognostic (1.01e-3)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (9.27e-3)" "unprognostic (1.63e-1)" "unprognostic (2.50e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.57e-1)" "unprognostic (2.54e-2)" "unprognostic (3.44e-2)" "unprognostic (4.44e-1)" 98.4 126.5 31.1 231.8 37.3 218.5 65.2 37.8 41.3 63.2 52.9 130.5 108.4 78.8 47.6 168.6 58.6 85.1 72.4 47.9 48.8 80.1 90.7 98.8 293.5 47.6 35.8 27.3 46.8 64.9 55.2 23.3 102.3 43.4 72.0 126.3 31.9 64.9 84.4 48.2 78.3 120.0 138.2 42.0 157.2 114.1 85.6 38.6 187.5 67.9 50.2 333.9 155.0 67.7 43.9 377.8 179.1 249.4 170.6 178.0 251.7 259.9 518.7 395.0 369.7 349.1 379.9 233.6 538.7 590.6 487.9 497.1 200.0 262.3 286.5 486.7 806.2 135.6 502.7 210.2 296.2 314.8 474.0 879.1 227.1 220.8 484.9 316.5 216.1 348.6 207.1 273.9 393.8 493.1 153.2 429.7 204.5 187.2 254.8 297.5 328.8 246.8 273.4 381.0 348.9 124.0 124.1 263.0 269.7 330.6 188.7 112.7 387.7 514.6 440.9 288.3 205.6 451.5 208.5 446.5 635.4 385.5 304.2 417.7 753.0 478.9 1048.4 464.4 728.1 381.6 455.9 424.6 460.6 634.4 385.0 371.4 437.9 777.1 479.9 887.7 191.4 587.0 1265.4 31.1 37.3 37.8 41.3 47.9 48.8 47.6 35.8 27.3 43.4 42.0 38.6 43.9 113.7 89.8 64.1 26.4 254.0 331.9 369.7 139.1 93.9 32.0 57.5 48.9 68.5 57.2 125.4 68.0 8.4 144.6 196.5 164.4 129.1 220.8 113.6 109.2 100.8 138.9 85.3 154.8 40.1 154.8 316.6 101.4 122.9 171.0 267.5 88.4 81.0 72.9 339.2 38.7 40.4 120.2 105.8 201.4 413.7 108.3 45.4 288.1 112.1 69.3 316.5 46.7 286.3 58.3 67.6 177.0 168.1 73.0 158.7 181.7 103.3 132.4 117.7 19.5 65.7 58.5 194.1 207.1 74.7 173.4 353.8 205.6 264.4 242.2 120.3 314.1 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 191.0;parathyroid gland: 79.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3" "Group enriched" "Detected in many" 6 "dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3" "Cell line enhanced" "Detected in many" "U-87 MG: 149.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA050510: AB_2681151" "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.7 6.4 3.9 3.9 5.1 17.1 14.7 7.4 4.3 16.9 10.2 9.6 22.3 3.7 5.3 16.0 7.8 2.3 8.4 6.8 9.7 6.9 191.0 9.2 0.9 14.2 8.6 2.4 4.4 27.4 79.5 13.9 11.4 12.8 11.9 7.0 0.7 34.5 7.5 30.2 8.4 11.0 3.1 8.8 1.8 22.7 1.9 9.1 2.2 5.4 12.6 3.1 7.1 7.3 13.7 21.8 25.6 0.0 8.7 12.1 112.9 22.1 6.8 7.4 13.1 11.8 19.5 29.0 0.1 49.9 38.5 94.1 35.9 11.1 22.4 14.9 0.1 35.9 42.1 22.2 38.8 30.0 10.5 7.7 67.3 38.7 78.0 27.7 89.8 11.4 0.0 20.9 4.2 37.6 20.6 0.1 6.2 34.2 33.3 52.7 0.2 14.7 18.5 16.2 54.1 41.9 7.7 18.8 64.1 4.9 4.9 12.7 13.7 49.6 81.2 46.8 17.4 37.4 0.1 0.1 0.2 149.1 26.2 17.2 0.0 2.4 0.4 0.1 2.7 0.0 0.4 0.0 0.0 4.1 0.1 0.0 0.0 0.0 1.3 0.4 0.2 0.0 1.0 3.9 5.1 7.4 4.3 6.8 9.7 14.2 8.6 2.4 12.8 8.8 9.1 13.7 9.1 0.0 7.9 2.3 1.0 2.0 7.4 11.9 8.0 0.6 15.5 10.7 6.2 2.8 16.2 0.0 0.0 33.3 0.2 12.2 0.0 8.1 0.2 8.1 1.9 6.2 1.8 29.5 1.3 36.2 4.1 3.6 23.4 5.7 3.8 3.5 1.4 91.6 10.9 0.0 1.0 6.0 8.2 5.9 3.8 0.7 1.8 6.1 0.0 1.9 1.4 0.1 0.0 0.5 0.0 20.8 7.7 7.5 0.1 8.3 11.8 1.5 36.1 0.1 6.6 4.1 3.3 0.6 0.2 19.5 1.4 23.7 0.4 13.1 11.6 8.9 EPB41L5 "BE37, FLJ12957, KIAA1548, LULU, LULU1, YMO1, YRT" ENSG00000115109 "Erythrocyte membrane protein band 4.1 like 5" Q9HCM4 2 120013077-120179119 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 55.5;MCF7: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037563, HPA037564" Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA037563: AB_2675546, HPA037564: AB_2675547" "unprognostic (1.27e-2)" "unprognostic (2.15e-1)" "unprognostic (2.56e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (5.93e-2)" "unprognostic (8.76e-2)" "unprognostic (2.20e-2)" "unprognostic (9.51e-2)" "prognostic favorable (2.28e-6)" "unprognostic (1.99e-1)" "unprognostic (3.88e-1)" "unprognostic (9.59e-2)" "unprognostic (2.61e-1)" 5.5 6.1 9.2 3.1 7.7 1.0 15.8 44.1 10.8 7.1 4.6 10.0 14.1 7.6 5.8 8.8 12.9 7.4 6.3 7.7 11.7 33.0 57.2 30.2 2.6 9.2 12.6 6.2 11.7 26.4 25.3 8.2 9.9 15.9 12.5 8.8 28.1 15.5 6.2 10.2 8.3 11.8 6.5 8.7 2.5 9.2 30.8 10.5 3.6 33.2 9.0 6.6 6.2 8.5 8.8 18.0 6.1 23.8 18.5 16.4 11.8 20.8 3.8 3.7 7.8 7.0 55.5 11.7 0.3 12.9 4.8 9.7 12.1 32.4 14.9 11.5 3.6 10.1 5.2 2.8 31.1 19.1 2.3 5.3 10.6 27.6 14.6 10.4 6.7 22.1 10.4 12.4 1.3 15.6 83.4 4.3 7.9 21.5 8.3 5.6 0.0 7.1 5.0 24.2 17.1 12.3 23.5 16.5 29.0 8.2 32.5 14.0 4.3 18.4 0.7 11.2 12.3 3.9 1.9 3.5 9.2 2.0 0.1 4.5 0.1 0.5 0.6 0.4 0.1 0.1 1.7 0.4 0.4 0.1 1.3 1.1 0.8 0.7 0.6 0.3 0.0 0.2 0.4 9.2 7.7 44.1 10.8 7.7 11.7 9.2 12.6 6.2 15.9 8.7 10.5 8.8 6.0 218.0 41.9 61.0 11.1 24.5 28.9 9.7 21.6 33.9 28.0 14.1 13.2 24.3 22.5 33.1 25.0 14.9 4.3 20.6 21.5 18.8 38.0 25.8 12.6 6.8 15.5 5.7 68.4 22.3 12.1 13.1 56.1 45.8 0.0 12.0 17.9 54.2 3.2 8.4 79.8 12.7 22.4 2.1 6.8 20.6 9.0 2.8 14.2 26.2 1.1 15.8 0.0 89.5 25.9 23.2 21.7 9.4 5.9 29.1 20.9 29.0 17.5 35.7 19.7 11.7 9.8 43.5 48.6 18.3 21.7 26.4 6.2 5.7 12.9 39.4 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285202 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 49.1;salivary gland: 98.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4" "Cancer enhanced" "Detected in many" "testis cancer: 21.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" Yes NA "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favorable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.4 0.4 0.7 1.7 1.3 0.2 29.0 1.7 1.1 18.3 15.3 19.2 0.6 0.5 8.4 13.4 3.6 3.0 0.2 1.7 0.8 49.1 0.2 5.6 0.2 1.6 2.0 0.1 0.1 6.5 2.6 0.8 7.5 1.0 13.7 22.8 0.0 98.4 2.0 2.7 30.1 3.2 0.6 0.6 1.8 16.4 1.1 1.9 0.2 37.9 0.1 1.2 1.9 11.0 1.0 0.0 1.6 0.0 0.1 0.0 0.0 18.2 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.7 0.0 0.7 0.4 4.4 4.5 0.0 0.0 3.2 15.7 0.0 0.0 0.0 0.0 0.6 0.0 17.3 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.9 0.1 0.0 0.5 2.1 42.4 31.8 13.3 0.1 1.7 0.1 0.0 6.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 1.7 1.1 1.7 0.8 1.6 2.0 0.1 1.0 0.6 1.9 1.0 0.1 6.4 28.8 3.9 0.3 1.7 38.0 10.3 28.5 0.0 22.1 11.6 2.6 17.2 35.4 79.1 0.0 32.2 0.9 117.9 31.3 2.7 0.1 43.5 5.8 1.0 10.2 0.0 0.2 1.5 2.3 0.8 58.6 83.0 0.0 1.2 0.0 0.4 4.9 0.0 0.3 31.2 262.4 4.6 0.8 0.5 0.3 5.5 7.2 9.4 0.2 0.5 0.0 0.0 0.1 7.4 28.0 0.0 2.1 36.3 0.3 27.7 11.9 0.0 0.0 1.9 1.1 0.1 1.5 41.0 3.3 20.2 1.1 9.5 44.3 40.7 SF3B6 "CGI-110, Ht006, P14, SAP14a, SF3B14a" ENSG00000115128 "Splicing factor 3b subunit 6" Q9Y3B4 2 24067586-24076373 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034829, HPA034830" Enhanced Supported Nucleoplasm NA NA 11000 Nucleoplasm "HPA034829: AB_10673104, HPA034830: AB_10669680" "unprognostic (6.37e-2)" "unprognostic (1.38e-1)" "unprognostic (3.59e-1)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (5.35e-3)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.74e-2)" "unprognostic (8.75e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-1)" 79.7 87.3 85.0 65.7 87.6 213.1 139.3 88.8 126.3 99.9 86.8 107.2 91.9 85.5 143.1 124.5 90.0 78.9 90.1 85.5 96.3 112.5 133.7 67.9 103.7 88.7 88.9 83.1 94.6 64.3 103.8 63.4 89.0 88.7 81.9 109.8 64.9 72.3 85.0 75.3 77.0 85.4 89.7 90.7 65.7 71.0 67.2 86.8 139.9 105.9 107.1 124.3 118.3 86.0 95.2 307.2 152.4 231.6 207.9 182.7 292.8 139.3 233.6 253.8 279.1 284.2 329.9 197.0 236.6 117.3 213.1 265.4 187.7 245.2 293.7 345.5 218.0 263.4 256.6 197.2 299.4 324.4 314.3 151.3 268.5 342.5 281.3 319.3 286.4 288.8 199.4 290.2 181.3 294.2 250.3 234.1 486.1 194.7 362.8 264.0 170.6 327.7 239.1 334.6 189.0 214.4 320.7 123.6 268.3 570.9 195.4 122.7 309.4 173.9 159.6 213.6 157.3 384.4 171.2 239.1 655.3 215.4 515.8 224.5 225.0 118.9 185.7 96.0 133.5 108.1 153.9 122.9 117.8 138.9 114.7 118.0 130.0 173.5 133.7 124.3 129.6 179.6 143.8 85.0 87.6 88.8 126.3 85.5 96.3 88.7 88.9 83.1 88.7 90.7 86.8 95.2 207.4 70.5 91.5 11.8 125.1 0.0 280.4 0.0 208.3 50.7 194.3 320.5 120.8 133.0 55.1 138.0 16.7 296.5 149.2 217.1 389.4 206.1 195.9 226.4 208.1 149.0 180.3 164.7 9.2 167.4 413.2 153.0 85.6 210.7 100.1 185.1 142.1 167.1 232.7 18.5 10.2 253.5 0.0 129.3 0.0 49.4 210.3 132.6 0.0 10.3 227.4 175.4 149.3 11.6 19.4 205.4 314.5 180.5 134.0 327.5 381.2 423.1 78.0 68.4 118.3 155.0 158.9 272.4 173.7 257.8 0.0 271.7 126.6 344.4 242.7 438.1 TP53I3 PIG3 ENSG00000115129 "Tumor protein p53 inducible protein 3" Q53FA7 2 24077433-24085861 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 120.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.8;Late spermatids: 213.9;Proximal enterocytes: 200.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "T-47d: 599.7" "Low region specificity" "Detected in all" "CAB017479, HPA022012, HPA028742" Enhanced Supported Vesicles NA NA 250000 Vesicles "CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456" "unprognostic (3.66e-2)" "unprognostic (1.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-3)" "unprognostic (4.47e-1)" "unprognostic (1.09e-2)" "unprognostic (1.53e-3)" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-1)" "unprognostic (3.67e-2)" "unprognostic (8.57e-3)" 20.2 24.8 8.1 16.3 8.9 20.2 17.4 7.8 9.7 25.3 10.2 44.6 52.0 17.5 4.5 120.2 16.6 26.5 13.9 6.9 13.0 44.0 15.3 30.1 7.3 8.7 10.4 7.2 8.2 40.5 7.1 11.8 10.7 7.7 15.1 41.2 2.0 25.5 11.3 6.3 7.9 69.7 17.0 7.4 12.0 25.6 38.7 11.0 14.3 23.8 6.0 10.2 22.5 64.3 9.3 27.5 86.8 50.6 21.1 38.8 85.3 37.2 27.3 32.3 22.6 31.1 22.1 48.4 3.5 15.0 44.0 6.1 8.0 13.1 46.5 13.8 21.6 2.0 8.7 33.3 57.5 25.2 4.1 15.3 92.3 72.3 60.2 14.7 46.1 102.0 16.3 7.3 23.4 95.5 18.1 5.0 0.6 39.2 30.8 36.0 10.1 45.7 0.9 38.1 41.4 7.2 32.9 35.1 7.8 6.1 40.5 599.7 5.6 80.6 26.9 63.8 18.5 13.7 10.6 7.4 3.0 8.9 0.4 7.0 11.8 19.1 16.9 0.2 12.6 0.2 4.9 0.2 0.6 16.0 5.5 0.1 0.4 4.1 0.3 5.6 7.1 0.5 6.1 8.1 8.9 7.8 9.7 6.9 13.0 8.7 10.4 7.2 7.7 7.4 11.0 9.3 19.2 28.9 38.4 3.9 6.8 4.7 24.7 69.7 6.8 0.8 25.8 33.0 9.0 50.1 51.9 42.3 0.0 41.9 1.1 175.8 109.5 93.5 127.8 50.4 47.4 20.3 79.4 7.2 0.4 134.7 31.9 30.6 83.6 68.2 12.7 85.8 23.9 12.9 45.0 0.0 0.4 63.9 57.0 22.9 11.1 213.9 7.8 20.9 14.2 4.7 23.9 9.5 0.0 5.0 0.3 91.1 138.5 9.1 8.0 11.4 200.9 104.7 19.2 1.9 19.7 14.1 36.8 56.6 14.3 38.8 7.0 28.9 3.4 16.2 75.2 49.9 DNAJC27 "RabJS, RBJ" ENSG00000115137 "DnaJ heat shock protein family (Hsp40) member C27" Q9NZQ0 2 24943636-24972094 "Predicted intracellular proteins" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 22.4" "Cell type enhanced" "Detected in many" "Early spermatids: 59.8;Spermatocytes: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036815, HPA036816" Uncertain Approved Cytosol NA NA Cytosol "HPA036815: , HPA036816: AB_10673506" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (4.53e-2)" "unprognostic (3.09e-1)" "unprognostic (5.17e-3)" "unprognostic (5.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.13e-1)" "unprognostic (4.60e-2)" "unprognostic (7.44e-4)" "unprognostic (8.84e-2)" "prognostic favorable (8.48e-5)" "unprognostic (3.35e-1)" "unprognostic (3.66e-1)" "unprognostic (3.05e-2)" "unprognostic (1.78e-3)" 4.3 3.4 4.6 2.1 5.8 3.8 3.7 7.2 7.2 3.6 4.0 3.3 2.0 4.2 5.1 2.2 4.6 3.0 5.0 4.9 8.9 3.8 2.0 2.7 2.8 7.8 6.7 4.5 7.1 2.8 5.2 6.2 2.9 8.4 3.3 2.8 13.4 2.2 3.1 4.7 2.9 2.7 3.0 6.3 2.9 2.9 22.4 6.1 3.6 3.3 7.0 2.4 3.2 3.0 8.4 2.8 1.2 2.6 2.6 3.6 3.0 2.0 2.1 3.2 2.2 1.9 1.3 1.3 2.6 0.5 1.5 1.8 2.2 1.9 1.3 2.3 1.1 1.6 1.6 1.6 1.2 2.3 1.5 2.2 2.3 2.2 1.7 3.5 2.5 0.9 3.1 1.1 2.4 2.4 1.0 2.7 2.6 1.7 1.0 1.1 1.6 5.1 1.4 2.1 1.5 0.9 3.2 2.0 1.5 3.0 2.7 1.3 1.1 0.8 2.9 2.0 1.5 2.0 6.1 2.3 3.1 1.5 2.4 1.3 0.0 0.2 0.9 0.2 0.1 0.5 0.4 0.3 0.2 0.2 0.3 0.4 0.5 0.0 1.3 0.3 0.1 0.3 0.2 4.6 5.8 7.2 7.2 4.9 8.9 7.8 6.7 4.5 8.4 6.3 6.1 8.4 7.8 9.6 10.0 19.2 11.2 2.0 5.6 3.6 8.0 24.1 9.8 8.5 25.4 4.3 3.0 7.3 37.5 3.6 10.8 4.5 3.9 2.6 59.8 12.5 9.7 7.7 15.5 11.8 18.2 2.5 2.0 8.8 8.2 5.2 10.8 9.5 6.1 3.4 3.3 37.0 22.1 5.9 6.1 3.2 4.6 32.5 8.7 5.9 1.8 7.5 4.3 12.2 4.1 12.1 24.1 1.7 0.9 6.4 8.8 4.6 4.3 3.1 17.3 25.1 0.0 12.8 23.9 70.7 17.0 8.3 3.3 4.2 11.3 23.2 5.4 3.8 POMC "ACTH, CLIP, LPH, MSH, NPP, POC" ENSG00000115138 Proopiomelanocortin P01189 2 25160853-25168903 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Endorphin, Hormone" "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1238 "pituitary gland: 34625.3" "Cell type enhanced" "Detected in many" "Early spermatids: 119.8;Late spermatids: 352.6;Spermatocytes: 83.0" "Cancer enriched" "Detected in many" 6 "testis cancer: 18.5" "Group enriched" "Detected in all" 4 "hypothalamus: 27.9;thalamus: 9.3" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;THP-1: 2.1" "Region enriched" "Detected in all" 7 "hypothalamus: 44.0" "Region enriched" "Detected in all" 5 "hypothalamus: 88.1" "CAB002762, HPA046135, HPA063644, CAB079881" Enhanced "Secreted to blood" NA NA 380000 "CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071" "unprognostic (8.02e-2)" "unprognostic (1.47e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-3)" "unprognostic (3.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (4.30e-2)" "unprognostic (8.74e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.70e-4)" "unprognostic (8.02e-2)" "unprognostic (4.29e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (3.84e-2)" 5.3 19.2 3.1 1.2 2.2 1.1 3.5 2.8 4.4 2.4 1.8 5.9 0.4 3.1 0.3 13.8 2.2 0.2 10.7 1.9 27.9 4.7 13.0 3.6 1.1 4.1 2.7 1.4 5.0 22.8 0.1 34625.3 1.2 3.5 5.0 0.0 0.2 5.9 0.3 5.7 21.4 4.8 0.1 3.4 11.1 15.6 25.9 9.3 1.3 8.5 5.3 0.4 2.5 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 12.6 8.6 11.5 13.2 9.1 16.8 8.8 11.3 15.9 17.4 11.6 12.6 3.8 18.2 8.0 27.9 10.5 9.7 3.1 2.2 2.8 4.4 1.9 27.9 4.1 2.7 1.4 3.5 3.4 9.3 4.1 22.3 0.0 2.2 1.0 16.1 4.5 2.2 6.9 2.2 2.6 6.1 6.7 2.5 2.8 2.5 0.0 0.0 0.5 24.4 0.2 15.6 7.8 119.8 0.6 4.9 11.6 0.0 28.8 0.3 17.3 6.0 5.2 4.6 0.6 7.0 9.7 15.4 2.0 34.5 6.7 0.6 0.0 6.1 10.9 7.9 352.6 4.7 17.2 17.8 1.9 8.5 11.5 15.5 0.0 0.3 10.1 1.1 13.2 17.8 4.1 0.1 3.9 0.7 7.5 13.1 4.6 3.8 83.0 27.3 1.6 5.5 0.4 14.9 12.9 0.6 3.8 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175763 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 16.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 9.8 10.0 7.8 7.9 8.6 3.2 12.6 8.0 9.0 11.0 8.6 10.3 9.4 11.0 8.8 9.1 12.9 9.4 9.7 7.0 8.1 14.8 11.0 10.8 8.8 8.1 8.3 6.4 11.1 8.9 12.9 6.5 10.4 8.4 13.0 11.0 11.2 12.0 9.0 5.9 10.8 9.3 10.2 8.2 8.3 11.8 12.7 8.1 8.6 14.4 7.8 9.0 10.8 6.7 10.3 8.3 7.9 7.2 8.8 18.5 22.0 7.7 16.8 19.4 10.7 13.6 7.8 7.8 10.8 13.1 24.2 9.4 8.3 8.0 15.6 17.1 13.3 6.3 7.8 5.1 11.8 21.2 11.5 14.6 16.9 14.6 20.0 26.8 15.5 11.7 7.2 5.1 7.5 22.2 8.1 6.1 8.9 4.5 6.1 11.2 4.9 8.9 5.9 16.7 14.1 3.8 5.9 9.3 8.2 14.1 8.0 11.1 10.5 15.3 23.7 7.6 18.8 10.3 6.1 6.7 6.8 17.9 9.2 13.2 16.8 3.4 4.6 1.7 4.6 1.6 1.7 1.8 1.9 2.7 2.0 1.5 1.9 8.6 2.6 7.1 3.2 2.2 1.6 7.8 8.6 8.0 9.0 7.0 8.1 8.1 8.3 6.4 8.4 8.2 8.1 10.3 17.6 25.6 33.5 39.2 10.9 13.8 12.0 16.4 15.9 10.6 17.9 11.6 30.5 7.2 28.9 16.5 16.7 7.4 14.7 22.1 23.5 13.9 147.8 37.2 25.5 15.1 8.3 13.5 43.8 14.2 14.6 22.7 27.0 22.2 27.1 14.8 17.5 16.0 16.7 1.7 39.7 20.2 20.3 20.0 13.0 64.4 15.8 16.9 14.2 32.8 19.6 14.7 8.2 51.8 61.0 21.2 18.2 15.4 10.9 14.3 13.9 14.8 55.6 11.6 26.3 18.0 16.1 54.1 20.1 13.5 13.2 20.2 9.3 18.2 13.5 16.1 OTOF "DFNB6, DFNB9, FER1L2" ENSG00000115155 Otoferlin Q9HC10 2 26457203-26558756 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Disease variant, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "bone marrow: 6.5;brain: 24.7" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 4.0;Skeletal myocytes: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "HDLM-2: 32.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012410 Approved NA NA "HPA012410: AB_1854836" "unprognostic (4.01e-3)" "unprognostic (7.85e-2)" "unprognostic (8.95e-2)" "unprognostic (7.20e-5)" "unprognostic (1.82e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.61e-2)" "unprognostic (1.78e-2)" "unprognostic (1.26e-1)" "unprognostic (2.97e-3)" "unprognostic (4.85e-14)" "unprognostic (1.33e-2)" "unprognostic (5.19e-1)" "unprognostic (9.65e-2)" "unprognostic (8.96e-5)" 0.2 0.5 24.7 0.3 15.7 6.5 0.2 0.3 13.7 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.3 0.1 4.3 7.1 0.0 0.0 0.2 0.1 7.7 2.6 3.7 0.0 0.1 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.1 2.3 0.5 0.2 1.1 2.4 0.9 0.1 0.3 0.1 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.3 0.0 0.1 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 24.7 15.7 0.3 13.7 4.3 7.1 7.7 2.6 3.7 5.8 2.3 2.4 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.2 0.8 0.3 0.0 0.0 0.1 0.5 0.4 0.0 0.0 GPD2 ENSG00000115159 "Glycerol-3-phosphate dehydrogenase 2" P43304 2 156435290-156613735 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 151.1;Late spermatids: 95.5;Oligodendrocyte precursor cells: 148.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.3;eosinophil: 1.7;intermediate monocyte: 1.6;myeloid DC: 2.7;neutrophil: 1.1;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;granulocytes: 1.7;monocytes: 3.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008012, HPA045506" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 620000 Mitochondria "HPA008012: AB_1079013, HPA045506: AB_2679355" "unprognostic (1.30e-1)" "unprognostic (2.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.79e-3)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (2.60e-3)" "unprognostic (6.67e-2)" "unprognostic (6.02e-3)" "unprognostic (1.73e-1)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (1.01e-2)" 8.3 5.8 14.2 8.2 16.4 13.5 16.3 16.1 18.8 10.4 8.4 18.7 14.6 6.9 5.3 20.5 18.4 9.0 6.3 19.6 16.6 8.1 3.5 11.5 7.1 15.6 15.8 14.8 8.7 6.9 20.6 5.5 6.8 14.0 11.0 18.1 9.6 15.1 7.2 24.9 12.6 15.8 6.2 14.3 8.6 17.6 5.5 17.3 6.2 12.3 14.4 8.7 14.5 9.6 15.1 39.0 27.2 15.3 24.5 32.6 39.6 0.1 48.0 31.2 32.1 38.6 53.9 35.7 8.4 31.9 27.4 13.2 44.5 28.9 44.5 41.4 23.9 9.5 6.0 46.9 0.0 12.0 11.2 12.6 19.5 15.4 55.6 27.1 20.6 24.1 3.7 12.0 1.9 41.7 24.4 0.3 1.0 28.7 15.2 31.0 12.3 9.8 9.2 41.8 50.7 27.3 9.9 45.0 34.4 30.4 25.9 10.9 30.8 22.8 5.7 26.9 26.5 36.5 1.3 0.3 0.4 32.9 3.0 47.1 0.3 3.3 1.7 0.3 1.6 0.5 0.1 0.1 0.4 2.7 0.2 0.3 0.2 1.1 0.4 2.3 0.3 0.5 1.5 14.2 16.4 16.1 18.8 19.6 16.6 15.6 15.8 14.8 14.0 14.3 17.3 15.1 12.1 19.2 12.3 151.1 7.8 20.0 23.3 24.9 21.1 5.5 23.4 12.8 13.1 7.2 19.8 22.0 6.2 9.6 6.2 52.1 1.9 9.5 84.8 12.3 6.1 11.3 17.4 6.9 27.9 13.4 15.2 9.2 30.5 23.3 12.7 13.0 10.4 3.4 21.3 5.0 46.9 17.1 10.2 18.6 18.7 95.5 12.2 21.0 24.9 61.8 10.8 4.2 4.1 148.3 48.7 16.2 17.4 7.2 5.6 66.7 16.0 3.9 18.2 11.1 0.0 8.3 12.3 2.6 3.2 41.7 21.5 11.1 7.6 7.0 19.4 77.8 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6" "Cancer enhanced" "Detected in many" "testis cancer: 24.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB008371: AB_591074, HPA073086: AB_2686569" "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (2.88e-8)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 0.3 0.3 0.0 4.0 0.0 3.8 0.4 0.1 0.1 0.3 0.0 3.0 4.1 0.7 0.0 3.7 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.4 7.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.1 2.7 0.0 0.6 0.0 0.0 3.6 2.9 0.9 0.0 2.1 1.6 2.2 0.1 13.4 0.1 0.0 8.5 0.7 1.1 0.2 86.4 21.0 34.9 19.3 2.4 4.5 24.3 26.2 22.2 37.3 31.5 15.4 30.0 25.7 16.2 10.4 45.7 25.6 28.9 15.3 37.7 77.3 25.6 44.0 11.0 28.6 0.8 26.7 49.0 0.4 1.6 16.1 24.4 6.7 22.1 33.7 36.7 58.5 32.5 30.1 39.0 42.2 26.6 35.3 34.3 45.4 53.6 30.8 17.5 5.5 27.5 26.7 25.7 32.7 23.6 12.9 18.2 27.2 12.6 23.9 54.2 27.9 46.4 51.5 53.5 107.3 11.1 54.7 46.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 5.2 6.2 0.7 1.9 1.8 0.0 2.0 2.5 2.7 0.0 0.5 0.0 0.0 15.3 1.0 2.3 0.0 0.5 0.6 1.6 1.6 1.5 4.2 45.0 0.1 0.2 33.2 4.9 2.6 3.0 0.0 24.2 3.9 0.6 15.7 0.0 0.1 6.6 0.0 2.9 2.8 0.1 0.9 4.4 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.1 1.4 0.0 17.8 2.1 0.8 0.2 0.1 0.0 0.0 0.6 3.9 16.1 28.6 12.5 5.3 3.4 3.4 1.5 11.1 2.0 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 106.6;lymphoid tissue: 115.2" "Cell type enhanced" "Detected in many" "B-cells: 240.4;dendritic cells: 244.3;Langerhans cells: 552.9;Macrophages: 164.0;monocytes: 490.1;NK-cells: 181.3;Plasma cells: 392.5;T-cells: 366.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 54.6;HDLM-2: 44.3;Karpas-707: 146.4;RPMI-8226: 46.9;U-266/70: 246.5;U-266/84: 99.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA007191 Approved Approved Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 8.6 2.7 1.3 70.7 1.6 106.6 7.8 1.6 3.3 5.7 4.7 12.9 27.5 3.2 2.1 6.9 3.5 11.9 2.9 1.3 3.3 5.2 12.4 26.3 92.3 3.1 2.0 0.8 1.5 3.4 0.9 1.4 4.4 2.5 3.3 14.8 0.5 14.4 3.9 1.1 2.8 23.3 7.0 2.4 42.6 42.0 2.5 2.1 54.1 4.0 2.2 115.2 21.0 3.8 2.6 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 54.6 0.1 0.6 0.0 0.1 0.0 0.0 0.1 44.3 0.0 0.3 0.0 0.0 0.0 7.8 6.4 0.0 0.0 0.2 0.0 4.0 0.0 0.2 0.0 146.4 0.7 0.0 0.0 6.3 0.3 0.8 0.1 0.0 0.1 46.9 5.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 2.0 0.2 246.5 99.8 24.1 2.4 6.8 0.0 248.9 37.6 109.9 121.8 122.5 122.5 91.5 127.9 115.7 56.1 91.6 205.5 161.0 203.6 90.2 247.9 28.1 136.5 154.8 1.3 1.6 1.6 3.3 1.3 3.3 3.1 2.0 0.8 2.5 2.4 2.1 2.6 3.2 3.2 12.2 0.0 240.4 20.9 1.0 0.0 0.6 0.0 24.4 2.5 2.1 5.7 1.3 1.8 0.0 0.7 244.3 0.6 15.6 0.3 1.4 0.3 0.4 4.5 1.8 14.9 0.1 1.9 13.6 6.4 29.0 0.8 7.0 0.0 6.8 1.7 25.2 0.0 0.1 3.7 0.0 86.1 552.9 2.0 0.0 164.0 83.6 12.2 490.1 0.0 181.3 0.0 0.0 0.3 0.3 0.0 392.5 0.7 0.4 1.1 0.0 0.1 0.0 1.5 4.5 0.0 0.6 1.2 17.8 3.0 366.6 0.0 3.8 0.5 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157876330 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 19.3 10.5 18.5 13.0 13.9 1.9 18.9 14.9 16.5 28.3 18.2 14.2 11.0 24.6 33.0 11.4 17.2 24.4 19.9 24.5 13.7 26.6 22.9 17.7 8.9 15.2 13.9 11.2 21.4 10.1 8.6 11.0 17.8 14.8 15.2 12.7 6.4 18.9 15.5 21.7 14.0 10.6 34.8 13.5 8.3 14.8 5.2 16.2 7.6 40.8 13.4 8.3 21.1 15.6 14.6 6.1 13.1 14.4 18.5 65.0 70.6 18.9 43.4 71.3 33.7 36.1 10.1 13.4 0.2 18.2 45.6 32.3 16.9 10.5 22.5 36.8 43.0 8.7 25.7 7.2 14.4 54.7 2.0 28.5 89.5 41.4 69.8 84.2 42.8 38.7 6.7 9.5 6.7 45.2 11.1 0.4 0.4 21.4 8.7 21.7 4.1 19.6 5.7 45.4 24.5 12.4 14.9 17.0 9.7 64.5 22.2 5.3 7.0 54.0 50.9 16.8 25.3 17.1 4.7 3.5 0.3 52.2 1.6 58.1 2.9 1.7 0.1 0.5 1.0 0.7 0.8 4.9 1.3 1.3 0.2 1.6 0.7 0.2 1.2 1.4 1.4 6.6 1.1 18.5 13.9 14.9 16.5 24.5 13.7 15.2 13.9 11.2 14.8 13.5 16.2 14.6 9.6 9.6 9.0 22.9 1.8 9.8 7.7 12.6 12.5 10.4 8.0 9.8 12.7 11.5 12.4 7.3 0.0 8.4 1.1 4.8 5.9 9.9 1.0 5.9 12.9 17.3 4.2 1.7 34.0 17.8 5.3 20.3 8.2 6.5 5.1 4.2 18.2 13.3 7.0 3.3 34.2 4.5 24.4 13.0 8.7 2.0 20.2 7.6 3.6 106.8 5.5 6.6 2.1 42.3 22.9 17.2 4.1 15.8 6.4 13.0 3.7 15.5 13.6 2.1 13.1 16.3 19.3 0.4 2.7 4.0 7.5 10.5 4.3 3.5 4.3 8.8 TANC1 "KIAA1728, ROLSB" ENSG00000115183 "Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1" Q9C0D5 2 158968640-159232659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 212.0;Microglial cells: 159.3;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036750 Approved NA NA "HPA036750: AB_10670241" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" "unprognostic (1.56e-1)" "unprognostic (8.91e-2)" "unprognostic (2.43e-2)" "unprognostic (3.96e-2)" "unprognostic (1.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.43e-2)" "unprognostic (3.94e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-2)" "unprognostic (2.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" 7.7 5.9 11.6 4.0 13.6 0.2 7.9 13.8 6.5 10.3 7.8 7.7 6.5 11.0 2.0 12.9 5.9 7.5 22.3 11.3 13.0 6.7 4.4 12.7 3.4 16.4 13.1 1.5 6.3 5.9 6.0 3.5 13.5 15.6 7.9 7.1 12.1 7.1 4.5 2.7 20.7 6.6 13.0 13.9 5.1 6.0 1.9 20.7 3.6 10.9 4.4 4.8 8.6 6.8 21.0 8.7 7.4 18.4 14.3 16.7 7.1 9.0 6.6 13.9 6.6 10.4 8.0 9.5 0.0 22.6 21.2 5.0 18.7 5.9 26.1 8.4 0.0 13.7 5.6 11.8 1.5 19.7 0.7 14.3 11.0 21.3 12.4 23.1 30.1 35.8 8.5 1.4 39.8 11.1 3.9 5.5 0.0 2.4 9.8 6.7 0.7 10.0 12.9 15.2 34.9 2.8 18.9 14.5 6.6 34.9 11.4 7.2 5.6 33.8 14.7 8.6 3.1 6.1 19.7 14.5 0.0 8.2 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 13.6 13.8 6.5 11.3 13.0 16.4 13.1 1.5 15.6 13.9 20.7 21.0 42.1 28.9 17.1 34.9 0.2 48.9 13.5 21.7 46.7 30.1 19.3 16.9 64.7 15.7 23.5 11.0 6.2 2.9 0.9 18.9 3.9 13.3 1.1 11.1 12.1 48.3 0.0 4.2 9.9 12.5 3.8 16.0 33.1 11.7 17.2 47.6 35.3 8.7 2.0 212.0 54.7 16.6 10.2 2.8 10.3 1.7 10.5 1.7 24.9 159.3 0.6 48.6 1.0 193.5 223.7 13.4 22.7 4.9 1.6 14.4 10.5 4.9 12.5 4.9 13.1 11.6 27.5 0.5 2.1 38.6 42.1 2.1 2.5 14.6 14.9 17.3 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 22.9;epididymis: 69.1;testis: 35.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0" "Group enriched" "Detected in all" 4 "amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7" "Group enriched" "Detected in many" 6 "amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.1 2.1 15.1 0.1 12.1 0.3 0.1 0.0 17.6 0.2 0.0 0.1 0.0 0.4 69.1 0.1 0.3 0.1 6.8 22.9 2.4 0.1 0.2 0.2 0.6 1.6 0.6 15.3 0.2 0.0 0.5 0.3 0.0 9.6 0.3 0.0 0.2 0.0 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 35.4 2.0 0.0 0.2 0.0 0.1 0.0 0.2 9.8 0.4 1.3 0.1 2.0 0.2 0.2 0.3 0.0 0.0 1.3 1.4 0.5 0.5 0.0 0.1 0.0 8.8 0.3 11.2 0.0 0.3 0.0 1.2 5.9 0.5 12.0 0.2 0.2 2.3 0.0 0.0 0.6 0.0 0.2 0.9 2.9 1.7 0.1 0.2 3.9 0.1 0.4 1.8 0.4 0.0 22.8 11.0 1.4 0.0 0.3 0.0 0.7 2.8 0.0 0.0 0.1 0.0 0.8 0.1 0.3 5.1 0.3 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 15.1 12.1 0.0 17.6 22.9 2.4 1.6 0.6 15.3 9.6 0.0 2.0 9.8 0.3 0.0 0.0 2.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 17.8 0.0 0.1 0.4 0.0 0.0 15.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.4 42.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 15.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 16.6 10.7 0.0 0.1 0.1 0.1 0.0 0.0 0.0 MPV17 SYM1 ENSG00000115204 "Mitochondrial inner membrane protein MPV17" P39210 2 27309492-27325680 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.34e-3)" "unprognostic (2.70e-1)" "unprognostic (9.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (6.99e-6)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (1.56e-1)" "unprognostic (2.22e-1)" "unprognostic (1.48e-1)" "unprognostic (1.44e-3)" "unprognostic (2.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.10e-3)" "unprognostic (4.62e-2)" 50.7 87.2 53.9 38.2 55.3 31.6 40.3 56.6 56.6 36.3 55.5 30.4 25.3 38.2 48.1 32.9 38.1 37.1 79.0 53.9 60.3 49.1 22.8 39.4 43.6 56.0 54.4 54.4 44.0 33.5 70.6 39.2 35.3 55.0 34.4 34.5 26.9 36.2 35.3 18.5 32.2 27.7 58.2 54.2 37.3 29.4 15.7 56.3 46.4 52.0 30.3 48.5 45.3 28.3 60.5 74.1 68.2 49.7 42.6 202.7 237.0 46.6 70.8 143.6 67.2 60.7 55.0 52.0 41.5 72.8 97.2 124.0 61.3 64.1 134.1 69.5 56.9 63.7 79.5 58.8 105.6 125.4 47.3 48.7 229.3 116.3 118.6 169.4 94.3 100.2 49.8 77.0 77.1 113.9 107.4 46.9 71.5 55.7 106.7 69.1 64.6 73.2 85.2 149.2 58.5 33.1 107.2 37.6 43.7 82.1 49.3 49.0 60.6 88.6 67.0 68.8 83.4 76.4 108.1 106.1 130.4 109.2 105.4 76.1 59.5 93.7 42.9 59.3 81.4 64.4 84.5 60.5 67.4 120.5 73.6 58.0 67.8 7.8 76.0 81.7 87.4 81.4 92.1 53.9 55.3 56.6 56.6 53.9 60.3 56.0 54.4 54.4 55.0 54.2 56.3 60.5 36.0 25.6 29.3 10.7 26.3 17.2 32.8 69.2 33.0 20.5 49.5 52.8 48.9 18.6 46.5 33.1 8.4 51.1 26.3 8.8 64.6 43.3 27.4 17.3 32.6 35.9 16.8 21.6 18.4 24.3 60.2 37.5 12.2 17.5 42.5 28.7 28.2 9.9 116.9 8.4 22.7 15.0 59.0 28.5 24.0 34.2 35.4 33.7 40.9 8.4 38.1 38.9 28.8 13.6 15.5 20.7 12.9 35.0 31.4 32.1 17.6 87.1 36.7 12.7 0.0 30.1 30.8 15.5 21.2 33.9 18.8 59.4 22.2 41.8 17.7 30.7 GTF3C2 "KIAA0011, TFIIIC110" ENSG00000115207 "General transcription factor IIIC subunit 2" Q8WUA4 2 27325849-27357034 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008274, HPA035836" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008274: , HPA035836: AB_10601813" "unprognostic (1.76e-1)" "unprognostic (9.64e-2)" "unprognostic (9.89e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (1.33e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (1.57e-1)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-2)" "unprognostic (7.39e-2)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.94e-1)" "unprognostic (7.97e-2)" "unprognostic (3.00e-1)" 17.8 25.8 20.2 23.4 21.7 23.8 21.4 25.8 27.8 18.3 22.7 25.5 22.7 20.0 23.9 34.8 24.6 15.5 23.4 20.6 19.9 22.1 21.2 19.8 26.8 21.3 19.6 20.3 20.9 30.9 33.4 20.1 19.8 21.8 20.3 27.9 25.5 25.4 18.7 29.0 32.0 24.4 23.5 18.7 27.0 24.5 26.2 21.0 30.6 29.6 18.6 33.8 23.5 21.6 28.8 86.2 75.7 62.5 60.6 36.2 35.2 91.2 30.8 41.8 39.8 33.7 56.3 53.7 75.1 54.1 43.0 40.8 50.6 93.2 59.2 38.0 59.5 81.0 63.3 48.5 76.0 33.0 69.7 60.6 44.4 52.3 45.4 58.4 38.0 51.8 50.4 90.1 54.9 38.8 70.4 64.9 50.7 118.2 69.0 47.6 79.1 69.2 83.9 56.8 63.9 58.0 101.5 33.1 78.6 57.7 52.8 42.2 39.3 39.6 48.2 52.4 36.9 58.1 60.2 71.9 169.4 48.1 55.4 53.8 29.6 18.2 14.5 14.3 15.0 15.1 13.3 12.6 15.2 15.6 11.4 12.4 12.2 8.4 13.3 19.2 9.8 8.5 19.7 20.2 21.7 25.8 27.8 20.6 19.9 21.3 19.6 20.3 21.8 18.7 21.0 28.8 7.9 19.2 22.1 11.8 17.5 9.8 9.8 11.9 18.2 11.3 13.9 11.6 11.7 14.3 14.9 5.5 22.9 19.3 12.9 22.2 9.8 16.6 54.9 13.6 10.9 10.3 3.5 24.8 17.3 22.8 23.6 10.0 17.3 14.6 18.3 16.2 10.0 11.1 16.1 10.1 16.2 17.6 12.2 18.4 7.6 61.9 9.3 12.1 5.4 16.9 18.3 8.9 12.3 14.1 18.9 21.5 9.0 7.9 18.6 13.0 16.0 11.8 14.8 18.0 6.6 9.7 11.8 9.1 16.4 19.4 12.6 20.0 13.7 11.8 15.1 14.4 EIF2B4 "DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta" ENSG00000115211 "Eukaryotic translation initiation factor 2B subunit delta" Q9UI10 2 27364352-27370457 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 196.4;Late spermatids: 299.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032234, HPA039993, HPA068855" Approved Approved "Nuclear membrane,Actin filaments" NA NA "Nuclear membrane" "Actin filaments" "CAB032234: AB_668909, HPA039993: AB_2676790, HPA068855: " "unprognostic (2.26e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" "unprognostic (7.55e-2)" "unprognostic (2.37e-1)" "unprognostic (4.63e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (3.64e-2)" "unprognostic (2.18e-1)" "unprognostic (3.56e-3)" "unprognostic (1.11e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (5.46e-8)" "unprognostic (1.79e-1)" "unprognostic (1.70e-1)" "unprognostic (8.76e-2)" "unprognostic (1.67e-2)" 21.0 25.0 22.4 15.3 23.1 10.8 20.9 23.0 23.6 21.1 21.2 27.4 14.7 21.2 17.0 28.0 20.5 13.5 25.2 22.3 22.5 16.6 21.7 18.3 17.4 23.7 22.7 22.0 20.0 31.7 20.6 20.5 19.0 23.3 25.6 18.6 19.5 24.8 21.0 52.2 29.5 18.6 23.0 22.5 18.7 24.9 38.4 23.3 19.1 18.2 35.5 23.1 24.3 21.5 23.2 38.7 59.8 44.3 34.6 58.4 42.7 48.4 41.0 43.7 55.7 37.3 89.2 16.9 49.7 38.7 48.7 46.6 27.6 62.5 50.8 36.2 37.4 40.7 61.7 39.3 104.5 51.1 58.2 23.0 41.3 51.1 69.2 51.6 40.4 53.3 37.2 59.5 24.9 53.0 35.2 28.8 61.7 49.1 59.8 38.9 52.9 69.9 43.2 50.0 32.7 34.3 37.4 34.1 53.8 42.6 39.6 31.3 23.4 52.8 40.1 47.0 35.4 49.7 50.9 65.7 74.7 33.9 47.9 38.6 56.6 53.9 38.8 32.1 48.1 44.6 31.1 31.6 32.6 52.5 25.3 30.2 32.9 7.7 30.8 52.2 38.6 43.8 43.2 22.4 23.1 23.0 23.6 22.3 22.5 23.7 22.7 22.0 23.3 22.5 23.3 23.2 19.9 12.8 14.8 9.8 17.5 35.9 18.9 32.0 15.4 22.6 28.0 18.7 33.0 14.3 27.0 22.0 66.7 40.9 27.8 23.4 19.6 29.0 196.4 22.3 23.9 19.9 24.0 8.2 6.6 33.4 25.0 24.6 14.8 17.6 31.6 16.9 25.7 34.4 24.3 10.1 6.5 24.8 28.5 20.7 28.0 299.6 23.3 16.5 23.2 2.8 29.5 23.2 16.5 6.0 8.8 26.7 27.1 24.8 28.4 21.2 23.0 27.6 24.9 58.9 19.7 17.0 34.9 71.5 38.9 14.5 34.8 46.1 24.3 23.8 20.5 14.4 NRBP1 "BCON3, MADM, MUDPNP, NRBP" ENSG00000115216 "Nuclear receptor binding protein 1" Q9UHY1 2 27427790-27442259 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 234.3;Extravillous trophoblasts: 231.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029527, CAB033078" Supported Supported Cytosol NA NA 39000 Cytosol "CAB033078: AB_2154375, HPA029527: AB_10601379" "unprognostic (4.95e-3)" "unprognostic (1.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (7.36e-2)" "unprognostic (1.44e-1)" "unprognostic (6.11e-2)" "unprognostic (3.13e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (5.84e-5)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.75e-2)" "unprognostic (3.48e-3)" 59.2 50.0 38.1 49.9 38.3 110.1 55.7 38.7 42.5 72.1 42.9 64.5 52.6 70.3 43.5 100.7 55.5 54.0 54.1 36.7 42.6 44.8 55.7 50.7 54.4 41.1 40.5 36.3 64.2 51.4 44.8 47.3 83.7 42.9 52.1 46.9 48.1 57.7 61.2 127.3 69.8 52.8 76.3 36.3 51.6 52.3 71.7 41.3 52.4 42.8 91.1 67.8 67.9 71.4 45.4 123.7 121.0 98.1 130.9 148.2 146.6 119.0 114.8 143.1 159.8 123.5 123.5 49.1 35.5 83.7 182.9 158.6 82.9 98.4 102.9 102.3 70.0 61.4 70.8 47.0 163.5 124.1 40.0 91.1 120.8 127.3 163.7 108.6 103.9 178.5 38.8 40.5 54.8 142.3 185.6 53.0 96.1 124.0 108.5 75.7 40.5 209.5 40.0 113.8 84.1 26.3 74.1 135.6 96.5 72.4 108.8 53.3 43.9 143.0 140.6 138.5 85.1 94.2 114.3 122.7 42.4 109.8 68.6 71.9 203.6 88.6 187.0 96.7 118.0 85.6 59.3 82.3 87.9 90.2 55.1 73.9 77.1 117.9 91.0 111.5 57.4 107.8 117.4 38.1 38.3 38.7 42.5 36.7 42.6 41.1 40.5 36.3 42.9 36.3 41.3 45.4 47.3 6.4 21.4 15.7 46.4 57.2 57.8 73.9 56.9 37.8 34.3 31.5 25.9 28.6 47.2 35.0 35.5 155.7 72.6 67.4 31.3 88.7 234.3 47.5 66.8 54.9 28.1 42.7 14.8 95.9 231.5 61.8 30.1 64.1 20.8 39.3 47.2 38.8 77.3 28.6 15.9 42.7 38.7 35.2 44.7 38.6 46.0 46.6 30.2 8.4 67.2 46.8 51.5 13.0 17.0 100.0 45.6 60.5 72.2 49.7 67.4 52.6 36.5 56.3 32.9 37.4 77.6 92.8 106.8 50.3 52.4 203.2 67.2 36.9 30.8 58.8 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099667-160200313 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 80.7;tongue: 65.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 139.2;RPTEC TERT1: 269.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.1 0.0 0.0 1.9 0.0 0.0 20.4 0.0 0.0 1.4 0.0 8.1 8.5 5.5 1.7 14.3 3.4 14.9 0.5 0.0 0.0 29.4 0.1 45.7 0.0 0.0 0.0 0.0 0.0 3.3 32.5 1.8 5.6 0.0 5.1 7.5 0.0 3.9 9.0 80.7 2.2 6.4 0.3 0.0 0.0 18.9 0.1 0.0 0.0 4.8 65.1 3.1 45.3 6.5 0.0 14.5 0.2 0.0 0.1 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.1 139.2 0.1 0.8 0.1 0.0 28.7 0.0 45.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 31.4 0.0 0.1 0.4 0.1 0.0 0.0 0.0 3.8 4.3 0.0 0.0 0.0 9.0 0.0 0.0 10.9 0.0 269.9 45.7 0.0 0.1 0.1 43.7 0.0 1.6 0.5 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 153.8 202.5 0.0 0.0 10.5 153.5 125.9 46.1 0.0 35.5 31.0 38.7 10.0 60.4 71.7 0.0 13.6 0.5 30.3 0.0 57.5 89.4 9.6 0.7 2.6 0.0 0.0 0.3 105.4 7.0 2.6 37.8 24.4 3.8 0.0 1.1 1.0 2.2 0.0 0.2 11.6 24.4 0.3 0.4 48.3 2.8 2.2 1.8 0.0 2.0 1.7 0.0 0.5 0.1 195.2 25.6 1.2 0.0 57.3 10.0 1.9 17.7 0.1 0.0 5.7 3.8 286.0 3.0 42.2 8.5 4.7 2.1 0.0 12.4 129.3 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 125.2;liver: 128.0" "Cell type enhanced" "Detected in many" "Early spermatids: 255.2;Hepatocytes: 130.9;Late spermatids: 557.6;Pancreatic endocrine cells: 89.2" "Cancer enhanced" "Detected in all" "glioma: 39.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 35.3;ASC diff: 34.7;HUVEC TERT2: 43.3;SH-SY5Y: 33.2;TIME: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 30.9 125.2 56.4 2.9 55.5 0.0 26.4 60.8 69.9 7.4 41.7 5.0 1.2 4.3 2.7 25.1 3.8 12.4 7.8 60.3 56.0 7.3 128.0 4.6 1.1 64.7 58.4 55.0 38.6 12.0 36.8 11.3 2.5 65.1 11.9 1.8 10.5 9.0 3.2 4.2 4.9 3.5 5.4 56.9 5.5 5.7 27.5 59.8 0.4 6.0 4.0 2.8 6.1 8.1 62.7 0.0 0.3 19.9 35.3 34.7 21.2 0.3 8.1 16.3 5.8 5.0 1.6 0.6 0.0 0.9 25.9 7.5 0.0 13.3 4.9 5.0 0.0 2.2 1.7 0.1 18.7 12.9 0.0 0.2 18.2 2.3 10.0 2.0 26.0 43.3 0.0 1.9 0.0 21.3 0.0 0.0 0.1 12.4 0.0 0.7 0.0 0.0 0.0 3.4 0.0 0.3 33.2 0.2 0.0 0.3 2.6 0.1 0.0 39.7 5.4 2.4 2.1 6.3 0.0 0.0 0.0 29.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.4 55.5 60.8 69.9 60.3 56.0 64.7 58.4 55.0 65.1 56.9 59.8 62.7 14.8 0.0 0.5 5.2 0.8 3.4 3.2 0.4 5.7 9.1 8.3 12.8 2.4 14.3 0.2 0.0 4.2 0.2 0.4 0.0 3.9 72.9 255.2 1.6 18.8 10.9 0.0 2.7 20.1 48.3 0.2 17.3 6.1 2.0 5.7 5.9 10.0 130.9 0.5 0.0 18.7 0.5 0.0 3.2 5.3 557.6 15.5 1.0 3.6 5.6 1.0 23.7 0.0 10.6 2.1 89.2 0.0 11.7 0.7 11.9 0.0 0.4 0.2 12.9 0.0 34.4 15.6 5.0 8.4 1.4 2.4 0.0 1.5 1.0 0.1 1.7 ITGA4 CD49D ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181538940 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 47.5;lymphoid tissue: 74.8" "Group enriched" "Detected in many" 4 "B-cells: 86.3;dendritic cells: 151.5;Erythroid cells: 169.3;Macrophages: 72.0;monocytes: 73.8;NK-cells: 126.7;Plasma cells: 141.6;T-cells: 129.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 164.0;HEL: 308.1;JURKAT: 142.3;MOLT-4: 373.6" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 12.9" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" NA NA 120000 "Plasma membrane" "HPA074961: AB_2732273" "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favorable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.3 2.3 1.2 31.8 0.6 47.5 3.8 4.1 1.5 12.8 3.5 8.7 8.8 3.3 1.4 2.3 1.5 9.8 1.5 3.7 1.1 2.7 5.7 12.8 37.5 1.0 1.8 0.6 1.4 1.5 0.9 0.4 14.8 1.9 3.5 10.4 8.7 3.0 2.5 0.7 1.2 11.8 5.3 1.4 45.9 10.5 0.8 2.1 74.8 2.1 0.9 26.3 9.6 1.4 1.2 0.3 1.3 4.6 0.1 38.9 55.0 0.0 42.3 46.7 19.5 42.0 0.0 0.0 32.4 0.2 164.0 17.4 23.4 14.0 0.7 22.3 0.0 3.4 308.1 1.1 0.0 4.0 123.4 6.8 39.2 0.0 1.2 0.0 20.5 2.3 142.3 0.1 45.5 12.7 0.0 373.6 117.9 3.7 0.0 0.2 78.1 20.3 5.1 0.0 0.0 8.2 2.6 0.1 0.4 1.4 1.6 0.0 82.9 23.2 6.5 4.1 0.7 8.5 90.9 77.5 18.6 3.7 59.5 90.3 29.5 55.0 137.4 42.0 131.3 32.1 37.3 46.9 52.4 66.0 33.0 26.5 33.1 7.1 32.2 139.6 17.5 13.4 65.2 1.2 0.6 4.1 1.5 3.7 1.1 1.0 1.8 0.6 1.9 1.4 2.1 1.2 2.8 0.0 6.7 0.0 86.3 0.3 0.2 1.2 0.0 2.3 1.1 1.4 1.2 2.8 1.8 0.0 6.2 0.1 151.5 0.1 0.0 0.0 0.0 4.4 6.5 1.4 0.0 169.3 9.4 0.0 0.3 6.3 7.1 6.4 18.9 0.3 1.8 0.2 5.9 0.0 0.5 0.1 0.0 24.5 4.4 0.0 0.6 72.0 0.0 7.5 73.8 0.2 126.7 15.6 0.3 0.0 0.4 0.0 141.6 0.3 0.0 0.2 0.8 6.4 0.0 0.7 8.3 0.7 1.2 0.3 0.6 0.4 129.9 0.4 0.2 0.2 PSMD14 "pad1, POH1, Rpn11" ENSG00000115233 "Proteasome 26S subunit, non-ATPase 14" O00487 2 161308425-161411717 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002114, HPA003828" Approved Supported Nucleoplasm NA NA 26000 Nucleoplasm "HPA002114: AB_1855850, HPA003828: AB_2667057" "unprognostic (3.50e-3)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (6.63e-2)" "unprognostic (2.57e-1)" "unprognostic (7.61e-3)" "prognostic unfavorable (2.66e-8)" "unprognostic (3.11e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-3)" "unprognostic (9.84e-3)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.10e-6)" "unprognostic (2.86e-2)" "unprognostic (4.70e-2)" "unprognostic (3.54e-1)" "unprognostic (1.66e-1)" 35.6 38.7 42.5 40.0 43.5 39.1 36.8 45.7 47.9 26.4 40.4 35.5 29.4 24.9 30.3 41.0 27.5 23.9 45.0 44.4 46.3 44.8 48.8 27.1 38.1 45.5 45.7 42.0 14.6 25.9 51.6 21.6 42.4 46.2 31.2 41.4 38.2 21.0 30.2 98.8 33.4 26.6 40.0 48.1 23.1 27.4 39.0 44.9 50.2 35.0 76.6 52.4 42.9 19.7 50.3 170.3 145.8 158.8 140.8 113.9 97.0 194.2 173.6 168.2 246.1 198.6 216.2 140.2 200.2 258.0 128.7 144.3 126.5 176.8 185.6 244.6 210.3 133.1 200.8 110.8 245.9 139.7 196.7 113.8 74.4 138.8 277.4 256.8 94.0 185.5 117.1 222.1 139.6 207.7 164.1 145.0 148.0 220.5 124.3 218.2 123.6 154.4 196.0 218.6 145.0 138.4 101.3 117.8 131.7 167.5 131.4 90.2 124.3 147.2 162.7 152.4 111.6 193.8 82.5 242.7 186.7 174.1 129.6 182.2 47.4 48.2 25.2 65.3 69.6 68.7 64.2 69.4 71.0 75.4 57.4 55.4 66.5 4.9 70.2 56.2 74.5 83.7 73.3 42.5 43.5 45.7 47.9 44.4 46.3 45.5 45.7 42.0 46.2 48.1 44.9 50.3 40.1 51.3 38.2 35.3 49.4 49.5 48.1 146.8 25.0 43.7 40.2 36.2 89.8 52.9 80.3 23.9 18.8 159.5 60.4 47.7 90.1 124.3 82.5 52.4 51.8 49.9 52.5 56.2 64.0 118.3 154.6 48.1 29.6 58.4 51.2 59.0 31.8 125.3 104.7 47.1 56.1 53.5 118.0 41.1 40.0 36.0 27.7 46.1 48.0 25.3 61.1 87.7 44.3 50.3 64.6 155.0 48.0 34.3 60.2 57.0 36.5 106.1 55.4 60.6 32.9 36.6 64.5 137.0 77.7 34.3 56.0 220.3 47.8 63.6 64.5 50.8 SNX17 KIAA0064 ENSG00000115234 "Sorting nexin 17" Q15036 2 27370496-27377535 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043867 Supported Enhanced Vesicles,Cytosol No No Vesicles Cytosol "HPA043867: AB_10961129" "unprognostic (2.57e-1)" "unprognostic (7.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.06e-3)" "unprognostic (1.86e-1)" "unprognostic (4.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.20e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-1)" "unprognostic (6.32e-3)" 62.0 75.2 30.8 23.3 30.6 20.0 57.5 33.6 30.7 59.6 29.2 56.3 17.5 63.3 16.7 62.7 58.2 22.3 57.5 28.9 33.2 54.9 63.4 54.2 32.5 32.7 31.5 27.3 62.9 54.3 42.9 61.5 28.4 35.4 54.7 23.5 12.9 50.7 31.9 49.6 56.3 53.7 33.7 35.1 81.4 54.5 34.4 33.2 44.3 54.8 34.2 34.1 60.3 51.3 35.4 40.1 70.0 45.3 56.4 85.9 71.5 29.0 47.3 85.2 71.8 52.2 43.5 37.8 39.5 55.4 113.9 61.9 23.7 42.4 63.8 57.9 40.7 72.5 44.8 20.3 55.4 80.9 47.6 41.6 66.9 56.7 49.6 59.5 54.1 78.3 32.7 35.5 32.8 87.2 47.7 50.2 31.3 29.2 62.5 67.1 22.7 74.0 64.9 53.5 34.1 46.3 55.1 38.6 39.0 18.1 31.9 30.5 29.6 50.6 57.4 31.6 33.8 45.5 56.8 47.5 49.4 50.0 49.8 60.9 87.5 138.7 88.9 65.6 135.2 66.9 72.7 61.2 67.6 135.6 73.2 57.5 60.6 30.8 72.2 146.9 73.8 78.5 231.9 30.8 30.6 33.6 30.7 28.9 33.2 32.7 31.5 27.3 35.4 35.1 33.2 35.4 60.8 16.0 39.1 6.5 68.3 32.5 48.2 78.3 32.5 30.9 47.1 61.3 31.5 35.8 43.3 29.5 14.6 173.5 69.3 56.9 82.2 84.0 8.9 34.4 39.9 52.7 55.1 49.2 6.8 63.9 132.7 60.3 35.2 25.6 43.1 64.5 47.5 64.9 134.9 45.4 7.7 48.3 79.3 118.1 42.7 9.7 58.4 83.4 69.4 2.8 141.9 80.1 76.2 11.1 11.2 64.8 54.1 85.0 60.3 41.4 75.4 95.3 38.6 23.2 32.9 41.4 68.4 58.0 53.2 55.0 34.4 99.6 63.2 102.1 60.0 34.9 ASB3 ASB-3 ENSG00000115239 "Ankyrin repeat and SOCS box containing 3" Q9Y575 2 53532672-53860160 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003940 Uncertain NA NA "HPA003940: AB_1845067" "unprognostic (8.32e-2)" "unprognostic (3.42e-2)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (1.64e-4)" "unprognostic (5.45e-5)" "unprognostic (6.73e-2)" "unprognostic (2.57e-1)" "unprognostic (2.07e-1)" "unprognostic (4.82e-1)" "unprognostic (1.43e-5)" "unprognostic (3.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.05e-2)" "unprognostic (1.82e-1)" 8.3 11.6 27.8 8.3 30.7 15.1 10.4 32.7 34.0 10.3 13.8 7.5 6.7 11.5 14.1 8.5 9.6 7.9 9.6 28.4 24.2 9.1 10.9 10.1 11.0 22.4 22.8 28.3 12.4 7.5 10.4 14.7 11.6 24.4 13.1 8.1 23.6 8.9 10.3 7.2 9.7 8.6 8.2 15.6 12.8 7.1 11.6 21.5 17.4 11.7 7.7 12.3 7.9 9.9 31.8 15.4 12.5 26.8 10.6 17.6 14.7 23.0 16.3 11.5 12.2 15.2 10.8 10.9 14.5 26.1 11.6 22.6 9.4 19.6 12.1 18.0 29.0 17.6 16.0 16.2 21.2 13.7 20.7 12.2 12.3 8.0 11.4 22.4 21.1 15.1 18.9 17.6 17.9 18.1 9.9 23.4 27.3 20.7 14.3 10.8 21.5 20.2 11.9 13.9 12.8 19.1 15.0 18.8 17.4 15.3 23.2 6.8 11.4 13.9 19.0 11.3 15.1 18.8 26.4 13.3 8.1 16.3 15.5 16.3 16.6 6.9 12.9 9.0 6.6 12.7 12.2 10.4 10.2 7.5 10.4 11.1 11.1 5.0 11.2 7.5 6.2 11.6 6.8 27.8 30.7 32.7 34.0 28.4 24.2 22.4 22.8 28.3 24.4 15.6 21.5 31.8 5.9 25.6 23.2 16.3 14.4 0.0 6.3 0.0 12.5 16.1 5.1 6.1 0.0 5.7 14.9 1.8 4.2 11.6 6.4 1.5 0.0 4.8 5.0 6.6 7.2 6.0 1.2 9.0 3.6 2.7 10.0 9.1 7.1 3.1 16.4 5.5 4.6 4.4 4.6 3.3 3.1 3.6 0.0 5.7 0.0 2.5 9.6 5.9 0.0 3.7 4.0 10.1 9.2 26.7 3.5 4.4 1.5 9.8 18.9 3.2 3.3 3.9 12.4 10.3 6.6 6.5 5.7 16.8 14.5 8.9 0.0 7.7 11.3 6.5 3.0 3.4 PPM1G "PP2CG, PP2Cgamma" ENSG00000115241 "Protein phosphatase, Mg2+/Mn2+ dependent 1G" O15355 2 27381195-27409591 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 235.8" "Cell type enhanced" "Detected in all" "Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035530, HPA035531" Enhanced Enhanced Nucleoplasm NA NA 19000 Nucleoplasm "HPA035530: AB_10670021, HPA035531: AB_10610283" "unprognostic (7.50e-2)" "unprognostic (8.89e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (2.27e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (3.14e-7)" "unprognostic (9.36e-3)" "unprognostic (7.73e-2)" "prognostic favorable (6.08e-5)" "unprognostic (3.74e-2)" "unprognostic (1.23e-1)" "unprognostic (7.46e-3)" "unprognostic (1.06e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (7.83e-2)" 45.1 50.0 36.1 45.5 36.0 74.2 44.0 36.8 38.1 37.5 37.3 48.7 40.3 46.0 26.4 63.1 39.4 28.2 40.4 35.7 37.9 36.5 45.7 41.0 60.0 36.9 35.5 35.0 35.2 53.4 41.8 43.8 37.9 36.3 36.3 51.8 20.2 45.5 39.2 96.5 41.1 43.4 45.3 36.1 47.5 48.2 235.8 37.6 65.5 37.1 53.4 76.0 47.5 39.9 36.4 302.0 243.1 174.0 134.8 108.7 88.0 160.6 182.8 119.8 214.8 170.9 377.7 154.4 352.7 130.9 130.9 181.8 160.3 296.4 205.6 191.4 148.4 241.1 343.6 172.9 404.0 97.9 343.5 139.2 95.7 116.9 219.2 175.1 101.7 209.1 171.1 293.3 106.0 165.5 269.4 256.7 370.5 254.1 207.1 173.1 261.1 365.0 185.3 145.9 206.4 233.2 264.0 164.4 178.9 135.9 137.4 99.4 111.3 169.5 159.3 192.6 141.6 281.8 229.0 277.0 545.5 124.8 275.6 122.5 67.3 41.5 59.0 57.5 52.3 56.8 44.7 61.1 60.3 65.4 37.9 45.1 47.4 20.9 55.0 71.4 91.9 88.9 48.0 36.1 36.0 36.8 38.1 35.7 37.9 36.9 35.5 35.0 36.3 36.1 37.6 36.4 72.9 64.1 51.3 9.8 76.7 81.1 88.7 71.9 83.6 40.8 63.1 59.3 37.9 52.9 63.7 69.9 29.2 93.9 114.2 81.0 33.2 135.7 1540.4 102.7 75.8 80.8 80.7 119.6 19.5 139.3 163.8 56.6 69.3 89.8 59.1 76.1 40.4 44.7 85.4 48.8 21.1 78.9 54.9 59.7 75.7 3492.8 70.2 68.2 24.9 17.8 127.3 69.7 112.3 17.1 15.9 156.7 52.7 71.1 137.8 152.1 52.6 61.4 61.8 41.7 46.0 54.9 80.5 793.3 298.9 108.7 80.6 53.1 89.7 123.7 106.4 122.6 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.1;thyroid gland: 46.2" "Cell type enhanced" "Detected in many" "Early spermatids: 396.3;Excitatory neurons: 764.9;Late spermatids: 592.1;Oligodendrocytes: 1178.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 37.2;HHSteC: 22.0;HSkMC: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 9.7 4.4 14.7 4.6 20.9 0.0 5.0 38.1 23.4 15.5 5.4 9.0 3.0 8.8 8.1 5.6 10.4 24.0 15.7 27.3 12.0 47.1 3.9 3.6 2.1 8.2 9.5 18.6 11.0 2.1 2.2 2.7 1.2 12.9 3.6 6.7 1.4 2.1 5.5 2.8 1.8 5.8 13.0 5.4 3.2 5.6 35.9 15.9 8.4 46.2 5.0 0.9 9.8 9.9 19.3 0.0 0.2 3.9 0.0 37.2 3.1 0.1 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 4.7 0.0 5.1 0.0 22.0 0.0 0.0 47.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.5 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.7 0.0 5.4 0.1 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.7 20.9 38.1 23.4 27.3 12.0 8.2 9.5 18.6 12.9 5.4 15.9 19.3 6.7 0.0 2.6 15.3 0.0 1.3 2.0 0.1 8.0 20.0 0.3 0.3 5.9 1.5 1.4 27.6 0.0 0.1 0.0 0.1 185.9 0.5 396.3 0.3 0.4 8.9 0.0 0.0 764.9 0.4 0.0 18.6 0.0 0.8 0.0 0.1 5.0 0.0 0.1 0.0 185.8 1.0 0.0 0.0 1.8 592.1 14.9 0.4 0.0 30.0 0.0 0.3 0.0 18.1 1178.0 0.2 0.1 8.2 0.2 2.6 0.1 1.5 0.0 1.2 52.6 21.0 45.1 9.1 4.9 1.0 1.3 0.0 0.2 7.6 0.1 0.7 REEP6 "C19orf32, DP1L1, FLJ25383, Yip2f" ENSG00000115255 "Receptor accessory protein 6" Q96HR9 19 1491166-1497927 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 219.4;liver: 401.3;testis: 286.1" "Cell type enhanced" "Detected in many" "Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7" "Cancer enhanced" "Detected in all" "liver cancer: 114.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4" "HPA003895, HPA048015" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA048015: AB_2680233" "unprognostic (1.21e-1)" "unprognostic (1.56e-1)" "unprognostic (7.76e-2)" "unprognostic (1.63e-3)" "unprognostic (3.24e-1)" "unprognostic (2.43e-2)" "unprognostic (1.92e-1)" "unprognostic (6.85e-2)" "unprognostic (7.38e-2)" "unprognostic (4.56e-1)" "unprognostic (1.49e-1)" "unprognostic (1.93e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-1)" "unprognostic (8.08e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-2)" 8.5 87.3 8.9 1.3 9.4 1.2 17.7 8.0 18.2 4.4 4.9 3.0 219.4 3.5 14.7 14.4 4.6 7.0 3.0 10.2 11.1 21.7 401.3 1.6 1.4 8.8 7.6 7.4 7.7 28.7 2.0 9.9 1.6 9.2 20.3 1.7 94.8 18.1 6.9 2.0 8.2 201.3 0.9 5.6 1.7 4.2 286.1 9.5 0.7 6.0 0.7 1.0 9.2 7.0 8.9 7.3 9.2 2.6 34.3 5.6 2.0 39.5 1.8 0.7 1.9 1.9 57.9 22.5 3.9 12.2 1.1 2.3 7.3 9.8 0.6 1.0 1.9 4.1 21.3 1.3 56.2 4.2 1.6 6.6 4.7 4.1 0.4 1.4 3.2 1.1 4.9 155.7 5.0 0.3 29.6 1.8 4.7 12.8 21.1 19.5 4.9 1.1 10.0 10.9 2.7 0.7 17.2 9.8 14.2 6.3 1.9 121.4 5.7 3.4 2.8 5.4 8.7 1.2 16.4 5.3 0.8 11.2 9.4 8.2 0.0 1.1 0.0 5.5 1.2 2.8 0.1 1.4 1.2 1.9 0.6 2.0 2.2 0.0 4.9 4.3 3.3 1.6 1.6 8.9 9.4 8.0 18.2 10.2 11.1 8.8 7.6 7.4 9.2 5.6 9.5 8.9 1.5 3.2 3.2 2.6 2.7 6.8 7.9 6.8 10.8 30.4 47.4 20.3 1.8 91.5 10.5 5.5 33.3 69.4 2.5 7.8 7.9 34.5 559.1 4.5 7.1 4.2 6.0 10.1 1.5 69.2 12.8 4.7 2.6 3.0 10.2 132.9 5.0 267.4 9.6 23.5 1.2 51.9 4.1 6.3 4.3 3135.0 34.2 4.1 30.2 0.0 1.7 44.2 2.1 0.0 1.5 25.0 53.6 16.6 1.9 13.1 898.7 52.0 8.3 292.8 19.7 0.8 3.3 29.9 36.5 17.5 6.7 36.0 4.3 50.1 70.7 14.7 PCSK4 "DKFZp434B217, MGC34749, PC4, SPC5" ENSG00000115257 "Proprotein convertase subtilisin/kexin type 4" Q6UW60 19 1481428-1490752 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 66.5" "Group enriched" "Detected in many" 4 "Early spermatids: 277.1;Late spermatids: 679.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.7;HMC-1: 3.7;JURKAT: 5.3;U-266/70: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA005572 Uncertain NA NA "HPA005572: AB_1855087" "unprognostic (1.00e-2)" "unprognostic (9.12e-2)" "unprognostic (2.36e-3)" "prognostic favorable (9.45e-5)" "unprognostic (5.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.78e-1)" "unprognostic (6.34e-3)" "unprognostic (2.94e-1)" "unprognostic (8.29e-3)" "unprognostic (1.93e-2)" "unprognostic (7.44e-2)" "unprognostic (6.56e-2)" "unprognostic (3.82e-2)" "unprognostic (1.71e-2)" "unprognostic (3.57e-2)" "unprognostic (7.03e-2)" 0.6 1.4 1.6 0.3 0.9 0.6 1.2 1.0 2.5 1.6 0.9 1.3 1.8 1.1 0.1 1.1 3.2 0.6 0.5 0.9 1.5 3.1 4.0 1.1 0.3 1.2 2.0 0.7 1.1 2.8 0.9 7.1 0.2 1.2 1.8 0.1 0.6 1.1 1.2 0.3 0.6 1.1 0.1 1.7 0.7 1.4 66.5 1.1 0.4 3.5 0.0 0.1 1.0 1.2 0.9 0.6 0.3 1.2 6.7 0.1 0.2 1.8 0.5 0.1 0.0 0.2 0.6 1.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.1 0.3 1.1 1.0 0.4 0.0 3.7 0.6 0.0 0.0 0.1 0.3 0.2 5.3 1.2 1.8 0.0 0.0 0.1 0.3 0.1 0.3 0.4 1.2 0.1 0.1 0.4 0.0 0.0 1.4 0.1 0.3 0.1 0.4 2.5 0.4 0.0 0.5 0.0 0.1 0.0 7.7 1.5 0.3 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.9 1.0 2.5 0.9 1.5 1.2 2.0 0.7 1.2 1.7 1.1 0.9 0.2 0.0 1.1 12.1 0.1 0.6 0.9 1.8 0.6 1.5 3.1 2.2 2.3 1.5 3.6 0.0 8.4 0.5 1.7 1.6 5.9 1.8 277.1 5.2 1.0 0.5 0.0 1.7 3.2 1.0 0.5 0.8 3.1 1.1 0.0 3.3 0.0 3.2 0.8 3.3 3.7 1.4 0.0 0.3 0.0 679.2 6.2 1.1 3.6 3.7 0.0 2.4 0.0 1.0 1.6 0.9 1.1 5.3 1.4 0.5 2.8 1.9 8.3 9.1 0.0 0.2 0.5 98.0 9.6 1.2 0.0 0.3 0.7 2.4 2.1 0.7 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142882-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "pancreas: 1959.8" "Cell type enriched" "Detected in some" 23 "Enteroendocrine cells: 5457.0" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Group enriched" "Detected in some" 27 "basal ganglia: 2.3;medulla oblongata: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5" "Region enriched" "Detected in single" 10 "pons and medulla: 3.5" "Region enriched" "Detected in some" 5 "spinal cord: 13.7" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" NA NA 127000 420000 "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 20.5 0.1 0.0 3.1 2.3 20.2 0.0 0.0 0.0 0.0 0.0 85.2 3.5 0.6 0.0 5.3 0.0 4.2 2.5 0.0 0.0 42.3 0.0 0.2 3.6 4.6 0.0 0.0 0.1 1959.8 0.0 0.0 0.1 0.0 0.8 153.3 0.0 0.3 0.0 0.0 37.5 131.3 0.8 0.0 0.2 41.6 0.0 0.1 0.4 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.4 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 186.8 0.2 12.1 0.0 5.6 44.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.2 0.0 0.0 0.3 0.1 5457.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 230.9 8.5 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.9 0.0 APC2 APCL ENSG00000115266 "APC regulator of WNT signaling pathway 2" O95996 19 1446302-1473244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 64.2" "Cell type enhanced" "Detected in some" "Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" Yes No "Cytokinetic bridge, Midbody" Cytosol "HPA078002: AB_2686874" "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 0.1 2.4 41.2 0.0 28.7 0.0 0.0 43.9 43.5 0.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.2 37.4 18.3 0.0 0.0 0.0 0.0 64.2 39.6 24.6 0.0 0.3 0.0 6.3 0.0 56.7 0.1 0.0 2.8 0.2 0.0 0.2 0.1 0.4 0.1 37.6 0.0 0.3 1.0 51.1 0.0 0.1 0.0 0.0 0.1 0.2 51.4 0.2 0.6 7.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.0 0.0 9.3 31.7 1.1 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.6 0.1 0.1 1.7 0.5 0.2 0.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 28.7 43.9 43.5 37.4 18.3 64.2 39.6 24.6 56.7 37.6 51.1 51.4 0.3 0.0 0.0 142.4 0.3 0.0 0.2 0.2 1.2 50.4 0.4 0.4 3.4 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.5 0.5 0.5 0.0 0.0 26.8 0.0 0.1 0.3 0.0 0.6 0.0 0.2 0.0 0.0 0.1 45.4 27.5 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 3.7 0.0 29.4 2.1 28.1 17.8 0.0 0.0 0.7 0.0 0.1 0.2 0.2 0.0 11.1 0.0 0.6 0.4 0.4 0.7 2.4 0.0 0.0 0.3 0.2 0.1 0.2 IFIH1 "Hlcd, IDDM19, MDA-5, MDA5" ENSG00000115267 "Interferon induced with helicase C domain 1" Q9BYX4 2 162267074-162318684 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.4" "Cell type enhanced" "Detected in many" "Early spermatids: 55.6;Late spermatids: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 62.3;BJ hTERT+ SV40 Large T+ RasG12V: 71.5;Karpas-707: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002656 Approved NA NA "HPA002656: AB_1079344" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (5.51e-2)" "unprognostic (3.85e-3)" "unprognostic (3.34e-1)" "unprognostic (1.39e-1)" "unprognostic (5.65e-2)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.62e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.41e-2)" "unprognostic (7.29e-2)" 6.1 6.5 4.6 12.8 4.1 38.4 6.0 3.5 3.1 5.3 5.2 7.5 13.3 6.5 4.3 7.6 7.3 9.6 5.1 2.2 4.5 5.5 8.6 10.9 11.8 5.8 3.4 1.4 7.0 7.1 8.2 5.9 8.3 4.2 5.5 6.9 1.1 17.7 4.7 1.7 5.0 10.1 5.8 4.0 16.5 9.7 2.4 4.8 11.0 6.1 3.2 9.8 6.4 5.3 9.2 6.7 0.3 0.2 0.0 7.4 6.0 2.8 1.2 17.7 62.3 71.5 1.2 16.7 13.3 10.5 1.0 31.9 8.5 1.1 9.8 6.3 35.4 4.5 7.1 0.8 2.8 5.0 8.2 6.4 5.3 4.8 8.9 1.7 6.5 4.9 6.9 0.3 38.9 1.0 12.5 9.3 6.4 0.0 5.4 3.8 7.5 0.0 18.8 5.9 7.3 0.4 0.1 3.7 20.7 34.0 0.3 5.7 7.1 4.1 1.9 1.7 1.1 2.7 15.2 26.8 1.9 3.5 6.5 5.6 4.4 11.5 4.4 6.6 12.5 9.2 12.4 8.2 7.2 11.1 12.8 6.7 6.9 15.2 4.0 12.7 1.6 10.3 7.8 4.6 4.1 3.5 3.1 2.2 4.5 5.8 3.4 1.4 4.2 4.0 4.8 9.2 24.7 32.1 12.0 4.6 20.1 6.8 11.2 7.7 6.2 0.0 4.8 5.2 5.0 12.8 11.1 7.3 0.0 6.4 10.2 10.9 5.9 18.7 55.6 17.3 7.9 22.3 15.7 8.2 2.8 18.7 17.5 8.8 10.7 20.2 13.3 10.4 13.6 6.5 14.4 0.0 0.7 11.5 8.2 12.8 8.7 53.3 13.7 20.0 5.4 28.1 23.9 7.3 10.3 0.5 4.0 13.4 10.1 13.2 16.0 9.1 11.8 4.8 17.5 0.1 0.0 10.9 4.9 1.6 1.3 10.2 5.8 3.4 13.1 6.9 6.7 11.1 RPS15 "MGC111130, RIG, S15" ENSG00000115268 "Ribosomal protein S15" P62841 19 1438358-1440495 "Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054510, HPA057793" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 460000 "Endoplasmic reticulum, Cytosol" "HPA054510: AB_2682510, HPA057793: AB_2683528" "unprognostic (4.47e-3)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.08e-3)" "unprognostic (5.98e-2)" "unprognostic (2.05e-1)" "unprognostic (4.33e-3)" "unprognostic (4.42e-2)" "unprognostic (2.58e-1)" "unprognostic (2.73e-2)" "unprognostic (3.28e-2)" "unprognostic (5.00e-2)" "unprognostic (1.44e-3)" "unprognostic (5.21e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.61e-2)" 1444.5 1263.4 962.7 599.9 960.9 1210.9 1560.7 922.4 1406.1 1644.3 884.6 1367.3 570.3 1215.7 340.5 1887.3 1427.9 167.8 1186.3 888.3 967.3 1229.3 1115.2 1034.5 711.6 957.8 914.9 857.1 2740.1 2350.3 412.7 1325.9 349.2 966.1 1679.1 301.0 236.7 1392.4 400.1 1856.9 2545.0 1260.6 285.6 1000.2 1536.2 1361.2 481.6 999.9 655.2 1112.2 599.5 605.6 1327.9 1736.0 979.3 1863.6 1949.4 837.1 1144.5 771.7 1118.2 1433.0 948.7 754.2 1116.7 871.3 3150.8 639.1 2285.2 829.1 618.8 394.6 1156.9 825.1 1177.6 426.5 1914.8 4301.3 748.4 1695.6 3041.6 811.7 1925.8 1374.1 1376.2 1406.1 757.0 737.2 1077.8 988.8 2049.0 1550.5 3197.1 703.7 3284.2 1608.3 2585.9 1887.0 1480.4 2481.0 1646.7 996.2 3053.8 1040.3 2026.5 1343.5 1589.3 801.9 1364.7 2927.8 442.0 1044.2 2555.0 1017.1 939.2 1077.7 1889.0 2131.4 2749.8 2994.2 2300.7 930.5 1737.0 1099.9 1348.7 2387.0 1017.0 2368.1 2005.8 3279.4 5335.9 3615.4 2988.4 3232.2 4867.3 4338.2 3612.2 457.2 2451.1 1592.7 2680.6 3662.4 7245.4 962.7 960.9 922.4 1406.1 888.3 967.3 957.8 914.9 857.1 966.1 1000.2 999.9 979.3 2203.3 910.2 1539.7 53.8 4976.8 9160.6 6537.1 4454.9 5021.3 436.1 7563.8 10700.9 365.8 2203.3 2335.6 1533.8 175.2 3985.2 3071.1 1757.4 3887.6 2275.1 984.8 1187.0 2584.3 2724.2 1811.8 2836.0 34.2 5298.7 6326.9 2621.6 1808.4 1631.3 1777.8 3650.4 3121.2 3161.6 3741.9 153.1 40.3 4148.0 1395.6 4863.0 7853.2 3297.3 3973.6 3101.3 4637.0 35.6 4562.7 1951.5 3042.3 20.1 73.6 3575.5 3343.2 2100.7 3087.8 6046.3 4380.3 5701.1 1076.4 622.3 1341.1 3160.4 2955.8 681.9 901.2 5781.9 12628.8 3849.3 4291.2 2492.1 4237.1 6173.2 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 329.0" "Cell type enhanced" "Detected in all" "Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 327.4;neutrophil: 864.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 864.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 1300000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 30.8 13.6 19.3 63.2 25.7 329.0 17.8 23.2 28.7 12.3 17.2 18.2 19.5 9.9 24.8 11.0 16.3 23.2 9.8 19.9 23.4 18.0 15.2 26.8 33.3 27.8 24.8 19.5 8.6 16.7 10.5 8.3 25.4 27.2 12.3 19.8 10.7 12.4 9.8 2.7 7.1 18.8 19.0 24.6 70.7 25.3 24.3 23.4 18.6 17.2 15.0 25.6 26.3 5.8 41.4 2.6 4.2 10.7 0.0 2.5 2.2 0.4 4.0 11.1 6.2 11.1 8.7 30.6 3.7 27.0 0.3 14.2 1.6 4.1 12.7 7.7 17.1 16.8 33.5 2.9 17.7 3.0 41.6 9.1 2.8 4.3 5.7 1.2 15.8 0.9 25.9 0.6 12.1 0.5 33.0 0.9 24.2 6.5 22.5 16.4 14.2 2.7 18.5 32.7 18.6 6.9 12.0 5.1 23.3 19.7 12.5 15.8 17.7 0.8 1.6 11.2 17.8 6.2 11.5 23.2 0.6 9.2 15.8 7.7 38.8 132.4 327.4 2.7 78.4 3.5 21.6 4.8 4.8 63.2 21.1 8.1 5.0 864.2 2.5 63.3 17.2 10.2 71.4 19.3 25.7 23.2 28.7 19.9 23.4 27.8 24.8 19.5 27.2 24.6 23.4 41.4 28.8 16.0 36.5 10.1 54.5 15.4 28.2 19.6 12.5 10.2 32.6 16.4 4.1 50.1 21.2 33.1 2.1 55.5 17.3 14.4 76.3 49.5 185.0 21.1 9.1 26.4 39.4 36.1 25.9 60.5 20.8 14.4 43.8 24.9 44.9 13.6 48.9 15.0 107.9 11.8 15.4 29.9 32.6 183.3 60.5 32.8 10.8 153.5 16.0 17.8 228.5 21.1 10.3 1.0 98.0 36.5 25.7 6.4 23.4 24.3 18.4 69.7 24.7 4.4 6.6 12.2 18.3 52.6 13.5 15.1 18.2 46.9 16.3 16.7 28.9 21.0 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455087-74457944 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA070644, HPA078274" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA Nucleoplasm "Nucleoli, Nuclear bodies" "HPA070644: AB_2732159, HPA078274: " "prognostic favorable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.56e-5)" "prognostic favorable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 25.2 30.7 19.6 18.2 19.3 20.8 29.3 16.4 27.8 38.1 15.1 22.9 19.6 30.7 17.2 31.4 31.8 15.2 19.9 19.0 15.0 27.2 32.3 26.2 19.1 18.2 17.0 17.6 48.5 42.3 19.8 42.4 11.7 20.0 35.0 12.4 18.9 30.1 18.1 30.3 39.8 24.1 14.9 13.9 24.7 33.0 31.2 15.5 13.0 39.6 9.2 20.2 27.3 32.5 20.4 27.8 29.0 11.0 14.2 21.0 29.6 28.2 25.7 23.0 19.4 16.3 19.9 34.4 46.7 32.2 18.8 18.2 29.1 9.1 20.4 15.8 42.5 28.8 35.9 14.5 20.5 22.4 33.9 17.2 29.5 35.0 27.8 31.2 48.4 26.2 27.4 20.7 18.5 16.5 32.7 44.3 47.7 7.7 20.2 39.7 26.3 34.9 47.4 23.5 18.9 16.7 31.8 13.5 37.3 15.4 12.1 16.1 11.6 22.1 17.7 27.9 29.7 20.0 65.8 48.4 16.9 33.3 21.3 18.9 3.2 2.5 1.0 1.2 1.9 1.6 2.6 1.4 0.7 1.6 2.1 1.2 1.1 3.2 2.1 1.7 3.2 2.2 0.9 19.6 19.3 16.4 27.8 19.0 15.0 18.2 17.0 17.6 20.0 13.9 15.5 20.4 4.4 0.0 2.2 0.0 5.4 28.0 2.8 8.5 2.2 14.0 11.3 6.0 0.9 4.3 6.8 3.7 12.5 4.3 7.1 5.8 0.0 15.9 3.0 6.5 5.7 5.4 4.8 9.3 0.0 27.0 4.7 3.4 2.6 3.8 5.7 2.4 6.8 10.8 5.6 13.5 0.0 7.9 12.2 9.7 21.0 6.5 3.1 4.3 5.4 0.0 12.5 4.7 9.2 0.0 0.0 17.4 3.3 3.0 5.1 2.2 11.6 6.5 12.3 15.0 0.0 2.1 4.9 5.6 1.9 3.3 31.7 5.3 7.5 2.2 6.7 2.0 MOGS "CWH41, DER7, GCS1" ENSG00000115275 "Mannosyl-oligosaccharide glucosidase" Q13724 2 74461057-74465410 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 222.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011322, HPA011969" Approved Supported "Endoplasmic reticulum" NA NA 1500000 "Endoplasmic reticulum" "HPA011322: AB_2668483, HPA011969: AB_1849579" "unprognostic (5.66e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.34e-6)" "unprognostic (1.48e-2)" "unprognostic (2.66e-2)" "unprognostic (3.32e-2)" "unprognostic (6.21e-2)" "unprognostic (4.36e-1)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.40e-2)" "unprognostic (3.06e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" 18.4 18.4 8.1 20.3 8.2 8.6 18.8 8.4 13.4 18.5 8.7 20.2 42.1 18.4 5.6 22.7 20.2 14.5 16.4 7.7 8.3 20.9 34.6 25.1 21.8 8.4 8.0 7.5 18.7 42.7 21.6 21.9 34.8 9.2 23.5 13.5 9.7 31.4 14.8 21.4 25.1 29.9 11.5 8.7 31.9 35.8 19.2 8.5 20.0 22.1 16.3 18.3 20.3 19.3 9.7 53.1 46.2 23.5 29.6 55.3 38.9 90.1 38.7 58.3 59.8 58.2 81.9 58.7 45.2 34.9 36.3 46.7 50.6 40.2 43.3 32.5 46.7 39.9 20.3 14.4 68.6 54.9 49.8 46.6 25.6 77.1 41.9 39.0 62.2 68.4 27.8 39.6 51.6 28.5 58.8 32.3 62.0 42.6 64.1 22.5 35.5 57.4 74.1 38.0 19.5 19.7 29.2 15.5 84.8 62.7 21.8 38.7 34.3 40.1 26.5 49.7 36.3 56.5 66.5 36.5 22.7 46.9 49.3 39.0 6.7 2.4 1.9 2.6 1.5 3.3 1.2 2.3 2.5 2.1 1.9 1.4 1.6 0.4 8.4 3.3 2.1 3.3 1.7 8.1 8.2 8.4 13.4 7.7 8.3 8.4 8.0 7.5 9.2 8.7 8.5 9.7 13.9 6.4 15.9 16.3 22.0 15.8 21.8 20.8 18.2 14.9 18.9 12.8 8.6 24.3 21.3 23.9 18.8 39.5 34.6 18.7 5.9 21.9 65.6 12.4 12.2 13.3 13.9 16.4 13.9 26.1 50.5 12.3 40.8 17.4 4.5 20.9 17.9 25.6 19.9 6.7 12.1 25.7 20.3 12.9 14.8 222.0 15.2 17.9 10.6 12.2 25.5 7.0 30.9 11.1 10.7 22.3 19.7 7.2 43.6 22.7 37.7 7.4 17.7 14.1 13.1 9.4 12.7 13.0 5.1 15.2 17.3 52.0 21.2 16.5 23.3 19.6 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favorable (2.49e-4)" 6.4 4.8 3.5 8.5 3.9 9.1 4.8 3.6 4.3 5.1 3.9 8.0 11.2 5.9 4.6 6.2 5.9 5.9 4.9 3.4 4.0 6.0 18.9 6.9 9.9 4.4 3.9 3.2 6.4 8.0 9.3 3.2 9.2 4.1 5.3 8.3 4.9 4.7 4.5 3.7 8.9 9.9 7.4 3.9 8.3 7.6 3.2 3.8 9.8 4.9 4.0 10.7 5.8 4.6 4.7 16.0 13.1 11.7 6.3 7.3 17.0 12.9 11.2 11.4 16.2 11.9 11.3 13.0 20.6 6.4 9.5 14.2 11.8 9.5 10.5 11.0 23.0 8.3 22.4 12.9 24.9 11.0 10.1 21.5 11.5 13.7 14.0 9.8 14.3 11.0 12.0 15.0 11.5 12.0 13.7 17.4 9.2 7.6 12.2 7.9 13.7 24.0 11.5 11.5 11.8 5.6 16.5 7.9 12.4 10.2 7.4 9.7 6.2 17.6 12.5 18.7 9.5 12.6 13.6 10.8 14.1 13.5 12.5 11.4 4.9 8.3 6.1 6.5 8.1 7.2 7.0 4.9 6.2 8.1 4.7 4.6 5.4 0.8 6.6 8.7 4.4 7.3 7.4 3.5 3.9 3.6 4.3 3.4 4.0 4.4 3.9 3.2 4.1 3.9 3.8 4.7 5.4 16.0 9.2 7.2 10.8 2.8 4.1 5.2 4.6 11.1 5.2 5.0 3.5 14.3 7.8 9.2 39.6 8.3 9.8 7.8 1.9 5.8 4.6 3.8 8.0 6.7 6.1 13.3 3.0 5.5 5.3 6.0 7.1 5.9 19.0 8.8 4.6 20.8 8.3 5.0 3.4 5.9 6.1 7.9 3.5 5.0 6.2 7.5 3.6 10.3 13.2 9.2 19.6 2.5 4.4 5.9 9.4 5.7 9.6 3.1 13.9 6.0 4.3 23.6 6.6 7.3 5.3 8.3 10.0 4.2 3.3 8.1 9.8 8.2 6.5 3.8 NDUFS7 "CI-20, FLJ45860, FLJ46880, PSST" ENSG00000115286 "NADH:ubiquinone oxidoreductase core subunit S7" O75251 19 1383527-1395589 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 672.2" "Cell type enhanced" "Detected in all" "Distal tubular cells: 812.0;Proximal tubular cells: 774.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.36e-2)" "prognostic favorable (2.03e-4)" "unprognostic (5.30e-2)" "unprognostic (3.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (2.41e-2)" "unprognostic (5.85e-2)" "unprognostic (4.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.99e-3)" "unprognostic (8.12e-2)" "prognostic favorable (4.90e-7)" "unprognostic (2.95e-1)" "unprognostic (2.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.34e-2)" 53.4 51.8 63.4 31.5 74.7 34.1 34.1 94.4 121.6 31.1 63.1 50.3 105.2 31.5 5.3 62.7 29.0 17.8 141.2 56.4 75.4 68.1 68.8 30.5 37.0 87.2 70.2 52.4 31.9 90.4 44.2 50.6 20.0 89.0 34.4 9.9 5.8 76.2 26.5 672.2 36.9 74.4 10.6 82.2 42.2 53.4 59.4 73.9 19.4 32.4 160.8 11.5 37.0 38.0 99.5 127.0 109.3 17.5 77.6 16.0 20.3 68.8 52.0 19.3 39.4 39.0 155.3 52.8 146.2 71.4 13.0 9.7 85.4 17.3 44.1 1.0 157.6 143.2 47.0 113.1 125.7 53.4 76.5 90.1 27.2 47.4 17.7 0.0 13.2 40.2 110.5 103.1 196.6 13.6 130.0 138.6 77.0 67.5 40.8 141.0 144.6 36.3 254.9 23.6 86.9 105.7 89.5 48.5 117.8 158.6 2.1 84.0 118.1 72.3 67.3 49.5 85.5 100.0 326.9 218.4 121.5 110.9 159.0 70.4 176.5 299.0 143.8 166.6 342.4 147.5 249.4 161.6 159.7 354.9 235.6 151.8 146.9 75.6 160.6 308.0 276.8 241.8 193.2 63.4 74.7 94.4 121.6 56.4 75.4 87.2 70.2 52.4 89.0 82.2 73.9 99.5 98.5 80.1 92.5 14.0 117.7 89.9 98.4 275.0 100.2 74.3 116.7 146.0 77.1 158.7 167.0 145.3 50.1 225.2 75.0 482.1 812.0 161.8 443.2 69.2 74.2 88.4 175.4 94.9 13.8 163.3 197.1 92.2 162.1 66.2 111.7 99.4 72.5 243.9 333.4 52.2 15.1 332.9 248.2 188.4 129.7 414.5 83.9 154.6 261.5 7.5 182.1 111.2 111.2 14.6 57.0 121.1 346.7 74.1 155.2 81.0 616.5 774.9 122.4 81.9 72.3 105.0 120.2 268.8 134.9 266.2 106.0 186.8 100.9 128.8 410.8 138.7 PCGF1 "MGC10882, NSPC1, RNF68" ENSG00000115289 "Polycomb group ring finger 1" Q9BSM1 2 74505043-74507695 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011356, HPA069156" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011356: AB_1855063, HPA069156: AB_2686095" "unprognostic (2.41e-1)" "unprognostic (5.97e-2)" "unprognostic (1.11e-3)" "unprognostic (2.71e-2)" "unprognostic (4.25e-2)" "unprognostic (2.73e-2)" "unprognostic (2.32e-2)" "unprognostic (4.18e-3)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.57e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.00e-1)" "unprognostic (5.09e-2)" "unprognostic (1.21e-1)" "unprognostic (2.13e-1)" 10.0 10.5 14.9 8.7 15.2 18.0 15.3 15.8 17.4 13.0 14.4 11.6 11.3 12.6 14.5 9.8 14.5 10.1 12.4 15.2 15.1 11.0 13.1 12.4 14.2 15.2 15.0 14.3 14.9 11.1 17.8 2.4 11.5 15.7 9.4 12.4 18.2 11.1 8.9 12.2 14.9 10.9 11.3 14.6 8.6 11.8 11.1 15.8 14.5 14.3 17.7 14.8 10.8 2.1 16.2 18.9 11.6 12.3 19.0 15.4 19.0 19.0 17.8 23.8 16.2 10.9 25.5 12.8 16.9 7.6 16.5 38.0 11.4 20.7 23.5 14.6 16.3 24.7 12.0 15.7 25.6 24.9 31.7 16.5 25.5 33.3 10.5 57.4 26.0 12.8 21.8 25.0 23.0 17.8 27.8 22.6 42.0 16.3 23.5 12.3 18.0 27.3 14.1 24.8 21.0 14.0 27.8 13.8 27.1 30.1 12.1 10.1 21.4 11.7 26.2 17.5 14.5 24.1 12.5 9.7 18.3 22.1 22.6 16.3 11.1 24.2 10.4 15.5 20.1 18.3 18.1 20.7 19.8 26.9 17.9 16.3 16.8 8.7 14.4 23.3 13.1 24.2 14.2 14.9 15.2 15.8 17.4 15.2 15.1 15.2 15.0 14.3 15.7 14.6 15.8 16.2 7.0 3.2 1.8 2.3 8.7 12.5 9.0 23.8 31.3 5.0 10.5 10.9 3.5 12.8 10.6 3.7 4.2 12.2 6.5 9.5 31.3 11.0 19.0 11.3 11.5 8.5 1.2 10.3 1.7 10.4 19.5 13.1 6.1 10.4 10.2 2.9 7.1 6.2 13.6 5.0 1.6 12.8 18.3 9.9 14.0 4.9 7.8 10.8 7.2 0.0 15.0 6.7 19.6 0.5 2.3 11.3 15.9 4.9 11.4 9.4 14.2 17.5 9.5 9.5 6.6 10.4 14.0 19.3 8.0 24.3 18.9 18.3 9.6 5.0 9.4 8.5 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492417-164621482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 12.7;tongue: 20.5" "Group enriched" "Detected in many" 4 "Distal tubular cells: 92.0;Granulosa cells: 272.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.5;HUVEC TERT2: 9.6;RPTEC TERT1: 9.1;TIME: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: AB_2674432" "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 0.7 3.0 0.2 0.3 0.5 0.0 0.3 0.0 0.8 0.2 0.2 0.6 0.9 0.2 5.5 1.2 0.1 0.1 2.2 1.3 0.1 6.7 12.7 0.4 0.0 0.3 0.3 0.3 2.0 4.7 0.0 0.3 1.7 0.1 0.3 0.3 0.4 0.3 0.3 2.4 0.2 0.2 0.4 0.0 0.2 0.2 2.6 0.2 0.0 0.9 20.5 0.0 0.0 0.1 0.2 0.8 5.5 0.3 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 2.5 0.5 0.0 2.9 0.0 0.9 0.3 0.8 1.2 0.3 0.0 4.1 0.0 0.3 1.3 0.1 0.0 0.0 0.3 0.8 1.8 0.0 1.6 9.6 0.0 0.0 0.0 1.5 2.1 0.0 0.0 1.9 0.2 1.2 0.0 0.0 0.1 9.1 0.4 3.1 0.3 0.0 0.3 0.0 1.1 0.7 0.0 11.8 0.1 1.2 0.0 0.1 0.4 0.1 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.5 0.0 0.8 1.3 0.1 0.3 0.3 0.3 0.1 0.0 0.2 0.2 4.5 0.0 5.4 0.7 0.1 0.1 0.3 0.0 0.0 1.3 1.6 1.4 17.7 22.8 0.0 16.5 0.0 0.2 1.3 0.3 92.0 13.5 1.5 0.6 0.2 3.0 0.0 0.0 24.5 3.3 0.2 2.4 0.0 1.9 0.0 272.4 1.1 40.4 0.0 0.0 6.2 2.6 0.0 1.0 0.3 4.4 9.3 3.2 19.6 1.9 1.0 0.3 0.0 3.5 2.3 4.0 0.0 17.3 0.0 0.8 0.3 14.7 0.0 0.8 13.1 0.8 10.9 0.7 6.4 0.1 0.0 0.1 0.2 30.4 1.6 0.2 CLIP4 "FLJ21069, RSNL2" ENSG00000115295 "CAP-Gly domain containing linker protein family member 4" Q8N3C7 2 29097705-29189643 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 169.2;Inhibitory neurons: 142.8;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 247.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 25.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 83.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043366, HPA056246" Uncertain Enhanced Vesicles NA NA Vesicles "HPA043366: AB_10963051, HPA056246: AB_2683078" "unprognostic (1.97e-2)" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (2.47e-3)" "unprognostic (3.64e-1)" "unprognostic (6.82e-2)" "unprognostic (1.15e-2)" "unprognostic (8.82e-3)" "unprognostic (3.62e-1)" "unprognostic (4.32e-2)" "unprognostic (2.73e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (1.83e-4)" "unprognostic (3.59e-3)" "unprognostic (6.35e-2)" "unprognostic (2.14e-1)" "unprognostic (1.99e-2)" 19.4 9.9 18.2 9.6 27.4 1.9 14.4 22.2 19.5 12.0 18.0 16.0 4.8 13.8 8.8 23.6 15.7 13.5 30.3 18.0 23.7 8.9 4.5 18.9 10.3 21.5 24.0 16.8 22.9 6.4 14.5 20.2 16.6 23.4 16.8 7.0 18.0 14.0 15.3 72.5 31.1 10.8 18.7 21.4 10.1 10.3 17.6 20.6 13.6 33.7 44.2 10.8 20.9 20.1 33.8 82.3 22.6 3.4 12.1 31.4 47.0 0.1 31.8 54.4 17.5 19.9 0.7 52.7 10.2 15.9 55.1 69.9 33.0 3.6 24.7 24.8 18.9 5.4 0.0 29.1 1.2 79.7 0.0 16.2 33.3 61.3 23.2 83.8 62.8 12.4 7.4 0.5 31.5 26.7 0.6 7.9 3.6 0.9 4.8 5.0 0.1 20.1 1.6 32.0 14.4 5.3 13.7 27.6 11.2 29.0 3.3 0.0 4.9 39.4 4.1 31.6 13.7 13.8 16.2 0.1 0.1 19.0 0.0 12.7 2.5 6.1 0.2 7.9 14.8 12.4 1.4 6.1 8.4 2.4 0.5 6.9 6.8 1.2 5.6 25.9 0.0 2.3 5.6 18.2 27.4 22.2 19.5 18.0 23.7 21.5 24.0 16.8 23.4 21.4 20.6 33.8 0.9 64.1 15.0 78.7 7.2 17.1 27.6 26.8 30.1 31.0 11.4 8.9 76.2 0.0 18.5 12.9 29.2 6.7 18.6 0.1 3.9 10.7 169.2 16.1 8.4 2.5 0.0 2.5 75.1 9.1 1.7 26.5 4.1 12.9 5.1 13.1 1.4 1.8 9.9 20.2 142.8 0.0 8.2 36.1 6.0 91.1 27.4 25.9 8.8 15.9 17.5 18.7 19.6 130.2 247.2 22.1 0.0 24.0 30.9 25.8 0.0 5.9 32.1 17.9 13.1 24.2 9.2 9.4 1.6 29.7 27.3 21.5 21.9 16.4 0.2 24.2 TLX2 "Enx, HOX11L1, NCX" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517148 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.0;retina: 3.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Rod photoreceptor cells: 18.0;Spermatocytes: 4.3;Spermatogonia: 7.4" "Cancer enhanced" "Detected in single" "cervical cancer: 0.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "SH-SY5Y: 64.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA062254 Approved Nucleoplasm NA NA Nucleoplasm "HPA062254: AB_2684727" "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.0 2.0 1.0 0.2 0.2 0.0 0.0 0.4 0.9 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.2 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.9 0.0 3.4 0.0 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 3.2 0.0 0.1 0.1 0.0 0.0 0.0 1.4 3.8 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.4 0.9 0.1 0.1 0.6 0.3 0.2 0.5 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 20.9 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 4.3 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPTBN1 ENSG00000115306 "Spectrin beta, non-erythrocytic 1" Q01082 2 54456317-54671446 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 615.4;Peritubular cells: 663.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012685, HPA013149" Supported Approved "Golgi apparatus" NA Yes 1500000 "Golgi apparatus" "HPA012685: AB_1857433, HPA013149: AB_1857434" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (3.00e-2)" "unprognostic (3.25e-1)" "unprognostic (4.09e-2)" "unprognostic (7.95e-2)" "unprognostic (9.24e-2)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (1.67e-1)" "unprognostic (2.26e-2)" "unprognostic (7.25e-2)" "prognostic favorable (2.59e-5)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.68e-3)" "unprognostic (5.18e-3)" 189.0 71.6 229.4 35.0 190.0 37.9 79.4 114.1 173.1 54.6 92.9 59.1 33.0 52.5 36.6 42.1 56.7 69.9 137.2 165.9 138.0 65.9 84.5 132.7 29.1 164.9 160.4 115.8 73.8 45.9 130.1 28.0 98.2 150.0 44.1 52.9 56.5 55.6 75.1 54.5 38.6 47.2 60.4 138.6 59.2 56.1 32.9 196.7 29.6 73.5 88.0 30.2 46.0 38.9 162.0 96.5 150.5 60.4 57.2 234.7 158.8 74.8 40.2 82.3 63.7 61.4 101.7 66.6 0.4 112.1 142.0 55.1 110.9 85.1 128.0 66.0 0.8 35.6 43.7 118.4 166.2 97.7 59.7 24.4 62.3 64.8 193.8 119.7 77.6 151.6 95.1 50.0 64.0 86.1 21.6 105.0 14.5 66.3 129.6 70.2 116.2 95.0 37.2 92.2 120.6 36.3 113.3 121.5 39.5 88.1 58.9 19.6 9.9 235.2 89.9 79.0 110.2 58.2 62.8 42.8 32.7 98.1 17.7 163.7 2.3 0.4 2.8 3.7 0.0 3.9 3.7 3.4 3.6 1.3 3.5 5.0 3.6 0.6 5.2 0.0 1.1 3.2 3.1 229.4 190.0 114.1 173.1 165.9 138.0 164.9 160.4 115.8 150.0 138.6 196.7 162.0 615.4 407.1 124.6 233.4 45.7 83.1 50.0 64.7 42.7 94.4 60.8 58.0 262.9 144.4 100.6 145.3 73.0 28.3 31.7 343.6 7.9 223.7 12.1 140.4 80.3 426.4 83.1 21.5 231.3 121.9 42.0 271.6 139.7 115.7 35.4 68.2 228.5 184.6 14.2 141.3 195.4 135.5 77.3 17.7 47.0 31.5 503.2 16.6 147.7 294.2 9.7 131.9 36.0 154.8 283.1 243.3 109.9 663.5 76.3 75.6 142.8 44.1 187.3 93.6 164.3 340.3 171.9 54.7 53.3 79.7 68.2 11.1 49.2 56.6 151.9 88.1 AUP1 ENSG00000115307 "AUP1 lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529760 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 48.5 42.6 66.9 44.8 67.1 79.5 53.2 69.5 86.5 56.4 69.7 77.6 71.2 39.1 79.2 50.4 45.7 46.4 38.8 66.1 70.8 49.3 107.7 49.2 41.7 71.8 68.0 62.8 38.4 128.4 78.2 2.1 61.1 67.9 39.3 81.7 32.7 89.9 46.7 58.2 42.6 69.0 56.3 68.9 39.9 57.2 24.7 68.7 42.9 51.4 67.1 51.9 70.3 20.9 72.2 114.2 133.4 55.3 87.5 183.1 107.7 124.9 89.1 152.6 122.3 77.3 196.9 130.6 126.4 61.9 126.5 210.3 143.4 140.4 115.1 98.5 100.1 128.7 153.6 71.2 180.7 181.5 97.8 127.9 128.5 256.7 174.4 198.6 101.1 117.3 105.1 202.2 164.5 134.0 124.6 79.0 200.6 111.4 298.3 111.9 95.3 150.0 270.3 139.3 90.9 80.7 79.6 65.2 200.4 162.2 70.8 90.2 156.7 59.3 162.9 97.2 50.6 146.8 87.9 88.1 120.4 129.6 155.9 184.9 113.8 132.9 108.9 81.9 169.3 89.6 90.6 81.0 82.0 124.6 113.9 72.9 75.8 68.8 85.3 144.7 118.3 107.9 132.2 66.9 67.1 69.5 86.5 66.1 70.8 71.8 68.0 62.8 67.9 68.9 68.7 72.2 64.8 67.3 44.6 22.5 97.3 73.2 120.7 161.1 80.8 31.7 71.4 59.6 34.9 74.4 108.1 68.0 14.6 140.0 86.6 150.4 23.5 125.2 24.3 36.2 50.1 74.9 73.8 72.4 17.7 208.7 217.3 73.0 121.8 58.7 89.9 57.3 50.0 114.3 161.8 37.0 16.1 127.7 136.3 83.5 95.5 29.7 44.4 95.2 97.8 17.8 67.2 74.5 72.1 14.6 23.4 153.1 141.3 38.0 229.9 141.1 196.0 59.6 46.6 43.2 59.2 60.0 104.2 85.9 64.6 95.7 78.7 223.8 77.6 68.4 134.2 143.9 RTN4 "ASY, KIAA0886, NOGO, NSP-CL" ENSG00000115310 "Reticulon 4" Q9NQC3 2 54972187-55112621 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 3547.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 95.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 1801.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005388, HPA023977" Supported Enhanced "Endoplasmic reticulum" NA NA 3400000 "Endoplasmic reticulum" "CAB005388: AB_2285559, HPA023977: AB_2671391" "unprognostic (1.31e-2)" "unprognostic (1.71e-3)" "unprognostic (6.76e-2)" "unprognostic (1.28e-3)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.79e-2)" "unprognostic (1.84e-3)" "unprognostic (2.47e-1)" "unprognostic (1.97e-1)" "unprognostic (3.91e-3)" "unprognostic (4.38e-1)" "unprognostic (4.41e-2)" "unprognostic (1.29e-2)" "unprognostic (4.99e-2)" "unprognostic (1.27e-1)" "unprognostic (4.91e-2)" 591.4 305.6 455.9 152.2 491.0 116.4 255.2 493.2 504.5 119.0 340.2 188.7 238.4 155.2 178.0 219.9 131.2 198.5 130.9 440.2 481.9 446.6 556.5 213.7 84.3 531.9 494.2 408.7 133.2 123.7 238.5 84.7 178.8 553.1 225.9 181.0 646.2 128.2 185.2 1005.4 255.0 294.9 248.6 520.3 111.2 125.1 79.3 491.0 87.9 131.9 784.8 89.0 294.0 149.2 626.9 402.9 285.3 273.3 71.7 908.4 845.0 153.2 1301.6 1097.4 393.5 365.7 235.5 371.7 87.1 673.8 889.9 657.7 355.6 181.5 524.4 596.2 248.3 139.4 120.3 159.6 376.6 1801.9 218.1 59.7 638.5 490.8 540.3 1041.9 792.3 751.3 215.6 249.8 195.0 1724.1 117.8 268.3 222.0 245.9 86.8 252.0 118.5 360.3 180.0 924.0 475.9 179.2 211.3 297.7 173.3 378.1 465.1 147.2 165.1 1074.9 764.8 326.1 304.8 756.5 118.0 103.4 56.1 778.7 247.9 630.1 95.8 9.5 27.5 9.2 11.6 7.6 6.8 14.7 8.2 9.2 3.8 24.1 10.2 15.6 41.1 19.0 13.7 37.6 9.9 455.9 491.0 493.2 504.5 440.2 481.9 531.9 494.2 408.7 553.1 520.3 491.0 626.9 451.4 176.3 203.4 201.4 102.3 1062.1 1456.6 367.0 225.9 644.6 297.6 260.6 182.0 243.1 251.0 676.8 379.5 529.6 173.6 408.6 291.6 559.7 459.7 316.6 264.6 308.0 222.1 98.2 454.5 323.4 611.9 421.9 98.4 324.7 150.4 161.5 181.3 633.4 669.1 425.7 370.4 280.5 231.9 339.0 578.4 266.6 167.4 371.7 341.5 215.5 396.4 3547.4 137.0 249.3 1334.3 571.2 309.7 226.1 81.6 921.4 897.1 678.3 233.6 540.0 216.9 420.5 324.6 382.7 90.1 247.1 1059.3 362.0 145.5 100.1 238.1 1226.5 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529725-74533332 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria NA NA 260000 Mitochondria "CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 11.5 8.7 7.7 8.2 7.7 11.2 6.9 8.4 9.7 6.9 7.1 6.3 6.9 7.0 1.0 6.1 7.2 4.8 9.5 7.4 7.7 7.3 6.5 6.6 7.8 7.9 8.0 7.3 11.0 7.5 9.5 4.7 6.3 7.7 4.9 3.4 2.5 8.6 5.4 14.7 5.4 8.0 5.3 7.8 10.0 6.4 6.3 8.5 9.2 6.9 9.1 4.9 6.6 5.8 8.5 19.1 14.7 14.7 12.6 21.3 9.0 30.1 17.0 10.3 10.3 7.0 21.1 8.5 16.6 12.9 10.7 26.0 19.7 12.0 19.6 2.4 34.0 31.4 33.3 10.8 19.0 19.8 15.3 22.4 9.9 13.7 18.4 19.5 18.4 14.2 23.5 43.9 24.9 9.7 14.1 22.0 31.1 10.0 22.8 37.7 15.8 37.0 17.1 9.6 8.2 15.1 17.7 8.9 18.6 32.5 7.3 9.3 13.2 10.6 19.2 19.7 33.4 35.3 29.5 10.2 9.8 13.6 23.4 13.0 5.8 7.0 4.0 4.8 5.7 5.8 11.0 4.8 4.1 8.6 9.9 4.3 4.1 2.6 5.0 4.5 4.5 5.7 5.5 7.7 7.7 8.4 9.7 7.4 7.7 7.9 8.0 7.3 7.7 7.8 8.5 8.5 30.7 0.0 4.8 6.2 27.3 20.6 19.7 33.8 13.6 12.0 17.4 21.7 0.9 21.5 15.7 11.0 0.0 24.7 25.8 12.5 35.2 32.4 30.8 11.9 18.1 29.6 9.0 118.5 6.3 17.7 37.8 23.3 11.2 12.9 27.3 20.9 22.9 12.7 31.5 10.1 6.3 12.3 20.3 10.7 19.4 48.9 24.8 14.6 30.2 2.8 26.3 20.2 30.9 5.5 7.5 26.1 16.8 20.7 36.0 21.3 24.8 36.8 13.5 16.3 26.3 18.7 56.5 64.3 43.3 16.7 22.0 20.2 20.6 27.1 20.0 15.7 LOXL3 ENSG00000115318 "Lysyl oxidase like 3" P58215 2 74532258-74555690 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Oxidoreductase "Deafness, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7" "Cancer enhanced" "Detected in many" "melanoma: 15.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 11.7;non-classical monocyte: 9.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035281 Approved "Secreted to extracellular matrix" NA NA 200000 "HPA035281: AB_10601766" "unprognostic (7.54e-2)" "unprognostic (2.53e-2)" "unprognostic (5.34e-3)" "unprognostic (4.55e-3)" "unprognostic (6.85e-2)" "unprognostic (1.96e-1)" "unprognostic (1.68e-3)" "unprognostic (6.84e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-8)" "unprognostic (1.22e-2)" "unprognostic (7.33e-3)" "unprognostic (7.09e-2)" "unprognostic (3.38e-2)" 6.3 5.4 4.2 7.9 4.4 14.5 3.0 4.5 5.3 5.0 4.1 6.0 4.1 7.4 1.7 3.2 4.9 6.6 6.4 4.2 6.9 1.9 1.5 4.6 4.1 6.7 4.4 3.2 3.0 1.1 1.7 2.7 16.0 5.8 3.3 3.7 5.0 1.7 4.1 1.3 2.0 3.9 8.2 5.5 9.0 2.7 2.6 5.3 1.4 2.3 1.5 2.4 5.2 4.0 7.1 1.6 0.3 21.8 3.7 17.1 20.6 4.5 71.0 143.4 33.8 31.8 25.6 1.3 0.1 0.9 73.1 1.6 1.1 2.8 1.8 19.8 110.7 1.0 17.6 1.8 0.2 5.7 0.6 16.7 22.6 0.2 90.6 3.8 12.0 0.7 0.8 0.8 2.8 6.4 4.1 0.2 6.5 12.0 0.8 0.7 2.0 3.1 0.3 0.3 1.2 11.2 12.8 0.6 1.1 14.7 3.2 2.3 1.3 0.3 245.9 8.2 1.4 0.9 1.4 0.5 0.1 92.5 6.8 549.6 0.1 6.0 0.3 0.0 11.7 0.0 0.1 0.1 0.0 3.5 0.1 0.0 0.0 2.5 0.0 9.3 0.4 0.0 2.6 4.2 4.4 4.5 5.3 4.2 6.9 6.7 4.4 3.2 5.8 5.5 5.3 7.1 0.9 0.0 0.5 14.0 0.3 0.9 0.2 0.6 0.6 0.9 0.4 0.8 0.3 1.5 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.8 0.0 0.2 4.8 1.2 0.0 0.4 0.4 0.0 1.5 7.1 0.0 0.5 1.3 0.7 0.4 0.1 17.9 1.7 4.2 0.1 0.0 12.5 2.5 0.7 5.0 12.3 0.0 30.0 4.8 10.6 1.0 11.6 0.6 0.3 0.0 4.5 0.1 0.3 0.0 0.1 0.0 0.9 19.7 1.6 5.3 0.6 0.8 0.1 0.1 0.8 0.4 0.2 0.0 0.2 DOK1 p62dok ENSG00000115325 "Docking protein 1" Q99704 2 74549026-74557551 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "granulocytes: 36.8;Hofbauer cells: 48.6;Macrophages: 31.2;monocytes: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 76.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004224, HPA048561" Approved Supported Cytosol NA NA 80000 Cytosol "CAB004224: AB_627447, HPA048561: AB_2680443" "unprognostic (2.40e-2)" "unprognostic (2.07e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.42e-4)" "unprognostic (9.86e-3)" "unprognostic (1.28e-1)" "unprognostic (7.10e-2)" "prognostic favorable (4.64e-4)" "unprognostic (7.57e-2)" "unprognostic (1.85e-2)" "unprognostic (1.89e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.16e-6)" "unprognostic (8.65e-2)" "unprognostic (2.40e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-2)" 10.9 3.8 7.9 10.3 7.4 13.8 4.8 7.7 9.1 6.7 7.0 5.3 4.4 5.0 0.7 1.4 6.4 3.2 2.6 7.0 7.8 2.7 1.5 6.6 12.4 9.6 7.7 6.3 4.2 3.7 6.3 2.2 4.1 8.4 3.2 3.8 0.9 3.1 4.0 1.1 1.5 5.8 4.8 8.6 11.7 6.7 1.7 8.5 7.7 3.9 1.7 10.2 4.7 2.8 8.9 5.3 2.0 6.0 3.0 13.9 16.8 4.2 12.8 10.0 5.2 8.5 1.6 6.1 3.3 18.0 12.3 11.3 0.7 6.1 2.8 1.9 76.3 5.7 43.1 4.4 0.3 10.0 22.0 41.0 12.5 0.0 28.5 14.7 21.7 6.2 13.8 12.7 9.5 10.5 5.6 15.8 45.7 11.1 10.8 1.6 13.0 12.9 3.5 2.7 4.5 2.0 10.0 2.5 0.7 6.7 1.7 3.3 24.1 11.7 32.7 15.1 15.3 2.9 12.6 9.6 0.1 32.9 35.3 5.5 39.0 52.3 38.9 17.3 51.4 13.9 22.9 14.1 15.4 51.3 26.3 10.3 10.3 52.9 27.4 59.3 10.8 24.3 39.8 7.9 7.4 7.7 9.1 7.0 7.8 9.6 7.7 6.3 8.4 8.6 8.5 8.9 6.7 9.6 8.8 2.9 15.0 2.0 1.1 3.7 1.2 0.5 2.2 2.8 1.8 4.3 2.0 5.5 0.0 1.9 13.6 8.7 0.0 11.9 0.3 7.4 5.8 7.2 3.0 12.4 0.1 9.1 4.2 6.5 6.1 5.6 36.8 5.8 9.7 0.6 48.6 1.7 0.5 5.9 2.0 26.3 24.2 1.0 5.0 31.2 3.6 4.7 41.1 9.8 16.5 0.5 0.6 10.2 10.0 6.0 6.3 2.4 8.1 3.9 1.7 0.5 6.6 4.1 8.3 0.5 2.1 0.3 1.6 2.3 13.5 7.0 6.8 1.6 GALNT3 "GalNAc-T3, HFTC, HHS" ENSG00000115339 "Polypeptide N-acetylgalactosaminyltransferase 3" Q14435 2 165747588-165794659 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 78.0" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 50.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007613 Enhanced Supported "Golgi apparatus" NA NA 440000 "Golgi apparatus" "HPA007613: AB_1078941" "unprognostic (1.95e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.16e-3)" "unprognostic (2.78e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (4.13e-2)" "unprognostic (4.47e-2)" "unprognostic (2.74e-1)" "unprognostic (6.44e-2)" "unprognostic (3.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-1)" 1.4 1.7 3.1 8.5 2.3 54.5 26.3 3.9 2.0 29.5 3.9 49.3 43.9 5.3 9.4 27.6 39.1 32.5 0.5 1.8 9.8 11.0 2.4 14.1 3.7 4.2 4.9 1.3 6.9 26.4 6.9 9.9 6.5 3.7 25.4 53.7 3.8 55.8 8.3 0.3 15.4 39.9 2.5 8.3 20.2 78.0 26.0 2.3 3.3 25.7 0.5 12.4 17.5 12.7 5.9 61.5 0.0 0.6 0.2 0.1 2.6 43.0 18.3 7.7 6.6 16.0 32.0 85.4 0.4 0.1 0.0 0.1 108.3 0.0 69.2 13.5 1.3 13.0 0.0 14.9 0.3 0.3 14.5 0.4 0.5 88.2 0.0 30.3 2.1 0.1 2.9 0.0 55.0 5.0 42.7 0.5 5.6 0.1 201.1 7.8 0.2 0.0 1.7 17.8 42.0 6.5 0.1 0.3 49.6 16.8 1.9 21.7 0.9 0.5 0.1 1.0 0.1 0.3 34.4 16.3 1.3 0.2 14.0 0.6 50.5 6.8 32.2 10.2 9.0 7.5 6.6 3.1 5.8 11.4 6.0 1.0 3.4 25.2 10.6 13.8 17.3 5.6 6.2 3.1 2.3 3.9 2.0 1.8 9.8 4.2 4.9 1.3 3.7 8.3 2.3 5.9 1.0 12.8 34.4 7.8 13.6 38.0 107.9 36.5 29.6 0.6 45.0 26.8 0.4 35.8 45.9 66.2 0.0 8.5 37.7 68.6 3.9 70.2 127.5 91.8 5.2 2.9 23.4 1.3 10.5 113.2 22.5 2.3 102.4 70.5 45.7 0.7 1.1 0.6 8.2 0.0 5.1 152.8 28.5 1.9 12.4 14.1 2.5 8.3 16.0 1.0 7.5 16.1 15.5 27.6 1.4 188.1 46.5 0.4 29.7 155.7 32.6 3.1 89.3 1.0 6.6 0.6 4.3 71.5 1.1 42.4 41.3 11.2 14.4 1.2 61.8 274.4 POLE4 p12 ENSG00000115350 "DNA polymerase epsilon 4, accessory subunit" Q9NR33 2 74958643-74970128 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 110.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054979, HPA071815" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054979: AB_2682661, HPA071815: AB_2686453" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.09e-1)" "unprognostic (1.99e-1)" "unprognostic (2.95e-1)" "unprognostic (1.39e-2)" "unprognostic (4.44e-2)" "unprognostic (8.64e-3)" "unprognostic (6.61e-2)" "unprognostic (3.73e-1)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" 19.5 17.2 15.2 5.4 15.7 23.5 20.1 14.0 25.5 14.5 13.9 15.6 5.9 12.1 2.7 11.5 12.0 7.7 14.1 15.4 14.8 14.5 15.3 12.2 12.6 15.1 15.3 15.3 13.7 8.6 3.0 3.2 6.6 15.2 10.8 6.0 7.2 12.3 6.8 29.2 10.2 13.3 7.4 14.8 12.2 14.7 6.9 15.3 5.4 10.4 17.1 7.4 15.1 12.1 17.0 37.4 33.5 3.3 3.3 11.2 23.4 0.0 24.3 29.1 36.6 30.7 43.1 16.2 33.3 19.9 26.6 10.1 16.0 15.6 19.5 39.6 15.5 42.2 28.0 20.3 46.7 38.8 40.4 41.5 23.8 37.0 15.3 33.3 12.6 16.1 4.8 33.9 21.2 28.1 35.6 12.0 110.1 24.2 23.0 59.1 14.1 28.8 29.4 30.3 1.0 10.8 15.9 33.5 13.9 19.1 1.9 10.4 13.6 18.4 8.7 9.6 6.0 24.7 7.3 5.0 12.8 31.2 58.8 43.4 7.0 53.6 19.1 13.3 32.7 14.5 35.2 19.2 16.1 29.7 33.3 20.5 14.7 3.5 10.6 30.2 33.8 20.4 31.8 15.2 15.7 14.0 25.5 15.4 14.8 15.1 15.3 15.3 15.2 14.8 15.3 17.0 156.9 25.6 40.4 3.9 83.9 84.5 96.6 82.4 62.0 33.9 89.9 80.4 40.3 48.6 52.6 73.5 43.8 156.3 69.5 116.4 148.7 53.6 12.1 37.3 34.2 96.0 12.2 50.9 6.2 80.7 154.7 66.4 30.5 33.4 61.6 53.9 94.2 147.1 115.6 18.5 6.6 100.8 44.7 113.7 111.5 24.0 67.1 91.9 97.8 9.4 134.1 174.9 87.6 4.0 11.1 83.5 157.5 54.5 55.8 100.3 190.7 182.3 49.2 126.8 78.9 99.4 68.8 45.9 91.5 57.8 97.7 94.0 70.3 108.1 88.3 95.4 TACR1 "NK1R, NKIR, SPR, TAC1R" ENSG00000115353 "Tachykinin receptor 1" P25103 2 75046463-75199520 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "Inhibitory neurons: 83.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 23 "basophil: 2.2" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074573 Enhanced NA NA "HPA074573: AB_2686701" "unprognostic (5.74e-4)" "unprognostic (2.41e-3)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (8.62e-3)" "unprognostic (1.10e-1)" "unprognostic (3.33e-2)" "unprognostic (4.38e-2)" "unprognostic (1.46e-1)" "unprognostic (2.14e-3)" "unprognostic (1.63e-2)" "unprognostic (5.91e-4)" "unprognostic (1.03e-2)" "unprognostic (2.75e-1)" "unprognostic (1.06e-1)" "unprognostic (2.76e-2)" 4.5 0.3 1.5 0.8 2.6 0.0 5.1 0.0 5.8 5.0 0.5 0.9 0.2 3.0 0.7 1.2 2.9 1.1 0.1 0.5 3.9 0.7 0.0 0.8 1.3 2.2 3.6 1.1 0.6 0.1 0.2 0.1 0.5 5.9 1.5 0.5 1.0 1.5 1.0 0.3 4.0 0.7 2.8 0.7 0.0 0.5 0.0 1.9 1.1 0.5 0.3 1.3 2.0 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.0 5.8 0.5 3.9 2.2 3.6 1.1 5.9 0.7 1.9 3.4 7.6 0.0 0.0 1.0 0.0 2.5 0.0 0.0 0.0 1.0 0.3 0.3 1.4 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 11.8 0.0 0.0 4.5 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 83.2 0.2 0.0 0.0 2.6 0.9 0.0 0.0 7.2 2.8 0.0 0.4 0.0 3.5 4.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 3.3 0.0 0.2 0.2 0.0 0.0 0.1 1.8 0.1 0.1 0.0 0.0 0.2 CCDC88A "APE, FLJ10392, GIV, GRDN, HkRP1, KIAA1212" ENSG00000115355 "Coiled-coil domain containing 88A" Q3V6T2 2 55287842-55419895 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA replication, Neurogenesis" "Guanine-nucleotide releasing factor" "Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.3" "Cell type enhanced" "Detected in many" "Early spermatids: 634.4;Late spermatids: 699.8;Oligodendrocytes: 754.9;Spermatocytes: 429.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 7.4;classical monocyte: 7.2;intermediate monocyte: 7.0;myeloid DC: 11.3;non-classical monocyte: 6.8;plasmacytoid DC: 23.9" "Group enriched" "Detected in all" 7 "dendritic cells: 23.9;granulocytes: 7.4;monocytes: 7.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038101, HPA038102" Enhanced NA NA "HPA038101: AB_10670654, HPA038102: AB_2675833" "unprognostic (1.20e-1)" "unprognostic (2.86e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.06e-4)" "unprognostic (1.91e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (4.86e-4)" "unprognostic (8.51e-2)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (3.18e-3)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.98e-8)" "unprognostic (1.42e-2)" "unprognostic (2.61e-1)" "unprognostic (5.74e-3)" "unprognostic (8.96e-3)" 10.7 9.7 57.9 14.2 71.3 15.7 8.5 61.5 69.8 8.6 40.6 8.2 3.8 9.9 3.3 5.5 7.6 7.8 8.7 57.5 61.9 4.5 8.5 14.6 17.4 68.2 69.8 52.9 9.3 10.8 3.4 13.3 8.4 72.8 5.9 5.2 26.5 6.7 5.5 7.4 4.2 7.2 9.4 61.3 13.4 6.5 47.7 65.3 19.0 5.9 9.7 15.3 9.7 6.3 91.3 22.8 19.7 45.2 18.3 29.4 24.3 4.0 32.3 30.1 18.9 20.6 2.1 12.0 60.2 19.5 32.6 28.9 0.4 28.9 19.3 46.8 69.8 16.8 41.4 21.7 28.6 12.6 70.7 26.8 15.8 3.8 44.6 28.6 27.1 50.3 48.1 44.9 95.9 51.9 0.2 33.5 41.1 37.4 0.3 24.8 39.7 71.1 0.3 22.9 12.1 23.5 34.8 57.4 0.1 28.9 26.2 1.1 20.2 34.9 54.4 36.5 36.6 39.6 28.8 24.0 25.8 38.0 56.2 23.7 7.4 7.2 2.1 1.4 7.0 0.8 1.8 0.6 1.1 11.3 0.6 0.7 0.6 0.6 1.2 6.8 23.9 0.3 2.1 57.9 71.3 61.5 69.8 57.5 61.9 68.2 69.8 52.9 72.8 61.3 65.3 91.3 35.6 12.8 27.9 197.9 25.5 8.4 7.4 11.2 9.1 225.1 7.2 11.9 52.8 4.3 12.8 5.5 37.5 6.5 90.5 0.2 1.9 4.2 634.4 8.0 58.8 41.0 10.8 51.3 317.1 16.8 18.4 38.1 9.2 3.1 152.8 64.4 22.1 18.5 110.8 79.1 318.9 0.0 4.1 142.0 126.7 699.8 29.8 184.2 16.0 129.3 236.1 109.8 11.3 296.6 754.9 31.1 0.2 28.6 114.7 2.9 0.0 8.1 10.1 61.9 32.9 45.1 55.4 429.0 95.5 5.9 6.5 2.3 22.4 82.3 0.1 2.8 ACADL "ACAD4, LCAD" ENSG00000115361 "Acyl-CoA dehydrogenase long chain" P28330 2 210187126-210225447 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.3;pancreas: 28.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 70.9;Early spermatids: 85.6;Late spermatids: 69.4;Leydig cells: 46.9;Peritubular cells: 46.6;Proximal tubular cells: 31.5" "Group enriched" "Detected in many" 8 "liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.4;RPTEC TERT1: 2.6;SuSa: 2.3;U-2 OS: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011990 Enhanced Supported NA NA "HPA011990: AB_1844465" "unprognostic (6.29e-3)" "unprognostic (7.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (1.33e-2)" "unprognostic (7.66e-3)" "unprognostic (3.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" "unprognostic (1.99e-1)" "prognostic favorable (1.58e-11)" "unprognostic (4.22e-3)" "unprognostic (1.18e-4)" "unprognostic (8.81e-3)" "unprognostic (1.06e-1)" 12.0 1.1 0.7 0.1 0.6 0.0 8.1 0.6 1.1 3.4 0.8 0.5 0.0 0.7 1.1 0.5 4.0 0.6 2.1 0.6 1.1 20.0 28.3 10.1 0.0 0.7 0.6 0.6 12.8 28.6 4.5 2.9 1.0 0.6 20.8 0.1 0.0 6.8 4.9 9.6 2.6 0.4 0.1 0.6 0.0 5.6 3.1 0.6 1.5 23.9 5.1 0.0 1.0 3.8 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.6 0.5 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.6 1.1 0.6 1.1 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.2 28.9 70.9 1.0 0.0 0.6 1.4 1.1 1.2 0.2 1.3 0.5 1.1 8.6 7.6 22.0 2.1 8.8 0.0 0.0 15.6 4.0 85.6 7.1 0.4 0.2 0.0 0.0 0.2 11.9 0.3 4.9 3.6 5.9 2.5 0.8 0.7 23.0 0.5 0.0 13.3 0.0 0.0 0.3 0.4 69.4 46.9 0.4 0.0 4.7 0.0 0.2 0.0 7.5 0.3 3.9 0.0 46.6 0.0 8.2 0.0 31.5 2.4 0.2 0.0 7.6 13.7 0.7 0.7 0.7 1.0 6.3 0.4 0.1 0.0 0.7 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 193.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 41.7;Cytotrophoblasts: 43.3;Hepatocytes: 78.1;Proximal tubular cells: 77.3;Syncytiotrophoblasts: 124.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 85.7;U-138 MG: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" NA Yes Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 1.1 0.5 0.3 1.1 0.7 0.1 3.5 0.6 0.4 9.9 0.3 0.7 1.7 2.8 9.7 0.4 3.7 1.2 1.0 0.2 0.6 20.2 193.2 20.9 0.4 1.3 0.5 0.1 0.5 24.0 7.6 1.1 17.4 0.9 0.9 0.7 0.5 9.0 2.3 1.2 2.6 1.8 2.0 0.7 10.8 0.6 2.9 0.6 5.2 1.8 1.6 0.3 0.8 0.8 0.8 1.0 14.5 1.5 0.4 3.1 21.2 1.4 68.0 45.3 59.2 30.1 0.5 1.2 0.1 6.3 85.7 54.2 9.4 1.7 14.4 36.8 0.0 1.1 0.0 2.5 45.7 2.2 0.0 0.1 15.0 8.3 73.2 33.3 59.0 37.2 0.0 0.0 0.0 46.1 0.0 0.1 0.0 3.3 0.2 23.5 7.9 0.1 0.0 32.5 0.5 0.9 1.6 6.2 0.4 53.7 2.2 0.2 0.3 31.0 110.3 46.3 2.0 71.9 0.7 0.1 0.3 62.5 0.0 59.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.6 0.4 0.2 0.6 1.3 0.5 0.1 0.9 0.7 0.6 0.8 6.1 41.7 35.4 1.0 0.9 2.8 13.7 14.3 3.4 1.2 11.7 12.3 0.3 1.5 23.0 11.0 0.0 43.3 0.4 0.1 27.4 30.5 12.2 13.3 1.4 4.8 1.8 0.0 1.1 16.1 25.9 4.7 0.0 11.4 0.0 0.0 2.2 78.1 3.5 0.0 0.9 1.1 4.1 0.8 1.2 9.4 0.3 0.6 28.4 2.8 0.1 0.0 0.0 1.5 0.9 9.7 0.0 0.7 0.0 12.3 0.5 77.3 1.7 0.1 0.0 2.2 9.0 2.2 0.9 1.1 0.9 124.8 1.1 0.0 1.6 10.5 MRPL19 "KIAA0104, MRP-L15, RLX1, RPML15" ENSG00000115364 "Mitochondrial ribosomal protein L19" P49406 2 75646783-75690851 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 167.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046805, HPA056622" Approved Supported Mitochondria NA NA Mitochondria "HPA046805: AB_2679816, HPA056622: AB_2683195" "unprognostic (9.24e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.39e-4)" "unprognostic (8.40e-2)" "unprognostic (1.59e-2)" "unprognostic (7.52e-3)" "unprognostic (5.75e-2)" "unprognostic (9.86e-2)" "unprognostic (6.21e-3)" "unprognostic (9.71e-3)" "prognostic unfavorable (1.97e-5)" "unprognostic (2.42e-1)" "unprognostic (3.67e-2)" "unprognostic (1.55e-1)" "unprognostic (3.30e-1)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" 31.5 30.3 22.8 19.1 28.0 14.1 28.9 27.8 23.7 29.4 16.2 28.1 23.9 21.9 25.4 25.2 18.3 20.9 35.3 19.5 27.0 56.5 64.2 18.0 20.5 26.3 25.0 18.3 17.5 23.8 45.6 12.3 25.9 25.8 21.8 31.2 19.5 24.3 25.3 67.1 24.1 20.1 29.2 30.0 17.1 18.6 16.7 25.1 24.5 37.2 45.2 25.3 24.8 15.2 33.9 100.7 57.5 53.3 48.3 57.0 68.1 75.6 63.4 57.0 78.5 62.2 88.5 40.6 56.5 62.1 69.2 73.8 69.5 83.7 95.8 117.8 63.2 72.4 77.4 44.4 114.3 61.0 82.9 44.5 45.6 72.4 79.7 72.3 49.6 84.1 60.8 86.4 32.3 78.5 61.9 76.1 64.9 69.9 102.9 65.2 94.5 116.5 74.5 134.1 61.9 58.8 50.2 62.2 71.2 72.4 53.3 61.1 32.8 57.0 68.3 75.4 61.2 94.6 33.3 53.8 47.1 53.9 81.0 61.1 17.7 20.2 14.2 22.1 26.8 25.1 26.8 22.7 23.8 29.7 22.7 19.9 24.6 1.4 24.4 24.9 35.0 26.5 17.2 22.8 28.0 27.8 23.7 19.5 27.0 26.3 25.0 18.3 25.8 30.0 25.1 33.9 31.8 19.2 29.6 10.7 27.4 29.1 28.6 77.8 21.1 38.3 32.4 29.5 40.2 25.8 49.4 49.7 52.1 90.3 26.3 24.0 125.2 88.7 27.6 42.7 48.4 27.7 27.6 32.8 13.9 61.1 87.3 33.7 36.7 50.3 19.0 35.8 27.1 67.6 47.3 48.8 14.3 36.5 44.7 14.6 17.0 11.2 35.4 23.7 33.8 12.2 35.0 39.6 34.0 15.1 20.0 53.6 27.7 36.5 36.5 36.1 36.5 167.7 32.8 50.9 19.7 31.4 38.1 55.5 17.6 44.3 28.3 57.7 25.3 62.2 50.7 35.6 LANCL1 "GPR69A, p40" ENSG00000115365 "LanC like 1" O43813 2 210431249-210477652 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 148.1" "Cell type enhanced" "Detected in all" "Early spermatids: 140.5;Inhibitory neurons: 157.1;Oligodendrocytes: 599.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034994 Enhanced Uncertain Microtubules NA NA 22000 Microtubules "HPA034994: AB_10601936" "unprognostic (2.34e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (2.67e-2)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.10e-2)" "unprognostic (9.76e-2)" "unprognostic (2.82e-2)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (1.23e-1)" "unprognostic (9.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 28.3 27.1 65.2 15.7 99.8 19.3 34.0 88.6 91.3 23.3 30.1 20.7 21.7 29.1 19.8 29.8 23.6 23.2 41.2 68.7 79.0 37.9 23.8 21.4 26.9 108.2 89.5 63.4 32.4 24.8 65.4 19.4 22.3 94.0 33.3 23.0 49.0 20.5 32.0 28.8 42.5 20.9 33.3 94.8 23.5 19.2 54.4 91.4 40.4 24.5 51.7 28.0 21.6 16.8 148.1 26.3 29.2 45.9 46.8 51.3 71.9 32.0 39.3 50.3 35.5 46.4 32.8 29.4 22.5 50.3 44.9 57.8 26.6 30.2 63.6 59.4 26.1 32.4 39.6 96.1 58.3 42.5 50.5 13.6 52.1 51.2 46.7 37.8 80.3 52.2 68.3 50.1 35.6 46.4 23.1 68.5 27.9 30.7 31.9 20.2 30.5 64.1 33.4 65.2 25.4 43.6 60.4 46.0 97.5 51.2 67.3 33.2 26.7 53.5 62.2 41.4 32.9 41.8 21.8 43.8 31.3 58.4 38.5 73.4 8.6 2.5 6.8 11.8 5.3 11.5 7.9 10.4 11.8 8.3 8.8 11.0 12.7 0.8 8.1 8.5 7.3 11.7 6.8 65.2 99.8 88.6 91.3 68.7 79.0 108.2 89.5 63.4 94.0 94.8 91.4 148.1 13.5 12.8 14.2 36.2 11.6 26.3 10.0 13.2 31.3 27.2 19.0 13.5 35.7 10.0 12.3 20.2 18.8 10.8 12.3 5.9 15.6 8.7 140.5 11.6 12.6 13.4 6.7 17.9 68.4 12.0 5.6 16.1 9.2 10.7 6.3 24.0 11.4 20.1 8.8 50.5 157.1 7.6 12.2 10.3 6.4 114.7 13.1 5.0 16.0 20.6 4.5 20.7 15.5 70.4 599.1 5.3 6.0 19.2 11.0 6.5 9.2 18.8 14.2 24.1 19.7 14.8 22.0 41.7 19.0 25.3 33.1 5.1 13.8 14.8 12.7 8.1 WDR75 "FLJ12519, NET16, UTP17" ENSG00000115368 "WD repeat domain 75" Q8IWA0 2 189441446-189475552 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.23e-1)" "unprognostic (7.34e-2)" "unprognostic (3.31e-1)" "unprognostic (1.54e-1)" "unprognostic (4.22e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.50e-8)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" "unprognostic (1.93e-2)" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.15e-11)" "unprognostic (1.34e-1)" "unprognostic (7.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-2)" 17.6 21.2 16.5 18.9 17.5 20.7 24.6 18.7 20.6 23.7 16.2 16.5 13.9 23.6 24.0 18.2 21.4 15.0 13.5 17.4 18.5 14.9 17.8 12.4 26.5 18.8 17.4 17.3 23.6 20.0 17.5 13.6 17.1 18.4 15.2 18.4 16.0 13.7 13.3 16.0 22.1 16.2 19.7 17.8 21.8 16.4 16.3 18.4 20.8 14.9 13.9 24.3 23.3 18.0 20.4 36.0 34.3 43.7 55.2 46.7 49.5 49.2 73.3 34.1 82.0 62.7 71.5 39.7 76.1 41.0 24.1 31.6 48.3 81.9 49.0 79.7 49.9 39.1 99.5 60.3 55.4 44.4 111.2 48.7 41.1 41.3 59.4 80.6 34.7 55.9 43.5 99.9 45.3 56.3 35.7 54.8 77.4 101.6 41.5 92.6 51.0 65.4 64.0 41.3 42.5 41.2 41.9 46.1 44.1 38.1 70.2 40.7 45.9 48.3 48.7 52.4 37.4 55.3 48.7 81.2 95.1 34.5 47.5 40.3 0.7 4.3 2.5 5.7 7.4 11.3 5.9 6.3 7.4 8.0 4.3 7.7 7.5 0.0 7.6 4.6 4.5 8.4 4.7 16.5 17.5 18.7 20.6 17.4 18.5 18.8 17.4 17.3 18.4 17.8 18.4 20.4 19.8 28.9 16.4 20.5 20.4 17.0 21.0 16.6 26.7 6.4 8.3 9.7 18.3 2.8 13.1 1.8 8.4 19.0 13.3 4.2 11.7 15.0 2.1 10.6 27.3 18.0 9.0 15.8 32.8 16.9 16.0 17.8 15.3 12.0 5.1 13.7 9.7 8.5 10.7 16.8 41.2 12.1 20.3 44.5 8.5 3.8 18.0 11.9 14.2 12.2 11.4 4.8 9.2 28.6 29.7 16.3 6.7 15.8 14.9 16.6 6.1 14.6 11.3 9.6 19.7 20.4 19.6 30.5 31.4 18.1 11.2 17.2 19.5 17.0 11.4 15.2 EFEMP1 "DHRD, FBLN3, FBNL, MTLV, S1-5" ENSG00000115380 "EGF containing fibulin extracellular matrix protein 1" Q12805 2 55865967-55924139 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6" "Cancer enhanced" "Detected in all" "glioma: 94.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016368, HPA049806, HPA070841, HPA071588" Supported Supported Mitochondria "Secreted to extracellular matrix" NA NA 1900000000 Mitochondria "CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: " "unprognostic (8.21e-2)" "unprognostic (7.68e-2)" "unprognostic (9.01e-3)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.43e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-1)" "unprognostic (9.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.89e-8)" "unprognostic (3.15e-3)" "unprognostic (4.94e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (6.68e-5)" 242.7 56.3 75.8 57.7 66.3 0.2 116.5 62.8 89.5 46.1 168.0 75.3 22.7 73.9 129.5 52.0 136.0 141.6 117.5 42.6 88.3 58.0 13.0 151.4 27.5 77.8 94.5 43.1 176.6 29.4 17.7 22.8 332.5 58.3 59.0 92.0 43.2 88.4 162.7 14.8 55.7 45.7 94.4 71.2 42.7 47.3 8.1 65.3 17.0 140.3 94.6 21.4 205.9 77.9 70.9 358.4 3.1 8.5 0.3 320.9 217.1 0.8 208.1 233.7 25.2 20.5 0.0 18.0 0.5 140.4 234.3 22.1 323.4 1.6 234.6 8.9 1.0 1.0 0.3 87.4 0.2 843.2 0.3 0.6 953.6 117.5 21.9 260.9 2226.5 4270.9 0.5 1.2 0.2 99.2 36.7 2.6 0.5 4.2 0.1 0.8 0.2 0.3 0.9 9.8 7.3 2.0 0.4 284.6 105.0 0.7 8.1 289.8 1.5 3554.3 1.5 107.5 397.9 138.5 13.7 0.5 1.4 73.1 0.3 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.8 66.3 62.8 89.5 42.6 88.3 77.8 94.5 43.1 58.3 71.2 65.3 70.9 26.6 250.0 109.1 234.1 0.1 79.4 79.1 367.7 42.1 2.8 6.2 78.2 12.5 12.8 98.2 27.6 0.0 1365.8 0.4 0.0 9.8 36.2 0.5 2.2 38.9 73.5 0.0 0.0 1.0 25.6 173.0 309.7 6.1 2.1 2.5 3.9 48.5 0.7 94.9 0.0 4.7 0.0 40.7 0.8 33.9 0.9 42.6 3.2 17.8 6.5 0.6 137.3 0.0 2.5 0.8 2.8 0.0 0.0 1.5 24.2 0.0 14.7 88.8 4.7 0.0 7.0 28.7 0.4 1.8 6.0 31.7 889.6 5.0 61.3 0.0 6.2 REG1A "PSP, PSPS, PSPS1, PTP, REG" ENSG00000115386 "Regenerating family member 1 alpha" P05451 2 79120362-79123409 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "pancreas: 104777.1" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 115721.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 1268.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.3;EFO-21: 18.3;HDLM-2: 15.2;NB-4: 11.0;OE19: 10.7;RPMI-8226: 32.5;SH-SY5Y: 12.5;U-2 OS: 31.1;U-251 MG: 10.8;U-266/84: 13.3" "CAB025138, HPA045549, HPA045579" Enhanced "Secreted to digestive system" NA NA 68000000 "CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374" "unprognostic (1.89e-1)" "unprognostic (2.91e-2)" "unprognostic (3.39e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.52e-2)" "unprognostic (3.54e-3)" "unprognostic (5.53e-2)" "unprognostic (5.54e-2)" 20.8 5.8 0.0 200.5 0.0 21.0 10.0 0.0 0.0 6.8 0.0 56.4 7666.5 5.4 0.0 9.4 6.4 97.5 10.3 0.0 0.0 90.6 16.0 4.5 7.6 0.0 0.0 0.0 25.8 104777.1 0.0 8.5 3.5 0.0 6.1 286.1 0.0 9.4 0.1 4.3 28.4 5685.1 179.8 0.0 8.6 954.4 3.9 0.0 0.0 4.1 0.0 0.4 3.2 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.5 10.7 0.0 0.0 0.0 32.5 0.0 0.0 1.4 12.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 31.1 2.0 10.8 0.0 13.3 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 25.5 1.9 1549.8 0.1 0.1 0.0 12.7 5.3 0.0 0.0 115721.8 0.0 0.9 692.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1813.1 0.0 0.0 0.0 0.1 0.0 17.0 0.0 0.0 507.5 0.0 0.0 0.0 0.0 22774.8 732.4 0.0 0.2 0.0 5100.1 20.8 0.0 0.0 0.0 0.0 51.7 0.0 0.4 0.0 0.0 0.0 0.6 0.0 5419.7 0.0 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "FA complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 188.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" NA Yes "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favorable (7.80e-5)" 8.5 35.6 42.9 11.1 51.1 15.2 19.7 36.9 40.5 18.4 29.6 12.2 11.6 20.1 18.5 11.6 14.0 12.1 13.1 36.5 44.2 10.0 21.8 9.6 15.0 52.5 51.0 33.4 25.0 14.7 14.1 44.7 12.6 58.3 14.9 15.0 24.8 18.9 10.8 9.2 18.0 12.9 13.6 45.3 16.9 13.2 19.2 45.3 13.3 17.2 9.1 12.7 11.8 14.8 71.6 48.6 35.0 69.4 34.0 11.9 15.1 36.9 34.8 21.5 33.8 43.5 30.9 59.4 33.4 43.8 11.4 46.3 27.5 39.0 26.4 56.0 78.8 61.7 54.8 49.5 42.1 13.0 53.3 29.0 11.8 12.4 24.8 9.7 29.9 27.0 23.5 51.9 29.6 23.2 24.6 18.9 65.8 75.2 77.4 7.2 35.2 52.5 26.1 29.9 47.2 78.1 39.3 49.5 20.2 33.8 37.0 18.7 35.4 15.9 30.0 45.0 22.3 39.0 30.4 20.6 19.7 63.7 35.7 46.6 3.2 3.0 4.9 3.7 5.6 3.0 9.1 3.2 4.2 5.9 9.3 1.0 2.3 0.8 7.6 4.3 5.3 4.8 2.2 42.9 51.1 36.9 40.5 36.5 44.2 52.5 51.0 33.4 58.3 45.3 45.3 71.6 16.7 19.2 20.0 18.6 9.4 10.3 13.9 26.1 11.4 16.6 12.5 15.4 16.4 8.6 16.1 9.2 4.2 29.1 4.8 7.2 11.7 9.7 2.5 11.1 15.8 14.8 9.0 14.5 45.0 4.2 14.0 12.2 15.3 6.2 10.8 25.8 13.2 12.5 10.9 8.4 38.4 15.0 30.5 6.3 4.6 3.6 10.8 7.0 26.6 34.7 6.8 22.8 3.1 81.4 188.9 4.6 13.3 14.3 9.7 6.2 21.7 5.7 23.2 18.7 13.1 10.8 12.4 52.6 37.9 9.5 6.8 7.4 5.6 13.2 16.0 9.3 FN1 "CIG, FINC, GFND2, LETS, MSF" ENSG00000115414 "Fibronectin 1" P02751 2 215360440-215436073 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Angiogenesis, Cell adhesion, Cell shape" Heparin-binding "Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 1740.1;placenta: 2952.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 833.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000126, HPA027066" Enhanced "Secreted to blood" NA NA 47000000000 "CAB000126: , HPA027066: AB_10602500" "unprognostic (8.08e-2)" "unprognostic (1.09e-3)" "unprognostic (2.20e-2)" "unprognostic (3.45e-3)" "unprognostic (1.82e-2)" "unprognostic (3.47e-3)" "unprognostic (3.36e-2)" "unprognostic (5.91e-3)" "unprognostic (2.96e-2)" "unprognostic (2.91e-3)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (3.44e-8)" "prognostic unfavorable (8.82e-5)" "unprognostic (7.88e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (3.33e-4)" 127.2 31.7 42.9 133.0 37.5 0.6 77.2 33.3 81.6 118.1 130.3 325.0 34.1 157.4 61.8 254.0 176.0 188.7 298.8 35.5 128.6 37.7 1740.1 792.7 37.6 34.7 36.2 22.0 110.9 26.2 19.4 26.4 2952.1 37.1 106.6 239.5 6.1 67.6 433.0 38.1 44.4 104.3 729.1 32.4 14.4 128.3 26.0 89.1 135.0 40.7 149.7 24.1 364.7 87.8 57.6 12.5 84.2 104.6 22.8 4456.5 34405.9 4.8 1799.2 1200.2 1765.3 1259.9 1059.2 43.7 1.2 9.7 6331.7 47.2 192.7 17.4 4220.9 946.9 1.0 7.4 0.8 24.7 3607.2 3192.2 1.2 6.6 16044.5 29.3 4136.5 9585.3 10587.1 2177.2 1.0 8.2 5.0 3673.9 17.0 2.9 1.5 52.7 2.4 15.2 1.0 2.4 8.0 47.4 13.7 6.0 25.0 213.7 116.4 1219.8 4649.5 19.4 3.2 4161.0 2553.1 269.9 2837.4 355.6 4.4 1.6 1.6 3161.2 1.0 694.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 37.5 33.3 81.6 35.5 128.6 34.7 36.2 22.0 37.1 32.4 89.1 57.6 138.9 67.3 67.8 13.4 2.3 55.1 4.1 227.0 2.2 6.4 4.2 5.2 36.3 30.0 34.0 16.5 0.0 216.6 2.3 3.4 0.0 6.5 1.8 6.5 265.8 215.4 21.0 16.8 9.5 9.8 2583.6 562.6 4.1 5.5 18.9 53.5 227.7 1012.4 365.2 1.7 8.1 10.2 12.2 38.0 73.7 4.6 186.4 85.9 110.3 101.2 1.2 1.9 0.0 11.6 10.7 12.5 1.4 88.4 1.7 17.8 0.0 0.6 23.1 8.7 72.3 401.5 450.2 1.6 7.8 5.0 37.4 205.8 11.3 8.5 23.7 1.7 STAT1 "ISGF-3, STAT91" ENSG00000115415 "Signal transducer and activator of transcription 1" P42224 2 190908460-191020960 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 533.6;BJ hTERT+ SV40 Large T+ RasG12V: 595.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000931, HPA000982, CAB004049" Approved Enhanced Nucleoplasm,Cytosol NA NA 92000 Nucleoplasm Cytosol "CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099" "unprognostic (6.90e-2)" "unprognostic (6.47e-2)" "unprognostic (4.27e-2)" "unprognostic (2.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.75e-4)" "prognostic unfavorable (4.23e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (3.35e-3)" "unprognostic (3.93e-2)" 41.6 35.9 7.9 114.3 9.3 35.4 27.4 4.3 21.7 27.6 6.5 43.9 51.8 27.8 15.2 36.1 25.3 67.2 35.9 10.0 21.1 41.1 66.6 69.7 146.8 19.7 8.1 5.2 33.3 41.0 39.3 24.0 29.1 13.3 35.1 41.0 20.2 108.3 24.4 30.0 24.9 42.2 47.9 8.9 115.5 56.2 31.5 15.1 105.3 33.7 30.0 59.5 62.8 25.3 39.9 54.8 58.6 26.8 41.4 105.7 158.8 79.3 82.4 257.1 533.6 595.5 95.1 62.8 21.7 48.1 180.8 173.9 45.9 29.8 62.0 108.6 179.6 24.6 99.0 43.8 47.3 72.2 48.4 58.3 94.7 36.8 100.4 31.0 56.5 63.5 38.4 56.8 103.9 93.6 42.5 38.0 41.1 36.6 34.2 95.3 31.4 71.4 27.9 58.9 70.1 37.9 35.0 100.3 35.7 236.5 37.5 38.6 59.9 56.2 105.1 57.5 90.0 51.4 202.1 330.7 21.0 80.8 40.3 47.8 50.0 143.9 104.9 51.6 191.1 71.4 38.3 129.3 77.4 61.4 31.7 128.2 94.2 203.9 77.3 117.3 28.9 227.8 210.2 7.9 9.3 4.3 21.7 10.0 21.1 19.7 8.1 5.2 13.3 8.9 15.1 39.9 46.8 73.7 34.3 14.0 48.8 22.2 17.5 32.3 22.2 13.3 27.6 26.0 44.6 51.5 40.3 53.3 25.0 13.6 48.0 44.4 7.9 47.5 18.5 30.9 43.9 42.1 21.0 15.5 9.0 37.8 53.9 44.1 51.5 39.3 51.4 38.5 28.5 54.1 92.6 3.3 12.2 26.7 16.2 72.0 26.2 5.2 21.8 96.9 17.8 31.9 107.3 13.7 62.8 25.1 11.9 36.0 21.7 29.7 69.4 26.7 24.7 44.0 47.7 19.3 39.5 35.4 31.1 25.4 24.6 28.8 31.3 8.3 78.1 37.9 29.2 26.9 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880821-190965552 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 319.7" "Cell type enhanced" "Detected in all" "Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 907.3;RPTEC TERT1: 419.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" No No 92000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 36.8 78.1 32.7 46.1 57.6 29.0 32.3 48.5 78.8 29.2 45.8 32.3 93.0 29.1 26.8 16.9 25.3 42.2 35.0 56.2 51.4 319.7 11.8 56.1 68.5 50.0 31.4 53.9 29.2 37.2 62.5 20.0 36.1 60.6 21.0 30.4 82.6 20.5 31.5 15.9 27.6 104.3 37.3 21.8 49.7 18.9 16.4 42.0 42.1 36.0 23.8 58.3 36.9 23.8 77.8 43.6 47.2 32.4 43.1 99.7 68.9 84.0 126.8 95.7 90.6 103.1 58.1 42.1 88.5 907.3 269.3 46.1 55.6 58.0 50.0 131.5 219.8 37.7 147.3 69.1 72.2 90.8 87.2 66.5 62.9 51.0 71.2 48.4 90.1 119.3 36.7 69.3 175.2 203.3 22.8 59.2 83.7 86.9 25.7 76.7 74.2 83.7 77.4 419.2 78.9 44.9 46.8 172.8 37.9 169.2 115.1 14.9 53.0 85.3 129.4 94.5 65.9 156.8 56.2 138.9 122.1 46.7 70.6 105.5 6.4 1.0 1.9 3.7 1.5 6.5 3.4 4.4 4.8 1.6 3.8 4.5 5.5 2.1 2.8 1.1 3.6 4.1 1.1 32.7 57.6 48.5 78.8 56.2 51.4 50.0 31.4 53.9 60.6 21.8 42.0 77.8 81.0 189.1 122.5 61.0 89.3 174.5 44.7 15.6 60.9 93.5 51.8 49.5 38.2 35.8 28.4 391.8 210.6 4.4 128.0 100.6 50.9 21.4 6.6 33.7 66.8 68.3 59.2 17.9 427.1 24.5 15.6 66.0 46.4 97.9 36.8 48.2 63.5 4.3 29.1 26.9 270.5 36.7 14.2 31.2 230.0 7.3 28.6 84.3 88.9 143.4 68.4 11.9 55.6 163.3 146.9 29.8 92.9 43.2 118.4 70.1 165.9 539.1 17.0 111.9 19.7 71.6 76.0 11.3 12.9 61.7 162.8 4.0 114.0 97.8 43.6 56.7 PAPOLG FLJ12972 ENSG00000115421 "Poly(A) polymerase gamma" Q9BWT3 2 60756253-60802086 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017795, HPA035349, HPA035350" Approved Enhanced Nucleoplasm No No Nucleoplasm "CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (3.39e-2)" "unprognostic (5.56e-2)" "unprognostic (3.54e-1)" "unprognostic (6.72e-4)" "unprognostic (2.49e-1)" "unprognostic (6.97e-3)" "unprognostic (6.83e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.62e-2)" 3.6 3.0 2.2 2.2 2.5 1.4 3.4 3.4 3.1 4.0 1.9 3.2 1.3 4.2 1.2 3.5 3.2 1.4 3.1 2.5 2.6 2.4 2.3 3.3 3.0 2.7 2.3 2.3 5.0 3.5 1.7 3.1 2.0 2.8 2.7 1.5 4.0 3.8 1.3 4.3 3.6 3.7 1.6 2.1 4.1 3.4 3.5 2.7 3.8 6.3 1.8 2.5 3.2 4.1 3.2 1.8 1.5 3.4 2.0 3.1 3.7 2.4 1.5 1.9 1.4 1.2 2.4 1.3 2.6 1.7 1.3 1.4 2.8 3.7 1.8 2.3 4.0 2.1 4.0 1.7 1.7 1.9 4.4 2.4 2.2 2.5 1.7 3.7 2.9 2.6 2.6 3.2 1.9 1.4 1.4 5.0 3.6 5.3 2.9 1.1 3.4 4.9 2.7 1.9 1.4 1.6 2.4 2.2 2.7 1.9 3.2 1.3 2.7 2.4 1.8 1.8 1.3 1.7 2.4 1.5 5.4 2.2 4.8 1.4 3.7 0.8 1.5 1.3 1.0 1.7 1.1 1.2 1.2 0.7 1.4 1.7 1.5 2.2 1.4 1.2 0.8 2.2 0.8 2.2 2.5 3.4 3.1 2.5 2.6 2.7 2.3 2.3 2.8 2.1 2.7 3.2 11.5 12.8 12.2 13.1 13.9 12.5 13.5 4.6 12.0 6.8 8.4 8.6 7.9 7.2 8.8 9.2 25.0 6.0 21.0 6.9 3.9 4.8 4.7 6.1 13.2 10.9 2.4 13.3 29.5 4.3 4.6 11.0 6.6 6.6 13.3 14.6 11.7 5.0 7.4 5.0 24.8 5.7 10.2 10.4 22.7 4.3 7.5 17.8 12.4 25.3 12.0 5.1 8.2 19.1 22.1 4.9 6.0 8.6 12.7 15.4 4.3 3.5 7.1 10.3 26.3 9.3 11.3 30.3 17.3 13.2 15.9 8.8 20.8 10.6 4.0 16.2 DNAH6 "Dnahc6, DNHL1, FLJ37357, HL-2" ENSG00000115423 "Dynein axonemal heavy chain 6" Q9C0G6 2 84516455-84819589 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;choroid plexus: 10.4;fallopian tube: 5.5" "Cell type enhanced" "Detected in many" "Early spermatids: 77.5;Endometrial ciliated cells: 98.2;Excitatory neurons: 94.2;Respiratory ciliated cells: 143.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036391, HPA061401" Enhanced NA NA "HPA036391: AB_10672220, HPA061401: " "unprognostic (4.87e-2)" "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.72e-2)" "unprognostic (1.67e-1)" "unprognostic (6.43e-2)" "unprognostic (6.06e-2)" "unprognostic (3.46e-1)" "unprognostic (8.11e-8)" "unprognostic (2.04e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.80e-2)" "unprognostic (5.97e-2)" 0.3 0.2 4.5 0.1 2.6 0.0 0.4 1.2 1.8 0.2 10.4 0.1 0.0 0.5 1.2 0.0 5.5 0.1 0.0 1.9 3.5 0.4 1.1 0.8 0.1 4.2 3.4 1.3 0.3 0.2 1.6 0.4 0.0 2.2 0.1 0.2 0.8 0.0 0.2 0.0 0.0 0.1 0.1 4.0 0.0 0.5 2.7 1.4 0.5 1.2 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 4.5 2.6 1.2 1.8 1.9 3.5 4.2 3.4 1.3 2.2 4.0 1.4 1.8 0.6 6.4 4.1 18.6 0.6 0.1 2.2 5.4 0.0 0.8 1.4 1.8 1.2 1.5 13.7 0.0 2.1 0.9 0.3 0.3 0.0 0.3 77.5 98.2 1.5 0.9 0.0 0.4 94.2 0.9 0.2 2.7 4.1 3.0 0.0 1.6 0.0 6.9 0.1 0.0 28.2 1.0 10.2 0.3 0.2 25.0 0.6 0.3 1.8 9.4 0.0 2.0 0.0 5.5 13.7 0.3 0.3 0.7 0.1 1.0 0.2 1.0 143.6 4.8 0.0 2.1 1.7 23.3 5.1 0.0 0.0 0.3 1.3 0.3 1.1 0.3 PECR "HSA250303, SDR29C1, TERP" ENSG00000115425 "Peroxisomal trans-2-enoyl-CoA reductase" Q9BY49 2 215996329-216082955 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 161.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 91.0;Proximal enterocytes: 49.5;Proximal tubular cells: 79.1" "Cancer enhanced" "Detected in all" "liver cancer: 30.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 38.3;RPTEC TERT1: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021593, HPA022539" Enhanced Supported Peroxisomes NA NA Peroxisomes "HPA021593: AB_1855177, HPA022539: AB_1855178" "unprognostic (7.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (2.90e-1)" "unprognostic (6.40e-2)" "unprognostic (1.16e-3)" "unprognostic (3.56e-2)" "unprognostic (4.03e-2)" "unprognostic (1.11e-1)" "unprognostic (5.01e-3)" "unprognostic (5.61e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.63e-2)" "unprognostic (1.84e-2)" "unprognostic (7.75e-2)" "unprognostic (6.64e-2)" 25.6 5.4 2.5 2.9 3.0 7.2 10.3 3.6 2.9 4.5 5.2 8.8 26.3 3.3 4.2 3.1 8.2 9.8 2.4 2.5 2.8 34.3 161.5 6.5 4.0 3.1 3.1 2.6 4.1 4.9 7.2 3.2 1.1 3.2 5.0 7.6 2.2 5.6 3.4 6.8 3.4 20.3 3.3 2.6 3.1 4.0 0.5 2.9 3.4 16.2 5.2 3.8 2.4 2.3 3.5 6.0 6.6 2.6 0.1 15.7 5.7 3.1 1.4 3.3 3.7 6.3 7.6 17.1 0.1 11.9 3.5 9.2 1.4 7.5 8.7 6.5 9.5 7.7 7.8 3.6 38.3 15.7 2.0 5.1 5.0 6.1 3.9 5.5 5.6 3.8 4.6 3.3 8.6 8.2 4.4 2.4 2.2 4.8 0.1 4.9 5.3 5.0 0.9 35.9 1.0 3.6 5.2 3.6 7.4 15.6 6.2 8.6 6.5 0.0 2.4 2.5 6.0 4.3 9.8 8.9 3.1 5.3 2.8 5.6 1.2 4.2 1.5 6.5 1.6 7.7 4.3 8.8 7.5 1.5 5.7 9.2 6.1 4.5 9.9 2.3 0.2 16.6 4.1 2.5 3.0 3.6 2.9 2.5 2.8 3.1 3.1 2.6 3.2 2.6 2.9 3.5 4.3 6.4 13.6 6.5 7.0 3.7 4.7 4.0 3.4 10.8 2.4 2.9 3.7 35.8 3.4 29.5 14.6 3.9 5.9 11.5 13.7 13.2 0.1 10.1 2.7 3.9 7.2 9.4 15.4 3.8 7.3 5.0 7.7 6.3 1.3 2.0 6.8 91.0 9.6 3.3 18.4 8.0 6.1 4.7 3.7 0.3 5.6 5.5 10.6 8.4 27.4 10.1 9.2 8.5 10.6 5.0 17.7 8.2 5.9 2.0 49.5 79.1 13.1 6.4 0.0 6.6 4.4 0.1 1.6 4.9 2.8 1.6 11.4 1.9 14.6 2.7 UNC50 "GMH1, UNCL, URP" ENSG00000115446 "Unc-50 inner nuclear membrane RNA binding protein" Q53HI1 2 98608579-98618515 "Predicted membrane proteins" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027009 Approved NA NA "HPA027009: AB_1858620" "prognostic unfavorable (4.79e-4)" "unprognostic (3.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.74e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (5.31e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.14e-1)" "unprognostic (4.38e-1)" "unprognostic (7.12e-3)" "unprognostic (4.82e-3)" 36.9 49.6 48.0 34.5 49.8 37.2 46.3 49.7 57.8 38.5 53.4 35.4 38.3 46.7 69.8 31.2 43.1 36.6 39.1 47.5 51.7 53.0 47.3 39.0 41.7 49.6 50.1 47.3 44.6 42.4 83.1 41.8 52.7 50.1 41.7 43.6 60.5 56.5 45.8 31.9 40.2 34.7 39.0 50.2 39.6 45.9 49.3 48.6 36.9 64.7 36.2 42.9 38.2 30.8 55.7 55.2 35.6 65.2 44.3 95.7 82.6 73.0 51.2 71.8 61.9 54.2 54.5 64.0 16.6 75.2 44.1 94.0 52.0 45.9 41.5 50.9 56.4 46.2 37.5 47.3 89.4 103.0 71.7 56.7 54.6 92.5 33.1 60.4 71.5 55.1 43.3 61.2 50.2 63.5 39.2 31.7 80.3 49.6 46.1 41.7 20.1 47.3 58.8 68.9 48.6 24.2 35.6 35.9 47.3 86.5 75.8 40.7 91.9 42.7 67.4 41.3 34.5 35.0 76.1 63.2 44.2 63.6 51.7 60.1 61.6 54.3 66.7 50.6 54.9 43.9 52.8 42.2 47.9 54.9 48.1 46.2 52.9 45.3 58.5 51.4 51.3 37.4 44.2 48.0 49.8 49.7 57.8 47.5 51.7 49.6 50.1 47.3 50.1 50.2 48.6 55.7 45.3 25.6 31.0 13.7 35.7 47.2 51.2 139.4 42.7 36.7 46.7 40.8 39.5 38.6 85.8 35.0 16.7 118.6 41.2 27.4 33.2 52.3 47.7 38.3 35.3 48.3 21.6 19.1 21.2 53.2 77.1 58.9 19.4 30.7 27.3 23.7 47.2 33.9 73.2 33.7 24.1 34.1 85.5 31.3 33.3 29.9 54.7 33.0 44.4 19.7 41.7 84.6 48.4 19.1 25.8 40.7 33.0 74.9 51.0 75.7 29.0 46.6 73.8 49.8 46.0 45.0 58.9 215.1 58.7 34.6 49.7 152.6 29.2 39.1 30.1 44.6 IGFBP2 IBP2 ENSG00000115457 "Insulin like growth factor binding protein 2" P18065 2 216632828-216664436 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 964.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077723 Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 303000000 810000000 "Endoplasmic reticulum" "HPA077723: AB_2686853" "unprognostic (2.58e-1)" "unprognostic (5.95e-2)" "unprognostic (1.94e-1)" "unprognostic (3.32e-3)" "unprognostic (9.50e-3)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (9.11e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (5.04e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (1.22e-1)" 140.0 59.3 18.0 28.6 13.1 21.6 91.2 17.9 30.5 86.8 123.2 86.3 77.5 234.4 60.4 146.8 158.4 27.1 162.5 15.6 38.0 188.4 612.7 71.6 8.9 14.3 17.8 12.2 284.1 964.2 12.5 67.5 81.6 18.4 219.1 35.3 2.4 77.0 198.1 23.5 28.9 44.9 50.2 13.6 402.1 496.2 58.5 20.3 33.9 58.2 22.1 14.6 133.7 98.2 13.0 0.1 52.3 402.1 396.3 2139.8 652.9 8.5 125.2 61.9 6.1 0.6 1.2 1.5 0.1 171.7 0.8 15.2 11.5 145.4 156.9 0.6 0.8 84.9 91.3 0.2 26.3 53.3 38.6 5110.0 219.3 15.8 2.5 7.1 12.5 0.2 184.7 3.9 11.7 2.8 103.1 162.8 1106.5 437.4 98.2 4.8 139.2 9.1 2.0 2.0 117.1 84.1 443.4 0.3 3.4 2.6 362.2 332.4 67.3 0.5 1.6 2.4 1.6 6.2 6.2 0.9 9.7 6.0 177.4 478.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 18.0 13.1 17.9 30.5 15.6 38.0 14.3 17.8 12.2 18.4 13.6 20.3 13.0 354.3 3.2 0.6 2.0 3.3 13.8 534.0 238.2 19.4 0.2 79.0 498.0 12.5 11.5 40.1 264.8 2.1 1.8 5.4 86.4 29.4 3.0 1.0 153.2 1379.1 149.2 321.0 31.1 4.5 128.4 7.7 296.7 411.8 176.0 4.5 1649.7 92.1 658.6 5.3 0.0 0.8 191.6 54.9 24.1 5.0 4.9 5.6 21.8 3.6 13.1 1.3 3.6 3.1 1.0 1.0 60.7 51.3 79.4 0.4 255.7 4.2 1.2 195.9 1.7 105.2 17.9 435.7 6.0 35.8 103.3 5.5 2.2 16.0 2199.1 133.8 304.0 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favorable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favorable (2.85e-5)" 10.5 8.2 7.0 3.8 7.0 2.8 8.8 6.4 8.1 7.1 5.0 6.9 4.9 5.7 5.9 5.0 7.0 6.1 5.3 5.8 6.3 6.0 8.9 5.0 5.4 6.8 6.6 5.0 6.5 6.1 9.0 6.7 6.2 6.3 8.5 5.0 3.1 6.3 7.1 12.2 5.1 5.6 6.8 6.6 6.7 7.1 2.8 6.9 5.5 6.3 10.3 5.1 7.4 6.3 6.9 4.9 6.0 6.7 10.0 20.9 9.2 4.0 8.6 6.7 12.6 11.7 5.0 2.4 3.7 6.7 7.2 15.9 5.1 9.7 11.9 11.4 13.0 6.7 6.5 3.4 3.7 10.9 4.9 8.2 9.6 10.6 12.1 13.6 10.6 9.1 7.4 6.6 4.2 11.9 3.9 7.2 2.9 3.3 9.8 6.4 5.2 13.9 3.5 5.8 3.0 6.3 3.3 5.3 7.3 7.9 7.6 4.0 3.5 4.8 9.1 4.9 7.9 8.0 5.0 9.9 4.9 9.1 5.7 9.4 6.5 2.7 8.0 5.0 1.9 2.7 3.1 3.2 2.0 3.2 2.6 2.7 4.8 2.5 5.0 4.5 0.9 5.5 2.8 7.0 7.0 6.4 8.1 5.8 6.3 6.8 6.6 5.0 6.3 6.6 6.9 6.9 9.0 6.4 8.4 36.9 15.7 4.7 10.0 13.0 8.6 27.2 10.7 7.6 5.2 10.0 16.7 11.0 29.2 15.2 9.8 17.3 7.9 8.6 5.6 4.6 6.9 9.5 8.4 7.4 24.3 9.1 5.9 10.0 12.8 4.0 8.9 20.7 12.5 7.5 8.6 30.3 21.4 11.4 14.2 10.0 9.3 5.6 19.3 9.5 17.8 18.7 16.5 14.1 28.8 28.6 49.7 10.4 15.3 23.7 7.7 10.8 24.9 7.1 11.7 30.9 19.7 10.0 8.0 19.7 10.9 6.7 6.5 12.4 14.0 18.3 12.7 9.4 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695549 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 1505.3;ovary: 1335.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 1104.1;Ionocytes: 980.6;Leydig cells: 1828.2;Peritubular cells: 981.7;Sertoli cells: 1275.3;Skeletal myocytes: 2750.9;Smooth muscle cells: 1376.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 831.3;BJ hTERT+: 2192.6;T-47d: 531.7;U-138 MG: 710.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" NA NA 110000000 380000000 "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: AB_2732640, HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 357.8 223.6 32.9 179.8 34.4 0.7 357.7 20.3 33.4 1505.3 55.6 198.6 35.3 844.7 122.3 168.0 961.4 130.4 156.5 50.8 113.4 321.6 34.5 78.8 71.8 34.7 35.8 22.7 1335.3 31.0 30.9 275.0 293.1 34.7 243.5 66.8 106.3 111.9 123.0 475.4 122.6 140.5 626.1 33.9 39.0 326.1 29.1 34.5 95.9 328.9 295.5 46.2 261.4 386.2 51.9 0.0 0.0 210.6 0.9 237.1 7.5 0.8 831.3 2192.6 108.8 10.4 0.0 1.0 0.1 3.3 2.3 0.0 0.1 26.2 0.0 5.6 0.1 8.2 218.1 4.4 0.2 103.1 0.1 1.8 33.1 0.0 14.7 0.1 24.8 0.1 0.2 0.7 0.1 0.5 70.9 0.9 1.2 2.3 0.0 3.4 0.3 0.8 1.2 70.3 249.1 14.5 8.5 14.6 100.4 0.0 12.8 531.7 0.1 80.3 710.2 42.2 109.3 41.0 0.7 0.1 0.1 1.4 0.1 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 34.4 20.3 33.4 50.8 113.4 34.7 35.8 22.7 34.7 33.9 34.5 51.9 237.3 3.2 4.4 40.1 20.6 102.5 13.5 211.0 25.0 8.7 73.9 199.9 92.0 5.7 251.6 112.2 6.2 3.9 1.7 0.0 5.9 10.3 8.4 140.2 250.7 120.8 0.0 0.0 6.0 0.0 4.5 1104.1 30.5 128.5 2.5 11.4 49.6 1.4 8.7 3.3 13.7 0.0 980.6 0.6 189.7 39.9 1828.2 18.4 101.4 29.0 0.6 674.4 0.0 5.5 0.4 2.2 0.0 981.7 5.5 17.0 0.0 1.1 120.9 18.7 1275.3 2750.9 1376.0 2.2 3.0 17.7 67.9 5.6 18.4 124.7 0.1 16.8 USP34 "KIAA0570, KIAA0729" ENSG00000115464 "Ubiquitin specific peptidase 34" Q70CQ2 2 61187463-61471087 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025815, HPA070764" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA025815: AB_1858681, HPA070764: AB_2686308" "unprognostic (4.04e-2)" "unprognostic (8.21e-3)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (8.91e-2)" "unprognostic (4.62e-2)" "unprognostic (9.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (6.34e-2)" "unprognostic (7.01e-2)" 31.7 36.3 53.3 21.9 56.3 38.0 35.9 60.8 56.1 35.8 60.8 41.8 14.9 38.7 54.9 36.1 33.6 21.3 32.7 52.4 55.1 30.1 35.1 36.7 44.5 56.0 55.3 51.7 43.8 32.7 35.4 45.4 17.6 55.2 39.0 27.1 78.2 27.4 32.7 54.4 41.7 41.1 28.1 53.5 46.2 36.6 45.5 56.7 48.2 32.5 37.2 45.5 37.3 33.0 59.8 43.6 29.9 38.9 40.3 71.8 48.1 32.4 26.3 37.1 23.0 21.7 43.0 16.3 102.2 27.0 56.9 24.3 23.4 30.9 34.4 42.6 36.7 24.4 61.6 29.5 69.6 60.2 46.1 37.8 52.9 43.6 41.9 62.1 55.7 49.0 28.8 42.7 32.2 51.5 40.6 30.6 66.6 26.3 43.9 23.9 32.4 46.5 27.7 67.9 52.2 31.9 34.0 40.5 30.1 48.3 49.4 16.0 33.2 43.6 36.1 48.2 21.5 34.7 37.0 19.7 103.6 33.8 42.5 31.7 2.1 1.2 1.6 3.8 1.1 3.5 2.6 2.6 2.9 1.0 3.1 2.9 3.9 1.8 3.1 2.8 3.2 2.5 1.4 53.3 56.3 60.8 56.1 52.4 55.1 56.0 55.3 51.7 55.2 53.5 56.7 59.8 64.5 64.1 68.3 193.6 82.8 61.1 54.2 40.3 46.7 139.7 54.0 46.6 46.0 48.6 54.6 33.1 250.2 33.5 87.3 46.0 9.8 41.4 133.5 59.9 66.9 59.3 48.6 53.2 256.6 33.6 23.8 53.0 73.9 70.6 32.3 78.0 31.8 38.9 21.6 107.7 240.4 37.8 59.0 45.4 48.6 138.0 56.8 56.0 40.9 212.7 55.2 60.0 87.6 232.2 310.0 49.9 41.1 67.0 69.9 79.9 38.3 23.4 44.1 178.1 26.3 78.2 63.9 95.8 115.9 53.1 61.4 53.4 70.5 74.7 35.6 69.9 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 427.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9" "Cancer enriched" "Detected in all" 5 "breast cancer: 100.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" No NA 14000 "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: AB_2680716, HPA056959: AB_2683288" "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 77.1 7.1 206.3 3.7 306.5 0.8 182.6 255.8 248.9 85.2 155.1 16.3 4.5 73.0 34.0 9.6 74.4 12.1 35.4 205.9 235.6 167.4 55.0 15.4 3.9 264.6 271.4 177.3 77.1 87.3 10.6 16.6 78.5 296.9 25.8 5.8 9.6 22.4 28.0 35.8 27.1 16.3 20.8 236.3 52.9 17.7 20.3 256.6 3.1 32.9 43.1 2.5 22.2 44.9 427.5 0.0 3.4 5.7 1.4 2.2 0.1 125.8 26.8 2.1 2.3 1.9 0.9 0.6 0.1 2.0 11.6 2.9 0.2 19.0 0.0 0.3 0.5 9.2 0.0 2.4 1.9 0.0 0.1 0.3 1.0 0.4 0.2 0.0 0.4 0.0 5.5 3.9 0.5 0.5 2.3 0.6 0.2 8.4 0.0 0.2 0.6 7.2 0.4 68.6 0.7 0.3 3.2 9.1 301.8 18.3 42.3 236.9 2.6 0.0 0.0 1.8 0.4 0.8 0.2 0.1 0.1 0.3 0.1 13.4 1.0 0.2 0.1 0.2 0.1 0.4 0.3 0.3 0.4 0.1 0.1 0.6 0.6 2.2 0.1 0.1 0.2 0.1 0.1 206.3 306.5 255.8 248.9 205.9 235.6 264.6 271.4 177.3 296.9 236.3 256.6 427.5 15.6 0.0 0.0 37.5 1.5 3.6 2.8 1.3 1.2 0.5 241.8 129.0 7.4 1.5 4.6 35.0 0.0 112.0 3.0 0.3 393.2 0.0 9.0 1.1 37.8 16.8 0.0 2.7 2.6 0.0 19.7 41.1 0.0 1.7 0.0 3.2 6.4 89.4 8.7 0.0 5.3 0.1 59.0 1.3 3.0 7.0 44.4 2.1 8.8 18.7 0.0 48.0 0.0 1.5 173.4 0.0 0.0 57.2 0.1 4.6 0.0 116.5 1.9 1.4 197.2 8.7 130.9 17.3 13.6 0.4 3.1 263.9 2.5 1.5 0.3 2.0 KCNJ13 "Kir1.4, Kir7.1, LCA16" ENSG00000115474 "Potassium inwardly rectifying channel subfamily J member 13" O60928 2 232765802-232776565 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cataract, Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 131.4;intestine: 92.1" "Group enriched" "Detected in some" 4 "Muller glia cells: 54.8;Proximal enterocytes: 217.4;Undifferentiated cells: 68.1" "Cancer enriched" "Detected in some" 5 "melanoma: 5.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "U-2197: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051609 Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA051609: " "unprognostic (4.29e-2)" "unprognostic (2.00e-1)" "unprognostic (2.69e-1)" "unprognostic (9.03e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-2)" "unprognostic (2.26e-1)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.41e-1)" "unprognostic (4.90e-2)" "unprognostic (1.86e-2)" "unprognostic (2.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-2)" "unprognostic (1.11e-2)" 0.1 0.1 0.9 0.0 1.4 0.4 0.1 7.2 2.4 0.1 131.4 0.1 7.9 0.1 0.3 0.1 0.0 2.2 0.1 8.4 0.5 3.3 0.2 0.1 0.2 1.5 3.7 0.1 0.2 0.8 16.0 0.2 0.0 1.5 0.1 0.0 13.8 0.2 1.1 0.1 3.3 92.1 0.1 0.5 0.1 2.4 0.5 4.6 0.1 7.1 0.0 0.0 0.1 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.3 0.0 0.2 0.2 0.1 0.0 1.9 0.3 0.3 0.3 0.0 0.4 0.2 0.6 0.2 0.1 0.3 0.7 0.3 0.3 0.4 0.4 0.3 1.0 0.0 0.9 1.4 7.2 2.4 8.4 0.5 1.5 3.7 0.1 1.5 0.5 4.6 3.5 0.1 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.5 0.5 0.0 0.0 1.8 0.0 0.0 0.2 0.1 1.9 0.0 3.0 0.7 0.3 0.2 0.0 0.0 1.1 1.3 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 25.7 0.0 0.0 0.0 0.6 0.0 0.1 21.4 0.0 0.0 54.8 0.0 1.5 2.0 0.0 8.8 0.0 0.0 0.1 217.4 0.2 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 68.1 0.0 CCT4 Cctd ENSG00000115484 "Chaperonin containing TCP1 subunit 4" P50991 2 61868085-61888671 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029349 Supported Supported Nucleoplasm,Cytosol NA NA 1700000 Cytosol Nucleoplasm "HPA029349: AB_10600800" "prognostic unfavorable (2.03e-4)" "unprognostic (2.80e-2)" "unprognostic (6.46e-2)" "unprognostic (1.74e-3)" "unprognostic (5.03e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (9.37e-12)" "unprognostic (1.28e-3)" "unprognostic (2.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-2)" "unprognostic (5.18e-2)" "unprognostic (2.00e-1)" "unprognostic (3.96e-1)" "unprognostic (2.14e-2)" 62.9 67.6 63.7 60.4 63.3 65.5 91.1 68.0 94.3 67.5 70.0 60.7 46.2 69.4 51.3 76.2 75.1 43.5 64.2 70.0 66.9 74.2 64.2 49.2 82.1 67.3 68.7 60.7 110.3 96.1 63.3 46.2 66.4 68.4 58.3 59.5 57.3 54.2 58.0 97.5 64.6 48.9 72.6 72.8 55.7 65.1 78.3 68.4 84.0 65.9 74.6 92.7 69.0 61.7 81.1 274.5 313.6 203.1 190.1 166.2 251.5 342.5 244.6 174.3 345.6 230.4 550.5 193.2 437.9 239.7 176.5 354.6 192.4 405.8 313.9 362.3 216.0 398.9 280.4 149.4 347.7 149.3 347.8 179.1 215.0 214.4 278.8 287.2 259.5 293.3 220.0 406.5 137.2 297.5 246.4 299.6 451.2 365.3 364.2 276.0 336.9 319.2 297.4 237.5 186.2 177.6 148.8 177.2 221.9 324.5 235.7 161.9 245.6 185.2 190.6 275.5 143.3 400.1 205.3 297.3 739.8 188.9 391.7 255.7 58.2 60.7 25.0 83.2 88.9 106.9 93.6 87.1 100.8 100.4 88.6 112.9 112.2 8.4 107.5 103.3 64.3 100.7 125.2 63.7 63.3 68.0 94.3 70.0 66.9 67.3 68.7 60.7 68.4 72.8 68.4 81.1 111.8 73.7 54.3 20.9 125.4 152.6 350.8 206.6 136.1 52.9 131.3 136.4 47.7 82.9 116.7 73.5 14.6 256.5 106.5 52.8 135.0 156.0 250.0 111.9 117.2 118.0 140.6 156.9 28.0 130.6 284.9 114.9 67.8 92.8 95.8 148.2 95.3 79.4 163.5 32.0 31.3 105.9 175.0 105.0 112.4 72.1 88.3 110.2 94.3 30.0 125.8 64.9 71.1 26.7 40.8 143.9 61.4 97.8 111.9 200.3 67.9 165.2 143.1 63.3 92.1 117.2 297.8 338.8 153.2 151.2 151.3 180.6 146.6 173.7 138.2 203.8 GGCX VKCFD1 ENSG00000115486 "Gamma-glutamyl carboxylase" P38435 2 85544720-85561547 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" Lyase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 119.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018284 Enhanced NA NA "HPA018284: AB_1849641" "unprognostic (4.88e-3)" "unprognostic (1.13e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.82e-6)" "unprognostic (5.67e-2)" "unprognostic (1.85e-3)" "unprognostic (2.96e-2)" "unprognostic (3.77e-2)" "unprognostic (5.64e-2)" "unprognostic (2.18e-2)" "unprognostic (6.45e-3)" "unprognostic (5.23e-2)" "unprognostic (8.17e-3)" "unprognostic (7.85e-2)" "unprognostic (2.59e-1)" "unprognostic (7.63e-3)" "unprognostic (9.38e-2)" 13.9 11.1 6.2 8.4 7.3 3.2 10.9 8.3 7.8 10.8 10.7 7.8 7.5 10.6 13.9 9.3 10.6 11.4 9.6 6.9 9.7 16.4 119.8 13.9 6.3 7.2 7.0 5.9 12.5 15.9 18.2 7.9 23.6 7.2 10.1 10.0 7.7 14.8 12.2 7.9 9.2 7.3 13.5 7.7 6.2 9.2 4.7 7.0 4.9 12.7 8.6 7.3 12.3 8.9 11.3 17.1 27.2 19.0 21.3 93.8 26.6 42.2 29.9 35.1 21.6 30.4 47.3 20.6 6.1 29.7 49.3 27.1 27.2 13.7 37.7 23.7 10.9 18.7 11.1 17.4 45.2 34.8 7.0 10.1 33.1 22.0 43.8 29.7 35.6 31.0 10.8 13.5 8.7 63.5 22.4 3.5 5.3 8.9 47.7 23.4 6.6 44.6 15.3 30.0 32.5 7.2 12.1 26.8 52.2 28.2 32.1 25.6 6.8 28.6 27.5 23.9 27.1 20.9 6.8 20.1 5.1 26.5 7.1 39.4 3.7 4.2 2.2 1.7 4.4 1.6 0.4 0.7 0.7 2.9 0.4 1.7 1.6 1.7 1.4 2.6 2.4 1.2 2.0 6.2 7.3 8.3 7.8 6.9 9.7 7.2 7.0 5.9 7.2 7.7 7.0 11.3 27.1 28.9 40.3 10.1 25.1 18.7 20.6 27.8 13.6 21.6 22.9 19.8 27.9 32.9 24.1 29.5 16.7 60.8 28.4 16.1 7.9 29.9 4.2 16.9 19.4 20.8 14.4 5.7 10.9 39.5 50.2 29.4 11.7 26.8 15.8 17.8 23.9 163.0 31.3 8.4 8.9 17.6 22.4 26.9 29.0 2.2 20.2 24.5 21.4 5.6 29.6 19.5 17.5 9.5 12.6 25.0 12.6 20.3 38.4 16.4 16.2 27.1 16.9 33.6 6.6 42.3 22.8 23.5 11.2 20.0 15.2 53.8 20.8 15.1 16.4 23.6 NEU2 SIAL2 ENSG00000115488 "Neuraminidase 2" Q9Y3R4 2 233032672-233035057 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.8" CAB022336 Uncertain NA NA 25000 "CAB022336: " "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EHBP1 "KIAA0903, NACSIN" ENSG00000115504 "EH domain binding protein 1" Q8NDI1 2 62673851-63046487 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 203.4;Early spermatids: 220.3;Excitatory neurons: 262.3;Inhibitory neurons: 245.4;Late spermatids: 495.6;Oligodendrocyte precursor cells: 226.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035468, HPA035469" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035468: AB_10671513, HPA035469: AB_10601365" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (8.78e-2)" "unprognostic (3.83e-3)" "unprognostic (1.43e-1)" "unprognostic (1.57e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.78e-1)" "unprognostic (1.95e-1)" "unprognostic (3.33e-2)" "unprognostic (3.14e-1)" "unprognostic (3.13e-3)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (1.95e-8)" 30.3 17.3 17.0 10.8 17.6 6.4 17.6 29.7 21.2 29.3 13.7 32.3 9.8 31.4 7.9 29.7 21.5 20.6 9.5 20.9 18.9 17.3 54.4 11.7 8.9 14.7 23.3 15.8 48.5 16.0 15.3 12.3 12.0 16.3 16.2 14.4 21.1 15.8 18.8 8.1 12.8 15.0 30.2 13.1 8.1 17.7 37.8 20.9 13.6 14.6 13.2 10.3 18.3 21.8 17.9 49.7 66.9 26.8 16.4 46.1 89.0 27.2 43.6 42.4 31.6 25.9 80.4 36.2 34.2 15.4 79.8 47.5 29.1 35.1 30.5 51.9 36.3 16.5 29.7 22.9 95.2 31.5 17.5 21.5 40.9 54.1 31.6 61.9 31.3 20.5 26.7 20.6 19.1 51.1 19.4 20.0 10.9 26.3 40.8 26.2 17.8 33.8 14.9 20.8 16.1 29.6 23.6 35.1 25.9 43.0 28.5 12.6 17.0 15.2 33.3 34.4 55.8 23.0 21.5 16.2 32.7 33.3 26.3 69.4 0.2 2.2 2.5 4.1 2.4 4.0 6.3 4.2 3.9 3.7 4.9 4.2 3.6 0.8 3.4 1.3 2.4 2.5 2.2 17.0 17.6 29.7 21.2 20.9 18.9 14.7 23.3 15.8 16.3 13.1 20.9 17.9 29.0 38.5 18.8 203.4 10.4 15.6 12.0 27.1 43.3 39.7 10.5 12.8 15.2 22.8 20.7 14.7 4.2 10.9 9.9 5.3 15.6 22.1 220.3 10.3 45.4 19.9 16.2 8.8 262.3 40.5 30.1 36.6 9.2 12.1 2.5 15.2 30.0 59.6 5.0 18.5 245.4 5.4 6.1 8.6 11.4 495.6 58.4 7.6 10.6 119.0 6.5 20.1 13.4 226.7 98.7 41.7 5.0 40.3 9.6 13.9 11.4 15.1 14.5 17.8 6.6 33.1 19.4 53.7 31.1 55.4 14.2 2.9 12.7 18.2 8.1 13.1 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "salivary gland: 18.2;skin 1: 7.9" "Cell type enhanced" "Detected in some" "Astrocytes: 9.8;Basal respiratory cells: 6.3;Club cells: 4.1;Ionocytes: 6.1;Respiratory ciliated cells: 6.8;Suprabasal keratinocytes: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 95 "neutrophil: 9.4" "Lineage enriched" "Detected in single" 95 "granulocytes: 9.4" "Cell line enriched" "Detected in many" 9 "THP-1: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052122 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.1 0.0 1.8 0.0 1.3 0.0 0.2 0.7 2.5 0.0 2.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.1 0.0 0.8 1.9 1.1 0.0 0.2 0.0 0.0 0.0 1.1 0.7 0.0 0.0 18.2 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.2 0.3 2.0 0.0 0.0 0.0 0.5 0.0 0.1 1.5 2.3 1.3 4.2 2.5 0.0 0.1 5.9 0.0 0.3 0.3 0.4 4.4 2.2 0.1 0.8 0.0 1.1 3.0 2.7 1.9 0.5 1.1 2.5 2.7 2.2 5.0 0.0 1.9 2.0 0.0 0.7 0.0 0.7 0.8 0.0 2.6 2.4 0.0 0.2 2.1 2.6 4.6 0.0 2.2 1.6 2.3 3.6 0.7 1.2 0.8 0.4 0.5 1.8 0.2 1.5 0.0 1.0 54.1 0.1 0.9 1.7 0.0 0.9 1.5 1.1 4.0 0.3 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.7 2.5 1.8 0.9 0.8 1.9 1.1 1.1 0.0 2.0 1.5 0.2 0.0 0.0 9.8 0.1 1.7 0.0 6.3 0.6 0.0 0.8 1.0 0.8 0.0 4.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.2 0.6 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.7 0.3 0.3 0.5 1.1 2.6 0.1 0.0 0.1 0.2 0.1 TXNDC9 APACD ENSG00000115514 "Thioredoxin domain containing 9" O14530 2 99318982-99340702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031844, HPA031845, HPA031846" Approved Enhanced Cytosol NA NA Cytosol "HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916" "unprognostic (3.63e-3)" "unprognostic (4.26e-2)" "unprognostic (7.28e-2)" "unprognostic (3.12e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (9.63e-7)" "unprognostic (2.06e-2)" "unprognostic (9.09e-2)" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.47e-3)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" 18.8 18.0 11.0 21.5 11.8 17.6 29.0 11.7 13.3 19.5 11.4 24.8 18.5 16.8 26.1 26.3 18.3 18.7 28.8 11.7 12.5 29.1 27.5 20.3 29.5 12.5 12.2 10.9 10.8 11.0 15.5 11.4 23.7 12.8 19.7 26.6 11.1 15.3 16.3 18.4 19.2 17.7 24.6 12.7 18.8 18.6 17.9 11.9 26.4 25.0 16.3 34.3 25.2 14.3 13.4 78.3 27.6 55.0 27.7 55.8 57.8 65.8 83.1 79.5 88.5 85.0 71.1 55.5 58.0 66.9 72.6 77.0 52.7 55.2 88.2 102.6 44.0 53.5 60.4 34.5 77.0 54.2 71.8 44.2 53.0 76.7 74.3 53.8 46.1 101.9 32.1 73.0 51.1 103.7 41.5 43.4 63.6 43.4 46.4 68.7 32.5 53.0 56.4 123.9 62.6 37.1 31.5 41.7 56.2 93.7 69.8 64.3 60.9 69.4 65.1 62.7 40.6 62.6 21.2 37.1 65.6 51.9 76.8 58.6 110.6 54.1 61.1 56.7 60.5 70.2 69.1 66.6 64.4 60.3 57.6 61.9 62.5 53.5 77.7 82.6 60.9 91.2 87.0 11.0 11.8 11.7 13.3 11.7 12.5 12.5 12.2 10.9 12.8 12.7 11.9 13.4 46.6 9.6 13.4 8.8 33.4 35.2 29.7 137.1 25.0 11.3 21.5 26.3 27.6 25.8 67.0 36.8 8.4 75.7 31.3 26.2 84.1 79.8 75.7 37.3 29.9 46.2 20.9 47.8 13.3 69.4 82.5 29.2 22.4 25.5 17.7 21.0 38.2 24.4 56.9 13.5 12.8 25.7 91.6 25.4 31.3 21.1 27.7 30.2 26.6 4.7 55.5 26.9 44.3 12.5 16.7 84.5 21.6 23.3 31.8 24.0 21.9 121.5 72.8 19.8 26.3 17.8 89.3 52.8 42.7 29.4 38.9 81.3 35.1 40.1 26.6 21.9 COQ10B FLJ13448 ENSG00000115520 "Coenzyme Q10B" Q9H8M1 2 197453423-197475308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046057 Approved Approved Cytosol NA NA Cytosol "HPA046057: AB_2679518" "unprognostic (9.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.82e-3)" "unprognostic (8.28e-3)" "unprognostic (5.76e-3)" "unprognostic (4.55e-1)" "unprognostic (2.93e-1)" "unprognostic (7.18e-2)" "unprognostic (6.00e-2)" "unprognostic (4.13e-2)" "unprognostic (3.99e-1)" "unprognostic (2.87e-3)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (3.13e-3)" 25.2 38.0 16.3 17.5 16.4 47.2 19.2 17.0 19.5 15.9 19.0 19.9 16.3 16.7 16.0 19.0 13.1 26.3 34.6 17.3 18.7 28.8 35.4 17.8 19.9 17.3 17.7 16.2 10.6 16.0 29.9 14.5 21.8 17.6 17.7 20.5 18.5 12.8 17.7 12.9 12.6 15.6 25.1 18.1 19.0 18.5 10.8 17.8 17.5 21.3 19.2 19.6 31.3 12.3 19.6 15.7 14.7 10.5 18.8 49.6 35.3 24.6 40.2 57.5 42.3 46.8 30.0 18.5 14.7 33.4 32.5 52.5 14.1 15.3 21.3 47.8 29.0 13.2 21.0 19.1 35.4 41.5 17.0 46.6 39.5 32.8 40.3 28.5 22.9 23.3 20.9 17.9 38.1 40.9 20.4 18.6 26.4 16.2 18.4 30.0 13.9 15.7 19.4 45.7 42.0 6.8 13.1 18.4 23.9 52.0 37.2 17.1 23.9 24.6 41.4 14.4 46.8 29.3 36.0 55.0 16.5 51.7 16.3 32.7 70.8 30.0 57.5 43.7 35.5 49.2 32.8 41.4 43.6 26.4 25.2 43.0 44.4 90.7 34.1 42.8 16.7 56.5 38.0 16.3 16.4 17.0 19.5 17.3 18.7 17.3 17.7 16.2 17.6 18.1 17.8 19.6 73.2 19.2 19.9 7.2 54.4 105.5 106.5 55.7 44.9 30.2 42.3 24.3 29.0 24.3 42.3 40.5 41.7 32.7 62.5 43.7 129.1 44.9 38.7 35.8 34.5 48.9 26.9 38.3 12.4 46.1 43.7 67.6 33.1 43.5 60.3 12.2 22.9 36.7 32.0 63.9 11.8 44.3 57.0 23.8 74.6 20.7 20.5 44.3 71.2 7.5 29.2 56.7 49.4 7.1 16.0 54.2 36.3 30.5 45.1 65.6 30.0 73.7 41.7 36.6 46.0 60.8 71.0 20.9 39.4 29.0 106.6 173.9 70.9 33.7 19.1 100.0 GNLY "D2S69E, LAG-2, LAG2, NKG5, TLA519" ENSG00000115523 Granulysin P22749 2 85685175-85698852 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 290.9;lymphoid tissue: 87.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5070.6;NK-cells: 8318.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "NK-cell: 17623.2" "Group enriched" "Detected in all" 63 "NK-cells: 17623.2;T-cells: 7874.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025186, HPA058021" Enhanced "Secreted to blood" NA NA 2920000 17000 "CAB025186: , HPA058021: AB_2683581" "unprognostic (5.80e-2)" "unprognostic (5.64e-3)" "unprognostic (6.68e-2)" "prognostic favorable (3.48e-5)" "unprognostic (4.34e-2)" "unprognostic (9.22e-2)" "unprognostic (2.60e-1)" "unprognostic (2.79e-2)" "prognostic favorable (6.60e-5)" "unprognostic (2.61e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.86e-1)" "prognostic favorable (8.07e-4)" 6.6 2.7 10.1 11.7 10.4 290.9 5.2 9.8 15.7 4.3 9.9 5.8 4.0 72.6 4.0 2.6 6.1 6.5 4.2 9.6 13.3 2.9 10.5 37.1 22.1 14.4 12.8 9.1 1.5 1.2 0.8 1.8 17.2 12.0 2.1 6.1 0.5 2.0 5.4 9.3 1.5 10.4 4.4 10.5 87.0 5.1 0.9 11.1 3.5 3.6 3.5 17.8 6.5 2.5 19.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.1 0.0 177.1 26.2 17.7 7874.6 26.3 2145.8 34.2 837.4 3344.7 22.4 23.0 231.3 2928.7 202.5 17623.2 32.3 58.2 40.3 8118.6 10.1 10.4 9.8 15.7 9.6 13.3 14.4 12.8 9.1 12.0 10.5 11.1 19.2 26.8 12.8 78.9 0.0 23.3 7.0 0.2 0.0 0.0 0.1 7.2 3.7 3.0 10.0 6.2 0.0 2.1 2.3 5070.6 1.3 1.9 1.9 0.0 7.5 12.0 13.0 1.8 47.2 0.2 0.0 3.4 29.3 0.5 10.6 52.4 0.1 23.2 5.3 6.0 0.0 0.1 3.3 0.0 22.4 7.2 0.2 0.3 28.4 80.0 9.4 48.6 0.1 8318.3 0.0 0.1 0.0 1.2 0.0 247.4 0.1 2.4 9.5 3.6 0.2 0.0 7.0 5.4 0.2 0.6 0.6 7.7 1.1 1230.0 1.0 1.6 0.6 SF3B1 "Hsh155, Prp10, PRPF10, SAP155, SF3b155" ENSG00000115524 "Splicing factor 3b subunit 1" O75533 2 197388515-197435079 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050275 Approved Enhanced "Nuclear speckles" NA NA 94000 "Nuclear speckles" "HPA050275: AB_2681071" "unprognostic (6.86e-2)" "unprognostic (2.78e-1)" "unprognostic (2.14e-1)" "unprognostic (3.51e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-3)" "unprognostic (2.44e-3)" "unprognostic (3.31e-3)" "unprognostic (1.25e-2)" "unprognostic (2.20e-1)" "unprognostic (6.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.57e-2)" "unprognostic (9.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" 175.6 175.3 106.0 133.9 116.5 307.5 182.3 125.6 127.1 215.0 138.5 171.2 111.4 197.4 201.8 137.9 185.3 124.3 133.2 104.0 110.6 135.3 169.9 164.2 204.7 110.4 110.5 102.0 228.4 202.4 156.1 148.9 166.7 113.8 164.6 148.7 139.6 181.8 134.5 173.8 151.5 233.5 117.5 109.7 290.1 170.6 92.2 107.4 223.9 169.2 146.0 201.0 155.7 168.5 140.8 134.9 105.4 288.6 155.9 222.8 219.2 237.8 172.6 196.7 163.2 205.9 233.0 147.2 247.5 116.6 193.1 165.8 133.7 273.4 151.2 271.8 196.5 154.8 237.5 257.4 294.3 155.4 270.1 198.6 232.1 163.0 175.9 209.3 278.6 205.9 171.0 210.2 174.0 192.3 134.2 251.1 285.6 231.4 167.5 163.8 234.4 197.9 182.9 245.8 286.4 154.2 186.7 174.7 118.2 139.2 345.1 115.2 242.5 186.8 126.9 109.4 123.3 145.8 168.7 238.8 342.0 123.7 174.8 146.5 49.8 50.4 57.5 54.5 51.7 55.4 46.1 46.2 50.9 60.5 44.1 48.7 49.2 60.8 56.7 52.5 37.5 71.3 56.2 106.0 116.5 125.6 127.1 104.0 110.6 110.4 110.5 102.0 113.8 109.7 107.4 140.8 175.6 179.5 222.9 92.4 187.4 119.0 172.0 127.1 125.7 103.4 96.4 83.3 129.2 72.9 194.0 92.0 73.0 116.8 224.1 90.1 56.7 104.8 9.2 123.9 191.0 143.1 110.5 109.0 55.5 94.8 102.3 151.6 132.0 179.0 246.9 171.1 107.1 74.4 100.6 94.2 59.7 108.1 89.5 124.7 144.1 20.6 120.2 166.1 76.5 75.9 163.9 111.1 116.4 87.0 121.1 112.0 68.3 104.6 195.6 103.8 84.2 70.5 221.5 98.5 118.3 159.5 227.9 104.6 100.5 94.3 118.8 142.7 216.2 119.4 91.4 156.1 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 47.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 112.8;Oligodendrocyte precursor cells: 94.0;Oligodendrocytes: 108.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 54.4;RT4: 47.0;SK-MEL-30: 40.8;U-266/84: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles NA NA Vesicles "HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060" "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favorable (4.99e-4)" "prognostic favorable (4.48e-4)" 13.9 47.8 16.2 4.7 25.6 2.4 8.6 15.2 19.8 5.4 7.3 4.9 1.0 9.9 0.9 2.7 10.5 8.2 4.1 14.8 18.8 2.4 9.9 14.8 9.1 23.9 22.3 11.7 10.2 3.9 0.4 12.9 17.9 27.4 6.7 2.6 31.3 7.1 0.5 12.5 6.1 6.9 3.5 20.3 20.1 5.6 10.8 21.5 5.0 28.1 3.5 4.4 21.0 6.0 41.2 0.3 27.0 2.5 54.4 22.0 11.8 8.0 5.9 18.0 5.6 5.0 0.5 19.6 0.7 0.2 10.2 2.5 1.0 3.6 6.4 7.0 0.2 3.2 0.6 1.1 1.0 17.6 0.4 7.8 6.9 0.8 2.1 0.8 10.1 13.7 7.4 0.8 30.2 18.3 1.8 1.9 3.1 0.2 9.6 0.0 3.5 17.0 11.0 2.9 47.0 3.8 3.8 0.2 0.1 40.8 5.4 0.2 1.1 4.5 0.1 2.7 0.1 0.4 30.0 42.5 0.5 4.2 5.6 27.7 0.6 0.8 0.1 0.6 3.0 0.8 1.1 0.3 0.4 0.5 0.7 0.3 0.3 0.6 0.6 2.4 0.2 0.1 0.3 16.2 25.6 15.2 19.8 14.8 18.8 23.9 22.3 11.7 27.4 20.3 21.5 41.2 8.5 86.6 112.8 37.5 29.1 5.6 27.6 20.5 1.2 56.6 3.1 2.3 1.9 40.0 33.9 3.7 58.4 0.4 48.3 0.2 3.9 12.0 12.3 9.0 27.8 8.1 6.7 0.4 46.9 16.6 1.1 21.7 6.1 8.5 34.8 35.2 29.6 21.1 35.6 72.3 60.2 0.1 12.2 45.4 18.1 12.0 8.1 24.9 32.0 45.9 20.1 56.0 12.3 94.0 108.4 6.2 0.1 1.9 19.5 6.8 0.0 3.7 10.7 45.2 0.0 21.3 5.0 8.4 16.1 0.2 3.8 0.3 28.9 6.3 0.1 8.3 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417668 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" NA NA 680000 Cytosol "HPA012884: AB_1846710, HPA051545: AB_2681529" "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favorable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.3 6.8 25.7 4.2 26.3 3.3 5.2 23.0 30.4 6.5 17.5 4.8 2.3 11.6 13.4 4.2 9.8 5.5 11.1 26.5 26.2 4.3 1.2 8.2 4.4 23.9 25.4 24.8 12.8 5.7 9.7 11.6 8.3 23.2 8.1 2.4 9.5 6.2 5.3 6.1 2.1 3.6 12.1 23.1 5.1 4.4 6.2 29.5 5.8 10.1 8.4 5.5 5.6 3.8 23.7 0.2 14.6 28.4 14.6 8.5 11.9 14.2 16.7 11.8 22.4 14.3 0.3 8.5 20.4 14.1 10.1 39.6 0.0 20.2 2.2 14.3 29.1 21.2 10.5 8.3 23.1 10.1 21.5 26.5 8.8 2.7 10.6 2.0 10.7 17.8 19.5 31.0 0.1 9.7 4.8 19.1 16.8 42.0 0.2 17.7 13.6 17.6 0.2 6.2 6.4 30.5 24.9 1.2 0.1 23.3 20.0 7.8 29.0 16.4 15.5 24.5 11.7 15.7 0.0 0.1 21.2 19.0 18.7 18.6 0.0 0.0 0.0 1.3 0.0 0.4 0.8 0.2 1.0 0.2 0.6 0.3 0.7 0.0 0.0 0.0 1.1 0.0 0.5 25.7 26.3 23.0 30.4 26.5 26.2 23.9 25.4 24.8 23.2 23.1 29.5 23.7 2.8 16.0 3.1 21.5 4.4 0.9 1.1 0.3 0.6 9.7 2.4 2.0 6.3 1.5 4.4 1.8 0.0 5.4 2.3 0.0 3.9 3.5 1.5 2.7 6.7 4.9 1.8 3.0 10.7 2.9 10.5 5.0 0.0 6.2 0.0 6.5 0.4 0.0 6.2 6.7 7.5 0.0 0.0 0.8 1.1 0.4 2.1 1.3 0.0 6.5 3.2 16.7 1.0 12.5 5.9 2.2 0.0 5.3 2.3 1.5 0.0 1.1 0.7 4.8 0.0 3.7 3.5 1.5 5.1 0.3 0.6 1.4 3.4 8.5 0.1 0.2 PDCL3 VIAF1 ENSG00000115539 "Phosducin like 3" Q9H2J4 2 100562993-100576739 "Predicted intracellular proteins" "Angiogenesis, Apoptosis" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018469, HPA027094" Approved Enhanced Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA018469: AB_1855116, HPA027094: AB_10601387" "unprognostic (1.34e-1)" "unprognostic (8.30e-2)" "unprognostic (2.20e-1)" "unprognostic (3.32e-2)" "unprognostic (5.07e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.07e-5)" "unprognostic (1.44e-1)" "unprognostic (5.46e-2)" "unprognostic (1.66e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (8.22e-2)" "prognostic favorable (4.23e-4)" 21.0 22.2 21.8 27.3 23.4 23.1 23.2 23.6 24.5 19.1 19.7 27.6 17.2 24.3 37.5 37.2 22.7 21.5 30.9 20.6 23.0 28.7 18.7 18.5 25.5 24.2 26.5 20.0 21.3 11.5 23.6 10.6 23.6 25.5 27.2 29.1 21.2 17.1 23.4 59.4 37.1 17.4 38.9 23.7 17.2 17.8 23.0 24.1 22.6 21.6 34.6 34.3 33.4 17.6 24.6 41.8 58.7 59.9 52.2 19.3 27.4 67.5 51.3 32.5 92.9 58.1 74.2 25.5 68.6 74.0 62.3 122.3 34.2 76.0 50.2 74.0 110.6 65.8 72.0 31.8 89.7 50.8 77.3 73.2 29.8 92.0 82.0 52.3 24.2 58.9 52.8 61.1 43.8 70.7 74.6 75.8 117.7 77.9 45.6 86.6 72.5 63.2 48.0 58.2 98.7 55.9 49.6 41.0 54.7 59.0 48.6 42.3 53.0 45.8 56.4 60.1 44.8 72.2 26.4 54.1 68.3 34.4 90.5 45.7 82.3 64.8 80.2 63.1 124.4 72.8 92.5 95.0 70.4 114.9 78.1 97.7 75.4 7.0 93.9 161.7 64.0 113.6 87.3 21.8 23.4 23.6 24.5 20.6 23.0 24.2 26.5 20.0 25.5 23.7 24.1 24.6 37.4 19.2 25.2 1.6 39.5 65.6 36.6 79.2 52.9 13.0 24.8 36.2 40.9 18.6 46.1 14.7 6.2 70.8 61.5 16.0 60.7 50.6 37.0 38.9 26.6 30.2 19.8 21.7 2.3 39.1 51.2 22.6 19.4 34.6 92.9 25.4 12.5 17.0 59.7 11.8 2.0 24.0 89.5 17.8 80.7 14.3 14.6 54.4 35.6 3.7 104.3 19.7 40.2 2.0 4.5 31.8 18.6 33.4 27.7 33.2 19.7 77.9 28.1 16.5 52.6 23.8 54.1 5.5 66.9 63.2 57.5 52.4 91.8 24.5 31.3 32.4 MOB4 "2C4D, CGI-95, DKFZP564M112, MOB3, MOBKL3, PHOCN, PREI3" ENSG00000115540 "MOB family member 4, phocein" Q9Y3A3 2 197515571-197553699 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 367.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034082, HPA044125" Approved NA NA "CAB034082: AB_1127220, HPA044125: AB_2678822" "unprognostic (4.60e-2)" "unprognostic (3.23e-1)" "unprognostic (2.16e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.23e-1)" "unprognostic (4.88e-2)" "unprognostic (1.72e-1)" "unprognostic (8.03e-2)" "unprognostic (8.44e-2)" "prognostic unfavorable (4.68e-4)" "unprognostic (3.35e-1)" "unprognostic (8.36e-2)" "unprognostic (3.30e-2)" "unprognostic (3.07e-2)" 22.3 89.2 17.6 18.2 18.3 65.4 28.8 21.7 29.8 23.3 18.4 25.2 18.6 27.8 24.0 43.3 19.0 22.3 41.5 21.3 18.8 22.1 21.7 20.2 23.9 16.7 18.5 16.3 23.8 18.0 28.9 12.0 32.6 17.0 28.5 26.7 14.1 19.6 22.4 36.4 21.2 20.8 32.7 19.0 19.3 19.1 11.0 18.3 24.0 24.9 37.3 29.0 31.3 19.5 20.0 51.6 27.1 68.2 26.1 54.3 51.3 63.9 57.3 57.1 77.5 64.2 64.8 39.5 46.5 52.4 65.2 54.6 30.2 56.0 57.5 92.2 36.8 41.1 61.4 46.8 62.6 49.5 50.6 50.2 51.1 40.1 52.8 37.7 49.3 53.6 34.5 33.3 28.1 75.0 57.0 31.6 84.2 62.7 51.5 63.8 32.6 55.4 36.2 72.8 84.5 33.3 46.0 42.0 58.5 54.9 89.2 38.6 55.0 46.1 54.6 27.5 58.3 60.6 30.0 43.9 58.7 44.8 35.2 56.6 24.8 9.2 18.2 9.7 11.7 12.1 12.8 10.9 13.0 11.4 10.9 12.9 14.0 22.8 14.7 12.3 10.5 16.9 10.8 17.6 18.3 21.7 29.8 21.3 18.8 16.7 18.5 16.3 17.0 19.0 18.3 20.0 53.6 28.9 26.1 0.0 70.5 77.5 50.8 107.0 56.9 39.8 38.3 36.4 54.3 32.9 60.2 20.2 10.4 145.8 77.9 45.3 88.0 64.3 1.7 23.3 28.2 54.1 34.0 31.5 0.0 50.4 101.6 49.5 32.6 23.4 41.3 18.8 40.0 25.9 57.8 47.1 0.0 48.3 97.6 33.7 98.6 4.6 42.6 42.3 58.7 0.0 50.8 56.2 54.6 0.0 0.0 66.4 35.7 38.4 61.7 54.4 34.2 66.7 44.4 32.5 52.6 39.3 74.8 54.3 43.3 54.7 83.5 367.4 82.9 58.5 36.6 65.7 HSPE1 "CPN10, EPF, GroES, HSP10" ENSG00000115541 "Heat shock protein family E (Hsp10) member 1" P61604 2 197500140-197503449 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1907.6;Proximal tubular cells: 1978.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 4135.5" "Low region specificity" "Detected in all" "CAB017366, HPA038755, HPA048272" Supported NA Yes 2500000 "CAB017366: AB_10998950, HPA038755: AB_2676190, HPA048272: AB_2680336" "unprognostic (2.75e-2)" "unprognostic (6.89e-2)" "unprognostic (1.86e-1)" "unprognostic (1.43e-2)" "unprognostic (1.98e-1)" "unprognostic (1.85e-2)" "unprognostic (5.83e-3)" "unprognostic (4.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.94e-3)" "unprognostic (1.39e-2)" "unprognostic (6.21e-3)" "unprognostic (2.63e-1)" "unprognostic (4.51e-2)" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.08e-3)" 147.7 716.2 428.6 145.2 423.2 117.8 214.9 445.1 821.5 123.3 439.3 259.7 166.4 85.1 214.9 134.0 132.5 98.3 210.0 441.8 446.1 414.6 668.1 112.0 155.8 440.8 437.3 410.2 131.2 113.6 174.4 126.4 165.3 446.2 139.1 248.6 86.5 122.9 115.9 183.1 81.2 169.6 117.8 451.4 87.2 131.6 59.2 445.6 146.1 105.4 215.0 209.5 218.7 86.2 487.3 593.1 926.1 675.1 521.5 560.5 314.0 905.5 586.2 307.9 620.8 577.3 2796.6 504.6 1079.2 782.2 333.8 1542.1 510.4 1895.0 681.2 782.0 512.3 874.7 1099.8 1789.0 4135.5 239.0 1503.6 497.2 382.4 532.1 577.8 297.6 392.7 631.0 720.9 1588.2 338.0 481.1 1027.2 1107.2 1706.9 1077.5 985.2 1513.4 747.6 568.2 1388.5 967.4 1028.3 581.5 375.1 546.4 713.9 545.5 1588.2 287.1 881.7 355.7 466.1 643.3 501.0 1019.4 427.8 1016.0 1758.3 515.6 726.7 640.6 33.2 95.5 24.4 166.3 174.5 216.3 287.1 223.6 210.1 156.6 221.8 251.7 264.1 12.6 200.3 143.1 263.4 198.7 176.0 428.6 423.2 445.1 821.5 441.8 446.1 440.8 437.3 410.2 446.2 451.4 445.6 487.3 341.6 195.5 160.2 0.0 380.6 435.1 1907.6 690.4 301.7 90.7 393.6 511.2 355.6 381.8 363.3 195.0 250.2 839.3 334.4 553.8 911.7 354.0 22.3 520.7 291.3 296.3 440.3 233.1 0.0 231.2 634.0 370.0 274.2 493.3 324.6 215.7 94.6 1092.0 517.2 63.9 0.0 605.0 427.2 150.6 616.4 36.1 216.6 534.4 409.1 0.0 214.2 204.2 133.9 0.0 0.0 285.3 466.2 141.8 323.4 830.7 562.1 1978.2 475.8 160.2 131.5 283.6 642.5 140.0 241.9 381.2 371.8 976.7 685.9 791.7 775.5 1111.7 KDM3A "JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA" ENSG00000115548 "Lysine demethylase 3A" Q9Y4C1 2 86440647-86492716 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055543, HPA065162" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055543: AB_2682842, HPA065162: AB_2685424" "unprognostic (1.97e-2)" "unprognostic (3.03e-3)" "unprognostic (1.32e-2)" "unprognostic (4.04e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.15e-6)" "unprognostic (2.01e-1)" "unprognostic (3.35e-3)" "unprognostic (9.50e-3)" "unprognostic (4.44e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (2.17e-1)" "unprognostic (2.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.66e-2)" 18.2 13.0 17.5 13.2 19.0 70.9 20.1 17.7 18.3 17.2 17.5 21.6 19.1 20.9 18.3 20.9 18.6 16.1 20.4 14.9 18.0 14.1 13.0 16.9 18.0 18.2 16.4 13.8 21.7 16.2 14.8 12.9 22.2 17.3 16.8 16.0 55.1 20.0 19.9 21.7 38.3 20.3 15.2 16.5 18.5 15.0 51.3 20.2 27.6 20.2 21.6 19.8 20.9 20.4 20.0 34.7 13.5 31.5 8.3 15.9 16.1 29.4 16.5 16.2 15.1 18.5 17.3 14.3 20.1 30.4 13.8 31.1 21.5 23.7 16.6 29.2 27.1 19.7 32.4 12.6 24.8 11.9 26.1 19.9 17.8 24.5 13.6 24.9 51.9 19.0 18.5 21.1 31.9 16.1 8.9 36.2 36.4 28.3 20.6 20.4 24.5 42.6 44.0 13.6 19.2 24.4 25.9 21.7 15.5 30.2 27.5 9.0 16.8 21.2 30.6 12.6 31.8 19.1 33.3 33.9 29.6 38.8 26.6 38.2 16.9 3.0 5.8 6.7 3.3 7.1 4.2 7.5 6.6 4.6 3.6 7.9 7.0 13.4 5.0 2.2 4.2 8.3 3.9 17.5 19.0 17.7 18.3 14.9 18.0 18.2 16.4 13.8 17.3 16.5 20.2 20.0 26.0 35.3 17.0 56.8 19.7 30.5 23.2 19.5 43.3 24.0 18.9 14.6 30.3 7.2 24.8 5.5 52.1 5.2 29.2 24.2 0.0 12.1 82.0 36.6 15.6 23.4 15.6 21.0 28.7 9.8 8.5 19.1 23.0 35.5 38.6 11.9 15.4 7.6 10.4 55.5 27.4 13.7 26.4 10.9 18.2 29.7 17.4 17.5 21.4 28.1 8.6 36.0 21.6 26.2 23.5 11.3 8.0 17.3 21.4 16.0 23.0 5.6 44.1 34.4 6.6 21.3 20.4 38.7 14.1 35.5 40.1 11.6 27.4 15.2 10.7 13.6 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607855-218637184 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 167.5;skeletal muscle: 115.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009914, HPA038139, HPA038140" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.2 2.7 4.2 0.2 4.0 0.0 1.4 4.2 7.2 1.1 3.2 11.5 0.6 0.6 0.3 4.8 0.6 0.4 1.0 4.2 4.1 10.5 0.6 0.6 0.1 4.9 4.8 4.0 0.7 0.5 1.7 9.7 0.2 4.6 4.4 1.7 167.5 2.4 0.3 115.1 0.8 3.4 1.3 3.7 0.3 7.0 9.9 5.0 0.1 1.6 30.7 0.1 20.7 2.0 4.4 0.0 0.9 1.2 0.0 0.3 1.2 1.1 0.0 2.5 0.4 1.3 0.0 0.1 0.0 1.5 0.4 0.4 0.1 0.0 1.5 0.3 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 2.8 0.1 1.9 0.5 4.2 2.8 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.1 4.3 0.0 1.8 20.2 0.3 0.1 0.1 0.2 2.1 0.0 4.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 4.0 4.2 7.2 4.2 4.1 4.9 4.8 4.0 4.6 3.7 5.0 4.4 0.3 0.0 1.1 7.8 0.1 0.5 0.3 0.9 3.4 139.9 1.5 0.9 1.0 0.0 0.1 0.0 246.0 0.1 0.1 0.0 0.0 0.1 21.4 0.6 0.4 1.5 0.0 0.0 6.7 0.0 13.5 0.7 0.0 1.0 0.0 0.1 0.7 0.0 0.6 8.4 4.9 0.1 0.0 0.0 0.4 33.8 0.3 0.2 0.0 0.0 0.1 9.1 0.0 2.0 2.3 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.2 176.9 0.0 6.1 1.8 3.6 1.2 0.6 0.1 0.8 0.1 0.0 0.1 0.2 CHMP3 "CGI-149, NEDF, VPS24" ENSG00000115561 "Charged multivesicular body protein 3" Q9Y3E7 2 86503430-86563479 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA015673, HPA073383" Supported NA NA "HPA015673: AB_1858761, HPA073383: AB_2732224" "unprognostic (2.49e-3)" "unprognostic (1.32e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (2.67e-1)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "prognostic unfavorable (7.39e-4)" "unprognostic (1.20e-1)" "prognostic favorable (5.32e-4)" "unprognostic (1.34e-1)" "unprognostic (8.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.64e-1)" 70.7 56.7 40.1 41.4 54.1 31.2 64.8 51.2 45.2 58.4 30.0 73.0 63.7 69.5 57.3 93.8 52.3 55.3 101.1 45.2 43.2 60.4 23.5 64.6 34.3 36.8 39.1 42.2 49.4 67.3 70.9 33.4 32.1 39.1 64.9 76.6 31.1 53.3 62.5 98.0 59.0 65.1 74.0 39.6 40.7 61.0 34.5 41.9 32.0 68.6 81.6 40.2 70.9 51.0 38.7 105.3 96.1 54.4 39.6 71.2 136.7 52.5 76.7 103.2 64.4 55.6 86.2 90.2 34.3 71.7 97.7 71.8 82.8 33.3 67.0 70.3 21.0 42.5 45.5 45.5 98.8 62.5 36.4 47.7 82.4 147.7 40.8 64.9 70.4 73.1 34.1 49.1 25.3 104.7 90.7 24.4 32.4 18.8 138.9 73.8 15.3 125.2 27.2 85.7 117.3 65.7 71.4 73.3 68.0 66.1 25.8 58.3 55.7 88.7 114.2 46.8 112.2 86.7 21.0 33.1 22.9 81.5 58.0 61.3 158.5 61.5 171.5 28.0 73.8 33.6 49.5 41.8 33.8 49.9 49.3 48.7 37.9 228.7 35.5 66.5 42.1 46.1 54.4 40.1 54.1 51.2 45.2 45.2 43.2 36.8 39.1 42.2 39.1 39.6 41.9 38.7 102.5 147.4 93.5 0.0 49.6 95.3 83.3 94.4 83.6 55.7 115.2 72.6 125.2 147.3 111.4 40.5 41.7 51.1 42.7 222.1 148.7 180.7 206.6 46.7 84.9 96.2 133.5 73.0 0.0 174.8 59.2 67.4 58.6 70.4 147.6 30.0 144.5 59.1 89.5 69.0 0.0 159.2 65.1 126.2 48.4 108.5 71.7 77.2 71.2 0.0 93.6 60.5 78.2 0.0 0.0 186.7 219.4 91.0 25.0 95.9 201.1 173.3 76.1 42.4 65.7 73.6 78.5 100.7 57.3 101.9 94.1 85.0 47.5 57.3 165.4 103.4 ZNF142 "KIAA0236, pHZ-49" ENSG00000115568 "Zinc finger protein 142" P52746 2 218633329-218659655 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049594 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA049594: AB_2680829" "unprognostic (2.17e-1)" "unprognostic (4.43e-1)" "unprognostic (8.20e-3)" "unprognostic (9.08e-2)" "unprognostic (3.54e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.94e-1)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" "unprognostic (9.63e-3)" "unprognostic (4.77e-2)" "unprognostic (1.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" 5.5 5.8 4.9 5.1 5.1 8.0 6.0 5.5 6.9 6.2 1.2 7.2 2.6 7.5 2.5 6.7 6.7 3.6 6.1 5.3 3.8 6.0 4.5 5.5 5.4 4.6 3.7 4.5 6.2 7.6 4.9 8.3 3.2 4.4 6.9 3.2 6.5 6.3 4.4 10.4 6.9 6.5 5.0 2.4 7.3 7.1 4.9 3.9 6.0 7.0 6.6 4.9 7.3 5.8 4.8 6.3 9.7 9.0 10.7 8.5 6.3 8.5 7.1 4.2 9.7 7.4 19.3 5.0 8.3 6.1 6.4 8.1 11.4 17.6 11.7 6.6 12.0 16.5 12.9 20.7 12.3 6.8 16.8 11.8 4.3 11.0 11.5 11.3 5.3 8.2 9.2 17.0 15.7 5.0 13.7 11.7 9.6 11.8 3.9 8.8 17.7 5.1 8.1 7.3 11.3 12.3 9.3 5.3 10.4 4.0 8.5 6.0 6.1 12.2 9.2 9.7 7.8 11.0 10.5 7.1 13.4 5.9 7.9 9.5 0.9 0.7 0.8 1.0 0.1 0.4 0.7 0.6 0.6 0.6 0.3 0.7 0.5 0.4 0.3 0.2 0.8 0.6 0.6 4.9 5.1 5.5 6.9 5.3 3.8 4.6 3.7 4.5 4.4 2.4 3.9 4.8 3.5 3.2 0.5 4.9 6.0 5.9 2.0 1.7 5.7 3.5 3.8 3.4 5.3 4.3 2.7 3.7 6.2 2.2 4.0 4.1 0.0 3.2 2.7 2.7 4.3 3.2 0.0 2.1 7.0 3.8 2.2 3.8 6.6 5.2 1.3 5.2 4.2 3.1 3.0 1.7 6.7 3.0 4.1 4.7 3.2 4.8 3.7 4.1 3.6 4.7 3.1 2.3 8.2 3.0 6.7 4.1 3.5 3.8 8.5 2.8 3.4 2.2 1.0 2.7 6.6 3.9 2.9 5.5 5.5 6.6 6.1 1.1 6.3 4.1 4.3 2.3 IL1R2 "CD121b, IL1RB" ENSG00000115590 "Interleukin 1 receptor type 2" P27930 2 101991960-102028544 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 90.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 495.7;Kupffer cells: 207.9;Langerhans cells: 1083.3;Macrophages: 210.8;Pancreatic endocrine cells: 211.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Group enriched" "Detected in some" 6 "cerebral cortex: 5.5;pons: 1.9" "Immune cell enriched" "Detected in some" 26 "neutrophil: 377.5" "Lineage enriched" "Detected in many" 26 "granulocytes: 377.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 469.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA027597, HPA027598" Uncertain "Secreted to blood" NA NA 7130000 27000000 "HPA027597: AB_10600768, HPA027598: AB_10601229" "unprognostic (3.54e-2)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (3.83e-2)" "unprognostic (6.59e-2)" "unprognostic (1.42e-1)" "unprognostic (6.36e-2)" "unprognostic (4.82e-3)" "unprognostic (1.62e-2)" "unprognostic (7.15e-2)" "unprognostic (8.20e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.58e-12)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "unprognostic (1.77e-1)" "unprognostic (6.62e-2)" 19.9 6.0 0.3 35.8 0.5 53.3 3.8 0.4 5.5 7.3 2.3 30.0 0.8 2.5 3.5 41.6 17.9 5.4 3.4 0.2 0.5 6.3 11.7 31.1 3.3 0.5 0.5 0.2 1.2 3.7 0.3 0.8 20.3 1.9 2.3 44.1 0.1 8.0 2.2 1.2 30.9 4.7 3.4 0.4 90.8 33.3 0.5 0.6 7.5 1.9 2.9 38.9 6.2 20.7 0.6 7.3 0.9 0.0 0.0 0.9 1.2 0.8 0.0 0.2 0.0 0.1 7.7 0.2 0.1 14.7 0.0 0.3 2.9 0.0 0.5 0.0 469.8 0.4 0.1 0.1 4.0 2.5 0.0 0.0 9.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 60.4 0.0 0.0 0.0 0.0 24.0 1.7 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 1.1 0.4 7.2 0.2 0.0 0.3 0.0 0.5 0.2 0.0 0.1 4.3 0.0 0.0 2.3 0.0 0.0 0.9 0.0 14.5 0.0 0.0 0.0 377.5 0.2 0.1 0.2 5.9 1.5 0.3 0.5 0.4 5.5 0.2 0.5 0.5 0.5 0.2 1.9 0.4 0.6 0.6 1.2 6.4 1.1 0.0 1.7 147.9 13.5 2.0 495.7 0.0 0.5 0.4 0.6 10.0 0.3 1.8 0.0 1.2 1.2 23.8 5.9 15.0 2.8 14.5 1.5 4.4 6.7 2.7 0.0 8.3 36.3 6.1 18.3 8.0 2.5 0.0 3.6 16.2 5.8 0.0 0.0 117.4 0.0 207.9 1083.3 4.0 0.3 210.8 32.0 0.0 3.5 0.0 0.0 0.0 0.0 211.0 26.8 0.0 1.6 20.4 0.0 0.7 2.2 0.0 6.6 0.7 3.8 0.7 2.2 38.1 84.0 27.8 2.7 0.4 26.8 14.4 PRKAG3 ENSG00000115592 "Protein kinase AMP-activated non-catalytic subunit gamma 3" Q9UGI9 2 218822383-218832086 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "skeletal muscle: 71.1;tongue: 18.1" "Cell type enhanced" "Detected in single" "Skeletal myocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (3.51e-1)" "unprognostic (4.41e-3)" "unprognostic (2.05e-1)" "unprognostic (1.53e-1)" "unprognostic (2.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.86e-3)" "unprognostic (7.74e-2)" "unprognostic (3.44e-2)" "unprognostic (5.85e-2)" "unprognostic (3.27e-1)" "unprognostic (9.04e-2)" "unprognostic (9.95e-2)" "unprognostic (1.49e-1)" "unprognostic (2.97e-1)" "unprognostic (7.69e-2)" 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.8 0.0 71.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 18.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.3 0.1 0.1 0.9 0.1 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SMYD1 "BOP, KMT3D, ZMYND22" ENSG00000115593 "SET and MYND domain containing 1" Q8NB12 2 88067825-88113384 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "heart muscle: 157.9;skeletal muscle: 498.3;tongue: 304.0" "Cell type enriched" "Detected in some" 27 "Cardiomyocytes: 208.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.9;stomach cancer: 1.6" "Region enhanced" "Detected in some" "basal ganglia: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HSkMC: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA062282 Enhanced NA NA "HPA062282: AB_2684736" "unprognostic (1.93e-2)" "unprognostic (2.49e-1)" "unprognostic (4.09e-2)" "unprognostic (8.51e-3)" "unprognostic (2.74e-1)" "unprognostic (3.91e-1)" "unprognostic (8.81e-3)" "unprognostic (1.40e-1)" 0.0 0.0 0.2 0.2 3.1 0.0 5.4 0.1 1.0 0.0 0.0 12.0 2.0 0.0 0.0 7.4 0.0 0.0 157.9 0.4 0.1 0.0 0.0 0.1 0.0 1.3 0.2 0.7 0.0 0.3 2.5 0.0 0.0 0.3 4.1 1.9 0.0 4.0 0.0 498.3 0.1 7.0 28.3 0.1 0.0 7.4 0.3 0.1 0.4 0.1 304.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 0.1 1.0 0.4 0.1 1.3 0.2 0.7 0.3 0.1 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.7 208.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1400000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094" "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 116.1 68.5 7.6 70.1 7.3 18.1 78.2 7.2 10.4 162.4 17.8 37.6 20.9 33.8 106.1 32.4 52.4 92.8 43.6 7.1 20.8 34.3 76.1 116.5 17.2 16.2 7.9 5.7 31.4 43.6 127.7 13.2 121.8 9.5 67.3 30.8 8.5 34.5 47.9 18.8 39.6 40.7 50.3 9.6 41.3 44.3 20.8 12.7 21.9 53.0 16.1 19.9 88.2 40.5 15.3 2.0 12.8 0.3 10.8 624.9 276.8 4.4 27.4 123.8 19.2 28.7 5.7 3.4 0.0 19.8 55.0 33.9 5.5 0.2 2.2 16.1 55.5 0.1 0.7 2.9 31.3 196.3 0.1 0.3 770.6 2.3 21.7 5.2 8.4 8.7 0.0 3.5 1.1 28.1 5.6 0.0 1.2 0.7 5.6 0.9 0.3 2.0 0.4 18.3 13.4 0.1 0.3 12.5 7.7 0.0 3.6 11.1 0.8 0.3 54.7 3.6 92.1 2.2 0.1 0.0 0.1 21.3 0.6 3.6 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.6 0.0 7.6 7.3 7.2 10.4 7.1 20.8 16.2 7.9 5.7 9.5 9.6 12.7 15.3 99.3 25.6 73.2 1.3 1.8 31.1 46.8 8.2 5.2 0.1 19.4 13.7 5.2 28.6 68.6 5.5 0.0 6.1 2.5 0.7 3.9 31.7 7.0 127.1 280.2 103.6 1.2 14.3 0.5 21.8 82.8 79.1 2.0 315.4 1.3 0.3 146.7 47.1 5.4 0.0 3.0 0.5 10.2 12.0 188.2 12.6 28.0 26.0 19.6 23.4 7.0 9.0 0.0 0.5 0.5 12.0 0.3 1.5 1.8 65.9 0.0 8.3 28.6 1.0 6.6 37.7 34.3 1.3 1.2 4.5 38.6 23.9 8.5 4.0 0.8 23.6 WNT6 ENSG00000115596 "Wnt family member 6" Q9Y6F9 2 218859805-218874233 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 92.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.7" "Region enhanced" "Detected in many" "basal ganglia: 8.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "BEWO: 34.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 7.7" HPA070759 Approved "Secreted to extracellular matrix" NA NA "HPA070759: AB_2732164" "unprognostic (1.86e-2)" "unprognostic (6.03e-2)" "unprognostic (5.14e-2)" "unprognostic (2.06e-1)" "unprognostic (5.32e-2)" "unprognostic (7.34e-2)" "unprognostic (8.08e-3)" "unprognostic (4.73e-2)" "unprognostic (1.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-3)" "unprognostic (5.26e-2)" "unprognostic (4.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.07e-1)" 3.3 0.6 0.8 0.1 8.1 0.0 3.6 0.2 3.1 3.9 0.6 5.7 0.1 2.4 0.0 1.3 3.2 0.0 2.8 0.7 1.2 1.1 0.3 0.3 0.1 4.0 0.8 0.5 3.1 0.8 0.0 2.0 2.0 2.1 3.1 0.0 0.1 1.1 0.1 1.1 2.6 2.8 0.0 0.4 7.2 2.7 3.6 1.7 0.0 1.1 0.0 0.1 2.0 3.7 0.1 0.0 0.0 0.0 1.2 0.0 0.0 34.4 0.0 0.0 0.0 0.0 3.3 0.5 0.0 3.7 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 5.0 1.7 0.0 0.0 3.7 0.1 4.7 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 8.1 0.2 3.1 0.7 1.2 4.0 0.8 0.5 2.1 0.4 1.7 0.1 2.5 0.0 0.0 0.0 1.6 0.5 21.0 1.1 0.6 3.5 1.4 8.5 0.6 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 0.1 3.4 0.4 3.1 5.9 0.0 0.0 0.2 0.0 1.6 2.0 0.0 0.1 0.0 0.4 2.5 0.0 0.8 1.7 0.1 0.0 0.0 0.0 0.3 4.5 0.0 0.3 1.8 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.4 3.1 5.5 0.0 0.0 0.0 2.0 92.1 0.3 15.5 16.9 0.3 0.2 0.1 0.7 0.2 0.1 0.0 1.3 IL1RL2 "IL1R-rp2, IL1RRP2" ENSG00000115598 "Interleukin 1 receptor like 2" Q9HB29 2 102187006-102240002 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 12.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 5.6;Excitatory neurons: 9.7;Glandular and luminal cells: 8.4;Langerhans cells: 7.1;Suprabasal keratinocytes: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.1;ASC TERT1: 5.1;HaCaT: 3.8;HSkMC: 4.4;hTCEpi: 2.3" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" NA NA "unprognostic (6.70e-2)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" "unprognostic (2.76e-4)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "unprognostic (3.13e-3)" "unprognostic (6.79e-2)" "unprognostic (9.10e-3)" "unprognostic (9.17e-2)" "unprognostic (4.61e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-2)" "unprognostic (8.33e-3)" "unprognostic (3.80e-1)" "unprognostic (1.47e-1)" "unprognostic (7.65e-2)" 1.1 1.5 0.5 0.5 0.6 0.3 2.7 0.1 1.0 1.5 0.1 0.9 0.1 0.5 1.4 5.9 2.3 2.3 0.4 0.7 2.5 2.1 2.9 0.5 0.0 0.7 0.4 0.8 0.3 0.5 2.6 0.3 0.3 0.9 0.9 1.1 0.0 2.2 2.3 0.4 12.4 0.3 0.3 0.1 0.1 1.6 0.1 0.6 0.3 2.4 0.7 1.0 1.0 2.5 0.9 8.1 0.0 0.0 0.0 1.5 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 3.8 0.0 0.6 0.4 0.4 0.0 0.0 1.1 0.0 1.5 0.0 0.0 4.4 2.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.1 1.0 0.7 2.5 0.7 0.4 0.8 0.9 0.1 0.6 0.9 1.1 0.0 1.1 0.3 0.0 5.6 2.7 0.7 3.4 0.0 2.1 2.4 0.3 1.5 0.4 1.8 0.0 0.1 0.2 0.5 3.9 0.2 0.3 3.8 2.4 0.9 1.2 0.0 9.7 0.2 0.2 1.4 0.5 8.4 0.0 0.0 0.0 1.3 0.6 0.0 1.1 1.1 0.0 2.8 7.1 0.2 1.5 4.2 0.0 1.9 0.6 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 2.0 0.0 0.4 0.1 0.0 0.0 1.8 1.7 0.0 0.0 5.2 5.5 0.1 0.2 0.6 0.7 1.8 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 124.7;lung: 163.4;placenta: 201.5" "Cell type enriched" "Detected in many" 9 "granulocytes: 501.5" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 64 "basophil: 38.3;eosinophil: 29.3" "Lineage enriched" "Detected in single" 72 "granulocytes: 38.3" "Group enriched" "Detected in some" 6 "HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 3100000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 16.8 30.5 7.1 3.1 8.2 0.7 14.8 7.2 11.0 3.7 10.8 4.1 1.7 2.5 0.6 4.4 2.6 14.8 21.8 7.5 7.0 124.7 16.1 163.4 0.7 7.8 7.3 5.7 1.1 4.9 0.8 5.7 201.5 8.6 5.0 3.4 2.9 1.8 4.7 2.5 3.9 8.0 3.8 7.5 1.4 25.3 0.5 8.3 1.3 4.1 0.7 0.8 6.6 4.0 8.6 0.9 0.2 0.7 0.1 15.1 0.6 0.3 0.5 0.7 0.4 0.6 0.3 0.5 0.5 0.7 0.2 0.2 1.4 0.2 6.3 0.4 0.2 0.1 45.7 0.8 0.8 245.1 1.9 373.7 5.1 1.5 6.2 40.0 0.6 185.5 0.2 0.9 0.8 0.7 0.4 0.6 8.7 0.3 0.4 0.7 0.3 0.2 0.2 1.0 0.3 0.6 0.4 0.5 0.3 0.2 0.4 0.3 0.1 15.4 0.5 0.5 3.5 0.5 0.1 0.3 0.4 0.7 0.6 0.5 38.3 0.0 29.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 7.1 8.2 7.2 11.0 7.5 7.0 7.8 7.3 5.7 8.6 7.5 8.3 8.6 22.6 9.6 13.1 0.0 0.1 8.5 20.3 0.4 0.0 0.0 0.3 0.1 2.7 0.0 7.7 1.8 0.0 0.0 3.3 0.1 0.0 3.2 0.4 1.1 14.8 49.7 0.0 1.3 0.2 0.5 0.1 54.5 0.0 2.5 501.5 0.0 26.4 0.7 0.0 0.0 0.2 0.0 0.0 0.3 19.1 1.3 0.9 3.0 3.6 0.0 0.0 0.0 0.0 0.5 0.1 37.2 0.0 0.0 3.2 15.7 0.0 0.0 6.6 0.3 39.5 1.5 37.7 0.0 0.0 0.0 5.1 0.0 31.5 0.0 0.0 16.4 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398777 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 24.4;lymphoid tissue: 18.7" "Cell type enhanced" "Detected in many" "dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 45.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA007615 Approved Approved Mitochondria Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 6.7 2.3 1.2 5.7 1.1 2.4 5.5 1.1 1.7 4.6 1.5 3.1 4.1 3.1 1.6 2.2 3.8 2.9 4.2 1.0 1.9 4.4 6.6 24.4 4.1 1.5 1.3 0.6 1.1 1.3 3.2 1.7 6.9 1.8 3.3 1.0 0.2 2.3 5.7 0.9 2.6 8.9 0.7 1.2 18.7 4.4 0.5 1.9 2.0 2.1 1.1 2.2 4.0 2.8 1.6 1.8 0.6 0.0 0.0 1.3 0.8 2.3 0.0 1.1 0.1 0.5 0.0 0.8 0.0 0.1 0.0 3.4 0.9 0.0 2.4 0.0 27.4 1.2 2.1 0.5 0.1 35.4 8.8 10.1 7.8 1.9 3.1 5.4 0.0 7.4 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 1.4 1.1 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.2 0.1 0.3 0.1 0.0 0.0 0.8 0.9 0.5 3.2 0.6 0.0 0.0 0.0 0.1 52.0 3.6 10.0 0.0 4.8 6.2 0.1 16.3 0.1 3.6 4.7 3.6 0.2 0.6 1.4 6.7 45.6 0.0 10.4 4.1 1.9 1.2 1.1 1.1 1.7 1.0 1.9 1.5 1.3 0.6 1.8 1.2 1.9 1.6 10.2 0.0 8.5 0.3 2.7 0.8 1.1 1.1 0.6 0.0 0.3 0.3 3.9 0.0 2.3 1.8 0.0 0.0 44.7 0.3 1.9 0.9 0.1 1.0 4.1 7.4 0.0 3.6 0.2 0.6 1.0 3.1 5.1 1.1 111.2 0.0 10.0 7.6 0.1 0.0 1.0 0.1 0.0 2.4 25.4 0.1 0.3 16.5 3.6 12.2 1.0 0.2 42.2 1.5 0.0 1.1 0.4 0.0 10.3 1.0 0.1 0.9 3.8 0.2 6.6 0.9 1.4 0.4 1.3 0.3 1.0 0.0 25.4 0.1 0.4 0.9 IL18RAP "AcPL, CD218b" ENSG00000115607 "Interleukin 18 receptor accessory protein" O95256 2 102418689-102452565 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 105.6;lymphoid tissue: 47.1" "Group enriched" "Detected in some" 6 "dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "NK-cell: 118.1" "Group enriched" "Detected in many" 107 "granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2" "Cell line enriched" "Detected in some" 11 "U-937: 54.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB025270 Enhanced NA NA "CAB025270: " "unprognostic (1.73e-3)" "unprognostic (6.27e-3)" "unprognostic (5.07e-3)" "unprognostic (4.64e-6)" "unprognostic (2.90e-1)" "unprognostic (1.18e-2)" "unprognostic (5.86e-5)" "unprognostic (5.09e-3)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (4.78e-2)" "unprognostic (5.31e-2)" "unprognostic (1.51e-2)" "unprognostic (2.71e-1)" "unprognostic (6.35e-2)" "unprognostic (8.56e-2)" "unprognostic (2.73e-2)" 6.9 0.6 0.4 12.1 0.4 105.6 1.5 0.4 1.1 0.7 0.8 1.9 2.4 0.5 0.3 1.1 5.6 3.0 1.6 0.4 0.4 1.5 3.5 16.3 2.6 0.6 0.5 0.3 0.4 0.6 0.1 0.6 1.4 0.8 1.1 1.8 0.0 0.8 0.6 0.5 0.4 6.4 1.0 0.6 47.1 2.6 0.1 0.6 0.8 1.1 1.1 2.8 2.5 1.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.1 2.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.3 0.2 0.1 19.3 46.2 0.1 65.2 0.0 5.9 12.6 0.5 0.0 0.2 1.5 67.6 118.1 0.0 0.7 0.4 6.4 0.4 0.4 0.4 1.1 0.4 0.4 0.6 0.5 0.3 0.8 0.6 0.6 0.5 0.4 3.2 1.1 0.0 0.8 0.3 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.3 1.1 0.1 1.3 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.8 5.3 0.0 0.0 1.9 0.0 1.9 0.6 0.0 66.9 0.0 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 22.5 0.0 0.0 0.0 SLC9A2 NHE2 ENSG00000115616 "Solute carrier family 9 member A2" Q9UBY0 2 102619553-102711355 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9;stomach 1: 26.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035121, HPA035122" Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA035121: AB_10602894, HPA035122: AB_2674477" "unprognostic (1.53e-2)" "unprognostic (8.05e-3)" "unprognostic (6.00e-2)" "unprognostic (3.00e-3)" "unprognostic (3.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-1)" "unprognostic (2.37e-2)" "unprognostic (1.97e-1)" "unprognostic (1.40e-3)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.70e-1)" 0.0 0.1 1.4 2.1 0.6 0.0 1.4 0.8 1.5 1.4 0.1 20.2 6.4 0.1 4.0 0.3 0.3 1.1 0.0 1.8 0.8 5.4 0.0 0.1 0.1 1.2 0.7 0.7 0.0 0.0 5.9 1.0 0.0 1.5 5.9 20.9 0.1 5.0 2.1 6.5 0.8 3.4 0.7 0.7 0.0 26.6 5.8 1.3 0.4 1.0 6.3 4.5 1.0 0.0 1.2 10.0 6.1 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.2 0.0 3.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 3.4 2.9 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 7.7 0.0 0.1 0.2 37.3 5.0 0.0 0.1 0.0 1.1 16.9 0.1 0.0 0.0 14.7 0.0 0.0 18.5 0.0 0.0 0.0 0.7 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.8 1.5 1.8 0.8 1.2 0.7 0.7 1.5 0.7 1.3 1.2 0.0 0.0 0.0 2.0 0.3 0.4 0.2 0.1 0.0 0.0 1.1 0.1 0.8 0.0 0.3 9.2 0.0 0.5 0.0 41.3 0.0 0.2 46.5 0.5 0.2 0.3 9.7 0.0 3.0 0.0 0.0 0.0 41.8 3.1 0.0 0.0 0.0 0.0 0.1 0.0 14.6 23.4 6.1 0.0 0.4 31.4 0.6 0.0 0.0 5.6 0.0 0.5 0.0 1.0 1.0 8.5 38.7 0.0 0.2 4.1 3.2 1.4 0.1 0.1 0.0 0.5 0.1 4.5 0.2 0.0 0.6 0.3 0.2 0.0 29.6 0.8 FHL2 "DRAL, SLIM3" ENSG00000115641 "Four and a half LIM domains 2" Q14192 2 105357712-105438513 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "heart muscle: 851.4;ovary: 540.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1077.5;Extravillous trophoblasts: 585.9;Granulosa cells: 851.4;Leydig cells: 567.0;Peritubular cells: 1049.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 5.7" "Group enriched" "Detected in many" 6 "granulocytes: 5.7;T-cells: 2.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 534.6;RPTEC TERT1: 489.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005922, HPA006028, CAB008368" Enhanced Enhanced "Actin filaments,Focal adhesion sites" NA Yes 14000 "Actin filaments, Focal adhesion sites" "CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858" "unprognostic (1.04e-1)" "unprognostic (1.63e-3)" "unprognostic (3.30e-1)" "unprognostic (3.42e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.80e-2)" "unprognostic (1.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.42e-2)" "unprognostic (3.34e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (6.42e-5)" "unprognostic (2.06e-1)" "unprognostic (3.49e-1)" "unprognostic (9.92e-3)" "unprognostic (4.73e-2)" 58.0 70.8 11.8 29.2 14.8 17.2 66.0 10.4 20.6 100.4 19.1 75.7 48.9 106.0 34.0 55.9 56.3 82.2 851.4 20.6 11.7 34.5 22.3 17.6 17.3 10.6 10.3 15.1 540.2 9.1 8.3 29.6 80.0 12.2 89.6 57.4 8.6 45.7 64.4 68.1 43.7 50.8 92.2 10.3 20.3 95.7 51.2 10.5 23.1 41.7 119.7 14.1 106.5 47.6 18.2 156.8 36.1 20.9 0.8 65.2 81.7 196.4 289.3 75.9 182.2 216.7 65.6 237.6 0.4 23.7 353.6 223.8 47.7 31.4 262.4 204.2 6.5 23.9 108.7 42.9 49.0 257.6 0.4 23.5 171.7 142.2 286.0 188.1 360.8 374.4 18.0 29.0 8.9 534.6 5.6 25.8 1.0 44.1 108.3 113.2 0.4 31.6 4.3 489.8 108.4 1.0 6.9 109.2 48.1 76.9 20.5 60.7 3.9 183.1 130.4 134.1 146.4 236.0 3.3 0.6 0.7 208.1 0.6 138.5 5.7 0.4 0.4 1.1 0.2 0.7 0.6 0.9 2.0 0.4 0.5 0.7 1.5 2.2 0.7 0.2 0.6 2.7 1.5 11.8 14.8 10.4 20.6 20.6 11.7 10.6 10.3 15.1 12.2 10.3 10.5 18.2 15.7 9.6 5.1 0.7 1.0 468.5 1077.5 342.5 389.9 9.5 59.8 126.2 362.1 15.7 91.0 29.5 2.1 220.4 1.7 212.6 3.9 100.7 5.7 44.8 40.4 27.4 58.2 63.5 46.3 117.9 585.9 96.1 186.1 32.5 10.2 851.4 17.2 9.2 25.3 0.0 4.9 169.8 73.2 0.6 31.8 17.3 567.0 10.4 23.2 25.3 2.7 1.6 0.0 0.5 1.6 234.5 258.2 1049.0 6.7 198.2 51.7 28.1 19.1 13.0 216.9 60.6 171.0 9.1 17.7 124.5 296.9 178.7 7.7 193.5 55.8 536.2 MLPH "exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a" ENSG00000115648 Melanophilin Q9BV36 2 237485428-237555322 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 137.1;salivary gland: 123.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 125.0;Alveolar cells type 2: 389.7;Gastric mucus-secreting cells: 251.8;granulocytes: 187.3;Intestinal goblet cells: 189.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 142.9;MCF7: 255.4;SK-BR-3: 234.5;SK-MEL-30: 182.2;U-87 MG: 236.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA014685 Enhanced NA NA "HPA014685: AB_1853997" "unprognostic (3.32e-3)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "prognostic favorable (5.14e-6)" "unprognostic (2.26e-4)" "unprognostic (1.36e-2)" "unprognostic (5.44e-2)" "unprognostic (2.66e-1)" "unprognostic (3.74e-3)" "unprognostic (8.16e-2)" "unprognostic (5.73e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.34e-1)" "unprognostic (9.37e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-3)" 10.2 1.4 0.8 2.4 0.8 0.1 57.5 0.7 1.6 62.6 1.4 20.6 8.9 18.3 9.0 6.5 18.1 31.3 52.4 1.1 0.7 1.9 39.3 63.3 0.6 1.0 1.0 0.5 11.9 16.2 9.1 2.1 1.9 0.7 137.1 21.9 0.3 123.0 13.1 6.7 11.3 15.3 2.8 0.7 0.2 98.9 2.5 0.7 0.9 40.2 2.6 1.2 22.3 22.1 0.9 0.3 133.7 0.3 0.3 58.5 39.5 0.4 26.8 31.5 14.7 18.5 1.1 101.1 0.2 0.1 49.6 51.0 0.3 0.1 0.9 13.0 0.1 0.3 0.1 0.1 0.0 23.3 0.1 0.7 48.1 14.7 43.4 56.2 75.6 0.1 0.0 0.1 0.3 142.9 255.4 0.4 0.6 0.4 105.4 77.1 0.5 0.1 0.2 0.5 3.2 1.5 0.2 0.1 234.5 182.2 0.7 61.5 1.7 26.8 80.1 2.3 0.9 38.0 0.2 0.2 0.2 236.0 0.1 63.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.7 1.6 1.1 0.7 1.0 1.0 0.5 0.7 0.7 0.7 0.9 12.3 125.0 389.7 0.0 0.8 4.1 17.3 6.0 0.0 0.0 95.6 59.7 63.2 52.9 64.2 12.9 0.0 0.4 0.7 34.9 1.9 12.0 0.2 9.5 10.1 10.1 14.4 0.0 0.2 41.3 0.3 4.5 251.8 17.5 187.3 0.2 1.4 28.8 1.2 0.0 0.1 189.0 32.6 0.8 2.9 0.7 8.4 7.4 30.2 5.6 0.6 0.0 0.0 0.0 0.0 58.1 22.4 3.0 0.8 54.4 9.1 0.6 48.5 0.0 0.0 3.1 3.7 0.3 0.6 1.2 2.4 0.7 6.1 0.4 30.5 38.6 CNPPD1 "C2orf24, CGI-57" ENSG00000115649 "Cyclin Pas1/PHO80 domain containing 1" Q9BV87 2 219171897-219178106 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049303 Uncertain NA NA "HPA049303: AB_2680703" "unprognostic (9.24e-2)" "unprognostic (4.12e-2)" "unprognostic (1.09e-1)" "unprognostic (9.43e-2)" "unprognostic (3.68e-2)" "unprognostic (5.74e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (1.77e-1)" "unprognostic (4.15e-3)" "unprognostic (5.54e-3)" "unprognostic (8.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.62e-10)" "unprognostic (1.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-2)" "unprognostic (2.54e-2)" 55.3 91.5 42.8 41.8 48.7 79.3 52.0 50.3 47.3 45.1 36.8 62.7 59.5 46.6 37.6 81.9 39.6 28.2 58.7 41.0 45.7 91.1 49.7 41.7 54.7 51.5 49.0 39.6 48.6 53.7 90.1 24.9 30.4 49.8 47.2 44.3 16.7 52.7 41.7 98.0 68.2 70.4 34.7 51.1 72.2 54.4 42.5 46.1 44.0 60.7 57.6 52.1 55.8 47.9 57.6 43.3 32.0 31.5 58.3 63.5 31.7 44.8 54.7 32.0 44.5 35.4 69.3 52.3 24.5 31.5 53.6 35.5 59.1 42.0 44.2 25.9 63.3 24.6 100.1 34.2 69.5 77.7 59.4 66.5 33.8 55.8 44.0 39.2 39.9 37.7 65.4 81.3 89.5 26.1 78.7 65.3 45.2 20.2 49.9 40.4 96.0 23.3 83.6 69.3 59.7 40.8 48.8 31.4 77.8 59.2 34.1 62.3 67.2 35.9 36.2 33.8 71.6 52.7 70.4 29.9 52.8 48.9 70.2 23.7 82.6 63.4 65.5 53.2 95.2 46.3 79.4 51.6 54.2 97.6 87.7 35.5 39.9 76.4 56.9 122.3 53.4 73.2 79.4 42.8 48.7 50.3 47.3 41.0 45.7 51.5 49.0 39.6 49.8 51.1 46.1 57.6 23.4 19.2 17.7 6.2 61.4 13.5 14.0 32.9 19.4 11.8 24.0 23.4 24.8 34.3 23.7 42.3 4.2 31.9 46.3 90.8 56.7 36.7 1.9 12.4 16.4 22.1 28.9 46.3 4.2 33.3 21.3 22.8 26.0 27.4 13.3 12.7 26.4 23.7 37.7 11.8 5.6 48.9 38.7 45.2 29.0 4.7 22.4 36.1 21.4 10.3 85.8 28.0 55.6 5.5 13.4 39.9 45.6 21.1 34.3 23.1 73.9 64.2 11.5 12.1 19.7 11.5 21.8 26.5 33.5 28.5 15.9 55.0 38.6 19.1 42.9 16.0 UXS1 "FLJ23591, SDR6E1, UGD" ENSG00000115652 "UDP-glucuronate decarboxylase 1" Q8NBZ7 2 106093308-106194301 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 323.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008825 Uncertain "Intracellular and membrane" NA NA 24000 "HPA008825: AB_1858708" "unprognostic (4.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.63e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.45e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.20e-3)" "unprognostic (2.07e-1)" "prognostic favorable (7.94e-4)" "unprognostic (3.95e-2)" "unprognostic (1.40e-2)" "unprognostic (8.46e-2)" "unprognostic (3.96e-2)" "unprognostic (6.18e-2)" "unprognostic (1.86e-2)" "unprognostic (5.32e-2)" 16.5 17.8 20.7 25.2 19.1 40.7 15.5 31.4 29.9 19.8 19.6 21.9 15.7 24.5 33.4 24.3 29.4 19.8 29.6 26.4 19.7 60.5 15.8 46.4 28.1 14.9 23.1 17.5 24.6 15.9 37.6 16.4 55.1 18.4 23.4 24.2 10.6 14.7 26.2 32.2 14.1 14.4 21.6 18.3 25.2 26.4 32.1 35.1 22.4 30.3 28.8 30.6 29.7 18.4 24.3 66.5 48.8 50.9 39.0 88.4 65.2 110.2 71.4 66.9 49.9 61.5 96.9 110.4 12.0 87.0 74.1 111.2 32.8 22.6 58.2 54.5 64.2 40.5 37.0 21.4 110.6 34.9 30.5 39.0 42.8 63.8 50.3 33.5 57.5 52.5 22.8 22.1 28.5 103.6 46.8 34.3 66.8 60.1 64.2 65.4 70.3 38.6 34.3 323.0 60.9 16.7 19.0 51.5 45.7 44.3 67.7 17.0 93.7 48.0 55.1 58.5 45.4 45.4 34.4 51.4 17.9 55.0 70.1 103.8 11.3 24.7 28.5 23.1 20.8 25.7 15.3 64.3 41.4 19.1 30.5 68.8 49.1 6.1 37.5 16.0 13.5 130.4 44.3 20.7 19.1 31.4 29.9 26.4 19.7 14.9 23.1 17.5 18.4 18.3 35.1 24.3 15.4 89.8 88.8 18.9 22.1 16.8 26.8 117.3 14.8 9.9 11.6 10.5 18.7 17.2 61.6 86.5 4.2 71.2 17.7 20.5 50.9 46.9 80.2 41.5 19.3 25.5 6.6 12.0 49.8 25.0 74.1 34.2 16.8 40.6 29.8 13.1 10.8 15.0 33.2 8.4 37.5 15.6 34.6 20.1 12.5 18.5 15.2 33.9 14.2 33.7 56.2 10.8 18.6 24.1 11.7 30.4 16.2 12.8 10.2 35.7 9.6 17.5 38.8 7.9 19.7 19.0 35.1 17.0 81.6 22.6 13.2 24.6 33.7 51.6 18.0 19.8 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209772-219218994 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 8.8 8.8 4.4 3.4 3.9 10.5 7.7 3.6 4.6 7.7 3.9 6.2 7.0 8.5 8.3 11.5 9.7 7.2 8.4 3.9 4.6 5.2 16.0 5.9 1.9 4.5 3.8 4.0 13.0 5.7 4.8 6.0 3.1 5.0 8.1 3.3 3.0 6.2 8.7 30.6 6.8 6.4 8.0 4.0 3.9 7.9 18.1 4.6 2.6 10.8 9.9 2.9 15.1 7.9 5.2 0.3 22.9 4.7 28.8 30.8 11.1 27.6 8.5 7.9 9.2 9.2 35.5 5.0 0.3 42.8 8.6 5.0 49.1 0.6 3.6 3.0 15.0 4.7 36.3 24.9 65.8 37.0 0.0 12.0 16.3 4.2 6.2 0.1 13.9 16.3 4.8 31.4 4.4 6.3 12.0 2.3 0.1 7.2 53.6 9.2 12.3 14.3 1.6 5.1 0.4 16.6 17.8 17.6 41.4 18.7 17.4 12.4 0.8 7.5 12.5 0.5 16.9 10.3 11.2 9.6 0.1 14.0 0.4 17.0 0.7 0.4 0.0 0.7 0.4 0.2 1.0 0.5 0.2 0.3 0.8 1.2 0.8 0.0 0.4 0.3 2.3 0.5 1.0 4.4 3.9 3.6 4.6 3.9 4.6 4.5 3.8 4.0 5.0 4.0 4.6 5.2 0.2 0.0 0.0 14.7 0.3 0.3 0.0 0.5 1.2 1.0 0.2 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.2 0.1 0.0 0.8 1.2 0.3 0.6 0.4 0.0 1.3 12.9 0.0 0.1 0.7 5.1 0.2 0.0 0.5 0.0 0.4 0.1 0.0 10.9 0.3 0.0 0.3 0.4 1.0 0.3 0.3 0.0 3.7 0.0 0.3 0.0 13.6 5.6 0.3 0.0 0.4 0.5 0.0 0.5 0.2 2.2 0.8 0.0 0.4 0.3 1.0 0.3 2.8 0.3 0.3 0.1 0.4 0.2 0.1 STK16 "MPSK, PKL12" ENSG00000115661 "Serine/threonine kinase 16" O75716 2 219245455-219250337 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029450 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA029450: AB_10603118" "unprognostic (1.99e-1)" "unprognostic (2.08e-1)" "unprognostic (5.84e-2)" "prognostic favorable (6.09e-4)" "unprognostic (6.21e-2)" "unprognostic (5.55e-2)" "unprognostic (4.98e-3)" "unprognostic (4.25e-1)" "unprognostic (1.48e-1)" "unprognostic (4.22e-2)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (4.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.00e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" 15.0 25.1 17.1 11.9 17.0 15.1 16.4 16.1 20.7 14.1 18.3 19.1 17.4 13.9 21.0 23.0 18.2 13.1 17.8 16.1 16.9 25.3 43.5 14.5 17.8 17.4 16.9 16.1 14.9 31.2 22.9 19.9 9.3 17.0 20.4 13.6 7.9 20.2 11.0 14.6 17.4 18.0 10.0 16.7 21.3 24.4 27.9 17.7 20.7 19.4 8.3 14.6 17.9 14.9 16.1 14.1 18.8 15.7 13.2 40.0 40.0 17.9 17.8 23.6 14.3 14.7 21.2 31.0 8.3 24.4 32.0 23.4 14.5 18.5 30.0 7.8 20.0 19.8 17.7 15.4 19.1 34.9 17.6 20.1 40.1 48.1 20.8 57.4 29.8 17.9 18.7 23.1 21.5 26.8 27.1 19.4 38.0 14.5 25.7 10.3 18.1 17.5 24.9 32.2 16.1 12.3 14.6 5.8 25.5 39.0 11.2 27.4 36.4 13.7 20.6 14.0 16.4 17.4 25.9 12.1 19.5 22.9 18.4 18.3 1.6 7.0 5.3 4.9 3.8 5.5 7.2 6.0 9.2 6.8 6.0 6.1 7.9 4.1 14.5 3.1 5.8 7.3 8.7 17.1 17.0 16.1 20.7 16.1 16.9 17.4 16.9 16.1 17.0 16.7 17.7 16.1 11.8 6.4 5.6 3.6 22.4 9.8 18.1 32.6 24.5 7.9 31.8 31.8 9.5 24.3 19.7 7.3 16.7 24.0 23.6 27.6 68.4 40.3 87.2 21.4 13.3 14.0 25.8 36.0 2.2 58.5 25.0 15.8 17.3 12.9 8.2 17.9 12.5 43.7 28.4 13.5 2.7 38.7 16.2 27.1 17.6 70.3 15.2 17.8 21.4 0.0 38.4 22.1 44.3 4.0 6.8 33.3 44.3 13.5 27.6 18.6 58.9 80.2 19.6 19.1 0.0 11.9 19.2 43.1 9.6 28.2 11.2 12.9 22.1 33.6 34.2 20.8 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 22.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "RT4: 3.6;SCLC-21H: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2" "Group enriched" "Detected in many" 6 "basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.1 0.7 1.1 0.5 2.5 0.0 0.1 0.0 7.0 0.7 0.8 1.9 0.7 0.1 0.1 0.3 0.1 0.1 0.3 0.2 5.8 0.3 0.0 0.2 0.0 15.9 13.5 0.9 0.2 0.1 0.0 0.0 0.0 22.2 0.3 0.7 0.9 0.3 1.1 0.0 0.0 0.8 0.7 4.4 0.0 0.5 0.1 3.3 0.0 1.2 0.1 0.0 1.3 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.5 0.0 7.0 0.2 5.8 15.9 13.5 0.9 22.2 4.4 3.3 7.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 HDLBP "HBP, VGL" ENSG00000115677 "High density lipoprotein binding protein" Q00341 2 241227264-241317061 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004189, CAB026457" Enhanced Supported Cytosol NA NA 95000 Cytosol "CAB026457: , HPA004189: AB_1079044" "unprognostic (2.57e-2)" "unprognostic (1.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-2)" "unprognostic (4.39e-3)" "unprognostic (3.92e-2)" "unprognostic (9.48e-3)" "unprognostic (2.47e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.39e-5)" "prognostic unfavorable (4.12e-4)" 161.2 136.8 53.5 115.1 59.3 106.3 152.5 53.1 53.2 205.9 147.9 183.6 137.5 139.8 181.6 196.0 214.7 157.5 161.8 55.7 71.6 136.4 249.8 113.8 81.8 64.4 60.5 46.3 152.8 608.9 165.4 142.7 177.6 57.2 183.6 172.8 67.4 450.6 144.3 371.1 119.5 137.1 173.3 57.8 79.9 233.7 228.5 67.8 75.3 193.0 369.0 112.0 160.0 99.5 72.4 310.0 239.5 237.4 383.7 587.9 715.3 362.6 736.7 719.9 319.7 451.3 233.1 299.2 93.2 88.1 1039.3 334.0 235.2 356.9 465.8 528.2 150.4 236.0 323.0 305.1 535.7 566.7 233.0 251.4 528.8 369.1 466.0 515.9 500.4 448.1 140.9 310.1 120.0 511.9 309.5 120.4 106.1 237.9 290.4 161.2 111.7 511.9 175.5 255.1 380.1 208.4 223.5 332.3 334.5 278.4 304.2 262.6 201.8 585.4 402.1 255.1 551.5 325.3 136.2 130.8 166.5 488.1 161.1 371.8 26.0 39.3 17.4 15.6 41.0 20.3 19.6 17.7 18.8 41.3 12.7 15.5 15.1 22.0 19.2 58.1 26.4 18.1 27.5 53.5 59.3 53.1 53.2 55.7 71.6 64.4 60.5 46.3 57.2 57.8 67.8 72.4 53.9 76.9 102.7 38.5 60.6 70.2 117.4 80.4 150.2 41.0 125.3 98.8 220.5 71.4 124.9 75.4 43.8 133.9 34.7 176.2 135.0 106.7 111.0 152.8 178.3 80.8 96.5 72.6 44.5 122.1 166.5 156.3 203.4 168.2 68.4 199.3 86.7 199.3 94.6 69.0 45.9 291.1 30.5 70.3 66.4 398.0 148.8 75.1 56.9 46.9 77.8 53.5 20.6 46.3 58.1 116.5 118.4 174.9 354.7 203.9 136.3 117.9 163.3 40.0 65.7 126.5 117.0 132.1 120.7 192.4 77.6 215.5 50.7 134.0 163.2 156.1 PPP1R7 sds22 ENSG00000115685 "Protein phosphatase 1 regulatory subunit 7" Q15435 2 241149576-241183652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 968.8;Late spermatids: 1709.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034500, HPA034501" Supported Approved Nucleoli NA NA 960000 Nucleoli "HPA034500: AB_2674192, HPA034501: AB_10670965" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (4.38e-1)" "unprognostic (8.07e-3)" "unprognostic (5.01e-2)" "unprognostic (2.49e-1)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (4.51e-3)" "unprognostic (1.23e-1)" 59.5 56.3 70.1 54.8 92.1 68.7 50.7 66.5 83.0 46.8 67.2 66.6 59.3 48.9 61.9 81.0 82.0 40.5 101.5 76.5 71.3 65.2 76.6 54.4 79.4 70.6 68.4 73.6 37.8 60.5 56.3 42.9 44.8 68.6 95.3 64.8 58.5 63.7 54.5 101.3 64.5 61.5 55.5 67.2 49.2 59.3 159.7 67.8 67.4 65.7 65.0 81.4 59.4 53.3 75.0 117.6 69.5 77.4 98.3 149.7 149.0 106.4 126.3 114.7 85.2 119.8 38.1 145.6 60.0 37.1 108.9 128.0 112.1 127.9 119.6 130.2 156.4 126.1 105.1 112.4 151.4 96.3 147.0 105.9 116.0 92.7 101.1 74.2 115.7 128.5 121.0 108.0 86.2 202.0 155.8 132.0 112.6 106.3 185.7 64.5 90.4 200.9 121.9 159.6 116.7 104.6 82.8 67.6 157.4 120.3 86.4 93.8 156.7 127.7 76.8 72.5 146.1 103.4 90.8 59.6 162.8 215.2 154.1 103.7 107.9 84.9 108.9 64.6 87.6 68.3 71.6 76.5 77.1 81.3 66.5 58.5 67.6 66.5 75.8 96.2 48.4 121.5 89.9 70.1 92.1 66.5 83.0 76.5 71.3 70.6 68.4 73.6 68.6 67.2 67.8 75.0 50.5 57.7 54.5 17.6 47.9 27.8 48.6 126.2 25.6 41.5 44.6 36.8 98.4 45.8 105.5 44.1 16.7 89.6 46.9 53.4 121.3 90.6 968.8 83.6 39.3 45.9 25.7 48.0 33.8 145.9 92.4 47.5 34.7 53.4 59.5 48.9 32.9 49.9 100.5 32.0 19.4 68.7 109.9 40.7 46.3 1709.4 51.0 49.4 87.2 13.1 63.7 78.6 80.3 18.1 21.9 94.5 71.3 67.4 54.5 52.1 81.7 120.8 112.2 58.9 72.3 35.1 65.6 315.5 122.5 45.9 38.1 71.6 57.9 117.2 55.3 56.0 PASK "KIAA0135, PASKIN, STK37" ENSG00000115687 "PAS domain containing serine/threonine kinase" Q96RG2 2 241106099-241150264 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.1" "Cell type enhanced" "Detected in many" "Peritubular cells: 24.5;Theca cells: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA016450, HPA021079" Uncertain Supported Cytosol NA Yes Cytosol "HPA016450: AB_1854992, HPA021079: AB_1854993" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.84e-1)" "unprognostic (1.41e-2)" "unprognostic (1.14e-1)" "unprognostic (8.99e-6)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.60e-3)" "unprognostic (1.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.52e-3)" "unprognostic (1.68e-1)" "unprognostic (6.44e-2)" "unprognostic (4.38e-3)" 1.5 1.1 3.8 7.2 16.2 8.8 2.1 1.4 6.3 2.2 2.7 1.9 3.4 2.2 4.0 3.4 6.1 2.0 1.1 2.5 2.3 3.5 1.4 3.2 13.8 8.3 2.0 4.0 1.9 3.7 2.4 4.6 1.0 5.8 10.1 2.3 12.0 2.9 1.5 0.8 4.1 4.5 1.2 0.6 4.2 3.0 16.3 2.1 23.1 5.2 0.2 7.9 2.1 2.2 5.7 7.4 9.9 12.9 16.7 1.1 1.9 17.4 7.0 2.2 6.3 8.8 8.1 7.4 3.8 1.4 1.5 13.8 17.9 15.1 6.1 4.6 15.6 13.8 10.6 19.1 14.4 0.8 14.7 16.0 0.9 4.7 6.5 1.9 2.6 4.6 16.2 14.0 5.2 4.5 8.0 17.5 15.4 14.6 8.8 5.9 27.5 13.3 4.7 2.5 16.0 23.1 7.0 3.9 8.0 3.2 6.8 6.7 10.5 6.1 8.8 7.7 11.1 9.6 6.8 7.4 18.1 5.4 10.9 8.2 4.4 0.6 0.5 1.0 0.4 0.9 4.5 3.9 3.5 0.8 3.9 2.3 2.6 0.8 1.9 0.7 0.4 4.1 2.2 3.8 16.2 1.4 6.3 2.5 2.3 8.3 2.0 4.0 5.8 0.6 2.1 5.7 2.3 3.2 7.9 2.6 8.5 2.7 1.2 1.6 2.2 2.6 3.5 4.3 3.1 2.8 1.9 3.7 4.2 0.9 2.2 3.1 0.0 1.5 14.9 13.9 1.6 8.5 0.0 13.3 12.5 2.0 1.7 2.7 3.6 4.4 3.8 11.7 17.5 1.5 2.0 1.7 6.1 3.5 0.0 4.7 2.0 3.5 5.9 2.1 12.4 3.7 2.7 2.1 7.2 0.5 2.6 0.9 1.0 24.5 4.7 1.7 1.9 1.4 12.3 18.7 0.0 2.1 2.1 16.1 12.7 2.6 1.4 0.3 19.1 26.5 3.9 0.9 STK25 "SOK1, YSK1" ENSG00000115694 "Serine/threonine kinase 25" O00506 2 241492670-241509730 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 494.6;tongue: 215.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047147 Uncertain NA NA "HPA047147: AB_10966137" "unprognostic (1.75e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.42e-2)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.91e-8)" "unprognostic (6.16e-2)" "unprognostic (7.15e-3)" "unprognostic (1.11e-1)" "unprognostic (2.58e-3)" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-1)" "unprognostic (3.19e-1)" "unprognostic (4.58e-1)" 53.7 51.0 47.5 37.5 47.0 47.4 53.3 33.8 57.2 60.0 26.8 57.1 36.5 63.4 24.2 63.1 61.1 33.2 64.0 49.8 47.0 56.7 50.5 50.0 37.0 38.2 41.5 51.4 59.9 70.9 46.3 65.8 39.1 40.1 55.9 30.8 29.1 49.1 40.6 494.6 51.5 51.0 42.5 29.2 62.1 59.2 49.0 43.7 38.9 72.5 215.7 32.0 61.3 57.2 40.5 75.2 46.9 91.1 114.0 109.9 75.9 140.1 122.3 81.8 90.9 103.4 52.3 64.4 28.5 33.7 163.9 82.3 62.9 130.2 132.9 109.9 107.0 136.4 79.7 98.3 136.6 99.3 48.7 59.0 110.1 93.9 88.3 70.3 111.1 208.7 102.6 125.2 24.6 168.8 78.6 73.0 75.9 127.9 69.5 66.3 121.1 116.2 42.6 79.5 62.4 152.8 70.2 59.4 44.2 77.0 102.7 35.7 85.2 245.7 68.2 83.0 79.1 88.3 50.3 12.1 48.8 66.0 39.6 79.1 17.0 16.3 12.9 17.3 15.5 16.3 15.9 15.9 18.5 15.0 16.9 12.3 11.8 5.8 24.6 19.7 11.8 23.3 12.6 47.5 47.0 33.8 57.2 49.8 47.0 38.2 41.5 51.4 40.1 29.2 43.7 40.5 43.6 22.4 41.4 23.2 19.7 25.5 29.0 29.7 19.9 48.7 33.2 39.4 36.3 42.9 24.0 25.8 27.1 82.7 19.8 35.2 27.4 46.0 13.8 18.5 28.4 52.7 35.4 48.6 29.8 34.2 80.7 35.1 36.7 25.4 25.4 40.8 45.7 21.5 45.1 32.0 26.1 40.0 20.3 27.3 25.7 14.4 32.6 20.8 19.6 21.5 47.0 58.9 18.6 16.1 27.5 36.9 74.5 39.9 15.8 37.1 43.4 46.1 16.2 41.1 46.0 41.7 35.3 90.2 54.7 31.7 30.4 52.4 25.4 53.2 44.9 29.9 TPO TPX ENSG00000115705 "Thyroid peroxidase" P07202 2 1374066-1543711 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 70 "thyroid gland: 1601.2" "Cell type enhanced" "Detected in some" "Adipocytes: 24.5;Early spermatids: 4.2;Endothelial cells: 12.6;Late spermatids: 7.5;Peritubular cells: 3.8" "Cancer enriched" "Detected in some" 364 "thyroid cancer: 188.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 2.0;T-reg: 1.2" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 5 "Karpas-707: 9.9;RPMI-8226: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007987, CAB009587" Enhanced "Intracellular and membrane" NA NA "CAB009587: , HPA007987: AB_1080270" "unprognostic (1.55e-1)" "unprognostic (1.04e-1)" "unprognostic (2.88e-1)" "unprognostic (1.77e-2)" "unprognostic (3.56e-2)" "unprognostic (9.11e-2)" "unprognostic (2.24e-2)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-4)" "unprognostic (2.61e-2)" "unprognostic (3.29e-1)" "unprognostic (5.44e-4)" "unprognostic (1.21e-1)" "unprognostic (3.73e-2)" "unprognostic (4.98e-3)" "unprognostic (7.10e-3)" 11.1 0.3 0.1 0.4 0.0 0.1 11.1 0.0 0.6 0.1 0.0 4.3 0.6 0.6 0.0 2.0 0.7 3.1 6.5 0.0 0.1 0.2 0.6 0.8 1.4 0.1 0.0 0.0 0.3 2.4 0.3 0.6 0.0 0.2 0.6 0.9 0.2 3.4 0.0 6.0 1.5 3.8 0.6 0.1 22.9 2.8 1.2 0.2 0.0 1601.2 5.7 0.4 2.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.4 24.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.0 0.2 12.6 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 1.1 3.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.8 0.3 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.1 PROC ENSG00000115718 "Protein C, inactivator of coagulation factors Va and VIIIa" P04070 2 127418427-127429242 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "liver: 603.4" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 432.9" "Cancer enriched" "Detected in many" 22 "liver cancer: 118.3" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 9 "plasmacytoid DC: 59.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 59.7" "Cell line enriched" "Detected in some" 16 "Hep G2: 156.1" "Low region specificity" "Detected in all" "HPA005550, CAB016721, CAB016792" Approved "Secreted to blood" NA NA 5200000000 "CAB016721: , CAB016792: , HPA005550: AB_1079687" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (6.64e-2)" "unprognostic (3.13e-2)" "unprognostic (4.90e-3)" "unprognostic (2.63e-1)" "unprognostic (1.67e-1)" "unprognostic (3.29e-1)" "unprognostic (3.74e-3)" "unprognostic (2.56e-2)" "unprognostic (8.12e-3)" "unprognostic (2.01e-2)" "unprognostic (1.71e-1)" "unprognostic (4.60e-3)" "unprognostic (8.06e-2)" 0.1 0.0 0.7 0.1 0.9 1.1 0.1 0.6 1.0 0.2 0.0 0.7 0.8 0.1 0.1 0.1 0.2 0.6 0.1 0.6 0.6 14.6 603.4 0.2 0.7 1.3 0.6 0.5 0.2 0.4 0.0 0.3 0.1 1.6 0.2 0.6 0.2 0.2 0.1 0.2 0.6 0.8 0.0 0.7 0.4 2.7 0.2 0.7 0.6 0.2 0.0 0.3 0.4 0.2 1.2 0.1 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.1 0.0 0.9 0.1 0.4 9.5 0.0 0.3 0.0 0.0 0.2 0.1 7.8 156.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.6 0.4 2.3 0.7 0.0 0.1 0.0 0.0 0.9 0.4 0.0 1.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.0 6.3 0.0 0.0 59.7 0.0 0.3 0.7 0.9 0.6 1.0 0.6 0.6 1.3 0.6 0.5 1.6 0.7 0.7 1.2 0.0 0.0 0.0 0.3 4.1 0.8 0.4 11.2 0.0 0.0 0.1 0.0 0.4 47.1 1.2 0.0 0.0 0.0 24.0 3.9 5.9 0.5 0.1 3.4 0.1 0.6 10.3 18.7 0.1 0.2 0.0 0.7 2.0 0.2 0.0 0.0 12.1 432.9 3.7 0.0 0.5 9.3 0.0 9.3 4.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 8.1 0.0 0.0 0.0 3.8 84.8 3.4 0.0 0.0 0.2 0.3 0.1 0.2 0.0 0.1 0.1 1.1 0.0 1.8 0.3 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684461 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 1219.4" "Cell type enhanced" "Detected in all" "Langerhans cells: 2393.2;monocytes: 1987.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 1038.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 731.4;HEK 293: 459.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" NA NA "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 120.7 177.6 89.2 74.6 92.1 393.7 83.3 91.4 118.9 90.6 79.8 129.4 100.0 70.3 21.2 35.6 109.3 152.1 120.3 92.0 96.4 129.4 567.1 109.1 93.4 84.9 84.5 82.4 214.9 60.7 1219.4 66.2 70.8 86.6 126.2 125.9 70.3 115.3 143.7 19.0 70.0 100.2 86.1 92.9 108.3 67.3 14.0 102.2 74.5 225.5 41.6 47.8 111.2 76.8 94.1 2.0 132.4 56.0 68.6 86.8 13.9 208.5 156.6 18.3 68.4 29.1 266.0 7.3 4.1 175.1 262.5 16.9 115.9 36.0 1.0 20.7 731.4 459.5 101.3 81.7 333.9 24.8 76.5 266.3 23.4 3.1 30.5 1.9 19.2 1.4 6.7 6.2 113.9 109.1 45.3 7.8 9.0 102.4 338.5 102.9 9.7 38.4 75.6 71.3 60.5 103.5 146.6 8.4 117.8 12.1 142.0 19.3 44.9 27.5 83.9 14.5 126.5 9.4 8.9 7.9 88.7 106.6 230.2 46.5 110.3 76.0 1038.0 356.7 221.7 214.2 3.6 108.1 251.9 223.8 1.6 133.7 262.1 96.6 880.8 248.9 10.3 9.2 200.1 89.2 92.1 91.4 118.9 92.0 96.4 84.9 84.5 82.4 86.6 92.9 102.2 94.1 429.9 141.1 237.9 316.7 41.4 131.3 143.0 494.8 138.9 9.8 231.2 218.4 179.5 316.0 211.2 101.2 16.7 260.3 604.5 337.7 555.7 471.0 12.0 601.1 344.6 281.1 425.9 59.8 23.5 160.3 142.4 276.0 189.1 647.2 973.6 17.1 487.6 554.7 700.3 6.7 13.8 548.0 494.4 415.8 2393.2 21.7 124.2 528.4 282.8 15.9 1987.9 519.9 1070.1 26.7 3.2 69.6 301.9 32.7 86.0 130.1 231.3 264.1 66.7 27.4 19.7 166.6 185.6 2.1 39.9 97.6 104.6 666.0 690.0 16.7 323.1 51.3 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843443-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 7.3 7.7 5.5 8.5 4.5 7.1 8.8 5.8 4.3 7.0 6.1 6.0 5.2 9.8 6.7 9.7 9.6 7.2 4.8 4.1 5.6 13.4 6.4 8.7 11.4 4.4 5.0 3.5 5.8 4.4 14.8 3.7 13.1 3.8 9.1 5.7 9.1 8.2 9.1 2.9 8.7 4.2 8.2 3.8 7.2 6.2 11.1 5.0 11.5 10.6 3.5 12.8 7.9 6.0 5.2 25.1 20.4 29.2 9.6 14.1 21.2 52.7 29.9 23.3 25.3 23.3 19.1 18.1 27.1 13.6 21.3 26.7 15.0 26.9 31.7 27.3 31.3 35.9 31.5 8.9 28.3 19.5 22.1 32.4 17.0 16.5 21.4 28.5 20.8 37.4 14.8 19.8 27.2 25.0 15.3 16.6 20.1 37.7 15.6 17.5 10.2 27.2 8.0 24.9 24.3 12.3 33.6 23.5 28.9 21.9 18.9 10.4 17.4 20.4 31.9 39.8 31.1 35.7 14.9 19.9 39.7 18.4 24.8 26.7 3.6 9.1 6.2 12.1 15.5 12.1 11.1 10.2 14.3 13.4 11.7 6.3 10.0 0.5 10.2 12.4 10.6 11.1 5.2 5.5 4.5 5.8 4.3 4.1 5.6 4.4 5.0 3.5 3.8 3.8 5.0 5.2 12.5 19.2 22.0 22.2 13.1 16.2 29.9 17.9 19.9 24.5 8.0 6.1 4.0 2.8 26.0 12.9 27.1 25.0 12.6 2.4 13.7 19.5 11.6 26.8 21.0 15.4 1.8 10.5 38.8 18.9 37.4 18.4 13.7 17.3 8.8 12.7 6.8 4.7 12.7 15.2 27.1 3.3 8.2 12.0 11.5 3.8 19.0 14.6 0.0 15.0 15.5 25.5 15.5 32.6 23.5 15.7 3.8 13.2 16.6 9.5 1.7 26.5 29.7 21.0 19.7 15.9 16.2 47.6 33.9 19.7 13.2 23.7 15.1 24.8 4.4 18.7 HPCAL1 "BDR1, HLP2, VILIP-3" ENSG00000115756 "Hippocalcin like 1" P37235 2 10302889-10427617 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 180.2" "Cell type enhanced" "Detected in all" "Horizontal cells: 228.8;Intestinal goblet cells: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 310.6;HDLM-2: 324.5;PC-3: 354.2;U-87 MG: 334.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Supported NA NA 92000 "HPA043245: AB_2678385" "unprognostic (3.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.11e-5)" "unprognostic (2.73e-1)" "unprognostic (6.76e-3)" "unprognostic (5.26e-2)" "unprognostic (7.36e-3)" "unprognostic (4.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (4.06e-1)" "unprognostic (3.64e-2)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" 39.2 62.6 101.6 24.3 136.3 14.5 31.7 180.2 148.0 39.3 52.7 37.2 35.5 91.1 9.4 17.1 40.7 15.3 39.5 104.1 159.3 71.3 63.0 103.2 28.0 124.8 113.6 109.1 15.6 53.0 8.6 65.5 22.3 100.0 22.1 21.5 21.4 20.5 9.0 27.5 18.6 64.2 28.4 78.2 47.7 73.9 47.2 122.0 16.7 33.4 15.2 17.4 21.1 23.2 78.0 51.8 88.6 6.2 25.5 13.8 35.4 59.8 41.0 110.5 58.3 63.6 31.4 128.5 20.1 47.3 30.6 310.6 18.9 16.7 56.8 26.1 324.5 30.1 44.8 94.8 69.2 61.4 27.8 86.5 19.3 25.9 139.1 43.1 207.3 77.7 30.5 41.8 129.1 105.5 70.5 23.2 168.4 32.5 43.2 354.2 29.5 24.3 88.8 85.0 14.8 22.8 152.5 43.0 51.6 102.7 21.6 16.2 72.5 94.2 72.8 22.4 77.7 69.8 38.5 44.7 10.5 334.9 67.4 174.0 24.5 50.9 61.9 21.6 39.9 23.6 26.7 38.9 27.4 43.5 21.3 46.3 30.7 70.0 24.5 36.3 15.7 36.0 29.5 101.6 136.3 180.2 148.0 104.1 159.3 124.8 113.6 109.1 100.0 78.2 122.0 78.0 88.6 83.3 86.8 9.4 48.2 33.8 23.4 4.3 11.4 76.9 19.9 12.4 15.9 30.0 16.9 18.4 16.7 4.9 30.1 39.7 93.9 48.6 25.7 10.3 15.1 72.2 62.6 18.7 23.5 37.1 145.6 22.9 53.0 10.8 55.2 26.3 81.8 32.7 67.6 228.8 23.3 308.8 4.1 79.2 77.9 19.2 17.1 65.1 56.9 31.9 43.9 51.7 46.4 12.5 10.3 46.1 64.5 10.9 45.5 14.8 111.7 100.3 6.8 33.6 6.6 18.2 14.5 20.8 14.9 15.6 30.1 41.3 45.0 6.2 44.8 19.2 ODC1 ODC ENSG00000115758 "Ornithine decarboxylase 1" P11926 2 10439968-10448327 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis" "Decarboxylase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001536, CAB035996" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB035996: , HPA001536: AB_1079521" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (7.25e-3)" "unprognostic (5.21e-3)" "unprognostic (4.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (3.06e-2)" "unprognostic (4.18e-2)" "unprognostic (6.27e-2)" "unprognostic (3.04e-1)" "unprognostic (6.65e-2)" "unprognostic (1.67e-3)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (2.26e-2)" "unprognostic (5.86e-2)" 47.6 23.3 30.0 69.9 29.8 174.4 33.3 30.5 32.5 32.0 43.8 65.4 32.7 66.6 49.6 29.7 56.8 44.0 56.4 29.3 134.4 98.6 92.9 52.8 111.9 31.8 31.4 25.6 55.3 62.4 100.4 93.2 20.2 29.5 91.9 72.7 46.6 27.2 55.6 164.6 23.9 42.0 71.8 32.8 43.3 51.9 134.5 32.1 77.8 59.0 74.2 150.3 114.7 27.2 35.5 166.8 130.6 177.1 211.4 31.1 92.4 410.1 234.6 114.9 216.3 99.9 697.3 75.4 870.2 114.6 143.6 208.6 30.2 549.1 265.5 261.2 334.0 231.5 398.1 212.2 429.9 250.8 680.1 91.8 62.5 70.5 490.1 608.3 111.4 176.3 237.6 674.2 274.3 121.7 109.0 680.1 267.3 324.9 228.3 418.8 478.5 556.0 586.3 130.9 119.5 246.6 209.9 293.6 88.8 121.8 135.7 60.0 300.5 124.7 174.4 362.6 227.9 511.7 128.0 416.1 780.8 156.7 443.6 109.9 0.0 1.5 3.0 2.9 2.9 3.3 14.8 4.1 4.8 3.4 15.0 2.8 4.5 0.5 1.4 1.8 12.2 4.4 3.2 30.0 29.8 30.5 32.5 29.3 134.4 31.8 31.4 25.6 29.5 32.8 32.1 35.5 78.2 44.8 161.4 7.5 228.9 58.0 123.7 48.8 19.4 36.8 53.2 68.3 55.1 81.5 33.9 40.5 31.3 1.5 188.1 77.7 72.4 50.6 560.8 90.9 66.2 52.2 271.0 111.3 7.5 27.6 70.0 63.2 204.4 127.6 58.9 103.8 14.6 50.3 46.8 6.7 4.1 234.1 22.4 32.1 22.4 834.9 15.5 191.8 23.2 8.4 22.1 126.3 37.0 4.5 2.4 28.6 64.5 11.3 287.4 412.4 31.6 154.1 21.9 77.4 0.0 223.0 79.9 186.5 75.8 52.2 87.5 3.4 133.0 30.2 180.5 142.2 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 9.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 9.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Approved Supported "Golgi apparatus,Vesicles,Mitotic spindle" Yes No "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: AB_2686710" "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 4.6 4.7 1.8 6.8 8.4 11.4 9.0 13.0 5.7 7.8 5.4 7.7 5.1 6.8 5.2 5.3 6.3 5.9 4.9 3.6 3.9 7.7 9.0 5.5 9.7 5.3 4.9 1.9 12.1 14.8 11.0 2.9 7.0 6.6 6.3 7.5 15.7 5.5 6.0 6.1 6.7 5.4 6.2 4.2 8.6 7.2 6.9 5.0 14.8 11.5 8.9 9.8 7.3 3.1 15.3 21.7 17.8 16.1 7.9 14.9 19.1 11.3 10.8 14.1 11.0 11.3 14.2 5.7 23.6 7.3 19.7 13.2 10.1 22.9 15.1 13.9 18.8 10.5 31.2 11.3 10.7 7.9 32.4 11.9 12.4 6.9 18.0 16.2 10.1 17.7 5.4 25.6 10.0 11.9 9.3 15.5 7.5 11.7 9.2 10.5 14.6 26.6 8.2 9.2 23.4 11.7 18.4 18.6 10.8 8.2 12.5 6.4 11.5 28.7 13.0 13.3 9.1 15.3 13.9 20.0 30.6 10.1 15.1 8.7 9.7 0.9 0.6 1.3 0.7 1.8 0.8 1.0 1.2 0.7 1.8 1.1 1.4 1.5 1.6 1.5 1.6 1.0 0.5 1.8 8.4 13.0 5.7 3.6 3.9 5.3 4.9 1.9 6.6 4.2 5.0 15.3 53.9 32.1 30.5 239.3 74.8 46.0 28.6 34.7 41.5 60.8 40.0 23.4 45.8 38.6 42.7 36.8 191.8 35.0 93.4 70.1 1.9 26.9 45.9 39.3 58.0 49.8 32.5 34.3 272.0 31.2 22.0 39.7 68.3 63.1 29.9 52.1 45.7 47.5 29.8 69.0 291.3 43.3 26.4 54.7 60.0 17.6 45.4 59.1 23.2 202.4 67.2 34.9 64.9 231.8 361.3 34.3 30.3 59.0 70.9 46.4 48.5 22.6 30.6 88.2 39.5 56.0 49.1 53.7 46.2 49.7 54.8 38.0 72.4 52.8 45.3 44.0 NOL10 "FLJ14075, PQBP5" ENSG00000115761 "Nucleolar protein 10" Q9BSC4 2 10570754-10689987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 189.3;Late spermatids: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035286, HPA043075" Approved Supported Nucleoli NA NA Nucleoli "HPA035286: AB_2674552, HPA043075: AB_10794652" "unprognostic (6.53e-3)" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.25e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (7.51e-5)" "unprognostic (2.43e-2)" "unprognostic (2.92e-1)" "unprognostic (3.82e-1)" "unprognostic (3.87e-2)" 12.2 14.9 6.5 10.2 7.6 16.3 11.4 10.1 8.3 9.2 4.9 10.6 8.2 9.4 11.1 13.8 7.8 6.7 10.6 7.2 8.5 11.2 14.5 9.1 10.4 6.1 6.5 6.5 9.2 16.2 12.2 8.4 11.0 6.9 10.0 10.7 6.2 13.0 8.7 19.6 13.1 9.1 8.8 6.4 9.7 11.8 13.2 7.0 10.0 10.3 12.0 11.8 12.4 10.8 8.6 19.7 33.2 18.6 32.6 22.1 24.2 34.9 33.1 25.8 36.9 27.5 37.5 24.0 45.4 19.5 32.1 30.8 24.5 43.8 38.7 43.6 32.2 33.8 43.8 20.3 46.6 28.0 52.8 23.9 22.6 28.7 40.7 39.1 16.7 25.5 25.0 59.4 28.5 33.9 38.2 36.4 37.4 49.7 51.8 28.8 32.0 49.2 41.4 26.1 30.6 31.6 34.3 24.2 39.4 29.1 20.2 20.8 20.4 24.2 33.8 41.1 33.6 53.9 37.9 63.7 52.4 28.1 49.7 41.5 1.5 3.9 2.2 4.0 5.2 5.9 4.8 4.2 4.2 4.9 3.7 3.2 4.8 0.5 4.8 5.9 3.1 6.0 2.8 6.5 7.6 10.1 8.3 7.2 8.5 6.1 6.5 6.5 6.9 6.4 7.0 8.6 22.2 16.0 16.7 31.6 17.1 33.0 29.9 17.2 17.1 13.0 16.3 12.8 19.2 11.5 16.1 12.9 12.5 32.7 16.4 9.9 15.6 27.5 189.3 8.9 19.5 22.9 11.4 19.8 72.9 24.1 33.7 20.2 13.3 17.8 14.0 20.2 12.5 12.2 15.4 16.8 57.6 12.4 18.3 9.8 13.0 163.0 17.1 12.2 8.8 36.5 23.8 13.9 20.6 54.3 54.2 19.0 7.0 16.6 22.1 30.3 10.6 17.0 7.3 16.7 13.1 36.4 22.5 26.4 42.1 17.8 34.2 29.6 17.7 30.4 18.3 22.3 PLEKHB2 "EVT2, FLJ20783" ENSG00000115762 "Pleckstrin homology domain containing B2" Q96CS7 2 131104847-131353709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075014 Approved NA NA "HPA075014: AB_2732275" "unprognostic (1.99e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-1)" "unprognostic (8.78e-2)" "unprognostic (5.18e-3)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (9.33e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (4.05e-2)" "unprognostic (1.00e-1)" "prognostic favorable (1.72e-8)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.14e-2)" "unprognostic (2.65e-1)" 27.3 55.9 52.1 38.7 59.1 65.4 26.3 62.2 58.3 25.7 53.6 60.5 47.3 16.8 31.0 30.5 27.0 29.9 33.8 60.8 65.5 112.9 22.6 44.8 37.3 66.2 71.6 55.3 11.8 21.0 89.2 26.4 31.2 77.2 34.9 61.5 81.8 26.2 26.6 35.8 23.6 56.7 26.1 61.8 42.9 59.1 36.5 68.0 31.5 49.1 30.9 34.8 38.7 18.4 85.3 85.3 65.4 48.6 38.1 37.4 36.2 79.2 94.4 80.0 88.9 73.8 140.0 83.4 68.2 97.5 92.0 64.4 58.8 89.0 81.5 98.8 40.0 48.6 119.4 31.0 81.4 51.9 115.4 88.8 31.9 67.2 105.2 96.9 54.6 71.1 36.5 57.5 53.0 166.9 46.7 71.4 57.0 73.9 80.8 99.1 52.5 37.7 72.7 138.6 89.7 60.3 39.7 29.6 166.3 107.6 64.9 23.6 89.0 86.6 89.2 60.4 76.7 86.5 51.2 85.6 46.5 130.8 76.6 82.8 27.5 54.9 29.0 24.4 69.2 23.9 15.5 18.2 23.2 52.7 17.1 19.4 23.2 32.3 26.5 78.2 18.7 23.6 48.3 52.1 59.1 62.2 58.3 60.8 65.5 66.2 71.6 55.3 77.2 61.8 68.0 85.3 37.8 60.9 53.9 14.4 50.0 114.3 35.6 47.2 64.9 85.6 57.6 26.5 28.6 34.3 59.5 64.4 125.1 44.9 59.5 174.4 158.5 62.4 66.4 108.8 44.2 57.2 56.8 44.2 38.9 43.1 51.0 29.6 62.2 164.1 58.9 25.4 31.4 20.9 106.3 101.0 41.5 67.6 128.1 111.0 169.5 22.1 14.3 117.9 76.5 26.2 86.2 46.0 49.4 15.1 32.0 81.5 68.4 24.0 35.8 58.6 120.2 193.4 52.1 78.8 13.1 26.1 35.9 92.3 65.9 97.6 140.4 92.9 59.1 51.0 76.1 70.7 GORASP2 "GOLPH6, GRASP55, GRS2" ENSG00000115806 "Golgi reassembly stacking protein 2" Q9H8Y8 2 170928464-170967130 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 380.7;Syncytiotrophoblasts: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035274, HPA035275, CAB075758" Enhanced Enhanced "Golgi apparatus" NA NA 830000 "Golgi apparatus" "CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600" "unprognostic (2.04e-2)" "unprognostic (4.37e-3)" "unprognostic (4.61e-1)" "unprognostic (1.64e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (3.13e-2)" "unprognostic (3.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.58e-1)" "unprognostic (4.56e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.38e-8)" "unprognostic (1.26e-1)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (3.13e-1)" 32.4 43.5 33.6 32.3 35.1 34.0 40.9 35.9 37.0 63.2 34.0 43.9 38.7 43.6 60.9 47.2 34.6 37.5 58.2 32.8 35.7 33.9 45.9 34.6 40.2 35.1 34.7 32.4 37.6 67.7 47.7 40.3 55.9 35.5 41.0 44.0 37.3 68.9 53.1 40.1 39.0 37.0 46.5 35.2 31.3 42.4 32.3 35.6 42.2 51.2 38.4 44.5 53.8 24.2 37.3 66.1 51.7 72.2 54.9 137.5 103.2 83.0 101.5 113.9 89.6 113.8 132.8 84.2 97.0 59.7 143.2 61.0 75.9 82.3 96.0 102.2 57.8 81.2 107.5 41.2 198.8 138.4 90.2 62.9 79.2 102.9 90.0 148.3 95.7 98.9 64.5 92.4 72.4 80.3 103.2 85.5 87.0 74.3 109.9 49.3 68.4 64.5 115.0 112.9 91.8 59.3 54.3 58.4 91.6 95.9 59.0 60.8 73.6 93.5 82.8 56.2 79.5 55.7 81.1 56.2 112.4 86.6 58.3 95.6 48.3 38.3 27.0 53.0 40.6 81.7 44.8 59.1 63.4 48.3 40.7 58.0 48.5 9.6 64.5 46.8 63.9 57.0 62.8 33.6 35.1 35.9 37.0 32.8 35.7 35.1 34.7 32.4 35.5 35.2 35.6 37.3 28.7 41.7 36.6 15.0 46.7 37.2 39.6 83.4 38.1 30.6 33.0 22.5 40.9 27.1 64.2 20.2 31.3 114.4 49.3 39.2 56.7 69.1 196.6 16.2 34.4 32.1 31.3 35.1 20.1 78.1 112.1 48.4 48.4 32.7 20.3 25.7 38.9 45.0 46.4 42.1 23.0 63.9 48.8 22.7 29.7 380.7 58.7 23.9 48.0 22.5 46.3 39.3 35.0 27.2 31.7 69.7 41.9 49.7 171.9 62.1 31.7 43.7 23.1 34.8 59.2 27.5 40.3 39.6 39.6 47.1 36.1 229.7 43.4 44.9 48.2 67.7 STRN "PPP2R6A, STRN1" ENSG00000115808 Striatin O43815 2 36837698-36966536 "Cancer-related genes, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 294.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017286 Approved Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA017286: AB_1857618" "unprognostic (1.65e-1)" "unprognostic (1.65e-1)" "unprognostic (3.57e-3)" "unprognostic (2.23e-2)" "unprognostic (3.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.63e-3)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.77e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (2.11e-1)" "unprognostic (3.43e-2)" 8.4 4.8 4.7 9.5 15.2 15.1 8.7 10.8 11.2 7.3 1.3 9.2 8.1 6.2 3.9 21.4 5.3 6.9 21.4 5.4 9.2 8.5 7.6 7.9 7.8 12.2 12.0 2.7 7.8 5.7 7.4 2.5 10.1 11.9 5.5 10.8 10.2 10.8 5.0 11.7 11.1 8.7 7.8 12.0 8.2 9.1 8.1 12.1 13.4 6.2 11.6 12.7 8.5 10.1 24.4 38.3 19.0 25.2 10.4 13.3 18.0 24.6 14.8 14.2 14.5 13.3 19.4 12.2 24.7 11.8 19.7 20.6 17.6 21.4 17.0 17.9 27.9 16.0 40.2 16.4 10.3 12.1 24.9 21.8 11.4 12.9 23.2 18.3 10.7 18.6 10.0 30.4 19.2 18.2 11.1 24.7 7.4 19.8 15.7 9.4 15.9 38.5 11.2 9.7 31.0 4.5 15.1 22.4 16.9 13.6 13.7 12.2 9.2 24.9 25.4 25.4 16.0 20.1 19.5 31.0 21.6 13.2 23.2 18.2 1.3 0.2 0.4 0.5 0.4 0.2 0.4 0.4 0.3 0.1 0.2 0.2 0.2 1.0 0.2 0.4 0.2 0.1 0.1 4.7 15.2 10.8 11.2 5.4 9.2 12.2 12.0 2.7 11.9 12.0 12.1 24.4 26.5 9.6 10.0 38.8 18.8 20.6 12.3 11.3 21.6 12.7 16.0 9.4 55.4 8.6 17.4 23.9 20.9 8.0 22.8 25.0 9.8 10.5 1.9 14.2 14.3 19.4 11.4 26.5 65.3 8.4 10.3 13.6 20.4 26.2 5.1 16.0 16.4 7.9 8.8 18.5 55.2 17.8 10.2 20.7 10.0 2.1 9.6 18.0 8.8 47.8 20.3 10.1 35.0 55.3 294.0 16.8 14.1 12.4 14.3 19.3 13.0 8.5 8.2 16.9 0.0 13.6 16.5 15.2 19.2 31.4 33.2 16.3 19.4 17.7 16.0 39.4 CEBPZ "CBF2, CTF2" ENSG00000115816 "CCAAT enhancer binding protein zeta" Q03701 2 37201612-37231596 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 282.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052065 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052065: AB_2681715" "unprognostic (1.64e-2)" "unprognostic (1.20e-1)" "unprognostic (3.00e-3)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.88e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (8.13e-4)" "unprognostic (2.65e-2)" "unprognostic (5.36e-2)" "unprognostic (4.19e-2)" "unprognostic (8.76e-2)" "unprognostic (2.05e-1)" "unprognostic (8.01e-2)" 21.2 28.1 10.9 19.1 12.2 31.5 26.5 16.5 12.9 18.1 12.8 19.7 17.6 20.3 20.1 20.7 17.3 16.8 15.4 10.6 13.1 25.6 27.3 19.5 24.8 12.1 13.0 9.1 24.1 20.8 22.5 10.3 23.2 12.5 19.9 20.2 24.6 16.4 15.7 36.6 18.0 18.2 17.1 12.0 20.1 17.6 38.7 11.5 24.2 22.6 24.6 24.6 26.8 12.7 14.9 61.2 46.6 46.9 26.1 45.2 48.6 39.9 57.0 39.2 47.2 50.5 74.5 45.1 111.5 49.4 33.8 64.4 51.0 122.8 58.5 60.2 71.8 53.9 104.0 47.5 60.9 35.8 105.7 44.9 37.3 56.4 62.8 63.4 31.1 43.3 27.8 114.8 49.8 48.6 31.8 61.5 82.4 153.3 81.0 43.2 48.6 76.3 84.3 45.3 56.9 49.9 80.7 47.5 57.6 65.5 67.6 41.8 45.9 35.5 45.8 52.3 41.3 79.1 55.5 62.0 88.1 40.8 95.6 51.2 34.8 16.8 16.3 23.8 21.7 30.0 29.6 24.7 23.4 17.6 30.0 31.1 26.1 6.1 26.1 22.3 25.6 21.4 14.6 10.9 12.2 16.5 12.9 10.6 13.1 12.1 13.0 9.1 12.5 12.0 11.5 14.9 73.4 86.6 82.9 15.0 91.6 107.1 109.2 64.4 83.1 45.5 50.4 54.1 34.4 47.1 81.9 49.7 43.8 54.7 93.4 36.7 107.6 56.1 282.1 56.0 87.2 60.5 44.2 66.7 15.6 62.5 37.4 67.4 52.5 67.5 73.4 44.7 43.9 76.4 35.1 43.7 19.3 56.6 44.7 37.0 36.1 43.3 60.9 44.6 21.4 15.0 54.1 57.1 63.8 18.6 21.4 54.9 30.2 50.8 67.7 79.0 30.2 89.1 54.2 95.5 52.6 94.3 68.3 186.7 99.3 56.8 101.2 45.0 87.7 62.1 64.2 80.9 PRKD3 "EPK2, PRKCN" ENSG00000115825 "Protein kinase D3" O94806 2 37250502-37324833 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 152.1;U-266/84: 159.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029529 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029529: AB_10602082" "unprognostic (1.39e-1)" "unprognostic (7.34e-2)" "prognostic favorable (4.84e-4)" "unprognostic (1.23e-2)" "unprognostic (5.61e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.10e-1)" "unprognostic (1.16e-1)" "unprognostic (2.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.81e-1)" "unprognostic (7.62e-3)" "unprognostic (2.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.35e-1)" 15.2 20.1 6.3 18.3 7.0 8.8 14.5 8.2 7.4 19.5 5.0 13.8 8.3 19.1 13.9 10.8 10.0 13.4 9.9 6.2 9.3 12.1 10.1 14.9 29.3 7.7 7.1 5.1 18.1 9.1 11.8 6.6 15.1 7.6 11.8 11.1 41.9 10.6 12.6 15.0 12.3 10.4 16.4 7.9 23.6 12.6 23.5 7.9 20.9 13.5 12.2 29.2 15.7 9.6 7.5 38.8 14.3 44.4 36.1 33.2 55.1 31.5 25.0 48.8 29.1 28.7 23.4 14.0 58.5 20.1 39.6 43.2 15.0 31.1 31.9 39.0 72.3 38.7 39.2 24.4 17.8 13.8 26.2 21.5 26.0 16.2 46.2 29.7 26.6 52.6 19.9 32.3 70.9 33.8 6.1 11.6 21.6 45.4 0.4 14.2 40.8 67.9 51.8 18.9 42.1 32.5 81.0 24.6 13.9 152.1 22.8 15.1 25.1 47.7 80.0 40.5 31.5 28.5 78.1 159.7 68.2 27.8 11.2 48.7 6.9 7.7 6.1 9.5 6.7 8.1 10.6 8.5 8.1 7.7 14.6 9.6 10.8 1.4 6.9 3.6 8.1 4.4 3.6 6.3 7.0 8.2 7.4 6.2 9.3 7.7 7.1 5.1 7.6 7.9 7.9 7.5 41.4 41.7 17.8 21.9 60.2 37.9 32.1 24.1 14.8 47.6 14.7 15.5 9.1 27.1 16.6 18.4 68.8 11.2 37.7 7.3 3.9 13.1 57.1 8.3 38.5 48.0 18.8 12.0 24.8 10.6 37.0 33.0 20.4 14.1 76.9 26.8 44.3 12.2 12.8 43.7 18.7 6.9 22.4 31.2 91.2 100.6 33.5 24.4 49.8 68.4 32.7 15.9 27.8 37.7 12.6 16.1 4.3 30.9 60.2 34.3 6.6 8.6 10.3 118.8 26.3 27.5 24.0 54.7 39.9 10.6 23.9 9.7 33.5 29.1 12.3 34.1 DCAF17 "C2orf37, FLJ13096" ENSG00000115827 "DDB1 and CUL4 associated factor 17" Q5H9S7 2 171434217-171485052 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Deafness, Diabetes mellitus, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053339, HPA055040" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA053339: AB_2682119, HPA055040: AB_2682680" "unprognostic (1.60e-2)" "unprognostic (1.21e-1)" "unprognostic (4.05e-1)" "unprognostic (1.03e-2)" "unprognostic (1.60e-1)" "unprognostic (5.98e-2)" "unprognostic (5.60e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-3)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (1.12e-2)" "unprognostic (1.41e-1)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.10e-4)" "unprognostic (2.79e-2)" 3.9 4.5 5.1 5.5 7.0 3.4 6.4 6.8 6.2 5.9 4.5 5.0 4.5 6.3 6.4 4.5 4.6 3.8 3.5 5.2 5.6 5.6 4.5 3.8 7.3 5.8 5.5 4.4 7.1 5.1 6.0 3.9 5.3 6.3 5.0 4.7 14.0 4.3 4.5 3.9 7.3 4.7 4.7 5.2 6.5 4.4 5.8 6.1 7.9 10.2 4.4 6.0 5.6 5.4 10.9 8.5 6.9 8.9 10.6 11.0 11.7 13.6 7.3 7.5 7.3 6.8 8.3 5.5 24.4 5.4 9.1 5.5 8.2 9.1 9.0 9.9 11.4 6.2 11.3 6.2 15.0 11.2 16.2 7.9 9.2 11.6 9.3 20.7 8.6 8.0 7.6 17.9 8.2 10.1 5.2 17.9 14.9 13.2 6.2 4.3 13.4 11.7 13.4 6.2 7.6 7.8 11.3 6.9 5.8 7.4 8.3 4.5 8.3 9.6 8.4 7.6 4.8 6.4 12.4 18.3 20.5 8.9 8.2 8.8 1.1 1.3 0.5 2.3 1.5 3.4 1.3 1.8 1.7 1.0 1.8 2.0 2.5 0.0 1.1 1.3 0.8 1.8 1.6 5.1 7.0 6.8 6.2 5.2 5.6 5.8 5.5 4.4 6.3 5.2 6.1 10.9 5.8 0.0 7.5 17.9 8.9 4.7 4.7 4.2 8.6 10.1 7.8 6.0 5.0 7.2 3.1 7.3 12.5 6.5 6.0 4.4 9.8 4.8 2.2 6.2 10.7 5.2 10.2 6.9 18.0 3.9 5.7 5.8 8.2 4.9 3.8 8.2 2.5 7.7 5.6 8.4 23.5 4.5 6.1 8.4 4.6 3.6 6.2 5.0 3.6 15.0 4.4 8.8 5.2 24.6 56.5 6.6 2.0 6.0 6.4 6.3 5.5 6.2 6.1 15.2 0.0 6.7 7.2 13.5 17.1 8.7 5.1 5.6 7.5 9.0 4.3 5.0 QPCT "GCT, QC" ENSG00000115828 "Glutaminyl-peptide cyclotransferase" Q16769 2 37342827-37373322 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 171.7;epididymis: 104.9" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3" "Cancer enhanced" "Detected in all" "melanoma: 97.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 1527.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 1527.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008406 Enhanced Approved Cytosol "Secreted to blood" NA NA 390000 Cytosol "HPA008406: AB_1855981" "unprognostic (6.25e-3)" "unprognostic (6.69e-2)" "unprognostic (4.95e-2)" "unprognostic (1.44e-1)" "unprognostic (1.44e-2)" "unprognostic (9.32e-2)" "unprognostic (1.13e-3)" "unprognostic (9.73e-2)" "unprognostic (2.71e-3)" "unprognostic (7.86e-2)" "unprognostic (3.67e-2)" "unprognostic (1.17e-1)" "unprognostic (6.78e-2)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (9.48e-3)" "unprognostic (3.62e-3)" 5.6 171.7 9.0 14.4 7.7 47.8 16.0 5.3 11.4 21.3 5.2 18.7 5.7 9.9 104.9 3.5 2.2 10.9 5.1 9.1 22.8 6.2 2.6 5.6 8.2 9.0 11.4 7.0 1.0 13.8 15.0 27.2 9.3 12.0 7.2 10.3 12.0 25.7 6.7 4.1 36.6 4.5 8.4 7.4 14.0 7.7 2.0 16.7 5.1 3.9 2.9 12.6 15.4 4.6 10.6 1.0 40.7 0.1 0.0 6.0 13.3 0.1 6.6 86.5 6.4 10.1 2.9 7.1 0.2 3.0 32.6 72.9 0.1 2.7 0.6 10.3 0.6 76.0 18.7 0.3 7.7 0.6 3.0 0.1 8.5 0.0 47.3 0.2 0.4 26.2 0.0 0.0 0.0 0.2 4.5 0.0 1.7 0.6 0.3 0.0 0.0 0.0 0.8 42.6 10.9 117.1 0.2 6.4 1.4 426.8 8.0 0.7 2.9 19.4 0.0 0.2 0.1 0.6 15.3 341.7 0.3 25.8 0.3 0.0 9.8 344.8 3.2 0.4 38.7 1.0 2.6 0.6 0.5 124.7 1.2 0.5 0.3 1527.7 0.2 3.3 2.4 0.1 169.8 9.0 7.7 5.3 11.4 9.1 22.8 9.0 11.4 7.0 12.0 7.4 16.7 10.6 1.8 3.2 2.3 0.3 12.5 39.0 13.6 40.0 2.2 21.8 7.9 8.5 1.1 1.5 17.7 22.0 2.1 0.7 0.8 6.1 1.9 45.4 0.6 2.6 24.7 17.5 217.0 1.7 8.5 2.4 6.1 26.7 3.1 4.0 55.3 1.6 22.5 0.3 20.5 43.7 7.3 6.6 138.4 21.2 163.4 2.9 3.1 26.8 528.3 6.5 64.3 0.8 3.1 3.0 1.3 31.8 1.8 23.7 26.0 9.1 0.2 11.7 4.3 3.2 13.1 0.6 6.6 1.7 0.7 0.6 14.5 4.7 5.6 5.0 7.3 5.8 RAB3GAP1 "KIAA0066, RAB3GAP, RAB3GAP130, WARBM1" ENSG00000115839 "RAB3 GTPase activating protein catalytic subunit 1" Q15042 2 135052292-135176394 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034494, HPA034495" Approved Approved Nucleoplasm,Cytosol NA NA 6300 Nucleoplasm Cytosol "HPA034494: AB_2674188, HPA034495: AB_10670158" "unprognostic (1.02e-2)" "unprognostic (2.43e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.18e-1)" "unprognostic (9.57e-2)" "unprognostic (2.96e-2)" "unprognostic (7.00e-2)" "unprognostic (3.18e-1)" "unprognostic (1.13e-2)" "unprognostic (3.15e-2)" "unprognostic (2.05e-1)" "unprognostic (8.40e-3)" "unprognostic (2.41e-2)" "unprognostic (3.75e-1)" "unprognostic (4.11e-1)" "unprognostic (2.15e-1)" 23.6 21.3 21.9 24.5 25.4 37.8 25.8 19.8 24.1 27.7 23.1 23.4 19.3 29.4 30.8 26.4 23.1 21.8 35.6 24.6 25.6 23.4 20.7 20.6 26.1 24.0 24.2 22.4 35.6 35.7 34.3 19.0 23.8 25.2 29.8 28.2 34.4 35.9 28.6 37.2 26.4 21.5 31.2 20.1 21.4 26.3 18.8 23.5 30.6 31.1 36.3 30.7 26.3 22.6 26.4 51.2 20.4 34.8 29.0 67.3 57.0 32.4 76.6 62.6 59.5 58.4 45.3 40.7 75.5 46.2 78.5 22.8 42.2 37.4 70.6 72.1 36.2 37.9 34.3 24.8 39.9 46.9 46.8 39.3 50.2 91.2 54.8 98.2 53.6 43.6 33.7 49.5 42.5 54.7 30.1 24.1 18.2 27.1 30.7 33.8 40.9 45.0 31.9 35.0 44.9 28.3 22.4 52.0 30.7 36.8 30.5 27.2 33.6 53.0 60.0 45.7 26.0 32.5 30.1 18.2 55.8 39.2 27.8 34.3 10.3 4.3 6.7 1.5 5.3 1.3 5.5 3.8 2.1 4.5 6.8 7.9 4.2 1.7 3.1 6.0 2.3 5.4 2.1 21.9 25.4 19.8 24.1 24.6 25.6 24.0 24.2 22.4 25.2 20.1 23.5 26.4 34.3 25.6 26.7 86.8 50.4 30.2 46.8 28.8 27.9 28.9 30.2 27.8 58.0 32.9 32.6 31.3 50.1 23.6 15.3 39.4 11.7 20.0 34.8 31.8 33.0 28.5 34.6 24.4 137.8 26.9 17.1 35.5 46.9 31.5 46.3 27.2 32.9 25.7 22.4 30.3 106.8 31.2 28.5 26.7 28.1 23.2 30.7 32.4 23.2 112.4 24.2 18.0 6.2 107.1 123.3 34.6 24.3 35.7 40.0 42.5 29.9 21.1 36.0 33.8 46.0 31.8 34.4 41.8 25.8 37.5 29.7 39.1 28.3 35.0 24.7 51.0 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171783405-171999859 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 97.7;Excitatory neurons: 148.5;Inhibitory neurons: 175.2;Oligodendrocyte precursor cells: 111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA 9100 "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 10.7 11.6 8.0 4.0 10.1 2.8 11.7 10.5 12.8 11.6 7.1 21.5 2.2 13.5 4.3 12.8 11.8 3.8 57.9 9.4 10.1 12.8 1.9 7.2 4.4 7.8 8.9 9.0 14.6 4.0 12.1 17.3 3.2 9.2 13.8 6.1 16.0 16.9 9.6 97.8 14.2 10.8 8.6 6.2 9.0 16.6 6.1 8.5 5.7 15.2 51.5 5.2 16.3 12.5 10.8 4.9 3.0 4.2 8.0 9.5 11.7 0.0 5.3 11.2 7.7 7.3 2.2 3.2 14.5 2.6 7.5 4.3 4.3 7.9 8.5 10.7 6.3 10.4 6.9 4.4 5.5 3.8 14.8 4.9 12.6 7.0 11.0 2.3 4.1 8.0 7.0 5.0 5.2 4.4 3.2 9.7 6.5 3.0 3.8 4.7 9.6 4.7 7.4 8.0 4.5 5.1 1.6 2.6 8.5 4.0 2.5 2.8 3.1 6.4 6.2 2.0 6.0 3.2 8.8 4.2 13.6 9.1 7.5 2.9 0.0 0.4 0.1 1.0 0.4 0.8 0.7 0.5 0.9 0.4 0.5 0.9 1.5 0.0 0.9 0.7 0.1 0.7 0.4 8.0 10.1 10.5 12.8 9.4 10.1 7.8 8.9 9.0 9.2 6.2 8.5 10.8 9.8 0.0 9.8 71.2 11.3 6.9 10.2 13.2 19.9 25.5 9.3 11.8 97.7 0.0 18.4 18.4 25.0 7.5 10.7 11.6 19.6 1.7 3.2 5.0 10.3 8.7 14.4 6.9 148.5 3.3 1.8 15.1 12.8 6.1 10.8 7.3 7.9 0.6 4.5 37.0 175.2 6.1 16.2 8.4 5.4 2.1 12.5 7.2 16.0 25.3 9.7 19.8 5.2 111.6 44.1 2.0 4.7 24.5 19.5 4.6 4.1 13.2 11.2 25.5 13.1 12.5 16.6 7.8 9.1 16.8 7.7 1.2 15.0 11.0 7.6 8.3 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 42.9" "Group enriched" "Detected in many" 4 "Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.5 42.9 4.2 4.1 3.7 3.4 5.4 5.3 4.8 7.8 3.4 12.6 8.5 5.1 9.3 3.5 3.9 6.2 4.3 4.5 3.3 7.9 29.4 11.4 4.6 4.4 3.0 2.5 2.9 4.2 3.2 3.1 3.9 3.3 7.3 10.7 4.2 3.7 12.9 5.1 2.9 14.0 5.8 3.3 20.1 4.4 21.9 3.6 6.0 5.5 3.2 2.9 4.3 3.5 4.1 3.3 4.7 2.6 1.8 10.4 11.4 1.5 7.0 9.3 3.6 3.2 1.1 10.9 2.2 2.8 9.9 2.2 3.5 0.8 5.1 4.9 5.0 3.0 3.6 1.6 3.1 5.3 0.0 3.8 16.2 4.6 4.5 0.7 5.4 2.0 1.8 4.4 2.1 6.8 1.3 0.9 4.5 5.1 6.5 3.8 0.0 0.8 0.6 9.0 2.7 2.1 7.5 5.7 0.7 7.3 2.2 1.1 5.9 3.8 4.4 5.1 2.5 2.6 3.8 7.7 4.6 5.4 1.1 4.6 0.0 2.8 0.7 2.0 4.6 3.1 4.1 1.0 1.3 1.8 2.3 1.0 2.2 2.7 3.7 3.5 3.4 0.1 1.4 4.2 3.7 5.3 4.8 4.5 3.3 4.4 3.0 2.5 3.3 3.3 3.6 4.1 3.4 28.9 29.6 25.1 6.5 2.4 6.8 16.3 8.6 3.5 1.9 4.2 5.3 11.5 20.0 5.5 2.1 2.1 6.0 20.9 7.9 5.4 270.4 3.7 11.8 4.6 4.8 3.0 33.8 3.8 1.0 9.2 2.6 3.1 15.8 13.1 5.3 15.5 4.7 5.0 24.5 11.4 6.1 6.3 1.7 163.5 9.3 4.8 5.4 19.7 4.4 4.7 6.2 39.2 7.1 2.5 6.1 6.0 1.8 2.2 29.6 6.7 10.2 2.6 6.6 6.4 5.1 9.4 4.8 1.7 2.4 0.8 3.9 77.6 15.2 2.3 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099438-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.7" "Cell type enhanced" "Detected in some" "dendritic cells: 6.5;Early spermatids: 6.9;Gastric mucus-secreting cells: 5.6;Inhibitory neurons: 10.0;Melanocytes: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "AN3-CA: 79.7;HEK 293: 50.8" "Region enhanced" "Detected in many" "olfactory bulb: 29.4" "Region enriched" "Detected in many" 5 "olfactory bulb: 23.2" HPA056965 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056965: AB_2683291" "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.0 0.3 0.9 0.0 1.0 0.1 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 79.7 0.5 0.3 2.2 4.3 1.0 0.7 0.2 0.5 0.2 0.0 2.4 2.0 3.8 4.1 2.6 0.3 0.2 0.1 50.8 1.3 8.8 2.0 0.2 0.4 0.3 0.0 3.7 0.1 0.5 0.3 0.0 2.0 0.6 0.0 0.5 0.2 0.1 0.6 0.1 0.0 1.1 0.0 0.4 0.0 0.1 0.1 2.8 0.0 2.1 1.2 5.0 1.3 0.6 0.4 0.4 5.5 0.0 3.0 0.5 0.1 0.1 0.5 4.7 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.6 0.2 1.7 0.2 0.0 0.4 0.2 0.0 1.0 0.1 1.4 0.0 0.0 0.0 1.3 1.8 0.2 0.9 0.6 0.0 3.1 3.6 0.4 0.0 0.2 0.0 0.0 0.4 6.5 1.0 0.0 0.0 6.9 1.6 0.3 0.5 0.0 0.0 0.1 0.0 0.3 0.2 5.6 1.1 0.0 0.0 0.0 0.0 0.5 0.0 10.0 1.1 0.0 0.0 0.3 0.1 0.0 1.8 5.4 1.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.4 0.1 1.3 0.0 0.1 0.0 0.0 0.3 1.5 0.9 0.7 1.6 0.0 0.4 1.5 0.2 0.6 0.0 LCT ENSG00000115850 Lactase P09848 2 135787850-135837184 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 186 "intestine: 227.5" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.4;Breast myoepithelial cells: 3.3;Early spermatids: 1.3;Proximal enterocytes: 2.8;Undifferentiated cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "JURKAT: 2.5;MOLT-4: 4.9;RPMI-8226: 9.7" "Region enriched" "Detected in some" 15 "hippocampal formation: 15.7" "Not detected" "Not detected" NA NA "unprognostic (2.21e-2)" "unprognostic (1.65e-4)" "unprognostic (2.54e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" "unprognostic (8.03e-4)" "unprognostic (3.55e-3)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (3.57e-1)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (1.64e-4)" "unprognostic (4.90e-2)" "unprognostic (8.92e-2)" "unprognostic (8.97e-2)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 227.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.4 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 4.9 0.8 0.0 0.0 0.0 1.1 0.0 9.7 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.3 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 DARS1 DARS ENSG00000115866 "Aspartyl-tRNA synthetase 1" P14868 2 135905881-135986100 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 85.1;Cytotrophoblasts: 115.4;Extravillous trophoblasts: 157.9;Hofbauer cells: 94.2;Syncytiotrophoblasts: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020451, HPA029804, HPA029805" Enhanced Enhanced Cytosol NA NA 210000 Cytosol "HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994" "unprognostic (6.13e-2)" "unprognostic (8.16e-3)" "unprognostic (5.54e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (2.39e-6)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.57e-4)" "unprognostic (6.00e-3)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.04e-1)" "unprognostic (9.12e-2)" "unprognostic (3.94e-3)" "unprognostic (2.00e-1)" 37.0 42.5 30.3 41.6 31.1 34.3 49.2 34.7 52.6 34.2 29.4 34.9 23.8 38.7 23.0 46.5 38.2 26.0 42.7 29.8 35.1 47.7 44.6 28.0 48.7 34.4 31.9 25.2 47.7 36.4 38.7 24.8 44.8 35.3 33.9 26.9 87.9 32.8 36.8 83.6 40.5 28.2 39.6 34.0 32.6 33.6 18.0 32.7 63.7 43.8 60.6 55.9 40.4 36.7 36.0 201.6 77.0 73.4 66.3 61.0 78.1 141.6 99.8 92.6 92.2 91.1 163.0 84.0 210.0 159.8 78.4 86.6 111.7 94.9 114.9 170.3 95.6 86.0 134.0 76.8 185.6 83.9 188.3 90.8 84.5 75.6 109.1 99.8 122.9 46.8 106.3 131.6 66.0 66.6 87.3 139.2 117.4 77.8 85.3 66.9 179.3 157.9 139.0 91.8 76.9 40.3 89.6 75.0 63.5 74.8 72.2 66.8 118.2 38.2 86.0 87.4 64.5 92.8 194.9 123.3 250.2 144.1 132.3 51.0 33.7 85.4 51.2 115.2 82.6 174.7 219.9 172.6 151.4 133.7 198.8 175.2 154.2 31.7 171.9 67.4 130.4 168.9 153.3 30.3 31.1 34.7 52.6 29.8 35.1 34.4 31.9 25.2 35.3 34.0 32.7 36.0 29.4 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.1 0.0 0.0 0.0 0.0 115.4 20.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 157.9 18.2 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 136.4 4.4 0.0 0.0 0.0 SRSF7 "9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2" ENSG00000115875 "Serine and arginine rich splicing factor 7" Q16629 2 38743599-38751494 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043850, HPA056926" Supported Enhanced Nucleoplasm NA NA 1300000 Nucleoplasm "HPA043850: AB_10964495, HPA056926: AB_2683277" "unprognostic (2.74e-1)" "unprognostic (1.53e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (3.24e-2)" "unprognostic (2.53e-2)" "unprognostic (2.61e-1)" "unprognostic (3.75e-1)" "unprognostic (4.44e-3)" "prognostic unfavorable (3.18e-8)" "unprognostic (1.02e-2)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-3)" 57.4 44.8 31.5 59.8 32.9 134.0 53.9 33.3 35.7 36.2 35.0 55.6 30.7 44.2 41.1 65.8 45.6 24.2 37.9 32.9 41.0 35.0 49.8 50.9 72.6 31.9 32.9 30.8 34.9 33.9 36.4 30.2 51.2 31.6 39.2 52.7 25.2 37.7 34.9 42.2 35.9 46.5 53.4 35.0 46.1 51.0 54.5 31.7 87.8 34.6 28.0 90.8 69.1 41.2 35.4 271.3 229.3 304.4 197.1 91.8 71.8 213.7 225.2 96.6 222.9 177.9 272.9 202.4 436.1 150.9 148.2 206.9 149.2 385.7 277.1 266.7 274.7 240.9 264.3 154.8 281.2 78.1 329.3 185.4 43.4 92.8 153.3 295.0 94.3 187.9 180.3 388.5 171.1 191.6 298.9 421.2 289.9 331.5 313.3 208.4 367.8 253.4 248.0 168.2 257.3 207.2 201.6 215.3 190.1 156.5 189.7 172.8 295.0 163.1 134.3 210.2 116.3 317.6 186.6 297.8 658.9 159.1 339.1 189.3 23.4 71.2 27.8 59.8 103.3 65.0 63.3 46.1 60.3 142.4 40.7 51.4 59.7 6.8 65.7 61.7 85.8 53.4 77.5 31.5 32.9 33.3 35.7 32.9 41.0 31.9 32.9 30.8 31.6 35.0 31.7 35.4 445.1 80.1 208.8 31.3 453.7 259.5 460.8 255.9 220.3 122.7 226.9 367.2 67.8 87.2 177.0 64.4 118.9 313.7 730.0 214.7 156.5 195.4 173.6 104.6 193.5 245.7 178.0 153.5 96.6 132.2 478.1 264.0 258.9 130.4 320.4 273.2 150.0 85.3 241.9 121.1 82.2 222.5 140.4 123.4 242.6 45.2 138.5 289.2 152.9 65.6 222.6 253.9 239.9 74.9 100.8 149.0 179.3 109.9 337.7 309.9 192.1 94.1 116.4 225.8 118.3 317.9 408.1 286.7 287.3 163.0 243.5 250.2 652.4 186.4 242.8 344.7 SDC1 "CD138, SDC, SYND1, syndecan" ENSG00000115884 "Syndecan 1" P18827 2 20200797-20225433 "Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 495.5;liver: 488.7;skin 1: 413.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 267.4;Hepatocytes: 603.1;Squamous epithelial cells: 246.6;Syncytiotrophoblasts: 250.8;Urothelial cells: 492.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 7 "midbrain: 15.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 482.2;hTCEpi: 436.6;U-251 MG: 470.0;U-266/70: 467.4;U-266/84: 1069.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB002424, HPA006185, HPA067477" Enhanced Approved "Focal adhesion sites" "Secreted to blood" NA NA 63100000 3100000 "Focal adhesion sites" "CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: " "prognostic unfavorable (2.22e-4)" "unprognostic (6.80e-3)" "unprognostic (6.80e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (4.02e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (3.66e-1)" "unprognostic (2.27e-3)" "unprognostic (1.79e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (4.27e-1)" "unprognostic (1.62e-2)" "unprognostic (1.52e-1)" 2.4 17.5 0.7 17.4 0.3 1.2 24.1 2.3 0.8 66.0 0.9 62.3 76.5 2.3 20.1 495.5 10.6 77.9 0.6 0.3 1.3 99.5 488.7 60.1 7.4 0.6 15.6 0.5 1.6 16.7 5.4 2.0 32.9 0.5 56.7 33.6 0.7 86.5 26.1 1.6 413.1 54.1 2.2 0.2 20.3 88.1 3.3 2.2 5.1 18.5 0.0 43.6 105.6 244.1 0.2 252.6 137.6 42.7 108.1 11.6 1.6 134.9 68.7 65.4 62.7 52.8 29.5 148.9 0.3 24.8 48.8 34.8 241.4 19.0 482.2 41.8 1.3 12.5 0.0 12.2 150.2 10.3 11.0 1.0 6.4 436.6 56.5 132.9 87.2 6.9 0.0 6.4 94.7 34.0 149.6 0.6 2.6 38.7 189.6 263.1 5.3 15.7 189.9 80.5 370.0 12.4 99.7 51.9 342.4 15.2 17.1 34.5 2.8 10.7 246.9 78.6 9.2 470.0 467.4 1069.8 1.0 74.5 0.6 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 2.3 0.8 0.3 1.3 0.6 15.6 0.5 0.5 0.2 2.2 0.2 0.4 93.0 99.0 0.0 33.0 113.9 189.1 162.8 81.4 0.6 29.9 26.7 0.9 267.4 161.8 42.3 0.0 3.8 0.7 147.2 31.3 61.3 0.1 16.6 5.0 3.5 10.8 13.5 0.3 21.8 46.3 5.0 55.0 22.9 6.3 7.5 7.5 603.1 2.3 21.9 0.2 73.1 50.8 10.6 11.9 0.3 0.6 2.5 21.4 0.0 0.6 0.3 0.0 1.0 0.0 111.4 78.0 1.2 165.1 78.0 106.5 88.5 43.4 0.4 0.0 0.1 15.0 1.0 14.0 246.6 229.0 250.8 4.0 0.1 85.1 492.8 PLCL1 "PLC-L, PLCE, PLCL, PPP1R127, PRIP" ENSG00000115896 "Phospholipase C like 1 (inactive)" Q15111 2 197804593-198572581 "Metabolic proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.7;tongue: 41.2" "Cell type enriched" "Detected in many" 10 "Oligodendrocytes: 2062.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 6 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 8.7;K-562: 15.6;Karpas-707: 10.7;MOLT-4: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031849 Enhanced NA NA "HPA031849: AB_10602192" "unprognostic (7.77e-3)" "unprognostic (2.57e-1)" "unprognostic (2.09e-1)" "unprognostic (5.18e-3)" "unprognostic (4.40e-2)" "unprognostic (7.14e-2)" "unprognostic (2.05e-1)" "unprognostic (4.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-2)" "unprognostic (7.42e-2)" "prognostic favorable (3.91e-7)" "unprognostic (1.07e-4)" "unprognostic (6.74e-2)" "unprognostic (1.68e-1)" "unprognostic (3.20e-2)" 4.0 4.2 18.9 2.7 37.7 1.6 2.4 31.0 23.5 4.5 9.1 3.3 0.6 14.9 3.1 3.6 3.3 3.1 32.7 14.1 30.0 31.8 0.5 3.2 3.5 40.2 38.3 9.0 7.1 1.6 14.9 2.1 8.0 43.0 10.6 1.4 4.1 2.3 7.1 31.1 0.8 1.8 6.1 28.5 1.9 2.3 1.7 29.3 17.4 3.3 41.2 2.6 4.1 2.0 65.7 0.0 0.0 0.1 0.0 1.6 0.4 0.0 0.4 0.2 0.1 0.1 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 1.5 0.0 0.2 0.0 1.8 4.2 0.0 0.0 0.0 0.0 8.7 2.9 15.6 10.7 0.1 0.4 11.4 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.2 0.0 1.6 0.9 1.8 0.0 2.5 0.8 0.2 0.0 0.7 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 1.4 0.0 18.9 37.7 31.0 23.5 14.1 30.0 40.2 38.3 9.0 43.0 28.5 29.3 65.7 7.0 19.2 4.4 44.4 0.9 1.3 0.8 0.0 0.6 14.8 2.0 1.8 159.0 1.5 1.9 14.7 0.0 0.1 0.8 1.8 58.7 0.9 15.5 2.0 102.7 5.4 1.8 0.0 201.0 0.4 0.0 6.0 1.1 1.9 6.3 3.8 0.4 0.0 3.1 15.2 160.9 0.0 2.0 4.1 2.0 3.8 1.8 4.6 0.0 49.6 2.9 2.7 0.0 181.5 2062.6 0.2 0.0 7.9 3.8 0.6 0.6 52.4 2.2 1.2 32.9 5.4 31.8 1.0 1.8 0.2 1.3 0.1 8.2 1.6 0.1 0.3 SLC1A4 "ASCT1, SATT" ENSG00000115902 "Solute carrier family 1 member 4" P43007 2 64988477-65023865 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 294.5;U-266/70: 132.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034963, HPA034964" Approved Enhanced Centrosome NA NA Centrosome "HPA034963: AB_2797223, HPA034964: AB_2674386" "unprognostic (7.61e-2)" "prognostic favorable (3.59e-4)" "unprognostic (2.49e-1)" "unprognostic (3.19e-3)" "unprognostic (1.26e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.23e-5)" "unprognostic (1.26e-2)" "unprognostic (2.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.28e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.37e-3)" "unprognostic (4.14e-2)" "unprognostic (3.53e-2)" "unprognostic (1.98e-2)" 4.4 26.6 47.9 9.2 45.3 13.5 13.7 30.9 49.0 14.1 17.2 9.5 6.2 12.9 8.3 7.5 4.8 3.9 5.8 42.8 46.5 1.7 9.1 5.0 10.8 35.3 40.4 39.3 13.4 29.9 5.5 13.9 6.7 43.6 9.7 8.5 19.4 7.6 7.1 40.5 18.8 5.6 12.4 26.7 7.5 8.2 11.8 49.3 20.6 5.7 17.1 19.1 4.9 6.3 33.5 15.3 11.6 6.6 34.9 14.7 9.5 9.4 28.5 14.0 11.7 19.8 3.2 2.2 49.7 6.5 44.8 14.7 43.2 13.7 3.6 12.0 20.1 5.4 26.0 13.1 30.9 31.0 43.8 23.1 4.4 73.8 15.8 24.2 3.9 7.3 49.1 20.7 122.0 8.4 13.5 37.7 29.1 4.7 20.1 13.9 13.5 1.9 125.5 4.9 7.7 29.3 14.1 17.9 16.1 294.5 3.0 19.3 47.8 1.6 16.0 19.0 31.2 17.5 132.8 71.2 118.8 23.6 86.5 86.2 0.0 2.1 1.8 0.9 4.8 1.2 0.9 0.9 1.5 3.9 0.3 0.0 0.8 0.0 5.1 9.4 7.2 3.5 1.4 47.9 45.3 30.9 49.0 42.8 46.5 35.3 40.4 39.3 43.6 26.7 49.3 33.5 3.6 0.0 2.7 69.9 13.6 20.0 2.1 6.7 46.1 6.3 21.0 7.1 5.5 1.5 1.7 1.8 33.3 2.4 20.2 2.9 0.0 2.0 32.4 5.4 8.2 5.3 8.4 6.1 20.6 9.3 1.3 4.0 5.1 5.6 7.0 49.2 7.5 13.1 17.7 6.7 25.5 9.0 6.1 6.8 11.8 47.5 11.1 11.1 85.4 8.4 5.1 14.6 2.1 5.0 3.9 7.1 0.8 29.7 65.7 2.6 0.4 1.5 5.4 17.7 0.0 5.1 7.3 2.0 0.9 5.9 6.1 2.5 10.9 0.4 5.8 1.0 SOS1 "GF1, GINGF, HGF" ENSG00000115904 "SOS Ras/Rac guanine nucleotide exchange factor 1" Q07889 2 38981549-39124345 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 134.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005396 Uncertain Approved Cytosol NA NA Cytosol "CAB005396: AB_2270724" "unprognostic (6.68e-2)" "unprognostic (2.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-3)" "unprognostic (4.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.74e-3)" "unprognostic (4.55e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-3)" "unprognostic (7.61e-2)" "unprognostic (5.59e-2)" "unprognostic (1.33e-2)" 17.6 8.5 9.0 14.9 10.6 10.9 9.9 14.6 10.7 13.2 8.1 11.1 14.8 14.4 10.4 12.5 11.3 13.6 9.6 9.9 10.2 11.1 12.0 11.1 17.0 9.7 8.8 7.3 20.3 9.2 17.2 0.1 17.2 10.6 13.5 13.0 13.3 9.1 12.3 13.8 9.5 15.8 13.9 7.2 12.6 11.6 10.4 9.8 15.6 15.2 16.5 18.0 13.7 0.1 13.8 24.8 15.1 22.8 16.2 29.1 35.0 23.8 15.3 18.7 12.0 11.4 16.3 14.6 35.8 10.3 20.1 18.5 14.4 26.9 13.9 22.1 36.3 11.9 55.5 12.8 22.0 11.8 17.9 134.9 21.6 20.5 16.3 15.8 19.5 18.9 8.1 23.9 16.4 15.4 13.5 19.4 15.8 14.3 30.4 10.4 21.5 20.5 10.5 12.1 19.8 22.0 22.0 18.3 32.3 18.2 18.5 10.4 9.3 21.5 19.8 16.0 15.7 15.4 19.3 20.9 18.4 15.8 17.3 12.0 0.0 0.5 1.4 1.3 0.7 1.9 1.6 1.3 1.4 0.4 1.0 1.5 1.4 0.6 2.7 0.9 0.6 0.9 0.4 9.0 10.6 14.6 10.7 9.9 10.2 9.7 8.8 7.3 10.6 7.2 9.8 13.8 72.3 16.0 31.2 120.5 20.9 20.8 15.5 10.9 19.9 19.0 18.4 16.9 33.9 18.6 17.8 9.2 10.4 10.2 27.6 19.5 1.9 11.0 64.9 30.0 36.6 43.2 12.0 12.8 226.6 11.9 8.4 22.9 21.4 34.0 3.8 30.0 12.8 18.6 10.3 8.4 224.0 16.9 26.4 19.1 13.2 11.4 22.7 19.9 7.2 161.1 19.6 15.1 26.8 173.4 125.2 14.2 14.6 21.8 37.5 25.3 28.0 12.8 20.4 11.2 6.6 27.1 22.7 11.3 7.0 17.1 25.3 10.4 33.2 18.4 17.0 28.4 KYNU ENSG00000115919 Kynureninase Q16719 2 142877657-143055833 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 89.2;urinary bladder: 52.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 17 "classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7" "Group enriched" "Detected in many" 19 "B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7" "Cell line enhanced" "Detected in many" "A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol NA NA 590000 Cytosol Nucleoplasm "HPA031686: AB_2673995" "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 5.3 4.1 2.2 24.7 2.1 10.9 31.1 2.7 4.2 4.1 4.1 2.4 1.1 2.5 1.3 6.7 1.2 9.9 1.0 2.1 3.6 18.8 89.2 13.6 15.1 2.8 1.6 2.0 0.4 0.9 0.8 1.2 7.4 3.2 0.9 2.9 1.5 1.9 0.7 0.7 1.1 3.0 4.9 0.7 9.0 5.9 16.7 5.4 3.9 2.3 0.3 29.1 52.0 3.4 3.8 0.2 185.2 0.3 0.4 0.4 0.6 0.5 0.4 5.1 0.2 0.2 3.3 2.7 11.9 0.5 0.1 298.5 0.7 0.1 0.2 0.2 0.6 0.2 4.3 195.5 128.3 2.4 0.4 0.8 17.3 15.0 106.5 0.6 0.2 0.2 0.3 0.5 1.1 1.7 96.7 0.2 11.8 0.7 0.2 0.9 0.2 0.9 0.4 3.2 96.0 0.5 0.3 102.2 15.2 1.0 1.0 50.9 26.5 1.5 5.9 0.5 89.1 0.3 0.7 0.3 0.3 314.5 22.2 0.6 0.7 109.4 2.4 0.5 142.7 0.4 73.6 0.6 0.3 111.2 51.3 0.5 0.3 5.8 1.8 123.4 77.7 0.6 49.2 2.2 2.1 2.7 4.2 2.1 3.6 2.8 1.6 2.0 3.2 0.7 5.4 3.8 3.0 3.2 2.7 0.7 46.8 4.0 0.5 136.1 0.0 0.5 5.8 0.9 1.6 7.2 109.6 3.7 4.2 3.3 16.1 0.7 5.9 14.5 46.3 1.5 1.1 5.1 0.0 2.5 1.3 9.5 2.3 1.8 20.4 15.7 0.0 0.0 2.5 49.1 38.8 10.1 0.9 0.0 114.0 64.7 190.5 42.8 1.8 122.9 1.8 29.0 248.0 0.2 1.0 0.5 0.8 59.6 1.1 0.4 5.1 1.1 0.0 44.4 21.1 0.6 6.6 0.5 3.9 47.8 8.0 1.5 3.1 104.7 2.2 0.1 1.0 22.6 WIPF1 "WASPIP, WIP" ENSG00000115935 "WAS/WASL interacting protein family member 1" O43516 2 174559572-174682916 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 127.9" "Cell type enhanced" "Detected in many" "dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0" "Low region specificity" "Detected in all" "HPA003739, CAB009737, HPA070706" Enhanced Approved "Plasma membrane,Cytosol" No No 520000 Cytosol "Plasma membrane" "CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300" "unprognostic (4.76e-2)" "unprognostic (4.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (2.27e-3)" "unprognostic (2.05e-1)" "unprognostic (1.21e-1)" "unprognostic (7.22e-2)" "unprognostic (1.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (3.65e-2)" "unprognostic (5.43e-2)" "unprognostic (1.58e-1)" "unprognostic (2.50e-2)" 31.3 14.8 17.2 93.8 33.5 57.3 21.2 35.1 21.3 30.8 17.0 22.2 18.4 22.6 11.6 14.3 14.5 35.1 15.4 14.0 32.0 13.1 16.5 32.1 127.9 44.3 38.5 7.8 12.4 7.4 13.0 4.8 33.8 41.0 15.0 21.0 3.4 17.8 23.2 5.9 9.6 32.8 29.4 31.2 90.5 22.0 4.7 30.8 67.0 15.6 11.6 111.4 31.8 17.1 53.4 0.7 7.0 16.3 0.2 40.4 70.9 16.9 31.1 26.4 12.1 18.7 1.9 1.4 209.1 9.2 47.0 15.6 0.5 2.8 0.0 15.1 144.8 4.1 106.5 26.9 0.0 15.1 94.9 167.2 29.6 5.1 27.7 2.6 16.0 25.0 18.7 3.3 296.8 34.4 0.1 106.6 87.1 19.1 0.0 1.4 90.0 6.6 37.9 11.3 0.7 2.6 33.8 0.3 8.8 18.7 30.4 0.4 46.8 21.2 41.0 11.5 30.1 29.9 233.0 165.2 113.7 60.4 64.7 111.7 41.5 35.4 87.2 71.6 37.3 59.4 35.1 47.6 71.1 26.1 28.6 38.0 51.4 166.1 57.4 43.7 11.2 57.7 54.7 17.2 33.5 35.1 21.3 14.0 32.0 44.3 38.5 7.8 41.0 31.2 30.8 53.4 32.1 19.2 21.7 27.7 134.5 12.5 6.3 0.9 2.8 2.1 3.3 4.3 10.5 1.5 4.6 3.7 25.0 2.0 172.7 0.3 5.9 1.7 40.2 3.3 21.9 30.8 4.9 30.1 5.3 11.6 82.5 40.5 9.7 2.1 67.2 2.1 36.8 3.7 86.2 0.0 7.2 1.6 0.0 142.2 128.0 96.9 25.1 139.8 26.6 98.4 187.2 1.2 245.1 120.6 217.2 16.8 0.8 18.0 162.8 5.0 0.2 35.9 0.1 3.4 13.1 15.7 21.4 4.4 4.1 1.2 11.1 4.1 208.1 8.8 2.1 3.1 ORC2 ORC2L ENSG00000115942 "Origin recognition complex subunit 2" Q13416 2 200908977-200963680 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003693, HPA073881" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB003693: AB_425574, HPA073881: AB_2686640" "unprognostic (3.04e-1)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (8.12e-3)" "unprognostic (3.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.37e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (8.42e-4)" "unprognostic (6.18e-2)" "unprognostic (4.56e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (9.67e-2)" "unprognostic (3.74e-1)" "unprognostic (1.42e-1)" "unprognostic (5.31e-3)" 5.6 5.0 2.3 6.8 3.5 5.7 8.1 7.6 5.0 5.6 4.0 7.2 9.2 6.0 6.1 5.9 5.2 4.4 8.9 3.3 2.3 5.7 5.3 5.0 8.6 3.0 2.8 3.1 6.8 6.9 7.3 5.1 5.6 3.6 6.4 6.9 7.8 7.2 5.9 6.8 8.4 7.7 4.8 1.6 6.6 7.1 21.0 2.6 9.5 8.4 6.0 8.5 5.4 5.9 4.6 17.8 12.3 13.9 13.9 5.6 9.5 23.4 18.1 11.4 16.3 16.1 26.3 14.2 11.2 12.6 10.7 18.3 14.3 30.6 20.6 24.7 24.9 28.2 26.1 22.1 32.4 11.0 20.7 17.7 8.9 12.0 16.7 20.4 12.8 19.1 18.3 42.5 13.3 14.6 16.9 29.1 19.5 33.6 17.2 29.6 20.6 14.1 16.3 17.2 14.1 22.0 16.5 15.9 14.0 10.4 27.2 10.0 10.2 14.7 14.2 14.6 12.3 18.3 9.4 24.1 17.9 11.3 19.9 13.6 0.3 2.5 3.9 3.2 1.0 4.3 5.5 4.5 3.2 2.1 4.6 5.7 4.1 1.2 3.2 1.9 4.9 3.3 1.6 2.3 3.5 7.6 5.0 3.3 2.3 3.0 2.8 3.1 3.6 1.6 2.6 4.6 12.9 9.6 18.5 30.7 16.5 19.1 9.0 7.7 23.9 14.6 12.3 7.6 18.0 14.3 14.8 9.2 25.0 20.6 17.5 12.8 7.9 10.0 56.0 11.5 14.1 12.7 4.2 26.7 54.6 12.3 18.5 10.0 14.8 13.3 10.8 27.5 13.2 10.9 8.9 6.7 61.4 13.1 4.1 7.0 7.1 11.6 12.2 7.0 10.6 24.4 11.4 7.0 20.6 41.7 55.9 10.5 9.0 8.2 16.3 9.7 15.2 9.1 12.1 14.9 19.7 13.1 9.1 107.2 22.1 16.1 15.5 10.8 14.7 6.9 14.7 8.4 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB073545: , HPA059124: AB_2683912" "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 79.4 224.6 54.9 18.9 59.0 57.4 79.0 54.6 61.9 91.4 56.5 83.6 32.8 75.4 43.1 61.3 81.7 22.9 100.4 56.7 57.6 130.8 114.9 64.5 32.5 55.5 54.8 55.0 128.6 90.6 72.4 129.0 23.0 57.3 72.2 39.6 62.9 67.7 32.7 84.0 71.1 66.5 28.3 54.4 66.4 100.7 55.0 56.3 42.3 57.0 39.7 35.3 74.8 71.0 58.5 72.1 50.7 49.0 54.0 92.4 121.8 55.8 58.2 85.8 51.5 66.0 56.9 48.9 63.1 54.8 71.9 70.0 30.3 65.5 65.9 80.1 99.5 47.5 46.0 31.9 95.5 106.2 66.5 42.5 123.7 128.6 55.5 132.6 78.5 77.4 49.7 64.1 101.1 83.9 68.6 75.3 96.8 45.3 91.6 48.1 40.7 87.5 51.6 84.6 57.4 55.8 63.7 25.7 60.4 166.1 58.2 43.2 73.3 60.1 45.4 61.2 55.3 57.1 84.1 98.7 46.0 63.1 68.8 39.9 103.7 78.6 43.2 57.9 71.1 75.6 72.6 70.4 67.1 84.4 61.9 77.8 67.0 34.1 69.1 80.1 99.0 87.3 189.3 54.9 59.0 54.6 61.9 56.7 57.6 55.5 54.8 55.0 57.3 54.4 56.3 58.5 150.7 32.1 76.3 11.4 152.5 265.6 197.9 387.2 135.5 114.8 206.8 237.6 158.7 171.6 173.4 149.0 37.5 228.1 163.4 103.8 645.6 239.1 27.4 189.5 133.3 144.0 288.7 188.7 28.2 229.5 316.2 128.5 123.8 175.9 87.0 155.8 132.1 222.3 234.0 131.2 26.1 285.8 282.8 236.3 225.1 26.3 161.8 161.6 220.5 19.7 298.4 326.8 166.9 13.6 24.5 202.1 173.0 158.7 167.7 214.2 247.1 492.4 160.9 123.6 111.7 137.6 175.2 220.4 270.8 162.7 245.5 329.6 161.8 296.2 257.0 241.7 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157888-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavorable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 13.9 14.3 6.8 12.2 7.9 19.6 11.7 7.4 12.2 7.6 7.1 8.9 7.7 9.9 11.3 11.2 8.9 10.0 10.3 11.6 8.0 10.8 12.7 8.7 12.7 7.1 7.2 6.9 7.1 12.8 12.6 7.1 12.8 7.1 10.1 9.2 19.2 7.2 10.9 20.2 8.9 6.8 11.6 7.3 8.3 8.9 9.0 7.2 8.2 12.6 12.7 12.3 20.0 7.7 7.8 37.8 40.1 18.5 30.5 22.5 18.3 46.0 34.7 23.0 39.1 27.8 77.9 21.9 51.4 28.5 23.6 54.0 31.6 60.6 41.9 61.3 35.2 40.6 49.7 17.4 58.2 34.6 40.2 22.4 24.1 30.2 39.4 45.0 11.3 29.1 32.7 69.7 27.3 35.7 27.4 39.9 38.1 52.0 68.7 43.1 33.3 45.2 54.8 29.8 31.7 32.7 24.0 26.1 32.4 57.8 29.7 22.9 22.4 21.2 44.2 48.0 40.1 97.9 21.6 33.1 78.1 36.3 59.1 62.1 0.9 12.6 2.8 12.2 18.1 19.1 19.2 13.8 14.4 16.8 14.5 16.0 14.6 2.4 15.0 13.0 11.8 16.0 21.3 6.8 7.9 7.4 12.2 11.6 8.0 7.1 7.2 6.9 7.1 7.3 7.2 7.8 23.7 16.0 13.2 3.3 29.9 83.2 62.8 29.5 25.6 22.7 18.6 18.4 11.9 18.6 36.2 7.3 12.5 39.5 20.2 7.9 19.6 36.7 33.5 28.7 37.7 25.5 17.3 21.4 10.6 29.8 43.5 28.3 9.7 20.9 31.6 13.6 12.5 15.8 26.0 18.5 9.0 12.1 30.5 10.4 38.7 7.7 12.5 20.7 12.4 4.7 18.9 21.0 14.4 7.1 10.4 29.1 5.8 16.6 27.8 56.6 4.6 34.7 28.6 51.3 6.6 40.4 29.6 28.9 41.7 21.0 56.1 47.6 25.7 20.5 20.2 37.6 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930396-148021604 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: AB_2685287" "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 9.8 11.3 10.4 10.2 13.3 19.5 14.7 22.2 16.5 9.1 8.2 12.7 12.1 12.1 11.1 10.7 14.3 9.8 11.7 12.1 13.3 20.7 12.9 9.4 11.0 10.3 9.4 12.3 16.9 8.3 16.3 7.6 10.2 12.1 12.2 13.9 19.8 13.5 10.4 15.2 9.3 11.5 11.6 6.0 9.0 9.5 15.6 10.5 15.9 15.7 11.0 12.0 10.3 6.6 14.3 22.8 19.3 37.2 20.4 14.2 13.9 39.9 25.2 21.3 31.3 31.0 47.9 22.6 29.3 26.8 15.1 27.7 22.4 43.4 25.2 32.4 20.6 36.1 40.2 19.0 32.8 18.8 25.9 14.5 11.9 29.4 34.0 13.9 23.3 21.4 27.5 38.8 14.9 21.2 23.8 20.1 20.9 42.3 18.9 28.0 21.6 24.9 26.5 34.5 46.3 35.0 27.4 22.6 24.7 30.1 33.6 18.9 12.2 15.5 23.5 23.2 17.3 23.4 14.7 37.9 27.5 19.1 20.0 14.6 24.1 13.1 18.3 13.6 17.5 13.9 14.1 12.9 13.9 16.4 14.5 13.4 13.5 18.8 19.3 14.0 8.3 15.1 11.7 10.4 13.3 22.2 16.5 12.1 13.3 10.3 9.4 12.3 12.1 6.0 10.5 14.3 21.5 83.3 62.5 53.5 26.0 26.0 21.8 47.1 27.3 48.7 20.3 24.0 25.9 11.5 66.1 12.9 39.6 40.3 27.3 21.7 45.0 31.6 34.0 47.9 17.6 23.8 22.9 46.5 88.4 17.2 48.2 27.7 14.3 26.1 45.5 28.3 19.2 17.1 23.8 53.8 91.4 18.9 28.5 18.8 20.7 15.7 22.4 19.7 21.4 34.7 22.0 33.8 24.7 69.9 71.3 18.3 15.4 21.4 12.8 24.4 23.2 55.4 85.8 37.5 32.9 23.2 31.5 61.2 26.8 22.6 24.9 32.7 25.6 16.9 21.8 20.6 PLEK P47 ENSG00000115956 Pleckstrin P08567 2 68365282-68397453 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 610.3" "Cell type enhanced" "Detected in many" "dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031838, HPA057341" Enhanced Approved Nucleoli NA NA 380000000 Nucleoli "HPA031838: AB_10602146, HPA057341: AB_2732609" "unprognostic (2.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.52e-3)" "unprognostic (3.52e-1)" "unprognostic (3.08e-2)" "unprognostic (4.67e-2)" "unprognostic (3.40e-2)" "unprognostic (4.00e-2)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.57e-1)" "unprognostic (4.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" 36.7 9.9 6.2 100.3 6.8 610.3 8.3 6.1 9.4 6.9 8.4 13.3 10.5 4.8 3.3 6.1 7.3 21.2 5.4 5.1 7.8 3.6 27.7 35.9 131.0 6.8 5.7 3.7 2.6 2.7 2.7 1.9 29.5 7.7 4.3 19.0 0.5 5.8 3.1 1.7 3.5 13.1 22.4 9.6 94.4 11.4 3.2 6.5 34.0 3.8 5.2 119.2 52.8 2.5 11.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 93.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 552.9 0.0 0.0 0.0 126.7 202.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 58.9 0.0 0.0 0.2 187.5 0.0 0.0 0.0 1.5 0.1 27.3 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 215.6 0.1 0.0 0.4 0.1 0.5 7.9 147.8 147.1 0.2 342.5 0.1 231.9 297.5 429.2 298.5 351.6 157.6 157.7 52.2 218.7 229.6 103.6 14.5 161.8 573.9 249.5 390.8 474.8 5.7 606.9 6.2 6.8 6.1 9.4 5.1 7.8 6.8 5.7 3.7 7.7 9.6 6.5 11.5 3.4 19.2 24.6 0.0 77.0 6.5 0.3 0.0 0.0 0.0 1.4 3.7 2.3 1.5 15.5 1.8 0.0 1.2 310.7 0.0 0.0 0.2 1.5 0.2 0.3 6.3 0.0 21.9 0.6 0.6 1.8 10.2 1.5 0.3 62.0 0.0 5.7 1.5 220.3 0.0 0.2 0.0 0.0 213.9 456.5 5.1 0.6 412.7 17.8 20.6 178.3 0.0 355.3 0.0 0.1 0.1 0.1 0.4 48.4 0.0 0.0 0.7 13.1 0.1 13.1 1.1 1.8 0.8 0.9 0.6 6.7 2.6 78.3 0.4 0.0 0.3 RND3 "ARHE, Rho8, RhoE" ENSG00000115963 "Rho family GTPase 3" P61587 2 150468195-150539011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 156.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1633.3;Endometrial stromal cells: 521.7;Suprabasal keratinocytes: 924.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 680.9;BJ hTERT+: 1331.5;hTERT-HME1: 650.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060504 Uncertain NA NA "HPA060504: AB_2684295" "unprognostic (8.03e-2)" "unprognostic (3.04e-2)" "unprognostic (2.36e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-3)" "unprognostic (4.23e-2)" "unprognostic (6.59e-2)" "unprognostic (1.27e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.47e-1)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (2.03e-2)" 58.5 50.5 11.9 28.1 7.9 1.2 100.2 8.7 9.2 48.2 9.9 27.5 17.0 45.6 7.4 156.8 14.1 60.4 23.8 7.9 14.1 14.0 133.0 23.4 11.5 8.4 8.2 7.8 8.5 16.3 1.9 7.9 46.8 14.2 46.4 27.4 5.3 29.2 38.1 14.5 43.6 20.1 62.8 6.8 39.8 20.4 4.7 11.6 8.2 7.4 14.1 24.7 109.8 44.4 8.1 46.5 27.5 49.2 93.8 137.1 65.7 0.4 680.9 1331.5 335.0 189.1 34.8 31.4 0.0 42.5 277.8 173.1 108.2 1.9 43.9 268.5 0.0 20.4 0.0 35.1 1.1 391.2 0.1 0.5 46.2 78.6 344.9 650.7 62.9 65.4 0.4 0.0 158.2 145.0 27.5 0.3 0.3 15.4 47.5 42.3 0.1 37.7 21.5 74.5 80.7 15.0 46.4 71.5 29.3 37.2 35.9 33.3 1.1 67.4 296.3 55.3 137.8 73.8 35.7 0.4 0.4 234.2 0.1 209.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 7.9 8.7 9.2 7.9 14.1 8.4 8.2 7.8 14.2 6.8 11.6 8.1 81.3 38.5 5.8 2.0 0.4 1633.3 231.2 304.7 368.2 40.5 131.9 218.1 95.6 45.8 192.5 9.2 14.6 71.7 1.8 359.8 3.9 63.4 1.9 389.9 521.7 46.3 32.8 5.3 0.6 14.6 12.8 353.4 56.6 400.3 4.5 0.6 26.4 129.3 12.2 1.7 35.3 130.5 97.6 76.8 83.0 2.2 10.5 12.0 136.9 15.0 0.0 9.6 0.0 0.5 0.5 107.4 249.5 10.5 4.6 102.4 174.8 3.9 157.0 2.7 19.7 182.0 166.8 0.9 3.4 458.0 924.7 91.1 10.9 36.8 117.5 262.9 ATF2 "CRE-BP1, CREB2, HB16, TREB7" ENSG00000115966 "Activating transcription factor 2" P15336 2 175072250-175168382 "Predicted intracellular proteins, Transcription factors" "DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 153.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003769, HPA022134" Supported Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003769: AB_562241, HPA022134: AB_1845138" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (9.81e-2)" "unprognostic (1.93e-1)" "unprognostic (9.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.28e-2)" "unprognostic (3.70e-2)" "unprognostic (6.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.02e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-2)" "unprognostic (1.50e-1)" "unprognostic (7.21e-3)" "unprognostic (6.70e-2)" 16.9 20.4 15.1 15.3 20.2 16.5 19.7 25.9 24.8 25.9 8.8 15.2 13.1 22.1 21.8 14.4 19.1 18.0 12.2 19.7 20.2 22.7 28.1 15.6 19.8 19.0 16.7 18.6 26.3 19.0 24.2 14.0 20.6 21.1 18.4 15.8 22.0 18.1 17.9 12.6 10.0 13.7 18.2 14.4 17.8 14.4 21.2 17.7 30.5 32.6 23.3 21.3 18.9 13.1 21.8 14.1 12.1 35.1 23.4 30.6 32.3 16.1 22.3 38.1 26.6 38.1 26.6 25.4 21.1 23.9 26.6 31.2 13.3 26.9 13.5 41.2 26.6 15.6 29.3 19.8 58.3 34.4 27.8 29.7 24.4 29.8 34.4 40.5 35.0 37.0 19.4 24.4 31.6 30.1 10.5 45.2 34.4 32.7 23.6 27.2 38.3 16.1 32.5 39.1 11.8 29.3 23.9 27.9 8.6 33.0 28.2 19.3 30.4 23.5 30.8 16.1 16.9 13.6 30.3 48.9 26.9 24.2 26.0 21.2 35.5 16.9 20.1 20.1 15.1 24.3 16.6 17.0 20.9 21.9 14.1 19.6 21.5 10.8 19.8 19.1 12.1 24.4 18.0 15.1 20.2 25.9 24.8 19.7 20.2 19.0 16.7 18.6 21.1 14.4 17.7 21.8 43.4 16.0 13.2 47.7 33.5 33.0 15.4 15.6 52.9 22.7 34.0 24.4 22.5 20.0 15.5 23.9 10.4 14.1 37.4 16.5 13.7 12.1 115.4 19.5 30.5 33.8 16.3 20.8 86.6 7.0 13.0 32.2 18.3 28.4 29.8 27.1 17.2 27.0 18.9 40.4 71.3 14.4 18.3 23.3 30.2 153.0 32.6 23.6 30.2 54.4 20.4 32.3 24.7 75.9 84.9 11.9 9.1 28.6 38.8 15.6 11.5 21.6 19.3 27.3 13.1 31.5 33.9 36.3 17.6 30.4 25.3 6.3 32.9 23.7 16.1 13.6 THADA "ARMC13, FLJ21877, GITA, KIAA1767" ENSG00000115970 "THADA armadillo repeat containing" Q6YHU6 2 43230851-43596038 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 74.7;Excitatory neurons: 77.5;Inhibitory neurons: 77.2;Microglial cells: 89.9;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 111.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 17.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035191, HPA035192" Uncertain Approved Cytosol NA NA Cytosol "HPA035191: AB_10670290, HPA035192: AB_2674512" "unprognostic (1.20e-1)" "unprognostic (2.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (8.27e-2)" "unprognostic (9.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.12e-1)" "unprognostic (3.43e-2)" "unprognostic (5.25e-2)" "unprognostic (2.14e-1)" 10.6 9.3 7.8 7.6 8.5 9.0 11.2 7.5 7.2 12.1 14.0 8.6 4.2 11.1 10.3 10.0 11.2 6.1 8.9 7.1 9.3 8.7 17.4 9.9 14.4 8.4 8.0 6.5 11.6 11.6 12.5 11.2 6.2 8.0 13.2 6.2 8.4 10.3 7.0 10.2 13.6 9.5 7.3 7.9 11.8 9.2 10.3 8.2 10.3 13.6 6.2 9.9 10.6 11.1 9.6 19.2 22.6 10.0 0.3 26.6 22.8 14.4 12.6 10.3 11.6 9.8 13.3 11.3 17.5 21.0 15.0 15.8 17.4 15.7 21.6 19.9 14.6 15.5 12.5 8.6 17.7 9.3 19.5 9.7 15.0 19.1 24.5 31.8 12.2 16.1 6.5 22.6 9.1 14.2 24.2 19.4 21.7 20.2 27.4 12.7 8.9 18.1 13.3 18.4 16.9 13.2 20.5 11.9 11.5 11.3 11.6 11.8 10.1 13.6 19.0 14.0 14.7 22.9 23.0 15.2 19.6 15.4 19.1 15.7 17.2 2.6 1.2 3.4 4.0 3.7 3.6 3.7 4.2 4.2 3.6 3.4 4.0 1.8 5.4 2.9 3.2 4.5 2.2 7.8 8.5 7.5 7.2 7.1 9.3 8.4 8.0 6.5 8.0 7.9 8.2 9.6 11.7 19.2 14.4 74.7 15.4 8.5 16.5 8.9 23.3 11.9 11.8 11.0 8.5 18.6 12.0 14.7 16.7 7.9 9.6 5.1 1.9 8.8 20.9 19.5 17.0 10.3 7.3 12.4 77.5 9.6 5.4 12.5 15.3 11.2 6.3 19.7 11.4 17.8 9.7 3.3 77.2 5.4 4.1 9.7 7.4 11.1 9.9 12.9 3.6 89.9 7.9 5.3 10.3 73.9 111.0 6.4 7.2 8.6 11.5 11.3 2.5 7.4 22.6 24.9 0.0 16.2 9.1 20.7 14.1 11.0 4.4 4.8 16.5 20.3 6.3 7.4 AAK1 "DKFZp686K16132, KIAA1048" ENSG00000115977 "AP2 associated kinase 1" Q2M2I8 2 69457997-69674349 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 90.3" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 777.7;Rod photoreceptor cells: 640.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 30.3;pons: 12.5" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017931, HPA020289" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA No "Vesicles, Plasma membrane" Cytosol "HPA017931: AB_1844406, HPA020289: AB_1844407" "unprognostic (2.11e-3)" "unprognostic (3.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.01e-3)" "unprognostic (5.06e-2)" "unprognostic (4.04e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (4.18e-2)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.76e-3)" "unprognostic (1.18e-1)" 9.2 12.7 0.3 8.2 0.6 12.1 8.1 1.1 30.3 7.0 0.0 7.0 4.7 10.0 10.0 7.5 7.6 5.4 15.5 4.8 0.8 9.9 5.2 10.4 9.1 5.2 3.4 0.0 5.5 13.2 90.3 13.8 10.0 12.5 8.6 6.4 28.4 6.8 8.3 13.1 6.1 8.6 7.7 0.0 8.7 12.7 6.8 4.6 13.3 23.6 6.8 7.7 7.9 7.1 4.6 25.1 15.3 14.6 12.3 13.7 14.3 41.0 19.4 16.8 12.0 11.3 15.6 10.0 0.9 4.6 27.6 16.5 11.4 11.7 11.4 27.1 20.6 4.4 13.3 9.0 10.0 11.7 9.5 31.3 12.9 9.6 23.7 30.9 10.2 27.4 12.3 3.2 14.1 22.5 3.7 8.8 5.6 6.4 4.9 8.3 5.8 13.8 2.2 10.0 51.0 4.2 6.6 12.0 8.8 10.2 9.9 5.3 12.9 25.6 26.4 17.5 19.7 19.4 12.9 3.9 1.5 23.0 16.0 19.1 1.4 0.5 0.2 1.4 0.2 1.4 0.1 1.3 1.0 0.3 0.3 1.7 1.5 1.5 1.1 2.2 0.2 1.0 0.5 0.3 0.6 1.1 30.3 4.8 0.8 5.2 3.4 0.0 12.5 0.0 4.6 4.6 54.6 35.3 34.2 77.7 13.4 15.9 20.8 15.9 32.5 254.4 42.2 40.9 86.7 102.9 19.3 143.5 777.7 81.6 149.1 130.6 43.0 46.0 23.9 36.6 67.4 56.0 72.1 35.3 265.8 67.4 56.3 29.5 44.9 65.7 21.0 24.4 118.2 38.2 62.4 306.2 327.7 31.6 12.2 128.8 23.5 32.7 38.2 67.1 10.6 156.4 72.7 53.2 252.4 147.8 113.9 55.9 76.3 46.6 57.4 42.1 56.0 90.0 10.7 640.8 19.7 26.7 45.5 46.9 59.3 23.3 9.9 213.3 158.1 33.6 21.7 49.0 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451500 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 123.3" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 157.8;Erythroid cells: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: AB_2684702" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favorable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 24.3 20.5 75.3 16.6 67.4 52.7 14.9 68.5 61.5 16.2 58.6 22.6 13.5 14.4 13.1 16.9 14.0 18.8 71.6 55.1 64.1 23.9 14.3 20.9 17.4 95.3 74.5 41.9 9.7 15.5 26.8 12.5 23.9 90.2 12.9 23.0 20.3 26.7 15.3 14.9 7.8 16.3 20.5 118.3 18.2 12.3 7.9 80.3 12.5 35.2 27.0 13.7 15.8 9.1 123.3 11.6 15.5 9.4 34.3 61.6 87.4 10.6 39.2 32.8 27.4 31.9 24.4 9.8 7.1 16.3 50.6 26.4 11.2 20.0 12.9 43.5 21.4 13.0 15.5 25.6 15.9 33.8 12.3 18.4 48.4 10.8 28.8 22.2 27.5 40.4 11.0 12.4 26.9 55.8 16.6 9.6 6.9 10.6 11.3 32.7 12.1 24.9 10.6 21.9 15.6 18.6 24.0 21.0 15.5 63.6 13.6 12.4 12.4 50.2 44.2 16.6 31.0 25.7 16.2 30.2 8.3 37.2 18.2 24.4 2.6 5.5 6.2 7.8 7.0 7.3 9.3 10.1 6.7 4.3 14.2 6.9 7.3 3.4 11.1 6.5 2.3 12.6 6.0 75.3 67.4 68.5 61.5 55.1 64.1 95.3 74.5 41.9 90.2 118.3 80.3 123.3 34.0 16.0 29.8 37.5 17.8 8.3 3.4 6.3 11.4 45.4 14.4 8.8 157.8 22.8 13.4 9.2 73.0 10.3 9.3 27.9 7.9 13.9 1.9 12.7 20.9 21.0 29.5 181.0 92.3 14.7 4.8 16.9 10.7 25.7 19.6 10.3 15.0 14.3 10.6 77.4 75.6 20.6 10.2 12.9 7.7 3.8 8.1 13.2 26.6 22.5 14.2 5.1 12.3 47.7 57.0 10.7 14.5 12.8 16.8 5.7 21.7 8.9 14.9 22.1 13.1 23.2 23.3 9.4 12.8 16.2 4.1 5.6 16.6 18.7 24.5 7.2 C2orf42 FLJ20558 ENSG00000115998 "Chromosome 2 open reading frame 42" Q9NWW7 2 70149885-70248615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.6" "Cell type enhanced" "Detected in many" "Early spermatids: 262.9;Late spermatids: 98.5;Spermatocytes: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031840, HPA031841, HPA031842" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068" "unprognostic (8.49e-2)" "unprognostic (2.09e-1)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.20e-3)" "unprognostic (2.26e-1)" "unprognostic (3.73e-1)" "prognostic favorable (5.94e-5)" "unprognostic (4.66e-2)" "unprognostic (9.41e-2)" "unprognostic (2.11e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (2.49e-3)" 6.2 7.4 11.8 5.9 12.5 4.8 6.4 16.2 12.4 7.9 10.4 6.1 4.5 8.6 11.0 6.5 11.3 7.6 5.7 10.2 11.7 8.3 15.5 6.1 12.5 10.9 11.2 9.6 10.3 6.8 11.6 7.9 8.0 12.0 6.8 5.3 7.6 6.5 7.3 6.8 6.8 6.4 7.6 10.7 8.9 6.1 59.6 11.5 10.2 8.2 8.5 11.7 8.2 6.3 15.9 5.9 9.6 8.9 8.1 17.9 10.4 10.1 13.9 9.4 11.0 9.4 7.8 5.1 7.5 7.9 8.3 18.0 8.0 9.4 7.9 12.2 13.1 8.3 8.8 6.8 7.7 15.9 7.3 8.6 12.5 14.1 10.5 13.3 12.0 10.8 9.4 7.5 27.6 14.7 4.6 9.4 10.7 6.4 9.9 10.6 8.8 12.1 13.8 9.0 6.8 7.4 7.5 7.5 11.6 14.4 6.2 5.2 8.9 8.5 9.8 6.7 9.1 11.4 15.1 16.2 7.5 7.6 11.8 8.9 2.3 7.7 9.9 12.1 7.2 15.5 14.2 12.2 14.7 7.9 13.0 13.9 14.9 8.3 21.9 7.8 7.0 15.5 10.9 11.8 12.5 16.2 12.4 10.2 11.7 10.9 11.2 9.6 12.0 10.7 11.5 15.9 4.0 0.0 2.2 7.8 8.9 2.5 3.4 3.7 5.7 5.8 4.0 5.0 2.8 1.5 2.8 5.5 0.0 8.8 6.1 4.2 7.9 4.5 262.9 3.8 3.3 3.6 1.2 4.0 9.2 2.4 4.0 4.4 3.6 2.8 2.5 5.0 6.4 6.9 4.3 0.0 8.9 2.1 2.0 4.7 3.1 98.5 7.5 3.6 3.6 2.8 3.1 9.0 9.2 8.0 12.3 2.0 3.1 7.9 8.4 2.9 3.3 6.4 6.6 4.1 0.0 4.2 3.8 63.1 12.0 3.5 4.3 9.6 5.3 4.3 2.5 2.0 TIA1 TIA-1 ENSG00000116001 "TIA1 cytotoxic granule associated RNA binding protein" P31483 2 70209444-70248660 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Apoptosis RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 172.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056961 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056961: AB_2683289" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (3.68e-2)" "unprognostic (1.07e-1)" "unprognostic (7.64e-3)" "unprognostic (2.51e-3)" "unprognostic (3.37e-3)" "prognostic favorable (6.79e-5)" "unprognostic (5.09e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.05e-7)" "unprognostic (4.00e-1)" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "prognostic favorable (1.02e-5)" 27.5 34.7 23.5 34.6 26.6 28.3 48.0 30.5 28.9 60.2 28.1 41.2 36.0 69.2 70.8 26.3 50.9 36.9 27.3 23.2 24.5 33.3 33.3 33.1 50.0 25.2 24.6 23.2 74.4 41.5 30.0 49.7 37.0 25.9 43.9 40.2 68.6 42.5 35.4 24.9 40.7 46.2 41.4 24.6 51.8 37.3 19.9 24.5 68.2 48.0 25.9 36.1 37.1 40.2 33.0 21.0 22.9 117.4 66.1 32.7 55.1 56.6 36.6 25.8 34.8 34.4 31.0 31.7 47.1 30.7 27.3 20.2 33.8 57.5 20.0 48.9 44.2 25.1 48.9 43.2 74.4 26.1 49.5 26.6 41.2 29.0 20.0 21.9 82.3 65.1 37.5 38.4 41.9 49.4 17.9 91.9 78.0 95.8 30.0 27.0 110.5 63.8 48.0 53.3 40.7 71.0 60.6 43.2 50.8 36.0 60.5 30.4 36.2 53.6 42.5 44.3 20.1 36.6 34.9 36.9 86.7 24.9 62.1 57.6 13.5 5.9 8.4 5.6 5.0 5.4 7.1 5.5 5.8 8.8 5.2 5.0 5.6 2.3 8.2 3.1 4.5 7.6 3.9 23.5 26.6 30.5 28.9 23.2 24.5 25.2 24.6 23.2 25.9 24.6 24.5 33.0 45.8 83.3 63.4 91.7 44.7 25.4 31.2 25.1 38.1 52.7 46.9 40.6 30.8 28.6 54.8 20.2 47.9 31.3 40.3 23.0 0.0 31.0 21.0 31.9 70.6 40.1 52.6 42.9 95.0 27.1 34.6 40.8 36.2 34.2 55.7 106.7 33.2 30.6 21.1 35.3 94.5 31.7 32.6 29.4 28.7 9.3 36.1 32.4 16.0 57.1 44.0 31.4 28.8 152.3 172.0 30.1 23.6 35.7 38.2 32.5 24.8 14.0 58.8 51.8 26.3 25.4 45.7 30.0 19.3 26.0 24.0 24.8 43.5 44.3 31.9 29.7 PCYOX1 "KIAA0908, PCL1" ENSG00000116005 "Prenylcysteine oxidase 1" Q9UHG3 2 70257386-70281185 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 599.4;Hepatocytes: 187.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 313.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035193 Approved "Intracellular and membrane" NA NA 510000000 "HPA035193: AB_10602017" "unprognostic (1.09e-1)" "unprognostic (1.72e-2)" "unprognostic (7.91e-2)" "unprognostic (1.15e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" "unprognostic (6.87e-2)" "unprognostic (6.28e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (1.61e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.89e-4)" "unprognostic (3.26e-2)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" 79.2 33.8 15.1 12.8 15.8 3.8 34.7 12.1 18.5 57.0 25.7 27.2 25.1 40.3 33.9 39.1 36.0 32.0 38.0 13.9 23.9 93.4 104.4 56.7 14.7 16.1 18.5 12.8 39.9 20.8 66.5 18.1 29.3 21.6 44.7 23.9 31.0 70.7 47.0 93.0 33.3 24.7 41.2 13.2 15.7 22.3 14.3 25.7 11.2 60.6 50.8 14.3 26.0 25.4 24.2 38.8 54.9 43.2 48.6 313.2 160.0 37.9 64.8 59.4 35.4 26.5 86.5 33.6 4.0 27.3 89.2 58.2 62.2 31.7 50.2 40.5 22.1 26.9 14.9 41.0 75.7 31.4 14.1 12.7 154.9 54.1 47.4 13.3 93.9 42.6 14.2 27.0 27.8 50.7 23.6 10.7 22.8 26.1 55.9 23.1 19.6 90.2 34.5 50.1 42.8 11.3 24.1 97.8 47.7 45.5 61.0 39.1 18.2 53.4 59.2 32.7 52.9 34.2 22.9 55.1 5.1 71.3 19.3 22.1 16.3 6.5 6.8 8.3 5.4 10.4 3.7 8.0 6.7 5.9 2.8 10.8 9.2 4.1 6.1 6.0 7.4 7.8 6.5 15.1 15.8 12.1 18.5 13.9 23.9 16.1 18.5 12.8 21.6 13.2 25.7 24.2 37.3 599.4 77.5 16.0 12.2 21.3 23.1 43.9 29.6 48.7 46.0 31.8 81.1 40.0 49.9 53.3 43.8 43.4 12.1 30.7 7.9 26.7 1.7 18.4 65.9 33.4 8.5 12.0 24.7 10.2 36.0 81.9 22.4 36.2 10.1 20.9 39.7 187.8 22.1 57.2 36.8 21.0 36.7 17.4 9.2 3.9 89.2 14.3 24.9 23.4 8.6 90.3 11.3 21.6 18.0 13.9 21.0 120.7 26.2 27.0 47.7 69.0 25.0 36.9 72.3 65.5 63.7 14.7 32.2 40.8 28.3 22.0 14.5 56.2 26.5 18.4 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921005 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.7" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 41.9" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA007156: , HPA071913: AB_2686471" "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavorable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.0 0.0 2.3 0.1 1.9 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 3.4 0.2 0.1 0.1 0.1 3.4 1.8 3.3 0.0 1.4 0.3 1.1 0.1 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.1 5.1 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 4.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.7 0.0 0.0 0.3 0.1 0.0 0.6 1.2 0.4 1.0 0.0 37.4 0.0 0.0 7.4 20.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.9 0.9 1.9 1.4 3.4 3.4 1.8 3.3 4.1 1.0 5.7 5.1 0.1 0.0 0.0 0.0 1.0 0.1 0.1 0.5 0.0 1.1 1.2 1.4 0.5 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 41.9 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.3 1.8 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.0 4.2 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.3 0.3 0.3 1.6 0.9 0.2 0.1 0.2 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386697 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 415.5;placenta: 449.3" "Cell type enhanced" "Detected in many" "Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 20.6;eosinophil: 8.4" "Lineage enriched" "Detected in single" 26 "granulocytes: 20.6" "Cell line enhanced" "Detected in many" "BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031200: AB_2673785, HPA069697: AB_2732139" "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 298.7 52.6 54.9 66.7 42.2 2.3 168.1 41.3 49.4 73.5 128.9 57.7 46.7 88.6 26.3 73.3 80.7 84.0 123.2 35.8 41.0 90.3 111.0 415.5 48.3 62.5 51.0 19.1 34.8 60.1 80.1 26.1 449.3 51.0 52.2 43.0 54.1 40.4 67.0 81.2 38.1 51.3 72.3 38.6 85.3 43.2 20.2 58.1 18.0 139.2 154.9 40.7 95.8 48.2 48.0 32.2 33.5 2.1 2.5 153.8 98.6 267.3 98.7 266.7 55.6 60.1 5.8 5.5 0.1 23.8 188.5 55.2 15.2 0.6 79.0 41.3 0.9 1.6 0.0 10.3 71.8 326.3 0.1 19.8 145.0 106.9 108.7 75.8 41.0 193.1 0.7 3.1 0.2 34.2 27.8 0.9 0.8 1.3 22.4 18.5 1.0 3.7 10.5 34.5 339.8 1.4 68.5 77.4 175.5 21.0 68.3 11.7 14.1 337.8 284.0 8.1 38.3 8.4 0.2 0.2 0.1 207.4 5.4 7.4 20.6 0.1 8.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.1 54.9 42.2 41.3 49.4 35.8 41.0 62.5 51.0 19.1 51.0 38.6 58.1 48.0 831.5 76.9 151.7 28.4 4.1 48.2 69.8 108.6 43.9 4.5 27.4 29.5 79.2 32.9 124.9 3.7 10.4 126.2 6.6 112.6 1.9 23.0 12.9 36.1 32.7 425.8 4.2 18.7 1.2 52.4 299.9 76.8 32.1 67.6 41.2 2.3 538.7 78.0 55.5 0.0 1.6 13.9 22.4 60.9 30.3 52.7 12.5 21.4 28.4 155.5 0.6 95.5 0.0 31.2 1.3 26.1 53.7 6.4 3.9 57.8 45.9 30.2 31.7 59.3 282.7 23.3 250.5 1.5 4.6 65.0 33.2 349.7 15.9 4.7 23.6 85.7 ARID3A "BRIGHT, DRIL1" ENSG00000116017 "AT-rich interaction domain 3A" Q99856 19 925781-975939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 23.6;testis: 17.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 191.8;Extravillous trophoblasts: 492.4;Langerhans cells: 163.7;Syncytiotrophoblasts: 518.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 206.5;CACO-2: 72.3;Hep G2: 65.8;K-562: 95.6;THP-1: 66.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004793, HPA076330" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004793: AB_1847870, HPA076330: AB_2732309" "unprognostic (1.34e-1)" "unprognostic (2.62e-3)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (1.31e-3)" "unprognostic (5.67e-2)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (5.22e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.95e-5)" "unprognostic (4.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (3.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.30e-1)" "unprognostic (8.95e-2)" 3.3 1.8 2.1 4.9 1.6 10.4 2.2 2.9 3.8 2.5 2.5 2.4 3.3 2.2 0.7 3.0 2.3 0.8 1.8 1.8 1.6 3.7 2.2 4.5 3.5 1.8 1.4 1.6 1.2 3.2 2.1 3.3 23.6 2.3 1.9 1.2 0.9 2.0 0.7 1.7 2.9 3.6 1.3 1.7 6.6 2.6 17.2 2.0 2.5 1.6 1.1 2.7 2.2 3.0 2.4 3.8 5.0 17.2 4.3 7.2 5.4 206.5 16.5 10.7 8.8 5.8 72.3 0.6 1.6 3.8 5.6 2.2 1.5 7.0 3.9 3.8 22.5 5.0 7.2 6.5 65.8 3.1 25.1 17.8 7.7 5.5 5.5 1.4 1.4 2.9 5.7 95.6 20.3 2.6 5.8 9.8 28.5 16.6 2.6 1.0 21.9 5.4 13.9 1.1 3.7 8.3 15.8 5.3 4.3 3.1 37.7 7.6 66.7 4.9 5.8 7.8 8.4 1.9 47.0 45.3 12.5 3.8 14.5 4.0 0.7 1.6 1.1 0.3 1.4 0.3 0.9 0.2 0.3 1.0 0.6 0.3 0.1 4.1 1.3 2.1 6.4 0.2 0.7 2.1 1.6 2.9 3.8 1.8 1.6 1.8 1.4 1.6 2.3 1.7 2.0 2.4 4.7 6.4 2.8 2.9 30.2 14.8 8.0 8.9 9.6 8.4 7.4 7.5 8.0 0.0 2.4 14.7 8.4 191.8 56.0 4.0 9.8 5.7 41.3 14.8 19.0 14.1 46.9 9.9 8.5 3.3 492.4 18.9 5.1 15.2 3.8 11.4 11.4 7.6 98.2 6.7 8.0 11.3 4.1 41.0 163.7 4.7 7.2 41.0 16.0 24.4 60.4 2.2 13.4 6.6 2.7 14.3 0.3 6.4 50.9 6.9 10.8 5.7 1.1 4.4 0.0 3.2 10.5 2.9 9.9 8.1 15.3 518.3 10.7 8.2 5.5 2.1 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin like modifier 1" P63165 2 202206182-202238599 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.6" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 78.2 100.0 83.5 63.3 88.6 134.9 84.4 92.7 100.7 69.4 87.4 83.5 72.6 65.8 87.1 72.3 66.3 72.4 80.6 86.5 87.8 119.2 175.6 67.1 87.1 83.6 83.2 82.5 55.0 56.2 92.4 57.2 76.2 84.7 76.0 83.6 80.9 67.4 62.4 108.5 57.6 81.2 72.1 83.1 68.7 74.4 55.2 85.1 113.1 103.2 104.3 96.1 78.7 55.4 90.0 164.1 82.4 291.4 155.8 159.3 168.5 129.7 171.0 214.6 209.0 274.6 178.1 203.7 111.6 153.5 199.0 193.5 117.1 242.2 237.9 325.0 104.8 185.7 207.6 159.0 211.2 114.9 237.2 188.5 130.9 225.2 164.0 123.9 195.1 197.3 219.0 194.2 176.0 226.4 141.1 298.3 391.6 351.7 168.5 172.2 190.9 163.2 197.9 255.5 134.3 201.7 219.3 140.3 133.6 236.4 313.9 120.0 223.2 139.9 152.5 153.0 141.4 152.8 151.7 322.9 285.8 170.2 165.4 137.2 242.2 220.0 284.2 169.2 226.5 179.6 276.3 206.8 200.0 223.6 231.6 193.8 202.3 256.5 246.5 239.7 187.8 329.0 394.7 83.5 88.6 92.7 100.7 86.5 87.8 83.6 83.2 82.5 84.7 83.1 85.1 90.0 182.7 112.2 61.1 10.7 143.1 422.1 204.4 448.6 177.6 99.6 196.8 170.2 58.1 130.1 215.3 189.4 64.6 259.4 162.3 136.6 481.3 250.4 91.3 148.3 115.1 170.7 142.4 140.1 31.4 173.3 297.8 161.8 89.7 115.2 92.6 114.7 142.8 202.1 205.3 87.5 27.8 156.4 319.4 140.7 330.2 28.0 129.8 137.7 211.7 15.9 241.3 182.3 176.1 16.6 21.2 208.1 191.1 127.9 130.5 258.5 272.2 534.4 185.5 87.8 111.7 92.5 221.9 212.0 141.5 183.9 424.5 209.7 174.5 134.9 157.5 254.1 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830211-70835816 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 88.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.0;Langerhans cells: 9.7;Macrophages: 7.6;Melanocytes: 5.4;Suprabasal keratinocytes: 5.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "myeloid DC: 1.1" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.1" "Cell line enriched" "Detected in some" 4 "AN3-CA: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.2 0.1 0.0 0.3 0.0 0.0 3.2 0.0 0.1 0.9 0.1 1.2 3.7 0.8 0.4 17.9 0.9 2.0 0.2 0.0 0.0 0.1 0.7 1.6 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 2.4 2.7 5.5 1.1 0.8 0.8 88.4 4.9 0.7 0.0 3.8 1.4 0.5 0.0 3.5 0.1 0.3 4.9 1.5 1.8 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.6 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.6 4.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.2 0.0 7.6 5.4 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 GRIN3B GluN3B ENSG00000116032 "Glutamate ionotropic receptor NMDA type subunit 3B" O60391 19 1000419-1009732 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;fallopian tube: 4.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 15.1;Respiratory ciliated cells: 18.5;Spermatogonia: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Region enriched" "Detected in single" 9 "spinal cord: 4.8" NA NA "unprognostic (7.86e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-2)" "unprognostic (3.43e-3)" "unprognostic (1.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (9.20e-2)" "unprognostic (1.49e-1)" "unprognostic (3.78e-3)" "unprognostic (9.35e-3)" "unprognostic (3.62e-2)" "unprognostic (3.34e-5)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" 0.1 0.1 0.7 0.1 0.5 0.1 0.1 0.7 0.5 0.5 0.2 0.1 0.2 0.1 0.0 0.1 4.2 0.0 0.1 0.2 0.6 0.7 0.1 1.4 0.3 1.7 1.6 0.0 0.2 0.2 0.0 0.5 0.1 3.0 0.2 0.0 0.3 0.2 0.0 0.1 0.4 0.1 0.0 0.5 0.9 0.1 0.5 0.3 0.0 0.4 0.0 0.0 0.1 0.2 0.9 0.1 0.4 0.3 0.1 0.1 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.1 0.2 0.3 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.2 0.3 0.0 3.5 0.9 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.7 0.5 0.2 0.6 1.7 1.6 0.0 3.0 0.5 0.3 0.9 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 15.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 1.7 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 0.0 0.1 1.5 10.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 VAX2 DRES93 ENSG00000116035 "Ventral anterior homeobox 2" Q9UIW0 2 70900576-70965373 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.2;retina: 11.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.5;Cone photoreceptor cells: 16.7;Horizontal cells: 11.8;Muller glia cells: 7.6;Rod photoreceptor cells: 19.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 4.7;MCF7: 5.6;RH-30: 4.6;SCLC-21H: 4.6;SH-SY5Y: 5.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 3.2" HPA009708 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA009708: AB_2668261" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.96e-2)" "unprognostic (3.16e-2)" "unprognostic (1.63e-2)" "unprognostic (2.17e-1)" "unprognostic (3.52e-2)" "unprognostic (7.23e-3)" "unprognostic (2.42e-1)" "unprognostic (1.98e-1)" "unprognostic (3.81e-1)" "unprognostic (2.16e-1)" "unprognostic (7.74e-3)" "unprognostic (6.63e-3)" "unprognostic (4.65e-1)" "unprognostic (6.67e-3)" "unprognostic (2.18e-2)" 1.0 0.4 1.7 0.1 0.9 0.0 1.2 5.2 1.7 0.8 0.4 0.5 0.0 1.1 0.0 0.4 0.7 0.0 0.6 1.8 1.7 0.4 0.0 0.5 0.0 0.8 1.0 0.6 0.7 1.2 0.2 0.9 0.2 2.7 0.7 0.0 11.2 0.8 0.0 0.5 1.1 0.3 0.3 0.6 0.0 0.2 0.2 1.6 0.0 0.2 0.1 0.0 0.5 0.4 0.8 1.5 3.6 0.8 4.7 1.2 0.7 2.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 1.8 0.0 0.1 0.0 3.0 0.0 0.0 2.1 0.6 0.0 0.0 1.2 0.0 0.2 0.0 1.3 0.4 0.2 0.0 0.0 1.8 5.6 0.0 0.0 2.0 0.0 0.0 0.0 4.6 0.0 1.5 1.2 4.6 5.6 3.7 0.0 2.1 0.1 2.1 0.2 0.9 2.2 0.5 1.1 0.9 0.0 0.0 0.0 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.9 5.2 1.7 1.8 1.7 0.8 1.0 0.6 2.7 0.6 1.6 0.8 3.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 9.5 1.4 1.4 0.1 0.0 0.1 0.0 16.7 0.1 0.1 0.2 1.9 1.2 0.1 0.0 0.1 1.5 0.0 0.0 0.6 0.6 0.4 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 11.8 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.8 0.0 4.2 7.6 0.0 2.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.5 0.0 0.8 0.8 0.0 0.2 0.0 0.0 0.1 0.1 0.8 0.1 0.0 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935900-70965431 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 124.7;salivary gland: 141.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 1.8 0.5 0.5 0.2 0.3 0.0 11.9 0.8 0.9 31.4 0.0 0.5 0.5 1.4 1.2 1.6 12.9 0.2 1.0 0.3 0.1 124.7 0.2 1.8 0.5 0.2 0.0 0.2 1.2 3.4 0.8 4.2 18.1 0.3 2.0 0.1 3.9 141.0 1.4 0.5 29.8 0.6 0.8 0.0 0.0 0.3 0.3 0.1 0.1 0.3 0.2 0.0 0.6 0.8 0.5 0.4 0.3 0.6 1.3 2.6 3.1 21.6 0.4 0.2 0.0 0.0 0.1 2.0 0.1 0.2 1.2 0.0 20.3 0.7 0.0 0.0 0.5 0.6 0.0 0.3 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.3 3.1 0.0 0.1 0.0 0.0 0.2 1.2 0.1 0.3 0.0 0.0 0.0 0.1 0.8 0.2 0.4 0.2 0.5 1.5 0.7 49.2 0.1 2.7 0.6 0.0 0.4 0.6 0.2 0.9 0.5 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.8 0.9 0.3 0.1 0.2 0.0 0.2 0.3 0.0 0.1 0.5 0.7 3.2 0.0 0.3 0.0 0.1 1.3 1.7 0.0 0.9 5.6 3.7 0.4 0.0 13.9 0.0 8.4 197.3 0.1 0.6 49.0 0.1 1.5 0.0 0.1 1.1 0.0 0.0 1.0 0.6 38.3 3.8 0.0 0.1 0.0 0.0 0.0 0.1 11.7 1.7 0.4 0.0 321.4 0.0 0.3 0.1 0.0 0.1 30.2 0.0 0.0 0.5 1.0 1.0 0.1 0.4 0.0 1.2 0.0 0.6 0.3 0.2 2.6 3.8 0.0 1.1 1.0 0.4 1.2 0.0 0.4 64.9 0.1 0.1 0.1 0.6 NFE2L2 NRF2 ENSG00000116044 "Nuclear factor, erythroid 2 like 2" Q16236 2 177227595-177392697 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002990, CAB020317, HPA043438" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482" "unprognostic (2.11e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.41e-1)" "unprognostic (5.95e-2)" "unprognostic (3.90e-1)" "unprognostic (5.27e-2)" "unprognostic (9.58e-2)" "unprognostic (3.48e-2)" "unprognostic (9.86e-2)" "unprognostic (4.86e-2)" "unprognostic (1.83e-1)" "prognostic favorable (2.26e-4)" "unprognostic (1.97e-2)" "unprognostic (1.61e-1)" "unprognostic (1.26e-1)" "unprognostic (9.77e-3)" 84.2 74.3 66.8 66.0 84.4 59.4 79.1 78.0 87.4 83.9 82.0 84.2 101.0 93.5 98.0 259.4 89.3 98.6 71.4 67.7 100.5 144.9 178.0 89.3 50.8 86.1 79.9 61.0 138.5 47.7 60.9 58.8 81.0 84.5 73.4 86.6 68.8 80.4 91.3 64.9 163.6 83.6 92.5 76.2 69.6 178.6 65.8 77.4 68.8 131.6 66.5 94.6 162.2 109.7 95.2 53.1 57.3 52.2 56.4 181.4 190.2 61.7 91.8 124.9 81.4 90.5 75.9 97.9 52.8 93.8 102.8 148.4 96.9 65.1 136.7 111.5 40.8 41.1 65.9 95.9 156.3 231.2 39.3 60.6 134.0 314.5 115.5 169.3 184.4 80.9 39.7 72.7 91.4 111.8 49.8 42.3 101.9 58.8 277.2 58.9 34.0 46.5 54.6 120.9 182.1 69.0 45.0 202.9 64.8 216.6 147.8 49.1 105.0 119.9 80.4 54.5 89.5 54.7 70.1 44.7 43.1 81.6 43.3 159.4 130.6 89.3 55.4 55.2 84.3 62.9 61.8 64.0 57.0 100.4 51.9 101.2 66.8 103.2 68.1 83.0 38.8 66.6 66.0 66.8 84.4 78.0 87.4 67.7 100.5 86.1 79.9 61.0 84.5 76.2 77.4 95.2 193.3 157.0 93.5 66.3 143.3 295.8 241.8 448.4 306.7 61.3 90.0 113.7 67.9 117.2 247.0 154.5 16.7 113.2 249.1 120.7 393.2 154.5 81.4 238.1 126.9 139.6 75.6 58.0 25.3 170.8 34.5 206.6 170.7 279.9 212.7 141.5 120.0 93.2 88.1 57.2 26.6 73.5 321.4 111.6 569.9 39.0 287.7 266.0 96.0 88.1 170.6 191.4 55.6 63.8 113.0 128.3 91.8 214.0 118.8 150.5 94.9 85.0 205.9 48.4 39.5 211.8 152.4 66.1 32.1 617.9 315.4 186.2 150.6 153.5 119.6 225.2 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810063 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 119.6;Theca cells: 114.9" "Cancer enhanced" "Detected in all" "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes 15000 Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 11.8 23.0 9.9 17.9 14.1 24.2 16.4 16.2 12.8 15.7 12.6 11.6 9.1 28.0 10.3 11.8 17.9 11.0 9.4 9.7 11.1 12.2 20.0 11.7 28.6 13.5 12.7 9.1 53.4 31.5 17.1 9.9 20.5 14.6 15.2 12.6 21.8 10.9 15.8 10.6 13.2 9.9 27.5 12.0 12.8 11.0 35.7 12.2 36.6 17.3 11.3 31.3 12.9 12.3 20.9 116.5 77.6 128.4 37.5 42.3 46.3 67.9 63.6 51.1 60.2 59.8 67.2 41.4 158.1 84.5 59.5 82.0 46.0 130.3 74.3 82.1 80.7 69.0 117.0 60.8 71.1 28.8 131.5 37.8 38.6 28.3 60.7 41.6 53.8 40.8 5.3 115.9 69.8 61.8 85.5 144.2 80.1 130.7 81.3 37.7 219.6 204.3 84.7 44.5 76.2 92.8 100.3 79.1 40.4 42.7 124.3 54.6 42.6 33.4 72.2 92.3 54.6 80.6 63.8 79.3 276.2 61.9 77.9 42.4 7.7 3.7 3.8 4.8 6.2 5.5 4.3 5.5 5.0 5.5 4.2 8.4 4.5 2.5 5.9 6.4 2.7 5.3 3.6 9.9 14.1 16.2 12.8 9.7 11.1 13.5 12.7 9.1 14.6 12.0 12.2 20.9 19.8 28.9 21.4 5.9 19.2 25.2 22.0 12.3 31.9 25.4 14.4 15.1 8.6 2.8 21.8 7.3 35.5 35.6 20.7 7.4 3.9 15.7 46.4 27.1 31.1 18.4 4.8 47.1 8.5 9.6 21.8 24.0 8.6 31.7 17.7 119.6 13.6 10.2 13.0 15.2 12.1 9.7 20.3 5.6 13.2 17.5 25.4 16.8 3.6 7.5 10.0 22.7 8.2 9.5 27.4 9.1 3.7 22.6 31.1 16.1 2.6 6.7 22.1 31.4 6.6 27.4 33.0 54.3 48.8 22.0 17.5 9.6 19.8 114.9 12.1 11.7 PLEKHA3 FAPP1 ENSG00000116095 "Pleckstrin homology domain containing A3" Q9HB20 2 178480457-178516463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 196.2;Late spermatids: 413.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034496, HPA034497" Approved Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA034496: AB_2674189, HPA034497: AB_10603126" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" "unprognostic (5.93e-2)" "unprognostic (3.74e-2)" "unprognostic (1.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.22e-3)" "unprognostic (8.83e-2)" "unprognostic (4.02e-2)" "unprognostic (8.23e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.51e-2)" "unprognostic (8.52e-2)" 3.6 6.6 4.4 3.9 4.9 5.5 3.0 7.6 5.3 3.5 5.8 3.5 4.6 3.5 6.2 3.3 3.5 3.0 6.4 4.7 5.0 4.8 4.2 3.2 3.6 4.4 4.7 4.2 3.8 2.7 4.7 4.2 2.7 4.8 3.7 2.6 8.1 2.7 4.3 2.8 1.7 3.4 3.5 4.2 3.4 4.0 10.1 4.5 1.4 3.8 3.2 2.8 3.8 2.5 5.6 4.1 2.7 3.1 4.0 6.0 3.2 5.9 6.6 5.0 3.2 3.5 1.1 2.7 3.5 8.3 4.7 9.0 2.8 2.9 1.7 6.0 10.8 2.8 5.5 2.7 3.2 4.2 3.5 6.0 2.9 5.6 5.9 3.7 5.7 2.9 3.1 2.6 5.4 4.3 1.3 4.7 5.1 5.2 2.9 3.9 2.5 4.6 6.1 4.1 2.4 3.2 4.5 3.3 2.4 10.4 4.3 2.8 6.1 3.3 6.3 6.1 8.0 7.4 6.7 14.2 3.5 8.2 2.9 3.7 0.5 0.2 0.3 0.4 0.2 0.4 0.5 0.7 0.5 0.2 1.5 0.4 0.5 0.6 0.8 0.4 0.6 0.3 0.1 4.4 4.9 7.6 5.3 4.7 5.0 4.4 4.7 4.2 4.8 4.2 4.5 5.6 56.7 16.0 14.6 9.8 32.7 43.2 48.4 12.6 50.7 90.3 39.6 35.2 56.1 32.9 13.4 27.6 41.7 29.2 53.6 15.3 78.2 36.9 196.2 44.9 39.5 44.9 25.8 35.3 15.8 47.3 18.6 43.0 21.4 38.0 10.8 23.7 39.3 42.8 15.8 132.9 20.4 23.3 12.2 28.3 44.9 413.6 34.8 33.1 30.2 18.7 28.6 56.7 40.2 11.6 18.5 45.0 11.3 52.3 39.9 91.7 20.0 67.9 17.9 64.0 78.9 54.2 54.4 66.0 41.5 28.6 30.4 30.5 44.0 44.8 19.0 79.7 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887382-72892158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9" "Group enriched" "Detected in many" 11 "dendritic cells: 8.9;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol NA NA 180000 "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 21.5 51.2 31.9 7.6 28.2 0.6 20.1 29.3 48.8 13.9 38.4 35.3 23.6 13.5 37.2 19.8 26.5 12.0 39.4 31.5 31.5 44.1 100.6 16.1 3.2 32.2 31.4 26.7 12.3 64.0 38.7 11.0 6.8 32.9 26.4 32.8 3.1 31.5 16.9 44.3 8.6 22.2 11.6 30.7 9.7 42.5 7.4 31.1 2.5 20.6 25.6 5.1 25.4 13.8 38.5 47.5 130.9 0.6 20.0 51.2 18.5 31.8 21.4 31.8 16.0 15.0 84.0 48.0 34.5 25.4 26.1 80.6 43.9 58.1 35.1 13.3 10.0 43.7 51.7 30.8 87.4 19.1 8.2 13.6 16.7 38.7 17.6 19.7 32.7 42.6 25.4 54.0 6.8 21.4 100.5 3.3 31.1 10.9 139.9 118.7 0.0 82.8 20.3 85.8 73.4 8.0 14.6 39.6 89.7 31.0 16.9 40.4 9.9 52.8 17.4 42.2 30.5 38.7 7.2 16.9 2.3 25.0 17.6 31.0 0.0 8.3 0.7 0.3 2.4 0.3 0.0 0.1 0.1 8.9 0.0 0.1 0.3 0.0 0.0 0.9 0.9 0.0 2.4 31.9 28.2 29.3 48.8 31.5 31.5 32.2 31.4 26.7 32.9 30.7 31.1 38.5 13.8 12.8 7.3 0.3 1.1 8.4 23.0 14.8 20.5 0.7 22.2 16.5 46.2 38.6 10.8 42.3 0.0 18.1 0.4 85.3 21.5 56.9 0.3 12.5 4.2 16.7 11.4 6.6 0.7 81.1 10.6 13.9 26.0 6.7 4.5 8.4 17.2 62.9 42.1 1.7 0.4 39.6 12.2 6.0 7.4 1.5 9.3 9.7 14.2 1.9 20.8 13.8 0.0 0.0 0.3 43.3 50.4 5.7 1.4 33.9 71.0 91.6 11.2 0.7 6.6 8.3 8.6 0.4 10.2 17.8 6.5 4.4 1.9 8.7 57.8 15.6 EPHA4 "Hek8, TYRO1" ENSG00000116106 "EPH receptor A4" P54764 2 221418027-221574202 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 32.0" "Cell type enriched" "Detected in many" 4 "Excitatory neurons: 317.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 14.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "basophil: 1.6;gdT-cell: 1.7;MAIT T-cell: 1.7;memory B-cell: 1.3;memory CD4 T-cell: 2.5;memory CD8 T-cell: 1.7;naive B-cell: 1.2;naive CD4 T-cell: 1.0;NK-cell: 3.5;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 77.0;ASC diff: 33.9;CACO-2: 59.3;U-2197: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB028368 Enhanced NA NA 9300000 "CAB028368: AB_2099353" "unprognostic (1.28e-1)" "unprognostic (5.87e-2)" "unprognostic (2.28e-1)" "unprognostic (2.46e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (7.05e-4)" "unprognostic (1.80e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (1.12e-1)" "unprognostic (2.85e-2)" "prognostic favorable (5.67e-4)" "unprognostic (3.12e-2)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (8.66e-2)" 7.9 1.6 1.5 1.9 4.8 3.7 4.0 0.0 22.6 4.6 32.0 4.0 1.0 6.4 2.8 4.8 4.9 3.1 17.5 18.0 15.5 4.9 0.8 3.7 2.7 0.0 2.1 4.9 11.2 1.1 1.9 0.6 1.6 2.8 5.4 4.5 4.3 2.6 6.1 2.8 13.0 2.8 8.0 0.0 3.4 2.4 11.8 2.4 3.9 9.6 4.0 3.2 3.6 3.5 0.6 2.6 2.4 77.0 0.0 33.9 20.9 0.1 18.2 8.3 16.9 6.2 59.3 0.9 0.0 0.1 26.7 0.0 7.0 12.3 0.1 7.0 9.7 6.4 0.0 0.9 0.0 0.9 0.0 1.4 8.5 4.2 5.3 0.1 10.3 14.9 0.0 0.0 0.0 4.4 9.5 0.2 0.0 5.6 5.9 1.7 0.1 8.5 0.0 25.8 4.3 13.2 0.0 6.2 1.3 1.3 6.2 2.9 0.0 0.0 1.7 3.2 38.4 1.0 0.0 0.1 0.0 6.9 0.0 3.6 1.6 0.0 0.0 1.7 0.0 1.7 1.3 2.5 1.7 0.0 1.2 1.0 0.2 0.1 3.5 0.0 0.1 1.2 0.4 1.5 4.8 0.0 22.6 18.0 15.5 0.0 2.1 4.9 2.8 0.0 2.4 0.6 36.3 0.0 6.4 51.9 8.2 6.1 0.7 9.7 2.8 9.8 4.3 6.0 31.6 7.2 13.7 9.2 0.0 0.1 12.2 4.7 7.9 0.2 3.9 1.9 5.7 26.3 3.5 0.0 317.9 0.2 0.0 5.1 4.6 5.2 1.3 9.0 20.0 0.4 0.3 1.7 68.8 12.8 8.2 0.0 1.5 5.8 1.2 0.9 7.2 70.3 0.2 7.2 3.1 8.0 7.9 30.9 3.6 8.6 2.1 1.4 0.1 1.7 4.5 3.2 0.0 3.6 10.2 10.0 1.9 4.1 12.5 0.0 5.4 11.3 6.6 2.4 PARD3B "ALS2CR19, PAR3beta, Par3L" ENSG00000116117 "Par-3 family cell polarity regulator beta" Q8TEW8 2 204545475-205620162 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 17.8;BJ hTERT+: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035283 Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA035283: AB_10671102" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.57e-1)" "unprognostic (2.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.67e-10)" "unprognostic (1.74e-1)" "unprognostic (8.13e-2)" "unprognostic (1.23e-1)" "unprognostic (8.09e-2)" 7.9 2.8 8.0 1.7 6.6 0.0 5.5 6.4 4.7 4.9 8.9 9.6 3.6 5.2 3.7 4.0 6.5 4.6 4.0 4.9 10.3 6.9 3.4 5.5 2.1 8.6 9.2 3.1 7.4 5.0 9.3 1.9 4.4 8.2 4.9 5.5 2.5 3.0 5.2 2.8 4.3 4.2 5.3 8.9 3.1 4.6 3.8 7.0 1.4 5.6 3.6 2.6 6.0 4.1 7.7 2.5 2.1 6.3 2.3 17.8 8.9 3.4 3.8 12.5 3.5 3.8 6.2 1.7 0.0 4.3 7.8 2.8 0.3 0.8 1.0 3.6 0.2 2.9 8.8 5.2 0.0 1.8 0.0 0.5 3.4 1.7 1.2 5.2 5.3 5.2 0.8 0.2 0.1 4.5 1.0 0.0 0.0 0.8 0.9 0.5 0.0 2.7 2.1 3.7 2.5 0.7 2.0 2.0 1.9 1.7 6.2 3.1 0.0 10.9 2.7 1.7 5.5 1.8 0.0 0.0 0.0 2.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 6.6 6.4 4.7 4.9 10.3 8.6 9.2 3.1 8.2 8.9 7.0 7.7 9.5 9.6 8.6 490.7 0.5 11.0 3.3 2.4 6.8 0.5 5.6 5.8 10.8 15.7 14.5 29.5 0.0 3.2 0.2 12.4 0.0 8.7 76.6 8.5 4.0 6.8 6.0 0.8 5.6 2.4 0.2 16.2 11.7 7.4 1.3 14.1 8.2 4.5 0.5 5.0 50.8 9.2 2.0 1.0 4.3 26.0 31.1 0.6 7.2 183.6 0.1 9.7 0.0 159.3 104.2 6.5 15.9 57.9 1.4 5.0 9.4 4.8 17.0 0.3 19.7 23.5 9.6 1.4 2.9 3.5 4.7 1.1 1.0 2.3 8.0 5.3 FARSB "FARSLB, FRSB, PheHB" ENSG00000116120 "Phenylalanyl-tRNA synthetase subunit beta" Q9NSD9 2 222566899-222656092 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036677, HPA036678, HPA061398" Enhanced Supported Nucleoplasm,Cytosol NA NA 28000 Nucleoplasm Cytosol "HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504" "unprognostic (9.95e-3)" "unprognostic (1.86e-3)" "unprognostic (7.02e-2)" "unprognostic (7.42e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.45e-10)" "unprognostic (8.89e-3)" "unprognostic (4.51e-2)" "unprognostic (3.63e-2)" "unprognostic (5.25e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.25e-4)" 12.7 11.0 8.8 7.7 10.0 8.0 12.9 10.5 11.4 12.4 6.6 14.0 9.2 13.6 6.6 20.9 12.0 4.0 15.3 9.8 10.7 9.3 14.2 9.5 7.4 9.2 9.5 9.4 14.4 15.8 8.1 13.3 5.0 10.1 11.2 11.2 10.1 10.5 6.1 32.1 14.8 10.9 8.2 7.9 9.8 14.0 13.6 9.8 7.8 9.8 13.4 8.4 13.3 13.8 10.5 31.1 17.8 20.7 27.2 18.0 26.3 31.0 31.0 19.2 29.4 23.9 45.3 16.6 15.3 22.7 22.6 24.7 25.8 39.7 34.7 43.0 22.8 20.7 35.1 18.9 28.8 27.9 51.9 14.0 17.6 27.0 33.9 51.2 10.5 28.3 26.4 53.5 30.3 36.1 28.9 31.2 29.2 26.6 37.0 22.0 30.2 49.4 49.8 24.5 19.9 33.4 11.2 12.9 22.4 27.6 24.7 20.9 21.3 15.8 25.5 21.1 37.8 38.5 14.8 15.5 54.5 20.8 34.0 27.2 0.5 7.6 1.2 9.6 9.4 14.3 15.1 12.8 11.9 14.4 12.7 16.4 14.2 0.9 17.4 11.3 7.2 12.5 13.7 8.8 10.0 10.5 11.4 9.8 10.7 9.2 9.5 9.4 10.1 7.9 9.8 10.5 10.2 6.4 6.4 21.2 25.2 12.4 19.5 32.7 19.4 17.9 16.3 18.0 28.6 5.7 18.5 22.0 4.2 37.0 7.5 18.1 35.2 24.7 57.5 17.3 15.8 13.3 20.9 24.2 50.2 30.4 43.3 18.0 32.6 18.6 5.1 21.8 7.5 17.8 27.4 3.3 56.7 19.9 20.3 10.1 9.7 73.1 15.2 11.8 7.2 26.2 11.3 13.2 15.5 38.7 38.2 22.8 11.3 19.9 27.3 18.1 9.9 31.0 16.8 19.5 6.6 17.6 34.4 67.4 33.7 28.8 14.2 22.2 16.9 24.3 45.8 14.3 ALMS1 KIAA0328 ENSG00000116127 "ALMS1 centrosome and basal body associated protein" Q8TCU4 2 73385758-73625166 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Cone-rod dystrophy, Deafness, Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.4" "Cell type enhanced" "Detected in many" "Early spermatids: 68.4;Excitatory neurons: 64.9;Late spermatids: 86.6;Oligodendrocytes: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "RH-30: 32.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035277, HPA043200" Enhanced Approved "Nuclear speckles,Centrosome,Cytosol" NA NA "Nuclear speckles, Centrosome" Cytosol "HPA035277: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 2.6 2.5 5.8 2.4 7.0 5.6 4.3 15.5 5.5 4.2 4.2 3.2 2.4 4.5 4.7 1.9 6.5 2.6 1.6 5.5 4.8 3.5 2.4 3.1 3.2 6.8 6.1 3.7 9.9 4.5 4.8 1.7 2.7 7.0 3.6 3.0 10.4 2.9 3.7 0.8 3.0 2.0 3.7 5.1 2.4 2.9 22.4 5.9 8.7 4.6 3.1 3.0 2.6 1.5 7.9 14.3 4.6 9.0 8.2 6.2 5.8 6.7 4.8 5.0 6.2 4.8 4.8 1.5 13.8 3.3 6.7 8.0 6.5 12.3 4.2 8.3 6.7 4.1 7.9 4.4 10.2 4.1 10.9 3.8 4.5 3.7 7.6 3.9 3.9 6.3 9.3 7.4 4.9 7.1 7.0 10.2 14.3 10.6 5.7 3.9 10.8 32.5 5.1 4.1 3.7 7.1 10.0 9.1 1.5 5.2 7.5 1.7 2.5 5.4 8.2 8.3 7.1 11.7 6.6 4.0 10.4 3.7 8.2 4.0 0.2 0.0 0.5 0.2 0.1 0.1 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.2 0.1 0.3 0.2 0.0 5.8 7.0 15.5 5.5 5.5 4.8 6.8 6.1 3.7 7.0 5.1 5.9 7.9 7.3 6.4 10.3 48.3 5.6 2.4 3.1 2.6 6.8 23.3 4.7 4.8 7.2 7.2 9.1 11.0 25.0 3.3 12.8 4.4 0.0 4.7 68.4 30.6 13.2 8.0 7.3 15.4 64.9 3.7 2.7 8.9 10.7 9.3 5.1 21.8 4.6 2.2 3.3 21.9 55.8 5.2 0.0 3.1 2.7 86.6 8.1 6.3 3.6 31.9 5.3 9.2 5.2 54.3 92.7 3.4 1.3 9.1 10.2 3.2 4.0 1.7 25.2 39.7 6.6 14.8 9.5 30.6 26.7 6.9 3.3 1.9 7.8 11.5 5.3 2.0 BCL9 ENSG00000116128 "BCL9 transcription coactivator" O00512 1 147541501-147626216 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Oligodendrocyte precursor cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "NTERA-2: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020274 Approved Approved "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA020274: AB_2670400" "unprognostic (2.31e-1)" "unprognostic (1.52e-2)" "unprognostic (5.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.29e-1)" "unprognostic (4.78e-3)" "unprognostic (3.92e-2)" "unprognostic (1.64e-3)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" 3.7 6.3 5.8 4.6 5.3 3.2 3.9 7.2 5.8 10.0 0.8 7.5 4.8 14.5 13.8 4.9 16.6 4.7 7.8 5.2 5.5 6.9 3.6 4.6 3.9 5.8 4.7 4.3 14.7 5.0 10.9 7.2 4.1 5.0 9.1 7.0 7.4 7.6 11.2 8.2 7.2 4.7 14.0 3.6 3.1 6.3 5.5 4.2 11.2 6.9 6.3 4.5 7.2 6.5 4.5 5.5 5.3 36.4 27.2 4.1 4.8 7.1 4.4 6.9 4.7 4.6 6.9 8.1 5.2 9.6 4.1 7.9 4.3 23.3 8.0 4.4 12.4 6.5 2.5 5.7 4.6 3.5 1.6 7.2 4.8 6.7 5.6 4.1 8.4 7.4 16.8 4.9 8.3 4.2 12.4 13.1 1.2 43.2 11.0 11.5 13.8 9.2 10.1 18.4 6.0 10.0 21.4 4.9 9.0 8.6 33.3 11.4 2.5 5.5 3.3 15.5 9.4 7.1 36.6 10.0 9.7 8.4 1.4 16.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 5.8 5.3 7.2 5.8 5.2 5.5 5.8 4.7 4.3 5.0 3.6 4.2 4.5 4.6 0.0 2.2 39.5 2.1 3.1 6.0 2.8 14.8 12.1 10.1 5.0 7.4 7.2 2.9 12.9 2.1 2.1 1.2 3.2 11.7 4.4 10.5 21.0 17.5 4.1 28.3 0.0 12.9 4.7 2.5 7.5 2.6 24.6 8.8 12.8 5.7 3.7 1.3 6.7 20.7 7.9 4.1 1.9 1.4 5.3 9.6 1.9 0.0 8.4 1.1 4.8 4.1 31.2 24.2 4.5 1.4 7.9 4.4 6.1 1.3 7.0 4.8 3.1 0.0 6.8 7.3 4.0 8.6 9.7 3.7 2.1 3.6 4.8 6.6 3.3 PRRX1 "PHOX1, PMX1" ENSG00000116132 "Paired related homeobox 1" P54821 1 170662728-170739421 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 351.7;Endometrial stromal cells: 158.6;Fibroblasts: 180.2;Late spermatids: 390.0;Leydig cells: 256.3;Oligodendrocyte precursor cells: 288.5;Smooth muscle cells: 206.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 367.0;ASC TERT1: 290.5;BJ: 109.7;BJ hTERT+: 213.2;HSkMC: 150.6;U-138 MG: 146.0;U-2197: 140.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051084, HPA063566" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA051084: AB_2681338, HPA063566: AB_2732702" "unprognostic (2.03e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" "unprognostic (7.00e-2)" "unprognostic (1.24e-1)" "unprognostic (4.97e-2)" "unprognostic (2.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.98e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (6.60e-10)" "unprognostic (4.23e-3)" "unprognostic (4.48e-2)" "unprognostic (2.68e-3)" "unprognostic (1.69e-3)" 64.9 10.3 14.3 17.8 13.1 0.0 43.3 16.0 13.5 92.8 6.0 4.9 1.1 69.2 20.5 20.2 42.6 34.4 44.6 12.2 27.4 1.9 0.4 21.9 34.9 17.3 15.5 7.7 28.4 3.8 7.6 5.0 6.3 20.6 33.8 5.8 0.1 38.9 76.3 52.2 19.9 3.6 52.8 8.2 2.0 3.5 14.3 14.9 18.8 42.0 74.5 36.6 33.3 59.3 24.2 0.0 0.0 2.1 0.0 367.0 290.5 0.1 109.7 213.2 15.0 14.8 0.0 0.1 0.1 0.0 90.2 0.0 0.0 18.5 0.0 4.7 0.0 0.2 0.0 1.6 0.0 1.2 0.0 0.0 150.6 0.0 73.4 0.4 25.7 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 0.1 146.0 2.6 140.4 16.9 0.0 0.0 0.0 77.3 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 13.1 16.0 13.5 12.2 27.4 17.3 15.5 7.7 20.6 8.2 14.9 24.2 49.8 0.0 0.5 114.3 0.3 16.3 0.6 0.1 4.0 0.0 1.3 10.2 29.8 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.0 1.2 351.7 4.9 158.6 11.4 0.0 0.0 17.4 0.2 0.1 180.2 0.5 3.5 0.0 0.6 0.0 0.0 0.8 0.0 5.5 0.0 0.0 0.0 27.9 390.0 256.3 2.8 14.2 124.6 0.0 0.5 0.0 288.5 0.9 0.7 0.0 104.6 0.4 1.7 0.0 0.1 0.0 0.2 52.6 59.1 206.5 15.4 1.9 1.2 11.8 0.1 2.3 0.6 0.0 1.2 DHCR24 "DCE, KIAA0018, seladin-1" ENSG00000116133 "24-dehydrocholesterol reductase" Q15392 1 54849627-54887195 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 1138.8;liver: 628.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 298.1;Alveolar cells type 2: 682.3;Hepatocytes: 1091.4;Theca cells: 442.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 1031.9" "Low region specificity" "Detected in all" "HPA017981, CAB037247, HPA063005" Enhanced NA NA "CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919" "unprognostic (2.88e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (1.69e-1)" "unprognostic (2.61e-1)" "unprognostic (1.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.68e-1)" "unprognostic (1.86e-1)" "unprognostic (6.18e-3)" "unprognostic (3.35e-1)" "unprognostic (7.82e-3)" "unprognostic (5.48e-2)" "unprognostic (1.83e-1)" "unprognostic (1.70e-1)" "unprognostic (3.97e-2)" 58.9 1138.8 70.7 20.0 79.3 1.6 105.8 128.8 76.2 31.5 34.5 56.1 62.7 13.2 1.6 298.5 61.0 42.6 18.1 77.8 85.1 31.2 628.5 217.8 9.4 194.9 122.9 47.4 28.7 30.7 159.2 17.1 21.8 147.0 129.7 40.9 15.9 137.4 8.4 199.4 249.6 29.9 12.7 205.0 135.2 99.7 74.9 114.9 10.2 15.6 11.2 34.2 13.6 104.7 327.0 342.1 58.5 210.6 257.1 1031.9 219.0 50.5 94.8 160.3 130.7 268.6 341.6 210.2 55.3 191.5 82.4 427.4 319.2 250.5 501.3 118.3 8.3 159.6 303.3 131.8 421.7 168.9 126.7 68.2 161.0 429.0 397.6 74.7 66.7 67.2 124.5 224.7 0.2 50.2 143.5 25.8 111.4 592.0 90.7 164.2 0.3 54.2 166.3 735.3 257.1 144.5 53.2 185.0 337.5 123.1 221.6 441.5 143.3 62.2 45.3 130.0 66.1 183.9 22.7 55.0 91.2 32.8 215.3 60.4 5.1 1.5 0.7 6.0 1.8 0.3 3.7 2.5 2.6 5.2 1.3 2.2 2.9 0.0 2.7 0.7 3.0 0.4 4.4 70.7 79.3 128.8 76.2 77.8 85.1 194.9 122.9 47.4 147.0 205.0 114.9 327.0 6.2 298.1 682.3 12.4 13.3 31.5 17.3 150.6 79.1 9.7 87.9 33.1 15.3 145.8 205.2 68.0 0.0 35.2 6.4 133.3 3.9 55.3 22.9 14.5 5.8 13.5 24.0 71.6 14.5 76.5 34.4 17.5 38.7 44.7 32.2 26.4 111.0 1091.4 28.0 5.0 8.7 39.2 69.2 68.9 8.2 77.2 14.0 9.4 14.2 1.9 6.8 3.6 2.1 5.5 62.6 48.6 27.7 7.9 1.8 52.4 22.6 14.4 136.3 6.4 0.0 1.5 23.2 5.4 14.7 145.4 80.4 30.6 10.6 442.4 35.2 45.2 DNAJC16 KIAA0962 ENSG00000116138 "DnaJ heat shock protein family (Hsp40) member C16" Q9Y2G8 1 15526813-15592379 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043643 Approved Approved Vesicles NA NA Vesicles "HPA043643: AB_10796794" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "prognostic favorable (6.77e-4)" "unprognostic (4.52e-2)" "unprognostic (5.51e-2)" "unprognostic (2.05e-2)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (4.28e-2)" "unprognostic (2.35e-2)" "unprognostic (3.74e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" "unprognostic (5.38e-2)" "unprognostic (4.70e-2)" 4.9 5.3 4.4 5.5 5.3 2.2 6.5 5.4 6.8 5.1 6.6 6.0 6.6 5.6 7.7 5.4 6.9 4.6 5.1 5.2 4.6 11.6 10.2 4.8 6.2 4.3 4.4 4.5 5.8 6.4 10.1 5.3 5.8 4.6 5.6 5.9 9.1 7.0 4.8 12.0 5.7 5.8 6.4 3.4 5.8 5.5 6.4 4.8 5.1 7.5 6.3 6.5 5.3 4.7 6.3 8.8 8.7 6.7 12.4 18.0 14.5 6.3 10.4 10.7 10.2 10.9 7.1 12.7 7.6 6.8 10.3 13.3 10.7 8.3 9.2 14.3 9.0 4.0 7.8 9.6 12.2 17.8 12.2 8.7 10.5 10.6 16.4 9.2 12.7 11.6 6.3 16.9 6.7 11.8 3.6 6.2 6.2 6.5 7.9 5.6 7.3 8.6 8.5 12.6 6.0 7.5 7.0 10.6 10.1 9.0 9.6 6.3 4.8 15.7 17.9 6.4 16.7 5.7 9.1 13.8 6.6 11.1 6.9 8.7 2.0 2.1 1.5 2.6 2.0 3.9 3.4 2.8 2.4 2.1 3.1 3.5 3.0 1.1 1.6 1.5 1.9 2.8 1.9 4.4 5.3 5.4 6.8 5.2 4.6 4.3 4.4 4.5 4.6 3.4 4.8 6.3 11.6 0.0 8.7 25.5 12.4 5.1 4.3 13.8 9.6 14.9 16.1 8.4 16.9 22.8 14.9 25.8 22.9 12.8 11.5 13.7 1.9 9.1 11.6 25.5 19.0 12.0 11.5 4.6 33.5 6.9 7.7 10.5 11.7 17.6 8.2 14.0 16.4 20.5 10.9 18.5 28.6 9.7 18.3 20.6 5.5 5.8 12.5 9.5 7.2 17.8 11.4 12.8 12.3 19.1 28.8 9.3 7.5 11.3 6.8 12.6 10.6 19.0 37.5 16.0 6.6 11.7 7.8 24.7 15.7 13.0 5.8 22.0 7.1 11.4 13.4 8.2 MARK1 "MARK, PAR-1C" ENSG00000116141 "Microtubule affinity regulating kinase 1" Q9P0L2 1 220528136-220664461 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 73.8;Excitatory neurons: 171.3;Inhibitory neurons: 170.1;Oligodendrocyte precursor cells: 167.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 11.3;RT4: 33.7;SuSa: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007421, HPA008061" Uncertain NA NA "HPA007421: AB_1079311, HPA008061: AB_1079310" "unprognostic (1.51e-1)" "unprognostic (6.27e-2)" "unprognostic (6.72e-2)" "unprognostic (3.63e-2)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (1.54e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (2.63e-4)" "unprognostic (4.59e-2)" "prognostic favorable (2.23e-5)" "unprognostic (6.62e-2)" "unprognostic (4.27e-2)" "unprognostic (9.56e-3)" "unprognostic (3.35e-2)" "unprognostic (1.72e-1)" "unprognostic (3.74e-2)" 6.1 1.8 6.7 1.4 7.7 0.0 5.0 6.9 9.3 4.3 8.0 4.3 0.4 4.3 9.8 4.8 3.3 1.7 8.1 7.6 7.6 1.8 0.3 3.1 0.5 6.8 7.1 7.1 1.8 0.9 2.5 7.0 1.1 8.0 3.0 1.2 9.4 3.7 4.0 2.2 2.4 2.5 3.9 5.8 1.4 2.8 6.9 7.3 1.4 4.3 3.5 2.0 5.4 5.1 7.8 0.4 0.0 5.4 1.1 0.0 0.0 1.8 1.6 2.2 1.8 2.5 0.0 0.0 0.0 0.0 0.0 2.5 2.5 11.3 6.0 1.0 0.0 8.4 0.0 2.3 0.0 0.0 0.7 0.8 0.9 4.7 0.0 3.0 0.8 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.5 1.8 0.0 7.4 0.0 0.0 33.7 6.4 6.2 0.3 0.3 0.5 12.2 0.5 0.0 0.0 0.0 2.4 4.0 7.1 0.0 0.0 0.0 1.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.7 6.9 9.3 7.6 7.6 6.8 7.1 7.1 8.0 5.8 7.3 7.8 3.2 0.0 0.5 73.8 0.5 3.4 2.6 10.0 13.1 28.6 1.6 3.8 21.9 0.0 4.7 3.7 31.3 2.1 0.0 0.7 0.0 1.6 7.3 19.3 6.4 3.4 9.0 0.0 171.3 0.0 2.3 6.3 2.6 35.5 0.0 13.6 3.3 0.0 0.3 10.1 170.1 0.4 4.1 0.3 1.5 3.6 2.1 0.2 0.0 15.0 0.0 12.3 0.0 167.9 45.9 0.1 0.0 6.4 0.6 4.8 1.5 0.2 4.1 11.9 0.0 6.9 17.5 17.4 5.1 13.1 3.3 1.0 0.4 1.1 0.9 4.8 TNR ENSG00000116147 "Tenascin R" Q92752 1 175315194-175743616 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 31.8;retina: 16.3" "Group enriched" "Detected in some" 6 "Horizontal cells: 580.5;Oligodendrocyte precursor cells: 2288.6" "Cancer enriched" "Detected in single" 46 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.9;U-937: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022343, HPA027134, HPA027150, HPA029859" Enhanced "Secreted in brain" NA NA 58000 "CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916" "unprognostic (1.04e-1)" "unprognostic (7.43e-2)" "unprognostic (3.11e-2)" "unprognostic (1.12e-3)" "unprognostic (2.38e-1)" "unprognostic (1.51e-2)" "unprognostic (9.66e-2)" "unprognostic (2.57e-2)" "unprognostic (5.79e-2)" "unprognostic (5.06e-2)" "unprognostic (3.03e-3)" "unprognostic (7.26e-4)" "unprognostic (4.48e-4)" "unprognostic (3.26e-3)" "unprognostic (3.83e-1)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" 0.0 1.4 31.8 0.2 25.3 0.1 0.0 15.9 25.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.1 24.8 0.0 0.4 0.5 0.2 24.2 16.1 24.6 0.0 0.4 0.0 2.7 0.0 21.3 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.4 0.0 18.4 0.2 0.3 0.4 17.9 0.1 0.1 0.0 0.3 0.0 0.0 31.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.8 25.3 15.9 25.5 31.1 24.8 24.2 16.1 24.6 21.3 18.4 17.9 31.3 0.0 0.0 0.0 20.2 2.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 226.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 580.5 179.6 0.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 3.7 0.0 1.8 0.0 2288.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.8 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 25.4;Endometrial ciliated cells: 38.1;Late spermatids: 25.1;Respiratory ciliated cells: 36.7;Spermatocytes: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: AB_2686299" "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 2.5 2.8 4.6 1.6 2.8 1.0 4.3 13.7 4.7 6.7 6.7 3.3 1.9 5.4 4.5 3.1 15.9 2.3 1.7 2.3 4.9 6.4 3.2 3.9 1.5 3.8 5.2 2.2 9.9 4.1 2.7 10.1 0.9 5.1 6.0 1.2 3.9 4.4 3.2 2.3 3.0 2.7 1.1 3.4 2.2 2.8 14.9 2.2 2.0 13.6 1.1 1.4 3.0 4.0 2.0 6.4 7.6 5.2 4.8 1.7 0.8 5.4 1.9 1.3 3.0 2.5 3.6 7.0 1.7 4.0 1.2 2.2 7.7 1.1 3.0 2.9 3.9 8.0 1.6 16.4 4.0 1.5 2.1 0.9 1.0 0.6 2.8 2.5 2.3 2.1 3.2 2.7 1.9 1.1 8.9 2.1 0.7 3.1 3.3 6.5 2.2 4.7 2.7 2.3 2.8 8.6 4.2 5.0 8.9 4.1 2.3 4.8 0.6 0.7 3.4 5.0 2.5 2.2 4.5 1.8 1.1 6.9 1.2 2.4 0.0 0.3 0.1 0.5 0.1 0.3 0.4 0.6 0.4 0.4 0.8 0.9 0.4 1.7 0.3 2.0 1.5 0.0 0.4 4.6 2.8 13.7 4.7 2.3 4.9 3.8 5.2 2.2 5.1 3.4 2.2 2.0 1.7 3.2 3.2 9.8 3.7 1.7 4.1 4.6 1.8 8.9 5.3 5.2 3.3 4.3 3.9 14.7 20.9 3.6 1.0 2.1 3.9 2.2 25.4 38.1 4.4 1.4 5.4 4.8 17.7 1.4 1.8 2.5 5.6 4.3 5.7 3.4 1.1 1.8 2.9 10.1 10.7 0.9 6.1 0.6 0.7 25.1 2.5 1.0 1.8 4.7 1.2 7.1 4.1 3.5 2.9 1.3 0.6 3.0 2.1 2.0 2.3 9.7 36.7 21.5 0.0 5.7 3.6 25.3 6.4 2.5 2.3 1.9 2.0 2.8 2.2 3.2 GPX7 "FLJ14777, GPX6, NPGPx" ENSG00000116157 "Glutathione peroxidase 7" Q96SL4 1 52602371-52609051 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 68.6;HEL: 63.9;REH: 76.4;RPMI-8226: 130.0;THP-1: 101.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (5.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.78e-1)" "unprognostic (7.43e-3)" "unprognostic (3.18e-1)" "unprognostic (5.64e-2)" "unprognostic (6.12e-3)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (8.18e-2)" "unprognostic (4.17e-1)" "unprognostic (2.48e-3)" "prognostic unfavorable (2.26e-5)" "unprognostic (1.14e-2)" "unprognostic (9.24e-2)" "unprognostic (3.08e-2)" "unprognostic (5.44e-2)" 8.3 7.9 4.6 12.5 4.9 18.4 12.0 5.0 5.5 11.7 8.4 7.7 3.3 13.2 7.4 4.3 9.1 13.5 10.9 4.5 5.4 6.9 5.4 6.9 16.6 5.1 4.6 4.4 9.0 11.5 8.5 12.6 29.6 5.0 8.8 5.6 1.7 5.9 9.8 12.2 4.8 6.0 10.9 4.8 8.2 5.1 5.5 4.7 16.1 17.3 11.6 14.1 12.5 6.9 5.1 0.1 0.0 18.1 33.9 6.6 19.1 0.1 12.5 0.7 14.8 15.3 12.2 0.0 0.1 9.8 68.6 0.0 0.0 29.0 0.0 8.1 0.0 0.2 63.9 3.6 11.3 23.9 0.0 0.0 44.4 0.0 2.5 0.0 0.0 22.9 0.4 0.0 0.0 28.2 0.0 3.3 33.5 31.5 0.0 0.0 76.4 0.0 130.0 1.3 0.0 13.7 27.0 33.3 0.0 21.9 3.0 0.0 101.1 1.4 0.0 3.7 3.8 0.1 0.1 0.0 47.9 0.0 0.2 11.3 0.2 1.7 5.4 22.6 0.4 31.8 32.0 34.6 27.1 5.4 35.2 44.5 29.0 0.9 31.6 0.2 73.7 27.6 21.4 4.6 4.9 5.0 5.5 4.5 5.4 5.1 4.6 4.4 5.0 4.8 4.7 5.1 8.4 3.2 5.5 1.0 16.1 2.2 9.0 8.3 1.2 1.0 7.1 13.6 3.9 12.8 6.5 3.7 0.0 22.8 9.2 0.2 5.9 11.1 6.9 8.2 43.7 12.4 1.2 6.7 1.6 15.6 19.8 30.5 0.5 6.5 1.3 25.8 15.4 3.8 12.3 5.0 2.7 1.2 2.0 1.9 0.7 6.6 15.2 6.0 7.2 4.7 5.0 8.3 9.2 4.5 2.0 4.7 0.7 13.5 25.2 5.7 0.0 3.0 7.0 0.6 13.1 13.3 14.5 10.8 12.1 1.9 3.3 15.6 10.9 19.3 0.6 4.9 CACYBP "S100A6BP, SIP" ENSG00000116161 "Calcyclin binding protein" Q9HB71 1 174999163-175012027 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 153.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025753, HPA057038" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 560000 Cytosol Nucleoplasm "HPA025753: AB_1845878, HPA057038: AB_2683318" "unprognostic (4.70e-3)" "unprognostic (9.92e-2)" "unprognostic (5.55e-2)" "unprognostic (2.22e-1)" "unprognostic (1.25e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.12e-6)" "unprognostic (1.50e-2)" "unprognostic (2.03e-2)" "prognostic favorable (1.39e-5)" "unprognostic (4.55e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.41e-1)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" 23.2 22.8 70.1 25.7 62.6 34.1 20.9 68.4 153.1 21.0 55.5 23.8 16.0 19.3 24.6 24.0 17.5 14.8 24.8 83.7 71.8 27.5 25.9 23.9 33.0 62.7 60.9 55.4 35.1 16.0 20.7 27.1 23.0 71.1 15.4 20.9 53.0 17.6 18.7 38.0 16.9 19.2 16.5 57.3 24.2 20.5 30.8 73.0 28.1 15.0 27.6 29.1 28.2 20.6 103.9 127.7 85.6 124.0 53.1 40.2 44.8 79.5 94.7 55.6 119.8 86.8 88.9 76.9 132.8 96.0 67.5 85.8 67.3 155.0 69.4 122.7 70.6 92.4 99.6 80.8 96.3 30.1 135.4 59.9 30.3 42.2 98.7 58.8 62.0 85.5 117.0 203.7 72.2 87.0 47.4 208.2 121.5 118.0 189.1 39.4 93.6 87.9 152.5 85.4 99.8 84.9 81.4 64.7 111.0 106.3 165.7 86.8 116.6 44.9 67.9 73.3 96.0 153.8 68.6 211.5 301.8 57.1 117.1 80.6 34.0 25.5 27.9 29.4 41.7 35.4 43.0 42.0 36.2 32.3 33.7 44.6 39.9 14.6 43.7 54.9 28.3 48.7 46.1 70.1 62.6 68.4 153.1 83.7 71.8 62.7 60.9 55.4 71.1 57.3 73.0 103.9 70.6 86.6 41.9 13.1 82.1 117.0 183.6 102.2 63.7 57.7 61.8 79.0 108.1 40.0 62.7 35.0 62.6 238.8 68.7 66.2 152.6 96.8 102.2 124.5 67.6 80.0 119.6 113.0 22.4 95.0 304.1 92.8 36.7 167.3 92.0 52.8 44.3 39.4 196.3 30.3 24.1 101.6 67.1 56.0 188.2 30.6 86.0 110.9 108.5 13.1 231.0 77.8 60.8 8.5 28.0 106.9 58.4 73.7 90.7 115.4 80.7 171.4 78.0 84.0 32.9 57.6 108.4 186.7 139.9 88.7 85.7 143.5 188.0 76.5 139.1 106.9 SCP2 ENSG00000116171 "Sterol carrier protein 2" P22307 1 52927276-53051698 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1126.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027101, HPA027135, HPA027317" Supported Supported Nucleoplasm,Peroxisomes NA NA 640000 Peroxisomes Nucleoplasm "HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422" "unprognostic (7.51e-2)" "unprognostic (5.23e-2)" "prognostic favorable (7.05e-5)" "unprognostic (9.68e-2)" "unprognostic (1.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.87e-3)" "unprognostic (1.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.59e-1)" "unprognostic (4.53e-2)" "unprognostic (6.16e-2)" "prognostic favorable (7.85e-8)" "unprognostic (1.49e-2)" "unprognostic (1.09e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-2)" 205.5 126.7 71.9 93.5 74.1 112.2 198.6 78.3 90.9 155.1 83.7 259.1 339.3 95.5 166.9 141.5 120.7 145.9 163.9 68.4 98.8 322.7 1126.1 141.9 106.9 78.1 74.3 65.2 95.4 120.2 132.0 65.2 79.7 79.8 152.2 273.1 77.2 115.0 98.2 143.4 131.6 308.3 113.9 79.4 84.6 236.5 64.0 76.4 133.1 142.2 154.1 126.5 140.5 77.6 82.8 120.6 64.8 85.5 157.9 273.6 232.6 92.7 140.0 208.9 90.1 129.2 58.7 127.5 114.7 147.6 206.6 105.3 82.5 59.6 131.0 136.5 168.2 86.4 123.4 88.8 122.1 182.0 179.9 197.5 190.2 175.0 107.1 52.9 196.2 260.0 132.6 111.5 58.2 184.7 70.1 200.7 155.2 94.6 304.4 126.0 101.9 150.9 158.3 252.2 192.2 70.9 85.3 122.0 246.3 121.6 189.6 125.9 201.4 203.8 122.4 63.4 213.2 114.9 95.9 131.0 134.2 159.0 175.7 113.8 285.6 193.7 286.0 185.9 208.8 152.1 150.8 144.9 184.6 230.5 132.6 120.8 171.4 29.4 176.8 204.2 150.9 195.2 289.5 71.9 74.1 78.3 90.9 68.4 98.8 78.1 74.3 65.2 79.8 79.4 76.4 82.8 167.0 134.6 198.4 52.2 91.1 150.4 123.8 222.2 110.4 37.5 189.8 86.0 157.4 258.7 166.2 185.8 31.3 182.7 128.3 512.7 473.5 168.1 57.4 150.4 81.6 126.8 235.1 93.4 45.0 162.4 156.5 124.3 180.4 125.3 138.4 54.0 146.7 1240.7 203.5 42.1 54.4 462.7 250.3 230.1 173.1 51.4 184.2 148.8 192.1 42.2 154.6 132.0 181.3 48.2 44.3 157.4 503.4 171.9 76.6 118.1 769.0 881.0 178.2 34.1 78.9 72.0 110.6 20.4 19.4 150.0 170.8 133.9 132.9 110.3 336.4 187.8 TPSG1 "PRSS31, TMT" ENSG00000116176 "Tryptase gamma 1" Q9NRR2 16 1221651-1225257 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 14.8" "Cell type enriched" "Detected in some" 6 "Intestinal goblet cells: 278.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HMC-1: 23.2;MCF7: 7.9" "Not detected" "Not detected" HPA060458 Enhanced NA NA "HPA060458: AB_2684283" "unprognostic (1.86e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-3)" "unprognostic (1.27e-1)" "unprognostic (5.58e-2)" "unprognostic (1.18e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-2)" "unprognostic (9.97e-2)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.76e-8)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (8.65e-4)" "unprognostic (5.70e-2)" 0.6 1.0 0.4 1.5 1.3 0.0 3.2 0.1 0.4 0.7 0.0 14.8 14.2 1.3 0.1 0.8 0.7 1.0 0.2 0.2 0.4 0.5 0.4 0.8 0.0 0.4 0.1 0.2 2.1 0.2 0.0 3.1 0.0 0.3 1.1 9.1 0.1 0.3 0.2 0.2 1.1 9.4 0.3 0.0 0.0 1.1 1.6 0.3 0.0 0.1 0.0 0.0 1.8 0.8 0.1 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.4 0.2 0.4 0.4 0.1 0.2 0.3 0.0 0.3 0.1 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.2 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.0 0.0 0.4 0.0 0.0 0.0 278.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.3 0.1 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 4.7 0.0 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845601 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 57.3" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 140.7;Extravillous trophoblasts: 71.9;Muller glia cells: 41.4;Oligodendrocytes: 37.6;Syncytiotrophoblasts: 74.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8;renal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-87 MG: 19.8" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 5.6" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" NA NA 2000000 "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.3 0.4 0.0 2.5 0.3 0.5 6.7 0.0 0.6 0.0 0.6 0.3 0.0 0.3 1.8 0.3 0.5 0.5 6.3 0.6 0.1 0.0 0.5 0.4 0.3 0.0 2.5 0.0 1.1 57.3 0.5 0.2 0.5 3.8 0.1 0.6 0.0 0.1 0.2 0.5 0.4 0.0 1.6 0.4 0.3 0.0 0.5 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 4.3 2.1 3.5 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.5 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.3 1.6 1.3 0.1 0.6 0.3 0.4 0.0 19.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.3 0.5 0.5 0.5 0.5 0.4 0.3 0.5 0.4 0.3 0.4 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.8 0.0 0.0 5.5 0.0 1.5 0.0 0.1 11.7 0.0 2.6 0.2 0.1 0.3 140.7 0.0 16.3 0.2 71.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.0 10.8 0.2 0.0 0.0 0.0 1.9 11.5 0.0 0.0 2.8 0.0 41.4 0.0 5.0 37.6 0.8 0.0 10.9 0.0 0.0 0.0 0.5 0.0 2.4 6.6 0.0 1.2 1.3 2.2 0.0 0.0 74.0 0.0 0.0 0.2 0.1 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.7;testis: 77.7" "Cell type enhanced" "Detected in many" "B-cells: 263.1;Cone photoreceptor cells: 206.4;Late spermatids: 185.9;Rod photoreceptor cells: 397.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 26.7;naive B-cell: 21.0" "Lineage enriched" "Detected in many" 11 "B-cells: 26.7" "Cell line enhanced" "Detected in many" "U-266/84: 250.4;U-698: 194.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 8.6 3.3 24.2 5.1 13.3 8.2 5.2 4.8 6.5 3.3 13.5 11.6 9.5 5.5 16.5 8.1 8.2 4.7 6.5 5.2 6.8 32.3 2.8 52.8 3.0 2.9 2.9 18.4 5.8 7.9 2.9 9.3 2.5 7.4 12.3 53.0 5.5 5.6 1.4 19.8 16.5 11.9 3.9 28.5 13.8 77.7 4.6 15.3 6.8 4.9 56.7 12.8 7.7 2.7 39.9 12.7 38.7 0.4 42.3 61.6 15.2 34.0 74.8 27.1 24.3 15.1 38.3 83.7 11.2 100.8 13.5 32.2 17.2 8.6 35.4 0.1 10.3 0.0 8.7 14.6 7.1 11.1 0.4 27.5 7.5 35.1 24.6 18.8 23.7 15.3 20.6 3.1 17.8 6.3 17.0 3.5 26.5 15.3 13.4 23.5 39.9 0.7 9.3 24.9 6.0 17.2 22.2 24.5 48.4 26.3 29.3 5.6 17.9 12.4 11.8 45.4 16.4 91.8 250.4 194.3 7.2 5.7 14.2 0.8 0.1 2.4 0.3 0.1 0.3 26.7 0.2 0.1 0.4 21.0 0.7 0.2 1.3 0.4 0.1 0.8 0.0 1.1 3.3 5.1 5.2 4.8 6.5 5.2 3.0 2.9 2.9 2.5 3.9 4.6 2.7 5.4 12.8 6.9 29.4 263.1 14.8 16.3 5.4 14.8 97.4 27.9 15.1 17.5 15.7 8.7 14.7 206.4 7.5 11.6 39.5 21.5 15.2 123.0 23.3 25.6 4.9 35.9 22.7 84.0 12.0 10.1 18.7 48.9 33.0 8.8 60.3 2.9 55.2 6.3 13.5 92.3 22.5 0.0 8.5 4.8 185.9 50.1 7.3 8.8 41.2 5.1 27.8 10.3 107.5 4.0 31.0 52.4 46.6 105.2 26.0 22.7 9.7 23.9 397.3 19.7 41.5 18.6 146.6 34.8 29.1 34.1 3.3 10.3 20.7 15.6 72.0 ANGPTL1 "ANG3, ANGPT3, AngY, ARP1" ENSG00000116194 "Angiopoietin like 1" O95841 1 178849535-178871077 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 134.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 81.7;Leydig cells: 425.9;Peritubular cells: 212.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "hypothalamus: 12.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "ASC diff: 149.9;ASC TERT1: 60.1;HHSteC: 64.9;HSkMC: 147.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009976 Approved "Secreted to blood" NA NA 380000 "HPA009976: AB_1844822" "unprognostic (2.59e-2)" "unprognostic (1.31e-1)" "unprognostic (5.80e-3)" "unprognostic (2.63e-2)" "unprognostic (3.60e-1)" "unprognostic (1.71e-2)" "prognostic favorable (8.73e-4)" "unprognostic (3.81e-2)" "unprognostic (5.78e-3)" "unprognostic (1.47e-1)" "unprognostic (1.39e-1)" "unprognostic (5.31e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.61e-3)" 57.1 45.5 2.1 10.6 2.6 0.9 27.1 2.2 2.7 21.5 1.8 44.4 9.7 69.7 14.2 34.1 59.5 28.2 23.0 2.8 12.7 17.7 24.1 12.7 3.6 2.2 1.6 2.1 68.8 22.0 1.1 2.2 134.9 1.7 12.4 27.8 9.7 36.6 9.6 30.6 8.4 26.9 66.0 1.9 11.0 21.8 15.7 1.4 8.7 41.5 57.8 7.0 24.1 17.3 2.4 0.2 0.0 4.0 0.0 149.9 60.1 0.0 0.1 0.0 0.4 0.8 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 64.9 0.0 0.1 147.5 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 2.6 2.2 2.7 2.8 12.7 2.2 1.6 2.1 1.7 1.9 1.4 2.4 16.5 0.0 0.0 9.4 1.3 3.7 0.0 0.0 1.2 2.3 0.8 0.5 3.7 41.5 0.0 1.8 6.2 0.6 0.1 0.0 1.9 2.4 1.4 3.3 40.3 4.1 0.0 0.0 14.8 0.4 0.4 81.7 1.1 5.5 0.0 1.6 8.9 1.0 1.4 0.0 14.9 0.0 0.0 0.0 4.6 10.6 425.9 0.8 3.6 8.4 0.0 31.6 0.0 21.6 0.7 0.0 5.0 212.1 0.4 0.1 0.1 0.1 0.7 10.9 39.5 10.0 51.8 0.8 0.6 0.2 3.7 1.4 0.5 2.7 0.0 0.1 CEP104 "CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4" ENSG00000116198 "Centrosomal protein 104" O60308 1 3812086-3857396 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Cone photoreceptor cells: 458.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010126 Approved NA NA "HPA010126: AB_10601583" "unprognostic (3.60e-2)" "unprognostic (1.39e-1)" "unprognostic (8.83e-2)" "unprognostic (2.00e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-3)" "unprognostic (8.35e-2)" "unprognostic (4.85e-1)" "unprognostic (2.16e-1)" "unprognostic (4.90e-1)" "unprognostic (2.89e-1)" "prognostic favorable (1.70e-5)" "unprognostic (7.06e-3)" "unprognostic (2.62e-1)" "unprognostic (1.46e-1)" "unprognostic (3.55e-1)" 9.1 9.2 8.5 6.7 10.0 3.1 6.5 9.2 7.0 7.0 10.4 7.7 5.2 7.2 4.3 7.7 8.0 6.3 7.6 5.3 8.0 11.4 8.8 7.5 7.1 11.7 11.5 3.9 7.5 8.9 14.1 8.1 6.7 13.7 7.7 6.7 9.1 7.9 8.6 9.6 7.1 7.2 9.4 8.0 6.6 7.7 9.7 10.2 8.4 10.0 7.0 8.8 8.2 6.7 9.1 13.4 10.8 8.8 11.8 20.9 15.9 6.8 14.0 11.2 19.5 12.8 8.0 11.4 15.7 17.6 14.8 14.0 12.8 20.3 13.1 23.1 22.1 15.5 15.8 12.7 10.2 13.5 15.5 13.3 8.0 13.0 17.9 28.0 13.6 16.6 17.3 19.6 15.7 18.3 6.2 22.8 6.3 6.3 18.9 20.2 14.1 12.3 17.1 12.7 7.8 22.1 8.8 21.7 23.8 15.0 10.8 10.2 8.0 19.1 14.0 6.5 23.6 11.4 13.0 20.6 22.5 7.9 17.4 5.6 0.3 0.1 1.5 0.6 0.2 0.5 0.2 0.4 0.6 0.3 0.7 0.7 0.1 0.2 0.7 0.4 0.9 0.2 0.1 8.5 10.0 9.2 7.0 5.3 8.0 11.7 11.5 3.9 13.7 8.0 10.2 9.1 13.7 25.6 25.9 15.7 14.7 15.9 14.2 9.2 12.0 24.8 12.8 9.1 14.1 12.8 13.9 25.8 458.7 16.3 18.6 16.2 7.9 26.0 74.9 34.3 14.4 15.4 11.3 10.7 23.7 19.6 24.4 12.9 12.2 18.9 10.8 12.6 8.9 18.4 13.2 58.9 24.6 13.5 4.1 14.6 7.8 91.7 12.5 14.3 19.6 12.2 21.0 13.8 22.6 12.1 34.1 24.3 11.7 20.7 23.2 19.2 16.6 18.5 28.7 55.2 19.7 19.8 16.1 63.7 23.5 15.0 20.0 11.4 17.2 18.2 12.7 13.7 FAM20B "GXK1, KIAA0475" ENSG00000116199 "FAM20B glycosaminoglycan xylosylkinase" O75063 1 179025804-179076567 "Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007409 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 14000000 "Golgi apparatus" Nucleoplasm "HPA007409: AB_10601649" "unprognostic (7.58e-2)" "unprognostic (1.12e-1)" "unprognostic (4.97e-2)" "unprognostic (6.23e-3)" "unprognostic (3.29e-1)" "unprognostic (3.07e-1)" "unprognostic (4.76e-2)" "unprognostic (7.70e-3)" "unprognostic (7.85e-2)" "unprognostic (3.93e-2)" "unprognostic (5.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.76e-1)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" 21.0 22.6 14.4 11.3 18.2 11.8 16.1 13.6 17.8 16.2 9.3 18.4 10.0 18.1 15.5 17.8 15.6 13.8 23.7 17.6 18.3 17.5 16.7 16.4 11.4 15.0 14.8 16.4 20.1 11.5 21.6 14.5 17.1 15.5 16.6 14.6 28.9 11.9 19.5 19.7 12.9 11.6 19.6 14.5 12.5 13.8 8.0 15.4 11.7 18.1 25.8 10.9 16.3 12.4 16.6 41.4 37.1 28.2 30.0 49.1 51.4 31.2 33.7 38.3 23.2 20.7 18.7 40.1 21.3 43.2 59.7 19.1 29.3 29.0 24.8 33.8 27.3 19.5 67.9 34.8 23.9 24.5 45.5 41.1 30.1 26.5 31.7 24.5 35.4 29.0 29.2 77.0 30.2 37.5 23.1 19.9 16.4 37.1 46.2 7.9 24.1 29.7 28.4 19.5 46.1 37.5 91.8 35.5 39.7 34.5 39.8 34.4 32.8 30.8 36.7 32.2 51.1 46.0 24.5 48.5 18.2 36.5 21.7 37.3 0.9 0.6 0.2 1.3 0.6 1.3 1.4 0.7 1.1 0.8 1.5 1.1 1.0 0.6 1.6 0.8 1.2 1.0 0.5 14.4 18.2 13.6 17.8 17.6 18.3 15.0 14.8 16.4 15.5 14.5 15.4 16.6 16.8 6.4 11.4 16.0 7.5 15.6 12.6 8.9 4.6 15.7 12.2 9.3 40.1 12.8 9.0 18.4 25.0 9.0 9.0 10.6 3.9 8.8 5.2 8.8 17.8 13.8 14.4 43.3 28.3 13.0 7.7 14.6 9.2 14.5 17.1 20.2 9.3 14.2 7.6 38.7 32.0 7.9 10.2 11.6 8.1 5.1 17.7 9.6 16.0 19.7 14.1 9.0 2.1 17.6 32.5 13.7 3.8 21.4 6.2 19.7 5.0 5.9 8.8 21.0 13.1 20.0 17.7 17.6 13.8 9.6 12.9 7.5 8.0 24.1 8.5 24.7 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053584-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 36.4;Spermatocytes: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046918: AB_2679864" "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 1.9 2.4 5.6 2.9 5.4 2.8 2.2 4.8 5.8 2.2 4.8 2.5 2.6 2.1 2.3 2.9 2.1 1.5 2.3 4.9 5.2 2.4 2.2 1.9 4.0 5.9 5.5 4.8 1.8 2.2 2.4 2.1 2.3 5.9 2.4 3.1 2.1 2.0 1.5 3.9 2.5 2.6 1.8 5.5 3.7 2.4 7.2 5.6 5.1 2.1 3.1 3.7 2.7 2.3 6.4 4.3 1.9 4.6 3.9 3.3 5.2 4.9 4.5 3.6 4.8 4.2 1.2 2.6 3.2 3.8 1.6 4.4 4.1 6.6 3.6 6.5 7.6 2.7 6.3 4.3 2.0 1.9 4.2 5.3 3.7 3.0 4.0 2.4 2.4 7.1 8.6 5.7 3.4 4.3 1.6 9.3 3.4 11.4 4.4 2.9 9.2 9.4 5.6 1.6 2.8 4.2 4.4 2.4 4.8 5.8 7.2 4.6 7.6 4.1 4.9 2.7 4.6 5.5 8.1 12.9 5.2 4.1 5.9 6.0 3.3 3.2 4.2 1.6 4.0 1.9 2.8 2.2 2.5 3.5 3.3 2.5 2.9 3.5 4.8 3.4 3.0 1.7 1.5 5.6 5.4 4.8 5.8 4.9 5.2 5.9 5.5 4.8 5.9 5.5 5.6 6.4 4.0 9.6 11.2 12.7 6.7 0.6 1.5 2.3 1.2 3.2 3.8 3.0 8.4 5.7 5.9 11.0 12.5 6.1 4.7 2.7 1.9 4.0 36.4 9.8 4.7 5.5 3.6 7.6 6.3 1.8 5.7 3.6 5.6 3.7 2.5 4.4 3.9 4.4 4.8 8.4 7.8 4.2 2.0 9.6 1.0 23.5 3.1 5.3 1.8 6.5 12.3 2.5 9.2 5.5 16.7 3.6 3.7 3.0 5.7 2.4 4.3 3.5 16.8 3.3 0.0 4.2 3.6 29.4 12.5 5.5 1.0 4.0 5.6 4.2 4.5 1.6 TMEM59 "C1orf8, HSPC001" ENSG00000116209 "Transmembrane protein 59" Q9BXS4 1 54026681-54053504 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075447 Approved NA NA 27000 "HPA075447: " "unprognostic (2.63e-1)" "unprognostic (9.88e-2)" "unprognostic (2.63e-2)" "unprognostic (2.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (8.28e-2)" "unprognostic (4.10e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (4.49e-2)" "unprognostic (6.34e-3)" "unprognostic (9.84e-2)" "unprognostic (1.70e-1)" "unprognostic (6.83e-3)" "unprognostic (7.38e-2)" 259.9 363.2 187.2 166.1 222.0 261.9 344.9 242.4 255.9 346.5 352.5 492.8 367.4 210.7 419.2 244.0 406.7 302.0 278.3 182.0 231.6 478.1 509.9 266.3 163.9 244.2 212.5 175.0 227.4 591.1 537.0 171.5 328.5 237.6 353.3 489.9 256.4 555.0 282.5 196.1 196.2 372.2 221.7 253.5 190.4 436.9 176.4 213.5 188.7 344.4 249.8 190.8 291.9 204.3 302.0 188.9 122.3 142.8 185.2 844.1 371.1 182.8 347.9 499.1 211.5 276.0 99.1 391.9 96.7 322.6 595.6 257.7 281.1 166.2 237.5 221.9 237.7 177.4 133.5 266.6 166.1 317.8 165.7 268.7 408.3 411.2 207.5 219.2 566.9 246.6 127.8 158.9 326.3 245.1 91.6 97.9 137.3 201.0 528.3 226.3 94.0 251.6 403.2 257.6 248.0 208.2 173.3 381.5 386.0 398.3 266.2 184.9 348.4 259.3 259.8 90.7 193.3 187.8 289.0 338.7 114.5 349.4 275.4 222.3 1183.5 654.6 831.5 439.7 532.9 461.8 449.3 465.9 480.4 520.9 405.2 430.3 426.4 1196.5 430.4 595.9 527.1 576.1 1153.8 187.2 222.0 242.4 255.9 182.0 231.6 244.2 212.5 175.0 237.6 253.5 213.5 302.0 355.3 233.9 181.3 49.6 221.3 404.2 637.0 1214.2 237.3 150.2 409.0 325.1 155.1 479.0 991.8 437.7 118.9 477.7 244.5 905.2 160.4 527.8 357.1 348.5 201.9 279.5 408.2 277.0 44.3 352.5 528.7 410.6 226.8 217.2 155.2 89.5 334.4 413.2 320.2 132.9 42.1 672.8 1131.1 302.9 290.3 183.1 432.7 225.4 690.1 27.2 209.3 473.5 190.5 60.3 176.6 329.3 1064.8 354.0 692.8 583.2 1015.8 468.8 977.4 183.6 368.1 198.6 350.4 488.9 210.1 245.5 414.3 687.1 227.2 185.8 534.9 750.4 LRRC42 MGC8974 ENSG00000116212 "Leucine rich repeat containing 42" Q9Y546 1 53946085-53968168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047458, HPA050537, HPA064581" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292" "unprognostic (3.13e-1)" "unprognostic (1.32e-1)" "unprognostic (5.88e-2)" "unprognostic (9.97e-3)" "unprognostic (4.01e-2)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.88e-5)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.24e-2)" "unprognostic (9.08e-2)" "unprognostic (7.36e-3)" "unprognostic (1.67e-2)" 14.7 29.3 10.6 9.8 10.5 11.9 15.0 9.9 13.7 16.2 13.9 15.7 12.4 18.9 15.4 22.0 16.7 12.6 14.6 10.5 12.8 14.5 24.5 15.4 11.5 10.9 10.1 10.8 17.3 13.4 15.5 24.3 22.6 10.1 15.3 13.4 8.7 16.9 14.9 17.7 22.0 11.9 18.3 10.5 9.3 16.9 19.6 11.4 16.5 23.8 15.9 14.5 18.9 18.4 10.9 73.3 26.9 66.0 38.9 34.0 45.9 45.2 56.7 78.7 74.4 100.4 90.8 48.0 41.4 44.4 70.6 88.0 63.5 57.0 81.4 85.4 32.7 35.5 38.2 40.4 57.9 61.7 23.9 35.2 41.8 110.6 64.5 69.5 54.1 47.6 37.7 48.8 10.6 73.2 25.5 45.1 33.1 56.6 53.5 42.0 75.9 70.2 28.8 53.1 54.1 39.3 42.3 76.5 42.7 63.4 103.1 63.4 28.3 39.6 56.1 71.7 50.1 35.9 29.4 36.4 61.7 54.3 24.8 30.4 0.0 3.1 5.7 4.9 3.1 4.3 4.2 4.2 5.9 3.9 2.3 4.2 3.2 4.8 4.9 2.3 6.9 4.8 2.9 10.6 10.5 9.9 13.7 10.5 12.8 10.9 10.1 10.8 10.1 10.5 11.4 10.9 7.8 12.8 5.8 3.6 6.7 51.6 36.4 46.6 29.6 4.4 15.9 14.1 10.5 30.0 24.2 11.0 4.2 43.8 5.4 14.9 19.6 35.0 2.9 16.2 17.0 11.1 68.2 16.0 8.0 16.7 31.4 22.6 17.3 16.8 0.0 19.8 8.2 15.0 17.8 10.1 4.9 9.6 30.5 5.7 11.7 3.5 23.9 8.5 10.6 7.5 10.6 28.7 9.2 5.5 8.4 32.6 13.3 17.7 16.7 46.4 9.9 17.6 19.2 3.6 13.1 15.5 22.7 21.9 48.5 25.5 39.1 57.5 7.9 75.7 14.6 41.0 WRAP73 WDR8 ENSG00000116213 "WD repeat containing, antisense to TP73" Q9P2S5 1 3630767-3652761 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026893 Uncertain NA NA "HPA026893: AB_10603459" "unprognostic (3.34e-2)" "unprognostic (2.78e-2)" "unprognostic (3.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.19e-1)" "unprognostic (1.40e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (2.35e-2)" "unprognostic (1.02e-2)" "unprognostic (6.19e-2)" "prognostic favorable (3.49e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.06e-1)" "unprognostic (4.60e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-3)" 13.4 14.4 10.6 10.8 11.6 24.1 13.5 12.1 16.2 14.1 11.0 14.7 14.0 14.3 8.0 15.8 13.5 9.1 13.1 10.6 10.8 13.7 13.6 13.4 17.8 11.3 11.0 10.1 14.1 18.3 10.2 17.7 9.7 11.6 13.7 9.1 8.5 13.6 7.9 16.4 13.0 18.2 8.9 10.6 21.6 16.9 16.0 11.6 14.5 14.8 9.7 14.2 14.0 13.6 12.4 30.5 17.4 17.0 33.1 22.4 14.3 16.8 14.9 14.6 24.8 21.5 27.5 39.4 33.5 27.5 19.0 20.2 22.6 50.0 29.8 12.8 59.3 75.8 19.1 23.7 31.3 24.0 22.5 29.2 13.2 20.7 20.1 25.6 13.8 22.2 39.7 31.8 19.9 18.1 27.2 47.6 33.7 23.5 30.4 36.7 29.3 24.5 17.9 13.1 12.6 43.7 61.1 17.3 23.5 43.1 14.4 23.3 35.9 17.9 19.1 19.1 32.6 21.7 27.0 34.7 68.7 9.8 45.8 8.6 57.3 23.4 70.3 21.7 22.5 21.6 22.2 22.7 21.1 24.3 22.4 19.9 21.0 28.8 24.2 33.3 20.5 27.3 19.3 10.6 11.6 12.1 16.2 10.6 10.8 11.3 11.0 10.1 11.6 10.6 11.6 12.4 15.4 3.2 13.4 12.1 18.3 7.0 10.8 22.3 12.0 23.5 8.7 9.4 7.9 10.0 12.9 14.7 35.5 21.3 21.0 15.4 13.7 13.1 12.1 11.3 9.4 11.2 10.3 5.9 9.0 14.2 12.5 12.0 14.3 8.7 4.5 14.8 10.0 7.0 18.3 42.1 7.9 13.8 16.2 11.9 6.8 25.7 12.5 13.5 12.4 9.4 14.8 17.6 15.5 6.0 10.3 16.6 7.8 9.8 16.5 14.2 30.3 9.4 14.2 26.9 6.6 9.8 15.3 38.1 15.8 12.3 6.8 14.5 20.3 15.4 13.0 9.6 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2 stomatin family member, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 136 "kidney: 248.3" "Group enriched" "Detected in some" 7 "Collecting duct cells: 20.2;Early spermatids: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "NTERA-2: 1.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB037267, HPA049486" Enhanced NA NA "CAB037267: AB_261982, HPA049486: AB_2680788" "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 248.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 MRPL37 "MRP-L2, RPML2" ENSG00000116221 "Mitochondrial ribosomal protein L37" Q9BZE1 1 54184041-54225464 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025767, HPA025826, HPA025951" Supported Supported Mitochondria NA NA Mitochondria "HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107" "unprognostic (2.00e-1)" "unprognostic (6.81e-2)" "prognostic favorable (6.99e-4)" "unprognostic (1.71e-3)" "unprognostic (8.24e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.49e-2)" "unprognostic (1.56e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-2)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.43e-1)" "unprognostic (2.62e-1)" "unprognostic (7.67e-3)" 44.4 74.4 28.2 32.7 30.1 68.0 41.8 34.9 37.5 33.6 38.6 51.2 51.9 35.0 27.2 66.3 38.6 25.8 71.3 30.0 29.4 55.3 109.0 30.5 41.4 31.2 30.2 28.7 41.4 68.2 47.6 21.0 31.7 32.8 34.1 54.0 21.9 41.6 30.1 169.5 56.4 41.4 41.9 26.9 34.9 49.6 31.6 30.2 41.6 28.7 155.6 51.8 38.3 40.8 30.8 168.3 94.9 84.6 114.5 83.4 110.9 150.5 111.2 103.5 194.0 167.7 190.7 75.4 226.1 98.2 125.3 184.8 131.6 168.2 164.6 150.6 111.1 211.7 194.8 186.9 194.8 142.9 233.3 87.1 123.2 138.7 201.8 156.5 108.7 176.1 174.2 219.2 66.1 140.2 123.3 161.7 226.4 173.5 134.4 208.2 175.3 171.7 191.6 110.8 123.4 166.3 77.6 153.8 261.4 214.0 110.6 113.2 260.7 88.5 123.6 112.2 157.7 227.1 83.1 126.0 175.5 161.1 234.2 119.9 53.0 103.4 45.4 67.5 91.8 79.1 120.4 81.9 76.1 120.4 105.1 82.0 72.8 5.6 94.0 88.7 101.5 116.4 126.6 28.2 30.1 34.9 37.5 30.0 29.4 31.2 30.2 28.7 32.8 26.9 30.2 30.8 24.0 22.4 18.7 3.9 33.4 34.7 43.8 84.6 45.5 8.9 46.3 57.0 71.3 55.8 43.1 18.4 2.1 118.0 15.5 36.6 80.3 81.2 31.0 25.7 23.2 30.3 33.1 103.3 7.5 96.3 145.8 37.3 41.8 33.1 14.5 40.6 37.5 156.5 87.0 6.7 8.4 53.0 52.9 43.6 25.6 57.5 26.1 30.9 23.2 4.7 53.1 9.2 24.7 4.5 5.4 69.0 41.1 28.6 72.2 54.2 73.8 105.2 29.4 8.7 13.1 28.8 34.3 23.6 50.4 79.6 37.4 73.9 24.5 57.2 86.0 55.2 ICMT "HSTE14, PCCMT, PPMT" ENSG00000116237 "Isoprenylcysteine carboxyl methyltransferase" O60725 1 6221193-6235972 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 112.8" "Low region specificity" "Detected in all" "HPA032024, HPA032025" Uncertain NA NA "HPA032024: AB_2674115, HPA032025: AB_10601819" "unprognostic (1.95e-3)" "unprognostic (3.83e-2)" "unprognostic (7.34e-2)" "unprognostic (4.40e-2)" "unprognostic (5.53e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-1)" "unprognostic (6.58e-2)" "unprognostic (2.11e-2)" "unprognostic (4.11e-1)" "unprognostic (5.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.99e-3)" 22.8 23.2 12.7 13.7 17.2 4.1 16.0 18.8 13.7 20.5 16.9 19.8 19.8 20.3 21.1 21.8 16.3 13.2 25.2 12.9 13.1 26.1 13.7 15.1 10.3 13.5 15.2 12.0 9.2 17.6 27.0 22.2 21.2 15.0 17.5 17.6 28.9 17.3 19.0 53.4 19.4 18.5 22.1 12.6 9.2 15.9 5.3 14.3 15.0 18.3 83.3 11.1 17.6 16.1 12.6 35.8 32.6 43.7 43.0 131.2 51.8 18.7 84.9 56.1 48.7 36.9 35.0 28.2 39.0 31.7 66.7 42.0 47.4 50.5 35.6 51.5 78.8 51.3 26.8 46.0 26.8 25.5 42.5 36.4 33.3 23.5 51.2 19.2 32.4 38.5 31.6 26.5 29.8 55.7 22.3 43.2 29.6 29.7 64.1 46.0 35.8 61.5 22.6 59.3 25.8 59.2 28.8 41.3 96.3 37.2 48.4 25.2 35.4 48.1 55.3 21.7 65.4 61.6 27.7 57.8 30.5 27.1 96.5 29.3 2.6 1.9 1.6 3.1 2.2 2.7 1.1 2.5 3.1 1.7 1.8 2.1 1.8 0.6 1.8 1.9 2.7 1.4 1.9 12.7 17.2 18.8 13.7 12.9 13.1 13.5 15.2 12.0 15.0 12.6 14.3 12.6 18.0 22.4 12.1 5.9 7.7 6.2 9.6 12.2 7.4 18.0 16.3 9.8 39.3 15.7 19.6 29.5 31.3 57.6 12.3 40.7 13.7 21.9 3.5 19.5 18.8 18.1 22.8 14.9 10.2 22.2 85.7 19.6 12.8 16.9 5.1 13.9 21.8 23.9 29.1 48.8 9.4 21.4 12.2 12.0 7.0 5.1 20.8 9.8 7.2 7.5 12.1 18.9 10.3 2.0 5.4 26.8 12.2 26.4 18.3 14.1 45.5 36.9 41.7 58.8 13.1 9.9 22.1 15.4 26.8 28.2 10.4 32.0 10.4 13.9 23.1 14.7 RPL22 "EAP, L22" ENSG00000116251 "Ribosomal protein L22" P35268 1 6185020-6209389 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA068294 Approved Nucleoplasm,Nucleoli NA NA 860000 Nucleoli Nucleoplasm "HPA068294: AB_2732781" "unprognostic (3.16e-3)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.62e-2)" "unprognostic (2.27e-2)" "unprognostic (1.09e-1)" "unprognostic (1.29e-3)" "unprognostic (4.40e-2)" "unprognostic (7.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.48e-1)" "unprognostic (4.24e-2)" "unprognostic (1.46e-3)" "unprognostic (3.83e-1)" "unprognostic (3.88e-2)" "unprognostic (2.46e-1)" "unprognostic (1.98e-1)" 583.8 493.7 257.3 516.6 263.8 1073.2 604.5 264.1 403.4 682.6 271.4 538.4 479.3 517.6 316.6 626.7 595.6 222.4 381.1 248.3 263.4 457.6 484.3 400.3 665.3 258.2 256.7 239.8 1106.7 696.4 314.8 334.5 310.9 265.8 491.4 323.4 319.3 594.5 220.4 921.0 655.1 465.2 249.5 271.6 506.1 504.9 138.8 268.8 489.3 403.7 402.3 513.9 556.2 605.5 280.4 1443.4 400.8 836.4 858.6 576.1 897.0 659.0 1224.2 488.1 440.4 372.9 802.5 1213.4 2217.7 981.3 458.1 304.2 810.7 636.9 638.2 576.9 1093.6 1033.3 2159.0 948.8 1016.3 569.4 2893.0 828.4 799.9 516.3 393.5 808.6 907.3 560.1 610.3 1817.3 1301.1 512.9 634.7 1274.0 2340.3 522.1 953.0 880.1 1207.4 1731.8 1731.8 656.1 490.4 1149.9 1051.9 996.9 2846.8 2387.4 721.1 918.2 2247.5 1380.1 623.1 689.2 833.9 1170.4 1037.2 1544.9 3289.7 413.0 2911.2 395.5 109.0 297.7 71.2 268.2 270.0 474.9 547.1 502.6 373.2 451.6 500.6 679.0 560.8 22.0 337.5 227.9 472.2 416.3 664.1 257.3 263.8 264.1 403.4 248.3 263.4 258.2 256.7 239.8 265.8 271.6 268.8 280.4 1090.2 445.5 731.5 5.9 2372.5 1821.1 2035.3 1455.3 2241.2 217.6 1764.0 2190.8 277.9 1225.3 883.4 584.9 131.3 1816.1 1450.8 669.0 1905.6 1332.1 442.9 736.9 1377.2 1104.5 912.5 1508.9 15.3 1823.0 2751.0 1022.5 940.9 944.1 921.5 1256.6 1457.4 1491.7 1504.9 141.3 14.2 2032.2 449.6 1997.8 2098.8 320.1 2027.4 1440.8 1076.1 14.0 2435.3 890.1 1442.9 8.0 10.7 1575.3 1413.5 1234.1 1218.7 1837.3 1182.5 2505.6 437.3 390.8 775.7 1773.9 1169.1 358.6 473.0 2759.8 1935.8 1851.9 1791.5 1289.9 2231.0 2084.3 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101787-6180321 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 54.8;pituitary gland: 57.7;testis: 32.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 12.9;U-2 OS: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 0.2 4.2 27.9 0.2 34.6 0.0 0.1 0.0 54.8 0.3 0.0 0.9 0.2 0.4 0.0 0.3 0.4 0.1 0.4 28.5 9.6 0.7 0.1 0.3 0.0 5.0 7.8 36.3 0.5 0.4 0.9 57.7 0.0 8.1 1.0 0.2 8.0 0.2 2.2 0.2 0.2 0.5 0.1 0.0 0.1 1.0 32.1 4.2 0.3 0.1 0.0 0.0 0.7 0.6 25.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 1.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 12.9 0.2 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 34.6 0.0 54.8 28.5 9.6 5.0 7.8 36.3 8.1 0.0 4.2 25.9 0.0 0.0 0.0 5.5 0.1 0.1 0.1 0.0 0.0 84.3 0.1 0.3 2.1 0.0 0.0 3.7 12.5 0.0 0.1 0.2 0.0 0.0 217.8 0.0 0.2 0.6 0.0 0.0 80.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 225.4 56.2 0.0 0.0 0.0 0.3 113.2 0.9 0.1 0.0 2.8 0.0 2.0 0.0 4.5 3.7 0.3 0.0 0.4 0.0 0.2 0.0 0.1 0.0 49.9 0.0 0.2 0.5 4.5 17.8 0.0 0.4 0.0 0.1 0.1 0.0 0.0 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154869-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Extravillous trophoblasts: 1616.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 1918.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056243 Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 2600000000 "Golgi apparatus" Vesicles "HPA056243: AB_2683077" "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 66.1 85.6 39.7 52.5 41.6 116.5 53.7 45.1 47.6 73.5 42.8 88.6 68.1 75.8 70.8 179.8 83.0 151.6 191.2 43.3 44.6 68.2 82.3 201.7 16.4 52.2 43.6 36.8 197.8 137.5 21.1 60.6 160.2 45.3 93.1 81.7 15.3 106.5 58.0 91.9 54.3 86.5 60.6 48.9 62.4 179.7 174.3 46.5 12.2 32.2 46.4 19.7 175.6 109.6 59.6 441.4 62.0 14.8 181.0 179.1 367.8 712.5 456.5 456.6 381.6 267.1 7.3 137.7 6.8 276.7 367.8 52.6 93.7 17.6 123.5 185.0 26.4 28.0 14.1 33.6 19.4 1918.6 48.6 129.2 197.9 55.5 408.0 484.3 499.9 569.4 32.1 20.2 66.3 255.3 76.4 10.4 89.7 49.4 302.6 174.6 19.7 33.0 11.8 63.1 123.6 51.9 52.6 133.8 179.8 91.9 32.2 33.0 226.3 678.3 473.8 187.5 322.0 392.9 48.3 84.4 12.2 180.9 153.9 146.0 16.2 53.1 20.6 14.0 29.9 10.2 5.4 9.1 9.6 39.2 3.2 8.1 8.0 40.2 16.9 28.6 8.0 11.5 28.6 39.7 41.6 45.1 47.6 43.3 44.6 52.2 43.6 36.8 45.3 48.9 46.5 59.6 36.6 57.7 101.6 8.5 7.7 13.8 27.4 81.2 7.4 11.5 86.2 47.9 48.3 51.5 112.5 71.7 25.0 19.5 10.7 138.1 0.0 230.4 49.2 49.2 19.4 41.7 46.2 6.9 17.2 130.1 1616.7 78.0 136.6 80.4 25.4 27.1 89.3 4.3 68.6 6.7 17.0 185.7 132.2 45.2 35.3 20.1 177.7 48.9 44.4 8.4 49.7 53.5 10.3 24.6 23.9 249.8 165.6 71.1 12.8 35.7 9.0 9.1 47.8 6.7 32.9 13.6 31.3 30.2 32.7 10.2 9.9 154.3 13.9 13.9 89.9 68.0 STXBP3 UNC-18C ENSG00000116266 "Syntaxin binding protein 3" O00186 1 108746674-108809523 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 206.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027225 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027225: AB_1857627" "unprognostic (3.14e-3)" "unprognostic (4.33e-2)" "unprognostic (7.18e-3)" "unprognostic (4.88e-2)" "unprognostic (6.54e-2)" "unprognostic (9.78e-3)" "unprognostic (2.00e-3)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "unprognostic (6.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.25e-2)" "unprognostic (1.65e-1)" "unprognostic (8.08e-2)" "unprognostic (1.08e-1)" "unprognostic (4.55e-2)" 22.2 24.5 33.1 27.2 41.9 24.1 27.9 41.9 41.0 24.9 29.5 28.8 26.4 27.4 25.9 25.3 19.8 28.3 20.7 31.9 36.9 40.7 25.2 23.3 28.1 44.0 40.1 30.4 21.1 28.3 42.3 14.3 28.3 43.2 24.0 29.4 34.7 21.8 19.6 19.5 27.4 33.7 24.3 41.6 26.4 25.4 16.5 37.3 31.9 37.4 24.2 25.5 31.4 21.7 55.2 47.1 18.1 30.6 16.1 36.3 35.1 42.9 42.9 38.9 27.9 28.2 16.8 18.3 41.7 28.4 34.7 25.8 27.4 20.9 25.3 38.8 46.7 28.9 34.5 23.8 21.9 28.7 54.2 56.0 27.4 34.5 31.5 34.0 34.8 35.2 26.2 26.0 39.3 39.0 31.7 34.8 42.9 32.6 30.9 28.4 28.4 45.1 22.8 45.7 38.4 18.4 16.9 52.3 49.6 64.6 27.6 20.1 49.9 40.2 36.3 21.4 50.8 37.1 26.3 24.8 34.1 65.2 41.0 56.4 62.7 17.1 42.7 14.2 20.8 18.4 11.3 16.6 14.5 16.6 10.8 14.0 13.7 48.1 17.9 24.9 7.7 20.4 11.9 33.1 41.9 41.9 41.0 31.9 36.9 44.0 40.1 30.4 43.2 41.6 37.3 55.2 35.9 12.8 25.2 59.1 25.6 44.0 37.4 32.5 14.2 38.2 21.8 20.2 36.4 32.9 34.5 20.2 20.9 43.7 38.7 46.5 45.0 38.1 7.3 33.6 29.3 32.9 21.0 22.7 30.0 27.4 35.4 36.2 16.8 33.9 69.7 18.7 15.4 16.1 31.5 26.9 31.4 28.3 24.4 45.5 44.2 5.4 33.5 41.7 39.2 48.7 57.3 40.5 41.2 68.9 206.2 34.5 27.3 31.6 20.0 32.9 30.4 47.5 28.7 19.3 19.7 34.2 33.6 26.4 24.7 16.1 40.3 95.5 36.7 29.6 26.8 44.8 PHF13 MGC43399 ENSG00000116273 "PHD finger protein 13" Q86YI8 1 6613731-6624030 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026830 Uncertain NA NA "HPA026830: AB_1855288" "unprognostic (6.59e-3)" "unprognostic (7.71e-2)" "unprognostic (2.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (8.41e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (9.84e-3)" "unprognostic (2.62e-1)" "unprognostic (1.59e-1)" "unprognostic (8.73e-3)" "unprognostic (1.40e-2)" "unprognostic (1.68e-3)" "unprognostic (1.58e-1)" "unprognostic (3.86e-2)" "unprognostic (6.68e-2)" "unprognostic (1.05e-1)" 11.3 9.0 8.3 4.8 7.8 9.6 11.5 7.2 8.7 18.1 7.0 13.2 5.3 17.3 10.2 15.3 15.4 10.6 7.7 8.2 9.9 7.0 12.4 10.1 6.3 8.4 8.0 7.8 14.2 10.1 9.9 10.0 8.0 7.6 11.5 3.4 6.3 9.6 10.6 10.1 14.4 7.8 8.1 7.9 7.1 9.6 34.2 8.9 8.7 8.9 7.0 5.8 12.4 14.5 8.9 19.2 8.9 25.8 31.8 13.0 17.7 15.1 29.0 21.2 22.5 20.4 17.7 18.2 17.2 11.1 22.2 13.9 15.9 17.1 18.6 22.1 22.9 22.3 26.3 14.3 15.1 13.6 7.0 16.9 19.8 7.9 21.6 10.1 24.9 14.0 16.0 31.7 12.1 19.4 21.3 16.4 19.8 19.1 10.1 15.3 27.7 20.3 9.3 12.2 9.8 18.3 22.7 12.4 21.5 19.1 17.7 17.2 13.4 14.9 39.1 19.1 16.3 14.3 25.2 26.1 29.0 21.6 18.0 8.5 2.3 1.3 4.6 2.4 1.2 3.6 1.5 3.0 2.3 1.3 1.4 2.0 2.4 4.1 2.8 2.0 1.2 2.5 2.3 8.3 7.8 7.2 8.7 8.2 9.9 8.4 8.0 7.8 7.6 7.9 8.9 8.9 11.8 3.2 5.0 8.5 8.9 37.5 18.0 7.8 62.0 7.2 23.9 14.7 5.6 5.7 4.5 3.7 0.0 11.4 8.1 4.3 9.8 6.2 7.9 11.5 17.6 10.2 7.8 12.0 3.0 3.7 12.2 15.1 4.6 14.3 5.1 9.6 8.2 9.5 4.3 18.5 3.9 4.2 2.0 4.1 19.1 7.4 10.5 5.0 16.0 1.9 4.5 10.6 1.0 3.0 5.0 5.8 2.2 7.9 8.0 17.5 3.6 4.6 5.4 6.0 26.3 12.1 15.1 14.7 33.2 41.1 40.2 21.2 9.5 8.4 2.8 12.0 ERRFI1 "GENE-33, MIG-6, RALT" ENSG00000116285 "ERBB receptor feedback inhibitor 1" Q9UJM3 1 8004404-8026309 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 750.1;pancreas: 684.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1242.3;Basal prostatic cells: 1428.1;Hepatocytes: 722.3;Suprabasal keratinocytes: 732.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 2.0" "Lineage enriched" "Detected in single" 5 "monocytes: 2.0" "Cell line enhanced" "Detected in many" "HHSteC: 558.4;LHCN-M2: 442.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076543 Supported Cytosol NA NA Cytosol "HPA076543: " "unprognostic (2.13e-3)" "unprognostic (1.01e-2)" "unprognostic (2.34e-1)" "unprognostic (1.71e-2)" "unprognostic (2.50e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.47e-1)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (1.19e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.34e-1)" "unprognostic (8.03e-3)" 144.0 42.1 15.4 31.3 17.7 1.8 128.7 32.0 25.7 76.5 38.5 54.5 33.6 78.9 18.5 51.7 76.5 132.2 37.6 18.2 51.9 158.7 750.1 83.5 17.8 33.9 18.9 14.9 149.8 684.6 88.8 112.9 126.6 19.0 53.6 23.6 36.6 76.8 26.2 227.7 123.6 47.6 89.1 30.1 9.6 126.0 16.7 19.8 18.6 114.3 30.5 12.6 87.8 76.2 22.0 86.1 49.7 20.8 28.2 192.6 143.0 215.7 81.9 23.8 15.0 17.5 22.2 218.9 1.4 47.9 27.6 102.5 18.2 5.8 144.7 68.2 2.6 16.1 1.3 15.1 260.1 558.4 0.9 3.3 195.8 142.7 49.4 118.7 208.4 38.3 3.6 6.1 0.7 442.5 36.8 0.3 5.5 50.0 66.3 121.7 7.4 233.8 1.4 69.3 27.0 14.3 8.5 16.2 36.5 26.0 145.6 25.4 2.0 54.4 57.7 33.9 49.0 116.6 1.3 1.1 1.5 222.0 3.8 54.4 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.1 0.3 0.4 0.0 0.0 2.0 0.1 0.2 0.0 15.4 17.7 32.0 25.7 18.2 51.9 33.9 18.9 14.9 19.0 30.1 19.8 22.0 93.0 221.2 108.7 22.5 9.2 1242.3 1428.1 228.6 249.8 9.8 186.3 115.9 52.1 177.3 198.7 27.6 14.6 87.6 25.7 161.9 31.3 99.1 24.0 209.6 74.4 29.8 109.5 21.5 18.4 111.2 51.0 130.1 56.6 336.3 14.5 3.9 32.5 722.3 10.0 3.3 16.5 70.2 59.0 11.7 95.0 63.9 51.9 17.9 71.2 8.4 0.6 40.0 3.1 13.0 30.9 144.9 127.2 38.4 6.6 382.2 78.1 131.1 86.3 9.9 6.6 113.9 93.3 21.1 21.8 152.6 732.9 259.0 33.5 4.9 82.7 543.4 PARK7 "DJ-1, DJ1, GATD2" ENSG00000116288 "Parkinsonism associated deglycase" Q99497 1 7954291-7985505 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response" "Chaperone, Hydrolase, Protease, RNA-binding" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004190, CAB005870" Supported Supported Nucleoplasm,Cytosol NA NA 35000000 "Nucleoplasm, Cytosol" "CAB005870: AB_444361, HPA004190: AB_1079566" "unprognostic (6.88e-3)" "unprognostic (7.50e-2)" "unprognostic (3.48e-2)" "unprognostic (1.16e-2)" "unprognostic (4.08e-2)" "unprognostic (5.68e-2)" "unprognostic (7.45e-2)" "unprognostic (9.63e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-3)" "unprognostic (8.17e-2)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" "unprognostic (7.43e-2)" 244.6 376.7 291.0 215.6 297.8 206.7 237.7 300.6 406.5 201.7 326.6 227.8 147.1 214.0 280.5 162.3 205.0 164.4 379.2 292.9 305.0 313.8 400.9 183.2 271.4 299.6 290.9 285.8 236.2 311.1 390.8 285.8 175.6 294.9 236.9 196.8 276.2 243.0 187.3 778.8 127.9 171.9 200.9 303.7 189.7 236.1 140.9 296.0 219.9 288.9 546.6 251.8 228.6 172.7 304.9 537.0 452.5 467.1 523.2 459.8 442.6 218.4 476.7 434.4 450.4 360.3 419.9 549.4 633.1 534.2 505.1 328.6 367.1 483.2 625.3 579.3 574.5 526.2 683.0 678.6 674.5 403.8 662.9 418.6 421.3 262.4 459.8 547.4 359.2 478.2 340.1 676.8 471.7 633.0 485.0 474.3 868.7 376.1 653.6 465.4 366.7 598.0 888.7 714.7 269.7 527.7 447.4 470.4 728.0 798.4 370.1 414.9 503.7 459.3 412.8 344.6 395.5 539.5 452.8 788.4 938.8 551.5 1002.9 606.4 298.4 590.2 394.0 484.7 553.7 459.2 483.6 478.2 577.3 717.4 374.6 406.8 466.8 202.5 551.1 456.9 1378.2 874.4 1060.8 291.0 297.8 300.6 406.5 292.9 305.0 299.6 290.9 285.8 294.9 303.7 296.0 304.9 243.6 131.4 157.1 23.2 211.8 208.9 402.4 677.7 200.9 196.2 342.0 381.8 453.3 257.4 318.5 248.3 79.2 553.0 382.3 131.1 851.0 504.3 32.1 272.1 263.9 241.7 238.0 177.1 19.5 478.4 612.1 302.3 146.3 195.9 206.5 291.2 183.1 368.1 435.1 186.7 22.9 279.6 484.2 204.5 304.5 53.6 358.2 258.9 359.3 21.5 605.4 816.4 327.5 18.1 36.0 378.9 186.9 378.7 269.7 523.4 227.1 941.5 327.8 235.5 276.1 277.8 342.6 288.2 302.2 220.4 143.8 469.6 244.4 535.3 312.2 433.1 ELAPOR1 "EIG121, KIAA1324, maba1" ENSG00000116299 "Endosome-lysosome associated apoptosis and autophagy regulator 1" Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 158.0;salivary gland: 167.6;stomach 1: 88.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;dendritic cells: 1.2;Hofbauer cells: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "neutrophil: 65.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 65.2" "Cell line enhanced" "Detected in some" "MCF7: 20.8;SCLC-21H: 16.8;SK-BR-3: 17.6;T-47d: 59.1;U-87 MG: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favorable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favorable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favorable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.8 3.2 2.4 4.2 4.0 0.5 57.2 0.0 3.4 70.7 0.0 28.6 45.9 12.9 9.8 1.6 24.1 5.6 0.2 4.2 9.4 0.1 0.2 5.1 2.5 1.1 0.4 2.8 0.1 158.0 9.2 33.1 0.2 0.8 49.0 28.1 0.4 167.6 0.3 0.0 3.4 35.5 1.1 0.0 0.8 88.9 18.5 6.3 0.8 9.1 0.1 1.9 0.4 0.1 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.5 0.2 0.1 0.2 0.0 0.0 0.5 0.6 0.7 1.3 0.1 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.1 1.0 0.0 0.0 0.5 20.8 0.2 0.3 0.5 0.0 0.1 0.1 0.3 1.1 0.1 0.0 16.8 0.4 0.1 17.6 0.0 0.1 59.1 0.0 0.4 0.0 2.1 0.2 0.2 1.3 3.6 0.0 12.4 0.0 0.1 0.0 0.1 0.0 4.6 0.0 7.6 0.4 7.5 3.2 0.0 0.1 3.3 1.5 65.2 0.5 0.0 0.0 9.8 2.2 2.4 4.0 0.0 3.4 4.2 9.4 1.1 0.4 2.8 0.8 0.0 6.3 2.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 OPRD1 ENSG00000116329 "Opioid receptor delta 1" P41143 1 28812142-28871267 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Excitatory neurons: 11.8;Inhibitory neurons: 15.7;Skeletal myocytes: 2.6" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "RH-30: 16.4;SCLC-21H: 6.4;SH-SY5Y: 6.5;WM-115: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070831 Approved NA NA "HPA070831: AB_2732167" "unprognostic (1.44e-1)" "unprognostic (4.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.89e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-3)" "unprognostic (6.28e-3)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (5.95e-3)" "unprognostic (4.28e-3)" "unprognostic (2.98e-1)" "unprognostic (1.52e-7)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-3)" 0.1 0.5 1.6 0.1 1.9 0.4 0.0 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 1.9 0.3 0.0 0.0 0.1 0.1 4.1 0.5 1.9 0.1 0.3 0.0 0.1 0.1 5.2 0.1 0.1 0.5 0.3 0.0 1.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.2 1.0 0.0 0.0 0.0 16.4 0.1 0.0 0.1 6.4 6.5 0.0 0.1 1.1 0.3 0.1 0.1 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.4 22.0 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.2 0.0 0.2 0.0 0.0 1.6 1.9 0.0 3.2 1.9 0.3 4.1 0.5 1.9 5.2 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 3.7 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 11.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 2.6 0.3 0.0 0.7 0.0 0.0 0.0 0.3 0.1 0.0 1.2 AMPD2 SPG63 ENSG00000116337 "Adenosine monophosphate deaminase 2" Q01433 1 109616104-109632051 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6" "Group enriched" "Detected in all" 5 "dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027137, HPA045760" Approved Enhanced Cytosol NA NA 230000 Cytosol "HPA027137: AB_2672129, HPA045760: AB_2679443" "unprognostic (2.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" "unprognostic (9.01e-2)" "unprognostic (5.25e-2)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.78e-10)" "unprognostic (9.16e-2)" "unprognostic (2.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" 7.6 17.6 29.5 12.1 38.5 28.9 7.5 22.5 35.0 13.1 33.1 6.8 10.8 11.6 4.1 7.2 13.2 8.9 6.0 34.4 33.5 9.5 16.3 13.5 7.6 33.3 31.1 29.4 17.6 10.1 9.5 46.1 7.6 33.4 10.9 4.2 10.6 9.3 12.1 3.3 8.5 10.9 7.1 25.5 19.1 8.6 4.4 34.2 5.0 10.7 1.5 6.0 7.6 11.5 33.5 20.6 22.5 20.5 20.1 18.0 18.7 8.6 25.6 57.2 24.9 25.0 19.1 7.0 10.5 21.8 39.1 16.0 11.3 15.8 20.0 13.4 13.0 20.7 46.0 15.6 19.3 24.9 15.7 45.7 23.3 13.2 32.5 24.1 28.2 26.7 17.0 17.4 13.0 16.0 23.2 26.7 29.0 20.6 17.1 22.9 18.6 15.8 17.3 24.2 8.7 19.3 22.4 17.4 19.8 24.6 5.7 10.4 16.2 16.7 27.7 39.0 33.7 25.4 48.4 28.4 12.1 50.8 25.9 35.1 0.5 19.4 19.2 5.3 40.7 8.0 5.3 5.2 4.9 18.9 2.7 6.4 5.1 61.1 4.3 44.6 2.6 4.0 12.3 29.5 38.5 22.5 35.0 34.4 33.5 33.3 31.1 29.4 33.4 25.5 34.2 33.5 3.6 3.2 5.5 13.7 9.4 8.9 5.4 5.0 9.1 41.0 8.8 11.4 3.2 12.8 5.4 0.0 62.6 4.9 10.0 4.2 7.9 9.8 3.5 4.4 9.4 7.1 17.5 5.0 13.3 11.2 8.6 12.6 14.3 5.5 3.8 11.0 6.1 20.5 10.8 52.2 17.6 9.6 2.0 42.1 42.0 1.3 13.1 52.5 5.4 6.5 16.1 10.5 6.2 12.1 10.6 10.3 3.0 21.4 11.1 11.1 6.1 4.5 4.2 7.2 13.1 8.8 10.6 4.2 3.8 7.9 8.1 2.6 15.4 8.5 10.7 4.0 SRSF4 "SFRS4, SRP75" ENSG00000116350 "Serine and arginine rich splicing factor 4" Q08170 1 29147743-29181900 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050975 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA050975: AB_2681296" "unprognostic (3.26e-3)" "unprognostic (8.08e-2)" "unprognostic (1.29e-2)" "unprognostic (1.57e-3)" "unprognostic (1.37e-1)" "unprognostic (5.89e-2)" "unprognostic (1.89e-3)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.36e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (4.26e-4)" "prognostic unfavorable (4.30e-4)" "unprognostic (6.25e-3)" "unprognostic (2.80e-1)" "unprognostic (7.75e-3)" "unprognostic (1.60e-2)" 81.9 61.6 46.3 47.2 46.9 78.2 78.9 48.9 48.6 82.2 46.3 82.0 50.0 80.4 38.9 74.1 72.3 36.7 62.4 44.8 46.0 63.4 96.5 84.3 57.9 47.1 45.4 42.7 88.9 62.2 39.0 56.5 58.1 47.3 72.7 35.9 52.2 63.0 40.0 94.9 74.6 73.7 40.9 45.2 82.5 67.3 44.9 47.2 63.8 74.3 52.2 43.8 78.4 77.2 47.5 108.2 63.5 117.0 42.8 83.9 63.0 72.5 87.6 65.5 103.3 88.0 58.6 64.9 122.2 79.9 74.5 66.9 99.0 99.7 81.4 104.5 148.6 118.9 185.7 95.6 92.9 87.2 127.8 114.0 51.1 101.1 87.7 111.8 83.9 86.6 70.2 154.8 95.7 71.1 54.1 162.2 110.4 125.2 64.4 60.0 150.6 126.9 83.3 71.1 110.0 71.3 81.4 107.4 61.5 105.8 103.4 41.0 76.3 84.2 82.9 66.1 91.0 146.4 88.0 70.6 134.5 79.4 161.0 91.9 72.7 45.7 102.2 64.6 55.1 63.3 49.0 59.7 70.5 55.8 53.1 51.0 55.0 89.6 48.4 62.3 43.2 78.9 51.1 46.3 46.9 48.9 48.6 44.8 46.0 47.1 45.4 42.7 47.3 45.2 47.2 47.5 142.3 80.1 129.8 23.8 94.2 99.8 179.6 65.0 91.0 70.2 50.2 42.9 51.1 45.8 92.8 51.5 85.5 132.7 100.0 68.4 54.8 64.9 8.2 85.4 98.4 131.0 39.0 114.3 20.1 47.2 124.6 87.8 76.5 99.4 91.7 76.2 101.0 75.9 68.8 57.2 21.1 72.7 59.0 69.8 79.0 11.6 85.7 83.4 55.2 14.0 88.6 74.8 92.7 19.6 19.6 56.3 78.8 89.1 121.4 172.3 83.1 58.3 91.7 108.3 72.3 99.5 97.4 64.7 51.9 95.9 103.3 142.8 105.1 75.9 78.7 210.4 MECR "CGI-63, ETR1, FASN2B, NRBF1" ENSG00000116353 "Mitochondrial trans-2-enoyl-CoA reductase" Q9BV79 1 29192657-29230942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 42.5" "Cell type enhanced" "Detected in all" "Late spermatids: 82.5;Rod photoreceptor cells: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022018, HPA022030, HPA028740" Enhanced Supported Mitochondria NA NA Mitochondria "HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133" "unprognostic (2.53e-1)" "unprognostic (1.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.06e-2)" "unprognostic (8.66e-2)" "prognostic favorable (5.81e-6)" "unprognostic (7.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.29e-4)" 14.6 14.7 5.0 1.7 5.2 1.8 13.5 3.3 5.8 10.1 3.0 10.0 1.4 13.0 2.5 12.6 9.5 1.3 21.6 6.2 4.1 14.1 15.9 7.4 2.0 5.4 4.2 6.1 10.1 9.0 4.5 7.3 3.5 5.5 7.9 2.7 10.0 12.4 3.0 42.5 15.3 7.3 3.1 3.2 6.8 11.2 7.6 4.3 1.4 8.4 5.9 2.1 9.7 9.7 5.5 3.9 4.5 3.2 4.6 2.9 2.5 6.8 3.7 3.8 4.7 3.9 2.3 5.6 7.3 5.1 3.7 1.3 3.0 5.4 6.3 4.0 4.4 6.9 6.4 3.4 4.1 6.6 6.1 1.9 4.3 5.9 3.1 11.0 3.8 3.5 6.9 5.8 4.2 4.7 4.5 3.9 2.9 6.5 5.8 4.3 3.5 4.2 9.3 5.9 2.4 5.1 4.5 4.1 4.7 7.0 4.4 2.3 5.4 3.8 2.4 2.9 4.1 4.7 2.7 2.2 5.0 3.9 8.4 5.2 0.1 2.2 0.0 1.5 2.1 4.1 2.2 1.6 1.7 1.9 1.1 2.3 1.6 0.3 2.9 1.6 2.5 2.4 1.2 5.0 5.2 3.3 5.8 6.2 4.1 5.4 4.2 6.1 5.5 3.2 4.3 5.5 8.8 12.8 3.9 14.7 9.1 5.6 15.6 26.9 7.4 12.8 12.0 14.6 19.8 21.5 21.4 20.2 10.4 46.0 3.8 7.4 41.1 24.3 40.8 19.7 13.6 9.1 7.8 10.1 25.1 19.7 42.4 12.8 4.6 12.8 5.7 17.5 7.1 19.7 20.8 8.4 20.3 9.4 12.2 6.0 5.1 82.5 13.7 5.3 16.0 3.7 10.8 14.5 10.3 11.6 15.2 16.3 8.0 10.9 10.3 20.6 10.9 46.0 11.3 68.5 13.1 13.2 12.9 8.5 16.1 14.0 7.4 27.9 6.0 25.8 18.3 20.5 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110210314-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Hepatic stellate cells: 50.3;Rod photoreceptor cells: 41.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 38.5;U-87 MG: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 3.2 4.0 26.6 2.2 11.1 1.1 3.7 3.0 14.4 3.6 0.0 2.1 1.2 2.7 1.2 2.4 3.6 4.3 4.0 22.6 9.3 7.8 0.8 2.8 2.2 19.3 12.9 10.3 3.6 5.7 6.8 6.1 2.9 23.4 3.4 1.2 7.5 7.2 3.2 4.9 3.7 2.3 1.6 4.5 4.2 3.5 2.5 10.9 1.9 2.8 5.8 1.7 3.0 3.4 20.5 4.1 2.7 0.4 3.3 1.2 0.3 6.3 13.5 1.4 0.9 0.8 7.2 1.4 5.8 6.1 4.0 3.4 5.5 1.7 1.0 0.5 38.5 4.1 0.5 5.4 0.8 0.4 3.6 1.5 0.2 0.3 2.2 0.2 0.7 5.5 2.8 1.2 1.9 0.1 0.6 3.6 1.1 2.7 1.1 6.8 4.5 0.1 1.0 4.2 0.1 1.0 1.0 0.6 11.9 1.3 3.0 1.5 2.1 2.5 1.5 7.0 1.1 0.5 5.0 3.2 1.0 19.5 3.5 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.6 11.1 3.0 14.4 22.6 9.3 19.3 12.9 10.3 23.4 4.5 10.9 20.5 11.0 0.0 1.1 8.5 2.6 3.2 15.7 2.5 12.0 4.7 10.6 9.3 8.9 8.6 2.0 3.7 41.7 0.4 1.7 10.0 0.0 6.8 0.5 7.9 2.8 14.0 13.2 0.8 13.4 17.0 0.4 4.3 5.1 19.8 1.3 3.4 50.3 0.4 1.3 3.3 10.0 4.8 0.0 2.2 1.1 0.9 1.5 1.5 1.8 7.5 1.4 3.8 0.0 6.0 1.7 11.8 7.1 4.1 1.2 11.0 2.3 0.6 2.5 41.1 26.3 4.2 8.4 0.7 7.4 4.1 3.0 1.1 2.6 0.4 8.3 9.7 EDEM3 C1orf22 ENSG00000116406 "ER degradation enhancing alpha-mannosidase like protein 3" Q9BZQ6 1 184690237-184754907 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025754, HPA025755, HPA027297" Approved Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205" "unprognostic (1.74e-1)" "unprognostic (1.64e-2)" "unprognostic (3.08e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-1)" "unprognostic (3.10e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-1)" "unprognostic (7.06e-2)" "unprognostic (1.66e-1)" "unprognostic (1.66e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.63e-6)" "unprognostic (4.72e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-2)" "unprognostic (2.01e-1)" 14.4 12.5 4.2 13.9 4.7 8.3 11.0 6.8 5.9 13.8 5.3 20.8 18.9 8.9 8.1 9.3 6.6 11.8 7.3 4.1 6.0 10.7 20.5 11.3 10.3 4.9 5.2 3.3 5.7 15.9 13.1 7.1 21.0 5.3 13.6 24.2 11.5 13.3 8.8 12.3 6.7 16.4 12.1 5.0 10.5 36.1 7.5 5.6 10.9 11.9 11.6 10.8 13.8 5.9 6.0 15.1 11.2 15.0 13.4 53.8 55.0 24.5 29.9 20.7 11.1 11.6 5.9 42.4 10.5 31.8 22.8 11.3 20.1 14.6 15.6 16.4 10.3 11.9 13.8 11.7 8.5 20.7 36.4 19.5 31.6 18.8 27.1 24.2 21.0 30.4 27.4 36.8 47.4 21.6 12.5 29.3 18.8 21.2 34.1 10.2 12.7 11.6 36.2 16.1 10.4 16.9 23.9 14.7 25.2 20.8 24.9 23.7 56.3 36.1 16.1 7.2 34.3 25.5 72.1 29.8 13.6 21.3 40.7 35.6 5.0 3.5 2.2 1.4 3.5 2.5 1.3 2.2 1.7 3.1 0.9 3.0 1.6 3.6 2.2 3.6 1.6 1.5 1.8 4.2 4.7 6.8 5.9 4.1 6.0 4.9 5.2 3.3 5.3 5.0 5.6 6.0 35.1 19.2 19.3 41.4 19.9 16.7 8.4 9.8 19.9 26.1 20.4 11.4 16.0 12.8 21.8 14.7 25.0 13.8 13.2 55.1 0.0 14.0 16.0 14.3 21.2 25.9 30.6 32.4 58.2 35.6 10.9 28.0 96.8 17.0 21.0 12.9 19.2 47.0 13.0 21.9 62.8 76.5 2.0 40.1 30.3 7.1 20.5 33.0 19.6 36.5 31.0 7.8 11.3 47.3 61.6 20.0 28.1 18.0 73.6 27.1 21.4 9.7 28.1 15.2 19.7 20.3 18.7 15.0 8.7 18.2 20.5 19.4 24.9 53.8 32.4 19.1 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 105.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 18000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 16.7 23.6 13.5 18.4 13.5 10.4 14.2 13.4 13.6 13.8 12.6 17.1 15.1 20.3 17.9 27.5 105.8 12.5 26.5 14.9 14.3 17.2 22.9 13.9 28.6 14.4 15.3 13.4 12.7 17.6 18.4 14.3 18.7 14.0 17.6 24.4 11.5 19.5 14.9 42.6 13.7 16.5 19.3 13.4 22.7 21.4 14.3 15.0 20.7 13.7 33.2 36.5 24.8 16.8 14.2 70.0 58.6 56.0 46.2 32.5 19.6 76.6 51.8 27.6 76.4 50.1 86.0 25.5 118.8 48.6 44.0 49.1 49.4 101.2 96.9 91.1 46.9 80.0 70.9 67.4 125.2 36.9 71.7 114.6 23.8 68.6 75.4 47.6 20.5 51.7 51.9 96.3 30.1 74.5 86.0 94.0 38.8 109.7 64.5 99.4 92.2 88.2 44.9 68.9 118.7 45.6 33.4 45.5 54.7 42.3 70.6 45.1 50.5 38.7 42.3 86.4 82.6 111.1 25.4 34.1 106.3 54.6 81.1 126.5 17.6 24.6 6.6 27.5 38.2 31.2 53.6 30.0 31.5 54.5 42.3 31.2 29.4 3.6 58.5 35.6 34.1 27.8 27.1 13.5 13.5 13.4 13.6 14.9 14.3 14.4 15.3 13.4 14.0 13.4 15.0 14.2 11.1 12.8 11.4 8.1 29.6 20.8 27.9 34.8 10.8 11.5 13.2 11.7 22.2 10.0 17.7 18.4 25.0 56.1 19.4 7.0 25.4 30.6 4.8 42.1 18.2 15.3 15.7 18.1 6.0 13.6 57.0 12.9 26.5 40.9 15.8 21.2 8.2 15.6 47.4 8.4 7.2 14.4 20.3 20.3 8.0 4.1 7.5 18.9 5.4 7.5 16.0 9.7 13.4 7.1 5.8 22.1 7.8 9.1 20.1 28.2 8.8 29.3 34.2 9.2 13.1 10.6 18.3 22.3 24.8 26.1 18.5 45.6 15.3 36.0 22.5 23.5 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 137.0;tongue: 132.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 346.5;Distal tubular cells: 461.8;Extravillous trophoblasts: 405.2;Hofbauer cells: 373.0;Proximal tubular cells: 434.6;Syncytiotrophoblasts: 347.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 170000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 19.5 15.9 9.4 11.6 12.2 15.5 19.0 14.5 27.6 17.6 3.9 52.1 29.1 16.7 16.1 27.0 24.1 16.5 110.0 12.3 9.9 40.7 40.6 13.8 24.2 13.1 12.1 8.4 19.3 18.6 34.1 7.1 21.7 13.7 22.5 33.9 28.8 30.1 18.9 137.0 15.8 19.2 18.0 8.4 15.4 22.8 15.7 12.3 15.9 31.4 132.1 22.6 22.1 7.5 13.9 55.6 17.6 44.1 36.9 35.6 34.2 34.1 57.0 68.9 67.3 54.7 31.8 29.1 84.9 52.3 45.5 14.3 56.1 69.4 79.5 65.1 61.9 33.2 76.1 21.3 21.5 26.0 98.3 70.8 30.3 40.9 69.3 66.9 17.7 60.0 11.9 78.7 33.6 46.3 35.4 153.3 30.0 34.9 19.2 90.5 41.2 143.6 34.0 54.7 26.0 37.2 13.4 49.4 72.7 55.6 12.6 54.8 46.0 50.6 32.0 49.1 59.4 61.2 41.8 44.5 172.1 70.8 77.6 60.8 3.5 15.4 7.1 14.8 10.0 12.2 12.9 15.1 13.3 16.1 15.2 16.9 10.4 4.8 9.8 9.0 9.2 15.1 44.2 9.4 12.2 14.5 27.6 12.3 9.9 13.1 12.1 8.4 13.7 8.4 12.3 13.9 73.2 67.3 83.8 0.0 31.5 0.0 0.0 0.0 0.0 0.0 112.9 155.3 0.0 0.0 57.6 125.0 0.0 346.5 56.4 0.0 461.8 237.3 0.0 132.5 111.0 58.8 0.0 0.0 0.0 196.7 405.2 57.0 0.0 125.4 89.6 82.1 0.0 0.0 373.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.8 0.0 0.0 98.8 0.0 0.0 0.0 0.0 162.6 0.0 0.0 9.8 0.0 0.0 434.6 74.3 0.0 0.0 0.0 58.0 0.0 0.0 0.0 0.0 347.7 41.8 208.0 0.0 0.0 RAP1A "KREV-1, SMGP21" ENSG00000116473 "RAP1A, member of RAS oncogene family" P62834 1 111542218-111716691 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" Neurogenesis Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 494.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.37e-3)" "unprognostic (7.49e-2)" "unprognostic (1.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.88e-2)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" "unprognostic (6.10e-2)" "unprognostic (4.98e-3)" "unprognostic (1.54e-2)" "unprognostic (1.84e-1)" "unprognostic (3.44e-2)" "unprognostic (1.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.76e-1)" "unprognostic (3.08e-1)" 92.4 60.4 54.1 102.8 62.8 82.1 58.1 63.7 71.7 52.6 53.6 125.1 68.4 54.3 82.9 108.5 52.0 63.9 94.8 51.8 60.9 71.4 98.9 78.0 114.9 66.7 62.6 48.2 41.6 36.3 124.4 33.2 66.0 66.5 68.5 95.3 27.1 66.9 97.3 90.1 39.0 75.7 90.3 68.1 90.3 79.6 18.0 60.0 77.4 65.8 87.3 124.6 101.8 45.8 77.0 162.8 25.1 61.1 36.1 121.7 116.7 56.5 105.7 112.2 75.0 84.4 83.3 65.9 132.0 72.5 133.1 48.2 57.6 56.5 79.4 138.9 494.7 58.7 96.0 61.4 51.9 124.0 101.4 95.7 76.0 90.9 83.5 86.8 69.7 100.3 73.9 73.8 142.3 104.6 74.4 52.7 128.0 36.2 72.1 66.5 56.9 129.4 65.9 120.2 80.9 43.3 30.8 129.9 75.6 99.3 61.9 38.3 127.9 94.5 60.2 77.2 76.2 104.4 151.2 54.7 145.4 83.9 152.7 161.1 15.6 22.1 21.1 17.0 23.6 20.0 16.4 29.0 25.9 26.2 10.6 21.5 20.9 48.4 22.1 21.6 13.0 29.0 19.0 54.1 62.8 63.7 71.7 51.8 60.9 66.7 62.6 48.2 66.5 68.1 60.0 77.0 107.5 67.3 83.1 36.2 104.8 123.9 103.5 65.2 31.9 17.4 49.3 33.1 122.6 41.5 60.0 46.0 4.2 70.5 117.8 134.2 158.5 73.4 28.1 27.6 39.9 118.4 40.8 149.7 73.1 69.8 76.1 78.4 56.6 38.8 85.6 24.8 97.1 60.3 209.2 50.5 78.1 130.8 46.8 245.4 265.5 14.4 63.3 193.6 101.4 182.7 179.7 71.4 148.3 62.4 203.4 74.9 88.3 78.2 119.2 125.1 104.7 133.8 40.4 11.7 118.3 80.5 141.5 26.0 10.9 42.1 101.7 82.1 168.3 89.6 84.0 152.7 HDAC1 "GON-10, HD1, KDAC1, RPD3L1" ENSG00000116478 "Histone deacetylase 1" Q13547 1 32292083-32333635 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005017, HPA029693, CAB068191" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659" "unprognostic (2.51e-2)" "unprognostic (9.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.57e-2)" "unprognostic (5.02e-2)" "unprognostic (3.47e-2)" "unprognostic (7.06e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (6.86e-2)" "unprognostic (3.78e-1)" "unprognostic (7.16e-2)" "unprognostic (1.72e-1)" 28.9 43.1 21.1 77.4 22.5 59.8 56.5 22.9 28.2 57.1 21.5 120.6 75.1 48.5 51.9 82.0 57.3 55.9 29.3 21.2 26.2 44.9 42.0 41.6 120.6 24.0 22.3 19.4 66.3 40.3 62.8 31.8 53.4 23.5 58.1 109.3 19.1 52.6 57.7 15.4 38.3 81.5 47.2 23.0 62.2 84.8 36.5 22.7 104.9 79.1 17.7 124.9 64.3 52.1 24.1 152.5 90.6 57.4 114.7 32.9 39.0 118.7 105.1 117.1 138.0 126.6 168.0 266.3 233.4 190.3 116.9 140.2 173.1 178.1 143.1 151.5 219.3 176.8 161.3 105.7 130.1 77.4 288.1 223.4 70.7 77.0 107.1 70.3 107.7 106.1 298.5 215.2 90.1 61.6 115.7 331.6 161.4 133.2 180.2 229.6 225.0 136.0 104.0 149.5 216.1 44.7 56.6 176.0 117.0 227.9 224.0 137.9 220.6 123.8 91.3 106.2 28.5 261.1 54.4 124.9 319.2 75.3 235.8 121.4 147.5 87.7 200.1 130.0 115.9 107.5 151.6 126.2 140.6 103.0 142.0 143.7 133.6 63.7 144.2 156.4 64.9 142.0 204.6 21.1 22.5 22.9 28.2 21.2 26.2 24.0 22.3 19.4 23.5 23.0 22.7 24.1 45.3 25.6 45.4 25.5 82.7 24.9 57.4 99.1 38.7 15.1 35.1 29.1 22.1 61.5 73.4 68.0 16.7 93.1 64.0 142.4 95.9 75.7 20.2 33.7 39.8 56.2 86.3 60.8 1.9 73.6 110.9 25.8 65.2 39.5 30.4 23.6 63.5 28.1 43.6 11.8 8.8 122.8 52.9 38.2 19.0 8.7 41.0 35.0 28.4 16.9 52.7 34.2 69.0 14.6 19.4 92.5 141.5 44.4 38.4 28.5 57.0 30.0 67.3 14.6 59.2 22.8 38.1 72.5 69.8 60.2 25.4 93.4 73.6 102.6 136.0 55.8 CAPZA1 ENSG00000116489 "Capping actin protein of muscle Z-line subunit alpha 1" P52907 1 112619805-112671616 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB045963 Approved NA NA 16000000 "CAB045963: AB_11126023" "unprognostic (7.06e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-3)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (1.17e-3)" "unprognostic (3.15e-2)" "unprognostic (3.82e-3)" "unprognostic (4.59e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (2.42e-1)" "unprognostic (2.82e-1)" 74.4 49.6 45.7 116.3 47.5 157.9 56.3 49.6 52.2 48.7 50.6 86.9 68.5 43.5 62.0 97.1 43.3 59.6 28.1 43.8 58.2 41.5 73.8 66.0 155.3 55.2 51.5 43.4 30.9 35.8 39.9 21.6 86.1 54.9 42.8 95.9 37.5 38.8 37.8 25.6 93.2 71.4 64.5 54.5 106.1 71.6 71.8 52.2 119.3 48.5 22.3 189.2 98.2 53.2 58.5 308.0 88.9 148.4 120.7 180.6 207.9 186.5 237.7 245.3 236.7 210.9 120.7 126.9 319.6 174.8 277.6 108.0 142.6 199.9 251.3 293.4 245.5 100.2 279.0 141.8 148.7 212.8 507.3 376.5 224.6 186.5 230.7 219.2 140.5 268.1 143.2 287.3 191.6 335.6 177.2 262.8 222.6 146.3 179.7 180.3 192.5 292.0 158.8 207.9 221.3 102.2 109.6 274.3 246.9 192.6 118.2 127.8 441.6 305.8 192.8 191.6 317.7 292.2 135.0 134.2 359.8 331.4 381.5 450.4 396.9 254.5 319.7 172.1 385.9 194.5 198.3 188.8 209.1 207.9 145.0 105.4 171.0 524.7 145.9 434.0 164.6 252.5 369.9 45.7 47.5 49.6 52.2 43.8 58.2 55.2 51.5 43.4 54.9 54.5 52.2 58.5 59.5 28.9 49.0 59.4 186.0 180.9 73.7 87.4 63.2 31.2 73.3 35.3 22.0 54.3 69.0 101.2 25.0 138.8 194.9 152.4 92.0 94.9 380.4 62.1 95.4 78.0 61.1 104.5 48.3 111.9 206.8 72.1 59.1 86.0 92.0 48.8 83.2 74.5 233.1 43.7 47.8 101.5 52.9 320.0 361.0 210.2 57.2 211.9 122.7 54.4 236.5 33.5 125.7 55.8 73.7 168.9 135.7 55.3 137.2 105.7 89.0 88.8 71.4 31.2 65.7 42.8 79.6 166.3 67.7 110.2 237.8 184.0 196.7 73.9 110.3 147.0 S100PBP "FLJ12903, S100PBPR" ENSG00000116497 "S100P binding protein" Q96BU1 1 32816767-32858875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.8;Spermatocytes: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027242, HPA027328" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA027242: AB_2672174, HPA027328: AB_2672221" "unprognostic (4.29e-2)" "unprognostic (8.54e-2)" "unprognostic (3.54e-1)" "unprognostic (2.52e-3)" "unprognostic (2.44e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.61e-1)" "unprognostic (2.52e-3)" "unprognostic (3.71e-1)" "unprognostic (6.79e-2)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.03e-4)" "unprognostic (2.87e-1)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.48e-1)" 9.6 11.0 14.4 10.1 19.4 14.4 9.7 14.1 14.1 13.9 14.3 10.1 6.1 12.3 10.2 7.2 12.6 10.0 7.1 11.4 15.9 7.9 8.8 9.3 15.8 15.0 14.3 11.4 17.0 7.0 6.5 11.2 11.0 14.5 10.1 7.7 14.2 9.0 8.6 7.1 8.4 11.3 11.0 13.2 15.7 8.3 34.8 15.4 18.9 11.7 8.2 15.0 10.1 10.2 18.5 11.7 15.0 32.2 17.8 15.0 21.0 16.6 22.3 15.7 20.5 22.7 9.5 18.6 36.5 17.2 14.8 19.7 18.3 31.7 13.1 25.2 18.6 10.6 45.7 31.1 12.1 17.6 21.1 18.0 15.2 12.3 19.5 23.9 27.9 21.8 30.8 27.5 27.2 25.0 6.8 32.6 19.0 38.2 7.9 11.7 29.7 34.5 31.3 9.3 7.6 15.0 14.6 22.9 6.6 24.9 49.2 13.8 13.0 11.4 28.3 18.9 24.3 14.7 40.2 39.2 36.5 13.8 22.2 15.9 7.5 3.6 6.5 6.6 2.0 7.9 8.7 5.2 7.1 3.8 5.4 3.6 5.2 4.6 18.7 1.7 11.3 5.5 3.8 14.4 19.4 14.1 14.1 11.4 15.9 15.0 14.3 11.4 14.5 13.2 15.4 18.5 18.3 12.8 21.0 32.3 20.0 10.5 10.4 12.5 26.2 21.2 18.0 16.1 6.0 18.6 13.6 20.2 35.5 14.8 32.6 7.7 13.7 11.0 7.8 13.0 20.6 15.4 8.4 23.1 17.9 5.0 17.0 15.5 12.8 13.1 14.5 29.1 21.4 11.5 15.2 18.5 23.9 7.8 8.2 19.3 9.6 6.9 19.0 14.5 5.4 48.7 10.6 13.1 33.0 51.8 78.8 6.6 4.4 17.7 29.2 9.7 12.6 5.9 9.8 25.0 26.3 12.5 16.6 109.9 74.4 17.6 7.1 6.2 22.0 12.3 9.9 6.5 RNF19B "FLJ90005, IBRDC3" ENSG00000116514 "Ring finger protein 19B" Q6ZMZ0 1 32936445-32964809 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 79.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.9" "Lineage enriched" "Detected in all" 8 "granulocytes: 16.9" "Cell line enhanced" "Detected in all" "Daudi: 107.6;Karpas-707: 124.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049587, HPA063640" Approved Approved Cytosol NA NA Cytosol "HPA049587: AB_2680826, HPA063640: " "unprognostic (2.83e-2)" "unprognostic (1.77e-2)" "unprognostic (1.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "prognostic favorable (3.39e-4)" "prognostic unfavorable (5.41e-6)" "unprognostic (8.78e-2)" "unprognostic (5.02e-1)" "unprognostic (1.69e-1)" "unprognostic (9.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.39e-5)" "unprognostic (2.58e-2)" "unprognostic (4.93e-2)" "unprognostic (3.30e-1)" "unprognostic (1.23e-2)" 13.9 19.3 10.9 24.5 9.4 74.8 11.0 14.4 10.4 13.1 8.1 23.5 25.3 15.1 5.0 35.5 12.4 17.5 9.5 9.6 11.5 21.3 11.4 21.3 17.8 10.5 9.5 8.8 9.7 9.3 11.6 7.9 15.0 11.7 11.1 26.1 19.1 15.5 9.0 16.3 21.6 21.9 18.2 11.3 15.2 13.2 79.7 11.4 13.2 9.1 11.2 30.8 30.4 21.1 11.9 18.7 14.3 11.9 11.3 7.1 9.6 79.5 8.5 10.0 14.7 15.6 16.8 54.9 107.6 14.2 10.7 18.2 26.5 14.3 19.8 13.3 39.6 9.5 9.2 10.5 16.9 22.5 14.7 19.0 7.9 36.3 32.5 39.3 17.2 31.9 10.3 11.7 124.8 14.5 6.1 9.6 18.4 19.2 21.1 15.8 12.7 17.3 11.3 11.5 26.4 18.9 9.6 27.0 9.1 63.1 29.1 8.0 20.8 35.1 8.1 11.5 21.1 15.1 29.6 16.1 38.0 11.9 14.7 12.5 6.1 2.0 4.0 1.6 1.9 1.3 1.2 1.4 0.7 1.4 1.5 0.4 0.6 16.9 1.0 1.7 0.6 1.7 0.8 10.9 9.4 14.4 10.4 9.6 11.5 10.5 9.5 8.8 11.7 11.3 11.4 11.9 20.6 12.8 4.4 5.5 8.7 46.1 27.0 26.7 24.5 4.6 15.8 11.7 16.2 10.0 9.9 7.3 2.1 12.6 14.6 48.0 1.9 12.9 34.8 25.4 7.3 15.3 11.3 5.2 9.7 11.5 6.3 8.4 13.3 36.9 4.5 3.2 7.1 4.8 13.5 3.3 9.8 22.1 6.1 20.9 37.7 26.3 2.1 42.4 5.4 19.7 39.5 2.8 2.1 7.5 6.6 25.7 31.9 3.8 4.6 34.2 38.6 9.2 14.4 7.7 0.0 5.9 9.6 34.7 16.3 23.9 32.5 7.4 10.3 2.3 16.3 41.7 SCAMP3 C1orf3 ENSG00000116521 "Secretory carrier membrane protein 3" O14828 1 155255979-155262430 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071167 Supported Vesicles NA NA 75000 Vesicles "HPA071167: AB_2686352" "unprognostic (4.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (2.17e-2)" "unprognostic (5.33e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (8.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.65e-1)" "unprognostic (3.74e-2)" "unprognostic (8.46e-3)" "unprognostic (1.60e-1)" "unprognostic (4.79e-1)" "unprognostic (1.07e-1)" "unprognostic (7.18e-2)" 45.1 70.2 3.9 7.2 5.5 8.0 43.9 5.1 8.2 37.0 2.9 35.7 7.8 35.5 0.2 50.3 32.1 5.1 59.5 3.5 7.0 46.6 48.8 41.2 12.2 5.4 4.3 2.0 35.2 52.3 4.7 34.1 7.4 6.0 37.3 2.4 1.1 49.7 6.2 91.6 56.1 38.7 3.5 5.3 46.9 47.4 28.5 4.2 8.4 38.9 3.2 7.3 39.8 38.9 6.9 19.7 30.2 11.2 8.8 8.3 6.8 14.5 21.6 20.7 26.3 19.4 30.0 15.7 45.1 49.3 10.9 15.7 20.5 9.0 18.7 1.8 29.8 68.3 25.7 11.7 8.5 26.1 30.5 17.4 9.7 20.9 21.2 10.3 3.3 18.9 49.3 38.2 18.3 11.6 38.3 50.5 14.6 16.5 27.9 59.4 43.1 9.1 67.5 4.8 13.1 8.3 20.0 26.2 8.0 39.1 3.4 32.1 13.7 29.0 20.9 17.5 29.3 29.6 43.3 84.8 52.9 16.7 41.1 15.2 41.0 47.5 52.8 94.4 51.7 86.8 98.8 91.3 91.1 58.1 100.3 83.3 86.6 6.7 76.0 71.4 102.4 101.0 100.9 3.9 5.5 5.1 8.2 3.5 7.0 5.4 4.3 2.0 6.0 5.3 4.2 6.9 23.0 16.0 37.1 12.4 33.8 38.2 23.8 57.3 54.1 18.5 27.3 19.3 39.1 30.0 43.7 33.1 4.2 86.4 27.2 19.0 9.8 49.0 1.7 16.3 20.8 33.1 30.1 14.5 9.9 69.4 55.1 27.1 27.0 26.3 25.3 16.6 32.9 37.9 57.3 18.5 11.9 24.3 42.7 21.3 26.7 5.3 17.1 23.0 24.9 7.5 41.3 20.2 30.9 9.5 17.4 48.5 19.9 18.8 56.1 24.7 36.8 24.4 22.6 10.9 13.1 16.7 27.3 20.0 5.5 46.7 40.1 71.3 33.4 20.5 30.1 22.5 TRIM62 "DEAR1, FLJ10759" ENSG00000116525 "Tripartite motif containing 62" Q9BVG3 1 33145399-33182059 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.4" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "AF22: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050061 Approved "Vesicles,Focal adhesion sites" NA NA "Vesicles, Focal adhesion sites" "HPA050061: AB_2681001" "unprognostic (1.57e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (2.62e-2)" "unprognostic (1.14e-2)" "unprognostic (5.80e-2)" "unprognostic (5.10e-5)" "unprognostic (2.05e-2)" "unprognostic (1.14e-1)" "unprognostic (4.32e-2)" "unprognostic (3.55e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (2.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" 2.9 6.6 9.5 2.9 12.8 4.8 3.7 10.2 10.0 3.2 2.9 3.2 2.4 3.1 2.6 5.1 3.0 2.0 3.0 8.0 9.6 3.5 1.8 3.1 4.7 11.6 11.5 6.1 3.7 3.1 2.9 6.5 3.4 14.8 5.2 2.1 2.1 5.2 2.9 4.9 12.5 4.3 2.8 7.7 5.2 4.4 2.3 12.5 5.3 3.9 2.6 4.5 4.9 4.4 21.4 3.7 2.7 23.9 3.9 5.7 2.5 7.6 3.4 9.9 6.3 5.5 3.0 3.7 5.9 3.8 3.0 3.2 7.2 5.0 4.3 5.6 5.8 3.8 6.5 3.2 2.5 5.7 2.2 16.2 5.2 3.9 8.7 2.0 9.9 6.3 5.0 1.1 3.8 6.1 9.9 6.8 2.0 6.0 4.3 3.5 8.6 12.8 2.7 3.8 9.6 6.0 3.7 3.8 14.5 16.8 12.6 4.1 1.4 6.3 2.7 3.8 8.1 2.8 6.9 3.3 2.7 5.1 3.9 3.5 1.2 1.0 3.4 1.3 1.8 2.3 1.1 1.9 1.8 0.9 1.4 1.3 1.2 2.3 1.0 1.1 0.4 4.7 1.1 9.5 12.8 10.2 10.0 8.0 9.6 11.6 11.5 6.1 14.8 7.7 12.5 21.4 2.0 3.2 2.2 2.6 1.8 2.7 0.8 1.7 2.8 3.4 3.5 1.9 0.9 0.0 1.2 1.8 0.0 1.1 2.5 1.5 0.0 1.4 0.5 0.6 1.1 1.4 1.8 0.4 1.9 1.9 1.8 2.1 4.1 1.3 1.3 1.7 1.1 0.7 1.2 10.1 10.2 1.5 4.1 1.2 1.6 0.5 2.5 1.3 0.0 10.3 1.4 1.5 3.1 50.8 26.0 2.6 0.6 4.9 2.6 2.1 1.2 1.0 0.4 1.0 6.6 2.0 2.1 1.3 0.6 2.8 4.7 1.4 3.0 3.4 0.9 2.0 ASH1L "ASH1, ASH1L1, huASH1, KMT2H" ENSG00000116539 "ASH1 like histone lysine methyltransferase" Q9NR48 1 155335268-155563162 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004806 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA004806: AB_1845087" "unprognostic (2.98e-1)" "unprognostic (3.15e-2)" "unprognostic (1.10e-1)" "unprognostic (1.70e-2)" "unprognostic (2.05e-2)" "unprognostic (4.75e-2)" "unprognostic (1.42e-1)" "unprognostic (1.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (6.84e-2)" "prognostic favorable (3.80e-4)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (2.45e-2)" "unprognostic (1.94e-1)" 14.2 12.9 22.4 8.6 24.8 12.0 17.0 27.6 25.9 14.5 16.8 11.6 9.8 14.6 21.0 9.3 11.5 9.1 12.7 25.0 21.3 14.0 10.1 10.4 11.0 20.9 21.1 22.3 21.5 10.0 18.4 8.4 10.4 21.1 15.8 11.6 26.4 15.0 15.5 30.6 20.6 10.3 12.8 20.9 10.6 12.0 6.9 20.9 12.3 15.9 24.5 9.8 11.8 10.1 24.7 17.2 12.3 9.5 9.4 28.0 22.8 9.6 14.7 13.5 8.3 6.5 10.5 12.3 5.4 14.2 17.0 5.4 19.2 13.6 12.6 13.6 7.6 8.9 8.0 13.2 9.8 14.5 8.8 6.6 16.2 18.0 13.6 15.0 17.1 11.0 6.0 12.3 8.3 18.8 19.0 6.4 8.8 8.3 28.8 13.1 6.1 18.5 10.4 18.6 16.0 9.1 14.3 20.1 25.9 12.9 9.3 16.6 26.6 17.4 13.6 15.8 13.4 17.9 8.0 5.3 8.9 10.7 9.1 13.1 1.0 0.4 0.8 0.7 0.2 0.5 0.9 0.5 0.5 0.2 0.8 0.8 0.5 1.0 0.6 0.1 0.7 0.9 0.2 22.4 24.8 27.6 25.9 25.0 21.3 20.9 21.1 22.3 21.1 20.9 20.9 24.7 96.5 60.9 103.2 171.7 108.3 103.9 97.4 52.9 109.3 147.6 75.9 58.3 107.8 50.1 82.7 51.5 202.3 53.6 83.3 76.2 17.6 41.5 25.9 72.0 107.4 77.6 67.5 46.7 220.6 39.8 25.2 93.7 101.4 87.9 81.1 72.3 63.1 39.0 24.6 114.4 211.8 59.0 26.4 42.1 106.9 22.8 102.2 69.1 53.4 203.3 85.2 68.4 89.6 190.5 265.0 37.5 64.8 118.8 110.1 112.0 68.9 31.0 47.1 116.7 98.6 134.4 104.6 85.6 56.1 80.9 112.0 76.2 98.7 87.3 60.2 111.6 DLGAP3 "DAP3, SAPAP3" ENSG00000116544 "DLG associated protein 3" O95886 1 34865436-34929650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 63.8" "Cell type enhanced" "Detected in many" "Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3" "Cancer enhanced" "Detected in some" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026445, HPA027304" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody" Yes NA "Endoplasmic reticulum" "Plasma membrane, Midbody" "HPA026445: AB_1847733, HPA027304: " "unprognostic (8.63e-2)" "unprognostic (8.58e-2)" "unprognostic (1.48e-1)" "unprognostic (5.77e-7)" "unprognostic (4.01e-2)" "unprognostic (5.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.69e-1)" "unprognostic (1.27e-4)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.12e-2)" "unprognostic (1.47e-1)" "unprognostic (2.26e-1)" "unprognostic (2.21e-1)" 0.2 0.4 49.5 0.5 32.7 1.1 0.2 0.0 53.3 0.2 0.0 0.3 0.2 0.3 0.0 0.1 0.3 0.1 0.1 37.1 17.5 0.6 0.1 0.2 0.3 18.2 21.9 21.0 0.1 1.2 0.2 4.9 0.0 27.2 0.2 0.0 1.8 0.2 0.2 0.1 0.2 0.5 0.0 0.0 2.0 0.3 7.5 63.8 0.3 0.4 0.0 0.1 0.2 0.2 8.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 8.0 0.1 0.0 1.0 0.0 1.3 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.3 0.0 0.0 4.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 12.5 2.4 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.2 1.6 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.2 49.5 32.7 0.0 53.3 37.1 17.5 18.2 21.9 21.0 27.2 0.0 63.8 8.1 0.2 0.0 0.0 1.0 1.8 0.3 0.9 0.8 1.8 4.1 0.7 0.8 1.0 0.0 0.1 1.8 4.2 0.1 0.9 0.8 3.9 0.4 18.9 0.2 0.1 0.4 1.2 0.0 39.1 0.6 0.2 0.4 0.0 0.1 0.0 0.3 0.4 0.1 10.1 21.9 27.9 0.4 0.0 7.1 0.6 19.3 0.9 4.1 0.0 1.9 0.7 1.5 1.0 8.0 0.7 0.2 0.0 0.0 0.8 0.2 1.3 0.8 0.0 2.2 0.0 0.7 0.4 3.4 4.9 1.1 0.3 0.0 1.3 0.1 0.9 0.6 SFPQ "PPP1R140, PSF" ENSG00000116560 "Splicing factor proline and glutamine rich" P23246 1 35176378-35193145 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009886, HPA047513, HPA054689" Enhanced Enhanced Nucleoplasm NA NA 640000 Nucleoplasm "CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574" "prognostic favorable (9.56e-5)" "unprognostic (1.01e-1)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (5.53e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (7.91e-13)" "unprognostic (3.10e-1)" "unprognostic (4.00e-3)" "unprognostic (3.85e-2)" "unprognostic (2.20e-2)" "unprognostic (8.03e-3)" "unprognostic (1.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.97e-3)" "unprognostic (3.07e-1)" "unprognostic (3.77e-3)" 60.2 47.1 30.0 62.6 29.2 217.0 53.6 41.3 34.7 53.8 25.8 47.3 45.0 60.8 51.4 60.3 55.1 40.2 42.5 28.8 29.9 42.5 51.0 41.1 77.1 33.5 31.3 24.0 75.0 53.3 45.3 34.6 52.2 33.4 50.2 54.9 47.8 53.2 35.9 64.4 60.4 48.0 53.4 29.4 54.6 48.5 46.3 30.2 86.3 45.1 27.6 95.3 58.6 53.0 48.2 180.5 147.3 251.1 142.9 60.5 90.0 234.7 96.1 97.1 160.4 116.3 161.5 126.4 325.6 130.1 111.8 100.6 160.4 276.1 188.3 217.0 175.2 183.0 245.5 156.2 193.6 81.5 258.2 140.1 72.4 71.7 139.4 67.3 70.9 142.3 169.1 282.6 150.9 158.3 156.8 304.2 220.1 299.7 107.8 140.7 304.5 170.4 213.6 156.2 214.4 180.1 200.3 138.6 106.3 147.1 174.4 125.0 181.7 152.3 127.7 188.3 84.7 208.9 171.2 156.5 327.6 91.1 168.6 185.9 2.6 4.1 3.0 4.7 5.8 5.4 4.1 4.6 3.8 3.8 4.5 4.3 4.8 2.1 3.4 4.7 7.3 5.6 2.3 30.0 29.2 41.3 34.7 28.8 29.9 33.5 31.3 24.0 33.4 29.4 30.2 48.2 286.7 169.9 237.7 149.8 317.4 357.5 239.3 80.6 234.5 230.0 231.6 191.0 149.6 82.9 146.2 110.3 191.8 206.5 339.0 149.7 82.2 120.1 126.8 230.1 318.9 222.2 219.6 198.9 127.3 138.4 222.9 255.8 267.6 333.1 155.8 450.5 123.5 109.1 141.4 171.6 143.4 189.5 59.0 129.4 216.9 361.9 142.9 258.5 140.5 104.9 146.2 152.6 127.7 248.8 183.1 162.0 126.7 116.6 291.8 159.9 94.8 87.6 114.8 223.6 52.6 530.6 259.2 199.1 171.9 287.9 327.3 305.5 313.7 223.7 220.0 167.7 RHOU "ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1" ENSG00000116574 "Ras homolog family member U" Q7L0Q8 1 228735479-228746664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 119.2;Endometrial stromal cells: 100.4;Extravillous trophoblasts: 91.5;Oligodendrocytes: 139.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 99.2;MOLT-4: 46.5;RT4: 43.3;THP-1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049592 Approved NA NA "HPA049592: AB_2680827" "unprognostic (7.90e-2)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (8.26e-3)" "unprognostic (3.26e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "unprognostic (6.21e-2)" "prognostic favorable (3.56e-5)" "unprognostic (4.20e-1)" "unprognostic (1.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.87e-2)" 20.0 11.2 26.1 5.7 36.8 8.5 16.6 30.8 37.1 16.4 20.0 14.7 23.8 14.0 5.8 6.2 19.1 17.0 8.2 26.2 29.3 6.7 26.2 14.0 3.9 37.9 36.6 22.3 25.8 18.8 14.0 7.4 17.6 39.0 18.0 10.0 2.3 18.7 10.5 37.6 6.1 24.1 8.6 31.0 15.6 22.7 9.6 32.7 4.7 13.8 5.1 1.2 18.4 9.0 47.0 1.0 2.5 7.9 0.6 1.8 0.9 99.2 0.5 0.9 0.6 0.4 11.0 14.8 0.0 5.8 1.3 0.5 0.6 2.9 0.0 0.5 16.0 5.6 0.1 0.7 3.4 11.0 8.1 0.9 0.5 0.8 0.2 0.5 0.1 0.2 4.0 0.0 0.0 0.5 2.5 46.5 8.5 2.5 13.5 0.9 0.2 2.5 1.3 0.4 43.3 2.9 8.7 0.9 6.7 0.0 16.9 0.0 29.9 0.7 0.1 1.2 0.0 0.1 2.3 10.6 0.0 0.0 20.5 5.2 0.0 0.3 0.4 0.4 0.5 0.8 0.0 0.3 0.6 0.4 0.0 0.0 0.2 0.0 0.1 0.2 0.4 0.0 0.1 26.1 36.8 30.8 37.1 26.2 29.3 37.9 36.6 22.3 39.0 31.0 32.7 47.0 76.4 16.0 16.4 16.6 0.7 4.6 3.6 0.5 0.0 4.5 27.4 18.9 77.3 38.6 15.6 1.8 0.0 25.9 5.1 82.1 0.0 4.7 0.7 119.2 100.4 28.9 3.0 3.2 13.6 8.9 91.5 28.9 20.4 83.7 0.0 56.8 30.7 40.8 21.9 8.4 6.9 10.3 4.1 28.3 38.6 3.1 1.8 29.9 16.0 5.6 15.1 5.5 1.0 24.6 139.5 5.1 35.7 1.2 1.9 23.0 64.3 1.2 21.0 0.9 0.0 21.5 10.2 1.5 2.8 0.3 3.3 33.9 5.9 1.2 9.6 18.6 GON4L "FLJ20203, GON-4, GON4, YARP" ENSG00000116580 "Gon-4 like" Q3T8J9 1 155749659-155859400 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 160.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006986, HPA057305, HPA074504" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696" "unprognostic (3.16e-2)" "unprognostic (9.26e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (9.85e-3)" "unprognostic (5.21e-2)" "unprognostic (1.83e-2)" "unprognostic (1.15e-1)" "unprognostic (7.49e-2)" "unprognostic (7.50e-2)" "unprognostic (1.69e-1)" "unprognostic (1.94e-1)" "unprognostic (5.12e-3)" "unprognostic (3.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.26e-2)" "unprognostic (5.83e-2)" 10.4 7.7 5.1 10.8 5.4 9.5 11.5 7.6 6.0 10.2 6.3 10.4 7.5 10.8 10.5 8.4 9.8 7.5 8.4 4.9 4.3 9.0 8.0 10.5 12.4 4.6 6.3 3.9 10.2 10.1 10.9 9.6 10.1 5.3 9.9 9.3 14.1 9.6 9.2 12.5 11.5 11.3 10.6 3.7 12.7 9.5 9.0 5.1 14.4 11.4 8.2 12.2 10.1 9.4 6.1 13.7 11.1 21.2 13.0 13.0 16.2 13.2 12.0 14.7 15.4 14.9 13.2 12.2 15.7 13.0 15.8 7.7 15.3 15.9 14.1 17.6 14.7 11.1 15.3 14.0 7.3 12.2 18.6 14.0 14.4 12.2 17.0 15.9 15.7 18.5 17.0 20.3 5.8 13.2 13.5 16.2 11.1 23.4 16.7 12.6 14.8 13.2 17.7 11.2 16.1 11.8 19.8 14.3 14.4 11.6 21.0 16.2 22.2 20.5 12.4 10.1 12.7 15.4 23.9 16.9 25.6 10.8 11.0 14.0 3.5 2.6 2.4 3.6 2.0 2.4 2.1 2.4 2.5 2.7 4.0 2.4 2.2 5.7 4.5 1.8 2.9 2.5 1.8 5.1 5.4 7.6 6.0 4.9 4.3 4.6 6.3 3.9 5.3 3.7 5.1 6.1 52.3 16.0 36.1 52.5 41.8 12.1 20.6 18.6 17.6 67.2 25.0 26.2 22.1 17.2 27.7 20.2 131.3 27.1 41.6 25.5 9.8 23.5 18.8 29.5 40.0 42.2 32.4 36.4 45.0 18.1 23.8 28.8 37.8 37.5 38.1 40.8 29.3 13.8 19.7 77.4 40.3 23.5 16.2 23.8 19.1 11.7 35.1 27.0 16.0 28.1 40.2 39.2 80.3 26.2 27.6 24.0 20.6 27.4 38.5 26.9 23.2 14.0 19.8 160.7 39.5 38.8 30.6 54.7 40.5 18.3 17.5 45.0 47.9 50.1 22.6 24.0 ARHGEF2 "GEF-H1, GEFH1, KIAA0651, Lfc, LFP40, P40" ENSG00000116584 "Rho/Rac guanine nucleotide exchange factor 2" Q92974 1 155946851-156007070 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Mitosis, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043437 Approved NA NA "HPA043437: AB_2678481" "unprognostic (2.27e-2)" "unprognostic (8.30e-3)" "unprognostic (3.24e-3)" "unprognostic (1.90e-3)" "unprognostic (4.14e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.20e-6)" "unprognostic (5.96e-2)" "unprognostic (2.14e-1)" "unprognostic (3.62e-2)" "unprognostic (2.59e-1)" "unprognostic (3.92e-1)" "prognostic unfavorable (7.17e-6)" "unprognostic (4.63e-2)" "unprognostic (2.70e-1)" "unprognostic (8.85e-3)" "unprognostic (7.98e-2)" 49.2 12.4 58.4 39.5 81.1 64.6 41.2 76.2 79.5 38.9 33.6 38.6 19.0 37.4 15.4 26.0 42.5 31.3 40.1 58.9 66.1 26.7 13.3 90.6 48.8 82.1 81.8 49.8 28.4 15.2 18.6 16.9 32.4 81.5 27.5 29.1 11.2 25.2 15.3 18.0 16.3 45.8 30.2 72.1 70.4 40.3 34.2 74.3 38.9 47.1 17.0 32.8 38.2 31.7 132.6 32.0 25.7 44.0 30.3 41.4 51.9 45.3 69.9 89.4 67.2 71.5 23.3 23.6 79.4 41.9 53.8 35.4 45.7 26.7 22.2 50.9 32.5 22.9 105.1 40.9 14.0 162.4 138.6 87.8 61.1 90.4 100.2 122.1 50.7 55.7 60.5 59.2 94.2 96.2 17.7 70.2 187.2 48.8 53.4 17.0 75.5 61.3 135.9 28.3 19.0 72.1 33.1 30.1 43.6 246.1 43.6 45.0 188.7 73.6 57.7 32.7 50.9 89.8 155.7 171.1 55.6 82.4 68.7 144.6 15.1 20.6 17.1 15.7 18.1 10.8 14.6 9.9 11.3 18.2 13.1 9.6 11.0 31.7 11.0 21.9 8.7 9.9 28.2 58.4 81.1 76.2 79.5 58.9 66.1 82.1 81.8 49.8 81.5 72.1 74.3 132.6 26.4 38.5 73.4 2.9 43.9 15.2 28.1 12.6 10.8 54.1 15.7 12.3 6.2 10.0 12.0 16.5 2.1 3.5 32.1 21.1 7.9 15.5 52.9 6.6 10.2 32.3 30.5 48.6 30.8 5.3 22.8 24.8 59.1 13.3 27.9 8.9 23.2 1.0 29.7 1.7 17.0 20.9 16.2 49.0 67.8 16.1 11.5 46.0 24.9 20.6 82.9 12.9 48.4 22.1 105.5 16.5 22.5 10.1 20.0 16.7 9.8 2.2 13.0 3.3 59.2 32.9 30.8 3.1 4.1 11.7 13.8 3.4 29.7 2.1 14.2 40.2 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054782-156058506 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 627.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 60.6 85.1 78.1 41.9 77.7 57.6 58.2 80.3 99.6 45.1 78.9 61.7 52.0 42.6 77.3 75.8 52.6 44.1 84.0 77.0 82.9 91.1 165.7 54.3 56.8 78.2 77.4 76.6 26.9 88.6 75.0 44.9 37.8 77.8 51.3 57.1 18.2 59.8 44.4 89.3 57.1 54.2 49.3 78.6 66.2 78.8 26.8 81.5 56.6 45.1 70.8 52.4 54.1 47.1 81.0 63.9 142.3 65.4 90.9 131.9 106.7 72.3 55.7 94.4 68.8 78.1 65.9 106.1 94.0 94.4 108.7 60.0 91.5 67.7 151.1 38.7 78.4 103.0 54.9 96.2 88.6 104.4 78.0 86.5 126.1 93.4 73.1 93.3 94.4 142.6 137.3 50.8 68.1 100.9 128.7 80.6 111.4 69.4 250.9 212.1 67.5 48.7 138.7 152.5 93.2 25.3 145.3 70.4 195.1 116.3 104.1 136.5 227.9 96.6 57.5 52.4 83.4 53.0 101.6 166.5 56.2 102.2 87.3 62.9 281.8 465.8 376.2 172.2 446.9 169.8 290.6 188.2 188.7 537.2 249.4 142.6 152.8 231.8 207.0 363.2 284.1 298.3 389.7 78.1 77.7 80.3 99.6 77.0 82.9 78.2 77.4 76.6 77.8 78.6 81.5 81.0 102.5 57.7 46.5 3.6 64.5 48.4 59.5 190.3 43.3 29.4 129.9 123.2 113.5 114.4 120.2 108.5 6.2 146.3 73.9 247.5 387.4 193.0 44.5 113.2 78.7 92.6 126.1 48.0 4.5 179.3 203.1 67.5 68.3 105.0 107.3 56.7 86.7 322.1 416.1 6.7 5.4 164.7 197.4 188.9 150.1 89.0 47.2 165.0 158.3 5.6 297.4 92.8 94.7 4.5 5.8 183.2 267.4 50.8 76.8 80.2 317.8 627.2 144.1 30.5 32.9 38.9 124.6 25.5 33.9 99.4 80.0 77.2 64.2 83.3 166.9 97.7 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500779 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 172.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 31.5 32.8 14.7 24.6 20.7 80.5 27.7 18.5 23.5 42.9 0.1 38.1 16.2 49.3 14.5 19.3 39.5 20.3 52.1 21.6 8.8 17.9 19.8 37.3 21.2 8.0 3.2 21.6 44.9 31.9 28.2 26.3 23.1 7.3 31.4 14.0 50.5 21.7 24.3 172.6 31.6 27.2 25.8 1.4 29.7 28.5 14.8 2.4 27.7 25.4 69.8 15.0 34.1 33.1 12.8 19.7 32.2 7.2 10.7 15.6 22.2 12.4 26.1 29.6 12.0 12.5 10.4 24.1 42.5 30.3 31.4 12.7 18.8 8.2 13.2 7.1 65.7 11.6 10.8 42.1 6.2 19.2 25.6 32.8 24.5 21.6 21.0 27.9 24.8 22.5 13.5 8.6 72.7 19.1 16.6 18.6 56.4 10.6 10.2 20.5 80.6 16.5 48.3 10.4 8.7 12.0 19.2 24.1 48.2 39.6 13.4 13.7 211.3 40.2 29.1 29.3 22.1 19.7 193.0 214.3 81.3 24.5 19.2 15.9 1.1 1.4 1.7 1.3 0.7 1.5 1.1 0.9 1.2 1.0 1.0 0.5 0.8 5.3 1.1 1.4 5.8 1.3 0.7 14.7 20.7 18.5 23.5 21.6 8.8 8.0 3.2 21.6 7.3 1.4 2.4 12.8 21.8 6.4 18.6 21.9 29.8 37.2 10.9 10.6 25.6 82.3 25.2 19.7 42.0 17.2 16.2 1.8 173.0 5.0 72.5 60.6 0.0 7.7 2.5 26.4 26.0 24.0 21.5 11.0 28.7 11.1 4.9 25.1 25.0 43.1 3.8 9.0 22.9 13.2 18.0 70.7 18.8 32.2 8.2 25.4 64.1 4.4 31.4 35.5 14.2 20.6 17.7 19.0 33.0 13.0 20.2 25.8 46.3 32.4 44.6 19.7 17.2 3.4 9.1 85.3 98.6 48.8 46.1 5.1 10.7 16.6 38.1 15.3 33.1 11.0 14.0 19.3 DOCK7 "KIAA1771, ZIR2" ENSG00000116641 "Dedicator of cytokinesis 7" Q96N67 1 62454298-62688386 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 347.0;Inhibitory neurons: 103.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.07e-1)" "unprognostic (1.35e-2)" "unprognostic (2.69e-2)" "unprognostic (1.44e-1)" "unprognostic (4.51e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (4.90e-2)" "unprognostic (6.34e-2)" "unprognostic (1.10e-2)" "unprognostic (3.74e-3)" "unprognostic (1.18e-1)" "unprognostic (8.16e-2)" "unprognostic (4.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-2)" 9.7 6.0 12.2 6.7 11.9 3.1 12.5 10.5 12.1 10.4 7.0 10.0 7.1 10.8 7.7 6.5 9.5 8.4 5.0 10.5 18.1 9.0 8.1 6.5 4.3 11.1 11.0 9.3 15.5 5.9 14.0 10.9 10.0 11.6 10.3 11.4 12.7 9.9 8.0 3.6 9.5 6.8 10.5 12.7 6.2 10.7 16.6 10.8 7.4 6.4 3.7 4.8 9.1 8.1 14.9 30.8 12.3 48.8 10.9 45.8 49.6 22.6 41.9 37.5 35.6 33.5 13.4 9.6 13.3 9.4 56.6 42.4 16.2 23.7 34.4 57.9 15.9 18.2 24.1 11.8 25.0 20.8 11.1 8.7 30.0 15.8 43.5 38.4 42.8 17.8 12.7 11.7 5.0 43.2 9.2 8.7 0.8 26.3 6.6 14.3 10.6 53.1 3.7 28.9 26.4 15.3 49.2 23.5 24.6 51.9 42.9 7.8 8.5 31.7 37.6 21.4 37.3 31.5 9.3 12.7 7.2 32.1 2.7 40.0 0.0 0.4 0.0 0.2 0.7 0.6 0.5 0.1 0.4 1.4 0.2 0.1 0.4 0.0 0.1 0.2 0.3 0.1 0.2 12.2 11.9 10.5 12.1 10.5 18.1 11.1 11.0 9.3 11.6 12.7 10.8 14.9 5.3 9.6 10.1 347.0 9.1 11.9 18.3 11.1 20.5 15.4 16.3 18.4 12.2 10.0 9.6 23.9 22.9 11.8 3.8 10.1 1.9 19.9 2.2 16.9 29.6 6.1 13.1 7.6 84.8 16.0 17.1 19.5 22.4 24.1 5.7 29.2 6.1 16.6 15.3 20.2 103.9 11.5 14.2 8.7 9.5 4.5 23.0 13.1 12.4 61.8 7.0 23.8 3.1 53.8 25.9 26.5 14.5 23.0 5.7 18.3 9.4 9.7 12.4 18.5 6.6 15.8 23.4 48.8 43.9 12.6 7.7 11.6 4.7 15.7 15.6 13.8 SRM "SPS1, SRML1" ENSG00000116649 "Spermidine synthase" P19623 1 11054584-11060020 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 371.7;Prostatic glandular cells: 249.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015746 Approved Approved Nucleoplasm,Cytosol NA NA 26000 Nucleoplasm Cytosol "HPA015746: AB_1857472" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (2.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.25e-5)" "unprognostic (2.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-2)" "unprognostic (3.01e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.74e-2)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (2.98e-2)" 70.2 70.0 49.7 54.8 49.9 31.8 65.0 41.8 71.7 56.2 40.3 49.8 19.2 69.2 16.1 64.4 58.3 18.9 85.2 53.0 46.7 39.6 78.1 54.2 44.7 45.3 54.8 48.5 61.1 192.4 15.2 53.8 26.3 45.9 50.5 20.0 10.2 52.9 29.0 128.1 54.5 40.5 41.2 43.9 71.3 58.1 33.3 50.3 24.4 34.6 48.7 38.5 75.2 49.0 44.3 149.6 212.1 69.1 232.5 134.8 144.6 107.7 224.9 114.7 315.1 168.1 263.5 87.4 284.3 127.8 197.2 98.8 114.0 222.6 181.6 104.2 140.5 337.0 180.1 225.3 302.0 197.7 305.6 157.6 145.9 129.1 306.0 266.0 73.8 134.8 183.2 298.1 234.7 155.8 326.5 261.7 266.3 150.5 136.0 405.4 194.6 71.3 466.2 112.4 58.3 132.3 126.5 116.8 248.4 182.3 53.1 87.1 153.2 113.4 204.3 161.7 357.5 257.1 185.6 201.7 429.6 142.4 406.2 241.2 0.0 5.9 0.4 7.4 6.8 10.8 12.5 7.2 9.3 7.0 11.3 8.5 10.0 0.2 5.7 3.5 11.2 8.8 2.3 49.7 49.9 41.8 71.7 53.0 46.7 45.3 54.8 48.5 45.9 43.9 50.3 44.3 68.5 0.0 4.6 4.9 115.2 95.0 92.6 6.9 18.2 27.4 75.7 165.7 31.7 28.6 4.0 29.5 20.9 78.0 44.9 23.0 76.3 20.0 4.1 11.0 97.9 54.5 27.5 67.9 13.9 43.2 198.4 91.8 36.2 16.6 26.7 102.0 35.0 50.5 96.4 30.3 23.0 39.9 6.1 41.2 41.7 14.7 71.7 39.8 67.6 10.3 22.4 44.0 29.9 15.6 9.6 30.4 10.8 53.0 371.7 249.9 3.5 86.0 2.5 18.3 0.0 70.7 66.3 14.1 75.9 47.8 113.1 36.0 49.5 108.3 43.1 95.5 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 217.9;choroid plexus: 103.6;pancreas: 87.6;pituitary gland: 119.3" "Cell type enriched" "Detected in many" 4 "Exocrine glandular cells: 685.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005472: AB_2667332" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 3.6 25.5 197.0 1.8 146.7 0.0 13.6 148.2 217.9 6.6 103.6 4.1 16.5 2.3 6.7 9.0 6.0 2.6 7.5 172.5 197.9 19.0 28.3 5.8 2.0 182.9 171.6 147.3 3.6 87.6 30.0 119.3 0.1 190.8 15.3 0.4 7.6 25.4 7.6 4.8 17.3 5.3 0.7 156.1 3.7 9.7 12.1 180.4 10.7 8.4 1.0 3.6 5.1 13.2 176.7 35.7 10.8 0.4 35.1 0.7 0.0 5.3 1.5 3.0 1.1 0.2 113.4 10.0 0.0 40.6 0.3 8.3 0.1 3.6 96.9 0.1 0.8 1.0 0.0 1.7 239.8 4.6 0.1 0.0 3.0 17.0 0.0 0.9 1.1 0.4 0.1 0.3 0.1 0.0 0.5 0.0 0.0 1.3 14.3 1.3 0.1 0.1 0.2 8.2 3.0 3.6 4.7 440.5 0.1 3.9 3.5 21.1 0.0 0.0 0.3 3.1 0.0 0.0 2.4 2.1 1.7 0.7 0.0 1.0 0.0 0.0 0.0 0.9 0.0 1.3 0.7 0.5 1.2 0.0 0.5 0.8 1.1 0.0 0.0 0.0 0.0 0.4 0.2 197.0 146.7 148.2 217.9 172.5 197.9 182.9 171.6 147.3 190.8 156.1 180.4 176.7 1.2 0.0 1.5 40.8 8.4 19.6 62.3 149.9 90.5 11.3 15.0 75.4 3.7 15.7 33.5 47.8 2.1 0.8 5.9 0.2 86.1 23.2 2.1 1.2 0.7 1.8 1.2 0.0 16.5 685.9 3.9 8.7 6.6 0.7 4.5 0.2 2.5 102.0 0.4 28.6 16.7 0.7 38.7 2.2 2.6 2.4 34.8 1.1 44.4 5.6 3.2 106.6 7.2 6.6 10.4 132.1 2.2 40.6 3.3 39.2 2.0 7.2 44.4 15.8 0.0 1.1 7.7 18.4 12.1 10.0 9.9 1.0 13.0 0.5 0.4 25.0 FBXO6 "FBG2, FBS2, FBX6, Fbx6b" ENSG00000116663 "F-box protein 6" Q9NRD1 1 11664200-11674354 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway, Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 60.6;Late spermatids: 117.8;NK-cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051175 Approved NA NA "HPA051175: AB_2681372" "unprognostic (3.23e-3)" "unprognostic (2.58e-2)" "unprognostic (8.27e-2)" "unprognostic (2.69e-3)" "unprognostic (1.11e-1)" "unprognostic (6.64e-2)" "unprognostic (9.46e-3)" "unprognostic (1.22e-1)" "unprognostic (1.18e-1)" "prognostic favorable (7.12e-4)" "unprognostic (1.47e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.83e-6)" "unprognostic (2.65e-2)" "unprognostic (2.11e-1)" "unprognostic (5.23e-2)" "prognostic favorable (5.90e-4)" 6.5 10.8 9.6 11.9 9.6 20.5 6.7 10.0 12.5 7.6 7.9 7.1 13.7 5.0 6.0 10.4 14.2 8.8 8.6 9.5 10.7 7.8 18.7 11.5 18.4 9.5 10.0 9.0 6.0 13.9 13.6 6.2 2.6 9.6 8.8 6.8 3.6 13.2 8.5 18.8 9.4 8.2 7.4 9.5 13.1 9.9 10.9 11.1 7.2 6.7 14.6 11.1 9.6 7.1 9.7 10.0 7.3 0.8 0.4 2.1 6.8 4.5 4.2 6.6 20.1 9.2 7.6 8.3 0.3 18.7 7.0 5.5 0.2 6.8 7.5 1.5 26.3 1.0 0.2 1.0 7.7 15.4 9.4 0.1 7.9 15.8 2.5 6.3 4.3 2.6 10.3 22.7 18.7 1.8 19.1 3.4 7.8 0.8 10.2 9.7 2.3 0.1 0.7 6.9 1.4 1.6 2.0 9.3 10.9 14.3 1.8 10.5 10.2 2.0 1.0 0.8 2.7 0.3 10.0 7.5 3.9 1.2 21.6 1.8 17.1 49.5 65.0 47.0 75.0 25.4 15.3 12.0 31.3 66.5 15.0 7.1 23.7 41.4 41.4 91.0 27.3 13.1 36.6 9.6 9.6 10.0 12.5 9.5 10.7 9.5 10.0 9.0 9.6 9.5 11.1 9.7 6.0 6.4 6.9 3.3 8.4 7.0 6.6 14.6 4.0 4.3 8.3 7.4 6.8 2.8 15.0 9.2 2.1 1.1 19.5 10.7 0.0 14.5 60.6 15.7 4.5 4.0 4.9 1.7 1.8 38.5 9.2 7.8 8.6 5.3 3.8 2.2 8.2 19.9 26.2 5.0 2.6 8.3 8.2 15.4 34.7 117.8 8.1 18.3 7.2 1.0 37.8 9.0 60.8 0.0 1.3 13.0 10.8 11.3 12.2 11.3 14.3 15.6 36.5 7.8 0.0 3.3 4.0 4.0 11.9 7.3 9.8 1.8 16.0 1.8 9.2 11.2 C1orf21 PIG13 ENSG00000116667 "Chromosome 1 open reading frame 21" Q9H246 1 184387029-184629019 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.0" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 305.1;Syncytiotrophoblasts: 284.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 3.9;memory CD8 T-cell: 2.0;naive CD8 T-cell: 1.8;NK-cell: 2.6" "Group enriched" "Detected in many" 13 "NK-cells: 2.6;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HDLM-2: 12.3;HSkMC: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026831 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026831: AB_1845636" "unprognostic (8.27e-2)" "unprognostic (7.45e-2)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (5.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (3.35e-8)" "unprognostic (1.81e-2)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (3.60e-2)" 9.8 13.3 6.7 1.3 12.4 0.5 13.5 8.7 12.5 14.3 0.0 12.8 3.0 13.1 6.8 8.3 12.9 2.9 12.0 10.2 6.0 3.3 5.7 8.0 0.8 6.8 3.8 8.2 11.4 3.4 2.5 4.7 1.9 8.2 14.2 5.0 7.5 4.7 6.8 53.0 16.5 12.0 3.8 2.7 5.6 9.8 1.7 4.6 1.5 3.4 20.8 1.0 15.8 15.1 7.0 0.2 0.1 3.8 0.2 5.9 6.0 5.0 1.7 1.7 1.0 0.6 0.0 0.0 0.0 0.0 2.5 0.3 1.1 1.6 1.7 0.9 12.3 3.9 0.0 0.8 0.0 2.3 1.2 0.6 8.7 4.0 1.2 0.9 4.4 1.4 2.8 0.0 3.5 1.4 1.3 1.4 0.3 4.4 2.0 0.3 1.9 2.5 2.1 0.0 0.8 1.6 6.0 1.0 0.7 3.5 2.2 0.1 0.1 1.7 2.2 0.8 4.2 2.3 7.2 4.1 0.0 3.7 1.8 2.4 0.0 0.0 0.0 3.9 0.0 0.4 0.0 0.5 2.0 0.2 0.0 0.2 1.8 0.0 2.6 0.0 0.1 0.0 0.9 6.7 12.4 8.7 12.5 10.2 6.0 6.8 3.8 8.2 8.2 2.7 4.6 7.0 107.5 38.5 113.0 201.4 1.2 152.6 234.9 29.6 82.6 23.4 87.9 63.6 90.7 25.8 38.1 1.8 0.0 119.3 99.8 149.9 7.9 6.7 47.0 11.0 89.3 98.4 19.2 14.5 144.2 19.6 99.3 91.8 7.1 21.7 10.1 11.2 101.4 83.7 40.9 26.9 165.9 66.3 24.4 8.8 31.5 37.8 76.4 9.5 64.0 16.9 19.7 42.9 141.1 305.1 3.6 14.1 203.3 19.2 20.2 105.7 193.6 12.3 17.5 9.5 19.7 108.8 48.2 3.4 17.3 76.3 145.6 284.6 32.2 32.8 76.4 181.7 SWT1 "C1orf26, FLJ20121, HsSwt1" ENSG00000116668 "SWT1 RNA endoribonuclease homolog" Q5T5J6 1 185157080-185291781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 38.6" "Cell type enhanced" "Detected in many" "Early spermatids: 150.8;Late spermatids: 52.7;Oligodendrocytes: 55.2;Spermatocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 18.4;U-266/84: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024214, HPA027334" Enhanced Approved Cytosol NA NA Cytosol "HPA024214: AB_1845642, HPA027334: AB_1845643" "unprognostic (2.67e-3)" "unprognostic (1.32e-1)" "unprognostic (3.65e-1)" "unprognostic (4.26e-2)" "unprognostic (3.17e-3)" "unprognostic (8.41e-3)" "unprognostic (5.71e-3)" "unprognostic (9.26e-3)" "unprognostic (7.37e-2)" "unprognostic (2.68e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.97e-1)" "unprognostic (4.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.35e-2)" 3.3 3.3 4.5 3.0 5.6 9.1 4.2 4.7 4.2 3.8 4.2 3.4 4.9 4.3 4.4 2.7 2.9 3.8 3.7 3.2 5.0 4.8 3.3 3.5 2.8 5.2 5.3 2.8 6.4 9.3 4.4 2.4 5.6 5.2 4.7 3.3 5.5 6.5 3.1 2.9 3.0 3.8 3.2 4.8 3.1 4.9 38.6 4.8 5.0 5.2 4.6 3.0 3.3 2.8 7.4 2.1 1.8 5.0 2.7 8.1 6.2 4.2 2.1 3.6 2.6 3.9 1.5 1.7 2.1 4.1 1.6 2.6 1.8 3.1 2.8 3.3 5.6 2.1 2.2 1.2 2.0 4.0 0.7 1.8 4.6 2.8 2.8 2.5 4.4 6.3 4.2 4.8 10.2 2.7 0.7 2.5 1.9 5.4 5.5 1.0 1.9 4.5 5.2 2.5 1.3 1.0 7.7 1.7 2.6 7.2 11.7 2.9 1.4 3.0 3.4 2.2 3.2 1.3 18.4 15.2 0.8 3.8 1.3 1.3 14.2 1.9 2.8 1.5 1.8 2.8 2.3 3.1 2.3 1.2 3.3 2.9 2.2 5.6 0.8 4.3 1.1 6.1 1.1 4.5 5.6 4.7 4.2 3.2 5.0 5.2 5.3 2.8 5.2 4.8 4.8 7.4 7.1 3.2 1.1 37.2 4.0 1.0 2.0 1.4 2.8 4.3 5.0 3.4 7.3 2.8 3.2 5.5 4.2 3.2 2.2 5.1 0.0 2.9 150.8 5.3 4.4 4.9 0.0 8.2 25.5 2.7 6.8 5.5 4.6 4.9 2.5 4.5 7.9 3.8 3.7 8.4 32.3 3.6 0.0 5.7 1.9 52.7 4.7 3.1 1.8 21.5 3.8 2.6 4.1 31.7 55.2 2.1 7.8 5.7 5.7 2.4 4.4 5.3 2.4 5.4 0.0 4.3 5.7 54.3 11.5 3.0 0.6 6.7 3.6 2.3 2.9 2.3 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.1;Late spermatids: 522.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 25.0 19.6 28.3 22.4 29.6 60.4 25.5 31.2 36.2 22.2 25.7 20.6 11.7 19.4 15.1 14.7 20.6 13.6 24.8 27.6 33.9 30.5 50.2 29.8 27.9 33.4 28.3 27.5 21.9 40.3 13.4 22.9 10.7 30.5 22.5 7.6 5.1 28.8 11.3 49.7 22.8 17.3 15.6 30.4 25.4 29.1 64.8 32.1 55.6 15.5 31.8 26.3 23.3 18.0 32.7 62.8 57.2 90.8 106.8 28.6 55.1 37.3 56.5 64.8 110.4 97.8 75.2 59.2 87.6 67.6 58.1 64.4 27.4 115.1 60.1 60.5 133.3 129.6 40.1 87.5 93.4 50.2 80.5 62.7 36.1 60.7 81.0 68.9 41.6 51.4 116.7 165.6 138.3 55.5 94.6 365.6 381.3 235.1 25.9 91.2 245.6 100.2 109.6 40.8 13.5 167.8 118.1 93.6 36.5 168.1 61.2 52.6 172.1 26.8 90.7 114.1 85.6 81.8 109.5 82.0 233.7 67.2 281.5 71.8 45.3 85.2 42.8 82.1 97.3 66.8 58.5 55.4 64.8 100.8 43.8 37.0 54.9 36.7 43.3 86.8 139.1 69.9 92.0 28.3 29.6 31.2 36.2 27.6 33.9 33.4 28.3 27.5 30.5 30.4 32.1 32.7 24.8 0.0 5.0 4.2 26.1 38.6 26.5 35.7 18.8 5.7 26.9 26.9 15.9 11.5 14.1 14.7 4.2 18.2 49.6 3.7 50.9 40.8 148.1 8.4 21.6 28.2 34.0 69.5 1.7 76.6 50.7 30.6 12.2 11.4 14.0 17.3 29.6 59.1 41.7 11.8 2.3 10.6 54.9 36.4 88.1 522.5 31.1 32.5 48.0 1.9 82.6 10.8 53.5 4.0 5.5 40.7 4.5 17.0 42.9 35.8 4.5 29.6 6.0 3.5 39.5 25.1 26.5 76.0 40.6 14.3 34.7 8.3 37.7 18.8 8.6 17.6 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415871 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 103.0;retina: 53.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1038.1" "Cancer enriched" "Detected in many" 4 "glioma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.1;HEL: 165.8;K-562: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: AB_2682641" "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favorable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 1.3 11.2 22.9 0.9 35.0 4.8 1.1 23.6 55.5 0.8 0.0 1.8 1.0 0.6 0.4 0.3 1.1 1.0 9.0 39.4 44.1 7.7 0.4 1.5 0.2 52.2 48.4 29.5 0.5 2.2 1.0 12.7 7.4 60.3 1.1 1.7 53.3 0.7 0.7 0.4 1.0 1.0 0.9 20.5 2.1 1.7 2.2 47.3 0.8 1.7 0.8 0.3 1.1 0.9 103.0 10.4 2.8 0.1 4.4 2.1 0.5 23.4 20.1 33.1 32.6 31.7 2.7 0.5 9.9 1.7 8.3 8.0 2.5 14.6 3.3 25.8 62.1 6.9 165.8 5.1 0.6 0.2 5.6 3.9 2.7 2.2 3.3 13.8 6.0 0.7 8.0 65.5 1.2 6.6 1.9 2.1 0.0 6.5 0.0 2.2 0.0 4.9 0.4 23.7 0.0 39.4 27.0 11.9 15.5 5.4 37.4 7.5 0.3 6.5 4.8 3.3 0.6 5.9 6.0 4.1 3.0 13.4 4.1 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 35.0 23.6 55.5 39.4 44.1 52.2 48.4 29.5 60.3 20.5 47.3 103.0 0.8 0.0 0.5 49.3 0.5 1.3 0.4 0.5 0.0 30.4 0.6 0.3 28.0 2.8 0.2 0.0 14.6 8.9 1.5 0.4 1.9 0.8 2.0 1.8 0.5 3.7 7.2 19.4 237.4 0.7 2.1 5.8 1.5 3.0 0.0 0.6 0.4 0.1 1.2 52.2 237.6 1.9 2.0 0.0 0.8 1.9 0.0 0.7 7.2 18.7 1.1 4.1 0.0 136.7 1038.1 0.4 0.2 0.0 0.9 1.7 0.0 7.2 1.2 21.6 0.0 0.2 8.5 1.7 2.5 0.0 0.3 7.4 0.6 6.9 0.6 0.2 LEPR "CD295, OBR" ENSG00000116678 "Leptin receptor" P48357 1 65420652-65641559 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 131.5" "Cell type enhanced" "Detected in many" "Adipocytes: 97.7;Endothelial cells: 80.5;Fibroblasts: 94.2;Hepatocytes: 175.2;Langerhans cells: 66.6;Microglial cells: 129.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 13.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "K-562: 114.7;RPTEC TERT1: 52.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030899 Approved Supported "Intracellular and membrane" NA NA 8240000 14000000 "HPA030899: AB_10610003" "unprognostic (1.59e-2)" "unprognostic (1.09e-3)" "unprognostic (3.09e-1)" "unprognostic (8.95e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-3)" "unprognostic (1.79e-1)" "unprognostic (2.41e-1)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.73e-1)" 24.5 7.3 5.3 3.9 5.2 5.0 20.8 4.9 6.8 21.7 23.8 6.0 4.0 24.9 6.7 9.3 16.2 14.8 7.0 5.3 9.8 7.9 131.5 22.7 9.6 5.1 5.1 3.9 25.2 3.0 2.9 11.8 5.4 5.1 9.1 5.1 2.5 12.0 7.3 2.1 15.2 5.7 18.9 6.1 3.3 13.8 4.0 7.0 4.7 10.5 32.4 5.8 9.2 4.8 6.7 3.3 2.0 2.6 2.9 11.5 10.6 9.0 14.2 8.1 4.8 4.5 1.5 7.6 1.4 10.1 18.0 1.3 2.7 2.2 12.3 12.7 17.2 3.7 18.8 7.9 0.3 7.0 1.4 1.6 29.7 6.8 2.9 10.8 36.2 13.9 1.4 114.7 2.2 22.5 0.9 1.4 0.4 4.2 2.0 0.2 0.4 2.2 0.8 52.3 1.4 1.6 26.3 3.5 1.5 4.0 14.9 5.0 5.0 5.3 4.9 10.0 1.1 7.8 3.0 2.2 0.5 10.2 5.3 4.8 4.5 0.8 1.2 0.5 0.6 0.4 0.2 0.4 0.4 0.7 0.1 0.3 0.5 0.4 0.4 0.7 0.5 1.0 0.7 5.3 5.2 4.9 6.8 5.3 9.8 5.1 5.1 3.9 5.1 6.1 7.0 6.7 97.7 0.0 11.3 47.0 2.6 35.3 1.9 3.3 2.2 4.0 3.1 3.3 6.6 11.5 4.2 9.2 0.0 1.6 1.6 0.5 3.9 1.5 1.1 2.0 4.4 80.5 0.0 10.3 20.9 1.1 2.6 94.2 2.6 12.8 1.3 2.6 52.5 175.2 2.0 1.7 21.8 0.8 2.0 6.3 66.6 2.3 34.5 6.1 35.6 129.3 3.4 0.4 2.1 29.1 24.5 1.7 1.9 7.5 2.4 7.5 0.7 6.4 2.6 1.0 0.0 41.1 10.3 1.1 1.2 4.1 29.5 2.6 4.7 3.3 0.8 2.1 IVNS1ABP "ARA3, HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317273 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 456.9" "Cell type enhanced" "Detected in all" "Granulosa cells: 309.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 250.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol NA NA Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 32.3 18.0 16.1 47.0 23.8 456.9 51.0 20.4 19.6 23.1 25.4 40.6 38.8 22.6 18.2 27.2 19.8 36.8 29.2 14.9 20.1 95.0 23.1 27.9 26.7 20.5 18.1 12.9 28.7 25.7 32.6 17.4 26.2 21.3 22.4 51.6 15.1 55.6 26.6 23.3 33.8 35.1 17.1 18.9 27.5 42.6 16.1 20.0 25.2 34.6 21.8 24.3 38.1 30.1 34.3 24.6 22.1 79.2 31.6 27.1 9.0 68.4 46.6 15.3 30.1 27.5 26.2 39.7 36.8 36.8 24.0 13.4 32.9 29.0 31.8 32.1 24.9 21.6 36.8 39.1 22.6 10.9 26.2 13.9 6.7 35.7 23.1 73.2 67.6 39.6 38.6 23.6 21.2 54.6 18.0 44.6 18.1 48.7 61.8 5.6 24.7 20.2 21.0 250.7 31.4 52.5 44.5 40.6 35.4 31.4 103.4 16.2 13.3 27.2 41.9 24.5 10.4 34.9 28.0 23.8 22.8 32.1 26.0 19.4 7.9 10.9 10.5 10.5 7.1 9.6 6.1 8.0 7.7 12.6 3.7 8.5 8.3 33.0 10.4 10.3 3.4 8.9 12.1 16.1 23.8 20.4 19.6 14.9 20.1 20.5 18.1 12.9 21.3 18.9 20.0 34.3 159.1 44.8 59.0 13.7 61.3 188.9 90.4 40.9 163.4 14.5 74.0 51.3 56.0 22.8 57.4 128.8 52.1 17.3 102.0 288.3 164.4 41.6 34.4 93.2 36.7 85.8 60.4 52.8 18.2 41.5 67.5 50.3 90.7 159.7 41.1 309.2 26.4 23.3 34.8 21.9 26.2 109.6 36.7 107.2 242.3 34.9 5.9 141.5 101.4 33.7 41.3 11.3 63.8 37.7 72.9 24.0 56.4 2.6 62.7 60.9 103.2 86.3 45.8 32.7 6.6 51.4 52.6 33.2 19.8 108.9 181.6 18.3 120.0 54.2 102.7 91.7 KIAA2013 "MGC33867, RP5-1077B9.1" ENSG00000116685 KIAA2013 Q8IYS2 1 11919591-11926428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 116.7;Proximal enterocytes: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052677, HPA060536" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA052677: AB_2681911, HPA060536: AB_2684313" "unprognostic (3.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.63e-2)" "unprognostic (1.48e-1)" "unprognostic (2.02e-2)" "unprognostic (1.87e-2)" "unprognostic (5.51e-3)" "unprognostic (8.60e-2)" "unprognostic (5.26e-2)" "unprognostic (2.92e-1)" "unprognostic (1.10e-2)" "unprognostic (5.04e-2)" "unprognostic (6.05e-2)" "unprognostic (2.04e-2)" "unprognostic (2.94e-2)" "unprognostic (8.24e-3)" "unprognostic (3.74e-3)" 27.3 25.8 22.7 17.4 26.3 19.4 25.8 26.9 24.0 25.4 23.1 41.5 66.1 35.8 36.0 30.3 27.3 20.8 35.7 22.5 22.6 30.2 59.9 24.0 21.9 30.7 27.3 19.0 19.8 42.7 20.2 32.1 21.0 28.2 28.1 20.2 6.1 40.8 26.0 52.3 37.4 62.3 17.3 27.8 35.4 31.7 37.4 25.2 16.9 27.0 23.4 13.2 32.5 25.8 31.4 61.2 44.5 20.5 40.6 34.0 23.2 33.8 38.1 39.8 45.0 46.4 55.1 61.7 39.8 56.9 36.2 35.2 69.3 27.8 37.6 23.8 46.3 71.4 27.4 39.7 95.7 38.4 57.2 54.3 29.7 41.0 44.1 19.4 48.7 43.6 31.2 42.6 51.5 27.2 46.2 36.6 80.1 27.0 27.0 60.6 46.3 37.4 97.6 29.0 16.5 76.1 43.0 30.9 34.1 74.8 20.4 28.6 52.6 42.1 37.9 49.2 56.3 52.6 61.8 47.1 46.0 45.1 91.8 41.1 3.3 4.9 5.1 4.7 4.2 3.7 5.2 2.5 3.6 3.5 6.8 2.5 3.3 11.1 4.1 3.5 8.5 5.5 2.6 22.7 26.3 26.9 24.0 22.5 22.6 30.7 27.3 19.0 28.2 27.8 25.2 31.4 26.1 22.4 13.4 12.4 18.7 22.2 9.2 13.6 6.8 20.7 30.5 27.1 18.7 18.6 13.0 25.8 12.5 18.1 32.6 116.7 3.9 15.5 24.4 23.7 18.4 22.9 40.9 11.8 9.9 19.3 30.8 18.7 17.3 27.7 13.3 23.1 27.1 75.2 26.5 32.0 8.8 50.1 22.4 40.3 23.0 41.5 22.7 27.1 19.6 6.5 26.5 18.7 28.8 8.5 22.1 24.7 72.2 23.0 18.4 17.3 139.9 22.3 17.8 22.1 19.7 27.5 15.7 17.6 8.6 15.0 28.1 13.3 16.0 31.1 59.4 17.3 MFN2 "CMT2A2, CPRP1, KIAA0214, MARF" ENSG00000116688 "Mitofusin 2" O95140 1 11980181-12015211 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" Hydrolase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 272.9;skeletal muscle: 313.5;tongue: 340.6" "Cell type enriched" "Detected in all" 7 "Cardiomyocytes: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030554, CAB079902" Uncertain Supported Mitochondria NA NA Mitochondria "CAB079902: AB_2724683, HPA030554: AB_10603018" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.38e-2)" "unprognostic (8.36e-2)" "unprognostic (9.71e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (3.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.43e-1)" "unprognostic (3.55e-1)" "prognostic favorable (2.36e-8)" "unprognostic (4.69e-2)" "unprognostic (2.76e-1)" "unprognostic (8.84e-3)" "unprognostic (2.12e-1)" 35.0 31.7 42.0 21.1 38.6 26.9 32.1 39.0 40.7 27.2 16.6 53.3 42.3 37.3 12.8 57.7 26.4 22.0 272.9 33.3 41.6 36.8 58.9 31.4 20.0 41.9 43.7 26.6 27.2 22.7 77.3 28.9 27.8 42.7 36.6 38.5 35.3 32.4 62.9 313.5 58.6 46.6 41.6 41.4 31.7 45.2 25.6 45.3 26.4 56.6 340.6 30.7 51.7 36.5 41.2 93.6 54.0 52.6 72.7 59.7 47.2 58.8 76.0 66.1 96.5 72.6 88.7 51.8 68.8 74.8 92.6 60.6 80.5 101.7 156.1 90.6 60.6 75.4 94.5 81.8 54.2 53.8 114.2 51.9 57.0 105.1 133.1 124.5 40.1 66.2 26.4 106.1 53.6 69.7 30.2 60.2 15.2 39.7 57.8 77.4 68.2 95.8 58.5 44.9 61.4 68.2 44.6 88.4 81.0 74.6 41.4 43.8 49.2 71.2 63.1 58.3 88.4 71.2 59.0 86.4 120.7 69.0 99.6 69.8 10.4 11.5 7.6 8.9 14.0 10.2 6.7 6.7 7.9 9.7 4.8 5.0 6.2 16.2 6.2 18.3 4.2 8.1 15.7 42.0 38.6 39.0 40.7 33.3 41.6 41.9 43.7 26.6 42.7 41.4 45.3 41.2 18.1 22.4 15.8 16.6 10.2 22.8 9.4 18.9 19.9 26.7 17.4 16.4 336.9 7.2 14.9 14.7 12.5 15.1 12.5 39.2 21.5 13.6 4.7 8.9 12.1 18.5 18.0 32.4 21.5 20.4 15.5 17.3 17.3 12.8 10.8 12.8 11.7 46.3 16.0 30.3 24.5 22.2 18.3 23.9 9.7 8.0 7.2 19.1 17.8 8.4 17.3 14.6 8.2 11.1 16.7 18.5 16.8 15.1 10.9 13.9 41.8 14.3 12.9 21.0 13.1 16.0 16.5 25.9 15.6 25.1 30.1 25.2 10.3 12.5 26.4 16.6 PRG4 "bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP" ENSG00000116690 "Proteoglycan 4" Q92954 1 186296279-186314567 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 72.6;liver: 187.3" "Group enriched" "Detected in some" 15 "Fibroblasts: 320.6;Hepatocytes: 364.7" "Cancer enriched" "Detected in many" 10 "liver cancer: 28.4" "Region enriched" "Detected in some" 12 "hypothalamus: 20.7" "Immune cell enriched" "Detected in single" 5 "T-reg: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enriched" "Detected in some" 6 "ASC diff: 284.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" CAB054258 Supported "Secreted to extracellular matrix" NA NA 4300000000 "CAB054258: " "unprognostic (8.67e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-3)" "unprognostic (1.98e-1)" "unprognostic (1.77e-1)" "unprognostic (7.87e-2)" "unprognostic (7.33e-2)" "unprognostic (1.78e-1)" "unprognostic (1.28e-1)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (4.11e-1)" "unprognostic (1.91e-13)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (1.60e-3)" "unprognostic (7.05e-3)" 72.6 2.3 0.0 2.3 0.0 0.3 15.3 0.4 1.7 0.4 3.6 1.0 0.0 0.6 0.9 0.3 20.2 0.4 18.7 0.0 20.7 0.2 187.3 26.7 0.4 0.0 0.1 0.1 2.1 1.5 0.0 2.1 0.0 0.1 0.6 0.1 0.1 4.0 0.1 9.6 4.8 0.4 0.3 0.2 0.7 1.4 0.2 0.2 0.3 1.7 8.1 0.3 2.6 0.5 0.1 0.0 0.1 0.0 0.0 284.6 11.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.1 0.1 0.2 0.2 0.0 26.2 0.0 44.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.7 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.4 1.7 0.0 20.7 0.0 0.1 0.1 0.1 0.2 0.2 0.1 5.1 22.4 16.2 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 2.7 10.0 21.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.2 3.7 4.1 0.0 2.7 0.0 0.0 0.0 320.6 0.0 0.8 16.4 0.0 6.4 364.7 0.1 0.0 0.1 0.0 0.0 9.4 1.9 0.8 0.0 2.8 1.8 0.0 0.1 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.1 0.1 0.0 0.0 10.9 0.0 0.0 3.5 1.5 0.0 0.3 0.0 1.1 0.0 2.3 0.1 0.0 0.1 MIIP "FLJ12438, IIp45" ENSG00000116691 "Migration and invasion inhibitory protein" Q5JXC2 1 12019466-12032045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "HDLM-2: 362.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044948 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044948: AB_10795887" "unprognostic (1.36e-2)" "unprognostic (1.95e-2)" "unprognostic (5.02e-3)" "unprognostic (3.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.65e-3)" "unprognostic (7.16e-2)" "unprognostic (2.97e-1)" "unprognostic (4.03e-2)" "unprognostic (3.73e-3)" "unprognostic (6.56e-2)" "prognostic unfavorable (8.26e-7)" "unprognostic (8.02e-3)" "unprognostic (5.09e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 15.5 9.7 10.6 12.4 11.2 43.9 15.1 10.5 16.5 15.2 7.4 15.1 7.3 21.0 2.3 10.6 18.2 5.6 14.7 10.1 9.5 12.4 16.5 17.6 14.3 11.4 10.5 9.7 24.0 17.6 5.6 9.2 7.3 10.4 14.6 2.3 2.8 12.6 8.6 28.3 14.8 15.9 6.6 10.6 26.3 13.4 27.0 11.9 7.6 15.8 7.9 5.4 17.4 12.5 11.5 20.4 13.4 10.4 20.8 5.7 6.3 36.3 10.9 5.6 20.9 15.1 26.8 32.2 25.8 25.3 5.8 14.7 21.0 7.9 12.3 2.7 362.4 29.4 16.3 22.8 28.5 11.7 24.6 47.4 8.3 15.7 18.6 7.9 3.6 11.7 33.7 49.1 23.4 6.5 20.8 24.6 37.5 19.0 15.2 19.7 34.6 13.3 39.8 9.1 6.2 19.2 20.2 15.9 20.3 39.1 5.8 13.5 42.2 12.3 19.2 20.2 38.8 17.0 19.3 26.4 35.7 12.5 43.0 20.1 18.0 68.7 22.8 25.1 82.2 23.3 44.1 25.9 22.1 43.5 41.5 16.1 12.6 55.7 33.8 90.8 139.5 60.1 41.3 10.6 11.2 10.5 16.5 10.1 9.5 11.4 10.5 9.7 10.4 10.6 11.9 11.5 16.4 12.8 7.7 12.4 28.7 13.0 7.4 11.6 9.1 14.0 29.5 17.4 5.4 5.7 7.2 9.2 8.4 37.8 35.5 17.0 25.4 13.8 40.6 7.9 17.2 12.7 16.7 26.7 4.1 18.5 95.9 14.4 14.3 7.3 17.7 17.9 8.9 13.5 39.7 8.4 4.6 10.7 10.2 23.2 20.7 55.6 8.4 30.8 16.0 4.7 56.6 15.4 26.8 5.0 5.0 16.7 16.8 6.8 16.6 11.4 26.0 15.1 8.1 15.3 13.1 12.4 16.2 24.7 48.2 9.9 17.2 33.1 23.6 16.6 16.9 6.2 SMG7 "C1orf16, EST1C, KIAA0250, SGA56M, SMG-7" ENSG00000116698 "SMG7 nonsense mediated mRNA decay factor" Q92540 1 183472216-183598246 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029350 Supported Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA029350: AB_10603031" "unprognostic (6.06e-2)" "unprognostic (1.79e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-3)" "unprognostic (1.98e-2)" "unprognostic (1.36e-1)" "unprognostic (5.44e-2)" "unprognostic (6.15e-2)" "unprognostic (1.46e-1)" "unprognostic (9.01e-2)" "unprognostic (6.17e-2)" "unprognostic (2.69e-1)" "unprognostic (6.47e-3)" "unprognostic (7.82e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 17.4 16.3 19.5 22.1 20.7 43.5 17.2 28.9 24.6 19.8 20.7 19.8 20.7 19.7 15.6 23.1 26.1 15.5 21.3 21.3 17.8 21.3 22.9 18.8 26.0 18.3 18.2 18.3 26.1 22.0 25.0 20.6 19.1 20.3 17.1 24.1 32.3 21.8 16.3 26.0 25.1 20.7 18.0 15.3 21.6 22.6 68.1 19.6 36.1 23.8 28.1 30.4 18.3 19.5 20.3 56.4 33.6 47.5 37.3 31.8 29.8 78.9 33.8 61.8 36.9 28.0 50.1 42.8 78.9 37.9 42.1 33.5 59.4 64.5 50.1 43.4 35.2 28.1 63.8 36.3 41.0 32.1 84.4 39.1 27.3 45.0 50.6 116.1 30.0 41.0 42.9 80.6 54.0 38.8 56.9 59.7 37.1 82.4 66.9 19.1 37.2 53.0 61.9 28.3 51.7 63.7 49.7 52.2 73.1 40.5 80.4 72.9 34.0 39.3 41.5 42.9 41.7 48.5 58.6 74.3 63.5 33.8 46.9 45.3 2.0 5.8 6.2 5.6 5.7 5.1 5.5 5.0 5.5 6.6 4.7 5.5 5.9 6.8 5.9 3.2 7.0 4.9 5.1 19.5 20.7 28.9 24.6 21.3 17.8 18.3 18.2 18.3 20.3 15.3 19.6 20.3 31.3 22.4 20.6 66.3 26.8 27.0 11.6 13.9 23.3 22.6 21.4 15.6 31.8 20.0 20.5 27.6 31.3 11.4 23.9 38.5 9.8 12.1 58.1 39.8 23.6 26.8 34.6 28.8 63.0 15.8 16.5 14.9 31.1 48.0 22.1 19.4 25.4 45.2 13.2 30.3 63.0 23.0 6.1 38.6 48.6 49.5 15.2 25.2 10.6 52.5 20.0 9.6 15.5 70.9 99.1 17.6 19.9 12.4 36.2 16.7 30.4 12.9 30.5 19.0 39.5 14.5 23.8 35.2 23.8 30.8 26.9 10.8 24.2 13.0 18.8 23.2 NCF2 "NOXA2, p67phox" ENSG00000116701 "Neutrophil cytosolic factor 2" P19878 1 183555562-183590876 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 193.7;lung: 75.3;lymphoid tissue: 79.4" "Group enriched" "Detected in many" 5 "Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 1313.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002327, HPA006040, CAB022160" Enhanced Supported Cytosol NA NA 12000 Cytosol "CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906" "unprognostic (4.97e-2)" "unprognostic (3.48e-2)" "unprognostic (2.40e-2)" "unprognostic (1.22e-3)" "unprognostic (5.83e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.29e-1)" "unprognostic (2.45e-1)" "unprognostic (2.33e-1)" "unprognostic (5.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-2)" "unprognostic (8.24e-2)" "unprognostic (2.36e-2)" 30.2 5.8 2.2 77.5 2.8 193.7 7.1 2.9 12.6 9.6 6.7 10.5 8.6 4.2 1.6 7.7 8.1 24.0 5.6 1.8 6.7 3.7 12.8 75.3 17.5 4.0 3.0 0.8 2.1 4.6 2.9 2.7 40.0 6.0 2.9 12.6 0.8 6.6 3.6 3.7 16.1 12.5 20.6 4.4 79.4 5.8 2.1 9.2 11.5 3.0 11.6 17.0 24.4 5.9 6.9 26.4 0.8 0.0 0.0 0.0 0.0 0.3 1.9 2.4 3.4 1.6 0.2 0.8 3.2 4.3 0.8 0.6 14.3 0.1 19.0 3.1 16.2 0.0 0.0 7.3 6.0 0.0 2.0 21.4 0.0 4.1 3.4 51.6 2.2 0.0 0.1 0.0 5.6 5.8 0.2 0.2 1.1 0.4 1.5 1.5 7.0 2.2 20.0 0.8 0.2 0.0 0.1 0.3 0.1 0.9 1.7 2.8 9.1 1.2 0.1 50.2 0.0 4.9 0.9 1.4 0.6 0.4 10.3 0.0 199.5 489.2 1313.6 1.0 348.8 1.6 14.1 4.0 1.6 246.0 10.8 2.2 1.3 799.7 2.1 326.1 13.5 11.1 298.9 2.2 2.8 2.9 12.6 1.8 6.7 4.0 3.0 0.8 6.0 4.4 9.2 6.9 0.7 9.6 15.7 0.0 8.4 5.5 0.2 13.7 1.8 0.3 0.1 0.3 1.3 7.2 17.3 0.0 0.0 1.0 9.6 0.1 3.9 68.6 1.1 1.9 0.5 3.5 0.0 1.7 0.3 3.9 1.1 2.0 0.5 1.3 7.6 0.0 3.3 1.0 212.0 0.0 0.3 0.2 26.4 137.9 129.5 2.9 0.6 194.4 7.2 3.7 223.6 0.0 6.2 0.0 0.2 27.3 2.6 0.0 3.2 0.6 0.0 0.3 32.0 0.7 13.1 0.7 6.8 0.1 0.6 0.6 4.3 1.9 3.7 0.2 0.0 1.2 PDC MEKA ENSG00000116703 Phosducin P20941 1 186443566-186461114 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 488 "retina: 674.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 99.1;Cone photoreceptor cells: 362.8;Muller glia cells: 179.8;Rod photoreceptor cells: 999.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "hippocampal formation: 3.0" "Low region specificity" "Detected in all" HPA062235 Enhanced NA NA "HPA062235: AB_2684720" "unprognostic (2.06e-2)" "unprognostic (3.31e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-4)" "unprognostic (2.18e-1)" "unprognostic (7.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (8.28e-3)" "unprognostic (4.07e-7)" "unprognostic (3.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.61e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 674.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.9 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 99.1 0.0 0.0 0.1 0.0 0.0 0.0 362.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 6.2 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 57.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 179.8 0.0 2.5 2.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 999.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 SLC35D1 "KIAA0260, UGTREL7" ENSG00000116704 "Solute carrier family 35 member D1" Q9NTN3 1 66999350-67054148 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 75.6;Early spermatids: 73.5;Hepatocytes: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.91e-2)" "unprognostic (3.69e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.63e-1)" "unprognostic (6.53e-2)" "unprognostic (2.49e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (2.12e-3)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (2.07e-1)" "unprognostic (7.65e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.08e-3)" "unprognostic (3.20e-1)" 4.9 6.7 4.2 7.8 4.8 9.0 5.2 4.3 4.3 7.6 8.8 26.2 16.0 5.8 4.9 5.3 5.0 6.5 3.7 3.9 11.1 12.6 75.3 3.8 7.6 4.9 6.2 3.9 7.9 7.5 8.2 5.7 9.6 4.7 7.2 27.1 12.4 4.4 5.8 7.6 9.9 16.4 7.0 4.4 4.2 13.0 6.3 5.5 10.2 6.5 5.0 8.6 7.4 6.9 7.2 8.3 4.7 14.2 12.0 14.4 16.6 16.8 18.4 24.1 13.1 9.1 10.2 2.0 25.7 7.9 14.6 15.4 12.5 9.9 11.6 16.4 25.8 4.6 19.2 9.8 20.2 12.1 22.0 12.2 16.3 25.4 15.4 10.9 21.0 5.1 10.6 11.8 13.3 32.0 2.8 13.6 6.8 5.9 22.5 6.4 10.4 29.3 2.9 6.0 15.6 1.7 6.3 27.8 8.5 11.9 7.9 7.0 16.2 5.6 24.2 5.7 15.0 17.9 27.6 15.4 14.1 17.2 3.3 10.4 8.5 0.9 2.6 2.0 0.7 2.4 1.3 1.5 1.6 1.1 0.9 2.1 2.0 0.2 3.5 1.7 0.6 2.8 0.9 4.2 4.8 4.3 4.3 3.9 11.1 4.9 6.2 3.9 4.7 4.4 5.5 7.2 4.9 6.4 2.2 34.6 12.8 5.5 5.9 9.4 13.1 6.9 7.5 4.8 3.1 20.0 4.6 5.5 12.5 40.5 18.3 75.6 0.0 3.1 73.5 6.3 10.9 4.3 15.0 9.1 22.8 9.6 5.7 8.3 14.8 8.7 4.5 13.2 7.5 114.3 6.9 6.7 28.2 18.9 2.0 8.8 4.6 13.7 6.2 5.5 1.8 23.4 3.1 17.8 9.2 37.7 51.2 8.3 20.8 4.5 9.3 5.8 24.9 10.6 7.5 9.4 0.0 8.6 7.5 7.7 6.4 8.2 7.7 16.3 12.8 11.3 21.7 8.8 PLA2G4A "cPLA2-alpha, PLA2G4" ENSG00000116711 "Phospholipase A2 group IVA" P47712 1 186828949-186988981 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 87.8;seminal vesicle: 48.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 7 "dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4" "Cell line enhanced" "Detected in many" "HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010050, HPA050062, HPA054206" Approved Supported Vesicles,Cytosol NA NA 35000 Cytosol Vesicles "CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417" "prognostic favorable (9.07e-4)" "unprognostic (1.18e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.85e-4)" "unprognostic (5.55e-2)" "unprognostic (1.51e-3)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (2.63e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (2.96e-2)" "unprognostic (8.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (4.26e-2)" 10.0 12.8 2.4 6.3 3.8 4.9 6.6 3.0 3.7 14.6 4.1 9.4 11.2 10.3 11.8 7.6 25.1 6.2 4.1 2.3 3.3 9.1 2.1 6.0 5.3 3.7 3.5 1.9 6.5 7.7 87.8 2.0 5.8 4.0 8.9 8.2 0.8 6.4 48.7 0.5 9.6 8.3 10.6 4.0 6.6 5.3 2.8 4.4 1.5 2.6 2.1 2.9 29.4 8.5 4.5 0.0 39.7 0.2 0.0 23.8 9.5 0.0 1.5 15.1 1.8 3.2 0.3 15.5 0.0 0.0 0.0 6.8 2.8 24.6 7.4 0.8 12.5 0.6 7.6 52.4 0.0 14.7 11.1 3.8 5.4 5.0 19.5 4.0 2.4 16.5 3.4 16.7 5.9 0.0 0.0 0.0 0.0 2.1 84.4 5.1 0.0 0.0 73.4 0.1 5.4 0.2 0.0 5.9 2.0 7.3 0.7 0.8 15.0 3.3 14.3 1.9 66.3 3.2 2.3 0.0 0.0 5.3 32.4 20.7 0.2 6.8 7.8 0.0 8.4 0.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.6 1.1 4.0 3.1 0.0 1.7 2.4 3.8 3.0 3.7 2.3 3.3 3.7 3.5 1.9 4.0 4.0 4.4 4.5 0.6 0.0 1.1 0.3 0.2 21.4 4.3 4.6 10.2 0.2 2.9 2.9 2.3 0.0 4.9 0.0 0.0 0.1 3.2 1.6 1.9 2.1 0.9 33.4 1.7 6.6 1.2 3.0 8.1 0.0 0.1 11.2 7.1 28.1 10.8 3.3 1.1 0.2 6.6 0.0 5.8 2.6 2.0 7.9 8.3 1.3 10.5 11.5 5.4 115.2 3.7 0.0 1.0 2.0 0.4 1.7 7.3 14.7 0.0 2.3 2.0 0.3 2.3 0.5 0.0 1.2 5.0 0.6 0.3 5.2 8.9 0.0 1.0 1.2 4.8 13.4 GADD45A "DDIT1, GADD45" ENSG00000116717 "Growth arrest and DNA damage inducible alpha" P24522 1 67685201-67688334 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 242.5" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 858.9;Basal prostatic cells: 2807.1;Glandular and luminal cells: 982.6;Urothelial cells: 1740.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 48.4" "Group enriched" "Detected in all" 5 "granulocytes: 48.4;T-cells: 18.6" "Cell line enhanced" "Detected in all" "HHSteC: 365.9;hTERT-HME1: 577.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053420 Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA053420: AB_2682144" "unprognostic (1.36e-2)" "unprognostic (3.29e-2)" "unprognostic (9.58e-2)" "unprognostic (3.76e-3)" "unprognostic (5.81e-2)" "unprognostic (1.36e-2)" "unprognostic (1.57e-3)" "unprognostic (2.80e-3)" "unprognostic (1.42e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-2)" "unprognostic (5.21e-2)" "prognostic favorable (8.06e-6)" "unprognostic (6.11e-2)" "unprognostic (2.89e-1)" "unprognostic (3.43e-3)" "unprognostic (1.93e-1)" 110.4 16.1 22.1 20.2 24.8 137.4 84.4 18.5 34.4 59.5 21.3 26.7 25.0 70.1 23.5 39.5 42.6 44.5 53.7 20.3 39.0 145.6 166.3 75.6 13.8 34.4 25.9 17.3 50.0 20.4 19.7 19.3 22.4 31.1 25.8 21.4 19.1 32.7 37.2 242.5 53.2 32.4 38.7 18.0 27.0 53.6 12.4 26.4 31.0 74.4 26.6 16.9 50.9 44.8 33.1 138.6 9.7 22.3 7.5 44.8 43.9 219.8 239.5 122.6 88.5 96.7 50.8 25.3 61.1 71.4 42.0 206.6 85.3 3.0 219.6 164.5 44.9 23.6 75.7 24.0 51.8 365.9 22.5 7.5 76.7 117.8 107.7 577.7 41.5 61.0 15.2 165.6 109.9 104.5 4.8 7.2 27.3 29.8 19.3 96.3 16.4 177.2 67.9 44.2 110.5 102.7 17.1 51.9 15.2 158.3 79.7 2.6 23.2 61.6 85.7 111.6 89.3 165.7 267.3 54.9 106.8 37.8 11.1 86.3 23.6 5.7 48.4 6.3 2.8 5.3 2.3 4.4 5.3 2.6 1.5 1.2 2.0 8.2 6.5 2.0 4.1 18.6 8.7 22.1 24.8 18.5 34.4 20.3 39.0 34.4 25.9 17.3 31.1 18.0 26.4 33.1 402.5 64.1 19.0 6.8 51.2 858.9 2807.1 273.2 225.3 45.1 56.7 100.6 190.5 47.1 155.8 103.0 10.4 24.6 85.1 175.3 236.7 264.4 1.6 410.7 250.6 176.6 131.7 116.2 6.1 253.6 117.8 177.0 87.7 982.6 44.5 18.9 74.6 110.1 18.6 26.9 7.0 99.6 122.1 23.5 290.6 4.0 38.2 94.7 158.3 7.5 273.2 30.3 12.3 6.6 1.0 367.3 202.0 64.7 116.8 786.2 101.4 530.0 135.1 72.8 52.6 136.0 201.6 3.7 18.8 365.2 390.8 17.6 139.5 88.6 70.3 1740.4 PRAMEF1 ENSG00000116721 "PRAME family member 1" O95521 1 12791397-12796628 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "Early spermatids: 7.6;Late spermatids: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF12 ENSG00000116726 "PRAME family member 12" O95522 1 12773738-12777906 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045286, HPA051704" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045286: AB_10794782, HPA051704: AB_2681581" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP" ENSG00000116729 "Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 22.1;neutrophil: 61.7" "Group enriched" "Detected in many" 46 "granulocytes: 61.7;monocytes: 22.1" "Cell line enhanced" "Detected in many" "AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA069520: AB_2686144" "prognostic favorable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favorable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favorable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.51e-4)" 37.2 43.4 76.2 21.7 72.2 4.7 36.8 89.2 74.1 47.3 115.2 63.8 24.0 49.5 137.0 62.9 49.2 68.8 64.3 62.9 141.9 93.5 23.6 53.4 13.1 110.1 107.0 59.6 77.4 84.4 38.9 17.0 77.9 88.9 72.3 57.9 138.4 32.9 103.0 14.3 46.3 34.3 62.4 104.7 30.0 57.1 24.1 115.2 13.6 22.8 25.4 19.4 65.0 38.1 98.3 11.5 17.3 392.1 0.3 214.0 294.1 228.4 55.6 135.1 75.7 104.0 24.3 26.2 0.2 54.9 16.0 70.7 116.0 89.3 91.7 63.6 0.6 67.8 0.4 45.4 0.2 187.2 0.1 0.9 214.0 60.3 185.3 60.6 77.2 181.0 21.4 0.0 1.0 113.0 1.7 0.3 1.3 17.7 24.7 27.3 0.1 82.2 0.5 13.5 60.3 21.8 46.0 51.0 2.3 67.3 357.0 10.6 1.6 209.7 71.7 56.9 116.9 76.1 26.6 0.8 0.2 165.0 1.8 134.1 0.0 22.1 0.0 0.0 5.4 0.1 0.1 0.0 0.0 0.9 0.1 0.0 0.0 61.7 0.0 0.7 0.3 0.0 4.8 76.2 72.2 89.2 74.1 62.9 141.9 110.1 107.0 59.6 88.9 104.7 115.2 98.3 20.9 48.1 34.6 145.3 1.2 42.4 60.1 28.5 95.0 8.9 25.4 61.2 32.6 42.9 41.3 27.6 139.7 134.7 0.9 65.7 9.8 74.3 15.3 110.8 60.1 31.5 9.6 0.0 27.0 60.3 6.7 44.9 28.5 235.3 5.7 4.6 43.5 10.9 24.9 13.5 132.3 24.5 61.1 10.6 11.2 9.4 32.6 14.7 19.6 61.8 18.0 11.8 0.0 59.3 3.7 69.1 27.2 55.3 0.2 31.3 8.9 36.2 81.1 166.4 39.5 15.7 46.4 0.8 1.0 39.7 30.0 55.1 3.2 39.2 38.4 46.8 PRDM2 "HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2" ENSG00000116731 "PR/SET domain 2" Q13029 1 13700198-13825079 "Enzymes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005809 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA005809: AB_1079673" "unprognostic (2.22e-1)" "unprognostic (3.28e-1)" "unprognostic (5.34e-2)" "unprognostic (1.28e-2)" "unprognostic (6.70e-2)" "unprognostic (2.72e-3)" "unprognostic (1.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.20e-2)" "unprognostic (2.53e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (9.63e-3)" "unprognostic (3.81e-1)" "unprognostic (2.45e-1)" "unprognostic (1.85e-1)" "unprognostic (5.85e-3)" 20.9 15.3 18.0 19.5 23.3 80.1 22.1 28.4 39.0 26.6 10.6 23.5 13.1 24.4 16.5 22.1 21.1 17.1 19.3 23.1 16.6 13.9 13.2 21.5 27.5 23.0 20.0 20.7 34.6 15.0 14.8 16.4 16.8 25.1 24.5 13.9 18.3 21.3 17.8 44.1 27.0 23.8 15.1 15.8 20.3 19.4 18.9 17.7 22.8 24.6 30.2 25.2 27.2 27.0 36.4 15.3 8.5 30.3 11.8 23.5 18.0 14.6 19.5 11.8 13.0 14.5 13.5 16.9 46.4 16.7 18.9 11.0 18.5 22.8 11.4 14.4 28.9 16.3 31.2 10.6 6.4 12.9 10.5 25.8 19.1 19.7 13.8 11.4 12.4 13.0 18.0 28.2 52.0 16.5 7.7 16.9 16.6 9.0 12.1 11.4 23.3 16.4 13.9 7.4 17.0 26.3 17.0 15.7 9.8 21.4 18.0 13.9 16.8 23.2 16.7 18.1 15.3 10.9 75.8 55.4 65.5 14.8 24.1 21.9 4.7 4.9 7.5 5.5 3.2 3.5 18.5 4.4 5.2 3.0 13.4 4.9 4.4 9.9 6.2 6.0 5.6 4.4 2.8 18.0 23.3 28.4 39.0 23.1 16.6 23.0 20.0 20.7 25.1 15.8 17.7 36.4 41.3 38.5 39.7 34.3 182.9 62.1 54.8 17.1 61.5 49.5 43.8 33.8 41.3 27.1 33.0 23.9 45.9 25.6 77.7 26.9 17.6 17.3 21.7 84.5 62.5 35.1 37.8 21.7 114.5 13.8 16.2 47.6 25.5 121.2 40.5 50.0 26.0 18.8 16.6 70.7 97.0 24.1 14.2 45.6 39.9 15.6 44.1 42.1 30.2 75.9 41.5 21.2 59.8 70.4 122.5 15.5 25.7 45.1 71.7 54.5 34.2 9.0 43.8 39.7 26.3 86.3 34.4 52.7 49.4 65.4 52.1 18.3 74.4 25.8 19.6 64.5 RGS2 G0S8 ENSG00000116741 "Regulator of G protein signaling 2" P41220 1 192809039-192812275 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Translation regulation" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 1871.8;Langerhans cells: 637.8;Macrophages: 621.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 3268.4;neutrophil: 4374.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 4374.2" "Cell line enhanced" "Detected in many" "hTCEpi: 141.8;hTERT-HME1: 96.8;Karpas-707: 94.0;PC-3: 226.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013385 Supported Cytosol NA NA Cytosol "HPA013385: AB_2668827" "prognostic favorable (2.43e-4)" "unprognostic (9.75e-2)" "unprognostic (1.28e-3)" "unprognostic (4.43e-2)" "unprognostic (1.79e-1)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.79e-2)" "unprognostic (1.36e-1)" "unprognostic (6.49e-2)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" 130.4 357.2 51.2 243.5 53.3 569.9 128.1 53.6 116.6 67.8 64.6 242.8 144.0 219.2 96.8 258.5 150.5 191.1 51.9 54.2 66.1 51.8 66.9 124.6 37.4 63.9 53.7 45.7 138.6 517.7 12.6 200.3 101.0 55.3 183.8 111.2 37.2 27.8 224.5 10.1 35.8 105.8 510.1 53.1 193.6 114.4 18.9 58.6 47.8 22.9 64.3 17.5 261.9 72.3 76.4 0.0 20.1 25.4 2.4 48.9 7.7 1.5 9.9 12.4 3.2 3.4 17.9 11.8 1.7 2.8 9.3 2.5 9.7 16.7 17.5 2.9 2.6 12.3 4.8 12.9 0.4 21.5 12.1 2.8 8.1 141.8 6.5 96.8 18.1 23.9 9.1 4.4 94.0 10.0 0.3 6.6 16.8 34.0 1.9 226.6 6.7 5.9 5.4 16.9 16.3 9.4 47.4 7.1 0.5 11.8 26.0 0.7 6.0 6.7 4.8 4.5 5.2 5.2 55.4 1.7 5.3 67.3 2.4 17.8 3268.4 517.9 754.6 14.3 200.8 32.1 6.4 10.2 10.4 118.8 3.3 5.2 6.6 4374.2 2.3 362.7 16.0 6.7 310.2 51.2 53.3 53.6 116.6 54.2 66.1 63.9 53.7 45.7 55.3 53.1 58.6 76.4 22.3 51.3 195.9 6.8 187.2 42.3 47.3 45.0 6.2 18.7 138.5 44.1 69.4 7.2 46.1 136.1 18.8 227.6 145.1 27.0 0.0 33.5 24.6 6.9 51.5 38.6 349.2 3.2 6.6 30.3 24.5 125.8 38.7 7.5 1871.8 2.3 18.5 3.1 374.4 21.9 8.4 96.9 42.7 345.0 637.8 18.3 16.4 621.2 88.9 8.4 305.0 41.5 25.7 3.5 2.4 14.8 60.3 62.8 135.9 36.3 141.5 2.5 20.4 39.0 0.0 61.4 55.5 4.2 16.9 6.1 31.1 124.2 346.1 16.6 32.3 11.3 RPE65 "BCO3, LCA2, rd12, RP20" ENSG00000116745 "Retinoid isomerohydrolase RPE65" Q16518 1 68428822-68449954 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Hydrolase, Isomerase" "Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;choroid plexus: 3.9;retina: 8.5;seminal vesicle: 4.5" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 17.8" "Group enriched" "Detected in some" 10 "glioma: 5.8;head and neck cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.4;PC-3: 5.6;U-2 OS: 1.3" "Group enriched" "Detected in many" 4 "amygdala: 3.2;basal ganglia: 2.5;cerebral cortex: 3.9;hippocampal formation: 2.5" "Low region specificity" "Detected in many" NA NA "unprognostic (1.59e-1)" "unprognostic (1.88e-1)" "unprognostic (3.15e-1)" "prognostic favorable (9.75e-4)" "unprognostic (4.55e-2)" "unprognostic (5.91e-2)" "unprognostic (6.59e-4)" "unprognostic (2.98e-2)" "unprognostic (1.57e-1)" "unprognostic (8.24e-2)" "unprognostic (3.21e-4)" "unprognostic (2.11e-1)" "unprognostic (2.05e-1)" "unprognostic (3.48e-2)" "unprognostic (8.40e-3)" 0.0 0.0 1.4 0.0 0.9 0.0 0.4 1.4 0.8 0.1 3.9 0.1 0.2 0.6 0.1 0.3 0.3 0.1 0.0 0.7 2.8 0.0 0.0 0.0 0.0 2.7 4.5 0.1 0.0 0.0 0.0 0.0 0.0 3.0 1.8 0.1 8.5 0.1 4.5 0.0 0.0 0.0 0.2 1.6 0.1 0.3 0.1 3.9 0.0 0.0 0.0 0.0 0.2 0.0 1.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 1.4 0.8 0.7 2.8 2.7 4.5 0.1 3.0 1.6 3.9 1.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.8 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RO60 "SSA2, TROVE2" ENSG00000116747 "Ro60, Y RNA binding protein" P10155 1 193059454-193091777 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 53.0;Cardiomyocytes: 53.0;Cytotrophoblasts: 47.1;dendritic cells: 41.3;Extravillous trophoblasts: 45.2;Hofbauer cells: 33.4;Syncytiotrophoblasts: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002835 Uncertain Supported Cytosol NA NA 50000 Cytosol "HPA002835: AB_1857490" "unprognostic (1.91e-2)" "unprognostic (5.11e-2)" "unprognostic (3.94e-3)" "unprognostic (7.34e-2)" "unprognostic (2.34e-2)" "unprognostic (1.41e-1)" "unprognostic (3.62e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-2)" "unprognostic (1.16e-2)" "unprognostic (8.45e-3)" "unprognostic (1.52e-1)" "unprognostic (1.05e-3)" "unprognostic (6.32e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.31e-4)" "unprognostic (5.62e-2)" 10.9 8.4 10.5 8.9 16.4 30.0 8.2 16.3 9.5 7.1 5.2 6.8 6.0 9.6 6.5 9.6 6.6 7.4 10.1 7.8 19.9 7.5 9.4 7.7 9.9 17.8 15.6 4.8 10.0 7.6 7.0 4.7 8.8 17.7 8.9 6.1 15.6 7.0 6.1 10.0 7.7 6.4 9.5 18.1 10.1 6.4 13.1 12.9 8.3 9.8 10.3 9.0 8.4 7.5 23.6 13.4 25.5 22.5 25.2 20.0 17.7 15.9 19.5 19.8 14.8 18.9 11.8 18.0 25.1 15.7 18.4 14.5 18.7 19.0 13.3 23.2 40.7 14.4 31.4 22.2 15.6 16.5 35.4 23.4 15.9 13.2 25.4 25.1 11.4 19.4 11.5 34.7 38.0 20.3 26.6 21.1 9.3 16.1 10.2 10.8 18.2 21.1 30.7 11.8 28.0 9.4 17.6 25.0 24.8 25.0 15.3 24.2 14.4 26.8 26.0 11.4 25.7 25.8 20.5 29.0 26.8 11.8 18.1 38.9 102.1 31.6 46.0 53.4 29.9 52.3 47.7 37.2 47.0 32.4 44.6 39.6 45.2 53.9 45.2 33.2 29.1 44.7 39.8 10.5 16.4 16.3 9.5 7.8 19.9 17.8 15.6 4.8 17.7 18.1 12.9 23.6 53.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 47.1 41.3 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 45.2 17.8 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 48.0 6.2 0.0 0.0 0.0 AMPD1 "MAD, MADA" ENSG00000116748 "Adenosine monophosphate deaminase 1" P23109 1 114673090-114695618 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 564.4;tongue: 213.3" "Group enriched" "Detected in some" 6 "Plasma cells: 43.8;Skeletal myocytes: 13.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "U-266/70: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026478, HPA028080" Enhanced "Intracellular and membrane" NA NA 38000 "HPA026478: AB_10599969, HPA028080: AB_10600776" "unprognostic (1.98e-3)" "unprognostic (1.43e-3)" "unprognostic (8.75e-3)" "unprognostic (8.03e-2)" "unprognostic (1.95e-2)" "unprognostic (5.61e-3)" "unprognostic (8.21e-2)" "unprognostic (4.29e-3)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.36e-5)" "unprognostic (1.68e-1)" "unprognostic (3.70e-1)" "unprognostic (3.36e-1)" "unprognostic (4.02e-1)" 0.1 0.1 0.0 0.5 0.0 0.3 3.0 0.0 0.0 0.2 0.0 5.7 16.6 0.2 0.0 5.8 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 0.0 1.0 0.1 0.3 0.0 0.0 0.0 3.6 5.6 0.0 4.5 0.9 564.4 0.0 7.6 0.1 0.0 1.6 3.8 0.1 0.0 0.4 0.1 213.3 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.8 1.9 0.0 0.0 0.0 3.0 4.2 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 18000 "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 20.1 19.2 11.2 22.7 13.2 24.8 22.9 21.5 16.7 13.7 6.9 23.5 24.9 14.9 17.6 32.5 11.4 15.7 30.8 14.7 13.5 27.4 38.2 16.1 29.3 13.8 12.7 12.0 16.6 33.4 20.5 9.8 23.3 13.8 21.5 24.2 38.1 26.2 16.1 40.0 21.5 24.4 18.2 13.3 18.2 18.0 13.5 11.6 25.1 19.3 37.1 32.9 19.2 14.4 16.1 136.6 74.0 61.7 65.5 37.1 37.8 76.4 80.1 40.4 74.8 65.8 71.4 94.9 104.7 72.5 44.4 43.2 85.5 84.1 99.5 100.9 110.0 61.9 126.0 97.5 97.3 57.6 198.5 67.8 33.9 44.5 106.1 91.2 33.6 76.4 100.3 285.1 86.2 67.3 105.9 146.2 70.1 57.7 89.1 46.9 84.5 68.3 216.4 70.8 81.0 61.2 76.7 72.7 97.3 110.4 64.9 82.2 95.8 49.9 71.9 21.4 70.0 125.0 62.8 105.2 117.5 40.2 119.5 123.6 60.9 31.7 41.6 53.3 40.1 59.5 43.8 48.0 51.2 39.0 37.4 51.0 57.1 19.5 75.2 45.0 41.3 51.3 44.8 11.2 13.2 21.5 16.7 14.7 13.5 13.8 12.7 12.0 13.8 13.3 11.6 16.1 33.9 9.6 30.2 12.7 28.6 24.3 13.5 27.9 18.8 20.6 19.4 16.6 79.5 21.5 28.5 27.6 43.8 35.8 45.7 18.9 45.0 26.3 2.8 13.0 15.4 21.4 10.8 39.7 35.4 28.3 34.5 22.8 20.9 16.0 56.3 21.4 17.9 24.6 28.0 25.2 33.2 20.2 16.2 18.8 20.7 3.8 14.9 25.0 17.8 19.7 23.4 27.4 75.2 18.1 29.6 25.3 10.6 17.3 58.5 21.8 30.2 39.9 21.1 43.5 19.7 19.6 34.9 22.1 16.8 32.7 30.0 25.2 34.5 31.9 23.2 12.4 BCAS2 "DAM1, Snt309, SPF27" ENSG00000116752 "BCAS2 pre-mRNA processing factor" O75934 1 114567557-114581629 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 613.4" "Low region specificity" "Detected in all" HPA067881 Supported Supported "Nuclear speckles,Centrosome" NA NA "Nuclear speckles, Centrosome" "HPA067881: AB_2685915" "unprognostic (6.93e-2)" "unprognostic (1.88e-2)" "unprognostic (8.58e-3)" "unprognostic (4.74e-2)" "unprognostic (2.49e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (8.23e-7)" "unprognostic (1.16e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.96e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (4.27e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.25e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.87e-1)" 32.2 41.0 36.9 28.2 38.8 76.9 38.6 40.1 43.6 27.3 39.0 31.9 25.8 35.5 50.1 34.4 25.1 32.1 39.7 38.3 42.0 45.0 51.7 27.2 38.8 37.8 38.9 35.5 32.8 29.1 41.6 33.3 28.0 39.3 35.9 32.4 40.7 29.8 27.5 57.0 30.0 26.3 28.0 37.8 26.3 29.0 32.1 38.1 32.5 42.8 26.2 36.5 41.9 23.6 41.1 100.0 35.6 70.8 69.9 37.8 43.8 108.8 71.3 57.0 95.6 97.4 50.8 40.6 88.8 93.9 46.9 64.3 47.8 85.5 72.7 133.3 76.7 75.7 45.0 67.2 74.6 68.8 117.8 48.1 39.2 79.4 97.5 121.3 44.2 63.7 95.0 89.6 64.5 80.5 613.4 103.1 87.5 125.6 60.8 80.8 73.9 127.6 62.2 68.1 85.9 93.5 62.2 90.3 70.3 114.3 59.6 62.3 91.0 52.8 58.2 74.7 116.9 138.2 68.5 76.9 143.4 113.4 94.7 223.9 54.4 36.8 65.3 56.0 45.2 78.9 63.3 71.6 70.6 39.7 58.0 73.8 71.9 34.7 75.0 51.0 51.2 77.6 72.8 36.9 38.8 40.1 43.6 38.3 42.0 37.8 38.9 35.5 39.3 37.8 38.1 41.1 51.6 28.9 45.4 11.1 110.1 77.9 114.2 155.9 91.0 62.6 36.7 49.1 76.0 27.1 85.4 49.7 37.5 76.6 99.0 26.4 95.9 66.6 30.3 79.0 51.5 46.9 50.0 30.5 16.4 66.8 89.8 60.0 25.0 139.1 99.1 46.0 28.2 31.3 66.9 38.7 15.1 43.1 103.7 34.9 93.3 17.7 39.7 80.8 67.6 12.2 50.6 98.3 55.6 15.1 18.1 51.2 37.9 43.6 176.7 49.8 29.4 103.9 55.6 67.1 39.5 55.5 71.4 80.8 40.6 95.7 63.4 101.2 117.4 64.2 36.0 114.2 SRSF11 "NET2, p54, SFRS11" ENSG00000116754 "Serine and arginine rich splicing factor 11" Q05519 1 70205682-70253052 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008762 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA008762: AB_1856782" "unprognostic (7.82e-3)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (2.85e-1)" "unprognostic (5.32e-3)" "unprognostic (1.30e-3)" "prognostic unfavorable (3.91e-4)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.22e-1)" "unprognostic (6.25e-3)" "prognostic unfavorable (6.53e-6)" "unprognostic (7.79e-2)" "unprognostic (1.63e-1)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" 75.8 67.6 48.4 51.9 51.5 138.0 77.6 56.6 60.5 86.0 49.7 71.5 45.1 76.6 70.7 62.6 84.4 45.5 50.0 48.7 50.7 60.5 94.9 70.7 76.4 51.0 50.3 46.6 97.1 86.4 43.3 80.4 56.5 52.7 74.3 45.5 58.2 70.1 41.2 66.8 76.5 85.6 39.6 49.2 90.5 73.5 58.9 50.4 76.1 86.9 33.2 65.2 69.1 75.6 57.0 92.8 46.2 118.4 76.2 59.5 79.7 162.4 111.6 57.5 89.0 80.3 81.6 68.0 156.6 74.7 56.5 58.4 77.4 151.5 61.4 120.7 105.9 118.1 159.0 112.4 98.5 71.1 221.0 63.3 64.2 76.0 82.5 83.5 111.3 80.4 79.0 159.1 96.1 88.7 36.4 133.3 163.1 190.9 72.3 76.9 156.1 130.9 99.9 104.3 65.7 99.3 82.1 94.5 101.1 139.8 109.1 80.9 98.1 96.0 97.8 70.4 71.3 102.3 110.4 94.5 169.9 70.2 161.3 87.7 111.7 63.5 103.6 65.7 51.6 74.9 76.3 67.0 65.2 66.1 70.7 72.2 67.8 31.7 85.8 64.6 91.7 80.4 52.7 48.4 51.5 56.6 60.5 48.7 50.7 51.0 50.3 46.6 52.7 49.2 50.4 57.0 198.6 211.5 224.9 90.4 208.6 354.0 295.5 229.6 222.5 164.8 166.9 171.7 119.6 115.8 184.5 195.0 118.9 242.0 243.4 123.8 115.4 151.0 64.4 160.0 267.9 186.8 173.8 218.5 219.0 135.3 253.1 228.9 165.6 231.0 194.1 218.1 146.3 152.6 150.4 159.9 183.0 158.3 150.5 124.9 244.4 56.9 255.7 155.4 168.9 126.5 183.1 115.5 145.2 168.9 219.8 144.9 104.7 264.4 234.9 317.8 122.1 101.4 157.8 158.1 170.9 199.1 218.3 270.0 138.0 181.4 353.6 303.7 226.2 195.5 172.9 315.0 CTH ENSG00000116761 "Cystathionine gamma-lyase" P32929 1 70411218-70439851 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Calmodulin-binding, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 123.9;ovary: 34.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 38.0;Hepatocytes: 141.6" "Group enriched" "Detected in all" 5 "liver cancer: 30.0;testis cancer: 8.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021591, HPA023300" Enhanced NA NA 220000 "HPA021591: AB_1847321, HPA023300: AB_1847322" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.76e-1)" "unprognostic (7.66e-2)" "unprognostic (2.45e-3)" "prognostic favorable (8.69e-4)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "unprognostic (1.00e-1)" "unprognostic (1.43e-3)" "unprognostic (5.05e-3)" "unprognostic (3.25e-2)" "unprognostic (1.03e-1)" "unprognostic (8.97e-2)" "unprognostic (3.05e-3)" "unprognostic (1.26e-1)" 3.4 13.1 3.4 1.3 3.0 3.4 3.0 3.3 4.0 2.4 3.9 5.2 5.2 2.3 1.6 4.5 3.8 1.9 2.1 3.2 6.6 13.6 123.9 3.1 0.9 3.4 3.4 3.2 34.7 17.1 1.4 2.9 1.1 3.2 4.3 6.3 8.2 2.5 2.1 3.6 1.2 5.3 1.3 2.6 1.0 7.5 4.2 3.3 0.6 7.8 3.0 1.3 2.2 1.9 3.2 10.2 1.5 7.1 10.0 8.5 4.8 15.0 4.3 4.1 3.8 15.7 3.2 6.4 5.8 3.4 3.1 9.3 4.9 27.3 3.1 7.2 17.3 5.9 7.0 5.1 9.4 39.7 7.8 1.7 7.5 24.4 7.5 8.8 1.5 3.2 11.9 14.0 63.8 2.2 3.2 2.7 1.9 7.2 4.2 5.9 3.0 3.7 16.2 7.3 0.1 3.9 3.3 6.6 7.7 85.7 13.3 2.6 4.6 1.1 1.2 7.7 5.7 4.1 23.8 15.3 3.1 9.8 16.1 3.1 0.8 0.3 0.1 1.2 0.2 2.1 2.2 1.1 1.7 0.5 1.7 3.2 1.5 0.4 0.2 0.2 0.7 0.3 0.6 3.4 3.0 3.3 4.0 3.2 6.6 3.4 3.4 3.2 3.2 2.6 3.3 3.2 2.8 6.4 5.6 16.6 6.7 2.5 8.0 2.2 6.2 9.4 6.2 5.8 1.9 5.7 2.5 5.5 10.4 0.8 5.5 16.1 11.7 1.8 27.2 38.0 6.4 3.3 3.0 7.4 7.8 4.2 1.8 13.6 14.8 19.7 0.0 1.9 3.9 141.6 1.2 0.0 7.4 7.9 2.0 3.5 5.7 5.2 1.2 4.7 19.6 1.9 0.0 4.4 0.0 7.1 4.2 6.4 12.9 4.1 10.8 4.0 11.1 29.2 0.7 11.6 0.0 2.8 17.7 1.4 0.6 4.8 2.0 0.8 11.2 4.5 9.1 3.8 AGMAT FLJ23384 ENSG00000116771 Agmatinase Q9BSE5 1 15571699-15585051 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Putrescine biosynthesis, Spermidine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 135.1;liver: 62.6;skeletal muscle: 34.5" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 306.8" "Group enriched" "Detected in all" 5 "colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 8.4" "Cell line enhanced" "Detected in many" "CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA026443, HPA028321" Enhanced NA NA 240000 "HPA026443: AB_1844644, HPA028321: AB_10600779" "unprognostic (2.27e-2)" "unprognostic (3.45e-1)" "unprognostic (1.79e-3)" "unprognostic (3.60e-2)" "unprognostic (8.72e-2)" "unprognostic (6.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.37e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.13e-4)" "unprognostic (4.43e-3)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-2)" 0.4 1.1 1.3 3.2 1.2 1.0 0.3 1.4 1.5 0.5 0.9 9.3 18.0 0.5 0.3 0.5 0.3 0.5 0.1 1.0 0.9 135.1 62.6 0.2 4.0 0.8 0.7 1.5 0.1 0.6 2.2 0.3 0.2 1.1 0.5 6.9 0.4 4.6 0.1 34.5 0.4 13.5 0.7 0.4 1.6 1.8 0.8 0.8 2.2 0.5 6.2 4.2 0.8 0.1 1.5 7.7 6.3 0.5 0.3 0.1 0.8 0.2 1.3 1.4 0.8 0.5 36.7 5.1 0.1 0.2 0.9 0.2 0.2 0.0 0.0 0.9 7.6 0.1 5.2 5.1 92.6 0.9 4.0 0.2 0.9 0.4 2.4 0.0 0.6 0.7 0.1 0.1 10.3 1.9 8.6 0.2 4.0 8.1 6.5 3.7 0.1 0.0 22.3 0.2 2.2 1.5 1.1 10.9 0.4 1.3 0.4 1.5 8.2 1.1 0.3 0.3 2.1 0.1 0.3 6.1 5.0 0.4 0.1 0.2 1.2 0.3 0.2 2.1 0.3 2.6 4.1 4.5 2.4 0.2 2.7 8.4 5.0 1.4 0.5 0.2 0.4 6.4 2.0 1.3 1.2 1.4 1.5 1.0 0.9 0.8 0.7 1.5 1.1 0.4 0.8 1.5 0.2 0.0 0.0 1.0 5.9 0.3 1.7 0.5 0.0 1.3 0.5 0.9 0.6 2.8 0.3 3.7 0.0 0.9 0.5 7.4 31.3 1.1 9.4 1.2 1.1 0.6 1.2 2.1 1.9 0.9 0.8 0.7 5.1 2.1 0.0 1.4 1.8 42.5 1.1 3.3 2.2 9.6 2.0 2.9 0.8 4.2 0.3 2.0 1.8 3.7 1.9 1.0 5.2 0.5 0.4 2.3 6.0 0.0 2.0 1.7 27.0 306.8 1.4 2.4 0.0 4.7 0.5 1.6 3.5 1.2 0.6 0.8 5.0 3.4 18.9 3.0 OLFML3 "HNOEL-iso, OLF44" ENSG00000116774 "Olfactomedin like 3" Q9NRN5 1 113979391-114035572 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 12 "dendritic cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027991 Supported Vesicles "Secreted to extracellular matrix" NA NA 3000000 Vesicles "HPA027991: AB_2732440" "unprognostic (1.04e-1)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (2.02e-1)" "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.80e-3)" "unprognostic (1.88e-1)" "unprognostic (2.61e-1)" "unprognostic (4.41e-3)" 69.5 43.0 5.6 25.2 7.2 0.9 90.6 7.2 12.5 172.1 15.8 57.5 15.3 125.8 43.0 26.8 97.2 95.8 40.6 5.0 9.2 34.4 36.6 55.9 12.1 8.4 6.6 4.1 179.0 35.5 9.9 18.0 112.8 8.3 43.2 34.8 0.2 16.9 74.5 10.4 35.0 32.6 95.4 8.2 10.0 48.8 9.4 7.7 9.0 21.9 38.5 15.0 71.7 99.7 12.7 0.0 19.7 9.7 0.1 577.3 312.6 0.6 77.1 374.8 26.5 85.3 25.2 0.2 0.0 4.1 222.4 0.2 0.0 3.2 0.3 4.0 0.0 0.0 0.0 0.1 19.3 149.6 0.2 0.0 581.6 0.0 37.2 0.5 10.7 2.1 0.0 0.0 0.1 602.3 0.3 0.2 0.4 45.8 0.0 0.7 0.1 142.6 0.3 0.0 0.0 0.3 5.4 0.1 0.2 10.5 143.3 224.6 0.9 1.8 14.9 27.6 5.9 0.0 0.2 0.1 0.0 7.3 0.0 94.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.6 7.2 7.2 12.5 5.0 9.2 8.4 6.6 4.1 8.3 8.2 7.7 12.7 13.6 0.0 3.7 0.0 0.4 13.0 0.2 0.0 0.6 0.0 2.1 2.9 1.4 4.3 0.8 1.8 0.0 6.8 1.1 0.2 0.0 0.8 2.9 6.2 136.6 9.5 6.0 0.0 0.0 0.0 4.9 246.9 5.6 3.5 1.3 0.3 45.7 0.5 33.3 0.0 0.0 0.6 0.0 5.9 22.7 1.7 73.3 15.5 12.4 16.9 0.6 0.0 0.0 0.0 0.1 0.3 0.1 33.1 0.2 0.7 0.0 0.5 0.0 0.1 0.0 44.8 28.0 0.3 0.4 1.2 11.5 12.4 2.6 126.1 0.2 0.2 TNNI3K CARK ENSG00000116783 "TNNI3 interacting kinase" Q59H18 1 74235387-74544428 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "heart muscle: 59.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 27.0;Early spermatids: 32.0;Late spermatids: 6.6;Proximal tubular cells: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" NA NA "unprognostic (1.04e-2)" "unprognostic (1.34e-2)" "unprognostic (3.83e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-1)" "unprognostic (3.40e-2)" "unprognostic (3.05e-1)" "unprognostic (2.48e-3)" "unprognostic (2.00e-1)" "unprognostic (9.66e-2)" "unprognostic (5.04e-2)" "unprognostic (1.80e-1)" "unprognostic (3.59e-3)" "unprognostic (4.88e-3)" "unprognostic (1.20e-1)" "unprognostic (8.80e-2)" "unprognostic (8.77e-2)" 1.5 1.4 4.3 0.3 4.5 0.1 1.5 5.9 7.2 0.9 3.0 1.6 0.4 1.3 2.5 0.6 1.5 0.4 59.2 4.4 4.3 3.5 0.4 0.9 0.4 4.5 4.6 4.3 1.5 0.4 0.7 2.3 0.0 4.7 1.1 0.5 5.3 0.8 0.4 1.5 1.5 0.8 0.9 4.5 1.4 1.1 4.0 4.4 0.4 1.0 0.6 0.5 1.4 0.9 5.6 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.3 4.5 5.9 7.2 4.4 4.3 4.5 4.6 4.3 4.7 4.5 4.4 5.6 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 1.2 0.2 0.3 27.0 0.0 0.1 1.8 0.0 0.0 0.0 0.1 1.9 0.1 32.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 6.6 0.9 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 8.0 0.1 0.5 0.0 0.6 0.8 0.5 1.4 0.0 0.3 0.1 0.1 0.0 0.0 0.2 CFHR3 "CFHL3, DOWN16, FHR-3, FHR3, HLF4" ENSG00000116785 "Complement factor H related 3" Q02985 1 196774813-196795407 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 581 "liver: 510.0" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 205.5" "Cancer enriched" "Detected in single" 80 "liver cancer: 27.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;SuSa: 1.5;T-47d: 3.6;U-266/70: 6.4" "Secreted to blood" NA NA 582000000 3100000000 "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (7.16e-2)" "unprognostic (6.77e-2)" "unprognostic (4.46e-1)" "unprognostic (4.20e-3)" "prognostic favorable (2.86e-5)" "unprognostic (1.78e-1)" "unprognostic (2.05e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (6.11e-3)" "unprognostic (2.06e-10)" "unprognostic (2.67e-4)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.32e-1)" 0.8 0.2 0.2 0.2 0.4 0.1 0.2 0.0 0.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.3 0.1 0.3 510.0 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.4 0.1 0.7 0.0 0.7 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.4 0.0 0.9 0.0 0.0 0.0 0.3 0.0 1.5 3.6 0.0 0.0 0.1 0.2 0.3 0.0 6.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.8 16.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 7.1 205.5 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 PLEKHM2 KIAA0842 ENSG00000116786 "Pleckstrin homology and RUN domain containing M2" Q8IWE5 1 15684320-15734769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032304 Approved NA NA "HPA032304: AB_10670964" "unprognostic (3.07e-2)" "unprognostic (1.89e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.36e-8)" "unprognostic (4.01e-2)" "unprognostic (1.60e-1)" "unprognostic (1.10e-3)" "unprognostic (1.03e-2)" "unprognostic (2.59e-1)" "unprognostic (6.73e-3)" "unprognostic (3.30e-1)" "unprognostic (5.50e-1)" "unprognostic (6.49e-2)" "unprognostic (1.89e-2)" 38.6 38.0 63.2 23.2 67.2 66.8 32.5 53.4 122.8 32.3 39.6 29.2 16.4 32.3 7.6 40.8 27.2 22.2 55.2 70.3 51.3 26.5 20.8 47.3 26.6 57.2 59.4 64.2 33.6 27.9 24.8 27.0 23.0 62.2 29.8 9.1 8.3 27.4 15.4 137.1 46.2 28.0 17.2 48.9 43.3 28.5 35.9 60.5 19.1 28.4 63.5 17.5 32.6 34.9 78.0 43.1 25.5 24.4 42.7 56.8 45.3 26.5 36.3 58.9 45.1 41.4 35.0 37.7 23.9 37.8 55.8 45.6 25.2 19.0 40.9 17.2 46.4 33.2 29.5 43.3 27.3 59.9 25.0 32.5 52.2 45.2 47.0 53.2 51.9 34.2 39.6 35.8 63.0 23.3 33.5 28.5 25.9 18.6 14.4 21.1 38.7 21.3 32.3 22.1 18.7 25.3 34.5 40.7 24.1 99.1 16.6 16.3 37.8 38.8 62.3 29.0 62.7 27.5 31.9 23.2 29.7 53.7 39.7 38.7 0.3 2.8 1.8 1.8 2.8 1.4 2.1 1.2 0.7 2.6 2.4 1.5 1.2 3.0 1.1 3.3 2.1 0.8 1.5 63.2 67.2 53.4 122.8 70.3 51.3 57.2 59.4 64.2 62.2 48.9 60.5 78.0 25.6 16.0 16.0 28.7 15.5 24.9 11.7 8.8 3.4 28.4 14.2 14.2 26.6 8.6 7.8 16.5 22.9 7.8 16.8 16.6 1.9 13.1 31.6 15.1 26.1 18.9 11.3 2.5 27.2 17.8 8.9 23.3 14.3 25.7 18.4 25.5 26.7 11.6 37.2 28.6 25.8 15.4 6.1 38.9 20.9 24.5 20.5 36.9 8.8 23.4 14.5 28.4 3.1 16.6 17.6 23.4 14.7 18.0 8.7 19.2 10.5 6.8 8.9 21.1 0.0 27.4 18.7 18.4 6.0 15.9 36.1 24.6 11.8 26.1 12.2 23.9 CRYZ ENSG00000116791 "Crystallin zeta" Q08257 1 74705482-74733408 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 334.1;liver: 285.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 160.0;Distal tubular cells: 226.9;Hepatocytes: 200.6;Proximal tubular cells: 526.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 439.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021921, HPA023290" Approved Supported Cytosol NA NA 6400000 Cytosol "HPA021921: AB_1847262, HPA023290: AB_1847263" "unprognostic (3.64e-2)" "unprognostic (3.38e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.32e-3)" "unprognostic (5.79e-2)" "unprognostic (6.29e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-1)" "unprognostic (6.38e-3)" "unprognostic (2.19e-1)" "unprognostic (1.35e-3)" "unprognostic (3.12e-1)" "unprognostic (7.50e-2)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" 19.9 34.5 23.6 13.1 21.8 2.2 39.4 21.7 29.0 55.1 49.6 21.6 51.7 41.2 121.7 29.3 50.4 69.6 46.1 24.0 28.3 334.1 285.2 32.7 24.6 23.7 24.5 21.1 31.9 65.2 53.3 17.1 17.0 24.8 39.2 22.2 15.5 25.2 57.5 25.3 22.4 44.4 40.5 23.8 19.6 25.3 9.3 28.4 34.2 44.9 23.2 24.0 41.2 21.9 27.3 12.1 112.2 57.6 16.3 64.4 70.2 38.6 36.5 57.1 51.8 57.4 88.9 46.1 64.9 62.0 71.3 92.2 31.0 47.2 46.0 83.6 75.2 19.2 27.0 32.2 179.0 33.8 23.1 52.6 33.1 40.0 82.8 15.1 49.1 43.7 35.9 85.9 22.8 109.2 27.0 42.3 38.6 43.1 93.6 72.6 26.8 53.6 23.7 439.4 36.0 15.9 27.9 8.5 60.1 41.2 64.3 54.0 7.7 21.9 12.3 30.7 38.8 55.7 16.2 33.3 32.1 99.4 9.0 35.6 13.1 9.4 1.9 32.1 15.1 26.2 32.8 31.6 30.3 17.1 26.5 27.4 29.5 1.5 30.3 17.9 14.4 42.3 18.8 23.6 21.8 21.7 29.0 24.0 28.3 23.7 24.5 21.1 24.8 23.8 28.4 27.3 6.9 28.9 22.6 4.9 20.4 17.8 28.0 32.4 24.5 4.0 16.8 16.8 32.3 84.4 15.7 160.0 2.1 13.5 8.6 6.6 226.9 53.8 0.2 54.8 7.8 8.0 6.7 8.4 4.5 32.4 18.1 20.7 20.9 27.0 14.5 7.8 12.8 200.6 18.5 0.0 4.4 12.0 8.2 15.7 13.7 2.1 20.8 11.4 10.6 4.7 7.1 7.7 11.3 7.1 9.1 31.2 14.5 20.7 20.5 10.2 79.1 526.6 17.3 2.9 0.0 10.6 16.2 1.7 7.4 19.7 21.2 7.3 16.9 13.8 16.2 17.0 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 198.5;Excitatory neurons: 93.4;Inhibitory neurons: 102.6;Late spermatids: 124.5;Spermatocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" No No "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 5.3 8.1 8.4 6.6 7.8 18.9 3.9 15.8 8.6 5.2 17.1 4.6 3.5 5.0 7.2 2.5 10.6 7.0 5.1 7.4 8.9 6.9 8.2 8.2 5.7 8.1 7.7 8.0 3.1 6.8 11.5 12.2 6.9 8.8 4.3 4.9 14.3 4.0 5.1 4.6 1.7 4.1 6.7 6.6 8.7 6.7 30.7 7.6 3.3 4.7 2.9 6.4 6.3 3.0 8.0 28.5 14.7 40.5 21.5 20.1 18.0 9.4 25.6 34.0 22.3 36.4 16.0 22.3 8.1 35.3 17.8 16.6 15.3 15.6 10.2 25.7 33.8 15.5 19.6 30.0 18.5 16.4 24.4 26.7 15.0 2.7 29.9 6.6 32.3 41.9 0.0 12.0 36.1 27.4 41.9 0.3 23.6 32.4 10.6 21.3 25.5 60.8 16.3 35.9 12.3 27.7 26.0 28.7 13.9 16.1 20.9 5.6 19.6 44.4 17.5 23.8 32.6 25.2 48.9 53.5 14.8 43.0 20.8 48.6 1.4 1.2 2.5 1.3 0.7 1.1 1.7 1.6 1.6 2.1 0.7 0.0 1.2 2.8 2.2 0.9 1.5 2.9 0.9 8.4 7.8 15.8 8.6 7.4 8.9 8.1 7.7 8.0 8.8 6.6 7.6 8.0 12.5 6.4 10.5 34.3 16.7 2.4 6.8 7.9 6.8 30.1 8.7 6.0 8.5 14.3 10.0 5.5 54.2 19.9 22.9 4.7 9.8 12.6 198.5 51.7 18.7 19.7 19.2 12.0 93.4 20.9 10.1 10.8 15.8 9.6 21.5 13.6 10.0 9.0 12.6 28.6 102.6 3.1 18.3 13.4 19.2 124.5 8.1 18.0 5.4 21.5 11.0 6.6 18.6 25.1 13.6 19.6 1.2 9.1 31.0 8.3 1.4 5.9 58.7 43.9 0.0 13.5 12.2 130.8 41.3 6.1 1.7 26.4 23.1 16.9 4.6 7.7 ZBTB17 "MIZ1, pHZ-67, ZNF151, ZNF60" ENSG00000116809 "Zinc finger and BTB domain containing 17" Q13105 1 15941869-15976132 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005789 Approved NA NA "HPA005789: AB_1080633" "unprognostic (2.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.57e-2)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.38e-6)" "unprognostic (2.28e-1)" "unprognostic (2.76e-1)" "unprognostic (5.08e-2)" "unprognostic (1.20e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.27e-5)" "unprognostic (2.08e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-2)" "prognostic favorable (2.04e-4)" 16.8 21.9 18.9 12.0 19.7 28.7 17.4 18.3 25.0 19.5 16.5 18.3 9.2 18.8 3.0 20.0 15.7 7.4 21.3 18.4 18.0 20.3 17.7 20.4 12.9 19.8 19.5 17.7 20.0 24.0 6.8 17.0 6.4 21.1 20.8 3.7 6.2 16.4 7.3 27.5 17.7 19.8 5.4 17.8 28.8 20.9 32.0 19.4 10.7 20.9 11.0 7.1 17.7 18.1 21.8 10.7 11.6 13.3 24.7 10.0 6.9 11.1 14.5 16.5 14.5 12.5 11.8 16.3 10.9 12.9 12.7 11.3 11.1 6.6 14.6 4.5 22.6 11.6 17.6 18.6 15.5 13.3 13.0 21.4 9.4 11.7 20.9 12.8 10.8 12.6 22.2 17.4 17.9 10.2 16.0 23.7 26.0 11.8 9.5 16.7 23.8 12.9 11.6 8.9 8.5 16.5 21.9 11.4 11.2 19.8 5.5 11.9 21.0 14.2 16.0 16.9 14.5 11.7 22.5 11.2 11.6 21.1 15.4 22.3 1.3 6.4 6.6 7.5 6.0 5.6 8.6 5.7 8.0 5.5 6.4 5.2 4.7 10.9 9.7 5.1 5.1 6.6 4.6 18.9 19.7 18.3 25.0 18.4 18.0 19.8 19.5 17.7 21.1 17.8 19.4 21.8 10.6 9.6 2.7 8.5 15.7 13.9 8.5 8.9 10.8 10.4 8.5 6.1 7.1 10.0 7.5 9.2 6.2 7.8 9.0 14.9 5.9 12.9 29.9 6.2 6.2 10.8 6.6 8.6 6.9 9.8 9.5 7.9 13.7 7.6 8.8 12.9 6.8 6.9 10.0 16.8 7.2 7.5 22.4 9.1 9.4 7.8 12.5 8.8 8.8 6.5 29.3 9.1 9.2 7.1 17.9 11.7 14.2 13.2 9.5 8.2 12.2 7.0 4.3 11.0 13.1 9.0 10.6 34.6 14.8 10.1 10.7 10.7 12.1 8.4 9.1 9.6 CD58 LFA3 ENSG00000116815 "CD58 molecule" P19256 1 116514534-116571039 "CD markers, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 144.1;Langerhans cells: 195.9;monocytes: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 135.9" "Low region specificity" "Detected in all" NA NA 6500000 "unprognostic (4.48e-3)" "unprognostic (3.20e-1)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "unprognostic (8.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.32e-6)" "unprognostic (9.84e-2)" "unprognostic (7.17e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.68e-2)" "unprognostic (2.17e-2)" "unprognostic (9.66e-2)" 22.9 10.2 7.6 25.1 8.7 58.4 18.2 8.5 10.6 13.8 11.2 22.5 29.1 12.9 16.2 25.6 12.6 21.7 31.4 7.5 12.0 20.2 12.8 29.4 19.1 9.5 8.5 6.4 5.5 7.1 12.0 6.7 17.0 9.4 9.4 29.3 2.0 20.9 10.4 8.8 20.2 29.9 17.0 9.4 24.9 19.2 6.9 9.0 9.8 13.3 10.9 20.4 30.0 19.8 9.6 36.4 20.5 14.7 14.2 24.4 40.7 9.3 18.2 31.3 31.0 30.2 9.2 68.4 6.5 33.2 31.8 36.2 45.9 11.0 31.4 32.7 35.8 12.8 32.8 36.9 12.9 15.5 45.8 43.5 11.2 41.4 25.9 23.0 66.4 17.9 8.5 29.4 135.9 19.2 64.7 19.8 34.6 7.3 53.7 22.3 38.4 49.9 8.6 63.0 29.4 4.9 10.3 36.6 26.9 108.3 15.1 14.0 16.8 33.8 22.3 17.1 30.3 47.2 20.6 39.4 4.6 51.3 22.4 113.2 133.7 50.6 89.8 37.3 51.0 26.1 20.7 32.7 31.7 43.9 9.5 4.2 18.2 165.7 18.5 64.4 5.0 64.3 37.4 7.6 8.7 8.5 10.6 7.5 12.0 9.5 8.5 6.4 9.4 9.4 9.0 9.6 52.3 9.6 31.5 10.1 23.8 18.2 20.0 144.1 15.4 0.2 9.9 7.1 28.9 30.0 63.2 14.7 0.0 4.4 40.2 48.1 3.9 39.4 3.2 16.0 5.1 38.1 10.8 46.7 3.2 27.6 1.6 31.9 13.3 19.0 53.0 3.4 28.2 7.7 58.7 1.7 1.5 18.7 34.6 33.0 195.9 3.6 10.5 72.2 12.4 45.0 156.1 3.3 34.0 4.5 1.4 46.7 41.7 11.7 24.3 16.9 46.3 26.5 41.3 0.7 32.9 27.9 23.6 11.3 2.4 28.2 27.8 1.9 44.7 9.6 18.6 42.6 TFAP2E AP2E ENSG00000116819 "Transcription factor AP-2 epsilon" Q6VUC0 1 35573314-35595328 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.8;Excitatory neurons: 9.0;Inhibitory neurons: 9.8;Oligodendrocytes: 11.3;Rod photoreceptor cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 4.6;SK-MEL-30: 1.7;U-937: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.06e-4)" "unprognostic (1.96e-2)" "unprognostic (9.05e-2)" "unprognostic (2.29e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-2)" "unprognostic (3.27e-2)" "unprognostic (9.39e-2)" "unprognostic (4.02e-1)" "unprognostic (7.45e-2)" "unprognostic (1.67e-15)" "unprognostic (2.03e-1)" "unprognostic (4.83e-1)" "unprognostic (3.48e-2)" "unprognostic (7.40e-2)" 1.0 0.6 3.0 0.9 3.0 1.5 1.1 8.5 4.1 2.9 0.5 1.0 0.1 1.3 0.3 1.2 2.5 0.2 0.8 2.9 2.7 0.7 0.3 1.3 0.9 3.1 3.1 2.8 2.5 0.6 0.0 3.3 0.2 5.9 1.7 0.1 4.4 1.0 0.1 0.4 5.1 1.2 0.0 2.6 1.9 1.0 2.2 2.7 0.3 0.5 0.0 0.3 0.8 3.1 5.5 0.2 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.2 0.5 0.4 0.3 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 4.6 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 1.7 0.1 0.4 1.4 0.1 0.1 0.7 0.4 0.1 0.8 0.4 0.0 0.1 3.6 0.5 0.5 0.8 0.5 0.9 0.3 0.3 0.4 0.5 0.8 0.4 0.4 0.2 0.8 0.0 0.9 0.4 0.3 0.8 0.5 3.0 3.0 8.5 4.1 2.9 2.7 3.1 3.1 2.8 5.9 2.6 2.7 5.5 0.2 0.0 1.3 4.9 0.2 3.7 0.1 0.3 0.0 9.8 0.5 0.5 0.4 0.0 0.8 0.0 2.1 0.4 0.9 0.1 0.0 0.2 0.5 0.3 0.4 0.3 0.0 0.0 9.0 0.0 0.0 0.4 2.6 0.5 0.0 0.1 0.4 0.2 1.0 0.0 9.8 0.0 0.0 1.0 0.0 1.0 2.1 0.6 1.8 1.9 0.5 0.3 3.1 3.5 11.3 0.2 0.3 0.7 0.3 0.1 0.1 0.0 0.2 5.6 0.0 0.2 0.4 2.4 0.4 0.0 4.4 0.1 0.9 0.1 0.4 0.2 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754430-116769229 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 252.1" "Group enriched" "Detected in many" 6 "dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 6 "gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2" "Group enriched" "Detected in all" 10 "NK-cells: 1108.0;T-cells: 714.1" "Group enriched" "Detected in some" 25 "HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002430, HPA003883" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 4.6 4.7 0.6 51.8 0.9 11.5 7.6 0.6 1.3 5.9 1.4 14.0 17.3 3.7 2.8 8.5 4.2 17.0 2.6 0.5 0.9 2.6 7.9 21.2 120.6 1.5 0.9 0.5 2.9 3.0 0.9 0.7 1.0 1.1 5.2 16.1 0.0 8.7 2.3 1.4 3.5 28.7 4.4 1.0 44.5 24.4 1.8 1.6 252.1 3.8 1.7 79.7 20.9 3.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 224.1 0.0 0.4 0.0 0.0 0.0 0.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 145.8 0.1 0.5 0.0 0.0 166.9 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.8 0.4 0.0 11.3 5.2 1.6 421.8 3.7 403.1 3.8 610.2 714.1 95.4 2.5 316.3 486.2 14.1 1108.0 2.8 21.0 655.2 565.1 0.6 0.9 0.6 1.3 0.5 0.9 1.5 0.9 0.5 1.1 1.0 1.6 2.0 5.0 3.2 17.5 0.0 12.3 5.0 0.4 0.0 2.2 0.0 4.0 4.7 2.1 0.0 2.5 3.7 0.0 0.1 158.3 0.2 0.0 0.5 23.5 1.1 1.0 2.9 3.0 24.0 0.0 0.0 0.0 2.5 10.7 0.9 5.1 0.0 8.2 1.5 0.6 0.0 0.0 0.0 0.0 10.9 16.6 7.8 0.6 19.1 1.8 1.0 15.5 0.0 178.2 0.0 0.0 0.0 0.0 0.4 42.3 0.1 0.0 1.7 0.0 0.0 0.0 2.9 4.1 0.3 0.2 0.4 3.7 0.0 476.8 0.0 0.5 0.2 TTF2 "HuF2, ZGRF6" ENSG00000116830 "Transcription termination factor 2" Q9UNY4 1 117060326-117107453 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005776, HPA070762" Approved Supported Cytosol NA Yes Cytosol "HPA005776: AB_1080416, HPA070762: AB_2686307" "unprognostic (1.82e-1)" "unprognostic (2.18e-1)" "unprognostic (3.29e-3)" "unprognostic (2.01e-3)" "unprognostic (4.90e-2)" "unprognostic (3.41e-3)" "unprognostic (5.27e-4)" "unprognostic (7.96e-2)" "unprognostic (1.92e-2)" "unprognostic (3.33e-1)" "unprognostic (4.64e-2)" "unprognostic (9.52e-3)" "unprognostic (7.34e-3)" "unprognostic (1.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.65e-2)" 3.8 4.8 3.2 6.5 3.8 5.5 4.2 2.9 3.5 3.0 3.5 5.1 4.3 3.0 1.7 5.2 2.6 2.8 3.2 2.4 3.7 2.6 1.5 2.6 7.4 5.1 3.5 2.3 2.7 3.5 3.9 2.3 2.8 3.8 2.5 5.5 2.5 3.3 2.5 4.7 4.9 4.0 4.1 3.0 4.3 3.9 4.2 3.6 9.0 3.6 2.3 7.9 3.4 3.6 4.9 27.7 10.0 19.8 28.0 7.7 6.7 24.6 14.5 6.7 20.8 18.3 14.1 4.8 33.4 21.8 9.6 23.2 28.1 35.2 18.7 32.0 25.9 24.8 28.5 19.5 18.2 5.5 42.1 31.5 7.7 7.0 15.4 28.4 5.2 14.4 26.0 22.3 29.6 15.9 42.4 28.1 26.0 30.9 26.3 20.0 40.0 72.7 14.6 12.7 12.4 16.8 7.0 21.7 21.4 8.4 14.9 11.7 17.0 14.6 13.1 27.6 31.0 31.8 13.5 12.5 40.6 8.8 31.2 53.7 0.9 2.3 1.5 1.2 2.8 1.2 1.5 1.4 2.0 2.6 1.5 1.4 1.7 0.4 2.6 1.6 1.4 2.7 1.0 3.2 3.8 2.9 3.5 2.4 3.7 5.1 3.5 2.3 3.8 3.0 3.6 4.9 4.4 6.4 6.4 6.8 13.4 13.3 17.1 8.5 12.0 5.7 7.6 6.3 7.3 5.7 7.3 12.9 8.4 9.7 8.9 10.6 5.9 6.6 6.9 8.9 15.6 6.9 4.9 30.3 8.1 8.0 7.6 11.0 8.6 12.3 9.5 24.7 5.7 3.0 11.4 11.8 4.7 8.3 0.0 8.6 12.1 7.0 6.5 14.5 7.2 10.3 22.1 3.3 14.4 2.5 13.5 9.3 5.1 4.1 16.0 22.7 6.2 3.8 5.1 7.2 0.0 18.4 8.5 9.2 12.4 19.4 14.3 3.8 12.3 12.2 13.5 17.9 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027614-200177420 "Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 18.0;liver: 38.9;pancreas: 61.7" "Cell type enriched" "Detected in many" 5 "Granulosa cells: 276.2" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 1.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 5.4 0.4 0.4 2.6 0.3 0.9 3.8 0.5 0.3 3.5 0.3 12.0 17.5 3.3 1.4 0.9 2.2 8.0 1.1 0.3 2.3 0.5 38.9 2.7 2.1 0.6 0.8 0.1 1.0 61.7 0.4 0.1 0.4 0.8 1.6 13.2 0.2 0.5 0.8 1.1 1.1 18.0 4.4 0.3 0.2 1.3 0.8 0.7 0.6 0.9 0.7 1.4 1.8 1.2 0.6 0.0 25.0 0.0 0.1 0.0 0.2 0.6 0.0 0.4 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.7 0.7 14.9 0.0 0.0 3.3 1.1 0.0 0.3 2.7 0.5 0.1 6.4 0.1 0.0 0.0 0.1 0.0 20.4 0.1 0.0 0.3 0.0 0.6 0.0 0.4 0.9 0.0 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.7 4.7 0.3 0.1 1.0 0.2 0.1 0.2 3.4 2.3 2.6 0.3 0.2 0.1 3.2 0.4 0.4 0.2 0.2 0.2 0.3 0.3 0.3 0.1 0.4 0.4 0.3 1.5 0.5 0.2 0.5 0.4 0.1 0.4 0.3 0.5 0.3 0.3 2.3 0.6 0.8 0.1 0.8 0.3 0.7 0.6 23.7 0.0 1.7 0.3 0.2 1.9 0.1 0.0 0.0 0.2 0.2 0.0 9.9 32.9 0.0 0.0 0.0 0.0 0.3 37.5 0.0 38.2 0.4 0.3 0.3 32.4 4.9 2.7 0.4 54.5 0.0 0.8 0.0 0.2 13.3 276.2 38.6 38.5 0.1 0.0 0.6 13.8 0.0 4.9 1.5 0.3 0.6 0.6 0.0 0.0 3.1 0.0 0.0 1.0 0.3 22.0 21.8 0.0 1.2 0.3 49.9 0.0 0.8 0.3 0.0 0.5 6.1 0.1 0.1 0.0 1.4 0.0 0.3 0.1 32.3 0.2 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023714 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.4;brain: 22.2;retina: 21.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "basophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 1.5 0.8 16.4 9.5 16.9 34.4 1.3 0.0 17.0 0.8 0.0 2.1 2.0 0.7 0.4 0.8 1.2 2.1 0.8 22.2 7.4 0.9 1.5 4.8 13.0 5.1 4.3 16.0 0.7 0.8 6.1 0.6 1.0 11.4 0.8 1.8 21.6 1.4 0.7 0.3 0.7 6.7 0.8 0.9 12.4 2.5 13.8 6.3 11.9 1.0 0.4 8.1 2.3 0.9 12.2 1.3 1.5 11.8 0.5 0.0 0.0 3.0 0.1 0.0 0.3 0.1 0.7 0.4 39.1 0.5 0.0 3.4 0.3 1.2 0.3 0.4 1.9 0.4 9.7 0.2 0.2 1.0 29.4 41.0 1.0 4.1 0.4 0.7 0.0 1.5 78.8 4.6 49.6 0.0 0.2 24.5 11.2 5.2 3.9 0.0 8.4 0.1 43.8 0.2 0.0 7.2 1.0 0.6 0.5 0.6 2.1 0.2 8.9 2.8 0.0 3.3 0.0 0.2 90.2 44.7 19.3 3.9 12.8 0.3 6.0 0.0 0.6 0.8 0.2 0.9 0.4 0.6 0.8 0.1 0.3 0.5 0.6 1.0 1.3 0.3 0.1 0.6 0.4 16.4 16.9 0.0 17.0 22.2 7.4 5.1 4.3 16.0 11.4 0.9 6.3 12.2 1.5 0.0 3.8 22.5 11.0 1.0 0.5 0.2 0.0 25.7 0.4 0.8 1.5 0.0 0.1 1.8 58.4 0.0 17.4 1.2 0.0 0.5 20.4 0.1 0.2 1.8 0.0 4.8 15.6 1.6 0.1 0.6 1.1 0.4 6.3 0.5 1.4 0.3 1.7 1.7 11.8 1.4 0.0 4.4 3.1 82.1 0.9 5.3 0.0 8.4 2.7 20.0 13.4 14.6 4.0 2.4 0.3 0.0 12.0 0.4 0.2 0.0 0.1 26.1 6.6 0.6 1.1 1.9 3.7 0.1 1.0 0.0 18.0 0.1 1.1 2.0 TMEM9 TMEM9A ENSG00000116857 "Transmembrane protein 9" Q9P0T7 1 201134772-201171574 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008483 Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Vesicles "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA008483: " "unprognostic (1.88e-1)" "prognostic unfavorable (6.57e-4)" "unprognostic (2.95e-1)" "unprognostic (3.67e-2)" "unprognostic (3.96e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (2.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.88e-2)" "unprognostic (2.38e-1)" "unprognostic (9.17e-2)" "unprognostic (3.32e-1)" "unprognostic (9.90e-2)" 33.6 103.1 98.0 21.0 99.3 28.1 45.4 89.2 127.6 75.5 110.6 40.7 25.6 71.5 65.9 31.4 76.0 39.8 42.9 101.8 103.4 74.0 74.4 44.9 23.7 94.7 107.8 99.9 82.1 74.5 93.0 63.8 28.8 94.3 60.8 25.6 44.3 61.2 46.3 45.2 34.9 30.6 37.8 93.0 31.4 50.2 67.5 102.5 26.5 69.1 25.2 17.8 46.1 52.2 96.3 63.1 117.0 72.6 168.9 38.5 54.5 128.5 48.6 51.5 76.0 68.2 115.7 99.8 33.2 69.2 73.4 70.1 123.3 76.5 80.1 37.3 21.3 131.9 58.1 182.4 76.6 73.8 28.2 51.9 65.0 87.0 71.2 43.0 91.3 47.7 46.2 105.6 35.5 66.2 81.0 34.1 46.1 111.0 57.3 285.3 60.7 108.4 44.0 87.9 48.0 67.6 137.7 86.7 146.9 91.8 107.4 180.3 48.5 35.7 84.8 70.0 68.5 59.8 143.9 135.2 26.1 64.4 30.1 42.0 49.8 59.8 33.7 45.7 41.8 52.2 54.5 44.0 37.8 51.5 49.2 64.6 42.7 41.0 32.9 38.5 56.1 43.0 75.5 98.0 99.3 89.2 127.6 101.8 103.4 94.7 107.8 99.9 94.3 93.0 102.5 96.3 20.9 51.3 49.5 17.0 13.4 12.9 31.4 65.6 27.3 61.0 56.2 65.7 39.3 40.0 48.0 36.8 31.3 44.4 9.3 7.9 17.6 88.8 58.0 37.3 58.6 26.3 31.8 43.6 15.7 74.7 52.1 59.9 20.9 46.4 13.3 46.3 30.0 40.4 28.1 8.4 22.1 26.9 36.7 13.4 11.9 60.9 70.8 15.6 23.2 8.4 11.8 102.3 25.7 15.6 10.1 40.3 18.8 53.0 18.8 28.5 8.3 56.9 54.5 32.8 13.1 33.3 42.1 54.8 76.7 14.5 13.9 13.0 13.0 130.7 28.4 27.8 ADPRS "ADPRHL2, ARH3, FLJ20446" ENSG00000116863 "ADP-ribosylserine hydrolase" Q9NX46 1 36088892-36093932 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026641, HPA027104, HPA027141" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA 54000 Nucleoplasm "HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619" "unprognostic (3.22e-3)" "unprognostic (5.10e-2)" "unprognostic (2.95e-2)" "unprognostic (1.61e-2)" "unprognostic (5.98e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.10e-7)" "unprognostic (3.71e-2)" "unprognostic (2.63e-1)" "unprognostic (5.34e-2)" "unprognostic (3.17e-2)" "unprognostic (7.80e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (9.31e-2)" "unprognostic (3.65e-2)" "unprognostic (4.74e-2)" 18.8 37.0 28.7 16.2 29.4 19.8 18.7 30.7 30.5 20.7 31.8 19.0 15.8 17.8 15.1 36.4 33.8 13.5 18.1 28.2 28.6 27.8 22.6 20.8 21.6 31.8 29.1 27.1 19.8 18.0 17.7 17.9 21.0 31.0 20.1 12.5 9.2 21.0 16.5 34.7 33.0 17.0 16.5 31.6 23.3 17.7 28.9 28.7 21.1 19.5 22.0 20.3 21.5 22.4 33.4 54.3 22.4 26.2 37.2 23.6 17.1 37.3 39.4 32.9 62.1 60.9 26.8 47.7 38.4 37.5 39.5 32.0 32.9 33.4 60.5 37.0 27.7 41.8 34.9 27.0 36.3 44.4 40.2 19.9 20.3 45.4 56.5 24.5 47.2 39.9 36.2 30.8 30.9 29.6 26.0 40.9 60.5 56.5 31.8 46.0 32.9 27.6 38.8 56.5 43.8 32.1 50.8 28.9 29.9 65.9 34.4 30.9 34.3 27.6 35.7 37.0 50.1 53.0 39.8 41.2 34.2 51.7 39.6 22.4 40.6 58.3 65.8 43.4 74.1 41.5 43.5 47.6 50.8 71.4 51.5 47.7 40.3 57.1 47.9 77.7 44.8 43.4 57.8 28.7 29.4 30.7 30.5 28.2 28.6 31.8 29.1 27.1 31.0 31.6 28.7 33.4 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 79.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 40.7 6.4 0.0 0.0 0.0 0.0 0.0 0.0 51.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 70.6 1.3 0.0 0.0 0.0 MAP7D1 "FLJ10350, FLJ39022, PARCC1, RPRC1" ENSG00000116871 "MAP7 domain containing 1" Q3KQU3 1 36155579-36180849 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 288.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028075 Approved NA NA "HPA028075: AB_10603778" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (5.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.49e-6)" "unprognostic (6.00e-3)" "unprognostic (2.05e-1)" "unprognostic (3.57e-2)" "unprognostic (1.88e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (8.56e-6)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (9.32e-3)" 68.5 23.4 44.6 41.9 54.6 36.5 47.5 47.2 53.3 36.3 0.4 63.2 19.1 50.5 3.9 49.2 35.1 29.0 112.0 43.7 35.6 21.9 7.8 53.6 25.2 81.4 60.5 13.7 25.0 14.8 12.6 36.8 24.2 108.4 39.8 9.5 13.1 33.8 28.5 288.7 67.9 31.7 34.3 28.2 33.8 39.6 12.7 48.2 22.8 33.3 107.4 17.7 62.6 41.5 76.8 104.8 60.3 92.7 58.9 55.6 41.9 68.3 102.3 102.8 105.4 92.5 33.9 104.6 43.8 85.7 93.5 57.7 112.3 38.3 139.1 34.4 74.9 34.4 29.7 42.5 13.2 87.3 44.0 73.3 73.4 38.6 142.6 87.8 81.5 72.9 59.8 29.1 65.3 59.3 21.0 81.6 37.2 84.7 14.7 33.5 83.8 68.4 41.5 53.0 35.7 35.7 68.6 58.7 32.3 79.6 49.7 21.6 30.9 138.3 123.6 94.4 105.5 140.6 64.4 20.6 52.5 105.8 29.7 75.9 0.1 0.4 0.4 0.3 0.2 0.4 0.0 0.2 0.2 0.2 0.1 0.5 0.2 1.4 0.1 0.1 0.2 0.1 0.0 44.6 54.6 47.2 53.3 43.7 35.6 81.4 60.5 13.7 108.4 28.2 48.2 76.8 40.6 44.8 14.4 12.1 26.5 143.1 147.3 18.4 47.8 35.4 44.0 26.3 172.6 17.2 17.9 23.9 10.4 48.3 58.2 39.9 17.6 43.3 36.9 32.1 38.6 46.7 10.1 16.2 17.4 27.4 111.3 48.0 29.6 60.1 12.7 56.3 30.7 9.7 69.9 48.8 35.1 14.9 10.2 40.6 125.3 77.1 30.7 65.1 32.0 9.4 35.9 32.3 75.2 9.5 62.3 66.1 29.2 47.8 53.2 98.5 63.0 14.3 10.0 39.8 19.7 51.6 55.8 17.6 16.1 62.7 141.8 130.2 59.8 17.0 19.5 157.6 WARS2 mtTrpRS ENSG00000116874 "Tryptophanyl tRNA synthetase 2, mitochondrial" Q9UGM6 1 119031216-119140654 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028007, HPA069692" Enhanced Supported Mitochondria NA NA Mitochondria "HPA028007: , HPA069692: AB_2686172" "unprognostic (1.00e-1)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (5.64e-2)" "unprognostic (3.42e-1)" "unprognostic (7.05e-2)" "unprognostic (7.73e-3)" "unprognostic (3.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.17e-2)" "unprognostic (3.96e-2)" "unprognostic (6.76e-3)" "prognostic favorable (1.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.83e-1)" "unprognostic (9.88e-3)" "unprognostic (4.71e-2)" 7.1 8.9 2.4 4.1 2.3 1.9 9.5 2.4 3.0 7.0 5.9 7.4 7.8 6.4 3.8 6.1 9.5 5.0 7.9 2.3 3.2 9.7 6.2 5.0 4.8 2.5 2.3 2.0 8.3 9.0 10.3 3.8 6.3 2.4 5.8 8.1 6.1 5.5 3.6 6.3 5.1 5.1 5.3 2.3 3.0 7.3 4.6 2.3 4.7 6.9 6.5 5.2 6.9 5.7 2.8 12.8 5.0 7.5 7.9 9.6 21.6 7.6 7.0 10.5 7.6 9.1 14.4 5.6 19.0 11.4 12.0 4.2 8.2 13.9 12.6 11.7 9.8 16.6 8.9 12.8 13.9 19.6 14.8 4.8 16.1 9.7 11.1 20.2 10.0 11.7 7.9 14.1 13.4 14.4 15.7 8.9 8.6 9.9 9.8 10.6 6.3 24.9 9.9 20.9 17.5 10.7 6.6 11.3 15.4 16.7 13.1 6.9 11.1 8.8 7.8 9.2 15.2 13.8 6.4 4.6 8.3 9.6 12.1 14.7 0.0 5.0 0.3 3.4 3.6 5.0 4.6 3.6 4.5 6.7 6.2 4.2 4.2 0.2 4.2 2.2 3.2 4.5 3.4 2.4 2.3 2.4 3.0 2.3 3.2 2.5 2.3 2.0 2.4 2.3 2.3 2.8 7.2 9.6 12.3 22.5 10.4 9.6 17.6 14.7 14.2 6.7 13.1 11.3 10.6 5.7 11.2 11.0 6.2 16.9 7.0 6.5 17.6 9.8 57.7 15.2 8.6 7.5 6.7 18.9 15.5 11.9 15.3 15.5 17.9 13.8 8.8 9.7 2.2 7.5 9.5 6.7 21.4 10.2 14.2 10.0 6.9 31.8 9.9 8.2 10.6 11.2 13.0 5.0 3.1 12.1 18.2 8.7 6.1 8.2 9.1 13.1 7.5 18.8 14.7 8.2 6.6 12.0 10.1 5.4 6.1 19.8 10.7 20.0 10.2 19.6 15.8 14.4 HAO2 "GIG16, HAOX2" ENSG00000116882 "Hydroxyacid oxidase 2" Q9NYQ3 1 119368779-119394130 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "kidney: 306.5;liver: 429.1" "Group enriched" "Detected in some" 7 "Hepatocytes: 256.8;Proximal tubular cells: 450.1" "Group enriched" "Detected in some" 26 "liver cancer: 25.6;renal cancer: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050355 Uncertain Vesicles,Cytosol NA NA Cytosol Vesicles "HPA050355: " "unprognostic (1.13e-1)" "unprognostic (1.68e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (6.22e-2)" "unprognostic (5.33e-3)" "unprognostic (2.80e-2)" "unprognostic (3.27e-1)" "unprognostic (3.15e-1)" "unprognostic (3.17e-1)" "unprognostic (1.41e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.92e-4)" "unprognostic (9.66e-2)" "unprognostic (1.79e-1)" "unprognostic (2.89e-2)" "unprognostic (5.14e-4)" 0.0 0.6 0.2 0.1 0.5 0.0 0.7 0.1 0.7 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 306.5 429.1 0.0 0.3 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.1 0.4 0.2 0.1 0.2 23.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.7 0.2 0.0 0.2 0.1 0.5 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 11.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.6 0.0 13.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 4.2 256.8 0.1 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 450.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.5;testis: 76.7" "Cell type enhanced" "Detected in many" "Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 6.7 8.3 13.7 2.4 11.1 2.1 9.5 9.5 11.1 9.6 27.2 5.9 2.9 10.1 22.2 5.1 58.5 8.9 8.0 12.0 14.8 19.3 2.8 11.1 1.9 11.9 12.9 9.5 9.1 8.2 30.4 23.3 5.6 11.0 10.0 3.9 23.3 8.8 9.0 4.9 6.6 2.7 8.0 11.8 1.4 6.4 76.7 11.4 3.6 18.1 5.3 1.5 5.9 4.9 9.3 6.7 6.3 7.6 8.9 8.9 8.6 1.4 4.0 9.7 9.7 6.6 0.1 5.8 1.5 7.3 7.3 7.1 5.1 0.2 7.5 6.2 1.1 5.9 0.1 3.9 0.7 10.9 0.8 1.2 9.8 12.0 13.7 5.9 14.1 6.7 6.3 0.1 1.7 7.7 4.8 3.6 2.5 7.8 2.6 2.6 3.8 3.1 1.2 16.0 2.3 20.4 9.0 7.5 3.5 5.4 7.2 7.6 1.1 5.8 7.0 2.6 12.7 6.9 2.8 3.1 0.8 13.4 0.2 4.7 0.0 0.2 0.0 0.2 0.6 0.0 0.1 0.3 0.2 0.6 0.2 0.6 1.0 0.1 0.1 0.0 1.2 0.7 0.2 13.7 11.1 9.5 11.1 12.0 14.8 11.9 12.9 9.5 11.0 11.8 11.4 9.3 3.0 9.6 10.9 4.6 0.4 1.5 5.5 21.3 3.4 5.4 7.9 7.5 5.5 5.7 21.3 12.9 16.7 12.2 0.0 2.0 23.5 15.1 453.5 88.6 5.8 3.3 4.9 1.7 8.1 9.3 3.4 6.4 6.1 7.7 0.0 4.8 2.2 2.3 4.2 5.0 6.9 2.3 32.6 0.8 1.2 66.8 12.5 1.4 3.6 1.0 0.1 12.9 0.0 5.0 2.6 7.2 4.0 9.1 0.4 3.5 0.5 26.1 199.1 21.3 0.0 4.7 7.7 163.7 20.6 3.6 3.1 20.1 0.7 13.9 2.3 5.2 MRPS15 FLJ11564 ENSG00000116898 "Mitochondrial ribosomal protein S15" P82914 1 36455718-36464384 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 290.0" "Cell type enhanced" "Detected in all" "Early spermatids: 776.7;Late spermatids: 2209.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028100, HPA028134, HPA067137" Supported Supported Mitochondria NA NA Mitochondria "HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787" "unprognostic (2.05e-2)" "unprognostic (6.98e-2)" "unprognostic (7.57e-2)" "unprognostic (4.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.20e-2)" "unprognostic (3.28e-2)" "prognostic favorable (7.83e-4)" "unprognostic (8.48e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (2.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.94e-2)" "unprognostic (1.39e-1)" 69.9 69.5 55.3 37.7 56.1 82.4 62.9 59.0 71.0 38.0 61.3 59.0 41.5 42.8 63.1 71.5 37.5 30.5 113.3 55.1 59.9 82.1 123.1 47.8 45.8 59.0 57.2 54.4 33.5 63.7 77.6 46.7 45.4 59.0 45.4 51.1 21.2 58.6 38.1 290.0 52.1 41.9 40.3 55.6 41.6 69.3 152.4 59.3 44.5 40.3 198.7 48.3 54.6 43.4 60.4 162.3 88.7 94.4 115.8 91.9 132.6 233.9 88.3 126.1 214.3 195.7 157.9 169.3 148.8 140.0 117.3 128.1 138.9 139.5 223.3 192.3 97.4 177.0 152.5 104.1 175.2 171.6 190.2 103.2 123.1 196.1 191.2 153.7 82.5 178.0 109.5 168.1 114.0 134.5 112.2 184.7 203.8 169.8 137.2 154.2 140.4 165.6 218.6 193.0 135.1 139.4 77.0 122.2 153.9 236.0 139.7 95.1 129.0 84.3 119.7 126.8 149.0 189.4 113.2 169.1 211.3 136.1 128.1 170.8 18.7 78.9 22.3 61.8 89.7 77.3 72.5 70.3 71.2 122.0 73.5 65.6 64.4 5.3 64.5 61.2 83.6 87.8 90.7 55.3 56.1 59.0 71.0 55.1 59.9 59.0 57.2 54.4 59.0 55.6 59.3 60.4 50.6 38.5 52.0 10.1 57.2 65.4 70.3 119.6 55.8 23.2 85.6 79.9 136.7 65.8 74.7 71.7 14.6 245.9 49.2 84.8 322.9 132.8 776.7 53.2 58.6 62.6 66.0 118.2 8.7 162.4 260.3 61.7 69.3 75.4 42.5 71.1 62.4 140.6 153.8 13.5 8.7 97.7 85.5 81.1 68.9 2209.2 62.7 75.7 56.9 4.7 86.7 31.3 56.7 5.5 7.2 143.1 64.2 74.4 108.4 128.8 118.3 361.6 50.3 23.5 65.7 56.3 103.2 502.4 76.0 107.0 80.4 281.6 59.0 113.1 127.2 118.3 EXOC8 "EXO84, Exo84p, SEC84" ENSG00000116903 "Exocyst complex component 8" Q8IYI6 1 231332753-231337852 "Human disease related genes, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027438 Approved Approved Cytosol NA NA Cytosol "HPA027438: AB_1848318" "unprognostic (3.85e-2)" "unprognostic (6.52e-2)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (4.83e-2)" "unprognostic (5.82e-2)" "unprognostic (4.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-1)" "unprognostic (2.69e-1)" "unprognostic (2.09e-2)" "unprognostic (1.74e-1)" "unprognostic (8.39e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" 6.2 5.5 2.8 8.0 3.3 17.1 6.8 5.0 4.0 5.2 3.3 5.1 5.9 4.6 4.8 5.5 4.8 5.0 5.3 3.3 4.2 5.9 6.3 6.0 9.3 3.4 3.1 2.9 7.1 6.3 8.8 3.0 6.5 3.6 5.6 4.7 7.5 5.5 3.8 14.2 5.9 6.4 4.4 3.6 8.3 6.9 4.2 3.6 7.4 8.5 9.9 9.2 5.3 3.7 4.5 8.2 9.0 5.4 5.4 13.9 11.2 13.0 10.0 8.4 7.4 7.0 8.6 8.1 9.4 8.6 10.1 6.6 13.2 7.9 10.8 8.1 12.2 19.0 5.7 11.8 5.5 7.8 10.1 15.2 11.3 11.7 11.0 10.4 8.7 9.2 9.6 10.6 21.9 12.0 4.3 9.4 6.2 8.2 10.4 7.6 6.1 8.3 12.0 9.3 9.5 7.1 7.6 10.1 13.1 10.1 4.3 12.5 14.5 12.6 9.9 7.0 13.3 17.7 16.2 9.9 10.1 11.3 8.9 12.7 1.7 0.7 1.3 0.4 0.8 0.5 0.4 0.6 0.5 0.5 0.5 0.7 1.2 2.2 0.8 1.6 0.7 0.6 0.5 2.8 3.3 5.0 4.0 3.3 4.2 3.4 3.1 2.9 3.6 3.6 3.6 4.5 10.0 9.6 9.8 2.0 10.9 18.5 5.6 4.0 8.0 4.3 8.1 5.5 8.9 11.5 8.3 9.2 6.2 4.6 10.4 6.7 1.9 3.3 1.6 8.1 9.0 9.3 4.8 7.4 5.3 3.5 2.8 8.2 14.3 10.4 2.5 4.3 6.8 9.6 5.8 3.3 5.9 3.7 2.0 13.3 7.1 1.1 4.1 7.6 3.6 3.7 5.7 5.8 5.2 2.5 6.6 5.0 1.2 5.7 7.9 6.0 6.9 5.2 5.6 12.3 0.0 8.4 5.2 5.1 5.0 11.0 14.8 9.3 10.0 4.6 4.2 8.6 GNPAT "DAP-AT, DAPAT, DHAPAT" ENSG00000116906 "Glyceronephosphate O-acyltransferase" O15228 1 231241207-231277973 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.87e-2)" "unprognostic (3.28e-2)" "unprognostic (3.36e-2)" "unprognostic (2.56e-2)" "unprognostic (5.25e-3)" "unprognostic (1.91e-1)" "unprognostic (5.07e-2)" "unprognostic (6.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.29e-6)" "unprognostic (5.69e-2)" "unprognostic (1.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.68e-1)" 22.6 27.1 21.4 20.7 23.8 17.5 21.9 23.7 28.4 18.5 24.3 26.9 30.3 20.5 23.9 22.3 28.1 18.4 45.3 22.2 24.0 25.9 31.2 18.9 23.8 24.1 22.3 21.0 22.7 29.8 22.8 18.0 19.6 23.4 23.0 25.1 17.2 26.6 21.1 102.7 23.8 28.3 26.6 24.0 18.7 27.1 32.3 23.2 27.8 21.0 84.9 26.0 21.7 17.1 26.0 39.8 43.6 60.4 46.1 48.7 71.4 40.7 32.9 37.1 34.1 39.1 56.1 48.3 57.0 40.4 49.5 35.9 41.9 40.6 44.7 50.0 64.8 37.2 41.2 41.4 81.7 49.4 70.9 31.4 50.1 53.8 35.5 39.6 44.5 81.2 56.0 61.1 53.3 71.7 13.1 63.6 41.0 97.1 112.0 49.5 68.7 81.0 66.9 42.7 29.2 40.0 57.1 55.2 30.7 49.1 23.8 53.7 110.7 42.8 34.5 32.1 50.5 83.3 68.2 93.6 65.1 49.8 58.8 65.3 34.1 36.4 37.3 23.7 37.1 27.2 35.1 30.6 31.3 36.4 37.7 26.4 24.4 14.3 26.9 50.3 17.2 37.9 29.8 21.4 23.8 23.7 28.4 22.2 24.0 24.1 22.3 21.0 23.4 24.0 23.2 26.0 17.7 25.6 20.8 19.9 32.3 13.5 19.5 23.1 16.5 23.3 14.9 12.6 55.8 30.0 21.2 27.6 39.6 25.3 20.1 16.4 17.6 41.5 70.3 21.5 19.4 21.4 28.2 13.2 18.9 43.4 19.2 19.5 21.4 14.1 11.4 30.1 19.2 26.9 27.4 11.8 18.6 21.0 22.4 24.8 18.3 119.2 25.4 21.8 12.4 15.9 38.7 22.7 26.8 17.1 29.2 40.2 30.3 26.7 30.1 24.9 41.7 28.0 30.8 24.2 19.7 16.5 22.4 50.9 31.5 18.8 13.9 12.4 24.5 19.7 30.1 19.0 TSNAX "C3PO, TRAX" ENSG00000116918 "Translin associated factor X" Q99598 1 231528541-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 194.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 36000 Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 22.9 32.2 13.9 20.4 14.5 15.2 25.7 12.8 15.0 19.6 18.0 18.6 17.8 21.7 23.0 19.6 18.2 18.9 26.5 14.1 15.8 32.0 26.2 21.0 26.6 14.8 14.4 13.2 18.4 16.4 40.3 17.1 20.6 13.4 23.0 19.8 20.1 18.3 20.7 50.9 22.0 17.5 20.9 13.5 28.8 17.9 21.0 13.9 26.8 30.1 41.1 26.0 20.1 15.0 15.0 30.3 24.1 36.7 29.7 27.1 32.6 41.4 33.1 50.9 42.2 36.0 21.4 40.8 42.3 55.0 38.0 15.7 31.9 29.3 31.4 53.9 38.4 51.7 40.7 23.9 28.6 35.8 67.8 82.1 40.4 32.4 40.9 32.3 26.4 30.7 31.6 66.6 28.8 58.0 12.9 44.0 32.9 53.4 26.5 28.3 42.8 39.8 56.8 46.9 33.9 34.1 65.7 35.3 43.3 116.8 14.5 63.2 113.0 28.9 28.3 26.3 57.6 61.0 48.2 68.9 46.4 46.8 52.0 79.7 194.4 34.8 85.6 30.6 40.2 30.3 28.5 33.5 30.6 33.2 28.3 34.6 34.0 37.7 51.9 55.7 22.3 39.4 33.6 13.9 14.5 12.8 15.0 14.1 15.8 14.8 14.4 13.2 13.4 13.5 13.9 15.0 48.3 28.9 41.3 0.0 25.5 43.8 21.4 42.4 8.6 59.2 27.2 20.1 24.1 40.0 25.3 42.3 29.2 44.4 36.9 21.8 54.8 30.6 12.6 23.6 20.5 46.1 28.9 59.5 0.0 31.1 51.5 28.1 11.7 19.3 77.3 26.2 31.8 32.8 49.5 65.6 0.0 28.2 38.7 62.2 35.0 9.4 33.5 40.5 26.6 0.0 51.7 72.0 37.0 0.0 0.0 26.5 21.8 36.1 13.4 17.3 22.4 45.8 31.9 47.1 39.5 34.4 30.2 40.8 65.4 13.0 51.4 36.3 30.5 46.8 25.6 14.9 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 8.5 10.8 7.4 7.4 6.7 8.1 9.7 6.9 7.4 9.0 5.9 6.8 8.3 10.3 10.1 10.2 9.9 7.0 8.4 7.0 7.4 9.3 7.9 5.5 11.9 7.1 8.1 7.1 13.5 14.7 15.2 6.1 10.5 7.5 10.7 5.6 5.4 12.4 10.2 9.8 10.6 5.7 8.3 8.1 7.7 7.0 8.4 8.9 9.2 11.5 10.1 9.8 8.2 8.0 8.6 17.7 20.1 16.9 27.8 14.5 10.4 38.5 20.9 14.7 30.7 22.6 30.8 20.8 25.0 24.4 9.2 14.2 25.3 31.5 21.2 31.3 40.3 35.1 28.3 20.7 19.5 27.9 31.6 18.0 14.2 25.7 30.4 39.8 13.4 15.7 21.6 57.2 29.5 17.7 12.1 30.9 13.9 52.9 18.1 38.0 30.2 35.4 69.0 16.4 14.9 50.8 24.4 18.4 27.9 43.1 16.9 15.7 13.9 10.6 30.7 19.3 25.0 40.8 24.0 29.0 52.0 15.4 30.4 33.0 3.5 9.7 6.9 18.9 7.9 29.9 21.2 22.8 18.3 11.6 18.7 28.8 25.0 1.9 24.8 8.8 54.1 12.5 15.0 7.4 6.7 6.9 7.4 7.0 7.4 7.1 8.1 7.1 7.5 8.1 8.9 8.6 10.9 6.4 7.9 4.2 12.9 50.2 24.1 5.9 22.8 10.1 15.6 15.1 5.5 5.7 10.8 3.7 10.4 14.9 12.2 6.7 13.7 10.5 1.5 5.8 12.8 11.5 4.2 45.3 9.5 7.3 14.0 14.4 6.1 6.2 11.4 9.6 6.4 6.6 5.4 16.8 7.2 5.1 8.2 4.4 9.0 1.0 9.9 4.8 12.4 4.7 7.3 10.4 17.5 5.0 5.0 10.2 8.1 13.9 10.9 21.3 5.5 8.9 5.6 14.6 0.0 17.5 8.5 25.7 25.5 15.5 62.1 7.9 12.0 11.9 8.3 13.2 RRAGC "FLJ13311, GTR2" ENSG00000116954 "Ras related GTP binding C" Q9HB90 1 38838198-38859772 "Disease related genes, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 224.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018247, HPA055489" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA018247: AB_1856475, HPA055489: AB_2682832" "unprognostic (2.04e-2)" "unprognostic (1.58e-1)" "unprognostic (2.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.40e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (9.97e-9)" "unprognostic (2.14e-1)" "unprognostic (3.61e-2)" "unprognostic (4.98e-2)" "unprognostic (2.23e-2)" "unprognostic (1.71e-1)" "unprognostic (5.13e-2)" "unprognostic (6.38e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-1)" "unprognostic (3.82e-2)" 37.3 17.0 18.6 16.8 19.7 30.5 25.4 20.4 19.5 16.2 17.2 19.9 18.9 16.2 14.1 25.1 14.0 17.9 21.8 18.0 21.0 24.7 18.6 19.4 20.7 21.1 20.7 18.1 21.8 14.3 24.2 10.1 28.7 21.2 15.1 17.1 16.2 14.3 17.1 17.5 29.6 16.3 22.1 20.5 17.5 15.3 17.6 21.4 19.0 16.9 19.1 22.0 19.2 18.3 21.6 37.0 16.6 21.3 23.3 110.7 74.6 33.0 33.7 68.6 44.8 47.2 12.7 23.9 23.0 18.9 52.6 71.8 21.7 40.1 22.2 36.8 37.6 28.3 22.1 19.2 14.7 135.6 26.0 23.9 66.7 55.2 48.0 61.9 35.4 47.5 24.5 22.9 44.9 65.7 10.2 19.0 14.7 27.2 15.9 28.0 18.1 37.6 15.6 31.6 42.5 11.1 16.5 27.0 20.0 73.2 47.5 18.3 19.5 42.5 54.3 22.4 60.0 29.2 35.0 60.5 26.8 50.5 29.1 28.8 0.5 2.4 5.5 1.7 2.3 2.9 3.3 2.6 2.2 2.3 3.6 2.2 2.1 5.9 1.7 1.8 8.4 2.5 1.6 18.6 19.7 20.4 19.5 18.0 21.0 21.1 20.7 18.1 21.2 20.5 21.4 21.6 31.2 32.1 28.0 6.5 42.1 111.9 47.1 19.2 40.9 20.0 31.0 25.0 22.2 24.3 16.1 12.9 12.5 84.9 38.4 30.3 11.7 55.7 56.3 32.0 26.6 34.3 14.4 24.0 7.4 48.1 57.7 39.4 12.2 42.9 16.5 16.9 35.7 14.2 72.1 38.7 8.3 10.3 20.3 34.4 65.0 49.8 30.7 49.2 53.4 9.4 63.3 43.4 10.3 7.5 15.8 47.0 14.0 37.2 20.1 47.3 21.5 30.4 15.0 22.8 19.7 28.1 37.5 24.7 28.5 46.1 140.5 224.1 23.3 18.6 12.2 51.1 NID1 "entactin, NID" ENSG00000116962 "Nidogen 1" P14543 1 235975830-236065109 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 232.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 362.9;Fibroblasts: 137.6;Hepatic stellate cells: 191.3;Leydig cells: 177.3;Peritubular cells: 125.6;Sertoli cells: 243.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "classical monocyte: 5.7;intermediate monocyte: 11.2;myeloid DC: 4.4;non-classical monocyte: 7.3" "Group enriched" "Detected in many" 18 "dendritic cells: 4.4;monocytes: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 1569.3;ASC TERT1: 726.8;HSkMC: 619.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010044 Approved "Secreted to extracellular matrix" NA NA 150000000 "CAB010044: AB_2153287" "unprognostic (1.17e-1)" "unprognostic (2.23e-3)" "unprognostic (3.24e-1)" "unprognostic (2.35e-1)" "unprognostic (4.03e-1)" "unprognostic (2.79e-2)" "unprognostic (2.44e-3)" "unprognostic (1.42e-2)" "unprognostic (7.88e-2)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (5.38e-8)" "unprognostic (3.64e-3)" "unprognostic (1.35e-1)" "unprognostic (7.36e-2)" "unprognostic (3.72e-3)" 107.0 35.8 4.5 30.8 5.4 2.6 89.6 3.2 8.7 78.2 10.2 80.3 21.9 88.4 21.5 27.1 88.8 66.7 52.1 3.5 8.0 28.0 77.6 56.9 12.4 4.1 3.8 2.7 78.3 18.5 12.7 10.4 232.9 4.3 33.4 21.5 2.1 17.5 40.5 25.3 23.6 61.5 80.5 3.6 38.3 67.6 6.3 4.7 5.5 27.8 27.1 6.2 63.4 53.9 4.0 1.2 5.3 55.3 0.1 1569.3 726.8 106.2 128.1 105.3 78.0 50.7 30.5 39.8 0.0 25.0 191.2 21.3 4.5 36.3 0.4 45.2 0.2 61.3 8.1 5.9 46.3 295.6 0.0 0.7 619.5 5.3 38.2 1.5 30.3 165.7 0.0 0.0 0.0 26.9 0.0 0.1 0.3 56.9 0.0 6.7 0.0 0.1 0.1 0.0 16.6 0.3 47.0 1.0 0.0 10.2 21.3 0.1 52.1 146.5 67.5 44.8 0.1 57.4 0.1 0.0 0.1 0.8 0.0 105.4 0.2 5.7 0.0 0.0 11.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.1 7.3 0.0 0.0 2.1 4.5 5.4 3.2 8.7 3.5 8.0 4.1 3.8 2.7 4.3 3.6 4.7 4.0 48.7 3.2 1.5 18.9 1.7 6.0 1.3 1.5 0.0 0.2 1.2 2.0 24.0 10.0 2.0 0.0 0.0 13.5 0.6 0.0 0.0 0.5 1.4 11.5 362.9 49.4 0.0 5.3 0.6 0.9 10.2 137.6 0.5 9.6 1.3 2.1 191.3 73.4 8.0 3.3 3.3 0.0 10.2 15.1 19.3 5.7 177.3 9.9 17.8 30.0 10.0 2.2 1.0 1.0 0.3 4.3 0.0 125.6 0.0 5.3 0.0 8.6 0.1 0.1 243.3 18.7 92.3 0.8 0.2 0.8 5.3 15.7 2.9 5.7 0.1 7.3 LGALS8 PCTA-1 ENSG00000116977 "Galectin 8" O00214 1 236518000-236552981 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 322.8;Late spermatids: 222.6;Syncytiotrophoblasts: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 118.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012734, HPA030491" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012734: AB_2668720, HPA030491: AB_10602345" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" "unprognostic (2.38e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (4.71e-3)" "unprognostic (3.93e-2)" "prognostic favorable (9.40e-4)" "unprognostic (9.96e-2)" "unprognostic (1.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.41e-1)" "unprognostic (1.57e-1)" "unprognostic (3.15e-2)" "unprognostic (8.21e-2)" 28.8 14.4 10.9 26.7 12.2 44.8 23.6 12.8 14.7 17.4 12.4 20.1 21.8 16.9 19.8 21.4 13.9 25.0 55.5 12.6 13.3 22.2 49.9 27.3 24.2 13.3 11.7 11.5 21.8 22.0 35.3 12.8 41.4 14.0 22.4 20.1 23.1 22.3 21.5 6.8 32.6 24.3 22.0 12.4 43.0 19.1 57.6 12.2 26.6 17.3 9.5 23.0 33.1 15.5 15.3 52.3 27.5 3.6 20.8 46.6 39.0 55.6 38.0 45.4 49.0 59.3 37.6 63.3 1.5 34.8 33.7 26.8 60.3 11.0 54.7 43.2 31.1 7.3 35.5 20.7 68.1 56.9 46.9 78.9 39.6 45.6 41.0 13.8 42.4 52.5 26.4 40.7 25.1 35.7 33.3 23.2 8.4 12.5 4.1 18.5 27.2 0.8 3.0 35.4 80.8 13.1 25.7 24.4 82.3 13.7 2.1 59.0 33.7 39.1 1.0 22.0 29.9 47.7 10.0 7.4 1.0 50.4 65.7 30.9 118.5 37.4 18.7 12.5 32.9 17.8 10.7 18.4 14.1 31.7 6.8 12.2 12.7 16.1 14.2 24.0 14.2 22.5 24.8 10.9 12.2 12.8 14.7 12.6 13.3 13.3 11.7 11.5 14.0 12.4 12.2 15.3 44.0 76.9 54.7 12.1 19.3 32.5 28.5 64.9 44.9 28.1 31.7 22.7 55.2 34.3 68.1 14.7 25.0 64.4 33.9 25.3 5.9 61.8 322.8 18.7 21.9 39.9 18.1 19.0 31.5 39.2 53.5 35.2 23.0 20.8 109.4 38.0 46.1 27.1 57.5 38.7 37.0 18.8 57.0 100.5 23.6 222.6 23.6 45.1 7.2 24.4 38.7 6.5 17.5 18.1 16.7 44.0 36.0 13.9 15.1 20.6 26.4 14.5 53.1 19.4 26.3 22.5 19.6 46.8 8.7 21.3 37.1 176.2 34.4 22.8 17.1 24.4 NT5C1A "CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201" ENSG00000116981 "5'-nucleotidase, cytosolic IA" Q9BXI3 1 39659121-39672038 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 73.1;tongue: 28.9" "Cell type enhanced" "Detected in single" "Inhibitory neurons: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SH-SY5Y: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050283, HPA054158" Supported NA NA "HPA050283: AB_2681072, HPA054158: AB_2682402" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (6.19e-1)" "unprognostic (1.51e-3)" "unprognostic (7.19e-2)" "unprognostic (2.87e-1)" "unprognostic (3.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.29e-2)" "unprognostic (1.81e-2)" 0.2 2.6 0.6 0.1 0.4 0.0 0.0 4.1 4.6 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.2 0.0 11.5 0.6 0.7 0.4 0.0 0.0 0.0 2.9 2.3 0.2 0.1 3.9 0.0 0.0 0.0 2.7 0.5 0.0 0.1 0.1 0.1 73.1 0.0 0.1 0.1 0.8 0.0 0.1 0.2 1.6 0.1 0.0 28.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 17.8 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 4.1 4.6 0.6 0.7 2.9 2.3 0.2 2.7 0.8 1.6 2.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 98.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.2;Distal tubular cells: 11.7;Excitatory neurons: 16.4;Inhibitory neurons: 20.0" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 3.0;naive CD4 T-cell: 2.6" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "Karpas-707: 2.7;SH-SY5Y: 9.1;SK-MEL-30: 2.9;U-2 OS: 1.9;U-266/70: 2.4;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 0.0 10.2 62.2 0.8 98.0 0.4 0.0 44.5 79.9 0.0 3.8 0.2 0.2 0.0 0.3 5.2 0.0 0.2 0.8 86.3 52.1 4.8 0.0 0.6 1.0 26.2 35.0 91.5 2.9 4.9 0.2 2.1 0.0 34.9 0.3 0.1 11.0 0.1 0.1 3.2 0.1 0.4 0.0 21.3 0.3 0.6 4.6 50.9 0.2 0.1 1.3 0.8 0.1 0.1 60.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 1.4 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.8 9.1 0.2 0.0 2.9 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 2.4 3.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 3.0 0.5 0.1 0.0 2.6 0.9 0.0 0.0 0.0 0.0 2.2 0.9 62.2 98.0 44.5 79.9 86.3 52.1 26.2 35.0 91.5 34.9 21.3 50.9 60.1 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 39.2 0.1 0.1 1.5 0.0 0.6 1.8 0.0 0.0 0.0 0.0 11.7 0.0 3.4 0.1 0.0 0.1 0.0 0.0 16.4 0.8 0.0 0.6 0.0 0.7 0.0 0.2 0.0 0.0 0.0 1.7 20.0 0.0 0.0 0.0 0.0 1.2 1.2 0.1 0.0 1.0 0.0 4.9 0.0 1.5 1.3 0.2 0.0 1.5 0.3 0.0 0.0 0.1 0.0 1.4 0.0 0.3 0.1 2.8 0.7 0.0 0.0 0.0 0.9 0.1 0.0 0.0 MTR cblG ENSG00000116984 "5-methyltetrahydrofolate-homocysteine methyltransferase" Q99707 1 236795260-236921278 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Methyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 100.0;Glandular and luminal cells: 130.9;Inhibitory neurons: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044474, HPA054915" Approved Supported Cytosol NA NA Cytosol "HPA044474: AB_10966696, HPA054915: AB_2732589" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (6.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (4.87e-1)" "unprognostic (1.02e-1)" "unprognostic (2.48e-2)" "unprognostic (3.34e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (1.67e-2)" "unprognostic (8.84e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (8.10e-2)" 8.7 6.7 4.7 6.9 5.8 4.6 8.1 5.6 5.6 10.0 6.7 9.3 4.9 10.3 10.6 5.0 12.0 8.9 15.1 5.3 4.8 12.8 6.1 7.1 8.1 7.1 5.6 4.1 14.8 13.1 20.3 6.5 11.7 6.8 7.7 5.1 5.6 6.5 9.2 16.7 9.3 7.2 8.7 5.4 9.4 9.1 9.1 5.3 10.1 13.5 18.3 7.1 10.4 7.7 7.0 17.6 11.0 13.0 8.8 22.6 20.3 15.3 14.9 14.8 18.8 19.0 12.6 12.5 40.0 13.2 16.6 8.7 10.6 18.4 13.1 20.4 19.8 13.7 23.7 14.2 18.3 15.1 37.2 13.3 28.9 7.0 22.9 17.9 11.5 22.3 19.8 33.1 16.4 13.1 10.1 19.6 10.3 16.2 12.9 5.4 20.9 24.8 24.2 11.2 21.3 11.1 27.8 17.7 11.9 14.8 9.3 16.7 13.0 28.8 24.1 9.1 19.6 18.8 34.4 12.3 22.7 17.2 21.1 26.2 0.6 0.5 1.5 1.1 0.8 2.3 0.7 1.4 1.4 0.7 0.8 1.4 1.5 0.0 0.9 0.5 0.5 0.9 0.9 4.7 5.8 5.6 5.6 5.3 4.8 7.1 5.6 4.1 6.8 5.4 5.3 7.0 23.0 57.7 35.0 53.8 25.8 8.2 8.3 8.3 17.1 0.0 10.7 11.9 100.0 20.0 10.9 40.5 0.0 24.2 25.9 3.4 1.9 13.8 9.8 57.5 80.1 21.4 8.4 23.5 87.7 14.8 9.2 22.8 15.8 130.9 30.4 35.0 15.4 10.8 14.4 0.0 106.8 7.7 4.1 16.6 6.8 6.2 23.9 17.1 10.6 47.8 15.3 0.0 19.6 62.8 73.6 12.3 8.0 33.1 20.3 14.9 9.7 9.1 13.3 0.0 6.6 39.4 23.2 17.2 22.0 11.5 5.1 22.6 26.1 40.2 12.0 6.4 BMP8B "BMP8, OP-2" ENSG00000116985 "Bone morphogenetic protein 8b" P34820 1 39757182-39788865 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7" "Group enriched" "Detected in many" 5 "Early spermatids: 72.1;Late spermatids: 106.5;Plasma cells: 38.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "medulla oblongata: 12.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "THP-1: 120.5;U-266/70: 33.7;U-266/84: 52.5;WM-115: 56.7" HPA047254 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA047254: " "unprognostic (1.53e-3)" "unprognostic (7.29e-2)" "unprognostic (2.18e-1)" "unprognostic (6.64e-3)" "unprognostic (8.79e-2)" "unprognostic (3.44e-2)" "unprognostic (7.27e-2)" "unprognostic (7.56e-2)" "unprognostic (1.88e-1)" "unprognostic (7.41e-2)" "unprognostic (2.68e-1)" "unprognostic (4.72e-4)" "unprognostic (1.79e-2)" "unprognostic (3.15e-1)" "unprognostic (9.67e-2)" "unprognostic (8.68e-3)" "unprognostic (4.82e-1)" 1.8 5.6 1.6 1.5 1.4 0.8 0.9 0.7 5.2 2.1 0.0 3.7 5.5 1.5 3.3 1.0 1.3 0.8 0.9 2.1 1.9 0.9 0.7 1.3 0.7 12.7 1.1 1.1 0.8 7.0 1.8 2.7 1.5 2.7 2.4 2.7 0.5 1.7 2.6 0.6 2.0 4.2 0.7 1.8 1.5 1.9 2.2 2.2 0.4 4.7 1.6 0.7 1.6 2.1 3.4 2.7 4.5 0.3 3.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 5.4 0.1 1.8 0.0 0.7 0.4 4.2 0.0 0.0 1.0 5.8 4.9 3.6 0.3 0.1 0.6 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.6 18.1 0.2 3.7 0.1 2.5 0.3 2.8 1.8 2.7 15.9 5.7 4.0 2.7 13.0 3.4 4.3 0.3 13.4 0.9 3.1 120.5 0.0 0.1 0.3 1.1 0.2 33.7 52.5 2.0 0.0 3.7 56.7 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.6 1.4 0.7 5.2 2.1 1.9 12.7 1.1 1.1 2.7 1.8 2.2 3.4 0.0 0.0 1.8 0.0 3.5 0.4 0.6 0.2 0.0 0.5 1.1 0.8 1.2 0.0 0.8 0.0 0.0 0.0 0.9 13.5 0.0 1.0 72.1 1.1 0.6 0.4 1.2 0.0 0.4 3.4 0.0 1.7 1.1 2.3 0.0 0.3 0.4 0.0 0.4 0.0 0.3 2.0 0.0 0.0 2.7 106.5 1.2 0.8 5.4 0.0 0.7 0.1 0.0 8.0 1.8 2.2 2.2 0.7 38.9 0.4 5.0 0.0 0.4 0.5 0.0 1.8 3.4 0.8 0.4 0.4 0.0 0.0 0.7 0.1 1.2 0.8 MYCL "bHLHe38, LMYC, MYCL1" ENSG00000116990 "MYCL proto-oncogene, bHLH transcription factor" P12524 1 39895426-39902256 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 68.4;skin 1: 41.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.9;Hepatocytes: 24.3;Intestinal goblet cells: 25.0;monocytes: 27.4;Squamous epithelial cells: 34.2;Urothelial cells: 27.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 28.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8" "Group enriched" "Detected in many" 72 "dendritic cells: 22.8;monocytes: 17.3" "Group enriched" "Detected in many" 7 "U-266/70: 444.0;U-266/84: 364.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA063132, HPA074515" Enhanced "Nucleoplasm,Mitotic chromosome" Yes NA Nucleoplasm "Mitotic chromosome" "HPA063132: AB_2684946, HPA074515: " "unprognostic (7.45e-2)" "unprognostic (6.91e-2)" "unprognostic (7.36e-2)" "unprognostic (1.83e-3)" "unprognostic (1.61e-2)" "unprognostic (2.92e-3)" "unprognostic (6.72e-3)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-1)" "unprognostic (1.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.01e-3)" "unprognostic (2.75e-2)" "unprognostic (5.21e-2)" "unprognostic (1.53e-2)" "unprognostic (5.80e-2)" 0.8 0.3 1.6 4.7 1.8 0.6 3.4 1.2 2.1 2.7 1.8 6.2 4.8 0.9 7.2 22.3 3.1 1.5 0.5 2.3 1.6 1.0 11.4 3.4 6.4 1.5 1.5 1.7 0.4 68.4 0.3 3.0 6.7 1.7 4.2 6.7 0.2 6.4 7.5 0.5 41.7 5.7 1.1 1.9 7.7 6.2 1.3 2.0 6.6 5.4 0.5 9.6 16.1 12.9 2.0 1.2 0.4 14.4 3.5 0.2 0.1 31.8 0.5 0.2 1.0 0.7 0.4 0.8 2.2 1.4 0.1 0.4 3.3 10.4 2.7 0.8 2.0 4.9 0.5 0.3 0.5 0.4 0.3 7.5 1.0 12.1 0.4 1.3 0.2 1.2 5.4 3.2 0.4 0.6 1.2 0.2 0.3 13.4 2.2 0.4 1.3 15.5 2.9 1.1 58.0 2.5 3.1 1.4 2.1 0.8 5.5 3.7 18.7 0.0 0.0 4.6 6.2 0.5 444.0 364.6 1.0 0.1 2.3 0.3 0.0 17.3 0.0 0.0 8.2 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.2 0.0 3.4 22.8 0.0 6.7 1.6 1.8 1.2 2.1 2.3 1.6 1.5 1.5 1.7 1.7 1.9 2.0 2.0 0.4 0.0 1.1 0.0 0.8 6.6 10.0 2.1 13.1 0.4 3.8 6.0 3.7 0.0 5.5 9.2 0.0 34.9 20.1 13.4 0.0 1.5 0.1 5.1 0.6 0.5 17.3 0.0 0.2 5.8 15.4 0.9 5.1 6.3 0.0 0.0 1.4 24.3 5.1 0.0 0.3 25.0 8.2 8.3 13.1 0.4 0.0 10.6 1.8 0.0 27.4 0.8 0.0 1.0 0.0 2.9 6.5 0.0 3.6 5.3 6.4 0.1 4.9 0.1 0.0 1.4 0.7 0.0 1.2 34.2 11.8 17.5 0.3 0.0 10.8 27.1 SIPA1L2 "KIAA1389, SPAR2" ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232630571 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus" No NA "Nucleoplasm, Nuclear membrane, Nuclear bodies" "Golgi apparatus" "HPA024181: AB_1856886, HPA027224: AB_2672165" "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 10.8 3.3 11.5 6.5 7.5 5.5 9.3 10.2 14.5 8.8 1.1 19.3 4.0 4.4 2.8 20.4 4.6 8.5 29.2 9.6 13.8 5.9 6.4 16.3 3.0 37.9 19.2 5.6 12.0 3.7 4.4 8.2 18.4 45.6 8.2 19.1 14.8 8.8 4.7 7.1 8.7 9.3 7.5 13.4 9.7 5.8 7.3 20.4 2.4 8.1 9.6 3.3 12.6 15.0 34.0 0.0 7.5 69.7 0.2 0.6 0.0 29.3 1.2 2.5 3.1 2.2 2.9 0.1 5.9 13.3 26.4 2.9 1.7 13.8 2.3 2.9 0.0 12.8 0.0 7.0 0.0 5.9 1.0 7.2 3.8 9.1 0.6 6.2 0.0 15.7 25.4 0.0 0.1 1.6 3.5 7.4 0.7 53.9 0.2 10.2 0.0 0.0 3.4 8.1 11.5 3.5 11.9 23.8 0.8 9.5 15.8 1.4 0.6 5.6 8.1 0.0 17.8 2.9 6.5 0.0 0.0 10.0 6.2 46.1 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.3 0.3 0.0 0.1 11.5 7.5 10.2 14.5 9.6 13.8 37.9 19.2 5.6 45.6 13.4 20.4 34.0 53.7 6.4 1.8 22.9 0.8 8.8 9.8 8.7 15.4 23.5 10.7 8.6 62.6 12.8 10.4 3.7 52.1 4.9 4.4 29.9 0.0 7.1 11.7 19.0 21.4 22.7 7.2 0.4 80.2 0.5 7.1 15.2 5.1 47.5 1.3 16.0 1.8 3.8 10.0 5.0 95.9 29.5 14.2 16.6 7.2 9.8 0.9 19.5 14.2 183.6 6.3 12.7 1.0 104.0 21.0 1.4 39.9 1.9 0.5 13.2 9.1 0.4 7.7 35.7 0.0 21.8 23.9 6.9 24.0 45.8 7.4 14.8 2.0 11.9 23.4 23.0 ZP4 ZPB ENSG00000116996 "Zona pellucida glycoprotein 4" Q12836 1 237877864-237890922 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "BJ hTERT+: 3.2" "Not detected" "Not detected" HPA008547 Supported "Secreted in female reproductive system" NA NA "HPA008547: AB_1080766" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.59e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RLF "Zn-15L, ZNF292L" ENSG00000117000 "RLF zinc finger" Q13129 1 40161387-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA054653: AB_2682557, HPA057300: AB_2683404" "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 8.5 4.9 5.4 6.2 6.4 33.1 8.4 12.6 8.5 7.9 3.4 6.7 5.2 8.0 4.8 7.4 7.1 6.6 6.5 6.1 6.5 4.9 7.8 8.3 7.8 4.6 5.5 6.4 8.4 5.6 6.6 5.1 7.4 6.1 6.6 5.3 15.5 5.8 5.5 8.5 11.8 6.2 6.2 4.7 6.3 5.8 10.4 5.9 10.3 5.9 7.1 8.6 7.9 8.4 8.7 18.3 6.9 13.3 13.9 11.6 9.4 15.8 6.7 9.9 11.3 14.9 14.0 9.4 18.1 8.6 8.6 8.4 16.8 16.9 11.8 20.4 8.5 11.4 14.9 8.0 8.7 9.2 12.5 8.7 9.3 12.1 12.0 13.5 13.5 7.8 9.8 23.0 10.8 10.4 5.8 10.6 7.5 17.8 6.7 7.9 8.2 21.8 10.6 7.2 18.2 9.4 13.1 12.5 16.5 12.0 20.5 7.8 44.6 6.7 13.2 14.1 11.0 12.6 9.8 9.8 16.6 11.5 11.4 8.4 6.9 1.5 3.0 1.8 2.0 2.4 2.3 1.8 1.9 1.9 2.1 2.3 2.0 3.2 2.4 2.4 0.8 1.8 1.3 5.4 6.4 12.6 8.5 6.1 6.5 4.6 5.5 6.4 6.1 4.7 5.9 8.7 36.7 32.1 15.1 52.2 55.8 65.6 50.3 12.7 30.7 17.8 25.5 18.4 16.9 2.8 23.9 3.7 16.7 8.9 40.6 10.4 5.9 13.8 41.3 43.8 41.6 24.9 20.2 11.3 87.1 6.7 10.6 34.9 29.6 56.0 26.6 23.0 16.1 9.0 9.7 26.9 84.7 8.8 14.2 13.8 45.2 8.7 9.0 39.9 17.8 60.9 17.5 14.1 9.2 71.9 89.0 10.1 15.5 7.9 44.6 28.7 8.9 5.5 26.0 17.2 13.1 52.8 36.1 32.2 20.8 29.3 61.1 17.2 45.8 17.0 10.8 33.0 KMO ENSG00000117009 "Kynurenine 3-monooxygenase" O15229 1 241532134-241595642 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Pyridine nucleotide biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 31.8;liver: 92.4" "Cell type enhanced" "Detected in many" "B-cells: 33.8;Hepatocytes: 46.9;Langerhans cells: 49.4;Macrophages: 33.0;Proximal tubular cells: 63.2;Syncytiotrophoblasts: 180.1" "Group enriched" "Detected in many" 4 "breast cancer: 1.6;liver cancer: 3.3;renal cancer: 3.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.8" "Group enriched" "Detected in many" 79 "classical monocyte: 11.0;intermediate monocyte: 32.3;memory B-cell: 36.1;myeloid DC: 11.3;naive B-cell: 42.0;non-classical monocyte: 33.8;plasmacytoid DC: 24.3" "Group enriched" "Detected in many" 97 "B-cells: 42.0;dendritic cells: 24.3;monocytes: 33.8" "Cell line enhanced" "Detected in some" "Daudi: 6.2;RPMI-8226: 9.1;RPTEC TERT1: 21.9;SK-BR-3: 10.9;U-698: 9.4" "Region enriched" "Detected in single" 4 "thalamus: 1.1" "Low region specificity" "Detected in many" "HPA031115, HPA056942" Enhanced NA NA "HPA031115: AB_10601924, HPA056942: AB_2683281" "unprognostic (4.27e-2)" "unprognostic (3.35e-2)" "unprognostic (3.95e-2)" "unprognostic (7.48e-3)" "unprognostic (8.37e-3)" "unprognostic (2.63e-1)" "unprognostic (9.79e-2)" "unprognostic (3.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.75e-3)" "unprognostic (8.07e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.49e-8)" "unprognostic (1.60e-2)" "unprognostic (3.65e-2)" "unprognostic (3.36e-2)" "unprognostic (6.81e-2)" 1.4 0.8 0.1 5.2 0.4 1.4 5.3 0.1 1.8 0.6 2.1 0.9 0.6 5.4 0.2 0.2 0.2 1.6 0.4 0.4 0.2 31.8 92.4 5.1 8.9 0.1 0.1 0.2 0.2 0.1 0.1 0.2 6.9 0.2 0.3 1.1 0.2 0.3 0.2 0.1 0.2 1.2 0.8 0.0 8.4 1.2 1.3 0.7 1.6 0.2 0.0 11.3 5.6 0.1 0.4 0.2 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.2 0.4 0.0 0.2 6.2 0.4 0.0 0.2 2.5 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.2 0.7 0.1 0.2 0.5 0.0 0.4 0.1 0.9 0.0 0.2 0.0 2.4 1.0 0.9 0.4 1.6 0.1 9.1 21.9 4.5 0.3 0.1 0.0 10.9 0.1 2.1 4.3 2.1 0.0 0.0 0.1 0.1 1.6 0.4 0.6 9.4 0.2 2.7 1.8 0.1 11.0 0.2 0.0 32.3 0.0 36.1 0.0 0.0 11.3 42.0 0.0 0.1 0.3 0.0 33.8 24.3 0.0 6.1 0.1 0.4 0.1 1.8 0.4 0.2 0.1 0.1 0.2 0.2 0.0 0.7 0.4 0.1 0.0 0.5 0.0 33.8 1.0 0.1 13.3 2.2 0.0 1.8 0.8 0.4 2.8 11.1 0.0 0.0 3.6 5.5 0.1 5.9 4.8 4.9 9.5 1.5 0.3 0.0 5.2 6.6 0.2 2.3 0.4 2.0 26.6 0.0 0.1 0.7 46.9 7.0 0.0 30.0 0.0 4.1 22.7 49.4 1.8 0.0 33.0 0.0 0.0 5.5 0.0 1.0 1.0 0.6 1.5 0.0 0.0 11.7 0.2 0.2 63.2 2.3 0.0 0.0 0.1 1.3 1.6 0.3 3.1 1.4 180.1 1.6 0.1 0.0 0.1 ZNF684 MGC27466 ENSG00000117010 "Zinc finger protein 684" Q5T5D7 1 40531573-40548167 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 36.0" "Low region specificity" "Detected in all" HPA059153 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059153: AB_2683932" "unprognostic (4.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-4)" "unprognostic (2.29e-2)" "unprognostic (2.96e-2)" "unprognostic (3.67e-4)" "unprognostic (8.49e-2)" "unprognostic (2.26e-3)" "unprognostic (2.10e-2)" "unprognostic (7.00e-2)" "unprognostic (4.14e-3)" "unprognostic (3.96e-2)" "prognostic favorable (4.89e-10)" "unprognostic (4.76e-3)" "unprognostic (7.11e-2)" "unprognostic (5.98e-2)" "unprognostic (1.52e-2)" 2.4 3.7 2.2 2.2 3.1 6.4 3.0 2.4 3.3 1.7 2.5 2.8 2.3 2.4 2.8 1.7 1.7 2.4 7.8 2.2 2.1 6.9 12.5 2.5 3.3 2.7 2.6 2.2 2.6 2.6 3.3 1.2 1.5 2.8 1.8 3.4 2.1 2.5 1.4 3.4 3.0 1.9 2.3 1.9 3.1 3.2 3.2 2.6 3.4 3.9 2.9 2.7 1.7 1.4 4.4 2.9 0.9 3.6 4.8 3.2 4.8 2.1 2.6 2.5 3.2 5.4 1.7 3.7 5.0 2.1 1.7 2.1 3.5 3.6 2.7 4.9 4.4 6.3 5.4 3.2 4.9 1.7 5.7 5.7 3.0 1.0 3.8 1.5 1.8 4.6 4.0 2.9 6.9 4.5 0.9 8.6 6.6 8.8 1.3 2.8 4.1 10.3 3.6 4.7 2.5 2.5 4.4 4.7 4.5 5.2 4.7 2.0 36.0 2.8 2.9 6.3 3.1 5.1 5.8 4.8 5.9 2.6 5.9 4.8 4.1 1.9 1.0 3.0 4.1 1.6 3.5 2.0 1.7 1.2 1.5 1.3 2.6 1.0 1.9 2.2 1.9 2.6 1.3 2.2 3.1 2.4 3.3 2.2 2.1 2.7 2.6 2.2 2.8 1.9 2.6 4.4 4.9 6.4 3.2 10.4 6.8 2.3 1.6 2.2 4.6 3.4 2.0 2.8 13.0 5.7 2.9 7.3 0.0 1.2 7.2 3.2 17.6 5.7 6.5 1.6 3.2 5.0 1.2 4.2 7.8 14.7 2.5 4.2 1.5 1.8 2.5 4.6 4.2 15.8 4.8 3.3 7.9 2.2 4.1 4.2 2.3 3.7 2.5 4.2 8.8 5.6 6.3 4.3 4.1 12.5 16.1 6.4 2.0 3.0 3.2 1.0 1.1 17.3 4.3 2.6 0.0 5.8 4.8 8.7 4.6 1.7 1.3 0.0 5.9 5.3 3.2 1.5 KCNQ4 "DFNA2, Kv7.4" ENSG00000117013 "Potassium voltage-gated channel subfamily Q member 4" P56696 1 40783787-40840452 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Hearing, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 4.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018305 Uncertain NA NA "HPA018305: AB_1855556" "unprognostic (1.42e-2)" "unprognostic (1.56e-1)" "unprognostic (8.43e-3)" "unprognostic (4.59e-3)" "unprognostic (8.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (5.86e-2)" "unprognostic (4.34e-2)" "unprognostic (6.64e-2)" "unprognostic (1.20e-1)" "unprognostic (7.40e-2)" "unprognostic (5.18e-4)" "unprognostic (2.68e-1)" "unprognostic (1.22e-1)" "unprognostic (3.17e-2)" "unprognostic (3.44e-2)" 0.7 0.1 0.3 0.3 0.5 0.0 0.6 0.3 1.6 0.8 2.0 3.9 0.4 2.9 0.1 1.0 2.3 0.3 0.6 0.3 0.5 0.1 0.1 0.5 0.0 0.9 4.4 0.4 0.5 0.4 0.2 0.3 0.5 0.8 1.1 0.3 0.4 1.4 1.1 3.2 0.5 1.2 1.5 0.7 0.0 1.3 0.2 0.1 0.3 0.3 1.0 0.0 2.3 0.7 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 2.2 0.9 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 0.0 1.4 0.3 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.2 0.0 1.1 0.2 0.0 0.6 0.2 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 1.6 0.3 0.5 0.9 4.4 0.4 0.8 0.7 0.1 1.9 0.3 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.4 1.8 1.5 2.1 0.0 0.0 0.0 2.1 0.1 0.0 0.5 0.0 1.2 0.2 0.2 0.1 0.3 1.8 0.8 5.1 0.2 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 2.2 0.0 9.7 1.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 4.2 0.0 2.5 1.5 0.6 0.5 0.7 0.3 0.2 0.0 0.0 0.0 0.3 6.6 2.0 2.8 0.2 0.7 1.0 0.4 0.0 0.0 0.1 1.1 0.1 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620680-40665682 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 104.4" "Cell type enhanced" "Detected in many" "Early spermatids: 12.6;Excitatory neurons: 37.7;Inhibitory neurons: 21.1;Late spermatids: 34.4;Muller glia cells: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 77.4;JURKAT: 26.7;SH-SY5Y: 35.2;U-87 MG: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 0.9 6.3 32.4 1.9 47.4 3.6 2.6 0.0 80.3 1.6 0.0 4.1 0.6 3.5 1.6 2.3 2.7 0.9 1.4 18.9 20.2 1.4 0.4 3.5 1.7 13.2 37.5 41.2 1.8 0.7 2.9 1.0 3.2 21.9 2.5 3.1 6.6 1.6 3.3 0.3 2.2 2.2 4.1 0.0 1.2 3.5 3.7 104.4 4.3 2.2 0.5 2.4 2.5 1.5 30.0 4.1 1.6 5.8 6.2 0.3 0.0 0.9 0.1 0.1 1.0 1.2 0.7 1.2 77.4 0.1 0.1 2.8 0.7 3.8 0.7 0.6 13.5 1.9 4.4 0.5 2.1 0.2 0.7 3.5 0.1 3.1 0.2 0.2 0.2 0.3 26.7 3.8 2.9 0.0 7.0 11.7 0.4 3.8 0.7 0.4 5.3 5.3 14.3 1.1 1.0 19.9 35.2 0.8 3.7 2.6 7.7 0.9 21.4 0.1 0.6 5.9 0.1 1.1 0.7 5.9 16.8 32.2 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 32.4 47.4 0.0 80.3 18.9 20.2 13.2 37.5 41.2 21.9 0.0 104.4 30.0 0.0 6.4 0.0 2.6 0.4 0.5 0.2 0.1 0.6 6.1 1.5 2.5 1.8 0.0 0.1 1.8 0.0 0.1 7.3 6.0 0.0 0.9 12.6 0.0 0.0 0.5 0.0 1.3 37.7 1.5 0.1 0.5 0.0 0.1 1.3 10.7 0.0 0.0 2.7 5.0 21.1 4.2 0.0 2.6 1.4 34.4 0.0 1.5 0.0 3.7 0.9 13.4 0.0 4.0 4.5 2.3 1.4 0.7 0.2 0.4 0.0 0.7 0.0 0.7 0.0 1.5 2.5 2.7 2.0 0.1 0.1 0.3 0.9 0.7 1.6 0.2 AKT3 "PKBG, PRKBG, RAC-gamma" ENSG00000117020 "AKT serine/threonine kinase 3" Q9Y243 1 243488233-243851079 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.4" "Group enriched" "Detected in many" 6 "Astrocytes: 457.4;Excitatory neurons: 756.1;Inhibitory neurons: 514.5;Microglial cells: 414.1;Oligodendrocyte precursor cells: 633.3;Oligodendrocytes: 475.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013090, HPA026441" Approved Supported Cytosol NA NA Cytosol "CAB013090: AB_2533692, HPA026441: AB_1844711" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (2.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.96e-1)" "unprognostic (3.77e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-1)" "unprognostic (5.47e-3)" "unprognostic (1.37e-1)" "unprognostic (6.71e-2)" "unprognostic (3.64e-3)" "unprognostic (1.29e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (9.27e-4)" 18.8 9.8 14.3 6.1 17.8 3.9 15.6 61.4 33.5 19.1 0.0 19.0 2.6 22.8 8.6 6.0 20.5 8.3 10.3 18.7 9.0 10.1 4.7 15.4 5.9 1.9 5.6 8.2 26.6 4.5 7.4 14.0 13.2 10.3 16.0 4.9 17.2 5.1 15.7 6.0 5.7 11.9 15.9 0.7 8.1 10.3 9.7 11.1 7.1 14.5 11.6 4.6 19.0 15.0 30.7 30.8 7.2 31.0 0.4 16.9 20.6 13.9 20.8 22.5 11.8 12.9 1.1 13.9 0.5 3.0 28.9 12.1 1.2 16.3 8.5 18.9 9.0 15.3 1.0 1.0 0.3 11.7 0.6 6.5 11.3 0.3 15.5 16.9 30.3 30.2 7.2 0.5 1.1 9.0 0.9 7.6 3.3 14.4 0.3 5.1 4.2 19.7 0.6 4.8 4.1 31.4 41.9 1.3 0.5 40.1 19.1 1.9 21.5 25.6 22.7 17.7 1.1 19.5 4.6 4.6 7.1 19.4 5.2 25.3 1.3 0.8 0.1 0.6 0.1 1.1 0.6 0.6 0.6 0.3 0.8 0.6 0.7 0.7 1.4 0.3 0.5 0.1 0.3 14.3 17.8 61.4 33.5 18.7 9.0 1.9 5.6 8.2 10.3 0.7 11.1 30.7 65.4 3.2 2.2 457.4 22.2 2.4 15.0 1.3 17.1 43.6 6.1 5.1 5.4 4.3 2.7 27.6 33.3 11.0 24.4 0.0 0.0 11.6 82.8 1.7 35.5 43.7 0.0 5.0 756.1 1.7 8.0 27.9 2.6 1.1 5.1 29.7 48.2 0.6 2.9 42.1 514.5 0.0 2.0 10.5 12.5 72.8 27.4 9.5 7.2 414.1 8.6 20.1 19.6 633.3 475.9 0.7 0.0 35.3 14.4 27.0 0.0 6.9 0.3 35.0 19.7 40.1 35.6 15.0 14.6 1.7 1.7 12.4 27.8 8.3 0.0 12.2 ETV3 PE-1 ENSG00000117036 "ETS variant transcription factor 3" P41162 1 157121191-157138474 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 361.2;monocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004794, HPA073211" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004794: AB_1078761, HPA073211: " "unprognostic (1.65e-1)" "unprognostic (2.37e-1)" "unprognostic (3.78e-2)" "unprognostic (4.39e-2)" "unprognostic (7.59e-2)" "unprognostic (5.23e-2)" "unprognostic (1.38e-2)" "unprognostic (3.30e-1)" "unprognostic (2.36e-2)" "unprognostic (5.37e-2)" "unprognostic (1.34e-2)" "unprognostic (8.02e-2)" "unprognostic (7.26e-3)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" "unprognostic (8.97e-2)" "unprognostic (6.65e-2)" 13.8 7.7 6.8 11.2 6.8 24.2 12.2 7.7 20.4 8.4 5.9 8.8 15.2 9.4 7.5 15.7 7.9 12.8 7.5 8.9 12.0 6.6 6.6 12.7 10.2 8.2 7.1 5.3 11.6 6.5 24.1 5.1 12.9 7.4 10.3 9.6 5.7 9.2 8.5 9.5 30.8 14.7 10.2 7.7 10.1 10.1 9.5 7.0 10.9 8.0 8.8 12.6 17.7 11.5 7.7 11.9 11.4 11.6 10.1 17.3 11.3 9.9 10.9 11.4 10.5 9.7 12.2 11.6 14.2 13.4 13.4 5.6 18.0 12.8 16.7 13.8 31.0 8.1 11.9 12.2 6.7 10.3 19.0 18.1 12.5 19.2 15.7 13.3 8.5 11.1 8.8 13.9 10.2 12.0 15.7 5.8 10.7 38.6 16.9 8.7 8.7 13.8 16.3 8.1 43.9 9.8 19.0 11.9 28.1 29.5 20.7 14.4 20.7 18.8 13.5 11.9 13.2 13.7 24.6 13.5 16.7 15.5 10.9 45.2 6.3 4.6 3.3 4.5 4.2 6.2 2.1 3.9 4.5 4.5 2.4 3.9 3.5 5.4 4.2 4.2 1.2 3.3 2.6 6.8 6.8 7.7 20.4 8.9 12.0 8.2 7.1 5.3 7.4 7.7 7.0 7.7 22.9 35.3 16.2 3.6 20.4 70.4 18.4 20.2 71.7 2.3 18.2 14.4 9.4 5.7 24.3 12.9 10.4 7.5 37.2 22.1 0.0 6.4 9.4 18.1 18.0 19.4 10.7 5.9 8.1 6.3 9.0 16.3 15.3 29.5 22.2 6.4 15.4 8.3 8.7 1.7 6.9 12.5 10.2 13.2 361.2 7.3 4.1 69.0 16.0 5.6 97.0 3.9 10.3 6.0 4.4 10.4 13.4 4.5 25.3 16.5 16.0 3.2 29.7 6.3 13.1 16.4 15.4 10.2 9.4 64.2 78.7 14.9 40.4 6.0 14.4 51.4 ACADM "ACAD1, MCAD, MCADH" ENSG00000117054 "Acyl-CoA dehydrogenase medium chain" P11310 1 75724431-75787575 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 370.3;skeletal muscle: 383.6;tongue: 480.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 289.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006198, HPA026542" Enhanced Enhanced Mitochondria NA NA 930000 Mitochondria "HPA006198: AB_1078087, HPA026542: AB_1844469" "unprognostic (9.04e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.30e-4)" "unprognostic (5.09e-3)" "unprognostic (1.61e-3)" "unprognostic (5.68e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (4.95e-2)" "unprognostic (9.40e-3)" "unprognostic (3.35e-1)" "prognostic favorable (3.83e-8)" "unprognostic (1.27e-1)" "unprognostic (4.09e-2)" "unprognostic (3.56e-2)" "unprognostic (1.24e-1)" 82.6 83.0 29.3 24.5 29.3 17.4 70.6 30.8 42.6 29.6 33.6 47.2 104.9 20.2 25.5 51.8 30.9 28.1 219.8 28.7 29.5 298.7 370.3 22.8 42.9 30.4 30.8 28.5 36.1 36.2 66.9 19.4 17.0 30.3 27.0 50.0 21.4 31.7 26.4 383.6 11.9 76.2 25.7 30.3 27.6 53.3 36.0 29.8 30.0 38.8 480.2 44.7 33.0 21.5 29.5 25.8 20.5 61.0 26.8 53.1 42.1 17.5 48.1 40.4 46.1 38.5 38.3 39.5 289.1 40.7 34.4 39.0 22.8 54.9 41.8 57.8 113.0 25.5 94.4 58.5 58.3 36.4 80.0 23.9 50.7 23.5 39.8 22.8 35.0 36.2 56.6 102.3 60.4 50.5 9.6 96.3 40.6 50.2 80.4 49.5 118.8 83.8 30.6 77.9 70.7 33.8 43.0 38.0 111.6 102.0 43.1 32.7 107.6 20.2 29.9 29.6 26.6 78.1 38.6 62.0 128.1 25.8 67.0 35.3 15.3 14.2 19.3 17.1 20.9 27.3 40.7 17.8 21.5 21.4 24.6 20.3 23.6 0.5 25.0 20.4 23.2 19.5 19.5 29.3 29.3 30.8 42.6 28.7 29.5 30.4 30.8 28.5 30.3 30.3 29.8 29.5 42.9 57.7 58.3 29.7 56.5 27.3 41.8 69.0 44.3 39.0 49.0 40.9 373.1 52.9 63.0 58.8 25.0 35.8 39.4 42.6 344.4 37.9 55.4 27.1 32.2 36.2 40.7 67.6 51.6 26.5 19.5 47.6 26.0 25.4 44.9 61.5 43.9 261.2 75.7 30.3 46.7 38.7 63.1 45.6 22.2 24.4 46.9 38.2 51.6 19.7 32.8 53.7 29.9 36.2 36.0 21.2 49.7 45.5 74.9 24.2 88.0 564.8 106.7 30.0 0.0 38.6 43.7 76.3 86.1 46.6 27.0 15.3 39.4 72.5 46.7 35.9 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867480-77067546 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.2" "Group enriched" "Detected in some" 8 "Excitatory neurons: 480.3;Inhibitory neurons: 417.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Region enhanced" "Detected in many" "cerebral cortex: 6.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.7;fHDF/TERT166: 5.4;HaCaT: 2.7;SH-SY5Y: 4.1;U-2 OS: 4.4;U-251 MG: 2.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 51.3" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" NA Yes 180000 Vesicles "HPA065593: AB_2685515, HPA070354: AB_2686260" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.1 3.0 1.7 1.5 1.5 0.0 1.2 0.0 6.2 0.7 0.0 1.4 0.2 0.1 0.0 1.0 1.9 2.2 0.3 5.7 0.7 0.0 0.0 3.6 0.4 0.0 0.6 1.9 1.7 0.1 0.0 1.9 0.1 0.4 1.0 0.6 3.2 0.5 0.3 0.0 0.2 0.9 3.1 0.0 0.2 1.5 0.3 0.0 0.0 0.0 0.0 0.3 1.6 0.6 1.0 1.2 0.0 4.7 0.0 0.0 0.0 0.0 0.4 1.5 1.1 0.4 0.0 0.1 0.0 0.0 5.4 0.0 2.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.4 0.0 0.0 1.1 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 4.4 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.0 6.2 5.7 0.7 0.0 0.6 1.9 0.4 0.0 0.0 1.0 0.0 54.5 0.5 35.6 0.1 0.0 0.0 0.1 0.0 20.7 2.8 1.7 1.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.2 1.9 0.4 0.0 0.0 480.3 0.0 0.1 0.8 0.0 0.2 1.3 0.9 0.0 0.0 0.1 0.0 417.3 0.2 0.0 0.0 0.0 2.3 0.6 0.1 0.0 8.4 0.0 0.7 0.0 10.6 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 1.3 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.1 SLAMF1 "CD150, SLAM" ENSG00000117090 "Signaling lymphocytic activation molecule family member 1" Q13291 1 160608106-160647295 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 77.3" "Cell type enhanced" "Detected in some" "B-cells: 29.8;Melanocytes: 14.2;monocytes: 22.9;Plasma cells: 49.2;T-cells: 35.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 66.3" "Group enriched" "Detected in many" 10 "B-cells: 22.7;T-cells: 66.3" "Cell line enriched" "Detected in some" 104 "HDLM-2: 195.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002438, HPA069319" Enhanced "Secreted to blood" NA NA 350000 "CAB002438: AB_564011, HPA069319: AB_2732129" "unprognostic (2.99e-3)" "unprognostic (3.33e-4)" "unprognostic (2.93e-4)" "unprognostic (1.38e-4)" "unprognostic (5.87e-2)" "unprognostic (6.06e-5)" "unprognostic (1.64e-2)" "unprognostic (1.70e-3)" "unprognostic (1.69e-2)" "unprognostic (2.74e-4)" "unprognostic (6.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-7)" "unprognostic (2.46e-1)" "unprognostic (8.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.18e-2)" 1.0 0.5 0.0 13.8 0.1 6.7 1.7 0.0 0.1 1.1 0.4 2.7 3.7 0.4 0.1 1.4 0.4 2.4 0.7 0.0 0.1 0.9 0.9 2.1 21.8 0.2 0.1 0.0 0.4 0.3 0.1 0.1 3.1 0.1 0.6 3.1 0.0 1.7 0.3 0.3 0.7 4.0 0.9 0.1 6.7 3.9 0.2 0.2 77.3 0.6 0.0 19.3 8.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 195.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.4 0.0 1.8 0.0 0.1 0.2 0.0 10.7 0.0 66.3 16.5 46.3 33.0 0.3 22.7 17.5 4.4 0.6 0.0 0.1 4.4 61.7 9.5 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 1.4 0.0 5.2 0.0 29.8 2.0 0.1 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.6 1.8 0.0 0.0 4.8 0.0 0.0 0.0 4.1 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.8 10.7 8.5 0.0 5.2 14.2 1.0 22.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 49.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.8 0.1 0.1 0.0 1.7 0.1 35.6 0.0 0.1 0.1 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711831 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 149.8;lymphoid tissue: 286.2" "Cell type enhanced" "Detected in many" "B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002497, HPA055146" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2000000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: AB_2682716" "prognostic favorable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 11.9 6.0 1.4 116.4 1.8 149.8 18.9 1.5 4.7 10.3 3.9 25.1 20.7 6.8 5.0 8.5 5.8 26.8 4.3 1.3 2.8 4.4 20.0 31.2 286.2 2.5 1.8 1.2 3.1 2.0 1.6 1.6 5.8 2.3 8.2 32.8 0.1 14.1 4.4 2.9 3.5 48.7 12.6 2.4 161.4 32.8 2.9 2.8 140.2 5.2 3.4 258.9 42.2 4.6 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 220.9 0.1 0.0 0.0 0.5 0.1 0.0 0.0 6.0 0.0 2.1 0.0 0.0 0.0 27.1 236.9 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.4 78.6 0.0 0.0 78.9 38.4 0.1 0.0 0.0 4.7 0.1 34.3 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.1 0.0 0.3 0.2 0.4 501.4 360.3 89.9 0.2 66.7 0.1 218.1 327.1 230.8 242.8 470.2 335.8 206.2 275.2 283.4 329.7 161.2 277.9 301.6 82.1 160.7 487.4 57.0 229.9 603.5 1.4 1.8 1.5 4.7 1.3 2.8 2.5 1.8 1.2 2.3 2.4 2.8 3.0 3.7 0.0 9.6 0.7 336.1 5.5 0.8 0.0 1.8 0.0 2.0 1.7 1.1 2.8 1.3 3.7 0.0 0.6 251.2 0.1 1.9 0.2 0.1 0.7 0.5 2.8 1.2 21.5 0.1 0.2 0.8 2.4 6.6 0.6 90.7 0.1 7.1 2.0 86.4 0.0 0.1 0.1 0.0 245.8 106.5 0.5 1.8 218.3 39.2 1.0 366.6 0.0 454.2 0.5 0.0 0.1 0.0 0.4 127.4 0.4 0.0 4.9 2.2 0.0 0.0 1.7 2.1 0.5 0.3 0.7 3.0 0.4 376.2 0.0 1.2 0.5 ADGRL2 "KIAA0786, LEC1, LPHH1, LPHN2" ENSG00000117114 "Adhesion G protein-coupled receptor L2" O95490 1 81306147-81992436 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 11 "Excitatory neurons: 902.7;Inhibitory neurons: 646.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 252.8;hTEC/SVTERT24-B: 130.3;NTERA-2: 100.0;SH-SY5Y: 168.3;U-2197: 118.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043447 Approved "Plasma membrane" NA NA 700000 "Plasma membrane" "HPA043447: AB_2678486" "unprognostic (2.54e-2)" "unprognostic (6.29e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (3.22e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.92e-4)" "unprognostic (3.55e-2)" "unprognostic (9.84e-2)" "unprognostic (2.42e-1)" "unprognostic (7.81e-2)" "unprognostic (8.01e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.76e-1)" "unprognostic (3.38e-3)" "unprognostic (1.41e-2)" 19.9 20.1 11.8 8.2 15.3 0.0 18.0 8.9 28.1 14.2 8.4 13.6 5.8 12.5 15.1 23.8 23.3 23.3 28.8 14.8 26.7 21.6 38.9 65.5 9.0 10.9 12.1 14.4 36.6 9.8 27.7 20.7 49.2 12.3 30.2 11.0 25.4 37.0 19.6 4.5 13.0 13.5 12.8 8.4 20.1 15.7 4.3 14.4 10.5 43.6 19.9 8.8 13.3 23.6 16.7 18.2 9.9 252.8 0.0 30.3 35.3 3.4 6.4 14.8 2.5 2.9 0.0 0.0 0.1 69.6 34.6 7.1 10.1 20.3 28.0 2.3 0.5 41.5 0.0 7.0 16.6 11.8 0.0 0.4 32.5 1.8 130.3 12.9 17.8 42.9 0.0 0.0 0.0 3.4 0.2 0.0 0.1 100.0 0.0 7.1 0.0 34.9 0.0 56.9 3.8 11.7 168.3 0.0 6.3 0.0 73.5 0.4 74.7 27.5 26.0 28.9 118.9 9.3 0.0 0.0 0.2 14.9 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.3 8.9 28.1 14.8 26.7 10.9 12.1 14.4 12.3 8.4 14.4 16.7 25.3 3.2 2.2 23.8 0.2 0.0 7.0 0.0 2.2 48.5 6.6 11.2 44.1 10.0 3.1 5.5 6.2 0.4 0.1 2.1 0.0 4.7 1.4 11.7 10.3 36.9 0.0 0.0 902.7 1.6 0.4 19.6 0.5 25.4 0.0 32.3 30.0 39.3 0.9 33.7 646.8 2.0 0.0 3.1 0.0 1.4 23.3 1.1 0.0 69.3 0.0 19.0 0.0 11.1 13.0 0.8 3.6 17.7 0.0 10.4 0.0 7.8 0.0 3.9 19.7 2.5 19.8 1.5 3.5 4.1 0.0 0.4 0.5 43.1 3.5 3.0 PADI2 "KIAA0994, PDI2" ENSG00000117115 "Peptidyl arginine deiminase 2" Q9Y2J8 1 17066761-17119451 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 248.4;skeletal muscle: 314.8;tongue: 496.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3" "Cancer enhanced" "Detected in many" "glioma: 24.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 43.3;neutrophil: 100.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 100.6" "Cell line enhanced" "Detected in some" "A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047735 Enhanced NA NA "HPA047735: AB_2680139" "unprognostic (2.61e-2)" "unprognostic (3.60e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (2.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (3.74e-3)" "unprognostic (2.78e-3)" "unprognostic (3.28e-3)" "unprognostic (1.29e-1)" "unprognostic (3.07e-1)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-1)" "unprognostic (2.27e-1)" "unprognostic (5.91e-3)" 2.1 0.9 98.8 9.4 150.8 24.0 41.6 166.8 107.1 3.3 41.9 90.6 1.4 0.8 0.6 6.2 2.7 1.6 0.5 86.4 155.9 9.3 0.7 4.4 1.0 203.3 172.6 61.8 0.2 1.5 2.1 3.7 1.4 200.5 2.6 93.2 51.0 44.8 1.6 314.8 8.7 8.5 5.9 185.1 13.5 2.3 0.8 143.1 2.2 0.6 496.7 1.3 2.5 1.0 248.4 0.0 11.6 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.1 0.1 4.9 0.2 1.5 0.5 0.1 1.6 0.4 0.1 0.3 0.0 0.8 0.5 0.0 0.0 0.0 0.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 3.8 0.6 1.4 1.6 3.9 0.0 0.0 0.0 0.4 33.1 0.0 2.1 0.2 0.0 50.7 0.0 2.7 13.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 0.0 1.3 16.2 43.3 0.0 0.9 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 100.6 0.0 0.2 0.4 0.0 6.4 98.8 150.8 166.8 107.1 86.4 155.9 203.3 172.6 61.8 200.5 185.1 143.1 248.4 0.2 0.0 1.3 28.4 1.0 0.3 0.4 0.6 0.0 2.2 31.2 32.5 0.4 0.0 3.3 1.8 95.9 0.2 0.7 178.7 11.7 0.6 6.1 0.0 0.0 8.2 3.6 0.0 1.5 0.0 0.5 0.6 0.0 0.1 17.1 0.5 0.7 0.0 7.2 0.0 1.4 77.3 2.0 4.8 25.8 10.3 0.3 9.2 28.4 15.9 33.8 33.6 0.0 13.6 117.1 0.0 72.3 0.7 0.4 0.5 15.0 0.3 0.2 29.6 0.0 5.6 1.3 0.2 0.4 0.0 0.4 0.1 0.4 0.0 51.8 0.2 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054032 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 496.1;tongue: 585.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 405.5;Proximal tubular cells: 449.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA 7900 Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favorable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 86.6 96.5 66.9 59.5 69.8 95.4 69.4 77.6 85.0 57.2 76.3 135.6 164.5 56.5 71.6 78.1 60.3 48.5 302.9 68.2 73.0 230.1 338.8 56.6 76.0 72.8 70.0 64.4 44.8 80.9 145.5 43.2 58.0 71.3 56.2 133.7 63.5 74.6 61.0 496.1 55.9 123.0 71.0 70.8 61.0 93.5 65.0 72.2 63.3 64.8 585.8 84.9 72.0 52.4 76.5 157.3 152.7 72.2 107.8 141.6 135.2 95.9 122.4 145.2 254.3 227.7 216.8 183.1 206.8 159.3 156.4 176.1 180.1 290.7 226.8 284.8 128.7 280.6 183.4 149.2 168.2 172.8 276.0 135.6 140.4 154.9 224.5 370.1 138.7 183.6 176.5 165.2 236.9 179.6 129.5 182.4 175.1 70.4 224.6 302.6 146.1 142.5 265.4 252.4 88.7 157.5 86.0 172.3 216.3 392.3 76.4 131.1 169.1 94.9 115.8 131.0 206.4 176.0 98.9 133.3 198.6 170.4 438.5 128.3 68.7 149.8 149.5 71.4 206.5 70.7 89.9 81.0 77.5 186.8 81.1 73.5 74.8 174.3 85.3 185.7 89.3 113.8 116.1 66.9 69.8 77.6 85.0 68.2 73.0 72.8 70.0 64.4 71.3 70.8 72.2 76.5 48.2 64.1 47.4 20.9 57.4 52.1 93.3 199.8 40.5 31.5 45.2 49.4 405.5 101.5 97.0 47.8 14.6 107.1 48.3 176.1 354.1 134.3 220.3 48.7 38.2 54.7 48.6 77.3 27.7 149.2 142.2 62.0 46.9 45.5 66.6 39.9 46.8 226.0 177.4 37.0 32.1 103.1 116.0 88.7 67.9 30.5 57.8 78.4 64.0 29.0 123.1 78.3 48.4 15.6 24.6 111.5 218.3 67.7 62.2 74.4 300.5 449.0 79.8 53.8 39.5 57.1 191.6 148.9 71.5 72.9 54.6 121.8 46.8 69.3 162.0 110.9 MFAP2 "MAGP, MAGP-1" ENSG00000117122 "Microfibril associated protein 2" P55001 1 16974502-16980632 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 80.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 197.8;Fibroblasts: 75.8;Granulosa cells: 93.3;Leydig cells: 53.7;Peritubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 249.4;ASC TERT1: 249.6;HUVEC TERT2: 263.1;SH-SY5Y: 212.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007354 Enhanced "Secreted to extracellular matrix" NA NA 210000 "HPA007354: AB_1079365" "unprognostic (5.10e-2)" "unprognostic (3.81e-2)" "unprognostic (2.62e-1)" "unprognostic (2.92e-2)" "unprognostic (4.86e-1)" "unprognostic (1.53e-3)" "unprognostic (3.72e-3)" "unprognostic (2.21e-1)" "unprognostic (1.85e-2)" "unprognostic (1.98e-1)" "unprognostic (9.45e-3)" "unprognostic (9.12e-2)" "prognostic unfavorable (2.52e-8)" "unprognostic (2.18e-3)" "unprognostic (1.34e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" 30.8 4.2 0.6 13.4 0.5 0.1 22.9 0.5 1.2 80.3 2.3 13.7 5.0 61.9 22.3 6.2 19.2 73.9 12.9 0.4 2.8 6.3 1.6 20.3 4.2 0.6 0.8 0.3 36.1 19.0 4.5 13.4 42.8 0.7 22.3 4.8 5.0 16.7 12.2 2.6 24.9 12.2 30.9 0.5 2.7 8.4 11.3 0.6 1.6 9.6 3.0 2.4 22.8 37.1 0.5 0.0 0.2 93.2 0.3 249.4 249.6 6.2 26.3 102.5 39.7 73.7 24.1 1.1 0.0 82.6 89.7 0.1 0.1 7.2 7.7 15.9 0.1 78.0 0.0 37.1 2.1 23.4 0.1 0.1 104.4 18.8 109.4 42.7 113.1 263.1 0.0 0.2 16.2 19.2 12.5 0.1 0.1 108.8 0.5 0.8 1.5 0.0 4.0 0.9 0.3 5.0 212.1 9.0 36.6 9.6 71.1 11.9 13.0 75.6 65.6 128.4 51.7 2.8 0.1 0.3 0.2 53.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.5 1.2 0.4 2.8 0.6 0.8 0.3 0.7 0.5 0.6 0.5 5.5 0.0 1.7 0.0 0.1 6.6 7.8 28.7 8.0 0.2 2.1 3.9 0.9 2.8 10.7 3.7 0.0 4.5 0.0 0.1 0.0 1.3 12.9 5.6 28.7 7.1 10.1 0.0 0.0 0.8 197.8 75.8 2.0 8.3 0.0 93.3 1.4 0.0 7.4 0.0 0.0 0.4 12.2 0.0 7.7 7.6 53.7 0.6 17.8 2.8 0.0 27.7 0.0 0.0 0.0 1.9 0.0 63.9 0.5 1.5 0.0 0.0 1.9 0.8 0.0 3.3 14.7 3.2 8.7 0.6 6.3 29.0 0.9 0.5 0.2 1.2 RPF1 BXDC5 ENSG00000117133 "Ribosome production factor 1 homolog" Q9H9Y2 1 84479259-84498352 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024642 Supported Supported Nucleoli No No Nucleoli "HPA024642: AB_1856428" "unprognostic (1.56e-3)" "unprognostic (2.65e-1)" "unprognostic (3.63e-2)" "unprognostic (7.95e-3)" "unprognostic (2.16e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-2)" "unprognostic (2.45e-1)" "unprognostic (1.45e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.42e-2)" "unprognostic (2.71e-1)" 24.4 21.8 13.8 19.2 17.3 45.3 24.9 15.0 19.6 23.7 15.7 27.5 17.9 26.3 23.2 27.2 23.4 14.2 31.0 13.5 14.8 23.4 26.4 20.7 27.0 14.4 13.8 13.3 20.9 23.0 18.9 21.1 15.0 14.3 20.9 21.1 16.9 22.1 15.7 43.1 25.2 23.4 18.3 13.6 26.4 25.8 25.5 13.9 29.7 23.5 24.1 28.3 25.1 23.5 15.5 43.1 29.2 36.6 30.2 27.1 35.5 40.5 46.8 36.5 53.2 47.0 21.4 17.6 31.9 50.1 33.9 89.0 31.7 54.3 43.2 57.7 51.0 57.6 85.2 30.7 37.8 37.2 80.0 25.4 29.0 63.0 56.0 39.2 30.7 42.6 60.7 79.9 40.7 46.9 21.8 76.3 53.0 91.5 43.0 62.5 48.3 58.5 25.7 51.3 47.6 45.2 42.2 27.7 52.7 107.3 32.8 29.6 53.4 30.3 40.1 41.3 64.8 90.4 29.5 39.0 73.0 19.2 71.0 37.0 64.0 35.2 34.6 41.4 41.0 45.4 65.4 46.0 42.0 37.4 58.6 51.3 50.7 14.7 52.6 46.3 39.5 52.9 47.4 13.8 17.3 15.0 19.6 13.5 14.8 14.4 13.8 13.3 14.3 13.6 13.9 15.5 28.2 38.5 39.5 7.2 35.8 34.7 41.5 71.6 12.0 15.7 20.4 19.6 39.3 30.0 43.0 16.5 16.7 35.5 51.7 18.0 74.3 60.3 72.7 34.9 27.6 35.0 33.5 17.2 10.1 64.1 33.1 25.0 16.8 26.5 65.2 18.6 28.9 36.6 44.0 8.4 9.8 29.6 28.5 31.7 30.2 13.2 32.6 28.4 28.4 9.4 37.0 30.1 60.8 8.5 10.4 53.0 23.6 35.0 16.2 26.8 21.7 67.4 53.8 25.6 46.0 23.4 43.3 94.7 63.7 18.0 32.7 27.5 40.3 21.4 36.0 39.7 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724495-202808487 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 62.8" "Cell type enhanced" "Detected in all" "Late spermatids: 243.6;Spermatocytes: 390.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 8.9 7.7 2.3 2.6 3.0 14.2 10.0 5.6 4.4 13.9 7.0 10.5 2.1 12.7 3.4 21.2 10.0 2.9 5.5 5.4 2.6 5.8 4.7 10.9 2.2 1.2 1.2 4.2 13.0 8.3 2.6 7.0 4.8 2.8 10.7 2.3 17.9 12.6 2.4 4.8 24.3 8.7 3.2 0.9 7.5 8.8 62.8 1.6 4.2 8.5 0.8 2.1 11.0 15.8 4.7 9.9 2.4 14.0 9.8 7.2 6.6 23.7 6.2 9.4 6.2 6.4 2.2 8.8 0.1 5.7 7.9 2.3 11.8 9.0 8.3 5.4 0.5 12.8 7.7 2.4 1.9 5.5 17.7 8.9 9.4 12.1 7.0 7.2 10.1 11.7 7.3 20.9 0.3 4.9 6.3 5.8 16.4 21.9 4.3 28.0 18.7 0.1 0.4 6.5 10.7 10.7 23.4 14.7 7.9 8.7 15.7 16.6 10.5 12.8 8.2 5.8 1.4 5.2 2.3 1.1 8.2 6.0 5.5 4.1 44.6 6.4 19.6 7.7 4.8 4.6 10.9 8.9 4.3 4.2 17.4 9.6 6.0 34.4 12.9 10.4 6.6 7.2 3.9 2.3 3.0 5.6 4.4 5.4 2.6 1.2 1.2 4.2 2.8 0.9 1.6 4.7 24.5 89.8 38.5 46.7 22.2 64.4 34.8 53.0 84.2 35.5 57.1 50.0 9.5 11.5 53.6 16.5 62.6 41.8 12.4 23.7 5.9 47.6 191.6 65.2 71.8 31.9 43.6 50.2 75.8 22.3 34.3 42.7 47.9 69.5 27.1 28.6 17.2 10.9 7.7 15.2 53.5 38.1 44.7 15.1 21.9 243.6 36.4 15.5 26.6 40.3 11.3 69.8 10.3 39.7 42.5 45.4 21.8 32.7 25.8 43.1 15.2 8.2 61.9 138.6 32.9 22.8 40.2 390.9 71.0 95.9 116.2 82.4 21.2 61.5 30.2 55.6 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 678.4;U-251 MG: 463.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No Yes 48000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 96.9 44.1 11.6 34.0 13.5 52.0 59.4 13.9 15.0 37.4 16.8 66.2 44.3 18.8 29.3 34.1 33.4 40.1 37.3 13.2 18.3 27.3 174.0 36.3 14.2 13.1 12.5 12.0 40.2 69.2 12.1 29.1 22.5 12.3 33.6 67.0 20.6 77.2 31.5 41.5 24.1 56.5 24.8 11.9 13.9 56.4 91.7 14.1 11.9 24.7 45.6 22.4 78.6 37.7 11.9 204.6 14.6 39.2 31.5 185.7 147.8 26.8 292.4 107.1 220.7 178.5 38.6 93.5 8.0 64.3 225.8 79.6 35.0 44.7 85.5 359.9 32.4 66.6 36.0 43.8 75.6 87.1 61.8 23.5 69.0 39.8 242.4 678.4 100.6 137.5 62.6 206.1 81.3 298.9 37.4 36.0 40.0 29.2 207.6 64.4 31.9 76.2 99.8 34.8 23.7 41.9 43.4 128.0 78.4 70.4 45.6 38.9 70.0 235.2 110.6 102.5 281.2 463.5 135.0 51.0 67.0 63.4 28.5 71.3 1.4 2.2 11.7 16.7 2.1 20.4 10.7 10.0 17.3 4.6 11.1 9.4 12.0 2.2 8.6 1.2 7.7 5.5 7.2 11.6 13.5 13.9 15.0 13.2 18.3 13.1 12.5 12.0 12.3 11.9 14.1 11.9 58.1 6.4 30.2 15.0 42.5 134.7 163.0 47.2 47.8 11.8 59.1 42.7 30.0 27.1 57.4 16.5 8.4 27.2 82.9 94.8 72.4 27.1 78.2 28.6 58.0 35.7 54.9 13.9 12.4 64.7 63.9 195.8 45.9 40.7 33.7 21.3 22.5 98.4 14.5 6.7 12.4 139.4 40.7 10.1 82.2 20.1 50.7 24.6 85.4 3.7 18.2 16.6 41.2 8.0 6.1 73.0 74.5 41.3 152.8 94.6 88.4 26.9 56.0 13.9 19.7 59.4 88.6 212.0 125.9 43.2 81.8 97.7 50.5 18.8 70.4 141.7 ACTL8 CT57 ENSG00000117148 "Actin like 8" Q9H568 1 17755333-17827063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 7.1" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 50.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 245.3" "Not detected" "Not detected" HPA027176 Approved Cytosol NA NA Cytosol "HPA027176: AB_1844553" "unprognostic (1.79e-3)" "unprognostic (3.18e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (6.18e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (1.63e-3)" "unprognostic (2.33e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (3.69e-1)" "unprognostic (4.89e-1)" "unprognostic (1.43e-1)" "unprognostic (5.49e-2)" "unprognostic (4.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.2 0.0 11.0 0.3 0.2 0.6 0.0 1.5 0.0 0.0 0.1 1.4 0.0 0.5 1.4 0.0 3.3 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.5 13.3 0.0 2.4 0.0 0.0 9.2 5.9 0.1 0.0 0.0 27.5 0.0 0.0 0.4 0.0 0.0 5.2 0.5 0.0 0.5 0.4 0.0 0.0 0.1 1.9 0.2 0.1 245.3 0.1 4.9 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 7.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 50.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549611-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 7 "basal ganglia: 7.4" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 370000000 Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 1.5 1.4 0.5 1.4 0.8 3.3 1.6 1.1 0.7 1.2 2.0 1.2 1.0 1.5 3.2 1.0 1.1 1.2 1.1 0.3 1.1 1.7 3.7 1.4 1.6 1.4 1.0 0.3 0.8 1.7 1.6 0.5 1.2 1.4 2.2 1.4 1.4 3.4 0.8 0.9 2.5 1.2 1.1 0.7 2.5 1.5 0.5 0.8 1.0 1.3 0.9 1.0 1.0 0.5 1.3 0.9 0.3 0.2 0.2 2.7 3.2 0.6 0.6 2.2 0.3 0.8 0.1 1.1 1.2 0.2 1.4 0.3 0.4 0.0 0.9 0.9 1.1 0.3 0.8 0.1 0.1 1.6 0.8 0.4 2.4 1.6 0.8 1.2 1.9 0.9 0.5 0.7 2.2 0.6 0.0 0.5 0.9 0.2 0.2 0.3 0.2 0.3 0.8 1.9 0.4 0.1 0.4 0.2 0.9 1.1 0.5 0.5 0.9 1.5 1.1 0.1 1.5 0.7 0.6 0.2 0.3 0.8 1.1 0.8 0.5 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.3 0.1 0.0 0.0 0.5 0.8 1.1 0.7 0.3 1.1 1.4 1.0 0.3 1.4 0.7 0.8 1.3 43.6 9.6 23.4 10.4 37.4 30.3 30.2 28.0 34.1 5.9 33.1 15.6 5.8 31.5 25.5 23.9 41.7 26.8 25.4 30.2 43.0 20.2 3.3 24.1 24.4 29.9 23.0 14.1 6.2 19.2 24.2 28.1 25.0 19.4 43.8 9.7 49.6 70.8 48.2 3.3 4.3 18.9 16.2 75.5 27.9 3.7 21.1 58.8 7.2 20.6 56.5 21.8 18.6 5.5 9.0 19.1 25.2 24.5 59.8 36.7 30.0 44.4 38.2 41.9 13.1 20.2 16.6 10.4 12.8 27.3 24.7 25.6 26.8 25.3 18.4 29.9 RGS4 SCZD9 ENSG00000117152 "Regulator of G protein signaling 4" P49798 1 163068775-163076802 "Disease related genes, Predicted intracellular proteins" "Signal transduction inhibitor" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 35.0;brain: 120.2" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 51.6;Excitatory neurons: 115.4;Inhibitory neurons: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "hTERT-RPE1: 527.4;LHCN-M2: 244.2;SH-SY5Y: 429.5;TIME: 959.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030802 Approved Cytosol NA NA Cytosol "HPA030802: AB_10602295" "unprognostic (1.03e-1)" "unprognostic (1.84e-1)" "unprognostic (3.02e-2)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.26e-2)" "unprognostic (1.27e-1)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (6.45e-2)" "unprognostic (2.12e-2)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.97e-4)" "prognostic unfavorable (1.92e-4)" "unprognostic (1.00e-1)" "unprognostic (8.33e-2)" "unprognostic (2.30e-2)" 4.2 35.0 21.6 3.1 48.5 0.0 1.7 0.0 120.2 5.9 0.0 3.5 4.3 7.9 1.2 9.8 7.4 18.5 8.8 47.5 54.1 1.9 4.1 3.0 3.7 3.3 8.0 42.2 2.2 4.7 2.3 14.4 1.6 13.5 4.8 2.5 6.7 0.9 6.5 0.4 0.3 2.8 4.7 0.0 1.7 8.5 3.0 1.3 1.8 3.2 1.4 0.4 6.0 1.4 41.0 0.3 0.0 1.2 7.2 25.1 115.9 0.2 77.8 92.1 12.6 31.9 0.0 0.3 0.3 35.6 50.2 0.5 0.2 0.0 0.1 42.2 0.4 0.1 0.3 0.0 0.0 11.0 0.2 0.2 19.0 0.0 123.0 14.3 527.4 127.5 0.0 0.1 0.6 244.2 0.0 0.0 0.5 6.5 0.0 9.6 0.1 0.0 0.4 0.0 0.0 2.9 429.5 0.0 0.1 0.2 4.0 0.1 0.1 959.6 91.5 5.2 19.1 129.5 0.1 0.1 0.3 11.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 48.5 0.0 120.2 47.5 54.1 3.3 8.0 42.2 13.5 0.0 1.3 41.0 0.8 0.0 0.0 15.7 0.0 0.3 1.7 0.1 0.0 4.3 0.7 0.0 0.7 0.0 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.3 12.6 0.5 16.9 2.6 51.6 0.0 115.4 0.2 0.1 20.2 0.0 0.4 0.0 1.1 1.1 0.0 0.4 0.0 59.9 0.0 0.0 0.0 0.5 3.8 0.0 0.1 0.0 13.1 0.0 15.7 0.0 13.0 13.0 2.7 0.1 0.0 0.0 0.5 0.0 0.0 0.7 1.6 0.0 0.2 17.0 0.1 0.6 0.5 0.3 0.1 0.6 0.1 0.1 0.3 KLHL12 C3IP1 ENSG00000117153 "Kelch like family member 12" Q53G59 1 202891116-202928636 "Predicted intracellular proteins" "ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 140.7;Late spermatids: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071324 Supported "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA071324: AB_2686389" "unprognostic (1.69e-2)" "unprognostic (2.84e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-3)" "unprognostic (3.35e-2)" "unprognostic (1.15e-2)" "unprognostic (9.11e-2)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (2.20e-3)" "unprognostic (6.22e-2)" "unprognostic (6.01e-2)" "unprognostic (3.32e-1)" "unprognostic (4.87e-2)" 12.9 16.0 26.5 14.8 27.1 19.0 17.5 24.8 28.1 13.6 24.6 19.6 14.6 15.0 22.9 15.9 18.6 12.4 20.6 27.0 29.2 22.0 16.3 15.1 19.1 25.2 26.7 26.1 17.9 16.5 21.4 15.4 15.7 26.9 19.5 23.6 24.8 13.9 13.7 14.4 13.6 14.9 17.4 24.6 17.2 16.1 45.2 27.8 20.6 19.9 18.5 22.6 14.3 13.2 26.6 20.4 24.5 30.2 34.3 46.2 34.2 35.6 24.1 28.0 29.7 27.0 23.3 33.0 57.8 18.5 27.7 29.8 25.8 40.5 33.8 32.3 29.9 17.6 20.1 19.5 23.6 33.4 42.3 31.7 33.0 43.0 25.7 56.1 23.5 26.8 56.9 51.5 36.7 41.3 28.0 35.6 20.4 43.4 25.8 18.3 36.5 52.8 37.0 26.1 25.7 22.5 25.8 29.9 27.6 33.2 54.7 49.2 29.4 22.0 29.0 20.2 7.1 21.7 26.4 22.5 48.0 28.6 29.9 28.3 7.5 10.1 15.6 6.9 12.3 10.2 7.1 6.9 8.3 10.5 6.7 7.3 7.9 10.1 8.3 13.2 6.1 11.1 9.2 26.5 27.1 24.8 28.1 27.0 29.2 25.2 26.7 26.1 26.9 24.6 27.8 26.6 7.0 6.4 11.5 12.7 13.3 5.4 9.4 8.9 6.2 11.2 8.5 5.7 16.6 12.8 9.2 16.5 12.5 11.9 9.3 17.6 23.5 12.1 140.7 8.6 7.8 7.8 10.8 15.8 14.9 8.9 12.1 9.3 5.6 7.4 3.8 15.0 8.6 7.8 17.2 5.0 19.3 13.2 6.1 15.9 5.6 88.1 8.4 12.9 5.4 14.0 16.8 11.3 10.3 11.1 18.6 11.4 10.1 8.2 9.3 8.7 11.6 15.9 8.2 10.2 6.6 6.9 7.6 26.0 44.9 9.2 6.7 11.1 11.5 9.5 12.5 7.2 IGSF21 "MGC15730, RP11-121A23.1" ENSG00000117154 "Immunoglobin superfamily member 21" Q96ID5 1 18107798-18378483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 177.8;Excitatory neurons: 82.2;Microglial cells: 74.9;Oligodendrocyte precursor cells: 141.3" "Group enriched" "Detected in many" 5 "breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 23000 "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.50e-3)" "unprognostic (7.06e-2)" "unprognostic (3.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.66e-2)" "unprognostic (7.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.34e-2)" "unprognostic (2.33e-1)" "unprognostic (7.85e-4)" "unprognostic (3.76e-5)" "unprognostic (2.10e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" 1.8 4.9 23.2 0.4 33.7 0.4 3.1 39.9 52.1 1.4 7.9 0.8 0.0 1.0 0.5 1.0 1.0 0.9 0.8 35.9 16.6 1.1 0.4 1.5 0.2 24.0 22.3 29.1 0.6 1.9 10.5 1.6 1.4 25.4 3.8 0.3 9.5 1.2 1.1 0.3 0.8 0.4 0.3 17.3 13.1 0.6 0.8 22.8 0.8 0.6 0.4 0.7 3.9 1.1 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 33.7 39.9 52.1 35.9 16.6 24.0 22.3 29.1 25.4 17.3 22.8 31.4 0.1 0.0 0.0 3.6 0.6 0.3 0.2 0.0 0.0 177.8 9.2 2.7 0.6 1.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 5.9 0.0 0.0 1.8 3.0 0.0 82.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 28.9 0.1 0.0 23.6 4.0 12.8 0.6 12.8 0.0 74.9 0.0 6.3 0.0 141.3 2.4 0.1 1.3 0.0 0.0 0.9 0.0 0.0 0.0 13.0 6.6 4.5 0.2 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.2 SSX2IP hMsd1 ENSG00000117155 "SSX family member 2 interacting protein" Q9Y2D8 1 84643706-84690803 "Predicted intracellular proteins" "Cell adhesion, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 119.7;testis: 106.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 260.6;Early spermatids: 774.9;Late spermatids: 1095.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075946 Supported Approved "Cell Junctions" NA NA "Cell Junctions" "HPA075946: " "unprognostic (5.18e-3)" "unprognostic (2.13e-1)" "prognostic favorable (1.45e-4)" "unprognostic (2.83e-2)" "unprognostic (2.75e-1)" "unprognostic (3.29e-2)" "unprognostic (1.28e-3)" "unprognostic (7.73e-2)" "unprognostic (2.38e-1)" "unprognostic (3.37e-2)" "unprognostic (9.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (7.23e-3)" "unprognostic (2.08e-2)" "unprognostic (2.45e-2)" "unprognostic (3.46e-2)" 2.0 3.1 7.8 5.9 15.5 15.0 5.1 15.9 24.5 6.8 5.7 7.2 43.6 9.4 22.8 6.4 7.2 8.7 9.5 14.3 10.3 16.7 14.6 3.9 6.4 4.8 4.3 13.2 2.0 7.2 9.3 9.6 6.3 6.2 12.8 7.9 119.7 6.9 11.9 3.5 6.5 27.1 10.8 2.3 5.4 7.1 106.6 4.5 12.2 8.3 2.6 6.4 5.8 3.5 13.6 39.1 19.0 15.1 27.7 5.0 15.7 18.4 65.6 33.2 28.3 22.7 13.7 8.4 38.6 11.3 55.8 36.5 21.4 27.0 21.2 39.5 7.7 23.0 36.4 22.2 11.9 10.3 32.1 2.9 6.7 34.1 31.9 20.1 18.9 9.7 14.7 76.5 14.1 18.1 15.0 22.5 12.7 22.3 7.4 29.6 15.1 66.0 17.0 29.5 22.3 29.4 36.7 18.4 29.6 32.9 9.5 17.2 16.4 2.9 26.8 39.2 36.9 65.9 14.7 18.7 42.0 22.4 28.2 16.9 0.8 0.8 3.9 8.2 1.9 4.5 1.2 2.6 3.3 3.5 1.2 3.3 5.1 1.1 4.6 2.6 4.5 1.5 3.9 7.8 15.5 15.9 24.5 14.3 10.3 4.8 4.3 13.2 6.2 2.3 4.5 13.6 4.4 3.2 3.0 38.2 3.7 10.5 8.6 8.7 12.5 45.6 10.5 7.0 36.8 21.5 7.3 11.0 260.6 5.3 23.9 3.9 7.9 7.3 774.9 14.9 8.9 5.0 8.4 46.7 108.5 12.0 1.9 15.7 5.6 11.6 4.5 4.2 3.6 14.9 2.7 20.2 70.2 9.3 2.0 1.9 5.6 1095.3 15.8 24.1 5.4 18.7 3.5 187.4 15.5 16.6 23.9 9.4 4.6 11.3 12.7 4.3 19.7 44.9 13.3 158.0 0.0 4.2 7.3 71.7 53.6 13.6 9.8 0.5 8.4 2.0 10.7 4.2 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649417-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" No No "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 10.3 6.6 8.1 5.2 8.8 5.2 10.2 7.6 8.0 13.6 6.1 8.7 2.9 11.1 4.4 11.9 9.7 3.6 7.4 7.6 8.1 6.4 6.8 6.9 6.4 9.0 8.1 6.4 10.4 7.3 4.3 7.6 4.7 8.6 9.0 4.3 3.4 9.6 4.4 7.8 11.2 8.0 5.6 9.2 8.1 7.0 6.2 8.6 5.5 8.5 3.9 6.0 11.7 11.4 9.5 13.5 9.1 8.9 8.1 19.2 17.4 11.3 17.0 16.3 11.5 11.0 9.2 6.8 10.4 19.7 10.4 24.7 11.2 15.9 10.9 18.6 14.3 13.7 21.6 10.3 10.7 16.2 35.4 8.3 17.2 10.0 15.3 13.4 11.4 13.7 16.4 20.2 13.3 17.6 5.1 20.9 9.2 13.5 11.0 16.5 16.6 19.7 12.0 18.7 25.2 8.6 5.6 13.3 20.3 19.3 9.3 9.0 8.9 15.6 14.8 10.0 12.5 24.7 8.5 9.3 28.2 3.4 22.0 13.1 0.6 0.7 0.1 1.8 0.7 2.0 1.9 1.6 2.0 1.2 2.4 2.0 2.0 0.1 1.8 0.7 2.1 1.8 0.8 8.1 8.8 7.6 8.0 7.6 8.1 9.0 8.1 6.4 8.6 9.2 8.6 9.5 22.0 16.0 22.5 22.5 20.3 16.2 14.4 12.5 13.1 31.8 10.6 9.9 17.6 11.5 38.0 31.3 33.3 9.0 21.0 25.6 3.9 11.9 4.2 15.5 47.4 20.9 9.5 8.4 40.4 8.8 13.7 22.2 6.1 16.1 27.8 22.4 14.3 10.6 7.5 15.2 30.0 20.9 16.2 13.5 7.4 3.8 13.4 9.1 7.2 22.5 11.0 17.6 27.8 34.2 45.3 12.2 11.6 12.8 11.1 11.1 15.5 6.3 18.0 38.8 19.7 22.4 20.7 35.8 21.6 14.0 16.3 2.7 20.1 25.8 20.5 10.8 PLA2G2D sPLA2S ENSG00000117215 "Phospholipase A2 group IID" Q9UNK4 1 20111939-20119566 "Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "lymphoid tissue: 107.3" "Cell type enhanced" "Detected in some" "B-cells: 1.6;dendritic cells: 1.3;Kupffer cells: 2.4;Melanocytes: 5.4;Plasma cells: 8.1" "Cancer enriched" "Detected in many" 6 "testis cancer: 25.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 3.7;naive B-cell: 3.6;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 6 "B-cells: 3.7;dendritic cells: 2.0" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "prognostic favorable (4.35e-4)" "prognostic favorable (8.15e-5)" "unprognostic (3.88e-3)" "prognostic favorable (9.74e-4)" "unprognostic (1.78e-1)" "unprognostic (2.56e-3)" "unprognostic (1.98e-1)" "unprognostic (1.60e-2)" "unprognostic (1.82e-5)" "unprognostic (7.51e-4)" "unprognostic (2.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (2.60e-1)" 0.7 0.1 0.1 15.9 0.1 0.8 1.0 0.3 0.3 0.3 0.0 2.3 1.5 0.4 0.1 0.4 0.4 1.7 0.2 0.2 0.1 0.1 0.7 2.4 107.3 0.1 0.1 0.2 1.0 0.3 0.0 0.0 0.1 0.2 0.4 3.3 0.1 1.2 0.4 0.0 0.2 4.6 0.2 0.1 11.1 2.3 0.4 0.1 3.2 0.3 0.0 59.6 4.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.6 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA049042: AB_2680610, HPA058085: AB_2683600" "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 6.3 8.3 4.6 7.3 5.3 9.6 8.0 6.7 6.5 7.9 3.4 7.1 7.2 8.2 7.6 7.1 7.6 6.2 6.4 6.0 5.1 12.6 11.0 6.6 11.4 3.8 4.3 5.5 9.6 8.3 9.5 6.1 6.5 4.4 7.0 8.1 9.9 7.7 7.0 8.8 8.5 6.8 7.2 4.7 9.4 6.7 6.2 4.7 13.3 9.9 10.0 12.9 7.6 5.3 6.6 16.3 16.9 16.0 19.0 21.8 12.5 17.3 15.2 12.9 19.0 18.8 17.9 19.1 25.3 11.3 11.1 15.5 18.2 26.9 10.1 22.4 21.6 14.5 21.2 16.4 14.6 14.1 26.9 16.6 10.1 12.9 17.6 15.0 12.7 15.4 17.9 41.6 25.2 16.0 15.0 26.1 11.3 26.1 14.2 27.9 22.9 33.9 31.6 13.2 11.7 25.0 20.1 21.3 22.3 19.2 19.0 24.2 14.9 11.8 15.6 16.6 23.1 20.2 12.2 18.3 30.6 13.9 16.5 24.5 22.0 4.9 7.9 8.0 6.4 8.5 7.8 7.4 8.1 5.4 6.2 7.1 8.7 11.6 8.2 8.3 6.0 8.1 3.5 4.6 5.3 6.7 6.5 6.0 5.1 3.8 4.3 5.5 4.4 4.7 4.7 6.6 14.7 19.2 12.2 11.4 31.0 26.9 9.7 5.9 15.9 14.5 18.9 14.6 7.1 8.6 13.4 22.0 29.2 9.1 25.2 15.8 9.8 12.1 7.3 13.1 14.0 13.2 12.1 23.1 19.9 11.6 10.7 13.5 9.7 21.0 13.9 25.6 17.2 21.8 10.9 16.8 15.7 14.0 10.2 15.6 25.9 3.2 12.8 17.9 19.6 8.4 15.6 12.6 15.5 14.6 21.2 13.6 9.8 16.1 25.9 13.5 14.7 28.8 13.2 18.3 19.7 21.9 14.1 10.2 20.4 14.6 33.8 10.8 27.9 12.6 15.8 13.4 GBP3 FLJ10961 ENSG00000117226 "Guanylate binding protein 3" Q9H0R5 1 89006679-89022894 "Predicted intracellular proteins" "Antiviral defense, Immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 79.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.2;Pancreatic endocrine cells: 106.7;Proximal enterocytes: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 80.9;BJ hTERT+ SV40 Large T+ RasG12V: 56.3;LHCN-M2: 71.3" HPA045657 Approved NA NA "HPA045657: AB_10961631" "unprognostic (1.14e-2)" "unprognostic (2.23e-1)" "unprognostic (6.30e-2)" "unprognostic (1.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (4.39e-2)" "unprognostic (3.47e-1)" "unprognostic (7.44e-2)" "unprognostic (4.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (1.66e-2)" "unprognostic (9.70e-3)" "unprognostic (3.06e-2)" "unprognostic (5.06e-3)" 7.9 9.3 3.4 11.0 3.5 1.6 12.9 3.4 4.9 7.0 3.5 39.5 79.0 8.9 10.1 6.1 15.4 10.9 5.1 3.3 8.1 14.0 15.0 23.0 14.6 4.8 3.8 2.3 8.3 5.9 4.2 4.3 13.9 4.9 10.4 27.7 0.6 11.9 20.4 1.8 7.2 60.3 9.4 4.0 16.2 32.0 2.3 4.9 10.1 9.8 4.2 8.6 27.6 7.8 4.8 26.4 1.6 0.0 0.0 24.5 28.6 4.3 44.4 80.9 41.5 56.3 0.0 2.0 1.9 8.5 40.4 24.0 10.9 0.0 29.5 40.2 0.6 0.0 2.5 4.0 0.5 20.8 9.0 0.1 22.3 5.7 31.1 11.0 28.3 13.9 4.2 0.0 5.8 71.3 0.0 6.5 1.1 0.2 14.3 20.0 2.0 4.8 3.1 41.6 49.1 0.0 0.2 14.0 7.9 0.0 0.8 0.1 2.6 17.2 44.6 3.1 0.4 4.8 7.6 2.6 0.1 0.4 0.2 11.4 0.1 6.0 0.3 11.8 7.0 10.5 3.6 10.5 9.8 6.5 2.8 6.5 9.7 3.1 6.9 13.3 0.4 8.6 5.6 3.4 3.5 3.4 4.9 3.3 8.1 4.8 3.8 2.3 4.9 4.0 4.9 4.8 20.7 6.4 18.1 2.9 7.3 6.9 25.7 19.4 6.8 0.1 11.5 7.4 1.4 35.8 24.8 22.0 0.0 7.6 12.4 127.2 13.7 59.4 0.1 46.7 15.0 21.2 9.1 5.7 0.3 61.6 8.2 12.5 27.0 35.0 4.5 5.6 22.5 10.6 5.0 0.0 0.2 34.8 14.2 12.0 5.8 1.5 9.9 18.0 0.0 2.8 21.1 0.7 28.8 0.5 0.1 106.7 71.4 15.4 13.6 17.5 133.3 32.8 69.3 0.2 19.7 3.9 8.0 0.5 0.2 5.9 4.8 2.2 21.8 10.9 28.8 37.2 GBP1 ENSG00000117228 "Guanylate binding protein 1" P32455 1 89051882-89065360 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 88.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 183.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 131.4;BJ hTERT+ SV40 Large T+ RasG12V: 175.2;GAMG: 129.1" CAB015450 Approved "Intracellular and membrane" NA NA 110000 "CAB015450: AB_2109333" "unprognostic (3.43e-2)" "unprognostic (1.82e-2)" "prognostic favorable (8.32e-4)" "unprognostic (9.56e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-1)" "unprognostic (9.50e-2)" "unprognostic (3.64e-2)" "unprognostic (7.67e-2)" "prognostic favorable (5.04e-4)" "unprognostic (8.36e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (5.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.17e-2)" "unprognostic (2.23e-2)" "unprognostic (2.01e-3)" 23.3 7.9 4.1 72.3 4.9 5.2 18.4 4.3 5.6 20.5 4.3 19.5 16.9 26.6 5.5 10.5 18.4 44.8 10.6 3.4 6.9 12.2 88.8 44.7 55.5 13.6 4.7 2.7 13.3 6.1 6.6 5.6 20.5 11.9 19.3 13.7 1.2 12.3 14.4 5.1 9.4 18.0 37.3 4.9 52.1 16.6 3.4 6.1 21.5 18.1 5.4 21.8 43.4 15.5 8.8 13.9 0.2 0.0 0.0 11.6 22.4 35.6 34.3 72.4 131.4 175.2 3.5 7.5 12.4 22.1 44.5 129.1 2.4 0.0 18.8 61.7 41.1 0.1 2.9 9.4 0.3 70.7 0.0 1.8 54.6 6.3 61.0 10.3 29.8 34.5 18.4 0.0 9.9 44.7 0.0 31.9 0.2 0.2 0.0 1.4 43.6 40.7 0.8 7.2 21.0 0.5 0.0 39.2 8.3 3.8 0.0 0.8 0.1 40.2 33.4 1.6 10.8 29.7 0.4 0.2 0.1 13.2 0.2 3.3 0.7 38.8 5.6 94.1 126.1 90.7 17.3 93.3 99.0 46.7 12.4 69.1 79.4 106.2 62.4 134.1 0.3 172.2 92.0 4.1 4.9 4.3 5.6 3.4 6.9 13.6 4.7 2.7 11.9 4.9 6.1 8.8 70.7 73.7 24.1 1.0 13.5 39.6 183.9 31.7 19.9 0.2 10.3 18.4 3.3 15.7 28.9 9.2 0.0 59.8 16.6 27.3 0.0 36.0 0.1 75.0 85.5 56.4 9.0 1.7 0.2 74.5 73.6 36.2 18.3 33.3 14.5 17.8 22.5 75.3 32.6 0.0 0.1 4.1 4.1 36.5 19.2 1.0 9.9 58.6 5.4 6.5 78.1 9.9 43.3 0.0 0.1 42.5 9.9 25.6 8.8 19.1 13.3 14.0 78.4 0.3 13.1 45.5 39.4 0.1 0.4 11.5 21.5 34.9 44.9 36.6 11.0 28.3 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 23.4" "Cell type enhanced" "Detected in many" "Adipocytes: 18.9;Early spermatids: 44.0;Hepatic stellate cells: 15.4;Late spermatids: 88.7;Sertoli cells: 19.7" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;hTERT-HME1: 3.7;U-2 OS: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.0 0.2 2.8 0.0 2.6 0.0 0.0 0.2 1.7 0.3 1.7 0.1 0.1 0.4 0.0 0.0 1.8 0.0 0.0 2.2 3.8 0.3 0.1 0.2 0.0 0.8 1.1 3.4 0.2 0.0 0.0 0.6 0.0 0.5 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.5 0.3 0.0 0.0 23.4 2.2 0.0 0.4 0.0 0.0 0.1 0.1 0.7 0.8 0.7 0.4 0.0 0.0 0.0 0.1 1.2 1.6 0.6 0.4 0.2 0.4 0.0 0.5 0.9 0.3 0.0 0.6 0.4 0.4 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.3 0.5 3.7 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.3 0.6 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.6 0.2 1.7 2.2 3.8 0.8 1.1 3.4 0.5 0.3 2.2 0.7 18.9 0.0 0.0 0.7 0.2 1.7 0.0 0.1 0.6 0.0 0.2 0.3 2.8 0.0 0.2 1.8 4.2 0.1 2.8 0.1 0.0 0.0 44.0 2.8 0.3 15.2 0.0 0.0 11.0 0.0 0.1 0.9 0.0 0.2 0.0 0.0 15.4 0.5 5.1 0.0 2.8 0.0 0.0 1.6 9.8 88.7 1.2 3.2 1.8 1.9 0.2 0.0 0.0 0.0 0.7 0.0 0.0 3.8 0.1 0.1 0.1 0.3 3.5 0.3 19.7 0.5 2.7 3.2 4.3 0.1 1.3 1.6 0.2 5.2 0.1 0.2 GPR89A UNQ192 ENSG00000117262 "G protein-coupled receptor 89A" B7ZAQ6 1 145607988-145670650 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA076096 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA076096: AB_2686777" "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.51e-3)" "unprognostic (4.51e-2)" "unprognostic (1.99e-3)" "unprognostic (8.14e-2)" "unprognostic (4.61e-3)" "unprognostic (5.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-2)" "unprognostic (1.02e-5)" "unprognostic (1.42e-1)" "unprognostic (3.70e-2)" "unprognostic (5.47e-2)" "unprognostic (1.21e-1)" 6.0 6.8 5.7 3.7 5.3 4.1 14.3 7.8 6.4 12.0 5.3 8.8 9.9 6.4 6.9 5.9 7.6 8.2 7.1 6.1 6.2 31.5 25.0 5.8 5.7 6.6 6.8 5.1 4.3 13.0 11.8 3.4 7.2 7.3 9.6 11.9 4.4 6.9 7.3 6.8 4.8 11.7 9.7 6.3 3.3 8.6 14.9 6.4 8.1 10.7 8.7 8.1 8.4 2.3 6.6 20.7 11.6 18.0 9.7 35.1 34.3 19.2 23.0 25.8 29.3 33.2 27.6 24.4 13.4 13.2 26.0 14.3 20.2 19.9 22.4 25.8 21.5 15.5 9.8 15.8 14.2 29.3 30.5 6.7 36.4 26.5 21.9 28.6 12.7 21.9 16.2 23.7 30.2 40.6 29.7 13.1 11.5 23.5 36.3 25.4 15.5 21.0 48.7 24.8 12.6 7.0 15.4 30.7 36.8 16.6 30.1 32.4 20.0 9.6 27.1 6.5 24.0 23.2 15.2 33.2 17.4 20.6 16.4 20.2 3.7 5.8 7.1 9.2 5.7 9.5 6.0 7.1 9.9 8.1 3.0 7.3 6.5 1.1 9.3 7.6 6.5 8.2 5.0 5.7 5.3 7.8 6.4 6.1 6.2 6.6 6.8 5.1 7.3 6.3 6.4 6.6 6.1 22.4 5.9 16.0 13.7 7.6 10.1 17.7 15.4 6.9 10.2 6.3 13.9 14.3 13.2 14.7 12.5 20.1 12.1 6.5 0.0 13.6 13.6 4.8 6.0 6.5 13.7 24.4 29.0 20.2 21.2 9.1 12.8 5.6 5.7 5.1 7.9 9.2 9.3 3.3 24.3 11.2 20.3 5.1 4.0 8.6 9.6 7.3 10.6 7.5 9.0 7.5 17.5 14.1 19.7 17.1 6.0 7.2 20.9 8.5 24.3 13.7 8.0 6.9 13.1 7.3 8.2 45.4 24.6 10.1 8.5 16.1 14.6 6.3 10.9 5.7 CDK18 "PCTAIRE3, PCTK3" ENSG00000117266 "Cyclin dependent kinase 18" Q07002 1 205504596-205532793 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 188.2;heart muscle: 109.9" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 462.9" "Cancer enhanced" "Detected in all" "renal cancer: 32.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 38.5;HeLa: 35.3;hTERT-RPE1: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045429 Approved Approved "Actin filaments" No No "Actin filaments" "HPA045429: AB_10961257" "unprognostic (7.95e-2)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (7.06e-3)" "unprognostic (2.93e-1)" "unprognostic (2.95e-1)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (5.07e-6)" "unprognostic (6.07e-2)" "unprognostic (1.45e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.81e-5)" 4.6 9.1 77.0 4.2 114.0 1.1 5.1 131.9 86.3 11.0 39.0 11.8 29.1 8.7 3.5 5.7 8.7 10.5 109.9 56.1 93.1 26.2 10.7 11.1 2.8 150.4 144.3 52.0 12.7 17.0 7.9 11.6 16.3 157.1 9.3 9.3 13.4 29.4 23.8 6.2 3.3 25.1 7.0 139.4 9.6 36.1 1.7 116.3 3.6 9.5 5.3 3.7 5.8 7.6 188.2 22.2 1.4 0.2 1.3 0.0 0.0 22.6 0.4 4.1 1.0 5.5 9.4 17.8 12.4 3.2 0.2 1.9 21.2 4.9 38.5 0.9 3.4 3.8 3.0 35.3 10.5 4.0 0.1 0.2 2.5 1.9 0.1 0.8 32.2 0.0 18.4 0.1 15.2 0.3 17.7 1.2 0.6 18.4 6.1 0.9 1.6 0.1 16.6 3.6 13.5 7.9 2.8 6.4 3.2 14.2 24.5 15.3 6.2 0.0 0.0 8.1 0.1 0.1 4.1 2.1 2.5 0.2 9.4 3.7 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 77.0 114.0 131.9 86.3 56.1 93.1 150.4 144.3 52.0 157.1 139.4 116.3 188.2 4.6 0.0 0.5 12.4 1.0 3.4 6.9 17.4 11.4 7.0 4.6 5.6 29.6 5.7 6.8 73.5 0.0 5.7 0.2 12.1 7.9 18.5 2.4 2.1 0.7 2.9 6.0 1.3 12.0 6.7 2.3 3.8 15.8 4.6 0.0 13.3 2.5 3.7 5.3 0.0 4.5 12.9 2.0 3.8 4.5 4.0 0.9 3.8 3.6 12.2 4.4 28.2 1.0 4.5 462.9 6.5 111.2 1.5 0.9 10.8 35.6 18.7 3.3 1.2 6.6 5.8 12.8 6.6 17.0 5.3 1.3 1.9 1.4 22.7 13.7 9.2 RAB29 "RAB7L, RAB7L1" ENSG00000117280 "RAB29, member RAS oncogene family" O14966 1 205767986-205775482 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.8" "Cell type enhanced" "Detected in many" "dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020822, HPA026303" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB020822: , HPA026303: AB_1856016" "unprognostic (5.38e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.82e-5)" "unprognostic (9.50e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.60e-2)" "unprognostic (3.14e-1)" "unprognostic (5.50e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.53e-1)" "unprognostic (8.20e-3)" "unprognostic (1.42e-1)" 13.6 14.5 12.1 20.5 13.7 7.1 14.3 14.7 12.2 8.8 10.3 10.7 10.7 8.4 24.0 7.8 6.3 17.1 13.3 12.2 19.1 73.8 19.6 13.6 35.4 15.8 12.8 9.6 8.0 9.3 25.7 6.0 7.2 15.3 13.9 10.2 6.8 19.9 14.0 6.5 5.5 12.5 15.0 14.6 24.5 10.5 4.6 15.2 12.2 33.7 6.1 28.2 15.8 5.7 17.5 20.4 18.6 2.8 13.1 52.5 29.8 9.7 14.1 43.2 28.9 34.4 5.6 28.7 21.6 13.6 24.3 34.6 11.2 32.8 37.3 26.4 88.3 15.3 16.4 7.3 9.5 25.4 16.1 23.2 29.0 24.6 23.3 32.8 24.0 37.2 19.8 16.2 24.2 41.2 7.6 17.7 8.3 13.1 25.4 14.0 3.7 43.1 17.5 33.6 27.7 4.4 12.5 10.0 45.0 37.8 10.3 22.0 13.2 38.7 29.7 15.0 43.5 20.6 39.4 87.0 11.5 30.1 26.3 22.5 92.4 22.6 62.3 92.2 43.8 86.9 50.8 51.0 79.5 33.4 45.8 37.2 63.5 8.8 94.1 53.9 10.4 53.3 51.3 12.1 13.7 14.7 12.2 12.2 19.1 15.8 12.8 9.6 15.3 14.6 15.2 17.5 16.3 19.2 17.7 11.1 61.2 0.0 6.3 0.0 13.6 2.1 19.5 16.0 19.3 21.5 6.2 31.3 0.0 12.0 82.3 1.9 29.4 18.7 5.1 2.0 6.3 18.6 4.9 10.8 7.8 10.1 6.4 11.2 10.7 3.5 13.3 9.2 14.6 33.7 32.8 0.0 10.2 3.7 0.0 30.1 0.0 4.1 14.3 34.0 0.0 10.3 76.4 26.5 129.8 10.6 9.8 8.3 4.8 20.7 34.8 10.7 9.5 187.7 2.9 2.0 6.6 10.0 6.7 3.8 11.8 9.3 0.0 2.9 51.7 19.7 5.5 6.9 CD160 "BY55, NK1, NK28" ENSG00000117281 "CD160 molecule" O95971 1 145719471-145739288 "CD markers, Predicted secreted proteins" "Adaptive immunity, Angiogenesis, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.6" "Cell type enriched" "Detected in some" 6 "NK-cells: 410.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 107.6;MAIT T-cell: 44.5;memory CD8 T-cell: 72.9;naive CD8 T-cell: 82.8;NK-cell: 85.9" "Group enriched" "Detected in all" 8 "NK-cells: 85.9;T-cells: 107.6" "Cell line enhanced" "Detected in some" "HeLa: 2.2" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (6.54e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.33e-1)" "unprognostic (3.40e-2)" "unprognostic (1.35e-1)" "unprognostic (8.25e-3)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.24e-2)" "unprognostic (7.49e-3)" "unprognostic (3.48e-5)" "unprognostic (4.05e-2)" "unprognostic (2.03e-1)" "unprognostic (2.89e-2)" "unprognostic (2.92e-4)" 0.4 0.3 1.1 1.0 1.1 5.2 0.6 3.1 0.9 0.8 0.9 1.6 4.7 0.7 0.4 0.4 0.6 1.0 1.0 0.9 0.5 0.4 5.1 1.4 3.6 0.5 0.8 0.6 0.4 0.5 0.0 0.5 0.4 1.2 0.5 1.0 1.4 1.5 0.5 0.8 1.1 4.6 0.1 0.3 13.6 0.8 0.5 0.7 0.3 0.4 0.1 1.5 0.9 0.5 0.7 0.5 0.4 0.6 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.1 0.0 1.3 0.6 1.2 2.2 0.5 0.0 0.8 1.2 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.3 0.5 0.0 0.6 0.4 1.5 0.4 0.3 1.1 0.1 0.0 0.4 0.0 0.2 0.4 0.6 0.3 0.5 0.2 0.4 0.5 0.8 0.6 0.5 0.2 0.3 1.1 0.8 0.6 0.2 0.2 0.9 0.1 12.7 0.3 0.3 107.6 0.6 44.5 1.1 1.2 72.9 0.2 1.2 0.7 82.8 5.6 85.9 1.7 1.2 0.0 81.3 1.1 1.1 3.1 0.9 0.9 0.5 0.5 0.8 0.6 1.2 0.3 0.7 0.7 1.1 0.0 0.0 0.7 1.0 0.1 0.2 0.1 0.0 1.8 0.6 0.4 0.5 0.0 0.0 0.0 10.4 0.1 59.8 3.1 0.0 0.1 4.4 0.7 0.5 1.0 0.0 6.6 0.5 0.4 0.0 0.9 3.1 0.8 2.5 0.3 3.9 0.4 0.0 6.7 0.4 0.5 0.0 4.6 0.4 11.1 0.0 0.9 0.0 0.0 1.3 0.9 410.9 0.5 0.2 0.0 0.1 0.0 2.7 0.4 0.3 0.2 0.0 2.9 0.0 1.1 0.4 0.1 0.2 0.0 0.1 0.1 44.0 0.3 1.0 0.2 ECE1 ECE ENSG00000117298 "Endothelin converting enzyme 1" P42892 1 21217247-21345572 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 29.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 673.8;TIME: 588.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001490, HPA013616" Enhanced NA NA 1300000 "HPA001490: AB_1078718, HPA013616: AB_1847963" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (1.49e-2)" "unprognostic (1.46e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (6.20e-2)" "unprognostic (1.92e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (7.70e-2)" "unprognostic (3.55e-2)" "unprognostic (9.10e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-2)" 81.9 124.2 23.2 48.1 25.1 48.5 80.1 21.2 30.4 60.0 17.1 62.9 30.4 42.7 10.1 26.9 47.3 37.1 64.9 18.7 59.3 33.9 54.5 72.7 36.0 32.4 22.9 16.8 71.6 92.6 125.9 47.8 67.0 31.9 53.6 35.0 14.9 33.9 25.3 20.0 33.9 46.5 42.7 18.6 48.9 43.7 22.9 24.1 21.3 51.8 33.4 35.2 59.3 44.2 25.5 93.0 60.1 77.9 38.3 111.0 116.4 44.1 135.4 236.8 72.9 66.6 44.1 275.8 34.0 323.6 138.8 157.7 38.4 32.6 64.9 63.5 83.0 27.2 48.7 89.9 34.8 144.3 7.1 11.8 61.6 74.3 112.6 55.8 199.2 673.8 27.6 10.0 17.7 62.9 19.4 14.6 11.4 23.2 26.3 46.5 17.5 45.0 49.2 114.0 17.0 26.4 63.1 134.3 79.2 57.4 42.5 55.9 20.2 588.7 160.7 77.9 73.3 79.9 26.4 49.0 39.1 332.6 16.5 196.6 0.2 8.4 3.3 2.9 10.0 4.2 6.1 6.1 4.6 0.7 4.1 4.0 2.7 29.8 1.5 7.8 2.8 8.6 7.2 23.2 25.1 21.2 30.4 18.7 59.3 32.4 22.9 16.8 31.9 18.6 24.1 25.5 164.0 19.2 7.5 46.4 25.1 20.3 19.7 81.6 18.8 5.0 71.3 44.7 18.9 10.0 54.7 23.9 0.0 6.0 12.4 105.8 5.9 25.8 1.5 19.6 35.2 106.1 25.2 20.2 19.2 56.7 35.0 51.8 20.9 51.8 18.4 35.4 97.1 36.0 3.3 0.0 14.8 13.0 57.0 9.6 14.3 4.2 43.5 17.3 7.2 31.9 25.5 50.4 8.2 13.6 22.5 100.4 106.5 55.3 29.4 34.9 45.7 7.5 24.2 4.4 39.5 72.7 47.5 1.3 5.9 8.5 16.1 10.5 17.9 80.6 21.6 40.8 HMGCL HL ENSG00000117305 "3-hydroxy-3-methylglutaryl-CoA lyase" P35914 1 23801885-23838620 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 325.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 172.4;Proximal tubular cells: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004727 Enhanced "Intracellular and membrane" NA NA 34000 "HPA004727: AB_1079074" "unprognostic (8.24e-2)" "unprognostic (3.21e-2)" "prognostic favorable (7.67e-4)" "unprognostic (1.23e-3)" "unprognostic (5.47e-3)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (3.05e-1)" "unprognostic (8.24e-2)" "prognostic favorable (5.07e-8)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (8.60e-2)" "unprognostic (3.39e-3)" 26.8 63.5 24.8 16.9 25.7 7.5 26.0 26.1 28.5 27.7 30.4 53.8 46.1 20.3 47.6 33.0 35.9 26.5 36.1 23.2 26.0 116.6 325.2 23.8 21.9 26.4 24.8 22.7 21.8 33.7 60.7 26.5 20.1 25.8 32.0 53.4 16.2 30.6 28.2 64.3 25.1 40.3 23.6 26.1 27.0 41.3 18.1 27.3 23.6 40.8 70.8 25.3 28.9 24.4 28.4 28.5 16.0 17.7 13.4 70.6 53.5 6.8 22.0 38.3 23.3 28.2 10.2 53.7 14.8 44.3 34.6 19.0 22.4 21.3 35.7 25.2 30.4 16.1 19.8 13.8 23.5 90.9 7.8 12.7 62.4 52.0 30.8 58.5 62.5 32.2 27.4 20.6 20.3 43.3 29.3 12.2 15.3 4.6 77.4 22.1 17.2 14.5 27.9 55.4 14.5 14.8 13.2 28.6 10.8 49.3 23.3 33.9 19.3 24.3 19.3 11.6 35.5 9.7 28.7 15.2 13.3 47.7 28.7 23.0 103.5 67.0 66.0 36.3 66.0 39.8 45.9 39.1 42.1 58.0 51.2 39.6 37.7 25.5 54.4 77.5 43.9 45.5 61.7 24.8 25.7 26.1 28.5 23.2 26.0 26.4 24.8 22.7 25.8 26.1 27.3 28.4 19.9 12.8 25.7 14.0 16.3 5.9 29.9 54.3 9.6 24.6 19.9 17.1 33.7 41.5 30.6 49.7 18.8 43.0 10.0 48.1 119.3 57.7 2.3 25.0 17.5 22.5 9.0 18.7 4.3 24.0 27.3 20.8 30.5 23.1 17.7 29.7 30.4 172.4 61.6 35.3 5.3 49.5 28.5 23.5 7.7 3.6 21.8 23.5 21.4 8.4 41.4 37.1 24.7 6.0 12.5 31.2 53.8 24.5 8.3 29.4 70.9 216.8 31.5 25.5 6.6 17.1 21.6 6.6 5.4 13.8 6.5 41.3 15.2 65.6 48.9 24.3 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800781 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 123.5" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070023 Approved "Golgi apparatus,Cytosol" NA NA 16000 "Golgi apparatus, Cytosol" "HPA070023: " "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.68e-4)" "unprognostic (1.41e-2)" 8.0 12.9 11.8 16.2 11.9 6.0 12.9 11.6 17.8 22.5 10.9 59.2 55.1 6.8 12.8 63.6 16.7 31.7 6.3 11.9 12.4 33.9 61.7 20.7 7.6 11.8 11.7 11.6 4.6 15.3 15.7 6.8 17.9 11.6 11.1 60.6 6.4 60.2 16.5 4.3 9.6 38.7 10.9 11.7 17.8 123.5 8.8 12.3 8.1 4.8 5.4 15.9 21.1 22.3 11.9 60.3 71.5 27.8 44.5 9.8 13.9 26.9 40.7 53.4 68.6 50.9 65.3 195.4 14.3 54.7 23.5 91.9 65.8 24.5 101.8 51.5 29.4 16.2 40.6 34.4 71.6 102.0 18.4 11.6 30.1 53.4 63.4 156.8 69.2 59.5 30.1 45.9 3.8 49.5 64.5 29.0 19.5 7.8 83.1 67.7 33.6 27.1 18.5 112.7 41.4 10.7 24.1 73.9 66.7 70.6 31.1 47.9 14.5 33.7 52.0 74.9 52.0 50.3 18.5 46.4 18.9 53.0 74.5 27.8 1.7 13.5 3.0 8.5 29.3 8.5 5.4 5.0 6.9 19.0 1.7 5.8 4.1 3.4 37.3 37.1 5.2 9.5 8.8 11.8 11.9 11.6 17.8 11.9 12.4 11.8 11.7 11.6 11.6 11.7 12.3 11.9 9.6 12.8 49.3 6.8 7.5 7.6 18.8 110.4 6.2 17.2 26.7 10.9 3.5 37.1 90.6 40.5 16.7 54.1 7.4 131.8 35.2 67.6 21.5 19.9 9.1 14.3 12.1 8.2 9.4 114.8 106.3 14.0 276.8 36.2 10.8 17.4 10.8 38.3 99.3 8.4 10.8 149.5 73.2 5.7 6.8 5.0 4.7 12.5 24.9 5.6 19.4 21.2 7.2 4.5 2.1 92.0 109.0 3.4 9.4 24.9 78.6 89.5 37.0 14.8 0.0 3.7 13.1 14.5 9.7 19.6 4.8 96.3 7.6 99.6 73.8 46.0 ID3 "bHLHb25, HEIR-1" ENSG00000117318 "Inhibitor of DNA binding 3, HLH protein" Q02535 1 23557926-23559501 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Myogenesis, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1710.3;Basal respiratory cells: 1091.1;Hepatic stellate cells: 1508.2;Ionocytes: 1210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 318.8;naive B-cell: 306.1" "Group enriched" "Detected in many" 39 "B-cells: 318.8;T-cells: 177.0" "Cell line enhanced" "Detected in many" "U-698: 598.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021353, HPA024677" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB021353: , HPA024677: AB_2671647" "unprognostic (6.73e-2)" "unprognostic (2.48e-1)" "unprognostic (5.19e-2)" "prognostic favorable (1.27e-5)" "unprognostic (5.58e-3)" "unprognostic (1.46e-1)" "unprognostic (8.98e-2)" "unprognostic (7.76e-2)" "unprognostic (3.89e-2)" "unprognostic (6.47e-3)" "unprognostic (2.42e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (4.37e-3)" "unprognostic (8.36e-2)" 126.0 49.9 36.3 22.9 29.9 6.9 115.1 33.3 52.0 77.1 41.3 76.8 30.1 84.9 15.7 43.3 135.3 39.5 154.0 31.9 55.9 78.5 31.8 100.5 26.5 53.4 40.3 23.6 107.0 41.4 8.4 121.4 51.5 41.4 111.2 22.5 10.2 40.2 109.1 41.7 60.1 76.9 21.1 41.8 42.2 89.8 7.0 57.2 35.1 197.5 52.5 13.4 132.7 91.0 38.5 24.1 152.6 57.2 199.1 27.2 2.8 53.0 154.2 16.8 105.0 14.5 8.9 1.2 150.2 168.2 80.3 21.7 216.1 77.7 25.1 12.3 1.2 68.8 2.4 227.5 89.6 77.9 0.2 0.4 80.1 141.9 2.8 1.5 104.0 91.7 67.1 0.9 2.0 107.8 59.9 21.0 0.6 41.9 140.0 37.6 189.5 82.1 5.6 1.3 66.3 78.3 55.0 148.4 155.8 12.7 49.9 38.1 5.2 162.3 151.5 72.4 69.4 92.2 47.4 45.9 598.1 34.4 1.8 79.0 0.6 1.3 0.3 3.8 1.8 1.3 318.8 69.8 13.9 5.0 306.1 113.3 45.6 3.6 0.7 2.1 6.2 177.0 36.9 36.3 29.9 33.3 52.0 31.9 55.9 53.4 40.3 23.6 41.4 41.8 57.2 38.5 1710.3 115.4 62.6 77.7 211.6 205.2 340.3 1091.1 583.4 4.1 128.3 187.3 35.8 20.0 337.1 209.7 10.4 193.4 27.8 384.8 23.5 216.6 1.9 555.2 270.3 988.8 432.3 41.0 0.1 441.5 931.4 496.5 384.3 562.4 15.2 394.7 1508.2 7.0 70.6 5.0 0.2 560.1 1210.5 71.7 254.9 3.7 41.0 91.1 249.1 62.8 21.0 378.5 1.0 0.5 3.1 88.4 388.8 0.7 67.1 168.4 223.1 7.9 110.6 17.7 519.4 266.4 780.2 0.9 2.8 577.6 189.5 279.2 86.7 19.5 323.3 116.5 CR2 "C3DR, CD21" ENSG00000117322 "Complement C3d receptor 2" P20023 1 207454230-207489895 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 175.4" "Group enriched" "Detected in some" 17 "B-cells: 54.9;Plasma cells: 14.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 7.1;stomach cancer: 5.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 17.5;naive B-cell: 20.3" "Lineage enriched" "Detected in many" 8 "B-cells: 20.3" "Cell line enhanced" "Detected in some" "Daudi: 24.0;JURKAT: 4.0;MOLT-4: 13.4;RPMI-8226: 4.7" "Not detected" "Not detected" "CAB002659, HPA052942, HPA060715" Enhanced NA NA 220000000 "CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349" "prognostic favorable (6.90e-4)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-1)" "unprognostic (6.62e-3)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (7.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.19e-1)" "unprognostic (2.09e-2)" "unprognostic (3.35e-2)" 2.0 0.0 0.1 53.6 0.1 0.8 0.6 0.0 0.2 0.0 0.0 5.2 0.9 0.4 0.0 0.7 0.1 2.0 0.2 0.2 0.1 6.2 0.4 1.1 175.4 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.1 1.1 4.0 0.0 4.3 0.0 0.2 0.0 16.9 0.4 0.0 73.9 7.0 0.5 0.1 15.4 0.8 0.0 172.4 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.1 13.4 0.0 2.1 0.0 0.3 0.0 0.2 4.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 17.5 1.0 0.6 0.0 20.3 2.4 2.2 0.3 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 1.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 14.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 1.0 0.1 0.0 0.0 CD46 "MCP, MGC26544, MIC10, TLX, TRA2.10" ENSG00000117335 "CD46 molecule" P15529 1 207752054-207795513 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 296.7;eosinophil: 382.4;neutrophil: 401.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 401.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB010401, HPA016903" Enhanced Approved "Plasma membrane" NA NA 1000000 "Plasma membrane" "CAB010401: AB_2291289, HPA016903: AB_1846309" "unprognostic (1.42e-2)" "prognostic unfavorable (8.54e-5)" "unprognostic (3.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (2.74e-1)" "unprognostic (8.79e-2)" "unprognostic (2.50e-1)" "unprognostic (6.78e-3)" "prognostic favorable (2.38e-4)" "unprognostic (1.76e-1)" "unprognostic (8.23e-2)" "unprognostic (1.49e-2)" 99.5 239.6 31.5 64.6 36.0 81.2 129.7 35.2 39.8 74.6 63.6 104.1 125.8 62.7 77.8 103.1 111.0 74.5 65.5 31.1 35.9 174.8 135.0 130.3 58.6 40.6 36.9 30.1 61.7 113.5 313.1 42.1 223.4 40.0 168.9 104.2 73.2 168.4 108.4 47.8 48.1 99.4 67.7 39.6 80.3 118.4 40.9 38.3 44.8 87.5 58.6 67.2 98.1 68.8 43.3 130.0 71.7 66.1 30.8 202.9 199.2 99.9 95.0 137.3 61.3 82.5 71.3 335.4 19.8 94.3 95.3 84.5 170.7 50.0 130.5 93.0 99.9 70.9 42.9 73.8 128.6 128.8 94.8 142.8 172.9 189.6 92.9 72.5 144.4 174.2 76.8 91.8 83.4 95.7 61.3 45.4 82.8 75.6 76.9 70.9 30.2 104.7 123.0 251.4 252.6 66.5 45.4 120.5 266.8 160.1 130.8 210.2 79.8 150.9 65.6 57.7 139.2 109.9 111.2 144.3 60.1 95.8 61.2 63.0 296.7 79.8 382.4 50.1 82.4 68.9 43.5 63.3 55.8 47.3 34.1 71.1 60.5 401.8 46.9 87.5 24.9 60.5 102.4 31.5 36.0 35.2 39.8 31.1 35.9 40.6 36.9 30.1 40.0 39.6 38.3 43.3 186.0 201.9 241.1 59.7 60.3 52.9 89.3 87.2 108.1 63.0 144.3 85.7 61.4 75.8 177.8 145.3 66.7 247.3 94.0 105.2 15.6 77.4 227.7 206.1 67.0 106.7 72.8 46.9 61.0 79.9 76.2 70.5 97.9 231.3 114.5 78.1 77.8 120.9 59.9 40.4 73.6 91.1 87.5 78.9 63.1 36.9 47.2 91.6 62.2 82.4 88.7 25.3 39.1 112.1 153.9 72.8 117.7 44.0 76.0 144.5 92.6 54.4 208.8 87.3 52.6 69.7 89.3 17.1 20.2 104.5 45.9 343.7 89.9 99.4 115.9 165.7 PRPF3 "hPrp3, Prp3, RP18, SNRNP90" ENSG00000117360 "Pre-mRNA processing factor 3" O43395 1 150321479-150353233 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027226, HPA067116" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027226: AB_1855770, HPA067116: AB_2685783" "unprognostic (2.75e-1)" "unprognostic (3.00e-1)" "unprognostic (2.20e-1)" "unprognostic (2.77e-1)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (7.89e-2)" "unprognostic (7.13e-3)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (6.77e-3)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.78e-3)" 25.7 24.9 18.4 22.5 20.2 45.2 27.2 22.7 23.3 27.4 22.1 24.0 17.0 25.3 26.9 22.3 25.9 14.0 19.5 17.9 18.8 22.8 30.6 24.5 28.9 19.4 18.9 16.2 34.4 24.0 17.8 27.2 21.1 19.8 27.8 19.8 43.9 21.9 19.7 22.4 23.0 24.8 18.9 17.3 34.1 19.2 20.3 19.0 31.1 32.2 15.0 28.7 24.5 24.5 21.9 44.8 47.5 47.1 30.3 31.0 33.5 63.8 45.6 31.9 69.1 47.5 36.6 40.8 58.7 29.7 37.6 64.4 51.5 86.1 32.2 61.7 29.7 38.3 50.7 72.1 35.2 30.7 62.5 31.6 24.6 43.7 59.0 50.5 32.9 42.7 39.0 61.3 34.8 50.0 66.5 52.3 55.0 67.6 114.3 41.9 75.1 38.5 38.8 28.5 26.7 40.3 35.7 37.9 44.2 34.9 63.3 52.9 150.5 34.3 43.2 33.3 36.7 75.8 33.1 62.8 64.7 28.8 56.2 45.9 9.3 9.0 13.3 14.9 11.8 14.6 13.0 10.8 9.8 9.5 10.0 11.0 11.4 5.3 11.5 21.8 7.6 9.1 8.3 18.4 20.2 22.7 23.3 17.9 18.8 19.4 18.9 16.2 19.8 17.3 19.0 21.9 26.1 35.3 23.4 31.6 26.1 11.7 13.1 13.0 10.8 30.4 10.8 10.8 13.2 11.5 19.7 11.0 18.8 16.1 22.9 15.8 13.7 15.6 11.5 13.2 20.0 22.5 2.4 19.0 19.5 11.9 16.0 16.3 17.9 17.8 22.8 25.5 14.6 11.0 12.1 32.0 17.5 17.5 4.1 8.6 11.8 5.3 20.2 14.5 10.6 15.0 14.2 27.8 17.5 18.1 28.4 13.4 9.5 18.4 12.4 12.6 12.6 5.0 20.6 42.6 13.1 19.1 21.2 44.3 23.5 11.6 10.1 20.0 24.0 11.3 11.6 10.0 APH1A "APH-1A, CGI-78" ENSG00000117362 "Aph-1 homolog A, gamma-secretase subunit" Q96BI3 1 150265399-150269580 "Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037272 Approved NA NA "CAB037272: AB_476776" "unprognostic (1.00e-1)" "unprognostic (5.55e-2)" "unprognostic (8.84e-2)" "unprognostic (1.20e-3)" "unprognostic (4.92e-2)" "unprognostic (3.55e-2)" "unprognostic (2.75e-3)" "unprognostic (4.42e-2)" "unprognostic (1.20e-1)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.53e-1)" "unprognostic (6.99e-2)" "unprognostic (4.48e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.87e-1)" 73.6 94.7 60.6 61.1 63.2 79.4 98.8 62.7 59.9 80.3 60.3 101.5 83.0 61.0 84.7 119.6 84.0 69.6 67.0 56.9 65.4 78.1 133.3 84.4 81.4 67.5 63.8 54.6 89.4 93.0 111.2 57.0 73.0 62.1 62.6 96.3 24.7 93.5 68.8 59.3 120.6 81.1 55.3 66.2 99.9 96.6 35.0 63.2 73.6 96.6 63.7 91.4 78.6 84.7 65.9 226.4 95.6 113.7 175.8 140.3 115.0 148.3 82.8 171.4 183.7 190.9 78.2 251.5 125.3 116.9 146.2 90.9 180.2 98.8 143.6 127.2 114.0 122.8 93.2 61.3 101.7 173.6 173.1 136.4 145.0 198.7 124.5 147.6 132.7 201.8 128.3 104.1 208.4 119.0 280.7 118.8 101.5 127.5 163.7 158.0 135.9 116.0 203.8 136.1 151.9 93.2 210.7 81.9 133.8 172.0 105.6 174.5 303.8 115.5 104.8 99.4 102.8 147.1 297.0 263.0 113.0 89.4 180.6 116.7 9.7 10.6 8.2 11.1 9.4 11.8 8.6 7.6 7.4 9.9 6.8 7.0 8.4 9.7 12.1 10.5 9.3 3.8 9.9 60.6 63.2 62.7 59.9 56.9 65.4 67.5 63.8 54.6 62.1 66.2 63.2 65.9 80.6 22.4 25.5 15.3 91.9 65.8 86.2 107.1 74.6 23.3 92.9 72.6 24.0 70.1 56.1 82.8 8.4 132.8 77.4 110.9 33.2 131.6 7.1 26.3 40.6 77.4 75.6 44.2 6.8 157.2 143.9 60.3 50.0 49.7 35.5 74.9 71.7 68.2 159.8 37.0 7.9 107.4 71.2 125.1 95.0 7.7 60.3 88.7 62.2 12.2 119.2 59.6 113.3 13.0 10.7 140.4 84.7 40.6 84.6 102.8 81.7 49.7 22.1 17.5 26.3 57.1 38.8 17.2 16.4 83.7 81.8 165.4 71.4 62.4 114.0 122.0 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Extravillous trophoblasts: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 193.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" NA NA 18000 Vesicles Nucleoli "HPA012113: AB_2668626, HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 12.2 11.2 3.8 8.8 3.7 6.2 10.3 3.7 4.4 13.0 6.8 7.6 2.4 13.9 6.2 4.4 9.9 12.1 8.4 3.9 4.4 7.2 13.4 11.7 5.2 5.3 3.7 3.6 12.9 6.9 5.9 15.6 37.7 4.0 7.6 5.5 1.3 6.7 6.0 3.0 7.1 7.4 20.5 3.7 11.6 6.8 15.4 3.9 7.7 7.6 4.0 5.1 12.4 8.6 3.8 8.7 22.3 48.7 115.0 112.8 85.4 20.1 101.8 131.9 71.9 121.7 11.3 18.8 13.0 79.7 193.0 29.2 7.8 20.9 25.9 49.2 19.5 26.3 30.5 32.2 32.6 65.2 30.9 34.0 73.8 17.4 72.6 30.9 102.4 102.9 18.3 17.5 16.1 49.0 4.7 20.6 17.8 53.1 4.7 16.0 19.9 71.9 17.7 38.2 4.9 10.2 17.3 62.5 1.7 45.8 85.2 3.7 127.0 85.1 53.8 47.2 43.4 41.2 14.5 17.5 11.9 61.5 41.5 77.0 5.0 18.9 16.8 8.3 20.4 8.8 4.1 6.3 7.0 23.6 3.3 5.1 5.3 1.8 17.8 26.3 10.9 12.4 9.3 3.8 3.7 3.7 4.4 3.9 4.4 5.3 3.7 3.6 4.0 3.7 3.9 3.8 13.7 3.2 2.3 5.9 10.5 0.0 6.4 0.0 6.2 10.2 4.5 6.5 5.0 7.2 0.6 11.0 25.0 47.9 11.1 0.4 0.0 11.5 17.1 3.2 30.1 16.4 6.1 11.3 12.9 7.6 56.6 34.4 3.6 4.4 1.3 28.8 16.8 11.3 17.6 15.2 10.8 2.5 0.0 8.7 0.0 10.8 19.3 11.7 0.0 9.4 10.5 3.5 6.2 9.5 6.9 7.4 2.0 16.1 11.2 3.4 1.7 1.9 0.7 22.1 0.0 17.2 22.3 30.6 18.8 3.5 0.0 17.5 9.6 27.0 1.9 4.5 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925353-42958893 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 99.5;skin 1: 77.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" No No 2000000 "Plasma membrane" "CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734" "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavorable (3.65e-8)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.05e-4)" 6.6 3.6 24.5 2.6 23.2 42.0 7.8 31.0 23.4 20.3 36.7 4.7 0.4 5.1 1.4 54.5 8.3 1.7 9.2 18.3 24.9 14.0 1.7 3.3 1.0 32.1 27.2 10.7 5.5 2.2 4.5 4.8 99.5 30.4 6.1 1.0 24.8 17.8 5.2 2.0 77.9 4.7 0.4 22.3 7.5 8.5 2.1 37.8 1.0 3.1 1.5 2.1 19.5 54.6 32.3 60.5 52.9 66.3 6.2 3.5 1.2 241.0 47.8 36.9 15.5 27.8 219.9 96.3 22.2 138.9 6.0 26.5 43.6 12.5 52.3 14.8 16.4 10.3 29.8 20.9 157.4 12.9 16.8 8.1 3.3 21.3 18.3 20.5 96.7 2.9 12.8 81.2 1.5 11.7 46.6 7.4 11.7 35.1 22.1 17.9 8.4 20.6 23.3 21.7 17.9 27.0 23.8 47.7 95.6 11.0 70.0 3.8 16.9 14.9 25.6 28.6 6.1 83.8 5.3 6.5 11.5 57.1 8.2 25.5 0.5 0.1 1.2 10.6 0.3 8.5 10.9 5.1 6.7 3.7 8.3 3.8 4.8 0.2 4.3 0.1 18.4 6.2 4.0 24.5 23.2 31.0 23.4 18.3 24.9 32.1 27.2 10.7 30.4 22.3 37.8 32.3 3.1 0.0 1.8 12.7 25.4 286.1 48.8 286.3 66.0 15.8 41.4 21.8 26.7 20.0 159.3 27.6 66.7 833.8 33.5 53.1 5.9 53.2 4.0 112.1 46.0 100.5 18.4 520.4 2.8 11.7 536.4 25.9 11.7 118.9 6.3 6.8 2.2 2.1 84.8 5.0 3.2 22.4 65.1 1.6 34.2 0.3 7.8 5.0 21.4 71.2 36.0 350.1 18.6 8.0 9.9 120.3 51.9 14.7 11.6 31.2 1.9 2.2 118.1 32.1 0.0 9.8 32.1 0.1 2.4 99.1 238.3 2482.5 20.8 5.5 11.8 105.8 EBNA1BP2 "EBP2, NOBP, P40" ENSG00000117395 "EBNA1 binding protein 2" Q99848 1 43164175-43270936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026512, HPA028277" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 38000 "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA026512: AB_1847954, HPA028277: AB_10603664" "unprognostic (9.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.05e-3)" "unprognostic (2.03e-2)" "unprognostic (8.59e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (7.64e-3)" "unprognostic (2.89e-2)" "unprognostic (1.24e-3)" "unprognostic (7.11e-2)" "unprognostic (1.64e-3)" "unprognostic (4.10e-3)" "unprognostic (3.04e-3)" "unprognostic (1.69e-1)" "unprognostic (3.22e-2)" "unprognostic (1.33e-2)" 32.7 39.1 30.5 35.5 31.6 34.5 40.0 29.4 33.8 28.5 31.5 35.8 23.8 35.8 56.2 46.9 43.9 21.9 33.7 30.9 31.2 55.7 127.6 27.9 36.2 29.9 29.3 30.5 27.6 36.4 46.0 49.3 33.4 30.3 29.3 36.9 19.8 34.8 31.3 52.3 35.6 24.7 35.3 29.3 25.0 33.7 44.8 31.3 30.8 41.8 28.8 40.1 53.0 34.8 31.5 325.0 180.2 66.0 192.7 52.1 58.3 142.6 219.4 107.8 338.7 210.5 215.2 192.5 211.0 167.9 157.0 157.2 218.2 144.5 200.9 360.5 101.2 146.5 144.8 160.9 188.5 95.7 248.7 106.8 47.6 197.4 248.6 197.3 64.2 185.5 145.2 220.3 67.8 165.1 172.8 190.0 152.0 290.8 209.5 165.0 139.2 150.4 235.5 123.7 135.0 132.0 139.9 127.3 228.6 219.0 105.6 94.5 136.1 147.6 128.7 248.9 211.4 360.7 102.9 219.7 262.7 107.6 258.7 265.2 19.7 45.4 24.9 52.3 54.1 55.2 61.5 52.8 54.5 68.7 68.5 48.3 48.3 3.9 59.6 53.3 65.6 60.5 43.6 30.5 31.6 29.4 33.8 30.9 31.2 29.9 29.3 30.5 30.3 29.3 31.3 31.5 38.0 35.3 39.5 5.9 36.9 123.0 91.6 78.0 40.5 26.3 50.6 62.1 32.0 52.9 52.5 31.3 6.2 102.2 23.3 34.0 90.1 144.5 163.5 56.8 47.3 51.0 24.1 45.0 5.6 124.4 135.1 51.5 33.1 31.6 50.7 35.1 27.8 148.3 63.3 15.2 3.8 49.7 48.8 22.5 24.7 94.9 33.2 28.9 55.2 3.7 41.4 55.7 35.0 6.0 4.9 135.3 25.8 38.4 53.1 179.3 29.4 135.9 81.3 29.5 39.5 55.0 68.1 92.6 97.8 54.2 99.4 84.3 26.8 57.8 66.2 95.3 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358981-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.3;lymphoid tissue: 53.1;testis: 49.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6" "Group enriched" "Detected in many" 9 "B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.4 1.5 0.8 16.3 1.2 54.3 5.3 0.9 1.3 2.4 0.6 15.0 13.8 2.3 2.5 27.4 1.7 1.2 0.8 0.8 1.6 2.2 1.7 2.5 32.8 1.3 1.4 0.8 0.7 0.6 0.2 0.3 9.7 1.3 0.8 16.2 0.2 4.4 0.7 0.3 11.4 12.3 7.4 1.2 11.8 7.1 49.5 1.6 53.1 1.7 0.2 51.2 3.4 7.1 1.6 311.9 148.2 202.8 133.4 6.9 17.6 193.5 140.3 125.0 400.0 211.4 234.5 250.9 178.3 80.1 130.1 140.6 212.8 225.3 267.9 331.5 140.8 165.6 261.4 143.6 147.3 2.1 184.3 91.4 6.0 12.4 278.2 249.6 35.1 172.2 167.5 120.2 119.3 184.0 120.4 179.2 113.5 257.2 147.0 196.9 255.8 277.9 112.9 98.5 81.3 119.2 58.9 248.1 165.8 76.6 154.9 116.3 231.7 90.2 118.9 276.2 133.7 445.0 90.6 86.7 185.7 85.2 227.6 181.6 0.0 0.1 0.0 0.3 0.0 0.0 4.2 3.2 3.5 0.9 0.9 0.1 0.3 0.7 9.5 0.0 0.2 11.6 2.8 0.8 1.2 0.9 1.3 0.8 1.6 1.3 1.4 0.8 1.3 1.2 1.6 1.6 2.1 0.0 1.1 0.0 12.2 10.5 3.8 17.6 6.2 0.5 6.4 9.7 0.7 1.5 4.8 0.0 0.0 65.0 2.8 16.9 0.0 2.2 135.0 14.6 2.4 4.5 0.0 96.0 0.2 0.4 146.2 9.3 11.7 4.6 0.0 46.5 7.9 1.3 37.4 0.0 0.0 18.5 24.4 6.2 7.5 18.5 2.8 9.3 0.0 0.0 1.8 0.3 0.0 0.0 1.6 0.7 0.5 1.9 34.4 2.7 3.2 3.1 8.3 2.9 0.0 1.0 25.4 126.5 39.8 47.3 8.4 10.7 5.1 1.6 37.5 7.4 MPL "CD110, THPOR, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337818-43354466 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Erythroid cells: 3.0;Excitatory neurons: 2.0;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 57 "HEL: 77.4" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Low region specificity" "Detected in many" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 0.6 0.5 0.9 0.2 1.6 1.8 0.4 0.8 1.3 0.3 0.2 0.3 0.3 0.7 1.2 0.5 0.8 0.3 1.0 0.7 0.6 0.4 0.4 0.6 0.2 1.1 1.1 0.7 2.9 0.8 0.4 0.0 0.3 1.5 0.9 0.4 1.6 0.5 0.7 0.6 0.5 0.2 0.8 0.8 0.4 0.5 1.2 1.0 0.1 1.0 0.3 0.1 0.2 0.0 3.0 0.4 0.7 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.3 0.1 0.3 0.1 0.0 0.6 0.0 0.2 0.0 0.4 0.1 77.4 1.2 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.1 0.1 0.2 0.0 0.2 0.7 0.6 0.4 0.2 0.6 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.2 1.4 0.1 0.1 0.3 0.1 1.8 0.9 1.6 0.8 1.3 0.7 0.6 1.1 1.1 0.7 1.5 0.8 1.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARTN "ENOVIN, EVN, NBN" ENSG00000117407 Artemin Q5T4W7 1 43933320-43937240 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 51.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "A-431: 61.9;HaCaT: 62.8;HBEC3-KT: 57.0;hTCEpi: 22.7;hTERT-HME1: 15.9" "Region enriched" "Detected in single" 9 "olfactory bulb: 3.3" "Region enhanced" "Detected in single" "olfactory bulb: 1.0" "Secreted in other tissues" NA NA "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (1.86e-1)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (3.07e-3)" "unprognostic (1.18e-1)" "unprognostic (3.08e-1)" "prognostic favorable (8.18e-4)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (9.59e-6)" "unprognostic (2.35e-2)" "unprognostic (3.04e-2)" "unprognostic (1.48e-3)" "unprognostic (1.53e-1)" 1.8 0.9 1.9 0.9 1.4 0.8 1.8 3.4 2.3 4.1 1.3 2.1 0.4 3.2 3.4 3.8 2.8 0.9 1.6 1.6 1.5 4.1 0.7 2.4 0.3 4.2 2.6 1.3 2.1 2.8 6.7 6.7 7.5 4.9 8.3 1.6 1.8 1.5 8.2 0.7 1.0 1.2 1.3 1.3 0.7 1.8 2.4 4.2 0.3 1.4 0.3 0.3 2.4 4.7 2.1 61.9 1.5 1.2 0.9 0.2 0.3 0.2 2.8 0.5 2.3 2.5 0.4 1.4 0.8 0.4 0.9 0.8 62.8 0.0 57.0 0.6 0.2 2.1 1.0 7.6 0.1 0.0 0.4 1.3 0.0 22.7 1.1 15.9 10.6 0.0 1.1 0.7 2.1 0.2 4.3 0.2 4.0 5.4 0.0 2.6 1.4 0.0 0.9 0.3 1.3 1.4 0.5 0.4 0.1 1.4 1.1 10.2 10.4 0.6 1.2 0.5 0.5 2.8 6.7 5.5 0.9 8.8 3.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.4 3.4 2.3 1.6 1.5 4.2 2.6 1.3 4.9 1.3 4.2 2.1 0.1 0.0 0.0 0.0 0.1 0.0 4.3 2.3 0.0 1.8 2.3 0.5 0.8 0.0 2.8 0.0 0.0 0.1 0.3 2.8 3.9 0.1 8.4 1.6 0.3 0.2 0.0 0.0 0.7 0.2 0.0 0.3 0.0 1.9 0.0 3.2 0.0 0.0 0.1 0.0 1.2 1.0 0.0 0.0 0.5 2.6 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.4 0.0 12.1 0.0 1.6 0.7 4.6 0.0 0.0 4.0 4.3 0.0 0.0 0.0 0.0 0.1 0.8 0.7 51.5 IPO13 "IMP13, KIAA0724, RANBP13" ENSG00000117408 "Importin 13" O94829 1 43946950-43968022 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 127.9;skeletal muscle: 129.5" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5;Late spermatids: 91.1;Oligodendrocytes: 79.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070425 Uncertain NA NA "CAB070425: AB_11157631" "unprognostic (7.15e-3)" "unprognostic (1.85e-1)" "unprognostic (1.56e-1)" "unprognostic (2.04e-1)" "unprognostic (4.15e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (8.26e-7)" "unprognostic (1.21e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-1)" "prognostic favorable (2.21e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (6.42e-2)" "unprognostic (4.22e-2)" "unprognostic (8.13e-2)" "unprognostic (5.93e-3)" 12.0 22.7 71.9 9.9 97.0 9.7 11.8 83.2 80.5 15.5 53.4 18.5 9.3 19.1 13.9 20.1 14.2 9.4 32.7 69.8 76.4 26.8 19.1 12.3 9.9 89.2 91.7 65.9 13.5 13.8 27.7 26.6 10.3 97.7 19.1 10.2 24.1 15.9 16.2 129.5 15.0 14.1 15.8 79.6 15.5 16.9 48.9 87.1 14.3 21.3 74.8 10.5 18.1 15.4 127.9 22.2 17.7 17.5 27.8 46.5 24.0 14.6 20.8 19.3 30.5 23.2 13.6 11.0 23.1 21.0 27.3 19.3 24.3 31.7 36.7 20.1 23.6 27.1 24.1 34.0 18.9 32.7 16.2 21.6 24.6 36.7 39.6 24.6 22.8 20.5 17.7 24.6 20.7 24.6 15.4 16.5 21.3 16.1 18.9 29.4 22.6 22.0 24.2 22.4 21.2 27.8 12.9 19.5 32.5 27.5 22.7 20.4 22.3 16.8 30.3 18.1 26.7 23.9 23.0 30.4 11.0 19.3 34.6 26.9 0.0 1.4 1.2 2.0 1.6 1.7 1.1 1.3 2.0 2.3 0.8 1.1 1.5 0.5 1.9 1.6 2.3 1.7 1.0 71.9 97.0 83.2 80.5 69.8 76.4 89.2 91.7 65.9 97.7 79.6 87.1 127.9 4.2 0.0 2.0 13.1 7.4 3.3 3.2 9.1 2.8 18.9 5.6 4.1 23.4 12.8 6.3 11.0 8.4 6.4 5.1 8.6 1.9 7.3 53.5 8.0 5.6 5.8 3.0 4.8 9.8 4.2 3.7 5.2 6.1 6.0 0.0 12.6 3.6 11.5 16.3 28.6 8.8 5.3 12.2 8.3 3.3 91.1 8.4 5.8 8.8 1.9 7.1 11.6 4.1 5.5 79.2 5.9 1.1 15.8 6.2 4.3 9.1 18.2 8.6 8.7 0.0 6.4 10.4 32.4 12.3 7.1 4.3 4.1 3.6 8.4 7.3 3.8 ATP6V0B "ATP6F, HATPL, VMA16" ENSG00000117410 "ATPase H+ transporting V0 subunit b" Q99437 1 43974487-43978295 "Metabolic proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 1694.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 2268.9" "Group enriched" "Detected in all" 4 "dendritic cells: 769.4;granulocytes: 2268.9;monocytes: 1046.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044281 Approved Cytosol NA NA Cytosol "HPA044281: " "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (5.69e-2)" "unprognostic (5.31e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (7.23e-2)" "prognostic favorable (3.24e-4)" "unprognostic (6.13e-2)" "prognostic favorable (3.62e-6)" "unprognostic (5.55e-2)" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.87e-4)" 71.8 163.5 231.8 68.9 233.1 288.9 80.2 240.5 269.0 64.4 250.2 90.2 61.6 58.0 98.2 101.8 62.1 65.1 100.4 239.1 245.8 234.8 169.7 116.8 72.2 242.8 240.7 235.6 50.1 173.5 183.5 158.7 77.3 252.7 102.2 91.7 107.6 113.0 61.3 139.7 96.5 84.5 56.2 245.7 144.9 126.0 57.2 255.9 60.7 102.5 84.8 75.3 93.5 71.5 269.0 150.4 135.9 99.4 129.1 149.3 78.0 142.9 134.1 168.5 217.1 183.6 143.2 144.5 140.3 119.7 119.0 253.2 118.4 233.4 170.1 99.8 135.4 266.4 175.0 209.7 195.1 238.0 262.7 307.9 97.4 219.6 235.3 206.5 136.7 105.1 167.3 189.5 260.9 177.1 147.3 103.2 411.3 182.4 184.8 271.1 150.7 108.1 371.7 225.2 159.1 260.9 137.2 89.0 303.1 319.0 111.4 128.8 419.5 62.8 119.0 105.7 222.6 311.4 241.9 397.5 150.3 161.2 355.5 188.5 528.7 1046.6 892.1 161.2 652.9 161.5 321.1 171.0 156.8 630.7 271.9 129.7 130.1 2268.9 124.4 618.8 769.4 187.2 1450.9 231.8 233.1 240.5 269.0 239.1 245.8 242.8 240.7 235.6 252.7 245.7 255.9 269.0 125.1 80.1 126.9 26.4 176.6 335.9 161.9 577.2 173.6 238.7 241.5 219.1 101.7 144.4 367.7 283.3 102.2 197.4 216.0 242.1 201.5 347.8 4.4 186.6 93.6 136.9 224.0 114.6 36.5 328.5 223.3 118.9 114.7 207.9 206.7 77.0 102.1 241.0 815.7 129.5 40.5 306.2 1694.7 347.6 454.5 12.9 78.9 489.8 281.1 24.4 379.2 220.2 103.0 28.6 62.4 379.0 382.7 65.5 301.2 355.1 186.0 223.5 244.1 231.7 78.9 77.4 444.3 116.6 197.9 192.9 358.3 496.5 121.2 135.9 241.8 337.5 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" NA NA 3100000 "Golgi apparatus, Vesicles" "HPA007620: AB_2667879, HPA047739: AB_2680141" "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavorable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 27.8 19.2 54.0 13.1 47.4 6.7 24.8 41.0 70.6 27.7 36.2 35.5 12.7 31.3 9.7 32.6 20.2 15.0 37.8 50.5 43.4 21.4 39.1 19.8 5.9 46.5 46.0 48.2 19.8 52.0 14.3 24.9 10.2 45.1 31.4 10.3 9.0 27.5 24.0 61.5 32.5 15.3 26.5 45.3 12.1 22.6 22.8 47.8 3.2 14.4 33.5 6.9 37.3 27.0 45.5 61.6 38.4 45.3 76.0 51.3 54.5 37.8 54.2 55.9 54.8 50.9 30.4 51.4 38.4 31.6 112.3 52.5 39.9 36.8 72.8 14.0 39.6 80.2 23.2 37.8 66.9 43.2 20.6 0.8 47.0 79.1 39.3 71.4 55.3 65.5 15.9 51.7 25.3 46.7 45.3 15.3 18.6 65.6 35.7 56.7 44.3 48.2 62.7 33.9 29.3 72.7 58.5 31.1 89.4 38.5 16.9 38.6 17.5 39.3 90.8 102.4 63.8 78.5 7.6 17.8 15.9 40.4 16.9 64.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 54.0 47.4 41.0 70.6 50.5 43.4 46.5 46.0 48.2 45.1 45.3 47.8 45.5 9.7 0.0 8.8 7.5 2.2 7.8 10.3 10.8 1.8 13.3 15.0 18.9 14.0 7.2 7.4 14.7 4.2 2.0 1.2 10.2 1.9 13.3 16.4 6.2 16.2 10.4 16.3 1.3 8.0 20.6 8.0 15.2 13.7 8.7 0.0 23.8 6.1 18.7 2.3 18.5 5.6 22.6 2.0 1.0 3.3 6.7 16.4 1.5 3.6 1.0 1.6 15.0 0.0 5.0 9.8 27.3 6.1 12.4 5.0 25.9 6.4 8.8 4.4 12.2 6.6 9.8 14.3 6.2 15.6 7.6 12.6 0.5 1.7 21.1 15.3 16.1 ERI3 "FLJ22943, PINT1, PRNPIP" ENSG00000117419 "ERI1 exoribonuclease family member 3" O43414 1 44221070-44355260 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 943.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027147, HPA029895" Approved Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA027147: AB_1855725, HPA029895: AB_2673239" "unprognostic (1.31e-1)" "unprognostic (2.39e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (5.94e-2)" "unprognostic (6.21e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (6.48e-2)" "unprognostic (2.67e-1)" "unprognostic (6.70e-3)" "unprognostic (5.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-1)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (2.07e-3)" 30.1 35.1 100.2 15.7 101.2 24.8 30.8 88.2 141.4 30.4 84.6 32.0 20.8 33.6 34.5 28.1 37.5 20.7 46.8 107.2 96.1 59.5 42.1 25.8 19.4 95.2 104.5 102.9 32.7 35.3 45.5 45.5 23.5 106.9 39.1 23.4 22.6 28.0 25.5 77.9 35.8 22.9 28.9 92.2 26.6 29.1 63.8 100.1 24.3 31.4 60.7 20.5 32.5 27.4 99.0 73.6 56.5 69.3 77.7 44.9 55.5 46.0 44.0 61.4 82.1 75.1 37.8 78.3 52.3 76.4 58.7 42.2 41.2 62.6 80.6 55.9 56.9 115.8 60.0 90.2 52.0 67.9 59.3 32.8 57.9 76.9 66.2 91.3 61.0 57.3 59.5 56.4 43.9 55.2 51.2 68.7 57.0 82.2 72.2 83.7 62.6 62.4 75.3 65.2 38.9 120.5 54.9 52.5 71.3 87.7 55.1 46.6 50.1 34.1 54.3 56.5 60.7 72.0 37.7 50.1 56.4 67.7 52.4 70.4 17.6 25.8 15.8 25.5 36.4 27.2 30.8 21.1 24.5 40.3 30.9 24.8 26.0 2.4 26.1 37.3 30.3 29.4 26.2 100.2 101.2 88.2 141.4 107.2 96.1 95.2 104.5 102.9 106.9 92.2 100.1 99.0 35.4 25.6 16.5 74.4 26.2 31.6 36.5 64.7 27.3 22.6 36.2 51.3 15.1 15.7 26.2 29.5 2.1 93.2 19.3 31.2 97.8 56.9 202.7 35.3 30.7 27.4 118.3 26.5 36.7 62.5 85.9 39.8 25.0 23.1 15.2 62.8 18.9 22.3 45.0 25.2 34.0 99.1 46.8 19.2 27.2 943.6 36.4 20.1 48.0 38.4 27.9 42.6 15.5 66.4 54.5 37.7 22.2 36.5 28.3 51.0 17.0 167.3 20.4 16.4 6.6 28.5 52.0 68.0 51.4 29.4 34.5 61.6 20.2 54.0 37.1 30.7 PTCH2 ENSG00000117425 "Patched 2" Q9Y6C5 1 44819844-44843253 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ovary: 24.8;parathyroid gland: 59.5;salivary gland: 75.8;testis: 25.8" "Cell type enhanced" "Detected in many" "Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7" "Cancer enhanced" "Detected in many" "testis cancer: 9.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046839 Supported "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA046839: " "unprognostic (6.54e-5)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (3.65e-3)" "unprognostic (3.89e-1)" "unprognostic (7.42e-3)" "unprognostic (3.01e-1)" "unprognostic (2.94e-2)" "unprognostic (1.51e-1)" "unprognostic (8.67e-2)" "prognostic favorable (5.74e-5)" "unprognostic (2.92e-1)" "unprognostic (5.74e-6)" "unprognostic (1.55e-2)" "unprognostic (4.86e-2)" "unprognostic (6.31e-2)" "unprognostic (6.81e-2)" 3.0 3.2 6.2 0.9 3.9 9.5 3.5 6.2 6.9 4.8 3.1 2.9 1.0 6.5 1.7 0.9 4.4 2.5 1.3 3.6 3.5 1.3 1.3 1.0 2.3 3.2 4.5 4.4 24.8 1.0 59.5 9.9 0.3 5.3 3.0 0.9 3.6 75.8 1.3 2.0 3.2 1.8 1.2 1.8 2.5 2.0 25.8 4.5 0.8 4.7 0.8 0.7 3.1 3.4 5.2 0.2 0.3 1.0 2.5 0.8 0.9 1.0 0.8 1.6 0.5 0.4 0.2 0.4 1.1 0.4 0.4 0.5 0.0 1.1 0.0 0.2 2.1 1.9 0.6 1.0 0.8 0.3 0.7 1.1 0.3 0.4 1.0 0.1 1.7 0.1 1.0 0.7 1.1 0.0 0.5 1.4 2.1 0.3 0.1 0.4 1.0 0.2 0.5 0.2 0.0 1.5 0.6 0.3 0.4 0.8 0.5 0.2 1.2 0.1 0.2 0.5 1.3 0.5 1.9 11.6 3.2 0.6 3.0 0.4 2.5 1.9 0.1 0.5 0.9 1.0 1.0 0.6 0.6 1.2 1.4 0.7 0.6 0.6 0.9 0.9 3.6 0.3 0.2 6.2 3.9 6.2 6.9 3.6 3.5 3.2 4.5 4.4 5.3 1.8 4.5 5.2 2.8 0.0 1.1 14.0 13.4 0.5 0.7 1.0 0.6 0.8 4.8 8.0 1.0 7.2 1.0 1.8 2.1 2.4 6.8 7.8 0.0 5.5 2.3 9.3 13.5 2.7 11.5 1.3 23.7 1.8 1.6 14.3 28.1 8.5 0.0 4.4 0.7 7.9 6.7 8.4 27.3 4.9 2.0 24.5 2.2 8.0 107.8 17.3 0.0 5.6 3.9 2.4 2.1 9.5 2.6 2.1 2.5 68.1 67.1 0.8 13.6 0.2 1.7 1.2 13.1 5.4 5.6 5.0 3.6 0.6 1.6 2.3 7.5 138.7 5.5 0.2 AKR1A1 "ALR, DD3" ENSG00000117448 "Aldo-keto reductase family 1 member A1" P14550 1 45550543-45570049 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006246, HPA017919, HPA019649, HPA027734" Approved Supported Nucleoplasm,Cytosol NA NA 7600000 Cytosol Nucleoplasm "CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976" "unprognostic (1.73e-1)" "prognostic favorable (2.66e-6)" "unprognostic (4.03e-1)" "prognostic favorable (2.92e-4)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (1.31e-3)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (8.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.56e-2)" "unprognostic (2.46e-1)" "unprognostic (2.89e-2)" "unprognostic (4.57e-2)" 68.1 73.3 37.4 74.1 40.4 49.0 124.4 41.1 40.6 84.7 47.7 107.6 190.4 60.4 91.5 153.1 89.7 62.2 57.6 36.4 43.2 326.5 326.3 76.5 98.1 43.4 39.2 36.2 62.3 159.4 61.3 100.1 64.4 42.3 76.5 116.5 23.4 124.1 60.6 46.9 69.8 173.1 79.7 42.6 93.2 113.8 21.3 42.0 78.0 81.4 42.9 117.9 73.0 71.5 52.2 74.3 94.5 91.2 73.7 173.1 124.8 67.9 78.3 178.0 68.8 133.5 40.1 50.3 179.5 68.5 86.2 71.6 94.5 94.0 118.3 60.0 74.3 92.6 101.2 82.2 167.8 152.0 132.4 102.7 140.2 104.7 87.0 157.4 123.4 154.7 125.1 59.4 131.2 77.1 49.1 147.3 61.2 106.0 219.4 68.2 170.1 119.5 211.9 185.5 89.3 117.5 65.3 71.8 271.1 108.5 113.2 80.3 72.3 97.2 30.2 72.0 113.1 54.2 97.0 140.5 87.6 59.1 168.7 26.6 141.8 229.5 45.4 65.3 224.5 71.6 99.8 59.6 63.5 196.8 108.9 51.4 52.4 11.1 66.1 174.8 170.0 81.9 182.7 37.4 40.4 41.1 40.6 36.4 43.2 43.4 39.2 36.2 42.3 42.6 42.0 52.2 53.0 48.1 57.3 7.2 96.6 49.2 99.3 210.0 87.6 21.2 121.0 94.7 46.1 95.8 173.8 79.1 37.5 115.2 45.1 113.7 181.9 195.9 5.4 48.7 49.1 58.6 118.4 48.0 8.3 156.5 142.1 82.0 135.5 54.7 112.1 59.2 78.1 294.5 399.3 16.8 7.1 201.9 118.0 141.8 153.7 9.6 68.3 142.1 81.8 20.6 140.3 33.6 49.4 9.0 16.2 123.6 199.9 56.1 187.2 115.1 872.9 1215.0 131.6 38.0 6.6 40.3 132.5 5.9 32.2 158.5 47.0 67.9 49.5 59.0 198.5 129.6 PRDX1 "NKEFA, PAGA" ENSG00000117450 "Peroxiredoxin 1" Q06830 1 45510914-45542732 "Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 2690.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004682, HPA007730" Approved Approved Mitochondria NA NA 110000000 Mitochondria "CAB004682: AB_437046, HPA007730: AB_1855204" "unprognostic (1.28e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.68e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.39e-2)" "unprognostic (5.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.89e-4)" 270.0 365.8 651.1 292.8 669.6 87.4 459.0 719.0 753.0 278.6 646.9 329.8 505.9 257.5 463.4 953.4 309.0 300.1 470.0 623.6 730.3 792.8 848.1 343.2 374.4 727.8 704.4 616.6 257.8 123.7 216.3 211.6 356.3 716.6 258.2 330.2 350.4 351.4 310.0 576.1 293.8 405.5 332.2 736.6 268.0 358.4 145.0 691.0 265.2 809.6 481.9 608.2 396.9 378.5 791.3 1028.1 1743.7 735.2 942.9 828.4 701.9 1459.3 1134.8 1144.1 1183.0 964.3 932.3 429.2 899.1 1125.9 1237.6 1448.6 967.6 1640.2 1101.3 1193.0 696.9 1266.4 678.6 2042.8 2484.7 361.0 793.6 848.9 610.4 813.6 1201.7 283.8 657.7 1409.7 1044.0 1271.8 292.7 1225.2 829.4 1053.7 772.5 2339.8 2241.0 1867.3 1863.6 934.0 1177.7 2211.5 872.4 987.5 495.1 1035.3 2524.2 73.3 2157.3 760.6 631.1 1208.1 474.8 1071.9 1034.4 1541.5 206.1 1220.5 1678.2 791.4 537.9 278.7 469.3 325.6 111.6 155.7 367.1 205.4 253.8 246.8 209.3 293.9 221.6 150.3 166.6 12.1 123.8 407.5 195.9 438.2 416.3 651.1 669.6 719.0 753.0 623.6 730.3 727.8 704.4 616.6 716.6 736.6 691.0 791.3 530.7 522.4 259.0 48.3 330.1 607.3 1115.3 1161.1 745.0 161.3 387.0 510.9 54.9 397.5 685.2 617.9 104.3 1258.6 151.5 339.3 946.9 1015.7 19.7 662.7 281.2 437.8 174.5 304.2 15.5 442.8 1773.2 462.0 500.0 435.5 325.3 463.2 326.3 875.2 1467.4 206.9 17.1 295.0 545.3 366.9 980.7 44.2 498.6 534.8 581.7 12.2 545.7 416.4 62.8 24.1 90.5 804.4 384.9 410.7 612.8 1100.9 995.0 2690.9 919.1 402.2 309.0 279.0 982.6 84.5 329.2 1346.9 528.6 1114.9 270.9 499.4 398.8 1462.7 PIK3R3 p55 ENSG00000117461 "Phosphoinositide-3-kinase regulatory subunit 3" Q92569 1 46040140-46133036 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 199.0;Endothelial cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 5.8" "Group enriched" "Detected in many" 9 "granulocytes: 5.8;monocytes: 2.4;T-cells: 2.3" "Cell line enhanced" "Detected in all" "RT4: 76.1" "Low region specificity" "Detected in all" "HPA005751, HPA071988" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA005751: AB_1855350, HPA071988: AB_2686479" "unprognostic (1.98e-1)" "unprognostic (3.75e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.32e-2)" "prognostic favorable (3.62e-4)" "unprognostic (4.88e-2)" "unprognostic (3.33e-3)" "unprognostic (4.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (9.99e-3)" "unprognostic (2.87e-2)" "unprognostic (9.74e-2)" "unprognostic (6.71e-2)" "unprognostic (8.22e-3)" 31.0 12.3 13.4 7.3 11.4 0.7 28.2 36.1 17.7 15.4 18.9 7.2 3.2 16.0 10.3 7.2 10.2 10.8 27.0 11.4 15.1 9.8 4.0 18.7 6.3 16.1 17.9 10.8 4.1 4.7 12.2 8.6 13.4 19.1 12.1 4.9 18.0 12.6 6.1 12.1 5.8 8.7 11.6 14.8 11.3 9.9 25.7 15.7 10.9 14.3 18.6 5.4 14.9 7.5 16.9 10.9 3.6 47.4 24.4 4.6 2.0 15.2 6.3 4.6 8.2 10.1 2.1 3.2 14.3 18.9 2.5 9.9 6.4 16.9 5.8 5.3 11.1 15.0 9.3 41.8 1.6 1.5 8.3 11.8 5.8 3.3 8.7 3.2 7.8 17.3 32.8 3.5 10.0 11.8 16.7 33.4 5.1 16.9 3.1 9.6 42.0 12.7 17.0 20.4 76.1 34.4 24.9 20.5 53.5 5.7 28.5 14.9 7.3 32.4 8.7 8.0 1.5 6.2 14.1 15.8 8.5 6.9 10.9 4.5 0.0 0.2 5.8 2.0 0.3 1.9 0.3 0.4 1.8 0.0 0.0 0.1 1.1 0.0 0.0 2.4 0.3 2.3 0.6 13.4 11.4 36.1 17.7 11.4 15.1 16.1 17.9 10.8 19.1 14.8 15.7 16.9 199.0 0.0 8.4 15.7 3.1 2.5 5.4 42.1 14.8 48.3 32.0 30.1 21.1 0.0 28.8 18.4 45.9 4.4 13.9 21.7 0.0 0.6 11.8 13.9 21.0 83.3 7.8 5.9 26.2 1.2 1.1 16.2 55.5 26.2 9.5 6.1 0.0 0.0 1.7 3.3 55.9 8.6 38.7 0.0 4.4 19.9 1.2 8.4 5.4 60.9 0.9 33.5 3.1 22.1 7.1 1.4 1.5 7.9 10.1 7.2 4.5 4.2 26.7 42.8 0.0 13.3 18.0 35.9 31.7 8.0 1.8 1.4 15.7 19.2 6.6 5.0 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 599.6" "Cell type enhanced" "Detected in many" "Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 57 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 57 "dendritic cells: 5.6" "Cell line enhanced" "Detected in many" "A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA011909 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.5 4.3 0.6 53.7 0.8 0.0 6.3 1.8 1.1 78.9 1.3 528.2 25.6 17.9 35.0 5.6 123.5 29.2 0.8 0.6 0.7 242.5 3.9 32.4 0.5 1.3 0.8 0.6 0.4 3.1 72.5 17.5 1.1 1.1 196.4 599.6 0.0 101.8 66.5 0.8 2.4 97.5 21.0 1.2 0.7 215.0 27.5 0.8 2.0 123.1 0.1 5.0 105.9 9.9 1.9 129.6 2.0 0.0 0.0 0.2 0.0 1.8 0.1 2.7 0.1 0.0 0.0 216.7 0.0 40.2 0.3 0.2 151.4 0.0 111.2 0.1 0.0 0.0 0.0 1.1 7.6 0.0 0.0 0.2 0.0 173.6 0.7 60.9 3.6 0.3 1.3 0.0 0.0 1.6 4.9 0.0 0.5 0.1 257.9 8.1 0.1 0.1 1.6 628.4 308.2 1.9 0.0 0.3 13.0 0.5 0.5 9.0 0.1 1.4 0.0 0.7 0.4 0.7 1.5 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.6 0.8 1.8 1.1 0.6 0.7 1.3 0.8 0.6 1.1 1.2 0.8 1.9 2.5 25.6 29.5 0.3 7.4 1.0 194.4 499.9 4.0 0.0 14.5 11.0 0.7 11.5 723.5 579.4 0.0 0.3 0.2 1983.8 46.9 61.3 141.3 268.3 14.1 4.5 201.8 0.0 1.2 525.1 0.1 6.0 223.3 144.3 11.4 0.0 1.4 3.6 0.3 0.0 1.3 648.1 242.1 0.3 0.3 838.1 5.0 5.3 5.4 1.0 1.6 0.0 0.0 0.5 1.6 484.4 1127.7 1.9 0.7 211.7 505.4 477.8 1817.6 0.0 0.0 0.4 54.1 4.7 2.6 2.9 1.3 0.0 7.4 0.0 275.9 517.0 BLZF1 JEM-1 ENSG00000117475 "Basic leucine zipper nuclear factor 1" Q9H2G9 1 169367970-169396540 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 85.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025703, HPA027331, HPA067113" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781" "unprognostic (5.25e-2)" "unprognostic (9.03e-2)" "unprognostic (9.31e-3)" "unprognostic (1.48e-2)" "unprognostic (4.66e-1)" "unprognostic (4.00e-1)" "unprognostic (2.34e-2)" "unprognostic (4.52e-3)" "unprognostic (1.07e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-3)" "unprognostic (4.86e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (3.28e-1)" "unprognostic (3.06e-2)" "unprognostic (7.53e-2)" "unprognostic (2.18e-1)" 15.0 13.2 9.2 12.6 11.4 25.8 19.6 12.2 10.9 14.8 10.5 14.0 12.4 15.7 14.5 32.7 11.4 16.5 16.1 9.7 12.1 17.2 15.0 13.1 11.9 10.5 10.5 9.5 14.6 9.5 15.2 8.8 18.4 10.3 15.7 15.7 23.0 12.8 16.1 11.4 18.2 12.8 18.0 10.1 12.6 13.2 35.3 10.0 13.9 18.9 11.1 16.4 16.7 14.9 15.2 52.8 16.6 16.5 13.6 24.9 37.6 26.2 46.6 32.0 48.1 52.5 19.5 33.3 7.5 26.8 31.6 30.7 38.6 16.6 30.3 37.4 16.8 16.1 13.7 20.0 13.6 26.4 27.2 18.9 27.6 36.9 35.8 31.7 27.3 25.1 14.9 25.6 20.0 46.0 10.8 12.1 12.7 19.9 38.2 25.2 6.8 26.0 16.6 48.1 17.5 9.3 30.6 30.3 41.3 36.9 28.3 44.8 20.4 30.5 28.9 22.5 26.7 39.6 20.4 26.1 19.5 22.1 11.7 44.6 85.6 12.2 51.5 12.2 16.2 16.0 11.3 15.0 14.1 10.8 10.4 13.2 14.4 25.1 19.8 15.8 8.2 23.9 10.9 9.2 11.4 12.2 10.9 9.7 12.1 10.5 10.5 9.5 10.3 10.1 10.0 15.2 14.7 22.4 16.4 34.9 11.7 18.4 46.7 22.6 16.5 14.3 18.0 12.1 29.6 11.5 24.4 11.0 14.6 18.3 15.2 18.2 23.5 24.2 131.4 28.0 18.6 11.9 12.6 16.0 30.2 13.2 17.3 18.7 22.4 28.5 26.0 12.3 12.5 4.8 14.3 33.7 32.8 11.7 14.2 10.7 6.8 72.8 14.6 11.6 14.2 17.8 10.3 21.2 17.5 30.2 57.8 36.7 11.6 17.7 13.9 17.0 15.4 22.4 31.6 27.9 0.0 23.0 21.7 84.9 25.8 16.7 15.6 20.1 18.8 17.1 11.6 65.3 CCDC181 "C1orf114, FLJ25846" ENSG00000117477 "Coiled-coil domain containing 181" Q5TID7 1 169394870-169460669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 41.9;testis: 27.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 66.1;Cone photoreceptor cells: 66.7;Early spermatids: 289.9;Late spermatids: 69.3;Respiratory ciliated cells: 109.6;Rod photoreceptor cells: 89.4;Spermatocytes: 201.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 7.1;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.4;SH-SY5Y: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027189, HPA027275, HPA027281, HPA027312" Enhanced Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349" "unprognostic (2.45e-1)" "unprognostic (2.20e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-3)" "unprognostic (3.00e-1)" "unprognostic (5.97e-2)" "unprognostic (6.87e-2)" "unprognostic (2.15e-3)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (4.89e-4)" "unprognostic (4.03e-2)" "unprognostic (3.06e-2)" "unprognostic (1.18e-2)" "unprognostic (8.41e-2)" 0.4 2.5 8.8 0.5 8.3 0.5 0.4 8.6 12.0 2.4 12.8 0.6 0.2 3.6 1.9 0.4 12.4 3.6 1.8 8.0 10.7 6.3 0.1 1.8 0.2 8.5 8.8 6.9 6.3 3.8 12.2 18.3 0.1 7.5 2.0 0.2 41.9 0.4 2.0 0.2 0.6 0.4 2.0 8.1 0.1 1.6 27.9 8.1 0.4 0.5 0.3 0.1 1.2 1.0 7.3 0.2 0.3 7.1 0.1 0.2 0.2 0.2 0.1 0.0 1.8 3.7 0.1 0.2 0.1 0.1 0.0 7.4 0.1 0.3 0.0 0.3 0.2 1.6 1.8 0.2 0.0 0.0 2.0 0.1 0.7 0.0 0.4 0.0 0.1 0.1 5.7 0.1 0.1 1.3 0.1 4.5 0.0 13.8 0.1 0.0 0.0 5.9 0.1 1.1 0.0 8.4 9.9 0.0 0.3 0.5 3.7 0.0 0.0 0.5 1.4 4.4 0.2 6.4 2.1 2.0 0.0 2.8 0.1 5.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 8.3 8.6 12.0 8.0 10.7 8.5 8.8 6.9 7.5 8.1 8.1 7.3 0.2 3.2 4.7 6.8 0.0 0.0 0.2 2.7 0.6 66.1 0.8 0.4 6.3 0.0 22.5 9.2 66.7 0.0 0.2 0.1 15.6 1.2 289.9 47.0 1.9 1.5 19.2 2.1 16.2 1.6 0.0 3.1 0.0 1.7 1.3 4.5 0.7 0.0 0.1 25.2 13.1 0.0 6.1 0.0 0.0 69.3 3.1 0.5 0.0 5.6 0.0 23.5 0.0 8.5 3.9 0.7 0.0 10.5 0.0 0.1 0.0 16.2 109.6 89.4 6.6 13.1 3.4 201.8 41.1 0.4 0.0 0.1 0.4 4.0 0.0 0.5 SLC19A2 "THTR1, TRMA" ENSG00000117479 "Solute carrier family 19 member 2" O60779 1 169463909-169485944 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.1;tongue: 85.7" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 84.5;Syncytiotrophoblasts: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006119, HPA016599" Uncertain Approved Cytosol NA NA Cytosol "HPA006119: AB_1079996, HPA016599: AB_1857005" "prognostic favorable (8.41e-4)" "unprognostic (8.82e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-3)" "prognostic favorable (2.90e-4)" "unprognostic (4.45e-2)" "unprognostic (9.69e-2)" "unprognostic (1.45e-1)" "unprognostic (2.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (3.60e-2)" "unprognostic (2.14e-2)" 36.3 17.9 3.6 8.3 3.7 8.7 21.1 5.7 5.9 9.4 8.5 11.3 3.5 8.7 6.2 11.4 21.5 26.0 27.8 4.5 17.5 13.1 37.4 19.7 2.6 5.5 4.3 3.6 20.7 22.4 25.1 19.2 18.2 4.8 10.5 4.3 7.6 12.6 3.9 125.1 15.5 11.5 6.1 4.6 2.8 19.4 7.8 5.2 4.1 15.8 85.7 2.8 18.3 13.0 4.5 7.4 5.1 11.4 9.0 34.4 12.7 25.0 5.8 4.3 4.6 6.5 20.9 7.6 6.5 6.4 3.9 8.5 7.7 13.9 8.5 5.1 18.8 13.0 6.2 16.7 19.3 18.7 15.8 5.9 15.0 12.2 7.4 18.8 6.4 7.0 11.3 25.3 4.1 7.9 5.0 8.2 7.1 25.8 14.1 7.7 0.0 24.6 7.5 12.2 15.5 9.9 13.3 8.0 13.6 29.2 12.8 8.5 10.1 5.8 5.5 7.7 6.9 11.4 5.6 5.6 2.1 8.1 6.0 7.4 0.0 0.6 1.1 0.3 0.2 1.1 0.4 0.4 0.7 0.7 0.4 1.0 1.0 0.4 0.9 2.0 0.2 0.3 0.2 3.6 3.7 5.7 5.9 4.5 17.5 5.5 4.3 3.6 4.8 4.6 5.2 4.5 13.6 9.6 19.3 11.8 7.3 29.6 16.5 4.4 43.9 5.3 34.1 13.6 27.7 7.2 11.4 5.5 2.1 26.9 11.3 10.6 0.0 7.4 4.3 22.6 9.7 3.7 9.0 5.2 15.6 5.3 4.5 52.7 49.5 42.7 10.2 4.1 1.1 29.8 7.0 6.7 22.8 6.4 12.2 2.9 8.8 2.7 6.8 18.3 21.4 7.5 1.0 2.5 2.1 16.1 3.3 9.6 5.4 4.9 14.0 16.5 5.6 2.0 12.7 5.1 0.0 84.5 14.2 6.7 4.1 35.2 50.4 156.4 7.5 3.1 6.7 28.9 FAAH FAAH-1 ENSG00000117480 "Fatty acid amide hydrolase" O00519 1 46394317-46413848 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 128.5;Proximal enterocytes: 87.4;Spermatocytes: 89.0" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 29.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 37.5;OE19: 18.8;RT4: 42.4;SK-BR-3: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007425 Approved Approved Cytosol NA NA Cytosol "HPA007425: AB_1078820" "unprognostic (6.12e-2)" "unprognostic (2.04e-1)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (2.00e-1)" "unprognostic (6.64e-3)" "unprognostic (2.91e-2)" "unprognostic (2.33e-1)" "unprognostic (4.39e-3)" "unprognostic (9.86e-2)" "prognostic favorable (4.25e-5)" "prognostic favorable (3.63e-5)" "unprognostic (2.66e-1)" "unprognostic (9.97e-2)" "unprognostic (5.00e-3)" 7.6 14.3 20.9 3.0 28.1 10.5 9.6 24.6 27.0 7.6 26.0 18.5 22.2 3.9 9.2 8.7 12.1 5.2 3.8 24.0 25.5 20.0 33.0 7.8 2.5 31.7 26.3 22.9 3.9 22.6 24.8 19.2 3.4 29.8 44.5 15.3 5.6 17.6 7.2 9.6 12.2 22.2 2.3 27.3 3.3 17.2 47.1 25.7 7.2 38.9 5.7 2.7 7.0 8.2 45.8 5.0 1.2 0.8 1.0 1.2 0.8 37.5 1.0 0.5 0.5 0.8 7.3 11.4 0.3 3.9 0.7 0.4 16.2 0.7 2.3 0.2 2.2 5.4 0.1 0.2 3.5 0.8 1.4 2.8 0.6 10.7 0.4 1.3 0.4 0.0 0.9 0.1 0.8 0.0 10.7 0.8 2.2 3.2 18.8 0.4 0.9 0.4 0.2 9.0 42.4 4.8 3.6 5.6 21.2 0.2 0.9 14.6 14.5 0.0 0.1 0.6 1.1 0.7 2.1 1.0 0.6 0.1 13.4 0.4 0.0 6.9 29.1 0.4 1.9 0.2 0.1 0.4 0.2 8.2 0.1 0.6 0.6 0.4 0.5 1.0 8.8 0.2 1.4 20.9 28.1 24.6 27.0 24.0 25.5 31.7 26.3 22.9 29.8 27.3 25.7 45.8 1.2 22.4 13.2 6.5 2.4 5.2 29.0 6.8 10.2 15.5 15.4 9.0 2.9 27.1 11.0 22.0 43.8 16.3 7.3 51.6 0.0 12.4 50.7 9.5 1.9 1.8 15.5 6.6 15.7 6.4 8.7 3.7 37.8 6.0 0.0 6.3 0.4 37.1 2.8 1.7 11.4 38.2 10.2 2.5 4.2 128.5 7.5 3.3 5.4 1.9 2.5 7.3 0.0 7.5 45.1 4.2 41.3 4.5 0.7 20.1 87.4 22.6 5.2 14.5 0.0 2.9 3.2 89.0 23.0 6.4 6.0 12.4 1.2 1.3 55.2 18.9 NSUN4 "MGC22960, SHTAP" ENSG00000117481 "NOP2/Sun RNA methyltransferase 4" Q96CB9 1 46340177-46365152 "Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 15 "testis: 89.7" "Group enriched" "Detected in many" 11 "Early spermatids: 144.5;Late spermatids: 513.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA028489 Approved NA NA "HPA028489: AB_10601444" "unprognostic (3.28e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-2)" "unprognostic (5.53e-2)" "prognostic favorable (8.99e-4)" "unprognostic (2.02e-2)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.50e-2)" "unprognostic (1.34e-2)" "unprognostic (6.79e-2)" "unprognostic (1.22e-1)" "unprognostic (2.19e-1)" "unprognostic (1.22e-3)" "unprognostic (2.65e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-3)" "unprognostic (2.28e-1)" 3.2 5.3 0.4 2.8 0.7 6.0 3.1 1.2 1.5 2.7 1.2 2.6 2.8 2.7 1.3 4.0 2.6 3.6 3.9 0.5 1.8 3.7 4.5 3.0 2.8 1.3 0.6 0.4 3.6 3.1 3.3 3.7 3.5 1.5 3.7 3.0 2.3 3.6 2.3 3.7 3.2 2.7 3.1 0.3 3.5 2.7 89.7 0.7 3.1 3.4 3.7 4.0 4.5 3.2 1.7 4.1 8.5 6.4 7.6 7.6 5.6 9.2 4.2 5.3 8.5 9.2 10.2 3.6 10.4 11.4 6.3 11.9 6.1 5.7 9.3 6.4 12.4 9.8 10.2 9.4 13.9 8.9 7.9 7.5 7.5 9.4 11.8 13.1 3.4 9.5 8.1 15.9 10.7 8.8 12.8 6.8 4.3 7.6 6.0 3.9 9.3 4.2 14.0 14.7 13.4 9.7 3.4 6.7 8.3 8.6 6.4 5.4 9.9 7.2 5.7 6.2 4.2 5.1 5.9 5.5 9.1 3.2 9.9 6.6 2.3 7.6 8.3 3.4 5.1 4.7 7.8 3.6 4.4 7.1 5.9 4.2 3.0 20.5 4.4 4.0 8.7 2.0 3.7 0.4 0.7 1.2 1.5 0.5 1.8 1.3 0.6 0.4 1.5 0.3 0.7 1.7 8.1 19.2 17.5 10.4 13.7 5.6 13.0 8.1 13.6 9.1 9.5 8.1 14.6 17.2 12.4 9.2 8.4 11.1 11.5 5.4 1.9 9.1 144.5 10.4 9.4 13.3 7.8 17.7 13.8 6.9 11.3 9.4 14.8 12.4 29.8 9.4 8.9 12.6 9.3 5.0 14.7 9.0 4.1 13.1 8.6 513.8 12.5 14.1 3.6 8.4 9.2 5.7 4.1 11.1 12.5 9.0 5.8 10.9 12.5 16.0 5.7 11.8 8.4 11.5 0.0 11.0 9.2 7.6 11.4 13.1 5.8 15.2 8.8 11.3 9.0 15.2 TMED5 "CGI-100, p24g2, p24gamma2" ENSG00000117500 "Transmembrane p24 trafficking protein 5" Q9Y3A6 1 93149742-93180516 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050289 Approved NA NA "HPA050289: AB_2681074" "unprognostic (3.35e-1)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (4.38e-1)" "unprognostic (3.16e-1)" "unprognostic (4.86e-2)" "unprognostic (2.83e-3)" "unprognostic (6.37e-2)" "unprognostic (8.60e-2)" "unprognostic (3.72e-2)" "unprognostic (1.64e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (6.01e-2)" "unprognostic (1.86e-1)" "unprognostic (4.46e-2)" "unprognostic (1.38e-1)" 19.3 18.7 5.0 18.9 6.3 31.3 9.3 7.3 6.7 9.6 13.9 15.4 16.8 6.7 13.0 9.3 6.1 15.4 12.0 5.2 11.4 27.9 52.4 18.7 16.1 8.2 7.4 4.1 6.8 14.3 11.7 5.5 16.7 8.0 11.2 13.9 5.0 13.6 8.0 20.0 4.5 15.6 8.6 8.6 13.7 14.9 8.2 8.2 10.3 16.4 18.9 13.7 18.5 6.2 9.6 46.5 19.4 21.0 21.4 60.4 36.2 46.5 36.2 35.5 28.4 41.9 33.1 35.5 22.5 36.1 31.2 60.5 24.6 24.3 22.0 32.2 25.7 30.5 21.0 19.9 34.9 36.0 24.8 30.7 43.0 31.9 44.3 40.3 32.5 34.4 18.1 35.6 62.3 28.0 7.5 27.4 19.4 13.9 25.1 26.1 20.6 35.8 36.5 36.2 25.9 12.3 14.1 43.6 39.4 41.0 17.4 18.6 20.9 34.4 30.1 29.6 38.4 37.6 42.5 57.8 27.4 20.1 23.3 13.6 56.7 32.4 45.4 22.0 32.6 26.4 24.2 22.5 25.9 26.6 17.9 16.9 20.0 15.8 16.2 36.0 18.2 27.7 28.9 5.0 6.3 7.3 6.7 5.2 11.4 8.2 7.4 4.1 8.0 8.6 8.2 9.6 39.0 73.7 45.9 21.2 66.6 71.8 81.7 39.3 55.2 5.8 33.2 22.9 42.3 34.3 37.7 58.8 20.9 36.1 61.1 52.5 11.7 34.3 97.8 32.5 33.2 33.1 20.4 20.4 16.6 40.8 87.3 59.4 50.4 52.3 40.5 18.9 18.9 116.1 68.1 8.4 19.2 32.9 26.4 74.9 91.7 143.6 23.6 78.6 33.8 22.5 57.9 13.2 46.4 32.2 42.0 37.2 48.8 16.1 163.4 101.9 53.6 66.2 29.2 8.5 59.2 52.1 49.1 32.1 15.0 53.7 64.8 85.4 64.5 19.7 35.5 115.8 MROH9 "ARMC11, C1orf129, FLJ23550" ENSG00000117501 "Maestro heat like repeat family member 9" Q5TGP6 1 170935471-171064765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;fallopian tube: 2.5;testis: 1.6" "Cell type enhanced" "Detected in some" "Early spermatids: 11.0;Endometrial ciliated cells: 20.7;Oligodendrocyte precursor cells: 56.8;Respiratory ciliated cells: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" "unprognostic (1.04e-1)" "unprognostic (7.94e-3)" "unprognostic (3.67e-2)" "unprognostic (9.73e-2)" "unprognostic (7.62e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (8.07e-5)" "unprognostic (3.66e-8)" "unprognostic (5.96e-2)" 0.0 0.0 0.9 0.0 0.7 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.4 0.8 0.0 0.0 0.8 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.7 0.5 0.4 0.4 0.8 1.3 0.6 0.0 1.0 0.9 0.9 0.9 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 20.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 3.8 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.3 3.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DR1 "NC2-BETA, NC2B, NCB2" ENSG00000117505 "Down-regulator of transcription 1" Q01658 1 93345907-93369493 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050785, HPA055308" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050785: AB_2681237, HPA055308: AB_2682779" "unprognostic (1.46e-1)" "unprognostic (9.62e-2)" "prognostic favorable (4.79e-4)" "unprognostic (1.03e-2)" "unprognostic (2.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.95e-7)" "unprognostic (8.70e-2)" "unprognostic (6.71e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.97e-1)" "unprognostic (1.60e-1)" 22.0 19.0 9.6 29.1 9.2 59.7 17.0 12.3 9.2 16.7 20.8 18.3 27.5 21.2 11.2 30.2 14.3 23.3 27.2 8.3 9.6 22.0 20.5 19.8 43.7 9.1 9.9 6.6 16.1 18.9 17.1 12.2 32.3 9.1 17.3 16.5 14.2 19.7 14.1 50.9 28.0 22.6 19.3 10.5 27.2 30.4 56.2 10.6 48.1 18.9 43.3 31.1 27.5 22.8 10.3 97.1 29.8 46.8 60.6 42.3 47.9 57.5 76.5 46.6 50.9 54.0 34.9 34.1 101.9 86.4 56.7 69.3 50.1 56.7 53.0 74.6 86.4 53.0 85.8 58.7 38.4 67.3 102.1 60.6 33.7 62.4 71.2 102.2 53.1 45.9 60.0 90.0 95.7 61.0 29.8 97.6 32.1 78.1 33.4 72.1 83.5 103.2 104.0 36.3 58.0 45.3 57.6 65.1 59.7 80.6 42.2 42.2 79.4 72.1 91.5 73.0 90.7 116.0 54.9 65.6 105.5 26.3 80.3 38.2 95.2 46.2 82.1 35.3 52.7 39.2 36.9 38.8 40.4 55.9 31.5 38.6 37.8 62.8 35.5 47.4 45.4 57.1 41.3 9.6 9.2 12.3 9.2 8.3 9.6 9.1 9.9 6.6 9.1 10.5 10.6 10.3 36.2 28.9 22.1 10.1 43.5 171.3 38.0 38.7 47.3 32.0 29.1 24.1 33.9 22.8 27.9 36.8 25.0 74.5 84.6 42.8 45.0 31.4 183.1 18.4 33.7 37.5 20.8 59.3 8.4 27.7 73.6 34.3 38.2 24.2 48.9 19.7 29.3 27.6 53.0 50.5 8.7 42.6 10.2 50.8 82.8 106.2 28.3 55.2 44.4 15.0 68.0 16.0 69.0 7.5 10.8 52.9 25.9 26.4 31.9 51.6 29.8 40.7 17.6 25.3 32.9 27.7 42.0 163.2 41.2 69.4 160.5 109.9 59.8 26.2 26.9 79.2 CNN3 ENSG00000117519 "Calponin 3" Q15417 1 94896949-94927223 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 315.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 10.5;naive CD4 T-cell: 11.6" "Group enriched" "Detected in many" 12 "B-cells: 10.5;T-cells: 11.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009849, HPA051237" Enhanced Enhanced "Actin filaments,Cytosol" NA NA 660000 "Actin filaments" Cytosol "CAB009849: AB_2276410, HPA051237: AB_2681399" "unprognostic (8.47e-2)" "unprognostic (5.19e-2)" "unprognostic (5.22e-2)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-2)" "unprognostic (8.87e-2)" "unprognostic (5.20e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-3)" "unprognostic (2.33e-2)" "unprognostic (8.71e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.99e-4)" 164.4 257.7 158.3 79.6 154.6 2.1 161.4 160.1 187.9 148.9 153.2 124.9 137.1 215.8 71.6 151.1 148.4 153.7 107.2 157.0 249.9 195.6 144.9 210.8 51.8 206.3 166.0 140.0 154.3 84.0 53.5 102.5 258.1 184.6 127.2 83.6 126.1 126.5 135.0 26.5 60.6 100.8 197.7 180.7 94.9 112.7 50.6 179.1 55.6 126.1 53.0 44.7 158.0 167.6 181.3 416.6 77.9 429.0 380.1 286.0 264.2 191.7 197.2 381.3 319.4 511.2 348.7 35.6 0.1 436.6 243.4 315.7 116.2 307.2 169.9 428.1 1.6 113.0 18.8 47.5 256.2 545.0 0.2 0.8 246.2 25.5 394.1 89.4 539.6 282.8 26.7 4.1 35.3 798.9 0.2 19.8 0.9 333.6 0.3 43.3 0.6 524.2 1.8 392.9 156.6 26.3 264.2 163.0 65.0 272.8 301.7 124.8 38.5 182.4 212.2 364.9 80.2 647.0 43.9 27.2 1.5 46.0 0.6 327.1 0.2 0.0 0.0 2.2 0.1 3.4 4.6 2.1 1.2 0.1 10.5 11.6 8.3 0.4 0.9 0.1 0.0 0.0 2.6 158.3 154.6 160.1 187.9 157.0 249.9 206.3 166.0 140.0 184.6 180.7 179.1 181.3 183.5 150.6 80.7 82.9 18.1 78.3 435.7 232.3 48.9 11.9 122.2 64.1 42.2 88.6 156.2 126.9 20.9 236.1 3.2 36.0 436.3 275.1 156.1 77.4 151.1 278.3 72.4 20.0 12.9 240.7 40.9 287.8 33.1 104.9 14.0 164.4 373.0 152.1 22.6 1.7 16.9 58.7 429.3 20.1 56.3 150.7 274.6 9.3 197.5 29.0 4.7 394.6 0.0 62.4 22.7 130.8 53.2 382.1 2.6 319.1 117.9 518.5 95.1 14.4 263.0 399.8 374.9 10.8 34.7 91.4 77.7 205.8 14.9 214.5 131.0 327.4 PRRC2C "BAT2D1, BAT2L2, KIAA1096, XTP2" ENSG00000117523 "Proline rich coiled-coil 2C" Q9Y520 1 171485551-171593511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025766, HPA028659" Approved Enhanced Cytosol NA NA Cytosol "HPA025766: AB_1845277, HPA028659: AB_10600786" "unprognostic (4.16e-1)" "unprognostic (2.40e-2)" "unprognostic (6.66e-3)" "unprognostic (8.71e-2)" "unprognostic (6.07e-3)" "unprognostic (1.85e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (7.76e-6)" "unprognostic (7.03e-2)" "unprognostic (2.62e-1)" "unprognostic (1.82e-1)" "unprognostic (4.34e-2)" 31.1 21.2 29.3 33.6 26.1 73.1 33.1 34.5 35.2 32.5 23.4 27.2 21.8 30.4 37.9 37.0 29.9 26.4 22.5 25.4 26.0 24.9 31.4 36.1 45.1 30.6 27.2 24.8 34.6 29.1 34.1 25.9 34.5 29.8 28.5 32.3 34.8 30.5 27.3 25.9 40.1 34.3 25.6 22.3 36.3 29.2 29.5 26.9 50.0 28.0 24.0 43.8 38.9 34.7 33.1 84.9 64.3 88.1 58.4 61.0 70.5 65.2 47.8 67.7 54.8 49.7 99.1 59.0 123.9 73.1 70.4 44.3 73.8 96.5 76.1 83.8 70.1 51.4 94.2 51.2 69.5 63.3 154.4 73.8 68.6 57.1 92.7 137.3 49.3 80.9 66.6 126.8 66.6 63.0 40.3 92.8 65.2 116.8 67.5 110.5 69.3 65.5 60.7 77.8 93.3 56.7 58.3 72.6 85.4 56.0 115.8 58.2 107.0 101.6 61.9 57.0 60.7 100.4 55.5 63.4 175.3 39.4 74.7 56.7 2.2 1.3 0.7 1.3 1.2 1.3 1.7 1.2 1.2 0.6 2.0 1.1 1.3 3.4 2.5 1.4 2.0 1.0 0.6 29.3 26.1 34.5 35.2 25.4 26.0 30.6 27.2 24.8 29.8 22.3 26.9 33.1 233.8 298.1 224.7 81.0 272.5 167.0 270.8 107.5 198.6 164.6 105.4 104.6 115.7 133.0 198.3 86.5 139.7 204.0 325.0 190.0 25.4 174.0 63.9 228.0 246.7 214.5 165.1 139.0 101.5 151.3 210.1 189.1 157.0 378.3 263.2 132.8 130.3 119.0 128.9 138.0 108.6 162.3 57.0 142.8 183.0 36.5 139.1 211.0 96.0 91.8 227.9 120.4 269.8 87.9 143.2 223.1 145.2 96.3 281.8 294.3 99.6 40.1 132.1 170.4 78.9 218.1 184.2 247.7 160.8 178.0 145.9 476.8 317.3 178.5 168.5 335.5 F3 "CD142, TF" ENSG00000117525 "Coagulation factor III, tissue factor" P13726 1 94529173-94541759 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Blood coagulation, Hemostasis" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009438, HPA049292, HPA069132" Uncertain Approved Vesicles "Secreted to blood" NA NA 603000 Vesicles "CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (8.04e-2)" "unprognostic (1.64e-1)" "unprognostic (2.69e-2)" "unprognostic (1.23e-3)" "unprognostic (4.93e-2)" "unprognostic (8.00e-2)" "unprognostic (5.88e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.02e-8)" "unprognostic (4.84e-2)" "unprognostic (4.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" 98.9 21.4 57.9 29.0 68.2 4.1 70.7 58.8 75.0 38.5 50.6 38.4 37.2 61.7 44.6 41.7 90.6 60.1 37.1 58.9 113.7 17.6 5.1 60.3 13.0 82.3 63.1 56.4 115.7 97.3 17.3 81.8 134.5 59.9 57.3 42.5 73.2 94.1 61.0 7.7 51.3 47.7 10.8 63.0 7.3 43.0 34.8 60.6 5.7 63.1 9.9 15.1 66.1 73.7 59.3 1062.0 1.8 2.2 0.5 108.0 53.1 57.2 147.0 87.6 155.4 167.9 18.6 220.6 0.0 73.3 183.5 33.4 490.7 13.2 1270.5 254.4 0.9 1.6 0.0 35.0 3.3 35.9 0.7 0.6 91.9 28.2 73.8 356.5 293.7 1.1 1.1 0.9 0.8 110.0 1.8 1.5 22.3 9.8 6.8 2.2 1.2 10.3 0.5 19.8 3.2 1.3 2.6 117.4 48.3 3.6 29.6 1.3 13.9 0.3 93.7 2.5 473.0 44.6 0.9 1.3 0.9 71.9 5.7 3.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 57.9 68.2 58.8 75.0 58.9 113.7 82.3 63.1 56.4 59.9 63.0 60.6 59.3 9.4 131.4 243.3 196.6 0.7 16.3 902.0 359.6 2.2 3.6 29.6 20.4 26.4 18.6 380.3 14.7 0.0 16.5 0.6 20.9 0.0 133.5 8.6 61.3 125.0 13.2 13.1 0.0 0.4 464.1 6.0 125.3 23.0 123.0 2.5 38.1 7.5 0.4 6.1 3.3 4.6 70.3 65.1 2.8 5.2 14.5 281.1 9.1 3.6 45.9 2.1 340.6 0.0 15.6 1.2 1755.7 15.5 530.7 1.2 121.6 10.1 0.4 92.0 16.1 6.6 39.3 76.7 1.7 4.4 6.4 7.5 7.7 7.3 7.9 14.3 497.9 ABCD3 "PMP70, PXMP1, ZWS2" ENSG00000117528 "ATP binding cassette subfamily D member 3" P28288 1 94418389-94518666 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 127.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032026, HPA032027, CAB032516, CAB075749" Enhanced Enhanced Peroxisomes NA NA 12000 Peroxisomes "CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103" "unprognostic (1.41e-2)" "unprognostic (3.21e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.56e-1)" "unprognostic (1.94e-2)" "unprognostic (2.54e-2)" "unprognostic (5.10e-2)" "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (9.12e-2)" "prognostic favorable (4.84e-5)" "unprognostic (5.45e-2)" "unprognostic (6.20e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" 17.0 18.8 21.4 16.3 24.3 25.3 33.2 24.5 24.5 22.6 22.8 45.0 44.9 14.8 21.4 26.9 16.9 27.0 25.6 20.2 27.7 60.0 127.7 23.5 13.4 25.1 23.5 18.6 10.2 28.9 29.9 13.4 14.6 24.2 21.7 40.6 26.6 17.7 27.3 23.8 35.8 46.5 17.9 26.1 11.1 43.9 16.5 23.3 48.0 27.8 30.1 21.4 23.1 16.3 29.5 81.5 37.6 37.8 36.1 28.3 31.0 55.8 41.4 32.0 46.8 51.5 117.5 25.0 49.8 52.1 52.8 50.0 58.2 43.7 53.7 64.9 40.1 36.9 56.7 52.3 102.5 27.5 51.2 17.0 26.2 29.6 54.2 20.8 30.2 29.0 47.0 25.8 29.2 48.6 11.4 86.4 26.8 43.7 61.7 50.7 48.0 78.4 19.4 45.6 122.2 28.5 46.7 71.5 75.2 55.7 28.4 27.7 41.8 28.9 34.5 49.5 61.3 55.9 16.5 16.5 48.4 27.1 25.6 16.4 0.4 3.8 2.9 4.2 4.3 4.0 1.8 3.8 4.9 5.9 1.8 4.5 4.4 0.9 5.9 3.8 1.5 4.6 3.3 21.4 24.3 24.5 24.5 20.2 27.7 25.1 23.5 18.6 24.2 26.1 23.3 29.5 16.9 35.3 48.8 64.3 10.2 23.3 16.2 32.8 14.8 27.5 43.7 21.1 39.1 58.6 43.2 42.3 22.9 25.0 12.3 72.1 23.5 22.8 9.0 37.5 16.8 16.4 39.7 8.4 32.7 44.5 12.0 18.3 37.8 30.6 27.9 19.1 18.2 108.9 11.0 33.7 47.5 37.5 26.4 21.9 7.4 8.2 13.7 15.0 16.0 40.3 15.1 78.4 11.3 67.3 96.5 37.5 33.0 24.5 15.4 20.4 75.7 72.3 49.8 26.3 19.7 19.0 17.7 14.5 23.2 21.0 34.0 15.3 15.4 16.7 39.5 32.5 VAMP4 ENSG00000117533 "Vesicle associated membrane protein 4" O75379 1 171700160-171742074 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050418 Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050418: AB_2681121" "unprognostic (9.38e-2)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.66e-2)" "unprognostic (6.97e-2)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (5.10e-2)" "unprognostic (3.14e-2)" "unprognostic (2.87e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (5.43e-6)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (1.15e-1)" 11.0 12.2 12.9 8.7 13.5 5.2 8.9 15.5 14.0 8.4 9.8 7.6 7.9 8.6 7.5 8.4 7.8 8.1 7.8 13.0 15.3 8.1 8.3 10.4 11.0 14.5 15.6 11.5 7.1 10.0 12.8 15.3 10.2 14.9 7.4 7.2 10.1 10.6 7.1 6.3 10.0 8.2 7.5 14.6 10.2 8.6 11.8 14.5 7.2 11.5 6.2 8.5 7.4 8.4 15.9 9.5 3.3 8.1 6.6 12.1 14.0 5.2 16.8 13.7 4.1 5.2 2.6 12.2 6.1 14.9 13.5 6.2 6.2 3.3 5.8 5.9 10.9 5.4 5.0 4.1 2.2 7.3 4.4 4.1 6.9 10.0 5.2 9.6 11.9 7.6 8.1 12.4 7.1 8.9 3.1 10.6 6.2 3.9 18.1 12.9 8.7 6.3 15.6 8.6 3.0 5.1 9.6 8.6 8.8 7.3 8.9 12.0 8.1 8.9 12.7 4.3 18.3 16.2 25.8 23.4 8.4 19.6 3.9 10.4 11.0 8.8 11.9 8.6 7.6 11.9 8.2 11.3 9.9 4.5 6.6 7.8 8.6 3.4 9.5 7.8 6.4 11.3 8.8 12.9 13.5 15.5 14.0 13.0 15.3 14.5 15.6 11.5 14.9 14.6 14.5 15.9 22.3 22.4 9.3 18.3 21.4 15.4 13.8 18.0 26.7 12.3 12.9 9.7 11.6 10.0 14.8 3.7 22.9 10.8 18.2 9.7 15.6 7.5 35.1 7.8 8.4 20.3 10.2 30.9 23.5 7.7 13.4 20.4 6.6 8.9 24.7 8.9 18.2 11.8 14.8 10.1 24.1 12.3 16.2 15.4 12.1 38.6 9.3 20.1 12.4 19.7 17.1 17.0 25.7 18.6 23.0 10.0 14.9 13.2 20.8 19.7 13.4 13.7 11.4 9.4 19.7 15.2 15.0 42.7 20.2 16.1 17.3 13.4 23.1 8.5 7.4 17.5 DPH5 CGI-30 ENSG00000117543 "Diphthamide biosynthesis 5" Q9H2P9 1 100989623-101026088 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046439, HPA076234" Approved Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA046439: AB_2679667, HPA076234: AB_2797274" "unprognostic (1.31e-1)" "unprognostic (3.37e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (3.57e-2)" "unprognostic (8.59e-2)" "unprognostic (8.12e-2)" "unprognostic (1.37e-2)" "unprognostic (2.56e-1)" "unprognostic (1.58e-2)" "unprognostic (2.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.88e-1)" "unprognostic (9.00e-2)" 12.0 23.4 17.8 8.5 18.5 10.8 29.0 17.9 22.7 23.4 18.8 14.8 7.2 17.4 24.0 13.8 26.4 11.7 23.3 17.9 18.9 19.7 25.6 10.2 18.3 18.5 18.3 17.7 50.3 31.6 20.2 15.6 12.4 18.5 15.2 17.7 8.8 12.0 17.2 20.9 15.1 11.3 19.9 18.1 15.6 14.2 9.9 19.0 29.2 20.8 25.2 25.6 14.8 13.4 18.7 28.1 30.1 40.1 37.0 48.3 154.7 34.9 24.9 42.9 41.0 34.5 35.3 7.7 46.0 33.2 22.2 23.1 20.0 47.5 41.1 62.6 20.0 35.8 22.1 26.7 71.4 84.1 33.4 13.8 97.1 63.9 38.8 118.6 67.4 64.8 33.4 62.6 16.7 70.3 26.3 40.7 36.7 31.5 15.2 46.4 37.8 51.1 32.6 50.0 25.7 44.2 22.2 13.7 36.2 114.0 29.6 27.3 18.3 25.1 23.0 28.7 28.8 34.4 20.0 24.1 31.9 31.5 29.6 7.9 5.7 7.5 4.6 16.1 8.9 21.7 19.2 17.9 17.7 13.6 15.1 24.0 20.9 2.7 24.7 10.6 9.8 12.8 10.2 17.8 18.5 17.9 22.7 17.9 18.9 18.5 18.3 17.7 18.5 18.1 19.0 18.7 8.1 6.4 14.6 17.0 30.3 15.8 17.0 24.2 19.9 5.3 18.7 12.3 23.8 21.5 12.7 7.3 0.0 26.2 10.1 4.7 23.5 14.0 1.8 14.2 19.6 11.2 10.2 17.7 12.0 18.4 27.8 13.5 5.6 8.2 25.4 29.0 12.1 29.3 18.9 1.7 14.6 15.0 22.4 28.4 13.1 3.0 27.1 14.0 12.4 8.4 27.7 16.5 27.8 27.2 28.3 8.9 12.9 13.9 10.3 10.8 8.1 30.9 16.8 6.5 6.6 16.6 12.5 15.7 17.6 17.0 18.0 13.0 19.4 33.4 23.7 11.3 FASLG "APT1LG1, CD178, FasL, TNFSF6" ENSG00000117560 "Fas ligand" P48023 1 172659103-172666876 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Apoptosis, Transcription, Transcription regulation" "Cytokine, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.7" "Group enriched" "Detected in some" 14 "dendritic cells: 43.4;NK-cells: 79.3;T-cells: 28.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 58.1" "Group enriched" "Detected in many" 9 "NK-cells: 41.5;T-cells: 58.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054959 Approved "Secreted to blood" NA NA 73600 "HPA054959: AB_2682650" "unprognostic (1.09e-3)" "unprognostic (1.41e-2)" "unprognostic (8.69e-2)" "unprognostic (1.54e-7)" "unprognostic (3.29e-1)" "unprognostic (2.23e-3)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.67e-2)" "unprognostic (4.76e-2)" "unprognostic (8.88e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.59e-6)" "unprognostic (3.49e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.82e-3)" 0.3 0.8 0.1 1.0 0.2 2.9 0.6 0.1 0.4 0.4 0.3 0.8 1.9 0.5 0.7 0.3 0.3 1.1 0.3 0.2 0.1 0.2 1.1 2.0 5.7 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.2 0.3 0.5 0.9 0.0 1.0 0.3 0.1 0.4 1.4 0.3 0.0 4.1 1.5 0.2 0.2 0.6 0.2 0.0 1.8 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.1 0.0 58.1 0.2 35.5 0.0 11.5 31.4 0.1 0.0 2.2 25.0 1.9 41.5 0.1 0.0 0.2 14.9 0.1 0.2 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.4 0.4 0.0 2.5 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 43.4 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.3 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.0 0.0 0.6 1.8 0.0 0.9 0.0 79.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 28.8 0.0 0.0 0.1 PTBP2 "brPTB, nPTB, PTB, PTBLP" ENSG00000117569 "Polypyrimidine tract binding protein 2" Q9UKA9 1 96721665-96823738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 126.2;Inhibitory neurons: 125.8;Oligodendrocyte precursor cells: 203.1;Oligodendrocytes: 625.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RH-30: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047420 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047420: AB_10962353" "unprognostic (2.14e-2)" "unprognostic (3.01e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-2)" "unprognostic (2.41e-5)" "unprognostic (2.26e-3)" "unprognostic (1.50e-2)" "unprognostic (6.83e-3)" "unprognostic (1.70e-2)" "unprognostic (3.31e-2)" "unprognostic (5.48e-3)" "unprognostic (3.01e-2)" "unprognostic (1.75e-1)" "unprognostic (5.24e-2)" "unprognostic (1.27e-2)" 13.0 8.1 22.0 6.1 23.4 15.8 13.6 22.1 26.0 20.3 14.5 25.3 4.2 18.2 5.2 8.0 15.6 5.9 7.5 22.7 23.2 7.8 7.6 8.7 6.1 22.7 24.4 21.6 13.2 7.1 2.4 11.5 4.2 22.2 12.5 6.6 14.8 8.3 9.7 11.4 8.6 13.0 13.2 22.5 11.6 12.3 23.9 24.2 10.6 12.0 9.1 4.9 17.6 14.4 28.1 6.6 3.5 27.2 15.4 6.3 6.8 15.1 5.7 6.5 9.7 9.1 4.3 5.7 22.4 6.6 3.4 22.1 3.9 17.8 4.0 14.1 4.1 5.1 12.6 8.4 5.9 3.8 5.9 6.1 4.6 2.7 12.2 4.6 7.5 4.9 10.9 9.3 5.2 13.0 2.1 21.0 18.0 17.2 2.7 7.9 11.3 72.0 3.2 9.6 3.2 16.7 16.8 7.4 4.4 9.5 13.4 4.5 13.4 4.8 5.8 12.6 5.0 7.5 4.5 4.0 25.7 2.9 9.5 2.8 0.3 0.5 0.3 0.8 0.6 0.7 1.2 1.1 0.8 0.3 1.3 1.3 0.9 0.5 1.4 0.7 0.6 1.1 0.2 22.0 23.4 22.1 26.0 22.7 23.2 22.7 24.4 21.6 22.2 22.5 24.2 28.1 26.1 9.6 13.9 116.2 16.9 13.9 9.6 4.1 14.2 27.4 14.4 13.8 10.9 10.0 6.0 20.2 14.6 5.6 13.9 3.8 13.7 6.8 4.8 11.5 27.9 16.7 24.5 16.2 126.2 5.1 4.2 20.5 10.7 18.3 7.6 21.4 8.2 8.4 3.3 30.3 125.8 6.2 6.1 13.0 13.9 7.1 9.0 8.5 14.2 102.1 7.1 47.6 10.3 203.1 625.1 4.9 3.9 7.9 14.4 7.3 4.5 9.1 8.1 22.6 6.6 15.0 33.1 79.0 35.4 12.1 7.1 2.1 13.7 11.0 5.5 6.3 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183731-173207331 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 8.5;Granulosa cells: 37.0;Macrophages: 26.4;monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 42.0;HHSteC: 17.3;HUVEC TERT2: 81.2;LHCN-M2: 67.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059579 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059579: AB_2684071" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 1.2 2.0 1.2 2.3 1.3 0.7 0.6 1.9 1.6 0.9 0.2 1.0 0.3 0.8 0.5 0.6 0.9 1.1 0.8 1.2 1.0 0.8 1.0 1.2 2.2 1.4 1.3 1.2 1.1 1.1 0.5 1.6 0.5 1.5 1.4 1.2 1.4 0.4 0.6 0.2 0.3 0.8 0.9 0.9 1.7 0.7 4.0 1.1 3.8 0.4 0.2 2.0 1.5 0.8 1.4 0.1 0.0 0.4 1.2 2.7 14.1 0.2 4.1 0.9 0.2 0.3 0.2 0.1 0.2 0.7 42.0 0.2 0.1 0.1 0.1 0.3 0.7 0.1 0.1 0.4 1.6 17.3 0.3 0.2 6.2 0.3 2.1 0.3 1.3 81.2 1.5 0.1 0.5 67.5 0.0 0.7 0.4 0.3 0.1 0.6 2.0 0.1 0.6 0.6 0.1 0.1 0.6 0.3 0.2 0.9 1.3 0.0 0.7 0.6 0.1 0.1 0.4 0.2 0.9 1.4 0.3 0.2 7.7 4.4 0.0 0.1 0.1 0.5 0.0 0.3 0.5 0.2 0.4 0.3 0.5 0.4 0.4 0.7 1.7 0.0 1.2 0.4 2.8 1.2 1.3 1.9 1.6 1.2 1.0 1.4 1.3 1.2 1.5 0.9 1.1 1.4 0.2 0.0 0.5 8.5 0.8 0.8 0.3 0.4 0.6 0.4 0.2 0.0 1.5 1.5 0.1 1.8 0.0 0.2 2.2 0.9 0.0 0.1 5.8 0.2 0.4 1.0 0.0 0.8 3.6 0.0 0.2 3.7 0.0 0.1 0.0 37.0 0.0 1.2 0.5 0.0 5.2 0.0 0.0 0.6 2.3 2.2 0.3 26.4 1.8 0.0 8.2 1.3 2.1 2.5 4.0 0.3 0.1 1.9 0.4 0.4 0.0 0.2 0.8 0.5 0.0 0.6 3.7 0.3 0.2 0.0 0.6 0.0 2.4 0.7 0.1 0.1 PRDX6 "1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX" ENSG00000117592 "Peroxiredoxin 6" P30041 1 173477330-173488815 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 1315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006983, CAB008663" Supported Supported "Plasma membrane,Cytosol" NA NA 120000000 "Plasma membrane, Cytosol" "CAB008663: AB_1620994, HPA006983: AB_1079595" "unprognostic (9.92e-2)" "unprognostic (1.50e-1)" "unprognostic (3.67e-1)" "unprognostic (2.99e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (5.71e-3)" "unprognostic (2.80e-2)" "unprognostic (5.27e-3)" "unprognostic (3.96e-3)" "unprognostic (3.19e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (1.15e-1)" "unprognostic (4.73e-3)" 343.7 158.8 171.5 69.0 179.5 101.0 213.0 201.8 211.9 105.0 166.4 190.9 46.8 109.7 208.1 128.9 151.1 72.5 242.7 184.3 238.5 186.1 486.5 117.7 72.8 182.4 192.5 160.4 116.6 115.4 219.2 68.0 71.3 186.6 153.5 223.7 54.3 86.3 99.9 568.1 103.9 60.3 161.5 175.7 71.3 136.3 120.2 173.4 71.3 107.0 385.8 79.7 100.4 110.7 187.7 420.3 127.7 204.7 230.9 778.5 372.7 169.5 843.9 284.3 342.7 241.8 243.9 276.4 272.4 256.4 694.2 120.4 239.8 272.0 259.9 279.0 234.0 243.6 179.5 200.0 277.7 425.7 191.3 56.1 301.0 262.6 181.3 256.6 210.8 339.5 106.7 405.4 52.8 392.9 86.3 131.7 249.1 456.2 219.8 760.5 154.5 236.6 277.0 518.1 95.4 94.9 173.4 285.0 334.0 199.2 296.3 283.8 262.9 228.2 132.5 149.9 201.8 229.5 76.4 123.2 220.7 159.4 162.3 124.3 36.2 42.5 24.8 29.8 39.8 32.8 32.6 29.8 38.4 53.5 24.4 39.8 47.9 25.2 25.7 36.5 79.7 36.1 58.1 171.5 179.5 201.8 211.9 184.3 238.5 182.4 192.5 160.4 186.6 175.7 173.4 187.7 278.1 176.3 170.8 127.3 127.4 235.4 404.1 382.8 209.5 31.9 186.1 250.7 528.6 301.7 228.6 277.7 29.2 714.3 158.6 1315.9 860.8 178.6 237.5 206.9 226.8 191.8 142.1 449.5 13.8 202.3 939.1 307.0 111.6 200.0 348.6 216.6 214.2 1120.2 345.0 45.4 13.2 257.4 205.4 164.3 161.0 667.5 340.5 227.1 183.2 17.8 212.9 462.5 83.4 12.5 15.4 147.2 663.4 416.8 176.4 427.1 264.4 827.3 209.1 52.0 184.1 185.7 253.8 123.5 76.8 305.9 264.1 963.5 157.7 512.5 303.6 308.9 DARS2 "FLJ10514, mtAspRS" ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824653-173858808 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 8.9 9.9 3.1 7.7 3.5 5.4 7.6 3.6 4.3 7.2 9.8 14.7 8.8 4.3 4.8 6.4 5.3 4.8 8.4 3.1 4.0 20.1 13.6 5.8 9.3 3.4 3.3 2.6 4.4 5.8 15.6 3.0 7.6 3.3 5.4 15.5 5.2 5.2 5.0 5.7 3.5 10.5 5.6 3.4 6.3 9.3 6.3 3.7 10.7 7.7 13.6 12.1 6.8 4.1 3.7 74.8 50.5 26.3 18.7 24.0 34.2 38.6 32.3 30.0 49.2 37.0 47.5 68.2 41.6 45.2 27.2 31.3 77.5 86.6 56.5 66.7 48.6 41.5 35.2 22.7 31.8 24.0 30.9 30.8 23.2 25.3 50.9 44.5 15.4 49.8 30.5 74.7 31.0 39.6 19.9 38.8 16.1 60.2 83.0 63.2 44.3 40.6 78.2 43.7 24.9 40.4 34.2 36.3 79.6 51.3 47.0 84.5 39.7 21.2 22.9 35.3 32.6 52.5 21.7 60.4 46.3 13.3 33.3 51.5 3.9 4.4 3.3 3.8 7.0 5.4 6.0 3.4 3.2 6.4 4.4 3.8 2.6 0.2 3.5 5.0 2.5 3.9 3.5 3.1 3.5 3.6 4.3 3.1 4.0 3.4 3.3 2.6 3.3 3.4 3.7 3.7 3.7 3.2 3.1 7.2 5.7 1.8 4.1 3.1 6.2 2.3 3.3 2.5 12.6 4.3 4.2 5.5 0.0 9.7 3.1 4.8 7.9 3.9 2.5 3.9 4.9 4.5 4.2 9.4 5.3 2.7 16.0 3.9 7.1 4.5 5.7 4.5 1.8 5.4 10.3 3.3 6.5 5.2 0.0 4.4 2.2 1.5 3.1 5.1 1.8 8.4 5.6 2.9 3.1 4.0 5.1 3.8 1.9 1.5 7.1 2.6 5.9 7.1 3.0 2.7 0.0 6.2 4.0 8.9 7.1 8.0 1.6 4.2 4.4 9.2 7.2 2.9 HSD11B1 "HSD11, HSD11B, SDR26C1" ENSG00000117594 "Hydroxysteroid 11-beta dehydrogenase 1" P28845 1 209686178-209734949 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "liver: 976.2" "Cell type enriched" "Detected in many" 9 "Hepatocytes: 646.2" "Cancer enriched" "Detected in all" 28 "liver cancer: 197.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 5.6" "Lineage enriched" "Detected in single" 17 "T-cells: 5.6" "Cell line enriched" "Detected in some" 5 "ASC diff: 989.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047729 Enhanced NA NA 110000 "HPA047729: AB_2680135" "unprognostic (1.08e-3)" "unprognostic (2.13e-1)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (3.63e-2)" "unprognostic (8.35e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.97e-10)" "unprognostic (3.41e-2)" "unprognostic (3.91e-2)" "unprognostic (6.45e-2)" "unprognostic (1.59e-2)" 18.5 7.8 10.2 14.7 15.6 0.3 12.1 23.2 22.2 2.3 9.3 3.9 1.2 4.3 15.9 2.1 5.1 8.1 6.8 11.5 16.0 10.8 976.2 40.2 4.3 14.8 22.5 9.5 60.4 3.3 0.2 8.9 73.1 16.8 28.0 3.3 0.7 2.5 13.1 5.5 30.5 5.1 13.0 9.7 7.3 7.1 7.2 13.2 0.7 5.3 10.7 1.9 28.2 6.3 17.9 0.4 0.0 0.0 0.0 989.2 102.8 0.0 0.1 36.0 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 206.6 0.2 0.1 5.4 0.0 6.9 0.4 0.9 0.0 0.0 0.0 51.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 16.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 34.9 8.4 4.0 0.2 0.2 0.3 1.4 0.3 0.3 5.7 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 5.6 1.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.7 0.4 10.2 15.6 23.2 22.2 11.5 16.0 14.8 22.5 9.5 16.8 9.7 13.2 17.9 0.4 3.2 0.0 1.3 0.8 0.1 0.4 4.8 0.6 0.5 0.2 0.0 1.4 30.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.9 0.6 1.0 0.0 5.3 3.3 0.0 0.1 66.4 0.5 2.8 0.0 0.0 7.5 646.2 8.3 0.0 2.8 0.0 0.0 7.9 2.3 2.8 29.2 3.7 0.0 28.1 0.6 16.2 0.0 0.5 55.7 0.4 0.0 7.9 0.0 0.9 0.0 0.2 0.1 0.5 0.0 2.6 5.5 0.0 0.2 0.1 0.1 0.3 1.1 0.3 0.0 1.7 IRF6 "LPS, OFC6, VWS, VWS1" ENSG00000117595 "Interferon regulatory factor 6" O14896 1 209785617-209806175 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 96.2;skin 1: 107.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA063121, HPA076162" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA063121: AB_2684942, HPA076162: AB_2686780" "unprognostic (2.59e-1)" "unprognostic (1.79e-3)" "unprognostic (1.74e-1)" "unprognostic (7.80e-2)" "unprognostic (1.33e-2)" "unprognostic (4.94e-3)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (7.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (2.70e-1)" "unprognostic (2.66e-2)" "unprognostic (2.14e-1)" "unprognostic (4.42e-2)" 1.3 11.5 1.4 3.2 1.4 2.8 36.3 11.3 4.5 13.4 7.3 27.4 27.1 6.0 49.7 96.2 21.9 10.9 30.0 1.6 3.2 17.1 33.6 8.9 0.9 1.5 2.7 1.3 1.9 19.8 26.6 6.6 20.6 5.0 32.6 31.8 2.4 39.4 26.7 0.5 107.2 25.2 2.1 2.3 2.2 25.0 2.9 1.7 20.4 17.3 2.7 23.2 40.9 47.2 1.1 61.9 0.0 0.0 0.0 0.4 0.0 20.9 0.1 0.5 0.1 0.3 13.6 20.7 0.0 0.1 0.1 0.0 210.7 0.0 80.5 0.0 0.0 1.3 0.1 0.2 0.0 0.2 0.0 0.2 0.1 170.1 0.1 82.2 0.0 3.7 0.0 0.1 0.2 0.0 8.3 0.0 0.3 1.2 17.0 0.2 0.0 0.0 0.3 7.7 78.8 18.7 6.1 1.4 34.1 1.9 3.8 24.1 0.3 0.0 0.0 0.1 0.0 0.3 0.8 15.8 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.6 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.4 1.4 11.3 4.5 1.6 3.2 1.5 2.7 1.3 5.0 2.3 1.7 1.1 1.9 16.0 10.4 0.3 1.0 387.2 253.9 154.0 217.9 0.1 47.2 33.3 26.0 32.9 70.4 35.0 0.0 94.2 1.3 95.5 27.4 36.7 1.1 120.2 9.5 6.0 59.9 0.4 0.0 19.2 25.4 4.5 53.0 121.7 2.5 0.0 1.1 35.9 8.3 0.0 0.1 74.9 38.7 1.0 30.1 0.7 0.6 2.3 35.6 1.9 1.0 6.5 0.0 0.0 0.0 49.2 43.8 0.0 2.5 153.9 49.5 11.9 82.1 0.6 0.0 0.4 7.4 8.2 3.7 251.9 552.4 161.6 2.5 0.7 44.5 290.3 UTP25 "C1orf107, DEF, DIEXF, MGC29875" ENSG00000117597 "UTP25 small subunit processor component" Q68CQ4 1 209827972-209857565 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 11.0;Endometrial stromal cells: 11.4;Glandular and luminal cells: 13.1;Granulosa cells: 10.7;Pancreatic endocrine cells: 11.2;Proximal tubular cells: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026640 Approved NA NA "HPA026640: AB_2067139" "unprognostic (3.11e-3)" "unprognostic (1.14e-3)" "unprognostic (1.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (4.75e-2)" "unprognostic (6.96e-3)" "unprognostic (2.03e-1)" "unprognostic (3.73e-2)" "unprognostic (1.42e-1)" "unprognostic (1.74e-3)" "unprognostic (1.52e-1)" "unprognostic (1.39e-2)" "unprognostic (9.86e-3)" "unprognostic (4.44e-2)" "unprognostic (8.49e-2)" "unprognostic (7.01e-2)" 3.4 3.0 2.4 4.0 3.1 2.9 6.6 1.2 3.1 3.7 1.4 3.4 2.8 4.2 3.5 3.2 4.5 2.7 2.5 2.8 2.4 3.5 4.4 2.5 4.9 1.7 1.9 3.0 7.2 3.5 3.6 1.5 3.3 2.0 3.0 3.9 2.4 3.0 3.3 2.7 4.6 3.1 3.9 1.6 3.9 3.4 2.0 2.2 3.5 4.2 2.8 4.7 4.1 3.3 2.8 9.5 9.6 3.5 6.3 7.4 6.9 10.2 11.9 14.4 8.4 7.7 6.1 10.3 11.5 6.9 12.7 10.2 10.2 10.6 7.3 11.5 8.3 10.3 6.1 6.6 4.2 5.2 9.0 6.1 6.8 10.2 13.8 12.8 7.3 7.0 6.1 15.6 7.3 8.8 4.8 8.1 5.1 15.3 8.7 7.0 6.4 11.2 14.7 6.1 8.7 8.2 10.0 6.1 15.5 12.3 9.3 6.4 7.1 8.3 17.7 8.2 11.5 13.1 8.0 9.4 11.0 7.7 6.7 7.2 4.1 2.3 0.7 3.7 3.0 5.1 5.3 4.0 3.6 3.1 4.5 5.0 4.5 0.2 4.9 4.1 2.1 3.2 2.5 2.4 3.1 1.2 3.1 2.8 2.4 1.7 1.9 3.0 2.0 1.6 2.2 2.8 8.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 9.9 10.0 0.0 0.0 0.0 11.0 0.0 6.8 6.7 0.0 7.9 10.2 0.0 10.6 11.4 4.0 0.0 0.0 0.0 9.1 7.8 3.1 0.0 13.1 0.0 10.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 1.4 0.0 0.0 10.8 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 4.0 3.2 6.6 0.0 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.7;retina: 1.6;testis: 2.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 11.9;SH-SY5Y: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.0 0.4 4.9 0.0 6.7 0.0 0.0 0.7 6.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.1 0.0 0.0 0.0 0.0 2.0 4.3 6.4 0.0 0.4 0.0 0.2 0.0 3.3 0.0 0.1 1.6 0.0 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.0 2.0 5.9 0.0 0.0 0.0 0.0 0.2 0.0 5.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 11.9 0.0 0.0 0.0 0.5 0.1 0.4 21.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.7 0.7 6.1 6.4 5.1 2.0 4.3 6.4 3.3 2.0 5.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.1 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 20.8" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 10.9;Horizontal cells: 30.3;Muller glia cells: 21.4;Smooth muscle cells: 7.0" "Group enriched" "Detected in many" 4 "glioma: 7.2;melanoma: 2.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 14.1;BJ hTERT+ SV40 Large T+ RasG12V: 6.3;fHDF/TERT166: 6.0;SH-SY5Y: 11.4;U-138 MG: 6.7;U-87 MG: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 1.5 0.6 8.5 0.2 14.3 0.0 0.7 0.0 15.3 1.8 0.0 0.3 0.3 0.4 0.3 1.5 0.3 3.0 0.3 20.8 9.8 0.3 0.0 1.5 0.4 1.1 0.2 14.8 0.0 0.5 0.3 2.1 0.8 1.8 0.1 0.4 3.9 0.3 0.2 0.1 1.7 0.5 0.7 0.0 0.3 0.3 2.9 3.4 0.3 0.6 0.2 0.6 3.4 0.4 4.9 0.0 0.0 0.0 2.3 0.2 0.0 0.0 3.2 14.1 3.6 6.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.1 0.0 0.1 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.5 14.3 0.0 15.3 20.8 9.8 1.1 0.2 14.8 1.8 0.0 3.4 4.9 4.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 10.9 2.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 30.3 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.2 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 1.3 0.7 4.5 0.0 0.0 7.0 1.2 0.2 0.1 0.0 0.0 0.1 0.7 0.0 0.0 SERPINC1 "AT3, ATIII, MGC22579" ENSG00000117601 "Serpin family C member 1" P01008 1 173903800-173917327 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1339 "liver: 5098.2" "Cell type enriched" "Detected in some" 49 "Hepatocytes: 2707.9" "Cancer enriched" "Detected in some" 871 "liver cancer: 1504.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "Hep G2: 84.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001816, CAB016790, HPA024007" Supported "Secreted to blood" NA NA 120000000000 "CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732" "unprognostic (1.28e-2)" "unprognostic (2.22e-1)" "unprognostic (3.83e-2)" "unprognostic (5.98e-2)" "unprognostic (6.91e-2)" "unprognostic (1.93e-2)" "prognostic favorable (3.40e-5)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (3.48e-2)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-2)" "unprognostic (5.28e-3)" "unprognostic (5.80e-2)" "unprognostic (6.35e-2)" "unprognostic (8.21e-2)" 0.2 0.1 0.3 0.0 0.3 0.0 0.1 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.3 0.2 3.8 5098.2 0.3 0.1 0.3 0.3 0.2 0.1 0.2 0.0 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.0 0.3 0.1 0.2 0.0 0.3 1.6 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 84.2 0.0 1.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.2 1.8 0.1 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.0 1.0 0.1 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.4 0.1 3.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 37.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.0 1.6 0.0 34.7 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.1 42.1 2707.9 0.2 0.0 0.1 0.0 0.0 55.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 4.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.3 3.7 0.0 0.0 0.2 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 34.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 88.0;Enteroendocrine cells: 82.1;T-cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 38.2" "Lineage enriched" "Detected in all" 7 "T-cells: 38.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: AB_2685232" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.7 1.9 4.1 12.4 3.6 7.1 7.2 26.8 3.7 4.6 2.9 6.8 6.9 3.1 6.4 12.5 14.5 5.5 3.4 1.6 6.4 3.6 1.7 8.1 20.1 8.3 6.7 1.7 0.6 15.9 6.4 6.3 2.1 9.0 34.1 6.8 11.6 11.7 2.4 1.8 11.3 6.2 3.5 4.7 9.4 17.4 2.1 6.0 16.2 12.4 3.1 19.7 7.1 6.0 6.9 17.6 13.9 0.2 4.3 3.5 8.4 15.6 11.8 6.4 9.5 9.0 4.3 23.0 13.1 10.8 19.9 7.4 16.4 12.0 14.8 10.2 12.9 7.3 1.4 3.8 13.1 2.2 4.6 11.5 2.9 10.8 3.8 4.6 7.9 1.9 16.2 2.0 0.5 4.1 6.3 12.1 6.7 17.7 13.4 10.2 4.7 0.2 0.4 6.9 17.9 35.6 8.8 9.7 12.0 37.2 7.9 12.8 8.9 13.6 11.2 13.2 0.6 8.2 18.2 22.8 17.5 4.5 18.0 12.9 3.5 1.8 2.2 1.2 1.0 10.0 5.2 24.9 9.0 3.0 5.1 33.1 17.7 0.6 4.0 0.4 2.1 38.2 7.9 4.1 3.6 26.8 3.7 1.6 6.4 8.3 6.7 1.7 9.0 4.7 6.0 6.9 19.7 19.2 13.3 0.0 32.4 14.1 27.3 8.9 11.4 43.0 29.9 36.8 6.4 25.8 15.8 20.2 64.6 4.0 18.9 16.4 13.7 19.0 1.2 88.0 6.8 8.6 82.1 2.5 1.6 28.2 10.3 6.0 26.5 34.1 16.5 14.8 7.1 2.2 8.5 25.2 6.7 14.4 14.2 8.4 28.0 0.0 1.8 23.0 30.2 5.6 31.5 9.1 6.2 0.0 21.2 43.2 11.3 1.2 22.0 53.9 4.3 1.0 67.7 34.5 0.0 4.7 10.4 0.7 17.5 26.9 21.7 5.3 106.8 0.1 12.2 26.3 SYF2 "CBPIN, DKFZp564O2082, fSAP29, NTC31, p29" ENSG00000117614 "SYF2 pre-mRNA splicing factor" O95926 1 25222276-25232502 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018265, HPA070710" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA018265: AB_10962002, HPA070710: AB_2686301" "unprognostic (4.19e-3)" "unprognostic (1.58e-2)" "unprognostic (9.98e-2)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (6.76e-2)" "unprognostic (6.76e-3)" "unprognostic (7.40e-3)" "unprognostic (2.36e-2)" "unprognostic (3.26e-1)" "unprognostic (1.33e-2)" "unprognostic (7.58e-2)" "unprognostic (4.89e-2)" "unprognostic (2.27e-2)" "unprognostic (4.80e-2)" "unprognostic (1.45e-3)" "prognostic favorable (5.72e-4)" 67.9 57.0 39.5 43.0 40.8 148.9 67.5 42.1 48.8 70.7 42.0 66.9 55.9 60.4 72.8 49.7 64.3 41.1 50.0 38.9 43.3 64.6 48.7 46.8 64.4 41.7 40.1 36.9 105.4 59.6 68.3 35.6 57.6 42.5 50.7 59.9 29.7 52.5 51.8 89.8 58.8 58.2 47.4 41.3 56.4 62.4 27.1 41.3 78.3 59.5 58.3 77.4 63.7 60.6 43.4 54.0 22.0 54.9 45.4 85.2 109.0 42.4 56.1 91.0 52.7 47.8 13.7 73.0 46.2 75.6 68.1 39.8 47.3 47.6 43.2 76.4 76.2 39.4 52.8 56.1 41.8 86.6 75.9 54.3 79.4 118.2 54.3 75.2 100.4 76.0 61.8 42.0 74.4 75.2 19.8 77.6 104.0 71.7 78.9 32.4 51.3 46.3 78.9 86.9 28.6 47.8 69.5 49.1 44.5 160.5 47.7 38.3 91.5 61.8 45.9 40.6 87.0 46.8 86.7 83.4 48.6 67.6 77.7 45.2 185.5 82.1 222.9 79.1 98.4 95.7 140.0 102.4 99.9 70.0 125.5 108.4 102.0 337.6 111.3 121.6 67.3 129.2 92.7 39.5 40.8 42.1 48.8 38.9 43.3 41.7 40.1 36.9 42.5 41.3 41.3 43.4 160.7 128.2 112.8 6.8 176.0 159.3 123.0 238.5 111.5 74.3 134.9 174.1 108.1 147.3 151.3 189.4 83.4 195.7 203.9 211.7 246.5 158.6 78.7 153.2 125.9 137.4 111.4 117.6 10.6 174.2 130.1 121.1 59.1 166.8 232.4 120.9 154.9 131.3 126.4 58.9 10.2 166.0 181.0 231.5 155.4 32.1 214.6 155.4 108.5 3.7 251.8 95.0 217.3 6.0 12.5 154.5 221.1 164.7 83.0 109.5 322.0 273.4 151.0 90.5 164.3 139.5 142.5 98.2 108.8 88.1 171.3 280.6 176.8 95.9 171.8 147.2 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242249-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA058992: AB_2683873, HPA067651: AB_2685879" "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favorable (2.91e-5)" 23.5 31.4 16.1 3.5 23.3 13.0 18.8 23.0 29.6 49.7 22.4 32.4 4.8 29.9 4.5 39.6 39.2 16.5 38.6 18.6 20.3 53.9 35.4 42.7 5.9 33.5 20.3 18.1 48.2 19.7 0.9 60.4 8.9 24.9 56.7 2.0 8.6 39.4 18.4 18.9 21.0 26.2 2.1 21.1 37.9 27.5 24.6 24.8 24.6 41.6 21.4 11.5 33.7 53.2 31.0 7.7 16.8 2.2 2.4 18.3 2.7 6.6 7.1 1.3 8.2 9.2 13.7 8.5 6.1 23.0 1.0 3.0 11.4 14.7 1.3 2.8 14.4 8.9 21.0 20.5 17.9 3.9 9.7 11.3 1.8 8.9 3.8 0.0 3.2 4.8 6.3 17.7 49.9 2.3 7.6 2.2 18.5 9.1 17.1 9.7 9.2 6.9 9.1 6.1 0.3 8.9 1.9 4.7 4.7 5.1 1.4 3.9 10.6 10.7 5.7 5.6 5.0 4.1 29.1 24.0 6.3 4.3 24.1 4.5 149.6 57.0 87.4 25.5 38.0 26.7 24.8 26.8 21.6 60.4 23.5 25.3 17.3 130.4 36.6 54.5 37.9 37.6 30.9 16.1 23.3 23.0 29.6 18.6 20.3 33.5 20.3 18.1 24.9 21.1 24.8 31.0 351.6 60.9 77.0 121.1 332.7 0.0 229.7 0.0 338.6 86.9 200.1 217.0 47.7 45.8 37.8 93.8 141.8 80.3 456.5 385.9 21.5 43.0 29.8 115.2 142.0 150.0 130.6 140.9 172.6 21.1 82.8 169.0 183.0 146.4 217.1 140.1 71.4 19.6 61.9 84.1 125.4 200.1 0.0 72.2 0.0 16.5 140.1 197.5 0.0 140.5 160.6 69.3 200.8 93.0 278.8 43.6 340.3 90.3 248.4 130.3 397.9 15.2 59.0 138.8 124.9 214.1 141.8 107.6 102.8 283.0 0.0 121.2 346.7 123.8 159.6 196.8 SLC35A3 ENSG00000117620 "Solute carrier family 35 member A3" Q9Y2D2 1 99969351-100035634 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 211.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015253 Uncertain NA NA "HPA015253: AB_1857106" "unprognostic (1.05e-1)" "unprognostic (2.69e-1)" "unprognostic (1.57e-3)" "unprognostic (5.89e-2)" "unprognostic (9.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (4.02e-2)" "unprognostic (2.59e-2)" "unprognostic (1.47e-1)" "unprognostic (1.76e-3)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-3)" "unprognostic (2.32e-1)" "unprognostic (2.73e-2)" "unprognostic (9.34e-2)" 11.7 7.4 4.8 10.5 5.8 11.5 18.4 7.2 5.8 19.3 9.4 53.8 50.2 9.7 11.5 14.6 13.2 13.6 5.6 4.8 5.4 21.5 37.6 11.6 8.1 5.4 5.4 4.6 8.2 11.6 19.9 4.8 10.3 5.8 23.2 54.3 7.0 22.2 11.7 4.9 10.9 41.7 8.9 4.9 7.9 33.7 2.8 5.7 19.1 25.1 6.2 9.0 10.6 10.3 7.0 28.3 7.6 6.7 7.1 14.8 12.9 26.7 24.5 14.8 9.4 13.6 4.9 15.1 15.1 30.0 14.3 13.3 16.0 12.7 11.0 21.6 18.7 9.4 13.7 10.7 11.8 9.2 22.1 1.6 6.8 12.1 11.5 22.2 11.3 11.1 11.9 23.0 21.9 19.3 7.1 14.6 11.4 8.2 16.0 24.9 4.5 20.4 9.4 17.1 16.0 8.6 4.8 17.0 32.3 13.7 6.2 19.7 16.6 13.0 14.3 13.0 32.0 13.3 12.9 16.2 11.2 23.0 13.5 6.1 4.4 2.1 1.1 2.2 2.1 2.5 2.5 2.2 2.6 1.7 1.8 2.7 2.3 0.6 4.3 1.7 5.0 2.8 1.9 4.8 5.8 7.2 5.8 4.8 5.4 5.4 5.4 4.6 5.8 4.9 5.7 7.0 23.5 80.1 28.6 12.4 17.8 25.0 21.6 30.5 18.8 15.7 33.9 15.4 8.8 27.1 50.5 55.2 20.9 19.4 51.4 211.0 7.9 18.1 4.4 49.4 22.4 20.5 19.8 9.7 24.4 15.3 30.5 17.0 43.3 46.3 17.1 19.5 20.7 49.3 14.2 10.1 26.6 110.6 22.4 17.8 17.1 2.1 13.4 14.2 8.8 23.4 18.0 19.0 14.4 30.2 46.7 21.7 82.8 13.2 25.6 43.3 112.4 25.3 92.6 25.1 6.6 14.4 17.7 16.2 8.3 21.2 29.7 23.3 23.8 12.8 116.4 48.4 RCOR3 FLJ10876 ENSG00000117625 "REST corepressor 3" Q9P2K3 1 211258377-211316385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007413, HPA007621, HPA071997" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193" "unprognostic (2.39e-2)" "unprognostic (1.23e-1)" "unprognostic (9.35e-2)" "unprognostic (3.07e-2)" "prognostic favorable (1.35e-5)" "unprognostic (4.02e-3)" "unprognostic (2.28e-2)" "prognostic favorable (5.75e-5)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (9.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.62e-2)" "unprognostic (1.82e-1)" "unprognostic (3.95e-1)" "unprognostic (3.56e-3)" 15.6 15.8 12.3 10.8 17.0 32.0 19.9 22.0 17.0 20.3 10.1 17.9 12.2 19.2 21.6 14.7 18.3 12.5 22.9 12.6 14.8 15.8 16.0 14.6 15.3 15.7 15.3 10.4 26.9 19.9 21.0 17.0 15.0 16.0 24.1 13.9 30.7 19.7 24.7 65.7 19.3 18.8 14.2 11.9 18.7 16.3 34.0 13.2 19.4 32.2 52.1 14.8 18.9 18.1 22.9 15.5 13.9 25.1 14.4 21.3 20.2 26.4 18.3 18.3 20.0 20.2 12.0 20.9 22.8 11.6 23.7 13.9 23.4 20.6 18.2 15.4 21.5 10.9 21.4 22.6 17.0 23.4 34.2 19.8 22.0 16.6 21.9 27.3 22.4 11.8 23.2 21.0 29.2 29.9 11.2 16.8 18.8 27.2 11.3 14.4 17.8 49.6 27.3 17.2 28.5 16.0 32.5 46.7 24.3 33.6 24.1 29.9 23.3 17.1 17.5 19.7 23.2 20.4 23.5 18.4 30.1 15.2 19.6 15.9 27.2 12.4 45.9 8.8 12.5 11.8 15.4 9.4 9.7 13.7 11.4 16.0 11.6 20.8 19.8 14.3 14.5 12.7 8.8 12.3 17.0 22.0 17.0 12.6 14.8 15.7 15.3 10.4 16.0 11.9 13.2 22.9 23.1 38.5 44.4 67.6 23.0 14.5 10.7 16.4 29.6 43.7 29.0 25.9 73.4 24.3 24.9 14.7 35.5 26.7 30.2 16.6 21.5 10.4 70.4 22.0 37.4 17.7 34.2 29.8 121.9 15.4 14.8 24.0 28.1 26.6 19.6 21.7 21.8 20.8 20.5 23.5 101.1 17.3 16.2 22.3 14.2 122.6 22.4 24.6 23.2 49.6 22.2 24.1 14.4 87.9 131.6 10.4 15.8 27.1 28.1 12.5 24.1 22.8 22.2 47.7 0.0 33.2 24.8 65.4 35.1 33.1 16.9 25.4 22.6 22.7 17.5 9.0 STMN1 "C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN" ENSG00000117632 "Stathmin 1" P16949 1 25884181-25906991 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 959.4;lymphoid tissue: 1355.5" "Cell type enhanced" "Detected in all" "Late spermatids: 2537.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 424.6" "Group enriched" "Detected in all" 5 "dendritic cells: 424.6;T-cells: 143.3" "Cell line enhanced" "Detected in all" "MOLT-4: 3270.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010107, HPA068438" Enhanced Approved Cytosol NA NA 320000 Cytosol "CAB010107: AB_628297, HPA068438: " "unprognostic (6.30e-2)" "unprognostic (2.40e-3)" "unprognostic (5.31e-2)" "unprognostic (7.94e-2)" "unprognostic (1.89e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (9.90e-7)" "unprognostic (9.45e-2)" "unprognostic (1.39e-2)" "unprognostic (1.61e-2)" "unprognostic (1.78e-1)" "unprognostic (3.33e-3)" "unprognostic (1.02e-2)" "unprognostic (1.68e-1)" "unprognostic (4.46e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-2)" 50.1 69.8 583.7 104.7 668.2 262.7 61.2 595.7 959.4 55.2 439.5 94.1 71.2 131.0 41.1 116.8 45.6 51.5 56.5 650.9 640.2 71.6 36.1 61.3 255.2 638.2 656.7 655.7 173.9 23.4 44.2 104.3 121.1 654.1 31.9 111.7 307.4 43.8 33.0 29.7 54.2 89.9 100.9 640.9 73.4 54.9 390.0 619.6 1355.5 33.9 30.2 248.0 59.5 76.7 891.4 1026.8 226.1 2191.0 882.5 128.9 126.0 225.7 776.3 609.7 1081.9 1037.9 157.2 1018.3 1260.3 426.3 572.0 425.8 304.6 618.6 450.9 1616.1 390.4 310.9 786.0 363.3 547.6 51.9 994.6 529.3 77.0 65.6 439.6 496.8 405.5 833.6 1594.4 1074.4 1203.0 1429.6 268.0 3270.7 1441.5 1350.8 615.1 302.8 1907.9 1709.2 740.7 536.9 91.7 1479.2 1282.3 710.0 348.3 638.4 695.8 500.7 1240.1 406.2 721.8 853.6 634.3 664.8 702.5 1212.0 1535.8 357.7 1904.8 798.2 13.4 4.1 23.5 53.9 8.6 32.2 37.0 47.8 68.2 23.2 45.6 77.8 71.6 1.9 56.3 4.5 424.6 143.3 57.2 583.7 668.2 595.7 959.4 650.9 640.2 638.2 656.7 655.7 654.1 640.9 619.6 891.4 257.3 41.7 31.6 32.7 125.1 201.6 148.9 350.0 577.7 454.6 91.0 175.1 77.2 31.5 100.0 174.7 64.6 439.3 261.7 35.1 226.9 148.9 917.2 92.8 100.3 196.3 250.8 505.7 109.5 20.1 604.1 134.9 121.3 141.1 262.0 712.4 109.2 15.4 530.1 195.2 73.0 100.9 567.6 87.3 287.0 2537.2 44.7 130.0 268.6 32.8 32.1 252.4 84.5 38.2 217.4 59.0 69.3 47.0 261.7 63.5 21.0 221.4 59.1 183.6 39.5 68.0 267.6 873.0 260.8 423.9 90.4 130.4 224.9 66.5 177.1 95.7 MTFR1L FAM54B ENSG00000117640 "Mitochondrial fission regulator 1 like" Q9H019 1 25818640-25832942 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 161.1;Early spermatids: 216.1;Late spermatids: 590.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027124, HPA027130" Approved Approved "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA027124: AB_10600211, HPA027130: AB_10611251" "unprognostic (9.90e-2)" "unprognostic (6.86e-3)" "unprognostic (9.29e-2)" "prognostic favorable (6.81e-4)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.52e-3)" "unprognostic (2.12e-1)" "unprognostic (2.24e-1)" "unprognostic (9.89e-3)" "unprognostic (5.33e-2)" "prognostic favorable (5.89e-12)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.69e-1)" "unprognostic (1.33e-1)" 38.6 139.1 81.3 22.4 84.0 18.0 37.8 82.1 89.2 50.2 83.3 63.4 47.2 51.4 58.3 39.7 45.2 33.0 157.9 83.4 83.1 72.4 92.1 32.7 26.0 82.0 85.2 81.9 69.0 46.4 106.8 52.1 41.1 80.6 56.3 37.6 62.6 43.7 70.8 223.9 35.2 47.3 50.4 79.7 44.5 57.1 83.1 84.7 24.9 48.5 241.8 26.6 58.8 40.8 80.4 19.5 26.7 53.2 53.6 67.6 63.8 22.2 44.7 63.7 45.2 49.9 8.7 39.7 6.6 38.9 80.1 40.0 17.4 44.1 38.6 44.8 43.9 39.8 55.6 44.3 35.9 64.6 45.5 52.9 65.3 36.4 48.3 36.1 67.0 37.9 27.0 34.7 29.2 66.1 21.6 26.3 33.6 29.4 26.0 39.4 26.0 47.4 19.8 47.1 18.3 53.6 48.5 33.6 32.4 67.8 35.8 26.7 43.1 38.6 36.7 28.9 86.6 28.5 30.5 19.3 23.2 63.6 62.5 41.2 71.7 50.5 111.7 25.7 50.8 15.6 28.1 24.1 22.9 55.0 28.8 25.4 23.1 13.6 27.6 58.3 22.7 27.3 51.1 81.3 84.0 82.1 89.2 83.4 83.1 82.0 85.2 81.9 80.6 79.7 84.7 80.4 18.7 16.0 24.5 24.2 14.1 13.5 20.8 38.6 25.0 0.0 21.6 23.6 161.1 25.8 21.7 22.0 0.0 55.9 14.8 15.7 103.7 32.4 216.1 11.3 16.7 17.1 15.6 12.4 18.2 33.5 36.7 28.4 21.4 10.6 36.1 21.9 21.4 35.5 34.9 0.0 24.1 14.9 34.6 15.1 17.3 590.4 34.2 25.6 44.4 6.5 43.5 0.0 12.3 12.5 15.2 27.7 15.0 39.1 15.4 16.2 39.3 70.6 10.5 0.0 26.3 23.3 31.3 144.7 49.9 15.4 12.9 59.4 13.1 29.8 18.0 16.5 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25616791-25786206 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2;Excitatory neurons: 72.8;Hepatic stellate cells: 63.9;Hepatocytes: 57.8;Inhibitory neurons: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "AF22: 30.5;HSkMC: 108.9;U-266/70: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles NA NA 1800000 "Nucleoplasm, Vesicles" "HPA048352: AB_2680368" "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favorable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 12.0 11.7 16.3 9.5 16.9 2.3 6.3 18.0 20.9 19.7 26.2 8.1 4.6 14.7 7.5 7.1 9.8 18.7 10.2 17.9 30.1 25.6 29.8 9.3 12.5 48.1 21.0 17.9 17.5 3.6 24.2 17.2 21.3 25.6 17.8 4.6 11.1 5.8 18.1 4.6 8.1 6.2 20.1 33.4 19.5 7.3 4.2 18.7 10.6 26.3 5.5 9.5 12.5 9.2 40.7 0.1 0.4 30.5 6.4 22.4 17.2 8.6 0.4 5.8 1.4 0.4 0.6 0.2 0.1 0.3 2.3 3.9 0.4 3.0 0.3 0.6 9.8 1.3 0.6 0.5 0.1 2.6 5.2 12.0 108.9 0.5 0.7 0.0 0.4 0.1 1.2 0.1 1.3 0.0 1.6 0.0 5.8 7.8 0.1 0.2 0.6 18.9 0.6 0.2 0.7 17.7 0.6 0.7 4.7 1.5 5.5 2.4 3.6 0.1 0.0 1.6 20.1 0.7 31.7 0.1 0.1 4.6 10.7 1.5 0.3 0.9 0.4 0.3 0.6 0.5 0.2 2.1 0.9 0.3 0.5 4.7 2.7 0.6 0.4 0.8 0.2 0.5 0.7 16.3 16.9 18.0 20.9 17.9 30.1 48.1 21.0 17.9 25.6 33.4 18.7 40.7 5.8 3.2 3.2 18.3 2.0 6.6 2.9 3.6 5.2 23.5 1.1 1.5 7.0 4.3 7.3 22.0 54.2 10.6 1.6 0.5 9.8 1.0 0.3 0.4 8.1 8.4 3.0 2.7 72.8 3.8 0.9 23.3 1.1 0.6 2.5 0.3 63.9 57.8 24.8 21.9 65.8 0.1 16.2 19.0 4.3 2.1 27.1 6.8 1.8 39.4 3.3 17.8 3.1 25.1 21.7 1.4 0.3 22.2 2.2 2.0 0.0 23.3 2.2 4.4 6.6 17.0 7.1 0.2 2.9 1.0 5.3 42.7 6.9 0.7 0.2 1.9 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 18.0;lymphoid tissue: 19.4;testis: 67.7" "Group enriched" "Detected in many" 4 "Early spermatids: 76.1;Spermatocytes: 244.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.7" "Low region specificity" "Detected in all" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: AB_2685393" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (9.47e-6)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 0.7 0.4 0.6 5.3 0.5 18.0 1.5 0.8 0.7 1.1 0.7 5.9 7.4 1.3 0.5 4.4 2.2 0.8 0.4 0.6 0.9 0.3 0.7 0.7 9.1 0.4 0.3 0.4 0.4 0.1 0.1 0.0 3.2 0.5 2.6 7.7 1.5 0.8 0.2 0.4 4.3 6.9 2.0 0.3 1.7 2.7 67.7 0.6 19.4 0.4 0.2 10.7 1.4 1.6 0.8 86.0 60.5 45.3 32.6 2.6 4.5 49.7 32.4 30.1 55.4 47.5 32.3 81.7 45.1 15.2 25.2 35.1 44.5 39.9 24.2 69.6 69.5 33.2 21.6 51.4 44.2 0.4 43.2 28.3 1.4 2.9 42.9 45.9 13.4 36.3 45.2 59.9 76.9 56.0 23.6 47.3 28.8 43.0 55.0 30.5 46.2 69.2 68.7 19.7 24.2 41.0 45.0 46.6 51.5 39.3 38.4 79.4 25.1 19.0 27.6 54.1 54.8 88.3 31.6 62.6 59.6 24.1 32.6 46.8 1.2 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 0.4 0.3 0.2 0.7 1.5 0.1 0.2 1.6 0.3 0.6 0.5 0.8 0.7 0.6 0.9 0.4 0.3 0.4 0.5 0.3 0.6 0.8 0.1 0.0 0.5 0.3 1.7 2.9 0.7 3.8 0.6 11.3 1.9 2.2 0.5 0.0 2.9 0.0 0.0 9.4 0.8 1.9 0.0 0.2 76.1 15.2 0.7 0.8 0.0 39.6 0.8 0.2 14.1 1.4 5.6 1.5 0.0 3.6 3.6 0.7 5.8 3.3 0.0 3.2 10.2 2.5 1.1 39.0 2.5 2.1 0.0 0.0 0.0 1.6 2.1 0.0 0.1 0.0 2.5 0.7 5.4 0.7 2.1 0.1 5.2 1.8 6.6 0.0 1.5 244.2 26.1 8.6 1.7 1.4 2.0 0.9 9.5 1.4 RPS6KA1 "HU-1, MAPKAPK1, p90Rsk, RSK1" ENSG00000117676 "Ribosomal protein S6 kinase A1" Q15418 1 26529761-26575030 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 77.6;U-937: 86.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003852, HPA007981" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003852: AB_289590, HPA007981: AB_1079850" "unprognostic (1.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.61e-3)" "prognostic favorable (7.20e-7)" "unprognostic (7.35e-2)" "unprognostic (3.69e-1)" "unprognostic (6.93e-3)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.84e-4)" "prognostic favorable (4.58e-4)" "unprognostic (4.77e-2)" "unprognostic (7.61e-2)" "prognostic favorable (8.33e-4)" 6.7 17.1 7.9 17.7 9.0 24.0 8.3 9.4 9.0 6.0 11.3 25.9 33.4 3.0 1.2 17.1 7.9 5.6 3.4 8.0 11.1 26.1 10.6 34.0 20.4 11.0 9.5 7.3 1.9 19.5 12.6 13.5 4.0 10.1 17.4 20.9 1.4 21.7 4.6 1.7 17.4 51.8 3.7 10.2 47.4 20.8 5.4 10.0 11.5 24.7 1.9 20.9 9.1 9.7 10.5 27.1 9.3 7.5 9.9 0.4 0.1 9.9 2.2 4.2 11.0 10.6 10.8 21.9 50.2 11.9 1.3 13.3 31.0 16.9 61.0 7.8 41.8 11.0 55.3 21.6 19.5 3.4 65.8 77.6 1.8 22.1 10.1 18.0 5.0 4.9 19.7 9.6 17.7 0.6 15.0 2.4 64.3 19.1 52.2 29.2 34.8 9.5 22.0 31.7 7.3 10.7 4.4 18.7 17.5 8.4 7.8 11.2 55.5 3.2 0.5 13.9 1.8 9.2 10.9 14.0 27.5 6.5 86.8 10.8 37.6 57.9 131.2 24.2 52.1 20.3 14.2 17.9 21.6 68.8 15.7 11.3 15.8 108.2 26.4 58.4 26.9 19.0 65.2 7.9 9.0 9.4 9.0 8.0 11.1 11.0 9.5 7.3 10.1 10.2 10.0 10.5 2.8 16.0 25.0 0.0 23.7 18.6 8.1 19.9 16.5 1.5 12.0 10.4 1.3 11.5 7.7 9.2 4.2 1.6 53.9 91.1 7.9 16.3 1.9 19.9 2.2 6.9 16.3 29.5 1.4 18.7 17.5 1.8 18.3 20.7 31.8 3.3 7.9 3.4 47.5 0.0 2.6 41.6 12.2 53.0 14.2 1.4 0.0 44.1 1.8 12.2 81.2 0.6 88.6 1.0 12.3 28.1 41.9 0.0 14.2 18.8 93.3 17.2 13.6 1.8 6.6 0.8 2.7 1.6 3.4 10.9 11.6 4.1 36.3 2.0 43.6 9.1 DHDDS "DS, FLJ13102, hCIT, HDS, RP59" ENSG00000117682 "Dehydrodolichyl diphosphate synthase subunit" Q86SQ9 1 26432282-26471306 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Transferase "Disease variant, Epilepsy, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 256.5;Early spermatids: 99.1;Rod photoreceptor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026721, HPA026727" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA026721: AB_1847643, HPA026727: AB_1847644" "unprognostic (1.11e-2)" "unprognostic (5.43e-2)" "unprognostic (5.12e-2)" "unprognostic (9.81e-2)" "unprognostic (6.71e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-3)" "unprognostic (3.81e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-2)" "unprognostic (4.51e-2)" "unprognostic (3.40e-2)" "prognostic favorable (4.08e-7)" "unprognostic (9.42e-2)" "unprognostic (2.85e-1)" "unprognostic (2.22e-1)" "unprognostic (2.95e-1)" 57.9 19.7 12.5 19.1 12.2 12.6 22.9 32.3 14.3 14.7 13.2 37.6 19.3 13.6 38.8 26.5 13.0 16.0 20.0 12.8 13.3 25.7 22.2 14.0 17.8 14.8 17.0 12.0 11.5 18.7 40.1 21.1 12.7 17.5 14.2 39.2 38.1 43.6 14.2 13.7 21.4 18.4 18.5 8.8 14.2 23.5 12.4 13.4 14.2 19.3 11.9 20.9 18.3 14.6 14.9 34.2 24.8 20.6 23.8 36.1 28.2 28.4 54.9 33.4 44.0 41.6 37.4 34.6 38.4 33.3 57.2 30.0 24.1 25.4 42.8 42.9 22.7 13.9 38.0 66.9 30.8 39.3 41.4 51.5 40.3 27.6 59.1 32.2 29.4 51.2 26.7 27.3 41.0 39.7 19.4 23.1 20.2 26.3 53.1 36.2 25.3 33.4 31.2 25.4 28.8 24.4 19.4 36.4 38.0 26.6 26.8 29.8 20.9 63.0 30.1 26.3 60.4 32.0 48.1 72.4 39.5 43.0 54.0 26.8 9.4 16.1 9.6 13.8 23.6 9.8 13.2 9.0 9.1 13.6 10.2 7.4 10.9 13.0 10.1 23.1 11.5 8.3 10.5 12.5 12.2 32.3 14.3 12.8 13.3 14.8 17.0 12.0 17.5 8.8 13.4 14.9 9.4 9.6 7.8 7.8 13.5 4.6 9.6 12.0 10.8 29.6 9.6 7.4 15.5 15.7 13.8 14.7 256.5 18.3 13.7 76.3 11.7 19.3 99.1 11.6 12.9 11.1 20.9 5.7 26.9 14.5 23.4 11.1 33.6 20.0 19.0 14.4 10.0 13.2 24.5 15.2 28.5 46.3 14.2 11.5 7.1 23.4 10.5 10.5 10.6 10.3 34.4 16.3 14.4 9.0 11.4 17.6 40.3 7.5 18.7 10.6 24.7 29.3 11.5 106.1 0.0 8.4 14.5 13.2 13.5 12.4 5.1 25.4 10.3 15.8 26.0 12.2 NENF "CIR2, SCIRP10, SPUF" ENSG00000117691 "Neudesin neurotrophic factor" Q9UMX5 1 212432920-212446379 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 512.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026763, HPA028488" Uncertain "Secreted to blood" NA NA 4000000 "HPA026763: AB_1854379, HPA028488: AB_2672638" "unprognostic (2.38e-3)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (2.49e-2)" "unprognostic (7.24e-2)" "unprognostic (7.41e-3)" "unprognostic (3.80e-3)" "unprognostic (5.35e-2)" "unprognostic (1.70e-2)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (4.99e-3)" "prognostic unfavorable (1.54e-6)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (4.28e-1)" "unprognostic (2.28e-2)" 61.7 53.9 146.1 17.0 159.6 27.1 66.4 154.6 189.6 80.1 149.5 48.9 20.0 60.3 70.8 46.3 58.8 24.1 126.7 143.5 153.2 70.5 63.2 45.8 16.6 155.3 155.5 139.3 83.4 69.3 64.7 149.3 29.7 154.4 69.9 36.5 22.9 73.0 51.0 95.8 54.3 35.5 45.1 158.3 33.9 48.1 16.8 154.8 23.2 58.1 105.5 25.8 58.5 58.1 169.8 78.8 65.3 26.6 103.2 155.3 116.6 38.9 39.5 94.5 67.5 65.7 74.0 49.8 36.0 29.0 93.0 68.4 49.7 55.1 56.0 55.1 45.7 107.2 26.5 39.9 24.4 59.3 25.1 66.2 83.9 82.5 47.8 40.0 76.1 44.1 54.1 60.2 39.0 60.5 40.2 45.4 95.3 39.0 73.9 137.9 42.1 62.6 50.2 70.3 23.1 43.2 77.5 59.2 89.6 74.0 40.4 70.8 75.2 9.1 54.9 49.0 76.8 73.3 36.2 62.6 26.9 57.5 36.0 43.0 0.9 4.8 2.1 3.9 7.1 6.9 8.1 4.7 8.8 7.8 5.3 6.1 6.2 0.5 0.9 5.0 13.5 5.8 2.5 146.1 159.6 154.6 189.6 143.5 153.2 155.3 155.5 139.3 154.4 158.3 154.8 169.8 124.8 12.8 21.6 14.0 72.0 166.2 233.0 10.8 173.6 44.0 322.5 418.5 152.9 163.0 13.4 248.3 12.5 291.4 64.3 101.0 164.4 50.9 5.3 40.7 119.1 87.4 135.8 135.0 11.9 49.0 182.0 219.7 65.7 58.4 47.1 45.7 145.3 211.8 189.3 38.7 12.6 143.7 6.1 149.4 198.1 23.9 297.6 127.2 186.7 11.2 69.2 329.6 34.0 21.6 80.5 32.7 70.7 223.8 136.0 322.9 56.1 512.7 7.6 28.4 118.3 162.1 233.9 13.3 138.5 158.8 170.6 184.4 70.4 61.8 157.0 264.5 NSL1 "C1orf48, DC8, DKFZP566O1646, MIS14" ENSG00000117697 "NSL1 component of MIS12 kinetochore complex" Q96IY1 1 212726153-212791782 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045761, HPA053721" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA045761: AB_2679444, HPA053721: AB_2682240" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-2)" "unprognostic (2.67e-2)" "unprognostic (2.58e-2)" "unprognostic (1.78e-2)" "unprognostic (8.22e-3)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (6.09e-3)" "unprognostic (3.44e-3)" "unprognostic (1.58e-1)" "unprognostic (3.10e-3)" "unprognostic (2.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (6.66e-2)" 16.8 14.7 12.4 19.5 15.3 19.3 11.3 15.4 17.7 12.9 13.3 13.4 17.6 14.6 8.1 15.4 14.0 15.1 25.1 11.9 14.6 16.1 19.4 12.6 27.2 16.0 13.4 11.4 16.9 12.6 14.0 11.1 17.8 15.7 12.9 10.2 12.7 14.0 10.1 22.8 8.9 17.6 13.2 15.6 19.6 11.8 13.6 13.8 22.9 15.2 15.8 16.8 13.7 10.1 19.8 39.7 44.3 45.0 43.3 18.9 19.5 59.4 32.5 22.1 38.7 33.2 37.3 42.2 55.6 29.4 18.7 21.6 28.4 35.6 29.9 20.1 102.9 33.6 37.0 31.2 61.8 21.7 62.5 34.9 20.2 14.6 39.6 19.8 17.8 28.8 62.9 83.0 45.7 24.6 23.1 80.6 24.6 82.9 20.6 32.8 69.2 68.1 61.5 31.3 19.8 41.1 57.0 46.0 22.3 55.7 33.3 65.6 44.9 33.3 39.4 34.1 36.4 54.5 26.4 76.3 73.8 33.7 42.2 50.7 21.8 49.3 63.1 35.9 62.3 43.0 59.0 38.8 39.2 55.6 47.4 46.7 41.9 49.6 45.3 64.3 53.8 51.2 60.7 12.4 15.3 15.4 17.7 11.9 14.6 16.0 13.4 11.4 15.7 15.6 13.8 19.8 39.4 16.0 20.7 25.5 43.5 14.8 21.2 51.4 31.3 34.1 22.8 26.8 22.4 31.5 28.1 18.4 14.6 64.0 40.9 14.7 43.0 32.2 29.2 19.9 29.0 32.0 21.7 50.7 50.2 21.1 62.2 28.9 13.3 15.1 15.2 31.6 29.6 27.9 61.6 33.7 50.1 14.1 30.5 68.2 28.5 15.2 34.8 44.6 19.6 33.7 56.0 37.1 35.0 36.2 68.9 22.7 15.9 32.7 26.7 10.5 32.5 58.5 25.6 32.7 59.2 30.2 32.6 48.7 65.5 22.7 16.2 20.9 36.6 27.0 18.5 10.3 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041510 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.3;liver: 87.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000842, HPA001030, HPA027298" Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 1.5 10.1 12.2 1.5 21.0 0.0 1.8 21.9 18.2 1.0 0.0 2.6 2.1 1.1 1.2 0.6 2.3 1.9 15.8 22.7 11.6 4.8 87.5 1.2 2.9 14.9 18.5 3.0 7.5 15.7 0.1 4.0 0.4 15.1 0.5 2.7 21.4 0.3 0.4 3.6 0.6 2.6 0.9 13.6 7.2 2.1 5.4 26.6 0.2 7.6 2.1 0.7 1.0 0.8 37.3 0.0 0.0 0.6 0.0 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.3 0.2 2.3 0.0 0.1 0.0 1.0 0.6 0.0 31.4 0.0 0.0 0.2 0.3 0.1 0.0 0.2 0.1 3.5 2.3 5.7 0.0 0.4 0.0 0.4 0.0 1.7 2.0 1.3 0.0 15.9 2.5 0.2 0.5 2.3 77.2 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.2 0.7 0.2 0.9 0.0 0.0 0.0 0.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 21.0 21.9 18.2 22.7 11.6 14.9 18.5 3.0 15.1 13.6 26.6 37.3 14.3 0.0 2.3 1.3 1.9 5.9 1.1 0.3 5.7 196.4 4.8 4.7 105.9 102.9 1.3 9.2 2.1 0.0 0.1 3.2 15.6 34.7 52.7 0.1 1.0 36.5 66.9 5.3 2.9 2.7 0.1 8.7 8.6 0.3 0.0 9.3 11.0 285.9 0.9 523.3 66.8 16.5 12.2 4.4 6.6 10.4 1.2 2.2 10.6 8.4 0.0 36.0 0.0 27.2 114.0 3.4 130.6 1.2 0.1 3.9 3.3 0.4 0.9 11.7 0.0 113.6 3.7 2.9 0.4 0.4 4.5 0.0 1.9 29.6 10.5 0.9 ARID1A "B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1" ENSG00000117713 "AT-rich interaction domain 1A" O14497 1 26693236-26782104 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005456, CAB016334" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB016334: AB_673396, HPA005456: AB_1078205" "unprognostic (2.83e-1)" "unprognostic (1.81e-1)" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" "unprognostic (7.76e-2)" "unprognostic (1.01e-2)" "unprognostic (1.62e-2)" "unprognostic (6.05e-2)" "unprognostic (2.66e-1)" "unprognostic (6.54e-2)" 16.0 16.5 12.0 22.9 10.0 37.4 16.5 12.8 25.0 16.3 0.0 17.7 15.5 20.6 15.9 22.4 18.4 14.1 15.9 10.6 16.8 12.1 16.9 17.0 26.0 32.6 9.0 0.9 21.0 23.4 19.4 14.4 18.7 14.3 15.3 15.5 20.3 19.5 14.5 21.8 20.6 20.5 17.6 3.0 24.5 19.6 16.8 11.4 46.8 22.8 17.7 23.9 18.6 18.0 34.7 53.2 49.5 68.6 71.5 19.6 18.5 32.3 24.4 21.1 32.7 23.0 36.3 34.1 74.3 20.7 31.8 20.7 31.6 60.3 26.9 37.9 92.7 22.6 63.6 33.0 24.7 16.1 95.2 19.6 21.7 18.8 38.7 27.5 18.2 28.6 52.5 77.7 81.1 21.5 25.1 80.1 36.8 72.4 34.5 22.9 82.2 45.3 42.1 20.3 35.3 62.9 50.7 42.7 35.7 29.0 37.8 10.6 53.4 50.6 34.9 33.5 32.4 39.9 38.0 54.9 34.1 21.2 59.8 31.5 0.2 1.5 1.5 1.6 1.2 2.1 1.8 1.3 2.1 1.4 1.6 1.7 1.9 3.3 2.1 1.3 2.4 0.7 1.9 12.0 10.0 12.8 25.0 10.6 16.8 32.6 9.0 0.9 14.3 3.0 11.4 34.7 49.9 60.9 40.4 99.9 66.6 73.4 21.0 32.5 90.0 68.0 77.2 61.5 33.0 38.6 35.9 38.6 52.1 36.5 56.1 46.5 1.9 35.3 23.3 48.8 59.3 46.3 47.5 56.6 47.1 37.6 40.2 35.9 35.7 72.3 61.2 68.4 49.6 65.6 51.0 74.0 59.8 50.2 28.5 89.0 47.5 9.0 38.5 73.2 40.9 89.9 86.4 30.8 53.5 78.9 116.1 49.7 36.4 41.8 48.5 50.0 32.4 16.7 36.1 42.3 52.6 38.2 47.3 44.1 52.2 101.8 94.3 36.7 57.0 45.8 52.1 43.2 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664571 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.0;lymphoid tissue: 33.3" "Cell type enhanced" "Detected in many" "Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "white matter: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 0.8 1.1 0.2 4.4 0.2 29.0 1.8 0.1 0.3 0.9 0.5 5.9 6.1 1.8 0.1 8.6 0.6 0.7 0.4 0.3 0.5 0.4 0.9 0.9 8.6 0.3 0.5 0.1 0.7 0.3 0.2 0.1 3.2 0.2 0.5 5.8 1.0 1.4 0.1 0.3 6.3 4.4 2.5 0.3 2.4 2.6 10.6 0.4 33.3 0.4 0.6 10.1 1.4 2.7 1.9 123.7 68.4 144.3 75.8 5.4 7.2 56.3 74.6 30.3 43.9 42.8 54.6 74.1 116.3 43.1 41.7 39.8 74.7 89.9 49.2 74.1 102.6 56.6 96.0 111.4 78.6 0.8 137.0 50.5 2.7 3.8 63.3 72.3 12.7 46.9 52.6 88.4 68.0 79.4 47.0 81.5 54.3 127.9 36.8 30.0 85.7 203.7 38.6 43.2 30.3 67.4 91.2 100.7 66.2 38.9 76.2 79.1 51.9 61.7 78.9 92.2 66.2 155.9 51.6 60.7 108.7 34.4 96.7 71.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.1 0.3 0.3 0.5 0.3 0.5 0.1 0.2 0.3 0.4 1.9 3.0 0.0 3.1 0.0 11.5 9.3 2.8 11.2 3.4 4.7 10.0 6.7 1.9 1.5 9.9 0.0 0.0 53.3 10.8 19.1 0.0 2.0 84.4 30.1 19.3 12.4 0.0 268.7 1.3 0.4 78.8 19.0 32.1 25.2 1.3 165.8 8.9 2.6 32.2 1.7 0.8 20.1 14.2 16.6 6.6 19.8 1.2 16.2 1.8 1.0 0.7 1.4 5.2 0.0 0.1 0.5 1.1 3.0 25.9 2.3 2.1 0.1 16.7 3.1 0.0 8.3 23.9 107.5 107.1 44.6 5.5 5.1 23.3 11.7 41.3 3.7 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 162.3;Spermatogonia: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favorable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favorable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 27.3 25.3 33.5 40.1 35.3 41.0 44.2 33.7 42.7 32.2 36.7 26.9 18.7 34.0 43.8 32.6 49.5 30.9 39.5 34.3 36.3 32.7 32.0 28.9 75.7 33.8 34.5 33.7 52.5 21.2 41.0 31.6 30.4 34.7 29.0 30.5 44.1 24.2 31.6 72.9 40.6 26.4 30.9 35.6 42.7 25.8 64.3 33.6 53.9 53.4 63.8 68.2 30.6 25.1 37.2 60.9 57.4 86.4 68.5 59.3 52.8 57.2 106.1 70.3 130.0 113.5 80.2 72.7 148.9 69.4 41.1 48.4 55.8 126.5 60.3 122.4 121.0 126.0 174.3 73.0 71.3 30.9 229.7 115.1 24.6 33.2 123.8 62.3 40.3 59.1 133.1 196.2 127.1 75.7 63.6 163.9 105.1 181.7 115.1 122.0 115.0 128.7 74.2 49.1 65.2 78.3 75.8 123.3 47.3 100.7 68.1 50.9 71.8 36.6 32.2 73.0 186.2 76.3 105.8 251.0 135.8 81.4 213.5 64.3 322.3 97.4 290.0 279.7 80.0 304.4 272.5 252.9 257.4 112.1 232.0 287.4 282.7 100.1 294.1 106.5 172.3 255.5 435.5 33.5 35.3 33.7 42.7 34.3 36.3 33.8 34.5 33.7 34.7 35.6 33.6 37.2 26.5 22.4 15.7 10.4 64.0 21.0 28.5 47.1 16.5 28.4 25.7 27.8 29.0 24.3 30.4 22.0 2.1 95.2 77.8 10.1 35.2 35.0 49.0 14.6 18.8 27.9 13.8 39.1 8.8 20.6 67.3 34.8 7.1 15.1 60.9 33.3 26.4 16.6 51.9 8.4 8.4 14.0 71.2 31.5 27.6 22.6 41.3 34.1 37.4 7.5 86.7 100.0 95.8 9.5 14.3 29.5 10.4 46.3 32.6 19.3 11.2 23.6 28.8 34.5 32.9 48.0 24.7 162.3 183.5 20.6 22.4 55.7 59.9 33.9 19.3 20.1 PPP1R8 "ard-1, ARD1, NIPP-1, NIPP1, PRO2047" ENSG00000117751 "Protein phosphatase 1 regulatory subunit 8" Q12972 1 27830782-27851676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027406, HPA027417, HPA027452" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490" "unprognostic (5.61e-2)" "unprognostic (2.55e-1)" "unprognostic (4.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-2)" "unprognostic (9.09e-3)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.82e-2)" "unprognostic (2.14e-3)" "unprognostic (2.20e-1)" "unprognostic (3.16e-2)" "unprognostic (9.16e-2)" "unprognostic (6.26e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-2)" "unprognostic (4.86e-2)" "unprognostic (2.58e-2)" 24.2 17.3 25.3 24.0 28.0 39.2 27.5 27.5 28.1 25.3 22.9 23.6 19.8 28.6 21.5 26.3 27.0 21.0 24.1 24.8 26.3 19.8 21.7 21.3 35.7 26.7 26.8 23.8 33.3 20.9 25.4 15.9 25.5 27.4 21.2 25.4 28.3 19.1 26.0 25.5 23.2 21.6 30.9 27.4 26.2 19.9 24.2 26.6 41.4 25.4 37.3 36.7 29.8 20.6 32.3 57.8 40.0 85.3 55.8 52.6 54.7 48.9 60.5 63.3 101.5 81.6 45.2 64.5 81.9 41.6 69.3 39.5 50.9 101.3 56.6 73.2 69.3 61.7 107.2 53.3 67.2 52.9 99.9 73.0 48.0 60.7 92.4 81.8 45.4 61.3 68.9 92.4 54.3 61.2 37.6 109.6 58.6 105.9 50.7 46.2 88.4 70.5 78.2 54.9 52.2 59.5 54.0 74.5 57.5 73.4 43.5 50.5 61.7 50.9 49.6 45.3 78.9 57.2 50.0 82.2 102.8 48.5 127.6 65.0 17.2 9.1 8.5 12.4 9.5 14.3 9.8 9.7 13.7 8.8 9.9 10.5 10.2 5.4 14.3 11.4 6.7 10.8 13.2 25.3 28.0 27.5 28.1 24.8 26.3 26.7 26.8 23.8 27.4 27.4 26.6 32.3 11.3 16.0 10.0 2.9 21.3 17.3 21.4 33.4 7.4 22.0 12.0 9.8 13.4 8.6 24.2 5.5 2.1 47.6 19.6 15.4 31.3 30.6 33.7 9.8 15.2 17.8 11.5 20.6 8.4 25.9 41.2 17.1 12.2 11.1 26.0 16.8 19.6 20.2 26.3 8.4 8.6 15.0 28.5 18.0 11.5 30.0 23.9 14.1 10.6 4.7 35.6 21.5 25.7 10.6 16.0 31.9 14.7 17.0 14.3 24.6 14.3 25.7 18.1 16.9 26.3 16.2 20.0 35.4 43.2 16.5 14.1 43.9 17.4 28.8 16.2 21.2 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773219-27824443 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 64.8 30.4 39.4 26.8 42.0 10.9 37.3 42.9 46.1 29.1 30.6 31.0 36.6 31.2 63.5 39.6 24.2 40.1 20.7 40.2 46.3 35.5 29.3 50.5 25.8 45.1 45.1 39.1 22.2 30.5 46.9 26.8 33.6 46.7 31.0 32.8 43.6 27.1 32.4 21.6 26.5 33.1 36.2 45.1 30.7 66.1 13.5 42.5 17.5 95.5 27.4 22.4 39.5 23.6 49.1 23.2 10.9 28.8 19.0 53.9 65.0 14.8 47.9 70.3 43.1 48.5 13.5 29.5 25.2 49.6 64.6 18.5 19.0 19.2 23.9 42.9 22.2 22.8 14.4 12.0 13.7 42.2 16.1 29.0 61.3 28.7 60.6 34.5 35.3 70.3 14.3 19.1 24.6 47.7 8.5 13.7 12.3 12.1 34.3 15.3 8.7 23.1 15.5 38.1 37.5 32.3 17.6 22.4 19.3 35.2 23.3 13.1 14.0 76.2 21.9 12.5 50.0 16.6 14.5 11.2 14.3 35.1 24.1 31.2 24.6 35.7 13.7 6.1 39.4 10.6 13.6 7.3 9.7 25.2 10.8 8.1 6.8 16.5 9.2 40.6 12.4 7.9 17.4 39.4 42.0 42.9 46.1 40.2 46.3 45.1 45.1 39.1 46.7 45.1 42.5 49.1 93.0 54.5 36.3 25.1 43.6 109.4 97.2 30.7 51.2 46.2 42.0 25.7 18.9 30.0 40.8 57.0 31.3 30.0 28.3 82.8 37.2 51.9 2.0 34.7 33.1 71.1 41.3 17.7 70.9 58.4 33.5 53.2 108.6 49.4 22.8 26.7 47.8 20.4 50.6 26.9 65.7 29.5 14.2 91.4 77.7 4.2 36.1 62.3 53.4 56.2 41.3 67.9 36.0 34.7 59.1 68.4 58.6 47.4 33.9 74.9 51.3 69.7 27.4 51.2 39.5 45.7 57.5 20.0 20.1 69.9 99.2 78.0 31.6 54.0 29.9 99.9 MTARC2 "FLJ20605, MARC2, MOSC2" ENSG00000117791 "Mitochondrial amidoxime reducing component 2" Q969Z3 1 220748225-220784815 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 133.7;liver: 225.4" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 29.0" "Cancer enhanced" "Detected in all" "liver cancer: 35.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 14.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.1" "Cell line enhanced" "Detected in many" "T-47d: 36.0;TIME: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015085, HPA017572" Enhanced NA NA "HPA015085: AB_1848780, HPA017572: AB_1848778" "unprognostic (8.17e-2)" "unprognostic (1.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.40e-10)" "unprognostic (4.78e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-1)" "unprognostic (1.90e-1)" "unprognostic (2.05e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (6.23e-2)" 30.7 18.0 10.5 6.2 12.1 0.6 16.6 8.8 15.6 11.7 47.7 18.0 59.7 6.8 15.7 9.8 10.9 21.8 25.3 11.2 10.0 133.7 225.4 31.5 7.4 9.0 10.8 11.0 22.1 30.2 125.9 9.6 12.8 8.7 20.4 20.7 3.0 36.7 12.6 34.8 4.6 58.7 9.6 8.0 11.7 28.1 11.1 10.8 3.1 42.5 21.5 8.3 12.6 10.5 10.1 9.5 7.8 4.1 5.4 10.1 4.6 3.2 6.7 11.7 8.0 8.1 5.3 11.9 0.0 4.6 6.5 4.3 1.3 0.0 9.4 7.5 0.0 15.7 0.0 16.5 11.0 9.3 4.5 0.0 8.0 14.1 3.0 0.0 12.1 22.2 0.0 6.3 0.1 5.1 2.3 0.0 15.7 6.6 3.2 7.8 0.0 13.0 0.2 28.2 10.3 2.3 6.1 10.6 0.1 15.2 4.5 36.0 5.6 33.9 0.0 4.8 10.6 12.0 2.0 0.1 0.0 1.7 0.0 0.1 14.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 12.1 8.8 15.6 11.2 10.0 9.0 10.8 11.0 8.7 8.0 10.8 10.1 7.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 SLC5A9 SGLT4 ENSG00000117834 "Solute carrier family 5 member 9" Q2M3M2 1 48222685-48248644 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 43.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 22.4;Proximal enterocytes: 84.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.1;renal cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA050263 Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA050263: " "unprognostic (3.09e-3)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-3)" "unprognostic (3.64e-2)" "unprognostic (4.59e-2)" "unprognostic (3.60e-2)" "unprognostic (1.59e-1)" "unprognostic (7.42e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.56e-1)" "unprognostic (2.11e-1)" "unprognostic (4.30e-3)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.6 43.7 0.1 1.3 0.2 0.1 2.5 0.0 0.0 0.0 3.7 7.8 3.0 0.0 0.2 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.8 0.1 1.1 42.3 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 22.4 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 2.8 0.0 0.0 0.0 0.0 0.0 3.1 1.9 0.5 6.3 0.5 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.5 4.5 0.0 0.7 4.4 0.1 0.0 0.2 2.9 0.0 1.3 0.0 11.0 0.3 0.3 0.0 1.9 0.1 0.0 0.0 7.5 2.9 0.1 1.7 0.4 0.0 0.0 84.0 4.1 0.0 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.0 3.0 0.0 OSBPL9 ENSG00000117859 "Oxysterol binding protein like 9" Q96SU4 1 51577179-51798427 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 216.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027378, HPA027397" Supported Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027378: AB_1854816, HPA027397: AB_1854817" "unprognostic (5.99e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-2)" "unprognostic (2.43e-3)" "unprognostic (3.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-3)" "unprognostic (1.58e-1)" "unprognostic (8.36e-3)" "unprognostic (8.61e-2)" "unprognostic (3.64e-2)" "unprognostic (7.53e-3)" "unprognostic (2.55e-1)" "unprognostic (4.95e-2)" "unprognostic (3.37e-1)" 24.3 38.4 21.4 18.3 25.4 30.4 32.9 28.3 22.7 24.1 29.3 20.3 17.6 31.4 31.3 17.9 23.5 17.8 37.4 19.9 25.9 43.2 61.3 27.7 26.2 26.9 25.1 18.2 30.8 33.6 60.4 21.3 22.0 29.6 28.0 19.3 54.0 22.2 22.6 70.6 18.9 21.9 24.4 25.8 27.4 34.5 28.6 24.7 22.0 24.9 35.5 33.2 23.9 24.9 34.7 66.3 31.7 69.0 11.2 38.1 17.9 90.7 30.1 50.8 54.9 60.0 53.0 46.6 105.8 54.4 34.1 120.9 26.9 59.2 57.4 76.9 71.9 41.9 77.4 62.7 104.7 36.9 81.7 35.5 44.7 55.0 56.8 31.4 66.8 68.9 52.1 154.4 31.1 26.7 45.4 20.3 92.5 97.0 26.8 15.1 58.2 102.8 110.5 74.0 47.4 31.8 45.2 22.4 79.6 93.7 154.7 38.0 82.8 22.9 11.6 51.2 17.2 58.1 80.2 52.5 120.4 39.3 32.8 23.0 52.7 12.2 30.5 20.1 9.9 28.9 32.6 19.7 20.8 25.0 23.9 21.0 22.2 16.9 16.3 9.4 23.2 20.5 16.4 21.4 25.4 28.3 22.7 19.9 25.9 26.9 25.1 18.2 29.6 25.8 24.7 34.7 32.5 80.1 56.8 75.4 39.2 17.7 33.8 25.7 34.1 102.0 34.2 33.0 47.9 38.6 50.5 46.0 41.7 89.2 30.4 20.5 125.2 47.6 40.7 36.3 46.3 30.1 29.8 35.7 64.8 47.8 50.2 48.6 54.0 52.9 33.6 75.7 18.2 61.7 40.1 26.9 113.0 18.3 38.7 22.7 16.0 38.3 62.4 25.3 65.8 63.7 50.1 43.8 29.9 62.8 216.4 41.9 14.3 50.0 81.4 38.5 26.4 59.7 32.1 35.3 46.0 36.9 62.9 32.3 18.9 26.9 18.9 75.5 32.0 52.2 21.2 27.4 TXNDC12 "AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19" ENSG00000117862 "Thioredoxin domain containing 12" O95881 1 52020131-52055191 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 160000 "unprognostic (6.54e-2)" "unprognostic (5.46e-2)" "prognostic favorable (4.44e-4)" "unprognostic (2.33e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.61e-4)" "prognostic unfavorable (1.28e-5)" "unprognostic (1.25e-1)" "unprognostic (3.28e-2)" "unprognostic (1.17e-1)" "unprognostic (6.14e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.40e-12)" "unprognostic (2.13e-1)" "unprognostic (5.83e-2)" "unprognostic (1.73e-2)" "unprognostic (1.17e-1)" 50.0 48.1 40.8 46.1 42.1 51.8 51.3 42.1 48.4 49.6 45.8 61.4 47.4 41.2 63.4 31.5 57.3 46.9 36.9 40.6 45.5 54.5 74.7 47.3 50.5 43.4 42.7 39.8 48.2 57.0 47.1 22.1 55.0 43.7 41.2 66.7 28.9 58.1 36.8 18.4 30.1 48.8 41.1 45.3 46.8 56.9 39.2 42.6 52.8 53.1 30.4 54.9 58.0 18.2 45.8 97.1 88.9 96.0 135.4 160.1 83.9 76.4 143.5 143.8 132.7 150.7 99.8 78.2 73.0 93.8 118.1 141.1 127.3 134.5 112.9 178.2 94.1 124.2 93.1 73.3 163.2 165.7 176.8 181.8 120.5 132.0 134.0 203.3 99.0 135.4 89.1 87.1 48.2 111.9 91.4 89.3 233.6 208.0 138.8 85.9 94.2 143.3 207.1 178.6 85.3 68.3 97.3 143.9 123.5 138.7 187.7 69.6 228.1 86.5 93.9 100.1 106.7 166.1 107.2 183.6 84.2 131.0 164.9 108.2 355.3 224.0 356.5 135.3 215.0 170.8 160.1 164.3 145.3 169.2 146.0 156.7 151.1 393.2 150.0 234.2 180.6 220.0 273.3 40.8 42.1 42.1 48.4 40.6 45.5 43.4 42.7 39.8 43.7 45.3 42.6 45.8 89.8 9.6 12.3 9.4 50.4 44.1 63.1 78.9 35.3 18.3 53.6 57.0 13.6 62.9 30.4 44.1 14.6 115.5 58.9 35.3 17.6 75.4 13.3 42.5 54.7 62.3 48.5 25.7 15.0 89.4 170.9 52.1 23.4 49.2 33.0 106.3 55.6 31.0 120.8 21.9 14.7 70.5 50.8 59.1 55.7 7.2 55.9 66.0 51.6 19.7 66.6 39.2 50.4 10.1 15.9 73.0 57.0 30.9 68.7 68.7 65.4 36.1 32.3 17.0 32.9 40.7 47.1 60.4 9.7 36.0 45.5 118.5 52.3 75.4 71.2 60.4 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 185.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002132, HPA070823" Approved Approved "Plasma membrane,Cytosol" NA NA 24000 "Plasma membrane, Cytosol" "HPA002132: AB_1078807, HPA070823: " "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (2.81e-5)" 54.3 37.4 24.9 25.9 24.1 35.1 34.3 21.9 28.8 30.4 24.2 34.3 22.5 36.4 30.3 45.4 34.7 32.5 35.4 27.8 33.2 27.5 24.7 33.7 27.7 22.4 22.9 19.7 48.5 29.4 31.2 20.7 43.7 24.0 25.6 30.6 14.3 32.4 30.8 45.3 29.6 27.9 39.0 20.9 21.6 25.7 15.9 28.7 37.3 39.7 42.2 25.6 36.1 29.5 23.2 92.9 57.8 19.5 19.8 62.2 72.6 55.3 47.5 48.9 36.7 40.6 29.7 106.1 27.5 52.2 86.2 66.6 46.0 27.8 50.2 35.1 31.5 28.3 26.2 44.0 32.2 64.1 95.0 55.8 53.4 51.8 41.8 55.2 73.1 44.8 81.9 56.4 97.8 61.9 71.7 96.0 66.7 29.2 53.9 56.7 82.4 37.0 38.8 58.6 38.4 46.8 30.2 151.6 109.7 66.7 43.4 37.7 96.3 69.3 40.3 18.8 178.7 60.5 68.6 17.3 27.5 102.4 93.8 121.5 1.7 1.4 1.2 6.1 1.8 3.4 1.1 5.1 4.3 2.8 0.6 4.6 5.5 0.9 5.4 1.2 1.8 4.2 2.3 24.9 24.1 21.9 28.8 27.8 33.2 22.4 22.9 19.7 24.0 20.9 28.7 23.2 65.7 38.5 32.4 55.5 18.1 46.1 12.9 22.6 19.4 15.0 32.6 21.6 30.8 21.5 33.7 47.8 16.7 31.6 54.0 41.0 3.9 15.3 18.0 60.6 17.8 48.5 21.1 17.7 137.1 20.0 26.1 44.2 15.8 47.0 12.6 36.8 23.2 20.9 20.2 13.5 119.3 31.2 24.4 20.2 83.6 5.3 35.1 27.7 51.6 185.5 21.9 12.1 43.3 67.3 61.4 29.9 14.1 54.5 36.2 23.2 28.0 8.7 61.8 10.8 32.9 42.6 60.4 10.6 10.2 22.0 51.7 40.8 43.4 19.5 26.0 25.8 POLR1G "A34.5, ASE-1, CAST, CD3EAP, PAF49, RPA34" ENSG00000117877 "RNA polymerase I subunit G" O15446 19 45406644-45410737 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 15.8;Extravillous trophoblasts: 26.3;Hofbauer cells: 11.5;Syncytiotrophoblasts: 7.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Lineage enriched" "Detected in all" 4 "dendritic cells: 14.5" "Cell line enhanced" "Detected in all" "U-251 MG: 200.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041664, HPA041734" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA041664: AB_10795693, HPA041734: AB_10794489" "unprognostic (1.03e-1)" "unprognostic (8.98e-2)" "unprognostic (9.28e-2)" "unprognostic (1.37e-3)" "unprognostic (2.46e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (4.79e-9)" "unprognostic (1.62e-3)" "unprognostic (3.21e-1)" "unprognostic (5.01e-2)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-9)" "unprognostic (1.02e-1)" "unprognostic (2.81e-1)" "unprognostic (1.38e-2)" "unprognostic (4.53e-2)" 3.2 2.5 2.8 3.4 3.1 2.1 3.1 4.2 4.2 2.4 0.8 2.5 2.4 2.7 1.4 4.3 3.0 2.8 3.0 3.0 1.3 1.6 2.7 2.0 3.5 3.4 2.5 2.5 3.5 3.8 2.9 1.9 2.2 4.2 2.2 2.1 2.7 2.9 1.9 6.7 4.4 1.9 3.0 1.1 2.1 1.9 1.8 3.0 2.1 2.4 4.5 4.0 4.2 2.4 3.4 31.4 29.0 5.3 20.6 7.5 6.5 20.3 15.3 5.2 26.2 15.1 32.5 21.5 48.3 14.8 11.3 20.6 29.5 46.4 43.0 18.4 22.1 28.7 24.3 11.0 23.9 12.8 25.3 8.9 9.4 27.3 38.2 20.7 7.0 19.2 16.0 63.0 8.9 25.6 37.0 18.7 9.3 37.0 34.6 27.3 25.1 19.5 32.2 10.5 22.7 30.8 9.6 30.9 40.6 6.4 10.6 19.9 15.4 18.2 36.5 36.7 20.4 200.5 16.1 74.0 51.6 16.8 37.6 25.9 1.5 2.7 0.3 1.4 3.5 3.1 2.7 2.0 2.2 4.2 3.0 2.9 3.5 1.3 3.3 2.8 14.5 1.3 2.0 2.8 3.1 4.2 4.2 3.0 1.3 3.4 2.5 2.5 4.2 1.1 3.0 3.4 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 15.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 26.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 1600000 "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favorable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favorable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 14.5 17.5 12.2 13.8 13.9 5.5 14.0 13.8 13.1 17.9 14.4 14.7 13.0 11.4 43.1 14.7 12.5 11.6 12.6 12.1 14.3 14.5 20.8 14.3 14.1 13.6 14.3 11.2 17.6 19.3 14.1 17.9 27.1 14.2 18.3 14.6 10.5 18.5 14.4 7.8 10.8 12.8 11.2 13.4 13.9 15.5 9.9 14.1 14.3 34.0 10.7 13.3 15.5 14.5 15.4 26.8 40.2 34.6 22.3 57.1 32.4 54.0 40.0 47.4 42.7 51.6 36.0 72.9 22.4 45.4 32.3 45.1 43.8 54.1 41.1 40.3 50.2 35.5 28.3 33.0 61.9 43.7 33.8 30.0 33.9 46.6 36.1 42.4 35.7 41.1 27.0 34.7 55.5 36.7 34.0 20.9 28.3 41.9 39.3 16.4 31.7 21.3 59.7 35.6 36.3 29.9 17.6 43.9 29.3 70.0 62.4 34.0 26.8 32.4 40.9 39.1 22.1 52.2 35.0 48.0 30.2 38.5 59.7 43.8 39.4 26.1 19.1 35.6 24.9 41.8 34.5 37.2 35.4 27.2 35.4 34.6 34.7 8.1 44.8 22.5 45.2 42.5 31.1 12.2 13.9 13.8 13.1 12.1 14.3 13.6 14.3 11.2 14.2 13.4 14.1 15.4 59.7 80.1 59.6 0.0 20.6 0.0 0.0 0.0 0.0 0.0 51.0 44.2 0.0 0.0 27.9 58.8 0.0 341.4 41.6 0.0 13.7 100.9 0.0 41.4 79.4 36.9 0.0 0.0 0.0 111.9 279.3 48.4 0.0 69.8 36.6 56.4 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 82.5 0.0 0.0 18.8 0.0 0.0 48.8 43.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 436.0 25.8 63.6 0.0 0.0 RCN2 "E6BP, ERC-55, ERC55, TCBP49" ENSG00000117906 "Reticulocalbin 2" Q14257 15 76931738-76954393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 324.3" "Cell type enhanced" "Detected in all" "Spermatocytes: 528.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030694, HPA030695" Enhanced Supported Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 92000 "Endoplasmic reticulum" "HPA030694: AB_2673573, HPA030695: AB_2673574" "unprognostic (1.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (2.42e-1)" "unprognostic (8.71e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (1.74e-1)" "unprognostic (2.20e-2)" "unprognostic (4.61e-3)" "unprognostic (1.39e-1)" "unprognostic (1.98e-1)" "unprognostic (1.70e-2)" "unprognostic (2.11e-2)" "unprognostic (2.99e-1)" "unprognostic (1.15e-1)" "unprognostic (3.67e-2)" 31.6 31.1 49.3 25.2 51.3 24.8 36.1 43.8 58.3 34.4 47.3 33.5 22.4 44.4 324.3 28.7 54.7 32.9 39.1 51.0 58.2 49.8 20.0 29.0 30.3 46.5 50.6 48.6 34.5 21.7 81.3 31.0 49.6 50.6 41.5 36.9 44.3 22.9 41.5 57.4 22.7 23.5 39.9 44.1 25.6 27.1 94.2 55.6 40.7 48.5 60.9 32.7 39.4 25.4 49.3 93.9 65.3 284.1 134.9 120.1 135.6 177.3 109.1 147.5 138.7 115.1 81.2 78.2 58.3 154.3 119.3 149.5 139.9 217.4 94.0 176.0 45.3 170.8 28.9 91.4 135.0 143.0 105.4 42.9 123.6 126.8 68.2 87.5 146.1 148.9 98.3 74.2 56.3 146.6 60.3 104.9 71.9 216.6 98.0 72.1 109.4 187.0 37.3 91.6 123.8 161.8 161.1 178.8 98.6 220.5 251.1 96.0 115.0 80.5 162.8 131.2 104.8 228.0 80.4 266.6 69.6 92.8 87.6 151.1 7.5 7.6 16.2 21.7 7.4 24.9 23.4 23.0 28.1 16.1 22.9 25.5 25.1 3.9 23.5 12.3 19.1 18.1 20.0 49.3 51.3 43.8 58.3 51.0 58.2 46.5 50.6 48.6 50.6 44.1 55.6 49.3 87.3 25.6 36.8 56.8 111.2 82.1 125.0 85.5 96.2 87.1 75.9 74.8 94.9 62.9 52.5 99.3 37.5 183.1 76.3 23.3 49.0 116.0 44.8 87.0 101.6 64.8 73.5 91.5 48.4 45.1 296.8 106.0 54.6 85.6 28.6 120.9 60.0 32.8 57.3 127.9 72.0 55.0 101.7 30.5 38.3 81.7 61.8 30.0 92.5 19.7 34.1 99.7 89.6 149.8 63.3 56.9 43.2 93.6 85.6 127.5 25.8 56.2 48.7 58.9 59.2 78.9 126.3 528.6 140.8 109.3 70.8 163.6 76.7 131.8 84.4 117.0 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624111-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.0;retina: 2.7;testis: 5.9" "Group enriched" "Detected in some" 11 "Early spermatids: 44.1;Late spermatids: 54.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "SCLC-21H: 30.9;SH-SY5Y: 40.7" "Group enriched" "Detected in some" 5 "olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" NA NA "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.0 2.5 0.2 0.6 0.2 0.3 0.0 0.1 0.3 0.2 0.2 0.8 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.5 0.7 1.9 0.2 0.1 0.0 0.2 0.4 0.0 0.9 0.0 0.4 2.7 0.1 0.0 0.3 0.1 0.3 0.4 0.0 0.4 0.3 5.9 0.3 3.0 0.1 0.0 0.4 0.0 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.6 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.9 40.7 0.2 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.5 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.4 0.7 1.9 0.2 0.9 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 44.1 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.5 0.1 0.2 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 1.6 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "salivary gland: 2643.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "OE19: 113.9;PC-3: 120.0" "Not detected" "Not detected" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" NA NA 1300000 Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.7 0.2 2.0 0.1 0.0 1.3 0.0 0.4 231.4 0.0 33.4 0.1 0.4 0.0 101.8 1.1 223.3 0.1 0.0 0.0 0.1 2.4 7.6 0.0 0.1 0.0 0.0 0.1 9.8 0.0 0.4 0.0 0.2 0.6 17.3 0.0 2643.6 0.0 0.3 0.4 2.6 0.6 0.0 0.0 6.9 0.3 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.2 0.0 17.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.2 0.0 113.9 120.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 32.8 0.0 2.3 0.0 0.0 6.7 0.6 0.0 6.4 4.3 12.4 443.2 64.0 0.0 0.0 0.1 0.0 158.4 0.0 0.9 0.0 1.4 0.8 0.9 24.5 0.0 0.1 0.0 0.1 1.1 12.8 7.2 4.5 0.0 0.0 1.2 0.2 0.0 0.0 210.1 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 53.4 0.0 1.4 1.3 0.1 0.2 24.5 0.0 0.0 0.0 3.0 0.0 0.5 1.6 0.0 0.1 0.7 0.1 183.1 1.1 CTSD "CLN10, CPSD" ENSG00000117984 "Cathepsin D" P07339 11 1752752-1764573 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5" "CAB000109, HPA003001" Supported "Secreted to blood" NA NA 370000000 "CAB000109: , HPA003001: AB_1078404" "unprognostic (9.95e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.46e-4)" "unprognostic (1.09e-1)" "unprognostic (1.71e-3)" "unprognostic (2.65e-2)" "unprognostic (9.40e-3)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-3)" "unprognostic (1.59e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.93e-5)" "unprognostic (8.98e-2)" "unprognostic (3.39e-2)" "unprognostic (2.13e-2)" "unprognostic (1.60e-1)" 314.7 740.6 140.3 206.8 170.4 503.5 246.1 184.1 216.9 273.1 554.7 282.6 391.1 172.1 83.5 322.0 173.1 442.4 423.1 175.4 250.9 682.3 468.6 544.3 243.0 242.1 195.4 112.1 131.8 287.2 138.5 132.5 182.2 193.5 139.3 154.8 48.7 425.8 233.8 595.1 337.7 401.7 106.0 223.3 445.6 289.6 89.6 275.2 78.8 183.6 179.8 124.1 299.0 310.1 288.3 204.6 578.9 51.4 246.2 586.5 206.3 112.1 149.4 362.2 161.8 182.8 147.5 2596.6 49.2 376.8 285.8 1265.6 1072.2 63.7 142.6 35.8 206.7 222.9 70.4 92.5 196.5 736.2 171.4 787.7 350.9 621.6 82.5 136.9 2780.1 128.2 62.1 89.2 267.6 263.3 832.6 47.0 110.9 153.1 719.7 247.9 62.5 72.5 191.2 586.6 610.8 84.2 94.8 173.3 2488.5 535.0 68.6 1022.8 232.6 170.3 556.8 92.9 79.0 216.7 432.0 382.3 26.8 867.7 468.6 509.6 211.2 578.7 170.1 156.5 309.9 90.6 28.8 72.1 110.3 144.5 18.8 82.5 107.4 319.5 192.3 265.2 120.3 89.2 489.1 140.3 170.4 184.1 216.9 175.4 250.9 242.1 195.4 112.1 193.5 223.3 275.2 288.3 139.3 112.2 228.6 48.3 62.8 72.0 223.5 473.2 71.7 168.6 108.9 113.8 251.9 314.5 459.5 548.1 110.5 211.7 156.1 1475.9 109.5 911.4 3.3 118.1 67.4 128.3 159.6 132.6 18.3 370.1 165.0 157.0 237.5 203.4 474.3 119.4 695.7 678.9 3763.5 264.2 25.2 418.2 498.5 1187.8 67.5 14.6 108.4 1512.6 227.7 20.6 382.6 179.0 256.4 27.2 42.2 392.3 832.5 128.2 122.5 111.7 1699.4 311.8 270.3 102.1 111.7 70.7 135.2 26.6 63.5 141.2 82.1 471.3 155.0 96.0 399.1 357.8 COLEC11 "CL-K1, MGC3279" ENSG00000118004 "Collectin subfamily member 11" Q9BWP8 2 3594832-3644644 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 54.6;liver: 144.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 37.4;Hepatic stellate cells: 89.3;Peritubular cells: 52.3;Proximal tubular cells: 127.1;Sertoli cells: 72.3" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 135.7;SH-SY5Y: 111.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA035241 Uncertain "Secreted to blood" NA NA 130000000 "HPA035241: AB_10600701" "unprognostic (3.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" "unprognostic (1.53e-2)" "unprognostic (1.40e-2)" "unprognostic (7.95e-3)" "unprognostic (5.85e-3)" "unprognostic (6.96e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-1)" "unprognostic (6.96e-2)" "unprognostic (2.26e-1)" "unprognostic (9.27e-3)" "unprognostic (7.54e-2)" "unprognostic (1.46e-1)" "unprognostic (1.60e-1)" 9.4 40.9 1.2 0.9 1.0 1.9 3.3 4.0 1.9 1.5 5.7 2.5 3.5 1.2 0.4 1.6 4.5 54.6 28.8 1.4 1.0 24.2 144.3 2.5 2.0 1.1 0.7 1.2 46.8 13.9 1.3 5.9 2.4 2.0 3.3 0.6 0.5 0.6 1.1 0.6 1.4 3.9 1.2 0.6 3.8 3.1 7.5 0.9 4.1 17.1 0.9 0.2 7.2 1.0 1.4 0.2 1.4 0.7 2.5 0.0 0.0 11.7 0.7 0.0 0.3 0.2 0.7 0.2 0.3 4.0 0.1 0.4 0.4 0.1 0.4 0.3 0.2 0.8 0.6 1.4 5.0 135.7 0.2 1.0 1.6 0.1 0.2 0.0 0.4 0.1 0.8 11.1 0.8 0.0 0.1 0.0 0.8 0.6 0.2 0.9 0.0 0.0 0.5 0.0 0.3 2.1 111.7 1.6 1.1 0.8 0.3 0.5 1.0 0.0 0.0 0.7 0.6 0.5 3.2 26.2 1.5 0.3 1.3 0.6 0.7 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.2 0.9 0.3 0.1 0.2 0.1 0.0 1.2 1.0 4.0 1.9 1.4 1.0 1.1 0.7 1.2 2.0 0.6 0.9 1.4 7.3 0.0 0.0 0.7 0.6 1.0 0.0 0.0 2.8 0.5 0.1 0.3 1.2 0.0 0.0 0.0 0.0 1.6 0.0 0.1 17.6 0.0 0.3 1.1 22.0 4.2 0.0 0.0 2.2 0.0 1.4 37.4 0.0 0.6 0.0 1.3 89.3 7.9 2.5 0.0 0.9 0.1 0.0 1.9 0.3 0.5 7.5 0.8 3.6 1.0 0.0 1.4 0.0 0.5 0.2 0.1 0.0 52.3 0.0 0.2 0.0 127.1 0.0 0.1 72.3 0.3 18.0 1.3 11.6 0.6 0.9 1.2 0.7 27.0 0.0 0.1 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336236-136752403 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 13.2 9.2 7.4 12.4 8.6 15.8 15.7 17.1 8.1 17.0 10.6 13.7 9.7 19.5 10.7 10.9 13.6 10.4 10.6 6.6 10.3 12.1 10.9 11.3 14.8 8.9 8.4 6.0 22.1 12.5 13.8 5.0 17.8 9.4 10.9 14.5 13.3 11.7 12.2 15.1 13.8 11.1 16.3 9.3 11.9 10.1 8.9 8.2 22.7 16.0 16.0 16.1 12.2 11.6 11.0 34.6 17.6 29.1 25.1 21.5 36.8 15.7 37.9 48.4 35.0 33.0 30.2 14.9 26.9 23.3 39.7 28.1 23.4 31.6 17.3 47.4 33.2 14.9 28.8 25.1 16.7 16.3 50.6 27.7 23.4 19.3 25.6 28.6 20.3 27.5 28.8 18.7 52.7 22.3 29.5 33.6 16.4 19.0 23.7 13.9 29.6 31.6 35.7 19.1 24.5 14.2 22.8 40.8 16.0 17.5 15.0 22.9 21.2 23.3 40.1 29.0 36.0 33.9 39.1 28.9 59.5 24.6 17.0 26.2 4.0 3.0 4.6 4.4 3.0 4.6 6.4 3.7 4.0 2.8 4.4 4.1 3.3 8.7 5.5 3.5 4.5 4.8 2.1 7.4 8.6 17.1 8.1 6.6 10.3 8.9 8.4 6.0 9.4 9.3 8.2 11.0 44.5 25.6 24.2 95.6 42.4 40.0 31.4 18.7 38.7 43.8 24.8 26.7 10.8 22.8 23.5 16.5 39.6 29.3 39.5 42.1 11.7 20.7 2.8 23.7 59.5 34.1 18.7 29.7 161.8 22.2 26.7 33.8 23.9 39.6 22.2 30.3 31.4 21.5 18.6 28.6 166.8 27.9 8.2 16.9 22.0 4.8 49.4 25.1 16.0 231.4 27.2 25.6 42.2 223.2 188.4 27.4 17.5 32.4 53.1 27.2 24.2 13.2 14.5 68.1 26.3 67.1 36.2 54.8 50.5 27.5 36.7 31.7 39.2 16.0 23.4 24.3 A4GNT alpha4GnT ENSG00000118017 Alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3 3 138123713-138132390 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "stomach 1: 23.8" "Group enriched" "Detected in some" 25 "Cholangiocytes: 4.3;Gastric mucus-secreting cells: 16.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 2.5;stomach cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA008017 Enhanced "Intracellular and membrane" NA NA "HPA008017: AB_1078073" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.48e-2)" "unprognostic (8.79e-2)" "unprognostic (9.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (4.03e-2)" "unprognostic (1.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.48e-3)" 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 2.7 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.1 0.2 0.0 0.2 0.3 0.0 0.1 3.3 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.2 23.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STK11 "LKB1, PJS" ENSG00000118046 "Serine/threonine kinase 11" Q15831 19 1177558-1228431 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.9;Late spermatids: 338.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016231, HPA017254, CAB022105, HPA067481" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: AB_2685847" "unprognostic (8.60e-2)" "unprognostic (1.68e-1)" "unprognostic (5.00e-2)" "prognostic favorable (3.69e-5)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (9.11e-3)" "unprognostic (3.19e-1)" "unprognostic (9.08e-2)" "unprognostic (1.26e-1)" "unprognostic (1.95e-3)" "unprognostic (7.70e-3)" "unprognostic (3.54e-2)" "unprognostic (3.16e-2)" "unprognostic (1.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.12e-3)" 31.6 44.6 17.9 18.4 14.8 34.4 32.5 22.2 23.7 35.6 20.9 37.7 25.9 33.8 5.6 40.0 35.2 11.9 45.9 17.5 13.9 36.6 45.9 30.7 20.7 18.2 18.1 15.7 38.2 34.5 16.2 37.1 12.7 16.0 39.6 7.8 5.7 30.0 16.3 109.1 40.2 38.0 9.7 15.1 48.7 38.4 103.2 18.7 15.1 34.6 27.9 13.0 34.7 35.3 15.0 50.0 25.8 19.9 35.9 18.6 17.0 35.5 24.0 27.7 25.1 25.4 22.5 37.1 31.9 24.8 27.8 11.2 32.3 20.1 41.9 8.2 60.2 37.8 34.8 1.7 26.4 38.1 36.6 53.5 30.5 28.9 19.4 29.2 22.3 25.2 28.1 63.1 51.1 13.9 39.3 31.9 27.7 33.0 19.6 25.1 50.0 20.0 36.1 21.1 39.7 39.8 26.6 0.0 19.7 24.2 11.4 30.3 55.2 33.7 24.6 25.0 45.2 38.7 85.3 38.1 25.7 22.6 48.1 25.5 1.7 3.3 3.9 0.4 5.5 0.3 2.3 0.8 1.4 1.6 0.7 0.7 0.6 9.9 1.4 5.7 0.8 0.6 0.5 17.9 14.8 22.2 23.7 17.5 13.9 18.2 18.1 15.7 16.0 15.1 18.7 15.0 24.5 6.4 13.7 12.7 10.5 16.7 7.4 9.5 9.6 25.5 22.0 18.4 13.7 15.7 9.0 23.9 18.8 7.5 20.1 44.4 7.9 9.4 154.9 18.0 18.1 15.7 15.0 27.3 7.9 14.0 5.3 13.2 21.9 17.8 2.5 80.3 15.4 31.6 15.2 18.5 8.5 33.1 6.1 18.3 26.4 338.7 24.5 20.7 16.0 11.2 20.4 21.2 9.2 9.0 6.5 16.7 29.3 20.7 10.2 15.1 27.5 11.0 9.3 21.0 13.1 21.5 23.7 85.5 20.1 14.6 15.5 8.8 16.6 45.2 35.4 12.6 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 8.8 6.7 8.3 8.6 8.9 19.7 9.9 20.0 9.7 10.3 1.9 9.6 5.4 10.7 8.2 6.9 10.4 6.4 6.4 7.9 6.8 6.8 6.1 10.6 12.5 7.8 9.0 6.7 21.4 11.2 9.9 10.3 5.6 9.3 9.3 6.5 24.1 9.4 8.5 7.5 10.4 9.8 7.7 3.7 9.8 8.2 5.3 6.6 14.2 10.0 8.4 11.3 10.8 9.4 12.5 17.9 8.6 20.1 14.5 11.1 16.1 6.2 8.7 11.8 9.0 9.6 17.3 11.4 23.1 15.9 10.8 14.6 16.0 22.9 7.2 17.9 26.0 10.0 45.7 8.9 9.3 6.1 28.5 7.8 7.2 7.4 20.3 24.0 8.9 12.8 13.3 32.8 18.8 9.2 12.7 18.2 12.7 13.6 6.6 13.7 13.8 21.9 6.9 9.8 13.8 18.0 11.8 22.0 6.7 3.9 9.8 11.9 9.1 20.4 14.1 12.7 9.4 14.7 5.1 4.4 15.6 4.7 17.6 8.3 2.1 0.6 1.9 1.6 0.6 1.6 2.5 1.8 1.5 0.3 1.8 1.8 1.2 0.5 2.0 0.7 1.4 1.7 0.4 8.3 8.9 20.0 9.7 7.9 6.8 7.8 9.0 6.7 9.3 3.7 6.6 12.5 87.1 70.5 65.8 93.4 83.4 86.9 67.6 29.4 64.9 158.1 76.8 73.9 44.5 40.0 32.2 38.6 152.2 13.9 81.0 26.2 3.9 33.0 10.1 62.1 101.4 74.4 66.4 67.3 146.0 25.6 10.2 65.6 44.4 85.2 29.0 57.5 60.0 27.3 16.8 195.2 170.1 29.6 20.3 37.0 63.7 5.8 66.8 44.8 42.7 62.8 49.9 98.9 78.2 106.6 131.9 28.2 20.1 78.6 83.3 88.3 22.7 10.5 52.7 152.4 65.7 113.4 84.6 25.5 30.7 46.3 80.6 6.0 102.8 55.8 30.6 64.8 TREH "MGC129621, TRE, TREA" ENSG00000118094 Trehalase O43280 11 118657316-118679690 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 66.8" "Group enriched" "Detected in some" 5 "Late spermatids: 315.7;Proximal enterocytes: 186.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039913, HPA042045" Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 12000000 Cytosol Vesicles "HPA039913: AB_10674988, HPA042045: AB_2677817" "unprognostic (1.29e-1)" "unprognostic (1.58e-1)" "unprognostic (1.01e-2)" "unprognostic (5.22e-4)" "unprognostic (2.52e-1)" "unprognostic (9.83e-2)" "prognostic favorable (3.76e-4)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (2.42e-1)" "unprognostic (1.04e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.09e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-1)" 0.5 0.2 1.5 0.3 3.2 0.0 0.4 0.7 2.9 0.3 0.0 1.6 60.6 0.4 0.6 1.6 0.3 2.6 0.7 0.9 3.2 13.5 6.1 0.2 0.1 2.7 2.1 0.6 0.2 1.8 0.0 0.3 0.1 4.2 0.5 1.4 0.0 0.2 0.0 0.0 0.1 66.8 0.1 0.7 0.1 1.7 1.8 2.0 0.0 0.4 0.0 0.0 0.4 0.3 4.9 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.7 2.9 0.9 3.2 2.7 2.1 0.6 4.2 0.7 2.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.3 0.3 1.5 0.0 1.8 0.0 0.1 0.0 2.3 7.9 0.2 45.6 0.8 1.6 0.1 3.0 0.0 0.1 2.5 0.0 0.3 4.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 7.0 0.0 0.0 0.4 315.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 5.3 0.9 6.3 1.9 0.1 0.3 186.3 32.8 0.0 0.0 0.0 0.3 0.2 1.7 0.8 2.1 0.0 0.0 0.1 0.0 3.7 0.0 IFT46 "C11orf2, C11orf60, CFAP32, FLJ21827" ENSG00000118096 "Intraflagellar transport 46" Q9NQC8 11 118544528-118572970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 64.9;Respiratory ciliated cells: 84.3;Spermatocytes: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037909, HPA057550" Approved Approved "Actin filaments" NA NA "Actin filaments" "HPA037909: AB_10672731, HPA057550: AB_2683464" "unprognostic (8.77e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-3)" "unprognostic (6.76e-2)" "unprognostic (1.55e-2)" "unprognostic (1.07e-1)" "unprognostic (3.29e-2)" "unprognostic (3.75e-3)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (3.61e-1)" "unprognostic (9.02e-3)" "unprognostic (1.42e-1)" "unprognostic (2.48e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-1)" 14.0 19.6 31.7 8.8 30.6 5.7 27.1 35.0 36.1 22.5 36.1 15.8 7.8 19.6 25.0 13.8 67.4 16.6 21.5 28.8 37.6 27.1 17.1 15.2 11.1 32.3 34.2 28.3 27.5 16.8 18.6 29.1 8.8 31.7 21.1 11.2 36.0 16.1 20.4 18.1 13.6 10.4 20.9 32.1 11.9 15.1 28.4 31.1 16.1 27.7 17.8 12.9 16.1 16.8 32.9 15.6 18.4 26.1 16.9 42.8 35.7 3.2 31.9 46.2 29.3 27.6 22.5 28.8 23.8 46.1 38.6 7.2 22.1 26.7 31.8 34.4 9.1 21.8 49.2 9.0 8.6 32.0 11.8 13.8 32.4 37.0 49.0 46.2 26.6 28.9 32.1 27.4 16.0 37.3 71.7 31.3 15.6 7.7 27.3 38.0 25.6 20.0 19.0 23.5 21.4 16.7 18.3 23.2 29.9 20.1 15.0 46.2 16.7 24.6 31.6 20.2 18.4 12.0 9.9 14.3 26.7 16.0 21.2 23.2 2.8 5.2 5.9 8.6 4.3 9.9 11.1 7.6 7.9 6.9 8.3 9.2 5.5 1.6 11.0 4.2 7.0 9.9 4.8 31.7 30.6 35.0 36.1 28.8 37.6 32.3 34.2 28.3 31.7 32.1 31.1 32.9 5.5 9.6 10.3 10.4 4.9 4.0 8.3 14.4 8.0 12.5 11.6 8.4 14.5 10.0 15.4 11.0 18.8 5.3 3.8 1.6 5.9 17.1 20.5 64.9 11.7 9.3 4.2 6.6 8.7 11.6 7.1 9.5 4.1 9.6 12.0 10.2 8.6 5.9 8.8 1.7 8.9 4.3 14.2 2.4 3.5 15.7 10.2 3.1 1.8 5.6 5.5 14.8 2.1 4.0 6.4 10.2 4.2 18.4 6.1 6.1 3.4 14.3 84.3 16.5 0.0 11.3 11.5 44.9 38.4 6.5 7.0 1.9 4.2 9.8 5.3 3.9 MMP8 CLG1 ENSG00000118113 "Matrix metallopeptidase 8" P22894 11 102711796-102727050 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "bone marrow: 506.1" "Group enriched" "Detected in some" 6 "Hofbauer cells: 4.0;Macrophages: 1.5" "Cancer enriched" "Detected in single" 17 "melanoma: 5.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 1.7" "Cell line enriched" "Detected in some" 8 "WM-115: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021221, HPA021763, HPA022935" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 360000 Vesicles "HPA021221: AB_1854043, HPA021763: , HPA022935: AB_1854044" "unprognostic (3.03e-1)" "unprognostic (8.49e-5)" "unprognostic (1.08e-2)" "unprognostic (3.95e-3)" "unprognostic (1.80e-1)" "unprognostic (1.01e-2)" "unprognostic (7.68e-3)" "unprognostic (1.27e-1)" "unprognostic (4.92e-2)" "unprognostic (6.64e-3)" "unprognostic (2.45e-6)" "unprognostic (2.33e-4)" "unprognostic (1.33e-1)" "unprognostic (4.97e-1)" "unprognostic (2.30e-2)" 0.4 0.0 0.0 0.3 0.1 506.1 0.2 0.1 0.2 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.6 4.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.2 0.0 13.9 0.1 0.0 0.4 2.6 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837622 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 19406.1" "Group enriched" "Detected in many" 21 "Hepatocytes: 27332.1;Proximal enterocytes: 18348.1" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 17 "Hep G2: 3460.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" NA NA 1450000000000 110000000000 Vesicles Cytosol "CAB016778: , HPA046715: AB_2679768" "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favorable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 1.8 1.4 1.0 3.7 1.0 0.0 2.1 1.0 1.4 0.7 0.9 4.8 1724.8 3.5 0.4 1.1 6.2 1.7 42.7 0.9 2.5 3.8 19406.1 2.7 3.3 0.9 1.0 0.9 23.3 2.5 0.0 4.3 1.6 0.9 1.2 0.2 0.1 0.7 1.0 0.8 0.9 4087.0 2.1 1.0 9.0 14.7 387.5 1.0 0.9 3.7 0.2 0.1 0.5 1.5 1.1 0.0 0.0 0.6 0.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 203.4 0.3 3.1 6.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 7.3 1.9 3460.4 0.0 16.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.2 0.3 15.0 1.2 1.2 0.1 0.5 15.0 20.3 0.0 2.6 5.7 20.7 8.9 0.0 0.0 3.9 0.0 0.1 2.6 0.0 0.4 2.1 0.1 1.2 0.2 4.9 0.0 5.5 0.2 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.5 0.2 0.1 0.2 0.5 0.0 0.2 0.0 1.2 0.6 0.1 1.0 1.0 1.0 1.4 0.9 2.5 0.9 1.0 0.9 0.9 1.0 1.0 1.1 2.0 3.2 3.3 0.3 49.7 0.1 0.5 0.2 0.6 0.5 0.9 0.9 37.0 479.0 1.3 0.0 0.0 0.6 5.1 0.4 0.0 0.1 36.9 15.2 4.3 50.3 1.8 541.9 0.5 1.1 4.2 5.8 17.9 1.7 2.5 419.2 458.7 27332.1 3.3 0.0 0.8 458.8 0.0 681.2 2.0 149.7 22.4 2.1 0.0 0.0 0.0 0.3 3.1 0.0 0.3 0.3 458.2 4.9 1.0 0.1 18348.1 9.0 0.4 0.6 6.6 1.6 13.0 39.8 11.2 0.0 0.6 4.2 35.7 1051.7 175.7 0.3 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 22.0" "Cell type enhanced" "Detected in some" "Early spermatids: 25.5;Late spermatids: 12.2;Proximal tubular cells: 19.1;Spermatocytes: 37.3;Spermatogonia: 11.7" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 1.5;SiHa: 5.0;U-87 MG: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058541: AB_2683748, HPA076453: AB_2732310" "unprognostic (4.49e-2)" "prognostic favorable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.0 3.1 0.3 0.1 0.3 0.1 0.6 0.2 0.8 0.1 0.0 0.5 0.1 0.3 0.0 0.0 0.2 0.2 0.6 0.4 0.1 0.7 0.1 0.1 0.2 0.3 0.1 0.3 2.4 0.1 0.1 0.6 0.3 0.3 0.1 0.1 0.5 0.1 0.1 0.5 0.3 0.3 0.2 0.0 0.5 0.1 22.0 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.5 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.8 0.4 0.1 0.3 0.1 0.3 0.3 0.0 0.1 0.3 4.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.5 0.3 1.8 0.0 0.0 1.8 2.1 0.0 0.3 0.0 0.0 0.0 25.5 0.0 0.1 1.6 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.3 0.0 2.0 6.1 0.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 12.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.5 19.1 0.0 0.8 0.0 0.0 0.1 37.3 11.7 0.0 0.1 0.0 0.4 0.5 0.0 0.0 SLC8A2 "KIAA1087, NCX2" ENSG00000118160 "Solute carrier family 8 member A2" Q9UPR5 19 47428017-47471893 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.6;Excitatory neurons: 40.3;Inhibitory neurons: 13.6;Oligodendrocytes: 6.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 3.0;SCLC-21H: 8.9;SH-SY5Y: 4.4;SiHa: 3.9;U-2 OS: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050818, HPA054671" Enhanced NA NA "HPA050818: AB_2681248, HPA054671: AB_2682568" "unprognostic (3.75e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (4.32e-2)" "unprognostic (1.34e-1)" "unprognostic (6.00e-3)" "unprognostic (1.38e-1)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (8.95e-2)" "unprognostic (4.77e-2)" "unprognostic (2.04e-2)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (9.40e-2)" "unprognostic (1.53e-1)" "unprognostic (1.63e-2)" 0.3 2.6 13.3 0.1 23.0 0.0 0.1 33.1 34.4 0.7 0.0 4.1 0.2 6.6 0.1 1.1 1.9 0.1 0.1 38.6 7.6 0.0 0.1 0.1 0.0 0.6 0.6 28.9 0.1 7.7 0.0 7.9 0.0 12.9 0.8 0.3 3.4 0.2 2.5 0.2 0.1 0.9 3.5 0.0 0.1 1.3 1.5 2.4 0.1 0.1 0.0 0.0 2.0 0.5 13.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 3.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 8.9 4.4 3.9 0.4 0.3 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 23.0 33.1 34.4 38.6 7.6 0.6 0.6 28.9 12.9 0.0 2.4 13.8 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 14.6 0.6 0.3 1.8 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.3 2.1 0.3 0.1 0.2 1.8 0.0 40.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.4 0.0 5.0 6.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.5 0.4 1.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475150-47484265 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 23.9" "Lineage enriched" "Detected in all" 4 "dendritic cells: 23.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 4.3 6.7 4.9 3.0 5.2 5.7 4.7 5.7 8.5 6.4 3.5 5.5 3.4 5.4 1.5 7.8 4.4 2.5 5.4 5.4 5.0 6.3 8.7 4.5 3.4 5.4 5.1 5.0 3.3 5.6 4.0 10.1 2.8 4.9 8.0 2.2 1.6 10.1 2.0 7.0 4.6 4.5 2.6 4.6 6.1 4.8 5.4 5.0 8.3 4.8 6.8 2.2 5.1 5.9 5.2 9.7 16.8 12.9 8.6 12.9 10.0 9.3 5.4 9.9 28.4 17.5 12.6 11.3 12.3 4.1 9.5 10.1 11.1 11.0 19.1 7.9 11.4 17.2 5.2 12.2 11.4 11.5 10.1 13.8 11.5 12.3 9.5 8.7 7.2 11.0 15.2 10.1 10.9 8.3 7.8 17.7 44.8 11.6 10.5 10.3 12.6 6.3 4.8 8.8 15.0 27.8 21.1 9.1 10.3 6.8 6.4 8.5 14.5 6.6 6.9 7.6 3.7 12.2 2.8 4.8 5.3 6.1 6.4 10.4 0.0 3.9 1.7 1.4 3.4 0.4 1.5 1.0 1.2 4.6 1.6 1.3 1.1 3.2 1.2 5.3 23.9 1.7 2.2 4.9 5.2 5.7 8.5 5.4 5.0 5.4 5.1 5.0 4.9 4.6 5.0 5.2 2.6 3.2 2.7 4.6 4.8 2.8 8.5 13.8 2.8 5.8 5.8 3.9 3.7 4.3 8.9 5.5 6.2 14.5 12.1 3.4 9.8 9.6 0.8 3.1 3.3 3.0 3.0 0.8 4.7 4.2 13.3 5.0 5.1 3.4 2.5 4.9 3.3 6.2 8.5 10.1 3.5 2.5 8.2 5.6 2.8 2.5 1.2 5.8 1.8 1.9 2.5 6.9 5.2 3.0 4.3 5.0 1.8 0.7 6.5 4.4 4.3 8.3 2.9 4.0 0.0 3.5 3.5 4.9 18.9 4.5 3.1 15.3 1.7 8.2 4.0 5.8 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031801, HPA078683" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 150000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA031801: AB_10610419, HPA078683: " "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavorable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 994.2 765.4 724.0 741.9 741.1 1665.0 1502.8 720.1 1143.2 1157.3 716.6 874.6 601.5 825.0 1039.4 906.0 1067.1 578.9 772.3 696.1 759.1 745.2 837.0 678.6 1500.8 739.4 729.1 689.6 2274.7 1290.2 539.5 814.0 639.0 741.8 848.4 704.6 464.3 1077.8 611.7 1891.5 1033.9 780.3 583.5 778.5 896.9 882.7 285.7 749.6 1110.9 824.2 1290.1 1318.0 975.4 1013.9 772.2 960.2 646.9 1024.1 1063.6 1461.7 2371.7 994.2 1098.1 1159.2 724.7 635.6 1753.4 1580.0 2269.6 2031.5 853.8 782.5 1146.8 951.4 1305.8 852.5 1166.9 1278.1 3013.6 598.3 1718.0 1102.2 2122.0 924.8 2043.3 2460.8 647.0 1673.7 2154.5 1384.9 1739.3 1670.1 1288.7 1072.8 2396.1 2072.1 3727.7 1045.8 2204.6 1573.1 1447.7 1055.6 2743.5 1319.2 1228.3 830.4 1737.6 578.1 1850.5 1467.1 1175.2 1533.2 2972.9 1144.8 703.2 768.0 724.7 1198.9 1051.5 1232.2 2109.6 489.5 2563.2 806.5 997.3 1197.8 775.1 1976.3 1284.0 3220.0 3716.4 3654.3 2784.5 1945.5 3077.2 4507.9 3661.8 319.1 2123.4 1145.7 2384.0 2614.1 5186.2 724.0 741.1 720.1 1143.2 696.1 759.1 739.4 729.1 689.6 741.8 778.5 749.6 772.2 1697.5 810.9 1658.7 42.7 4105.7 3970.2 4377.8 2769.0 2486.4 284.5 3671.0 4464.2 177.0 2040.3 1857.3 932.5 114.7 3745.3 2579.2 1009.2 3273.2 1883.0 1859.4 927.5 1934.9 1947.4 1330.6 2078.2 25.4 3163.4 4115.0 1768.2 946.5 1319.1 2024.6 5691.5 2726.5 2709.6 2534.6 134.6 27.4 2786.8 895.2 3338.1 3963.7 2384.8 3824.6 2101.3 2186.0 30.9 4048.0 1305.0 2802.3 16.6 39.3 2301.3 2254.2 1713.3 1821.2 4000.4 2308.2 4494.5 909.9 475.7 1334.5 2501.7 2382.7 788.8 827.3 3140.7 4661.0 3656.0 3604.7 1427.9 2788.0 4153.7 KIF14 KIAA0042 ENSG00000118193 "Kinesin family member 14" Q15058 1 200551497-200620751 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.6;lymphoid tissue: 11.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038061, HPA058220" Uncertain Supported "Midbody ring,Cytosol" Yes Yes Cytosol "Midbody ring" "HPA038061: AB_10669515, HPA058220: AB_2683642" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.00e-2)" "unprognostic (1.87e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.47e-3)" "unprognostic (1.02e-1)" "unprognostic (2.54e-5)" "unprognostic (2.31e-2)" "unprognostic (0.00e+0)" "unprognostic (6.28e-3)" "unprognostic (3.31e-1)" "unprognostic (8.14e-2)" "unprognostic (7.44e-2)" 0.2 0.2 0.1 2.0 0.1 6.6 0.3 0.2 0.3 0.2 0.1 0.9 1.3 0.3 0.0 1.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.2 3.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.2 0.1 0.1 0.0 0.0 1.0 1.1 0.6 0.0 0.6 0.6 2.5 0.1 11.0 0.1 0.0 3.3 0.4 0.3 0.5 29.7 17.3 26.8 15.0 0.8 3.0 14.8 20.0 11.7 18.7 16.8 10.5 15.1 18.0 7.0 9.6 11.6 23.0 21.6 13.3 26.7 22.1 11.3 28.8 24.8 10.3 0.1 45.5 15.7 0.6 0.6 20.9 17.8 4.0 13.5 26.3 44.0 22.6 23.5 12.1 26.9 14.2 22.6 8.7 15.0 24.3 35.4 22.8 6.3 8.3 12.7 14.0 28.3 9.5 11.0 19.8 12.9 11.6 11.1 14.7 17.3 16.2 35.3 8.2 8.9 25.8 8.6 24.0 30.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 1.9 2.4 1.0 1.1 0.6 2.3 1.5 1.9 0.8 0.0 0.9 0.0 2.1 4.2 0.6 2.5 0.0 0.2 4.1 3.7 2.2 1.6 0.0 27.1 1.1 0.0 7.7 3.3 10.2 5.0 2.5 13.2 2.5 0.9 5.4 0.0 0.9 5.2 0.0 2.9 1.9 2.5 0.6 2.3 0.0 0.0 0.4 0.5 0.0 0.5 0.8 0.3 0.0 0.7 11.3 1.2 0.2 0.1 1.4 0.8 6.6 1.4 2.1 22.8 16.3 8.3 0.9 1.4 2.3 0.7 4.3 1.9 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377764 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 175 "heart muscle: 8893.8" "Cell type enriched" "Detected in many" 32 "Cardiomyocytes: 12561.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 1077.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.8" "CAB015371, HPA015774, HPA017888" Enhanced Approved "Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules" No No 57000 "Nucleoplasm, Nucleoli" "Focal adhesion sites, Microtubules" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 2.2 5.0 13.3 0.6 14.8 0.1 12.0 12.9 21.1 1.9 13.0 1.2 0.3 3.2 0.8 7.9 2.0 3.8 8893.8 18.1 13.0 50.7 2.3 22.2 2.7 13.7 13.3 13.9 1.3 5.0 0.0 4.5 10.4 13.8 6.2 0.1 0.4 3.7 0.7 16.6 21.8 1.6 0.1 12.8 0.7 2.0 1.7 12.8 2.1 2.0 9.5 0.5 19.4 5.1 17.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.5 0.0 0.0 6.7 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.0 44.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 1.1 0.0 0.0 2.2 3.3 0.0 0.0 1077.7 0.0 0.7 0.4 1.1 0.8 0.1 2.0 0.0 61.2 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 14.8 12.9 21.1 18.1 13.0 13.7 13.3 13.9 13.8 12.8 12.8 17.0 0.6 3.2 3.0 0.3 0.0 3.4 1.4 1.7 1.8 3.9 0.9 1.7 12561.8 0.0 1.1 1.8 0.0 3.5 0.0 2.3 0.0 0.4 11.6 1.2 0.2 93.3 0.0 0.0 9.4 0.4 1.2 385.3 1.1 2.4 0.0 0.0 0.0 0.0 3.1 0.0 0.5 1.7 0.0 0.0 0.8 19.3 0.6 0.3 0.0 1.9 2.6 0.0 0.0 0.5 0.7 1.2 1.4 1.2 0.0 2.1 0.8 0.9 0.7 0.6 0.0 8.7 145.8 0.5 0.2 2.5 7.2 4.2 0.1 0.8 3.2 1.5 DDX59 "DKFZP564B1023, ZNHIT5" ENSG00000118197 "DEAD-box helicase 59" Q5T1V6 1 200623896-200669907 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047166 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA047166: AB_2679966" "unprognostic (1.99e-1)" "unprognostic (1.60e-1)" "unprognostic (3.44e-2)" "unprognostic (4.87e-2)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (4.83e-2)" "unprognostic (3.40e-3)" "unprognostic (2.43e-3)" "unprognostic (4.16e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (9.02e-4)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (6.66e-2)" "unprognostic (5.98e-2)" 15.5 16.2 14.6 14.3 16.0 33.4 26.8 17.8 18.9 16.1 16.5 13.3 10.3 17.8 20.2 13.7 15.7 12.3 12.6 14.6 15.8 15.5 18.0 14.7 17.1 17.0 16.4 13.2 17.8 18.9 15.2 11.4 18.9 17.3 15.4 15.1 17.5 14.5 13.3 33.1 26.4 14.5 14.2 17.0 22.6 12.2 11.1 15.9 22.2 16.4 20.3 17.1 15.1 14.8 18.6 17.5 20.1 22.6 19.0 10.1 17.4 49.9 19.1 17.4 20.5 16.5 6.3 20.2 17.9 9.5 15.7 16.4 16.2 13.0 19.4 14.5 56.8 13.3 13.6 26.4 18.6 20.2 19.5 24.0 18.8 29.1 15.4 41.7 16.7 15.9 24.8 17.4 25.9 20.1 20.0 12.0 29.0 23.8 10.5 16.3 10.1 15.5 34.7 21.9 19.8 13.8 35.7 30.8 31.7 35.6 28.8 27.3 27.3 14.4 17.1 9.5 16.8 20.0 19.5 27.2 23.5 16.3 12.2 30.0 33.3 12.4 24.7 15.1 11.1 12.4 14.9 12.5 13.8 10.6 14.8 12.7 11.8 22.9 16.4 22.0 11.8 19.8 10.2 14.6 16.0 17.8 18.9 14.6 15.8 17.0 16.4 13.2 17.3 17.0 15.9 18.6 22.5 19.2 20.1 8.8 19.9 16.2 13.1 16.1 24.5 4.3 10.0 13.2 18.4 7.2 10.6 7.3 2.1 22.2 14.6 9.8 15.6 8.8 2.4 14.6 13.3 16.7 1.2 10.5 4.5 8.2 28.0 14.9 6.6 12.8 20.8 7.1 14.3 7.3 13.0 6.7 6.1 11.0 14.2 12.0 13.0 1.1 8.1 16.1 5.4 8.4 18.5 8.3 25.7 19.1 10.3 8.8 7.9 13.5 13.1 12.0 8.0 11.6 10.8 6.7 0.0 22.8 15.7 14.2 20.0 12.9 15.6 43.8 18.9 9.3 8.5 11.1 CAMSAP2 "CAMSAP1L1, KIAA1078" ENSG00000118200 "Calmodulin regulated spectrin associated protein family member 2" Q08AD1 1 200739558-200860704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 194.4;Inhibitory neurons: 189.1;Oligodendrocyte precursor cells: 275.5;Oligodendrocytes: 155.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 161.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026304, HPA026511, HPA027302" Enhanced Supported "Microtubule ends,Cytosol" NA NA "Microtubule ends" Cytosol "HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380" "unprognostic (1.19e-1)" "unprognostic (9.98e-3)" "unprognostic (1.44e-1)" "unprognostic (9.52e-2)" "unprognostic (7.96e-3)" "unprognostic (4.82e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.34e-2)" "unprognostic (5.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "unprognostic (1.56e-1)" "unprognostic (2.92e-2)" "unprognostic (1.38e-3)" "unprognostic (1.95e-1)" "unprognostic (8.23e-3)" "unprognostic (9.56e-2)" 15.1 16.2 16.2 6.6 22.6 0.3 12.0 24.8 29.8 13.7 2.6 8.5 3.9 16.4 10.3 11.1 10.8 12.2 11.2 22.2 19.8 11.9 7.2 12.6 3.7 16.1 15.9 17.5 19.3 5.0 22.0 9.8 18.5 19.1 11.0 6.4 26.3 7.9 13.1 8.2 13.8 5.1 15.8 13.4 8.4 7.4 15.1 16.8 5.3 19.0 13.5 5.5 14.5 12.3 21.3 33.4 22.1 29.9 27.1 23.6 30.9 34.3 32.9 28.4 26.0 21.5 16.1 19.7 0.0 18.3 36.7 23.8 29.4 31.1 48.5 31.1 19.8 15.8 1.7 32.9 7.4 26.3 2.1 8.2 22.6 72.9 41.7 161.7 28.0 40.1 2.8 4.3 10.2 42.6 17.5 0.4 0.7 27.9 10.2 30.8 13.4 32.8 15.1 22.2 24.3 15.6 27.7 48.5 29.6 27.6 36.1 28.4 1.8 48.3 42.3 25.1 26.6 41.2 20.4 36.0 17.2 30.7 5.2 32.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.2 22.6 24.8 29.8 22.2 19.8 16.1 15.9 17.5 19.1 13.4 16.8 21.3 64.0 60.9 39.1 114.9 1.2 79.8 26.8 22.4 51.8 50.9 14.4 15.6 93.5 10.0 34.5 14.7 14.6 17.3 0.6 4.3 1.9 15.2 30.3 14.3 44.7 50.1 11.9 0.0 194.4 8.2 16.4 36.4 14.3 29.9 5.1 22.3 29.6 6.4 10.1 50.5 189.1 2.6 10.2 11.3 32.7 35.7 28.6 12.5 19.6 78.7 4.3 53.5 2.1 275.5 155.5 18.7 2.0 45.5 1.1 24.8 1.5 6.3 9.3 17.0 26.3 39.6 41.4 27.4 20.0 25.8 49.2 40.0 2.6 37.8 4.3 30.0 ATF6 ATF6A ENSG00000118217 "Activating transcription factor 6" P18850 1 161766298-161977574 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005935 Approved NA NA 46000000 "HPA005935: AB_2667472" "unprognostic (1.31e-1)" "unprognostic (5.15e-3)" "unprognostic (3.18e-2)" "unprognostic (8.43e-3)" "unprognostic (1.59e-1)" "unprognostic (5.58e-3)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" "unprognostic (3.37e-2)" "unprognostic (3.24e-1)" "unprognostic (6.09e-3)" "unprognostic (3.38e-1)" "unprognostic (7.55e-2)" "unprognostic (2.03e-1)" "unprognostic (2.43e-1)" "unprognostic (1.56e-2)" "unprognostic (7.57e-3)" 13.7 10.2 7.0 14.0 8.4 12.7 11.6 8.4 7.5 8.4 13.0 10.0 10.0 10.7 19.1 11.1 9.0 11.4 9.5 6.7 16.6 14.7 22.2 11.5 10.6 10.0 9.1 5.8 9.1 34.7 19.1 7.1 18.2 9.8 10.7 11.3 16.8 13.4 10.4 9.0 11.0 9.5 12.9 9.2 11.3 11.3 10.2 8.0 8.5 15.2 9.5 11.2 13.8 7.9 12.4 23.3 17.9 15.1 22.4 18.6 17.7 26.7 27.8 25.3 17.7 19.2 11.6 38.2 16.9 39.6 34.6 19.9 34.0 15.1 18.6 17.6 23.2 12.9 15.9 22.6 12.7 40.3 29.7 40.6 18.3 29.0 18.2 53.3 23.8 40.3 22.7 37.9 19.2 19.3 23.0 15.9 17.3 12.2 24.5 23.1 13.7 21.4 39.2 19.3 11.1 9.1 13.8 33.3 19.8 41.0 32.9 24.5 39.2 54.4 23.2 21.9 8.7 31.5 28.0 29.2 20.4 28.2 5.1 29.0 9.7 17.8 12.0 9.2 18.3 9.0 8.7 8.3 7.7 12.8 9.5 9.5 9.7 33.2 7.4 24.4 5.7 9.6 10.6 7.0 8.4 8.4 7.5 6.7 16.6 10.0 9.1 5.8 9.8 9.2 8.0 12.4 40.5 102.5 85.1 41.8 31.4 34.8 45.4 28.4 18.2 38.6 38.0 25.4 21.6 25.8 67.0 51.5 50.1 49.2 23.2 30.5 7.9 45.9 13.0 27.1 25.3 49.8 37.1 17.9 79.9 37.6 43.1 46.2 23.9 40.2 54.3 24.0 37.5 53.5 50.3 26.9 69.7 28.2 30.5 59.5 59.4 10.8 23.0 66.6 26.6 103.0 62.0 34.1 21.6 60.3 105.8 35.9 15.6 24.5 53.9 43.3 22.3 18.8 61.7 29.9 6.6 61.3 31.8 43.1 30.5 22.7 47.7 103.0 29.0 22.1 22.9 44.1 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124524 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "ovary: 8.1" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 140.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 10.0" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA041269: AB_2732491, HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.5 0.0 0.4 1.3 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.5 0.7 0.4 8.1 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.8 0.4 0.6 0.5 0.7 0.4 0.6 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.1 0.0 4.6 0.3 0.0 0.1 0.9 0.0 0.0 0.0 140.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 34.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.9 0.1 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MREG "DSU, FLJ10116, WDT2" ENSG00000118242 Melanoregulin Q8N565 2 215942584-216034096 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 47.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Glandular and luminal cells: 34.1;Rod photoreceptor cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068583 Approved Vesicles NA NA Vesicles "HPA068583: AB_2686009" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.24e-1)" "unprognostic (1.13e-2)" "unprognostic (3.70e-1)" "unprognostic (7.37e-2)" "unprognostic (2.39e-1)" "unprognostic (5.85e-3)" "unprognostic (8.11e-3)" "unprognostic (8.93e-2)" "unprognostic (6.38e-3)" "unprognostic (6.62e-3)" "unprognostic (6.92e-2)" "prognostic favorable (4.20e-4)" "unprognostic (9.99e-2)" 6.0 8.3 4.2 5.5 7.8 6.0 21.6 17.9 5.9 6.2 6.2 5.6 6.4 3.4 5.1 30.1 5.8 2.9 0.7 5.5 5.2 5.4 18.0 10.4 10.9 6.3 6.0 4.8 2.5 2.2 7.3 7.6 7.8 9.4 2.4 5.8 47.3 5.0 6.2 2.7 20.4 5.5 1.8 3.7 4.5 6.9 1.2 7.0 10.0 6.7 0.9 15.3 5.6 14.4 6.1 20.9 5.1 5.9 3.5 3.9 2.1 13.1 7.0 5.6 4.6 8.9 24.3 15.5 6.7 6.0 4.3 11.5 13.0 17.9 26.5 10.1 14.1 15.1 10.6 5.6 43.5 2.3 6.0 3.9 3.9 11.2 5.3 7.4 4.6 4.0 15.2 5.3 17.8 2.9 82.8 17.0 5.7 23.3 12.4 4.8 9.8 13.9 10.7 12.3 29.3 16.4 8.6 4.4 36.4 40.3 13.7 20.2 2.8 0.5 9.8 2.5 5.0 10.7 23.0 15.3 17.5 6.0 22.2 7.5 1.6 0.1 0.2 0.7 0.1 1.2 1.1 0.6 1.1 0.1 0.6 0.3 0.5 0.8 0.8 0.2 2.1 1.0 0.1 4.2 7.8 17.9 5.9 5.5 5.2 6.3 6.0 4.8 9.4 3.7 7.0 6.1 0.6 3.2 13.4 7.8 4.3 2.7 12.1 0.6 9.6 14.4 24.1 12.1 0.8 2.8 9.2 7.3 60.5 21.7 8.5 3.8 3.9 3.2 0.3 14.0 1.9 1.1 1.8 2.1 21.1 2.5 4.7 1.8 5.6 34.1 1.3 0.6 1.4 8.3 13.4 1.7 21.4 1.8 2.0 0.8 3.0 0.0 2.5 4.0 5.4 6.5 21.3 7.6 2.1 8.5 12.8 7.5 4.6 7.5 7.0 7.0 3.1 1.1 3.0 40.1 6.6 1.2 1.2 1.1 4.6 28.7 1.6 25.9 4.0 1.0 2.9 22.6 TNP1 ENSG00000118245 "Transition protein 1" P09430 2 216859458-216860064 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1159 "testis: 5999.9" "Group enriched" "Detected in some" 205 "Early spermatids: 41424.6;Late spermatids: 136509.6" "Group enriched" "Detected in some" 58 "liver cancer: 6.0;testis cancer: 4.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044387 Enhanced NA NA "HPA044387: AB_2678923" "unprognostic (1.67e-1)" 0.9 0.9 0.9 0.5 4.0 0.0 4.0 1.6 1.7 0.8 0.0 0.9 0.8 0.6 0.0 0.8 0.6 0.0 0.7 1.8 0.7 1.1 2.0 0.6 0.1 0.5 0.2 1.7 0.8 1.3 0.0 0.8 0.0 1.3 5.1 0.0 0.0 0.8 0.0 2.4 1.4 1.6 0.0 0.0 0.6 1.0 5999.9 0.9 0.0 2.4 0.0 0.0 0.6 0.5 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.0 1.6 1.7 1.8 0.7 0.5 0.2 1.7 1.3 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41424.6 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136509.6 410.1 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 246.7 0.0 0.0 0.0 0.0 0.0 0.0 249.8 0.0 0.1 433.2 234.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 FASTKD2 KIAA0971 ENSG00000118246 "FAST kinase domains 2" Q9NYY8 2 206765357-206796189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067191 Supported Mitochondria NA NA Mitochondria "HPA067191: AB_2685801" "unprognostic (1.19e-1)" "unprognostic (2.45e-1)" "unprognostic (3.50e-3)" "unprognostic (1.36e-3)" "unprognostic (7.40e-2)" "unprognostic (2.69e-3)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.69e-2)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.32e-2)" "unprognostic (4.87e-2)" "unprognostic (7.18e-2)" "unprognostic (1.03e-3)" "unprognostic (3.57e-2)" 14.5 14.1 5.4 12.5 6.5 11.5 17.5 5.4 6.5 12.9 7.4 15.2 15.1 16.0 8.8 16.0 13.0 11.6 25.1 5.9 5.6 17.5 27.5 11.9 14.4 6.2 5.1 6.1 15.9 11.7 18.6 6.9 13.1 7.1 13.4 17.2 11.3 11.3 11.2 31.8 11.7 12.6 15.8 4.3 11.3 13.4 12.1 5.1 13.3 18.0 36.9 17.4 20.6 9.7 6.5 30.2 27.0 24.7 28.1 27.2 32.7 46.2 34.3 29.0 57.3 32.4 48.3 32.0 37.4 37.5 35.5 66.7 40.0 30.7 47.4 50.4 11.7 19.8 29.4 25.6 46.6 33.1 64.3 26.5 35.2 48.8 43.8 47.2 29.1 39.3 27.2 56.4 18.6 42.8 25.3 27.3 27.4 44.0 28.2 51.2 23.7 38.1 38.8 39.4 49.7 36.0 22.9 26.6 44.7 41.3 36.8 20.9 33.4 30.8 35.0 31.5 24.4 36.3 18.5 32.9 48.0 40.6 29.2 29.5 9.6 21.4 5.2 19.2 21.4 21.5 20.1 21.3 20.2 31.0 17.3 28.0 25.2 1.4 31.2 16.5 14.6 18.7 20.5 5.4 6.5 5.4 6.5 5.9 5.6 6.2 5.1 6.1 7.1 4.3 5.1 6.5 17.8 28.9 11.4 19.6 20.3 23.7 33.7 28.8 32.5 18.9 11.1 12.2 23.2 7.2 22.8 12.9 22.9 28.2 15.1 6.7 9.8 19.2 30.9 14.5 23.1 14.6 7.3 11.6 41.9 15.1 22.4 21.2 27.5 14.9 5.1 17.5 9.3 17.6 14.8 6.7 40.3 10.5 12.2 7.9 9.4 8.0 9.6 10.8 5.4 25.3 12.9 9.3 8.2 26.2 23.2 12.1 8.2 13.9 20.0 13.7 8.8 12.7 15.9 22.8 13.1 19.3 17.4 37.5 12.8 24.5 21.5 25.7 18.4 18.6 13.1 22.6 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039980, HPA054974" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in other tissues" NA NA 29000000 "Vesicles, Plasma membrane" Nucleoplasm "HPA039980: AB_10795517, HPA054974: AB_2682657" "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavorable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (7.80e-5)" 18.9 22.4 18.5 18.0 13.1 4.6 12.7 10.0 11.9 18.0 8.1 55.9 5.3 52.2 3.7 13.4 21.3 31.4 6.0 20.9 37.4 4.9 9.7 24.5 8.3 31.8 17.5 8.2 47.2 1.9 2.5 9.7 47.4 19.9 13.2 10.6 3.7 3.3 31.1 2.3 4.5 15.0 55.3 13.2 7.5 26.1 1.4 26.2 6.2 10.9 3.4 4.5 38.6 16.0 19.3 2.5 50.4 32.2 0.2 30.1 9.6 9.3 8.5 14.8 10.0 9.5 48.0 123.6 0.0 11.9 25.3 20.5 19.2 1.5 15.9 16.8 0.1 6.8 0.5 2.4 0.4 80.7 0.0 2.1 68.5 12.2 14.4 12.3 64.5 105.7 0.2 0.2 0.1 6.8 0.2 0.0 0.0 41.5 0.1 9.2 0.2 2.0 12.0 21.7 0.0 29.0 1.0 1.1 0.3 75.4 84.9 0.1 0.8 106.3 43.1 0.4 11.3 217.0 0.0 0.2 3.2 96.9 0.3 88.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.5 13.1 10.0 11.9 20.9 37.4 31.8 17.5 8.2 19.9 13.2 26.2 19.3 88.7 89.8 57.5 2.0 3.8 19.4 19.5 30.8 97.9 36.5 1.3 11.3 4.5 5.7 53.2 1.8 0.0 89.7 0.1 0.6 0.0 6.4 6.3 8.8 8.1 134.4 1.2 2.7 4.1 3.8 8.7 47.0 1.5 13.2 3.8 2.7 137.8 1.8 141.3 0.0 9.4 1.1 4.1 28.0 129.8 18.9 2.8 53.7 19.6 53.4 224.8 4.8 0.0 4.0 8.1 53.2 0.0 4.9 0.2 9.1 0.0 0.6 48.1 2.7 0.0 4.6 32.2 1.4 1.4 17.8 12.6 25.7 2.4 48.1 0.4 51.5 CREB1 ENSG00000118260 "CAMP responsive element binding protein 1" P16220 2 207529737-207605988 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Early spermatids: 417.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003803, HPA019150" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003803: AB_562092, HPA019150: AB_1847220" "unprognostic (1.20e-1)" "unprognostic (3.15e-1)" "unprognostic (3.30e-2)" "unprognostic (2.69e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (8.41e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (9.58e-2)" "unprognostic (1.74e-2)" "unprognostic (4.82e-3)" "unprognostic (5.53e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (8.45e-2)" 13.1 8.7 10.8 15.5 11.4 22.6 14.9 17.7 12.4 15.9 12.8 11.5 10.1 15.8 10.9 15.1 13.2 14.1 11.7 10.7 13.3 12.5 11.7 13.8 22.3 10.8 10.2 8.9 17.3 8.8 15.7 7.0 18.2 12.1 13.1 14.1 18.0 9.0 12.7 6.7 11.6 10.7 16.5 10.8 17.3 12.2 32.7 11.4 29.0 18.3 14.7 25.2 17.0 9.6 14.6 24.9 20.9 38.6 15.6 22.9 22.4 21.8 15.9 23.5 26.6 26.5 21.6 22.9 15.4 19.8 21.1 29.8 19.5 34.8 20.4 37.7 25.1 13.2 29.2 18.9 23.0 18.7 27.7 20.0 16.0 16.3 21.1 31.1 25.4 34.9 28.9 20.5 22.5 30.4 16.8 41.0 16.1 27.8 24.2 13.1 31.4 22.1 20.2 25.1 24.6 27.1 23.4 21.6 16.2 18.1 35.5 16.5 30.1 18.5 21.8 22.6 22.1 20.5 19.6 27.5 36.4 25.2 25.3 22.0 33.6 28.2 28.2 27.0 29.2 23.7 36.7 25.3 26.2 34.1 34.8 30.0 20.7 56.1 45.6 34.9 18.6 38.6 26.7 10.8 11.4 17.7 12.4 10.7 13.3 10.8 10.2 8.9 12.1 10.8 11.4 14.6 46.7 19.2 18.2 47.0 52.3 70.9 47.1 33.3 34.1 38.9 25.3 18.5 26.3 17.2 29.0 12.9 33.3 29.1 35.5 25.3 23.5 23.6 417.8 19.6 39.2 47.2 32.4 54.7 56.1 20.3 24.9 35.8 18.8 21.0 43.7 41.5 35.7 15.8 29.4 40.4 51.1 28.2 30.5 48.8 75.9 47.2 26.1 35.8 44.4 68.4 60.9 42.1 33.0 66.9 70.7 26.4 27.5 29.3 29.1 56.5 22.8 19.7 18.9 40.2 39.5 37.4 40.7 44.5 29.4 33.5 57.8 18.6 42.6 19.6 25.7 62.6 KLF7 UKLF ENSG00000118263 "Kruppel like factor 7" O75840 2 207074137-207167267 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 95.2;Oligodendrocytes: 160.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003423, HPA030490" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003423: , HPA030490: AB_10601922" "unprognostic (5.93e-2)" "unprognostic (2.49e-3)" "unprognostic (2.98e-1)" "unprognostic (3.99e-3)" "unprognostic (2.56e-1)" "unprognostic (2.85e-3)" "unprognostic (5.44e-2)" "unprognostic (1.24e-2)" "unprognostic (6.75e-2)" "unprognostic (8.78e-2)" "unprognostic (3.67e-2)" "unprognostic (1.47e-1)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (3.47e-2)" 18.5 8.3 11.0 13.9 13.3 40.7 15.1 17.7 9.6 9.0 1.7 9.2 4.7 17.0 6.0 9.8 10.1 11.9 10.2 8.0 12.4 8.0 7.1 15.4 7.8 19.9 14.4 5.6 14.3 5.1 3.0 4.9 5.9 19.5 8.2 5.4 4.7 7.4 7.4 4.9 6.6 10.4 21.0 14.0 10.4 9.2 6.9 14.5 14.5 8.9 7.5 7.3 9.9 9.8 20.8 8.8 6.1 16.3 1.1 5.6 14.4 3.4 10.0 8.0 15.3 6.7 0.1 7.1 0.1 6.3 20.6 26.5 21.5 13.9 46.2 8.2 6.0 0.8 0.2 18.5 3.5 9.7 4.6 6.7 19.3 15.3 10.7 35.0 22.0 18.1 4.6 0.0 8.2 11.8 0.2 5.6 1.7 9.7 0.9 3.0 2.4 4.3 6.4 3.7 6.8 25.0 30.5 8.6 12.0 7.8 13.0 2.0 6.9 35.9 30.3 14.5 12.9 12.0 6.2 4.5 0.0 26.7 3.8 6.1 28.9 9.4 12.3 1.6 12.1 0.6 5.7 8.4 1.6 5.3 7.7 14.3 9.9 40.8 22.9 22.7 2.4 7.7 6.1 11.0 13.3 17.7 9.6 8.0 12.4 19.9 14.4 5.6 19.5 14.0 14.5 20.8 95.2 41.7 6.7 74.4 15.8 21.9 23.1 35.0 6.2 9.0 9.9 11.4 17.6 14.3 15.1 9.2 12.5 0.5 6.9 0.4 1.9 22.7 10.2 13.9 33.7 65.8 6.0 2.5 46.4 51.5 0.8 22.0 11.7 17.3 12.0 3.6 79.9 14.7 15.6 11.8 31.1 2.6 34.6 50.0 22.9 5.2 13.7 37.6 3.6 61.8 28.3 7.1 8.2 68.9 160.5 79.9 1.4 10.1 4.3 9.2 14.1 4.3 9.8 8.7 46.0 38.6 42.0 0.8 14.8 8.1 15.3 1.1 7.6 7.9 4.3 9.3 TTR "CTS, CTS1, HsT2651, PALB" ENSG00000118271 Transthyretin P02766 18 31557009-31598833 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Transport "Hormone, Thyroid hormone" "Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "choroid plexus: 113301.2" "Cell type enriched" "Detected in many" 30 "Hepatocytes: 23659.3" "Group enriched" "Detected in many" 28 "liver cancer: 928.2;pancreatic cancer: 666.0" "Region enhanced" "Detected in all" "hippocampal formation: 1942.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0" "Group enriched" "Detected in all" 5 "basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4" "Region enhanced" "Detected in all" "medulla oblongata: 1381.8" "CAB002517, HPA002550, CAB062567, CAB073406" Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 345000000000 99000000000 "Golgi apparatus" "CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419" "unprognostic (6.79e-3)" "unprognostic (3.38e-2)" "unprognostic (4.10e-1)" "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (8.15e-2)" "unprognostic (3.74e-2)" "unprognostic (9.66e-3)" "unprognostic (8.72e-2)" "unprognostic (1.23e-2)" "unprognostic (8.35e-3)" "unprognostic (5.26e-1)" "unprognostic (3.52e-2)" 4.2 0.6 128.7 0.5 52.0 9.7 0.4 721.6 513.1 2.0 113301.2 6.1 15.1 1.3 0.9 2.3 0.8 51.7 3.0 1942.6 44.9 18.6 21460.6 0.9 2.4 103.8 810.7 6.3 1.1 1800.0 188.4 6.1 2.7 259.3 1.6 4.5 80.7 1.8 0.4 1.1 15.7 6.8 0.3 9.7 3.9 50.3 2.3 568.1 1.1 1.3 0.0 0.1 2.3 0.6 108.9 1.6 0.4 0.6 0.5 0.8 0.1 1.0 0.8 0.3 0.0 0.0 160.1 0.0 2.9 39.6 0.5 0.6 0.4 0.0 0.3 0.0 5.9 0.8 5.2 1.8 249.0 0.4 11.2 1.0 0.1 0.1 0.1 0.0 0.7 0.0 0.3 2.8 0.4 0.0 0.5 0.4 0.7 0.6 4.5 0.3 0.3 7.4 0.2 0.3 1.6 0.9 1.1 5.8 0.0 0.2 1.7 0.6 0.2 1.7 2.4 57.0 0.5 4.3 1.0 2.6 17.6 0.7 4.3 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 128.7 52.0 721.6 513.1 1942.6 44.9 103.8 810.7 6.3 259.3 9.7 568.1 108.9 0.0 0.0 0.0 0.0 15.1 0.5 0.0 0.0 0.0 144.8 0.0 0.0 1.8 779.2 0.0 5.5 162.6 0.3 0.0 1.5 5.9 3.1 6.8 0.5 0.5 14.1 356.2 192.5 0.0 2.0 3.6 0.7 13.3 0.0 0.0 0.2 192.4 23659.3 2.4 26.9 0.1 19.6 0.0 313.7 0.0 8.7 0.3 1.2 0.0 0.0 0.0 24.9 0.0 0.0 0.0 130.5 5.2 0.0 0.0 0.2 1.3 26.9 0.0 56.0 0.0 0.0 0.3 3.3 1.1 0.0 0.1 4.0 10.9 0.0 1.7 0.0 B4GALT6 beta4GalT-VI ENSG00000118276 "Beta-1,4-galactosyltransferase 6" Q9UBX8 18 31622247-31685836 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 25.5" "Group enriched" "Detected in many" 5 "Bipolar cells: 101.3;Cone photoreceptor cells: 39.6;Excitatory neurons: 71.5;Inhibitory neurons: 103.7;Oligodendrocyte precursor cells: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "REH: 46.8;WM-115: 126.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020701, HPA058284" Approved "Intracellular and membrane" NA NA "CAB020701: , HPA058284: AB_2683668" "unprognostic (3.79e-1)" "unprognostic (4.52e-1)" "unprognostic (6.54e-3)" "unprognostic (2.23e-4)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.31e-2)" "unprognostic (4.50e-2)" "unprognostic (5.18e-1)" "unprognostic (1.13e-1)" "prognostic favorable (5.65e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.40e-5)" "unprognostic (5.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (4.00e-1)" 3.9 12.2 2.0 2.8 3.5 4.5 1.3 9.3 9.8 1.1 1.2 3.5 7.2 1.9 2.0 4.5 2.3 6.6 3.7 5.8 8.3 3.2 2.6 1.1 1.4 1.7 3.2 3.2 3.8 1.9 7.4 1.8 2.6 2.4 5.1 3.3 25.5 4.6 3.9 3.5 2.1 9.2 1.7 0.0 1.6 3.0 5.2 5.0 6.3 2.0 6.4 1.1 2.4 0.6 9.0 6.0 13.1 23.7 13.4 0.4 0.5 8.7 1.9 0.0 0.4 0.2 25.2 5.0 9.4 10.9 2.3 28.4 2.4 12.7 10.7 1.5 37.1 11.2 12.4 1.3 0.6 2.6 22.6 2.0 2.4 2.3 3.6 7.5 12.0 13.3 21.9 1.8 0.0 0.1 3.6 25.4 1.7 10.2 7.1 7.2 46.8 4.2 0.0 2.9 12.3 12.6 19.7 8.7 1.5 15.7 19.1 1.7 6.8 13.4 26.5 5.5 0.0 14.9 8.9 0.5 19.4 10.8 20.2 126.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.0 0.1 2.0 3.5 9.3 9.8 5.8 8.3 1.7 3.2 3.2 2.4 0.0 5.0 9.0 3.2 0.0 0.5 12.7 0.0 5.5 0.9 1.5 12.0 101.3 2.0 1.8 7.6 0.0 1.2 1.8 39.6 0.6 5.9 2.6 3.9 1.3 6.1 1.2 6.2 3.6 3.0 4.6 71.5 1.1 0.2 3.0 2.6 1.3 0.0 4.5 4.2 2.1 0.7 13.5 103.7 2.1 0.0 0.6 1.2 3.5 1.2 1.5 0.0 9.4 0.3 4.6 6.2 81.4 5.3 2.3 3.1 2.6 1.1 2.3 5.4 1.2 0.6 5.6 0.0 1.2 1.6 1.0 9.7 3.7 1.7 0.3 1.4 1.4 3.8 0.7 C1orf54 FLJ23221 ENSG00000118292 "Chromosome 1 open reading frame 54" Q8WWF1 1 150268200-150280916 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 115.7;Endothelial cells: 101.3;Kupffer cells: 145.7;Langerhans cells: 282.7;Leydig cells: 95.1;Peritubular cells: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "myeloid DC: 103.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 103.5" "Cell line enhanced" "Detected in many" "AF22: 77.8;AN3-CA: 110.5;ASC diff: 86.1;ASC TERT1: 141.3;HSkMC: 102.1;HUVEC TERT2: 108.4;U-87 MG: 68.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA026518, HPA043874" Approved Approved "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "HPA026518: AB_1845647, HPA043874: AB_2732511" "unprognostic (4.64e-3)" "unprognostic (6.81e-3)" "unprognostic (4.01e-3)" "unprognostic (5.69e-3)" "unprognostic (2.22e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-2)" "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.16e-2)" "unprognostic (8.06e-2)" "unprognostic (1.33e-2)" "unprognostic (4.48e-2)" 38.0 19.3 55.5 26.6 56.9 12.0 31.0 57.9 97.0 27.8 54.4 24.5 13.4 30.4 39.5 18.0 33.5 46.8 34.9 53.2 58.7 28.6 30.0 29.4 63.2 57.8 56.4 51.6 8.0 5.1 14.6 10.6 59.7 57.5 29.0 26.2 16.4 8.5 76.3 24.8 11.2 15.2 60.8 58.5 70.0 12.8 14.0 59.4 31.1 14.0 48.8 28.1 36.5 18.3 61.3 1.6 0.3 77.8 110.5 86.1 141.3 2.2 14.0 20.5 3.8 12.0 0.9 1.9 0.6 4.1 12.3 1.5 2.7 0.2 0.5 5.6 1.4 12.2 1.9 2.0 1.3 17.7 3.9 2.6 102.1 5.9 24.8 1.9 13.2 108.4 1.8 1.8 12.2 15.0 4.2 0.7 24.0 5.7 0.1 3.9 18.8 1.7 1.4 1.1 6.1 1.5 1.3 1.4 0.8 7.5 16.4 1.4 58.0 0.7 28.1 2.1 0.8 0.9 5.0 4.8 1.2 68.3 3.1 0.7 0.1 21.2 0.8 0.6 20.8 2.5 0.9 3.8 1.7 103.5 0.7 3.5 2.0 1.0 0.8 5.6 2.1 1.9 6.4 55.5 56.9 57.9 97.0 53.2 58.7 57.8 56.4 51.6 57.5 58.5 59.4 61.3 115.7 3.2 4.5 19.6 3.3 6.4 2.2 2.4 1.8 0.8 2.3 3.7 10.6 2.8 2.5 22.0 0.0 1.3 1.5 2.0 76.3 0.7 9.4 3.1 37.6 101.3 1.2 0.4 4.1 2.3 0.8 29.3 5.1 3.1 1.3 0.7 51.8 1.3 45.3 0.0 3.8 1.3 0.0 145.7 282.7 19.6 95.1 65.6 12.4 16.9 24.9 23.4 1.0 0.5 0.3 2.0 1.5 104.2 3.0 4.9 2.7 4.9 0.5 1.6 32.9 7.5 70.4 16.6 1.9 7.5 5.1 3.6 3.3 5.2 1.4 8.4 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257251-150265078 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 34.1;retina: 39.7;skeletal muscle: 34.1;tongue: 47.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 69.5;Melanocytes: 53.4;Muller glia cells: 164.5;Oligodendrocytes: 25.7" "Cancer enriched" "Detected in many" 5 "melanoma: 23.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AF22: 102.2;AN3-CA: 65.9;NTERA-2: 83.9;SK-MEL-30: 217.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favorable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.0 0.2 14.4 0.2 19.4 1.2 0.3 21.0 24.3 0.1 34.1 2.8 0.4 0.1 0.4 2.0 1.8 0.6 7.5 14.5 16.9 0.3 8.8 0.2 0.1 23.8 20.1 13.3 1.4 0.2 3.4 0.6 0.3 21.6 4.0 0.7 39.7 0.4 20.5 34.1 5.4 1.3 0.5 19.5 0.2 1.2 0.5 18.4 0.1 1.0 47.8 0.0 0.6 0.1 26.2 0.9 0.2 102.2 65.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.7 0.1 0.5 0.0 0.1 0.3 0.2 0.1 0.0 0.2 1.1 0.3 0.3 6.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.1 0.6 0.0 0.9 0.3 0.3 83.9 0.4 1.1 0.1 0.3 0.3 0.0 0.2 3.2 1.8 0.0 0.3 217.9 14.6 0.8 0.4 0.1 0.1 0.2 0.2 0.4 0.9 4.9 0.4 0.7 0.5 0.2 0.0 0.2 0.4 0.4 0.5 0.1 0.5 0.2 0.3 0.0 0.6 0.3 0.3 0.5 0.0 0.1 0.6 0.0 0.0 14.4 19.4 21.0 24.3 14.5 16.9 23.8 20.1 13.3 21.6 19.5 18.4 26.2 0.1 3.2 0.5 0.3 0.2 2.2 0.3 0.3 0.0 1.3 0.1 0.0 69.5 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.0 0.8 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.7 0.1 3.4 0.0 0.2 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.3 0.0 0.3 0.9 0.2 0.9 0.1 53.4 0.0 0.0 164.5 0.0 0.0 25.7 1.9 0.3 3.4 0.0 0.3 0.0 0.1 0.1 4.9 0.0 0.6 0.5 0.0 0.2 0.0 0.4 0.3 0.1 0.0 0.2 0.5 CFAP94 "CASC1, FLJ10921, LAS1, PPP1R54" ENSG00000118307 "Cilia and flagella associated protein 94" Q6TDU7 12 25108289-25195162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2;testis: 23.1" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.9;Fibroblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039662, HPA040141" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA039662: AB_10795468, HPA040141: " "unprognostic (6.42e-3)" "unprognostic (1.26e-2)" "unprognostic (1.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.62e-1)" "unprognostic (1.85e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (2.22e-1)" "unprognostic (3.91e-2)" "unprognostic (6.21e-4)" "unprognostic (2.54e-2)" "prognostic favorable (3.13e-4)" "unprognostic (2.01e-1)" "unprognostic (8.74e-3)" "unprognostic (7.16e-2)" "unprognostic (1.19e-1)" 0.3 0.7 4.5 0.2 2.5 0.6 1.5 1.9 2.5 2.0 10.4 0.2 0.0 1.6 6.0 0.5 14.2 0.7 0.3 1.9 3.9 2.8 0.0 1.9 0.4 5.3 4.8 1.3 1.2 0.7 3.3 4.1 0.1 4.1 1.0 0.0 5.2 0.7 1.1 0.1 1.0 0.1 0.3 5.4 0.2 0.7 23.1 2.3 0.4 4.2 0.0 0.1 0.2 0.2 2.7 0.1 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.0 1.0 1.1 0.3 0.0 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.4 0.0 1.1 0.6 0.4 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.4 0.1 0.0 1.0 0.1 0.6 0.2 0.1 0.0 0.1 0.5 1.3 0.0 0.0 0.1 0.8 0.5 0.1 0.4 0.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.6 0.0 0.2 0.0 0.9 0.1 0.2 1.3 0.3 0.2 0.3 0.0 0.1 4.5 2.5 1.9 2.5 1.9 3.9 5.3 4.8 1.3 4.1 5.4 2.3 2.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 IRAG2 "JAW1, LRMP" ENSG00000118308 "Inositol 1,4,5-triphosphate receptor associated 2" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 60.8;lymphoid tissue: 204.4" "Cell type enhanced" "Detected in some" "Adipocytes: 13.1;B-cells: 6.2;dendritic cells: 42.9;Hofbauer cells: 14.1;Plasma cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 210.1" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 634.3;REH: 221.9;U-698: 722.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA002967, HPA007356, HPA018505" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" NA NA 6700 "Endoplasmic reticulum, Plasma membrane" "HPA002967: AB_1079161, HPA007356: , HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 9.7 1.9 8.8 47.6 5.8 60.8 6.6 2.6 5.6 2.4 3.4 10.2 8.8 2.5 2.8 5.2 5.2 7.9 2.5 6.4 3.4 9.5 6.3 7.8 173.1 6.0 4.3 5.0 5.8 31.0 1.5 2.4 4.5 6.5 3.4 9.3 1.1 3.6 4.4 1.1 5.9 19.2 4.6 3.8 37.8 10.2 1.0 3.0 96.0 4.9 1.6 204.4 14.6 8.3 5.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 634.3 0.3 0.0 0.0 0.2 0.0 2.4 0.0 22.1 0.0 37.8 0.0 0.1 0.0 49.7 54.2 0.0 0.0 0.7 0.0 0.1 0.0 31.5 7.8 40.6 0.0 0.0 54.5 91.2 0.1 0.0 0.0 221.9 0.3 63.8 0.7 29.7 0.2 0.1 0.2 0.3 0.2 0.1 0.0 36.7 0.5 0.0 1.5 0.0 0.1 40.4 7.8 722.4 0.2 21.8 0.0 80.2 21.0 210.1 23.6 40.8 20.2 66.1 14.9 24.2 22.4 51.0 25.5 25.4 151.3 49.0 51.5 20.8 2.7 20.2 8.8 5.8 2.6 5.6 6.4 3.4 6.0 4.3 5.0 6.5 3.8 3.0 5.5 13.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 ATP10B "ATPVB, FLJ21477, KIAA0715" ENSG00000118322 "ATPase phospholipid transporting 10B (putative)" O94823 5 160563120-160852214 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3;gallbladder: 16.8;intestine: 46.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 136.4;Oligodendrocyte precursor cells: 293.0;Oligodendrocytes: 419.4;Undifferentiated cells: 90.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 19.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034574 Uncertain NA NA "HPA034574: AB_10669992" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (4.47e-4)" "unprognostic (3.99e-2)" "unprognostic (6.10e-3)" "unprognostic (4.69e-2)" "unprognostic (4.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.20e-2)" "unprognostic (3.42e-2)" "unprognostic (5.12e-2)" "unprognostic (2.38e-3)" "unprognostic (5.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-1)" "unprognostic (2.14e-1)" 0.1 0.0 4.1 5.0 8.2 0.0 0.4 8.1 6.6 0.5 0.6 44.9 24.9 0.0 12.4 6.3 0.4 16.8 0.0 4.0 5.3 0.1 0.0 0.0 0.0 11.9 8.8 3.3 0.0 3.0 0.0 0.0 0.0 9.8 0.0 46.1 0.0 1.8 0.7 0.0 6.7 21.2 1.5 7.5 0.0 4.8 0.3 7.0 5.1 0.0 0.0 3.0 1.5 2.6 17.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 8.2 8.1 6.6 4.0 5.3 11.9 8.8 3.3 9.8 7.5 7.0 17.3 0.1 0.0 0.0 42.7 0.6 0.4 0.1 12.9 0.0 0.0 0.1 0.0 1.2 21.5 15.1 1.8 0.0 0.0 0.0 136.4 0.0 23.6 0.2 0.2 0.0 0.3 13.2 0.0 4.0 20.3 0.1 0.0 10.7 0.3 0.0 0.0 0.0 0.3 0.1 0.0 3.9 55.4 4.1 0.0 1.2 0.6 0.0 0.1 1.8 1.9 1.6 0.0 0.0 293.0 419.4 16.4 64.7 0.0 0.4 0.1 24.1 0.0 16.0 0.0 0.0 0.0 0.6 0.0 0.1 2.9 0.9 0.5 0.3 0.0 90.7 6.5 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979033 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 933.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 81.8 100.3 84.7 105.9 93.6 60.6 109.3 96.5 132.2 128.6 86.3 120.5 91.3 93.1 222.0 73.4 96.7 67.1 75.1 83.6 106.8 106.5 152.8 80.2 99.0 96.9 93.4 81.1 85.0 138.4 148.9 75.7 81.9 96.1 107.8 116.2 76.1 140.1 94.2 72.1 56.9 84.0 93.9 99.1 93.3 106.4 50.9 91.7 98.7 145.2 70.1 156.1 95.9 68.6 105.7 141.7 163.4 213.2 192.2 183.2 122.0 115.9 198.6 192.4 179.0 154.8 322.9 311.7 228.2 244.1 168.9 213.6 254.2 187.3 146.1 220.5 190.0 136.4 232.2 189.7 268.9 208.1 249.3 156.7 109.7 186.1 151.5 245.5 156.8 173.7 166.6 271.9 578.0 163.9 215.0 179.1 158.0 131.0 558.3 153.5 219.2 328.2 522.4 208.2 232.3 172.3 172.6 198.1 262.9 687.6 146.7 254.1 187.6 142.0 201.9 124.9 212.1 177.5 245.1 268.8 423.8 83.0 173.4 209.4 546.3 229.2 219.2 279.8 231.0 315.2 400.7 253.7 269.4 222.0 344.3 191.7 229.5 148.5 260.9 209.8 459.5 272.0 428.3 84.7 93.6 96.5 132.2 83.6 106.8 96.9 93.4 81.1 96.1 99.1 91.7 105.7 192.3 86.6 143.6 40.5 323.2 304.5 314.0 812.0 129.7 97.6 212.6 199.9 69.1 214.4 406.0 239.1 52.1 330.8 233.5 130.3 189.8 290.0 36.5 126.4 250.4 181.4 125.4 191.5 46.6 288.0 334.4 239.4 104.5 240.2 155.2 114.7 158.1 338.0 278.9 95.9 55.4 255.1 431.3 140.1 283.3 27.2 240.8 159.7 521.2 23.4 188.6 215.6 197.8 48.7 73.5 253.2 140.0 195.6 933.5 355.5 141.7 280.8 231.1 87.3 170.9 153.6 253.6 127.8 133.1 112.1 229.4 464.8 204.6 192.2 189.5 298.1 USP35 KIAA1372 ENSG00000118369 "Ubiquitin specific peptidase 35" Q9P2H5 11 78188812-78215232 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 39.1;Granulosa cells: 30.8;Late spermatids: 121.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055213, HPA058592" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA055213: AB_2682740, HPA058592: AB_2683766" "unprognostic (6.69e-2)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (6.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.08e-2)" "unprognostic (2.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.57e-2)" "unprognostic (3.84e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (1.29e-3)" "unprognostic (2.93e-1)" "unprognostic (1.31e-1)" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" 5.8 20.0 8.1 3.7 7.6 2.5 5.2 5.5 8.2 8.6 7.4 6.4 3.5 6.8 3.2 6.0 6.5 3.5 7.8 8.6 7.7 6.1 17.0 7.1 3.3 8.7 8.4 7.6 7.5 6.0 12.5 13.5 4.8 10.2 6.0 1.9 2.2 4.0 3.2 4.1 2.8 4.5 4.8 4.4 5.0 4.6 4.5 10.2 6.2 8.8 4.0 2.6 6.7 7.7 8.0 2.2 3.3 5.7 6.1 9.7 8.7 3.9 5.0 5.8 5.8 4.0 8.4 4.7 1.7 5.0 9.5 6.2 5.8 3.8 7.8 3.4 12.8 2.0 2.9 9.8 5.0 7.4 1.8 8.3 7.4 5.1 12.1 3.5 11.4 7.2 6.5 4.1 4.2 4.6 2.0 4.7 7.6 1.7 6.2 5.3 2.9 5.2 2.0 4.5 4.1 2.8 5.9 3.9 5.1 1.9 8.1 4.3 1.6 8.9 10.6 5.9 12.8 2.7 5.7 2.0 2.7 3.1 2.0 6.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 7.6 5.5 8.2 8.6 7.7 8.7 8.4 7.6 10.2 4.4 10.2 8.0 1.3 0.0 1.8 5.9 1.2 0.8 0.2 0.7 3.4 0.8 1.0 0.6 3.5 0.0 0.3 0.0 6.2 0.7 1.0 1.2 0.0 1.1 39.1 1.3 2.7 1.9 0.0 0.4 5.2 2.0 1.6 2.0 5.1 1.2 0.0 30.8 1.4 2.7 1.6 0.0 4.8 0.9 0.0 0.6 0.8 121.6 1.5 1.4 1.8 2.8 2.7 0.4 0.0 3.5 2.8 2.0 0.1 3.0 0.8 0.3 0.8 1.0 0.5 0.6 6.6 0.7 1.3 1.2 2.4 4.1 1.0 0.3 2.9 2.1 1.3 0.2 ELOVL4 "CT118, SCA34, STGD2, STGD3" ENSG00000118402 "ELOVL fatty acid elongase 4" Q9GZR5 6 79914814-79947553 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, FDA approved drug targets, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 106.4;retina: 178.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.8;Cone photoreceptor cells: 148.0;Excitatory neurons: 55.3;Rod photoreceptor cells: 355.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "MAIT T-cell: 23.7" "Lineage enriched" "Detected in single" 238 "T-cells: 23.7" "Cell line enhanced" "Detected in many" "JURKAT: 41.2;MOLT-4: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-2)" "unprognostic (8.58e-3)" "unprognostic (2.38e-2)" "unprognostic (3.08e-6)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (3.46e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-1)" "unprognostic (1.38e-2)" "unprognostic (3.45e-3)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.27e-4)" 0.7 2.1 7.6 1.1 9.6 0.1 4.2 12.6 17.4 2.3 10.1 1.5 0.6 2.3 1.1 10.7 0.7 1.7 0.6 10.6 11.5 1.5 0.1 0.3 0.4 15.4 9.0 9.6 1.7 0.5 10.9 6.5 1.8 17.9 4.1 1.1 178.2 2.9 1.7 0.2 43.5 0.8 2.7 6.7 0.5 0.9 5.8 13.3 106.4 1.5 0.5 1.8 1.2 4.0 25.9 0.0 0.8 10.8 12.0 8.8 8.5 1.6 5.6 6.1 4.7 10.2 1.5 0.0 0.0 1.0 7.7 19.3 1.1 14.1 7.9 3.5 0.0 18.2 0.4 2.2 0.0 8.1 4.4 1.7 6.9 2.9 4.8 4.9 6.8 7.8 41.2 0.0 0.0 10.0 1.9 32.8 0.0 10.4 0.0 5.6 0.0 15.5 0.0 0.1 0.0 14.2 4.2 6.0 9.6 1.7 7.4 3.8 0.3 0.8 2.1 4.1 3.2 4.3 7.2 15.3 0.0 5.0 0.0 3.3 0.0 0.0 0.0 2.3 0.0 23.7 0.0 3.3 3.9 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.2 0.9 7.6 9.6 12.6 17.4 10.6 11.5 15.4 9.0 9.6 17.9 6.7 13.3 25.9 0.7 0.0 0.0 7.5 0.2 11.3 2.3 7.5 15.4 63.8 0.7 1.7 0.9 0.0 3.9 0.0 148.0 0.9 1.7 0.0 0.0 0.1 6.3 0.3 7.0 2.2 8.9 0.0 55.3 0.0 1.5 6.5 0.0 0.1 0.0 1.5 0.0 0.0 0.2 42.1 53.0 0.5 6.1 0.3 1.5 2.1 1.2 0.2 3.6 8.4 0.1 50.7 0.0 20.1 8.6 0.0 1.1 3.4 0.3 3.1 0.0 2.3 0.5 355.3 0.0 2.0 4.3 15.4 15.4 14.8 37.8 1.0 2.6 1.3 0.2 0.7 FILIP1 "FILIP, KIAA1275" ENSG00000118407 "Filamin A interacting protein 1" Q7Z7B0 6 75291859-75493800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 54.3;skeletal muscle: 36.1;tongue: 49.3" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 582.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053564 Enhanced Approved "Plasma membrane,Actin filaments" No NA "Plasma membrane, Actin filaments" "HPA053564: AB_2682192" "unprognostic (4.90e-2)" "unprognostic (3.77e-2)" "unprognostic (9.77e-3)" "unprognostic (3.83e-1)" "unprognostic (1.52e-1)" "unprognostic (4.98e-1)" "unprognostic (2.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.17e-3)" "unprognostic (3.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-3)" "unprognostic (3.97e-3)" "unprognostic (2.34e-1)" "unprognostic (4.65e-2)" "unprognostic (7.66e-3)" 6.9 1.5 1.3 3.0 1.8 0.2 2.4 0.2 2.5 1.5 1.1 8.5 1.8 8.6 0.9 9.6 4.8 5.8 54.3 4.1 1.5 1.8 3.2 7.7 1.3 0.3 0.4 1.3 1.3 1.4 12.5 1.4 5.1 0.4 3.9 3.3 0.4 1.2 3.5 36.1 0.5 2.6 13.3 0.5 0.3 3.3 2.1 0.7 1.2 2.3 49.3 0.9 11.0 1.6 1.5 0.0 1.3 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 6.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.0 0.0 1.7 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.1 0.1 0.0 0.1 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.9 0.7 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 1.3 1.8 0.2 2.5 4.1 1.5 0.3 0.4 1.3 0.4 0.5 0.7 1.5 82.1 128.2 82.6 5.9 0.5 0.6 0.5 2.8 0.0 3.5 0.5 0.8 582.5 0.0 9.1 0.0 0.0 0.8 0.5 0.1 1.9 0.1 54.2 18.2 1.7 45.9 0.0 2.7 9.7 0.4 0.3 60.3 0.0 19.2 1.3 1.7 72.1 0.7 1.3 0.0 12.8 0.1 8.2 1.9 1.2 17.6 2.5 1.8 1.8 5.6 0.0 2.5 1.0 6.0 10.0 0.0 0.0 4.5 0.0 0.8 0.4 0.1 62.4 3.5 92.1 70.2 114.2 7.1 7.9 0.7 0.9 0.8 1.8 11.9 0.1 0.4 CASP8AP2 "CED-4, FLASH, FLJ11208, KIAA1315, RIP25" ENSG00000118412 "Caspase 8 associated protein 2" 6 89829894-89874436 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.6" "Cell type enhanced" "Detected in many" "Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053573 Approved "Nucleoli,Nuclear bodies" NA NA "Nucleoli, Nuclear bodies" "HPA053573: AB_2682194" "unprognostic (7.80e-2)" "unprognostic (1.47e-1)" "unprognostic (6.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.64e-2)" "unprognostic (1.22e-2)" "unprognostic (1.75e-4)" "unprognostic (4.58e-1)" "unprognostic (4.36e-3)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (2.35e-1)" "unprognostic (1.63e-1)" "unprognostic (4.16e-2)" "unprognostic (3.53e-1)" 0.5 0.3 0.4 0.4 0.8 0.2 0.5 2.6 1.1 0.7 0.3 0.7 0.0 0.7 0.0 0.4 0.6 0.1 0.3 0.6 0.3 0.2 0.2 0.5 0.4 0.6 0.8 0.2 0.5 0.5 0.1 0.4 0.1 0.8 0.5 0.1 0.0 0.4 0.0 0.8 0.4 0.5 0.2 0.8 0.5 0.3 0.3 0.7 0.6 0.6 0.7 0.2 0.6 0.5 2.0 0.4 1.0 1.3 1.0 0.1 0.4 0.3 2.1 0.2 0.7 0.5 0.8 0.5 2.4 0.7 1.0 0.8 0.7 2.5 0.6 0.7 3.7 3.5 4.0 3.0 0.0 0.0 2.6 1.1 0.2 0.2 1.6 0.6 0.2 0.8 1.4 4.4 1.3 0.6 0.7 1.6 0.0 0.2 0.2 1.3 3.3 3.8 0.9 0.0 3.2 1.4 0.8 1.8 0.0 0.5 0.5 0.4 1.2 1.6 0.3 0.5 1.6 1.6 0.2 2.8 1.3 0.5 1.4 1.4 14.4 1.5 5.6 6.2 2.6 5.9 5.5 7.1 6.5 1.9 6.3 5.4 5.6 3.1 12.6 2.3 4.9 6.6 2.3 0.4 0.8 2.6 1.1 0.6 0.3 0.6 0.8 0.2 0.8 0.8 0.7 2.0 27.3 32.1 14.5 26.1 26.8 0.0 9.1 0.0 13.6 19.5 13.3 16.4 47.5 7.2 11.8 7.3 6.2 20.5 21.4 12.7 3.9 15.1 5.9 9.6 22.1 21.1 2.4 35.7 32.3 12.3 15.8 21.4 11.7 13.7 15.8 31.8 9.7 6.9 12.4 35.3 33.5 11.7 0.0 11.5 0.0 4.7 23.0 16.1 0.0 33.7 26.9 18.1 34.0 23.6 38.2 9.3 10.3 25.9 14.4 13.2 11.8 7.2 13.8 25.5 19.7 30.6 25.1 47.2 74.2 15.7 0.0 10.9 24.7 16.7 14.6 9.1 HMGN3 TRIP7 ENSG00000118418 "High mobility group nucleosomal binding domain 3" Q15651 6 79201245-79234738 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018370, HPA027971, HPA063572" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703" "unprognostic (1.02e-1)" "unprognostic (2.04e-2)" "unprognostic (5.92e-2)" "unprognostic (5.26e-2)" "unprognostic (3.48e-1)" "unprognostic (3.88e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.76e-4)" "unprognostic (8.78e-2)" "unprognostic (5.31e-3)" "unprognostic (1.47e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (1.02e-7)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.69e-1)" "unprognostic (6.43e-3)" 93.2 175.8 149.9 70.2 155.2 73.4 117.3 159.2 190.8 79.8 167.4 88.5 91.2 94.5 170.1 95.9 211.1 83.5 229.3 151.1 155.2 169.7 148.7 112.5 128.2 154.4 153.9 145.6 106.5 91.0 117.7 153.2 115.5 156.8 85.5 74.1 166.0 155.6 68.6 152.8 81.8 74.7 76.8 153.5 92.3 107.7 83.9 152.2 113.8 114.3 131.2 110.8 77.8 82.6 163.1 101.7 90.3 309.7 135.0 121.9 99.6 70.1 69.0 73.7 75.6 110.3 508.3 83.9 1.2 124.2 56.5 101.0 63.4 203.6 78.3 74.2 298.7 170.9 355.9 292.3 268.9 78.0 294.9 52.3 121.5 85.4 50.3 27.7 72.9 170.9 74.3 212.3 275.0 123.8 92.9 136.3 564.7 227.8 87.7 224.5 229.7 472.6 103.8 525.3 145.3 126.0 168.5 131.3 149.4 102.4 271.1 85.1 488.6 75.0 20.9 91.7 73.5 155.3 235.3 375.2 1.9 11.8 1.1 103.0 38.3 147.3 13.6 107.8 148.0 95.9 112.9 75.7 92.8 179.2 99.8 88.7 106.8 7.2 142.3 143.9 208.6 90.4 169.3 149.9 155.2 159.2 190.8 151.1 155.2 154.4 153.9 145.6 156.8 153.5 152.2 163.1 140.6 96.1 167.9 129.9 110.1 171.1 193.7 516.8 234.5 261.8 301.4 376.3 424.5 231.6 373.7 242.8 75.0 940.6 169.9 35.3 602.6 229.3 72.5 775.8 108.1 166.0 272.9 95.4 115.8 198.6 823.7 165.3 116.2 199.2 109.6 80.9 261.3 256.3 309.7 195.2 105.3 131.1 435.4 186.0 206.5 60.9 187.0 148.4 257.9 58.1 403.3 320.2 198.8 66.9 159.7 107.2 52.4 167.0 211.3 85.3 36.5 852.5 900.3 134.3 144.7 102.4 233.9 26.8 52.0 260.0 149.9 555.3 109.9 232.4 121.5 173.2 UBE3D "C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W" ENSG00000118420 "Ubiquitin protein ligase E3D" Q7Z6J8 6 82892390-83065841 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 95.7;Inhibitory neurons: 74.5;Oligodendrocyte precursor cells: 78.9;Oligodendrocytes: 70.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027231 Approved Approved "Rods & Rings" NA NA "Rods & Rings" "HPA027231: AB_2256689" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (5.05e-2)" "unprognostic (6.17e-3)" "unprognostic (2.91e-3)" "unprognostic (5.03e-2)" "unprognostic (2.39e-5)" "unprognostic (6.93e-2)" "unprognostic (2.08e-1)" "unprognostic (2.70e-2)" "unprognostic (3.48e-3)" "unprognostic (1.14e-1)" "unprognostic (1.47e-1)" "unprognostic (4.26e-1)" "unprognostic (1.78e-1)" "unprognostic (1.58e-2)" "unprognostic (3.18e-1)" 1.6 2.4 1.2 1.4 1.4 0.8 1.5 0.7 2.2 1.7 0.4 1.6 2.1 1.7 1.2 1.7 5.0 1.3 1.4 1.1 1.3 2.2 1.2 1.1 1.6 1.1 2.0 1.0 2.1 2.3 2.0 2.4 1.1 1.3 1.2 1.7 3.4 1.9 1.4 2.7 1.3 1.4 1.6 1.6 1.7 1.7 1.1 1.3 2.1 2.7 2.5 1.9 2.1 1.9 1.3 2.9 4.0 3.8 3.5 3.0 4.9 3.0 3.0 3.7 3.8 6.5 5.7 1.5 13.2 4.6 1.8 6.6 3.0 7.5 3.7 6.0 5.6 17.0 7.6 2.0 6.2 4.1 6.5 3.6 3.9 5.2 4.2 5.0 2.8 5.0 7.0 11.1 5.8 3.3 3.3 4.1 8.3 4.8 10.4 6.3 6.1 8.6 5.2 7.2 3.8 6.8 4.2 1.7 4.4 2.8 5.1 2.8 4.7 1.5 1.6 4.6 3.6 7.5 6.4 13.8 4.4 2.8 12.0 3.5 0.0 0.7 0.2 3.3 2.0 4.3 4.7 3.5 2.6 2.2 3.2 3.7 5.5 0.0 1.0 0.9 1.7 4.0 2.2 1.2 1.4 0.7 2.2 1.1 1.3 1.1 2.0 1.0 1.3 1.6 1.3 1.3 4.7 6.4 6.4 35.9 8.1 6.2 5.2 6.7 6.2 11.0 2.7 2.7 3.1 2.8 5.1 7.3 35.5 7.4 10.0 1.5 1.9 5.4 2.1 15.7 6.2 5.8 7.7 2.1 95.7 4.7 4.7 5.1 2.0 2.8 1.3 6.8 4.2 2.7 5.2 6.7 74.5 5.2 8.2 4.6 3.4 1.1 6.8 3.1 7.2 36.5 2.7 3.9 3.1 78.9 70.9 3.6 5.9 4.1 4.8 3.6 3.6 5.5 31.9 14.9 6.6 11.1 4.3 7.3 14.7 4.8 6.8 3.0 5.8 8.4 6.7 3.7 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.1;brain: 24.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 44.6;Inhibitory neurons: 200.3;Sertoli cells: 98.6" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 81.4;HSkMC: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA042256: AB_2677917, HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 23.1 5.5 9.4 3.5 24.8 0.7 17.0 10.8 17.4 5.2 0.0 10.0 1.2 7.0 2.7 2.4 11.3 2.0 0.8 19.0 21.1 0.9 0.1 4.1 4.5 10.0 3.8 21.3 3.8 1.5 0.5 20.8 3.1 5.1 2.9 3.0 1.5 2.6 2.1 2.4 3.4 10.6 3.7 0.2 1.7 4.3 1.2 14.7 1.3 5.2 1.2 6.6 4.1 5.2 9.5 0.0 0.1 3.8 0.0 81.4 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.2 1.9 2.9 0.0 5.3 0.0 0.0 53.8 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.5 0.0 6.8 0.0 1.7 0.1 0.0 0.0 0.0 0.3 0.0 1.4 4.9 0.0 0.0 0.1 0.0 0.0 1.6 7.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 24.8 10.8 17.4 19.0 21.1 10.0 3.8 21.3 5.1 0.2 14.7 9.5 3.4 0.0 10.4 3.6 7.1 0.6 0.5 0.0 0.0 1.7 0.1 0.4 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.4 3.8 0.0 0.0 44.6 0.0 0.0 0.9 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 200.3 0.0 0.0 0.3 0.8 0.0 1.5 0.2 0.0 5.6 0.0 0.0 0.0 9.0 3.2 0.0 0.1 0.4 4.2 0.0 0.0 0.0 0.0 0.2 98.6 6.4 12.4 0.0 0.5 0.2 0.1 0.1 0.5 0.0 0.0 0.8 SPACA1 SAMP32 ENSG00000118434 "Sperm acrosome associated 1" Q9HBV2 6 88047841-88066838 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 406 "testis: 42.2" "Cell type enriched" "Detected in some" 11 "Early spermatids: 910.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026744, HPA043297" Enhanced NA NA "HPA026744: AB_2194642, HPA043297: AB_2678413" "unprognostic (4.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 910.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 80.5 5.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 61.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD13C "dJ677H15.3, DKFZP566D1346" ENSG00000118454 "Ankyrin repeat domain 13C" Q8N6S4 1 70258999-70354734 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 98.5;Inhibitory neurons: 91.0;Oligodendrocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.05e-3)" "unprognostic (3.11e-1)" "unprognostic (1.28e-2)" "unprognostic (1.91e-2)" "unprognostic (6.38e-3)" "unprognostic (6.59e-2)" "unprognostic (3.48e-2)" "unprognostic (2.41e-1)" "unprognostic (2.28e-2)" "unprognostic (3.17e-2)" "unprognostic (1.47e-3)" "unprognostic (1.57e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-1)" "unprognostic (7.42e-2)" 9.9 8.8 5.5 8.4 7.1 5.8 7.9 9.9 7.9 7.9 2.8 8.8 7.7 9.2 5.9 7.2 6.3 7.1 5.4 6.7 5.5 9.2 7.5 7.5 9.5 5.1 5.5 6.3 9.7 8.5 9.1 4.7 7.5 5.6 8.4 8.7 13.4 7.3 6.5 9.1 10.0 8.3 8.5 5.0 8.3 8.3 4.3 5.1 9.1 8.6 8.7 8.3 8.5 6.7 7.3 18.4 8.5 14.1 14.7 17.1 22.8 5.6 16.9 19.8 14.5 14.5 11.5 10.1 15.7 16.0 19.9 14.3 12.0 13.8 10.0 17.1 22.6 15.8 17.0 19.5 10.7 18.0 18.8 8.7 19.6 11.1 16.7 15.2 12.9 14.0 8.4 14.4 22.2 14.4 8.3 11.1 8.3 15.2 8.4 16.2 11.5 17.8 10.9 20.5 11.9 11.1 11.1 21.7 26.6 23.7 13.5 14.0 12.5 17.8 22.6 14.4 34.9 20.6 21.4 28.8 12.9 19.5 14.6 19.2 14.6 7.0 8.6 8.8 9.1 12.4 9.8 11.1 11.0 10.6 8.5 10.3 9.7 0.7 8.4 8.0 5.6 14.0 9.1 5.5 7.1 9.9 7.9 6.7 5.5 5.1 5.5 6.3 5.6 5.0 5.1 7.3 15.1 28.9 15.1 40.1 17.0 16.2 11.4 7.9 15.9 19.3 10.6 7.5 12.3 5.7 14.1 11.0 31.3 8.9 17.0 12.9 13.7 10.0 1.7 11.9 20.3 13.2 12.5 5.5 98.5 10.5 10.9 18.7 20.4 15.1 3.8 9.4 12.5 7.2 10.3 6.7 91.0 9.5 12.2 12.9 7.8 2.1 11.8 11.7 17.8 43.1 10.5 10.9 13.4 64.8 103.6 13.0 10.6 11.3 16.6 14.9 5.9 13.2 15.7 23.5 0.0 18.3 17.7 8.5 6.2 13.3 12.1 13.1 20.3 18.0 10.3 15.9 SGIP1 DKFZp761D221 ENSG00000118473 "SH3GL interacting endocytic adaptor 1" Q9BQI5 1 66533383-66751139 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 132.6" "Group enriched" "Detected in many" 4 "Astrocytes: 390.1;Cone photoreceptor cells: 350.3;Excitatory neurons: 323.3;Inhibitory neurons: 401.5;Oligodendrocyte precursor cells: 482.0;Oligodendrocytes: 363.6;Rod photoreceptor cells: 344.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 29.9;BJ hTERT+: 38.0;fHDF/TERT166: 24.5;hTERT-RPE1: 15.8;RPTEC TERT1: 27.5;SH-SY5Y: 15.3;U-138 MG: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017963 Approved Approved Mitochondria NA NA Mitochondria "HPA017963: AB_10964882" "unprognostic (1.74e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" "unprognostic (9.04e-2)" "unprognostic (9.51e-2)" "unprognostic (7.64e-2)" "unprognostic (1.86e-1)" "unprognostic (1.61e-1)" "unprognostic (1.83e-1)" "unprognostic (1.95e-1)" "unprognostic (3.48e-7)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (4.25e-2)" "unprognostic (9.63e-2)" 5.3 4.3 12.5 2.0 15.5 0.2 2.7 6.8 16.8 9.1 0.5 2.5 1.7 10.7 4.6 2.7 3.8 4.6 5.0 13.9 9.3 7.9 0.7 8.4 0.7 5.4 5.4 13.9 1.7 0.6 0.2 7.7 1.9 8.8 5.9 1.5 132.6 1.7 5.1 2.5 1.3 2.1 3.8 0.3 0.3 3.3 4.4 5.8 0.7 9.0 1.2 0.4 2.7 5.5 11.3 0.0 0.0 0.0 0.0 0.9 5.5 0.0 29.9 38.0 2.3 3.4 0.0 0.0 0.0 0.1 24.5 0.2 0.0 0.0 0.1 4.3 0.0 0.0 1.1 0.4 0.0 6.5 0.0 0.0 4.1 0.0 2.3 0.0 15.8 11.3 0.2 0.0 0.0 13.8 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 27.5 0.0 0.7 15.3 0.0 0.0 0.0 0.6 0.0 1.1 1.9 27.3 0.0 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 15.5 6.8 16.8 13.9 9.3 5.4 5.4 13.9 8.8 0.3 5.8 11.3 5.0 0.0 0.0 390.1 0.1 1.0 0.3 0.4 0.0 89.8 0.2 4.7 2.5 2.8 0.0 9.2 350.3 0.1 0.0 0.1 7.9 0.5 0.6 2.9 7.8 13.8 0.0 0.0 323.3 0.0 0.0 15.8 0.5 5.7 10.1 0.0 0.4 0.2 0.2 74.0 401.5 0.0 0.0 0.0 1.1 1.2 2.1 0.4 10.6 48.7 0.0 49.4 0.0 482.0 363.6 0.0 0.0 11.3 0.8 0.8 0.0 0.2 0.0 344.1 13.1 3.2 32.2 0.2 0.4 0.1 1.0 0.3 0.5 0.0 0.1 0.3 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635802-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 18.2 18.4 12.6 17.1 19.1 39.8 21.6 33.0 16.0 20.8 13.0 16.9 16.1 23.0 17.6 12.9 16.8 16.2 13.9 11.9 14.2 19.9 28.2 16.2 21.7 16.7 14.7 8.0 32.5 18.5 24.0 12.3 24.5 18.9 18.3 17.8 27.9 15.3 16.0 20.5 16.4 16.2 15.6 15.8 21.4 18.4 14.4 13.9 30.9 26.4 23.1 18.2 15.5 17.0 31.4 35.8 17.5 28.1 17.0 27.3 29.6 28.6 23.0 32.5 16.9 22.3 24.0 16.6 44.0 19.3 20.7 24.4 15.3 27.7 23.9 27.8 35.2 23.3 52.5 21.7 38.2 24.7 45.3 20.7 21.4 21.2 24.0 34.1 29.1 19.8 23.0 58.4 39.9 17.4 21.2 19.5 23.9 16.3 22.9 10.4 33.7 25.6 21.2 20.5 21.0 30.8 22.7 27.7 12.5 20.1 30.7 21.3 41.2 28.2 25.9 30.4 20.0 27.6 33.9 37.6 41.0 11.9 35.6 20.3 15.5 6.2 7.1 7.6 8.0 7.4 7.3 7.1 6.1 5.5 8.9 10.0 7.6 14.4 5.0 11.5 6.7 5.5 4.4 12.6 19.1 33.0 16.0 11.9 14.2 16.7 14.7 8.0 18.9 15.8 13.9 31.4 87.9 157.0 133.2 76.0 108.0 54.9 62.1 42.2 71.7 67.9 49.4 56.8 95.2 34.3 88.6 46.0 47.9 47.6 91.2 50.1 15.6 48.4 40.5 68.8 93.7 61.1 43.1 63.1 71.1 37.6 31.5 77.2 60.6 84.3 103.0 85.5 41.7 47.1 28.8 50.5 80.5 46.1 28.5 46.2 33.2 26.5 81.1 65.3 23.2 70.3 69.6 47.4 74.2 76.9 129.8 29.8 40.5 56.8 92.4 64.1 55.5 36.4 72.9 66.8 59.2 103.7 58.5 103.0 69.3 48.4 42.9 31.2 97.1 114.2 49.4 51.0 ZC2HC1B "C6orf94, dJ468K18.5, FAM164B" ENSG00000118491 "Zinc finger C2HC-type containing 1B" Q5TFG8 6 143864436-143938343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 14.9" "Cell type enhanced" "Detected in some" "Astrocytes: 2.6;Early spermatids: 9.6;Excitatory neurons: 3.1;Inhibitory neurons: 5.7;Late spermatids: 5.5;Oligodendrocyte precursor cells: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.3 5.5 0.0 0.0 1.8 1.0 0.0 0.0 0.0 4.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598967-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 26.3" "Cell type enhanced" "Detected in some" "Early spermatids: 305.4;Endometrial ciliated cells: 57.1;Late spermatids: 74.8;Respiratory ciliated cells: 92.5;Spermatocytes: 68.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HDLM-2: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.0 0.0 3.5 0.0 0.8 0.0 0.0 1.2 0.4 0.2 5.0 0.3 0.0 0.1 0.2 0.0 7.6 0.0 0.0 0.5 2.0 0.0 0.0 1.4 0.0 4.8 2.9 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 26.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.8 1.2 0.4 0.5 2.0 4.8 2.9 0.0 2.2 4.4 0.9 1.1 0.0 3.2 1.5 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.0 9.5 0.0 4.2 0.0 0.0 0.4 0.0 0.0 305.4 57.1 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.4 2.0 0.0 1.9 74.8 2.8 0.4 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.3 2.6 0.0 0.1 0.0 0.1 92.5 0.1 0.0 0.0 0.9 68.4 3.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 254.4" "Cell type enhanced" "Detected in many" "Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 99.0;RH-30: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 33.4 75.4 3.3 18.6 5.1 21.9 29.9 1.8 6.3 30.4 7.3 24.1 9.7 29.8 9.1 33.1 21.0 27.1 25.3 3.8 3.4 16.2 3.7 27.0 12.2 3.1 3.8 3.3 36.8 27.9 9.6 82.3 254.4 3.8 26.2 21.5 1.6 30.4 12.2 12.3 62.4 20.8 19.9 2.5 15.7 27.1 8.8 6.0 6.6 14.0 22.5 12.2 40.0 34.7 3.9 0.2 5.0 99.0 0.1 39.4 78.0 0.3 32.9 21.6 16.1 33.5 0.3 6.0 2.7 16.0 30.4 4.0 0.0 0.8 12.0 32.2 3.1 4.4 45.2 58.7 0.9 13.9 40.9 8.9 60.5 4.6 15.8 13.8 23.4 33.5 16.1 4.4 0.8 18.0 6.2 16.9 19.8 17.2 0.0 3.7 20.7 94.1 0.1 33.1 1.1 8.7 10.3 51.0 0.1 0.1 29.6 0.1 50.1 19.8 0.2 35.2 77.7 36.4 9.1 9.0 0.6 25.3 16.6 2.0 4.9 12.0 25.1 1.4 9.1 1.4 3.7 1.3 1.9 14.9 5.8 0.9 1.5 21.7 2.2 2.9 6.7 2.0 3.8 3.3 5.1 1.8 6.3 3.8 3.4 3.1 3.8 3.3 3.8 2.5 6.0 3.9 19.5 51.3 51.0 28.4 15.2 21.7 14.6 5.3 34.1 2.1 16.8 14.0 8.4 5.7 12.6 5.5 0.0 4.6 19.0 16.1 7.9 11.8 1.8 8.6 91.9 23.8 16.7 19.3 60.3 11.3 15.0 143.6 11.7 13.0 18.4 38.7 8.6 0.2 20.3 8.4 76.6 33.6 18.3 26.8 27.8 5.5 138.5 26.8 8.8 49.6 37.6 0.9 2.1 10.6 5.5 13.0 22.5 97.0 5.7 52.0 4.3 15.3 4.4 0.4 13.1 61.7 31.1 0.9 1.0 24.1 43.3 9.9 10.0 205.8 28.5 19.7 FBXO30 "Fbx30, MGC21674" ENSG00000118496 "F-box protein 30" Q8TB52 6 145793502-145814795 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 9.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012583 Approved Approved Microtubules NA NA Microtubules "HPA012583: AB_2668686" "unprognostic (8.69e-2)" "unprognostic (3.35e-3)" "unprognostic (2.92e-2)" "unprognostic (4.29e-2)" "unprognostic (5.47e-3)" "unprognostic (8.36e-2)" "unprognostic (7.61e-7)" "unprognostic (5.79e-2)" "unprognostic (1.63e-1)" "unprognostic (6.32e-2)" "unprognostic (1.18e-2)" "unprognostic (9.25e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (5.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.78e-1)" 4.6 4.0 4.0 4.3 5.1 7.2 4.0 5.0 4.0 4.1 3.0 7.5 4.1 6.8 3.2 9.7 3.2 5.7 7.2 3.5 5.8 4.1 3.5 3.2 4.3 4.9 5.6 2.7 5.9 3.8 4.1 1.7 4.8 5.0 6.0 4.7 5.3 4.5 6.9 11.6 2.6 3.5 8.1 4.7 3.7 3.8 6.5 5.3 2.9 8.1 9.2 4.1 5.7 2.9 5.7 3.7 6.9 9.7 13.2 9.9 8.8 9.9 10.3 9.6 6.9 6.8 8.7 3.3 17.0 7.8 11.8 12.6 5.7 8.4 7.5 10.4 10.0 5.8 10.8 9.1 8.8 17.8 14.1 10.8 14.6 8.3 8.6 11.4 9.0 10.1 4.1 12.6 11.9 13.6 2.9 6.4 7.5 11.2 2.4 5.1 8.2 21.7 5.9 7.2 3.8 4.3 6.9 12.6 6.5 6.1 9.6 3.0 13.8 13.4 7.1 6.0 9.1 10.4 8.8 7.2 6.8 11.4 6.0 7.7 9.3 1.3 1.6 0.4 1.1 0.3 0.6 0.4 0.8 1.6 1.3 0.6 0.6 1.2 0.5 0.9 0.5 0.3 0.6 4.0 5.1 5.0 4.0 3.5 5.8 4.9 5.6 2.7 5.0 4.7 5.3 5.7 11.1 3.2 5.9 7.2 5.4 14.3 5.3 4.2 12.5 8.8 10.5 8.3 22.9 10.0 4.7 3.7 4.2 5.8 5.7 4.9 11.7 4.7 10.9 4.1 13.7 13.8 6.0 36.7 5.3 3.2 3.4 15.4 7.1 6.2 12.0 37.1 11.4 9.7 7.5 26.9 6.4 5.0 2.0 11.9 20.8 4.4 11.1 10.2 7.2 7.5 7.5 12.0 0.0 5.0 7.6 5.1 3.2 10.1 11.1 7.1 4.3 8.2 2.8 8.7 0.0 26.5 18.4 19.7 10.5 12.4 17.3 5.6 6.2 7.2 5.0 5.0 TNFAIP3 "A20, OTUD7C" ENSG00000118503 "TNF alpha induced protein 3" P21580 6 137867214-137883312 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Inflammatory response, Ubl conjugation pathway" "DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 524.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002116 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA002116: AB_1858162" "unprognostic (5.50e-3)" "unprognostic (9.98e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-2)" "unprognostic (4.01e-2)" "unprognostic (9.47e-2)" "unprognostic (5.01e-3)" "unprognostic (4.40e-2)" "unprognostic (2.92e-2)" "unprognostic (2.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (6.06e-2)" "unprognostic (3.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" 46.1 15.7 4.4 115.6 4.0 524.4 23.5 3.1 20.7 27.8 13.2 22.8 21.6 31.6 5.2 26.9 23.7 48.2 16.0 3.8 11.2 13.7 27.6 56.7 77.4 5.8 3.8 1.6 73.8 26.0 26.0 7.5 29.1 5.8 17.4 25.0 19.3 16.3 10.4 8.6 42.3 31.0 33.8 5.9 46.5 23.0 8.4 7.7 71.8 11.8 3.8 56.1 172.8 14.7 7.9 32.6 4.8 1.8 2.8 10.1 16.9 7.8 18.8 67.6 4.8 5.7 34.9 8.8 7.3 43.1 20.0 106.5 22.6 1.1 50.4 8.9 46.8 2.2 7.5 19.8 21.1 11.2 10.3 12.8 15.6 7.3 56.4 53.6 5.6 2.9 21.2 17.4 161.3 8.4 1.8 56.2 41.4 1.5 2.1 1.4 151.5 39.4 6.1 14.8 15.1 0.7 0.3 3.6 5.3 16.9 7.0 3.4 11.7 14.8 46.9 6.8 46.0 9.6 48.7 131.4 14.0 16.9 13.1 6.1 7.3 12.6 9.6 19.6 9.3 27.9 7.4 19.4 18.0 14.3 7.8 13.1 10.1 13.6 11.1 5.1 26.2 19.2 14.8 4.4 4.0 3.1 20.7 3.8 11.2 5.8 3.8 1.6 5.8 5.9 7.7 7.9 71.8 38.5 76.3 2.0 94.5 774.9 150.2 102.1 384.7 1.1 29.0 42.3 4.6 25.8 53.7 0.0 29.2 8.1 395.5 53.9 1.9 60.0 2.6 605.2 365.9 114.8 11.9 5.2 0.1 26.9 104.8 110.1 111.1 1498.3 255.9 2.3 48.5 13.5 45.7 0.0 0.3 38.6 67.1 125.2 461.8 3.2 6.8 596.6 129.9 8.4 59.1 1.7 14.4 2.0 0.3 30.5 29.5 6.0 331.4 170.2 37.3 3.1 84.3 13.3 6.6 29.0 94.9 2.7 2.2 367.9 745.7 23.1 624.2 14.9 20.9 78.1 AKAP7 "AKAP15, AKAP18" ENSG00000118507 "A-kinase anchoring protein 7" "O43687, Q9P0M2" 6 131135467-131283535 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.1" "Cell type enhanced" "Detected in many" "Astrocytes: 88.8;Cholangiocytes: 177.3;Oligodendrocyte precursor cells: 123.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 27.2;RPTEC TERT1: 23.5;RT4: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027172, HPA027200, HPA028327" Approved Approved Vesicles NA NA Vesicles "HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353" "unprognostic (2.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.45e-3)" "unprognostic (4.57e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (4.41e-1)" "unprognostic (1.18e-1)" "unprognostic (3.89e-1)" "unprognostic (1.54e-1)" "unprognostic (1.32e-3)" "unprognostic (2.52e-1)" "unprognostic (6.03e-3)" "unprognostic (2.53e-1)" "prognostic favorable (2.56e-4)" 9.0 57.1 15.6 6.4 16.1 11.0 6.8 17.6 20.9 8.2 11.4 19.3 30.0 6.4 5.8 4.3 6.9 9.9 6.8 15.8 16.1 8.2 24.6 6.6 11.3 15.5 16.0 14.3 9.9 42.3 4.0 4.3 4.1 15.2 14.1 19.1 7.7 4.6 6.5 16.1 2.7 16.7 6.0 15.3 9.7 5.3 8.8 16.0 12.0 5.9 14.5 7.6 8.7 5.7 15.7 1.2 2.1 7.8 3.8 4.4 9.0 5.4 3.3 5.3 5.5 7.3 2.8 2.2 0.1 6.1 5.7 4.1 0.1 2.3 3.6 4.0 0.0 3.3 8.0 2.7 12.2 6.1 0.4 2.5 7.8 2.4 3.6 4.6 5.1 5.8 4.6 1.4 11.7 5.3 2.1 3.6 2.1 27.2 0.8 2.9 7.3 5.1 0.1 23.5 27.2 0.1 2.7 4.5 0.4 11.1 4.5 1.8 17.1 2.1 2.5 3.5 7.5 8.3 10.5 0.1 2.0 6.3 8.1 5.9 15.2 1.9 0.3 8.1 3.8 12.8 3.7 11.1 11.0 2.4 5.5 17.6 11.0 0.5 4.4 4.7 0.1 4.3 6.0 15.6 16.1 17.6 20.9 15.8 16.1 15.5 16.0 14.3 15.2 15.3 16.0 15.7 11.7 19.2 9.1 88.8 16.4 6.2 6.5 0.8 6.8 22.3 10.1 13.2 10.4 177.3 1.6 5.5 16.7 8.2 18.0 22.1 19.6 35.7 8.2 31.6 13.4 6.5 1.2 63.8 44.7 4.2 10.2 7.4 6.1 35.6 10.8 22.9 9.7 39.9 8.6 8.4 79.1 14.8 10.2 20.8 9.9 2.7 8.4 12.9 1.8 68.4 9.8 38.2 25.7 123.6 62.7 2.2 33.2 5.7 3.4 8.2 13.6 26.5 1.4 13.2 0.0 12.6 6.9 4.6 10.0 7.0 4.1 4.7 23.9 26.0 22.0 4.9 RAB32 ENSG00000118508 "RAB32, member RAS oncogene family" Q13637 6 146543833-146554953 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 176.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 232.6;Kupffer cells: 254.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 86.5" "Group enriched" "Detected in many" 42 "dendritic cells: 42.5;granulocytes: 86.5;monocytes: 46.8" "Low cell line specificity" "Detected in many" HPA025731 Approved Approved Cytosol NA NA 63000 Cytosol "HPA025731: AB_1856001" "unprognostic (3.07e-1)" "unprognostic (5.32e-2)" "prognostic favorable (1.56e-4)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.26e-1)" "unprognostic (2.34e-3)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.64e-2)" "unprognostic (9.71e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" 33.4 16.6 7.1 29.9 7.3 176.7 27.2 8.3 11.1 19.0 9.8 38.7 17.5 26.8 14.7 11.7 20.9 24.3 15.0 6.9 9.0 21.5 50.6 32.4 22.5 9.5 7.7 6.4 13.1 12.3 8.4 5.1 14.9 8.3 14.6 38.1 2.2 18.2 17.0 4.6 18.1 18.6 46.9 9.2 54.6 19.5 33.6 9.0 22.7 11.1 8.4 15.3 28.9 15.6 10.6 65.5 34.5 38.7 65.3 58.0 98.5 0.1 123.3 138.4 167.7 276.7 21.2 31.6 0.1 43.9 132.2 183.5 84.2 2.4 80.4 225.2 0.4 29.1 82.4 78.3 77.3 252.1 114.2 115.9 87.6 133.1 95.8 135.3 86.7 110.5 0.0 15.8 0.4 92.8 15.8 52.0 61.8 5.0 0.0 65.2 0.0 41.5 0.9 65.6 45.2 0.1 50.6 144.7 17.6 219.3 34.3 33.7 91.7 88.0 50.2 67.7 133.1 152.6 0.2 9.4 0.4 115.1 86.0 69.3 86.5 46.8 8.2 0.0 21.2 0.0 0.0 0.0 0.1 42.5 0.0 0.1 0.0 16.5 1.3 15.4 2.2 0.0 14.4 7.1 7.3 8.3 11.1 6.9 9.0 9.5 7.7 6.4 8.3 9.2 9.0 10.6 30.8 48.1 9.4 2.9 4.1 53.5 95.3 92.6 17.6 1.4 29.0 38.9 2.0 52.9 36.8 11.0 4.2 2.2 3.4 64.1 25.4 164.4 96.9 8.5 40.3 34.3 60.1 14.9 2.3 105.7 6.9 51.5 18.3 12.4 57.8 27.7 27.5 75.4 232.6 0.0 1.3 31.3 22.4 254.6 101.7 156.7 24.5 146.7 168.9 24.4 147.2 9.0 2.1 4.0 4.6 154.3 46.3 25.6 0.5 99.6 33.3 83.2 9.5 1.4 19.7 46.1 46.3 70.9 14.2 2.5 19.0 3.1 7.0 33.1 62.5 65.6 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181308-135219173 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 35.5;breast: 20.3;intestine: 26.8;lymphoid tissue: 66.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0" "Group enriched" "Detected in many" 5 "breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 5.4" "Cell line enhanced" "Detected in many" "HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favorable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favorable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.2 0.5 1.7 5.3 1.6 35.5 20.3 0.1 0.6 1.6 0.4 25.5 11.0 1.0 0.1 3.1 8.5 1.0 0.1 0.3 0.4 0.1 0.4 2.0 6.3 0.8 0.8 0.3 0.0 0.3 3.7 0.0 0.4 0.7 1.5 26.8 0.3 0.6 0.9 0.1 3.0 9.5 1.4 0.3 1.2 2.1 0.7 0.4 66.7 0.1 0.0 7.1 1.2 1.3 0.2 1.8 0.3 1.9 3.0 0.0 0.1 0.3 1.0 0.6 1.1 1.1 0.3 1.4 10.9 0.4 0.3 0.4 0.9 5.6 0.0 0.7 18.0 2.5 138.8 1.0 0.5 0.1 219.8 105.1 0.0 0.1 0.6 0.0 0.5 0.3 133.4 114.6 20.1 1.1 11.6 403.1 208.5 1.5 19.2 1.7 244.9 5.9 33.2 0.3 1.5 10.5 6.9 0.5 10.4 0.6 0.5 7.9 343.8 0.4 0.3 1.6 7.9 2.4 27.7 7.7 66.0 0.1 186.1 2.3 4.6 0.7 5.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.4 0.2 1.7 1.6 0.1 0.6 0.3 0.4 0.8 0.8 0.3 0.7 0.3 0.4 0.2 0.2 0.0 1.3 0.0 2.3 2.7 1.3 1.3 0.6 0.9 47.8 12.6 0.4 2.8 7.1 0.0 0.0 1.4 9.1 18.1 0.0 0.0 0.1 24.3 0.3 0.3 17.6 83.2 0.6 0.8 0.4 0.5 4.6 2.2 26.0 0.4 0.0 0.0 1.1 0.0 2.7 32.7 26.4 1.2 1.7 0.2 0.0 2.1 8.8 0.0 2.8 0.9 0.0 0.0 0.2 0.1 10.2 0.0 4.6 2.1 2.3 0.0 37.2 0.0 0.0 0.6 0.9 0.0 1.8 10.2 7.0 0.3 3.6 0.1 52.0 2.2 ALDH8A1 ALDH12 ENSG00000118514 "Aldehyde dehydrogenase 8 family member A1" Q9H2A2 6 134917393-134950115 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "kidney: 72.9;liver: 249.2" "Group enriched" "Detected in some" 4 "Hepatocytes: 142.5;Proximal tubular cells: 136.9" "Group enriched" "Detected in some" 7 "liver cancer: 26.3;renal cancer: 17.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA026292, HPA055414" Enhanced Approved Nucleoplasm,Centrosome NA NA 110000 Centrosome Nucleoplasm "HPA026292: AB_1844741, HPA055414: AB_2682810" "unprognostic (1.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "unprognostic (1.75e-1)" "unprognostic (2.70e-2)" "unprognostic (6.32e-2)" "unprognostic (4.30e-3)" "unprognostic (1.12e-1)" "unprognostic (3.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (2.36e-2)" "unprognostic (5.86e-5)" 1.0 1.3 6.6 0.7 6.4 2.4 1.2 6.8 9.8 1.2 2.5 2.4 0.8 1.3 2.1 0.8 1.0 0.9 0.7 6.9 4.2 72.9 249.2 0.9 0.6 6.0 5.7 7.9 0.5 0.9 0.4 0.8 0.5 7.2 1.7 0.8 2.8 0.8 0.8 3.7 1.7 1.1 0.9 3.4 1.3 1.2 0.5 5.6 0.7 0.7 0.3 0.6 1.9 0.9 10.1 0.1 0.5 0.8 0.5 0.2 0.1 0.6 0.2 0.2 0.0 0.5 0.2 0.3 0.1 0.2 0.0 0.1 0.6 0.6 0.0 0.4 0.6 2.9 2.0 2.1 2.9 0.3 0.8 1.0 0.8 0.9 0.2 0.4 0.6 0.2 0.8 3.0 1.1 0.1 0.0 0.9 1.0 0.2 0.2 0.3 0.0 0.2 0.2 3.3 0.4 0.8 0.2 0.1 0.0 0.5 0.2 0.3 0.2 0.2 0.2 1.6 0.6 0.8 2.8 1.0 0.5 0.3 0.7 0.2 2.5 0.3 0.3 0.4 0.1 0.1 0.4 0.4 0.2 0.0 0.4 0.3 0.3 0.8 0.8 0.1 0.4 0.5 0.3 6.6 6.4 6.8 9.8 6.9 4.2 6.0 5.7 7.9 7.2 3.4 5.6 10.1 0.3 3.2 0.6 3.6 0.8 0.0 0.2 0.2 0.0 2.6 0.7 0.9 0.6 1.5 0.7 31.3 0.0 0.2 0.3 0.1 19.6 0.2 0.1 0.4 0.4 0.7 0.0 0.0 14.3 0.0 1.7 0.4 0.0 1.6 0.0 0.5 2.5 142.5 0.1 3.3 12.9 0.1 0.0 2.5 0.3 0.0 0.0 0.8 0.0 1.0 0.7 0.3 0.0 3.0 9.6 0.0 0.1 0.0 0.3 0.1 0.0 136.9 0.0 1.8 0.0 1.2 0.5 0.0 0.0 0.0 0.4 0.0 0.9 0.5 0.2 0.1 SGK1 SGK ENSG00000118515 "Serum/glucocorticoid regulated kinase 1" O00141 6 134169246-134318112 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 1015.7" "Cell type enhanced" "Detected in many" "Langerhans cells: 1238.4;Proximal enterocytes: 789.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6" "Group enriched" "Detected in all" 8 "granulocytes: 170.2;monocytes: 43.4" "Cell line enhanced" "Detected in many" "HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022085, CAB025148, HPA051251" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB022085: , CAB025148: , HPA051251: AB_2681407" "unprognostic (2.05e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.12e-1)" "unprognostic (5.09e-3)" "unprognostic (2.76e-1)" "unprognostic (4.20e-2)" "unprognostic (4.53e-2)" "unprognostic (5.62e-2)" "unprognostic (4.03e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (2.55e-1)" "unprognostic (5.82e-3)" "unprognostic (9.10e-2)" "unprognostic (3.81e-2)" "unprognostic (1.79e-1)" "unprognostic (6.59e-2)" 92.7 122.7 31.4 47.8 53.4 69.6 84.0 37.2 51.8 61.7 80.2 69.0 51.9 37.3 9.6 109.4 36.9 171.4 33.7 37.3 57.3 106.2 100.1 82.5 33.9 62.1 44.7 28.3 126.8 178.6 1015.7 12.1 71.2 47.7 48.0 39.4 14.2 71.4 60.8 50.7 73.1 284.9 48.8 37.2 21.7 105.2 30.7 45.1 40.0 57.2 34.2 78.7 142.7 97.5 91.2 4.1 6.9 4.2 0.4 51.7 12.9 5.9 76.7 159.4 98.4 79.8 12.2 10.6 13.1 11.3 79.8 48.0 2.5 6.8 12.2 72.0 0.5 3.1 0.6 175.7 9.2 298.1 0.7 6.8 77.3 75.4 96.7 124.3 39.3 167.1 2.3 25.6 192.8 35.6 0.6 1.1 3.0 4.8 20.3 8.3 2.4 8.9 1.5 469.5 1.4 2.2 18.6 241.7 0.7 319.7 43.2 0.5 2.1 373.9 28.8 12.3 176.9 17.1 36.2 358.5 40.3 26.7 12.0 39.5 2.2 43.4 170.2 0.7 24.4 1.6 1.9 1.3 0.8 14.1 1.4 1.6 2.0 91.6 3.6 14.5 0.9 2.5 12.6 31.4 53.4 37.2 51.8 37.3 57.3 62.1 44.7 28.3 47.7 37.2 45.1 91.2 346.2 38.5 177.8 34.0 68.0 183.3 133.7 277.3 329.0 12.0 87.1 112.0 28.4 88.6 168.6 68.0 35.5 41.0 27.0 132.2 21.5 81.3 9.6 145.8 73.1 232.1 10.7 14.7 68.2 171.2 33.6 88.8 206.4 483.4 271.8 33.9 353.4 21.9 284.2 0.0 225.7 65.1 91.6 181.3 1238.4 7.7 15.2 492.5 268.6 58.1 29.6 4.6 2.1 270.9 377.7 36.2 123.9 15.8 92.4 51.0 789.1 124.3 61.5 29.3 13.1 43.5 102.9 38.1 10.2 348.1 116.2 579.8 46.9 48.9 36.3 123.8 RNF146 "dactylidin, dJ351K20.1, DKFZp434O1427" ENSG00000118518 "Ring finger protein 146" Q9NTX7 6 127266682-127288567 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027158, HPA027209" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" Nucleoplasm "HPA027158: AB_10600772, HPA027209: AB_10602312" "unprognostic (8.22e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.37e-1)" "unprognostic (5.47e-3)" "unprognostic (1.87e-1)" "unprognostic (6.74e-2)" "prognostic favorable (5.26e-5)" "unprognostic (2.65e-2)" "prognostic favorable (7.32e-4)" "unprognostic (4.04e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "unprognostic (2.15e-2)" 53.4 37.3 54.7 32.7 60.5 10.7 43.2 84.8 59.8 47.7 42.4 35.9 22.1 57.9 61.4 25.5 42.8 39.0 47.4 55.5 56.8 37.4 32.1 39.0 35.4 56.7 58.0 50.6 49.9 23.5 40.3 33.5 52.2 59.7 32.0 31.2 48.6 31.4 34.9 116.0 29.7 31.3 46.3 63.0 47.5 30.2 31.6 57.4 24.6 47.4 92.3 33.6 37.2 34.5 66.3 13.2 16.2 60.3 53.6 54.7 54.3 22.2 43.5 69.0 22.8 32.4 21.3 19.3 23.6 30.3 35.7 36.2 16.4 18.1 20.4 32.9 27.6 16.0 30.3 21.8 30.0 54.0 18.0 20.6 47.6 42.1 26.1 51.1 52.5 40.6 23.2 33.0 22.5 50.7 25.2 17.9 32.0 22.1 8.1 17.1 22.6 15.7 12.1 32.4 14.3 36.0 36.6 17.1 23.6 27.7 35.5 16.1 60.8 48.3 39.7 13.1 41.8 31.7 32.3 22.0 15.6 30.5 31.0 38.5 27.5 30.0 26.6 14.3 32.4 14.7 17.4 12.2 16.3 22.8 17.9 11.0 15.5 37.0 19.8 40.1 11.7 15.0 16.1 54.7 60.5 84.8 59.8 55.5 56.8 56.7 58.0 50.6 59.7 63.0 57.4 66.3 24.6 35.3 29.3 35.6 23.7 17.7 14.3 15.1 18.8 34.7 16.9 14.7 38.9 31.5 16.7 9.2 4.2 29.0 14.7 13.5 41.1 28.0 52.5 15.7 29.5 30.5 20.4 12.8 53.5 15.8 27.2 50.6 7.1 11.5 22.2 28.1 31.4 30.5 26.3 30.3 54.5 12.1 38.7 68.4 24.6 45.4 69.6 29.9 46.2 42.2 31.1 41.1 28.8 56.3 76.5 18.0 17.0 66.5 9.3 26.3 15.7 51.7 23.9 20.9 32.9 36.2 31.9 41.7 24.9 15.0 20.0 38.4 20.8 36.0 10.9 25.9 ARG1 ENSG00000118520 "Arginase 1" P05089 6 131470832-131584332 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 1213.5" "Cell type enriched" "Detected in some" 22 "Hepatocytes: 991.4" "Cancer enriched" "Detected in some" 45 "liver cancer: 167.7" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "neutrophil: 44.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 44.9" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Region enhanced" "Detected in single" "cerebellum: 2.4" "Low region specificity" "Detected in all" "HPA003595, CAB009434, HPA024006, CAB056159, CAB080011" Enhanced NA NA 9500000 "CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987" "unprognostic (2.00e-1)" "unprognostic (2.09e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-1)" "unprognostic (9.95e-2)" "unprognostic (7.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.22e-1)" "unprognostic (1.56e-2)" "unprognostic (7.55e-3)" "unprognostic (8.35e-2)" "unprognostic (1.25e-2)" "unprognostic (2.90e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.79e-2)" 2.2 0.2 0.2 0.3 0.1 294.9 4.9 1.0 0.4 0.2 0.3 0.2 0.0 0.1 0.0 2.2 1.9 0.0 0.8 0.2 0.2 0.3 1213.5 6.6 0.3 0.5 0.2 0.1 0.2 0.4 0.0 0.2 1.7 0.6 0.3 0.0 0.3 0.9 0.0 0.5 74.8 0.3 0.2 0.0 20.8 0.4 0.1 0.1 1.3 0.5 0.6 0.7 0.2 2.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.0 0.2 0.7 0.3 44.9 0.0 0.9 0.2 9.3 0.4 0.2 0.1 1.0 0.4 0.2 0.2 0.5 0.2 0.1 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 1.5 0.0 43.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.2 991.4 0.0 0.0 0.1 0.1 0.0 27.6 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 CCN2 "CTGF, IGFBP8" ENSG00000118523 "Cellular communication network factor 2" P29279 6 131948176-131951372 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cell adhesion, DNA synthesis" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "naive B-cell: 8.1" "Lineage enriched" "Detected in single" 81 "B-cells: 8.1" "Cell line enhanced" "Detected in many" "EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005123, HPA031074, HPA031075" Approved Approved "Golgi apparatus,Vesicles" "Secreted in other tissues" No No 1010000 5900000 "Golgi apparatus, Vesicles" "CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248" "unprognostic (2.87e-1)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (5.68e-2)" "unprognostic (9.79e-2)" "unprognostic (1.82e-2)" "unprognostic (3.38e-1)" "unprognostic (4.96e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.27e-3)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.62e-1)" "unprognostic (1.77e-2)" "unprognostic (3.84e-3)" 244.1 108.5 19.2 169.5 18.0 2.0 208.5 20.4 25.7 535.5 44.1 146.6 44.1 422.4 34.7 274.4 245.9 445.1 237.5 26.9 19.1 237.9 83.6 228.3 74.2 25.0 25.1 14.6 77.6 195.7 43.4 45.1 199.9 23.7 367.9 137.4 2.4 139.3 155.8 52.2 131.8 152.5 581.0 17.0 574.1 184.1 24.8 24.8 50.0 469.1 62.5 15.0 327.2 103.4 35.5 4.6 7.5 126.8 3.7 279.9 158.5 1.8 373.1 178.2 226.8 119.4 0.2 12.2 0.6 1605.0 482.7 185.0 6.2 4.2 26.4 211.3 2.5 3.5 0.2 55.7 137.3 109.6 0.3 0.5 232.2 5.9 163.9 40.2 340.7 1377.0 0.0 0.4 0.3 650.8 2.5 0.5 1.2 61.8 41.3 21.7 32.6 6.0 0.7 81.9 0.4 0.5 0.8 38.3 62.2 18.3 308.5 6.1 3.1 2874.4 311.6 242.4 397.8 694.0 11.5 1.7 4.1 42.5 0.7 399.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.2 18.0 20.4 25.7 26.9 19.1 25.0 25.1 14.6 23.7 17.0 24.8 35.5 101.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 17.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 47.1 261.8 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 TCF21 "bHLHa23, POD1" ENSG00000118526 "Transcription factor 21" O43680 6 133889113-133895553 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 101.2;ovary: 89.1;placenta: 138.4" "Group enriched" "Detected in some" 5 "Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.7;hippocampal formation: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HHSteC: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA013189 Uncertain NA NA "HPA013189: AB_10601215" "unprognostic (2.43e-2)" "unprognostic (8.45e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "unprognostic (4.78e-5)" "unprognostic (2.58e-2)" "unprognostic (6.66e-2)" "unprognostic (9.74e-2)" "unprognostic (2.88e-2)" "unprognostic (2.91e-3)" "unprognostic (2.01e-2)" "unprognostic (8.48e-2)" "unprognostic (5.37e-2)" "unprognostic (2.95e-1)" 4.6 10.8 0.1 11.1 0.0 0.0 0.3 0.4 1.7 3.4 2.1 24.9 23.6 9.5 13.2 19.6 3.5 20.3 19.1 1.6 0.0 38.7 5.2 59.0 0.3 0.1 0.0 0.0 89.1 10.5 1.3 3.5 138.4 0.1 37.3 21.4 0.0 0.1 42.6 1.2 0.1 26.9 14.5 0.0 101.2 21.2 3.4 0.0 0.1 0.3 0.7 0.0 40.7 8.5 0.2 0.0 1.3 0.0 0.2 0.2 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 51.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.0 2.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.7 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 3.2 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 5.5 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.6 1.3 0.0 0.0 0.0 0.0 1.9 123.8 0.5 0.0 0.0 0.5 0.7 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 102.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.9 0.1 0.3 0.0 0.0 0.0 0.0 118.3 0.3 20.8 0.3 0.4 1.4 0.0 5.7 0.1 14.5 0.0 0.4 PMFBP1 ENSG00000118557 "Polyamine modulated factor 1 binding protein 1" Q8TBY8 16 72112157-72176878 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 13.6;testis: 21.1" "Group enriched" "Detected in some" 6 "Early spermatids: 115.6;Late spermatids: 259.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0;SH-SY5Y: 10.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA056716, HPA075825" Approved Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056716: AB_2683215, HPA075825: " "unprognostic (1.46e-1)" "unprognostic (3.62e-1)" "unprognostic (5.95e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-2)" "unprognostic (7.03e-2)" "unprognostic (1.06e-4)" "unprognostic (1.60e-1)" "unprognostic (3.81e-1)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (2.68e-5)" "unprognostic (9.85e-2)" "unprognostic (2.66e-1)" "unprognostic (9.85e-2)" "unprognostic (8.67e-2)" 1.7 2.2 0.8 1.3 1.0 4.5 1.5 2.4 1.2 1.8 0.5 2.6 2.9 1.7 13.6 2.9 2.0 0.9 2.5 0.9 1.5 3.0 3.1 1.7 2.0 3.3 3.3 0.2 2.6 6.5 1.2 2.8 0.6 8.3 3.7 3.4 3.5 1.7 0.3 0.6 4.5 3.9 0.4 1.7 4.7 2.6 21.1 1.3 2.5 2.2 0.0 0.6 1.9 1.9 2.8 0.2 0.4 2.8 2.8 0.0 0.6 1.9 0.6 0.2 0.6 2.1 1.1 2.8 1.9 0.4 0.1 0.1 1.8 1.0 0.1 1.4 0.2 4.3 1.9 3.7 3.1 0.0 4.2 3.2 0.0 0.9 0.1 2.1 0.6 0.8 2.3 0.4 1.7 0.1 2.4 1.1 6.8 0.8 0.1 1.2 2.9 0.2 1.5 0.3 0.8 21.0 10.7 0.0 0.0 0.2 2.0 0.5 2.7 1.8 1.3 2.2 0.6 1.4 3.9 1.5 1.2 0.6 2.8 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.8 1.0 2.4 1.2 0.9 1.5 3.3 3.3 0.2 8.3 1.7 1.3 2.8 0.0 0.0 0.6 1.0 0.3 0.4 0.1 0.1 1.2 0.9 0.1 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.0 0.2 115.6 0.3 0.2 0.3 5.4 0.8 0.7 0.2 0.1 0.6 0.0 0.1 3.8 0.3 0.0 0.1 4.7 30.3 0.7 0.7 0.0 1.9 5.5 259.5 1.2 2.4 0.0 1.0 0.0 1.1 0.0 1.0 1.6 0.1 0.1 1.5 0.0 0.1 0.2 0.6 1.6 0.2 0.0 0.0 0.1 2.9 0.9 0.3 0.0 0.1 1.0 0.0 0.9 0.2 FBXL5 "FBL4, FBL5, FLR1" ENSG00000118564 "F-box and leucine rich repeat protein 5" Q9UKA1 4 15604381-15681679 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 252.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 407.0" "Group enriched" "Detected in all" 5 "dendritic cells: 108.2;granulocytes: 407.0;monocytes: 225.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002484 Approved NA NA "HPA002484: " "unprognostic (1.53e-1)" "unprognostic (8.08e-2)" "unprognostic (6.34e-3)" "unprognostic (1.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (2.18e-2)" "unprognostic (6.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "unprognostic (3.70e-2)" "unprognostic (5.14e-2)" "prognostic favorable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (5.39e-3)" "unprognostic (6.18e-2)" 73.4 51.3 54.1 40.6 59.2 111.9 52.5 61.3 66.1 54.3 54.8 44.5 30.1 42.5 64.1 43.4 46.5 52.1 49.9 52.7 56.6 129.2 78.0 49.2 35.6 56.4 58.0 50.3 41.9 32.9 59.8 44.7 37.4 55.2 52.0 36.6 48.4 37.2 56.9 80.8 35.7 32.0 55.6 54.3 45.5 41.9 68.6 55.8 46.7 71.2 86.2 32.9 54.4 38.0 60.5 23.3 17.8 42.3 23.9 65.0 63.9 13.4 30.4 37.2 32.7 45.9 14.3 34.1 18.1 14.2 36.4 57.8 8.5 21.9 36.5 50.3 17.7 11.2 17.8 12.9 16.9 65.3 21.7 16.4 59.0 48.4 30.4 46.9 74.9 86.8 15.7 15.2 14.8 99.1 10.5 41.3 33.4 22.3 19.1 15.8 29.5 43.0 14.8 51.8 32.9 20.4 19.2 28.4 10.0 32.8 57.7 16.2 35.8 20.8 37.8 10.7 26.0 38.0 20.1 22.2 16.8 32.4 37.7 46.6 204.3 225.4 115.2 46.2 112.9 44.9 33.5 42.5 44.7 108.2 31.3 44.0 44.8 407.0 42.4 101.7 16.6 40.6 206.8 54.1 59.2 61.3 66.1 52.7 56.6 56.4 58.0 50.3 55.2 54.3 55.8 60.5 37.0 44.8 62.0 63.6 31.3 27.3 37.2 40.5 62.0 52.3 34.6 28.2 88.1 41.5 46.9 36.8 6.2 53.3 38.9 24.4 78.2 29.2 80.3 32.5 41.2 42.5 25.9 29.9 73.6 23.3 41.8 47.0 36.2 42.1 39.9 38.6 40.0 69.1 48.5 40.4 78.7 20.1 32.6 109.9 28.4 52.9 39.7 81.1 30.2 63.7 138.4 36.2 44.3 65.9 120.2 18.8 20.4 58.3 39.1 30.8 37.2 252.3 61.9 41.1 59.2 42.1 46.2 188.5 73.5 63.1 26.1 26.4 45.4 38.4 25.6 32.7 MED28 "DKFZP434N185, EG1, magicin" ENSG00000118579 "Mediator complex subunit 28" Q9H204 4 17614641-17634105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035900, HPA035901" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA035900: AB_10673223, HPA035901: AB_2674853" "unprognostic (1.14e-3)" "unprognostic (6.97e-2)" "unprognostic (1.95e-1)" "unprognostic (6.08e-3)" "unprognostic (8.22e-3)" "unprognostic (3.90e-1)" "unprognostic (1.55e-2)" "unprognostic (5.47e-2)" "unprognostic (5.71e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (7.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.30e-2)" "unprognostic (8.46e-2)" "unprognostic (1.14e-1)" "unprognostic (5.07e-3)" 6.9 5.6 9.0 7.5 9.4 12.3 9.3 9.3 9.0 12.2 8.5 9.2 6.0 11.7 9.8 7.9 10.7 5.3 6.4 8.6 8.7 7.3 6.2 9.8 10.9 9.4 8.9 8.4 15.0 7.4 6.6 10.4 8.6 8.7 9.1 7.0 11.8 9.2 7.3 12.7 10.3 9.7 7.3 8.9 10.3 8.8 6.1 9.1 11.3 9.9 5.9 11.2 9.2 10.0 12.1 4.6 2.9 23.2 11.7 10.0 7.8 9.4 6.5 7.7 8.6 7.8 8.1 10.9 12.6 4.5 6.0 7.6 4.5 14.1 7.0 8.6 5.0 7.0 22.2 10.1 12.3 7.0 15.7 10.7 7.6 9.6 5.4 4.5 9.0 7.5 18.0 20.0 11.3 7.7 4.5 23.3 27.0 16.1 9.1 4.8 17.8 8.5 5.9 8.2 6.8 16.6 8.3 5.7 4.9 5.7 13.6 9.3 16.0 9.4 5.6 3.9 4.0 6.2 8.4 4.0 16.1 5.1 14.9 6.1 5.2 6.6 6.5 4.5 5.2 4.4 5.5 4.9 4.2 6.4 5.6 6.4 5.0 9.0 5.5 4.4 4.4 4.2 7.5 9.0 9.4 9.3 9.0 8.6 8.7 9.4 8.9 8.4 8.7 8.9 9.1 12.1 45.7 19.2 27.6 4.9 67.6 92.2 114.0 86.2 46.1 42.6 54.9 65.8 19.5 38.6 55.2 22.0 16.7 114.5 69.9 25.9 84.1 61.6 11.6 31.2 47.3 63.9 44.3 93.2 5.1 53.8 167.8 57.9 19.4 35.5 59.1 78.4 52.5 31.5 93.9 33.7 5.8 41.2 65.1 74.1 103.0 20.4 56.5 61.7 60.5 5.6 115.4 58.9 94.7 9.5 8.9 57.2 47.4 47.0 33.0 110.2 33.6 58.8 40.6 35.1 32.9 50.5 74.7 76.0 100.5 46.0 93.5 134.6 61.3 62.7 47.5 104.6 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596029-59789855 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 22.2" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.2 6.9 0.8 4.0 1.4 4.8 4.1 5.6 4.0 2.7 3.0 1.9 1.6 3.1 1.5 6.4 2.3 5.4 34.8 1.4 2.2 11.7 3.9 4.5 4.9 2.8 2.3 1.3 2.8 9.9 1.0 1.5 1.6 3.2 1.6 2.6 1.9 2.9 1.6 1.8 8.0 2.5 3.6 0.9 6.4 10.1 2.2 1.3 4.6 1.7 3.6 4.3 4.0 3.1 4.3 0.2 3.6 0.8 0.5 10.9 18.1 0.2 8.8 8.1 4.0 3.4 0.3 6.3 5.8 2.5 16.8 3.8 0.8 1.0 1.7 6.0 2.4 0.5 10.7 12.6 0.5 5.9 14.3 0.1 8.5 3.9 1.4 10.3 7.5 1.6 7.2 0.2 13.0 6.5 3.4 5.5 3.2 0.8 1.2 3.3 0.5 0.1 2.7 9.5 16.0 3.0 1.0 0.1 0.4 6.2 0.7 0.5 2.4 0.0 8.6 3.3 15.6 0.5 11.3 0.2 10.0 10.2 0.1 1.6 0.2 1.5 0.0 4.2 3.2 5.6 1.8 3.3 3.6 1.5 4.1 3.5 5.8 0.1 3.0 8.4 2.1 3.8 2.3 0.8 1.4 5.6 4.0 1.4 2.2 2.8 2.3 1.3 3.2 0.9 1.3 4.3 15.3 28.9 21.4 13.7 28.4 10.1 7.8 9.9 16.5 24.5 1.5 3.9 135.4 90.1 16.5 46.0 10.4 0.3 29.7 0.8 23.5 53.3 117.3 2.1 25.0 22.0 0.0 2.5 150.5 67.1 0.3 36.2 7.1 9.1 10.1 4.7 9.3 14.5 3.6 8.4 128.2 27.2 6.1 32.7 6.1 135.5 6.8 24.8 3.6 14.0 14.9 1.3 37.0 63.8 82.8 28.0 1.2 10.1 26.3 8.1 1.0 0.7 14.4 6.0 6.6 14.0 18.9 4.2 4.5 61.5 12.6 0.7 35.8 80.1 1.5 3.4 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779842-63809562 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 37.2;Endometrial stromal cells: 34.5;Extravillous trophoblasts: 33.8;Syncytiotrophoblasts: 37.1;Theca cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA064014: AB_2685176" "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 6.3 12.1 7.7 5.0 8.3 4.5 10.9 7.8 8.6 7.2 7.7 6.9 5.8 6.8 15.4 5.6 7.9 5.6 14.4 7.5 8.3 11.0 8.6 5.3 7.4 7.9 7.8 7.2 12.1 11.9 15.5 9.0 5.8 8.3 8.4 7.6 10.0 8.4 7.1 10.8 8.3 4.3 6.1 7.9 5.8 5.6 11.9 7.9 7.4 12.9 8.7 7.3 7.5 5.5 9.8 9.6 19.9 14.2 11.7 12.2 16.4 13.5 10.4 18.5 17.7 11.9 6.6 10.1 20.5 17.7 13.4 14.2 9.3 17.5 16.0 22.3 18.5 13.4 11.5 5.1 12.2 18.1 17.6 10.0 14.6 15.6 17.1 22.6 16.8 10.4 16.5 14.0 19.8 27.8 18.3 10.2 8.1 8.1 10.4 20.6 9.0 14.8 13.1 17.8 15.1 30.7 5.9 10.4 9.5 24.5 9.0 20.2 9.9 10.1 14.9 15.2 9.7 15.4 10.6 17.9 15.6 10.9 11.4 20.9 0.8 1.7 1.0 1.9 1.6 3.5 3.0 2.4 2.6 1.7 2.2 2.8 2.6 0.3 3.0 2.2 4.1 4.3 1.2 7.7 8.3 7.8 8.6 7.5 8.3 7.9 7.8 7.2 8.3 7.9 7.9 9.8 17.5 9.6 8.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 26.8 26.8 0.0 0.0 10.5 16.5 0.0 24.7 6.9 0.0 37.2 23.1 0.0 28.6 34.5 8.1 0.0 0.0 0.0 30.7 33.8 12.1 0.0 16.6 7.6 15.5 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.3 0.0 0.0 2.4 0.0 0.0 30.3 13.8 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 37.1 4.8 45.0 0.0 0.0 ZNF430 FLJ13659 ENSG00000118620 "Zinc finger protein 430" Q9H8G1 19 21020634-21060050 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (2.47e-1)" "unprognostic (4.29e-1)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.75e-3)" "unprognostic (5.86e-2)" "unprognostic (1.91e-1)" "unprognostic (1.51e-4)" "unprognostic (2.03e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.24e-3)" 3.1 3.0 3.3 5.4 4.7 12.1 5.3 7.5 3.8 4.0 0.3 3.1 3.7 4.3 8.5 6.9 3.8 3.5 1.9 2.1 2.7 2.7 1.2 3.8 10.4 3.2 3.5 1.9 12.8 4.1 7.9 1.9 3.4 4.3 4.9 4.3 2.9 3.6 3.8 1.5 7.0 3.4 3.5 2.5 6.8 5.0 3.1 3.2 9.9 8.7 2.7 7.9 4.6 4.7 6.1 6.6 1.9 8.0 5.7 6.0 11.2 7.7 6.0 6.4 8.6 8.2 3.7 6.0 10.4 5.7 5.2 5.4 3.7 0.3 6.0 13.0 3.8 7.7 7.3 4.3 3.5 2.9 2.5 14.4 5.9 7.3 5.4 9.9 6.1 6.2 10.8 8.2 12.0 7.8 3.0 17.4 7.8 8.0 3.4 12.8 11.2 10.8 6.0 6.3 9.6 8.9 5.8 1.7 0.8 5.1 7.7 3.5 12.9 4.3 4.6 2.9 8.9 7.4 6.2 7.0 13.1 2.1 7.2 4.6 19.6 4.4 15.9 8.5 5.2 10.4 10.2 10.6 10.1 3.6 13.0 13.9 11.2 10.3 10.4 5.5 6.6 11.4 4.8 3.3 4.7 7.5 3.8 2.1 2.7 3.2 3.5 1.9 4.3 2.5 3.2 6.1 16.8 9.6 12.8 16.3 48.2 28.7 23.7 13.2 21.6 33.1 11.4 11.0 4.0 5.7 9.8 18.4 20.9 12.3 50.8 8.3 1.9 11.9 0.8 11.6 17.8 14.4 10.7 16.2 13.8 8.0 10.6 15.1 13.7 33.3 17.7 45.6 16.1 0.8 10.2 23.5 18.6 7.7 12.2 16.9 17.7 1.8 15.2 20.6 3.6 11.2 19.0 8.6 28.8 23.1 31.1 13.9 7.5 11.3 27.9 26.8 7.0 1.9 12.1 19.7 0.0 13.9 14.8 18.4 16.8 33.5 35.5 9.9 40.9 32.8 9.6 50.4 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 873.4;NB-4: 1362.5;U-937: 912.8" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 220000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 74.6 35.1 26.6 149.8 29.0 302.3 227.3 28.8 54.2 122.8 48.9 252.9 232.0 30.9 145.8 305.5 167.6 120.3 20.9 26.3 36.1 282.7 249.5 268.9 214.2 35.6 28.5 24.6 10.4 184.0 272.6 33.9 267.9 33.3 108.7 303.8 4.4 325.3 91.2 24.5 199.8 254.2 72.1 31.3 177.3 230.5 23.6 33.0 175.1 127.2 27.5 314.3 199.9 151.3 34.1 255.0 33.2 2.6 2.3 2.4 1.4 241.6 0.7 0.3 0.2 0.3 191.2 225.2 56.8 174.4 1.2 17.9 175.2 2.4 451.6 0.6 232.3 173.7 290.3 104.4 220.7 3.3 873.4 287.1 2.3 317.5 0.3 72.3 1.2 58.2 1.2 214.9 11.6 103.8 363.9 0.8 1362.5 3.2 315.9 26.0 5.2 8.9 381.7 516.9 384.3 8.4 2.9 120.9 628.3 19.4 126.3 231.4 665.4 113.9 0.3 15.3 2.9 2.7 3.0 151.1 340.0 2.6 912.8 1.1 601.3 868.6 328.4 469.3 740.3 455.6 519.3 537.0 463.3 787.3 508.3 423.2 442.0 52.4 556.3 460.0 2135.6 665.3 1536.0 26.6 29.0 28.8 54.2 26.3 36.1 35.6 28.5 24.6 33.3 31.3 33.0 34.1 39.4 371.8 283.2 1.3 147.7 259.1 303.3 800.9 164.4 1.2 289.7 251.7 6.3 356.0 662.1 366.0 0.0 980.8 447.1 832.3 765.0 630.7 28.0 231.3 22.8 46.1 129.1 147.4 0.1 730.0 460.4 35.6 188.6 212.9 269.4 3.3 163.1 314.8 1191.1 0.0 0.1 391.8 545.3 1000.4 488.7 49.1 9.3 537.2 352.2 2.8 686.1 7.9 375.9 0.0 0.5 865.5 843.2 7.5 103.0 302.7 1184.0 1046.8 600.5 2.0 46.0 21.4 56.5 48.0 8.3 239.8 329.7 877.8 219.5 13.8 299.4 602.0 DCLRE1B "APOLLO, FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905213-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.6;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "HPA064934: AB_2685387" "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 3.5 1.2 2.5 3.8 2.5 6.1 2.9 4.4 3.9 2.6 2.7 2.8 1.7 2.4 1.7 3.1 2.7 2.3 1.4 2.6 2.5 1.6 1.7 3.2 4.2 2.3 2.5 1.9 3.0 0.9 1.1 0.7 3.5 2.8 1.7 3.0 1.2 1.2 1.9 0.8 2.6 1.9 3.3 2.4 4.0 1.6 2.4 2.6 4.9 2.0 1.0 4.0 2.3 1.6 3.2 14.1 5.5 9.9 10.5 7.9 5.4 5.7 11.1 7.4 14.2 15.3 6.0 3.9 14.3 6.8 7.8 6.4 6.4 13.7 11.2 19.6 12.0 10.1 12.4 7.8 5.9 1.5 14.1 12.1 6.2 4.4 18.5 10.6 3.9 7.9 16.5 17.5 11.8 16.7 57.8 21.7 11.5 7.7 5.5 12.6 17.2 30.4 6.5 5.6 6.1 8.7 8.0 12.0 9.2 7.7 7.8 6.1 14.9 4.8 18.6 19.6 31.3 15.8 5.2 5.6 16.0 15.7 13.8 32.9 1.9 4.5 1.3 2.3 3.7 2.5 0.9 2.6 2.2 2.6 1.4 1.7 2.2 0.2 5.8 2.1 1.0 1.8 2.5 2.5 2.5 4.4 3.9 2.6 2.5 2.3 2.5 1.9 2.8 2.4 2.6 3.2 3.0 3.2 2.0 0.3 2.8 3.6 1.2 1.7 8.0 3.0 2.6 2.0 1.2 1.5 0.8 0.0 2.1 4.6 4.0 1.0 1.9 4.4 1.3 4.1 2.3 3.4 3.0 23.6 0.8 2.7 9.8 3.4 0.5 2.4 1.3 5.6 2.2 1.6 9.7 1.7 0.9 3.1 2.0 8.5 12.8 0.6 1.8 10.5 0.0 1.0 13.5 0.9 2.1 0.0 1.1 3.7 0.5 2.2 5.0 1.5 0.3 1.7 3.1 1.4 26.3 2.1 5.5 7.9 11.4 6.2 2.7 1.4 4.4 3.0 4.2 1.0 MYL12B MRLC2 ENSG00000118680 "Myosin light chain 12B" O14950 18 3261479-3278461 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039262, HPA045244, HPA059197" Supported NA NA "HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (2.55e-2)" "unprognostic (7.31e-2)" "unprognostic (5.69e-2)" "unprognostic (4.05e-2)" "unprognostic (3.66e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-2)" "unprognostic (7.65e-2)" "unprognostic (2.89e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.18e-1)" "prognostic favorable (8.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.77e-1)" "prognostic favorable (6.62e-6)" "unprognostic (1.27e-2)" 355.2 445.0 176.4 234.7 180.5 304.4 381.6 182.0 234.9 320.6 215.6 440.5 423.9 268.2 487.2 513.2 299.6 281.4 301.6 184.6 191.1 516.2 409.5 430.6 274.5 187.2 180.4 175.4 233.6 226.2 422.2 191.2 408.6 185.1 246.1 443.8 104.8 367.9 275.6 271.9 339.8 406.9 250.6 182.9 276.3 324.3 154.2 180.9 306.6 343.3 216.6 317.4 408.1 350.9 192.7 565.6 294.1 253.8 247.3 726.9 598.1 437.1 839.9 719.9 751.9 769.3 611.7 439.0 282.5 360.1 1154.6 576.7 277.3 424.3 967.7 748.6 166.1 180.7 285.0 297.2 482.8 744.0 645.0 428.0 533.6 879.0 512.7 320.4 659.9 1128.1 283.3 247.8 266.3 971.9 1146.7 372.0 450.3 170.1 666.5 249.7 181.0 320.2 228.5 1572.8 995.6 208.1 217.4 836.3 497.2 524.7 403.6 429.2 379.3 1422.8 736.3 1111.3 654.0 1036.9 148.1 153.2 342.8 448.2 256.9 586.8 1484.7 500.6 1513.2 643.7 666.4 548.3 436.8 619.3 701.5 582.0 360.0 501.2 582.5 1141.6 485.2 799.0 797.2 742.7 1294.1 176.4 180.5 182.0 234.9 184.6 191.1 187.2 180.4 175.4 185.1 182.9 180.9 192.7 846.5 807.7 516.2 16.3 279.4 634.5 889.6 2141.6 412.6 82.6 394.7 556.9 755.3 444.7 1157.4 542.6 25.0 1084.6 470.9 1301.7 1048.7 1453.7 164.3 617.3 362.5 674.4 243.9 269.7 21.9 1470.9 1082.5 447.4 290.0 705.2 446.8 372.9 683.9 292.2 614.1 65.6 20.4 590.3 990.7 375.7 450.1 225.0 446.4 448.1 345.1 52.5 911.6 185.7 461.4 14.1 21.6 2199.0 1180.2 433.3 121.6 814.9 1459.2 1477.9 891.9 94.5 355.0 269.5 542.6 240.0 208.9 486.5 568.4 1402.6 532.9 671.1 568.9 1097.6 FOXO3 "AF6q21, FKHRL1, FOXO2, FOXO3A" ENSG00000118689 "Forkhead box O3" O43524 6 108559835-108684774 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004074, HPA063104" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004074: AB_2106672, HPA063104: AB_2684941" "unprognostic (3.42e-2)" "unprognostic (3.76e-2)" "unprognostic (4.28e-2)" "unprognostic (1.96e-2)" "unprognostic (6.68e-2)" "unprognostic (4.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.73e-1)" "unprognostic (3.81e-2)" "unprognostic (5.18e-2)" "unprognostic (1.98e-2)" "unprognostic (1.75e-1)" "unprognostic (2.54e-2)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "unprognostic (5.81e-2)" "unprognostic (5.68e-2)" 47.1 11.5 16.3 13.5 16.4 69.1 43.6 33.5 20.6 25.4 19.3 20.2 12.5 23.7 15.4 35.7 25.6 28.5 18.7 15.0 11.5 16.5 23.3 30.6 12.9 18.5 16.7 13.2 43.4 87.6 30.5 8.7 21.5 16.8 20.2 17.1 28.9 25.4 11.6 84.8 29.8 17.1 21.3 12.9 19.0 22.4 12.0 16.9 18.7 18.2 51.8 15.9 23.3 27.6 15.3 21.6 6.8 9.1 20.4 41.2 48.4 16.1 17.0 17.7 13.5 19.9 11.9 19.5 11.7 14.8 20.0 22.3 15.0 12.1 20.8 20.4 12.9 18.3 32.5 6.2 9.8 47.4 8.6 24.8 56.0 43.2 29.3 40.4 19.8 10.3 10.2 21.8 94.5 26.9 12.2 9.4 12.6 6.1 10.1 11.6 12.1 32.4 48.7 30.7 16.5 23.4 59.9 12.7 11.8 16.6 18.1 12.1 27.7 18.3 24.9 12.9 13.8 20.6 0.9 16.8 13.5 13.4 16.2 16.4 7.8 2.8 6.1 3.2 1.5 3.8 0.8 1.7 2.6 1.7 1.7 1.4 2.0 15.6 3.7 5.3 2.7 1.9 1.1 16.3 16.4 33.5 20.6 15.0 11.5 18.5 16.7 13.2 16.8 12.9 16.9 15.3 88.2 44.8 46.0 112.6 41.2 67.7 73.3 34.4 91.6 63.4 64.1 46.9 31.6 71.4 44.4 25.8 70.9 25.4 41.4 86.9 17.6 50.4 19.9 91.2 41.8 55.6 66.9 246.9 102.7 30.9 36.9 105.8 46.9 105.6 15.2 46.2 84.6 77.7 46.4 52.2 99.9 55.0 20.3 85.2 83.3 17.7 106.6 96.6 56.9 160.2 55.9 78.9 22.6 108.6 133.2 73.3 44.2 100.4 83.3 122.2 28.3 21.1 57.7 68.6 32.9 236.6 81.6 9.1 17.8 61.1 46.5 41.2 37.6 30.6 34.5 184.2 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974476 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" "Astrocytes: 80.0;Early spermatids: 117.7;Excitatory neurons: 86.1;Inhibitory neurons: 69.3;Late spermatids: 145.3;Respiratory ciliated cells: 61.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA025809: AB_1845032, HPA053696: AB_2682233" "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 5.4 3.9 8.0 4.0 8.8 8.9 7.1 1.6 7.1 6.6 28.1 3.0 1.8 7.6 7.7 3.4 20.6 5.2 9.4 4.2 3.4 3.6 2.6 8.6 4.2 5.2 6.1 3.1 5.4 2.4 9.5 6.7 7.0 4.6 4.0 4.6 26.9 3.5 4.7 4.0 5.3 3.5 4.1 2.4 6.0 5.0 33.7 5.5 3.9 10.7 1.4 4.3 2.4 2.7 4.5 3.5 2.1 10.1 6.5 4.9 5.9 2.2 2.1 2.9 5.3 7.0 3.2 3.0 5.5 2.6 3.4 8.1 3.0 5.6 4.2 9.1 1.5 4.9 5.1 5.2 3.4 2.6 8.0 2.2 6.8 5.8 6.1 1.7 7.1 5.0 16.6 2.2 8.4 5.5 2.7 7.0 7.3 3.2 3.4 2.6 7.8 8.3 4.3 4.9 4.1 14.0 5.2 7.3 1.8 5.1 5.6 3.7 4.1 2.5 4.4 2.3 3.8 2.9 3.8 5.5 4.7 7.6 5.5 5.6 3.7 2.1 0.6 2.0 3.0 1.8 0.8 1.5 2.2 1.7 1.9 0.9 2.2 6.0 2.9 2.4 2.8 4.7 1.0 8.0 8.8 1.6 7.1 4.2 3.4 5.2 6.1 3.1 4.6 2.4 5.5 4.5 2.0 9.6 3.7 80.0 3.4 1.0 1.1 1.9 0.6 2.0 1.2 1.5 6.8 1.5 10.9 0.0 0.0 1.5 2.9 0.3 0.0 1.2 117.7 33.0 2.7 2.2 1.8 2.1 86.1 1.0 2.1 3.0 1.5 1.8 0.0 2.8 0.7 0.3 3.9 1.7 69.3 0.4 4.1 4.4 0.4 145.3 6.8 3.1 5.4 11.2 0.5 1.7 3.1 35.7 24.4 0.7 0.0 10.1 5.9 0.6 0.4 1.8 61.8 4.9 0.0 4.2 4.2 41.5 6.3 1.9 1.4 0.5 5.1 2.5 0.6 0.7 GHRH GHRF ENSG00000118702 "Growth hormone releasing hormone" P01286 20 37251086-37261814 "Human disease related genes, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 130.9" "Cell type enriched" "Detected in single" 7 "Cardiomyocytes: 5.2" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 8.5" "Region enriched" "Detected in some" 12 "hypothalamus: 130.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 2.1;U-266/84: 7.9" "Region enriched" "Detected in many" 9 "hypothalamus: 32.9" "Region enhanced" "Detected in some" "hypothalamus: 3.7" "Secreted in other tissues" NA NA "unprognostic (4.78e-2)" "unprognostic (2.57e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-1)" 0.0 1.0 0.7 0.0 0.3 0.0 0.3 0.3 0.5 0.0 0.1 0.0 3.5 0.0 0.0 0.3 0.0 0.0 6.3 0.3 130.9 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 0.6 0.1 11.2 9.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.5 0.3 130.9 0.2 0.4 0.3 0.3 0.2 11.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 RPN2 "RIBIIR, RPN-II, RPNII, SWP1" ENSG00000118705 "Ribophorin II" P04844 20 37178410-37241619 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008297, CAB019277, HPA025922" Enhanced Supported "Endoplasmic reticulum" NA NA 1300000 "Endoplasmic reticulum" "CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458" "unprognostic (9.59e-3)" "unprognostic (5.22e-2)" "unprognostic (1.66e-2)" "unprognostic (1.06e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.44e-10)" "unprognostic (2.83e-1)" "unprognostic (6.99e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.44e-4)" 113.6 133.6 46.6 133.1 48.6 182.4 147.6 48.9 56.3 163.2 88.0 158.4 126.7 109.7 347.1 107.7 124.0 120.9 101.2 47.5 73.3 146.4 213.8 130.9 110.1 52.6 48.2 45.9 95.7 161.0 182.4 79.7 260.1 51.2 165.8 176.9 118.1 159.5 159.0 111.3 92.2 111.9 157.9 53.0 119.0 146.4 145.5 52.7 109.5 234.6 75.7 144.5 167.0 88.6 58.0 328.2 290.6 302.7 401.2 413.1 308.2 586.7 426.7 516.8 544.8 459.2 939.2 564.8 255.3 501.6 572.3 506.4 468.4 318.8 516.4 492.0 121.2 196.5 295.3 308.4 634.1 398.9 468.4 467.0 294.6 505.1 432.3 447.5 519.8 530.4 239.2 458.7 805.1 389.1 300.9 270.6 451.0 240.4 839.3 415.7 242.3 549.1 852.7 371.6 304.3 246.4 261.0 517.9 1231.1 489.4 353.6 606.1 765.6 338.0 600.8 358.2 317.1 371.9 474.7 608.4 259.9 583.4 314.9 493.2 424.2 427.5 285.5 365.5 410.5 417.0 291.0 336.1 363.8 481.2 232.4 298.8 308.7 78.3 398.8 357.6 591.0 338.2 676.5 46.6 48.6 48.9 56.3 47.5 73.3 52.6 48.2 45.9 51.2 53.0 52.7 58.0 85.7 118.6 158.0 22.2 107.8 61.8 134.1 264.6 62.0 72.6 90.0 74.2 81.4 133.0 197.7 80.9 45.9 461.6 109.6 113.9 23.5 278.0 37.3 73.2 103.5 98.6 63.0 91.7 18.8 241.1 599.6 127.4 84.1 151.2 105.2 109.3 100.6 206.3 233.2 63.9 18.6 168.5 162.8 150.4 75.3 24.4 105.0 117.0 90.7 20.6 122.2 136.8 65.9 24.1 20.5 160.1 109.5 110.9 392.3 121.3 64.6 82.3 98.5 100.8 85.5 65.3 122.0 335.2 288.9 67.7 57.8 621.0 81.5 213.7 138.7 117.6 TGIF2 ENSG00000118707 "TGFB induced factor homeobox 2" Q9GZN2 20 36573488-36593950 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053786, HPA064522" Enhanced Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053786: AB_2682261, HPA064522: " "unprognostic (1.42e-2)" "unprognostic (8.27e-2)" "unprognostic (2.80e-1)" "unprognostic (2.10e-3)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (7.19e-2)" "unprognostic (4.88e-2)" "unprognostic (2.70e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (1.51e-1)" "unprognostic (3.75e-2)" "unprognostic (8.53e-2)" "unprognostic (1.22e-1)" "unprognostic (8.79e-3)" "unprognostic (1.14e-2)" 7.0 6.0 3.9 12.5 4.1 7.7 10.3 3.7 3.9 9.9 7.9 7.5 4.9 22.2 4.5 5.8 24.4 8.7 6.4 3.7 4.1 9.3 9.4 8.7 17.0 5.0 4.4 2.8 13.9 15.2 13.3 3.0 11.7 4.9 9.1 5.6 5.3 10.3 7.9 2.1 5.8 8.4 18.7 4.8 14.7 7.1 11.5 4.7 18.0 8.6 3.7 18.8 9.6 6.7 4.6 16.1 4.2 45.0 52.3 6.2 5.6 16.1 8.9 10.3 21.3 15.5 22.9 20.5 42.5 23.2 9.2 9.7 16.4 36.1 23.6 20.8 20.0 13.2 53.5 10.6 30.5 9.6 23.6 12.7 9.1 15.0 4.8 16.4 19.1 20.9 20.6 26.1 27.3 10.4 22.8 38.8 43.6 37.1 23.0 11.1 33.2 52.7 24.0 13.8 10.7 13.5 40.0 3.1 23.3 23.1 34.8 28.7 51.2 15.6 3.7 13.7 0.3 17.2 29.6 11.9 40.3 0.3 27.2 16.6 16.0 5.0 1.6 4.0 4.3 4.4 7.2 3.6 4.1 6.7 4.9 6.0 5.1 2.0 3.8 3.0 6.7 3.8 3.8 3.9 4.1 3.7 3.9 3.7 4.1 5.0 4.4 2.8 4.9 4.8 4.7 4.6 11.5 9.6 8.8 0.0 41.7 44.6 31.4 10.5 50.7 0.2 25.5 16.6 17.3 14.3 9.4 7.3 2.1 6.6 26.5 1.3 7.9 19.7 2.8 11.4 13.4 17.9 6.6 13.5 0.0 7.7 1.7 12.9 8.6 13.7 16.5 35.7 10.8 5.8 10.4 0.0 0.0 3.7 10.2 10.0 25.8 3.2 6.2 13.2 14.2 0.0 12.7 7.4 3.1 0.0 0.0 15.9 4.8 7.5 35.3 27.5 0.3 7.0 5.3 2.0 6.6 10.0 13.9 3.0 19.8 11.6 25.4 9.0 27.0 11.0 4.2 16.4 CASQ2 PDIB2 ENSG00000118729 "Calsequestrin 2" O14958 1 115700021-115768714 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1066.4" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 777.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "HSkMC: 13.6" "Region enriched" "Detected in all" 6 "cerebellum: 43.1" "Low region specificity" "Detected in all" "HPA027285, HPA055298" Enhanced "Intracellular and membrane" NA NA "HPA027285: AB_1845933, HPA055298: AB_2682777" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (9.70e-3)" "unprognostic (1.28e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.03e-4)" "unprognostic (1.78e-1)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (7.20e-3)" "unprognostic (1.82e-2)" "unprognostic (1.80e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.25e-5)" 32.1 3.1 3.8 6.4 2.3 0.0 9.0 3.1 3.6 7.2 3.8 40.8 3.4 17.3 6.6 38.8 14.8 6.7 1066.4 2.0 3.7 3.4 0.6 5.4 0.8 2.1 5.0 1.8 5.3 1.2 1.6 1.0 1.6 2.3 13.9 17.2 0.3 7.7 20.4 183.8 3.7 9.2 39.5 2.1 0.8 14.3 1.5 7.8 1.6 4.1 166.5 1.3 44.3 7.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 2.3 3.1 3.6 2.0 3.7 2.1 5.0 1.8 2.3 2.1 7.8 2.2 2.7 0.0 0.0 0.3 0.0 0.6 0.3 0.0 0.6 0.2 0.1 0.4 777.8 0.0 0.0 1.8 0.0 0.4 0.1 0.0 0.0 0.0 15.5 0.3 0.0 4.8 0.0 0.0 0.7 0.0 0.3 17.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 20.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 1.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 92.1 11.0 73.4 0.1 0.4 0.2 0.3 0.0 0.1 0.0 0.0 0.0 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802560-101996926 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 12.5;retina: 7.4" "Group enriched" "Detected in some" 17 "Excitatory neurons: 653.3;Inhibitory neurons: 174.6" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AF22: 5.7;HAP1: 3.9;HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 2.2" "Region enhanced" "Detected in all" "cerebellum: 177.3" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.0 1.4 3.9 0.4 6.0 0.0 0.0 8.2 12.5 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 6.5 8.4 0.4 0.0 0.0 0.0 2.0 3.1 8.0 0.0 0.0 0.0 1.2 0.0 2.1 0.0 0.5 7.4 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.1 0.2 0.1 5.8 0.0 0.3 0.0 0.0 0.0 0.0 12.3 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 2.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.0 8.2 12.5 6.5 8.4 2.0 3.1 8.0 2.1 0.0 5.8 12.3 0.1 0.0 0.0 10.7 0.0 0.0 0.1 0.0 0.0 23.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 653.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.7 0.0 8.5 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 6.5 0.0 0.0 PKD2 "Pc-2, PC2, PKD4, TRPP2" ENSG00000118762 "Polycystin 2, transient receptor potential cation channel" Q13563 4 88007635-88077777 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway" "Calcium channel, Ion channel, Potassium channel, Voltage-gated channel" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004544, HPA015794, HPA055297" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: " "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (1.22e-1)" "unprognostic (6.83e-2)" "unprognostic (9.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.17e-2)" "unprognostic (1.88e-1)" "unprognostic (8.64e-2)" "unprognostic (1.08e-1)" "unprognostic (6.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.17e-3)" "unprognostic (3.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.51e-1)" 27.9 24.4 9.9 14.1 12.7 10.8 18.8 10.7 11.9 40.3 8.8 25.2 10.8 61.7 14.8 12.9 39.6 27.2 19.9 9.6 10.0 49.0 15.1 22.4 11.5 10.9 12.1 8.4 48.1 15.0 28.2 9.0 24.7 12.0 23.6 13.3 14.1 9.8 39.5 5.8 10.4 14.9 54.2 10.3 11.0 20.1 10.4 10.6 7.6 16.5 11.8 8.8 20.8 18.6 15.4 7.4 40.8 44.9 23.2 101.8 67.6 13.3 137.2 207.1 62.9 62.2 2.0 12.8 4.0 29.3 166.4 24.0 9.1 8.1 20.4 54.5 21.2 7.1 6.6 21.8 4.3 56.5 16.2 12.9 56.4 9.1 49.4 26.4 85.6 28.8 7.6 0.9 10.9 55.5 14.4 11.4 7.7 23.4 5.3 6.7 21.5 26.8 6.0 55.6 17.2 9.0 20.1 25.5 1.2 32.5 45.0 9.7 12.1 44.7 59.1 12.9 16.8 18.8 8.7 2.9 4.4 35.2 2.5 55.3 1.4 0.1 0.2 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.2 0.3 0.1 0.4 0.1 0.1 9.9 12.7 10.7 11.9 9.6 10.0 10.9 12.1 8.4 12.0 10.3 10.6 15.4 14.8 3.2 6.3 59.4 3.5 7.4 5.3 7.4 23.3 16.7 7.4 11.3 7.1 18.6 7.2 69.9 10.4 10.4 2.7 0.6 0.0 14.0 0.3 10.3 41.7 19.2 6.7 13.5 129.1 3.8 3.4 42.0 2.0 11.1 1.3 12.7 21.4 10.6 12.2 26.9 148.6 3.4 4.1 5.0 6.8 1.1 23.0 9.8 23.2 95.5 9.5 17.3 4.1 178.9 219.4 2.2 4.6 50.8 3.1 6.5 3.9 17.0 12.3 1.9 26.3 53.0 31.5 0.8 3.8 13.3 6.7 2.7 6.1 11.5 2.8 3.4 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090150-88231628 "Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6" "Cancer enhanced" "Detected in many" "glioma: 9.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.3 4.1 32.9 1.0 27.4 2.3 4.1 28.7 33.4 22.3 17.6 15.8 48.7 23.4 6.8 2.4 9.9 5.2 2.9 24.3 30.3 3.6 36.3 5.2 1.2 43.1 30.0 19.2 8.4 0.8 4.5 9.0 11.8 36.5 7.1 14.0 2.5 5.1 34.1 0.3 0.6 89.1 20.0 29.0 1.4 1.9 3.1 33.8 1.3 6.4 0.9 2.1 2.4 4.1 35.1 1.7 43.5 11.9 0.0 0.4 0.0 75.8 1.9 1.3 2.1 3.5 9.8 0.5 0.0 0.4 0.3 5.4 13.2 0.4 1.2 3.1 13.2 1.9 0.6 0.3 13.0 0.0 0.6 0.1 0.2 5.1 4.8 0.3 1.2 4.1 1.0 1.1 0.0 1.3 26.2 6.3 0.2 4.1 58.6 0.0 3.2 0.0 38.9 0.1 9.5 0.2 0.5 8.9 0.9 1.2 26.1 0.3 0.1 0.0 1.7 1.6 0.4 0.2 11.9 4.7 0.0 3.1 0.0 1.8 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.2 0.2 0.0 0.5 0.2 0.1 0.0 1.1 0.1 0.2 0.8 0.2 32.9 27.4 28.7 33.4 24.3 30.3 43.1 30.0 19.2 36.5 29.0 33.8 35.1 9.4 3.2 1.1 3.9 0.9 3.8 0.3 0.0 0.0 0.4 24.3 1.9 1.6 1.5 0.2 0.0 0.0 16.8 0.6 106.7 1.9 0.0 3.3 0.4 3.8 45.8 3.0 20.6 1.1 0.2 81.7 2.4 0.5 0.5 5.7 0.2 31.4 23.4 137.4 0.0 0.7 12.0 0.0 1.3 2.5 1.2 1.2 2.8 5.4 185.5 0.1 0.7 2.1 11.1 0.9 0.1 44.3 0.4 2.0 0.2 216.6 7.6 0.8 0.9 0.0 0.4 4.3 1.0 4.3 1.1 0.4 37.6 1.0 4.3 6.1 0.2 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 1911.4;gallbladder: 2446.6;kidney: 3595.2;placenta: 2815.3" "Cell type enriched" "Detected in many" 8 "Hofbauer cells: 60702.5" "Group enriched" "Detected in all" 4 "glioma: 1690.9;renal cancer: 1385.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "neutrophil: 24.8" "Lineage enriched" "Detected in single" 249 "granulocytes: 24.8" "Cell line enhanced" "Detected in many" "EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3" "Region enhanced" "Detected in all" "pons and medulla: 316.8" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 73000000 "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 93.0 24.6 589.6 60.0 601.1 1.0 70.8 752.2 742.8 27.7 402.8 33.0 9.6 132.4 9.9 4.9 53.3 2446.6 26.4 454.8 930.8 3595.2 35.9 18.9 9.2 941.4 689.7 385.0 10.0 294.4 19.4 20.8 2815.3 817.7 15.9 7.7 752.0 89.4 22.3 16.2 2.3 14.5 38.6 904.2 9.3 11.1 11.8 708.7 8.5 8.4 0.4 5.8 25.3 6.0 1911.4 2.2 144.0 19.1 1.1 0.0 0.2 0.3 5.6 4.4 1.4 9.1 0.6 0.2 0.2 4825.8 2.3 371.5 1.4 0.0 0.0 3.1 11.2 0.0 0.0 1.8 2469.7 0.3 6.8 5.1 0.5 0.3 34.9 0.1 118.8 4.2 0.2 0.1 10.8 1.3 0.2 1.2 21.3 227.5 0.3 0.0 2.4 0.5 1189.8 10348.3 1.8 1.1 0.9 0.3 0.8 339.1 441.9 0.5 5.2 0.3 11.5 27.1 0.4 25.8 0.9 7.9 13.9 436.3 1.1 457.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 589.6 601.1 752.2 742.8 454.8 930.8 941.4 689.7 385.0 817.7 904.2 708.7 1911.4 35.7 3.2 4.7 5.2 34.0 1.5 5.2 0.1 1.2 46.6 1767.7 22.4 17.9 1584.2 0.3 2183.1 27.1 335.6 6.9 0.0 1003.7 7273.8 0.1 61.2 25.2 367.9 0.0 2.7 1.4 71.7 294.5 48.9 0.0 154.2 0.0 1.7 5.7 5.0 60702.5 785.7 9.9 0.0 0.0 57.4 7.7 1.0 0.9 247.7 1.8 99.3 69.2 3862.9 0.0 4.5 532.1 215.4 0.0 0.0 0.1 0.4 0.0 5594.0 1.6 169.7 0.0 0.9 21.6 0.5 0.2 1.1 1.0 667.8 30.0 0.4 0.0 9.9 STBD1 "FLJ41801, GENX-3414" ENSG00000118804 "Starch binding domain 1" O95210 4 76306733-76311130 "Plasma proteins, Predicted intracellular proteins, Transporters" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 131.4;skeletal muscle: 250.9;tongue: 156.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 9.1;Ductal cells: 7.9;Glandular and luminal cells: 5.1;Plasma cells: 7.0;Proximal enterocytes: 19.5;Respiratory ciliated cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 140.7;U-266/70: 62.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011952, HPA012849" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA011952: AB_1847461, HPA012849: AB_1847460" "unprognostic (1.46e-1)" "unprognostic (1.02e-3)" "unprognostic (4.29e-2)" "unprognostic (1.95e-1)" "unprognostic (2.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (6.84e-2)" "unprognostic (3.06e-1)" "unprognostic (1.03e-1)" "unprognostic (4.96e-3)" "unprognostic (4.42e-2)" "unprognostic (3.52e-2)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (2.84e-1)" "unprognostic (5.74e-2)" 110.7 5.4 4.5 7.3 4.0 20.1 11.9 3.5 6.3 7.1 3.5 29.3 9.7 9.4 3.2 15.2 13.8 12.9 53.2 3.9 6.9 10.0 131.4 14.2 1.4 6.6 4.7 4.0 10.1 12.1 8.0 1.7 17.0 6.3 20.9 26.6 4.0 4.8 14.1 250.9 1.4 26.3 28.2 5.8 2.2 15.6 9.8 5.1 1.3 2.6 156.0 2.1 22.4 4.6 5.7 15.9 9.9 2.0 10.0 46.3 13.9 12.7 21.9 21.6 12.0 12.6 12.6 17.9 0.0 13.1 25.8 26.2 9.2 9.6 6.1 7.4 52.4 3.6 1.7 18.2 16.5 4.8 9.5 10.5 7.1 24.0 10.2 8.2 32.4 0.9 0.0 0.6 140.7 23.7 13.0 0.6 7.4 2.5 24.1 7.2 0.0 3.8 9.9 8.0 17.2 2.6 17.7 12.9 20.2 0.3 5.0 4.9 3.7 3.9 11.6 5.9 29.4 12.5 62.8 17.1 0.0 19.6 7.5 5.4 0.1 2.6 5.7 2.0 3.1 1.1 0.1 2.4 2.4 2.5 0.0 0.5 0.9 0.3 4.4 1.2 0.3 0.8 1.3 4.5 4.0 3.5 6.3 3.9 6.9 6.6 4.7 4.0 6.3 5.8 5.1 5.7 0.0 0.0 0.5 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.2 9.1 0.0 7.9 0.0 2.8 1.5 0.1 0.0 0.4 0.0 3.9 1.4 1.0 2.6 5.1 0.0 0.3 0.0 1.5 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 1.0 0.0 0.0 3.3 2.9 0.0 7.0 0.5 19.5 0.3 6.6 0.0 0.0 1.1 3.0 0.2 0.0 1.1 0.0 0.8 0.3 0.3 1.4 0.9 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047155-77076309 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 169.5 99.3 198.1 110.8 189.1 224.8 185.4 251.6 226.1 236.8 148.9 157.4 100.9 213.0 251.3 179.6 198.2 152.0 197.5 168.0 182.8 185.5 134.8 146.1 186.8 197.0 194.4 144.1 344.7 156.5 146.4 71.7 139.2 205.5 200.7 131.1 215.0 184.6 210.8 228.0 135.8 121.8 197.3 177.3 150.4 150.2 132.9 195.2 231.3 275.9 179.4 240.8 188.2 171.9 199.1 163.3 96.0 305.0 268.6 447.6 406.7 117.0 122.5 298.4 189.9 181.5 119.3 240.6 300.1 183.2 309.4 118.9 83.4 211.7 428.9 300.2 214.0 83.7 180.3 102.1 114.0 438.1 312.0 346.4 320.4 502.6 175.1 426.2 542.6 270.1 154.3 157.2 315.9 273.4 187.7 406.3 292.5 135.2 113.9 59.0 250.7 290.0 126.5 283.5 182.7 387.3 211.8 162.9 247.2 209.2 212.6 141.2 131.6 184.6 231.0 137.0 249.0 170.4 173.7 86.1 310.9 195.4 210.6 153.3 160.7 113.2 236.7 95.6 108.0 131.2 148.2 157.0 142.0 119.5 153.7 165.2 143.8 145.8 109.3 134.0 135.3 149.7 100.0 198.1 189.1 251.6 226.1 168.0 182.8 197.0 194.4 144.1 205.5 177.3 195.2 199.1 368.4 173.1 231.3 59.7 606.6 422.9 633.0 489.3 578.8 629.5 550.2 523.5 460.5 323.1 238.7 196.8 68.8 273.7 441.5 258.8 794.3 400.9 71.0 250.5 321.3 405.5 412.3 510.9 125.8 334.3 427.4 510.9 220.2 231.2 278.4 300.9 382.7 121.5 337.0 181.7 150.3 346.6 329.6 685.1 676.5 147.5 604.0 490.4 402.0 77.8 613.0 403.2 390.3 52.3 69.1 515.1 317.6 989.2 500.8 854.8 468.4 596.6 161.4 228.7 552.2 373.3 510.8 200.4 745.5 466.1 394.8 379.5 497.3 326.5 345.9 747.1 RARRES1 "LXNL, TIG1" ENSG00000118849 "Retinoic acid receptor responder 1" P49788 3 158696892-158732489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 208.1;salivary gland: 166.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 217.1;Club cells: 621.4;Prostatic glandular cells: 312.9;Urothelial cells: 737.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 93.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 10 "CAPAN-2: 1319.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003892 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA003892: AB_1856079" "unprognostic (5.76e-3)" "unprognostic (2.13e-1)" "unprognostic (8.85e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.09e-2)" "unprognostic (8.93e-2)" "unprognostic (3.86e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.88e-6)" "unprognostic (3.49e-1)" "unprognostic (1.33e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" 106.0 21.5 1.0 65.7 1.4 0.6 44.9 1.5 1.7 56.5 9.3 32.0 5.2 26.1 27.3 11.3 208.1 19.9 49.9 1.4 2.5 24.7 4.3 53.1 19.1 0.7 0.5 1.5 61.0 10.1 0.2 27.9 3.6 0.8 79.2 36.6 0.9 166.6 37.5 5.6 8.4 38.8 51.7 0.2 2.8 23.9 4.6 0.8 1.8 20.5 2.8 6.2 93.0 32.5 1.4 19.2 6.9 0.2 1.0 4.0 12.6 0.3 1.8 5.7 1.0 1.4 1.4 1319.3 0.0 1.2 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.1 12.0 0.0 0.0 131.3 0.0 0.5 0.0 8.9 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.7 5.8 0.0 0.0 0.0 0.1 0.3 22.9 0.5 1.7 16.7 1.3 0.3 0.0 1.9 2.3 1.3 1.1 0.0 4.6 0.0 0.0 0.0 0.0 1.5 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 1.4 1.5 1.7 1.4 2.5 0.7 0.5 1.5 0.8 0.2 0.8 1.4 5.2 0.0 0.6 2.3 0.9 0.5 217.1 92.7 11.4 0.4 99.7 35.6 0.9 11.5 621.4 14.7 0.0 2.9 1.6 59.0 0.0 10.5 29.5 14.4 98.4 18.1 37.5 3.6 14.2 4.7 0.8 101.3 1.1 16.9 29.9 0.3 31.8 6.0 10.8 0.0 10.6 102.3 40.7 1.6 1.7 33.1 10.8 11.0 5.4 1.9 0.0 4.2 0.0 4.5 7.6 2.3 106.1 1.2 1.2 312.9 140.7 19.7 149.3 0.7 0.0 7.7 46.7 3.8 0.7 7.8 0.4 11.4 3.3 0.1 88.3 737.7 MFSD1 "FLJ14153, Minerva, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 40.1 27.6 10.4 38.4 13.3 36.2 27.1 19.5 18.4 22.7 23.3 31.4 25.9 16.3 19.5 35.3 21.6 32.6 17.3 16.1 14.9 30.6 39.8 40.9 34.7 13.9 12.3 12.6 18.1 31.7 36.3 7.6 30.9 16.7 27.1 22.4 8.5 48.8 23.6 11.3 23.5 23.4 26.4 12.9 42.4 36.4 18.2 14.6 16.3 28.1 17.1 21.7 40.4 19.7 19.9 83.3 28.9 9.1 26.3 51.0 45.0 35.9 109.7 61.8 46.5 45.9 10.3 82.8 19.7 73.5 81.9 24.1 37.0 22.0 26.7 40.9 68.2 33.7 57.2 24.0 6.7 52.1 206.0 135.7 59.3 38.5 39.7 9.5 15.9 38.0 14.0 39.9 32.9 85.1 19.2 11.3 83.2 8.5 29.9 50.9 19.8 11.3 170.9 18.1 16.3 18.2 29.8 76.7 70.0 25.0 8.3 56.9 100.1 102.8 58.6 23.2 87.3 60.5 98.3 94.4 9.6 74.1 162.0 39.7 102.4 288.8 246.0 36.6 223.4 35.3 54.2 30.3 33.9 254.5 44.5 32.2 35.5 97.1 32.9 187.8 81.8 38.9 252.1 10.4 13.3 19.5 18.4 16.1 14.9 13.9 12.3 12.6 16.7 12.9 14.6 19.9 28.5 19.2 34.0 12.1 39.6 21.4 46.2 38.4 33.0 11.8 33.3 19.7 22.2 20.0 51.6 22.0 6.2 27.5 24.1 33.3 19.6 34.0 5.3 13.6 22.7 28.2 22.8 56.0 14.6 28.5 33.6 33.7 23.9 17.2 48.8 8.9 37.1 34.4 214.4 18.5 15.2 28.6 34.6 289.7 90.7 6.7 12.2 212.3 32.0 16.9 88.7 26.0 25.7 15.1 29.4 29.0 29.9 11.3 32.9 30.0 27.1 31.8 59.3 10.5 13.1 11.8 23.8 11.6 8.7 61.2 26.0 56.0 22.3 19.4 28.3 58.4 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272453 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavorable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 10.2 9.1 5.8 9.7 6.4 10.3 11.3 10.7 7.8 8.8 19.8 8.8 7.9 9.5 8.5 9.1 7.1 7.9 9.4 7.3 9.6 11.8 10.1 8.7 12.7 6.6 6.4 5.1 9.7 8.7 18.8 6.3 11.6 7.5 8.6 8.3 18.2 9.3 7.9 8.8 7.9 7.8 9.3 4.8 9.3 9.5 6.6 7.6 13.3 13.0 12.3 14.5 9.1 6.1 9.1 21.3 15.8 18.9 14.3 21.2 25.1 21.4 21.4 20.3 18.9 22.2 14.7 17.3 26.4 14.8 20.9 14.3 19.9 19.8 16.4 21.8 22.1 12.9 20.6 21.5 13.8 27.9 29.8 20.3 20.0 18.4 18.5 28.5 21.2 17.6 11.4 36.2 16.6 21.6 6.0 23.0 10.5 40.8 11.4 9.3 12.5 26.0 23.7 16.1 17.3 18.8 22.7 22.2 21.4 35.3 20.3 22.4 28.0 25.7 20.6 9.6 14.4 23.2 14.6 19.2 22.8 17.7 24.6 24.8 10.0 2.8 5.6 4.8 3.6 5.9 4.8 4.7 6.2 3.8 3.8 4.1 4.9 1.8 2.8 3.9 2.4 6.0 3.3 5.8 6.4 10.7 7.8 7.3 9.6 6.6 6.4 5.1 7.5 4.8 7.6 9.1 28.5 41.7 21.9 60.7 30.4 11.6 13.6 15.8 17.6 57.9 18.9 16.3 34.8 32.9 23.4 25.8 68.8 18.5 30.6 23.8 5.9 17.4 4.3 21.4 27.7 22.3 35.4 18.7 106.8 16.7 13.5 23.4 20.4 28.5 19.6 40.8 28.9 24.2 25.4 42.1 105.1 22.1 16.2 29.0 9.4 2.8 18.0 22.2 14.2 68.4 25.2 39.8 26.8 82.0 81.5 21.7 14.2 25.9 24.7 21.0 19.4 14.9 17.2 50.5 6.6 24.1 20.4 17.7 13.6 17.5 9.8 23.1 27.1 23.6 19.3 13.2 EEF2KMT "EFM3, FAM86A, MGC19636, SB153" ENSG00000118894 "Eukaryotic elongation factor 2 lysine methyltransferase" Q96G04 16 5084284-5097795 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 189.0;Late spermatids: 393.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 104.8" "Low region specificity" "Detected in all" HPA041610 Approved Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581" "unprognostic (4.50e-2)" "unprognostic (1.53e-1)" "unprognostic (8.89e-3)" "unprognostic (3.95e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.53e-1)" "unprognostic (1.37e-1)" "unprognostic (4.03e-2)" "unprognostic (9.73e-2)" "unprognostic (1.53e-1)" "unprognostic (5.24e-3)" "unprognostic (1.82e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (2.35e-4)" 4.7 6.0 3.1 4.0 3.1 1.1 4.9 2.8 3.5 5.1 3.0 5.0 5.2 6.7 2.7 6.0 5.0 2.8 5.0 2.5 3.0 5.3 8.3 3.7 4.5 3.2 3.3 2.2 3.7 6.8 5.8 5.1 2.3 3.2 4.8 3.5 1.1 5.4 4.3 8.6 4.3 4.1 5.2 2.7 4.8 5.3 10.7 3.8 2.4 5.0 3.4 3.5 6.1 4.5 3.0 6.3 20.1 8.9 16.5 9.2 7.3 11.3 11.8 6.7 11.6 7.3 15.1 18.2 17.9 7.6 12.2 15.1 13.5 14.5 14.6 8.5 18.7 15.3 7.7 8.6 25.5 11.5 16.4 9.5 8.4 10.9 13.5 23.6 5.4 11.6 21.3 13.8 16.1 9.6 42.0 7.7 9.8 16.3 33.7 13.6 17.9 9.9 104.8 12.6 8.1 11.0 9.2 14.4 20.0 8.6 6.9 14.0 5.7 7.1 18.7 12.6 59.8 12.3 10.3 13.8 11.8 5.4 12.9 18.3 10.1 7.2 0.7 10.7 13.7 15.8 12.8 10.4 11.6 9.7 9.5 7.9 11.9 0.9 10.5 17.2 2.8 17.8 8.3 3.1 3.1 2.8 3.5 2.5 3.0 3.2 3.3 2.2 3.2 2.7 3.8 3.0 7.2 3.2 3.7 0.3 8.6 0.0 9.1 0.0 8.0 2.6 9.7 11.4 1.1 7.2 2.5 5.5 0.0 6.0 3.6 1.8 31.3 18.5 189.0 6.8 14.7 7.3 3.6 3.8 0.7 18.3 12.5 6.0 6.1 4.2 1.3 9.9 6.4 9.9 14.6 6.7 0.9 4.6 0.0 4.1 0.0 393.3 7.8 5.8 0.0 1.9 5.7 7.3 6.2 0.5 1.5 17.0 2.9 3.8 10.2 23.4 3.4 19.6 7.3 2.8 0.0 5.3 6.4 5.8 16.8 12.8 0.0 4.1 5.9 16.2 5.3 8.5 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 733.9;vagina: 291.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 80000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: AB_2678048, HPA059859: AB_2684145" "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 39.8 4.9 3.4 1.0 3.9 0.2 40.1 0.5 4.0 85.5 2.9 9.9 6.5 5.7 7.4 733.9 11.6 7.2 5.0 4.3 0.4 7.3 13.4 18.7 0.4 0.4 1.8 2.7 5.9 10.7 4.1 14.4 6.4 2.0 17.4 3.4 2.4 150.7 11.6 12.1 183.2 12.4 1.7 0.0 0.3 11.2 1.9 1.3 3.5 22.3 5.3 57.5 22.2 291.0 1.1 24.0 8.6 0.1 0.1 60.0 86.5 29.6 0.1 1.6 0.2 0.6 39.5 59.5 0.4 13.5 1.2 3.4 191.1 1.3 23.0 0.0 0.0 1.3 0.1 46.3 7.1 3.8 0.1 0.1 4.2 20.7 0.2 7.1 4.6 0.1 0.2 0.2 0.2 0.1 71.5 0.1 0.2 6.0 31.3 18.1 0.1 0.1 30.0 44.6 37.5 30.9 0.3 102.5 33.8 0.3 8.9 17.4 0.5 0.3 0.2 0.3 0.3 0.1 0.4 1.1 0.1 12.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.5 4.0 4.3 0.4 0.4 1.8 2.7 2.0 0.0 1.3 1.1 4.1 73.7 29.1 1.6 1.2 35.1 32.5 30.5 35.9 8.4 18.8 13.8 5.1 35.8 42.6 57.0 6.2 2.1 2.0 3.6 1.9 18.4 0.7 31.6 4.1 8.0 39.4 0.0 6.6 4.5 1.6 38.0 9.2 28.0 0.0 0.8 2.9 12.7 0.7 1.7 2.5 3.8 18.3 0.9 9.0 1.3 55.3 1.4 17.8 1.0 1.2 3.7 2.1 1.0 1.7 23.4 8.3 4.1 0.2 35.1 13.5 1.2 32.5 12.5 0.0 28.7 4.3 3.9 3.1 138.0 51.3 1.4 2.7 0.4 4.8 53.2 UBN1 ENSG00000118900 "Ubinuclein 1" Q9NPG3 16 4846665-4882401 "Predicted intracellular proteins" "Host-virus interaction" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 14.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 14.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061029, HPA069036, HPA069045" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072" "unprognostic (8.20e-2)" "unprognostic (1.01e-1)" "unprognostic (8.99e-3)" "unprognostic (1.75e-1)" "unprognostic (1.65e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-3)" "unprognostic (6.53e-3)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (6.89e-2)" 14.0 12.4 8.1 14.6 7.8 49.4 13.0 9.8 8.0 13.3 11.2 13.8 14.8 12.5 6.5 25.2 12.0 11.9 16.8 8.9 5.7 9.8 13.8 13.6 15.5 6.4 6.9 7.0 13.5 14.3 12.3 10.2 11.6 6.9 11.7 14.5 20.3 15.9 9.6 23.0 15.6 14.7 13.9 5.9 21.6 12.8 37.8 7.4 22.7 11.5 19.6 15.6 11.7 16.6 7.5 21.0 26.0 29.5 29.3 25.3 23.6 23.7 25.7 24.5 29.6 28.4 21.7 24.4 39.2 23.1 25.3 32.1 27.2 38.2 23.6 25.0 38.4 19.0 32.2 35.0 17.1 24.3 39.4 33.6 15.8 30.6 34.4 36.7 22.5 39.3 38.3 53.6 32.5 22.0 30.1 43.6 18.0 25.1 21.8 19.3 67.5 36.6 37.5 15.5 24.0 39.9 22.0 44.7 36.4 22.3 21.8 36.0 34.6 39.7 31.3 29.5 102.5 32.4 30.4 34.7 77.5 18.5 24.5 53.9 1.7 1.2 0.9 1.4 1.1 1.0 0.9 1.0 1.3 0.8 1.0 1.1 0.7 14.2 1.0 0.9 1.7 0.9 0.9 8.1 7.8 9.8 8.0 8.9 5.7 6.4 6.9 7.0 6.9 5.9 7.4 7.5 31.2 9.6 15.9 17.3 31.9 18.0 22.0 7.5 30.1 59.9 23.6 20.3 25.5 22.8 9.8 9.2 110.5 28.1 51.3 41.1 7.9 16.7 46.2 39.2 36.8 36.4 30.9 32.4 17.9 18.2 23.3 22.9 29.6 29.8 7.6 27.9 28.5 31.0 23.2 50.5 16.8 27.4 8.2 33.2 21.5 57.8 29.2 37.0 26.6 30.0 28.9 27.9 61.8 19.6 20.3 27.7 33.4 22.6 44.0 33.4 27.4 13.3 16.4 100.8 13.1 26.8 21.8 153.8 128.4 30.9 22.3 29.1 40.4 35.2 26.8 27.3 KLF12 "AP-2rep, AP2REP, HSPC122" ENSG00000118922 "Kruppel like factor 12" Q9Y4X4 13 73686089-73995056 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Astrocytes: 319.3;Excitatory neurons: 211.9;Inhibitory neurons: 562.2;Microglial cells: 208.9;Oligodendrocyte precursor cells: 760.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064146, HPA075652" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064146: AB_2685198, HPA075652: " "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (9.22e-2)" "unprognostic (8.59e-2)" "unprognostic (5.19e-2)" "unprognostic (3.70e-2)" "unprognostic (2.60e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (6.67e-3)" 2.9 1.9 4.1 6.1 3.1 3.1 2.9 5.7 5.3 2.3 2.9 3.1 1.6 3.6 11.3 2.0 2.8 3.0 5.3 5.0 4.2 5.5 9.9 2.6 11.4 3.3 5.1 2.0 5.2 0.9 0.8 3.4 0.8 4.1 2.5 2.9 9.0 1.4 3.3 3.7 1.6 3.6 3.4 3.2 7.6 2.8 1.6 5.4 10.4 1.6 8.5 9.9 2.6 2.1 3.7 0.0 1.4 13.6 0.0 7.5 16.3 0.1 5.4 2.7 5.9 6.2 1.1 3.4 10.5 2.5 8.1 2.3 3.7 3.6 4.2 15.7 6.9 4.9 0.4 6.3 0.0 2.4 7.0 2.5 14.3 1.1 8.4 6.7 11.4 11.9 8.0 0.0 2.6 18.0 1.1 13.6 0.0 1.9 0.5 2.7 7.4 4.9 0.1 3.3 0.2 3.2 13.8 3.8 1.7 6.3 5.0 0.4 1.1 0.1 11.4 3.5 5.2 2.6 7.0 9.6 3.3 20.2 0.0 5.9 0.6 0.0 0.0 2.0 0.2 2.4 0.8 1.7 2.3 0.2 0.7 1.2 1.9 0.0 1.4 0.3 0.4 0.9 0.8 4.1 3.1 5.7 5.3 5.0 4.2 3.3 5.1 2.0 4.1 3.2 5.4 3.7 6.6 6.4 1.8 319.3 30.5 4.2 1.3 4.3 0.6 20.8 5.4 6.2 18.7 5.7 3.7 3.7 37.5 0.1 35.4 3.0 3.9 2.1 0.8 4.6 18.8 8.4 0.0 7.8 211.9 0.0 0.1 12.3 2.0 6.3 0.0 29.2 5.0 20.3 0.1 8.4 562.2 1.5 10.2 8.0 12.1 1.6 20.8 5.0 3.6 208.9 6.4 11.2 43.3 760.0 25.4 0.4 3.2 28.6 21.9 3.3 0.2 7.0 6.0 13.1 0.0 12.2 18.1 0.5 3.5 0.7 6.7 0.1 40.3 4.9 3.9 1.8 UCHL3 ENSG00000118939 "Ubiquitin C-terminal hydrolase L3" P15374 13 75549480-75606020 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019678, CAB037139, CAB037208" Approved Supported Nucleoplasm,Cytosol No No 700000 "Nucleoplasm, Cytosol" "CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583" "unprognostic (4.16e-1)" "unprognostic (3.84e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (5.15e-2)" "unprognostic (6.46e-3)" "prognostic unfavorable (6.41e-4)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (9.71e-2)" "unprognostic (1.24e-1)" "unprognostic (7.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.97e-1)" "unprognostic (2.76e-2)" "unprognostic (8.84e-2)" "unprognostic (3.26e-2)" 20.9 57.3 22.3 20.4 25.6 33.8 34.6 22.1 25.4 15.1 19.0 35.8 21.8 12.5 63.7 58.4 13.2 17.9 26.4 23.1 21.8 32.5 51.3 15.1 21.5 20.4 20.5 21.7 7.5 31.1 24.1 23.1 24.8 20.2 19.7 39.9 9.8 27.4 18.4 54.3 49.0 20.0 25.3 21.1 16.0 25.4 43.7 21.9 25.9 44.8 41.0 34.9 44.7 26.9 22.5 196.0 31.9 26.9 18.8 49.9 58.6 78.6 72.3 70.3 90.7 100.5 177.5 92.1 100.4 50.2 75.7 70.2 105.8 64.1 175.3 137.1 53.8 55.9 62.2 50.7 114.9 71.6 150.4 45.7 52.6 118.7 71.7 114.2 38.4 90.1 79.6 70.0 27.9 138.9 70.2 62.4 100.2 40.3 229.0 95.1 49.5 42.9 66.3 108.4 77.9 81.0 23.8 40.8 78.3 34.5 58.2 45.7 42.0 70.8 39.6 47.9 42.7 98.2 39.5 45.5 117.1 80.4 161.3 29.0 57.6 68.7 49.3 29.9 134.4 39.6 51.5 54.1 43.0 99.5 51.5 53.0 49.5 15.6 62.7 117.9 134.9 71.8 50.1 22.3 25.6 22.1 25.4 23.1 21.8 20.4 20.5 21.7 20.2 21.1 21.9 22.5 18.2 9.6 23.4 9.1 20.3 76.3 80.4 197.5 35.9 9.3 48.8 66.2 27.2 28.6 88.2 46.0 2.1 105.2 32.9 39.0 92.0 146.2 198.2 35.4 17.4 26.6 24.0 24.4 22.5 143.1 163.6 25.1 23.9 36.2 24.1 19.3 13.9 45.7 88.0 16.8 22.3 54.6 81.4 28.8 28.8 43.5 16.8 32.8 26.6 18.7 33.3 17.3 22.6 22.6 24.9 153.1 44.3 11.7 33.3 133.1 40.4 119.6 48.0 8.9 19.7 24.5 73.5 159.3 36.8 64.8 79.1 169.0 22.1 47.6 60.8 96.2 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631744-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;lung: 14.2;lymphoid tissue: 25.3" "Group enriched" "Detected in many" 4 "Adipocytes: 57.6;Astrocytes: 77.1;Early spermatids: 60.7;Endothelial cells: 126.7;Excitatory neurons: 125.2;Hepatic stellate cells: 79.6;Inhibitory neurons: 67.9;Oligodendrocyte precursor cells: 193.0;Oligodendrocytes: 101.1;Spermatocytes: 68.3" "Cancer enhanced" "Detected in many" "glioma: 9.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.7;HEK 293: 9.3;U-87 MG: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA 690000 "Vesicles, Cytosol" "Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 1.6 1.9 14.4 1.8 21.0 0.0 0.8 8.1 10.1 2.2 0.0 1.1 0.8 2.1 0.8 0.6 2.0 3.2 2.2 10.9 21.2 1.5 1.0 14.2 0.6 10.1 13.4 13.2 0.5 6.0 1.6 0.9 4.4 11.6 1.0 0.8 1.0 0.8 0.8 1.7 0.3 0.8 2.1 6.3 25.3 1.5 8.9 22.7 0.2 2.9 1.3 0.5 2.7 0.8 10.8 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 9.3 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.3 0.0 2.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 1.2 0.0 1.0 0.0 0.0 0.0 5.3 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 21.0 8.1 10.1 10.9 21.2 10.1 13.4 13.2 11.6 6.3 22.7 10.8 57.6 0.0 4.3 77.1 0.1 2.7 0.1 0.0 1.2 7.1 0.4 0.6 6.0 1.5 8.6 1.8 0.0 0.2 0.5 0.1 0.0 11.1 60.7 2.6 2.0 126.7 0.0 0.0 125.2 8.3 0.1 11.7 0.0 19.8 0.0 20.5 79.6 0.3 0.6 0.0 67.9 0.0 0.0 1.9 2.5 19.0 1.8 0.5 10.6 12.2 1.6 2.3 0.0 193.0 101.1 1.3 0.0 1.2 1.2 0.3 0.0 0.0 5.1 0.0 6.6 1.9 10.7 68.3 10.6 0.4 1.0 0.0 1.1 1.6 0.0 0.4 HS1BP3 HS1-BP3,FLJ14249 ENSG00000118960 "HCLS1 binding protein 3" Q53T59 2 20560448-20651130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035050 Approved Approved Nucleoli,Cytosol No No 54000 Nucleoli Cytosol "HPA035050: AB_10601816" "unprognostic (4.52e-2)" "unprognostic (5.93e-2)" "unprognostic (2.67e-1)" "unprognostic (4.39e-1)" "unprognostic (4.61e-2)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.97e-5)" "unprognostic (2.06e-3)" "unprognostic (1.88e-2)" "unprognostic (2.16e-1)" "unprognostic (9.53e-2)" "unprognostic (8.00e-2)" "prognostic favorable (2.30e-4)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-1)" 17.8 31.2 14.7 10.1 18.5 13.8 16.1 15.9 19.8 21.3 16.5 27.7 13.2 22.4 13.4 18.8 19.6 16.5 21.3 14.8 15.6 24.7 57.9 18.7 9.3 18.2 17.3 13.6 17.6 14.6 13.2 16.4 15.6 19.8 27.0 12.7 3.8 16.8 17.6 13.1 22.8 17.8 21.3 14.5 18.6 22.2 13.9 17.3 7.5 18.0 10.2 7.7 29.5 17.9 21.5 20.3 23.1 11.5 14.1 58.8 39.2 22.7 7.6 34.9 17.7 23.0 18.2 24.0 13.5 5.9 11.1 80.1 12.5 23.1 24.0 8.6 17.4 19.1 7.2 11.3 61.2 54.8 5.5 30.5 42.1 53.8 20.0 36.5 20.7 34.1 11.9 4.7 28.3 20.5 17.4 2.5 9.3 9.6 29.9 16.4 13.3 23.3 13.4 39.0 24.4 10.9 16.7 5.4 23.4 45.0 23.2 14.6 11.2 21.7 17.3 18.5 27.0 11.7 19.9 24.5 12.9 37.3 25.8 18.7 17.9 14.7 14.5 6.0 13.9 4.2 6.8 3.6 4.7 9.9 4.3 3.0 3.3 17.7 3.8 18.3 3.6 3.4 8.6 14.7 18.5 15.9 19.8 14.8 15.6 18.2 17.3 13.6 19.8 14.5 17.3 21.5 17.6 6.4 17.9 3.3 8.2 4.5 7.4 5.6 2.2 4.0 6.2 8.0 6.2 8.6 10.9 7.3 0.0 9.8 6.5 12.5 17.6 21.4 20.8 9.3 9.4 8.4 6.7 7.0 2.6 14.9 17.8 9.7 8.2 12.5 2.5 8.5 11.0 9.2 30.7 15.2 2.5 7.3 12.2 20.1 5.5 42.7 8.4 13.9 14.2 4.7 13.1 8.9 15.5 3.0 5.4 9.7 11.9 10.5 4.9 5.2 21.6 28.2 10.4 5.3 0.0 7.1 17.1 16.7 10.5 5.8 5.3 17.5 6.3 7.8 7.7 4.5 LDAH "C2orf43, FLJ21820" ENSG00000118961 "Lipid droplet associated hydrolase" Q9H6V9 2 20684014-20823130 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034729, HPA034730" Approved NA NA "HPA034729: AB_10603684, HPA034730: AB_2674304" "unprognostic (1.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" "unprognostic (2.21e-2)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.09e-6)" "unprognostic (3.57e-2)" "unprognostic (1.36e-1)" "unprognostic (1.27e-2)" "unprognostic (6.45e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.18e-4)" "unprognostic (1.05e-1)" "unprognostic (2.31e-1)" "unprognostic (2.22e-1)" "unprognostic (3.97e-2)" 7.4 14.2 5.2 7.4 7.0 5.1 7.7 5.1 5.7 8.0 6.7 10.9 7.5 7.4 9.4 8.1 6.3 6.8 4.0 5.2 6.6 17.0 12.2 5.6 11.2 5.8 5.1 5.3 8.1 7.4 9.5 5.8 8.7 5.8 7.0 11.8 8.4 7.0 6.3 1.2 6.1 6.6 8.2 6.0 9.1 7.9 5.1 6.1 11.8 8.3 1.8 13.5 9.8 6.0 7.4 20.2 18.3 45.6 0.0 18.6 24.6 28.5 17.9 12.2 14.5 11.1 19.8 12.3 25.3 0.0 13.1 25.4 16.9 34.8 12.9 14.9 31.6 17.2 37.1 16.6 30.5 19.0 28.2 8.9 20.9 18.9 14.0 3.6 19.7 27.7 33.8 49.7 18.6 25.5 13.0 41.1 19.4 29.1 41.7 0.0 33.1 36.6 28.8 29.0 29.4 25.0 37.9 11.8 18.7 19.9 37.9 15.9 19.7 25.6 13.0 6.6 17.0 10.7 22.7 45.2 11.6 25.3 26.8 24.6 0.9 3.2 0.3 6.6 4.9 4.3 7.8 6.5 5.6 5.8 5.5 5.9 5.9 0.2 5.5 3.9 5.4 6.1 4.2 5.2 7.0 5.1 5.7 5.2 6.6 5.8 5.1 5.3 5.8 6.0 6.1 7.4 5.0 16.0 10.6 0.0 9.3 0.0 3.4 0.0 5.7 9.3 5.3 3.9 2.8 7.2 4.3 7.3 16.7 12.0 4.6 3.4 7.9 7.4 8.7 4.2 10.9 6.3 3.6 13.3 0.0 6.4 11.6 5.1 9.7 6.1 6.3 14.8 8.6 7.9 9.0 11.8 0.0 6.0 0.0 9.8 0.0 2.7 7.5 5.5 0.0 0.0 4.7 15.0 5.2 0.0 0.0 6.5 5.5 6.8 9.9 3.7 5.0 12.0 0.0 9.6 6.6 4.2 5.4 4.3 5.2 7.7 0.0 11.5 6.7 15.8 6.1 3.6 WDR35 "FAP118, IFT121, IFTA1, KIAA1336, MGC33196" ENSG00000118965 "WD repeat domain 35" Q9P2L0 2 19910263-19990105 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "basophil: 2.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044147 Approved NA NA "HPA044147: AB_10970242" "unprognostic (2.51e-1)" "unprognostic (4.93e-2)" "unprognostic (9.13e-2)" "unprognostic (4.01e-2)" "unprognostic (3.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.94e-3)" "unprognostic (3.08e-2)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (3.68e-2)" "unprognostic (6.98e-2)" "unprognostic (2.17e-2)" "unprognostic (5.03e-2)" "unprognostic (1.02e-1)" "unprognostic (2.71e-1)" 3.7 5.1 5.5 2.7 4.6 2.1 7.8 4.8 4.7 6.0 9.0 4.0 1.7 9.3 7.3 3.0 11.4 3.5 3.3 4.4 6.8 8.0 2.0 4.5 2.7 5.8 5.6 3.7 9.7 3.8 14.5 9.1 2.7 5.2 5.5 3.0 12.7 3.0 6.3 2.5 3.5 3.0 6.2 5.3 2.0 3.7 10.7 5.2 4.8 8.8 2.7 2.6 4.5 3.7 6.0 8.3 10.4 9.9 9.5 7.6 7.4 0.5 4.2 7.4 6.0 4.3 3.2 3.6 0.0 1.8 4.7 5.0 2.6 10.6 10.3 9.9 1.6 8.2 8.1 6.6 10.0 6.6 15.8 3.1 9.0 7.2 10.7 15.2 10.8 7.4 3.3 13.1 2.3 6.1 3.0 2.3 11.4 11.9 1.5 10.0 0.0 7.1 3.5 12.8 4.7 18.6 21.9 6.9 4.6 12.3 4.7 4.9 3.4 7.7 6.8 3.3 9.4 12.4 4.7 8.3 0.0 12.7 1.1 6.8 2.9 0.1 0.3 0.5 0.0 0.1 0.4 0.3 0.3 0.2 0.6 0.3 0.4 0.2 0.4 0.0 0.1 0.4 0.2 5.5 4.6 4.8 4.7 4.4 6.8 5.8 5.6 3.7 5.2 5.3 5.2 6.0 2.9 3.2 9.0 36.6 5.7 3.3 3.5 5.0 2.2 6.5 5.8 7.2 10.8 11.5 7.2 11.0 2.1 0.2 2.9 0.3 0.0 3.3 1.9 16.1 13.1 3.1 6.0 7.8 30.0 4.0 1.0 9.7 5.1 4.0 9.5 9.4 3.6 2.4 1.3 6.7 21.9 1.5 4.1 0.9 2.8 3.5 10.2 2.0 3.6 18.7 1.1 10.0 2.1 25.1 27.6 6.3 0.7 10.9 2.4 2.0 0.7 5.6 28.6 15.2 6.6 14.6 7.4 28.8 9.0 2.2 2.6 0.3 5.4 9.0 1.5 1.1 CCND2 ENSG00000118971 "Cyclin D2" P30279 12 4269771-4305353 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2" "HPA049138, HPA054196" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA049138: AB_2680650, HPA054196: AB_2682412" "unprognostic (2.98e-3)" "unprognostic (1.15e-1)" "unprognostic (7.21e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.01e-3)" "unprognostic (3.16e-2)" "unprognostic (1.66e-2)" "prognostic favorable (2.52e-4)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (8.23e-2)" "unprognostic (4.52e-1)" "prognostic favorable (9.76e-5)" "unprognostic (7.06e-2)" 15.1 53.0 5.6 8.8 14.4 20.5 13.1 0.0 12.6 23.9 0.0 35.7 17.6 26.3 7.6 12.3 22.3 2.8 47.1 13.1 27.5 5.5 2.0 17.3 5.3 11.0 1.0 7.3 14.3 24.7 10.0 23.7 13.0 4.3 20.8 10.5 0.7 10.9 9.1 1.8 11.0 26.1 9.9 6.9 19.9 12.8 4.0 0.8 3.2 20.5 0.0 5.1 26.8 20.1 6.7 0.0 0.0 152.4 0.0 10.1 0.4 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 0.4 0.0 0.0 16.2 0.1 136.6 0.0 238.8 2.5 0.7 0.0 0.0 0.0 57.0 12.6 23.8 2.4 0.0 97.0 0.0 0.0 0.8 17.0 287.9 6.8 0.0 0.0 52.8 50.8 0.0 0.0 0.0 202.7 114.2 0.0 8.1 0.0 0.0 0.0 0.0 0.0 89.6 0.0 0.0 4.2 0.0 39.3 0.0 0.0 1.4 60.7 0.0 0.0 32.3 0.0 6.6 0.4 4.7 11.1 0.0 17.1 3.1 16.3 13.8 0.4 1.7 10.4 12.1 1.1 9.4 0.0 1.1 13.6 6.8 5.6 14.4 0.0 12.6 13.1 27.5 11.0 1.0 7.3 4.3 6.9 0.8 6.7 23.9 60.9 46.6 10.1 82.9 106.8 23.9 73.4 174.2 7.6 3.4 41.8 354.3 2.8 37.4 12.9 0.0 4.0 128.7 37.5 0.0 3.1 0.8 3.3 110.8 35.7 64.8 37.2 54.1 68.3 2.7 123.6 4.6 3.6 55.8 438.5 19.6 2.2 13.0 3.3 55.2 147.7 12.2 11.9 255.3 3.3 52.5 39.3 39.2 19.7 9.8 170.0 89.6 55.3 4.0 20.7 49.4 124.1 371.2 35.8 34.4 1.4 10.3 6.5 26.3 21.4 112.6 0.8 5.1 50.9 39.6 6.3 122.6 41.5 159.7 8.4 FGF23 ENSG00000118972 "Fibroblast growth factor 23" Q9GZV9 12 4368227-4379712 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters" Differentiation "Growth factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 109.8;choroid plexus: 85.2" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 10.4;Early spermatids: 6.6;Hepatic stellate cells: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 10.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 10.8" "Cell line enhanced" "Detected in some" "AF22: 1.9;HBEC3-KT: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 56800 "unprognostic (1.31e-1)" "unprognostic (2.18e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" 0.2 0.1 62.5 0.1 61.1 0.5 0.2 61.4 109.8 0.0 85.2 0.2 0.3 0.3 1.2 0.2 0.3 0.1 2.9 61.8 61.7 0.2 4.2 0.2 0.2 61.5 73.7 61.1 0.2 0.1 0.1 0.0 0.2 65.5 0.1 0.6 2.3 0.5 0.0 1.2 0.3 0.1 0.3 60.6 0.5 0.2 0.5 60.9 0.1 0.1 0.3 0.6 0.1 0.0 66.4 0.0 0.0 1.9 0.6 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.3 0.1 0.4 0.2 1.4 0.0 0.0 0.2 0.0 0.3 0.2 0.5 0.4 0.1 0.5 0.0 0.9 1.1 0.1 0.1 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.0 0.3 0.0 0.3 0.2 0.4 0.4 0.3 0.0 0.6 0.1 0.3 0.4 0.3 0.0 0.7 0.1 0.5 0.1 0.0 0.0 0.1 0.4 0.1 0.4 10.8 1.4 2.0 1.6 1.5 1.9 1.8 1.5 1.2 1.2 1.9 1.7 1.7 4.8 2.2 2.5 1.9 1.6 1.1 62.5 61.1 61.4 109.8 61.8 61.7 61.5 73.7 61.1 65.5 60.6 60.9 66.4 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.9 1.5 0.0 0.0 10.4 0.1 0.3 0.0 0.0 0.0 6.6 0.0 0.2 0.5 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 13.6 0.0 0.2 1.7 0.3 0.0 0.0 0.6 0.3 1.8 0.3 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.5 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.2 ELL2 MRCCAT1 ENSG00000118985 "Elongation factor for RNA polymerase II 2" O00472 5 95885098-95961851 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 382.9;Plasma cells: 430.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013569 Supported Nucleoplasm No No Nucleoplasm "HPA013569: AB_2668853" "unprognostic (1.18e-2)" "unprognostic (1.88e-2)" "unprognostic (3.41e-2)" "unprognostic (2.94e-2)" "unprognostic (1.93e-1)" "unprognostic (5.82e-2)" "unprognostic (9.14e-2)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (8.05e-2)" "unprognostic (9.16e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.31e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-2)" 49.5 19.7 18.4 28.9 30.9 48.8 37.7 22.9 41.5 19.1 9.8 13.6 14.6 9.2 5.8 61.6 16.2 35.9 30.8 21.1 99.4 16.7 87.5 36.1 14.7 52.2 28.3 15.7 25.0 95.1 15.7 25.3 25.5 34.0 39.5 13.2 3.7 97.4 23.2 33.8 59.4 14.6 11.5 25.7 18.2 44.6 15.4 34.7 8.2 17.2 10.8 22.0 33.5 36.0 60.4 31.7 12.3 3.8 0.5 45.0 56.1 4.6 322.3 56.2 105.4 89.7 23.7 7.2 1.4 6.7 173.7 24.6 40.0 10.0 103.5 129.3 291.4 7.6 20.5 53.5 52.3 29.0 4.5 33.3 55.1 70.1 64.0 191.4 63.2 17.0 3.8 11.5 120.3 100.6 3.3 0.1 5.6 4.9 5.0 16.8 3.1 19.2 25.3 20.3 30.0 6.4 2.1 118.6 6.2 7.3 15.1 3.6 3.7 35.5 137.6 27.4 32.0 59.4 84.0 216.0 1.5 71.9 2.1 9.4 7.0 0.8 5.7 0.6 1.0 1.0 3.5 0.8 0.9 0.4 1.7 0.6 0.5 1.8 1.6 0.8 0.3 1.1 0.6 18.4 30.9 22.9 41.5 21.1 99.4 52.2 28.3 15.7 34.0 25.7 34.7 60.4 30.9 28.9 94.9 28.1 93.2 183.2 137.3 47.1 134.9 0.6 56.0 37.6 31.6 14.3 61.5 18.4 0.0 2.0 98.6 19.4 5.9 24.6 2.5 46.2 32.4 33.4 107.8 25.7 138.6 91.9 14.8 64.4 85.6 88.6 172.4 11.2 18.5 141.1 36.7 0.0 87.5 18.1 12.2 64.4 52.0 4.3 7.8 126.5 46.2 83.4 25.3 1.2 2.1 49.8 382.9 70.8 14.7 7.2 430.1 134.7 12.7 15.8 35.2 0.5 13.1 213.2 76.8 17.2 9.2 185.8 171.5 25.9 72.4 2.4 14.3 88.8 DNAH7 KIAA0944 ENSG00000118997 "Dynein axonemal heavy chain 7" Q8WXX0 2 195737703-196068837 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.0;choroid plexus: 25.0" "Cell type enhanced" "Detected in many" "Astrocytes: 197.2;Cone photoreceptor cells: 70.9;Early spermatids: 59.3;Endometrial ciliated cells: 103.5;Excitatory neurons: 93.0;Respiratory ciliated cells: 139.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 5.9;RPTEC TERT1: 2.8" "Region enhanced" "Detected in many" "midbrain: 4.4" "HPA034724, HPA044070" Enhanced Supported Cytosol NA NA Cytosol "HPA034724: AB_10670977, HPA044070: AB_2678798" "unprognostic (1.71e-1)" "unprognostic (2.81e-2)" "unprognostic (2.65e-2)" "unprognostic (1.04e-2)" "unprognostic (3.56e-1)" "unprognostic (1.58e-2)" "unprognostic (6.74e-3)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.24e-1)" "unprognostic (7.76e-2)" "unprognostic (2.52e-3)" "unprognostic (3.98e-2)" 0.3 1.0 14.0 0.2 7.4 0.0 0.6 4.6 10.2 1.9 25.0 0.7 0.1 0.8 1.8 0.2 9.9 0.6 0.4 7.0 8.6 2.3 0.3 2.3 0.1 9.8 9.7 6.4 0.5 2.7 2.0 7.3 0.1 6.6 1.1 0.5 9.0 0.8 0.9 0.0 0.2 0.7 0.3 9.5 0.1 0.6 10.9 5.6 0.1 3.3 0.0 0.2 0.3 0.3 5.9 0.3 1.3 0.3 0.1 0.7 0.4 0.1 0.1 0.8 0.3 0.3 0.2 1.0 0.0 0.3 0.3 1.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 1.7 0.4 0.1 0.0 0.1 0.2 0.2 1.1 0.2 1.7 0.0 0.0 0.3 1.8 0.5 1.4 0.0 0.0 0.3 0.7 5.9 0.0 0.3 0.5 2.8 0.2 0.6 1.0 0.3 0.2 0.1 0.1 0.5 0.1 0.0 0.7 0.2 1.1 0.3 1.4 1.4 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 14.0 7.4 4.6 10.2 7.0 8.6 9.8 9.7 6.4 6.6 9.5 5.6 5.9 0.5 0.0 6.1 197.2 0.0 0.9 1.2 3.3 0.0 1.9 2.1 1.3 1.3 0.0 12.3 1.8 70.9 0.0 0.1 4.4 0.0 2.9 59.3 103.5 2.8 1.8 0.0 0.0 93.0 0.7 0.0 1.0 1.5 3.0 0.0 0.8 0.7 0.0 0.1 1.7 25.6 1.0 4.1 0.0 1.2 27.8 0.6 0.4 1.8 13.1 0.0 2.9 0.0 5.5 2.2 0.6 0.2 1.5 0.1 1.8 3.7 2.6 139.5 36.8 0.0 2.1 1.1 28.0 5.7 0.0 1.3 0.1 0.2 0.8 0.7 0.7 CYP20A1 CYP-M ENSG00000119004 "Cytochrome P450 family 20 subfamily A member 1" Q6UW02 2 203238977-203306026 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055872, HPA058461" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments" No No "Plasma membrane, Cell Junctions, Actin filaments" Nucleoplasm "HPA055872: AB_2682951, HPA058461: AB_2683725" "unprognostic (4.72e-2)" "unprognostic (2.06e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.06e-2)" "unprognostic (5.21e-2)" "unprognostic (2.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.62e-2)" "unprognostic (4.53e-2)" "unprognostic (4.42e-2)" "unprognostic (7.64e-3)" "unprognostic (9.39e-2)" "unprognostic (2.18e-1)" "unprognostic (1.23e-2)" "unprognostic (1.95e-3)" 3.2 3.2 3.3 2.1 4.1 2.2 2.5 3.7 3.1 2.7 4.3 3.6 2.2 2.4 2.4 2.4 1.9 3.2 1.7 2.7 3.0 6.1 4.6 3.5 3.9 4.2 3.8 2.2 3.8 3.2 2.9 0.9 3.4 3.8 3.5 3.2 1.7 2.4 2.1 2.6 3.8 2.6 3.2 3.0 3.7 3.7 2.9 4.2 2.2 8.1 1.3 3.0 3.2 1.0 5.7 2.8 4.7 2.9 2.9 12.1 2.9 2.5 5.0 3.3 2.4 1.7 9.1 5.2 1.9 3.8 4.8 4.4 4.0 1.9 2.7 4.6 2.9 1.0 6.1 3.0 3.5 7.2 6.4 3.3 5.5 2.2 5.7 4.9 2.1 6.4 2.8 8.0 9.9 5.1 4.2 4.3 3.7 7.7 2.3 4.2 3.5 3.7 4.5 3.2 9.2 2.0 2.2 0.4 4.0 5.5 3.3 2.7 4.8 8.5 8.4 2.5 4.0 4.1 5.2 4.4 2.3 6.4 2.8 3.6 5.7 5.2 2.1 6.5 5.6 7.1 6.1 8.0 5.9 2.3 9.6 5.9 3.5 3.0 4.9 6.5 7.4 8.0 4.3 3.3 4.1 3.7 3.1 2.7 3.0 4.2 3.8 2.2 3.8 3.0 4.2 5.7 41.2 16.0 33.2 24.2 55.5 12.4 41.6 20.2 29.6 42.0 17.1 17.8 33.6 50.1 33.8 16.5 58.4 33.4 55.8 40.3 11.7 18.3 96.6 24.2 33.6 40.5 45.4 45.5 12.1 20.3 23.0 49.0 53.0 23.7 29.1 65.4 88.2 50.4 37.9 50.5 20.5 33.0 22.4 38.1 22.5 21.9 123.0 35.8 7.2 34.7 44.5 32.4 74.2 24.1 39.1 15.2 30.6 83.8 51.7 33.6 30.8 26.2 23.5 70.5 65.7 76.6 45.7 104.5 64.1 25.4 13.4 40.8 54.4 59.7 32.8 28.7 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 711.0;tongue: 734.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1711.2;Distal tubular cells: 1064.4;Proximal tubular cells: 780.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Enhanced NA NA "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 120.5 115.5 152.5 89.7 154.3 80.4 106.6 166.7 229.4 70.5 161.0 187.4 138.0 46.8 133.4 99.1 66.7 66.9 393.0 152.1 164.8 249.4 196.9 64.1 104.5 159.2 156.5 148.2 46.6 55.2 221.2 58.2 78.7 160.9 77.8 176.3 142.0 101.7 76.5 711.0 52.4 129.0 74.4 158.5 62.2 116.6 83.9 160.9 144.7 96.9 734.2 129.9 96.3 54.2 162.1 180.1 148.9 227.5 122.0 226.3 207.0 183.1 224.8 160.1 171.9 200.3 347.2 211.3 144.4 249.8 211.4 261.9 154.5 209.6 287.7 269.4 294.5 460.6 349.0 363.8 394.8 141.2 500.9 170.5 180.1 223.6 203.3 119.2 211.3 250.3 259.2 311.1 240.3 313.1 234.4 313.8 459.8 129.9 392.4 536.7 215.6 200.4 388.0 380.6 278.7 209.5 150.1 176.0 153.2 258.2 353.2 150.7 373.0 227.3 144.8 179.7 150.9 222.8 174.5 435.3 452.6 246.0 284.4 172.6 205.2 135.4 159.4 116.1 205.3 129.2 148.8 132.7 135.7 177.3 117.3 115.2 140.9 267.3 141.6 213.3 211.8 183.1 109.6 152.5 154.3 166.7 229.4 152.1 164.8 159.2 156.5 148.2 160.9 158.5 160.9 162.1 95.3 80.1 57.7 18.9 100.9 78.1 100.0 433.7 66.6 52.9 101.7 128.1 1711.2 141.5 205.1 187.6 12.5 254.6 83.5 473.9 1064.4 247.0 218.1 191.6 93.9 101.9 146.4 113.8 13.2 201.7 208.9 103.4 118.7 135.2 78.0 61.0 86.7 260.5 288.2 32.0 14.7 299.0 248.2 121.6 107.1 59.9 95.4 126.8 168.9 10.3 292.9 184.6 116.4 7.5 19.9 177.3 411.0 101.5 135.2 72.5 496.3 780.3 229.2 92.0 92.1 82.3 125.4 270.0 89.7 169.2 91.9 157.6 89.7 113.9 322.1 132.9 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763035-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA069179: AB_2686099" "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 10.5 11.0 18.4 9.7 20.3 37.1 19.7 25.4 23.3 11.0 22.2 10.9 10.3 12.3 15.3 11.5 12.0 19.8 10.1 20.0 26.6 9.6 13.0 10.6 19.0 20.2 18.4 15.5 14.0 13.2 13.8 9.1 12.6 25.5 10.3 13.2 18.7 9.8 10.1 13.7 21.1 10.9 14.5 16.5 14.0 12.2 14.1 18.3 13.6 15.2 7.3 11.0 11.7 9.5 31.0 14.4 19.2 28.4 22.2 13.1 19.4 28.0 26.2 16.3 24.7 25.0 41.4 23.0 29.8 15.9 15.7 24.1 19.2 24.4 23.3 28.7 35.0 26.6 37.2 59.9 38.6 21.8 32.8 28.9 25.8 21.4 17.8 25.0 21.9 22.6 25.7 45.6 54.6 14.9 34.0 28.6 29.2 16.9 16.9 29.3 24.4 20.7 19.8 17.6 43.2 22.6 20.5 16.7 14.6 17.8 35.9 15.4 21.1 15.0 21.2 15.1 16.7 19.3 26.0 34.4 22.2 21.8 24.4 16.9 8.4 4.7 4.4 3.9 3.1 3.5 4.8 3.5 4.0 2.8 6.8 4.2 4.0 4.4 4.8 5.8 4.3 4.8 2.3 18.4 20.3 25.4 23.3 20.0 26.6 20.2 18.4 15.5 25.5 16.5 18.3 31.0 17.4 22.4 16.0 19.2 11.6 4.0 12.2 16.6 10.2 18.1 8.8 8.8 35.8 7.2 21.4 14.7 18.8 15.3 18.1 7.7 13.7 12.4 4.4 18.2 17.4 17.0 12.5 19.1 24.7 12.3 12.6 12.9 11.2 13.3 14.0 24.7 12.8 8.2 13.5 0.0 29.8 10.1 16.2 12.7 5.0 4.6 13.4 11.8 7.2 27.2 22.0 12.5 9.2 23.1 38.5 14.7 6.4 10.9 16.3 8.4 12.9 10.9 37.2 15.6 6.6 10.1 13.6 44.7 24.8 11.6 5.5 15.7 12.2 18.2 11.9 9.4 SATB2 "FLJ21474, KIAA1034" ENSG00000119042 "SATB homeobox 2" Q9UPW6 2 199269500-199471266 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 13.5;intestine: 39.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 129.7;Enteroendocrine cells: 99.7;Excitatory neurons: 363.9;Intestinal goblet cells: 66.9;Paneth cells: 70.0;Undifferentiated cells: 84.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.0" "Region enhanced" "Detected in many" "cerebral cortex: 13.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 40.3;K-562: 45.1;THP-1: 59.8" "Region enhanced" "Detected in many" "cerebral cortex: 29.2" "Group enriched" "Detected in all" 5 "cerebral cortex: 46.4;hippocampal formation: 37.1" "HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737" "unprognostic (1.77e-2)" "unprognostic (1.90e-1)" "unprognostic (8.53e-3)" "unprognostic (4.77e-2)" "unprognostic (1.07e-1)" "unprognostic (9.39e-3)" "unprognostic (1.80e-1)" "unprognostic (5.54e-3)" "unprognostic (8.26e-2)" "unprognostic (3.75e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.37e-8)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (7.95e-6)" "unprognostic (1.08e-3)" 2.7 4.9 0.2 4.3 8.9 0.3 2.2 0.0 13.5 2.6 0.0 34.5 1.5 1.7 0.9 0.8 1.4 1.4 0.6 4.6 0.0 4.0 3.0 0.9 0.5 3.0 1.3 2.4 1.9 3.9 2.1 1.0 0.6 4.8 1.9 39.8 0.8 1.5 2.8 2.2 1.8 5.7 3.0 0.0 0.8 1.1 2.8 0.0 0.2 1.6 2.7 1.0 1.6 3.1 3.4 2.6 1.7 17.6 8.1 8.3 9.9 1.3 6.2 8.9 4.4 5.7 0.4 5.8 0.9 0.2 13.3 6.9 0.5 14.0 3.7 7.0 9.4 12.3 40.3 4.1 4.9 1.9 18.7 17.1 4.8 6.4 8.8 5.6 11.3 0.4 6.0 45.1 0.0 12.8 0.9 0.8 22.9 3.2 2.0 2.9 1.7 6.0 0.1 6.6 0.6 3.8 0.0 3.1 0.0 9.5 3.1 3.6 59.8 6.2 31.5 5.9 10.1 16.6 2.6 8.9 25.9 21.7 14.6 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 0.0 13.5 4.6 0.0 3.0 1.3 2.4 4.8 0.0 0.0 3.4 1.4 0.0 1.1 18.6 0.6 1.8 2.7 0.5 0.6 2.4 0.9 0.4 1.5 0.0 0.7 0.0 4.2 0.1 0.2 129.7 1.9 0.3 1.0 0.9 3.9 1.5 99.7 0.0 363.9 2.7 0.3 3.6 0.0 0.7 0.0 1.6 1.8 5.4 0.8 0.0 3.5 66.9 0.0 2.5 3.0 0.9 2.5 1.0 5.4 9.4 0.6 0.5 0.0 21.1 34.1 1.2 70.0 1.2 0.0 4.3 19.1 7.6 0.2 0.5 0.0 1.7 10.4 6.1 4.1 0.8 3.0 0.1 1.3 3.9 84.7 2.2 UBE2B "HHR6B, RAD6B, UBC2" ENSG00000119048 "Ubiquitin conjugating enzyme E2 B" P63146 5 134371469-134392108 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 268.3" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 723.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 444.6" "Lineage enriched" "Detected in all" 6 "granulocytes: 444.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (7.39e-2)" "unprognostic (6.66e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-1)" "unprognostic (2.49e-1)" "unprognostic (8.39e-2)" "unprognostic (1.64e-3)" "unprognostic (6.30e-3)" "unprognostic (3.42e-2)" "unprognostic (2.04e-1)" "unprognostic (5.52e-2)" 52.9 74.9 33.4 50.4 35.8 85.1 44.5 39.0 46.5 38.0 34.1 43.8 41.1 54.1 35.1 71.1 37.6 51.4 119.5 38.0 40.8 51.1 57.1 45.3 47.5 33.9 34.7 34.0 44.8 54.2 26.0 40.2 48.8 34.4 33.2 42.4 29.5 40.0 23.4 268.3 43.5 46.8 43.7 33.5 44.1 39.9 49.6 35.8 29.5 41.6 100.7 48.5 43.1 43.5 42.4 109.4 27.9 58.2 55.0 50.0 54.1 92.7 80.2 43.5 51.4 60.9 85.6 70.9 58.7 94.1 52.3 138.7 42.7 45.8 60.4 56.0 94.5 47.6 32.1 75.9 92.8 58.2 38.8 63.7 46.5 80.2 47.4 39.3 68.1 44.1 48.8 61.1 103.5 46.8 63.4 62.5 102.1 24.9 32.6 26.7 61.6 63.8 83.8 46.6 82.9 77.6 60.1 62.9 29.3 147.9 62.5 63.0 106.0 87.6 57.8 40.8 78.9 89.4 86.1 129.4 87.0 65.2 72.8 59.4 236.7 58.3 174.0 46.9 68.3 42.9 49.7 58.8 48.1 42.6 47.9 69.9 60.6 444.6 53.0 78.9 48.0 77.5 64.1 33.4 35.8 39.0 46.5 38.0 40.8 33.9 34.7 34.0 34.4 33.5 35.8 42.4 187.5 73.7 61.6 40.1 176.5 364.7 321.2 215.1 175.8 77.8 169.9 156.5 315.8 147.3 113.7 75.4 81.3 144.5 182.0 183.1 172.1 173.8 233.2 139.8 102.2 149.7 131.8 261.2 103.0 169.5 123.0 183.3 113.2 167.8 116.8 81.7 115.3 97.4 119.4 87.5 84.2 141.0 181.0 131.5 323.9 315.4 155.0 184.2 227.7 49.6 190.6 150.0 113.3 44.7 68.4 210.6 195.2 113.2 162.5 343.9 153.4 170.7 111.7 91.3 151.2 154.9 262.9 223.5 201.7 145.5 369.7 723.5 192.0 140.4 105.7 488.1 TRPM6 "CHAK2, FLJ22628, HOMG, HSH" ENSG00000119121 "Transient receptor potential cation channel subfamily M member 6" Q9BX84 9 74722495-74888094 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.8;intestine: 16.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 23.1;neutrophil: 7.5" "Lineage enriched" "Detected in single" 41 "granulocytes: 23.1" "Cell line enhanced" "Detected in some" "BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.95e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "unprognostic (7.80e-2)" "unprognostic (9.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" "unprognostic (5.72e-4)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (8.10e-2)" "unprognostic (7.54e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-2)" 0.5 0.0 2.1 0.6 3.4 2.7 0.6 2.9 2.4 0.3 0.6 13.3 7.1 0.3 0.2 0.3 0.2 0.3 0.2 1.5 2.7 2.0 0.1 0.3 0.3 3.8 3.6 1.1 0.0 0.1 1.4 0.5 0.3 4.3 0.5 16.7 0.5 0.3 0.1 0.1 0.7 7.9 0.5 3.1 0.5 0.2 1.4 3.1 0.4 0.2 0.1 0.3 0.4 0.3 6.8 0.0 0.8 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.0 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.1 2.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.5 0.1 0.0 1.4 0.0 0.1 0.0 0.1 0.1 23.1 0.1 2.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 7.5 0.5 0.2 0.3 0.0 0.1 2.1 3.4 2.9 2.4 1.5 2.7 3.8 3.6 1.1 4.3 3.1 3.1 6.8 3.3 0.0 1.7 1.0 0.3 0.1 1.9 0.3 2.2 0.3 0.2 0.4 0.9 0.0 1.3 3.7 0.0 0.2 0.2 128.9 0.0 0.0 4.0 11.3 3.4 3.2 3.6 0.0 1.3 0.0 0.1 0.3 0.0 36.5 0.0 0.1 3.3 0.1 0.0 0.0 0.5 3.0 0.0 0.3 0.6 0.9 0.0 0.4 0.0 39.4 0.0 0.3 0.0 0.5 81.1 0.0 13.8 0.4 0.1 1.3 23.3 0.0 0.8 2.7 0.0 0.7 0.4 1.6 2.4 0.5 1.0 0.1 0.5 0.2 7.5 0.8 GDA ENSG00000119125 "Guanine deaminase" Q9Y2T3 9 72114595-72257193 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 80.3;intestine: 95.5;kidney: 43.3;liver: 60.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2" "Cancer enhanced" "Detected in many" "renal cancer: 13.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3" "HPA019352, HPA024099, HPA030387" Enhanced Approved Nucleoplasm No NA 1500000 Nucleoplasm "HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351" "unprognostic (2.64e-2)" "unprognostic (7.10e-2)" "unprognostic (2.83e-2)" "unprognostic (2.92e-1)" "unprognostic (4.35e-2)" "unprognostic (8.45e-2)" "unprognostic (2.00e-1)" "unprognostic (5.60e-2)" "unprognostic (3.26e-1)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "prognostic favorable (2.66e-5)" "unprognostic (2.23e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (8.30e-4)" 0.3 2.7 48.9 1.2 73.5 0.4 0.2 22.2 80.3 1.2 25.3 9.9 95.1 3.8 0.4 0.4 8.6 16.1 0.1 61.5 45.0 43.3 60.8 0.2 0.4 24.9 28.3 62.1 0.2 2.7 8.6 2.8 2.9 30.4 0.1 10.0 0.1 0.0 6.7 1.6 2.1 95.5 0.4 22.6 0.1 3.4 1.3 48.4 0.6 0.1 0.4 4.7 4.1 0.2 51.8 34.4 4.5 0.1 0.1 0.0 0.0 0.8 0.3 24.9 0.0 0.0 3.2 19.3 0.0 127.9 0.0 0.2 2.9 0.2 0.0 0.0 0.4 0.1 0.0 46.4 0.2 0.0 0.1 0.1 0.2 62.3 0.0 0.6 0.1 0.0 0.0 9.6 0.1 0.0 0.2 0.2 0.3 0.2 157.0 0.0 0.0 0.1 1.1 1.1 7.9 0.2 0.6 2.5 0.1 0.1 0.2 0.1 0.2 0.6 0.2 0.4 0.2 0.1 0.3 0.2 0.3 0.1 0.3 0.1 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.4 0.3 0.1 0.1 0.1 0.0 48.9 73.5 22.2 80.3 61.5 45.0 24.9 28.3 62.1 30.4 22.6 48.4 51.8 0.0 0.0 0.5 3.9 1.9 0.0 0.7 19.0 0.0 0.0 0.0 0.0 0.8 14.3 24.7 0.0 0.0 0.2 0.0 65.5 3.9 11.7 1.2 112.3 7.4 0.4 4.8 0.0 109.3 10.7 1.9 0.3 12.2 171.1 0.0 0.0 1.1 56.9 0.2 0.0 22.8 22.1 2.0 1.9 0.4 0.6 0.3 1.2 0.0 5.6 0.6 0.0 0.0 5.0 3.8 6.7 83.7 0.0 0.1 0.8 321.3 98.2 58.6 0.0 0.0 0.8 3.0 1.4 4.7 0.0 0.1 1.9 1.2 0.2 16.1 2.2 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 264.3;Skeletal myocytes: 223.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 60.4;ASC TERT1: 83.0;HHSteC: 107.4;HSkMC: 71.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favorable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 80.7 36.8 16.2 23.0 24.0 18.3 68.2 33.1 25.5 25.9 17.2 54.4 15.5 56.9 16.9 41.5 73.6 43.0 48.7 19.0 30.8 55.4 92.0 72.3 14.5 24.3 25.1 13.2 63.9 53.4 51.5 25.7 10.3 23.7 36.8 26.5 19.4 35.7 24.7 124.3 39.9 33.5 59.4 18.7 23.1 49.3 7.7 23.9 12.2 57.5 95.5 14.4 43.8 37.6 26.3 0.4 0.6 0.0 7.8 60.4 83.0 0.8 4.1 27.1 1.4 3.0 0.1 3.6 0.1 3.0 7.5 2.0 0.1 11.9 18.4 2.8 0.0 9.3 4.2 13.1 2.4 107.4 2.1 10.9 71.6 18.4 1.1 25.9 37.1 23.9 1.8 8.4 16.4 10.2 1.3 0.3 6.2 0.7 1.2 3.9 0.0 3.7 10.9 5.0 0.0 1.0 5.2 37.3 21.5 45.2 2.5 7.1 6.7 32.8 7.1 5.1 8.2 2.2 11.8 13.5 0.6 6.4 6.6 35.9 0.7 0.1 0.1 0.4 0.1 0.6 0.9 0.5 0.4 0.3 0.6 0.7 0.4 0.0 0.1 0.2 0.4 0.6 0.1 16.2 24.0 33.1 25.5 19.0 30.8 24.3 25.1 13.2 23.7 18.7 23.9 26.3 264.3 41.7 25.5 25.8 36.5 48.2 62.7 13.0 97.3 45.3 48.3 34.7 74.1 64.3 22.3 14.7 20.9 0.2 51.0 36.7 31.3 10.5 22.3 40.6 171.6 124.3 13.8 14.5 32.1 13.1 0.5 180.8 55.5 59.6 7.6 2.0 109.9 158.8 3.7 80.8 13.7 32.3 14.2 70.1 44.6 18.1 90.7 81.3 39.2 29.0 9.7 126.1 19.6 3.0 11.1 12.8 26.1 85.0 30.2 74.0 54.5 39.7 17.4 10.1 78.9 223.8 203.5 2.1 3.2 72.7 34.2 0.0 54.9 16.3 31.9 33.3 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69274615 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 212.4;Rod photoreceptor cells: 267.6;Urothelial cells: 244.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 237.5" "Low region specificity" "Detected in all" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 580000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161" "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favorable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 42.9 15.0 35.1 11.7 43.9 12.1 30.5 46.0 42.9 17.0 27.2 39.3 54.9 20.0 13.2 46.2 24.0 24.7 28.0 39.2 42.5 45.1 65.3 48.0 9.8 53.8 41.8 27.0 37.3 22.1 58.3 5.4 18.5 62.7 25.0 35.4 123.1 37.4 22.1 14.3 33.6 50.0 16.2 53.9 5.8 58.8 32.4 41.5 32.8 45.3 15.2 23.3 55.9 22.5 69.9 237.5 6.4 24.4 25.8 92.9 90.3 108.5 37.3 26.7 54.9 29.0 31.8 106.6 33.0 37.0 20.3 31.4 158.3 33.2 79.3 75.9 115.3 20.7 34.5 22.5 165.2 28.9 13.8 59.1 71.3 65.2 43.1 32.4 19.6 143.6 9.9 19.7 24.7 34.3 36.0 5.5 2.3 49.5 194.5 50.0 23.1 26.9 2.9 192.0 194.2 8.3 14.9 13.3 111.2 3.4 55.7 37.0 7.9 196.3 44.3 48.3 32.4 38.6 23.0 5.2 0.9 48.0 19.6 16.1 0.0 0.3 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.8 0.1 35.1 43.9 46.0 42.9 39.2 42.5 53.8 41.8 27.0 62.7 53.9 41.5 69.9 2.9 44.8 22.8 76.4 2.3 65.1 79.1 26.3 4.6 212.4 4.6 1.3 38.5 40.0 33.1 3.7 35.5 27.9 2.7 74.4 0.0 32.5 3.5 7.1 1.7 36.4 11.5 10.5 10.1 24.3 25.6 15.5 64.2 9.9 5.7 0.2 27.5 104.9 5.6 18.5 13.4 45.0 36.7 14.6 28.9 6.7 29.2 8.2 28.4 22.5 9.0 111.1 1.0 21.6 82.5 44.2 65.8 13.9 5.2 115.4 73.4 1.9 51.3 267.6 0.0 4.9 13.1 19.6 18.0 40.6 64.1 43.2 3.2 0.2 50.3 244.5 ECRG4 "augurin, C2orf40" ENSG00000119147 "ECRG4 augurin precursor" Q9H1Z8 2 106063246-106078155 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 185.4" "Cell type enhanced" "Detected in some" "Adipocytes: 87.6;Fibroblasts: 25.3;Smooth muscle cells: 19.1" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 72.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 8.5;naive CD8 T-cell: 7.2" "Lineage enriched" "Detected in single" 83 "T-cells: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008546 Uncertain "Secreted to blood" NA NA 330000 "HPA008546: AB_2066524" "prognostic favorable (4.58e-4)" "unprognostic (3.91e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-2)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.61e-3)" "unprognostic (6.56e-3)" "unprognostic (1.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (1.36e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (9.11e-3)" "unprognostic (1.30e-4)" 61.6 27.9 7.3 1.1 5.8 0.0 50.1 8.9 7.3 67.8 185.4 38.5 5.3 24.8 28.7 20.3 48.0 9.5 17.5 12.1 43.5 46.3 3.3 27.8 1.8 12.1 17.8 2.2 13.3 5.9 0.7 96.9 8.6 14.6 55.6 5.7 0.1 20.6 102.7 10.4 12.8 19.3 9.1 19.8 26.1 167.2 27.2 13.2 2.8 101.9 7.0 0.3 80.2 58.7 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 2.0 1.3 0.0 0.0 8.5 7.2 0.0 0.0 0.0 0.0 0.8 1.4 7.3 5.8 8.9 7.3 12.1 43.5 12.1 17.8 2.2 14.6 19.8 13.2 12.7 87.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 ITGB1BP1 "ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B" ENSG00000119185 "Integrin subunit beta 1 binding protein 1" O14713 2 9403475-9423528 "Predicted intracellular proteins" "Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 391.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067348, HPA071538" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA067348: AB_2732765, HPA071538: AB_2686413" "unprognostic (2.21e-1)" "unprognostic (8.31e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.39e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (4.67e-5)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (6.46e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (3.75e-2)" "unprognostic (2.01e-1)" "unprognostic (1.14e-3)" "unprognostic (4.08e-3)" 114.7 23.4 51.5 19.5 59.0 31.6 60.9 50.0 58.4 43.4 47.5 31.5 13.7 31.2 26.8 21.1 24.6 22.8 35.2 47.3 48.5 38.6 13.4 23.0 22.3 50.8 47.9 47.2 22.5 11.9 26.4 19.3 24.4 55.5 18.7 24.4 27.7 15.7 23.9 30.1 30.0 19.2 36.2 44.8 15.3 23.1 9.5 55.7 27.2 22.5 33.8 25.9 30.7 32.8 53.7 53.5 35.4 43.4 51.5 148.9 131.2 23.3 94.9 66.2 83.8 66.1 49.5 33.1 55.6 43.1 135.9 56.1 50.1 66.3 62.7 92.8 158.6 30.2 53.2 43.2 61.1 54.1 42.2 57.4 70.5 49.5 78.4 56.5 75.2 76.6 43.0 29.9 46.1 109.0 44.6 74.7 25.5 35.9 90.3 53.9 39.4 59.1 51.4 88.5 40.6 44.1 45.0 54.8 40.3 71.3 38.9 30.5 32.1 48.6 73.8 54.5 103.3 105.7 46.8 111.0 89.0 106.1 54.8 54.5 86.1 43.1 56.0 54.9 54.0 52.5 40.1 46.6 53.2 56.8 33.0 35.2 45.7 9.3 50.4 41.1 52.8 61.7 53.1 51.5 59.0 50.0 58.4 47.3 48.5 50.8 47.9 47.2 55.5 44.8 55.7 53.7 90.0 28.9 18.1 18.3 47.1 61.2 40.6 70.4 40.9 25.2 30.4 41.8 104.3 22.8 35.1 38.6 2.1 45.0 70.7 16.1 391.3 72.0 26.3 31.3 51.9 85.5 33.1 49.4 61.6 72.7 73.9 98.6 25.5 30.9 41.7 44.4 53.6 21.6 91.4 35.3 47.3 30.4 32.6 45.0 88.5 25.7 54.3 51.7 97.8 15.9 95.6 64.2 121.5 25.6 40.1 108.9 27.0 57.2 42.7 35.2 24.7 88.4 35.6 30.6 92.1 49.0 102.4 27.8 19.0 47.5 63.1 31.5 63.0 70.7 35.2 60.4 CPSF3 "CPSF-73, CPSF73, YSH1" ENSG00000119203 "Cleavage and polyadenylation specific factor 3" Q9UKF6 2 9423651-9473101 "Predicted intracellular proteins" "mRNA processing" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 187.6;Spermatocytes: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034657 Uncertain NA NA "HPA034657: AB_10669728" "unprognostic (9.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-2)" "unprognostic (1.89e-2)" "unprognostic (2.56e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (8.45e-3)" "unprognostic (7.39e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (3.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (3.64e-1)" "unprognostic (1.10e-2)" 14.3 15.2 11.1 18.6 12.5 23.6 17.0 12.3 13.6 14.6 12.5 17.3 14.1 13.3 23.6 16.3 14.5 11.4 11.2 10.7 12.1 15.7 20.1 13.0 26.5 12.3 11.6 9.9 10.5 12.8 14.4 10.7 16.3 12.7 12.8 19.6 11.7 11.6 13.5 15.2 19.3 13.3 17.0 12.2 15.6 14.0 51.4 12.9 32.5 16.5 12.5 30.8 16.6 11.6 14.2 35.7 79.2 85.1 74.4 46.6 54.6 89.2 56.2 60.3 67.2 63.7 100.6 64.5 112.2 51.8 49.3 61.0 61.6 96.0 66.6 81.5 73.9 70.5 95.6 37.7 94.5 40.1 92.8 61.0 49.0 44.6 84.6 61.3 38.2 55.9 71.9 117.0 46.9 64.1 78.7 96.2 121.0 125.9 89.2 54.9 92.6 107.2 94.2 59.9 52.4 46.4 110.7 55.0 41.5 63.5 71.5 40.7 63.1 42.5 53.3 46.1 54.3 70.8 56.1 80.5 118.9 62.3 95.0 57.9 32.9 34.4 23.1 22.2 39.9 23.3 25.3 20.3 23.3 50.1 23.6 20.9 22.6 5.8 38.0 38.4 33.2 36.7 30.5 11.1 12.5 12.3 13.6 10.7 12.1 12.3 11.6 9.9 12.7 12.2 12.9 14.2 7.1 6.4 12.7 3.9 15.7 10.5 10.5 26.4 8.6 12.2 7.2 6.5 11.1 8.6 19.5 5.5 8.4 39.5 19.7 9.0 19.6 22.5 187.6 14.6 15.7 11.8 12.6 36.2 9.8 22.5 43.4 13.1 8.6 14.0 8.2 19.9 6.8 14.2 26.1 21.9 9.6 11.9 26.4 20.1 9.5 33.9 11.1 20.6 19.6 10.3 36.3 18.2 16.5 8.5 13.7 16.4 7.4 12.4 15.7 6.5 9.7 18.7 18.0 20.1 6.6 12.3 38.0 151.4 43.2 16.1 8.8 27.2 13.1 26.1 15.1 8.7 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946356-196969060 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 205.1;Intestinal goblet cells: 61.3;Paneth cells: 129.7;Proximal enterocytes: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA058599, HPA059920" Approved NA NA "HPA058599: AB_2683771, HPA059920: AB_2684162" "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.0 1.6 8.0 2.0 8.1 1.0 5.4 8.2 9.3 4.3 4.0 25.3 1.6 3.4 0.7 4.3 3.4 2.0 6.4 7.8 7.9 2.1 2.6 3.7 1.1 7.5 6.8 8.2 0.8 2.7 3.1 4.2 1.0 8.2 6.1 16.9 3.1 4.7 2.6 7.5 4.7 11.8 2.7 4.5 1.9 4.6 1.6 7.3 1.2 2.0 3.2 0.5 10.5 4.6 7.4 1.8 1.2 0.7 2.8 7.7 3.7 0.7 2.6 7.3 2.0 1.6 1.7 1.5 0.3 5.1 5.9 1.3 3.0 0.1 0.4 0.5 0.5 0.3 0.8 0.6 6.5 3.6 0.0 2.9 3.7 5.6 0.3 0.9 2.2 2.4 4.7 0.2 2.2 1.9 3.2 0.3 1.5 0.1 2.2 0.9 0.4 0.1 0.6 3.0 3.3 1.1 1.2 3.7 0.3 1.5 0.3 7.2 2.6 6.0 1.6 0.4 4.7 0.9 1.0 0.1 0.1 0.4 1.1 0.6 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.1 8.0 8.1 8.2 9.3 7.8 7.9 7.5 6.8 8.2 8.2 4.5 7.3 7.4 8.9 0.0 1.1 20.5 1.7 7.8 9.1 3.8 6.8 7.1 22.6 33.9 8.0 1.5 2.8 9.2 2.1 0.0 2.8 205.1 5.9 2.3 2.1 5.1 3.0 5.5 13.8 3.0 31.3 3.6 0.0 5.0 1.5 6.5 5.7 0.3 12.1 10.3 1.8 15.2 21.9 61.3 10.2 4.4 3.4 5.0 4.1 2.2 8.8 5.6 4.1 4.6 2.1 12.5 2.7 3.2 129.7 6.4 1.9 7.4 50.0 5.4 2.7 7.0 0.0 7.7 6.5 1.2 0.2 11.5 5.1 0.1 1.7 0.0 44.4 14.7 SENP5 MGC27076 ENSG00000119231 "SUMO specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 8.1 7.1 11.2 8.4 12.4 16.0 8.2 14.7 14.2 10.3 10.3 9.5 5.9 8.5 8.0 8.5 9.2 7.3 9.1 13.0 14.4 7.5 10.2 10.0 9.1 13.2 13.4 11.9 10.4 8.2 8.9 10.3 9.2 14.3 9.4 7.0 17.6 7.8 7.4 12.0 9.1 8.4 7.9 11.7 10.6 8.3 21.0 13.2 10.7 8.4 12.3 11.6 9.1 9.9 16.1 26.0 11.1 18.1 16.4 15.0 17.8 14.7 16.2 17.1 17.1 27.2 20.2 10.0 24.3 44.1 17.6 29.1 17.8 18.9 8.6 27.5 13.1 13.3 32.8 17.1 14.3 17.4 27.1 14.8 15.5 22.7 17.4 18.4 12.4 16.9 21.0 22.2 36.1 20.2 22.1 26.1 16.0 14.2 14.0 23.4 16.5 14.7 16.6 8.4 14.5 11.3 15.0 18.9 20.1 19.8 18.0 33.8 20.5 19.3 16.5 17.2 23.0 33.5 38.6 73.6 51.4 22.4 21.7 19.3 16.3 6.5 6.3 7.1 7.1 6.4 7.4 6.8 7.0 4.3 7.0 6.3 6.7 12.5 6.5 8.1 6.9 5.9 3.6 11.2 12.4 14.7 14.2 13.0 14.4 13.2 13.4 11.9 14.3 11.7 13.2 16.1 25.7 22.4 12.6 43.4 27.7 60.8 28.4 8.6 16.5 28.6 22.7 13.0 14.6 12.8 13.2 9.2 16.7 18.3 33.4 19.9 11.7 16.0 42.9 22.1 26.9 21.6 21.6 19.3 71.2 14.2 15.7 21.1 18.8 27.5 26.6 25.9 22.5 17.6 13.4 28.6 69.1 16.6 8.2 20.4 41.4 48.0 16.1 17.4 14.2 48.7 18.7 13.8 27.8 50.8 57.3 27.4 19.4 16.6 24.4 21.4 13.3 20.5 11.2 30.5 26.3 25.8 23.9 67.5 56.8 14.3 62.1 22.8 25.7 13.7 13.8 36.1 CCDC92 FLJ22471 ENSG00000119242 "Coiled-coil domain containing 92" Q53HC0 12 123918660-123972831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 89.2;Excitatory neurons: 123.0;Inhibitory neurons: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038560, HPA057580" Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA038560: AB_10672717, HPA057580: AB_2683476" "unprognostic (4.77e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "prognostic favorable (7.15e-4)" "unprognostic (4.82e-2)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (5.01e-2)" "unprognostic (5.69e-2)" "unprognostic (7.14e-2)" "prognostic favorable (4.59e-5)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (3.08e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" 55.4 26.9 20.5 3.8 19.4 1.2 48.0 4.3 44.9 38.2 0.0 43.8 5.8 40.7 7.1 20.3 38.0 4.0 68.2 26.8 7.0 39.9 38.7 38.0 3.4 18.1 13.8 20.8 35.8 21.3 5.6 58.9 7.1 18.9 36.6 2.8 7.3 25.0 4.7 78.4 16.8 34.6 5.6 5.1 27.2 33.2 74.6 12.0 3.2 41.2 7.6 2.4 37.8 28.9 20.8 4.9 5.5 2.7 4.9 17.5 9.6 4.9 8.1 15.3 4.5 4.8 2.9 1.4 2.4 2.7 10.2 2.5 3.4 3.0 2.1 3.0 15.0 7.0 3.1 2.2 1.8 9.2 0.5 11.3 5.5 9.2 5.7 3.5 13.7 12.6 5.3 3.2 1.1 4.0 3.3 3.0 5.4 1.2 2.4 11.6 3.7 1.5 0.7 6.1 5.1 5.1 7.3 4.0 1.9 5.7 6.3 5.7 2.7 12.6 8.9 1.9 5.8 2.8 3.7 2.1 0.7 7.1 4.2 3.9 1.6 0.4 0.7 0.7 0.2 1.2 0.5 0.9 1.1 0.3 0.5 0.6 0.9 0.4 0.5 0.0 0.4 0.1 0.6 20.5 19.4 4.3 44.9 26.8 7.0 18.1 13.8 20.8 18.9 5.1 12.0 20.8 17.6 19.2 28.5 52.5 8.3 3.8 7.5 8.1 4.0 33.6 14.2 11.7 40.8 18.6 8.6 18.4 14.6 4.4 16.4 7.2 7.9 14.7 89.2 15.1 13.0 17.7 4.8 4.4 123.0 10.9 2.7 19.2 10.2 14.5 20.3 31.2 18.9 14.5 18.9 21.9 106.1 6.2 8.2 12.0 6.3 63.9 13.7 14.2 8.8 30.9 9.9 15.0 22.6 50.8 70.0 15.5 2.7 17.3 3.2 9.5 10.0 37.0 9.0 13.6 72.3 15.3 24.6 40.9 10.1 6.3 3.0 5.6 13.7 26.3 7.6 7.5 C1orf198 "DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710" ENSG00000119280 "Chromosome 1 open reading frame 198" Q9H425 1 230837119-230869589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 139.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 13.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 13.1" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 138.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004798 Approved Supported Cytosol "Intracellular and membrane" NA NA 80000 Cytosol "HPA004798: AB_1848722" "unprognostic (7.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.52e-1)" "unprognostic (1.65e-1)" "unprognostic (2.32e-1)" "unprognostic (3.75e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.50e-5)" "unprognostic (3.53e-2)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (3.77e-2)" 38.2 13.6 85.2 11.1 106.3 5.4 30.2 102.2 82.6 33.9 51.7 27.5 11.9 39.1 15.0 15.0 32.9 32.6 45.8 76.2 90.2 17.4 14.8 67.5 15.6 113.2 110.5 65.0 27.5 28.2 20.3 7.6 31.3 109.4 21.6 11.5 9.9 23.6 32.6 107.1 32.0 14.0 46.5 115.7 18.1 30.2 6.9 99.0 6.7 35.2 26.3 9.1 33.5 26.6 139.3 22.4 16.7 44.9 30.8 81.9 59.9 76.7 40.4 63.7 20.4 20.6 53.0 12.3 26.8 24.5 138.1 10.3 14.1 23.5 8.9 15.0 87.5 22.3 4.2 15.0 17.9 35.7 13.9 4.0 72.9 13.4 8.1 8.9 43.7 12.9 16.9 8.7 9.0 14.1 15.0 11.0 6.6 52.6 49.5 13.7 25.6 32.1 6.0 16.2 26.7 26.0 41.5 20.5 27.2 14.2 23.6 34.6 11.8 10.3 32.9 32.8 7.7 24.5 16.0 7.7 8.0 8.7 8.7 95.3 13.1 1.3 0.3 2.0 2.7 2.4 1.9 1.3 0.8 1.7 1.2 2.6 2.3 1.0 2.9 1.3 0.2 0.6 4.7 85.2 106.3 102.2 82.6 76.2 90.2 113.2 110.5 65.0 109.4 115.7 99.0 139.3 11.1 192.3 23.2 35.3 1.2 26.0 13.1 6.4 7.4 2.0 32.7 23.7 36.4 32.9 17.3 11.0 10.4 17.5 1.3 2.6 1.9 41.9 11.4 8.2 8.9 11.6 5.4 9.9 2.6 26.3 32.2 33.2 3.6 10.6 2.5 15.1 8.6 4.5 11.0 25.2 5.3 9.0 8.2 1.8 19.4 8.3 13.4 11.6 65.8 13.1 3.6 12.8 0.0 6.0 67.5 31.1 3.7 9.1 2.5 21.3 2.8 7.4 12.2 4.6 32.9 26.8 45.1 10.4 5.7 8.9 29.0 12.9 3.4 5.2 6.9 18.7 TRIM67 TNL ENSG00000119283 "Tripartite motif containing 67" Q6ZTA4 1 231162112-231221556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 8.0;retina: 3.5" "Group enriched" "Detected in some" 4 "Horizontal cells: 69.0;Inhibitory neurons: 24.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034776 Uncertain NA NA "HPA034776: AB_10603997" "unprognostic (1.56e-3)" "unprognostic (1.54e-1)" "unprognostic (5.20e-2)" "unprognostic (5.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.82e-2)" "unprognostic (6.02e-2)" "unprognostic (4.63e-3)" "unprognostic (1.84e-2)" "unprognostic (1.74e-1)" "unprognostic (4.93e-10)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.30e-2)" "unprognostic (5.10e-3)" 0.0 0.2 1.3 0.0 0.8 0.0 0.0 8.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 1.6 0.0 0.0 0.0 0.0 3.5 2.0 0.7 0.0 0.0 0.0 0.5 0.1 3.7 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 8.0 2.2 1.3 1.6 3.5 2.0 0.7 3.7 1.4 1.9 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 24.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.5 0.0 6.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 HEATR1 "BAP28, FLJ10359, UTP10" ENSG00000119285 "HEAT repeat containing 1" Q9H583 1 236549005-236604516 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046917, HPA062200" Approved Enhanced "Nucleoli fibrillar center,Mitochondria" NA NA 470000 "Nucleoli fibrillar center" Mitochondria "HPA046917: AB_2679863, HPA062200: AB_2684709" "unprognostic (2.61e-1)" "unprognostic (1.44e-3)" "unprognostic (6.26e-2)" "unprognostic (1.34e-3)" "unprognostic (7.18e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (5.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.80e-1)" "unprognostic (4.67e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (8.08e-2)" "unprognostic (3.38e-1)" "unprognostic (3.27e-2)" "unprognostic (4.00e-2)" 8.5 5.6 3.3 11.2 4.1 12.8 9.9 4.6 4.0 6.9 3.3 6.3 5.6 8.8 6.5 7.4 7.0 5.5 4.4 3.4 4.3 5.4 5.6 5.2 13.0 3.7 3.3 3.6 9.5 8.8 7.9 3.5 7.8 3.8 6.2 7.6 4.9 6.2 6.4 6.6 10.4 6.2 8.1 3.3 8.5 6.3 14.5 4.0 10.2 8.0 5.7 13.6 10.9 6.7 6.5 35.2 41.4 21.2 32.3 29.1 32.5 47.4 27.7 17.8 31.2 27.7 41.8 29.0 57.3 30.4 25.8 19.3 41.5 48.7 29.7 42.0 29.0 56.0 40.7 28.3 36.1 26.1 73.5 25.2 26.7 26.2 47.2 40.5 14.9 36.3 25.9 93.8 18.8 31.5 18.8 35.1 20.1 84.9 44.8 16.9 38.6 30.6 53.8 19.9 34.9 19.9 44.1 33.5 23.7 28.3 14.1 28.2 27.2 34.7 31.2 29.5 40.6 69.4 35.4 47.2 65.5 27.8 40.2 47.4 1.6 3.3 1.0 6.0 4.2 5.6 9.1 5.9 6.6 4.0 6.5 8.1 7.8 0.4 5.7 4.2 5.2 5.3 2.3 3.3 4.1 4.6 4.0 3.4 4.3 3.7 3.3 3.6 3.8 3.3 4.0 6.5 13.3 3.2 12.8 19.6 21.8 19.8 16.3 8.3 26.2 12.4 9.8 7.6 4.2 7.2 11.7 5.5 18.8 8.1 15.0 3.6 3.9 8.9 10.5 8.4 26.3 12.4 4.2 12.6 35.1 8.5 10.8 15.2 8.6 11.3 32.9 23.4 10.4 9.7 7.5 6.7 30.4 6.2 4.1 11.3 7.5 2.7 14.0 11.7 1.8 26.2 9.6 3.0 9.2 36.2 34.1 12.0 4.3 10.1 19.0 15.7 3.3 5.6 11.5 9.6 0.0 19.4 11.8 29.3 30.1 19.3 16.9 4.9 18.1 15.6 11.1 12.0 PTBP3 "DKFZp781I1117, ROD1" ENSG00000119314 "Polypyrimidine tract binding protein 3" O95758 9 112217716-112333664 "Predicted intracellular proteins" "Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048374 Approved Nucleoplasm NA NA Nucleoplasm "HPA048374: AB_2680376" "unprognostic (6.12e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.44e-1)" "unprognostic (2.12e-1)" "unprognostic (4.38e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.39e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.72e-2)" "unprognostic (4.99e-2)" "unprognostic (3.04e-2)" "unprognostic (5.10e-2)" 14.8 11.7 6.1 31.3 8.9 41.3 21.9 6.3 8.5 15.4 7.8 32.1 28.9 13.4 15.3 37.5 12.5 21.1 7.7 5.9 11.6 25.9 15.7 21.7 37.0 6.1 5.4 5.9 11.0 14.4 11.2 7.5 25.0 4.9 11.6 34.4 8.7 17.8 9.4 5.9 29.0 31.4 12.6 5.8 28.7 33.6 23.9 7.3 46.6 19.8 7.1 39.8 37.3 17.7 6.8 62.3 64.3 24.2 21.0 20.9 22.8 123.0 24.8 20.1 29.9 30.9 74.3 90.7 70.3 26.9 32.5 23.8 86.5 34.0 71.0 39.6 79.7 11.7 71.5 25.1 52.6 26.6 95.7 83.7 25.8 47.2 40.3 55.1 19.1 51.9 53.2 97.6 64.6 34.7 57.8 93.7 25.9 38.3 95.6 21.7 60.6 82.0 35.9 44.4 81.6 30.0 19.4 49.3 63.9 24.1 51.6 75.4 42.9 40.5 26.3 35.3 38.2 31.3 32.6 86.6 62.9 22.7 47.6 26.4 23.0 8.8 16.7 10.8 10.3 11.3 7.0 7.8 8.8 9.9 8.6 6.2 7.3 32.5 5.8 14.4 16.1 9.1 6.8 6.1 8.9 6.3 8.5 5.9 11.6 6.1 5.4 5.9 4.9 5.8 7.3 6.8 75.5 28.9 68.6 18.6 76.8 80.2 52.2 47.8 87.0 7.7 49.9 31.0 9.5 45.8 65.1 114.0 18.8 39.0 129.1 111.1 29.4 41.6 71.2 83.1 53.1 53.1 90.4 75.1 54.2 71.2 107.3 32.5 90.7 115.3 65.8 31.6 46.8 31.4 57.5 8.4 37.5 76.8 24.4 110.8 89.4 131.0 21.8 104.1 28.4 89.0 116.7 3.6 62.8 45.2 26.5 115.9 66.6 18.8 54.6 81.7 62.3 31.5 86.2 16.1 19.7 34.5 36.9 25.1 20.6 110.5 104.0 35.0 77.8 21.6 84.7 190.7 RAD23B "HHR23B, HR23B, P58" ENSG00000119318 "RAD23 homolog B, nucleotide excision repair protein" P54727 9 107283137-107332192 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 420.5;Late spermatids: 1201.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029718, HPA029720, CAB033868" Enhanced Supported Nucleoplasm,Cytosol No No 5900000 "Nucleoplasm, Cytosol" "CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008" "unprognostic (3.95e-3)" "unprognostic (1.01e-2)" "unprognostic (2.28e-2)" "unprognostic (8.14e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.94e-1)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.34e-1)" "unprognostic (3.72e-1)" "unprognostic (3.31e-2)" "unprognostic (1.20e-1)" "unprognostic (2.94e-3)" "unprognostic (2.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" 74.4 48.2 29.9 44.8 29.4 83.5 49.0 43.0 37.6 43.2 23.5 48.1 42.3 42.3 69.4 64.2 41.2 34.4 48.9 33.9 29.3 44.8 141.9 39.7 39.7 30.1 29.1 24.9 38.1 65.1 50.9 30.8 78.4 29.8 48.6 48.1 42.5 38.7 43.9 154.4 62.7 41.0 55.5 24.7 36.5 41.9 60.0 32.0 59.0 43.0 124.6 50.3 68.2 43.2 32.7 132.9 114.9 158.6 102.9 107.5 166.6 179.9 200.6 162.3 172.8 116.9 190.1 140.5 184.8 79.3 218.6 156.4 181.2 221.0 175.9 172.9 126.4 73.0 96.2 112.0 147.6 140.3 174.2 79.3 141.1 161.3 165.3 248.0 136.0 124.3 79.6 158.3 133.6 159.5 215.0 169.6 88.3 170.5 231.2 133.0 125.3 209.6 87.8 149.8 122.1 144.9 98.2 138.8 193.1 125.8 237.5 197.7 70.5 114.3 129.0 127.0 161.6 152.5 91.9 181.2 98.5 138.0 101.7 138.0 0.9 1.1 1.1 1.9 1.2 2.1 1.8 1.1 1.6 1.0 2.1 1.7 1.5 2.9 2.3 0.8 1.1 2.2 0.6 29.9 29.4 43.0 37.6 33.9 29.3 30.1 29.1 24.9 29.8 24.7 32.0 32.7 49.7 44.8 40.4 32.3 54.7 195.5 148.1 40.5 79.1 40.5 65.3 36.6 117.4 68.6 42.2 35.0 27.1 269.7 37.1 82.9 50.9 89.2 420.5 69.8 80.8 68.7 101.0 76.1 54.9 77.4 259.7 79.3 60.6 90.8 36.2 83.0 55.6 209.9 99.5 50.5 47.2 83.8 38.7 65.6 131.1 1201.4 75.5 70.7 74.7 38.4 83.7 40.4 39.1 50.3 54.1 81.0 50.5 87.3 89.3 146.0 51.2 95.9 47.6 43.9 78.9 71.6 88.5 45.3 74.7 126.9 240.9 291.8 50.5 91.1 74.9 141.2 FKBP15 "FKBP133, KIAA0674, PPP1R76, WAFL" ENSG00000119321 "FKBP prolyl isomerase 15" Q5T1M5 9 113161006-113221318 "Predicted intracellular proteins" "Endocytosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 23.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007979 Approved Approved Nucleoli,Cytosol NA NA 9800 Nucleoli Cytosol "HPA007979: AB_1848615" "unprognostic (2.81e-1)" "unprognostic (2.51e-1)" "unprognostic (2.55e-3)" "unprognostic (1.61e-3)" "unprognostic (2.54e-1)" "unprognostic (2.67e-1)" "unprognostic (2.16e-3)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-3)" "unprognostic (1.02e-1)" "unprognostic (6.45e-2)" "unprognostic (4.28e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (3.44e-2)" "unprognostic (5.62e-3)" 17.2 14.9 6.8 17.2 9.5 13.2 15.5 8.0 9.1 16.3 7.5 14.8 9.7 14.9 8.6 16.3 14.8 8.3 14.6 7.0 10.2 12.2 15.3 24.1 16.0 10.3 8.8 5.8 15.1 13.5 12.1 15.5 14.3 10.7 15.0 10.3 12.6 17.3 7.4 18.2 20.4 16.9 11.0 8.3 31.3 14.2 5.9 9.2 11.1 15.8 7.7 13.6 16.5 16.5 14.4 13.4 13.2 9.4 8.8 15.6 14.8 12.1 16.6 20.8 15.6 14.2 8.1 13.3 21.7 7.1 18.6 31.2 30.0 10.4 14.0 15.3 16.6 7.1 8.8 16.3 8.0 12.7 18.7 20.9 15.0 13.8 16.1 17.4 18.3 15.1 13.3 10.9 13.4 15.7 19.2 13.8 9.7 8.8 17.4 10.6 12.5 19.1 7.5 11.2 12.2 8.0 8.1 19.5 15.5 8.5 11.6 17.7 6.2 19.9 18.4 6.9 19.2 16.9 12.2 13.0 9.4 19.7 10.3 14.9 2.5 11.3 1.8 3.2 13.9 2.7 1.8 1.9 2.0 7.9 3.1 2.4 1.9 6.4 4.4 23.3 3.3 2.0 4.7 6.8 9.5 8.0 9.1 7.0 10.2 10.3 8.8 5.8 10.7 8.3 9.2 14.4 11.1 16.0 26.7 23.5 14.9 5.7 6.2 9.6 11.4 13.7 7.0 5.6 15.4 7.2 14.3 14.7 27.1 13.8 17.3 9.7 1.9 12.7 1.2 13.4 13.9 12.5 4.8 14.7 25.1 13.6 12.4 14.7 11.7 10.0 11.4 13.3 17.2 9.3 61.3 11.8 25.0 8.6 8.2 58.4 13.6 1.7 16.8 57.5 7.2 27.2 31.2 8.0 18.6 21.1 30.1 17.3 8.1 15.8 8.8 6.1 9.2 5.4 15.9 16.1 19.7 10.0 9.2 7.1 10.5 11.1 4.1 12.2 14.9 14.5 8.2 10.5 CTNNAL1 "alpha-CATU, CLLP" ENSG00000119326 "Catenin alpha like 1" Q9UBT7 9 108942569-109013522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 276.1" "Cell type enhanced" "Detected in all" "Theca cells: 616.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.93e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-2)" "unprognostic (6.07e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.05e-1)" "unprognostic (4.72e-2)" "unprognostic (3.55e-2)" "unprognostic (7.45e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (1.67e-1)" 30.9 276.1 22.0 12.2 23.6 39.4 22.5 21.9 34.0 21.0 29.7 31.1 12.4 28.5 33.1 24.7 31.7 18.8 68.4 23.0 29.3 38.8 29.7 52.8 13.2 22.2 21.1 23.6 130.3 25.0 33.3 21.8 45.6 21.3 25.1 17.8 34.0 19.3 28.1 34.3 24.2 18.9 31.2 20.8 24.9 38.7 44.7 22.2 14.8 85.3 18.9 14.9 27.0 16.1 23.5 158.4 54.9 59.6 48.6 40.3 105.6 107.6 205.8 92.1 199.8 129.5 171.7 241.1 48.2 62.6 105.0 155.5 115.7 78.7 182.3 243.1 68.4 49.8 25.6 51.6 115.0 55.2 62.6 6.0 81.9 12.5 105.9 144.2 167.4 98.4 39.6 60.6 48.0 92.1 15.9 43.5 44.9 67.7 145.3 115.6 85.4 158.5 42.9 206.3 33.7 46.3 31.7 65.8 6.5 48.0 57.6 48.5 23.3 111.1 79.1 115.9 70.8 116.9 36.4 37.0 44.4 110.8 46.8 90.3 0.0 0.2 0.9 0.6 0.0 2.1 1.2 0.8 1.6 0.1 0.2 1.4 0.4 3.2 4.0 0.0 0.0 6.4 1.9 22.0 23.6 21.9 34.0 23.0 29.3 22.2 21.1 23.6 21.3 20.8 22.2 23.5 50.5 19.2 34.9 10.7 7.1 110.0 100.3 57.8 161.6 10.1 16.8 33.5 140.1 15.7 25.2 29.5 29.2 203.3 6.6 12.1 131.0 112.2 67.9 103.8 48.7 144.2 21.0 77.5 83.1 105.0 106.0 66.2 25.0 135.0 5.1 57.3 189.2 20.1 25.2 33.7 55.1 20.1 14.2 5.0 33.6 26.2 55.0 17.8 55.2 16.9 4.6 103.5 1.0 12.1 4.3 219.8 15.1 45.1 29.8 119.3 2.4 21.0 52.9 16.7 13.1 31.8 72.6 117.9 38.8 12.2 24.0 86.7 14.7 616.1 22.0 27.7 ABITRAM "C9orf6, CG-8, FAM206A, FLJ20457, Simiate" ENSG00000119328 "Actin binding transcription modulator" Q9NX38 9 108934400-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 14.3 12.0 17.9 10.1 19.1 15.7 17.4 17.8 22.1 12.6 18.8 15.0 14.5 13.7 25.3 16.6 21.7 11.0 15.9 17.9 19.5 13.7 14.8 12.8 9.1 18.0 18.0 17.3 13.6 13.4 23.4 14.0 12.6 17.6 12.2 16.3 24.9 15.4 14.4 13.3 24.7 13.2 12.6 18.4 8.5 14.6 20.4 17.7 12.0 19.1 11.9 12.1 12.0 11.5 19.0 18.5 19.8 19.5 23.4 36.2 44.6 28.1 17.1 20.0 17.0 13.9 29.5 9.7 17.0 9.8 16.6 22.3 41.3 17.2 18.3 16.0 10.4 17.6 10.5 25.8 27.0 30.7 40.4 13.3 25.3 33.6 20.7 47.6 20.9 23.7 26.1 39.7 16.6 20.3 53.0 28.9 16.3 22.6 55.9 28.7 13.9 33.9 18.9 22.5 19.2 26.7 13.7 27.0 23.3 30.1 20.0 31.6 21.4 14.9 9.2 16.9 39.3 21.7 14.7 38.5 12.6 30.1 15.6 13.4 38.8 31.2 31.0 14.8 33.4 22.6 16.5 23.1 19.6 35.5 10.8 22.9 17.6 37.4 21.1 34.6 37.0 21.1 20.1 17.9 19.1 17.8 22.1 17.9 19.5 18.0 18.0 17.3 17.6 18.4 17.7 19.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 6.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 10.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 DYNC2I2 "bA216B9.3, CFAP133, DIC5, FAP133, MGC20486, WDR34" ENSG00000119333 "Dynein 2 intermediate chain 2" Q96EX3 9 128633653-128656847 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 20.4;Cytotrophoblasts: 89.8;Extravillous trophoblasts: 95.3;Hofbauer cells: 21.9;Syncytiotrophoblasts: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 35.8;naive B-cell: 52.9" "Lineage enriched" "Detected in all" 5 "B-cells: 52.9" "Cell line enhanced" "Detected in all" "MCF7: 432.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040764, HPA041091" Approved Approved Cytosol NA Yes Cytosol "HPA040764: AB_10795625, HPA041091: AB_10796237" "unprognostic (1.45e-1)" "prognostic favorable (1.63e-4)" "unprognostic (2.55e-1)" "prognostic favorable (7.01e-5)" "unprognostic (2.27e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (8.79e-4)" "unprognostic (6.04e-2)" "unprognostic (4.39e-1)" "unprognostic (3.65e-1)" "unprognostic (8.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-3)" "unprognostic (2.06e-2)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 14.1 50.3 14.3 11.5 12.6 33.5 20.3 12.8 20.3 28.0 24.6 23.7 22.4 22.6 9.0 38.2 30.7 11.2 31.2 12.7 18.2 49.6 39.4 25.3 12.0 14.0 15.1 12.1 19.2 37.0 21.3 36.4 11.1 13.2 31.3 10.4 4.5 32.2 14.1 11.2 23.8 27.9 6.4 14.0 23.8 26.5 70.4 13.2 24.0 56.1 4.3 9.6 19.4 23.9 11.8 112.7 202.8 49.8 78.8 11.4 16.1 141.4 46.2 32.9 66.5 42.8 96.6 197.3 40.4 32.4 30.8 62.0 169.4 47.5 50.8 16.6 93.5 40.1 24.0 134.8 52.0 13.9 41.5 39.4 8.0 25.0 66.3 18.9 24.0 46.5 112.6 83.5 34.0 36.4 432.4 151.3 106.1 63.7 97.3 121.0 157.2 66.6 136.8 42.1 36.0 125.1 100.1 143.9 135.9 36.8 13.7 230.5 40.7 28.3 75.9 114.8 95.6 90.7 34.6 100.7 39.6 71.4 41.9 74.0 1.7 1.1 0.4 1.4 1.6 2.3 35.8 2.9 3.9 2.8 52.9 1.1 1.7 0.8 4.5 5.7 11.0 5.7 3.8 14.3 12.6 12.8 20.3 12.7 18.2 14.0 15.1 12.1 13.2 14.0 13.2 11.8 2.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 89.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 95.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 37.4 0.2 0.0 0.0 0.0 SET "2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA" ENSG00000119335 "SET nuclear proto-oncogene" Q01105 9 128683424-128696400 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, DNA-binding" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005232, HPA063683" Supported Enhanced "Nucleoplasm,Lipid droplets" NA NA 880000 Nucleoplasm "Lipid droplets" "CAB005232: AB_2185634, HPA063683: AB_2685088" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.31e-1)" "unprognostic (3.77e-1)" "unprognostic (7.15e-2)" "unprognostic (4.37e-3)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.00e-2)" "unprognostic (1.88e-2)" "unprognostic (3.62e-1)" "unprognostic (3.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (7.57e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (1.54e-2)" 125.3 123.9 139.5 197.4 141.4 264.1 176.0 129.1 131.5 149.0 123.9 161.6 126.7 176.3 88.8 198.1 156.3 150.4 154.1 125.0 129.8 156.9 161.2 130.5 311.0 133.2 138.4 114.3 192.3 176.8 144.4 79.2 207.9 142.9 137.0 171.4 143.6 140.6 136.1 184.0 155.4 133.3 166.0 154.5 171.9 141.1 106.3 141.4 289.5 213.0 135.7 302.8 222.9 124.0 149.3 579.4 644.4 908.7 723.6 265.2 412.2 835.7 465.8 511.8 656.9 449.9 892.0 688.8 1483.4 383.1 482.8 513.6 1053.0 1358.8 700.1 745.2 681.2 577.8 855.2 968.5 734.5 591.3 1581.1 535.5 346.7 535.7 561.6 1114.6 526.1 626.1 781.8 1692.1 583.3 545.4 974.2 1333.9 580.0 1521.8 876.7 678.6 1198.7 1128.2 1198.7 506.5 640.5 921.0 576.5 1024.4 679.0 560.5 641.6 847.6 483.9 604.4 770.6 576.9 481.4 784.1 455.0 1417.0 1737.1 367.1 824.8 753.1 165.1 207.3 182.0 224.0 235.4 277.6 287.4 253.0 240.4 215.1 258.0 241.0 286.1 141.4 329.2 199.5 271.6 223.1 335.1 139.5 141.4 129.1 131.5 125.0 129.8 133.2 138.4 114.3 142.9 154.5 141.4 149.3 249.9 121.8 145.0 25.1 337.1 673.6 507.5 134.0 352.8 187.6 372.3 250.6 204.2 238.8 134.0 196.8 43.8 316.7 365.9 136.8 389.4 254.6 43.5 318.3 502.1 266.9 256.1 355.6 41.7 218.7 504.0 194.8 126.9 438.5 132.3 308.3 193.1 198.5 239.4 124.5 40.2 261.8 93.6 264.0 436.5 33.6 164.1 249.0 327.3 22.5 274.3 240.6 211.2 38.2 36.6 294.5 132.5 173.4 356.2 647.6 106.7 338.6 87.0 132.5 131.5 323.9 297.0 124.6 259.7 448.0 702.1 314.5 292.3 238.9 342.8 580.9 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol NA NA 4300000 Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favorable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 43.9 118.9 164.5 56.7 152.2 53.3 61.5 132.7 186.5 70.0 122.6 90.9 50.0 88.1 56.3 117.8 77.9 49.7 151.5 157.2 148.8 116.0 155.4 73.3 50.3 150.8 149.0 152.1 64.3 71.0 147.9 73.7 50.2 150.8 120.0 51.8 43.8 98.0 87.6 344.0 74.3 57.6 92.9 138.1 83.5 84.2 125.5 158.2 59.6 75.9 208.0 55.4 71.7 62.7 159.1 108.9 183.9 111.0 219.9 74.4 94.5 118.3 115.5 120.2 144.8 100.1 103.4 135.4 113.9 83.3 187.3 173.1 184.1 110.9 138.2 100.6 198.6 68.1 64.6 193.6 101.7 229.1 113.1 147.2 114.6 133.1 109.8 101.8 230.9 146.5 120.3 102.0 124.7 117.1 293.8 103.0 76.6 186.8 301.0 193.0 108.3 93.7 216.2 159.0 119.8 120.6 86.9 220.4 237.3 147.3 99.4 253.4 55.0 101.7 127.6 113.8 129.9 165.2 114.9 284.1 96.8 153.2 79.1 180.7 7.6 19.2 9.8 20.8 18.4 19.9 10.8 15.8 18.5 23.0 13.4 13.8 13.9 6.1 20.4 18.3 16.4 16.9 20.4 164.5 152.2 132.7 186.5 157.2 148.8 150.8 149.0 152.1 150.8 138.1 158.2 159.1 19.8 3.2 8.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 51.9 38.6 0.0 0.0 3.1 53.3 0.0 49.5 9.2 0.0 54.8 70.3 0.0 33.7 21.8 19.0 0.0 0.0 0.0 62.3 44.2 12.2 0.0 32.9 8.8 24.8 0.0 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.9 0.0 0.0 41.9 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 37.9 4.0 31.8 0.0 0.0 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1 RNA export mediator" Q53GS7 9 128504719-128542288 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane" Nucleoli "HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560" "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 11.1 14.1 9.7 15.9 9.4 15.2 15.9 12.8 11.4 13.1 12.9 17.6 16.3 11.7 10.9 16.6 14.3 7.8 15.0 9.1 9.9 14.3 16.4 12.4 20.6 9.0 9.2 9.2 16.3 9.6 17.8 14.2 9.3 10.5 11.9 18.5 16.6 11.2 12.5 22.7 19.2 15.9 13.0 9.0 15.3 13.1 32.3 9.6 26.1 13.4 12.5 22.4 12.9 12.4 9.2 29.6 54.5 26.2 44.9 25.3 25.5 34.6 29.2 24.9 40.2 28.4 36.8 20.1 59.6 23.0 33.0 38.6 101.4 45.9 41.7 34.5 56.9 29.8 30.6 57.8 34.6 28.5 49.9 38.8 18.1 39.7 45.6 48.5 22.3 22.9 54.7 44.7 51.0 46.7 68.6 49.5 35.2 22.2 79.1 46.7 49.8 64.2 79.0 27.3 26.1 30.9 23.1 71.3 42.7 25.9 21.1 78.9 34.9 17.0 42.5 28.1 50.2 41.2 50.9 131.9 45.9 39.9 37.5 46.8 40.0 21.1 24.4 22.1 26.0 18.1 13.4 17.2 20.0 22.1 20.5 15.2 17.7 18.0 27.4 27.5 13.0 22.3 19.8 9.7 9.4 12.8 11.4 9.1 9.9 9.0 9.2 9.2 10.5 9.0 9.6 9.2 4.0 9.6 9.0 11.1 11.4 6.5 5.3 10.4 8.6 7.6 8.8 7.6 13.0 5.7 7.2 7.3 8.4 16.1 6.9 13.2 5.9 11.7 77.0 12.2 7.4 3.6 5.4 12.0 14.0 6.2 11.7 7.6 10.2 9.4 9.5 10.9 4.6 14.2 15.7 10.1 15.5 12.7 8.2 15.1 5.7 58.1 10.2 13.5 3.6 10.3 20.0 8.9 15.5 18.1 15.5 8.3 8.0 6.4 13.4 6.1 16.3 13.7 12.6 8.6 13.1 7.7 7.3 51.3 25.5 14.4 6.8 13.3 12.1 7.1 14.1 5.4 RAB14 "FBP, RAB-14" ENSG00000119396 "RAB14, member RAS oncogene family" P61106 9 121178133-121223014 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026419, CAB037066" Approved Supported Vesicles NA NA 2700000 Vesicles "CAB037066: AB_1841128, HPA026419: AB_1855996" "unprognostic (1.30e-3)" "unprognostic (3.12e-2)" "unprognostic (9.01e-2)" "unprognostic (7.18e-2)" "unprognostic (6.53e-2)" "unprognostic (3.00e-1)" "unprognostic (1.39e-1)" "unprognostic (1.18e-1)" "unprognostic (2.52e-1)" "unprognostic (6.90e-2)" "unprognostic (3.05e-2)" "unprognostic (9.71e-3)" "prognostic favorable (1.79e-8)" "unprognostic (1.38e-1)" "unprognostic (3.17e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" 39.3 39.1 42.4 35.9 43.7 67.1 42.5 44.3 48.1 38.1 37.1 43.2 40.2 36.0 34.5 63.7 34.3 30.9 32.0 42.4 45.6 50.5 83.5 49.7 41.5 44.1 44.7 40.2 36.2 27.8 46.2 29.1 43.4 45.5 39.2 42.8 45.9 34.9 38.4 39.8 54.6 39.2 33.7 45.7 38.7 44.8 34.1 44.2 35.5 44.2 39.2 49.9 44.3 41.2 51.1 53.8 53.7 66.9 56.3 76.2 82.5 52.6 74.8 59.6 56.6 44.7 42.6 57.0 51.2 42.5 72.0 49.2 100.1 48.1 55.8 63.6 44.4 31.7 55.7 69.0 43.9 52.6 60.1 63.8 53.0 98.5 58.2 63.4 62.5 81.2 47.1 42.8 45.6 85.6 50.8 58.5 48.1 39.7 104.8 59.9 45.8 72.3 60.4 62.3 76.0 58.9 34.4 89.0 78.0 53.8 47.1 82.1 46.8 76.0 60.1 43.9 75.3 53.0 40.8 82.6 52.3 56.6 51.9 80.7 34.4 29.4 33.5 22.4 41.5 22.4 24.6 20.9 24.7 31.4 23.4 24.6 25.0 31.8 26.5 43.7 19.0 29.3 24.0 42.4 43.7 44.3 48.1 42.4 45.6 44.1 44.7 40.2 45.5 45.7 44.2 51.1 102.6 160.3 103.9 23.5 64.4 157.9 78.2 84.8 97.3 93.8 70.7 58.8 39.2 62.9 96.2 62.5 37.5 85.2 79.6 95.1 86.1 81.3 41.9 80.7 89.8 84.5 60.3 44.4 42.5 64.4 83.0 68.7 64.7 94.4 77.2 58.1 61.1 113.6 91.0 94.2 38.0 59.8 95.6 89.9 105.4 36.2 51.9 80.7 110.3 44.0 84.8 100.5 49.4 38.2 59.0 80.7 52.9 56.4 50.2 81.0 63.2 103.3 86.8 62.0 59.2 64.0 105.6 112.9 113.6 120.0 202.4 116.2 74.3 82.5 64.0 106.0 CNTRL "CEP1, CEP110" ENSG00000119397 Centriolin Q7Z7A1 9 121074753-121177610 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.2;testis: 35.6" "Cell type enhanced" "Detected in many" "Early spermatids: 131.7;Spermatocytes: 385.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 81.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020468, HPA020480, HPA051583" Approved Approved "Centriolar satellite,Centrosome,Cytosol" NA Yes "Centrosome, Cytosol" "Centriolar satellite" "HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542" "unprognostic (4.33e-3)" "unprognostic (2.89e-3)" "unprognostic (2.09e-2)" "unprognostic (7.97e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.21e-5)" "unprognostic (1.05e-2)" "unprognostic (3.22e-3)" "unprognostic (3.74e-3)" "unprognostic (2.02e-1)" "unprognostic (1.78e-2)" "unprognostic (5.47e-2)" "unprognostic (3.60e-3)" "unprognostic (9.83e-3)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" "unprognostic (1.13e-2)" 5.3 3.7 3.8 13.9 3.3 28.2 5.0 3.8 2.8 4.4 6.4 4.6 4.0 6.7 2.7 4.1 7.8 5.4 2.8 1.9 3.7 2.9 4.1 6.8 23.5 4.6 4.7 1.2 7.6 3.9 2.9 3.1 6.3 3.6 4.6 5.7 7.5 3.6 3.8 1.1 5.0 5.2 5.0 4.2 12.8 7.9 35.6 3.5 24.1 4.8 1.8 21.9 6.5 2.8 5.2 12.6 8.3 22.5 16.4 3.3 4.9 4.2 8.4 6.2 6.6 5.6 4.7 13.2 55.7 3.3 6.3 11.8 25.2 7.6 5.2 10.4 34.3 5.5 29.4 15.2 6.1 4.5 81.0 34.1 3.1 3.8 6.9 16.5 2.8 14.6 22.7 19.2 31.0 6.5 7.9 31.2 21.5 8.1 16.0 6.6 30.1 33.4 17.4 3.1 5.7 8.5 12.9 28.4 5.2 6.3 3.9 11.0 36.0 10.3 6.7 11.6 10.8 15.8 22.0 25.6 37.8 5.6 32.2 16.1 16.2 7.0 17.0 7.2 4.3 5.5 11.7 7.5 5.5 3.7 11.9 9.0 6.4 2.7 5.0 6.5 10.6 11.5 2.8 3.8 3.3 3.8 2.8 1.9 3.7 4.6 4.7 1.2 3.6 4.2 3.5 5.2 19.8 28.9 32.8 34.9 78.7 3.3 13.8 6.8 9.1 33.5 7.4 12.2 8.9 10.0 29.5 3.7 37.5 2.7 58.2 2.7 3.9 5.1 131.7 61.8 12.3 14.8 8.4 33.2 35.4 6.0 3.0 15.1 14.8 10.9 53.0 20.6 14.6 3.9 27.2 30.3 43.8 8.4 4.1 33.9 16.5 44.3 13.7 50.7 8.8 52.5 55.2 8.2 49.4 37.2 53.1 6.3 4.5 12.0 39.1 4.3 2.2 1.4 114.6 59.6 39.5 33.8 14.5 385.0 114.1 10.9 5.7 0.8 57.0 13.1 6.4 6.2 TRIM32 "BBS11, HT2A, LGMD2H, TATIP" ENSG00000119401 "Tripartite motif containing 32" Q13049 9 116687305-116701300 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050060 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA050060: AB_2681000" "unprognostic (2.47e-2)" "unprognostic (7.06e-3)" "unprognostic (5.50e-2)" "unprognostic (3.63e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (4.53e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.41e-3)" "unprognostic (2.92e-1)" "unprognostic (5.01e-2)" "unprognostic (1.79e-2)" "unprognostic (5.63e-2)" "unprognostic (6.03e-2)" "unprognostic (7.06e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-3)" "unprognostic (9.77e-2)" 6.8 7.3 3.9 5.5 4.3 1.0 6.8 16.4 5.3 10.1 12.1 5.9 5.9 10.7 6.6 7.5 13.2 6.4 7.9 5.3 5.3 5.2 3.8 5.5 8.2 3.2 3.1 3.2 10.2 6.3 8.7 3.5 6.1 5.2 7.0 6.2 7.3 5.3 7.4 18.7 4.4 7.2 10.8 1.3 6.3 5.5 5.3 3.7 7.5 6.4 12.6 7.5 7.7 5.7 4.2 10.9 24.5 14.3 15.7 28.3 20.1 10.8 19.9 21.7 22.1 18.4 16.4 11.7 11.3 8.6 30.7 16.5 22.8 17.5 22.4 20.0 9.9 8.5 6.1 15.4 10.2 14.7 4.1 19.1 17.4 19.7 21.0 12.3 24.4 14.6 12.4 8.6 9.3 26.3 13.9 11.0 0.1 13.0 26.2 14.6 12.7 38.2 7.4 9.0 25.1 14.2 7.2 15.7 10.8 11.4 14.3 29.8 4.0 18.2 20.4 16.2 15.3 15.2 15.1 4.3 17.7 17.0 2.7 20.5 0.0 1.7 0.0 10.9 3.3 8.4 7.3 9.5 8.7 2.3 5.1 9.6 9.8 0.3 7.0 3.0 4.3 20.9 6.0 3.9 4.3 16.4 5.3 5.3 5.3 3.2 3.1 3.2 5.2 1.3 3.7 4.2 2.5 6.4 0.6 5.5 4.3 4.2 6.3 9.3 5.7 11.7 3.1 3.7 7.6 7.2 7.3 9.2 0.0 6.7 2.1 1.7 1.9 8.5 3.5 7.1 10.7 3.6 4.2 0.4 7.6 8.0 3.6 6.1 3.6 2.3 2.5 4.5 2.9 4.1 7.2 1.7 10.1 4.0 8.2 2.4 4.7 2.1 5.3 2.2 1.8 1.9 0.8 4.0 3.1 6.6 5.1 5.0 2.6 12.0 3.1 2.8 10.6 3.1 10.8 4.8 0.0 6.0 6.6 17.7 13.1 5.6 3.7 7.4 4.7 5.0 5.3 4.8 FBXW2 "FBW2, Fwd2, Md6" ENSG00000119402 "F-box and WD repeat domain containing 2" Q9UKT8 9 120751978-120793416 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 177.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067878 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA067878: AB_2685913" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (6.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.57e-1)" "unprognostic (8.06e-3)" "unprognostic (1.40e-1)" "unprognostic (2.95e-1)" "unprognostic (3.88e-3)" "prognostic favorable (1.38e-6)" "unprognostic (1.66e-1)" "unprognostic (2.75e-1)" "unprognostic (2.86e-1)" "unprognostic (3.83e-2)" 23.9 21.9 9.9 21.2 10.0 37.8 20.3 10.6 10.3 21.9 11.9 17.3 16.8 20.1 15.5 21.5 16.6 14.8 23.7 11.1 11.2 18.2 22.4 23.3 22.3 10.0 10.4 9.3 17.0 18.7 22.9 13.1 17.5 9.7 18.5 20.0 15.4 19.2 19.0 16.2 21.5 16.2 22.9 9.8 22.6 18.8 17.8 11.9 26.5 20.1 21.9 25.5 22.6 16.9 11.3 30.1 37.3 27.5 46.5 50.7 41.4 25.4 39.5 45.1 42.7 41.3 29.8 35.4 44.9 20.4 51.8 43.1 64.4 39.9 39.4 53.0 60.6 17.2 29.1 64.8 43.5 28.6 65.6 38.6 30.3 47.9 47.2 50.0 40.1 50.8 45.7 39.4 47.5 37.4 48.2 47.3 19.6 41.0 50.8 35.3 36.1 43.8 45.1 29.5 33.5 21.9 33.0 55.3 40.6 29.5 32.2 66.5 18.7 38.1 36.3 28.9 59.3 49.6 34.1 74.2 38.5 38.4 28.7 38.1 15.3 12.0 17.2 17.3 11.4 13.1 10.0 12.3 16.3 11.0 6.2 10.0 13.8 12.4 15.5 13.7 9.6 13.0 9.8 9.9 10.0 10.6 10.3 11.1 11.2 10.0 10.4 9.3 9.7 9.8 11.9 11.3 32.3 25.6 56.9 17.3 17.6 22.7 26.4 27.3 13.1 20.0 23.5 16.6 21.9 12.8 28.7 11.0 12.5 18.5 50.9 27.1 21.5 27.1 38.8 14.5 22.7 31.9 27.6 24.0 34.0 34.0 29.2 23.2 28.1 17.8 15.8 27.2 33.5 33.9 25.2 33.7 29.0 19.0 28.5 25.0 30.0 177.2 26.4 21.7 48.0 23.4 38.0 16.5 36.0 27.6 37.0 32.5 19.4 35.7 24.5 34.9 22.7 24.7 21.0 25.1 6.6 20.4 36.1 40.5 53.7 21.9 32.0 17.8 31.2 31.0 23.2 28.1 PHF19 "DKFZP727G051, MTF2L1, PCL3, TDRD19B" ENSG00000119403 "PHD finger protein 19" Q5T6S3 9 120855651-120894896 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 43.9;Plasma cells: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "intermediate monocyte: 58.2;non-classical monocyte: 79.7;T-reg: 31.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 508.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (8.44e-2)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.78e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (2.74e-3)" "unprognostic (5.18e-2)" "unprognostic (2.84e-1)" "unprognostic (8.29e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (2.55e-2)" "unprognostic (2.67e-1)" "unprognostic (1.87e-3)" "unprognostic (2.01e-2)" 15.3 15.7 24.2 24.2 28.8 58.0 13.8 24.0 25.9 27.5 17.1 22.3 7.5 19.1 10.4 26.0 27.3 12.6 14.2 23.8 30.1 9.0 6.1 19.7 40.7 29.1 27.9 22.0 29.7 5.3 5.2 30.2 12.9 26.4 23.9 17.9 21.2 9.8 17.4 9.5 10.9 21.4 24.4 24.8 28.3 19.7 11.8 25.5 39.4 11.1 11.8 46.2 28.6 23.9 37.6 48.6 165.8 34.3 78.1 27.9 57.0 6.1 52.1 70.1 227.7 165.0 92.3 105.4 102.1 32.7 69.7 71.8 112.8 104.2 108.0 107.0 105.1 44.3 105.6 215.2 61.0 15.8 156.4 48.2 32.5 17.9 100.2 105.5 61.5 151.3 96.9 290.3 272.9 124.2 117.7 105.2 151.9 37.8 147.4 275.2 79.7 38.8 279.1 70.5 15.9 110.0 50.4 97.4 1.6 51.6 31.5 92.4 64.3 55.9 48.1 59.4 47.5 111.1 142.5 508.4 167.9 30.6 94.0 134.7 1.0 13.7 2.1 5.6 58.2 4.5 5.8 12.2 4.6 14.1 3.7 6.1 4.8 2.0 4.6 79.7 5.0 31.4 9.8 24.2 28.8 24.0 25.9 23.8 30.1 29.1 27.9 22.0 26.4 24.8 25.5 37.6 4.0 0.0 7.9 5.2 18.0 9.3 9.4 3.2 6.2 7.4 5.0 9.9 5.2 1.5 6.0 0.0 10.4 0.9 18.0 7.5 1.9 2.2 2.5 1.1 9.1 8.4 1.2 18.1 2.0 2.2 2.6 14.9 3.1 2.0 26.0 8.1 6.1 1.1 28.6 0.0 1.9 7.7 0.0 18.6 43.9 3.5 7.8 23.1 16.0 2.8 9.5 18.7 9.2 4.5 9.5 3.0 4.6 15.4 46.1 6.2 1.8 1.5 0.2 23.4 0.0 7.0 12.9 8.2 15.1 15.9 6.8 1.4 25.0 12.7 13.3 8.4 NEK6 SID6-1512 ENSG00000119408 "NIMA related kinase 6" Q9HC98 9 124257606-124353307 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 250.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045993, HPA056828" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Cytosol" "Centriolar satellite" "CAB045993: AB_2150651, HPA056828: AB_2683250" "unprognostic (6.27e-2)" "unprognostic (1.02e-2)" "unprognostic (4.15e-2)" "unprognostic (1.65e-2)" "unprognostic (5.22e-2)" "unprognostic (2.47e-2)" "unprognostic (3.13e-3)" "unprognostic (2.13e-2)" "unprognostic (2.38e-1)" "unprognostic (3.30e-2)" "unprognostic (1.38e-3)" "unprognostic (6.53e-2)" "unprognostic (5.03e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (5.27e-2)" "unprognostic (4.77e-3)" 18.1 6.2 32.8 32.9 35.6 19.7 14.9 28.7 34.7 26.3 25.5 22.5 17.6 12.3 3.4 8.6 11.3 25.6 7.5 30.9 41.5 17.4 68.8 24.5 27.7 50.4 35.0 24.3 9.1 16.8 1.9 6.2 30.5 31.7 19.7 22.7 11.4 20.8 16.9 8.2 5.2 26.0 18.9 34.7 16.7 27.3 7.9 39.9 10.3 7.3 3.1 32.0 24.6 6.4 37.2 31.8 50.0 47.8 18.8 88.3 113.9 59.3 38.8 61.1 58.4 48.4 47.7 57.0 38.2 61.0 74.6 133.2 5.9 24.7 111.7 39.4 43.7 21.8 104.4 42.1 85.4 105.2 19.4 250.0 152.8 17.8 55.4 56.9 152.3 64.3 17.6 19.5 1.7 105.6 32.6 0.9 20.8 12.2 163.7 45.5 40.6 35.6 19.6 62.6 11.4 21.4 7.5 12.6 23.6 54.5 48.3 51.4 76.4 127.5 42.2 42.8 29.5 26.7 8.4 11.4 21.6 53.5 42.3 57.5 28.1 47.6 76.4 9.2 32.1 5.9 52.5 5.5 7.8 29.0 30.2 0.9 3.8 58.8 23.3 41.4 26.9 7.6 21.6 32.8 35.6 28.7 34.7 30.9 41.5 50.4 35.0 24.3 31.7 34.7 39.9 37.2 8.4 9.6 4.7 37.9 24.5 2.4 13.8 18.9 4.6 1.0 9.4 6.5 3.3 18.6 8.8 3.7 0.0 47.1 11.3 8.5 1.9 41.3 18.2 9.4 17.7 8.4 6.0 4.0 8.3 23.3 121.0 11.1 19.4 22.2 22.2 1.1 5.0 43.5 112.0 0.0 5.3 18.2 18.3 10.4 22.5 20.0 5.0 31.2 7.2 12.2 57.7 34.6 8.2 15.1 2.4 30.6 11.9 3.8 5.5 17.1 17.2 38.0 3.3 2.1 0.0 4.9 6.4 1.3 17.1 2.4 1.1 36.1 4.5 2.1 18.7 10.2 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 451.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 21 "plasmacytoid DC: 4.4" "Lineage enriched" "Detected in single" 21 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 3.8" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.3 3.1 3.5 2.6 10.5 6.0 14.8 5.7 3.9 6.5 1.1 12.1 8.9 1.1 11.0 30.4 4.4 4.5 1.5 2.2 3.0 11.4 0.8 5.7 0.9 3.0 4.3 2.7 0.0 42.1 451.1 8.4 1.7 4.6 5.1 11.1 6.9 82.3 4.5 0.0 25.3 7.0 0.7 1.3 0.5 24.9 2.8 5.6 1.8 30.6 0.1 3.1 3.1 7.6 2.2 41.8 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 8.6 25.9 0.0 0.4 0.0 0.0 3.6 0.4 0.0 0.0 4.6 3.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.3 0.0 0.0 62.0 0.7 0.0 1.0 70.9 0.0 0.9 0.0 32.3 4.0 8.8 13.7 0.0 0.0 29.9 0.0 1.7 30.3 4.3 0.0 0.0 0.0 0.1 0.0 9.7 13.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.4 0.0 0.0 3.5 10.5 5.7 3.9 2.2 3.0 3.0 4.3 2.7 4.6 1.3 5.6 2.2 0.3 6.4 6.9 0.0 2.5 1.0 2.0 4.4 0.0 1.8 61.9 31.2 2.8 17.2 9.5 27.6 6.2 9.2 9.9 20.8 39.2 66.8 0.5 11.3 1.6 0.9 20.4 15.6 1.0 65.8 1.1 0.7 21.4 17.3 3.8 1.5 0.0 0.8 1.4 0.0 3.2 19.1 12.2 0.3 0.3 0.6 0.0 0.5 10.6 0.0 1.0 0.8 3.1 0.5 0.2 48.6 14.5 0.0 2.5 13.8 13.5 21.2 9.7 12.1 0.0 0.0 1.7 0.6 4.3 26.4 14.2 6.7 1.3 0.1 24.9 17.7 PPP6C PP6 ENSG00000119414 "Protein phosphatase 6 catalytic subunit" O00743 9 125146573-125189939 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Immunity, Innate immunity" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050940 Uncertain NA NA "HPA050940: AB_2681283" "unprognostic (6.45e-2)" "unprognostic (4.01e-3)" "unprognostic (7.12e-2)" "unprognostic (5.36e-2)" "unprognostic (2.78e-2)" "unprognostic (2.92e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (2.14e-1)" "unprognostic (2.44e-1)" "unprognostic (1.71e-2)" "unprognostic (2.28e-2)" "prognostic favorable (4.50e-6)" "unprognostic (1.54e-2)" "unprognostic (3.51e-1)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" 33.1 25.5 23.0 24.6 24.6 42.5 30.2 24.2 27.2 23.0 20.5 28.7 20.6 19.9 23.9 25.3 18.7 18.7 21.8 23.1 26.5 32.9 25.3 24.2 31.1 23.0 22.7 21.6 19.8 27.9 32.9 14.8 19.7 23.4 20.4 31.2 17.7 26.4 19.9 70.5 23.7 22.7 22.0 24.0 27.9 21.1 28.3 23.0 39.3 31.8 54.0 36.5 23.1 18.9 28.8 32.6 23.4 41.6 39.3 43.6 36.2 41.8 33.7 36.5 48.7 40.4 37.6 33.5 46.5 25.5 45.6 41.3 64.7 56.8 36.7 56.2 42.0 27.3 38.3 33.5 33.6 35.7 67.6 50.8 30.0 49.2 40.1 38.1 37.5 46.2 52.6 45.7 52.2 53.3 48.6 64.0 42.5 38.8 90.4 42.8 51.5 62.7 62.2 42.1 32.3 42.8 42.3 60.3 47.8 41.0 35.0 74.0 42.0 45.3 29.7 28.4 58.4 45.5 57.5 112.4 62.3 40.1 43.5 49.4 61.7 21.8 35.9 22.4 28.6 27.2 26.8 28.2 25.3 24.0 20.2 27.6 26.5 50.9 23.7 33.6 17.2 38.9 25.8 23.0 24.6 24.2 27.2 23.1 26.5 23.0 22.7 21.6 23.4 24.0 23.0 28.8 39.8 41.7 37.8 20.5 62.6 77.4 55.5 64.0 60.3 14.0 42.5 28.3 37.9 31.5 43.1 27.6 8.4 45.7 43.7 47.5 56.7 46.3 130.5 22.7 21.5 44.8 47.9 60.2 35.3 55.2 57.5 37.2 34.1 24.7 45.0 20.4 48.5 41.7 52.3 15.2 30.0 43.0 67.1 61.2 60.9 83.3 29.8 51.8 44.4 32.8 60.0 29.2 40.2 22.6 35.8 48.2 37.4 36.1 82.7 47.2 43.7 79.1 34.3 12.5 52.6 28.7 46.1 124.8 48.3 76.8 87.5 87.2 57.1 23.2 43.9 59.8 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159779 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 383.7;tongue: 366.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 579.5;Distal tubular cells: 614.3;Early spermatids: 499.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria NA NA 25000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favorable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 54.6 74.8 145.1 34.2 148.2 28.9 54.5 150.4 160.6 45.2 143.9 90.9 66.4 46.9 87.6 57.7 62.9 39.6 383.7 147.1 150.8 98.8 82.2 37.3 43.4 146.0 143.3 145.6 36.0 46.5 138.6 57.4 48.6 146.0 58.4 89.1 72.6 73.0 62.5 261.5 44.3 54.0 74.6 142.5 41.7 75.9 96.2 149.1 49.0 53.7 366.5 56.7 58.4 41.2 149.7 84.8 154.1 99.5 132.0 105.7 96.4 123.3 96.0 114.1 130.0 108.5 197.0 81.9 123.1 92.6 113.6 234.6 206.8 191.3 208.7 127.0 121.5 132.6 96.9 254.2 172.6 113.3 172.7 95.5 106.1 200.3 130.0 82.9 118.1 189.1 134.8 151.0 89.6 150.3 215.6 108.1 112.1 91.2 377.1 293.1 85.0 156.7 179.4 189.4 116.0 172.1 67.6 151.0 176.7 122.6 100.9 187.6 82.1 123.2 71.2 70.9 135.2 109.3 100.1 176.1 123.8 148.0 110.7 120.2 17.4 82.1 66.8 78.3 100.9 76.2 88.0 71.3 77.3 109.2 92.8 76.0 80.3 13.7 79.0 88.7 114.2 91.9 74.7 145.1 148.2 150.4 160.6 147.1 150.8 146.0 143.3 145.6 146.0 142.5 149.1 149.7 70.6 28.9 40.4 16.3 38.6 48.3 73.8 298.1 43.9 47.2 61.0 73.5 579.5 48.6 128.0 82.8 29.2 130.5 34.1 87.3 614.3 103.8 499.0 80.1 52.4 98.5 77.4 100.6 19.4 101.6 113.1 70.3 47.9 52.9 20.3 68.5 60.7 110.9 124.4 45.4 26.0 105.7 185.1 40.5 42.0 121.1 56.5 48.8 94.3 18.7 72.9 91.3 65.9 14.1 17.9 100.8 80.3 75.2 56.9 91.1 163.4 249.8 113.0 59.0 26.3 52.5 114.8 294.9 116.2 67.0 56.8 126.6 36.6 104.4 136.3 86.4 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 157.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 73.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favorable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favorable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 10.9 157.7 15.8 11.2 15.8 8.5 19.7 14.4 19.5 18.8 12.6 41.7 83.6 13.6 15.0 42.5 16.7 18.0 20.0 14.3 15.3 56.0 123.8 10.3 10.3 14.1 14.9 14.9 20.0 53.4 69.0 23.3 5.1 14.2 30.7 36.2 8.1 52.7 16.3 8.8 27.7 69.1 7.8 13.9 17.7 50.5 7.1 15.6 6.8 39.1 5.8 7.7 17.7 21.2 13.7 7.4 20.8 4.4 12.3 10.7 4.7 37.0 5.4 10.1 8.6 9.3 38.3 36.1 16.2 6.6 3.0 17.0 28.3 7.0 8.3 2.9 22.9 16.1 22.4 12.5 24.1 12.5 1.4 16.6 7.4 17.4 7.0 19.7 9.9 4.5 14.9 18.0 4.0 4.1 48.3 10.4 6.5 9.9 73.7 16.1 8.5 0.0 13.2 11.0 15.4 11.1 7.0 9.3 39.4 14.0 9.5 24.8 4.7 4.5 1.7 0.1 1.4 1.9 9.7 20.2 6.8 2.1 0.1 1.3 0.2 3.7 8.2 12.4 2.1 14.0 14.8 14.2 11.5 6.1 16.6 14.5 11.1 2.4 8.2 0.2 14.1 17.1 8.5 15.8 15.8 14.4 19.5 14.3 15.3 14.1 14.9 14.9 14.2 13.9 15.6 13.7 4.1 9.6 10.1 24.5 19.7 9.9 20.6 26.6 10.8 10.3 38.6 31.2 15.8 80.1 32.6 23.9 10.4 29.4 11.7 214.0 86.1 84.8 0.2 20.9 6.4 9.4 40.3 15.4 9.2 156.4 16.5 8.6 112.7 22.3 7.6 122.4 9.7 85.4 20.6 1.7 10.4 80.4 28.5 6.5 3.7 2.0 14.3 6.9 10.6 6.5 13.7 12.1 15.5 5.5 4.9 104.8 208.6 9.1 9.3 23.7 254.0 275.1 33.3 13.8 6.6 5.5 11.1 0.3 6.0 42.9 14.6 31.6 14.0 26.0 94.6 51.4 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237622-122264840 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Enhanced "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA057281: AB_2683394, HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favorable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 9.1 9.6 8.4 6.5 9.0 11.9 16.6 8.9 9.8 9.0 8.4 7.2 7.0 8.9 10.3 7.8 7.4 7.7 13.6 9.0 9.9 11.5 8.4 7.2 8.1 9.2 9.4 8.5 9.6 7.0 11.9 5.7 10.5 9.5 11.2 8.2 11.6 8.0 8.4 20.9 6.8 6.2 8.7 9.1 8.0 8.6 3.7 9.0 9.6 10.1 23.3 7.7 8.8 5.4 9.6 8.1 8.3 11.2 12.4 16.1 19.8 9.7 18.0 14.7 12.1 11.2 9.6 7.8 14.1 7.7 11.8 13.3 18.5 17.6 18.7 15.1 14.5 8.0 10.5 12.6 8.2 18.1 21.1 14.0 17.0 20.8 12.7 25.8 12.1 17.6 11.3 14.6 10.7 18.3 8.8 11.1 13.0 8.7 27.2 13.7 9.7 23.2 19.3 16.9 9.0 23.3 12.3 13.6 18.9 21.3 8.8 11.0 11.8 9.8 11.3 6.4 18.3 18.0 15.5 30.7 11.7 18.6 12.9 13.8 4.5 6.2 11.4 6.3 7.2 6.1 5.8 5.5 6.2 6.5 4.0 5.7 6.0 6.5 5.4 9.7 4.6 6.4 5.8 8.4 9.0 8.9 9.8 9.0 9.9 9.2 9.4 8.5 9.5 9.1 9.0 9.6 19.7 32.1 12.8 2.0 18.3 21.7 11.7 28.5 19.9 12.4 27.2 20.7 51.6 10.0 23.1 25.8 2.1 32.8 23.3 17.2 27.4 23.2 75.0 14.7 19.9 21.6 19.7 28.4 9.1 16.2 44.7 15.9 13.3 16.4 17.7 14.1 13.6 13.7 27.7 3.3 12.9 16.5 34.6 21.0 17.2 76.9 13.4 18.4 19.6 4.7 20.6 16.9 27.8 6.0 10.7 23.0 18.7 17.0 16.4 20.8 14.8 26.6 19.8 14.7 19.7 15.2 25.4 19.7 22.1 16.5 25.9 56.9 23.5 16.7 14.2 20.7 SLC46A2 "Ly110, TSCOT" ENSG00000119457 "Solute carrier family 46 member 2" Q9BY10 9 112878920-112890876 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 16.6;lung: 10.5;lymphoid tissue: 16.2;skin 1: 22.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 39.8;Endometrial ciliated cells: 15.8;Glandular and luminal cells: 6.9;Kupffer cells: 11.8;monocytes: 12.4" "Cancer enhanced" "Detected in some" "lung cancer: 1.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 24.6;intermediate monocyte: 12.1" "Lineage enriched" "Detected in many" 5 "monocytes: 24.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA020098 Approved NA NA "HPA020098: AB_2670363" "unprognostic (1.26e-1)" "unprognostic (5.15e-3)" "unprognostic (1.10e-2)" "unprognostic (1.53e-3)" "unprognostic (3.57e-3)" "unprognostic (2.10e-2)" "unprognostic (4.56e-1)" "unprognostic (2.18e-1)" "unprognostic (8.10e-2)" "unprognostic (1.50e-3)" "unprognostic (3.50e-1)" "unprognostic (1.38e-1)" "unprognostic (1.77e-2)" "unprognostic (2.37e-1)" "unprognostic (2.71e-2)" "unprognostic (1.83e-1)" "unprognostic (7.82e-2)" 0.1 0.0 0.1 0.6 0.2 0.1 0.9 0.5 0.4 16.6 0.0 0.0 0.0 3.1 4.8 1.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 10.5 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 1.5 0.0 22.3 0.0 0.4 0.1 0.9 0.0 0.6 0.3 16.2 0.0 0.0 0.1 3.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.1 12.1 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.3 0.0 10.1 0.2 0.0 6.6 0.1 0.2 0.5 0.4 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.2 0.0 0.0 39.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 15.8 0.8 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 6.9 0.0 0.0 0.4 0.1 2.1 0.0 0.4 0.0 0.0 11.8 1.8 4.4 0.0 4.1 0.0 0.0 12.4 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112380080-112472405 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 182.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 214.8;Early spermatids: 153.9;Granulosa cells: 187.2;Late spermatids: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favorable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favorable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 76.9 64.3 28.9 13.4 30.0 11.7 23.0 27.1 29.7 23.5 27.5 32.0 39.3 23.0 11.6 30.1 21.4 19.1 81.0 26.3 33.7 69.7 150.2 29.0 14.0 33.1 31.5 22.8 51.3 20.2 22.0 8.9 16.9 30.7 20.5 27.2 12.7 18.9 16.0 153.2 31.3 32.4 20.6 27.3 18.8 24.8 14.1 31.1 19.8 30.7 182.9 16.0 29.5 15.1 29.3 45.0 39.4 29.0 14.8 49.0 48.4 33.4 30.1 18.6 21.1 17.7 77.0 49.4 28.5 16.2 44.4 26.9 50.6 31.9 42.2 25.8 120.9 21.0 30.0 58.5 76.1 30.7 17.1 18.5 52.0 29.9 31.3 22.8 30.5 24.8 34.7 42.3 18.9 58.2 29.6 42.5 15.3 17.2 106.9 50.3 27.1 87.4 42.7 44.5 40.4 20.7 14.5 75.8 49.5 26.0 23.7 70.0 20.0 28.3 30.2 27.9 85.2 29.6 21.5 57.3 13.5 37.0 24.8 18.2 54.3 8.4 32.8 4.6 8.1 6.8 6.9 4.8 5.0 9.5 8.4 5.6 5.9 48.0 5.9 11.5 9.4 8.7 4.9 28.9 30.0 27.1 29.7 26.3 33.7 33.1 31.5 22.8 30.7 27.3 31.1 29.3 32.0 99.3 84.3 48.6 14.1 13.3 17.5 21.6 29.6 9.3 12.0 13.3 214.8 14.3 32.2 14.7 6.2 26.5 18.3 23.7 64.6 15.5 153.9 38.6 38.3 19.1 14.9 32.8 10.8 18.7 30.9 31.1 29.0 27.8 30.4 187.2 17.2 124.2 35.7 6.7 12.2 32.2 8.2 23.6 12.5 163.0 27.4 27.5 8.8 15.9 47.3 24.1 6.2 16.1 19.3 13.2 23.5 47.0 20.9 16.0 52.4 111.1 37.7 14.5 46.0 18.1 46.9 12.9 16.4 34.2 16.2 31.7 16.2 108.9 36.2 29.5 MAPKAP1 "MGC2745, MIP1, SIN1" ENSG00000119487 "MAPK associated protein 1" Q9BPZ7 9 125437393-125707234 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029091, HPA029092" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029091: AB_10599732, HPA029092: AB_10601568" "unprognostic (6.65e-2)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (5.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.68e-1)" "unprognostic (8.94e-2)" "unprognostic (2.59e-1)" "unprognostic (8.08e-2)" "prognostic favorable (7.23e-6)" "unprognostic (1.66e-1)" "unprognostic (2.04e-1)" "unprognostic (2.98e-1)" "unprognostic (4.27e-2)" 43.3 47.5 41.3 37.0 45.9 35.0 33.1 37.2 46.0 36.7 41.8 40.2 30.7 29.3 36.2 44.4 29.5 28.3 59.8 41.4 39.9 48.5 46.4 30.4 35.0 46.1 43.5 38.7 26.3 37.2 53.7 19.3 30.4 39.1 30.6 38.8 43.3 42.5 36.4 104.7 26.2 32.9 46.7 40.9 29.1 36.5 42.3 47.3 37.0 47.9 77.0 38.3 39.7 31.9 39.0 87.4 97.1 64.3 68.3 86.7 82.2 107.9 108.6 110.0 82.0 57.2 97.9 94.9 89.1 65.9 151.6 89.7 119.1 99.5 126.9 110.8 101.8 41.1 64.3 111.9 95.1 97.3 116.0 72.1 80.9 114.6 117.0 121.7 91.2 123.0 85.8 103.6 67.7 176.4 180.3 87.5 46.8 102.4 204.3 122.0 72.4 152.0 119.3 90.2 62.3 77.9 76.7 109.7 100.9 70.0 86.6 115.8 67.1 79.7 115.3 76.1 140.5 182.5 86.1 225.2 89.9 165.5 52.5 127.6 4.4 6.1 5.7 4.3 6.0 5.9 8.2 4.7 4.8 4.9 7.4 4.1 7.1 19.1 5.8 5.6 7.2 5.8 2.5 41.3 45.9 37.2 46.0 41.4 39.9 46.1 43.5 38.7 39.1 40.9 47.3 39.0 22.3 12.8 17.0 64.6 33.5 15.8 30.2 15.3 25.6 25.6 30.6 24.1 68.3 22.8 27.5 14.7 41.7 35.4 31.7 28.9 54.8 48.3 80.2 26.2 42.6 27.1 9.6 22.3 82.6 65.6 50.9 27.0 32.1 29.3 17.7 31.2 19.6 34.5 50.7 32.0 80.1 20.8 22.4 29.5 23.4 116.9 19.0 37.3 23.2 59.0 55.1 30.1 35.0 97.0 96.4 59.2 20.1 17.7 32.3 45.2 27.2 84.6 14.6 26.2 6.6 29.1 33.0 75.4 71.4 29.1 19.5 50.9 29.5 38.4 27.6 37.8 NR4A3 "CHN, CSMF, MINOR, NOR1" ENSG00000119508 "Nuclear receptor subfamily 4 group A member 3" Q92570 9 99821855-99866891 "Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 305.7;Langerhans cells: 417.5;Macrophages: 172.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "hypothalamus: 99.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BJ hTERT+: 24.1;HeLa: 8.0;SK-MEL-30: 18.5;U-266/70: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043360 Uncertain NA NA "HPA043360: AB_10961186" "prognostic favorable (5.97e-4)" "unprognostic (6.92e-3)" "unprognostic (5.34e-2)" "unprognostic (2.78e-3)" "unprognostic (1.40e-1)" "unprognostic (9.46e-2)" "unprognostic (2.89e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-3)" "unprognostic (1.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.30e-1)" "unprognostic (2.25e-1)" "unprognostic (1.29e-3)" "unprognostic (6.11e-2)" "unprognostic (2.80e-2)" "unprognostic (1.69e-1)" 23.2 61.8 3.1 15.0 6.7 33.0 7.5 12.5 9.7 11.5 4.2 8.5 0.7 15.8 0.7 4.0 25.0 23.7 42.0 8.7 99.0 7.7 9.1 19.8 1.3 7.4 2.1 2.2 47.2 5.2 3.0 21.3 6.6 3.8 15.7 4.1 8.8 2.4 3.4 63.3 2.4 5.9 13.5 1.9 3.5 13.9 1.1 3.6 6.6 7.3 6.3 0.9 33.1 5.2 6.3 0.1 0.1 0.7 0.1 1.3 0.4 1.1 1.5 24.1 0.2 0.2 0.2 0.1 0.2 0.3 0.7 0.5 0.1 0.5 0.0 0.1 1.8 0.3 0.1 8.0 0.0 0.2 0.1 2.3 0.3 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.7 0.0 0.2 0.0 0.2 0.6 0.0 1.1 0.0 0.0 0.1 0.4 0.4 2.7 2.0 18.5 0.2 0.0 0.0 0.1 1.4 0.4 1.8 0.1 9.2 0.1 0.0 0.9 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.1 6.7 12.5 9.7 8.7 99.0 7.4 2.1 2.2 3.8 1.9 3.6 6.3 9.6 12.8 19.7 3.9 101.5 79.5 14.0 3.5 97.9 0.9 44.2 58.5 305.7 4.3 10.0 16.5 10.4 2.3 91.3 2.0 0.0 0.1 1.4 93.1 12.8 16.2 27.3 0.4 13.1 1.7 2.2 60.3 32.6 124.3 120.7 1.2 7.5 0.5 10.5 0.0 6.2 3.8 2.0 12.3 417.5 2.4 1.5 172.8 88.9 2.8 43.0 3.6 1.0 1.5 0.9 0.2 2.3 1.2 37.9 4.7 0.6 0.1 11.4 1.7 0.0 35.7 75.0 1.1 1.6 15.9 59.5 5.6 69.6 1.0 1.7 3.4 INVS NPHP2 ENSG00000119509 Inversin Q9Y283 9 100099243-100302175 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Calmodulin-binding, Developmental protein" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 132.9;Excitatory neurons: 144.8;Inhibitory neurons: 142.8;Microglial cells: 112.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049994 Approved Cytosol NA NA Cytosol "HPA049994: " "unprognostic (3.84e-3)" "unprognostic (3.11e-2)" "unprognostic (1.74e-1)" "unprognostic (2.86e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.53e-3)" "unprognostic (2.93e-3)" "unprognostic (1.99e-1)" "unprognostic (6.46e-2)" "unprognostic (1.15e-1)" "unprognostic (3.56e-2)" "unprognostic (1.34e-3)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (6.37e-2)" "unprognostic (1.83e-1)" 6.2 6.2 4.9 4.3 6.9 4.7 5.1 6.9 5.7 7.3 6.5 5.1 4.1 7.1 6.3 4.4 5.7 5.4 4.3 3.9 5.3 8.8 9.5 5.3 5.8 6.3 5.6 3.7 9.8 4.7 9.8 6.8 5.9 6.4 6.2 4.7 11.9 4.3 5.2 3.7 3.5 4.7 6.2 4.9 5.2 4.4 6.6 5.9 7.8 6.6 4.2 5.8 5.4 6.0 11.5 7.4 13.2 11.0 11.7 13.3 10.7 9.2 8.6 9.0 7.5 6.1 6.7 4.5 17.3 4.9 10.0 13.7 11.1 8.8 11.3 6.1 13.3 6.0 13.0 12.4 7.3 10.0 13.1 10.4 11.2 13.1 7.8 15.8 10.1 13.7 11.7 11.4 10.4 7.8 6.4 10.4 5.1 6.4 13.5 7.6 9.3 19.3 3.9 7.0 6.9 10.0 7.9 9.7 5.8 9.9 8.9 4.1 7.2 10.2 8.7 6.3 9.0 6.5 10.5 13.2 3.5 9.2 5.4 4.8 0.0 1.2 1.9 2.2 0.8 1.9 2.6 1.9 1.2 1.7 2.5 2.4 2.4 0.1 2.5 2.1 1.7 1.2 1.3 4.9 6.9 6.9 5.7 3.9 5.3 6.3 5.6 3.7 6.4 4.9 5.9 11.5 5.8 3.2 4.1 132.9 7.1 1.8 7.0 1.5 12.0 4.8 1.7 2.4 2.9 7.2 2.7 0.0 8.4 4.4 5.4 1.4 3.9 2.7 21.5 3.2 7.8 4.8 1.2 6.5 144.8 1.1 3.9 6.0 8.6 3.3 1.3 7.8 1.1 4.0 3.6 6.7 142.8 1.5 2.0 2.2 1.0 35.6 4.7 4.0 0.0 112.4 2.6 2.5 9.2 144.3 233.9 1.5 2.0 3.4 7.4 2.9 2.7 5.8 0.7 5.8 0.0 6.4 4.4 11.0 4.7 5.0 1.6 3.4 6.3 5.3 1.3 4.1 GALNT12 GalNAc-T12 ENSG00000119514 "Polypeptide N-acetylgalactosaminyltransferase 12" Q8IXK2 9 98807670-98850081 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 75.4;intestine: 56.3;stomach 1: 55.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 128.4;U-2197: 160.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA048292, HPA071076" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 47000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA048292: AB_2680343, HPA071076: " "unprognostic (7.85e-3)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (1.47e-2)" "unprognostic (2.97e-3)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.61e-2)" "unprognostic (7.71e-2)" "prognostic favorable (3.24e-4)" "unprognostic (9.05e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-3)" "unprognostic (6.87e-2)" 3.9 2.0 1.3 7.7 1.4 2.2 3.4 6.5 1.8 8.8 3.9 55.8 34.5 3.7 75.4 19.7 7.5 10.6 1.0 1.3 2.6 4.9 0.4 11.8 3.2 2.6 1.9 1.2 0.4 13.7 6.4 3.5 2.7 3.7 4.6 56.3 0.6 25.7 4.3 1.3 3.0 27.4 14.1 1.2 2.3 55.3 4.7 1.5 3.3 14.8 0.6 6.1 12.0 4.7 2.0 5.4 4.1 3.4 13.5 10.0 7.8 0.0 1.4 2.1 2.0 4.6 0.8 21.6 0.0 5.0 0.9 12.2 38.0 2.9 1.3 1.6 26.2 1.7 2.4 0.2 0.0 0.5 1.6 0.5 3.8 0.9 6.4 0.0 2.7 2.3 19.3 30.2 0.0 0.6 13.9 2.6 4.7 16.7 128.4 5.6 6.5 0.3 0.1 2.3 7.7 12.4 1.1 0.5 30.6 3.0 7.7 4.5 4.5 4.3 0.0 0.3 160.9 0.0 2.1 4.8 2.3 37.1 0.0 0.9 0.0 0.0 0.5 0.3 0.0 0.6 0.0 0.4 0.2 0.0 0.1 0.6 0.3 0.0 0.6 0.0 0.1 0.0 0.1 1.3 1.4 6.5 1.8 1.3 2.6 2.6 1.9 1.2 3.7 1.2 1.5 2.0 1.3 3.2 25.7 2.0 2.3 2.4 1.3 8.3 1.2 2.4 0.4 0.1 1.0 18.6 16.9 11.0 16.7 1.0 2.6 101.2 0.0 11.2 1.8 4.8 1.6 1.6 19.9 1.3 7.4 25.4 1.7 12.5 32.1 8.7 2.5 2.4 0.0 0.0 2.3 0.0 5.7 142.4 2.0 0.3 3.9 1.4 2.1 3.9 0.0 3.7 0.2 0.8 3.1 3.5 7.0 32.0 36.5 7.5 1.7 7.4 21.9 2.7 16.9 0.2 0.0 0.7 1.5 5.9 10.5 9.9 1.3 1.1 4.5 5.1 42.5 11.1 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favorable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 8.3 8.4 8.3 10.4 8.5 27.2 7.2 3.0 10.4 7.7 6.2 10.7 11.4 8.4 4.6 7.8 8.8 7.3 7.2 8.4 7.3 11.5 10.9 7.0 9.1 5.9 5.8 7.3 8.0 6.3 12.0 10.3 11.4 6.0 7.8 9.7 10.4 6.1 7.7 8.5 6.5 12.7 10.0 5.0 14.3 7.0 9.6 5.9 7.1 10.9 4.8 6.3 7.6 6.5 6.2 29.0 16.7 14.7 28.0 9.8 15.3 68.3 27.4 41.0 22.9 19.6 23.0 12.5 23.1 5.5 22.3 30.1 15.9 12.6 19.9 22.2 9.8 9.7 10.9 39.1 17.1 13.2 13.2 7.0 14.2 17.6 18.9 32.2 8.0 20.6 21.8 30.3 17.2 18.7 16.5 15.8 19.1 29.4 33.1 25.2 24.3 14.4 19.5 11.4 10.1 31.1 25.3 22.1 14.4 16.9 9.6 19.8 32.8 9.7 24.5 9.4 28.9 14.6 26.0 21.7 16.0 20.6 25.9 16.5 20.4 21.1 4.3 1.8 14.6 0.9 1.7 1.3 0.8 12.1 1.8 0.8 1.0 12.8 0.8 12.8 1.9 0.6 5.3 8.3 8.5 3.0 10.4 8.4 7.3 5.9 5.8 7.3 6.0 5.0 5.9 6.2 6.4 0.0 1.5 258.9 10.0 5.1 2.6 2.5 1.8 16.1 4.8 4.3 7.7 7.2 1.7 16.5 16.7 10.0 6.8 25.3 5.9 4.3 35.1 5.0 8.2 10.5 12.0 20.2 188.2 5.1 32.2 7.6 20.9 3.9 4.5 8.8 7.5 14.5 18.0 32.0 175.8 7.6 2.0 21.4 8.2 88.5 14.6 18.7 3.6 178.0 18.7 11.6 5.2 165.4 145.2 6.1 9.5 11.3 13.1 5.3 18.3 16.0 2.9 13.1 0.0 6.7 5.9 3.8 1.4 3.8 2.8 8.8 5.3 4.5 7.8 3.9 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2 alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216425-99221942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Approved "Golgi apparatus" NA No "Golgi apparatus" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favorable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 17.9 38.6 14.5 19.5 15.5 23.2 27.3 17.5 17.4 35.4 19.6 25.1 22.1 24.0 74.7 15.2 29.7 26.4 13.5 15.3 19.6 34.6 47.7 24.5 20.9 15.7 16.4 14.0 30.5 42.4 37.3 22.0 30.2 16.0 33.1 27.6 15.1 38.2 34.9 15.4 18.1 20.7 24.4 15.9 18.1 25.2 19.3 16.2 16.8 42.7 13.6 27.7 32.0 11.0 17.8 22.9 28.7 22.7 34.4 82.6 52.7 42.0 46.7 75.3 45.6 39.3 34.9 31.2 24.6 18.8 54.3 60.0 85.3 37.9 49.1 45.7 35.2 16.2 14.4 23.7 54.0 99.7 28.2 26.2 61.9 65.2 37.7 72.8 45.8 52.3 15.1 23.2 56.2 44.7 47.8 12.9 29.8 27.6 75.0 39.6 14.0 43.4 38.1 65.2 31.1 22.5 19.3 33.5 63.8 61.6 33.5 24.4 23.3 38.8 31.4 27.9 40.9 28.6 45.8 28.0 10.5 58.6 20.5 16.3 38.7 35.5 22.0 33.7 28.2 49.2 30.8 32.0 33.9 45.1 26.3 27.7 27.4 9.3 38.0 28.4 79.9 38.3 36.0 14.5 15.5 17.5 17.4 15.3 19.6 15.7 16.4 14.0 16.0 15.9 16.2 17.8 12.6 12.8 22.9 6.8 22.1 23.3 26.8 56.2 10.2 11.3 22.6 16.6 6.9 32.9 35.8 23.9 2.1 50.3 30.2 20.0 21.5 36.1 28.7 16.9 30.9 19.8 12.5 12.0 8.1 35.2 34.2 30.4 15.3 26.4 7.6 14.1 21.8 55.5 28.1 10.1 8.3 26.3 38.7 25.8 45.4 20.3 26.8 23.0 21.4 10.3 64.2 15.5 15.5 9.5 9.7 31.9 16.0 25.2 47.0 37.3 18.7 36.6 33.1 8.3 6.6 17.2 18.2 22.6 24.6 15.0 23.7 89.2 16.6 25.6 20.8 31.3 CSF3R "CD114, GCSFR" ENSG00000119535 "Colony stimulating factor 3 receptor" Q99062 1 36466043-36483278 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 383.2;lung: 137.9;lymphoid tissue: 378.6;placenta: 106.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 230.8;Cytotrophoblasts: 423.8;Kupffer cells: 177.7;monocytes: 197.6;Syncytiotrophoblasts: 1194.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 1962.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 1962.3" "Group enriched" "Detected in some" 18 "BEWO: 70.8;NB-4: 20.3;THP-1: 50.3;U-937: 47.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017116, HPA048086" Enhanced "Intracellular and membrane" NA NA 150000 "CAB017116: , HPA048086: AB_2680257" "unprognostic (5.57e-3)" "unprognostic (8.05e-2)" "unprognostic (7.23e-2)" "unprognostic (3.87e-2)" "unprognostic (2.88e-1)" "unprognostic (2.92e-2)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (5.65e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (6.33e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (2.03e-1)" "unprognostic (2.31e-2)" 30.9 7.2 5.4 149.5 6.0 383.2 13.1 6.9 16.3 4.5 9.1 5.8 2.6 3.2 0.4 5.7 31.8 15.9 14.7 5.5 7.1 9.6 23.1 137.9 7.4 10.0 6.6 3.6 3.2 5.0 1.6 5.6 106.0 11.2 7.6 1.8 0.1 7.5 1.8 3.6 1.5 9.9 12.3 8.0 378.6 10.0 1.2 8.3 5.7 5.8 21.9 2.7 22.4 6.2 12.2 0.0 0.0 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 1.6 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.5 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 47.8 0.0 1.1 280.8 8.7 0.2 56.8 0.6 0.1 0.4 0.2 97.2 0.4 0.1 0.3 1962.3 3.4 24.1 3.3 0.6 158.4 5.4 6.0 6.9 16.3 5.5 7.1 10.0 6.6 3.6 11.2 8.0 8.3 12.2 0.7 25.6 230.8 0.0 3.3 1.0 0.5 0.0 0.0 0.0 5.9 4.7 1.8 0.0 10.0 0.0 0.0 423.8 2.9 0.0 0.0 0.0 0.4 0.3 6.4 4.8 0.0 4.6 0.2 0.0 47.3 8.0 1.5 0.2 18.9 1.1 3.9 1.2 64.1 0.0 0.2 0.0 0.0 177.7 39.2 0.7 0.3 111.5 0.0 77.8 197.6 0.2 6.2 0.5 0.3 0.1 0.0 0.0 0.7 0.3 0.0 0.5 6.6 0.2 0.0 0.3 1.0 0.0 0.4 0.2 0.1 1194.8 4.0 0.0 0.0 3.0 KDSR "DHSR, FVT1, SDR35C1" ENSG00000119537 "3-ketodihydrosphingosine reductase" Q06136 18 63327726-63367228 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Cancer-related genes, Disease variant, Palmoplantar keratoderma, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 90.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003673, HPA044884" Approved NA NA "CAB003673: AB_425440, HPA044884: AB_2679131" "unprognostic (4.44e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-2)" "unprognostic (4.56e-2)" "unprognostic (5.88e-3)" "unprognostic (7.50e-3)" "unprognostic (1.80e-2)" "unprognostic (2.66e-1)" "unprognostic (2.97e-1)" "unprognostic (1.97e-1)" "unprognostic (2.70e-2)" "unprognostic (6.81e-2)" "prognostic favorable (9.53e-6)" "unprognostic (3.32e-2)" "unprognostic (5.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-3)" 29.7 22.6 12.9 8.2 19.0 4.8 25.6 19.7 15.9 23.6 12.2 22.0 7.1 22.9 21.0 22.6 19.1 12.7 19.4 12.9 20.8 15.3 37.0 21.7 7.1 21.1 18.2 10.5 21.5 15.9 13.2 12.2 8.6 21.0 16.4 7.5 7.1 23.0 11.7 16.8 43.0 15.3 13.4 19.0 8.4 16.6 6.2 17.4 7.2 17.3 9.0 6.8 24.1 23.6 23.3 14.9 6.5 6.7 7.5 52.6 39.0 13.0 48.8 29.7 10.5 13.9 2.7 10.0 15.1 20.3 19.1 17.4 64.6 8.7 27.3 12.8 28.6 14.5 11.6 8.7 3.4 40.1 22.0 7.8 37.4 50.7 16.8 47.9 19.3 10.5 9.9 9.5 21.0 28.1 6.2 23.6 9.7 8.0 3.7 23.5 15.5 19.7 21.9 29.0 9.6 8.5 16.4 23.4 11.3 21.9 8.8 6.1 12.1 24.9 44.0 10.6 14.8 21.3 90.4 44.9 8.7 33.2 13.0 13.4 0.1 5.2 0.5 6.5 8.1 26.6 5.7 13.6 10.2 8.0 4.7 9.3 6.1 1.3 14.2 3.9 3.8 19.1 5.3 12.9 19.0 19.7 15.9 12.9 20.8 21.1 18.2 10.5 21.0 19.0 17.4 23.3 53.1 35.3 49.1 21.9 30.1 158.6 131.7 47.0 122.3 37.4 63.4 63.6 27.7 62.9 43.5 38.6 27.1 58.8 15.6 34.6 15.6 50.7 1.0 43.9 53.0 48.1 20.4 17.4 19.1 36.7 70.4 82.0 26.5 64.9 26.0 52.3 51.8 88.3 36.4 40.4 24.2 31.8 42.7 32.2 47.7 6.5 71.1 39.9 56.9 14.0 31.5 56.5 13.4 21.6 57.0 47.4 44.6 70.7 24.5 104.3 43.4 39.6 41.2 41.1 32.9 73.7 48.4 1.3 5.2 89.7 143.1 91.4 37.7 51.1 40.3 94.7 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" No No 32000 Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489" "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 24.4 18.5 11.7 25.7 13.7 53.0 29.1 13.7 17.0 23.0 10.5 42.7 35.4 22.9 19.7 76.1 18.8 23.9 16.4 11.5 14.8 24.0 28.7 24.0 31.5 17.1 14.9 10.3 19.5 17.4 28.0 11.6 29.0 14.8 23.6 37.4 7.1 24.9 19.7 11.1 32.5 36.7 21.2 13.6 29.0 32.8 12.2 13.6 31.7 28.8 13.1 39.4 30.4 31.3 18.4 57.1 21.9 22.4 24.5 33.5 47.1 38.9 48.6 45.5 36.4 39.2 15.7 39.4 54.1 31.2 35.7 30.9 119.6 26.8 53.1 47.5 40.6 22.3 27.6 27.8 23.7 48.6 94.5 56.8 43.1 80.3 32.3 56.2 36.5 33.9 31.0 14.3 49.4 52.1 20.2 59.9 29.2 23.2 22.7 32.3 48.8 47.2 52.4 45.6 66.2 38.2 33.6 36.9 35.4 55.3 28.3 34.2 50.5 52.8 55.4 27.3 21.6 32.7 163.6 86.5 69.3 31.9 44.0 42.3 163.6 54.6 125.0 52.2 56.5 49.0 64.8 54.3 54.2 46.2 73.4 48.2 51.1 185.9 68.4 76.5 45.6 66.7 56.6 11.7 13.7 13.7 17.0 11.5 14.8 17.1 14.9 10.3 14.8 13.6 13.6 18.4 52.0 115.4 57.4 21.5 62.4 68.8 47.2 66.5 44.9 37.0 54.4 46.0 39.5 47.1 72.4 33.1 22.9 70.0 92.2 142.0 45.0 48.0 113.3 92.2 74.0 44.6 45.5 27.8 27.3 42.1 56.7 51.0 47.4 145.5 59.3 37.7 36.8 55.8 46.4 43.7 29.6 76.8 67.1 58.8 33.0 15.5 49.0 58.0 32.0 18.7 53.4 39.2 76.2 18.6 49.5 91.3 120.7 36.5 42.1 43.1 61.8 57.9 85.1 31.5 59.2 45.6 54.7 30.1 29.4 87.5 83.4 140.4 67.4 56.5 72.6 79.5 ONECUT2 OC-2 ENSG00000119547 "One cut homeobox 2" O95948 18 57435374-57491298 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.1;gallbladder: 10.2;intestine: 10.2;liver: 8.5;retina: 5.5" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 964.0" "Group enriched" "Detected in many" 7 "liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4" "Region enhanced" "Detected in many" "basal ganglia: 7.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5" HPA057058 Enhanced Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA057058: AB_2683323" "unprognostic (3.02e-2)" "unprognostic (5.36e-2)" "unprognostic (9.06e-3)" "unprognostic (3.79e-5)" "unprognostic (1.13e-2)" "unprognostic (4.48e-4)" "unprognostic (2.10e-2)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (4.56e-3)" "unprognostic (8.66e-3)" "unprognostic (1.16e-2)" "unprognostic (5.34e-4)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.13e-1)" "unprognostic (3.21e-1)" 0.0 0.1 0.2 0.0 7.1 0.0 0.0 0.6 1.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 10.2 0.0 0.3 4.2 0.0 8.5 0.0 0.0 2.2 0.3 0.1 0.0 2.4 0.8 0.8 0.0 2.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.0 1.2 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 1.4 0.0 3.4 0.0 0.1 20.3 3.1 0.7 14.1 3.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.3 4.0 0.7 0.0 0.5 1.9 0.0 0.1 1.6 0.7 0.0 1.2 0.0 1.6 6.7 10.1 1.7 0.1 0.0 0.2 0.1 0.5 0.7 0.0 1.0 1.3 0.2 0.2 0.3 3.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.1 0.6 1.9 0.3 4.2 2.2 0.3 0.1 2.0 0.0 1.0 0.3 0.3 0.0 0.0 2.3 0.0 0.1 0.2 0.0 0.0 4.5 0.4 1.1 2.8 184.5 0.0 7.3 14.6 0.0 0.0 2.0 0.0 79.7 4.9 0.2 0.1 0.5 8.9 0.0 38.7 8.8 0.1 0.3 0.0 0.3 0.0 0.5 5.3 47.0 1.0 964.0 1.8 0.6 0.0 1.3 0.0 3.2 0.3 0.1 0.0 1.0 0.0 3.0 0.0 3.5 1.0 38.7 3.3 0.0 0.0 0.4 0.1 0.1 0.0 5.6 0.0 0.9 0.7 1.9 2.0 0.0 0.1 0.0 0.1 0.2 0.5 0.0 C19orf25 FLJ36666 ENSG00000119559 "Chromosome 19 open reading frame 25" Q9UFG5 19 1461143-1479219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050270, HPA067491" Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA050270: AB_2681069, HPA067491: AB_2685849" "unprognostic (5.82e-2)" "unprognostic (3.87e-2)" "unprognostic (6.51e-2)" "prognostic favorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (2.14e-3)" "prognostic unfavorable (3.81e-4)" "unprognostic (1.10e-2)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.35e-2)" "prognostic favorable (9.20e-8)" "unprognostic (3.50e-3)" "unprognostic (8.01e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 14.0 23.7 28.4 8.8 28.2 7.9 16.0 26.5 44.2 17.2 23.8 17.6 15.8 16.0 5.4 20.6 15.8 8.2 20.3 26.6 26.2 30.7 29.7 14.9 15.1 30.4 28.3 24.9 16.1 20.1 15.7 27.3 8.6 27.3 22.3 5.2 7.0 17.8 8.2 16.3 16.9 17.9 6.2 28.2 23.6 17.9 22.1 28.1 9.7 24.0 7.5 7.1 17.7 15.7 31.7 25.0 19.2 11.6 18.3 11.0 10.0 23.4 24.4 16.8 25.5 23.5 27.4 12.1 14.2 18.7 13.0 12.1 30.1 17.9 15.0 6.0 44.7 27.1 17.3 12.2 32.3 23.6 27.5 33.5 9.2 33.2 10.7 17.2 18.3 13.2 29.3 46.1 32.7 16.6 13.9 25.6 21.8 36.2 15.2 29.5 41.4 16.0 36.5 17.8 16.7 19.8 26.5 18.0 23.0 28.5 6.0 33.4 31.8 16.3 19.8 22.4 40.6 23.4 46.3 26.7 24.2 20.4 27.4 35.1 50.1 32.1 59.1 41.3 33.0 33.5 36.6 37.9 35.7 23.4 45.6 38.2 30.9 52.0 30.5 27.7 47.6 52.6 38.6 28.4 28.2 26.5 44.2 26.6 26.2 30.4 28.3 24.9 27.3 28.2 28.1 31.7 24.2 16.0 8.7 10.4 44.3 19.2 30.5 27.3 18.8 62.7 28.9 29.7 10.3 21.5 19.9 51.5 64.6 41.5 45.2 68.1 49.0 40.1 6.2 14.7 21.0 23.0 50.6 17.2 14.5 46.1 33.3 21.7 31.1 19.3 11.4 30.4 29.3 18.2 35.9 97.6 11.5 33.7 34.6 27.9 24.9 7.3 26.4 26.4 24.9 8.4 56.7 49.2 82.4 14.1 20.6 52.6 52.0 21.8 26.7 33.5 83.2 35.5 15.3 87.8 46.0 20.0 24.1 33.8 33.0 14.8 19.7 52.9 47.3 36.1 38.2 33.6 ZBTB45 "FLJ14486, ZNF499" ENSG00000119574 "Zinc finger and BTB domain containing 45" Q96K62 19 58513530-58538911 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035754, HPA075485" Uncertain Approved "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA035754: AB_10603461, HPA075485: " "unprognostic (1.38e-1)" "unprognostic (7.12e-2)" "unprognostic (2.31e-1)" "unprognostic (7.34e-2)" "unprognostic (2.60e-1)" "unprognostic (4.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.19e-2)" "unprognostic (2.63e-2)" "unprognostic (3.02e-1)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.38e-4)" "unprognostic (2.08e-1)" "unprognostic (1.06e-1)" "unprognostic (5.47e-2)" "unprognostic (1.40e-1)" 7.4 8.6 5.0 5.1 5.1 4.9 8.7 3.9 11.5 9.7 0.6 9.5 6.1 12.1 1.1 10.2 9.6 3.1 8.3 5.7 3.5 7.2 7.0 6.2 4.2 7.1 5.2 5.1 9.4 8.3 4.3 7.2 3.1 7.9 9.6 1.6 2.1 9.1 4.1 10.4 12.6 7.7 2.4 3.0 8.1 8.4 5.0 5.3 3.3 8.4 3.0 2.3 10.6 9.1 6.4 21.3 29.7 7.6 11.7 7.7 6.6 9.6 11.8 4.8 3.0 2.9 5.8 13.4 31.9 15.6 6.6 8.4 13.2 4.2 10.7 1.1 21.4 55.3 17.3 15.1 7.1 4.9 11.1 11.1 6.3 7.4 4.7 3.9 5.6 6.2 32.1 16.0 1.8 4.6 14.2 17.4 11.6 10.6 12.5 26.1 13.8 4.7 19.4 6.2 19.4 23.4 16.7 8.7 22.5 6.1 4.6 33.4 7.6 13.1 12.9 5.6 4.3 11.7 34.8 27.2 15.9 14.7 4.6 8.4 5.8 5.0 10.2 5.7 7.6 6.8 4.4 3.9 5.3 5.3 5.0 4.6 3.4 4.4 5.5 9.1 6.4 3.7 4.7 5.0 5.1 3.9 11.5 5.7 3.5 7.1 5.2 5.1 7.9 3.0 5.3 6.4 3.3 9.6 0.5 2.9 5.6 1.7 3.7 5.5 2.2 4.2 4.5 4.6 3.3 1.5 4.0 12.9 0.0 8.9 5.1 6.3 5.9 10.6 0.6 3.4 4.6 5.0 10.3 7.4 1.9 8.9 8.0 3.9 8.6 3.8 0.0 5.6 8.6 4.5 6.6 6.7 2.0 4.6 8.2 6.8 2.4 1.3 5.9 3.7 7.2 0.0 12.3 3.7 7.2 1.5 1.6 8.8 2.6 9.8 3.6 3.8 5.9 5.6 3.8 3.0 13.1 2.5 5.1 5.2 5.9 3.5 2.7 5.6 3.1 4.8 6.0 2.6 YLPM1 "C14orf170, PPP1R169, ZAP" ENSG00000119596 "YLP motif containing 1" P49750 14 74763316-74859435 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048070, HPA061123" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA048070: AB_2680247, HPA061123: AB_2684435" "unprognostic (2.17e-1)" "unprognostic (3.32e-2)" "unprognostic (3.95e-1)" "unprognostic (2.98e-1)" "unprognostic (3.79e-2)" "unprognostic (7.64e-2)" "unprognostic (3.22e-3)" "unprognostic (8.74e-2)" "unprognostic (3.60e-2)" "unprognostic (2.56e-1)" "unprognostic (7.83e-3)" "unprognostic (6.63e-2)" "prognostic favorable (6.08e-7)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" 13.2 13.1 11.9 10.5 12.3 17.7 13.9 18.0 15.7 17.6 2.5 12.4 7.0 16.2 13.0 12.8 16.1 8.6 11.3 11.5 8.8 10.2 8.6 11.3 13.2 11.5 9.3 9.8 22.3 13.2 12.2 15.7 11.3 12.1 14.1 9.3 17.8 15.1 10.4 15.1 15.2 13.5 9.5 4.4 13.5 12.0 18.6 10.5 15.0 17.0 7.4 12.0 14.1 15.2 12.3 28.3 28.9 31.8 7.1 25.2 20.8 18.0 18.3 18.7 18.9 18.9 25.8 19.6 40.9 13.4 20.8 13.7 26.1 28.6 19.6 30.2 24.6 17.3 29.4 19.8 20.0 12.2 22.3 21.9 19.0 13.5 20.9 16.5 23.3 25.3 22.9 24.1 18.9 23.5 29.9 26.4 24.4 20.0 19.2 26.1 40.5 31.8 14.3 16.5 37.2 24.2 23.8 29.4 20.2 8.3 21.8 22.9 17.4 37.0 22.6 28.3 15.6 23.9 23.3 24.8 43.6 19.3 17.3 17.2 0.3 1.4 1.5 1.5 1.6 1.7 1.9 1.3 1.3 1.1 1.9 1.8 1.8 1.0 2.3 1.5 3.4 1.1 1.4 11.9 12.3 18.0 15.7 11.5 8.8 11.5 9.3 9.8 12.1 4.4 10.5 12.3 26.8 25.6 34.3 54.2 32.7 19.9 11.2 13.3 27.9 42.0 27.7 25.3 45.9 14.3 25.0 9.2 41.7 19.7 32.4 15.7 1.9 15.7 35.4 26.8 36.0 29.7 20.4 23.5 86.7 15.5 13.5 24.4 23.0 28.6 17.7 54.1 21.8 16.8 19.1 52.2 84.3 18.9 12.2 22.6 12.3 17.7 33.8 19.5 5.4 51.5 28.6 24.6 32.0 68.9 76.5 18.0 13.3 48.5 30.3 18.9 14.0 14.7 33.0 30.8 19.7 35.5 24.8 62.8 49.0 29.2 23.3 15.7 29.3 32.5 21.6 13.2 DCAF4 "DKFZp434K114, WDR21, WDR21A" ENSG00000119599 "DDB1 and CUL4 associated factor 4" Q8WV16 14 72926377-72959703 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047276 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047276: AB_10959615" "unprognostic (6.01e-2)" "unprognostic (1.96e-1)" "unprognostic (9.31e-2)" "unprognostic (1.78e-2)" "unprognostic (1.78e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.38e-2)" "unprognostic (2.86e-1)" "unprognostic (7.56e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.80e-2)" "unprognostic (1.87e-1)" "unprognostic (9.96e-3)" "unprognostic (2.11e-2)" 6.9 8.0 6.1 4.9 6.3 5.0 7.2 5.4 6.9 7.2 4.9 7.5 4.1 7.1 5.3 7.7 5.7 3.7 5.1 6.6 7.1 8.9 7.5 4.5 6.5 7.4 6.5 6.4 9.2 12.6 5.5 3.7 9.3 7.9 7.0 6.6 2.6 6.8 5.2 12.9 12.9 7.0 6.0 5.4 6.8 8.1 7.1 6.4 4.0 11.5 5.2 7.5 8.1 7.6 7.7 20.7 9.4 2.3 10.8 9.9 12.5 19.0 11.6 11.6 14.9 17.4 11.3 8.9 26.0 8.5 21.9 13.6 15.6 16.0 18.2 25.5 13.2 8.9 10.8 4.4 15.1 13.9 7.4 17.8 21.9 17.4 15.5 29.1 10.0 5.2 25.1 16.2 16.1 12.1 35.3 12.7 18.4 6.3 20.2 20.3 8.9 12.2 15.2 22.5 12.3 12.5 4.9 7.0 37.4 14.1 10.4 12.5 9.9 7.8 8.0 18.5 22.6 5.7 22.8 23.5 17.7 11.0 6.1 4.9 0.4 1.6 0.3 4.1 2.5 6.1 11.6 5.0 4.6 3.3 8.7 5.7 6.0 0.9 9.1 5.4 2.5 7.2 3.0 6.1 6.3 5.4 6.9 6.6 7.1 7.4 6.5 6.4 7.9 5.4 6.4 7.7 2.9 6.4 5.3 3.3 10.8 6.1 7.3 5.8 8.0 3.4 5.8 5.1 4.0 2.8 8.3 3.7 4.2 20.9 4.4 4.3 3.9 6.7 3.8 4.3 6.6 4.4 4.2 4.2 5.7 5.6 15.3 4.9 12.8 7.5 0.0 10.9 1.1 4.7 5.8 0.0 4.7 4.3 6.1 2.2 4.2 2.6 3.7 1.9 1.8 3.7 4.1 2.1 4.1 3.5 5.8 4.4 7.0 5.7 4.7 4.0 2.9 6.6 2.6 3.5 0.0 4.4 4.0 7.5 18.6 6.4 6.7 5.6 5.3 11.8 7.1 3.3 PROX2 FLJ36749 ENSG00000119608 "Prospero homeobox 2" Q3B8N5 14 74852871-74876154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.9;Excitatory neurons: 1.6;granulocytes: 1.3;Inhibitory neurons: 1.1;Late spermatids: 1.0;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045057 Uncertain NA NA "HPA045057: AB_10960259" "unprognostic (4.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (1.36e-2)" "unprognostic (1.31e-2)" "unprognostic (3.95e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (5.98e-3)" "unprognostic (2.98e-1)" "unprognostic (1.22e-2)" "unprognostic (9.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.59e-2)" "unprognostic (1.73e-4)" 0.3 0.2 0.6 0.4 0.5 1.2 0.3 1.2 0.8 0.8 1.1 0.3 0.2 0.4 0.6 0.2 0.5 0.1 0.3 0.5 0.4 0.3 0.2 0.3 0.6 0.4 0.3 0.3 1.0 0.3 0.1 0.5 0.2 0.5 0.5 0.3 1.2 0.5 0.3 0.2 1.1 0.5 0.1 0.1 0.5 0.2 0.3 0.5 0.2 0.6 0.0 0.3 0.3 0.5 0.7 0.0 0.1 1.6 0.6 0.5 0.2 0.4 0.1 0.0 0.0 0.1 1.4 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.9 0.0 0.2 0.0 0.0 0.2 1.1 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 1.4 1.1 0.1 0.3 0.0 0.0 0.6 0.5 1.2 0.8 0.5 0.4 0.4 0.3 0.3 0.5 0.1 0.5 0.7 0.0 0.0 1.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 VSX2 "CHX10, HOX10, RET1" ENSG00000119614 "Visual system homeobox 2" P58304 14 74239449-74262738 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Repressor" "Cataract, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "retina: 74.3" "Group enriched" "Detected in some" 10 "Bipolar cells: 152.4;Muller glia cells: 86.0" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "midbrain: 1.3;pons and medulla: 1.7" "Region enhanced" "Detected in single" "pons: 1.7" HPA003436 Enhanced NA NA "HPA003436: AB_1078523" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-1)" "unprognostic (3.21e-4)" "unprognostic (7.77e-2)" "unprognostic (8.39e-4)" "unprognostic (3.13e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 74.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 1.2 0.4 0.0 1.7 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 152.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 86.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1 rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 104.7;Smooth muscle cells: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favorable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 32.7 23.3 9.5 25.6 12.2 27.3 35.2 12.5 13.1 30.8 11.7 28.8 19.1 29.5 21.1 25.1 38.7 22.2 27.1 9.2 13.5 30.4 33.1 28.1 34.7 12.4 12.6 8.3 40.3 16.6 26.8 13.0 32.4 12.8 28.5 29.6 13.3 20.1 30.8 25.5 17.4 20.7 30.5 11.7 23.7 23.2 18.5 11.7 33.5 43.7 22.6 41.6 29.5 19.2 17.5 109.3 78.7 55.8 63.5 86.8 76.3 73.5 93.6 71.7 91.4 81.2 88.1 87.3 97.2 59.6 82.1 44.2 78.5 94.1 88.5 160.7 90.6 40.8 67.4 46.4 57.9 62.6 83.1 59.5 60.3 76.6 97.3 101.4 72.4 86.6 82.7 82.2 56.9 83.3 77.5 97.0 29.6 75.0 63.2 90.5 72.9 109.5 46.3 46.4 88.1 39.1 56.9 120.1 62.8 55.0 61.4 80.7 57.0 79.9 72.7 77.6 69.5 108.3 49.9 140.7 147.7 69.2 77.5 82.5 13.5 17.0 20.5 19.1 15.3 21.0 24.3 18.4 16.6 13.9 21.2 19.5 20.5 14.7 15.3 18.8 31.3 19.6 9.2 9.5 12.2 12.5 13.1 9.2 13.5 12.4 12.6 8.3 12.8 11.7 11.7 17.5 11.9 6.4 18.3 7.5 18.8 3.1 7.6 10.5 11.4 7.5 12.2 7.5 24.0 34.3 14.9 12.9 6.2 11.8 26.6 16.3 15.6 17.4 23.8 28.0 18.5 13.7 10.2 36.2 11.6 19.0 14.7 13.3 6.1 13.5 26.0 9.3 28.5 104.7 12.8 11.8 11.7 15.9 8.2 33.6 4.3 11.9 15.5 12.6 0.0 7.5 16.4 13.5 24.7 11.6 17.5 17.4 10.3 17.0 12.0 6.1 13.1 18.4 45.4 7.2 13.1 12.5 67.7 12.4 12.3 11.1 4.8 8.8 14.3 8.2 15.6 6.7 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955626 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;thyroid gland: 53.0" "Group enriched" "Detected in many" 11 "Extravillous trophoblasts: 1604.4;Syncytiotrophoblasts: 2122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "BEWO: 422.4;HUVEC TERT2: 199.1" "Low region specificity" "Detected in all" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 11.9 4.9 8.3 7.8 7.2 0.1 11.4 7.2 11.8 21.6 18.1 6.5 2.4 7.7 1.5 10.1 22.0 5.9 15.5 8.5 16.9 8.1 6.1 7.3 6.4 9.4 8.8 6.1 6.5 4.9 8.5 5.5 50.9 9.9 19.5 2.0 1.2 10.6 10.4 10.0 15.0 12.6 7.8 7.2 3.4 4.9 3.2 8.7 3.9 53.0 5.9 3.3 13.8 14.9 9.8 1.4 1.5 1.3 1.3 2.0 0.2 422.4 4.0 3.6 1.8 2.2 10.9 0.6 0.3 9.1 2.8 0.2 0.5 1.8 19.2 1.6 0.2 2.4 0.0 0.1 11.3 1.5 0.2 11.0 4.7 4.5 7.5 1.8 0.5 199.1 0.0 0.0 0.1 55.6 0.9 0.0 0.5 2.1 0.1 3.4 0.2 51.3 0.0 0.5 1.0 31.0 17.0 0.0 0.8 7.7 25.0 0.1 0.5 40.6 0.3 10.2 0.1 17.0 0.4 0.2 0.7 6.3 0.5 0.5 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 8.3 7.2 7.2 11.8 8.5 16.9 9.4 8.8 6.1 9.9 7.2 8.7 9.8 32.4 9.6 4.6 1.0 1.0 24.6 10.3 111.4 34.7 1.3 8.9 16.0 3.6 0.0 26.0 0.0 14.6 83.8 2.4 2.0 0.0 2.7 0.1 1.1 3.3 169.4 7.1 2.7 0.1 0.5 1604.4 30.8 1.1 0.8 6.3 0.2 5.3 0.3 37.4 0.0 0.2 2.1 18.3 0.6 8.9 0.8 13.1 2.1 21.4 0.0 0.0 1.9 0.0 0.0 0.2 0.5 1.2 19.5 0.2 3.2 0.6 1.1 12.1 7.8 105.2 7.1 86.4 0.2 6.8 8.1 19.6 2122.6 3.0 3.0 2.3 5.8 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 446.8" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 44.0 115.5 139.9 42.8 146.6 47.0 43.5 150.6 209.0 70.8 135.1 53.4 22.7 51.9 14.6 74.5 54.6 46.8 98.0 139.4 152.9 52.5 10.3 60.5 58.4 154.4 141.9 134.1 79.5 28.1 55.5 84.0 10.8 151.7 36.1 20.6 52.1 27.0 21.7 8.9 47.4 53.3 25.8 154.5 72.8 35.8 31.4 153.6 47.3 35.4 10.0 50.9 41.9 72.7 163.2 61.5 39.3 10.8 90.8 70.1 166.5 7.6 118.1 129.9 92.3 99.6 12.1 28.0 29.0 128.3 134.2 59.1 81.6 8.8 150.5 36.8 185.4 3.0 44.0 41.0 4.6 98.5 53.2 116.7 163.1 55.8 50.5 39.0 162.6 49.1 108.5 3.8 446.8 107.5 128.3 32.3 33.9 16.4 41.9 49.2 1.9 40.2 42.2 137.8 25.2 24.1 28.7 3.8 0.0 78.4 22.9 146.4 87.6 65.9 61.5 35.0 79.5 30.1 171.8 164.4 10.4 201.7 124.1 39.2 167.4 238.3 48.0 153.4 167.9 99.4 214.2 140.6 168.4 184.2 201.3 104.2 134.9 37.6 44.3 121.5 153.5 203.5 217.4 139.9 146.6 150.6 209.0 139.4 152.9 154.4 141.9 134.1 151.7 154.5 153.6 163.2 86.5 38.5 50.9 10.1 71.8 92.8 73.1 218.3 111.0 27.2 47.9 103.6 162.8 50.1 55.8 178.4 20.9 2.3 79.3 58.2 178.1 159.2 8.2 78.1 113.7 70.1 99.6 20.6 1.6 29.1 2.7 133.0 43.8 11.6 90.7 64.8 121.1 4.2 190.8 23.5 3.6 193.8 57.0 163.7 107.6 31.1 183.0 119.1 236.5 0.0 134.7 181.0 137.0 5.5 13.9 68.1 150.2 115.5 104.4 23.7 125.6 113.3 61.8 113.3 124.9 70.4 87.7 8.3 22.1 105.2 66.9 2.9 92.2 92.7 82.8 55.9 BBOF1 "C14orf45, CCDC176, FBB10" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019349-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.0" "Group enriched" "Detected in many" 4 "Early spermatids: 239.3;Endometrial ciliated cells: 166.4;Late spermatids: 111.3;Respiratory ciliated cells: 177.8;Spermatocytes: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.0 2.8 10.2 2.3 6.9 6.5 7.4 6.7 9.1 6.5 14.7 5.6 2.0 7.2 14.7 5.2 22.7 5.8 4.3 6.6 9.4 9.7 2.2 6.9 1.8 10.0 9.4 5.7 5.2 2.8 5.1 10.8 2.4 8.7 5.6 3.5 24.5 3.9 7.2 2.3 3.1 2.5 5.5 9.9 1.4 3.4 39.0 7.1 2.8 13.3 3.3 2.1 5.1 3.1 7.3 5.4 3.1 1.3 8.7 5.7 12.5 1.1 4.6 6.5 4.6 4.3 1.1 3.7 5.3 1.2 5.7 2.0 1.3 1.8 0.8 5.2 0.8 1.0 0.6 3.1 1.2 4.8 2.7 0.3 6.1 4.2 10.3 1.3 7.3 1.7 9.7 2.9 0.9 3.4 4.3 8.5 1.3 0.4 0.5 2.1 3.0 3.4 0.9 7.9 1.4 5.2 3.3 9.0 3.6 2.6 1.3 9.2 0.2 3.8 5.7 4.0 7.6 1.3 1.9 4.9 3.3 16.7 0.3 1.6 1.1 0.0 0.1 1.5 0.0 1.8 0.5 1.4 1.0 0.1 0.6 1.9 1.5 1.0 1.1 0.0 2.4 0.3 1.2 10.2 6.9 6.7 9.1 6.6 9.4 10.0 9.4 5.7 8.7 9.9 7.1 7.3 3.8 12.8 8.1 0.0 1.4 0.0 3.8 0.0 4.0 7.8 15.8 8.0 0.0 7.2 30.3 3.7 29.2 1.8 3.9 1.8 15.6 9.0 239.3 166.4 15.1 3.1 2.4 39.6 0.0 3.5 2.6 7.4 2.0 18.2 1.3 4.3 3.6 4.5 2.3 6.7 0.0 2.7 0.0 1.6 0.0 111.3 10.8 3.9 0.0 0.0 0.8 5.7 4.1 0.0 0.0 3.0 0.2 6.0 0.7 2.5 1.0 23.5 177.8 29.9 0.0 4.3 4.0 149.2 14.7 1.3 0.0 1.0 2.3 4.1 0.9 3.4 NEK9 "DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1" ENSG00000119638 "NIMA related kinase 9" Q8TD19 14 75079353-75127344 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001405 Approved NA NA "HPA001405: AB_1079467" "unprognostic (1.00e-1)" "unprognostic (5.37e-2)" "unprognostic (9.97e-3)" "unprognostic (2.64e-2)" "unprognostic (3.86e-1)" "unprognostic (2.77e-1)" "unprognostic (1.12e-1)" "unprognostic (5.60e-3)" "unprognostic (2.81e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.63e-4)" "unprognostic (8.58e-2)" "unprognostic (1.36e-2)" "unprognostic (4.54e-2)" "unprognostic (9.22e-2)" "unprognostic (2.61e-1)" "unprognostic (1.57e-2)" 24.4 18.7 6.3 18.8 7.5 11.9 17.4 7.2 8.0 24.5 8.5 14.4 15.6 26.3 10.6 18.0 25.5 18.0 37.5 5.5 10.1 18.5 21.2 18.9 21.2 7.8 7.1 5.4 36.1 16.1 34.5 3.1 21.4 7.3 23.7 16.5 16.6 12.5 28.4 44.0 8.2 17.0 32.4 7.4 19.8 13.2 20.6 7.2 28.5 19.9 37.2 23.7 16.5 2.9 8.8 21.3 30.8 44.8 45.4 86.3 88.8 37.9 32.4 54.6 29.7 29.4 25.5 24.7 52.7 0.1 54.2 23.1 31.8 45.0 27.0 38.5 38.2 16.8 23.0 27.3 17.3 48.6 10.8 26.8 76.6 32.8 31.8 26.7 71.6 46.1 36.2 23.8 31.4 40.2 4.8 35.5 11.5 21.9 43.3 18.8 53.5 49.4 23.9 21.3 28.2 19.5 41.3 39.5 19.3 30.0 50.4 41.7 37.6 46.3 30.2 12.7 31.5 15.8 34.3 36.5 49.6 24.9 24.8 26.4 3.4 3.5 3.1 2.5 3.4 4.0 1.3 2.4 2.3 5.0 1.9 3.1 2.8 1.2 3.3 2.5 1.1 1.5 2.9 6.3 7.5 7.2 8.0 5.5 10.1 7.8 7.1 5.4 7.3 7.4 7.2 8.8 15.3 12.8 30.2 49.3 21.2 8.8 7.7 6.6 21.1 16.8 14.5 12.4 55.7 12.8 14.8 11.0 35.5 17.4 11.1 10.2 7.9 6.9 11.9 13.3 23.1 17.6 5.4 16.2 31.3 4.9 16.2 18.1 10.7 10.4 16.4 36.8 17.9 30.3 13.9 13.5 35.9 10.7 6.1 18.6 11.8 8.3 24.8 17.0 3.6 30.9 16.0 12.0 15.5 41.2 59.5 5.3 11.7 26.4 14.7 7.4 13.1 8.4 17.4 23.1 0.0 18.9 16.7 28.8 13.9 17.4 10.2 14.0 16.5 20.8 10.5 5.6 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053237-75069483 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol NA NA 89000 Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favorable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 13.3 38.8 53.5 15.3 53.4 21.3 22.3 54.1 61.4 17.3 53.0 21.7 15.8 14.5 37.0 21.0 29.8 10.3 17.0 49.3 53.1 22.2 9.7 19.9 28.0 55.5 54.2 49.1 13.7 12.5 21.3 36.8 15.4 56.2 17.5 27.2 44.4 15.9 15.1 34.3 35.3 21.3 15.8 51.7 16.6 19.5 27.1 53.6 40.0 30.4 21.3 28.3 16.2 17.8 60.5 78.9 43.1 60.9 37.4 24.5 26.6 32.6 44.7 17.2 45.5 63.5 42.8 86.9 86.5 26.4 18.2 25.7 68.1 39.9 19.1 73.8 127.8 49.3 57.6 123.6 32.1 14.3 36.6 56.8 14.9 27.7 61.5 30.0 28.8 60.0 80.9 45.2 103.0 60.0 52.3 82.7 67.7 18.6 67.6 40.8 64.7 80.8 41.2 62.2 39.0 112.0 44.5 29.5 20.8 74.2 29.1 44.5 35.4 27.3 29.5 55.6 61.3 48.4 23.8 52.4 94.6 46.1 42.5 32.8 5.3 2.8 17.5 10.9 6.2 12.7 13.7 18.3 12.9 5.1 14.1 15.4 14.5 1.2 14.0 10.5 10.3 24.6 6.7 53.5 53.4 54.1 61.4 49.3 53.1 55.5 54.2 49.1 56.2 51.7 53.6 60.5 18.5 6.4 9.1 17.0 18.2 28.7 44.4 54.1 30.1 38.6 20.8 24.0 21.2 31.5 28.9 66.2 12.5 27.3 18.7 24.5 39.2 20.6 31.6 89.2 18.4 26.5 30.1 47.5 17.8 18.7 33.7 22.7 13.7 17.8 12.0 19.8 10.4 5.7 22.3 43.7 25.0 25.2 73.2 6.6 11.7 11.0 16.8 12.3 39.2 15.9 10.1 23.2 16.5 16.1 44.4 20.2 20.6 16.6 16.9 20.2 16.7 22.3 137.9 32.4 26.3 11.1 31.5 89.8 14.1 23.8 24.0 13.7 22.3 20.4 33.8 34.4 IFT43 "C14orf179, FLJ32173, MGC16028" ENSG00000119650 "Intraflagellar transport 43" Q96FT9 14 75902136-76084585 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 305.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003438 Approved Supported "Microtubules,Centriolar satellite" NA NA Microtubules "Centriolar satellite" "HPA003438: AB_1078327" "unprognostic (1.64e-2)" "unprognostic (5.75e-3)" "unprognostic (2.10e-1)" "unprognostic (1.81e-3)" "unprognostic (1.48e-1)" "unprognostic (8.73e-2)" "unprognostic (1.53e-2)" "unprognostic (5.27e-2)" "unprognostic (8.87e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-2)" "unprognostic (9.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (1.75e-1)" "unprognostic (1.07e-2)" 20.5 24.2 28.6 12.3 28.1 5.4 25.3 28.5 31.7 23.0 35.3 23.6 23.2 24.8 50.0 18.2 65.1 18.4 43.6 27.3 33.1 39.2 41.9 20.8 11.7 28.2 28.1 27.3 16.3 22.8 27.4 33.1 21.7 29.2 27.1 19.6 25.3 16.3 30.8 14.1 14.9 19.4 27.9 29.2 15.6 21.7 40.9 28.3 16.0 33.3 8.8 17.1 25.8 18.5 28.3 34.8 38.2 27.5 42.7 33.9 54.3 19.5 22.3 42.7 33.6 33.5 14.6 34.9 3.9 23.8 39.5 30.4 36.2 26.7 41.3 37.6 18.3 25.6 1.8 22.3 0.1 94.9 3.8 8.0 48.6 44.4 37.1 48.3 48.6 52.1 38.5 9.6 15.2 40.8 69.7 14.3 6.0 14.2 42.7 48.9 9.1 22.2 10.9 77.0 30.0 26.7 31.9 43.9 29.8 31.5 36.9 77.4 10.2 24.3 19.7 24.7 28.9 19.6 20.1 18.8 4.4 76.9 1.6 20.6 34.5 11.6 19.7 13.8 16.4 17.6 33.8 14.9 14.4 15.7 23.1 24.3 23.4 5.8 15.4 16.4 20.2 19.6 13.4 28.6 28.1 28.5 31.7 27.3 33.1 28.2 28.1 27.3 29.2 29.2 28.3 28.3 40.9 12.8 27.4 50.3 14.8 18.6 44.1 103.7 38.1 27.8 36.0 45.6 43.8 42.9 66.1 64.4 66.7 41.9 8.7 24.7 64.6 53.8 147.5 171.0 54.5 35.3 15.7 5.9 46.4 38.7 14.7 39.4 38.2 33.2 26.6 28.7 38.6 32.9 22.4 10.1 55.0 30.2 61.1 7.6 20.0 33.2 33.8 11.5 26.6 14.0 32.0 49.8 14.4 38.2 38.5 33.5 18.7 35.0 13.7 25.8 45.1 160.2 305.8 87.7 32.9 31.2 63.5 124.4 37.2 24.6 21.6 41.9 16.2 32.8 26.1 34.5 NPC2 "EDDM1, HE1, NP-C2" ENSG00000119655 "NPC intracellular cholesterol transporter 2" P61916 14 74476192-74494177 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease variant, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 21 "epididymis: 16929.9" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 769.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2" "Group enriched" "Detected in all" 5 "dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7" "Cell line enhanced" "Detected in all" "ASC diff: 1619.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000835, CAB032888" Enhanced "Secreted to blood" NA NA 53000000 "CAB032888: AB_2157036, HPA000835: AB_1079499" "unprognostic (1.27e-3)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (1.17e-1)" "unprognostic (1.82e-2)" "unprognostic (3.72e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (6.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-3)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.97e-1)" "prognostic favorable (6.55e-4)" "unprognostic (1.42e-1)" 262.0 299.9 131.0 263.7 148.2 308.0 223.5 160.1 192.2 286.9 395.4 262.1 203.5 198.6 16929.9 186.7 171.5 359.2 217.1 123.6 225.9 325.4 204.1 793.0 363.3 190.3 145.8 114.3 285.6 221.8 243.5 199.1 265.3 179.8 165.7 223.0 49.0 223.7 263.8 59.3 175.9 194.9 182.1 165.9 308.3 208.7 158.2 159.9 135.6 448.6 115.7 243.9 350.7 189.5 194.1 297.2 199.3 124.8 179.4 1619.3 498.6 404.8 194.1 707.1 200.9 398.9 351.7 420.3 78.6 141.6 181.9 372.6 595.9 170.0 405.5 188.6 120.4 126.3 29.6 96.7 296.2 348.6 51.0 548.4 467.7 388.9 173.7 336.9 930.2 298.1 87.0 32.9 601.4 224.0 106.9 70.1 75.9 52.9 489.0 307.9 39.5 219.1 281.6 511.1 735.0 5.5 91.3 296.3 120.3 298.0 359.6 205.2 225.7 268.9 291.9 342.0 396.1 188.2 253.7 452.5 24.2 292.1 168.4 163.4 668.7 1300.7 274.1 92.2 1772.7 87.9 295.2 126.5 92.3 587.8 241.8 120.9 100.5 674.2 99.5 1252.1 2113.2 187.8 1304.5 131.0 148.2 160.1 192.2 123.6 225.9 190.3 145.8 114.3 179.8 165.9 159.9 194.1 154.9 381.4 2034.2 11.1 160.2 374.9 557.8 1074.2 170.2 9.9 138.6 220.5 55.4 163.0 626.9 331.1 22.9 228.3 664.0 301.0 305.2 500.4 90.9 123.8 168.5 276.5 119.7 65.4 2.1 279.4 803.3 318.1 61.7 161.0 341.4 104.2 447.3 195.6 2898.5 8.4 3.8 264.8 832.1 2035.4 750.9 69.6 566.7 1462.6 602.9 6.5 790.5 167.4 117.4 7.5 24.4 368.3 405.1 291.9 287.4 357.9 298.1 969.0 393.3 25.1 131.5 118.3 155.9 268.1 166.7 182.6 320.7 210.4 109.9 330.0 298.5 521.6 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.7" "Cell type enhanced" "Detected in all" "Early spermatids: 335.4;Endometrial ciliated cells: 104.0;Respiratory ciliated cells: 141.4;Spermatocytes: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA053129: AB_2682051, HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 7.6 6.3 11.6 6.2 11.9 6.2 5.2 12.2 10.8 6.0 16.1 4.8 2.7 8.0 12.3 4.6 23.9 9.4 9.3 12.1 18.5 11.3 3.7 7.7 5.2 9.3 12.2 9.1 7.5 6.2 14.9 8.5 4.8 8.8 5.8 5.5 18.3 4.5 7.0 5.2 3.0 3.1 9.5 9.3 4.8 5.7 55.7 9.4 6.2 16.5 6.0 4.5 6.2 3.3 9.0 15.4 11.2 13.5 12.3 9.3 11.8 10.7 15.2 11.6 19.3 20.0 11.7 23.9 6.1 11.1 16.2 18.4 9.2 12.8 11.7 28.0 9.0 5.3 5.1 16.7 4.3 9.7 5.9 5.8 9.0 9.0 21.3 15.2 14.8 12.7 9.7 5.8 13.7 23.8 25.2 15.4 7.0 6.3 12.7 10.9 10.7 20.2 2.6 16.1 16.1 20.7 9.8 25.0 4.8 12.2 10.3 26.7 3.9 12.0 24.1 43.8 18.2 14.3 7.8 18.2 13.4 19.9 3.1 17.2 4.3 2.3 2.5 2.7 2.5 3.8 2.7 2.6 2.7 2.1 4.1 2.3 2.6 2.1 2.1 2.1 5.9 2.6 1.3 11.6 11.9 12.2 10.8 12.1 18.5 9.3 12.2 9.1 8.8 9.3 9.4 9.0 10.8 19.2 14.9 11.4 6.3 3.2 7.4 19.8 2.2 16.0 9.4 5.7 14.4 15.7 23.1 18.4 60.5 5.4 5.4 5.7 9.8 15.5 335.4 104.0 20.4 11.2 10.2 4.8 21.7 14.0 9.3 12.9 7.7 16.4 10.1 11.8 11.0 5.3 8.4 15.2 15.5 6.1 18.3 6.7 7.9 57.8 17.4 6.9 12.4 6.5 6.5 19.9 12.3 10.1 5.8 12.3 4.1 16.6 5.8 5.9 1.7 24.9 141.4 40.2 13.1 21.6 12.4 187.7 24.7 2.1 2.0 2.5 6.2 11.9 5.6 5.0 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028708 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 25.2 25.5 12.6 9.3 13.8 5.7 28.8 13.3 12.1 20.2 11.2 26.0 7.0 26.1 5.1 13.4 34.0 6.5 21.2 14.4 17.0 19.0 19.3 21.1 6.3 14.6 14.1 10.3 32.6 17.6 19.9 22.8 8.0 11.4 18.5 3.3 7.4 19.4 10.2 16.9 25.4 15.3 8.0 11.0 19.2 19.0 13.6 14.8 9.8 18.9 4.2 3.3 26.6 18.3 12.0 15.4 13.2 32.2 36.3 9.6 8.8 45.8 15.9 13.0 4.4 5.9 6.2 24.8 5.4 11.3 13.6 12.4 23.6 5.6 11.8 3.7 25.8 19.1 6.9 13.0 8.5 12.5 1.9 29.7 11.8 9.1 7.8 6.8 34.8 6.0 10.9 10.4 59.4 5.7 42.2 21.0 14.5 14.5 6.6 68.2 4.4 9.1 13.0 15.6 22.4 24.9 36.0 22.5 23.2 42.5 8.6 16.1 3.4 10.4 20.2 19.5 6.8 10.3 22.9 26.3 9.0 31.3 4.7 25.8 1.7 1.4 1.3 2.8 1.9 2.7 1.4 2.5 2.6 1.3 1.6 2.0 2.3 9.0 5.9 2.3 10.7 2.6 0.8 12.6 13.8 13.3 12.1 14.4 17.0 14.6 14.1 10.3 11.4 11.0 14.8 12.0 71.4 22.4 14.3 5.9 40.2 73.7 32.5 22.5 115.5 57.1 54.6 41.5 19.5 32.9 11.6 64.4 29.2 22.8 58.9 10.8 37.2 19.6 1.3 25.3 26.0 44.0 47.6 10.8 8.2 19.0 49.7 47.8 12.2 25.6 26.6 15.2 55.6 60.5 33.3 10.1 8.6 14.7 16.2 54.7 78.9 4.0 30.1 26.6 35.6 9.4 10.0 57.8 38.1 8.5 4.8 17.8 7.0 34.3 21.1 30.0 6.7 23.1 13.8 10.4 39.5 56.4 83.2 1.6 50.5 54.2 50.6 46.0 39.0 27.5 12.8 20.6 ACOT2 "Mte1, ZAP128" ENSG00000119673 "Acyl-CoA thioesterase 2" P49753 14 73567620-73575658 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 119.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 62.4" "HPA043705, HPA060170" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043705: AB_2678626, HPA060170: AB_2732642" "unprognostic (4.44e-3)" "unprognostic (1.68e-2)" "unprognostic (3.17e-1)" "unprognostic (8.66e-2)" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (2.78e-2)" "unprognostic (6.61e-2)" "unprognostic (4.10e-2)" "unprognostic (9.21e-2)" "unprognostic (6.42e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.66e-3)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (4.35e-1)" 93.1 48.1 9.9 7.1 9.9 5.7 49.3 9.1 12.5 15.7 10.8 36.2 24.9 43.3 10.8 11.0 24.3 6.2 79.8 9.6 9.6 49.8 119.9 17.4 4.7 8.6 8.7 9.6 11.8 12.9 22.6 8.3 4.4 8.6 18.0 11.2 4.1 17.9 11.2 115.1 12.8 24.7 23.0 8.6 11.5 22.7 12.1 11.1 3.8 14.6 50.5 3.3 31.5 13.4 8.8 22.8 25.0 4.9 22.1 21.3 7.9 1.0 13.7 31.5 21.9 28.6 18.1 12.6 0.1 9.7 7.0 10.3 12.7 0.0 1.2 11.4 33.1 31.6 16.0 7.6 62.4 14.5 0.1 43.3 19.5 0.0 7.6 0.1 21.0 9.5 0.0 0.0 0.1 18.7 7.4 2.5 18.2 7.5 2.3 37.8 37.2 21.9 0.3 8.0 9.5 21.6 27.3 33.1 24.3 29.6 2.1 51.1 12.7 17.0 17.9 47.2 11.8 13.0 0.0 0.1 9.5 15.8 0.1 18.2 3.5 5.9 3.1 22.1 7.0 15.8 15.0 20.2 16.6 21.9 12.4 17.8 19.9 0.2 15.3 6.5 13.6 31.3 13.6 9.9 9.9 9.1 12.5 9.6 9.6 8.6 8.7 9.6 8.6 8.6 11.1 8.8 4.3 0.0 6.4 3.3 6.6 1.7 1.0 5.9 16.5 1.1 5.2 4.2 50.0 7.2 3.0 7.3 10.4 6.1 3.0 20.1 13.7 20.9 1.5 1.4 1.9 4.0 15.7 8.4 2.9 33.2 3.2 7.0 11.7 2.1 13.4 1.9 4.2 27.7 14.9 1.7 3.1 15.5 10.2 3.8 1.6 1.1 5.9 5.6 5.4 1.0 18.5 5.5 7.2 3.0 1.7 21.8 8.6 8.2 7.9 0.4 27.5 36.5 3.3 4.9 6.6 1.4 9.8 0.3 4.8 8.5 0.4 8.2 5.8 1.7 18.8 0.4 LTBP2 "C14orf141, LTBP3" ENSG00000119681 "Latent transforming growth factor beta binding protein 2" Q14767 14 74498183-74612378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Disease variant, Dwarfism, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5" "Group enriched" "Detected in some" 10 "cerebellum: 5.3;olfactory bulb: 2.4" "Region enhanced" "Detected in many" "olfactory bulb: 15.4" HPA003415 Approved Approved Nucleoplasm "Secreted to extracellular matrix" NA NA 14000000 Nucleoplasm "HPA003415: AB_1079284" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (5.10e-2)" "unprognostic (3.92e-3)" "unprognostic (2.08e-3)" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (4.43e-2)" "unprognostic (1.08e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (3.77e-1)" "unprognostic (1.98e-3)" "unprognostic (2.22e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.94e-4)" 29.2 4.0 1.3 15.4 2.1 0.6 24.6 4.2 10.6 58.4 20.8 6.2 3.2 22.6 24.1 10.7 11.8 33.3 42.6 1.2 3.1 4.1 2.2 65.5 8.4 2.4 1.5 0.5 39.8 8.8 9.7 7.4 28.2 2.1 15.9 2.6 2.3 26.9 19.8 13.7 11.4 6.9 16.2 1.7 3.9 8.5 5.5 1.7 3.2 53.5 21.6 6.1 14.3 21.8 1.8 2.5 4.9 1.2 0.2 36.9 67.7 0.2 47.4 16.2 9.2 5.7 0.0 17.4 0.4 13.8 240.8 4.1 4.8 0.2 17.7 3.8 0.2 0.8 0.8 2.2 2.1 8.8 0.1 0.6 70.2 7.7 50.7 29.1 68.9 129.1 0.1 0.2 0.1 129.4 1.1 0.1 0.3 0.3 0.2 4.5 0.5 1.1 0.1 11.3 6.7 1.0 3.3 33.1 0.1 1.1 3.4 1.1 0.2 564.5 3.3 54.0 17.0 18.0 0.7 0.7 0.1 13.1 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 2.1 4.2 10.6 1.2 3.1 2.4 1.5 0.5 2.1 1.7 1.7 1.8 3.8 0.0 2.2 2.3 0.1 5.6 15.1 13.0 13.1 2.1 1.9 60.6 6.4 0.0 6.1 0.0 0.0 0.5 1.2 0.1 5.9 1.4 1.2 0.5 7.9 6.5 0.0 5.7 1.1 0.4 0.3 59.5 1.5 0.9 1.3 1.9 9.3 0.4 4.2 3.3 0.7 0.0 20.3 0.3 5.8 5.8 16.4 3.7 0.0 22.5 0.1 0.4 0.0 1.0 0.3 4.4 0.0 82.4 0.3 10.7 0.0 0.0 0.3 1.0 6.6 3.2 10.8 2.8 3.8 5.2 1.0 1.2 0.9 2.2 0.1 2.1 AREL1 "FIEL1, KIAA0317" ENSG00000119682 "Apoptosis resistant E3 ubiquitin protein ligase 1" O15033 14 74653437-74713117 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051306 Uncertain NA NA "HPA051306: AB_2681433" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (1.92e-3)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.58e-3)" "unprognostic (9.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.12e-1)" "prognostic favorable (4.67e-6)" "unprognostic (6.73e-2)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" "unprognostic (7.18e-2)" 6.2 7.0 4.0 10.5 4.5 17.1 6.8 2.9 4.5 7.8 2.8 10.5 12.0 6.5 7.2 10.1 10.5 6.8 10.7 6.1 4.2 14.7 5.3 9.1 10.1 3.3 4.0 3.9 6.9 9.5 15.5 4.5 8.4 2.7 8.5 12.4 13.4 9.8 7.8 9.9 7.8 12.8 8.4 3.2 8.5 9.8 17.2 5.4 13.2 15.6 13.2 13.4 10.1 5.6 4.1 19.2 24.6 25.1 23.6 21.3 14.1 19.3 20.7 23.5 25.2 25.1 19.2 22.2 16.4 10.8 26.6 22.9 25.3 26.9 23.2 32.4 30.4 12.7 25.5 14.5 13.7 14.2 18.5 23.9 18.4 15.8 18.6 20.0 31.6 25.0 23.5 20.3 17.1 32.9 25.8 19.2 7.8 15.4 26.0 24.2 19.5 28.4 10.2 20.5 42.6 24.6 33.0 18.1 23.9 13.4 16.6 21.0 18.5 34.6 23.8 28.5 14.3 24.3 22.6 32.8 32.2 28.8 14.0 18.8 2.2 3.5 7.1 4.6 5.1 3.3 2.1 2.8 4.2 4.5 1.4 2.9 2.6 6.8 3.4 2.7 2.1 2.6 3.4 4.0 4.5 2.9 4.5 6.1 4.2 3.3 4.0 3.9 2.7 3.2 5.4 4.1 3.7 12.8 4.6 23.2 6.5 3.6 3.4 6.0 7.4 12.3 7.0 3.7 11.1 5.7 7.5 11.0 27.1 4.2 11.2 18.3 1.9 6.6 3.1 7.2 7.1 5.0 14.9 21.0 24.8 9.2 3.3 4.6 12.8 10.5 1.3 10.3 6.4 12.9 8.0 16.8 24.1 11.6 8.2 15.0 5.3 4.6 8.7 9.6 5.4 23.4 13.9 5.2 11.3 22.6 32.5 11.2 6.5 6.8 9.1 6.8 11.8 5.1 7.3 11.7 0.0 4.4 4.9 6.7 11.1 10.5 3.3 5.9 8.4 6.4 11.5 6.3 MLH3 ENSG00000119684 "MutL homolog 3" Q9UHC1 14 75013769-75051532 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease variant, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060570 Approved Nucleoplasm NA NA Nucleoplasm "HPA060570: AB_2684323" "unprognostic (2.94e-1)" "unprognostic (6.70e-3)" "unprognostic (7.14e-3)" "unprognostic (7.35e-2)" "unprognostic (7.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.49e-2)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-2)" "unprognostic (8.42e-2)" "unprognostic (3.53e-1)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" 4.3 9.5 7.0 5.7 11.1 2.4 8.0 13.0 9.2 7.3 5.8 5.8 5.3 7.5 7.5 5.3 6.6 6.1 6.0 6.6 8.5 7.6 7.4 5.2 6.7 9.0 9.2 6.3 8.2 5.4 12.7 5.2 5.8 11.5 7.7 6.7 8.6 5.4 8.7 6.7 4.8 4.8 5.5 8.4 6.4 4.5 6.8 8.9 6.5 11.2 7.9 7.7 5.3 3.2 20.2 13.1 13.5 10.3 1.7 10.6 17.0 10.4 4.5 4.2 7.0 6.3 11.7 16.5 14.2 3.7 5.5 9.2 9.2 0.2 4.3 10.4 14.1 0.2 9.3 8.7 7.1 8.6 4.0 6.3 6.3 10.4 7.2 0.5 8.7 12.0 0.1 8.8 11.4 15.8 11.3 6.3 4.5 8.7 10.6 7.6 11.3 6.3 3.1 17.4 13.4 14.9 10.5 14.4 9.9 0.9 10.3 13.1 9.0 6.1 2.9 5.9 4.3 4.5 14.4 15.0 15.4 10.7 0.4 13.2 5.1 2.6 1.7 4.6 2.1 3.5 3.0 2.5 4.2 2.9 5.9 4.1 3.3 1.1 6.3 1.5 2.4 3.1 5.9 7.0 11.1 13.0 9.2 6.6 8.5 9.0 9.2 6.3 11.5 8.4 8.9 20.2 19.4 25.6 17.3 47.3 16.6 7.9 23.3 14.3 8.6 49.8 11.6 11.0 19.5 27.1 15.6 36.8 43.8 16.2 15.0 8.5 7.9 16.4 6.0 13.6 35.3 18.5 13.1 6.7 43.4 11.1 6.8 25.8 6.6 10.8 23.5 40.8 13.6 15.6 10.3 35.3 52.9 12.4 12.2 9.1 6.1 7.9 39.7 47.7 16.0 31.9 14.6 28.5 29.9 51.8 106.7 12.3 12.0 51.1 8.7 16.9 29.2 17.1 17.6 59.3 46.0 29.7 23.3 54.4 10.8 7.9 8.7 10.1 13.6 31.0 18.9 12.2 TTLL5 KIAA0998 ENSG00000119685 "Tubulin tyrosine ligase like 5" Q6EMB2 14 75633625-75955079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transcription Ligase "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 127.2;Early spermatids: 111.0;Excitatory neurons: 134.3;Inhibitory neurons: 114.2;Oligodendrocytes: 242.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032128 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA032128: AB_10600835" "unprognostic (7.35e-2)" "unprognostic (7.29e-2)" "unprognostic (7.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (5.96e-2)" "unprognostic (7.21e-5)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (7.93e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-1)" "unprognostic (5.67e-3)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (8.97e-2)" "unprognostic (2.15e-2)" 5.5 5.6 5.1 6.0 6.2 11.8 7.2 8.0 9.1 7.4 12.7 5.8 4.8 8.1 7.2 7.9 11.7 6.5 5.7 4.1 4.5 6.2 4.1 6.5 5.2 9.1 8.7 3.2 7.2 5.0 11.2 5.4 7.6 8.3 6.9 7.4 24.1 6.6 6.9 4.8 7.2 4.6 8.7 7.8 4.1 5.9 57.9 7.0 10.2 7.9 5.8 7.5 6.1 6.5 12.5 22.8 16.2 13.9 14.5 10.9 16.8 12.9 13.1 15.9 15.4 19.9 10.3 20.8 6.4 7.2 13.9 11.3 21.3 12.3 21.7 29.3 7.6 7.3 12.5 16.8 11.3 9.3 9.2 11.5 13.1 10.6 19.4 21.5 16.8 33.8 17.5 7.2 10.5 15.7 32.1 15.6 12.6 9.9 18.0 16.6 9.5 19.6 8.8 15.0 22.2 18.4 11.6 27.5 20.2 6.8 11.0 27.6 9.8 38.1 20.5 18.0 18.5 12.2 8.8 13.5 14.6 20.7 10.4 13.9 11.6 2.0 1.7 2.6 2.0 2.4 2.3 2.5 2.7 3.2 1.8 2.9 2.7 2.4 2.3 2.5 3.4 2.2 1.4 5.1 6.2 8.0 9.1 4.1 4.5 9.1 8.7 3.2 8.3 7.8 7.0 12.5 7.1 3.2 10.1 71.8 6.1 5.0 5.5 5.4 8.0 10.9 17.3 11.6 8.7 17.2 10.2 11.0 127.2 8.1 8.5 7.6 3.9 7.1 111.0 37.4 11.9 10.7 7.7 5.0 134.3 5.3 13.2 9.3 8.6 10.8 12.6 11.7 19.6 7.4 5.6 0.0 114.2 6.5 16.2 5.8 5.1 93.1 12.5 6.6 5.4 82.4 8.5 10.0 6.2 78.4 242.9 6.1 11.9 11.7 7.6 6.2 6.0 2.4 40.1 80.1 13.1 9.5 6.0 37.7 16.4 9.0 6.3 6.0 8.3 9.1 8.0 4.6 FLVCR2 "C14orf58, CCT, FLJ20371, MFSD7C, SLC49A2" ENSG00000119686 "FLVCR heme transporter 2" Q9UPI3 14 75578620-75663214 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 75.6;Kupffer cells: 44.9;Late spermatids: 142.5;Microglial cells: 41.2;Proximal enterocytes: 50.4;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 14.0;intermediate monocyte: 14.6;myeloid DC: 7.6;non-classical monocyte: 11.8" "Group enriched" "Detected in many" 7 "dendritic cells: 7.6;monocytes: 14.6" "Cell line enhanced" "Detected in many" "ASC diff: 53.8;ASC TERT1: 23.2;BEWO: 73.5;MCF7: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037984 Enhanced NA NA "HPA037984: AB_10672733" "unprognostic (2.42e-1)" "unprognostic (4.85e-2)" "unprognostic (4.19e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.44e-2)" "unprognostic (8.72e-2)" "unprognostic (2.78e-1)" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.22e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.53e-5)" "unprognostic (6.69e-2)" "unprognostic (9.94e-2)" "unprognostic (9.38e-2)" "unprognostic (1.16e-1)" 5.2 13.7 3.6 9.4 3.4 5.5 2.5 3.2 6.9 2.1 14.1 8.5 17.6 1.0 1.5 3.0 1.9 3.6 1.9 2.7 3.6 11.4 20.6 16.4 5.3 4.2 3.4 1.6 2.3 0.6 2.1 3.4 10.4 3.6 2.3 7.2 0.7 12.8 1.7 8.3 5.6 24.6 4.2 4.8 13.9 0.9 21.2 4.0 1.2 3.3 1.6 5.1 5.0 2.6 5.3 3.7 2.8 0.8 4.0 53.8 23.2 73.5 0.7 3.1 3.3 2.6 6.2 0.4 0.0 0.2 0.2 5.4 0.4 9.8 0.2 1.3 19.3 0.6 0.1 2.8 13.3 4.3 0.1 0.6 10.9 7.7 4.0 2.4 0.1 0.8 0.3 0.2 0.5 10.1 26.4 0.2 1.9 1.6 1.1 4.4 0.1 2.6 0.0 3.5 5.1 0.0 0.1 2.0 8.1 1.6 4.6 4.5 10.1 8.8 4.0 1.4 2.0 0.1 0.6 1.1 0.0 11.4 2.5 0.7 0.0 14.0 0.7 0.4 14.6 1.1 0.0 1.1 0.3 7.6 0.1 0.8 0.2 0.5 0.5 11.8 0.1 1.6 4.1 3.6 3.4 3.2 6.9 2.7 3.6 4.2 3.4 1.6 3.6 4.8 4.0 5.3 0.3 6.4 6.4 2.6 0.5 0.6 0.3 0.4 0.6 0.0 1.5 0.6 0.8 0.0 3.2 3.7 0.0 23.2 1.7 14.0 0.0 0.1 75.6 2.1 3.9 2.5 0.0 0.0 0.2 0.2 31.0 2.2 0.0 2.7 1.3 0.2 1.8 21.1 16.4 0.0 0.2 2.2 4.1 44.9 5.6 142.5 3.4 19.0 0.0 41.2 10.1 1.3 2.1 0.0 0.2 0.1 3.2 1.9 0.5 0.8 50.4 7.0 0.3 0.3 0.0 0.4 0.3 2.4 1.3 0.2 0.9 54.5 1.2 2.3 5.5 0.2 ABCD4 "EST352188, P70R, PMP69, PXMP1L" ENSG00000119688 "ATP binding cassette subfamily D member 4" O14678 14 74285269-74303055 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003396 Approved NA NA "HPA003396: AB_1078078" "unprognostic (3.92e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-3)" "unprognostic (5.86e-2)" "unprognostic (3.69e-1)" "unprognostic (1.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.34e-2)" "unprognostic (3.46e-2)" "unprognostic (4.63e-2)" "unprognostic (2.21e-3)" "unprognostic (5.26e-2)" "unprognostic (2.35e-2)" "unprognostic (1.25e-1)" "unprognostic (6.69e-2)" "unprognostic (7.45e-3)" "unprognostic (7.93e-3)" 6.5 4.8 3.0 3.9 3.5 4.7 6.4 4.1 5.4 5.6 2.6 5.5 8.8 4.9 2.2 4.8 8.6 7.8 6.0 3.0 3.3 5.4 7.7 5.8 6.6 4.0 3.3 2.8 7.0 6.0 3.9 3.9 7.5 3.5 3.6 4.0 3.3 4.0 3.5 4.0 4.1 8.8 5.2 2.8 6.3 4.5 3.4 3.5 5.6 7.3 2.0 3.8 4.6 4.4 4.3 2.6 3.1 7.9 6.2 6.4 4.3 9.8 3.9 5.6 5.8 6.0 6.5 13.7 4.3 7.4 5.9 3.2 9.2 6.0 5.4 3.0 3.9 3.8 2.3 5.1 5.2 2.1 2.9 4.4 10.4 2.4 4.1 2.8 3.0 9.9 5.4 4.3 1.9 4.5 4.3 7.1 5.6 3.0 5.0 5.9 9.7 11.4 6.3 8.6 8.5 3.7 7.3 5.4 5.3 5.5 3.7 12.3 1.7 9.7 3.6 7.0 3.2 2.5 4.4 4.5 3.3 5.1 4.3 4.5 6.0 1.3 1.8 2.6 1.2 1.7 1.9 2.2 2.9 2.1 1.8 1.2 1.8 1.1 2.6 1.0 4.0 5.2 1.4 3.0 3.5 4.1 5.4 3.0 3.3 4.0 3.3 2.8 3.5 2.8 3.5 4.3 50.0 28.9 18.6 32.3 16.7 15.6 14.8 23.0 12.0 46.5 21.4 14.2 9.7 34.3 21.2 20.2 64.6 51.6 28.9 31.4 9.8 25.3 10.3 27.9 23.5 50.2 12.0 9.9 29.6 11.3 19.9 23.0 13.7 20.1 20.3 43.2 44.6 23.3 51.1 32.0 34.7 15.7 18.3 24.8 27.1 7.7 40.4 19.5 21.4 20.6 22.8 36.4 32.0 23.6 38.1 17.9 19.4 25.2 13.3 12.6 60.1 23.9 19.5 55.5 32.9 23.3 19.1 35.8 27.2 10.6 10.7 28.5 23.4 27.9 22.9 16.7 DLST "DLTS, KGD2, OGDC-E2" ENSG00000119689 "Dihydrolipoamide S-succinyltransferase" P36957 14 74881891-74903743 "Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003010 Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA 70000 Nucleoplasm "Mitochondria, Cytosol" "HPA003010: AB_1078679" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "unprognostic (2.45e-3)" "unprognostic (6.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (3.03e-1)" "unprognostic (1.37e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.13e-12)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "unprognostic (4.55e-3)" 64.2 86.2 33.1 32.6 34.2 75.6 60.1 35.5 34.6 62.7 41.3 62.6 59.3 47.9 43.5 63.4 46.5 36.6 112.7 30.6 34.7 101.4 79.0 49.0 37.2 35.7 34.8 30.6 46.2 45.2 79.4 35.7 45.1 33.9 41.6 59.8 37.4 46.9 43.9 146.0 63.9 58.8 52.6 33.0 46.5 58.1 29.6 36.8 42.9 43.3 226.2 46.0 58.5 50.2 33.2 79.1 81.1 63.7 45.4 98.1 110.6 97.5 106.3 107.8 106.8 99.0 80.9 88.1 81.0 44.3 118.1 48.1 87.8 109.0 105.6 112.0 61.5 43.3 68.4 66.3 74.8 101.4 49.5 45.4 114.0 90.5 103.8 126.7 95.5 106.1 36.6 53.4 55.6 110.3 112.0 59.0 69.7 55.0 146.6 79.0 73.8 93.8 46.7 125.8 100.8 75.5 64.1 100.6 129.4 71.3 54.2 121.7 70.5 90.8 63.8 83.2 79.5 74.0 38.7 43.7 73.4 93.9 47.9 68.8 3.0 1.3 2.3 2.1 2.0 1.8 1.6 1.9 1.6 2.1 1.0 1.5 2.2 1.3 3.5 1.8 2.8 2.0 1.5 33.1 34.2 35.5 34.6 30.6 34.7 35.7 34.8 30.6 33.9 33.0 36.8 33.2 24.2 6.4 4.8 14.0 22.7 26.4 23.5 19.7 21.6 19.1 25.1 20.4 28.5 21.5 10.1 20.2 31.3 41.0 27.7 41.9 56.7 37.8 7.3 10.9 20.4 19.8 14.8 22.5 21.9 25.7 38.8 25.6 30.5 18.9 21.0 19.4 23.2 43.6 32.1 13.5 24.6 31.8 12.2 20.9 19.0 6.2 18.0 18.8 23.2 13.1 27.1 10.0 20.6 18.6 18.5 44.3 28.0 20.7 20.0 28.2 49.8 73.3 8.7 20.8 26.3 18.3 24.0 12.1 15.3 34.2 28.4 79.5 23.1 19.3 40.5 27.7 PPP4R4 "CFAP14, KIAA1622, PP4R4" ENSG00000119698 "Protein phosphatase 4 regulatory subunit 4" Q6NUP7 14 94146128-94279734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 5.4;testis: 8.0" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Cone photoreceptor cells: 75.0;Excitatory neurons: 63.1;Inhibitory neurons: 63.0;Spermatocytes: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 6.7;RH-30: 19.4;T-47d: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041866, HPA050321" Approved Supported Cytosol NA NA Cytosol "HPA041866: AB_10804120, HPA050321: AB_2681086" "unprognostic (2.65e-3)" "unprognostic (3.06e-1)" "unprognostic (9.07e-2)" "unprognostic (9.49e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (2.45e-1)" "unprognostic (1.25e-1)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (1.72e-2)" "unprognostic (8.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.35e-2)" "unprognostic (1.77e-1)" "unprognostic (6.24e-2)" 0.2 0.4 2.7 0.3 3.0 0.1 0.5 2.1 4.1 3.6 0.9 0.1 0.0 0.8 0.0 0.3 1.6 0.3 0.2 3.0 3.7 0.2 3.0 1.5 0.2 2.8 2.4 3.0 5.2 0.4 0.9 2.6 0.6 2.8 0.4 0.1 5.4 0.3 0.6 0.1 0.4 0.1 0.3 1.5 0.0 0.7 8.0 3.4 0.1 0.2 0.0 0.6 0.2 1.2 4.3 0.8 0.1 3.5 0.9 0.8 0.0 0.9 0.4 3.1 1.0 0.9 0.2 0.9 0.0 0.0 0.0 2.5 0.1 4.5 4.7 0.6 0.3 0.7 0.0 0.0 1.9 0.3 0.0 0.6 0.0 0.9 0.1 6.7 0.0 0.0 2.1 0.0 0.3 0.6 1.0 0.0 0.1 1.8 0.0 0.1 0.2 19.4 0.1 0.2 0.9 0.4 0.1 0.1 0.1 0.1 1.3 23.6 0.0 0.0 3.0 2.9 0.2 0.3 0.9 0.1 0.6 1.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 3.0 2.1 4.1 3.0 3.7 2.8 2.4 3.0 2.8 1.5 3.4 4.3 0.1 3.2 9.5 44.4 0.1 4.8 4.9 4.9 5.7 1.4 3.6 0.8 0.4 0.0 2.9 0.0 75.0 0.0 0.0 0.0 0.0 2.4 17.9 3.5 0.2 0.6 0.0 0.0 63.1 0.4 0.2 0.5 2.0 3.1 0.0 19.5 6.4 1.0 0.1 1.7 63.0 0.0 2.0 1.3 0.7 18.0 5.9 0.2 0.0 1.9 0.0 6.0 0.0 17.6 3.7 0.2 0.0 5.7 0.1 17.8 0.0 0.2 14.5 0.8 0.0 0.6 1.6 33.7 9.2 1.6 2.6 0.0 0.4 1.2 0.0 7.2 TGFB3 "ARVD, ARVD1" ENSG00000119699 "Transforming growth factor beta 3" P10600 14 75958097-75983011 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 28.8;Late spermatids: 48.9;Leydig cells: 27.1;Sertoli cells: 32.9;Smooth muscle cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "SK-BR-3: 104.6;T-47d: 75.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063582 Approved Vesicles "Secreted to blood" NA NA 44800 Vesicles "HPA063582: AB_2685049" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (4.32e-3)" "unprognostic (1.29e-1)" "unprognostic (3.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (9.79e-2)" "unprognostic (2.83e-2)" "unprognostic (1.51e-2)" "unprognostic (5.63e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (4.01e-7)" "unprognostic (6.38e-3)" "unprognostic (1.10e-1)" "unprognostic (1.22e-2)" "unprognostic (3.27e-3)" 16.3 13.1 52.6 15.9 52.4 1.1 15.8 43.0 50.7 47.0 29.1 9.8 4.2 25.7 9.7 7.7 14.6 36.9 24.6 41.4 42.9 12.5 17.8 26.0 7.3 52.0 51.6 32.3 8.1 27.9 9.9 8.4 55.8 63.6 44.0 4.9 1.9 10.9 18.0 38.9 4.9 6.7 34.6 48.7 5.3 14.2 4.6 51.1 6.5 12.4 11.1 8.8 46.2 16.3 67.2 1.1 1.5 1.1 13.4 2.1 4.3 0.4 1.0 1.5 0.7 0.7 0.8 3.4 0.1 1.0 2.8 0.4 0.9 2.9 0.7 0.3 0.8 1.5 0.1 3.5 1.5 2.7 0.6 0.9 10.2 0.4 1.0 0.4 2.3 3.2 2.7 1.5 6.3 0.8 7.0 0.8 0.8 0.4 0.8 5.3 3.3 4.2 0.7 1.2 0.6 21.9 6.3 4.3 104.6 0.8 1.5 75.2 0.5 0.8 2.0 4.5 2.1 5.8 0.8 1.3 0.4 3.6 1.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 52.4 43.0 50.7 41.4 42.9 52.0 51.6 32.3 63.6 48.7 51.1 67.2 8.6 0.0 2.8 5.5 0.8 4.5 1.2 2.1 1.2 0.7 15.1 6.1 3.6 0.0 3.3 1.8 4.2 0.5 1.2 1.3 0.0 0.5 16.4 2.6 9.9 10.2 0.0 0.0 1.3 1.3 0.4 28.8 0.0 2.4 0.0 0.5 7.9 0.8 0.9 0.0 3.0 2.6 6.1 0.6 4.4 48.9 27.1 0.9 10.6 1.0 0.7 2.1 3.1 5.5 4.7 0.4 0.1 12.8 0.5 20.6 1.4 0.4 4.2 3.9 32.9 13.9 24.4 0.4 1.4 2.4 3.1 1.4 1.3 1.6 0.4 0.8 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064109-75119502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.1;testis: 55.8" "Group enriched" "Detected in many" 5 "Early spermatids: 165.2;Late spermatids: 195.1;Spermatocytes: 198.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.9 2.6 3.8 0.6 2.8 0.4 1.7 2.9 2.9 1.8 4.4 2.7 3.1 1.3 24.1 1.3 11.1 1.6 4.4 2.4 2.9 5.6 8.5 2.5 0.2 3.0 3.1 2.3 0.6 5.2 7.0 6.2 0.9 2.9 1.3 2.4 2.6 3.0 3.4 4.7 1.5 2.4 1.0 3.1 0.8 1.6 55.8 2.8 2.3 7.1 1.5 0.5 1.4 0.6 3.4 3.8 2.8 0.3 3.3 0.2 0.0 1.8 0.3 1.1 1.4 0.8 4.8 6.9 3.3 2.6 0.4 2.6 1.0 0.0 0.0 1.2 3.9 0.3 0.6 1.0 2.3 2.5 0.0 1.8 0.3 0.4 1.6 0.0 1.7 1.1 0.2 5.8 1.0 0.7 0.6 0.4 0.3 0.7 2.4 1.8 0.0 0.2 0.7 4.3 0.3 5.7 1.3 2.4 2.0 1.5 0.6 2.9 0.9 0.7 0.9 0.9 1.0 0.8 4.0 4.9 1.1 1.4 0.4 0.6 0.3 0.0 0.2 0.6 0.0 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.2 0.1 0.2 0.9 0.1 3.8 2.8 2.9 2.9 2.4 2.9 3.0 3.1 2.3 2.9 3.1 2.8 3.4 0.8 6.4 9.7 2.0 0.9 1.8 1.9 1.3 4.6 4.5 7.9 5.1 7.0 2.8 6.6 11.0 10.4 2.3 1.6 2.5 3.9 4.6 165.2 21.0 2.1 2.0 5.3 0.4 2.4 1.4 1.1 2.5 1.1 1.9 1.3 1.1 2.9 4.7 1.7 11.8 2.1 2.3 0.0 1.0 0.7 195.1 3.1 1.0 3.6 1.0 0.9 3.0 8.2 0.5 1.0 1.6 0.6 2.6 0.6 2.8 4.2 7.4 32.5 8.5 6.6 5.2 2.0 198.5 5.5 1.9 0.9 5.1 0.9 2.3 3.9 1.3 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1099.6;Proximal tubular cells: 1027.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria No Yes 32000 Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 116.3 132.1 256.6 81.1 264.8 123.7 156.6 260.8 394.2 90.2 243.4 162.8 113.6 92.3 198.1 165.0 90.4 68.9 287.9 259.4 263.2 186.5 212.9 81.8 83.4 264.0 261.0 256.2 82.6 111.5 146.4 121.1 92.6 262.2 96.5 142.7 110.8 105.9 91.1 368.0 89.4 108.5 97.9 263.6 93.7 141.3 123.9 261.2 98.3 95.4 446.2 114.5 125.0 102.7 273.7 422.5 867.3 340.9 330.8 226.0 227.7 441.2 240.0 234.8 484.1 419.6 1187.1 387.1 314.2 238.9 284.7 295.6 415.7 645.4 508.0 647.3 166.5 717.2 316.3 816.1 1199.5 343.4 211.8 216.6 242.5 332.3 387.3 428.2 232.4 408.7 403.2 321.2 172.8 430.0 1442.6 325.3 562.2 525.1 938.0 1211.5 294.8 282.9 345.6 508.8 840.3 425.5 274.1 253.3 533.0 360.3 373.7 555.7 360.9 227.0 237.1 422.5 254.0 416.9 184.8 374.7 605.0 325.7 407.2 309.6 88.9 276.1 103.9 105.2 275.3 112.0 169.4 139.0 104.6 239.8 143.1 143.4 120.3 87.8 93.3 288.8 247.4 154.9 216.2 256.6 264.8 260.8 394.2 259.4 263.2 264.0 261.0 256.2 262.2 263.6 261.2 273.7 130.4 109.0 140.0 8.5 112.3 178.8 164.5 542.9 92.8 68.8 168.8 154.3 1099.6 270.2 303.9 264.8 47.9 393.0 82.7 330.9 770.9 405.1 548.5 163.7 141.9 169.0 246.8 203.2 10.8 530.1 382.3 166.0 119.3 123.7 171.5 73.1 179.2 793.4 313.6 43.7 9.6 373.1 388.6 202.8 119.5 123.0 168.0 135.2 250.8 2.8 211.4 206.4 93.7 8.5 16.7 440.6 334.4 170.0 136.9 190.5 563.3 1027.1 254.5 126.8 170.9 178.6 202.7 382.6 210.3 178.5 214.4 240.5 80.6 84.7 404.0 163.8 RBM25 "fSAP94, NET52, RNPC7, S164, Snu71" ENSG00000119707 "RNA binding motif protein 25" P49756 14 73058532-73123899 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003025, HPA070713" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA003025: AB_1079748, HPA070713: AB_2686302" "unprognostic (1.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.28e-1)" "unprognostic (4.85e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.22e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (8.09e-4)" "prognostic unfavorable (4.26e-4)" "unprognostic (6.98e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (1.73e-1)" 30.6 23.4 15.5 36.4 16.1 73.3 31.0 21.8 21.1 28.7 17.4 28.6 23.6 31.6 22.9 29.1 29.8 21.4 21.5 15.8 17.7 19.3 21.3 30.6 40.3 16.4 16.4 13.5 31.4 33.5 22.9 25.5 26.9 17.5 22.7 24.3 42.3 31.7 20.0 41.4 32.6 30.2 23.4 13.6 30.0 28.0 28.7 15.3 36.7 29.5 22.1 33.7 28.3 30.0 21.2 97.8 55.6 86.9 66.6 38.1 44.6 76.5 78.4 54.6 59.5 65.2 74.5 61.2 116.7 40.5 54.0 45.1 72.3 100.9 47.2 101.6 73.8 53.3 98.2 43.2 57.7 24.1 87.5 60.0 32.4 33.3 69.7 56.7 51.1 60.0 42.4 102.7 47.6 65.2 73.3 114.4 51.1 73.8 59.6 60.1 97.4 94.8 57.1 49.0 67.4 58.5 55.8 98.5 64.4 35.0 52.2 92.7 37.9 77.2 87.5 85.5 47.3 79.7 50.2 96.0 141.5 39.1 61.3 61.2 17.4 17.2 16.6 19.9 19.2 18.7 22.3 15.8 16.9 18.2 23.7 16.6 17.6 20.3 27.2 17.5 28.7 19.2 11.7 15.5 16.1 21.8 21.1 15.8 17.7 16.4 16.4 13.5 17.5 13.6 15.3 21.2 177.8 230.8 319.9 94.7 226.2 227.4 194.3 109.8 198.6 253.8 136.2 139.2 131.5 77.2 191.8 92.0 268.9 151.8 268.4 137.5 17.6 111.0 71.1 160.4 295.6 170.2 155.2 149.3 115.4 122.6 183.5 185.1 146.8 223.2 247.8 183.3 95.3 98.3 113.1 180.0 99.3 146.3 54.9 110.8 180.8 29.2 157.8 169.9 81.8 71.2 176.9 131.2 155.5 84.9 134.1 132.9 111.0 137.7 233.2 236.5 86.3 32.9 137.0 263.0 72.3 234.2 213.4 213.8 212.9 196.7 236.7 185.4 242.9 161.0 162.5 235.1 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056847-74084492 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "kidney: 382.6;liver: 370.2" "Cell type enhanced" "Detected in all" "Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 43.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 43.2" "Cell line enhanced" "Detected in all" "T-47d: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria No No 37000 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favorable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favorable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 39.0 14.9 56.0 4.8 60.4 3.4 14.5 57.2 56.3 17.4 54.1 15.3 26.8 11.5 9.9 9.9 12.9 9.5 40.7 49.4 48.5 382.6 370.2 9.5 5.2 59.7 51.1 45.3 28.6 23.6 37.3 6.7 7.6 57.4 25.7 16.0 15.4 20.0 16.2 27.7 6.2 23.5 9.0 53.2 5.4 24.2 17.2 58.7 5.8 28.6 35.1 5.3 11.5 7.1 60.8 8.9 7.8 11.0 23.5 39.3 19.2 17.5 6.3 11.8 6.8 11.5 17.3 10.2 10.5 13.6 13.5 5.3 4.8 24.9 7.0 14.5 9.5 3.5 5.1 8.0 19.2 45.0 2.7 2.4 28.2 12.0 8.7 20.7 17.0 12.0 23.7 8.1 14.7 4.6 36.2 7.6 4.0 8.7 32.6 5.2 15.1 11.2 14.6 9.2 5.8 4.4 7.0 21.0 21.9 5.7 18.0 57.5 9.6 3.8 7.4 9.0 11.7 2.4 9.3 18.9 10.2 9.9 3.2 7.3 29.1 6.2 43.2 6.9 4.8 10.6 7.2 7.8 8.4 9.2 6.1 9.9 7.0 2.4 9.7 4.2 5.3 6.1 4.9 56.0 60.4 57.2 56.3 49.4 48.5 59.7 51.1 45.3 57.4 53.2 58.7 60.8 15.4 38.5 60.4 24.5 11.8 9.2 26.8 10.0 20.5 20.6 28.4 18.9 81.4 67.2 22.9 66.2 4.2 31.0 7.1 18.9 201.5 11.6 23.4 26.2 27.5 27.0 16.9 28.6 5.5 3.1 14.8 25.9 34.7 90.2 7.6 27.1 87.4 523.6 17.7 11.8 10.0 39.3 8.2 26.5 8.9 19.0 28.9 13.4 24.9 1.9 15.8 98.5 9.2 12.5 23.4 4.1 16.3 48.2 8.0 27.6 55.3 962.4 15.4 17.0 13.1 25.6 16.9 11.0 4.2 25.2 7.4 30.6 11.0 10.2 35.7 17.2 GPR68 OGR1 ENSG00000119714 "G protein-coupled receptor 68" Q15743 14 91232532-91253925 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Amelogenesis imperfecta, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.3" "Cell type enhanced" "Detected in many" "dendritic cells: 8.0;Hofbauer cells: 17.3;Langerhans cells: 22.6;NK-cells: 12.3;T-cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 22.9" "Group enriched" "Detected in many" 9 "NK-cells: 20.2;T-cells: 22.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 9.0;U-87 MG: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.44e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.10e-2)" "unprognostic (1.58e-1)" "unprognostic (6.84e-2)" "unprognostic (9.63e-2)" "unprognostic (9.42e-2)" "unprognostic (3.73e-1)" "unprognostic (8.31e-9)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (9.44e-2)" "unprognostic (2.78e-3)" 2.5 1.0 2.5 5.7 2.2 1.4 2.3 3.7 5.5 1.9 0.7 2.6 1.8 1.3 0.5 8.8 1.0 3.7 2.1 1.8 2.8 1.6 1.0 5.0 6.0 1.9 3.0 2.4 0.3 0.7 1.0 12.3 3.1 2.7 2.8 1.5 0.2 3.8 0.4 0.7 6.2 2.9 2.0 0.2 4.2 5.8 2.1 2.5 1.2 1.7 0.2 2.9 7.6 3.9 2.1 0.2 0.1 0.6 0.0 0.0 0.9 0.6 1.1 0.6 0.0 0.0 0.2 1.0 0.9 0.4 9.0 0.0 1.0 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.2 0.0 0.6 4.1 0.4 0.1 4.8 0.0 4.4 0.4 2.9 5.8 0.8 3.9 1.2 0.8 6.4 0.1 0.0 0.1 0.3 0.3 0.2 0.1 0.3 3.1 4.4 0.1 0.1 0.0 0.2 1.5 0.4 2.8 6.1 0.1 1.1 0.4 1.0 1.3 0.2 28.6 1.1 0.1 0.0 0.1 0.1 22.9 0.0 13.8 0.5 5.0 13.5 0.2 0.4 0.6 4.5 2.3 20.2 0.0 0.0 8.7 4.1 2.5 2.2 3.7 5.5 1.8 2.8 1.9 3.0 2.4 2.7 0.2 2.5 2.1 1.1 0.0 4.8 0.3 0.7 3.6 0.2 4.2 0.6 0.5 0.8 0.8 1.7 0.0 1.0 0.0 0.0 0.1 8.0 0.1 0.0 0.0 5.4 0.5 0.2 6.9 0.0 2.7 4.1 0.2 0.1 4.3 0.0 0.3 0.0 0.1 0.4 0.0 17.3 0.0 2.1 0.0 0.0 0.0 22.6 1.6 0.3 3.0 3.6 0.0 0.6 0.0 12.3 1.0 0.3 2.9 0.0 4.5 1.3 0.1 0.0 0.4 0.4 0.2 0.0 0.1 1.1 3.4 0.4 0.9 3.0 0.7 13.1 0.2 0.0 0.3 ESRRB "DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2" ENSG00000119715 "Estrogen related receptor beta" O95718 14 76310712-76501837 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 36.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA074772 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074772: " "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.92e-5)" "unprognostic (5.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.14e-1)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.46e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-4)" "unprognostic (4.40e-2)" 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 4.9 0.3 0.5 6.2 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 36.8 0.0 0.0 6.6 0.0 0.0 0.0 0.6 0.2 2.4 1.2 0.8 0.1 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.2 0.0 0.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.4 0.0 0.2 2.3 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.3 0.5 1.1 0.8 0.0 0.8 0.6 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.4 1.0 0.4 5.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 13.7 0.0 14.1 0.0 0.0 0.8 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 2.0 0.0 0.0 0.0 0.0 37.6 0.0 0.1 0.0 3.7 0.0 4.6 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 40.3 0.0 0.1 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002921-75012366 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 12000 "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: AB_2680235" "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favorable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 2.7 5.4 4.3 3.0 4.7 3.2 3.6 8.7 5.0 3.9 2.1 3.0 3.0 3.6 4.9 3.9 3.1 4.0 4.0 3.7 4.5 5.0 3.3 2.7 4.0 4.4 4.4 3.0 2.9 4.0 8.6 3.6 4.9 5.6 4.2 3.8 6.8 2.8 4.5 5.5 4.0 2.9 3.4 3.2 2.7 2.6 4.0 4.7 3.9 11.6 7.2 4.2 4.0 2.6 7.0 5.9 7.0 5.6 6.4 6.3 5.2 7.4 3.7 6.1 7.1 8.2 9.0 5.9 5.2 2.3 5.8 4.5 4.4 8.8 8.7 10.6 3.2 6.5 4.6 6.3 6.2 8.2 3.4 5.3 4.8 8.2 9.1 9.3 6.1 24.8 4.5 4.2 4.9 15.5 17.4 5.5 4.3 4.0 7.3 10.3 3.4 6.6 4.3 10.1 7.0 6.0 4.8 3.9 5.5 8.4 6.9 9.0 3.2 6.4 5.4 5.2 2.4 4.8 8.4 7.5 6.2 5.9 4.3 4.2 4.2 1.8 1.4 3.0 1.9 2.5 2.1 2.6 2.5 2.4 2.0 1.9 2.0 1.0 3.3 1.8 2.0 4.0 2.5 4.3 4.7 8.7 5.0 3.7 4.5 4.4 4.4 3.0 5.6 3.2 4.7 7.0 18.9 19.2 11.5 6.2 14.1 17.7 19.5 28.9 18.2 28.2 15.4 17.0 18.2 22.8 21.5 25.8 45.9 51.5 16.1 15.3 41.1 36.2 12.1 17.0 14.5 32.1 15.6 20.8 5.3 33.1 56.5 18.3 12.8 12.8 21.5 17.5 13.2 11.9 33.7 28.6 5.4 9.0 20.3 19.1 11.9 12.7 15.8 18.8 14.2 1.9 28.0 27.3 28.8 2.5 8.5 28.1 11.7 16.1 11.3 17.5 19.0 50.8 17.2 29.4 26.3 16.9 27.9 84.2 27.4 27.3 21.9 165.5 14.9 30.5 19.7 19.2 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267860-90331969 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 111.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047050: AB_2679917, HPA050583: AB_2681182" "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 1.0 1.0 1.7 1.4 2.8 3.5 1.3 6.4 2.2 1.3 1.9 1.3 2.6 1.6 1.3 1.1 1.2 0.9 1.0 1.8 2.7 1.1 1.7 1.2 1.2 2.2 1.9 1.3 1.6 1.3 1.4 1.8 1.1 3.3 1.4 1.0 3.2 1.4 0.9 1.6 2.0 1.6 1.1 1.5 1.6 1.3 0.9 2.3 1.7 1.7 1.1 1.1 1.1 1.2 3.1 0.7 1.4 2.0 1.2 0.3 1.0 1.4 1.4 0.9 1.0 1.1 1.8 1.3 1.3 0.7 1.4 1.3 1.9 1.1 1.9 1.9 2.5 1.7 1.7 5.0 1.3 0.5 4.6 2.2 1.8 1.3 1.0 0.6 2.1 0.9 3.3 0.8 2.0 0.9 1.4 2.1 1.9 0.7 0.6 1.1 1.8 2.9 0.5 0.6 2.9 1.8 2.1 0.6 3.8 1.0 0.7 1.7 1.9 1.2 1.5 0.7 0.9 0.6 1.6 1.9 1.3 1.4 0.8 1.8 1.6 0.8 1.0 0.8 0.5 0.6 0.8 0.5 0.6 0.4 1.0 0.5 0.6 1.3 0.7 0.4 1.1 0.5 0.2 1.7 2.8 6.4 2.2 1.8 2.7 2.2 1.9 1.3 3.3 1.5 2.3 3.1 18.2 35.3 29.7 11.4 21.6 5.9 7.0 13.3 17.1 79.4 19.7 14.9 13.2 37.1 18.8 18.4 87.6 19.1 26.4 23.3 7.9 16.6 8.6 15.2 23.8 20.8 24.7 13.7 10.0 14.6 13.0 16.7 18.8 18.0 38.6 24.7 28.2 42.1 11.8 53.8 12.2 24.2 14.2 17.6 6.7 9.7 23.6 12.8 8.8 4.7 25.1 30.4 30.9 15.1 18.8 14.0 17.7 33.1 9.4 8.0 36.5 18.6 11.4 111.3 0.0 26.6 16.5 24.3 39.4 9.3 6.3 25.2 18.6 18.3 23.7 5.5 COQ6 CGI-10 ENSG00000119723 "Coenzyme Q6, monooxygenase" Q9Y2Z9 14 73949926-73963670 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Deafness, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051371 Uncertain NA NA "HPA051371: AB_2681459" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.26e-2)" "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "unprognostic (2.88e-1)" "unprognostic (1.75e-2)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (8.33e-3)" "unprognostic (9.45e-3)" "unprognostic (2.90e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.19e-1)" "unprognostic (1.94e-1)" "unprognostic (7.46e-2)" "unprognostic (1.89e-1)" 11.1 38.7 11.0 5.7 11.3 5.6 12.1 11.3 13.2 12.0 14.7 11.9 10.3 10.1 11.4 10.1 10.6 6.8 31.0 11.1 11.5 23.2 25.9 7.5 6.3 11.0 11.0 10.9 11.6 7.0 25.3 16.0 8.1 11.0 12.7 9.6 5.8 11.2 10.0 39.0 9.2 10.9 9.9 11.0 11.4 13.5 22.2 11.1 7.4 12.4 43.0 7.1 13.7 10.6 11.4 12.2 21.7 11.1 25.7 13.2 10.7 15.4 14.8 13.6 21.8 18.4 16.4 21.0 10.7 13.7 15.3 15.0 19.1 16.6 14.8 20.6 16.3 13.3 7.2 12.8 14.3 18.0 7.2 24.9 18.1 19.2 19.9 19.5 14.1 13.9 21.5 6.4 9.6 19.2 33.3 12.4 11.7 4.0 24.8 26.0 11.7 14.1 7.6 22.9 15.2 16.6 8.8 25.2 21.5 14.6 7.2 36.4 13.3 9.4 24.8 22.9 19.0 10.8 8.9 9.0 9.0 13.7 10.6 17.1 5.4 11.3 9.2 11.3 14.2 11.3 10.3 11.2 11.3 12.1 5.3 15.6 9.4 2.3 14.5 13.1 8.9 7.6 8.5 11.0 11.3 11.3 13.2 11.1 11.5 11.0 11.0 10.9 11.0 11.0 11.1 11.4 11.9 25.6 25.5 6.2 11.4 4.7 8.1 26.9 6.8 18.9 12.3 12.4 10.3 11.5 23.1 12.9 12.5 26.3 4.1 8.3 19.6 10.8 167.0 14.1 11.0 9.1 4.8 7.4 10.0 10.9 12.6 11.9 12.2 9.9 25.3 13.9 11.4 14.7 16.2 20.2 10.0 9.7 20.3 5.4 4.2 49.5 10.8 7.5 10.6 3.7 9.6 12.0 15.5 5.0 8.4 8.6 8.4 12.4 10.6 6.0 23.3 41.3 15.8 28.1 19.7 10.5 20.5 24.7 21.0 11.5 6.0 23.8 11.9 39.9 9.4 7.1 ZNF410 "APA-1, APA1" ENSG00000119725 "Zinc finger protein 410" Q86VK4 14 73886617-73932521 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002871 Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA002871: AB_1080712" "unprognostic (5.84e-2)" "unprognostic (5.04e-2)" "unprognostic (9.29e-2)" "unprognostic (6.36e-3)" "unprognostic (5.86e-4)" "unprognostic (4.91e-2)" "unprognostic (2.83e-3)" "unprognostic (2.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.79e-2)" "unprognostic (2.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.19e-1)" 27.4 33.3 28.8 18.8 30.4 58.2 29.7 31.0 34.2 28.7 29.5 28.2 19.2 27.8 44.1 33.7 28.3 22.8 20.1 27.3 35.7 28.1 29.0 27.8 25.8 29.4 27.9 26.0 39.1 20.8 27.3 27.2 32.4 29.1 29.8 24.6 23.0 24.6 27.6 21.3 37.7 25.4 28.7 27.9 26.3 25.9 45.1 28.6 30.2 24.8 18.5 30.9 29.4 28.9 37.2 46.7 35.8 42.4 45.2 44.8 39.8 52.4 51.4 56.9 88.2 82.0 37.6 40.1 38.4 21.7 65.7 28.2 42.1 42.9 52.8 83.2 56.2 26.9 36.2 31.6 29.9 67.4 30.6 45.6 37.0 72.4 44.5 83.1 39.5 47.5 43.9 38.2 33.0 43.3 88.6 45.8 51.2 15.5 56.3 41.7 40.7 48.5 24.7 57.0 43.7 39.0 50.3 57.2 52.5 54.6 35.5 48.3 52.2 30.7 62.7 59.0 37.1 47.2 45.2 83.4 48.0 40.1 34.1 53.7 65.9 45.3 74.8 47.5 43.1 51.9 37.7 49.0 49.0 45.6 43.0 42.3 43.5 34.4 60.5 50.1 30.8 46.7 55.9 28.8 30.4 31.0 34.2 27.3 35.7 29.4 27.9 26.0 29.1 27.9 28.6 37.2 4.3 0.0 3.1 27.7 10.8 0.6 1.5 1.0 10.8 1.5 2.2 1.7 1.1 0.0 2.9 0.0 4.2 1.8 5.0 1.7 0.0 1.0 3.8 4.7 5.6 2.6 0.0 5.9 22.7 0.9 1.5 5.3 10.7 6.7 10.8 2.9 1.8 0.4 1.2 1.7 23.8 1.1 0.0 2.2 3.1 1.1 1.2 5.4 1.8 18.7 1.1 2.4 2.1 18.1 31.0 1.3 1.4 0.4 13.4 1.0 2.4 0.7 0.2 4.7 0.0 4.0 5.1 3.3 1.9 10.1 1.1 2.6 10.5 4.1 0.8 1.4 RHOQ "ARHQ, RASL7A, TC10" ENSG00000119729 "Ras homolog family member Q" P17081 2 46541806-46584688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 189.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.5;classical monocyte: 2.5;eosinophil: 4.2;intermediate monocyte: 2.7;memory B-cell: 1.7;myeloid DC: 1.6;naive B-cell: 2.4;neutrophil: 4.8;non-classical monocyte: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 164.0;ASC TERT1: 132.0;SK-MEL-30: 150.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044938 Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA044938: AB_2679149" "unprognostic (1.24e-1)" "unprognostic (1.30e-2)" "unprognostic (5.82e-2)" "unprognostic (2.07e-2)" "unprognostic (3.61e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.60e-5)" "unprognostic (2.01e-2)" "unprognostic (9.24e-2)" "unprognostic (2.11e-2)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (3.88e-3)" "unprognostic (1.39e-2)" "unprognostic (1.87e-1)" "unprognostic (7.68e-2)" "unprognostic (3.52e-2)" 95.1 36.0 38.0 30.4 44.2 12.5 65.4 43.3 41.8 58.0 46.5 54.2 11.1 53.6 68.3 19.1 59.8 26.9 151.2 37.5 51.6 37.5 22.7 56.5 24.0 46.0 46.7 32.5 41.2 28.9 50.8 29.8 28.8 43.1 51.0 13.6 28.0 32.9 36.8 163.7 27.1 35.6 38.7 42.8 43.1 33.1 10.1 40.7 10.0 39.4 183.0 19.2 63.4 45.1 48.0 12.3 12.4 21.0 28.6 164.0 132.0 3.7 32.8 84.1 16.2 24.4 6.2 4.1 28.7 34.0 58.5 52.4 5.8 20.6 9.8 29.3 10.2 15.3 8.2 9.8 20.9 81.8 8.8 10.7 118.1 17.3 20.1 22.5 39.0 19.3 3.1 12.1 44.0 35.2 8.1 6.9 17.9 20.8 8.9 14.4 5.3 34.5 10.1 23.1 22.4 15.3 50.3 11.6 16.4 150.8 32.9 9.0 20.7 13.2 50.1 44.8 49.3 14.1 48.5 17.7 28.4 73.6 22.1 18.4 1.5 2.5 4.2 0.4 2.7 0.3 1.7 0.2 0.4 1.6 2.4 0.0 0.3 4.8 0.3 1.9 0.6 0.3 0.7 38.0 44.2 43.3 41.8 37.5 51.6 46.0 46.7 32.5 43.1 42.8 40.7 48.0 27.9 57.7 22.4 65.3 38.1 22.4 31.0 18.1 11.4 21.1 30.4 22.4 189.2 14.3 22.1 20.2 10.4 14.6 32.2 1.0 17.6 21.4 30.8 22.1 90.2 23.4 6.0 2.1 12.8 32.0 3.6 82.8 4.1 24.6 12.0 12.1 17.5 12.2 44.5 121.1 27.7 5.5 8.2 90.9 77.8 11.4 35.4 90.7 42.7 68.4 55.1 52.9 15.5 52.3 41.5 22.4 0.3 42.5 42.0 41.2 0.2 30.1 18.8 24.2 46.0 54.2 82.3 2.3 4.5 6.8 19.7 25.9 17.0 10.9 1.9 31.9 GPR75 WI-31133 ENSG00000119737 "G protein-coupled receptor 75" O95800 2 53852912-53859967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.2;retina: 7.8" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Cone photoreceptor cells: 2.1;Gastric mucus-secreting cells: 2.0;Glandular and luminal cells: 1.9" "Cancer enriched" "Detected in many" 5 "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (2.77e-1)" "unprognostic (4.44e-2)" "unprognostic (5.96e-2)" "unprognostic (5.27e-3)" "unprognostic (8.31e-3)" "unprognostic (2.59e-3)" "unprognostic (4.71e-2)" "unprognostic (2.20e-1)" "unprognostic (3.07e-4)" "unprognostic (1.10e-1)" "unprognostic (3.97e-3)" "unprognostic (8.23e-2)" "unprognostic (1.94e-1)" "unprognostic (3.38e-1)" "unprognostic (5.75e-2)" 1.2 1.5 10.8 1.1 9.4 1.4 2.2 9.0 6.5 0.9 0.0 0.7 0.4 1.5 0.8 0.9 1.3 1.3 0.8 7.0 22.2 0.5 2.7 1.0 1.1 13.9 14.6 2.3 2.0 1.3 3.3 2.0 0.5 12.7 1.6 0.6 7.8 1.9 1.3 1.1 0.9 0.9 1.6 5.0 1.4 1.1 0.7 15.1 1.1 2.0 0.7 0.7 0.9 0.8 6.2 1.6 1.7 2.4 2.2 0.8 0.5 3.2 1.3 0.8 1.5 1.4 4.4 0.7 3.4 1.1 1.8 1.3 2.4 2.9 2.4 2.3 2.9 1.9 3.9 2.8 2.4 0.5 2.2 2.6 1.1 0.7 3.8 0.7 0.8 1.2 1.2 2.3 0.9 1.3 1.2 1.0 1.7 3.2 0.4 1.9 1.7 2.2 0.6 0.8 2.4 1.4 2.1 1.1 0.9 0.6 2.5 0.8 0.7 3.2 2.6 2.5 2.1 3.7 0.7 0.5 1.0 2.4 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 10.8 9.4 9.0 6.5 7.0 22.2 13.9 14.6 2.3 12.7 5.0 15.1 6.2 0.3 0.0 0.0 0.0 0.1 0.6 0.2 0.2 1.2 0.2 0.6 0.4 0.3 0.0 0.2 0.0 2.1 0.1 0.9 0.1 0.0 0.0 0.2 0.6 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.3 2.0 1.9 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.7 0.3 0.1 0.2 1.0 0.9 0.0 0.3 0.1 0.1 0.2 SUPT7L "KIAA0764, SPT7L, STAF65, STAF65gamma" ENSG00000119760 "SPT7 like, STAGA complex subunit gamma" O94864 2 27650809-27663840 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039565, HPA063643" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039565: AB_10795109, HPA063643: AB_2685070" "unprognostic (1.10e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (7.54e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (4.46e-7)" "unprognostic (5.15e-2)" "unprognostic (1.43e-3)" "unprognostic (2.27e-2)" "unprognostic (1.97e-3)" "unprognostic (9.75e-3)" "prognostic unfavorable (1.53e-4)" "unprognostic (2.26e-1)" "unprognostic (4.86e-1)" "unprognostic (3.79e-1)" "unprognostic (5.23e-3)" 28.2 35.4 33.1 22.7 32.6 36.0 28.0 32.6 37.8 33.8 37.9 30.7 23.1 32.1 25.2 26.0 32.5 20.6 36.6 32.5 33.3 32.5 38.2 29.9 27.6 32.0 32.4 31.6 39.9 31.4 23.0 46.5 27.4 32.5 34.3 25.6 55.9 24.2 22.3 30.4 19.2 33.0 28.3 30.2 41.9 30.0 20.7 32.4 26.4 36.6 27.4 24.4 29.5 29.8 36.0 33.6 28.6 41.2 31.9 36.8 30.1 49.0 32.0 30.9 28.4 30.4 37.2 36.8 29.2 32.9 34.0 40.0 35.8 37.3 35.6 27.6 33.7 36.1 39.8 43.7 42.4 48.1 32.4 37.5 42.3 43.8 42.0 44.0 52.7 37.3 35.3 45.8 34.0 37.3 23.1 28.1 52.9 27.5 33.5 25.0 26.8 44.1 37.4 36.7 31.1 32.5 42.3 28.6 29.6 54.7 52.0 20.5 27.9 28.8 39.2 29.0 19.9 30.8 60.9 47.8 60.4 30.5 39.8 27.3 30.4 14.8 13.6 18.2 15.7 20.7 10.6 14.3 19.0 20.9 17.3 17.2 16.3 3.7 22.9 14.7 14.0 17.6 13.6 33.1 32.6 32.6 37.8 32.5 33.3 32.0 32.4 31.6 32.5 30.2 32.4 36.0 15.3 22.4 17.1 33.6 15.9 8.4 13.2 19.9 13.1 18.6 12.7 11.7 21.3 12.8 21.6 22.0 41.7 34.2 25.8 12.1 21.5 18.1 12.5 19.1 18.3 18.5 10.8 11.1 31.2 14.6 29.3 17.7 21.4 14.7 19.6 20.7 15.7 15.6 25.1 15.2 32.7 12.3 12.2 12.3 11.1 3.9 13.7 17.1 3.6 14.0 13.4 19.0 16.5 17.6 33.1 13.9 8.2 15.4 25.5 8.5 10.8 20.6 24.3 24.7 19.7 15.0 16.5 29.4 22.6 15.4 8.7 42.3 19.3 22.1 13.9 11.6 KLHL29 "KBTBD9, KIAA1921" ENSG00000119771 "Kelch like family member 29" Q96CT2 2 23385179-23708611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Excitatory neurons: 146.4;Inhibitory neurons: 132.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 16.9;RH-30: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049057, HPA057379" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA049057: AB_2680615, HPA057379: AB_2683422" "unprognostic (8.08e-3)" "unprognostic (2.91e-1)" "unprognostic (7.43e-3)" "unprognostic (2.65e-2)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (3.54e-3)" "unprognostic (1.16e-1)" "unprognostic (4.71e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.19e-4)" "unprognostic (2.53e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.12e-2)" "unprognostic (9.06e-2)" "unprognostic (7.44e-2)" "unprognostic (5.25e-4)" 6.2 9.3 3.0 2.2 4.4 0.1 5.9 1.0 9.5 5.1 3.0 6.8 0.9 6.1 1.2 2.9 4.4 3.1 2.0 5.7 3.5 4.2 2.6 3.9 2.7 2.4 3.3 4.6 2.5 1.9 2.3 10.3 3.3 3.1 7.7 1.2 7.1 3.1 4.8 10.8 5.5 3.8 3.1 1.6 5.0 3.9 0.9 4.1 1.6 1.6 2.9 1.6 4.5 5.1 5.0 1.4 1.1 7.5 3.8 7.0 4.6 12.9 7.8 6.0 3.1 2.2 0.0 0.4 5.1 2.6 3.0 16.9 0.2 1.7 6.7 2.1 0.0 8.0 0.0 6.7 0.0 2.4 0.0 9.9 3.4 8.9 4.1 11.6 1.0 5.3 0.2 0.0 0.0 1.7 0.7 1.8 0.0 3.7 0.0 2.3 0.5 19.3 0.1 5.8 2.3 11.3 2.3 1.0 0.8 4.5 3.0 0.0 0.1 5.4 3.1 14.4 6.7 2.7 0.2 0.0 0.0 11.8 0.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 4.4 1.0 9.5 5.7 3.5 2.4 3.3 4.6 3.1 1.6 4.1 5.0 1.2 6.4 5.3 6.8 0.3 4.7 10.4 2.9 7.4 8.4 0.4 6.0 2.3 4.3 1.3 1.8 27.1 1.2 0.1 0.1 0.0 1.2 1.8 3.5 5.4 2.3 4.2 0.0 146.4 0.2 0.9 3.9 0.0 3.9 0.0 0.2 0.7 0.5 0.3 1.7 132.7 0.7 0.0 0.0 0.0 0.7 5.0 0.4 1.8 7.5 0.0 1.7 0.0 5.5 4.7 0.4 0.4 4.1 0.0 1.9 0.0 1.3 1.7 26.1 6.6 6.5 6.5 0.1 1.1 2.0 5.8 0.8 0.4 0.4 0.8 1.5 DNMT3A ENSG00000119772 "DNA methyltransferase 3 alpha" Q9Y6K1 2 25227855-25342590 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009469, HPA026588" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009469: AB_2093990, HPA026588: AB_1847812" "unprognostic (2.38e-1)" "unprognostic (2.94e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (8.38e-2)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.18e-4)" "unprognostic (2.35e-2)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.43e-1)" "unprognostic (1.87e-1)" "unprognostic (1.14e-1)" "unprognostic (2.70e-2)" 5.6 9.1 9.3 9.9 12.6 8.8 6.3 9.5 10.2 8.8 2.6 10.0 6.7 9.3 8.8 6.0 7.5 6.4 5.9 9.1 6.9 6.7 5.3 7.4 11.2 9.4 7.9 8.4 13.2 8.4 4.3 11.5 15.8 10.7 7.3 6.6 15.5 6.2 6.0 21.2 4.9 9.0 7.2 5.6 13.5 8.6 5.2 8.1 20.8 7.0 10.3 9.1 7.4 6.2 11.7 1.6 8.1 34.6 8.3 3.8 2.7 45.2 1.9 2.2 4.7 3.8 21.1 13.2 0.0 4.7 4.7 3.5 2.2 3.8 5.2 2.8 5.7 4.3 14.7 12.8 25.4 8.8 2.9 7.6 8.2 2.6 6.0 2.2 9.1 19.5 34.0 18.0 2.9 3.5 20.6 33.7 36.5 59.6 14.3 4.2 59.5 32.5 3.8 2.9 3.4 18.6 71.5 2.7 19.6 6.2 29.5 2.1 16.2 6.8 5.4 4.7 1.0 2.5 5.6 5.1 19.6 2.2 8.4 5.5 2.8 1.0 2.1 2.7 1.7 4.0 1.3 1.7 2.4 1.3 1.6 4.6 3.9 2.5 5.5 2.7 2.3 1.9 1.2 9.3 12.6 9.5 10.2 9.1 6.9 9.4 7.9 8.4 10.7 5.6 8.1 11.7 18.5 6.4 13.1 28.1 11.0 5.2 10.2 6.6 5.7 73.3 12.1 9.8 15.8 5.7 9.9 20.2 127.2 40.6 15.3 6.3 5.9 16.9 1.6 13.3 19.1 20.5 13.1 15.8 49.4 9.8 10.7 16.4 9.7 10.7 37.4 37.3 11.0 6.4 23.2 95.9 43.2 11.4 2.0 14.2 3.9 1.9 19.3 13.7 7.2 38.4 7.4 20.6 13.4 36.7 63.4 9.3 9.4 15.4 9.8 12.4 6.2 6.6 7.3 143.5 19.7 15.1 14.3 2.8 14.6 8.1 2.6 32.2 19.6 26.1 12.1 10.2 TMEM214 FLJ20254 ENSG00000119777 "Transmembrane protein 214" Q6NUQ4 2 27032910-27041694 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034551 Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Golgi apparatus, Cytosol" "HPA034551: AB_10602481" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.10e-1)" "unprognostic (4.12e-3)" "unprognostic (1.90e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.96e-1)" "unprognostic (3.70e-1)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.39e-10)" "unprognostic (1.54e-2)" "unprognostic (1.97e-2)" "unprognostic (2.04e-1)" "unprognostic (2.92e-2)" 45.4 39.4 13.9 31.0 14.3 23.3 43.6 14.4 17.5 45.3 24.6 38.7 30.8 44.1 66.7 31.8 37.8 31.0 33.3 14.0 15.9 30.0 46.9 38.1 25.3 18.2 16.7 13.1 41.8 80.6 56.4 60.8 46.2 16.3 38.2 42.1 8.8 84.3 44.8 36.0 36.1 33.9 45.5 14.7 37.7 41.2 19.7 16.5 21.9 42.7 21.5 34.7 37.0 34.2 15.6 82.4 53.5 32.2 68.2 102.8 103.7 69.4 105.9 142.4 76.0 85.2 53.0 67.3 37.6 52.4 156.6 59.7 57.6 39.3 74.9 61.0 36.3 44.1 49.9 41.4 109.8 128.1 45.7 82.5 90.4 52.7 66.8 112.0 58.6 83.5 24.3 46.0 75.3 85.9 59.6 23.3 34.1 23.1 110.0 42.8 31.3 58.5 91.0 57.1 57.0 27.8 32.3 49.4 83.3 38.2 31.0 45.9 27.0 72.4 55.2 52.8 57.0 60.4 100.9 73.3 59.2 71.1 56.8 77.9 5.7 3.5 2.8 3.9 3.8 5.0 2.5 3.0 2.8 2.8 2.8 1.5 2.1 0.6 5.6 2.2 5.0 2.6 2.5 13.9 14.3 14.4 17.5 14.0 15.9 18.2 16.7 13.1 16.3 14.7 16.5 15.6 15.8 3.2 20.1 3.9 18.5 7.6 9.6 10.4 3.4 9.3 19.8 11.0 8.2 21.5 15.0 14.7 10.4 43.6 15.0 37.5 1.9 24.7 6.4 11.3 25.4 17.5 17.9 18.5 4.8 34.6 62.9 26.9 33.1 23.8 14.5 17.0 32.5 28.9 27.3 6.7 4.4 37.6 10.2 18.9 12.8 7.8 32.6 11.7 5.4 6.5 14.6 6.9 14.4 4.0 3.8 21.7 22.3 20.3 63.0 20.8 25.4 10.4 11.0 8.4 26.3 11.6 19.6 24.4 12.7 8.4 9.2 71.7 12.0 17.6 27.6 15.8 ATAD2B KIAA1240 ENSG00000119778 "ATPase family AAA domain containing 2B" Q9ULI0 2 23748664-23927123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 93.0;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034555 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034555: AB_10601665" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (2.58e-1)" "unprognostic (2.16e-1)" "unprognostic (1.62e-2)" "unprognostic (5.93e-3)" "unprognostic (5.57e-3)" "unprognostic (2.22e-2)" "unprognostic (1.85e-2)" "unprognostic (1.23e-1)" "unprognostic (9.14e-2)" "unprognostic (7.56e-3)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.46e-1)" "unprognostic (2.68e-1)" "unprognostic (2.67e-2)" "unprognostic (1.98e-1)" 4.5 3.1 5.1 5.9 5.7 9.9 4.5 8.0 5.1 5.7 10.1 4.0 5.1 4.9 2.7 6.0 4.7 3.5 3.6 4.0 5.9 3.0 4.2 4.8 7.4 6.6 5.6 3.0 5.8 4.3 3.4 4.1 4.1 6.0 4.3 4.3 9.5 4.8 2.4 4.5 8.3 5.2 2.9 5.0 5.1 4.0 4.4 5.5 10.4 5.3 2.9 6.6 4.0 6.7 8.0 4.1 3.4 11.0 5.0 3.1 3.4 8.5 2.7 2.2 3.5 2.4 5.5 2.0 13.4 2.4 2.5 1.6 5.3 8.6 3.0 2.9 8.8 4.1 11.3 4.5 6.6 3.4 10.2 8.1 2.7 5.2 2.1 3.4 2.9 4.8 7.4 12.2 5.8 2.7 7.0 9.5 11.9 6.5 6.8 1.9 10.8 11.8 3.1 3.8 9.1 5.1 8.4 7.4 9.0 4.2 6.0 4.4 10.0 4.6 3.5 4.0 3.0 3.2 6.0 2.9 10.0 1.9 11.5 3.3 15.8 7.9 5.1 3.9 4.7 4.4 8.5 3.6 3.5 7.6 6.4 5.2 4.2 12.0 6.0 6.2 11.0 3.4 1.8 5.1 5.7 8.0 5.1 4.0 5.9 6.6 5.6 3.0 6.0 5.0 5.5 8.0 18.4 3.2 16.0 93.0 26.1 10.7 7.7 6.4 13.1 27.6 9.5 7.1 11.3 10.0 12.2 9.2 47.9 8.4 33.8 15.2 0.0 7.7 60.2 10.1 20.1 14.6 15.6 11.1 60.3 12.2 7.4 14.7 19.9 17.0 13.3 21.2 11.7 10.7 8.2 10.1 95.5 11.0 10.2 14.4 17.6 36.1 12.5 23.8 3.6 85.3 30.9 13.0 22.6 143.7 125.3 8.9 18.6 10.9 14.0 10.8 17.2 2.4 8.5 45.4 6.6 19.1 13.5 23.5 16.8 20.0 17.5 10.9 22.6 13.1 11.3 16.5 FKBP1B "FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase" ENSG00000119782 "FKBP prolyl isomerase 1B" P68106 2 24049701-24063681 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.3" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.2;T-reg: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 47.9;NTERA-2: 42.9;SH-SY5Y: 30.7;SuSa: 46.1;TIME: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045572, HPA051798" Uncertain Approved Vesicles NA NA Vesicles "HPA045572: AB_2732521, HPA051798: AB_2681615" "unprognostic (3.01e-3)" "unprognostic (3.35e-1)" "unprognostic (7.05e-2)" "unprognostic (9.89e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-1)" "unprognostic (9.55e-2)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.43e-2)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" 5.3 4.4 32.0 2.2 34.8 1.6 5.6 27.6 48.3 6.2 24.1 6.2 19.8 4.9 2.8 8.3 4.0 5.4 5.0 39.9 33.0 8.7 6.7 10.6 1.5 28.7 29.1 35.3 5.5 7.6 7.1 6.4 4.0 28.7 7.3 3.3 7.7 6.7 6.4 1.4 6.1 6.9 2.8 25.8 2.8 15.1 1.6 32.1 1.6 6.8 1.2 2.3 5.7 8.1 31.9 0.2 2.0 17.2 0.0 10.9 4.7 6.2 5.8 6.0 2.5 3.6 1.2 2.0 0.0 4.3 10.3 15.4 6.8 25.7 20.2 1.6 3.0 16.1 6.0 0.2 47.9 4.5 0.0 14.1 3.9 4.6 5.9 1.1 14.7 16.5 6.8 1.5 0.1 5.9 0.2 2.0 0.0 42.9 1.7 3.0 3.1 1.5 0.2 2.0 1.3 4.1 30.7 0.3 0.1 5.8 46.1 1.2 2.2 38.0 0.0 5.2 0.2 1.4 1.1 0.5 0.0 6.4 0.0 1.3 0.4 0.4 2.2 0.1 0.4 0.0 0.1 0.2 0.2 1.0 1.2 0.0 0.1 0.0 0.1 0.0 0.2 2.8 0.5 32.0 34.8 27.6 48.3 39.9 33.0 28.7 29.1 35.3 28.7 25.8 32.1 31.9 9.3 0.0 6.8 2.9 1.8 9.2 14.0 13.7 11.4 2.1 6.5 13.7 0.9 22.8 4.7 7.3 0.0 4.9 2.7 15.8 13.7 27.6 0.6 3.5 5.0 10.9 9.5 7.0 16.9 38.2 31.9 6.9 16.3 7.1 1.3 3.4 15.7 10.2 7.5 1.7 7.8 8.9 2.0 4.0 17.4 2.9 2.8 9.1 28.4 4.7 13.0 31.4 1.0 2.5 1.3 49.8 25.4 4.1 2.4 15.5 10.6 6.8 2.0 3.6 26.3 2.9 10.6 1.6 5.4 9.1 7.4 5.2 4.9 1.4 4.5 19.3 ATL2 ARL6IP2 ENSG00000119787 "Atlastin GTPase 2" Q8NHH9 2 38293954-38377285 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029108, HPA075302" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029108: AB_10670557, HPA075302: AB_2732289" "unprognostic (5.80e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.64e-2)" "unprognostic (1.18e-1)" "unprognostic (9.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.81e-3)" "unprognostic (1.09e-2)" "unprognostic (1.27e-3)" "unprognostic (8.22e-2)" "unprognostic (6.86e-2)" "unprognostic (4.28e-2)" "unprognostic (2.09e-1)" "unprognostic (6.33e-2)" "unprognostic (1.84e-1)" 18.3 32.7 14.7 17.1 20.4 32.7 42.0 28.0 18.4 25.7 18.0 42.9 34.1 33.8 19.6 42.3 29.8 18.7 16.0 17.2 15.6 28.4 40.5 23.1 19.3 14.9 15.4 16.7 37.4 15.8 15.9 13.7 16.9 16.6 31.7 26.9 25.7 52.3 31.5 54.2 47.8 31.7 36.3 12.2 20.5 31.9 18.0 15.7 28.2 55.4 46.6 35.3 27.6 33.5 16.4 84.3 36.0 51.0 37.2 44.8 27.9 61.1 31.5 25.0 33.9 38.7 40.8 65.2 61.6 33.7 20.2 47.4 94.8 64.7 32.2 56.4 74.5 44.7 38.9 26.6 58.7 24.5 47.1 35.8 20.3 68.6 32.7 45.2 21.7 34.6 23.5 60.3 37.5 28.7 31.1 56.0 46.1 64.1 89.5 22.4 46.9 50.4 45.4 25.9 43.6 26.1 44.2 32.0 40.3 38.2 39.0 22.1 28.7 21.9 34.8 52.4 33.2 57.8 48.8 48.3 79.0 23.4 47.9 42.7 1.3 2.7 10.6 2.3 2.1 3.8 2.8 2.7 2.7 3.4 4.3 4.1 3.3 3.3 2.5 3.8 2.0 3.6 2.4 14.7 20.4 28.0 18.4 17.2 15.6 14.9 15.4 16.7 16.6 12.2 15.7 16.4 18.5 12.8 32.4 62.7 18.7 36.8 32.5 25.9 14.8 20.6 40.8 33.8 7.6 11.5 44.8 7.3 14.6 15.7 14.9 12.0 7.9 11.7 22.1 12.3 17.4 17.0 6.6 22.9 66.3 5.0 14.7 16.5 11.7 17.8 4.5 14.3 14.3 34.4 10.8 21.9 55.5 11.7 77.3 8.5 16.1 19.5 14.3 12.9 12.4 59.0 8.2 8.6 7.2 46.3 20.4 5.7 8.7 16.6 13.1 23.9 17.8 12.6 23.5 21.1 32.9 16.9 19.4 16.7 21.3 46.4 46.9 14.6 13.6 9.0 12.7 31.3 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 442.0" "Cell type enhanced" "Detected in all" "Late spermatids: 548.0;Plasma cells: 545.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA042809: AB_2678179" "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 65.8 67.7 65.1 45.3 73.0 442.0 55.8 65.4 81.3 61.8 74.3 59.8 40.8 51.9 85.1 56.1 51.7 64.6 57.2 72.9 71.0 88.3 65.0 61.7 63.2 70.0 65.8 69.8 60.9 45.2 102.4 45.9 65.2 70.6 69.4 45.9 77.9 63.8 96.4 54.6 49.1 44.8 65.7 69.8 59.4 49.8 72.0 68.7 77.9 62.3 49.1 63.3 78.9 47.4 83.1 35.9 18.1 42.5 20.9 113.3 109.4 35.0 50.7 152.6 28.5 43.3 16.3 36.7 21.4 32.7 100.7 65.0 19.1 9.9 50.5 40.2 94.1 19.1 11.0 8.0 26.0 98.3 3.7 24.9 114.1 100.7 53.0 67.6 122.5 53.8 13.5 15.5 36.8 77.2 18.5 11.3 26.3 23.9 41.2 22.7 7.0 56.8 20.9 96.4 69.6 16.7 51.1 24.6 24.4 65.2 77.1 27.3 20.5 70.6 77.4 29.5 21.2 14.2 86.5 34.9 28.7 55.1 9.9 31.7 229.3 82.4 190.7 53.3 95.4 54.7 89.9 65.8 64.2 78.0 74.0 62.2 55.8 306.9 56.5 149.5 152.9 95.8 146.6 65.1 73.0 65.4 81.3 72.9 71.0 70.0 65.8 69.8 70.6 69.8 68.7 83.1 83.8 83.3 90.5 13.4 398.6 134.0 162.9 184.8 122.3 70.7 142.5 105.5 73.2 47.1 119.3 101.2 47.9 172.8 300.4 104.1 138.9 90.9 253.9 178.0 71.0 74.3 208.9 93.7 30.9 78.8 140.4 84.2 126.9 213.7 81.3 46.4 56.0 43.3 103.3 63.9 25.9 94.5 114.0 132.1 168.7 548.0 57.8 214.9 170.7 15.9 321.0 103.4 50.4 19.6 28.3 110.2 108.6 82.8 545.7 143.3 84.8 137.0 101.4 63.5 52.6 87.4 114.9 133.8 78.0 97.4 142.6 408.0 358.5 53.5 46.8 281.2 FAM98A DKFZP564F0522 ENSG00000119812 "Family with sequence similarity 98 member A" Q8NCA5 2 33583660-33599382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036250, HPA036251" Uncertain Approved Vesicles NA NA Vesicles "HPA036250: AB_2675020, HPA036251: AB_10673124" "unprognostic (7.25e-2)" "unprognostic (9.92e-2)" "unprognostic (1.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (3.51e-1)" "unprognostic (2.02e-2)" "unprognostic (2.38e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (8.18e-5)" "unprognostic (6.01e-2)" 29.5 21.6 24.3 20.7 28.4 7.2 16.5 30.2 30.8 21.9 29.3 20.9 13.7 19.2 19.5 20.1 12.3 15.8 41.0 33.5 27.1 27.6 25.7 11.6 18.6 28.2 27.2 24.6 16.7 14.7 51.6 20.7 20.7 31.9 23.2 17.3 17.3 28.2 16.8 61.9 14.6 12.2 36.7 30.4 14.4 20.0 49.9 29.4 17.5 19.3 63.0 22.8 27.8 13.0 41.9 93.4 47.2 25.5 43.9 99.4 108.3 41.9 224.1 81.6 62.3 80.2 49.8 18.8 144.5 41.3 101.8 55.3 41.3 84.8 60.8 84.2 67.7 56.3 119.7 46.9 69.3 47.2 95.5 44.7 56.1 42.2 83.9 52.1 63.5 83.3 15.5 84.4 43.8 108.7 46.1 53.3 28.5 64.4 83.2 59.9 41.1 82.5 51.9 65.0 72.2 45.6 26.1 60.0 89.5 27.0 40.7 36.2 15.6 135.7 39.5 66.1 82.9 89.2 80.2 106.6 142.4 91.2 68.2 56.8 1.3 4.1 2.3 6.4 7.2 6.9 10.7 5.4 5.8 6.1 5.5 6.9 5.7 0.1 4.0 4.6 3.5 9.0 4.1 24.3 28.4 30.2 30.8 33.5 27.1 28.2 27.2 24.6 31.9 30.4 29.4 41.9 19.0 22.4 11.5 6.8 17.4 20.4 19.0 12.2 18.8 16.8 15.0 14.0 74.6 11.5 19.8 7.3 2.1 25.5 9.8 6.9 25.4 20.3 14.9 16.7 29.9 21.1 5.4 12.8 22.8 29.2 33.2 31.9 17.9 18.9 2.5 44.4 17.2 23.4 16.4 47.1 15.7 15.1 8.2 7.7 11.8 13.8 22.4 8.7 8.8 6.5 5.9 17.4 16.5 9.0 36.1 26.0 8.7 21.8 40.3 22.6 9.3 46.2 16.5 15.7 0.0 21.7 27.1 41.5 40.1 26.1 20.5 40.0 13.7 54.9 12.1 23.4 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277904-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 130.1;choroid plexus: 51.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 7.1 6.3 55.6 5.5 52.4 2.5 8.5 55.2 130.1 6.1 51.2 7.0 5.8 6.9 7.2 5.1 5.0 4.5 7.5 56.7 53.7 7.8 9.3 5.7 5.9 55.2 53.2 52.8 6.7 14.9 6.5 5.2 5.9 57.6 6.6 6.3 13.2 7.5 5.7 8.1 7.1 5.9 6.6 52.4 7.0 6.5 4.3 52.8 8.0 10.2 6.1 5.1 5.4 5.2 61.2 8.9 4.4 8.6 7.7 9.8 12.4 4.5 7.5 7.5 7.7 5.0 5.9 6.6 4.7 5.1 8.2 7.4 6.8 9.2 6.6 10.0 7.6 14.3 7.6 9.8 10.7 11.5 10.2 6.2 8.7 12.4 6.9 11.0 10.6 6.6 5.2 10.7 9.6 8.5 5.8 8.0 10.6 7.0 9.6 7.5 5.5 12.7 8.9 8.4 3.8 9.6 9.2 6.4 6.4 11.7 5.5 3.5 8.6 7.4 10.1 4.8 7.1 7.2 14.2 19.1 5.8 15.9 9.7 5.7 14.9 5.4 5.7 4.4 5.1 3.7 4.6 4.4 4.1 4.6 4.0 4.5 4.0 14.9 6.4 5.1 5.4 4.6 4.7 55.6 52.4 55.2 130.1 56.7 53.7 55.2 53.2 52.8 57.6 52.4 52.8 61.2 61.4 93.0 69.8 13.1 68.5 51.4 56.9 59.5 50.7 113.8 63.3 28.2 88.0 60.1 58.3 42.3 106.3 68.4 81.3 68.8 33.2 45.3 34.7 39.5 57.9 59.0 57.1 86.9 18.8 39.3 69.9 66.6 28.1 40.1 40.0 56.3 67.8 80.9 48.3 101.0 20.1 70.2 50.8 81.7 60.7 21.0 86.6 58.0 81.8 21.5 85.1 53.1 114.4 22.1 31.8 41.8 66.8 74.9 62.6 78.5 62.7 60.1 62.2 122.2 78.9 71.9 66.2 160.2 59.6 41.1 65.9 192.8 60.7 65.4 46.8 74.7 AFTPH "FLJ20080, FLJ23793, MGC33965, Nbla10388" ENSG00000119844 Aftiphilin Q6ULP2 2 64524305-64593005 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034990, HPA034991" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA Cytosol "Golgi apparatus, Vesicles" "HPA034990: AB_2674398, HPA034991: AB_10603577" "unprognostic (7.30e-2)" "unprognostic (4.72e-2)" "unprognostic (9.16e-2)" "unprognostic (8.54e-2)" "unprognostic (3.24e-1)" "unprognostic (4.25e-2)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (8.44e-2)" "unprognostic (3.42e-2)" "unprognostic (4.65e-2)" "prognostic favorable (2.37e-5)" "prognostic favorable (8.44e-4)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.83e-4)" 15.5 20.3 29.1 21.3 29.7 21.5 32.7 36.0 36.8 22.7 32.4 30.8 23.3 19.0 44.1 29.8 23.1 22.1 12.1 30.0 30.5 56.6 33.8 22.1 37.5 29.7 29.4 28.3 19.4 31.9 38.3 25.3 15.1 30.1 34.8 34.0 37.1 29.2 18.7 15.5 33.5 24.7 17.4 30.4 26.6 34.0 24.9 29.8 29.6 25.6 13.0 41.8 25.7 22.6 30.8 29.8 19.3 14.1 17.1 17.8 15.1 23.4 16.7 24.9 26.9 20.1 22.4 21.9 43.9 16.0 20.7 31.1 23.5 24.6 23.3 34.8 42.8 13.5 21.0 12.0 26.5 18.8 40.5 34.5 7.5 48.6 17.4 39.6 19.8 21.4 21.8 16.0 38.7 16.8 16.9 21.9 49.1 13.0 55.9 14.3 17.7 22.6 28.8 48.9 31.5 25.9 13.1 17.7 39.9 35.7 18.0 24.0 30.6 18.5 20.0 23.0 17.0 18.8 43.3 27.8 66.7 15.1 45.3 22.6 40.5 9.3 16.6 7.4 9.3 8.7 21.8 9.3 9.1 12.2 20.3 8.8 6.9 16.3 7.1 14.7 15.8 12.8 5.9 29.1 29.7 36.0 36.8 30.0 30.5 29.7 29.4 28.3 30.1 30.4 29.8 30.8 24.6 25.6 39.7 43.1 75.4 122.6 29.6 21.5 55.8 24.2 43.8 23.0 16.0 40.0 33.6 20.2 20.9 13.8 40.5 60.7 37.2 25.5 34.8 44.6 17.8 27.1 46.6 52.0 72.1 25.7 12.4 23.6 35.2 55.9 46.9 17.8 17.5 36.8 20.8 37.0 62.9 40.3 20.3 45.2 77.9 55.1 15.8 52.1 23.2 65.6 60.8 35.0 26.8 52.3 67.0 27.3 43.0 20.7 60.5 42.6 29.0 70.5 40.2 32.9 26.3 25.3 21.2 43.1 21.9 59.0 123.5 27.2 36.5 10.2 40.3 46.1 LGALSL "GRP, HSPC159" ENSG00000119862 "Galectin like" Q3ZCW2 2 64453969-64461381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 91.3;skin 1: 94.4" "Cell type enhanced" "Detected in many" "Muller glia cells: 95.6;Rod photoreceptor cells: 152.8;Suprabasal keratinocytes: 137.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 1.5;neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 50.2;CACO-2: 35.6;HAP1: 72.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046079 Approved Approved Nucleoplasm NA NA 4100000 Nucleoplasm "HPA046079: AB_10967075" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "unprognostic (7.18e-2)" "unprognostic (3.77e-2)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.25e-2)" "unprognostic (8.43e-2)" "unprognostic (3.57e-3)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (4.34e-2)" "unprognostic (6.57e-2)" "unprognostic (6.20e-2)" "unprognostic (9.19e-2)" "unprognostic (2.77e-2)" 9.4 17.1 6.6 4.1 9.1 8.2 17.3 10.3 8.8 8.8 8.6 12.8 10.2 7.3 8.9 24.8 5.3 6.4 13.6 8.0 9.2 9.3 9.7 16.1 2.1 6.5 6.4 7.4 6.4 6.3 19.4 7.6 10.7 6.6 15.7 11.9 91.3 9.4 7.2 60.7 94.4 11.0 7.4 5.2 6.0 8.9 4.3 6.3 3.0 5.3 18.4 15.9 4.4 10.1 7.2 11.6 7.5 20.7 50.2 0.7 0.2 6.2 2.9 8.1 6.3 6.0 35.6 2.4 0.0 4.7 1.6 12.2 14.3 72.8 13.7 5.0 13.8 19.1 0.2 4.0 17.8 6.2 3.4 4.4 3.1 8.6 2.6 9.7 5.6 3.9 7.7 0.1 3.5 0.2 9.3 4.9 0.6 16.8 7.1 8.8 5.3 12.0 3.5 7.5 8.5 3.5 13.1 10.5 7.2 6.2 12.7 5.1 0.5 1.7 4.0 12.4 2.5 6.2 14.7 7.1 10.0 0.0 2.1 5.4 0.0 0.1 1.5 0.0 0.0 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.4 6.6 9.1 10.3 8.8 8.0 9.2 6.5 6.4 7.4 6.6 5.2 6.3 7.2 28.9 22.4 66.2 2.3 6.0 67.6 25.5 9.7 29.0 31.9 39.0 20.8 16.5 10.0 6.3 11.0 33.3 1.4 1.6 45.2 15.6 6.2 11.8 10.9 8.1 18.2 9.1 0.8 6.6 13.3 2.7 14.8 23.4 23.0 1.3 4.1 17.9 11.9 1.0 13.5 6.0 38.6 6.1 6.6 14.4 6.3 8.1 26.2 10.6 1.9 2.4 95.6 2.1 5.0 2.4 19.9 22.6 4.5 29.8 24.1 31.0 14.3 1.6 152.8 19.7 15.1 45.9 8.1 5.1 51.9 137.0 1.5 2.7 2.8 24.3 36.2 CNRIP1 "C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924" ENSG00000119865 "Cannabinoid receptor interacting protein 1" Q96F85 2 68284171-68320051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.2;Erythroid cells: 116.2;granulocytes: 122.9" "Cancer enhanced" "Detected in all" "glioma: 14.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 109 "basophil: 12.2" "Lineage enriched" "Detected in single" 109 "granulocytes: 12.2" "Cell line enhanced" "Detected in many" "HEL: 158.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035337 Approved Cytosol NA NA 54000 Cytosol "HPA035337: AB_10601359" "unprognostic (1.23e-1)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (6.51e-2)" "unprognostic (3.52e-2)" "unprognostic (2.86e-2)" "unprognostic (4.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.04e-2)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (3.38e-3)" 27.3 6.5 49.4 5.9 61.5 6.2 20.4 49.9 72.1 30.3 30.3 14.9 3.6 22.6 6.1 5.3 24.4 8.5 14.1 61.8 51.8 7.4 2.9 18.4 5.1 40.3 44.1 56.1 31.5 3.0 1.8 15.5 12.2 44.5 15.2 4.7 29.9 5.8 8.9 6.7 7.3 11.0 9.3 40.4 10.3 10.7 2.6 47.3 2.8 9.0 7.0 3.0 20.9 19.4 50.3 0.0 1.1 9.0 0.0 34.1 24.6 0.1 34.5 26.6 30.6 22.3 0.0 0.0 0.0 1.2 33.2 22.6 0.0 0.7 0.2 32.6 0.0 8.1 158.7 2.3 0.0 34.7 0.1 21.7 22.1 0.0 20.0 11.5 18.7 47.8 0.0 0.2 0.1 23.4 0.1 0.0 0.4 16.3 0.0 15.6 0.0 13.2 0.0 0.0 0.0 45.8 47.8 2.2 0.0 28.3 0.1 0.0 1.7 51.4 21.1 12.9 18.5 51.0 0.0 0.0 0.1 16.9 0.0 15.5 12.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 49.4 61.5 49.9 72.1 61.8 51.8 40.3 44.1 56.1 44.5 40.4 47.3 50.3 50.2 0.0 4.3 15.0 0.6 12.9 0.4 0.0 4.6 72.2 0.6 1.7 2.1 0.0 0.6 0.0 22.9 1.2 0.1 0.0 0.0 0.4 0.7 1.9 30.4 60.6 0.0 116.2 48.8 0.2 9.3 44.4 0.5 0.6 122.9 1.3 36.4 0.8 56.3 28.6 39.5 0.0 0.0 25.7 40.9 2.6 45.4 13.9 37.4 16.9 2.5 42.0 0.0 24.1 19.6 0.5 0.0 42.5 0.5 1.2 0.0 0.1 0.0 54.3 46.0 18.7 41.9 0.7 0.5 0.7 10.7 2.1 3.8 27.3 0.0 1.0 BCL11A "BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856" ENSG00000119866 "BAF chromatin remodeling complex subunit BCL11A" Q9H165 2 60450520-60554467 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.5;lymphoid tissue: 41.2;skin 1: 33.1" "Cell type enhanced" "Detected in many" "B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0" "Group enriched" "Detected in all" 15 "B-cells: 415.7;dendritic cells: 899.0" "Cell line enhanced" "Detected in many" "Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7" "CAB014891, HPA029003, HPA075941" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB014891: , HPA029003: AB_2672863, HPA075941: " "unprognostic (4.10e-3)" "unprognostic (6.72e-2)" "unprognostic (4.50e-2)" "unprognostic (9.41e-3)" "unprognostic (2.37e-1)" "unprognostic (4.47e-3)" "unprognostic (2.53e-2)" "unprognostic (1.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.45e-1)" "unprognostic (4.27e-4)" "unprognostic (1.23e-2)" "unprognostic (2.35e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-1)" "unprognostic (4.40e-2)" "unprognostic (2.99e-2)" 0.7 2.2 24.1 11.4 35.2 25.5 7.2 11.0 46.5 3.3 10.9 14.2 9.8 2.1 1.4 18.6 5.8 2.5 5.0 40.0 22.3 0.6 0.5 2.2 29.4 32.2 20.4 27.0 0.6 10.9 1.8 3.1 0.9 32.7 7.9 6.2 1.7 13.9 1.9 1.7 33.1 14.0 3.5 13.2 19.8 4.9 2.1 15.6 34.2 2.3 0.2 41.2 3.3 11.6 38.9 0.6 0.0 4.2 0.1 0.8 0.8 0.3 1.5 0.0 0.1 0.0 0.0 0.2 51.1 0.2 0.2 0.0 10.5 15.4 7.4 0.2 0.9 15.2 0.1 0.6 0.2 0.0 18.7 0.1 1.7 4.1 0.0 2.5 4.0 2.6 17.1 0.8 0.3 0.1 0.1 49.0 19.9 28.6 7.7 0.2 48.3 1.3 19.7 0.0 0.9 20.1 4.8 0.3 0.4 0.3 8.0 0.3 9.1 1.0 0.3 11.6 0.3 0.1 0.8 0.2 106.7 0.1 34.0 1.6 4.5 23.8 5.1 0.5 44.1 1.1 312.7 0.5 0.5 89.9 415.7 1.3 1.1 11.0 8.4 33.7 899.0 1.1 11.4 24.1 35.2 11.0 46.5 40.0 22.3 32.2 20.4 27.0 32.7 13.2 15.6 38.9 0.6 0.0 7.4 3.6 149.0 46.3 16.0 34.0 118.4 2.5 31.6 28.6 18.2 4.3 11.7 1.8 0.0 0.6 140.3 7.5 5.9 9.5 12.0 3.9 2.0 1.4 19.8 69.6 180.8 6.4 0.5 3.6 5.1 4.8 10.1 67.4 0.7 0.1 43.2 52.2 153.2 13.6 6.1 7.0 86.1 5.0 0.3 20.5 16.0 11.2 16.0 0.3 0.0 3.5 4.6 4.7 12.5 0.0 6.0 11.7 16.2 0.5 5.5 0.3 0.0 0.2 2.0 2.9 6.9 120.3 69.9 0.8 4.6 1.0 28.9 5.8 CRIPT HSPC139 ENSG00000119878 "CXXC repeat containing interactor of PDZ3 domain" Q9P021 2 46616416-46630176 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046080, HPA056765" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA046080: AB_2679529, HPA056765: AB_2683230" "unprognostic (3.38e-2)" "unprognostic (4.08e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.54e-2)" "unprognostic (3.38e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-2)" "unprognostic (4.42e-2)" 6.3 7.7 5.1 2.2 5.4 6.1 6.6 7.9 6.4 5.7 5.0 6.7 3.0 5.9 5.6 6.4 5.5 1.8 10.6 5.0 4.5 7.2 6.2 4.3 3.3 5.2 4.9 4.7 7.2 5.4 2.7 6.0 2.2 5.2 5.6 2.8 10.8 7.1 1.9 12.4 5.8 5.7 2.2 3.7 4.8 6.4 5.9 5.1 2.4 4.7 2.8 3.1 6.4 6.4 8.2 3.8 2.5 2.3 2.4 2.7 2.9 3.4 2.7 1.8 1.7 1.7 2.9 2.7 2.9 5.7 2.9 2.4 2.6 2.3 2.4 3.3 4.4 2.6 3.6 3.4 3.8 3.1 2.8 2.2 3.3 2.9 2.4 1.7 3.2 2.7 1.6 3.7 3.4 2.1 2.4 1.9 3.5 3.0 3.6 2.5 1.7 4.6 4.4 3.2 2.7 4.2 6.7 3.1 2.4 3.2 2.3 2.0 2.1 3.5 2.7 2.6 2.7 3.0 3.7 3.1 2.8 4.1 3.1 2.3 6.3 2.6 3.8 2.9 2.3 2.6 3.6 3.0 2.6 2.1 3.5 3.0 2.9 5.8 3.0 2.4 3.2 3.6 1.9 5.1 5.4 7.9 6.4 5.0 4.5 5.2 4.9 4.7 5.2 3.7 5.1 8.2 28.6 19.2 13.7 19.2 34.5 43.1 65.5 71.3 28.5 28.9 56.5 54.4 60.4 45.8 51.8 31.3 25.0 56.7 48.4 38.5 68.4 64.5 41.8 46.4 33.7 29.5 65.1 91.8 22.5 39.8 81.4 35.1 20.4 37.7 28.5 28.3 38.6 57.5 48.1 16.8 25.7 39.9 42.7 38.9 30.2 15.9 36.4 29.3 30.2 20.6 48.7 40.4 51.5 44.2 31.2 67.6 58.4 25.6 46.2 58.6 81.0 102.6 48.7 51.2 19.7 26.0 48.0 56.0 49.6 39.1 53.0 95.6 35.8 26.2 32.6 74.9 EPCAM "17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1" ENSG00000119888 "Epithelial cell adhesion molecule" P16422 2 47345158-47387601 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 813.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2317.0;Ductal cells: 999.6;Intestinal goblet cells: 1378.2;Paneth cells: 2437.0;Proximal enterocytes: 2681.1;Undifferentiated cells: 1607.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 538.9;CACO-2: 680.9;CAPAN-2: 944.4;OE19: 911.8;RPTEC TERT1: 398.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB003809, HPA026761, CAB030012, CAB055098, HPA067463" Enhanced Supported "Plasma membrane" NA NA 22000 "Plasma membrane" "CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846" "unprognostic (6.79e-2)" "unprognostic (2.28e-1)" "unprognostic (1.59e-2)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (3.49e-2)" "unprognostic (2.01e-1)" "unprognostic (3.61e-2)" "unprognostic (3.40e-1)" "prognostic favorable (3.30e-4)" "unprognostic (5.27e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.04e-6)" "unprognostic (6.38e-3)" "unprognostic (1.28e-1)" "unprognostic (6.45e-3)" "unprognostic (6.08e-2)" 4.5 12.3 3.3 77.7 4.1 10.3 100.7 1.7 2.9 117.1 1.2 813.5 733.1 33.3 241.0 10.9 115.3 71.7 0.7 3.3 7.9 225.2 3.1 75.4 0.9 2.9 3.4 2.3 1.2 126.5 221.3 87.6 1.7 3.1 61.1 758.2 0.6 120.9 53.3 0.1 8.7 776.0 22.4 2.4 1.4 174.0 21.9 8.1 6.4 289.4 0.1 2.8 31.2 4.2 2.7 538.9 5.4 0.4 1.2 0.0 0.0 321.3 0.2 0.0 0.6 0.0 680.9 944.4 0.1 141.5 1.0 0.4 247.3 4.6 62.2 2.0 0.1 56.3 0.3 2.5 261.6 0.1 0.3 0.4 0.0 17.6 0.0 0.0 0.0 0.8 0.0 160.9 0.0 0.3 269.7 0.5 24.0 164.3 911.8 31.4 0.3 0.0 136.9 398.6 231.3 354.0 3.2 4.3 187.7 0.6 132.7 158.3 1.0 0.7 0.3 6.3 2.0 1.1 39.2 0.6 0.8 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 4.1 1.7 2.9 3.3 7.9 2.9 3.4 2.3 3.1 2.4 8.1 2.7 3.7 310.9 148.1 1.3 7.0 9.3 227.6 127.4 14.2 0.5 184.7 112.9 2.0 243.1 222.8 448.8 0.0 16.4 2.3 2317.0 76.3 999.6 8.6 434.7 35.3 5.8 498.1 23.1 1.1 402.8 6.5 6.3 150.3 445.3 32.5 11.8 1.4 0.6 2.9 0.0 0.4 1378.2 486.2 0.0 5.2 5.6 20.5 5.6 35.6 0.0 11.5 15.7 0.0 0.5 1.2 617.5 2437.0 18.8 1.8 257.9 2681.1 195.9 219.0 0.7 13.1 0.5 13.7 83.5 130.3 33.3 10.4 6.0 9.4 70.3 1607.7 230.7 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73653992 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "parathyroid gland: 312.8" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "thyroid cancer: 47.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 99.9;ASC TERT1: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.09e-1)" 10.3 10.6 6.0 6.5 6.2 6.8 13.9 6.2 7.1 10.8 5.9 20.6 16.6 9.5 45.0 8.5 5.4 10.5 7.7 6.6 8.2 32.2 17.7 13.3 5.4 6.6 6.9 6.1 4.0 11.7 312.8 10.0 21.9 7.4 16.9 22.3 18.4 30.5 14.8 5.5 7.2 21.2 10.7 5.9 7.0 14.5 6.2 7.3 4.6 43.9 6.3 5.6 12.7 6.4 7.3 7.4 9.9 9.7 15.6 99.9 74.2 12.8 23.8 59.4 6.3 22.0 6.6 17.6 6.8 11.2 32.9 14.8 12.6 13.7 5.9 11.2 4.8 15.5 2.8 5.1 15.4 19.4 5.6 10.8 34.2 8.8 14.2 9.7 26.4 16.2 9.0 7.1 7.2 22.3 4.9 2.3 3.3 7.1 30.9 5.7 5.0 12.1 28.5 16.0 20.2 3.8 6.7 4.8 14.0 14.4 14.0 6.3 34.1 23.5 3.0 2.8 12.1 5.7 20.4 30.6 1.9 10.5 11.6 9.0 13.3 7.9 3.3 6.0 7.4 5.8 3.9 6.6 5.8 7.6 2.4 5.4 6.0 5.7 8.9 4.8 5.5 6.6 4.9 6.0 6.2 6.2 7.1 6.6 8.2 6.6 6.9 6.1 7.4 5.9 7.3 7.3 8.8 22.4 20.7 16.3 8.2 9.6 13.2 13.7 5.7 8.2 22.6 5.5 6.8 18.6 17.4 51.5 29.2 19.4 11.0 46.4 3.9 14.2 36.6 16.6 7.8 13.8 12.1 3.8 47.7 13.7 13.5 25.8 14.8 19.6 14.5 3.2 23.9 32.9 64.6 0.0 46.8 47.7 20.3 24.8 22.7 48.3 7.5 25.4 10.6 14.0 11.2 8.3 13.4 17.6 16.3 19.2 17.5 11.3 20.6 29.1 23.9 36.3 21.5 28.9 0.0 10.5 9.1 8.4 3.6 10.2 11.2 22.8 11.0 2.9 19.2 30.7 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288811-71309059 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 74.1" "Cell type enhanced" "Detected in many" "Astrocytes: 175.3;Langerhans cells: 144.0;Macrophages: 155.7;monocytes: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 11.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 25.5 11.3 33.9 16.2 34.1 27.0 51.5 47.4 33.6 8.0 11.4 7.7 3.6 10.5 13.8 33.5 6.5 10.9 6.8 41.9 47.6 7.2 6.4 11.6 14.6 48.4 60.5 16.4 6.6 8.1 6.3 7.7 13.6 52.1 8.5 5.3 13.4 46.7 12.9 5.2 20.3 6.8 33.7 56.0 16.9 6.3 2.9 52.2 11.5 5.3 12.2 25.7 7.5 12.6 74.1 9.7 2.9 10.0 0.0 26.5 24.1 3.6 42.2 26.5 16.9 17.0 3.7 1.8 59.1 56.3 18.5 15.6 4.7 7.8 29.4 59.5 12.5 6.1 13.0 10.0 1.5 21.4 6.2 4.4 24.4 24.7 12.5 38.8 14.2 13.7 0.0 0.8 4.5 58.8 8.1 0.0 9.7 4.0 3.8 2.3 4.2 30.4 13.8 38.8 0.7 33.8 15.3 12.6 7.8 2.8 14.3 13.4 48.0 21.1 41.3 20.5 4.3 14.1 6.0 0.4 7.6 13.8 41.0 7.2 3.4 2.6 0.1 0.4 1.7 0.4 0.3 0.3 0.4 2.1 0.5 0.0 0.3 11.1 0.5 1.3 0.8 0.1 0.6 33.9 34.1 47.4 33.6 41.9 47.6 48.4 60.5 16.4 52.1 56.0 52.2 74.1 40.3 6.4 18.6 175.3 17.4 38.9 22.3 18.4 22.8 42.8 79.4 86.4 8.7 11.5 14.1 11.0 25.0 23.2 31.7 1.4 1.9 17.0 0.5 8.0 14.2 30.2 14.4 11.1 29.1 32.9 11.0 50.8 5.6 19.1 6.3 6.6 8.9 5.1 61.7 38.7 28.0 2.2 8.2 95.5 144.0 1.2 16.4 155.7 32.0 71.2 133.5 87.0 18.6 13.0 4.0 19.3 2.4 33.1 11.6 16.2 0.1 4.9 3.2 6.0 26.3 26.8 31.3 0.6 1.2 57.9 46.5 19.0 19.3 3.4 4.4 19.3 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912963-100965134 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 108.1;Peritubular cells: 105.7;Theca cells: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: AB_2683471" "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 8.7 17.3 17.4 11.0 28.7 12.0 8.9 20.2 22.6 12.8 11.2 12.4 7.9 21.0 49.1 9.0 17.8 8.1 10.4 17.2 23.1 11.3 11.7 10.9 14.8 24.0 25.3 15.5 25.3 13.2 7.9 23.9 15.6 28.5 15.4 10.2 11.8 9.5 13.0 17.9 13.5 12.8 10.8 22.6 23.3 10.5 26.0 23.3 12.3 11.4 13.4 11.6 11.4 11.3 47.5 25.7 20.6 29.6 31.4 16.1 20.9 11.3 26.3 18.5 24.1 29.0 15.2 17.5 24.1 15.8 11.3 17.9 25.3 20.4 8.8 29.1 26.6 16.6 21.7 14.2 31.0 11.7 28.0 24.9 10.0 13.2 18.6 19.9 25.1 15.7 14.7 15.6 22.5 37.3 17.7 19.1 16.0 13.7 9.9 15.2 18.5 145.7 8.3 10.1 12.8 6.6 12.9 16.5 4.6 30.6 14.1 26.3 10.7 20.6 28.2 23.4 18.0 31.1 18.1 28.5 19.1 20.0 32.9 15.1 6.1 6.6 7.0 9.8 6.7 8.9 8.6 7.8 8.5 5.2 11.0 8.5 7.8 3.6 9.1 7.5 7.5 8.0 4.6 17.4 28.7 20.2 22.6 17.2 23.1 24.0 25.3 15.5 28.5 22.6 23.3 47.5 18.4 25.6 18.9 0.0 18.2 0.0 8.4 0.0 12.5 33.8 13.8 12.6 0.0 5.7 8.6 25.8 25.0 17.4 29.4 9.0 13.7 11.0 8.4 22.7 64.8 20.8 12.2 11.3 0.0 8.0 7.1 20.2 10.7 25.0 24.0 32.3 26.7 12.8 17.9 38.7 0.0 10.5 0.0 18.2 0.0 10.4 108.1 18.6 0.0 0.0 19.2 19.7 46.4 0.0 0.0 7.0 8.4 105.7 12.3 9.4 9.3 8.9 13.8 31.4 19.7 44.5 12.8 33.5 43.0 10.4 0.0 5.1 19.7 77.6 8.2 6.0 IDE ENSG00000119912 "Insulin degrading enzyme" P14735 10 92451684-92574096 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063478 Approved "Secreted in other tissues" NA NA 310000 "HPA063478: AB_2685020" "unprognostic (1.70e-1)" "unprognostic (6.40e-2)" "prognostic favorable (3.69e-4)" "prognostic favorable (3.53e-4)" "unprognostic (2.54e-1)" "unprognostic (1.78e-1)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (8.88e-2)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (7.79e-2)" "unprognostic (6.81e-2)" "unprognostic (9.24e-3)" "unprognostic (6.13e-2)" "unprognostic (3.89e-2)" "unprognostic (3.91e-1)" 6.5 10.2 3.6 2.8 3.8 3.6 6.1 3.9 4.3 7.5 5.6 8.2 3.4 7.5 9.8 9.9 6.6 2.9 11.0 3.6 4.3 5.9 11.5 6.0 3.4 4.0 3.9 3.5 5.5 12.4 9.5 4.7 2.7 4.1 9.2 3.9 10.4 7.9 4.2 29.0 34.1 6.8 3.7 3.9 6.4 8.3 26.0 3.8 2.5 6.8 9.8 4.1 9.0 8.0 4.0 12.1 22.9 6.2 15.1 10.5 5.8 8.5 10.4 13.3 6.1 5.2 19.4 9.5 12.5 16.4 14.3 7.2 16.3 14.6 10.0 3.9 14.7 8.8 5.1 13.7 25.9 11.5 14.9 6.5 5.4 6.6 9.1 14.0 7.8 8.6 3.3 10.0 8.1 5.4 18.0 6.6 8.8 10.2 10.4 5.2 10.2 10.8 9.0 10.9 19.3 2.2 5.6 14.3 6.4 6.7 6.8 12.6 6.3 15.3 4.4 8.2 5.0 10.4 11.2 12.2 14.5 6.9 10.9 4.4 0.3 3.5 1.4 2.0 4.2 2.2 2.9 2.6 2.9 4.6 2.1 1.9 2.0 0.0 3.7 5.9 1.3 3.9 2.3 3.6 3.8 3.9 4.3 3.6 4.3 4.0 3.9 3.5 4.1 3.9 3.8 4.0 12.9 9.6 14.1 20.9 11.1 5.2 6.1 10.5 5.2 15.0 8.7 4.3 45.7 7.2 10.6 7.3 47.9 11.2 10.0 14.0 1.9 14.0 46.4 14.9 19.3 10.8 10.8 19.6 43.3 20.2 5.7 9.1 22.4 16.5 1.3 9.9 11.7 24.1 11.9 6.7 42.6 12.7 18.3 16.6 5.4 12.0 6.5 12.5 8.8 23.4 7.8 7.8 4.1 20.6 24.0 16.5 5.7 10.1 24.2 12.2 9.0 10.7 23.3 26.9 6.6 7.6 13.2 51.5 11.0 19.6 16.3 3.8 8.5 9.8 9.8 9.6 TECTB ENSG00000119913 "Tectorin beta" Q96PL2 10 112283400-112305038 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Late spermatids: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted in other tissues" NA NA "unprognostic (3.14e-2)" "unprognostic (2.84e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.32e-2)" "unprognostic (5.54e-2)" "unprognostic (2.80e-2)" "unprognostic (8.10e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226299-102229589 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 18.2" "Cell type enhanced" "Detected in some" "Adipocytes: 2.5;Breast myoepithelial cells: 3.2;Skeletal myocytes: 5.0;Spermatogonia: 3.4;Theca cells: 2.2" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 10 "classical monocyte: 7.1;intermediate monocyte: 2.4;myeloid DC: 2.0;non-classical monocyte: 5.9" "Group enriched" "Detected in many" 10 "dendritic cells: 2.0;monocytes: 7.1" "Cell line enhanced" "Detected in many" "ASC diff: 9.5;ASC TERT1: 9.4;HSkMC: 13.9;NB-4: 11.6;SiHa: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 3.3 0.7 1.0 0.4 0.7 1.8 3.6 0.4 1.3 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.9 0.4 0.3 0.0 1.0 0.1 0.4 0.8 0.9 0.1 0.0 0.1 0.0 0.9 0.5 0.2 0.1 0.1 0.3 0.1 0.2 18.2 0.2 0.0 0.4 0.8 0.1 1.2 0.4 0.0 0.0 0.3 0.0 0.2 0.3 0.7 3.2 0.2 0.2 7.8 9.5 9.4 2.8 0.1 0.3 0.4 0.5 0.5 3.0 0.0 0.3 0.0 0.0 0.1 5.9 0.1 0.5 0.0 0.0 0.2 0.4 0.8 0.3 0.0 0.1 13.9 1.6 3.6 0.0 0.0 0.0 0.9 0.1 3.5 0.8 0.0 0.0 11.6 0.1 1.1 1.0 0.0 5.1 0.0 2.0 0.1 0.0 0.4 22.6 0.9 0.7 0.6 8.1 2.7 0.0 1.5 0.0 0.3 0.3 0.5 7.2 0.0 3.4 6.5 0.0 0.0 7.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 1.7 1.0 0.7 0.4 1.3 0.9 0.4 0.4 0.8 0.9 0.5 0.4 0.4 0.7 2.5 0.0 1.1 0.0 0.2 0.4 0.5 0.6 0.6 0.0 1.1 3.2 0.3 0.0 0.5 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 1.3 1.9 0.0 0.0 0.3 0.0 0.7 1.3 0.0 0.2 0.0 0.0 1.4 0.4 0.2 0.0 0.0 0.2 0.0 1.5 0.8 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 5.0 1.2 0.1 3.4 0.6 0.1 0.3 0.3 2.2 0.2 0.1 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327307-89377473 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 89.5;Ductal cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 488.1" "Group enriched" "Detected in all" 19 "granulocytes: 488.1;monocytes: 125.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 198.8;BJ hTERT+ SV40 Large T+: 468.4;BJ hTERT+ SV40 Large T+ RasG12V: 540.2" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA059914: AB_2684159" "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 18.8 20.2 11.0 20.6 20.9 43.3 14.4 12.9 17.5 10.7 0.4 11.3 25.6 13.0 11.8 6.9 17.8 24.8 15.6 9.5 14.4 19.5 28.9 44.6 9.0 23.0 15.9 6.0 18.3 7.4 5.5 6.1 31.4 23.4 6.0 9.1 3.8 34.9 12.7 7.2 5.8 18.8 18.3 14.2 48.0 12.7 6.8 14.5 33.4 7.4 14.9 5.4 13.6 7.9 35.7 38.7 2.7 0.9 10.3 41.7 43.9 0.5 25.4 198.8 468.4 540.2 2.0 54.3 3.3 11.2 39.0 112.0 33.6 0.6 4.9 34.0 5.6 0.7 15.9 10.1 1.2 23.8 4.5 13.8 27.8 0.6 40.6 3.4 17.9 2.8 1.5 1.1 8.3 12.7 0.3 10.7 11.7 0.7 0.1 12.1 10.2 3.3 2.4 13.3 19.1 0.4 0.2 5.9 0.7 96.8 1.4 1.4 5.7 4.0 8.2 1.9 14.7 7.4 13.8 11.3 0.9 12.0 19.9 7.9 105.7 45.8 172.5 4.6 101.9 1.0 9.7 6.6 3.0 15.6 10.9 3.7 4.5 488.1 2.1 125.0 3.5 16.3 19.4 11.0 20.9 12.9 17.5 9.5 14.4 23.0 15.9 6.0 23.4 14.2 14.5 35.7 89.5 51.3 10.1 5.9 8.0 3.2 6.7 13.0 4.0 10.7 3.1 5.5 32.5 10.0 12.5 9.2 4.2 5.2 8.3 6.8 21.5 70.6 0.9 26.0 16.6 66.4 0.0 10.3 9.1 36.3 12.8 20.1 4.6 39.3 13.9 19.8 20.0 13.6 34.6 60.6 8.4 4.0 4.1 21.7 4.4 0.5 30.4 26.8 3.6 17.8 22.0 20.8 8.2 6.0 50.2 23.3 9.4 28.2 2.5 10.0 34.6 14.5 12.3 2.1 46.0 16.0 22.2 1.2 1.6 2.9 1.8 1.9 6.3 14.4 3.7 6.2 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532942-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 31.2;lymphoid tissue: 31.6;salivary gland: 15.8" "Group enriched" "Detected in some" 4 "Endothelial cells: 2.2;Hepatic stellate cells: 4.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.7;REH: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 11.6 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 4.9 0.0 15.8 0.0 0.0 0.0 22.6 3.6 0.0 31.6 2.6 0.1 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 IFIT2 "cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K" ENSG00000119922 "Interferon induced protein with tetratricopeptide repeats 2" P09913 10 89283694-89309271 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.8" "Cell type enhanced" "Detected in many" "Adipocytes: 53.5;Glandular and luminal cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 420.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 420.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 141.0;BJ hTERT+ SV40 Large T+ RasG12V: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003408 Approved Approved Vesicles NA NA Vesicles "HPA003408: AB_1079100" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (1.75e-2)" "unprognostic (9.28e-2)" "unprognostic (6.71e-3)" "unprognostic (2.22e-1)" "unprognostic (5.40e-1)" "unprognostic (1.36e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.92e-2)" "unprognostic (1.03e-2)" "unprognostic (5.33e-3)" "unprognostic (6.46e-2)" 7.7 6.7 15.5 13.2 18.1 48.8 5.5 16.0 16.3 6.2 10.1 5.5 6.8 5.1 6.3 2.8 9.4 13.7 7.6 13.2 19.0 10.3 22.0 21.2 7.9 20.5 18.6 11.7 9.3 3.1 10.1 2.5 16.6 20.7 4.2 4.6 1.8 8.8 6.5 2.3 3.8 5.8 6.6 19.2 27.7 3.7 2.2 17.2 12.7 3.4 6.8 5.7 6.3 3.0 33.6 29.3 1.1 0.3 14.5 13.0 14.4 5.2 10.7 32.4 141.0 113.0 0.1 20.0 3.2 5.9 7.8 20.6 28.9 0.6 1.5 15.4 11.6 0.1 5.3 14.3 0.0 22.2 0.7 2.3 8.2 0.7 10.7 1.6 8.6 0.7 2.8 0.1 0.5 2.2 0.1 3.4 6.6 3.5 0.0 6.1 2.1 3.7 0.8 4.8 5.6 0.1 0.2 3.8 0.6 24.7 1.8 0.7 1.6 0.9 1.5 0.3 3.9 1.1 1.4 5.1 0.5 2.3 2.4 2.9 97.6 32.6 107.8 9.5 75.9 5.1 19.2 8.0 6.5 10.6 17.7 7.6 6.8 420.2 8.9 92.3 12.7 3.9 17.6 15.5 18.1 16.0 16.3 13.2 19.0 20.5 18.6 11.7 20.7 19.2 17.2 33.6 53.5 41.7 6.7 1.6 12.3 1.5 5.3 6.6 1.2 1.3 5.6 9.5 7.4 11.5 9.4 12.9 0.0 2.9 27.6 23.5 9.8 35.0 0.2 34.9 9.1 34.9 3.5 0.8 1.0 4.2 1.6 10.9 2.0 67.0 5.1 3.8 16.4 6.1 26.0 25.2 2.1 5.9 4.1 25.5 3.3 0.2 8.1 29.5 7.2 4.7 20.9 13.3 12.3 2.0 20.3 6.3 11.5 11.7 2.4 19.1 18.9 30.8 4.7 0.9 0.0 8.3 14.3 0.2 0.2 3.2 0.6 1.4 13.1 6.2 2.1 5.8 GPAM "GPAT1, KIAA1560, MGC26846" ENSG00000119927 "Glycerol-3-phosphate acyltransferase, mitochondrial" Q9HCL2 10 112149865-112215377 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 308.5;liver: 145.3" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Hepatocytes: 184.5;Horizontal cells: 45.4" "Cancer enriched" "Detected in all" 5 "liver cancer: 20.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "ASC diff: 250.3;Hep G2: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046339, HPA060090" Approved Approved Mitochondria NA NA Mitochondria "HPA046339: AB_2679627, HPA060090: AB_2684202" "unprognostic (1.82e-1)" "unprognostic (6.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (6.80e-2)" "unprognostic (8.75e-2)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" "unprognostic (4.59e-1)" "unprognostic (4.80e-1)" "unprognostic (2.37e-2)" "unprognostic (5.44e-2)" "prognostic favorable (4.54e-6)" "unprognostic (2.84e-1)" "unprognostic (4.41e-2)" "unprognostic (2.52e-2)" "unprognostic (1.37e-1)" 308.5 34.2 15.2 4.8 15.8 3.5 68.2 12.4 13.9 3.0 7.2 6.4 4.0 4.2 75.8 2.9 3.1 6.0 12.4 12.7 12.4 4.4 145.3 4.1 4.7 14.9 15.0 11.3 5.3 5.0 4.3 2.1 3.0 13.8 3.9 4.7 5.1 17.3 5.4 8.4 3.1 6.1 4.9 11.2 3.0 4.9 5.7 15.8 3.7 12.5 8.9 4.3 4.9 2.6 11.5 9.9 7.4 9.7 12.9 250.3 9.1 12.7 9.2 10.5 6.6 5.1 17.3 5.7 6.9 5.0 6.5 6.1 12.3 15.5 7.9 12.3 5.0 8.4 6.4 7.9 71.8 7.7 11.2 3.4 43.8 13.1 11.7 23.6 49.7 5.8 9.7 8.5 6.1 7.7 5.6 9.6 8.8 8.1 5.6 10.1 9.7 25.4 5.1 4.3 6.8 4.1 12.1 12.8 6.1 14.5 8.9 6.3 4.0 4.4 7.5 4.6 9.4 14.8 6.1 7.3 14.3 8.8 9.8 5.8 0.0 0.3 0.1 0.7 0.4 0.9 0.5 0.5 0.5 0.4 1.1 0.5 0.9 0.0 0.3 0.3 0.6 0.6 0.3 15.2 15.8 12.4 13.9 12.7 12.4 14.9 15.0 11.3 13.8 11.2 15.8 11.5 9.1 9.6 27.1 90.8 5.2 0.4 0.8 1.6 4.6 5.3 8.1 8.4 18.9 20.0 4.3 5.5 10.4 5.2 4.3 1.7 1.9 2.7 0.5 5.1 10.0 5.0 1.2 12.2 8.2 3.3 2.9 5.1 3.6 4.2 2.5 12.7 6.4 184.5 3.1 45.4 9.4 3.0 0.0 9.3 1.0 0.9 5.3 1.9 1.8 10.3 1.4 6.1 3.1 10.1 10.1 3.4 2.7 12.0 6.4 1.1 3.7 3.3 4.7 9.1 6.6 4.3 6.6 4.0 3.2 5.4 0.1 1.9 3.3 8.6 5.0 0.6 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 389.2;tongue: 206.1" "Cell type enriched" "Detected in all" 4 "Spermatocytes: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 32.6 15.6 22.0 14.7 24.5 23.8 27.6 23.6 25.1 16.7 20.4 18.4 11.2 14.9 11.1 16.1 17.2 12.2 36.5 21.4 22.8 13.3 30.4 15.2 22.5 23.7 23.5 21.1 12.7 14.3 8.7 7.8 11.4 24.0 16.2 16.0 28.5 17.0 11.3 389.2 17.9 21.1 14.6 23.2 28.9 18.7 43.7 22.9 24.1 13.3 206.1 19.8 44.2 16.8 28.0 27.4 57.7 19.9 60.7 71.8 32.8 10.8 22.0 28.0 21.6 24.2 26.7 20.5 98.9 19.1 37.5 10.6 22.9 40.8 36.6 23.9 29.5 39.0 32.9 26.1 42.7 33.2 61.5 15.5 34.0 22.3 34.5 71.1 26.8 37.8 56.2 29.6 21.4 16.4 19.4 55.7 63.2 20.0 27.7 21.4 37.5 23.3 38.3 22.8 11.2 6.5 14.8 10.1 15.9 28.9 27.1 25.3 34.7 21.2 9.0 12.2 9.9 29.5 34.7 48.5 69.6 29.4 130.0 8.2 70.6 42.6 111.7 56.9 35.2 60.0 73.4 53.9 54.9 47.1 66.5 74.4 57.2 68.6 63.1 46.0 54.2 57.0 45.3 22.0 24.5 23.6 25.1 21.4 22.8 23.7 23.5 21.1 24.0 23.2 22.9 28.0 26.3 9.6 12.5 15.3 32.8 12.1 14.7 23.1 5.7 18.7 12.6 15.2 40.6 14.3 14.9 5.5 8.4 18.6 23.2 4.6 21.5 16.9 12.6 11.4 12.0 19.8 12.1 28.2 8.5 17.4 13.5 32.8 10.7 8.3 30.4 14.4 27.5 23.4 20.9 11.8 9.0 7.4 12.2 17.0 11.7 10.8 13.1 16.6 30.2 7.5 28.0 25.9 21.6 8.0 26.9 10.5 7.4 16.1 27.2 16.1 19.2 34.8 21.5 33.0 19.7 27.1 15.5 163.3 36.7 14.3 10.9 13.5 25.6 36.3 9.6 11.6 PPP1R3C "PPP1R5, PTG" ENSG00000119938 "Protein phosphatase 1 regulatory subunit 3C" Q9UQK1 10 91628442-91633071 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 916.5;tongue: 452.5" "Group enriched" "Detected in many" 8 "Astrocytes: 201.8;Cardiomyocytes: 232.0;Hepatocytes: 64.2;Muller glia cells: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 41.9;HHSteC: 51.7;hTERT-RPE1: 85.4;LHCN-M2: 102.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027041 Uncertain NA NA "HPA027041: AB_1855649" "unprognostic (2.11e-1)" "unprognostic (1.86e-3)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.15e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-2)" "unprognostic (6.38e-2)" "unprognostic (1.85e-2)" "unprognostic (1.75e-3)" "unprognostic (5.63e-3)" "unprognostic (1.59e-2)" "unprognostic (5.48e-3)" "unprognostic (8.44e-3)" "unprognostic (4.86e-2)" "unprognostic (2.49e-1)" "unprognostic (4.61e-3)" 11.6 12.3 37.1 3.4 45.7 0.0 9.9 39.5 47.1 52.5 21.6 12.4 4.0 10.4 12.1 107.7 10.3 14.5 172.1 38.5 50.1 11.7 165.5 12.4 1.4 42.7 40.5 30.9 10.3 18.9 4.6 5.8 15.7 45.2 29.4 4.1 83.9 28.6 36.0 916.5 13.8 5.8 15.5 38.2 3.0 17.6 2.5 41.8 0.5 2.7 452.5 6.3 20.0 137.8 37.0 0.0 6.6 1.8 26.8 11.9 5.6 0.0 29.8 23.2 12.0 12.8 0.0 2.2 0.0 1.2 28.0 4.8 1.6 0.7 3.2 22.0 0.0 0.1 0.4 41.9 4.8 51.7 0.0 0.0 19.1 5.2 7.6 0.4 85.4 3.0 0.0 14.4 0.0 102.5 1.0 0.0 0.0 1.7 0.0 0.0 0.0 6.4 0.0 1.1 26.2 0.9 1.8 0.0 0.0 0.0 0.0 0.2 4.5 20.3 5.3 5.2 7.0 4.3 0.2 0.6 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 45.7 39.5 47.1 38.5 50.1 42.7 40.5 30.9 45.2 38.2 41.8 37.0 2.4 0.0 0.0 201.8 0.4 4.6 9.3 0.8 0.6 9.7 4.8 2.5 232.0 1.5 0.2 3.7 0.0 0.2 0.0 0.3 7.9 3.1 0.1 0.3 0.7 3.5 10.1 0.0 1.7 11.4 0.5 11.9 0.0 0.6 0.0 0.4 2.5 64.2 1.4 18.5 3.0 0.5 2.0 1.6 1.5 0.1 2.8 0.6 12.4 5.6 0.0 133.1 0.0 3.5 0.5 4.0 0.1 7.5 0.0 2.5 0.0 1.8 0.4 12.8 0.0 9.4 18.6 0.7 1.7 5.4 4.0 0.3 0.7 0.1 0.1 0.7 PYROXD2 "C10orf33, FLJ23849" ENSG00000119943 "Pyridine nucleotide-disulphide oxidoreductase domain 2" Q8N2H3 10 98383565-98415182 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 189.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 189.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 46.1;U-937: 31.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037566, HPA037567, HPA067394" Approved Approved Mitochondria NA NA Mitochondria "HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832" "unprognostic (2.35e-2)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (6.76e-2)" "unprognostic (1.27e-2)" "unprognostic (3.38e-2)" "unprognostic (2.69e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic favorable (3.37e-4)" 10.1 14.6 6.2 2.2 6.2 2.6 8.5 6.3 7.9 8.6 8.3 6.5 2.0 5.6 8.4 2.5 9.5 4.3 8.1 5.8 6.9 6.3 12.3 4.4 2.6 7.0 6.3 5.1 9.3 3.6 2.8 4.8 4.2 6.7 10.6 4.8 0.7 22.6 4.2 9.4 2.9 3.8 5.7 6.4 5.1 5.4 3.7 6.5 2.3 8.7 10.5 1.4 9.8 6.3 7.4 3.6 8.9 4.9 0.2 7.6 15.1 1.9 5.8 18.0 3.2 6.1 0.0 12.3 0.0 10.2 6.2 0.9 1.8 1.5 2.0 3.3 0.3 1.4 7.3 16.1 0.8 9.7 0.1 16.2 8.9 2.6 2.6 3.1 46.1 2.5 3.4 0.2 0.2 4.9 11.1 0.2 17.2 1.4 7.0 3.0 2.3 1.9 0.1 4.7 5.5 0.3 0.1 6.4 0.8 4.6 6.7 5.1 8.1 3.3 0.0 3.6 1.1 5.9 1.2 0.8 0.0 5.7 31.5 0.5 5.4 0.3 189.8 6.1 0.0 1.3 0.0 2.1 5.2 1.9 0.2 1.2 3.6 0.3 44.5 0.0 0.3 0.6 1.8 6.2 6.2 6.3 7.9 5.8 6.9 7.0 6.3 5.1 6.7 6.4 6.5 7.4 3.8 9.6 5.1 19.9 1.3 0.5 6.1 9.7 4.0 0.4 15.0 18.4 11.2 5.7 9.5 1.8 0.0 5.6 6.5 3.5 7.9 3.8 0.2 4.1 4.9 4.6 1.2 1.7 3.4 2.4 3.8 7.2 11.2 3.2 2.5 11.2 4.6 2.9 9.8 0.0 4.3 4.9 8.2 3.2 6.6 0.9 3.4 2.0 1.8 5.6 1.8 2.3 19.6 1.5 9.5 1.7 1.6 3.8 0.5 2.7 2.2 12.1 12.2 0.8 6.6 9.7 5.9 2.9 1.5 0.8 0.6 1.8 5.4 17.8 6.3 10.0 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329356-99394330 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;testis: 9.9" "Cell type enhanced" "Detected in many" "Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.2 1.1 6.8 0.2 10.0 0.0 0.5 5.5 16.7 1.7 0.0 0.6 0.4 0.9 1.7 0.8 1.0 0.3 0.1 6.8 5.9 0.9 0.2 0.1 0.0 4.0 4.0 10.3 2.6 1.1 0.7 3.7 0.0 5.5 1.7 0.4 5.3 0.8 0.8 0.0 1.1 0.6 0.4 1.0 0.1 0.6 9.9 5.0 0.1 0.1 0.1 0.1 1.8 1.4 10.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 2.8 7.4 6.7 11.3 0.0 4.4 0.0 0.0 1.4 0.1 1.7 8.7 0.0 4.8 0.0 0.9 1.9 2.8 3.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.4 2.7 0.3 0.0 0.9 7.7 0.8 0.0 0.0 0.0 0.9 0.0 2.2 6.1 2.0 0.4 1.0 0.5 0.0 0.0 0.0 0.6 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 10.0 5.5 16.7 6.8 5.9 4.0 4.0 10.3 5.5 1.0 5.0 10.1 0.6 0.0 0.0 4.6 0.0 2.3 3.3 0.1 5.2 25.3 0.7 2.8 1.4 0.0 0.2 1.8 14.6 0.0 0.0 0.0 0.0 0.6 103.1 0.5 1.0 0.4 0.0 0.8 69.9 1.5 0.0 1.0 0.0 0.3 0.0 0.2 1.8 0.0 0.0 50.5 89.5 0.1 0.0 0.0 0.8 88.0 2.1 0.3 1.8 4.7 0.1 1.3 0.0 10.6 2.2 2.0 0.3 2.6 0.0 5.9 0.1 0.7 0.6 3.4 0.0 2.0 0.5 1.9 1.6 1.5 1.0 0.0 0.2 1.2 0.1 2.4 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 264.7;Oligodendrocytes: 214.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 108.2;SK-MEL-30: 167.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" Yes No Nucleoplasm "Nucleoli, Nucleoli rim, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229" "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavorable (9.17e-4)" "prognostic unfavorable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 31.7 33.1 92.2 13.3 100.6 68.6 45.6 96.8 107.0 37.5 73.8 49.7 24.6 46.0 36.5 52.8 42.8 33.1 63.8 88.4 104.7 39.6 51.6 26.7 13.9 101.5 95.3 79.4 82.1 45.0 51.0 22.3 28.7 98.5 41.3 35.3 80.9 80.8 52.6 47.7 45.9 29.9 30.1 93.2 14.9 28.2 23.5 98.3 31.5 55.0 53.6 12.4 34.8 41.6 115.6 18.2 8.3 18.0 39.6 30.7 21.4 7.4 11.1 39.2 7.1 23.1 3.2 33.5 24.6 17.6 20.0 11.3 24.3 23.5 27.8 20.0 13.5 30.9 7.3 15.7 14.5 19.5 14.3 14.4 21.7 96.0 12.4 55.2 108.2 7.1 17.5 26.9 54.9 11.3 12.3 10.1 26.1 7.7 31.0 21.2 6.1 26.0 39.9 22.8 1.6 34.3 52.4 11.1 7.3 167.1 23.3 9.9 42.2 7.7 13.5 21.0 13.6 5.6 44.6 26.1 10.0 34.3 46.1 12.7 1.8 2.7 9.7 2.7 2.3 5.1 3.9 5.1 2.8 1.6 3.6 7.7 1.9 5.6 1.4 5.0 1.7 4.8 2.0 92.2 100.6 96.8 107.0 88.4 104.7 101.5 95.3 79.4 98.5 93.2 98.3 115.6 28.9 16.0 16.8 139.1 27.9 58.0 57.9 22.8 51.2 49.9 67.2 66.8 80.2 41.5 27.6 33.1 47.9 5.4 23.0 160.7 46.9 19.3 5.1 29.1 36.4 34.1 16.9 264.7 60.8 14.8 20.1 36.0 15.8 37.3 3.8 19.1 27.8 56.6 11.1 52.2 102.5 20.1 18.3 24.1 20.5 8.8 45.1 22.6 104.9 30.9 29.9 144.2 9.2 131.7 214.9 10.4 52.5 55.7 22.5 73.4 57.0 67.1 25.3 46.0 46.0 69.6 63.0 23.8 28.2 37.4 67.3 9.7 36.9 27.4 16.6 36.9 SMNDC1 "SMNR, SPF30, TDRD16C" ENSG00000119953 "Survival motor neuron domain containing 1" O75940 10 110290730-110304938 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061214, HPA070666" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA061214: AB_2684451, HPA070666: " "unprognostic (4.65e-2)" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (3.07e-2)" "unprognostic (3.63e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.08e-6)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.68e-3)" "unprognostic (6.88e-3)" "unprognostic (1.35e-1)" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (2.00e-1)" 15.7 12.1 7.4 15.3 7.9 32.1 13.8 11.3 11.2 13.6 8.6 12.8 9.9 14.5 8.8 16.3 13.4 11.7 12.0 6.9 8.8 13.8 15.0 14.3 17.0 7.5 7.7 6.4 13.6 10.3 13.2 9.0 18.5 7.9 10.1 11.2 16.7 11.6 10.3 25.0 13.2 11.6 14.7 8.3 14.8 11.6 13.3 7.7 20.6 12.2 18.1 18.4 17.5 13.8 9.9 36.2 27.0 38.9 44.9 29.6 35.1 28.9 41.0 42.6 53.3 54.6 35.1 43.7 51.2 25.7 25.9 30.5 38.5 57.8 28.2 59.9 29.0 30.6 51.1 21.9 41.2 35.3 56.9 47.2 27.4 29.7 42.2 71.1 39.5 30.0 29.0 46.8 46.5 41.9 17.1 61.0 55.0 43.5 27.8 18.4 52.0 77.9 26.8 30.0 25.7 19.4 26.0 26.6 22.4 48.9 33.3 27.7 32.3 33.0 31.2 35.2 28.9 52.9 37.8 42.4 76.7 31.4 77.9 24.6 5.7 8.9 14.5 5.2 9.2 6.4 5.4 6.8 6.7 8.6 4.8 5.9 5.9 16.6 6.3 9.8 5.2 8.1 4.3 7.4 7.9 11.3 11.2 6.9 8.8 7.5 7.7 6.4 7.9 8.3 7.7 9.9 57.7 28.9 37.1 6.8 53.4 69.6 42.5 27.2 89.4 27.3 31.7 26.7 23.4 14.3 27.9 11.0 20.9 33.0 55.7 23.9 33.2 22.8 10.7 34.2 52.0 41.5 18.6 37.0 7.8 18.0 32.0 39.1 37.8 58.8 58.3 27.3 27.1 26.5 32.4 33.7 8.0 21.4 38.7 40.9 79.7 4.4 29.2 47.7 35.6 6.5 45.8 23.0 22.6 5.0 11.2 21.7 21.0 22.2 45.7 53.3 20.6 40.9 28.6 33.0 19.7 30.8 39.7 46.2 37.7 72.4 83.4 46.1 57.4 33.5 24.1 65.8 C10orf88 "Em:AC073585.5, FLJ13490, PAAT" ENSG00000119965 "Chromosome 10 open reading frame 88" Q9H8K7 10 122930901-122954311 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 146.8;Late spermatids: 45.9;Spermatocytes: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039681, HPA040991" Approved NA NA "HPA039681: AB_10796333, HPA040991: AB_10794432" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (3.00e-2)" "unprognostic (1.36e-1)" "unprognostic (4.42e-2)" "unprognostic (4.04e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (2.65e-2)" "unprognostic (2.86e-1)" "unprognostic (7.59e-3)" "unprognostic (7.40e-3)" "unprognostic (2.69e-2)" "unprognostic (4.95e-2)" "unprognostic (3.74e-2)" "unprognostic (6.78e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-2)" 3.0 4.4 5.0 4.5 5.2 1.5 4.0 5.2 6.0 3.7 4.6 3.1 3.5 3.9 4.3 3.1 2.9 2.9 3.4 5.2 5.6 3.5 3.3 3.0 5.9 5.4 5.2 5.0 4.7 2.3 4.3 2.1 4.4 5.4 3.6 3.6 6.6 2.7 3.0 4.4 3.6 3.3 3.2 4.9 3.9 3.0 10.8 5.4 5.2 4.3 4.3 4.8 3.9 1.5 5.7 6.1 6.3 7.9 7.7 5.9 8.4 6.0 9.8 11.9 10.4 12.2 5.1 5.8 6.0 4.1 7.6 9.2 6.6 8.5 4.9 15.3 10.3 7.0 6.6 5.7 5.9 8.8 7.0 10.0 6.6 9.6 9.9 13.5 14.1 10.9 7.9 6.3 6.8 17.7 3.5 7.8 7.8 4.7 5.2 5.4 7.6 9.2 1.8 6.1 3.8 4.4 9.0 5.1 4.9 11.2 8.8 4.1 4.8 8.2 7.6 4.6 7.4 12.2 6.9 6.7 7.8 8.1 9.6 6.3 1.4 1.7 3.3 2.7 0.8 3.2 3.0 3.6 3.6 2.4 3.1 3.5 3.4 0.2 3.9 1.0 2.1 5.3 2.7 5.0 5.2 5.2 6.0 5.2 5.6 5.4 5.2 5.0 5.4 4.9 5.4 5.7 4.7 3.2 4.8 9.4 5.8 6.0 2.3 6.9 6.8 9.8 3.4 3.0 4.6 5.7 6.8 0.0 6.2 5.6 7.2 2.8 11.7 5.3 146.8 4.0 7.0 4.6 4.8 6.9 10.9 3.0 5.3 6.0 3.6 6.0 2.5 4.9 2.2 2.4 4.9 6.7 11.9 3.2 6.1 3.3 2.0 45.9 4.1 4.1 3.6 6.5 3.1 6.1 5.2 13.0 16.7 4.5 1.3 5.7 2.4 2.2 2.5 5.5 5.6 9.2 6.6 5.0 5.7 52.2 14.8 5.3 4.1 3.6 5.9 3.2 3.2 1.7 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in many" "Spermatocytes: 182.0;Spermatogonia: 173.9" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 36.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.1 1.3 0.6 6.5 0.6 16.5 3.1 5.7 1.3 2.7 1.3 4.3 2.9 2.9 1.4 6.0 1.7 2.0 0.6 0.5 1.4 1.9 1.8 1.7 12.5 1.1 1.0 0.3 2.6 1.2 1.4 3.1 4.2 2.8 2.1 5.1 1.1 1.9 1.0 0.3 5.3 3.9 2.2 1.2 4.3 3.8 12.9 1.1 16.0 1.1 0.2 12.7 3.7 3.2 1.8 57.7 55.4 70.6 90.1 2.9 6.4 37.4 42.9 27.8 34.4 54.6 70.3 45.5 70.0 16.7 15.5 29.1 56.3 40.9 34.9 50.7 68.5 45.5 37.3 56.3 58.0 1.7 71.2 31.6 3.6 2.0 42.1 20.0 9.4 24.0 46.0 20.7 43.5 43.1 54.9 75.2 35.6 73.4 42.3 24.1 70.3 62.1 16.3 24.2 72.2 28.4 22.8 50.3 14.5 7.8 59.0 60.9 23.1 17.2 38.4 19.4 35.4 52.4 22.3 47.6 74.5 19.0 42.8 17.9 0.3 0.7 0.0 7.0 1.5 2.4 18.8 11.4 9.4 2.3 23.2 5.2 7.7 1.0 10.2 1.0 36.8 19.7 2.3 0.6 0.6 5.7 1.3 0.5 1.4 1.1 1.0 0.3 2.8 1.2 1.1 1.8 4.7 9.6 3.9 0.0 19.7 21.5 11.5 12.6 13.1 16.4 10.0 15.0 1.0 12.8 12.6 22.0 0.0 46.3 13.2 26.2 3.9 9.0 2.0 9.3 16.4 8.1 10.8 50.5 3.3 6.2 43.4 13.0 17.9 16.3 5.7 60.6 5.7 3.6 15.1 6.7 5.4 17.8 8.2 2.2 10.3 5.3 9.0 7.3 1.8 9.4 5.7 4.3 1.0 4.5 6.6 4.7 1.8 5.7 37.5 3.7 1.7 1.6 6.3 11.4 19.7 10.5 16.4 182.0 173.9 22.9 9.9 11.1 15.7 16.5 30.9 11.7 PRLHR "GPR10, PrRPR" ENSG00000119973 "Prolactin releasing hormone receptor" P49683 10 118589997-118595648 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.2;brain: 8.5;pituitary gland: 7.0" "Group enriched" "Detected in some" 4 "Granulosa cells: 7.7;Horizontal cells: 13.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Low region specificity" "Detected in many" HPA039361 Enhanced NA NA "HPA039361: AB_10673527" "unprognostic (1.83e-1)" "unprognostic (2.62e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" 0.0 5.2 0.9 0.0 2.6 0.0 0.0 1.2 2.7 1.4 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 6.0 8.5 0.5 0.0 0.3 0.0 7.0 0.0 8.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 3.5 0.2 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.1 3.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 2.6 1.2 2.7 0.2 4.8 6.0 8.5 0.5 8.0 0.2 5.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.0 0.0 0.0 13.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 TCTN3 "C10orf61, DKFZP564D116, JBTS18, TECT3" ENSG00000119977 "Tectonic family member 3" Q6NUS6 10 95659823-95694143 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026987 Approved Approved Microtubules "Intracellular and membrane" NA NA 4400000 Microtubules "HPA026987: AB_10600911" "unprognostic (1.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.78e-2)" "prognostic favorable (5.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.50e-2)" "unprognostic (8.88e-3)" "unprognostic (1.08e-1)" "unprognostic (3.03e-2)" "unprognostic (9.25e-3)" "unprognostic (3.78e-3)" "unprognostic (7.29e-2)" "unprognostic (4.60e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (9.30e-3)" "unprognostic (1.59e-1)" 21.5 25.5 8.2 15.9 8.6 5.1 25.5 8.7 11.4 26.6 20.5 22.3 17.7 25.1 65.6 17.1 35.7 22.9 16.6 8.4 13.0 32.8 27.0 19.6 14.4 9.3 9.1 8.0 30.8 27.3 70.4 23.0 27.1 8.9 25.8 25.9 22.4 25.6 28.0 9.6 20.6 15.5 27.0 8.8 17.4 19.3 19.6 8.9 14.1 71.3 11.6 18.2 24.1 18.7 8.9 34.0 54.1 44.1 89.3 93.6 74.6 25.7 45.3 94.8 46.9 55.3 35.4 57.3 31.3 40.1 60.4 49.8 46.7 43.9 54.5 56.5 33.6 36.4 10.9 21.6 49.2 46.9 37.4 22.8 65.2 49.2 46.6 72.4 88.0 80.7 27.7 21.0 40.3 63.4 32.5 23.4 27.9 12.1 49.7 38.1 25.3 33.9 38.3 67.8 23.3 11.5 24.5 37.7 18.5 52.6 40.8 71.0 35.1 37.9 35.6 24.9 23.9 49.5 18.9 37.9 20.7 57.5 47.1 19.0 6.8 14.2 4.9 25.8 21.9 32.0 28.3 23.1 25.2 45.2 19.4 24.2 20.0 1.6 26.8 24.3 23.6 22.2 21.3 8.2 8.6 8.7 11.4 8.4 13.0 9.3 9.1 8.0 8.9 8.8 8.9 8.9 14.8 19.2 16.2 16.6 29.3 14.4 23.7 33.8 31.3 24.0 18.2 15.0 8.5 27.1 20.3 31.3 37.5 50.3 18.8 20.2 7.9 27.2 18.6 25.5 25.7 20.4 13.8 11.6 17.3 20.3 44.2 27.3 11.7 18.3 8.2 29.8 21.4 16.8 28.5 25.2 17.7 12.5 26.4 14.1 59.1 14.1 20.8 18.7 16.0 16.9 14.8 36.7 15.5 20.6 13.7 14.1 12.7 25.2 35.9 19.8 16.2 16.1 27.5 44.4 13.1 23.9 19.8 39.8 34.1 15.3 11.5 31.5 23.0 34.2 23.7 14.6 DENND10 FAM45A ENSG00000119979 "DENN domain containing 10" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 36.5;Cytotrophoblasts: 53.8;Extravillous trophoblasts: 27.7;Hofbauer cells: 56.0;Syncytiotrophoblasts: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 16.9 14.4 19.8 14.1 21.2 32.7 14.2 19.6 23.8 14.3 18.4 18.1 12.7 13.4 16.9 20.7 11.5 12.8 15.7 20.0 20.3 26.3 31.4 12.7 13.2 21.1 20.6 19.9 21.1 9.4 18.2 3.0 15.8 21.6 13.5 14.6 10.7 11.0 10.7 17.7 18.9 15.3 13.3 20.7 14.2 14.4 7.4 20.6 13.2 20.1 11.2 14.7 15.0 9.4 22.8 23.7 24.9 38.6 45.5 75.9 59.1 15.9 32.3 85.9 29.4 30.1 23.7 35.8 16.1 12.8 41.4 33.8 42.2 25.7 28.0 27.0 29.2 24.1 3.8 11.5 32.9 75.4 11.0 10.3 63.7 31.5 20.9 32.6 75.0 36.1 16.8 7.8 22.9 42.0 20.0 17.2 48.5 23.6 22.1 14.6 17.0 40.6 14.3 38.6 25.9 6.9 27.7 21.7 30.2 67.5 36.1 24.9 48.5 36.6 23.3 12.3 28.9 19.4 23.0 10.0 17.7 35.9 54.7 11.2 44.9 26.6 55.6 6.9 31.8 6.6 3.9 10.9 10.0 16.6 3.6 5.7 7.1 40.0 6.1 36.4 5.0 20.4 11.6 19.8 21.2 19.6 23.8 20.0 20.3 21.1 20.6 19.9 21.6 20.7 20.6 22.8 9.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 53.8 11.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 27.7 9.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 45.3 1.7 0.0 0.0 0.0 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687241 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 246.7;Granulosa cells: 385.5;Langerhans cells: 326.1;Late spermatids: 278.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 119.7;HHSteC: 119.1;hTCEpi: 230.5;SK-MEL-30: 194.5;U-2197: 134.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 29.4 41.8 19.9 6.5 24.0 5.0 21.4 22.0 23.4 28.4 16.7 24.8 14.1 11.3 4.7 26.4 19.1 10.5 17.5 19.6 36.7 12.1 47.2 22.7 2.4 24.4 21.2 20.3 86.3 9.5 5.7 19.4 17.1 22.5 26.6 19.1 25.7 22.9 16.7 12.6 92.5 15.8 5.4 23.9 21.0 30.8 16.1 22.3 2.0 9.2 3.9 4.5 25.7 46.4 29.4 38.8 99.8 0.5 14.3 20.2 9.1 20.0 18.5 100.7 25.0 37.5 18.8 47.2 0.8 13.0 10.5 18.0 40.0 7.6 32.3 9.4 1.0 8.9 2.6 119.7 52.6 119.1 2.6 3.0 14.6 230.5 18.7 49.1 22.8 3.4 3.6 5.7 2.0 14.0 33.4 1.7 3.1 3.5 10.6 9.3 1.3 11.3 1.5 24.9 20.9 1.7 4.0 63.9 22.7 194.5 3.2 17.2 3.1 5.5 5.9 11.7 134.4 4.6 4.4 3.3 0.8 22.2 8.1 3.8 0.0 6.2 2.3 4.2 5.7 2.0 2.8 2.8 3.1 11.1 2.0 3.0 3.7 0.5 2.0 0.5 2.3 2.6 2.9 19.9 24.0 22.0 23.4 19.6 36.7 24.4 21.2 20.3 22.5 23.9 22.3 29.4 6.3 19.2 19.0 0.7 8.0 96.0 87.6 246.7 145.1 9.6 13.6 16.8 9.7 52.9 63.4 38.6 6.2 149.6 15.4 137.5 43.0 18.8 60.9 33.2 17.1 11.4 31.8 2.1 3.6 24.1 64.8 23.4 58.1 57.9 6.3 385.5 34.2 42.4 41.8 13.5 4.3 70.4 48.8 21.7 326.1 278.5 10.2 49.6 83.6 0.0 6.4 128.2 2.1 0.5 4.4 43.3 100.6 14.7 5.9 55.2 109.0 11.2 16.7 14.6 6.6 10.2 19.3 3.5 4.9 68.0 108.4 194.7 19.0 10.9 100.6 106.3 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851305-120909524 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favorable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 15.3 12.4 6.1 17.1 6.3 6.6 15.4 7.0 6.0 15.5 10.6 15.3 14.4 15.4 10.9 15.0 17.8 15.2 7.9 6.0 7.5 24.6 20.3 15.3 18.7 9.8 6.8 4.6 16.1 13.8 38.9 5.4 16.9 11.1 15.7 16.8 15.2 14.5 14.3 3.5 9.8 15.0 17.1 10.9 18.6 16.2 11.6 6.5 18.0 22.7 6.5 20.4 15.8 8.7 14.8 28.5 25.1 24.8 43.4 35.4 42.2 18.0 26.0 52.4 28.3 34.9 14.7 29.1 19.9 13.1 37.5 22.5 26.5 29.1 35.8 35.4 26.5 24.2 20.8 19.9 15.3 33.6 29.6 23.6 36.7 28.5 26.2 42.2 51.7 53.1 14.0 16.9 23.3 30.1 12.1 18.7 12.9 12.8 24.8 16.1 7.7 43.3 17.4 33.7 21.8 12.2 21.8 22.6 24.9 68.8 43.3 18.4 18.7 40.0 18.6 11.6 2.8 25.1 12.9 8.6 24.3 26.4 24.8 9.9 27.4 8.5 3.8 4.5 11.2 3.6 8.5 3.0 4.1 9.7 4.6 3.1 3.3 0.6 5.9 25.3 2.3 4.3 5.2 6.1 6.3 7.0 6.0 6.0 7.5 9.8 6.8 4.6 11.1 10.9 6.5 14.8 23.7 6.4 16.4 77.7 42.3 12.0 13.5 15.5 10.8 42.8 16.6 13.6 8.3 27.1 20.1 25.8 98.0 19.3 30.5 24.3 11.7 18.3 3.8 31.7 33.1 24.4 27.1 16.6 57.0 10.5 12.1 21.8 29.6 32.7 9.5 34.2 33.9 33.9 32.2 25.2 54.2 24.5 12.2 43.2 16.5 4.4 43.5 34.9 3.6 30.9 42.4 21.0 20.6 112.1 84.7 25.3 23.4 38.7 25.6 17.9 34.8 19.9 30.1 85.3 19.7 28.9 17.9 25.8 16.3 15.6 14.2 15.2 18.9 41.7 20.6 19.3 ARMH3 "C10orf76, FLJ13114" ENSG00000120029 "Armadillo like helical domain containing 3" Q5T2E6 10 101845599-102056193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.2;dendritic cells: 10.5;Extravillous trophoblasts: 14.8;Granulosa cells: 11.5;Hofbauer cells: 12.6;Syncytiotrophoblasts: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050913, HPA053580" Approved Approved Vesicles NA NA Vesicles "HPA050913: AB_2681270, HPA053580: AB_2682198" "unprognostic (5.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "unprognostic (3.41e-2)" "unprognostic (9.41e-2)" "unprognostic (9.55e-2)" "unprognostic (5.28e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (6.03e-3)" "unprognostic (1.40e-3)" "unprognostic (2.76e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-1)" "unprognostic (2.48e-1)" "unprognostic (3.85e-1)" "unprognostic (4.87e-2)" 9.6 9.2 6.3 12.1 8.0 22.0 10.0 10.3 7.4 10.9 7.8 12.6 12.9 10.6 9.5 14.4 10.5 9.3 16.7 6.1 7.5 10.1 12.1 11.9 12.8 7.5 8.6 5.6 11.3 10.2 16.5 8.0 11.1 7.3 10.9 13.3 16.5 9.5 10.6 19.9 12.3 12.4 13.1 6.5 13.7 10.4 8.9 7.3 13.2 10.1 20.0 13.4 10.9 10.2 8.3 23.2 17.7 15.5 19.1 12.9 17.3 13.9 20.3 24.0 20.0 16.9 12.2 18.6 17.0 13.5 22.9 14.5 17.7 20.4 22.4 18.3 17.9 18.9 30.3 15.9 14.6 15.2 21.3 26.4 16.0 17.7 22.6 19.9 23.4 15.3 15.3 0.9 15.9 16.6 14.4 16.5 13.8 8.5 18.8 11.6 16.0 28.1 11.0 16.4 18.6 7.3 12.1 15.8 10.9 21.0 15.8 28.8 12.4 15.1 10.5 17.1 9.8 14.7 15.4 17.0 17.1 16.9 23.7 7.9 19.4 7.3 7.4 5.9 8.7 5.5 6.1 6.2 4.5 7.7 7.0 4.8 4.9 1.9 5.2 10.7 7.4 6.0 4.7 6.3 8.0 10.3 7.4 6.1 7.5 7.5 8.6 5.6 7.3 6.5 7.3 8.3 8.8 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 7.4 6.0 0.0 0.0 0.0 0.0 0.0 11.2 10.5 0.0 1.9 7.8 0.0 6.9 6.8 1.9 0.0 0.0 0.0 9.7 14.8 2.7 0.0 7.7 0.0 11.5 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 9.9 0.0 0.0 2.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 16.3 3.9 5.7 0.0 0.0 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 229.4;brain: 128.0;heart muscle: 286.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 54.3;Cardiomyocytes: 135.7;Cone photoreceptor cells: 25.0;Excitatory neurons: 23.3;Horizontal cells: 48.8;Inhibitory neurons: 41.9" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 21.3;HMC-1: 12.7" "Group enriched" "Detected in all" 4 "amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles NA NA Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 229.4 6.9 77.1 3.6 128.0 0.9 67.7 51.2 86.7 7.4 43.9 4.6 1.8 4.1 4.1 2.5 4.9 3.1 286.0 102.2 58.4 2.4 2.3 2.5 8.2 65.2 56.4 77.3 11.6 2.4 1.7 19.8 2.9 66.6 5.3 4.7 53.0 10.0 3.5 8.1 5.9 5.3 2.6 49.3 5.7 2.8 8.6 59.0 2.4 3.6 5.5 8.4 4.8 4.5 63.6 1.7 2.6 2.5 3.2 1.0 1.1 0.6 1.2 1.0 0.6 0.9 3.6 3.4 1.6 0.9 0.8 0.7 1.7 0.9 0.4 0.6 2.4 2.0 21.3 3.0 1.9 0.9 1.4 12.7 2.6 1.7 1.0 1.4 3.7 1.0 4.7 6.3 1.8 1.0 1.2 0.8 4.0 0.8 0.7 0.6 1.0 0.2 1.4 1.0 1.1 7.4 1.2 0.8 0.6 2.4 1.5 2.2 0.9 2.3 1.3 2.0 0.6 1.2 1.7 1.9 1.7 1.4 5.3 0.2 0.0 0.0 0.7 0.0 0.5 0.1 0.9 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 77.1 128.0 51.2 86.7 102.2 58.4 65.2 56.4 77.3 66.6 49.3 59.0 63.6 0.4 0.0 0.0 8.5 2.3 0.4 0.1 0.3 0.0 54.3 0.3 0.5 135.7 0.0 0.1 1.8 25.0 0.2 0.0 0.8 0.0 0.2 6.6 0.0 0.2 1.6 0.0 0.0 23.3 0.0 0.2 5.8 0.0 0.0 0.0 0.8 0.4 0.1 2.2 48.8 41.9 0.4 0.0 0.6 0.8 5.2 1.8 0.3 0.0 1.0 0.5 8.3 0.0 5.5 3.7 0.3 0.2 0.7 0.3 0.1 0.5 0.1 0.2 4.7 0.0 0.1 1.3 2.5 5.5 0.5 0.0 0.3 0.1 0.5 0.3 0.1 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353833-104455102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 8.5;testis: 13.5" "Group enriched" "Detected in some" 4 "Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.1;U-2 OS: 6.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.9" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.4 0.6 2.6 0.5 1.3 0.4 0.4 1.1 0.8 2.2 2.0 0.4 0.1 1.8 0.2 0.2 8.5 0.2 2.4 0.6 2.7 0.5 0.1 1.3 0.3 2.4 2.5 0.7 0.5 0.3 0.7 1.5 0.4 2.0 0.5 0.0 0.6 0.2 0.4 1.3 0.3 0.2 0.6 2.3 0.3 0.3 13.5 1.2 0.1 0.8 0.8 0.4 0.3 0.7 1.1 0.1 0.0 0.7 0.1 0.1 0.3 0.1 1.0 3.1 0.6 1.6 0.0 0.0 2.4 0.2 0.4 1.7 0.2 0.0 0.2 1.8 0.3 0.1 0.5 0.9 0.0 0.3 0.3 0.4 0.3 1.3 0.5 1.6 1.3 1.0 0.1 0.7 0.7 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.2 0.0 0.1 0.5 0.7 0.1 0.4 2.0 0.6 6.5 0.3 1.8 0.2 0.0 0.1 0.7 0.8 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.6 1.3 1.1 0.8 0.6 2.7 2.4 2.5 0.7 2.0 2.3 1.2 1.1 0.4 0.0 0.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 10.0 0.0 9.3 0.0 0.0 0.1 0.1 0.0 0.0 0.6 73.3 25.1 0.3 0.4 0.0 0.0 4.0 0.2 0.4 0.7 0.0 0.4 0.0 0.3 1.8 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.0 58.9 0.6 0.2 0.0 1.9 0.1 0.7 1.0 1.0 0.0 0.3 0.0 1.2 0.0 0.2 0.0 0.0 56.9 0.3 0.0 0.8 1.0 34.4 4.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 515.8;liver: 372.6;skeletal muscle: 494.5;tongue: 1020.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 449.0;Distal tubular cells: 240.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol NA Yes 100000000 Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favorable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favorable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 13.0 55.4 69.0 14.8 82.2 8.0 22.9 79.9 128.5 53.6 82.6 51.3 62.5 13.2 26.1 43.0 18.0 49.4 515.8 79.1 86.5 144.5 372.6 15.6 14.2 91.4 74.0 78.9 18.2 34.3 143.7 22.6 14.5 95.5 22.9 59.7 107.2 49.0 27.6 494.5 23.7 46.2 21.6 58.2 17.0 59.4 33.9 88.6 17.9 48.1 1020.5 30.5 22.5 21.2 141.9 73.7 40.3 46.0 114.4 35.1 30.7 127.1 58.9 108.7 101.8 109.8 89.9 56.4 71.9 20.4 50.2 89.2 88.6 107.1 78.9 105.8 25.7 46.7 28.1 46.7 114.3 184.9 77.9 44.0 47.3 82.5 86.9 228.4 69.5 49.5 48.6 71.1 106.2 65.4 64.9 42.5 56.5 29.2 118.7 56.1 45.5 44.4 72.8 173.7 37.5 19.6 28.7 44.8 59.3 222.6 66.8 115.7 27.1 23.3 25.4 56.3 28.0 68.7 76.8 99.7 74.3 65.4 40.8 34.1 4.0 8.7 6.8 19.7 25.8 18.4 17.6 21.5 20.7 21.9 21.2 15.6 22.7 0.8 20.5 31.5 36.4 27.6 15.6 69.0 82.2 79.9 128.5 79.1 86.5 91.4 74.0 78.9 95.5 58.2 88.6 141.9 10.3 16.0 16.2 26.1 38.8 11.9 41.8 82.7 24.5 95.6 18.8 21.2 449.0 72.9 34.4 73.5 62.6 35.9 10.7 62.1 240.7 51.9 166.7 17.8 9.3 16.7 19.7 39.5 47.4 30.8 18.1 23.5 76.9 21.5 31.8 20.2 17.2 191.8 31.6 75.7 63.3 45.3 54.9 12.4 6.9 24.1 11.1 13.0 49.8 13.1 10.5 36.6 6.2 21.1 37.2 27.6 34.4 14.3 22.4 13.1 97.0 163.3 27.9 76.5 13.1 15.2 20.5 116.7 10.4 40.9 10.4 55.1 14.6 47.0 66.4 42.3 CPN1 ENSG00000120054 "Carboxypeptidase N subunit 1" P15169 10 100042193-100081869 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "liver: 82.3" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 37.2" "Group enriched" "Detected in some" 12 "liver cancer: 26.6;melanoma: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "SK-MEL-30: 141.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 13000000000 "unprognostic (2.97e-2)" "unprognostic (2.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (6.75e-2)" "unprognostic (2.93e-2)" "unprognostic (5.26e-2)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 82.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 37.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.6 4.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 C10orf95 FLJ14280 ENSG00000120055 "Chromosome 10 open reading frame 95" 10 102449837-102451543 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 9.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 30.1;Rod photoreceptor cells: 18.4;Syncytiotrophoblasts: 38.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.8;JURKAT: 11.7" "Low region specificity" "Detected in single" "Secreted - unknown location" NA NA "unprognostic (2.31e-1)" "unprognostic (7.76e-3)" "unprognostic (3.19e-1)" "unprognostic (5.62e-3)" "unprognostic (4.02e-1)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (5.98e-2)" "unprognostic (1.50e-2)" "unprognostic (1.01e-1)" "unprognostic (4.42e-2)" "unprognostic (2.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.22e-2)" "unprognostic (4.80e-3)" 0.5 1.5 0.7 1.8 0.7 2.0 0.2 2.8 1.0 0.7 0.7 1.2 2.5 1.2 0.4 1.3 9.7 1.4 0.6 0.7 0.5 1.4 0.4 3.5 3.0 0.3 0.4 1.0 1.1 4.7 0.1 1.3 0.7 1.2 1.6 0.4 4.8 4.0 0.1 0.7 4.1 2.3 0.0 0.0 2.6 3.6 0.7 0.7 0.0 5.3 0.0 0.5 0.6 0.5 0.3 5.7 1.1 0.1 2.3 0.0 0.0 4.9 0.2 0.0 0.0 0.0 4.4 9.8 5.0 2.2 0.0 0.7 9.8 0.0 0.4 0.0 4.3 11.8 3.2 4.7 3.7 0.0 4.4 3.0 0.1 1.8 0.0 0.1 3.1 0.0 11.7 5.6 4.1 0.0 4.5 2.4 4.2 2.2 2.0 3.3 7.0 0.1 5.4 1.1 2.0 8.8 1.3 2.4 1.5 3.1 1.7 4.8 0.3 0.4 0.2 1.0 0.2 0.5 3.5 2.9 3.3 0.2 6.5 0.1 2.1 1.2 1.7 7.8 0.6 7.4 10.7 8.4 7.9 3.6 8.3 11.7 9.9 0.9 10.1 0.3 6.3 9.6 4.9 0.7 0.7 2.8 1.0 0.7 0.5 0.3 0.4 1.0 1.2 0.0 0.7 0.3 0.3 0.0 3.2 0.7 3.1 1.5 4.3 0.5 0.0 4.6 2.4 2.5 0.1 2.8 4.2 5.5 10.4 2.3 6.4 2.5 3.9 1.5 0.1 30.1 0.7 1.0 1.2 1.3 0.7 1.1 1.7 0.3 1.5 4.0 0.0 0.8 0.4 0.3 2.3 3.3 0.7 3.7 4.1 1.0 1.0 0.5 0.6 1.4 0.0 0.0 2.2 2.7 6.2 0.0 0.0 0.7 0.4 0.7 2.5 3.3 2.0 4.2 8.7 18.4 0.0 0.9 0.5 0.7 1.4 1.9 1.6 38.0 3.2 0.7 3.2 2.9 SFRP5 SARP3 ENSG00000120057 "Secreted frizzled related protein 5" Q5T4F7 10 97766751-97771999 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 87.0;pancreas: 144.4" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 273.1" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 30.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 4 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 2.5;CACO-2: 12.4;RPMI-8226: 4.5;SCLC-21H: 2.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 8 "spinal cord: 120.7" "Secreted in other tissues" NA NA "unprognostic (2.63e-4)" "unprognostic (3.03e-3)" "unprognostic (6.74e-2)" "unprognostic (3.43e-2)" "unprognostic (9.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.19e-1)" "unprognostic (2.85e-1)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (4.51e-9)" "unprognostic (1.67e-2)" "unprognostic (1.57e-1)" "unprognostic (9.17e-2)" "unprognostic (1.62e-1)" 2.1 9.7 2.9 0.3 3.8 0.3 2.5 3.0 1.3 3.2 87.0 27.8 30.1 1.8 2.2 2.0 2.2 4.1 41.0 6.3 6.2 0.4 8.9 3.4 0.3 4.0 7.9 0.5 0.6 144.4 0.0 0.9 0.0 9.8 6.8 0.5 0.2 2.8 4.1 1.3 2.5 26.5 0.4 1.5 0.1 10.6 0.8 11.2 0.1 1.0 3.0 0.1 3.2 4.9 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 4.5 0.0 0.0 2.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.8 0.0 0.2 2.9 3.8 3.0 1.3 6.3 6.2 4.0 7.9 0.5 9.8 1.5 11.2 0.5 0.0 3.2 3.6 0.3 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 7.8 273.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 16.8 0.0 3.2 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.0 0.3 1.3 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 3.3 2.5 0.0 0.0 0.0 37.8 0.0 0.0 0.2 0.0 1.2 0.4 0.1 5.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 GNA13 "G13, MGC46138" ENSG00000120063 "G protein subunit alpha 13" Q14344 17 65009289-65056740 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 145.9" "Cell type enriched" "Detected in all" 4 "Langerhans cells: 537.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010087 Approved Supported Cytosol NA NA 320000 Cytosol "HPA010087: AB_10601478" "unprognostic (2.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.33e-3)" "unprognostic (1.23e-3)" "unprognostic (8.21e-2)" "unprognostic (7.05e-2)" "unprognostic (4.22e-3)" "unprognostic (1.09e-1)" "unprognostic (7.77e-2)" "unprognostic (4.66e-1)" "unprognostic (1.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" 23.9 22.7 21.3 41.9 24.2 145.9 16.0 26.8 22.7 17.8 23.5 27.9 21.2 18.0 10.6 18.3 16.1 26.7 12.5 20.2 36.7 17.8 27.3 27.3 47.2 28.1 21.5 14.4 22.8 15.4 15.9 8.3 39.6 28.9 15.3 26.5 17.3 10.5 16.3 37.1 12.0 23.5 23.1 28.5 33.8 18.2 15.6 25.1 50.4 18.0 39.0 45.0 30.7 12.4 36.5 33.3 36.9 32.6 21.6 31.8 29.5 32.2 25.3 28.7 35.0 39.7 20.7 23.0 130.0 16.1 26.6 42.0 22.5 35.0 29.4 51.5 35.4 19.5 69.0 20.7 38.7 45.7 54.2 45.5 23.9 43.8 32.2 42.0 29.1 48.6 33.6 29.7 82.3 36.9 29.3 88.9 18.8 19.4 30.2 25.7 49.0 64.8 47.2 32.0 53.3 24.5 48.8 19.7 34.8 43.8 62.1 40.7 50.0 37.9 58.4 48.8 25.0 33.2 57.3 79.4 151.4 20.1 32.2 30.4 7.3 6.0 7.6 5.6 12.5 5.7 4.5 6.8 6.8 5.2 4.0 3.9 4.4 13.8 6.8 8.5 2.1 9.7 4.0 21.3 24.2 26.8 22.7 20.2 36.7 28.1 21.5 14.4 28.9 28.5 25.1 36.5 34.5 12.8 13.0 68.9 80.9 67.8 27.8 13.1 42.1 5.3 21.0 13.0 11.7 18.6 10.1 9.2 4.2 16.6 60.5 82.2 7.9 11.8 4.5 25.3 23.6 35.4 16.8 21.2 20.7 11.6 15.1 24.3 23.9 49.9 30.4 21.9 32.5 13.8 57.4 6.7 27.3 11.6 12.2 57.9 537.6 8.0 11.5 123.8 69.4 44.0 44.1 34.4 29.9 29.1 36.7 13.4 30.7 24.0 45.9 28.3 23.5 16.4 13.8 6.1 32.9 19.2 19.9 6.7 13.6 33.7 65.9 14.0 66.5 15.4 13.7 36.2 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48615292 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 80.5;epididymis: 48.5;kidney: 26.5;seminal vesicle: 21.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Group enriched" "Detected in many" 8 "medulla oblongata: 34.4;spinal cord: 80.5;white matter: 41.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3" "Region enriched" "Detected in single" 65 "pons and medulla: 6.5" "Region enriched" "Detected in all" 5 "spinal cord: 51.2" HPA075905 Supported Nucleoplasm NA NA Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.6 7.3 0.0 1.5 3.8 0.0 2.7 0.0 0.0 10.8 0.0 3.1 0.0 2.8 48.5 0.0 1.4 0.0 0.0 0.0 0.1 26.5 0.0 0.4 0.0 34.4 0.0 0.0 0.1 0.1 0.8 0.1 0.3 3.5 1.0 1.2 0.0 0.0 21.0 0.4 0.5 7.1 1.5 80.5 0.1 6.7 1.0 6.2 0.0 0.1 0.0 0.0 3.7 0.7 41.6 2.1 5.3 0.0 0.8 0.7 1.0 0.8 0.0 0.0 0.0 0.0 0.3 0.8 0.0 34.0 5.3 0.6 0.0 0.1 0.0 0.0 17.2 36.9 1.0 0.1 0.0 0.3 0.0 5.5 1.1 0.0 0.1 0.0 0.7 2.1 0.2 11.6 0.0 17.3 0.0 0.0 0.4 0.0 11.3 0.0 0.0 3.6 0.1 35.3 1.0 0.0 0.1 0.6 0.0 5.4 0.1 0.4 0.0 8.8 0.0 1.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 34.4 0.0 0.0 3.5 80.5 6.2 41.6 4.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.4 1.0 0.0 0.0 88.3 0.0 0.0 0.1 1.8 72.4 0.0 0.3 21.3 2.1 2.6 44.1 0.0 0.0 0.0 0.8 0.3 0.0 26.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.7 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.2 2.7 8.9 0.0 0.0 0.0 0.1 0.8 2.3 9.2 0.0 0.0 0.0 0.3 0.0 5.0 0.0 KANSL1 "CENP-36, DKFZP727C091, KIAA1267, MSL1v1, NSL1" ENSG00000120071 "KAT8 regulatory NSL complex subunit 1" Q7Z3B3 17 46029916-46225389 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 334.6;Inhibitory neurons: 326.7;Microglial cells: 327.9;Oligodendrocyte precursor cells: 313.6;Oligodendrocytes: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006874, HPA007208" Approved Supported Nucleoplasm No No Nucleoplasm "HPA006874: AB_1852393, HPA007208: AB_1852395" "unprognostic (2.46e-1)" "unprognostic (2.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (1.54e-2)" "unprognostic (9.28e-2)" "unprognostic (7.79e-3)" "unprognostic (2.01e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-2)" "unprognostic (6.13e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-2)" 11.0 9.3 3.2 7.7 4.0 13.0 11.4 12.0 6.8 13.7 2.1 11.2 4.2 15.4 9.2 13.0 11.8 4.1 7.1 3.9 3.9 8.5 5.9 9.4 7.7 4.7 3.9 3.1 15.3 12.5 12.0 9.0 7.2 5.0 9.2 8.5 9.5 11.2 4.6 16.5 16.5 12.1 9.9 3.5 9.3 10.1 17.6 4.2 17.0 12.1 9.0 9.8 12.8 13.2 5.5 3.1 2.4 11.2 5.1 2.5 4.0 7.0 3.0 5.8 5.4 6.4 11.6 0.9 11.8 4.9 12.5 16.2 6.7 22.6 8.1 10.7 14.9 11.3 1.6 5.8 14.3 17.3 1.3 4.3 4.1 17.2 12.2 19.6 7.6 13.4 18.6 5.1 12.3 12.1 4.5 42.5 2.9 3.4 2.8 14.1 24.3 21.9 20.2 8.3 7.4 5.7 13.8 15.3 0.5 9.8 29.8 17.4 21.5 11.8 23.2 13.5 9.0 3.2 20.6 15.2 17.6 6.4 6.4 16.2 0.0 0.1 0.3 0.2 0.1 0.2 0.4 0.3 0.5 0.0 0.1 0.3 0.2 0.3 0.3 0.1 0.2 0.3 0.2 3.2 4.0 12.0 6.8 3.9 3.9 4.7 3.9 3.1 5.0 3.5 4.2 5.5 53.4 32.1 36.7 226.9 47.7 27.1 19.7 22.4 42.7 68.1 57.4 39.5 13.2 20.0 18.2 47.8 102.2 15.0 95.5 35.0 1.9 37.1 162.9 58.2 80.2 40.9 31.8 22.1 334.6 25.4 20.4 33.3 33.1 85.9 24.1 111.4 30.4 25.3 21.1 69.0 326.7 29.2 28.5 41.7 25.3 136.6 34.8 38.1 21.4 327.9 52.3 23.6 60.8 313.6 346.4 40.8 27.2 30.1 60.1 33.7 28.9 12.7 18.9 78.5 26.3 42.0 43.7 29.4 50.9 48.9 30.1 14.6 70.6 71.6 27.2 32.7 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593779 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;epididymis: 18.6;kidney: 17.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 53.3;Distal tubular cells: 25.4;Endometrial ciliated cells: 48.8;Glandular and luminal cells: 46.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enhanced" "Detected in many" "medulla oblongata: 38.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;HeLa: 8.7;RPTEC TERT1: 21.7" "Region enriched" "Detected in single" 230 "pons and medulla: 22.9" "Group enriched" "Detected in some" 9 "medulla oblongata: 19.3;spinal cord: 14.3" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 2.7 3.9 0.3 2.5 6.8 0.1 1.8 0.0 0.8 5.7 0.0 12.8 1.7 2.3 18.6 0.2 7.5 0.2 0.1 0.0 0.1 17.6 0.6 5.9 0.1 38.1 0.5 0.0 0.2 0.7 1.0 0.0 1.2 10.4 1.1 4.9 0.0 0.0 6.9 0.4 0.7 12.3 2.0 21.6 2.6 4.9 0.8 4.1 0.0 0.5 0.2 0.0 2.8 1.6 13.4 2.6 6.5 0.0 3.2 3.2 3.5 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.0 6.5 3.7 0.7 0.0 0.3 0.0 0.0 0.0 28.8 1.3 8.7 0.0 5.5 0.0 1.4 1.8 0.0 3.9 0.0 1.1 2.0 0.2 2.1 0.0 4.4 0.0 0.0 0.0 0.0 3.6 2.3 0.0 1.2 0.0 21.7 2.2 0.0 0.0 0.2 0.0 3.3 0.1 0.6 0.0 6.5 0.9 2.6 0.7 0.4 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.8 0.0 0.8 0.0 0.1 38.1 0.5 0.0 10.4 21.6 4.1 13.4 4.9 0.0 1.1 0.0 0.0 0.9 0.2 0.0 1.2 0.0 0.3 0.3 0.4 0.0 0.0 53.3 0.0 0.0 0.1 13.5 25.4 0.0 0.9 48.8 4.1 6.6 4.2 2.7 0.0 0.0 0.0 3.8 1.1 46.0 0.0 0.0 8.2 0.0 0.7 0.0 0.0 11.4 0.0 4.2 0.8 0.5 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.1 7.0 0.5 0.0 0.0 0.0 0.2 4.9 8.6 11.0 0.3 0.3 0.0 0.6 0.0 11.3 0.1 CRHR1 "CRF-R, CRF1, CRHR" ENSG00000120088 "Corticotropin releasing hormone receptor 1" P34998 17 45784280-45835828 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 8.7;pituitary gland: 22.7" "Group enriched" "Detected in some" 4 "Early spermatids: 41.0;Late spermatids: 53.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 3.4;SH-SY5Y: 1.8" CAB025251 Enhanced "Intracellular and membrane" NA NA "CAB025251: " "unprognostic (4.59e-2)" "unprognostic (1.43e-2)" "unprognostic (2.59e-7)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.48e-1)" "unprognostic (4.55e-4)" "unprognostic (1.65e-2)" "unprognostic (2.21e-1)" "unprognostic (3.33e-4)" "unprognostic (2.07e-5)" "unprognostic (3.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" 0.1 0.0 3.9 0.0 1.4 0.0 0.4 8.7 3.9 1.6 0.0 0.0 0.0 1.1 0.1 0.1 0.7 0.0 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.2 1.9 1.5 0.1 0.0 0.1 22.7 0.0 2.4 0.6 0.0 3.5 0.2 0.3 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.2 2.6 0.0 0.2 0.0 0.0 0.1 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.4 8.7 3.9 1.4 1.4 0.2 1.9 1.5 2.4 0.0 2.6 0.9 0.0 0.0 0.0 0.0 2.8 1.1 1.3 1.2 10.2 0.7 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 41.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.0 1.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 53.4 0.6 0.3 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.4 3.2 1.6 0.1 0.1 0.4 0.5 0.0 0.5 1.6 5.1 1.5 9.9 3.3 0.0 2.5 0.0 0.1 1.7 HOXB3 "HOX2, HOX2G" ENSG00000120093 "Homeobox B3" P14651 17 48548870-48604912 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 71.1" "Cell type enhanced" "Detected in many" "Adipocytes: 26.6;Collecting duct cells: 99.3;Early spermatids: 37.9;Endometrial ciliated cells: 25.6;Glandular and luminal cells: 35.0;Hepatic stellate cells: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.9;HEK 293: 47.4;RPTEC TERT1: 35.0;U-251 MG: 38.2" "Region enriched" "Detected in single" 39 "pons and medulla: 8.8" "Group enriched" "Detected in some" 22 "medulla oblongata: 10.1;pons: 3.9;spinal cord: 12.2" "CAB009860, HPA064990" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009860: AB_2119262, HPA064990: AB_2685398" "unprognostic (5.88e-2)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (7.04e-2)" "unprognostic (8.39e-3)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (3.09e-2)" "unprognostic (4.32e-3)" "unprognostic (8.14e-2)" "unprognostic (8.27e-2)" "unprognostic (3.17e-1)" "unprognostic (7.60e-2)" "unprognostic (7.85e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.45e-6)" 17.1 11.4 3.1 7.8 5.9 1.8 19.4 0.1 2.3 20.3 0.3 37.1 6.6 13.8 71.1 13.6 38.9 7.6 5.1 0.2 0.8 32.7 4.2 12.7 4.8 26.7 2.5 0.0 1.6 4.8 20.1 0.2 4.3 12.5 9.3 11.9 0.0 0.6 25.7 10.7 7.8 27.8 9.5 19.5 15.9 17.9 10.4 4.8 1.3 4.9 8.2 1.2 11.4 10.3 15.4 6.6 13.9 10.1 4.6 8.7 12.1 2.5 0.2 0.0 0.2 0.2 6.2 43.9 3.5 34.0 30.1 4.4 0.3 2.0 0.7 0.1 10.6 47.4 10.9 7.0 0.0 13.4 0.0 27.3 12.3 0.0 13.3 0.7 6.5 13.8 13.2 14.8 0.4 8.4 0.2 0.7 0.3 0.2 14.3 1.3 0.0 7.0 1.4 35.0 6.7 0.0 0.1 1.5 0.0 7.8 7.5 13.9 3.0 15.1 4.5 13.6 2.5 38.2 3.5 4.5 0.4 9.5 0.0 8.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.6 0.2 0.1 3.1 5.9 0.1 2.3 0.2 0.8 26.7 2.5 0.0 12.5 19.5 4.8 15.4 26.6 0.0 1.9 0.0 0.5 2.5 3.0 0.0 11.4 0.0 5.9 2.7 1.8 1.5 0.7 99.3 0.0 3.2 2.0 11.4 7.9 0.2 37.9 25.6 4.3 13.6 2.4 0.8 0.0 0.0 0.8 8.1 0.0 35.0 8.8 0.0 25.0 0.4 0.7 0.0 0.0 7.5 0.0 1.6 4.2 12.9 0.3 0.8 5.4 0.0 0.3 0.0 6.2 0.0 0.0 0.4 7.7 0.4 0.4 3.2 7.6 0.9 0.0 0.0 0.0 4.8 6.2 6.1 11.7 13.9 1.4 0.4 2.0 0.0 9.5 7.0 HOXB1 "HOX2, HOX2I" ENSG00000120094 "Homeobox B1" P14653 17 48528526-48531011 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Early spermatids: 2.2" "Cancer enriched" "Detected in single" 15 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044576 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044576: AB_10794501" "unprognostic (1.80e-2)" "unprognostic (9.50e-3)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (6.26e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (6.74e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 DUSP1 "CL100, HVH1, MKP-1, PTPN10" ENSG00000120129 "Dual specificity phosphatase 1" P28562 5 172768096-172771195 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 2357.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 7426.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 7426.8" "Cell line enhanced" "Detected in all" "HHSteC: 201.0;hTCEpi: 359.3;REH: 202.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069577 Approved Nucleoli,Cytosol NA Yes Nucleoli Cytosol "HPA069577: AB_2686156" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (9.73e-2)" "unprognostic (8.17e-2)" "unprognostic (4.64e-1)" "unprognostic (1.58e-3)" "unprognostic (4.18e-2)" "unprognostic (6.94e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (2.69e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-3)" 804.4 520.3 104.6 368.1 81.7 698.9 591.2 123.4 119.4 505.6 147.8 298.6 66.6 385.9 42.4 531.3 683.4 575.5 353.9 75.3 264.6 281.3 727.2 726.2 180.0 128.2 90.3 60.1 545.8 242.2 117.3 322.0 299.8 96.2 442.3 230.6 204.4 353.2 360.2 253.8 899.9 171.8 456.5 120.6 307.1 399.4 68.6 113.0 132.5 618.7 455.3 56.6 785.8 615.0 126.8 10.7 26.5 8.2 11.5 175.6 102.2 14.0 170.3 49.3 111.9 45.0 29.2 12.4 3.5 48.6 120.4 128.1 4.7 8.1 42.3 52.1 95.8 22.4 2.3 63.1 12.6 201.0 1.2 3.8 98.1 359.3 50.9 82.1 58.2 35.6 7.4 9.0 66.1 73.1 12.6 5.7 5.0 7.4 8.2 7.7 202.2 15.3 32.3 80.2 5.4 35.5 14.9 46.2 76.9 6.3 34.1 6.7 1.9 94.1 79.1 39.8 77.8 13.4 13.6 8.4 3.1 70.3 1.8 3.3 931.4 584.5 1640.7 85.0 589.2 212.6 57.6 75.6 88.6 263.4 54.1 35.9 40.7 7426.8 114.5 791.6 14.3 68.1 409.9 104.6 81.7 123.4 119.4 75.3 264.6 128.2 90.3 60.1 96.2 120.6 113.0 126.8 1856.5 410.3 341.0 23.8 918.4 1279.8 1140.5 456.9 1810.4 73.0 464.2 567.7 211.3 739.2 243.1 211.5 27.1 316.2 618.9 633.7 56.7 335.9 71.6 531.6 990.9 870.4 715.5 193.5 11.9 88.7 407.2 1367.4 597.3 1013.7 301.1 175.8 781.4 345.7 1043.0 48.8 13.4 891.8 207.5 1525.5 2357.3 40.3 384.9 1965.5 542.5 66.5 173.3 1159.3 33.0 6.6 4.1 226.3 683.3 311.1 952.2 685.7 736.1 35.5 218.0 190.5 769.2 720.7 671.9 12.9 24.6 1996.9 1956.6 582.0 1015.2 223.4 415.8 676.6 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579368 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078669 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA078669: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favorable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 12.6 20.3 8.4 13.6 9.6 18.0 25.7 21.9 10.7 10.6 4.2 27.3 41.9 13.3 9.4 13.2 8.0 10.1 10.4 9.6 9.2 15.1 43.5 10.3 13.2 9.8 10.9 8.6 11.4 10.6 22.0 6.4 14.2 10.9 12.9 25.9 18.2 10.6 7.9 7.7 15.0 30.7 11.8 9.5 12.9 16.3 12.6 11.4 14.3 15.3 12.2 12.6 11.6 11.3 11.7 29.0 16.1 65.2 34.9 23.8 27.5 27.5 17.1 18.0 22.3 32.5 26.9 26.1 44.9 27.3 24.3 35.6 20.3 44.2 34.2 40.1 42.1 21.6 23.4 15.2 20.1 27.7 31.1 29.4 22.1 45.4 28.1 31.4 15.8 26.5 33.1 21.5 43.4 31.0 16.0 31.3 14.1 27.7 22.2 12.1 22.3 44.8 18.2 28.1 42.2 30.2 64.4 19.6 31.5 48.9 32.6 41.2 38.8 27.8 29.9 41.3 17.9 36.8 30.0 45.1 32.5 17.8 31.3 23.8 1.1 1.0 0.5 0.5 1.2 0.7 1.4 0.6 0.6 0.6 0.5 0.4 0.7 0.4 0.3 1.7 0.9 0.7 0.3 8.4 9.6 21.9 10.7 9.6 9.2 9.8 10.9 8.6 10.9 9.5 11.4 11.7 26.3 25.6 19.3 6.2 18.3 34.3 23.6 27.4 4.6 28.7 59.1 29.0 16.4 17.2 26.4 25.8 27.1 17.6 29.9 114.8 9.8 17.9 12.8 20.4 28.7 24.8 34.2 36.4 23.3 20.1 14.2 22.0 36.7 32.4 15.2 31.4 14.3 94.2 23.0 28.6 22.6 37.5 26.4 33.6 30.5 17.0 16.8 25.0 23.2 10.3 23.1 12.6 14.4 12.5 17.5 23.0 40.4 17.7 17.0 40.1 98.3 27.2 22.7 26.4 26.3 30.7 28.0 42.1 25.1 26.7 56.1 41.9 18.0 42.4 50.6 52.3 MSX2 "CRS2, FPP, HOX8, MSH, PFM, PFM1" ENSG00000120149 "Msh homeobox 2" P35548 5 174724582-174730896 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 26.0;placenta: 33.8;urinary bladder: 17.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 18.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "BEWO: 322.0" "Region enriched" "Detected in some" 5 "cerebellum: 6.2" "Low region specificity" "Detected in many" HPA005652 Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA005652: AB_1079418" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.08e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (1.36e-4)" "unprognostic (7.64e-3)" "unprognostic (5.06e-2)" "unprognostic (2.12e-6)" "unprognostic (1.43e-2)" 2.1 0.3 0.8 0.5 1.4 0.0 8.2 4.2 1.1 2.7 1.0 0.6 0.3 6.9 0.0 0.6 0.9 0.9 1.7 1.1 4.3 0.2 0.0 0.8 0.1 7.7 1.5 0.5 0.2 0.4 26.0 0.3 33.8 4.1 2.5 0.1 0.0 0.8 0.8 1.9 5.9 0.8 1.4 4.8 0.8 2.8 5.6 1.4 0.1 0.7 1.8 0.1 17.7 1.8 5.3 0.4 4.0 1.1 3.2 0.0 0.0 322.0 2.2 3.6 0.7 0.1 56.6 23.0 0.0 8.6 0.2 19.6 6.2 17.6 6.4 0.2 0.0 10.7 0.0 1.4 0.0 2.4 0.0 3.0 3.7 4.5 3.1 3.5 0.0 0.0 0.0 0.0 0.0 5.0 27.7 0.0 0.4 2.5 38.3 8.5 0.0 8.8 0.1 4.0 35.3 0.0 2.5 0.0 43.0 2.9 69.6 25.7 0.2 0.0 1.1 5.5 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 4.2 1.1 1.1 4.3 7.7 1.5 0.5 4.1 4.8 1.4 5.3 1.5 0.0 0.0 2.3 0.0 9.6 2.4 0.1 3.4 0.2 15.8 18.9 1.7 0.0 0.1 0.0 0.0 162.6 0.2 0.3 0.0 0.6 0.2 65.7 4.9 0.7 0.0 0.0 0.0 0.0 13.9 5.3 5.1 62.2 4.5 0.1 0.4 0.0 11.3 0.0 0.0 1.9 0.0 0.6 2.9 0.6 0.0 1.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.3 1.9 0.1 0.1 0.0 0.0 8.9 4.8 1.4 4.5 2.0 11.4 233.8 1.0 0.6 1.2 9.8 TEK "CD202b, TIE-2, TIE2, VMCM, VMCM1" ENSG00000120156 "TEK receptor tyrosine kinase" Q02763 9 27109141-27230174 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 46.6" "Group enriched" "Detected in many" 10 "Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010359, HPA073265" Approved Supported "Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 7750000 13000000 "Plasma membrane" "Centriolar satellite" "CAB010359: AB_2203226, HPA073265: AB_2686592" "unprognostic (2.24e-1)" "unprognostic (1.74e-1)" "unprognostic (5.55e-2)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.26e-3)" "prognostic favorable (2.31e-5)" "unprognostic (7.48e-2)" "unprognostic (1.72e-2)" "unprognostic (1.41e-1)" "unprognostic (5.58e-2)" "unprognostic (2.72e-1)" "prognostic favorable (7.81e-4)" "unprognostic (7.50e-3)" "unprognostic (6.87e-3)" "unprognostic (1.83e-1)" "unprognostic (5.24e-3)" 20.3 9.2 8.0 5.8 6.3 0.2 14.2 5.8 10.4 9.3 7.4 5.0 3.8 12.5 2.3 5.4 6.8 11.3 16.9 7.5 6.6 23.2 10.6 29.0 3.7 7.1 6.4 5.5 3.5 3.5 4.4 3.0 46.6 7.2 3.8 5.4 0.7 3.1 6.3 10.6 2.5 5.5 12.8 6.4 29.0 4.1 1.4 8.3 1.8 9.2 23.1 2.8 6.9 4.0 7.0 0.3 0.0 3.5 0.0 0.4 5.6 0.1 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 2.4 0.0 1.6 0.0 0.0 1.8 0.0 2.2 0.8 0.1 90.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 45.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.3 0.0 0.0 99.1 0.0 0.5 9.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.0 6.3 5.8 10.4 7.5 6.6 7.1 6.4 5.5 7.2 6.4 8.3 7.0 70.8 3.2 1.3 1.3 0.4 1.5 0.0 0.0 0.0 0.0 0.3 0.5 8.6 0.0 0.6 1.8 0.0 0.4 0.4 0.0 0.0 0.0 0.6 0.6 0.8 73.9 0.0 2.7 4.3 0.0 2.8 4.2 0.0 0.7 0.0 0.3 122.0 1.3 0.3 0.0 5.0 0.0 0.0 6.7 2.2 0.9 0.6 0.4 0.0 38.4 0.0 0.1 0.0 137.7 2.1 1.3 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.2 0.0 1.6 1.9 0.1 0.4 0.3 1.3 1.4 0.5 1.8 0.0 0.0 RCL1 "RNAC, RPCL1" ENSG00000120158 "RNA terminal phosphate cyclase like 1" Q9Y2P8 9 4792944-4885917 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 247.8" "Cell type enhanced" "Detected in many" "Early spermatids: 74.1;Hepatocytes: 183.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "HDLM-2: 145.5;HEL: 375.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071308 Approved Nucleoplasm NA NA Nucleoplasm "HPA071308: AB_2686384" "prognostic favorable (5.48e-4)" "unprognostic (7.60e-3)" "unprognostic (7.55e-2)" "unprognostic (4.19e-2)" "unprognostic (1.07e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.02e-4)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.59e-2)" "prognostic favorable (2.40e-7)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-1)" "unprognostic (3.66e-2)" 37.5 13.5 6.5 9.1 7.5 44.6 21.9 6.7 7.4 9.0 8.4 7.2 4.1 8.3 10.0 10.5 10.7 6.3 6.5 6.0 7.8 11.4 247.8 13.2 15.1 8.4 8.0 4.4 17.8 65.2 8.8 7.1 14.0 8.3 7.0 7.6 3.9 6.9 7.1 14.5 21.3 8.1 7.8 9.0 9.2 10.5 13.9 8.0 9.8 8.2 8.6 12.6 12.7 10.6 10.2 23.3 27.6 10.3 16.5 15.0 10.1 27.3 10.8 12.0 19.9 16.8 13.9 13.4 45.2 7.4 9.7 22.1 14.4 48.0 32.5 22.8 145.5 24.2 375.0 33.5 28.1 21.5 34.1 28.9 22.4 18.2 19.0 28.7 11.2 19.7 32.4 38.9 28.0 12.0 30.4 27.8 57.8 35.7 27.7 11.0 34.2 13.8 24.2 24.3 25.9 29.6 24.3 13.6 20.0 15.8 20.4 18.9 39.8 13.9 11.6 13.3 16.6 34.0 11.5 35.3 48.1 21.3 20.8 8.1 16.2 1.6 4.3 5.7 2.5 7.0 8.7 6.5 7.7 4.3 11.5 8.7 9.0 0.6 12.1 1.3 7.4 5.9 3.7 6.5 7.5 6.7 7.4 6.0 7.8 8.4 8.0 4.4 8.3 9.0 8.0 10.2 10.9 6.4 6.8 18.9 14.7 25.5 21.8 11.9 25.0 5.4 9.3 8.0 10.6 11.5 7.8 3.7 0.0 39.8 8.5 3.0 25.4 12.4 74.1 8.3 8.8 12.1 3.0 68.4 14.1 11.5 16.6 11.9 8.6 5.7 14.5 16.7 16.1 183.4 17.7 5.0 15.9 6.4 6.1 11.3 6.2 39.7 23.0 7.6 3.6 36.5 9.7 9.2 5.2 18.1 34.3 10.6 3.7 37.6 14.3 18.1 3.2 13.7 14.0 7.0 13.1 19.1 10.2 18.2 18.4 18.6 21.2 35.4 8.9 12.1 8.9 16.6 CAAP1 "C9orf82, CAAP, FLJ13657" ENSG00000120159 "Caspase activity and apoptosis inhibitor 1" Q9H8G2 9 26840685-26892803 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020404, HPA024029, HPA024100" Uncertain Approved Vesicles NA NA Vesicles "HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.73e-2)" "unprognostic (6.74e-2)" "unprognostic (8.83e-2)" "unprognostic (1.35e-2)" "unprognostic (4.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-2)" "prognostic favorable (1.27e-5)" "unprognostic (1.46e-1)" "unprognostic (1.89e-1)" "prognostic favorable (7.94e-9)" "unprognostic (2.74e-2)" "unprognostic (7.57e-2)" "unprognostic (1.46e-1)" "unprognostic (1.43e-2)" 7.1 20.6 4.5 10.6 4.6 7.8 10.9 5.1 6.2 9.2 10.0 18.8 17.6 8.3 17.0 11.4 9.3 9.9 5.3 4.6 5.2 16.4 24.0 7.9 14.8 4.6 4.8 3.9 6.7 10.9 19.0 7.5 9.8 4.6 10.7 19.7 8.7 11.3 9.6 7.1 10.3 12.8 10.1 4.1 8.5 11.3 12.7 4.7 14.3 27.6 7.5 15.2 10.7 6.9 4.8 24.2 14.9 24.3 23.9 15.9 13.4 18.5 17.4 17.1 16.4 20.1 4.4 14.9 28.6 17.5 14.9 9.4 12.8 25.3 17.0 22.4 39.0 15.4 49.6 22.6 28.2 26.4 21.7 23.9 13.7 21.4 12.7 29.7 18.5 27.8 18.4 14.1 21.0 19.1 13.9 33.8 9.0 32.2 23.8 12.3 23.1 10.9 19.0 42.6 17.7 19.4 38.5 15.9 17.5 16.3 21.5 14.9 25.6 16.7 0.0 24.5 10.1 16.4 9.6 19.2 33.0 8.0 22.3 10.3 14.9 11.3 8.2 16.2 17.6 20.9 18.8 17.7 18.9 18.4 18.7 14.7 15.3 1.4 20.1 15.7 17.2 18.8 16.0 4.5 4.6 5.1 6.2 4.6 5.2 4.6 4.8 3.9 4.6 4.1 4.7 4.8 13.9 22.4 21.6 42.1 20.3 9.9 11.3 18.4 15.9 10.8 18.2 14.6 9.7 14.3 27.6 31.3 8.4 18.3 16.4 28.1 58.7 20.6 18.8 25.6 15.3 14.9 15.5 21.7 34.0 19.8 14.7 13.4 18.8 25.5 18.3 15.8 10.4 34.3 12.1 8.4 42.5 26.0 26.4 11.1 10.3 5.4 8.4 17.7 8.8 26.2 15.6 22.1 12.3 41.2 33.8 22.6 23.1 6.4 26.0 17.5 13.4 29.5 23.7 12.7 13.1 16.9 14.8 41.9 18.4 31.6 14.6 10.8 20.1 28.0 32.1 12.6 EQTN "AFAF, C9orf11, equatorin, SPACA8" ENSG00000120160 Equatorin Q9NQ60 9 27284654-27297150 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 38.2" "Cell type enriched" "Detected in some" 10 "Early spermatids: 739.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015089, HPA015504" Enhanced Approved "Plasma membrane,Actin filaments" "Secreted in male reproductive system" NA NA "Plasma membrane, Actin filaments" "HPA015089: AB_1845795, HPA015504: AB_2067598" "unprognostic (7.83e-2)" "unprognostic (1.55e-1)" "unprognostic (5.64e-2)" "unprognostic (8.12e-3)" "unprognostic (1.34e-3)" "unprognostic (4.41e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.32e-1)" "unprognostic (1.89e-1)" "unprognostic (5.67e-2)" "unprognostic (1.14e-1)" "unprognostic (4.59e-2)" "unprognostic (8.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" 0.2 0.0 0.4 0.0 1.2 0.0 0.2 0.7 0.9 0.2 0.2 0.3 0.4 0.2 0.5 0.0 0.2 0.0 0.0 0.2 0.5 0.2 0.0 0.3 0.2 1.3 1.0 0.1 0.5 0.4 0.0 0.0 0.0 1.3 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.9 0.2 0.2 38.2 1.0 0.0 0.2 0.1 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.7 0.9 0.2 0.5 1.3 1.0 0.1 1.3 0.9 1.0 2.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 739.3 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 67.8 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.7 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 16.2 2.4 0.0 0.3 0.1 0.0 0.1 0.2 0.1 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 431.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.5;myeloid DC: 2.7;naive B-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.0;HAP1: 16.7;K-562: 49.9;SK-BR-3: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favorable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.99e-2)" 5.8 1.7 10.3 3.9 24.1 0.7 6.2 19.0 12.2 6.9 11.0 12.2 17.7 9.7 5.1 3.6 8.0 5.0 1.2 8.3 14.3 7.5 1.4 6.8 4.0 21.6 19.8 6.0 26.2 3.6 0.5 1.1 4.6 21.1 2.3 13.3 7.4 3.4 2.9 5.9 6.3 15.8 6.4 22.1 8.2 5.6 3.2 18.3 3.6 5.5 5.3 5.6 3.6 4.7 31.2 3.4 2.5 7.6 0.0 1.9 0.1 16.0 0.0 0.1 0.1 0.1 1.9 0.0 0.1 3.2 0.0 0.0 10.9 16.7 13.2 0.0 7.7 2.6 4.9 9.8 0.1 0.0 0.0 1.0 3.4 13.7 0.0 2.5 0.0 0.0 0.0 49.9 0.1 0.0 0.0 0.0 0.0 9.8 6.3 0.9 3.3 0.7 0.1 4.6 6.4 0.1 2.4 2.7 19.8 4.7 9.9 1.3 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.5 0.0 0.5 0.0 0.0 0.8 0.0 2.5 0.0 0.0 2.7 2.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 10.3 24.1 19.0 12.2 8.3 14.3 21.6 19.8 6.0 21.1 22.1 18.3 31.2 6.9 3.2 4.1 13.7 22.1 22.7 7.7 7.6 40.9 2.1 6.7 12.6 1.5 27.1 4.3 11.0 0.0 22.1 0.4 83.3 9.8 16.4 1.0 6.5 20.1 8.7 2.4 1.7 81.7 21.0 56.0 20.8 21.4 9.2 1.3 1.9 4.6 3.1 5.4 1.7 88.9 26.9 12.2 13.2 30.6 3.1 15.8 20.4 16.0 76.8 10.8 65.3 2.1 79.4 431.9 10.6 26.1 16.1 1.2 6.5 50.3 10.5 2.7 1.3 0.0 4.5 19.2 2.2 5.0 8.4 9.5 11.8 1.6 7.7 36.8 6.9 INSL6 RIF1 ENSG00000120210 "Insulin like 6" Q9Y581 9 5123880-5185647 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "retina: 6.8;testis: 15.0" "Cell type enhanced" "Detected in some" "Early spermatids: 134.0;Excitatory neurons: 22.0;Inhibitory neurons: 26.2;Late spermatids: 17.9;Microglial cells: 21.5;Spermatocytes: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;Karpas-707: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021364 Enhanced "Secreted to blood" NA NA "HPA021364: AB_1851807" "unprognostic (3.85e-4)" "unprognostic (7.41e-4)" "unprognostic (1.28e-1)" "unprognostic (1.94e-1)" "unprognostic (2.22e-1)" "unprognostic (6.92e-2)" "unprognostic (2.31e-2)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (2.52e-3)" 0.1 0.3 0.4 0.6 0.5 1.5 0.0 1.1 1.2 0.0 0.1 0.2 0.3 0.4 0.0 0.4 0.1 0.5 0.5 0.4 0.5 0.1 0.1 0.2 1.1 0.9 0.3 0.4 0.4 0.0 0.0 0.0 0.8 0.6 0.2 0.0 6.8 0.2 0.0 0.3 1.1 0.2 0.0 0.2 1.1 0.6 15.0 0.5 0.1 0.2 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.3 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 1.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.1 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.1 1.2 0.4 0.5 0.9 0.3 0.4 0.6 0.2 0.5 1.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 134.0 0.1 0.0 0.1 0.0 0.0 22.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 26.2 0.0 0.0 0.0 0.0 17.9 1.2 0.0 0.0 21.5 0.0 0.0 0.0 9.5 8.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 35.7 10.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 INSL4 EPIL ENSG00000120211 "Insulin like 4" Q14641 9 5231419-5235304 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "placenta: 16.0" "Cell type enriched" "Detected in some" 10 "Syncytiotrophoblasts: 3575.7" "Cancer enhanced" "Detected in some" "lung cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 24.6" HPA065145 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA065145: " "unprognostic (9.77e-2)" "unprognostic (2.02e-1)" "unprognostic (4.66e-1)" "unprognostic (7.74e-2)" 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 24.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 325.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 26.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3575.7 0.0 0.0 0.0 0.0 MLANA MART1 ENSG00000120215 Melan-A Q16655 9 5890889-5910606 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 43.3" "Cell type enriched" "Detected in some" 23 "Melanocytes: 1718.2" "Cancer enriched" "Detected in single" 556 "melanoma: 277.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 406 "SK-MEL-30: 703.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000057, HPA048662" Enhanced NA NA "CAB000057: AB_442107, HPA048662: AB_2680485" "unprognostic (2.52e-2)" "unprognostic (6.87e-2)" "unprognostic (5.20e-2)" "unprognostic (5.61e-2)" "unprognostic (2.58e-2)" "unprognostic (1.46e-1)" "unprognostic (4.53e-1)" "unprognostic (3.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-3)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (8.01e-2)" "unprognostic (5.78e-2)" "unprognostic (9.43e-2)" 0.1 0.2 0.2 0.4 0.5 0.7 1.4 1.9 0.6 0.0 4.7 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.5 0.1 0.4 0.5 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.3 1.1 0.0 0.3 43.3 0.1 0.0 0.1 0.2 0.2 0.3 0.6 0.1 0.2 0.0 0.0 0.2 0.3 0.6 0.8 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.2 1.7 1.3 1.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.0 0.3 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.4 0.1 703.0 0.1 0.1 0.3 0.6 0.2 0.4 0.1 0.7 0.2 0.7 0.3 0.2 0.4 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.2 0.5 1.9 0.6 0.2 0.1 0.5 0.3 0.2 0.7 0.1 0.6 0.6 0.0 0.0 0.0 0.3 0.0 73.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.9 0.0 0.0 1.3 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 15.5 0.9 0.0 0.2 1718.2 0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.3 14.5 0.0 0.5 0.1 0.0 0.0 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 16.9" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 27.7;granulocytes: 28.4;Langerhans cells: 50.9;monocytes: 42.4;Syncytiotrophoblasts: 44.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 6.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.6" "Cell line enhanced" "Detected in many" "HDLM-2: 89.6;HHSteC: 55.5;U-251 MG: 98.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 2.3 2.0 1.0 10.4 1.1 1.9 1.5 0.9 1.3 1.9 0.8 1.4 2.7 1.5 1.9 2.5 1.8 4.0 8.9 0.9 1.9 2.3 3.4 16.9 6.6 1.8 1.3 0.7 1.5 1.9 5.0 2.6 6.8 2.0 2.0 2.1 1.2 1.5 1.5 4.6 0.7 1.9 2.2 1.1 10.3 1.9 0.9 1.5 13.1 3.6 4.4 5.4 7.3 1.3 1.6 15.6 0.2 0.0 0.5 0.1 0.1 0.0 30.5 25.7 7.7 10.4 0.0 5.0 0.2 0.6 0.8 3.8 0.6 0.0 13.2 24.6 89.6 0.0 9.0 0.3 0.0 55.5 0.0 0.0 0.5 0.1 15.7 22.9 7.7 15.0 0.9 0.0 2.9 23.4 0.0 0.4 0.1 0.0 0.0 0.3 0.1 4.2 0.8 1.6 0.3 0.0 0.3 0.4 2.4 1.9 2.2 0.1 0.3 28.1 16.1 5.1 0.5 98.1 0.5 0.2 0.3 5.4 0.3 0.2 6.6 0.0 0.2 0.7 0.1 1.2 0.5 1.4 1.1 0.0 0.1 0.7 0.4 3.6 0.3 0.0 0.0 0.7 0.4 1.0 1.1 0.9 1.3 0.9 1.9 1.8 1.3 0.7 2.0 1.1 1.5 1.6 3.0 12.8 11.4 0.7 1.9 4.6 1.5 4.4 1.8 1.4 1.4 1.3 7.8 0.0 2.9 0.0 0.0 6.1 2.4 2.6 0.0 5.9 1.0 1.4 0.3 5.5 0.0 3.2 1.9 4.4 27.7 1.9 0.5 0.9 28.4 0.2 7.1 0.8 5.7 0.0 3.3 0.5 4.1 2.9 50.9 0.2 0.3 4.2 3.6 8.4 42.4 0.5 1.0 1.0 0.9 19.0 0.1 0.4 2.2 2.1 1.9 0.4 4.0 0.2 0.0 2.3 0.9 1.0 0.8 1.2 2.6 44.5 3.1 0.1 0.4 2.0 IFNA6 IFN-alphaK ENSG00000120235 "Interferon alpha 6" P05013 9 21349835-21351378 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA8 IFN-alphaB ENSG00000120242 "Interferon alpha 8" P32881 9 21409117-21410185 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIA2 "GluA2, GLUR2, GLURB" ENSG00000120251 "Glutamate ionotropic receptor AMPA type subunit 2" P42262 4 157204182-157366075 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.4;retina: 29.3" "Cell type enhanced" "Detected in some" "Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7" "Group enriched" "Detected in some" 10 "breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008441 Enhanced NA NA "HPA008441: AB_1078983" "unprognostic (1.36e-1)" "unprognostic (9.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (3.87e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-3)" "unprognostic (7.40e-2)" "unprognostic (2.91e-5)" "unprognostic (2.42e-1)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (6.55e-2)" 0.3 7.0 36.7 0.2 68.4 0.0 1.1 16.5 84.4 9.3 0.0 0.2 0.1 17.1 11.6 0.1 11.0 0.0 0.1 83.0 25.9 0.4 0.0 0.2 0.0 5.2 16.0 49.0 0.6 1.4 0.0 21.9 0.1 16.1 0.8 0.1 29.3 4.2 2.3 0.2 1.6 0.1 6.3 1.0 0.2 1.2 1.4 30.4 0.1 0.0 0.6 0.0 0.1 0.4 49.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 68.4 16.5 84.4 83.0 25.9 5.2 16.0 49.0 16.1 1.0 30.4 49.4 0.0 0.0 0.0 335.0 0.0 0.0 0.0 0.0 0.0 252.7 2.1 1.0 2.3 0.0 0.0 0.0 43.8 0.0 0.1 0.0 0.0 0.0 0.1 1.7 1.1 0.3 0.0 0.0 1090.5 0.0 0.0 0.2 0.0 2.7 0.0 0.1 0.0 0.0 0.1 138.0 725.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 58.1 0.0 4.2 0.0 1106.8 324.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.5 3.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NUP43 "bA350J20.1, FLJ13287" ENSG00000120253 "Nucleoporin 43" Q8NFH3 6 149724315-149749665 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027126, HPA027291, HPA028500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287" "prognostic unfavorable (2.08e-4)" "unprognostic (3.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.45e-3)" "unprognostic (2.29e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (7.13e-7)" "unprognostic (5.14e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-2)" "unprognostic (6.25e-3)" "unprognostic (2.02e-1)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" 7.8 8.7 6.3 11.5 7.6 6.2 13.8 7.5 6.9 9.8 6.8 9.5 8.8 9.9 7.6 9.5 8.3 6.5 10.9 5.8 7.3 10.0 9.7 8.1 16.0 7.4 7.0 5.9 9.1 12.3 9.0 5.6 11.5 6.9 10.4 9.8 9.9 8.9 9.2 14.4 13.6 11.0 9.5 6.6 13.7 9.9 7.9 6.7 12.9 11.2 11.7 17.1 9.0 9.2 8.6 21.1 34.9 31.1 49.6 20.0 23.7 48.9 36.3 20.3 34.0 43.0 49.5 19.5 61.4 36.6 20.2 32.1 33.5 54.6 31.6 58.3 27.8 38.2 70.9 35.5 49.6 13.4 73.2 44.1 15.3 16.4 49.9 33.1 13.0 27.5 34.6 71.4 33.6 29.6 20.7 52.2 30.4 28.3 24.1 21.0 50.2 43.2 20.6 23.2 28.9 12.9 21.2 43.4 27.1 14.2 25.6 28.7 30.9 21.3 28.3 30.2 41.2 53.9 20.5 43.3 63.9 25.2 49.3 40.5 2.9 4.9 3.4 3.5 5.4 3.8 4.3 4.2 3.5 2.6 6.2 4.3 5.5 1.9 3.7 4.8 5.0 4.9 2.2 6.3 7.6 7.5 6.9 5.8 7.3 7.4 7.0 5.9 6.9 6.6 6.7 8.6 5.8 3.2 7.8 9.1 11.5 7.9 5.5 4.7 2.8 11.9 4.5 5.0 14.3 11.5 5.2 3.7 6.2 10.9 11.3 4.7 3.9 9.0 33.3 4.3 8.7 5.7 10.2 7.6 4.8 7.8 12.2 6.4 6.1 6.0 0.0 12.8 8.2 4.4 7.8 6.7 5.1 6.9 2.0 11.9 6.9 78.9 10.2 6.5 8.8 9.4 15.1 10.5 9.2 11.1 17.4 6.6 2.3 10.5 8.7 6.2 3.9 5.4 4.2 9.5 13.1 6.9 22.1 7.1 9.2 5.5 8.5 6.6 7.6 7.4 8.4 6.7 MTHFD1L "DKFZP586G1517, FLJ21145, FTHFSDC1" ENSG00000120254 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like" Q6UB35 6 150865679-151101887 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "One-carbon metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 84.0;Extravillous trophoblasts: 166.5;Granulosa cells: 86.9;Microglial cells: 126.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;T-cells: 1.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015006, HPA029040, HPA029041, HPA050052, HPA074911" Approved Enhanced Mitochondria NA NA 89000 Mitochondria "HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723" "unprognostic (3.66e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (3.25e-1)" "prognostic unfavorable (5.10e-4)" "prognostic unfavorable (8.33e-5)" "unprognostic (6.35e-3)" "unprognostic (2.45e-1)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "unprognostic (2.93e-2)" "unprognostic (3.51e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (8.69e-5)" 10.8 12.3 7.3 11.5 6.9 13.3 8.0 25.3 7.9 5.9 8.9 6.5 3.2 8.5 6.3 6.8 7.2 6.0 8.3 6.8 23.3 9.7 5.6 19.7 11.2 11.6 9.2 6.8 14.8 10.8 6.9 9.2 14.4 13.3 5.6 8.0 7.6 3.2 7.1 1.4 5.3 5.2 10.1 11.7 9.3 6.1 10.0 7.7 8.7 11.0 0.5 10.9 12.9 4.2 13.4 40.6 35.1 44.9 110.0 11.5 40.0 108.4 63.0 68.3 62.1 75.7 71.8 37.4 152.3 41.1 96.9 36.8 42.7 72.4 61.8 76.8 63.4 65.3 62.7 60.4 66.1 72.4 115.7 9.8 47.7 76.9 60.6 109.8 55.5 105.5 81.6 150.9 76.2 65.0 86.1 57.1 23.9 45.5 40.7 32.1 67.2 33.2 67.1 42.1 19.6 44.1 32.5 83.9 36.7 53.0 40.6 11.5 79.5 80.6 41.4 90.6 91.9 90.5 62.3 63.5 154.0 68.8 105.7 54.0 0.0 0.2 0.0 0.2 0.3 0.4 0.2 0.6 0.7 1.1 0.3 0.5 0.6 0.0 0.3 0.3 0.5 1.8 0.2 7.3 6.9 25.3 7.9 6.8 23.3 11.6 9.2 6.8 13.3 11.7 7.7 13.4 6.9 0.0 1.7 47.7 6.9 6.5 8.0 15.7 1.8 0.0 3.3 4.1 2.4 1.5 9.8 14.7 0.0 25.8 1.4 2.6 7.9 9.0 44.9 11.3 18.4 10.7 1.2 5.0 84.0 18.1 166.5 14.4 8.2 22.2 0.0 86.9 6.1 1.7 24.9 0.0 73.8 3.0 46.8 3.0 13.3 6.2 0.6 13.8 35.6 126.5 2.4 0.0 2.1 60.8 59.3 19.2 1.4 7.9 14.0 31.3 0.9 15.2 5.3 0.0 0.0 8.7 13.1 0.5 6.8 2.3 3.4 73.6 4.0 42.9 4.0 35.1 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818757-149864359 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 61.3;Respiratory ciliated cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 1500000 "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 14.7 18.2 25.6 5.3 29.2 1.4 11.9 21.8 28.6 15.0 17.9 13.3 11.8 11.6 16.6 28.8 22.5 11.4 9.0 28.7 26.3 20.4 10.1 13.7 2.9 26.9 27.7 29.0 16.6 20.0 43.1 17.7 12.6 28.4 25.7 12.5 13.7 20.3 13.1 5.2 20.8 9.2 12.1 22.0 4.1 16.5 8.1 27.9 2.5 23.1 4.8 6.0 18.2 21.0 31.5 26.5 22.9 17.2 15.0 37.8 67.2 3.5 27.7 52.1 18.5 22.4 7.3 52.9 0.2 36.7 43.3 79.4 69.4 19.2 47.1 13.3 43.7 19.4 13.3 74.3 30.4 22.6 13.2 0.8 42.8 93.1 23.0 46.5 52.5 28.9 11.8 26.8 11.0 22.3 45.4 0.5 1.3 10.4 52.0 19.6 14.5 25.5 6.4 33.9 53.8 22.4 15.6 86.7 46.3 17.0 8.5 38.8 26.4 21.1 22.6 4.8 48.4 21.3 0.1 8.7 6.3 40.9 12.9 13.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 25.6 29.2 21.8 28.6 28.7 26.3 26.9 27.7 29.0 28.4 22.0 27.9 31.5 7.3 6.4 2.8 17.6 0.5 11.3 14.3 17.9 5.7 12.2 10.2 6.0 8.8 12.8 18.3 20.2 2.1 2.1 0.5 7.7 5.9 6.5 27.0 61.3 6.4 7.4 29.4 5.5 42.5 22.7 1.8 20.5 15.3 16.5 0.0 12.4 9.3 9.5 3.6 8.4 44.3 5.0 16.2 1.9 6.2 31.7 16.4 1.7 14.2 11.2 0.1 6.0 0.0 17.6 40.1 19.7 4.2 14.7 0.6 22.2 4.0 7.0 107.7 5.5 0.0 10.0 11.7 14.7 10.4 14.9 14.3 5.6 1.8 15.7 13.2 23.6 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494017-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 33.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 10.4;T-47d: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" NA NA "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favorable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 4.2 2.7 1.4 1.5 0.1 3.7 1.7 1.1 3.0 7.0 0.7 2.6 3.6 0.4 0.4 33.7 1.3 0.8 1.1 3.5 0.8 1.3 4.1 1.4 3.1 3.7 0.6 5.6 0.1 0.1 0.2 1.4 2.9 0.4 0.6 0.2 0.2 0.4 0.3 0.2 1.1 0.9 3.7 2.2 1.7 2.8 1.8 0.3 5.6 0.1 0.6 1.1 0.5 2.9 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.1 5.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 6.2 0.0 2.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.1 2.8 0.1 0.0 0.6 2.7 1.5 1.7 1.1 1.1 3.5 3.1 3.7 0.6 2.9 3.7 1.8 2.9 1.2 3.2 1.5 7.5 0.4 0.6 0.3 6.5 1.2 0.3 27.3 8.9 0.7 0.0 39.5 0.0 22.9 0.1 0.4 1.1 0.0 0.3 53.0 236.6 23.6 1.2 0.0 0.0 5.5 1.1 0.4 5.2 3.1 14.1 3.8 3.5 1.1 1.5 11.9 0.0 5.9 0.0 12.2 17.5 11.3 82.6 7.2 16.8 0.0 0.0 11.0 2.5 0.0 3.0 0.8 2.7 5.8 0.0 0.1 0.9 0.5 5.8 379.4 1.0 0.0 0.4 6.5 19.1 1.1 0.2 1.0 0.0 1.2 14.0 0.3 0.5 PCMT1 ENSG00000120265 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase" P22061 6 149749443-149811420 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1022.2;Late spermatids: 428.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003239 Approved Supported Cytosol No No 4100000 Cytosol "HPA003239: AB_1079580" "prognostic unfavorable (4.02e-7)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.35e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.88e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.91e-2)" "unprognostic (1.58e-2)" "unprognostic (9.02e-2)" "unprognostic (6.45e-2)" "unprognostic (6.77e-2)" "unprognostic (6.14e-2)" "unprognostic (4.38e-1)" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "prognostic unfavorable (6.38e-4)" 49.1 43.6 83.0 33.1 99.0 76.6 46.6 81.6 105.2 46.8 69.4 42.5 36.9 39.1 48.9 45.7 39.6 28.7 122.8 96.5 98.1 51.6 74.4 38.2 41.7 91.1 88.3 94.7 39.7 38.4 46.7 43.6 43.3 98.6 52.6 43.5 56.2 40.1 50.5 213.6 43.7 34.9 49.3 84.3 34.7 38.1 77.3 86.2 58.0 49.4 164.7 47.1 41.1 38.3 118.1 87.3 68.4 70.4 88.6 152.1 125.9 77.6 140.7 82.9 114.7 143.4 200.1 65.4 117.9 113.0 127.5 126.5 106.6 123.9 143.6 159.9 79.2 180.0 175.5 122.2 192.1 99.2 203.7 197.7 62.8 105.2 128.5 138.5 80.7 107.6 89.8 256.5 107.7 142.3 258.9 98.5 150.4 56.5 84.7 78.6 83.4 89.7 82.6 108.9 62.4 137.5 52.4 111.2 173.9 97.7 82.5 107.8 146.1 83.3 67.2 80.7 124.7 151.2 64.1 109.9 115.4 103.6 135.8 137.7 162.9 193.2 178.0 93.0 182.4 94.7 105.0 93.7 102.8 176.0 81.5 86.5 98.0 101.6 108.5 185.7 79.9 129.2 204.1 83.0 99.0 81.6 105.2 96.5 98.1 91.1 88.3 94.7 98.6 84.3 86.2 118.1 57.0 54.5 41.4 21.2 62.6 175.1 74.4 204.4 56.3 72.6 48.0 40.6 154.1 60.1 96.4 79.1 37.5 169.3 66.8 56.6 78.2 113.5 1022.2 51.9 58.4 69.8 55.2 170.1 77.0 110.7 214.0 79.2 26.0 48.8 107.7 38.8 53.9 115.6 119.1 65.6 52.8 72.9 187.2 78.7 127.5 428.1 71.7 78.2 138.7 31.9 143.7 121.2 74.2 30.7 72.2 106.6 57.9 73.7 71.8 67.8 65.1 89.3 106.2 66.3 111.7 64.0 110.4 224.9 96.3 60.7 157.6 148.3 83.0 55.0 58.7 59.1 PLEKHG1 "ARHGEF41, KIAA1209" ENSG00000120278 "Pleckstrin homology and RhoGEF domain containing G1" Q9ULL1 6 150599883-150843665 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 31.5" "Cell type enhanced" "Detected in many" "Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "memory B-cell: 23.9;naive B-cell: 22.9" "Lineage enriched" "Detected in single" 31 "B-cells: 23.9" "Cell line enhanced" "Detected in many" "AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6" "Region enhanced" "Detected in all" "thalamus: 51.3" "Low region specificity" "Detected in all" "HPA027128, HPA027319, HPA028270" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388" "unprognostic (2.93e-1)" "unprognostic (3.44e-1)" "unprognostic (3.04e-3)" "unprognostic (2.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.80e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-3)" "unprognostic (3.63e-1)" "unprognostic (4.30e-2)" "unprognostic (3.83e-1)" "unprognostic (2.15e-2)" 15.2 1.6 11.6 9.5 11.9 2.4 13.8 15.4 9.1 7.6 5.3 6.0 4.9 5.7 10.9 9.5 8.8 8.0 5.9 5.8 27.2 4.5 5.0 10.5 14.8 18.4 15.9 3.5 3.1 2.7 6.7 3.6 14.3 18.2 2.7 6.0 4.7 3.5 5.0 3.5 7.3 6.6 5.6 18.0 31.5 4.6 6.4 18.9 22.6 5.7 5.1 14.0 9.2 5.4 22.9 0.0 0.2 17.6 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.0 10.1 4.4 7.2 6.8 0.0 1.6 2.5 26.4 2.4 0.0 11.4 2.9 0.4 1.4 0.0 0.0 0.0 1.9 1.1 6.7 0.0 0.2 0.0 11.0 5.9 0.0 23.4 0.0 0.3 2.3 0.1 1.3 7.0 0.7 1.2 0.0 0.0 5.1 11.9 0.5 0.1 0.1 3.1 2.2 1.9 0.0 0.1 11.2 0.1 2.4 0.0 4.9 0.0 0.0 16.6 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.7 23.9 0.4 0.6 0.0 22.9 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.7 11.6 11.9 15.4 9.1 5.8 27.2 18.4 15.9 3.5 18.2 18.0 18.9 22.9 91.2 0.0 6.2 98.6 50.3 4.2 0.5 5.5 2.8 0.9 2.0 3.3 2.1 1.5 6.8 7.3 0.0 5.5 0.7 7.2 3.9 2.6 3.8 20.7 6.2 58.4 5.4 5.0 12.8 1.1 1.6 11.8 7.1 19.2 0.0 7.9 35.0 4.3 0.6 0.0 5.8 8.2 8.2 5.9 3.8 1.6 0.3 2.0 5.4 131.2 4.7 11.3 0.0 14.1 168.5 9.4 12.4 0.4 5.2 1.1 3.9 3.6 9.6 0.7 0.0 2.0 3.0 0.7 1.5 6.2 3.7 2.9 5.1 1.1 5.5 3.6 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Group enriched" "Detected in some" 5 "Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 33 "eosinophil: 30.7" "Lineage enriched" "Detected in single" 248 "granulocytes: 30.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 124.6;TIME: 104.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047992 Approved Nucleoplasm,Vesicles NA NA 120000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 26.6 3.2 7.5 5.3 6.4 1.2 21.6 6.5 9.3 9.1 6.2 5.8 3.5 10.2 4.5 4.6 9.2 10.6 16.8 6.0 6.7 6.6 13.2 15.8 6.3 7.4 6.7 4.8 3.6 2.7 4.4 2.2 20.9 7.8 4.4 5.9 1.0 3.8 3.8 12.9 4.3 5.7 12.5 6.3 50.0 4.5 1.8 8.8 2.5 12.3 20.6 3.0 8.1 7.3 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 17.7 0.1 0.0 0.2 0.0 0.1 0.0 23.0 0.3 0.0 0.7 0.1 0.1 0.0 0.2 0.2 0.3 0.0 124.6 0.0 0.3 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 104.4 0.5 0.8 1.5 0.0 1.1 0.0 15.6 0.0 0.0 0.0 0.9 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.6 7.5 6.4 6.5 9.3 6.0 6.7 7.4 6.7 4.8 7.8 6.3 8.8 8.2 123.0 0.0 5.2 0.7 0.8 7.1 0.2 0.1 2.8 0.2 0.4 0.9 3.1 2.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 10.2 1.3 0.2 141.3 0.0 13.7 0.1 0.2 0.0 4.0 0.0 0.1 1.3 0.0 230.6 2.1 0.1 0.0 0.1 0.0 0.0 7.3 7.3 3.7 0.3 13.3 14.2 30.9 0.1 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.6 0.5 0.0 0.0 17.7 0.0 0.0 1.5 2.2 0.1 0.1 0.5 5.5 0.0 0.9 0.5 0.0 0.7 TASL "CXorf21, FLJ11577" ENSG00000120280 "TLR adaptor interacting with endolysosomal SLC15A4" Q9HAI6 X 30558809-30577766 "Disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 11.0" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "THP-1: 166.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001185 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 1.8 1.8 0.7 11.0 0.8 19.7 2.1 0.8 1.6 1.1 1.8 3.5 4.8 0.6 0.4 1.6 0.8 3.9 0.6 0.8 1.5 1.1 2.4 4.8 10.5 1.4 0.9 0.5 0.3 0.3 0.7 0.3 2.9 1.3 1.0 3.4 0.2 1.0 0.7 0.1 0.7 3.0 2.2 1.6 9.9 3.6 0.3 1.4 5.8 0.6 0.4 10.3 4.1 0.3 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.0 13.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 21.5 0.0 0.0 0.0 20.5 0.0 21.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.0 0.0 0.0 0.0 0.0 0.1 15.0 1.6 7.5 0.0 23.9 0.0 8.6 21.9 24.1 1.6 19.8 0.3 23.0 2.0 1.1 25.3 23.6 1.8 1.3 30.6 7.1 44.4 45.9 3.4 8.0 0.7 0.8 0.8 1.6 0.8 1.5 1.4 0.9 0.5 1.3 1.6 1.4 2.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 MAGEB4 "CT3.6, MGC33144" ENSG00000120289 "MAGE family member B4" O15481 X 30242000-30244187 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 100 "epididymis: 27.5;testis: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030456 Enhanced NA NA "HPA030456: AB_10602707" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYSTM1 "C5orf32, ORF1-FL49" ENSG00000120306 "Cysteine rich transmembrane module containing 1" Q9H1C7 5 140175156-140282052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 1329.6" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2568.9;Gastric mucus-secreting cells: 2148.3;Late spermatids: 1327.7;Pancreatic endocrine cells: 1331.5;Proximal tubular cells: 1301.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 425.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 425.2" "Cell line enhanced" "Detected in all" "OE19: 773.7;RPTEC TERT1: 364.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050930 Enhanced NA NA "HPA050930: AB_2681278" "unprognostic (7.39e-2)" "unprognostic (3.68e-2)" "unprognostic (4.46e-2)" "prognostic favorable (1.31e-4)" "unprognostic (5.38e-2)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.26e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.69e-5)" "unprognostic (7.63e-2)" "unprognostic (2.23e-1)" "unprognostic (4.67e-2)" "unprognostic (1.14e-2)" 87.1 189.1 104.3 54.2 105.1 162.8 61.7 108.7 132.5 49.0 133.7 186.0 323.4 36.9 54.4 28.6 140.8 152.2 115.6 103.3 143.0 267.2 75.0 97.5 23.6 111.0 108.8 97.5 29.4 142.5 129.7 54.4 65.1 111.0 31.6 167.8 35.5 82.4 42.1 296.3 22.8 169.4 60.5 107.0 33.7 1329.6 36.0 109.2 32.0 88.0 363.2 21.0 159.6 22.1 109.1 68.5 118.8 10.1 65.8 152.5 118.2 51.0 26.7 77.1 34.5 67.8 142.0 115.1 28.4 92.2 44.8 180.1 42.8 55.7 70.8 27.5 54.3 74.6 2.7 50.4 92.3 119.1 9.1 63.5 31.4 92.2 42.2 77.0 62.7 67.5 91.1 48.7 68.4 8.2 66.2 31.4 16.6 16.4 773.7 44.5 7.0 12.4 51.4 364.9 284.0 25.4 16.6 45.8 28.8 280.6 33.3 96.9 27.0 16.0 17.0 17.1 12.8 31.8 62.5 48.6 26.4 87.9 8.9 32.8 15.6 32.4 22.4 4.3 37.3 8.1 18.2 11.5 7.2 41.3 14.4 3.1 4.8 425.2 4.5 39.1 64.0 17.2 16.4 104.3 105.1 108.7 132.5 103.3 143.0 111.0 108.8 97.5 111.0 107.0 109.2 109.1 259.9 317.3 115.2 34.6 52.8 169.5 525.6 252.8 51.2 5.6 85.5 77.8 107.2 424.7 186.1 573.8 2.1 422.8 42.8 1024.7 2568.9 674.9 444.3 469.0 60.8 147.8 435.8 47.4 10.6 846.6 53.6 174.0 2148.3 218.9 119.2 9.4 120.0 88.5 205.2 11.8 12.5 285.8 205.4 45.3 150.0 1327.7 101.5 77.1 394.8 13.1 105.5 153.3 3.1 4.5 11.1 1331.5 1148.5 116.6 37.4 365.1 727.1 1301.6 576.5 18.8 144.7 115.6 190.6 208.6 81.4 28.4 113.7 393.1 53.9 30.2 429.3 736.7 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 9.5 9.3 5.0 9.6 5.2 13.1 9.3 5.8 5.3 7.6 6.1 9.4 9.4 7.9 4.4 13.5 7.4 6.2 7.2 5.0 5.3 8.8 12.4 8.9 10.2 6.0 5.5 4.8 7.5 11.2 6.2 9.1 7.6 5.8 8.8 10.4 4.0 10.6 5.5 9.2 10.9 11.1 6.4 5.3 12.7 10.6 4.9 5.5 7.9 7.5 6.0 10.7 8.9 8.0 5.8 13.2 18.0 8.5 34.4 12.8 10.1 23.7 12.9 15.5 13.3 15.2 31.1 17.7 12.3 16.8 16.6 24.3 16.1 11.5 22.4 10.2 11.6 9.6 14.1 15.9 12.7 12.2 14.8 25.5 12.2 12.7 18.3 9.6 9.2 14.4 13.7 9.9 9.3 14.9 19.2 14.0 13.3 8.9 18.9 15.2 11.6 12.2 11.6 15.9 19.7 8.3 11.1 17.7 51.3 20.2 10.4 36.3 15.8 13.0 17.5 9.0 20.3 17.6 15.6 12.9 9.6 22.7 19.5 10.6 6.4 10.2 7.8 11.3 16.6 11.7 8.5 10.5 9.8 9.9 7.3 8.3 8.5 9.0 10.3 14.2 7.2 12.6 10.0 5.0 5.2 5.8 5.3 5.0 5.3 6.0 5.5 4.8 5.8 5.3 5.5 5.8 17.1 9.6 16.7 5.9 16.9 14.5 10.9 9.1 9.6 13.5 15.5 10.3 5.3 5.7 16.2 18.4 12.5 21.6 28.9 31.9 21.5 20.2 29.3 20.6 13.1 12.9 14.9 13.9 7.2 28.2 42.8 12.6 25.0 13.9 19.7 16.4 12.5 14.9 20.8 23.5 7.0 22.6 8.2 16.1 13.9 9.7 9.6 18.3 8.8 1.0 20.5 5.7 23.7 4.5 6.5 27.2 39.3 7.5 23.0 15.6 24.9 20.8 17.2 8.3 13.1 13.0 14.1 7.9 9.8 15.1 13.4 23.3 21.0 14.2 26.0 16.4 ARAP3 "CENTD3, DRAG1, FLJ21065" ENSG00000120318 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3" Q8WWN8 5 141653401-141682230 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 33.2;Endothelial cells: 28.3;Hepatic stellate cells: 28.5;Horizontal cells: 38.7;Microglial cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 3.3;neutrophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "EFO-21: 39.4;HUVEC TERT2: 74.3;TIME: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042887 Uncertain NA NA "HPA042887: AB_10796681" "unprognostic (1.98e-1)" "unprognostic (4.88e-2)" "unprognostic (9.30e-2)" "unprognostic (1.31e-1)" "unprognostic (5.58e-2)" "unprognostic (5.26e-2)" "unprognostic (3.77e-3)" "unprognostic (9.76e-2)" "unprognostic (3.43e-2)" "unprognostic (1.39e-1)" "unprognostic (4.42e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.59e-6)" "unprognostic (4.96e-2)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.98e-2)" 11.5 4.2 5.3 5.4 3.6 6.3 10.2 4.5 7.4 9.3 4.7 4.5 3.3 7.5 5.4 3.3 7.8 6.8 12.0 3.0 2.9 7.8 2.1 15.9 2.4 3.9 4.3 2.0 3.7 2.6 5.3 5.1 12.0 4.1 7.5 2.7 3.9 4.0 5.8 7.1 2.4 4.7 5.9 2.5 7.4 4.3 1.6 6.2 0.7 8.6 9.3 1.2 7.9 7.4 4.4 11.9 7.5 29.4 0.0 1.8 4.5 0.3 7.0 7.9 7.2 9.2 4.7 0.9 0.1 39.4 2.6 11.7 12.8 5.0 16.8 5.5 0.2 2.1 11.0 12.6 0.1 8.2 0.9 0.4 8.3 7.6 3.9 8.9 20.1 74.3 0.0 0.8 0.1 1.0 0.3 0.0 9.5 17.4 3.9 9.4 0.2 2.3 0.0 0.8 5.4 0.5 24.7 15.1 0.8 12.7 10.6 0.4 2.8 53.3 4.8 10.8 1.3 14.7 0.0 0.1 0.1 12.4 12.6 24.3 0.3 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.1 0.2 5.3 3.6 4.5 7.4 3.0 2.9 3.9 4.3 2.0 4.1 2.5 6.2 4.4 33.2 3.2 8.6 0.3 0.3 0.5 1.7 3.1 0.0 6.1 0.9 2.2 5.2 0.0 2.6 1.8 0.0 0.1 1.6 1.3 0.0 1.2 0.0 0.7 2.3 28.3 0.0 0.0 2.4 0.7 0.1 2.2 1.1 1.2 1.3 0.0 28.5 0.3 1.3 38.7 3.2 1.3 2.0 4.4 2.1 0.6 0.3 2.2 0.0 15.0 2.7 3.6 2.1 1.5 0.1 4.6 1.8 1.5 1.6 2.8 0.0 0.1 0.9 0.9 0.0 1.2 3.3 0.5 0.9 0.8 0.4 0.1 1.5 0.4 2.7 3.6 PCDHB8 "PCDH-BETA8, PCDH3I" ENSG00000120322 "Protocadherin beta 8" Q9UN66 5 141177790-141180539 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Early spermatids: 5.0;Spermatocytes: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;T-47d: 31.4;U-138 MG: 12.1;U-2197: 34.2" HPA057773 Uncertain NA NA "HPA057773: AB_2683525" "unprognostic (1.16e-3)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (1.72e-1)" "unprognostic (7.56e-2)" "unprognostic (2.02e-2)" "unprognostic (5.72e-3)" "unprognostic (5.82e-4)" "unprognostic (3.54e-2)" "unprognostic (5.52e-3)" "unprognostic (1.95e-2)" "unprognostic (2.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.11e-2)" "unprognostic (8.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.30e-4)" 0.8 0.5 0.1 0.2 0.4 0.0 0.5 0.2 1.8 0.6 0.0 0.3 0.1 1.3 0.7 0.3 0.5 0.6 0.6 1.0 0.6 0.4 0.1 0.6 0.0 0.6 0.3 0.0 0.9 0.6 1.0 0.8 0.2 0.3 0.4 0.2 0.8 0.3 0.3 0.1 0.4 0.1 0.7 0.1 0.2 0.2 1.1 0.2 0.0 0.3 0.3 0.0 0.3 0.3 1.0 0.0 0.0 0.1 1.3 3.8 2.4 0.2 0.2 7.7 0.0 0.1 0.0 0.0 0.0 20.9 0.1 7.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.2 0.4 0.0 0.0 1.3 0.0 0.3 0.1 1.7 6.2 0.2 0.0 0.0 0.0 0.0 0.5 0.1 8.4 0.0 0.1 0.0 6.0 1.6 0.1 0.0 1.1 0.0 31.4 0.0 0.9 12.1 6.0 34.2 0.0 0.0 0.0 0.0 3.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 1.8 1.0 0.6 0.6 0.3 0.0 0.3 0.1 0.2 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 6.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 PCDHB10 ENSG00000120324 "Protocadherin beta 10" Q9UN67 5 141192353-141195647 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.9;Endometrial stromal cells: 3.4;Endothelial cells: 3.2;Enteroendocrine cells: 4.2;granulocytes: 4.5;Peritubular cells: 4.1" "Cancer enhanced" "Detected in many" "glioma: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 6.6;ASC TERT1: 6.4;EFO-21: 14.1;U-2197: 7.0" HPA013445 Uncertain NA NA "HPA013445: AB_1855054" "unprognostic (1.08e-1)" "unprognostic (8.41e-2)" "unprognostic (4.03e-2)" "unprognostic (1.51e-2)" "unprognostic (1.94e-1)" "unprognostic (7.30e-2)" "unprognostic (1.81e-2)" "unprognostic (2.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.96e-3)" "unprognostic (2.16e-1)" "unprognostic (3.25e-1)" "unprognostic (5.40e-3)" "unprognostic (4.56e-2)" "unprognostic (3.11e-2)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" 1.4 1.8 2.3 0.5 2.1 0.0 1.7 1.2 2.9 2.2 0.1 2.0 0.5 3.4 1.7 0.9 1.8 1.6 1.3 2.4 1.0 0.7 0.2 1.4 0.3 1.8 2.5 1.7 2.5 0.7 1.4 3.7 0.7 1.6 1.6 0.7 1.5 1.1 1.5 0.5 0.9 0.8 3.1 1.2 0.6 0.9 0.7 3.0 0.2 0.9 0.8 0.1 1.6 1.4 2.3 0.0 0.0 3.9 3.7 6.6 6.4 0.2 0.4 3.6 0.1 0.3 0.0 0.3 0.1 14.1 1.0 2.9 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.7 2.5 0.0 0.0 3.5 0.3 0.0 0.0 4.3 1.3 0.1 0.1 0.1 0.1 0.0 0.2 0.8 2.4 0.0 0.5 0.0 2.6 5.4 4.4 0.1 0.6 0.4 2.9 0.2 1.4 3.6 2.0 7.0 1.0 0.0 0.0 0.0 4.4 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.1 1.2 2.9 2.4 1.0 1.8 2.5 1.7 1.6 1.2 3.0 2.3 2.6 0.0 0.5 0.0 0.0 0.0 0.1 1.5 0.0 8.9 0.5 0.9 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 3.4 3.2 4.2 0.0 0.0 0.9 0.0 2.1 0.0 0.2 4.5 0.2 1.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.4 0.6 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 2.9 1.6 1.9 0.6 0.2 0.4 0.1 0.1 0.3 0.0 0.3 PCDHB14 PCDH-BETA14 ENSG00000120327 "Protocadherin beta 14" Q9Y5E9 5 141223343-141227759 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 15.1;Early spermatids: 8.1;Horizontal cells: 13.5;Peritubular cells: 8.6;Spermatocytes: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.4;SiHa: 12.0;U-2197: 8.5" "Low region specificity" "Detected in all" "HPA007692, HPA045248" Uncertain Approved Vesicles NA NA 39000 Vesicles "HPA007692: AB_2667896, HPA045248: AB_10959599" "unprognostic (2.57e-3)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (8.97e-2)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" "unprognostic (2.11e-2)" "unprognostic (2.38e-2)" "unprognostic (6.60e-2)" "unprognostic (2.57e-2)" "unprognostic (1.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.58e-1)" "unprognostic (3.12e-2)" "unprognostic (3.77e-2)" "unprognostic (3.90e-2)" 2.9 2.8 2.1 0.8 3.1 0.1 3.5 2.1 3.9 5.6 0.0 3.8 0.3 7.1 2.4 2.1 4.3 1.9 3.9 2.4 1.3 2.1 1.2 3.0 0.4 1.5 2.2 2.7 4.8 4.0 3.7 6.3 1.1 1.3 3.1 0.9 2.3 3.7 2.0 1.6 4.3 1.6 2.6 1.0 2.0 1.9 2.5 2.3 0.5 2.3 1.5 0.3 3.5 3.6 3.3 0.0 0.0 3.3 6.3 5.4 6.4 0.4 0.5 5.5 0.5 1.7 0.1 1.0 0.3 4.5 1.5 2.9 0.3 0.7 1.0 0.5 0.0 0.1 0.0 1.3 0.1 0.2 0.3 0.2 1.2 4.7 0.1 0.2 4.8 0.6 0.2 0.0 5.8 2.3 0.5 0.4 0.0 0.4 0.0 1.1 3.8 4.1 0.0 0.1 0.2 7.6 14.4 12.0 0.3 1.3 0.5 6.1 0.5 1.7 2.2 1.9 8.5 2.2 0.0 0.1 0.1 4.5 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.1 2.1 3.9 2.4 1.3 1.5 2.2 2.7 1.3 1.0 2.3 3.3 4.1 0.0 4.8 0.0 0.0 0.4 1.1 3.1 0.0 15.1 1.6 2.4 3.3 0.0 3.1 1.8 0.0 0.0 0.2 0.3 0.0 0.9 8.1 0.8 6.3 3.9 3.5 0.0 0.0 2.4 0.0 5.0 0.0 0.9 0.0 1.3 3.3 1.3 0.1 13.5 0.0 0.6 4.1 0.0 0.7 2.1 3.4 0.3 0.0 0.0 0.0 6.8 0.0 0.0 0.0 2.2 0.5 8.6 0.0 0.5 0.0 0.8 0.6 1.3 0.0 6.3 3.9 8.0 0.1 0.7 2.8 0.0 0.2 2.5 0.3 0.7 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.0;Endometrial stromal cells: 2.8;Fibroblasts: 2.8;Melanocytes: 3.6;Peritubular cells: 2.6;Skeletal myocytes: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.7;ASC diff: 2.5;EFO-21: 3.0;RH-30: 3.2;U-2 OS: 2.3;U-2197: 2.4" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 1.3 0.6 0.1 0.4 0.7 0.0 1.2 1.0 1.2 1.8 0.0 1.1 0.2 2.7 0.8 0.4 1.9 1.0 1.1 0.9 0.1 0.6 0.3 1.4 0.1 0.4 0.3 0.2 2.2 1.3 1.0 2.0 0.4 0.4 0.9 0.4 0.8 0.6 0.9 0.7 0.5 0.6 1.8 0.1 0.7 0.6 1.1 0.2 0.1 0.6 0.9 0.1 1.2 1.1 0.8 0.0 0.0 0.7 2.7 2.5 1.4 0.4 0.0 1.9 0.1 0.2 0.0 0.0 0.0 3.0 0.3 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.1 0.0 0.5 0.5 3.2 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.6 0.2 2.1 0.4 0.2 0.4 2.3 2.4 0.0 0.0 0.0 0.0 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.0 1.2 0.9 0.1 0.4 0.3 0.2 0.4 0.1 0.2 0.8 1.9 0.0 1.1 0.0 0.0 0.4 0.0 0.2 0.0 4.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.8 0.1 2.8 1.3 1.8 0.0 0.0 0.9 0.0 2.8 0.5 0.1 0.0 0.1 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.0 3.6 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.1 0.0 0.2 0.0 0.3 0.0 2.2 1.6 1.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 SLC25A2 ORNT2 ENSG00000120329 "Solute carrier family 25 member 2" Q9BXI2 5 141302635-141304049 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 6.6" "Group enriched" "Detected in some" 21 "Early spermatids: 18.2;Late spermatids: 12.0;Spermatocytes: 27.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042146 Uncertain NA NA "HPA042146: AB_2677874" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "unprognostic (4.63e-2)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (4.72e-3)" "unprognostic (2.81e-1)" "unprognostic (2.62e-2)" "unprognostic (6.69e-2)" "unprognostic (1.17e-1)" "unprognostic (8.82e-10)" "unprognostic (2.56e-1)" "unprognostic (1.87e-1)" "unprognostic (1.26e-2)" "unprognostic (1.14e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 27.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TNN TNW ENSG00000120332 "Tenascin N" Q9UQP3 1 175067833-175148075 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 12.1;breast: 4.9" "Cell type enhanced" "Detected in some" "Adipocytes: 6.1;Fibroblasts: 7.5;Hepatic stellate cells: 2.5;Langerhans cells: 2.5;Smooth muscle cells: 10.4" "Cancer enhanced" "Detected in some" "breast cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;NB-4: 3.6;THP-1: 11.1;U-266/70: 2.7;U-937: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB010907, HPA026726, HPA026764" Uncertain "Secreted to extracellular matrix" NA NA 34000000 "CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859" "unprognostic (1.16e-3)" "unprognostic (2.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-2)" "unprognostic (1.34e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.55e-1)" "unprognostic (5.25e-3)" "unprognostic (1.01e-2)" "unprognostic (4.69e-1)" "unprognostic (5.07e-1)" "unprognostic (1.08e-3)" "unprognostic (1.76e-2)" "unprognostic (9.38e-3)" "unprognostic (1.89e-2)" "unprognostic (1.02e-2)" 12.1 0.2 0.0 0.1 0.1 0.0 4.9 0.0 0.3 0.1 0.5 0.2 0.8 0.0 0.0 0.1 0.0 1.7 0.3 0.2 0.2 0.4 1.3 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.8 2.0 0.1 0.0 0.0 0.1 0.0 3.3 0.0 0.0 2.0 0.4 0.4 0.1 0.4 0.4 0.1 0.1 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 11.1 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.7 0.0 0.1 7.5 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 2.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 10.4 0.4 1.4 0.0 1.8 0.1 0.1 0.0 0.0 0.1 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.4 20.5 26.5 11.3 28.2 4.5 20.8 28.3 29.6 16.3 22.1 13.5 12.5 17.6 21.9 9.5 15.6 14.0 15.2 25.4 28.0 20.6 19.3 13.3 15.9 28.4 27.4 22.5 18.5 14.9 28.2 12.3 14.0 28.3 20.4 15.9 22.7 17.2 17.1 13.1 11.5 12.0 15.1 28.9 14.4 14.2 11.3 27.5 17.7 23.4 14.4 15.2 12.2 9.4 30.2 16.2 12.8 29.5 10.5 32.6 23.4 9.4 13.8 16.8 23.0 23.7 16.7 13.9 20.4 16.5 18.6 10.1 14.0 18.5 16.1 24.3 22.6 25.4 16.8 25.6 19.2 13.8 18.9 14.5 25.6 19.4 13.6 9.4 20.3 19.4 17.4 20.7 17.6 16.2 8.9 20.8 13.7 16.2 30.1 6.7 17.8 15.6 24.4 15.8 12.8 24.8 17.4 20.0 18.3 13.8 23.1 21.7 19.7 15.9 7.8 8.6 16.4 12.5 19.1 17.5 25.1 11.1 17.5 16.6 9.3 15.2 7.7 14.8 15.1 21.2 17.5 15.5 15.8 16.2 17.3 20.8 17.6 5.2 18.2 12.3 14.0 19.0 14.3 26.5 28.2 28.3 29.6 25.4 28.0 28.4 27.4 22.5 28.3 28.9 27.5 30.2 29.8 28.9 24.5 5.5 38.4 22.0 52.6 105.9 22.2 17.5 31.6 33.8 78.1 44.3 64.0 55.2 14.6 95.4 26.7 26.4 137.0 69.8 23.8 26.5 35.8 39.1 31.8 46.3 7.8 44.8 107.0 41.4 20.4 26.6 18.3 34.8 33.9 67.2 80.7 1.7 9.4 35.8 103.7 34.7 23.9 12.9 46.6 25.6 49.8 9.4 73.9 46.1 45.3 6.6 10.4 47.7 45.7 42.9 48.7 50.0 35.3 126.1 50.6 22.6 39.5 25.1 66.4 96.9 39.1 36.7 29.3 56.1 28.8 43.0 48.8 52.6 CENPL "C1orf155, dJ383J4.3, FLJ31044" ENSG00000120334 "Centromere protein L" Q8N0S6 1 173799550-173824720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.7;testis: 9.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA044520 Uncertain NA Yes "HPA044520: AB_10794500" "unprognostic (8.72e-3)" "unprognostic (2.82e-2)" "unprognostic (3.39e-1)" "unprognostic (1.34e-3)" "unprognostic (7.89e-2)" "unprognostic (7.88e-3)" "unprognostic (6.43e-6)" "unprognostic (8.18e-2)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.60e-4)" "unprognostic (1.78e-3)" "unprognostic (5.00e-2)" "unprognostic (1.46e-10)" "unprognostic (2.16e-2)" "unprognostic (4.41e-2)" "unprognostic (3.10e-2)" "unprognostic (3.09e-1)" 1.7 1.3 1.4 3.1 1.5 9.7 2.4 1.5 1.8 2.0 1.0 2.4 2.3 1.8 1.0 2.4 1.3 1.7 1.7 1.3 1.5 1.4 1.0 1.3 6.6 1.6 1.3 1.2 1.6 0.7 1.2 0.6 3.0 1.6 1.3 3.0 1.6 1.4 1.2 1.5 2.2 1.8 2.4 1.7 2.2 2.1 9.9 1.4 9.2 1.8 2.8 5.8 1.9 1.5 1.9 27.5 7.3 13.5 18.2 3.9 6.7 9.9 23.6 14.4 24.9 17.3 9.5 14.3 19.8 11.0 12.9 9.4 17.6 14.6 11.6 27.4 18.0 7.2 14.6 7.6 5.5 1.9 22.4 14.7 3.4 3.9 17.6 14.0 4.7 14.8 15.2 25.8 28.6 23.0 6.4 18.5 10.3 14.1 19.3 40.4 18.9 16.7 16.7 8.9 7.5 13.6 11.3 18.7 22.5 15.7 10.9 15.8 18.5 8.6 28.6 19.6 14.8 27.6 15.9 29.2 31.5 9.4 16.4 26.6 3.9 1.0 2.4 4.7 1.1 5.3 3.3 4.3 5.5 0.9 5.0 5.5 6.0 0.6 8.6 0.7 4.3 7.1 2.6 1.4 1.5 1.5 1.8 1.3 1.5 1.6 1.3 1.2 1.6 1.7 1.4 1.9 16.0 9.6 3.7 1.6 8.5 4.7 6.9 2.8 1.2 4.9 7.3 24.5 5.0 2.8 2.1 1.8 14.6 9.2 13.1 4.8 0.0 2.2 2.2 4.6 12.8 6.3 1.8 22.7 2.2 3.8 15.9 7.7 3.1 7.9 4.5 13.1 3.3 0.8 6.7 1.7 2.0 4.8 2.0 4.4 7.1 3.3 4.7 4.5 5.4 2.8 3.6 2.4 7.2 1.5 2.5 3.6 4.5 1.9 7.4 6.3 4.0 1.3 1.7 4.7 0.0 14.5 10.7 38.8 20.2 8.8 6.0 5.9 9.2 11.2 5.3 4.5 TNFSF18 "AITRL, hGITRL, TL6" ENSG00000120337 "TNF superfamily member 18" Q9UNG2 1 173039960-173050963 "Predicted intracellular proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "gallbladder: 1.9" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 13.6;Hofbauer cells: 6.4;Squamous epithelial cells: 6.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "EFO-21: 51.4;HUVEC TERT2: 78.8;TIME: 110.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.78e-1)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (1.32e-2)" "unprognostic (3.39e-2)" "unprognostic (5.72e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (2.22e-2)" "unprognostic (3.53e-2)" "unprognostic (1.13e-1)" "unprognostic (6.34e-2)" "unprognostic (2.71e-4)" "unprognostic (8.42e-3)" "unprognostic (6.21e-2)" "unprognostic (1.99e-1)" "unprognostic (8.74e-2)" 0.1 0.2 0.1 0.2 0.3 0.0 0.2 0.4 0.9 0.2 0.0 0.2 0.5 0.0 0.0 0.8 0.0 1.9 0.0 0.4 0.2 0.3 0.8 0.2 0.2 0.4 0.3 0.2 0.0 0.2 0.5 0.1 0.4 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.1 0.3 0.7 0.3 0.0 0.1 0.3 0.0 0.4 0.2 0.0 0.0 0.2 0.1 0.3 0.0 1.1 2.5 0.5 0.0 0.0 0.0 0.0 51.4 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 78.8 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.4 0.9 0.4 0.2 0.4 0.3 0.2 0.4 0.2 0.3 0.4 0.1 0.0 0.0 0.7 0.0 0.6 0.5 0.3 13.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.6 0.0 0.0 0.0 2.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.1 0.0 0.0 0.0 0.0 0.1 SEC16B "LZTR2, PGPR-p117, RGPR, Sec16S" ENSG00000120341 "SEC16 homolog B, endoplasmic reticulum export factor" Q96JE7 1 177923956-177984303 "Predicted intracellular proteins" "ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.7;liver: 36.7" "Cell type enhanced" "Detected in many" "Hepatocytes: 66.3;Late spermatids: 50.4;Proximal enterocytes: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.6;CAPAN-2: 7.2;EFO-21: 5.4;HDLM-2: 5.8;Karpas-707: 4.8;RPMI-8226: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054292, HPA072913" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Actin filaments" NA NA "Endoplasmic reticulum, Plasma membrane" "Actin filaments" "HPA054292: AB_2682439, HPA072913: AB_2732213" "unprognostic (2.31e-1)" "unprognostic (1.90e-1)" "unprognostic (6.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-2)" "unprognostic (1.50e-2)" "unprognostic (4.76e-3)" "unprognostic (2.43e-1)" "unprognostic (7.34e-4)" "unprognostic (6.67e-2)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 4.0 2.5 0.3 1.1 1.1 0.3 3.3 0.0 2.9 3.1 0.0 3.7 28.3 3.5 2.0 2.0 3.6 4.3 2.6 0.9 0.1 3.4 36.7 2.4 1.1 0.2 0.4 0.9 4.2 9.1 0.5 1.4 0.9 0.7 1.6 4.0 5.8 3.6 2.1 9.4 2.7 28.7 2.7 0.0 5.9 8.8 1.5 0.2 0.4 2.1 3.1 0.9 1.4 1.1 1.7 1.9 1.5 0.1 1.5 1.9 6.6 0.0 1.5 0.5 0.1 0.7 1.0 7.2 0.6 5.4 1.2 0.1 0.0 0.4 0.2 0.0 5.8 0.1 0.0 0.0 3.4 0.1 0.1 0.0 3.8 0.5 0.2 0.0 0.2 2.2 0.0 0.0 4.8 3.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 6.5 0.1 0.1 0.6 1.2 0.1 0.2 0.8 0.0 0.1 1.3 0.7 1.0 0.2 0.6 0.0 1.5 0.7 0.1 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 2.9 0.9 0.1 0.2 0.4 0.9 0.7 0.0 0.2 1.7 7.7 0.0 2.0 2.9 0.7 0.3 0.3 0.4 1.8 1.3 6.3 1.8 0.5 7.2 1.9 1.8 2.1 0.5 0.0 0.9 0.0 0.6 10.1 2.3 1.6 3.9 3.6 0.0 15.8 1.1 0.0 1.9 9.2 2.7 1.3 1.9 3.6 66.3 0.6 11.8 4.8 4.6 0.0 3.2 0.4 50.4 2.5 0.7 1.8 3.7 0.6 1.4 0.0 1.0 1.3 1.1 5.2 1.2 2.9 0.1 34.8 3.1 3.3 4.7 0.0 2.7 1.0 0.3 0.8 0.6 1.0 0.0 0.3 0.1 5.4 0.2 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532131-170553834 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027250, HPA027746" Approved Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 3.0 5.2 2.3 1.9 2.2 0.6 2.8 2.3 3.2 3.6 2.4 3.1 1.4 3.2 3.5 2.3 2.2 2.1 2.9 2.1 2.9 2.4 4.3 2.5 3.6 2.3 2.5 2.0 4.3 3.7 1.9 3.0 3.1 2.3 2.9 3.4 1.3 3.4 2.6 1.1 1.9 2.7 2.0 2.3 3.1 2.1 2.0 2.5 2.9 3.0 2.1 3.0 3.1 3.4 2.5 3.4 3.8 4.5 2.0 9.0 5.8 2.9 4.8 7.5 3.6 4.6 1.9 4.9 5.1 6.1 4.3 2.4 4.0 6.4 2.8 6.0 4.8 1.6 2.5 4.0 2.8 4.9 4.4 3.1 4.4 2.5 4.2 3.9 5.5 3.5 2.3 4.4 2.3 5.3 0.6 5.8 4.0 4.7 6.2 4.0 3.9 3.8 6.0 4.2 1.9 1.4 3.0 3.6 4.8 11.5 3.1 2.7 8.4 4.4 6.8 3.1 2.9 7.2 3.5 4.4 3.8 5.2 4.0 5.4 0.7 3.9 0.0 2.3 4.2 3.9 2.8 4.1 3.5 4.3 2.8 3.6 3.0 0.5 3.8 3.1 2.7 5.3 2.6 2.3 2.2 2.3 3.2 2.1 2.9 2.3 2.5 2.0 2.3 2.3 2.5 2.5 8.1 0.0 11.4 8.8 8.9 2.8 4.0 6.5 8.6 4.7 5.2 7.1 9.4 10.0 7.1 5.5 2.1 6.0 6.2 12.8 3.9 12.3 2.3 5.5 10.4 8.3 0.0 3.4 9.3 6.0 7.3 10.5 9.2 6.7 13.9 5.2 5.3 6.6 7.1 5.0 7.7 9.4 8.2 6.9 4.6 3.2 14.0 5.6 3.6 3.7 10.1 4.3 3.1 9.0 7.3 5.7 9.8 6.4 10.3 4.9 4.3 6.0 2.4 7.1 6.6 8.2 9.3 13.1 8.1 5.4 1.6 5.6 6.3 5.1 6.4 3.0 GPR31 "12-HETER, HETER1" ENSG00000120436 "G protein-coupled receptor 31" O00270 6 167155247-167157980 "G-protein coupled receptors, Predicted membrane proteins" "Lipid metabolism" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014014, HPA027108" Uncertain NA NA "HPA014014: AB_1849292, HPA027108: AB_10601474" "unprognostic (9.92e-2)" "unprognostic (1.52e-1)" "unprognostic (1.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-3)" "unprognostic (2.20e-3)" "unprognostic (5.95e-3)" "unprognostic (4.03e-2)" "unprognostic (3.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (8.10e-4)" "unprognostic (2.45e-1)" "unprognostic (6.01e-2)" 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAT2 ENSG00000120437 "Acetyl-CoA acetyltransferase 2" Q9BWD1 6 159762045-159779112 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 233.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021106, HPA025736, HPA025765, HPA025811" Enhanced Approved Nucleoplasm,Cytosol NA NA 14000000 Cytosol Nucleoplasm "CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488" "unprognostic (3.31e-1)" "unprognostic (2.44e-2)" "prognostic favorable (1.12e-4)" "prognostic unfavorable (7.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" "unprognostic (9.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (8.56e-2)" "unprognostic (2.54e-2)" 11.0 21.8 24.0 18.6 26.1 22.6 23.8 31.8 30.3 12.9 22.3 38.8 31.4 11.0 40.4 32.9 11.5 10.7 9.5 25.8 27.5 27.3 233.2 20.4 25.2 38.5 29.9 24.4 17.4 9.4 12.6 3.2 11.9 40.6 35.9 34.1 19.7 15.7 9.4 4.9 18.2 18.0 16.0 27.6 9.8 19.6 28.8 29.6 39.7 9.0 7.1 37.0 13.8 9.2 39.8 70.1 58.8 451.9 160.8 57.2 111.6 14.4 57.4 70.5 141.8 244.5 234.0 87.1 55.9 29.0 48.7 458.2 64.5 174.8 465.8 166.7 35.2 174.4 127.4 97.2 418.8 62.0 81.4 35.8 62.2 40.1 231.1 92.9 21.4 68.8 160.1 139.9 104.3 85.5 113.0 137.0 154.0 142.8 65.5 41.7 83.9 94.4 173.1 377.2 93.7 107.8 63.2 67.5 43.3 26.2 18.5 83.4 157.3 39.2 50.3 45.7 72.1 154.0 47.7 89.0 142.0 15.7 151.2 77.1 30.1 24.9 46.7 47.9 33.9 47.3 46.6 54.1 47.8 34.7 51.4 53.3 43.2 11.0 41.3 23.6 30.4 79.0 46.2 24.0 26.1 31.8 30.3 25.8 27.5 38.5 29.9 24.4 40.6 27.6 29.6 39.8 11.8 12.8 45.4 15.3 25.8 26.1 32.4 262.1 22.2 19.4 33.4 24.5 1.2 42.9 115.5 20.2 2.1 53.7 28.6 34.7 70.5 78.8 187.0 14.3 9.9 18.8 17.2 38.5 14.3 176.6 97.0 21.6 9.7 25.9 13.3 47.7 16.1 214.8 58.1 13.5 14.7 23.6 83.4 14.8 29.8 128.8 13.7 25.7 30.2 1.0 58.9 22.5 30.9 13.0 17.5 65.6 28.8 19.2 25.5 38.7 15.4 50.0 30.1 24.7 0.0 25.1 44.9 28.5 45.6 43.0 21.0 35.2 31.0 102.5 33.0 38.9 TCP1 "CCT1, Ccta, D6S230E" ENSG00000120438 "T-complex 1" P17987 6 159778498-159789703 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 586.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017460, HPA027337, HPA031082" Approved NA NA 2300000 "CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990" "prognostic unfavorable (8.88e-5)" "unprognostic (1.34e-2)" "unprognostic (1.64e-3)" "unprognostic (2.67e-2)" "unprognostic (5.50e-2)" "unprognostic (1.39e-3)" "prognostic unfavorable (1.49e-5)" "unprognostic (1.54e-2)" "unprognostic (2.44e-1)" "unprognostic (2.64e-2)" "unprognostic (9.34e-2)" "unprognostic (5.17e-2)" "unprognostic (2.10e-3)" "unprognostic (1.81e-1)" "unprognostic (2.15e-1)" "unprognostic (1.76e-1)" "unprognostic (1.54e-1)" 113.3 93.6 118.8 91.6 119.1 183.0 107.1 119.5 153.1 86.8 124.7 104.6 72.3 98.7 85.6 104.7 94.1 69.8 105.9 125.2 122.4 106.8 98.8 90.2 106.5 123.2 120.1 111.3 123.9 96.9 99.0 57.5 84.2 123.3 81.7 109.1 77.5 92.9 73.3 173.2 101.4 85.4 100.6 128.0 82.9 93.1 175.5 121.9 99.1 77.8 126.5 129.4 102.9 85.5 143.4 236.3 284.1 296.9 405.2 260.5 209.0 456.5 344.6 170.4 423.3 320.9 571.4 170.9 579.5 233.4 275.2 494.7 339.0 793.5 350.2 601.5 301.8 380.6 606.7 292.7 545.9 199.1 496.7 308.9 204.3 215.0 417.5 392.0 241.8 381.7 498.8 856.1 262.8 399.4 201.5 620.2 590.4 321.6 305.0 310.3 447.8 219.7 474.7 345.1 170.7 365.8 237.7 323.3 452.3 161.3 386.2 212.6 464.2 264.0 203.9 310.0 467.0 717.6 238.5 531.7 638.4 293.8 571.8 329.1 92.0 73.8 93.6 84.3 99.1 110.1 95.8 92.6 91.7 90.4 74.2 94.4 92.4 34.4 101.1 131.5 55.4 105.0 114.2 118.8 119.1 119.5 153.1 125.2 122.4 123.2 120.1 111.3 123.3 128.0 121.9 143.4 122.4 51.3 38.8 12.4 95.4 171.7 304.4 153.2 75.7 39.1 95.2 75.2 68.2 81.5 108.6 27.6 29.2 161.7 80.7 93.8 115.4 191.9 427.4 113.4 140.1 106.4 104.4 119.5 22.8 134.6 288.7 98.6 64.2 122.2 104.6 109.8 51.0 43.8 118.7 30.3 24.3 84.6 120.1 65.7 134.4 586.4 86.0 91.5 108.5 22.5 99.9 73.3 77.2 18.1 25.3 151.1 75.7 92.2 93.0 235.2 84.0 152.3 127.1 53.1 72.3 111.9 247.2 307.3 237.1 93.4 148.0 240.4 116.6 100.6 133.8 249.3 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325071-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.6" "Group enriched" "Detected in some" 184 "Early spermatids: 389.3;Late spermatids: 274.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.9" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 1.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 389.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 274.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130866250-130916479 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favorable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 15.9 18.7 19.5 12.5 22.9 8.8 14.9 18.5 16.4 15.2 16.6 19.7 11.9 18.2 19.3 14.8 16.4 15.0 19.4 15.6 19.3 13.9 19.4 14.8 11.1 28.0 22.7 13.5 14.1 19.6 16.2 17.3 12.7 22.5 16.8 14.2 15.6 19.6 14.5 24.0 12.7 15.5 19.7 22.8 15.4 19.1 21.5 22.3 11.2 21.7 13.2 11.8 19.3 13.6 29.3 13.8 23.2 17.4 27.7 52.9 36.9 13.2 35.7 38.1 17.9 18.1 20.6 26.2 12.4 27.0 40.3 45.3 25.6 3.2 25.1 20.8 20.9 13.7 24.3 18.3 0.1 30.9 0.0 19.1 42.1 24.4 20.0 17.9 35.3 20.9 17.9 23.5 0.1 35.3 10.9 18.6 10.6 4.9 30.0 19.3 16.1 17.2 8.0 11.9 27.8 19.6 16.4 16.7 22.4 11.1 13.4 46.6 13.0 34.4 26.7 20.9 21.8 21.3 4.5 0.0 0.1 9.7 13.5 28.9 6.5 3.6 2.5 2.1 3.2 3.0 2.8 1.9 2.5 2.9 1.8 2.3 2.0 1.7 1.6 4.0 2.7 1.9 3.5 19.5 22.9 18.5 16.4 15.6 19.3 28.0 22.7 13.5 22.5 22.8 22.3 29.3 12.6 25.6 7.9 44.4 14.8 4.0 7.2 7.8 8.6 25.6 11.6 9.1 20.4 15.7 12.9 23.9 10.4 10.3 10.0 19.4 9.8 11.5 35.8 10.8 14.3 12.2 11.4 7.4 30.0 16.0 5.7 11.4 15.8 11.0 18.4 13.5 13.9 21.3 10.1 16.8 34.9 12.5 6.1 11.7 5.2 44.7 13.7 11.9 3.6 20.6 9.6 22.4 13.4 35.7 112.6 16.6 14.5 15.8 15.5 10.2 14.4 8.6 16.9 37.9 13.1 12.7 9.8 37.1 15.5 9.8 4.3 14.0 9.2 13.1 10.3 10.8 KCNJ5 "CIR, GIRK4, KATP1, Kir3.4, LQT13" ENSG00000120457 "Potassium inwardly rectifying channel subfamily J member 5" P48544 11 128891356-128921163 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cancer-related genes, Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 64.9;pancreas: 20.6" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "HBEC3-KT: 13.3" "Group enriched" "Detected in many" 6 "basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6" "Low region specificity" "Detected in all" "HPA014722, HPA017353, CAB022569" Approved NA NA "CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135" "unprognostic (2.01e-1)" "unprognostic (2.43e-3)" "unprognostic (2.56e-3)" "unprognostic (5.81e-2)" "unprognostic (4.24e-2)" "unprognostic (3.60e-2)" "unprognostic (2.90e-1)" "unprognostic (3.54e-2)" "unprognostic (6.83e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.81e-2)" "unprognostic (6.82e-2)" "unprognostic (9.49e-2)" "unprognostic (1.88e-2)" "unprognostic (2.23e-2)" 1.5 64.9 1.1 0.6 1.6 0.4 0.9 0.5 3.1 1.3 0.5 0.6 0.8 0.3 0.9 1.0 0.9 2.2 8.6 0.6 2.8 2.9 0.5 6.0 1.6 2.9 1.6 0.6 1.0 20.6 1.3 12.0 7.3 4.0 1.3 0.7 1.0 0.9 9.7 0.4 0.4 0.5 0.6 1.6 13.7 2.3 1.1 5.1 5.8 0.5 0.4 0.5 1.5 0.4 2.9 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.3 13.3 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 1.1 1.6 0.5 3.1 0.6 2.8 2.9 1.6 0.6 4.0 1.6 5.1 2.9 0.2 0.0 10.0 0.3 0.2 1.5 2.2 4.7 0.0 2.7 0.2 1.4 7.6 0.0 0.3 1.8 0.0 0.8 0.1 0.0 0.0 0.1 2.3 0.2 0.2 0.6 0.0 0.0 0.2 3.9 0.7 1.1 0.0 0.3 0.0 0.2 0.4 0.1 48.3 1.7 3.1 0.0 0.0 2.2 2.9 7.8 0.9 10.9 3.6 3.7 1.2 0.3 3.1 0.5 0.1 0.8 0.0 0.7 0.3 0.6 0.0 0.1 0.3 1.4 0.0 0.9 0.2 0.9 0.5 0.5 1.7 1.2 0.6 2.3 0.0 0.6 MSANTD2 "C11orf61, FLJ23342" ENSG00000120458 "Myb/SANT DNA binding domain containing 2" Q6P1R3 11 124766498-124800706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 33.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038694, HPA038695" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038694: AB_2676155, HPA038695: AB_10674693" "unprognostic (2.20e-1)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (6.19e-2)" "unprognostic (7.77e-4)" "unprognostic (4.77e-3)" "unprognostic (3.32e-2)" "unprognostic (3.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.67e-2)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.65e-4)" 9.6 6.3 8.9 3.9 9.5 0.7 10.0 9.1 10.9 15.3 9.1 9.8 4.0 11.6 7.6 7.6 12.9 2.8 6.9 8.1 9.0 12.6 8.4 9.4 4.5 9.4 9.3 7.8 14.2 14.3 3.2 15.4 5.1 9.7 13.7 3.8 6.0 9.4 4.1 4.7 8.4 10.2 2.9 8.9 13.8 10.6 4.8 9.2 3.4 25.6 1.9 3.9 9.4 11.5 11.8 3.0 0.9 10.5 9.9 5.2 6.7 6.1 6.4 3.6 2.3 3.0 4.3 6.2 3.5 5.9 3.3 3.4 5.5 4.5 2.1 3.6 5.8 4.0 3.3 3.9 4.5 2.6 1.9 2.7 3.4 3.8 4.0 3.3 9.1 5.3 3.0 3.9 4.7 5.8 2.6 1.4 9.4 8.0 5.5 14.4 4.2 2.6 3.3 4.4 2.6 3.3 13.0 2.9 3.7 1.9 7.7 8.6 2.1 6.8 15.4 4.3 4.5 6.4 3.0 2.2 2.1 3.2 3.4 8.0 0.0 0.2 0.6 0.6 0.4 0.3 0.3 0.5 0.9 0.3 0.8 0.5 0.4 0.0 0.2 0.5 0.2 1.1 0.2 8.9 9.5 9.1 10.9 8.1 9.0 9.4 9.3 7.8 9.7 8.9 9.2 11.8 10.9 3.2 10.3 28.7 7.7 8.8 4.4 2.5 9.6 8.7 6.7 6.7 3.3 5.7 1.8 7.3 2.1 2.9 7.7 3.4 3.9 4.6 5.2 3.2 11.1 9.4 1.2 1.3 33.5 1.0 4.4 10.1 6.6 5.6 1.3 9.0 10.4 3.0 3.0 13.5 30.6 3.1 4.1 3.8 7.3 1.5 9.6 4.1 1.8 31.9 4.4 5.6 8.2 33.7 48.4 4.6 4.0 7.2 4.3 5.0 2.2 3.6 2.9 6.2 13.1 11.3 14.0 2.4 1.6 4.4 4.1 1.9 5.8 7.3 5.0 3.2 TP53AIP1 p53AIP1 ENSG00000120471 "Tumor protein p53 regulated apoptosis inducing protein 1" Q9HCN2 11 128934731-128943399 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "esophagus: 24.7;lymphoid tissue: 29.8;skin 1: 20.6;vagina: 13.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 45.5;Basal respiratory cells: 42.4;Basal squamous epithelial cells: 179.2;Endometrial ciliated cells: 38.7;Respiratory ciliated cells: 27.3;Squamous epithelial cells: 72.1;Suprabasal keratinocytes: 32.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044300, HPA048797" Uncertain NA NA "HPA044300: AB_2678888, HPA048797: AB_2680524" "unprognostic (4.12e-7)" "unprognostic (3.00e-2)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-2)" "unprognostic (1.18e-1)" "unprognostic (4.66e-2)" "unprognostic (1.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.94e-1)" "unprognostic (6.57e-6)" "unprognostic (1.10e-2)" "unprognostic (3.71e-1)" "unprognostic (7.75e-2)" "unprognostic (1.78e-2)" 0.0 0.6 1.0 0.0 1.0 0.0 1.3 1.1 1.3 2.9 0.6 0.1 0.0 0.1 2.5 24.7 2.7 0.0 0.0 0.9 0.7 0.5 0.1 0.2 0.0 1.1 1.1 0.9 0.0 0.2 0.0 1.9 0.0 1.1 2.0 0.0 0.5 3.9 0.8 0.1 20.6 0.1 0.0 0.7 0.0 0.0 1.6 0.9 29.8 0.0 0.0 1.1 0.0 13.7 0.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 1.0 1.1 1.3 0.9 0.7 1.1 1.1 0.9 1.1 0.7 0.9 0.8 0.2 0.0 0.5 1.0 0.0 45.5 11.4 42.4 179.2 0.7 1.5 23.9 0.3 0.0 5.3 0.0 0.0 0.1 0.0 0.3 7.9 0.0 0.9 38.7 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 1.8 1.1 0.0 0.4 1.8 1.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.2 27.3 0.4 0.0 0.6 1.6 0.2 0.3 72.1 32.7 0.3 0.3 0.0 0.3 2.6 TEX11 "MZIP4, Spo22, TGC1, TSGA3, ZIP4" ENSG00000120498 "Testis expressed 11" Q8IYF3 X 70528940-70908711 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 59.3" "Cell type enhanced" "Detected in some" "Distal enterocytes: 20.1;Early spermatids: 14.7;Exocrine glandular cells: 9.7;Late spermatids: 28.0;Paneth cells: 12.5;Spermatocytes: 46.5;Spermatogonia: 30.0" "Cancer enhanced" "Detected in some" "renal cancer: 1.3;testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA002950 Approved NA NA "HPA002950: AB_1080249" "unprognostic (6.78e-3)" "unprognostic (3.57e-3)" "unprognostic (2.87e-3)" "unprognostic (7.77e-2)" "unprognostic (7.75e-3)" "unprognostic (2.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (1.74e-1)" "unprognostic (8.30e-2)" "unprognostic (5.74e-3)" "unprognostic (2.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-1)" "unprognostic (3.48e-1)" "unprognostic (1.56e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.2 1.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 59.3 0.0 0.0 0.2 0.0 0.1 1.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.5 11.7 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 14.7 0.1 0.0 0.2 1.2 0.0 2.6 9.7 0.0 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.8 0.0 0.0 0.3 28.0 0.6 0.1 0.0 0.0 0.6 0.0 0.0 2.0 1.9 0.5 12.5 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 46.5 30.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 ARR3 ARRX ENSG00000120500 "Arrestin 3" P36575 X 70268305-70281840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 170 "retina: 395.6" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 1538.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA063129 Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA063129: AB_2732696" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-2)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.02e-3)" "unprognostic (2.77e-7)" "unprognostic (8.64e-2)" "unprognostic (6.53e-2)" "unprognostic (6.06e-2)" "unprognostic (1.43e-1)" 0.2 0.3 0.2 0.5 0.3 0.5 0.0 0.0 0.2 0.0 0.5 0.3 0.6 0.4 0.0 0.2 0.1 0.4 0.4 0.1 0.3 0.1 0.0 0.2 0.9 0.3 0.2 0.0 0.3 0.4 0.0 0.0 0.3 0.4 0.3 0.2 395.6 0.3 0.0 0.3 2.3 0.9 0.0 0.2 0.5 0.4 0.2 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.2 1.2 0.8 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.5 1.2 0.1 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.1 2.2 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.4 0.2 0.0 0.0 0.5 0.1 0.3 0.2 0.0 0.0 0.7 0.0 0.1 0.9 0.5 0.7 0.5 0.0 0.5 0.3 0.3 0.5 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.3 0.3 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.3 0.0 0.0 0.0 1538.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.2 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 172.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDZD11 PDZK11 ENSG00000120509 "PDZ domain containing 11" Q5EBL8 X 70286595-70290514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003972 Approved "Intracellular and membrane" NA NA "HPA003972: AB_1855165" "unprognostic (1.51e-2)" "unprognostic (1.70e-3)" "unprognostic (2.75e-1)" "unprognostic (3.52e-1)" "unprognostic (9.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.89e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (5.44e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-2)" "unprognostic (2.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.28e-2)" "unprognostic (3.72e-3)" 27.9 35.9 66.6 19.6 66.7 11.1 33.8 67.3 86.6 30.7 66.4 39.8 33.7 26.4 43.6 41.7 31.4 28.0 51.7 65.7 69.0 44.6 35.7 21.5 27.9 67.7 68.8 64.2 26.6 23.0 53.6 29.7 22.4 70.4 31.4 45.2 52.2 30.6 32.9 24.3 33.0 32.0 35.5 66.8 23.2 28.1 11.0 70.1 36.6 38.2 41.1 36.1 37.8 29.1 69.4 75.5 83.7 56.1 63.0 90.6 107.3 47.8 79.4 88.0 115.4 107.0 80.6 92.9 40.2 95.7 140.4 130.0 55.7 92.4 107.2 130.4 56.5 75.6 26.4 79.2 62.1 80.9 36.4 34.8 110.8 73.4 128.0 78.6 108.7 95.0 49.7 42.5 140.9 187.8 113.0 58.9 49.2 44.4 167.6 148.1 41.4 113.3 79.6 99.7 67.4 60.5 61.0 87.7 67.3 86.1 66.5 62.2 31.8 75.5 82.9 70.5 128.2 79.0 30.8 58.8 42.1 120.0 52.1 99.0 17.9 25.6 18.2 40.1 47.6 44.9 37.1 41.3 45.5 38.5 37.0 25.2 36.5 10.6 36.5 62.1 28.9 77.4 34.8 66.6 66.7 67.3 86.6 65.7 69.0 67.7 68.8 64.2 70.4 66.8 70.1 69.4 26.6 12.8 11.8 4.6 12.3 24.6 28.8 76.2 22.8 26.0 30.4 42.7 45.0 24.3 36.6 33.1 4.2 42.0 16.7 39.0 117.4 46.1 0.6 25.1 32.4 25.4 18.5 20.2 3.2 41.1 61.0 35.0 16.8 25.7 26.6 29.8 20.0 20.5 62.6 32.0 3.6 48.2 48.8 27.5 18.8 1.0 30.4 22.1 30.2 4.7 27.9 71.3 16.5 3.5 2.5 55.9 52.3 38.0 23.2 18.6 66.7 92.0 27.7 21.7 39.5 19.9 40.4 7.7 19.8 44.9 28.1 26.8 22.1 52.5 43.9 33.8 SLC10A7 "C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043" ENSG00000120519 "Solute carrier family 10 member 7" Q0GE19 4 146253975-146521964 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Microglial cells: 50.6;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039996 Uncertain NA NA "HPA039996: AB_10673266" "unprognostic (9.44e-2)" "unprognostic (4.03e-1)" "unprognostic (3.39e-3)" "unprognostic (5.07e-2)" "unprognostic (1.01e-1)" "unprognostic (9.02e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (3.55e-1)" "unprognostic (8.53e-2)" "unprognostic (2.68e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-2)" "unprognostic (8.99e-2)" "unprognostic (2.79e-1)" "unprognostic (6.69e-2)" "unprognostic (9.57e-2)" 5.5 4.6 2.6 5.0 3.8 6.0 6.1 3.2 2.8 7.3 2.2 7.0 4.6 4.9 12.1 5.8 4.4 5.7 2.7 2.9 5.1 3.8 7.3 5.9 5.6 4.3 3.7 1.9 5.6 6.6 3.8 3.7 8.9 4.8 6.3 9.3 3.9 6.9 3.3 2.3 3.7 5.5 5.9 3.8 5.4 9.8 3.4 3.4 6.6 7.0 3.2 6.0 4.8 4.9 5.0 5.2 1.7 12.2 5.0 8.6 10.3 5.8 6.3 8.2 5.7 5.8 4.7 21.6 9.6 4.4 6.9 3.6 5.2 7.2 8.6 6.8 11.1 3.5 11.8 4.2 8.5 5.5 20.5 18.3 4.9 6.8 6.9 8.7 3.1 10.2 10.2 13.2 25.6 4.3 3.6 15.6 5.2 2.2 11.4 8.6 8.6 8.9 13.7 4.0 3.8 3.7 3.1 4.3 12.8 5.3 6.4 7.5 8.1 5.8 5.1 5.4 7.8 4.4 20.7 24.9 13.4 7.0 8.2 7.4 10.9 3.0 4.5 3.7 4.8 3.8 3.9 3.7 3.3 4.0 2.8 3.5 3.4 0.3 5.1 3.9 2.7 4.9 2.2 2.6 3.8 3.2 2.8 2.9 5.1 4.3 3.7 1.9 4.8 3.8 3.4 5.0 10.8 3.2 3.9 44.4 7.9 3.3 4.2 2.0 2.8 6.8 5.2 3.7 2.1 8.6 3.2 1.8 4.2 6.4 8.2 6.2 1.9 4.0 2.3 4.8 6.2 5.4 4.8 9.9 34.3 5.1 13.2 6.1 11.2 6.0 22.9 5.8 8.9 10.3 5.8 8.4 37.1 14.7 2.0 7.3 3.1 1.2 7.5 6.1 0.0 50.6 4.9 3.4 6.2 62.4 82.0 3.6 3.4 4.9 15.8 3.3 4.2 1.9 7.3 11.8 0.0 4.0 5.5 7.0 4.5 5.2 4.8 6.2 8.6 2.3 7.6 4.1 NUDCD1 "CML66, FLJ14991" ENSG00000120526 "NudC domain containing 1" Q96RS6 8 109240919-109334121 "Predicted intracellular proteins" Immunity "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023183 Uncertain Supported Nucleoplasm,Cytosol NA NA 7300 Nucleoplasm Cytosol "HPA023183: AB_1854695" "unprognostic (5.08e-3)" "unprognostic (3.73e-2)" "unprognostic (2.52e-2)" "unprognostic (9.03e-3)" "unprognostic (7.52e-2)" "unprognostic (3.62e-3)" "prognostic unfavorable (1.39e-5)" "prognostic unfavorable (4.37e-5)" "unprognostic (2.13e-1)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (8.22e-2)" "prognostic unfavorable (8.71e-6)" "unprognostic (1.95e-1)" "unprognostic (1.63e-1)" "unprognostic (3.35e-1)" "unprognostic (1.65e-1)" 10.5 5.0 3.6 6.1 3.9 1.3 9.6 4.0 4.3 7.8 3.5 5.5 2.8 7.3 5.3 5.7 7.0 4.8 6.3 3.7 4.1 7.8 6.5 7.1 9.4 4.1 3.9 3.6 6.3 7.0 5.9 4.2 15.2 3.8 5.9 6.8 4.7 6.1 6.9 6.2 4.3 5.2 7.9 4.1 7.4 5.8 13.1 3.7 10.2 9.0 9.4 8.6 11.5 6.9 4.1 28.9 16.7 24.7 13.7 13.1 18.0 13.1 20.6 24.8 57.8 54.4 17.6 21.8 18.5 13.1 22.5 16.3 17.1 36.3 34.3 79.8 23.6 12.6 28.8 9.9 19.6 27.2 13.7 10.6 12.7 18.4 28.1 40.3 18.3 53.0 22.7 32.2 9.5 49.5 23.3 33.3 15.1 17.3 59.7 22.7 21.4 20.4 18.3 35.6 14.8 20.5 18.1 9.4 26.1 21.6 25.6 19.2 9.9 14.2 28.2 17.2 12.1 17.6 6.9 9.4 22.3 10.4 22.2 24.1 0.0 0.4 0.5 0.8 1.3 1.4 1.2 1.0 1.6 1.4 1.1 1.1 1.6 0.0 1.7 1.7 0.9 1.5 0.7 3.6 3.9 4.0 4.3 3.7 4.1 4.1 3.9 3.6 3.8 4.1 3.7 4.1 25.4 3.2 10.0 6.2 11.3 17.7 24.4 19.4 10.2 5.0 7.4 6.3 11.3 2.8 23.2 3.7 6.2 23.4 9.7 2.5 7.9 17.1 122.3 11.2 19.2 26.5 9.0 14.5 22.9 11.0 21.2 16.2 5.6 10.2 17.7 11.8 8.9 6.2 9.8 5.0 23.5 5.7 14.2 4.7 11.5 22.5 13.1 8.7 7.2 13.1 16.9 4.4 5.2 15.1 15.3 14.1 4.7 6.8 12.1 29.6 3.4 13.0 15.4 9.0 0.0 13.7 15.8 53.3 36.4 8.9 16.8 8.2 9.5 12.5 9.9 22.7 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2 transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345954 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavorable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 54.6 56.0 30.1 45.1 31.4 88.3 57.6 30.8 45.7 44.6 34.0 60.0 55.0 38.2 54.2 48.6 36.4 30.1 59.6 31.0 33.2 75.1 102.1 40.7 50.0 32.5 32.3 29.7 29.7 45.3 47.6 34.7 41.7 31.5 39.4 55.6 24.7 44.0 36.4 72.3 33.6 48.3 44.5 31.7 48.0 48.3 35.1 31.2 60.9 38.3 69.1 54.2 48.8 39.3 33.0 180.3 145.9 213.6 97.1 79.5 101.0 61.4 140.0 89.9 141.2 177.2 109.0 109.1 115.3 127.9 110.9 63.6 89.7 96.8 99.5 171.7 184.1 113.9 223.5 106.7 227.4 85.4 78.3 133.5 77.5 66.7 92.5 87.3 102.2 215.1 111.5 216.5 63.7 162.7 289.9 235.9 175.5 156.1 207.1 140.3 148.4 93.2 144.5 192.5 134.7 128.9 137.5 87.7 109.3 127.2 117.0 138.6 132.3 146.9 94.1 158.9 97.8 144.7 107.9 125.6 222.2 95.2 128.3 112.7 65.6 102.5 93.5 28.9 112.8 36.7 41.4 39.0 35.6 93.8 27.3 31.9 35.8 56.8 42.4 121.8 80.3 42.3 74.5 30.1 31.4 30.8 45.7 31.0 33.2 32.5 32.3 29.7 31.5 31.7 31.2 33.0 231.3 70.5 93.8 16.3 135.0 185.6 196.3 305.7 159.9 63.8 149.2 192.7 170.6 138.7 184.6 145.3 123.0 263.3 157.0 171.5 381.5 214.3 173.3 146.4 134.7 226.3 154.2 160.1 22.7 200.0 284.5 161.0 88.7 144.8 91.8 99.3 142.5 371.1 276.8 45.4 23.9 245.1 225.9 230.3 265.7 111.0 148.2 205.0 158.3 17.8 260.9 112.4 126.7 19.6 27.6 251.2 237.1 112.5 147.2 230.3 264.5 546.1 125.0 139.9 78.9 163.9 262.9 208.7 130.4 151.0 174.6 167.3 132.4 143.9 209.1 208.0 MASTL "FLJ14813, Gwl, THC2" ENSG00000120539 "Microtubule associated serine/threonine kinase like" Q96GX5 10 27154824-27187953 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027175, HPA054273" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA027175: AB_1853591, HPA054273: AB_2682433" "unprognostic (4.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.22e-2)" "unprognostic (3.14e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (2.19e-2)" "unprognostic (4.00e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.81e-5)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (1.55e-3)" "unprognostic (2.27e-1)" "unprognostic (2.66e-1)" "unprognostic (1.79e-1)" 4.8 4.0 1.9 6.3 2.0 18.9 5.4 2.4 2.3 3.3 2.3 4.2 4.5 3.9 4.5 6.0 3.0 3.9 2.4 2.0 2.1 4.0 4.9 4.0 9.0 2.2 2.1 1.8 3.5 3.3 6.0 3.1 6.6 2.4 3.1 5.2 2.7 4.2 3.1 2.3 6.1 4.3 4.5 1.7 4.6 4.7 6.5 2.1 10.5 4.8 2.2 7.2 4.5 4.3 2.6 29.4 22.0 43.8 15.5 6.2 9.1 25.4 43.3 18.0 68.4 83.8 26.7 27.2 22.4 16.1 18.4 33.5 26.8 27.9 16.0 48.2 20.2 26.5 26.9 14.5 15.5 3.8 10.4 19.8 5.6 7.5 41.6 7.9 9.0 14.7 18.2 21.1 49.9 41.5 17.9 34.8 11.2 32.0 15.9 8.9 22.2 71.9 18.9 17.4 10.6 19.2 26.8 26.0 17.6 19.1 28.1 17.2 21.4 12.6 17.0 36.3 44.0 37.4 5.9 10.3 34.7 18.3 31.1 14.8 0.2 1.8 1.7 0.7 1.7 1.1 1.1 0.9 0.7 1.0 1.6 0.9 0.8 2.3 1.0 1.8 1.1 1.6 0.8 1.9 2.0 2.4 2.3 2.0 2.1 2.2 2.1 1.8 2.4 1.7 2.1 2.6 4.3 6.4 7.8 2.6 7.4 11.0 4.9 4.4 4.0 1.7 4.2 4.8 3.0 2.8 7.0 1.8 0.0 8.6 10.1 7.0 0.0 4.0 3.0 9.7 5.3 4.6 4.2 7.8 4.3 2.5 24.9 7.3 6.1 17.9 12.7 6.9 2.5 2.5 5.8 3.3 4.3 3.7 4.1 7.8 19.3 1.7 3.1 11.3 0.0 3.7 5.1 1.8 3.1 3.5 4.9 4.4 2.9 2.6 7.1 5.0 2.8 1.9 4.0 1.0 0.0 3.8 5.3 14.9 14.1 10.9 9.9 6.2 11.6 5.4 4.5 6.6 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 82.6;Karpas-707: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 28.7 16.6 7.2 3.5 12.6 0.2 30.7 3.1 9.3 15.8 34.6 13.2 13.1 6.0 13.4 31.1 17.1 14.8 14.1 28.7 4.3 18.1 17.7 14.6 2.7 6.3 11.7 5.9 13.2 13.7 43.1 6.6 21.1 7.5 20.6 14.9 24.0 39.5 22.7 109.3 17.7 11.4 3.4 0.5 7.6 17.6 15.8 3.6 12.7 33.9 53.1 9.4 12.2 19.3 17.0 19.5 9.7 3.8 0.1 2.4 6.8 82.6 3.7 6.0 8.6 18.2 16.6 30.3 1.0 18.6 7.6 17.6 31.5 4.7 36.2 9.5 7.2 3.4 0.4 23.1 19.4 4.2 0.0 0.3 25.3 22.8 19.0 5.2 3.9 0.0 1.7 0.0 75.7 4.4 6.8 10.8 0.6 8.5 18.9 8.7 0.8 22.0 16.2 20.1 25.3 2.4 1.3 9.4 31.4 0.0 38.3 15.2 0.0 20.3 13.1 14.1 52.9 4.9 33.4 30.4 0.1 43.4 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 12.6 3.1 9.3 28.7 4.3 6.3 11.7 5.9 7.5 0.5 3.6 17.0 149.7 38.5 34.4 27.4 1.0 121.3 74.1 58.0 145.1 13.6 38.8 39.0 39.1 24.3 73.7 33.1 8.4 50.2 0.4 52.5 3.9 32.3 33.7 64.5 19.6 34.4 23.9 0.0 609.1 26.2 21.2 23.3 50.0 85.9 1.3 6.6 25.0 24.8 5.3 0.0 1251.8 22.8 26.4 14.6 7.8 11.3 17.7 1.3 1.8 30.0 0.0 93.6 0.0 255.9 10.3 24.1 22.7 33.1 3.1 36.8 15.4 6.3 36.9 3.1 13.1 19.6 20.4 0.8 1.1 96.4 51.0 65.1 2.2 14.2 19.4 43.7 LYZL1 "LYC2, MGC33408" ENSG00000120563 "Lysozyme like 1" Q6UWQ5 10 29289061-29318328 "Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 429 "testis: 51.5" "Group enriched" "Detected in some" 37 "Early spermatids: 600.3;Late spermatids: 201.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.88e-1)" "unprognostic (8.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 600.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 201.8 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 10.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLXDC2 "FLJ14623, TEM7R" ENSG00000120594 "Plexin domain containing 2" Q6UX71 10 19816239-20289856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Microglial cells: 1508.4;Oligodendrocytes: 470.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3" "Group enriched" "Detected in many" 13 "dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5" "Cell line enhanced" "Detected in some" "HHSteC: 19.4;U-2197: 45.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017268, HPA070793" Approved Supported "Nuclear bodies" No No 720000000 "Nuclear bodies" "HPA017268: AB_10965928, HPA070793: AB_2686313" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (3.05e-1)" "unprognostic (3.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.94e-2)" "unprognostic (1.57e-1)" "unprognostic (5.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (5.44e-2)" "unprognostic (3.91e-3)" "unprognostic (8.71e-2)" "unprognostic (3.35e-1)" "unprognostic (2.66e-2)" 12.5 9.5 11.2 7.4 11.9 5.3 11.7 9.6 14.8 10.6 18.3 5.3 4.2 10.8 3.5 7.6 10.2 17.6 10.3 9.3 21.8 10.8 3.1 17.3 2.4 14.7 13.8 7.5 9.5 3.6 16.3 3.3 4.7 16.5 7.6 4.6 18.4 6.2 7.8 5.0 15.5 7.2 16.4 20.6 9.4 3.8 6.0 17.2 2.5 6.9 10.1 2.8 8.6 9.0 20.2 0.0 0.0 5.8 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 7.7 2.2 1.8 0.0 0.0 0.7 2.8 8.6 0.4 19.4 0.0 0.0 7.7 0.6 0.0 2.3 8.9 0.0 0.0 0.1 1.7 0.9 1.1 0.6 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.2 2.4 0.4 0.0 1.8 0.8 0.9 0.0 7.6 3.9 45.9 0.0 0.1 0.0 0.0 3.5 0.1 0.0 10.7 57.5 11.8 1.3 33.4 2.7 0.0 0.0 0.3 36.0 0.0 0.0 0.0 81.6 4.4 37.3 1.6 0.0 17.7 11.2 11.9 9.6 14.8 9.3 21.8 14.7 13.8 7.5 16.5 20.6 17.2 20.2 101.4 16.0 8.9 131.9 2.6 36.8 23.8 12.3 41.5 44.2 14.4 45.3 10.9 15.7 10.9 5.5 8.4 0.9 2.9 7.1 0.0 6.9 2.9 16.5 7.6 45.3 3.0 10.5 190.9 0.0 8.1 97.2 1.1 19.4 31.6 80.9 82.1 4.2 94.3 1.7 59.9 27.3 8.2 91.3 46.3 2.1 19.3 147.7 7.2 1508.4 94.5 25.5 5.2 158.3 470.2 1.0 16.6 57.2 3.8 5.5 16.0 22.2 3.0 73.6 19.7 110.1 12.7 1.6 1.2 35.5 38.1 1.2 4.2 71.4 8.8 11.7 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 151.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028931 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA028931: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 13.4 9.7 12.8 14.0 14.2 151.0 19.6 21.9 14.6 17.5 12.6 14.1 11.6 20.8 16.0 11.3 15.0 12.9 12.0 12.9 13.5 12.0 13.9 14.8 21.7 13.1 13.6 12.5 23.6 14.5 14.7 10.4 11.8 14.9 15.1 16.2 19.4 15.1 10.4 22.9 13.6 13.1 16.9 12.9 18.8 14.1 14.5 13.2 32.2 16.9 23.7 17.8 15.3 14.2 16.6 12.0 9.6 21.4 17.9 10.6 14.1 12.4 12.2 6.9 15.6 12.8 10.7 15.1 21.8 8.0 13.6 8.2 12.1 12.1 10.4 10.8 15.9 19.4 18.0 13.5 19.2 11.4 14.1 24.7 12.9 15.8 9.3 7.3 13.9 12.8 18.3 18.8 27.7 12.6 12.9 21.5 10.1 5.3 11.4 8.4 27.7 18.3 11.2 12.1 10.9 18.7 17.8 11.4 8.3 20.1 11.8 8.6 18.7 11.6 9.3 22.7 7.8 10.6 11.3 12.2 35.6 10.0 21.1 8.4 65.8 15.3 36.3 18.9 10.2 16.0 27.4 16.9 15.0 9.1 30.9 17.5 16.1 46.8 13.4 13.2 27.4 21.1 7.7 12.8 14.2 21.9 14.6 12.9 13.5 13.1 13.6 12.5 14.9 12.9 13.2 16.6 103.8 41.7 50.9 133.2 166.8 28.6 85.0 54.0 78.6 101.4 69.6 84.3 32.4 52.9 49.2 40.5 68.8 34.9 182.6 55.5 9.8 51.5 11.8 54.1 86.7 70.1 98.6 74.9 108.0 43.6 40.7 71.8 58.1 65.8 85.4 74.9 58.5 35.8 35.2 114.4 106.7 63.9 50.8 55.7 46.8 13.1 94.8 84.4 40.9 134.0 75.4 57.3 148.3 161.9 131.8 49.9 52.3 68.1 139.4 71.6 50.4 20.5 44.1 85.8 98.6 134.9 82.5 77.8 58.3 62.9 24.9 46.1 175.3 56.5 51.0 72.4 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain ArfGEF 3" Q9UPP2 12 66767-178455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 39.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.8;Excitatory neurons: 81.6;Horizontal cells: 114.4;Inhibitory neurons: 76.2;Spermatocytes: 48.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 7.1;U-266/70: 9.1;U-266/84: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039025 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 4.1 0.9 4.2 0.5 7.7 0.7 1.4 17.2 39.5 2.1 0.0 0.5 0.4 2.5 0.3 0.3 3.3 1.5 1.3 10.7 4.7 2.0 0.2 2.0 0.4 4.9 2.9 5.5 1.6 0.8 0.0 8.7 0.9 9.5 1.2 0.2 7.5 0.3 2.9 1.0 0.2 0.5 1.2 1.4 0.4 0.5 1.4 8.0 3.2 0.4 0.4 0.1 1.0 1.6 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 2.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.2 7.7 17.2 39.5 10.7 4.7 4.9 2.9 5.5 9.5 1.4 8.0 16.0 9.9 3.2 0.0 1.6 0.0 0.3 0.0 0.0 0.6 50.8 0.1 0.1 2.2 0.0 0.0 0.0 8.4 0.0 2.1 0.1 0.0 0.0 0.8 0.1 0.9 3.3 0.0 0.0 81.6 0.0 0.0 1.3 0.0 0.2 2.5 0.1 2.2 0.4 1.6 114.4 76.2 0.0 0.0 0.8 0.6 4.3 0.6 1.4 0.0 7.5 0.1 6.6 1.0 4.5 1.4 0.2 0.0 0.0 0.0 0.1 0.7 5.2 0.0 16.1 0.0 0.5 1.1 48.6 21.8 0.1 0.1 0.0 0.5 0.1 0.2 0.1 CCDC77 MGC13183 ENSG00000120647 "Coiled-coil domain containing 77" Q9BR77 12 389273-442642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 24.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038854 Approved Approved "Nuclear membrane" NA Yes "Nuclear membrane" "HPA038854: AB_10673121" "unprognostic (3.25e-1)" "unprognostic (2.32e-1)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (7.26e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (8.11e-7)" "unprognostic (2.54e-2)" "unprognostic (3.41e-3)" "unprognostic (2.89e-1)" "unprognostic (3.82e-1)" "unprognostic (2.62e-1)" "unprognostic (4.11e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-1)" "unprognostic (3.19e-2)" "unprognostic (4.41e-3)" 3.3 5.1 3.4 6.3 5.1 4.7 4.6 3.4 4.9 3.6 2.3 4.2 4.6 5.0 2.2 4.2 3.8 3.2 3.1 3.9 3.9 3.8 3.5 4.0 6.9 4.7 4.4 3.3 5.2 2.5 2.3 2.5 3.6 5.0 3.6 4.8 3.5 3.0 2.6 4.8 5.3 3.6 3.4 3.6 4.8 3.3 12.6 4.1 9.8 4.0 3.2 6.3 3.2 3.7 8.1 10.0 13.2 28.7 18.9 9.5 8.1 29.4 24.7 11.6 23.3 37.4 13.4 17.1 23.8 5.9 9.8 13.6 13.6 20.5 7.2 25.0 52.0 20.1 26.9 26.5 17.8 5.5 22.2 12.9 6.5 4.3 21.9 13.5 14.0 15.6 22.7 22.4 24.2 23.9 6.0 21.6 15.7 57.0 13.8 9.9 24.4 51.8 14.7 8.7 7.3 8.2 21.1 24.5 9.4 12.9 42.4 7.4 16.7 14.8 11.6 22.5 20.6 29.0 6.8 13.9 29.8 15.7 22.0 20.3 2.5 4.5 3.9 4.7 6.4 4.9 5.9 4.3 5.2 4.8 8.1 3.0 4.5 3.4 6.2 8.1 5.2 3.3 3.1 3.4 5.1 3.4 4.9 3.9 3.9 4.7 4.4 3.3 5.0 3.6 4.1 8.1 4.6 0.0 6.2 2.6 9.4 4.1 3.6 3.5 3.4 3.1 4.1 4.4 3.7 2.8 4.4 3.7 6.2 6.8 8.6 2.9 7.9 3.2 24.2 5.6 5.5 4.4 2.4 5.0 8.1 2.0 8.0 4.7 6.6 4.5 7.0 8.1 3.6 2.3 5.5 1.7 7.9 4.5 8.2 6.6 2.9 15.3 4.1 5.5 1.8 3.7 6.0 6.5 8.2 8.0 13.7 2.0 5.9 4.5 7.0 2.6 2.0 3.4 5.4 5.5 6.6 7.4 4.3 22.3 18.0 6.7 3.8 5.6 6.6 4.4 4.1 2.2 TAF12 "TAF2J, TAFII20" ENSG00000120656 "TATA-box binding protein associated factor 12" Q16514 1 28589323-28643085 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 244.4;Spermatogonia: 196.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008519 Approved NA NA "HPA008519: AB_1080181" "unprognostic (4.81e-3)" "unprognostic (3.00e-1)" "unprognostic (3.51e-2)" "unprognostic (5.24e-3)" "unprognostic (4.14e-2)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (2.15e-2)" "unprognostic (4.32e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.36e-7)" "unprognostic (4.02e-2)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-2)" 18.0 15.5 16.9 16.8 17.4 18.3 16.6 18.4 20.8 18.2 19.6 15.2 13.2 14.7 17.9 19.4 15.0 13.9 19.5 16.5 17.6 16.0 19.3 14.7 24.5 17.5 17.3 15.8 16.6 17.8 16.4 14.9 15.9 17.8 12.4 15.1 16.3 14.1 10.4 22.6 19.7 13.4 15.5 17.2 16.3 14.3 22.6 18.0 29.6 13.7 17.0 26.1 17.2 17.5 19.8 39.0 19.3 27.2 18.0 63.7 71.5 16.6 47.0 29.8 29.7 38.6 10.5 33.7 50.3 43.9 43.9 23.0 31.0 45.7 39.8 48.4 29.0 16.7 49.9 20.5 17.6 42.0 39.1 21.1 41.2 42.5 53.2 50.1 31.4 31.3 42.8 43.3 37.3 48.6 38.2 46.0 32.4 37.8 45.2 33.0 46.5 26.8 32.2 42.5 15.7 10.4 25.9 61.6 32.3 70.1 31.8 25.7 46.2 27.9 12.1 21.4 48.8 48.1 43.9 42.6 40.0 28.4 64.8 34.5 105.1 44.7 115.6 38.5 45.6 40.2 40.1 37.7 43.4 39.1 36.1 32.3 40.4 106.4 50.6 49.2 31.0 55.3 41.2 16.9 17.4 18.4 20.8 16.5 17.6 17.5 17.3 15.8 17.8 17.2 18.0 19.8 34.4 32.1 16.5 7.8 35.4 29.4 30.8 74.2 32.5 14.8 34.5 43.2 26.6 22.8 32.2 23.9 6.2 69.3 34.9 21.1 58.7 33.6 41.0 22.5 36.5 29.3 7.7 24.2 9.9 39.6 82.3 38.3 14.3 20.1 25.4 13.0 28.2 33.4 79.0 3.3 10.8 21.4 52.9 51.0 33.6 13.1 50.1 43.7 30.2 7.5 68.2 28.0 51.5 9.5 11.5 40.8 29.6 33.4 35.9 34.7 37.6 68.8 19.6 27.3 32.9 31.5 41.5 244.4 196.4 34.2 33.2 117.1 43.3 28.3 23.9 28.6 ENOX1 "cCNOX, CNOX, FLJ10094, PIG38" ENSG00000120658 "Ecto-NOX disulfide-thiol exchanger 1" Q8TC92 13 43213518-43786908 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3" "Cell type enhanced" "Detected in many" "Astrocytes: 173.3;Early spermatids: 190.8;Excitatory neurons: 452.3;Inhibitory neurons: 692.0;Late spermatids: 264.8;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 771.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.3;RH-30: 24.1;TIME: 17.8;U-2197: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038355 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA038355: AB_10673171" "unprognostic (9.64e-2)" "unprognostic (3.38e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-3)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (2.88e-1)" "unprognostic (6.72e-3)" "unprognostic (2.60e-1)" "unprognostic (2.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.93e-2)" "unprognostic (1.32e-3)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.08e-3)" "unprognostic (1.42e-2)" 3.4 1.0 8.0 2.5 10.8 0.3 1.8 4.3 9.4 2.9 0.6 6.2 0.6 5.1 0.9 1.0 2.7 1.6 4.7 7.9 7.8 3.5 0.4 0.9 2.2 10.0 7.9 8.8 6.4 1.3 0.7 1.9 4.5 10.5 3.0 1.5 2.0 0.4 3.7 8.2 0.5 1.4 4.3 6.6 0.7 2.3 9.1 9.0 2.8 0.4 0.8 1.4 3.2 2.2 14.3 0.2 0.3 3.4 0.0 3.4 13.2 0.7 1.6 3.8 5.7 5.4 2.4 0.4 0.0 0.2 5.1 0.6 0.1 0.7 0.4 2.5 4.2 5.6 0.7 4.0 0.1 2.1 0.1 0.9 12.7 1.2 17.3 8.7 0.9 0.4 2.8 0.0 0.8 3.5 0.3 5.9 0.2 3.8 0.1 1.5 0.0 24.1 0.0 3.0 0.7 11.8 4.5 2.1 3.5 0.9 2.6 0.7 0.1 17.8 1.9 0.6 17.9 1.9 0.0 0.1 0.1 8.3 0.0 12.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 10.8 4.3 9.4 7.9 7.8 10.0 7.9 8.8 10.5 6.6 9.0 14.3 1.5 3.2 0.0 173.3 0.0 0.6 1.3 0.0 2.2 4.3 1.2 0.6 3.0 0.0 2.5 0.0 0.0 0.1 0.0 0.1 5.9 0.6 190.8 0.1 1.9 0.4 0.0 0.0 452.3 0.4 0.0 2.5 0.0 0.1 0.0 2.3 0.0 0.0 0.2 1.7 692.0 0.0 0.0 0.0 1.8 264.8 12.2 0.4 0.0 15.0 0.0 0.3 0.0 167.9 771.1 0.1 0.0 4.5 0.0 2.7 0.0 1.1 5.3 0.4 6.6 6.1 5.1 3.8 7.3 0.3 0.3 0.3 0.1 12.3 0.0 0.5 TNFSF11 "CD254, ODF, OPGL, RANKL, TRANCE" ENSG00000120659 "TNF superfamily member 11" O14788 13 42562736-42608013 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Cytokine, Developmental protein, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 4.5;liver: 5.3;lymphoid tissue: 15.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 10.8;Breast myoepithelial cells: 5.1;Ductal cells: 6.2;Early spermatids: 8.0;Late spermatids: 15.3" "Cancer enhanced" "Detected in many" "pancreatic cancer: 2.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 7 "NK-cell: 13.6" "Lineage enriched" "Detected in many" 7 "NK-cells: 13.6" "Cell line enhanced" "Detected in some" "HSkMC: 2.1;NTERA-2: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB009193, HPA045142" Enhanced "Secreted to blood" NA NA 17200 "CAB009193: , HPA045142: AB_2679231" "unprognostic (3.97e-4)" "unprognostic (1.40e-1)" "unprognostic (9.01e-3)" "unprognostic (3.81e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (7.09e-2)" "unprognostic (7.70e-2)" "unprognostic (2.29e-1)" "unprognostic (1.25e-3)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (3.94e-5)" "unprognostic (1.87e-1)" "unprognostic (9.67e-2)" "unprognostic (5.46e-2)" "unprognostic (7.74e-2)" 0.2 0.0 0.1 4.8 0.1 0.2 4.5 0.1 0.2 0.8 0.2 0.9 0.4 0.1 0.0 0.1 0.0 1.4 0.1 0.0 0.1 0.1 5.3 0.1 15.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.4 1.1 0.0 0.1 1.9 0.0 0.0 0.6 0.5 1.3 0.1 1.6 0.0 0.1 5.0 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.1 0.0 0.3 0.0 0.0 10.8 5.1 0.4 1.5 0.2 0.0 0.0 0.0 2.3 0.0 0.0 6.2 8.0 0.5 0.1 0.1 1.2 0.0 0.2 0.2 0.0 0.2 0.0 0.7 0.0 0.3 0.0 1.0 0.0 0.0 0.7 0.9 0.0 0.0 0.4 15.3 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.1 3.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.3 0.0 1.8 0.0 0.0 0.0 MTRF1 "MGC47721, MTTRF1, RF1" ENSG00000120662 "Mitochondrial translation release factor 1" O75570 13 41216369-41263577 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 28.6;Spermatocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043316 Uncertain NA NA "HPA043316: AB_10795038" "unprognostic (3.87e-1)" "unprognostic (3.83e-2)" "unprognostic (2.52e-2)" "unprognostic (1.89e-3)" "unprognostic (7.27e-3)" "unprognostic (5.07e-2)" "unprognostic (7.45e-2)" "unprognostic (1.74e-3)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (7.74e-2)" "unprognostic (3.50e-1)" "unprognostic (1.42e-1)" "unprognostic (2.05e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (3.46e-2)" 5.2 9.8 6.7 8.8 6.5 10.9 7.0 7.3 8.2 6.2 9.9 8.5 10.9 6.2 12.1 8.6 5.1 11.1 6.8 6.4 6.7 11.8 11.5 5.9 12.6 7.1 6.5 6.2 6.2 12.5 7.5 6.8 6.0 7.9 7.4 12.0 5.1 6.8 6.3 13.9 10.1 9.3 6.9 6.4 11.4 10.9 14.1 6.9 10.3 7.1 12.8 11.7 7.2 6.3 7.3 9.2 12.1 14.8 12.6 16.2 18.7 10.0 13.0 9.3 15.4 15.2 29.0 23.1 25.3 8.6 10.5 25.4 26.3 21.7 14.0 20.6 15.6 18.0 23.8 17.9 23.7 10.3 21.3 21.6 10.6 12.7 14.0 8.3 11.7 22.3 26.0 15.9 5.9 18.9 9.1 18.9 21.8 13.8 33.6 9.1 14.8 12.4 12.0 16.0 7.8 3.7 8.9 11.9 10.7 12.6 17.8 7.3 11.2 9.8 12.4 5.3 11.7 12.9 6.8 12.0 22.4 17.3 14.8 13.2 3.3 2.5 4.9 3.9 3.3 5.2 5.0 2.8 4.0 5.4 2.8 5.4 7.9 1.5 3.2 2.5 3.4 4.8 2.5 6.7 6.5 7.3 8.2 6.4 6.7 7.1 6.5 6.2 7.9 6.4 6.9 7.3 3.7 3.2 3.6 5.5 8.3 3.6 5.3 8.8 5.2 0.0 4.6 4.7 9.4 10.0 9.5 9.2 0.0 7.2 10.0 4.3 11.7 6.2 28.6 5.0 4.7 4.8 4.2 7.4 10.1 7.5 9.2 5.1 7.1 4.4 5.1 5.7 5.7 4.6 6.1 0.0 9.4 4.6 14.2 3.5 1.6 8.0 1.5 6.2 1.8 6.5 5.4 0.0 3.1 10.1 11.7 7.2 4.4 3.8 7.5 3.7 5.2 15.5 3.9 0.0 0.0 5.6 5.4 26.6 8.7 6.4 3.4 4.2 7.6 7.3 5.7 6.2 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168217-36214588 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 27.8" "Group enriched" "Detected in some" 5 "Early spermatids: 55.5;Extravillous trophoblasts: 19.5;Late spermatids: 77.0;Spermatocytes: 22.5;Spermatogonia: 33.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.3;HL-60: 11.2;Karpas-707: 12.1;NB-4: 16.1;U-266/84: 16.5" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.5 0.4 0.9 0.1 1.0 0.8 0.5 0.6 1.1 0.3 0.2 1.3 0.3 0.4 2.1 0.4 0.3 0.3 1.0 1.0 1.0 0.7 0.0 0.1 0.3 1.3 0.8 0.8 0.3 0.0 1.4 0.3 1.1 1.0 1.9 0.1 1.2 0.2 1.3 0.6 0.3 0.2 0.5 0.9 0.1 0.3 27.8 1.0 0.3 0.5 5.3 0.0 0.9 0.1 1.1 8.3 0.2 0.8 0.0 0.7 1.3 4.8 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.2 0.0 0.1 0.0 0.1 1.9 0.1 0.0 0.1 11.2 0.0 2.2 0.6 0.0 0.0 0.4 1.0 0.3 0.4 12.1 2.5 0.1 0.0 16.1 0.2 0.0 0.0 0.2 0.2 0.9 1.2 0.8 0.2 1.5 0.0 0.0 0.0 2.9 0.1 0.7 0.0 0.0 0.9 0.6 0.5 1.6 16.5 0.2 0.9 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.6 1.1 1.0 1.0 1.3 0.8 0.8 1.0 0.9 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 55.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 19.5 0.1 0.0 0.3 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 77.0 0.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 2.1 0.0 0.3 0.0 0.0 0.1 22.5 33.5 0.0 0.1 3.4 0.0 0.1 0.0 0.1 DNAJC15 "DNAJD1, MCJ" ENSG00000120675 "DnaJ heat shock protein family (Hsp40) member C15" Q9Y5T4 13 43023203-43114213 "Disease related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 462.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-1)" "unprognostic (2.89e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-2)" "unprognostic (1.53e-2)" "unprognostic (3.07e-3)" "unprognostic (3.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.38e-2)" "unprognostic (3.40e-1)" "unprognostic (2.50e-1)" "unprognostic (2.51e-2)" "unprognostic (2.90e-1)" "unprognostic (5.92e-3)" "unprognostic (3.17e-1)" 5.2 7.3 14.2 5.2 15.1 3.8 5.1 15.0 20.3 6.1 10.7 7.2 8.9 3.2 1.5 4.7 3.3 4.0 10.9 13.3 15.9 9.4 7.1 5.4 6.6 15.7 15.2 12.1 1.0 4.1 6.9 3.2 5.5 15.3 3.1 6.4 4.8 4.4 8.6 7.0 3.5 8.5 4.5 17.4 4.1 4.7 3.9 16.0 5.9 6.7 6.9 6.0 4.3 2.4 17.3 0.0 0.0 2.6 2.3 9.3 13.9 1.9 10.7 10.4 12.6 6.7 12.8 11.1 8.2 0.0 13.5 6.3 7.8 1.2 9.2 13.3 17.7 0.0 7.8 5.5 9.2 10.7 0.0 5.4 14.0 17.6 6.3 6.0 6.4 10.2 4.8 0.0 1.4 10.4 4.5 0.1 2.0 0.0 9.5 0.0 3.0 2.5 12.2 19.8 4.1 3.3 3.8 0.0 5.8 8.2 4.3 4.2 11.1 10.8 5.1 2.3 8.5 2.8 0.5 1.4 0.0 11.0 0.0 5.0 5.8 4.4 2.3 2.8 4.9 2.6 5.7 3.5 3.3 8.2 4.6 2.7 3.1 0.3 3.9 4.0 5.2 4.9 3.0 14.2 15.1 15.0 20.3 13.3 15.9 15.7 15.2 12.1 15.3 17.4 16.0 17.3 82.2 83.3 49.0 16.6 111.2 42.3 23.0 59.2 53.5 25.9 73.2 80.9 166.4 100.1 71.7 132.4 25.0 76.9 58.4 192.9 115.4 271.7 462.8 172.3 77.8 83.1 133.7 98.7 16.6 329.0 291.3 72.5 63.2 289.2 39.2 13.9 71.7 238.5 140.3 30.3 22.4 147.2 63.1 143.8 104.3 124.8 15.2 130.5 88.9 22.5 159.3 50.8 64.9 25.6 17.3 274.7 241.3 12.0 148.1 20.5 263.3 342.9 72.4 26.2 26.3 71.4 92.8 279.4 117.8 90.6 45.6 92.6 70.2 16.2 176.3 38.8 PROSER1 "bA50D16.2, C13orf23, FLJ12661" ENSG00000120685 "Proline and serine rich 1" Q86XN7 13 39009865-39038089 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034225, HPA055687" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB034225: AB_1564157, HPA055687: AB_2682886" "unprognostic (6.75e-3)" "unprognostic (9.56e-3)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (7.06e-2)" "unprognostic (2.92e-2)" "unprognostic (3.73e-3)" "unprognostic (5.98e-2)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-1)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (9.31e-3)" "unprognostic (2.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.95e-1)" 9.0 7.8 4.5 11.2 4.9 25.7 9.2 6.8 6.2 7.7 4.1 11.4 10.7 9.1 9.1 11.7 7.3 6.1 8.0 4.6 4.6 9.0 9.6 12.3 13.5 6.5 5.0 4.5 7.0 15.6 5.7 7.8 21.2 5.9 10.7 13.8 10.0 13.7 6.3 10.2 15.8 12.5 7.9 5.3 12.9 11.0 12.8 4.9 14.2 10.1 7.2 14.7 8.6 9.4 6.2 16.0 12.2 37.3 25.9 12.5 10.0 59.1 14.8 13.0 14.6 15.5 39.0 24.3 37.1 11.7 14.5 19.7 26.9 40.5 26.6 23.8 56.6 33.1 54.7 13.4 27.1 28.5 57.7 32.4 13.3 31.4 23.2 52.3 9.0 24.2 41.9 27.6 21.8 15.7 27.8 35.2 30.6 55.8 31.4 13.0 36.6 39.6 23.3 14.6 24.6 21.0 24.2 10.4 26.8 21.7 28.9 28.8 32.9 22.2 8.4 13.5 16.7 18.9 20.2 22.6 39.7 13.6 31.5 16.8 4.6 1.9 0.4 2.8 1.6 3.1 2.0 2.8 3.0 2.2 1.4 2.4 2.6 0.5 4.2 2.5 2.5 1.7 2.7 4.5 4.9 6.8 6.2 4.6 4.6 6.5 5.0 4.5 5.9 5.3 4.9 6.2 9.5 3.2 15.3 13.7 11.7 7.0 5.2 4.6 8.0 11.7 8.4 7.6 6.2 5.7 5.6 0.0 8.4 19.3 19.4 12.7 1.9 7.3 16.8 9.0 9.4 10.0 11.4 6.3 16.8 13.5 18.5 6.4 11.2 12.1 12.0 12.5 8.6 6.0 10.4 16.8 12.7 16.3 0.0 16.3 8.0 5.6 6.5 9.9 5.4 12.2 9.9 4.5 13.4 14.1 27.3 15.0 19.2 4.9 16.9 11.2 6.5 3.6 6.0 9.5 0.0 7.8 7.2 14.0 11.6 10.5 7.2 26.8 11.5 5.2 14.8 8.1 UFM1 "bA131P10.1, C13orf20" ENSG00000120686 "Ubiquitin fold modifier 1" P61960 13 38349849-38363619 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039758 Approved NA NA 240000 "HPA039758: AB_10697555" "unprognostic (8.08e-2)" "unprognostic (3.29e-2)" "unprognostic (1.49e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.33e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (9.67e-2)" "unprognostic (1.68e-1)" "unprognostic (3.92e-2)" "unprognostic (1.45e-1)" "unprognostic (8.11e-2)" "unprognostic (7.03e-2)" "unprognostic (4.90e-3)" "unprognostic (1.12e-2)" "unprognostic (3.99e-1)" "unprognostic (8.23e-2)" "unprognostic (1.90e-1)" 42.3 43.5 39.9 48.2 41.8 101.0 47.8 40.3 41.9 43.9 45.0 40.0 48.9 58.9 65.4 30.2 37.4 42.6 36.2 41.9 43.6 45.7 53.3 41.9 52.7 43.3 41.8 36.0 50.7 67.6 33.0 37.5 53.6 43.2 50.3 51.0 32.3 59.0 50.8 25.0 43.2 48.2 39.5 45.0 47.3 52.8 20.0 41.0 32.2 52.6 26.5 48.9 42.1 36.1 48.6 31.3 18.1 47.4 46.2 81.8 97.4 43.3 94.1 72.8 47.7 50.3 56.2 63.1 50.9 29.1 81.8 94.5 51.6 44.9 57.4 67.6 71.4 27.5 42.5 33.9 50.0 107.8 63.3 59.1 81.6 84.3 46.4 127.6 69.9 47.7 39.6 28.5 68.5 68.6 35.6 42.8 52.5 48.9 94.4 45.8 48.9 84.8 50.6 60.2 40.6 17.9 40.6 32.4 54.8 80.8 64.9 40.0 49.1 56.5 55.1 33.5 88.1 53.1 64.7 43.9 67.6 116.6 32.2 84.5 71.5 30.6 41.1 30.7 42.0 37.3 40.1 31.2 28.7 26.7 37.6 30.4 31.8 15.5 39.6 40.3 45.0 32.4 34.7 39.9 41.8 40.3 41.9 41.9 43.6 43.3 41.8 36.0 43.2 45.0 41.0 48.6 92.1 80.1 73.3 20.9 141.6 136.9 151.7 147.8 108.1 24.0 102.7 64.4 66.3 64.3 115.3 62.5 20.9 87.2 112.7 84.8 99.7 91.5 38.6 126.8 113.4 78.8 31.7 52.6 29.0 102.3 140.2 121.5 92.8 148.1 115.3 53.4 68.9 119.6 97.6 6.7 34.9 113.5 107.8 94.3 148.3 13.3 59.0 102.0 94.3 43.1 92.3 26.7 62.8 26.2 58.9 161.9 102.2 40.3 330.9 215.8 95.2 136.5 141.2 22.3 19.7 87.3 88.1 56.6 44.9 110.2 173.3 140.4 93.0 45.2 80.8 220.3 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061509-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: AB_2683803" "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.89e-4)" "unprognostic (2.52e-1)" 17.7 16.1 16.7 9.9 17.3 15.7 13.5 17.1 24.1 11.8 14.2 11.3 11.3 18.7 16.1 11.3 11.2 9.4 23.3 16.6 17.4 12.4 16.4 10.5 11.9 17.0 16.8 15.4 13.3 8.7 12.5 8.2 11.6 17.4 14.2 9.2 16.6 8.2 14.8 41.3 11.4 11.6 14.9 16.3 9.9 9.4 12.3 16.8 14.8 11.3 30.1 11.7 11.4 11.1 19.3 15.0 9.8 26.7 17.3 17.1 25.9 16.2 33.3 23.4 25.9 19.7 15.5 15.7 21.4 13.0 23.6 31.2 20.6 10.2 16.7 33.0 22.3 14.3 30.2 10.0 16.0 26.3 19.1 18.8 21.3 25.0 18.8 26.5 21.1 22.0 20.3 16.4 9.1 27.5 12.6 27.3 20.6 16.3 23.2 8.0 25.3 16.5 8.4 23.6 14.6 6.1 14.7 10.6 11.3 16.1 21.5 9.4 29.3 19.3 16.0 14.7 22.2 19.5 6.0 7.0 14.7 19.7 13.7 22.2 19.2 13.0 12.4 10.6 12.0 9.7 14.2 13.6 11.5 11.0 12.6 14.4 14.3 27.3 12.5 21.8 18.5 14.4 6.1 16.7 17.3 17.1 24.1 16.6 17.4 17.0 16.8 15.4 17.4 16.3 16.8 19.3 42.4 51.3 29.3 21.2 23.9 54.4 60.3 54.8 33.0 46.8 33.5 37.5 110.0 40.0 32.5 25.8 33.3 55.6 23.0 32.3 76.3 52.3 11.9 32.9 58.4 46.9 37.8 111.7 17.0 42.0 61.1 52.2 15.8 44.5 45.7 27.5 38.2 63.1 40.9 45.4 16.6 28.1 18.3 26.7 47.1 9.7 47.8 33.0 32.0 10.3 60.4 63.8 28.8 17.1 33.3 50.3 33.2 52.6 16.8 60.9 33.8 70.6 23.6 49.2 26.3 55.3 66.7 87.5 103.9 29.7 44.9 49.9 22.3 31.9 27.6 40.9 ELF1 ENSG00000120690 "E74 like ETS transcription factor 1" P32519 13 40931924-41061440 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 202.8" "Cell type enhanced" "Detected in all" "T-cells: 365.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 271.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001755, CAB005172" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005172: AB_631428, HPA001755: AB_1078732" "unprognostic (1.21e-1)" "unprognostic (8.73e-3)" "unprognostic (4.20e-2)" "unprognostic (8.45e-2)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.11e-2)" "unprognostic (5.78e-2)" "unprognostic (3.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.02e-3)" "unprognostic (2.96e-1)" "unprognostic (4.11e-2)" "unprognostic (8.98e-2)" "unprognostic (3.72e-2)" 64.7 22.8 9.0 64.9 13.3 202.8 45.7 13.3 10.4 46.2 14.8 46.0 53.9 35.6 29.2 53.1 41.4 60.2 29.4 7.7 15.3 32.2 50.9 47.8 96.1 19.1 13.4 4.4 34.9 56.5 40.1 9.8 49.0 17.5 35.5 48.8 4.2 35.6 34.2 21.5 38.4 58.3 44.3 15.3 68.9 50.1 15.2 12.2 135.8 55.4 26.2 97.7 61.9 36.8 20.5 35.5 20.5 15.3 15.3 68.6 72.6 57.2 35.9 84.9 48.7 55.1 51.2 90.9 199.7 22.1 60.4 36.5 78.7 2.9 45.4 30.8 44.9 23.7 179.6 16.3 36.5 50.9 103.3 271.2 75.1 78.5 32.9 62.0 32.8 69.2 93.1 45.0 51.7 32.4 32.5 136.6 63.1 12.1 117.7 15.8 179.2 25.1 58.7 49.9 54.8 6.1 21.3 31.0 31.0 62.9 21.2 22.0 132.8 63.8 21.5 12.4 17.7 13.0 23.7 14.8 131.2 29.0 65.0 45.9 265.9 60.4 134.2 70.0 66.1 73.8 63.0 79.3 77.9 58.6 65.1 84.8 75.9 97.4 73.0 98.4 38.9 86.8 80.1 9.0 13.3 13.3 10.4 7.7 15.3 19.1 13.4 4.4 17.5 15.3 12.2 20.5 156.8 76.9 68.0 51.6 326.8 108.8 188.2 86.0 90.0 2.8 71.5 37.7 41.3 52.9 86.1 57.0 10.4 35.7 292.0 62.9 19.6 70.2 47.7 121.6 69.5 122.0 58.1 78.8 8.2 69.4 55.8 79.0 64.2 126.0 323.1 8.1 91.4 25.2 97.5 3.3 8.6 57.0 95.6 115.4 206.3 21.9 42.9 244.1 120.9 125.5 123.5 8.1 133.9 52.8 138.7 65.9 54.4 43.2 211.5 150.4 58.7 28.3 84.6 3.7 39.5 52.7 52.8 7.7 11.2 95.6 114.8 53.5 365.3 26.9 56.0 221.9 SMAD9 "MADH6, MADH9, SMAD8, SMAD8/9" ENSG00000120693 "SMAD family member 9" O15198 13 36844831-36920765 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 39.0" "Cell type enhanced" "Detected in many" "Astrocytes: 48.0;Enteroendocrine cells: 51.6;Glandular and luminal cells: 73.4;Hepatic stellate cells: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.9;HEK 293: 12.3;SH-SY5Y: 40.2" "Low region specificity" "Detected in all" "CAB009119, HPA031162" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009119: AB_2286517, HPA031162: AB_2673767" "unprognostic (2.88e-1)" "unprognostic (1.38e-1)" "unprognostic (9.68e-3)" "unprognostic (3.50e-3)" "prognostic favorable (5.99e-4)" "unprognostic (1.30e-1)" "unprognostic (1.34e-1)" "unprognostic (3.71e-3)" "unprognostic (4.23e-2)" "unprognostic (6.62e-2)" "unprognostic (4.07e-3)" "unprognostic (3.74e-2)" "unprognostic (9.70e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.47e-2)" 4.0 2.6 10.3 2.8 7.3 0.1 1.6 11.5 7.1 4.9 3.4 5.1 2.3 9.0 9.9 4.2 4.3 7.1 5.7 10.5 13.9 3.3 0.9 5.0 2.2 16.6 12.0 4.0 9.3 0.9 2.4 1.9 6.5 17.5 14.0 5.3 7.1 21.2 11.3 3.0 1.5 2.5 6.8 17.5 1.0 3.7 2.3 10.7 0.5 39.0 5.2 2.9 3.3 2.1 23.6 0.0 0.1 0.8 8.6 2.6 1.1 0.3 10.5 1.1 2.7 1.7 0.0 0.2 0.2 7.2 12.9 0.9 0.4 9.3 0.2 2.8 0.3 12.3 0.0 4.4 6.6 2.4 0.8 0.1 4.4 0.8 0.0 0.0 5.7 5.3 1.1 0.1 0.0 6.0 0.6 0.1 0.8 1.2 0.3 1.1 0.2 9.2 0.0 0.0 1.5 7.6 40.2 1.9 0.2 0.5 2.3 0.6 0.4 9.6 4.0 3.5 2.4 2.6 0.1 0.0 0.1 2.8 0.3 0.6 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 10.3 7.3 11.5 7.1 10.5 13.9 16.6 12.0 4.0 17.5 17.5 10.7 23.6 22.5 28.9 11.5 48.0 0.4 2.8 4.3 1.8 1.8 13.1 2.5 2.2 5.9 2.8 6.9 11.0 4.2 0.2 0.2 3.3 1.9 0.3 0.1 30.3 14.0 26.7 51.6 0.0 18.1 0.2 0.6 11.6 3.6 73.4 0.0 19.7 43.9 0.1 0.1 0.0 33.0 15.6 8.2 2.2 1.9 0.3 18.6 1.1 0.0 31.9 0.0 20.4 0.0 14.1 39.3 0.5 3.4 15.1 0.0 17.2 0.0 7.3 1.6 3.2 0.0 7.2 10.1 1.2 14.1 0.2 1.8 0.3 1.4 0.5 5.7 1.2 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134973-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 864.4;choroid plexus: 240.3" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 1316.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 1300000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 32.7 42.4 256.2 23.8 242.9 20.9 28.2 232.2 864.4 24.5 240.3 29.3 11.4 26.1 37.9 36.1 55.3 32.6 56.5 355.4 244.9 47.8 48.0 67.2 35.2 256.6 231.7 226.6 56.8 28.8 30.5 64.3 38.1 250.4 28.7 25.6 27.0 20.3 29.5 36.9 20.5 20.6 28.2 254.7 32.6 53.5 68.4 274.9 37.7 32.4 32.9 45.5 59.4 35.7 297.4 69.9 130.7 105.1 10.2 99.1 56.0 70.0 117.8 104.6 179.0 82.8 154.9 105.4 179.6 71.9 82.4 253.7 131.2 411.7 104.8 229.2 141.6 51.7 155.7 69.3 137.2 32.3 109.1 118.8 35.5 236.5 119.6 68.3 93.0 105.4 62.0 132.7 27.8 127.4 94.7 158.1 124.2 150.3 338.6 96.6 122.5 85.8 58.9 135.0 83.5 108.5 90.1 107.4 104.0 56.6 160.6 35.0 104.7 64.4 61.3 77.4 89.2 132.4 21.8 76.0 150.6 51.0 129.8 104.7 1.4 5.0 2.7 7.6 12.2 9.4 11.1 9.7 11.8 8.4 10.6 14.7 13.8 0.5 16.7 19.6 6.6 7.0 7.7 256.2 242.9 232.2 864.4 355.4 244.9 256.6 231.7 226.6 250.4 254.7 274.9 297.4 171.1 131.4 87.7 36.6 130.8 214.6 1316.2 44.7 175.2 38.7 152.2 143.3 163.6 40.0 123.3 46.0 417.0 23.2 78.9 153.2 29.4 49.8 100.0 346.1 140.1 132.3 227.7 58.9 121.0 35.9 64.2 249.6 94.3 250.6 248.6 61.7 26.4 25.7 90.6 30.3 77.7 159.0 65.1 38.6 452.1 36.5 33.8 281.3 163.7 55.3 42.6 28.2 26.8 30.7 53.2 45.5 154.0 39.1 142.0 426.3 18.2 31.6 290.5 79.0 39.5 98.1 153.1 161.3 164.6 151.1 143.3 42.5 363.8 58.5 166.1 511.8 KBTBD7 DKFZP434E2318 ENSG00000120696 "Kelch repeat and BTB domain containing 7" Q8WVZ9 13 41189834-41194569 "Predicted intracellular proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043709, HPA046861, HPA048914" Uncertain NA NA "HPA043709: AB_10961260, HPA046861: AB_2679843, HPA048914: AB_2680554" "unprognostic (8.68e-2)" "unprognostic (6.36e-2)" "unprognostic (3.67e-1)" "unprognostic (3.28e-2)" "unprognostic (5.46e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-1)" "prognostic favorable (5.29e-4)" "unprognostic (4.36e-2)" "unprognostic (7.59e-2)" "prognostic favorable (6.62e-4)" "unprognostic (4.98e-1)" "unprognostic (1.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.68e-2)" "unprognostic (1.29e-1)" "unprognostic (1.38e-1)" 3.0 4.2 4.8 2.9 5.1 4.4 5.5 6.9 5.8 4.6 4.8 3.2 3.9 3.4 5.3 2.4 5.0 2.2 4.6 4.7 4.8 5.5 7.0 3.1 4.3 4.6 4.9 4.7 5.9 4.3 6.2 3.2 4.5 5.0 5.9 2.7 6.1 5.9 5.1 4.2 3.5 3.1 2.8 4.6 4.5 4.9 3.5 4.8 4.7 6.3 4.0 4.7 2.8 1.5 6.4 2.2 4.5 9.0 10.5 9.5 4.1 3.3 2.2 3.1 2.9 2.0 5.9 4.2 3.9 3.3 2.8 3.8 7.3 6.9 4.7 2.9 5.4 8.8 10.5 6.0 5.3 4.4 1.8 8.3 2.3 8.2 1.0 2.7 5.4 3.2 7.1 5.1 0.4 5.6 6.5 9.5 4.1 8.9 9.4 2.3 10.4 5.7 2.0 6.3 5.0 5.2 7.1 3.3 9.9 3.1 7.9 6.0 9.6 3.2 1.7 2.2 1.6 1.9 2.6 3.3 0.0 4.1 4.7 4.1 2.1 5.0 11.5 2.9 5.1 3.4 2.3 3.4 3.4 3.6 2.1 5.0 4.5 13.7 3.2 3.9 1.8 2.6 2.9 4.8 5.1 6.9 5.8 4.7 4.8 4.6 4.9 4.7 5.0 4.6 4.8 6.4 10.4 9.6 6.7 4.2 8.3 4.1 14.3 10.3 13.1 27.8 17.2 15.1 9.2 17.2 9.2 12.9 14.6 16.8 7.1 17.1 19.6 6.6 53.2 5.6 9.6 9.7 12.7 16.0 5.4 5.8 14.7 16.6 16.3 8.6 8.9 10.7 15.7 27.6 8.5 5.0 7.2 12.5 16.2 14.2 3.5 5.1 15.8 7.5 5.4 4.7 10.0 17.2 13.4 9.0 9.7 3.7 13.7 21.8 6.1 6.9 12.4 17.4 6.2 19.2 19.7 15.6 12.5 17.7 15.0 10.6 6.8 9.9 6.7 12.2 11.3 11.5 ALG5 bA421P11.2 ENSG00000120697 "ALG5 dolichyl-phosphate beta-glucosyltransferase" Q9Y673 13 36949738-37000763 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007989 Approved Approved Cytosol No No Cytosol "HPA007989: AB_1078132" "unprognostic (1.87e-1)" "unprognostic (1.73e-2)" "unprognostic (6.07e-2)" "unprognostic (1.05e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.57e-2)" "unprognostic (5.82e-2)" "unprognostic (5.21e-2)" "unprognostic (7.46e-2)" "unprognostic (3.51e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.40e-5)" "unprognostic (7.44e-2)" "unprognostic (1.66e-1)" "unprognostic (7.14e-3)" "unprognostic (1.86e-1)" 29.0 32.5 16.9 19.8 18.0 27.2 42.0 18.0 22.5 34.5 19.2 36.3 27.3 23.7 78.6 21.9 23.5 23.4 17.3 17.0 18.0 41.6 62.4 24.7 20.9 18.4 17.8 16.9 20.7 90.8 40.5 18.8 25.6 18.4 26.7 46.9 11.3 52.3 31.2 18.7 21.0 27.9 23.7 18.5 23.8 36.9 15.3 17.4 22.9 55.4 10.6 29.1 30.8 21.8 19.5 24.3 35.0 31.5 29.4 95.1 61.8 22.5 63.9 81.1 63.7 53.7 71.0 84.1 35.2 25.9 45.7 55.0 57.5 41.9 55.0 62.6 37.4 77.7 77.2 27.5 40.1 85.1 69.6 43.7 62.7 88.8 49.4 60.6 41.5 47.7 43.9 39.8 49.7 59.9 45.6 47.4 59.8 29.1 188.2 27.5 54.3 30.4 102.5 71.5 49.8 25.2 45.5 29.2 62.8 34.2 25.4 34.4 79.1 36.1 32.7 20.4 37.2 45.8 35.8 28.8 37.4 51.2 41.9 57.1 59.1 55.7 26.2 53.4 62.3 54.4 44.1 49.1 55.6 57.1 40.2 46.4 47.2 5.8 54.7 53.0 109.0 65.7 69.2 16.9 18.0 18.0 22.5 17.0 18.0 18.4 17.8 16.9 18.4 18.5 17.4 19.5 52.0 51.3 51.9 11.1 51.5 34.7 45.9 142.9 27.3 19.8 50.2 42.5 14.2 61.5 86.0 53.3 10.4 81.4 49.4 28.9 23.5 93.5 33.7 31.5 44.1 45.5 36.1 25.9 19.5 140.2 74.4 46.0 32.1 40.1 29.2 25.9 37.9 77.3 69.7 11.8 22.4 76.3 111.9 37.1 52.1 25.8 40.0 39.4 80.0 14.0 45.2 36.6 25.7 18.1 30.6 85.9 50.9 38.4 166.6 56.4 51.4 62.7 43.8 25.2 46.0 34.4 70.7 57.6 23.7 33.6 30.3 81.3 43.0 58.5 62.2 50.7 EXOSC8 "bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p" ENSG00000120699 "Exosome component 8" Q96B26 13 36998816-37009614 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034240, HPA039702, HPA043942, HPA075230" Uncertain Supported "Nucleoli fibrillar center,Mitotic chromosome,Vesicles" Yes NA "Nucleoli fibrillar center, Mitotic chromosome, Vesicles" "CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: " "unprognostic (8.67e-2)" "unprognostic (9.39e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.01e-2)" "unprognostic (3.24e-3)" "unprognostic (2.45e-2)" "unprognostic (2.35e-2)" "unprognostic (7.32e-3)" "prognostic unfavorable (8.39e-7)" "unprognostic (9.58e-3)" "unprognostic (7.42e-2)" "unprognostic (1.10e-1)" "unprognostic (4.51e-1)" 15.0 14.3 17.7 19.3 18.5 27.8 19.0 19.0 24.5 16.5 17.7 17.1 12.7 14.4 14.5 18.4 17.0 8.5 17.9 17.8 18.6 15.1 20.0 13.7 21.3 18.5 18.3 17.5 16.6 14.0 11.7 10.9 15.7 18.9 14.4 19.2 15.4 11.4 13.4 24.4 16.8 14.2 16.7 18.1 17.7 15.4 28.0 18.0 31.7 12.4 25.0 25.3 16.3 14.9 20.7 47.5 33.5 97.7 66.4 28.4 30.1 73.8 68.9 48.8 93.2 74.2 72.7 93.6 65.1 29.8 38.2 91.4 64.7 92.7 67.1 111.5 96.3 73.9 174.8 34.2 87.4 37.0 148.3 58.9 17.4 51.3 62.6 100.2 24.1 72.8 93.6 86.6 41.3 66.4 59.1 78.6 116.6 101.4 113.2 44.0 48.5 98.6 53.5 51.1 30.8 23.8 46.1 38.1 44.5 65.3 51.1 35.4 117.6 37.2 35.5 49.1 42.9 95.5 23.3 29.4 135.7 56.0 104.1 66.8 28.9 29.8 23.5 42.8 39.6 44.8 66.0 54.1 50.5 33.9 57.2 67.1 62.7 6.0 46.2 41.7 54.8 54.6 52.4 17.7 18.5 19.0 24.5 17.8 18.6 18.5 18.3 17.5 18.9 18.1 18.0 20.7 43.5 32.1 38.9 15.7 40.1 36.1 51.6 109.6 25.0 20.8 25.0 50.0 50.2 18.6 69.5 11.0 8.4 86.8 46.8 13.1 56.7 58.1 115.7 21.5 31.4 39.4 13.2 57.9 7.0 52.1 92.3 41.8 19.4 20.6 103.6 46.2 18.5 17.4 46.8 28.6 8.6 19.1 79.3 13.6 34.2 54.6 40.7 26.0 26.6 10.3 32.6 27.1 35.0 17.1 22.0 36.1 16.4 36.5 38.8 29.0 18.0 26.6 53.4 32.0 26.3 38.8 52.1 163.3 85.9 29.0 36.2 67.0 38.7 42.7 30.2 37.7 ETF1 "ERF, ERF1, RF1, SUP45L1, TB3-1" ENSG00000120705 "Eukaryotic translation termination factor 1" P62495 5 138506095-138543236 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 456.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011686, HPA037511" Approved NA NA 220000 "CAB011686: AB_732263, HPA037511: AB_2675516" "unprognostic (2.56e-2)" "unprognostic (9.99e-2)" "prognostic favorable (9.33e-5)" "unprognostic (1.63e-1)" "unprognostic (3.45e-1)" "unprognostic (1.40e-2)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.65e-2)" "unprognostic (2.33e-1)" "unprognostic (2.44e-1)" "unprognostic (9.19e-2)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (2.10e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.63e-2)" 68.9 46.9 28.9 47.5 29.0 171.0 52.4 29.3 33.3 37.7 35.2 43.9 34.1 42.1 37.0 89.0 34.2 49.5 48.7 30.6 42.8 46.6 59.4 57.3 40.6 30.6 30.7 26.6 29.6 48.8 55.0 33.3 60.3 30.0 39.4 46.1 27.6 38.0 46.7 98.9 59.8 33.8 52.1 31.3 31.3 41.9 59.7 30.7 35.8 49.6 74.9 58.3 70.8 39.8 30.6 137.9 132.2 92.0 151.4 120.5 112.5 161.4 148.1 152.2 172.4 199.7 321.5 123.3 171.6 125.1 151.2 243.6 112.4 218.0 277.2 258.0 96.7 117.2 137.2 142.9 128.8 162.0 117.3 110.5 117.8 158.5 176.4 231.2 90.4 141.4 110.4 180.1 101.9 179.0 102.9 146.3 104.4 113.5 104.8 75.8 123.5 152.2 139.7 119.0 191.7 119.6 120.6 164.8 110.8 264.0 238.4 129.6 138.3 117.4 136.1 78.2 108.9 218.4 211.9 215.0 249.2 122.2 173.4 131.1 17.7 22.9 14.4 17.0 27.1 19.7 17.2 17.5 19.7 23.8 10.8 12.3 16.3 15.1 16.7 25.6 16.9 19.9 17.1 28.9 29.0 29.3 33.3 30.6 42.8 30.6 30.7 26.6 30.0 31.3 30.7 30.6 54.8 160.3 62.4 14.4 57.2 209.3 179.0 70.4 85.4 16.1 78.9 63.6 63.3 41.5 77.9 57.0 14.6 118.0 80.0 51.0 62.6 77.9 456.1 110.3 74.9 54.1 39.9 63.7 18.6 75.0 90.1 68.5 44.4 128.4 54.5 32.1 26.0 50.8 76.5 25.2 18.1 47.4 26.4 62.5 146.6 178.4 23.3 116.1 72.9 13.1 71.4 25.6 34.0 10.1 17.8 91.3 39.6 27.1 64.2 109.2 36.9 54.5 72.1 19.9 59.2 118.4 79.8 46.3 52.7 98.1 202.0 285.5 67.6 40.5 58.9 181.5 TGFBI "BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1" ENSG00000120708 "Transforming growth factor beta induced" Q15582 5 136028988-136063818 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Sensory transduction, Vision" "Amyloidosis, Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 461.4" "Cell type enhanced" "Detected in many" "Hofbauer cells: 251.8;Kupffer cells: 292.9;Langerhans cells: 251.2;Macrophages: 198.9;Pancreatic endocrine cells: 590.1;Smooth muscle cells: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 32 "classical monocyte: 252.3;intermediate monocyte: 149.1;myeloid DC: 156.9;non-classical monocyte: 121.4;plasmacytoid DC: 324.5" "Group enriched" "Detected in all" 46 "dendritic cells: 324.5;monocytes: 252.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 2857.3;GAMG: 2417.8;HSkMC: 2675.6;hTCEpi: 1915.6;LHCN-M2: 2269.4;U-2197: 1916.3;U-87 MG: 3667.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008612, HPA017019" Enhanced "Secreted to blood" NA NA 1600000000 "HPA008612: AB_1857970, HPA017019: AB_2669511" "unprognostic (1.05e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.38e-3)" "prognostic favorable (1.17e-4)" "unprognostic (5.21e-3)" "unprognostic (5.53e-3)" "unprognostic (4.60e-2)" "unprognostic (8.71e-3)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.42e-3)" "unprognostic (2.26e-1)" "prognostic unfavorable (7.82e-10)" "unprognostic (8.81e-3)" "unprognostic (1.73e-2)" "unprognostic (3.42e-1)" "unprognostic (1.70e-3)" 129.9 55.7 8.3 165.5 9.7 26.1 113.2 9.6 26.9 39.2 49.0 89.2 48.6 60.2 41.9 29.0 60.2 147.3 93.4 9.1 36.2 58.6 133.2 90.5 66.7 14.7 11.5 7.5 25.6 22.5 18.6 78.2 461.4 12.0 70.1 85.3 2.8 68.8 59.4 35.1 316.6 65.8 293.8 11.0 122.2 68.0 7.7 59.4 58.3 40.7 42.1 44.7 140.2 39.3 14.6 102.2 405.6 0.8 3.8 1104.3 354.4 1.5 295.1 42.9 209.9 125.1 186.4 1276.3 0.1 181.6 2857.3 2417.8 498.0 1.0 981.4 208.0 2.3 0.1 0.1 451.6 501.3 718.9 0.7 3.9 2675.6 1915.6 77.9 93.1 827.5 188.1 0.2 0.2 3.8 2269.4 4.8 0.7 0.7 13.1 5.1 0.9 0.4 24.3 3.4 96.7 8.8 1.3 0.7 473.7 15.5 3.9 452.8 3.7 110.9 745.6 1419.3 59.8 1916.3 1139.6 0.3 0.7 1.9 3667.3 0.9 1077.5 1.6 252.3 1.0 0.9 149.1 1.0 1.0 1.0 2.0 156.9 0.4 0.3 1.0 5.3 6.2 121.4 324.5 0.5 108.5 8.3 9.7 9.6 26.9 9.1 36.2 14.7 11.5 7.5 12.0 11.0 59.4 14.6 12.4 3.2 21.4 0.0 6.3 119.4 4.8 141.8 4.6 0.4 1.9 5.5 8.9 4.3 21.8 1.8 0.0 9.9 146.5 1.3 0.0 67.5 2.4 2.3 57.9 16.4 3.5 8.8 0.4 112.6 8.5 113.5 0.5 1.7 5.1 0.0 21.0 25.7 251.8 1.7 0.0 7.8 6.1 292.9 251.2 1.9 10.2 198.9 49.8 4.7 151.1 0.3 6.2 0.0 0.0 590.1 0.0 2.2 1.9 1.0 0.1 2.7 8.5 0.2 26.3 156.8 326.1 0.2 0.9 1.9 55.7 19.4 8.5 10.8 0.9 2.5 FAM53C C5orf6 ENSG00000120709 "Family with sequence similarity 53 member C" Q9NYF3 5 138331935-138349729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 311.8;Late spermatids: 588.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 29.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 29.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042796 Approved NA NA "HPA042796: AB_10794158" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (3.29e-3)" "unprognostic (3.49e-2)" "unprognostic (2.14e-2)" "unprognostic (4.06e-2)" "unprognostic (2.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.50e-2)" "unprognostic (2.00e-1)" "unprognostic (2.52e-1)" "unprognostic (1.86e-2)" "unprognostic (8.95e-2)" 15.5 15.5 25.5 14.3 27.2 85.3 16.3 26.0 27.8 13.4 17.3 17.4 8.2 19.7 17.0 13.6 16.6 16.6 17.5 26.7 24.2 10.4 11.8 16.2 13.6 24.0 24.7 25.9 16.9 29.8 14.7 16.4 14.6 23.7 17.0 9.3 12.4 21.3 14.2 52.4 11.7 11.5 20.9 21.7 19.5 17.7 66.6 27.3 22.7 11.6 34.6 14.7 14.7 12.2 24.6 25.7 19.1 41.5 54.7 39.5 28.8 27.8 24.2 32.4 44.2 53.2 48.8 24.0 44.7 24.5 27.4 48.3 23.8 46.8 45.3 43.9 27.2 43.7 19.9 24.8 22.1 33.6 18.0 38.6 33.2 22.2 44.3 30.6 34.5 33.5 29.6 27.2 45.2 28.1 21.6 24.4 29.6 38.5 15.8 15.5 36.6 25.7 40.7 26.0 18.8 30.1 23.3 31.6 23.4 47.7 61.9 43.4 32.4 28.3 29.8 18.8 18.2 28.2 71.6 28.9 43.6 24.8 29.7 23.5 0.5 4.9 5.4 2.3 3.8 2.5 2.9 2.0 1.9 4.6 2.3 2.6 2.8 29.4 2.3 2.9 2.5 2.5 3.2 25.5 27.2 26.0 27.8 26.7 24.2 24.0 24.7 25.9 23.7 21.7 27.3 24.6 27.1 6.4 11.5 19.6 45.0 25.0 27.2 24.3 37.0 30.6 57.3 64.0 6.2 10.0 22.0 20.2 91.8 22.3 54.5 46.4 3.9 9.5 311.8 24.1 15.3 24.9 57.8 14.1 21.5 7.2 28.2 26.2 35.7 26.0 48.2 33.0 13.2 9.9 21.0 16.8 20.9 34.5 28.5 37.4 46.3 588.4 21.1 43.1 21.4 15.9 17.6 23.6 12.3 22.1 25.7 9.9 35.3 18.4 28.1 25.2 49.6 6.4 24.3 83.2 32.9 64.1 24.2 24.4 26.3 31.4 26.1 52.0 43.2 21.7 33.3 31.8 SIL1 "BAP, MSS, ULG5" ENSG00000120725 "SIL1 nucleotide exchange factor" Q9H173 5 138946724-139293557 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 195.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011949 Enhanced "Intracellular and membrane" NA NA 710000 "HPA011949: AB_1856875" "unprognostic (1.06e-1)" "unprognostic (9.01e-2)" "unprognostic (2.04e-1)" "prognostic favorable (4.34e-4)" "prognostic unfavorable (4.27e-4)" "unprognostic (9.12e-3)" "unprognostic (3.60e-1)" "unprognostic (2.45e-1)" "unprognostic (1.33e-1)" "unprognostic (6.91e-2)" "unprognostic (2.31e-2)" "unprognostic (9.46e-2)" "unprognostic (3.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.65e-1)" "unprognostic (6.79e-2)" "unprognostic (1.22e-2)" 26.6 46.8 8.4 19.9 9.8 24.3 21.8 7.9 11.9 21.9 15.7 20.1 24.8 21.9 32.8 16.7 19.4 23.4 27.2 8.5 13.3 20.8 55.3 22.8 14.2 9.8 8.4 7.8 19.3 68.3 34.0 28.7 29.0 9.3 24.1 12.9 5.7 37.0 26.0 41.8 22.6 16.5 17.3 7.9 17.4 29.7 50.2 9.8 9.1 36.6 18.2 10.1 20.8 16.3 9.6 33.7 34.9 11.3 56.2 84.0 48.3 65.0 54.0 58.2 26.6 57.3 36.9 78.9 12.4 89.7 74.2 32.2 29.8 12.0 76.0 15.8 33.7 20.7 16.4 23.9 40.9 67.2 4.9 72.6 60.7 73.1 46.4 79.0 42.7 40.5 15.4 8.7 131.3 32.2 52.1 12.4 15.1 2.4 38.6 4.2 8.9 7.8 92.7 38.9 17.7 19.5 13.0 46.3 44.3 74.5 24.8 38.4 30.6 30.6 46.8 10.9 17.9 23.6 56.3 31.6 8.2 34.3 38.1 39.9 18.1 47.7 19.4 17.4 52.4 10.9 20.1 12.1 16.8 51.3 14.7 12.1 15.1 5.7 22.1 42.3 37.3 11.7 27.1 8.4 9.8 7.9 11.9 8.5 13.3 9.8 8.4 7.8 9.3 7.9 9.8 9.6 22.5 19.2 47.0 51.6 32.5 22.0 33.4 61.6 15.4 9.0 33.8 21.6 30.3 38.6 48.1 42.3 37.5 121.2 19.0 41.5 11.7 61.8 109.1 25.5 37.0 21.9 33.5 7.6 75.7 81.7 104.2 46.3 38.7 32.1 60.3 29.2 29.3 143.8 70.3 25.2 73.7 64.3 52.9 33.9 21.0 195.7 28.6 36.7 48.0 49.6 113.8 15.2 17.5 66.4 57.6 46.2 34.9 22.2 114.5 32.1 51.1 46.5 51.6 26.6 19.7 21.4 27.7 96.9 61.8 13.0 23.9 153.6 16.9 60.3 43.0 30.1 PAIP2 PAIP2A ENSG00000120727 "Poly(A) binding protein interacting protein 2" Q9BPZ3 5 139341587-139369720 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 834.4;Late spermatids: 2779.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035945, CAB037212, HPA056766" Approved Supported Vesicles NA NA 21000 Vesicles "CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231" "unprognostic (1.07e-1)" "unprognostic (1.44e-1)" "unprognostic (1.19e-1)" "unprognostic (5.86e-2)" "unprognostic (7.40e-2)" "unprognostic (3.80e-3)" "unprognostic (7.70e-3)" "unprognostic (8.91e-2)" "unprognostic (4.64e-2)" "unprognostic (2.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.27e-1)" "unprognostic (2.01e-3)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (3.36e-1)" "unprognostic (6.92e-2)" 104.2 150.0 112.7 77.9 113.9 116.7 91.2 123.9 150.8 77.9 122.1 67.5 44.6 95.0 86.3 69.4 92.4 67.1 174.7 110.2 120.0 105.7 115.1 73.7 109.9 122.3 125.7 104.7 113.3 64.7 89.6 96.9 94.5 125.9 85.1 54.4 170.4 92.9 83.2 171.2 48.6 50.5 83.8 121.6 92.9 58.6 170.5 116.5 148.8 75.3 163.4 108.5 82.2 54.8 142.4 91.9 102.7 196.2 118.5 144.0 81.3 95.6 81.9 113.6 104.7 163.6 138.5 86.7 160.7 170.8 62.3 120.1 88.9 173.5 112.5 137.4 155.7 136.4 148.5 145.7 125.8 93.0 92.8 105.4 93.2 92.4 78.5 88.8 112.9 108.7 173.3 143.7 138.6 95.8 121.1 254.3 227.3 118.9 130.5 74.6 140.0 248.1 177.2 84.0 163.2 90.9 165.2 121.2 110.7 251.2 245.4 214.4 192.6 66.9 55.9 67.9 61.3 67.3 200.0 262.6 167.8 98.2 161.6 58.9 569.5 292.2 735.8 286.2 329.3 317.0 378.7 314.7 330.4 292.0 337.7 364.4 356.5 800.5 347.5 380.6 298.7 449.5 577.2 112.7 113.9 123.9 150.8 110.2 120.0 122.3 125.7 104.7 125.9 121.6 116.5 142.4 154.8 73.7 87.5 26.4 173.8 159.8 164.3 168.2 79.1 102.4 108.2 98.0 59.7 97.2 100.9 99.3 58.4 198.6 253.1 74.0 170.2 126.4 834.4 228.6 109.2 126.9 97.0 190.0 40.6 115.1 134.1 129.5 38.7 109.0 109.0 108.2 123.1 103.8 142.3 97.6 46.6 57.7 120.1 142.2 196.1 2779.9 160.9 170.6 135.2 29.0 239.2 158.5 247.2 29.7 59.9 122.5 64.7 155.3 146.8 232.8 62.1 256.2 149.4 93.6 170.9 87.7 180.3 432.3 238.1 57.0 208.3 479.7 191.3 145.8 59.5 178.3 MYOT "LGMD1, LGMD1A, TTID" ENSG00000120729 Myotilin Q9UBF9 5 137867858-137887851 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 61 "skeletal muscle: 2204.3;tongue: 2056.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 40.9;Skeletal myocytes: 42.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037733, HPA037734" Enhanced NA NA 9100 "HPA037733: AB_10697082, HPA037734: AB_2675638" "unprognostic (5.85e-2)" "unprognostic (2.38e-2)" "unprognostic (6.93e-2)" "unprognostic (3.08e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (8.03e-2)" "unprognostic (1.17e-2)" "unprognostic (1.54e-2)" "unprognostic (2.02e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (7.56e-4)" "unprognostic (1.72e-2)" "unprognostic (2.42e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" 0.8 1.7 6.3 1.4 9.8 0.0 0.8 6.6 8.4 3.1 4.7 6.0 2.1 0.4 0.5 34.9 0.8 0.7 17.1 6.2 7.2 0.9 0.4 0.2 0.1 7.0 8.0 5.5 0.4 0.4 1.1 0.5 0.0 8.7 20.2 1.6 0.5 19.6 3.8 2204.3 0.8 3.1 1.1 6.2 0.6 1.9 0.2 7.8 0.2 1.0 2056.7 0.3 2.3 3.7 8.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 9.8 6.6 8.4 6.2 7.2 7.0 8.0 5.5 8.7 6.2 7.8 8.7 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.0 1.2 0.0 0.0 0.1 40.9 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 0.0 2.3 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.7 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.9 0.5 3.6 0.0 0.0 0.0 0.0 2.0 8.2 0.0 0.1 0.0 0.1 0.3 0.3 0.2 0.1 0.8 0.0 42.0 1.3 0.2 0.2 0.2 0.0 0.0 0.3 0.1 0.5 0.1 KDM3B "C5orf7, JMJD1B, KIAA1082, NET22" ENSG00000120733 "Lysine demethylase 3B" Q7LBC6 5 138352685-138437028 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016610, HPA057202" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA016610: AB_1852004, HPA057202: AB_2683367" "unprognostic (1.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-3)" "unprognostic (1.34e-1)" "unprognostic (6.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.21e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.68e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "prognostic favorable (6.67e-4)" "unprognostic (1.73e-1)" "unprognostic (3.05e-1)" "unprognostic (1.43e-1)" "unprognostic (7.60e-2)" 20.1 19.5 22.9 17.1 23.1 25.6 25.5 22.9 23.0 22.9 21.3 23.4 18.8 23.2 28.5 21.3 24.4 14.3 20.0 21.9 21.6 21.6 14.7 19.5 23.2 23.9 23.1 20.2 31.1 20.5 34.5 16.6 20.6 23.1 22.0 24.2 36.6 22.4 26.2 41.8 28.3 23.6 20.9 22.0 26.2 21.8 19.6 22.8 36.2 23.4 27.3 29.6 25.0 20.1 22.4 24.3 32.4 65.0 58.7 27.2 23.3 47.0 15.6 27.1 30.0 33.5 35.7 27.2 46.3 27.9 30.3 41.0 24.3 53.2 37.8 32.6 30.3 29.3 39.2 28.6 27.1 25.4 32.2 43.3 26.9 39.0 22.1 26.7 23.2 34.6 29.3 31.8 26.1 34.3 30.3 46.4 41.0 31.0 34.1 13.7 53.1 48.5 30.9 40.4 31.6 32.7 35.9 27.0 28.0 25.7 93.2 27.3 43.5 31.9 17.9 17.4 19.3 28.8 32.8 16.7 40.2 12.5 45.6 25.6 0.2 2.9 4.2 2.3 2.2 3.2 2.3 2.7 3.0 2.5 2.0 2.5 2.3 5.5 4.2 2.3 3.0 1.7 1.3 22.9 23.1 22.9 23.0 21.9 21.6 23.9 23.1 20.2 23.1 22.0 22.8 22.4 22.8 16.0 15.7 43.1 22.1 15.9 13.7 15.1 20.5 21.3 29.1 29.5 33.2 17.2 17.0 22.0 29.2 13.4 24.0 26.8 0.0 16.0 6.1 22.8 19.9 18.9 21.0 25.4 40.9 16.8 10.7 18.5 17.9 24.2 13.3 26.3 18.2 23.0 17.6 23.5 39.1 26.4 18.3 39.2 18.3 2.8 21.1 27.9 16.0 50.6 27.0 17.3 16.5 41.7 56.9 19.9 28.0 23.0 16.2 21.2 20.9 16.1 25.6 31.9 26.3 21.8 18.7 13.0 15.5 26.2 21.6 10.9 19.1 17.1 24.6 21.0 EGR1 "AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225" ENSG00000120738 "Early growth response 1" P18146 5 138465479-138469303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 1113.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 247.8" "Immune cell enhanced" "Detected in some" "neutrophil: 7.1" "Group enriched" "Detected in many" 7 "granulocytes: 7.1;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019427, HPA029937, HPA029938" Supported Enhanced Nucleoplasm No No Nucleoplasm "CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259" "unprognostic (5.47e-2)" "unprognostic (4.09e-1)" "unprognostic (1.57e-1)" "unprognostic (7.74e-2)" "unprognostic (6.32e-2)" "unprognostic (2.66e-1)" "unprognostic (1.80e-1)" "unprognostic (2.96e-1)" "unprognostic (7.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (3.51e-3)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" 570.6 357.4 8.4 136.6 15.2 178.2 175.4 109.9 75.9 305.2 12.6 200.0 55.3 199.5 13.6 374.2 920.0 348.2 207.1 17.5 247.8 174.8 150.7 174.9 146.3 12.2 15.1 5.8 983.2 138.1 94.3 245.1 54.6 13.3 312.5 162.6 56.5 142.2 85.2 66.6 259.1 108.1 478.1 9.1 78.2 256.7 27.2 11.4 304.3 589.9 358.0 19.3 193.2 116.9 36.1 21.8 0.9 45.0 67.6 119.6 192.0 5.1 36.7 22.7 48.4 39.0 26.4 18.9 1.1 5.9 80.2 165.8 10.1 2.6 74.5 22.2 1.1 3.3 3.0 11.5 7.6 15.5 8.0 57.8 15.2 286.6 43.2 9.8 37.6 4.2 53.9 112.5 26.0 14.3 108.2 3.2 34.1 4.1 80.3 0.1 0.8 6.7 4.1 36.8 13.1 56.5 6.4 44.7 120.1 106.6 43.3 1.5 6.6 1.8 17.5 22.6 8.7 14.2 60.1 478.8 8.6 20.3 103.5 5.2 0.0 2.6 0.3 0.1 3.6 0.0 0.7 0.1 0.0 0.7 0.2 0.1 0.1 7.1 0.1 1.2 0.0 0.2 0.5 8.4 15.2 109.9 75.9 17.5 247.8 12.2 15.1 5.8 13.3 9.1 11.4 36.1 920.4 275.7 485.6 6.8 116.4 181.8 719.6 207.4 816.1 43.5 550.0 459.0 652.4 420.4 124.0 29.5 64.6 159.5 46.2 645.2 7.9 255.4 1.4 356.0 836.5 383.1 960.5 27.3 20.3 101.7 110.1 989.9 736.0 645.4 354.0 274.8 347.0 183.1 131.4 3.3 2.7 747.6 93.6 218.6 109.7 3.8 164.7 300.7 106.7 20.6 8.6 191.6 0.0 1.5 2.4 135.3 380.8 53.0 67.2 405.1 224.8 5.7 127.4 101.3 223.5 1113.1 613.2 3.2 2.9 644.8 200.3 129.7 83.4 104.9 480.2 145.4 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541998-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 542.5;U-266/70: 735.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 60.7 94.8 52.8 65.0 55.4 87.6 104.9 52.0 68.3 105.2 57.7 79.2 63.9 51.4 159.4 81.2 80.9 48.6 34.0 56.1 69.3 64.9 159.0 83.1 66.6 55.7 51.3 51.0 81.4 257.7 57.7 85.2 60.8 53.8 93.2 68.5 26.3 187.1 70.4 17.0 50.1 64.8 45.4 59.0 88.5 115.8 37.8 61.7 67.0 114.2 17.2 75.1 65.2 64.8 60.0 216.1 46.3 68.9 52.5 99.7 116.0 152.9 150.4 98.7 82.2 96.5 121.6 93.7 175.8 274.8 111.7 67.7 102.2 113.6 79.5 108.6 104.7 93.3 187.1 38.4 123.9 193.9 170.8 117.4 69.6 139.4 47.7 236.7 89.2 97.7 118.1 92.7 241.0 70.8 95.3 144.5 143.3 128.1 138.5 115.1 181.2 52.5 542.5 100.4 69.7 116.8 99.3 57.8 128.4 244.5 83.2 112.8 165.0 93.8 38.9 69.6 84.4 117.0 735.1 230.5 236.0 70.9 165.2 36.8 347.2 410.6 375.2 237.4 399.6 304.5 239.7 250.3 238.5 317.6 222.1 244.0 227.3 299.9 188.5 456.8 321.1 268.0 508.0 52.8 55.4 52.0 68.3 56.1 69.3 55.7 51.3 51.0 53.8 59.0 61.7 60.0 168.0 67.3 162.7 66.0 468.4 538.0 677.4 277.8 363.7 74.5 500.8 451.2 44.5 158.7 246.5 172.9 58.4 284.6 337.7 351.1 365.9 231.3 361.1 246.5 198.9 189.5 254.0 157.5 51.6 304.3 553.8 213.0 218.2 359.7 219.7 135.4 249.5 480.7 373.5 42.1 48.0 563.2 168.9 662.6 477.8 627.0 219.6 512.6 348.6 25.3 558.1 174.5 279.1 63.3 60.6 349.0 564.2 190.3 923.0 744.8 326.1 293.7 218.5 69.6 111.7 98.1 192.4 208.0 91.3 347.4 592.7 944.7 335.5 94.2 404.3 1101.9 PLS1 "I-plastin, Plastin-1" ENSG00000120756 "Plastin 1" Q14651 3 142596393-142713664 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 318.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 471.4;Intestinal goblet cells: 147.9;Paneth cells: 200.5;Proximal enterocytes: 335.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 36.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.6;NK-cells: 3.2;T-cells: 2.6" "Cell line enhanced" "Detected in many" "A-431: 90.0;BEWO: 112.3;OE19: 166.4;RPTEC TERT1: 143.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055744, HPA061936" Enhanced NA NA 56000000 "HPA055744: AB_2682903, HPA061936: " "unprognostic (1.29e-1)" "unprognostic (2.61e-1)" "unprognostic (3.15e-3)" "unprognostic (2.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (4.84e-4)" "unprognostic (3.14e-2)" "prognostic favorable (8.76e-6)" "unprognostic (1.99e-2)" "unprognostic (8.64e-2)" "unprognostic (7.22e-2)" "unprognostic (3.82e-2)" 1.6 3.9 0.5 18.9 1.4 7.5 5.8 2.6 2.3 10.2 9.3 145.5 193.3 3.4 3.2 9.7 7.8 28.0 1.2 1.2 1.2 26.9 27.7 14.9 1.7 2.8 0.7 1.0 0.9 12.3 15.8 6.3 1.6 3.3 3.2 140.5 25.1 9.2 2.0 1.0 3.7 318.1 4.4 0.3 0.9 46.2 7.5 0.5 6.0 7.8 0.9 2.9 19.8 3.8 2.0 90.0 69.2 4.8 10.4 0.7 0.0 112.3 1.7 2.3 9.4 20.1 31.7 68.8 15.2 35.8 0.1 31.9 18.9 18.8 28.7 20.0 5.5 27.0 27.2 10.2 11.4 0.9 13.0 1.7 0.1 4.7 17.8 11.4 14.8 4.5 16.4 11.8 1.7 1.1 21.0 21.4 7.0 18.9 166.4 25.9 8.7 20.3 12.7 143.6 81.7 24.1 9.7 10.0 7.0 7.8 13.3 55.6 2.2 1.2 1.1 11.3 3.5 21.3 12.7 12.6 18.1 3.2 12.8 3.5 1.9 0.2 2.6 1.5 0.2 2.0 0.3 1.8 2.0 0.4 0.3 2.2 2.6 1.8 3.2 0.2 0.5 1.3 1.0 0.5 1.4 2.6 2.3 1.2 1.2 2.8 0.7 1.0 3.3 0.3 0.5 2.0 0.6 54.5 38.0 1.3 1.6 2.9 4.1 23.2 2.8 3.4 9.7 4.2 3.1 54.3 46.8 44.1 16.7 5.8 0.7 471.4 21.5 21.8 64.3 22.2 1.8 0.7 53.9 5.9 18.7 34.0 1.9 1.1 50.0 26.8 8.9 32.3 1.1 31.5 0.6 5.0 25.2 147.9 24.4 1.6 1.0 20.5 1.2 1.4 1.8 5.6 0.8 2.8 0.0 4.0 3.1 70.2 200.5 0.0 2.8 6.8 335.1 40.6 42.2 13.4 0.0 1.2 1.9 4.6 4.1 7.6 3.3 1.4 1.8 1.3 85.2 20.7 ZFP30 "KIAA0961, ZNF745" ENSG00000120784 "ZFP30 zinc finger protein" Q9Y2G7 19 37613749-37692337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030606 Uncertain Approved Cytosol NA NA Cytosol "HPA030606: AB_10602684" "unprognostic (1.86e-2)" "unprognostic (3.00e-2)" "unprognostic (1.09e-3)" "unprognostic (3.64e-2)" "unprognostic (6.10e-3)" "unprognostic (1.14e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "unprognostic (5.62e-3)" "unprognostic (7.03e-2)" "unprognostic (2.72e-2)" "unprognostic (5.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (3.01e-1)" "unprognostic (4.92e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-3)" 2.8 3.7 2.1 2.2 3.1 1.1 4.8 8.8 3.5 3.3 0.7 3.1 2.3 4.6 3.8 3.4 4.1 2.6 2.7 2.5 2.5 3.4 2.3 3.2 4.1 2.2 2.5 2.4 5.2 3.6 5.9 1.1 4.4 3.4 4.5 2.9 8.7 2.6 4.3 3.0 5.4 2.0 3.5 2.3 4.1 3.2 7.4 2.6 4.6 6.1 3.9 3.9 2.5 1.1 4.8 9.4 8.1 12.9 18.2 6.8 6.6 3.9 9.5 8.7 7.0 7.6 6.5 1.7 0.0 9.5 8.7 5.7 3.4 12.9 5.0 7.5 14.2 5.0 9.4 10.0 5.0 5.1 1.3 7.0 6.0 7.6 6.1 9.1 5.6 4.1 6.4 7.2 0.0 9.1 4.3 10.3 4.8 2.8 1.2 5.5 4.0 16.8 0.1 4.3 15.3 14.4 15.6 11.1 4.3 3.4 5.1 5.9 2.5 9.0 9.5 32.5 4.6 9.6 4.9 5.5 5.9 0.0 0.1 7.3 2.2 0.5 1.3 1.1 0.6 1.5 0.5 1.4 1.1 0.4 2.1 1.7 1.8 0.3 2.8 0.2 0.9 1.1 1.0 2.1 3.1 8.8 3.5 2.5 2.5 2.2 2.5 2.4 3.4 2.3 2.6 4.8 4.6 6.4 1.8 9.8 6.7 0.8 1.2 1.5 2.8 11.4 2.6 2.5 7.3 4.3 2.7 3.7 4.2 2.6 3.0 1.4 1.9 3.4 60.5 3.5 5.5 6.3 4.2 1.7 17.6 2.3 1.6 5.1 4.6 3.6 9.5 7.3 3.6 0.9 2.5 8.4 19.1 3.1 0.0 2.1 1.1 14.3 7.5 2.4 0.0 11.2 1.6 4.8 5.2 20.1 17.5 1.8 0.8 6.4 1.4 1.8 0.6 2.8 3.2 9.2 6.6 5.4 4.6 9.4 5.2 2.9 0.4 0.8 4.0 4.1 2.2 0.7 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073628 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898" "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favorable (5.62e-5)" 7.8 10.5 5.3 5.1 6.3 9.4 7.8 14.0 9.3 8.9 8.5 8.2 5.6 10.4 9.9 5.4 10.3 4.5 9.5 5.9 5.3 6.6 10.1 8.7 5.5 5.7 5.8 5.1 10.0 8.2 6.1 7.3 5.8 7.8 6.8 6.3 15.8 5.3 7.6 14.4 6.1 7.7 7.8 5.1 9.3 6.2 12.1 5.9 5.8 12.0 5.5 5.3 8.2 7.5 7.3 11.4 13.9 23.0 10.2 5.8 10.0 30.5 10.9 7.9 10.6 9.9 12.2 6.2 13.8 3.8 7.3 6.8 11.8 10.7 8.6 8.1 6.0 23.1 16.7 11.5 15.4 11.1 11.3 7.0 10.2 7.0 7.9 9.5 13.3 11.6 16.8 12.9 5.2 12.9 8.3 12.4 26.0 14.5 9.1 24.0 11.7 15.0 8.1 12.3 13.9 11.1 8.8 17.6 7.4 8.4 11.8 12.9 7.5 10.9 8.6 8.4 10.7 6.2 7.7 13.1 13.0 2.1 13.0 4.2 0.3 2.4 2.1 3.9 2.6 5.0 2.0 3.1 3.3 3.7 2.3 4.0 2.8 1.5 2.1 2.3 3.6 2.3 2.3 5.3 6.3 14.0 9.3 5.9 5.3 5.7 5.8 5.1 7.8 5.1 5.9 7.3 18.7 35.3 15.4 28.4 14.4 8.3 14.4 7.8 15.4 44.8 7.6 7.5 18.5 8.6 5.6 11.0 18.8 15.3 19.9 10.3 3.9 11.6 25.2 14.8 23.3 15.5 7.2 15.6 55.4 9.4 12.7 17.4 16.3 18.8 10.1 28.0 13.2 12.7 9.5 25.2 73.4 11.4 12.2 11.1 9.5 6.4 43.8 10.9 14.2 34.7 10.7 14.9 12.3 26.2 51.1 18.7 9.9 30.1 13.7 9.4 5.8 8.1 19.6 49.6 6.6 17.3 14.6 67.0 25.9 12.1 7.4 7.8 15.0 18.0 13.3 20.2 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20 small subunit processome component" O75691 12 101280105-101386618 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" No No Nucleoli "Plasma membrane" "HPA049341: AB_2680720" "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favorable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 4.3 4.3 2.2 5.0 3.6 4.2 5.7 2.9 2.7 5.8 2.5 3.2 2.1 4.6 2.7 4.0 3.8 2.5 3.0 2.2 2.5 3.3 3.0 3.0 5.1 3.0 2.8 2.0 6.4 4.8 5.3 2.2 4.3 3.2 3.5 4.3 3.5 5.6 3.3 5.3 4.7 3.1 4.1 2.5 3.6 3.2 5.6 3.0 4.3 4.2 4.0 4.9 5.2 3.6 5.0 8.1 19.9 14.8 6.9 13.0 15.1 18.2 13.8 10.8 21.5 11.8 23.1 5.7 21.6 7.1 15.4 16.2 16.6 33.0 14.2 27.8 9.8 13.4 22.8 10.0 17.3 7.3 38.4 10.2 9.9 7.3 29.9 10.3 8.2 15.0 10.9 36.7 4.3 15.8 10.6 16.8 10.9 38.9 11.3 20.6 18.8 24.2 16.8 9.1 24.4 17.0 11.5 25.8 16.1 15.7 12.2 17.0 8.5 17.1 25.3 12.5 17.8 27.1 7.8 12.6 35.1 13.8 17.2 39.6 0.0 0.2 0.0 0.5 0.3 0.5 0.9 0.5 0.7 0.4 0.6 0.6 0.7 0.0 0.6 0.2 0.8 0.5 0.2 2.2 3.6 2.9 2.7 2.2 2.5 3.0 2.8 2.0 3.2 2.5 3.0 5.0 14.3 9.6 9.9 16.0 16.7 10.1 9.7 7.7 11.4 9.9 8.7 8.4 10.3 7.2 13.6 3.7 10.4 7.8 4.4 3.4 5.9 7.6 1.5 11.4 24.5 12.6 6.6 14.9 17.0 11.6 8.8 13.0 7.7 10.1 13.3 18.6 7.1 7.6 5.8 21.9 17.0 6.3 4.1 6.3 3.5 1.2 9.6 8.6 3.6 8.4 3.3 3.3 4.1 16.1 34.2 5.9 1.9 8.2 13.2 14.5 1.1 3.0 9.0 9.4 6.6 24.9 11.0 22.6 22.3 17.3 11.1 2.9 10.0 23.7 9.8 7.2 TMPO "LAP2, LEMD4, TP" ENSG00000120802 Thymopoietin "P42166, P42167" 12 98515579-98550351 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" DNA-binding Cardiomyopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 141.2" "Cell type enhanced" "Detected in all" "Erythroid cells: 172.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008150, CAB009847, HPA070805" Enhanced Enhanced "Nuclear membrane" NA Yes 190000 "Nuclear membrane" "CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: " "unprognostic (2.36e-1)" "unprognostic (4.46e-3)" "unprognostic (5.90e-2)" "unprognostic (2.80e-2)" "unprognostic (1.35e-1)" "unprognostic (2.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-2)" "unprognostic (3.69e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-3)" "prognostic unfavorable (9.34e-4)" "unprognostic (6.01e-3)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (3.26e-2)" 17.3 14.0 10.0 44.5 9.6 94.0 24.5 19.7 15.3 22.2 11.8 34.8 34.5 31.1 34.7 27.2 23.0 17.9 11.0 9.9 9.5 21.9 37.6 22.1 79.3 10.2 10.2 7.6 56.7 25.5 17.9 8.5 29.6 12.9 17.3 36.8 20.9 16.6 19.3 12.3 22.9 39.9 22.5 10.2 39.4 36.0 23.3 12.2 141.2 15.3 12.3 78.7 20.9 20.9 14.1 180.5 117.5 283.3 145.5 23.1 30.7 166.2 145.0 77.1 193.9 139.5 129.5 88.9 314.4 86.2 85.6 70.7 113.0 240.8 110.1 177.1 217.7 148.5 269.1 103.3 86.5 21.2 315.4 170.8 17.6 35.4 115.0 61.2 66.9 112.8 192.0 231.8 118.1 122.0 114.7 514.9 248.6 170.1 167.2 108.6 421.3 187.2 218.6 69.3 167.7 221.9 132.2 248.9 155.2 79.3 110.6 174.3 149.2 60.4 111.1 96.5 76.8 150.8 125.9 231.9 344.0 32.0 179.5 151.0 48.6 30.4 13.4 18.9 54.1 20.5 22.4 21.9 21.6 23.4 27.2 30.0 23.5 2.4 20.7 75.9 12.9 28.5 30.5 10.0 9.6 19.7 15.3 9.9 9.5 10.2 10.2 7.6 12.9 10.2 12.2 14.1 45.4 32.1 27.9 3.6 70.1 27.8 23.7 18.7 28.5 21.1 21.2 28.6 9.0 25.8 33.5 31.3 12.5 36.0 48.5 63.0 31.3 19.5 42.7 29.5 29.8 38.0 28.7 172.1 20.3 31.5 89.7 32.2 56.1 42.7 29.1 70.1 34.2 50.0 38.2 10.1 15.3 63.4 16.2 63.1 34.9 32.1 28.6 73.4 17.8 23.4 63.5 20.3 54.6 14.6 19.1 26.7 28.5 40.6 81.9 21.1 33.7 33.1 25.6 52.6 19.7 27.3 32.0 54.0 59.4 62.8 23.3 11.8 60.8 32.4 62.4 21.8 ARL1 ARFL1 ENSG00000120805 "ADP ribosylation factor like GTPase 1" P40616 12 101393116-101407772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062656, HPA073012" Approved Supported "Golgi apparatus" NA NA 13000 "Golgi apparatus" "HPA062656: AB_2684821, HPA073012: AB_2686564" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.61e-4)" "unprognostic (6.41e-2)" "unprognostic (3.15e-2)" "unprognostic (2.62e-3)" "unprognostic (1.69e-1)" "unprognostic (1.97e-1)" "unprognostic (4.82e-2)" "unprognostic (2.28e-1)" "unprognostic (4.54e-2)" "unprognostic (1.04e-2)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (3.46e-2)" 46.9 66.6 25.3 40.3 27.8 16.6 63.2 26.8 31.9 87.2 39.4 57.1 48.4 51.7 71.8 49.6 50.6 44.0 66.2 26.7 32.6 77.3 69.1 36.9 33.5 31.0 28.6 24.3 65.8 45.0 93.3 59.6 51.9 30.8 74.0 61.0 49.2 74.5 69.7 52.4 28.0 43.6 60.2 26.4 29.1 58.1 33.0 27.9 33.1 85.5 57.2 49.2 53.5 36.2 33.5 64.9 61.2 58.8 51.6 162.0 161.5 77.8 129.2 155.2 85.9 81.9 71.4 46.9 58.4 77.3 150.7 76.4 44.3 67.1 88.6 98.0 47.0 51.5 54.9 32.9 110.7 120.2 63.7 40.2 97.7 77.1 85.6 135.7 146.1 93.1 39.7 74.1 33.5 113.3 76.1 55.4 63.4 56.6 93.9 82.5 40.8 58.8 67.1 130.5 128.6 38.8 25.5 62.1 80.5 104.2 82.6 136.0 43.5 70.4 65.1 37.3 88.5 56.4 55.5 59.5 58.9 93.3 47.4 71.5 50.4 25.3 18.2 21.8 30.7 32.5 30.1 25.8 28.4 32.8 28.8 25.6 20.1 2.5 23.7 34.2 39.6 34.1 24.6 25.3 27.8 26.8 31.9 26.7 32.6 31.0 28.6 24.3 30.8 26.4 27.9 33.5 57.0 41.7 46.7 13.4 39.4 51.2 71.4 175.5 38.7 42.1 65.1 64.4 75.2 41.5 119.1 69.9 18.8 102.6 30.5 42.3 125.2 97.0 90.2 54.8 68.4 44.6 47.5 24.6 14.5 64.3 119.4 88.4 36.2 60.6 37.4 37.4 36.8 50.2 65.8 32.0 19.5 125.6 75.3 27.7 31.9 31.8 78.6 31.6 55.2 6.5 39.6 81.9 25.7 12.5 15.8 62.1 52.2 71.1 79.3 117.2 70.4 131.3 100.0 48.9 46.0 51.2 75.7 134.6 86.1 46.2 55.4 135.3 28.8 54.6 65.7 100.1 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988987-104064183 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.58e-6)" "prognostic unfavorable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 14.1 11.0 3.8 5.2 4.8 1.6 19.7 2.5 5.1 28.9 10.6 14.4 5.9 27.7 21.8 7.5 22.5 36.1 15.3 4.5 3.7 4.3 2.8 10.3 6.0 3.0 3.0 4.8 42.0 4.6 6.6 9.7 9.5 3.1 13.4 11.5 1.0 7.7 16.1 3.2 4.0 7.8 22.0 2.7 1.6 8.5 6.8 3.3 2.2 26.6 11.6 5.8 21.0 19.1 4.4 0.3 0.6 0.7 22.2 28.3 69.3 0.5 32.0 89.4 8.3 10.5 0.4 0.2 0.9 1.8 37.5 0.4 0.1 0.4 11.9 7.0 1.6 10.0 0.6 11.2 0.2 12.7 0.9 0.5 63.2 0.7 10.0 13.8 51.9 4.4 0.6 0.4 1.3 36.5 0.3 0.8 0.5 2.7 0.1 6.7 1.0 33.6 0.2 45.5 0.4 1.3 1.7 33.5 0.8 0.4 2.4 6.0 0.5 0.7 13.2 6.2 1.3 1.9 3.9 0.8 0.3 1.0 0.7 1.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 4.8 2.5 5.1 4.5 3.7 3.0 3.0 4.8 3.1 2.7 3.3 4.4 8.0 0.0 4.6 2.9 0.3 2.8 4.2 2.4 0.0 0.8 1.0 26.3 3.9 1.5 0.1 0.0 2.1 4.1 0.4 0.0 0.0 0.1 41.2 0.6 8.3 7.5 1.8 0.0 10.2 0.0 0.8 55.9 1.1 0.4 0.0 0.1 20.7 0.3 0.6 0.0 10.5 1.3 0.0 0.6 2.8 11.5 55.9 0.4 3.6 4.7 0.6 0.5 0.0 1.0 2.6 0.3 0.0 51.9 1.2 1.4 0.0 0.0 0.1 0.5 6.6 25.2 18.0 1.1 1.1 0.2 2.4 1.4 0.6 10.7 0.0 0.1 MTERF2 "FLJ14062, MTERFD3" ENSG00000120832 "Mitochondrial transcription termination factor 2" Q49AM1 12 106977277-106987160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003526 Approved NA NA "HPA003526: AB_1079423" "unprognostic (1.54e-2)" "prognostic favorable (8.50e-4)" "unprognostic (1.17e-1)" "unprognostic (4.87e-2)" "unprognostic (7.62e-2)" "unprognostic (7.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.37e-3)" "unprognostic (1.15e-2)" "unprognostic (2.57e-1)" "unprognostic (3.54e-3)" "unprognostic (1.60e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (2.88e-2)" "unprognostic (1.29e-1)" "unprognostic (1.24e-3)" 14.1 25.0 24.4 6.3 24.6 6.5 17.5 32.5 27.9 19.1 24.3 21.9 17.6 16.1 13.3 9.6 17.1 13.0 28.0 24.2 25.0 22.4 29.3 15.2 8.1 24.0 25.1 24.2 21.6 34.3 12.8 20.4 7.2 26.8 22.7 9.9 30.4 15.7 11.9 23.2 22.5 16.7 11.8 23.2 15.2 22.6 17.7 25.4 6.6 30.7 16.5 5.6 16.2 13.5 24.6 10.3 13.0 14.5 20.6 16.7 8.5 7.0 10.0 5.2 8.1 8.5 8.2 7.2 7.0 10.5 6.7 6.6 10.0 11.1 5.4 6.7 14.2 13.2 23.9 18.4 14.5 12.6 0.0 7.8 15.2 9.7 8.1 5.9 13.0 10.5 0.5 31.8 6.9 9.8 7.8 3.3 10.6 7.4 4.2 13.0 10.3 13.0 4.4 14.6 11.9 14.3 16.5 13.4 18.0 18.4 13.4 26.0 9.3 10.0 9.1 6.1 7.3 8.3 14.7 19.4 6.7 3.5 2.4 13.8 0.3 0.7 3.0 11.8 2.1 10.1 2.8 11.1 9.3 5.2 2.8 9.1 9.8 5.0 7.2 1.3 11.0 10.7 5.8 24.4 24.6 32.5 27.9 24.2 25.0 24.0 25.1 24.2 26.8 23.2 25.4 24.6 11.7 35.3 11.4 24.8 4.3 0.0 20.2 0.0 8.0 0.0 23.6 21.7 20.1 27.1 4.3 14.7 0.0 10.8 19.3 1.8 39.2 6.3 32.3 10.7 16.6 9.1 3.6 12.4 13.9 6.4 8.7 12.7 10.2 10.7 5.1 15.0 10.4 16.8 7.0 0.0 20.6 4.4 0.0 3.2 0.0 12.1 20.2 3.8 0.0 2.8 4.3 0.0 16.5 16.1 15.3 3.6 7.6 24.8 4.8 6.7 8.5 27.1 6.6 0.0 13.1 27.1 10.3 17.7 10.7 5.7 0.0 4.2 10.8 20.6 8.1 7.3 SOCS2 "CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2" ENSG00000120833 "Suppressor of cytokine signaling 2" O14508 12 93569814-93583487 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 203.6;Hepatic stellate cells: 134.6" "Cancer enhanced" "Detected in all" "prostate cancer: 16.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 177.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 177.8" "Cell line enhanced" "Detected in many" "CACO-2: 192.0;K-562: 145.6;REH: 336.6;THP-1: 142.3" "Low region specificity" "Detected in all" CAB010356 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB010356: AB_2239660" "unprognostic (4.16e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.87e-1)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" "prognostic favorable (1.09e-6)" "unprognostic (1.07e-1)" "unprognostic (1.49e-1)" "unprognostic (5.35e-3)" "prognostic favorable (8.17e-7)" "unprognostic (1.71e-1)" "unprognostic (1.67e-3)" "unprognostic (2.35e-2)" "unprognostic (1.51e-1)" "unprognostic (7.40e-2)" "unprognostic (9.09e-2)" 53.6 35.2 8.0 10.5 11.3 11.6 68.6 7.8 8.9 91.0 21.6 32.7 11.8 92.5 42.4 16.7 42.8 20.9 25.9 10.0 35.8 29.6 59.5 62.4 9.2 8.8 10.6 7.8 19.4 13.9 65.0 55.7 36.8 10.6 82.1 17.2 4.9 9.6 45.9 9.6 9.0 17.5 90.2 6.3 8.6 31.0 8.7 10.4 21.6 33.1 6.2 9.2 32.3 50.8 8.5 3.5 4.9 16.8 15.2 9.1 16.6 19.8 20.8 77.0 15.2 6.6 192.0 7.8 1.0 0.7 19.3 4.1 39.8 88.6 5.9 17.3 69.0 2.5 13.9 1.2 2.7 13.8 4.2 28.5 28.3 4.9 16.7 22.7 1.6 2.1 8.7 145.6 3.1 2.4 1.8 0.8 6.8 47.4 3.2 7.4 336.6 0.3 3.6 4.1 7.4 28.8 34.2 7.3 11.5 57.5 16.0 0.2 142.3 2.3 47.2 0.7 0.3 11.7 2.0 1.1 1.4 0.9 12.0 28.8 177.8 0.2 7.7 25.4 0.5 34.2 0.4 31.2 23.3 0.2 4.3 30.6 18.4 1.1 26.8 0.4 2.0 19.8 14.4 8.0 11.3 7.8 8.9 10.0 35.8 8.8 10.6 7.8 10.6 6.3 10.4 8.5 203.6 9.6 78.7 1.0 1.4 18.0 46.0 3.2 1.2 8.2 30.5 16.9 6.5 0.0 24.3 22.0 4.2 36.3 15.5 20.8 62.6 13.7 9.8 10.5 94.9 100.5 8.3 33.2 10.9 37.4 6.7 34.6 7.1 20.2 24.1 9.9 134.6 11.6 14.2 69.0 12.3 13.3 4.1 8.9 20.7 20.3 91.6 6.0 17.8 8.4 108.4 1.5 18.6 1.0 1.3 8.8 21.2 101.2 6.4 95.2 20.0 27.5 5.4 1.2 78.9 15.8 32.9 9.9 10.5 1.8 10.5 35.0 15.7 12.7 15.7 30.1 NFYB "CBF-A, HAP3, NF-YB" ENSG00000120837 "Nuclear transcription factor Y subunit beta" P25208 12 104117086-104138241 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Syncytiotrophoblasts: 433.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004211, HPA065646" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004211: AB_628018, HPA065646: " "unprognostic (5.82e-2)" "unprognostic (2.44e-3)" "unprognostic (4.90e-2)" "unprognostic (7.10e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "unprognostic (2.10e-2)" "unprognostic (2.44e-1)" "unprognostic (7.36e-2)" "unprognostic (2.63e-1)" "unprognostic (9.39e-2)" "unprognostic (8.51e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.62e-3)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.81e-3)" 32.1 41.2 41.7 15.3 41.6 14.8 27.4 38.4 46.1 27.1 34.8 45.5 15.1 30.7 33.4 16.2 30.3 18.7 34.5 38.8 39.1 21.7 30.8 29.2 24.9 41.3 41.7 36.6 23.4 21.4 21.9 17.6 23.8 44.2 39.3 18.6 21.4 20.8 68.6 36.5 18.3 21.9 21.3 42.4 19.5 26.5 22.8 40.9 26.5 22.9 36.6 23.0 38.4 24.1 44.3 30.1 25.3 55.3 35.7 34.2 35.6 48.6 31.5 27.2 37.2 25.6 21.2 14.0 44.4 15.1 30.3 22.9 22.0 46.5 20.9 37.4 28.9 14.7 27.4 31.0 19.7 31.0 35.0 17.6 49.3 25.6 14.5 25.5 62.0 24.0 40.1 27.1 16.2 31.6 29.6 53.2 40.5 52.8 22.1 26.0 43.5 30.9 18.8 27.3 25.3 31.3 26.2 58.0 132.5 19.3 36.8 53.1 42.9 15.2 21.3 13.1 17.5 24.0 28.5 29.5 42.0 12.5 23.7 22.8 18.0 5.7 18.5 12.1 7.8 16.6 12.3 12.1 12.5 5.7 8.5 13.0 13.7 7.2 13.5 9.0 5.0 16.9 9.1 41.7 41.6 38.4 46.1 38.8 39.1 41.3 41.7 36.6 44.2 42.4 40.9 44.3 42.5 54.5 26.7 8.8 21.1 37.3 106.8 42.9 15.9 22.7 24.3 31.8 39.5 12.8 30.3 18.4 4.2 58.8 24.5 13.3 37.2 24.2 6.2 20.4 36.4 36.5 12.0 39.4 13.1 18.3 86.3 43.0 11.2 17.5 21.5 30.8 77.1 31.2 23.1 15.2 13.7 15.4 30.5 14.4 29.8 5.4 34.2 19.2 28.4 8.4 20.2 43.3 22.6 11.1 25.3 27.3 16.9 30.5 17.1 54.5 12.6 42.5 26.7 27.2 19.7 35.4 40.0 90.0 32.4 18.0 37.1 433.2 25.6 18.8 18.3 55.7 WASHC3 "CCDC53, CGI-116" ENSG00000120860 "WASH complex subunit 3" Q9Y3C0 12 102012840-102062149 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 125.2;Hofbauer cells: 73.1;Proximal tubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038339 Uncertain Approved Vesicles NA NA Vesicles "HPA038339: AB_2675966" "unprognostic (4.25e-2)" "unprognostic (1.61e-2)" "unprognostic (2.28e-1)" "unprognostic (3.45e-3)" "unprognostic (1.21e-2)" "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.63e-2)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "unprognostic (7.81e-2)" "unprognostic (7.41e-2)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" 27.3 32.5 43.1 14.4 43.9 13.3 24.9 44.7 57.7 26.6 40.6 29.7 13.7 27.7 36.0 28.6 18.1 17.9 35.3 44.0 46.2 42.0 41.5 20.8 23.0 46.6 45.3 42.7 20.5 17.5 38.2 33.7 20.2 45.9 26.3 20.9 25.5 19.9 35.3 34.8 19.6 20.7 29.5 44.9 22.9 27.6 98.8 44.7 31.5 25.9 42.5 26.4 29.0 23.6 47.6 17.1 23.3 20.1 12.6 75.2 90.9 18.9 23.3 48.0 33.6 37.3 18.8 16.0 18.0 16.4 52.9 34.2 32.1 21.4 57.0 44.5 41.8 12.9 25.3 15.9 29.5 67.0 22.4 13.9 55.9 72.4 42.1 42.2 92.1 46.3 43.5 15.3 19.6 88.4 23.1 23.6 39.9 6.1 32.7 41.0 13.6 30.4 27.2 59.4 27.7 19.6 10.8 32.6 22.9 50.2 36.5 29.1 12.8 25.5 41.5 9.9 24.7 16.3 49.5 32.7 22.7 59.0 15.6 17.8 125.7 41.3 95.3 37.5 66.6 45.4 61.9 56.3 50.7 56.1 49.4 41.2 49.4 18.2 59.9 70.9 54.9 118.5 52.8 43.1 43.9 44.7 57.7 44.0 46.2 46.6 45.3 42.7 45.9 44.9 44.7 47.6 55.4 28.9 41.5 0.0 18.5 0.0 0.0 0.0 0.0 0.0 36.4 55.4 0.0 0.0 14.2 33.1 0.0 60.3 28.4 0.0 125.2 47.9 0.0 40.5 49.2 15.0 0.0 0.0 0.0 38.8 48.5 24.8 0.0 27.4 40.4 36.1 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 35.5 0.0 0.0 5.4 0.0 0.0 98.9 22.6 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 39.4 18.8 60.9 0.0 0.0 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645290-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32.3" "Cell type enhanced" "Detected in many" "monocytes: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 71.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 4.6 2.8 1.6 8.9 2.8 32.3 5.1 2.6 3.0 5.6 1.9 8.5 5.1 5.6 3.6 3.2 4.1 7.4 2.4 2.6 2.1 3.7 4.7 6.8 9.5 2.2 1.4 1.9 7.8 4.0 2.8 3.1 7.7 1.9 3.9 9.7 5.9 4.7 3.5 3.5 5.7 7.2 5.1 2.2 9.8 6.7 3.1 1.6 7.8 4.7 3.1 8.8 5.9 3.9 3.2 6.8 8.7 30.3 11.6 9.4 18.2 8.3 17.3 12.1 11.7 11.6 6.3 4.8 9.8 4.5 12.7 4.4 11.3 20.2 11.4 13.9 7.3 8.0 18.5 9.6 7.7 3.5 18.6 22.7 7.5 3.5 12.1 5.5 14.1 19.6 7.3 9.1 5.2 18.7 1.8 9.4 19.0 8.1 7.5 5.8 11.9 22.8 3.1 7.1 11.5 4.1 7.4 13.5 5.3 4.6 18.6 9.2 25.7 17.7 7.5 6.6 9.0 5.4 3.5 7.1 11.5 3.3 25.4 11.5 16.8 18.1 17.0 4.0 8.0 3.1 5.5 2.8 2.3 14.3 6.2 2.9 1.9 71.1 2.9 8.5 10.4 2.1 3.9 1.6 2.8 2.6 3.0 2.6 2.1 2.2 1.4 1.9 1.9 2.2 1.6 3.2 11.7 12.8 8.2 10.4 13.8 3.8 5.7 8.7 8.6 5.8 6.4 6.5 1.5 1.5 7.8 7.3 14.6 3.8 21.4 22.3 0.0 9.4 0.7 5.9 11.6 11.1 12.0 7.6 12.8 8.0 8.0 9.1 14.8 8.7 6.3 18.6 13.2 6.7 12.3 5.0 13.8 18.9 4.1 34.7 25.3 1.3 5.9 34.1 10.6 30.9 54.6 2.7 20.6 14.1 11.2 19.7 20.3 5.3 8.9 8.7 9.2 2.7 8.9 9.8 0.0 6.9 8.1 6.9 10.0 8.7 3.3 1.9 14.6 4.3 13.3 15.0 DUSP4 "HVH2, MKP-2, TYP" ENSG00000120875 "Dual specificity phosphatase 4" Q13115 8 29333064-29350684 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;pancreas: 32.5;stomach 1: 32.6" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2" "Cancer enhanced" "Detected in all" "melanoma: 42.9" "Region enhanced" "Detected in many" "hypothalamus: 38.1" "Immune cell enriched" "Detected in single" 9 "T-reg: 6.7" "Lineage enriched" "Detected in single" 20 "T-cells: 6.7" "Cell line enhanced" "Detected in many" "A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061967 Supported Nucleoplasm NA NA Nucleoplasm "HPA061967: AB_2684648" "unprognostic (1.92e-1)" "unprognostic (5.97e-3)" "unprognostic (3.24e-1)" "unprognostic (6.54e-2)" "unprognostic (2.18e-2)" "unprognostic (7.66e-3)" "unprognostic (7.30e-2)" "unprognostic (7.08e-2)" "unprognostic (1.83e-2)" "unprognostic (9.73e-3)" "unprognostic (9.60e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (6.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (6.07e-2)" 14.7 5.2 2.4 5.4 1.6 6.2 23.9 4.1 9.0 6.1 0.4 1.2 1.2 4.5 0.1 2.5 1.9 11.4 1.7 17.0 38.1 0.9 0.7 5.7 2.6 1.6 1.0 1.4 0.4 32.5 0.6 5.4 7.5 1.7 5.3 1.4 6.0 16.3 10.2 4.2 5.6 2.0 1.2 0.4 1.0 32.6 2.9 2.7 4.3 1.2 0.9 2.7 14.0 2.8 1.2 38.0 100.0 57.9 2.8 7.2 0.0 4.9 7.7 42.0 22.8 10.1 1.1 18.8 0.0 20.5 3.6 16.0 12.0 0.7 25.7 13.5 1.0 1.9 0.3 3.7 0.7 0.2 0.5 47.3 4.6 16.7 7.1 42.1 49.7 18.9 0.4 0.3 4.5 46.0 42.9 0.1 7.1 10.1 91.7 60.5 1.2 1.9 8.1 52.3 19.7 0.4 32.0 10.8 49.5 157.2 1.1 10.7 1.1 53.3 16.7 0.3 0.0 5.7 11.6 1.4 0.1 50.2 8.9 122.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 6.7 0.0 2.4 1.6 4.1 9.0 17.0 38.1 1.6 1.0 1.4 1.7 0.4 2.7 1.2 11.1 0.0 2.8 0.0 33.5 12.1 98.3 27.3 4.0 43.2 80.4 62.2 2.6 51.5 51.1 0.0 12.5 3.2 24.0 1.9 0.0 74.3 7.6 64.7 13.3 16.3 97.8 0.0 3.8 78.6 40.9 9.6 121.8 155.5 6.3 0.0 21.8 0.3 25.0 43.7 8.2 8.5 126.1 4.0 102.8 25.6 0.3 47.4 65.8 0.0 75.6 0.8 0.0 1.5 0.3 195.2 0.0 0.0 31.0 30.9 0.4 0.2 43.6 3.4 13.1 18.9 17.8 1.4 8.2 2.3 11.9 17.8 115.6 0.1 4.6 102.7 CLU "APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2" ENSG00000120885 Clusterin P10909 8 27596917-27614700 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Complement pathway, Immunity, Innate immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10199.9;liver: 9859.6" "Group enriched" "Detected in all" 4 "Cholangiocytes: 2586.5;Collecting duct cells: 3525.7;Hepatocytes: 4230.2;Muller glia cells: 8522.6" "Cancer enhanced" "Detected in all" "glioma: 1485.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "basophil: 767.1" "Lineage enriched" "Detected in all" 33 "granulocytes: 767.1" "Cell line enhanced" "Detected in all" "HeLa: 3644.3;SK-BR-3: 3500.4;T-47d: 2562.4;U-2 OS: 2225.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000572, CAB016253, HPA075983" Enhanced Supported Cytosol "Secreted to blood" NA NA 169000000000 29000000000 Cytosol "CAB016253: AB_673562, HPA000572: AB_1078539, HPA075983: " "unprognostic (1.10e-2)" "unprognostic (1.81e-2)" "unprognostic (1.14e-3)" "unprognostic (2.74e-2)" "unprognostic (5.59e-2)" "unprognostic (4.13e-2)" "unprognostic (1.76e-2)" "unprognostic (2.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-2)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "prognostic favorable (7.66e-5)" "unprognostic (5.29e-2)" 1451.6 3841.1 6324.6 905.3 6280.0 53.7 1438.0 7083.7 8112.5 1196.6 5564.6 1041.8 326.9 1162.1 9228.8 775.6 3574.5 2889.5 465.8 6256.3 10098.6 1154.9 9859.6 835.0 2328.2 10199.9 7306.1 5587.1 763.5 2265.3 1701.1 833.7 132.3 7699.8 995.2 278.8 3303.2 1464.9 5517.0 115.0 267.1 668.3 1452.6 8251.0 297.9 1090.7 2733.9 7541.8 391.7 2426.6 270.1 2362.0 1792.2 747.3 9359.1 13.0 1673.1 73.2 86.4 401.4 546.1 230.7 297.8 584.8 77.3 40.1 323.4 265.5 6.6 1159.9 267.1 926.6 561.2 318.4 48.1 50.3 1268.7 306.4 741.8 3644.3 403.7 348.8 19.2 1891.2 923.4 189.1 334.0 95.5 719.5 1028.1 10.6 10.1 842.2 27.5 288.4 5.7 56.5 603.3 505.3 197.6 6.5 276.1 236.3 763.0 1220.2 66.7 41.7 412.3 3500.4 18.1 349.1 2562.4 10.3 153.2 24.0 2225.3 131.8 101.9 108.1 419.0 16.1 1808.8 122.4 10.3 767.1 18.4 8.9 19.8 6.2 7.4 0.7 23.1 21.3 6.2 1.6 2.8 7.0 79.8 9.3 1.1 11.8 6.5 1073.6 6324.6 6280.0 7083.7 8112.5 6256.3 10098.6 10199.9 7306.1 5587.1 7699.8 8251.0 7541.8 9359.1 255.3 32.1 91.8 720.5 16.1 81.3 944.6 134.1 118.9 74.3 475.3 480.4 86.1 2586.5 514.0 3525.7 77.2 116.3 15.2 23.6 41.1 488.3 311.3 196.9 31.1 442.0 9.5 92.4 73.4 620.7 22.7 614.8 226.8 185.6 803.0 31.4 1037.7 4230.2 12.6 30.3 81.0 30.9 28.5 180.5 88.9 789.3 114.3 244.6 206.3 69.3 25.1 8522.6 11.3 61.3 54.3 174.8 15.0 57.2 11.6 200.5 9.9 459.2 709.1 221.4 13.1 334.4 157.7 189.8 20.3 58.8 55.3 85.6 58.7 288.9 49.3 353.7 TNFRSF10B "CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB" ENSG00000120889 "TNF receptor superfamily member 10b" O14763 8 23020133-23069031 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 81.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023625 Approved NA NA "HPA023625: AB_1847860" "unprognostic (8.43e-3)" "unprognostic (7.43e-3)" "unprognostic (3.04e-2)" "unprognostic (4.94e-3)" "unprognostic (1.13e-1)" "unprognostic (7.74e-2)" "unprognostic (2.15e-1)" "unprognostic (9.51e-3)" "unprognostic (2.70e-1)" "unprognostic (2.82e-2)" "unprognostic (2.30e-3)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (4.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.86e-1)" "unprognostic (5.52e-2)" 19.9 21.9 4.1 17.3 4.1 14.1 16.9 3.9 4.2 10.7 16.9 14.8 22.2 11.2 6.8 10.5 13.7 24.1 14.1 4.7 9.1 15.1 35.0 23.1 15.0 4.6 4.6 2.8 18.0 22.1 19.7 6.5 13.7 4.2 12.3 21.9 1.1 13.3 10.8 10.7 7.0 25.3 16.3 4.7 17.6 14.2 5.2 5.2 8.4 16.9 4.8 16.9 31.4 9.6 4.6 39.0 98.4 144.6 46.5 71.7 93.7 143.0 91.2 123.5 50.7 77.6 40.9 39.1 23.1 59.1 52.4 88.4 37.2 39.3 179.7 90.4 22.9 31.2 0.0 43.6 85.4 238.0 9.6 37.5 136.1 164.6 110.5 121.1 131.9 160.4 27.5 16.1 0.2 104.5 12.3 0.8 14.3 37.0 52.6 34.6 21.0 53.5 14.8 100.2 62.7 0.2 24.2 46.4 14.0 51.1 101.6 23.1 9.9 145.3 71.8 36.4 23.2 66.6 27.4 4.7 10.8 74.6 17.8 106.6 3.8 17.8 0.6 1.9 12.6 3.0 4.0 2.4 2.0 15.8 1.9 4.7 1.9 3.6 1.2 17.5 0.0 1.6 7.8 4.1 4.1 3.9 4.2 4.7 9.1 4.6 4.6 2.8 4.2 4.7 5.2 4.6 41.8 12.8 35.6 8.1 17.6 31.6 35.0 55.9 34.7 0.8 31.7 26.7 3.7 12.8 36.4 12.9 0.0 4.2 10.4 28.4 3.9 29.1 1.3 42.2 16.8 39.4 0.0 4.0 3.3 26.5 8.8 18.8 60.6 81.9 9.5 17.1 18.9 27.1 9.8 0.0 1.1 20.8 14.2 21.3 69.6 2.3 7.2 33.1 19.6 38.4 15.5 2.6 1.0 15.1 0.6 50.7 22.6 6.8 5.1 37.7 36.4 9.2 18.7 0.3 0.0 15.4 14.3 0.3 2.1 25.3 18.2 4.2 14.3 21.0 26.0 53.1 SORBS3 "SCAM-1, SH3D4, vinexin" ENSG00000120896 "Sorbin and SH3 domain containing 3" O60504 8 22544986-22575788 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 169.4;Late spermatids: 505.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015849 Approved Uncertain "Focal adhesion sites,Cytosol" NA NA 7700 Cytosol "Focal adhesion sites" "HPA015849: AB_1857365" "unprognostic (6.15e-3)" "unprognostic (2.09e-2)" "unprognostic (2.34e-1)" "unprognostic (3.90e-3)" "unprognostic (1.72e-1)" "unprognostic (9.30e-2)" "unprognostic (2.51e-2)" "unprognostic (2.44e-2)" "unprognostic (5.83e-3)" "unprognostic (1.70e-1)" "prognostic favorable (4.88e-4)" "unprognostic (4.21e-2)" "unprognostic (3.08e-3)" "unprognostic (7.41e-2)" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.53e-5)" 152.0 65.8 51.1 26.4 50.5 5.1 130.1 59.8 73.1 153.4 45.0 99.1 30.1 125.0 23.8 66.0 119.9 39.0 105.1 45.3 49.6 85.0 122.2 112.8 21.3 78.6 53.0 38.0 126.7 49.7 36.0 73.8 67.2 59.0 128.3 35.3 11.5 89.4 49.0 65.2 98.5 71.8 54.2 52.3 80.6 64.2 129.2 55.2 7.7 94.6 37.6 13.6 104.4 135.1 63.8 83.0 101.8 54.6 61.9 86.4 114.4 55.7 83.0 127.8 95.0 58.8 103.6 36.2 0.7 55.3 130.1 38.3 69.7 82.5 75.7 48.9 58.1 36.2 6.9 58.3 48.4 98.2 0.8 0.5 72.6 55.6 33.3 48.4 105.2 74.6 42.7 18.4 2.6 68.4 32.8 7.1 2.4 19.3 14.1 42.5 79.0 36.8 7.7 43.7 15.8 3.1 48.9 40.4 9.8 52.7 56.8 16.7 29.2 116.9 83.8 59.8 61.9 59.3 1.7 2.5 11.5 49.0 19.4 58.3 0.0 2.5 0.6 11.4 4.7 23.4 0.8 12.6 13.4 8.1 1.3 12.7 7.6 0.5 5.8 1.1 2.7 0.6 5.2 51.1 50.5 59.8 73.1 45.3 49.6 78.6 53.0 38.0 59.0 52.3 55.2 63.8 89.6 19.2 7.2 27.1 5.8 29.2 24.6 23.3 39.9 2.7 29.0 27.8 12.2 31.5 18.3 12.9 0.0 24.1 4.7 53.5 9.8 21.3 169.4 10.9 39.5 51.9 14.6 2.1 3.8 19.2 30.5 48.8 8.6 20.5 17.2 19.3 79.9 49.5 35.3 5.0 4.5 35.2 8.2 39.0 31.5 505.8 61.2 23.8 24.9 13.1 5.7 21.9 3.1 19.6 7.6 26.2 53.2 58.6 3.7 38.8 65.1 26.0 10.7 3.5 59.2 23.1 84.1 7.0 8.0 25.3 21.3 20.5 19.7 7.1 31.3 23.7 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 107.3;brain: 103.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 127.4;REH: 141.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favorable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favorable (5.11e-4)" "unprognostic (3.33e-3)" 16.1 10.9 49.3 53.1 57.6 107.3 11.6 26.2 103.1 11.0 35.2 30.1 34.4 10.0 9.0 19.4 15.7 12.8 8.5 97.1 30.0 15.9 15.3 28.8 78.9 10.0 34.5 58.9 4.7 12.7 7.2 13.8 8.1 13.7 25.7 23.7 4.4 26.8 12.4 5.1 42.6 49.2 10.8 0.4 79.0 22.4 9.6 36.6 86.8 12.6 5.5 74.2 21.1 15.2 36.7 38.2 10.4 2.8 3.0 76.6 5.5 21.5 2.9 1.9 1.9 2.7 9.9 21.5 127.4 4.0 5.8 3.1 34.3 1.1 31.3 1.1 8.7 0.8 26.4 10.6 2.0 15.7 28.5 45.5 41.6 46.0 2.6 17.3 13.0 1.0 36.0 31.7 85.6 2.1 4.0 49.1 57.0 2.2 33.0 2.6 141.2 0.7 88.3 8.5 29.5 19.2 3.5 13.4 9.3 5.0 6.5 11.5 72.1 17.5 1.3 2.8 2.5 1.0 68.0 32.0 68.9 5.2 60.6 2.4 47.3 48.4 36.9 33.9 43.0 22.2 46.0 17.0 24.3 36.1 46.6 20.8 25.9 45.8 29.0 53.5 11.7 18.2 50.1 49.3 57.6 26.2 103.1 97.1 30.0 10.0 34.5 58.9 13.7 0.4 36.6 36.7 6.9 3.2 29.8 16.6 64.3 37.7 38.7 19.7 6.8 5.4 5.9 7.7 3.7 8.6 13.0 14.7 0.0 2.9 33.4 65.5 0.0 8.0 1.2 7.1 1.8 9.6 7.8 20.2 109.2 8.3 26.5 3.5 22.4 5.3 28.5 1.1 5.0 24.1 23.1 8.4 9.2 21.9 10.2 68.4 32.1 1.0 1.5 55.3 8.8 22.5 62.5 2.8 70.0 7.5 15.1 13.3 42.0 0.7 68.1 18.6 44.6 16.1 13.9 3.9 0.0 3.3 3.3 4.2 6.4 4.8 30.1 1.9 46.6 1.0 18.1 17.9 CHRNA2 ENSG00000120903 "Cholinergic receptor nicotinic alpha 2 subunit" Q15822 8 27459756-27479883 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 77.3;prostate: 29.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.5;Inhibitory neurons: 14.8;Prostatic glandular cells: 2.4;Theca cells: 3.4" "Cancer enriched" "Detected in single" 421 "prostate cancer: 30.2" "Region enhanced" "Detected in many" "thalamus: 77.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA048348 Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Nucleoplasm, Cytokinetic bridge" "HPA048348: " "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (2.23e-2)" "unprognostic (3.19e-1)" "unprognostic (6.19e-2)" "unprognostic (6.29e-3)" "unprognostic (1.19e-2)" "unprognostic (2.13e-1)" "unprognostic (1.91e-1)" "unprognostic (7.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.47e-1)" 0.0 0.5 13.0 0.2 8.2 0.9 1.5 37.7 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 6.5 0.0 0.0 0.2 0.1 15.1 21.7 0.0 0.0 0.2 0.0 0.3 0.0 4.3 29.3 0.0 3.7 0.0 0.0 0.1 0.2 0.3 0.0 2.7 0.1 0.0 0.0 77.3 2.9 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 13.0 8.2 37.7 3.0 1.5 6.5 15.1 21.7 0.0 4.3 2.7 77.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867278 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.0;brain: 43.4;liver: 60.6" "Cell type enhanced" "Detected in some" "Astrocytes: 105.4;Early spermatids: 51.3;Inhibitory neurons: 123.2;Late spermatids: 28.3;Oligodendrocyte precursor cells: 114.1" "Cancer enhanced" "Detected in some" "liver cancer: 0.9;prostate cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 22.0 0.5 13.7 1.1 11.5 0.0 3.7 4.2 23.3 0.5 0.0 1.1 0.9 1.5 0.6 0.8 0.2 0.3 6.1 43.4 16.3 0.7 60.6 3.9 1.8 8.3 4.9 3.4 0.9 0.0 0.0 0.1 0.0 11.5 12.5 0.5 0.3 6.2 13.7 0.2 0.5 1.1 2.9 1.6 9.3 0.9 0.1 3.6 0.1 0.1 1.4 0.4 0.4 0.3 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 11.5 4.2 23.3 43.4 16.3 8.3 4.9 3.4 11.5 1.6 3.6 7.5 0.0 0.0 0.0 105.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.3 0.0 0.0 0.1 0.0 0.0 15.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 16.2 0.0 0.0 123.2 0.0 0.0 0.0 0.5 28.3 0.6 0.0 0.0 9.4 0.0 0.0 0.0 114.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PPP3CC "CALNA3, PP2Bgamma" ENSG00000120910 "Protein phosphatase 3 catalytic subunit gamma" P48454 8 22440819-22541142 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 145.8;Spermatocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023396, CAB024950" Approved Approved Vesicles NA NA Vesicles "CAB024950: , HPA023396: AB_1855663" "unprognostic (7.66e-3)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-2)" "unprognostic (7.71e-2)" "prognostic favorable (6.80e-5)" "unprognostic (9.25e-2)" "unprognostic (1.97e-1)" "unprognostic (8.84e-2)" "unprognostic (4.05e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (4.00e-1)" "unprognostic (2.78e-2)" "unprognostic (1.64e-2)" 25.7 12.0 12.0 16.7 12.1 26.7 20.9 18.0 15.4 16.8 28.7 14.7 9.2 14.6 10.7 17.1 15.7 15.9 31.3 11.8 11.6 13.0 12.5 21.7 33.3 12.1 11.3 9.7 14.2 14.5 18.6 11.8 19.5 12.2 14.5 10.4 78.6 14.1 8.3 90.1 13.1 15.5 15.6 10.7 22.6 14.7 56.6 13.3 15.2 16.7 54.7 27.1 17.2 16.6 15.2 12.2 8.8 7.7 9.4 19.8 24.4 11.2 16.5 28.9 23.9 26.5 5.1 7.5 45.7 19.7 25.6 40.0 8.4 17.9 16.5 30.5 26.3 9.5 9.8 10.5 14.7 26.8 7.1 15.6 15.0 22.3 16.2 16.5 25.6 21.1 22.0 19.6 58.8 27.2 5.7 16.8 11.7 5.6 12.5 12.0 54.0 18.1 15.2 22.4 11.3 5.4 12.7 12.3 7.4 17.4 14.4 4.9 11.8 22.8 37.1 7.9 56.7 12.9 29.3 38.5 48.3 19.6 9.3 25.1 5.4 2.7 10.7 16.6 3.2 12.7 26.3 19.0 23.6 5.1 21.3 18.1 14.9 0.6 19.2 4.7 6.2 17.2 7.1 12.0 12.1 18.0 15.4 11.8 11.6 12.1 11.3 9.7 12.2 10.7 13.3 15.2 27.2 6.4 5.1 49.6 74.7 16.6 21.3 32.6 12.0 12.8 10.0 6.0 8.0 14.3 14.0 7.3 47.9 18.0 50.3 6.7 7.9 15.0 145.8 6.5 12.7 24.2 10.3 10.8 78.9 21.0 23.8 25.1 6.6 14.6 3.8 3.9 23.6 7.8 13.1 3.3 83.6 2.5 38.7 10.8 24.6 22.6 22.4 19.3 28.4 76.8 30.4 13.1 59.8 99.5 64.8 21.1 7.4 21.4 96.8 26.3 10.6 11.6 7.8 50.5 32.9 19.5 23.3 131.8 29.6 17.1 11.4 14.1 53.4 4.8 6.3 25.5 PDLIM2 ENSG00000120913 "PDZ and LIM domain 2" Q96JY6 8 22578279-22598025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 793.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in all" "white matter: 429.2" "Low region specificity" "Detected in many" HPA003880 Approved Supported "Actin filaments,Focal adhesion sites" NA NA "Actin filaments, Focal adhesion sites" "HPA003880: AB_1855149" "unprognostic (1.04e-1)" "unprognostic (3.53e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-3)" "unprognostic (9.33e-2)" "unprognostic (3.69e-2)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-3)" "unprognostic (1.52e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.37e-7)" "unprognostic (6.14e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-2)" "unprognostic (3.08e-3)" 62.9 31.8 34.3 32.2 33.3 23.9 51.5 42.6 57.1 72.6 35.5 70.7 61.5 80.8 9.9 132.6 56.5 53.2 49.4 29.6 37.2 76.4 59.9 89.6 54.9 46.4 46.0 27.4 50.0 54.1 9.9 35.6 40.9 52.0 45.9 11.3 2.0 49.0 31.2 203.8 152.3 64.9 23.4 42.4 233.9 39.1 12.3 42.8 20.5 27.6 61.4 24.6 58.0 92.5 48.4 90.3 54.5 36.2 63.9 69.9 118.5 40.9 139.1 102.4 97.6 98.5 62.4 14.7 36.9 38.4 126.4 18.1 44.7 20.5 95.0 19.0 0.1 14.1 11.6 35.2 46.1 88.2 13.0 85.9 127.2 11.6 48.2 13.2 76.8 54.2 20.2 3.3 23.4 67.4 46.5 16.7 15.4 29.8 37.8 5.5 13.3 6.9 3.9 17.3 18.3 11.3 26.9 29.1 78.1 128.7 21.3 27.5 25.8 68.2 105.7 108.6 127.9 64.8 0.4 0.8 12.5 109.0 51.3 79.6 78.2 48.0 162.3 47.0 64.4 42.2 25.0 35.5 46.9 38.4 27.6 23.8 35.4 101.6 28.1 63.8 24.7 40.7 34.6 34.3 33.3 42.6 57.1 29.6 37.2 46.4 46.0 27.4 52.0 42.4 42.8 48.4 85.8 76.9 13.1 5.5 45.0 95.1 12.9 48.1 39.9 3.0 34.0 42.5 10.2 18.6 34.2 18.4 0.0 73.1 70.9 92.0 15.6 24.9 1.0 8.8 94.0 48.7 1.2 10.5 3.2 26.1 115.1 98.9 7.7 13.8 27.3 25.7 86.4 49.4 59.0 3.3 2.3 12.6 20.3 59.1 73.8 3.4 132.0 37.9 48.0 8.4 42.5 33.1 122.6 7.1 3.9 93.2 126.1 218.2 6.8 52.7 217.6 146.3 5.2 3.6 59.2 27.1 108.3 0.7 6.3 39.7 100.7 793.0 71.6 21.0 15.0 30.6 EPHX2 ABHD20 ENSG00000120915 "Epoxide hydrolase 2" P34913 8 27490781-27545564 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism" "Hydrolase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 335.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6" "Lineage enriched" "Detected in many" 23 "T-cells: 106.7" "Cell line enhanced" "Detected in many" "JURKAT: 139.4;K-562: 51.6;OE19: 102.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023094, HPA023660" Enhanced Enhanced Cytosol NA NA 1100000 Cytosol "HPA023094: AB_1848214, HPA023660: AB_1848215" "unprognostic (1.30e-1)" "prognostic favorable (2.45e-4)" "unprognostic (2.99e-2)" "unprognostic (3.62e-2)" "unprognostic (1.76e-2)" "unprognostic (3.30e-3)" "unprognostic (1.26e-3)" "unprognostic (3.31e-3)" "unprognostic (1.46e-1)" "unprognostic (3.55e-2)" "unprognostic (4.14e-3)" "unprognostic (1.98e-1)" "prognostic favorable (1.98e-10)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (8.12e-2)" "unprognostic (2.26e-1)" 19.5 74.6 13.9 9.2 13.7 1.9 30.4 14.4 14.2 20.4 36.2 62.0 113.8 17.8 27.4 38.9 41.9 9.5 29.4 12.4 20.1 167.9 335.9 11.3 17.3 14.5 15.5 11.2 38.3 65.1 55.3 36.0 8.6 14.8 65.2 58.2 21.7 36.8 27.5 16.3 43.7 129.5 15.5 15.3 10.9 23.6 9.1 15.4 66.5 22.8 13.9 21.0 19.8 23.6 14.7 15.3 10.1 6.3 8.1 0.4 0.0 4.8 1.3 0.9 0.7 0.2 8.0 10.1 0.1 5.9 4.1 3.2 10.7 1.1 2.6 0.5 0.0 4.7 22.5 1.1 24.8 3.4 0.1 4.5 8.6 10.7 0.1 1.1 2.5 0.5 139.4 51.6 0.2 0.0 4.7 14.9 0.5 10.1 102.4 17.2 0.1 0.1 0.4 8.7 2.2 5.1 16.0 12.1 14.2 15.0 4.6 21.8 4.2 0.2 0.0 3.8 1.8 0.1 12.5 10.1 0.2 0.4 0.1 0.1 0.1 0.1 0.0 7.8 0.0 11.3 4.5 35.0 12.7 0.1 2.5 106.7 50.4 0.2 4.6 0.1 0.2 29.6 20.0 13.9 13.7 14.4 14.2 12.4 20.1 14.5 15.5 11.2 14.8 15.3 15.4 14.7 6.3 6.4 17.0 16.3 6.1 11.9 18.6 10.1 29.6 34.1 17.2 18.4 23.7 20.0 9.7 27.6 79.2 22.8 1.0 82.7 180.0 8.8 7.5 6.9 4.8 9.4 23.4 3.8 3.0 6.4 2.5 12.1 15.8 1.5 5.7 17.4 17.5 131.5 2.2 33.7 7.2 63.4 2.0 4.6 1.2 4.8 29.8 3.6 5.4 2.8 2.6 91.5 3.1 7.5 5.1 3.1 83.7 18.8 4.5 20.5 399.0 259.3 24.1 52.4 0.0 11.5 10.2 1.3 13.9 39.2 18.3 8.2 11.9 78.5 101.3 10.8 RNF170 "ADSA, DKFZP564A022, SNAX1" ENSG00000120925 "Ring finger protein 170" Q96K19 8 42849637-42897290 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050931, HPA054621" Uncertain NA NA "HPA050931: AB_2681279, HPA054621: AB_2682545" "unprognostic (3.06e-2)" "unprognostic (4.20e-1)" "unprognostic (9.54e-2)" "unprognostic (6.37e-2)" "unprognostic (4.59e-2)" "unprognostic (2.84e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (3.03e-2)" "unprognostic (1.61e-3)" "unprognostic (4.13e-3)" "unprognostic (2.00e-1)" "unprognostic (1.49e-1)" "unprognostic (2.13e-1)" 9.3 11.8 15.2 7.6 16.5 2.4 12.9 17.1 17.0 8.0 12.0 11.2 10.4 9.6 15.0 14.3 9.3 9.3 7.8 14.7 16.8 16.6 19.9 9.4 9.5 17.8 16.3 13.7 12.5 8.2 13.6 9.6 19.3 17.1 11.1 11.4 35.9 11.1 10.7 12.0 15.2 11.5 7.6 15.6 9.1 10.8 5.9 15.8 6.1 29.1 9.3 10.0 7.7 8.5 19.1 11.4 18.1 18.2 9.2 29.4 29.7 10.8 13.3 18.1 12.3 13.2 8.5 36.0 13.6 15.7 12.8 22.1 9.6 9.6 13.2 10.8 9.4 10.4 15.9 8.5 9.3 16.1 2.0 10.9 26.0 20.4 9.3 18.8 16.0 13.3 15.0 14.6 15.8 19.9 3.4 17.0 9.5 8.6 24.1 6.5 8.7 24.2 7.7 19.6 10.8 4.7 14.3 12.8 8.9 23.0 17.7 23.1 9.5 19.5 13.2 5.8 17.8 4.3 25.2 26.4 15.7 18.2 6.7 13.6 1.4 5.7 2.1 2.9 5.7 4.2 6.6 4.8 5.3 8.8 3.9 5.6 4.1 0.6 4.9 5.5 8.9 6.7 4.5 15.2 16.5 17.1 17.0 14.7 16.8 17.8 16.3 13.7 17.1 15.6 15.8 19.1 13.5 48.1 20.5 41.1 16.1 7.6 13.1 22.3 5.7 44.8 14.9 9.5 11.5 15.7 29.2 23.9 89.6 41.6 9.8 22.1 17.6 21.6 1.7 16.0 14.5 15.2 13.1 5.5 36.7 27.8 19.4 20.0 11.2 13.3 9.5 25.5 21.8 21.7 22.9 21.9 43.7 15.3 20.3 18.5 9.2 2.4 15.2 15.4 8.8 15.9 21.9 31.8 30.9 36.2 75.9 32.2 18.4 20.7 10.7 9.6 34.5 22.1 33.3 72.1 13.1 23.9 12.1 14.9 19.3 12.5 11.5 31.2 12.8 25.7 16.6 12.2 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858945 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 768 "heart muscle: 5206.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7" "Region enhanced" "Detected in single" "pons and medulla: 1.4" HPA077324 Approved Vesicles,Cytosol "Secreted to blood" NA NA 9680 Vesicles Cytosol "HPA077324: " "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 0.9 0.3 0.3 0.1 3.4 0.0 0.7 0.4 1.4 0.1 0.1 0.3 0.0 0.3 0.3 0.2 0.0 0.6 5206.4 0.3 1.3 0.3 0.5 6.7 0.9 0.4 0.4 0.4 0.8 4.1 0.1 0.5 0.8 0.3 0.5 0.0 0.1 1.2 0.0 0.8 0.5 0.4 0.0 0.5 0.1 0.7 0.8 0.4 0.1 0.5 0.0 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 135.5 0.3 0.0 2.1 1.1 362.2 0.0 0.0 0.1 0.1 0.3 3.8 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 67.7 0.0 0.0 0.0 0.0 32.0 0.2 0.2 0.0 0.1 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.4 1.4 0.3 1.3 0.4 0.4 0.4 0.3 0.5 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 351.7 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 266.6 0.1 0.8 0.1 4.9 0.0 0.0 0.2 8.3 2.2 11.7 0.0 1.4 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.2 0.0 0.0 0.0 86.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 17.6 5.8 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.1 UBIAD1 "SCCD, TERE1" ENSG00000120942 "UbiA prenyltransferase domain containing 1" Q9Y5Z9 1 11273198-11296049 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Menaquinone biosynthesis, Ubiquinone biosynthesis" "Prenyltransferase, Transferase" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044862 Approved Vesicles NA NA Vesicles "HPA044862: AB_2679117" "unprognostic (1.79e-2)" "unprognostic (2.26e-1)" "unprognostic (5.06e-2)" "unprognostic (1.74e-1)" "unprognostic (7.95e-3)" "unprognostic (7.55e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "prognostic favorable (6.80e-5)" "unprognostic (3.00e-1)" "unprognostic (3.89e-1)" "unprognostic (2.03e-2)" "unprognostic (1.25e-1)" 7.0 7.6 5.2 7.7 7.4 7.7 8.4 6.6 6.1 6.5 2.2 7.1 5.6 8.5 6.1 5.9 9.7 4.6 8.3 4.9 5.5 6.5 10.1 6.2 10.3 7.2 7.2 5.0 11.6 10.9 10.0 5.8 6.5 6.7 7.2 6.8 8.1 7.0 6.6 17.8 7.5 6.5 7.9 6.9 7.2 7.3 9.3 6.6 12.1 7.8 13.9 10.6 8.2 5.7 9.9 14.5 14.1 11.0 21.3 8.0 7.4 14.8 15.6 12.7 16.4 14.9 16.4 13.1 28.5 15.6 11.1 15.4 19.5 28.1 18.7 19.9 20.0 24.1 19.1 14.5 22.0 14.5 29.5 15.9 11.2 24.9 22.2 26.3 8.7 12.2 25.8 23.1 22.9 11.2 14.8 19.1 14.7 13.3 27.1 20.7 18.0 24.6 34.6 12.7 9.5 13.6 14.5 16.6 16.3 21.5 4.5 12.1 15.3 10.2 14.4 15.5 15.1 20.5 18.6 27.9 52.4 9.2 38.3 18.3 11.5 12.8 19.5 24.3 17.5 27.3 45.3 32.5 24.8 16.9 42.1 48.5 33.3 3.9 20.5 15.6 21.1 33.8 22.2 5.2 7.4 6.6 6.1 4.9 5.5 7.2 7.2 5.0 6.7 6.9 6.6 9.9 9.4 9.6 14.6 4.2 19.6 15.4 16.7 11.2 22.2 11.9 13.3 13.7 8.3 11.5 18.1 5.5 8.4 10.6 17.5 7.4 11.7 10.8 34.1 6.3 9.6 9.5 4.9 13.3 4.2 13.3 14.7 11.4 13.3 9.6 7.0 11.3 7.9 19.7 8.7 13.5 6.5 11.1 14.2 8.2 14.1 23.1 12.5 9.5 5.4 4.7 7.1 9.5 14.4 9.0 11.1 11.0 5.3 10.9 14.2 15.0 5.8 8.6 8.9 15.8 0.0 20.2 10.4 24.7 15.7 15.7 12.6 18.9 14.4 12.0 14.1 10.3 TARDBP "ALS10, TDP-43" ENSG00000120948 "TAR DNA binding protein" Q13148 1 11012344-11030528 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003703, HPA017284" Supported Enhanced Nucleoplasm NA NA 29000 Nucleoplasm "CAB003703: AB_425904, HPA017284: AB_1857775" "unprognostic (3.72e-3)" "prognostic favorable (1.15e-5)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (8.52e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (4.75e-3)" "unprognostic (2.24e-1)" "unprognostic (2.54e-2)" "unprognostic (2.27e-3)" "unprognostic (2.27e-1)" "unprognostic (1.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.71e-2)" 81.8 80.8 73.6 87.9 81.0 70.3 84.0 86.6 79.7 92.7 79.3 93.4 78.1 91.6 79.5 112.0 84.8 59.2 89.9 71.6 76.7 84.5 106.4 92.4 107.3 76.1 78.7 67.9 104.3 77.8 87.4 89.8 83.4 76.9 90.8 95.4 120.9 87.3 79.5 140.0 94.8 95.3 81.9 78.7 98.2 83.1 68.8 77.0 116.2 97.4 103.8 123.9 88.3 96.6 87.5 244.7 164.4 270.4 143.5 143.9 118.2 160.3 164.7 142.3 263.6 195.5 187.9 175.6 316.3 118.1 180.6 154.3 169.2 333.1 187.6 336.0 175.1 153.8 241.2 275.2 257.9 119.4 290.5 158.9 99.5 211.4 184.5 147.9 143.8 188.6 126.7 319.0 176.4 221.7 195.0 215.6 228.6 221.0 232.2 141.7 256.9 214.4 206.2 186.0 179.1 187.9 150.8 221.3 173.7 128.8 197.1 173.8 200.9 174.8 173.8 207.8 146.3 236.9 133.3 176.2 336.3 116.2 288.2 192.0 38.0 38.0 33.7 46.7 48.6 57.4 55.2 46.9 45.4 61.7 39.6 46.3 50.5 15.4 67.2 50.0 43.1 54.3 36.4 73.6 81.0 86.6 79.7 71.6 76.7 76.1 78.7 67.9 76.9 78.7 77.0 87.5 35.5 32.1 74.4 29.4 57.6 114.6 89.9 40.8 52.3 37.6 52.0 38.6 68.0 31.5 57.0 29.5 29.2 63.2 46.3 54.2 33.2 50.8 9.7 50.7 50.0 54.9 66.3 63.5 29.5 54.2 84.5 45.2 34.7 61.7 42.3 45.8 40.0 51.7 50.1 37.0 29.8 50.1 38.7 45.9 46.3 12.3 47.2 37.8 35.6 23.4 54.3 36.2 35.0 37.2 57.2 52.9 36.1 51.6 48.8 71.7 43.2 43.9 54.4 38.8 32.9 42.8 56.9 64.9 32.8 52.4 114.5 73.5 41.3 23.6 52.6 71.3 TNFRSF8 "CD30, D1S166E, KI-1" ENSG00000120949 "TNF receptor superfamily member 8" P28908 1 12063303-12144207 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 4.9" "Cell type enhanced" "Detected in some" "Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1" "Cancer enriched" "Detected in some" 12 "testis cancer: 9.3" "Region enhanced" "Detected in single" "basal ganglia: 2.0" "Group enriched" "Detected in many" 4 "intermediate monocyte: 59.4;non-classical monocyte: 96.6" "Lineage enriched" "Detected in many" 5 "monocytes: 96.6" "Cell line enriched" "Detected in some" 21 "HDLM-2: 552.9" "Region enhanced" "Detected in many" "hypothalamus: 5.5" "CAB000016, HPA014823, HPA032081, HPA032082" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142" "unprognostic (1.07e-2)" "unprognostic (2.06e-2)" "unprognostic (2.52e-2)" "unprognostic (5.98e-2)" "unprognostic (2.50e-1)" "unprognostic (1.46e-3)" "unprognostic (2.19e-1)" "unprognostic (3.93e-2)" "unprognostic (1.18e-1)" "unprognostic (9.18e-3)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-8)" "unprognostic (3.31e-1)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" 4.9 0.1 0.1 3.1 2.0 0.6 3.5 0.0 0.4 0.2 0.3 0.4 0.0 0.8 0.0 0.2 0.9 0.6 1.4 0.0 0.5 0.3 0.0 0.9 1.2 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.4 0.2 0.2 0.0 0.3 0.1 0.9 0.7 0.7 0.5 0.1 1.4 2.6 1.4 0.5 1.0 0.1 1.2 1.2 0.9 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.4 0.0 0.1 0.8 11.7 0.0 0.0 0.0 0.0 0.0 0.1 552.9 0.1 0.0 0.1 0.0 0.0 10.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 26.3 1.5 0.0 0.0 1.5 0.2 21.7 0.0 0.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.1 0.0 1.4 1.4 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 17.6 1.0 0.1 59.4 0.3 0.1 0.1 0.0 8.7 0.0 0.0 0.0 18.3 0.0 96.6 2.3 0.8 8.5 0.1 2.0 0.0 0.4 0.0 0.5 0.6 0.1 0.1 0.4 0.1 0.5 0.2 7.1 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.1 0.5 2.2 0.0 0.0 0.6 0.0 0.2 1.1 2.6 0.1 0.0 0.1 2.2 0.1 1.5 0.0 0.5 0.0 0.0 5.3 3.3 9.8 0.3 5.8 0.0 1.0 5.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.3 1.0 0.0 0.1 0.3 0.4 0.2 0.0 0.1 PRAMEF2 FLJ43580 ENSG00000120952 "PRAME family member 2" O60811 1 12857086-12861909 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF706 HSPC038 ENSG00000120963 "Zinc finger protein 706" Q9Y5V0 8 101177878-101206193 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1090.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042793 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042793: AB_10795710" "unprognostic (2.05e-2)" "unprognostic (3.29e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "unprognostic (2.48e-3)" "unprognostic (5.22e-2)" "unprognostic (3.19e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (5.90e-11)" "unprognostic (9.65e-2)" "unprognostic (1.59e-1)" "unprognostic (3.57e-1)" "unprognostic (2.17e-2)" 96.2 84.1 92.4 57.8 93.1 77.6 93.4 96.2 115.6 77.1 61.7 92.5 94.1 72.1 91.2 148.4 69.6 69.9 82.9 92.3 80.4 77.8 96.8 82.6 96.3 78.0 79.7 85.3 70.8 272.1 70.4 94.6 55.8 80.2 71.5 88.1 47.3 99.9 49.6 111.6 178.8 100.8 51.2 76.5 101.3 93.4 119.0 78.1 67.8 83.0 86.9 103.4 75.8 101.9 90.0 203.0 113.9 196.0 62.7 69.0 78.0 124.8 82.4 105.5 83.5 89.0 81.8 121.5 121.9 139.4 99.1 170.4 108.4 113.3 111.0 95.8 90.5 98.0 122.1 69.5 159.2 90.7 92.2 114.1 69.1 170.9 78.9 170.7 115.1 144.0 121.4 134.8 230.6 75.0 142.6 194.5 252.2 59.7 408.6 278.8 80.8 65.3 251.1 112.7 103.2 129.4 57.6 57.6 95.0 375.9 166.3 99.3 96.5 96.3 45.6 93.9 121.9 87.0 194.1 202.6 197.0 123.5 199.2 215.8 255.1 280.0 162.6 138.0 463.2 143.4 400.0 191.5 178.0 264.1 344.1 214.7 206.3 38.7 130.9 492.1 532.8 302.8 268.7 92.4 93.1 96.2 115.6 92.3 80.4 78.0 79.7 85.3 80.2 76.5 78.1 90.0 131.4 60.9 41.0 29.0 188.6 459.7 242.3 252.7 149.7 59.3 159.3 182.6 79.8 137.2 138.1 79.1 18.8 190.6 175.0 288.4 180.0 264.5 439.7 125.5 70.1 137.7 265.1 107.1 31.5 259.8 339.0 131.4 106.5 114.9 122.2 85.1 99.2 123.4 265.3 85.8 21.1 275.3 231.9 162.3 186.4 1090.7 86.9 214.8 206.3 16.9 298.4 131.3 114.4 14.6 57.6 401.5 265.4 86.9 329.4 326.5 339.2 195.1 110.8 55.9 105.2 111.6 169.8 84.3 82.7 224.8 518.0 193.3 112.7 72.7 153.5 311.7 LYPLA1 "APT-1, LPL1" ENSG00000120992 "Lysophospholipase 1" O75608 8 54046367-54102017 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 787.7;Late spermatids: 796.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol NA NA 330000 "Nucleoplasm, Cytosol" "HPA050941: AB_2681284, HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 26.0 30.6 9.8 32.1 9.1 44.0 45.4 11.7 12.8 23.5 14.7 43.0 44.8 19.8 16.3 55.5 23.1 26.2 41.3 9.2 11.7 64.0 84.2 26.1 49.4 10.9 10.7 7.8 11.8 24.0 41.1 8.9 50.9 10.4 35.3 42.5 46.3 35.9 15.2 55.0 41.7 43.2 24.6 10.9 30.5 35.7 65.7 11.7 29.1 28.6 71.4 52.4 63.7 27.7 11.6 124.0 69.3 85.9 78.7 31.0 49.4 109.8 71.7 41.6 65.0 61.1 53.2 116.7 214.8 83.6 47.2 70.5 80.7 122.8 119.9 89.8 78.9 70.0 148.8 37.9 80.0 50.8 91.4 196.1 44.6 103.8 50.8 114.0 55.6 171.6 91.6 154.5 63.4 91.3 32.7 141.1 69.9 129.3 206.3 31.5 85.3 45.2 99.3 100.2 163.6 45.2 77.6 50.1 93.6 113.4 81.0 137.0 81.7 83.4 39.0 56.9 68.7 67.8 89.3 143.8 194.0 52.9 97.1 78.7 93.7 80.7 111.1 44.8 79.6 44.6 73.0 42.2 43.5 92.3 64.4 42.1 41.1 49.3 69.6 108.2 59.7 75.5 98.3 9.8 9.1 11.7 12.8 9.2 11.7 10.9 10.7 7.8 10.4 10.9 11.7 11.6 60.4 28.9 53.3 19.9 83.8 61.7 94.8 96.6 82.6 34.9 103.8 64.0 70.8 57.2 71.8 62.5 52.1 199.7 74.5 70.4 303.3 82.8 787.7 86.6 34.7 69.3 57.5 50.0 30.0 89.0 318.3 36.4 74.9 96.3 49.5 31.5 81.4 120.1 121.0 18.5 43.7 77.3 99.7 108.4 83.3 796.2 28.3 82.6 74.7 25.3 102.1 36.9 69.0 20.6 9.8 127.4 63.7 23.0 104.5 171.0 91.6 194.3 62.9 70.3 46.0 24.5 43.1 92.1 239.1 118.2 81.1 334.2 57.0 94.0 90.2 229.7 CRISPLD1 "Cocoacrisp, DKFZp762F133, LCRISP1" ENSG00000121005 "Cysteine rich secretory protein LCCL domain containing 1" Q9H336 8 74984505-75034558 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 29.7" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 36.1;Endometrial ciliated cells: 62.2;Oligodendrocyte precursor cells: 81.4" "Cancer enhanced" "Detected in many" "glioma: 30.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 134.4;SH-SY5Y: 72.0;SuSa: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024725 Uncertain "Secreted - unknown location" NA NA 8200 "HPA024725: AB_1847238" "unprognostic (2.16e-1)" "unprognostic (5.88e-2)" "unprognostic (4.01e-2)" "unprognostic (3.78e-2)" "unprognostic (3.85e-2)" "unprognostic (1.65e-1)" "unprognostic (2.09e-4)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (5.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (7.39e-3)" "unprognostic (2.38e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" 2.7 1.3 8.7 2.5 3.7 1.5 29.7 4.8 4.6 6.3 2.8 2.1 0.7 8.7 5.0 5.0 7.5 10.1 8.9 4.0 15.4 2.2 2.1 2.3 2.9 6.0 7.6 1.6 5.7 2.4 19.4 1.2 7.8 7.7 24.8 1.6 3.1 19.4 2.6 0.5 2.0 1.2 7.1 6.7 2.1 0.9 3.8 4.3 9.5 15.3 1.2 1.1 2.5 1.1 10.8 0.0 1.7 134.4 0.0 0.0 0.0 4.5 0.0 0.0 1.6 1.9 0.8 0.0 0.0 19.0 0.0 2.2 0.1 11.3 0.1 0.0 0.1 5.2 0.2 5.1 0.0 3.0 0.0 1.0 7.2 0.3 0.1 1.0 16.6 0.0 1.0 0.0 0.0 0.0 0.1 0.9 0.2 13.9 0.0 5.0 0.0 18.5 0.2 0.0 0.0 0.8 72.0 0.0 0.1 8.0 27.5 10.4 6.4 0.0 3.8 19.6 0.2 0.5 2.4 0.9 0.0 4.6 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.7 3.7 4.8 4.6 4.0 15.4 6.0 7.6 1.6 7.7 6.7 4.3 10.8 1.0 3.2 0.0 12.7 0.0 0.8 6.1 1.4 17.6 1.6 10.3 36.1 0.4 0.0 5.4 1.8 0.0 22.7 0.3 0.0 0.0 0.0 15.3 62.2 4.9 3.2 0.0 3.0 15.7 0.0 3.8 9.2 0.0 22.4 3.8 1.8 23.6 0.1 2.0 0.0 11.1 0.0 0.0 0.9 0.0 1.5 4.1 0.4 7.2 1.9 0.0 8.8 0.0 81.4 0.9 0.0 0.0 1.5 0.0 9.4 0.0 0.2 22.5 0.9 0.0 0.4 1.5 1.3 6.0 2.5 1.0 12.0 0.4 6.3 0.0 2.3 COPS5 "CSN5, JAB1, MOV-34, SGN5" ENSG00000121022 "COP9 signalosome subunit 5" Q92905 8 67043079-67083783 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 347.5;Late spermatids: 427.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004242, HPA004845, HPA051531" Supported Enhanced Nucleoplasm NA NA 37000 Nucleoplasm "CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (2.53e-1)" "unprognostic (4.16e-2)" "unprognostic (2.04e-3)" "unprognostic (1.39e-1)" "unprognostic (2.15e-2)" "unprognostic (4.48e-2)" "unprognostic (4.74e-3)" "unprognostic (1.96e-2)" "unprognostic (1.90e-3)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-2)" 43.9 44.2 55.0 33.6 56.1 39.8 45.7 60.1 63.0 34.5 54.5 46.0 46.0 34.3 44.0 42.6 35.9 31.9 101.0 55.0 59.0 56.8 71.6 33.4 41.3 58.1 56.1 53.6 33.7 43.4 59.0 31.3 51.3 58.5 36.7 52.1 40.1 42.6 36.9 126.2 36.3 48.2 48.0 60.7 33.7 37.9 59.2 57.7 53.1 38.2 136.1 49.1 42.6 30.2 62.4 104.0 97.8 79.6 74.4 83.1 88.3 63.3 89.0 74.0 121.2 108.9 62.6 125.4 96.5 39.9 93.6 86.8 84.1 109.2 98.9 134.0 92.4 92.1 135.9 95.2 87.3 82.2 86.3 79.1 81.0 126.2 99.1 132.6 95.2 121.2 100.3 163.0 64.6 111.8 96.5 154.3 157.6 107.1 217.2 108.6 97.2 56.7 76.4 131.3 91.6 48.6 66.7 51.0 98.4 91.6 71.2 160.9 90.8 89.9 60.1 74.9 74.7 70.3 81.4 108.5 127.7 89.1 97.6 84.1 65.8 52.0 64.5 35.8 55.7 37.2 36.8 34.6 39.9 63.9 33.7 36.1 32.4 38.3 51.9 56.6 34.0 53.2 43.8 55.0 56.1 60.1 63.0 55.0 59.0 58.1 56.1 53.6 58.5 60.7 57.7 62.4 55.0 22.4 26.0 19.2 40.6 49.3 45.1 102.6 28.5 36.4 43.7 51.8 119.9 58.6 61.2 31.3 33.3 143.8 58.0 38.1 88.0 73.4 347.5 44.6 38.2 46.4 34.2 69.2 21.5 60.0 101.4 45.2 25.5 37.1 36.1 50.9 34.2 35.5 79.3 25.2 21.5 41.5 59.0 31.7 28.5 427.2 43.2 40.2 28.4 10.3 59.9 62.0 56.7 18.6 32.4 50.1 48.6 51.1 46.6 54.0 87.8 81.9 46.1 53.0 32.9 49.1 87.8 123.4 49.6 42.9 47.5 127.8 42.3 72.5 55.4 50.6 RDH10 SDR16C4 ENSG00000121039 "Retinol dehydrogenase 10" Q8IZV5 8 73294602-73325281 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Club cells: 131.7;Collecting duct cells: 204.1;Muller glia cells: 342.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "ASC diff: 143.6;BJ: 107.4;CACO-2: 97.0;HDLM-2: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049199 Supported "Lipid droplets" NA NA "Lipid droplets" "HPA049199: AB_2680673" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.86e-2)" "unprognostic (2.52e-1)" "unprognostic (2.45e-2)" "unprognostic (1.13e-2)" "unprognostic (1.14e-1)" "unprognostic (2.80e-2)" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.18e-3)" "unprognostic (8.88e-3)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (1.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.23e-2)" 43.7 6.3 4.6 23.6 5.3 3.3 10.5 4.9 6.2 18.4 14.0 16.1 32.7 14.2 3.9 20.0 7.8 30.5 10.9 5.2 36.0 44.2 41.4 13.7 11.1 11.8 5.9 3.9 5.0 34.8 8.4 27.0 36.6 6.5 21.7 15.3 87.1 39.5 13.2 7.0 8.1 30.9 15.0 6.5 7.3 25.0 16.8 16.8 6.2 6.5 8.3 8.9 69.9 11.4 19.0 13.8 39.2 4.3 17.9 143.6 10.5 39.0 107.4 17.4 4.1 6.8 97.0 38.6 9.6 13.9 60.4 6.3 35.6 19.6 15.5 8.4 110.7 49.0 17.0 37.6 30.1 5.6 8.2 18.0 6.3 19.6 16.5 15.3 18.3 15.6 9.4 20.0 13.7 7.0 6.1 8.5 3.4 5.2 84.0 19.0 7.4 4.4 5.8 28.2 19.4 2.6 3.4 9.1 66.3 5.5 5.4 13.1 4.2 24.0 6.3 10.6 28.9 8.3 8.8 10.0 7.8 5.0 7.3 14.7 1.2 0.1 0.2 0.3 0.1 0.2 0.1 0.3 0.4 0.2 0.0 0.6 0.3 0.1 0.0 0.1 0.0 0.2 0.1 4.6 5.3 4.9 6.2 5.2 36.0 11.8 5.9 3.9 6.5 6.5 16.8 19.0 14.5 12.8 29.8 3.6 2.5 13.5 9.7 75.6 16.5 3.2 29.1 25.5 9.1 25.8 131.7 204.1 22.9 19.1 11.2 25.5 3.9 16.3 80.6 38.3 50.0 9.7 4.2 1.3 1.4 17.6 23.8 44.6 49.5 71.5 2.5 1.2 3.3 49.2 20.9 3.3 1.0 16.8 40.7 5.4 7.8 9.9 2.8 10.0 17.8 6.5 1.9 342.1 3.1 4.5 2.0 56.9 31.5 3.8 6.4 41.2 47.7 22.6 44.2 16.2 0.0 11.4 20.5 11.0 8.0 24.7 13.9 42.0 7.1 1.6 24.2 17.7 EPX "EPO, EPP, EPX-PEN" ENSG00000121053 "Eosinophil peroxidase" P11678 17 58192726-58205174 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "bone marrow: 34.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.5;Inhibitory neurons: 1.2;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 23 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Cell line enriched" "Detected in some" 68 "NB-4: 248.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076792 Enhanced NA NA "HPA076792: " "unprognostic (5.67e-2)" "unprognostic (1.73e-2)" "unprognostic (3.36e-2)" "unprognostic (3.30e-1)" "unprognostic (2.18e-1)" "unprognostic (1.34e-3)" "unprognostic (4.83e-1)" "unprognostic (3.16e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-2)" "unprognostic (1.71e-4)" "unprognostic (7.38e-2)" "unprognostic (1.64e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.02e-2)" "unprognostic (1.73e-1)" 0.0 0.1 0.0 0.2 0.1 34.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.1 0.6 0.1 0.0 0.0 1.3 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 248.2 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121346 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 209.7" "Group enriched" "Detected in all" 9 "Early spermatids: 584.7;Late spermatids: 2219.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria NA NA Mitochondria "CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favorable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 41.0 15.7 31.7 17.9 32.8 7.0 35.5 29.3 35.5 23.2 17.2 72.7 55.3 24.7 19.9 36.7 31.8 18.1 83.4 28.6 26.4 26.5 50.3 19.7 10.8 27.3 27.0 29.7 20.2 22.4 48.5 17.3 7.2 27.8 35.0 49.3 35.0 33.9 25.0 209.7 27.3 56.3 26.6 20.8 11.4 55.8 113.7 29.9 11.5 36.6 139.1 9.6 47.2 25.7 28.1 46.1 54.3 80.7 27.5 18.2 12.8 46.8 19.0 18.3 24.2 16.8 61.2 42.2 74.1 52.3 14.5 26.5 74.6 50.1 44.4 24.7 40.6 63.5 63.1 51.4 118.1 19.4 59.9 23.8 11.7 41.8 26.2 39.2 14.4 25.7 22.9 42.3 28.6 14.8 39.8 76.1 24.1 28.7 97.9 61.7 58.2 32.8 61.0 17.1 61.9 58.9 40.3 15.8 45.1 23.9 16.6 31.4 61.4 18.8 24.3 24.2 28.3 45.0 28.9 36.9 55.8 14.0 47.5 19.7 1.6 1.0 0.4 2.6 2.0 2.3 1.8 2.0 2.1 2.3 1.2 4.0 2.1 0.1 3.3 0.5 4.0 1.7 1.3 31.7 32.8 29.3 35.5 28.6 26.4 27.3 27.0 29.7 27.8 20.8 29.9 28.1 34.5 35.3 49.9 26.4 16.6 22.6 23.5 11.9 32.5 33.0 29.4 42.3 154.9 28.6 32.1 5.5 47.9 21.5 10.6 89.1 1.9 16.3 584.7 16.8 12.6 16.4 45.9 12.6 14.9 16.3 13.8 12.2 54.0 37.8 3.8 21.0 11.4 60.2 9.5 37.0 26.3 86.6 8.2 9.0 9.5 2219.5 19.6 10.9 7.2 4.7 8.7 8.2 3.1 10.6 9.6 12.7 68.5 13.9 13.2 32.3 65.6 7.4 6.5 77.1 46.0 17.9 54.4 18.3 14.9 44.9 19.7 6.8 11.5 13.3 117.6 17.0 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938199-56961050 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 99.4" "Cell type enhanced" "Detected in all" "Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA057480, CAB069400" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 7.4 7.2 7.2 8.9 7.4 20.1 12.3 10.3 9.0 9.3 7.8 9.3 10.3 10.5 11.7 9.8 9.8 7.2 8.1 7.2 7.3 8.8 13.1 7.7 12.9 7.3 7.3 7.0 12.0 8.8 12.4 6.2 13.1 8.0 9.4 10.7 12.7 9.9 7.8 11.6 9.6 10.1 8.6 7.3 10.4 9.3 99.4 7.1 13.3 12.2 9.2 13.6 9.4 8.8 8.6 25.0 18.6 37.4 14.5 12.5 14.9 25.8 17.5 16.4 26.1 27.7 25.6 21.0 29.9 34.6 14.0 19.5 14.1 25.6 20.2 37.1 36.1 32.3 48.7 17.4 29.2 13.5 41.5 28.5 13.9 24.7 19.7 21.1 15.5 22.6 17.4 42.9 24.3 24.8 31.6 32.9 26.3 22.0 27.4 18.4 15.5 45.9 23.9 18.1 24.7 31.6 31.2 11.7 11.5 30.1 21.5 41.8 40.0 16.0 30.2 22.7 14.8 23.0 35.6 47.7 34.5 15.8 22.7 18.8 22.3 13.3 17.5 15.5 12.6 17.5 27.6 17.0 16.6 13.5 25.0 19.5 18.9 8.1 16.0 17.2 16.4 18.6 10.1 7.2 7.4 10.3 9.0 7.2 7.3 7.3 7.3 7.0 8.0 7.3 7.1 8.6 21.3 12.8 21.0 6.8 26.5 18.7 39.5 34.0 21.1 35.9 21.6 22.5 14.1 22.8 28.3 14.7 37.5 42.2 26.2 12.5 13.7 30.1 249.2 22.7 23.1 26.6 23.9 17.5 8.8 27.7 32.3 23.5 18.3 19.9 22.2 20.3 22.5 23.9 22.7 25.2 10.9 16.5 16.2 16.5 10.4 591.1 42.3 12.3 3.6 10.3 19.6 28.5 34.0 9.5 13.3 23.5 17.3 30.5 15.1 32.2 16.6 23.0 22.0 52.4 13.1 24.9 21.9 142.2 46.8 20.3 22.7 29.1 23.3 17.1 20.8 29.0 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56836387-56914080 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 23.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 23.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favorable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favorable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 16.3 20.8 9.7 20.0 10.2 48.1 13.2 9.4 22.1 14.2 13.9 19.9 19.5 12.2 8.6 20.6 18.4 9.8 10.3 8.9 10.5 10.4 30.0 25.3 17.4 10.2 9.9 8.1 14.4 16.9 13.1 10.4 9.6 10.4 9.4 17.5 11.9 15.4 7.5 12.7 29.5 20.4 12.5 9.2 41.9 17.1 9.2 11.4 18.7 10.9 7.7 19.8 12.2 14.8 11.4 77.2 37.4 9.0 30.7 66.6 55.8 0.1 29.6 59.6 69.4 59.3 36.7 41.1 74.6 59.8 28.6 75.4 44.5 44.5 39.9 38.5 64.1 35.0 48.1 29.0 41.0 57.0 58.2 33.2 25.1 65.7 36.2 76.4 32.9 46.7 50.2 12.0 43.8 35.8 51.3 65.6 41.9 5.8 63.3 71.5 46.3 30.2 47.4 40.5 59.7 17.5 16.3 23.3 37.1 69.7 5.8 50.3 46.8 31.3 32.2 23.1 50.1 31.2 24.7 51.1 12.1 31.2 39.4 13.0 4.8 3.0 1.2 1.0 2.5 1.3 2.2 0.9 1.0 3.1 1.7 0.7 1.0 23.5 1.1 1.8 2.2 2.0 1.1 9.7 10.2 9.4 22.1 8.9 10.5 10.2 9.9 8.1 10.4 9.2 11.4 11.4 27.3 35.3 19.8 7.5 12.7 18.5 8.5 10.5 13.1 9.9 12.6 11.9 7.5 20.0 16.6 9.2 29.2 5.4 15.1 54.8 0.0 19.1 3.5 44.9 20.0 32.7 18.6 11.1 4.1 21.6 10.7 16.0 32.6 72.5 3.8 23.0 32.2 30.9 14.8 3.3 8.2 28.7 6.1 27.5 24.6 2.1 9.6 29.3 14.2 8.4 28.3 5.7 11.3 12.1 0.3 32.2 54.2 9.4 17.7 21.6 20.0 8.0 18.5 22.2 6.6 13.1 9.2 0.4 0.3 24.5 30.5 15.9 11.5 45.3 25.7 25.4 SCPEP1 RISC ENSG00000121064 "Serine carboxypeptidase 1" Q9HB40 17 56978129-57006768 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 303.2" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 456.2;Club cells: 304.9;Respiratory ciliated cells: 397.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 319.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 389.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039102, HPA057200" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA039102: AB_10673605, HPA057200: AB_2683365" "unprognostic (5.83e-3)" "unprognostic (7.43e-3)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (9.26e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.00e-3)" "unprognostic (1.68e-1)" "unprognostic (1.70e-1)" "unprognostic (3.56e-3)" "unprognostic (1.40e-1)" "unprognostic (3.25e-1)" "unprognostic (7.28e-2)" "unprognostic (8.89e-2)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 64.7 122.6 27.9 32.8 27.4 76.5 91.9 29.0 43.2 70.4 36.5 41.3 31.7 37.9 73.8 55.3 48.9 71.9 56.6 28.1 38.1 89.4 32.3 96.0 49.1 31.5 30.1 26.6 54.1 17.1 303.2 28.9 20.9 31.6 62.1 34.0 8.1 90.8 103.9 15.9 44.8 40.6 61.4 31.6 45.2 54.6 14.4 29.1 14.7 136.4 32.8 61.1 71.8 51.5 32.8 48.3 20.9 49.4 41.4 389.3 85.6 26.0 23.3 119.6 41.9 77.8 13.7 33.3 63.3 126.4 55.9 65.8 44.0 22.0 105.4 46.8 82.0 36.1 19.8 28.2 8.7 89.1 39.1 190.1 103.7 45.0 52.0 43.0 37.5 72.3 24.3 5.1 257.9 59.1 20.3 19.9 100.4 20.4 15.2 39.3 24.2 53.8 41.4 9.3 143.7 13.8 33.8 56.3 45.6 33.3 57.1 19.1 104.1 34.1 118.3 29.9 68.8 26.5 250.5 187.2 35.9 88.1 28.5 34.4 2.1 228.5 319.0 11.8 137.1 8.0 56.0 8.2 8.3 105.7 55.1 11.3 12.3 34.8 23.7 141.0 18.0 10.2 118.7 27.9 27.4 29.0 43.2 28.1 38.1 31.5 30.1 26.6 31.6 31.6 29.1 32.8 48.8 44.8 61.8 25.1 52.7 23.7 208.6 456.2 37.5 12.7 52.4 110.7 32.5 10.0 304.9 95.6 16.7 9.9 20.5 2.0 19.6 22.2 1.0 51.5 24.5 27.1 24.4 21.2 37.2 6.8 19.4 115.4 4.6 13.6 8.2 4.3 62.8 15.7 160.5 10.1 24.9 5.0 126.1 135.0 33.7 3.4 64.3 110.2 24.9 20.6 142.2 18.9 25.7 21.1 20.7 4.8 1.6 68.1 39.0 74.1 62.4 29.7 397.8 17.0 52.6 28.1 63.2 4.4 12.3 38.1 19.9 11.1 18.8 67.1 8.0 122.6 SPOP "BTBD32, TEF2" ENSG00000121067 "Speckle type BTB/POZ protein" O43791 17 49598884-49678163 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (8.83e-2)" "unprognostic (3.23e-1)" "unprognostic (2.15e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (1.89e-2)" "unprognostic (7.20e-2)" "unprognostic (1.17e-2)" "unprognostic (1.51e-2)" "unprognostic (1.24e-3)" "unprognostic (7.67e-2)" "unprognostic (2.81e-1)" "unprognostic (3.45e-2)" "unprognostic (1.10e-2)" "unprognostic (3.29e-1)" 32.6 27.1 37.1 28.9 39.4 13.7 30.5 50.5 40.1 46.1 39.8 72.2 27.6 50.5 36.1 57.4 42.6 30.1 41.3 39.8 39.2 29.8 37.4 33.4 39.2 35.8 36.9 36.9 41.3 25.4 31.1 22.9 32.7 39.9 65.3 39.5 38.5 33.1 82.4 57.7 26.7 34.3 78.5 34.5 33.1 35.3 17.1 38.9 44.0 35.5 52.9 43.2 47.1 30.8 45.9 33.7 30.9 40.9 18.3 49.0 51.8 28.0 44.1 47.6 57.6 62.8 71.1 36.8 56.4 84.2 41.3 38.5 29.2 49.3 29.1 68.8 111.4 57.6 70.6 38.9 47.8 54.6 45.9 50.3 39.0 41.4 42.9 46.2 43.1 60.9 39.6 73.3 54.2 42.4 33.3 79.2 44.0 11.4 80.9 46.3 48.8 64.5 79.9 32.9 21.0 65.2 26.7 29.7 14.1 37.2 22.5 54.2 45.8 55.4 65.9 41.0 49.9 39.5 52.3 51.7 50.6 37.6 41.0 32.9 145.3 71.2 93.0 61.3 68.7 59.8 76.4 66.0 68.9 91.8 80.2 98.2 78.9 107.9 74.9 88.8 67.9 63.9 92.4 37.1 39.4 50.5 40.1 39.8 39.2 35.8 36.9 36.9 39.9 34.5 38.9 45.9 54.5 48.1 41.6 80.6 59.2 42.8 36.2 26.7 34.7 72.7 44.5 38.7 51.6 35.8 30.4 29.5 43.8 23.3 47.3 25.9 29.4 36.5 24.4 30.3 38.8 57.5 51.5 53.2 50.5 28.2 23.3 55.9 18.8 28.4 31.0 39.2 66.8 47.3 38.5 75.7 50.1 46.2 30.5 62.2 59.4 8.9 56.2 49.0 39.2 45.9 67.7 100.2 33.0 54.3 49.3 25.6 30.5 73.4 61.4 30.6 40.1 29.6 32.4 58.7 72.3 37.1 59.2 36.6 45.8 28.2 43.9 36.1 46.7 50.1 33.3 22.8 TBX2 ENSG00000121068 "T-box transcription factor 2" Q13207 17 61399843-61409466 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 134.1;Collecting duct cells: 95.6;Muller glia cells: 139.8;Sertoli cells: 170.9;Smooth muscle cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 129.3;MCF7: 78.5;SH-SY5Y: 65.4;SK-MEL-30: 49.3;WM-115: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA008586, CAB013636" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013636: , HPA008586: AB_1080222" "unprognostic (6.18e-2)" "unprognostic (8.51e-2)" "unprognostic (4.50e-1)" "unprognostic (2.09e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (9.29e-2)" "unprognostic (2.10e-2)" "unprognostic (2.10e-1)" "unprognostic (2.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" "unprognostic (6.34e-3)" 19.2 3.7 3.0 2.6 3.1 0.0 16.2 2.6 4.7 13.5 2.0 7.8 5.0 22.2 14.2 7.2 15.8 4.5 15.5 2.0 7.8 31.5 5.0 63.4 1.0 3.7 3.9 1.5 10.3 3.6 2.1 6.2 24.9 5.6 16.4 1.9 6.4 4.2 27.8 8.1 4.7 11.5 4.7 2.5 13.8 11.6 5.5 3.2 0.8 16.0 5.9 0.5 31.4 13.1 2.9 0.5 1.9 0.0 129.3 4.2 4.4 15.6 22.4 21.2 1.0 0.2 3.6 0.4 0.0 1.6 3.3 2.5 0.0 2.4 0.0 0.4 0.0 8.8 2.2 0.0 6.4 14.0 0.4 2.1 8.0 0.2 23.4 1.3 0.3 0.0 0.0 0.5 0.0 1.4 78.5 0.0 0.4 0.1 0.0 9.4 0.0 5.3 0.2 0.0 31.0 0.3 65.4 0.0 0.0 49.3 0.2 1.6 2.5 0.0 2.9 0.0 7.3 4.7 0.1 0.3 0.0 17.6 0.0 43.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.1 2.6 4.7 2.0 7.8 3.7 3.9 1.5 5.6 2.5 3.2 2.9 12.7 0.0 0.6 2.3 0.1 0.6 0.3 0.0 0.0 134.1 0.4 1.1 11.1 0.0 0.0 95.6 22.9 0.4 0.5 0.0 1.9 0.1 0.8 1.4 45.7 12.2 0.0 0.0 0.1 0.0 0.4 13.7 0.5 1.6 0.0 0.1 12.1 0.0 0.9 1.7 0.0 0.0 0.0 1.0 1.8 1.1 39.4 1.1 1.8 5.6 0.0 139.8 0.0 0.0 0.1 0.0 0.0 47.4 0.0 0.5 0.0 25.1 0.0 13.4 170.9 0.8 104.0 0.4 0.7 0.1 0.3 0.3 0.9 1.1 0.0 0.2 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700934-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: AB_2680481, HPA057418: AB_2683432" "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 13.5 10.0 17.2 15.7 17.4 19.6 18.8 17.4 20.2 16.8 20.7 20.1 27.1 11.5 53.2 17.3 18.2 12.6 32.5 16.9 20.0 29.0 46.8 15.4 14.5 18.0 18.1 16.7 8.6 18.5 31.8 13.8 17.2 17.6 13.9 24.4 17.2 16.6 15.7 62.0 10.6 26.2 15.7 16.3 12.5 17.5 14.2 18.0 15.4 36.4 60.8 21.8 23.2 7.9 17.7 45.2 75.5 52.4 87.7 47.5 32.9 59.7 46.4 77.8 98.7 80.5 156.6 52.3 31.5 104.7 66.7 55.0 32.6 87.1 55.3 103.5 38.3 65.3 38.5 43.8 94.0 85.3 71.9 34.9 31.9 60.3 73.1 83.6 24.6 64.7 46.5 40.0 84.2 68.1 94.2 51.9 52.5 23.6 82.4 92.2 37.4 56.6 85.6 47.1 45.5 45.8 60.4 25.9 21.3 34.0 57.7 68.7 50.0 26.6 74.0 33.3 84.0 61.9 48.3 79.6 42.7 50.2 54.6 63.8 25.1 27.2 10.1 15.8 27.7 12.0 11.6 10.9 15.4 32.1 6.8 11.2 10.0 11.2 13.5 19.3 43.3 13.6 16.1 17.2 17.4 17.4 20.2 16.9 20.0 18.0 18.1 16.7 17.6 16.3 18.0 17.7 32.1 16.0 29.7 10.7 37.1 22.3 40.0 56.4 22.8 28.2 37.1 29.0 40.5 21.5 45.3 27.6 35.5 57.8 47.4 34.9 35.2 78.4 52.4 19.1 25.1 39.2 50.6 20.4 11.7 101.7 121.0 28.6 16.3 24.1 42.5 22.8 27.8 56.6 73.5 21.9 10.4 56.2 59.0 28.0 45.2 17.6 30.1 34.0 37.4 4.7 39.6 44.6 26.8 11.6 11.2 77.5 33.2 20.7 103.7 70.1 139.9 51.3 33.9 35.4 13.1 25.3 47.9 63.2 41.2 24.5 25.1 80.4 31.1 24.1 41.7 50.6 TBX4 ENSG00000121075 "T-box transcription factor 4" P57082 17 61452404-61485110 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 32.6;placenta: 21.2;prostate: 9.1" "Group enriched" "Detected in some" 8 "Early spermatids: 6.2;Late spermatids: 14.6" "Cancer enhanced" "Detected in some" "lung cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.9;Hep G2: 1.2;OE19: 1.2;THP-1: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB032413, HPA044457" Uncertain Approved Vesicles NA NA Vesicles "CAB032413: AB_2200705, HPA044457: AB_2678948" "unprognostic (1.03e-2)" "unprognostic (2.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.63e-3)" "unprognostic (6.07e-2)" "unprognostic (3.80e-2)" "unprognostic (1.25e-2)" "unprognostic (4.14e-2)" "unprognostic (7.77e-3)" "unprognostic (7.41e-2)" "unprognostic (6.83e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-8)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 32.6 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 21.2 0.1 9.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 2.9 0.3 0.2 0.2 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.1 0.0 5.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2" "Cancer enhanced" "Detected in some" "breast cancer: 0.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA030620: AB_10601598, HPA077020: AB_2732327" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.8 0.1 0.6 1.8 0.2 1.1 0.7 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.8 0.0 0.2 0.2 0.1 0.6 0.5 0.3 0.3 0.1 0.0 0.2 0.1 0.6 0.2 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.1 27.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.1 6.3 0.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 7.9 0.0 3.3 0.3 0.0 0.4 0.1 0.1 0.3 0.2 1.2 0.0 0.1 0.9 0.1 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 1.1 0.7 0.5 0.8 0.6 0.5 0.3 0.6 0.5 0.5 0.8 4.4 0.0 0.0 2.9 5.7 0.9 1.8 0.7 2.8 0.6 4.7 7.2 1.3 5.7 1.5 1.8 0.0 1.6 0.7 0.1 0.0 0.0 23.3 0.4 0.2 1.5 0.0 0.0 2.2 0.0 1.0 0.7 0.5 1.8 1.3 0.2 1.4 0.8 3.7 0.0 2.2 0.5 2.0 0.6 2.3 6.4 0.3 4.6 3.6 2.8 0.0 0.6 1.0 1.0 3.0 0.1 0.0 0.4 4.3 0.7 0.0 0.1 0.2 1.3 0.0 1.2 1.5 56.4 16.2 1.7 0.1 1.1 0.7 0.0 0.0 0.4 FAM117A ENSG00000121104 "Family with sequence similarity 117 member A" Q9C073 17 49710332-49789180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.2" "Cell type enhanced" "Detected in many" "dendritic cells: 56.4;Erythroid cells: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 50.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 82.0;U-266/84: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022531 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022531: AB_2101087" "prognostic favorable (5.30e-5)" "unprognostic (8.06e-3)" "unprognostic (2.82e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (3.90e-3)" "unprognostic (1.69e-1)" "prognostic favorable (8.25e-7)" "unprognostic (4.05e-1)" "unprognostic (3.58e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.99e-2)" "unprognostic (3.73e-2)" "unprognostic (9.12e-2)" "unprognostic (1.45e-1)" "unprognostic (4.07e-2)" "unprognostic (4.66e-2)" 12.4 7.4 7.4 15.0 6.6 77.2 12.6 9.5 5.7 12.5 31.5 18.6 10.7 20.6 9.7 9.5 16.8 10.5 19.0 9.4 4.4 9.0 11.8 12.2 23.0 5.8 4.1 5.7 21.7 16.2 18.8 14.7 5.5 5.9 10.1 8.6 8.1 13.7 11.4 4.1 18.9 18.8 16.9 3.0 34.5 13.4 19.2 5.3 23.7 14.6 6.3 17.5 20.3 10.6 4.8 7.2 1.7 11.4 0.2 5.0 1.0 20.2 2.4 4.0 4.3 7.1 51.2 11.8 34.4 12.4 1.4 19.1 4.1 9.0 8.5 3.3 2.4 14.5 37.9 0.1 16.6 5.6 5.8 29.1 4.9 7.1 7.1 3.9 4.4 7.8 28.9 46.9 28.1 4.1 18.6 37.5 31.1 17.0 10.0 5.7 11.6 9.6 18.4 6.7 6.4 11.1 7.5 2.4 1.1 8.5 11.1 16.7 21.5 0.7 4.2 3.4 4.6 2.0 82.0 60.2 23.0 3.6 8.4 3.5 50.4 1.7 9.1 8.5 1.1 9.2 23.6 5.5 7.2 1.3 15.3 4.5 6.2 3.6 12.8 0.3 3.6 5.9 3.4 7.4 6.6 9.5 5.7 9.4 4.4 5.8 4.1 5.7 5.9 3.0 5.3 4.8 15.5 6.4 9.3 5.2 19.5 9.1 1.3 2.1 7.4 15.1 14.6 21.7 22.2 1.5 4.1 7.3 14.6 1.1 56.4 2.2 5.9 2.0 4.1 4.2 5.9 9.9 10.7 104.4 4.5 3.5 1.9 9.3 9.2 7.9 2.5 2.9 7.1 8.6 1.2 5.0 4.0 4.9 6.1 2.9 4.5 5.6 14.3 7.6 7.2 1.9 13.0 3.5 37.0 2.0 2.3 3.8 1.0 15.4 34.9 2.6 0.5 3.6 1.5 4.0 0.0 14.2 10.2 15.5 14.5 8.8 14.1 0.8 27.9 5.5 2.7 1.1 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335766-96377091 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.5;lymphoid tissue: 37.8;testis: 35.7" "Cell type enhanced" "Detected in many" "Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.8;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.2 0.7 0.4 10.0 0.5 35.5 1.9 1.0 0.9 0.8 0.1 7.8 5.6 0.9 0.2 6.4 0.5 1.6 0.4 0.4 0.2 0.4 1.0 1.2 20.5 0.2 0.1 0.3 0.3 0.3 0.5 0.2 5.3 0.4 0.4 9.4 1.8 1.5 0.2 0.3 4.8 6.2 2.8 0.0 3.8 3.6 35.7 0.2 37.8 0.4 0.1 22.2 2.6 2.0 0.7 134.1 52.0 115.1 60.6 3.9 6.1 80.8 58.7 40.3 115.1 118.4 93.5 71.5 121.0 41.8 26.6 106.2 57.2 100.2 39.6 117.2 110.0 63.4 123.7 49.3 74.5 0.7 112.2 101.3 1.8 4.2 89.1 35.9 10.2 46.6 89.7 89.5 88.8 53.0 59.5 183.8 104.2 85.9 57.6 56.6 133.4 106.7 95.5 23.6 49.6 71.2 52.3 34.8 46.5 19.9 42.4 36.6 80.0 24.1 83.5 126.3 76.9 101.9 44.4 70.1 134.0 33.7 111.5 95.3 3.8 0.0 0.2 0.8 0.9 0.1 0.9 1.2 1.0 0.4 0.9 0.0 0.4 0.3 0.1 0.0 0.0 6.2 0.5 0.4 0.5 1.0 0.9 0.4 0.2 0.2 0.1 0.3 0.4 0.0 0.2 0.7 4.9 0.0 0.0 0.0 3.5 0.6 0.7 1.9 1.2 0.4 1.0 0.8 0.5 0.0 1.6 0.0 8.4 9.4 2.0 2.1 0.0 0.5 5.9 1.7 0.9 1.8 0.0 16.4 0.4 0.0 16.3 1.8 4.1 1.2 1.3 5.5 1.4 0.4 8.5 0.0 0.3 2.8 0.0 3.8 3.7 4.9 0.9 2.2 1.8 0.0 0.2 8.5 0.0 0.5 1.0 0.2 0.1 0.4 26.3 0.7 0.4 0.0 1.6 2.3 0.0 0.2 3.5 89.3 29.4 8.8 0.9 1.9 5.1 0.6 5.7 1.1 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753120 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6" "Cell type enriched" "Detected in many" 6 "Granulosa cells: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "NTERA-2: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.3 0.2 1.0 0.2 0.8 0.6 0.4 0.9 2.6 0.2 1.5 0.3 1.2 0.1 0.3 0.0 0.2 0.5 0.0 0.8 1.8 0.1 2.2 0.3 0.1 1.2 1.1 0.7 0.3 0.8 0.2 0.2 0.1 1.8 0.4 0.1 1.0 0.1 0.5 0.8 0.4 1.6 0.1 0.8 0.1 0.3 0.9 0.9 0.0 1.5 0.0 0.1 0.1 0.1 1.1 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.1 1.4 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.6 1.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 1.5 0.2 0.1 0.1 0.8 0.2 0.2 0.2 0.1 2.2 1.0 0.8 0.9 2.6 0.8 1.8 1.2 1.1 0.7 1.8 0.8 0.9 1.1 0.2 0.0 4.4 4.6 0.1 1.1 4.4 4.0 0.6 0.5 8.6 9.1 0.3 11.5 1.7 0.0 0.0 0.1 0.3 0.8 3.9 1.2 15.2 0.9 0.5 0.3 0.0 0.0 2.2 0.8 0.1 1.5 2.0 2.2 0.0 104.4 1.4 2.2 0.1 0.0 0.6 0.9 2.0 0.8 2.8 3.2 0.0 0.3 5.4 0.0 0.0 3.9 0.0 1.0 2.2 1.2 0.0 0.0 0.0 2.4 12.3 1.0 0.9 0.8 0.0 1.4 8.1 10.5 4.7 1.4 1.1 0.3 0.6 0.0 1.2 0.6 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 49.9;lymphoid tissue: 48.7" "Cell type enhanced" "Detected in many" "Adipocytes: 13.6;Alveolar cells type 2: 9.6;B-cells: 9.9;dendritic cells: 13.2;Exocrine glandular cells: 9.3;monocytes: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 105.2;MOLT-4: 99.9;U-698: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" NA NA Vesicles "Nucleoli fibrillar center" "HPA043472: AB_2678496, HPA048443: AB_2680395" "unprognostic (1.12e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 9.9 1.7 1.4 21.1 3.9 49.9 7.3 1.0 2.5 5.1 1.3 5.6 2.4 6.3 9.5 6.8 5.0 4.9 8.8 1.7 2.0 3.1 20.9 6.7 48.2 2.3 1.6 1.7 4.7 31.4 1.1 3.9 3.9 2.3 6.0 4.7 0.4 8.2 4.8 24.8 7.0 11.0 6.9 1.2 24.8 6.1 4.4 1.7 48.7 4.1 6.2 45.7 6.2 6.0 2.7 5.8 3.7 15.7 16.5 9.1 7.9 0.3 8.3 4.0 5.6 7.1 25.8 3.7 105.2 2.0 11.1 6.2 5.7 12.1 14.3 8.5 9.7 8.7 20.6 7.0 6.7 5.9 22.9 1.2 7.3 8.7 7.4 6.9 6.3 14.4 19.1 19.7 0.4 5.7 10.7 99.9 16.6 14.0 0.2 5.4 34.3 15.2 6.8 3.8 2.4 11.7 9.1 6.5 14.2 8.6 8.0 5.5 16.6 11.6 7.5 13.2 9.1 6.9 11.2 12.1 122.4 2.2 13.5 6.2 11.8 19.4 21.1 12.3 36.8 16.7 28.2 15.5 11.7 20.9 27.3 25.8 17.5 21.0 24.3 31.6 2.1 20.9 17.6 1.4 3.9 1.0 2.5 1.7 2.0 2.3 1.6 1.7 2.3 1.2 1.7 2.7 13.6 6.4 9.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 5.5 4.3 0.0 0.0 1.8 0.0 0.0 0.5 13.2 0.0 1.9 2.0 0.0 1.3 8.2 3.2 0.0 0.0 0.0 9.3 0.2 3.7 0.0 1.1 5.1 5.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 16.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 4.8 0.0 0.0 1.5 5.8 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 7.2 5.1 0.0 0.0 MND1 GAJ ENSG00000121211 "Meiotic nuclear divisions 1" Q9BWT6 4 153344649-153415118 "Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;lymphoid tissue: 27.0;testis: 16.0" "Cell type enhanced" "Detected in many" "Early spermatids: 25.9;Erythroid cells: 30.9;Spermatocytes: 55.5;Spermatogonia: 96.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 1.3;T-reg: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043499 Supported NA NA "HPA043499: AB_2732506" "unprognostic (2.21e-2)" "unprognostic (6.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (6.21e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (5.28e-2)" "unprognostic (1.28e-2)" "unprognostic (9.43e-2)" "unprognostic (2.71e-8)" "unprognostic (7.65e-2)" "unprognostic (5.70e-2)" "unprognostic (9.84e-2)" "unprognostic (7.64e-2)" 0.5 0.5 1.6 4.7 1.7 13.4 2.5 1.4 1.9 0.5 1.1 4.5 3.0 0.7 1.2 3.3 0.5 1.0 0.4 1.5 1.5 0.6 1.3 0.8 12.1 1.9 1.6 1.5 0.3 0.3 0.0 0.3 2.4 1.8 0.5 5.2 0.0 0.9 0.9 1.3 2.1 2.6 1.5 1.6 1.8 1.6 16.0 1.7 27.0 0.4 0.6 14.2 1.4 1.3 1.9 38.6 17.7 52.7 30.6 0.7 7.2 20.9 35.1 15.4 31.4 25.6 32.8 26.1 74.4 5.8 8.5 29.5 15.7 52.3 15.8 39.9 47.7 19.9 39.1 17.3 42.9 1.1 88.2 17.9 1.9 3.3 24.4 21.1 7.8 10.7 86.0 71.0 91.9 26.8 21.5 124.1 116.0 39.1 17.9 17.8 74.1 18.2 35.8 19.3 9.7 26.5 23.3 15.7 17.7 30.0 26.5 14.7 72.1 2.6 24.1 34.8 28.1 32.6 79.0 96.0 58.8 24.1 69.6 28.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.0 0.4 0.0 0.1 1.7 0.1 1.6 1.7 1.4 1.9 1.5 1.5 1.9 1.6 1.5 1.8 1.6 1.7 1.9 0.2 0.0 0.5 2.6 1.9 2.8 1.8 5.1 0.0 0.0 2.2 4.6 0.6 2.8 0.7 0.0 0.0 14.5 1.0 4.1 1.9 0.3 25.9 3.5 1.6 1.3 0.0 30.9 1.6 0.5 20.6 3.6 2.0 5.7 0.0 11.8 1.4 1.0 12.5 0.0 2.6 4.3 4.1 2.5 5.0 20.5 0.9 2.4 3.6 1.9 0.1 0.0 1.0 2.0 23.3 0.6 1.6 2.2 7.7 1.2 0.7 0.1 1.0 0.0 6.6 0.9 8.6 55.5 96.3 10.2 1.4 2.5 2.5 1.5 10.3 2.7 TRIM6 RNF89 ENSG00000121236 "Tripartite motif containing 6" Q9C030 11 5596109-5612958 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 21.1" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 74.4" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA060514 Uncertain NA NA "HPA060514: AB_2684300" "unprognostic (9.00e-2)" "unprognostic (2.10e-3)" "unprognostic (9.16e-3)" "unprognostic (1.82e-1)" "unprognostic (3.25e-3)" "unprognostic (3.25e-3)" "unprognostic (2.35e-2)" "unprognostic (3.26e-3)" "unprognostic (8.59e-2)" "unprognostic (3.40e-2)" "unprognostic (8.61e-2)" "unprognostic (3.90e-1)" "unprognostic (5.68e-2)" "unprognostic (4.65e-4)" "unprognostic (4.77e-1)" "unprognostic (3.33e-2)" "unprognostic (4.36e-1)" 2.8 3.8 0.4 1.8 0.3 2.0 3.3 0.2 0.4 1.9 0.8 1.7 0.5 3.3 4.9 4.3 3.2 2.3 0.9 0.2 1.1 21.1 0.8 2.1 0.7 0.7 0.5 0.3 4.4 1.3 1.3 0.9 5.4 0.5 2.6 1.7 0.2 10.6 3.6 0.8 1.0 1.1 5.2 0.6 3.8 1.0 9.4 0.5 1.3 3.9 0.6 1.3 2.6 2.8 0.7 0.7 16.2 1.1 0.0 2.0 2.9 18.7 4.4 3.3 4.3 4.2 0.4 3.6 0.0 2.5 4.5 12.1 2.9 7.5 6.7 6.1 0.6 5.0 2.0 1.6 0.1 0.7 6.6 8.7 5.1 6.4 6.2 4.3 6.4 3.8 0.1 8.0 0.2 1.8 0.2 0.0 0.9 22.2 2.6 5.7 7.7 0.0 0.1 0.9 6.6 0.1 0.2 0.0 8.4 0.8 36.7 3.2 1.1 19.2 4.0 21.3 0.1 4.7 0.2 0.1 0.0 3.7 0.0 3.5 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 0.0 0.2 0.0 0.1 0.4 0.3 0.2 0.4 0.2 1.1 0.7 0.5 0.3 0.5 0.6 0.5 0.7 1.2 0.0 4.8 0.0 0.1 0.5 0.6 0.5 1.8 0.0 3.1 1.8 0.4 0.0 0.8 1.8 0.0 12.5 0.0 0.2 3.9 1.2 1.2 0.7 1.7 1.5 0.0 2.1 0.0 0.2 15.5 2.1 0.0 1.0 0.0 4.1 0.0 0.5 3.1 0.0 0.0 0.3 2.0 3.5 0.3 0.8 0.9 1.1 1.8 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.1 1.9 0.0 0.4 0.3 74.4 1.1 0.0 0.0 0.5 0.7 10.8 3.3 1.8 0.4 5.7 0.4 4.1 0.2 0.3 ABCC11 MRP8 ENSG00000121270 "ATP binding cassette subfamily C member 11" Q96J66 16 48165773-48247568 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "breast: 46.9" "Cell type enhanced" "Detected in some" "Astrocytes: 3.3;Breast glandular cells: 4.4;Early spermatids: 3.3;Hepatocytes: 2.5;Late spermatids: 1.9;Spermatocytes: 4.0" "Cancer enriched" "Detected in some" 4 "breast cancer: 8.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 67.1" "Not detected" "Not detected" NA NA "unprognostic (1.35e-1)" "unprognostic (3.47e-2)" "unprognostic (3.87e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-2)" "unprognostic (2.39e-1)" "unprognostic (2.64e-1)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-2)" "unprognostic (1.58e-1)" "unprognostic (1.13e-2)" "unprognostic (5.54e-4)" 0.1 0.0 0.2 0.0 0.2 0.1 46.9 0.3 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.0 1.6 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 3.6 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 16.0 0.1 0.0 67.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.5 3.3 0.2 0.0 0.0 0.0 0.0 0.4 4.4 0.9 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.3 0.3 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.3 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.0 0.4 0.5 0.0 0.3 0.2 0.1 0.0 0.1 TENT4B "PAPD5, TRF4-2, TUT3" ENSG00000121274 "Terminal nucleotidyltransferase 4B" Q8NDF8 16 50152911-50235310 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042968, HPA048225" Uncertain Supported "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "HPA042968: AB_2678244, HPA048225: AB_2680319" "unprognostic (1.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.27e-1)" "unprognostic (2.91e-2)" "unprognostic (4.33e-2)" "unprognostic (2.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (3.30e-2)" "prognostic favorable (1.85e-4)" "unprognostic (4.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (7.00e-2)" 5.8 6.4 2.9 1.7 2.4 7.2 4.7 4.0 4.5 7.3 3.0 6.2 4.6 7.0 2.3 5.4 6.6 2.0 3.7 4.0 2.7 4.2 9.0 5.1 2.3 2.6 2.5 2.2 6.9 4.3 3.9 4.9 2.8 3.0 5.4 1.9 1.4 4.7 1.7 5.4 5.6 5.9 2.6 2.4 4.6 5.6 5.8 3.1 1.7 4.8 2.1 1.9 7.3 6.5 4.0 5.5 1.9 0.6 3.3 3.8 2.0 4.3 3.9 2.3 3.5 1.6 3.4 2.3 6.5 5.6 2.7 1.4 3.6 3.9 2.0 3.1 3.8 4.5 3.6 1.6 5.4 3.8 2.4 4.9 1.9 2.6 2.3 3.3 2.3 1.8 2.1 4.2 1.5 4.1 1.5 3.5 4.6 4.2 1.5 4.5 4.9 4.8 6.9 1.7 0.5 4.0 2.2 4.9 2.7 2.3 1.5 1.5 0.9 3.0 2.1 4.1 4.0 1.9 4.9 3.7 6.9 1.7 2.7 2.7 0.0 0.4 0.0 0.4 0.2 0.1 0.3 0.2 0.5 0.2 0.2 0.3 0.5 0.7 0.2 0.2 0.4 0.1 0.1 2.9 2.4 4.0 4.5 4.0 2.7 2.6 2.5 2.2 3.0 2.4 3.1 4.0 17.9 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 17.8 16.3 0.0 0.0 0.0 14.7 0.0 18.1 82.8 0.0 3.9 10.9 0.0 44.3 24.4 6.1 0.0 0.0 0.0 14.9 11.5 6.7 0.0 31.5 0.0 13.5 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.2 0.0 0.0 22.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 18.3 14.9 17.3 0.0 0.0 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 42.8;granulocytes: 50.6;Kupffer cells: 65.1;Langerhans cells: 48.0;Macrophages: 45.4;Microglial cells: 52.5;monocytes: 42.4;NK-cells: 76.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 81.0;HMC-1: 194.6;RPMI-8226: 100.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041218, HPA048241" Uncertain Approved Cytosol NA NA Cytosol "HPA041218: AB_2677365, HPA048241: AB_2680326" "unprognostic (1.98e-1)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 8.2 3.9 8.4 24.2 9.9 25.0 5.7 9.0 13.9 3.9 10.7 8.3 4.2 3.8 2.4 14.4 7.6 12.5 4.6 8.7 11.6 1.5 3.8 23.5 27.3 14.1 11.3 5.6 19.6 2.0 1.6 2.0 14.6 12.0 2.7 8.9 0.8 4.1 2.1 2.3 13.8 8.7 7.9 13.8 29.9 7.8 1.9 12.9 19.5 2.4 3.6 24.7 7.6 4.8 18.3 16.3 18.5 0.7 2.6 1.9 24.0 1.7 9.7 4.5 8.1 7.0 23.4 28.4 4.2 25.4 41.0 0.5 50.5 22.3 10.0 8.9 50.7 6.9 81.0 18.4 5.8 20.6 10.6 194.6 12.0 8.5 5.7 8.3 4.4 2.3 17.7 30.4 7.9 10.5 9.2 5.8 34.9 3.5 8.4 31.1 5.7 7.1 100.6 5.0 1.1 4.0 9.8 5.4 2.0 4.8 4.4 0.1 38.7 17.6 0.9 25.5 2.9 3.6 0.3 0.6 8.5 9.3 32.6 3.4 9.2 7.6 2.8 6.9 10.7 5.1 2.8 2.9 5.2 12.2 3.3 2.5 3.6 4.1 9.5 18.1 6.8 4.4 5.6 8.4 9.9 9.0 13.9 8.7 11.6 14.1 11.3 5.6 12.0 13.8 12.9 18.3 1.4 19.2 35.9 2.0 15.4 3.7 0.4 0.6 1.2 1.2 1.3 2.8 1.0 0.0 7.9 0.0 6.2 11.6 42.8 3.3 0.0 1.9 1.5 6.7 6.5 1.9 0.0 12.4 6.4 0.2 1.8 9.2 3.6 13.6 50.6 4.7 1.4 0.5 35.2 0.0 3.8 0.7 0.0 65.1 48.0 1.3 0.6 45.4 5.4 52.5 42.4 0.5 76.2 3.5 0.7 4.2 10.4 1.2 15.6 0.5 0.1 0.2 1.0 0.8 6.6 28.3 2.2 0.0 1.5 7.2 4.0 4.0 26.6 16.0 2.3 1.3 CEP89 "CCDC123, FLJ14640" ENSG00000121289 "Centrosomal protein 89" Q96ST8 19 32875925-32971991 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039382, HPA040056" Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA039382: AB_2676479, HPA040056: AB_10671048" "unprognostic (4.23e-2)" "unprognostic (7.50e-3)" "unprognostic (1.97e-1)" "unprognostic (1.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.04e-2)" "unprognostic (1.80e-2)" "unprognostic (4.00e-2)" "unprognostic (1.74e-1)" "unprognostic (4.48e-2)" "unprognostic (6.53e-2)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" 5.8 6.1 6.1 5.4 6.1 4.8 6.5 6.9 6.2 8.9 6.6 8.0 4.1 9.9 6.8 6.3 9.0 5.1 5.7 6.3 5.9 8.4 3.3 5.8 6.1 5.3 4.8 6.1 10.1 6.1 7.1 9.4 5.4 5.3 12.6 4.4 7.4 6.7 6.0 6.0 6.7 6.7 6.9 4.0 6.5 6.2 4.2 6.1 6.3 7.6 4.4 4.4 8.1 6.8 5.5 19.1 25.7 17.1 14.7 9.1 11.0 9.9 14.7 9.8 25.5 19.4 9.3 11.2 7.6 7.8 15.1 14.4 10.5 16.9 11.9 17.6 20.2 10.4 5.9 18.5 8.9 7.2 8.3 5.7 13.3 16.2 24.1 16.2 10.4 19.5 10.4 9.2 11.0 12.3 14.2 9.4 6.4 7.3 10.4 8.0 10.4 9.2 6.6 11.9 10.3 24.1 17.7 15.1 10.3 8.8 10.3 7.7 6.7 12.6 18.4 16.1 16.0 15.3 5.3 9.1 7.0 15.8 7.8 14.0 12.8 3.1 1.6 2.7 4.6 4.9 3.3 2.9 2.4 1.8 5.7 2.8 3.3 3.7 2.1 2.4 3.7 3.4 1.7 6.1 6.1 6.9 6.2 6.3 5.9 5.3 4.8 6.1 5.3 4.0 6.1 5.5 12.7 28.9 16.0 17.3 9.5 5.1 11.5 14.5 8.0 16.3 11.7 11.8 17.5 10.0 19.0 20.2 18.8 9.3 9.6 8.0 11.7 19.1 15.1 49.2 24.9 14.8 9.7 13.3 17.2 16.6 11.2 17.7 10.7 17.3 17.1 21.1 14.6 5.6 11.8 20.2 13.6 9.7 8.2 5.3 5.1 8.5 16.1 8.9 5.4 14.0 9.8 9.6 10.3 9.5 15.9 15.1 5.2 12.8 5.4 6.7 9.9 16.3 48.3 38.6 0.0 17.5 16.1 20.3 13.8 7.5 4.5 4.2 9.0 12.7 8.6 6.6 TSHZ3 "KIAA1474, TSH3, ZNF537" ENSG00000121297 "Teashirt zinc finger homeobox 3" Q63HK5 19 31149979-31349436 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 33.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008834, HPA071010" Approved Enhanced "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA008834: AB_1080731, HPA071010: " "unprognostic (2.56e-1)" "unprognostic (3.88e-1)" "unprognostic (4.56e-2)" "unprognostic (3.66e-1)" "unprognostic (1.66e-3)" "unprognostic (4.07e-2)" "unprognostic (1.67e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (3.58e-3)" "unprognostic (2.23e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (8.76e-3)" "unprognostic (8.22e-2)" "unprognostic (1.91e-2)" "unprognostic (1.73e-3)" 7.0 3.7 3.0 4.8 4.6 1.1 6.3 0.0 7.8 17.0 0.6 12.2 2.2 21.7 9.2 5.8 13.1 9.4 5.1 5.9 2.5 3.0 1.4 6.4 1.3 3.5 1.3 2.4 33.1 1.5 1.3 4.6 5.8 3.1 11.7 4.0 1.8 3.4 9.6 1.9 2.9 5.6 18.6 2.5 5.5 6.8 2.7 2.5 0.8 10.3 2.4 0.5 15.0 8.9 3.9 0.0 2.0 0.7 0.0 9.4 22.2 0.0 6.0 8.8 3.7 6.6 0.0 1.2 0.0 0.0 14.8 7.0 1.0 2.7 5.3 8.2 0.0 2.2 0.0 0.0 0.0 19.4 5.2 9.1 13.0 4.5 13.7 6.8 0.0 0.0 4.4 0.0 0.0 16.9 0.9 0.0 0.0 0.7 0.0 0.0 5.9 46.4 0.0 0.0 0.0 0.0 13.8 0.1 0.0 4.7 4.4 0.0 3.6 0.0 32.8 10.3 3.4 8.8 0.0 0.0 0.0 21.2 8.8 0.9 0.0 0.9 0.0 1.1 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.3 1.9 0.0 0.1 0.0 0.3 0.3 3.0 4.6 0.0 7.8 5.9 2.5 3.5 1.3 2.4 3.1 2.5 2.5 3.9 8.3 3.2 1.1 10.1 0.2 4.8 7.3 9.2 15.4 14.0 0.8 2.4 2.1 1.5 5.1 3.7 0.0 0.4 2.5 0.0 0.0 0.4 0.2 1.3 54.0 9.0 0.0 0.4 34.4 0.6 0.3 20.2 0.0 1.3 1.3 2.6 17.2 0.2 11.6 16.8 84.7 0.0 2.0 9.7 10.4 1.1 17.7 5.0 5.4 14.0 6.4 0.2 0.0 59.3 1.9 0.6 0.0 29.3 0.3 3.8 0.0 0.1 1.3 0.2 0.0 29.7 7.8 0.3 4.0 1.7 1.7 0.8 1.7 1.0 0.0 3.2 ECHDC2 FLJ10948 ENSG00000121310 "Enoyl-CoA hydratase domain containing 2" Q86YB7 1 52895910-52927212 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 175.7" "Cell type enhanced" "Detected in all" "Hepatocytes: 875.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 15.8;HHSteC: 11.0;THP-1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026731, HPA026768" Enhanced Approved Mitochondria NA NA 240000 Mitochondria "HPA026731: AB_1847969, HPA026768: AB_1847970" "unprognostic (2.73e-3)" "unprognostic (1.52e-2)" "unprognostic (4.08e-2)" "unprognostic (3.76e-1)" "unprognostic (7.67e-2)" "prognostic favorable (6.65e-4)" "unprognostic (1.51e-3)" "unprognostic (1.40e-3)" "unprognostic (6.11e-2)" "unprognostic (7.16e-2)" "unprognostic (2.98e-3)" "unprognostic (4.40e-2)" "unprognostic (5.47e-2)" "unprognostic (5.12e-2)" "unprognostic (2.93e-1)" "unprognostic (3.62e-1)" "prognostic favorable (2.70e-4)" 20.1 35.5 5.2 1.2 5.3 2.8 25.1 6.9 7.9 16.6 6.2 17.8 16.8 17.3 5.6 28.4 23.3 5.1 24.7 4.9 6.0 49.9 175.7 12.9 2.3 4.9 5.2 4.8 29.4 23.4 14.4 14.7 4.5 5.5 24.2 3.6 5.1 19.2 8.5 30.2 14.6 17.5 2.4 4.8 9.4 29.3 7.0 5.1 3.0 39.2 27.1 1.5 18.3 17.0 5.0 0.0 1.8 0.0 0.0 1.1 0.5 15.8 1.2 7.6 1.6 2.4 0.0 1.5 0.0 7.7 1.2 0.0 0.8 0.0 1.2 0.3 0.0 8.1 0.0 3.1 3.6 11.0 0.0 1.8 1.6 3.2 1.0 1.1 2.4 4.5 0.0 1.2 0.2 0.0 4.2 0.0 0.9 0.2 7.0 1.7 0.0 0.2 0.7 5.2 6.4 0.8 0.3 2.3 6.3 0.1 0.9 1.3 10.2 2.3 0.0 0.0 0.7 0.2 0.3 0.6 0.0 0.5 0.0 0.4 0.0 2.1 1.8 12.1 1.4 9.1 6.9 9.9 11.4 9.5 3.3 10.7 6.6 0.4 6.1 0.8 2.4 13.6 4.0 5.2 5.3 6.9 7.9 4.9 6.0 4.9 5.2 4.8 5.5 4.8 5.1 5.0 23.9 54.5 92.0 161.3 17.9 30.7 85.6 67.2 83.1 32.3 96.4 86.7 61.5 153.0 71.1 86.5 327.4 206.0 26.7 96.4 178.1 59.3 150.2 54.9 19.5 18.7 52.1 29.9 26.0 59.4 18.0 64.6 94.3 41.3 29.8 50.6 30.4 875.3 31.8 42.1 34.9 78.3 40.7 27.6 13.8 180.6 154.1 12.8 40.9 51.5 7.6 60.0 23.7 54.8 6.9 44.6 115.7 112.5 10.0 66.5 172.6 284.7 62.5 160.6 19.7 118.3 39.5 17.0 16.7 66.9 29.5 124.0 36.1 23.7 64.7 80.0 TAS2R8 "T2R8, TRB5" ENSG00000121314 "Taste 2 receptor member 8" Q9NYW2 12 10806051-10807286 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PLBD1 FLJ22662 ENSG00000121316 "Phospholipase B domain containing 1" Q6P4A8 12 14503661-14567883 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 288.7" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 187.7;Hofbauer cells: 105.6;Kupffer cells: 109.4;Macrophages: 116.3;monocytes: 192.8;Paneth cells: 105.9" "Cancer enhanced" "Detected in all" "testis cancer: 113.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 662.9;intermediate monocyte: 204.4;myeloid DC: 357.3;neutrophil: 443.8" "Group enriched" "Detected in all" 135 "dendritic cells: 357.3;granulocytes: 443.8;monocytes: 662.9" "Cell line enhanced" "Detected in many" "AN3-CA: 48.6;BEWO: 98.4;CAPAN-2: 245.6;MCF7: 46.3" "Not detected" "Not detected" HPA040303 Enhanced "Intracellular and membrane" NA NA 3400000 "HPA040303: AB_2676922" "unprognostic (9.13e-3)" "unprognostic (5.77e-2)" "unprognostic (2.29e-1)" "unprognostic (7.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (4.80e-2)" "unprognostic (1.85e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.12e-1)" "unprognostic (3.03e-3)" "unprognostic (3.47e-1)" "unprognostic (1.97e-1)" "unprognostic (4.99e-2)" "unprognostic (5.44e-2)" 29.7 5.7 1.9 34.0 2.4 288.7 28.1 2.4 3.7 22.6 22.7 59.3 28.4 13.6 10.7 56.8 16.7 33.4 32.9 2.0 4.4 26.5 10.6 64.6 9.3 3.5 2.6 1.4 4.4 30.2 3.2 3.4 36.2 2.8 10.3 80.0 0.8 12.0 15.5 10.0 25.0 43.0 28.4 3.0 25.4 36.9 10.1 2.8 7.8 6.2 17.3 33.0 59.0 29.8 5.8 7.1 5.0 0.5 48.6 0.3 0.0 98.4 0.2 0.0 3.0 2.4 14.1 245.6 0.0 1.4 1.0 0.4 9.4 0.0 0.0 0.5 0.0 0.1 0.0 6.4 0.0 3.8 0.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 1.1 46.3 0.1 0.2 16.5 0.7 0.3 0.1 0.1 0.5 0.7 28.9 0.0 0.4 30.2 14.8 1.9 26.5 9.0 9.6 0.0 0.5 0.4 0.0 0.6 8.7 23.7 0.2 0.0 0.1 0.4 0.4 662.9 5.8 1.0 204.4 0.6 3.6 0.5 0.4 357.3 0.8 0.7 0.7 443.8 1.7 73.5 4.1 0.9 423.2 1.9 2.4 2.4 3.7 2.0 4.4 3.5 2.6 1.4 2.8 3.0 2.8 5.8 15.5 9.6 8.6 0.3 2.9 6.8 8.8 4.9 6.8 0.0 11.9 6.6 16.5 30.0 20.4 33.1 0.0 94.5 1.5 67.8 11.7 13.1 51.8 2.5 9.1 7.2 9.1 1.7 1.6 46.5 187.7 59.6 13.3 0.9 5.1 5.9 4.6 2.9 105.6 0.0 0.9 31.3 6.1 109.4 68.6 5.8 26.1 116.3 5.4 7.5 192.8 1.6 1.0 1.5 0.2 28.6 105.9 27.8 3.6 3.8 52.8 15.7 19.0 0.2 0.0 12.0 10.4 17.4 12.0 17.8 19.9 70.3 1.6 6.1 75.2 30.1 TAS2R10 "T2R10, TRB2" ENSG00000121318 "Taste 2 receptor member 10" Q9NYW0 12 10825317-10826358 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Astrocytes: 6.2;Excitatory neurons: 14.4;Inhibitory neurons: 14.4;Microglial cells: 4.7;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070201 Approved "Vesicles,Plasma membrane,Actin filaments" NA NA "Vesicles, Plasma membrane" "Actin filaments" "HPA070201: " "unprognostic (1.28e-1)" "unprognostic (3.89e-4)" "unprognostic (1.77e-1)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (5.82e-3)" "unprognostic (3.86e-1)" "unprognostic (7.72e-2)" "unprognostic (5.27e-2)" "unprognostic (1.67e-1)" "unprognostic (1.24e-2)" "unprognostic (1.20e-1)" "unprognostic (4.16e-5)" "unprognostic (5.41e-2)" "unprognostic (3.18e-2)" "unprognostic (2.87e-2)" "unprognostic (2.56e-3)" 0.2 0.6 0.1 0.0 0.1 0.0 0.2 0.1 0.4 0.2 0.0 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.3 0.2 0.0 0.4 0.0 0.2 0.2 0.0 0.3 0.4 0.0 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 14.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 14.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 PRB2 "cP7, PRPPRB1, Ps" ENSG00000121335 "Proline rich protein BstNI subfamily 2" P02812 12 11391540-11501041 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1099 "salivary gland: 12171.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 25000000 "unprognostic (1.36e-1)" "unprognostic (1.01e-2)" "unprognostic (2.61e-1)" "unprognostic (2.07e-2)" "unprognostic (9.21e-2)" "unprognostic (5.51e-3)" "unprognostic (1.97e-4)" "unprognostic (1.51e-1)" 0.0 0.0 1.5 0.0 4.9 1.6 0.0 0.4 7.9 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.3 0.0 6.2 1.1 0.5 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.2 12171.6 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.7 1.7 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 4.9 0.4 7.9 6.6 0.3 6.2 1.1 0.5 2.4 0.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PYROXD1 "DKFZp762G094, FLJ22028" ENSG00000121350 "Pyridine nucleotide-disulphide oxidoreductase domain 1" Q8WU10 12 21437615-21471250 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 179.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038319, HPA038320" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA038319: AB_10669522, HPA038320: AB_2675956" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.15e-2)" "unprognostic (9.89e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-3)" "unprognostic (1.50e-1)" "unprognostic (9.31e-2)" "unprognostic (8.94e-3)" "unprognostic (1.17e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (1.06e-2)" "unprognostic (3.78e-2)" "unprognostic (2.30e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.70e-4)" 8.0 10.1 4.3 9.3 4.7 9.4 10.5 5.7 5.2 7.2 5.5 12.1 14.1 7.2 8.7 8.4 7.2 8.8 10.8 4.3 5.4 16.9 12.4 8.7 10.7 5.6 5.4 3.8 6.6 13.5 10.5 5.2 5.9 5.7 10.0 11.3 14.1 12.0 5.9 12.5 10.1 16.1 6.4 5.2 8.0 12.9 5.8 4.8 7.6 15.8 9.7 8.6 7.7 6.2 6.1 9.3 3.5 5.2 5.8 3.7 6.8 11.8 14.5 6.7 5.2 4.0 4.5 8.6 10.2 6.0 11.0 4.4 11.3 5.8 11.4 5.8 12.1 5.1 11.8 9.2 5.7 17.2 17.7 12.0 11.3 13.5 3.3 14.3 6.7 7.8 11.0 5.8 4.2 10.7 5.9 8.3 24.3 8.6 8.2 6.5 1.4 11.2 11.2 16.3 9.2 1.7 13.1 6.7 12.2 27.0 7.1 14.5 20.8 11.2 6.2 5.9 13.5 13.4 6.4 4.8 12.7 25.4 13.1 7.5 1.2 0.8 0.6 1.7 1.5 1.9 1.2 2.0 2.1 0.8 0.9 1.6 1.7 0.3 1.6 2.7 1.1 1.6 0.9 4.3 4.7 5.7 5.2 4.3 5.4 5.6 5.4 3.8 5.7 5.2 4.8 6.1 12.5 12.8 28.4 12.7 18.3 6.6 10.2 10.7 8.0 21.8 15.1 10.8 11.7 27.1 13.6 27.6 25.0 15.4 22.9 40.0 23.5 24.7 179.8 26.0 13.0 9.4 20.4 13.3 14.0 33.4 14.2 10.4 19.9 21.1 25.3 8.6 8.9 21.2 16.2 8.4 17.0 21.3 12.2 21.8 5.8 32.6 10.5 18.1 5.4 17.8 15.6 14.5 17.5 13.0 34.2 41.2 25.1 6.4 19.5 12.0 39.4 43.8 28.6 28.2 13.1 15.0 13.8 49.7 18.8 14.5 7.7 19.4 20.1 10.6 20.6 14.1 IAPP "AMYLIN, DAP, IAP" ENSG00000121351 "Islet amyloid polypeptide" P10997 12 21354959-21379980 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "pancreas: 168.1" "Group enriched" "Detected in some" 5 "Early spermatids: 44.5;Pancreatic endocrine cells: 15.2" "Cancer enriched" "Detected in single" 76 "pancreatic cancer: 21.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000352, HPA053194" Enhanced Approved Vesicles "Secreted to blood" NA NA 11900 Vesicles "CAB000352: AB_2121635, HPA053194: AB_2682076" "unprognostic (5.52e-3)" "unprognostic (1.00e-1)" "unprognostic (4.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.91e-1)" 0.5 0.0 0.1 0.0 0.2 1.0 0.0 0.5 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.1 2.3 0.0 0.2 1.2 0.5 0.1 0.0 168.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 3.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.2 1.2 0.5 0.1 0.3 0.0 0.7 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 44.5 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 1.5 0.3 0.3 0.2 0.0 0.4 0.3 0.3 0.1 0.0 0.8 KCNJ8 Kir6.1 ENSG00000121361 "Potassium inwardly rectifying channel subfamily J member 8" Q15842 12 21764955-21775600 "Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.7" "Group enriched" "Detected in many" 4 "Sertoli cells: 197.2;Smooth muscle cells: 61.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "BJ: 11.1;CACO-2: 58.4;SH-SY5Y: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031066 Uncertain NA NA "HPA031066: AB_10602240" "unprognostic (8.12e-3)" "unprognostic (1.89e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.81e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-2)" "unprognostic (3.90e-2)" "unprognostic (3.66e-3)" "unprognostic (2.88e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (4.70e-3)" "unprognostic (9.61e-2)" "unprognostic (1.73e-2)" "unprognostic (3.54e-3)" 28.5 17.4 4.3 3.3 4.5 0.0 22.3 4.3 5.8 16.0 9.8 11.9 1.2 18.9 0.7 3.6 15.0 1.8 52.7 4.0 7.0 11.2 42.3 13.9 2.5 4.7 4.7 3.6 16.9 42.8 1.8 7.8 3.0 4.5 13.1 0.3 0.8 6.4 8.5 17.2 5.0 5.9 5.6 4.4 8.1 12.8 1.0 5.9 0.6 16.2 4.5 0.4 15.3 11.6 4.4 0.0 0.1 0.9 0.0 1.4 3.2 0.0 11.1 4.4 6.5 1.9 58.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 4.3 2.9 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.2 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.6 2.7 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.5 4.3 5.8 4.0 7.0 4.7 4.7 3.6 4.5 4.4 5.9 4.4 18.7 3.2 29.5 2.9 0.0 1.3 0.4 0.0 0.6 0.0 9.2 3.0 28.3 0.0 0.6 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.7 10.8 12.8 1.2 0.0 3.6 1.3 0.0 9.8 0.0 0.9 0.0 1.0 2.9 23.0 0.3 0.0 0.2 0.0 0.0 0.8 1.5 0.1 0.3 0.3 1.8 0.0 0.0 13.2 0.0 0.5 0.4 1.2 0.0 0.7 0.1 0.4 0.0 0.0 0.0 2.0 197.2 3.3 61.6 0.0 1.0 0.1 0.9 0.3 0.3 0.5 0.2 0.6 TAS2R7 "T2R7, TRB4" ENSG00000121377 "Taste 2 receptor member 7" Q9NYW3 12 10801532-10802627 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 BCL2L14 "BCL-G, BCLG" ENSG00000121380 "BCL2 like 14" Q9BZR8 12 12049844-12211084 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.7;stomach 1: 9.4;testis: 31.6" "Group enriched" "Detected in many" 6 "Early spermatids: 385.6;Late spermatids: 863.1" "Group enriched" "Detected in many" 4 "colorectal cancer: 5.2;pancreatic cancer: 1.8;stomach cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;NTERA-2: 1.6;OE19: 2.0;RT4: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040665, HPA059846" Enhanced Uncertain Cytosol NA NA Cytosol "HPA040665: AB_10964282, HPA059846: " "unprognostic (3.65e-4)" "unprognostic (4.95e-3)" "unprognostic (1.68e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-1)" "unprognostic (2.70e-4)" "unprognostic (1.10e-1)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "unprognostic (4.59e-5)" "unprognostic (1.06e-2)" "unprognostic (1.06e-2)" "unprognostic (5.79e-6)" "unprognostic (3.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-2)" "unprognostic (1.73e-8)" 0.0 0.0 0.1 2.6 0.0 0.1 0.5 0.0 0.3 0.3 0.0 10.8 13.8 0.1 0.1 0.2 0.1 1.2 0.0 0.2 0.0 0.1 0.5 0.4 1.3 0.1 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.2 1.1 15.7 0.0 0.9 0.0 0.0 0.0 13.0 0.4 0.0 0.7 9.4 31.6 0.0 1.2 0.0 0.0 0.8 1.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.0 2.3 1.6 0.2 0.4 2.9 3.2 0.0 0.3 2.5 1.3 0.7 2.8 4.5 1.8 0.0 0.1 0.2 30.1 0.0 0.3 385.6 1.2 0.2 0.7 6.7 0.0 2.1 7.5 0.0 0.5 28.5 0.8 0.0 0.1 0.0 0.3 0.2 0.0 1.4 45.0 2.0 0.3 3.8 863.1 5.6 0.9 0.0 0.0 3.8 0.1 0.0 1.5 1.1 2.6 22.9 3.8 0.5 4.0 95.0 0.0 5.0 1.0 6.6 1.2 0.6 6.5 2.8 0.0 0.4 0.1 0.6 0.1 30.6 9.4 TAS2R9 "T2R9, TRB6" ENSG00000121381 "Taste 2 receptor member 9" Q9NYW1 12 10809094-10810168 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSPC1 "FLJ10955, PSP1" ENSG00000121390 "Paraspeckle component 1" Q8WXF1 13 19674752-19783019 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 173.4;Inhibitory neurons: 164.7;Spermatocytes: 171.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038904 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA038904: AB_10673291" "unprognostic (2.13e-3)" "unprognostic (3.48e-1)" "unprognostic (1.52e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-3)" "unprognostic (2.14e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.13e-3)" "unprognostic (9.57e-2)" "unprognostic (1.09e-1)" "unprognostic (1.69e-3)" "unprognostic (3.04e-3)" "unprognostic (2.92e-1)" "unprognostic (3.69e-2)" "unprognostic (8.61e-2)" "prognostic favorable (1.46e-4)" "unprognostic (7.72e-2)" 10.3 13.1 9.9 13.3 12.1 54.2 16.4 13.3 13.4 12.7 10.2 15.0 12.5 14.9 21.9 14.1 16.4 12.2 11.2 12.1 10.6 12.4 9.0 10.0 20.9 12.8 9.9 13.8 13.8 9.6 9.5 10.4 13.9 12.1 11.1 15.6 17.6 10.1 8.4 21.1 14.5 12.5 12.7 9.6 11.2 12.1 25.2 10.3 23.3 12.3 12.8 22.0 20.6 10.1 14.3 50.5 20.4 46.6 23.3 18.9 19.8 60.3 26.1 34.0 48.3 43.6 68.4 27.8 67.8 27.7 27.9 25.4 24.6 54.7 32.2 50.0 28.9 27.3 76.4 14.1 83.1 37.4 55.3 46.7 31.6 6.5 29.8 32.9 19.2 41.7 65.9 42.8 26.1 43.2 54.1 65.5 52.8 65.5 27.3 28.0 43.7 46.8 34.6 50.8 74.6 42.7 22.0 35.8 59.1 23.1 44.9 34.5 56.6 25.1 28.9 27.7 28.0 25.4 22.5 14.5 115.1 13.2 32.7 35.2 14.8 21.3 14.5 11.8 22.7 12.0 23.3 15.1 11.0 19.1 22.5 15.4 11.2 16.9 11.9 18.1 20.9 21.8 15.7 9.9 12.1 13.3 13.4 12.1 10.6 12.8 9.9 13.8 12.1 9.6 10.3 14.3 21.0 19.2 29.5 79.3 36.4 33.3 24.9 16.4 23.3 43.2 24.6 21.0 28.6 21.5 18.9 16.5 58.4 70.0 41.0 16.4 21.5 31.3 17.4 40.0 33.9 24.0 25.2 23.1 173.4 34.1 104.7 25.1 25.5 39.4 9.5 28.0 23.9 11.1 27.2 30.3 164.7 20.0 12.2 25.7 25.3 21.4 31.4 27.7 19.6 92.8 45.2 25.5 27.8 115.6 156.4 26.8 22.2 26.7 31.8 16.5 16.1 23.8 25.9 69.1 32.9 27.2 27.4 171.5 75.4 24.0 34.1 80.4 38.9 48.1 27.2 26.2 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Rod photoreceptor cells: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 11.2" "Group enriched" "Detected in all" 4 "B-cells: 4.5;NK-cells: 11.2;T-cells: 4.6" "Low cell line specificity" "Detected in many" HPA039511 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 2.5 3.3 4.5 3.4 4.7 3.6 4.4 9.5 4.5 2.8 3.1 3.0 2.0 3.3 3.9 2.0 4.1 2.7 3.2 4.7 3.6 3.0 1.3 3.3 5.0 3.6 3.7 4.3 5.7 2.4 5.6 4.9 3.8 5.8 4.2 2.3 11.9 3.0 3.3 3.1 3.9 3.3 3.3 2.3 5.7 2.9 4.0 3.7 6.0 4.7 2.5 5.3 3.4 2.4 4.8 1.5 2.0 7.9 6.6 2.4 1.9 1.9 3.8 4.5 3.6 17.5 2.1 1.4 2.2 2.6 3.5 4.5 0.9 2.5 5.5 5.9 0.2 14.7 10.2 1.9 3.1 3.3 8.6 7.0 3.4 4.2 3.7 5.1 5.2 2.3 5.7 0.1 0.3 6.6 0.9 9.8 3.6 6.8 0.2 5.3 6.8 6.6 4.7 1.4 3.9 3.3 5.7 0.1 0.5 4.4 6.6 4.5 6.7 1.9 6.9 4.7 0.3 5.5 3.7 11.6 7.0 1.1 2.9 6.4 0.6 0.8 1.5 2.4 0.7 3.2 2.2 3.3 3.8 1.5 4.5 4.6 3.0 0.5 11.2 1.2 1.4 2.2 1.9 4.5 4.7 9.5 4.5 4.7 3.6 3.6 3.7 4.3 5.8 2.3 3.7 4.8 2.2 0.0 2.8 5.9 7.0 1.7 1.7 1.3 0.6 7.5 2.2 1.7 3.2 4.3 0.8 1.8 14.6 1.6 5.6 0.4 3.9 1.4 0.6 2.2 2.3 3.6 3.6 5.7 9.8 0.7 0.8 2.2 1.1 1.9 6.3 6.1 3.9 0.6 1.5 8.4 7.9 0.5 0.0 3.2 0.4 0.4 3.1 2.3 5.4 6.5 1.5 3.9 7.2 8.0 4.1 0.7 1.8 2.2 1.3 1.8 0.7 0.8 5.8 14.8 6.6 2.6 2.3 1.2 4.7 0.6 1.6 1.1 4.0 2.3 0.9 1.2 A1BG ENSG00000121410 "Alpha-1-B glycoprotein" P04217 19 58345178-58353492 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1492 "liver: 1234.7" "Cell type enriched" "Detected in many" 13 "Hepatocytes: 1548.5" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;RH-30: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB016673, HPA044252" Supported "Secreted to blood" NA NA 200000000000 51000000000 "CAB016673: AB_1611892, HPA044252: AB_2678876" "unprognostic (9.95e-2)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-2)" "unprognostic (4.19e-5)" "unprognostic (2.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (6.72e-2)" 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.2 0.1 0.0 0.1 1234.7 0.1 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.0 2.5 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.9 0.3 0.8 0.0 0.1 0.1 0.7 1.3 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.3 0.4 0.0 0.6 0.2 0.0 0.0 0.9 0.9 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 10.2 12.8 14.1 0.7 50.2 8.8 2.2 16.2 12.0 3.4 52.0 64.3 0.7 27.1 10.6 22.0 2.1 1.0 71.2 0.0 7.9 0.9 0.6 5.0 52.6 10.9 1.2 56.2 2.2 9.2 15.6 20.3 5.1 2.1 17.7 10.8 43.2 1548.5 25.1 8.4 1.7 0.1 20.3 110.9 66.0 2.1 1.2 49.4 115.6 0.0 60.8 3.1 15.5 0.0 8.7 5.4 0.0 1.2 94.4 11.1 0.0 2.0 15.0 5.5 26.3 29.2 43.8 4.1 7.9 1.5 3.7 1.9 52.6 0.7 0.2 0.6 ZSCAN18 "FLJ12895, ZNF447" ENSG00000121413 "Zinc finger and SCAN domain containing 18" Q8TBC5 19 58083838-58118427 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 128.4;SCLC-21H: 59.3;U-266/84: 46.6" "Low region specificity" "Detected in all" HPA024318 Supported Approved Nucleoplasm No No Nucleoplasm "HPA024318: AB_1859494" "unprognostic (1.85e-2)" "unprognostic (3.48e-2)" "unprognostic (7.07e-2)" "unprognostic (6.45e-3)" "unprognostic (1.28e-1)" "unprognostic (1.22e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (2.24e-1)" "unprognostic (8.27e-2)" "unprognostic (2.59e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.95e-7)" "unprognostic (3.68e-2)" "unprognostic (7.23e-2)" "unprognostic (3.70e-1)" "unprognostic (9.04e-2)" 27.9 31.4 72.6 8.4 72.1 5.8 33.1 53.7 72.6 49.0 54.1 47.3 10.0 63.6 20.9 21.5 66.8 15.1 55.4 67.5 70.1 49.4 14.5 29.1 9.4 70.0 64.8 68.7 64.1 23.1 28.2 83.4 15.1 60.5 46.7 6.2 37.2 24.0 29.2 23.9 26.3 29.2 18.9 58.8 28.3 32.7 42.9 69.7 10.4 61.4 13.3 6.7 49.9 34.9 63.3 0.2 1.7 14.4 35.2 1.7 1.9 32.4 9.5 0.2 12.8 2.3 0.0 8.7 3.8 18.8 13.6 14.4 0.2 1.2 7.7 12.4 0.1 128.4 0.4 0.1 0.2 25.7 0.0 25.8 23.1 0.4 9.5 0.0 17.1 0.9 9.3 0.2 1.4 18.1 0.0 18.9 7.2 22.6 0.0 0.0 21.8 0.0 1.5 11.8 29.1 59.3 13.8 0.0 0.5 0.1 12.5 39.5 0.0 0.0 0.6 15.0 15.4 0.1 15.2 46.6 0.1 0.0 0.2 10.5 1.0 0.2 1.3 0.1 0.1 0.8 0.6 0.6 0.6 0.3 1.4 0.9 0.8 1.4 0.8 0.2 0.8 0.0 0.3 72.6 72.1 53.7 72.6 67.5 70.1 70.0 64.8 68.7 60.5 58.8 69.7 63.3 30.6 16.0 26.9 31.0 24.9 12.1 51.2 6.7 7.4 77.5 22.5 25.0 44.3 25.8 26.2 42.3 33.3 45.9 10.1 3.7 15.6 25.1 52.3 46.9 26.8 33.2 26.5 3.4 29.5 5.8 8.6 28.5 11.7 24.0 23.5 39.8 33.5 4.1 9.0 112.7 26.4 14.7 10.2 3.2 6.4 75.9 40.0 6.0 10.6 13.1 6.0 73.0 25.7 21.6 40.7 5.9 13.1 58.6 3.6 38.4 7.3 11.1 36.7 110.5 19.7 32.6 30.1 30.0 27.9 6.5 12.1 65.7 15.8 39.3 10.5 32.6 ZNF211 "CH2H2-25, ZNF-25" ENSG00000121417 "Zinc finger protein 211" Q13398 19 57630395-57644041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011340, HPA049967" Approved Approved "Mitochondria,Rods & Rings" NA NA Mitochondria "Rods & Rings" "HPA011340: AB_2668488, HPA049967: AB_2680973" "unprognostic (6.47e-2)" "unprognostic (3.28e-2)" "unprognostic (2.83e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-1)" "unprognostic (2.77e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "unprognostic (6.66e-2)" "unprognostic (1.03e-1)" "unprognostic (3.27e-3)" "unprognostic (1.83e-2)" "unprognostic (1.03e-1)" "unprognostic (3.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (4.72e-3)" 7.2 11.4 15.0 7.3 14.0 23.9 9.4 15.7 16.0 8.0 18.5 10.0 4.2 8.7 10.2 6.9 10.1 6.3 12.5 14.4 13.8 11.4 6.8 9.2 12.1 14.0 13.3 13.8 11.0 7.0 16.9 17.3 10.7 13.7 13.2 8.2 18.7 8.6 11.8 6.4 10.4 11.3 8.2 12.7 17.6 15.4 6.6 13.5 13.7 16.2 7.1 12.8 11.3 7.6 15.3 4.6 3.1 13.5 12.2 7.9 7.5 7.8 6.3 7.9 9.1 5.9 2.5 2.7 4.3 2.6 6.8 5.4 1.0 6.4 9.4 18.9 5.4 15.3 8.6 7.0 5.6 6.5 5.8 8.5 6.8 11.5 6.9 6.2 13.2 6.9 7.8 1.8 5.4 11.5 2.3 12.1 4.5 5.3 5.9 7.0 7.6 10.3 3.8 7.7 17.9 6.1 8.4 7.5 3.5 3.0 14.8 4.1 8.5 3.3 9.1 4.4 3.9 5.3 7.7 10.1 8.9 2.4 4.9 5.3 10.0 5.8 12.4 7.3 5.7 12.4 8.0 9.6 10.8 7.1 10.8 11.6 8.3 7.8 7.5 4.1 1.6 11.6 6.5 15.0 14.0 15.7 16.0 14.4 13.8 14.0 13.3 13.8 13.7 12.7 13.5 15.3 5.0 3.2 3.4 10.4 8.2 1.1 1.8 4.4 4.0 4.0 5.0 3.8 4.3 1.5 3.6 1.8 8.4 8.2 7.8 2.1 0.0 4.1 0.8 5.0 4.5 4.8 1.2 12.8 4.1 1.1 5.2 3.0 8.6 2.7 5.7 3.9 4.6 2.0 4.0 0.0 3.9 2.8 6.1 5.7 3.9 1.2 1.2 4.0 1.8 5.6 3.9 4.7 6.2 12.5 7.6 1.3 1.0 2.2 4.1 1.9 5.0 1.4 12.0 7.2 13.1 2.3 4.0 2.4 3.1 1.9 1.7 17.8 8.5 3.1 2.9 3.0 PDZRN3 "KIAA1095, LNX3, SEMACAP3, SEMCAP3" ENSG00000121440 "PDZ domain containing ring finger 3" Q9UPQ7 3 73382431-73624941 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4" "Group enriched" "Detected in many" 4 "amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2" "Low region specificity" "Detected in many" "HPA038822, HPA061420" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038822: AB_10675952, HPA061420: AB_2684512" "unprognostic (3.22e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.35e-5)" "unprognostic (1.09e-1)" "unprognostic (5.54e-2)" "unprognostic (8.47e-2)" "unprognostic (3.67e-1)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "prognostic favorable (4.93e-4)" "unprognostic (8.38e-2)" "prognostic favorable (3.65e-7)" "unprognostic (8.63e-3)" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (2.86e-3)" 30.1 36.0 15.1 10.3 15.5 0.0 24.2 10.2 18.8 42.0 50.2 61.7 9.3 64.6 24.8 28.0 26.9 27.7 42.7 16.8 14.6 10.8 2.1 15.1 4.5 13.3 12.2 14.0 70.0 6.9 0.9 4.7 17.7 11.7 31.9 14.0 6.4 21.1 29.3 92.7 14.7 24.6 38.7 13.8 2.5 39.0 6.5 15.5 2.9 3.6 22.6 1.4 47.1 32.3 13.6 0.0 0.0 32.1 0.1 57.0 29.6 0.1 16.9 42.0 5.0 3.2 16.2 0.0 0.1 0.1 22.8 0.8 0.0 0.0 0.0 4.8 0.0 2.2 0.0 0.0 0.0 9.5 0.0 0.1 41.4 0.0 13.8 0.1 6.0 0.0 0.0 0.0 0.0 4.9 2.1 0.0 0.2 4.6 0.0 0.2 0.0 8.4 0.1 0.0 0.0 3.7 10.5 0.0 7.8 12.7 9.2 4.5 0.0 0.0 20.6 1.5 23.6 2.2 0.7 0.0 0.2 30.4 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 15.1 15.5 10.2 18.8 16.8 14.6 13.3 12.2 14.0 11.7 13.8 15.5 13.6 5.9 0.0 0.0 256.0 0.5 2.4 9.7 0.0 1.8 19.3 7.5 7.6 65.0 0.0 0.0 5.5 6.2 0.5 2.7 1.0 1.9 0.0 0.4 2.1 45.2 2.3 21.1 0.0 183.1 0.4 0.5 25.2 2.0 3.3 0.0 35.0 0.0 0.0 0.8 0.0 258.3 9.1 0.0 0.0 2.9 1.3 23.3 0.7 16.0 329.8 0.0 22.5 0.0 21.6 5.5 0.3 0.9 28.2 0.1 10.9 0.1 7.1 0.0 1.9 0.0 4.6 19.6 0.5 6.2 2.9 1.8 0.8 0.5 12.4 3.9 6.3 RGSL1 RGSL2 ENSG00000121446 "Regulator of G protein signaling like 1" A5PLK6 1 182409192-182560599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 5.0" "Group enriched" "Detected in some" 31 "Early spermatids: 123.9;Late spermatids: 33.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-1)" "unprognostic (5.20e-2)" "unprognostic (2.07e-1)" "unprognostic (6.47e-2)" "unprognostic (4.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.69e-5)" "unprognostic (2.93e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 123.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.4 33.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LHX4 Gsh4 ENSG00000121454 "LIM homeobox 4" Q969G2 1 180230264-180278984 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 15.5" "Group enriched" "Detected in some" 12 "Bipolar cells: 98.6;Cone photoreceptor cells: 52.1;Early spermatids: 43.0;Late spermatids: 73.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 4.5;BEWO: 10.5;HeLa: 4.9" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Region enhanced" "Detected in single" "spinal cord: 1.9" HPA055705 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055705: AB_2682892" "unprognostic (2.83e-2)" "unprognostic (3.23e-2)" "unprognostic (1.94e-1)" "unprognostic (2.86e-2)" "unprognostic (9.38e-2)" "unprognostic (5.76e-5)" "unprognostic (9.39e-4)" "unprognostic (1.47e-1)" "unprognostic (2.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.77e-3)" "unprognostic (2.72e-3)" "unprognostic (4.07e-8)" "unprognostic (3.63e-1)" "unprognostic (1.43e-1)" "unprognostic (6.44e-3)" "unprognostic (7.83e-3)" 0.5 0.6 0.3 0.8 0.4 0.6 0.6 1.9 0.5 0.8 0.0 0.8 0.8 0.8 0.0 0.7 0.8 0.4 0.4 0.2 0.1 0.9 0.5 0.6 0.7 0.6 0.5 0.3 1.1 1.4 0.0 1.5 0.9 1.0 0.7 0.3 15.5 0.8 0.0 0.5 1.1 1.0 0.0 0.0 0.9 0.7 1.8 0.2 0.0 1.1 0.0 0.0 0.7 0.9 0.4 1.0 4.5 1.1 2.3 0.0 0.0 10.5 1.2 0.3 0.3 0.1 0.8 1.9 1.1 0.3 0.0 0.4 1.9 2.1 0.0 0.5 0.6 1.7 0.8 4.9 0.5 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.4 0.0 1.1 1.3 0.4 0.0 2.3 0.6 2.2 0.9 0.3 0.2 0.7 2.8 0.4 0.0 0.9 1.1 0.9 1.2 0.9 0.4 0.9 2.5 0.2 1.4 1.0 1.8 1.0 0.7 0.7 0.3 0.9 0.3 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.9 0.5 0.2 0.1 0.6 0.5 0.3 1.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.0 98.6 0.4 0.0 0.7 0.0 0.1 0.0 52.1 0.5 0.5 2.2 0.0 0.0 43.0 0.5 0.8 0.2 0.0 0.0 0.3 0.0 0.5 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.1 5.0 0.3 0.5 0.0 0.0 0.0 73.9 0.6 0.3 0.0 0.0 0.0 2.6 0.0 0.5 0.4 0.0 0.1 0.0 0.2 0.0 0.4 1.6 0.1 5.4 0.0 1.2 0.2 0.3 0.6 0.0 0.0 0.1 0.1 0.4 0.3 0.0 RNF2 "BAP-1, BAP1, DING, HIPI3, RING1B, RING2" ENSG00000121481 "Ring finger protein 2" Q99496 1 185045526-185102603 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026803 Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA026803: AB_10602086" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (1.35e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (5.85e-2)" "unprognostic (3.56e-3)" "unprognostic (1.62e-2)" "unprognostic (2.01e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.94e-7)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.89e-3)" "unprognostic (2.52e-1)" 8.9 8.2 4.9 10.3 7.0 14.0 12.6 6.3 7.0 10.4 4.4 9.4 8.4 10.8 8.6 8.4 8.6 9.5 7.5 6.6 7.0 9.7 8.3 8.4 11.6 4.3 4.9 5.3 9.4 9.6 8.8 5.6 21.9 4.7 8.5 9.7 11.9 9.7 10.5 8.3 6.4 6.5 11.0 4.9 10.4 9.7 22.1 6.6 12.4 10.9 9.0 12.4 16.6 8.7 5.1 34.0 18.6 62.8 25.4 17.8 30.3 65.3 24.0 28.4 35.5 28.3 29.9 53.3 10.2 29.2 29.0 24.4 11.5 43.7 32.7 41.7 31.1 28.4 54.9 10.2 25.8 27.5 56.1 29.7 29.7 19.6 29.6 36.4 27.9 36.6 34.4 44.7 22.5 25.1 21.2 48.5 17.6 86.3 27.4 11.0 55.1 41.3 9.8 25.7 23.6 18.9 33.4 17.3 9.9 46.7 67.8 19.7 27.5 28.4 25.4 33.6 25.1 29.8 39.0 26.2 36.3 16.1 25.7 28.9 31.0 22.4 27.7 17.1 27.7 24.4 20.1 15.5 15.8 25.7 21.9 15.1 15.6 9.8 24.4 29.9 13.4 17.8 16.3 4.9 7.0 6.3 7.0 6.6 7.0 4.3 4.9 5.3 4.7 4.9 6.6 5.1 22.6 3.2 6.4 11.4 23.6 23.2 27.6 10.2 26.7 10.3 18.2 11.8 8.4 7.2 6.6 9.2 4.2 25.4 24.5 11.2 23.5 11.5 6.1 11.2 10.8 20.3 29.5 29.4 23.1 12.6 53.0 17.9 12.8 10.3 12.7 16.9 23.2 8.8 20.1 6.7 20.5 9.2 8.2 21.4 55.2 5.6 9.6 22.0 21.4 20.6 25.4 13.3 10.3 18.6 15.1 11.3 16.9 11.7 15.5 30.2 4.1 16.4 8.8 7.2 0.0 11.7 13.4 35.6 83.1 15.8 20.3 28.5 20.7 15.6 11.3 38.0 TRMT1L C1orf25 ENSG00000121486 "TRNA methyltransferase 1 like" Q7Z2T5 1 185118101-185157072 "Metabolic proteins, Predicted intracellular proteins" "Behavior, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 73.0;Spermatocytes: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026728 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA026728: AB_1845641" "unprognostic (1.07e-2)" "unprognostic (1.31e-1)" "unprognostic (8.55e-3)" "unprognostic (2.96e-1)" "unprognostic (1.46e-2)" "unprognostic (8.95e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-2)" "unprognostic (2.32e-1)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (8.75e-2)" "unprognostic (1.16e-2)" "unprognostic (7.44e-2)" "unprognostic (9.45e-2)" "unprognostic (7.87e-2)" "unprognostic (2.26e-1)" 6.9 8.7 8.3 8.5 9.6 5.8 7.7 10.3 9.8 7.9 10.1 7.7 8.6 7.3 9.5 7.0 10.7 7.1 12.2 8.1 8.9 13.2 14.6 7.5 10.9 9.3 9.4 7.6 11.5 5.0 12.2 7.0 8.3 9.2 7.7 7.3 9.0 5.7 8.2 21.0 4.8 7.1 7.0 9.3 10.7 7.2 27.9 9.0 10.3 10.5 18.8 12.0 7.1 5.6 12.9 12.4 22.3 15.1 11.3 21.8 20.0 21.5 11.7 10.5 15.7 16.4 20.4 23.1 13.5 28.5 8.1 24.0 15.6 25.7 15.3 15.4 16.1 11.2 13.0 15.9 20.9 15.2 19.3 20.6 9.6 20.3 16.1 16.1 16.6 17.5 17.9 34.5 18.0 18.9 10.5 14.7 11.2 24.9 25.3 4.6 17.1 21.7 21.6 15.2 13.5 13.4 12.0 22.8 22.0 16.2 34.2 22.4 10.7 16.9 14.3 11.4 9.9 15.8 28.7 41.5 21.3 9.4 16.8 14.0 24.0 10.6 21.9 7.5 14.7 8.1 12.3 9.9 9.3 13.3 18.1 12.3 9.7 12.3 12.8 19.2 5.5 14.2 9.2 8.3 9.6 10.3 9.8 8.1 8.9 9.3 9.4 7.6 9.2 9.3 9.0 12.9 8.2 12.8 15.6 24.2 18.0 2.7 8.1 11.6 7.4 8.7 6.9 6.5 29.5 11.5 15.1 16.5 8.4 16.3 10.0 8.9 27.4 12.2 73.0 22.4 8.9 11.7 6.1 29.0 19.8 6.0 9.9 12.0 10.7 8.2 8.8 14.5 11.0 25.0 13.0 3.3 19.6 9.2 12.2 17.5 6.2 25.0 12.5 13.7 1.8 20.6 16.3 9.6 6.2 18.6 36.8 7.6 10.9 12.0 10.7 5.9 9.6 23.9 44.2 8.6 0.0 11.0 9.6 103.8 32.0 9.7 2.4 11.4 10.7 13.6 8.3 5.3 SEC22A SEC22L2 ENSG00000121542 "SEC22 homolog A, vesicle trafficking protein" Q96IW7 3 123201927-123274136 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 67.5;Inhibitory neurons: 67.5;Oligodendrocytes: 75.0;Spermatocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (8.25e-3)" "unprognostic (2.16e-1)" "unprognostic (9.04e-2)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (6.59e-2)" "unprognostic (2.16e-1)" "unprognostic (2.05e-1)" "unprognostic (2.66e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.25e-1)" 10.1 11.4 6.2 8.2 7.1 4.6 11.0 8.9 7.1 9.9 6.7 9.0 6.8 9.7 8.8 12.4 9.7 9.0 7.9 7.4 8.1 10.3 13.0 9.2 10.4 6.6 6.9 7.1 10.7 10.2 9.6 11.4 10.2 7.4 9.0 9.6 10.0 9.6 7.4 6.1 13.8 8.6 11.7 6.5 9.9 8.5 21.7 6.9 10.3 10.0 5.6 13.2 9.0 10.0 8.2 40.4 12.5 20.2 15.6 27.1 25.4 20.2 35.3 22.2 20.4 28.8 10.3 22.0 20.9 25.8 19.9 23.8 30.5 16.0 20.8 34.0 9.1 13.6 14.1 11.7 9.0 24.7 18.3 11.6 18.2 27.2 19.4 18.7 20.5 27.6 18.3 9.4 17.4 20.6 17.6 17.0 13.5 7.1 29.2 25.0 12.9 21.5 21.2 18.6 11.0 14.6 11.3 20.8 14.5 21.0 14.6 30.2 22.5 12.6 17.8 19.5 29.4 21.5 11.4 11.4 34.6 26.5 20.5 27.3 19.3 19.9 16.7 24.1 19.3 29.8 18.7 24.7 26.4 19.9 15.7 26.3 22.0 2.9 28.9 19.5 19.2 27.6 16.9 6.2 7.1 8.9 7.1 7.4 8.1 6.6 6.9 7.1 7.4 6.5 6.9 8.2 10.5 3.2 12.1 39.8 13.9 8.4 17.9 29.7 10.8 7.5 7.9 7.4 5.6 17.2 20.4 7.3 4.2 27.5 7.3 6.1 9.8 17.8 30.5 4.7 9.0 9.8 7.8 8.6 67.5 10.4 19.5 12.5 12.2 6.4 7.0 11.6 12.1 9.0 13.6 1.7 67.5 9.4 10.2 5.0 8.0 16.5 12.2 7.8 5.4 56.2 11.7 6.7 9.2 59.3 75.0 11.3 4.6 6.8 18.4 9.9 5.7 9.5 11.1 7.6 19.7 8.8 12.3 75.6 17.0 12.1 9.5 44.1 12.9 11.2 6.8 10.9 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325248-122341969 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 5960.3;vagina: 1868.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6" "Cancer enhanced" "Detected in all" "cervical cancer: 227.7;head and neck cancer: 405.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7" "Group enriched" "Detected in all" 193 "dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol No No 28000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favorable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 31.0 4.8 0.8 27.3 1.0 300.4 56.9 0.9 3.7 460.5 1.5 3.9 1.1 2.2 10.4 5960.3 4.7 7.3 4.5 0.7 1.3 2.3 39.2 26.3 25.3 1.4 0.9 0.7 21.3 3.7 0.8 5.1 19.1 1.2 19.8 3.6 0.3 1004.0 9.6 4.6 372.1 5.9 6.3 1.0 20.5 30.6 1.3 1.2 46.9 2.7 2.9 949.1 39.4 1868.5 1.4 14.6 1.3 0.2 3.2 31.5 58.0 2.9 0.6 0.8 0.0 0.0 0.0 0.0 3.2 7.6 5.9 0.5 86.9 0.0 282.0 0.0 0.3 0.2 0.7 0.0 6.8 6.8 117.6 1.9 30.5 1218.6 2.9 119.1 0.0 0.0 1.5 0.8 29.9 0.5 0.8 0.2 108.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 141.3 0.0 0.0 14.1 7.5 10.4 0.1 1.6 789.0 0.5 1.7 19.7 0.2 0.9 0.0 1.7 504.5 26.4 250.3 0.3 8.8 514.7 16.4 0.6 269.1 1.5 1.5 0.7 0.6 382.9 0.5 0.5 0.7 245.6 1.9 161.7 6.9 1.0 283.2 0.8 1.0 0.9 3.7 0.7 1.3 1.4 0.9 0.7 1.2 1.0 1.2 1.4 1.1 6.4 19.8 0.0 5.0 83.5 136.5 2493.8 117.8 0.0 7.1 119.8 0.2 2.8 768.0 0.0 0.0 230.6 7.4 3.9 0.0 2.1 0.4 0.3 0.4 3.0 0.0 3.8 0.1 22.1 17.8 13.6 12.8 0.3 13.9 0.1 6.1 96.0 134.5 0.0 0.1 0.5 179.0 579.4 90.6 2.4 10.2 243.7 8.8 0.0 1298.6 0.0 20.6 0.5 0.2 46.2 1.5 3.8 2.8 30.2 0.0 0.7 115.7 0.0 32.9 8.8 24.3 0.1 0.5 3020.6 205.0 334.2 4.9 26.1 2.0 134.1 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.7;lymphoid tissue: 12.3;testis: 4.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "plasmacytoid DC: 7.3" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.3" "Group enriched" "Detected in some" 4 "HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.0 0.0 0.0 0.1 0.1 4.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 12.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 89.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 327.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.5 0.0 7.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 22.3 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 16.4 0.1 0.0 17.2 0.5 0.0 0.0 1.3 0.0 0.4 1.6 1.7 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.7 0.0 0.0 0.9 0.3 0.3 11.7 0.0 0.0 6.2 0.5 0.2 0.0 0.3 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 343.9;tongue: 97.8" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 272.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA024255 Enhanced NA NA "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 2.9 2.1 0.6 3.9 0.5 0.3 3.3 0.7 0.9 6.7 1.2 64.6 2.8 12.6 2.6 2.0 9.7 11.0 343.9 0.5 0.6 2.4 1.0 2.5 6.7 0.6 0.6 0.4 2.0 1.3 8.4 1.3 1.4 0.6 16.4 6.3 0.9 3.3 49.7 78.4 2.6 12.3 24.2 0.5 2.9 10.8 1.0 0.6 1.6 2.4 97.8 2.6 35.6 6.1 0.5 0.1 0.2 0.5 0.0 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.4 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 24.8 0.0 0.0 0.6 2.5 0.0 0.3 0.0 0.2 0.1 0.2 0.1 1.0 0.0 0.2 0.2 0.3 0.5 0.5 0.0 0.7 0.3 0.0 0.4 0.1 0.5 0.4 0.0 0.4 0.8 0.2 0.0 0.2 1.3 0.2 0.7 0.1 0.6 0.5 0.7 0.9 0.5 0.6 0.6 0.6 0.4 0.6 0.5 0.6 0.5 4.7 0.0 0.5 1.0 0.6 0.4 0.3 0.5 0.0 3.1 0.9 3.0 272.7 0.0 0.9 0.0 0.0 0.5 2.3 0.4 0.0 0.5 0.3 0.6 0.5 6.4 3.0 0.0 0.8 0.2 0.1 8.0 0.5 0.3 1.3 1.6 1.4 0.2 1.6 1.7 1.2 0.8 0.0 1.0 2.3 0.8 1.2 1.6 0.0 2.8 1.8 1.2 0.0 1.0 1.9 0.5 0.2 1.9 0.0 0.8 0.7 0.3 1.9 2.4 59.2 5.9 11.1 1.0 0.3 0.1 0.6 1.2 1.6 0.6 0.3 0.2 B4GALT4 beta4Gal-T4 ENSG00000121578 "Beta-1,4-galactosyltransferase 4" O60513 3 119211732-119240946 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 76.7" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 123.6;Urothelial cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 125.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046819, HPA063546" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA046819: AB_2679824, HPA063546: AB_2685036" "unprognostic (4.07e-2)" "unprognostic (1.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.14e-3)" "unprognostic (4.59e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (6.30e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-1)" "unprognostic (6.10e-3)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" 10.1 9.2 7.0 10.8 8.9 20.3 11.2 6.9 8.1 16.5 8.5 30.9 28.8 14.9 76.7 17.8 22.0 33.5 12.6 7.2 8.0 24.4 16.8 10.0 10.0 7.2 7.1 7.2 18.6 19.7 15.3 18.3 25.9 7.7 13.8 35.5 9.9 12.3 14.8 6.4 14.3 32.8 13.7 7.4 9.5 29.6 8.3 7.0 7.5 16.6 6.6 11.6 37.9 10.6 7.7 60.1 100.3 12.8 9.8 36.0 31.1 65.3 125.8 54.4 54.4 56.2 65.4 18.3 11.8 23.9 61.3 32.2 78.6 20.7 15.0 59.9 23.5 6.8 15.1 20.3 31.7 25.3 8.9 15.7 21.2 21.4 23.0 19.3 21.6 5.8 8.0 11.2 11.7 25.5 18.4 5.3 10.7 17.6 34.0 27.2 4.9 11.8 4.7 31.2 60.3 10.9 24.0 29.4 14.6 27.9 28.2 30.2 5.7 4.9 27.3 24.0 15.2 13.5 27.2 21.5 16.1 23.5 10.1 23.5 20.1 4.1 8.3 13.3 5.2 7.3 4.2 7.3 7.9 5.5 3.2 13.6 7.1 2.5 14.8 5.0 3.4 2.7 5.7 7.0 8.9 6.9 8.1 7.2 8.0 7.2 7.1 7.2 7.7 7.4 7.0 7.7 8.5 0.0 9.4 7.2 17.1 10.7 22.2 48.9 12.0 10.8 14.9 12.4 9.2 61.5 69.1 7.3 4.2 36.2 46.0 43.2 1.9 30.7 2.1 40.1 16.9 8.4 13.8 7.8 11.9 33.2 123.6 24.0 36.2 74.5 13.3 35.0 3.9 10.8 14.4 18.5 11.1 78.7 16.2 9.8 14.8 2.4 14.9 14.9 14.2 6.5 10.9 22.2 39.1 10.6 10.2 40.5 50.2 28.2 27.4 30.7 59.3 22.6 52.6 10.2 19.7 13.9 16.9 1.7 8.4 14.0 10.5 52.3 23.1 20.0 23.6 171.6 NAA50 "FLJ13194, MAK3, NAT13, NAT5, San" ENSG00000121579 "N-alpha-acetyltransferase 50, NatE catalytic subunit" Q9GZZ1 3 113716458-113746300 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 323.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074489 Approved Supported Nucleoli NA NA Nucleoli "HPA074489: " "unprognostic (9.74e-2)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.62e-3)" "unprognostic (6.82e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.92e-5)" "unprognostic (2.97e-3)" "unprognostic (1.09e-1)" "unprognostic (2.25e-2)" "unprognostic (9.59e-2)" "unprognostic (7.13e-3)" "unprognostic (2.43e-1)" 89.0 64.8 22.9 72.7 23.7 88.0 59.0 25.8 30.2 49.6 28.8 63.1 49.3 50.6 31.7 94.3 38.8 51.0 51.4 23.9 27.3 65.0 91.1 43.9 85.6 25.4 24.6 20.7 52.1 59.2 60.2 23.3 45.4 28.0 53.3 54.7 31.8 70.3 42.5 323.7 53.9 47.9 51.6 28.8 53.1 66.1 53.6 26.9 57.3 59.1 155.7 91.5 88.4 46.6 29.2 589.6 250.7 135.2 158.5 179.4 144.6 281.4 308.5 172.4 186.0 212.4 362.3 205.7 403.4 185.8 164.6 146.9 236.5 238.0 211.1 338.6 85.2 121.5 435.7 182.7 220.3 164.4 459.1 135.7 124.0 163.0 208.8 298.3 122.1 168.7 167.3 279.3 157.8 194.3 277.0 306.2 99.3 303.4 228.3 365.3 309.5 207.2 318.9 141.7 439.9 207.4 119.6 223.6 164.1 229.0 116.5 228.1 150.4 156.9 255.1 253.9 109.1 235.7 174.1 314.2 736.0 200.2 253.2 160.6 17.7 40.8 22.5 45.5 40.5 40.6 55.2 33.7 43.1 44.4 37.1 29.4 39.1 51.8 31.8 38.1 25.6 39.9 52.5 22.9 23.7 25.8 30.2 23.9 27.3 25.4 24.6 20.7 28.0 28.8 26.9 29.2 33.9 48.1 39.9 24.8 75.7 168.4 86.6 42.6 76.2 24.8 52.3 31.6 47.5 25.8 45.8 36.8 8.4 46.0 78.2 51.3 78.2 52.9 68.0 44.4 53.1 45.7 19.9 79.5 41.5 55.1 94.6 55.2 35.7 94.3 47.5 45.5 29.3 66.1 61.9 40.4 39.0 31.5 42.7 55.3 148.8 50.7 30.7 60.1 62.2 20.6 49.9 29.7 29.9 33.2 28.4 65.2 36.8 31.2 74.9 142.0 31.4 71.0 30.0 18.4 19.7 53.1 64.1 53.5 60.8 99.8 177.9 62.5 74.7 37.7 49.3 193.3 CD80 "B7-1, B7.1, CD28LG, CD28LG1" ENSG00000121594 "CD80 molecule" P33681 3 119524293-119559614 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 3.0;lymphoid tissue: 6.9" "Group enriched" "Detected in some" 4 "Langerhans cells: 17.4;monocytes: 65.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;T-reg: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 11.9;HDLM-2: 42.3;Karpas-707: 17.0;U-266/70: 7.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB025368, HPA050092" Enhanced "Intracellular and membrane" NA NA "CAB025368: , HPA050092: AB_2681012" "unprognostic (2.36e-1)" "unprognostic (1.55e-2)" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (3.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.14e-3)" "unprognostic (1.02e-2)" "unprognostic (4.96e-3)" "unprognostic (1.16e-2)" "unprognostic (1.15e-1)" "unprognostic (9.03e-8)" "unprognostic (3.20e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (1.94e-2)" 0.4 0.1 0.1 5.4 0.1 1.4 0.2 0.1 0.3 0.2 0.7 0.7 1.0 0.2 0.0 0.1 0.1 0.6 0.1 0.1 1.0 0.1 1.5 3.0 5.7 0.4 0.1 0.0 0.0 0.3 1.7 0.1 0.4 0.4 0.1 1.3 0.0 0.2 0.2 0.1 0.0 0.8 0.3 0.2 3.4 0.6 0.2 0.4 2.6 0.6 0.0 6.9 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 17.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.2 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.1 0.1 0.1 0.3 0.1 1.0 0.4 0.1 0.0 0.4 0.2 0.4 0.5 0.2 0.0 1.5 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 1.3 0.0 0.4 0.0 0.0 4.5 17.4 0.5 0.0 8.5 0.0 1.0 65.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020619-28108156 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 8.3;lymphoid tissue: 9.7;testis: 13.9" "Cell type enhanced" "Detected in many" "Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" Yes Yes "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.2 0.1 0.1 1.9 0.1 8.3 0.7 0.1 0.1 0.7 0.1 1.6 1.5 0.5 0.3 1.4 0.3 0.5 0.0 0.1 0.4 0.3 0.3 1.0 4.7 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.5 0.1 0.3 2.1 0.6 0.3 0.4 0.2 1.3 1.4 0.8 0.1 0.7 0.6 13.9 0.1 9.7 1.1 0.1 4.6 0.7 0.5 0.3 27.9 27.4 27.2 19.0 0.9 3.7 9.1 28.3 13.2 44.2 46.0 9.2 11.0 23.3 10.0 14.7 24.1 27.2 23.4 11.1 61.4 23.4 14.2 15.2 17.8 11.8 2.1 22.6 13.4 6.8 1.4 15.5 18.1 7.8 17.2 19.0 24.6 20.0 25.2 14.8 23.1 16.7 13.4 18.0 11.1 17.8 65.0 11.6 12.5 8.0 16.3 12.6 23.7 11.1 7.8 16.5 23.8 6.9 10.1 35.0 27.2 33.2 37.4 7.9 19.8 23.4 21.0 16.5 25.2 4.1 0.0 0.3 0.1 0.2 0.3 1.0 0.4 0.2 0.3 0.4 0.3 0.1 0.0 1.4 0.0 0.3 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.3 1.2 3.2 0.0 0.0 4.7 2.3 1.3 1.4 1.2 0.3 1.3 2.9 0.5 0.0 2.2 0.0 6.2 4.6 2.8 1.9 0.0 0.6 43.1 3.4 2.5 1.1 1.8 15.4 0.2 0.9 7.1 5.4 1.5 3.4 4.5 9.7 1.4 0.0 2.2 0.0 0.1 1.9 0.0 1.6 1.4 8.7 0.6 1.4 0.0 1.0 1.1 0.7 1.0 0.5 0.9 0.5 0.1 0.4 5.1 0.2 0.2 0.6 1.7 1.9 0.0 2.5 1.9 78.7 28.3 4.3 1.0 1.6 3.9 2.7 3.6 0.5 GJA8 "CAE, CAE1, CX50, CZP1" ENSG00000121634 "Gap junction protein alpha 8" P48165 1 147902795-147909269 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 5.9" "Group enriched" "Detected in some" 4 "Early spermatids: 14.6;Spermatocytes: 39.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014715, HPA062940" Enhanced NA NA "HPA014715: AB_2732411, HPA062940: AB_2732693" "unprognostic (3.73e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DESI2 "C1orf121, CGI-146, DESI-2, FAM152A, FLJ21998, PNAS-4, PPPDE1" ENSG00000121644 "Desumoylating isopeptidase 2" Q9BSY9 1 244653103-244709033 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 171.8;Spermatocytes: 192.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049950 Approved Vesicles NA NA Vesicles "HPA049950: AB_2680969" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (5.40e-2)" "unprognostic (1.95e-2)" "unprognostic (7.62e-2)" "unprognostic (1.38e-3)" "unprognostic (1.51e-1)" "unprognostic (4.47e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (4.52e-2)" "unprognostic (8.27e-2)" "unprognostic (2.27e-2)" "unprognostic (9.49e-2)" 17.3 13.7 8.1 13.7 11.1 17.3 14.1 13.6 8.3 18.5 12.8 16.6 16.2 22.9 13.8 16.3 13.4 18.0 16.5 7.8 9.3 11.9 12.9 23.4 18.0 8.2 8.8 7.6 13.7 9.4 14.0 7.2 18.7 9.5 14.5 18.3 16.4 11.2 15.7 24.3 15.3 13.4 22.5 8.6 11.8 15.8 55.3 8.5 19.9 23.5 23.8 19.2 18.6 12.1 8.6 68.1 24.3 47.0 40.8 52.8 54.8 61.7 40.8 65.9 36.9 33.9 43.8 31.0 121.8 53.8 47.7 21.5 29.5 58.1 43.1 50.5 43.1 53.6 31.0 17.5 33.0 46.2 52.8 36.1 38.4 57.3 49.3 61.6 35.6 52.8 52.8 48.4 63.7 56.2 11.7 49.6 28.0 109.0 62.7 67.7 36.9 71.9 46.0 28.4 27.6 42.5 57.2 55.4 26.4 47.7 37.7 27.6 39.0 59.7 41.7 45.4 57.4 68.5 69.4 94.1 69.8 33.8 55.7 78.0 2.5 1.7 5.6 2.1 2.1 2.1 5.2 2.2 3.0 2.7 2.7 2.9 2.8 1.4 2.2 2.3 2.4 3.2 0.7 8.1 11.1 13.6 8.3 7.8 9.3 8.2 8.8 7.6 9.5 8.6 8.5 8.6 32.7 86.6 60.4 17.9 31.0 55.3 41.3 23.0 38.7 43.2 21.5 26.3 22.1 27.1 25.5 18.4 20.9 29.8 36.1 28.1 21.5 19.8 171.8 32.0 39.6 36.2 15.6 21.7 18.4 33.4 40.0 44.2 28.5 25.0 7.0 28.7 25.7 21.5 23.8 40.4 23.1 19.0 26.4 23.3 27.1 101.5 34.8 27.2 16.0 18.7 25.5 23.8 28.8 35.7 26.9 34.3 28.6 51.9 34.5 69.5 17.0 16.5 17.6 25.1 39.5 41.7 50.2 192.7 105.4 42.4 41.3 43.2 31.2 38.4 25.4 55.5 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 156.0;pituitary gland: 119.1" "Cell type enhanced" "Detected in many" "Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332, HPA079657" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 4.5 23.5 116.0 2.3 112.9 1.3 4.9 106.3 148.9 7.4 19.0 6.6 1.4 11.0 3.5 2.2 11.4 3.6 5.2 150.5 103.6 11.5 5.6 4.1 0.6 141.4 121.0 115.4 9.2 43.4 19.4 119.1 1.5 124.4 11.7 1.3 11.6 11.5 6.2 2.4 3.8 3.8 5.7 123.8 2.3 9.0 28.0 115.0 1.0 7.1 2.6 0.4 6.8 4.9 156.0 0.0 7.1 9.4 26.2 3.4 1.8 0.3 5.1 4.6 9.9 7.2 6.3 1.1 0.4 2.5 5.9 16.8 5.8 10.2 4.8 4.4 4.0 13.1 0.1 8.6 4.1 3.1 0.6 4.4 2.4 1.0 6.4 1.3 6.6 2.2 0.9 11.5 1.6 2.8 3.9 0.4 0.6 24.9 3.3 10.5 0.6 15.4 0.3 4.6 0.2 76.4 28.5 8.4 6.8 10.0 3.6 11.0 0.4 2.1 12.5 19.1 19.0 9.3 1.1 1.3 0.5 7.9 0.2 3.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 116.0 112.9 106.3 148.9 150.5 103.6 141.4 121.0 115.4 124.4 123.8 115.0 156.0 1.7 6.4 4.1 7.2 0.9 2.4 5.8 2.0 2.8 34.4 6.1 5.3 1.1 5.7 3.3 11.0 22.9 1.6 0.4 2.2 13.7 6.9 43.8 23.9 15.9 2.9 40.2 0.0 10.3 28.9 0.6 6.5 4.1 19.9 0.0 2.8 0.4 4.6 0.5 67.3 11.6 1.6 4.1 0.8 3.5 39.2 6.2 1.1 3.6 1.0 1.6 41.3 0.0 3.5 48.7 11.6 0.5 6.4 0.1 6.3 1.4 8.9 10.9 18.3 0.0 14.2 6.0 10.6 8.2 0.9 1.0 5.7 1.3 7.7 0.9 5.5 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 141.9;Horizontal cells: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favorable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favorable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 29.5 22.5 32.1 8.9 33.7 29.7 27.3 35.0 37.1 23.8 21.0 22.5 10.9 23.6 17.0 16.0 29.3 17.6 60.5 35.3 30.2 22.6 63.2 23.1 10.5 26.7 30.6 34.0 39.0 35.0 22.5 31.1 13.6 27.7 25.5 10.0 53.3 21.9 22.3 97.6 48.3 16.9 17.2 24.6 14.2 24.8 34.7 32.7 12.7 34.3 65.3 10.4 26.2 18.5 30.4 1.4 4.2 6.3 7.5 16.7 8.4 13.8 5.0 8.9 6.2 4.5 6.8 3.3 9.8 3.8 10.5 5.9 8.5 6.0 5.2 4.3 9.8 5.5 6.4 8.2 9.4 6.4 8.0 8.5 9.9 7.5 4.8 7.6 7.0 4.4 7.5 12.7 16.2 5.6 5.3 6.8 9.4 17.1 17.8 5.0 11.5 9.1 4.6 4.5 7.8 10.1 3.8 8.3 7.5 4.5 8.0 10.0 5.5 5.5 8.7 5.3 13.5 3.6 15.0 10.8 7.9 5.3 3.5 5.3 4.1 3.5 5.4 5.7 4.8 4.7 5.0 5.5 6.1 3.6 4.6 6.6 6.9 1.8 7.5 8.0 2.6 4.9 5.3 32.1 33.7 35.0 37.1 35.3 30.2 26.7 30.6 34.0 27.7 24.6 32.7 30.4 11.7 12.8 18.2 48.0 12.6 17.0 9.7 5.1 8.0 141.9 10.6 8.6 34.7 14.3 11.6 7.3 27.1 8.0 10.0 17.2 29.4 5.4 24.2 28.1 7.5 9.2 7.1 3.0 30.3 4.7 5.6 19.8 12.8 15.4 14.7 10.8 8.6 47.3 3.6 101.0 26.0 7.4 6.1 8.5 12.5 8.7 31.4 7.2 16.0 10.3 6.2 34.4 10.3 13.0 13.6 6.0 6.0 39.9 8.5 11.6 10.5 11.6 23.8 27.5 19.7 14.5 14.6 29.1 15.0 4.4 17.5 9.3 9.1 8.4 6.0 9.8 PEX16 ENSG00000121680 "Peroxisomal biogenesis factor 16" Q9Y5Y5 11 45909663-45918812 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043286 Approved NA NA "HPA043286: AB_10794179" "unprognostic (2.48e-1)" "unprognostic (1.95e-2)" "unprognostic (8.14e-2)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (9.06e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-3)" "unprognostic (1.51e-1)" "unprognostic (6.75e-3)" "unprognostic (5.72e-3)" "unprognostic (2.71e-1)" "unprognostic (1.00e-1)" "prognostic favorable (9.06e-4)" 21.2 27.4 19.8 11.0 20.9 20.5 22.4 20.7 24.6 18.2 14.1 19.0 21.5 18.9 6.3 21.4 19.0 10.2 16.6 20.6 20.0 26.7 50.6 16.3 16.8 23.9 20.7 19.8 18.5 40.3 10.2 32.2 6.8 22.5 21.9 5.2 4.5 21.8 9.7 18.3 27.1 25.5 6.0 19.7 24.7 27.8 26.0 20.3 12.0 22.0 7.5 8.6 20.3 18.2 23.5 15.0 19.9 6.7 16.8 11.0 13.2 19.4 11.6 15.2 15.5 12.0 22.6 10.7 25.6 15.0 10.9 14.7 27.2 6.9 23.0 3.7 22.4 23.6 16.7 28.8 20.1 34.8 24.9 33.8 21.3 20.1 9.4 15.1 9.1 17.0 21.9 13.4 29.6 10.7 42.0 21.3 32.5 15.1 28.7 20.0 18.4 16.8 29.4 10.0 26.5 17.0 22.7 13.3 27.1 24.5 4.2 40.4 21.1 13.6 14.8 19.0 36.9 21.5 47.1 33.1 16.2 16.2 14.7 16.2 35.3 44.1 36.8 47.9 51.0 44.9 57.0 48.9 49.6 47.8 50.5 44.4 46.7 32.2 44.9 38.6 44.7 61.1 46.1 19.8 20.9 20.7 24.6 20.6 20.0 23.9 20.7 19.8 22.5 19.7 20.3 23.5 25.1 3.2 5.4 3.9 35.7 16.6 24.4 47.6 19.4 15.7 25.9 22.4 3.8 22.8 25.1 14.7 10.4 39.9 31.9 45.8 50.9 37.3 25.9 19.7 13.8 21.5 28.1 25.9 4.8 88.7 22.2 15.7 17.9 20.3 21.0 16.2 21.8 68.6 34.2 15.2 5.1 26.5 30.5 37.7 19.7 32.6 19.3 20.0 21.4 3.7 46.6 28.8 26.8 5.0 10.6 55.9 49.2 14.3 27.1 26.1 90.5 68.1 26.4 18.0 32.9 16.8 24.4 27.2 15.4 21.6 21.0 64.0 33.0 19.9 29.6 28.2 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015876-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 29.3;kidney: 19.7;liver: 74.7;testis: 28.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.8 2.6 1.9 3.3 1.8 0.9 3.0 3.6 2.2 2.9 4.6 24.9 1.0 2.2 4.4 0.9 4.4 0.8 2.8 2.8 19.7 74.7 0.9 0.8 3.3 3.0 2.4 1.6 3.9 2.3 0.9 1.5 3.2 1.9 5.2 0.1 2.0 1.5 5.0 6.0 29.3 1.7 2.9 0.3 3.1 28.5 2.9 2.9 0.5 0.9 1.5 1.2 3.4 5.2 9.4 5.2 7.3 3.3 3.8 3.6 4.9 16.2 5.4 9.8 13.0 13.5 0.9 0.0 3.7 16.2 4.5 9.4 10.8 3.8 11.5 0.0 14.9 2.5 16.1 19.3 3.2 9.1 10.9 4.6 5.7 5.7 4.2 5.3 0.0 0.0 6.2 0.0 53.7 1.0 0.0 14.6 4.8 7.7 0.0 0.0 40.1 0.1 3.2 1.3 1.6 4.2 37.3 6.6 34.4 5.1 1.7 4.7 0.0 6.3 10.4 34.1 10.6 0.0 0.0 0.1 2.3 0.0 31.5 4.1 0.5 6.7 0.2 0.1 0.0 0.0 0.4 0.2 3.2 0.0 1.9 2.1 0.0 2.4 0.0 1.2 0.0 0.4 2.6 3.3 3.0 3.6 2.8 2.8 3.3 3.0 2.4 3.2 2.9 2.9 5.2 0.2 0.0 0.0 1.0 0.0 34.8 12.8 4.5 12.5 0.0 0.2 0.6 0.1 1.5 0.9 0.0 0.0 0.5 0.5 6.0 3.9 0.9 153.3 0.2 0.2 0.3 3.5 3.2 0.1 0.6 47.0 1.6 0.0 0.1 2.5 0.1 1.4 22.6 3.1 0.0 0.4 2.4 0.0 0.6 9.5 16.3 1.5 1.7 1.8 3.7 1.2 0.0 0.0 3.5 10.4 0.8 0.6 1.2 0.1 2.4 33.2 18.4 0.9 0.0 0.0 4.5 1.4 42.3 6.5 6.6 7.4 1.5 0.7 0.2 2.4 1.6 CAT ENSG00000121691 Catalase P04040 11 34438934-34472060 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Mitogen, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1227.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 722.4;Hepatocytes: 443.4;Proximal tubular cells: 333.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 13 "eosinophil: 4736.8" "Lineage enriched" "Detected in all" 13 "granulocytes: 4736.8" "Cell line enhanced" "Detected in many" "HL-60: 391.4;THP-1: 321.2;U-937: 265.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001515, HPA051282, HPA055838" Enhanced Enhanced Vesicles NA NA 760000000 Vesicles "CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937" "unprognostic (3.62e-2)" "unprognostic (2.72e-1)" "unprognostic (3.59e-3)" "unprognostic (5.43e-2)" "unprognostic (4.44e-2)" "unprognostic (5.80e-3)" "prognostic favorable (9.67e-4)" "unprognostic (9.95e-3)" "unprognostic (3.22e-1)" "unprognostic (7.23e-2)" "unprognostic (3.34e-2)" "unprognostic (9.77e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.01e-1)" "unprognostic (7.31e-2)" "unprognostic (4.77e-2)" "unprognostic (6.59e-3)" 283.8 116.2 26.8 52.6 29.3 411.2 124.6 28.9 35.8 82.7 38.0 83.4 146.4 53.6 35.1 40.5 87.6 60.4 58.7 26.4 38.9 299.4 1227.3 164.6 58.9 35.2 28.4 23.7 47.1 87.0 43.6 13.8 78.6 33.1 67.4 72.0 9.9 84.4 64.6 104.6 66.4 137.4 59.9 30.0 79.3 74.8 11.5 27.3 75.6 123.7 137.8 57.2 106.7 40.2 40.9 31.7 34.3 24.5 38.9 233.2 100.6 52.3 39.3 49.8 43.3 47.1 19.7 30.9 78.3 37.5 79.2 63.9 73.9 42.3 42.9 47.3 68.8 38.8 65.6 34.0 113.7 27.6 391.4 31.1 54.5 29.3 13.2 5.1 59.9 53.2 46.2 139.3 31.3 55.1 30.2 81.1 77.4 0.1 148.7 82.6 56.5 117.9 64.9 120.2 117.2 13.1 19.8 44.5 70.6 60.0 0.0 101.4 321.2 38.3 25.9 24.9 65.4 23.8 25.0 15.2 16.8 51.3 265.6 19.3 256.5 324.7 4736.8 54.4 265.1 64.6 133.9 63.7 61.0 353.5 124.1 61.7 66.7 290.2 105.7 298.5 235.8 92.7 397.9 26.8 29.3 28.9 35.8 26.4 38.9 35.2 28.4 23.7 33.1 30.0 27.3 40.9 196.9 227.6 275.9 41.1 53.8 28.9 93.7 44.9 27.9 13.5 42.6 36.1 44.9 82.9 66.9 73.5 27.1 96.8 92.0 59.4 225.0 36.0 2.7 72.2 41.4 43.8 48.0 722.4 12.6 26.2 30.0 53.1 54.6 29.3 24.0 38.7 57.1 443.4 138.5 0.0 1.2 56.9 91.6 125.5 95.8 6.2 78.3 93.9 26.6 16.9 253.4 19.5 28.8 22.6 45.6 15.3 44.8 77.5 25.4 37.0 151.6 333.2 96.9 19.4 78.9 46.6 68.0 6.3 11.3 24.4 27.1 40.5 37.7 57.7 95.6 97.5 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 221.1;neutrophil: 141.8" "Group enriched" "Detected in all" 8 "granulocytes: 221.1;monocytes: 75.5" "Cell line enhanced" "Detected in all" "SK-BR-3: 344.6" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" NA Yes Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 61.8 89.8 70.8 71.7 71.7 72.3 78.3 95.7 86.9 75.9 84.9 64.8 66.7 63.4 68.2 47.5 84.5 52.7 43.9 73.2 67.4 119.1 126.0 44.3 84.4 68.7 73.4 68.8 82.8 92.5 58.7 183.4 33.2 79.8 103.6 57.9 67.4 67.0 58.5 79.4 90.8 76.5 42.6 61.3 114.4 69.3 158.8 70.1 59.5 124.0 34.6 66.3 62.4 56.7 75.5 62.5 51.4 57.9 100.7 63.0 14.4 56.2 37.0 16.5 25.7 24.9 36.5 70.3 50.3 68.0 19.0 45.7 65.1 32.3 38.9 17.5 41.6 47.3 46.5 204.8 32.2 14.0 47.4 116.0 18.1 44.8 34.8 70.2 31.9 21.8 73.6 50.7 118.9 18.3 83.9 74.8 243.3 25.2 51.7 26.9 43.3 16.9 51.6 116.4 100.3 53.8 38.5 31.2 344.6 45.7 61.7 60.5 72.3 52.4 90.8 57.9 58.8 48.7 71.2 98.6 61.8 25.5 69.4 54.6 21.2 35.6 221.1 10.7 59.2 6.7 0.6 1.3 7.1 17.8 1.6 1.2 2.6 141.8 17.9 75.5 0.5 0.6 25.7 70.8 71.7 95.7 86.9 73.2 67.4 68.7 73.4 68.8 79.8 61.3 70.1 75.5 22.8 38.5 45.9 0.0 25.3 15.7 18.1 17.1 11.4 44.7 32.9 33.7 1.1 44.3 32.2 14.7 68.8 12.9 49.5 12.3 1.9 7.6 18.4 43.1 17.5 19.8 29.4 7.4 0.0 5.6 12.1 13.4 36.2 57.2 25.2 26.0 24.3 77.7 10.0 75.7 0.0 21.2 22.4 16.0 16.6 13.6 74.0 11.7 19.6 0.0 10.0 19.0 134.9 0.0 0.0 7.4 16.2 51.1 14.5 17.9 20.3 4.9 40.3 64.9 26.3 18.2 14.3 49.4 10.2 10.5 13.5 15.7 37.0 23.5 22.4 16.7 ZMYM2 "FIM, MYM, RAMP, ZNF198" ENSG00000121741 "Zinc finger MYM-type containing 2" Q9UBW7 13 19958677-20091829 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031765 Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA031765: AB_10601927" "unprognostic (2.96e-1)" "unprognostic (3.42e-3)" "unprognostic (1.85e-1)" "unprognostic (1.69e-1)" "unprognostic (7.71e-2)" "unprognostic (2.33e-1)" "unprognostic (2.66e-3)" "unprognostic (1.16e-1)" "unprognostic (6.78e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (2.80e-2)" "unprognostic (6.65e-3)" "unprognostic (2.05e-1)" "unprognostic (8.74e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.07e-4)" 14.4 17.5 6.6 12.4 9.6 26.7 17.2 6.8 10.9 17.6 9.4 13.9 14.4 15.1 12.6 16.5 14.8 16.1 18.3 7.2 7.0 17.5 14.7 13.3 14.9 7.8 8.7 4.0 16.5 16.9 17.9 8.5 14.8 8.0 19.3 14.0 25.6 14.1 17.0 13.8 12.8 12.3 15.3 4.2 14.4 17.3 49.7 7.0 21.1 24.8 20.8 19.0 17.8 9.9 13.3 14.9 13.1 50.2 22.0 21.0 23.2 23.7 15.4 24.2 19.1 23.4 20.4 29.4 35.5 13.6 21.3 18.5 23.8 38.2 16.3 25.7 14.2 10.5 63.5 19.4 10.5 21.4 54.8 18.5 22.5 30.1 15.2 16.0 30.2 33.5 35.8 24.7 24.8 27.4 21.4 51.8 16.4 46.5 45.4 8.2 58.4 54.7 16.7 14.5 21.2 58.3 56.6 29.1 21.0 27.6 33.3 28.1 37.6 19.5 9.6 14.8 12.0 8.1 19.3 16.3 36.4 8.2 12.3 23.4 0.1 2.7 2.2 2.7 3.0 3.4 2.7 3.6 2.7 3.2 2.0 3.7 3.3 3.8 3.0 2.7 3.3 2.8 1.9 6.6 9.6 6.8 10.9 7.2 7.0 7.8 8.7 4.0 8.0 4.2 7.0 13.3 40.1 44.8 39.3 140.7 85.3 55.1 47.1 51.4 55.2 112.8 43.8 34.0 36.8 25.8 58.5 51.5 112.6 13.6 71.2 24.4 5.9 23.8 105.8 45.4 53.1 38.5 55.8 32.8 218.4 17.8 15.3 43.0 49.5 59.1 46.3 61.2 42.1 34.4 21.6 72.3 179.5 28.4 44.7 57.5 101.8 174.6 55.9 53.6 33.8 124.6 40.0 34.9 41.2 225.7 305.6 35.3 41.4 41.0 42.1 51.3 27.4 16.1 51.7 106.6 32.9 45.2 38.3 94.9 54.9 55.1 44.6 11.4 68.0 37.3 29.6 82.6 GJB6 "CX30, DFNA3, ED2, EDH, HED" ENSG00000121742 "Gap junction protein beta 6" O95452 13 20221962-20232365 "Disease related genes, Human disease related genes, Predicted membrane proteins" Hearing "Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 96.5;esophagus: 196.9;vagina: 140.5" "Cell type enhanced" "Detected in some" "Astrocytes: 58.8;Basal keratinocytes: 12.2;Basal respiratory cells: 15.6;Ionocytes: 12.2;Squamous epithelial cells: 31.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 145.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 2.6" "Lineage enriched" "Detected in single" 5 "T-cells: 2.6" "Cell line enriched" "Detected in some" 10 "RT4: 186.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014846 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA014846: AB_1847135" "unprognostic (5.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "unprognostic (7.90e-2)" "unprognostic (2.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.83e-1)" "unprognostic (8.96e-2)" "unprognostic (9.64e-2)" "unprognostic (2.82e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-2)" "unprognostic (1.14e-11)" "unprognostic (8.99e-2)" "unprognostic (1.16e-1)" "unprognostic (6.35e-3)" "unprognostic (5.04e-2)" 0.4 0.2 56.4 0.3 54.8 96.5 3.8 72.8 81.6 31.5 34.5 0.0 0.0 0.9 0.2 196.9 0.4 1.3 0.1 49.2 58.1 0.0 0.1 0.3 0.8 57.4 62.2 49.0 0.0 0.1 0.0 4.5 0.0 67.3 0.2 0.1 0.0 34.8 0.0 0.1 51.1 0.2 0.0 42.6 0.3 0.3 1.4 72.3 37.9 5.4 0.0 15.6 10.4 140.5 40.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 4.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 186.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 1.1 0.6 0.5 0.0 0.0 0.0 2.6 0.2 56.4 54.8 72.8 81.6 49.2 58.1 57.4 62.2 49.0 67.3 42.6 72.3 40.8 0.0 0.0 0.0 58.8 0.0 12.2 1.7 15.6 4.0 0.0 0.0 0.1 0.6 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.9 5.8 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 12.2 0.0 0.4 4.6 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.1 0.3 31.0 3.8 0.0 0.3 0.0 0.0 2.4 GJA3 "CX46, CZP3" ENSG00000121743 "Gap junction protein alpha 3" Q9Y6H8 13 20138255-20161052 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 7.8;parathyroid gland: 4.1;placenta: 2.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.3;melanoma: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014821 Supported NA NA "HPA014821: AB_2669097" "unprognostic (2.32e-1)" "unprognostic (1.01e-1)" "unprognostic (4.37e-2)" "unprognostic (2.58e-3)" "unprognostic (2.98e-2)" "unprognostic (1.04e-2)" "unprognostic (6.87e-3)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (7.52e-2)" "unprognostic (7.70e-2)" "unprognostic (4.02e-2)" "unprognostic (9.65e-8)" "unprognostic (2.87e-1)" "unprognostic (1.91e-1)" "unprognostic (2.55e-2)" "unprognostic (8.04e-3)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 7.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.1 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.1 4.4 0.2 0.0 3.7 0.1 1.1 0.0 0.5 3.5 0.6 0.7 0.4 7.7 0.0 0.1 1.3 1.2 0.1 2.5 2.1 0.5 0.2 1.9 1.8 0.0 0.0 0.0 6.6 0.0 0.2 1.2 0.1 0.3 0.0 0.0 2.8 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.1 1.5 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 3.7 0.1 0.8 1.4 0.0 0.0 0.0 1.5 0.2 1.7 4.7 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.2 0.0 0.0 0.0 13.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 2.7 0.3 0.0 0.0 0.1 0.0 0.0 0.1 TBC1D15 "DKFZp761D0223, FLJ12085" ENSG00000121749 "TBC1 domain family member 15" Q8TC07 12 71839707-71927248 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013388, HPA015592" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA013388: AB_2199233, HPA015592: AB_1857789" "unprognostic (3.87e-2)" "prognostic favorable (7.06e-4)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "unprognostic (6.13e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-2)" "unprognostic (4.07e-2)" "unprognostic (2.18e-1)" "prognostic favorable (5.34e-4)" "unprognostic (5.73e-2)" "unprognostic (4.34e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" 27.1 26.1 11.7 15.9 14.5 42.6 25.6 13.8 17.1 21.2 11.2 14.7 15.6 21.5 13.2 16.4 15.3 21.8 15.4 11.0 13.0 22.9 30.9 21.6 22.7 15.0 13.0 10.5 22.5 24.0 23.2 14.5 23.6 14.8 18.0 15.0 14.2 22.8 13.1 43.8 17.9 18.0 18.4 14.3 22.0 17.3 18.7 12.5 25.1 28.1 25.7 20.0 18.0 15.0 20.4 21.0 20.3 17.1 18.4 35.2 38.8 25.6 20.8 58.5 30.6 39.7 13.9 18.4 26.9 14.0 21.6 21.9 13.7 22.3 15.7 32.6 23.1 18.0 23.5 17.0 12.3 29.9 33.1 17.1 35.0 20.5 23.1 39.3 39.7 26.9 25.7 27.9 16.0 25.4 15.3 24.9 25.3 37.4 19.2 17.4 17.9 19.1 29.3 23.3 18.6 18.9 17.3 29.5 25.9 26.2 23.7 26.5 23.1 25.3 23.9 10.6 26.5 14.4 38.1 36.1 35.5 14.3 22.6 21.8 2.6 5.7 7.8 6.1 5.5 6.8 4.3 7.5 5.8 5.1 4.2 9.5 8.6 11.7 5.7 8.1 2.8 10.8 5.4 11.7 14.5 13.8 17.1 11.0 13.0 15.0 13.0 10.5 14.8 14.3 12.5 20.4 83.4 48.1 69.3 42.4 34.7 58.6 33.6 23.8 25.6 33.7 30.2 25.5 24.8 24.3 38.5 18.4 10.4 20.4 43.1 18.3 13.7 29.3 160.8 38.1 40.4 53.3 13.8 27.8 60.3 25.5 15.5 44.5 17.3 82.0 34.1 30.8 79.2 35.6 24.0 52.2 57.7 22.0 20.3 54.2 41.8 26.7 34.8 46.0 32.0 35.6 27.5 29.9 16.5 45.2 85.7 25.1 11.0 32.7 33.9 39.9 21.5 39.8 49.8 25.6 19.7 58.2 35.7 76.9 24.5 18.1 68.5 38.3 39.2 38.8 15.0 37.1 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 59.6" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Bipolar cells: 16.0;Excitatory neurons: 55.7;Inhibitory neurons: 13.8;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 13.2" "Cancer enriched" "Detected in many" 4 "glioma: 20.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 37.7;SH-SY5Y: 25.1;T-47d: 29.5;U-2 OS: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069175 Supported "Plasma membrane" NA NA 32000 "Plasma membrane" "HPA069175: " "prognostic favorable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavorable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 1.4 3.9 29.2 0.4 23.3 0.2 1.3 0.0 39.5 2.3 0.0 1.3 4.0 2.9 0.2 0.6 1.3 1.1 3.8 59.6 4.6 0.8 0.0 0.7 0.4 7.4 1.4 32.8 1.5 0.5 1.2 8.1 2.7 8.5 1.9 0.2 3.0 0.5 1.8 0.7 0.7 3.9 1.3 0.0 0.8 1.1 2.9 3.9 8.7 2.7 0.4 0.2 1.5 1.0 10.5 1.0 7.5 6.9 20.1 1.9 1.2 3.3 4.8 7.6 4.6 8.1 0.4 2.3 0.0 4.7 2.1 7.7 0.8 3.1 0.4 0.8 5.4 3.2 0.0 37.7 0.0 0.1 0.0 2.6 1.2 0.5 6.4 0.0 14.4 0.7 14.7 0.8 0.2 5.2 0.6 13.9 0.1 8.7 0.2 2.1 20.8 0.8 0.7 0.0 9.7 5.2 25.1 11.0 0.7 0.8 2.4 29.5 0.0 0.2 3.6 27.5 0.5 1.3 0.0 0.0 0.8 11.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 23.3 0.0 39.5 59.6 4.6 7.4 1.4 32.8 8.5 0.0 3.9 10.5 0.1 0.0 0.0 20.9 0.3 0.0 0.5 0.0 0.0 16.0 2.0 1.3 4.3 0.0 0.0 0.0 6.2 1.0 1.2 0.0 0.0 0.1 3.6 1.4 0.6 0.1 1.2 0.0 55.7 0.0 1.4 2.3 0.5 0.4 0.0 1.5 0.0 0.0 0.4 8.4 13.8 0.9 0.0 0.0 0.0 12.0 1.2 0.0 0.0 4.7 0.0 11.4 4.1 20.6 13.2 0.1 0.1 1.9 0.1 0.5 5.7 2.5 0.0 5.2 0.0 1.4 0.7 0.9 4.5 0.0 0.0 0.3 0.4 0.8 0.5 1.3 HCRTR1 OX1R ENSG00000121764 "Hypocretin receptor 1" O43613 1 31617686-31632518 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.3" "Cell type enhanced" "Detected in some" "Early spermatids: 1.1;Inhibitory neurons: 1.0;Late spermatids: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014018 Approved NA NA "HPA014018: AB_1854810" "unprognostic (2.96e-2)" "unprognostic (2.34e-2)" "unprognostic (7.86e-3)" "unprognostic (3.72e-3)" "unprognostic (2.42e-1)" "unprognostic (3.45e-3)" "unprognostic (2.54e-5)" "unprognostic (3.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.93e-1)" "unprognostic (3.77e-3)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" 0.3 0.9 0.3 0.0 0.1 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.9 1.8 0.0 0.0 0.0 0.0 0.3 0.5 2.3 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.0 0.1 1.9 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.0 1.1 0.9 1.8 0.0 2.3 0.1 1.9 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 ZCCHC17 "HSPC251, pNO40, PS1D" ENSG00000121766 "Zinc finger CCHC-type containing 17" Q9NP64 1 31296982-31364953 "Predicted intracellular proteins" Ribonucleoprotein "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 249.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053727 Approved NA NA "HPA053727: AB_2732581" "unprognostic (1.49e-3)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-3)" "unprognostic (2.01e-1)" "unprognostic (3.81e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.43e-2)" "unprognostic (1.00e-3)" "unprognostic (2.70e-1)" "unprognostic (2.43e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-1)" "unprognostic (8.41e-2)" "unprognostic (4.88e-2)" "unprognostic (2.17e-1)" 21.6 27.2 72.9 17.0 74.0 19.3 30.0 66.0 92.9 21.8 53.7 23.2 12.6 21.5 58.3 22.1 20.8 15.1 41.4 75.2 71.4 26.7 17.0 18.4 21.5 73.4 72.7 71.8 19.9 18.0 23.8 26.3 21.4 75.3 21.9 20.1 38.2 19.9 26.6 32.3 22.9 18.6 22.9 74.6 20.8 20.6 48.5 71.5 27.2 21.2 24.5 26.1 23.8 21.0 80.9 42.5 35.4 59.4 38.9 55.5 46.4 34.8 63.7 56.1 71.4 64.5 58.0 38.0 45.3 48.2 48.5 31.3 30.6 67.9 59.9 81.2 29.8 45.4 60.5 53.5 66.4 46.5 56.1 25.1 34.0 60.8 81.7 84.1 50.9 77.6 48.7 64.8 26.8 65.6 35.6 48.8 59.1 105.8 51.8 61.3 46.0 81.4 41.3 78.2 42.2 42.7 26.7 54.7 43.9 205.9 87.9 32.2 34.9 52.7 36.1 38.8 83.1 66.2 26.0 45.1 55.6 49.1 69.4 103.5 87.1 35.8 60.2 41.0 38.5 36.9 39.7 41.1 43.1 35.9 47.7 37.7 45.5 12.2 36.6 38.3 40.7 42.2 52.3 72.9 74.0 66.0 92.9 75.2 71.4 73.4 72.7 71.8 75.3 74.6 71.5 80.9 38.1 19.2 23.7 25.5 31.6 31.0 36.4 55.1 20.5 52.8 34.8 43.3 61.6 31.5 37.0 27.6 27.1 87.7 48.7 24.7 72.4 54.3 80.4 37.4 39.8 41.3 24.7 48.0 46.9 52.4 71.8 33.3 13.7 41.9 41.8 50.2 36.4 24.3 54.2 85.8 41.3 28.5 32.6 26.8 30.8 122.7 42.9 50.6 35.6 24.4 56.5 71.5 69.0 39.2 33.2 54.8 35.4 53.8 27.8 54.0 22.3 64.7 29.2 53.8 46.0 35.5 50.5 249.2 177.6 28.7 34.2 83.9 41.8 45.3 29.4 58.6 FABP3 "FABP11, H-FABP, MDGI, O-FABP" ENSG00000121769 "Fatty acid binding protein 3" P05413 1 31365253-31376850 "Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "heart muscle: 4497.7;skeletal muscle: 2220.7;tongue: 1455.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 629.8;Cardiomyocytes: 2495.2;Distal tubular cells: 452.0;Proximal tubular cells: 703.6" "Cancer enhanced" "Detected in all" "renal cancer: 92.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "ASC TERT1: 215.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017830, HPA055754" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Focal adhesion sites" NA NA 1640000 3000000 "Focal adhesion sites" "Golgi apparatus, Plasma membrane" "CAB017830: , HPA055754: AB_2682909" "unprognostic (2.07e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.73e-2)" "unprognostic (2.05e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-3)" "unprognostic (1.04e-1)" "unprognostic (6.86e-2)" "unprognostic (1.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-7)" "unprognostic (5.80e-3)" "unprognostic (3.45e-1)" "unprognostic (7.38e-3)" "unprognostic (9.76e-3)" 24.4 64.0 40.5 2.1 44.3 1.6 96.5 48.5 53.7 39.0 23.4 13.5 0.8 94.7 6.4 9.6 37.5 3.8 4497.7 58.9 42.0 166.2 6.6 26.7 3.4 54.8 45.1 44.4 20.4 2.3 0.3 9.1 2.9 61.8 49.3 4.8 17.9 46.9 52.7 2220.7 12.3 7.5 44.5 38.4 29.1 60.8 15.5 49.1 2.3 6.9 1455.2 1.4 12.7 32.8 67.2 1.0 0.4 8.8 1.1 50.6 215.0 2.0 2.6 17.3 0.3 6.6 1.3 1.9 1.6 17.8 5.2 0.3 2.1 2.5 0.0 0.5 0.8 3.7 1.8 2.7 5.3 2.2 1.7 0.5 16.9 0.0 3.9 0.0 2.5 0.0 1.4 2.2 0.5 2.2 0.5 0.7 1.5 11.4 0.9 3.1 0.4 5.7 0.6 4.1 0.7 2.1 0.5 1.5 0.7 28.4 13.2 0.9 3.1 1.7 1.0 1.0 6.0 1.3 1.0 2.3 1.3 2.9 1.5 1.7 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.1 40.5 44.3 48.5 53.7 58.9 42.0 54.8 45.1 44.4 61.8 38.4 49.1 67.2 4.9 0.0 1.7 2.9 7.7 3.6 1.5 0.4 0.0 6.1 629.8 13.2 2495.2 2.8 1.3 27.6 2.1 3.8 2.1 0.4 452.0 0.4 2.5 0.4 0.5 25.6 0.0 0.0 16.1 0.4 1.4 67.2 1.1 3.1 1.3 43.8 2.2 0.1 114.7 8.4 14.6 0.1 0.0 27.8 10.3 5.4 6.8 19.1 8.8 3.7 0.0 2.6 0.0 3.5 8.9 0.3 12.3 7.9 0.1 6.8 0.1 703.6 1.5 10.2 0.0 14.9 40.7 2.9 0.2 0.2 3.0 1.6 5.1 97.9 0.3 36.5 KHDRBS1 "FLJ34027, p62, Sam68" ENSG00000121774 "KH RNA binding domain containing, signal transduction associated 1" Q07666 1 32013868-32060850 "Predicted intracellular proteins" "Cell cycle, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005355, HPA051280, HPA056813" Supported Enhanced Nucleoplasm NA NA 110000 Nucleoplasm "CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240" "unprognostic (1.31e-1)" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.55e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (5.01e-2)" "unprognostic (2.51e-3)" "unprognostic (4.03e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.26e-1)" "unprognostic (7.03e-2)" 60.4 47.8 38.8 67.6 40.0 94.1 62.3 46.6 38.3 60.0 37.8 63.5 62.8 83.4 47.6 57.9 70.9 49.0 57.4 38.4 44.6 54.5 51.0 52.5 94.8 42.9 39.5 35.8 111.6 51.4 62.2 38.6 64.3 40.8 55.6 57.8 59.0 45.6 56.4 46.3 57.8 59.7 66.2 39.2 64.5 52.8 42.6 41.0 113.2 64.3 41.0 97.5 62.7 48.0 48.6 204.6 121.0 272.6 201.6 92.5 115.4 159.5 120.7 152.1 221.5 185.5 136.2 178.1 302.9 131.5 153.5 128.4 139.2 221.9 165.1 225.6 181.7 188.8 191.1 111.8 188.0 121.5 256.2 123.8 127.6 92.7 168.9 132.8 145.6 212.6 183.1 251.0 136.5 172.6 132.6 379.2 218.7 277.0 127.3 144.3 300.1 230.2 257.7 156.0 203.7 185.7 241.7 175.7 148.8 157.2 192.9 177.3 183.7 160.5 143.9 154.5 155.3 205.9 140.3 163.5 296.0 149.2 202.3 112.1 5.8 5.7 5.9 7.8 8.9 11.7 9.9 9.2 8.2 7.8 8.0 9.8 9.5 5.0 8.0 7.5 8.9 9.3 3.0 38.8 40.0 46.6 38.3 38.4 44.6 42.9 39.5 35.8 40.8 39.2 41.0 48.6 130.6 38.5 77.4 40.8 181.9 147.6 200.3 58.8 183.2 94.8 111.1 109.9 104.4 97.2 89.8 69.9 50.1 192.7 131.9 87.9 84.1 96.2 24.7 122.5 154.4 125.7 117.8 131.6 46.0 103.1 234.5 132.4 103.5 127.0 128.1 224.5 99.6 64.6 120.8 63.9 48.1 101.1 28.5 141.9 148.4 21.7 111.2 139.2 108.5 36.5 142.6 142.6 105.0 43.7 59.6 107.1 76.2 124.1 141.8 136.4 74.5 123.8 93.3 89.3 92.1 140.4 157.9 198.2 122.7 173.8 130.6 173.5 161.7 138.7 152.0 167.1 TMEM39B FLJ10315 ENSG00000121775 "Transmembrane protein 39B" Q9GZU3 1 32072031-32102866 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040191, HPA040224" Approved Approved Vesicles NA NA Vesicles "HPA040191: AB_10805706, HPA040224: AB_10795274" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (4.38e-2)" "prognostic unfavorable (3.00e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-2)" "prognostic unfavorable (2.82e-6)" "unprognostic (1.10e-2)" "unprognostic (3.37e-2)" "unprognostic (1.74e-1)" "unprognostic (3.63e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (5.11e-9)" "unprognostic (2.20e-1)" "unprognostic (5.80e-2)" "unprognostic (4.45e-2)" "unprognostic (2.10e-1)" 6.1 4.6 0.6 3.7 0.6 3.8 5.6 0.5 2.7 7.6 0.1 5.3 3.3 8.9 5.6 4.5 5.7 4.5 4.4 0.6 0.8 3.0 5.2 4.7 5.9 0.9 0.5 0.3 7.2 3.5 3.6 5.2 5.0 0.8 4.7 3.6 0.6 4.4 5.6 5.3 6.3 4.7 5.9 0.5 5.2 4.5 2.5 0.7 8.5 5.0 3.4 5.4 6.5 5.7 0.7 11.4 3.4 4.6 11.7 13.3 7.7 6.3 9.1 15.7 12.2 11.8 6.9 16.6 13.7 15.5 7.7 7.7 13.1 3.4 14.6 4.0 7.0 10.9 8.2 7.9 3.6 14.8 14.1 9.0 10.7 5.9 18.3 12.7 7.0 8.7 7.9 11.5 11.5 10.4 7.5 11.1 3.9 14.6 13.1 8.7 18.0 15.1 17.0 5.8 6.9 10.6 6.3 12.9 7.7 11.4 2.0 6.2 6.7 10.5 20.5 13.3 7.3 12.0 6.1 7.8 13.0 12.4 12.7 15.4 3.7 22.1 8.4 7.8 18.9 10.6 17.7 11.8 9.7 22.8 16.1 15.2 12.6 6.2 7.7 15.0 33.9 13.8 13.9 0.6 0.6 0.5 2.7 0.6 0.8 0.9 0.5 0.3 0.8 0.5 0.7 0.7 12.3 9.6 1.1 4.9 15.3 11.1 14.6 16.2 19.4 8.4 9.7 10.3 2.7 10.0 9.2 3.7 18.8 33.4 17.6 4.7 1.9 8.3 6.7 4.9 10.9 22.0 5.4 6.5 15.8 16.0 22.0 14.1 5.1 7.0 15.2 9.8 14.6 7.0 15.5 6.7 12.3 8.2 12.2 13.5 13.9 2.2 12.2 13.7 10.6 8.4 16.9 4.9 4.1 7.1 12.2 6.3 3.4 13.9 11.4 7.1 6.0 4.4 4.6 5.8 6.6 10.8 17.0 17.4 22.2 14.7 10.2 40.8 8.5 12.6 9.6 7.5 CCRL2 "ACKR5, CKRX, CRAM-A, CRAM-B, HCR" ENSG00000121797 "C-C motif chemokine receptor like 2" O00421 3 46407166-46412997 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 35.0;Erythroid cells: 26.5;Hofbauer cells: 42.7;Kupffer cells: 22.1;Langerhans cells: 36.5;Macrophages: 56.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 21.0;OE19: 8.4;PC-3: 15.3;RT4: 8.3;TIME: 15.4;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043238 Approved NA NA "HPA043238: AB_10794924" "unprognostic (3.94e-1)" "unprognostic (7.02e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.64e-1)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (4.10e-2)" "unprognostic (4.17e-2)" "unprognostic (9.73e-2)" "unprognostic (1.98e-2)" "unprognostic (5.17e-2)" "unprognostic (1.78e-1)" "unprognostic (3.04e-2)" "unprognostic (2.57e-1)" "prognostic favorable (9.67e-5)" 9.6 1.7 2.1 11.5 2.1 9.1 8.5 2.1 3.7 2.3 2.2 11.6 11.8 1.2 0.6 0.9 1.1 5.6 2.1 1.9 2.5 1.5 4.4 12.5 4.9 2.3 2.0 1.6 0.5 1.6 0.8 0.9 5.1 3.0 0.8 10.5 0.2 0.9 0.9 1.1 0.7 12.2 2.5 2.5 8.5 5.5 0.3 2.5 7.8 1.3 1.1 3.8 6.0 1.1 2.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.7 4.6 0.0 21.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 5.0 0.2 0.0 7.2 4.2 2.8 0.1 5.0 0.0 1.6 2.6 0.0 8.4 15.3 0.4 0.3 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 15.4 0.6 0.3 0.7 0.3 0.0 8.6 0.2 7.5 6.5 0.0 8.7 15.4 4.3 2.8 22.1 3.4 1.7 1.6 4.7 9.9 3.9 1.0 2.5 2.6 6.7 10.1 3.0 4.7 5.0 2.1 2.1 2.1 3.7 1.9 2.5 2.3 2.0 1.6 3.0 2.5 2.5 2.9 35.0 0.0 4.7 0.0 4.4 2.0 0.2 0.2 0.0 0.0 0.4 0.4 1.1 1.5 1.2 0.0 0.0 0.3 4.5 19.5 0.0 0.6 0.1 0.1 0.2 12.1 0.0 26.5 0.0 8.8 1.2 1.4 4.6 0.1 9.5 0.1 6.4 0.4 42.7 0.0 0.0 16.6 0.0 22.1 36.5 0.0 0.0 56.2 1.8 1.9 6.7 0.0 0.0 0.0 0.0 9.8 12.4 0.0 4.2 0.2 17.2 0.2 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 1.1 2.5 6.4 0.4 9.2 1.1 CCR2 "CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R" ENSG00000121807 "C-C motif chemokine receptor 2" P41597 3 46353744-46360940 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Host-virus interaction, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in some" "dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 560.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 2.4" "CAB003793, HPA063255" Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "CAB003793: AB_344889, HPA063255: " "unprognostic (1.09e-2)" "unprognostic (6.28e-4)" "unprognostic (3.49e-2)" "unprognostic (6.35e-4)" "unprognostic (1.89e-2)" "unprognostic (4.16e-4)" "unprognostic (8.06e-2)" "prognostic favorable (5.87e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (3.12e-1)" "unprognostic (1.56e-1)" "unprognostic (5.52e-3)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (4.88e-2)" "unprognostic (4.19e-1)" 2.7 1.9 0.1 26.2 0.2 2.0 3.1 0.1 0.2 1.6 0.3 4.6 7.5 1.2 0.9 1.2 1.2 3.4 1.2 0.1 0.3 1.1 2.1 5.8 11.6 0.3 0.2 0.1 1.1 0.9 0.3 0.2 0.8 0.2 1.2 5.1 0.0 3.1 1.7 0.5 1.9 5.8 7.2 0.3 20.6 5.3 1.0 0.3 4.4 1.1 0.5 7.3 5.5 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.7 0.0 185.5 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.3 416.5 177.7 0.0 0.1 3.3 0.1 560.9 146.2 2.6 11.9 12.8 89.2 7.9 24.3 20.2 145.2 1.8 0.6 0.7 3.8 14.0 0.4 113.6 11.4 81.6 0.1 0.2 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.2 0.3 0.3 0.3 0.1 0.0 1.3 0.0 5.8 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.3 1.5 0.0 0.0 0.0 0.1 40.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 4.4 0.0 0.0 0.0 0.4 1.1 0.1 0.0 0.0 1.8 0.9 0.8 0.0 0.0 0.0 0.0 43.1 10.5 0.7 0.0 25.2 0.0 0.0 34.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 8.2 0.1 0.1 0.0 POLR3GL "flj32422, MGC3200" ENSG00000121851 "RNA polymerase III subunit GL" Q9BT43 1 145964690-145978848 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 196.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA027288 Uncertain NA NA "HPA027288: AB_10602119" "prognostic favorable (2.96e-4)" "unprognostic (3.58e-3)" "unprognostic (1.55e-2)" "prognostic favorable (6.52e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (2.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.15e-2)" "unprognostic (2.11e-1)" "unprognostic (5.98e-3)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-1)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" 49.4 42.3 36.2 26.7 36.9 29.0 42.2 35.7 43.3 29.4 37.2 37.3 19.9 30.5 28.0 20.2 31.7 21.2 64.9 35.6 37.1 28.0 55.7 32.0 40.9 38.1 36.6 34.4 36.5 21.3 31.6 33.6 19.9 37.1 29.0 25.3 28.5 26.4 24.9 141.0 26.6 37.0 24.6 36.0 47.0 33.9 19.9 37.8 41.5 34.0 66.7 42.0 33.0 25.3 37.1 28.5 12.6 28.6 26.4 70.3 78.8 6.9 28.3 43.9 19.0 28.6 3.9 31.0 60.9 41.4 39.6 15.4 8.6 14.1 27.7 28.8 66.8 15.5 40.6 10.6 19.8 43.2 41.1 55.3 60.1 18.1 31.2 36.0 55.5 50.5 64.2 68.9 51.5 73.1 30.5 33.6 51.4 5.9 42.9 27.8 27.8 35.3 92.8 30.6 6.5 15.5 28.8 40.0 2.6 58.3 23.2 24.8 65.5 52.7 17.7 11.7 35.0 19.3 83.9 27.4 47.4 32.1 48.5 16.4 225.8 53.8 266.1 124.2 73.3 119.0 118.4 125.3 123.2 56.0 110.0 126.7 130.6 41.2 116.2 79.0 44.1 179.5 103.5 36.2 36.9 35.7 43.3 35.6 37.1 38.1 36.6 34.4 37.1 36.0 37.8 37.1 69.8 28.9 52.8 12.1 63.0 27.9 27.5 52.4 15.9 32.3 34.8 37.8 83.7 52.9 35.7 20.2 8.4 19.9 76.0 35.1 123.3 35.2 38.8 21.9 24.7 51.4 21.1 46.7 6.5 38.6 26.5 40.1 21.9 15.5 85.4 35.6 60.7 84.3 70.2 57.2 7.9 31.1 63.1 70.0 46.6 11.2 45.1 54.9 58.7 10.3 73.1 84.9 196.7 4.0 9.3 38.6 33.8 47.0 48.2 20.1 31.6 41.2 42.7 20.9 26.3 32.6 40.5 22.9 29.4 25.2 30.0 9.4 94.6 50.0 33.1 24.6 GHSR ENSG00000121853 "Growth hormone secretagogue receptor" Q92847 3 172443291-172448456 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "brain: 10.4;pituitary gland: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hippocampal formation: 3.2;hypothalamus: 10.4;thalamus: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 3.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.27e-1)" "unprognostic (3.31e-2)" 0.0 0.2 0.7 0.1 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 10.4 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.6 3.2 10.4 1.2 0.1 0.0 0.6 0.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNFSF10 "Apo-2L, CD253, TL2, TRAIL" ENSG00000121858 "TNF superfamily member 10" P50591 3 172505508-172523475 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 732.8;Exocrine glandular cells: 424.6;Proximal tubular cells: 556.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 265.4;classical monocyte: 133.4;intermediate monocyte: 203.5;neutrophil: 257.1;non-classical monocyte: 213.2" "Group enriched" "Detected in all" 5 "granulocytes: 265.4;monocytes: 213.2" "Cell line enhanced" "Detected in many" "BEWO: 73.1;CAPAN-2: 53.7;HaCaT: 51.5;HMC-1: 244.5;RPTEC TERT1: 122.1" "Low region specificity" "Detected in all" HPA054938 Uncertain "Secreted to blood" NA NA 67400 18000 "HPA054938: AB_2682643" "unprognostic (9.16e-2)" "unprognostic (2.79e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-3)" "unprognostic (2.52e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-1)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (1.32e-1)" "unprognostic (6.27e-2)" 50.3 50.3 9.6 55.9 9.6 14.9 85.4 9.2 17.2 37.0 16.6 77.5 101.2 47.5 19.8 66.9 39.4 45.7 32.0 8.4 10.1 146.4 210.7 178.7 55.1 10.9 9.5 7.8 27.3 22.4 78.3 10.5 169.2 10.6 87.5 92.3 1.4 129.0 43.1 20.9 55.0 96.0 26.5 9.5 71.5 47.7 4.8 10.6 34.5 29.5 62.3 47.2 70.9 62.9 12.0 12.4 0.6 0.1 0.2 8.2 6.6 73.1 0.0 0.5 3.7 5.9 0.3 53.7 7.9 34.7 0.0 3.2 51.5 0.3 6.3 0.7 19.6 0.2 0.2 1.5 1.1 0.4 14.7 244.5 8.2 8.0 1.3 0.2 0.0 25.6 1.6 0.3 8.7 0.0 0.1 1.9 19.4 0.3 0.2 0.5 2.9 0.2 3.5 122.1 4.6 0.3 0.5 27.2 1.0 0.6 0.4 15.3 8.0 1.1 0.1 0.2 0.1 0.7 9.3 1.1 9.5 0.6 8.0 0.2 265.4 133.4 14.7 10.9 203.5 15.0 16.7 30.4 16.8 49.1 18.2 21.6 8.5 257.1 49.3 213.2 2.9 36.8 73.6 9.6 9.6 9.2 17.2 8.4 10.1 10.9 9.5 7.8 10.6 9.5 10.6 12.0 326.5 70.5 114.4 0.0 26.2 22.0 169.5 398.4 69.4 0.3 146.5 97.3 7.9 84.4 281.1 66.2 0.0 6.6 20.7 294.2 45.0 732.8 4.5 60.5 18.2 247.5 48.3 9.7 0.1 424.6 189.4 69.2 44.9 121.0 257.0 2.4 186.7 75.2 23.5 1.7 0.1 111.3 175.0 79.8 23.7 3.8 18.3 70.5 7.2 52.5 160.3 18.7 52.5 0.0 0.1 244.0 216.4 4.9 23.2 82.7 317.0 556.7 114.5 1.5 0.0 6.5 22.3 0.1 0.3 103.1 25.6 10.9 51.8 19.7 74.3 170.1 ZNF639 "ANC-2H01, ZASC1" ENSG00000121864 "Zinc finger protein 639" Q9UID6 3 179323031-179338583 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049023, HPA052163" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA049023: AB_2680603, HPA052163: AB_2681747" "unprognostic (5.64e-2)" "unprognostic (6.16e-2)" "unprognostic (8.15e-2)" "unprognostic (1.33e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (7.74e-2)" "unprognostic (1.05e-2)" "unprognostic (2.16e-3)" "unprognostic (4.70e-3)" "unprognostic (4.58e-2)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" 20.8 19.7 17.6 18.2 18.5 59.7 28.2 23.4 19.4 27.9 16.0 22.6 17.6 31.8 25.8 21.1 26.3 20.0 27.7 17.5 19.3 25.3 24.1 22.1 26.8 17.6 18.0 16.2 33.0 24.8 38.9 18.3 22.6 17.8 26.5 22.4 40.3 24.7 27.2 27.5 17.1 18.7 31.3 17.6 23.9 20.8 19.2 17.6 26.9 41.8 30.6 24.8 21.7 18.5 19.1 81.3 18.7 35.5 43.9 31.7 38.4 35.2 37.8 56.4 61.0 54.8 31.7 31.3 94.2 56.4 46.6 74.1 30.1 55.2 50.5 76.0 86.7 43.1 96.1 26.8 31.8 55.0 76.1 34.5 31.1 51.9 31.3 72.5 45.7 42.1 61.3 59.4 48.6 48.6 41.2 79.5 33.7 59.9 56.9 43.5 75.4 37.1 112.1 37.8 32.4 65.3 39.9 37.9 41.1 49.2 29.8 104.9 59.4 34.5 41.3 43.7 33.1 98.7 19.7 19.0 174.2 30.3 58.5 28.9 2.5 1.1 1.2 1.6 0.7 1.5 1.8 2.6 2.6 0.9 2.0 2.2 2.2 0.7 2.2 0.5 0.3 2.4 0.8 17.6 18.5 23.4 19.4 17.5 19.3 17.6 18.0 16.2 17.8 17.6 17.6 19.1 16.9 19.2 11.7 9.4 24.2 20.9 34.0 7.0 32.5 21.5 21.6 13.2 19.4 10.0 8.8 14.7 54.2 14.7 18.3 8.6 33.2 12.2 29.8 21.6 22.4 19.4 18.7 29.0 8.7 10.0 11.3 21.8 11.2 30.3 10.1 18.5 18.5 17.0 9.9 16.8 10.6 15.6 6.1 13.2 17.2 8.8 24.5 13.8 14.2 4.7 13.5 19.6 13.4 8.5 9.6 11.5 9.4 24.0 27.5 36.1 11.2 22.2 7.2 44.9 26.3 27.1 22.7 29.9 21.3 29.9 17.5 3.4 23.2 19.8 12.2 24.9 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.6;fallopian tube: 9.7;liver: 8.0" "Group enriched" "Detected in some" 6 "Bipolar cells: 8.4;Excitatory neurons: 11.0;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 21.1" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.6;HAP1: 2.2;SCLC-21H: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria No NA 2600000 Mitochondria "HPA017636: AB_1857232, HPA048042: AB_2732542" "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.1 0.1 2.7 1.0 3.0 0.0 0.1 4.3 8.3 4.2 0.0 1.9 0.4 7.3 0.9 4.5 9.7 0.2 0.4 8.6 2.2 0.1 8.0 0.3 0.0 0.4 1.4 3.4 1.0 0.0 0.0 0.1 0.0 1.9 1.7 1.6 3.2 0.2 5.5 0.3 0.0 1.1 3.7 0.3 0.0 0.4 0.4 0.7 0.0 0.1 0.0 0.0 0.5 0.9 2.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.0 4.3 8.3 8.6 2.2 0.4 1.4 3.4 1.9 0.3 0.7 2.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 15.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 21.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Lipid metabolism, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 14.8 8.0 3.5 8.1 4.2 12.5 8.6 10.1 8.7 8.7 1.1 5.8 4.2 8.4 4.8 8.0 5.8 8.4 9.6 4.3 3.8 8.3 7.1 8.0 9.2 5.3 4.9 2.2 10.4 4.3 11.6 3.4 11.2 6.1 7.3 5.8 12.5 4.5 7.1 7.1 5.5 5.3 9.0 2.6 8.9 5.8 6.1 4.7 13.8 8.0 13.1 9.3 8.6 5.9 6.8 19.9 6.5 9.6 9.2 22.7 27.7 6.5 10.8 16.5 10.9 16.0 5.1 13.0 16.1 21.7 10.8 14.1 5.9 8.4 9.8 16.5 32.0 6.2 22.4 5.2 4.4 10.7 13.1 12.6 16.8 10.6 12.4 15.0 13.4 15.8 12.9 10.6 17.3 18.9 6.9 10.9 8.5 8.0 8.8 7.8 13.9 10.0 16.7 8.5 10.0 5.2 9.9 13.1 10.8 16.1 9.1 19.0 11.1 21.1 10.4 6.5 18.1 13.3 9.3 13.8 29.0 11.3 9.6 5.4 1.3 1.2 0.4 1.2 1.0 0.8 1.5 0.8 0.6 0.8 1.6 1.0 0.8 2.2 0.7 0.9 0.9 0.8 0.3 3.5 4.2 10.1 8.7 4.3 3.8 5.3 4.9 2.2 6.1 2.6 4.7 6.8 31.3 32.1 26.8 60.7 28.3 14.7 17.9 11.2 2.2 27.9 14.4 15.2 18.5 5.7 15.9 7.3 31.3 10.2 17.9 8.7 1.9 10.7 2.0 14.1 21.7 25.6 2.4 9.2 126.7 13.9 6.1 23.5 8.6 21.6 31.6 19.9 33.5 21.9 11.1 38.7 122.0 10.3 14.2 23.5 24.3 3.4 32.6 20.9 14.2 75.9 24.5 17.4 18.6 130.2 84.2 16.9 10.8 39.5 15.1 34.6 9.5 14.8 20.1 27.1 26.3 25.7 28.6 11.8 10.2 9.8 14.9 8.8 19.9 19.6 9.2 32.0 PDS5A "KIAA0648, PIG54, SCC-112" ENSG00000121892 "PDS5 cohesin associated factor A" Q29RF7 4 39822863-39977956 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036661, HPA036662" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036661: AB_2675233, HPA036662: AB_10696783" "unprognostic (4.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.62e-3)" "unprognostic (6.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (9.97e-3)" "unprognostic (2.97e-1)" "unprognostic (6.67e-3)" "unprognostic (3.19e-2)" "unprognostic (2.59e-2)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.81e-2)" 19.5 16.3 15.7 23.4 16.6 29.7 24.5 21.7 19.2 20.8 19.2 23.2 19.8 20.1 20.4 26.0 16.0 16.6 14.6 14.5 17.7 22.2 33.7 22.9 33.4 16.9 16.3 14.2 23.8 21.1 29.9 10.6 23.1 16.4 18.7 24.1 21.1 20.3 16.1 17.8 24.5 19.6 19.6 15.8 21.6 20.8 14.1 16.4 42.4 28.7 19.7 35.0 23.1 16.1 25.2 54.8 40.0 50.3 53.4 47.5 47.5 40.2 43.4 40.9 50.1 49.6 39.2 60.2 106.6 46.5 51.6 79.5 29.4 86.9 50.5 71.7 36.1 33.2 73.1 47.6 41.3 47.5 90.2 60.1 31.5 55.9 53.3 78.2 44.5 64.7 62.1 88.0 43.8 52.0 38.5 113.2 78.8 28.6 51.4 26.7 104.3 89.6 38.9 48.2 54.6 69.5 41.2 59.9 40.7 39.0 37.5 41.4 78.7 61.5 56.4 58.6 41.2 74.3 37.0 69.7 112.3 40.1 90.6 45.3 2.3 1.2 1.9 2.3 1.6 3.0 2.0 2.2 2.5 1.8 2.5 2.6 2.1 0.4 3.0 1.1 2.2 2.0 1.0 15.7 16.6 21.7 19.2 14.5 17.7 16.9 16.3 14.2 16.4 15.8 16.4 25.2 36.2 86.6 70.3 75.7 52.3 56.6 37.0 29.3 51.8 32.7 42.6 30.1 40.5 32.9 45.8 22.0 60.5 32.4 50.8 39.2 7.9 22.0 9.7 34.9 50.0 40.7 30.5 69.6 120.5 25.8 39.1 36.8 41.3 52.8 29.1 45.1 40.0 58.2 30.9 13.5 115.3 36.3 28.5 46.6 54.5 10.0 32.9 44.6 46.2 119.9 38.7 13.3 42.2 98.5 138.0 38.9 28.2 33.1 52.8 53.7 28.5 27.4 25.5 27.9 32.9 36.3 31.1 44.2 48.5 66.9 68.2 38.7 49.9 30.9 40.4 59.6 TMEM156 FLJ23235 ENSG00000121895 "Transmembrane protein 156" Q8N614 4 38966744-39032922 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 27.1" "Cell type enhanced" "Detected in many" "B-cells: 99.8;Microglial cells: 68.4;NK-cells: 28.8;Plasma cells: 123.1;T-cells: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 74.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 39.6;GAMG: 29.6;HBEC3-KT: 84.8;hTERT-HME1: 64.0;NB-4: 35.2;PC-3: 37.3;U-698: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "prognostic favorable (4.09e-4)" "unprognostic (7.36e-3)" "unprognostic (3.31e-3)" "unprognostic (4.17e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-3)" "unprognostic (4.10e-2)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (9.45e-3)" "unprognostic (5.17e-2)" "unprognostic (8.73e-4)" "unprognostic (3.89e-1)" "unprognostic (1.74e-2)" "unprognostic (3.92e-4)" "unprognostic (9.06e-2)" 0.4 1.7 1.7 9.1 1.9 1.9 1.1 2.1 1.7 0.5 1.6 1.7 1.8 0.5 0.2 0.5 0.5 1.9 0.3 1.7 2.2 0.5 2.8 0.9 23.8 2.7 2.0 1.4 0.4 0.3 0.2 0.1 0.1 2.7 0.6 1.9 0.5 0.9 0.5 0.5 0.4 5.2 0.4 2.9 11.2 2.6 0.2 2.3 5.2 0.4 0.0 27.1 3.0 0.2 2.9 2.4 23.9 0.2 0.2 0.0 0.6 0.2 0.1 6.4 0.0 0.0 0.2 0.3 39.6 0.3 0.0 29.6 0.2 0.2 84.8 0.3 0.4 0.0 2.1 7.7 0.5 13.3 16.8 0.3 0.1 4.2 1.7 64.0 4.9 7.3 6.5 5.8 0.2 2.8 0.2 3.1 35.2 0.1 0.9 37.3 0.8 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.2 17.9 2.9 0.5 0.2 0.7 0.2 0.1 45.3 5.0 15.2 0.1 16.8 0.8 48.6 12.2 0.3 14.3 74.8 20.7 12.2 8.4 59.9 8.0 10.4 1.8 12.5 0.3 12.4 15.4 8.3 1.7 1.9 2.1 1.7 1.7 2.2 2.7 2.0 1.4 2.7 2.9 2.3 2.9 0.6 0.0 1.8 0.7 99.8 0.5 0.8 0.5 0.0 0.6 2.3 2.4 0.3 17.2 1.9 0.0 0.0 0.1 22.1 0.0 0.0 0.5 1.3 0.3 1.1 3.3 0.0 4.2 0.6 0.0 1.2 0.8 1.5 0.2 0.0 0.0 2.9 0.4 1.6 1.7 0.7 0.2 2.0 22.8 2.7 2.8 0.0 8.4 10.6 68.4 2.7 0.1 28.8 0.5 2.5 1.1 0.0 0.0 123.1 0.8 0.0 0.4 1.5 0.5 0.0 1.4 0.6 0.8 0.1 0.0 0.6 0.3 30.2 0.1 0.3 0.8 LIAS LAS ENSG00000121897 "Lipoic acid synthetase" O43766 4 39459004-39485109 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 86.0;Late spermatids: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018842, HPA019076" Approved Supported Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA018842: AB_1852864, HPA019076: AB_1852866" "unprognostic (3.61e-1)" "unprognostic (1.89e-1)" "unprognostic (8.44e-2)" "unprognostic (2.33e-1)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (8.31e-2)" "unprognostic (1.57e-1)" "unprognostic (4.19e-2)" "unprognostic (3.68e-2)" "unprognostic (2.46e-3)" "unprognostic (3.80e-2)" "prognostic favorable (4.11e-7)" "unprognostic (9.41e-3)" "unprognostic (2.35e-1)" "unprognostic (5.45e-2)" "unprognostic (6.98e-2)" 5.4 7.5 6.2 3.0 6.9 6.6 5.8 7.8 9.9 4.8 6.1 6.4 5.6 4.6 5.3 6.7 6.1 3.7 9.0 6.4 6.8 8.8 8.7 2.9 5.2 6.5 6.5 6.3 10.1 6.8 6.5 4.1 3.3 6.7 4.1 6.5 5.5 4.3 3.2 27.4 5.5 5.3 5.2 5.8 3.6 6.3 9.9 6.4 4.4 4.2 21.2 4.3 5.8 4.8 8.6 5.7 4.5 5.4 5.2 11.5 11.4 4.8 6.6 3.7 6.1 4.1 6.8 7.8 20.8 7.3 2.5 15.2 4.9 15.9 9.1 8.0 2.4 4.0 8.8 2.3 7.0 10.4 19.1 5.5 10.8 14.6 7.1 22.4 13.4 7.0 12.7 21.1 5.2 7.5 3.6 10.9 24.9 7.3 15.3 14.2 9.1 15.2 12.9 7.1 2.9 6.0 4.8 3.8 4.9 22.5 7.6 5.6 8.8 2.6 4.7 10.6 6.3 15.5 9.9 15.8 14.3 7.2 22.2 4.0 2.5 6.4 3.9 5.7 7.6 12.7 10.0 8.1 8.0 6.2 7.6 16.2 11.6 3.4 7.7 5.6 5.5 5.7 4.7 6.2 6.9 7.8 9.9 6.4 6.8 6.5 6.5 6.3 6.7 5.8 6.4 8.6 11.0 9.6 12.6 14.0 12.9 9.7 11.6 17.4 12.0 25.8 15.7 17.3 20.1 17.2 12.7 18.4 10.4 24.0 22.6 12.9 21.5 13.2 86.0 11.2 15.8 10.3 18.1 12.4 11.9 6.4 18.2 10.4 9.2 10.3 17.7 19.0 11.4 19.0 17.5 10.1 18.8 13.5 18.3 13.5 7.8 100.1 10.2 11.4 1.8 6.5 17.6 15.4 16.5 14.6 22.9 10.3 10.1 12.4 5.8 6.6 18.3 32.6 14.1 26.7 0.0 10.8 20.5 64.9 25.1 13.7 9.2 9.6 14.2 19.0 18.4 8.8 CPXM2 "CPX2, UNQ676" ENSG00000121898 "Carboxypeptidase X, M14 family member 2" Q8N436 10 123706207-123940267 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 68.7" "Cell type enhanced" "Detected in many" "Early spermatids: 106.8;Late spermatids: 202.5;Oligodendrocytes: 35.6;Peritubular cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BJ: 18.4;fHDF/TERT166: 71.8;SuSa: 28.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048375 Uncertain "Secreted - unknown location" NA NA 62000 "HPA048375: AB_2680377" "unprognostic (1.50e-1)" "unprognostic (3.66e-1)" "unprognostic (2.58e-2)" "unprognostic (4.02e-3)" "unprognostic (2.69e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.57e-2)" "unprognostic (4.42e-2)" "unprognostic (2.14e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (1.16e-3)" 29.4 6.5 4.9 6.0 6.4 0.0 21.0 9.3 3.5 5.7 68.7 52.0 6.3 10.3 60.4 18.5 16.1 11.3 13.3 3.5 11.7 11.0 2.4 7.1 2.8 16.3 10.8 0.8 16.9 5.2 2.5 11.0 1.2 11.8 15.3 7.0 0.5 9.4 12.9 3.8 7.2 15.0 57.5 18.6 17.0 20.1 9.7 11.0 7.9 15.1 8.0 6.7 28.5 9.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.4 0.7 1.1 0.1 0.0 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 28.0 0.5 0.0 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.4 9.3 3.5 3.5 11.7 16.3 10.8 0.8 11.8 18.6 11.0 19.1 22.3 0.0 0.6 0.3 0.1 2.2 0.0 0.2 6.2 0.0 0.3 0.4 2.4 0.0 0.0 1.8 0.0 8.3 0.1 0.2 1.9 0.4 106.8 0.2 0.2 26.1 0.0 0.0 5.0 0.2 0.3 23.0 1.1 0.3 0.0 0.1 16.8 0.0 0.3 1.7 0.5 0.7 0.0 0.0 2.7 202.5 10.8 0.6 3.6 0.0 0.0 0.0 0.0 1.0 35.6 0.1 0.1 79.0 1.4 0.0 0.4 0.0 0.0 0.1 0.0 1.6 2.0 1.3 1.9 0.6 2.0 5.1 0.2 0.0 2.7 0.2 TMEM54 CAC-1 ENSG00000121900 "Transmembrane protein 54" Q969K7 1 32894594-32901438 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1231.3;Intestinal goblet cells: 357.2;Paneth cells: 800.1;Proximal enterocytes: 418.6;Undifferentiated cells: 355.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 198.9;OE19: 242.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA060864, HPA061992" Approved Approved Vesicles NA NA Vesicles "HPA060864: , HPA061992: AB_2684652" "unprognostic (2.67e-1)" "unprognostic (2.57e-2)" "unprognostic (2.55e-1)" "unprognostic (4.98e-2)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.42e-2)" "unprognostic (3.48e-2)" "unprognostic (9.43e-2)" "unprognostic (6.82e-3)" "unprognostic (2.13e-2)" "unprognostic (9.06e-2)" "unprognostic (3.12e-2)" "unprognostic (3.40e-2)" 16.2 15.7 56.9 40.3 51.5 0.0 24.8 50.3 99.2 45.8 41.5 223.2 117.0 40.8 26.8 146.5 25.7 62.5 18.6 52.5 58.3 44.4 15.0 27.0 4.6 60.2 56.0 51.5 20.5 32.0 49.9 22.7 18.6 51.9 58.7 114.2 4.2 54.4 23.1 6.9 114.7 124.1 21.5 56.3 13.3 108.9 12.0 56.6 2.5 48.2 4.9 13.1 51.5 79.3 55.7 133.3 33.9 0.0 32.0 59.1 35.4 119.9 20.0 29.2 43.1 55.2 84.7 198.9 0.0 57.1 24.8 55.2 80.0 28.6 107.4 12.8 158.3 6.4 0.2 11.3 4.5 42.9 0.4 2.0 30.5 96.2 66.1 18.1 29.1 19.3 13.0 18.7 0.1 22.7 135.6 0.1 2.6 10.3 242.7 60.8 17.7 52.2 0.6 16.2 159.8 1.8 17.1 14.4 82.1 44.0 19.3 89.3 24.2 39.9 42.3 47.5 95.9 40.8 5.2 12.4 15.8 30.1 3.3 61.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 51.5 50.3 99.2 52.5 58.3 60.2 56.0 51.5 51.9 56.3 56.6 55.7 6.4 19.2 27.6 3.9 6.6 20.4 92.3 36.9 20.5 8.2 82.0 61.0 4.7 97.2 36.9 47.8 4.2 42.8 1.3 1231.3 27.4 150.2 43.4 7.5 16.1 12.3 60.7 0.0 3.3 202.4 149.1 22.9 160.0 14.3 5.7 11.8 18.9 3.7 8.4 0.0 2.9 357.2 12.2 1.0 6.5 32.3 19.9 3.7 14.2 0.0 3.1 33.7 0.0 3.5 2.6 166.3 800.1 24.5 1.6 160.9 418.6 84.9 14.0 10.3 6.6 8.5 20.6 10.9 8.8 65.0 63.6 64.3 3.3 2.4 355.8 193.3 ZSCAN20 "KOX29, ZNF31, ZNF360" ENSG00000121903 "Zinc finger and SCAN domain containing 20" P17040 1 33472645-33496507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017933 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017933: AB_1859028" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-3)" "unprognostic (9.28e-2)" "unprognostic (3.03e-3)" "unprognostic (1.77e-6)" "unprognostic (3.13e-1)" "unprognostic (6.94e-2)" "unprognostic (4.05e-2)" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (2.92e-2)" "unprognostic (4.43e-2)" "unprognostic (1.74e-2)" 0.8 0.8 1.6 0.7 1.7 0.2 1.3 2.4 1.5 1.2 1.4 1.1 2.7 1.4 0.9 0.9 1.2 0.7 2.0 1.2 1.3 1.1 0.5 0.9 0.6 1.7 1.6 0.9 2.3 0.9 2.6 0.9 1.2 2.1 1.2 1.3 1.5 1.0 1.6 1.1 0.8 1.2 1.5 1.5 0.9 1.2 1.8 1.8 1.2 1.3 2.0 1.0 1.0 0.7 2.5 2.4 1.7 4.0 2.7 3.1 3.1 2.6 2.9 2.9 3.8 3.1 1.8 3.0 1.7 1.5 3.0 2.2 2.9 3.3 1.5 3.9 0.0 3.7 3.6 4.2 1.5 2.9 2.0 1.2 2.2 2.7 4.0 3.3 3.5 3.0 2.9 2.4 2.2 3.4 0.8 1.6 1.2 3.3 2.2 1.0 1.7 4.6 0.7 2.1 2.0 1.5 2.3 2.2 2.4 3.2 5.2 1.6 2.2 2.7 3.3 2.3 3.1 4.2 2.9 2.0 0.8 3.5 0.6 2.2 0.0 0.5 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.4 0.1 0.4 0.6 0.1 0.2 0.2 0.2 0.2 0.1 1.6 1.7 2.4 1.5 1.2 1.3 1.7 1.6 0.9 2.1 1.5 1.8 2.5 0.8 0.0 1.3 1.3 0.2 0.0 0.6 0.7 1.8 1.8 0.5 0.4 2.2 2.8 0.4 0.0 4.2 0.9 0.1 1.0 0.0 0.8 15.9 0.4 1.2 0.9 1.2 2.7 2.6 0.2 0.8 1.7 2.6 0.4 1.3 2.8 1.8 0.4 0.6 0.0 2.7 0.7 0.0 1.2 0.0 2.6 1.2 0.3 0.0 4.7 2.0 1.0 1.0 4.0 3.7 0.9 1.6 1.9 0.4 0.5 0.4 0.5 0.9 1.9 0.0 1.4 1.2 3.2 1.5 1.0 0.0 0.3 0.8 0.9 0.4 0.5 CSMD2 KIAA1884 ENSG00000121904 "CUB and Sushi multiple domains 2" Q7Z408 1 33513999-34165842 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 7.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 159.0;Inhibitory neurons: 148.9;Oligodendrocyte precursor cells: 314.7;Oligodendrocytes: 52.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.6;fHDF/TERT166: 6.8;HEL: 10.5;NTERA-2: 8.1;PC-3: 8.4;U-87 MG: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-2)" "unprognostic (2.98e-1)" "unprognostic (6.47e-2)" "unprognostic (2.14e-1)" "unprognostic (7.03e-2)" "unprognostic (2.77e-1)" "unprognostic (1.31e-3)" "unprognostic (5.90e-2)" "unprognostic (7.44e-2)" "unprognostic (5.36e-2)" "unprognostic (2.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.25e-5)" "unprognostic (1.03e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.38e-2)" 0.2 0.5 3.9 0.2 3.7 0.0 0.1 0.7 5.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.1 7.7 3.8 0.1 0.0 0.1 0.2 2.4 2.3 3.6 0.0 0.2 0.0 0.1 0.0 3.0 0.2 0.1 0.9 0.0 0.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.5 7.3 0.0 0.1 0.1 0.4 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.2 1.1 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 1.4 0.0 2.4 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.7 0.7 5.8 7.7 3.8 2.4 2.3 3.6 3.0 1.1 7.3 3.4 1.4 6.4 3.0 2.6 0.0 0.3 0.6 0.0 0.0 11.2 0.1 0.0 5.5 0.0 0.0 1.8 2.1 0.0 0.1 0.0 0.0 4.3 3.2 0.2 2.3 1.2 0.0 0.0 159.0 2.9 0.1 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.7 148.9 0.0 0.0 0.0 0.3 6.0 1.5 0.4 0.0 12.2 0.3 0.1 0.0 314.7 52.5 1.4 0.0 3.8 0.0 0.9 0.0 0.1 0.0 1.9 0.0 1.4 0.7 0.3 2.1 0.0 0.4 0.0 0.2 0.2 0.0 0.3 HPCA DYT2 ENSG00000121905 Hippocalcin P84074 1 32885994-32898441 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 396.4" "Group enriched" "Detected in many" 7 "Bipolar cells: 198.3;Early spermatids: 155.4;Late spermatids: 119.7" "Cancer enriched" "Detected in many" 9 "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SCLC-21H: 4.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basal ganglia: 1309.6;hippocampal formation: 990.7" "CAB012340, HPA043245" Enhanced NA NA "CAB012340: AB_2120209, HPA043245: AB_2678385" "unprognostic (4.60e-2)" "unprognostic (5.96e-3)" "unprognostic (2.16e-3)" "unprognostic (1.19e-3)" "unprognostic (6.72e-3)" "unprognostic (5.18e-2)" "unprognostic (9.08e-3)" "unprognostic (6.71e-3)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-3)" "unprognostic (1.98e-2)" "unprognostic (2.36e-2)" "unprognostic (1.12e-2)" "unprognostic (6.42e-2)" "unprognostic (3.09e-2)" "unprognostic (2.85e-3)" 0.1 0.4 71.0 0.0 396.4 0.0 0.1 46.3 327.1 0.7 35.4 0.5 0.1 0.5 0.0 0.1 0.3 0.2 0.2 282.4 68.9 0.3 0.2 0.1 0.0 100.4 55.2 93.7 0.6 0.5 0.3 1.8 0.0 156.2 0.5 0.4 18.6 0.1 0.1 0.2 0.1 0.4 0.2 41.6 0.1 0.2 3.7 81.6 0.0 0.4 0.0 0.0 0.2 0.4 80.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.9 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 396.4 46.3 327.1 282.4 68.9 100.4 55.2 93.7 156.2 41.6 81.6 80.1 0.1 0.0 0.0 3.6 0.0 0.0 1.4 0.5 0.0 198.3 0.4 0.9 0.4 0.0 0.1 0.0 6.2 0.1 0.1 1.7 0.0 0.3 155.4 0.0 0.4 0.3 18.0 0.0 21.9 0.5 0.3 0.7 0.0 0.1 0.0 0.9 0.0 0.0 0.1 13.5 7.8 2.8 0.0 0.0 0.0 119.7 1.2 0.1 0.0 2.8 0.0 9.1 0.0 4.5 3.7 0.3 5.9 0.4 0.0 1.3 2.0 2.0 0.2 19.3 0.0 0.1 0.5 4.2 8.5 0.1 0.3 0.1 0.0 0.0 2.2 1.4 LRIF1 "C1orf103, FLJ11269, RIF1" ENSG00000121931 "Ligand dependent nuclear receptor interacting factor 1" Q5T3J3 1 110947190-110963965 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044515 Uncertain Supported "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA044515: AB_10796800" "unprognostic (5.06e-2)" "unprognostic (4.82e-2)" "unprognostic (4.74e-1)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.73e-4)" "unprognostic (5.14e-2)" "unprognostic (9.23e-3)" "unprognostic (3.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-1)" "unprognostic (3.88e-2)" "unprognostic (2.70e-1)" 5.9 9.4 10.5 10.4 10.9 5.6 11.5 12.3 15.4 6.3 11.0 6.5 6.0 6.9 20.0 5.7 8.1 5.0 14.7 12.2 11.4 8.0 13.3 6.8 16.1 10.4 10.8 9.7 15.6 6.2 6.6 7.7 10.0 10.9 8.3 6.4 21.7 7.2 5.5 18.4 9.4 6.0 4.7 10.8 13.1 7.1 25.9 10.7 13.4 11.0 17.4 17.5 7.7 4.6 12.2 33.2 14.4 26.8 18.4 12.3 19.8 30.2 19.9 22.7 33.8 27.2 36.4 40.4 25.2 27.5 15.1 36.5 21.0 12.9 12.0 40.6 45.9 15.2 27.9 14.3 37.4 35.8 52.7 32.5 12.5 32.3 23.5 41.0 14.4 18.6 26.4 88.3 111.5 23.2 11.1 5.4 41.4 40.0 20.1 32.6 35.0 43.4 30.5 8.8 17.0 22.3 24.4 0.1 33.8 59.1 16.3 28.0 83.6 13.5 30.0 1.0 35.4 16.3 51.7 19.4 46.9 17.1 59.2 53.6 24.8 8.3 18.6 21.0 9.4 26.6 29.9 16.6 22.1 16.8 22.7 18.1 24.8 31.4 28.2 13.0 15.0 16.9 12.8 10.5 10.9 12.3 15.4 12.2 11.4 10.4 10.8 9.7 10.9 10.8 10.7 12.2 22.5 12.8 8.4 11.8 39.4 14.4 48.4 21.0 19.9 22.4 27.9 35.1 27.8 8.6 17.0 9.2 18.8 19.5 21.9 15.5 15.6 18.8 15.3 15.9 15.2 21.5 11.3 24.8 17.9 19.9 32.3 16.5 23.0 18.5 8.2 11.2 17.5 31.8 13.9 15.2 16.5 13.2 18.3 10.7 53.1 11.4 15.8 23.2 32.0 3.7 20.1 28.6 49.4 4.0 16.1 23.4 12.9 13.9 28.4 56.8 10.0 11.8 22.3 35.1 13.1 20.0 19.0 49.9 54.8 25.1 17.6 37.8 31.5 21.4 11.3 50.9 TMIGD3 AD026 ENSG00000121933 "Transmembrane and immunoglobulin domain containing 3" P0DMS9 1 111483348-111563962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 55.6" "Cell type enhanced" "Detected in some" "Early spermatids: 272.5;Hofbauer cells: 236.3;Kupffer cells: 161.3;Late spermatids: 118.9;Spermatocytes: 198.3" "Cancer enriched" "Detected in all" 5 "glioma: 16.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 44 "eosinophil: 62.8" "Lineage enriched" "Detected in many" 44 "granulocytes: 62.8" "Cell line enhanced" "Detected in some" "HDLM-2: 7.0;HMC-1: 2.5;Karpas-707: 1.2;NB-4: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (3.58e-4)" "unprognostic (7.64e-3)" "unprognostic (7.47e-3)" "unprognostic (2.11e-2)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (9.48e-2)" "unprognostic (5.70e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (4.46e-2)" "unprognostic (9.50e-2)" "unprognostic (4.48e-2)" "unprognostic (5.69e-3)" "unprognostic (3.30e-1)" "unprognostic (1.44e-5)" "unprognostic (9.22e-2)" 0.7 3.4 1.9 1.3 3.2 2.0 0.8 2.5 4.1 0.6 4.2 0.8 0.3 0.2 0.0 0.7 0.4 0.7 0.4 2.9 6.0 0.2 2.6 0.7 0.9 4.6 4.1 1.8 0.2 0.2 0.4 0.2 4.6 4.8 0.3 0.5 0.3 0.3 1.4 0.1 0.1 1.5 0.8 5.7 1.4 0.6 55.6 4.0 0.6 0.2 0.5 0.4 0.4 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 7.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 62.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.3 0.3 0.6 0.0 0.6 1.9 3.2 2.5 4.1 2.9 6.0 4.6 4.1 1.8 4.8 5.7 4.0 6.7 1.0 0.0 2.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 272.5 0.0 0.0 5.1 0.0 2.7 0.7 0.2 1.9 0.3 0.0 0.0 0.0 0.0 5.3 1.2 236.3 0.0 0.7 0.0 0.0 161.3 0.0 118.9 3.7 59.5 0.0 29.0 1.3 0.5 0.0 0.5 4.4 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.0 0.3 13.1 0.0 0.1 198.3 2.6 0.1 0.0 2.9 0.7 0.2 0.0 0.1 CLCC1 MCLC ENSG00000121940 "Chloride channel CLIC like 1" Q96S66 1 108927361-108963504 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009087, HPA013210" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA009087: AB_1078532, HPA013210: AB_1846895" "unprognostic (2.95e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-1)" "unprognostic (2.40e-2)" "unprognostic (1.45e-1)" "unprognostic (5.30e-2)" "unprognostic (9.23e-2)" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (7.50e-2)" "unprognostic (1.74e-1)" "unprognostic (2.04e-1)" "unprognostic (4.68e-3)" "unprognostic (9.65e-2)" 14.8 16.7 9.6 11.5 13.5 6.2 16.5 10.3 11.8 17.0 7.1 14.2 13.3 17.2 24.5 10.0 15.2 14.1 18.5 9.9 10.6 11.1 22.3 13.1 10.6 12.5 10.5 9.5 18.7 25.0 21.4 18.5 17.9 11.3 20.3 13.3 11.9 22.5 20.2 27.4 10.4 12.8 15.0 9.6 11.6 16.3 7.7 10.4 5.3 22.1 25.1 10.9 15.4 13.5 15.7 44.2 22.3 25.1 45.8 36.7 33.9 35.6 43.8 34.2 30.1 34.2 22.6 21.0 10.8 43.7 33.3 18.5 17.1 23.9 16.1 39.4 38.0 23.2 30.4 24.7 23.5 28.9 28.7 28.2 25.2 21.9 33.2 25.7 28.3 27.1 12.1 38.6 47.7 22.1 18.9 2.3 10.1 21.5 16.6 19.8 24.5 13.1 31.2 24.3 30.5 15.9 22.7 46.9 49.6 38.9 18.9 15.9 19.7 26.7 38.3 27.7 35.1 38.4 32.1 33.3 17.1 44.7 21.8 82.5 4.1 5.6 6.1 5.6 8.4 6.1 6.1 4.5 4.4 5.6 3.2 4.9 4.5 1.4 4.7 12.4 6.4 6.8 4.4 9.6 13.5 10.3 11.8 9.9 10.6 12.5 10.5 9.5 11.3 9.6 10.4 15.7 13.3 25.6 20.9 26.8 11.8 3.7 14.0 11.7 1.8 12.3 11.8 9.1 5.9 20.0 18.0 11.0 29.2 28.7 9.0 7.1 0.0 18.6 6.7 8.1 21.3 10.9 3.6 5.9 25.0 21.1 12.8 19.5 10.7 13.5 12.0 16.3 9.7 22.3 13.1 21.9 30.3 9.0 16.2 6.7 5.1 2.8 19.9 9.3 8.8 14.0 12.0 11.4 3.1 35.7 39.3 17.7 3.8 18.8 17.7 17.7 7.2 5.0 14.9 18.9 19.7 18.6 10.7 5.5 5.4 6.4 6.3 18.5 8.4 12.5 9.8 9.9 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.3;tongue: 54.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 133.5;Oligodendrocyte precursor cells: 134.7;Oligodendrocytes: 127.4;Syncytiotrophoblasts: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;T-reg: 1.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;T-cells: 1.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol NA Yes Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favorable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavorable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 4.6 3.6 27.5 4.5 37.3 14.5 7.6 33.2 25.0 8.3 10.5 14.6 9.2 6.8 2.6 34.4 4.3 2.7 3.4 22.5 28.6 2.3 2.9 9.0 6.5 35.4 35.7 17.8 3.4 3.7 9.8 3.1 7.8 32.7 6.0 15.3 8.7 10.2 4.7 10.8 38.0 11.6 10.6 34.9 2.7 5.1 11.6 36.1 18.6 3.2 54.9 13.3 6.1 17.9 47.3 135.6 16.2 36.8 27.7 36.4 20.2 30.0 24.2 61.4 29.9 45.4 16.0 31.7 30.5 6.7 33.4 21.0 28.3 25.3 59.1 39.6 30.7 15.8 19.8 34.7 16.5 4.8 28.6 18.5 4.1 113.9 29.4 129.8 9.4 26.9 19.5 14.9 42.3 58.4 37.8 26.1 12.2 8.7 52.1 29.4 20.1 66.7 6.6 24.3 18.6 30.4 26.9 37.0 69.2 26.9 10.3 27.6 24.3 18.0 21.7 36.7 64.8 48.5 18.4 20.9 28.6 34.3 47.4 108.9 0.1 0.3 3.2 0.2 0.3 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.3 0.3 0.1 0.1 0.1 1.8 0.1 27.5 37.3 33.2 25.0 22.5 28.6 35.4 35.7 17.8 32.7 34.9 36.1 47.3 4.6 16.0 3.3 63.0 5.7 62.7 18.8 12.9 47.3 47.7 3.0 3.7 2.5 2.8 12.5 7.3 133.5 46.3 6.7 10.8 11.7 2.5 54.0 5.2 20.6 5.1 9.1 33.9 11.7 1.9 47.7 19.5 8.6 9.2 2.5 14.4 2.9 1.6 9.0 43.7 24.0 14.1 10.2 5.3 11.3 21.3 18.6 4.9 26.6 3.7 5.3 8.0 2.1 134.7 127.4 4.8 7.8 5.3 5.3 5.6 8.4 0.9 9.0 48.1 0.0 43.6 6.9 20.6 28.9 24.0 40.6 89.2 7.1 10.0 18.7 15.5 GTDC1 "FLJ11753, Hmat-Xa" ENSG00000121964 "Glycosyltransferase like domain containing 1" Q4AE62 2 143938068-144332568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 330.7;Inhibitory neurons: 188.0;Microglial cells: 130.2;Oligodendrocyte precursor cells: 196.6;Oligodendrocytes: 399.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036694 Approved Cytosol NA NA Cytosol "HPA036694: AB_10671709" "unprognostic (1.44e-1)" "unprognostic (1.22e-1)" "unprognostic (9.00e-3)" "unprognostic (3.36e-2)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-7)" "unprognostic (8.01e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-3)" "unprognostic (6.96e-2)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.44e-1)" "unprognostic (8.23e-2)" "unprognostic (6.31e-3)" "unprognostic (1.89e-1)" 15.3 12.7 16.7 7.6 18.1 14.4 9.4 12.3 21.1 11.9 6.5 7.2 4.2 6.7 9.4 7.5 5.9 10.2 15.9 17.1 14.2 9.7 6.7 7.9 11.1 16.0 15.5 15.3 12.1 7.3 7.4 4.2 9.6 16.4 6.2 6.7 7.7 6.2 5.8 10.1 5.0 4.8 6.0 19.4 13.6 5.2 12.4 15.1 8.8 10.6 11.4 11.7 9.6 5.5 24.0 6.9 2.8 20.0 3.7 20.1 18.4 6.0 4.7 11.9 10.3 14.2 3.1 6.3 14.8 3.3 8.5 6.6 1.9 4.0 7.1 21.9 19.2 4.7 23.0 2.6 3.3 8.3 9.4 12.0 12.8 17.1 11.1 16.2 7.0 14.9 6.1 4.2 16.8 23.7 3.2 2.5 10.3 5.7 5.3 4.5 7.0 10.4 4.0 11.4 14.0 10.2 7.9 9.1 7.7 9.3 12.4 5.1 10.5 9.2 11.4 8.3 5.1 6.0 10.6 0.0 8.5 6.6 6.2 15.6 2.3 2.6 7.9 5.5 2.4 11.8 4.3 3.6 9.3 2.1 3.5 0.8 5.9 11.3 8.5 2.7 0.7 5.1 3.6 16.7 18.1 12.3 21.1 17.1 14.2 16.0 15.5 15.3 16.4 19.4 15.1 24.0 7.7 9.6 23.2 82.3 11.2 7.1 4.4 6.4 4.0 20.4 5.2 5.0 18.5 4.3 14.9 5.5 4.2 4.1 13.6 6.1 5.9 4.5 9.9 3.3 11.4 9.6 4.2 9.4 330.7 10.5 5.2 16.0 4.6 5.6 17.7 15.5 20.3 3.8 10.2 18.5 188.0 3.2 4.1 18.3 11.8 7.7 12.8 16.4 5.4 130.2 11.6 10.8 18.6 196.6 399.6 9.4 4.0 13.9 8.6 4.2 2.6 7.7 13.4 3.9 13.1 25.2 17.0 5.4 23.5 4.9 4.7 4.2 19.7 14.8 3.7 8.7 CXCR4 "CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R" ENSG00000121966 "C-X-C motif chemokine receptor 4" P61073 2 136114349-136118149 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1185.4;lymphoid tissue: 553.9" "Cell type enhanced" "Detected in many" "B-cells: 1446.9;dendritic cells: 1015.1;Langerhans cells: 486.2;Macrophages: 513.6;Plasma cells: 534.2;T-cells: 1436.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 580.8;JURKAT: 323.6;Karpas-707: 302.1;MOLT-4: 538.9;REH: 281.0;U-266/70: 648.5;U-698: 677.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (5.97e-2)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (4.99e-2)" "unprognostic (9.25e-2)" "unprognostic (6.06e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.23e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.41e-7)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.57e-1)" "unprognostic (3.47e-2)" "unprognostic (9.33e-2)" 38.8 186.2 13.7 300.6 14.9 1185.4 40.1 17.5 25.0 36.4 21.5 33.5 12.7 35.6 5.6 35.2 65.5 85.3 17.6 12.9 25.7 28.5 52.8 96.4 387.0 27.3 15.2 10.7 13.0 10.1 12.4 32.8 58.0 18.9 34.5 49.0 7.9 30.4 11.9 5.3 8.7 248.6 28.4 20.0 349.3 64.6 4.1 16.3 495.7 37.1 12.1 553.9 100.3 27.1 30.1 0.8 0.3 9.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 580.8 1.8 0.0 0.4 0.7 1.7 0.0 0.0 29.6 6.9 35.1 84.3 0.0 0.0 81.5 60.7 0.0 0.0 0.0 0.0 0.0 54.5 323.6 1.0 302.1 0.0 1.5 538.9 72.8 9.3 45.4 2.9 281.0 62.6 102.5 4.5 0.0 30.9 26.1 0.6 2.0 0.3 2.9 0.7 156.7 8.1 0.0 2.0 0.5 0.4 648.5 116.7 677.4 0.1 131.8 0.1 87.0 28.5 117.8 83.8 15.6 67.3 115.6 76.5 79.6 25.7 166.2 113.1 109.5 143.3 17.2 9.1 63.7 76.1 51.9 13.7 14.9 17.5 25.0 12.9 25.7 27.3 15.2 10.7 18.9 20.0 16.3 30.1 32.0 16.0 42.2 8.5 1446.9 41.0 5.7 0.3 9.6 8.6 46.1 42.2 5.2 11.5 4.4 3.7 0.0 1.5 1015.1 1.1 13.7 5.1 1.2 20.0 8.9 67.6 1.8 67.5 0.0 0.9 4.2 28.9 52.0 71.0 12.6 9.0 29.6 9.1 159.9 0.0 0.2 2.0 10.2 270.0 486.2 2.9 1.5 513.6 113.8 3.7 189.2 1.0 153.5 0.0 2.0 2.3 1.1 2.6 534.2 3.2 0.0 3.2 2.4 0.8 46.0 99.1 23.1 0.5 7.8 8.5 35.7 6.3 1436.5 4.6 1.8 4.5 ZRANB3 "AH2, DKFZP434B1727" ENSG00000121988 "Zinc finger RANBP2-type containing 3" Q5FWF4 2 135136916-135531218 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Astrocytes: 34.9;Excitatory neurons: 69.4;Inhibitory neurons: 46.2;Oligodendrocytes: 67.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035234 Supported Nucleoplasm NA NA Nucleoplasm "HPA035234: AB_2674530" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (2.52e-3)" "unprognostic (4.09e-1)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (3.53e-3)" "unprognostic (1.74e-1)" "unprognostic (3.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.77e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.00e-2)" "unprognostic (9.88e-2)" 0.8 1.4 0.5 0.9 0.7 1.1 0.8 0.3 0.9 0.9 0.2 0.7 0.5 0.9 0.5 0.7 0.9 0.7 0.7 0.6 0.5 0.6 1.1 0.6 0.6 0.4 0.2 0.6 1.5 1.3 0.6 1.4 0.5 0.4 0.9 0.4 1.5 0.7 0.5 2.0 0.8 0.6 0.4 0.0 0.8 0.7 3.2 0.3 0.8 1.0 0.6 0.4 0.8 0.8 0.8 0.9 0.9 1.7 1.1 0.8 1.5 1.5 1.3 0.9 0.9 1.1 1.5 0.7 2.8 1.3 1.0 0.6 0.9 2.4 1.1 1.6 2.5 1.8 3.2 0.4 3.5 0.6 2.5 0.6 1.3 1.0 1.3 3.2 1.5 1.3 1.6 3.1 1.3 0.7 1.3 1.5 1.4 1.1 0.8 1.1 1.8 1.3 1.0 1.3 0.6 1.8 2.3 1.1 0.5 0.9 1.6 0.9 1.1 1.0 0.7 0.6 0.4 0.8 1.1 1.4 2.6 1.0 1.7 1.0 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.5 0.7 0.3 0.9 0.6 0.5 0.4 0.2 0.6 0.4 0.0 0.3 0.8 1.7 3.2 1.5 34.9 7.3 1.3 4.5 4.5 8.0 5.8 2.8 2.3 3.3 2.8 4.3 0.0 8.4 5.7 2.0 0.5 0.0 2.0 16.9 3.2 5.0 1.9 1.8 10.1 69.4 0.9 8.3 4.7 1.5 3.5 0.0 9.1 1.8 8.9 2.5 5.0 46.2 1.2 4.1 0.8 1.5 4.5 3.1 2.3 0.0 26.2 2.9 2.7 2.1 24.6 67.0 1.4 1.7 2.2 4.7 2.1 0.4 4.5 1.6 7.5 0.0 8.3 3.4 14.1 10.3 4.8 2.3 3.8 3.9 10.8 2.6 3.0 ACVR2A "ACTRII, ACVR2" ENSG00000121989 "Activin A receptor type 2A" P27037 2 147844517-147930826 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 62.5;Inhibitory neurons: 63.4;Oligodendrocyte precursor cells: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 26.3;RH-30: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046997 Approved Approved Cytosol NA NA Cytosol "HPA046997: AB_10970077" "unprognostic (4.55e-2)" "unprognostic (2.26e-2)" "unprognostic (2.09e-1)" "unprognostic (7.34e-3)" "unprognostic (2.75e-1)" "unprognostic (1.17e-1)" "unprognostic (4.41e-3)" "unprognostic (8.73e-3)" "unprognostic (1.30e-2)" "unprognostic (3.61e-1)" "unprognostic (1.34e-2)" "unprognostic (1.52e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.95e-1)" "unprognostic (3.99e-2)" 6.9 4.1 6.2 4.7 8.0 3.4 7.0 11.6 6.5 4.7 2.0 6.4 7.7 5.2 6.6 7.3 4.6 7.8 3.7 7.4 7.1 5.7 7.4 4.7 3.2 3.2 4.4 6.5 4.5 4.4 4.4 3.9 7.8 4.7 6.8 6.5 8.3 7.5 5.3 17.7 19.3 9.4 7.0 3.8 4.0 6.9 6.4 7.4 2.3 6.8 6.4 4.0 7.4 7.5 6.1 1.8 2.1 13.2 5.0 7.3 4.7 5.4 4.1 5.0 6.9 12.0 5.8 8.1 0.1 3.6 6.7 2.5 6.2 12.0 6.1 8.8 1.4 7.3 0.9 3.6 10.2 26.3 1.0 0.9 8.1 7.3 4.5 8.9 5.2 5.3 1.6 2.0 3.5 4.7 4.8 0.4 0.8 14.9 5.5 3.6 0.2 23.3 1.3 5.6 11.5 13.0 7.3 3.5 4.2 5.4 5.6 2.5 1.4 4.1 6.4 7.5 6.1 2.9 1.0 0.3 2.4 3.9 0.5 5.2 0.2 1.7 0.2 0.6 2.0 0.2 0.1 2.4 1.1 1.3 0.3 1.5 0.3 0.0 4.8 2.0 1.7 0.2 0.7 6.2 8.0 11.6 6.5 7.4 7.1 3.2 4.4 6.5 4.7 3.8 7.4 6.1 13.7 6.4 7.0 26.8 1.5 29.7 6.9 9.5 13.1 15.4 6.8 12.4 7.9 17.2 10.7 7.3 14.6 4.9 6.0 16.5 1.9 6.3 5.3 6.4 12.2 11.9 9.0 0.0 62.5 6.3 2.5 17.4 6.6 5.7 0.0 2.2 11.7 12.1 5.4 11.8 63.4 12.9 8.2 7.3 18.9 2.1 9.9 5.7 10.6 33.7 7.2 3.3 6.2 84.9 34.1 7.6 10.0 11.3 5.2 7.7 23.7 5.8 10.2 9.4 32.9 8.3 10.9 18.2 14.1 14.4 29.8 5.3 5.9 2.9 11.7 11.8 POLK "DINB1, DINP, POLQ" ENSG00000122008 "DNA polymerase kappa" Q9UBT6 5 75511756-75601144 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 236.8;Oligodendrocytes: 159.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012035, HPA057303, HPA068117, HPA069375" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131" "unprognostic (9.66e-2)" "unprognostic (5.29e-2)" "unprognostic (5.37e-2)" "unprognostic (2.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.65e-2)" "unprognostic (6.29e-3)" "unprognostic (2.42e-1)" "unprognostic (5.93e-2)" "unprognostic (1.80e-2)" "unprognostic (9.96e-3)" "unprognostic (1.58e-1)" "unprognostic (9.64e-2)" "unprognostic (2.02e-1)" 4.7 4.3 2.7 3.7 5.6 2.7 5.4 7.6 5.4 6.9 3.0 3.1 2.4 6.3 4.6 3.4 4.0 3.7 4.7 3.5 5.0 4.8 5.0 5.0 4.0 5.4 5.1 1.4 6.0 4.4 5.6 3.2 6.3 5.7 4.3 3.1 5.3 4.2 3.9 4.6 4.1 3.1 4.2 3.7 5.7 3.7 3.1 4.3 4.0 7.6 3.3 3.6 3.3 3.9 11.0 6.7 6.7 4.1 5.3 5.3 10.5 3.5 12.5 8.8 9.5 9.8 4.3 5.2 6.9 10.0 8.3 6.2 2.5 3.8 4.3 11.4 7.6 4.5 6.3 5.7 2.1 10.1 4.0 4.9 5.0 5.1 7.7 5.3 7.6 8.0 4.4 5.6 3.9 9.1 0.5 7.9 3.2 1.5 0.7 3.9 3.3 10.6 4.8 5.7 2.2 4.1 4.6 9.4 2.5 3.4 2.8 3.7 3.8 10.4 6.9 3.6 3.3 7.2 4.5 4.4 6.0 4.6 6.2 12.2 5.8 5.3 2.7 2.4 6.0 2.0 5.1 2.6 3.0 4.8 4.1 3.2 2.2 4.6 3.9 11.5 5.8 3.4 2.0 2.7 5.6 7.6 5.4 3.5 5.0 5.4 5.1 1.4 5.7 3.7 4.3 11.0 45.8 32.1 44.6 65.6 36.3 14.7 21.8 22.1 20.5 32.9 19.5 15.0 21.8 24.3 26.1 29.5 20.9 17.3 37.5 8.3 23.5 20.3 236.8 19.5 32.1 34.4 14.9 29.2 63.5 15.8 13.0 33.7 17.3 21.0 51.9 33.8 57.1 25.0 21.8 65.6 60.0 11.3 24.4 39.2 25.0 58.7 37.6 33.3 23.2 73.1 55.8 19.6 25.7 84.4 159.6 19.1 15.1 38.4 26.4 14.6 17.8 21.2 20.8 38.8 6.6 38.5 27.8 61.3 23.6 14.5 12.9 6.7 27.6 48.8 12.2 11.6 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083383-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 36.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 85.0;Inhibitory neurons: 82.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.0 1.2 8.3 0.2 27.8 0.1 0.2 11.0 32.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 1.7 24.2 0.0 0.0 0.0 0.0 23.4 36.2 1.7 0.5 0.1 0.0 0.4 0.0 28.4 0.1 0.2 4.3 0.3 0.2 0.0 0.0 0.2 0.2 10.2 0.0 0.5 0.1 18.7 0.0 0.0 0.0 0.0 0.0 0.1 15.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 8.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 27.8 11.0 32.2 1.7 24.2 23.4 36.2 1.7 28.4 10.2 18.7 15.5 0.5 0.0 0.0 5.5 0.1 0.0 0.7 0.4 0.0 5.4 0.7 0.1 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 2.5 0.6 0.4 19.8 0.0 85.0 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.7 0.0 0.1 0.0 82.6 0.6 2.0 0.6 0.3 0.8 0.0 0.2 3.6 2.8 0.0 1.0 0.0 3.0 3.1 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.1 5.6 0.0 0.2 0.4 0.2 0.7 0.0 0.1 0.0 0.2 0.8 0.2 1.5 FLT3 "CD135, FLK2, STK1" ENSG00000122025 "Fms related receptor tyrosine kinase 3" P36888 13 28003274-28100592 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.3;brain: 4.9;lymphoid tissue: 6.5" "Cell type enhanced" "Detected in some" "dendritic cells: 24.4;Inhibitory neurons: 59.9;Kupffer cells: 29.1;Langerhans cells: 21.4;Macrophages: 16.9;monocytes: 39.5" "Cancer enhanced" "Detected in some" "breast cancer: 1.8" "Region enhanced" "Detected in some" "cerebellum: 4.9" "Group enriched" "Detected in many" 13 "myeloid DC: 68.7;plasmacytoid DC: 26.2" "Lineage enriched" "Detected in many" 19 "dendritic cells: 68.7" "Group enriched" "Detected in some" 11 "REH: 42.5;THP-1: 26.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047539 Approved "Endoplasmic reticulum" NA NA 210000 "Endoplasmic reticulum" "HPA047539: AB_2680080" "unprognostic (2.19e-3)" "unprognostic (3.16e-3)" "unprognostic (6.54e-3)" "unprognostic (9.96e-2)" "unprognostic (3.88e-1)" "unprognostic (3.96e-7)" "unprognostic (7.99e-3)" "unprognostic (1.65e-2)" "unprognostic (5.37e-2)" "unprognostic (1.01e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (3.65e-1)" "unprognostic (3.91e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" 0.5 0.1 0.4 3.0 0.3 5.3 1.5 4.9 0.8 0.5 0.2 0.7 0.3 0.2 0.1 0.6 0.4 1.6 0.1 0.2 0.5 1.5 0.5 0.7 6.5 1.2 0.9 0.2 0.1 2.8 0.0 0.0 0.0 1.7 0.1 0.8 0.1 0.4 0.2 0.0 0.7 1.6 0.8 0.8 5.7 0.6 0.6 0.8 4.7 0.1 0.3 3.6 1.3 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.2 0.6 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.6 3.4 0.0 0.8 0.0 0.2 0.0 0.0 68.7 0.0 0.0 0.0 0.1 2.0 0.0 26.2 0.0 2.7 0.4 0.3 4.9 0.8 0.2 0.5 1.2 0.9 0.2 1.7 0.8 0.8 1.2 0.0 0.0 0.0 2.3 1.5 0.3 0.0 0.0 0.0 0.0 1.5 1.0 0.4 1.5 0.0 0.0 0.0 0.0 24.4 0.0 0.0 2.7 3.7 0.3 0.1 0.2 0.0 8.2 7.4 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.7 0.1 0.5 0.0 59.9 0.0 0.0 29.1 21.4 2.3 0.0 16.9 1.8 1.9 39.5 0.0 0.0 1.5 4.2 0.1 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.6 0.0 0.6 0.0 1.7 0.0 0.0 0.0 RPL21 "DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252" ENSG00000122026 "Ribosomal protein L21" P46778 13 27251309-27256691 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047252 Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 34000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA047252: AB_2680000" "unprognostic (4.79e-2)" "unprognostic (3.69e-2)" "unprognostic (1.99e-1)" "unprognostic (2.31e-1)" "unprognostic (3.57e-1)" "unprognostic (1.90e-3)" "unprognostic (2.55e-2)" "unprognostic (7.72e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.47e-2)" "unprognostic (4.53e-2)" "unprognostic (4.83e-3)" "unprognostic (1.28e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-1)" 1535.6 1051.1 1086.6 720.7 1096.8 2313.1 1703.9 1063.6 1962.5 1965.9 1065.6 1592.6 630.7 1340.2 732.0 1517.1 1732.9 558.4 1306.2 1044.6 1111.4 1348.8 1094.8 1191.6 1647.2 1102.6 1080.3 1029.9 3126.5 2470.4 518.9 1055.2 631.8 1106.5 1392.8 811.0 422.7 1336.2 649.3 1870.5 1883.8 1484.0 599.4 1111.3 1808.5 1500.1 319.8 1108.7 1082.7 1124.2 776.4 1406.7 1645.3 1664.9 1112.4 942.9 772.1 1337.0 1086.2 1361.4 2569.1 1130.1 1664.7 1515.8 1277.2 822.1 1875.1 1700.0 3578.7 627.8 1332.5 571.7 1220.3 1552.8 1694.0 1495.8 1139.5 1410.3 2803.5 738.9 1470.3 1284.7 3871.3 1063.8 2304.6 2722.2 837.5 2112.0 1751.9 1454.0 1562.9 1181.8 865.5 1468.6 1340.3 1970.6 2398.9 1754.3 2792.4 1281.4 1446.1 2566.6 1511.2 1201.2 1111.2 1153.8 1071.6 773.3 1531.6 1390.1 1120.4 1033.9 3406.6 1619.7 563.1 731.3 895.3 1384.6 579.7 874.2 2583.3 722.1 2415.5 978.6 948.5 1201.5 493.2 1996.0 1257.2 3233.0 3717.7 2993.5 2504.4 1607.9 3347.5 4294.2 3510.3 249.1 2178.4 1308.5 2181.4 2271.1 6723.7 1086.6 1096.8 1063.6 1962.5 1044.6 1111.4 1102.6 1080.3 1029.9 1106.5 1111.3 1108.7 1112.4 1464.4 1685.9 2658.5 9.4 6395.0 7645.1 5673.8 7552.7 1649.3 375.0 4496.8 3380.2 191.6 4000.5 3789.8 1565.1 143.9 5240.1 4382.0 1695.3 5290.4 3849.1 74.4 1089.9 2417.7 2670.0 2385.5 4124.1 9.0 7829.6 6183.8 2401.4 924.6 1200.5 2817.5 2227.4 4446.9 4944.4 3952.9 159.9 10.1 4869.4 2518.7 7461.4 9266.1 225.9 3957.2 3114.0 5229.4 7.5 9465.6 1525.3 6167.9 8.5 14.1 4983.3 3923.7 2403.1 2133.1 4379.8 4261.8 6230.7 1742.7 634.1 1899.8 4878.6 2645.8 650.7 1016.0 2107.5 8226.2 5507.4 5413.5 1829.5 5416.3 4837.4 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 610.0;Proximal tubular cells: 475.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favorable (8.41e-4)" 58.2 55.5 66.4 29.5 66.7 17.2 51.5 67.7 94.2 36.9 67.4 45.0 43.2 28.7 67.7 40.2 30.7 37.3 115.5 65.8 66.9 63.7 66.0 29.5 44.9 67.3 67.5 63.6 37.4 54.9 43.7 51.2 31.1 68.2 45.7 45.0 75.4 83.6 44.3 91.6 40.2 42.1 30.8 66.0 50.0 48.5 62.3 66.5 47.7 37.2 110.7 46.5 37.1 34.3 69.1 29.9 21.9 48.5 23.5 53.2 78.8 22.6 44.0 51.1 33.8 33.8 28.3 37.5 33.3 28.4 50.8 22.8 25.1 27.2 37.1 46.3 34.3 31.2 42.6 19.1 36.7 52.2 43.8 38.8 44.6 65.5 27.7 35.1 75.6 60.0 33.8 24.0 13.6 51.2 54.0 39.7 54.2 24.4 100.1 24.0 22.8 24.3 37.5 69.8 31.3 32.9 20.6 28.4 39.1 50.7 51.8 31.3 62.5 38.1 21.4 12.5 56.1 29.5 10.0 14.9 19.1 21.5 44.3 31.1 85.8 53.0 75.4 30.8 51.2 32.9 49.1 38.9 31.1 55.2 42.8 34.0 35.2 36.5 37.2 48.3 88.2 47.4 41.3 66.4 66.7 67.7 94.2 65.8 66.9 67.3 67.5 63.6 68.2 66.0 66.5 69.1 88.5 28.9 47.4 29.0 74.0 34.0 34.0 103.9 43.9 0.0 91.6 95.4 179.1 87.2 76.3 115.8 0.0 102.6 60.4 102.2 326.8 89.6 610.0 93.7 63.4 70.3 64.1 59.7 22.8 104.1 67.0 62.7 47.4 74.5 71.7 50.6 79.9 223.0 102.3 0.0 26.4 112.8 103.7 114.8 50.2 283.4 139.8 67.7 106.7 24.4 106.4 0.0 80.3 30.7 43.7 98.3 108.8 124.8 71.1 43.7 142.8 475.5 83.2 0.0 124.9 48.8 69.2 243.6 87.6 62.8 42.5 56.8 58.5 69.6 96.8 44.8 GTF3A "AP2, TFIIIA" ENSG00000122034 "General transcription factor IIIA" Q92664 13 27424619-27435823 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007990 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007990: AB_1857960" "unprognostic (9.88e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (8.64e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (1.98e-1)" "unprognostic (1.33e-1)" "unprognostic (3.26e-1)" "unprognostic (1.41e-1)" 64.1 40.7 55.3 50.8 56.5 86.0 59.9 56.8 60.9 32.2 54.4 39.5 30.5 26.8 57.9 38.6 33.1 33.7 127.9 57.0 55.7 53.0 130.9 33.5 81.8 57.3 57.3 54.3 16.1 117.3 34.8 27.1 28.6 56.4 31.0 40.8 10.4 71.0 35.1 90.0 25.0 32.6 38.4 59.0 55.0 47.4 17.5 59.5 112.6 31.4 133.8 90.5 46.5 23.9 59.1 91.2 78.8 65.4 136.8 90.4 98.8 93.3 95.1 86.0 118.3 75.4 118.5 139.4 275.3 65.9 112.6 73.9 64.9 136.6 131.0 165.8 289.2 93.1 229.9 71.6 135.4 102.5 432.3 150.9 81.5 137.9 109.2 142.4 81.8 107.2 246.9 184.2 88.6 140.5 178.3 311.3 467.9 115.8 299.6 210.7 154.8 169.3 254.0 142.5 39.2 158.9 81.5 67.6 101.6 141.7 83.7 73.7 223.6 66.0 62.5 67.1 49.3 99.1 57.0 104.9 275.1 67.1 264.9 117.4 116.8 173.8 162.5 250.2 180.1 335.2 290.5 251.6 271.7 218.4 250.3 192.5 219.6 38.3 243.7 169.5 298.3 345.1 484.4 55.3 56.5 56.8 60.9 57.0 55.7 57.3 57.3 54.3 56.4 59.0 59.5 59.1 96.9 44.8 33.0 15.0 183.3 63.2 62.4 109.1 56.3 41.7 107.2 117.6 207.8 91.5 58.3 27.6 29.2 76.3 207.1 20.0 150.6 195.7 33.9 60.1 68.1 76.3 34.8 126.4 28.7 190.6 187.4 75.0 63.2 49.1 75.5 93.0 40.0 146.7 215.5 35.3 25.8 60.6 77.3 156.1 119.3 85.6 63.6 133.9 97.8 15.9 185.3 73.1 236.9 7.1 24.3 153.3 28.9 58.3 248.4 122.7 35.6 207.7 37.9 35.7 85.5 58.3 76.1 34.8 145.1 83.4 64.4 42.1 187.1 89.0 69.8 70.3 RASL11A ENSG00000122035 "RAS like family 11 member A" Q6T310 13 27270830-27275192 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "ASC diff: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004859, HPA053296" Supported Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA004859: AB_2667270, HPA053296: AB_2682106" "unprognostic (1.59e-1)" "unprognostic (9.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (6.65e-2)" "prognostic favorable (5.43e-4)" "unprognostic (3.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.65e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (3.71e-2)" "unprognostic (3.34e-1)" 29.4 4.1 2.0 3.1 3.3 2.3 22.0 3.2 3.2 20.9 2.2 19.5 7.8 21.8 4.0 9.9 22.2 3.8 9.7 3.0 8.4 24.5 13.0 13.1 10.9 1.8 2.4 1.5 9.6 5.0 1.4 10.7 3.0 2.2 20.5 12.6 0.1 5.4 5.6 3.5 9.5 21.1 5.6 2.1 15.0 13.5 2.9 3.2 1.3 12.2 1.8 10.1 19.3 16.1 2.5 0.3 1.3 0.3 0.6 42.4 4.3 0.2 1.9 1.8 0.1 0.1 8.1 0.8 0.3 0.5 1.4 0.9 0.1 2.5 0.8 0.1 1.7 8.8 1.8 0.2 0.5 6.8 0.6 0.6 5.0 0.7 0.1 0.1 1.7 0.6 0.7 0.3 0.1 0.0 0.8 0.0 2.4 1.5 8.0 10.2 0.5 0.0 0.2 1.4 6.2 0.7 0.3 0.7 3.3 0.2 1.0 0.2 0.8 0.3 0.1 0.3 2.9 0.4 0.1 0.0 0.0 0.4 1.9 0.1 0.4 0.4 0.4 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.2 0.1 0.1 0.2 0.1 1.3 0.1 0.0 0.1 2.0 3.3 3.2 3.2 3.0 8.4 1.8 2.4 1.5 2.2 2.1 3.2 2.5 29.6 16.0 11.2 0.3 6.0 4.6 3.2 0.9 17.6 0.0 6.2 11.9 1.4 0.0 8.6 7.3 0.0 0.7 4.5 9.3 3.9 1.8 0.0 5.1 9.8 5.9 0.0 4.0 0.6 2.4 0.2 30.1 42.3 6.1 0.0 2.1 2.5 0.2 1.4 0.0 0.6 5.6 4.1 0.8 6.5 0.0 0.3 6.1 1.8 1.9 1.7 0.3 0.0 0.5 1.8 0.5 12.7 1.5 17.1 1.1 11.4 1.7 10.3 0.2 32.9 11.6 112.0 0.0 0.0 13.5 4.4 0.8 4.5 1.2 6.7 1.1 UBL3 "DKFZP434K151, FLJ32018, HCG-1, PNSC1" ENSG00000122042 "Ubiquitin like 3" O95164 13 29764371-29850617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 350.5;Late spermatids: 316.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBF TERT88: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053772, HPA058781" Uncertain Approved Centrosome NA NA Centrosome "HPA053772: AB_2682258, HPA058781: AB_2683818" "unprognostic (2.83e-2)" "unprognostic (5.48e-2)" "unprognostic (3.20e-1)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (3.22e-1)" "unprognostic (3.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "prognostic favorable (4.23e-4)" "unprognostic (8.49e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.84e-1)" 23.5 20.9 43.9 18.0 53.7 22.4 29.6 62.9 45.4 38.6 31.1 28.8 28.0 42.8 25.9 43.2 27.4 31.8 20.7 43.5 57.2 35.4 42.1 37.3 19.4 54.6 60.2 34.9 31.0 56.3 30.2 17.3 22.8 53.6 22.7 28.0 47.6 29.5 23.0 30.0 24.3 29.2 31.0 61.2 25.4 73.5 22.7 52.6 21.7 40.8 35.9 19.1 19.7 23.8 66.6 12.5 7.8 23.9 14.5 33.0 31.7 25.3 101.2 59.2 42.5 34.0 18.6 27.7 10.9 22.3 101.3 19.7 12.2 11.0 15.1 121.0 17.3 13.5 11.5 9.9 15.0 10.4 17.0 14.8 18.8 48.2 22.4 14.3 36.7 15.5 12.9 5.8 7.7 18.1 84.5 12.8 14.3 14.3 29.3 11.1 14.5 30.8 12.5 28.2 14.7 27.8 13.9 14.3 49.0 106.8 50.6 26.4 28.6 13.4 54.7 13.6 30.3 13.8 17.7 7.4 8.2 19.4 14.4 37.0 10.4 11.2 10.0 10.7 11.4 5.0 2.9 13.5 10.5 10.9 4.1 7.6 9.5 11.2 6.9 13.0 5.1 34.7 9.1 43.9 53.7 62.9 45.4 43.5 57.2 54.6 60.2 34.9 53.6 61.2 52.6 66.6 60.7 192.3 46.2 58.4 47.0 77.0 99.6 30.6 57.5 166.8 47.3 29.6 35.6 70.1 63.3 36.8 77.2 17.2 55.2 81.8 92.0 36.7 350.5 113.7 66.4 44.0 60.6 8.6 77.2 37.3 87.9 73.0 154.5 103.6 14.5 16.4 35.0 58.0 39.1 95.9 95.1 58.8 42.7 60.0 92.1 316.1 34.8 69.4 97.8 91.8 56.6 174.9 38.1 97.0 214.1 60.9 34.8 33.1 58.3 65.9 45.1 50.8 80.4 67.9 19.7 91.0 49.6 72.5 24.5 55.2 80.0 29.6 56.8 76.5 43.8 104.0 FYTTD1 "DKFZp761B1514, UIF" ENSG00000122068 "Forty-two-three domain containing 1" Q96QD9 3 197737179-197787596 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054474, HPA074880" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA054474: , HPA074880: " "unprognostic (3.61e-2)" "unprognostic (6.01e-2)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.33e-2)" "unprognostic (3.80e-1)" "unprognostic (3.69e-2)" "unprognostic (9.57e-3)" "unprognostic (4.44e-2)" "unprognostic (1.66e-1)" "unprognostic (5.04e-3)" "unprognostic (8.74e-2)" "unprognostic (8.49e-3)" "unprognostic (3.40e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-1)" "unprognostic (3.15e-1)" 30.0 21.1 12.6 27.4 12.9 39.6 26.9 16.6 16.7 25.0 10.3 20.1 16.8 30.7 19.8 44.3 19.3 24.6 41.7 12.6 22.9 26.0 29.2 23.8 32.6 12.7 13.2 11.8 27.8 36.7 28.9 12.7 33.8 13.1 25.3 21.8 34.1 18.3 29.0 93.5 27.3 19.5 35.2 13.7 26.6 18.3 41.5 13.6 34.4 29.8 67.6 38.0 33.9 17.0 15.3 104.5 22.6 43.7 41.7 50.1 55.3 13.4 50.0 50.8 75.4 61.4 35.3 34.8 66.4 177.1 59.3 40.0 36.7 55.5 51.0 79.8 14.5 24.9 99.8 32.9 16.1 48.9 75.1 46.5 40.0 64.6 40.8 58.3 52.1 60.4 36.8 45.9 139.0 67.6 86.9 82.2 18.1 9.6 45.1 41.2 74.9 53.6 47.4 54.8 67.3 82.4 35.7 76.8 60.0 56.4 31.8 141.2 39.1 54.0 38.5 38.1 49.0 53.6 83.5 137.2 79.3 40.8 106.4 40.6 59.2 26.9 26.5 32.4 31.8 40.7 20.0 30.7 35.9 29.9 18.9 33.4 32.2 8.5 64.6 31.0 16.9 30.2 45.7 12.6 12.9 16.6 16.7 12.6 22.9 12.7 13.2 11.8 13.1 13.7 13.6 15.3 60.6 35.3 27.2 14.7 78.5 82.3 46.6 24.3 42.7 35.1 47.0 34.4 109.7 25.8 30.1 47.8 31.3 24.4 63.9 19.0 90.1 35.5 21.7 27.3 58.9 55.2 56.4 25.2 23.7 36.1 27.5 53.7 30.1 42.6 66.6 29.4 36.4 50.7 38.0 45.4 19.6 23.7 28.5 48.6 67.8 18.3 32.0 54.8 51.6 22.5 108.6 41.8 82.4 19.6 23.0 34.3 16.5 37.2 65.4 74.5 17.1 51.1 44.6 45.2 39.5 45.8 63.1 96.3 90.7 54.0 91.1 50.1 60.7 51.9 20.0 63.6 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favorable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 15.4 15.8 10.2 22.9 11.9 24.0 22.1 18.4 14.6 20.0 7.9 18.4 16.2 25.5 16.2 19.6 19.1 14.4 16.2 10.6 9.4 15.9 20.6 17.2 39.1 10.9 11.1 9.5 28.1 17.6 16.3 15.4 14.3 12.6 34.1 20.1 29.7 19.9 18.3 54.9 17.8 22.2 20.3 7.9 22.2 18.5 10.3 10.4 25.4 35.1 42.2 31.1 14.9 16.1 14.2 17.2 14.9 29.7 16.4 38.2 17.5 22.1 27.4 31.5 25.8 36.0 10.5 23.2 24.7 10.0 31.0 30.8 17.6 41.0 38.5 33.8 35.4 28.9 32.2 30.5 46.5 25.5 40.2 23.3 29.0 37.8 30.2 35.6 32.8 30.2 32.4 29.4 10.5 31.9 24.0 28.2 26.4 33.7 35.5 25.8 27.7 33.1 14.1 24.8 31.5 26.2 22.9 20.3 26.8 20.7 19.5 19.6 19.4 39.3 23.4 23.0 27.3 25.7 28.0 7.9 61.2 19.8 24.1 21.4 8.3 10.8 24.9 18.6 10.5 22.7 32.3 29.1 26.8 12.3 31.8 46.0 36.7 3.4 18.1 8.7 9.1 32.5 22.1 10.2 11.9 18.4 14.6 10.6 9.4 10.9 11.1 9.5 12.6 7.9 10.4 14.2 20.7 12.8 27.7 40.8 45.6 0.0 20.3 0.0 15.9 0.0 19.8 23.9 19.8 27.1 13.0 20.2 0.0 30.2 34.1 12.1 41.1 24.1 49.2 11.7 19.1 22.4 10.9 22.9 31.2 24.6 28.2 18.6 14.3 12.0 11.4 37.9 20.0 30.6 24.8 0.0 28.8 20.7 0.0 24.5 0.0 61.0 23.3 17.0 0.0 25.3 31.6 0.0 42.2 33.2 39.8 23.7 20.7 26.4 44.8 22.0 43.4 51.4 17.5 0.0 39.5 22.7 18.4 59.0 34.3 23.4 0.0 23.7 37.0 42.9 17.2 17.1 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738949-129769536 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 168.0;kidney: 157.4" "Cell type enriched" "Detected in some" 6 "Proximal enterocytes: 475.9" "Cancer enhanced" "Detected in many" "liver cancer: 18.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4" "Group enriched" "Detected in many" 7 "monocytes: 2.8;T-cells: 4.3" "Cell line enhanced" "Detected in some" "ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 13000000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 6.9 0.9 0.2 3.7 0.1 0.2 3.0 0.1 0.1 3.7 0.1 4.9 99.9 2.5 0.1 2.2 6.3 4.4 3.3 0.1 0.1 157.4 23.2 2.1 0.5 0.2 0.1 0.1 1.8 0.3 0.3 0.1 1.2 0.1 1.8 6.4 0.0 1.5 0.4 0.5 3.9 168.0 6.0 0.1 0.3 3.4 0.1 0.1 1.0 1.4 2.4 0.4 7.8 4.0 0.1 0.0 0.0 0.5 0.0 8.2 40.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 4.3 1.4 1.2 0.0 1.3 2.8 0.2 0.2 0.4 2.0 0.1 0.0 2.8 0.4 1.4 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.2 0.5 11.4 5.9 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.2 0.0 0.0 10.0 1.1 0.0 0.0 0.0 0.4 18.5 0.8 0.0 0.3 12.8 0.0 1.0 3.6 0.0 0.0 1.0 1.8 1.0 0.0 0.0 3.1 0.0 0.1 0.0 21.0 0.0 0.1 0.0 475.9 75.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.0 1.2 0.9 0.0 8.4 0.0 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779949-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 109.1;intestine: 36.8;lymphoid tissue: 121.9" "Cell type enhanced" "Detected in some" "B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA 14000 "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favorable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 8.7 5.7 5.0 62.4 5.7 109.1 4.4 5.6 7.4 3.2 5.9 9.5 11.7 3.1 1.8 3.7 4.9 10.3 2.7 4.7 9.4 3.7 6.0 21.5 121.5 8.3 6.2 3.9 1.8 2.5 1.5 2.2 7.6 8.0 4.3 10.0 0.2 8.0 2.2 1.3 2.1 36.8 7.6 8.2 101.1 13.7 1.3 7.5 121.9 3.9 1.7 109.1 15.5 3.0 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 58.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 119.4 0.2 13.6 0.0 0.0 120.6 89.1 0.0 0.0 0.0 88.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 24.0 0.3 0.0 0.3 0.1 0.1 0.1 35.0 150.2 0.0 117.2 0.0 41.6 135.4 245.5 192.2 195.3 159.1 79.1 108.2 178.9 121.5 90.8 76.9 120.9 128.0 153.3 209.9 55.1 145.6 343.7 5.0 5.7 5.6 7.4 4.7 9.4 8.3 6.2 3.9 8.0 8.2 7.5 9.3 0.8 0.0 3.6 0.0 69.5 0.5 0.1 0.0 0.0 0.0 0.5 1.1 1.0 1.5 0.0 0.0 0.0 0.5 66.3 0.1 0.0 0.1 0.1 0.2 0.2 1.2 0.0 13.5 0.2 0.0 0.6 0.9 2.6 0.3 22.2 0.0 3.3 0.9 51.3 0.0 0.2 0.1 0.0 58.9 19.1 0.0 0.3 40.0 0.0 7.5 45.3 0.0 101.0 0.0 0.1 0.0 0.0 0.0 39.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.1 1.3 0.5 60.6 0.0 0.1 0.0 OCRL "Dent-2, OCRL1" ENSG00000122126 "OCRL inositol polyphosphate-5-phosphatase" Q01968 X 129539849-129592561 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" Hydrolase "Cataract, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 3.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012495 Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA Cytosol "Microtubules, Centriolar satellite" "HPA012495: AB_1851804" "prognostic unfavorable (2.93e-5)" "unprognostic (3.17e-2)" "unprognostic (2.30e-1)" "unprognostic (6.34e-3)" "unprognostic (9.88e-2)" "unprognostic (1.35e-1)" "unprognostic (2.82e-2)" "unprognostic (2.68e-1)" "unprognostic (3.08e-3)" "unprognostic (2.56e-2)" "unprognostic (6.30e-3)" "unprognostic (1.74e-1)" "unprognostic (4.61e-3)" "unprognostic (4.10e-1)" "unprognostic (5.83e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" 13.1 24.0 10.8 4.7 12.8 5.1 12.8 5.2 13.0 14.7 22.5 16.0 8.1 19.6 16.3 11.7 16.9 8.4 10.7 12.8 16.9 9.5 15.8 10.0 2.8 9.2 13.1 10.3 28.6 13.1 34.8 25.8 11.3 13.7 18.7 12.5 10.0 11.1 21.5 14.9 12.5 12.3 15.1 6.7 7.9 14.7 24.8 15.2 4.4 17.0 6.7 3.0 23.0 12.4 13.5 19.3 20.5 17.0 18.7 29.3 24.1 17.1 28.5 22.3 28.2 26.3 14.2 13.3 1.5 46.7 24.1 33.0 11.6 30.5 20.9 29.2 0.1 21.5 5.8 18.5 14.1 21.1 5.7 0.6 20.7 27.3 28.3 27.3 27.7 21.2 8.4 7.9 13.6 28.7 24.2 4.3 8.2 6.2 24.4 30.9 4.2 17.6 11.5 16.1 19.1 20.5 26.1 13.5 18.0 14.6 21.5 13.2 10.0 19.3 23.0 10.6 24.6 29.1 3.8 3.3 3.7 16.2 21.4 18.8 0.0 1.0 0.0 0.1 1.1 0.3 0.1 0.0 0.0 1.2 0.1 0.2 0.1 0.1 0.0 3.6 0.4 0.0 0.4 10.8 12.8 5.2 13.0 12.8 16.9 9.2 13.1 10.3 13.7 6.7 15.2 13.5 6.7 3.2 7.8 14.4 2.6 4.7 3.4 5.4 3.4 9.9 9.3 5.6 10.3 4.3 8.8 18.4 6.2 6.4 0.3 14.4 3.9 5.3 31.2 4.9 6.9 6.4 17.5 3.8 20.0 3.6 5.4 7.8 11.7 6.1 0.0 17.0 8.2 11.5 5.0 13.5 23.1 11.8 6.1 11.8 4.0 8.9 23.0 5.8 8.8 21.5 4.3 9.6 0.0 17.6 21.0 8.5 8.3 34.3 1.4 5.9 15.7 5.2 5.4 7.2 0.0 4.5 6.0 6.8 14.6 8.3 7.4 5.7 1.0 7.6 12.2 8.4 PAEP "GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14" ENSG00000122133 "Progestagen associated endometrial protein" P09466 9 135561756-135566955 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "endometrium 1: 258.4" "Cell type enriched" "Detected in some" 10 "Glandular and luminal cells: 10785.5" "Cancer enriched" "Detected in many" 8 "melanoma: 275.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.1;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 21.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016762, HPA020108, HPA029473" Enhanced "Secreted in female reproductive system" NA NA 120000 "CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147" "unprognostic (3.39e-2)" "unprognostic (8.47e-3)" "unprognostic (6.84e-2)" "unprognostic (3.46e-2)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.61e-6)" "unprognostic (1.27e-2)" "unprognostic (1.72e-1)" "unprognostic (3.95e-3)" "unprognostic (1.93e-3)" "prognostic unfavorable (0.00e+0)" "prognostic unfavorable (5.46e-4)" "unprognostic (4.24e-1)" "unprognostic (4.98e-2)" 0.1 0.2 0.3 1.1 0.4 1.7 0.5 0.8 0.7 49.9 1.7 0.1 1.0 258.4 0.9 0.2 4.8 0.4 0.1 0.5 0.4 0.1 0.1 0.5 0.6 0.3 0.2 0.4 0.8 0.0 0.0 0.0 27.4 0.3 2.7 0.1 0.4 0.4 45.3 0.7 2.1 0.8 0.1 0.2 0.3 6.0 0.7 0.3 0.0 0.3 0.0 0.1 0.3 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.0 0.9 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 1.6 2.2 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.2 2.9 0.2 0.0 0.3 0.0 0.7 0.5 0.0 0.0 0.2 0.2 0.3 0.0 0.2 0.4 0.2 0.1 0.2 21.0 0.6 0.3 0.2 0.0 0.0 1.0 0.2 0.1 0.8 2.2 0.1 0.2 0.2 0.2 3.1 0.3 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.3 0.3 0.5 0.1 0.1 0.3 0.4 0.8 0.7 0.5 0.4 0.3 0.2 0.4 0.3 0.2 0.3 1.1 0.0 0.0 0.5 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.9 0.6 0.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 613.5 1008.8 67.9 0.0 0.0 0.0 0.2 0.0 1.6 0.0 10785.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 144.0 0.0 0.0 0.0 0.0 0.0 86.5 0.0 0.0 0.0 OBP2A "hOBPIIa, LCN13, OBP" ENSG00000122136 "Odorant binding protein 2A" Q9NY56 9 135546126-135549969 "Predicted secreted proteins" "Olfaction, Sensory transduction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "fallopian tube: 25.2" "Cell type enhanced" "Detected in some" "Breast glandular cells: 2.4;Breast myoepithelial cells: 3.4;Late spermatids: 1.8;Leydig cells: 1.5;Melanocytes: 1.8" "Cancer enriched" "Detected in some" 6 "ovarian cancer: 18.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "U-266/70: 1.6;U-266/84: 6.4" HPA055955 Uncertain "Secreted in other tissues" NA NA "HPA055955: AB_2682985" "unprognostic (2.30e-1)" "unprognostic (3.68e-1)" "unprognostic (4.63e-1)" "unprognostic (1.66e-2)" "unprognostic (2.17e-1)" "unprognostic (3.20e-1)" "unprognostic (2.75e-1)" "unprognostic (7.65e-2)" "unprognostic (2.23e-2)" "unprognostic (8.27e-2)" "unprognostic (1.91e-1)" "unprognostic (6.83e-11)" "unprognostic (5.17e-2)" "unprognostic (3.61e-1)" "unprognostic (1.26e-1)" "unprognostic (3.84e-1)" 0.0 0.0 0.1 0.1 0.1 0.1 1.7 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.2 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.0 6.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 MRPS2 CGI-91 ENSG00000122140 "Mitochondrial ribosomal protein S2" Q9Y399 9 135499984-135504673 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029487, HPA057261" Approved Supported Mitochondria NA NA Mitochondria "HPA029487: , HPA057261: AB_2683385" "unprognostic (3.18e-3)" "unprognostic (9.42e-3)" "unprognostic (1.46e-1)" "unprognostic (7.81e-2)" "unprognostic (3.55e-1)" "unprognostic (8.45e-2)" "unprognostic (1.63e-1)" "unprognostic (5.63e-3)" "unprognostic (3.83e-1)" "unprognostic (2.90e-2)" "unprognostic (4.81e-2)" "unprognostic (7.58e-2)" "prognostic favorable (6.96e-9)" "unprognostic (2.74e-2)" "unprognostic (1.06e-1)" "unprognostic (8.29e-2)" "unprognostic (2.24e-1)" 30.2 57.4 28.2 14.8 28.2 23.4 31.1 27.9 38.2 28.3 30.5 34.9 23.2 29.9 13.0 38.0 36.0 16.0 55.1 29.3 27.7 46.2 80.3 22.2 21.2 27.6 28.6 27.4 35.2 46.2 32.5 26.6 16.9 28.0 33.4 17.4 7.8 31.5 21.4 76.1 38.3 28.3 15.4 26.6 32.2 39.6 17.1 29.9 16.3 26.1 50.8 17.8 34.0 29.1 28.1 59.9 98.4 35.3 48.0 39.1 43.5 60.0 43.0 39.0 71.7 53.0 149.0 55.4 75.4 57.2 40.1 75.8 132.6 88.9 101.4 27.7 46.2 137.4 37.4 96.1 101.8 68.4 76.6 44.3 58.6 77.6 78.3 55.6 45.7 67.9 74.2 125.1 54.3 42.3 185.8 73.9 133.7 80.2 110.8 153.9 81.3 57.3 159.5 59.9 50.8 104.9 55.2 58.8 110.9 63.2 23.6 92.4 60.5 42.4 52.3 58.4 90.3 78.8 58.9 124.5 84.1 53.0 69.2 49.1 8.4 28.4 13.6 30.0 27.5 34.5 34.4 30.1 32.4 29.1 34.3 32.4 32.9 2.4 28.7 24.0 25.1 41.8 26.4 28.2 28.2 27.9 38.2 29.3 27.7 27.6 28.6 27.4 28.0 26.6 29.9 28.1 23.8 12.8 14.1 4.9 32.5 44.7 38.8 55.0 33.0 22.2 37.3 51.7 31.2 42.9 31.6 12.9 6.2 71.3 19.0 21.5 72.4 50.7 14.7 27.8 34.2 32.6 21.7 41.4 4.6 38.6 65.8 27.9 21.4 77.7 8.2 37.9 21.8 46.5 42.5 25.2 5.9 37.9 28.5 17.6 15.4 32.5 24.2 21.0 19.6 1.9 31.7 24.8 20.6 4.0 4.5 39.9 27.1 23.0 38.6 48.6 36.3 84.5 14.7 17.0 32.9 27.1 29.4 13.3 21.5 47.1 45.7 37.4 23.4 77.5 55.7 35.5 TBX22 "CLPA, CPX" ENSG00000122145 "T-box transcription factor 22" Q9Y458 X 80014753-80031774 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "testis: 11.2;thyroid gland: 4.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HDLM-2: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.58e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FMOD SLRR2E ENSG00000122176 Fibromodulin Q06828 1 203340628-203351758 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 26.7;Fibroblasts: 52.5;Intestinal goblet cells: 80.2;Leydig cells: 28.0;Peritubular cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.6;CACO-2: 38.6;HHSteC: 11.8;HSkMC: 22.1;OE19: 45.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 71.7" "Secreted to extracellular matrix" NA NA 2600000 "unprognostic (1.48e-1)" "unprognostic (8.88e-2)" "unprognostic (9.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "unprognostic (4.17e-3)" "unprognostic (1.86e-1)" "unprognostic (3.30e-1)" "unprognostic (5.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (9.40e-3)" "unprognostic (3.58e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (2.67e-4)" 123.8 13.7 1.8 31.4 1.8 0.1 65.0 1.4 6.6 101.0 18.2 39.8 50.0 106.7 17.3 19.3 86.6 124.7 90.0 0.9 3.6 15.0 11.1 60.7 28.8 2.5 1.2 0.9 126.2 33.4 28.2 21.8 81.9 2.1 58.9 62.8 10.0 50.0 49.6 12.7 24.4 21.4 107.5 2.1 18.3 136.8 6.4 1.7 9.7 71.9 25.8 34.1 45.9 60.5 1.6 0.0 0.1 0.0 0.0 10.6 0.7 0.2 7.1 8.1 0.0 1.1 38.6 0.0 0.0 0.8 7.7 0.0 0.3 0.0 0.6 0.5 0.0 0.0 0.0 0.9 0.0 11.8 0.0 0.0 22.1 0.1 0.0 0.4 5.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.3 0.0 45.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.4 0.0 0.1 1.0 0.3 2.0 0.0 0.3 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 1.4 6.6 0.9 3.6 2.5 1.2 0.9 2.1 2.1 1.7 1.6 9.3 0.0 6.3 0.0 0.0 6.9 5.0 1.5 6.2 0.2 10.3 26.7 1.6 2.8 2.1 7.3 0.0 1.1 0.4 2.9 0.0 1.9 0.1 1.1 12.1 8.3 6.1 0.0 0.1 0.7 0.7 52.5 12.8 1.6 0.0 0.5 19.2 0.1 1.2 0.0 0.0 80.2 0.0 0.3 9.3 0.4 28.0 0.6 12.4 7.5 0.6 11.9 0.0 0.0 0.0 1.5 2.2 28.6 0.0 11.7 0.7 0.2 0.7 1.0 6.6 1.3 15.5 0.0 0.3 0.6 4.3 3.1 1.2 2.0 8.6 1.6 MYOG "bHLHc3, MYF4" ENSG00000122180 Myogenin P15173 1 203083129-203086012 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "skeletal muscle: 101.8;tongue: 47.1" "Cell type enriched" "Detected in single" 36 "Skeletal myocytes: 11.0" "Group enriched" "Detected in some" 6 "head and neck cancer: 3.9;testis cancer: 1.7" "Region enhanced" "Detected in single" "cerebellum: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 222 "HSkMC: 29.6;RH-30: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA028336 Supported Nucleoplasm NA NA Nucleoplasm "HPA028336: AB_2672562" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (2.22e-1)" "unprognostic (2.79e-9)" "unprognostic (3.96e-1)" "unprognostic (2.56e-1)" 0.0 0.0 0.6 0.0 0.3 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.8 2.2 0.0 0.2 4.1 0.0 101.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.6 0.0 47.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 57.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.0 0.6 0.3 2.5 0.4 0.6 0.1 0.3 0.2 0.5 0.8 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765177-203776372 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 21.3" "Cell type enhanced" "Detected in some" "dendritic cells: 23.2;granulocytes: 82.2;NK-cells: 30.9;Plasma cells: 65.1;T-cells: 29.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 14 "B-cells: 7.5;NK-cells: 5.2;T-cells: 12.0" "Group enriched" "Detected in some" 4 "Karpas-707: 22.8;U-266/70: 28.2;U-266/84: 71.9;U-698: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 0.5 0.6 0.2 8.9 0.3 1.6 1.7 0.4 0.4 1.4 0.3 3.7 3.1 0.3 0.3 0.9 0.4 2.6 0.3 0.3 0.2 0.2 0.9 2.8 11.9 0.4 0.2 0.2 0.2 0.4 0.1 0.0 0.1 0.5 0.7 3.5 0.1 1.3 0.4 0.1 0.2 2.0 0.7 0.2 7.2 4.5 0.3 0.3 11.2 0.2 0.3 21.3 5.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 8.0 0.2 22.8 0.0 0.0 8.7 0.0 0.1 0.0 0.0 2.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.2 71.9 24.9 0.0 1.9 0.0 0.3 0.0 0.5 12.0 0.0 9.1 7.5 7.1 9.4 0.0 2.5 5.5 7.1 0.3 5.2 0.0 0.0 8.1 3.5 0.2 0.3 0.4 0.4 0.3 0.2 0.4 0.2 0.2 0.5 0.2 0.3 0.5 0.9 0.0 1.9 0.0 14.6 1.1 0.4 0.0 0.0 0.0 0.3 0.1 2.6 0.0 0.6 0.0 0.0 0.1 23.2 0.1 0.0 0.2 0.0 0.4 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.6 1.5 0.4 82.2 0.0 2.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 1.9 10.6 0.0 0.4 0.0 30.9 0.5 0.0 0.1 0.0 0.0 65.1 0.4 0.6 0.1 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.2 0.4 0.0 29.2 0.1 0.3 0.5 PLG ENSG00000122194 Plasminogen P00747 6 160702238-160754097 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 2688.2" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 1772.7" "Cancer enriched" "Detected in some" 84 "liver cancer: 180.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000668, CAB016678, HPA021602, HPA048823" Supported "Secreted to blood" NA NA 140000000000 45000000000 "CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.44e-1)" "unprognostic (8.54e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (6.28e-2)" "unprognostic (7.25e-2)" "prognostic favorable (4.22e-4)" "unprognostic (3.97e-3)" "unprognostic (5.21e-2)" "unprognostic (2.33e-2)" 0.4 0.4 0.2 0.2 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.2 0.0 0.1 2.4 0.5 0.0 0.3 0.2 243.2 2688.2 0.4 0.7 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.1 0.6 0.0 0.1 0.9 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.3 0.2 0.1 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.6 30.0 0.0 1.8 0.0 0.0 0.3 0.0 19.6 0.0 0.2 3.0 0.1 1.2 0.0 24.0 0.6 0.0 0.0 0.0 0.0 0.1 1.3 0.0 28.5 1772.7 0.1 0.0 0.5 0.0 0.0 35.4 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 235.7 1.5 0.1 0.0 0.4 0.2 0.4 0.4 0.0 0.0 0.0 2.3 0.1 0.0 0.0 KIAA1191 "FLJ21022, p33MONOX, p60MONOX" ENSG00000122203 KIAA1191 Q96A73 5 176346062-176361807 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044701, HPA048145" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044701: AB_2679053, HPA048145: AB_2680283" "unprognostic (7.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.46e-1)" "unprognostic (1.48e-2)" "unprognostic (4.39e-1)" "unprognostic (7.10e-2)" "unprognostic (8.93e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.94e-5)" "unprognostic (5.02e-3)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.73e-2)" 42.0 44.7 37.4 27.0 40.1 31.0 46.5 29.8 42.5 51.4 37.4 46.8 50.0 49.8 53.0 61.8 67.4 43.3 87.5 39.5 42.2 201.2 71.0 48.4 29.4 32.9 36.3 37.4 90.8 57.8 87.7 33.3 38.6 36.8 55.7 44.9 59.1 72.9 65.4 71.5 44.6 51.4 55.5 27.5 34.3 62.6 12.9 36.8 37.0 61.4 63.8 37.8 50.1 34.5 32.0 61.5 63.4 105.1 142.7 95.6 72.8 82.6 86.8 86.2 96.6 106.1 118.2 60.2 24.0 111.9 105.5 145.2 53.8 67.6 157.6 113.1 125.0 81.4 27.9 41.4 63.1 111.0 24.0 47.2 73.9 115.2 83.2 70.8 109.6 120.7 39.1 43.1 51.2 108.6 81.7 34.7 14.5 47.1 65.6 81.2 25.2 66.1 21.1 92.6 60.0 82.8 91.6 92.3 45.7 103.6 94.6 66.9 27.1 106.5 88.4 40.2 65.7 107.5 33.7 49.7 27.7 69.0 46.5 71.3 33.8 23.8 32.9 28.7 28.6 32.1 25.1 27.3 27.6 23.1 18.3 28.4 29.7 10.4 27.4 29.0 18.2 40.2 28.6 37.4 40.1 29.8 42.5 39.5 42.2 32.9 36.3 37.4 36.8 27.5 36.8 32.0 26.8 54.5 41.0 16.6 31.3 34.0 40.6 29.1 39.3 31.3 40.8 35.6 61.2 34.3 35.9 33.1 25.0 25.0 35.8 38.7 93.9 37.2 2.5 27.5 24.5 30.2 43.2 17.4 19.6 27.4 13.7 29.6 28.1 35.6 17.7 20.6 26.0 45.8 15.8 48.8 22.7 28.3 30.5 21.4 27.1 7.9 31.1 19.8 21.4 12.2 29.5 33.5 13.4 12.5 16.0 37.9 37.5 38.4 28.6 45.0 50.1 304.3 35.1 30.8 13.1 23.8 26.0 7.2 6.0 38.7 31.7 33.4 30.3 20.0 30.6 47.5 COPA HEP-COP ENSG00000122218 "COPI coat complex subunit alpha" P53621 1 160288594-160343273 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 150000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 47.1 43.5 49.4 38.8 52.5 30.3 42.3 58.8 58.7 53.3 65.6 41.9 54.2 47.1 55.6 38.6 41.5 38.9 55.6 51.1 56.3 49.1 55.5 47.4 36.3 58.4 54.0 51.4 47.3 50.3 52.2 60.3 48.7 61.2 43.9 48.4 26.4 58.1 39.8 59.6 40.2 49.4 50.4 58.0 43.1 43.9 24.6 57.1 37.9 60.6 38.6 39.2 41.7 38.2 73.1 91.0 68.5 70.1 66.9 164.9 154.7 78.6 116.5 144.3 103.1 138.7 72.0 60.5 64.4 73.3 194.0 57.7 86.0 92.0 81.3 126.5 68.6 64.3 76.8 95.2 79.0 115.1 94.1 74.5 134.8 49.1 140.0 128.9 126.3 126.4 64.4 71.9 69.7 124.4 43.6 49.3 53.3 80.1 97.3 79.0 49.2 89.2 118.9 94.3 94.7 62.1 84.3 157.3 109.2 148.0 115.0 140.4 133.9 162.8 84.3 54.1 108.2 80.2 106.8 76.3 106.6 104.2 51.3 122.8 48.1 39.0 25.4 18.6 36.7 25.5 17.8 16.7 21.3 40.4 14.2 14.3 17.9 10.9 26.7 36.2 17.8 22.9 35.5 49.4 52.5 58.8 58.7 51.1 56.3 58.4 54.0 51.4 61.2 58.0 57.1 73.1 53.6 76.9 54.7 44.7 66.4 28.2 35.5 41.6 29.6 52.4 53.0 41.3 51.8 42.9 49.7 40.5 81.3 41.0 83.2 66.8 13.7 49.9 14.7 50.7 68.1 50.4 55.3 37.0 77.6 49.6 63.3 66.2 65.2 64.3 45.6 63.0 52.8 71.1 51.2 45.4 73.8 83.8 30.5 93.7 58.0 6.4 71.1 84.3 26.6 67.5 75.0 41.0 38.1 65.9 178.9 55.5 48.1 56.8 115.9 52.9 98.9 41.4 66.2 53.7 39.5 57.6 52.4 37.6 25.7 35.8 31.8 69.2 58.3 58.1 66.6 61.2 CD244 "2B4, NAIL, NKR2B4, Nmrk, SLAMF4" ENSG00000122223 "CD244 molecule" Q9BZW8 1 160830160-160862887 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.1;lymphoid tissue: 17.0" "Cell type enhanced" "Detected in some" "dendritic cells: 28.4;Kupffer cells: 17.7;NK-cells: 66.9;T-cells: 21.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 4 "basophil: 472.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 472.1" "Cell line enhanced" "Detected in some" "HEL: 20.6;HMC-1: 69.4;NB-4: 14.4;U-937: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 280000 "unprognostic (6.11e-3)" "unprognostic (1.54e-2)" "unprognostic (1.85e-2)" "unprognostic (6.95e-6)" "unprognostic (5.79e-2)" "unprognostic (1.43e-4)" "unprognostic (1.93e-2)" "unprognostic (7.36e-2)" "unprognostic (3.36e-1)" "unprognostic (2.85e-1)" "unprognostic (1.60e-1)" "unprognostic (2.32e-1)" "unprognostic (5.40e-4)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.79e-1)" 1.1 0.4 0.3 3.7 0.4 10.1 0.4 0.3 0.6 0.4 0.4 1.1 3.1 0.3 0.3 0.4 0.5 1.0 0.6 0.4 0.3 0.3 4.2 3.3 3.5 0.4 0.3 0.2 1.0 0.1 0.1 0.1 0.4 0.3 0.4 1.4 0.0 1.1 0.4 0.3 0.3 2.8 1.2 0.4 17.0 1.0 2.8 0.3 2.8 0.3 0.2 2.0 1.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.4 6.8 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 2.1 14.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 2.6 1.1 0.1 0.0 28.7 0.0 472.1 43.3 107.9 71.3 59.1 35.2 0.3 3.7 39.7 41.0 0.2 5.3 36.0 3.1 78.5 73.6 2.4 0.2 70.7 0.3 0.4 0.3 0.6 0.4 0.3 0.4 0.3 0.2 0.3 0.4 0.3 0.4 0.1 3.2 6.1 0.3 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 5.2 0.0 0.1 0.2 0.0 2.1 0.7 1.7 0.0 0.3 0.5 0.1 3.8 0.0 0.7 0.2 0.6 0.0 0.1 0.0 0.0 17.7 3.1 2.4 1.8 8.3 0.0 0.0 8.5 0.0 66.9 0.0 0.2 0.0 0.0 2.2 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 0.1 0.0 21.9 0.5 0.0 0.0 LY9 "CD229, hly9, mLY9, SLAMF3" ENSG00000122224 "Lymphocyte antigen 9" Q9HBG7 1 160796074-160828261 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.6;intestine: 12.1;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in some" "B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050917 Approved Approved "Plasma membrane,Centriolar satellite" NA NA 43000 "Plasma membrane" "Centriolar satellite" "HPA050917: AB_2681272" "unprognostic (8.04e-4)" "unprognostic (2.31e-5)" "unprognostic (8.08e-3)" "unprognostic (1.20e-3)" "unprognostic (9.83e-3)" "unprognostic (1.87e-5)" "unprognostic (1.16e-2)" "unprognostic (3.84e-3)" "unprognostic (1.23e-2)" "unprognostic (2.89e-3)" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.69e-2)" "unprognostic (9.47e-2)" "unprognostic (3.49e-2)" "unprognostic (6.88e-2)" 1.7 0.9 0.1 13.8 0.2 11.6 2.1 0.2 0.4 0.8 0.5 3.9 4.0 0.7 0.5 0.9 0.9 2.5 0.5 0.1 0.2 1.0 2.3 3.9 30.5 0.3 0.3 0.1 0.6 0.2 0.0 0.2 0.3 0.2 1.1 3.8 0.0 7.2 0.4 0.3 0.8 12.1 0.5 0.3 26.9 6.1 0.2 0.4 25.8 1.4 0.2 31.4 3.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 28.0 0.0 0.0 2.3 0.5 0.1 0.8 0.0 1.6 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 70.7 29.3 0.3 0.0 4.0 0.0 1.2 0.8 0.4 112.9 1.1 113.5 56.1 97.6 109.8 5.2 52.8 109.6 112.3 2.4 22.2 0.8 72.8 80.3 53.5 0.1 0.2 0.2 0.4 0.1 0.2 0.3 0.3 0.1 0.2 0.3 0.4 0.3 0.4 0.0 1.8 0.3 244.0 1.0 0.5 0.1 0.0 0.0 0.4 0.8 0.9 0.0 0.0 0.0 0.0 0.1 36.2 0.1 0.0 0.0 0.1 0.1 0.1 0.7 1.2 28.0 0.1 0.2 0.0 1.4 0.5 0.1 0.0 0.0 1.8 0.4 1.9 0.0 0.1 0.0 0.0 3.2 31.9 0.0 0.0 6.3 71.2 1.9 2.1 0.0 22.6 0.0 0.1 0.1 0.0 0.0 102.5 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.5 1.0 0.1 44.8 0.0 0.3 0.3 HS3ST2 3OST2 ENSG00000122254 "Heparan sulfate-glucosamine 3-sulfotransferase 2" Q9Y278 16 22814162-22916338 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 34.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 99.8;Hofbauer cells: 16.9;Inhibitory neurons: 25.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 9.7;SH-SY5Y: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017736 Approved NA NA "HPA017736: AB_1851095" "unprognostic (4.09e-2)" "unprognostic (2.90e-3)" "unprognostic (5.97e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-1)" "unprognostic (2.75e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "prognostic favorable (1.35e-4)" "unprognostic (4.89e-2)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (3.00e-2)" 2.7 1.2 9.4 0.0 14.6 0.0 2.1 1.6 34.3 1.7 1.6 0.6 0.0 0.7 0.0 0.2 0.6 0.0 0.7 12.3 6.0 0.2 0.6 5.4 0.0 7.4 6.9 10.3 0.3 0.2 0.0 0.3 0.1 6.2 1.9 0.2 0.4 3.1 0.0 0.4 1.9 0.5 0.1 2.7 0.3 0.7 0.3 5.8 0.0 1.8 0.1 0.0 1.1 1.1 16.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 14.6 1.6 34.3 12.3 6.0 7.4 6.9 10.3 6.2 2.7 5.8 16.4 0.8 0.0 0.0 1.6 0.0 3.6 0.2 0.0 0.0 10.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.6 0.1 0.0 0.0 2.3 0.0 0.0 99.8 0.0 0.2 1.9 0.0 0.2 0.0 0.0 0.4 0.2 16.9 0.0 25.7 0.0 0.0 1.0 2.7 1.5 1.2 7.3 0.0 0.0 0.0 0.0 0.0 3.5 1.8 0.9 0.0 5.7 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.3 5.8 0.1 0.0 0.0 2.0 0.3 0.1 0.0 0.0 0.8 RBBP6 "P2P-R, PACT, SNAMA" ENSG00000122257 "RB binding protein 6, ubiquitin ligase" Q7Z6E9 16 24537693-24572863 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA replication, Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 144.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032866, HPA041725, HPA043544" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543" "unprognostic (1.04e-1)" "unprognostic (5.08e-2)" "unprognostic (3.35e-1)" "unprognostic (3.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.15e-2)" "unprognostic (1.08e-2)" "unprognostic (6.60e-2)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.01e-2)" "unprognostic (1.21e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (2.83e-2)" 24.3 25.2 24.5 21.3 24.9 144.9 26.1 34.5 30.2 27.9 23.2 28.0 15.1 33.9 26.5 23.3 32.7 25.8 23.0 24.0 29.4 20.8 27.0 28.2 29.9 25.1 25.3 22.9 39.1 22.4 21.9 28.3 32.0 26.4 26.3 20.6 51.5 21.5 20.1 30.0 32.9 26.2 24.3 24.4 29.6 25.8 45.9 24.4 26.9 27.5 26.0 23.7 25.5 24.9 29.1 35.4 18.4 42.5 44.4 31.9 32.9 45.9 28.1 26.1 25.1 27.3 20.5 28.3 49.6 20.3 24.4 28.7 33.3 46.2 24.8 41.9 26.9 35.7 41.9 57.1 58.6 24.7 57.5 23.7 28.8 33.7 33.2 38.9 28.6 36.9 42.2 54.5 43.8 29.7 36.5 45.5 51.2 48.7 24.0 17.3 62.8 42.5 43.3 24.7 31.7 33.4 28.5 39.7 35.1 52.3 47.0 27.4 49.7 32.3 31.0 22.8 27.0 30.8 37.7 40.9 60.9 25.1 36.5 26.1 7.1 1.2 2.0 2.0 2.0 2.2 2.0 2.1 1.5 0.9 1.7 1.8 2.0 2.5 3.5 1.1 3.7 1.7 0.6 24.5 24.9 34.5 30.2 24.0 29.4 25.1 25.3 22.9 26.4 24.4 24.4 29.1 139.1 86.6 115.3 47.3 125.7 100.7 103.5 40.8 223.1 67.1 145.6 160.8 147.0 44.3 56.5 27.6 100.1 46.3 88.9 71.5 25.4 48.8 307.5 109.8 123.7 93.7 82.0 83.1 52.5 47.6 57.6 127.1 121.8 203.1 51.3 127.8 64.2 59.5 38.4 62.2 53.4 76.0 28.5 53.5 70.2 41.9 72.4 101.5 62.2 54.4 54.0 53.1 52.5 61.3 58.7 56.4 32.8 58.6 173.7 99.9 54.5 23.9 52.0 61.4 52.6 247.0 112.9 100.3 45.8 161.0 101.7 101.5 110.2 105.3 69.3 111.9 ZC3H7A "FLJ20318, HSPC055, ZC3H7, ZC3HDC7" ENSG00000122299 "Zinc finger CCCH-type containing 7A" Q8IWR0 16 11750586-11797258 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040808, HPA059849" Supported Cytosol NA NA Cytosol "HPA040808: AB_10794150, HPA059849: AB_2684141" "unprognostic (2.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.07e-1)" "unprognostic (5.64e-2)" "unprognostic (2.07e-2)" "unprognostic (5.75e-2)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (9.16e-2)" "unprognostic (1.44e-1)" "unprognostic (2.27e-2)" "unprognostic (7.27e-3)" "unprognostic (6.00e-2)" "unprognostic (1.05e-2)" "unprognostic (1.50e-2)" "unprognostic (3.55e-2)" 21.3 18.0 11.8 22.0 13.2 38.4 21.3 18.0 12.5 19.9 23.8 17.8 17.9 22.6 18.2 13.0 18.8 19.1 19.9 11.5 16.1 23.0 21.5 23.8 29.5 13.0 12.0 11.7 26.8 26.4 23.6 14.8 26.6 13.2 24.4 19.9 30.5 30.3 25.7 33.1 15.6 19.0 23.0 12.2 24.1 18.9 10.4 13.4 28.4 25.9 22.0 27.8 18.5 16.1 16.2 33.5 16.9 58.2 31.8 40.0 39.4 23.3 52.4 52.2 38.9 47.7 18.9 28.5 46.7 32.2 62.7 25.0 21.1 33.1 50.9 56.0 36.9 37.5 20.1 35.5 31.8 56.6 46.5 42.4 44.7 27.7 36.7 68.7 45.4 49.5 41.8 33.5 40.8 57.1 26.2 35.3 23.6 34.2 23.2 15.2 51.0 32.6 33.3 36.0 25.6 44.3 35.2 42.5 40.5 52.4 34.3 29.6 30.2 47.2 45.1 27.6 61.9 35.8 32.5 26.2 68.5 33.3 34.3 118.7 16.6 12.9 20.4 14.0 17.8 19.8 15.5 18.1 15.4 12.8 16.5 21.1 15.0 16.0 22.3 32.2 10.2 24.2 9.4 11.8 13.2 18.0 12.5 11.5 16.1 13.0 12.0 11.7 13.2 12.2 13.4 16.2 39.4 64.1 36.4 36.9 46.2 15.0 15.2 9.6 27.3 29.4 21.2 23.7 44.3 17.2 29.0 14.7 54.2 14.9 40.5 16.4 15.6 18.5 3.2 30.9 48.7 32.7 20.9 22.5 29.4 22.7 15.4 31.1 27.5 33.9 18.3 31.3 32.9 18.5 14.5 53.8 35.3 25.1 18.3 36.3 26.2 5.3 32.6 39.3 19.6 30.9 40.2 25.6 22.6 65.9 32.7 22.3 16.9 35.7 45.2 18.0 20.3 16.4 29.5 52.4 19.7 42.2 37.1 17.2 9.0 18.0 15.8 7.5 40.3 28.9 18.5 16.0 PRM2 CT94.2 ENSG00000122304 "Protamine 2" P04554 16 11275639-11276480 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1082 "testis: 11788.4" "Cell type enriched" "Detected in some" 7 "Late spermatids: 506606.3" "Cancer enriched" "Detected in single" 187 "testis cancer: 11.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 1.1;NB-4: 1.3;U-2197: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032738, HPA056386" Enhanced NA NA "CAB032738: AB_2171312, HPA056386: AB_2683111" "unprognostic (3.88e-2)" 1.8 1.9 0.0 0.3 0.0 0.0 8.6 0.0 0.0 1.5 0.0 1.8 0.6 1.0 0.0 1.6 1.1 0.0 1.5 0.0 0.0 2.1 3.6 1.1 0.5 0.0 0.0 0.0 1.4 2.6 0.0 1.7 0.0 0.0 10.8 0.0 0.0 1.7 0.8 4.7 3.1 3.2 0.0 0.0 1.1 2.1 11788.4 0.0 0.2 3.6 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70432.4 0.2 0.0 77.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 506606.3 1538.1 115.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1673.0 0.0 0.0 0.0 0.0 0.0 0.0 913.8 0.0 0.0 1879.2 957.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERAC1 FLJ14917 ENSG00000122335 "Serine active site containing 1" Q96JX3 6 158109519-158168280 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 95.8;Late spermatids: 111.7;Oligodendrocytes: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025715, HPA025716" Enhanced NA NA "HPA025715: AB_1856697, HPA025716: AB_2185128" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (2.17e-1)" "unprognostic (6.92e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (2.50e-2)" "unprognostic (1.75e-1)" "unprognostic (1.61e-2)" "unprognostic (4.46e-1)" "unprognostic (5.98e-2)" "unprognostic (6.11e-3)" "unprognostic (4.21e-2)" "unprognostic (7.56e-2)" "unprognostic (1.34e-2)" "unprognostic (4.03e-2)" 2.8 7.1 3.7 1.6 4.2 0.6 3.1 3.9 5.6 2.9 4.3 3.5 3.1 3.6 3.5 6.3 2.2 3.7 3.0 4.5 3.9 4.7 2.9 2.7 2.0 4.2 4.2 3.8 2.5 7.9 3.4 2.6 2.4 5.0 4.0 3.2 6.4 4.5 3.9 5.8 4.4 3.1 6.0 4.0 2.6 3.8 6.2 4.1 1.9 5.3 4.5 2.6 3.7 3.8 4.6 4.0 5.9 9.4 11.3 6.7 4.8 4.1 5.0 5.2 8.6 11.2 3.1 1.5 1.9 3.6 10.3 6.1 3.5 9.1 3.8 7.2 2.1 5.2 6.2 2.1 5.3 6.9 2.7 2.8 3.0 6.5 6.7 6.8 13.3 5.6 4.4 5.5 1.3 7.5 1.8 2.6 3.1 4.1 6.3 3.0 1.7 6.5 2.5 9.4 3.3 6.4 4.9 5.4 6.3 4.6 7.7 2.9 4.4 6.6 5.8 4.4 13.4 10.8 1.5 2.9 1.7 4.0 3.3 5.8 1.2 2.2 0.6 1.0 2.5 1.1 0.3 0.7 0.9 2.4 0.3 0.7 0.8 1.1 1.1 1.7 0.6 0.8 1.1 3.7 4.2 3.9 5.6 4.5 3.9 4.2 4.2 3.8 5.0 4.0 4.1 4.6 4.3 3.2 14.1 9.4 3.2 6.9 4.3 4.7 4.0 9.5 5.6 2.8 5.8 7.2 10.7 1.8 4.2 2.7 6.5 7.2 1.9 11.7 95.8 18.0 3.1 5.3 5.4 3.8 22.4 5.8 1.1 4.6 5.1 11.1 12.0 14.7 4.6 4.6 4.9 5.0 19.1 4.4 10.2 7.6 17.7 111.7 5.0 6.8 10.6 7.5 6.4 5.0 4.1 10.6 47.5 6.3 8.3 6.4 4.0 8.0 7.4 5.5 9.8 10.7 0.0 4.5 4.8 16.8 9.7 5.8 11.5 5.7 6.3 7.3 5.0 8.1 ANXA11 ANX11 ENSG00000122359 "Annexin A11" P50995 10 80150889-80205572 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 443.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004851, HPA027545" Supported Supported Nucleoplasm,Cytosol NA NA 210000 Nucleoplasm Cytosol "CAB004851: AB_626682, HPA027545: AB_1844851" "unprognostic (1.85e-2)" "unprognostic (2.85e-2)" "unprognostic (5.35e-3)" "unprognostic (5.06e-2)" "unprognostic (8.18e-3)" "unprognostic (1.99e-1)" "unprognostic (4.01e-3)" "unprognostic (6.28e-2)" "unprognostic (2.32e-2)" "unprognostic (4.88e-2)" "unprognostic (3.46e-2)" "unprognostic (2.56e-2)" "prognostic favorable (6.69e-8)" "unprognostic (2.69e-3)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (2.02e-1)" 124.9 29.7 37.8 100.3 41.2 194.7 108.5 27.6 44.9 75.5 47.7 131.5 139.3 74.9 108.4 212.2 110.0 85.6 238.4 45.3 44.0 125.3 48.1 110.4 81.9 27.5 24.7 36.9 78.9 96.2 82.4 27.4 91.8 29.4 101.2 121.9 4.9 94.8 82.6 190.7 72.3 138.4 86.7 26.8 76.8 140.6 24.7 26.4 101.1 61.9 167.7 102.6 149.5 103.7 29.0 221.7 195.7 10.4 53.9 220.2 201.1 119.6 149.5 397.3 95.7 98.8 168.7 338.2 13.1 113.6 236.7 8.1 277.7 44.6 136.2 54.2 384.3 76.0 84.4 98.9 131.5 129.4 92.0 212.3 222.9 74.6 57.8 39.4 178.9 143.9 117.9 82.1 163.7 76.8 127.3 119.8 200.9 19.6 211.5 367.7 91.7 14.9 344.0 155.1 191.8 5.1 37.9 65.0 269.9 156.4 83.4 80.6 120.6 160.0 68.7 101.4 157.6 84.4 91.7 145.6 96.0 66.6 155.4 47.4 130.8 66.8 443.8 72.9 52.4 75.0 64.9 92.5 100.5 49.4 54.2 83.7 74.4 231.8 61.3 59.1 78.5 126.5 85.4 37.8 41.2 27.6 44.9 45.3 44.0 27.5 24.7 36.9 29.4 26.8 26.4 29.0 150.5 96.1 78.4 17.3 101.4 51.2 266.4 219.4 92.8 1.6 58.8 50.4 293.3 203.0 227.1 220.7 0.0 271.7 137.1 457.7 332.6 429.2 4.5 180.6 49.7 82.7 77.5 29.9 29.5 352.5 309.8 113.1 175.8 265.7 116.1 81.4 91.4 40.8 228.1 3.3 15.5 186.9 97.6 149.7 167.4 9.6 92.9 155.0 90.7 24.4 208.2 38.9 159.6 3.0 2.3 420.6 461.0 92.6 98.2 414.9 367.7 156.8 229.0 2.8 92.1 56.4 137.9 2.8 51.5 98.4 42.1 185.5 131.9 50.8 227.8 581.4 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668507-86736072 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 26 "heart muscle: 1079.8;skeletal muscle: 2973.6;tongue: 1825.5" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 1825.0" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 750000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: AB_2680568" "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 9.2 1.4 12.9 2.8 35.5 0.4 6.6 26.8 32.4 9.6 1.7 26.0 2.4 15.2 5.0 55.0 17.4 3.1 1079.8 12.5 23.2 2.0 0.8 5.2 0.5 52.7 36.0 6.5 6.4 1.3 0.5 2.4 2.8 52.5 38.5 5.4 0.7 21.0 25.4 2973.6 4.0 8.9 23.9 32.2 0.6 9.1 4.8 30.8 0.7 5.2 1825.5 0.3 7.0 10.3 76.2 0.1 0.1 0.2 1.7 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.4 0.4 0.7 0.0 0.0 0.0 0.9 3.0 0.2 0.0 0.0 3.3 0.0 0.3 0.1 1.0 0.0 0.8 0.2 0.1 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.6 4.9 0.9 0.2 0.1 2.4 0.7 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.9 35.5 26.8 32.4 12.5 23.2 52.7 36.0 6.5 52.5 32.2 30.8 76.2 1.5 0.0 0.0 1.0 0.0 1.0 0.5 0.2 0.0 1.5 0.2 0.3 1825.0 0.0 0.2 1.8 0.0 0.1 0.0 0.0 0.0 0.0 23.4 0.1 0.4 15.5 0.0 0.0 4.5 1.1 0.0 31.5 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.0 2.6 0.0 4.1 0.0 1.2 19.6 11.1 0.5 1.8 1.9 0.0 0.7 0.0 1.5 245.1 0.1 0.0 6.8 0.0 0.3 0.0 0.1 0.1 4.1 39.5 48.0 54.9 1.0 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654547-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;skeletal muscle: 2.6" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 4.6;Excitatory neurons: 2.8;Inhibitory neurons: 1.9;Smooth muscle cells: 2.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 6.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved NA NA "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 1.2 0.1 1.3 0.0 6.1 0.0 0.7 0.0 2.9 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.4 0.2 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.1 0.4 0.3 0.0 1.2 0.0 0.1 1.1 0.6 0.0 2.6 0.5 0.4 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.8 0.4 0.0 0.2 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.1 0.0 2.9 1.4 0.2 1.7 0.0 1.3 1.2 0.0 1.4 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHLD2 "bA163M19.1, FAM35A, FAM35A1, MGC5560, RINN2" ENSG00000122376 "Shieldin complex subunit 2" Q86V20 10 87094161-87191465 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 31.3;Endometrial stromal cells: 28.6;Glandular and luminal cells: 29.0;Proximal tubular cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favorable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 14.9 20.3 9.6 12.7 8.1 9.7 17.5 7.2 10.5 11.7 9.9 15.8 22.5 11.5 7.0 12.9 11.3 10.8 9.7 8.9 9.5 32.4 37.5 11.7 13.2 28.0 9.4 8.5 12.8 12.6 6.1 11.0 9.8 11.7 15.1 16.6 15.8 14.4 9.6 10.7 11.8 25.0 12.3 8.1 12.0 12.1 8.1 13.1 10.5 23.5 11.8 14.6 13.4 11.3 10.5 33.6 26.7 14.9 34.4 16.4 15.8 21.7 22.1 31.0 29.0 31.8 30.8 25.2 24.4 12.1 30.2 17.0 21.9 37.2 16.9 29.8 35.1 24.6 33.9 24.3 29.1 25.4 53.4 28.5 14.5 30.4 26.6 45.4 25.6 19.6 26.3 43.7 42.7 27.2 19.2 43.7 37.8 17.2 24.2 18.4 26.8 29.6 27.0 26.6 27.7 7.4 30.6 17.1 19.9 29.8 13.7 44.0 29.6 19.4 16.5 15.0 24.8 44.7 23.9 55.8 58.5 27.8 65.4 9.1 7.1 7.3 2.8 6.7 11.8 13.7 9.2 10.0 10.0 11.3 8.8 10.0 10.1 0.1 12.5 9.5 3.9 10.4 8.7 9.6 8.1 7.2 10.5 8.9 9.5 28.0 9.4 8.5 11.7 8.1 13.1 10.5 21.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 20.9 13.2 0.0 0.0 0.0 5.5 0.0 7.2 17.4 0.0 31.3 12.6 0.0 16.7 28.6 4.2 0.0 0.0 0.0 13.7 15.1 7.9 0.0 29.0 0.0 20.2 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 8.8 0.0 0.0 0.0 0.0 14.7 0.0 0.0 7.6 0.0 0.0 48.2 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 2.2 7.8 19.1 0.0 0.0 PRXL2A "Adrx, C10orf58, FAM213A, MGC4248, PAMM" ENSG00000122378 "Peroxiredoxin like 2A" Q9BRX8 10 80407829-80437115 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Antioxidant "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 409.3" "Group enriched" "Detected in some" 7 "Adipocytes: 161.4;Cardiomyocytes: 161.5;Hofbauer cells: 75.1;Smooth muscle cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "plasmacytoid DC: 166.0" "Lineage enriched" "Detected in all" 11 "dendritic cells: 166.0" "Cell line enhanced" "Detected in many" "ASC diff: 947.9;HaCaT: 276.4;HUVEC TERT2: 436.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009025, HPA024565" Enhanced "Secreted in other tissues" NA NA "HPA009025: AB_1078312, HPA024565: AB_1845519" "unprognostic (1.73e-2)" "unprognostic (2.96e-2)" "unprognostic (6.96e-3)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (4.31e-2)" "unprognostic (3.14e-1)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (7.01e-2)" "unprognostic (3.54e-2)" "unprognostic (2.83e-3)" "unprognostic (3.32e-3)" "unprognostic (3.55e-1)" "unprognostic (6.78e-2)" "unprognostic (1.80e-1)" "prognostic favorable (6.11e-4)" 409.3 25.3 106.7 16.0 102.5 3.7 212.0 95.0 120.8 92.7 110.7 52.3 84.8 53.0 214.7 84.6 31.2 31.0 68.2 113.8 98.6 111.9 198.9 21.1 18.1 103.5 104.0 92.9 31.0 66.6 69.6 59.5 45.6 102.9 71.0 43.7 43.2 51.0 44.7 50.2 81.8 60.3 20.0 97.1 12.4 25.0 51.9 126.9 35.1 55.6 76.4 27.1 72.1 52.4 96.4 26.0 62.9 105.3 0.4 947.9 0.1 7.2 4.0 22.0 2.0 0.5 60.1 76.3 16.6 82.1 0.3 47.1 276.4 9.5 10.9 0.5 1.1 17.6 32.5 23.8 89.0 91.9 0.3 9.0 71.1 20.2 6.7 0.3 250.1 436.7 95.1 26.9 0.6 0.0 89.6 41.9 4.7 51.2 39.1 0.3 117.5 48.5 0.8 223.1 106.2 107.6 76.6 11.0 147.7 168.4 78.9 66.2 46.2 119.1 0.6 1.0 0.5 0.6 9.3 22.0 0.4 66.0 0.6 7.6 1.3 3.5 11.6 6.6 0.8 5.1 15.8 3.7 5.5 3.3 11.1 13.4 13.9 2.2 6.2 0.2 166.0 0.2 4.8 106.7 102.5 95.0 120.8 113.8 98.6 103.5 104.0 92.9 102.9 97.1 126.9 96.4 161.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.5 0.0 0.0 0.0 0.0 13.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 7.4 13.4 0.0 0.0 0.0 0.0 0.0 0.0 75.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 ZNF205 "Zfp13, ZNF210" ENSG00000122386 "Zinc finger protein 205" O95201 16 3112560-3120517 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001791 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001791: AB_1080688" "unprognostic (8.46e-2)" "unprognostic (1.57e-1)" "unprognostic (1.94e-2)" "unprognostic (5.72e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-2)" "unprognostic (1.98e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.71e-2)" "unprognostic (7.26e-2)" "unprognostic (6.17e-2)" "unprognostic (4.15e-2)" "unprognostic (3.46e-2)" "unprognostic (8.41e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-3)" 9.5 10.5 7.4 4.1 5.6 1.9 10.2 17.0 10.0 11.7 3.5 10.6 8.1 13.1 2.0 10.8 11.2 6.3 11.0 5.8 5.2 12.1 14.1 9.3 3.1 6.7 6.0 4.8 14.5 16.4 6.9 10.7 5.6 9.0 14.1 3.2 4.0 10.6 5.3 20.6 14.2 7.8 4.5 4.1 7.7 12.0 3.8 6.1 1.6 11.6 6.9 1.6 10.0 10.8 8.8 11.0 14.3 12.2 19.6 4.7 6.2 16.5 9.0 9.3 11.5 14.1 7.6 10.2 0.4 11.4 5.6 7.4 16.5 10.8 9.3 5.5 2.9 22.1 4.5 21.2 9.0 10.6 0.5 2.5 7.0 14.4 11.1 7.5 11.9 13.4 0.2 9.9 8.1 5.8 18.6 0.2 0.5 12.8 7.2 11.3 0.7 15.1 9.9 6.8 6.3 17.1 14.9 9.3 19.9 13.1 6.3 13.9 3.9 7.8 11.5 13.2 11.3 13.0 0.2 8.6 0.5 5.0 0.6 9.8 0.0 0.1 0.4 0.5 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.5 0.0 0.8 0.0 0.0 0.3 0.1 7.4 5.6 17.0 10.0 5.8 5.2 6.7 6.0 4.8 9.0 4.1 6.1 8.8 12.7 0.0 0.0 4.6 1.4 5.7 3.8 4.3 8.0 7.8 8.4 9.8 1.5 14.3 2.3 5.5 4.2 9.7 0.3 12.7 5.9 13.1 0.8 7.5 7.8 9.9 10.3 0.8 3.2 13.7 13.8 7.5 10.2 7.3 4.5 20.1 12.1 8.6 8.9 6.7 4.3 14.6 2.0 4.4 4.2 1.5 17.1 3.7 5.4 3.7 4.2 9.6 0.0 3.5 6.7 14.0 7.7 19.5 0.1 3.8 19.5 15.3 1.9 8.4 26.3 9.1 9.8 1.7 2.1 7.5 5.5 4.8 0.4 15.0 13.0 2.1 NAA60 "FLJ14154, NAT15" ENSG00000122390 "N-alpha-acetyltransferase 60, NatF catalytic subunit" Q9H7X0 16 3443649-3486953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromosome partition" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040916 Approved Uncertain "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA040916: AB_10794428" "unprognostic (8.59e-2)" "unprognostic (2.16e-3)" "unprognostic (3.39e-1)" "prognostic favorable (3.14e-4)" "unprognostic (1.81e-1)" "unprognostic (5.90e-2)" "unprognostic (2.88e-2)" "unprognostic (1.53e-2)" "unprognostic (5.23e-2)" "unprognostic (5.12e-2)" "prognostic favorable (4.30e-4)" "unprognostic (9.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.60e-2)" "unprognostic (8.96e-2)" "unprognostic (3.59e-1)" "unprognostic (6.74e-3)" 25.3 45.7 28.2 17.1 27.2 20.3 25.3 32.7 36.1 26.4 19.5 37.4 40.9 31.8 18.9 31.3 28.5 20.5 43.8 28.6 24.6 52.6 68.0 32.3 20.4 27.6 27.5 24.0 27.0 48.3 49.5 41.9 19.6 26.8 35.5 22.8 16.4 26.2 24.2 43.3 23.7 39.6 19.3 25.9 43.3 59.3 33.0 27.3 19.7 32.2 21.3 16.8 28.7 23.4 27.8 16.8 61.9 40.1 44.1 26.5 19.4 39.1 26.9 25.0 29.3 26.6 43.9 30.5 31.7 30.0 29.6 21.0 37.4 40.1 31.2 29.4 49.7 27.8 35.4 25.7 53.0 32.9 53.1 45.6 24.4 27.9 20.4 38.9 29.2 45.1 29.4 44.8 41.4 19.4 73.6 33.4 36.3 50.1 35.8 18.1 42.3 30.8 47.5 27.7 29.7 21.6 42.5 45.8 48.3 24.6 38.5 40.2 34.7 30.8 36.0 27.7 12.8 26.7 35.2 33.6 30.5 12.1 29.0 29.2 33.3 18.6 53.8 17.7 20.6 19.2 11.6 15.8 17.7 18.1 11.0 12.3 16.4 20.0 18.4 23.6 11.6 20.1 19.5 28.2 27.2 32.7 36.1 28.6 24.6 27.6 27.5 24.0 26.8 25.9 27.3 27.8 26.3 9.6 16.0 24.8 17.7 0.1 13.4 0.1 17.6 21.2 24.5 16.4 15.5 38.6 5.6 12.9 6.2 28.3 22.7 66.7 43.0 30.1 55.7 33.3 25.7 21.0 27.0 18.7 22.2 41.7 40.0 18.0 37.2 30.9 30.4 18.4 26.7 53.5 32.1 11.8 26.5 43.1 0.0 34.8 0.3 54.4 11.5 23.6 0.0 25.3 27.0 29.3 26.8 22.1 34.8 37.0 54.3 15.8 15.4 20.2 84.2 49.0 3.7 15.3 26.3 16.8 17.7 19.6 24.5 16.5 0.3 33.0 22.9 21.1 35.3 23.5 RPL5 "L5, PPP1R135, uL18" ENSG00000122406 "Ribosomal protein L5" P46777 1 92832013-92841924 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Cancer-related genes, Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043717, HPA054444" Approved Supported "Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol" NA NA 430000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nucleoli rim" "HPA043717: AB_10964719, HPA054444: AB_2732584" "unprognostic (5.81e-3)" "unprognostic (3.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (9.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.03e-3)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (1.23e-1)" "unprognostic (3.98e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.81e-5)" "unprognostic (2.26e-2)" "unprognostic (3.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-1)" 1242.9 1043.6 531.3 794.1 552.4 1758.2 1816.7 541.0 784.4 1677.6 541.7 1266.2 805.2 1307.4 1400.8 1195.2 1432.9 653.3 872.3 506.0 565.4 864.7 801.4 801.6 1447.5 549.2 531.6 488.3 3386.5 2254.6 701.2 876.2 742.3 556.1 1112.5 991.4 349.6 1199.9 855.1 1125.0 1253.1 968.1 970.4 569.1 906.2 1144.9 377.2 563.9 1363.8 1190.0 838.0 1450.8 1320.7 1284.9 570.8 2211.5 924.6 1611.4 1369.2 2045.7 4096.6 2577.6 1283.0 1703.7 1560.0 1108.9 2467.5 933.6 4112.3 2002.9 1451.6 1477.1 1370.3 1871.2 2405.7 1976.3 1314.2 2557.4 2142.3 1402.4 2303.5 2447.2 3322.0 864.6 3382.6 3711.3 1390.4 3027.2 2813.9 2191.6 2129.9 2706.3 2106.7 1814.5 1247.7 2665.7 3741.2 2497.9 1659.1 1724.1 2407.7 3118.5 2702.2 1912.0 1798.7 1367.2 1632.0 836.3 2298.6 3961.6 1316.4 1268.8 4480.6 1345.5 781.6 1429.6 1498.4 2357.4 1290.8 1314.5 2793.5 531.3 2814.4 544.2 234.9 665.6 101.3 758.7 619.1 1520.2 1320.3 1385.5 1151.0 1138.3 1105.7 1729.8 1570.9 56.7 1005.7 552.2 942.7 1140.0 2356.3 531.3 552.4 541.0 784.4 506.0 565.4 549.2 531.6 488.3 556.1 569.1 563.9 570.8 1586.8 653.9 1042.2 29.7 3056.7 2843.0 4383.1 2206.0 3168.8 339.6 3182.0 5498.6 375.2 1522.7 1266.7 412.0 89.6 2557.1 2009.8 595.2 1993.7 1697.1 1438.3 840.8 2334.8 1567.8 1236.6 1980.6 35.0 2708.5 4211.6 1464.3 978.1 1009.8 1041.9 2287.9 1546.3 1087.2 1452.5 146.4 33.8 1986.9 720.2 1758.7 2200.6 1189.4 2829.9 1536.8 1406.9 35.6 2171.5 806.3 1969.1 27.2 37.7 1851.6 1567.8 2156.4 2067.8 3935.4 1225.7 2454.6 571.0 298.8 1051.8 2546.2 2122.7 682.8 501.7 3198.9 2893.0 2613.1 2318.2 2797.0 2572.8 3991.1 ODF2L KIAA1229 ENSG00000122417 "Outer dense fiber of sperm tails 2 like" Q9ULJ1 1 86346824-86396342 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 335.7;Respiratory ciliated cells: 361.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028020, HPA028095, HPA028333" Uncertain NA NA "HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007" "unprognostic (4.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.03e-1)" "unprognostic (4.72e-2)" "unprognostic (2.92e-2)" "unprognostic (3.80e-3)" "unprognostic (5.61e-3)" "unprognostic (2.25e-1)" "unprognostic (2.08e-3)" "unprognostic (1.07e-1)" "unprognostic (6.27e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (4.69e-7)" "unprognostic (2.40e-1)" "unprognostic (5.86e-2)" "unprognostic (2.40e-1)" "unprognostic (5.04e-3)" 21.1 20.4 16.0 14.1 17.0 17.2 23.2 18.3 21.3 20.6 14.5 17.1 8.4 18.2 23.5 17.8 23.9 15.3 13.2 13.9 12.8 17.8 7.2 23.1 16.7 15.2 12.9 14.5 19.0 11.5 7.2 28.3 10.2 10.8 20.2 14.9 41.5 15.7 10.6 5.2 12.0 23.0 9.8 11.5 36.8 8.8 13.4 12.0 22.1 22.3 3.7 13.3 15.5 17.8 19.2 30.0 7.9 19.7 15.1 21.0 35.8 20.6 28.6 17.4 27.6 32.0 6.2 16.3 0.7 26.3 15.3 35.2 15.3 8.1 16.7 23.6 14.1 12.8 7.3 24.5 0.6 15.9 13.1 9.3 16.5 20.2 41.7 11.4 19.9 45.3 19.8 10.2 6.8 16.4 4.0 15.7 13.8 24.1 6.5 14.5 21.0 14.8 3.2 27.7 40.0 19.5 14.1 25.8 26.2 54.9 30.7 8.5 12.6 41.7 23.0 21.4 31.8 29.4 1.9 1.0 12.3 5.4 6.7 26.5 5.6 2.2 13.6 26.1 3.4 51.5 20.9 30.2 21.0 2.4 21.2 19.3 18.8 6.3 14.8 4.1 12.7 31.8 4.9 16.0 17.0 18.3 21.3 13.9 12.8 15.2 12.9 14.5 10.8 11.5 12.0 19.2 72.9 93.0 76.2 22.5 54.0 25.0 54.6 49.0 15.4 139.3 67.0 49.3 12.0 21.5 133.2 80.9 141.8 7.3 73.9 23.1 23.5 61.9 48.5 335.7 57.3 78.7 41.3 16.6 119.1 27.1 35.1 52.5 13.3 70.6 36.7 55.9 72.8 3.9 15.5 57.2 107.2 68.5 42.7 21.2 19.7 10.3 24.8 18.6 56.9 38.4 21.8 28.8 80.3 29.1 49.9 55.9 28.1 28.6 38.9 16.5 9.3 23.1 361.9 120.3 19.7 24.3 32.1 64.0 27.4 19.2 17.3 2.9 106.4 60.6 28.2 67.3 PTGFR FP ENSG00000122420 "Prostaglandin F receptor" P43088 1 78303884-78540701 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 20.3" "Cell type enhanced" "Detected in many" "Club cells: 14.3;Fibroblasts: 22.7;Inhibitory neurons: 10.4;Langerhans cells: 10.6;Microglial cells: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "ASC TERT1: 271.2;HSkMC: 85.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.14e-2)" "unprognostic (1.35e-2)" "unprognostic (5.89e-3)" "unprognostic (6.03e-2)" "unprognostic (5.63e-2)" "unprognostic (1.45e-3)" "unprognostic (7.61e-2)" "unprognostic (2.25e-1)" "unprognostic (9.90e-2)" "unprognostic (8.46e-4)" "unprognostic (2.21e-1)" "unprognostic (5.34e-2)" "unprognostic (2.16e-4)" "unprognostic (3.21e-4)" "unprognostic (8.48e-2)" "unprognostic (2.16e-2)" "unprognostic (1.21e-3)" 6.6 3.5 0.6 5.7 0.4 0.0 7.3 0.1 1.8 4.7 0.5 2.0 1.0 18.0 2.4 0.9 4.6 7.0 1.7 1.6 2.0 3.9 1.3 2.5 1.2 0.6 0.5 0.3 4.7 0.9 0.0 0.2 8.1 1.2 3.1 2.7 0.2 4.7 2.0 2.1 4.7 2.5 16.8 0.4 0.6 1.7 1.4 2.5 0.1 0.8 20.3 4.3 12.0 4.4 0.4 0.0 0.0 1.0 0.0 26.5 271.2 0.0 20.5 20.0 7.0 2.7 0.0 0.0 0.0 0.0 12.4 3.8 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 85.7 0.0 1.8 17.6 18.3 0.1 0.0 0.0 0.7 10.9 0.0 0.0 0.0 0.1 0.0 15.9 0.0 0.0 0.0 2.4 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.2 5.9 8.5 4.7 2.1 1.6 1.1 0.0 0.0 0.5 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.8 1.6 2.0 0.6 0.5 0.3 1.2 0.4 2.5 0.4 1.2 0.0 8.0 0.3 0.0 6.4 0.0 1.0 0.0 1.2 0.2 0.0 0.4 5.7 14.3 9.2 0.0 0.1 0.0 0.0 3.9 4.2 8.5 0.4 0.6 0.6 0.0 0.0 0.4 0.0 0.0 22.7 0.5 0.1 0.0 0.1 0.0 2.3 0.1 0.0 10.4 0.0 0.0 0.0 10.6 9.3 5.6 0.4 5.4 17.8 0.0 0.3 0.0 0.0 0.2 0.0 1.1 0.4 0.2 0.1 0.0 0.3 6.3 0.0 6.6 7.1 1.4 1.1 0.2 0.1 4.7 0.3 0.5 0.3 0.0 0.0 SPATA1 SP-2 ENSG00000122432 "Spermatogenesis associated 1" Q5VX52 1 84506300-84566194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 2.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Astrocytes: 12.7;Microglial cells: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.00e-3)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (2.46e-2)" "unprognostic (4.82e-2)" "unprognostic (8.84e-3)" "unprognostic (7.54e-2)" "unprognostic (2.77e-3)" "unprognostic (5.52e-4)" "unprognostic (2.03e-1)" "unprognostic (5.81e-8)" "unprognostic (1.63e-1)" "unprognostic (5.34e-1)" "unprognostic (7.71e-2)" "unprognostic (3.79e-4)" 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.1 0.1 0.3 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 2.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.3 0.3 0.2 0.1 0.4 0.1 0.2 0.4 2.5 6.4 4.8 12.7 1.7 0.0 0.0 0.0 0.0 0.0 3.5 2.7 3.0 0.0 2.5 5.5 0.0 0.0 2.8 2.9 1.9 0.9 0.0 2.6 3.1 1.3 0.0 0.0 5.4 1.4 0.0 0.9 0.0 2.4 0.0 1.7 0.0 0.0 0.0 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 8.4 1.6 0.0 0.0 4.5 5.0 0.3 2.2 0.0 0.3 0.0 0.0 1.8 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.7 1.3 0.0 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150498 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 8.8 8.8 6.9 12.3 9.7 5.2 14.7 10.2 9.7 11.1 7.1 8.9 11.3 14.0 12.0 8.6 9.3 7.2 8.1 6.9 8.6 7.6 8.8 7.9 18.4 8.8 9.4 5.5 13.6 11.6 13.0 6.9 10.8 8.8 10.5 11.4 21.8 9.2 8.2 13.2 14.8 10.8 10.2 7.8 14.2 10.1 9.5 8.9 11.4 12.1 6.3 14.7 9.6 10.3 15.6 17.5 10.0 16.5 11.5 8.7 16.9 18.0 18.0 7.1 13.4 11.1 11.9 7.0 28.7 21.8 14.4 8.9 15.4 30.6 14.0 23.1 29.0 24.2 17.2 23.1 11.6 15.7 30.0 15.4 11.9 15.5 25.5 33.3 8.4 12.4 21.0 36.6 17.9 13.6 6.7 24.6 15.6 23.0 16.7 19.9 26.0 25.0 15.7 11.1 13.6 10.7 17.9 16.6 15.8 21.6 16.1 9.3 26.1 13.0 17.8 11.9 15.1 24.3 22.8 20.0 34.0 20.1 23.5 7.0 0.2 5.8 3.1 10.5 6.1 13.0 19.9 11.3 10.6 7.0 18.7 16.8 14.0 2.5 7.9 5.1 12.8 8.6 5.6 6.9 9.7 10.2 9.7 6.9 8.6 8.8 9.4 5.5 8.8 7.8 8.9 15.6 13.1 25.6 17.0 34.0 29.0 9.7 14.2 14.2 19.9 38.9 10.7 7.9 11.1 12.8 22.2 14.7 29.2 14.2 18.9 8.0 13.7 10.5 20.9 14.3 21.0 15.7 20.4 11.3 23.1 6.1 10.2 13.7 11.7 8.0 21.5 18.7 17.9 11.4 7.6 28.6 32.1 9.9 18.3 10.1 7.0 6.0 24.8 10.3 10.6 25.3 14.7 16.6 41.2 33.7 97.4 8.5 9.6 18.4 9.0 12.6 13.0 10.7 20.4 44.7 19.7 16.0 13.4 47.6 21.9 12.2 11.9 7.3 21.5 15.8 13.6 10.0 LRRC39 "MGC14816, myomasp" ENSG00000122477 "Leucine rich repeat containing 39" Q96DD0 1 100148448-100178273 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 108.0;retina: 119.0;skeletal muscle: 435.1;tongue: 174.4" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 96.4;Cone photoreceptor cells: 60.5;Early spermatids: 204.8;Hofbauer cells: 76.4;Inhibitory neurons: 62.2;Rod photoreceptor cells: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA077159 Enhanced NA NA "HPA077159: AB_2732333" "unprognostic (7.68e-2)" "unprognostic (3.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-1)" "unprognostic (6.40e-2)" "unprognostic (1.27e-1)" "unprognostic (4.07e-3)" "unprognostic (1.58e-2)" "unprognostic (1.87e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (8.17e-2)" "unprognostic (1.79e-1)" "unprognostic (3.38e-4)" 1.9 9.8 3.9 1.5 4.3 1.6 1.9 3.4 4.6 1.6 1.9 1.6 1.0 1.4 1.4 4.2 1.7 1.1 108.0 3.5 4.0 1.7 2.6 1.7 2.4 4.4 3.6 3.6 1.6 1.6 5.4 2.3 4.3 3.4 4.3 0.6 119.0 2.9 0.5 435.1 3.9 1.7 0.7 2.7 2.3 1.7 6.5 4.4 1.1 1.9 174.4 0.9 1.7 1.3 4.2 0.4 0.5 1.8 2.4 0.4 0.8 1.5 0.8 0.3 0.3 0.7 0.1 1.1 2.0 0.9 0.3 0.4 1.1 0.2 0.2 0.7 0.3 1.7 0.9 2.4 0.4 0.2 0.6 1.1 1.5 0.3 0.3 0.1 0.5 0.3 1.5 0.9 1.7 0.5 0.3 1.0 2.4 0.8 0.5 0.6 1.0 0.8 0.8 0.3 0.6 0.7 2.5 0.5 0.7 6.7 0.6 0.6 1.4 0.5 1.0 0.9 1.3 1.6 3.2 1.6 0.7 1.7 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 4.3 3.4 4.6 3.5 4.0 4.4 3.6 3.6 3.4 2.7 4.4 4.2 0.3 0.0 1.3 6.8 0.4 0.1 0.1 0.0 0.0 13.1 0.3 0.1 96.4 0.0 0.0 0.0 60.5 0.5 0.3 0.3 0.0 0.2 204.8 0.2 0.5 1.8 0.0 0.0 14.6 0.6 0.6 3.8 0.0 0.5 1.3 0.2 0.7 0.2 76.4 18.5 62.2 0.0 0.0 0.3 0.0 21.7 2.1 8.0 0.0 1.9 0.8 8.1 1.0 5.5 10.2 0.3 0.1 0.4 0.5 0.1 0.0 0.0 0.7 74.2 0.0 8.6 1.4 9.9 1.2 0.0 0.1 0.7 0.4 0.4 0.0 0.0 RWDD3 "DKFZP566K023, RSUME" ENSG00000122481 "RWD domain containing 3" Q9Y3V2 1 95234210-95247225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.87e-3)" "unprognostic (1.62e-1)" "unprognostic (1.99e-1)" "unprognostic (2.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.09e-1)" "unprognostic (7.54e-3)" "unprognostic (8.58e-3)" "unprognostic (9.48e-2)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.46e-8)" "unprognostic (2.58e-2)" "unprognostic (2.14e-1)" "unprognostic (9.37e-3)" "prognostic favorable (2.06e-4)" 6.5 7.1 6.2 5.4 6.5 5.9 9.3 6.2 9.2 9.2 6.1 7.4 5.6 9.6 10.0 5.4 9.9 5.1 13.3 6.1 6.1 7.5 8.6 5.2 9.1 6.4 6.2 6.2 8.7 7.4 5.9 6.0 6.8 6.1 8.8 6.9 6.8 7.7 7.6 10.6 5.8 6.2 7.7 6.1 7.5 7.1 4.3 6.0 7.5 7.4 8.5 6.8 8.5 8.0 6.5 14.6 5.0 17.2 5.3 11.1 15.2 9.9 7.8 10.3 9.2 10.5 7.8 4.6 12.7 13.0 10.3 21.5 8.2 7.5 8.9 9.8 9.4 6.6 8.1 6.7 10.3 13.3 7.2 4.6 15.1 9.3 5.0 7.0 15.2 14.0 14.1 10.4 6.2 12.5 2.4 8.4 8.9 8.4 6.1 7.7 10.4 25.3 3.7 11.7 7.4 5.1 9.9 7.5 11.2 20.1 11.0 3.3 12.6 9.1 6.2 6.5 4.6 7.3 5.8 5.9 8.7 3.3 6.6 6.2 24.9 12.3 19.9 13.9 13.6 17.8 28.1 18.1 13.5 15.1 27.9 19.1 17.1 8.0 17.7 10.0 13.1 25.2 9.6 6.2 6.5 6.2 9.2 6.1 6.1 6.4 6.2 6.2 6.1 6.1 6.0 6.5 3.4 6.4 10.8 15.7 14.3 0.9 0.5 2.8 18.2 1.3 2.2 1.7 5.3 2.8 5.7 1.8 2.1 1.3 4.0 0.7 0.0 1.8 1.0 7.5 4.2 3.8 0.0 14.9 4.7 1.1 0.7 5.2 12.2 6.0 7.6 3.5 3.6 3.0 0.9 0.0 8.0 1.2 0.0 2.8 0.4 2.0 1.8 6.4 0.0 7.5 1.8 6.5 5.2 15.1 12.7 1.2 0.3 1.9 16.6 0.2 1.6 1.9 8.7 2.0 0.0 2.0 5.4 0.9 2.2 15.2 1.6 0.4 10.6 1.8 0.9 0.5 ZNF644 "BM-005, KIAA1221, MGC60165, MGC70410" ENSG00000122482 "Zinc finger protein 644" Q9H582 1 90915298-91022272 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057795 Uncertain Uncertain Vesicles NA NA Vesicles "HPA057795: AB_2683529" "unprognostic (8.20e-2)" "unprognostic (5.86e-3)" "prognostic favorable (4.27e-4)" "prognostic unfavorable (8.39e-4)" "unprognostic (3.19e-3)" "unprognostic (4.62e-3)" "unprognostic (8.04e-2)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (3.07e-1)" 12.1 9.9 21.0 11.9 25.1 17.4 17.3 27.4 22.2 15.8 16.5 13.4 8.5 17.4 11.5 10.3 11.0 10.3 10.1 18.0 19.7 11.1 20.0 10.4 16.1 21.0 23.6 15.4 14.9 9.7 12.7 8.0 13.3 23.0 11.7 13.6 11.3 15.6 10.5 14.6 10.5 10.5 12.3 22.3 13.3 10.6 13.2 22.1 19.9 18.8 17.5 15.4 13.6 12.2 31.4 24.1 11.2 32.0 17.1 14.9 17.1 19.4 21.0 21.1 22.1 24.1 15.4 8.3 29.0 23.2 15.6 29.3 19.1 31.6 23.7 33.4 21.5 19.8 38.3 21.8 21.1 20.6 34.6 11.9 16.3 27.0 22.4 30.1 20.8 23.8 21.6 26.8 32.0 23.6 9.5 27.9 30.0 30.3 12.5 22.7 28.7 52.3 16.6 23.5 21.5 25.8 20.6 24.5 19.1 55.2 21.7 12.4 33.7 19.0 24.5 21.3 20.4 31.9 24.5 17.8 39.7 10.3 25.8 12.9 5.4 3.5 4.0 4.6 3.6 5.3 6.8 5.0 5.3 4.4 5.2 6.4 5.5 1.1 9.9 3.8 5.4 4.4 2.6 21.0 25.1 27.4 22.2 18.0 19.7 21.0 23.6 15.4 23.0 22.3 22.1 31.4 72.6 70.5 30.0 98.9 85.9 54.2 98.9 45.0 48.3 37.3 49.8 45.0 51.2 28.6 47.0 11.0 25.0 25.6 85.2 34.3 31.3 31.1 11.4 87.3 68.7 44.9 55.0 30.9 96.0 22.6 19.6 51.8 43.8 107.9 43.2 51.9 27.1 26.1 22.5 55.5 106.2 30.4 36.7 29.2 38.6 13.3 46.6 49.7 35.6 124.6 30.7 40.2 38.1 144.3 262.3 29.6 29.2 34.6 79.6 58.8 22.2 29.2 41.7 36.8 52.6 83.5 67.4 51.5 49.2 39.8 47.5 12.0 72.9 44.5 34.0 75.2 CCDC18 NY-SAR-41 ENSG00000122483 "Coiled-coil domain containing 18" Q5T9S5 1 93179919-93278730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.7;lymphoid tissue: 9.0;testis: 9.6" "Cell type enhanced" "Detected in many" "Early spermatids: 50.5;Spermatocytes: 137.2;Spermatogonia: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028035 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028035: AB_10601795" "unprognostic (8.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (1.49e-4)" "unprognostic (4.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.44e-2)" "unprognostic (3.41e-2)" "unprognostic (1.63e-2)" "unprognostic (3.50e-2)" "unprognostic (3.64e-13)" "unprognostic (4.94e-2)" "unprognostic (9.19e-2)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" 1.9 1.0 1.5 4.4 1.5 10.7 1.1 1.7 1.3 0.9 1.1 1.9 1.8 1.2 0.9 1.6 0.7 1.1 0.9 1.3 2.4 0.6 2.0 1.7 9.0 1.5 1.4 0.6 1.3 0.4 0.3 0.8 1.3 1.5 0.6 2.8 0.6 0.7 0.3 2.0 2.2 1.6 1.2 1.5 3.5 1.5 9.6 1.3 6.6 0.7 0.9 6.0 1.6 0.9 2.5 24.8 8.1 18.7 5.9 4.5 4.7 9.7 15.1 7.9 15.1 15.3 4.3 8.3 31.9 8.2 8.1 14.7 11.5 8.2 11.8 21.9 15.9 10.7 21.9 18.5 7.6 1.6 23.1 9.8 3.1 1.0 11.5 11.1 4.2 10.0 14.0 23.8 23.9 20.4 3.5 11.1 9.3 17.1 6.7 10.0 14.0 22.3 9.4 7.4 10.9 8.2 5.2 21.4 10.8 6.1 8.3 5.1 13.3 7.7 17.7 12.4 11.5 17.5 10.2 14.5 18.8 3.7 20.1 4.8 5.1 3.6 5.8 2.3 4.1 2.7 10.2 2.1 2.2 1.7 11.6 1.7 1.9 6.0 1.2 3.8 12.5 2.5 0.5 1.5 1.5 1.7 1.3 1.3 2.4 1.5 1.4 0.6 1.5 1.5 1.3 2.5 5.0 19.2 9.6 16.6 17.6 4.1 7.9 4.5 8.0 2.4 3.8 4.2 9.5 0.0 3.6 3.7 4.2 5.7 18.4 3.6 0.0 2.3 50.5 6.6 7.6 4.6 0.0 40.2 13.2 2.9 6.7 8.8 8.2 6.1 19.0 13.5 5.0 4.5 8.2 1.7 12.6 3.2 6.1 14.2 10.4 16.3 6.2 17.5 3.6 15.0 12.9 0.7 7.2 7.5 15.7 2.0 4.4 6.4 22.7 4.6 2.1 1.5 5.6 0.7 6.6 9.8 8.1 137.2 47.7 8.2 7.2 2.9 15.7 5.1 6.9 8.9 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92299059-92402056 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol No No "Nucleoli, Cytosol" "HPA046443: AB_2679669" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 1.4 1.9 3.5 2.2 4.5 3.9 2.2 12.9 9.0 1.6 0.3 1.5 1.8 2.2 3.2 1.3 1.4 1.5 1.6 3.7 1.4 2.3 3.0 1.4 2.6 2.4 2.2 2.5 2.1 2.5 2.0 1.8 1.5 4.9 2.1 1.6 9.4 2.1 1.3 3.0 3.2 1.7 1.5 0.2 2.4 1.8 2.0 1.1 2.9 2.7 2.4 1.9 1.4 1.1 8.7 4.0 2.3 4.1 3.8 3.3 4.2 3.4 3.0 2.1 2.0 1.6 1.7 1.7 5.9 5.1 2.3 2.7 2.7 3.4 1.9 3.0 4.0 2.4 3.5 4.6 2.3 1.9 6.3 3.4 2.1 2.4 2.5 2.5 2.9 2.1 3.6 3.7 3.7 3.0 2.0 5.4 3.9 3.1 2.2 2.7 3.9 5.4 2.5 2.6 3.4 3.8 2.7 4.4 4.5 2.5 3.0 2.3 4.7 3.6 2.8 3.7 3.3 4.4 3.7 4.5 3.0 2.0 3.9 1.9 1.9 0.7 0.6 1.3 0.5 1.5 1.1 1.0 1.1 0.6 1.3 1.0 1.2 1.4 1.3 0.7 1.1 1.0 0.4 3.5 4.5 12.9 9.0 3.7 1.4 2.4 2.2 2.5 4.9 0.2 1.1 8.7 23.1 64.1 78.5 66.9 20.1 9.2 16.7 15.7 23.9 63.6 16.3 16.5 24.7 10.0 44.5 7.3 110.5 21.3 31.5 6.4 11.7 19.2 68.1 18.8 48.6 23.4 12.6 13.3 97.1 13.6 14.2 24.8 13.3 17.6 62.0 37.7 9.3 8.0 9.7 35.3 91.3 13.3 14.2 8.7 4.6 9.7 19.0 15.6 1.8 43.1 16.6 31.4 42.2 68.3 78.8 13.8 13.6 21.4 28.5 15.9 11.9 15.6 45.0 95.2 26.3 44.4 20.3 27.3 20.0 16.8 9.8 23.7 35.8 42.3 12.1 10.4 SLC66A2 "FLJ22378, PQLC1" ENSG00000122490 "Solute carrier family 66 member 2" Q8N2U9 18 79902420-79951657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 186.9" "Cell type enhanced" "Detected in some" "Adipocytes: 20.3;Cardiomyocytes: 10.8;Cytotrophoblasts: 14.3;dendritic cells: 9.6;Extravillous trophoblasts: 14.6;Hofbauer cells: 36.1;Syncytiotrophoblasts: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051666 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051666: AB_2681567" "unprognostic (6.03e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (6.45e-2)" "unprognostic (3.94e-2)" "unprognostic (2.07e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" "unprognostic (4.34e-1)" "unprognostic (1.40e-3)" "unprognostic (2.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.70e-2)" 56.9 24.6 27.3 14.5 25.6 38.7 53.8 20.8 40.4 29.0 26.7 34.8 9.8 27.6 5.6 46.8 27.2 14.6 29.6 31.5 23.9 48.6 186.9 37.8 18.2 29.9 26.2 25.7 21.7 34.1 11.6 24.0 10.4 27.1 32.5 7.6 7.2 39.2 10.0 84.6 54.2 24.7 8.6 23.3 34.7 25.8 77.6 30.6 12.4 68.9 26.1 9.0 26.6 34.4 25.1 34.8 11.7 11.9 23.0 26.0 16.6 16.0 22.4 15.1 17.6 16.6 15.6 18.5 14.6 8.5 20.4 10.3 34.8 16.2 23.8 4.7 44.3 23.8 18.2 16.7 42.6 30.9 44.2 44.5 18.6 23.2 16.2 6.2 9.0 15.3 15.8 6.9 11.6 9.2 26.6 22.1 47.6 3.9 4.7 31.5 38.7 12.4 24.6 12.0 24.4 34.8 15.7 16.9 21.3 25.6 3.1 12.7 48.0 19.4 26.8 27.2 14.3 17.2 5.8 10.0 18.8 20.5 53.2 12.1 0.3 1.7 2.0 0.6 1.7 0.4 0.8 0.7 0.3 1.9 0.6 0.9 1.1 1.2 1.0 1.6 3.5 0.8 0.8 27.3 25.6 20.8 40.4 31.5 23.9 29.9 26.2 25.7 27.1 23.3 30.6 25.1 20.3 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 14.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 14.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 20.8 2.0 0.0 0.0 0.0 BBS9 "B1, PTHB1" ENSG00000122507 "Bardet-Biedl syndrome 9" Q3SYG4 7 33109557-33877180 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 125.7;Excitatory neurons: 162.6;Inhibitory neurons: 159.0;Microglial cells: 266.1;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 366.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021289 Uncertain NA NA "HPA021289: AB_1845286" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.13e-1)" "unprognostic (3.17e-1)" "unprognostic (4.86e-1)" "unprognostic (2.34e-1)" "unprognostic (1.19e-3)" "unprognostic (2.27e-1)" "unprognostic (8.68e-2)" "unprognostic (4.13e-2)" "unprognostic (7.22e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.86e-4)" "unprognostic (2.75e-2)" "unprognostic (1.28e-1)" "unprognostic (5.20e-1)" "unprognostic (6.90e-3)" 6.6 8.1 9.2 2.5 10.3 1.9 6.8 8.9 7.8 9.8 12.3 5.5 0.7 5.8 4.2 4.7 6.9 3.8 6.1 8.1 10.0 6.8 4.3 5.9 3.4 9.9 9.3 6.2 9.6 3.9 10.5 13.3 4.5 10.0 7.0 3.0 22.1 6.3 5.8 3.6 5.2 4.2 4.4 10.1 4.9 4.4 10.0 10.3 5.5 11.5 3.6 3.0 6.3 8.5 10.6 3.1 3.2 6.0 6.4 12.1 11.0 2.7 3.7 11.7 3.4 10.1 2.7 5.2 4.7 4.4 8.5 9.6 3.9 3.1 7.0 8.3 2.3 4.8 0.9 5.6 3.2 5.3 1.4 2.1 10.1 3.8 6.6 2.6 10.5 8.8 9.9 2.8 5.5 7.3 2.9 3.0 2.5 3.3 4.6 4.4 3.6 2.0 2.7 4.4 1.4 2.7 5.2 7.6 3.3 6.6 8.8 8.0 0.8 4.0 3.3 4.9 6.9 2.3 6.8 10.3 6.6 8.7 2.3 5.4 4.9 2.9 4.5 4.9 4.6 5.5 4.4 4.5 5.3 2.4 4.4 4.3 5.4 1.1 7.4 2.3 0.9 5.6 2.9 9.2 10.3 8.9 7.8 8.1 10.0 9.9 9.3 6.2 10.0 10.1 10.3 10.6 7.3 3.2 3.7 125.7 6.9 3.7 6.7 3.1 7.4 6.8 3.6 3.4 14.2 2.8 5.0 5.5 29.2 3.6 4.3 1.8 3.9 3.7 28.6 17.6 7.2 7.4 3.6 3.8 162.6 1.5 4.6 7.3 5.1 3.6 0.0 5.9 5.3 2.5 3.7 5.0 159.0 2.7 8.2 2.5 2.9 6.6 4.1 3.4 1.8 266.1 2.2 7.8 4.1 238.8 366.6 1.5 0.5 5.7 8.1 1.6 1.8 3.8 15.6 51.2 0.0 6.0 5.5 25.6 14.7 6.0 3.3 2.5 7.1 4.6 2.3 4.3 PMS2 "H_DJ0042M02.9, HNPCC4, MLH4, PMSL2" ENSG00000122512 "PMS1 homolog 2, mismatch repair system component" P54278 7 5970925-6009106 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010235, HPA066490, HPA070310" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250" "unprognostic (5.13e-2)" "unprognostic (6.55e-3)" "unprognostic (1.54e-1)" "unprognostic (1.43e-3)" "unprognostic (5.14e-2)" "unprognostic (1.29e-1)" "unprognostic (7.36e-2)" "unprognostic (1.02e-1)" "unprognostic (7.43e-2)" "unprognostic (2.35e-1)" "unprognostic (1.86e-1)" "unprognostic (7.38e-2)" "prognostic favorable (1.23e-5)" "unprognostic (5.31e-2)" "unprognostic (2.01e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-2)" 5.3 5.2 5.8 5.3 7.4 5.8 6.5 6.5 7.8 4.8 3.0 4.8 5.8 5.0 5.1 5.3 5.7 4.0 4.1 7.2 6.8 10.5 4.8 4.5 8.4 5.7 5.5 6.5 5.7 4.0 11.1 4.6 4.8 6.3 5.2 4.8 8.5 5.8 5.5 4.5 11.9 5.4 5.4 4.2 6.0 5.0 4.0 5.4 8.9 9.2 3.5 9.0 5.1 5.0 7.3 15.1 16.7 12.9 32.2 9.0 13.6 10.9 7.8 5.8 6.6 5.6 14.0 9.9 28.2 8.7 10.9 17.2 19.6 19.2 6.6 8.0 11.3 7.2 12.0 12.5 10.1 15.9 15.8 9.4 15.1 14.8 5.4 22.3 11.4 13.7 15.2 22.9 12.6 11.9 15.5 5.2 17.1 13.3 7.6 9.6 16.3 15.3 14.0 16.4 11.0 11.9 25.7 13.3 23.0 16.2 18.0 27.1 11.8 12.4 9.3 21.2 14.2 14.6 19.8 32.8 27.5 7.2 15.3 22.9 5.0 2.9 1.9 4.5 4.1 4.9 3.4 3.5 3.8 3.0 3.4 4.4 3.4 1.4 2.3 1.8 3.1 3.4 3.4 5.8 7.4 6.5 7.8 7.2 6.8 5.7 5.5 6.5 6.3 4.2 5.4 7.3 12.2 12.8 8.2 11.4 13.6 5.0 9.3 10.9 15.9 13.2 10.7 11.3 3.2 12.8 9.7 11.0 22.9 9.4 15.2 1.8 35.2 5.5 9.9 11.0 14.6 10.1 5.4 8.4 14.0 3.3 6.3 6.6 8.2 11.8 5.1 11.4 7.9 7.6 5.2 30.3 12.2 2.2 10.2 7.1 5.9 6.6 12.8 6.3 7.2 5.6 8.7 7.8 20.6 3.5 8.3 4.7 2.6 10.1 9.6 12.6 2.2 39.5 9.3 14.3 26.3 10.0 8.0 34.5 11.7 10.5 8.1 12.7 11.4 11.9 2.6 11.1 ZMIZ2 "DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7" ENSG00000122515 "Zinc finger MIZ-type containing 2" Q8NF64 7 44748581-44769881 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Langerhans cells: 70.1;Late spermatids: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040716 Supported Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA040716: AB_10805826" "unprognostic (2.28e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-2)" "unprognostic (2.21e-2)" "unprognostic (9.46e-3)" "unprognostic (1.01e-3)" "prognostic unfavorable (6.82e-5)" "unprognostic (2.47e-1)" "unprognostic (2.36e-1)" "unprognostic (2.73e-1)" "unprognostic (5.89e-2)" "unprognostic (4.58e-2)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (1.66e-1)" "unprognostic (1.15e-1)" "unprognostic (3.15e-3)" 19.0 27.6 18.1 23.3 14.7 19.5 21.5 0.0 27.1 21.9 0.0 22.8 21.0 23.8 9.5 25.3 26.4 12.6 25.4 18.7 1.6 30.5 17.5 28.6 23.0 8.1 3.6 17.5 25.5 34.6 17.1 36.6 9.4 8.2 26.5 10.3 6.5 29.6 18.3 21.0 29.1 27.2 9.9 0.0 33.8 23.4 31.9 2.6 17.8 39.9 9.1 16.7 23.3 22.0 12.0 33.1 37.4 17.1 33.3 11.4 7.6 18.1 16.6 15.6 13.9 16.7 21.4 50.5 22.6 25.3 17.5 34.7 44.4 10.6 18.9 8.4 53.3 20.1 9.1 36.8 17.0 23.3 13.2 19.2 11.6 11.4 21.9 14.3 12.4 26.3 24.2 27.0 49.7 20.9 31.8 29.3 36.3 32.4 24.8 35.5 36.6 9.4 29.6 16.1 25.0 60.6 40.0 22.3 43.3 9.9 16.0 41.4 20.2 39.4 13.3 28.5 36.2 38.6 71.4 24.4 17.3 25.7 23.0 55.4 0.3 0.6 0.2 0.8 0.8 0.5 1.0 0.4 0.6 0.6 1.8 0.2 0.3 0.2 1.1 0.4 1.5 0.4 0.3 18.1 14.7 0.0 27.1 18.7 1.6 8.1 3.6 17.5 8.2 0.0 2.6 12.0 16.9 12.8 16.9 23.5 22.0 10.1 4.3 11.1 10.8 14.1 18.9 18.4 17.5 7.2 14.7 23.9 14.6 8.2 16.5 18.6 1.9 17.5 26.2 19.3 12.7 12.7 19.9 6.9 17.8 15.7 2.3 11.8 34.7 27.8 14.5 22.3 13.6 16.4 11.2 11.8 14.7 19.6 14.2 14.5 70.1 88.8 13.4 19.9 14.2 14.0 24.8 5.4 10.3 8.5 21.0 24.4 14.2 18.0 15.9 9.3 14.2 8.4 19.7 7.5 6.6 12.2 11.7 4.4 4.2 16.8 18.5 7.3 12.9 13.4 21.2 9.8 OCM OCM1 ENSG00000122543 Oncomodulin P0CE72 7 5879827-5886363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.2" "Cell type enhanced" "Detected in some" "Astrocytes: 2.6;Early spermatids: 2.3;Excitatory neurons: 8.6;Inhibitory neurons: 7.0;Late spermatids: 2.4;Microglial cells: 4.7;Oligodendrocytes: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 2.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " "unprognostic (1.79e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (1.50e-1)" "unprognostic (5.39e-2)" "unprognostic (1.31e-2)" "unprognostic (2.30e-2)" "unprognostic (7.62e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-3)" "unprognostic (6.13e-2)" "unprognostic (2.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.02e-1)" "unprognostic (3.23e-1)" "unprognostic (3.90e-4)" 0.2 0.2 3.0 0.3 2.2 0.7 0.5 2.5 3.2 0.3 1.8 0.2 0.0 0.1 0.9 0.2 0.3 0.2 0.1 2.2 2.2 0.3 0.3 0.2 2.1 2.3 2.1 2.3 0.3 0.2 0.0 0.3 0.0 2.2 0.3 0.2 0.6 0.3 0.3 0.1 0.7 0.7 0.1 2.0 1.2 0.2 2.1 2.4 0.8 0.3 0.0 0.8 0.1 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.8 0.4 0.2 0.1 0.4 1.1 0.3 0.0 1.4 1.5 0.4 0.6 0.0 0.2 0.0 2.7 0.4 3.0 2.2 2.5 3.2 2.2 2.2 2.3 2.1 2.3 2.2 2.0 2.4 2.3 0.1 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 7.0 0.0 0.0 0.6 0.0 2.4 0.0 0.1 0.0 4.7 0.3 0.5 1.0 1.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 SEPTIN7 "CDC10, CDC3, SEPT7, SEPT7A" ENSG00000122545 "Septin 7" Q16181 7 35800932-35907105 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 527.8" "Group enriched" "Detected in some" 4 "Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023309, HPA029524" Enhanced Approved "Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol" Yes No 4300000 "Actin filaments" "Nucleoli, Plasma membrane, Midbody, Cytosol" "HPA023309: AB_10600093, HPA029524: AB_10601573" "unprognostic (7.91e-3)" "unprognostic (6.89e-3)" "unprognostic (9.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (2.00e-2)" "unprognostic (4.43e-2)" "unprognostic (7.13e-2)" "unprognostic (3.56e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.43e-3)" 128.3 96.0 431.9 99.7 457.3 132.2 100.5 411.3 527.8 112.5 375.1 97.4 56.2 127.6 122.6 107.6 84.9 118.5 173.7 423.6 419.5 83.7 77.5 99.4 152.1 422.6 437.4 414.6 139.5 37.4 81.7 63.1 144.7 442.8 94.7 95.7 120.5 50.7 96.4 83.7 105.8 75.5 146.4 424.9 109.3 59.9 70.9 432.9 160.5 78.9 105.3 151.0 126.2 87.6 492.8 198.1 94.3 232.0 153.2 256.7 263.1 119.3 248.6 228.6 206.7 177.0 147.7 148.9 186.2 164.2 254.9 274.9 146.3 166.3 166.4 294.0 127.8 88.4 149.8 123.4 80.8 149.4 182.7 157.7 171.7 127.1 163.8 159.4 215.6 221.0 143.3 120.1 141.9 341.6 92.8 185.6 304.3 249.7 183.1 132.6 188.3 220.9 107.6 202.6 146.1 124.3 217.4 173.5 220.1 151.8 377.1 163.1 198.7 187.3 207.2 246.7 129.9 278.5 165.9 163.4 470.2 132.4 301.2 449.3 266.8 86.0 150.1 214.8 100.1 220.7 165.6 151.5 199.6 100.8 155.5 134.4 171.2 160.9 298.7 110.5 71.0 147.4 241.7 431.9 457.3 411.3 527.8 423.6 419.5 422.6 437.4 414.6 442.8 424.9 432.9 492.8 192.1 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 227.0 0.0 0.0 0.0 0.0 171.4 196.6 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 198.2 153.5 0.0 0.0 0.0 0.0 0.0 0.0 191.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.0 0.0 0.0 0.0 0.0 124.2 30.4 0.0 0.0 0.0 EEPD1 KIAA1706 ENSG00000122547 "Endonuclease/exonuclease/phosphatase family domain containing 1" Q7L9B9 7 36153254-36301538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.2" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 88.0;Oligodendrocytes: 175.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 51.8;neutrophil: 46.4" "Group enriched" "Detected in many" 6 "granulocytes: 51.8;T-cells: 23.0" "Cell line enhanced" "Detected in many" "HDLM-2: 18.3;PC-3: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053668 Approved "Nuclear speckles,Vesicles" NA NA "Nuclear speckles" Vesicles "HPA053668: AB_2682223" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-3)" "unprognostic (5.21e-3)" "unprognostic (1.14e-1)" "unprognostic (4.76e-1)" "unprognostic (1.19e-2)" "unprognostic (3.75e-2)" "unprognostic (7.89e-2)" "unprognostic (8.77e-2)" "unprognostic (7.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (4.59e-2)" 18.1 5.3 10.9 4.1 12.9 8.2 18.5 11.0 14.3 9.7 8.7 10.5 9.9 7.7 3.6 7.2 7.4 11.8 8.0 11.0 12.6 5.1 24.2 8.1 4.7 12.6 13.3 9.5 8.6 11.6 2.2 4.4 4.0 14.2 12.6 3.8 1.5 4.1 3.4 47.2 12.2 11.6 5.6 11.3 10.9 17.1 5.3 13.0 12.9 3.1 12.9 3.0 11.0 9.2 20.1 2.2 5.9 1.8 5.6 16.2 3.5 0.1 1.5 7.2 1.1 2.0 1.2 4.5 5.9 1.8 2.2 16.8 2.4 2.4 2.8 1.0 18.3 4.0 0.7 0.5 11.0 1.5 0.9 5.5 7.3 1.7 0.7 0.4 4.5 0.1 4.4 7.3 0.6 1.2 2.3 6.1 14.6 8.2 7.4 22.4 1.6 2.0 1.3 3.6 4.7 4.4 3.1 0.5 0.8 2.2 3.2 1.8 7.0 0.5 2.2 6.5 1.5 1.7 4.3 5.1 0.0 5.4 3.8 1.4 23.1 5.9 51.8 3.0 3.6 5.2 0.3 23.0 6.6 3.2 0.0 5.0 1.5 46.4 3.9 1.6 2.9 11.6 4.2 10.9 12.9 11.0 14.3 11.0 12.6 12.6 13.3 9.5 14.2 11.3 13.0 20.1 32.4 0.0 0.5 30.0 1.3 2.7 14.7 1.8 1.8 4.2 4.9 7.2 4.0 34.3 2.1 0.0 20.9 0.2 0.9 10.8 5.9 26.2 17.4 8.4 3.0 14.8 9.6 1.3 28.4 7.4 0.3 4.0 20.9 7.2 8.9 0.9 3.9 16.9 25.3 6.7 88.0 6.2 0.0 5.8 5.5 3.6 5.0 9.8 3.6 45.0 3.8 2.0 0.0 1.5 175.4 16.9 12.6 16.6 0.7 8.7 19.4 1.9 2.6 1.4 6.6 2.1 6.6 0.7 5.4 4.2 4.0 0.5 3.3 6.4 6.2 10.2 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.3" "Cell type enhanced" "Detected in all" "Early spermatids: 560.6;Late spermatids: 242.7;Oligodendrocyte precursor cells: 168.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favorable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 9.4 19.0 13.3 7.0 15.0 12.6 13.1 18.1 16.0 10.6 12.9 8.3 7.8 11.6 12.3 9.1 9.8 9.8 51.3 14.2 14.5 12.0 10.5 7.7 8.4 13.8 14.9 13.8 11.9 7.8 10.9 7.4 8.7 14.0 10.1 7.9 15.0 8.6 8.2 9.1 10.8 6.9 10.6 13.5 8.1 6.4 42.6 15.4 12.5 9.3 9.8 9.2 8.8 9.5 16.2 24.7 20.7 55.7 66.3 26.8 23.2 20.3 21.3 31.5 30.7 35.6 25.3 17.5 24.1 16.8 26.2 50.5 26.2 21.5 15.0 25.8 6.4 15.5 15.9 16.7 32.9 20.0 32.5 12.0 20.7 19.1 35.2 28.8 24.2 39.6 29.4 28.3 25.5 50.7 28.4 27.3 51.3 77.0 16.7 24.5 23.7 31.2 22.2 29.2 21.0 33.5 32.5 46.2 22.7 23.3 33.9 18.9 16.9 17.0 25.7 26.6 56.9 25.7 39.9 35.3 58.6 17.0 33.8 31.5 44.1 15.3 67.2 13.0 17.9 13.7 9.2 13.8 12.3 11.1 11.9 10.1 10.0 14.4 9.5 15.8 8.0 16.7 12.6 13.3 15.0 18.1 16.0 14.2 14.5 13.8 14.9 13.8 14.0 13.5 15.4 16.2 12.1 22.4 5.5 45.7 13.0 23.6 18.2 13.0 18.2 23.7 12.3 13.5 101.2 8.6 11.3 9.2 29.2 20.7 14.4 5.7 11.7 17.7 560.6 18.3 16.7 15.8 10.8 25.6 74.5 17.6 27.1 19.8 10.2 13.2 21.5 16.3 13.2 7.0 19.7 37.0 75.2 7.6 14.2 16.0 17.2 242.7 16.8 12.6 12.4 35.6 13.4 30.3 8.2 168.9 45.6 19.4 1.9 20.7 12.3 11.5 7.4 13.5 18.8 16.3 6.6 14.3 17.9 83.7 19.7 24.6 33.8 23.7 17.2 12.1 7.0 24.0 HERPUD2 FLJ22313 ENSG00000122557 "HERPUD family member 2" Q9BSE4 7 35632659-35697459 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 329.7;Late spermatids: 660.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015630, HPA076087" Approved Approved "Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "HPA015630: AB_1850609, HPA076087: AB_2686774" "unprognostic (1.85e-2)" "unprognostic (5.31e-3)" "unprognostic (2.76e-1)" "unprognostic (3.79e-1)" "unprognostic (3.46e-1)" "unprognostic (2.73e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.30e-2)" "unprognostic (7.95e-2)" "unprognostic (5.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" 17.0 13.8 16.7 19.8 19.6 33.9 14.8 18.4 19.3 17.2 18.5 15.6 16.1 21.2 15.2 21.4 16.7 19.4 16.8 16.0 16.0 16.3 23.7 21.3 21.6 17.9 17.1 15.5 32.9 29.1 14.4 10.4 17.9 17.2 15.3 17.0 23.2 15.0 13.0 16.5 23.3 16.9 18.0 16.1 24.6 17.3 26.2 17.4 18.2 23.5 14.6 19.9 18.5 16.1 21.1 36.4 13.1 25.5 28.2 34.0 26.7 18.0 25.4 31.3 14.6 16.9 15.3 39.3 28.2 35.0 28.9 58.4 41.7 12.7 16.8 22.4 17.0 16.3 18.5 17.1 12.6 29.3 17.2 20.9 31.5 31.4 18.1 29.6 32.9 24.8 32.9 28.2 34.8 27.3 19.3 21.1 31.3 19.5 23.8 15.9 22.6 34.0 20.0 20.4 16.4 23.8 37.9 35.3 30.5 23.0 42.2 31.5 25.0 28.9 26.1 29.4 24.5 19.9 45.0 57.4 28.0 24.9 27.9 48.0 8.8 7.4 23.2 11.0 8.4 12.6 4.8 9.7 12.0 6.3 7.0 6.1 8.6 12.4 13.7 11.3 3.8 10.1 5.7 16.7 19.6 18.4 19.3 16.0 16.0 17.9 17.1 15.5 17.2 16.1 17.4 21.1 30.8 25.6 17.1 66.6 48.1 16.8 17.0 9.0 20.5 14.1 12.0 12.7 12.8 20.0 11.8 5.5 8.4 17.6 57.4 19.8 17.6 25.0 329.7 20.5 19.3 21.5 14.3 27.4 25.8 28.9 25.0 23.2 24.5 25.5 36.8 24.4 24.3 21.8 17.5 11.8 44.2 11.8 12.2 25.1 20.0 660.5 27.4 27.3 23.2 31.9 28.5 24.0 40.2 37.2 34.7 34.7 16.0 25.2 42.8 17.9 24.3 12.7 11.1 13.9 13.1 26.5 26.6 45.0 18.7 19.9 15.8 31.1 83.2 16.6 14.2 20.3 CBX3 HP1Hs-gamma ENSG00000122565 "Chromobox 3" Q13185 7 26201162-26213607 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001973, HPA004902" Supported Supported "Nucleoplasm,Nuclear bodies" NA Yes 180000 Nucleoplasm "Nuclear bodies" "CAB001973: , HPA004902: AB_1850635" "prognostic unfavorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (4.84e-2)" "unprognostic (1.12e-2)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "prognostic unfavorable (2.20e-8)" "unprognostic (2.13e-2)" "unprognostic (3.95e-2)" "unprognostic (3.71e-3)" "prognostic unfavorable (4.00e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.56e-7)" "unprognostic (7.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.17e-1)" "unprognostic (5.78e-2)" 75.4 93.9 62.5 100.0 64.3 170.3 99.5 65.8 72.9 65.6 64.0 76.0 106.8 77.4 80.4 64.4 63.5 59.0 64.8 62.1 68.5 76.7 85.6 62.6 146.9 67.3 66.8 61.0 80.2 56.7 51.9 40.8 89.5 67.6 57.1 88.1 123.7 61.8 60.4 87.9 55.2 99.8 66.5 69.1 82.7 62.3 100.5 65.2 192.2 55.8 69.2 141.5 84.8 56.2 70.9 365.4 156.3 330.0 332.2 115.0 205.8 257.8 275.9 209.1 205.2 207.2 185.8 296.8 544.1 218.7 183.9 440.6 283.0 275.7 231.2 332.1 151.8 209.1 312.8 201.0 208.5 126.1 508.3 294.7 153.9 197.5 163.2 231.2 253.9 281.7 343.2 506.1 263.9 351.7 207.5 489.4 625.9 424.4 311.3 225.1 313.6 303.9 452.3 303.8 201.4 401.1 448.2 230.5 482.6 274.9 345.3 412.4 455.1 212.0 186.0 340.5 222.1 376.8 394.6 596.5 929.3 163.2 422.3 864.3 135.7 85.9 137.7 77.3 116.3 96.9 86.8 114.4 96.1 89.1 77.7 118.4 119.6 92.6 99.2 123.2 72.4 148.3 87.2 62.5 64.3 65.8 72.9 62.1 68.5 67.3 66.8 61.0 67.6 69.1 65.2 70.9 139.1 109.0 98.4 16.3 158.5 143.6 93.3 128.0 105.3 101.8 223.8 181.0 124.1 133.0 119.7 64.4 77.2 176.3 138.7 111.2 140.8 167.6 162.2 132.4 215.4 142.6 110.2 306.6 27.4 141.4 362.1 123.6 81.1 129.0 222.0 166.2 145.3 289.2 143.1 50.5 26.8 156.6 107.8 254.9 200.0 41.9 136.4 157.6 104.9 15.0 183.3 155.9 166.9 23.1 35.8 166.3 103.8 98.2 129.1 135.1 112.6 187.4 107.3 132.1 78.9 60.0 110.1 274.5 388.6 112.5 107.8 270.8 155.2 133.1 205.9 110.9 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26171151-26201529 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 321.2 424.8 110.0 152.8 115.5 78.3 316.8 121.0 141.5 403.5 113.4 356.8 126.0 407.7 117.1 421.0 379.5 62.9 435.8 109.8 113.6 377.0 391.7 368.1 185.6 115.7 113.9 105.7 532.2 353.1 81.4 340.2 119.9 117.8 303.3 128.7 132.3 327.7 79.9 771.2 268.7 422.5 85.0 113.4 451.1 356.4 373.4 115.5 176.4 370.2 92.8 173.9 342.8 363.9 121.6 202.5 101.8 491.6 312.7 110.7 117.5 249.6 255.8 110.7 149.6 183.6 159.8 338.5 210.2 104.2 180.1 218.8 300.0 196.3 268.7 288.5 74.9 191.2 232.6 309.9 212.1 72.9 374.6 359.4 123.6 192.4 156.3 253.3 194.6 161.1 273.9 210.9 250.4 280.4 229.1 216.5 817.2 320.7 81.7 117.7 239.5 122.1 159.3 287.0 335.8 190.7 245.6 203.5 291.8 127.7 393.6 326.3 359.7 222.0 193.2 265.6 184.6 253.7 367.0 296.0 308.7 149.9 453.8 316.5 0.0 1.7 1.3 4.8 1.0 4.0 2.7 3.0 0.8 0.8 0.8 2.7 2.6 0.6 3.3 0.8 1.6 1.0 0.5 110.0 115.5 121.0 141.5 109.8 113.6 115.7 113.9 105.7 117.8 113.4 115.5 121.6 717.8 487.2 591.0 194.6 667.5 738.5 797.7 793.2 560.5 469.4 361.0 361.3 702.1 316.0 665.8 343.9 298.2 971.6 707.7 435.1 461.8 568.0 128.2 465.8 640.8 600.5 491.4 683.2 123.3 452.2 939.9 602.7 449.6 591.1 644.7 680.5 333.4 382.8 613.1 312.9 147.2 533.1 496.4 388.5 681.9 150.0 411.0 640.3 393.1 157.4 572.0 545.4 484.1 198.0 320.6 438.2 438.7 390.0 751.0 520.4 428.4 506.8 608.0 547.0 440.4 599.4 726.5 596.9 490.6 573.8 600.5 1082.8 701.7 652.2 541.4 632.1 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6;ovary: 42.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 45.1;Granulosa cells: 149.4;Leydig cells: 50.7;Peritubular cells: 100.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 49.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 18.1;HEK 293: 4.1;K-562: 6.6;NTERA-2: 5.1;RPMI-8226: 11.3;SK-MEL-30: 4.5" "Region enhanced" "Detected in all" "hippocampal formation: 213.9" "Region enhanced" "Detected in all" "hippocampal formation: 156.3" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favorable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.0 5.7 8.6 1.0 16.5 0.5 1.1 0.1 49.6 0.4 0.6 0.7 2.9 3.3 19.8 1.3 8.9 1.4 4.1 34.8 6.1 2.5 0.5 0.5 0.7 4.5 2.6 6.9 42.1 1.7 1.2 0.9 0.2 3.4 4.5 0.5 3.8 4.0 4.9 25.2 0.9 2.6 4.1 4.6 1.0 5.9 19.0 5.9 0.4 2.0 8.9 0.8 1.4 0.2 7.2 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 18.1 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.1 0.0 0.1 0.0 0.0 5.1 0.0 3.6 0.0 0.0 11.3 0.0 0.0 1.8 1.5 0.1 0.1 4.5 2.4 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.1 0.0 8.6 16.5 0.1 49.6 34.8 6.1 4.5 2.6 6.9 3.4 4.6 5.9 7.2 1.5 0.0 0.0 6.2 0.0 2.2 1.5 0.6 1.2 8.2 4.9 4.6 9.3 0.0 1.4 3.7 2.1 0.0 0.3 0.5 3.9 3.8 1.8 5.0 0.4 4.1 1.8 3.0 45.1 3.5 0.1 7.3 11.7 1.2 0.0 149.4 0.4 0.5 4.5 5.0 27.0 0.7 0.0 0.0 1.0 4.8 50.7 1.0 5.4 1.9 0.0 6.2 0.0 2.0 1.9 2.4 1.5 100.4 0.1 1.1 5.5 5.5 5.1 2.9 6.6 7.2 16.0 4.4 9.9 0.9 0.4 0.0 1.0 8.7 2.0 0.4 NXPH1 ENSG00000122584 "Neurexophilin 1" P58417 7 8433609-8752961 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "adrenal gland: 42.4;brain: 24.3" "Group enriched" "Detected in some" 40 "Inhibitory neurons: 1486.5;Oligodendrocyte precursor cells: 1500.4" "Group enriched" "Detected in some" 62 "breast cancer: 2.3;glioma: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 10.9;WM-115: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-2)" "unprognostic (1.46e-4)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (5.32e-1)" "unprognostic (9.46e-2)" 0.1 42.4 8.3 0.0 10.5 0.0 0.4 3.5 8.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 13.4 0.0 0.0 0.0 0.0 10.7 24.3 7.6 0.0 0.0 0.0 1.5 0.0 12.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 10.5 3.5 8.6 8.0 13.4 10.7 24.3 7.6 12.0 5.1 19.1 19.5 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1486.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 36.5 0.0 0.6 0.0 1500.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284188-24291862 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Neuropeptide "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "adrenal gland: 123.8;brain: 288.7;prostate: 335.8" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Region enriched" "Detected in all" 6 "hypothalamus: 288.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "SH-SY5Y: 700.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 30700000 21000 "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371" "unprognostic (2.00e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.8 123.8 32.1 12.9 51.3 5.6 2.2 10.4 39.5 1.1 11.3 2.6 9.8 0.3 0.3 2.3 0.5 1.1 0.6 30.6 288.7 0.3 0.2 0.3 0.0 26.1 26.6 27.3 0.5 8.9 0.1 4.8 0.0 18.0 335.8 1.9 4.4 0.4 3.9 0.2 0.2 13.2 1.2 14.8 0.0 8.9 1.2 24.8 0.2 0.9 0.2 0.0 1.4 24.0 29.8 0.0 0.0 2.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 2.0 0.0 0.2 20.5 0.0 0.6 0.0 0.0 0.8 700.2 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 51.3 10.4 39.5 30.6 288.7 26.1 26.6 27.3 18.0 14.8 24.8 29.8 0.0 0.0 0.0 2.0 0.5 0.1 1.3 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 56.7 0.0 0.0 0.0 0.0 16.1 0.3 0.7 1.8 1.0 0.0 0.8 0.0 2.0 1.9 0.3 0.0 0.4 0.0 100.6 0.0 0.0 0.0 0.7 0.0 15.6 0.3 2.4 2.8 0.0 0.0 5.1 0.3 0.0 0.0 2.0 FAM126A "DRCTNNB1A, HCC, HYCC1, hyccin" ENSG00000122591 "Family with sequence similarity 126 member A" Q9BYI3 7 22889371-23014130 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cataract, Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 133.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042873 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042873: AB_2678207" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (1.96e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-4)" "unprognostic (1.35e-1)" "unprognostic (9.76e-3)" "unprognostic (1.30e-2)" "unprognostic (7.23e-2)" "unprognostic (6.19e-2)" "prognostic unfavorable (6.04e-7)" "prognostic unfavorable (5.99e-4)" "unprognostic (1.87e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (9.03e-4)" 14.8 4.8 5.6 8.6 7.4 4.2 12.4 5.1 6.6 9.8 8.5 7.8 9.5 8.8 1.4 12.3 6.8 11.5 10.1 11.6 10.3 4.7 8.5 13.8 11.6 6.2 6.4 4.8 6.6 6.2 2.3 5.0 14.9 6.9 5.9 4.4 4.9 6.9 4.8 25.3 4.7 6.9 11.6 5.2 11.9 4.6 12.1 6.5 4.3 6.6 15.4 9.2 9.5 11.3 8.5 22.4 12.4 63.6 22.3 61.3 100.9 10.6 103.0 101.8 41.6 63.9 19.8 10.6 13.3 15.9 82.6 87.2 7.7 44.3 14.7 72.6 6.6 22.4 14.7 18.1 13.0 48.0 19.3 15.7 41.1 9.2 85.0 61.3 83.4 42.5 7.5 30.4 58.6 77.5 7.9 10.8 24.2 63.0 0.1 22.9 15.7 63.5 9.5 13.1 11.2 10.4 0.1 38.1 0.4 19.2 52.5 8.2 20.4 51.0 150.0 18.3 71.8 37.4 67.2 30.6 60.9 91.1 12.5 112.6 4.7 2.9 13.7 1.4 7.8 1.3 6.4 2.6 1.3 3.9 7.4 0.9 1.5 0.3 2.1 9.8 1.6 4.0 2.5 5.6 7.4 5.1 6.6 11.6 10.3 6.2 6.4 4.8 6.9 5.2 6.5 8.5 27.8 3.2 15.1 19.6 29.1 25.5 5.1 8.3 15.9 60.3 5.4 32.4 21.9 2.8 4.2 3.7 2.1 11.8 28.8 0.5 0.0 6.8 49.0 12.5 22.4 31.4 7.7 19.8 13.6 4.8 15.5 42.9 2.6 11.3 8.2 8.6 26.0 17.7 15.2 16.8 13.6 3.0 2.0 25.1 55.2 22.4 20.2 31.5 35.6 47.8 24.0 6.8 11.3 23.6 133.2 3.6 1.4 19.5 26.4 4.7 8.3 5.7 2.4 4.6 19.7 24.0 31.7 72.2 11.1 35.0 24.0 6.0 20.6 12.2 4.7 6.5 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "spinal cord: 7.8" "Immune cell enriched" "Detected in single" 6 "NK-cell: 4.7" "Lineage enriched" "Detected in single" 6 "NK-cells: 4.7" "Cell line enhanced" "Detected in many" "HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3" "Region enriched" "Detected in single" 12 "pons and medulla: 1.3" "Region enriched" "Detected in some" 6 "spinal cord: 21.4" HPA074048 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA074048: AB_2686655" "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 8.2 17.9 0.1 6.0 0.9 0.3 9.4 0.0 0.2 4.2 0.0 12.9 0.2 5.8 17.9 2.8 15.6 0.1 0.0 0.0 0.0 15.9 0.0 2.8 2.1 3.7 0.1 0.0 0.8 0.2 0.2 0.0 0.3 1.8 4.9 9.0 0.0 0.0 6.7 16.7 11.8 8.7 3.9 7.8 1.7 3.9 2.4 0.5 2.9 0.5 0.1 0.4 7.3 5.2 5.2 13.6 4.6 0.0 14.1 0.0 0.0 0.8 4.7 8.0 9.6 11.0 7.0 5.1 9.2 12.8 3.7 0.3 9.1 36.9 0.0 5.8 0.0 23.2 0.6 4.8 0.2 0.9 0.8 0.5 7.5 0.4 1.1 12.9 0.0 18.5 15.7 0.0 0.0 3.7 2.4 0.0 2.2 0.5 9.6 1.4 4.8 8.5 0.0 45.4 9.1 36.3 0.1 25.6 0.0 0.1 2.5 0.4 3.7 1.6 0.0 8.6 26.0 4.6 0.0 0.2 0.2 0.0 17.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.3 0.2 0.1 0.1 0.9 0.0 0.2 0.0 0.0 3.7 0.1 0.0 1.8 7.8 0.5 5.2 11.0 0.0 0.0 0.0 0.6 9.1 7.2 0.1 12.0 0.0 18.7 29.1 0.4 0.0 0.1 12.9 0.0 1.1 1.3 10.3 131.0 0.0 29.4 0.2 2.1 5.9 16.2 5.5 0.0 0.0 3.9 5.8 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 12.5 0.0 0.0 1.9 7.2 0.6 0.6 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.8 0.0 1.7 5.2 2.3 53.4 0.1 0.0 0.0 10.8 16.1 27.4 4.1 8.6 12.4 0.3 1.0 1.2 16.1 5.3 INHBA ENSG00000122641 "Inhibin subunit beta A" P08476 7 41667168-41705834 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4;gallbladder: 21.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 94.4;Langerhans cells: 68.0;Leydig cells: 137.6;Smooth muscle cells: 218.3;Syncytiotrophoblasts: 178.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 29.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 75.9;hTEC/SVTERT24-B: 227.0;hTERT-HME1: 92.9;hTERT-RPE1: 139.2;TIME: 120.1;U-138 MG: 174.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 210000 "unprognostic (4.11e-3)" "prognostic unfavorable (1.46e-5)" "unprognostic (4.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (7.91e-8)" "unprognostic (6.22e-3)" "unprognostic (1.11e-2)" "unprognostic (3.25e-2)" "unprognostic (3.18e-3)" 2.3 1.5 2.1 5.2 2.3 10.5 0.9 2.4 7.8 1.5 2.6 0.7 0.8 17.4 3.8 2.2 1.2 21.8 3.7 8.6 29.4 1.6 9.6 11.1 1.2 3.7 7.7 1.3 6.8 0.6 0.6 0.5 11.0 3.3 3.2 0.6 2.3 5.4 5.0 0.5 2.0 0.5 4.4 4.8 0.5 0.8 1.7 2.7 0.2 1.2 4.7 0.4 10.4 1.1 3.4 4.2 0.0 0.4 0.1 3.3 7.1 0.0 18.2 1.9 9.9 3.3 0.0 0.4 0.0 1.1 6.9 11.6 15.3 0.0 75.9 9.6 5.1 0.0 0.0 0.0 0.0 13.9 0.0 0.2 7.0 4.2 227.0 92.9 139.2 8.2 0.0 0.5 0.0 23.0 0.2 0.0 0.3 1.5 0.0 10.5 0.0 0.0 0.0 0.0 0.1 0.1 5.7 11.1 0.6 0.0 6.2 0.1 0.2 120.1 174.7 49.7 18.9 19.0 0.0 0.0 0.0 6.7 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 2.1 2.3 2.4 7.8 8.6 29.4 3.7 7.7 1.3 3.3 4.8 2.7 3.4 0.7 3.2 15.7 0.0 0.9 17.3 10.8 13.5 2.2 0.1 3.5 6.5 6.0 0.0 4.4 0.0 0.0 1.4 0.3 0.1 0.0 23.6 0.6 1.4 4.1 5.9 0.0 0.0 2.4 2.0 4.6 42.0 0.0 2.6 7.6 94.4 0.7 18.5 1.5 0.0 0.2 0.2 4.1 1.4 68.0 5.9 137.6 55.8 14.2 0.0 27.0 16.1 0.0 4.0 0.3 11.1 0.1 23.3 0.0 12.5 0.0 0.1 2.8 1.3 0.0 4.9 218.3 0.7 0.3 1.4 8.9 178.4 1.7 18.8 0.2 2.3 FKBP9 "FKBP60, FKBP63" ENSG00000122642 "FKBP prolyl isomerase 9" O95302 7 32957404-33006930 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 108.6;Fibroblasts: 89.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 379.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012595, HPA055256" Approved Approved "Golgi apparatus,Vesicles,Mitochondria" "Intracellular and membrane" No No 63000 "Golgi apparatus, Mitochondria" Vesicles "HPA012595: AB_1848629, HPA055256: AB_2682761" "unprognostic (1.23e-2)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.94e-2)" "unprognostic (6.25e-3)" "prognostic unfavorable (5.80e-4)" "prognostic unfavorable (2.02e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (3.40e-2)" "unprognostic (9.59e-2)" "unprognostic (2.58e-1)" "unprognostic (3.63e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-2)" "unprognostic (6.31e-2)" "unprognostic (1.97e-1)" "unprognostic (8.90e-3)" "prognostic unfavorable (7.02e-6)" 70.0 45.1 24.5 16.9 23.4 2.3 59.6 27.0 25.1 66.4 28.9 43.6 19.8 56.2 22.6 36.0 51.0 44.7 72.9 21.1 31.6 38.5 21.3 50.1 13.7 28.4 28.4 19.7 46.7 41.1 25.3 35.0 78.0 28.8 42.7 45.8 11.8 36.3 52.6 35.3 61.1 31.3 75.0 27.7 23.9 41.4 11.5 31.9 8.3 41.1 50.2 16.0 43.7 52.7 28.2 38.9 71.4 27.6 113.4 254.1 290.2 36.4 202.6 209.9 65.5 103.9 31.6 89.2 0.2 80.7 379.5 105.1 73.3 40.8 100.0 75.2 0.1 11.9 6.6 72.3 31.6 105.6 0.4 10.8 191.8 59.6 59.0 56.9 156.3 83.9 0.1 15.0 7.7 137.3 37.1 0.2 19.4 5.8 76.6 37.3 0.3 73.7 0.3 73.0 13.0 25.7 62.4 115.6 58.4 73.4 69.6 41.1 18.7 112.8 107.0 99.8 67.4 46.8 23.9 48.9 0.2 104.4 0.3 218.5 0.9 2.2 0.5 0.0 1.6 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.0 4.0 0.1 0.4 0.1 0.0 0.6 24.5 23.4 27.0 25.1 21.1 31.6 28.4 28.4 19.7 28.8 27.7 31.9 28.2 108.6 12.8 21.7 22.9 0.6 34.3 12.7 31.4 10.2 8.2 15.7 16.5 46.1 17.2 10.3 18.4 10.4 18.8 0.6 23.2 5.9 19.5 0.5 22.6 25.8 80.1 12.2 1.7 9.8 41.5 27.7 89.1 17.9 23.0 5.7 81.0 60.0 18.0 7.6 11.8 10.2 25.4 10.2 8.6 23.5 3.2 36.7 5.4 60.5 15.0 2.9 30.5 0.0 8.5 8.8 36.5 22.1 55.3 4.4 8.1 18.8 8.1 11.0 5.2 46.0 21.2 45.8 1.0 1.3 12.1 28.6 13.1 3.1 12.3 27.7 10.5 NT5C3A "cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1" ENSG00000122643 "5'-nucleotidase, cytosolic IIIA" Q9H0P0 7 33014114-33062797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.2" "Cell type enhanced" "Detected in all" "Distal enterocytes: 191.0;Paneth cells: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010520, HPA010630, HPA029058" Uncertain Supported "Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 10000 "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380" "unprognostic (7.50e-2)" "unprognostic (3.10e-1)" "unprognostic (1.14e-1)" "unprognostic (2.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.25e-2)" "unprognostic (3.12e-2)" "unprognostic (2.82e-3)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (9.37e-2)" "unprognostic (2.05e-1)" "unprognostic (2.12e-3)" "unprognostic (3.43e-3)" 12.5 14.4 12.5 26.4 12.9 32.9 21.5 16.7 15.7 12.6 12.5 52.3 40.3 17.1 14.5 18.8 16.1 23.6 16.7 12.7 13.2 22.7 11.8 17.8 31.0 12.7 13.5 11.7 13.6 21.6 9.8 7.5 16.5 13.0 12.4 51.5 20.6 9.8 10.1 88.2 29.0 37.6 13.3 12.7 23.1 27.2 9.6 13.3 22.7 17.3 51.5 46.2 24.1 14.5 14.5 42.2 27.6 25.2 29.6 21.2 16.1 20.3 44.8 30.5 29.2 38.9 19.9 115.1 100.4 27.7 29.6 48.3 63.8 28.3 30.8 40.4 16.2 36.2 54.7 36.5 28.7 23.3 55.6 36.9 21.7 23.8 35.9 63.0 16.4 22.2 33.2 43.3 24.8 37.3 29.9 25.0 87.8 27.8 47.1 31.2 25.9 22.9 60.0 87.8 39.8 28.1 37.0 31.1 52.4 66.6 24.5 35.2 33.5 19.8 25.1 20.9 42.6 55.7 50.6 69.0 54.8 20.6 34.9 42.5 112.5 25.9 82.5 26.6 32.7 30.6 64.0 34.2 30.8 22.1 63.6 34.5 29.1 103.8 28.2 39.2 20.6 56.2 37.9 12.5 12.9 16.7 15.7 12.7 13.2 12.7 13.5 11.7 13.0 12.7 13.3 14.5 39.1 22.4 13.7 30.7 85.1 46.8 40.9 85.3 47.8 23.9 22.6 18.9 16.9 32.9 40.4 16.5 41.7 36.9 42.5 191.0 29.4 34.4 5.7 40.9 21.0 40.8 119.6 127.1 45.3 79.0 31.6 35.2 42.8 21.4 17.7 38.3 30.0 18.9 25.0 1.7 49.4 98.9 40.7 31.2 23.5 5.0 33.8 111.4 26.6 29.0 37.0 23.4 55.6 48.2 52.4 48.3 186.6 22.2 43.8 45.7 91.8 84.8 53.7 27.1 13.1 30.7 24.9 46.4 24.0 35.5 38.9 28.3 53.7 23.3 71.0 65.9 ARL4A ARL4 ENSG00000122644 "ADP ribosylation factor like GTPase 4A" P40617 7 12686856-12690958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 192.6" "Group enriched" "Detected in all" 4 "Early spermatids: 1523.0;Late spermatids: 3892.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 261.3;K-562: 328.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064513 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064513: AB_2685276" "unprognostic (8.29e-2)" "unprognostic (1.34e-1)" "unprognostic (3.94e-1)" "unprognostic (4.97e-2)" "unprognostic (3.88e-2)" "unprognostic (7.43e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-2)" "unprognostic (7.27e-3)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (9.42e-3)" "unprognostic (9.49e-3)" 31.5 8.0 17.4 16.9 20.2 99.2 55.8 14.2 26.0 27.8 21.1 41.1 30.1 17.0 13.9 60.5 27.9 19.4 15.3 21.6 16.8 8.9 15.7 19.5 18.8 14.3 14.1 18.4 8.1 7.2 5.3 9.2 23.8 14.6 21.2 35.0 6.7 87.3 16.6 9.2 77.8 63.2 25.3 14.5 21.1 24.7 192.6 15.0 22.9 19.4 8.7 16.0 21.6 64.3 18.3 45.0 46.7 121.5 261.3 19.3 31.8 0.3 17.9 16.2 28.7 17.2 41.6 32.9 0.3 7.5 25.4 73.4 12.6 27.3 22.6 28.9 9.8 20.4 9.2 61.7 39.3 39.8 39.6 16.0 14.3 88.3 16.7 74.2 18.1 69.0 17.7 328.1 42.5 29.4 19.3 2.2 55.6 44.2 129.2 53.1 0.0 42.4 20.8 37.8 21.3 22.3 20.8 29.5 31.1 6.3 31.3 15.3 32.0 24.3 11.5 40.6 43.5 73.1 19.4 27.2 10.3 29.7 16.5 46.4 8.1 14.8 0.7 11.3 25.7 31.7 41.0 26.8 17.7 14.4 44.7 12.9 10.8 2.2 13.0 32.1 12.8 17.8 13.6 17.4 20.2 14.2 26.0 21.6 16.8 14.3 14.1 18.4 14.6 14.5 15.0 18.3 134.0 22.4 20.3 1.0 96.9 339.7 179.1 144.5 70.0 20.9 217.9 230.0 15.8 64.3 86.6 20.2 85.5 152.9 61.0 236.6 27.4 47.8 1523.0 179.1 41.5 162.5 62.6 249.9 11.6 29.6 18.7 46.1 63.2 86.5 80.5 27.7 157.1 21.7 59.5 3.3 3.4 107.1 337.7 168.2 171.1 3892.8 69.0 170.9 120.9 17.8 38.7 11.0 3.1 36.7 8.7 55.3 118.0 26.7 24.4 53.4 641.5 14.6 102.5 125.9 13.1 59.5 55.3 564.1 57.5 134.9 234.7 444.0 98.0 32.4 124.2 89.1 CCZ1 "C7orf28A, CCZ1A, CGI-43" ENSG00000122674 "CCZ1 homolog, vacuolar protein trafficking and biogenesis associated" P86791 7 5898725-5926550 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (1.91e-1)" "unprognostic (2.97e-3)" "unprognostic (3.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.82e-1)" "unprognostic (5.35e-2)" "unprognostic (3.74e-3)" "unprognostic (4.10e-1)" "unprognostic (9.25e-3)" "unprognostic (7.66e-2)" "unprognostic (6.64e-2)" "unprognostic (2.67e-2)" "unprognostic (5.27e-3)" "unprognostic (3.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-1)" "unprognostic (4.41e-1)" 32.0 56.3 11.6 12.9 11.9 27.1 30.4 13.1 13.8 28.7 13.4 31.2 13.1 29.9 9.5 41.1 25.4 10.4 31.1 12.3 11.9 26.1 27.5 26.2 15.5 11.7 11.2 11.0 23.2 27.6 30.2 25.1 12.3 11.6 24.8 16.2 12.7 32.3 12.0 43.5 29.7 27.1 14.0 11.3 31.8 29.3 22.3 11.6 20.7 25.7 13.1 16.3 31.9 29.2 12.6 52.2 29.8 30.3 27.1 41.8 35.4 15.3 15.6 30.1 23.1 25.0 9.1 27.2 42.8 4.8 40.8 61.9 27.8 16.6 26.7 26.5 16.2 37.3 18.1 30.2 16.8 38.0 13.1 7.1 40.5 42.4 15.6 19.5 42.5 57.2 25.4 52.4 29.7 38.8 26.9 16.8 56.9 39.5 26.4 28.3 36.0 13.8 28.9 21.1 38.3 23.9 31.9 15.3 36.6 13.6 57.9 26.1 21.0 27.7 28.8 57.4 18.7 25.7 13.6 24.6 58.0 9.6 30.8 41.6 3.1 1.9 2.7 1.8 2.3 1.4 1.3 2.2 2.2 1.8 1.3 1.5 1.6 3.4 3.0 2.4 1.8 4.6 0.7 11.6 11.9 13.1 13.8 12.3 11.9 11.7 11.2 11.0 11.6 11.3 11.6 12.6 30.7 3.2 23.5 15.7 26.3 45.2 30.6 21.2 9.6 59.2 29.5 20.2 11.0 24.3 24.0 31.3 62.6 45.0 47.2 38.0 31.3 61.0 6.5 18.7 18.1 35.0 29.9 26.7 20.2 71.4 35.9 26.7 11.2 21.3 15.8 21.1 76.4 17.6 35.7 23.5 20.5 30.8 50.8 39.0 61.6 4.9 37.9 27.5 46.2 8.4 80.8 41.5 72.1 15.6 28.7 74.0 30.1 36.1 14.3 26.2 40.2 21.9 32.9 69.2 78.9 19.4 32.0 40.6 34.5 11.0 54.1 34.9 32.8 38.2 34.4 33.7 POLM Tdt-N ENSG00000122678 "DNA polymerase mu" Q9NP87 7 44072062-44082530 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 63.0" "Lineage enriched" "Detected in all" 6 "granulocytes: 63.0" "Cell line enhanced" "Detected in all" "HBEC3-KT: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058900, HPA066007" Approved Nucleoplasm NA NA Nucleoplasm "HPA058900: AB_2683848, HPA066007: AB_2685595" "unprognostic (2.44e-2)" "unprognostic (8.18e-2)" "unprognostic (2.21e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (3.91e-1)" "unprognostic (9.36e-2)" "unprognostic (8.26e-2)" "unprognostic (2.46e-3)" "unprognostic (6.31e-2)" "unprognostic (1.47e-1)" "unprognostic (2.87e-1)" "unprognostic (3.87e-3)" 7.0 6.0 3.8 4.5 3.9 4.5 7.9 4.3 4.1 8.8 3.8 6.3 5.7 6.2 3.7 8.4 6.4 4.5 7.0 3.5 4.3 9.0 9.8 6.0 7.6 4.3 4.2 3.1 9.0 8.5 4.4 6.0 2.8 5.1 8.5 3.4 4.3 7.5 6.7 8.0 8.5 9.1 3.5 3.8 13.2 9.2 3.9 5.4 9.9 10.6 5.0 7.2 7.7 7.9 4.0 1.8 2.5 2.6 5.8 3.6 4.2 7.5 6.1 6.2 4.5 2.5 3.2 4.2 18.1 5.6 4.7 5.5 5.3 2.7 67.0 2.6 6.3 6.0 2.3 2.8 1.1 4.8 5.8 7.7 6.1 6.0 3.7 4.4 8.6 8.1 18.5 2.7 9.2 3.8 4.1 10.5 4.7 5.4 5.5 14.2 9.6 1.6 7.3 4.7 2.9 2.7 4.8 2.9 11.3 5.6 4.0 6.7 10.2 5.7 3.1 4.4 3.2 8.6 14.1 7.5 13.9 5.6 5.2 6.9 23.9 3.5 10.7 6.3 4.3 6.5 7.9 5.5 5.6 3.3 11.1 7.9 6.3 63.0 7.4 3.3 9.5 5.8 2.9 3.8 3.9 4.3 4.1 3.5 4.3 4.3 4.2 3.1 5.1 3.8 5.4 4.0 8.3 3.2 7.8 13.1 33.4 4.5 11.2 8.3 11.4 24.5 10.3 6.2 5.6 15.7 11.4 12.9 29.2 12.3 19.9 11.1 1.9 7.6 0.6 5.0 7.1 8.7 5.4 3.0 4.0 9.4 9.4 7.1 27.5 6.0 24.1 11.1 12.5 9.2 10.2 18.5 4.3 8.5 10.2 11.1 5.0 0.7 14.0 9.9 10.6 6.5 14.4 11.9 23.7 3.5 5.7 8.3 22.5 10.1 15.6 16.6 19.4 5.6 7.4 48.3 0.0 6.9 9.0 17.5 14.3 6.5 5.1 9.7 18.8 13.5 12.1 15.0 RAMP3 ENSG00000122679 "Receptor activity modifying protein 3" O60896 7 45157791-45186302 "FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 145.8" "Group enriched" "Detected in many" 12 "Adipocytes: 287.8;Endothelial cells: 366.0;Hepatic stellate cells: 555.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "Karpas-707: 2.5" "Group enriched" "Detected in all" 4 "cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 174.9;white matter: 60.0" "Low region specificity" "Detected in all" HPA075527 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA075527: " "unprognostic (1.62e-3)" "prognostic favorable (2.89e-4)" "unprognostic (4.85e-2)" "unprognostic (6.88e-3)" "unprognostic (3.68e-2)" "unprognostic (1.44e-3)" "prognostic favorable (2.50e-6)" "unprognostic (1.14e-1)" "unprognostic (2.35e-1)" "unprognostic (3.19e-1)" "unprognostic (2.79e-2)" "unprognostic (9.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.20e-2)" "unprognostic (2.43e-1)" "unprognostic (1.91e-1)" "unprognostic (9.21e-2)" 78.1 32.9 17.6 23.2 17.5 0.2 72.3 25.9 22.8 31.0 19.8 23.2 10.3 26.1 4.0 19.1 23.0 28.9 75.4 17.6 27.3 84.2 24.1 145.8 55.5 35.6 24.8 14.3 7.5 19.9 28.3 22.5 8.7 29.7 29.9 8.7 1.1 22.3 13.0 19.4 20.8 30.2 24.6 35.1 11.5 25.9 6.3 21.9 7.4 72.5 27.2 30.6 28.8 30.8 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 17.6 17.5 25.9 22.8 17.6 27.3 35.6 24.8 14.3 29.7 35.1 21.9 42.2 287.8 0.0 1.9 0.3 3.6 16.3 0.3 0.0 2.2 0.6 5.9 2.8 8.7 1.5 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 20.8 0.4 7.3 366.0 0.0 13.5 3.5 0.7 0.1 10.7 0.0 0.2 0.0 0.0 555.4 7.3 0.5 0.0 0.2 0.0 0.0 31.2 19.1 6.7 1.2 1.3 26.6 5.6 0.0 0.2 0.0 0.0 6.5 0.0 0.0 1.2 1.3 0.6 0.0 0.0 0.0 0.5 0.0 2.8 4.9 0.3 0.9 0.9 14.5 0.0 1.7 1.5 0.0 0.5 MRM2 "FJH1, FTSJ2, RRMJ2" ENSG00000122687 "Mitochondrial rRNA methyltransferase 2" Q9UI43 7 2234195-2242205 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 59.7;Distal tubular cells: 31.3;Extravillous trophoblasts: 37.0;Hofbauer cells: 35.8;Syncytiotrophoblasts: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019826, HPA049622" Uncertain NA NA "HPA019826: AB_2670282, HPA049622: AB_2680834" "unprognostic (8.05e-2)" "unprognostic (1.65e-1)" "unprognostic (2.14e-2)" "unprognostic (2.59e-1)" "unprognostic (1.49e-2)" "unprognostic (2.50e-3)" "prognostic unfavorable (5.21e-6)" "unprognostic (8.49e-2)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (9.99e-2)" "unprognostic (8.33e-2)" "unprognostic (1.69e-1)" "unprognostic (2.37e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (1.48e-1)" 9.3 12.9 13.1 12.2 13.5 6.1 13.2 13.8 15.8 9.3 14.0 10.8 10.9 8.3 11.6 11.6 10.9 6.8 14.2 12.9 13.9 12.7 17.4 11.1 17.9 14.2 13.6 12.9 11.8 8.1 13.4 7.0 13.8 13.9 10.1 10.9 8.0 10.2 12.1 21.9 11.3 9.2 9.2 14.0 12.9 9.8 10.8 13.8 12.3 8.5 12.7 18.4 10.5 8.0 14.3 62.2 39.9 34.2 25.2 21.3 22.3 24.8 35.3 35.5 45.3 43.9 56.7 29.8 57.5 15.8 27.4 37.5 48.0 49.3 40.0 49.0 22.2 37.9 36.6 37.0 35.0 25.8 54.3 34.5 19.1 34.2 30.4 35.4 19.6 20.2 35.3 59.3 33.0 35.6 73.4 17.1 68.7 94.9 38.6 38.0 34.1 42.5 45.1 31.9 46.4 31.2 44.3 28.9 81.1 34.1 44.8 70.0 81.6 15.1 27.4 64.2 53.8 56.0 29.1 43.4 59.0 31.7 55.9 85.2 17.2 49.1 32.9 28.0 57.1 33.9 52.1 29.9 32.1 71.8 48.8 36.9 32.1 3.7 47.8 48.9 37.8 36.5 40.4 13.1 13.5 13.8 15.8 12.9 13.9 14.2 13.6 12.9 13.9 14.0 13.8 14.3 11.3 22.4 19.8 0.0 5.1 0.0 0.0 0.0 0.0 0.0 15.0 19.6 0.0 0.0 8.1 11.0 0.0 59.7 6.6 0.0 31.3 24.1 0.0 7.7 14.3 6.0 0.0 0.0 0.0 19.9 37.0 7.2 0.0 6.7 11.4 15.9 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.9 0.0 0.0 20.4 9.5 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 37.1 3.6 28.8 0.0 0.0 TWIST1 "ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST" ENSG00000122691 "Twist family bHLH transcription factor 1" Q15672 7 19020991-19117636 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.3;breast: 25.4" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 92.8;Fibroblasts: 73.4;Langerhans cells: 30.3;Smooth muscle cells: 34.4;Theca cells: 29.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 263.5" "Low region specificity" "Detected in single" NA NA "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.62e-1)" "unprognostic (1.29e-2)" "unprognostic (9.80e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-2)" "unprognostic (8.51e-3)" "unprognostic (5.91e-2)" "unprognostic (8.99e-3)" "unprognostic (3.69e-1)" "unprognostic (1.29e-9)" "unprognostic (8.55e-3)" "unprognostic (1.54e-1)" "unprognostic (6.83e-3)" "unprognostic (1.97e-2)" 22.3 4.9 2.2 1.3 1.6 0.0 25.4 1.5 3.2 5.6 3.0 2.0 0.0 19.1 0.6 6.0 3.0 7.2 3.4 1.9 1.8 0.8 0.2 0.6 2.4 1.8 2.1 1.8 6.5 0.4 0.2 7.2 12.7 1.9 2.7 0.4 0.0 8.2 0.8 1.5 16.0 0.7 5.1 1.6 0.0 5.4 2.7 2.2 0.5 3.7 2.0 1.6 8.3 5.0 2.1 1.6 2.0 8.9 0.0 45.0 18.4 0.2 38.3 17.8 28.9 37.7 0.0 0.0 0.0 4.0 32.0 6.9 0.0 3.7 3.0 19.0 8.5 10.1 0.0 3.9 0.0 26.8 10.0 0.1 44.8 9.9 6.0 15.7 8.6 0.0 0.5 0.0 0.0 31.0 0.0 0.0 0.5 3.9 0.0 15.7 0.0 0.0 0.0 0.0 0.0 15.9 263.5 6.2 0.0 8.2 5.6 0.8 12.4 0.2 35.5 0.1 28.3 6.6 0.0 0.0 0.0 19.4 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.6 1.5 3.2 1.9 1.8 1.8 2.1 1.8 1.9 1.6 2.2 2.1 10.3 0.0 0.0 0.7 0.1 12.5 0.2 2.9 1.8 0.0 0.5 3.3 0.9 0.0 0.5 0.0 0.0 0.3 0.1 0.1 1.9 0.0 0.2 11.5 92.8 3.8 0.0 0.0 5.2 0.0 0.2 73.4 0.0 13.3 0.0 2.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 30.3 0.8 2.1 0.9 12.4 7.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.3 0.0 1.6 34.4 0.5 4.7 0.6 8.5 1.4 2.2 29.9 0.1 0.4 SMU1 "BWD, FLJ10805, fSAP57, SMU-1" ENSG00000122692 "SMU1 DNA replication regulator and spliceosomal factor" Q2TAY7 9 33041765-33076674 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019708 Supported Approved Vesicles NA NA 25000 Vesicles "HPA019708: AB_1857300" "unprognostic (2.20e-2)" "prognostic favorable (2.66e-4)" "unprognostic (1.17e-1)" "unprognostic (1.58e-1)" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (2.59e-3)" "unprognostic (5.06e-2)" "unprognostic (3.04e-2)" "prognostic favorable (1.25e-4)" "unprognostic (4.98e-3)" "unprognostic (3.15e-1)" "prognostic favorable (1.67e-5)" "unprognostic (1.09e-2)" "unprognostic (7.04e-2)" "unprognostic (8.71e-2)" "unprognostic (5.96e-2)" 11.6 11.4 11.8 10.7 13.3 16.2 12.1 14.6 12.5 11.5 9.7 10.4 8.7 13.3 11.9 10.7 11.5 8.7 10.4 11.3 12.3 11.3 13.1 10.1 12.9 12.8 12.7 11.1 14.8 8.2 15.9 8.2 8.5 13.1 12.0 11.0 12.7 9.4 11.6 14.6 12.7 9.4 13.3 13.7 12.2 9.2 8.6 12.4 14.2 11.3 13.1 15.3 11.6 10.0 17.3 26.3 20.4 24.0 20.9 25.4 19.3 18.7 20.1 18.1 26.9 26.5 20.8 10.7 33.0 14.4 25.1 14.6 15.7 31.1 24.1 29.7 38.1 14.9 24.8 33.4 24.5 22.1 43.5 22.4 20.4 27.0 24.9 17.6 20.1 22.9 22.7 23.4 20.5 22.7 12.1 34.2 46.3 33.1 19.6 21.4 28.8 19.9 17.9 20.5 19.4 20.3 17.7 27.2 19.4 13.1 18.6 18.7 15.7 24.6 17.2 19.1 25.2 23.8 9.1 18.1 38.0 19.2 20.2 12.5 23.4 13.9 11.5 12.4 15.4 13.3 12.9 14.0 11.6 15.8 11.7 13.9 14.3 8.1 12.4 17.9 20.0 12.6 10.8 11.8 13.3 14.6 12.5 11.3 12.3 12.8 12.7 11.1 13.1 13.7 12.4 17.3 45.5 25.6 31.4 17.9 48.0 53.7 45.7 41.0 43.3 29.5 23.8 22.4 30.6 30.0 39.9 20.2 37.5 34.9 72.7 19.1 21.5 32.3 29.6 41.6 42.8 38.2 28.1 24.4 23.4 24.3 36.3 37.7 17.9 47.3 39.2 32.1 21.4 29.4 30.8 23.5 25.3 19.5 44.7 29.2 40.8 8.7 32.3 40.2 23.2 14.0 39.7 34.8 32.0 21.6 28.3 27.9 20.1 25.9 28.3 33.3 18.1 31.7 44.1 39.3 19.7 53.9 44.7 41.4 30.5 36.3 57.5 57.7 43.7 37.0 23.5 35.5 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules NA NA 19000000 Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 34.5 21.1 20.9 53.2 24.9 74.5 32.7 24.1 23.5 43.8 20.2 61.2 14.9 78.5 15.2 18.8 37.2 24.4 20.3 20.1 26.4 6.7 7.0 63.1 30.2 29.9 25.8 18.9 13.4 5.7 2.6 4.9 8.9 26.4 38.6 33.4 2.8 15.4 39.6 7.8 11.2 32.5 64.4 26.0 41.6 25.5 3.4 26.7 18.8 16.0 11.2 19.3 39.2 27.6 35.1 3.7 2.9 20.9 22.3 71.6 33.3 2.4 32.9 20.0 7.8 14.1 1.3 0.3 0.2 10.2 30.9 19.7 0.2 7.9 1.1 4.7 72.9 6.4 8.8 6.2 0.4 27.9 5.7 28.3 23.4 1.0 44.5 7.8 14.0 62.5 22.6 0.4 5.0 17.4 7.9 27.9 15.2 20.1 0.3 10.7 18.9 44.1 1.0 1.6 1.8 5.6 11.3 4.4 2.2 3.6 42.2 2.3 24.0 127.3 10.7 24.8 9.6 28.0 7.8 2.2 12.7 11.0 35.0 2.5 268.6 360.9 540.3 168.4 162.5 89.1 24.4 114.3 108.2 208.3 24.5 47.0 74.7 657.0 125.5 124.9 18.5 132.2 414.0 20.9 24.9 24.1 23.5 20.1 26.4 29.9 25.8 18.9 26.4 26.0 26.7 35.1 11.9 3.2 25.4 4.6 22.3 13.4 2.5 14.7 1.8 0.3 46.9 19.0 2.6 2.8 30.9 5.5 0.0 3.8 66.9 14.7 0.0 21.2 0.7 1.8 33.9 13.3 8.4 58.7 1.1 1.3 3.3 54.3 11.7 2.1 52.6 1.9 16.1 0.9 188.5 0.0 0.8 42.4 14.2 83.2 203.6 2.3 18.0 117.6 62.2 2.8 203.0 21.4 180.2 3.0 28.6 5.2 16.1 25.9 22.8 16.0 4.0 1.1 64.3 0.5 46.0 44.7 43.2 0.9 6.4 0.9 10.2 3.4 75.5 10.9 45.3 3.3 SLC25A51 "CG7943, MCART1, MGC14836" ENSG00000122696 "Solute carrier family 25 member 51" Q9H1U9 9 37879400-37904353 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 93.6;Late spermatids: 169.6;Spermatocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 16.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046388, HPA058261" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046388: AB_2679649, HPA058261: AB_2683657" "unprognostic (5.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.67e-2)" "unprognostic (5.63e-2)" "unprognostic (1.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (6.87e-2)" "unprognostic (1.04e-1)" "unprognostic (7.98e-3)" "unprognostic (1.26e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.52e-4)" "unprognostic (8.27e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (2.08e-2)" 9.1 3.1 2.5 5.0 3.5 12.1 4.1 3.4 4.3 5.5 2.2 4.6 7.6 4.1 4.7 5.6 3.4 5.1 4.6 3.3 4.2 6.4 3.2 5.2 5.7 3.4 3.3 2.7 3.8 5.9 8.4 4.2 4.7 3.9 3.5 4.1 4.9 4.8 3.7 6.2 5.8 6.1 5.9 2.7 5.7 4.3 8.0 3.3 5.7 4.7 7.5 6.5 4.3 3.6 4.4 12.4 10.1 7.3 11.6 34.4 15.2 7.4 10.6 10.7 8.8 12.6 13.0 5.2 26.2 5.9 24.2 12.5 6.1 19.6 14.5 16.5 18.0 6.1 8.0 27.5 18.0 19.1 12.5 11.1 15.3 16.7 13.4 16.6 13.6 16.1 24.4 17.9 20.2 19.1 7.3 15.2 3.2 9.2 12.7 7.1 10.6 9.9 16.1 8.7 8.9 15.2 10.0 8.3 10.1 6.0 12.2 5.4 13.7 17.3 14.7 17.4 7.2 12.8 7.7 17.5 17.5 19.4 9.3 12.3 16.7 1.5 2.8 1.6 3.1 2.7 2.6 1.7 2.3 1.1 1.5 1.6 1.8 1.3 1.9 1.3 0.5 2.7 0.9 2.5 3.5 3.4 4.3 3.3 4.2 3.4 3.3 2.7 3.9 2.7 3.3 4.4 4.3 9.6 1.1 13.4 9.3 4.7 5.8 7.6 8.6 4.0 5.1 3.8 6.3 5.7 4.6 1.8 4.2 3.7 7.6 3.8 17.6 9.5 93.6 2.5 5.3 4.3 3.6 6.9 22.0 7.2 14.1 5.2 8.2 5.1 3.8 3.4 3.9 3.6 11.7 1.7 21.3 5.8 0.0 5.7 4.7 169.6 3.7 8.8 1.8 19.7 8.4 5.3 3.1 16.1 22.1 7.3 7.2 4.1 14.3 3.8 17.4 16.8 2.2 3.7 0.0 4.3 4.5 44.0 10.2 11.7 5.8 4.0 6.5 4.8 3.6 3.8 CLTA Lca ENSG00000122705 "Clathrin light chain A" P09496 9 36190856-36304781 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1299.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002665, HPA050918, HPA054667" Enhanced Enhanced Vesicles,Endosomes,Lysosomes NA NA "Vesicles, Endosomes, Lysosomes" "CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565" "prognostic favorable (5.64e-4)" "unprognostic (7.62e-2)" "unprognostic (9.22e-2)" "unprognostic (8.45e-3)" "unprognostic (1.71e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (9.46e-5)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-3)" "unprognostic (7.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.98e-2)" 172.3 175.6 136.4 81.5 139.5 67.8 167.0 146.0 166.4 169.1 139.5 155.0 108.9 167.0 101.6 208.8 160.2 65.0 97.7 138.8 142.1 212.7 148.0 147.4 84.8 150.8 141.1 135.1 207.3 165.7 105.2 140.4 125.4 154.3 146.2 109.7 85.5 164.1 71.8 88.4 161.3 137.2 85.7 150.2 154.2 162.7 109.4 143.9 86.0 161.4 52.0 94.1 152.2 159.7 157.7 326.3 257.2 188.4 146.3 270.0 269.8 302.6 328.5 248.2 258.1 301.5 194.2 143.9 243.8 177.0 220.9 460.7 136.2 238.8 228.2 238.4 166.0 193.1 187.5 255.0 199.8 359.4 201.0 166.5 297.3 250.5 297.4 234.3 241.0 329.6 129.3 166.0 126.4 399.0 113.3 182.2 254.8 301.8 218.8 360.3 173.3 124.8 142.1 353.7 229.1 146.1 245.3 137.3 160.0 289.4 220.2 146.9 244.2 418.4 209.4 234.0 240.3 347.9 83.0 208.9 259.5 256.9 278.0 188.9 142.2 221.7 115.4 97.1 239.6 101.9 121.0 104.9 100.2 222.6 119.6 92.9 82.0 86.7 96.2 191.8 192.2 162.9 209.4 136.4 139.5 146.0 166.4 138.8 142.1 150.8 141.1 135.1 154.3 150.2 143.9 157.7 291.5 128.2 143.9 14.4 105.9 197.3 274.3 374.3 169.0 139.4 274.0 315.0 51.5 217.3 247.4 180.3 60.5 958.0 140.1 349.3 463.7 480.5 51.9 241.5 174.3 244.0 183.8 154.8 28.5 335.6 469.1 187.5 142.2 182.7 73.5 198.4 312.7 170.6 903.7 92.5 30.4 350.5 248.2 391.7 172.0 97.6 262.9 249.3 195.7 20.6 343.5 282.8 117.4 16.1 49.0 465.2 426.4 215.5 97.7 320.5 411.5 651.7 304.7 127.3 177.5 170.0 310.4 288.0 216.8 210.9 193.2 1299.5 103.7 281.6 380.0 360.4 RECK "hRECK, ST15" ENSG00000122707 "Reversion inducing cysteine rich protein with kazal motifs" O95980 9 36036913-36124455 "Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Protease inhibitor, Serine protease inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025109, HPA071729" Supported Supported "Plasma membrane" NA NA 64000000 "Plasma membrane" "CAB025109: , HPA071729: AB_2686438" "unprognostic (3.42e-1)" "unprognostic (4.01e-3)" "unprognostic (5.50e-2)" "unprognostic (5.05e-4)" "unprognostic (8.87e-2)" "unprognostic (8.47e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.75e-2)" "unprognostic (1.51e-2)" "unprognostic (9.06e-2)" "unprognostic (8.48e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (7.31e-4)" "unprognostic (2.68e-2)" "unprognostic (1.50e-2)" "unprognostic (3.60e-2)" 14.8 7.5 3.1 4.7 3.4 1.2 13.8 3.7 4.3 15.3 3.5 6.1 3.7 14.5 6.2 11.8 8.0 13.8 8.6 4.4 3.5 5.8 5.9 12.8 5.8 3.6 3.3 2.9 14.4 3.3 3.7 3.1 11.4 3.7 8.4 6.4 4.7 4.7 7.3 3.7 7.7 5.1 14.8 3.4 7.4 5.7 3.3 3.4 6.6 6.2 16.2 4.5 12.2 7.6 4.1 1.4 2.4 8.0 4.4 199.5 158.5 0.1 65.1 93.0 4.7 11.0 0.0 0.0 2.5 6.0 57.8 3.7 0.4 1.8 1.2 6.4 4.1 3.7 2.6 2.8 0.2 16.2 0.3 11.1 71.3 1.6 7.1 2.7 18.4 14.6 4.8 0.0 2.1 12.2 0.3 6.6 1.0 2.7 0.0 2.0 6.9 6.2 0.0 3.2 0.2 0.7 4.5 1.5 0.8 2.7 8.3 0.0 8.9 44.4 9.0 3.3 5.9 3.6 2.9 3.4 2.7 5.5 8.7 5.8 1.0 2.6 0.7 3.9 2.8 4.4 1.2 5.2 4.2 2.9 2.7 6.3 4.6 0.3 3.0 4.8 1.6 2.6 2.3 3.1 3.4 3.7 4.3 4.4 3.5 3.6 3.3 2.9 3.7 3.4 3.4 4.1 12.8 3.2 5.4 40.1 11.7 7.1 4.0 5.0 4.6 12.5 4.2 5.6 3.6 1.5 2.5 3.7 14.6 0.9 9.3 0.2 0.0 6.6 38.3 0.9 11.6 19.6 6.1 5.7 63.1 1.5 7.7 53.4 3.6 0.6 9.5 9.2 25.4 1.1 15.6 8.4 71.1 1.3 4.1 15.7 15.9 35.5 18.6 8.3 3.6 41.2 8.8 14.3 2.1 80.4 119.8 1.3 0.4 17.7 5.9 4.3 0.3 1.6 4.1 7.8 0.0 14.2 15.3 41.2 27.4 1.3 7.5 0.8 10.2 7.8 0.8 1.2 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 991.0" "Cell type enriched" "Detected in some" 14 "Intestinal goblet cells: 8017.1" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 1.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.8" "Group enriched" "Detected in some" 12 "HMC-1: 175.7;OE19: 480.7" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in single" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 1.4 0.6 0.0 85.0 0.1 0.6 0.1 0.6 0.3 0.0 0.1 645.5 265.8 1.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.9 2.2 0.9 0.0 0.1 0.0 991.0 92.9 0.1 0.5 0.3 0.0 643.6 42.6 0.0 0.2 1.5 0.3 0.0 0.1 0.0 0.0 0.0 17.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 3.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 11.7 27.8 1.1 0.0 0.0 175.7 0.0 0.0 0.0 0.4 0.5 0.0 0.1 4.1 0.3 0.0 3.9 0.4 2.3 0.0 480.7 0.4 0.0 0.0 0.2 0.0 0.5 0.4 1.4 15.2 3.1 0.0 0.1 14.2 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.3 0.1 1.4 0.3 0.0 1.8 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 21.7 0.1 0.0 0.0 0.0 0.0 5.5 12.5 0.1 0.0 56.5 0.0 0.2 1.0 0.1 0.0 0.6 88.2 0.0 0.0 0.0 0.0 0.0 43.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8017.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.5 0.1 0.1 106.8 0.0 0.1 0.2 541.4 0.0 0.0 129.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.1 191.5 0.2 TAF1L ENSG00000122728 "TATA-box binding protein associated factor 1 like" Q8IZX4 9 32629454-32635669 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "retina: 1.7;testis: 1.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 15.4;Early spermatids: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056605 Uncertain NA NA "HPA056605: AB_2683186" "unprognostic (7.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-1)" "unprognostic (5.79e-2)" "unprognostic (4.35e-2)" "unprognostic (1.25e-1)" "unprognostic (9.13e-2)" "unprognostic (1.60e-1)" "unprognostic (9.55e-3)" "unprognostic (1.68e-1)" "unprognostic (8.33e-2)" "unprognostic (4.07e-1)" "unprognostic (4.86e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 15.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.6 2.1 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 ACO1 "IREB1, IREBP, IRP1" ENSG00000122729 "Aconitase 1" P21399 9 32384603-32454769 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Lyase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 135.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 194.4;Proximal tubular cells: 183.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 194.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019371, HPA024157" Enhanced Supported Mitochondria,Cytosol NA NA 10000000 "Mitochondria, Cytosol" "HPA019371: AB_1844519, HPA024157: AB_1844520" "unprognostic (2.11e-1)" "unprognostic (5.61e-2)" "unprognostic (8.38e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-1)" "unprognostic (3.12e-2)" "unprognostic (4.25e-3)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (1.19e-1)" "unprognostic (2.55e-1)" "unprognostic (3.08e-1)" "prognostic favorable (5.73e-5)" "unprognostic (2.54e-1)" "unprognostic (6.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.23e-2)" 97.5 51.0 15.1 16.2 15.3 3.6 50.5 14.3 15.1 19.0 17.9 22.5 49.1 19.3 30.4 15.5 14.8 15.7 34.4 13.4 18.4 90.0 135.6 20.5 8.9 16.1 14.8 15.0 17.5 38.0 23.0 13.2 16.2 14.4 22.1 20.8 13.0 16.7 19.2 25.3 11.5 36.1 23.1 12.8 9.4 29.0 17.8 15.5 13.7 34.8 38.1 7.2 24.6 13.9 15.8 37.5 33.7 25.7 40.7 194.5 104.8 11.6 69.3 169.1 31.2 24.5 36.0 11.4 7.4 21.6 73.1 84.9 5.1 51.3 66.3 62.3 23.8 13.8 54.7 33.4 39.3 97.4 5.1 21.2 91.7 20.1 80.4 56.1 95.6 81.7 28.4 20.0 15.7 89.9 9.9 29.5 26.4 26.9 23.3 35.5 22.8 38.0 7.8 118.9 34.1 3.3 10.5 71.9 2.8 7.6 27.1 16.7 13.5 89.2 112.5 38.2 38.2 18.2 7.8 15.5 14.7 78.7 18.2 10.2 33.2 11.3 3.3 9.2 11.3 8.0 5.6 6.2 6.9 9.3 5.0 8.1 8.2 1.2 6.7 10.0 4.3 3.9 8.4 15.1 15.3 14.3 15.1 13.4 18.4 16.1 14.8 15.0 14.4 12.8 15.5 15.8 16.3 3.2 25.7 43.8 6.7 4.5 7.9 11.9 9.1 21.4 17.8 7.4 45.5 38.6 11.7 23.9 22.9 50.8 6.2 26.4 19.6 19.0 8.7 10.0 30.7 18.7 4.9 11.6 24.6 41.0 22.1 29.7 39.3 13.9 2.5 17.1 15.7 194.4 15.1 33.7 46.5 27.7 10.2 14.8 6.7 6.9 23.6 15.6 7.2 20.6 8.6 25.7 8.2 22.1 24.1 19.4 23.7 23.3 7.2 10.1 56.1 183.4 10.7 14.3 19.7 30.5 22.2 9.8 19.4 10.3 5.4 53.5 7.5 22.2 34.6 8.7 PHF24 KIAA1045 ENSG00000122733 "PHD finger protein 24" Q9UPV7 9 34957608-34982544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 44.8;testis: 16.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Cone photoreceptor cells: 8.4;Early spermatids: 3.9;Late spermatids: 7.9;Muller glia cells: 14.2;Spermatocytes: 4.9;Spermatogonia: 4.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in single" "WM-115: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020974 Approved NA NA "HPA020974: AB_1852364" "unprognostic (5.54e-3)" "unprognostic (1.21e-1)" "unprognostic (9.00e-2)" "unprognostic (2.44e-1)" "unprognostic (1.00e-2)" "unprognostic (6.30e-2)" "unprognostic (3.66e-2)" "unprognostic (1.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.97e-1)" "unprognostic (4.80e-4)" "unprognostic (1.24e-1)" "unprognostic (4.58e-6)" "unprognostic (1.87e-2)" "unprognostic (1.41e-1)" "unprognostic (9.23e-2)" "unprognostic (2.30e-1)" 0.5 0.2 12.2 0.4 27.9 0.0 0.6 0.2 44.8 0.3 0.0 0.4 0.1 0.5 0.2 0.3 0.4 0.2 0.1 22.4 12.6 0.1 0.1 0.2 1.0 10.7 8.6 26.1 0.1 0.0 0.0 0.4 0.0 15.9 0.1 0.2 6.8 0.1 0.0 0.1 1.0 0.5 0.4 0.0 0.2 0.3 16.2 12.7 0.7 0.4 0.0 0.8 0.1 0.3 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 12.2 27.9 0.2 44.8 22.4 12.6 10.7 8.6 26.1 15.9 0.0 12.7 23.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.2 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.1 0.4 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DNAI1 "CILD1, DIC1, PCD" ENSG00000122735 "Dynein axonemal intermediate chain 1" Q9UI46 9 34457414-34520988 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 23.7;fallopian tube: 34.2;testis: 33.8" "Cell type enhanced" "Detected in some" "Early spermatids: 29.6;Endometrial ciliated cells: 48.8;Late spermatids: 35.0;Respiratory ciliated cells: 132.2;Spermatocytes: 56.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;HDLM-2: 1.4;SK-BR-3: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021649, HPA021843" Enhanced NA NA "HPA021649: AB_1847913, HPA021843: AB_1847914" "unprognostic (9.61e-2)" "unprognostic (5.16e-2)" "unprognostic (4.59e-2)" "unprognostic (1.44e-3)" "unprognostic (3.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (6.39e-2)" "unprognostic (4.38e-1)" "unprognostic (1.51e-1)" "unprognostic (8.16e-3)" "unprognostic (8.14e-2)" "unprognostic (2.74e-2)" "unprognostic (3.77e-2)" "unprognostic (2.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" 0.0 0.0 5.8 0.0 2.8 0.0 0.5 3.6 2.6 1.3 23.7 0.0 0.0 0.9 0.2 0.0 34.2 0.1 0.0 2.8 5.7 1.1 0.1 4.6 0.0 6.2 7.4 1.4 0.1 0.9 1.2 9.6 0.0 4.6 0.2 0.0 2.7 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.0 0.2 33.8 3.3 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.6 0.2 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 1.0 0.2 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 2.8 3.6 2.6 2.8 5.7 6.2 7.4 1.4 4.6 6.3 3.3 2.4 0.0 0.0 0.5 3.9 0.1 0.0 0.0 5.0 0.0 0.0 0.5 0.3 0.4 0.0 11.0 0.0 4.2 0.2 0.0 0.0 1.9 0.0 29.6 48.8 0.5 0.2 0.0 0.0 9.4 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 16.2 0.0 2.0 0.0 0.0 35.0 0.3 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.4 132.2 1.3 0.0 0.0 1.4 56.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 DCAF10 "FLJ23201, MGC10765, WDR32" ENSG00000122741 "DDB1 and CUL4 associated factor 10" Q5QP82 9 37800554-37867666 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 182.4;Late spermatids: 325.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024160 Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA024160: AB_1858802" "unprognostic (2.16e-2)" "unprognostic (2.74e-2)" "unprognostic (1.14e-2)" "unprognostic (1.09e-1)" "unprognostic (4.46e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (4.50e-3)" "unprognostic (2.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.02e-6)" "unprognostic (1.01e-1)" "unprognostic (5.42e-2)" "unprognostic (1.08e-1)" "unprognostic (9.05e-2)" 6.9 11.3 3.5 4.5 3.9 6.1 7.8 5.2 4.2 6.7 5.0 7.2 5.5 7.6 7.7 7.9 6.6 4.5 5.5 3.7 3.5 8.6 11.5 5.5 5.1 3.4 3.8 3.6 7.2 8.5 14.2 5.5 6.3 3.9 7.0 6.4 7.3 7.4 7.0 10.0 7.2 5.5 7.5 3.6 5.2 6.5 17.8 3.7 5.3 9.1 5.8 5.3 7.5 6.8 4.0 11.7 5.7 7.1 6.1 12.2 16.4 7.1 9.6 10.6 5.8 7.3 2.2 4.4 12.2 4.0 12.7 6.6 4.5 6.7 7.9 8.3 9.4 5.3 5.6 9.8 4.1 21.0 7.4 4.2 14.9 17.4 6.4 26.0 13.2 10.3 7.8 17.9 5.9 10.7 4.9 7.1 3.9 6.1 18.2 4.0 6.6 3.4 6.2 11.1 5.9 6.8 9.5 9.1 11.9 8.5 8.5 8.1 16.1 11.1 6.1 3.7 8.1 6.7 5.4 9.2 6.8 10.2 8.1 8.8 0.3 0.3 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.2 0.6 0.6 0.5 0.7 0.6 0.8 0.3 0.3 0.1 3.5 3.9 5.2 4.2 3.7 3.5 3.4 3.8 3.6 3.9 3.6 3.7 4.0 21.4 16.0 28.7 54.2 21.4 40.8 28.3 24.6 28.5 28.6 26.9 17.5 16.5 17.2 27.4 12.9 25.0 17.8 15.9 21.8 9.8 22.7 182.4 18.9 26.8 26.8 19.2 41.9 89.9 21.9 17.1 26.5 21.4 23.9 5.1 35.7 23.6 43.0 15.3 25.2 90.2 20.7 24.4 15.5 23.3 325.7 28.0 16.4 26.6 38.4 19.3 23.4 22.6 82.4 80.6 22.9 16.1 38.4 18.3 42.4 20.5 28.7 18.3 27.3 39.5 32.5 24.0 100.9 11.3 31.7 52.4 22.8 17.7 40.4 25.2 30.1 CNTFR ENSG00000122756 "Ciliary neurotrophic factor receptor" P26992 9 34551432-34590140 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.3;skeletal muscle: 130.7" "Cell type enhanced" "Detected in many" "Astrocytes: 57.1;Fibroblasts: 22.4;Muller glia cells: 83.6;Paneth cells: 30.6" "Cancer enhanced" "Detected in many" "glioma: 22.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 109.3;SH-SY5Y: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025310 Approved NA NA 55000000 "CAB025310: " "unprognostic (1.39e-1)" "unprognostic (9.40e-2)" "unprognostic (1.93e-2)" "unprognostic (1.90e-2)" "unprognostic (2.59e-1)" "unprognostic (1.22e-1)" "unprognostic (2.18e-1)" "unprognostic (2.94e-2)" "unprognostic (1.28e-1)" "unprognostic (9.70e-2)" "unprognostic (4.45e-3)" "unprognostic (1.72e-2)" "unprognostic (6.32e-2)" "unprognostic (4.99e-3)" "unprognostic (7.37e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" 58.9 10.4 58.8 1.4 73.0 0.0 50.1 74.4 69.6 25.3 10.2 7.6 3.3 2.8 2.6 3.9 13.2 6.3 21.4 46.9 64.3 2.9 12.5 3.8 1.1 65.6 75.2 37.0 5.2 2.2 0.2 9.8 5.2 58.7 11.1 2.2 14.1 11.4 7.7 130.7 10.4 8.7 0.7 38.9 30.8 7.0 7.3 83.3 5.2 13.8 35.5 0.4 5.7 17.2 40.5 0.0 0.0 109.3 0.0 13.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 3.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 52.1 0.1 0.1 0.0 1.0 0.4 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.8 73.0 74.4 69.6 46.9 64.3 65.6 75.2 37.0 58.7 38.9 83.3 40.5 0.9 0.0 0.0 57.1 0.0 3.6 1.1 0.0 1.2 19.3 11.9 1.5 1.3 8.6 0.0 0.0 6.2 0.9 0.1 6.5 1.9 0.1 4.3 0.1 2.4 0.3 0.0 0.0 4.1 0.0 0.6 22.4 0.0 0.1 0.0 0.0 2.5 1.4 1.4 3.3 9.3 0.5 0.0 0.0 2.7 1.9 9.9 0.1 3.6 2.8 0.0 83.6 0.0 15.1 0.5 0.0 30.6 2.2 0.3 0.2 14.1 0.1 0.0 3.2 0.0 1.2 1.9 5.5 19.8 0.3 2.4 2.3 0.2 0.0 0.5 0.3 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981389 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 92.2;Inhibitory neurons: 54.6;Oligodendrocyte precursor cells: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.6;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA 14000 "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 0.6 1.7 3.0 0.3 3.4 0.3 1.5 1.0 4.9 1.3 0.0 0.8 0.7 1.8 1.8 0.5 2.2 1.0 0.8 4.8 1.5 4.0 0.4 1.8 0.2 2.2 1.9 3.2 1.2 6.4 2.5 1.8 1.3 3.4 1.6 0.7 5.8 2.4 5.6 0.6 0.8 0.8 1.3 1.8 0.3 1.3 1.2 3.3 2.4 0.8 0.8 0.2 1.1 0.6 2.5 4.9 9.2 9.1 14.9 0.1 0.0 4.2 5.2 4.6 2.6 3.4 8.4 2.6 0.0 2.9 8.2 8.6 1.0 5.7 1.4 3.6 2.5 3.8 2.6 11.5 2.2 1.3 3.8 3.2 1.2 2.8 0.9 1.4 3.5 4.8 3.4 1.7 0.1 3.6 4.5 2.9 4.7 7.8 4.1 20.6 6.8 4.5 0.0 1.7 3.3 11.8 21.5 2.6 5.2 2.2 5.1 3.7 2.4 3.3 2.9 2.8 0.1 5.1 0.9 0.0 0.1 4.0 1.4 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 3.4 1.0 4.9 4.8 1.5 2.2 1.9 3.2 3.4 1.8 3.3 2.5 2.0 0.0 2.2 11.8 0.1 0.5 2.1 1.6 0.6 18.5 6.3 4.6 2.5 0.0 2.9 7.3 56.3 2.5 0.2 0.3 0.0 2.3 0.5 8.5 8.1 4.8 10.8 1.3 92.2 3.2 2.2 3.0 3.6 8.0 16.5 13.8 2.2 0.8 0.5 3.3 54.6 2.5 6.1 0.8 1.2 0.2 1.5 0.5 1.8 26.2 0.0 7.2 0.0 69.9 2.2 5.0 1.4 2.6 1.0 3.1 0.5 8.1 12.2 29.2 6.6 2.2 2.9 0.3 7.2 0.1 0.9 1.5 1.1 2.4 2.9 1.6 TRIM24 "hTIF1, RNF82, TIF1, Tif1a" ENSG00000122779 "Tripartite motif containing 24" O15164 7 138460259-138589996 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "AF22: 146.5;HMC-1: 196.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043495, HPA061717" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043495: AB_10962915, HPA061717: AB_2684592" "unprognostic (2.40e-1)" "unprognostic (9.52e-3)" "unprognostic (2.23e-1)" "unprognostic (3.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.94e-4)" "prognostic favorable (6.57e-4)" "unprognostic (4.01e-2)" "unprognostic (8.93e-2)" "unprognostic (2.53e-1)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (1.62e-1)" "unprognostic (2.25e-2)" "unprognostic (5.54e-2)" "unprognostic (6.34e-2)" 6.8 26.0 6.2 6.9 7.1 10.7 9.2 6.3 7.4 6.4 5.1 8.2 10.1 8.9 8.5 9.1 5.8 5.4 10.5 6.2 8.7 8.0 23.3 11.5 8.1 7.0 6.5 6.0 30.2 10.9 14.3 3.8 12.4 6.7 11.8 9.3 12.3 8.3 5.3 14.0 8.6 9.8 7.7 6.3 7.3 11.7 27.5 8.0 17.5 9.1 16.5 7.9 7.6 6.1 9.3 15.0 18.1 146.5 42.7 9.6 8.9 11.4 13.7 14.4 10.5 10.2 28.7 13.6 28.7 13.2 13.2 21.5 7.9 71.9 11.4 15.4 22.1 17.7 63.1 13.1 88.9 13.1 49.8 196.8 7.9 11.8 8.8 13.9 7.3 25.0 15.4 72.6 17.1 12.7 29.2 85.2 44.8 56.3 77.6 16.0 66.5 17.3 24.2 23.6 43.9 30.3 68.8 25.5 22.6 7.5 50.6 15.5 32.3 10.7 12.1 9.9 21.4 19.1 15.6 18.2 47.8 20.1 32.1 18.0 0.3 0.6 1.0 0.5 0.6 0.1 0.2 0.4 0.3 0.5 0.3 0.4 0.5 0.9 0.6 0.3 0.3 0.7 0.2 6.2 7.1 6.3 7.4 6.2 8.7 7.0 6.5 6.0 6.7 6.3 8.0 9.3 29.0 51.3 46.9 26.1 9.5 13.9 13.4 13.8 10.8 13.6 14.7 14.4 39.7 20.0 18.8 7.3 16.7 28.4 14.9 12.2 5.9 7.1 70.4 16.7 22.9 18.9 10.1 31.3 27.9 12.4 15.2 16.0 20.4 25.2 40.4 85.2 14.3 31.9 10.3 40.4 46.6 10.9 14.2 9.5 14.9 38.7 14.0 13.8 14.2 21.5 12.2 23.3 9.2 64.3 67.1 9.5 9.5 16.1 13.7 12.2 6.8 10.6 14.5 22.4 13.1 21.5 17.6 72.8 14.7 22.2 11.8 22.2 15.8 34.6 19.4 12.8 CYREN "C7orf49, FLJ22450, FLJ27285, MGC5242, MRI, MRI-2" ENSG00000122783 "Cell cycle regulator of NHEJ" Q9BWK5 7 135092363-135170795 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 69.1;Distal tubular cells: 72.4;Ductal cells: 51.0;Extravillous trophoblasts: 65.6;Hofbauer cells: 41.3;Proximal tubular cells: 47.3;Syncytiotrophoblasts: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020060 Approved NA NA "HPA020060: AB_2290651" "unprognostic (3.32e-1)" "unprognostic (1.78e-2)" "unprognostic (1.20e-1)" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (1.92e-3)" "prognostic unfavorable (2.52e-5)" "unprognostic (8.89e-3)" "unprognostic (2.92e-2)" "unprognostic (3.21e-3)" "unprognostic (8.39e-2)" "unprognostic (3.09e-1)" "unprognostic (1.59e-1)" "unprognostic (1.60e-1)" "unprognostic (8.65e-2)" "unprognostic (3.96e-1)" "unprognostic (2.69e-1)" 15.6 20.3 12.6 15.6 14.7 16.6 16.3 14.3 11.7 16.6 17.4 14.7 13.8 18.6 16.7 18.7 21.3 11.7 16.1 10.5 12.7 27.0 14.3 14.1 19.4 18.3 14.0 8.7 18.4 21.2 26.4 16.4 20.8 15.7 15.5 14.1 6.7 22.7 23.0 33.7 13.6 13.7 18.3 14.3 17.3 18.7 14.0 14.4 19.7 15.1 19.0 23.9 16.7 15.0 18.4 59.9 62.7 29.4 46.0 24.9 23.7 49.1 38.3 38.8 49.0 38.1 40.1 42.0 48.3 42.2 39.2 52.1 32.8 42.2 69.6 31.6 62.1 27.1 32.0 34.2 37.2 35.4 64.0 37.4 27.6 68.4 38.3 44.0 22.5 21.2 37.4 117.5 31.9 40.3 60.4 60.6 44.0 67.8 50.5 46.1 44.1 36.4 64.1 57.1 35.4 34.7 53.4 43.4 37.7 42.5 32.1 30.0 57.4 18.4 43.8 24.6 39.0 66.3 56.8 69.8 65.8 60.7 62.5 90.9 32.2 27.5 27.9 12.3 24.5 13.4 18.3 10.8 16.7 30.3 19.4 15.8 15.9 6.1 27.2 24.1 25.8 5.4 20.9 12.6 14.7 14.3 11.7 10.5 12.7 18.3 14.0 8.7 15.7 14.3 14.4 18.4 12.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 15.2 13.8 0.0 0.0 0.0 31.3 0.0 69.1 9.9 0.0 72.4 51.0 0.0 11.8 13.4 6.3 0.0 0.0 0.0 35.4 65.6 8.0 0.0 25.6 0.0 17.0 0.0 0.0 41.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 32.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 2.2 0.0 0.0 47.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 46.7 4.3 17.8 0.0 0.0 CALD1 "CDM, H-CAD, L-CAD" ENSG00000122786 "Caldesmon 1" Q05682 7 134744252-134970729 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000006, HPA008066, HPA017330" Enhanced Enhanced "Plasma membrane,Actin filaments" Yes No 39000000 "Plasma membrane, Actin filaments" "CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917" "unprognostic (2.16e-2)" "unprognostic (1.19e-2)" "unprognostic (2.80e-3)" "unprognostic (3.05e-2)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (6.52e-3)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" 211.2 120.4 30.2 166.4 33.2 1.3 162.4 29.2 46.7 235.1 52.4 667.7 81.0 527.7 152.0 278.2 307.1 205.0 106.9 27.6 32.5 135.9 226.3 156.8 76.0 33.4 31.0 24.1 329.1 52.9 33.0 53.7 433.6 31.3 352.1 151.2 13.2 70.9 789.1 46.9 71.1 235.1 694.8 28.4 130.3 326.9 53.2 32.8 28.7 115.0 75.8 34.7 509.5 209.8 36.3 115.9 75.3 163.3 146.1 572.7 464.8 161.6 661.6 736.3 227.2 246.6 138.3 3.5 0.7 153.3 1202.8 148.1 26.9 106.0 202.3 308.4 1.5 38.9 4.0 87.8 94.7 375.6 1.5 0.8 360.9 153.6 252.8 147.4 343.6 193.0 0.0 0.6 1.6 338.7 0.3 0.6 3.2 197.7 0.1 25.6 1.4 146.6 2.3 46.9 32.2 29.0 72.1 235.3 31.7 90.0 491.0 7.2 1.4 508.5 733.2 130.0 143.8 230.3 0.9 1.1 1.3 259.0 0.8 573.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.2 0.0 0.0 0.0 2.9 30.2 33.2 29.2 46.7 27.6 32.5 33.4 31.0 24.1 31.3 28.4 32.8 36.3 400.6 22.4 17.6 43.1 7.3 420.4 379.6 218.8 164.4 172.0 115.5 466.1 456.5 228.8 33.5 44.1 6.2 202.7 5.0 0.3 23.5 392.6 61.0 89.4 1190.3 432.9 3.6 16.0 95.4 23.6 903.9 886.9 16.3 206.2 5.1 251.0 422.0 638.4 43.5 92.5 58.3 1.2 28.5 21.0 112.8 83.6 1745.0 38.8 336.2 94.6 8.4 140.6 6.2 98.5 158.8 146.0 0.2 2005.6 4.2 456.9 0.1 332.1 11.3 21.2 2294.3 326.1 2549.3 12.1 12.2 70.1 171.8 276.6 27.5 414.1 0.8 36.7 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138118305 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease variant, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 82 "liver: 430.4" "Group enriched" "Detected in some" 31 "Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "Hep G2: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057002 Enhanced Approved Nucleoplasm,Cytosol No NA 61000 Nucleoplasm Cytosol "HPA057002: AB_2683308" "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favorable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.1 0.2 0.0 0.1 0.2 5.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 430.4 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 12.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.3 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.4 110.3 0.4 0.0 0.2 0.2 0.0 3.2 0.4 126.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 1.6 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 NUDT10 "DIPP3a, hDIPP3alpha" ENSG00000122824 "Nudix hydrolase 10" Q8NFP7 X 51332231-51337525 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.5" "Group enriched" "Detected in many" 5 "Hepatic stellate cells: 60.3;Peritubular cells: 29.0" "Group enriched" "Detected in many" 6 "glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.61e-2)" "unprognostic (1.12e-2)" "unprognostic (7.40e-3)" "unprognostic (7.84e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-3)" "unprognostic (1.80e-3)" "unprognostic (1.04e-2)" "unprognostic (1.12e-2)" "unprognostic (5.04e-5)" 0.5 1.7 9.5 0.8 10.7 1.6 0.8 4.5 9.5 5.8 3.0 2.3 0.5 5.3 16.3 1.1 3.6 1.4 0.7 9.2 10.3 3.8 1.3 0.3 0.4 5.8 6.5 9.3 17.0 0.3 0.0 2.1 0.0 6.6 15.1 0.7 1.5 0.5 14.7 0.1 0.4 1.0 4.1 4.4 3.4 1.2 26.5 10.3 0.4 0.6 0.2 0.3 3.9 3.6 10.0 0.0 0.0 7.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.0 14.2 0.6 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 25.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.5 10.7 4.5 9.5 9.2 10.3 5.8 6.5 9.3 6.6 4.4 10.3 10.0 0.2 0.0 1.3 0.7 0.2 1.0 4.9 0.6 1.8 0.5 0.1 1.5 0.2 0.0 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.0 1.5 0.7 3.5 2.5 0.0 0.8 5.0 0.0 1.0 3.1 0.0 0.1 0.0 5.0 60.3 0.3 0.2 0.0 1.9 0.0 0.0 1.9 0.4 6.2 5.9 0.1 1.8 1.0 0.0 1.7 0.0 3.5 0.6 0.0 0.0 29.0 1.4 2.8 0.0 0.1 0.0 0.5 0.0 1.5 1.9 3.8 7.8 0.4 0.1 0.4 0.2 0.9 0.0 0.2 SFTPA1 "COLEC4, SFTP1, SP-A, SP-A1" ENSG00000122852 "Surfactant protein A1" Q8IWL2 10 79610939-79615455 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Gaseous exchange" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1048 "lung: 7147.2" "Cell type enriched" "Detected in some" 11 "Alveolar cells type 2: 13480.7" "Cancer enriched" "Detected in some" 25 "lung cancer: 706.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 27 "plasmacytoid DC: 2.7" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.7" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 43.2" "CAB016793, HPA042638, HPA045752, HPA049368" Supported "Secreted in other tissues" NA NA "CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (5.83e-4)" "unprognostic (1.17e-1)" "unprognostic (3.38e-2)" "unprognostic (4.24e-1)" "unprognostic (3.47e-2)" "unprognostic (9.09e-2)" 0.4 6.8 0.1 2.6 0.1 0.0 0.5 0.2 0.3 0.9 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.8 0.1 0.0 0.2 0.9 7147.2 0.0 0.1 0.0 0.0 6.4 0.7 0.0 0.3 1.4 0.1 1.0 0.0 0.0 0.2 4.8 0.8 0.7 0.4 0.0 0.0 4.9 3.8 0.3 0.0 1.5 0.5 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.1 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 7.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1160.3 13480.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 183.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 454.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573422 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "brain: 4.6;intestine: 2.6" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Group enriched" "Detected in some" 23 "cerebral cortex: 4.5;hippocampal formation: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "THP-1: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.5 0.0 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 PLAU "UPA, URK" ENSG00000122861 "Plasminogen activator, urokinase" P00749 10 73909177-73917496 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 129.7" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.0;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070796 Supported Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 647000 88000 "Golgi apparatus, Vesicles" "HPA070796: " "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (7.40e-2)" "prognostic favorable (3.38e-4)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.39e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.26e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.83e-1)" "unprognostic (3.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.77e-2)" 41.3 4.8 2.3 42.1 3.0 36.5 17.7 2.5 8.4 7.5 4.2 13.2 12.1 22.2 16.9 14.5 10.4 28.7 18.3 2.2 4.9 48.4 5.0 22.2 14.4 3.1 2.6 1.9 2.3 10.2 8.4 2.9 36.8 5.2 9.2 18.4 0.3 17.4 13.8 10.9 25.7 13.8 23.6 3.0 40.9 15.9 3.8 3.9 5.9 18.0 19.0 7.3 129.7 16.3 3.7 171.1 88.9 36.8 1.7 3.1 59.5 2.0 101.9 461.6 40.0 62.2 2.3 856.0 0.1 184.0 14.5 416.9 114.1 0.9 165.8 44.8 9.9 0.0 0.1 4.4 1.7 72.6 15.6 32.3 158.7 20.2 271.4 103.7 447.0 114.7 1.0 1.1 0.9 822.4 0.2 0.2 22.7 10.8 0.3 244.5 0.4 112.6 0.9 3100.7 130.6 0.1 0.2 0.3 4.0 2.4 25.4 1.2 22.9 300.6 3.5 20.3 21.6 869.8 0.2 1.3 1.6 216.0 25.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.1 2.3 3.0 2.5 8.4 2.2 4.9 3.1 2.6 1.9 5.2 3.0 3.9 3.7 29.0 3.2 4.6 0.3 1.4 37.3 635.9 237.3 19.9 0.0 3.0 24.4 2.5 0.0 103.6 29.5 0.0 28.0 1.6 0.6 68.4 62.7 0.5 50.7 22.2 46.4 3.5 0.0 0.2 21.3 21.7 69.7 0.0 68.9 31.1 0.1 3.9 0.0 39.8 0.0 0.3 0.1 140.4 4.0 33.1 1.3 2.5 53.4 7.2 4.7 23.8 0.0 0.0 0.5 0.2 613.9 0.3 0.0 0.5 695.0 0.0 1.4 35.4 0.0 6.6 27.6 65.2 0.0 0.2 60.6 29.5 17.5 4.7 0.6 1.7 869.6 SRGN "PPG, PRG, PRG1" ENSG00000122862 Serglycin P10124 10 69088103-69104805 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Biomineralization" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 8168.5" "Cell type enhanced" "Detected in many" "dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 5714.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 5714.1" "Cell line enhanced" "Detected in many" "HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000759 Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 100000000 "Golgi apparatus" "HPA000759: AB_1079675" "unprognostic (3.61e-2)" "unprognostic (1.62e-2)" "unprognostic (2.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (4.50e-2)" "unprognostic (1.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.63e-1)" "unprognostic (8.22e-2)" "unprognostic (5.80e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.65e-1)" "unprognostic (2.32e-2)" "unprognostic (4.07e-2)" "unprognostic (4.08e-2)" 408.3 116.0 50.1 806.9 56.7 8168.5 137.6 57.6 91.4 94.0 86.6 102.8 78.6 64.1 26.2 91.8 97.7 319.1 103.2 49.5 93.6 90.5 241.4 350.4 440.8 83.4 54.6 45.1 31.0 69.0 132.8 62.5 358.6 66.3 59.4 120.1 15.6 40.4 57.9 37.8 18.8 112.3 221.4 65.6 366.0 95.8 18.4 62.0 231.1 73.3 118.1 317.2 513.0 46.4 69.3 5.3 43.0 0.2 0.4 768.1 749.7 1.2 94.9 63.9 235.1 283.5 0.1 18.2 9.1 117.4 4.1 134.4 1.1 0.0 20.6 799.9 535.7 0.4 87.1 29.8 0.3 312.7 4442.1 914.9 306.8 1.1 641.5 39.2 223.8 1227.8 13.3 82.5 419.9 1239.9 0.2 18.7 2549.7 0.7 0.1 84.6 2.4 2.3 446.7 0.6 6.0 0.3 0.8 2.3 0.6 16.0 0.0 2.2 4346.8 2609.1 187.9 12.9 3.8 20.1 486.4 508.4 57.3 112.2 3546.9 1.2 2349.8 1105.3 2730.6 474.9 774.6 313.4 73.5 228.5 362.8 583.0 39.0 125.5 268.4 5714.1 962.8 693.6 631.9 392.6 1590.5 50.1 56.7 57.6 91.4 49.5 93.6 83.4 54.6 45.1 66.3 65.6 62.0 69.3 1081.4 112.2 198.1 0.7 592.0 175.9 12.5 38.3 8.6 1.1 16.0 28.2 21.2 21.5 57.5 33.1 0.0 10.2 2922.2 2.9 0.0 4.2 4.1 4.6 15.0 566.8 1.8 277.8 0.2 9.8 10.2 87.9 70.3 6.6 2343.1 0.4 636.1 22.1 847.1 0.0 0.5 1.7 0.0 1789.9 6618.2 8.4 7.5 3639.1 556.7 80.6 3188.2 1.4 1292.5 0.0 0.2 1.3 1.2 18.0 1740.9 12.2 0.3 4.7 45.6 5.0 72.3 22.8 97.5 0.9 2.2 8.7 141.8 14.2 2235.9 1.2 5.5 18.1 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964395-72013558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 65.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 690000 "Golgi apparatus, Cytosol" "HPA047523: AB_2680075, HPA055704: AB_2682891" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 18.5 13.5 10.9 5.6 16.4 0.0 11.5 16.0 10.5 9.9 7.1 9.4 0.9 16.1 3.8 6.5 13.0 4.7 14.2 8.3 16.1 7.9 1.2 8.0 1.6 26.2 17.4 6.5 20.7 4.6 1.2 4.6 8.1 18.4 11.2 2.2 2.2 6.5 15.0 17.8 8.4 5.4 17.2 15.1 2.5 14.8 18.3 14.0 4.3 5.6 9.0 1.4 9.5 8.5 24.9 15.4 16.4 8.2 20.3 36.6 14.4 0.3 32.0 30.4 19.3 12.8 14.4 30.1 0.0 21.4 37.9 15.5 19.7 7.4 21.9 15.3 0.4 5.5 0.1 27.8 13.8 18.7 0.0 0.1 19.8 24.9 19.0 25.9 37.3 5.7 0.7 4.7 0.0 20.6 0.4 0.0 0.1 3.5 0.5 5.3 0.2 9.9 0.0 26.9 15.7 0.5 8.1 24.2 0.6 24.1 9.9 1.8 3.1 11.9 23.6 27.1 39.6 65.1 0.0 0.1 0.1 17.2 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 16.4 16.0 10.5 8.3 16.1 26.2 17.4 6.5 18.4 15.1 14.0 24.9 23.9 0.0 1.9 14.0 0.1 2.8 4.9 6.1 13.6 0.1 4.3 8.0 10.4 5.7 2.5 7.3 0.0 4.6 0.0 0.1 3.9 9.7 0.8 20.1 24.7 5.6 0.0 0.0 0.2 2.7 2.2 9.3 2.6 17.9 1.3 26.9 13.6 0.3 0.8 0.0 0.3 0.0 2.0 0.6 1.9 3.2 20.5 0.7 8.8 4.7 0.7 6.6 0.0 26.7 27.1 12.7 0.0 21.8 0.0 4.2 0.0 3.6 2.0 0.2 6.6 26.8 13.9 1.0 2.1 7.5 2.4 1.1 0.4 5.5 0.1 1.3 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58512872-58831435 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.9" "Cell type enhanced" "Detected in many" "Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2" "Group enriched" "Detected in all" 4 "pancreatic cancer: 9.2;renal cancer: 25.6" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 10 "basophil: 6.2" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070797 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA070797: " "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 10.4 6.2 0.6 4.1 0.6 0.3 8.7 0.1 1.7 5.7 2.6 3.9 1.2 5.0 4.0 3.5 7.6 11.7 7.9 0.7 4.0 28.9 2.4 5.9 2.4 1.0 0.7 0.3 14.0 17.0 0.8 3.7 3.6 0.4 3.8 4.2 1.4 4.4 4.2 7.7 5.4 2.8 4.7 1.3 2.9 2.7 3.1 0.6 1.4 4.6 6.2 2.7 5.6 5.6 0.8 0.0 59.1 0.8 0.0 17.9 23.0 0.0 38.5 61.4 34.4 40.4 93.1 12.3 0.0 39.8 39.3 8.8 0.8 6.1 7.0 47.4 0.1 5.9 0.0 7.4 0.1 11.5 0.0 0.0 36.0 2.2 26.9 28.6 42.3 0.1 0.0 0.0 0.2 13.4 0.1 0.0 0.0 0.5 0.0 3.8 0.0 14.3 0.0 140.8 7.1 0.2 7.3 0.1 0.4 3.4 2.4 0.0 0.6 0.0 8.2 7.7 1.4 5.0 0.0 0.0 0.1 23.8 0.0 7.8 6.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.2 0.5 0.1 0.0 0.6 0.6 0.1 1.7 0.7 4.0 1.0 0.7 0.3 0.4 1.3 0.6 0.8 4.1 0.0 0.5 120.5 1.5 7.1 1.3 1.3 0.6 0.6 1.1 4.3 3.3 158.7 1.7 86.5 0.0 0.4 0.1 0.3 78.2 98.5 5.2 43.8 14.4 1.4 3.6 0.0 70.4 3.5 0.2 79.6 0.5 7.2 0.0 4.2 3.3 1.4 3.5 0.0 37.2 1.2 0.0 0.6 18.5 3.2 71.1 1.7 21.4 165.8 1.1 10.1 0.0 25.6 2.7 35.3 1.2 50.0 0.3 2.4 0.0 148.2 14.1 0.2 6.6 40.0 9.8 0.1 3.9 0.3 4.7 4.1 1.5 8.7 1.6 0.1 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269162-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 83.0" "Cell type enhanced" "Detected in all" "Distal tubular cells: 716.1;Proximal enterocytes: 539.1;Proximal tubular cells: 726.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Supported Mitochondria NA NA 13000 Mitochondria "HPA074383: AB_2686684" "prognostic unfavorable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (6.69e-4)" 5.2 10.2 10.5 6.4 11.3 0.9 6.0 11.9 14.0 6.7 12.3 9.8 22.9 5.6 3.4 11.3 6.2 7.3 43.4 11.1 13.3 26.7 16.8 4.4 6.1 11.7 11.4 10.3 6.9 5.3 83.0 5.8 5.5 12.7 7.7 8.9 8.2 10.0 7.2 46.9 8.5 22.0 8.0 10.8 4.7 7.3 2.8 12.0 6.5 10.2 50.3 5.9 7.9 3.0 16.9 20.5 10.2 8.0 14.6 10.5 11.6 4.7 16.9 19.2 16.4 22.5 24.1 18.8 36.1 13.9 17.5 9.6 12.9 21.7 15.1 14.7 16.2 29.4 9.5 16.4 19.6 11.9 17.0 7.1 14.6 12.1 15.7 23.9 13.9 19.5 17.9 21.2 16.5 11.6 6.8 14.6 18.2 8.5 15.5 31.4 11.0 29.3 19.0 22.1 7.1 25.0 9.0 12.9 34.1 12.4 7.0 22.7 9.0 19.3 7.1 12.8 20.5 20.4 16.6 29.0 27.2 18.9 16.6 7.0 0.0 4.5 0.2 4.3 3.4 5.3 6.3 4.9 5.0 7.6 5.4 5.7 5.7 2.3 5.4 2.3 5.0 6.8 4.2 10.5 11.3 11.9 14.0 11.1 13.3 11.7 11.4 10.3 12.7 10.8 12.0 16.9 31.4 60.9 45.7 27.4 33.0 128.7 87.3 309.4 78.0 84.6 46.4 61.1 321.6 97.2 180.2 134.3 43.8 174.8 22.7 71.1 716.1 98.0 240.9 42.8 30.4 61.6 225.4 24.8 47.2 82.1 78.5 52.7 38.2 43.8 34.3 23.0 63.9 249.6 68.6 42.1 53.1 141.9 272.6 37.0 37.9 366.1 42.3 31.0 183.2 21.5 34.0 47.2 44.3 36.7 30.9 83.2 121.9 40.3 31.7 109.1 539.1 726.8 138.6 56.3 32.9 50.1 55.6 159.4 65.6 94.9 114.2 72.7 26.2 65.0 147.3 69.4 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 60.4;thyroid gland: 137.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 55.5;Breast myoepithelial cells: 68.1;Enteroendocrine cells: 73.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.7" "Region enhanced" "Detected in many" "hypothalamus: 20.0" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.5;non-classical monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-87 MG: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031165 Supported Nucleoplasm NA NA Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 13.8 10.7 0.3 9.9 1.0 8.2 8.7 1.2 10.2 18.7 1.8 3.3 2.0 6.0 60.4 8.8 4.6 32.2 11.4 4.2 20.0 8.0 5.5 15.3 14.5 0.3 0.3 0.1 9.5 4.2 7.1 8.7 3.0 0.5 17.7 3.8 1.4 3.0 1.9 0.9 11.1 4.6 16.9 0.2 4.6 2.3 4.1 0.4 26.7 137.7 9.2 7.2 15.8 1.7 1.5 0.0 0.2 2.5 1.0 1.8 2.4 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 3.8 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.8 0.2 0.1 1.1 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.5 4.2 0.5 0.0 0.5 0.1 0.5 0.4 0.2 0.3 1.3 0.7 0.3 22.5 0.5 0.4 0.0 0.5 0.2 0.1 2.5 0.0 0.4 0.0 0.1 0.5 0.4 0.0 0.1 0.7 0.2 2.3 0.0 0.0 0.4 0.3 1.0 1.2 10.2 4.2 20.0 0.3 0.3 0.1 0.5 0.2 0.4 1.5 15.9 0.0 12.6 0.0 14.0 21.3 30.1 36.0 33.0 1.4 55.5 68.1 7.8 0.0 9.4 0.0 0.0 1.1 9.9 9.5 0.0 1.4 8.9 13.9 14.0 16.7 73.1 0.0 1.7 0.6 1.6 30.4 13.3 26.1 20.8 2.3 5.3 2.4 25.2 0.0 0.5 29.4 14.2 28.1 39.5 4.3 1.8 40.5 8.8 0.0 0.8 4.1 0.0 0.0 0.1 1.0 4.4 7.2 6.4 5.5 7.7 0.0 7.1 0.7 6.6 20.7 12.0 0.1 2.0 14.8 12.5 1.1 13.6 5.1 25.8 3.1 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA006465: AB_2667595" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 13.6 17.4 7.9 14.7 11.1 32.2 18.1 12.7 10.8 14.9 9.7 13.2 12.2 16.1 16.4 15.4 12.0 16.0 12.9 8.7 10.0 17.6 19.0 12.7 17.9 7.8 7.5 8.4 14.0 16.8 23.0 11.4 17.9 8.0 16.7 14.0 17.1 14.6 14.4 13.9 15.4 11.8 14.8 6.6 14.5 13.2 19.3 7.5 21.2 19.2 14.4 18.5 20.2 12.6 12.5 41.0 28.8 32.0 48.1 28.8 28.2 26.3 31.1 48.5 49.9 57.8 52.0 41.4 31.8 29.9 30.5 36.7 33.0 34.6 36.9 50.3 26.1 33.5 39.9 21.2 38.0 43.7 48.3 25.3 31.5 30.9 41.6 51.7 37.9 53.3 29.3 42.1 21.4 47.6 34.8 44.5 28.6 33.0 37.7 81.8 32.1 35.6 17.6 40.4 29.5 13.9 26.5 28.4 62.5 40.3 32.6 36.1 23.0 33.3 21.1 42.8 23.3 36.2 25.2 18.1 54.5 40.1 40.4 18.5 21.0 23.3 26.3 24.7 24.9 26.4 24.3 23.0 24.4 20.3 21.2 29.9 21.5 27.5 32.5 34.7 13.8 24.8 20.3 7.9 11.1 12.7 10.8 8.7 10.0 7.8 7.5 8.4 8.0 6.6 7.5 12.5 21.2 28.9 12.1 13.1 22.7 11.0 27.9 16.6 24.5 13.9 11.9 10.3 12.5 8.6 23.0 7.3 25.0 22.7 22.7 9.0 7.9 15.8 39.4 15.3 15.5 17.4 10.8 21.8 17.3 12.2 15.7 15.7 23.4 24.8 19.6 12.2 15.0 8.8 16.6 20.2 16.3 11.8 8.2 12.4 10.1 11.5 15.8 16.0 14.2 9.4 10.8 10.3 14.4 11.6 18.6 14.7 5.7 13.2 16.7 13.1 9.8 12.2 10.5 13.1 6.6 17.8 18.2 32.9 16.0 19.2 10.9 33.2 22.1 11.6 9.2 24.7 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 494.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" Yes No 60000 "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavorable (9.01e-4)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavorable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 23.9 26.2 32.1 21.0 28.2 15.6 26.5 31.5 51.4 32.1 36.9 16.5 11.1 27.3 19.0 10.2 41.4 26.6 37.4 35.2 39.1 36.2 73.4 28.0 16.3 35.7 29.4 24.0 35.2 17.6 17.1 11.7 65.8 33.8 20.2 17.6 33.6 13.1 18.6 111.8 16.7 14.5 28.7 38.8 19.8 19.9 19.5 36.9 13.1 14.0 54.4 14.7 29.9 18.4 62.0 84.0 21.2 60.1 117.6 181.2 138.3 50.1 239.9 215.8 90.8 215.8 35.6 63.6 28.4 89.7 239.0 55.1 92.5 38.3 87.7 197.1 36.5 14.5 24.4 18.6 42.5 75.3 45.1 16.4 84.5 50.3 77.7 101.6 494.2 43.5 23.8 38.3 14.7 79.3 22.4 17.9 42.9 21.6 38.9 92.3 16.4 40.2 52.4 51.0 35.6 5.5 33.7 49.2 143.2 58.3 135.0 21.9 41.9 41.9 110.5 44.8 31.3 56.9 81.8 31.3 13.7 198.1 64.5 54.9 1.1 18.8 14.9 6.7 23.5 8.7 8.2 8.1 7.9 20.7 9.2 5.9 6.1 10.4 5.2 25.7 16.6 10.7 9.1 32.1 28.2 31.5 51.4 35.2 39.1 35.7 29.4 24.0 33.8 38.8 36.9 62.0 29.0 6.4 28.4 87.1 31.7 36.3 33.0 138.0 22.2 13.5 23.8 15.7 42.0 7.2 69.2 23.9 27.1 31.5 24.9 25.1 0.0 33.1 16.8 85.6 89.2 25.9 10.3 7.2 48.8 19.5 116.4 67.7 14.3 131.4 40.5 16.9 20.0 29.8 43.9 11.8 41.6 9.5 46.8 54.1 75.7 8.1 51.9 51.5 44.4 62.8 39.0 34.0 6.2 86.5 44.8 36.6 27.1 47.0 32.9 24.9 13.5 25.1 94.6 17.2 39.5 37.0 44.7 61.7 34.0 9.8 23.9 33.2 27.7 31.1 7.0 17.6 SLC25A16 "D10S105E, GDA, HGT.1, ML7" ENSG00000122912 "Solute carrier family 25 member 16" P16260 10 68477998-68527523 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036243, HPA044580" Uncertain Approved Mitochondria NA NA Mitochondria "HPA036243: AB_2675019, HPA044580: AB_10962723" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.23e-2)" "unprognostic (9.13e-3)" "unprognostic (1.92e-1)" "unprognostic (4.13e-2)" "unprognostic (8.65e-2)" "unprognostic (1.17e-1)" "unprognostic (8.37e-3)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (2.06e-2)" "unprognostic (1.44e-3)" 10.4 3.6 5.2 2.1 5.3 3.7 4.2 7.6 6.8 2.0 0.1 3.3 3.9 3.5 3.3 2.6 2.1 2.4 2.7 5.3 5.7 5.8 11.5 3.1 2.7 3.2 3.8 4.2 2.4 5.1 3.6 2.6 2.9 3.6 8.3 2.8 4.8 4.6 2.9 4.9 3.1 3.8 2.6 3.0 2.4 4.6 1.5 4.7 2.1 3.5 2.3 2.0 2.7 2.2 7.0 2.8 1.1 3.2 4.4 4.2 5.0 3.4 3.8 4.2 2.4 2.6 6.6 1.9 3.0 2.7 7.6 1.3 1.6 10.2 1.9 6.1 2.2 6.3 1.6 3.5 2.9 5.1 5.2 3.4 4.3 4.9 4.6 6.4 3.6 2.0 2.6 1.8 4.8 5.2 2.6 2.9 3.7 0.7 0.8 14.8 1.6 2.3 1.0 6.8 9.2 2.2 1.8 5.4 5.2 4.4 2.2 2.9 2.1 8.9 3.6 4.8 6.1 4.5 4.9 2.8 4.9 3.5 4.2 1.6 1.4 0.7 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.8 0.4 0.6 1.3 0.6 0.4 0.8 0.4 0.3 5.2 5.3 7.6 6.8 5.3 5.7 3.2 3.8 4.2 3.6 3.0 4.7 7.0 9.6 44.8 20.7 23.5 9.9 6.4 6.3 4.9 4.6 19.2 11.0 6.7 10.4 12.8 7.4 12.9 39.6 19.0 12.4 12.9 11.7 8.1 9.9 9.6 9.3 7.8 15.0 9.9 44.0 19.2 32.3 8.8 20.9 14.1 8.2 6.1 13.9 37.7 10.6 20.2 53.7 9.4 8.2 10.3 6.5 13.0 3.1 7.9 1.8 13.1 8.2 9.5 15.5 29.7 48.0 14.4 7.8 7.9 16.4 13.5 17.7 21.4 9.9 31.2 0.0 13.4 11.3 4.5 2.5 10.5 6.8 59.8 9.4 9.4 9.0 10.6 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357227-56361273 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.9;lymphoid tissue: 43.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 17.0" "Lineage enriched" "Detected in many" 5 "T-cells: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 2.7 2.5 1.3 15.8 1.3 41.9 6.6 1.2 1.8 3.9 1.1 19.0 13.8 3.2 1.7 12.5 2.8 2.5 1.5 1.4 1.5 4.4 4.9 2.9 26.7 1.3 1.4 1.2 1.5 2.5 5.5 0.8 10.9 1.3 2.5 22.7 0.5 3.4 1.4 0.3 10.9 15.0 6.9 1.2 5.1 12.6 26.4 1.5 43.9 3.9 0.7 33.2 5.0 4.3 1.5 199.8 154.8 107.9 120.9 7.5 10.8 88.1 143.1 108.0 169.6 153.4 275.4 116.1 102.0 53.2 49.6 79.1 99.9 153.2 108.3 156.7 259.9 80.2 101.6 120.8 129.4 0.7 169.6 131.0 5.1 6.8 157.7 64.9 20.8 86.8 134.2 140.2 121.4 151.1 160.1 150.7 108.3 77.0 135.9 188.7 151.7 209.5 54.0 53.5 87.5 99.8 61.2 135.2 304.2 35.3 62.2 197.3 163.4 47.4 73.6 189.4 76.9 223.2 105.8 55.3 176.0 103.8 210.0 94.7 0.0 0.8 0.7 2.4 3.0 0.3 1.6 5.3 3.6 1.4 0.3 6.3 3.6 0.0 3.5 2.3 1.1 17.0 3.1 1.3 1.3 1.2 1.8 1.4 1.5 1.3 1.4 1.2 1.3 1.2 1.5 1.5 0.9 3.2 1.7 0.3 11.1 18.4 6.0 20.2 4.6 2.0 9.4 5.5 1.4 2.8 7.3 5.5 0.0 73.7 3.3 17.9 0.0 9.7 74.0 7.0 4.3 5.7 0.0 133.0 1.3 13.3 108.6 10.3 16.8 8.0 0.0 27.6 7.9 3.5 49.4 0.0 0.3 22.8 14.2 8.5 8.8 208.8 5.0 9.2 7.2 0.0 2.6 1.3 0.0 0.0 0.6 8.6 16.4 2.6 42.4 1.9 8.7 6.0 2.5 0.9 0.0 1.4 10.6 121.0 100.3 24.5 8.2 23.1 7.9 6.5 39.4 8.4 VPS26A "Hbeta58, PEP8A, VPS26" ENSG00000122958 "VPS26, retromer complex component A" O75436 10 69123512-69174412 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 243.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011602, HPA057498, CAB075733" Supported Enhanced Endosomes,Lysosomes NA NA 41000 "Endosomes, Lysosomes" "CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448" "unprognostic (1.17e-2)" "unprognostic (6.94e-2)" "unprognostic (5.58e-2)" "unprognostic (9.35e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (1.72e-4)" "prognostic unfavorable (1.70e-6)" "unprognostic (1.17e-1)" "unprognostic (1.35e-1)" "unprognostic (7.88e-2)" "prognostic unfavorable (9.18e-6)" "unprognostic (4.63e-2)" "unprognostic (2.15e-2)" "unprognostic (7.14e-2)" "unprognostic (6.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.72e-1)" 37.4 27.3 27.5 24.6 30.0 36.5 33.2 31.5 32.6 25.1 28.2 32.4 25.0 27.1 22.3 42.1 22.9 22.9 22.1 28.2 30.0 34.3 30.6 27.8 23.4 29.9 29.8 27.0 26.1 24.0 38.4 12.1 40.3 29.4 24.8 32.6 19.8 26.3 21.1 33.7 37.2 25.7 25.9 31.5 23.3 24.3 43.1 28.7 28.1 30.2 31.5 28.1 33.3 30.2 32.9 113.1 42.5 51.7 87.1 80.8 73.8 46.1 66.3 106.0 79.7 90.1 91.8 110.9 34.3 53.1 72.3 78.2 75.9 73.1 63.5 108.5 31.3 38.7 54.0 36.7 52.2 104.9 80.6 39.4 66.3 90.8 79.8 161.5 99.8 81.9 40.8 104.7 46.0 119.2 35.8 35.8 86.4 34.0 51.9 97.9 44.2 85.0 40.4 86.6 68.3 30.5 45.5 89.3 119.5 117.6 44.5 50.3 62.9 97.9 53.0 69.7 91.7 83.8 28.0 74.4 57.4 71.2 123.6 27.8 54.6 39.6 38.6 40.8 46.6 37.4 26.3 30.7 42.2 44.8 20.0 26.7 37.7 38.1 54.6 40.9 17.7 38.3 44.4 27.5 30.0 31.5 32.6 28.2 30.0 29.9 29.8 27.0 29.4 31.5 28.7 32.9 49.0 73.7 56.6 21.5 40.6 120.7 83.4 79.6 60.3 24.4 43.0 34.8 44.2 40.0 75.2 40.5 14.6 117.1 59.2 47.3 80.3 69.3 59.4 29.8 42.2 52.7 16.2 58.3 29.4 53.4 87.8 57.4 30.5 42.0 45.5 32.4 35.3 29.4 85.8 20.2 30.3 38.3 85.5 53.2 108.7 29.6 42.3 66.0 62.2 28.1 62.4 63.2 52.5 21.6 39.8 65.7 43.3 44.8 28.2 65.2 30.5 80.6 45.5 27.4 13.1 48.0 61.9 89.3 73.7 57.5 107.0 243.7 59.5 38.2 44.4 77.6 RBM19 "DKFZp586F1023, KIAA0682, Mrd1" ENSG00000122965 "RNA binding motif protein 19" Q9Y4C8 12 113816738-113966325 "Plasma proteins, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038860, HPA058732" Supported Supported Nucleoli NA NA Nucleoli "HPA038860: AB_10697400, HPA058732: AB_2683801" "unprognostic (2.10e-1)" "unprognostic (1.54e-1)" "unprognostic (3.61e-2)" "unprognostic (4.83e-3)" "unprognostic (1.50e-1)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.87e-7)" "unprognostic (9.32e-3)" "unprognostic (2.61e-1)" "unprognostic (5.14e-2)" "unprognostic (4.43e-2)" "unprognostic (3.53e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" 11.4 14.2 7.3 12.6 8.0 16.6 13.6 5.3 8.4 13.3 7.0 12.8 8.8 13.2 8.4 12.6 13.0 6.5 11.5 6.4 5.9 13.4 12.4 12.3 14.1 8.2 7.6 5.7 19.1 14.4 10.2 12.8 10.0 10.4 15.3 9.0 7.7 12.7 8.4 16.9 12.2 13.6 9.1 4.9 13.4 13.4 12.0 8.6 10.5 21.0 9.4 13.0 14.5 12.5 10.8 13.0 25.6 15.0 29.3 14.7 11.7 22.7 22.9 17.9 25.3 18.5 34.4 17.7 23.1 13.9 19.5 18.5 18.1 35.4 22.1 19.8 42.0 20.8 49.6 28.0 33.4 11.1 37.9 22.7 14.6 14.3 31.0 11.2 16.2 18.6 17.8 54.3 9.3 15.9 19.4 21.4 28.6 32.8 12.9 21.6 28.2 14.4 20.1 17.3 24.9 17.9 14.4 20.5 29.3 14.2 12.4 32.3 10.9 21.3 16.6 20.3 14.4 14.3 16.7 13.5 22.7 22.3 26.7 21.5 0.1 4.4 1.3 7.7 7.7 6.0 7.3 5.5 6.4 6.1 5.9 4.4 6.0 0.2 7.6 12.4 4.2 5.4 4.8 7.3 8.0 5.3 8.4 6.4 5.9 8.2 7.6 5.7 10.4 4.9 8.6 10.8 8.1 16.0 9.6 18.9 15.6 13.8 14.6 5.1 10.8 11.8 10.3 8.3 20.4 7.2 9.2 11.0 8.4 10.6 13.2 6.5 1.9 11.7 7.2 9.1 11.7 11.2 9.0 12.4 13.8 13.3 9.2 13.6 10.2 9.8 15.2 15.5 4.6 6.9 12.3 6.7 13.1 8.4 6.1 7.6 8.7 9.5 10.8 9.8 3.6 24.4 16.8 5.4 8.2 11.1 15.5 14.5 5.6 7.2 15.1 15.3 6.4 9.8 12.8 13.5 0.0 14.1 12.9 16.6 15.1 11.8 11.5 11.4 15.1 10.4 7.8 11.4 CIT "CITK, CRIK, KIAA0949, STK21" ENSG00000122966 "Citron rho-interacting serine/threonine kinase" O14578 12 119685791-119877320 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019082, HPA048812, HPA075506" Uncertain Approved Cytosol NA NA Cytosol "HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752" "unprognostic (5.64e-2)" "unprognostic (5.00e-2)" "unprognostic (8.16e-2)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (3.61e-6)" "unprognostic (6.02e-2)" "unprognostic (7.78e-2)" "unprognostic (4.42e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-2)" "unprognostic (2.55e-3)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (1.70e-1)" "unprognostic (3.30e-1)" 0.6 2.2 14.3 1.6 20.7 6.4 0.6 0.4 20.0 0.9 0.2 2.1 1.2 0.4 0.0 2.5 0.5 0.5 0.5 14.3 6.1 2.5 0.3 1.8 1.5 5.5 5.5 12.4 0.3 0.2 0.1 1.7 1.4 7.4 0.5 2.5 3.4 0.8 0.2 0.5 1.6 1.9 0.9 1.2 3.0 2.2 4.8 14.8 6.9 0.6 0.3 2.3 0.5 1.3 8.6 26.2 20.6 21.7 15.3 2.4 6.3 10.4 22.0 19.1 21.8 16.6 14.5 10.3 18.4 10.0 14.2 9.3 14.6 14.4 9.5 32.1 13.6 7.5 25.7 13.2 7.1 0.3 12.7 20.6 0.9 1.2 23.7 14.8 7.3 15.5 19.9 14.5 15.2 19.5 12.2 22.4 14.0 10.4 8.7 12.5 19.3 39.8 6.3 5.0 11.1 15.5 8.4 31.9 6.5 16.0 9.6 23.2 10.6 11.5 21.9 21.4 17.2 22.7 9.9 12.6 14.2 16.8 12.5 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 20.7 0.4 20.0 14.3 6.1 5.5 5.5 12.4 7.4 1.2 14.8 8.6 4.1 6.4 13.0 8.5 1.2 3.3 0.7 1.0 0.6 8.2 1.8 1.5 1.8 0.0 5.6 9.2 87.6 3.5 0.6 1.1 0.0 0.2 72.8 2.4 2.1 2.7 1.8 12.8 147.0 0.8 4.8 2.2 3.1 3.6 1.3 10.5 1.1 0.7 3.6 0.0 139.8 4.4 6.1 3.7 0.8 44.1 1.2 2.0 3.6 7.5 0.0 15.4 1.0 82.4 18.7 0.2 0.1 1.2 4.1 0.4 0.8 7.5 1.7 15.2 0.0 0.6 3.3 33.2 4.2 7.7 1.3 1.0 2.2 4.3 4.4 1.0 IFT81 "CDV-1R, CDV1, MGC4027" ENSG00000122970 "Intraflagellar transport 81" Q8WYA0 12 110124335-110218793 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 79.1;Respiratory ciliated cells: 148.2;Spermatocytes: 179.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019087, HPA020051" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA019087: AB_1851462, HPA020051: AB_1851465" "unprognostic (2.54e-1)" "unprognostic (1.47e-1)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "unprognostic (9.79e-2)" "unprognostic (1.10e-1)" "unprognostic (7.95e-2)" "unprognostic (3.91e-1)" "unprognostic (3.21e-1)" "unprognostic (1.40e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (1.88e-1)" "unprognostic (2.45e-1)" 5.2 9.1 7.3 4.6 5.6 1.5 8.9 8.0 6.1 15.1 9.7 10.5 2.7 14.6 18.7 6.0 18.4 8.6 7.2 5.9 8.0 9.4 4.1 8.4 3.0 7.4 7.2 5.2 14.6 5.2 16.7 15.3 5.1 5.1 12.4 5.8 23.2 9.4 14.5 6.9 5.8 5.2 8.6 6.0 4.1 7.5 32.1 5.4 5.8 14.0 6.8 3.0 11.6 9.7 5.1 14.1 26.2 53.0 22.7 9.6 19.6 4.0 8.8 13.5 18.7 16.0 5.1 7.8 4.6 4.8 17.0 13.2 12.2 19.7 10.4 24.1 5.9 10.8 9.7 15.4 8.4 8.3 6.0 4.5 14.1 11.6 17.7 4.5 45.2 11.8 9.0 12.0 2.5 17.3 3.0 12.3 10.1 26.2 8.1 8.6 14.4 13.9 6.2 23.2 9.4 32.8 36.2 24.1 5.0 36.8 14.7 26.9 9.1 8.0 10.5 5.4 8.8 8.4 7.9 8.0 6.3 25.3 7.6 12.2 0.0 0.3 0.1 0.2 0.2 0.5 0.4 0.5 0.2 1.0 0.4 0.4 0.1 0.8 0.7 0.3 1.0 0.2 0.3 7.3 5.6 8.0 6.1 5.9 8.0 7.4 7.2 5.2 5.1 6.0 5.4 5.1 5.2 12.8 20.1 26.4 2.4 6.1 12.9 20.3 11.4 16.4 8.6 11.6 22.1 8.6 26.0 14.7 41.7 2.5 0.6 2.3 15.6 10.9 51.8 79.1 36.1 6.0 21.6 2.5 30.1 4.0 1.6 14.9 8.2 11.9 3.8 16.8 4.6 4.8 2.6 25.2 31.8 4.3 18.3 1.3 1.4 18.1 14.0 2.5 35.6 11.2 2.1 19.1 1.0 41.2 14.5 5.7 1.9 27.8 1.9 3.6 0.9 10.5 148.2 37.7 6.6 14.4 25.6 179.0 46.0 7.4 6.5 1.0 1.5 36.3 3.5 4.8 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725774-120740008 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 247.5;skeletal muscle: 159.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Supported Mitochondria NA NA Mitochondria "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.34e-5)" 50.8 53.2 11.4 11.2 12.3 14.5 41.2 11.8 16.7 11.0 11.0 51.6 85.6 10.3 0.9 14.2 10.3 8.6 65.5 10.3 11.6 51.3 247.5 13.5 6.5 12.9 12.1 9.6 8.6 33.4 4.7 9.3 7.6 12.9 14.0 21.5 0.9 19.4 7.3 159.5 13.3 73.8 5.9 11.5 31.8 34.8 20.5 12.7 6.7 22.1 80.4 3.4 18.1 12.8 13.4 3.2 11.4 0.6 9.7 12.9 5.1 11.1 4.7 4.6 6.0 4.5 8.9 8.0 0.3 11.9 3.9 2.7 5.2 6.6 2.1 0.8 16.7 8.2 8.2 3.6 19.3 9.3 0.7 36.0 15.4 3.1 2.6 0.2 1.8 6.1 20.6 6.9 0.1 2.7 6.8 11.7 19.2 2.0 10.6 4.6 8.6 4.2 2.2 11.3 18.2 1.1 6.0 9.7 0.0 15.8 0.9 7.7 13.1 6.9 0.2 4.7 4.5 0.9 15.3 9.3 4.1 10.2 7.0 4.1 8.3 15.3 7.5 13.7 16.3 9.3 6.3 12.2 14.2 13.2 8.9 15.3 14.4 1.4 19.9 10.2 11.0 14.7 12.8 11.4 12.3 11.8 16.7 10.3 11.6 12.9 12.1 9.6 12.9 11.5 12.7 13.4 18.8 12.8 13.7 10.1 6.7 6.6 9.5 21.1 4.0 1.0 25.0 14.9 44.0 27.1 13.0 18.4 0.0 78.8 9.8 303.1 50.9 35.2 23.5 12.8 8.2 13.4 45.6 38.5 2.3 32.6 31.3 18.1 28.5 10.8 19.1 12.8 19.2 203.3 55.1 1.7 2.8 105.3 20.3 21.0 8.9 36.5 21.5 15.3 17.8 0.0 26.1 13.6 18.6 3.0 3.6 26.7 185.7 18.0 7.9 8.3 435.0 94.8 7.3 0.6 6.6 13.2 12.7 41.5 8.1 9.4 4.5 75.5 11.9 140.6 185.9 12.7 HVCN1 "Hv1, MGC15619, VSOP" ENSG00000122986 "Hydrogen voltage gated channel 1" Q96D96 12 110627841-110704950 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 139.4;lymphoid tissue: 73.5" "Cell type enhanced" "Detected in many" "B-cells: 178.4;Early spermatids: 87.3;Hofbauer cells: 57.0;Late spermatids: 76.4;Spermatocytes: 117.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NB-4: 286.4;U-698: 90.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039329 Enhanced NA NA "HPA039329: AB_10674284" "unprognostic (3.43e-2)" "unprognostic (6.32e-3)" "unprognostic (7.05e-2)" "unprognostic (1.54e-2)" "unprognostic (4.62e-3)" "unprognostic (3.89e-2)" "unprognostic (1.96e-1)" "unprognostic (5.85e-3)" "unprognostic (2.40e-1)" "unprognostic (3.09e-2)" "unprognostic (1.54e-2)" "unprognostic (5.67e-2)" "unprognostic (3.35e-3)" "unprognostic (4.82e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-1)" 8.2 5.1 22.2 32.2 31.5 6.9 5.3 25.2 21.3 8.9 139.4 6.6 4.9 10.2 11.6 4.6 9.3 8.3 15.9 26.3 25.7 3.4 4.4 13.8 65.6 30.8 29.9 14.6 13.6 1.7 2.3 3.0 8.2 33.5 6.4 6.7 2.8 4.0 8.8 8.0 3.0 18.0 10.4 20.4 43.1 7.7 45.1 26.8 16.3 3.9 9.8 73.5 9.7 5.3 24.9 0.1 0.5 2.8 0.2 4.5 4.7 1.4 0.9 1.1 2.6 1.4 0.5 0.0 2.9 2.4 5.1 0.0 0.4 3.3 0.2 3.7 0.2 0.6 0.1 0.3 0.7 4.0 44.1 3.1 6.2 0.4 2.4 0.0 0.4 6.4 13.4 1.9 2.4 4.7 0.2 6.4 286.4 3.2 0.0 2.7 5.4 0.2 0.3 0.0 0.1 0.3 0.4 0.1 0.0 0.2 2.9 0.0 42.8 1.9 0.0 0.2 0.4 0.1 27.4 3.7 90.5 0.3 2.2 0.2 378.0 208.3 675.7 14.0 197.8 7.7 550.4 13.2 22.7 88.7 799.8 25.2 17.2 327.4 182.6 185.0 131.7 31.0 193.2 22.2 31.5 25.2 21.3 26.3 25.7 30.8 29.9 14.6 33.5 20.4 26.8 24.9 18.4 3.2 5.3 9.4 178.4 0.8 1.9 2.0 1.2 0.5 1.2 2.8 6.6 0.0 3.6 1.8 0.0 0.4 25.8 0.0 0.0 0.5 87.3 0.5 5.8 13.1 0.0 0.8 0.6 0.2 1.4 5.4 1.5 0.3 8.2 3.9 12.1 0.3 57.0 0.0 0.5 0.2 0.0 41.7 17.2 76.4 13.4 42.2 12.4 15.0 31.6 15.2 23.7 2.0 0.1 0.5 0.1 13.9 9.9 0.6 0.0 0.5 1.7 1.8 13.1 4.7 15.1 117.5 2.8 0.7 0.4 1.2 7.6 0.5 0.2 1.2 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157173-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: AB_2686311" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 19.1 21.9 7.6 29.2 7.7 39.1 18.8 7.4 9.8 18.8 10.5 18.1 27.1 21.5 5.7 24.2 21.2 13.4 16.0 6.6 7.5 16.2 21.0 17.2 28.7 8.2 7.4 6.0 23.4 30.5 20.9 8.5 16.9 7.5 16.3 11.5 7.4 19.9 16.0 54.3 24.5 21.2 13.6 7.6 21.7 22.0 9.2 7.7 21.4 19.1 20.6 16.6 20.1 18.4 8.3 82.7 84.0 30.8 57.1 20.2 24.1 79.3 43.8 40.3 58.3 31.9 87.1 39.0 105.8 49.7 36.8 43.4 59.8 55.0 56.8 22.0 61.3 67.7 64.0 45.1 60.3 35.3 107.5 72.1 39.8 44.1 56.7 34.7 47.7 48.4 63.2 94.2 37.1 30.4 75.8 93.0 152.4 72.1 57.6 59.2 68.2 45.6 107.8 31.7 84.3 39.8 36.0 61.8 93.4 39.9 25.2 80.4 82.6 36.3 49.2 54.8 59.1 92.7 53.3 66.4 119.5 43.4 59.0 52.9 13.0 11.3 2.9 12.6 16.7 13.1 12.4 11.5 12.6 14.5 11.3 11.6 12.9 0.6 13.1 11.7 10.9 10.1 12.7 7.6 7.7 7.4 9.8 6.6 7.5 8.2 7.4 6.0 7.5 7.6 7.7 8.3 19.1 32.1 29.8 6.5 39.4 17.3 35.9 26.4 34.7 20.5 28.2 24.3 14.5 21.5 24.1 12.9 2.1 63.9 30.6 29.2 25.4 44.5 1.2 23.3 21.8 25.7 28.2 33.4 5.9 49.9 57.2 23.2 26.0 28.5 25.3 35.6 17.9 38.2 38.6 26.9 4.3 31.5 24.4 35.9 20.9 2.4 29.5 22.3 12.4 6.5 29.5 26.8 51.5 2.0 4.8 43.0 33.4 24.0 35.0 52.9 49.3 50.5 12.8 18.1 6.6 28.7 24.9 14.8 20.1 39.5 19.6 72.4 33.3 56.8 43.8 38.0 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13L" Q71F56 12 115957905-116277693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "T-47d: 124.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 18.6 7.9 5.2 15.9 6.1 53.1 21.0 25.7 7.6 15.9 7.7 13.0 10.3 20.7 6.6 13.9 12.7 13.3 11.6 5.5 6.4 12.5 8.0 14.5 14.7 9.2 5.6 3.1 24.6 17.7 15.4 5.6 16.4 9.0 12.8 13.6 12.7 14.9 12.9 18.8 19.1 13.5 16.0 5.6 16.8 12.3 13.9 5.4 39.5 18.2 26.1 16.3 13.2 12.8 9.8 16.9 33.2 19.6 16.9 23.6 42.0 16.5 15.8 21.3 23.7 16.3 25.2 5.9 13.3 13.6 29.0 14.5 9.9 20.4 14.2 29.6 24.3 14.0 26.9 10.0 7.2 26.2 24.8 28.6 30.6 21.8 26.8 40.7 17.4 15.9 28.2 28.9 11.4 18.7 21.8 42.1 22.2 10.5 7.1 8.2 28.7 25.0 24.8 11.1 18.4 17.7 12.4 14.2 7.8 15.0 34.9 124.8 39.9 20.7 26.0 16.8 17.2 19.5 17.9 9.7 21.6 12.0 22.3 12.8 1.5 0.6 1.5 0.2 0.3 0.2 0.3 0.5 0.2 0.7 0.7 0.3 0.4 3.5 0.3 0.4 1.1 0.0 0.1 5.2 6.1 25.7 7.6 5.5 6.4 9.2 5.6 3.1 9.0 5.6 5.4 9.8 84.4 64.1 54.9 303.9 47.5 99.2 38.4 21.7 70.6 52.4 51.4 42.4 35.6 21.5 35.5 25.8 54.2 9.4 38.5 30.5 3.9 13.5 84.0 42.5 115.2 56.9 31.3 49.6 311.5 26.0 19.6 56.0 29.0 96.7 14.0 93.4 53.6 30.6 21.1 57.2 321.0 31.8 14.2 48.7 60.6 47.2 92.2 60.5 32.0 427.2 56.4 22.8 17.5 352.8 305.4 26.8 21.0 67.0 65.6 49.4 22.7 12.3 27.2 44.6 46.0 61.9 57.0 20.3 23.3 48.0 101.6 14.2 30.5 23.7 25.9 51.0 CDKN2C "INK4C, p18" ENSG00000123080 "Cyclin dependent kinase inhibitor 2C" P42773 1 50960745-50974634 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 99.2;lymphoid tissue: 97.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 73.5;Sertoli cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 273.1;U-937: 284.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005303, CAB018398, HPA019057, HPA019764" Approved Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866" "unprognostic (4.07e-2)" "unprognostic (1.47e-3)" "unprognostic (2.89e-1)" "unprognostic (4.86e-2)" "unprognostic (6.70e-2)" "unprognostic (4.76e-3)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.70e-10)" "unprognostic (2.55e-2)" "unprognostic (2.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.24e-1)" 99.2 23.4 22.0 9.2 23.4 36.3 30.9 22.4 31.7 17.0 21.3 16.5 13.6 20.6 11.9 11.2 15.3 15.6 24.4 21.4 22.6 10.5 7.2 10.0 22.7 22.9 22.8 20.6 48.1 17.5 20.0 7.8 7.4 23.5 10.0 12.7 7.9 8.8 25.1 20.7 19.1 14.3 22.4 21.6 11.2 7.5 5.2 22.2 97.1 9.8 8.6 23.5 13.2 16.4 30.0 67.6 32.9 5.9 99.6 108.0 16.4 1.5 61.8 76.2 121.8 107.8 1.8 25.7 140.3 58.5 63.5 41.6 8.2 71.4 9.8 63.4 78.4 90.7 102.5 254.6 21.5 5.5 74.0 42.8 5.6 1.9 32.8 14.6 45.6 32.7 115.0 45.0 0.0 76.2 22.0 91.1 40.4 0.1 31.6 71.3 108.6 86.8 0.4 42.9 34.1 49.6 114.3 88.1 67.5 23.6 0.6 31.3 273.1 21.6 130.8 44.1 76.3 0.9 128.1 131.9 113.2 0.0 284.5 118.3 22.4 3.7 17.9 7.3 2.2 8.4 4.9 10.8 9.7 9.3 4.3 6.0 5.8 0.4 10.5 0.9 11.5 22.0 5.6 22.0 23.4 22.4 31.7 21.4 22.6 22.9 22.8 20.6 23.5 21.6 22.2 30.0 9.5 0.0 3.9 2.0 5.6 10.1 2.6 8.1 23.9 8.2 3.8 29.5 14.3 5.7 6.1 3.7 16.7 4.9 11.3 2.8 17.6 6.3 4.9 1.1 18.2 8.1 8.4 73.5 0.6 3.4 12.1 31.0 3.1 1.2 16.5 12.6 20.3 8.8 28.3 5.0 0.6 10.2 14.2 20.5 16.0 7.1 39.4 11.0 7.2 1.9 17.1 26.9 17.5 2.0 3.3 3.1 10.2 47.8 14.0 1.8 24.6 40.8 3.2 9.9 85.5 38.9 26.7 32.0 15.0 22.0 11.2 1.9 18.2 28.6 9.1 1.2 RNF11 "CGI-123, MGC51169, Sid1669p" ENSG00000123091 "Ring finger protein 11" Q9Y3C5 1 51236273-51273447 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 22.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045781 Uncertain NA NA "HPA045781: AB_2679450" "unprognostic (2.66e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (8.30e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (3.57e-2)" "unprognostic (3.75e-2)" "unprognostic (2.66e-1)" "unprognostic (9.04e-2)" "unprognostic (2.11e-1)" "prognostic favorable (3.14e-4)" "unprognostic (2.14e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-1)" "unprognostic (3.92e-2)" 70.7 71.3 94.4 24.7 98.5 71.8 47.4 82.9 113.6 50.2 68.3 39.0 34.6 49.0 52.4 67.4 36.1 40.8 69.6 99.8 98.6 66.1 61.7 42.9 20.9 89.1 98.7 92.2 77.9 27.6 68.2 51.8 47.4 91.3 51.7 30.7 65.3 37.6 49.0 108.1 35.5 34.9 48.6 93.0 33.6 34.9 29.4 98.5 23.8 72.7 95.3 26.0 53.9 46.5 94.7 66.3 15.7 32.6 44.7 114.2 91.8 49.6 72.3 83.5 62.4 76.5 18.4 24.6 0.5 72.1 133.4 77.1 22.2 36.6 53.9 105.2 124.5 40.4 43.2 23.7 28.7 78.6 20.4 113.0 67.8 87.3 68.3 71.5 97.4 80.2 23.6 14.9 26.2 130.4 24.1 24.9 17.2 46.5 33.1 40.6 19.1 59.8 29.4 111.2 61.4 31.7 34.3 53.9 61.8 79.3 77.9 35.8 28.9 85.8 97.6 51.9 76.1 82.8 58.9 62.9 6.6 51.3 40.5 60.9 22.1 1.6 7.1 2.6 2.3 3.9 0.9 2.6 3.6 1.7 0.7 2.8 3.6 6.2 3.6 2.1 6.7 3.2 3.6 94.4 98.5 82.9 113.6 99.8 98.6 89.1 98.7 92.2 91.3 93.0 98.5 94.7 54.7 57.7 41.6 19.9 30.0 136.9 108.7 37.5 84.8 37.0 70.5 33.1 120.6 37.1 41.1 40.5 25.0 38.6 63.4 62.7 105.7 56.7 154.4 44.5 46.0 61.3 77.0 110.7 56.4 60.7 43.3 61.7 40.2 53.0 54.7 21.4 57.1 63.4 30.6 35.3 62.1 38.5 57.0 41.5 84.2 171.5 57.5 88.0 65.8 23.4 39.7 75.3 37.0 26.2 38.0 64.7 35.5 86.9 43.8 117.7 51.9 132.6 33.8 37.5 39.5 47.8 55.6 59.1 33.9 97.7 168.8 196.9 49.6 39.4 29.5 173.9 RASSF8 "C12orf2, HoJ-1" ENSG00000123094 "Ras association domain family member 8" Q8NHQ8 12 25959029-26079892 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.1" "Cell type enhanced" "Detected in many" "Early spermatids: 606.9;Horizontal cells: 430.7;Late spermatids: 722.1;Microglial cells: 229.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-2197: 107.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038163, HPA038164" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA038163: AB_2675874, HPA038164: AB_10672621" "unprognostic (2.77e-1)" "unprognostic (1.71e-1)" "unprognostic (3.10e-1)" "unprognostic (6.10e-3)" "unprognostic (3.88e-1)" "unprognostic (3.15e-1)" "unprognostic (6.10e-3)" "unprognostic (8.28e-2)" "unprognostic (2.86e-1)" "unprognostic (6.29e-3)" "unprognostic (2.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.00e-2)" "unprognostic (1.32e-3)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" 11.4 16.4 16.6 7.6 19.3 1.2 7.8 22.8 13.1 17.3 15.2 10.6 2.6 28.6 11.0 7.5 11.0 17.3 14.1 12.6 31.7 23.0 5.9 15.0 2.4 23.2 20.6 9.3 30.4 6.0 3.6 7.0 9.1 24.5 16.6 4.9 17.0 4.1 14.1 14.5 3.3 4.4 20.0 22.6 6.0 6.1 60.1 21.8 4.6 11.3 15.7 2.1 10.5 7.6 26.4 9.8 7.7 32.8 4.0 49.9 56.0 45.5 51.6 75.3 21.4 23.5 16.7 2.9 0.7 39.8 56.1 23.7 3.7 7.2 6.1 27.3 3.5 9.6 1.7 19.0 0.8 24.9 6.0 0.4 33.5 5.9 47.7 31.6 33.1 25.9 12.1 1.9 6.7 25.1 13.0 7.1 1.2 32.8 0.2 70.9 9.1 31.7 0.5 12.9 14.4 1.5 23.4 27.3 0.5 25.3 28.3 5.0 5.0 30.9 42.0 21.7 107.9 39.3 2.9 2.0 1.0 38.9 0.5 60.3 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 1.1 0.0 0.0 16.6 19.3 22.8 13.1 12.6 31.7 23.2 20.6 9.3 24.5 22.6 21.8 26.4 22.6 38.5 16.0 139.7 0.7 7.8 50.5 5.6 5.2 17.0 5.2 11.8 34.3 24.3 7.8 22.0 10.4 9.6 10.0 0.1 13.7 10.4 606.9 7.8 50.0 22.1 0.0 0.0 15.1 4.3 21.3 41.3 1.1 12.0 1.3 9.0 16.4 6.7 5.7 430.7 89.7 0.0 2.0 2.2 10.2 722.1 18.0 5.9 14.2 229.5 0.2 31.0 0.0 78.4 92.9 5.2 0.0 15.1 1.9 29.1 0.0 24.5 1.6 11.1 13.1 30.6 20.7 27.9 10.7 1.1 5.4 4.5 3.5 13.2 0.2 13.4 BHLHE41 "BHLHB3, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120030-26125037 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 123.5;skeletal muscle: 93.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 347.5;Cone photoreceptor cells: 183.5;Horizontal cells: 250.7;Muller glia cells: 239.8;Rod photoreceptor cells: 309.5" "Cancer enhanced" "Detected in all" "thyroid cancer: 78.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 92.4;RT4: 126.6;U-266/70: 52.6;U-87 MG: 44.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056035: AB_2683017, HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favorable (1.09e-4)" 9.8 14.8 35.7 7.4 45.5 0.6 13.7 55.0 35.0 39.1 13.3 9.6 2.7 8.2 19.4 3.3 45.9 18.4 20.2 32.2 39.5 3.9 0.7 11.7 8.0 57.7 49.4 23.7 13.0 7.8 6.6 16.8 10.6 61.1 9.8 11.2 123.5 18.5 14.1 93.3 5.2 6.4 4.1 63.9 9.2 4.9 4.4 51.8 6.3 58.3 13.0 18.1 21.5 10.0 71.3 11.4 0.1 0.3 0.0 20.4 9.4 4.7 2.2 3.8 0.4 1.4 0.0 13.4 0.0 1.9 4.4 31.4 11.3 0.4 1.9 1.1 0.1 1.7 1.0 0.2 0.0 0.9 5.7 0.3 1.5 1.1 7.8 15.0 92.4 0.0 0.1 0.0 39.6 2.4 1.3 0.0 3.9 10.4 3.7 7.8 0.0 1.9 31.6 4.9 126.6 0.2 0.2 1.4 0.6 29.7 0.6 0.0 0.2 6.7 7.1 8.2 0.8 5.9 52.6 32.3 0.1 44.9 4.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 45.5 55.0 35.0 32.2 39.5 57.7 49.4 23.7 61.1 63.9 51.8 71.3 1.6 0.0 1.1 46.0 25.0 6.0 59.8 34.1 10.8 347.5 9.2 56.0 46.7 37.1 11.2 29.5 183.5 26.6 0.2 55.0 0.0 40.6 0.6 78.5 27.1 12.0 13.1 0.0 10.1 21.9 3.6 22.7 3.1 60.8 5.7 0.2 2.5 0.1 91.1 250.7 12.4 4.4 0.0 4.0 4.4 1.3 30.1 39.8 14.2 120.9 27.4 239.8 0.0 22.1 56.2 21.9 12.0 26.7 61.8 49.0 0.4 2.3 34.8 309.5 6.6 13.0 7.5 0.5 3.7 3.5 3.3 7.1 2.4 2.3 5.0 83.8 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 79.7" "Cell type enhanced" "Detected in many" "Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "memory B-cell: 57.4;naive B-cell: 16.9" "Lineage enriched" "Detected in many" 19 "B-cells: 57.4" "Group enriched" "Detected in many" 4 "ASC diff: 24.4;hTERT-RPE1: 91.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA066432: AB_2685669" "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 21.4 10.8 17.8 6.5 22.7 0.1 20.3 29.2 14.7 39.8 9.8 16.4 4.4 24.1 18.0 18.5 25.4 22.1 46.4 15.1 34.9 6.2 1.4 8.9 7.1 29.1 23.7 9.7 34.1 8.1 3.3 3.8 4.6 27.8 22.6 12.8 2.9 9.5 34.7 61.3 4.5 7.7 24.5 31.2 8.7 7.8 8.3 25.0 8.8 17.3 79.7 12.2 19.4 15.5 38.1 0.8 1.6 4.0 0.0 24.4 14.5 0.2 6.9 10.8 1.1 3.1 0.1 9.5 0.0 1.8 11.0 6.0 3.0 0.0 0.5 2.1 0.1 0.0 0.0 0.1 0.0 2.9 0.1 0.0 9.3 1.0 3.5 0.8 91.6 0.4 0.0 0.0 0.1 8.4 1.9 0.6 1.9 7.9 0.6 2.7 0.3 10.7 3.2 2.4 8.3 0.4 6.3 2.7 0.6 7.0 4.0 0.9 0.3 3.0 2.5 1.8 3.4 1.8 0.3 1.2 0.2 5.3 0.0 8.6 0.0 0.0 2.7 0.0 0.0 0.5 57.4 0.0 0.0 0.1 16.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.7 17.8 22.7 29.2 14.7 15.1 34.9 29.1 23.7 9.7 27.8 31.2 25.0 38.1 10.8 3.2 3.2 39.2 30.7 13.6 23.1 21.6 30.1 2.1 21.8 89.2 95.4 10.0 14.8 18.4 0.0 74.0 1.4 36.0 5.9 11.4 4.0 12.4 52.1 10.2 4.9 1.3 3.5 7.1 7.5 140.8 3.6 6.0 0.0 10.7 9.7 0.2 15.3 6.7 5.8 10.1 0.0 0.6 11.1 5.8 185.8 6.6 19.6 18.7 18.6 41.2 0.0 41.7 18.4 2.8 7.3 267.4 41.2 19.4 0.6 3.1 7.9 2.7 39.5 139.9 56.3 0.7 3.8 7.7 7.1 27.8 2.1 30.7 7.7 24.7 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26335352-26833194 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.7" "Cell type enhanced" "Detected in many" "Astrocytes: 551.4;Excitatory neurons: 287.2;Microglial cells: 802.9;Oligodendrocyte precursor cells: 441.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 32.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA059144: AB_2683925, HPA062260: AB_2684728" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.4 10.5 10.2 8.2 8.6 6.0 17.5 8.1 10.4 4.8 7.2 5.7 5.3 5.2 5.7 7.5 5.6 5.6 3.2 8.7 12.2 12.8 44.7 5.7 7.9 20.0 11.6 4.0 6.0 7.7 11.5 2.2 11.0 14.5 5.6 6.7 8.8 17.1 2.9 1.9 10.3 4.9 4.5 14.3 6.8 5.2 2.5 13.6 20.3 4.3 4.1 6.9 5.0 4.7 16.5 4.9 2.0 2.9 4.6 8.5 8.6 3.0 4.4 6.1 3.0 3.1 0.2 2.4 16.5 2.7 5.9 3.3 5.2 15.1 9.3 4.0 3.9 5.1 13.5 4.4 27.1 7.9 12.0 5.8 8.1 1.2 6.3 11.6 6.2 28.5 6.5 6.4 5.1 3.9 4.0 8.6 17.8 12.2 4.4 1.5 2.9 7.0 10.7 7.3 7.4 0.9 4.5 19.8 3.5 11.4 11.3 7.7 6.0 62.6 6.0 2.3 5.9 5.7 4.9 4.2 31.2 5.7 5.6 3.9 32.4 6.4 9.9 2.9 2.7 2.5 5.4 2.6 2.4 1.4 5.0 3.0 2.7 17.3 4.8 4.3 11.9 4.4 1.0 10.2 8.6 8.1 10.4 8.7 12.2 20.0 11.6 4.0 14.5 14.3 13.6 16.5 27.1 48.1 52.9 551.4 45.7 20.9 17.8 3.3 31.3 3.2 87.0 57.1 24.5 34.3 8.6 23.9 146.0 21.0 39.1 7.7 7.9 20.8 3.1 13.3 64.9 38.5 78.5 33.4 287.2 23.4 9.5 20.3 16.8 22.7 44.4 60.0 25.0 123.7 39.5 0.0 99.1 46.1 32.6 46.3 8.2 6.7 18.0 68.7 33.8 802.9 28.2 13.0 41.2 441.8 22.3 17.6 37.0 17.7 83.6 25.9 14.5 14.6 5.0 64.7 0.0 22.7 17.6 3.6 6.3 54.3 26.7 27.9 29.2 43.4 11.7 15.8 CCDC91 "DKFZp779L1558, FLJ11088, p56" ENSG00000123106 "Coiled-coil domain containing 91" Q7Z6B0 12 28133249-28581511 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 18 "Early spermatids: 2093.1;Late spermatids: 7910.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038169 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038169: AB_10672506" "unprognostic (6.25e-2)" "unprognostic (4.25e-2)" "unprognostic (3.67e-2)" "unprognostic (1.91e-2)" "unprognostic (6.71e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.98e-2)" "unprognostic (2.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.69e-4)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.85e-2)" "unprognostic (2.38e-1)" 17.6 18.5 18.7 13.1 19.3 12.4 16.3 26.1 32.4 11.6 7.1 14.5 12.2 18.0 17.4 14.4 12.4 14.7 31.2 19.5 16.3 20.4 14.4 12.1 16.5 22.7 18.7 15.8 17.9 27.4 31.0 12.2 8.6 24.3 15.2 12.7 27.4 13.7 14.1 42.0 10.2 13.2 13.1 14.1 13.8 17.3 34.7 19.1 21.9 24.8 21.9 13.8 16.8 10.5 23.9 21.2 14.8 13.4 0.4 13.6 12.6 25.1 17.5 18.5 15.1 19.3 8.4 27.6 11.0 14.7 20.9 9.0 23.7 12.3 28.2 22.6 29.7 10.2 36.2 29.4 7.7 21.3 35.0 17.1 12.5 27.6 15.0 43.7 28.5 12.3 19.2 33.4 36.0 14.6 7.6 34.8 29.7 27.5 16.2 13.5 21.1 38.7 18.3 24.6 14.3 11.3 20.4 32.7 10.9 55.4 36.4 21.3 27.3 9.3 31.8 22.1 31.5 10.3 44.4 52.5 30.1 27.6 28.0 18.4 21.8 2.3 3.6 5.1 4.5 6.7 6.7 6.5 7.4 3.4 5.2 7.6 7.0 0.7 7.1 5.9 4.1 8.4 3.4 18.7 19.3 26.1 32.4 19.5 16.3 22.7 18.7 15.8 24.3 14.1 19.1 23.9 23.4 38.5 41.0 129.3 47.2 34.9 37.4 49.5 34.7 61.5 42.1 36.8 80.8 20.0 40.8 22.0 45.9 14.0 48.4 26.0 43.0 46.2 2093.1 36.9 19.0 19.7 38.4 19.1 199.3 47.3 16.3 24.8 21.4 26.2 40.4 21.9 11.7 26.7 30.6 45.4 266.0 23.9 28.5 35.0 39.3 7910.6 57.8 39.0 37.4 135.9 35.7 52.0 53.5 152.8 221.0 33.8 25.0 51.9 34.2 33.6 25.5 35.0 54.5 74.9 39.5 28.6 31.7 72.0 39.0 19.9 40.5 16.0 50.6 28.5 18.3 33.6 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791741-90959393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.5;choroid plexus: 26.8" "Group enriched" "Detected in many" 4 "Excitatory neurons: 374.6;Oligodendrocytes: 307.8" "Cancer enhanced" "Detected in many" "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 4.0;MOLT-4: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.2 3.5 23.9 0.9 35.3 2.4 1.6 12.5 57.5 3.2 26.8 5.9 0.6 5.6 3.1 2.2 3.4 1.8 9.1 36.4 23.7 2.3 0.2 5.5 0.4 19.6 22.1 32.0 3.2 0.3 0.5 3.8 1.7 19.2 3.3 0.1 0.9 1.3 0.8 0.3 1.7 1.7 0.2 18.5 1.4 2.9 4.9 28.6 0.0 2.0 0.1 0.0 4.5 2.4 42.9 0.1 0.1 1.4 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.3 0.0 0.7 0.0 0.0 0.0 2.7 4.0 1.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 3.9 0.0 1.0 2.8 2.8 0.0 3.7 4.2 2.2 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.8 2.8 0.1 0.0 1.4 1.7 0.0 0.1 1.0 2.5 2.4 0.0 1.0 3.8 2.4 2.0 2.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 23.9 35.3 12.5 57.5 36.4 23.7 19.6 22.1 32.0 19.2 18.5 28.6 42.9 0.8 19.2 69.7 20.9 0.0 0.5 0.2 0.1 0.0 4.8 0.2 0.8 64.0 0.0 2.5 12.9 0.0 0.0 0.4 0.1 0.0 0.0 4.4 0.4 2.2 3.4 0.0 12.2 374.6 0.2 0.0 6.4 0.0 0.2 1.3 0.2 0.7 0.0 0.1 0.0 63.5 0.0 0.0 0.0 0.6 1.4 2.5 0.3 3.6 38.4 0.0 0.4 0.0 17.6 307.8 0.1 0.0 2.2 0.1 0.1 0.0 9.0 0.0 0.5 6.6 1.0 6.1 4.6 2.2 0.1 0.9 0.0 0.2 0.5 0.0 0.0 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342547-86478420 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 173.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favorable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 33.9 22.3 16.9 26.0 20.9 18.4 41.0 20.6 18.0 23.8 24.5 27.2 26.6 23.2 24.8 33.5 18.7 45.7 51.3 15.3 20.9 41.3 112.6 27.5 39.3 19.7 19.2 13.7 24.9 28.2 117.2 9.9 37.2 20.2 33.7 33.4 43.6 26.1 25.8 173.0 41.1 28.3 24.8 19.2 46.1 34.6 29.8 18.8 22.9 32.9 123.3 30.9 34.0 15.9 23.9 59.8 27.1 18.3 13.1 23.0 22.4 16.3 21.0 22.5 16.5 19.5 18.9 35.3 24.9 14.0 36.5 22.9 49.3 26.4 34.1 28.5 31.6 21.0 28.7 24.4 44.7 16.8 11.7 14.0 20.5 42.5 18.2 33.3 25.3 74.1 29.0 14.3 28.7 28.4 29.6 27.7 8.1 11.2 82.6 30.0 18.0 21.4 22.5 37.3 44.5 5.5 12.9 21.2 104.7 23.0 39.8 31.3 10.8 84.4 23.9 28.7 26.3 10.7 33.9 22.0 25.7 29.9 1.6 19.0 6.2 2.1 3.9 5.2 1.9 4.6 2.7 6.4 5.3 1.5 2.4 7.5 4.7 1.3 2.4 2.2 1.9 6.5 2.0 16.9 20.9 20.6 18.0 15.3 20.9 19.7 19.2 13.7 20.2 19.2 18.8 23.9 51.2 25.6 22.6 29.0 13.0 35.8 26.9 15.4 26.7 28.8 41.7 23.5 82.7 44.3 19.2 29.5 58.4 28.3 19.5 23.7 43.0 20.5 42.1 22.6 20.1 32.3 23.6 3.0 55.3 37.6 3.3 27.6 35.2 35.5 3.8 18.0 62.4 88.8 55.9 40.4 134.6 25.3 14.2 95.2 28.1 12.7 32.3 43.0 30.2 61.8 18.6 23.3 18.6 60.3 103.8 45.1 16.0 36.5 18.5 45.1 15.8 45.7 17.2 52.6 6.6 18.8 16.6 12.4 21.2 28.8 39.5 23.0 32.0 25.1 19.7 38.3 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23701055-23766475 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 7600 "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 23.5 19.0 7.3 19.6 7.2 16.0 20.0 7.1 9.5 17.6 9.6 19.9 15.7 22.7 8.5 12.3 17.4 13.8 49.7 6.8 7.9 15.4 14.6 26.4 12.8 7.6 7.2 7.2 15.2 14.1 11.8 8.9 18.0 8.2 16.2 16.5 9.7 18.8 22.3 27.8 11.7 15.9 32.5 6.5 18.6 17.8 6.3 7.7 6.3 17.5 14.3 12.6 21.6 14.9 7.5 81.5 54.0 23.1 51.4 37.2 42.0 11.7 62.7 54.3 60.7 58.4 48.5 71.4 4.1 39.1 70.5 81.8 48.3 29.6 79.9 84.2 18.8 44.6 27.4 55.0 35.6 49.9 10.8 33.3 37.5 53.6 71.5 80.5 39.6 90.3 0.6 17.7 26.7 66.7 28.4 15.2 26.1 33.9 31.8 65.3 15.7 87.6 34.4 72.8 29.8 4.5 22.1 68.4 28.3 41.6 85.5 31.9 14.0 84.7 50.7 33.8 73.3 34.7 6.4 16.1 0.5 37.4 10.5 43.6 24.7 30.2 22.2 10.2 43.5 14.1 11.1 12.6 11.3 32.4 9.9 4.0 9.4 15.8 12.3 56.2 5.4 20.8 18.6 7.3 7.2 7.1 9.5 6.8 7.9 7.6 7.2 7.2 8.2 6.5 7.7 7.5 34.6 48.1 27.3 12.1 23.0 20.1 45.9 51.8 7.4 5.3 5.6 6.7 44.3 18.6 36.8 16.5 25.0 4.0 21.5 9.7 5.9 59.6 0.8 20.8 22.9 38.7 2.4 11.2 6.1 52.5 11.4 33.4 16.8 21.6 37.3 14.8 32.9 11.8 42.4 5.0 8.6 10.3 16.2 37.1 95.4 0.4 18.0 57.3 33.8 13.1 192.3 11.9 19.6 4.5 3.1 83.4 15.0 25.6 27.7 52.4 14.6 30.3 38.0 9.9 26.3 35.2 65.1 1.6 10.4 3.5 10.7 3.0 21.2 30.4 11.2 38.2 PRDX4 AOE37-2 ENSG00000123131 "Peroxiredoxin 4" Q13162 X 23664262-23686397 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 1222.4" "Cell type enhanced" "Detected in all" "Late spermatids: 1007.4;Plasma cells: 810.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008659, CAB027389, CAB047362, HPA067039" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 4400000 "Endoplasmic reticulum" Cytosol "CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: " "unprognostic (3.82e-2)" "unprognostic (6.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.06e-3)" "unprognostic (1.64e-1)" "unprognostic (1.65e-2)" "unprognostic (1.29e-3)" "unprognostic (1.08e-1)" "unprognostic (8.32e-2)" "unprognostic (3.75e-2)" "unprognostic (2.97e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (7.44e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-1)" "unprognostic (4.10e-2)" 79.2 85.3 25.9 54.4 27.8 34.6 75.6 29.6 36.8 83.0 38.7 73.4 64.6 68.7 19.7 63.0 66.6 65.3 86.2 25.1 33.0 42.2 279.5 47.5 59.2 31.5 27.9 24.5 81.9 1222.4 69.8 94.5 97.0 29.6 60.4 79.5 30.4 125.9 63.8 44.0 46.4 51.8 63.4 32.0 72.5 94.3 122.4 28.8 26.8 50.0 25.6 67.7 69.6 56.2 38.4 176.4 238.2 94.5 191.1 523.9 266.6 138.0 229.6 249.2 204.9 297.5 251.4 214.3 150.0 106.1 299.0 233.6 206.5 279.8 142.6 193.8 92.5 551.5 105.8 187.8 322.1 215.9 138.4 96.9 283.6 182.6 197.7 193.5 213.8 262.0 48.4 209.7 535.4 192.8 262.3 70.3 214.5 339.8 329.5 344.9 97.2 244.3 861.2 181.0 60.5 143.8 121.7 212.6 248.6 174.9 504.1 263.1 174.4 172.7 145.1 95.1 378.4 176.1 173.8 228.6 161.5 259.9 177.0 211.9 5.9 65.6 6.9 53.8 107.8 67.4 89.9 68.1 57.1 101.6 56.0 48.4 49.7 4.8 83.8 137.8 71.3 74.6 69.8 25.9 27.8 29.6 36.8 25.1 33.0 31.5 27.9 24.5 29.6 32.0 28.8 38.4 143.8 57.7 68.2 5.5 132.8 59.8 88.6 277.2 62.0 16.7 98.8 119.0 50.7 107.2 124.0 49.7 8.4 328.7 17.9 34.0 9.8 270.4 402.0 66.5 117.4 96.2 58.7 60.6 2.4 358.8 531.6 162.1 65.2 117.6 43.1 206.7 92.1 539.5 173.4 11.8 3.3 151.6 187.2 54.2 55.1 1007.4 252.5 47.1 199.3 1.9 75.2 55.0 27.8 8.5 7.3 241.4 44.1 144.0 810.1 174.6 61.2 54.2 89.9 21.7 144.7 79.2 185.3 258.2 251.7 83.3 52.1 258.6 42.0 311.8 115.7 73.1 DDX39A "BAT1L, DDX39, DDXL, URH49" ENSG00000123136 "DExD-box helicase 39A" O00148 19 14408798-14419383 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 149.0" "Cell type enhanced" "Detected in many" "Early spermatids: 308.4;Late spermatids: 283.3;Spermatocytes: 307.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055334 Approved Approved "Nuclear speckles" NA NA 200000 "Nuclear speckles" "HPA055334: AB_2682787" "unprognostic (1.31e-1)" "prognostic favorable (6.86e-4)" "unprognostic (2.41e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (5.20e-2)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.50e-10)" "unprognostic (1.55e-3)" "unprognostic (8.57e-2)" "unprognostic (3.92e-1)" "unprognostic (7.38e-3)" 26.9 21.7 19.0 50.0 21.7 106.4 25.0 23.3 23.2 22.1 19.7 25.5 28.8 22.1 8.8 39.6 18.4 13.8 22.0 18.4 21.0 21.0 22.1 25.3 76.8 23.5 21.2 18.0 15.0 15.8 10.3 15.6 18.2 23.1 17.0 20.4 4.7 19.2 8.9 20.9 24.5 34.1 15.3 21.6 56.1 27.4 149.0 21.7 81.2 20.6 12.8 65.6 26.2 22.9 26.6 198.8 175.9 87.8 147.2 32.4 22.4 73.5 84.8 48.0 176.1 105.7 183.3 98.7 375.0 87.5 71.1 101.0 114.8 215.7 135.9 74.3 129.0 127.3 408.5 201.0 133.1 55.1 225.1 164.0 30.1 30.6 113.1 47.0 25.4 89.1 134.4 253.4 150.3 95.7 270.9 375.4 320.1 147.9 208.8 280.4 248.9 139.7 212.0 62.5 179.6 181.5 98.2 64.3 127.8 98.6 54.3 138.0 216.5 83.1 144.5 92.7 245.7 192.6 156.0 313.0 399.3 167.1 232.2 148.9 33.2 92.8 29.6 120.1 107.9 106.2 132.5 96.0 96.3 131.1 125.8 83.1 90.1 27.0 84.1 94.3 82.7 153.0 135.5 19.0 21.7 23.3 23.2 18.4 21.0 23.5 21.2 18.0 23.1 21.6 21.7 26.6 55.6 16.0 21.4 4.9 90.0 76.0 43.6 53.0 50.1 10.5 30.0 24.8 10.9 21.5 27.4 5.5 0.0 60.6 75.1 60.5 37.2 55.3 308.4 26.6 30.6 53.0 25.7 88.1 3.1 67.2 117.9 33.3 87.7 44.5 93.0 32.7 26.0 12.9 90.5 11.8 3.5 55.4 26.4 48.6 85.2 283.3 26.4 62.7 49.8 4.7 56.7 16.2 50.4 4.0 9.2 53.5 42.7 18.8 115.6 44.5 41.7 26.0 21.1 4.9 19.7 24.8 62.0 307.5 95.4 69.4 71.0 59.9 78.7 32.1 63.8 34.2 PKN1 "DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1" ENSG00000123143 "Protein kinase N1" Q16512 19 14433053-14471867 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003982, CAB010278" Approved Approved "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Cytokinetic bridge" "CAB010278: AB_2163965, HPA003982: AB_1855440" "unprognostic (3.83e-2)" "unprognostic (2.14e-1)" "unprognostic (4.13e-2)" "unprognostic (1.13e-2)" "unprognostic (1.94e-1)" "unprognostic (4.58e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (8.55e-3)" "unprognostic (4.08e-3)" "unprognostic (2.11e-1)" "unprognostic (1.45e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (4.08e-1)" "unprognostic (2.24e-2)" 58.0 45.5 44.3 40.8 43.7 67.4 49.4 40.1 52.8 44.0 39.7 56.8 14.6 61.5 13.7 16.3 49.1 24.1 76.8 35.9 41.3 43.1 25.2 71.7 49.8 49.0 43.8 37.5 39.1 52.9 33.1 45.3 33.5 47.8 44.2 9.4 11.6 41.7 30.9 82.4 18.0 45.6 33.3 44.3 91.2 51.8 50.6 43.6 35.9 40.0 54.2 26.0 60.9 33.0 43.9 152.8 88.9 32.3 67.8 51.3 59.8 53.0 53.5 63.5 55.2 52.5 34.9 84.2 144.4 135.0 92.2 68.9 34.4 52.1 23.8 21.2 117.6 67.7 172.8 55.4 75.2 169.1 68.2 103.9 43.3 17.0 33.5 52.2 62.5 129.8 74.9 78.0 96.7 41.4 62.5 104.1 63.2 59.2 54.7 100.0 138.5 43.9 104.7 27.3 24.2 117.3 166.0 33.2 41.7 88.9 15.5 37.8 117.7 196.6 108.8 46.1 133.2 82.8 126.5 123.6 78.9 71.5 135.7 87.4 27.6 27.9 40.6 30.4 38.5 23.3 15.9 20.5 21.1 26.8 16.9 18.6 21.0 32.6 22.1 52.3 17.0 25.7 29.0 44.3 43.7 40.1 52.8 35.9 41.3 49.0 43.8 37.5 47.8 44.3 43.6 43.9 78.1 3.2 2.2 17.3 35.3 3.7 6.4 1.9 1.8 37.2 17.6 14.7 4.0 27.1 3.1 35.0 16.7 2.8 77.9 4.9 1.9 28.2 4.9 27.0 25.4 49.4 40.2 17.7 3.6 30.1 14.5 20.8 30.1 20.7 2.5 80.9 53.2 11.3 59.8 48.8 8.6 10.9 8.2 69.0 17.0 8.4 19.9 56.2 17.8 17.8 48.2 61.2 102.0 7.5 11.9 64.2 10.6 23.0 27.1 12.7 1.1 15.2 12.4 29.2 26.3 21.7 29.2 9.3 42.2 1.3 2.7 3.7 55.5 34.3 4.8 4.9 TRIR "C19orf43, fSAP18, MGC2803, TERCIR" ENSG00000123144 "Telomerase RNA component interacting RNase" Q9BQ61 19 12730640-12734684 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 390.7;Exocrine glandular cells: 381.0;Extravillous trophoblasts: 514.9;Proximal tubular cells: 510.1;Syncytiotrophoblasts: 579.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059965 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059965: AB_2684182" "unprognostic (5.57e-2)" "unprognostic (2.73e-3)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (3.17e-3)" "unprognostic (1.93e-2)" "unprognostic (1.74e-1)" "unprognostic (9.33e-3)" "unprognostic (2.43e-3)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (4.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.63e-3)" "unprognostic (1.02e-2)" 167.2 147.6 165.7 77.4 166.2 134.7 162.7 163.6 213.0 162.6 154.1 179.4 78.9 166.0 109.5 171.4 143.0 46.0 157.4 156.0 162.4 166.0 263.9 134.0 99.5 166.0 158.8 148.2 167.8 153.6 77.0 132.9 72.5 162.6 146.1 69.3 53.9 139.0 62.0 168.4 156.5 156.7 66.8 168.6 180.2 164.7 100.4 173.3 105.7 125.7 74.2 108.4 164.5 153.7 164.5 276.7 148.0 185.0 135.2 146.5 156.5 174.3 230.8 144.4 175.7 171.6 195.9 94.1 221.0 294.2 142.8 143.0 188.6 185.5 150.3 143.1 250.9 353.8 147.8 177.6 327.5 140.0 214.8 265.8 158.9 182.6 134.4 108.6 151.1 171.0 156.5 208.3 88.4 168.0 612.7 350.0 504.5 200.8 161.7 416.8 302.3 141.1 222.1 209.2 192.7 203.9 268.2 158.0 159.4 277.4 122.8 138.6 311.5 175.5 212.9 164.4 323.0 296.0 292.2 341.3 248.1 173.7 257.0 147.3 22.5 22.9 85.3 25.0 22.0 28.2 66.5 31.4 31.1 21.5 48.6 29.5 26.1 45.3 23.7 20.2 29.1 37.7 13.8 165.7 166.2 163.6 213.0 156.0 162.4 166.0 158.8 148.2 162.6 168.6 173.3 164.5 264.0 70.5 76.0 0.0 93.5 0.0 0.0 0.0 0.0 0.0 262.4 287.0 0.0 0.0 34.0 183.9 0.0 390.7 254.9 0.0 272.0 313.9 0.0 162.2 165.6 95.0 0.0 0.0 0.0 381.0 514.9 92.1 0.0 153.6 25.2 177.4 0.0 0.0 359.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 247.6 0.0 0.0 0.0 0.0 351.9 0.0 0.0 29.7 0.0 0.0 510.1 30.6 0.0 0.0 0.0 113.7 0.0 0.0 0.0 0.0 579.3 113.6 162.0 0.0 0.0 ADGRE5 "CD97, TM7LN1" ENSG00000123146 "Adhesion G protein-coupled receptor E5" P48960 19 14380501-14408725 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 213.5" "Cell type enhanced" "Detected in many" "dendritic cells: 245.4;Kupffer cells: 111.1;Macrophages: 131.6;NK-cells: 160.6;Plasma cells: 141.5;T-cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013707 Enhanced Approved Cytosol "Secreted to blood" NA Yes 10000000 2400000 Cytosol "HPA013707: AB_1846345" "unprognostic (3.16e-1)" "unprognostic (1.80e-1)" "unprognostic (5.10e-2)" "unprognostic (2.30e-1)" "unprognostic (2.85e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.51e-2)" "unprognostic (6.06e-3)" "unprognostic (3.14e-2)" "unprognostic (1.08e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (2.08e-2)" "unprognostic (4.14e-2)" "unprognostic (2.44e-2)" "unprognostic (6.41e-2)" 46.0 21.6 4.3 80.3 6.6 213.5 21.7 7.1 6.1 55.5 6.8 48.7 44.0 144.8 7.1 15.2 49.3 33.5 30.1 4.2 8.0 23.2 20.1 80.9 58.6 8.2 7.0 2.4 14.7 31.7 6.2 7.5 32.9 8.0 17.2 30.0 0.4 22.3 10.5 29.8 14.0 51.5 76.0 6.4 146.2 40.8 3.4 7.1 32.8 21.5 13.7 32.2 42.6 29.6 10.5 118.1 81.9 0.8 77.2 33.3 54.1 12.2 79.6 127.0 56.0 61.0 23.5 115.9 13.5 78.5 103.1 79.6 27.2 21.0 38.8 25.0 73.4 23.7 26.4 113.0 10.4 41.0 57.4 117.3 23.9 1.0 57.1 19.4 18.2 5.6 22.7 35.0 101.9 61.9 26.6 3.7 76.3 2.3 92.7 100.4 7.8 33.7 61.8 18.7 10.4 1.0 2.8 45.4 64.1 57.9 1.8 16.7 52.3 14.0 19.0 31.1 79.5 133.2 0.2 0.4 1.1 67.6 100.4 72.0 371.6 158.5 772.8 187.5 281.4 123.9 28.5 94.2 129.6 102.6 18.5 65.5 91.9 623.2 179.2 352.9 48.4 70.6 242.4 4.3 6.6 7.1 6.1 4.2 8.0 8.2 7.0 2.4 8.0 6.4 7.1 10.5 10.0 35.3 93.1 1.3 88.6 0.0 8.5 0.0 2.2 0.5 7.2 6.7 3.7 12.8 17.3 0.0 0.0 4.1 245.4 25.8 0.0 18.1 0.1 16.1 26.9 13.1 4.9 25.7 1.4 22.5 46.3 20.0 49.5 13.3 77.0 1.4 23.9 2.9 50.8 0.0 1.8 25.9 0.0 111.1 0.0 1.4 6.5 131.6 0.0 6.5 55.3 2.6 160.6 2.0 11.2 21.2 30.6 4.9 141.5 12.8 17.8 0.9 27.7 1.5 26.3 34.6 23.1 0.5 5.3 3.2 0.0 7.9 184.3 3.7 29.1 17.6 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666802-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved "Nucleoplasm,Vesicles,Centriolar satellite" NA NA Vesicles "Nucleoplasm, Centriolar satellite" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favorable (3.12e-4)" 5.1 6.8 6.9 3.4 7.2 5.3 5.2 7.3 9.4 5.9 6.4 6.1 2.6 6.3 2.0 4.2 6.9 2.9 6.4 6.8 7.2 6.9 4.9 4.7 5.1 7.1 7.1 6.4 6.6 6.3 5.6 5.7 2.7 7.2 6.0 1.4 2.5 8.2 3.3 4.2 6.6 4.7 1.9 7.2 5.3 7.0 10.0 7.3 6.8 5.8 2.9 3.2 5.8 4.5 7.6 6.8 11.0 6.2 8.1 11.0 4.4 4.9 6.1 5.8 7.3 7.5 13.4 5.7 10.0 8.7 5.6 4.2 7.0 7.3 9.6 1.3 10.2 16.0 8.0 7.6 8.0 9.3 11.3 8.4 8.0 7.6 6.0 4.9 5.1 7.2 21.6 7.2 0.8 3.4 25.6 16.4 9.2 4.8 8.0 18.8 10.9 7.7 9.3 7.1 8.0 12.6 8.6 6.4 9.0 5.3 3.5 5.1 11.2 4.0 8.0 2.4 6.2 6.1 24.7 17.7 4.9 12.7 8.7 4.6 5.6 13.4 5.7 10.2 12.4 12.2 9.7 10.2 10.2 14.0 10.8 9.8 12.8 6.7 21.9 6.4 23.5 12.2 10.8 6.9 7.2 7.3 9.4 6.8 7.2 7.1 7.1 6.4 7.2 7.2 7.3 7.6 10.8 0.0 14.4 4.2 13.5 15.4 12.1 15.9 11.4 21.1 10.1 9.8 4.4 17.2 12.0 18.4 12.5 12.4 22.3 9.0 17.6 15.6 17.8 12.2 7.3 12.0 9.6 16.2 7.2 17.5 13.9 9.9 9.2 6.1 14.0 12.4 8.6 9.2 13.2 20.2 7.1 7.8 16.2 11.6 19.2 61.9 15.8 9.6 16.0 1.9 17.8 18.2 24.7 4.5 4.4 13.5 5.8 18.0 11.6 15.4 13.6 33.7 18.4 22.7 19.7 8.1 11.3 25.8 17.6 8.3 16.1 9.0 12.4 10.1 9.6 14.6 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Human disease related genes, Predicted intracellular proteins" "Congenital muscular dystrophy, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 348.6" "Cell type enhanced" "Detected in all" "Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 11000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 51.2 55.3 73.2 22.6 80.7 3.3 54.7 80.9 95.1 74.3 57.9 98.0 25.0 54.1 17.8 348.6 49.4 23.6 61.5 67.7 74.0 82.4 58.8 76.9 16.0 83.5 85.7 65.4 34.7 43.8 21.0 56.5 28.9 89.6 64.2 41.5 18.1 101.7 31.3 65.7 150.9 45.9 17.6 74.7 38.0 79.3 25.1 83.2 18.8 56.3 23.5 21.2 74.7 141.3 85.8 328.1 148.6 44.7 70.6 40.6 40.7 35.2 119.7 59.8 96.7 87.3 80.3 120.6 4.7 220.3 85.2 64.6 183.8 38.7 100.6 32.6 33.8 69.0 63.9 100.7 79.7 123.7 6.9 75.3 46.7 98.5 58.8 51.3 57.4 66.0 47.2 30.1 54.4 49.9 243.8 21.3 13.3 48.6 182.1 147.8 21.7 37.4 43.7 121.6 281.6 41.8 46.2 67.1 163.2 157.0 23.1 102.5 35.1 115.4 135.7 74.6 191.7 130.1 50.5 70.5 17.3 113.9 51.9 146.2 3.0 0.7 0.1 5.1 1.1 4.7 1.9 5.1 5.1 1.1 0.8 4.2 3.3 0.3 1.5 0.5 3.6 12.0 1.7 73.2 80.7 80.9 95.1 67.7 74.0 83.5 85.7 65.4 89.6 74.7 83.2 85.8 30.6 28.9 15.2 22.9 8.3 113.9 77.4 52.1 35.9 69.8 73.6 31.6 14.8 37.1 62.8 82.8 35.5 36.3 19.3 501.1 52.8 167.9 1.1 92.2 30.5 32.4 43.1 1.7 28.8 164.3 77.1 32.6 69.3 76.8 10.2 37.3 23.2 18.0 55.9 75.7 32.2 87.8 42.7 10.8 29.8 2.4 20.5 16.1 58.7 10.3 23.4 73.3 18.6 17.1 71.6 296.7 285.4 25.2 6.8 120.4 36.0 52.7 38.0 46.0 19.7 18.1 44.5 6.4 20.4 107.0 169.8 25.7 22.9 47.7 138.1 199.7 ACTRT1 "AIP1, ARIP1, Arp-T1, KIAA0705" ENSG00000123165 "Actin related protein T1" Q8TDG2 X 128050962-128052398 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "testis: 4.1" "Group enriched" "Detected in some" 79 "Early spermatids: 28.7;Late spermatids: 82.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003119 Supported NA NA "HPA003119: AB_1078219" "unprognostic (3.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC70 "DKFZP434K1172, FLJ25853" ENSG00000123171 "Coiled-coil domain containing 70" Q6NSX1 13 51861969-51866232 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 222 "testis: 136.3" "Group enriched" "Detected in some" 122 "Early spermatids: 982.5;Late spermatids: 3017.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA079644 Enhanced "Secreted in male reproductive system" NA NA "HPA079644: " "unprognostic (5.73e-3)" "unprognostic (1.88e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 982.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3017.7 13.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPRYD7 "C13orf1, CLLD6" ENSG00000123178 "SPRY domain containing 7" Q5W111 13 49912702-49936490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 131.4;Spermatocytes: 167.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043934 Approved Approved Vesicles NA NA Vesicles "HPA043934: AB_10960545" "unprognostic (1.83e-2)" "prognostic unfavorable (8.48e-6)" "unprognostic (2.57e-1)" "unprognostic (4.95e-2)" "unprognostic (4.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (4.05e-1)" "unprognostic (3.12e-3)" "unprognostic (3.34e-3)" "unprognostic (1.17e-1)" "unprognostic (1.01e-1)" "unprognostic (6.53e-2)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.06e-2)" 5.3 8.7 10.2 3.9 11.6 3.3 5.7 9.6 13.9 4.4 6.7 7.6 6.3 4.4 5.4 7.7 4.7 3.2 11.7 11.5 11.8 8.5 10.8 10.2 3.2 10.2 9.9 11.2 5.4 5.6 9.5 6.1 6.3 11.1 6.5 6.6 12.4 4.7 5.0 24.1 6.1 7.3 5.3 8.9 4.0 7.0 9.0 11.0 2.6 6.8 15.5 3.7 5.7 5.5 12.4 10.1 8.5 5.4 6.0 6.5 9.2 12.3 19.5 9.1 13.5 7.7 15.5 8.1 9.8 6.1 14.4 11.1 8.5 12.1 18.1 18.7 16.3 10.9 10.5 6.5 10.9 22.1 25.4 7.2 8.0 20.0 11.8 23.0 8.4 8.4 5.5 12.0 8.6 31.6 6.2 0.9 11.9 2.1 15.3 9.6 4.7 9.1 6.0 14.1 7.6 4.5 5.6 5.7 12.8 9.8 6.8 11.9 15.7 10.8 12.2 6.8 11.3 19.8 5.3 8.8 7.5 9.5 10.2 14.0 0.7 2.0 1.7 2.0 2.3 4.1 5.3 1.9 2.6 2.5 4.3 1.5 2.3 0.4 6.8 4.6 1.7 3.1 1.8 10.2 11.6 9.6 13.9 11.5 11.8 10.2 9.9 11.2 11.1 8.9 11.0 12.4 23.7 131.4 32.8 22.2 17.0 20.3 23.3 64.1 21.1 29.4 17.2 20.1 60.1 21.5 32.1 12.9 8.4 38.8 11.2 42.4 52.8 32.1 118.5 25.9 20.0 21.5 23.4 6.5 35.5 25.8 45.0 21.4 15.3 13.3 17.7 12.5 19.2 52.1 27.9 23.5 33.3 21.4 26.4 7.6 13.9 24.3 21.1 14.1 23.2 24.4 14.6 21.6 12.3 24.6 60.1 37.2 23.6 20.3 12.4 23.9 34.5 82.1 26.6 30.7 6.6 20.1 29.8 167.1 56.9 33.8 31.0 39.8 11.9 27.7 22.2 10.4 EBPL EBRP ENSG00000123179 "EBP like" Q9BY08 13 49660674-49691486 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 100.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 305.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049891 Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049891: AB_2680937" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.23e-2)" "unprognostic (3.06e-2)" "unprognostic (2.81e-1)" "unprognostic (8.63e-3)" "unprognostic (3.91e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.63e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (7.18e-8)" "unprognostic (1.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" 18.4 60.2 7.1 12.2 6.5 20.1 23.5 7.0 9.0 33.1 8.1 21.0 14.3 20.6 6.7 62.8 25.7 11.1 7.8 6.8 8.6 12.8 100.1 19.2 11.0 6.8 6.9 6.5 33.6 48.1 10.6 10.4 11.3 7.1 21.5 16.4 4.4 28.1 13.6 5.3 31.0 14.5 13.4 7.6 14.6 27.7 11.1 7.6 10.4 16.2 2.5 11.1 24.0 48.0 8.4 46.7 34.9 21.0 88.5 26.0 66.4 37.5 48.5 33.1 30.9 25.0 66.8 65.1 57.9 21.6 23.7 27.1 93.7 38.3 47.4 45.0 46.4 126.8 43.7 23.4 83.3 75.2 69.4 35.0 77.7 100.4 25.6 68.1 49.9 53.6 61.5 36.7 23.0 40.2 25.0 27.4 124.8 72.4 153.2 78.2 58.5 11.7 89.0 66.4 15.2 19.5 50.1 18.0 62.1 21.6 21.7 54.4 54.0 24.6 23.4 23.2 20.2 40.7 14.9 41.2 46.7 11.2 68.6 21.6 2.4 3.0 0.8 2.4 3.6 6.8 4.3 4.8 5.0 5.0 5.4 7.1 4.1 6.4 4.1 3.9 3.3 3.7 1.4 7.1 6.5 7.0 9.0 6.8 8.6 6.8 6.9 6.5 7.1 7.6 7.6 8.4 75.5 35.3 23.1 9.8 46.5 108.6 157.6 17.4 115.5 7.9 139.8 192.1 5.4 104.4 17.4 23.9 8.4 32.3 25.5 26.5 41.1 61.2 13.3 61.5 90.6 76.8 27.8 65.6 8.0 52.1 37.1 56.9 56.6 50.0 17.8 64.9 78.9 305.3 38.5 1.7 11.6 80.1 8.2 45.8 36.5 10.0 94.1 27.4 46.2 8.4 30.9 23.6 36.0 8.0 5.1 41.0 42.0 70.0 79.3 116.6 16.5 62.3 8.5 8.4 19.7 57.7 52.7 26.9 17.2 208.6 154.6 15.2 40.3 194.2 133.6 108.9 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA009137: AB_2668214, HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 2.6 0.9 1.1 0.6 1.1 2.2 1.7 1.9 2.0 1.7 0.6 2.9 10.7 1.5 0.1 0.7 2.1 7.0 2.0 2.3 1.1 2.3 8.6 1.4 0.3 1.0 1.2 1.2 2.0 2.0 6.5 1.2 7.2 1.0 2.0 2.7 3.8 3.0 0.9 1.1 1.0 6.0 1.7 0.3 0.4 4.4 8.5 1.5 0.7 1.2 1.8 0.3 1.6 1.2 0.7 0.8 2.8 5.2 4.5 1.0 0.8 32.8 1.5 0.5 1.6 1.2 21.1 0.1 0.1 0.6 2.7 3.6 0.3 4.0 4.4 1.0 0.4 7.5 53.0 0.5 14.7 1.4 0.6 11.8 1.9 4.7 0.2 2.0 2.1 3.7 3.7 14.4 0.2 1.5 1.0 0.2 0.9 1.7 6.6 1.8 2.0 1.4 0.0 22.5 3.4 3.3 2.2 1.9 2.8 1.8 5.5 8.0 0.5 2.0 0.3 1.7 2.8 0.6 0.6 0.7 0.2 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.9 2.0 2.3 1.1 1.0 1.2 1.2 1.0 0.3 1.5 0.7 5.4 6.4 0.0 10.7 0.9 0.4 0.7 1.7 0.0 3.1 2.3 1.8 2.1 4.3 5.2 1.8 22.9 14.3 1.8 6.6 0.0 1.6 30.2 2.4 1.3 2.7 2.4 4.2 24.5 1.0 5.5 2.1 9.2 4.2 0.0 13.3 3.9 23.6 2.3 0.0 25.4 3.4 4.1 0.8 0.3 74.2 2.1 0.2 1.8 15.0 0.2 0.2 0.0 12.1 4.3 2.0 3.0 0.7 0.2 1.3 11.4 2.2 4.3 6.1 6.6 1.0 1.4 2.2 1.7 0.7 0.4 4.5 0.2 0.4 5.0 1.2 ZC3H13 "DKFZp434D1812, KIAA0853, Xio" ENSG00000123200 "Zinc finger CCCH-type containing 13" Q5T200 13 45954465-46052759 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 166.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039340, HPA040140, HPA047806" Uncertain Approved "Nuclear membrane,Actin filaments" NA NA "Nuclear membrane, Actin filaments" "HPA039340: AB_2676454, HPA040140: AB_2676858, HPA047806: AB_2680161" "unprognostic (1.50e-1)" "unprognostic (6.28e-3)" "unprognostic (1.25e-1)" "unprognostic (2.22e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.77e-1)" "unprognostic (1.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.69e-4)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.45e-1)" "unprognostic (9.21e-3)" 15.5 10.2 25.1 13.5 29.1 15.2 16.0 20.0 24.8 14.9 10.7 13.4 9.3 18.7 15.4 10.8 12.1 11.5 11.8 20.9 21.3 12.8 59.1 12.7 16.0 25.6 27.3 15.0 17.9 9.5 17.8 9.1 15.7 32.8 15.7 12.5 15.9 12.6 14.4 16.1 13.9 11.8 14.7 21.2 16.6 12.1 11.5 26.9 22.7 17.7 15.9 13.2 13.0 11.1 29.8 16.6 20.9 51.1 19.9 36.0 36.6 21.4 29.9 24.5 24.1 15.9 32.3 28.9 46.4 18.8 31.9 16.6 29.0 32.1 25.0 38.4 41.4 32.5 53.3 21.0 28.2 21.2 68.5 28.3 28.2 20.4 25.5 30.0 22.9 26.6 26.5 29.1 13.8 25.6 21.6 34.8 34.7 46.2 31.7 13.4 34.9 33.1 14.2 19.9 25.4 13.4 30.4 29.6 19.0 166.2 33.6 14.7 32.0 44.7 21.5 19.3 19.6 26.3 13.8 17.2 45.5 24.5 35.9 27.8 15.3 4.6 10.5 7.4 5.7 7.4 5.4 5.2 5.8 4.6 5.1 5.1 4.6 7.7 8.8 6.9 7.9 6.3 3.9 25.1 29.1 20.0 24.8 20.9 21.3 25.6 27.3 15.0 32.8 21.2 26.9 29.8 79.1 214.7 186.1 37.5 70.9 40.7 65.6 44.2 34.7 84.6 47.3 63.5 164.0 90.1 89.0 55.2 43.8 88.3 75.8 43.6 27.4 64.5 4.2 67.0 114.7 82.7 55.6 117.6 69.4 48.6 78.6 76.2 29.6 79.8 129.3 64.1 75.7 269.2 63.5 85.8 71.2 42.4 40.7 82.5 31.4 11.8 76.7 66.0 28.4 48.7 90.2 87.1 112.3 55.3 149.5 54.7 38.7 81.6 44.0 60.9 34.4 19.5 83.9 69.2 52.6 120.2 99.4 183.6 106.0 37.7 50.6 80.3 80.8 66.9 49.7 54.5 NLN "AGTBP, KIAA1226" ENSG00000123213 Neurolysin Q9BYT8 5 65722205-65871725 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 52.8;Excitatory neurons: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.6;intermediate monocyte: 3.4;myeloid DC: 2.2;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 5 "dendritic cells: 2.2;monocytes: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031862 Approved Approved Mitochondria Yes No 64000 Mitochondria "HPA031862: AB_10600827" "unprognostic (5.91e-3)" "unprognostic (4.52e-2)" "unprognostic (1.34e-3)" "unprognostic (4.37e-2)" "unprognostic (3.85e-1)" "unprognostic (1.45e-2)" "unprognostic (7.29e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-1)" "unprognostic (3.58e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.27e-1)" "prognostic favorable (5.58e-7)" "unprognostic (1.52e-2)" "unprognostic (1.98e-1)" "unprognostic (1.29e-1)" "unprognostic (6.18e-3)" 2.2 1.1 3.9 2.4 4.1 1.6 3.8 3.1 5.3 1.8 2.1 3.6 1.1 2.7 2.4 2.5 1.5 1.2 2.7 3.9 3.9 3.9 10.0 1.7 1.7 4.2 3.9 3.8 1.8 2.5 1.5 0.9 2.5 4.4 2.6 3.3 2.5 1.9 1.1 9.0 2.8 2.7 2.8 3.4 1.3 4.0 1.1 4.0 0.9 2.7 6.5 2.1 2.7 1.5 4.9 13.3 12.5 7.2 12.0 9.0 15.3 14.5 13.1 5.5 7.6 8.2 7.2 7.7 18.8 16.1 15.8 15.1 10.3 9.5 20.2 13.1 5.6 6.4 5.2 8.7 18.5 7.7 12.0 3.0 11.7 10.8 10.5 12.4 6.3 21.7 8.3 11.4 3.9 16.5 10.2 8.3 10.8 22.2 6.7 3.6 9.6 15.3 29.9 12.6 5.9 22.3 11.5 10.6 10.7 11.0 19.4 12.9 14.1 12.5 5.0 5.9 7.4 10.0 3.3 7.1 8.2 7.7 23.2 7.7 0.1 2.6 0.1 0.1 3.4 0.1 0.4 0.2 0.1 2.2 0.4 0.3 0.2 0.3 0.5 2.3 0.1 0.0 1.0 3.9 4.1 3.1 5.3 3.9 3.9 4.2 3.9 3.8 4.4 3.4 4.0 4.9 5.9 6.4 2.8 19.6 4.0 5.7 9.0 6.2 8.6 2.4 10.1 8.9 14.5 7.2 8.5 12.9 4.2 5.3 0.6 52.8 5.9 17.8 0.3 7.4 12.9 8.3 1.8 9.0 58.9 14.5 14.0 7.1 20.4 20.9 15.2 16.2 4.6 32.4 28.8 5.0 32.2 5.8 6.1 22.9 8.9 0.4 4.4 13.5 1.8 5.6 17.9 13.1 2.1 22.6 44.5 30.2 35.9 2.2 4.9 16.5 32.3 22.4 3.1 4.7 0.0 19.7 8.1 2.1 5.2 15.3 5.3 2.9 2.3 15.8 8.2 6.1 CENPK "CENP-K, FKSG14, SOLT" ENSG00000123219 "Centromere protein K" Q9BS16 5 65517766-65563168 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.8;lymphoid tissue: 22.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 50.9;Extravillous trophoblasts: 50.6;Spermatocytes: 101.3;Spermatogonia: 75.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA Yes "unprognostic (4.04e-2)" "unprognostic (1.77e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-2)" "unprognostic (1.85e-1)" "unprognostic (3.04e-3)" "unprognostic (3.69e-4)" "unprognostic (3.22e-3)" "unprognostic (9.59e-3)" "unprognostic (3.32e-2)" "unprognostic (3.16e-3)" "unprognostic (1.98e-2)" "unprognostic (6.33e-15)" "unprognostic (2.22e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-2)" "unprognostic (3.11e-1)" 1.1 0.9 0.7 10.7 0.8 24.8 3.8 0.9 0.8 1.0 1.4 9.1 8.4 1.9 0.9 5.7 2.3 1.9 0.5 0.4 0.8 0.8 1.9 2.1 14.7 0.8 0.6 0.4 0.9 0.6 1.0 0.3 5.6 0.9 1.3 12.0 0.7 1.4 0.8 0.2 8.7 8.6 3.4 0.9 4.5 5.5 13.5 0.8 22.4 1.2 0.5 12.5 2.6 2.4 1.6 65.3 41.4 85.6 29.5 4.4 12.0 40.8 69.8 26.5 58.7 73.6 35.1 97.2 39.3 25.2 23.6 59.5 39.7 33.3 35.4 92.7 45.2 28.5 42.1 50.7 33.8 1.7 50.1 36.8 5.6 5.0 56.9 27.3 10.6 56.4 42.2 31.8 57.7 59.1 21.5 85.4 56.2 41.1 18.5 17.1 52.5 81.9 43.8 38.8 34.4 35.8 28.9 53.7 22.1 28.7 31.8 40.0 36.9 20.3 44.9 46.5 31.1 82.2 30.0 51.9 83.0 41.9 74.0 49.9 3.7 0.7 2.3 9.9 1.0 14.8 4.0 21.1 12.5 1.7 7.0 28.5 20.2 1.7 10.2 1.1 1.6 23.2 10.0 0.7 0.8 0.9 0.8 0.4 0.8 0.8 0.6 0.4 0.9 0.9 0.8 1.6 2.7 0.0 3.4 0.3 11.7 23.6 8.5 14.0 4.6 1.6 6.0 7.9 0.9 0.0 8.1 0.0 0.0 28.8 18.7 5.8 1.9 3.1 27.6 25.5 4.5 5.7 0.0 50.9 3.1 1.0 50.6 6.3 9.2 7.2 2.5 22.7 3.9 1.1 22.4 0.0 2.3 14.7 8.2 1.9 12.0 17.4 1.5 5.7 1.8 11.2 1.8 0.6 7.2 2.0 1.4 2.3 2.1 1.5 14.1 2.2 1.1 0.3 7.1 1.1 0.0 2.3 9.1 101.3 75.1 17.0 8.1 6.7 20.7 3.9 15.8 11.4 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 886.6;tongue: 398.0" "Cell type enhanced" "Detected in all" "Late spermatids: 933.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol NA NA 370000 Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 93.6 91.3 47.8 36.1 51.8 50.6 64.5 48.2 56.8 47.3 39.9 53.8 63.8 40.0 22.1 62.3 38.0 41.9 106.7 54.8 50.8 73.0 74.4 59.4 46.0 50.6 56.9 47.9 92.9 35.7 33.4 34.1 58.0 53.8 34.4 57.8 49.2 46.7 41.8 886.6 78.5 70.1 43.7 48.1 57.7 56.6 73.4 49.4 30.4 27.3 398.0 37.9 44.2 56.8 51.9 83.3 23.1 12.8 17.8 171.4 175.6 15.2 97.6 110.7 72.1 119.0 41.1 108.1 0.7 37.6 134.3 113.2 75.6 17.3 93.5 54.8 192.9 9.2 17.2 32.1 22.0 175.4 0.6 59.5 94.6 72.6 69.2 71.8 177.9 62.4 23.8 21.5 123.7 98.7 17.6 8.3 2.3 5.2 22.4 10.3 1.4 25.5 8.5 87.9 57.6 2.8 13.6 84.9 25.0 64.3 49.9 54.6 11.4 171.6 58.8 28.9 81.0 27.5 63.3 23.5 0.6 88.3 14.3 11.4 47.9 2.5 0.3 56.1 1.5 43.3 18.0 71.2 65.8 0.5 11.7 28.0 34.5 1.7 51.2 3.8 5.2 109.6 30.2 47.8 51.8 48.2 56.8 54.8 50.8 50.6 56.9 47.9 53.8 48.1 49.4 51.9 68.2 67.3 29.4 18.6 25.9 74.4 46.6 104.5 67.2 38.7 30.5 32.9 237.7 68.6 81.3 31.3 18.8 112.8 89.8 199.8 33.2 135.5 281.9 36.0 38.6 82.4 42.6 126.5 48.9 114.0 39.8 91.6 88.7 37.4 70.8 92.8 47.8 30.9 31.6 90.9 26.6 106.4 65.1 15.1 26.0 933.6 95.7 14.5 90.7 25.3 36.6 36.4 119.4 13.6 28.1 166.3 186.9 103.4 86.3 92.3 209.9 162.4 73.7 103.4 111.7 63.1 106.6 102.0 13.7 58.1 77.9 75.4 107.5 166.3 44.1 75.0 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 113.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 113.7 3.8 19.9 19.6 17.9 0.2 53.8 19.7 19.5 16.6 27.7 46.9 14.0 24.5 6.4 21.6 10.6 28.0 16.2 14.3 16.8 16.5 1.6 22.6 12.6 20.5 17.4 11.1 21.4 15.1 6.3 5.5 87.7 21.5 24.2 17.0 3.5 9.6 47.1 18.0 10.3 21.8 29.1 14.4 3.4 24.2 6.2 20.9 3.8 24.8 22.7 13.5 51.8 15.5 15.6 0.0 0.0 0.0 0.1 0.0 0.0 7.0 18.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 14.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 0.1 0.0 0.0 0.0 102.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 17.9 19.7 19.5 14.3 16.8 20.5 17.4 11.1 21.5 14.4 20.9 15.6 74.9 3.2 2.7 1.3 0.2 11.3 3.0 0.1 6.8 2.7 1.6 17.3 8.7 8.6 3.7 0.0 2.1 282.7 0.8 0.1 0.0 25.7 2.0 18.7 1.5 58.8 0.0 0.0 0.5 0.4 70.2 111.3 0.0 34.1 2.5 0.5 1.8 0.1 20.7 0.0 0.7 0.0 8.2 1.2 19.6 2.2 5.3 3.6 14.2 160.2 1.1 21.9 0.0 1.5 1.0 0.3 0.0 15.4 0.9 1.8 0.2 2.1 0.7 3.2 78.9 32.3 110.1 1.7 7.7 0.7 8.8 221.9 3.0 0.3 0.0 1.6 ATF1 TREB36 ENSG00000123268 "Activating transcription factor 1" P18846 12 50763710-50821162 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016222, HPA055069, HPA055406" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807" "unprognostic (1.71e-1)" "unprognostic (1.50e-3)" "unprognostic (1.50e-1)" "unprognostic (9.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.65e-1)" "unprognostic (8.17e-3)" "unprognostic (5.94e-2)" "unprognostic (4.31e-3)" "unprognostic (5.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.74e-2)" "unprognostic (2.46e-1)" "unprognostic (2.27e-1)" "unprognostic (8.75e-2)" 13.8 21.4 5.7 16.0 5.6 15.0 17.0 14.6 7.1 16.9 8.6 18.1 16.1 18.4 13.9 17.2 17.9 16.7 14.8 5.4 8.9 17.6 21.0 16.0 21.7 6.0 6.7 5.4 23.3 9.2 20.0 10.2 16.8 8.0 14.5 18.8 12.0 14.7 13.7 32.7 10.4 14.9 16.8 6.7 18.0 14.4 8.7 6.7 29.4 22.9 23.9 21.7 16.7 13.0 7.6 28.6 20.4 21.0 21.4 29.0 30.4 52.2 29.5 50.7 45.7 35.8 41.7 43.7 38.7 47.6 34.5 20.0 22.8 24.9 30.6 47.6 39.0 25.8 42.8 43.1 22.6 56.5 62.3 39.6 33.7 45.7 32.8 52.8 47.6 22.5 27.1 53.2 36.2 33.9 42.4 39.6 37.3 30.0 33.0 32.1 37.5 32.3 45.9 33.6 19.5 27.9 14.9 61.8 26.5 44.7 28.5 37.3 37.6 16.1 32.1 38.2 26.4 24.1 20.2 25.8 63.6 30.9 33.9 15.3 6.6 17.9 42.7 20.2 18.8 23.1 20.2 21.7 24.1 21.1 21.7 26.4 20.4 11.2 20.8 12.7 9.6 28.8 19.1 5.7 5.6 14.6 7.1 5.4 8.9 6.0 6.7 5.4 8.0 6.7 6.7 7.6 25.5 54.5 18.5 22.2 41.5 75.3 48.4 34.8 52.3 12.1 26.0 18.5 14.6 15.7 26.7 12.9 0.0 34.6 25.4 23.4 52.8 24.9 9.2 24.6 20.8 23.8 6.0 46.7 25.8 21.1 77.1 33.1 14.3 21.0 10.1 14.1 20.0 16.2 27.5 13.5 29.2 18.7 24.4 25.2 48.4 5.9 32.0 24.2 23.2 16.9 24.6 14.2 27.8 12.5 25.3 22.8 17.9 27.8 22.1 43.7 20.7 34.6 19.9 7.2 39.5 34.1 33.7 10.9 10.3 30.3 54.6 80.6 38.4 20.4 22.8 36.9 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782761-57808071 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "RH-30: 962.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria NA NA 9200 Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favorable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 23.3 58.1 17.6 23.8 18.9 26.3 26.6 19.1 21.5 16.9 19.8 29.2 27.6 15.1 17.6 22.5 18.2 14.0 44.0 19.7 18.9 39.5 45.6 15.2 24.4 18.5 18.5 18.9 13.6 17.3 35.3 16.6 16.6 19.5 16.7 27.1 16.9 20.1 16.5 59.1 21.8 21.1 17.7 17.7 17.5 19.9 25.4 18.9 22.7 16.3 64.9 20.8 24.6 15.8 20.7 56.3 63.1 35.5 52.5 33.7 33.9 53.2 46.4 39.8 71.6 50.2 74.1 71.6 142.6 85.8 38.9 39.1 64.9 60.1 66.2 51.3 57.7 78.0 82.6 51.9 64.7 50.5 112.7 47.2 39.6 65.3 55.6 25.4 52.2 44.7 75.7 110.3 70.0 56.3 64.8 64.8 113.0 57.5 81.7 83.7 78.3 962.0 125.5 70.5 64.1 80.0 49.1 47.7 84.8 83.6 31.5 148.9 71.7 33.1 39.6 54.6 58.9 49.1 52.0 120.2 108.7 53.6 63.7 48.1 8.5 24.6 15.3 28.0 23.7 36.0 28.5 30.9 28.3 30.3 26.9 31.1 31.7 6.5 33.6 30.5 23.4 30.9 26.9 17.6 18.9 19.1 21.5 19.7 18.9 18.5 18.5 18.9 19.5 17.7 18.9 20.7 16.5 19.2 10.8 6.2 18.5 25.9 14.5 57.4 10.8 19.4 24.6 21.1 31.8 27.1 28.7 46.0 14.6 68.5 23.5 13.2 95.9 66.0 73.3 19.5 19.7 18.7 13.8 20.0 8.4 87.6 52.3 18.8 13.3 16.3 22.2 31.0 16.4 38.3 35.4 15.2 8.5 20.9 36.7 11.4 13.9 42.5 22.7 18.1 26.6 10.3 66.6 23.1 12.3 9.5 8.4 47.2 15.7 24.0 17.5 21.3 19.9 146.2 26.0 20.1 59.2 19.7 31.6 46.1 65.8 21.1 36.2 47.6 18.6 71.1 35.3 13.9 NEUROD4 "ATH-3, Atoh3, bHLHa4, MATH-3" ENSG00000123307 "Neuronal differentiation 4" Q9HD90 12 55019974-55030017 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "pituitary gland: 8.2;retina: 30.5" "Cell type enriched" "Detected in some" 21 "Bipolar cells: 217.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "midbrain: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 1.3;SCLC-21H: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA015545 Enhanced NA NA "HPA015545: AB_2669215" "unprognostic (1.78e-2)" 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 217.6 0.0 0.0 2.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP9 "10C, MGC1295" ENSG00000123329 "Rho GTPase activating protein 9" Q9BRR9 12 57472264-57488814 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 120.8;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" "dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 388.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA078822 Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA078822: " "unprognostic (1.02e-2)" "unprognostic (4.01e-3)" "unprognostic (1.91e-2)" "prognostic favorable (6.61e-5)" "unprognostic (1.24e-1)" "unprognostic (2.38e-3)" "unprognostic (4.79e-2)" "unprognostic (5.56e-3)" "unprognostic (1.28e-2)" "unprognostic (2.80e-1)" "unprognostic (3.05e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.90e-9)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" 8.0 4.2 4.9 34.6 7.3 120.8 4.1 8.6 11.2 2.6 6.2 7.8 8.2 3.4 1.6 4.7 7.5 10.6 3.8 5.3 6.1 5.1 7.5 22.2 57.3 8.0 6.8 4.8 1.6 3.5 0.6 2.2 5.2 9.4 4.3 10.8 0.5 4.8 1.9 1.3 2.0 37.9 5.9 6.2 101.5 8.8 19.5 6.6 35.3 4.5 6.4 61.2 9.6 3.6 8.1 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.4 0.5 0.1 0.2 0.1 0.0 14.3 0.3 0.3 0.0 0.2 0.4 0.0 0.0 0.7 0.0 27.6 0.1 0.0 1.1 16.4 116.2 0.7 0.0 0.0 0.3 0.2 0.0 14.3 0.5 7.9 0.0 0.0 22.5 22.1 1.0 0.0 0.0 9.1 10.2 4.6 0.0 0.1 3.9 3.0 0.0 0.0 0.4 0.5 0.0 34.9 0.9 0.2 0.3 0.1 0.1 9.2 7.2 13.3 0.3 27.3 0.5 51.9 86.1 243.4 43.3 89.2 30.0 35.9 47.3 39.6 72.1 44.0 61.9 46.0 388.9 68.2 71.0 97.4 63.6 70.8 4.9 7.3 8.6 11.2 5.3 6.1 8.0 6.8 4.8 9.4 6.2 6.6 8.1 2.2 0.0 14.2 1.0 49.1 1.5 0.2 0.0 1.8 0.2 1.6 2.9 2.1 1.5 1.3 0.0 2.1 0.4 171.0 0.6 0.0 0.2 96.8 0.6 0.8 1.5 0.0 11.6 3.7 0.0 0.6 2.4 4.6 0.8 12.0 0.0 3.6 1.2 43.5 0.0 1.9 0.5 0.0 39.0 19.7 44.8 1.8 35.1 0.0 8.4 34.8 0.0 123.6 0.0 0.2 0.2 0.1 0.0 50.8 0.2 0.0 0.3 2.2 0.7 0.0 0.6 1.2 89.0 17.5 0.4 1.4 0.3 108.2 0.3 0.4 0.1 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497752-54548243 "Plasma proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 45.3" "Cell type enhanced" "Detected in many" "B-cells: 66.2;dendritic cells: 92.3;Hofbauer cells: 115.5;Kupffer cells: 175.1;Macrophages: 108.1;monocytes: 153.2;NK-cells: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 112.4;HMC-1: 112.4;NB-4: 82.6;REH: 59.1;THP-1: 121.3;U-937: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" NA NA 33000 Cytosol "Plasma membrane" "HPA039490: AB_2676540, HPA040772: AB_2677129" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 9.8 4.7 3.1 35.1 3.7 28.7 4.7 3.8 4.6 4.0 4.6 14.3 5.9 2.6 1.3 6.2 3.4 7.4 2.2 2.9 7.8 2.4 7.1 20.4 42.9 6.9 4.1 2.3 1.8 1.6 4.1 1.5 11.1 5.9 4.7 9.8 0.4 3.5 5.3 1.2 2.1 18.3 10.4 6.0 45.3 6.7 1.2 5.6 37.8 2.3 2.1 43.8 28.2 2.8 6.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.3 47.9 0.0 0.0 0.0 112.4 112.4 0.0 0.0 0.0 0.0 0.0 0.7 40.1 7.7 43.7 0.0 0.0 47.9 82.6 0.1 0.0 0.0 59.1 0.2 47.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 121.3 0.0 0.2 0.0 0.1 0.1 2.4 2.9 38.4 0.2 70.4 0.0 31.7 68.6 55.0 31.7 103.9 26.2 30.2 28.3 32.7 72.0 28.8 17.9 26.4 16.9 36.1 121.3 40.8 45.1 65.1 3.1 3.7 3.8 4.6 2.9 7.8 6.9 4.1 2.3 5.9 6.0 5.6 6.8 1.0 0.0 11.6 0.3 66.2 1.3 0.3 0.0 0.0 1.3 0.6 2.2 1.5 4.3 1.8 0.0 0.0 0.7 92.3 0.2 0.0 0.1 0.9 0.2 0.3 3.6 0.0 22.1 0.8 0.4 1.0 2.7 2.0 0.3 56.3 0.1 7.5 1.4 115.5 0.0 0.5 0.0 0.0 175.1 28.5 2.3 1.2 108.1 5.4 42.2 153.2 0.4 113.3 0.5 0.0 0.0 0.1 0.0 40.0 0.1 0.0 0.3 0.7 0.9 0.0 0.8 1.3 0.9 1.6 0.1 0.6 1.4 59.7 0.2 0.0 0.2 MMP19 "MMP18, RASI-1" ENSG00000123342 "Matrix metallopeptidase 19" Q99542 12 55835433-55842966 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Angiogenesis, Collagen degradation, Differentiation" "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 54.4;Fibroblasts: 52.8;Hofbauer cells: 30.8;Kupffer cells: 35.7;Langerhans cells: 100.7;Macrophages: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "BEWO: 75.6" "Region enriched" "Detected in many" 5 "olfactory bulb: 7.2" "Low region specificity" "Detected in all" HPA070804 Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 2100000 "Endoplasmic reticulum, Vesicles" "HPA070804: AB_2686315" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (2.28e-2)" "unprognostic (2.42e-1)" "unprognostic (4.77e-3)" "unprognostic (4.77e-3)" "unprognostic (2.01e-2)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (8.56e-9)" "unprognostic (5.06e-3)" "unprognostic (1.28e-3)" "unprognostic (2.73e-2)" "unprognostic (4.00e-2)" 37.3 3.7 0.1 11.5 0.1 0.7 18.4 0.1 0.5 10.1 0.5 6.4 1.2 20.8 0.5 2.4 17.4 25.8 6.2 0.1 0.6 2.9 2.7 25.6 2.8 0.1 0.1 0.0 12.0 7.3 0.5 0.8 10.9 0.2 3.3 3.3 0.1 3.1 2.4 0.9 4.9 8.7 8.8 0.1 27.6 9.7 0.4 1.0 2.9 4.4 0.6 7.0 9.7 6.2 0.3 1.5 0.0 0.2 0.0 7.8 12.4 75.6 10.1 10.6 3.9 4.4 0.6 0.6 0.0 0.0 12.8 0.3 0.0 0.0 3.0 4.0 0.8 0.0 0.0 0.3 0.1 6.5 0.0 0.6 12.1 0.4 1.9 2.4 6.2 0.7 0.0 0.2 0.1 11.2 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.8 0.0 1.7 4.7 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.2 15.7 2.2 5.0 0.2 0.3 0.1 0.0 0.0 8.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.0 0.2 0.1 1.0 0.3 2.8 0.0 4.6 0.7 1.3 7.1 0.3 1.9 0.6 0.4 0.3 0.3 0.7 11.5 3.3 0.0 4.2 18.6 0.7 0.0 0.0 0.3 0.5 2.4 20.8 1.5 0.0 0.0 0.2 0.5 54.4 52.8 1.1 1.7 2.5 0.4 3.6 0.7 30.8 0.0 0.2 0.1 0.0 35.7 100.7 0.9 5.9 61.2 12.4 1.9 22.5 0.4 0.0 0.0 0.3 0.1 0.0 5.3 1.0 0.3 0.0 0.1 1.5 1.7 0.0 3.8 7.6 0.2 0.2 1.0 4.3 18.7 0.9 0.2 0.0 0.4 PFDN5 "MM-1, PFD5" ENSG00000123349 "Prefoldin subunit 5" Q99471 12 53295291-53299452 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 3559.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA008587 Approved Supported "Intermediate filaments,Cytosol" NA NA 110000 "Intermediate filaments, Cytosol" "HPA008587: AB_1079597" "unprognostic (3.56e-3)" "unprognostic (2.31e-2)" "unprognostic (2.87e-2)" "unprognostic (4.02e-3)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.12e-1)" "prognostic favorable (5.45e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.34e-2)" "unprognostic (9.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-3)" 702.1 661.8 929.5 310.2 942.1 871.3 827.4 922.5 1289.3 879.2 929.7 602.8 240.7 559.9 875.0 524.3 659.6 369.3 613.9 908.4 940.9 681.9 509.8 543.8 615.5 933.5 926.7 898.6 1016.1 730.6 611.3 693.5 402.9 935.1 677.3 375.4 375.1 562.1 397.9 729.2 676.8 518.3 360.3 970.4 718.5 596.8 391.1 954.2 552.7 639.8 621.0 631.1 619.9 657.0 963.8 333.3 492.3 472.8 426.6 889.1 1220.7 347.2 814.5 1081.9 730.8 489.3 456.0 496.9 449.2 479.3 871.1 285.7 299.0 416.7 575.0 702.6 425.4 575.7 410.6 639.1 634.6 574.3 676.8 425.6 1174.9 823.4 522.7 398.6 1269.3 658.4 539.4 485.7 589.1 735.3 1150.9 478.1 993.0 447.7 359.1 757.4 381.1 514.6 530.8 842.9 477.8 396.5 454.1 525.6 450.1 612.1 481.8 588.1 843.6 585.6 408.2 319.1 198.7 372.6 444.5 500.8 670.7 450.3 528.5 386.0 1641.6 2761.6 989.6 1636.2 2095.6 2283.3 3705.2 2468.1 2003.4 2060.9 3368.6 3147.1 2533.0 740.8 1645.0 2221.2 1921.0 2149.1 8653.7 929.5 942.1 922.5 1289.3 908.4 940.9 933.5 926.7 898.6 935.1 970.4 954.2 963.8 711.6 262.8 501.5 27.7 1274.1 1505.2 1217.7 1648.8 900.3 184.0 1219.6 1850.4 598.0 684.9 778.6 566.4 102.2 899.8 862.2 593.0 1412.6 561.2 902.9 629.9 703.6 734.7 659.9 587.9 25.3 961.0 973.4 708.4 362.9 440.2 655.9 647.4 782.8 584.8 1830.1 72.3 25.0 892.0 734.5 1977.7 2549.4 3559.9 948.7 1235.9 1538.5 15.9 1663.4 619.2 905.3 21.6 27.6 705.6 990.6 655.2 582.9 971.9 1053.0 2024.3 862.7 321.5 552.2 713.6 902.4 469.7 234.3 762.4 1526.5 876.0 1147.0 658.2 849.4 1114.8 SPATS2 "FLJ13117, SCR59, SPATA10" ENSG00000123352 "Spermatogenesis associated serine rich 2" Q86XZ4 12 49366584-49527425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 144.8;Spermatogonia: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 6.0;dendritic cells: 8.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038642, HPA038643, HPA076823" Uncertain Enhanced Cytosol NA NA Cytosol "HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: " "unprognostic (2.87e-2)" "unprognostic (2.63e-1)" "unprognostic (2.20e-2)" "unprognostic (1.89e-1)" "unprognostic (5.56e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (9.57e-8)" "unprognostic (4.55e-2)" "unprognostic (6.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-1)" "unprognostic (4.81e-1)" 7.8 7.9 8.6 10.4 11.1 6.6 9.5 14.8 12.8 12.9 9.7 11.1 11.7 11.2 8.0 6.9 7.0 11.2 6.7 11.0 7.8 9.1 4.8 8.0 15.8 10.5 8.4 10.5 8.0 12.3 21.7 13.9 9.0 11.1 9.9 11.6 10.2 18.5 6.1 11.2 16.4 10.4 11.4 4.7 10.9 13.2 26.3 7.5 13.3 13.0 6.5 18.2 10.4 13.2 11.2 17.9 39.7 33.2 38.7 19.1 29.3 10.7 20.8 29.8 34.2 29.6 36.0 39.0 44.4 47.5 18.4 22.5 20.8 28.9 39.1 43.8 33.9 17.2 40.4 28.2 29.1 34.7 11.1 23.1 25.6 19.0 53.8 50.9 111.8 82.0 19.8 21.7 38.9 35.2 32.3 22.7 16.5 34.2 29.0 40.1 32.7 56.5 53.4 31.9 22.5 37.2 33.4 45.4 28.6 49.0 20.4 49.2 12.0 75.7 15.1 36.5 13.5 13.2 52.4 65.7 37.5 19.7 18.6 22.0 1.6 1.3 0.3 1.7 0.4 1.7 6.0 1.4 1.0 4.1 3.2 1.2 1.0 0.9 1.3 0.3 8.0 1.1 1.1 8.6 11.1 14.8 12.8 11.0 7.8 10.5 8.4 10.5 11.1 4.7 7.5 11.2 35.0 19.2 19.8 34.6 33.8 58.0 48.8 52.0 25.0 44.5 29.9 29.8 9.9 35.8 19.6 36.8 22.9 9.7 19.2 9.6 5.9 26.0 77.4 28.3 63.1 44.6 36.6 22.7 114.0 27.9 12.0 34.8 23.0 45.1 10.8 37.1 29.3 5.6 8.0 42.1 67.6 21.6 20.3 9.2 39.8 46.3 31.7 15.3 19.6 27.2 15.0 22.3 16.5 59.3 30.6 46.4 11.7 33.4 144.8 36.4 13.3 12.4 10.1 5.9 52.6 20.5 27.7 137.3 138.1 17.0 60.4 5.3 16.2 31.5 30.2 29.4 ORMDL2 "adoplin-2, HSPC160, MST095, MSTP095" ENSG00000123353 "ORMDL sphingolipid biosynthesis regulator 2" Q53FV1 12 55818041-55821879 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (1.12e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" "prognostic favorable (3.30e-5)" "unprognostic (6.92e-2)" "unprognostic (1.52e-3)" "prognostic unfavorable (9.75e-4)" "unprognostic (1.45e-2)" "unprognostic (1.11e-1)" "unprognostic (2.88e-2)" "unprognostic (1.84e-3)" "unprognostic (1.49e-1)" "unprognostic (2.75e-3)" "unprognostic (1.25e-1)" "unprognostic (2.20e-1)" "unprognostic (3.04e-2)" "unprognostic (5.68e-2)" 32.7 38.4 15.0 24.5 16.6 20.5 31.6 18.0 20.6 26.3 22.8 44.9 27.4 28.6 51.8 76.5 26.6 20.8 26.8 14.8 19.4 35.9 47.8 35.8 23.2 18.8 16.9 13.7 16.9 33.2 44.9 29.9 22.5 18.9 31.1 48.9 15.0 40.5 23.4 19.9 35.6 30.5 26.7 17.3 33.5 33.2 43.0 17.2 27.8 27.7 11.2 38.8 42.1 37.1 20.1 55.9 103.5 43.1 22.4 81.2 40.4 47.7 66.5 66.0 57.0 49.9 116.6 133.8 34.5 69.3 80.7 58.5 100.3 34.6 138.7 56.6 35.9 51.4 46.7 89.7 65.9 85.8 56.7 47.4 50.9 125.2 99.9 103.3 73.3 81.0 38.2 25.0 91.1 73.7 89.3 34.8 25.3 20.9 87.8 82.0 22.8 34.5 88.4 149.8 159.1 37.4 23.8 84.9 99.9 38.4 64.8 120.0 40.1 59.4 30.5 42.6 36.4 42.7 43.6 39.1 28.1 48.9 22.4 43.1 50.4 73.0 107.1 86.5 92.8 76.8 93.2 82.1 92.1 73.4 76.1 67.8 81.5 91.8 74.1 108.7 119.9 107.8 72.1 15.0 16.6 18.0 20.6 14.8 19.4 18.8 16.9 13.7 18.9 17.3 17.2 20.1 43.1 73.7 38.3 1.3 39.8 23.3 71.9 132.9 15.4 9.9 43.1 30.0 3.9 45.8 99.4 53.3 12.5 74.7 49.6 125.7 29.4 133.7 171.0 77.9 25.7 42.0 46.1 26.5 0.7 168.1 117.5 22.0 28.1 86.0 51.9 14.0 35.3 82.2 125.3 8.4 0.8 66.7 69.2 42.5 49.1 68.0 25.4 57.4 56.9 2.8 111.4 24.8 77.2 1.0 4.0 197.4 133.5 23.3 50.8 95.7 89.7 76.0 149.2 18.4 19.7 13.5 32.9 107.0 61.7 50.6 33.4 151.6 44.6 30.5 56.2 91.3 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 879.9;Basal squamous epithelial cells: 729.1;Glandular and luminal cells: 739.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebellum: 116.7;cerebral cortex: 82.9;hypothalamus: 198.9" "Group enriched" "Detected in some" 12 "intermediate monocyte: 36.7;non-classical monocyte: 54.2" "Lineage enriched" "Detected in many" 15 "monocytes: 54.2" "Cell line enhanced" "Detected in many" "HeLa: 78.4;MCF7: 86.9;SK-BR-3: 80.5;SK-MEL-30: 150.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: AB_2732149" "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 432.4 567.4 31.5 97.8 17.0 34.8 229.5 116.7 82.9 152.9 50.2 191.4 29.9 125.8 7.2 134.8 500.3 380.8 495.5 19.5 198.9 201.8 96.3 293.4 46.3 24.3 17.1 10.1 883.3 89.2 87.5 445.9 42.3 23.8 305.8 72.1 28.6 147.8 86.7 296.5 189.3 112.9 145.5 12.2 36.3 266.9 32.6 21.7 59.7 304.2 72.5 3.8 299.5 187.6 27.4 5.7 28.2 5.6 10.2 4.0 1.3 21.3 5.4 10.8 4.3 6.0 28.2 5.4 5.9 2.3 9.7 4.2 3.2 16.9 2.6 2.5 0.3 6.0 8.1 78.4 8.3 4.1 3.1 26.5 0.8 3.3 4.2 0.3 2.9 1.3 6.6 7.9 1.4 0.3 86.9 2.2 8.5 15.3 9.2 3.1 2.7 0.9 14.6 0.2 2.2 4.6 14.0 17.4 80.5 150.9 3.8 5.1 9.1 0.0 4.2 13.3 2.8 4.7 46.8 25.2 13.0 2.8 2.3 23.7 0.3 1.3 0.0 0.2 36.7 0.3 0.9 0.1 0.1 3.7 0.8 0.5 0.1 0.4 0.2 54.2 0.3 0.2 2.0 31.5 17.0 116.7 82.9 19.5 198.9 24.3 17.1 10.1 23.8 12.2 21.7 27.4 328.9 240.4 879.9 4.2 259.5 445.7 289.5 211.3 729.1 34.8 353.8 384.9 9.8 65.8 178.4 86.5 125.1 64.5 102.1 195.7 5.9 19.9 19.7 346.9 183.5 209.6 345.3 16.0 17.4 12.3 34.7 378.8 380.7 739.1 674.8 45.3 227.0 10.1 54.1 16.8 5.9 492.5 105.8 64.4 527.4 7.3 30.4 283.0 371.8 8.4 6.3 85.4 0.0 6.6 1.3 5.1 277.2 23.7 244.1 160.6 74.6 0.9 92.6 94.6 124.9 268.0 379.3 2.5 13.4 200.2 472.8 110.5 135.1 85.1 259.0 86.8 PDE1B PDES1B ENSG00000123360 "Phosphodiesterase 1B" Q01064 12 54549601-54579239 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 58.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 58.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2" "Region enriched" "Detected in all" 6 "basal ganglia: 999.4" "Region enriched" "Detected in all" 7 "basal ganglia: 228.7" HPA018492 Enhanced NA NA "HPA018492: AB_1855119" "unprognostic (2.90e-1)" "unprognostic (1.51e-1)" "unprognostic (7.67e-4)" "unprognostic (5.63e-3)" "unprognostic (7.02e-2)" "unprognostic (7.51e-2)" "unprognostic (1.97e-1)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "unprognostic (5.11e-2)" "unprognostic (3.84e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (6.64e-4)" "unprognostic (2.14e-1)" "unprognostic (3.09e-1)" "unprognostic (2.83e-2)" 9.2 1.1 5.2 4.0 58.9 4.9 4.6 0.0 13.5 2.0 0.0 4.7 1.0 2.7 1.8 1.7 2.0 2.3 1.4 6.6 7.0 0.7 1.0 2.3 1.3 14.6 0.5 9.8 8.7 0.4 6.1 0.3 0.2 23.7 1.3 1.0 0.4 1.0 1.4 0.6 1.2 3.5 4.0 0.0 4.1 3.3 0.7 5.6 1.0 2.0 1.0 0.8 8.8 1.5 5.9 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 2.1 0.0 0.0 12.7 0.6 4.3 0.0 0.0 0.0 5.5 14.9 0.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 2.3 0.0 0.0 0.5 10.7 3.5 0.0 0.0 2.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 9.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 2.5 0.0 7.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 58.9 0.0 13.5 6.6 7.0 14.6 0.5 9.8 23.7 0.0 5.6 5.9 2.3 0.0 1.1 1.6 1.8 1.0 0.2 0.0 0.6 2.7 0.2 0.6 3.6 0.0 0.6 3.7 0.0 0.1 1.4 0.0 0.0 0.0 6.3 0.1 0.0 0.8 1.8 3.6 18.6 0.0 0.0 1.5 0.0 0.0 0.0 4.4 0.0 0.3 8.5 5.0 10.2 0.0 0.0 13.0 2.5 4.9 2.1 9.4 0.0 2.8 6.7 0.1 4.1 1.0 0.9 0.0 0.0 3.0 2.6 0.4 0.0 0.0 0.0 0.2 13.1 0.6 13.7 0.8 0.6 0.2 0.4 0.3 2.8 0.4 0.1 0.1 HOXC13 "HOX3, HOX3G" ENSG00000123364 "Homeobox C13" P31276 12 53938831-53946544 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "skin 1: 9.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.7;Breast myoepithelial cells: 3.0;Spermatogonia: 1.2;Suprabasal keratinocytes: 2.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 31.2;HaCaT: 66.1;SK-BR-3: 36.0;T-47d: 28.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA051634 Enhanced NA NA "HPA051634: AB_2616459" "unprognostic (5.16e-3)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (2.27e-3)" "unprognostic (2.78e-2)" "unprognostic (1.20e-1)" "unprognostic (2.20e-1)" "unprognostic (4.04e-2)" "unprognostic (1.53e-1)" "unprognostic (9.77e-2)" "unprognostic (9.74e-9)" "unprognostic (2.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.68e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.7 10.5 0.0 31.2 0.5 0.0 18.4 1.9 4.4 2.8 1.5 2.7 0.5 0.0 0.4 0.0 2.0 66.1 8.0 2.1 1.6 0.0 6.4 0.0 8.4 0.0 0.0 0.0 6.6 0.0 15.4 0.0 6.0 0.0 0.0 0.1 11.8 0.0 11.5 20.1 0.0 0.0 0.3 6.6 2.7 0.0 0.4 0.0 0.0 6.0 0.0 0.0 10.4 36.0 4.9 7.4 28.1 0.1 0.0 0.1 13.1 0.2 4.2 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.7 3.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.0 2.4 0.1 0.0 0.0 0.0 0.0 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966781-55972789 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 540.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: AB_2685748" "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.94e-4)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavorable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 13.7 9.2 3.7 16.5 3.7 36.3 14.3 3.9 4.7 13.4 6.3 12.2 9.9 13.8 6.3 15.0 13.8 10.9 10.9 3.6 5.8 10.5 16.3 23.1 21.7 4.8 4.1 3.3 16.5 10.1 8.0 4.9 47.7 4.3 12.7 15.0 6.6 11.0 14.5 7.1 22.9 12.4 19.7 4.4 14.6 12.3 6.6 4.5 37.5 9.7 8.2 25.0 18.3 13.0 4.4 81.7 39.1 93.6 52.4 19.2 24.9 172.2 98.9 53.5 123.3 114.8 89.4 76.3 77.5 70.9 37.9 46.4 50.8 73.4 44.9 126.8 86.9 68.0 89.0 65.0 34.6 6.3 70.4 61.4 12.6 10.9 83.8 29.1 36.1 63.1 76.8 85.6 68.0 88.3 60.8 149.9 61.7 36.9 55.8 60.7 143.7 86.2 57.1 36.5 77.1 37.4 48.1 114.1 41.7 540.3 54.9 88.9 51.1 34.5 82.9 76.3 65.0 71.0 37.4 46.3 95.5 47.4 51.1 74.2 3.6 2.6 2.2 4.7 2.7 4.6 6.5 2.1 3.5 1.9 3.7 2.0 3.7 1.2 3.4 1.2 7.9 5.4 3.3 3.7 3.7 3.9 4.7 3.6 5.8 4.8 4.1 3.3 4.3 4.4 4.5 4.4 17.9 16.0 4.8 1.3 7.3 28.0 23.9 6.2 12.5 0.0 14.5 8.9 3.1 11.5 7.6 1.8 0.0 92.8 7.1 3.7 1.9 11.5 0.6 7.4 6.5 18.2 5.4 14.7 0.1 5.7 84.7 15.7 9.2 13.0 10.8 12.0 10.4 9.1 13.3 1.7 0.1 7.2 6.1 4.7 43.8 0.8 14.9 4.9 87.2 1.9 28.4 4.2 5.2 0.0 0.5 12.3 1.5 4.5 11.8 13.4 2.8 4.5 4.4 3.6 0.0 10.1 11.6 3.1 7.4 14.5 31.4 170.7 9.6 4.8 9.7 19.3 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128483-57213361 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Endocytosis "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 110.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 21 "dendritic cells: 1.6;monocytes: 4.3" "Cell line enhanced" "Detected in many" "ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 180000000 Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.29e-5)" 110.2 14.3 23.1 29.3 27.7 8.3 40.4 34.2 27.7 32.1 19.2 22.1 23.4 37.2 6.3 19.5 30.5 31.8 28.7 16.7 42.2 5.7 35.3 34.3 4.9 45.8 31.5 9.3 71.6 10.8 7.8 10.2 40.2 28.7 13.9 11.3 10.0 20.5 20.4 13.1 20.6 18.6 29.2 28.8 13.7 15.3 7.4 44.4 5.6 17.8 23.7 2.7 25.7 29.6 26.2 7.7 14.5 30.4 24.2 484.8 488.4 91.2 85.3 109.0 27.5 26.7 26.9 12.4 0.4 10.4 222.2 6.0 33.6 5.3 8.7 9.7 0.7 1.3 0.4 17.9 56.4 66.5 0.5 14.6 318.5 3.1 61.8 7.2 248.7 1.7 1.1 0.4 1.3 87.2 1.7 0.2 0.4 34.8 11.0 8.8 3.2 171.0 1.6 1.9 2.2 1.4 16.4 19.0 0.6 13.2 42.0 2.9 1.2 1.2 96.0 35.0 53.9 5.2 1.1 0.1 0.2 167.4 0.1 18.7 0.0 4.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 1.6 23.1 27.7 34.2 27.7 16.7 42.2 45.8 31.5 9.3 28.7 28.8 44.4 26.2 24.6 12.8 8.4 113.6 3.2 24.0 11.9 28.7 19.9 29.2 4.9 19.3 14.8 15.7 14.7 1.8 0.0 87.5 1.1 81.7 0.0 7.4 1.9 9.7 111.4 13.0 4.2 0.8 39.3 1.8 53.0 273.4 49.5 4.2 6.3 36.9 11.0 188.4 73.8 8.4 41.6 14.1 6.1 145.3 28.6 8.4 233.3 102.9 28.4 89.9 48.8 154.7 1.0 173.4 6.6 14.7 27.2 184.3 4.4 5.5 86.0 2.1 15.1 7.3 39.5 129.7 77.0 1.6 2.4 35.4 16.1 125.9 4.2 11.4 25.0 12.3 HOXC11 HOX3H ENSG00000123388 "Homeobox C11" O43248 12 53973126-53977643 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.8;skin 1: 4.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "spinal cord: 1.3" HPA038291 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038291: AB_10674552" "unprognostic (1.50e-3)" "unprognostic (1.93e-2)" "unprognostic (1.14e-2)" "unprognostic (1.51e-1)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (6.90e-3)" "unprognostic (1.32e-2)" "unprognostic (7.41e-3)" "unprognostic (4.46e-3)" "unprognostic (2.25e-1)" "unprognostic (3.26e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-1)" "unprognostic (1.82e-1)" 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 1.8 4.0 1.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 9.3 1.1 0.0 34.7 3.2 4.9 0.0 5.1 17.5 7.4 5.3 0.3 1.3 0.0 0.3 4.8 0.0 15.4 6.6 0.0 3.3 1.0 0.1 0.2 12.4 0.0 0.0 0.1 0.1 0.9 1.4 0.0 0.4 0.0 0.0 0.3 1.5 0.0 4.8 2.2 0.0 0.1 0.0 10.1 0.1 0.0 0.6 0.0 0.7 1.2 0.0 0.2 3.2 7.8 3.1 0.3 27.4 0.0 0.0 0.0 5.8 0.4 0.3 0.0 0.0 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.7 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.9 0.0 0.0 0.0 1.0 1.0 3.5 0.9 0.0 3.8 0.0 0.1 0.0 0.2 0.0 ATG101 "C12orf44, FLJ11773" ENSG00000123395 "Autophagy related 101" Q9BSB4 12 52069246-52077494 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 261.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 261.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039904 Approved NA NA "HPA039904: AB_10673262" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (3.19e-1)" "unprognostic (6.33e-3)" "prognostic unfavorable (8.07e-7)" "unprognostic (9.39e-2)" "unprognostic (1.40e-1)" "unprognostic (5.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "unprognostic (3.63e-2)" "unprognostic (1.27e-1)" "unprognostic (1.89e-1)" "unprognostic (3.36e-1)" "unprognostic (1.15e-1)" 27.4 30.4 24.7 21.6 25.0 24.1 26.5 25.7 29.7 22.2 25.2 27.5 19.8 24.6 34.9 32.3 24.6 27.9 29.9 26.2 24.9 31.9 38.3 31.4 24.4 24.5 24.0 23.8 24.3 34.2 28.1 29.2 20.4 24.1 30.6 17.7 8.6 38.0 19.4 39.8 44.2 24.4 21.6 24.6 30.8 40.0 36.7 25.4 27.8 27.2 24.9 22.0 34.8 25.4 26.7 63.0 173.0 35.8 49.0 52.3 40.3 52.7 75.6 76.0 69.8 54.7 202.3 71.2 46.7 67.8 91.3 61.3 51.0 44.6 69.4 47.2 53.2 46.8 46.0 135.0 126.1 135.2 39.6 60.0 39.0 77.8 93.8 66.3 53.6 54.7 39.3 44.0 81.8 50.9 237.9 52.0 88.4 69.7 46.6 74.4 36.5 29.8 64.9 49.9 97.4 34.7 46.7 51.6 74.9 103.3 27.3 81.1 47.1 62.0 61.3 55.2 58.1 60.0 51.8 70.8 47.5 63.2 45.7 95.6 8.9 38.2 46.4 28.4 38.0 30.8 40.6 27.9 32.7 49.7 46.3 27.3 30.6 7.1 25.9 47.7 261.9 36.4 38.2 24.7 25.0 25.7 29.7 26.2 24.9 24.5 24.0 23.8 24.1 24.6 25.4 26.7 36.0 19.2 22.4 3.9 48.3 0.0 104.6 0.0 56.9 14.8 78.7 54.7 3.1 38.6 9.9 29.5 12.5 52.1 80.9 43.5 70.5 60.8 19.6 52.6 25.2 34.4 30.5 12.8 3.9 65.4 55.7 40.4 38.7 57.8 45.1 26.6 45.3 46.7 45.1 5.0 3.0 54.4 0.0 28.6 0.0 33.1 27.1 40.6 0.0 3.7 57.1 23.0 22.6 2.5 4.4 63.1 49.4 36.5 49.8 108.9 56.5 61.0 9.5 21.3 26.3 65.0 43.9 77.0 75.1 48.1 0.0 65.8 36.2 45.7 41.3 133.5 NFE2 NF-E2 ENSG00000123405 "Nuclear factor, erythroid 2" Q16621 12 54292111-54301015 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 113.4;lymphoid tissue: 45.7" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 265.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 1489.2;neutrophil: 810.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 1489.2" "Group enriched" "Detected in some" 5 "HEL: 376.9;K-562: 168.1;NB-4: 118.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA001914 Enhanced Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA001914: AB_1079475" "unprognostic (2.68e-4)" "unprognostic (2.93e-2)" "unprognostic (2.20e-2)" "unprognostic (2.31e-2)" "unprognostic (2.33e-2)" "unprognostic (1.85e-1)" "unprognostic (1.20e-2)" "unprognostic (4.55e-2)" "unprognostic (4.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-3)" "unprognostic (9.90e-6)" "unprognostic (1.81e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-2)" "unprognostic (3.46e-2)" 3.5 0.3 0.6 6.3 0.6 113.4 0.6 0.5 1.4 1.4 2.1 0.4 0.5 0.3 0.1 0.8 2.4 1.2 1.6 0.5 0.5 1.3 2.6 13.1 0.3 0.7 0.6 0.4 0.2 0.7 1.1 0.9 4.0 0.7 0.5 0.2 0.0 0.5 0.1 1.4 4.9 0.6 1.9 0.5 45.7 0.8 1.2 0.7 1.4 1.4 3.7 0.1 2.3 0.5 0.6 0.3 0.3 0.0 0.0 0.0 0.5 1.4 1.1 6.9 0.7 0.9 5.5 10.0 0.1 0.9 0.9 0.4 0.3 0.0 0.0 0.3 0.0 0.1 376.9 0.9 9.1 0.0 5.8 48.5 0.5 0.1 0.3 0.2 4.4 0.0 0.1 168.1 0.1 0.0 0.1 15.3 118.8 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.2 0.6 1.8 1.0 18.9 0.3 0.2 0.4 1.1 0.1 0.0 0.0 0.1 0.4 23.4 0.0 1489.2 241.7 232.3 0.6 66.7 1.0 0.3 0.8 0.5 156.7 0.5 1.0 0.7 810.6 1.1 42.0 2.7 0.2 160.2 0.6 0.6 0.5 1.4 0.5 0.5 0.7 0.6 0.4 0.7 0.5 0.7 0.6 0.0 0.0 3.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.0 0.2 1.3 0.0 0.0 0.1 5.9 0.1 0.0 0.0 0.0 265.6 0.0 0.0 0.5 0.4 0.0 0.1 3.8 0.1 0.4 0.2 1.0 0.0 0.0 0.0 0.0 22.8 0.2 19.0 0.0 44.3 1.8 0.0 33.9 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.3 1.3 0.0 0.3 1.2 1.1 0.0 0.1 0.1 HOXC12 "HOC3F, HOX3, HOX3F" ENSG00000123407 "Homeobox C12" P31275 12 53954903-53958956 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skin 1: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 1.8;stomach cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 23.4;OE19: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA055632 Uncertain NA NA "HPA055632: AB_2682867" "unprognostic (6.95e-2)" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.37e-2)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.17e-3)" "unprognostic (3.84e-2)" "unprognostic (2.55e-1)" 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.6 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 1.1 0.2 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IKZF4 "Eos, ZNFN1A4" ENSG00000123411 "IKAROS family zinc finger 4" Q9H2S9 12 56007659-56038435 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 12 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "HDLM-2: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046270, HPA049016" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046270: AB_2679607, HPA049016: AB_2680600" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (1.34e-1)" "unprognostic (8.95e-3)" "unprognostic (5.67e-2)" "unprognostic (2.08e-2)" "unprognostic (3.63e-3)" "prognostic favorable (3.46e-4)" "unprognostic (2.42e-1)" "unprognostic (5.43e-2)" "prognostic favorable (4.37e-4)" "unprognostic (6.52e-2)" "unprognostic (7.97e-2)" "unprognostic (3.64e-1)" "unprognostic (1.26e-1)" "unprognostic (9.98e-3)" "unprognostic (7.74e-3)" 4.4 9.2 5.8 2.1 5.6 3.8 3.7 7.1 6.5 4.5 5.2 4.6 1.6 4.5 4.0 2.6 5.9 2.8 4.0 5.3 5.9 3.8 3.2 3.7 2.1 6.5 6.0 5.2 7.6 2.9 8.1 7.5 3.0 6.1 3.9 2.0 8.5 2.8 4.2 10.0 2.5 3.5 2.9 5.6 2.9 4.1 5.1 6.1 4.0 5.2 5.5 2.3 4.4 3.2 5.8 1.7 1.6 11.6 3.9 2.3 2.4 2.7 1.8 3.1 2.1 3.0 6.5 2.5 1.1 2.0 2.9 2.3 1.3 1.5 1.8 4.6 36.2 1.7 7.3 1.7 3.0 2.6 3.3 2.6 4.0 2.1 2.2 1.7 3.9 2.2 0.2 10.7 5.5 3.4 2.0 4.1 1.6 5.1 1.8 1.4 3.6 3.1 1.3 3.1 1.4 4.4 3.8 2.6 0.8 4.3 2.9 3.0 3.3 1.3 1.8 3.1 1.8 1.5 3.5 2.2 1.5 3.7 3.2 2.4 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.9 0.1 5.8 5.6 7.1 6.5 5.3 5.9 6.5 6.0 5.2 6.1 5.6 6.1 5.8 5.5 3.2 9.4 10.7 2.5 3.6 1.9 3.4 10.2 20.3 16.6 15.4 7.5 10.0 4.2 3.7 8.4 3.0 0.8 3.9 1.9 2.9 13.8 7.7 10.4 5.3 6.0 4.2 13.3 4.2 2.8 8.8 2.0 8.0 1.3 4.0 8.2 6.7 2.7 8.4 17.7 3.0 4.1 9.8 3.1 2.7 8.7 4.1 5.4 7.5 6.0 18.3 0.0 14.6 15.5 4.3 2.1 10.9 1.6 2.4 1.7 4.9 4.3 12.3 0.0 10.3 9.9 21.2 5.9 10.4 3.3 4.0 3.8 16.0 2.3 2.1 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 98.9;Syncytiotrophoblasts: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 19.4 29.4 22.5 14.0 23.1 10.8 26.6 21.5 24.4 16.8 22.9 20.7 17.3 17.2 40.3 38.9 24.7 17.1 18.3 23.0 22.9 29.1 50.0 14.8 19.0 24.4 22.3 22.8 19.0 30.3 24.2 17.0 19.3 23.3 24.2 18.9 14.4 30.0 18.3 27.7 29.6 21.5 16.5 23.0 22.0 32.5 16.0 22.7 17.9 22.1 22.0 18.8 20.4 20.2 25.6 31.9 57.5 22.2 23.2 40.4 31.3 37.7 24.2 31.4 37.2 33.8 58.0 69.5 19.0 60.4 35.1 34.8 40.3 15.7 63.7 23.5 19.7 33.3 28.6 47.4 42.3 48.2 19.3 34.0 35.7 97.7 43.9 43.2 40.4 30.2 33.3 48.2 40.3 41.4 60.8 24.3 37.2 27.7 54.3 51.7 17.5 22.6 34.3 46.6 46.2 33.1 39.2 27.6 47.3 43.5 44.9 73.7 35.9 14.3 24.7 27.5 22.5 28.1 37.3 32.1 13.1 35.8 15.0 38.4 89.6 46.2 57.1 28.5 39.5 28.4 49.7 27.3 30.7 40.3 36.6 24.6 24.6 45.5 27.1 31.5 45.5 41.0 33.9 22.5 23.1 21.5 24.4 23.0 22.9 24.4 22.3 22.8 23.3 23.0 22.7 25.6 6.6 6.4 16.0 2.9 13.3 7.5 14.4 40.2 11.4 10.5 25.5 22.5 17.7 22.8 26.4 25.8 8.4 87.5 8.8 28.4 60.7 37.1 5.2 15.3 8.9 11.0 11.5 7.4 6.8 40.2 98.9 13.6 16.3 11.0 2.5 10.1 18.2 49.4 46.1 6.7 6.1 25.8 32.6 19.2 5.8 11.8 18.6 14.0 5.4 3.7 34.0 16.3 19.6 5.0 8.1 41.4 24.6 17.7 12.6 20.7 58.4 56.6 27.1 11.9 32.9 8.5 13.8 26.2 28.0 20.8 10.4 100.0 9.5 19.4 23.7 19.6 TUBA1B K-ALPHA-1 ENSG00000123416 "Tubulin alpha 1b" P68363 12 49127782-49131397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 2143.3;Extravillous trophoblasts: 2555.5;Hofbauer cells: 2114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011513, HPA039247, HPA043684, HPA063394" Enhanced Supported Microtubules NA Yes Microtubules "CAB011513: AB_2210057, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic unfavorable (5.49e-4)" "unprognostic (4.19e-2)" "unprognostic (3.84e-3)" "unprognostic (5.84e-2)" "unprognostic (2.91e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (2.98e-3)" "unprognostic (9.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.69e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.85e-12)" "unprognostic (1.60e-1)" "unprognostic (3.52e-1)" "unprognostic (4.67e-2)" "unprognostic (3.55e-3)" 536.8 322.0 1018.6 655.8 1163.1 1504.4 458.3 981.2 1328.8 309.1 868.9 604.2 281.9 464.3 407.2 555.4 372.4 308.3 499.6 1115.1 1119.9 306.8 235.8 515.7 756.9 1170.1 1067.4 1079.3 328.8 181.4 264.7 324.7 587.7 1205.2 249.9 671.6 658.6 307.0 397.9 245.9 407.6 355.4 1013.4 1091.6 439.3 358.6 325.6 1108.6 1571.6 269.5 244.1 889.3 645.6 342.2 1279.4 3063.5 3381.9 3587.5 2051.4 910.0 1321.7 1939.2 2635.0 2642.5 5018.6 4034.6 4300.0 3144.6 3430.1 1854.8 3732.5 2047.5 1864.3 3993.2 3609.1 4586.7 1938.3 2103.5 2445.9 1822.2 2219.9 251.5 3705.8 1863.3 793.6 540.2 3930.9 1298.9 1697.4 4353.5 3121.3 2788.0 2182.3 4142.7 3362.1 4985.5 2943.8 2504.9 7570.8 3944.4 3980.1 3023.6 2137.4 2377.1 2008.1 2250.7 1921.9 2211.7 1697.3 803.9 1804.3 2403.1 3624.8 2321.3 2393.9 2752.4 2404.5 3470.2 1196.5 1876.2 3685.5 1668.2 2924.3 2303.6 197.9 240.0 411.5 241.8 1022.1 266.7 268.9 230.1 225.3 632.4 239.6 241.0 192.4 271.6 230.9 1107.4 632.0 293.2 731.1 1018.6 1163.1 981.2 1328.8 1115.1 1119.9 1170.1 1067.4 1079.3 1205.2 1091.6 1108.6 1279.4 702.9 198.7 231.8 36.6 445.8 584.0 653.7 875.4 288.5 426.4 267.9 391.8 0.8 90.1 373.4 187.6 492.1 1143.1 514.2 482.6 361.9 814.5 272.5 189.3 218.3 643.9 303.7 2143.3 201.8 630.1 2555.5 603.4 237.0 203.9 542.8 1069.6 353.4 106.3 2114.8 498.0 99.1 508.1 512.7 361.8 1353.1 204.8 326.8 729.8 473.2 68.4 1248.5 455.7 228.6 34.7 82.7 703.3 298.4 236.6 595.9 373.5 240.0 245.1 287.7 970.8 263.0 321.5 957.4 161.6 488.9 560.6 449.8 304.4 480.3 172.4 551.2 539.1 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "RH-30: 152.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" Yes NA Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 6.9 6.3 2.7 3.7 2.7 2.6 9.3 4.0 2.8 10.0 2.8 5.2 3.9 9.4 9.7 5.6 8.5 5.5 3.2 2.5 2.2 11.7 6.6 5.3 3.6 3.0 2.8 2.6 11.5 21.9 6.4 3.7 4.7 3.4 8.3 4.6 3.7 19.6 8.7 2.9 7.4 3.8 7.6 2.4 4.1 7.3 4.2 2.8 2.0 10.2 3.1 3.1 6.3 7.4 3.0 5.4 11.0 4.6 5.9 12.8 12.0 4.0 5.8 10.9 8.9 9.0 5.6 9.5 3.1 7.4 7.6 7.2 5.2 3.7 3.3 9.3 4.0 5.6 14.9 6.6 9.2 11.3 3.7 6.6 12.6 8.7 9.3 9.8 15.2 9.7 13.2 8.9 22.6 5.4 3.8 4.7 11.0 3.4 4.3 8.0 8.5 152.1 10.0 6.0 5.3 4.4 6.0 10.0 7.5 6.2 4.1 11.9 10.0 9.5 13.7 7.7 5.8 6.4 5.7 2.3 3.8 11.3 15.4 10.0 0.4 3.0 0.1 1.8 1.1 7.8 0.5 3.5 2.2 3.1 0.4 1.7 1.4 0.7 1.5 4.6 1.5 2.2 2.3 2.7 2.7 4.0 2.8 2.5 2.2 3.0 2.8 2.6 3.4 2.4 2.8 3.0 3.9 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 7.6 0.0 0.0 1.8 1.8 0.0 3.4 1.3 0.0 5.9 5.5 0.0 2.0 6.0 1.9 0.0 0.0 0.0 12.7 4.9 3.4 0.0 2.5 2.5 5.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 16.4 1.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 4.7 0.0 0.0 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47578976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: AB_2675671" "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favorable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 9.0 14.0 5.7 4.6 6.0 8.8 10.1 7.2 6.3 9.4 6.0 11.6 4.2 13.3 8.8 9.3 10.7 4.6 9.4 5.7 5.9 8.6 8.3 8.4 6.5 5.4 5.7 5.6 11.0 8.4 12.5 13.1 4.4 5.6 8.6 6.3 7.5 10.4 6.8 24.5 12.8 10.6 6.8 5.7 11.0 10.5 14.6 5.7 8.0 9.4 11.1 8.4 11.4 8.4 5.9 5.0 11.8 13.0 10.2 7.8 10.6 3.7 9.0 11.8 12.8 11.2 4.0 9.8 9.6 4.8 11.6 9.2 8.5 7.5 13.3 10.9 12.6 10.7 7.2 15.9 5.7 5.8 15.3 14.5 9.6 9.1 5.4 6.9 8.8 13.4 6.7 5.4 7.6 10.2 13.1 11.2 4.6 6.4 14.0 7.6 10.2 17.0 5.4 13.8 11.9 17.2 11.0 7.7 10.4 6.5 4.3 17.4 4.8 10.7 7.9 8.4 12.1 9.0 10.3 20.3 14.2 11.5 4.2 8.8 11.6 4.6 11.7 12.5 3.8 13.8 11.6 9.8 11.4 5.9 10.9 10.6 11.4 8.3 13.5 4.1 2.5 12.8 10.4 5.7 6.0 7.2 6.3 5.7 5.9 5.4 5.7 5.6 5.6 5.7 5.7 5.9 6.2 6.4 3.6 3.3 9.6 4.8 6.2 16.4 7.4 14.0 6.9 4.4 0.1 8.6 11.3 11.0 8.4 12.3 9.7 6.9 23.5 13.9 14.5 10.2 5.2 9.0 7.2 9.5 5.7 13.7 7.3 5.8 1.5 4.6 10.8 6.8 7.5 8.8 8.1 13.5 6.6 4.0 20.3 4.1 2.9 18.3 5.0 4.3 1.8 3.7 11.4 24.9 10.3 2.5 4.6 9.0 2.9 9.4 5.8 4.1 6.3 10.9 18.8 12.1 13.1 6.9 6.0 23.7 20.1 4.0 4.5 14.1 10.2 7.6 5.4 4.6 SARDH "DMGDHL1, SDH" ENSG00000123453 "Sarcosine dehydrogenase" Q9UL12 9 133663560-133739955 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 48.3;liver: 115.3;pancreas: 43.6" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 120.6" "Cancer enriched" "Detected in many" 8 "liver cancer: 18.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8" "Lineage enriched" "Detected in single" 16 "T-cells: 8.8" "Cell line enhanced" "Detected in many" "AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA057267, HPA058086" Approved Approved Mitochondria NA NA 230000 Mitochondria "HPA057267: AB_2683388, HPA058086: AB_2683601" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (2.31e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.62e-4)" "unprognostic (5.83e-2)" "unprognostic (1.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "unprognostic (7.74e-3)" "unprognostic (2.78e-1)" "unprognostic (3.48e-1)" "unprognostic (9.73e-2)" "unprognostic (1.30e-2)" 1.0 2.2 3.6 2.5 3.3 0.9 0.8 1.8 4.0 2.3 0.6 1.0 1.8 2.1 48.3 0.6 1.9 1.3 1.6 3.1 2.9 12.2 115.3 2.7 4.1 4.2 2.7 2.9 3.1 43.6 2.1 4.1 0.9 2.9 2.3 0.4 0.6 5.3 1.8 0.6 0.4 1.3 0.9 2.6 1.3 3.0 0.7 3.7 4.3 1.6 0.3 2.4 1.1 1.0 2.8 0.0 0.1 1.4 17.4 0.1 0.5 2.3 0.1 0.7 0.9 1.1 0.3 0.2 0.0 2.4 0.3 2.2 0.1 0.0 0.3 0.7 0.0 0.3 2.5 0.0 31.1 1.9 0.1 0.3 4.2 0.0 2.0 0.1 0.4 0.2 13.1 0.1 0.4 11.1 3.2 22.5 2.4 2.8 1.7 0.2 1.6 18.5 39.1 0.0 0.1 1.7 14.7 0.0 0.4 3.9 0.8 2.4 0.2 0.1 3.3 3.0 0.3 0.0 0.3 0.0 1.3 2.1 1.4 0.1 0.3 0.1 0.1 0.3 0.0 0.8 0.0 3.3 0.8 0.0 0.3 6.7 1.2 0.5 0.1 0.0 0.3 8.8 1.4 3.6 3.3 1.8 4.0 3.1 2.9 4.2 2.7 2.9 2.9 2.6 3.7 2.8 0.1 0.0 1.9 6.8 0.4 0.3 0.4 0.0 1.2 0.1 0.2 0.8 0.8 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.8 1.2 5.7 1.5 1.1 0.1 2.3 0.0 0.3 1.3 0.8 2.9 120.6 0.1 0.0 0.7 0.0 0.0 1.6 0.6 0.8 4.7 0.2 0.0 1.9 0.0 4.2 1.0 0.5 0.3 0.1 0.0 3.0 0.7 0.3 0.0 21.3 0.0 0.3 0.0 1.6 3.5 0.1 0.8 0.0 0.1 0.0 4.2 1.6 0.0 0.2 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636363-133659329 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 275.3;brain: 130.0" "Cell type enriched" "Detected in some" 6 "Hepatic stellate cells: 10.0" "Cancer enhanced" "Detected in some" "liver cancer: 1.7" "Group enriched" "Detected in many" 7 "midbrain: 48.9;pons: 130.0;white matter: 35.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 346 "SH-SY5Y: 1826.4" "Region enriched" "Detected in some" 6 "pons and medulla: 22.1" "Region enriched" "Detected in single" 26 "pons: 18.5" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 1600000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 2.8 275.3 1.2 1.1 1.8 0.2 0.1 0.0 3.5 0.4 0.0 0.1 0.4 0.3 0.2 0.1 0.3 0.4 0.3 0.3 0.3 1.3 36.4 0.8 2.3 9.7 48.9 0.1 0.4 4.3 0.0 1.4 1.4 130.0 0.4 0.0 0.1 0.7 0.2 0.1 0.2 0.6 0.0 0.1 0.9 0.4 0.2 0.6 0.2 0.4 0.0 0.0 0.4 1.1 35.7 0.0 0.0 0.1 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 3.2 0.9 0.1 0.0 0.0 0.3 5.2 4.7 0.0 0.0 2.1 1826.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.0 3.5 0.3 0.3 9.7 48.9 0.1 130.0 0.1 0.6 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 ATPAF1 "ATP11, Atp11p, FLJ22351" ENSG00000123472 "ATP synthase mitochondrial F1 complex assembly factor 1" Q5TC12 1 46632737-46673867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 265.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 284.7;Distal tubular cells: 172.1;Early spermatids: 261.4;Late spermatids: 373.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028382, HPA044950" Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA028382: AB_2672574, HPA044950: AB_2679151" "unprognostic (1.34e-1)" "unprognostic (2.97e-3)" "unprognostic (1.18e-2)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (5.97e-2)" "unprognostic (3.53e-1)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (1.19e-2)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "prognostic favorable (5.33e-7)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-1)" "unprognostic (2.62e-1)" 66.6 90.6 83.3 23.5 84.1 27.6 30.5 92.3 116.1 30.3 90.5 45.3 35.6 22.7 29.7 30.4 27.5 26.1 223.0 78.5 99.0 98.0 96.1 22.1 28.1 82.0 81.6 76.3 29.0 41.6 122.5 44.1 32.5 81.2 32.5 48.5 64.5 48.8 29.3 223.1 19.9 35.5 32.6 72.0 21.8 42.4 41.8 86.8 38.2 37.4 265.7 28.7 26.6 20.4 77.2 57.8 46.1 61.1 54.8 65.1 52.3 51.0 42.2 52.6 62.0 49.7 37.2 24.5 34.1 55.2 53.6 54.9 43.6 97.3 54.7 83.1 75.0 76.7 60.2 54.5 65.0 52.4 60.2 3.4 51.4 64.3 66.5 57.7 49.2 39.3 62.8 28.2 65.4 48.0 52.3 89.3 33.3 96.3 49.8 68.8 38.1 16.5 74.3 71.4 45.2 71.8 53.8 71.4 74.9 114.6 70.0 69.3 83.8 34.4 21.1 52.1 43.1 58.5 80.6 78.9 23.2 34.7 23.0 40.6 0.0 1.6 4.1 2.1 2.8 2.7 1.8 2.2 2.5 1.6 1.2 3.1 1.4 1.3 5.6 1.2 1.2 4.5 1.2 83.3 84.1 92.3 116.1 78.5 99.0 82.0 81.6 76.3 81.2 72.0 86.8 77.2 12.6 3.2 18.6 31.0 22.3 9.4 21.2 9.7 27.3 34.0 27.8 19.4 284.7 31.5 13.1 31.3 27.1 64.0 14.5 26.7 172.1 22.1 261.4 15.6 15.4 13.2 19.2 31.3 37.1 20.1 30.0 28.5 29.0 15.9 15.9 40.6 10.4 39.8 39.2 47.1 48.5 38.1 16.2 21.6 12.9 373.7 19.0 16.1 24.9 15.9 14.6 39.2 15.5 28.1 33.7 11.3 18.0 26.7 36.3 15.2 30.2 119.1 10.2 29.2 26.3 25.1 28.9 45.2 40.4 34.3 13.5 46.9 19.2 55.1 42.2 21.9 STIL "MCPH7, SIL" ENSG00000123473 "STIL centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.9;lymphoid tissue: 10.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Glandular and luminal cells: 12.4;Spermatocytes: 17.8;Spermatogonia: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.0 0.5 0.7 3.1 0.7 10.9 2.9 0.7 1.2 1.1 0.4 4.1 2.9 1.4 1.4 2.5 0.9 1.5 0.6 0.8 0.6 0.7 1.0 0.9 4.9 0.8 0.8 0.6 0.8 0.7 0.9 0.4 1.9 0.9 1.3 5.7 1.2 1.7 0.5 0.6 3.1 2.7 1.4 0.6 1.5 1.9 6.6 0.8 10.0 0.9 0.7 5.8 1.1 1.0 1.0 33.7 17.4 24.7 22.1 1.8 3.8 15.7 29.3 14.0 32.0 33.2 18.5 16.1 39.4 13.3 14.4 32.7 21.4 29.4 15.3 33.7 29.6 12.9 44.5 20.9 16.6 0.8 35.7 21.5 1.6 2.1 27.2 17.5 3.8 21.5 29.5 31.7 35.9 24.1 14.3 35.6 10.9 30.0 18.6 14.2 23.0 40.3 19.0 9.0 20.0 22.0 13.2 31.4 22.2 14.6 29.6 14.5 20.6 12.2 29.6 29.9 21.2 40.0 11.9 26.4 38.1 13.8 27.0 28.0 0.3 0.1 0.2 0.2 0.0 0.0 0.4 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.7 0.0 0.3 0.3 0.1 0.7 0.7 0.7 1.2 0.8 0.6 0.8 0.8 0.6 0.9 0.6 0.8 1.0 1.6 3.2 0.5 2.0 2.4 0.9 0.6 2.0 1.2 1.1 2.8 3.0 0.5 0.0 2.3 0.0 4.2 2.5 1.6 5.4 0.0 1.6 1.6 7.8 3.2 2.2 1.8 12.8 5.1 0.4 4.4 1.6 3.1 12.4 2.5 8.2 1.4 0.5 2.9 0.0 3.9 6.1 0.0 2.4 1.2 1.1 0.3 2.7 0.0 0.0 3.0 0.8 1.0 2.0 4.8 1.9 1.8 0.7 10.2 1.1 1.4 0.4 7.6 0.6 0.0 1.7 2.0 17.8 14.4 5.3 2.4 0.8 3.3 2.6 5.5 1.4 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.8;lymphoid tissue: 30.7" "Cell type enhanced" "Detected in many" "Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 0.6 0.6 0.1 5.6 0.1 47.8 1.1 0.1 0.2 0.5 0.1 4.0 4.1 0.9 0.2 5.6 0.3 0.6 0.3 0.1 0.3 0.4 0.8 1.4 12.7 0.2 0.3 0.1 0.2 0.2 0.1 0.1 3.1 0.1 0.4 5.3 0.1 1.0 0.1 0.2 3.6 3.8 2.0 0.1 4.1 2.4 11.2 0.3 30.7 0.3 0.0 12.1 1.4 2.1 1.0 54.5 73.6 68.4 32.7 2.6 5.4 42.8 79.5 37.9 55.2 59.9 51.3 57.6 17.1 9.0 31.4 98.0 61.7 54.9 40.9 72.6 40.0 21.6 65.5 61.4 50.9 0.3 54.1 43.2 1.8 1.5 45.1 30.9 15.7 35.5 51.3 56.6 40.8 103.0 55.3 76.4 59.7 58.9 42.2 49.1 58.4 103.0 30.3 28.6 32.3 39.4 24.7 45.8 34.2 31.7 31.0 25.7 42.1 26.0 59.6 64.6 44.3 87.2 38.6 32.7 67.9 35.7 39.3 151.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 1.2 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.3 1.0 0.2 0.0 0.5 0.0 2.9 1.3 0.5 1.9 0.0 0.0 0.7 0.5 1.2 0.0 2.1 0.0 0.0 8.2 0.5 5.6 0.0 0.2 17.4 0.3 1.3 1.1 0.0 38.3 0.0 0.0 16.1 2.0 5.1 1.3 0.0 14.8 2.2 0.3 7.1 0.0 0.0 3.5 0.0 3.0 2.9 9.0 0.6 3.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 11.4 1.0 0.5 0.1 0.1 0.0 0.0 0.1 1.9 37.5 16.3 8.9 0.9 1.5 2.3 0.3 7.6 0.9 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.4;pituitary gland: 12.1;testis: 30.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 322.4" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Region enhanced" "Detected in many" "hypothalamus: 12.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 133.0;U-2197: 425.6;U-251 MG: 297.4;U-87 MG: 167.9" "Region enhanced" "Detected in many" "olfactory bulb: 7.0" "Low region specificity" "Detected in some" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 1.8 4.1 2.1 0.0 0.4 0.7 1.1 1.1 1.5 0.4 0.3 0.8 4.4 0.6 0.1 0.8 0.4 1.4 12.4 3.7 10.1 1.4 0.1 2.7 2.8 1.2 0.1 0.1 0.5 12.1 0.4 1.9 4.2 0.7 0.0 0.9 3.6 0.0 0.2 0.3 0.3 0.6 0.2 0.1 30.3 4.4 2.1 1.2 0.1 0.1 4.5 0.2 1.6 0.4 0.0 4.6 0.1 0.7 3.6 0.0 29.2 28.0 0.1 0.1 0.0 0.0 0.0 0.5 14.6 46.6 0.1 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.1 4.8 0.8 4.6 26.9 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 133.0 0.0 0.0 0.0 2.4 0.2 0.0 6.8 2.1 0.3 0.4 0.0 0.1 0.4 0.0 14.7 0.4 425.6 297.4 0.0 0.2 0.1 167.9 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 0.7 1.1 1.4 12.4 2.7 2.8 1.2 1.9 0.6 4.4 1.6 0.3 0.0 0.0 0.0 0.1 0.1 4.7 0.3 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 322.4 0.4 0.3 1.3 4.2 0.0 0.4 0.0 0.0 10.3 0.0 0.4 0.0 0.0 46.4 0.4 0.0 0.0 0.6 0.0 0.0 2.8 0.3 58.6 2.8 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 8.5 0.0 4.9 0.1 10.9 0.0 0.0 2.9 0.0 0.0 0.0 3.4 63.1 4.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 COL10A1 ENSG00000123500 "Collagen type X alpha 1 chain" Q03692 6 116118909-116158747 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.1;choroid plexus: 32.6;gallbladder: 9.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 26.6;Inhibitory neurons: 6.3;Microglial cells: 8.4;Oligodendrocytes: 27.9" "Cancer enhanced" "Detected in many" "breast cancer: 42.8;pancreatic cancer: 51.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTEC/SVTERT24-B: 39.7" "Low region specificity" "Detected in many" HPA053268 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 160000 "Endoplasmic reticulum" "HPA053268: " "unprognostic (3.83e-2)" "unprognostic (6.81e-2)" "unprognostic (7.20e-2)" "unprognostic (7.45e-3)" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (3.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (4.37e-2)" "unprognostic (7.03e-2)" "unprognostic (1.38e-11)" "unprognostic (2.16e-3)" "unprognostic (7.22e-2)" "unprognostic (3.60e-1)" "unprognostic (2.06e-3)" 0.3 0.0 2.1 0.2 7.7 0.3 0.3 3.8 5.2 1.2 32.6 0.2 0.0 0.3 0.0 0.0 0.0 9.0 0.3 1.0 3.2 0.4 0.2 2.9 0.6 7.0 5.0 0.4 3.9 3.3 2.5 0.4 0.1 6.6 2.0 0.1 0.9 2.7 0.8 0.1 0.4 0.1 0.5 4.8 2.5 0.1 0.2 5.6 0.1 0.8 0.0 1.9 0.2 0.1 15.1 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.2 2.9 0.4 6.0 0.1 0.0 0.1 0.0 1.0 0.0 0.7 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.0 39.7 0.0 0.2 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 6.3 0.1 0.4 0.5 0.0 0.0 0.1 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 7.7 3.8 5.2 1.0 3.2 7.0 5.0 0.4 6.6 4.8 5.6 15.1 2.6 0.0 0.6 3.9 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.1 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.4 26.6 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.4 0.0 2.2 0.0 2.5 27.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.2 5.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 AMD1 SAMDC ENSG00000123505 "Adenosylmethionine decarboxylase 1" P17707 6 110874770-110898879 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 204.7" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "prostate cancer: 70.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029281, HPA029282" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029281: AB_10600101, HPA029282: AB_10599965" "prognostic unfavorable (3.87e-4)" "unprognostic (4.68e-2)" "unprognostic (1.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.91e-6)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (6.50e-2)" "unprognostic (2.25e-1)" "unprognostic (4.20e-1)" "prognostic favorable (4.28e-4)" "unprognostic (8.62e-3)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (7.71e-2)" 32.1 28.6 42.8 35.0 51.4 90.7 34.3 46.1 53.8 33.1 38.2 37.3 29.5 35.8 26.0 56.5 25.9 33.6 33.7 44.9 66.1 49.1 33.8 33.7 40.2 48.1 46.3 42.2 30.2 40.1 40.7 26.2 60.4 48.4 204.7 36.9 36.2 37.7 34.8 26.9 27.1 26.8 35.7 49.3 27.6 31.5 32.2 44.9 40.9 46.6 50.7 50.8 37.7 26.0 72.5 85.8 57.4 68.6 130.6 101.1 63.9 89.8 119.9 131.8 91.4 106.7 92.2 52.3 149.7 56.7 76.7 97.0 57.4 163.9 108.6 125.1 88.5 94.6 155.4 47.5 96.5 60.2 135.7 88.9 43.4 98.0 63.4 126.4 31.8 81.0 75.4 118.2 126.8 156.3 51.8 181.9 103.3 84.7 84.1 51.9 98.5 68.9 89.3 103.9 112.9 87.4 62.2 73.2 91.7 110.7 55.5 59.5 114.9 53.8 60.5 45.7 325.0 131.5 34.4 59.7 152.8 69.6 106.7 79.4 42.9 23.9 37.7 17.4 28.9 20.2 14.5 17.4 20.3 31.5 14.8 20.4 20.8 102.6 15.5 37.3 13.9 22.5 17.0 42.8 51.4 46.1 53.8 44.9 66.1 48.1 46.3 42.2 48.4 49.3 44.9 72.5 169.5 38.5 92.5 23.2 164.8 315.3 241.5 49.5 262.4 101.4 178.5 151.1 95.7 125.8 82.7 55.2 60.5 44.5 208.7 144.1 146.8 67.2 31.8 145.0 106.2 104.4 124.4 184.1 39.2 70.0 152.0 132.1 96.4 214.8 93.9 36.9 53.6 59.3 77.0 77.4 37.9 108.2 28.5 109.1 244.2 53.6 43.8 176.7 131.6 23.4 92.0 303.7 60.8 36.7 111.6 87.6 95.9 50.0 118.9 379.4 66.2 89.9 29.3 105.6 19.7 170.5 124.9 93.0 76.7 246.4 288.1 54.6 184.6 45.7 128.8 147.7 NDUFAF4 "bA22L21.1, C6orf66, HRPAP20, HSPC125, My013" ENSG00000123545 "NADH:ubiquinone oxidoreductase complex assembly factor 4" Q9P032 6 96889315-96897891 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction" Calmodulin-binding "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 168.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046560 Uncertain Supported Mitochondria NA Yes Mitochondria "HPA046560: AB_10966700" "prognostic unfavorable (1.31e-4)" "unprognostic (1.32e-1)" "unprognostic (1.09e-2)" "unprognostic (1.14e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (6.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (2.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" 5.8 7.9 15.0 3.5 16.1 2.2 7.1 18.4 20.8 6.5 12.0 7.4 4.9 5.6 4.7 5.5 4.4 4.5 25.9 16.0 16.6 12.7 9.3 3.2 4.7 16.1 16.3 14.2 7.9 5.6 10.1 2.5 4.8 17.4 7.3 7.6 9.9 6.2 9.7 23.4 4.9 4.4 5.6 13.6 5.0 4.8 4.6 17.3 5.4 7.5 31.3 4.7 7.9 3.7 20.3 2.2 6.1 10.5 14.3 10.3 5.9 5.6 6.0 5.6 8.8 6.6 8.4 3.7 20.6 10.7 5.6 8.4 4.4 24.7 9.3 8.5 14.5 19.5 23.0 3.2 7.4 11.2 24.4 9.2 5.7 14.2 7.6 7.7 4.4 6.9 14.3 21.0 13.6 13.9 7.0 15.7 13.1 20.1 11.3 10.0 7.4 5.9 10.7 14.6 6.0 17.9 8.4 3.1 10.7 17.5 10.2 3.3 16.1 5.8 4.6 3.5 16.2 9.9 3.1 5.4 20.0 6.2 18.1 6.9 0.2 1.8 0.5 4.0 3.6 5.3 5.1 5.2 5.4 3.3 5.4 7.6 6.9 0.3 3.0 2.3 3.8 5.9 3.2 15.0 16.1 18.4 20.8 16.0 16.6 16.1 16.3 14.2 17.4 13.6 17.3 20.3 31.9 9.6 19.8 9.8 43.2 108.8 74.4 82.6 60.9 15.1 28.5 48.1 126.9 25.8 37.3 23.9 0.0 49.6 27.9 23.5 168.3 37.7 3.3 19.2 18.3 30.7 39.3 23.3 18.5 27.6 47.6 34.4 33.6 15.9 20.3 42.5 26.0 51.8 53.9 26.9 17.8 44.3 67.1 18.3 33.7 6.2 26.1 20.2 55.2 11.2 19.7 20.7 24.7 8.0 13.1 21.4 19.7 24.8 40.6 63.7 24.2 118.0 16.6 16.6 26.3 57.8 49.1 42.3 63.7 63.1 96.7 32.8 34.3 43.4 58.1 46.4 USP45 MGC14793 ENSG00000123552 "Ubiquitin specific peptidase 45" Q70EL2 6 99432325-99521728 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 54.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 54.2" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029602, HPA029604" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029602: AB_10600418, HPA029604: AB_10602283" "unprognostic (7.81e-3)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.15e-2)" "unprognostic (1.01e-1)" "unprognostic (2.77e-2)" "unprognostic (8.65e-2)" "unprognostic (2.95e-3)" "unprognostic (1.10e-1)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" "unprognostic (1.43e-1)" "unprognostic (6.91e-2)" 6.2 4.5 6.1 5.0 6.0 4.5 4.6 54.2 10.0 4.3 4.6 5.3 7.4 5.2 4.8 5.3 4.1 6.3 6.2 6.2 7.2 6.4 4.2 3.8 7.5 6.4 10.1 4.6 4.5 4.1 4.6 3.7 5.3 16.0 5.1 6.7 6.8 4.1 4.2 6.1 6.3 5.8 4.5 5.8 4.6 4.4 3.3 7.3 3.2 5.3 5.5 5.3 4.3 3.9 9.6 5.9 4.0 8.1 11.2 14.3 13.5 8.7 10.3 11.1 10.1 14.7 8.2 6.4 15.2 7.3 10.3 11.9 7.7 12.1 9.8 13.9 12.2 12.0 15.2 8.4 6.7 11.4 14.2 8.3 15.3 7.6 9.2 15.5 10.7 15.4 13.8 37.2 14.8 9.6 5.5 4.5 13.3 12.8 9.1 8.9 6.8 5.9 8.9 13.8 6.8 11.3 9.2 7.0 9.1 7.8 10.0 4.9 6.8 15.5 5.5 7.1 8.1 15.5 6.3 6.2 29.1 9.8 13.1 10.1 2.9 1.4 0.4 3.2 0.8 4.2 5.3 2.7 4.0 2.4 6.7 1.9 1.9 0.3 1.9 2.0 3.6 2.6 1.0 6.1 6.0 54.2 10.0 6.2 7.2 6.4 10.1 4.6 16.0 5.8 7.3 9.6 13.3 3.2 5.8 22.5 13.3 2.3 9.6 6.8 4.6 10.3 4.4 4.6 9.4 4.3 4.7 3.7 18.8 6.4 7.3 5.9 5.9 4.3 15.7 10.1 10.3 7.6 2.4 4.2 47.1 2.5 6.6 7.1 9.7 4.3 2.5 5.8 6.8 4.5 4.0 10.1 44.4 2.9 10.2 4.8 2.6 10.2 13.1 4.6 3.6 22.5 10.0 5.4 2.1 32.6 39.4 5.0 3.1 8.6 6.5 8.6 8.3 15.8 10.4 7.4 0.0 6.3 6.7 1.9 7.5 5.2 2.8 7.4 7.1 5.8 7.3 6.9 PLP1 "GPM6C, PLP, SPG2" ENSG00000123560 "Proteolipid protein 1" P60201 X 103773718-103792619 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 7049.5" "Cell type enriched" "Detected in some" 12 "Oligodendrocytes: 4822.5" "Group enriched" "Detected in many" 22 "glioma: 160.5;melanoma: 75.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SK-MEL-30: 241.0;WM-115: 139.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004128 Enhanced NA NA "HPA004128: AB_1079635" "unprognostic (5.72e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-2)" "unprognostic (4.09e-3)" "unprognostic (1.32e-1)" "unprognostic (3.95e-2)" "unprognostic (2.57e-2)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-5)" "unprognostic (4.91e-2)" "unprognostic (1.86e-1)" "unprognostic (3.46e-2)" "unprognostic (1.16e-2)" 7.4 15.9 2495.4 4.2 4076.4 0.1 5.5 4190.6 3190.4 15.0 1305.5 54.6 6.4 6.9 6.7 10.0 7.4 9.7 18.8 2415.6 3200.5 1.5 2.0 1.3 0.4 5172.3 3764.4 1867.1 5.8 2.5 83.7 6.5 0.0 5014.7 21.2 15.0 7.5 6.7 30.3 2.4 24.6 22.6 22.9 4863.3 0.5 15.6 33.8 3716.8 3.8 3.5 6.8 0.4 13.0 22.0 7049.5 0.2 0.0 20.7 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.8 1.9 0.0 0.0 0.2 0.7 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 4.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.0 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 241.0 6.3 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.3 0.2 4.0 0.0 139.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2495.4 4076.4 4190.6 3190.4 2415.6 3200.5 5172.3 3764.4 1867.1 5014.7 4863.3 3716.8 7049.5 0.5 0.0 0.0 23.8 0.1 15.9 0.3 0.0 6.2 1.7 0.2 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 9.7 0.0 0.0 13.3 0.0 0.0 0.0 188.3 3.3 0.0 0.1 0.0 11.2 0.0 0.0 0.0 5.8 3.1 7.5 0.8 396.6 17.8 0.0 30.7 0.0 31.2 4822.5 0.0 0.0 3.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 3.1 2.4 0.6 0.3 0.8 2.6 0.0 0.2 5.6 0.0 0.1 SERPINA7 TBG ENSG00000123561 "Serpin family A member 7" P05543 X 106032435-106038727 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 612 "liver: 284.5" "Cell type enriched" "Detected in some" 27 "Hepatocytes: 182.8" "Cancer enriched" "Detected in single" 203 "liver cancer: 82.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 475 "Hep G2: 69.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA002803 Approved "Secreted to blood" NA NA 39800000000 25000000000 "HPA002803: AB_1079915" "unprognostic (6.22e-2)" "unprognostic (1.63e-3)" "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (2.15e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 284.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 182.8 0.0 0.0 0.0 0.7 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 MORF4L2 "KIAA0026, MRGX" ENSG00000123562 "Mortality factor 4 like 2" Q15014 X 103675496-103688158 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1214.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031872, HPA054102" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA031872: AB_2674081, HPA054102: AB_2682379" "prognostic unfavorable (9.83e-4)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (7.14e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (5.27e-2)" "unprognostic (6.34e-3)" "unprognostic (2.41e-1)" "unprognostic (4.49e-3)" "unprognostic (1.88e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.86e-7)" "unprognostic (8.54e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-1)" 122.3 186.2 188.6 98.2 198.6 99.9 181.1 173.0 236.2 251.4 195.8 114.5 90.3 264.7 219.6 122.0 211.7 130.3 139.7 192.2 212.2 131.4 206.6 133.8 73.1 185.6 188.2 182.6 361.2 138.3 138.3 200.4 244.6 197.5 163.3 141.4 95.0 122.3 193.4 177.2 99.2 100.5 331.2 182.3 91.4 119.0 90.9 198.4 80.0 160.7 131.8 110.5 173.7 144.3 227.7 404.7 257.2 372.6 167.3 541.7 388.2 486.6 533.0 479.4 437.1 462.2 259.6 369.5 289.1 401.4 533.5 522.0 272.0 477.1 406.9 535.6 120.9 219.0 157.5 413.9 308.9 602.7 212.2 141.6 449.6 351.2 380.8 489.6 389.2 478.9 142.2 249.5 383.0 551.5 403.7 188.0 207.6 355.5 512.0 322.3 186.9 340.9 292.1 456.5 221.4 347.3 275.5 425.7 310.1 418.5 385.2 203.3 198.1 433.8 263.2 171.2 459.1 289.3 179.3 221.3 241.2 472.1 420.1 403.8 54.1 40.9 32.9 41.2 44.0 46.9 37.0 38.9 38.2 41.8 32.3 41.7 37.0 16.1 46.0 47.3 70.2 36.1 40.3 188.6 198.6 173.0 236.2 192.2 212.2 185.6 188.2 182.6 197.5 182.3 198.4 227.7 102.5 125.0 160.1 39.8 75.8 363.5 572.5 292.0 75.1 46.9 198.6 103.6 130.1 123.0 242.0 110.3 10.4 443.3 106.2 103.2 246.5 269.1 46.9 231.7 235.5 146.6 178.6 68.5 109.6 129.9 1214.1 266.0 90.7 187.2 155.8 153.5 118.5 196.8 163.6 58.9 104.4 202.0 219.7 61.7 254.9 34.2 330.9 90.8 188.5 32.8 68.7 117.0 40.2 59.3 78.2 176.8 118.9 574.8 120.9 332.7 105.1 282.9 429.7 38.8 144.7 164.9 287.9 37.2 48.0 112.7 317.8 583.5 118.2 171.5 134.4 396.8 H2BW1 H2BFWT ENSG00000123569 "H2B.W histone 1" Q7Z2G1 X 104011147-104013687 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA056289, HPA060383" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA056289: AB_2683087, HPA060383: " "unprognostic (5.07e-2)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB9B RAB9L ENSG00000123570 "RAB9B, member RAS oncogene family" Q9NP90 X 103822327-103832257 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 21.3;Cardiomyocytes: 79.0;Excitatory neurons: 28.4;Inhibitory neurons: 18.7;Muller glia cells: 32.2;Oligodendrocyte precursor cells: 37.7;Peritubular cells: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.5;MOLT-4: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061932 Approved "Intracellular and membrane" NA NA "HPA061932: AB_2684640" "unprognostic (1.69e-2)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (7.28e-5)" "unprognostic (5.81e-2)" "unprognostic (3.89e-2)" "unprognostic (8.40e-2)" "unprognostic (1.42e-2)" "unprognostic (8.34e-2)" "unprognostic (8.29e-2)" "unprognostic (3.52e-4)" "unprognostic (1.10e-1)" "unprognostic (9.21e-4)" "unprognostic (1.37e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" 1.8 2.9 5.5 0.9 7.4 0.1 1.3 9.0 8.0 2.8 0.5 4.6 1.0 5.1 2.4 8.4 6.9 2.4 21.7 6.4 8.3 0.4 0.1 0.7 0.6 4.6 4.9 6.5 7.2 1.0 4.0 5.2 0.2 5.9 7.2 2.3 5.2 1.1 9.6 9.5 0.4 1.7 9.9 3.7 0.5 2.2 1.8 8.0 1.5 1.5 5.7 0.4 7.0 1.7 7.6 0.0 0.0 2.9 1.5 0.8 0.1 0.1 0.7 1.8 1.8 1.7 0.2 0.0 0.1 1.7 1.5 1.1 0.0 0.5 0.1 1.6 0.1 1.9 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.8 0.0 1.8 0.1 4.5 0.0 1.1 0.1 1.3 3.7 0.0 0.5 0.0 0.5 3.2 3.3 0.1 1.0 0.3 3.0 2.1 0.2 0.1 0.6 0.5 0.3 0.2 0.1 0.1 0.5 1.0 0.6 0.1 0.0 0.2 1.6 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 5.5 7.4 9.0 8.0 6.4 8.3 4.6 4.9 6.5 5.9 3.7 8.0 7.6 1.0 0.0 2.4 8.5 0.7 0.4 0.7 0.1 0.6 21.3 1.6 1.9 79.0 0.0 0.7 0.0 0.0 0.4 0.2 0.5 0.0 0.5 0.0 0.3 0.7 2.4 7.7 1.3 28.4 1.0 0.3 4.1 0.0 0.2 4.5 2.8 0.7 0.0 0.3 0.0 18.7 0.7 0.0 0.0 0.4 0.9 6.5 0.2 0.0 1.9 0.0 32.2 2.1 37.7 6.2 1.0 2.5 30.1 0.1 0.2 0.1 0.2 0.8 3.6 6.6 2.3 5.0 0.8 0.9 0.5 0.3 0.0 0.2 4.7 0.6 0.2 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822539-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.3;ovary: 32.8;placenta: 24.4" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Group enriched" "Detected in some" 11 "cerebellum: 7.1;pons: 2.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5" "Region enriched" "Detected in single" 28 "cerebellum: 14.2" "Region enhanced" "Detected in all" "cerebellum: 41.6" HPA017238 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 0.8 16.3 0.1 0.9 0.0 0.0 0.7 7.1 0.3 1.8 0.0 0.9 0.1 1.8 4.6 0.6 0.9 10.1 3.5 0.0 0.1 6.3 0.1 0.2 0.0 0.1 0.4 0.0 32.8 0.4 0.1 0.3 24.4 2.8 4.9 0.3 0.1 1.2 0.9 0.2 0.1 0.3 1.7 0.1 0.0 0.5 3.3 0.1 0.1 0.2 3.3 0.0 1.0 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 10.6 0.0 0.1 0.0 3.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 12.8 0.0 34.8 0.7 0.0 0.2 0.0 1.8 0.0 40.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 0.3 0.0 0.1 0.1 0.4 0.0 2.8 0.1 0.1 0.4 3.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.6 0.0 1.2 1.0 4.8 0.0 0.0 0.0 0.0 79.4 0.0 0.2 19.6 0.2 1.3 0.0 3.2 0.7 0.0 0.0 0.9 0.0 10.1 8.9 0.0 0.0 0.0 2.1 0.0 0.0 7.1 0.0 0.9 0.0 0.0 0.0 0.0 2.6 113.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 13.5 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.7 1.6 1.7 0.1 0.0 67.9 0.0 70.2 0.2 0.1 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166453-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 20.1 11.8 19.1 7.2 19.0 14.0 11.7 20.3 18.3 9.3 12.5 8.5 8.0 10.7 35.1 7.9 9.2 6.9 7.3 17.0 20.1 15.3 7.8 8.2 8.7 18.6 20.8 16.0 12.0 11.1 20.0 8.6 9.1 18.9 10.3 8.5 16.2 10.3 14.1 9.5 9.6 7.3 8.7 18.5 8.8 8.4 10.2 22.4 9.1 17.6 9.8 7.9 8.1 7.7 20.7 23.9 14.9 13.2 14.5 9.6 11.5 13.3 12.4 11.6 15.8 14.7 11.6 19.4 13.1 15.0 11.4 12.5 17.6 23.9 18.3 25.7 6.4 13.4 10.4 19.0 13.2 13.7 20.0 14.1 9.0 22.9 15.5 15.6 24.7 16.2 8.3 11.5 28.6 17.8 17.1 10.8 14.2 13.2 20.9 17.3 11.4 8.6 16.5 26.9 15.8 7.1 8.8 30.0 19.7 21.4 12.9 9.8 9.8 20.1 17.6 6.4 13.8 13.5 13.6 12.1 14.4 19.8 21.1 13.1 0.6 0.5 0.3 0.7 0.4 0.7 0.4 0.6 0.8 0.6 1.3 0.9 0.5 0.6 0.3 0.5 0.3 0.8 0.3 19.1 19.0 20.3 18.3 17.0 20.1 18.6 20.8 16.0 18.9 18.5 22.4 20.7 18.6 16.0 14.5 33.0 17.8 24.0 11.5 12.6 13.6 23.3 21.3 14.7 13.7 17.2 12.2 62.5 14.6 11.8 23.1 23.9 23.5 11.9 0.6 20.6 27.3 15.7 16.8 9.4 25.9 18.7 13.0 11.7 18.3 31.5 9.5 16.8 14.6 18.8 17.6 33.7 24.5 17.0 16.2 21.4 27.0 3.9 11.8 15.7 10.6 15.9 14.6 20.0 22.6 26.2 21.6 15.4 18.9 14.7 20.2 14.6 14.2 34.8 10.3 16.9 26.3 17.1 13.7 4.1 9.7 21.0 26.3 14.6 15.9 21.6 15.9 15.5 ESX1 "ESX1L, ESXR1" ENSG00000123576 "ESX homeobox 1" Q8N693 X 104250038-104254933 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 9.0" "Cell type enriched" "Detected in some" 25 "Spermatogonia: 98.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "TIME: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051992, HPA073330" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA051992: AB_2681684, HPA073330: " "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 98.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 3.8" "Group enriched" "Detected in some" 16 "Spermatocytes: 2.3;Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "U-266/70: 45.2;U-266/84: 32.9" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATXN3L MJDL ENSG00000123594 "Ataxin 3 like" Q9H3M9 X 13318236-13320399 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 3.3" "Group enriched" "Detected in some" 86 "Early spermatids: 68.4;Late spermatids: 192.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024123, HPA027539" Uncertain NA NA "HPA024123: AB_1845133, HPA027539: AB_10602435" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 192.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB9A RAB9 ENSG00000123595 "RAB9A, member RAS oncogene family" P51151 X 13689128-13710504 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 345.3;Syncytiotrophoblasts: 370.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003094, CAB016411" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016411: AB_630176, HPA003094: AB_1079736" "unprognostic (3.40e-2)" "unprognostic (1.36e-2)" "unprognostic (3.56e-3)" "unprognostic (3.08e-2)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.77e-2)" "unprognostic (8.23e-2)" "unprognostic (1.27e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.35e-5)" "unprognostic (3.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.46e-1)" "unprognostic (2.68e-2)" 27.6 52.2 23.1 18.6 26.2 56.5 33.2 27.6 28.4 28.0 21.5 28.6 15.1 29.7 21.5 30.0 21.7 23.0 19.9 22.7 29.9 30.5 25.1 25.2 25.3 26.5 24.8 21.5 28.4 33.5 38.4 15.6 29.0 27.2 20.4 25.3 21.9 37.3 19.1 19.9 36.3 19.2 22.3 27.0 22.2 21.6 7.7 24.7 16.6 21.3 16.7 31.9 27.7 28.1 31.6 34.8 18.1 22.9 54.5 75.1 59.7 20.4 19.0 66.4 28.5 41.2 19.6 37.7 31.3 45.7 29.9 68.1 34.8 34.4 40.4 27.8 69.6 53.4 9.9 36.6 22.9 45.0 17.7 25.8 64.6 69.5 35.8 38.2 45.7 26.8 17.3 19.5 44.8 30.9 23.9 16.8 28.8 24.7 24.0 34.1 22.7 24.2 94.7 78.8 31.7 18.8 13.2 40.3 56.3 69.3 56.8 31.4 18.5 21.1 21.5 11.2 76.9 11.6 35.4 66.4 12.8 21.5 15.1 21.5 34.1 37.7 17.5 38.1 25.3 29.9 20.0 20.7 31.9 26.5 14.2 15.3 26.3 22.5 31.0 24.1 29.1 18.0 22.0 23.1 26.2 27.6 28.4 22.7 29.9 26.5 24.8 21.5 27.2 27.0 24.7 31.6 25.4 48.1 27.3 19.9 35.0 64.7 69.0 73.4 29.6 8.7 35.9 39.0 16.6 42.9 64.1 33.1 0.0 83.6 121.0 85.3 80.3 135.0 0.6 78.8 46.2 23.7 24.5 27.8 11.1 64.0 60.5 39.2 23.4 105.8 45.1 13.5 14.3 19.2 54.9 15.2 13.7 32.2 52.9 45.0 104.9 2.2 37.6 46.7 56.9 6.5 345.3 50.9 68.0 33.7 36.6 81.1 103.1 40.3 53.8 93.1 30.7 68.9 42.8 9.4 13.1 28.1 37.2 9.7 17.7 44.5 83.4 370.4 75.6 51.4 26.6 111.8 METTL8 "FLJ13984, TIP" ENSG00000123600 "Methyltransferase like 8" 2 171317405-171434802 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035421 Uncertain Approved Cytosol NA NA Cytosol "HPA035421: AB_10670116" "unprognostic (3.13e-1)" "unprognostic (2.72e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.76e-1)" "unprognostic (3.76e-1)" "unprognostic (1.43e-4)" "unprognostic (2.94e-3)" "unprognostic (7.29e-2)" "unprognostic (6.52e-3)" "unprognostic (4.83e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.45e-1)" "unprognostic (2.04e-1)" "unprognostic (2.10e-3)" "unprognostic (2.59e-3)" 3.6 2.9 2.9 3.2 4.3 3.7 3.8 2.6 3.9 3.0 1.9 4.3 2.2 3.0 2.1 8.7 2.4 2.9 2.5 2.7 1.9 3.2 3.6 2.1 3.5 2.7 2.6 3.0 2.2 1.7 2.2 1.2 2.6 3.0 3.9 5.3 1.6 2.1 4.0 3.7 6.8 3.6 6.4 2.5 3.4 2.1 4.2 2.6 2.1 1.9 2.3 3.9 5.3 3.8 4.2 10.3 7.4 5.0 13.0 11.7 14.1 19.1 12.8 9.8 11.1 10.0 13.8 13.5 25.1 9.5 8.1 8.2 10.0 17.7 19.4 13.9 10.8 9.9 15.0 6.5 25.0 11.1 17.0 9.1 12.5 24.7 16.0 28.1 2.6 18.6 10.9 26.7 4.1 9.7 13.5 14.3 4.8 16.9 8.3 8.8 7.0 15.4 21.9 9.1 6.8 12.2 5.1 14.5 11.4 9.2 6.6 9.4 7.0 13.8 11.4 6.1 7.6 7.5 3.6 13.0 15.0 7.2 15.9 11.2 0.5 2.1 0.5 3.4 2.7 4.4 3.4 4.4 3.3 2.1 5.1 1.9 2.1 0.7 3.7 1.6 6.7 4.8 2.5 2.9 4.3 2.6 3.9 2.7 1.9 2.7 2.6 3.0 3.0 2.5 2.6 4.2 8.1 6.4 6.1 25.1 72.3 25.5 10.7 18.3 27.9 8.4 10.6 9.1 8.2 14.3 14.1 3.7 2.1 15.5 13.1 8.4 11.7 7.6 13.3 4.0 19.2 8.2 6.7 16.2 28.7 6.2 21.2 14.9 6.1 6.1 6.3 18.5 7.5 10.6 11.8 11.8 33.0 5.7 12.2 9.8 10.2 4.1 14.0 11.9 10.6 17.8 11.4 6.3 7.2 29.1 48.2 8.8 5.3 16.1 24.2 20.4 9.8 18.3 6.4 9.2 6.6 10.8 10.8 11.8 21.3 32.8 26.7 12.9 18.3 23.0 13.7 10.0 TTC21B "FAP60, FLA17, FLJ11457, IFT139B, JBTS11, NPHP12, THM1" ENSG00000123607 "Tetratricopeptide repeat domain 21B" Q7Z4L5 2 165857475-165953851 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 67.8;Excitatory neurons: 81.2;Inhibitory neurons: 85.5;Oligodendrocyte precursor cells: 77.9;Oligodendrocytes: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035495, HPA073293" Supported Approved Cytosol NA No Cytosol "HPA035495: AB_10672866, HPA073293: " "unprognostic (1.63e-2)" "unprognostic (1.17e-1)" "unprognostic (3.10e-1)" "unprognostic (1.60e-2)" "unprognostic (2.96e-1)" "unprognostic (2.51e-1)" "unprognostic (7.09e-3)" "unprognostic (2.81e-2)" "unprognostic (2.98e-2)" "unprognostic (7.57e-2)" "unprognostic (3.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (1.84e-2)" 5.1 4.2 3.2 3.2 3.6 2.1 5.4 6.5 4.3 6.6 2.6 4.8 2.6 6.3 2.8 3.0 7.4 2.8 5.2 3.2 3.3 5.2 4.0 4.7 4.2 3.4 3.6 3.1 8.0 5.0 4.3 4.7 4.8 4.3 6.1 4.0 7.6 4.6 4.3 9.2 4.7 4.3 4.1 3.2 4.1 4.4 4.4 3.2 5.1 4.4 9.3 3.4 4.8 6.0 3.9 4.1 2.1 11.8 6.2 11.0 7.0 3.6 8.2 5.9 4.9 5.8 4.4 2.5 8.9 3.8 3.2 4.7 5.0 8.2 4.8 6.9 6.4 4.9 6.5 4.4 13.6 6.2 6.7 0.0 4.0 2.9 5.9 5.2 8.4 7.0 5.6 9.6 6.1 9.0 2.4 7.0 7.8 6.9 4.6 6.9 9.5 9.1 3.9 6.2 8.2 9.6 6.9 4.7 1.7 8.6 6.3 2.5 7.2 3.9 12.0 5.1 6.5 5.4 3.5 4.5 5.8 5.2 5.4 7.2 3.2 0.5 0.6 0.8 0.6 1.1 1.2 1.0 0.8 0.9 1.0 1.0 1.3 0.2 1.4 1.0 0.4 1.1 0.5 3.2 3.6 6.5 4.3 3.2 3.3 3.4 3.6 3.1 4.3 3.2 3.2 3.9 11.1 3.2 9.8 32.7 12.9 9.2 8.3 5.3 22.8 21.6 7.2 6.9 12.5 4.3 9.4 5.5 33.3 3.8 20.2 4.6 0.0 3.3 2.4 67.8 15.3 8.2 7.2 13.7 81.2 1.8 4.6 11.3 11.2 21.6 6.3 12.8 10.8 8.4 13.1 15.2 85.5 7.7 6.1 8.1 4.9 3.2 10.5 7.2 10.6 44.0 5.7 9.9 9.2 77.9 58.9 1.1 6.5 12.8 14.5 6.3 4.0 7.2 34.7 22.7 6.6 15.9 10.7 7.1 12.1 8.5 3.8 2.9 12.5 8.5 5.8 4.7 NMI ENSG00000123609 "N-myc and STAT interactor" Q13287 2 151270470-151289894 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 207.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008588 Approved Supported Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA008588: AB_1079493" "unprognostic (5.28e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.42e-2)" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.91e-1)" "unprognostic (4.69e-2)" "unprognostic (1.52e-2)" "unprognostic (4.57e-2)" 20.8 15.9 6.6 44.9 7.0 75.2 23.5 6.6 10.5 15.3 7.6 26.1 34.0 14.0 16.8 19.2 20.0 24.2 7.6 6.5 8.0 13.2 35.8 28.8 43.8 7.7 6.9 5.7 16.9 7.9 6.3 4.2 34.5 7.6 13.3 27.0 1.4 20.3 17.3 4.9 19.5 34.0 21.1 7.0 47.9 25.1 6.6 7.5 44.9 17.1 8.4 33.7 28.2 10.6 8.8 53.2 25.7 1.3 0.0 14.4 39.4 49.3 14.6 36.8 74.1 112.0 5.9 119.9 51.0 55.4 23.5 24.5 29.6 5.6 13.8 18.6 110.0 3.0 144.9 27.3 3.1 63.1 139.9 40.2 25.7 18.3 44.1 10.0 32.1 91.8 56.4 74.0 12.6 14.4 41.6 116.4 207.7 29.5 10.9 37.6 125.5 2.9 45.8 60.9 46.1 7.4 0.3 32.0 35.1 20.5 5.1 5.6 157.9 47.5 10.5 23.3 33.8 22.3 1.8 2.0 3.2 24.5 166.4 11.3 251.3 121.3 140.5 62.7 172.8 74.3 64.8 66.1 63.4 108.8 58.5 52.1 54.3 466.8 98.1 170.0 43.3 62.3 104.3 6.6 7.0 6.6 10.5 6.5 8.0 7.7 6.9 5.7 7.6 7.0 7.5 8.8 37.3 25.6 24.9 2.9 22.9 16.7 21.1 47.0 15.4 0.3 13.8 15.1 7.0 18.6 35.6 12.9 0.0 76.4 33.4 21.4 15.6 66.6 3.4 36.2 9.0 41.1 18.0 55.5 0.4 41.1 69.4 19.1 15.3 23.8 36.1 17.7 27.5 17.8 80.2 0.0 0.2 25.1 8.2 49.7 25.6 1.7 19.6 51.5 1.8 12.2 86.5 7.4 57.7 5.0 0.7 40.2 34.5 13.9 12.9 19.1 35.3 35.3 47.4 0.1 6.6 11.7 15.2 3.6 2.2 19.4 17.8 54.5 36.2 23.1 24.9 23.3 TNFAIP6 "TSG-6, TSG6" ENSG00000123610 "TNF alpha induced protein 6" P98066 2 151357592-151380046 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "urinary bladder: 197.8" "Cell type enhanced" "Detected in many" "Early spermatids: 443.9;Fibroblasts: 302.3;Langerhans cells: 137.4;Melanocytes: 74.7" "Cancer enhanced" "Detected in many" "renal cancer: 27.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 22 "neutrophil: 183.0" "Lineage enriched" "Detected in many" 22 "granulocytes: 183.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 67.5;HHSteC: 40.3;hTEC/SVTERT24-B: 54.9;SH-SY5Y: 21.6;U-2197: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB032719, HPA050884" Uncertain "Secreted to blood" NA NA 100000 "CAB032719: AB_2204650, HPA050884: AB_2681261" "unprognostic (1.31e-1)" "prognostic unfavorable (8.18e-5)" "unprognostic (8.66e-2)" "unprognostic (2.51e-2)" "unprognostic (1.15e-3)" "unprognostic (3.26e-3)" "unprognostic (3.75e-4)" "unprognostic (4.49e-3)" "unprognostic (1.22e-1)" "unprognostic (1.90e-1)" "unprognostic (5.87e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.59e-4)" "unprognostic (1.06e-2)" "unprognostic (1.25e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (9.16e-5)" 15.7 0.5 2.5 27.8 2.7 7.6 11.2 2.2 2.8 9.3 2.0 4.5 0.7 2.1 0.3 2.2 2.2 19.9 11.8 2.3 4.5 0.4 1.2 11.1 0.6 2.3 2.8 2.3 0.5 1.2 0.3 0.4 1.8 2.5 3.3 2.8 0.0 3.4 1.0 1.7 2.5 2.2 7.3 2.2 3.1 4.1 10.7 3.1 1.5 1.6 2.8 0.5 197.8 1.6 3.0 0.0 0.0 0.0 0.0 3.8 15.5 0.0 2.5 67.5 2.5 12.4 0.0 0.0 0.0 0.8 1.1 1.4 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.3 0.0 40.3 0.0 0.0 19.5 0.0 54.9 3.8 2.3 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.3 0.0 15.5 0.0 1.1 0.0 0.0 0.0 0.0 21.6 0.5 0.0 0.0 0.4 0.0 0.0 0.0 2.2 4.4 44.3 0.8 0.0 0.0 0.0 4.8 0.7 3.3 0.0 8.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 183.0 0.0 2.1 0.0 0.0 2.5 2.5 2.7 2.2 2.8 2.3 4.5 2.3 2.8 2.3 2.5 2.2 3.1 3.0 4.5 3.2 1.7 1.3 1.1 64.7 0.9 11.1 0.0 0.0 1.5 1.4 2.2 0.0 1.5 0.0 0.0 0.1 0.3 0.1 0.0 2.8 443.9 2.9 2.7 7.3 0.0 0.8 0.7 0.0 0.9 302.3 0.5 10.6 2.5 0.0 1.4 0.0 1.4 0.0 0.4 0.0 0.0 6.9 137.4 38.5 2.5 49.6 74.7 1.9 5.9 0.0 0.0 13.6 7.1 1.5 0.0 0.4 1.4 3.0 0.0 0.2 0.2 0.0 0.0 40.6 45.5 10.7 1.9 1.0 53.0 1.8 6.0 0.3 0.0 3.8 ACVR1C "ACVRLK7, ALK7" ENSG00000123612 "Activin A receptor type 1C" Q8NER5 2 157526767-157628864 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adipose tissue: 31.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 26.2;Leydig cells: 31.7;Oligodendrocytes: 55.8;Proximal enterocytes: 17.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 10.9;HDLM-2: 5.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 29.7" "HPA007982, HPA011933" Uncertain "Intracellular and membrane" NA NA "HPA007982: AB_1078134, HPA011933: AB_1844754" "unprognostic (1.03e-1)" "unprognostic (4.55e-2)" "unprognostic (9.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (1.00e-1)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (7.12e-3)" "unprognostic (3.62e-1)" "unprognostic (9.31e-6)" "unprognostic (7.28e-2)" "unprognostic (1.95e-1)" "unprognostic (9.74e-2)" "unprognostic (1.30e-1)" 31.6 2.5 3.3 0.6 6.2 0.2 6.2 1.3 3.6 0.4 0.0 4.2 4.1 0.1 0.3 0.2 0.1 0.3 0.4 6.6 6.8 0.4 2.2 0.2 0.5 1.5 2.2 1.3 3.6 1.5 0.0 2.3 0.1 1.9 0.2 3.1 0.4 0.8 0.3 0.8 0.3 3.4 0.2 0.7 0.1 2.2 0.4 5.0 0.2 0.2 0.3 0.4 0.1 0.2 3.9 1.5 0.0 0.0 0.1 10.9 0.3 0.2 0.3 0.3 0.1 0.3 1.7 0.2 0.0 0.1 0.9 0.7 0.0 0.1 0.0 0.2 5.1 0.7 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 1.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.2 0.0 0.2 0.0 0.6 0.2 0.0 0.1 0.6 1.9 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.2 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.3 6.2 1.3 3.6 6.6 6.8 1.5 2.2 1.3 1.9 0.7 5.0 3.9 0.5 0.0 1.1 14.7 1.4 0.6 0.7 0.9 1.8 0.8 0.9 0.3 1.9 0.0 0.9 0.0 0.0 0.2 0.3 14.3 0.0 0.2 1.9 0.4 4.9 0.7 7.8 0.0 26.2 0.2 0.8 0.9 2.6 0.5 0.0 0.4 1.1 5.9 0.1 0.0 11.0 9.2 2.0 0.0 1.3 2.9 31.7 0.1 3.6 3.7 4.3 1.8 0.0 3.5 55.8 0.4 7.6 9.1 2.9 1.8 17.7 1.1 0.2 0.3 0.0 0.6 0.8 0.4 2.4 0.7 1.4 0.3 2.5 0.4 13.5 0.5 BAZ2B WALp4 ENSG00000123636 "Bromodomain adjacent to zinc finger domain 2B" Q9UIF8 2 159318979-159616569 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 477.3;Oligodendrocytes: 604.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 115.8;neutrophil: 213.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 213.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019819, HPA059292" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019819: AB_1845282, HPA059292: AB_2683968" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.94e-3)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" "unprognostic (5.49e-3)" "unprognostic (9.01e-2)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.14e-1)" "unprognostic (3.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.14e-2)" 20.8 24.0 24.7 18.2 43.3 37.0 22.3 55.3 32.1 24.0 7.4 18.4 17.3 33.9 19.8 22.3 24.6 26.4 18.6 19.7 24.4 17.5 16.9 24.9 14.8 45.0 35.2 7.6 42.8 19.4 24.8 17.6 20.7 46.2 18.6 16.5 52.5 23.6 20.0 18.5 17.6 18.6 23.7 31.9 21.1 17.1 26.6 30.3 21.7 25.7 22.5 13.7 21.1 14.8 77.6 7.4 14.7 48.4 29.4 14.2 22.8 8.4 15.3 18.7 8.2 9.6 22.1 19.9 12.4 25.8 15.0 8.4 16.6 19.4 20.7 13.0 4.5 11.1 24.7 26.9 3.1 9.3 16.3 17.0 18.0 22.2 20.6 22.2 30.4 42.5 8.3 25.7 2.3 13.1 9.1 5.6 10.5 16.1 1.5 12.4 13.1 15.7 8.8 16.4 26.2 32.1 27.9 30.3 3.7 18.5 25.0 5.8 46.7 42.6 14.9 30.1 6.5 10.3 9.0 1.0 14.0 14.1 17.5 10.0 115.8 27.4 36.4 10.1 12.0 8.3 6.5 6.1 10.5 17.7 9.6 4.1 6.6 213.2 19.7 11.3 24.5 7.1 6.0 24.7 43.3 55.3 32.1 19.7 24.4 45.0 35.2 7.6 46.2 31.9 30.3 77.6 105.3 99.3 148.0 477.3 34.3 32.6 70.1 35.8 66.0 91.8 56.4 38.9 60.8 61.5 71.5 68.0 310.6 18.5 40.1 45.4 9.8 55.5 158.0 69.8 63.9 82.5 99.9 42.1 180.4 38.9 7.2 54.9 59.7 118.9 73.9 71.9 71.0 29.4 25.5 94.2 177.3 52.1 36.7 58.0 37.1 35.4 59.4 76.6 14.2 289.5 81.4 87.3 41.2 300.6 604.3 54.3 55.5 35.0 42.2 50.0 51.7 12.4 73.3 332.3 13.1 74.9 54.1 98.2 20.7 49.6 37.5 26.7 38.9 83.2 48.6 91.6 SLC36A1 "LYAAT-1, PAT1, TRAMD3" ENSG00000123643 "Solute carrier family 36 member 1" Q7Z2H8 5 151437046-151492379 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.1;parathyroid gland: 104.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 52.9;Early spermatids: 76.7;Excitatory neurons: 92.8;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 48.7;Proximal enterocytes: 48.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "cerebellum: 68.1;pons: 24.5" "Group enriched" "Detected in many" 4 "basophil: 21.7;classical monocyte: 8.7;neutrophil: 19.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.7;monocytes: 8.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035937 Approved NA NA "HPA035937: AB_10672995" "unprognostic (5.49e-2)" "unprognostic (4.04e-2)" "unprognostic (1.24e-1)" "unprognostic (8.27e-3)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (6.30e-5)" "unprognostic (1.86e-1)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (5.08e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.83e-6)" "unprognostic (2.66e-2)" "unprognostic (1.03e-2)" "unprognostic (2.49e-1)" "unprognostic (1.42e-1)" 6.4 4.9 0.8 8.0 2.2 29.7 4.0 68.1 7.5 3.6 0.0 14.9 44.6 4.0 4.4 5.4 3.3 10.5 3.1 2.8 2.2 4.7 2.8 5.7 6.2 3.3 4.3 1.2 3.2 6.2 104.0 3.7 5.6 24.5 12.6 22.8 1.9 4.8 6.2 7.8 4.9 39.6 6.7 0.0 8.6 4.4 13.6 0.4 18.5 3.1 5.9 5.3 6.1 4.3 5.8 5.4 9.2 4.7 3.2 11.6 8.5 25.4 15.4 8.6 10.4 11.7 21.2 7.8 12.4 8.9 18.5 11.1 13.0 15.1 9.5 10.2 3.4 13.1 3.8 14.7 7.1 14.9 9.3 20.3 6.2 10.8 8.8 5.8 2.9 9.4 6.7 9.0 10.5 8.9 5.9 2.7 4.6 4.7 6.8 8.6 0.0 11.4 4.9 2.7 8.0 4.2 8.0 9.6 11.4 5.6 9.5 8.7 13.4 9.5 13.8 7.7 22.8 8.7 5.0 7.6 7.9 8.8 16.0 9.4 21.7 8.7 3.6 1.5 3.8 1.1 2.0 1.4 2.5 3.0 2.1 1.1 1.0 19.6 0.4 4.1 0.6 1.6 1.3 0.8 2.2 68.1 7.5 2.8 2.2 3.3 4.3 1.2 24.5 0.0 0.4 5.8 2.1 0.0 1.7 10.4 2.3 1.5 1.4 1.1 1.2 1.0 4.1 1.3 3.0 4.3 1.3 1.8 2.1 0.6 1.9 52.9 0.0 1.8 76.7 1.1 3.6 1.4 0.0 32.4 92.8 2.0 8.1 3.6 10.2 1.3 1.3 18.0 3.6 2.0 13.9 1.7 62.1 5.4 0.0 22.7 3.0 29.5 5.0 10.6 1.8 11.2 6.2 0.8 1.0 48.7 30.4 1.8 22.2 11.7 2.3 1.9 48.4 4.6 0.6 1.1 0.0 1.7 2.4 0.5 2.0 4.5 1.3 0.3 2.4 0.8 9.8 1.8 LPGAT1 "FAM34A, FAM34A1, KIAA0205, NET8" ENSG00000123684 "Lysophosphatidylglycerol acyltransferase 1" Q92604 1 211743457-211830763 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 416.1;Oligodendrocytes: 474.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 16.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (9.47e-3)" "unprognostic (1.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (3.70e-2)" 20.2 19.9 17.6 13.5 30.1 20.2 13.5 14.0 21.9 11.5 20.0 9.4 23.8 9.0 10.1 7.8 8.6 12.2 11.9 16.1 19.4 9.9 36.7 8.9 10.6 20.7 23.1 13.2 6.0 13.8 14.0 9.0 9.2 23.4 10.2 10.4 41.5 9.5 12.5 10.0 6.2 35.3 12.3 16.3 16.8 7.5 22.5 20.9 8.3 26.0 15.0 9.9 14.0 7.4 40.8 28.2 30.4 9.8 23.5 17.4 24.2 14.1 19.7 31.2 18.0 16.5 9.1 22.9 11.5 11.3 30.7 20.1 15.0 33.2 17.6 22.6 22.6 11.2 12.0 24.5 20.8 20.9 29.9 19.8 14.3 21.2 16.6 21.6 33.1 21.9 16.2 14.0 0.2 24.1 8.8 11.4 11.1 10.7 12.0 4.9 27.2 38.8 3.5 20.1 23.0 56.6 29.3 32.3 33.9 33.9 15.1 17.3 19.3 21.3 32.7 14.4 30.3 32.5 16.1 21.2 30.2 16.2 25.0 22.8 12.3 2.7 16.1 1.4 2.2 1.1 1.8 0.9 1.0 3.2 1.0 0.2 0.8 12.1 5.3 1.7 2.4 0.2 0.9 17.6 30.1 14.0 21.9 16.1 19.4 20.7 23.1 13.2 23.4 16.3 20.9 40.8 50.0 28.9 21.0 28.7 42.2 12.2 77.7 11.5 38.1 206.3 32.2 18.9 40.4 72.9 16.9 12.9 62.6 2.3 73.2 25.3 1.9 71.9 416.1 39.1 39.2 31.6 13.8 15.3 73.5 59.4 4.7 30.9 19.9 28.0 12.7 22.0 25.0 56.2 20.9 35.3 92.3 14.6 26.4 49.7 27.3 60.2 47.2 44.9 30.2 46.9 58.6 34.7 49.4 70.4 474.0 47.8 19.5 55.7 15.0 53.3 126.1 24.2 38.2 127.6 19.7 47.1 33.2 67.2 33.3 30.7 7.5 1.1 32.5 129.4 23.4 63.1 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686417-212699840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3" "Group enriched" "Detected in many" 34 "dendritic cells: 55.3;monocytes: 99.3" "Cell line enriched" "Detected in many" 11 "HDLM-2: 497.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 5.1 1.1 2.1 3.6 3.1 3.1 3.1 1.6 2.8 1.6 8.0 1.6 0.6 1.3 0.0 1.1 2.0 2.0 1.8 2.3 2.2 2.1 1.1 5.9 6.0 2.1 1.8 2.2 0.6 1.7 0.4 0.9 2.5 2.1 1.9 0.6 0.0 0.9 0.4 0.5 0.9 2.3 1.8 2.1 7.4 1.5 0.5 2.0 4.3 1.6 0.6 2.6 4.9 1.4 2.8 2.4 6.6 0.7 0.0 0.2 3.1 4.3 2.3 7.4 6.5 7.0 0.0 1.7 0.0 0.9 0.4 10.6 0.0 7.0 1.1 4.5 497.4 12.5 0.1 1.9 0.0 1.2 22.6 3.9 0.5 0.0 12.5 1.8 1.0 0.1 43.5 1.1 6.5 1.3 0.0 17.8 9.3 2.7 0.0 8.4 3.5 2.4 0.3 6.0 0.0 1.4 0.9 1.6 0.0 0.5 2.3 0.0 17.8 0.0 2.7 11.1 0.5 13.4 0.5 1.4 2.7 8.7 21.3 6.2 0.0 13.6 0.0 0.0 65.9 0.0 0.7 0.2 0.3 55.3 0.0 0.0 0.0 2.2 1.5 99.3 0.2 1.8 8.8 2.1 3.1 1.6 2.8 2.3 2.2 2.1 1.8 2.2 2.1 2.1 2.0 2.8 9.6 3.2 0.6 0.3 2.4 5.7 2.3 0.9 0.0 0.2 5.2 5.5 0.5 0.0 1.6 0.0 0.0 2.1 0.7 0.0 0.0 0.7 0.7 1.5 3.1 8.2 0.0 0.4 4.5 0.4 41.0 6.8 0.0 2.3 5.1 1.0 6.1 0.4 5.8 0.0 0.6 0.1 0.0 14.4 50.4 0.8 0.9 24.4 1.8 7.5 65.7 0.1 0.0 0.5 0.9 1.1 0.0 0.0 0.0 18.9 0.0 0.4 2.7 0.4 0.0 5.2 20.0 1.0 4.1 0.1 2.8 4.5 1.9 0.1 0.0 1.4 G0S2 ENSG00000123689 "G0/G1 switch 2" P27469 1 209675412-209676390 "Metabolic proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 803.6;bone marrow: 1357.0;liver: 670.2" "Cell type enriched" "Detected in many" 4 "Langerhans cells: 5188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 60 "neutrophil: 549.5" "Lineage enriched" "Detected in many" 213 "granulocytes: 549.5" "Cell line enhanced" "Detected in many" "ASC diff: 460.8;HBEC3-KT: 726.2;PC-3: 180.6;RPMI-8226: 242.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.04e-3)" "unprognostic (3.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.32e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (7.57e-3)" "unprognostic (1.53e-2)" "unprognostic (4.78e-2)" "unprognostic (2.64e-1)" 803.6 195.9 11.2 96.6 7.7 1357.0 523.8 8.1 45.7 7.7 8.7 19.3 7.6 34.6 11.8 8.7 27.0 15.8 158.0 17.6 9.6 184.4 670.2 321.3 7.7 11.2 7.6 6.5 47.8 31.2 0.8 9.5 13.9 10.3 38.7 4.0 0.7 60.3 14.9 657.5 22.7 31.9 11.0 9.9 49.7 64.3 30.3 9.3 5.9 23.9 306.1 5.4 137.5 17.4 14.9 0.0 4.3 0.0 0.0 460.8 16.1 0.3 0.7 1.4 1.9 1.8 19.3 14.8 0.0 4.1 3.4 2.5 0.0 0.0 726.2 4.4 0.7 1.2 0.0 1.5 0.6 37.5 0.2 0.1 47.8 1.6 32.4 0.0 15.8 0.0 0.0 0.2 0.0 0.2 0.0 0.2 15.7 1.3 0.0 180.6 0.0 0.0 242.8 1.7 0.3 0.9 1.4 16.3 0.0 4.0 0.0 0.2 56.7 73.6 0.0 4.9 0.2 0.1 0.0 1.1 0.1 13.1 0.1 0.0 0.0 1.0 9.1 0.0 1.1 0.4 0.1 2.5 0.1 0.3 0.3 0.0 0.0 549.5 0.0 0.2 0.0 0.0 0.4 11.2 7.7 8.1 45.7 17.6 9.6 11.2 7.6 6.5 10.3 9.9 9.3 14.9 52.3 9.6 59.5 5.9 16.1 232.4 654.8 760.7 124.1 0.6 295.2 43.3 359.1 14.3 111.6 11.0 0.0 1.8 5.0 16.6 299.3 52.3 25.3 42.7 12.0 264.5 29.3 6.9 0.9 148.2 3.6 730.2 11.7 112.0 39.1 34.7 12.1 179.4 174.2 0.0 3.1 32.6 22.4 78.2 5188.4 12.3 114.6 1060.3 327.3 2.8 30.7 23.1 1.0 11.1 0.9 736.5 42.9 71.5 10.3 416.7 41.1 304.9 42.3 0.3 32.9 56.4 60.1 52.1 1.1 35.2 161.4 4.2 33.3 7.5 52.5 513.7 KCNJ2 "IRK1, Kir2.1, LQT7" ENSG00000123700 "Potassium inwardly rectifying channel subfamily J member 2" P63252 17 70168673-70180044 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.6;parathyroid gland: 36.3" "Group enriched" "Detected in many" 4 "Horizontal cells: 240.6;Oligodendrocytes: 164.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 30.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 30.4" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.9;HUVEC TERT2: 6.3;REH: 7.5;RH-30: 29.2;U-138 MG: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029109 Approved NA NA "HPA029109: AB_10602913" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (3.50e-1)" "unprognostic (6.36e-3)" "unprognostic (1.22e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" "unprognostic (1.62e-1)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.74e-3)" "unprognostic (6.15e-3)" "unprognostic (9.60e-3)" "unprognostic (4.89e-2)" "unprognostic (5.49e-3)" 2.0 0.8 7.9 5.2 18.4 1.9 5.0 12.2 13.6 0.6 0.7 3.9 0.9 0.9 0.6 2.9 6.7 1.4 9.9 5.1 12.1 1.0 1.3 2.1 1.3 15.7 15.7 3.9 0.7 0.4 36.3 0.6 6.4 20.1 1.8 3.2 7.7 1.3 1.9 9.8 4.7 1.4 1.0 14.4 7.4 0.8 0.3 14.5 1.8 1.2 8.4 1.5 1.9 1.8 42.6 0.0 0.9 1.8 0.0 1.9 0.5 0.0 0.6 4.5 0.1 0.1 0.0 0.0 0.0 0.4 0.5 1.2 0.5 0.1 0.3 0.1 0.0 0.2 0.0 0.6 0.0 5.4 0.0 0.0 2.0 0.1 2.8 0.3 8.9 6.3 0.0 0.0 0.0 1.9 0.0 0.7 0.0 0.2 0.8 0.2 7.5 29.2 0.0 0.7 0.0 0.4 0.8 0.5 0.1 0.0 3.5 0.3 0.5 0.1 10.6 0.1 0.1 2.4 0.0 0.0 0.1 2.3 0.0 1.5 4.2 3.5 5.6 0.0 6.9 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 30.4 0.0 7.3 0.2 0.0 0.8 7.9 18.4 12.2 13.6 5.1 12.1 15.7 15.7 3.9 20.1 14.4 14.5 42.6 12.0 0.0 3.2 0.0 0.6 8.2 4.1 4.9 16.5 43.5 5.8 9.3 19.3 0.0 1.9 1.8 0.0 0.5 0.1 13.5 0.0 0.1 0.3 2.3 0.2 16.0 10.7 0.4 3.8 0.0 0.4 1.7 4.1 1.6 0.0 0.1 3.3 0.1 6.8 240.6 16.2 2.7 0.0 36.9 7.4 0.0 1.5 7.8 3.6 2.8 8.2 5.8 0.0 1.5 164.7 0.0 12.3 1.2 0.0 2.2 0.9 0.1 4.9 5.2 0.0 3.9 2.6 0.1 0.9 6.9 3.3 1.4 0.8 0.2 8.5 0.3 RAP2C DKFZp313B211 ENSG00000123728 "RAP2C, member of RAS oncogene family" Q9Y3L5 X 132203024-132219480 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 92.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.37e-2)" "unprognostic (8.80e-2)" "unprognostic (6.66e-2)" "unprognostic (1.54e-2)" "unprognostic (8.63e-2)" "unprognostic (4.14e-2)" "unprognostic (4.95e-2)" "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.21e-2)" "unprognostic (1.51e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.44e-2)" "unprognostic (1.00e-1)" 16.3 16.7 9.6 19.9 9.4 53.2 11.7 9.1 11.1 11.5 8.7 12.3 17.3 92.9 31.0 16.6 19.0 13.2 13.2 8.8 9.5 20.4 47.3 15.0 26.4 10.9 9.4 7.9 11.7 12.8 7.7 5.4 21.1 9.9 11.2 14.3 6.0 11.3 12.5 24.5 15.4 15.0 55.7 10.0 20.5 14.1 7.2 9.9 21.0 9.1 16.3 25.9 15.5 12.9 9.9 20.9 17.1 24.7 27.0 20.8 33.2 35.4 23.9 30.6 23.6 23.9 15.9 25.2 31.1 36.9 27.2 21.3 15.9 23.0 24.2 30.6 54.3 20.2 23.8 19.7 24.3 31.6 39.7 31.9 26.9 27.3 26.2 27.9 24.0 26.6 17.6 19.1 29.9 26.1 33.6 23.0 32.2 16.9 22.0 22.9 16.9 18.8 31.1 31.3 14.3 4.9 26.2 13.7 17.4 26.8 38.2 28.2 22.0 20.9 23.9 13.0 48.2 44.9 28.0 24.2 29.5 26.9 38.6 21.4 6.8 3.9 10.7 4.6 8.9 5.6 4.7 5.4 4.9 4.4 3.6 5.0 5.9 8.1 6.8 14.4 2.2 6.1 3.6 9.6 9.4 9.1 11.1 8.8 9.5 10.9 9.4 7.9 9.9 10.0 9.9 9.9 13.7 9.6 9.7 8.8 39.9 32.2 16.6 11.8 17.6 5.9 13.5 7.6 20.5 8.6 8.4 22.0 4.2 33.6 45.0 25.2 76.3 10.1 0.4 14.5 13.0 15.5 5.4 9.5 4.0 13.2 37.7 17.5 20.4 17.8 13.3 8.6 16.1 46.3 24.6 8.4 4.2 9.6 20.3 37.7 53.2 2.2 20.2 36.1 32.0 13.1 24.9 22.7 29.9 7.5 6.8 20.7 17.4 15.1 28.0 16.8 20.3 18.2 11.5 6.4 6.6 13.2 14.9 4.9 3.7 29.6 32.8 74.6 34.5 14.2 11.4 21.1 EXOSC9 "p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p" ENSG00000123737 "Exosome component 9" Q06265 4 121801318-121817021 "Disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.0;Spermatocytes: 170.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041838, HPA048257, CAB070171" Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331" "unprognostic (7.36e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-2)" "unprognostic (2.23e-1)" "unprognostic (2.78e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.89e-2)" "unprognostic (3.73e-2)" "unprognostic (1.66e-2)" "unprognostic (9.25e-2)" "unprognostic (9.85e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.28e-2)" "unprognostic (6.66e-2)" "unprognostic (1.68e-1)" "unprognostic (7.21e-2)" 14.3 14.4 9.4 16.9 10.2 38.2 14.5 11.1 15.4 12.0 9.1 11.6 9.4 13.0 14.5 12.4 13.0 8.2 15.8 9.8 9.9 11.9 16.2 13.7 26.0 10.6 9.6 9.0 13.0 11.3 14.8 11.1 14.2 10.1 10.5 12.7 10.0 11.9 9.4 21.7 14.0 12.1 10.3 9.5 15.9 11.8 43.8 9.9 33.1 10.2 18.8 21.3 15.0 12.0 10.7 66.3 29.9 76.7 44.4 10.7 20.6 39.2 83.7 45.4 114.6 84.5 32.5 53.2 113.9 20.1 50.5 35.7 23.2 83.1 38.1 95.6 51.1 39.9 56.8 43.4 43.0 26.0 98.5 51.1 16.1 20.1 77.8 20.3 23.7 56.0 72.6 102.2 42.3 110.0 38.9 154.6 78.6 42.7 25.2 34.7 80.6 134.4 52.4 41.4 21.0 51.3 53.7 28.8 45.5 52.3 38.9 38.2 64.2 35.2 50.4 76.5 44.4 80.9 63.0 49.7 132.5 52.4 67.8 34.2 15.8 14.5 23.4 17.6 21.1 18.5 20.7 20.9 25.4 17.9 22.4 22.1 22.6 3.8 14.4 21.3 15.9 24.9 14.0 9.4 10.2 11.1 15.4 9.8 9.9 10.6 9.6 9.0 10.1 9.5 9.9 10.7 20.4 44.8 19.1 4.9 20.8 12.7 15.5 31.7 18.8 10.7 6.7 10.7 13.2 17.2 25.4 3.7 10.4 31.4 21.5 5.7 1.9 23.7 154.0 10.9 15.6 17.6 6.0 27.0 10.4 30.5 31.3 15.8 7.7 11.8 31.0 25.4 10.0 5.5 24.5 16.8 8.8 9.8 28.5 11.9 10.1 21.8 13.1 16.3 8.8 11.2 22.2 15.3 16.5 6.6 10.9 20.2 9.2 10.9 22.9 8.4 6.5 8.5 16.8 17.7 6.6 23.4 21.8 170.4 62.8 14.1 14.8 10.9 26.2 16.5 11.6 12.1 PLA2G12A PLA2G12 ENSG00000123739 "Phospholipase A2 group XIIA" Q9BZM1 4 109709989-109730070 "Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035908, HPA035909" Approved "Secreted to blood" NA NA "HPA035908: AB_2674856, HPA035909: AB_10672074" "unprognostic (8.40e-2)" "unprognostic (3.87e-1)" "unprognostic (3.81e-3)" "unprognostic (3.09e-2)" "unprognostic (2.10e-1)" "unprognostic (1.35e-1)" "unprognostic (4.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.90e-1)" "unprognostic (2.71e-3)" "unprognostic (1.02e-1)" "unprognostic (8.42e-2)" "prognostic favorable (2.54e-9)" "unprognostic (3.10e-1)" "unprognostic (1.39e-1)" "unprognostic (9.16e-3)" "unprognostic (3.64e-2)" 10.1 9.1 12.3 3.4 13.2 6.2 12.1 13.5 12.8 8.4 11.9 11.6 10.6 8.2 7.3 11.5 8.5 7.3 15.5 11.5 12.5 14.9 21.3 7.5 4.0 14.3 14.8 10.4 10.6 34.8 23.2 12.6 3.7 13.8 15.2 10.9 15.7 11.9 7.2 22.3 9.4 10.7 7.0 15.6 5.2 9.9 5.0 13.1 4.9 18.0 19.5 4.6 7.1 7.7 16.5 17.2 6.2 4.8 7.4 15.0 14.9 9.4 14.9 11.0 8.5 8.9 15.6 29.1 24.5 11.6 11.1 14.0 9.3 14.9 20.1 13.0 8.3 22.8 8.7 17.5 11.5 14.2 19.2 5.9 15.1 22.9 8.6 21.3 14.3 7.7 22.5 48.8 10.7 14.7 30.3 15.7 8.6 8.6 39.0 24.1 9.3 14.3 19.5 16.2 25.0 30.8 10.1 13.7 35.5 11.9 12.3 21.3 4.0 10.4 12.4 10.1 12.9 10.8 18.5 36.0 17.8 13.5 11.0 15.5 5.4 4.1 2.7 6.2 2.7 5.7 3.7 7.8 6.0 8.2 4.3 8.7 8.0 1.8 5.0 4.5 7.0 8.3 12.1 12.3 13.2 13.5 12.8 11.5 12.5 14.3 14.8 10.4 13.8 15.6 13.1 16.5 11.7 25.6 21.8 14.4 11.7 36.7 36.3 39.7 25.0 52.5 27.5 18.3 56.8 30.0 24.9 22.0 50.1 42.7 8.3 31.5 27.4 15.0 26.7 15.1 9.5 17.1 107.7 48.4 24.1 25.9 53.4 29.3 32.6 14.0 14.0 147.4 23.9 103.1 19.4 26.9 28.6 52.8 34.6 22.4 17.1 8.7 33.2 64.6 30.2 18.7 6.1 47.7 13.4 16.6 20.1 13.9 38.9 34.6 20.6 67.8 78.9 19.2 16.4 42.3 19.7 38.2 21.1 62.7 47.5 39.0 42.6 34.5 14.3 28.6 58.9 44.9 B9D2 "MGC4093, MKS10, MKSR-2" ENSG00000123810 "B9 domain containing 2" Q9BPU9 19 41354417-41364165 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 64.8;Respiratory ciliated cells: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 127.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042229, HPA042618" Enhanced NA NA "HPA042229: AB_10959591, HPA042618: AB_10960695" "unprognostic (9.25e-2)" "unprognostic (1.82e-3)" "unprognostic (1.66e-1)" "unprognostic (9.68e-3)" "unprognostic (1.23e-1)" "unprognostic (2.19e-3)" "unprognostic (1.04e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (2.58e-1)" "unprognostic (8.22e-3)" "unprognostic (4.50e-1)" "unprognostic (1.62e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-3)" 4.0 8.6 4.5 4.1 4.1 8.8 4.4 3.9 5.7 5.0 7.3 6.2 3.2 6.6 1.9 4.4 10.6 2.7 4.0 4.2 5.0 9.0 5.0 5.6 3.9 3.7 4.3 3.7 3.4 4.5 2.2 5.8 2.1 3.9 5.5 1.8 1.2 4.3 3.7 3.0 3.5 5.2 2.5 4.3 7.8 5.5 8.5 4.8 4.8 6.0 1.5 2.2 5.2 3.8 4.0 6.7 22.0 5.8 5.2 2.1 3.4 1.4 4.2 5.0 7.1 4.4 5.9 5.8 1.7 15.6 5.1 3.0 2.0 3.9 5.8 1.7 6.8 5.9 5.6 7.4 5.1 4.2 7.0 12.6 3.9 4.0 6.3 1.6 4.9 8.0 6.1 4.1 5.9 3.4 5.8 6.5 9.0 2.8 3.1 6.6 5.4 1.3 6.0 6.0 4.3 4.9 4.1 7.3 3.1 3.7 1.1 3.9 12.9 11.9 8.1 3.6 4.3 8.4 2.6 2.4 3.9 8.6 7.4 5.4 47.2 32.3 25.6 10.7 19.8 14.0 15.8 19.7 14.7 22.6 10.3 20.5 14.0 127.5 21.0 16.3 26.1 24.8 18.3 4.5 4.1 3.9 5.7 4.2 5.0 3.7 4.3 3.7 3.9 4.3 4.8 4.0 4.0 0.0 9.4 2.0 12.0 4.1 9.8 17.3 5.7 1.6 5.9 3.7 2.0 20.0 17.1 20.2 8.4 8.3 8.0 20.1 37.2 17.4 24.2 64.8 5.6 9.9 15.5 4.8 1.1 16.8 14.9 6.1 8.2 7.6 12.6 4.3 10.0 4.6 13.1 0.0 1.1 13.3 18.3 12.9 4.3 36.7 2.8 8.0 3.6 0.0 8.7 5.4 6.2 0.0 0.6 12.1 37.4 6.4 5.5 7.8 9.9 32.6 76.9 6.1 6.6 9.1 6.8 18.4 12.0 3.9 3.3 6.8 10.3 9.2 10.2 12.6 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691514-40725784 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 16.5;Endometrial ciliated cells: 16.4;Theca cells: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria NA NA Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 14.9 25.4 10.3 5.8 10.1 6.0 15.5 10.6 12.9 22.9 10.4 18.3 9.8 22.2 2.3 16.1 30.0 7.7 20.0 9.6 10.7 19.9 25.9 16.6 6.1 10.5 10.6 9.4 22.7 20.8 8.5 49.7 3.5 10.3 23.4 2.3 1.3 17.0 7.3 14.5 19.9 17.9 3.8 10.8 18.4 24.1 17.5 10.5 8.9 23.5 8.6 3.3 20.5 18.5 10.4 9.9 39.5 7.9 18.5 7.8 6.1 8.5 6.6 7.8 5.6 5.1 15.4 14.3 13.8 20.0 4.3 7.8 9.8 7.0 10.5 2.0 20.0 10.4 11.6 12.7 6.4 12.1 4.1 19.2 8.4 10.6 5.4 5.4 5.2 7.4 13.7 7.7 8.1 6.0 6.4 4.9 5.7 6.4 11.5 3.6 11.5 13.1 12.4 15.7 17.6 15.1 11.0 12.5 20.4 21.0 4.4 22.8 17.1 9.4 5.1 20.6 3.9 5.5 9.4 9.0 7.3 27.8 5.2 9.1 10.2 9.4 8.7 6.7 9.3 8.3 7.1 5.5 7.8 9.9 5.9 4.6 5.1 9.0 6.9 9.2 4.6 4.9 7.3 10.3 10.1 10.6 12.9 9.6 10.7 10.5 10.6 9.4 10.3 10.8 10.5 10.4 8.5 12.8 3.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 11.6 8.0 0.0 0.0 2.5 12.9 0.0 11.1 6.8 0.0 11.7 16.5 0.0 16.4 7.8 1.7 0.0 0.0 0.0 10.9 9.8 5.0 0.0 10.3 1.3 11.7 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 9.5 0.0 0.0 1.2 0.0 0.0 13.0 8.7 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.4 3.2 19.8 0.0 0.0 PFKFB2 ENSG00000123836 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2" O60825 1 207034366-207081024 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 84.1" "Cell type enhanced" "Detected in many" "Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 20.8;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 8 "dendritic cells: 23.8;granulocytes: 20.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049975, HPA063575" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049975: AB_2680977, HPA063575: AB_2685046" "unprognostic (1.30e-1)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.27e-1)" "unprognostic (3.76e-2)" "unprognostic (9.96e-3)" "unprognostic (9.74e-2)" "unprognostic (7.27e-2)" "unprognostic (2.27e-2)" "unprognostic (6.01e-2)" "unprognostic (1.30e-1)" "prognostic favorable (3.23e-7)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (1.86e-2)" 4.3 6.8 13.1 8.4 14.7 23.7 6.5 10.4 15.9 9.2 36.6 22.4 32.5 5.0 11.7 9.7 5.7 5.8 33.2 14.6 23.3 29.9 4.0 13.4 7.1 13.1 13.9 8.9 5.2 16.1 15.5 23.2 3.9 11.8 4.8 24.3 84.1 7.7 4.2 49.9 7.2 22.4 5.0 10.4 15.2 15.6 7.1 21.7 20.4 52.1 43.1 6.7 4.3 4.2 17.5 15.0 6.5 4.2 7.3 8.4 4.1 6.9 2.1 2.5 3.6 2.0 16.0 21.1 2.7 3.3 3.3 10.8 20.8 3.1 7.9 2.1 0.6 3.2 21.1 17.4 5.9 7.0 0.0 14.2 5.9 11.7 3.5 19.1 4.3 0.8 8.7 14.6 0.1 2.0 4.5 3.6 0.6 5.8 7.2 9.7 0.0 0.0 0.4 4.9 15.3 6.6 4.0 13.7 22.8 17.4 4.5 15.6 1.8 0.4 0.0 7.6 11.0 1.9 6.6 7.0 1.4 8.8 0.0 3.9 1.6 1.2 20.8 0.3 2.6 0.4 1.9 0.2 0.4 1.1 2.3 0.5 0.6 3.5 1.6 1.9 23.8 0.0 0.7 13.1 14.7 10.4 15.9 14.6 23.3 13.1 13.9 8.9 11.8 10.4 21.7 17.5 1.0 6.4 54.8 105.1 5.0 15.2 3.8 5.0 10.2 7.0 3.7 4.2 79.0 4.3 8.7 16.5 0.0 0.7 24.6 53.8 25.4 5.0 51.0 18.0 3.7 4.2 6.0 0.8 14.5 7.6 0.4 4.6 14.8 21.3 9.5 2.3 2.5 5.8 5.6 3.3 13.0 20.1 8.2 13.6 4.9 158.2 2.8 8.5 21.4 11.2 5.4 9.8 5.2 4.5 10.6 16.6 26.2 3.0 3.8 13.5 45.4 32.8 15.3 110.5 0.0 3.3 3.1 5.1 3.2 9.9 11.6 1.5 1.6 7.5 36.9 11.5 C4BPA C4BP ENSG00000123838 "Complement component 4 binding protein alpha" P04003 1 207104233-207144972 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 1934.6" "Group enriched" "Detected in many" 14 "Alveolar cells type 1: 493.6;Alveolar cells type 2: 660.8;Hepatocytes: 1020.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 434.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 137 "neutrophil: 29.5" "Lineage enriched" "Detected in single" 137 "granulocytes: 29.5" "Cell line enriched" "Detected in some" 5 "Hep G2: 37.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000926, HPA001578" Enhanced "Secreted to blood" NA NA 30800000000 28000000000 "HPA000926: AB_1078355, HPA001578: AB_1078354" "unprognostic (3.85e-4)" "unprognostic (9.07e-2)" "unprognostic (2.06e-1)" "prognostic favorable (6.37e-5)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "prognostic favorable (2.24e-4)" "unprognostic (3.64e-2)" "unprognostic (1.94e-1)" "unprognostic (5.90e-4)" "unprognostic (4.47e-2)" "unprognostic (2.58e-1)" "unprognostic (5.51e-7)" "unprognostic (9.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-1)" 0.6 0.7 0.3 2.5 0.2 0.1 4.6 0.7 0.2 6.4 0.0 1.7 0.0 4.5 0.0 0.1 1.0 3.2 0.1 0.1 0.3 0.6 1934.6 174.8 0.3 0.4 0.3 0.0 1.5 9.7 0.3 0.1 0.8 0.5 0.1 0.8 0.0 1.1 0.0 0.0 0.0 0.8 0.1 0.1 1.2 0.4 0.3 0.2 0.0 0.1 0.0 1.1 0.1 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 37.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 7.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.7 0.2 0.1 0.3 0.4 0.3 0.0 0.5 0.1 0.2 0.4 0.0 493.6 660.8 0.0 3.7 0.0 0.0 0.2 0.0 0.0 2.7 0.4 0.2 41.5 22.5 0.0 0.0 0.0 0.0 3.2 0.0 11.2 0.3 18.0 7.6 1.9 0.0 21.5 0.7 18.7 0.0 1.1 0.0 48.8 3.8 0.0 22.1 1020.8 0.2 0.0 1.4 0.3 0.0 39.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 5.6 32.0 0.0 0.0 0.3 0.1 0.1 3.6 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 3.9 16.7 0.2 1.4 C4BPB C4BP ENSG00000123843 "Complement component 4 binding protein beta" P20851 1 207088860-207099993 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 475.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 597.6" "Cancer enriched" "Detected in many" 19 "liver cancer: 83.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1" "Not detected" "Not detected" "HPA000925, HPA051620" Approved Uncertain "Golgi apparatus" "Secreted to blood" NA NA 265000000000 1100000000 "Golgi apparatus" "HPA000925: , HPA051620: AB_2681554" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-1)" "unprognostic (2.07e-3)" "unprognostic (1.72e-1)" "unprognostic (2.54e-2)" "unprognostic (4.58e-3)" "unprognostic (9.49e-2)" "unprognostic (1.37e-1)" "unprognostic (4.25e-1)" "unprognostic (6.39e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (8.25e-2)" 3.1 0.1 0.0 3.4 0.0 0.0 1.9 0.0 0.1 2.8 0.0 2.8 3.8 0.1 0.0 0.2 0.5 3.1 0.0 0.0 0.0 0.4 475.2 1.5 0.4 0.0 0.0 0.0 44.6 9.2 0.0 0.0 6.3 0.1 0.0 1.8 0.0 0.5 0.0 0.1 0.1 4.4 0.7 0.0 0.4 8.5 0.7 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.4 5.8 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 46.2 151.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 12.8 2.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 7.3 2.2 0.5 54.3 3.2 0.0 0.0 1.0 0.2 10.2 1.9 11.4 4.1 0.7 0.1 0.8 1.8 8.0 0.1 88.8 0.3 3.4 5.6 0.8 0.0 0.3 9.7 597.6 2.1 0.0 0.2 5.6 0.0 13.1 0.3 2.8 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 69.2 15.9 0.0 0.1 0.2 4.3 0.0 2.2 0.0 0.0 1.1 0.4 0.1 0.4 0.0 0.0 0.1 1.1 143.8 4.8 0.1 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113251-88175443 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.0;skin 1: 42.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 4 "NK-cell: 18.0" "Lineage enriched" "Detected in many" 4 "NK-cells: 18.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.1" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 1.8 28.0 0.4 1.4 0.4 1.6 8.7 0.3 0.8 6.6 5.2 1.9 2.4 4.8 6.8 49.0 5.6 6.1 0.9 0.7 1.3 4.5 1.8 5.9 1.7 0.5 0.6 0.4 3.4 1.6 1.8 2.8 14.8 0.4 2.5 1.3 2.9 7.7 6.5 0.6 42.5 2.3 3.7 0.4 1.6 1.6 2.5 0.6 3.5 8.0 0.4 18.1 8.8 23.7 0.5 10.7 1.4 0.3 0.5 0.4 2.4 0.6 6.5 26.1 10.4 19.0 4.7 4.8 0.5 6.3 6.9 1.2 71.2 5.7 87.7 14.1 1.3 5.1 54.0 6.2 0.0 1.0 0.6 0.6 2.2 308.0 1.4 271.4 13.0 12.3 1.0 0.3 0.9 0.0 0.0 0.7 18.4 8.2 0.7 0.1 0.5 0.1 0.8 20.0 40.6 1.9 1.2 0.3 0.1 175.6 6.2 15.7 4.6 6.7 0.0 4.6 0.0 1.1 1.5 6.5 0.2 1.7 2.2 1.2 0.0 0.8 0.1 1.5 0.6 0.8 0.0 0.4 1.8 1.6 0.0 0.1 0.8 0.6 18.0 1.3 4.4 1.0 0.7 0.4 0.4 0.3 0.8 0.7 1.3 0.5 0.6 0.4 0.4 0.4 0.6 0.5 1.0 0.0 6.7 0.7 0.1 46.4 15.9 74.8 21.1 0.1 6.9 9.7 0.2 8.6 25.0 0.0 0.0 94.5 2.7 0.5 3.9 1.7 0.0 2.1 0.9 2.7 0.0 5.5 0.6 1.1 10.5 9.1 3.1 2.3 16.5 5.3 1.1 0.0 17.5 0.0 0.4 0.3 14.2 1.6 21.2 0.1 3.4 3.9 131.6 3.7 6.3 0.6 1.0 2.0 0.1 2.6 2.6 1.2 0.1 9.5 2.1 5.3 7.4 6.4 0.0 0.6 5.3 0.1 5.9 38.1 98.5 54.7 2.7 5.9 2.5 23.3 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377316-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "brain: 10.6;thyroid gland: 3.0" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 2.7;Excitatory neurons: 2.6;Inhibitory neurons: 4.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.6" "Region enhanced" "Detected in many" "basal ganglia: 67.5" "Low region specificity" "Detected in many" NA NA "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.1 0.7 1.2 0.1 3.2 0.4 0.0 10.6 3.7 0.2 0.7 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.3 3.9 4.5 0.3 0.2 0.0 0.2 1.1 5.3 2.3 0.1 0.1 0.0 0.3 0.0 2.5 0.1 0.1 0.7 0.1 0.0 0.3 0.2 0.1 0.1 0.5 0.2 0.1 0.4 2.2 0.1 3.0 0.0 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.6 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 1.2 3.2 10.6 3.7 3.9 4.5 1.1 5.3 2.3 2.5 0.5 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 2.7 0.1 0.0 0.0 0.0 2.6 0.4 0.0 0.2 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 AGO2 "CASC7, EIF2C2, hAGO2, LINC00980, Q10" ENSG00000123908 "Argonaute RISC catalytic component 2" Q9UKV8 8 140520156-140635633 "Enzymes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019309, HPA067849" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 65000 "Cytoplasmic bodies" Cytosol "CAB019309: , HPA067849: " "unprognostic (2.75e-2)" "unprognostic (1.79e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.46e-1)" "unprognostic (2.15e-1)" "unprognostic (1.49e-3)" "unprognostic (8.86e-2)" "unprognostic (2.21e-1)" "unprognostic (8.50e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.82e-5)" "unprognostic (1.32e-1)" "unprognostic (2.77e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-1)" 7.0 4.2 8.9 6.3 12.6 11.4 5.9 11.6 8.8 6.7 4.1 7.7 3.2 7.8 5.9 6.3 8.4 5.1 7.1 5.9 13.6 4.0 3.9 9.2 6.1 14.7 10.5 3.6 9.6 5.1 7.1 8.0 5.8 11.5 5.8 4.0 6.8 4.9 4.6 17.6 8.6 6.3 5.3 7.6 5.3 6.6 3.3 11.5 7.7 6.3 9.2 5.5 6.7 6.8 19.9 18.9 15.2 15.3 17.6 9.9 11.5 12.9 11.6 8.4 5.1 6.3 17.0 5.5 21.5 14.1 11.3 5.5 12.4 26.2 12.5 11.3 12.2 13.7 25.2 28.7 11.0 8.9 10.5 8.2 7.9 11.0 14.1 14.6 7.0 12.0 13.4 26.9 13.2 16.8 28.5 18.2 8.3 11.4 12.9 26.3 18.5 12.9 9.7 6.5 19.3 18.0 13.0 18.1 6.1 12.8 15.7 15.7 15.1 16.9 8.8 24.5 14.0 18.9 11.5 4.0 14.7 6.5 18.7 13.2 0.7 0.8 0.2 0.8 0.7 0.9 0.4 0.8 0.7 0.7 0.7 0.8 0.8 2.2 0.8 0.8 0.5 0.7 0.6 8.9 12.6 11.6 8.8 5.9 13.6 14.7 10.5 3.6 11.5 7.6 11.5 19.9 30.8 22.4 25.1 50.3 40.7 21.9 74.8 5.7 17.6 26.5 34.5 24.5 22.2 8.6 22.6 14.7 43.8 46.5 63.1 14.8 7.9 25.6 21.2 73.1 54.3 37.8 24.2 122.9 32.6 18.2 21.5 44.3 28.5 129.4 17.1 31.6 27.5 14.6 14.9 42.1 36.4 19.1 2.0 26.0 48.5 14.9 37.3 53.0 5.4 32.8 36.0 26.1 32.0 51.3 83.2 37.9 18.6 46.3 46.6 115.0 12.7 9.4 15.4 29.7 32.9 65.9 44.5 3.1 4.0 31.8 23.9 79.1 49.1 12.0 19.3 100.1 MXD4 "bHLHc12, MAD4, MST149, MSTP149" ENSG00000123933 "MAX dimerization protein 4" Q14582 4 2247432-2262109 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 169.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053363 Supported Cytosol NA NA Cytosol "HPA053363: AB_2682128" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (3.54e-2)" "prognostic favorable (2.21e-5)" "unprognostic (1.64e-1)" "unprognostic (5.94e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.39e-5)" "unprognostic (5.65e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.12e-2)" 38.6 42.4 37.1 11.4 32.2 30.1 36.3 52.1 58.9 28.0 30.3 31.9 18.4 37.5 11.7 21.2 28.1 15.2 29.3 33.0 31.0 38.8 20.8 38.8 20.3 35.5 32.9 31.1 23.4 25.5 12.5 64.0 14.4 38.9 33.3 7.3 6.0 35.3 25.2 24.3 26.1 28.9 14.1 30.4 58.1 31.4 22.3 32.6 23.4 33.6 14.5 9.2 25.3 19.6 35.8 2.3 8.3 12.9 15.5 44.2 32.6 3.0 16.4 16.6 12.0 12.2 2.0 7.1 7.1 36.1 25.0 6.4 11.2 3.7 13.0 3.1 6.3 39.5 1.3 29.0 23.6 32.4 5.5 14.5 51.1 22.9 3.9 6.1 26.5 28.9 10.3 9.8 11.6 11.3 16.2 12.6 31.6 5.1 9.6 36.4 8.5 4.4 15.1 14.2 13.0 20.8 38.7 15.4 7.5 12.3 15.7 35.2 34.4 68.7 13.3 5.3 9.9 3.7 17.6 13.2 2.8 18.2 4.9 4.0 7.2 2.7 3.4 3.3 3.0 2.7 2.2 3.0 3.3 2.5 2.0 1.5 1.5 1.1 2.0 3.0 7.2 4.0 1.4 37.1 32.2 52.1 58.9 33.0 31.0 35.5 32.9 31.1 38.9 30.4 32.6 35.8 169.7 19.2 19.9 48.0 37.9 19.1 15.3 13.6 7.4 81.6 67.8 67.1 18.4 17.2 16.1 60.7 87.6 44.3 129.6 47.9 15.6 16.5 10.1 39.6 81.9 54.7 33.6 20.6 11.6 18.3 48.4 53.6 23.0 42.8 24.1 37.9 103.5 35.5 50.3 65.6 20.5 55.9 10.2 72.9 27.5 28.8 33.2 58.8 23.2 27.2 21.6 67.9 68.0 19.1 19.7 17.5 31.8 56.4 54.0 28.7 44.0 22.1 13.4 97.1 26.3 39.6 48.5 7.0 37.0 17.3 26.3 32.7 54.7 100.5 38.2 13.1 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311195-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 178.8;testis: 188.0" "Cell type enhanced" "Detected in many" "Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 187.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 9.6 83.7 13.5 38.8 13.3 178.8 20.3 15.3 21.8 9.3 15.5 44.5 43.7 13.1 8.9 53.7 12.2 18.9 9.2 15.9 13.4 32.0 31.4 24.2 103.6 13.7 13.7 13.0 9.5 4.2 20.0 4.9 44.7 14.4 15.2 41.4 28.1 10.9 18.0 9.5 20.1 33.4 17.7 14.6 32.9 20.6 188.0 14.2 122.2 12.9 4.9 85.4 26.8 20.1 16.4 685.9 570.1 342.6 230.6 98.7 89.1 249.5 396.1 211.4 428.1 340.0 236.1 328.6 504.9 228.4 149.1 761.4 466.5 415.5 305.1 488.2 398.1 335.5 257.5 378.9 637.5 42.4 531.7 281.2 33.0 69.2 307.2 269.1 162.9 403.2 409.1 313.2 430.6 556.0 509.1 420.7 928.3 501.6 795.5 521.5 358.4 376.4 303.7 342.8 153.5 288.4 171.7 328.7 314.9 324.5 318.4 379.7 304.2 231.4 184.1 350.3 449.6 588.2 345.9 759.2 415.3 271.3 303.1 268.5 40.8 19.5 44.1 22.6 26.5 25.3 61.3 30.4 21.9 22.5 44.7 16.3 21.8 14.5 40.9 14.8 187.9 62.7 23.6 13.5 13.3 15.3 21.8 15.9 13.4 13.7 13.7 13.0 14.4 14.6 14.2 16.4 138.6 38.5 103.9 0.3 175.7 280.2 92.1 126.1 259.0 4.1 107.2 169.0 61.3 5.7 49.9 14.7 0.0 231.1 201.1 79.4 23.5 20.1 37.3 149.7 66.4 66.1 122.3 266.9 1.2 11.2 379.4 63.1 74.9 250.2 145.0 144.7 29.3 25.0 184.6 0.0 1.9 164.9 111.9 40.5 474.6 77.0 25.7 164.3 140.5 1.9 31.0 26.1 28.8 1.0 1.1 31.1 67.1 16.6 89.3 72.1 37.6 209.7 32.8 7.3 46.0 75.2 206.5 692.7 503.6 197.5 299.1 199.5 156.0 70.3 162.7 102.1 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 21.6;fallopian tube: 32.9;testis: 51.8" "Group enriched" "Detected in some" 13 "Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1" "Cancer enhanced" "Detected in some" "lung cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7" "Low region specificity" "Detected in many" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.3 0.0 9.0 0.1 5.7 0.3 0.4 3.9 4.8 0.7 21.6 0.2 0.0 0.1 0.3 0.5 32.9 0.3 0.4 4.9 6.5 0.1 0.4 3.1 0.2 7.0 8.1 3.5 0.1 0.0 0.2 0.2 0.9 5.5 0.0 0.0 0.7 0.1 0.0 3.6 0.2 0.0 0.1 8.3 0.2 0.1 51.8 4.5 0.4 0.1 0.0 0.2 0.1 0.0 5.8 0.8 0.0 0.1 0.0 0.3 1.2 0.6 0.8 0.4 0.9 0.6 5.4 0.5 0.2 0.0 0.2 8.8 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.7 0.0 1.0 0.7 5.8 21.8 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.1 0.3 0.1 0.2 0.4 0.1 0.8 0.0 0.0 0.2 0.0 0.5 2.2 0.2 2.0 40.7 0.0 0.0 0.1 0.3 3.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 5.7 3.9 4.8 4.9 6.5 7.0 8.1 3.5 5.5 8.3 4.5 5.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.7 0.0 11.5 0.0 4.2 0.2 0.0 0.0 0.0 0.2 106.7 11.2 0.0 0.2 0.0 0.0 6.2 0.0 2.8 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 8.2 0.0 0.0 215.3 3.4 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.1 3.0 0.2 2.6 0.0 0.1 0.0 0.1 113.9 0.3 0.0 0.7 2.1 177.1 4.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860942-222944639 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 173.3" "Cell type enhanced" "Detected in all" "Horizontal cells: 523.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 410.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Nucleoli rim,Lipid droplets" NA NA 37000 "Nucleoli, Nucleoli rim" "Lipid droplets" "HPA011315: AB_1848344, HPA071021: AB_2686335" "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.75e-4)" "prognostic unfavorable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 25.4 20.0 25.6 17.7 24.2 27.9 91.7 23.4 29.7 18.6 10.8 27.3 22.4 12.7 25.1 36.4 11.1 16.8 13.1 23.1 26.9 24.5 31.2 20.8 12.4 23.8 28.3 22.1 10.9 16.9 173.3 10.1 28.2 24.5 66.7 25.7 32.5 45.7 16.3 25.5 15.0 16.1 14.6 24.6 10.6 51.1 23.5 31.4 20.0 24.0 15.3 14.4 33.8 20.8 29.0 49.7 77.0 118.3 121.9 42.1 121.3 35.0 61.0 159.5 70.5 139.8 75.0 126.4 24.0 33.8 51.9 147.2 143.9 20.4 121.3 76.0 44.0 50.1 55.8 52.2 68.0 91.0 36.2 26.6 60.0 180.7 120.0 163.6 34.7 65.6 39.8 109.6 83.1 78.1 104.8 70.4 42.5 59.9 102.9 42.4 40.0 85.4 39.7 80.8 198.2 57.3 49.3 36.0 79.5 410.5 67.5 49.8 64.8 58.0 43.9 76.2 41.5 41.0 30.0 17.2 81.3 40.7 26.0 140.0 10.7 14.0 20.0 18.0 16.0 17.5 10.5 11.2 13.6 15.2 11.1 16.0 14.9 15.6 16.6 17.2 20.8 9.5 17.5 25.6 24.2 23.4 29.7 23.1 26.9 23.8 28.3 22.1 24.5 24.6 31.4 29.0 73.1 35.3 70.8 110.4 29.6 46.5 101.8 97.5 55.2 101.9 89.9 62.9 57.2 28.6 93.8 36.8 77.2 43.7 45.0 46.6 7.9 32.7 59.2 68.9 39.6 41.4 20.9 35.8 91.0 31.1 10.7 56.6 81.1 100.7 27.3 25.3 32.2 52.7 37.4 523.3 124.2 36.0 99.7 49.0 62.7 27.1 26.1 75.3 48.0 69.3 32.1 184.7 20.6 149.3 120.1 37.3 41.3 35.7 24.6 109.4 17.5 14.6 80.3 55.6 46.0 52.8 68.2 49.7 45.3 108.6 48.7 60.6 32.4 52.0 50.7 117.1 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538948-219543809 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 163.7;Extravillous trophoblasts: 182.7;Syncytiotrophoblasts: 310.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" NA NA 570000 Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.96e-4)" 22.9 46.1 22.8 12.6 20.6 1.7 22.5 22.1 34.4 55.3 28.4 20.6 26.9 56.4 13.8 27.5 30.5 24.5 128.1 32.6 36.3 41.2 98.6 43.2 6.5 29.5 28.3 22.4 128.4 140.0 24.8 129.3 41.0 24.3 59.1 4.8 8.6 56.5 25.8 16.4 25.9 23.4 12.7 22.3 16.8 41.3 98.3 28.7 3.6 53.3 3.9 4.6 34.6 30.2 26.5 67.5 13.0 9.6 81.0 36.0 55.8 109.7 66.4 55.4 18.5 16.8 36.8 57.5 20.7 139.0 64.6 63.3 84.1 6.3 40.3 2.9 32.3 22.5 7.4 18.0 161.9 49.8 6.6 42.1 75.0 69.2 18.8 17.9 66.7 0.1 7.1 47.2 49.6 17.7 105.5 1.0 17.6 39.8 22.8 50.6 0.1 30.4 41.6 22.4 29.7 23.4 36.0 32.1 30.7 94.3 17.9 10.5 22.6 1.6 67.9 37.1 81.9 35.2 58.9 19.9 9.7 62.1 6.7 70.4 1.7 0.0 6.5 1.9 0.1 2.4 1.0 1.5 1.3 0.0 0.1 1.7 0.6 0.0 1.9 0.0 9.5 1.2 0.7 22.8 20.6 22.1 34.4 32.6 36.3 29.5 28.3 22.4 24.3 22.3 28.7 26.5 2.1 0.0 15.2 16.0 16.5 14.5 23.2 52.8 17.1 14.6 40.0 29.6 30.5 22.8 31.2 75.4 10.4 163.7 21.7 15.9 9.8 58.1 4.1 14.0 22.2 2.9 43.0 3.2 4.3 80.4 182.7 56.0 25.5 42.4 10.2 27.4 4.2 64.0 18.5 43.7 9.2 57.8 36.7 2.4 9.1 7.1 24.8 2.3 67.6 5.6 1.8 56.8 9.2 5.5 3.7 65.6 32.7 63.2 123.6 42.3 60.7 20.6 14.6 11.5 26.3 19.3 27.1 11.9 6.3 14.2 11.1 310.3 9.7 46.3 14.3 33.0 DNPEP "ASPEP, DAP" ENSG00000123992 "Aspartyl aminopeptidase" Q9ULA0 2 219372043-219400022 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 364.4;Late spermatids: 462.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036398, HPA044860" Enhanced Supported Cytosol NA NA 2700000 Cytosol "HPA036398: AB_10970915, HPA044860: AB_10961275" "unprognostic (3.71e-1)" "unprognostic (6.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.75e-1)" "unprognostic (2.54e-3)" "unprognostic (3.34e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-2)" "unprognostic (1.61e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-1)" "unprognostic (5.63e-3)" "unprognostic (3.49e-1)" "unprognostic (2.50e-1)" "unprognostic (1.85e-3)" 24.5 19.1 13.3 25.3 13.3 18.2 23.8 12.9 18.7 24.9 12.6 34.8 57.0 22.6 21.7 25.3 25.3 22.8 35.5 14.1 14.9 22.2 32.3 27.8 23.6 13.8 13.0 12.1 30.5 27.4 26.0 13.1 37.4 13.7 22.8 31.0 9.6 26.4 24.6 65.0 31.9 56.6 20.1 13.5 24.9 25.6 59.0 14.5 17.7 15.4 46.8 16.4 29.9 21.8 12.7 47.5 25.8 15.4 45.7 39.7 32.2 122.0 23.0 46.5 59.3 62.5 72.6 61.2 27.2 48.7 49.5 76.0 45.0 18.6 53.6 21.3 56.4 12.5 46.6 25.0 79.8 107.2 38.9 32.2 54.4 55.4 61.8 50.2 37.9 41.2 38.6 53.8 45.3 31.0 103.7 60.8 44.5 25.5 67.7 15.1 77.2 35.7 36.5 33.0 74.0 19.1 26.0 27.1 86.5 34.5 26.9 25.8 43.3 23.5 55.4 46.1 31.4 33.7 49.6 31.8 21.3 80.0 37.7 24.1 8.7 17.2 7.3 16.1 19.7 18.8 13.2 13.2 18.3 20.8 16.2 14.0 18.7 1.6 21.2 17.0 7.2 16.6 14.8 13.3 13.3 12.9 18.7 14.1 14.9 13.8 13.0 12.1 13.7 13.5 14.5 12.7 43.1 12.8 18.2 8.8 35.6 38.6 74.1 55.1 52.9 19.3 41.2 36.7 33.6 55.8 27.2 25.8 33.3 90.4 26.7 70.4 49.0 62.9 364.4 16.5 36.5 41.8 48.0 19.8 3.1 66.3 96.9 43.4 29.0 19.6 24.1 39.1 30.4 47.9 51.0 10.1 5.2 110.3 38.7 31.5 26.8 462.0 52.5 26.2 32.0 4.7 53.0 29.8 45.3 3.0 3.3 52.3 75.6 41.0 38.3 113.1 202.6 79.6 16.3 37.6 26.3 31.9 120.0 20.1 20.1 43.4 44.8 66.4 34.1 36.9 70.9 74.6 INHA ENSG00000123999 "Inhibin subunit alpha" P05111 2 219569162-219575711 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 76.2;ovary: 105.3;testis: 96.0" "Cell type enhanced" "Detected in some" "Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 1.1 76.2 3.7 0.2 3.8 0.1 1.4 2.9 4.7 1.9 2.5 0.7 0.2 2.0 2.2 0.8 3.0 0.4 10.0 3.8 3.5 2.3 0.7 0.8 0.1 3.9 3.1 3.8 105.3 12.4 0.8 6.7 11.4 3.8 3.1 0.0 1.9 1.6 1.2 0.8 2.1 0.4 0.4 2.6 0.4 0.7 96.0 3.2 0.0 3.3 0.0 0.0 1.1 1.8 3.3 0.4 0.2 0.0 1.9 0.6 0.1 3.5 0.3 0.2 0.5 0.2 0.3 3.2 0.0 0.2 0.7 0.5 2.0 0.2 0.5 0.0 0.0 0.6 4.5 1.8 2.4 0.3 0.0 0.0 0.6 0.8 0.0 0.5 1.4 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.1 1.2 0.1 0.9 0.1 0.2 0.0 0.5 0.2 0.3 0.8 1.1 9.9 0.3 4.9 0.5 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.8 2.9 4.7 3.8 3.5 3.9 3.1 3.8 3.8 2.6 3.2 3.3 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.8 0.0 2.7 0.3 0.3 2.2 0.0 0.1 7.3 2.1 11.8 0.0 0.0 0.0 2.8 0.8 0.5 0.5 0.2 0.0 0.0 5.9 8.9 35.5 1.2 0.0 0.5 0.0 254.3 0.7 0.1 2.6 6.7 6.9 0.0 0.0 0.3 0.0 5.0 4.1 0.2 0.0 0.0 0.0 3.7 0.0 1.0 0.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 3.4 0.6 0.0 0.0 331.0 0.0 75.6 0.0 0.0 MOGAT1 "DGAT2L, DGAT2L1, MGAT1" ENSG00000124003 "Monoacylglycerol O-acyltransferase 1" Q96PD6 2 222671658-222709930 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "gallbladder: 16.9" "Cell type enhanced" "Detected in some" "Astrocytes: 8.1;Breast glandular cells: 7.2;Cholangiocytes: 7.2;Endometrial ciliated cells: 3.9;Exocrine glandular cells: 5.1;Glandular and luminal cells: 4.9;Hepatocytes: 3.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049944, HPA076308" Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA049944: AB_2680964, HPA076308: " "unprognostic (6.32e-2)" "unprognostic (2.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.41e-1)" "unprognostic (4.28e-3)" "unprognostic (4.39e-2)" "unprognostic (4.32e-2)" "unprognostic (9.44e-2)" "unprognostic (1.91e-1)" "unprognostic (8.59e-2)" "unprognostic (3.07e-3)" "unprognostic (4.99e-2)" "unprognostic (3.89e-1)" "unprognostic (9.03e-3)" 0.9 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.6 0.1 0.0 16.9 0.4 0.1 0.0 0.8 3.1 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.5 8.1 0.0 0.0 0.0 0.0 0.0 0.4 7.2 0.3 0.7 7.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.9 3.9 0.6 0.1 0.0 0.0 2.5 5.1 0.0 0.1 0.0 4.9 0.0 0.2 0.0 3.2 0.9 0.0 1.9 0.0 0.0 0.3 0.3 0.1 0.0 1.3 0.0 0.0 0.6 1.5 0.0 1.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.9 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 OBSL1 KIAA0657 ENSG00000124006 "Obscurin like cytoskeletal adaptor 1" O75147 2 219550728-219571859 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 340.2" "Group enriched" "Detected in many" 8 "Early spermatids: 1140.1;Late spermatids: 1994.5;Spermatocytes: 572.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.4;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "BEWO: 155.2;SK-BR-3: 150.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036404, HPA036405" Approved Approved Centrosome NA NA Centrosome "HPA036404: AB_10670437, HPA036405: AB_2675104" "unprognostic (2.36e-1)" "unprognostic (6.79e-2)" "unprognostic (3.86e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.27e-3)" "unprognostic (2.89e-2)" "unprognostic (9.89e-2)" "unprognostic (4.22e-3)" "unprognostic (1.25e-1)" "unprognostic (4.21e-3)" "unprognostic (7.00e-2)" "unprognostic (3.95e-2)" "unprognostic (3.62e-2)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (2.16e-1)" 48.2 118.5 23.2 9.7 21.4 3.1 54.0 21.1 32.4 67.3 28.0 36.0 9.5 78.7 22.7 17.8 85.3 29.1 83.4 23.8 37.1 81.8 44.3 38.9 9.7 28.0 25.9 19.7 340.2 121.6 49.9 75.5 46.1 21.2 63.6 5.5 15.0 63.4 44.6 64.6 38.6 22.7 21.1 20.9 31.9 48.4 40.8 23.3 7.0 150.1 30.4 4.7 41.6 37.1 20.7 34.2 22.7 40.9 85.8 27.7 20.4 155.2 25.3 36.8 31.5 29.0 20.0 52.2 0.2 51.6 34.7 30.5 34.4 31.9 19.0 6.5 0.3 56.2 74.3 23.0 102.1 20.9 1.9 0.3 55.3 15.4 7.3 12.1 56.1 3.4 0.1 31.3 0.7 22.7 84.6 0.1 21.3 97.8 9.7 23.1 37.5 36.3 0.2 57.4 31.9 18.1 61.3 28.6 150.9 59.2 102.8 14.0 63.9 8.6 33.3 35.6 10.6 10.0 0.2 0.2 0.3 19.5 0.2 33.7 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 1.3 0.0 0.0 23.2 21.4 21.1 32.4 23.8 37.1 28.0 25.9 19.7 21.2 20.9 23.3 20.7 10.4 9.6 20.4 45.7 1.1 8.4 22.8 11.7 19.9 35.8 27.0 38.7 52.4 27.1 10.0 53.3 2.1 64.7 2.5 1.5 52.8 15.9 1140.1 19.5 33.0 11.4 20.4 0.0 21.1 12.5 69.7 30.1 6.6 21.7 4.5 152.8 11.4 15.4 7.7 42.1 43.3 3.7 6.1 1.0 3.9 1994.5 77.0 3.4 14.2 9.4 0.7 87.0 0.0 23.1 3.1 7.6 2.0 74.1 0.1 8.8 7.1 20.3 7.8 11.6 13.1 29.9 27.0 572.7 57.0 4.3 6.7 86.5 1.4 114.0 3.3 10.2 FAM124B FLJ22746 ENSG00000124019 "Family with sequence similarity 124 member B" Q9H5Z6 2 224378698-224402107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 8.6" "Group enriched" "Detected in some" 4 "Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5" "Cancer enriched" "Detected in many" 10 "testis cancer: 7.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 29.5;eosinophil: 17.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 103.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA070240 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA070240: AB_2686238" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (6.87e-3)" "unprognostic (2.49e-1)" "unprognostic (7.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.28e-2)" "unprognostic (5.78e-2)" "unprognostic (3.19e-1)" "unprognostic (1.85e-1)" "unprognostic (1.57e-1)" "unprognostic (3.36e-1)" "unprognostic (7.61e-3)" "unprognostic (1.36e-2)" "unprognostic (4.30e-1)" "unprognostic (2.25e-1)" "unprognostic (5.80e-3)" 4.2 0.5 1.6 1.1 1.2 4.8 4.4 1.3 1.7 1.5 1.0 0.9 1.0 1.6 0.3 1.4 1.2 1.2 1.5 1.2 1.5 0.4 1.9 2.3 0.7 1.5 1.8 0.9 0.4 0.4 2.5 0.2 8.6 1.3 0.5 1.1 0.2 0.9 0.5 1.2 1.8 1.0 2.4 1.4 0.6 0.6 0.3 1.5 1.1 1.0 4.6 0.7 1.5 1.4 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 103.4 0.0 4.8 0.2 0.0 0.1 0.0 0.1 6.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.7 7.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.5 3.0 17.2 0.2 2.3 0.0 0.0 0.7 0.0 7.9 0.0 0.0 0.0 0.1 5.4 0.8 0.0 2.5 1.1 1.6 1.2 1.3 1.7 1.2 1.5 1.5 1.8 0.9 1.3 1.4 1.5 2.2 13.8 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 1.2 0.3 0.2 10.8 0.0 9.4 0.2 0.0 0.1 0.4 0.0 0.8 4.5 0.0 2.2 0.4 0.4 0.0 0.2 0.0 0.0 0.9 0.6 0.0 0.0 0.7 0.0 1.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.0 0.0 SLC12A4 KCC1 ENSG00000124067 "Solute carrier family 12 member 4" Q9UP95 16 67943474-67969601 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041138 Approved Approved Endosomes NA NA Endosomes "HPA041138: AB_10794544" "unprognostic (5.07e-2)" "unprognostic (6.18e-2)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (9.28e-2)" "unprognostic (1.48e-2)" "unprognostic (4.28e-2)" "unprognostic (3.26e-3)" "unprognostic (9.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.01e-2)" "unprognostic (1.81e-2)" "prognostic favorable (2.25e-6)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (7.64e-2)" "unprognostic (2.26e-1)" 30.4 29.3 10.1 11.9 11.3 5.1 29.1 15.0 11.0 33.1 50.7 26.0 7.3 34.3 8.6 13.2 27.7 14.9 41.1 9.7 15.3 17.7 17.6 35.0 9.4 15.9 13.0 6.3 24.1 19.3 23.4 13.2 27.5 12.5 30.7 5.9 3.8 18.1 27.0 21.1 24.5 16.6 27.6 13.8 15.5 18.8 12.4 12.5 12.1 35.7 17.0 5.8 27.6 23.4 14.7 13.4 17.5 13.3 25.3 43.0 37.5 71.6 39.9 41.1 33.5 29.1 35.2 20.8 4.7 19.3 55.3 18.7 23.7 6.2 49.2 25.2 4.8 5.3 3.4 23.4 38.9 48.7 0.4 16.0 41.6 31.6 45.3 16.3 39.1 21.0 8.6 10.9 3.8 46.6 2.1 5.2 13.3 10.0 3.8 9.2 5.3 25.1 4.4 18.5 11.4 0.1 8.0 76.1 4.5 6.8 32.8 35.8 5.4 28.8 47.6 33.4 21.4 17.6 23.2 6.3 8.0 27.9 3.6 42.1 7.1 2.5 1.2 0.8 3.3 0.5 0.3 0.5 0.5 1.4 0.5 0.4 0.4 0.9 1.9 2.4 0.7 0.9 1.1 10.1 11.3 15.0 11.0 9.7 15.3 15.9 13.0 6.3 12.5 13.8 12.5 14.7 25.8 16.0 9.1 10.4 2.4 10.1 15.8 13.3 17.6 1.2 3.9 6.6 26.9 2.8 10.6 14.7 0.0 30.1 2.2 0.5 0.0 13.7 3.5 4.0 10.7 15.6 0.0 2.5 0.2 8.3 16.4 19.5 3.1 3.2 1.3 10.9 12.1 10.3 8.0 0.0 0.3 0.1 24.4 5.3 4.3 2.7 19.9 4.2 10.6 4.7 11.4 20.5 3.1 2.0 0.7 15.5 0.1 36.5 10.8 16.9 0.1 5.3 8.3 1.0 39.5 17.3 23.1 12.0 9.1 2.4 5.3 63.5 2.6 13.9 0.2 12.9 ENKD1 "C16orf48, DKFZP434A1319, FBB11" ENSG00000124074 "Enkurin domain containing 1" Q9H0I2 16 67662945-67667265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 67.7" "Cell type enhanced" "Detected in many" "Early spermatids: 34.2;Endometrial ciliated cells: 38.3;Respiratory ciliated cells: 42.5;Spermatocytes: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041163, HPA041478" Approved Approved "Plasma membrane,Centrosome,Cytosol" Yes No "Plasma membrane, Centrosome" Cytosol "HPA041163: AB_10794986, HPA041478: AB_10794668" "unprognostic (6.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-3)" "prognostic favorable (1.68e-4)" "unprognostic (4.41e-1)" "unprognostic (1.06e-1)" "unprognostic (3.78e-3)" "unprognostic (1.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (5.69e-2)" "unprognostic (6.58e-2)" "unprognostic (1.67e-1)" "unprognostic (2.44e-1)" "unprognostic (3.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" 12.9 12.9 8.8 4.6 7.5 3.6 15.0 20.7 11.6 21.1 11.7 22.4 3.9 21.3 5.7 8.7 30.9 3.6 12.6 7.3 11.1 24.7 11.7 14.9 2.3 8.8 9.0 6.6 21.4 67.7 16.1 25.8 3.4 12.1 20.8 2.7 8.6 13.8 9.2 9.6 11.8 11.2 4.4 9.6 12.0 16.1 41.5 8.8 4.7 22.5 1.6 2.5 21.7 14.4 7.8 11.1 7.5 17.2 8.0 5.6 5.8 8.5 8.5 5.1 6.7 8.1 5.5 16.5 4.1 14.3 5.3 0.0 12.7 4.5 10.2 8.2 6.5 10.2 4.1 25.7 13.1 9.1 7.4 5.4 5.1 7.3 9.1 8.2 15.4 5.5 13.3 6.9 2.5 3.5 5.7 8.2 30.9 8.2 11.5 3.0 28.5 1.8 31.3 7.2 1.1 17.4 18.9 18.2 1.8 9.7 3.9 15.8 10.5 14.3 8.1 11.4 15.2 0.1 19.1 9.2 4.5 12.3 10.8 2.5 0.0 0.4 0.0 0.1 0.1 0.4 0.2 0.3 0.2 0.1 0.0 0.2 0.3 0.9 0.2 0.2 1.3 0.0 0.1 8.8 7.5 20.7 11.6 7.3 11.1 8.8 9.0 6.6 12.1 9.6 8.8 7.8 8.8 22.4 14.4 8.8 1.7 6.9 5.9 6.2 4.0 3.6 10.4 11.2 5.5 10.0 4.0 9.2 4.2 3.1 1.5 4.4 1.9 13.1 34.2 38.3 10.5 8.6 13.2 2.1 2.1 10.7 2.4 7.5 1.5 9.5 1.3 7.4 10.4 26.4 4.7 3.3 2.2 6.0 2.0 3.2 4.3 20.6 13.1 2.6 5.4 0.0 3.0 8.8 0.0 2.5 1.7 9.5 1.4 14.3 2.6 6.0 1.8 7.3 42.5 10.5 6.6 9.1 8.0 37.0 7.9 1.2 5.3 3.4 1.9 11.6 4.9 4.4 MC3R MC3 ENSG00000124089 "Melanocortin 3 receptor" P41968 20 56248732-56249815 "G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 80 "brain: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 10.2;thalamus: 8.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 4.8;hypothalamus: 4.5;thalamus: 1.3" "Group enriched" "Detected in some" 5 "basal ganglia: 3.2;hypothalamus: 2.2;thalamus: 2.6" HPA074739 Uncertain NA NA "HPA074739: " 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.1 0.6 10.2 0.2 0.5 0.0 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "bone marrow: 4.4" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052617, HPA059403" Uncertain Approved "Nuclear bodies,Vesicles,Cytosol" NA NA "Nuclear bodies, Vesicles" Cytosol "HPA052617: AB_2681886, HPA059403: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.0 0.1 0.2 0.3 0.3 4.4 0.0 0.5 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.9 0.0 0.1 0.2 0.2 0.0 0.2 0.3 0.5 0.2 0.2 0.2 0.3 0.1 0.0 0.3 0.1 0.3 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 11.1" "Group enriched" "Detected in some" 15 "Spermatocytes: 61.3;Spermatogonia: 143.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Region enhanced" "Detected in some" "white matter: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "HMC-1: 79.6;K-562: 116.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.1 0.2 0.3 0.2 0.3 1.0 0.2 1.0 0.7 0.0 0.0 0.1 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.4 0.2 0.4 0.2 0.0 0.1 0.2 0.5 0.1 0.2 0.3 0.6 0.2 0.2 0.9 0.1 0.1 0.2 0.5 0.3 0.1 0.0 0.3 0.2 11.1 0.2 0.1 0.4 0.1 0.1 0.1 0.0 1.9 0.1 0.1 0.1 0.5 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.3 0.4 0.2 0.1 0.3 0.4 0.2 0.1 0.0 0.4 0.2 0.3 0.7 0.1 0.2 0.2 79.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 116.1 0.6 0.0 0.1 0.3 0.4 0.3 0.1 0.1 0.3 0.2 0.2 0.1 0.3 0.3 0.3 0.1 0.2 0.3 0.4 0.2 0.1 0.5 0.3 0.2 0.3 0.1 0.3 0.1 2.9 0.3 0.3 0.4 0.5 0.1 0.3 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.1 0.9 0.2 0.2 0.2 0.1 0.0 0.3 0.3 1.0 0.7 0.3 0.2 0.2 0.0 0.1 0.6 0.0 0.2 1.9 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 3.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.0 0.0 6.6 0.1 0.2 61.3 143.8 0.0 0.0 0.0 0.1 0.0 0.1 0.2 FAM210B "C20orf108, dJ1167H4.1, DKFZP434A1114" ENSG00000124098 "Family with sequence similarity 210 member B" Q96KR6 20 56358974-56368663 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 449.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 299.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042652 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA042652: AB_2678098" "unprognostic (3.29e-1)" "prognostic favorable (5.44e-4)" "unprognostic (3.24e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-1)" "unprognostic (3.34e-2)" "unprognostic (9.45e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" "prognostic favorable (1.44e-10)" "unprognostic (1.08e-1)" "unprognostic (3.27e-2)" "unprognostic (1.84e-1)" "unprognostic (3.00e-1)" 38.5 88.3 31.6 14.0 33.5 85.9 62.7 30.1 33.8 44.1 38.5 33.3 24.9 36.8 46.1 31.4 40.5 40.9 41.4 33.1 30.8 34.9 101.2 28.5 14.0 30.1 33.3 26.0 109.9 41.9 33.0 28.3 37.0 29.7 67.4 30.9 30.3 55.3 59.3 75.9 36.8 23.5 34.5 29.3 19.7 34.5 14.2 36.4 20.8 28.7 103.1 20.2 32.8 32.9 31.0 19.9 7.5 29.3 71.6 83.2 93.4 57.1 23.8 53.4 42.6 48.7 13.9 9.6 1.6 12.1 40.9 24.6 56.2 15.9 68.7 71.0 2.9 24.9 12.2 16.9 132.0 54.4 1.3 7.4 80.2 75.2 24.1 34.0 49.3 69.4 10.2 93.6 12.7 52.7 20.6 10.4 5.4 24.9 29.0 46.7 0.1 60.4 15.9 21.9 22.9 40.4 72.9 57.9 124.6 299.1 62.3 55.0 11.1 48.4 37.8 25.2 61.0 14.7 9.9 10.9 0.4 30.0 7.7 25.2 2.3 2.3 6.9 1.7 3.3 1.3 1.1 1.9 2.3 1.7 1.3 2.0 1.9 1.0 1.4 1.5 1.5 2.3 1.0 31.6 33.5 30.1 33.8 33.1 30.8 30.1 33.3 26.0 29.7 29.3 36.4 31.0 30.3 16.0 29.3 4.2 7.4 24.9 85.4 28.2 70.6 10.3 57.5 98.8 56.8 54.3 19.3 16.5 39.6 77.7 13.5 23.8 64.6 27.9 1.0 41.4 49.0 28.8 50.9 449.3 5.7 19.5 26.3 46.1 44.9 37.4 19.1 47.5 46.1 154.5 28.0 1.7 6.6 28.6 20.3 44.1 21.2 4.7 66.8 26.2 37.4 5.6 36.6 27.8 14.4 4.0 8.4 35.7 15.3 155.7 9.4 48.7 34.1 46.1 15.6 19.2 19.7 28.1 37.1 1.1 9.4 68.6 32.5 41.9 14.6 123.4 33.4 56.3 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174902-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 2288.8;lymphoid tissue: 2120.9;vagina: 1608.8" "Group enriched" "Detected in many" 10 "Basal respiratory cells: 5354.5;Club cells: 2170.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Group enriched" "Detected in many" 7 "cerebral cortex: 10.2;hypothalamus: 22.9;pons: 7.3;thalamus: 14.3" "Immune cell enriched" "Detected in some" 1021 "neutrophil: 1763.3" "Lineage enriched" "Detected in single" 4377 "granulocytes: 1763.3" "Group enriched" "Detected in many" 5 "EFO-21: 89.3;HaCaT: 109.8;OE19: 103.7;PC-3: 189.9" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 1400000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 6.1 0.7 0.2 102.8 0.3 1.8 8.8 0.2 10.2 88.1 1.0 106.0 1.9 2.3 1.1 2288.8 4.9 57.1 1.6 0.2 22.9 1.5 3.4 32.8 0.4 0.2 0.2 2.0 0.7 1.6 0.2 2.8 1.1 7.3 11.8 43.7 0.0 464.6 3.5 0.6 77.1 42.6 7.6 0.2 20.2 9.1 0.5 14.3 91.4 0.8 2.0 2120.9 45.2 1608.8 1.3 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.4 0.0 3.1 2.1 1.4 89.3 0.0 1.1 109.8 0.0 23.2 0.1 1.2 0.0 0.5 6.3 0.9 0.0 0.7 0.0 0.0 21.7 17.8 1.9 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.1 0.1 0.2 103.7 189.9 0.0 1.0 0.0 21.9 0.4 0.0 0.0 15.7 2.1 0.1 0.0 0.0 0.0 0.8 1.0 10.9 0.3 0.9 0.3 1.8 0.4 14.3 0.7 0.1 0.3 0.4 1.7 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1763.3 0.0 0.1 0.1 0.1 0.6 0.2 0.3 0.2 10.2 0.2 22.9 0.2 0.2 2.0 7.3 0.2 14.3 1.3 0.1 0.0 8.6 0.0 7.4 0.1 4.7 5354.5 0.0 0.0 39.4 8.4 0.2 8.6 2170.2 18.4 0.0 0.2 0.5 375.4 0.0 46.6 0.1 3.7 0.7 3.0 16.6 0.0 0.0 317.3 0.0 0.8 2.6 6.9 4.5 0.0 0.0 0.0 0.1 0.0 0.0 31.8 197.4 0.0 0.4 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 231.8 219.6 0.0 0.2 29.1 33.9 0.2 152.9 0.0 0.0 0.0 50.5 0.0 0.0 36.2 3.8 0.0 2.5 0.1 154.1 150.4 FAM209A "C20orf106, dJ1153D9.3" ENSG00000124103 "Family with sequence similarity 209 member A" Q5JX71 20 56517187-56526152 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 105.0" "Cell type enriched" "Detected in some" 8 "Early spermatids: 2173.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.5;Karpas-707: 1.0;U-266/84: 1.5" HPA079442 Uncertain "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA079442: " "unprognostic (1.03e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (8.58e-3)" "unprognostic (1.06e-2)" "unprognostic (2.12e-1)" "unprognostic (2.10e-1)" "unprognostic (9.83e-2)" "unprognostic (5.56e-3)" "unprognostic (7.68e-2)" "unprognostic (1.86e-9)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-2)" 0.6 0.2 0.1 0.9 0.2 16.8 0.5 0.2 0.4 0.4 0.1 0.4 0.3 0.3 0.4 0.3 0.5 0.5 0.2 0.2 0.2 0.3 0.6 0.8 1.6 0.1 0.1 0.1 0.2 1.0 0.0 0.7 0.0 0.2 0.6 0.4 0.1 0.5 0.3 0.2 1.2 1.1 0.2 0.1 2.3 0.5 105.0 0.1 0.2 0.3 0.0 1.3 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.3 0.0 0.4 2.5 0.0 0.7 0.0 0.1 0.1 0.1 0.5 0.0 1.0 0.0 0.4 0.1 0.7 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.2 0.1 0.5 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.0 2.3 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.2 0.3 0.7 0.0 0.7 0.0 0.0 0.1 2.0 0.4 0.0 0.0 2173.4 0.2 0.2 1.1 1.2 0.4 0.0 0.0 0.2 0.2 0.0 0.5 1.3 0.1 1.1 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 266.1 8.7 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 6.4 0.0 0.1 0.2 0.0 0.8 0.0 0.0 0.3 0.2 10.4 5.9 0.1 0.0 0.3 0.5 0.1 0.1 0.2 SNX21 "C20orf161, dJ337O18.4, SNX-L" ENSG00000124104 "Sorting nexin family member 21" Q969T3 20 45833799-45843276 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Theca cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.8;classical monocyte: 1.6;eosinophil: 4.8;intermediate monocyte: 2.6;non-classical monocyte: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 4.8;monocytes: 2.6" "Cell line enhanced" "Detected in many" "EFO-21: 17.9;PC-3: 29.8;U-87 MG: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046359 Approved Approved "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA046359: AB_10963216" "unprognostic (1.97e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (4.96e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-2)" "unprognostic (2.18e-1)" 22.1 28.0 4.3 1.1 3.7 0.7 18.8 5.2 7.6 25.9 3.8 13.4 3.7 28.9 0.8 14.2 24.8 5.0 12.6 2.8 1.8 11.0 6.2 11.0 1.3 8.6 4.8 2.1 30.8 4.3 3.3 11.0 2.9 6.3 14.5 1.2 0.7 9.8 4.9 32.1 47.2 7.6 1.9 2.1 7.4 11.4 6.1 5.6 0.5 9.1 6.7 0.6 26.0 19.6 4.2 4.3 6.7 1.0 6.5 7.8 7.5 4.3 6.8 5.0 5.0 4.0 5.0 3.0 0.1 17.9 4.8 4.1 5.5 0.2 4.5 0.8 0.3 1.4 0.1 4.1 4.6 3.3 0.0 1.3 3.9 2.7 4.8 0.4 1.7 3.6 1.1 0.1 0.0 0.9 11.1 0.1 0.8 1.8 0.8 29.8 0.1 0.5 0.2 1.0 0.7 1.2 11.6 14.6 10.3 8.1 0.8 5.9 1.2 6.4 6.0 7.2 17.2 5.5 0.2 0.9 0.2 18.1 0.0 4.4 2.8 1.6 4.8 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.4 0.3 4.3 3.7 5.2 7.6 2.8 1.8 8.6 4.8 2.1 6.3 2.1 5.6 4.2 11.1 9.6 8.3 25.1 1.0 10.1 4.7 6.4 8.6 18.4 8.6 8.5 4.8 7.2 10.3 5.5 8.4 4.9 0.4 10.3 25.4 10.3 3.7 5.0 27.0 10.3 9.0 0.0 4.8 11.7 5.2 37.0 6.6 7.5 0.0 27.0 10.4 4.3 4.8 15.2 5.7 9.2 4.1 7.1 10.0 18.3 19.6 5.4 10.6 3.7 3.3 14.8 1.0 8.5 6.5 8.4 5.9 17.0 0.8 3.7 15.9 15.7 6.6 15.6 6.6 16.4 20.1 0.9 2.4 4.1 22.7 2.5 2.2 62.2 7.0 3.4 SLPI "ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4" ENSG00000124107 "Secretory leukocyte peptidase inhibitor" P03973 20 45252239-45254564 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 28152.9;salivary gland: 14255.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 79 "neutrophil: 321.8" "Lineage enriched" "Detected in many" 79 "granulocytes: 321.8" "Cell line enhanced" "Detected in many" "EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002303, HPA027774" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 26400000 9600000 "Golgi apparatus" "CAB002303: AB_564008, HPA027774: AB_10602405" "unprognostic (2.31e-2)" "unprognostic (3.07e-1)" "unprognostic (3.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.16e-2)" "unprognostic (9.98e-2)" "unprognostic (2.90e-1)" "unprognostic (3.23e-1)" "unprognostic (1.83e-3)" "unprognostic (4.01e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (6.91e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-1)" "unprognostic (8.81e-2)" "unprognostic (8.31e-2)" 128.9 13.9 4.5 71.4 3.9 356.8 309.8 4.8 22.7 28152.9 27.1 98.7 4.6 108.1 16.7 1383.7 720.4 297.4 38.4 4.3 17.2 247.5 270.2 1192.2 2.0 5.7 5.4 9.2 11.6 36.4 5.5 473.9 8.4 5.3 113.5 107.7 0.7 14255.5 2972.6 604.7 270.7 20.1 14.1 4.5 22.6 156.1 28.3 8.5 48.1 30.7 52.0 217.6 228.5 691.0 5.0 4.9 19.4 0.0 0.3 0.2 0.0 1.1 0.1 0.0 0.1 0.0 1.5 318.7 0.9 1719.5 0.2 23.9 132.8 0.0 64.1 0.0 8.6 0.3 0.3 227.1 0.2 326.4 0.5 1.0 8.8 2037.1 0.1 134.0 0.0 0.2 0.0 0.2 0.3 0.0 0.4 0.4 24.4 0.4 767.9 120.1 0.6 0.7 0.1 355.5 14.6 0.3 0.0 622.1 131.4 1.8 0.4 2.8 531.8 0.3 0.4 8.5 1.2 1.1 1.2 9.7 6.1 0.0 33.0 0.5 3.6 0.9 0.4 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 321.8 0.0 4.0 0.0 0.0 7.9 4.5 3.9 4.8 22.7 4.3 17.2 5.7 5.4 9.2 5.3 4.5 8.5 5.0 6.3 1807.7 4134.5 0.3 5.4 100.7 1330.7 18759.4 2.2 0.0 594.2 607.6 3.9 1609.9 20435.8 3428.2 0.0 2.3 10.1 225.8 0.0 407.5 381.6 632.0 170.7 43.3 200.2 18.7 0.0 258.9 1.2 326.0 193.7 1398.8 77.0 0.0 15.7 508.5 6.8 0.0 0.0 74.7 2616.3 8.5 73.3 69.8 25.4 27.1 39.2 0.0 5.3 0.0 0.0 1.0 0.1 901.6 370.3 0.0 1.3 1289.4 2.7 3.4 8096.4 0.0 0.0 8.6 971.2 1.8 1.8 347.3 138.9 2.1 29.5 0.0 224.5 3338.5 WFDC3 "dJ447F3.3, WAP14" ENSG00000124116 "WAP four-disulfide core domain 3" Q8IUB2 20 45747944-45791932 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "skin 1: 16.5;testis: 20.2" "Group enriched" "Detected in many" 5 "Early spermatids: 115.9;Late spermatids: 222.8;Spermatocytes: 108.1" "Cancer enhanced" "Detected in many" "lung cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (2.64e-1)" "unprognostic (2.39e-2)" "unprognostic (1.06e-1)" "unprognostic (5.75e-2)" "unprognostic (9.30e-4)" "unprognostic (6.63e-3)" "unprognostic (4.02e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-3)" "unprognostic (1.79e-1)" "unprognostic (1.36e-8)" "unprognostic (8.53e-2)" "unprognostic (2.45e-1)" "unprognostic (5.27e-3)" "unprognostic (3.03e-2)" 0.2 0.0 0.8 0.1 0.5 0.0 1.3 0.6 0.5 0.0 0.4 0.1 0.3 0.1 0.8 0.0 0.6 0.0 0.0 0.4 0.4 0.1 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.0 0.2 0.0 16.5 0.0 0.9 0.7 0.0 0.0 20.2 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.6 0.5 0.4 0.4 0.5 0.6 0.3 0.5 0.7 0.5 0.5 0.5 0.0 2.6 0.7 0.1 1.1 5.9 2.7 0.0 1.2 2.4 1.8 0.8 0.0 12.3 3.7 6.2 0.4 0.0 5.7 11.7 2.5 115.9 17.6 0.7 0.2 3.6 0.0 0.6 10.0 1.8 2.1 3.1 3.4 1.3 1.7 2.9 0.9 1.1 0.0 0.6 12.1 24.4 0.6 0.8 222.8 1.5 1.3 0.0 0.0 0.3 2.2 0.0 1.0 0.8 13.1 2.0 2.6 0.0 6.2 5.8 5.9 9.0 28.7 0.0 0.5 1.5 108.1 2.6 1.5 3.1 0.0 0.4 0.4 1.1 14.3 TTPAL "C20orf121, dJ179M20.3" ENSG00000124120 "Alpha tocopherol transfer protein like" Q9BTX7 20 44475874-44494603 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 28.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 91.0;HSkMC: 78.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046957, HPA066532" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA046957: AB_10959741, HPA066532: AB_2685686" "unprognostic (8.71e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (2.32e-1)" "unprognostic (5.06e-2)" "unprognostic (4.50e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.09e-5)" "unprognostic (2.09e-2)" "unprognostic (2.88e-1)" "unprognostic (2.24e-2)" "unprognostic (7.93e-2)" 8.2 4.4 5.0 5.8 5.3 9.1 5.3 4.4 5.2 6.1 5.8 3.6 3.6 5.1 4.7 5.6 5.0 4.1 2.7 5.7 5.7 3.6 28.9 3.3 8.5 4.8 5.9 4.8 4.2 6.5 7.3 7.0 2.8 6.5 4.7 4.0 2.9 5.1 4.3 2.7 12.6 4.0 5.5 2.6 4.7 4.1 3.0 5.3 6.2 7.6 1.7 8.0 5.1 5.3 5.7 21.1 10.8 8.2 14.6 91.0 35.3 8.2 22.4 31.1 21.3 18.1 40.1 12.5 13.1 18.8 20.9 38.8 20.4 10.5 35.2 22.9 13.6 4.8 6.2 11.6 11.8 25.2 9.3 14.1 78.5 22.6 20.9 35.0 10.1 7.3 11.0 8.0 13.4 17.2 24.2 9.1 5.9 9.8 11.4 18.0 2.8 8.8 7.1 8.3 15.0 18.2 8.6 31.1 13.5 14.0 10.1 14.8 6.0 7.5 47.2 18.8 14.2 19.5 19.8 14.5 14.0 22.8 6.6 14.1 0.6 1.1 1.8 4.0 2.2 4.4 3.6 3.6 4.2 1.1 3.8 3.0 4.7 2.6 5.7 2.3 2.0 3.8 2.3 5.0 5.3 4.4 5.2 5.7 5.7 4.8 5.9 4.8 6.5 2.6 5.3 5.7 3.9 9.6 11.4 6.2 15.7 6.4 17.2 9.5 1.8 24.4 8.0 5.8 5.3 18.6 10.3 22.0 25.0 7.4 19.8 8.7 1.9 10.2 4.9 8.4 30.5 7.5 9.5 38.9 8.3 9.4 8.6 13.8 2.6 9.3 9.5 8.3 8.2 60.7 4.9 18.5 9.1 5.3 2.0 17.6 6.5 10.3 18.6 6.9 3.6 2.8 8.4 11.5 30.9 8.5 7.1 13.3 9.3 11.3 8.6 14.3 11.0 4.7 8.4 20.3 6.6 16.3 10.1 9.6 11.4 6.1 20.0 10.9 17.9 12.3 9.5 10.9 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827999 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.0;brain: 75.0" "Cell type enhanced" "Detected in many" "Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favorable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 14.9 10.7 26.6 37.8 49.4 53.0 15.1 39.7 38.5 12.4 3.0 7.1 6.4 4.0 1.4 6.5 4.7 13.1 6.7 25.4 36.4 4.8 5.3 27.0 36.9 47.1 47.8 14.8 2.5 5.3 6.9 7.6 11.8 50.3 4.9 6.1 3.9 5.3 3.5 6.6 3.5 12.8 7.8 40.9 43.3 8.9 6.1 41.2 9.9 9.4 8.7 22.0 12.4 3.2 75.0 2.3 6.1 78.4 0.0 1.3 5.7 27.2 2.7 3.5 11.2 2.8 0.4 0.3 16.4 49.5 7.2 21.4 1.0 4.1 0.2 7.5 3.7 2.0 2.4 8.8 0.0 4.6 9.0 51.1 6.3 0.0 25.7 0.0 7.6 68.4 7.2 0.2 0.6 14.8 157.9 0.2 24.7 3.1 8.1 6.4 24.1 22.8 9.8 0.5 0.0 16.5 2.4 14.7 162.2 17.8 4.4 145.0 67.4 77.2 4.5 15.6 0.2 4.6 0.9 3.5 20.1 72.4 17.8 24.3 4.5 1.9 2.2 3.7 2.2 2.2 1.5 2.0 3.2 1.6 1.4 0.3 1.1 9.2 1.8 2.0 1.3 7.3 2.0 26.6 49.4 39.7 38.5 25.4 36.4 47.1 47.8 14.8 50.3 40.9 41.2 75.0 43.2 3.2 6.6 87.1 35.4 2.5 0.3 0.4 1.2 0.3 40.0 21.5 3.7 2.8 2.6 1.8 8.4 0.7 84.0 0.9 0.0 0.2 3.5 3.5 4.7 24.5 1.2 14.1 13.3 1.2 4.4 10.3 4.1 6.2 1.3 0.7 20.7 1.9 32.1 0.0 4.6 1.8 0.0 104.7 28.2 2.9 0.9 76.5 8.8 95.5 47.1 19.4 90.6 49.3 190.2 0.1 1.0 0.4 23.3 0.7 0.3 0.2 4.5 0.7 0.0 18.1 3.3 2.2 11.6 0.4 2.4 9.3 63.9 41.2 4.5 0.7 KCNS1 Kv9.1 ENSG00000124134 "Potassium voltage-gated channel modifier subfamily S member 1" Q96KK3 20 45091214-45101127 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 23.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.0;Cholangiocytes: 7.2;Collecting duct cells: 1.8;Excitatory neurons: 6.2" "Cancer enriched" "Detected in many" 5 "cervical cancer: 6.1" "Region enhanced" "Detected in many" "cerebral cortex: 23.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.3;HHSteC: 2.1;hTEC/SVTERT24-B: 1.0;THP-1: 1.8;U-87 MG: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (2.46e-2)" "unprognostic (2.95e-3)" "unprognostic (2.03e-1)" "unprognostic (3.11e-4)" "unprognostic (8.91e-3)" "unprognostic (6.01e-3)" "unprognostic (7.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (6.74e-2)" "unprognostic (4.65e-2)" "unprognostic (6.35e-2)" "unprognostic (5.62e-2)" "unprognostic (3.06e-2)" "unprognostic (1.15e-1)" "unprognostic (1.39e-1)" 0.0 0.4 2.7 0.1 5.0 0.1 0.2 0.0 23.9 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.1 5.2 1.8 0.1 0.0 0.2 0.0 1.1 1.2 3.1 0.0 0.0 0.0 0.2 0.0 3.8 0.3 0.0 0.1 1.5 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.1 0.3 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.4 0.4 0.1 0.1 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.8 0.0 0.9 0.2 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.7 5.0 0.0 23.9 5.2 1.8 1.1 1.2 3.1 3.8 0.0 0.1 10.0 0.0 0.0 2.0 0.3 0.0 0.4 0.1 0.1 0.0 0.0 0.3 0.1 1.1 7.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060150 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 155.3;retina: 118.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 244.0;Cone photoreceptor cells: 383.7;Excitatory neurons: 92.7;Inhibitory neurons: 91.3;Rod photoreceptor cells: 170.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 24.9;NB-4: 50.8;SK-BR-3: 24.8;U-2 OS: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced NA NA "HPA072058: AB_2686485" "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.5 26.9 94.1 0.9 111.1 0.4 1.0 108.3 155.3 0.9 26.5 1.3 1.0 0.7 0.9 0.4 0.5 0.7 2.8 110.1 95.4 1.1 1.3 2.5 2.2 85.5 93.9 111.9 2.3 2.3 1.8 41.8 2.1 88.2 1.1 0.9 118.5 0.7 0.5 0.4 0.5 1.6 0.4 67.7 3.0 1.9 7.9 90.7 2.9 0.7 0.2 1.4 0.6 0.7 98.6 0.0 15.2 6.6 4.9 0.6 0.0 1.5 0.6 0.0 0.0 0.5 2.0 0.0 5.8 22.5 0.4 5.9 1.4 4.3 2.3 0.4 3.7 5.7 4.9 3.0 24.9 2.5 0.0 6.5 0.8 0.0 0.0 0.3 10.0 1.4 5.4 9.3 0.0 0.0 23.1 3.5 50.8 2.4 2.1 7.7 5.8 4.2 1.3 2.3 0.0 8.1 11.5 2.9 24.8 7.9 6.0 9.0 14.4 2.3 2.7 28.0 0.2 1.1 0.0 4.2 8.2 5.9 5.9 0.2 0.0 0.6 0.0 1.1 0.4 0.5 0.4 0.1 0.1 0.1 0.5 2.4 1.3 0.0 0.4 0.1 0.0 1.9 0.3 94.1 111.1 108.3 155.3 110.1 95.4 85.5 93.9 111.9 88.2 67.7 90.7 98.6 2.2 0.0 0.0 10.4 0.4 0.5 0.0 0.0 0.0 244.0 0.8 2.2 1.2 0.0 0.0 0.0 383.7 1.6 0.9 0.0 1.9 0.1 1.9 0.4 0.1 2.9 19.9 4.4 92.7 0.2 2.5 0.4 1.5 0.6 0.0 14.4 4.6 1.3 19.8 13.5 91.3 0.7 0.0 2.6 5.3 6.1 0.0 3.4 5.4 10.3 0.6 28.2 0.0 3.5 6.3 0.4 0.0 0.0 0.8 0.2 0.0 0.3 0.0 170.9 0.0 0.0 2.2 4.2 7.7 0.1 0.6 1.6 1.0 8.5 0.3 0.1 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "breast: 32.7;epididymis: 36.0;esophagus: 28.9;skin 1: 45.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 14.7;Breast myoepithelial cells: 8.6;Club cells: 4.3;Collecting duct cells: 3.7;Early spermatids: 7.2;Late spermatids: 4.3;Respiratory ciliated cells: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.3;HBEC3-KT: 13.6;RPTEC TERT1: 11.7;SK-BR-3: 12.7;T-47d: 15.4" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" No NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.1 0.0 0.4 0.0 1.1 0.0 32.7 0.6 0.5 2.0 0.2 0.0 1.7 0.7 36.0 28.9 0.1 0.1 0.0 0.2 0.5 5.6 0.1 0.8 0.0 0.3 1.0 0.2 0.0 0.3 0.0 0.0 0.0 0.8 4.7 0.0 0.0 3.6 8.0 0.4 45.6 0.0 0.0 0.2 0.0 4.6 2.7 0.4 0.0 0.9 0.0 3.7 3.2 7.5 0.2 4.5 0.0 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.1 0.2 0.9 0.0 3.6 0.0 0.0 0.0 0.0 13.6 0.2 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 12.7 0.0 1.6 15.4 0.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.6 0.5 0.2 0.5 0.3 1.0 0.2 0.8 0.2 0.4 0.2 0.1 0.0 1.5 0.7 0.0 0.3 0.0 1.8 0.0 0.0 14.7 8.6 0.1 0.0 4.3 3.7 0.0 0.0 0.2 0.0 0.0 0.0 7.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.4 3.4 0.0 0.0 0.0 0.3 0.7 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 414.4" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 512.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 320000 "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 52.7 73.8 98.9 26.5 112.2 10.2 114.2 105.0 110.7 53.4 76.5 90.3 38.1 53.4 11.9 125.3 77.2 72.9 66.4 78.5 96.7 160.5 414.4 169.8 9.9 125.5 123.3 68.3 26.5 91.1 35.0 43.6 27.6 120.9 53.4 63.2 35.4 104.6 46.3 102.3 176.3 42.7 54.3 93.3 32.6 141.4 47.6 137.9 8.3 51.5 35.7 35.4 126.0 69.3 84.7 162.1 20.7 11.1 0.8 269.2 164.3 474.4 201.5 273.0 222.9 158.6 242.7 400.0 0.2 88.1 255.4 224.5 203.1 8.2 512.2 269.0 46.7 7.4 4.9 15.8 95.8 292.4 1.0 8.2 223.1 336.5 92.4 223.2 123.3 29.9 3.7 8.2 0.5 130.5 159.9 0.2 14.2 20.4 139.9 63.1 0.3 99.7 0.6 367.7 211.7 4.3 15.6 277.2 169.4 51.4 125.2 123.1 9.7 56.4 169.4 141.4 17.3 131.8 8.5 6.7 0.7 266.2 16.4 103.2 1.5 1.6 0.4 0.7 0.6 2.1 0.3 2.0 0.8 1.5 0.3 0.4 0.5 0.8 0.7 0.6 1.4 4.4 0.7 98.9 112.2 105.0 110.7 78.5 96.7 125.5 123.3 68.3 120.9 93.3 137.9 84.7 21.9 291.7 391.2 106.7 3.8 373.7 322.2 352.8 75.1 14.5 208.8 90.6 59.3 245.9 218.4 189.4 12.5 38.9 7.8 174.3 64.6 296.0 1.2 116.6 20.8 16.0 55.1 7.4 0.2 515.9 230.0 43.0 170.7 179.0 13.9 10.8 11.4 260.6 18.8 0.0 0.3 131.9 160.7 19.3 106.0 3.8 4.1 39.5 76.5 5.6 33.0 10.0 0.0 3.5 1.8 476.4 121.7 5.3 2.1 284.2 59.0 153.8 178.6 23.6 0.0 34.9 33.5 1.8 2.5 170.9 472.8 67.5 16.8 3.2 90.7 423.9 NCOA3 "ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1" ENSG00000124151 "Nuclear receptor coactivator 3" Q9Y6Q9 20 47501887-47656877 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 155.8;Plasma cells: 168.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 187.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009800, HPA024210" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009800: AB_2251314, HPA024210: AB_10602011" "unprognostic (7.26e-3)" "unprognostic (1.00e-1)" "unprognostic (2.69e-1)" "unprognostic (3.23e-2)" "unprognostic (5.78e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (2.83e-2)" "unprognostic (1.47e-1)" "unprognostic (5.22e-3)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.95e-1)" "unprognostic (2.04e-2)" "unprognostic (4.18e-1)" "unprognostic (1.63e-1)" 14.9 8.3 4.5 23.1 4.5 13.5 11.6 5.7 7.9 11.1 6.0 10.0 8.9 11.9 7.1 14.4 10.8 10.4 11.5 4.3 5.4 9.5 10.6 15.0 35.2 6.2 5.4 3.2 14.2 11.2 11.3 6.1 28.4 6.9 9.7 11.3 11.7 11.4 8.9 25.4 14.2 14.9 11.6 5.3 27.7 14.9 7.6 5.7 18.0 13.0 16.7 39.5 15.5 12.6 6.0 17.6 50.1 16.1 21.5 37.5 41.9 105.2 16.4 24.2 27.3 14.1 25.2 19.0 61.8 11.0 28.5 36.1 43.2 12.2 20.7 20.9 31.3 6.4 8.1 15.3 39.3 22.6 6.8 43.3 19.9 61.2 24.4 30.3 23.5 20.0 10.0 18.7 14.0 16.2 187.0 9.9 12.8 5.8 14.2 20.6 17.8 11.0 27.4 16.8 38.2 3.1 5.7 41.0 53.7 18.8 18.0 24.3 17.8 35.8 16.4 12.9 20.5 7.4 38.5 35.9 60.6 19.4 7.0 10.8 2.8 3.9 3.0 2.5 5.2 2.2 9.3 2.3 2.2 5.0 6.8 2.6 2.9 4.5 2.1 5.0 4.2 3.1 2.6 4.5 4.5 5.7 7.9 4.3 5.4 6.2 5.4 3.2 6.9 5.3 5.7 6.0 86.7 12.8 23.7 27.7 155.8 34.5 15.7 25.0 52.9 18.1 23.8 13.8 26.1 20.0 29.0 14.7 8.4 69.5 39.9 12.5 5.9 12.9 12.1 36.4 29.1 49.8 14.9 14.9 48.5 19.6 26.2 26.4 26.5 78.8 8.8 15.3 68.2 20.0 22.8 13.5 64.3 10.7 36.7 46.8 62.2 6.0 24.8 58.2 33.8 109.6 46.1 9.3 28.8 49.3 54.1 21.0 16.9 27.4 168.8 28.1 9.0 6.5 39.8 23.8 19.7 19.7 30.3 43.2 30.0 63.3 51.7 89.2 47.6 14.2 11.7 59.2 PIGT ENSG00000124155 "Phosphatidylinositol glycan anchor biosynthesis class T" Q969N2 20 45416084-45456934 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (6.06e-2)" "unprognostic (4.60e-3)" "unprognostic (7.63e-2)" "unprognostic (6.00e-2)" "unprognostic (6.18e-3)" "unprognostic (6.68e-2)" "unprognostic (7.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (3.32e-1)" "prognostic favorable (2.51e-4)" "unprognostic (5.48e-2)" "unprognostic (7.60e-2)" "unprognostic (9.21e-2)" "unprognostic (5.66e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-2)" 53.6 52.3 33.1 39.7 39.8 71.4 53.1 42.0 37.8 66.1 44.3 76.6 50.4 70.2 90.3 38.1 61.7 48.7 114.5 32.2 44.1 47.4 49.3 45.7 26.8 43.3 40.7 29.3 46.5 65.5 106.2 49.3 48.9 42.1 39.8 77.9 13.1 48.6 56.1 61.7 44.6 54.8 70.3 41.8 36.8 62.6 38.5 40.7 26.1 57.5 52.2 27.6 57.5 43.2 51.1 79.0 95.3 35.8 138.7 218.0 152.9 68.5 90.4 172.8 126.8 99.7 179.9 123.6 47.1 122.0 142.9 108.4 152.4 43.6 124.8 67.8 25.2 53.5 49.0 80.8 100.9 99.9 93.5 203.1 117.3 117.0 99.9 108.6 179.4 109.3 39.2 65.0 163.8 107.4 165.3 44.8 74.7 29.4 227.5 162.1 38.0 107.6 168.0 102.5 51.1 60.2 77.0 177.7 173.2 88.7 61.4 150.6 169.8 96.5 301.4 138.1 57.1 128.8 93.9 144.0 30.0 190.7 74.7 140.9 58.9 77.9 66.3 57.4 83.2 43.6 27.2 41.0 53.8 92.2 28.1 35.7 41.8 30.7 57.6 79.2 71.4 61.6 83.1 33.1 39.8 42.0 37.8 32.2 44.1 43.3 40.7 29.3 42.1 41.8 40.7 51.1 41.9 41.7 29.5 9.1 43.9 30.0 46.4 86.8 13.6 21.0 43.7 31.4 169.2 41.5 63.7 44.1 14.6 62.1 58.9 106.1 13.7 107.5 31.8 45.2 32.3 46.0 65.5 24.2 7.6 114.5 73.9 94.2 44.9 59.2 33.6 58.5 39.7 41.5 76.8 38.7 9.8 145.3 85.5 49.6 42.6 81.4 60.6 44.3 88.9 4.7 39.8 25.8 37.0 6.0 27.1 79.5 61.8 56.1 69.2 40.7 103.8 26.1 46.2 15.6 65.7 39.4 47.2 88.4 96.9 23.5 27.8 52.1 43.4 47.9 111.6 57.7 SEMG2 SGII ENSG00000124157 "Semenogelin 2" Q02383 20 45221373-45224458 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 149 "seminal vesicle: 10504.6" "Group enriched" "Detected in some" 9 "Basal prostatic cells: 1.2;Collecting duct cells: 3.7;Early spermatids: 1.2;Late spermatids: 1.8;Prostatic glandular cells: 1.9" "Cancer enriched" "Detected in single" 25 "prostate cancer: 9.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042767, HPA042835" Enhanced "Secreted in male reproductive system" NA NA 5000000 "HPA042767: AB_10959312, HPA042835: AB_10964060" "unprognostic (1.39e-1)" "unprognostic (2.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 0.0 0.0 10504.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MATN4 ENSG00000124159 "Matrilin 4" O95460 20 45293445-45308529 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pancreas: 25.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.4;Fibroblasts: 8.5;Langerhans cells: 6.3;Spermatogonia: 4.9;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;NB-4: 2.5;U-937: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 14000 "unprognostic (1.54e-1)" "unprognostic (2.39e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-2)" "unprognostic (8.38e-2)" "unprognostic (9.67e-2)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (6.27e-2)" "unprognostic (6.74e-3)" "unprognostic (5.53e-1)" "unprognostic (6.19e-3)" "unprognostic (3.63e-6)" "unprognostic (2.38e-1)" "unprognostic (4.69e-2)" "unprognostic (4.27e-1)" "unprognostic (5.38e-2)" 0.7 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.2 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 2.5 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 6.4 0.7 1.0 0.0 0.0 1.6 1.9 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.1 0.7 0.2 0.4 0.0 0.0 1.0 2.5 0.0 8.5 1.1 0.8 0.0 0.3 0.4 0.2 0.1 0.0 0.4 0.1 0.0 0.0 6.3 0.5 0.0 0.1 1.8 1.0 0.0 0.0 0.0 3.0 0.4 0.9 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.4 0.4 1.6 4.9 0.3 4.3 0.3 0.3 0.1 0.2 1.0 NCOA5 "bA465L10.6, CIA" ENSG00000124160 "Nuclear receptor coactivator 5" Q9HCD5 20 46060991-46089962 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050231 Uncertain Supported "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA050231: AB_2681058" "unprognostic (1.78e-1)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (7.93e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.41e-5)" "prognostic favorable (8.07e-4)" "unprognostic (2.32e-1)" "unprognostic (7.75e-2)" "prognostic favorable (1.09e-4)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.07e-1)" "unprognostic (8.78e-2)" "unprognostic (1.91e-2)" 19.2 17.1 15.5 18.7 16.2 9.6 19.8 21.1 17.5 23.4 16.1 21.5 14.4 25.0 19.5 18.8 22.0 12.3 14.8 15.6 16.3 15.1 15.5 15.4 25.3 16.0 15.2 14.8 28.8 20.7 20.5 22.0 18.9 17.0 21.6 16.4 23.3 20.6 14.7 19.8 21.3 21.8 17.8 15.5 26.0 19.3 26.0 15.6 26.5 20.9 14.7 25.2 21.0 19.8 17.1 39.5 34.2 47.4 49.0 22.2 23.3 37.8 26.7 24.0 42.5 34.7 47.8 30.6 64.3 44.0 26.0 36.1 51.2 39.6 33.5 36.5 39.1 19.9 38.7 33.4 40.7 23.5 53.4 36.1 16.8 43.8 22.5 20.4 22.2 30.6 33.1 36.3 50.9 33.9 50.9 74.2 41.3 43.2 33.3 41.8 55.6 31.4 28.0 25.1 44.3 42.5 38.5 42.8 51.7 37.3 26.9 41.1 62.3 28.7 44.6 33.8 27.1 42.2 32.9 50.5 43.2 31.1 31.1 29.1 3.9 9.5 13.4 13.4 10.3 15.4 13.1 14.3 13.6 9.8 17.7 13.3 12.4 7.0 8.8 10.7 21.6 10.0 7.1 15.5 16.2 21.1 17.5 15.6 16.3 16.0 15.2 14.8 17.0 15.5 15.6 17.1 7.3 9.6 12.6 24.2 12.5 6.4 3.1 6.7 10.8 13.2 9.7 8.0 5.2 10.0 7.3 9.2 22.9 11.2 11.8 8.2 0.0 8.9 7.5 6.9 11.7 9.1 9.5 9.7 29.4 12.4 8.8 7.9 12.2 7.7 1.3 11.6 9.3 9.3 7.8 3.3 31.6 10.4 4.1 10.1 3.2 5.0 13.7 6.7 3.6 42.2 9.2 7.4 13.4 19.6 35.8 11.7 3.2 15.4 12.1 4.4 4.5 5.2 8.6 9.0 6.6 10.7 7.0 28.1 15.7 8.7 5.4 6.7 8.7 8.4 9.2 3.6 VAPB "ALS8, VAP-B, VAP-C" ENSG00000124164 "VAMP associated protein B and C" O95292 20 58389229-58451101 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013144, CAB013722" Supported Enhanced "Endoplasmic reticulum" NA NA 240000 "Endoplasmic reticulum" "CAB013722: , HPA013144: AB_1858717" "unprognostic (3.28e-3)" "unprognostic (3.88e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (9.36e-2)" "unprognostic (3.15e-2)" "unprognostic (4.76e-3)" "unprognostic (2.80e-1)" "unprognostic (4.47e-2)" "unprognostic (8.06e-3)" "unprognostic (3.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (1.08e-8)" "unprognostic (1.05e-1)" "unprognostic (5.31e-1)" "unprognostic (6.34e-3)" "unprognostic (2.99e-2)" 15.8 36.7 34.5 11.3 28.9 4.2 14.3 29.5 30.2 13.3 19.4 23.0 19.7 16.6 10.4 19.5 15.0 9.8 26.1 29.0 31.6 25.0 35.2 14.2 9.7 33.1 33.3 24.4 18.1 19.1 28.2 21.2 9.3 36.5 17.9 10.0 14.4 16.3 12.4 46.8 13.1 18.4 11.7 35.8 15.1 19.2 8.9 33.2 12.3 23.5 39.9 6.8 18.2 13.0 31.7 31.0 30.4 33.6 18.0 30.3 12.5 29.5 27.0 11.2 41.0 20.1 123.0 29.0 27.2 37.7 18.3 32.3 57.6 27.1 38.9 24.6 12.8 20.2 16.5 32.2 38.9 30.2 15.5 19.8 28.9 44.4 22.8 18.7 19.8 20.5 26.7 39.5 14.9 20.0 96.7 24.5 30.6 17.7 60.2 40.0 24.2 31.3 18.0 31.6 40.7 47.1 32.6 44.7 117.0 48.0 18.4 48.0 23.2 28.6 65.8 31.9 33.3 36.9 19.9 23.1 31.4 55.7 16.8 33.8 2.1 2.3 3.1 3.9 2.4 4.5 2.8 4.6 3.2 2.3 2.3 3.3 4.8 3.7 3.7 3.0 2.3 2.7 2.6 34.5 28.9 29.5 30.2 29.0 31.6 33.1 33.3 24.4 36.5 35.8 33.2 31.7 22.5 44.8 26.8 31.6 18.7 11.7 13.5 17.2 23.9 29.7 23.6 21.1 46.5 24.3 16.6 31.3 29.2 34.8 20.7 28.6 35.2 35.1 5.0 18.2 20.9 23.2 21.7 18.7 34.3 30.5 50.3 24.0 20.4 16.0 9.5 23.3 15.7 40.3 16.1 35.3 34.7 23.4 22.4 18.5 10.0 6.1 18.6 17.3 14.2 40.3 22.8 34.3 20.6 35.2 43.7 37.5 22.4 25.2 14.0 17.7 38.9 42.9 19.1 29.7 13.1 22.2 26.0 22.0 29.4 18.2 10.5 44.5 20.5 37.4 27.6 16.6 PARD6B PAR-6B ENSG00000124171 "Par-6 family cell polarity regulator beta" Q9BYG5 20 50731580-50756795 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 16.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 189.1;Glandular and luminal cells: 179.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 29.0;MCF7: 51.7;T-47d: 48.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013376 Uncertain Supported Cytosol NA NA Cytosol "HPA013376: AB_1854972" "unprognostic (1.13e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-3)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.27e-1)" "prognostic favorable (6.38e-5)" "unprognostic (1.84e-2)" "unprognostic (1.97e-1)" "unprognostic (4.18e-2)" "unprognostic (1.07e-2)" 1.0 1.1 2.9 0.8 2.3 2.3 3.5 3.9 2.0 1.7 7.0 2.5 3.7 1.4 8.2 3.2 3.8 2.5 0.7 2.7 2.0 16.3 4.4 5.4 1.0 1.9 2.1 1.4 1.1 4.7 4.3 1.4 3.9 2.0 1.2 2.4 9.0 1.8 1.7 3.9 2.9 3.2 0.8 2.3 1.1 5.8 2.8 1.8 0.9 3.7 0.9 2.1 1.7 1.5 2.6 5.4 6.2 1.7 3.7 1.1 0.4 8.0 0.4 0.6 0.9 0.7 29.0 12.7 2.4 5.4 0.1 3.8 4.3 2.6 3.9 1.5 1.2 1.5 1.3 2.1 11.5 1.2 0.9 1.3 0.1 1.9 0.5 1.6 1.7 0.1 2.3 3.1 1.6 0.1 51.7 2.5 2.3 3.0 9.0 2.3 1.4 1.7 2.3 12.9 5.9 1.1 1.6 4.1 9.6 3.0 7.2 48.8 1.3 0.2 0.5 3.2 0.5 1.0 1.9 1.3 2.0 1.3 0.9 1.1 1.6 0.2 1.5 1.4 0.3 1.5 1.1 1.4 1.4 0.3 1.3 2.2 1.4 1.1 1.6 0.6 1.3 0.9 0.4 2.9 2.3 3.9 2.0 2.7 2.0 1.9 2.1 1.4 2.0 2.3 1.8 2.6 0.4 189.1 50.4 2.9 4.5 63.0 58.9 17.0 30.7 14.4 60.3 15.0 4.3 37.1 31.1 90.1 54.2 35.5 4.0 68.6 41.1 26.2 4.0 110.1 14.4 1.7 14.9 0.4 11.5 24.4 15.0 4.7 55.5 179.2 1.3 1.8 1.8 20.1 3.7 5.0 10.6 26.7 22.4 0.8 4.2 2.5 1.8 3.5 16.0 1.9 1.2 12.3 2.1 1.5 4.6 57.5 39.7 0.7 6.3 43.6 29.3 102.0 30.0 62.7 6.6 1.2 4.8 16.6 9.4 34.7 68.3 48.4 6.3 1.5 27.3 102.7 ATP5F1E ATP5E ENSG00000124172 "ATP synthase F1 subunit epsilon" P56381 20 59025475-59032345 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 3414.2;Hofbauer cells: 2765.4;Proximal tubular cells: 4125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.73e-1)" "unprognostic (6.30e-2)" "unprognostic (8.16e-2)" "unprognostic (9.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.92e-3)" "unprognostic (7.88e-3)" "unprognostic (2.51e-1)" "unprognostic (5.01e-2)" "unprognostic (6.41e-2)" "unprognostic (4.35e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (3.98e-1)" "unprognostic (3.21e-1)" "unprognostic (1.67e-1)" "unprognostic (2.44e-2)" 82.2 89.1 88.4 99.4 90.8 126.6 62.8 91.5 136.9 45.5 92.1 75.4 80.8 51.7 25.5 77.6 45.6 14.0 146.0 88.9 92.2 90.8 80.8 69.9 70.4 91.2 90.1 86.4 42.4 45.3 53.4 105.6 34.3 90.9 51.1 33.4 43.2 63.2 24.0 242.3 40.8 79.5 25.9 97.9 94.3 70.1 48.0 90.7 65.3 64.7 107.9 40.4 64.0 56.0 93.7 150.0 49.6 98.1 90.0 94.0 87.2 65.2 155.9 60.6 102.2 66.0 156.3 143.5 81.1 184.7 82.7 159.6 141.5 70.3 123.7 67.0 66.7 76.4 271.4 107.2 136.5 86.4 193.2 234.6 95.0 105.3 62.5 77.8 99.8 76.9 107.6 103.6 113.8 59.4 144.4 247.8 299.1 32.9 220.4 203.4 120.2 138.3 156.8 107.5 83.0 98.0 146.6 261.6 273.9 328.4 83.5 182.5 312.8 264.3 208.3 222.0 138.9 213.7 180.2 245.9 238.1 201.5 117.9 117.1 613.1 420.6 757.3 237.5 463.8 224.9 351.4 285.8 268.7 356.0 291.7 227.8 259.4 713.9 243.1 470.7 601.7 393.3 781.7 88.4 90.8 91.5 136.9 88.9 92.2 91.2 90.1 86.4 90.9 97.9 90.7 93.7 1036.3 516.0 530.8 0.0 331.5 0.0 0.0 0.0 0.0 0.0 1042.4 1138.3 0.0 0.0 289.7 1121.9 0.0 705.8 812.6 0.0 3414.2 998.0 0.0 1145.2 1007.1 436.6 0.0 0.0 0.0 1202.6 956.9 341.7 0.0 1410.3 352.0 594.0 0.0 0.0 2765.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.4 0.0 0.0 1473.1 0.0 0.0 0.0 0.0 1427.7 0.0 0.0 132.5 0.0 0.0 4125.3 392.8 0.0 0.0 0.0 334.0 0.0 0.0 0.0 0.0 590.5 431.2 731.9 0.0 0.0 CHD6 "CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB" ENSG00000124177 "Chromodomain helicase DNA binding protein 6" Q8TD26 20 41402083-41618384 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015543 Supported Nucleoplasm NA NA Nucleoplasm "HPA015543: " "unprognostic (5.13e-3)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.27e-1)" "unprognostic (6.66e-2)" "unprognostic (1.36e-1)" "unprognostic (4.72e-3)" "prognostic favorable (3.42e-4)" "unprognostic (1.17e-1)" "unprognostic (3.17e-1)" "unprognostic (4.75e-2)" "unprognostic (1.14e-1)" "unprognostic (2.12e-3)" "unprognostic (6.66e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-1)" "unprognostic (1.14e-2)" 6.7 7.8 11.3 6.9 12.5 13.7 12.5 18.9 13.0 9.5 6.3 6.4 4.0 12.9 12.5 6.1 10.1 7.3 8.1 9.4 12.1 7.2 6.9 7.6 8.5 12.7 15.3 8.6 16.3 8.1 16.3 7.9 8.4 15.5 12.3 6.2 15.8 8.5 9.4 5.5 8.6 6.2 9.0 7.9 8.3 7.5 7.2 10.5 17.4 13.8 7.9 8.3 8.1 8.9 17.4 8.4 9.8 20.6 9.2 11.5 11.7 13.3 7.2 14.8 12.6 15.2 13.5 6.7 10.0 12.7 12.4 14.2 12.2 12.9 12.4 14.3 3.2 6.3 13.7 9.1 13.2 6.5 10.9 6.6 11.8 11.3 9.2 10.1 13.5 11.0 13.7 11.0 10.4 9.9 23.3 17.3 11.8 6.8 5.2 16.5 13.2 24.2 7.1 7.9 19.3 18.6 12.8 22.1 5.8 14.2 14.9 9.9 8.1 12.7 19.8 9.6 10.0 6.3 9.9 8.6 12.8 8.7 5.2 6.2 20.2 6.0 7.5 8.1 6.1 8.2 8.5 7.0 6.9 5.2 10.6 9.4 8.0 0.9 10.2 10.0 11.4 6.0 2.4 11.3 12.5 18.9 13.0 9.4 12.1 12.7 15.3 8.6 15.5 7.9 10.5 17.4 42.2 48.1 30.8 148.2 42.8 18.1 38.6 30.3 37.0 140.4 39.5 34.7 56.6 30.0 34.4 22.0 93.8 34.2 53.3 14.5 21.5 24.4 14.5 50.3 65.3 36.5 60.6 19.6 143.2 15.8 28.2 33.8 19.9 76.0 21.5 65.1 34.2 21.1 16.5 151.4 179.0 35.9 42.7 27.7 44.7 20.3 49.7 27.5 17.8 87.1 40.8 62.2 39.1 182.9 160.6 15.4 16.0 45.5 32.3 30.3 4.1 13.9 35.6 133.8 19.7 71.0 44.4 20.6 61.9 21.8 17.2 32.7 45.5 40.4 24.5 32.9 PLCG1 "NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1" ENSG00000124181 "Phospholipase C gamma 1" P19174 20 41136960-41196801 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8" "Group enriched" "Detected in many" 9 "NK-cells: 3.4;T-cells: 6.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004277, HPA036681, HPA036682" Approved Enhanced Cytosol NA NA Cytosol "CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246" "unprognostic (2.77e-1)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (4.31e-2)" "unprognostic (5.82e-2)" "unprognostic (2.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "prognostic favorable (4.72e-4)" "unprognostic (3.32e-1)" "unprognostic (2.73e-3)" "unprognostic (1.82e-1)" "unprognostic (2.65e-1)" "unprognostic (9.27e-2)" "unprognostic (2.79e-2)" 32.1 22.6 34.5 21.9 34.7 10.1 32.1 40.8 41.6 42.8 26.7 24.2 17.9 36.4 13.9 19.0 32.2 20.1 29.9 34.4 31.5 23.3 9.8 32.7 36.7 33.6 35.2 32.1 43.0 11.5 13.4 21.8 24.0 38.1 30.4 13.8 11.0 20.3 20.7 18.7 31.4 29.1 23.1 31.1 30.3 19.5 26.5 36.6 61.1 45.4 20.4 24.2 30.7 32.3 37.4 16.6 20.8 97.2 71.6 38.0 26.5 30.9 26.7 34.1 52.4 44.3 50.1 5.4 37.0 31.9 29.1 55.0 30.2 42.7 47.8 30.4 10.5 22.7 2.6 36.4 59.6 28.9 14.7 9.7 34.1 26.3 38.8 30.0 47.2 59.4 77.3 28.0 23.6 48.0 123.8 90.7 11.5 36.2 21.3 37.6 71.1 70.8 18.2 28.7 30.1 34.4 65.7 47.8 22.1 48.4 54.1 25.8 17.0 64.6 124.4 40.3 40.2 32.9 26.1 12.4 30.3 29.7 15.6 52.9 0.0 0.0 0.0 4.7 0.0 6.4 0.2 4.1 3.9 0.0 0.5 4.3 4.3 0.0 3.4 0.0 0.0 3.8 3.0 34.5 34.7 40.8 41.6 34.4 31.5 33.6 35.2 32.1 38.1 31.1 36.6 37.4 33.4 16.0 7.0 69.2 5.1 5.6 1.8 5.3 14.8 4.3 4.7 5.8 9.6 1.5 3.8 3.7 10.4 1.9 7.4 9.4 0.0 3.3 7.0 5.4 16.9 24.2 1.8 2.1 9.7 1.6 2.0 11.5 10.2 10.3 1.3 19.8 11.7 3.1 4.0 3.3 9.1 9.5 4.1 2.9 4.3 7.2 15.2 1.7 3.6 16.9 1.2 6.7 2.1 13.0 16.4 3.3 4.8 18.4 6.3 2.3 7.8 3.0 1.8 5.1 13.1 8.5 10.2 15.9 13.0 6.1 7.0 0.8 17.0 5.7 6.4 0.9 TOX2 "C20orf100, dJ1108D11.2, GCX-1" ENSG00000124191 "TOX high mobility group box family member 2" Q96NM4 20 43914852-44069616 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.6" "Cell type enhanced" "Detected in many" "Early spermatids: 22.3;Excitatory neurons: 20.5;Hepatic stellate cells: 34.2;Inhibitory neurons: 76.9;Oligodendrocyte precursor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 92.0;U-266/70: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA049900, HPA058396" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049900: AB_2680942, HPA058396: AB_2683704" "unprognostic (2.15e-2)" "unprognostic (1.82e-2)" "unprognostic (8.97e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.53e-3)" "unprognostic (6.29e-2)" "unprognostic (1.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (7.45e-8)" "unprognostic (1.60e-1)" "unprognostic (2.00e-1)" "unprognostic (7.60e-2)" "unprognostic (3.12e-1)" 7.8 4.1 11.5 6.3 7.9 1.8 6.9 4.9 18.2 9.5 2.2 6.4 1.3 6.3 1.1 12.9 3.6 2.9 3.5 9.1 27.0 5.0 5.3 36.7 13.4 11.9 14.8 5.9 3.1 2.0 10.2 24.8 2.6 11.3 16.8 2.4 1.9 3.8 2.7 1.5 4.4 10.3 1.6 5.1 5.8 9.8 21.0 19.9 50.6 7.5 6.5 8.2 17.8 8.9 10.2 9.9 12.5 4.9 0.9 4.7 13.3 0.1 11.5 5.3 8.1 8.9 0.0 4.0 0.0 16.8 16.6 35.2 5.1 3.2 0.3 8.4 15.5 2.7 0.0 1.1 0.0 92.0 0.1 19.4 31.0 14.0 27.0 1.6 25.8 9.4 9.5 0.0 14.5 4.6 11.3 3.2 4.5 3.0 0.3 42.2 0.0 10.1 15.4 0.0 1.2 4.3 35.8 2.4 0.0 18.0 0.5 0.0 9.2 11.3 0.0 7.5 0.3 0.1 57.4 13.5 9.0 16.9 0.1 27.0 0.0 0.2 6.5 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.7 1.1 0.0 2.6 1.2 0.1 11.5 7.9 4.9 18.2 9.1 27.0 11.9 14.8 5.9 11.3 5.1 19.9 10.2 8.0 0.0 0.6 3.9 3.4 1.0 1.0 0.7 0.0 0.8 0.2 0.1 0.8 1.5 0.1 0.0 0.0 0.0 7.3 0.3 0.0 0.1 22.3 0.3 8.9 8.9 0.0 0.0 20.5 0.2 0.1 6.7 1.5 0.3 0.0 10.7 34.2 0.5 1.5 3.3 76.9 0.6 0.0 2.9 3.6 17.3 1.8 1.2 1.8 3.7 0.2 4.6 1.0 45.2 0.5 0.1 2.2 0.7 12.1 0.5 0.0 0.1 0.0 0.1 0.0 0.4 8.7 1.3 1.8 0.2 1.3 0.3 10.5 0.1 1.8 0.3 SRSF6 "B52, SFRS6, SRP55" ENSG00000124193 "Serine and arginine rich splicing factor 6" Q13247 20 43457893-43466046 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029005, CAB034889" Supported Supported "Nuclear speckles" NA NA 50000 "Nuclear speckles" "CAB034889: AB_785899, HPA029005: AB_10610424" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.25e-2)" "unprognostic (6.41e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "unprognostic (1.27e-3)" "unprognostic (6.03e-3)" "prognostic unfavorable (2.82e-4)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" "unprognostic (4.31e-1)" "unprognostic (1.18e-2)" 43.7 54.2 39.7 34.9 41.6 116.9 56.8 46.1 42.4 41.3 52.9 38.0 36.7 53.2 60.2 33.1 47.8 31.7 29.1 38.2 42.1 38.4 50.7 40.6 48.8 39.6 39.6 38.7 59.1 66.8 42.2 48.4 39.6 40.6 49.2 43.8 39.1 45.7 30.3 30.8 49.1 45.8 40.1 41.0 56.3 47.9 30.6 40.2 54.2 51.2 18.3 41.1 29.9 30.6 51.8 52.7 79.1 88.7 57.3 50.7 67.7 86.3 79.6 38.3 55.4 47.1 112.9 55.9 95.9 73.9 73.3 45.1 77.6 91.7 116.9 71.7 40.2 85.7 74.6 83.3 94.1 62.3 94.9 78.9 115.7 61.9 51.0 46.2 85.1 52.7 83.8 63.3 54.5 52.6 112.3 144.5 107.6 57.8 87.4 107.4 100.2 54.4 76.9 63.1 93.7 69.0 90.9 89.5 108.7 105.0 61.7 70.4 103.3 54.9 57.9 61.6 49.9 67.3 98.2 67.3 131.4 69.9 67.2 42.8 26.0 19.9 9.7 19.7 33.4 22.4 16.0 20.8 19.1 24.5 15.9 27.3 25.7 10.8 21.2 29.6 20.4 18.7 22.9 39.7 41.6 46.1 42.4 38.2 42.1 39.6 39.6 38.7 40.6 41.0 40.2 51.8 78.9 64.1 80.0 49.6 75.8 94.4 61.0 58.5 50.7 48.9 110.7 78.7 28.7 75.8 61.3 46.0 39.6 97.8 103.3 67.8 88.0 60.2 12.3 60.1 87.7 62.3 101.4 71.1 32.1 43.7 108.2 80.0 70.8 79.1 97.0 103.2 60.7 94.7 56.5 32.0 37.2 97.2 46.8 73.2 93.7 14.7 55.0 77.3 101.4 26.2 61.2 45.0 37.0 89.0 79.6 46.2 74.3 44.8 49.3 68.9 66.7 67.7 47.6 46.4 59.2 166.1 99.8 53.8 61.0 51.5 98.3 139.1 76.4 90.7 105.5 55.3 GDAP1L1 ENSG00000124194 "Ganglioside induced differentiation associated protein 1 like 1" Q96MZ0 20 44247099-44280947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 31.7;pituitary gland: 17.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.4;Early spermatids: 9.8;Excitatory neurons: 20.9;Horizontal cells: 15.2;Inhibitory neurons: 23.4;Late spermatids: 30.4;Oligodendrocyte precursor cells: 10.1" "Cancer enriched" "Detected in single" 14 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 12.5;SCLC-21H: 32.3;SH-SY5Y: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054182, HPA063265" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA054182: , HPA063265: AB_2684972" "unprognostic (6.58e-3)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (2.23e-4)" "unprognostic (3.69e-1)" "unprognostic (5.15e-1)" "unprognostic (6.45e-2)" "unprognostic (7.69e-2)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (4.74e-3)" "unprognostic (2.41e-1)" "unprognostic (3.81e-5)" "unprognostic (8.57e-2)" "unprognostic (1.87e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-1)" 0.1 2.3 18.7 0.2 27.6 0.1 0.1 14.9 31.7 1.0 0.8 0.5 0.0 0.6 0.0 0.0 0.2 0.0 1.1 25.1 17.1 0.1 0.1 0.0 0.0 18.0 11.8 26.6 2.7 0.5 0.9 17.9 0.0 20.0 0.2 0.0 5.8 0.0 0.0 0.0 0.3 0.3 0.1 5.6 0.0 0.7 3.6 12.8 0.0 0.2 0.0 0.0 0.1 0.3 22.0 0.0 0.0 3.8 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 14.8 0.0 0.1 1.5 0.2 0.0 3.9 0.1 1.1 0.7 0.3 0.0 0.0 0.2 0.8 1.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 27.6 14.9 31.7 25.1 17.1 18.0 11.8 26.6 20.0 5.6 12.8 22.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.1 0.2 0.0 0.0 20.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 15.2 23.4 0.4 0.0 0.0 0.0 30.4 0.6 0.0 0.0 6.5 0.0 1.1 0.0 10.1 3.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43727002 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 147 "testis: 225.5" "Group enriched" "Detected in some" 115 "Early spermatids: 2791.6;Late spermatids: 4158.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "T-reg: 4.0" "Lineage enriched" "Detected in single" 5 "T-cells: 4.0" "Cell line enhanced" "Detected in some" "REH: 1.1;U-698: 1.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA054694 Enhanced Uncertain Nucleoli NA NA Nucleoli "HPA054694: AB_2682576" "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 225.5 0.0 0.4 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.5 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2791.6 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4158.1 19.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 30.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARFGEF2 BIG2 ENSG00000124198 "ADP ribosylation factor guanine nucleotide exchange factor 2" Q9Y6D5 20 48921711-49036693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 102.6;Inhibitory neurons: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026078, CAB026382" Supported Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB026382: , HPA026078: AB_1844983" "unprognostic (1.50e-2)" "unprognostic (9.56e-3)" "unprognostic (4.14e-2)" "unprognostic (4.94e-3)" "unprognostic (5.30e-2)" "unprognostic (6.94e-2)" "unprognostic (1.57e-2)" "unprognostic (2.99e-1)" "unprognostic (8.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.15e-7)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.85e-1)" "unprognostic (3.90e-2)" 8.7 20.4 1.7 8.8 3.4 10.5 16.0 1.6 5.4 11.6 6.4 14.3 13.8 9.0 6.0 11.1 7.6 8.6 13.6 3.8 3.6 15.5 12.5 7.9 9.8 2.2 3.4 2.9 7.7 19.4 82.2 8.8 9.3 3.5 10.6 15.8 6.9 11.1 9.8 11.9 11.1 11.0 9.5 1.7 10.5 16.4 13.7 2.8 11.4 24.0 18.4 14.3 11.3 8.3 4.5 18.3 16.5 8.9 5.1 18.0 14.8 21.8 15.5 19.5 36.6 19.0 37.1 19.8 25.5 22.1 19.7 33.8 21.0 18.6 23.6 33.8 9.0 7.6 17.5 17.9 25.4 19.7 22.6 19.7 15.0 21.6 23.9 27.6 12.7 28.4 11.7 15.0 22.3 20.8 6.3 13.0 6.8 8.3 20.5 17.4 14.0 25.5 30.3 13.6 23.4 7.1 9.0 42.6 66.0 23.4 10.3 26.6 18.6 34.5 35.6 16.5 18.2 13.1 35.9 35.0 18.7 23.4 10.7 11.6 1.1 0.6 0.2 0.5 0.4 0.6 0.5 0.5 0.4 0.7 0.9 0.8 0.7 0.3 0.3 0.3 0.9 0.1 0.3 1.7 3.4 1.6 5.4 3.8 3.6 2.2 3.4 2.9 3.5 1.7 2.8 4.5 16.6 19.2 26.0 37.2 21.2 11.3 12.2 11.0 11.4 15.3 27.7 14.7 40.7 17.2 20.0 11.0 14.6 10.5 14.7 30.4 1.9 10.9 16.6 19.5 17.1 19.5 12.5 14.3 102.6 13.3 10.0 12.6 16.3 24.7 15.2 11.0 20.7 27.8 10.8 11.8 96.7 23.3 8.2 15.7 13.9 24.6 10.2 17.8 10.6 60.9 15.6 5.4 10.3 43.2 57.0 15.5 21.6 11.3 29.0 24.1 18.6 11.5 17.2 16.1 6.6 14.2 12.5 32.6 20.4 17.5 15.5 30.0 13.2 16.6 21.0 21.2 ZNFX1 "FLJ11277, KIAA1404" ENSG00000124201 "Zinc finger NFX1-type containing 1" Q9P2E3 20 49237946-49278426 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 132.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046629 Approved Approved Mitochondria No No Mitochondria "HPA046629: AB_2616451" "unprognostic (1.03e-1)" "unprognostic (2.80e-1)" "unprognostic (1.15e-1)" "unprognostic (3.21e-2)" "unprognostic (1.21e-1)" "unprognostic (3.58e-1)" "unprognostic (2.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (1.49e-1)" "unprognostic (3.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.50e-1)" "unprognostic (2.79e-1)" "unprognostic (8.71e-3)" "unprognostic (7.40e-2)" "unprognostic (7.86e-2)" 17.2 9.5 9.7 14.5 10.4 29.0 12.5 9.2 9.7 10.2 12.0 10.9 11.1 11.3 9.1 8.2 10.8 14.2 11.8 8.8 13.7 10.1 9.7 18.9 14.3 11.8 10.5 7.3 10.0 9.3 13.1 8.5 12.4 10.8 9.8 10.6 8.8 10.4 9.7 15.6 11.9 12.5 13.8 9.9 19.3 11.5 13.5 11.5 13.2 14.0 14.6 13.5 16.7 9.1 14.4 16.3 24.9 5.8 8.2 31.4 24.5 9.8 21.6 50.9 132.7 54.9 28.4 13.2 13.5 27.3 43.5 37.6 30.7 10.8 29.3 45.1 12.8 3.6 16.0 18.1 12.5 27.2 13.0 18.7 26.3 26.9 29.7 22.0 24.3 20.3 8.0 12.4 16.2 33.6 6.8 14.2 8.7 5.6 14.0 20.7 8.9 19.6 3.8 21.8 22.1 5.9 4.3 31.6 61.1 22.4 7.1 15.7 10.8 50.9 64.8 18.3 23.8 21.1 10.7 4.0 7.2 26.0 8.7 14.6 19.3 12.3 20.1 13.5 15.2 12.0 9.4 13.6 13.1 9.1 7.1 12.9 10.0 51.9 9.9 27.1 5.2 11.0 11.5 9.7 10.4 9.2 9.7 8.8 13.7 11.8 10.5 7.3 10.8 9.9 11.5 14.4 36.5 41.7 27.2 10.4 25.8 27.8 21.2 14.4 19.4 15.7 13.7 11.2 14.4 10.0 24.8 20.2 10.4 6.1 18.7 28.0 0.0 23.9 37.4 15.9 17.9 38.1 13.1 10.7 12.5 22.7 7.0 28.0 28.5 18.6 27.3 8.1 29.3 13.4 15.1 11.8 11.7 14.2 16.2 26.4 38.0 21.1 22.7 34.2 19.6 15.0 30.2 29.5 17.5 7.1 9.9 32.3 21.8 27.1 9.3 32.8 18.7 6.7 42.8 15.1 0.0 27.8 29.9 42.0 16.3 16.2 21.7 11.4 31.4 10.2 10.4 35.7 ZNF831 "C20orf174, dJ492J12.1" ENSG00000124203 "Zinc finger protein 831" Q5JPB2 20 59123381-59259113 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.6;intestine: 2.0;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 4 "dendritic cells: 20.5;Excitatory neurons: 19.5;NK-cells: 17.5;Plasma cells: 9.5;T-cells: 31.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 1.2;T-cells: 2.1" "Group enriched" "Detected in some" 6 "Daudi: 4.0;HMC-1: 1.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 25 "amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4" HPA016839 Uncertain NA NA "HPA016839: AB_1859466" "unprognostic (2.90e-3)" "unprognostic (7.70e-6)" "unprognostic (9.71e-4)" "unprognostic (1.31e-3)" "unprognostic (7.00e-2)" "unprognostic (3.00e-5)" "unprognostic (3.08e-3)" "unprognostic (2.23e-2)" "unprognostic (2.89e-3)" "unprognostic (2.21e-3)" "unprognostic (2.80e-3)" "unprognostic (4.31e-1)" "unprognostic (3.40e-3)" "unprognostic (2.39e-1)" "unprognostic (3.42e-2)" "unprognostic (2.21e-1)" "unprognostic (1.93e-2)" 0.2 0.1 2.4 2.3 2.0 0.9 0.3 0.0 2.9 0.1 0.0 0.3 0.2 0.1 0.2 0.2 0.2 0.5 0.0 3.6 0.8 0.1 0.2 0.6 6.2 0.5 0.0 2.1 0.0 0.2 0.0 0.3 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.0 0.1 2.0 0.0 0.0 2.6 0.6 0.2 0.8 1.6 0.3 0.0 3.9 0.6 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.8 0.0 1.4 0.2 1.0 1.5 0.0 0.1 0.8 1.0 0.1 1.2 0.0 0.0 2.1 0.4 2.4 2.0 0.0 2.9 3.6 0.8 0.5 0.0 2.1 0.6 0.0 0.8 0.6 0.3 0.0 0.6 0.7 4.8 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.7 0.0 0.0 1.8 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 19.5 0.0 0.0 0.1 0.5 0.1 2.5 0.0 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 17.5 0.5 0.9 0.0 0.0 0.0 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 0.5 0.0 0.0 0.0 31.2 0.0 0.0 0.0 EDN3 ET3 ENSG00000124205 "Endothelin 3" P14138 20 59300443-59325992 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Deafness, Disease variant, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 246.8;vagina: 107.4" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 99.6;Distal enterocytes: 86.6;Paneth cells: 72.4;Proximal enterocytes: 93.0;Skeletal myocytes: 110.0;Squamous epithelial cells: 69.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 32 "hypothalamus: 246.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 30900 "unprognostic (4.64e-3)" "unprognostic (7.87e-2)" "unprognostic (7.49e-2)" "unprognostic (2.88e-3)" "prognostic favorable (1.73e-4)" "unprognostic (1.58e-1)" "unprognostic (1.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (4.01e-2)" "unprognostic (4.08e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-2)" "unprognostic (1.55e-1)" "unprognostic (6.40e-2)" 0.1 2.3 5.4 2.0 5.0 0.0 7.9 5.1 5.3 29.6 4.0 20.4 42.4 5.2 6.1 20.8 0.2 0.4 0.1 5.1 246.8 0.2 0.0 0.4 0.2 6.5 5.9 3.6 1.3 8.8 0.3 45.1 0.2 7.5 5.7 19.0 2.0 68.9 0.5 1.5 1.9 40.9 3.0 5.1 8.0 1.7 1.2 7.7 3.2 24.4 2.4 0.1 0.1 107.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.4 5.0 5.1 5.3 5.1 246.8 6.5 5.9 3.6 7.5 5.1 7.7 6.2 0.1 9.6 0.5 0.0 0.0 0.4 5.1 0.0 99.6 0.1 1.7 21.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 86.6 0.0 0.3 0.0 1.6 11.2 0.4 1.2 0.0 0.8 0.0 0.3 2.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 0.4 0.0 0.0 0.5 0.0 20.6 0.0 0.4 0.0 0.0 0.0 0.2 72.4 1.9 1.2 0.2 93.0 0.0 0.0 0.4 0.0 110.0 0.4 0.1 0.8 69.2 0.3 0.0 0.3 0.1 15.9 0.3 CSE1L "CAS, CSE1, XPO2" ENSG00000124207 "Chromosome segregation 1 like" P55060 20 49046246-49096960 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 164.0;Spermatogonia: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002140, HPA038059, HPA038060" Enhanced Enhanced Nucleoplasm,Cytosol No Yes 320000 Nucleoplasm Cytosol "CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812" "unprognostic (4.01e-2)" "unprognostic (3.15e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.91e-5)" "unprognostic (4.86e-1)" "unprognostic (4.91e-2)" "prognostic unfavorable (2.42e-8)" "unprognostic (3.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.63e-2)" "unprognostic (2.72e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.59e-1)" "unprognostic (4.84e-1)" "unprognostic (5.71e-1)" "prognostic unfavorable (6.91e-4)" 23.8 24.7 17.4 29.3 21.0 26.7 34.5 27.7 21.3 25.9 14.2 23.8 20.0 28.3 24.0 38.6 27.3 19.1 24.9 17.7 20.3 30.1 31.1 19.9 35.3 23.0 20.1 16.3 27.5 20.6 31.1 13.8 37.8 23.1 26.0 29.0 23.5 21.9 25.9 40.1 34.6 19.3 35.3 22.2 20.5 20.9 88.4 19.4 41.1 23.6 41.8 43.2 27.8 22.3 30.1 224.3 152.4 182.1 140.9 69.0 88.5 196.7 172.1 90.5 528.1 222.0 501.8 175.4 227.3 224.1 109.7 213.9 251.4 270.7 322.9 500.0 37.4 131.3 158.0 166.1 244.7 42.0 176.2 83.3 50.0 118.7 259.0 148.7 72.4 177.5 124.3 227.2 87.1 201.1 76.8 213.9 90.6 153.5 185.1 224.0 133.9 299.5 176.4 116.5 153.2 159.6 92.6 275.2 293.3 97.1 137.7 245.3 113.3 115.5 279.3 233.9 166.4 247.9 50.5 130.8 210.8 166.8 139.5 152.2 18.6 16.3 3.8 13.8 20.6 21.1 16.7 21.0 17.1 20.1 13.6 22.1 19.3 4.4 23.0 23.6 8.9 20.1 18.3 17.4 21.0 27.7 21.3 17.7 20.3 23.0 20.1 16.3 23.1 22.2 19.4 30.1 16.4 6.4 26.8 8.1 20.3 30.2 25.8 29.5 31.3 14.9 17.4 15.9 26.6 24.3 22.4 27.6 10.4 71.8 15.7 7.4 13.7 32.2 95.9 14.7 19.4 22.9 5.4 40.4 20.9 26.6 61.2 24.6 13.7 17.8 4.5 35.1 19.2 26.7 29.7 15.2 24.4 11.8 20.3 17.9 21.9 57.8 25.4 17.9 26.6 9.4 28.0 22.6 7.2 17.1 41.7 26.7 10.0 31.6 26.7 28.8 9.9 21.6 21.7 15.5 39.5 19.3 22.1 164.0 121.5 36.7 34.5 72.7 17.5 31.1 23.7 22.2 PEDS1-UBE2V1 "CROC-1B, Kua-UEV, TMEM189-UBE2V1" ENSG00000124208 "PEDS1-UBE2V1 readthrough" 20 50081124-50153637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "HPA052535, HPA053186" Supported Nucleoplasm NA NA Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-3)" "unprognostic (2.71e-2)" "unprognostic (1.52e-1)" "unprognostic (6.05e-3)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" 2.2 1.6 3.2 1.8 7.2 0.0 1.5 10.3 3.9 1.6 1.2 0.9 0.2 1.8 0.0 4.2 0.9 0.4 1.5 3.2 5.9 0.7 1.2 1.8 0.7 8.8 9.3 2.2 0.8 2.1 2.9 1.0 3.5 10.2 0.7 0.1 0.1 1.7 0.5 2.9 2.7 0.9 0.9 9.8 1.0 1.5 2.7 5.6 1.1 1.0 1.3 0.2 1.6 2.5 12.8 3.8 6.9 2.2 6.5 9.7 6.4 6.8 6.8 4.5 9.1 5.1 15.7 8.3 2.0 8.5 3.7 8.0 16.3 3.6 7.5 1.5 1.0 1.3 2.8 12.2 9.3 4.4 5.2 5.0 6.6 13.6 6.7 2.4 0.6 9.2 0.8 4.9 6.1 4.2 5.3 3.9 0.7 1.8 1.4 1.6 3.5 1.9 3.4 2.5 10.9 3.5 1.4 3.0 13.5 2.3 0.0 3.1 4.5 13.7 10.6 3.8 3.0 4.2 1.5 2.1 0.8 4.6 1.3 7.1 7.7 8.7 11.0 7.6 12.5 6.6 3.6 6.8 7.4 8.4 6.0 6.1 6.6 1.2 7.8 15.2 5.0 7.8 10.8 3.2 7.2 10.3 3.9 3.2 5.9 8.8 9.3 2.2 10.2 9.8 5.6 12.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB22A ENSG00000124209 "RAB22A, member RAS oncogene family" Q9UL26 20 58309715-58367507 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066920 Approved NA NA "HPA066920: AB_2685749" "unprognostic (4.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.68e-1)" "unprognostic (8.34e-3)" "unprognostic (6.20e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.12e-1)" "unprognostic (2.00e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (7.01e-3)" 6.4 10.3 9.2 5.4 11.3 4.7 6.5 6.6 11.6 6.3 2.1 7.0 7.2 6.2 7.9 11.7 4.8 5.6 4.2 11.3 9.9 7.5 7.4 6.0 5.8 9.0 9.1 9.4 5.7 5.6 11.7 6.1 4.8 9.3 5.3 6.9 5.5 6.4 5.6 4.6 7.5 6.9 5.9 8.9 6.2 7.1 5.5 10.3 6.3 8.6 5.0 7.2 7.0 7.8 10.2 17.5 7.1 8.8 5.7 17.9 16.7 5.2 12.9 14.9 17.4 10.4 11.9 11.8 9.6 15.7 18.2 19.5 13.7 4.5 20.4 19.7 6.5 4.4 6.8 10.0 9.5 13.8 8.5 11.5 11.4 24.4 12.4 12.7 12.3 11.0 7.5 6.0 13.4 18.4 25.1 10.0 8.0 2.2 15.3 17.4 5.2 8.6 8.3 10.9 11.1 6.7 9.1 18.2 34.0 15.6 4.6 12.6 11.5 17.6 28.7 11.9 18.0 15.6 11.5 17.0 6.3 29.5 8.0 10.0 1.5 1.0 0.8 2.2 1.3 2.1 1.5 1.7 1.9 1.4 1.4 1.5 1.8 2.0 2.2 2.1 1.1 1.5 0.8 9.2 11.3 6.6 11.6 11.3 9.9 9.0 9.1 9.4 9.3 8.9 10.3 10.2 34.2 22.4 16.2 25.1 34.2 56.0 68.9 21.3 32.5 14.6 32.7 22.5 18.6 32.9 20.9 20.2 8.4 16.6 39.7 39.9 50.9 37.0 6.4 30.1 32.8 29.9 19.2 22.3 27.8 36.0 24.7 39.3 31.1 33.7 11.4 19.9 26.0 25.3 28.0 11.8 26.5 23.5 22.4 23.0 69.7 9.2 31.4 33.6 24.9 35.6 23.0 27.9 34.0 24.6 32.1 75.2 26.2 20.7 29.3 75.4 24.5 44.1 22.4 12.6 13.1 42.4 39.7 22.2 39.7 47.6 68.9 35.4 40.6 30.1 22.5 124.3 PTGIS "CYP8A1, PGIS" ENSG00000124212 "Prostaglandin I2 synthase" Q16647 20 49503874-49568137 "Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 79.6;fallopian tube: 81.4;urinary bladder: 82.4" "Cell type enhanced" "Detected in many" "Endothelial cells: 28.1;Fibroblasts: 70.8;Hepatic stellate cells: 117.8;Leydig cells: 26.8;Peritubular cells: 104.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 6.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 45.1;ASC TERT1: 45.2;U-2197: 143.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009517, HPA014193, HPA052244" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (5.09e-3)" "unprognostic (1.38e-2)" "unprognostic (1.80e-2)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (1.29e-2)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (2.45e-2)" "unprognostic (5.22e-2)" "prognostic unfavorable (4.74e-8)" "unprognostic (2.29e-2)" "unprognostic (7.61e-2)" "unprognostic (4.89e-3)" "prognostic unfavorable (9.99e-5)" 36.7 4.7 0.6 9.1 1.7 0.3 24.2 0.4 6.7 26.3 8.7 27.8 3.3 79.6 16.2 16.7 81.4 31.6 30.3 0.5 0.9 3.2 6.1 18.3 0.7 1.0 0.9 0.8 38.4 2.6 0.3 0.9 1.2 0.8 22.4 6.6 0.2 7.7 8.3 4.0 7.2 10.6 40.9 0.6 0.5 18.0 5.2 0.8 0.3 7.9 2.4 0.8 82.4 18.3 0.5 0.0 0.1 1.9 0.1 45.1 45.2 0.5 1.0 5.7 0.2 0.0 0.0 0.0 0.1 18.4 13.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.1 3.3 0.0 0.6 0.0 15.1 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.2 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.2 0.0 8.2 0.1 0.0 0.0 0.8 2.4 143.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.6 1.7 0.4 6.7 0.5 0.9 1.0 0.9 0.8 0.8 0.6 0.8 0.5 5.3 3.2 2.7 0.0 0.0 3.7 0.7 0.0 0.0 1.1 2.2 1.3 5.0 2.8 1.9 3.7 0.0 0.3 0.3 0.0 0.0 0.6 1.8 0.0 0.9 28.1 0.0 2.7 2.7 0.0 0.2 70.8 1.5 0.1 0.0 25.0 117.8 1.0 0.3 0.0 2.4 0.0 0.0 3.1 6.7 3.3 26.8 1.0 1.8 6.5 0.1 0.4 0.0 1.0 0.2 1.2 0.0 104.9 0.3 0.4 0.0 0.2 2.2 4.5 0.0 7.9 3.5 0.7 1.4 0.5 4.8 0.3 1.0 0.5 0.0 0.6 STAU1 "PPP1R150, STAU" ENSG00000124214 "Staufen double-stranded RNA binding protein 1" O95793 20 49113339-49188367 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020839, HPA049892, HPA072004" Approved Enhanced Cytosol NA NA Cytosol "CAB020839: , HPA049892: AB_2680938, HPA072004: " "unprognostic (7.73e-2)" "unprognostic (1.38e-1)" "unprognostic (1.97e-1)" "unprognostic (1.01e-2)" "unprognostic (7.97e-2)" "unprognostic (9.56e-2)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-1)" "unprognostic (9.17e-3)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.42e-2)" "unprognostic (2.73e-1)" "unprognostic (8.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-2)" 46.8 40.8 35.8 34.4 37.7 66.6 40.9 37.2 41.1 41.8 35.2 45.6 55.4 42.7 37.1 47.6 66.9 49.1 50.1 35.6 37.6 89.3 123.8 42.2 37.1 41.2 38.6 33.6 36.6 70.3 82.1 15.1 50.3 41.5 46.7 47.6 36.7 39.6 46.5 63.1 41.9 51.4 52.6 40.9 33.6 53.3 36.2 39.4 43.2 70.3 47.5 41.2 52.4 31.3 44.3 113.9 85.1 90.7 40.2 90.1 111.3 100.7 84.4 100.8 246.8 111.2 292.0 121.8 77.1 141.7 106.2 118.3 121.5 122.4 150.8 205.9 30.2 70.5 63.3 62.1 233.0 76.1 51.7 59.9 89.6 126.9 100.5 117.0 100.9 123.0 57.4 112.3 46.7 94.6 72.3 90.7 83.5 74.5 109.1 117.9 69.1 119.4 75.0 100.1 98.2 104.8 93.1 209.9 199.0 124.8 91.6 127.4 72.9 113.0 148.2 128.1 92.6 101.6 41.8 52.3 86.8 108.5 54.6 87.4 31.5 19.3 19.8 17.8 15.8 19.7 16.8 18.9 19.1 16.9 15.4 17.1 16.7 38.0 14.2 20.2 15.9 22.9 13.6 35.8 37.7 37.2 41.1 35.6 37.6 41.2 38.6 33.6 41.5 40.9 39.4 44.3 76.5 89.8 82.0 45.7 66.4 112.5 125.5 79.9 95.0 32.9 87.5 65.0 63.1 97.2 71.3 77.3 14.6 105.4 72.2 98.4 93.9 130.6 18.6 146.1 80.1 83.0 76.0 137.4 47.9 118.2 45.0 84.8 71.4 87.3 48.1 79.2 72.8 158.3 64.7 43.7 42.2 77.5 59.0 62.9 91.3 21.9 65.6 66.8 49.8 26.2 85.9 57.0 61.8 39.2 51.2 138.5 89.9 70.0 86.8 189.7 107.8 170.0 105.9 29.1 59.2 72.6 74.2 109.1 69.8 92.1 119.8 194.4 78.5 64.6 69.3 196.5 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958423-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 8.0" "Cell type enhanced" "Detected in many" "Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 36.4" "Low region specificity" "Detected in some" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.4 1.2 0.3 1.6 1.0 0.8 1.3 1.9 2.1 0.5 0.6 0.4 0.6 0.5 3.4 2.0 0.4 0.7 1.1 0.9 0.4 0.3 2.1 0.4 1.6 1.6 1.0 0.3 0.5 0.3 1.7 0.4 1.9 8.0 0.3 0.4 2.0 0.5 1.0 0.5 0.8 0.4 0.8 0.8 1.2 0.7 1.5 0.9 0.6 0.3 3.0 2.7 1.3 2.9 0.0 0.7 0.2 0.0 0.6 0.2 0.4 0.2 0.0 0.1 0.0 0.8 0.8 0.1 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.1 7.9 0.1 0.1 0.0 0.3 0.3 0.1 1.1 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.1 0.0 0.0 0.7 0.1 36.4 0.8 0.1 0.4 0.2 0.1 0.4 0.2 0.4 0.2 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 1.3 1.9 1.1 0.9 1.6 1.6 1.0 1.9 0.8 1.5 2.9 4.3 6.4 6.1 17.9 0.1 0.1 1.2 6.6 0.0 0.5 1.6 0.5 0.7 0.0 18.7 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.2 2.1 0.4 2.1 0.0 2.5 9.3 0.0 0.0 0.3 0.0 0.4 1.3 0.0 0.7 0.1 0.6 0.0 8.4 0.0 6.1 1.3 0.4 1.7 0.0 1.4 0.0 7.5 0.6 0.2 1.0 7.1 14.9 0.0 0.0 0.0 0.4 10.9 0.2 0.1 39.6 0.0 0.0 0.5 2.4 0.9 0.2 0.2 0.0 14.9 0.2 0.1 0.2 7.4 SNAI1 "SLUGH2, SNA, SNAH, SNAIL, SNAIL1" ENSG00000124216 "Snail family transcriptional repressor 1" O95863 20 49982980-49988886 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 191.3;Endothelial cells: 54.4;Extravillous trophoblasts: 79.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.2" "Cell line enhanced" "Detected in many" "SiHa: 28.1;TIME: 39.3;WM-115: 25.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "spinal cord: 7.0" "CAB005883, HPA056831, HPA069985, CAB078687" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146" "unprognostic (4.60e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (4.76e-4)" "unprognostic (2.60e-2)" "unprognostic (1.15e-2)" "unprognostic (4.22e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (3.34e-3)" "unprognostic (9.85e-3)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.63e-7)" "unprognostic (3.75e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (8.82e-7)" "unprognostic (1.88e-2)" 19.9 12.1 2.3 4.5 2.1 4.6 16.9 2.5 2.8 4.8 3.4 4.6 1.0 7.1 0.7 2.7 9.6 16.6 12.4 2.0 3.4 8.2 5.3 16.9 2.1 4.5 2.5 1.8 2.4 5.2 1.4 6.6 7.3 2.6 4.1 0.8 0.3 4.0 2.5 2.3 4.1 3.3 3.1 2.2 9.7 6.0 3.9 3.5 0.8 15.5 1.3 0.7 9.5 4.6 2.9 1.2 0.9 5.4 0.7 1.6 1.0 10.9 4.7 5.8 0.9 0.6 8.9 1.4 0.7 12.6 8.4 5.6 0.1 1.6 0.0 0.5 0.1 1.1 0.6 2.0 5.4 13.6 1.5 4.3 3.1 0.3 2.0 0.0 14.3 14.0 0.7 7.0 0.2 0.0 2.0 0.1 1.6 7.2 0.8 3.8 2.5 1.4 0.8 6.4 0.0 2.3 5.6 28.1 7.1 1.2 4.6 1.4 6.5 39.3 0.0 6.8 0.0 0.1 0.2 0.1 7.5 2.3 2.1 25.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.3 2.1 2.5 2.8 2.0 3.4 4.5 2.5 1.8 2.6 2.2 3.5 2.9 191.3 0.0 5.3 0.3 11.8 5.2 2.4 0.5 5.2 0.6 18.6 37.0 4.5 2.8 3.8 0.0 0.0 8.3 29.7 2.8 0.0 1.5 3.0 5.8 18.6 54.4 1.8 0.0 0.6 0.2 79.9 31.7 5.6 8.7 1.3 1.0 17.5 0.3 8.0 3.3 0.4 4.5 2.0 6.4 40.3 0.8 5.6 35.6 5.4 0.0 1.0 0.8 0.0 0.0 0.7 4.7 1.6 14.3 2.2 1.6 1.4 0.2 1.0 0.4 6.6 7.6 17.5 1.4 3.8 7.2 4.8 14.0 12.2 7.2 3.0 0.6 MOCS3 "dJ914P20.3, UBA4" ENSG00000124217 "Molybdenum cofactor synthesis 3" O95396 20 50958818-50963929 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis, tRNA processing" "Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9;Late spermatids: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027556 Uncertain NA NA "HPA027556: AB_2672333" "unprognostic (1.29e-1)" "unprognostic (2.57e-1)" "unprognostic (3.16e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.76e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-2)" "unprognostic (8.67e-3)" "unprognostic (4.90e-2)" "prognostic favorable (7.55e-4)" "unprognostic (8.39e-2)" "unprognostic (8.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" 1.5 1.9 1.7 1.9 1.7 1.0 1.8 1.8 1.7 1.6 1.6 1.8 2.1 1.8 2.7 2.3 2.6 1.4 1.6 1.6 1.7 1.9 2.5 1.5 2.4 1.5 1.5 1.8 2.8 2.2 2.1 1.2 1.8 1.6 1.8 1.6 1.4 2.3 1.8 2.5 2.1 2.2 1.4 1.3 2.3 2.0 5.1 1.7 2.1 2.2 1.4 2.3 1.9 1.3 1.8 3.5 5.9 3.6 5.0 5.0 4.1 6.6 4.1 4.4 10.1 4.3 12.8 5.1 5.3 5.3 3.7 6.6 10.0 3.8 10.1 6.4 1.9 4.0 4.2 4.7 7.4 5.1 4.2 4.3 4.6 8.4 4.2 4.1 3.3 3.5 4.6 6.2 3.1 3.8 5.8 7.0 5.1 5.3 5.4 10.2 2.7 5.6 4.7 4.0 5.4 5.2 6.0 6.4 20.3 6.8 4.0 8.5 8.0 4.2 7.6 4.3 4.2 4.5 7.7 7.4 2.2 6.8 2.5 3.3 2.8 4.1 3.8 3.2 3.8 4.2 4.7 3.4 3.6 4.8 3.3 5.6 4.4 2.1 4.5 5.9 2.6 5.9 3.9 1.7 1.7 1.8 1.7 1.6 1.7 1.5 1.5 1.8 1.6 1.3 1.7 1.8 2.2 0.0 1.5 0.3 3.7 1.8 5.0 5.2 5.7 5.6 3.8 3.8 2.0 4.3 4.6 0.0 4.2 10.3 1.3 4.0 1.9 7.8 90.9 7.4 5.3 2.7 2.4 5.2 1.7 8.0 6.3 3.4 2.0 5.5 0.0 6.6 6.1 7.5 4.9 0.0 1.8 3.8 4.1 3.8 1.1 26.2 5.0 3.2 3.6 0.0 5.2 6.9 5.2 0.5 1.0 5.9 2.5 3.0 2.0 3.2 3.7 7.3 7.7 5.9 13.1 2.2 3.3 20.0 7.6 5.4 3.8 11.6 3.1 5.8 4.6 4.8 STX16 "hsyn16, SYN16" ENSG00000124222 "Syntaxin 16" O14662 20 58651253-58679526 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041019, HPA042033" Uncertain Enhanced Vesicles NA NA Vesicles "HPA041019: AB_10964273, HPA042033: AB_10963935" "unprognostic (7.52e-2)" "unprognostic (1.91e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (4.18e-4)" "unprognostic (7.32e-2)" "unprognostic (5.11e-2)" "unprognostic (3.51e-2)" "unprognostic (2.80e-3)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.56e-1)" "unprognostic (5.89e-2)" 39.8 44.9 43.7 35.0 43.9 54.8 43.0 39.6 45.9 59.8 38.6 50.0 26.5 50.5 45.0 41.1 59.4 25.1 38.1 40.3 40.4 40.0 46.3 44.6 46.6 44.8 42.8 36.0 59.4 50.4 21.3 69.3 26.6 44.6 53.2 26.2 39.0 43.9 30.3 33.5 54.1 49.7 28.1 40.5 65.9 44.6 36.5 42.1 33.3 49.6 19.7 32.6 56.0 50.0 51.9 37.2 21.4 27.6 26.9 49.7 52.6 38.2 45.1 30.5 45.3 28.0 41.9 53.0 42.5 61.3 32.4 56.7 53.9 25.5 53.6 37.3 20.2 26.9 26.6 63.9 51.3 49.2 38.2 57.8 58.9 80.4 30.5 46.0 84.6 46.4 49.2 31.3 36.8 36.9 86.9 29.8 45.9 11.2 30.1 35.9 27.3 25.8 29.6 34.6 27.3 18.2 27.7 47.7 82.8 83.2 46.4 33.1 50.1 49.5 74.1 36.0 28.6 50.3 75.7 37.7 23.4 54.7 29.2 31.7 18.2 5.8 5.0 4.3 5.3 4.8 2.3 3.9 3.1 3.8 3.7 5.1 4.9 12.6 5.4 3.9 3.9 4.7 4.1 43.7 43.9 39.6 45.9 40.3 40.4 44.8 42.8 36.0 44.6 40.5 42.1 51.9 40.2 22.4 46.6 0.0 27.0 26.9 19.3 22.8 29.0 65.2 44.3 41.5 24.3 41.5 31.2 29.5 85.5 24.2 33.7 23.4 5.9 16.6 6.2 32.6 51.2 36.3 46.1 26.5 0.0 13.7 20.6 28.3 38.2 26.1 19.6 54.8 37.1 30.8 22.2 42.1 0.0 25.4 20.3 42.9 35.9 8.9 22.7 37.1 21.4 0.0 44.0 29.5 33.0 0.0 0.0 19.7 22.5 29.0 16.2 20.1 30.0 12.5 45.6 52.8 13.1 32.1 30.4 47.5 20.2 35.2 42.3 17.5 42.6 27.8 26.0 21.5 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 111.7" "Cell type enhanced" "Detected in many" "Ductal cells: 339.6;Muller glia cells: 325.9;Pancreatic endocrine cells: 827.5" "Cancer enhanced" "Detected in all" "prostate cancer: 157.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "naive B-cell: 6.3;plasmacytoid DC: 23.9" "Group enriched" "Detected in many" 8 "B-cells: 6.3;dendritic cells: 23.9" "Cell line enhanced" "Detected in many" "SiHa: 206.1;U-2 OS: 129.9;U-251 MG: 481.8;WM-115: 237.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA072291: AB_2686509" "unprognostic (2.72e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavorable (7.60e-4)" 50.9 14.6 26.8 14.3 65.3 1.3 25.3 39.7 29.3 95.6 7.5 24.7 6.5 48.8 7.2 7.7 20.1 26.3 28.3 24.1 26.5 15.1 3.8 22.0 7.5 32.7 32.3 13.9 15.1 31.6 5.0 13.6 4.0 40.5 111.7 8.4 23.9 30.7 20.8 33.6 17.5 12.7 29.1 24.9 6.7 12.3 5.4 30.9 2.4 13.7 13.8 9.0 13.2 29.9 32.7 32.2 75.4 2.3 3.9 2.4 0.0 0.8 4.9 0.2 1.7 0.8 1.5 97.4 0.2 17.7 7.4 51.8 121.1 1.6 100.8 1.3 1.0 4.1 0.0 23.2 0.1 1.5 0.3 0.8 1.2 55.8 4.4 12.1 16.5 13.0 67.8 0.8 1.2 6.2 66.1 3.8 0.7 9.4 15.0 9.6 0.3 36.0 11.3 24.2 0.0 17.7 13.7 206.1 120.3 15.1 5.6 18.8 4.1 33.1 17.9 129.9 1.9 481.8 5.9 0.8 0.5 8.1 1.1 237.1 0.0 0.4 0.0 0.0 0.0 0.0 2.6 0.8 0.2 0.1 6.3 1.8 1.2 0.1 0.0 0.1 23.9 0.5 0.6 26.8 65.3 39.7 29.3 24.1 26.5 32.7 32.3 13.9 40.5 24.9 30.9 32.7 59.4 57.7 32.3 4.9 32.7 167.0 143.1 120.6 30.7 59.0 38.0 23.0 23.2 125.8 31.7 11.0 2.1 0.2 27.8 57.3 3.9 339.6 1.2 33.4 88.8 55.6 10.1 0.0 19.1 62.5 4.1 40.5 5.1 80.2 59.8 17.5 24.7 0.5 6.1 1.7 32.7 16.9 14.2 3.5 68.0 2.7 3.1 13.4 32.0 31.9 5.8 325.9 0.0 17.6 9.0 827.5 54.2 21.8 25.3 203.1 6.2 2.7 10.1 11.5 72.3 43.8 155.2 0.2 8.8 10.0 178.4 0.1 17.8 9.1 19.3 87.5 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953885 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 167.4" "Group enriched" "Detected in all" 6 "Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 561.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.36e-2)" 31.9 32.3 43.9 30.0 47.7 52.0 31.5 46.7 45.5 35.7 41.5 45.4 43.2 29.0 33.1 31.1 35.0 29.0 35.8 40.5 45.5 49.0 49.4 38.2 39.7 47.8 46.6 38.9 39.4 52.7 30.4 28.3 35.3 46.6 34.2 40.4 16.8 41.4 34.4 84.0 24.4 41.1 25.7 48.1 52.9 36.2 167.4 46.1 39.5 38.3 53.3 37.6 29.2 28.9 50.2 83.9 80.5 42.9 43.7 84.3 57.8 118.0 73.0 86.2 153.2 64.4 241.7 67.6 39.9 142.9 40.1 91.6 66.3 62.5 74.7 90.6 73.5 44.3 51.5 50.1 173.2 73.3 95.3 59.5 51.5 68.8 58.4 39.9 52.6 36.8 69.7 98.0 46.7 45.5 281.0 82.6 98.0 42.3 67.4 114.3 85.7 45.5 73.6 83.4 67.9 63.2 45.4 88.8 561.6 118.5 45.4 149.7 86.6 47.8 134.6 62.3 71.6 87.0 93.6 107.1 79.2 76.4 63.2 76.1 112.2 97.8 86.1 48.1 92.5 53.1 63.9 52.6 48.6 75.3 71.2 61.6 50.2 100.5 57.8 112.5 61.9 68.9 92.7 43.9 47.7 46.7 45.5 40.5 45.5 47.8 46.6 38.9 46.6 48.1 46.1 50.2 47.1 48.1 53.7 13.4 69.9 107.2 127.8 103.4 63.2 24.4 50.7 55.8 46.1 41.5 101.4 69.9 12.5 91.3 61.0 61.7 72.4 107.5 1500.7 72.2 36.3 55.3 60.4 45.4 22.8 101.1 77.4 61.9 41.3 71.4 45.0 31.9 46.1 63.7 110.6 40.4 24.4 79.5 42.7 76.6 146.5 923.4 70.5 66.0 71.2 27.2 96.3 38.0 56.7 10.6 26.2 92.1 77.9 59.8 81.9 122.5 96.4 120.9 75.8 22.6 39.5 45.5 59.2 558.0 138.4 45.8 87.1 124.8 69.2 46.5 80.4 113.3 ANKRD60 "bA196N14.3, C20orf86" ENSG00000124227 "Ankyrin repeat domain 60" Q9BZ19 20 58218495-58228653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 3.6" "Group enriched" "Detected in some" 25 "Early spermatids: 3.7;Late spermatids: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060561 Uncertain NA NA "HPA060561: AB_2684318" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.9 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDX27 "dJ686N3.1, DRS1" ENSG00000124228 "DEAD-box helicase 27" 20 49219347-49244077 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047087, HPA053455" Approved Approved Nucleoli NA No Nucleoli "HPA047087: AB_10964059, HPA053455: " "unprognostic (4.47e-2)" "unprognostic (2.41e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (2.82e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (6.70e-7)" "unprognostic (2.28e-1)" "unprognostic (9.53e-2)" "unprognostic (2.74e-1)" "unprognostic (7.18e-2)" "unprognostic (5.84e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.26e-1)" "unprognostic (4.32e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" 20.5 21.1 15.7 26.1 15.8 46.9 19.7 18.7 20.7 19.9 15.4 21.2 22.8 21.5 15.3 20.9 17.6 19.6 15.4 16.3 18.8 16.2 17.3 18.2 34.6 16.7 15.7 15.1 27.5 24.7 20.6 15.5 20.5 16.8 18.9 21.0 11.0 20.7 16.1 25.0 25.2 27.0 18.7 15.7 24.9 20.6 24.6 16.3 30.1 19.2 16.8 35.9 27.8 18.1 19.4 75.2 69.7 34.9 27.4 38.3 35.1 99.6 48.6 39.9 149.7 69.3 228.3 82.2 88.8 88.1 40.0 129.7 103.7 79.1 77.8 111.0 31.6 46.1 67.6 58.4 113.2 55.7 86.1 76.0 37.0 90.2 87.5 67.3 34.0 25.1 67.5 93.7 47.6 49.8 50.6 90.9 114.0 66.9 91.3 89.2 77.6 87.0 82.4 54.9 57.1 45.8 54.0 135.8 194.2 83.0 48.5 102.5 98.5 31.0 96.0 84.3 80.8 102.9 54.1 62.6 115.6 61.4 67.5 63.4 21.1 32.8 39.4 34.2 36.8 36.0 48.6 32.3 31.5 39.2 50.8 41.1 31.4 13.6 32.6 45.7 45.4 46.3 33.9 15.7 15.8 18.7 20.7 16.3 18.8 16.7 15.7 15.1 16.8 15.7 16.3 19.4 33.9 28.9 44.7 7.8 93.3 35.7 55.1 41.8 30.7 25.7 28.0 32.3 25.7 21.5 45.7 33.1 14.6 58.1 114.0 45.8 19.6 54.0 176.7 45.4 58.4 28.6 31.0 41.2 10.0 43.6 50.5 44.7 27.0 67.4 113.4 42.2 21.0 23.1 33.7 28.6 9.1 44.3 20.3 25.1 54.1 145.7 39.7 48.5 19.6 5.6 42.9 29.9 63.8 4.5 5.4 55.4 44.6 33.8 57.9 38.2 55.0 44.9 35.4 29.4 26.3 52.4 41.7 69.1 56.6 29.5 32.1 74.6 67.9 37.3 50.7 42.1 RBPJL "RBP-L, RBPSUHL, SUH, SUHL" ENSG00000124232 "Recombination signal binding protein for immunoglobulin kappa J region like" Q9UBG7 20 45306840-45317824 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 270 "pancreas: 983.8" "Cell type enhanced" "Detected in some" "Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.0;Spermatogonia: 1.4" "Cancer enriched" "Detected in some" 4 "pancreatic cancer: 4.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB006846 Enhanced NA NA "CAB006846: " "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.34e-2)" "unprognostic (6.09e-1)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (9.60e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.65e-1)" "unprognostic (3.92e-3)" "unprognostic (2.48e-7)" "unprognostic (5.08e-1)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (3.49e-5)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 983.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEMG1 "CT103, SEMG" ENSG00000124233 "Semenogelin 1" P04279 20 45207033-45209768 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 147 "seminal vesicle: 30689.9" "Group enriched" "Detected in some" 18 "Basal prostatic cells: 7.5;Prostatic glandular cells: 3.4" "Cancer enriched" "Detected in some" 14 "prostate cancer: 20.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 239 "eosinophil: 26.8" "Lineage enriched" "Detected in single" 269 "granulocytes: 26.8" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;THP-1: 3.1" "HPA042476, HPA064892" Enhanced "Secreted in male reproductive system" NA NA 7000000 "HPA042476: AB_10794799, HPA064892: AB_2732724" "unprognostic (3.71e-1)" "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.32e-1)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 208.9 0.0 0.0 0.0 30689.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 C20orf85 "bA196N14.1, LLC1" ENSG00000124237 "Chromosome 20 open reading frame 85" Q9H1P6 20 58150902-58161150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 459.2" "Group enriched" "Detected in some" 6 "Early spermatids: 412.1;Endometrial ciliated cells: 1096.5;Late spermatids: 413.4;Respiratory ciliated cells: 1504.4" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 57.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "basal ganglia: 1.6" "Region enhanced" "Detected in many" "midbrain: 20.0" "HPA058271, HPA065540" Enhanced NA NA "HPA058271: AB_2683661, HPA065540: AB_2685510" "unprognostic (4.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "unprognostic (6.46e-2)" "unprognostic (3.62e-1)" "unprognostic (2.79e-2)" 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.4 0.0 8.6 1.1 0.0 0.0 5.1 0.2 0.0 459.2 0.0 0.0 0.1 0.9 0.1 0.0 25.7 0.0 2.0 2.0 0.0 0.3 0.0 0.0 0.4 0.0 1.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.8 0.1 0.1 78.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.4 0.0 0.1 0.9 2.0 2.0 0.0 1.0 2.8 0.9 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 98.3 0.0 0.0 0.0 0.0 0.0 0.0 122.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 412.1 1096.5 6.2 0.9 0.0 0.0 0.1 0.0 0.0 1.2 0.0 11.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 120.1 0.0 0.0 413.4 3.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.1 1504.4 0.0 0.0 0.0 34.5 95.9 3.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 BCAS4 "CNOL, FLJ20495" ENSG00000124243 "Breast carcinoma amplified sequence 4" Q8TDM0 20 50794894-50882676 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 71.6;B-cells: 76.0;granulocytes: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 73.9;naive B-cell: 76.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 96.5;U-698: 88.7" "Low region specificity" "Detected in all" HPA038812 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA038812: AB_10795141" "unprognostic (3.48e-1)" "unprognostic (1.60e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (8.35e-2)" "unprognostic (2.98e-1)" "unprognostic (2.47e-3)" "unprognostic (1.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.33e-1)" "unprognostic (2.35e-2)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" "unprognostic (4.30e-2)" 1.5 1.2 6.4 7.8 8.0 2.3 3.1 4.4 14.9 4.9 6.2 3.0 1.1 4.1 4.1 2.7 2.8 2.0 1.7 14.1 5.9 5.3 0.8 2.1 21.4 4.7 5.6 7.4 2.0 2.0 4.8 4.0 2.2 5.5 6.1 0.7 2.3 2.8 4.0 1.0 1.1 7.7 1.9 3.0 9.5 3.5 3.6 5.7 11.8 4.3 0.8 23.3 5.4 2.8 6.6 12.3 21.8 1.7 9.3 3.3 8.7 3.7 15.8 14.2 11.1 7.8 10.4 7.3 96.5 5.8 6.7 22.3 18.2 10.8 22.9 6.3 6.2 9.4 0.4 8.3 8.7 4.7 0.1 0.5 2.8 13.0 8.5 4.2 13.7 0.6 7.5 0.3 0.6 4.0 42.9 3.7 0.3 7.6 1.8 17.6 30.5 2.9 0.9 5.1 11.0 9.5 9.9 24.5 23.2 0.5 8.1 45.9 1.1 0.5 11.8 17.3 12.1 3.9 1.4 7.4 88.7 4.9 0.7 1.1 2.2 0.3 0.2 15.3 0.2 8.7 73.9 9.4 19.0 0.2 76.1 32.2 25.4 1.4 20.0 0.2 18.8 8.9 13.3 6.4 8.0 4.4 14.9 14.1 5.9 4.7 5.6 7.4 5.5 3.0 5.7 6.6 1.2 22.4 71.6 6.5 76.0 2.0 27.5 28.9 2.2 6.2 12.6 8.3 17.7 4.3 35.3 9.2 2.1 29.1 16.1 0.3 41.1 11.8 4.0 6.0 6.4 23.7 33.6 5.2 11.5 3.1 4.8 26.6 3.1 7.7 113.5 9.4 2.2 0.4 3.2 8.4 14.3 3.7 44.7 1.3 2.8 1.1 1.5 6.2 5.4 0.0 1.9 10.6 21.6 8.5 0.8 8.9 0.1 3.0 6.1 15.0 0.7 5.2 40.0 6.6 6.6 4.9 35.7 3.2 11.0 1.2 2.4 10.9 35.7 1.5 1.1 25.5 KCNK15 "dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5" ENSG00000124249 "Potassium two pore domain channel subfamily K member 15" Q9H427 20 44745865-44752313 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Collecting duct cells: 9.2;Exocrine glandular cells: 7.0;Granulosa cells: 6.3;Leydig cells: 6.5;Prostatic glandular cells: 5.6;Urothelial cells: 7.4" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 47.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MCF7: 48.9" "Region enriched" "Detected in single" 18 "olfactory bulb: 6.8" "Region enriched" "Detected in single" 7 "olfactory bulb: 3.9" HPA064861 Uncertain NA NA "HPA064861: AB_2685373" "unprognostic (8.70e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.05e-2)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.50e-2)" "unprognostic (4.22e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.11e-2)" "unprognostic (7.38e-4)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (2.21e-3)" "unprognostic (2.11e-1)" 3.1 2.1 0.2 0.2 0.5 0.0 3.0 0.1 0.5 2.9 0.3 0.5 0.2 2.4 0.2 0.7 5.2 1.0 1.2 0.2 0.8 1.4 0.3 2.0 0.0 0.2 0.4 0.2 2.2 1.6 0.1 3.5 0.1 0.2 1.6 0.0 0.2 1.7 1.4 0.4 1.3 0.6 1.1 0.1 0.1 2.8 3.3 0.2 0.0 2.7 0.2 0.0 1.0 1.5 0.3 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.4 0.3 0.1 0.1 0.3 0.0 0.0 0.8 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.4 0.0 1.4 0.6 4.6 0.0 0.5 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.5 0.2 0.8 0.2 0.4 0.2 0.2 0.1 0.2 0.3 1.0 0.0 0.0 0.0 0.1 0.5 1.9 0.0 0.6 0.1 1.6 1.0 0.7 15.7 0.4 9.2 0.0 0.0 0.0 0.3 0.0 3.9 0.2 1.7 2.3 2.5 1.2 0.0 1.0 7.0 0.0 3.9 1.1 1.6 0.0 6.3 1.4 0.3 0.1 0.0 0.5 0.4 0.0 0.0 0.3 0.3 6.5 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 1.5 0.3 0.4 0.0 5.6 0.0 0.2 0.1 0.1 0.0 0.5 0.6 0.2 0.4 1.4 0.9 0.0 0.1 0.3 1.0 7.4 TP53TG5 "C20orf10, CLG01, dJ453C12.5" ENSG00000124251 "TP53 target 5" Q9Y2B4 20 45372557-45407889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 17.9" "Cell type enhanced" "Detected in some" "Early spermatids: 671.5;Late spermatids: 254.4;Oligodendrocytes: 157.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041979, HPA058510, HPA077455" Enhanced Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA041979: AB_2677778, HPA058510: , HPA077455: " "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.29e-3)" "unprognostic (3.10e-3)" "unprognostic (9.26e-2)" "unprognostic (3.56e-2)" "unprognostic (1.72e-5)" "unprognostic (2.09e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.72e-4)" "unprognostic (1.41e-1)" 0.1 0.1 1.7 0.2 2.4 0.7 0.1 1.5 2.7 0.1 1.7 0.2 0.1 0.2 0.4 0.1 0.2 0.3 0.2 1.7 1.4 0.1 0.1 0.2 0.4 2.4 2.1 1.8 0.1 0.1 0.0 0.2 0.1 2.9 0.1 0.0 0.8 0.2 0.0 0.2 0.2 0.2 0.0 1.3 0.2 0.2 17.9 2.4 0.0 0.2 0.0 0.0 0.2 0.1 4.0 0.3 0.7 0.4 1.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.3 0.3 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.3 0.4 1.0 0.6 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.1 0.0 0.5 0.4 0.3 0.1 0.3 0.3 0.0 0.2 0.2 0.0 0.4 0.4 0.3 1.0 0.4 0.2 0.1 1.1 0.1 0.6 1.4 0.4 0.9 0.2 0.3 0.4 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.4 1.5 2.7 1.7 1.4 2.4 2.1 1.8 2.9 1.3 2.4 4.0 0.1 0.0 0.0 2.9 0.0 0.1 0.4 0.0 0.0 0.8 0.5 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 671.5 0.5 0.2 0.3 0.0 0.0 7.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 7.8 0.5 0.0 0.0 1.1 254.4 4.7 0.1 0.0 1.9 0.0 0.1 0.0 2.5 157.5 0.0 1.2 4.5 0.0 0.2 0.2 0.1 0.3 1.0 0.0 0.4 1.2 2.1 1.8 0.0 1.1 0.0 0.1 0.0 0.3 0.9 PCK1 PEPCK-C ENSG00000124253 "Phosphoenolpyruvate carboxykinase 1" P35558 20 57561080-57568121 "Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Kinase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 436.1;liver: 687.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 99.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "ASC diff: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006277, HPA006507, CAB017027" Approved NA NA 840000 "CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578" "unprognostic (3.50e-2)" "unprognostic (5.60e-2)" "unprognostic (4.60e-2)" "unprognostic (8.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.43e-2)" "unprognostic (1.84e-1)" "unprognostic (2.37e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.47e-5)" "unprognostic (1.03e-1)" "unprognostic (6.40e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-1)" 59.7 1.2 0.8 1.7 0.7 0.0 30.0 0.7 1.6 0.0 0.6 58.3 111.4 1.2 0.2 0.4 0.9 5.0 0.7 0.7 2.5 436.1 687.0 0.2 0.3 0.8 1.1 0.6 1.6 0.4 0.0 21.3 0.3 0.7 0.2 80.6 0.5 1.2 0.2 0.4 0.8 145.2 2.9 0.6 0.3 0.9 0.0 1.2 0.1 0.8 6.6 0.0 0.8 0.1 0.8 0.0 0.0 0.0 0.0 20.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.7 1.6 0.7 2.5 0.8 1.1 0.6 0.7 0.6 1.2 0.8 0.7 0.0 0.0 0.0 21.3 0.1 0.0 0.0 15.9 0.3 0.7 0.6 1.0 61.5 0.6 90.1 0.0 0.1 0.1 703.8 588.9 0.6 0.1 1.3 1.5 2.7 53.9 40.2 0.0 0.0 0.0 2.3 19.9 8.5 8.9 0.1 29.6 1184.0 0.0 3.3 0.0 293.6 0.0 22.6 0.0 0.0 0.0 12.8 0.0 1.9 0.0 9.9 0.0 0.0 0.0 0.1 285.5 0.0 0.0 0.0 2209.9 3547.9 0.0 0.4 0.0 0.3 6.0 0.0 0.1 10.3 0.3 0.3 10.2 1.5 348.5 0.1 ZBP1 "C20orf183, DAI, dJ718J7.3, DLM-1, DLM1" ENSG00000124256 "Z-DNA binding protein 1" Q9H171 20 57603846-57620576 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Necrosis" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.0;lymphoid tissue: 25.3" "Cell type enhanced" "Detected in some" "B-cells: 34.0;dendritic cells: 42.7;NK-cells: 53.5;Plasma cells: 189.2;T-cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 34.1;U-266/70: 16.6;U-266/84: 22.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041256 Enhanced NA NA "HPA041256: AB_2677380" "unprognostic (5.78e-3)" "unprognostic (9.86e-2)" "unprognostic (6.14e-2)" "unprognostic (6.20e-2)" "unprognostic (6.65e-2)" "unprognostic (1.05e-4)" "unprognostic (1.37e-2)" "unprognostic (1.31e-1)" "unprognostic (1.19e-3)" "unprognostic (1.38e-3)" "unprognostic (7.19e-2)" "unprognostic (2.58e-1)" "unprognostic (1.58e-8)" "unprognostic (8.29e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-2)" "unprognostic (9.79e-2)" 2.6 1.5 1.0 19.0 1.3 29.0 3.6 5.7 4.1 2.1 0.4 9.9 13.3 1.9 2.2 2.1 1.0 7.9 1.9 2.4 0.3 1.3 2.1 5.1 24.1 1.1 0.4 0.2 1.8 2.0 0.2 0.4 1.3 2.4 1.8 10.9 4.1 6.3 1.7 0.8 4.0 10.7 1.2 0.2 22.0 8.5 2.2 0.6 5.1 2.8 1.3 25.3 8.6 0.8 3.8 0.8 0.6 1.9 3.5 0.6 0.5 1.0 0.6 0.3 0.2 0.9 3.0 1.6 9.3 0.7 0.0 1.1 1.5 0.0 1.1 0.0 0.8 2.0 2.9 5.5 1.4 0.5 2.5 2.2 0.0 0.4 1.1 0.9 1.8 0.4 1.5 1.2 34.1 1.3 4.7 1.5 4.8 2.2 0.5 4.1 1.4 0.2 10.0 0.0 4.3 1.9 2.0 0.3 1.6 1.4 1.3 1.3 1.4 1.6 4.3 1.5 2.8 1.6 16.6 22.8 4.1 1.6 2.8 0.8 1.6 3.8 17.5 18.8 3.9 12.5 16.2 12.6 11.4 4.4 12.1 5.6 7.8 38.0 19.6 2.4 0.2 18.4 7.0 1.0 1.3 5.7 4.1 2.4 0.3 1.1 0.4 0.2 2.4 0.2 0.6 3.8 1.2 0.0 0.6 0.0 34.0 0.3 1.0 0.2 0.0 0.0 0.5 0.3 1.0 0.0 0.0 0.0 2.1 0.1 42.7 12.9 0.0 0.1 0.1 0.1 0.2 0.5 0.0 0.8 0.0 0.2 0.0 0.5 3.1 0.4 3.8 0.0 0.0 0.0 1.0 0.0 0.1 1.1 0.0 1.0 0.4 0.0 0.0 2.1 14.2 0.0 3.1 0.5 53.5 0.0 0.1 1.3 3.4 0.0 189.2 1.8 0.8 0.2 0.0 0.3 0.0 1.5 0.8 0.0 0.0 0.0 0.3 0.0 25.8 0.0 1.0 0.8 NEURL2 "C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3" ENSG00000124257 "Neuralized E3 ubiquitin protein ligase 2" Q9BR09 20 45888625-45891208 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 25.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 13.1;Proximal tubular cells: 17.3;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;Hep G2: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043402, HPA059842" Approved Approved Vesicles NA NA Vesicles "HPA043402: AB_2678464, HPA059842: AB_2684139" "unprognostic (6.26e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (8.04e-2)" "unprognostic (2.90e-1)" "unprognostic (1.73e-3)" "unprognostic (5.58e-2)" "unprognostic (1.99e-2)" "unprognostic (6.94e-2)" "unprognostic (1.97e-1)" "unprognostic (8.12e-2)" "unprognostic (1.58e-1)" 12.7 9.2 1.8 2.6 2.8 1.3 6.9 4.0 3.1 5.2 5.2 7.0 4.4 6.2 3.0 2.6 7.4 2.9 8.8 1.7 4.2 25.9 8.3 4.0 1.5 2.2 2.2 1.5 9.5 4.4 3.8 4.2 3.1 2.5 4.5 2.2 4.3 5.6 2.8 18.2 4.3 6.6 4.0 1.8 5.9 5.0 2.6 2.1 7.7 5.9 9.0 1.4 7.9 4.3 3.1 0.9 0.7 1.9 1.6 3.1 1.3 1.6 1.2 1.4 1.3 0.6 8.2 5.2 1.0 1.7 0.9 2.3 2.7 1.6 0.0 0.8 0.6 1.4 0.6 6.4 8.5 3.9 0.6 1.4 2.9 1.1 1.3 0.5 2.0 1.0 1.6 0.8 2.1 0.7 3.2 1.0 0.6 0.9 0.5 2.9 1.7 1.4 0.5 0.8 0.7 4.2 3.0 1.7 4.1 5.2 0.4 3.1 1.7 2.0 1.5 1.3 1.2 1.2 6.0 1.3 0.2 1.7 0.8 1.4 0.0 0.6 1.8 0.4 0.3 0.2 2.8 0.7 0.6 0.2 1.0 1.5 1.3 0.2 1.0 0.2 0.3 0.5 0.3 1.8 2.8 4.0 3.1 1.7 4.2 2.2 2.2 1.5 2.5 1.8 2.1 3.1 1.7 0.0 0.0 2.0 2.3 0.1 2.1 1.0 2.8 3.5 2.2 3.4 5.7 0.0 0.4 0.0 4.2 0.7 0.5 5.0 7.9 3.2 2.8 0.8 2.3 2.7 3.0 1.3 1.4 2.0 0.9 3.3 3.1 0.9 0.0 7.8 5.7 5.7 13.1 0.0 2.3 2.3 0.0 5.1 0.3 8.6 5.3 1.2 0.0 1.0 1.5 2.5 2.1 2.0 1.4 2.9 0.7 3.8 2.2 2.3 6.7 17.3 0.5 3.4 13.1 3.2 6.1 0.0 0.3 1.8 1.1 0.5 0.7 11.0 2.1 1.7 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "placenta: 9.5;testis: 2.6" "Cell type enhanced" "Detected in some" "Sertoli cells: 6.6;Spermatocytes: 57.3;Spermatogonia: 26.2;Syncytiotrophoblasts: 11.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 3.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "GAMG: 78.6" "Not detected" "Not detected" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: AB_2686310" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.5 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.1 0.0 0.0 0.0 0.2 4.9 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.0 6.0 0.0 0.4 0.0 12.7 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 57.3 26.2 0.0 0.0 11.2 0.0 0.0 0.0 0.1 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 70.1;Late spermatids: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 11.3 10.7 5.5 9.6 11.1 5.8 6.4 9.5 11.0 6.8 3.8 8.3 9.0 11.8 12.4 9.4 9.7 11.9 14.6 7.3 10.8 18.8 19.6 13.2 11.1 10.0 11.0 5.7 11.5 12.0 12.9 6.7 10.9 11.1 9.1 10.2 19.4 10.6 7.2 29.1 9.1 10.3 12.1 9.0 6.8 6.8 7.1 9.6 7.6 9.1 33.2 10.7 14.6 5.6 20.3 19.3 18.1 10.2 20.0 34.0 13.6 25.1 31.1 18.5 16.5 15.4 27.8 15.1 32.6 27.9 24.6 27.4 11.8 17.0 14.2 27.9 22.9 15.8 14.6 62.0 15.3 21.9 23.4 6.8 18.3 11.4 24.6 18.4 20.4 10.4 8.0 21.9 24.2 9.8 4.2 14.2 11.7 7.3 29.4 19.0 12.4 9.5 14.1 16.2 16.0 14.0 2.5 51.6 33.7 28.6 18.1 10.7 17.5 14.6 31.9 19.7 24.1 22.7 34.7 13.5 27.3 23.1 50.5 19.1 5.3 4.0 3.0 4.1 5.5 7.0 3.3 6.5 5.7 3.6 3.3 4.1 3.6 0.1 3.1 4.4 2.3 9.1 3.3 5.5 11.1 9.5 11.0 7.3 10.8 10.0 11.0 5.7 11.1 9.0 9.6 20.3 7.7 16.0 70.1 10.1 11.1 16.3 9.4 4.6 12.0 0.0 9.7 5.1 12.9 5.7 9.0 9.2 0.0 9.9 11.4 11.0 21.5 10.2 50.1 10.0 10.7 8.0 9.6 12.4 25.4 5.5 8.9 11.8 9.2 6.7 10.2 6.5 8.6 19.3 7.7 0.0 20.8 9.1 0.0 11.1 9.4 99.2 10.5 9.7 1.8 15.0 8.1 0.0 7.2 20.1 50.9 7.2 6.0 11.7 26.5 14.3 8.7 28.9 10.1 0.0 6.6 10.7 10.1 17.4 13.1 10.5 20.6 11.2 13.8 11.8 9.4 8.7 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA068525: AB_2685999, HPA074462: AB_2686692" "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favorable (8.53e-4)" 3.5 5.5 2.8 3.9 2.8 4.4 6.3 2.6 3.4 4.0 3.2 5.7 5.4 3.4 4.0 3.1 3.1 3.3 3.3 2.6 2.8 9.1 6.7 3.6 5.6 2.7 2.8 2.7 4.5 3.0 5.9 2.8 3.3 2.8 4.2 6.7 3.5 3.4 3.4 5.7 4.7 6.0 3.9 2.8 4.7 4.8 2.7 2.5 5.3 4.1 4.3 6.5 3.4 2.7 3.1 10.5 9.0 8.5 11.1 5.2 6.6 16.8 8.5 7.2 13.0 9.9 13.6 10.8 36.0 16.6 9.3 16.5 10.8 21.5 12.0 18.7 9.9 11.1 12.6 28.7 10.7 7.2 21.0 9.8 7.7 5.0 12.3 7.3 5.8 7.2 14.1 17.5 6.1 10.0 7.6 14.2 12.2 7.8 10.9 12.7 16.0 10.4 8.3 10.8 11.1 5.9 5.6 25.9 11.1 12.6 7.7 10.0 9.5 4.8 12.8 13.2 13.6 14.3 7.0 7.2 22.9 8.7 18.9 10.8 2.9 4.2 5.9 4.6 5.7 6.1 7.7 6.6 4.8 5.2 5.7 7.2 6.8 0.2 4.2 4.7 3.0 8.1 3.6 2.8 2.8 2.6 3.4 2.6 2.8 2.7 2.8 2.7 2.8 2.8 2.5 3.1 5.3 16.0 5.9 3.9 5.7 2.5 2.3 11.6 1.8 3.3 5.4 4.7 5.0 5.7 5.1 0.0 0.0 7.8 8.8 6.5 5.9 9.1 0.4 3.1 5.4 5.3 7.2 4.6 5.6 11.8 7.1 4.8 4.1 3.3 3.8 4.2 6.4 9.7 8.4 5.0 4.9 6.5 12.2 7.0 5.1 1.1 5.3 5.2 1.8 0.0 12.1 3.5 10.3 2.0 5.9 11.6 4.4 4.5 4.9 3.0 12.4 21.3 6.5 5.3 0.0 3.5 4.0 4.0 6.0 6.6 5.5 4.2 6.8 8.0 7.7 2.1 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521791 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 211.2;kidney: 280.3" "Group enriched" "Detected in all" 4 "Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm NA NA 860000000 Nucleoplasm "HPA015599: AB_1855192, HPA072045: AB_2732194" "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 50.9 56.5 25.8 27.1 30.5 14.4 44.0 33.2 30.7 35.9 28.8 42.1 182.1 50.1 10.0 43.2 34.5 31.5 24.1 25.5 33.0 280.3 118.8 38.4 31.0 33.7 28.2 22.0 36.2 27.3 29.5 42.9 22.1 32.2 23.8 14.9 11.9 33.9 23.1 35.9 42.2 211.2 24.7 34.3 38.5 33.8 18.5 30.3 21.0 37.3 23.5 21.5 40.5 28.4 41.4 43.2 118.7 26.4 53.1 114.9 44.9 80.6 37.4 65.3 45.6 52.7 104.7 34.2 18.8 53.5 73.2 33.9 11.2 39.5 28.5 23.4 51.3 50.4 107.7 24.6 108.3 91.6 29.6 128.8 63.6 29.0 38.2 18.3 27.8 56.4 34.4 22.7 49.4 44.2 54.3 19.0 11.7 46.2 79.6 48.8 45.3 41.0 51.2 39.4 108.8 40.3 106.4 64.2 31.3 62.5 18.2 25.1 36.3 56.6 48.3 46.6 62.3 41.8 45.2 59.1 13.1 49.5 48.2 65.8 113.7 117.2 8.3 75.5 123.6 65.5 49.6 74.0 69.8 100.6 50.5 47.1 55.6 6.1 55.6 92.5 31.0 76.1 119.6 25.8 30.5 33.2 30.7 25.5 33.0 33.7 28.2 22.0 32.2 34.3 30.3 41.4 56.9 22.4 27.4 11.4 29.0 19.4 32.9 36.0 11.4 33.3 16.2 24.4 13.3 52.9 23.8 73.5 4.2 21.4 32.6 17.6 197.6 77.2 8.0 15.0 20.1 50.7 17.3 25.4 19.9 44.2 67.3 38.6 18.3 13.0 57.6 41.9 52.8 180.3 227.2 62.2 14.9 35.6 30.5 59.7 40.9 13.2 49.4 75.3 67.6 15.9 102.2 73.6 34.0 21.6 24.3 33.8 79.3 60.5 31.5 22.9 833.0 1278.3 27.1 33.7 39.5 37.0 43.1 10.2 44.5 34.3 20.3 30.4 33.7 48.7 44.6 22.2 CHST8 GALNAC-4-ST1 ENSG00000124302 "Carbohydrate sulfotransferase 8" Q9H2A9 19 33621953-33773509 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "brain: 29.8;pituitary gland: 64.4" "Cell type enhanced" "Detected in some" "Early spermatids: 15.4;Excitatory neurons: 11.8;Granulosa cells: 7.9;Late spermatids: 56.5;Oligodendrocyte precursor cells: 12.1" "Group enriched" "Detected in many" 4 "breast cancer: 4.1;glioma: 4.9;testis cancer: 3.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 24.7;SCLC-21H: 13.5;SH-SY5Y: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016004 Enhanced "Intracellular and membrane" NA NA "HPA016004: AB_1846731" "unprognostic (1.00e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (9.44e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-2)" "unprognostic (5.75e-2)" "unprognostic (8.41e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (6.98e-8)" "unprognostic (9.37e-3)" "unprognostic (2.61e-1)" "unprognostic (3.28e-1)" "unprognostic (3.87e-2)" 0.6 0.7 6.4 0.3 6.4 0.0 1.9 9.3 10.0 0.8 0.0 0.3 0.0 0.6 0.0 0.3 1.2 0.9 0.4 10.4 8.6 0.1 0.1 0.2 0.4 24.9 9.6 3.6 1.0 0.7 0.0 64.4 0.0 29.8 0.7 0.0 0.7 0.2 0.0 0.1 0.3 0.3 0.1 3.5 1.3 0.3 1.4 11.5 0.0 0.6 0.0 0.2 0.3 0.6 21.3 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 4.7 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.6 0.0 0.0 0.0 0.1 24.7 0.0 0.4 13.5 23.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 6.4 9.3 10.0 10.4 8.6 24.9 9.6 3.6 29.8 3.5 11.5 21.3 0.2 0.0 0.0 0.7 0.0 0.8 0.4 0.0 0.0 3.1 3.8 0.6 5.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.3 0.2 0.4 0.0 0.0 11.8 0.0 1.3 0.2 0.0 0.1 0.0 7.9 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 56.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 12.1 3.6 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.3 3.2 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.0 1.1 IQSEC2 "BRAG1, IQ-ArfGEF, KIAA0522, MRX1, MRX18, MRX78" ENSG00000124313 "IQ motif and Sec7 domain ArfGEF 2" Q5JU85 X 53225828-53321350 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.0;Late spermatids: 41.6;Proximal enterocytes: 42.1;Proximal tubular cells: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 10.4;plasmacytoid DC: 10.6" "Group enriched" "Detected in many" 16 "dendritic cells: 10.6;monocytes: 10.4" "Cell line enhanced" "Detected in many" "A549: 47.3;GAMG: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003973, HPA076533" Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA003973: AB_2280343, HPA076533: " "unprognostic (1.85e-1)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (1.32e-1)" "unprognostic (4.66e-3)" "unprognostic (6.02e-2)" "unprognostic (2.80e-1)" "unprognostic (3.78e-2)" "unprognostic (2.82e-1)" "unprognostic (9.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.56e-2)" "unprognostic (1.75e-1)" "unprognostic (4.30e-2)" "prognostic favorable (2.38e-4)" 10.9 19.0 20.2 5.9 24.2 2.4 10.0 11.3 34.6 9.5 0.0 13.9 12.6 12.1 4.4 9.6 10.8 6.2 10.3 38.6 8.8 19.2 1.9 8.7 2.8 5.7 1.5 28.8 7.7 9.1 14.3 11.0 3.8 11.5 12.1 7.1 3.1 15.0 8.9 59.2 8.7 14.3 7.3 0.2 5.3 10.5 9.9 3.6 3.4 9.8 34.3 3.4 12.2 9.8 15.8 4.8 47.3 1.8 4.4 6.5 13.1 5.3 7.7 13.4 6.2 10.9 1.2 18.2 0.3 12.4 18.3 58.5 6.4 1.7 7.7 4.4 4.8 8.3 5.4 20.8 1.3 14.2 0.2 2.8 9.8 11.8 16.1 9.0 14.4 8.5 0.1 17.3 5.3 12.4 11.2 0.0 1.0 14.6 14.2 21.0 3.5 3.7 6.0 9.0 10.1 1.9 1.8 18.0 11.0 7.5 8.3 15.7 2.3 9.5 5.6 10.6 3.1 3.5 1.5 0.2 0.2 34.6 3.5 3.1 0.1 10.4 0.5 0.0 3.7 0.1 0.2 0.0 0.0 5.4 0.1 0.1 0.0 0.6 0.0 2.0 10.6 0.0 2.3 20.2 24.2 11.3 34.6 38.6 8.8 5.7 1.5 28.8 11.5 0.2 3.6 15.8 8.4 6.4 5.9 15.0 1.4 4.0 6.7 11.5 7.4 1.5 12.2 9.5 4.0 12.8 9.3 14.7 0.0 8.0 2.0 21.1 21.5 5.2 18.0 5.4 3.5 6.2 3.6 0.8 54.0 7.1 6.5 6.6 8.2 4.7 3.8 9.1 6.4 0.9 14.7 0.0 25.7 9.7 8.2 12.0 5.0 41.6 1.5 14.1 10.6 17.8 11.9 5.0 0.0 9.5 2.5 5.5 12.6 2.2 1.0 7.0 42.1 52.4 7.6 0.1 0.0 2.7 8.4 0.8 1.5 9.3 3.8 4.5 1.5 2.5 10.7 14.6 VAMP7 "SYBL1, TI-VAMP, VAMP-7" ENSG00000124333 "Vesicle associated membrane protein 7" P51809 X 155881345-155943769 "Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036733 Approved Supported Vesicles NA NA Vesicles "HPA036733: AB_10672228" "unprognostic (7.54e-3)" "unprognostic (1.35e-2)" "unprognostic (2.07e-1)" "unprognostic (1.04e-1)" "unprognostic (6.15e-3)" "unprognostic (2.70e-2)" "unprognostic (5.77e-2)" "unprognostic (7.95e-2)" "unprognostic (7.18e-2)" "unprognostic (3.38e-3)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.29e-1)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (2.97e-1)" 29.7 24.5 20.9 24.3 23.1 37.4 24.0 25.3 23.8 23.4 21.5 23.1 23.6 21.6 15.6 22.8 16.6 22.3 19.8 20.6 24.2 39.6 48.3 25.0 26.6 23.7 23.6 20.0 18.0 14.4 32.5 8.8 40.8 24.5 21.6 24.6 10.4 17.4 20.3 22.1 20.3 27.7 28.4 24.0 22.0 18.5 15.0 22.6 30.2 24.6 24.3 28.8 25.8 16.0 26.1 72.9 31.3 21.0 43.6 57.0 54.3 56.3 55.3 49.1 49.0 98.4 33.8 46.5 100.6 100.0 66.9 55.5 25.5 47.6 38.9 64.5 42.3 41.6 41.8 43.1 24.3 63.6 86.9 62.8 50.9 37.9 54.8 49.8 42.8 55.4 43.5 91.1 54.2 56.0 36.5 34.1 48.8 15.0 54.1 45.3 25.5 41.2 75.3 65.6 36.2 16.0 46.0 32.7 32.6 49.6 54.8 31.9 71.8 58.4 44.8 46.7 65.0 79.6 123.8 167.8 138.9 39.2 104.4 51.0 86.8 25.3 39.6 15.1 27.0 19.1 12.3 17.7 18.6 26.4 13.2 16.2 17.5 21.9 22.7 26.7 15.0 22.0 22.4 20.9 23.1 25.3 23.8 20.6 24.2 23.7 23.6 20.0 24.5 24.0 22.6 26.1 17.8 3.2 9.2 11.1 21.2 19.6 14.7 11.8 20.5 7.6 16.6 9.5 12.3 5.7 12.5 7.3 6.2 48.4 24.9 14.1 41.1 28.0 6.9 13.8 14.5 19.8 13.2 31.4 14.2 26.0 49.7 19.6 12.2 13.7 31.1 22.5 20.3 25.1 31.1 6.7 14.6 12.8 10.2 30.8 49.0 6.9 17.7 35.9 19.6 7.5 32.5 10.4 29.9 8.0 19.2 29.9 13.5 19.5 15.2 17.5 25.3 52.9 10.5 4.6 26.3 10.8 18.9 45.4 26.3 20.3 19.5 69.8 21.6 25.3 15.3 20.1 IL9R CD129 ENSG00000124334 "Interleukin 9 receptor" Q01113 X 155997581-156010817 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.5;urinary bladder: 4.5" "Group enriched" "Detected in some" 5 "granulocytes: 4.5;T-cells: 2.7" "Group enriched" "Detected in some" 4 "cervical cancer: 0.7;urothelial cancer: 1.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 3.4" "Group enriched" "Detected in many" 23 "B-cells: 1.8;granulocytes: 3.4;T-cells: 1.4" "Cell line enriched" "Detected in some" 10 "HMC-1: 247.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA063240, HPA064557" Approved "Intracellular and membrane" NA NA "HPA063240: AB_2732700, HPA064557: AB_2732716" "unprognostic (1.07e-2)" "unprognostic (3.27e-3)" "unprognostic (9.52e-3)" "unprognostic (4.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.26e-4)" "unprognostic (8.94e-2)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.82e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (3.98e-8)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (4.07e-1)" "prognostic favorable (1.90e-7)" 0.1 0.0 0.2 1.0 0.2 0.5 0.2 0.1 0.2 0.2 0.0 0.4 0.6 0.2 0.1 0.5 0.3 0.8 0.0 0.2 0.1 0.1 0.2 1.1 2.4 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.3 0.9 0.1 0.4 0.1 0.1 0.5 1.7 0.1 0.1 1.7 0.7 0.0 0.1 3.5 0.3 0.0 2.2 4.5 0.2 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.3 23.8 0.0 0.0 0.0 0.5 247.8 0.0 0.2 0.0 0.0 0.0 0.0 5.6 3.7 0.8 0.0 1.1 9.5 4.9 0.0 0.1 0.0 0.6 0.1 0.0 0.0 19.2 0.2 0.1 0.0 0.4 0.2 0.0 0.3 0.4 0.0 0.1 0.6 0.1 0.1 1.2 0.6 0.9 0.2 0.3 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.8 0.3 0.6 0.0 1.8 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.5 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 XG PBDX ENSG00000124343 "Xg glycoprotein (Xg blood group)" P55808 X 2752040-2816500 "Blood group antigen proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 14.4;Basal respiratory cells: 15.1;Basal squamous epithelial cells: 30.7;Fibroblasts: 30.1;Melanocytes: 10.6;Squamous epithelial cells: 10.1;Suprabasal keratinocytes: 21.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 63.7;ASC TERT1: 50.6;fHDF/TERT166: 31.5;hTCEpi: 49.6;T-47d: 28.2" "Low region specificity" "Detected in all" NA NA 22000 "prognostic unfavorable (4.25e-4)" "unprognostic (1.69e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" "unprognostic (8.62e-2)" "unprognostic (7.21e-2)" "unprognostic (2.30e-1)" "unprognostic (8.10e-6)" "unprognostic (3.96e-3)" "unprognostic (7.98e-2)" "unprognostic (5.83e-3)" "unprognostic (6.77e-3)" 10.8 0.0 0.1 0.1 0.0 1.2 9.0 0.1 0.1 7.1 0.0 0.3 0.1 1.2 0.0 11.8 0.8 3.4 1.6 0.1 0.2 0.3 0.7 0.6 0.3 0.3 0.1 0.0 0.2 0.1 0.1 0.1 1.8 0.2 0.8 0.1 0.0 7.7 0.6 3.2 36.7 0.1 0.2 0.4 0.1 0.3 0.1 0.1 2.2 1.9 5.0 3.1 2.1 12.8 0.6 0.1 0.0 0.0 0.1 63.7 50.6 0.6 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 31.5 0.0 5.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.1 49.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 4.2 0.1 28.2 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.4 0.1 0.6 3.3 0.0 0.0 1.0 0.0 14.4 0.5 15.1 30.7 0.0 0.2 0.4 0.4 0.0 1.3 1.8 0.0 0.8 0.5 0.0 0.0 0.0 0.0 2.4 0.5 0.8 0.0 1.3 0.9 0.0 0.1 30.1 0.0 1.2 0.0 6.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 9.0 0.0 0.0 0.1 10.6 1.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 2.5 2.5 0.2 0.5 10.1 21.9 0.5 0.5 0.5 0.0 0.2 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 1108.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 18000 Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: AB_2732470" "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 15.7 11.7 23.0 14.8 29.5 13.5 20.4 29.3 25.1 19.4 19.7 21.7 20.9 20.8 15.7 25.7 18.5 17.0 22.5 20.7 25.5 22.1 19.1 15.8 19.5 30.7 28.5 18.7 17.9 12.3 24.5 9.4 17.5 29.9 22.3 23.5 14.7 21.7 15.7 37.7 16.9 20.6 21.5 31.1 15.0 18.4 15.9 27.7 23.4 22.8 43.1 21.8 17.0 16.1 39.2 39.0 44.0 34.0 31.6 31.1 37.2 39.1 23.3 31.7 42.1 40.3 73.7 35.9 32.2 35.8 19.8 55.7 30.0 36.6 81.7 47.6 56.6 41.3 43.3 29.1 58.1 43.4 35.8 50.0 30.1 57.6 49.6 70.7 53.5 25.1 43.7 47.9 47.8 1108.9 46.8 55.9 32.4 54.9 55.1 22.7 38.6 89.4 46.1 45.2 43.0 62.0 45.8 28.4 34.6 49.1 36.4 32.3 21.4 22.0 37.5 44.5 22.9 41.9 44.8 46.9 24.9 46.4 38.1 44.7 30.7 18.9 34.2 15.9 21.4 17.2 21.5 18.3 15.6 19.9 19.3 18.9 14.4 27.6 22.3 19.9 19.5 25.8 14.9 23.0 29.5 29.3 25.1 20.7 25.5 30.7 28.5 18.7 29.9 31.1 27.7 39.2 22.1 19.2 17.7 22.9 21.5 16.3 28.9 61.7 31.3 22.3 28.8 27.7 41.1 28.6 34.4 25.8 12.5 43.0 27.4 48.7 49.0 37.9 80.8 35.6 37.3 21.4 10.3 34.9 18.5 36.3 32.5 26.0 18.8 45.8 52.6 21.2 17.5 41.1 33.0 26.9 22.1 36.4 40.7 27.7 16.2 125.0 32.6 25.2 7.2 16.9 34.1 24.9 25.7 26.2 67.2 44.5 41.8 34.6 21.5 40.9 57.2 68.8 24.5 21.0 39.5 28.2 27.2 33.1 44.2 44.5 21.6 44.5 21.4 27.5 34.3 27.1 NAGK GNK ENSG00000124357 "N-acetylglucosamine kinase" Q9UJ70 2 71064344-71079808 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 216.9;Syncytiotrophoblasts: 318.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 391.8;granulocytes: 288.7;monocytes: 594.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035206, HPA035207" Enhanced Approved Nucleoplasm,Cytosol NA NA 1000000 Cytosol Nucleoplasm "HPA035206: AB_2674517, HPA035207: AB_10602031" "unprognostic (6.15e-2)" "unprognostic (4.23e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.44e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.65e-3)" "unprognostic (2.18e-2)" "unprognostic (2.31e-1)" "unprognostic (9.99e-2)" "unprognostic (4.32e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (4.35e-4)" "unprognostic (8.60e-2)" "unprognostic (1.45e-2)" "unprognostic (5.50e-3)" "unprognostic (2.13e-2)" 40.0 36.3 46.7 61.8 46.5 22.1 35.4 48.3 52.6 45.7 46.1 36.5 21.2 33.9 41.0 157.5 29.2 44.5 31.2 45.8 51.8 35.1 43.2 39.9 80.2 49.9 47.6 45.9 31.2 42.6 81.4 42.6 44.7 51.5 30.3 34.5 16.6 75.6 38.3 26.9 63.5 33.9 50.5 48.0 89.6 34.2 50.5 47.6 61.4 27.6 32.5 99.2 72.4 60.2 50.4 55.9 39.2 22.6 25.8 114.2 67.5 98.3 119.0 65.5 95.6 86.8 54.3 29.5 30.3 29.3 107.4 113.5 25.7 22.4 43.9 62.7 44.9 16.4 17.0 12.6 37.5 91.6 10.5 37.7 60.7 49.6 101.8 16.4 68.3 107.7 31.7 8.1 34.8 143.4 52.2 28.6 40.2 28.7 53.5 38.4 22.1 64.2 15.8 65.5 91.4 25.1 13.0 35.2 62.1 45.1 50.7 30.4 13.9 66.0 99.0 37.8 36.9 44.8 23.0 24.8 18.0 69.6 31.5 54.5 86.6 594.1 245.1 36.9 526.5 39.2 102.5 44.2 37.0 391.8 103.7 36.7 30.0 288.7 65.3 378.2 318.5 54.7 466.2 46.7 46.5 48.3 52.6 45.8 51.8 49.9 47.6 45.9 51.5 48.0 47.6 50.4 22.9 38.5 34.2 15.0 48.6 26.9 28.4 60.8 19.4 46.1 27.4 27.6 18.0 17.2 56.9 38.6 22.9 146.0 67.4 13.9 41.1 66.1 151.3 22.5 26.1 31.7 23.4 12.8 11.5 45.7 144.0 35.6 15.8 24.9 51.9 31.1 30.0 12.9 216.9 47.1 15.2 20.4 28.5 121.8 67.5 33.0 30.1 106.0 39.2 26.2 118.6 45.4 17.5 17.1 24.0 59.1 32.3 37.6 51.2 15.5 23.3 64.7 35.2 55.6 19.7 31.8 37.4 68.0 25.6 39.9 41.6 318.8 29.1 32.2 16.2 34.7 MCEE "GLOD2, MCE" ENSG00000124370 "Methylmalonyl-CoA epimerase" Q96PE7 2 71109684-71130239 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 92.0;Proximal tubular cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035196 Approved Nucleoli "Intracellular and membrane" No No 29000 Nucleoli "HPA035196: AB_10601871" "unprognostic (7.65e-2)" "unprognostic (8.20e-2)" "unprognostic (3.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" "prognostic favorable (4.76e-4)" "prognostic favorable (5.78e-4)" "unprognostic (4.86e-3)" "unprognostic (6.48e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-3)" "unprognostic (8.59e-2)" "unprognostic (9.40e-3)" "unprognostic (4.90e-2)" "unprognostic (3.55e-1)" "unprognostic (6.51e-2)" "unprognostic (5.38e-2)" 18.0 30.2 9.7 12.4 10.4 9.2 33.0 11.3 12.6 20.2 15.1 20.3 20.3 13.2 30.8 26.5 14.9 14.3 36.3 9.7 10.1 34.0 70.4 13.8 14.8 11.0 10.2 9.2 18.6 36.4 35.9 24.3 17.8 10.9 24.2 24.2 12.4 43.2 18.0 36.8 28.6 17.0 12.3 10.5 16.1 23.8 6.0 10.0 13.4 14.2 62.2 15.6 16.6 22.0 12.5 12.1 5.2 10.6 7.6 34.3 46.6 30.2 18.5 23.3 9.2 13.9 14.7 14.8 18.7 5.5 18.5 7.0 12.5 12.4 9.6 9.5 17.1 10.7 12.7 16.3 42.5 19.5 14.5 10.3 31.3 13.5 6.2 12.3 20.5 10.6 14.6 17.1 31.9 9.1 15.5 10.9 16.9 9.6 33.1 14.6 12.8 12.3 35.2 14.8 10.4 11.9 8.8 6.9 40.1 18.1 12.1 31.7 13.4 13.7 10.6 8.3 10.9 7.5 30.7 13.1 20.0 17.5 23.7 9.9 20.3 23.2 27.6 15.4 25.6 21.9 21.6 19.3 15.5 19.9 16.7 17.6 15.0 6.1 16.5 25.3 23.9 35.3 14.6 9.7 10.4 11.3 12.6 9.7 10.1 11.0 10.2 9.2 10.9 10.5 10.0 12.5 11.1 25.6 13.4 13.7 12.8 8.5 10.5 18.4 21.6 2.6 37.5 27.3 75.2 25.8 18.2 5.5 2.1 36.2 11.2 14.0 92.0 13.3 1.1 17.2 16.2 9.0 9.0 12.0 13.3 18.4 36.8 23.3 17.3 20.2 0.0 5.2 12.8 73.0 15.1 5.0 14.5 32.5 18.3 10.4 8.7 1.0 29.2 9.4 14.2 14.0 9.1 7.3 5.2 16.1 20.8 9.6 16.2 17.7 42.0 11.0 35.0 77.1 19.4 8.6 26.3 12.7 17.9 3.7 5.1 25.6 20.9 11.4 10.1 16.9 23.0 11.9 PAIP2B KIAA1155 ENSG00000124374 "Poly(A) binding protein interacting protein 2B" Q9ULR5 2 71182738-71227103 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 200.2;choroid plexus: 88.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 86.0;Early spermatids: 95.1;Hepatocytes: 67.1;Proximal tubular cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 15.8;SCLC-21H: 23.1" "Low region specificity" "Detected in all" "HPA046784, HPA072371" Approved Approved Cytosol NA NA Cytosol "HPA046784: AB_2679804, HPA072371: AB_2686514" "unprognostic (8.70e-2)" "unprognostic (8.20e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (8.17e-5)" "unprognostic (4.56e-2)" "unprognostic (1.34e-1)" "unprognostic (9.67e-3)" "unprognostic (1.51e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.96e-12)" "unprognostic (1.63e-2)" "unprognostic (3.87e-1)" "unprognostic (1.21e-2)" "unprognostic (4.61e-2)" 2.4 1.7 166.8 1.8 169.3 1.3 4.5 128.2 148.0 2.9 88.0 3.9 3.7 3.0 1.8 6.2 7.3 1.1 19.9 116.4 127.5 10.4 18.2 2.8 2.1 157.2 156.9 100.6 11.6 54.7 6.1 2.2 0.6 173.0 4.8 3.7 28.0 38.2 3.6 49.0 16.5 2.8 1.8 153.0 2.2 10.5 2.2 147.4 2.4 11.7 26.9 4.7 2.8 4.0 200.2 2.5 0.6 1.0 3.6 0.4 0.5 4.4 0.3 0.1 0.3 0.2 0.9 1.0 3.2 0.6 0.0 2.4 2.0 6.1 3.7 1.2 1.7 5.0 3.1 0.4 0.1 1.6 0.8 0.2 0.6 3.3 0.2 3.6 0.9 0.6 7.2 5.5 3.0 0.2 3.2 1.0 1.7 2.6 5.8 2.3 0.0 10.5 15.8 1.9 1.7 23.1 1.3 2.6 1.7 1.1 5.5 7.5 0.2 0.1 0.3 1.9 1.9 1.0 6.1 5.5 3.9 0.2 1.1 0.5 0.5 0.3 0.5 1.0 0.4 1.2 2.5 1.3 1.0 0.4 2.6 2.1 1.9 0.2 0.8 0.4 2.3 0.6 0.6 166.8 169.3 128.2 148.0 116.4 127.5 157.2 156.9 100.6 173.0 153.0 147.4 200.2 3.3 3.2 4.5 5.2 9.9 7.8 7.0 4.0 5.7 11.3 14.8 8.8 86.0 12.8 2.7 7.3 6.2 3.2 13.2 2.7 21.5 4.9 95.1 18.4 3.9 3.9 41.5 15.6 4.2 41.3 9.2 4.7 11.2 17.5 1.3 7.5 7.1 67.1 1.9 6.7 4.6 6.3 14.2 3.2 1.6 30.0 5.3 2.6 14.2 2.8 2.4 12.3 4.1 2.5 31.9 10.4 4.0 5.3 29.9 9.4 1.3 56.9 15.5 43.3 0.0 9.3 4.0 32.9 7.7 17.3 20.0 6.3 4.7 4.3 8.1 6.0 SNRNP27 "RY1, U4/U6.U5-27K" ENSG00000124380 "Small nuclear ribonucleoprotein U4/U6.U5 subunit 27" Q8WVK2 2 69893956-69905575 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034541 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034541: AB_10602408" "unprognostic (2.24e-1)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.61e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.18e-1)" "unprognostic (4.35e-3)" "unprognostic (9.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" 31.3 33.7 28.4 24.1 31.0 43.6 26.4 32.5 37.4 20.1 25.6 18.4 17.6 23.7 24.5 20.0 19.3 21.7 39.9 30.6 30.6 23.7 24.8 19.3 33.1 28.4 30.1 28.7 21.9 18.7 32.4 16.4 30.5 28.4 23.9 21.1 25.6 22.0 19.5 62.8 19.6 20.6 24.2 29.9 22.8 18.6 14.3 29.5 32.0 27.1 72.4 28.0 25.0 13.6 34.4 27.9 16.2 52.0 31.4 44.7 49.0 41.7 38.5 45.4 54.2 42.9 34.0 31.3 29.6 30.5 31.5 56.0 15.3 34.9 16.1 67.3 33.3 34.1 34.2 14.4 42.2 40.1 43.6 57.9 36.0 38.6 35.4 30.4 44.4 42.0 41.6 49.0 46.6 72.1 15.6 59.4 73.9 38.1 30.1 16.2 46.0 42.9 31.1 60.0 18.5 53.0 41.9 28.7 30.8 42.7 39.0 28.1 35.4 24.6 37.1 51.3 53.7 58.5 28.5 29.9 45.7 33.2 52.4 71.7 43.2 25.1 38.9 23.6 23.5 25.2 37.9 25.7 23.4 22.2 32.2 27.8 27.7 13.7 32.2 25.2 40.8 30.3 25.1 28.4 31.0 32.5 37.4 30.6 30.6 28.4 30.1 28.7 28.4 29.9 29.5 34.4 45.3 54.5 39.3 6.5 57.1 49.1 40.5 47.0 44.9 31.6 53.0 32.4 60.7 47.1 36.1 62.5 14.6 49.2 69.9 40.5 74.3 57.7 37.4 37.0 44.8 42.0 38.9 82.7 14.1 55.1 70.1 50.5 18.8 44.6 60.0 24.5 56.4 78.8 57.4 23.5 11.6 52.7 22.4 57.7 46.6 12.4 51.3 48.5 37.4 8.4 50.6 41.8 68.0 4.0 7.6 70.4 42.8 57.9 60.2 34.3 33.9 63.8 47.2 31.2 39.5 32.4 45.2 76.2 61.7 33.9 46.0 52.5 51.7 20.3 37.5 37.7 MPHOSPH10 "CT90, MPP10, MPP10P, PPP1R106" ENSG00000124383 "M-phase phosphoprotein 10" O00566 2 71130632-71150101 "Predicted intracellular proteins, Predicted membrane proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035059, HPA035060, HPA049907" Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947" "unprognostic (3.20e-3)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (3.58e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-3)" "unprognostic (6.13e-2)" "unprognostic (3.50e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (3.89e-7)" "unprognostic (1.24e-1)" "unprognostic (2.91e-1)" "unprognostic (2.47e-1)" "unprognostic (2.23e-2)" 22.8 18.6 17.0 20.5 18.1 26.8 25.3 19.5 21.6 20.1 17.3 17.8 17.9 22.3 27.8 28.9 16.8 18.6 23.4 17.2 18.1 18.0 31.0 17.0 25.4 18.9 18.2 16.5 26.1 19.9 23.1 16.0 20.5 18.9 24.9 19.3 15.2 21.2 16.9 33.4 26.9 15.7 17.0 17.7 19.7 18.0 15.5 18.2 22.7 21.9 24.2 27.8 24.0 18.3 19.4 45.8 33.7 42.7 51.3 39.1 36.7 58.3 49.8 39.6 40.6 29.7 60.7 32.9 64.3 30.5 35.3 31.0 41.1 54.8 35.3 54.1 44.7 43.2 77.3 26.3 139.1 34.1 101.0 58.2 32.0 44.4 33.4 44.4 27.4 34.8 39.1 113.5 49.1 41.0 49.1 81.6 101.5 71.0 63.5 38.1 66.6 66.7 75.4 33.1 49.0 51.8 40.0 33.6 75.0 49.9 36.1 38.2 44.5 36.0 47.2 51.1 45.3 64.0 41.0 50.6 104.1 40.5 82.8 49.1 17.6 12.4 9.8 15.2 17.8 20.2 18.0 19.6 18.8 15.3 15.0 21.4 19.2 1.9 17.1 26.1 16.3 18.3 11.3 17.0 18.1 19.5 21.6 17.2 18.1 18.9 18.2 16.5 18.9 17.7 18.2 19.4 38.6 35.3 55.5 8.1 36.8 33.4 42.7 37.8 30.7 37.2 26.0 36.8 44.5 30.0 53.0 18.4 4.2 50.5 47.7 17.9 25.4 47.8 6.0 40.4 52.4 40.4 18.0 26.9 9.8 41.8 48.1 43.2 19.9 65.4 48.1 31.2 21.8 33.2 27.2 18.5 11.4 21.6 26.4 17.7 20.8 6.3 48.7 19.0 12.4 15.0 39.2 25.5 47.4 12.1 15.9 33.1 15.0 43.6 25.6 40.6 14.2 22.7 29.2 53.2 39.5 62.2 49.1 70.2 84.5 35.6 33.5 32.4 39.9 42.8 28.2 31.9 IL17C "CX2, IL-17C, IL-21, MGC126884, MGC138401" ENSG00000124391 "Interleukin 17C" Q9P0M4 16 88638572-88640468 "Predicted secreted proteins" "Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.1;urinary bladder: 1.7" "Group enriched" "Detected in some" 6 "Basal respiratory cells: 210.7;Club cells: 191.2;Ionocytes: 52.9" "Cancer enhanced" "Detected in some" "stomach cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA065051 Supported "Secreted to blood" NA NA 30500 "HPA065051: AB_2685413" "unprognostic (1.60e-1)" "unprognostic (1.69e-1)" "unprognostic (7.31e-2)" "unprognostic (4.45e-1)" "unprognostic (5.58e-2)" "unprognostic (2.93e-2)" "unprognostic (3.50e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-2)" "unprognostic (3.46e-1)" "unprognostic (1.89e-2)" "unprognostic (3.04e-3)" "unprognostic (2.73e-2)" "unprognostic (7.91e-2)" "unprognostic (3.56e-3)" "unprognostic (8.37e-3)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.7 0.0 0.0 0.1 0.0 0.1 4.3 191.2 0.0 0.0 0.0 1.6 0.7 0.0 0.9 0.0 0.9 0.2 0.1 0.0 0.0 0.0 4.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 52.9 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.3 0.1 21.8 0.0 0.0 0.0 1.3 0.4 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.4 ATP8A1 ATPIA ENSG00000124406 "ATPase phospholipid transporting 8A1" Q9Y2Q0 4 42408373-42657105 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1218.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Region enhanced" "Detected in all" "white matter: 82.3" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052935 Enhanced Supported Vesicles NA NA Vesicles "HPA052935: AB_2681992" "unprognostic (8.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (6.59e-2)" "unprognostic (6.82e-3)" "unprognostic (7.69e-2)" "unprognostic (2.02e-3)" "unprognostic (3.99e-1)" "unprognostic (2.99e-3)" "unprognostic (4.39e-2)" "unprognostic (9.71e-2)" "prognostic favorable (5.54e-10)" "unprognostic (2.43e-1)" "unprognostic (3.25e-1)" "unprognostic (8.21e-2)" "unprognostic (2.25e-1)" 2.8 9.0 2.5 9.6 26.9 23.7 3.7 5.9 23.9 2.2 0.0 12.9 4.3 2.4 12.3 2.3 2.4 2.5 8.5 13.5 17.7 3.8 1.7 12.0 15.1 8.4 8.3 4.9 16.4 7.1 36.3 2.2 2.4 13.2 8.3 11.8 19.5 4.4 5.3 10.1 1.7 8.9 2.8 8.1 9.1 12.6 2.1 11.3 10.0 40.1 15.7 11.9 2.5 1.5 82.3 0.0 0.1 0.4 27.5 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 0.4 46.3 12.6 0.2 0.0 2.4 6.5 0.1 0.0 7.4 4.5 16.4 1.6 0.7 0.1 4.0 0.3 0.4 0.0 0.0 0.0 0.6 0.2 10.3 0.0 5.1 0.0 2.0 6.0 1.4 2.0 1.9 0.6 16.1 0.0 5.3 9.5 0.6 4.9 14.8 0.3 9.4 0.0 1.1 3.1 0.0 0.4 0.0 2.0 0.5 0.0 1.7 0.0 9.4 0.7 5.6 0.2 0.0 0.6 0.6 3.7 0.2 1.9 1.5 1.1 4.1 0.6 2.5 1.7 4.4 0.5 2.2 2.5 2.4 1.0 0.6 2.5 26.9 5.9 23.9 13.5 17.7 8.4 8.3 4.9 13.2 8.1 11.3 82.3 26.1 28.9 80.1 136.1 23.3 1.5 1.8 0.6 2.2 19.7 4.0 1.5 14.4 0.0 5.3 5.5 81.3 0.0 52.9 48.4 3.9 0.2 4.6 1.3 1.3 13.6 84.6 13.9 295.9 2.5 0.1 4.8 19.9 4.2 8.2 26.5 16.8 1.1 1.6 62.2 255.9 28.6 0.0 8.8 4.6 2.9 3.4 8.9 3.6 31.9 5.1 2.2 33.0 144.8 1218.1 0.6 10.2 1.9 37.6 9.6 45.6 2.0 0.3 38.1 0.0 6.3 2.7 1.5 3.6 5.0 1.4 0.0 51.6 8.6 25.0 3.0 USP22 "KIAA1063, USP3L" ENSG00000124422 "Ubiquitin specific peptidase 22" Q9UPT9 17 20999596-21043760 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044980 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044980: AB_10794503" "unprognostic (7.24e-2)" "unprognostic (5.38e-2)" "unprognostic (7.67e-2)" "unprognostic (6.19e-2)" "unprognostic (4.72e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.17e-2)" "unprognostic (7.81e-2)" "unprognostic (6.37e-2)" "unprognostic (1.07e-3)" "unprognostic (5.68e-2)" "prognostic favorable (1.53e-7)" "unprognostic (8.95e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (1.79e-2)" 41.0 67.4 82.0 40.7 92.9 53.4 42.9 71.1 79.8 50.5 43.5 46.8 33.9 64.3 48.7 41.0 57.8 40.3 80.5 88.0 99.1 49.8 44.5 46.7 48.7 70.6 77.4 84.7 76.3 48.4 68.8 65.7 39.6 75.6 50.7 35.5 57.6 36.6 48.7 109.5 40.4 39.8 54.5 67.7 45.5 50.2 29.5 103.4 64.5 57.5 82.0 50.6 42.7 35.6 78.7 106.9 189.7 179.9 155.5 102.7 105.9 85.9 120.2 91.8 105.6 89.3 220.0 46.9 145.4 112.5 185.2 71.3 111.7 176.7 143.1 157.1 70.0 122.8 120.8 121.5 107.9 121.3 134.2 101.0 117.4 83.9 119.9 125.1 119.8 134.1 93.3 139.7 51.4 151.6 109.5 189.8 63.7 93.1 125.5 61.9 206.2 284.5 99.2 97.7 153.9 86.3 177.8 154.9 63.5 124.9 488.4 106.4 78.0 171.0 107.4 140.8 111.3 164.1 55.0 79.6 476.2 109.0 70.3 169.4 5.5 9.6 10.0 7.9 7.6 7.9 8.0 8.1 7.8 9.2 9.9 10.7 10.2 9.9 7.1 9.7 7.6 6.1 6.0 82.0 92.9 71.1 79.8 88.0 99.1 70.6 77.4 84.7 75.6 67.7 103.4 78.7 46.6 41.7 48.8 31.6 47.9 33.0 43.8 33.8 38.7 97.6 80.3 63.8 23.8 45.8 41.5 60.7 93.8 51.4 36.6 59.3 23.5 51.6 36.0 59.3 75.3 56.1 88.2 43.7 53.1 59.0 37.5 51.0 57.6 68.7 30.4 86.5 76.8 68.5 38.1 117.8 66.0 48.8 30.5 53.8 36.1 51.2 51.0 31.7 35.6 43.1 42.2 55.4 28.8 38.7 50.6 69.6 40.3 71.8 36.6 62.2 33.4 48.9 37.4 59.1 13.1 58.6 52.2 15.9 19.7 49.6 29.1 65.8 33.4 77.9 53.3 53.5 POF1B "FLJ22792, POF" ENSG00000124429 "POF1B actin binding protein" Q8WVV4 X 85277396-85379717 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.8;skin 1: 124.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 7 "B-cells: 2.9" "Group enriched" "Detected in some" 5 "OE19: 179.0;RT4: 78.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002033, HPA050027" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 200000 "Golgi apparatus" Nucleoplasm "HPA002033: AB_1079650, HPA050027: " "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.54e-3)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.97e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (1.86e-1)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (1.17e-2)" "unprognostic (2.50e-1)" "unprognostic (4.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.81e-1)" "unprognostic (5.57e-4)" "unprognostic (1.01e-2)" 0.7 0.3 0.1 6.2 0.1 0.2 11.1 0.9 0.3 3.1 0.0 54.8 34.7 0.2 0.5 33.4 6.2 9.0 10.7 0.1 0.0 1.4 0.4 1.8 0.5 0.0 0.0 0.0 0.1 7.0 0.0 0.3 1.0 0.3 2.9 51.4 0.4 8.6 1.3 0.8 124.9 43.7 2.0 0.0 3.5 23.9 0.2 0.0 0.5 0.5 0.0 12.1 14.5 14.8 0.2 3.7 22.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.5 23.9 12.0 3.3 0.0 0.1 23.7 5.1 0.4 0.0 2.4 0.1 4.4 0.1 0.1 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.3 0.7 3.9 0.0 9.6 0.1 0.2 0.0 179.0 0.0 0.2 1.0 0.1 0.0 78.2 0.1 0.1 0.0 6.0 0.0 1.8 2.4 1.0 0.2 0.1 0.1 0.2 0.3 2.0 4.8 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.5 0.7 1.2 9.1 4.9 7.9 12.0 0.0 2.5 0.8 24.2 8.6 10.2 5.5 0.0 3.2 0.0 129.8 0.0 13.8 0.0 0.3 0.0 1.7 22.8 0.0 0.4 15.6 0.6 3.4 48.9 0.2 0.0 0.0 0.4 0.2 0.3 0.0 0.4 61.1 6.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.4 24.8 62.5 0.0 0.2 3.9 73.6 0.1 9.5 0.0 0.0 0.1 0.9 0.0 0.1 39.2 28.6 5.3 0.3 0.0 51.1 17.1 HIF3A "bHLHe17, IPAS, MOP7, PASD7" ENSG00000124440 "Hypoxia inducible factor 3 subunit alpha" Q9Y2N7 19 46297042-46343433 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation" "Developmental protein, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 83.5;Astrocytes: 257.9;Endothelial cells: 60.4;Leydig cells: 136.4;Muller glia cells: 79.9;Oligodendrocyte precursor cells: 69.9;Peritubular cells: 103.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.3;HHSteC: 19.1;HSkMC: 16.8;TIME: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041141 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041141: AB_10803997" "unprognostic (9.20e-2)" "unprognostic (2.99e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (6.90e-9)" "unprognostic (4.12e-2)" "unprognostic (2.35e-2)" "unprognostic (3.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.32e-2)" "unprognostic (1.38e-2)" "unprognostic (3.76e-2)" "unprognostic (7.07e-2)" "unprognostic (3.41e-4)" "unprognostic (1.55e-2)" "unprognostic (1.61e-1)" "unprognostic (4.45e-4)" "unprognostic (5.98e-2)" 28.4 8.9 23.5 1.1 20.8 0.7 24.4 16.9 24.3 25.1 9.1 42.2 1.1 31.3 4.1 10.9 36.1 2.6 49.8 18.1 15.2 7.2 2.7 33.1 1.2 29.0 19.2 15.1 34.5 6.6 0.5 22.8 27.6 29.1 22.5 2.0 10.1 7.6 7.2 10.8 9.9 25.0 3.0 14.3 32.0 37.6 5.5 20.1 0.5 13.1 9.8 0.4 55.5 25.4 15.9 0.0 0.0 1.5 0.2 4.3 9.3 0.4 0.0 0.0 0.0 0.0 2.1 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 19.1 0.1 0.5 16.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 2.3 0.0 0.1 16.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 1.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.7 0.1 0.4 0.7 0.1 0.0 23.5 20.8 16.9 24.3 18.1 15.2 29.0 19.2 15.1 29.1 14.3 20.1 15.9 83.5 3.2 1.8 257.9 0.5 1.1 2.2 0.3 0.6 1.5 1.4 0.9 45.7 17.2 0.7 0.0 0.0 0.2 0.3 0.2 1.9 0.0 1.9 2.4 7.0 60.4 1.2 8.0 0.7 0.0 0.4 13.6 1.1 2.3 0.0 3.1 51.0 0.9 0.6 0.0 3.5 1.2 0.0 1.3 2.1 7.4 136.4 0.7 3.6 33.7 0.0 79.9 0.0 69.9 1.2 0.1 8.0 103.4 0.0 1.6 0.5 0.1 0.0 2.5 6.6 5.5 8.4 1.6 3.6 0.2 2.3 0.5 0.4 0.1 2.1 0.7 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA050064: AB_2681003" "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 9.8 14.0 9.6 7.2 10.0 3.4 10.6 11.7 12.7 10.7 5.2 11.7 9.5 11.5 4.8 11.2 9.9 8.0 11.1 9.4 8.9 12.1 18.8 6.9 8.4 10.4 10.8 8.1 11.9 9.5 8.8 15.1 5.1 10.7 15.2 4.8 5.4 10.8 6.8 14.1 9.0 9.8 5.5 8.7 9.3 10.3 13.7 11.5 7.6 9.2 10.8 5.2 12.0 10.2 10.1 21.9 24.9 9.1 11.6 11.7 10.5 8.1 17.8 11.6 17.5 19.4 12.2 16.2 14.3 19.7 13.4 10.2 8.6 13.0 12.6 4.7 15.6 22.3 10.5 16.7 15.4 9.9 14.2 18.8 9.1 15.4 15.3 6.0 8.7 12.6 12.3 13.3 18.0 13.2 21.4 20.0 6.3 6.4 18.0 21.0 16.7 8.0 14.1 10.5 19.2 16.7 10.5 11.7 23.3 9.3 6.5 11.0 16.2 13.2 23.3 13.1 10.5 26.5 9.4 11.4 10.0 20.1 16.4 20.6 10.5 15.2 16.2 17.2 15.4 15.5 28.2 17.2 14.6 15.9 18.6 18.5 14.6 8.5 19.3 15.6 25.4 18.9 11.5 9.6 10.0 11.7 12.7 9.4 8.9 10.4 10.8 8.1 10.7 8.7 11.5 10.1 12.7 6.4 7.3 1.3 11.3 10.6 8.7 17.1 11.4 23.2 15.1 20.1 13.1 10.0 12.7 14.7 31.3 13.7 11.0 16.8 21.5 18.9 34.2 8.6 12.5 13.5 11.4 8.6 3.4 18.9 20.3 13.4 6.6 7.9 9.5 42.0 14.6 20.3 15.4 23.5 3.1 11.9 6.1 6.3 9.2 96.2 13.4 6.6 19.6 0.0 11.1 24.8 12.3 4.0 3.7 19.3 13.0 15.4 9.6 18.0 30.6 32.4 10.7 33.4 6.6 11.3 11.3 28.4 19.4 11.8 12.4 5.7 8.7 14.7 16.0 10.9 IRGC "CINEMA, Iigp5, IRGC1" ENSG00000124449 "Immunity related GTPase cinema" Q6NXR0 19 43716076-43720021 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 609 "testis: 150.8" "Group enriched" "Detected in some" 139 "Early spermatids: 1460.2;Late spermatids: 2465.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA046769, HPA060064" Enhanced NA NA "HPA046769: AB_2679797, HPA060064: AB_2684195" "unprognostic (3.38e-2)" "unprognostic (3.83e-2)" "unprognostic (8.52e-2)" "unprognostic (1.26e-1)" "unprognostic (2.55e-1)" "unprognostic (2.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 150.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1460.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2465.6 10.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 14.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF45 ZNF13 ENSG00000124459 "Zinc finger protein 45" Q02386 19 43912624-43935282 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038611, HPA075124" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038611: AB_10669544, HPA075124: AB_2686735" "unprognostic (1.67e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-2)" "unprognostic (1.84e-3)" "unprognostic (1.23e-1)" "unprognostic (9.31e-2)" "unprognostic (5.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.60e-3)" "unprognostic (1.91e-1)" "unprognostic (7.68e-3)" "unprognostic (5.17e-3)" "unprognostic (5.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (4.43e-2)" "unprognostic (5.82e-2)" 4.9 5.6 3.3 5.2 4.1 6.3 7.2 6.5 3.6 6.7 3.7 5.2 5.7 7.2 5.6 4.7 6.6 5.1 4.6 3.3 4.0 5.8 5.9 6.0 7.3 3.5 3.5 2.8 9.0 4.1 9.8 5.0 5.3 3.6 6.8 6.1 8.6 5.0 5.9 6.6 5.9 5.3 6.0 3.3 7.3 5.0 3.6 3.8 10.8 7.5 5.8 7.2 5.1 3.9 4.7 9.2 12.1 16.9 15.1 8.0 7.0 5.9 11.7 12.7 12.0 18.2 5.9 3.7 13.3 7.0 7.3 9.2 5.2 12.9 8.5 15.0 11.2 13.7 19.7 10.6 5.3 7.4 19.5 12.8 7.1 8.4 8.8 7.7 11.9 9.7 4.5 6.3 5.2 13.0 4.2 11.6 4.9 19.8 8.6 5.1 9.4 16.8 4.8 7.3 20.1 11.6 19.0 16.4 6.6 5.8 10.8 6.9 12.7 10.1 13.3 19.4 5.6 10.8 21.1 37.1 14.5 5.6 7.5 15.7 3.4 3.7 5.7 5.6 3.4 8.4 5.8 5.4 6.0 4.9 4.1 7.4 5.0 1.1 6.3 4.7 3.2 6.1 4.2 3.3 4.1 6.5 3.6 3.3 4.0 3.5 3.5 2.8 3.6 3.3 3.8 4.7 2.9 3.2 1.7 7.5 4.2 1.5 0.8 2.2 3.4 1.8 3.1 2.0 3.3 1.5 3.6 0.0 6.2 2.0 5.1 2.4 0.0 2.3 0.2 2.4 1.9 2.4 2.4 3.4 5.0 1.5 1.1 2.3 3.6 2.6 0.0 3.2 1.8 2.1 2.9 3.3 4.9 3.2 2.0 2.8 1.6 0.6 1.8 2.5 1.8 10.3 2.4 1.6 1.0 8.0 9.0 1.2 0.7 4.9 1.5 1.7 2.6 1.9 4.1 2.4 19.7 2.4 1.9 1.1 2.1 3.9 1.6 1.2 3.7 2.4 2.1 1.5 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465608 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 1075.4;skin 1: 661.9;vagina: 491.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9" "Cancer enhanced" "Detected in many" "cervical cancer: 158.5;head and neck cancer: 235.7" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 5.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA 7600000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 1.7 3.6 0.7 1.7 0.7 6.6 32.5 0.6 1.0 125.1 1.3 1.1 0.5 7.7 1.8 1075.4 3.5 1.4 1.1 0.7 0.8 1.8 1.3 1.6 2.6 0.7 0.7 0.6 9.0 1.3 1.8 2.4 12.4 0.7 12.0 0.7 1.0 184.7 1.3 2.8 661.9 1.6 0.8 0.6 2.2 3.3 1.1 0.7 12.4 1.2 0.2 133.0 55.6 491.0 0.7 38.6 0.6 0.2 0.6 0.3 0.0 15.3 1.5 3.9 1.4 1.9 0.5 42.5 0.4 1.7 1.1 5.6 99.5 0.2 4.4 0.7 0.0 0.3 0.7 4.5 0.8 0.4 0.0 0.9 1.7 37.2 0.2 0.3 1.7 0.0 3.1 0.2 0.1 0.1 114.2 0.9 0.0 0.2 24.3 8.3 0.5 0.0 0.2 1.0 108.2 0.1 0.3 0.5 158.9 1.8 4.7 17.7 0.1 0.0 0.0 0.7 0.5 0.7 0.6 3.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.8 0.0 1.1 0.1 2.9 1.1 2.6 0.0 5.5 4.7 2.1 0.0 0.0 0.3 0.9 1.2 0.7 0.7 0.6 1.0 0.7 0.8 0.7 0.7 0.6 0.7 0.6 0.7 0.7 0.9 0.0 1.1 0.0 1.3 504.7 102.5 161.2 111.0 0.7 66.6 38.0 0.6 2.8 72.6 14.7 0.0 96.5 2.1 0.9 1.9 1.6 0.1 4.5 4.4 7.5 0.0 0.4 0.0 0.2 87.2 18.1 3.6 24.5 5.7 0.5 0.0 0.3 14.0 3.3 0.1 2.2 24.4 0.3 139.8 0.0 0.6 23.2 147.7 0.0 0.7 4.5 0.0 0.0 0.2 4.7 0.2 0.4 0.0 40.4 0.3 0.7 5.7 0.5 0.0 1.5 10.5 0.1 0.9 811.7 2306.1 715.8 9.6 0.5 1.1 642.9 PSG8 ENSG00000124467 "Pregnancy specific beta-1-glycoprotein 8" Q9UQ74 19 42752686-42855691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "placenta: 6.6" "Cell type enriched" "Detected in some" 11 "Syncytiotrophoblasts: 34.3" "Cancer enriched" "Detected in single" 17 "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046327 Supported "Secreted in female reproductive system" NA NA 55000000 "HPA046327: AB_2679624" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.3 0.0 0.0 0.0 0.0 CEACAM8 "CD66b, CGM6" ENSG00000124469 "CEA cell adhesion molecule 8" P31997 19 42580243-42595055 "CD markers, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "bone marrow: 219.6" "Cell type enhanced" "Detected in single" "Paneth cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 1.6;non-classical monocyte: 1.2" "Group enriched" "Detected in many" 6 "granulocytes: 1.6;monocytes: 1.2" "Not detected" "Not detected" CAB033676 Approved "Intracellular and membrane" NA NA 9200000 "CAB033676: AB_1125678" "unprognostic (2.01e-1)" "unprognostic (4.52e-2)" "unprognostic (3.31e-1)" "unprognostic (6.30e-2)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (1.71e-2)" "unprognostic (7.77e-2)" "unprognostic (9.62e-2)" 0.2 0.0 0.4 0.2 0.2 219.6 0.0 0.4 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.2 1.7 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.4 0.2 0.4 0.0 0.1 0.5 0.1 0.0 0.0 6.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 1.6 0.2 1.2 0.0 0.0 2.7 0.4 0.2 0.4 0.5 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 NDP "EVR2, norrin" ENSG00000124479 "Norrin cystine knot growth factor NDP" Q00604 X 43948776-43973395 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.1;ovary: 46.7" "Group enriched" "Detected in some" 4 "Granulosa cells: 181.3;Muller glia cells: 105.5" "Cancer enriched" "Detected in many" 5 "glioma: 25.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-87 MG: 72.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.5 0.0 31.5 0.0 32.7 0.0 3.4 30.7 36.1 21.1 22.4 0.2 0.1 15.6 22.2 0.0 21.0 0.4 0.3 31.2 28.8 0.1 0.0 0.0 0.2 30.6 32.0 29.6 46.7 0.0 0.2 0.1 4.0 30.8 7.1 0.2 19.4 0.1 13.3 0.0 0.7 0.2 11.5 31.1 0.1 0.3 1.0 31.2 0.0 0.2 0.0 0.2 0.5 2.3 32.3 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.1 1.9 0.0 0.0 0.0 1.8 0.0 4.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 2.2 0.0 0.0 0.0 72.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 32.7 30.7 36.1 31.2 28.8 30.6 32.0 29.6 30.8 31.1 31.2 32.3 0.0 0.0 0.0 29.0 0.0 0.1 0.0 1.2 0.0 0.6 1.3 0.1 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 9.1 17.7 0.2 0.0 0.0 4.2 0.0 0.3 0.9 0.0 17.0 0.0 181.3 0.0 0.0 0.1 0.0 0.8 0.0 2.0 0.0 0.0 0.7 13.4 0.6 0.0 0.0 0.0 105.5 0.0 1.5 9.5 1.2 0.0 9.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 5.4 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 USP9X "DFFRX, FAF, MRX99" ENSG00000124486 "Ubiquitin specific peptidase 9 X-linked" Q93008 X 41085445-41236579 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011618, HPA047417, CAB070164" Approved Uncertain Vesicles NA NA 24000 Vesicles "CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: " "unprognostic (5.42e-3)" "unprognostic (6.42e-2)" "unprognostic (3.19e-3)" "unprognostic (2.94e-2)" "unprognostic (5.99e-2)" "unprognostic (4.76e-1)" "unprognostic (1.82e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.07e-2)" "unprognostic (1.09e-1)" "unprognostic (5.82e-2)" "unprognostic (1.59e-1)" "unprognostic (4.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.33e-1)" 16.5 16.9 12.5 14.5 14.3 18.3 14.4 12.9 13.2 15.4 15.1 14.9 13.7 15.5 15.0 14.3 16.1 13.1 15.5 14.2 16.5 18.0 34.2 14.5 15.9 12.6 13.7 12.2 13.5 16.1 30.3 10.2 18.6 13.2 12.4 13.8 22.1 11.6 15.5 39.4 13.9 14.4 16.5 13.1 13.4 13.9 17.7 13.2 19.0 19.7 28.7 16.3 15.2 12.7 16.7 38.6 44.2 39.1 40.2 33.0 32.7 8.8 21.5 28.8 23.8 27.5 21.1 16.9 25.7 11.5 48.5 71.3 25.3 67.1 39.7 39.7 32.0 50.5 29.3 41.3 19.9 27.6 26.4 21.0 29.3 17.9 56.4 53.4 35.5 37.2 17.1 36.0 20.3 38.6 29.1 18.8 12.7 42.6 14.1 24.7 20.3 51.8 16.9 24.7 30.7 22.2 20.8 89.0 26.7 26.0 69.8 24.3 16.2 40.2 36.6 27.6 34.6 24.0 19.1 22.3 30.9 26.4 12.1 18.5 1.7 2.3 3.0 2.5 1.9 3.6 2.8 3.0 2.7 2.6 2.1 3.0 2.8 6.4 2.5 2.5 2.1 2.8 1.5 12.5 14.3 12.9 13.2 14.2 16.5 12.6 13.7 12.2 13.2 13.1 13.2 16.7 38.1 41.7 35.1 48.0 42.6 48.3 30.8 29.6 55.2 38.1 41.3 29.5 83.5 54.3 37.9 27.6 37.5 39.6 46.3 58.5 7.9 28.4 14.9 85.5 56.9 43.6 26.9 41.0 84.9 26.5 25.4 41.4 41.8 136.9 25.9 58.3 45.7 62.8 32.6 37.0 86.0 39.1 18.3 47.8 42.1 15.4 33.2 55.5 33.8 67.5 44.6 31.3 30.9 74.9 108.0 32.6 40.1 49.2 38.8 35.6 47.7 21.5 35.8 31.2 32.9 70.6 48.3 86.4 82.9 55.2 55.3 46.7 42.4 45.8 38.0 40.2 CRISP2 "CRISP-2, CT36, GAPDL5, TPX1" ENSG00000124490 "Cysteine rich secretory protein 2" P16562 6 49692358-49713590 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "testis: 509.0" "Group enriched" "Detected in some" 33 "Early spermatids: 5765.5;Late spermatids: 21517.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031248 Enhanced "Secreted in male reproductive system" NA NA 820000 "HPA031248: AB_10602211" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (7.38e-2)" "unprognostic (2.35e-2)" "unprognostic (9.23e-3)" "unprognostic (4.05e-2)" 0.1 0.0 0.0 0.0 0.0 16.8 0.5 0.0 0.0 1.9 0.5 0.0 0.1 0.2 0.9 3.6 17.8 7.8 0.0 0.0 0.2 0.8 0.2 1.2 0.0 0.1 0.0 0.0 0.1 0.6 0.0 2.0 0.0 0.0 1.2 0.0 0.1 15.7 2.5 0.2 0.4 0.3 0.0 0.0 0.5 0.1 509.0 0.1 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5765.5 17.8 0.5 6.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 21517.6 133.9 6.1 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 83.8 0.0 2.8 0.2 0.1 24.1 0.0 65.7 0.0 0.0 409.8 65.1 0.0 0.0 0.0 0.0 0.0 0.3 2.3 F13A1 F13A ENSG00000124491 "Coagulation factor XIII A chain" P00488 6 6144084-6321013 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Acyltransferase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 234.9;placenta: 493.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 863.3;Langerhans cells: 205.1;Macrophages: 232.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 141.1;myeloid DC: 179.6" "Group enriched" "Detected in many" 184 "dendritic cells: 179.6;granulocytes: 50.2;monocytes: 141.1" "Cell line enhanced" "Detected in some" "AF22: 24.0;LHCN-M2: 8.9;RH-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA001804, CAB002155" Enhanced "Secreted to blood" NA NA 1400000000 "CAB002155: AB_564077, HPA001804: AB_1078792" "unprognostic (4.44e-1)" "unprognostic (5.90e-2)" "unprognostic (2.65e-2)" "unprognostic (3.93e-2)" "unprognostic (5.02e-2)" "unprognostic (3.75e-2)" "unprognostic (5.27e-2)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (6.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.61e-6)" "unprognostic (2.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.57e-1)" "unprognostic (2.54e-3)" 234.9 58.4 3.8 52.7 4.8 16.2 47.4 1.5 13.1 50.9 39.6 46.4 9.8 18.7 5.6 51.7 29.4 53.1 39.6 2.5 8.7 20.9 3.0 39.1 30.3 8.6 6.1 1.9 10.7 10.1 13.4 8.1 493.3 8.8 8.8 64.5 21.8 18.9 13.6 10.4 22.9 22.2 90.5 3.3 8.8 25.6 18.0 5.3 21.1 17.2 33.1 12.6 145.8 12.2 3.8 0.0 0.1 24.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.9 0.0 0.1 0.2 0.0 0.0 0.0 0.0 43.8 0.8 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 50.2 141.1 1.4 0.5 25.4 0.6 0.4 0.3 0.4 179.6 0.4 0.4 0.2 32.9 0.3 0.7 12.5 0.3 364.9 3.8 4.8 1.5 13.1 2.5 8.7 8.6 6.1 1.9 8.8 3.3 5.3 3.8 2.0 0.0 1.9 0.3 1.8 18.7 0.0 0.0 0.6 0.1 0.3 0.4 10.6 5.7 0.0 0.0 0.0 5.0 4.5 0.0 0.0 0.0 5.1 0.6 10.6 3.8 0.0 1.3 3.9 0.0 5.6 13.7 0.0 0.4 1.3 0.0 2.9 0.9 863.3 0.0 1.4 0.0 0.0 92.4 205.1 5.8 4.4 232.0 19.6 64.6 53.1 0.9 6.2 0.5 0.7 0.1 0.0 0.7 1.2 0.0 0.0 11.0 2.2 6.5 59.2 2.5 3.3 1.6 0.9 1.2 15.2 10.1 2.6 0.4 0.0 0.1 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018643-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "brain: 73.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Group enriched" "Detected in all" 6 "cerebellum: 73.2;pons: 21.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 7.6;SCLC-21H: 18.2" "Region enhanced" "Detected in all" "cerebellum: 79.1" "Region enriched" "Detected in many" 5 "cerebellum: 138.8" CAB022096 Enhanced NA NA "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.0 0.2 3.1 0.0 8.1 0.0 0.0 73.2 4.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 2.0 0.0 0.0 0.0 0.0 4.4 7.9 2.4 0.1 0.7 0.0 0.5 0.0 21.2 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.8 6.6 0.0 0.0 0.0 0.1 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 8.1 73.2 4.5 2.3 2.0 4.4 7.9 2.4 21.2 1.0 6.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 5.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 0.4 0.1 0.2 3.0 0.0 9.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 10.8 1.1 0.0 0.3 0.3 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.0 0.1 0.9 5.0 0.0 0.0 0.1 0.4 0.0 0.3 0.1 TRERF1 "BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132" ENSG00000124496 "Transcriptional regulating factor 1" Q96PN7 6 42224931-42452051 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 144.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027771, HPA051273, HPA059943" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173" "unprognostic (5.85e-3)" "unprognostic (4.38e-2)" "unprognostic (2.39e-1)" "unprognostic (3.28e-3)" "unprognostic (6.64e-2)" "unprognostic (3.92e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (2.05e-4)" "unprognostic (2.67e-1)" "unprognostic (1.16e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (8.60e-2)" "unprognostic (5.39e-2)" "unprognostic (6.05e-2)" "unprognostic (2.78e-2)" 3.1 5.7 1.6 5.8 2.1 14.0 2.7 1.1 4.1 6.9 0.1 3.7 3.2 6.1 2.9 8.9 5.1 3.9 1.8 1.3 1.1 2.9 1.0 3.0 7.8 1.1 1.1 1.2 7.2 1.6 3.9 3.5 2.6 1.8 5.4 3.4 2.1 2.3 3.6 1.1 6.4 4.7 3.9 0.1 7.3 4.2 6.1 1.4 10.4 2.0 1.2 5.1 7.1 8.1 1.2 13.7 9.4 10.3 13.2 4.7 10.4 14.5 10.2 16.2 11.4 9.4 0.1 7.1 12.7 2.2 15.5 15.6 16.2 13.2 12.6 9.1 144.3 1.0 13.7 8.0 0.0 3.2 25.4 42.1 4.3 17.3 10.2 4.1 10.3 0.0 8.5 0.1 4.1 5.0 3.0 6.6 42.9 11.3 10.1 9.6 11.8 0.8 4.7 6.7 16.7 8.3 4.4 6.1 0.2 1.0 5.6 5.9 34.1 4.5 6.5 7.5 10.7 2.9 1.7 9.5 13.7 4.4 22.7 0.1 1.1 0.6 4.6 1.5 0.2 1.4 0.2 1.1 1.3 0.7 0.0 0.9 1.0 2.0 1.5 0.1 0.6 1.2 0.7 1.6 2.1 1.1 4.1 1.3 1.1 1.1 1.1 1.2 1.8 0.1 1.4 1.2 2.7 3.2 1.3 37.9 3.6 8.3 2.9 3.2 6.2 9.9 4.1 2.5 1.9 1.5 5.9 5.5 0.0 3.4 20.9 8.4 0.0 1.8 2.7 3.3 16.2 5.4 3.0 0.4 96.9 1.0 0.9 11.8 11.2 1.7 12.0 14.7 6.4 0.3 2.6 8.4 111.4 2.1 4.1 4.7 10.4 3.2 14.0 8.0 3.6 52.5 7.9 4.2 12.3 80.4 3.8 1.2 2.5 22.2 7.2 1.6 1.0 0.2 8.5 0.5 26.3 4.4 7.9 10.0 7.4 23.5 7.4 1.2 18.0 4.2 3.8 4.3 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535229 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 148.4;retina: 64.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "plasmacytoid DC: 15.8" "Lineage enriched" "Detected in many" 4 "dendritic cells: 15.8" "Cell line enhanced" "Detected in some" "MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834" "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 0.2 0.7 42.0 1.2 71.8 0.8 0.2 0.0 148.4 0.3 0.0 0.8 0.5 0.5 0.1 0.1 0.6 0.3 4.9 55.3 27.0 1.4 0.2 0.2 3.6 57.3 14.8 77.1 0.6 5.1 1.8 6.4 0.0 62.9 0.7 0.2 64.8 1.0 0.4 0.2 0.2 1.5 0.1 0.0 1.3 1.3 0.9 19.8 1.4 0.2 0.1 2.2 0.4 0.3 94.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 4.5 0.8 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 1.1 0.1 0.0 12.1 0.7 0.0 2.8 0.1 0.1 0.1 0.0 14.0 0.0 0.4 4.2 0.3 0.0 2.2 0.0 0.4 21.5 2.4 0.0 0.0 0.3 0.0 0.0 3.5 16.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.6 0.0 15.8 0.0 0.1 42.0 71.8 0.0 148.4 55.3 27.0 57.3 14.8 77.1 62.9 0.0 19.8 94.9 0.2 0.0 0.0 2.3 0.3 0.0 0.1 0.0 0.0 76.1 0.2 0.1 4.5 0.0 0.0 0.0 81.3 0.1 24.9 0.1 0.0 0.3 0.2 1.3 0.2 0.6 0.0 0.0 49.9 0.7 0.0 0.1 0.5 2.0 0.0 0.2 0.0 0.0 0.0 69.0 47.6 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 6.5 0.0 12.7 1.0 1.0 2.0 0.1 0.0 0.0 0.2 0.1 0.0 2.3 0.0 89.4 0.0 0.2 0.2 0.4 1.7 0.0 0.0 0.0 0.6 0.1 0.1 0.1 BTN2A2 "BT2.2, BTF2, BTN2.2" ENSG00000124508 "Butyrophilin subfamily 2 member A2" Q8WVV5 6 26383096-26394874 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 30.3;Plasma cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 72.8;U-266/70: 58.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA051504 Uncertain Approved Mitochondria NA NA Mitochondria "HPA051504: AB_2681510" "prognostic favorable (1.01e-4)" "unprognostic (4.93e-3)" "unprognostic (1.37e-2)" "unprognostic (6.78e-2)" "unprognostic (9.26e-2)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.04e-3)" "unprognostic (1.01e-1)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (1.93e-1)" "unprognostic (1.73e-2)" "unprognostic (3.45e-1)" "unprognostic (6.54e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" 7.0 13.6 6.0 22.1 6.7 4.4 8.8 13.4 6.6 7.5 17.7 8.0 7.2 10.3 7.6 5.2 8.5 8.5 4.9 6.5 6.8 7.5 6.1 16.3 32.4 8.2 6.3 3.6 10.5 5.2 17.7 5.7 4.0 8.0 8.4 10.6 2.9 12.2 6.9 2.9 11.1 11.4 11.0 6.3 22.0 10.5 6.1 6.1 15.4 7.5 4.2 36.9 8.3 6.9 8.8 10.6 6.6 13.2 14.2 4.4 6.8 0.9 11.4 29.7 17.4 30.0 4.2 4.1 9.6 12.1 20.5 14.1 9.5 10.7 8.7 23.1 29.9 17.9 15.0 13.2 8.4 9.1 3.4 5.1 14.5 2.7 33.5 11.3 20.7 16.3 18.5 12.3 72.8 7.9 4.6 12.1 4.4 5.0 0.4 6.6 28.1 18.7 29.8 12.7 5.9 12.6 17.6 7.4 2.8 31.1 7.5 13.5 6.6 19.5 6.4 7.3 5.6 17.7 58.9 38.8 16.9 6.4 13.4 16.3 2.1 13.7 2.4 6.1 14.6 5.8 24.1 5.0 5.7 23.9 29.4 4.1 5.1 12.4 8.7 6.3 9.7 10.3 7.9 6.0 6.7 13.4 6.6 6.5 6.8 8.2 6.3 3.6 8.0 6.3 6.1 8.8 8.1 9.6 12.6 0.0 30.3 3.8 7.3 6.5 6.2 0.6 5.2 5.1 2.5 2.8 8.5 3.7 0.0 2.3 15.0 0.6 0.0 8.6 0.4 8.8 4.5 13.1 1.8 3.6 0.0 5.6 0.8 5.0 3.6 7.5 19.6 9.6 6.1 3.8 8.4 0.0 0.0 7.8 12.2 16.0 24.2 0.6 6.5 17.1 7.2 0.0 15.4 14.3 7.2 0.0 0.0 8.3 0.8 4.9 30.7 6.4 2.6 2.3 10.2 0.7 0.0 5.0 4.4 0.3 1.5 4.5 4.5 1.0 10.0 10.6 2.1 4.2 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574227-13615158 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 52.5;Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria NA NA Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favorable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 7.3 6.0 8.8 5.2 9.7 5.8 6.7 9.4 11.4 5.4 11.6 8.1 7.8 6.2 5.7 5.6 9.3 5.3 28.9 9.3 9.4 11.6 33.7 5.5 8.3 8.5 9.0 9.1 10.2 6.7 16.4 7.4 5.6 9.8 6.4 8.8 6.1 10.7 6.9 33.7 8.0 9.9 6.0 7.4 9.7 8.3 6.8 9.9 8.3 9.1 38.4 7.2 6.1 5.4 10.3 10.5 8.9 8.1 10.4 5.7 8.9 7.6 5.1 5.3 6.1 8.0 12.9 11.1 14.1 35.7 4.3 10.9 16.9 7.4 11.1 7.6 5.9 10.3 8.5 5.6 20.5 11.0 6.7 6.7 7.8 19.9 4.5 19.9 12.7 10.3 20.3 13.8 4.6 6.5 12.3 8.2 13.2 7.7 16.9 13.7 15.4 4.4 24.4 10.3 11.0 13.7 4.5 4.3 7.9 25.9 25.0 11.6 4.9 8.6 6.6 3.4 4.2 5.8 11.6 15.4 10.7 4.5 7.3 8.4 0.7 6.0 16.7 9.9 9.2 10.7 14.0 13.0 9.5 6.3 12.7 11.8 10.8 2.6 11.8 17.3 5.9 10.7 7.9 8.8 9.7 9.4 11.4 9.3 9.4 8.5 9.0 9.1 9.8 7.4 9.9 10.3 16.6 28.9 3.2 30.0 8.2 4.1 11.4 14.9 10.8 7.3 9.7 9.9 52.5 15.7 16.8 11.0 0.0 20.5 6.6 9.4 52.8 13.0 2.9 13.1 5.4 12.3 6.1 15.8 36.6 6.7 10.5 6.7 6.6 8.1 0.0 23.5 9.7 25.7 9.4 1.7 39.2 13.2 8.2 13.9 3.8 2.0 8.1 8.4 5.4 14.0 6.3 11.6 10.3 15.1 25.8 7.2 13.4 5.7 4.7 6.2 18.1 34.1 22.5 7.2 0.0 9.8 6.6 8.5 12.0 9.8 4.5 10.7 7.9 13.2 15.0 9.0 MRS2 MRS2L ENSG00000124532 "Magnesium transporter MRS2" Q9HD23 6 24402908-24426194 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017642 Uncertain NA NA "HPA017642: AB_2669628" "unprognostic (2.12e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-3)" "prognostic unfavorable (5.32e-4)" "unprognostic (7.23e-2)" "unprognostic (8.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (3.89e-3)" "prognostic favorable (5.14e-11)" "unprognostic (8.75e-2)" "unprognostic (2.94e-2)" "unprognostic (8.32e-2)" "unprognostic (2.53e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (8.03e-4)" "unprognostic (1.55e-3)" 14.7 17.2 12.1 12.1 12.8 6.7 14.4 18.4 14.1 10.8 15.1 14.0 15.5 10.4 14.2 14.2 10.2 9.4 31.0 12.1 13.4 24.5 20.6 11.0 15.0 11.9 13.7 12.0 12.4 18.9 22.7 13.5 16.5 13.6 12.9 15.5 30.4 16.1 13.5 53.4 12.4 12.2 10.8 11.9 11.5 15.8 6.3 13.3 8.7 16.4 49.8 14.9 13.3 11.6 13.0 36.7 21.0 24.7 46.3 15.9 14.4 54.8 16.6 19.3 20.5 18.5 80.9 16.9 21.2 67.3 14.6 32.2 21.8 25.6 31.6 22.0 26.8 44.9 33.6 16.4 93.7 23.0 38.7 30.0 22.8 24.7 20.9 16.7 23.8 22.2 27.2 49.5 0.0 22.6 28.9 37.1 35.3 64.6 20.6 18.9 0.2 4.3 48.4 90.5 37.1 39.3 23.7 28.1 84.9 46.5 72.0 43.3 26.3 9.6 9.1 13.8 18.9 30.8 37.4 68.1 29.4 11.3 45.4 38.3 3.4 16.8 7.3 11.6 20.2 14.9 14.4 12.4 12.5 24.8 11.9 13.4 12.6 1.9 15.3 18.8 14.8 11.5 12.1 12.1 12.8 18.4 14.1 12.1 13.4 11.9 13.7 12.0 13.6 11.9 13.3 13.0 10.5 35.3 20.0 18.6 18.0 7.1 13.6 18.8 16.5 33.5 15.7 10.4 55.6 20.0 16.4 20.2 39.6 46.5 23.3 13.6 52.8 22.6 0.6 15.7 11.5 11.3 9.6 17.1 33.7 19.1 24.6 14.8 13.3 12.9 12.0 23.3 11.4 14.4 21.9 50.5 35.6 15.4 22.4 15.8 10.0 0.7 12.2 14.8 7.2 9.4 19.6 21.8 16.5 15.1 16.5 15.9 14.9 16.6 19.7 14.7 20.0 40.7 14.4 43.6 19.7 9.2 12.9 5.4 11.6 22.7 11.2 25.3 13.1 27.2 22.3 15.7 WRNIP1 "bA420G6.2, CFAP93, FAP93, FLJ22526, WHIP" ENSG00000124535 "WRN helicase interacting protein 1" Q96S55 6 2765393-2786952 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031752, HPA031753" Enhanced Approved Nucleoplasm No No Nucleoplasm "HPA031752: AB_10603004, HPA031753: AB_2674028" "unprognostic (5.52e-2)" "unprognostic (5.95e-2)" "unprognostic (6.83e-3)" "unprognostic (8.35e-3)" "unprognostic (7.66e-2)" "unprognostic (7.10e-2)" "unprognostic (5.63e-3)" "unprognostic (3.40e-2)" "unprognostic (1.39e-2)" "unprognostic (1.73e-2)" "unprognostic (1.81e-1)" "unprognostic (6.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.37e-1)" "unprognostic (2.61e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" 23.6 31.3 45.1 22.8 47.2 49.4 29.1 47.9 46.5 28.2 45.0 29.7 23.9 27.0 37.4 48.7 35.9 24.8 39.8 47.3 47.1 31.6 33.3 30.5 35.0 44.5 44.9 45.8 30.4 44.3 46.8 43.4 43.6 44.1 28.7 29.4 46.2 46.5 27.1 44.4 37.5 27.6 24.1 43.6 28.9 29.4 31.7 46.4 44.3 39.4 77.0 35.0 32.4 31.9 44.5 86.8 42.7 42.5 70.1 44.1 37.7 56.5 38.9 54.2 69.8 69.2 67.8 39.4 77.4 103.1 50.4 75.6 65.9 70.2 78.1 67.8 77.9 77.5 80.9 50.3 107.4 50.1 51.4 53.8 38.7 62.7 64.4 69.5 48.5 89.8 71.8 62.8 27.2 51.6 84.5 76.7 92.7 36.5 59.3 52.5 60.3 62.2 78.4 75.3 52.5 127.8 36.5 45.9 46.1 93.7 66.7 59.4 57.1 49.4 52.1 39.4 45.8 95.8 34.8 65.3 59.8 20.4 55.0 72.1 9.4 1.6 2.3 4.0 1.8 1.2 2.3 2.7 2.8 1.3 1.3 3.1 3.0 0.7 2.6 0.9 2.6 4.2 1.4 45.1 47.2 47.9 46.5 47.3 47.1 44.5 44.9 45.8 44.1 43.6 46.4 44.5 16.4 19.2 14.6 14.0 12.4 32.5 13.4 20.1 23.9 24.8 22.3 19.4 23.7 24.3 12.3 11.0 8.4 30.4 11.8 29.6 3.9 14.5 45.0 21.9 19.7 20.9 39.7 26.1 23.5 13.5 25.6 15.1 11.7 17.5 9.5 12.7 28.2 25.0 12.4 8.4 20.8 21.2 24.4 16.2 17.9 13.4 22.4 12.4 21.4 23.4 15.0 20.0 10.3 26.2 23.0 18.0 16.3 22.2 10.2 18.5 14.8 13.7 24.1 17.4 6.6 19.9 17.8 22.1 23.9 32.4 32.1 25.4 12.5 20.5 25.0 16.3 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021623-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 29.5 34.9 20.1 27.6 20.2 29.0 28.9 22.0 23.3 25.5 20.1 28.0 21.0 25.8 23.1 38.1 23.4 19.1 27.8 20.6 22.2 31.4 37.6 25.7 32.5 21.8 21.4 19.0 18.6 36.1 35.0 32.1 24.4 22.3 28.7 24.6 16.7 27.3 25.2 51.8 34.3 26.1 30.0 21.2 33.6 30.9 17.9 21.5 31.4 23.6 35.1 35.5 30.3 26.6 22.1 141.5 77.9 75.8 111.3 79.7 74.0 63.6 108.9 97.7 136.1 132.6 141.9 59.8 64.7 86.3 113.8 100.1 73.5 127.7 131.8 149.3 82.5 129.9 104.1 82.7 153.2 92.3 87.5 77.7 75.6 79.0 163.0 69.1 48.7 112.2 57.6 128.2 68.4 127.8 148.1 106.0 95.6 84.3 249.7 79.6 98.7 74.7 74.9 83.2 130.5 96.4 84.5 80.1 72.8 129.1 70.6 100.1 106.0 91.2 125.1 95.1 83.4 173.8 63.8 103.9 172.0 54.5 108.6 119.1 2.4 2.2 2.0 3.3 3.0 2.7 4.5 2.4 4.2 2.3 1.4 2.2 4.5 2.5 2.0 2.4 6.0 1.4 0.8 20.1 20.2 22.0 23.3 20.6 22.2 21.8 21.4 19.0 22.3 21.2 21.5 22.1 26.8 0.0 15.6 4.6 14.7 13.4 11.2 13.5 5.7 16.1 19.7 22.1 15.1 20.0 14.1 20.2 16.7 29.3 33.1 12.7 13.7 33.7 10.1 18.3 26.5 18.5 13.9 4.6 8.1 44.8 41.8 18.0 12.8 18.0 6.3 27.3 21.0 36.0 29.1 18.5 8.1 12.6 12.2 16.6 11.7 23.0 11.8 20.0 14.2 2.8 26.1 36.9 20.6 6.6 9.6 44.0 7.4 18.8 18.8 17.7 12.4 20.5 10.0 20.3 6.6 19.3 24.7 9.5 10.6 16.5 18.6 33.7 16.5 61.5 14.2 14.3 BTN1A1 "BT, BTN, BTN1" ENSG00000124557 "Butyrophilin subfamily 1 member A1" Q13410 6 26501221-26510422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 39 "breast: 32.8" "Cell type enriched" "Detected in some" 43 "Breast glandular cells: 111.9" "Cancer enhanced" "Detected in single" "breast cancer: 0.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "CACO-2: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011126, CAB037340" Supported "Intracellular and membrane" NA NA "CAB037340: , HPA011126: AB_1845491" "unprognostic (4.07e-2)" "unprognostic (1.40e-1)" "unprognostic (1.90e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.77e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" "unprognostic (3.24e-3)" "unprognostic (2.85e-1)" "unprognostic (1.88e-1)" "unprognostic (5.35e-10)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (5.31e-4)" 0.0 0.0 0.0 0.3 0.0 0.0 32.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 111.9 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SNRPC "U1-C, Yhc1" ENSG00000124562 "Small nuclear ribonucleoprotein polypeptide C" P09234 6 34757505-34773857 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 384.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034338, HPA042419, HPA055490" Supported Enhanced Nucleoplasm NA NA 320000 Nucleoplasm "CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (1.59e-1)" "unprognostic (2.32e-3)" "unprognostic (1.45e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.48e-2)" "unprognostic (6.16e-2)" "unprognostic (1.16e-3)" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (8.20e-5)" "unprognostic (4.39e-2)" "unprognostic (8.64e-2)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" 71.1 74.5 67.0 68.4 71.7 178.2 74.8 71.6 85.2 65.9 72.4 78.9 73.8 84.2 63.7 86.2 85.5 49.4 167.0 68.7 70.4 85.2 92.8 63.1 102.5 70.6 68.4 67.0 75.7 87.7 78.9 58.0 74.1 71.5 66.4 66.3 40.0 75.9 55.9 163.3 67.5 76.2 65.9 71.8 85.3 82.5 125.4 72.8 116.5 76.0 126.1 96.1 74.5 67.1 76.2 332.8 203.2 260.7 331.6 137.7 134.7 199.0 186.6 204.9 367.9 308.6 349.6 128.4 373.9 239.1 235.0 255.6 156.0 398.7 279.1 297.8 247.6 420.0 287.7 158.7 493.4 240.1 371.2 171.0 167.3 266.4 372.5 264.1 144.9 237.0 354.4 471.2 205.0 270.4 280.8 443.8 592.0 282.4 493.9 245.8 295.2 219.4 350.5 242.0 140.9 316.9 229.9 167.3 167.0 422.3 167.7 256.0 541.5 157.4 219.8 258.3 181.0 460.4 228.5 645.6 522.4 101.2 629.7 381.1 122.8 165.7 133.4 127.2 200.4 149.4 233.5 156.2 148.4 196.1 210.7 168.3 153.9 30.3 163.3 238.6 207.6 235.7 245.6 67.0 71.7 71.6 85.2 68.7 70.4 70.6 68.4 67.0 71.5 71.8 72.8 76.2 43.6 121.8 107.9 5.2 70.5 44.0 76.0 178.6 72.8 25.9 47.4 64.4 229.3 82.9 131.3 68.0 25.0 239.8 69.0 49.1 189.8 148.4 185.6 74.2 58.0 74.3 90.7 73.2 11.1 156.8 213.9 72.3 51.5 63.7 80.4 83.6 71.4 101.1 232.2 28.6 10.1 92.6 118.0 77.3 55.1 83.8 55.3 75.4 64.0 1.9 158.2 96.6 123.6 8.5 14.6 149.3 66.7 41.8 116.6 70.0 96.0 214.6 127.4 41.4 65.7 49.0 82.8 384.6 99.7 83.8 44.8 113.3 70.7 86.3 109.6 67.8 SLC17A3 NPT4 ENSG00000124564 "Solute carrier family 17 member 3" O00476 6 25833066-25882286 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 165.8" "Cell type enriched" "Detected in some" 13 "Proximal tubular cells: 197.8" "Cancer enriched" "Detected in some" 17 "renal cancer: 57.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 210 "RPTEC TERT1: 114.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.31e-3)" "unprognostic (1.56e-2)" "unprognostic (2.51e-1)" "unprognostic (4.65e-2)" "unprognostic (5.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.34e-1)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.8 37.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 1.8 0.0 0.0 0.2 0.1 7.9 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.1 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 197.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 SLC17A1 "NAPI-1, NPT1" ENSG00000124568 "Solute carrier family 17 member 1" Q14916 6 25782915-25832052 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "kidney: 170.8;liver: 49.8" "Cell type enhanced" "Detected in some" "Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2" "Group enriched" "Detected in some" 150 "liver cancer: 7.6;renal cancer: 19.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 647 "RPTEC TERT1: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050513 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050513: AB_2681152" "unprognostic (6.98e-2)" "unprognostic (2.99e-1)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.32e-1)" "unprognostic (2.37e-1)" "unprognostic (4.74e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 170.8 49.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 SERPINB6 "CAP, DFNB91, PI6, PTI" ENSG00000124570 "Serpin family B member 6" P35237 6 2948159-2972165 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 563.0;Late spermatids: 1154.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009668, HPA012736" Enhanced Approved Centrosome NA NA 4800000 Centrosome "HPA009668: AB_1079919, HPA012736: AB_1856729" "unprognostic (3.44e-1)" "unprognostic (1.03e-1)" "unprognostic (8.72e-2)" "unprognostic (1.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.56e-2)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (7.63e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.51e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.59e-1)" "unprognostic (5.08e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 116.4 172.1 101.0 67.5 108.4 67.2 108.8 104.7 135.4 134.5 104.2 132.8 192.9 96.7 82.9 132.6 119.9 78.4 224.4 98.8 111.0 136.9 63.9 153.1 53.1 111.2 107.5 95.3 171.1 284.9 95.2 92.7 134.6 108.9 161.8 104.3 56.9 93.3 96.5 233.9 49.9 212.1 90.2 106.9 165.9 116.0 205.4 106.5 27.0 102.2 269.2 47.6 108.6 96.3 116.2 156.2 99.6 32.2 134.3 85.6 189.2 99.2 142.1 170.7 109.9 127.3 35.0 108.5 0.8 161.6 161.7 124.8 228.8 90.3 144.1 102.2 204.9 41.2 90.7 111.8 60.0 148.5 1.1 53.0 109.4 98.5 104.8 26.9 191.1 263.7 0.5 118.7 2.0 198.0 110.7 0.5 1.5 19.1 175.5 188.8 10.1 59.3 130.7 138.7 37.1 1.5 82.5 116.9 17.3 162.4 118.6 75.3 73.8 188.7 111.1 41.4 252.0 97.1 3.0 0.6 2.7 85.4 90.8 117.8 60.6 104.9 121.2 51.5 107.6 25.7 27.3 28.9 35.5 103.6 22.9 33.7 56.1 8.6 86.0 90.7 10.3 5.0 91.1 101.0 108.4 104.7 135.4 98.8 111.0 111.2 107.5 95.3 108.9 106.9 106.5 116.2 127.8 51.3 69.6 34.3 33.0 20.5 68.4 141.8 23.9 28.4 62.4 63.0 142.6 42.9 141.6 75.4 20.9 146.4 56.8 237.9 99.7 194.6 563.0 89.4 91.4 137.5 73.0 29.9 14.2 338.3 346.6 84.9 108.6 47.8 104.5 83.5 232.7 31.9 182.3 30.3 21.5 169.7 114.0 181.9 70.2 1154.3 83.3 124.2 64.0 92.8 151.8 172.4 46.4 31.7 56.2 318.5 237.0 85.0 17.4 99.3 418.3 216.4 174.2 50.4 78.9 119.7 104.6 233.2 33.1 34.0 26.3 161.4 42.2 65.0 206.5 94.9 XPO5 KIAA1291 ENSG00000124571 "Exportin 5" Q9HAV4 6 43522334-43576038 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012357, HPA018402, HPA023959, HPA029909" Enhanced Enhanced Nucleoplasm NA NA 13000 Nucleoplasm "CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245" "unprognostic (6.98e-2)" "unprognostic (4.34e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (6.16e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (4.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.72e-1)" "unprognostic (4.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (9.48e-2)" "unprognostic (5.66e-3)" 7.3 8.1 4.6 9.1 5.1 8.4 8.6 5.0 5.9 7.3 3.9 7.2 6.3 8.0 9.1 12.1 7.0 5.9 6.5 4.7 4.8 7.5 6.8 6.5 8.8 4.8 4.8 5.0 6.3 14.1 11.2 6.6 7.7 4.4 8.0 8.9 11.9 8.2 7.1 11.3 12.4 6.4 9.8 4.0 7.0 8.4 23.9 5.1 12.1 13.3 6.0 11.3 11.3 7.9 4.9 48.8 28.5 46.7 94.4 23.7 19.9 43.3 24.8 17.3 47.9 34.4 79.1 16.5 65.6 31.4 23.7 45.1 40.8 78.4 36.2 53.5 48.0 61.9 63.6 34.5 57.8 34.0 71.0 32.6 14.5 36.8 50.4 78.0 17.2 34.6 46.0 138.5 50.2 32.6 59.5 53.9 35.1 50.1 132.3 28.7 57.9 49.5 49.2 27.6 37.6 95.7 39.7 34.5 31.5 44.7 40.6 36.3 56.1 29.2 35.2 41.9 34.0 52.8 31.8 37.1 126.3 12.6 60.7 38.4 0.0 4.3 3.1 4.8 5.4 4.4 2.8 4.3 5.3 4.9 2.4 3.4 4.6 0.4 7.1 10.8 1.4 4.7 4.0 4.6 5.1 5.0 5.9 4.7 4.8 4.8 4.8 5.0 4.4 4.0 5.1 4.9 4.7 6.4 3.3 21.2 6.0 8.9 6.8 4.6 5.2 11.3 7.0 7.4 6.5 2.8 3.5 11.0 8.4 5.5 8.4 3.6 1.9 6.7 12.3 7.1 10.9 6.6 14.4 9.4 31.7 7.7 6.5 7.5 10.2 7.5 11.4 13.4 2.5 4.6 6.2 21.9 35.2 5.9 2.0 5.3 2.5 13.5 4.1 4.9 1.8 25.3 5.1 4.5 13.4 26.7 32.0 6.6 2.2 8.2 10.8 13.0 4.1 4.7 5.5 14.3 0.0 10.0 7.3 26.9 23.5 10.2 7.1 4.4 5.4 11.5 7.2 5.8 ABCC10 "EST182763, MRP7, SIMRP7" ENSG00000124574 "ATP binding cassette subfamily C member 10" Q5T3U5 6 43427366-43450427 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041607, HPA045464" Approved NA NA "HPA041607: AB_2677579, HPA045464: AB_2679336" "unprognostic (2.41e-1)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-2)" "unprognostic (3.01e-3)" "unprognostic (1.85e-2)" "unprognostic (8.88e-2)" "unprognostic (2.64e-1)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.58e-1)" "unprognostic (2.80e-2)" 8.5 17.9 17.6 8.3 17.6 7.6 9.0 19.1 24.3 14.0 16.0 12.6 9.5 13.3 8.4 16.4 11.9 6.9 11.0 17.3 16.6 14.1 10.1 10.9 8.7 17.0 16.7 17.6 17.7 19.6 5.0 19.7 7.8 17.0 17.4 7.6 4.5 12.8 7.7 7.9 10.6 13.1 8.6 15.1 15.6 13.6 9.3 16.9 8.3 12.9 3.4 7.5 16.3 13.9 17.8 13.3 6.7 8.7 19.9 18.8 12.0 9.0 13.7 9.6 10.1 8.6 14.9 5.6 2.8 15.9 16.7 7.9 16.5 5.8 10.6 7.2 17.1 11.7 9.5 8.4 29.8 11.5 13.2 13.7 20.9 13.9 13.5 7.4 10.0 13.8 8.9 11.3 14.9 12.1 13.1 7.8 20.3 5.6 32.1 8.0 3.9 2.3 9.8 11.7 21.6 12.1 9.8 8.1 11.5 10.2 7.6 11.3 12.8 14.4 12.4 4.2 11.6 16.6 13.3 6.2 6.9 5.8 9.4 5.9 5.0 1.9 2.2 2.9 0.6 1.3 1.0 2.2 2.6 1.1 0.9 1.2 1.8 0.7 1.3 1.5 0.8 2.8 1.8 17.6 17.6 19.1 24.3 17.3 16.6 17.0 16.7 17.6 17.0 15.1 16.9 17.8 4.6 3.2 5.6 15.7 5.6 1.1 5.9 6.7 10.2 9.3 3.2 3.8 2.5 4.3 3.4 0.0 10.4 7.1 6.6 5.4 1.9 4.5 1.3 4.9 5.5 5.1 7.8 1.7 16.0 3.3 6.0 4.1 15.3 4.9 6.3 11.8 6.1 2.0 6.9 11.8 14.9 3.6 4.1 4.1 3.3 0.8 7.5 5.2 3.6 9.4 3.4 2.1 13.4 13.6 11.1 4.7 6.1 6.0 7.1 2.1 5.4 3.4 9.9 5.6 0.0 3.3 3.7 2.2 4.5 4.7 1.8 4.4 7.9 14.4 5.4 2.8 H1-3 "H1.3, H1d, H1F3, H1s-2, HIST1H1D" ENSG00000124575 "H1.3 linker histone, cluster member" P16402 6 26234212-26234987 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 21.3;brain: 18.8" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.4;dendritic cells: 23.3;Extravillous trophoblasts: 18.3;Hofbauer cells: 7.5;Plasma cells: 7.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 18.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 5.8;MOLT-4: 9.9;NB-4: 4.3;REH: 4.0;SiHa: 3.8;U-266/70: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA055907 Supported NA NA 4000000 "HPA055907: AB_2682966" "unprognostic (8.78e-2)" "unprognostic (1.01e-4)" "unprognostic (8.69e-2)" "unprognostic (5.67e-2)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (2.13e-1)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (1.14e-2)" "unprognostic (8.96e-2)" "unprognostic (3.61e-8)" "unprognostic (8.78e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-2)" 0.7 0.1 1.4 0.2 0.8 21.3 1.1 18.8 4.5 1.2 3.4 1.0 0.0 0.1 0.1 0.7 0.4 0.0 0.2 0.6 2.3 0.4 0.3 1.3 1.9 2.0 2.1 0.0 0.3 0.0 0.0 0.1 0.5 4.7 1.4 0.7 0.0 0.5 0.0 0.0 1.4 2.5 0.1 3.2 1.3 0.6 0.3 2.8 5.5 0.5 0.0 0.4 0.2 3.8 6.7 0.7 0.5 0.1 0.0 0.2 0.0 5.8 0.3 0.2 0.7 0.5 0.1 0.6 0.0 0.1 0.1 0.3 0.7 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.2 0.8 1.7 1.7 0.1 0.0 9.9 4.3 0.5 0.0 1.7 4.0 0.1 2.2 0.0 0.0 1.9 0.3 3.8 1.6 0.0 0.5 0.7 0.9 0.0 0.2 0.0 0.1 0.6 4.8 2.5 0.3 0.6 1.2 0.5 22.3 7.5 6.5 31.4 4.4 21.9 32.1 28.7 21.7 18.2 46.7 37.1 30.6 2.6 25.8 6.9 32.8 23.4 14.1 1.4 0.8 18.8 4.5 0.6 2.3 2.0 2.1 0.0 4.7 3.2 2.8 6.7 3.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 18.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.6 3.6 0.0 0.0 0.0 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963865-42979181 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 76.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 10.5 20.7 23.5 9.2 23.5 9.6 12.2 22.4 28.0 18.8 22.6 15.7 9.4 15.6 7.8 16.5 22.9 9.7 16.9 23.4 23.6 16.1 28.0 10.1 14.6 25.1 23.2 23.2 26.3 76.8 15.3 24.5 9.7 23.7 21.8 7.9 10.0 14.9 11.5 23.6 14.1 16.5 9.7 22.3 17.7 16.5 16.4 24.6 14.8 20.0 15.1 10.5 17.4 15.8 24.3 35.0 16.4 8.1 30.6 29.6 28.3 8.4 6.0 9.4 4.8 10.0 10.5 10.1 14.1 8.2 14.3 20.5 32.2 28.7 31.1 5.0 27.6 15.2 4.7 24.4 6.2 20.0 4.8 9.4 35.5 35.5 19.9 5.5 39.1 24.7 18.9 25.2 14.1 10.7 3.9 12.7 15.8 10.0 78.8 14.3 26.8 14.3 5.8 12.3 10.0 25.4 11.1 5.6 21.9 32.7 13.1 43.2 21.2 14.0 15.2 2.9 7.5 14.0 21.0 19.8 19.7 5.2 24.6 12.4 1.3 1.3 2.1 1.2 1.1 2.1 1.0 1.8 2.5 1.9 1.9 2.2 2.1 0.8 2.0 0.7 1.0 0.9 1.1 23.5 23.5 22.4 28.0 23.4 23.6 25.1 23.2 23.2 23.7 22.3 24.6 24.3 5.6 6.4 2.6 19.9 5.6 5.0 10.2 6.2 10.8 15.2 11.8 12.7 4.1 10.0 5.6 7.3 2.1 11.4 5.4 10.2 13.7 2.8 2.5 17.6 10.6 5.8 5.4 1.7 24.6 1.5 6.7 9.2 11.2 9.1 0.0 19.8 8.6 14.1 5.8 21.9 22.4 8.5 6.1 9.7 3.2 3.6 14.6 5.4 8.8 9.4 4.5 11.8 9.2 13.0 16.6 1.9 10.4 9.4 3.1 6.3 15.1 13.9 14.3 7.0 0.0 13.0 6.6 7.3 2.6 6.3 5.5 7.4 7.8 26.1 10.5 6.6 NQO2 "DHQV, DIA6, NMOR2, QR2" ENSG00000124588 "N-ribosyldihydronicotinamide:quinone reductase 2" P16083 6 2987987-3019755 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 202.5;Proximal tubular cells: 730.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 240.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021283, HPA021332" Enhanced Supported Nucleoplasm,Cytosol NA NA 6000000 Cytosol Nucleoplasm "HPA021283: AB_1854600, HPA021332: AB_1854601" "unprognostic (7.11e-3)" "unprognostic (1.43e-3)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.00e-2)" "unprognostic (3.58e-1)" "prognostic unfavorable (8.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (4.90e-2)" "unprognostic (6.59e-2)" "unprognostic (3.60e-2)" "unprognostic (8.28e-2)" "unprognostic (2.03e-1)" "unprognostic (3.32e-2)" "unprognostic (3.96e-1)" "unprognostic (2.02e-1)" 60.6 122.5 46.9 27.2 48.7 72.7 45.3 60.7 65.9 30.2 61.3 24.7 35.6 26.0 33.2 33.1 30.2 31.7 68.6 48.2 49.7 192.1 125.2 30.7 19.7 59.2 48.7 49.8 30.1 43.0 33.8 21.4 28.9 61.9 28.4 19.8 31.4 62.4 29.2 124.6 51.1 35.9 20.0 42.9 39.6 36.4 18.4 52.5 18.5 27.0 146.2 18.3 32.0 29.2 55.0 45.7 75.7 42.1 95.3 73.0 42.9 45.4 40.5 51.2 37.1 40.9 80.0 16.1 36.9 144.7 71.1 86.4 33.7 45.4 28.5 28.9 95.9 37.1 23.6 83.0 77.3 59.7 24.4 73.9 27.8 34.2 44.9 40.9 53.4 36.8 47.9 142.3 24.1 30.8 95.5 27.0 44.4 54.9 87.6 59.8 49.3 50.1 108.2 56.6 24.0 11.4 15.9 59.5 25.9 128.9 75.0 35.4 16.9 60.7 34.8 14.4 45.9 18.1 45.4 116.7 12.3 43.3 69.5 72.7 25.2 91.8 52.8 33.1 64.2 24.4 12.1 29.6 29.8 61.7 9.1 17.8 19.6 240.2 30.0 60.8 6.5 37.2 43.2 46.9 48.7 60.7 65.9 48.2 49.7 59.2 48.7 49.8 61.9 42.9 52.5 55.0 30.3 9.6 16.1 9.8 16.3 35.2 41.5 32.7 12.5 34.8 34.2 32.1 72.8 47.1 21.3 25.8 10.4 42.6 18.2 21.2 162.4 29.1 51.6 15.1 21.4 28.0 4.8 43.8 47.0 63.4 53.9 51.5 33.1 9.0 13.9 11.0 25.7 202.5 76.6 42.1 46.7 23.3 30.5 44.7 105.7 62.8 35.8 75.4 67.6 19.7 148.6 54.0 20.6 10.6 9.1 55.8 18.3 41.0 15.0 38.6 103.7 730.3 28.7 22.5 26.3 35.0 42.9 24.8 11.4 35.4 41.2 31.2 20.8 21.9 25.4 41.8 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 294.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 19.0 25.8 27.6 20.5 30.8 26.6 30.4 29.4 31.2 19.7 27.0 29.1 31.7 17.8 38.6 23.5 30.4 19.5 22.2 26.6 29.0 44.7 59.7 17.5 28.7 30.5 28.9 24.7 36.0 40.9 35.2 22.8 20.1 31.2 25.2 31.4 44.2 25.8 22.2 25.7 21.8 30.4 15.1 29.9 23.2 39.9 59.1 29.0 40.0 31.2 37.4 33.7 20.2 20.3 36.4 44.2 25.0 55.8 40.6 32.1 37.6 36.9 28.0 36.5 29.1 31.4 39.7 33.1 61.7 29.3 15.4 32.1 33.4 38.1 33.1 41.0 53.2 18.6 73.8 28.0 75.4 29.1 50.1 47.6 28.7 45.6 28.1 102.2 26.5 20.3 77.4 95.4 48.8 32.2 59.0 88.1 55.1 51.4 294.4 17.3 36.8 52.4 54.7 58.0 21.4 60.5 38.7 25.5 25.2 88.6 43.2 41.9 42.3 21.9 32.0 39.3 20.0 43.6 65.8 72.7 140.1 25.2 48.5 27.1 49.1 21.8 42.4 26.2 23.3 34.3 45.7 30.6 26.6 26.8 43.2 37.2 36.9 20.8 45.0 28.2 26.0 37.2 22.7 27.6 30.8 29.4 31.2 26.6 29.0 30.5 28.9 24.7 31.2 29.9 29.0 36.4 30.5 16.0 40.9 7.8 49.8 28.6 40.3 51.8 38.7 63.2 47.5 41.1 43.4 52.9 40.6 60.7 45.9 89.5 44.1 28.5 86.1 42.9 164.2 43.3 19.6 34.2 22.1 56.4 2.9 48.0 60.2 23.5 37.8 29.8 48.2 21.7 35.0 69.5 45.6 42.1 3.9 52.2 50.8 53.4 37.0 153.8 28.3 33.4 35.6 3.7 42.1 75.9 59.8 4.0 13.1 34.6 44.0 25.9 29.3 37.1 63.0 112.9 56.6 70.5 26.3 23.9 26.7 193.0 148.0 43.4 29.3 45.6 47.5 34.2 61.7 32.4 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026895-41039221 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 37.4;kidney: 58.5;liver: 53.2;pancreas: 36.5;stomach 1: 23.8" "Group enriched" "Detected in many" 6 "Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 44.8;RPTEC TERT1: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA015725 Enhanced Approved Centrosome NA NA Centrosome "HPA015725: AB_2669283" "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 1.0 1.1 1.6 1.0 1.7 0.9 1.6 1.4 1.8 1.3 1.4 2.2 37.4 1.1 0.3 1.3 2.0 9.3 1.1 1.4 1.6 58.5 53.2 2.1 1.0 1.8 1.6 1.3 1.5 36.5 0.3 0.8 0.4 2.2 1.5 1.3 0.8 1.7 0.6 0.7 1.9 29.7 0.4 1.6 3.4 23.8 2.2 1.7 2.8 1.6 0.2 0.7 1.1 1.1 2.4 0.5 0.2 0.6 0.9 0.2 0.1 0.6 0.0 0.1 0.0 0.0 7.0 0.1 0.1 2.5 0.0 0.0 0.2 0.1 0.2 0.1 1.1 1.3 0.6 0.0 3.8 0.1 0.3 0.2 0.1 0.6 0.0 0.4 0.1 0.0 2.8 0.5 0.4 0.0 0.1 0.9 2.3 0.2 44.8 0.2 0.9 0.1 0.5 13.0 0.0 0.6 0.6 0.0 0.0 1.3 0.7 0.1 0.2 0.2 0.0 0.4 0.3 0.1 4.3 2.3 0.6 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.6 1.7 1.4 1.8 1.4 1.6 1.8 1.6 1.3 2.2 1.6 1.7 2.4 0.3 3.2 1.1 4.2 1.3 0.8 0.6 0.4 0.6 0.6 1.0 1.0 0.8 30.0 0.3 22.0 4.2 0.4 1.8 2.3 3.9 25.7 2.4 0.6 0.3 0.4 1.2 0.4 0.3 68.6 0.8 0.5 36.7 1.6 0.0 0.3 1.4 30.0 0.3 1.7 0.2 5.0 0.0 0.8 0.3 0.4 0.3 0.8 1.8 0.0 0.8 0.2 2.1 0.0 3.5 19.8 3.1 0.7 0.3 0.6 37.3 41.8 0.9 0.3 0.0 0.3 0.4 0.9 0.8 0.5 0.1 0.8 1.0 0.1 5.4 0.4 AARS2 "AARSL, bA444E17.1, KIAA1270" ENSG00000124608 "Alanyl-tRNA synthetase 2, mitochondrial" Q5JTZ9 6 44298731-44313347 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035636, HPA061396" Approved Enhanced Mitochondria NA NA Mitochondria "HPA035636: AB_10670837, HPA061396: AB_2684502" "unprognostic (1.56e-1)" "unprognostic (3.24e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (8.83e-3)" "unprognostic (5.12e-2)" "unprognostic (3.64e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" 4.3 5.2 6.1 5.7 6.0 5.4 4.9 9.2 6.6 7.4 6.0 5.3 6.5 6.2 3.3 9.2 6.5 4.6 5.6 6.7 5.3 5.2 6.9 4.3 6.0 6.4 5.7 6.3 8.4 6.5 5.9 6.3 4.2 7.8 7.0 4.1 5.5 6.2 4.3 4.8 7.3 8.0 4.2 5.3 7.3 5.5 3.8 5.6 6.2 6.2 3.4 5.3 5.6 7.5 6.6 14.6 9.9 13.9 23.8 8.1 7.2 18.3 10.9 5.7 11.2 10.6 11.4 7.1 16.3 16.2 4.8 12.2 10.0 14.7 16.0 4.7 10.9 23.7 18.9 10.6 14.5 4.8 17.9 16.0 5.9 9.8 9.0 10.2 7.3 9.5 21.8 21.0 15.4 6.2 16.0 14.2 15.9 9.9 40.3 9.8 16.4 8.7 10.4 6.7 12.7 32.0 11.4 9.4 10.9 15.5 9.7 9.9 21.6 8.4 12.1 13.5 7.6 13.9 8.8 8.7 16.5 6.8 15.9 22.1 2.2 1.1 0.1 1.3 1.3 2.1 1.5 1.9 1.7 1.0 2.9 1.8 1.7 0.2 1.9 1.4 1.3 1.2 1.3 6.1 6.0 9.2 6.6 6.7 5.3 6.4 5.7 6.3 7.8 5.3 5.6 6.6 2.6 6.4 3.3 5.2 3.7 0.6 2.1 1.9 4.0 6.6 2.8 2.7 3.5 5.7 2.8 0.0 12.5 5.0 4.9 3.0 0.0 2.3 10.1 3.5 5.4 3.0 0.0 8.2 5.5 0.4 5.0 3.4 5.1 6.2 0.0 5.9 3.9 2.5 3.3 0.0 9.0 2.2 2.0 2.8 1.8 1.0 4.7 2.5 0.0 1.9 3.9 2.0 4.1 3.0 3.6 1.4 0.7 4.5 6.9 1.6 6.3 1.0 3.0 7.1 0.0 4.7 2.8 4.3 6.1 4.4 0.4 5.3 4.1 4.5 3.7 1.6 H1-1 "H1.1, H1a, H1F1, HIST1H1A" ENSG00000124610 "H1.1 linker histone, cluster member" Q02539 6 26017032-26017787 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "REH: 1.0" "Not detected" "Not detected" "HPA043753, HPA056830" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA043753: AB_2678654, HPA056830: " "unprognostic (3.80e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (3.05e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.8 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.3 1.7 0.1 0.1 0.0 0.0 0.5 0.4 0.5 0.1 0.1 0.4 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 ZNF391 dJ153G14.3 ENSG00000124613 "Zinc finger protein 391" Q9UJN7 6 27374615-27403908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 52.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050886 Uncertain NA NA "HPA050886: AB_2681262" "unprognostic (1.59e-1)" "unprognostic (4.97e-2)" "unprognostic (1.85e-1)" "unprognostic (1.41e-1)" "unprognostic (1.88e-1)" "unprognostic (4.68e-3)" "unprognostic (6.27e-5)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.89e-4)" "unprognostic (5.62e-2)" "unprognostic (3.02e-1)" "unprognostic (3.73e-2)" "unprognostic (2.39e-2)" "unprognostic (3.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.82e-2)" 2.4 2.1 1.7 0.9 3.7 0.3 3.3 1.1 3.9 3.7 0.0 1.4 0.8 3.2 3.2 1.8 4.0 1.3 1.1 3.3 1.2 2.8 0.3 1.9 1.9 1.3 0.4 2.8 5.0 2.2 3.8 1.7 1.4 1.0 2.6 1.7 2.1 2.2 3.4 0.6 1.8 1.1 2.4 0.1 2.3 1.6 5.0 0.7 1.4 4.0 0.8 1.7 1.7 1.5 2.9 4.9 0.7 2.9 10.2 1.2 1.6 5.9 1.2 0.9 1.7 3.9 2.7 1.0 0.0 4.3 1.1 3.4 1.6 5.8 4.5 2.7 0.0 3.5 1.8 0.2 0.9 1.9 5.4 2.5 4.9 5.7 0.3 4.5 3.5 0.2 8.1 8.1 0.0 0.3 1.0 6.4 7.6 3.6 0.7 3.2 0.0 0.0 1.3 1.1 1.9 1.1 4.7 0.0 6.7 0.5 4.7 1.1 4.6 0.6 5.5 1.7 0.3 3.7 3.1 8.1 0.0 0.2 0.5 6.0 0.1 0.0 0.0 0.3 0.0 0.7 1.4 0.5 0.2 0.0 1.3 1.0 0.7 0.0 0.3 0.0 0.4 0.1 0.2 1.7 3.7 1.1 3.9 3.3 1.2 1.3 0.4 2.8 1.0 0.1 0.7 2.9 1.7 0.0 1.1 2.3 1.2 0.9 0.5 0.7 0.6 2.2 1.8 1.7 1.0 0.0 2.9 1.8 0.0 2.4 0.1 0.1 0.0 1.0 52.5 7.0 2.4 2.0 1.8 1.3 12.1 1.4 1.1 2.4 0.0 1.7 0.0 3.9 1.8 0.0 1.1 3.3 6.7 0.2 2.0 0.0 0.6 4.7 1.8 0.4 0.0 3.7 0.0 4.4 0.0 7.5 1.7 1.2 0.6 2.6 0.3 0.2 0.0 1.3 12.4 0.9 0.0 1.6 1.3 6.5 2.8 1.3 0.3 0.3 0.6 1.9 1.1 0.4 RPS10 "MGC88819, S10" ENSG00000124614 "Ribosomal protein S10" P46783 6 34417454-34426069 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 4571.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047268, HPA048084" Approved Approved Cytosol NA NA 130000 Cytosol "HPA047268: AB_2680007, HPA048084: AB_2680255" "unprognostic (1.92e-1)" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.78e-1)" "unprognostic (8.92e-3)" "unprognostic (3.79e-2)" "unprognostic (9.72e-3)" "unprognostic (1.93e-2)" "unprognostic (4.30e-3)" "unprognostic (2.04e-1)" "unprognostic (3.59e-1)" "unprognostic (3.82e-1)" "prognostic unfavorable (2.57e-6)" "unprognostic (4.98e-2)" "unprognostic (7.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.45e-1)" 1407.9 1384.8 1025.5 946.2 1014.2 2711.7 2023.1 983.4 1294.5 1889.6 1009.5 1411.3 928.2 1343.1 1073.6 2011.3 1620.8 763.5 1031.1 977.6 1043.3 1121.6 1170.9 1015.2 2155.1 1024.9 1007.0 963.3 2902.5 2444.8 638.8 936.5 836.3 1015.1 1445.1 924.8 275.6 1546.0 903.6 1431.0 2339.5 1354.1 917.7 1062.5 1551.0 1467.3 562.9 1051.7 1499.9 1100.3 781.2 1710.8 1483.1 1730.5 1030.4 2314.3 1481.2 1486.9 3397.3 2550.1 3757.4 2454.7 1847.4 2604.3 3061.1 2200.4 3633.8 1140.6 4393.3 1873.0 2105.8 1522.9 1688.8 2814.8 3224.9 1840.0 1869.0 5082.5 1974.1 1475.4 3504.8 3492.4 3158.5 2028.2 4156.0 5548.7 2111.2 3977.8 2642.2 2725.4 2459.5 3452.0 2175.2 2327.1 3633.7 2591.3 4761.0 2242.3 5664.1 2144.7 2409.8 1736.7 4221.2 2314.1 2558.9 2492.6 1515.7 1328.4 2213.1 5332.3 1391.5 2878.1 7936.5 1837.0 1338.8 1699.0 1543.5 3072.5 1764.4 4423.0 3815.8 732.4 4092.2 2465.9 746.2 1242.2 378.2 1406.3 996.8 2067.1 2824.8 2408.2 1994.5 1679.6 2732.8 3083.6 2462.3 251.9 1676.0 963.1 1983.5 1767.5 5386.9 1025.5 1014.2 983.4 1294.5 977.6 1043.3 1024.9 1007.0 963.3 1015.1 1062.5 1051.7 1030.4 597.4 359.0 714.8 0.0 2967.8 1351.9 563.2 354.6 3754.5 62.0 1279.7 1271.1 65.3 1096.6 494.1 263.0 29.2 1497.5 1221.5 911.7 598.7 1451.9 447.1 169.2 282.1 670.4 1232.9 1778.0 0.0 2404.1 1918.4 612.0 1241.6 181.4 589.1 215.5 1258.9 970.6 1034.5 52.2 0.0 2462.2 130.2 1695.5 1330.7 1537.7 849.0 1006.5 633.3 0.0 1923.1 488.6 1562.3 0.0 0.0 1813.3 1843.4 472.4 2267.5 640.3 2166.8 1066.8 284.9 103.5 263.0 652.5 649.4 268.8 270.0 4571.8 1657.0 1454.1 1851.6 284.8 2985.5 573.4 MOCS1 MOCOD ENSG00000124615 "Molybdenum cofactor synthesis 1" Q9NZB8 6 39899578-39934551 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 40.4;JURKAT: 51.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045783, HPA058177, HPA075505" Uncertain Enhanced Cytosol NA NA Cytosol "HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751" "unprognostic (1.22e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (3.26e-2)" "unprognostic (1.44e-1)" "unprognostic (9.03e-2)" "unprognostic (1.99e-1)" "unprognostic (2.61e-2)" "unprognostic (4.85e-2)" "unprognostic (3.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (6.07e-5)" "unprognostic (5.34e-3)" "unprognostic (1.21e-1)" "unprognostic (3.97e-3)" "unprognostic (2.78e-1)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" 34.0 9.6 13.9 3.2 16.1 0.0 27.0 15.9 14.8 8.3 10.5 9.4 16.3 10.1 10.1 6.8 10.4 5.6 21.7 11.9 14.8 20.6 40.7 23.1 4.5 16.5 17.8 11.6 9.0 12.0 9.7 5.3 35.9 15.9 5.4 5.6 3.0 6.2 7.5 25.9 7.0 12.8 9.3 15.1 2.6 7.7 3.2 16.4 3.3 16.2 45.4 3.4 10.1 6.7 15.7 0.0 2.1 7.0 11.4 19.3 7.2 15.2 8.7 15.0 12.1 10.0 40.4 0.1 0.0 8.4 7.4 7.0 0.4 8.2 9.8 8.7 0.0 8.6 0.0 0.0 13.7 12.2 0.0 3.1 12.0 3.7 7.9 4.2 7.2 10.1 51.1 8.4 0.7 11.7 5.0 16.0 0.0 7.9 0.1 4.6 0.0 6.3 1.1 7.6 8.2 6.1 8.5 0.0 4.2 7.0 6.3 5.2 1.4 16.2 12.2 9.8 7.7 4.1 0.0 1.7 0.0 1.3 0.0 4.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 0.0 0.2 13.9 16.1 15.9 14.8 11.9 14.8 16.5 17.8 11.6 15.9 15.1 16.4 15.7 5.7 6.4 1.5 6.2 0.1 0.6 0.6 0.7 1.2 1.6 9.3 6.5 11.6 8.6 0.3 9.2 12.5 33.7 0.5 3.6 5.9 4.4 0.8 0.9 1.6 3.3 0.0 0.0 3.2 4.1 2.3 4.3 1.1 1.4 1.3 6.3 3.3 36.2 2.9 3.3 2.6 3.5 0.0 2.8 1.0 1.8 3.7 0.4 1.8 2.8 0.0 4.6 0.0 1.0 4.4 1.0 9.1 3.0 1.3 0.2 13.2 17.8 0.0 2.2 78.9 3.9 20.3 1.6 1.9 1.2 1.1 6.2 0.3 0.8 5.5 0.6 H2BC11 "H2B/r, H2BFR, HIST1H2BJ" ENSG00000124635 "H2B clustered histone 11" P06899 6 27125897-27132795 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.2" "Cell type enhanced" "Detected in some" "Adipocytes: 1.7;Cardiomyocytes: 3.0;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 6.0;Hofbauer cells: 4.1;Syncytiotrophoblasts: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 16.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.2" "Cell line enhanced" "Detected in many" "K-562: 150.1;Karpas-707: 86.7;SiHa: 134.1;U-2 OS: 137.1;U-266/70: 129.2;U-266/84: 151.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (4.02e-2)" "prognostic favorable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 2.5 1.4 4.2 2.4 3.8 9.1 1.9 4.0 4.8 9.5 5.6 3.7 1.4 1.6 3.0 9.6 3.8 2.0 3.9 3.4 5.1 2.4 4.2 9.2 3.2 5.3 5.1 1.6 1.3 0.6 0.3 1.0 1.7 6.2 6.9 2.5 0.3 3.2 2.3 6.2 2.2 2.5 2.0 5.8 12.8 4.0 32.2 7.6 7.3 2.7 3.7 2.6 2.5 10.8 8.8 13.4 17.1 5.3 4.6 26.3 1.4 7.0 7.1 3.9 29.7 12.6 14.1 7.7 2.4 22.7 7.8 12.9 9.3 6.5 6.3 15.5 16.2 14.3 4.3 18.2 0.8 2.5 1.7 10.2 11.0 0.7 6.6 2.2 4.2 1.3 6.8 150.1 86.7 8.5 6.9 5.9 8.1 5.8 15.1 15.5 3.1 3.5 16.5 2.8 4.7 35.3 3.5 134.1 8.7 4.2 6.9 0.3 6.4 4.1 7.2 137.1 5.6 3.3 129.2 151.8 35.6 1.9 42.3 3.7 2.3 0.7 1.1 0.5 0.8 0.9 1.9 0.9 0.4 0.5 2.4 0.5 0.6 16.2 1.3 0.3 1.2 3.0 15.9 4.2 3.8 4.0 4.8 3.4 5.1 5.3 5.1 1.6 6.2 5.8 7.6 8.8 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 MED20 "DKFZp586D2223, PRO0213, SRB2, TRFP" ENSG00000124641 "Mediator complex subunit 20" Q9H944 6 41905354-41921139 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040717 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA040717: AB_10794146" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (2.58e-3)" "unprognostic (8.32e-2)" "unprognostic (9.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.16e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.58e-3)" "unprognostic (4.23e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.71e-2)" "unprognostic (4.63e-1)" "unprognostic (4.13e-3)" "unprognostic (2.31e-1)" 8.2 11.9 6.3 7.7 7.1 6.2 11.0 8.7 8.1 10.7 7.8 10.7 10.6 9.8 13.6 9.9 10.0 7.7 9.9 6.4 7.1 12.9 10.5 7.4 10.1 6.4 6.6 6.5 8.2 9.4 10.7 6.4 13.7 7.3 11.3 11.9 5.9 8.7 10.3 14.6 9.8 8.7 12.1 6.1 9.3 9.7 7.4 6.9 12.8 12.0 16.8 13.4 10.3 7.7 9.1 28.5 23.0 25.7 32.1 23.1 24.8 31.7 18.2 17.1 25.9 20.5 29.5 20.3 41.4 34.3 23.0 15.5 22.0 39.7 26.4 31.2 22.2 14.7 37.5 19.6 28.6 23.9 30.5 22.2 18.6 36.8 22.5 33.3 19.6 33.9 36.4 49.0 19.3 32.7 25.7 36.3 22.3 35.1 93.5 19.3 48.0 29.4 15.1 34.9 19.9 23.7 18.6 25.3 12.6 26.5 28.7 24.7 32.4 33.2 18.2 38.9 11.4 22.5 19.3 27.1 85.7 9.9 33.3 26.3 18.7 24.9 18.4 10.7 29.4 14.0 19.0 7.3 12.2 26.1 23.6 9.4 11.3 9.3 17.4 20.7 23.5 14.4 16.7 6.3 7.1 8.7 8.1 6.4 7.1 6.4 6.6 6.5 7.3 6.1 6.9 9.1 4.4 9.6 3.9 2.3 6.6 3.7 4.2 7.2 6.8 2.4 7.0 5.1 5.2 2.8 6.8 7.3 0.0 22.7 7.3 6.6 7.9 6.9 0.6 5.1 7.1 4.2 9.6 8.0 2.8 3.3 18.6 5.0 6.1 6.7 7.0 8.3 8.6 8.3 8.7 1.7 2.8 5.6 14.2 6.3 2.6 0.7 3.4 3.7 1.8 4.7 6.3 3.7 7.2 5.5 3.0 4.9 3.1 6.8 5.7 4.7 5.8 10.1 4.6 4.2 0.0 3.6 4.9 8.3 13.6 5.8 5.7 24.9 3.0 7.1 7.2 5.4 OR2B6 "dJ408B20.2, OR2B1, OR2B1P, OR2B5, OR2B6P, OR5-40, OR5-41, OR6-31" ENSG00000124657 "Olfactory receptor family 2 subfamily B member 6" P58173 6 27957241-27958182 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Macrophages: 1.9;Squamous epithelial cells: 1.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6;K-562: 1.5;U-266/84: 4.0;U-937: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.98e-2)" "unprognostic (3.10e-3)" "unprognostic (7.02e-3)" "unprognostic (1.58e-4)" "unprognostic (3.07e-1)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (4.29e-2)" "unprognostic (6.54e-3)" "unprognostic (1.75e-2)" "unprognostic (1.89e-15)" "unprognostic (1.23e-2)" "unprognostic (5.26e-1)" "unprognostic (1.25e-1)" "unprognostic (3.47e-3)" 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.2 0.0 0.3 0.0 0.3 0.5 0.3 0.0 0.4 0.4 0.1 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.0 0.0 1.1 0.0 1.0 0.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.0 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.1 0.2 0.1 0.1 TBCC CFC ENSG00000124659 "Tubulin folding cofactor C" Q15814 6 42744498-42746103 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035073, HPA035074" Approved Supported Cytosol NA NA Cytosol "HPA035073: AB_10602897, HPA035074: AB_2674448" "unprognostic (7.16e-2)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (4.23e-2)" "unprognostic (8.20e-2)" "unprognostic (6.79e-2)" "unprognostic (5.80e-3)" "unprognostic (1.41e-2)" "unprognostic (2.47e-1)" "unprognostic (3.96e-3)" "unprognostic (1.84e-2)" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.28e-1)" "unprognostic (1.29e-1)" "unprognostic (6.31e-2)" "unprognostic (3.76e-3)" 10.3 15.2 15.5 18.0 17.0 40.0 10.0 16.1 19.3 9.2 13.1 15.6 14.6 14.5 13.0 16.3 15.7 10.2 16.2 17.2 16.7 10.4 13.2 11.7 29.3 18.5 15.9 17.5 12.3 15.0 11.3 11.2 7.6 20.0 11.4 10.0 15.5 14.6 11.9 26.9 16.9 23.7 10.8 16.3 30.4 15.6 18.1 16.3 22.1 14.1 14.5 19.6 13.2 10.1 22.0 34.5 11.2 16.9 31.7 23.9 16.0 22.3 23.2 26.1 25.3 27.4 17.4 13.3 31.0 18.3 22.7 21.0 29.5 22.9 23.2 14.0 17.0 25.0 16.3 16.7 29.7 27.2 17.9 25.5 26.2 27.8 19.7 16.1 22.7 20.1 17.1 37.8 27.4 22.9 42.4 14.8 34.3 15.8 93.5 30.4 14.8 20.3 20.3 24.5 18.6 64.7 28.1 15.1 25.8 41.1 15.4 28.3 59.7 21.9 24.1 21.6 19.6 32.3 36.1 43.7 53.0 11.8 24.2 23.7 139.1 91.4 174.5 105.5 79.2 108.9 101.7 111.9 116.7 83.5 90.9 129.6 119.9 162.1 170.8 74.1 142.3 154.8 170.4 15.5 17.0 16.1 19.3 17.2 16.7 18.5 15.9 17.5 20.0 16.3 16.3 22.0 19.3 3.2 24.0 2.6 50.8 25.1 25.9 49.3 51.2 55.0 25.4 29.1 6.8 24.3 25.7 11.0 41.7 21.4 83.8 25.1 33.2 38.6 30.3 23.0 21.2 20.9 45.3 13.0 7.0 30.9 23.5 17.1 18.3 22.9 31.0 21.0 19.6 10.0 18.8 18.5 7.8 21.2 71.2 16.2 27.8 10.2 17.7 15.9 28.4 8.4 33.6 46.3 77.2 5.0 12.8 28.5 27.0 20.7 37.1 15.9 29.8 23.9 22.0 51.7 19.7 13.0 46.1 50.1 22.7 30.7 24.9 21.1 80.2 26.6 22.3 22.1 SPDEF "bA375E1.3, PDEF" ENSG00000124664 "SAM pointed domain containing ETS transcription factor" O95238 6 34537802-34556333 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 141.9;salivary gland: 115.8" "Cell type enhanced" "Detected in many" "Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7" "Cancer enhanced" "Detected in many" "prostate cancer: 388.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "midbrain: 2.9" HPA055707 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA055707: AB_2682894" "unprognostic (2.98e-1)" "unprognostic (9.68e-2)" "unprognostic (2.84e-1)" "prognostic favorable (9.26e-9)" "unprognostic (1.57e-1)" "unprognostic (7.10e-3)" "unprognostic (2.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.63e-1)" "unprognostic (7.39e-3)" "unprognostic (3.48e-3)" "unprognostic (2.92e-1)" "unprognostic (6.16e-11)" "unprognostic (8.04e-2)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-2)" 0.3 0.1 0.6 1.4 0.6 0.1 36.9 0.8 1.1 28.2 0.0 16.7 11.7 9.1 0.5 2.2 6.4 2.5 0.3 0.6 0.3 0.1 0.1 1.2 0.0 0.3 0.5 0.6 0.1 0.6 0.0 0.2 0.0 0.4 141.9 10.3 0.0 115.8 0.1 0.3 8.5 14.4 0.6 0.1 0.1 35.7 0.3 0.6 0.0 0.1 0.0 0.0 1.0 0.3 0.7 0.0 30.9 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 288.4 0.3 0.4 0.0 118.0 38.6 0.1 0.0 0.3 0.3 0.3 2.1 0.2 0.0 192.2 0.0 0.0 154.0 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.8 1.1 0.6 0.3 0.3 0.5 0.6 0.4 0.1 0.6 0.7 0.8 0.0 2.2 0.7 0.3 0.1 13.3 20.7 0.0 0.0 94.2 61.1 0.3 5.7 31.7 0.0 0.0 0.0 1.4 27.1 0.0 2.6 1.1 6.2 0.7 0.6 5.4 0.0 0.8 1.2 0.0 0.4 28.1 18.7 0.0 0.2 0.4 0.0 0.0 0.0 0.6 315.1 12.2 0.0 0.2 5.5 0.0 0.9 3.6 0.0 0.0 0.0 0.0 0.0 0.2 20.2 12.3 0.0 0.1 72.7 5.7 0.0 2.9 0.0 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.3 0.8 0.0 30.0 11.5 TCP11 "D6S230E, FPPR, KIAA0229" ENSG00000124678 "T-complex 11" Q8WWU5 6 35118071-35148610 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 338 "testis: 343.5" "Group enriched" "Detected in some" 11 "Early spermatids: 1921.3;Late spermatids: 6899.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.6;WM-115: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048311 Supported NA NA "HPA048311: AB_2680351" "unprognostic (1.35e-1)" "prognostic favorable (5.02e-4)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (6.43e-4)" "unprognostic (8.09e-7)" "unprognostic (4.06e-3)" "unprognostic (1.25e-1)" "unprognostic (9.98e-2)" "unprognostic (9.53e-2)" "unprognostic (2.95e-1)" "unprognostic (1.61e-1)" "unprognostic (5.54e-4)" "unprognostic (9.41e-2)" "unprognostic (4.56e-2)" "unprognostic (2.77e-2)" "unprognostic (2.49e-1)" 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.7 0.1 1.0 0.1 0.1 0.0 0.1 0.5 0.2 0.2 0.1 0.0 0.1 0.1 0.8 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.2 343.5 0.0 0.1 0.2 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.6 0.1 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.3 0.4 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1921.3 0.3 0.1 1.7 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 6899.4 30.1 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 29.0 0.0 0.1 0.0 0.1 3.6 0.0 13.1 0.0 0.1 375.1 26.2 0.0 0.1 0.0 0.0 0.2 0.0 0.2 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640941 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 13.3 16.3 13.6 14.2 14.2 54.0 17.5 14.4 16.0 14.8 15.1 26.2 23.8 12.5 17.4 17.7 16.9 14.5 25.6 14.5 14.8 17.6 22.1 15.1 21.9 14.0 13.6 14.1 13.2 16.8 21.2 12.7 14.1 14.5 14.5 28.0 15.3 23.0 13.7 28.8 13.3 19.0 14.6 14.1 17.5 19.4 20.6 14.4 29.5 15.8 45.0 26.8 21.6 10.7 15.0 53.9 24.4 37.7 42.2 32.1 34.7 22.7 31.7 50.9 68.5 63.8 50.3 21.4 41.6 17.6 37.3 62.2 34.4 59.2 43.9 52.6 38.5 46.0 51.5 26.1 43.8 34.6 30.6 29.9 35.3 53.0 51.1 31.0 34.5 52.2 32.8 67.2 21.8 48.4 50.6 27.4 56.5 23.3 221.1 31.3 31.3 29.3 39.4 48.9 42.5 44.7 45.3 22.8 34.5 152.2 28.6 40.6 80.3 28.7 36.5 30.7 24.4 51.3 27.7 25.8 99.0 33.2 51.3 41.0 105.4 41.4 49.4 46.3 42.8 46.5 52.6 54.7 51.4 52.7 47.9 56.5 51.2 35.2 55.6 41.3 34.9 78.9 43.6 13.6 14.2 14.4 16.0 14.5 14.8 14.0 13.6 14.1 14.5 14.1 14.4 15.0 11.6 25.6 12.7 3.3 18.2 14.4 20.5 44.9 17.6 12.8 11.6 9.3 10.8 15.7 32.5 3.7 12.5 21.1 11.1 30.7 27.4 28.0 47.0 13.2 8.6 12.5 17.4 20.6 3.0 21.2 21.5 12.0 14.3 10.8 31.6 7.8 11.4 12.7 17.6 10.1 3.2 17.1 32.6 10.4 8.6 36.5 12.2 19.6 28.4 1.9 17.3 13.9 11.3 3.0 5.0 24.7 29.5 12.0 11.1 11.5 28.2 21.2 21.1 15.1 26.3 8.3 13.4 26.4 18.3 12.6 9.7 6.2 14.8 11.9 23.4 27.2 APOBEC2 "ARCD1, ARP1" ENSG00000124701 "Apolipoprotein B mRNA editing enzyme catalytic subunit 2" Q9Y235 6 41053202-41064891 "Enzymes, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 861.5;tongue: 290.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.8;Cardiomyocytes: 103.5;Early spermatids: 25.7;Exocrine glandular cells: 21.8;Extravillous trophoblasts: 18.1;Late spermatids: 25.1;Skeletal myocytes: 36.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.7;pancreatic cancer: 4.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "CACO-2: 2.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA014252, HPA017957" Enhanced NA NA "HPA014252: AB_1844932, HPA017957: AB_1844933" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-1)" "unprognostic (2.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (7.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.50e-2)" "unprognostic (1.21e-1)" "unprognostic (3.87e-1)" "unprognostic (2.01e-2)" "unprognostic (7.02e-2)" "unprognostic (3.69e-1)" "unprognostic (1.31e-3)" "unprognostic (2.19e-2)" 0.2 0.8 0.5 0.3 0.7 1.1 0.3 0.2 0.4 0.0 0.1 0.6 1.4 0.1 0.0 12.1 0.1 0.1 140.3 0.1 0.2 0.3 0.1 0.5 0.3 0.8 0.4 0.1 0.1 12.8 0.0 0.1 0.7 0.9 7.8 0.1 5.7 12.8 0.0 861.5 1.1 1.2 2.2 0.5 0.2 12.7 2.8 0.6 11.0 0.3 290.6 0.0 0.3 0.1 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.7 0.1 0.3 0.1 0.1 0.0 0.8 0.6 1.3 1.6 0.5 1.4 2.1 1.5 1.7 0.4 1.9 1.6 1.8 0.6 0.6 0.9 2.2 1.6 0.1 0.5 0.7 0.2 0.4 0.1 0.2 0.8 0.4 0.1 0.9 0.5 0.6 1.5 0.0 0.0 0.0 1.0 0.0 0.3 0.7 1.0 0.0 15.8 0.0 0.0 103.5 0.0 0.0 0.0 2.1 1.6 0.1 0.0 0.0 8.0 25.7 0.0 0.0 1.2 0.0 0.0 0.5 21.8 18.1 2.3 8.6 0.1 0.0 0.0 0.0 0.0 0.4 1.7 0.5 0.1 0.0 0.3 0.3 25.1 0.3 0.1 1.8 0.0 0.0 0.9 0.0 2.0 3.7 2.2 0.0 0.0 0.0 0.0 0.5 2.0 0.0 3.1 0.0 36.7 2.0 1.1 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 KLHDC3 "dJ20C7.3, hPeas, PEAS" ENSG00000124702 "Kelch domain containing 3" Q9BQ90 6 43014103-43021298 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 399.7" "Group enriched" "Detected in all" 5 "Early spermatids: 552.0;Late spermatids: 1588.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030131, HPA030132, HPA030133, HPA030134" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350" "unprognostic (3.85e-2)" "prognostic favorable (9.15e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (9.97e-3)" "unprognostic (2.80e-1)" "unprognostic (2.09e-3)" "unprognostic (1.05e-2)" "unprognostic (5.09e-2)" "unprognostic (1.58e-3)" "prognostic favorable (9.08e-4)" "unprognostic (6.34e-2)" "unprognostic (2.88e-2)" "unprognostic (8.73e-2)" "unprognostic (9.78e-2)" "unprognostic (2.88e-1)" "unprognostic (1.52e-1)" 50.5 65.4 159.2 34.2 170.1 49.0 53.1 145.7 204.9 48.3 136.5 65.2 40.5 44.9 56.8 49.9 53.5 37.8 99.7 173.5 152.8 53.3 73.6 43.5 45.8 152.0 159.0 171.2 56.1 51.5 55.1 69.3 59.7 160.2 57.2 41.1 48.6 61.1 48.2 399.7 50.6 49.0 43.7 140.7 54.5 65.3 193.7 158.0 67.7 50.1 205.7 45.2 50.2 46.6 165.5 119.1 36.0 117.1 197.3 79.0 59.4 83.8 52.6 67.7 100.7 109.4 104.5 60.6 117.0 58.7 77.3 37.8 61.6 126.1 67.8 68.5 62.8 171.3 146.0 102.1 109.7 77.4 86.5 99.7 95.8 67.1 77.6 45.2 77.9 98.7 131.1 180.7 80.9 38.4 147.3 142.3 148.9 153.4 297.3 38.0 137.2 86.0 141.4 62.3 67.9 216.1 168.8 55.8 63.2 93.1 75.7 109.8 247.6 58.8 45.7 83.9 50.8 52.9 88.0 118.8 170.9 19.9 122.7 39.4 42.3 83.5 100.3 62.0 78.9 51.9 41.6 50.8 56.0 90.7 39.6 65.6 51.8 40.4 54.7 63.3 49.8 59.5 76.5 159.2 170.1 145.7 204.9 173.5 152.8 152.0 159.0 171.2 160.2 140.7 158.0 165.5 21.3 12.8 17.0 10.4 26.7 18.7 32.9 33.5 14.8 31.9 37.8 33.7 40.3 37.1 19.1 18.4 14.6 99.6 32.7 34.8 86.1 61.7 552.0 19.2 19.0 30.4 52.3 59.3 29.1 54.7 115.1 36.2 20.9 18.8 13.4 50.7 32.5 28.4 63.8 32.0 22.0 43.7 34.6 47.0 22.7 1588.3 44.7 31.8 33.8 11.2 54.7 55.4 55.6 11.6 14.8 46.3 44.3 59.0 31.7 44.4 72.6 55.3 16.9 25.9 52.6 30.4 32.2 180.8 35.6 22.8 20.6 107.0 28.3 71.4 53.7 36.7 GNMT ENSG00000124713 "Glycine N-methyltransferase" Q14749 6 42960754-42963880 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 298.9;pancreas: 605.1" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 842.9" "Group enriched" "Detected in many" 20 "liver cancer: 69.6;prostate cancer: 49.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1" "Region enriched" "Detected in some" 4 "cerebellum: 15.7" "Low region specificity" "Detected in many" HPA027501 Enhanced Approved Cytosol NA NA 390000 Cytosol "HPA027501: AB_1849879" "unprognostic (1.53e-2)" "unprognostic (8.02e-4)" "unprognostic (3.11e-2)" "unprognostic (4.24e-3)" "unprognostic (3.91e-2)" "unprognostic (6.40e-4)" "prognostic favorable (1.86e-4)" "unprognostic (4.08e-6)" "unprognostic (1.01e-1)" "unprognostic (2.67e-2)" "unprognostic (1.63e-3)" "unprognostic (2.52e-1)" "unprognostic (3.50e-3)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-2)" "unprognostic (4.92e-2)" 0.8 0.9 2.8 1.3 2.9 3.9 7.1 3.1 2.8 0.8 2.3 0.6 0.2 0.9 2.2 0.6 1.4 0.5 3.2 2.9 2.5 0.9 298.9 2.0 1.0 2.2 1.7 2.8 1.9 605.1 0.2 8.5 0.4 2.4 20.5 0.3 2.2 9.8 1.2 1.9 0.9 1.6 0.5 1.8 2.9 51.2 0.7 2.2 1.8 1.9 0.4 1.2 0.8 0.7 2.8 0.4 0.3 1.4 3.9 0.4 0.1 0.2 0.3 1.6 0.6 0.9 0.0 0.1 1.3 0.1 0.3 0.7 0.4 0.2 0.2 0.2 1.6 1.2 1.0 0.9 8.5 0.0 0.9 1.8 0.3 0.0 0.3 0.1 0.9 0.0 3.0 1.2 1.5 0.2 1.8 1.6 3.0 0.1 0.4 0.4 1.4 1.3 0.8 0.6 0.2 9.5 1.3 0.1 1.3 0.6 0.4 6.1 2.8 0.3 0.7 0.7 0.4 0.8 1.0 1.0 1.1 0.1 1.6 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.5 0.0 0.0 0.7 0.0 0.1 2.8 2.9 3.1 2.8 2.9 2.5 2.2 1.7 2.8 2.4 1.8 2.2 2.8 0.3 0.0 2.2 5.5 2.8 0.3 5.2 0.7 0.0 1.7 10.2 14.7 5.4 24.3 0.2 1.8 0.0 0.1 1.7 0.0 3.9 0.5 0.2 1.6 0.2 2.2 0.0 77.9 18.4 0.9 0.1 0.3 0.5 0.8 0.0 2.6 24.3 842.9 0.7 1.7 18.2 0.0 6.1 28.9 0.7 0.1 0.9 1.1 0.0 11.2 0.3 0.2 0.0 7.1 4.7 0.6 0.0 2.6 0.5 17.9 0.3 3.4 4.6 0.3 0.0 0.2 0.6 0.6 0.7 0.0 0.1 0.1 3.0 0.0 0.2 1.9 DNAH8 hdhc9 ENSG00000124721 "Dynein axonemal heavy chain 8" Q96JB1 6 38715311-39030792 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.6;prostate: 2.2;testis: 7.9" "Group enriched" "Detected in some" 4 "Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3" "Cancer enriched" "Detected in single" 7 "prostate cancer: 2.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "basophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enriched" "Detected in some" 8 "HMC-1: 47.1" "Not detected" "Not detected" HPA028447 Uncertain NA NA "HPA028447: AB_10599600" "unprognostic (2.83e-1)" "unprognostic (4.46e-4)" "unprognostic (1.27e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "unprognostic (1.22e-2)" "unprognostic (1.41e-1)" "unprognostic (3.47e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.17e-9)" "unprognostic (1.46e-3)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-3)" 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.0 0.9 0.1 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 35.4 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 13.2 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 33.3 5.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286682 "CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 96.9;lung: 65.9;lymphoid tissue: 44.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Region enhanced" "Detected in many" "cerebral cortex: 7.6" "Immune cell enriched" "Detected in many" 7 "neutrophil: 615.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 615.1" "Group enriched" "Detected in some" 4 "SuSa: 6.2;U-87 MG: 24.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005563, HPA053612" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA005563: AB_1858259, HPA053612: " "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 20.6 1.4 0.5 44.4 0.4 96.9 1.2 0.5 7.6 0.8 3.2 0.9 0.4 2.3 0.0 1.5 4.0 10.0 2.9 0.4 1.5 1.0 6.9 65.9 0.4 1.0 1.1 0.2 0.5 4.0 1.1 2.4 7.7 2.0 0.7 0.4 0.6 1.2 0.5 0.5 0.2 1.1 8.5 0.7 11.2 0.8 0.3 2.2 3.1 0.7 2.6 1.4 12.7 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.6 0.0 0.1 82.7 2.3 0.0 20.7 0.1 0.6 0.1 0.0 32.8 1.5 0.2 0.0 615.1 0.2 10.1 0.7 0.0 32.5 0.5 0.4 0.5 7.6 0.4 1.5 1.0 1.1 0.2 2.0 0.7 2.2 2.7 0.0 6.4 26.1 0.0 1.8 0.4 0.4 5.4 0.0 0.0 0.1 0.1 0.3 2.8 12.4 0.0 0.0 0.4 0.3 0.1 0.0 0.3 12.1 0.3 1.8 3.8 0.0 0.0 0.0 0.2 1.1 2.5 1.1 0.1 6.3 0.0 0.7 0.5 25.1 0.0 0.0 0.0 2.0 35.5 21.5 20.6 0.0 104.2 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.2 0.0 0.3 13.3 0.1 0.0 0.8 2.8 0.0 0.1 0.0 0.1 14.6 2.0 0.0 0.0 0.1 MEA1 MEA ENSG00000124733 "Male-enhanced antigen 1" Q16626 6 43011143-43016868 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 804.1;Late spermatids: 2062.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017921, HPA073087" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017921: AB_1853708, HPA073087: " "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (1.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.74e-2)" "prognostic favorable (3.37e-4)" "unprognostic (8.56e-2)" "unprognostic (2.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (2.07e-1)" "unprognostic (8.62e-2)" "unprognostic (1.89e-2)" "unprognostic (5.58e-2)" 49.1 56.5 94.1 41.6 95.9 39.9 48.9 92.7 115.3 55.3 88.7 49.2 36.9 50.4 66.5 51.4 55.6 33.4 42.6 95.9 100.3 58.5 53.1 38.7 45.5 95.8 93.1 92.4 60.0 46.5 69.9 59.4 43.9 97.4 53.4 46.7 56.1 46.2 52.9 30.6 55.7 40.1 53.9 92.4 44.2 46.4 224.7 98.2 71.5 46.0 34.1 62.0 59.4 49.8 96.6 200.9 113.7 166.9 133.0 147.6 97.7 66.3 130.6 137.9 156.8 172.3 169.9 51.6 103.6 133.9 159.9 232.8 99.7 128.8 177.7 147.0 119.8 176.3 192.7 121.8 188.1 76.4 142.7 97.8 79.0 87.5 211.3 137.3 162.0 96.8 166.7 132.9 113.4 176.0 384.7 193.0 165.5 78.3 569.8 99.1 93.3 98.6 104.2 112.4 186.9 160.3 112.0 100.5 86.2 155.3 134.2 130.8 154.9 73.1 175.8 141.2 115.3 229.4 128.0 113.4 174.1 88.3 105.4 146.3 229.1 112.3 214.8 128.9 136.0 118.7 190.3 116.3 126.8 119.8 180.7 115.6 122.7 104.7 145.5 161.6 117.3 158.3 201.2 94.1 95.9 92.7 115.3 95.9 100.3 95.8 93.1 92.4 97.4 92.4 98.2 96.6 45.1 25.6 16.7 10.1 46.9 66.3 73.6 129.3 85.4 19.6 56.9 69.8 28.2 42.9 78.1 55.2 4.2 111.8 32.8 56.7 168.3 89.4 804.1 36.2 27.1 51.1 29.9 42.7 11.5 92.4 101.5 52.0 36.7 29.3 46.9 38.9 45.3 54.0 108.1 16.8 11.6 48.7 89.5 39.2 55.3 2062.6 63.3 51.6 67.6 5.6 70.1 98.5 68.0 7.5 11.9 80.5 61.4 59.8 55.0 84.7 82.8 142.2 73.0 23.4 118.3 26.8 102.8 285.9 98.1 73.6 69.6 85.0 51.1 35.0 49.9 86.3 KLHL31 "bA345L23.2, BKLHD6, KBTBD1" ENSG00000124743 "Kelch like family member 31" Q9H511 6 53647916-53665756 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 44.2;skeletal muscle: 147.4;tongue: 35.1" "Cell type enriched" "Detected in some" 33 "Cardiomyocytes: 248.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (7.67e-4)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (3.98e-2)" "unprognostic (5.50e-2)" "unprognostic (4.24e-1)" "unprognostic (1.09e-4)" "unprognostic (8.73e-2)" "unprognostic (2.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" 8.7 0.8 0.2 0.2 0.5 0.0 3.1 0.2 0.2 0.1 0.6 0.2 0.4 0.3 0.8 0.7 0.8 0.2 44.2 0.1 0.6 0.2 0.4 0.2 0.1 0.4 0.2 0.2 0.3 0.4 0.0 0.4 0.1 0.3 1.3 0.2 0.4 1.2 0.1 147.4 1.3 0.3 0.0 0.3 0.1 0.3 0.3 0.3 0.1 0.9 35.1 0.2 0.3 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.0 0.3 0.1 0.6 0.4 0.0 0.1 0.0 0.5 0.7 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.2 0.0 0.8 0.0 0.2 0.2 1.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.1 0.6 0.4 0.2 0.2 0.3 0.3 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.6 0.8 0.7 0.0 0.5 0.9 0.9 248.9 0.0 0.5 0.0 0.0 1.0 0.1 0.6 0.0 0.1 0.4 2.0 0.3 1.7 0.0 3.2 0.2 0.4 0.2 7.5 0.5 3.1 0.0 0.9 0.0 0.2 0.2 0.0 0.2 0.1 2.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.2 0.2 0.1 0.0 3.7 2.2 0.0 0.2 0.0 0.4 0.8 0.3 0.4 0.3 0.4 COL21A1 ENSG00000124749 "Collagen type XXI alpha 1 chain" Q96P44 6 56056590-56394094 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.3;placenta: 28.6" "Cell type enhanced" "Detected in many" "Astrocytes: 66.6;Cardiomyocytes: 36.9;Extravillous trophoblasts: 75.3;Inhibitory neurons: 63.3;Respiratory ciliated cells: 51.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 23.4;BEWO: 7.6;HSkMC: 24.0;SuSa: 11.1" "Low region specificity" "Detected in all" HPA031212 Supported Cytosol "Secreted to extracellular matrix" NA NA 290000 Cytosol "HPA031212: AB_10599941" "unprognostic (1.69e-1)" "unprognostic (4.53e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-1)" "unprognostic (1.21e-1)" "unprognostic (9.32e-3)" "unprognostic (6.84e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-3)" "unprognostic (2.17e-1)" "unprognostic (5.29e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-3)" "unprognostic (3.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-3)" 2.6 1.4 4.0 0.6 3.2 0.0 1.4 3.6 1.9 24.3 10.0 5.3 0.5 12.6 2.8 2.4 7.5 3.9 4.2 2.7 7.0 1.1 1.3 7.6 0.5 2.2 4.2 1.9 3.8 1.9 0.6 1.9 28.6 3.2 3.5 2.0 0.0 5.1 10.8 1.3 6.7 1.4 8.0 1.7 0.5 2.7 2.7 3.0 0.7 1.0 6.7 0.6 6.2 6.0 2.7 0.0 3.4 0.2 0.0 1.3 23.4 7.6 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.2 0.1 0.0 24.0 0.9 0.0 0.3 0.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.2 3.6 1.9 2.7 7.0 2.2 4.2 1.9 3.2 1.7 3.0 2.7 6.4 0.0 1.5 66.6 0.0 5.9 2.2 2.8 2.2 0.0 0.3 0.4 36.9 0.0 8.2 0.0 0.0 27.5 0.1 0.0 0.0 0.0 7.4 24.8 10.6 6.6 0.0 0.0 16.0 0.0 75.3 28.2 0.5 1.2 0.0 0.2 2.9 0.0 6.1 0.0 63.3 0.0 16.2 0.3 3.0 1.7 15.2 0.3 5.4 0.0 0.0 0.0 0.0 3.5 1.6 0.0 0.0 12.4 0.0 0.1 0.1 0.1 51.3 0.0 0.0 7.3 15.0 1.2 2.5 1.0 4.1 23.3 0.4 2.1 0.2 1.3 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687337 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 74.5" "Group enriched" "Detected in many" 9 "B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5" "Cell line enhanced" "Detected in many" "HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2" "Region enhanced" "Detected in all" "olfactory bulb: 76.0" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477" "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favorable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 242.8 98.9 51.7 62.6 47.2 73.4 145.4 46.7 61.4 96.5 76.9 115.7 116.2 75.0 41.4 204.9 215.8 133.8 154.2 44.9 186.5 104.2 174.8 183.8 17.4 63.6 52.0 41.1 186.5 131.6 70.7 105.2 45.1 51.6 92.2 109.2 29.5 79.7 29.7 243.6 205.8 131.0 115.3 52.1 34.6 122.4 47.4 50.6 60.3 78.2 27.1 22.0 214.8 143.5 72.4 27.0 108.1 80.1 2.0 273.3 490.3 149.5 435.6 344.8 52.3 203.7 9.6 25.3 18.3 15.5 267.9 48.0 60.2 3.7 477.7 82.4 36.2 22.0 3.0 85.8 137.0 798.5 0.5 127.7 586.5 775.8 476.2 147.1 309.3 275.3 1.4 5.1 120.8 604.2 57.4 3.9 11.3 10.2 112.8 15.5 54.4 67.1 31.9 91.2 201.5 36.7 35.6 101.3 8.4 21.3 185.2 32.7 111.2 155.8 91.5 86.9 6.2 36.4 202.0 42.9 54.5 118.7 9.9 261.0 0.0 22.8 0.5 0.5 52.2 0.8 20.7 1.1 0.6 20.0 16.2 0.3 0.4 4.2 0.7 74.5 21.5 2.9 34.2 51.7 47.2 46.7 61.4 44.9 186.5 63.6 52.0 41.1 51.6 52.1 50.6 72.4 571.2 83.3 45.1 1.0 126.9 440.5 340.1 293.1 512.8 0.8 203.9 187.6 151.6 41.5 214.4 68.0 0.0 42.1 56.4 505.3 46.9 217.6 0.9 227.9 57.3 327.1 175.5 5.7 0.5 264.7 52.8 302.4 150.9 199.2 104.4 20.4 71.7 68.9 72.9 0.0 0.4 197.1 156.6 62.0 556.0 3.9 34.5 277.6 218.7 5.6 280.6 58.4 2.1 0.0 0.5 429.9 466.1 16.6 376.4 201.7 383.2 17.2 215.1 3.1 26.3 303.6 471.6 1.2 1.7 620.9 672.0 155.3 106.0 10.7 75.8 478.0 SOX4 ENSG00000124766 "SRY-box transcription factor 4" Q06945 6 21593751-21598619 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.1" "Cell type enhanced" "Detected in many" "Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 45.7" "Group enriched" "Detected in all" 5 "dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0" "Cell line enhanced" "Detected in many" "AN3-CA: 254.1;MOLT-4: 229.9" "Region enhanced" "Detected in all" "olfactory bulb: 54.2" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 11.9 4.4 4.9 9.3 5.1 24.2 18.1 8.6 7.5 18.0 3.1 12.0 12.6 58.3 15.1 5.4 13.6 20.6 6.5 4.3 6.1 14.8 6.5 19.5 5.9 3.8 5.3 4.7 52.2 10.3 3.7 4.1 6.2 4.6 14.6 14.6 6.4 17.6 6.9 3.5 8.6 11.7 17.6 4.3 5.5 17.7 9.9 6.0 74.1 8.7 6.2 7.5 21.3 7.8 4.4 8.5 24.4 60.5 254.1 22.0 5.5 98.7 3.8 7.8 4.6 4.1 16.7 16.5 2.9 100.2 6.2 3.5 25.1 32.0 17.9 3.3 36.6 66.8 2.7 11.5 11.2 3.5 9.0 2.1 9.6 18.1 2.1 7.3 64.1 72.3 138.8 0.6 0.2 5.2 20.6 229.9 21.6 45.3 12.7 23.1 99.7 5.3 0.4 44.1 78.3 78.9 141.2 35.9 41.1 14.0 74.9 20.1 30.9 55.7 7.1 23.1 1.7 18.6 1.5 0.1 71.8 2.4 30.6 28.5 33.3 19.3 2.1 0.5 11.7 0.1 7.0 0.3 0.3 8.7 6.6 2.2 1.6 0.8 7.4 22.0 45.7 2.1 4.7 4.9 5.1 8.6 7.5 4.3 6.1 3.8 5.3 4.7 4.6 4.3 6.0 4.4 235.0 198.7 50.4 0.7 36.2 112.5 129.2 660.7 676.7 99.7 586.1 676.5 297.4 423.2 457.3 154.5 12.5 74.8 104.4 247.6 66.5 1128.5 6.1 669.0 624.2 264.5 340.8 114.3 3.2 604.4 409.4 247.3 313.0 650.9 60.6 1047.5 119.2 6.8 35.5 48.8 4.6 263.0 1320.3 78.0 266.7 12.2 12.2 94.0 243.7 3.7 91.4 189.1 17.5 70.4 1.0 1288.2 153.8 11.3 40.9 151.1 76.7 132.5 162.1 31.6 6.6 234.2 439.9 4.9 236.8 400.7 93.1 30.2 36.6 69.6 299.4 272.5 GLO1 GLOD1 ENSG00000124767 "Glyoxalase I" Q04760 6 38675925-38703145 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HMC-1: 2571.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB040541, CAB040542, HPA059791" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 1500000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB040541: , CAB040542: , HPA059791: AB_2684126" "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (1.08e-2)" "unprognostic (3.96e-3)" "unprognostic (2.51e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (5.09e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (8.71e-2)" "unprognostic (1.20e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (6.21e-2)" 55.9 62.9 73.0 39.2 77.2 31.8 74.9 77.7 84.1 56.4 78.6 52.3 117.3 58.4 111.9 60.5 72.9 41.8 89.7 75.4 79.5 88.0 159.0 67.2 48.8 76.5 77.5 72.0 83.5 42.4 107.0 23.4 64.6 77.5 172.9 52.8 101.2 43.6 62.7 155.7 67.1 68.2 62.3 78.4 48.7 48.9 28.2 75.8 50.4 55.3 130.0 60.8 52.9 52.0 83.0 201.6 92.0 257.4 256.7 119.2 213.9 227.0 171.1 161.4 235.4 243.0 224.4 75.3 222.5 132.2 137.5 280.1 129.5 222.5 221.1 295.8 203.8 343.0 329.4 105.7 211.3 178.5 126.7 2571.5 183.9 133.5 223.7 159.0 153.2 258.5 154.9 264.7 143.6 223.3 170.6 199.5 160.5 185.5 179.2 176.7 171.0 311.1 145.8 217.8 149.9 199.3 201.3 120.6 165.4 329.8 175.9 192.4 628.3 107.6 182.0 167.1 159.8 275.9 112.7 227.0 608.6 66.1 322.7 299.6 23.7 20.7 15.3 35.5 33.4 48.0 51.9 35.3 36.7 39.0 51.4 32.7 34.9 2.7 23.5 26.9 60.4 34.1 33.3 73.0 77.2 77.7 84.1 75.4 79.5 76.5 77.5 72.0 77.5 78.4 75.8 83.0 69.2 131.4 174.4 26.1 86.3 64.6 112.6 88.2 37.0 56.1 67.7 55.8 133.2 58.6 84.5 90.1 20.9 102.7 68.3 34.1 248.4 132.1 4.5 76.2 58.8 74.3 36.5 83.5 23.9 73.3 323.0 86.0 53.0 67.5 71.4 78.7 161.0 114.0 78.8 69.0 21.9 39.3 99.7 125.7 72.8 6.5 83.9 70.0 104.9 17.8 92.6 190.3 49.4 25.1 24.8 77.3 36.0 109.9 86.4 178.8 103.2 132.2 80.7 65.5 46.0 62.0 70.9 15.0 16.1 77.2 88.2 73.2 62.4 123.7 63.4 130.2 CPNE5 "COPN5, CPN5, KIAA1599" ENSG00000124772 "Copine 5" Q9HCH3 6 36740775-36839444 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.6;heart muscle: 71.0" "Cell type enhanced" "Detected in many" "B-cells: 50.6;Cardiomyocytes: 30.0;Excitatory neurons: 35.1;Oligodendrocyte precursor cells: 36.7;Plasma cells: 89.6" "Cancer enhanced" "Detected in all" "glioma: 11.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 80 "memory B-cell: 51.6;naive B-cell: 26.8" "Lineage enriched" "Detected in single" 105 "B-cells: 51.6" "Group enriched" "Detected in some" 5 "Daudi: 59.4;HUVEC TERT2: 25.7;U-266/70: 19.7;U-266/84: 17.1;U-698: 28.1" "Region enhanced" "Detected in many" "basal ganglia: 103.3" "Region enhanced" "Detected in many" "basal ganglia: 135.5" HPA031369 Enhanced Approved Cytosol NA NA Cytosol "HPA031369: AB_10601801" "unprognostic (5.71e-3)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.73e-2)" "unprognostic (1.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (1.07e-1)" "unprognostic (3.07e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-3)" "unprognostic (2.45e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.00e-1)" "unprognostic (3.57e-1)" 4.3 0.9 12.1 10.8 66.6 1.4 2.4 0.0 31.2 3.8 0.6 6.2 5.7 5.8 1.0 2.5 20.1 2.0 71.0 23.3 13.4 3.7 0.8 2.6 23.8 15.9 8.9 34.5 6.6 1.0 0.4 11.1 1.4 16.6 5.9 5.0 2.9 3.5 2.5 0.5 1.6 8.6 4.7 0.9 20.1 5.2 25.5 5.7 2.3 3.3 0.2 28.3 4.9 5.8 17.6 0.9 0.0 0.5 0.1 0.1 0.0 0.3 0.2 0.2 0.3 0.5 0.0 0.2 59.4 0.5 0.8 2.7 0.4 0.1 0.4 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.7 0.0 4.1 25.7 0.2 0.2 1.7 0.5 0.0 0.0 0.4 0.1 0.8 0.0 0.3 0.5 0.0 0.0 0.1 0.5 0.1 0.0 0.0 5.3 0.3 0.0 0.8 5.9 0.4 0.7 0.0 2.1 19.7 17.1 28.1 0.3 6.5 0.1 0.0 0.1 0.0 0.0 0.2 0.2 51.6 0.2 0.0 0.1 26.8 0.0 0.0 0.4 0.0 0.2 0.3 0.0 4.5 12.1 66.6 0.0 31.2 23.3 13.4 15.9 8.9 34.5 16.6 0.9 5.7 17.6 2.8 0.0 3.6 1.3 50.6 0.6 0.2 0.2 0.0 13.4 0.3 0.5 30.0 0.0 0.0 0.0 0.0 0.0 1.5 15.1 1.9 0.0 3.3 0.4 0.8 7.4 4.2 0.0 35.1 0.2 0.0 2.8 1.5 1.4 12.6 0.3 5.0 1.0 0.4 0.0 8.6 1.8 0.0 1.9 0.6 4.8 0.0 6.2 3.6 2.8 0.2 1.3 2.1 36.7 0.8 0.5 12.5 0.4 89.6 0.2 2.3 0.1 0.0 1.6 0.0 2.3 1.0 0.8 1.5 1.1 0.1 0.0 2.0 0.2 1.7 0.4 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314461 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 7.8;thyroid gland: 6.5" "Cell type enhanced" "Detected in some" "dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 34 "plasmacytoid DC: 63.8" "Lineage enriched" "Detected in many" 34 "dendritic cells: 63.8" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 83.8" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.3 0.3 0.3 0.5 0.4 1.2 0.8 0.3 0.6 0.4 0.6 0.6 1.9 1.2 0.0 0.3 0.8 2.5 3.1 0.3 0.4 0.1 4.0 7.8 0.7 0.5 0.4 0.2 0.2 3.9 0.1 1.8 4.1 0.4 0.6 0.5 0.0 0.7 0.2 0.1 0.1 1.1 1.0 0.2 0.7 3.0 0.2 0.4 1.4 6.5 0.5 1.1 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 83.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 63.8 0.0 0.3 0.3 0.4 0.3 0.6 0.3 0.4 0.5 0.4 0.2 0.4 0.2 0.4 0.3 0.0 0.0 2.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 7.9 0.0 1.8 1.1 0.1 6.3 0.0 0.7 0.2 0.1 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.9 0.0 17.8 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.3 5.4 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 RREB1 HNT ENSG00000124782 "Ras responsive element binding protein 1" Q92766 6 7107597-7251980 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001756, HPA034843" Approved Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA001756: AB_1856477, HPA034843: AB_2674357" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (2.93e-1)" "unprognostic (5.05e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-3)" "unprognostic (2.53e-1)" "unprognostic (1.32e-2)" "unprognostic (2.45e-2)" "unprognostic (6.51e-2)" "unprognostic (3.31e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.92e-1)" 10.4 12.2 4.1 7.8 3.6 31.9 10.9 5.1 5.2 9.0 11.9 10.8 12.1 7.8 5.7 26.4 8.8 6.4 7.8 2.8 7.6 8.2 18.5 9.2 6.5 9.4 6.2 1.1 9.9 18.3 12.3 6.4 8.2 6.3 8.2 9.9 5.8 15.2 6.3 16.7 16.3 13.2 6.2 6.4 10.7 10.8 11.7 7.4 9.3 12.1 7.9 8.0 7.9 14.4 8.7 13.1 12.3 10.3 11.9 9.5 6.3 40.1 5.2 7.3 6.2 7.6 20.3 10.0 6.6 10.9 9.9 6.9 9.3 14.7 16.5 5.9 9.2 11.3 24.8 9.6 23.5 13.1 15.0 18.5 10.5 12.7 9.3 13.8 4.2 7.5 15.2 44.6 0.1 6.5 16.5 8.8 35.2 4.9 10.6 10.0 13.1 12.4 10.4 9.0 25.1 2.8 2.6 12.4 16.0 11.1 15.3 12.3 31.0 13.0 11.4 7.1 8.8 6.4 4.1 4.7 9.0 3.3 11.4 9.3 5.5 2.7 6.6 1.5 2.1 1.3 2.2 1.0 1.0 1.7 1.0 1.6 1.3 2.0 3.3 2.4 5.7 0.5 1.7 4.1 3.6 5.1 5.2 2.8 7.6 9.4 6.2 1.1 6.3 6.4 7.4 8.7 39.3 25.6 28.7 44.4 19.0 31.5 22.4 30.1 27.9 0.9 27.0 16.9 24.2 31.5 31.4 36.8 70.9 25.8 31.9 62.7 7.9 14.7 46.2 35.5 24.7 22.5 31.8 31.1 3.9 16.3 32.8 16.3 30.1 63.0 10.1 20.7 30.7 70.4 33.4 0.0 0.7 35.7 14.2 66.1 54.9 9.0 19.9 42.1 23.2 78.7 32.6 9.5 13.4 2.0 0.9 22.3 36.3 19.2 27.7 37.1 34.5 16.8 23.9 27.5 52.6 25.5 15.2 13.7 17.4 48.9 34.7 45.8 15.7 27.4 45.0 54.3 SSR1 TRAPA ENSG00000124783 "Signal sequence receptor subunit 1" P43307 6 7268306-7347446 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011276, HPA017062" Enhanced Supported "Endoplasmic reticulum" NA NA 1600000 "Endoplasmic reticulum" "HPA011276: AB_1857503, HPA017062: AB_1857505" "unprognostic (2.27e-1)" "unprognostic (2.10e-1)" "unprognostic (5.98e-3)" "unprognostic (1.57e-2)" "unprognostic (3.10e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (7.83e-2)" "unprognostic (2.27e-2)" "unprognostic (4.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.79e-6)" "unprognostic (3.17e-1)" "unprognostic (2.56e-2)" "unprognostic (6.51e-3)" "unprognostic (2.19e-2)" 64.6 65.1 21.0 90.5 25.7 102.8 71.0 26.6 25.0 89.3 38.5 65.9 66.2 63.3 74.9 72.2 51.3 65.1 41.5 19.8 32.5 59.2 96.3 57.2 68.9 28.6 24.9 19.6 67.6 68.4 49.8 26.0 72.1 27.8 59.7 77.2 36.9 80.3 56.6 28.6 42.9 62.9 77.5 24.9 62.9 68.8 38.8 27.6 56.4 85.5 29.3 84.8 75.0 33.1 35.9 122.2 121.7 92.3 171.7 244.9 173.1 144.4 274.5 225.5 183.4 219.1 167.5 98.5 162.9 472.1 282.5 168.3 107.0 112.0 156.6 251.6 172.2 94.6 174.3 130.6 350.7 253.4 325.6 189.6 154.2 169.0 210.2 429.2 140.4 205.2 80.4 199.3 191.1 204.6 146.4 89.6 86.6 78.2 136.5 137.2 120.1 116.0 615.7 161.3 171.5 124.6 57.9 167.0 91.1 263.4 276.8 147.9 141.7 183.1 196.1 149.0 153.3 238.1 195.7 312.1 130.4 95.3 180.4 367.1 146.1 169.5 114.5 82.9 121.9 105.6 73.0 91.7 93.9 199.9 56.1 86.3 86.9 93.3 85.7 110.1 139.3 109.4 214.7 21.0 25.7 26.6 25.0 19.8 32.5 28.6 24.9 19.6 27.8 24.9 27.6 35.9 54.0 28.9 48.1 32.3 106.1 77.8 62.1 120.2 69.4 75.4 85.3 46.1 48.5 84.4 93.7 130.6 100.1 78.2 118.6 65.4 15.6 96.0 16.1 48.7 96.0 69.6 62.3 80.8 38.6 103.0 208.5 95.4 68.8 74.3 47.5 64.0 78.1 148.1 130.0 70.7 41.3 130.4 81.4 157.3 251.5 12.4 78.6 129.7 94.3 35.6 131.5 64.1 87.6 49.8 47.8 71.9 47.0 73.0 302.1 111.2 61.5 67.1 57.8 104.2 26.3 57.6 71.6 53.4 58.7 96.0 75.4 121.8 83.6 61.2 93.6 70.4 RIOK1 "AD034, bA288G3.1, FLJ30006, RRP10" ENSG00000124784 "RIO kinase 1" Q9BRS2 6 7389793-7418037 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017866, HPA051446" Enhanced Supported Cytosol NA NA Cytosol "HPA017866: AB_2669670, HPA051446: AB_2681488" "unprognostic (2.33e-2)" "unprognostic (1.24e-1)" "unprognostic (2.38e-1)" "unprognostic (1.03e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.41e-5)" "unprognostic (2.23e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (3.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (2.33e-1)" "unprognostic (2.09e-1)" "unprognostic (6.12e-3)" "unprognostic (2.59e-2)" 12.2 9.4 4.3 10.9 4.3 20.8 11.1 5.0 5.4 10.1 4.1 8.0 6.6 10.6 5.3 11.5 8.3 7.6 8.1 4.4 4.6 6.5 7.9 7.2 14.1 4.6 4.6 3.7 11.0 10.2 7.4 4.7 11.5 4.6 8.1 8.7 7.4 7.1 8.2 11.6 9.1 6.3 10.9 4.4 9.5 7.0 20.1 4.5 15.8 7.3 10.4 16.0 15.0 7.6 4.9 20.4 11.7 18.3 45.8 27.0 22.6 28.7 25.6 16.6 22.1 18.5 33.1 10.0 51.8 43.3 19.7 19.4 20.3 45.7 19.5 29.0 35.8 49.6 28.3 18.3 39.4 23.0 81.5 37.5 17.2 27.2 24.1 50.4 11.5 20.1 38.6 72.1 12.3 21.0 26.7 56.8 50.2 39.6 36.3 26.1 42.9 23.3 56.6 13.8 19.9 60.8 30.4 20.8 13.3 41.6 48.4 18.9 28.4 19.9 24.4 18.9 17.5 38.3 17.1 33.0 75.7 7.7 44.0 38.7 12.0 11.5 9.0 14.9 15.6 18.0 21.5 15.4 15.9 20.5 23.0 17.8 19.2 2.3 26.7 14.0 17.3 16.2 11.3 4.3 4.3 5.0 5.4 4.4 4.6 4.6 4.6 3.7 4.6 4.4 4.5 4.9 22.2 6.4 26.4 5.5 27.5 52.8 32.3 29.5 38.1 10.0 18.9 22.0 22.8 4.3 35.2 7.3 10.4 34.1 25.3 9.9 3.9 15.9 74.8 14.9 28.4 24.8 7.2 17.9 10.2 11.7 34.7 29.8 16.8 19.1 33.6 13.4 19.2 10.2 22.6 5.0 12.0 17.4 20.3 11.2 25.1 12.5 19.9 19.7 17.8 11.2 15.1 8.9 6.2 13.0 8.4 12.2 8.2 19.9 27.0 33.7 7.1 9.3 20.9 13.7 19.7 33.8 23.9 58.9 75.4 33.7 64.8 27.9 29.0 23.9 16.9 23.8 NRN1 NRN ENSG00000124785 "Neuritin 1" Q9NPD7 6 5997999-6007605 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.4;parathyroid gland: 81.8" "Cell type enhanced" "Detected in many" "Adipocytes: 262.9;Endothelial cells: 115.3;Excitatory neurons: 71.9;Extravillous trophoblasts: 64.7;Hepatic stellate cells: 160.3" "Cancer enhanced" "Detected in all" "glioma: 38.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "MAIT T-cell: 2.6;neutrophil: 2.2" "Group enriched" "Detected in many" 7 "granulocytes: 2.2;T-cells: 2.6" "Cell line enhanced" "Detected in many" "ASC diff: 140.0;ASC TERT1: 107.6;fHDF/TERT166: 147.5;JURKAT: 134.8;REH: 196.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 23000 "unprognostic (6.24e-2)" "unprognostic (2.47e-2)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.26e-2)" "unprognostic (5.57e-2)" "unprognostic (4.70e-3)" "unprognostic (2.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (1.67e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.90e-1)" "unprognostic (4.37e-3)" 57.5 5.2 52.3 6.5 49.0 0.6 64.7 50.4 88.9 15.9 26.7 17.4 3.7 9.5 4.0 8.3 13.7 11.3 18.7 95.4 34.2 7.5 4.5 15.8 9.6 35.0 36.5 43.9 4.8 2.9 81.8 12.3 42.5 45.3 10.1 4.7 23.6 8.7 7.5 17.5 17.7 10.9 10.6 25.7 15.9 10.4 0.6 53.7 3.6 9.4 16.3 3.5 13.9 17.1 50.3 16.7 0.6 1.4 0.1 140.0 107.6 19.1 2.6 0.0 11.8 16.1 0.2 0.1 0.0 2.5 147.5 25.0 0.5 43.3 0.0 11.4 26.1 21.2 13.7 0.0 0.0 0.0 58.0 43.7 17.3 0.0 10.5 0.0 0.1 57.4 134.8 0.2 0.6 42.5 0.1 89.7 2.6 0.1 0.0 0.0 196.3 47.7 0.4 0.2 0.2 24.9 9.2 0.0 0.8 13.9 0.2 0.4 16.4 12.1 56.4 1.6 21.4 36.5 0.1 2.2 0.9 85.8 0.2 8.9 0.0 0.1 0.0 0.1 0.1 2.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 0.1 52.3 49.0 50.4 88.9 95.4 34.2 35.0 36.5 43.9 45.3 25.7 53.7 50.3 262.9 0.0 1.3 7.2 1.6 10.5 0.1 0.0 1.2 6.7 1.4 2.4 2.5 1.5 0.0 0.0 2.1 1.5 1.0 0.0 0.0 0.1 0.1 0.0 0.1 115.3 0.0 0.0 71.9 0.5 64.7 15.9 0.0 0.1 0.0 0.0 160.3 0.9 1.8 3.3 3.0 0.0 0.0 4.1 21.5 0.4 0.9 1.4 16.0 8.4 0.5 4.5 0.0 13.6 8.3 0.2 0.0 0.0 1.4 0.4 0.0 0.0 0.0 20.2 0.0 4.4 18.3 0.4 0.3 0.6 11.2 1.4 1.9 0.1 0.0 0.7 SLC35B3 "C6orf196, CGI-19, dJ453H5.1, PAPST2" ENSG00000124786 "Solute carrier family 35 member B3" Q9H1N7 6 8411435-8435561 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054661, HPA057801" Approved NA NA "HPA054661: AB_2682561, HPA057801: AB_2683532" "unprognostic (2.84e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (4.93e-2)" "unprognostic (5.23e-3)" "unprognostic (5.00e-2)" "unprognostic (9.45e-2)" "unprognostic (9.27e-2)" "unprognostic (3.43e-1)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (3.08e-3)" "unprognostic (3.88e-3)" 11.1 9.8 7.2 10.3 8.7 4.7 13.0 7.7 9.6 12.3 8.2 24.4 14.9 9.5 43.3 10.4 9.6 15.2 9.7 7.5 7.8 16.5 23.6 10.7 12.3 8.2 7.9 7.3 8.1 18.6 14.7 12.1 14.8 8.2 12.2 25.1 5.2 15.1 17.6 5.7 10.8 17.1 9.5 7.8 13.5 18.1 8.9 7.8 10.0 18.4 4.6 11.9 12.4 11.0 10.6 14.8 7.7 10.4 14.1 23.4 35.7 8.5 37.9 31.4 13.5 17.3 24.7 13.9 12.5 20.9 27.7 19.5 10.6 11.5 10.3 22.6 18.0 8.4 6.1 6.1 15.0 24.5 9.1 13.2 24.4 14.3 14.3 15.5 17.5 18.5 7.4 13.2 5.1 30.5 10.2 6.9 13.7 8.2 20.6 9.2 6.2 9.7 12.6 36.7 13.2 9.9 8.4 9.8 8.6 17.9 29.6 6.5 18.4 15.9 22.3 6.4 15.9 17.2 12.8 23.9 6.3 12.8 10.0 29.6 5.4 4.5 4.8 6.2 3.5 6.9 4.2 6.2 6.6 4.0 5.8 7.0 5.5 5.2 10.8 5.8 2.7 7.0 4.3 7.2 8.7 7.7 9.6 7.5 7.8 8.2 7.9 7.3 8.2 7.8 7.8 10.6 13.3 6.4 10.6 21.9 14.9 13.5 13.0 29.4 10.8 5.7 20.9 10.3 9.1 20.0 27.5 29.5 4.2 21.1 18.5 42.8 7.9 20.5 9.9 28.6 19.4 15.1 14.9 5.5 19.5 24.3 29.1 21.8 28.1 15.5 6.3 11.5 18.5 23.6 19.9 10.1 17.7 47.3 36.7 15.1 10.4 7.6 15.5 11.3 21.4 24.4 16.7 7.1 13.4 30.7 65.7 15.4 33.4 12.0 22.2 22.6 31.1 27.5 46.8 3.7 13.1 9.9 15.7 32.1 14.2 13.7 17.6 16.4 13.1 10.7 33.5 22.9 RPP40 "bA428J1.3, RNASEP1" ENSG00000124787 "Ribonuclease P/MRP subunit p40" O75818 6 4994717-5004063 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Theca cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035685, HPA035686" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA035685: AB_2674734, HPA035686: AB_10670153" "unprognostic (2.93e-2)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.10e-6)" "unprognostic (8.00e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.17e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (7.54e-8)" "unprognostic (1.54e-1)" "unprognostic (5.10e-1)" "unprognostic (4.08e-2)" "unprognostic (2.19e-1)" 4.7 11.4 4.6 4.3 4.7 4.9 6.8 4.4 5.8 4.5 4.0 3.5 2.9 4.1 3.7 8.7 3.3 2.9 3.2 4.6 5.2 3.4 7.4 2.0 5.8 4.7 4.6 4.7 3.6 3.9 3.8 3.5 3.5 4.9 2.8 3.2 0.7 2.7 2.7 5.6 6.2 2.4 4.7 4.7 4.7 3.1 6.0 5.1 4.7 3.4 3.3 5.5 8.1 5.3 5.2 13.0 21.2 6.6 18.7 11.9 15.1 20.7 12.5 6.3 23.4 18.4 29.0 9.7 27.8 53.6 13.1 32.2 13.4 13.7 19.3 20.9 10.6 27.4 17.5 12.8 39.5 14.0 22.8 9.6 11.8 16.2 23.5 23.0 5.2 23.4 25.2 28.1 5.4 17.3 36.8 11.6 39.0 10.9 15.2 34.0 24.4 12.5 51.0 12.2 13.8 23.5 6.8 11.7 11.1 13.2 17.3 20.2 18.7 11.2 30.6 20.7 20.9 29.1 9.7 43.7 22.0 5.8 37.8 16.1 0.0 7.1 0.0 3.3 11.9 4.9 8.1 5.7 4.1 12.9 7.2 7.6 7.1 0.0 8.6 3.9 6.4 9.1 5.2 4.6 4.7 4.4 5.8 4.6 5.2 4.7 4.6 4.7 4.9 4.7 5.1 5.2 7.3 0.0 1.1 2.0 5.3 12.4 10.4 20.6 6.8 0.2 6.3 9.3 4.5 0.0 9.5 1.8 0.0 13.3 3.6 2.2 11.7 7.9 8.1 9.1 13.7 10.9 3.0 2.5 3.6 9.4 14.5 5.8 4.6 4.6 0.0 11.7 6.4 5.5 11.5 0.0 3.1 4.2 6.1 2.5 4.7 3.7 5.6 3.2 8.8 1.9 3.7 1.2 3.1 3.5 3.1 4.3 2.1 4.9 5.7 7.7 0.7 15.1 10.6 0.5 0.0 8.3 8.4 15.1 24.1 12.6 14.8 9.6 3.6 30.8 7.4 7.7 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 4.0 4.0 2.6 6.0 3.1 2.6 4.1 0.0 15.7 7.5 0.0 7.3 3.8 11.0 4.3 5.1 6.3 5.7 5.8 8.8 0.9 4.1 4.7 7.0 4.2 4.2 2.1 2.4 5.5 4.9 5.6 6.5 4.9 9.6 7.5 3.8 14.1 4.7 6.3 14.7 5.8 4.8 7.6 0.0 5.7 5.4 3.0 3.9 2.6 6.2 15.0 3.2 6.8 6.6 4.8 4.5 2.6 0.9 0.0 4.4 5.9 5.8 4.8 11.2 2.9 3.3 2.8 2.8 0.2 6.3 9.3 3.7 4.2 0.3 3.0 4.2 2.6 4.7 0.7 4.4 9.0 7.0 4.2 7.0 4.6 5.7 6.1 5.1 11.2 5.9 0.9 0.0 5.3 2.4 2.3 0.3 4.8 0.9 1.4 4.3 0.3 5.8 4.0 4.0 7.6 0.3 2.5 4.4 5.5 9.1 8.4 3.6 7.2 9.1 4.0 6.1 4.8 4.4 30.7 19.2 0.2 2.6 4.3 10.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.5 0.7 0.2 0.0 0.0 0.4 1.3 0.0 0.2 0.1 0.4 0.3 2.6 3.1 0.0 15.7 8.8 0.9 4.2 2.1 2.4 9.6 0.0 3.9 4.8 16.0 48.1 25.9 206.3 20.7 91.4 72.2 22.8 48.9 39.8 20.7 14.4 35.9 25.8 26.0 11.0 100.1 0.6 48.4 23.6 7.9 16.7 4.3 80.5 144.4 21.7 1.2 5.7 582.5 8.5 4.0 32.9 22.4 75.8 38.7 67.4 17.2 25.2 22.4 38.7 519.0 16.5 2.0 39.6 79.1 3.3 10.5 41.7 32.0 217.4 42.3 24.1 33.0 318.2 466.8 32.3 16.3 28.2 82.6 56.6 13.9 8.8 33.2 99.9 52.6 19.0 41.6 1.0 6.9 60.9 48.7 0.4 61.5 6.4 7.7 63.8 NUP153 HNUP153 ENSG00000124789 "Nucleoporin 153" P49790 6 17615035-17706925 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027896, HPA027897, HPA027898, HPA027899" Supported Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: " "unprognostic (2.49e-1)" "unprognostic (5.37e-1)" "unprognostic (3.17e-2)" "unprognostic (6.20e-3)" "unprognostic (3.36e-1)" "unprognostic (7.64e-3)" "unprognostic (2.53e-2)" "unprognostic (6.49e-2)" "unprognostic (1.95e-2)" "unprognostic (7.16e-3)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.60e-2)" "unprognostic (3.66e-1)" "unprognostic (5.40e-2)" "unprognostic (8.69e-2)" 16.6 10.4 6.8 18.4 6.4 46.0 16.8 12.9 7.5 15.0 9.7 12.3 10.2 17.2 11.7 16.3 15.1 15.0 10.8 6.6 9.5 13.2 23.6 14.0 24.1 6.4 7.1 5.7 18.8 13.3 18.1 9.3 19.1 7.3 12.1 13.2 15.9 12.1 13.2 25.3 16.0 12.9 14.5 6.4 18.0 11.7 27.0 6.5 25.4 13.9 19.7 27.9 18.9 14.6 10.0 55.6 27.2 57.7 50.8 24.9 29.3 57.8 42.3 39.3 61.8 65.7 45.5 24.9 104.3 69.7 37.7 51.9 39.4 68.1 41.0 99.0 56.2 52.7 55.6 29.4 47.0 18.6 81.0 50.2 31.0 32.5 64.9 46.5 23.6 37.0 34.5 131.7 32.5 41.9 29.5 60.5 50.1 45.6 20.8 29.5 80.1 74.2 97.9 27.3 53.1 64.6 37.5 36.0 58.3 36.2 90.5 37.8 29.0 34.8 63.2 36.2 30.2 66.7 41.8 63.8 102.8 15.6 36.8 76.1 1.2 1.3 3.2 2.8 1.2 3.7 1.7 3.5 3.4 1.9 2.1 2.1 2.1 3.4 3.0 1.8 1.1 1.7 1.3 6.8 6.4 12.9 7.5 6.6 9.5 6.4 7.1 5.7 7.3 6.4 6.5 10.0 28.9 19.2 23.2 39.8 31.4 76.3 37.9 11.1 51.2 14.2 32.5 18.7 14.3 11.5 11.9 16.5 16.7 20.9 24.0 19.4 1.9 8.8 27.3 69.3 56.8 23.3 20.9 44.0 53.0 6.0 21.7 31.8 23.4 91.0 3.8 17.7 13.6 30.7 17.5 16.8 48.8 13.6 12.2 15.6 36.7 19.6 17.4 27.5 21.4 47.8 12.7 7.2 20.6 37.2 50.5 13.4 7.0 14.7 27.9 41.7 10.1 9.8 23.4 12.7 13.1 55.1 26.4 30.4 22.3 51.8 79.3 23.9 35.8 11.7 16.8 35.1 DEK D6S231E ENSG00000124795 "DEK proto-oncogene" P35659 6 18223860-18264548 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015226, HPA054505, HPA057799" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530" "unprognostic (6.35e-2)" "unprognostic (6.11e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (3.66e-1)" "unprognostic (5.02e-3)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.61e-3)" "unprognostic (6.49e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (2.31e-1)" "unprognostic (3.78e-1)" 51.2 43.4 20.2 83.2 23.1 160.0 63.7 32.7 25.6 48.5 23.9 75.6 77.6 74.9 30.2 66.0 46.0 49.4 61.6 20.1 22.2 46.4 68.5 53.6 126.5 23.5 21.8 18.2 62.0 40.7 43.6 19.5 68.3 24.0 56.7 74.9 46.7 37.6 56.6 117.1 50.2 87.5 64.5 21.6 64.4 59.2 22.3 22.4 117.9 103.3 74.0 113.8 59.9 43.4 29.2 450.1 118.6 330.9 276.6 68.9 118.4 184.2 347.4 210.9 338.9 457.1 190.7 165.5 504.2 390.2 181.8 269.1 251.1 260.7 196.2 591.3 346.5 221.3 305.7 179.9 260.0 70.3 499.2 238.2 58.2 98.1 238.2 198.2 164.7 170.9 188.1 392.9 0.6 236.5 156.2 380.3 222.1 208.6 177.4 131.8 471.7 459.7 299.8 184.2 239.6 196.1 183.8 328.9 290.5 224.6 218.4 277.8 212.7 168.7 382.7 220.0 223.9 474.1 32.4 77.0 540.3 95.0 251.3 380.8 116.2 78.2 41.8 69.6 74.9 83.1 66.3 72.5 78.0 72.9 56.1 55.6 55.7 93.4 70.9 92.9 49.0 75.2 67.8 20.2 23.1 32.7 25.6 20.1 22.2 23.5 21.8 18.2 24.0 21.6 22.4 29.2 149.7 121.8 130.8 16.3 126.2 271.2 189.8 128.8 146.3 70.3 143.3 161.3 218.8 161.5 112.0 79.1 81.3 284.2 174.5 156.7 82.2 172.0 17.4 118.8 157.7 156.6 88.5 448.8 10.4 173.1 235.4 159.6 85.1 170.6 111.2 195.1 105.7 125.1 190.9 26.9 18.6 188.1 67.1 185.3 300.7 26.2 189.5 219.1 101.4 31.9 263.3 136.2 212.1 26.2 37.1 136.9 117.3 191.5 44.0 252.9 140.0 129.5 89.0 138.8 210.4 189.1 197.0 87.2 220.7 169.9 233.6 108.6 189.1 138.6 232.5 209.2 EEF1E1 "AIMP3, P18" ENSG00000124802 "Eukaryotic translation elongation factor 1 epsilon 1" O43324 6 8073360-8102559 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 244.3;Late spermatids: 231.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA027901, HPA057866" Approved Supported Nucleoplasm,Cytosol NA NA 18000 "Nucleoplasm, Cytosol" "HPA027901: AB_10611960, HPA057866: AB_2683547" "unprognostic (9.39e-3)" "prognostic favorable (3.16e-4)" "unprognostic (2.23e-1)" "unprognostic (2.36e-2)" "unprognostic (1.42e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.79e-1)" "unprognostic (5.67e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" 15.6 29.8 27.7 21.7 28.6 58.3 26.8 34.7 33.7 15.0 26.2 18.6 12.1 19.5 26.5 22.8 15.1 13.7 19.3 29.2 32.0 41.4 20.5 13.9 31.9 32.7 31.9 29.0 14.8 28.5 31.6 24.1 17.5 34.2 17.9 21.1 25.7 20.2 18.3 23.0 12.4 12.8 19.3 29.7 16.5 23.2 58.0 33.0 26.2 20.8 24.9 31.4 26.7 14.0 37.1 129.5 67.1 104.8 71.9 35.0 56.5 63.6 105.7 67.0 94.4 97.0 111.8 52.5 140.9 229.3 69.8 169.8 51.9 122.3 123.9 156.8 79.6 160.6 113.9 92.0 196.4 63.9 228.2 79.2 47.4 113.5 117.4 116.2 66.4 136.2 113.8 283.3 35.9 91.2 54.0 98.0 183.2 95.8 123.9 107.8 117.9 61.0 221.0 156.3 98.5 156.7 48.0 45.6 100.5 131.9 141.5 79.7 75.7 70.2 77.0 76.7 70.7 156.3 58.4 290.7 199.3 43.1 95.8 126.0 16.2 22.2 14.2 25.7 31.8 36.8 42.9 34.4 34.8 61.2 46.9 38.1 39.5 2.3 30.7 25.5 26.8 45.8 29.3 27.7 28.6 34.7 33.7 29.2 32.0 32.7 31.9 29.0 34.2 29.7 33.0 37.1 31.9 16.0 30.0 0.0 39.7 65.9 61.4 99.1 60.3 34.4 43.1 54.1 23.5 21.5 63.4 60.7 10.4 78.7 23.5 11.8 140.8 67.9 244.3 59.0 31.0 34.1 40.1 43.5 0.0 89.0 76.6 30.8 32.1 71.0 15.8 45.4 24.3 30.0 49.7 30.3 0.0 36.6 75.3 31.1 33.4 231.1 26.4 31.3 42.7 0.0 32.6 44.7 29.9 0.0 0.0 69.0 12.9 23.7 48.0 81.3 7.5 186.7 45.9 21.8 13.1 32.8 38.9 131.2 92.2 59.3 76.1 32.3 34.1 69.9 42.0 44.8 CRISP1 "AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP" ENSG00000124812 "Cysteine rich secretory protein 1" P54107 6 49834257-49877096 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "epididymis: 1587.6" "Group enriched" "Detected in some" 29 "Early spermatids: 45.5;Late spermatids: 71.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;NB-4: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028445, HPA030534" Enhanced "Secreted in male reproductive system" NA NA 35000 "HPA028445: AB_10670428, HPA030534: AB_2732459" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1587.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 71.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RUNX2 "AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1" ENSG00000124813 "RUNX family transcription factor 2" Q13950 6 45328157-45664349 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 22.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008374, HPA022040, CAB062561, CAB068226, HPA070715" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: " "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (3.99e-2)" "unprognostic (2.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-1)" "unprognostic (1.23e-1)" "unprognostic (3.70e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (3.97e-9)" "prognostic unfavorable (2.24e-4)" "unprognostic (5.52e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (6.66e-5)" 1.4 0.7 1.1 4.3 1.3 9.8 2.9 1.3 1.5 6.8 1.5 3.5 2.1 1.5 0.8 1.4 0.9 3.5 0.7 1.4 2.9 1.5 0.7 2.7 4.6 1.9 1.7 0.8 2.2 0.6 0.6 1.6 1.5 2.0 4.9 4.0 0.1 10.8 2.6 0.8 2.4 6.0 1.6 1.9 3.7 3.3 0.5 1.9 4.5 1.9 0.9 5.6 3.6 4.9 2.0 3.6 1.1 0.8 0.0 3.2 8.3 0.0 3.3 7.9 10.9 15.2 0.0 1.9 0.0 3.8 4.7 4.9 4.3 0.0 3.1 19.7 13.7 1.5 0.0 2.4 0.0 16.7 14.2 0.1 22.5 2.5 9.7 10.9 39.3 0.2 5.6 0.0 62.3 19.7 1.0 0.4 24.7 0.7 3.2 0.5 0.1 51.8 0.0 10.7 7.0 0.0 0.0 2.4 0.1 4.1 9.2 3.6 1.2 0.5 11.1 8.8 17.2 12.1 19.6 0.0 55.2 12.5 5.3 5.0 8.6 0.9 4.5 1.5 0.2 12.9 0.2 3.5 4.0 2.4 0.2 0.6 1.8 6.5 22.1 0.1 15.4 3.2 1.0 1.1 1.3 1.3 1.5 1.4 2.9 1.9 1.7 0.8 2.0 1.9 1.9 2.0 0.9 0.0 2.7 4.6 5.7 2.8 16.6 5.3 1.2 0.0 2.0 1.4 2.7 0.0 4.9 3.7 0.0 0.0 55.8 0.3 0.0 0.6 128.3 0.7 3.5 0.8 0.0 3.8 17.4 0.2 0.0 7.0 4.1 0.5 2.5 0.1 1.1 0.8 3.7 0.0 95.2 1.0 20.3 6.7 20.8 20.0 1.2 16.3 7.2 128.4 18.6 0.0 7.2 6.6 5.2 0.4 0.1 2.2 44.4 16.5 0.0 3.3 5.1 0.0 6.6 1.5 6.2 0.8 0.5 1.2 1.6 0.1 21.4 0.2 0.2 28.0 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 2.6" "Group enriched" "Detected in some" 11 "Early spermatids: 27.1;Late spermatids: 25.6;Spermatocytes: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026084 Supported NA NA "HPA026084: AB_2671807" "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 13.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GCM2 "GCMB, hGCMb" ENSG00000124827 "Glial cells missing transcription factor 2" O75603 6 10873223-10882041 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 358 "parathyroid gland: 264.8" "Cell type enhanced" "Detected in some" "Astrocytes: 1.3;Early spermatids: 2.6;Excitatory neurons: 2.3;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.55e-1)" "unprognostic (4.94e-1)" "unprognostic (2.18e-2)" "unprognostic (7.17e-2)" "unprognostic (2.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 264.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRFIP1 "FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP" ENSG00000124831 "LRR binding FLII interacting protein 1" Q32MZ4 2 237627587-237813682 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 322.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006979 Approved Supported Cytosol NA NA 580000 Cytosol "HPA006979: AB_1079282" "unprognostic (2.07e-1)" "unprognostic (2.99e-2)" "unprognostic (4.09e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.08e-2)" "unprognostic (3.99e-3)" "unprognostic (8.90e-2)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (2.69e-2)" "unprognostic (8.07e-2)" "unprognostic (7.64e-2)" 42.7 21.2 11.7 49.7 9.4 87.6 34.2 4.0 14.3 32.0 25.9 53.5 36.3 64.8 15.8 58.7 32.4 39.8 62.8 11.7 16.2 39.5 49.3 62.3 45.8 7.9 6.6 9.0 16.2 21.3 55.6 15.0 41.8 7.3 41.3 40.7 6.5 38.3 31.5 111.9 23.5 36.2 59.3 7.1 46.1 50.0 5.5 9.2 43.9 38.2 51.1 53.0 70.0 43.7 8.4 99.1 50.1 17.5 45.9 25.4 55.6 77.7 67.4 62.3 37.8 37.2 19.2 64.6 8.4 27.4 108.8 81.2 80.9 54.0 100.4 80.2 322.6 34.7 78.0 55.1 54.8 58.5 104.2 71.0 23.9 205.8 88.2 216.0 50.6 59.8 54.0 58.4 77.8 79.5 47.8 60.5 79.5 29.6 73.3 45.1 87.9 125.3 80.1 122.0 141.8 46.3 24.0 33.5 76.2 92.2 37.6 42.9 129.2 99.4 42.4 41.1 49.5 77.0 15.8 14.3 53.2 63.4 102.7 51.0 78.5 104.1 248.4 74.8 97.5 55.1 55.9 89.0 77.3 84.1 60.1 46.1 52.2 326.2 46.9 168.9 73.1 76.7 61.4 11.7 9.4 4.0 14.3 11.7 16.2 7.9 6.6 9.0 7.3 7.1 9.2 8.4 236.4 487.2 307.3 35.6 249.6 307.0 391.9 166.0 113.3 46.4 128.6 86.2 160.3 127.2 269.9 172.9 37.5 111.2 347.1 319.5 52.8 229.7 7.9 368.3 88.2 213.0 190.5 62.4 175.9 333.0 359.2 109.1 159.0 426.3 241.0 56.9 122.0 149.1 175.8 21.9 237.5 168.3 79.3 271.2 721.3 7.9 29.8 398.9 167.2 57.1 365.0 25.1 213.1 111.1 12.5 389.6 220.6 23.3 146.6 430.5 152.8 49.5 286.1 6.0 78.9 147.3 182.9 10.1 27.4 179.3 243.1 25.3 288.5 158.3 150.0 588.4 RAB17 ENSG00000124839 "RAB17, member RAS oncogene family" Q9H0T7 2 237574322-237601614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 77.4;liver: 108.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 106.3;Distal tubular cells: 137.0;Hepatocytes: 121.7;Proximal enterocytes: 222.5;Proximal tubular cells: 170.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 42.4;Hep G2: 39.9;MCF7: 52.0;SK-BR-3: 48.1;SK-MEL-30: 86.7;T-47d: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA035176 Approved NA NA "HPA035176: AB_10696368" "unprognostic (8.66e-2)" "unprognostic (1.13e-1)" "unprognostic (1.44e-3)" "unprognostic (9.14e-2)" "unprognostic (2.48e-3)" "unprognostic (1.26e-3)" "unprognostic (1.33e-1)" "unprognostic (5.36e-2)" "unprognostic (3.49e-2)" "unprognostic (2.68e-2)" "prognostic favorable (4.14e-4)" "unprognostic (5.87e-2)" "prognostic favorable (3.33e-13)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (3.44e-1)" "prognostic favorable (2.51e-4)" 0.5 1.0 1.0 1.6 0.7 0.4 15.1 0.6 1.3 6.8 21.0 16.6 77.4 2.3 19.6 2.1 11.2 14.8 1.2 2.3 1.0 50.2 108.5 23.3 0.4 0.9 0.8 0.6 0.6 39.0 37.3 3.0 14.0 0.8 7.1 15.7 4.2 35.1 15.5 1.5 0.9 74.3 1.1 0.8 0.5 33.9 0.7 1.0 1.0 33.7 0.0 0.8 3.9 0.3 1.0 9.5 0.3 0.0 17.7 0.1 0.2 42.4 0.2 0.1 0.0 0.1 28.7 26.6 0.0 5.6 0.2 0.1 0.4 0.0 12.5 0.2 0.0 0.0 0.0 0.1 39.9 0.0 0.2 0.0 0.0 7.8 0.0 0.9 0.7 0.0 0.1 0.0 0.0 1.0 52.0 0.0 0.6 0.5 28.6 0.1 1.1 0.0 3.4 13.7 25.1 10.5 0.1 0.0 48.1 86.7 9.4 34.8 0.7 0.0 0.2 0.6 0.1 0.1 0.1 1.2 0.0 0.1 2.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.6 1.3 2.3 1.0 0.9 0.8 0.6 0.8 0.8 1.0 1.0 1.2 60.9 34.3 0.3 0.5 1.8 3.4 3.3 22.8 1.7 32.2 18.3 1.0 65.8 11.9 46.0 106.3 16.0 0.1 49.6 137.0 40.0 0.0 18.2 1.6 1.8 30.3 0.0 0.8 28.0 3.8 0.7 29.0 22.1 0.0 0.4 2.5 121.7 1.9 0.0 1.5 23.9 24.4 2.2 0.6 0.7 8.7 1.3 5.4 0.0 0.6 0.2 0.0 1.0 0.1 27.9 50.1 3.8 0.1 5.3 222.5 170.2 13.7 0.6 0.0 0.3 0.7 0.0 0.2 6.6 0.6 12.3 1.3 0.7 21.9 6.5 CXCL6 "CKA-3, GCP-2, SCYB6" ENSG00000124875 "C-X-C motif chemokine ligand 6" P80162 4 73836640-73849064 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 36.4;lymphoid tissue: 101.7;urinary bladder: 26.8" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 241.2;Basal respiratory cells: 509.4;Cholangiocytes: 317.4;Club cells: 361.3;Ductal cells: 1120.6;Prostatic glandular cells: 245.5;Urothelial cells: 328.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "Immune cell enriched" "Detected in single" 104 "neutrophil: 10.4" "Lineage enriched" "Detected in single" 104 "granulocytes: 10.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 53.2;EFO-21: 136.5;hTEC/SVTERT24-B: 28.8;HUVEC TERT2: 84.5;RPTEC TERT1: 98.4" "Region enhanced" "Detected in many" "basal ganglia: 9.6" "Not detected" "Not detected" "Secreted to blood" NA NA 108000 "unprognostic (4.35e-4)" "unprognostic (4.47e-2)" "unprognostic (6.09e-2)" "unprognostic (4.60e-2)" "unprognostic (1.98e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-3)" "unprognostic (2.62e-1)" "unprognostic (2.05e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "unprognostic (9.02e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.47e-1)" "unprognostic (4.88e-1)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" 2.7 0.1 0.5 14.2 0.5 2.1 0.6 0.2 4.0 4.6 3.0 0.9 8.1 0.1 0.1 2.5 2.5 36.4 2.1 0.2 1.6 3.7 6.6 2.7 0.3 0.3 0.4 0.2 0.1 5.3 0.0 0.2 0.1 0.7 3.5 0.6 0.0 3.8 10.9 0.0 0.0 10.3 0.3 0.1 101.7 1.2 0.3 0.8 2.6 0.0 0.3 2.8 26.8 5.6 0.6 0.0 0.0 0.5 0.0 4.4 16.6 0.0 3.3 53.2 0.4 0.7 0.0 0.0 0.0 136.5 0.2 5.3 11.8 0.0 0.0 8.1 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 10.1 0.3 28.8 0.0 0.4 84.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 3.9 0.0 0.0 0.0 98.4 1.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 1.4 0.9 0.5 0.0 0.6 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 4.0 0.2 1.6 0.3 0.4 0.2 0.7 0.1 0.8 0.6 0.0 3.2 2.0 0.0 0.1 0.4 241.2 509.4 0.0 0.0 2.9 1.3 0.2 317.4 361.3 0.0 0.0 0.0 0.0 0.2 0.0 1120.6 0.0 0.7 0.1 2.0 78.1 0.0 0.0 3.9 0.0 13.2 0.0 1.3 0.0 0.3 0.0 0.6 0.2 0.0 0.0 0.2 97.6 0.3 0.8 0.1 0.0 1.1 0.0 0.0 7.8 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 245.5 0.0 0.3 75.7 0.0 0.0 1.5 18.4 0.0 1.2 0.3 0.1 0.0 0.1 0.0 0.1 328.4 EREG ER ENSG00000124882 Epiregulin O14944 4 74365145-74388749 "Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "bone marrow: 130.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 179.1;Kupffer cells: 133.9;Langerhans cells: 171.1;Macrophages: 570.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 270.0;CAPAN-2: 76.7;hTEC/SVTERT24-B: 83.7;U-2197: 181.4;U-87 MG: 307.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054373 Approved Vesicles "Secreted to blood" NA NA 46000 Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 4.6 0.0 0.3 10.4 0.2 130.2 2.5 0.1 0.5 0.9 0.3 2.0 0.2 0.2 0.2 12.7 0.8 5.7 0.7 0.2 0.4 0.1 0.2 2.7 0.1 0.2 0.2 0.2 0.1 0.3 0.0 0.0 0.6 0.2 0.1 3.5 0.1 1.3 0.0 0.2 8.4 1.6 3.1 0.0 0.5 0.2 0.1 0.5 0.1 0.1 0.0 1.0 5.0 4.0 0.5 1.4 41.1 0.0 0.0 3.8 6.6 0.1 9.2 270.0 2.6 1.6 32.5 76.7 0.0 44.1 0.0 20.1 2.4 0.0 59.3 2.7 0.0 0.0 1.2 1.6 1.2 1.1 0.1 0.1 3.9 20.2 83.7 43.5 0.0 0.0 0.0 0.1 0.5 0.2 0.4 0.1 0.1 0.1 0.2 0.6 0.1 0.0 0.1 0.6 1.6 0.0 0.0 27.0 0.2 0.0 0.0 0.1 0.0 0.0 1.6 0.6 181.4 0.0 0.0 0.0 0.2 307.0 0.0 0.2 0.4 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.5 0.5 4.9 6.4 7.2 0.0 5.7 5.4 5.6 179.1 4.0 0.0 24.4 2.3 18.2 5.7 82.4 0.0 0.0 0.4 2.2 56.3 0.0 1.8 3.7 2.4 0.7 2.5 3.6 17.0 0.1 0.2 0.7 4.4 0.5 3.9 7.0 0.1 0.4 1.9 26.8 0.0 1.8 38.2 16.2 133.9 171.1 1.0 0.3 570.7 7.2 0.0 23.2 0.0 0.0 0.0 0.0 0.8 27.1 0.0 11.7 2.5 32.4 0.2 41.9 0.0 0.0 2.5 3.1 0.5 0.3 3.8 9.2 0.7 3.3 0.2 33.1 7.4 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 112 "basophil: 11.2" "Lineage enriched" "Detected in single" 112 "granulocytes: 11.2" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 61.3" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752636-61788518 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 148.6;stomach 1: 89.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1;Cholangiocytes: 60.1;Gastric mucus-secreting cells: 130.0;Oligodendrocytes: 255.8;Pancreatic endocrine cells: 70.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 38.8;CACO-2: 63.6;CAPAN-2: 34.0;EFO-21: 48.6;Hep G2: 21.8;OE19: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol NA NA 1400000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 7.2 0.6 17.7 1.1 70.8 0.3 0.4 45.9 39.9 1.9 0.0 2.7 11.5 13.2 0.1 2.4 15.6 17.5 1.4 17.2 39.6 11.3 17.0 22.5 0.1 70.8 72.7 6.9 17.8 31.8 0.0 0.4 1.1 99.1 0.7 1.1 0.4 0.6 0.3 0.1 0.5 10.9 1.9 38.7 0.5 89.0 3.1 62.0 0.0 0.3 0.0 0.1 0.5 0.6 148.6 3.1 38.8 4.7 1.5 0.0 0.0 0.2 0.2 0.1 0.9 0.8 63.6 34.0 0.9 48.6 0.0 1.2 0.3 1.3 0.0 0.9 0.1 0.6 0.2 0.7 21.8 18.9 0.0 0.4 0.3 0.0 0.6 0.0 10.9 0.1 1.6 11.7 0.3 0.2 0.5 0.0 0.9 1.6 37.2 4.8 0.0 0.1 1.9 6.5 0.0 0.1 0.9 0.0 0.4 0.3 10.6 0.6 0.4 1.4 0.4 19.5 0.0 0.6 0.2 0.1 0.3 0.1 2.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 70.8 45.9 39.9 17.2 39.6 70.8 72.7 6.9 99.1 38.7 62.0 148.6 0.1 48.1 5.1 2.3 0.6 0.1 0.1 0.2 0.0 0.5 0.8 0.8 1.3 60.1 3.4 3.7 0.0 0.4 1.6 6.4 0.0 31.7 0.2 1.4 3.2 0.6 1.2 0.0 0.9 36.7 0.3 5.6 130.0 4.1 0.0 4.4 0.7 6.0 0.9 0.0 1.1 4.5 6.1 0.0 0.6 1.2 5.9 0.8 3.6 0.0 1.0 3.5 0.0 5.5 255.8 70.5 13.0 3.8 0.4 0.2 12.8 2.2 1.3 0.3 0.0 0.2 1.2 1.4 3.7 0.8 0.0 0.8 0.7 0.3 7.7 3.1 SCGB1D2 "LIPB, LPHB" ENSG00000124935 "Secretoglobin family 1D member 2" O95969 11 62242239-62244812 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "breast: 1240.5;cervix: 4036.1" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 3242.1;Glandular and luminal cells: 3417.9" "Group enriched" "Detected in many" 6 "breast cancer: 625.1;endometrial cancer: 226.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 10.4" HPA035318 Approved "Secreted in other tissues" NA NA "HPA035318: AB_10610421" "unprognostic (8.76e-2)" "unprognostic (2.14e-1)" "prognostic favorable (3.46e-6)" "unprognostic (2.39e-2)" "unprognostic (5.89e-2)" "unprognostic (4.72e-2)" "unprognostic (1.99e-1)" "unprognostic (6.43e-2)" "prognostic favorable (8.03e-6)" "unprognostic (1.55e-1)" "unprognostic (1.15e-2)" 7.4 5.0 3.5 0.0 3.4 0.0 1240.5 3.0 5.4 4036.1 11.4 0.3 0.1 89.7 358.9 10.2 111.2 0.1 2.6 3.0 6.5 9.0 0.2 0.1 0.1 4.1 4.5 2.5 1.1 4.5 0.5 5.2 0.2 3.5 8.6 0.2 1.8 69.7 2.9 7.3 305.1 0.5 0.0 2.9 0.0 0.3 0.2 3.9 0.4 0.6 6.0 0.0 0.2 0.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 0.1 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 3.0 5.4 3.0 6.5 4.1 4.5 2.5 3.5 2.9 3.9 4.1 2.1 0.0 0.0 0.0 1.6 27.4 4.8 0.0 0.0 0.5 647.8 251.6 10.9 0.0 0.0 7.3 0.0 0.0 5.3 0.0 23.5 0.3 0.0 3242.1 409.9 12.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 3417.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 15.0 823.6 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 46.1 0.0 0.9 0.0 0.2 8.6 0.0 0.0 0.0 7.0 0.1 20.0 0.0 0.0 1.1 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208673-62213943 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 2037.7;epididymis: 1384.0" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 971.9" "Region enriched" "Detected in single" 5 "medulla oblongata: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 8.6" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.1 0.0 0.2 0.2 0.5 0.0 58.4 0.1 0.1 2037.7 0.1 12.9 1.3 119.7 1384.0 4.2 240.5 13.6 0.1 0.2 0.4 1.7 0.1 2.4 0.0 3.4 0.4 0.0 0.7 17.3 1.1 5.1 0.1 0.7 6.9 16.5 0.0 29.8 15.7 0.0 7.1 1.0 2.2 0.7 0.0 46.3 0.0 0.7 2.7 5.8 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 1.6 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.2 0.4 3.4 0.4 0.0 0.7 0.7 0.7 0.2 0.6 0.0 4.8 0.0 0.4 0.1 3.8 4.8 0.0 0.0 123.6 71.0 0.0 48.6 10.1 16.5 0.0 0.2 1.6 9.7 3.9 6.6 0.0 2506.4 397.7 7.6 37.1 0.0 0.0 5.3 0.0 3.8 26.5 2597.0 0.0 0.3 0.0 0.1 4.9 0.0 0.0 59.9 10.2 0.3 0.0 0.0 0.0 14.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 10.8 0.0 0.0 27.0 0.7 0.1 109.3 0.0 0.0 0.0 8.5 0.0 0.0 1.7 0.4 0.0 13.7 0.1 7.0 16.6 AHNAK MGC5395 ENSG00000124942 "AHNAK nucleoprotein" Q09666 11 62433542-62556235 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 561.4;fHDF/TERT166: 554.5;TIME: 582.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 395.4" "HPA019010, HPA019070, HPA026643" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA 10000000 "Plasma membrane, Cytosol" "HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (3.46e-1)" "unprognostic (3.19e-1)" "unprognostic (1.96e-2)" "unprognostic (5.99e-2)" "unprognostic (2.53e-1)" "unprognostic (1.63e-2)" "unprognostic (4.84e-2)" "unprognostic (1.98e-3)" "prognostic unfavorable (2.42e-4)" "unprognostic (4.30e-1)" "unprognostic (4.49e-3)" "unprognostic (5.42e-2)" "unprognostic (1.18e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.47e-6)" 217.9 28.2 61.5 43.8 46.3 44.5 192.3 37.6 47.0 165.5 76.7 222.4 49.5 184.8 52.2 250.2 146.8 75.5 105.6 66.5 110.9 59.8 60.6 145.3 37.0 73.7 45.3 29.6 126.9 30.6 26.5 17.0 98.1 71.9 89.3 97.5 10.2 128.5 106.7 190.1 337.4 137.7 114.1 59.3 60.0 134.6 18.2 54.1 28.1 65.5 173.7 64.3 143.2 215.1 80.8 188.2 107.9 9.8 44.1 421.8 561.4 70.3 166.0 201.4 103.0 57.4 93.7 64.9 0.2 61.7 554.5 79.8 244.1 41.2 203.7 130.7 154.2 7.3 22.6 173.4 27.9 80.8 31.5 142.2 204.2 233.0 202.4 183.6 131.5 215.4 2.7 21.8 138.8 211.7 72.1 0.4 60.7 3.0 59.6 171.7 0.4 45.1 113.9 227.1 120.2 0.3 9.2 167.5 69.3 69.0 198.8 133.7 28.4 582.1 182.4 119.8 229.8 74.4 25.0 5.4 0.6 138.2 10.1 60.9 44.1 75.6 0.3 38.7 45.0 25.8 20.0 24.8 31.7 73.8 16.1 3.2 17.3 1.1 31.5 37.8 20.2 21.5 36.8 61.5 46.3 37.6 47.0 66.5 110.9 73.7 45.3 29.6 71.9 59.3 54.1 80.8 413.1 439.1 106.3 49.3 171.4 479.4 133.8 285.0 253.2 1.4 173.0 226.8 199.9 195.9 224.1 193.1 0.0 110.8 194.3 400.8 13.7 99.6 10.6 188.5 195.0 282.5 47.6 43.7 0.9 64.1 145.6 312.9 538.2 351.2 238.9 4.3 201.4 88.5 79.4 1.7 0.8 164.8 138.4 329.8 458.3 33.2 451.4 292.3 318.4 43.1 284.8 30.7 138.0 0.5 0.4 262.5 195.5 466.0 329.0 202.4 262.3 6.8 149.3 1.2 177.5 349.5 244.4 3.1 8.1 596.4 610.3 102.2 256.5 3.0 101.8 198.0 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 360.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved NA NA "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 71.7 41.4 27.3 29.1 28.4 66.3 33.7 29.4 30.2 26.3 30.2 41.0 37.8 23.4 27.2 46.5 29.1 28.1 34.6 29.6 30.7 40.7 66.3 36.4 22.9 31.2 30.0 28.1 22.7 44.0 71.1 17.4 20.5 31.1 26.0 36.4 24.4 43.2 32.3 79.1 32.4 37.6 32.3 29.8 23.3 35.6 49.0 29.5 27.5 40.3 47.2 28.8 41.1 25.3 31.6 48.9 100.7 37.4 22.5 232.6 90.3 125.1 98.1 84.6 60.1 64.8 69.5 75.6 38.7 69.8 111.9 115.2 66.7 64.2 58.3 61.7 105.2 64.3 63.6 69.9 46.5 100.4 71.8 68.2 107.4 102.5 104.9 60.1 76.5 75.6 41.8 82.0 109.2 90.2 119.5 38.3 35.6 41.5 103.2 68.7 49.0 52.4 115.7 72.8 86.7 26.4 53.1 69.9 103.3 63.4 39.1 87.5 58.0 87.6 59.8 49.6 65.0 100.8 58.3 165.6 79.0 126.2 52.0 76.4 119.7 115.1 108.5 64.5 93.6 66.8 65.6 63.7 74.5 88.3 71.2 45.8 61.5 103.5 77.3 95.3 79.1 107.3 156.1 27.3 28.4 29.4 30.2 29.6 30.7 31.2 30.0 28.1 31.1 29.8 29.5 31.6 59.1 54.5 72.9 19.9 45.3 50.6 59.9 178.0 24.5 40.6 43.0 39.9 108.1 57.2 121.4 46.0 39.6 49.5 52.7 58.6 46.9 100.6 360.7 61.6 50.2 59.2 21.1 240.2 25.4 119.9 51.8 51.1 38.7 64.0 34.1 36.5 46.1 105.0 97.8 23.5 21.1 40.2 109.9 51.0 66.6 109.3 50.4 101.7 58.7 9.4 97.5 65.2 57.7 21.1 17.8 107.4 71.3 37.6 55.6 58.7 92.6 76.9 99.1 63.5 59.2 44.7 60.7 199.7 63.0 49.6 60.7 85.8 52.7 60.6 52.0 80.2 SSUH2 "C3orf32, fls485, ssu-2" ENSG00000125046 "Ssu-2 homolog" Q9Y2M2 3 8619400-8745040 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.8;testis: 4.0" "Group enriched" "Detected in some" 4 "Early spermatids: 61.7;Late spermatids: 43.6;Proximal enterocytes: 16.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "Hep G2: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA049777 Approved NA NA "HPA049777: AB_2680876" "unprognostic (2.49e-1)" "unprognostic (7.62e-2)" "unprognostic (9.65e-2)" "unprognostic (1.68e-1)" "unprognostic (2.46e-1)" "unprognostic (8.86e-2)" "unprognostic (1.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.53e-1)" "unprognostic (4.09e-1)" "unprognostic (7.97e-3)" "unprognostic (1.52e-1)" "unprognostic (3.15e-3)" "unprognostic (1.31e-1)" "unprognostic (3.65e-2)" "unprognostic (4.96e-2)" "unprognostic (7.50e-2)" 0.5 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 3.8 0.2 0.0 0.2 0.2 0.4 1.8 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 3.3 0.1 0.0 1.6 0.3 4.0 0.0 0.0 0.8 0.1 0.1 0.2 0.2 0.1 0.0 0.5 0.6 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 9.9 0.0 0.0 1.3 0.0 0.3 0.1 0.1 0.0 0.0 0.3 0.8 1.8 0.0 0.1 0.0 0.0 0.0 0.1 3.1 0.0 0.0 61.7 1.7 0.1 3.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.2 0.0 0.7 2.2 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.4 43.6 1.2 0.2 1.8 1.0 0.0 0.0 0.0 2.0 1.4 0.1 1.2 0.4 0.0 0.1 16.1 0.9 4.0 0.0 0.0 0.4 0.7 0.5 1.1 0.3 0.1 0.0 0.1 0.5 0.8 0.2 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978322-48982620 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.1;Gastric mucus-secreting cells: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Group enriched" "Detected in some" 8 "gdT-cell: 3.1;MAIT T-cell: 5.1;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 29 "T-cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.0 0.0 0.7 0.5 4.5 1.1 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.7 1.2 0.0 0.0 0.2 0.8 0.8 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.3 0.7 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.1 0.1 2.0 2.9 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.2 0.5 0.7 4.5 0.0 1.9 0.7 1.2 0.8 0.0 1.1 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.3" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 17.7" "Group enriched" "Detected in many" 5 "B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: AB_2683239" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 7.9 3.5 3.5 8.8 3.6 4.6 5.6 4.2 4.0 3.0 5.4 2.5 0.9 2.2 0.7 8.5 3.0 5.5 3.6 2.9 8.8 19.1 9.7 9.1 9.2 9.7 4.7 1.3 1.2 6.3 0.7 2.5 3.1 6.1 4.8 1.0 1.3 4.6 2.7 1.6 2.5 4.9 2.0 6.8 14.2 6.1 0.6 8.2 28.3 4.6 0.7 4.5 4.4 5.9 8.5 3.9 6.1 0.1 0.0 0.0 0.5 4.1 0.4 0.2 0.5 0.8 3.2 2.2 5.2 5.2 0.0 0.8 2.0 0.0 12.4 0.0 14.2 0.2 0.0 6.1 5.7 4.3 0.1 0.8 0.2 15.3 0.3 9.9 0.5 25.8 3.2 0.8 7.3 0.4 4.1 41.8 3.4 0.0 2.3 5.1 3.1 0.7 1.6 0.4 1.0 0.1 3.1 1.7 0.4 26.8 1.0 0.0 1.0 14.2 0.0 3.0 19.0 0.2 0.0 1.0 4.7 0.2 1.9 4.1 0.0 9.9 1.3 0.7 8.8 0.9 4.9 1.7 1.1 7.7 6.8 0.9 0.7 0.3 0.3 12.3 17.7 2.5 4.3 3.5 3.6 4.2 4.0 2.9 8.8 9.7 4.7 1.3 6.1 6.8 8.2 8.5 12.6 0.0 5.8 1.3 18.1 0.8 10.5 6.9 0.6 1.0 0.8 1.4 3.3 4.3 4.1 25.8 0.0 2.1 18.2 2.5 7.9 3.6 0.5 0.9 0.3 12.6 1.2 3.2 0.2 5.6 3.4 1.6 32.6 2.2 17.2 0.3 27.5 8.6 22.7 23.5 0.1 2.5 14.2 33.7 16.7 1.5 0.6 35.7 0.0 17.8 15.6 13.3 7.2 0.5 0.1 9.3 4.5 0.7 17.1 8.3 0.1 17.2 2.0 0.9 0.0 0.6 1.2 0.0 0.3 2.5 0.6 3.0 11.7 2.5 1.8 15.3 CNOT1 "AD-005, CDC39, KIAA1007, NOT1, NOT1H" ENSG00000125107 "CCR4-NOT transcription complex subunit 1" A5YKK6 16 58519951-58629885 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Autism spectrum disorder, Disease variant, Holoprosencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046577, HPA049664" Approved Supported Cytosol NA NA Cytosol "HPA046577: AB_2679706, HPA049664: AB_2680844" "unprognostic (1.30e-2)" "unprognostic (6.86e-2)" "unprognostic (9.25e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-2)" "unprognostic (7.11e-2)" "unprognostic (3.58e-2)" "unprognostic (2.19e-1)" "unprognostic (6.43e-2)" "unprognostic (6.99e-2)" "unprognostic (1.83e-2)" "unprognostic (6.63e-2)" "unprognostic (1.33e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (5.53e-2)" "unprognostic (1.52e-1)" 30.1 35.4 7.8 47.4 10.2 46.0 36.7 16.4 11.9 35.0 30.2 60.7 55.5 32.1 27.9 73.8 39.3 28.6 25.1 8.5 16.1 40.2 36.3 33.6 58.6 11.2 8.9 5.4 39.5 41.4 60.1 21.4 35.4 10.5 31.5 57.9 32.6 39.1 30.9 52.9 43.5 52.8 34.0 8.1 43.3 42.5 109.2 9.4 77.1 42.7 44.5 70.1 49.6 38.9 14.7 128.8 148.2 110.0 88.1 52.1 66.2 127.6 99.6 85.8 111.4 82.0 167.6 75.3 194.0 47.4 75.8 65.5 122.3 177.9 101.0 149.2 72.5 98.8 150.4 121.8 193.7 70.8 235.8 162.4 64.0 67.5 129.7 151.5 66.9 87.7 107.2 181.0 55.3 76.4 52.0 182.6 61.2 114.4 84.9 127.2 229.0 189.5 122.7 62.4 180.0 90.9 58.6 336.0 113.5 56.0 100.5 67.9 121.3 100.9 81.3 80.0 62.2 88.7 124.7 138.2 390.3 85.5 99.4 76.9 18.3 12.1 13.4 13.8 15.6 18.2 14.7 12.9 14.0 14.6 13.8 12.1 12.6 18.6 15.4 22.5 7.3 15.4 11.5 7.8 10.2 16.4 11.9 8.5 16.1 11.2 8.9 5.4 10.5 8.1 9.4 14.7 44.4 16.0 42.9 33.0 57.8 47.4 32.6 42.9 25.6 28.2 33.9 27.9 23.8 37.1 45.2 23.9 29.2 33.7 86.3 64.5 9.8 29.8 107.7 57.6 48.0 31.3 36.1 45.0 31.7 47.0 29.9 30.7 35.2 78.2 32.2 45.9 23.9 42.3 35.7 40.4 35.6 54.2 24.4 51.5 39.5 38.6 24.8 46.4 19.6 42.2 50.0 20.0 34.0 42.3 54.9 42.5 34.9 32.4 59.8 43.6 60.1 22.9 51.6 24.3 32.9 38.7 30.4 136.6 64.3 56.0 47.0 37.9 52.1 27.9 64.5 61.2 BBS2 BBS ENSG00000125124 "Bardet-Biedl syndrome 2" Q9BXC9 16 56466836-56520087 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 144.3;Oligodendrocytes: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041315 Approved NA NA "HPA041315: AB_10960892" "unprognostic (1.43e-1)" "unprognostic (3.13e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (7.58e-2)" "unprognostic (1.51e-2)" "unprognostic (4.22e-2)" "unprognostic (2.79e-2)" "unprognostic (2.11e-1)" "unprognostic (3.29e-2)" "unprognostic (3.76e-3)" "unprognostic (2.68e-1)" "prognostic favorable (2.83e-6)" "unprognostic (2.16e-1)" "unprognostic (1.61e-1)" "unprognostic (2.95e-1)" "unprognostic (2.95e-2)" 19.8 79.0 92.4 9.4 105.1 6.0 29.8 96.5 118.6 31.4 81.7 21.0 13.7 26.1 47.6 23.5 33.0 21.8 33.1 91.6 93.1 42.1 13.3 20.4 18.5 102.7 93.2 88.4 41.0 15.8 54.2 38.4 16.2 98.3 27.1 17.1 87.3 20.2 27.3 41.9 36.5 17.9 24.2 88.9 21.2 17.4 28.9 94.4 18.5 28.3 51.3 16.3 21.3 29.9 111.2 22.3 19.7 29.6 29.9 47.1 56.9 17.4 10.7 40.9 23.1 29.8 11.0 18.0 22.1 17.6 24.3 19.0 25.3 11.7 36.4 36.0 4.9 26.3 10.4 19.4 28.1 30.7 12.1 11.4 35.4 26.7 18.3 16.8 49.0 50.0 16.7 4.7 2.7 28.9 15.2 16.8 14.1 7.9 14.9 32.7 12.9 8.3 25.7 36.2 18.1 20.7 15.5 51.9 20.2 27.8 23.7 17.2 14.3 43.3 18.3 11.6 8.3 5.7 10.4 8.7 17.1 31.6 10.5 13.7 9.9 9.6 24.5 15.6 13.6 15.8 11.4 18.7 20.6 11.8 12.4 24.4 23.2 2.7 7.4 22.4 3.4 16.4 14.0 92.4 105.1 96.5 118.6 91.6 93.1 102.7 93.2 88.4 98.3 88.9 94.4 111.2 11.5 0.0 24.3 144.3 9.6 11.2 15.6 19.1 23.9 21.5 10.7 11.3 24.4 5.7 18.7 11.0 25.0 14.3 6.6 8.7 7.9 7.1 21.1 22.4 10.7 12.3 6.7 4.6 41.0 5.8 7.3 18.6 7.7 16.9 10.1 27.0 12.1 6.9 11.2 20.2 39.6 10.3 24.4 11.3 6.3 19.7 18.0 8.9 10.6 26.2 9.0 26.6 7.2 71.4 97.8 6.0 10.4 20.7 4.1 4.7 11.5 20.0 56.1 34.6 19.7 16.7 12.0 18.4 20.7 13.1 14.1 7.5 10.5 59.2 11.1 10.0 MT1G "MT1, MT1K" ENSG00000125144 "Metallothionein 1G" P13640 16 56666730-56668065 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 3506.9;liver: 7016.2;thyroid gland: 2912.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 77919.3" "Group enriched" "Detected in all" 4 "liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "U-937: 1103.8" "Intracellular and membrane" NA NA "unprognostic (1.62e-1)" "unprognostic (4.21e-1)" "unprognostic (2.77e-2)" "unprognostic (3.15e-1)" "unprognostic (1.32e-2)" "unprognostic (1.73e-3)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (5.97e-2)" "unprognostic (2.49e-2)" "unprognostic (4.21e-1)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (7.92e-2)" "unprognostic (2.26e-2)" 124.7 21.7 342.2 106.7 413.9 2.9 28.3 393.5 919.5 12.4 301.5 828.7 518.4 8.4 2.4 257.4 76.2 12.1 6.8 338.0 346.5 3506.9 7016.2 50.3 5.6 403.6 361.9 358.6 3.2 1822.1 0.3 21.8 2.1 372.5 428.9 521.1 43.0 44.5 5.9 8.5 56.7 1105.7 77.0 331.0 3.9 1272.7 4.0 363.1 0.9 2912.8 1.0 2.6 14.3 26.1 402.5 0.4 0.0 0.0 0.0 0.0 0.0 4.4 8.6 1.7 1.1 0.4 0.0 0.0 0.1 16.2 0.0 0.1 1.8 0.2 1.2 0.9 0.8 0.0 4.3 0.0 3.5 4.5 1.0 0.6 1.7 0.0 11.4 0.0 0.1 0.0 0.0 0.3 1.2 0.7 0.0 3.7 251.3 0.5 0.0 0.0 0.0 0.8 70.8 40.8 0.0 21.8 3.0 0.5 1.3 1.1 10.8 0.0 107.8 0.0 0.0 0.8 1.7 0.3 0.6 1.9 0.6 2.0 1103.8 0.0 0.2 0.3 0.1 0.3 0.3 0.3 0.0 0.4 0.6 0.3 0.0 0.4 0.7 0.0 0.0 0.1 0.1 0.7 0.5 342.2 413.9 393.5 919.5 338.0 346.5 403.6 361.9 358.6 372.5 331.0 363.1 402.5 10.6 28.9 8.7 38.5 338.7 57.9 26.0 4.5 46.1 0.0 87.0 116.2 11.7 330.3 9.1 2302.6 0.0 3.9 9.8 3657.8 6849.7 74.4 0.3 2960.7 777.1 49.2 246.7 878.6 0.1 283.4 403.2 50.7 443.9 8167.8 17.2 16.8 310.2 16307.3 26.3 0.0 0.1 3688.0 0.0 379.5 4.9 0.9 23.3 765.6 30.2 2.8 10.6 0.0 2.1 2.0 0.1 339.8 10431.2 2.2 26.3 823.7 8631.3 77919.3 3.9 0.0 0.0 25.1 42.9 0.3 0.8 42.2 77.9 132.7 247.5 4.7 3786.7 21.1 MT2A MT2 ENSG00000125148 "Metallothionein 2A" P02795 16 56608584-56609497 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 5836.6" "Cell type enhanced" "Detected in many" "Adipocytes: 8010.7;Hepatocytes: 20955.4;Proximal enterocytes: 9666.9;Proximal tubular cells: 18370.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 30056.8;LHCN-M2: 13670.8;RPTEC TERT1: 8267.0;U-87 MG: 8331.2" NA NA "unprognostic (1.14e-1)" "unprognostic (8.90e-2)" "unprognostic (2.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.76e-1)" "unprognostic (4.89e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (5.69e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (9.52e-4)" "unprognostic (8.59e-2)" "prognostic unfavorable (2.92e-9)" "unprognostic (4.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.42e-1)" "unprognostic (1.03e-2)" 2495.5 2370.9 1088.0 562.9 1147.3 244.6 893.7 1202.8 2213.4 385.9 891.9 684.9 274.7 157.7 88.2 589.4 579.8 792.0 382.1 1013.8 1182.3 830.7 5836.6 1113.7 187.5 1313.1 1229.4 963.2 291.4 1639.4 64.3 212.0 280.6 1280.7 623.6 305.0 57.4 333.4 126.9 2351.4 554.3 708.7 324.3 1103.6 135.7 680.6 69.6 1282.5 97.0 877.4 480.1 72.4 984.4 398.9 1478.5 813.8 474.4 10.3 313.8 2919.3 4441.2 47.3 6998.3 4553.1 1693.0 1546.9 2.9 1499.9 137.5 941.0 709.0 502.6 874.6 394.4 30056.8 856.7 1324.8 255.2 164.3 499.3 217.2 1297.5 1020.9 99.3 2558.0 1541.9 3695.4 1569.0 1744.1 2273.5 55.6 10.6 12.4 13670.8 853.9 132.6 1393.5 677.8 0.5 3925.4 123.8 402.4 13.6 8267.0 9.8 173.8 40.0 1688.2 613.6 492.6 38.6 100.3 127.7 2200.6 7229.9 2617.8 1165.3 1973.0 8.4 20.7 14.3 8331.2 1530.1 451.2 251.3 135.0 177.0 250.2 210.3 166.7 29.3 149.8 274.6 108.7 19.1 105.0 203.1 75.8 90.3 237.8 18.2 261.4 180.8 1088.0 1147.3 1202.8 2213.4 1013.8 1182.3 1313.1 1229.4 963.2 1280.7 1103.6 1282.5 1478.5 8010.7 298.1 186.5 254.0 227.0 1833.4 1766.0 3977.6 2360.7 0.0 748.4 1639.4 110.5 762.0 642.7 1116.4 0.0 642.4 860.3 3180.2 2807.6 863.8 56.4 1744.2 565.0 2039.5 242.1 890.0 0.9 358.8 888.1 3744.8 792.0 4445.9 257.0 335.0 1201.1 20955.4 280.3 0.0 0.6 2411.2 480.1 1616.0 972.8 16.5 340.8 1565.2 626.1 47.8 387.6 0.0 224.6 25.6 15.0 702.2 6836.2 74.1 405.1 4471.7 9666.9 18370.1 434.3 0.0 1091.3 5048.3 6135.5 4.1 11.7 974.0 729.8 449.4 629.8 394.2 2478.5 439.7 C16orf70 "C16orf6, FLJ12076, lin-10, LIN10" ENSG00000125149 "Chromosome 16 open reading frame 70" Q9BSU1 16 67109941-67148544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 47.9;Oligodendrocytes: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041131, HPA041214" Approved Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" No No "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA041131: AB_10795487, HPA041214: AB_10794267" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (3.74e-3)" "unprognostic (1.81e-2)" "unprognostic (6.29e-2)" "unprognostic (1.07e-1)" "unprognostic (4.38e-2)" "unprognostic (1.68e-1)" "unprognostic (2.15e-2)" 10.3 10.1 14.8 7.6 17.3 18.3 11.2 15.7 18.1 12.4 12.0 10.3 7.4 11.3 9.0 18.0 10.7 7.6 9.5 19.0 15.1 14.0 57.8 9.9 9.2 17.4 16.9 17.4 11.2 8.3 16.3 10.9 11.9 17.9 14.5 10.2 8.1 12.1 8.6 29.9 30.3 10.1 10.9 17.0 14.8 8.6 13.9 16.1 9.3 9.1 15.4 11.8 10.6 14.7 22.0 13.7 19.3 19.0 19.9 23.6 13.9 44.5 15.4 16.6 30.7 33.3 22.1 11.7 13.9 13.3 18.2 16.9 18.0 23.7 14.9 39.7 7.1 19.7 10.6 12.2 47.4 14.5 10.9 58.0 14.1 20.6 30.2 13.9 16.6 17.3 17.5 17.5 5.8 19.4 13.6 21.2 16.6 21.5 18.4 29.4 29.5 32.2 21.9 13.4 8.2 24.5 13.2 46.2 10.7 12.0 18.7 22.0 9.0 13.4 21.5 18.4 15.5 13.5 8.8 17.3 41.3 19.4 10.9 17.5 3.2 17.4 6.1 4.4 12.2 5.9 6.9 6.6 8.1 14.6 4.5 6.8 6.3 6.2 5.9 13.6 4.8 7.2 8.9 14.8 17.3 15.7 18.1 19.0 15.1 17.4 16.9 17.4 17.9 17.0 16.1 22.0 5.1 6.4 5.9 11.1 6.6 9.1 2.5 5.1 19.4 7.4 8.7 6.7 1.3 1.5 3.2 0.0 0.0 8.8 5.0 4.9 5.9 4.4 1.6 12.9 8.5 6.2 7.2 11.1 20.4 2.9 9.5 5.1 8.6 30.6 9.5 8.7 5.0 47.9 18.6 10.1 18.5 8.4 4.1 13.5 7.8 1.6 4.7 13.2 10.6 17.8 13.3 2.7 3.1 11.1 41.6 4.8 8.6 6.4 7.5 4.6 5.4 10.3 11.0 5.9 13.1 5.3 6.4 24.7 24.8 20.5 12.1 7.0 6.7 8.2 5.7 1.3 GOT2 "KAT4, KATIV, KYAT4, mitAAT" ENSG00000125166 "Glutamic-oxaloacetic transaminase 2" P00505 16 58707131-58734342 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Lipid transport, Transport" "Aminotransferase, Transferase" "Cancer-related genes, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 307.2;liver: 324.0;skeletal muscle: 705.0;tongue: 733.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 341.9;Hepatocytes: 176.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018139, HPA058537" Enhanced "Intracellular and membrane" NA NA 2800000 "HPA018139: AB_1849903, HPA058537: " "unprognostic (1.50e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-3)" "unprognostic (2.63e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (1.61e-4)" "prognostic favorable (5.75e-5)" "unprognostic (1.12e-2)" "unprognostic (3.19e-1)" "unprognostic (3.72e-2)" "unprognostic (2.27e-1)" "unprognostic (3.00e-1)" "prognostic favorable (2.90e-9)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (2.22e-1)" 19.5 74.5 54.9 27.6 59.8 21.2 36.6 65.2 69.2 34.4 113.8 58.1 37.7 36.8 66.9 67.5 47.1 24.3 307.2 59.8 63.7 88.8 324.0 25.4 35.9 63.7 57.6 58.2 29.6 33.4 99.4 47.0 24.9 65.6 59.6 65.7 92.2 48.1 66.3 705.0 41.2 36.0 47.2 52.8 28.7 55.4 29.2 61.8 36.2 43.0 733.2 57.4 57.5 45.5 74.8 137.2 182.4 93.8 114.8 66.6 59.8 122.0 101.4 108.8 197.6 107.7 158.9 120.1 302.3 117.3 114.6 86.5 195.5 203.2 199.2 250.1 83.1 182.0 81.4 92.1 179.3 84.2 132.3 71.9 58.4 110.9 125.2 108.2 112.4 201.8 141.9 167.0 30.6 102.2 122.5 164.0 128.0 127.7 90.8 338.0 177.8 142.7 291.1 187.9 197.7 148.2 107.6 195.2 208.5 74.8 84.2 105.5 42.7 82.3 71.4 129.3 56.2 132.4 69.9 68.6 247.4 76.7 130.9 73.8 4.6 20.6 7.4 28.3 16.9 43.7 26.5 33.1 34.1 34.7 22.3 30.1 28.4 1.8 30.2 18.4 30.0 48.7 31.2 54.9 59.8 65.2 69.2 59.8 63.7 63.7 57.6 58.2 65.6 52.8 61.8 74.8 15.1 9.6 15.8 11.8 19.8 32.0 37.0 39.4 34.1 34.5 27.5 16.3 341.9 22.8 22.5 36.8 77.2 42.6 11.8 42.6 56.7 50.8 4.0 30.4 20.0 23.8 20.5 39.3 24.7 42.5 38.8 21.1 30.1 25.4 14.5 37.5 23.2 176.1 39.1 20.2 27.1 33.5 26.4 17.0 15.1 8.1 18.0 13.5 24.9 5.6 12.7 16.1 8.2 11.6 17.6 40.3 13.3 22.6 39.2 38.2 27.6 63.2 17.5 48.9 0.0 15.2 24.0 11.9 15.0 68.9 30.0 23.7 17.4 36.4 54.4 69.6 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.9;Paneth cells: 99.9;Proximal enterocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 94.2;CACO-2: 107.8;SH-SY5Y: 239.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008348, HPA055849" Supported Approved Cytosol NA No Cytosol "HPA008348: , HPA055849: AB_2682942" "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 9.9 9.3 9.7 9.7 11.8 1.8 8.8 11.9 12.8 20.7 8.9 44.3 46.5 17.1 12.2 33.1 15.3 17.6 13.9 10.7 10.3 41.6 33.9 23.5 4.4 7.9 9.8 11.0 19.9 17.8 12.1 19.9 11.0 10.1 18.4 31.6 4.1 12.7 26.0 3.0 43.5 50.3 12.3 6.3 10.6 37.6 7.0 9.5 3.8 10.8 3.9 7.4 16.8 21.8 9.7 10.3 94.2 15.0 26.8 20.6 22.6 16.7 17.7 23.5 12.4 3.8 107.8 53.1 1.1 75.4 37.2 7.3 21.0 9.2 4.9 5.3 2.7 6.9 22.3 28.2 63.2 29.3 0.3 2.3 15.8 14.2 16.4 1.8 27.6 19.0 3.8 7.3 4.3 14.9 9.9 1.1 4.1 9.6 46.1 4.0 8.9 7.8 1.2 64.8 3.9 73.6 239.9 14.5 6.3 4.5 66.0 5.6 4.2 20.5 2.1 15.1 6.1 0.8 2.9 4.1 0.8 6.7 4.7 9.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 9.7 11.8 11.9 12.8 10.7 10.3 7.9 9.8 11.0 10.1 6.3 9.5 9.7 8.3 12.8 14.0 0.7 1.4 7.9 7.2 3.6 5.2 15.5 3.7 5.0 2.4 30.0 3.3 14.7 0.0 0.9 1.8 127.9 5.9 15.0 1.2 2.1 5.3 11.3 3.6 1.3 5.0 23.7 7.6 7.9 36.2 2.9 0.0 19.6 6.8 20.4 0.9 8.4 7.1 30.3 2.0 0.8 1.6 2.0 13.4 1.0 3.6 1.0 0.7 2.2 0.0 2.0 0.4 30.8 99.9 12.0 1.4 7.1 96.6 46.9 2.5 0.8 6.6 1.1 6.9 0.2 4.1 11.6 18.0 0.5 2.5 4.8 34.1 6.1 PIWIL1 "CT80.1, HIWI, PIWI" ENSG00000125207 "Piwi like RNA-mediated gene silencing 1" Q96J94 12 130337887-130372637 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 43.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 123.0;Early spermatids: 48.6;Rod photoreceptor cells: 177.9;Spermatocytes: 125.6" "Cancer enhanced" "Detected in some" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;OE19: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA066880 Enhanced NA NA "HPA066880: " "unprognostic (1.00e-2)" "unprognostic (1.46e-2)" "unprognostic (8.28e-2)" "unprognostic (2.22e-1)" "unprognostic (1.48e-1)" "unprognostic (3.01e-2)" "unprognostic (2.14e-1)" "unprognostic (8.81e-2)" "unprognostic (3.95e-1)" "unprognostic (1.86e-1)" "unprognostic (9.36e-2)" "unprognostic (9.85e-6)" "unprognostic (3.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.43e-2)" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 43.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.0 1.3 0.3 0.7 0.0 8.1 0.7 0.1 1.0 1.5 0.1 1.8 123.0 0.5 0.1 0.7 0.0 0.3 48.6 0.4 0.3 1.4 1.2 0.0 4.4 0.0 0.3 0.6 0.0 0.6 0.0 0.1 1.1 0.0 0.4 1.7 5.8 0.6 0.0 1.9 3.1 30.6 2.8 0.5 0.0 0.0 0.8 12.2 4.1 1.0 0.4 0.6 0.3 2.2 0.1 0.4 0.4 0.9 0.1 177.9 0.0 0.0 0.2 125.6 5.3 0.0 1.3 1.0 0.6 0.5 0.5 0.2 GPR18 ENSG00000125245 "G protein-coupled receptor 18" Q14330 13 99254732-99261744 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.8;lymphoid tissue: 39.2;testis: 13.1" "Group enriched" "Detected in some" 4 "Early spermatids: 172.6;Late spermatids: 190.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 65.3;NK-cells: 52.9;T-cells: 41.9" "Group enriched" "Detected in some" 4 "Daudi: 8.1;THP-1: 20.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013873 Enhanced NA NA "HPA013873: AB_1849285" "unprognostic (3.87e-6)" "unprognostic (1.31e-3)" "unprognostic (3.22e-2)" "unprognostic (1.31e-6)" "unprognostic (2.89e-1)" "unprognostic (7.55e-4)" "unprognostic (4.27e-5)" "unprognostic (3.45e-3)" "unprognostic (2.31e-3)" "unprognostic (5.43e-2)" "unprognostic (9.70e-2)" "unprognostic (4.03e-1)" "unprognostic (3.20e-6)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (6.92e-3)" 0.4 0.1 0.1 12.3 0.2 9.8 0.2 0.6 0.5 0.3 0.8 0.9 1.0 0.4 0.2 0.5 0.2 1.2 0.3 0.1 0.5 0.3 0.9 0.7 39.2 0.7 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.4 0.5 1.0 0.0 0.9 0.1 0.1 0.3 4.1 0.2 0.2 10.6 1.6 13.1 0.2 8.0 0.4 0.1 32.7 2.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.9 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 20.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 3.5 0.0 0.2 1.9 0.5 24.4 5.5 41.3 65.3 22.1 34.0 12.6 53.3 41.9 38.9 2.2 52.9 5.3 12.5 6.4 13.1 0.1 0.2 0.6 0.5 0.1 0.5 0.7 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 1.3 0.3 44.7 0.3 0.0 0.0 0.0 1.0 0.1 0.3 1.0 0.0 0.6 0.0 0.0 0.0 14.4 0.1 0.0 0.0 172.6 1.3 0.2 0.2 1.2 6.1 0.4 0.0 0.0 0.2 1.1 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.3 1.2 190.5 0.9 3.9 0.0 0.0 0.6 0.0 18.6 0.5 0.1 0.0 0.1 1.2 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.2 1.8 0.4 0.0 0.3 0.0 20.5 0.1 0.1 0.1 CLYBL CLB ENSG00000125246 "Citramalyl-CoA lyase" Q8N0X4 13 99606669-99897134 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 110.6" "Cell type enhanced" "Detected in many" "Astrocytes: 84.9;Distal tubular cells: 138.9;Hepatocytes: 84.1;Proximal tubular cells: 144.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 56.1;SCLC-21H: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039959, HPA040691" Enhanced NA NA 7300 "HPA039959: AB_10793857, HPA040691: AB_10794746" "unprognostic (1.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.30e-3)" "unprognostic (7.57e-3)" "unprognostic (3.69e-1)" "unprognostic (2.90e-2)" "unprognostic (1.57e-3)" "unprognostic (2.91e-1)" "unprognostic (2.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.49e-2)" "unprognostic (2.85e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.74e-2)" "unprognostic (5.41e-2)" "unprognostic (4.78e-2)" "unprognostic (7.82e-2)" 6.8 16.3 11.8 5.5 12.1 5.1 10.6 24.2 13.3 7.7 30.5 20.8 25.3 6.6 13.1 11.4 8.0 6.9 20.5 13.0 13.3 66.7 110.6 5.6 10.4 9.1 9.8 8.1 5.8 9.9 14.5 6.8 3.7 14.3 6.9 22.1 7.4 12.4 9.0 43.7 8.8 23.7 6.5 5.3 8.7 8.8 9.4 9.9 5.9 12.4 70.1 10.9 7.5 7.0 9.0 0.4 2.3 16.6 7.5 7.6 7.0 3.6 0.8 1.6 1.4 2.6 0.3 12.4 3.0 4.8 1.0 3.2 3.9 1.5 2.8 1.8 15.3 2.4 19.2 4.9 11.8 5.2 10.4 1.3 3.8 8.3 0.2 6.4 1.6 2.2 15.7 2.7 9.8 1.6 4.3 4.7 14.3 10.8 56.1 3.4 6.0 0.7 7.1 16.6 1.1 53.1 8.1 3.4 3.8 3.6 5.9 8.0 13.2 0.3 0.7 1.9 1.4 2.7 22.3 4.7 0.6 11.3 14.9 2.3 1.7 4.5 0.5 9.9 10.0 12.0 14.5 17.4 13.9 9.4 15.7 13.3 15.8 0.6 14.2 4.8 10.3 24.2 7.7 11.8 12.1 24.2 13.3 13.0 13.3 9.1 9.8 8.1 14.3 5.3 9.9 9.0 7.4 6.4 5.0 84.9 8.6 5.5 9.1 18.4 8.6 2.3 8.9 11.3 36.1 21.5 10.9 14.7 2.1 14.3 9.2 17.9 138.9 11.6 1.6 6.1 4.1 6.2 1.2 2.5 30.6 8.1 3.2 5.9 5.6 4.4 6.3 7.1 4.6 84.1 7.6 0.0 25.6 11.5 10.2 6.7 4.5 4.8 2.1 5.4 16.0 48.7 4.4 6.5 7.2 21.6 9.5 4.0 13.8 4.1 3.8 4.3 23.1 144.7 4.1 5.0 0.0 7.6 18.1 3.0 10.5 6.9 6.3 7.4 8.3 13.6 19.1 6.7 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane O-mannosyltransferase targeting cadherins 4" Q5T4D3 13 100603625-100675093 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.6" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 139.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016489, HPA057056" Approved Approved Vesicles NA NA Vesicles "HPA016489: AB_1858157, HPA057056: " "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 5.2 4.3 17.3 6.0 25.3 3.1 6.6 22.5 31.4 6.9 16.0 8.5 10.0 9.7 8.0 5.1 14.5 5.8 4.0 18.1 22.4 12.6 11.4 4.3 4.8 27.3 24.5 16.0 6.2 10.6 10.8 3.3 5.0 29.6 8.7 8.6 10.1 8.7 6.1 13.7 7.5 8.6 7.1 23.1 4.3 9.3 11.9 23.3 7.1 8.2 8.8 5.8 7.8 4.6 36.6 10.4 7.7 42.2 21.2 5.7 10.5 44.6 5.5 5.0 5.0 4.1 8.1 17.5 29.6 18.4 5.0 12.0 6.8 13.5 7.8 6.6 16.9 9.3 12.6 15.4 13.0 7.1 15.7 0.4 14.7 11.1 2.2 8.8 14.8 23.5 16.1 9.5 3.7 5.7 9.2 12.5 9.0 11.3 27.8 7.8 13.9 7.7 6.8 19.8 7.4 21.1 21.9 11.1 19.7 5.3 26.0 14.6 44.6 36.6 4.8 8.2 4.1 9.7 9.5 9.1 5.8 22.4 9.9 13.5 0.0 1.1 0.1 1.3 1.2 1.1 1.0 1.3 2.1 3.3 1.2 1.5 0.5 0.0 0.7 1.8 2.3 2.1 0.8 17.3 25.3 22.5 31.4 18.1 22.4 27.3 24.5 16.0 29.6 23.1 23.3 36.6 4.7 6.4 3.9 18.9 4.5 3.1 7.2 4.2 3.4 19.0 10.7 4.1 11.3 18.6 6.2 5.5 8.4 11.6 5.6 7.7 1.9 11.6 5.8 12.2 9.7 8.4 10.7 5.0 11.1 18.7 19.8 6.2 6.1 14.4 0.0 12.8 39.7 15.3 4.3 26.9 19.4 10.1 2.0 6.9 2.5 6.2 4.1 3.7 3.6 9.4 3.3 8.2 5.2 15.1 139.6 13.0 7.4 6.8 3.6 10.9 10.5 14.2 6.8 8.6 6.6 4.2 5.8 9.7 32.3 7.9 5.8 3.1 4.1 5.3 11.7 5.3 RAP2A "K-REV, RAP2" ENSG00000125249 "RAP2A, member of RAS oncogene family" P10114 13 97434169-97469128 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 83.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018552 Uncertain NA NA "CAB018552: AB_2177305" "unprognostic (2.40e-1)" "unprognostic (7.72e-2)" "unprognostic (1.94e-1)" "unprognostic (4.34e-2)" "unprognostic (2.04e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" "unprognostic (2.10e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.53e-1)" 15.0 8.3 30.5 10.8 38.6 4.1 11.8 27.4 37.8 11.8 19.3 10.3 8.0 8.8 4.5 16.0 6.8 12.8 11.4 36.5 32.1 14.5 8.7 13.9 18.1 29.7 31.7 30.6 6.7 4.9 7.9 8.0 25.6 31.3 6.4 11.3 7.5 5.5 7.3 10.6 7.2 8.2 12.5 33.9 15.2 6.5 4.6 35.1 13.4 6.6 15.5 13.0 11.6 7.7 36.2 18.5 5.2 19.3 13.9 31.2 18.5 7.6 13.4 8.8 12.9 14.4 9.8 10.6 14.1 8.4 22.1 12.6 14.1 16.6 13.4 16.9 26.3 8.6 15.4 19.8 14.5 22.5 13.6 9.5 28.5 17.1 12.8 17.6 19.5 28.2 15.8 5.2 26.2 17.3 6.7 9.4 21.1 11.1 16.0 7.8 12.1 20.7 9.3 12.7 6.0 21.9 37.4 9.5 22.5 19.8 26.1 18.1 6.8 21.2 12.6 12.5 12.5 13.1 18.7 15.8 7.7 35.0 16.1 20.8 0.0 0.3 0.4 1.9 1.4 0.8 0.5 0.7 1.4 1.0 0.2 0.4 1.5 0.1 0.4 2.0 1.6 1.3 0.4 30.5 38.6 27.4 37.8 36.5 32.1 29.7 31.7 30.6 31.3 33.9 35.1 36.2 34.0 12.8 6.4 17.3 6.7 22.7 4.5 8.2 8.6 10.7 19.1 15.6 15.8 14.3 6.3 1.8 8.4 2.0 31.1 17.0 9.8 5.3 2.5 7.1 19.6 23.7 16.8 9.9 83.8 6.2 11.5 20.0 7.7 9.8 5.1 12.0 29.6 18.1 32.9 28.6 33.3 13.4 10.2 49.1 66.4 1.9 7.2 33.7 16.0 49.6 22.0 17.6 4.1 54.3 44.1 11.1 16.9 6.0 12.3 8.4 6.5 21.9 4.6 5.9 26.3 11.6 36.0 6.5 8.0 22.3 21.9 3.7 12.7 11.1 12.9 4.5 SLC10A2 "ASBT, ISBT" ENSG00000125255 "Solute carrier family 10 member 2" Q12908 13 103043998-103066417 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 81.5" "Cell type enriched" "Detected in some" 29 "Proximal enterocytes: 371.2" "Cancer enriched" "Detected in single" 11 "renal cancer: 4.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004795 Approved NA NA "HPA004795: AB_1856953" "unprognostic (2.82e-2)" "prognostic favorable (5.78e-5)" "unprognostic (1.64e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.3 0.0 0.0 0.2 24.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 17.1 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 81.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.2 0.4 0.3 0.0 0.6 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 371.2 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.1 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019835-95301475 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 41.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002476 Enhanced Supported "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 2.0 1.3 2.4 6.2 2.1 4.1 6.9 2.7 2.3 5.0 7.1 8.7 5.0 3.5 19.0 2.0 10.3 6.1 2.0 2.2 5.1 18.2 1.3 7.6 3.9 4.2 3.0 1.3 3.8 3.3 22.7 1.4 2.1 4.3 41.5 8.6 0.9 1.5 5.5 5.4 2.6 5.5 6.3 4.5 4.1 5.2 4.7 3.6 3.9 7.8 1.7 6.4 15.6 1.8 5.1 18.5 31.7 5.3 9.4 9.5 12.3 1.3 14.4 14.3 12.6 10.9 43.8 13.2 10.2 9.3 19.5 9.0 24.0 7.9 7.1 15.8 30.7 12.1 245.7 8.8 8.8 19.2 28.6 256.3 9.4 3.2 9.1 18.5 17.9 16.4 11.3 25.8 0.4 17.1 5.9 5.4 4.6 6.2 22.3 7.9 7.7 14.3 26.9 69.3 40.4 12.5 9.3 4.8 1.2 10.1 5.9 0.0 15.1 27.0 13.3 8.6 11.2 17.3 0.1 0.0 4.0 25.4 16.0 6.6 0.2 0.5 0.2 1.3 0.6 1.1 1.4 1.0 1.5 1.8 1.6 0.6 1.5 0.3 1.9 2.3 0.3 1.5 1.3 2.4 2.1 2.7 2.3 2.2 5.1 4.2 3.0 1.3 4.3 4.5 3.6 5.1 4.6 9.6 32.7 28.4 5.8 4.2 7.0 7.3 4.0 0.1 0.6 0.6 4.5 8.6 9.1 23.9 22.9 0.1 2.0 2.7 0.0 6.9 3.8 4.2 11.3 19.8 0.0 51.3 13.6 3.1 0.4 5.7 6.1 6.0 53.9 9.5 2.9 0.6 4.5 0.0 10.3 4.0 0.0 2.5 8.1 2.0 6.8 10.7 1.8 203.3 13.5 0.5 4.1 16.1 2.5 2.9 8.3 1.9 8.3 27.1 0.5 26.4 4.7 0.8 0.0 8.2 3.1 0.9 8.3 3.4 7.5 0.3 6.4 17.3 9.2 4.5 EFNB2 "EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228" ENSG00000125266 "Ephrin B2" P52799 13 106489745-106535662 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 239.7;Hepatic stellate cells: 187.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 76.5;OE19: 45.5;SH-SY5Y: 42.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008999, CAB009368" Supported Supported Nucleoplasm,Cytosol NA NA 940000 Nucleoplasm Cytosol "CAB009368: AB_2095700, HPA008999: AB_1078721" "unprognostic (1.70e-1)" "unprognostic (1.95e-3)" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (4.52e-3)" "prognostic unfavorable (3.11e-6)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.70e-5)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.30e-1)" "unprognostic (3.07e-1)" "unprognostic (4.62e-2)" "unprognostic (2.27e-3)" 18.7 6.2 3.1 4.4 6.9 0.2 17.2 2.4 6.3 11.0 1.8 16.9 8.0 10.3 0.7 12.2 8.9 4.3 13.2 5.7 4.8 11.1 4.8 23.6 3.2 0.7 0.7 5.7 7.3 4.0 3.2 6.4 15.6 1.7 12.6 10.0 3.2 14.1 10.7 6.5 16.2 14.6 5.5 0.4 7.5 15.1 5.5 1.8 3.6 12.0 8.1 3.3 6.6 14.2 5.2 23.3 1.8 76.5 0.1 0.2 0.7 0.3 10.8 5.4 8.2 4.7 19.1 28.7 0.0 11.0 2.5 0.6 28.4 2.9 10.9 8.9 0.0 24.3 0.1 6.0 0.0 1.5 6.9 0.6 3.5 19.0 0.4 16.1 4.1 10.4 0.2 0.1 0.0 9.1 3.3 0.2 0.1 4.7 45.5 5.0 21.9 3.3 0.1 11.9 2.5 5.8 42.7 3.6 1.7 0.1 21.4 1.0 0.2 9.6 16.3 0.0 0.5 23.8 0.4 0.0 0.0 34.5 0.4 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 6.9 2.4 6.3 5.7 4.8 0.7 0.7 5.7 1.7 0.4 1.8 5.2 239.7 6.4 35.7 38.8 4.4 83.2 52.9 15.4 13.1 10.4 39.8 45.3 8.8 5.7 13.2 25.8 0.0 1.4 8.6 114.6 0.0 6.8 0.4 24.7 69.8 106.5 50.6 0.0 49.3 1.4 3.1 15.4 69.3 42.1 17.8 11.8 187.4 1.3 1.1 6.7 29.7 59.8 26.4 5.8 11.9 1.0 0.3 4.0 32.0 48.7 0.0 89.1 0.0 3.5 13.9 46.3 64.3 0.4 1.0 25.1 15.9 0.2 8.7 3.4 0.0 33.1 22.8 0.7 3.3 41.1 86.0 1.9 7.9 6.4 71.5 72.0 SOX21 SOX25 ENSG00000125285 "SRY-box transcription factor 21" Q9Y651 13 94709622-94712545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.4;esophagus: 10.4;skin 1: 16.1;stomach 1: 35.4" "Cell type enhanced" "Detected in some" "Astrocytes: 24.5;Basal squamous epithelial cells: 11.4;Gastric mucus-secreting cells: 55.5;Oligodendrocyte precursor cells: 17.1;Squamous epithelial cells: 57.1" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 79.7;NTERA-2: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048337, HPA064084" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048337: AB_2732547, HPA064084: AB_2685187" "unprognostic (3.33e-1)" "prognostic favorable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favorable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.0 0.0 9.3 0.0 8.4 0.0 0.6 8.1 9.5 0.4 2.7 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 8.7 8.3 0.0 0.0 0.1 0.0 10.4 8.9 7.3 0.0 0.0 0.0 0.2 0.0 7.3 0.5 0.0 0.0 1.4 0.0 0.0 16.1 0.0 0.0 8.5 0.0 35.4 0.1 9.5 0.0 0.0 0.0 3.3 0.3 2.3 7.9 0.0 2.4 79.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 6.4 12.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 8.4 8.1 9.5 8.7 8.3 10.4 8.9 7.3 7.3 8.5 9.5 7.9 0.0 0.0 0.0 24.5 0.0 5.4 1.1 6.6 11.4 0.0 0.0 0.0 1.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 17.1 0.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.4 57.1 9.1 0.0 0.0 0.0 0.0 0.9 TM9SF2 P76 ENSG00000125304 "Transmembrane 9 superfamily member 2" Q99805 13 99446311-99564048 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005657 Supported NA NA 2100000 "HPA005657: AB_1080303" "unprognostic (9.77e-3)" "unprognostic (3.51e-2)" "unprognostic (2.85e-2)" "unprognostic (1.09e-2)" "unprognostic (3.76e-1)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.96e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.21e-7)" "unprognostic (6.49e-2)" "unprognostic (8.55e-2)" "unprognostic (2.20e-2)" "unprognostic (2.21e-1)" 67.2 67.9 36.4 67.3 39.8 65.2 91.5 38.2 41.7 101.0 59.8 116.9 120.5 64.2 120.0 56.6 77.2 74.2 51.5 37.2 42.9 109.4 170.8 79.3 62.7 38.0 38.8 36.2 53.7 91.0 127.9 41.9 99.0 38.6 98.7 124.9 42.3 110.6 73.9 36.6 57.1 120.3 66.3 40.9 63.0 105.0 60.1 39.4 50.2 122.3 48.7 71.9 90.8 44.8 45.7 187.3 56.7 75.8 107.8 223.2 134.8 108.2 124.1 154.5 86.6 134.8 93.1 234.7 72.1 100.0 150.1 88.4 183.1 81.1 108.7 117.8 80.8 57.8 89.6 90.9 100.2 118.0 235.8 100.0 106.2 132.4 75.1 76.8 133.2 110.4 72.8 90.7 70.0 103.0 62.8 59.1 91.9 66.3 335.7 70.0 49.3 61.0 78.7 178.9 137.3 71.7 87.5 71.7 285.6 94.8 145.5 174.0 280.5 109.1 69.6 50.7 70.5 77.8 96.6 120.8 29.0 163.8 120.0 103.0 192.4 156.4 174.9 57.7 180.5 72.8 86.9 68.4 65.3 139.6 60.1 62.8 58.4 251.3 76.0 182.1 159.6 109.6 178.1 36.4 39.8 38.2 41.7 37.2 42.9 38.0 38.8 36.2 38.6 40.9 39.4 45.7 68.9 83.3 76.3 29.0 72.5 40.9 57.3 132.8 48.9 20.6 82.9 40.5 44.0 70.1 170.7 86.5 18.8 99.3 94.5 141.1 11.7 98.6 149.2 101.0 75.6 65.4 83.0 47.9 36.6 102.7 122.8 74.6 89.2 93.9 54.5 35.2 87.4 172.9 116.0 21.9 44.4 167.9 128.1 137.6 57.2 41.8 50.1 100.7 72.9 44.0 97.4 42.7 42.2 34.2 44.8 83.4 116.7 52.3 143.1 69.0 123.5 70.8 187.7 25.3 19.7 44.1 104.1 109.7 56.3 69.8 52.1 171.4 53.2 43.2 119.4 104.0 HROB "C17orf53, MCM8IP, MGC3130" ENSG00000125319 "Homologous recombination factor with OB-fold" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA synthesis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.4;testis: 11.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.3;Cytotrophoblasts: 3.4;Extravillous trophoblasts: 8.6;Hofbauer cells: 2.9;Syncytiotrophoblasts: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 1.4 0.5 0.2 1.1 0.1 9.4 1.4 0.5 0.3 0.8 0.0 0.9 0.9 0.8 0.1 2.8 0.6 0.2 0.7 0.1 0.2 0.4 0.6 0.6 1.6 0.3 0.2 0.1 0.8 0.3 0.4 0.4 0.9 0.4 0.7 1.1 0.3 0.7 0.3 1.0 1.6 0.9 0.7 0.2 1.3 0.6 11.5 0.2 2.3 0.3 0.2 1.9 0.6 1.2 0.4 8.9 11.1 8.3 7.6 0.6 2.3 9.8 6.7 5.9 12.8 13.9 11.3 5.4 9.4 5.8 5.8 13.3 7.5 10.9 10.5 11.1 10.6 14.0 6.0 10.1 7.7 0.3 6.6 7.3 1.9 1.6 15.7 7.7 1.5 5.3 10.2 13.8 11.6 6.2 6.7 15.7 10.2 5.6 4.0 10.8 10.0 13.2 11.6 3.0 7.0 5.1 2.9 4.1 4.0 3.4 9.4 8.1 7.7 2.4 12.1 9.5 8.3 9.9 6.7 12.2 8.0 5.7 5.1 7.1 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.9 0.4 0.1 0.2 0.1 0.5 0.3 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 KIF25 KNSL3 ENSG00000125337 "Kinesin family member 25" Q9UIL4 6 167996241-168045095 "Predicted intracellular proteins" "Motor protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.5;retina: 2.6" "Cell type enriched" "Detected in some" 4 "Adipocytes: 165.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 2.0" "Not detected" "Not detected" HPA046153 Uncertain NA NA "HPA046153: AB_10960550" "unprognostic (1.11e-1)" "unprognostic (9.32e-3)" "unprognostic (1.39e-1)" "unprognostic (6.65e-2)" "unprognostic (1.60e-1)" "unprognostic (4.46e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-3)" "unprognostic (2.45e-1)" "unprognostic (7.08e-5)" "unprognostic (1.55e-2)" "unprognostic (5.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.77e-3)" 2.1 0.1 1.6 0.2 1.8 0.1 1.3 4.5 3.8 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.4 1.8 0.2 0.6 0.4 0.5 2.7 2.0 1.6 0.5 0.0 0.1 0.0 0.4 4.4 0.3 0.1 2.6 0.2 0.0 1.3 0.4 0.3 0.0 1.6 0.2 0.3 0.5 2.1 0.1 0.1 0.0 0.1 0.2 0.1 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 4.5 3.8 1.4 1.8 2.7 2.0 1.6 4.4 1.6 2.1 2.6 165.2 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 4.2 1.3 1.1 1.0 0.0 0.0 3.7 0.0 1.1 0.3 0.1 0.0 0.2 0.0 0.1 0.4 9.3 0.0 0.0 6.0 0.0 0.3 0.6 0.0 0.3 4.5 0.1 0.7 0.1 0.1 3.3 4.7 0.3 0.0 0.0 0.0 0.5 0.0 0.1 1.8 1.0 0.0 0.7 0.0 3.5 34.4 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 1.0 0.3 3.2 0.0 0.4 0.0 0.1 0.1 0.0 0.2 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132440440-132508719 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 143.4" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 516.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 138.1;REH: 114.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: AB_2684945" "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 42.0 19.2 7.1 88.8 7.3 143.4 29.8 7.0 9.5 21.2 8.8 46.8 85.6 21.5 11.8 24.5 24.6 32.9 24.2 6.4 12.0 28.9 54.9 120.0 87.0 14.6 7.2 4.9 18.5 15.8 7.4 17.5 22.4 14.8 36.7 38.4 2.8 28.9 16.3 16.8 19.4 69.4 33.4 7.3 118.3 47.8 13.6 10.1 67.0 26.0 13.5 45.7 64.5 24.3 8.0 26.7 22.8 2.3 8.1 22.1 18.9 42.5 14.7 58.8 41.6 52.2 11.3 79.4 26.7 15.8 18.4 64.8 35.7 7.4 33.7 14.3 54.2 7.1 33.2 8.1 6.9 138.1 14.6 34.3 36.9 9.4 31.7 32.2 26.5 22.4 19.1 6.9 97.5 13.1 15.9 87.6 32.7 3.4 9.3 14.6 114.5 23.2 31.7 22.5 27.8 6.4 3.6 14.6 30.8 13.4 10.1 4.7 24.2 13.0 20.5 8.1 12.8 19.8 74.8 27.0 19.3 24.9 27.2 15.5 175.3 167.1 257.0 157.2 244.1 106.9 68.4 104.2 129.9 95.7 62.5 63.5 91.7 621.0 136.9 272.4 52.4 122.1 160.0 7.1 7.3 7.0 9.5 6.4 12.0 14.6 7.2 4.9 14.8 7.3 10.1 8.0 369.9 102.5 114.3 1.0 216.5 88.1 129.4 66.3 306.7 14.7 216.5 186.6 17.0 47.1 58.0 22.0 33.3 24.0 396.3 183.6 19.6 112.1 92.5 242.3 170.8 223.1 87.1 36.6 1.1 114.3 42.6 224.4 212.0 288.1 105.2 32.0 58.2 14.6 49.7 1.7 1.2 137.4 57.0 73.9 228.7 9.1 27.4 134.1 72.9 7.5 257.2 16.7 399.6 2.5 1.1 88.6 140.6 7.9 248.6 270.9 155.5 22.4 110.9 46.5 13.1 516.2 225.0 1.3 6.8 118.8 82.7 11.2 301.4 20.5 94.6 95.0 UPF3B "HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 157.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.3 8.2 18.2 10.2 18.5 13.7 9.6 22.3 30.3 11.9 17.2 11.2 11.9 11.8 10.6 12.8 10.0 6.9 7.5 17.7 18.2 9.5 12.5 9.1 15.5 18.6 18.3 16.6 13.4 8.2 11.4 13.0 8.9 19.0 10.9 10.6 22.2 8.9 9.0 13.0 15.7 10.1 9.3 17.1 11.4 8.7 15.8 19.0 14.8 11.6 11.0 15.8 10.6 11.8 19.7 29.2 17.3 35.1 28.8 15.7 10.3 22.5 27.4 15.3 20.9 18.3 32.7 20.4 51.9 22.6 11.5 29.9 27.1 45.9 16.6 26.5 29.9 33.9 48.3 57.9 17.2 17.9 52.7 23.0 8.7 12.4 35.8 43.3 19.0 19.7 30.5 47.4 41.8 17.6 35.9 36.8 65.6 67.7 37.1 46.8 35.9 40.2 38.2 17.3 14.5 46.7 32.1 55.6 22.4 42.4 36.2 11.9 30.4 17.3 21.6 16.6 34.9 58.6 23.1 27.5 69.5 17.5 76.1 25.7 8.1 4.4 6.5 5.9 4.8 4.8 12.5 5.6 4.8 3.3 13.7 6.3 6.4 4.9 7.7 5.6 8.7 7.4 2.2 18.2 18.5 22.3 30.3 17.7 18.2 18.6 18.3 16.6 19.0 17.1 19.0 19.7 26.3 32.1 25.7 31.6 47.4 37.7 31.1 31.6 47.8 50.7 26.4 28.2 19.0 17.2 38.7 25.8 56.3 39.0 46.1 33.5 5.9 31.6 157.3 26.1 23.5 31.1 27.6 52.2 30.6 26.4 48.2 25.5 23.0 33.8 58.9 32.8 23.2 22.9 28.5 28.6 39.5 35.5 26.4 19.1 43.3 31.7 30.4 28.2 24.9 27.2 44.9 32.6 56.7 33.7 45.4 21.5 33.6 32.7 32.5 33.8 30.4 16.5 35.2 99.0 13.1 34.4 42.0 65.8 41.4 38.8 38.1 64.3 39.9 28.1 37.6 25.0 RNF113A "Cwc24, RNF113, ZNF183" ENSG00000125352 "Ring finger protein 113A" O15541 X 119870475-119871733 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000160, HPA076658" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA000160: AB_1079821, HPA076658: AB_2732319" "unprognostic (2.85e-1)" "unprognostic (4.38e-3)" "unprognostic (5.55e-3)" "unprognostic (2.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-3)" "unprognostic (2.02e-3)" "unprognostic (6.29e-2)" "unprognostic (2.57e-1)" "unprognostic (6.49e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (7.93e-4)" "unprognostic (7.99e-2)" "unprognostic (3.19e-1)" "unprognostic (3.91e-2)" "prognostic favorable (6.23e-4)" 10.2 9.7 12.2 13.1 12.9 35.6 10.3 13.6 14.5 10.3 12.1 10.8 13.3 9.9 9.6 11.4 10.2 8.3 12.8 12.2 13.8 9.3 17.8 11.1 24.9 13.3 13.1 12.4 13.5 19.2 9.3 10.1 9.1 13.6 9.0 9.6 15.7 14.5 8.9 12.4 17.2 17.7 7.5 12.7 24.5 12.2 3.5 13.5 24.9 10.0 10.7 19.1 10.9 10.3 14.6 16.9 22.9 11.0 17.7 20.7 14.9 22.3 14.8 25.0 17.6 21.0 19.7 14.1 28.0 28.1 13.8 25.1 20.4 24.4 19.1 13.1 21.9 18.0 17.0 25.8 23.5 28.3 33.7 28.3 18.4 20.6 17.7 26.0 20.7 17.1 19.4 12.2 38.4 17.3 47.5 23.5 39.9 16.1 29.5 32.8 21.7 23.2 45.3 18.5 20.6 14.7 12.9 23.1 35.5 33.1 12.9 8.7 32.9 13.1 18.6 6.6 26.7 29.7 43.2 36.0 27.9 16.8 44.1 12.3 96.4 59.5 109.5 73.9 60.3 74.4 83.6 78.3 79.0 63.4 88.6 81.3 73.1 27.5 65.9 72.6 53.3 96.6 73.6 12.2 12.9 13.6 14.5 12.2 13.8 13.3 13.1 12.4 13.6 12.7 13.5 14.6 14.8 9.6 14.8 2.6 42.8 24.3 17.2 26.6 30.7 11.5 13.6 21.1 8.9 18.6 21.4 14.7 14.6 18.5 51.6 10.8 9.8 18.3 0.5 13.1 18.8 17.4 4.2 10.3 3.0 16.8 37.6 15.2 16.3 16.5 26.5 14.4 18.2 13.1 24.4 13.5 4.1 16.8 14.2 17.6 23.1 1.4 12.2 17.0 26.6 5.6 17.2 16.5 39.1 2.0 6.2 15.5 17.8 9.8 59.6 12.3 34.9 25.1 19.6 17.7 6.6 8.3 19.3 2.9 5.8 20.9 24.4 26.4 50.2 15.9 15.5 14.3 SEPTIN6 "KIAA0128, MGC16619, MGC20339, SEP2, SEPT2, SEPT6" ENSG00000125354 "Septin 6" Q14141 X 119615724-119693370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 233.5" "Cell type enhanced" "Detected in some" "B-cells: 20.3;Cytotrophoblasts: 43.9;dendritic cells: 66.5;Extravillous trophoblasts: 50.1;Hofbauer cells: 54.8;Plasma cells: 28.4;Syncytiotrophoblasts: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 273.0;MOLT-4: 300.5;REH: 271.8;SH-SY5Y: 394.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Supported Approved Cytosol NA NA 2900000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (6.35e-3)" "unprognostic (1.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.09e-1)" "unprognostic (1.73e-1)" "unprognostic (6.23e-2)" "unprognostic (2.13e-1)" "unprognostic (7.24e-2)" "unprognostic (6.27e-2)" "unprognostic (1.46e-1)" "unprognostic (1.95e-1)" "unprognostic (2.55e-1)" "unprognostic (2.88e-1)" "unprognostic (1.92e-1)" "unprognostic (2.60e-2)" 13.3 74.0 13.5 67.3 13.4 61.7 12.9 17.5 17.5 11.6 10.7 36.6 14.5 11.3 17.0 18.0 18.2 17.6 14.9 13.0 18.3 15.1 21.5 16.6 120.7 18.7 17.0 11.8 11.5 4.6 9.9 9.9 14.9 20.1 13.5 18.7 39.2 18.3 40.8 4.6 7.0 35.6 24.6 14.5 62.5 20.2 40.7 18.3 233.5 7.7 5.9 104.7 18.8 9.8 23.3 6.5 10.1 37.9 68.5 3.5 7.7 53.9 18.9 41.7 31.4 53.8 3.4 14.4 130.7 14.6 23.9 32.6 3.7 60.2 12.1 21.7 80.6 13.9 58.1 20.3 23.5 9.1 66.3 29.4 14.0 2.6 24.8 0.6 13.1 46.4 273.0 43.6 68.0 18.7 4.8 300.5 38.6 40.2 1.9 31.0 271.8 31.3 106.7 33.5 6.8 16.8 394.7 49.1 17.9 20.6 40.7 24.3 33.8 29.0 8.5 17.2 27.5 4.7 33.8 14.5 170.7 0.8 69.0 6.3 34.2 17.2 39.9 58.6 26.1 61.4 65.0 75.3 68.6 34.0 64.0 79.3 69.4 11.8 81.3 38.8 63.7 112.4 53.9 13.5 13.4 17.5 17.5 13.0 18.3 18.7 17.0 11.8 20.1 14.5 18.3 23.3 13.8 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 43.9 66.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 50.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 43.0 15.5 0.0 0.0 0.0 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8;ovary: 19.7" "Group enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.8" "Lineage enriched" "Detected in single" 9 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 2.8 3.3 11.5 1.8 6.2 0.7 3.3 5.9 8.0 8.5 1.9 2.4 0.7 1.9 1.6 2.8 3.9 1.1 1.0 3.8 20.8 1.4 0.6 3.0 3.6 23.0 40.8 4.0 19.7 0.4 1.5 3.8 0.2 23.9 1.4 2.3 1.6 1.2 1.9 1.4 2.6 2.3 0.9 19.7 1.7 1.8 0.2 26.4 8.1 0.4 2.7 3.9 1.9 8.6 16.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.2 0.0 0.1 0.3 0.0 2.9 0.0 1.9 0.7 0.7 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 25.3 0.4 0.0 0.0 0.1 9.5 0.0 0.0 0.1 0.0 17.1 0.0 0.0 5.1 0.1 0.5 0.0 27.7 0.3 0.0 0.3 0.0 0.0 11.8 0.0 5.1 0.0 5.2 3.7 29.7 0.0 0.0 0.0 0.3 0.0 2.8 0.1 1.4 0.2 0.2 1.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 11.5 6.2 5.9 8.0 3.8 20.8 23.0 40.8 4.0 23.9 19.7 26.4 16.1 0.1 3.2 0.0 1.6 0.0 0.4 0.1 0.1 0.6 1.9 0.2 1.3 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.2 0.0 0.0 4.4 0.0 0.4 0.0 0.3 0.4 0.0 1.3 0.0 4.3 0.0 0.0 1.0 0.7 1.6 0.6 1.6 5.4 1.9 3.7 0.3 0.0 32.6 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 14.6 0.6 0.1 0.1 0.0 1.3 0.1 0.4 0.0 0.0 0.0 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871832-119876662 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3202.9;Distal tubular cells: 2191.3;Proximal tubular cells: 1764.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No Cytosol Mitochondria "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 262.7 279.4 558.3 181.0 562.2 319.0 277.8 573.3 752.7 228.4 634.6 471.8 390.9 133.6 326.7 146.3 194.9 134.1 993.0 552.1 565.6 499.7 453.3 155.1 188.3 565.0 556.2 546.7 150.7 230.4 780.7 122.4 172.8 563.8 187.4 374.8 402.1 282.5 242.5 1394.1 91.6 337.4 182.3 562.4 170.9 300.1 66.3 564.6 275.7 174.9 1380.0 221.2 230.7 91.3 575.5 436.8 561.9 342.0 365.6 466.3 317.8 423.6 346.6 395.9 297.8 368.1 326.5 377.8 385.1 509.4 431.0 514.7 416.5 555.7 392.8 354.6 492.2 751.7 380.6 1110.1 750.5 357.0 575.9 387.2 485.4 577.0 296.5 232.5 413.2 389.1 372.4 230.9 553.4 435.6 965.3 412.5 563.2 489.1 1214.3 988.4 405.3 315.2 1169.8 887.0 765.2 255.9 319.8 714.9 871.1 479.6 476.5 224.2 653.8 395.1 209.4 198.2 422.7 672.5 469.4 798.3 524.9 377.5 719.5 262.1 1064.7 680.6 822.0 486.1 726.1 468.4 560.6 540.8 516.7 745.6 447.7 435.9 523.1 851.5 468.5 815.5 809.1 675.4 780.5 558.3 562.2 573.3 752.7 552.1 565.6 565.0 556.2 546.7 563.8 562.4 564.6 575.5 251.9 160.3 188.6 10.7 261.6 213.7 251.4 991.0 194.1 156.2 268.0 322.7 3202.9 511.9 445.8 562.8 79.2 396.5 273.9 1264.2 2191.3 503.6 34.2 332.0 237.9 228.9 459.0 272.3 12.3 512.5 416.1 266.9 322.1 348.9 210.3 177.5 260.3 1022.5 661.7 82.4 14.8 907.2 581.8 413.5 350.6 43.8 294.5 329.3 570.9 14.0 492.3 364.2 277.1 8.0 16.5 506.4 1024.5 285.1 389.2 228.8 1546.3 1764.0 443.2 231.2 216.9 208.4 289.9 50.8 105.2 394.3 249.3 380.6 255.7 126.7 887.7 339.3 AMELX "AIH1, AMG" ENSG00000125363 "Amelogenin X-linked" Q99217 X 11293413-11300761 "Disease related genes, Human disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.76e-1)" "unprognostic (1.00e-1)" "unprognostic (2.00e-1)" 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.1 0.2 0.6 0.6 0.3 0.2 0.3 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DMAC2L "ATP5S, ATPW, HSU79253" ENSG00000125375 "Distal membrane arm assembly complex 2 like" Q99766 14 50312324-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 60.5;Cytotrophoblasts: 36.6;Extravillous trophoblasts: 24.6;Hofbauer cells: 28.5;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062690 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA062690: AB_2684836" "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favorable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 8.1 5.6 4.9 5.6 6.5 13.6 8.7 4.4 5.4 6.6 2.8 6.9 10.4 6.4 7.2 10.1 5.2 7.0 10.1 3.9 4.6 8.1 7.5 5.4 8.7 6.9 5.4 4.3 4.7 10.9 8.9 3.8 3.7 6.1 6.2 6.4 10.2 6.8 5.0 15.8 10.9 7.4 3.8 5.8 5.9 6.3 15.5 4.6 6.3 13.0 8.9 7.6 7.3 4.3 10.3 18.8 6.7 8.5 5.6 7.2 11.8 18.8 5.9 8.5 11.4 13.3 9.5 10.4 21.1 5.9 8.8 5.4 10.9 2.3 6.3 6.8 10.9 5.0 9.1 5.4 22.5 5.6 20.6 17.6 12.0 11.3 3.5 6.5 3.0 8.9 14.3 5.4 25.9 8.0 14.2 5.2 7.7 6.2 14.0 7.7 10.2 9.6 8.7 9.1 20.4 11.2 9.1 6.9 14.5 13.4 3.1 18.6 10.4 4.2 11.3 15.4 5.3 7.4 13.2 12.4 12.2 3.4 10.2 10.4 20.5 13.1 19.8 14.3 15.6 12.4 19.3 11.7 13.5 9.9 17.1 13.8 15.4 2.5 12.3 20.4 19.0 14.5 12.5 4.9 6.5 4.4 5.4 3.9 4.6 6.9 5.4 4.3 6.1 5.8 4.6 10.3 9.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 36.6 12.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.6 6.3 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 41.7 1.9 0.0 0.0 0.0 BMP4 BMP2B ENSG00000125378 "Bone morphogenetic protein 4" P12644 14 53949736-53958761 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 47.3;Fibroblasts: 65.2;Hepatic stellate cells: 52.8;Pancreatic endocrine cells: 40.1;Skeletal myocytes: 51.0;Syncytiotrophoblasts: 34.8" "Cancer enhanced" "Detected in all" "colorectal cancer: 28.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "monocytes: 1.9;T-cells: 1.3" "Cell line enhanced" "Detected in many" "CACO-2: 120.1;CAPAN-2: 298.6;Hep G2: 326.0;OE19: 219.1;SuSa: 168.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006863, HPA066235" Uncertain "Secreted to blood" NA NA 162000000 "CAB006863: , HPA066235: AB_2685641" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (5.20e-3)" "unprognostic (3.39e-2)" "unprognostic (3.32e-1)" "unprognostic (2.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.45e-3)" "unprognostic (7.67e-2)" "unprognostic (2.45e-3)" "unprognostic (7.06e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (1.24e-1)" 13.4 13.5 3.2 6.2 2.8 0.1 13.6 7.3 6.2 17.2 28.0 25.9 17.1 9.0 2.6 13.0 9.8 14.5 16.4 3.0 3.6 7.5 4.3 13.5 9.7 3.5 3.8 2.5 24.0 3.4 2.7 4.8 44.8 3.9 22.1 29.2 2.7 10.5 18.8 11.6 14.7 19.4 9.1 3.5 6.5 24.0 2.0 3.7 3.5 8.6 17.8 4.2 27.7 23.7 4.6 15.6 40.0 2.1 1.8 0.5 0.4 0.6 7.9 34.0 20.1 15.5 120.1 298.6 0.0 97.2 0.1 2.2 73.2 8.6 1.0 10.7 4.1 5.9 0.2 8.3 326.0 19.4 0.0 1.0 0.0 2.8 9.5 0.5 61.1 59.3 6.8 0.0 0.3 9.7 6.9 5.3 0.3 13.9 219.1 3.4 0.2 10.5 0.3 28.5 1.3 0.1 0.3 0.0 1.1 0.9 168.2 38.8 1.5 2.9 0.6 87.1 0.3 1.4 0.2 0.1 1.0 0.1 0.1 4.3 0.0 0.6 0.0 0.1 1.1 0.0 0.0 0.9 0.2 0.1 0.0 1.3 0.4 0.0 0.0 1.9 0.0 0.0 0.3 3.2 2.8 7.3 6.2 3.0 3.6 3.5 3.8 2.5 3.9 3.5 3.7 4.6 7.6 9.6 7.3 1.0 0.6 27.5 4.0 16.1 47.3 0.3 8.0 10.4 5.7 14.3 6.0 5.5 0.0 29.3 0.1 1.0 3.9 5.5 2.5 0.7 18.9 18.2 0.0 2.7 1.3 0.2 18.9 65.2 0.5 0.7 1.3 0.9 52.8 2.0 3.7 0.0 0.4 5.3 2.0 0.6 5.9 1.0 10.5 0.4 3.6 1.9 0.0 0.5 0.0 1.0 0.3 40.1 4.0 1.5 0.1 2.3 0.6 2.4 5.8 1.5 0.0 51.0 10.5 1.4 2.2 7.5 17.5 34.8 1.0 1.4 4.0 1.4 PTGER2 EP2 ENSG00000125384 "Prostaglandin E receptor 2" P43116 14 52314305-52328598 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Cell type enhanced" "Detected in many" "dendritic cells: 55.6;Macrophages: 33.2;NK-cells: 177.1;T-cells: 63.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.1;ASC TERT1: 68.3;HHSteC: 43.8;HL-60: 25.2;HSkMC: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.48e-1)" "unprognostic (2.48e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (1.55e-2)" "unprognostic (3.24e-1)" "unprognostic (3.11e-3)" "unprognostic (1.79e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-3)" "unprognostic (1.18e-1)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (8.48e-3)" "unprognostic (5.26e-3)" "unprognostic (6.71e-2)" "unprognostic (5.74e-2)" 8.8 1.4 0.1 12.7 0.4 38.7 3.6 0.1 0.6 17.3 2.9 8.1 6.3 9.4 0.6 1.9 4.6 9.8 0.8 0.1 0.5 3.1 3.6 5.4 4.5 0.5 0.5 0.1 8.3 1.3 0.4 0.7 14.5 0.3 10.0 6.7 0.0 3.2 2.8 0.7 1.2 9.4 5.1 0.6 11.9 17.6 2.9 0.4 3.2 1.8 0.3 1.7 5.9 2.2 0.4 1.3 0.5 0.0 0.0 26.1 68.3 0.1 2.1 0.4 2.3 2.8 0.0 0.1 0.0 1.8 1.4 0.0 9.3 0.0 0.5 3.3 0.0 13.2 0.0 0.7 0.0 43.8 25.2 0.3 56.2 1.1 5.8 0.9 7.4 0.0 0.0 0.0 0.0 13.4 1.2 0.0 1.0 1.0 4.5 8.8 0.2 0.0 0.0 20.6 0.1 0.7 20.6 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.9 1.5 15.5 0.0 0.0 0.0 0.0 6.1 14.2 0.2 5.8 35.9 35.5 106.7 30.6 129.3 0.2 91.0 114.3 19.0 0.1 21.7 67.7 4.7 73.5 61.5 0.9 50.0 66.3 0.1 0.4 0.1 0.6 0.1 0.5 0.5 0.5 0.1 0.3 0.6 0.4 0.4 4.0 3.2 1.7 0.0 3.2 1.8 0.4 0.8 1.2 0.0 2.0 2.5 1.2 1.5 0.7 3.7 0.0 0.1 55.6 0.7 0.0 0.3 0.0 24.0 1.6 0.9 6.0 3.0 0.1 0.0 0.3 13.9 15.3 7.7 20.8 2.9 4.2 0.6 10.0 0.0 0.1 6.0 0.0 28.0 19.6 0.5 4.1 33.2 3.6 0.0 16.6 0.0 177.1 0.0 0.0 1.5 0.1 3.0 3.7 1.4 0.0 0.3 9.6 0.0 0.0 1.3 11.6 0.1 1.2 0.2 1.6 0.3 63.1 0.2 0.6 0.2 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536647-2732573 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 13.2 11.8 9.1 7.7 9.3 13.1 13.3 13.4 11.6 14.1 8.2 12.3 7.9 14.0 6.9 9.6 13.0 6.1 9.5 8.8 8.5 10.0 11.7 10.2 9.7 9.7 8.4 7.5 15.1 11.2 9.3 15.6 7.7 10.3 12.2 6.0 9.0 10.2 7.0 15.2 13.0 12.4 8.1 6.1 12.1 10.6 21.2 8.5 12.5 12.3 8.8 6.7 11.6 11.3 11.7 8.7 10.7 20.0 11.3 12.0 12.2 10.5 13.1 11.3 12.7 10.8 10.9 13.9 17.1 7.7 14.7 15.7 7.4 14.0 9.4 10.8 10.3 8.9 25.7 14.3 11.5 14.4 15.8 17.2 13.3 9.8 12.7 13.0 11.6 12.8 10.0 18.2 18.5 10.8 9.4 25.5 25.6 15.9 8.9 11.8 24.7 10.3 8.4 8.7 11.1 17.1 14.6 11.2 7.8 11.3 10.9 14.3 15.9 17.4 19.2 11.3 10.5 17.5 18.0 14.5 16.1 10.7 12.8 13.8 3.3 0.9 0.8 0.8 0.6 0.6 0.6 0.7 1.2 0.6 0.9 0.7 1.1 1.8 1.3 3.1 1.7 0.6 0.5 9.1 9.3 13.4 11.6 8.8 8.5 9.7 8.4 7.5 10.3 6.1 8.5 11.7 21.8 12.8 18.2 62.7 11.2 9.4 6.7 6.5 9.1 25.7 10.5 9.0 14.7 4.3 15.6 1.8 47.9 7.3 20.0 12.9 1.9 9.4 8.9 19.8 21.8 19.4 14.4 17.9 62.4 7.5 7.1 13.2 15.8 27.1 8.8 30.2 11.0 6.3 8.7 15.2 70.8 11.1 8.2 7.6 11.6 13.4 17.1 15.9 14.2 51.5 11.1 15.8 11.3 45.8 58.3 10.1 11.0 14.7 12.4 11.3 11.4 2.8 5.6 26.2 6.6 20.5 17.5 36.2 32.4 9.6 9.9 5.6 14.4 13.6 9.6 9.2 GRK4 "GPRK2L, GPRK4" ENSG00000125388 "G protein-coupled receptor kinase 4" P32298 4 2963571-3040760 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;testis: 42.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 123.0;Early spermatids: 357.7;Late spermatids: 500.3;Spermatocytes: 180.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057023 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA057023: AB_2683313" "unprognostic (1.86e-2)" "unprognostic (2.88e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (3.65e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-1)" "unprognostic (2.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.87e-1)" "unprognostic (3.90e-4)" "unprognostic (3.20e-1)" "unprognostic (1.01e-2)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.89e-1)" 2.8 3.3 6.5 1.1 6.4 1.3 2.4 19.0 8.6 3.0 0.4 2.3 1.0 2.7 2.3 1.8 2.1 2.4 4.9 6.7 5.6 2.2 2.0 2.1 1.2 6.1 6.2 6.0 3.5 5.4 4.4 6.2 1.6 9.6 2.0 1.4 10.2 2.9 2.1 4.8 2.4 1.4 2.1 3.7 1.4 3.0 42.7 7.1 1.7 3.4 4.4 1.2 2.3 2.2 7.4 2.3 0.8 2.7 7.9 6.3 6.1 1.6 4.3 1.9 2.4 2.1 2.3 0.7 5.1 1.9 7.1 4.8 0.7 3.6 3.6 2.1 3.4 3.4 5.6 3.2 2.6 3.8 2.3 1.9 4.1 5.7 4.3 2.0 2.7 4.7 5.5 5.4 6.6 5.8 2.6 4.8 4.8 2.1 3.3 6.0 6.1 3.4 2.1 2.3 2.9 15.2 4.8 2.7 1.2 4.1 1.9 6.0 3.5 5.5 6.6 1.7 4.5 4.0 6.5 4.0 3.8 3.3 5.0 2.2 2.1 0.3 0.6 0.3 0.7 0.4 0.3 0.2 0.2 0.1 0.3 0.5 0.4 1.1 0.5 0.2 0.7 0.1 0.4 6.5 6.4 19.0 8.6 6.7 5.6 6.1 6.2 6.0 9.6 3.7 7.1 7.4 3.9 3.2 7.4 34.6 2.1 11.2 3.2 5.0 7.4 57.1 5.0 5.5 11.4 4.3 5.6 3.7 123.0 2.1 4.7 0.8 13.7 2.7 357.7 4.2 7.2 4.2 10.3 8.6 53.9 3.8 5.3 8.7 5.1 3.8 5.7 75.0 6.1 3.0 3.4 18.5 71.1 2.4 4.1 2.9 4.6 500.3 13.1 3.1 7.2 9.4 3.0 11.4 2.1 48.2 29.3 2.1 0.4 8.2 5.3 1.8 2.0 5.0 1.2 58.2 6.6 8.4 5.7 180.4 22.3 6.5 11.4 3.0 4.0 34.6 1.3 2.4 SOX9 "CMD1, CMPD1, SRA1" ENSG00000125398 "SRY-box transcription factor 9" P48436 17 72121020-72126416 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.6;salivary gland: 80.7" "Cell type enhanced" "Detected in many" "Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001758, CAB022456, CAB068240" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (4.47e-3)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (7.96e-3)" "unprognostic (4.32e-3)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.87e-2)" "unprognostic (3.31e-1)" "unprognostic (8.92e-3)" "unprognostic (1.21e-1)" "unprognostic (3.26e-3)" "unprognostic (2.77e-3)" "unprognostic (1.15e-1)" "unprognostic (8.88e-2)" "unprognostic (1.21e-2)" 2.9 2.2 53.5 4.4 46.5 0.1 28.3 48.1 59.0 7.4 42.3 17.2 19.9 2.9 0.9 13.8 7.6 13.1 13.8 52.0 70.6 12.8 3.6 3.1 1.1 74.6 55.3 35.5 0.3 38.7 0.1 10.4 0.3 46.5 25.1 18.0 15.1 80.7 11.0 2.7 22.2 15.2 1.2 52.3 0.2 40.8 31.0 53.1 0.5 20.4 1.2 4.4 2.0 6.5 46.5 31.1 19.2 38.9 78.1 3.9 1.1 0.1 4.8 4.2 8.2 4.4 27.0 40.8 0.0 2.9 1.1 43.8 31.3 0.0 18.6 7.5 0.0 2.5 0.0 4.2 97.0 0.3 0.0 0.1 0.7 1.6 9.5 9.0 47.0 0.0 0.0 0.0 0.1 11.7 0.4 0.0 0.1 1.5 74.3 29.1 0.0 31.4 0.4 35.2 2.0 1.9 1.9 4.0 4.7 0.1 21.0 16.7 0.2 0.0 15.8 42.0 8.5 66.5 0.0 0.0 0.1 11.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 46.5 48.1 59.0 52.0 70.6 74.6 55.3 35.5 46.5 52.3 53.1 46.5 1.1 12.8 5.6 160.0 1.9 55.4 88.2 28.9 166.8 3.0 141.0 108.2 13.6 190.1 21.1 36.8 0.0 0.3 2.8 52.1 7.9 55.3 5.1 18.4 0.9 3.2 59.7 0.0 3.1 46.7 0.0 26.0 144.8 21.7 4.5 1.9 0.0 3.4 0.2 0.0 1.5 99.0 24.4 0.0 3.4 14.5 4.4 2.3 12.4 9.4 1.0 141.3 0.0 4.5 11.1 40.8 39.1 0.4 2.8 81.1 17.7 61.0 36.4 6.8 6.6 59.9 14.5 10.2 3.1 273.5 17.8 0.1 2.8 0.1 103.8 77.2 TEKT3 FLJ32828 ENSG00000125409 "Tektin 3" Q9BXF9 17 15303811-15341632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 31.3" "Group enriched" "Detected in some" 10 "Early spermatids: 413.1;Late spermatids: 408.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;SuSa: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027293, HPA044354, HPA073565" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA027293: , HPA044354: AB_10962623, HPA073565: " "unprognostic (1.85e-1)" "unprognostic (6.64e-3)" "unprognostic (9.73e-2)" "unprognostic (5.38e-4)" "unprognostic (4.59e-2)" "unprognostic (3.09e-2)" "unprognostic (9.07e-2)" "unprognostic (8.63e-3)" "unprognostic (4.91e-2)" "unprognostic (1.23e-1)" "unprognostic (9.67e-4)" "unprognostic (1.29e-1)" "unprognostic (1.09e-4)" "unprognostic (1.69e-2)" "unprognostic (3.00e-1)" "unprognostic (2.90e-3)" "unprognostic (7.85e-2)" 0.3 0.2 1.0 0.3 0.7 0.1 0.5 1.5 1.1 1.0 0.7 0.3 0.3 0.5 0.6 0.1 5.0 0.4 0.2 0.6 0.6 0.3 0.2 0.8 0.1 0.9 0.6 0.6 0.9 0.7 0.2 1.0 0.3 1.0 0.4 0.2 0.7 0.5 0.1 0.1 0.6 0.4 0.3 0.7 0.2 0.2 31.3 0.7 0.1 0.7 0.0 0.1 0.2 0.4 1.1 0.0 0.0 0.4 0.5 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.1 0.1 0.1 1.5 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.7 0.3 0.0 0.1 0.0 0.0 1.0 0.7 1.5 1.1 0.6 0.6 0.9 0.6 0.6 1.0 0.7 0.7 1.1 0.7 3.2 0.5 0.7 0.1 0.3 0.1 0.7 0.0 0.7 0.5 0.5 0.7 1.5 4.7 0.0 0.0 0.3 0.2 0.5 0.0 0.1 413.1 16.3 1.7 0.7 1.8 0.0 1.2 0.0 0.5 3.9 0.0 0.5 0.0 0.7 0.4 0.1 3.8 0.0 1.1 0.0 0.0 0.0 1.4 408.9 11.1 0.3 0.0 1.0 0.0 1.7 0.0 2.0 0.8 0.0 0.1 6.4 0.0 0.2 0.7 0.1 39.1 0.2 6.6 3.2 1.4 25.9 2.6 0.0 0.1 0.0 0.1 3.4 0.0 0.2 MYH2 "IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2" ENSG00000125414 "Myosin heavy chain 2" Q9UKX2 17 10521148-10549700 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 84 "skeletal muscle: 12912.1;tongue: 6194.6" "Cell type enriched" "Detected in some" 18 "Skeletal myocytes: 129.6" "Cancer enriched" "Detected in single" 60 "head and neck cancer: 27.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.0;HSkMC: 1.9;NTERA-2: 8.3;SuSa: 1.7" "HPA001349, CAB010760" Enhanced Uncertain "Focal adhesion sites" NA NA 81000000 "Focal adhesion sites" "CAB010760: AB_477190, HPA001349: AB_1079437" "unprognostic (6.50e-2)" "unprognostic (1.86e-2)" "unprognostic (4.76e-2)" "unprognostic (1.92e-2)" "unprognostic (1.05e-4)" "unprognostic (2.89e-1)" "unprognostic (9.51e-2)" "unprognostic (2.03e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" 0.4 0.1 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 46.9 0.3 0.0 0.5 0.4 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 21.7 0.0 0.0 114.0 1.0 12912.1 0.7 0.2 0.4 0.0 0.1 0.2 0.2 0.0 0.3 0.9 6194.6 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301081-14349404 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.7;retina: 11.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6;dendritic cells: 32.5;Hepatic stellate cells: 25.7;Hepatocytes: 39.7;Syncytiotrophoblasts: 36.3" "Cancer enhanced" "Detected in many" "liver cancer: 5.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 35.1" "Group enriched" "Detected in many" 5 "dendritic cells: 35.1;T-cells: 26.2" "Cell line enhanced" "Detected in many" "AF22: 20.7;BEWO: 14.9;Hep G2: 18.8;HSkMC: 20.2;U-251 MG: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA064126 Approved Vesicles NA NA Vesicles "HPA064126: AB_2685194" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 0.9 0.9 0.5 4.7 1.1 1.4 0.9 0.6 1.4 2.4 1.5 1.3 1.3 0.6 0.2 1.8 0.9 1.4 1.1 0.5 1.2 3.0 28.7 1.6 6.3 5.4 3.0 0.6 3.5 0.6 0.3 0.7 3.5 1.9 2.0 1.7 11.6 5.3 2.0 1.0 1.2 1.8 0.5 2.7 3.4 1.2 0.4 1.6 3.2 0.7 0.9 4.9 2.6 1.9 1.7 0.0 0.4 20.7 0.0 6.2 6.9 14.9 6.1 8.7 5.3 5.6 0.0 0.1 0.0 0.0 8.2 0.0 0.1 0.5 3.3 2.7 1.8 4.5 0.5 2.9 18.8 8.1 0.8 3.2 20.2 1.1 1.9 4.8 1.2 0.0 1.1 6.6 0.1 4.3 1.1 1.0 0.8 0.7 0.1 0.6 3.9 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.4 0.6 0.0 5.2 0.0 0.1 19.9 0.0 0.0 0.0 4.0 0.0 1.2 0.2 0.4 0.0 10.2 0.7 8.1 0.9 12.0 8.0 0.8 0.7 12.1 11.8 0.9 6.6 0.8 35.1 26.2 5.1 0.5 1.1 0.6 1.4 0.5 1.2 5.4 3.0 0.6 1.9 2.7 1.6 1.7 2.9 0.0 1.1 6.2 3.5 11.5 0.3 4.9 21.1 3.2 1.2 2.2 3.0 10.0 3.9 7.3 39.6 7.2 32.5 0.0 0.0 0.7 14.3 0.3 1.5 2.9 0.0 0.4 3.3 0.2 11.9 6.6 0.0 0.8 0.0 2.4 25.7 39.7 1.6 8.4 2.2 0.1 2.0 3.8 12.9 3.3 2.8 6.7 1.8 1.9 1.3 7.3 14.4 3.5 0.1 0.2 0.0 1.2 2.2 1.1 0.4 0.1 3.9 17.9 13.1 15.0 2.6 4.0 0.3 10.0 14.8 36.3 12.4 0.1 0.2 0.3 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295400 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4" "Cancer enhanced" "Detected in all" "endometrial cancer: 14.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051720 Uncertain Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA051720: AB_2681584" "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favorable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favorable (1.91e-5)" 5.7 8.4 3.1 5.0 3.9 6.1 8.6 3.9 4.4 8.7 4.3 7.4 6.1 13.5 7.7 5.5 7.2 5.2 4.6 3.0 3.9 14.3 4.7 6.9 5.1 4.5 3.9 2.2 2.9 12.3 6.1 12.9 4.2 5.3 8.7 5.4 4.6 6.5 5.3 2.2 4.0 7.8 4.1 3.7 9.0 12.7 24.7 4.0 5.3 9.2 1.5 3.5 6.1 5.0 4.2 5.0 13.5 2.4 10.0 7.5 2.9 5.5 3.2 2.8 3.4 3.7 1.6 12.4 5.8 3.3 3.7 7.1 11.0 2.8 3.8 1.9 3.2 3.6 4.8 11.1 1.9 2.7 0.7 12.8 5.9 2.1 6.5 1.2 2.5 5.4 6.8 1.4 2.0 2.9 2.7 5.3 2.7 0.8 3.4 4.4 5.8 1.6 2.6 2.6 12.6 1.2 3.0 9.2 5.4 4.1 2.4 12.2 3.6 7.6 2.3 1.7 5.6 2.7 4.3 2.9 2.1 5.9 8.6 6.1 4.1 5.6 7.6 4.0 8.8 3.3 1.9 3.7 4.3 5.7 3.6 1.3 2.5 1.1 2.8 6.5 3.0 4.1 2.5 3.1 3.9 3.9 4.4 3.0 3.9 4.5 3.9 2.2 5.3 3.7 4.0 4.2 3.1 0.0 5.4 5.2 3.6 0.8 1.5 1.4 2.8 4.3 6.3 4.1 1.0 5.7 1.8 11.0 8.4 9.2 2.1 3.8 11.7 2.8 3.8 10.2 1.9 2.8 9.0 4.6 0.5 7.1 2.3 3.0 5.1 10.6 5.1 1.3 1.8 2.8 6.7 1.7 0.7 3.0 2.0 6.4 1.5 5.5 1.5 4.2 0.0 4.7 5.8 7.9 3.1 1.0 2.5 3.2 6.0 1.2 3.7 1.9 2.4 7.3 2.0 9.0 0.0 1.1 1.2 20.9 0.8 1.9 0.3 17.4 3.2 9.1 3.1 1.9 MRPS7 "MRP-S, RP-S7, RPMS7" ENSG00000125445 "Mitochondrial ribosomal protein S7" Q9Y2R9 17 75261674-75266376 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 454.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022522, HPA023007" Supported Approved Mitochondria No No Mitochondria "HPA022522: AB_1854131, HPA023007: AB_1854132" "unprognostic (1.24e-1)" "unprognostic (4.74e-2)" "prognostic favorable (1.12e-4)" "unprognostic (5.82e-3)" "unprognostic (3.62e-2)" "unprognostic (5.05e-3)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (4.95e-2)" "unprognostic (8.56e-3)" "unprognostic (1.03e-1)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (8.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.15e-1)" 44.7 58.9 54.4 38.4 54.5 33.2 41.6 58.7 62.4 28.6 56.2 50.4 49.3 28.6 24.6 58.9 39.6 27.3 120.4 53.9 58.2 61.1 65.2 32.7 41.6 55.4 56.3 53.4 29.4 39.3 77.3 36.3 41.2 55.9 34.4 48.6 47.7 41.4 36.1 203.3 31.5 40.3 34.1 56.4 39.8 47.9 30.1 57.1 34.0 36.3 214.2 44.0 43.0 35.3 55.1 113.8 188.6 78.8 57.6 63.9 35.7 139.4 73.3 60.9 137.4 101.1 209.8 93.5 96.4 66.4 79.8 91.4 104.5 122.3 135.8 82.2 50.8 173.5 131.8 133.6 201.3 62.5 134.3 69.6 60.0 131.8 108.6 109.6 69.2 177.3 117.8 130.1 93.3 91.1 203.5 151.8 104.7 85.4 157.7 176.2 100.7 229.5 145.2 128.4 124.6 135.8 122.8 93.8 249.9 150.0 83.9 188.4 108.7 72.2 124.0 125.3 68.2 155.7 97.9 61.5 106.6 89.5 88.3 96.9 43.2 155.1 48.2 115.7 161.6 124.2 140.2 112.0 126.0 172.0 128.1 128.6 120.7 11.0 130.5 138.5 164.9 141.6 236.0 54.4 54.5 58.7 62.4 53.9 58.2 55.4 56.3 53.4 55.9 56.4 57.1 55.1 44.1 51.3 48.3 12.1 69.3 39.5 75.1 148.1 37.0 65.8 56.5 63.0 77.8 70.1 74.3 57.0 98.0 192.9 63.3 94.1 230.9 112.9 139.2 50.9 43.2 55.6 47.5 61.4 11.8 104.1 175.3 50.2 55.5 43.5 39.3 68.6 45.3 91.7 148.8 47.1 14.0 84.3 77.3 60.0 35.6 454.3 48.4 52.6 42.7 3.7 107.0 85.6 73.2 9.5 11.3 89.8 69.3 39.9 87.7 85.3 129.2 219.3 81.0 114.4 59.2 40.8 73.0 60.5 68.5 68.5 41.9 137.9 53.8 110.0 133.8 77.4 GGA3 KIAA0154 ENSG00000125447 "Golgi associated, gamma adaptin ear containing, ARF binding protein 3" Q9NZ52 17 75236599-75262363 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022945, HPA024645" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA022945: AB_1849639, HPA024645: AB_2671629" "unprognostic (9.16e-2)" "unprognostic (8.89e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.20e-1)" "unprognostic (4.60e-3)" "prognostic unfavorable (2.77e-6)" "unprognostic (6.33e-2)" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (4.63e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.41e-4)" "unprognostic (1.27e-1)" "unprognostic (2.99e-3)" "unprognostic (1.28e-2)" "unprognostic (9.68e-3)" 11.4 9.9 8.9 13.1 8.3 15.9 10.9 7.4 11.5 11.4 4.3 12.5 11.6 10.9 9.9 17.2 10.3 11.5 12.0 8.4 6.5 11.2 11.7 13.2 17.6 9.3 7.4 6.7 15.4 12.4 9.2 9.1 14.7 8.3 10.1 11.8 6.8 12.4 7.9 22.8 15.4 15.1 11.9 6.4 19.8 13.1 11.6 7.9 12.9 9.9 10.6 19.1 11.7 12.3 8.4 16.9 21.1 19.5 11.9 21.5 17.9 22.8 18.5 13.3 24.9 21.2 24.8 18.4 21.4 8.2 16.4 19.9 10.6 13.8 8.0 25.7 15.1 21.4 34.3 19.2 19.6 10.3 32.5 24.3 14.1 19.7 13.6 23.5 13.2 26.5 16.1 37.8 19.1 17.7 17.4 42.5 9.6 13.8 19.6 14.9 16.9 28.0 14.3 17.1 18.4 14.0 23.9 18.5 33.2 14.9 27.3 25.3 17.4 29.6 25.7 18.7 17.4 19.9 19.8 15.1 27.5 20.8 23.0 17.2 5.1 6.8 2.9 5.5 5.9 5.1 3.9 4.9 4.2 6.4 4.7 4.3 4.6 7.3 8.4 5.8 6.6 5.4 6.0 8.9 8.3 7.4 11.5 8.4 6.5 9.3 7.4 6.7 8.3 6.4 7.9 8.4 9.5 35.3 21.0 13.4 15.5 2.5 4.9 5.2 8.0 8.1 8.8 7.6 12.6 4.3 9.6 0.0 10.4 10.3 21.2 14.3 5.9 5.2 27.6 10.5 13.6 10.2 0.0 4.6 20.6 7.0 11.0 7.7 21.9 14.7 10.1 12.4 9.7 10.4 12.5 6.7 20.2 10.0 6.1 19.2 7.1 30.1 9.3 19.4 12.4 16.9 20.3 5.9 10.3 18.1 21.2 11.6 9.1 10.1 11.0 8.2 9.5 3.5 10.2 8.9 0.0 7.7 6.1 8.1 6.9 7.8 5.3 13.0 12.2 7.0 12.8 8.5 ARMC7 FLJ22160 ENSG00000125449 "Armadillo repeat containing 7" Q9H6L4 17 75109952-75130272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024229, HPA053076" Uncertain Supported Cytosol NA NA Cytosol "HPA024229: AB_2059152, HPA053076: AB_2682036" "unprognostic (1.35e-1)" "prognostic favorable (2.98e-4)" "unprognostic (7.73e-2)" "unprognostic (5.84e-2)" "unprognostic (4.15e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.84e-2)" "unprognostic (3.68e-1)" "unprognostic (4.28e-2)" "unprognostic (3.40e-2)" "unprognostic (4.86e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.93e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.98e-2)" 7.0 6.7 7.4 5.9 7.4 4.2 7.4 12.1 9.1 7.7 7.5 10.2 9.7 7.0 4.8 11.3 6.6 4.8 8.6 7.4 7.2 31.7 13.3 12.4 7.1 7.0 6.9 6.9 5.3 7.1 6.7 7.0 5.8 8.5 11.9 7.0 2.7 8.9 6.5 5.5 11.7 12.0 4.0 6.9 14.1 11.5 7.3 7.3 8.2 10.0 4.0 6.4 8.8 9.4 7.1 15.2 30.2 8.9 8.5 7.0 4.3 9.4 8.3 9.0 15.9 14.3 25.3 14.7 9.0 10.8 7.7 8.7 12.4 14.6 6.1 7.6 8.7 23.2 17.5 13.4 15.9 15.5 13.5 16.1 5.6 11.4 10.0 5.8 7.7 14.6 14.5 15.8 17.6 5.3 21.7 25.9 14.8 4.5 32.8 22.6 14.6 18.0 16.8 35.6 27.4 8.3 11.9 15.6 15.7 18.6 15.2 18.4 12.9 11.3 16.1 14.9 6.4 13.1 14.7 5.5 12.7 7.2 9.6 11.8 31.7 13.7 28.5 18.0 9.9 15.8 13.4 12.9 15.1 12.7 10.0 9.8 14.9 18.6 15.7 7.9 11.1 20.8 11.7 7.4 7.4 12.1 9.1 7.4 7.2 7.0 6.9 6.9 8.5 6.9 7.3 7.1 6.6 12.8 8.8 1.3 10.4 4.6 2.8 5.8 2.2 6.0 6.0 5.1 2.5 7.2 5.2 22.0 0.0 14.1 10.1 28.6 35.2 8.7 6.2 4.6 3.0 9.0 6.0 1.7 3.0 9.4 8.3 4.1 8.6 5.1 10.8 4.4 14.3 4.6 15.2 0.0 2.9 9.8 6.1 7.5 3.3 12.2 5.3 9.7 12.4 1.9 13.9 3.3 11.3 2.5 1.8 11.3 27.1 3.8 6.4 4.8 15.8 15.4 7.2 3.4 19.7 2.2 4.6 3.8 5.9 4.4 4.5 4.9 8.7 6.6 12.4 3.8 NUP85 "FLJ12549, NUP75" ENSG00000125450 "Nucleoporin 85" Q9BW27 17 75205659-75235758 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061910, HPA062595" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061910: AB_2684634, HPA062595: AB_2684801" "unprognostic (2.30e-1)" "unprognostic (5.10e-2)" "unprognostic (5.12e-3)" "unprognostic (2.52e-3)" "unprognostic (2.25e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.73e-7)" "unprognostic (3.46e-1)" "unprognostic (1.09e-2)" "unprognostic (9.93e-2)" "unprognostic (2.94e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.03e-3)" "unprognostic (2.16e-1)" "unprognostic (9.10e-3)" "unprognostic (2.11e-1)" 20.2 13.0 15.3 18.8 15.7 21.0 20.1 21.8 17.1 21.4 15.6 18.5 16.0 20.9 16.2 20.7 21.1 11.7 16.0 15.7 15.3 15.1 22.3 18.9 26.7 15.7 15.4 15.1 21.0 18.8 12.2 12.8 19.2 17.9 19.1 21.2 11.3 16.9 14.4 16.8 24.1 20.6 19.8 15.2 25.5 17.1 22.4 15.1 33.5 18.2 14.2 27.2 18.0 19.6 17.0 66.5 74.0 53.4 37.3 20.3 31.5 74.0 47.3 37.4 108.5 101.7 63.2 61.4 61.1 26.6 41.1 70.5 55.9 88.8 50.6 96.1 19.3 70.1 51.0 83.3 56.3 16.6 52.8 40.7 30.3 30.5 76.1 32.8 24.9 84.7 49.0 63.3 38.1 53.8 73.0 100.2 64.8 40.0 82.2 67.4 68.9 115.1 55.5 42.1 47.5 40.6 38.5 58.2 73.7 42.5 59.4 83.3 59.1 30.8 80.2 74.4 52.5 76.3 23.6 21.0 79.2 41.4 47.3 50.6 8.1 24.9 21.5 16.1 22.6 22.9 16.1 17.5 15.9 20.5 21.5 17.0 12.8 8.2 16.7 16.5 22.5 16.6 17.3 15.3 15.7 21.8 17.1 15.7 15.3 15.7 15.4 15.1 17.9 15.2 15.1 17.0 13.2 6.4 12.5 7.2 13.9 6.1 8.9 19.1 6.2 7.8 10.3 7.5 9.0 8.6 15.0 7.3 10.4 23.0 11.7 9.1 7.9 16.0 3.7 11.1 13.6 15.0 7.7 16.2 13.5 19.4 22.1 13.8 9.7 10.3 11.4 13.0 21.0 23.1 23.0 6.7 9.9 11.0 16.2 13.3 7.2 3.9 14.3 13.7 8.8 10.3 15.8 4.8 22.6 3.5 10.6 18.3 7.5 9.8 8.6 7.9 8.8 11.7 11.8 8.8 32.9 7.9 19.2 24.9 29.3 7.3 7.1 12.7 10.9 7.4 13.3 8.0 SLC25A19 "DNC, MCPHA, MUP1, TPC" ENSG00000125454 "Solute carrier family 25 member 19" Q9HC21 17 75272981-75289510 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 82.2;Langerhans cells: 160.3;Spermatocytes: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021936 Supported Mitochondria NA NA Mitochondria "HPA021936: " "unprognostic (2.28e-1)" "unprognostic (7.05e-3)" "unprognostic (8.21e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.21e-7)" "unprognostic (6.71e-2)" "unprognostic (2.73e-1)" "unprognostic (2.85e-1)" "unprognostic (7.72e-2)" "unprognostic (1.77e-3)" "unprognostic (2.71e-3)" "unprognostic (3.58e-2)" "unprognostic (4.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.13e-1)" 9.3 31.5 11.4 16.2 12.1 8.1 6.5 13.0 13.4 6.8 11.9 9.5 9.5 6.8 2.5 8.6 6.3 6.2 10.0 11.8 13.7 8.6 8.9 11.8 23.1 15.0 12.5 11.9 6.2 8.8 8.2 4.8 12.2 13.5 6.2 8.9 3.2 6.3 3.8 14.6 5.0 8.6 7.1 12.7 14.7 11.0 33.3 13.8 8.6 6.1 16.9 18.9 11.7 5.7 14.6 28.3 34.8 6.2 18.4 13.6 7.0 20.0 18.1 7.0 20.3 20.5 59.8 17.4 89.8 12.8 6.4 17.7 24.7 43.5 20.9 25.3 26.5 70.5 41.1 40.4 58.4 11.5 58.7 44.9 6.1 11.6 31.5 25.2 4.7 33.9 44.9 51.0 41.9 6.5 59.3 61.8 59.3 13.5 55.3 67.8 47.4 19.8 85.1 14.1 19.7 60.7 15.3 19.3 51.4 22.2 10.2 32.1 47.3 12.0 12.1 24.1 23.5 49.0 102.7 53.4 95.8 9.5 66.9 15.5 0.3 21.0 2.3 16.2 25.2 16.6 36.3 12.7 15.4 24.9 29.7 14.2 14.7 1.7 10.0 14.8 31.0 17.7 14.5 11.4 12.1 13.0 13.4 11.8 13.7 15.0 12.5 11.9 13.5 12.7 13.8 14.6 5.1 6.4 6.7 3.3 27.6 15.2 10.8 6.0 2.8 1.2 5.4 7.5 0.6 2.8 6.1 7.3 2.1 7.5 13.3 8.6 23.5 6.5 18.0 5.6 8.7 6.7 3.0 11.1 3.1 5.3 82.2 8.6 9.7 3.5 11.4 2.7 2.5 2.9 44.1 3.3 3.5 6.2 4.1 9.5 160.3 24.1 3.1 31.5 24.9 4.7 38.8 1.6 11.3 2.0 2.4 5.1 8.6 3.4 26.5 14.1 6.5 6.4 3.9 6.0 6.6 5.9 10.0 79.6 11.9 7.9 12.9 8.9 12.5 11.4 11.0 9.7 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271231 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 25.6 22.7 14.9 18.9 16.8 44.0 23.6 16.6 16.5 20.7 13.1 23.2 12.7 23.3 8.3 28.6 18.4 17.5 21.1 14.7 15.9 22.7 17.7 25.6 33.5 16.8 16.8 13.6 14.3 27.9 21.7 11.9 12.4 17.4 16.5 15.2 6.1 20.0 14.5 63.7 30.9 25.3 17.1 16.7 36.0 19.6 18.0 16.0 24.7 16.7 27.0 27.2 23.9 21.8 18.9 25.6 43.5 8.9 20.3 17.9 5.4 12.7 6.2 19.1 13.0 9.5 14.4 29.8 38.7 11.7 11.9 14.6 19.8 13.6 24.4 10.5 19.2 27.3 20.2 16.5 14.1 19.9 18.9 20.4 4.8 37.7 8.7 39.7 17.7 27.3 44.7 25.7 50.0 3.6 47.6 58.6 39.0 3.5 29.0 21.3 36.6 11.3 58.6 29.4 14.1 11.7 17.1 13.9 34.5 33.0 23.4 65.9 41.2 9.7 5.6 13.8 7.2 12.1 67.8 17.5 33.3 11.7 31.3 8.7 27.5 77.6 44.4 54.6 41.1 56.6 49.3 43.0 47.9 91.4 44.2 37.1 39.9 13.1 56.4 55.4 226.4 68.3 60.3 14.9 16.8 16.6 16.5 14.7 15.9 16.8 16.8 13.6 17.4 16.7 16.0 18.9 33.2 0.0 11.0 3.3 30.5 11.5 14.8 11.1 5.2 3.8 23.8 23.4 4.2 31.5 15.3 12.9 0.0 15.0 73.4 12.1 21.5 45.2 32.6 11.6 4.7 20.1 15.6 11.1 3.0 43.4 9.4 12.3 9.2 12.0 31.8 13.0 17.5 9.0 44.9 1.7 3.1 18.0 28.5 47.4 45.1 19.8 9.3 45.4 16.0 7.5 47.7 30.5 53.5 5.0 8.2 24.8 22.7 15.8 22.5 14.3 22.3 29.3 17.6 6.0 19.7 13.0 22.0 19.6 22.1 23.2 18.9 9.3 33.5 7.4 16.9 14.1 NT5C "cdN, DNT-1, DNT1, PN-I, UMPH2" ENSG00000125458 "5', 3'-nucleotidase, cytosolic" Q8TCD5 17 75130225-75131757 "Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021581, HPA023632" Approved Supported Cytosol NA NA 760000 Cytosol "HPA021581: AB_1854663, HPA023632: AB_1854662" "unprognostic (3.83e-2)" "unprognostic (4.45e-2)" "unprognostic (2.39e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.26e-1)" "unprognostic (7.25e-2)" "unprognostic (8.26e-3)" "unprognostic (7.15e-2)" "unprognostic (2.22e-1)" "unprognostic (6.57e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "prognostic favorable (7.66e-4)" 30.4 31.7 13.1 18.1 14.2 16.4 32.1 15.2 17.6 35.2 13.3 38.4 24.7 35.0 5.2 46.2 32.4 8.4 30.6 12.9 16.1 42.0 29.3 29.4 18.5 18.4 14.2 11.3 37.8 34.0 11.8 19.0 10.3 15.6 36.0 13.2 8.8 26.0 15.4 41.4 33.3 44.0 7.7 15.2 41.0 37.1 15.3 14.2 16.2 38.0 16.3 15.3 38.2 36.2 17.1 52.5 77.7 25.3 26.5 7.5 15.4 33.7 29.5 26.2 29.7 18.8 29.5 58.3 35.5 21.5 21.0 5.2 33.7 18.1 37.7 16.5 16.1 51.3 40.5 68.7 50.0 38.0 38.8 17.2 23.1 17.4 21.3 57.0 11.9 33.0 27.6 38.4 16.8 30.2 51.2 28.0 39.0 26.5 43.6 50.6 24.9 32.9 50.9 39.3 26.7 30.0 60.1 28.3 34.8 43.9 14.0 49.8 27.2 20.4 25.0 62.1 9.8 40.3 33.3 5.6 41.1 23.8 23.3 40.4 183.7 29.7 48.9 39.2 49.6 27.7 94.9 25.5 33.6 37.9 87.4 21.6 33.5 14.4 72.6 50.7 50.4 45.2 30.2 13.1 14.2 15.2 17.6 12.9 16.1 18.4 14.2 11.3 15.6 15.2 14.2 17.1 23.0 32.1 19.5 22.2 132.9 47.4 86.1 108.8 90.5 66.0 58.8 101.9 16.4 77.2 35.2 58.8 20.9 64.9 85.8 272.8 78.2 102.2 2.1 53.2 53.5 26.6 64.1 59.5 7.7 121.4 100.4 59.8 181.5 43.2 46.3 59.0 11.7 41.9 74.5 42.1 8.0 133.4 52.9 55.7 64.4 6.8 59.4 56.2 58.7 18.7 108.4 55.9 98.9 19.6 19.2 127.5 221.6 47.4 51.2 115.8 231.6 144.2 31.1 65.5 32.9 39.0 107.6 19.0 49.6 89.4 44.3 31.2 67.4 98.4 152.8 85.9 MSTO1 "FLJ10504, LST005, misato, MST" ENSG00000125459 "Misato mitochondrial distribution and morphology regulator 1" Q9BUK6 1 155610205-155614951 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1482.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005899, HPA005914, HPA006075" Approved Enhanced Cytosol NA NA Cytosol "HPA005899: AB_2667460, HPA005914: AB_2667466, HPA006075: " "unprognostic (1.80e-2)" "unprognostic (3.43e-1)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (1.15e-1)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.63e-2)" "unprognostic (1.26e-1)" "unprognostic (5.28e-2)" "unprognostic (3.73e-2)" "unprognostic (3.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (5.35e-2)" "unprognostic (1.28e-1)" 18.1 18.4 8.3 10.3 8.6 7.4 19.0 9.4 9.5 16.8 7.6 11.4 8.8 16.3 18.1 14.8 16.9 7.3 13.7 9.3 8.7 18.0 32.0 12.8 11.5 10.2 9.7 7.7 17.2 25.3 15.0 24.5 8.7 10.6 20.9 9.1 7.9 14.5 15.0 6.9 11.7 15.8 11.9 8.0 21.4 14.8 23.3 9.8 8.7 18.7 4.7 10.8 16.0 12.9 8.9 23.0 31.1 26.7 41.1 21.9 18.5 33.3 28.8 24.5 35.1 27.9 30.8 14.3 39.5 26.1 25.9 22.6 24.7 40.2 38.8 24.2 15.3 33.6 34.1 29.5 17.8 34.8 36.7 26.4 19.2 19.4 38.8 55.7 15.6 29.2 28.5 28.4 17.3 29.3 37.7 24.7 24.9 35.4 38.6 40.8 21.2 25.0 35.4 29.6 23.1 22.0 26.7 20.2 60.6 26.3 31.2 33.5 49.2 19.5 22.2 24.3 24.0 44.9 36.4 33.8 29.3 25.0 35.6 30.9 3.5 5.9 0.4 10.0 8.3 11.2 7.4 9.4 9.1 8.4 5.5 9.8 6.2 0.7 9.6 5.5 8.4 7.5 6.8 8.3 8.6 9.4 9.5 9.3 8.7 10.2 9.7 7.7 10.6 8.0 9.8 8.9 4.6 6.4 6.0 3.9 8.8 2.7 6.1 8.6 5.2 9.1 6.6 4.4 9.7 2.8 7.2 7.3 22.9 7.9 5.8 2.9 3.9 9.6 324.5 4.2 8.2 6.1 5.4 3.8 2.0 13.4 23.7 6.3 12.8 4.7 14.5 9.5 2.2 7.1 8.7 11.8 2.1 4.9 2.0 2.6 3.5 1482.8 9.0 5.5 3.6 1.0 6.3 4.6 3.1 2.5 2.2 8.0 0.9 11.3 17.0 5.5 2.8 9.9 10.9 9.7 0.0 6.7 6.4 23.0 12.6 6.3 1.4 6.6 7.2 7.1 4.6 2.8 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA054837: AB_2682621" "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 7.5 5.1 7.2 6.2 7.9 16.8 9.7 9.4 8.3 7.5 7.0 8.3 4.7 8.5 9.1 6.5 7.4 5.4 13.4 7.1 7.3 6.5 4.2 7.0 10.5 7.4 7.5 6.7 8.7 6.7 7.1 5.0 6.5 7.7 8.0 6.7 8.7 6.2 7.4 13.8 7.2 6.6 7.1 7.2 8.0 6.6 9.7 7.3 19.1 10.5 10.4 10.1 8.0 6.9 8.6 12.5 11.5 16.4 14.8 9.0 11.5 14.7 14.1 10.7 16.2 12.0 11.8 13.2 20.9 11.5 10.6 18.3 29.7 18.5 10.8 17.1 13.9 12.6 9.6 17.2 9.5 9.1 25.6 14.9 7.1 12.0 13.8 10.5 13.1 14.0 34.1 19.3 17.5 12.7 19.0 59.8 15.5 30.0 22.3 16.8 37.1 22.8 24.9 13.1 10.1 14.4 24.8 19.8 14.4 10.7 15.3 17.9 13.7 13.2 25.0 15.8 21.8 16.8 8.2 24.8 25.0 14.7 20.6 25.1 17.0 5.8 12.0 6.6 6.0 8.6 13.6 8.4 7.8 3.6 12.2 9.3 7.0 20.9 8.2 7.4 11.2 9.6 3.3 7.2 7.9 9.4 8.3 7.1 7.3 7.4 7.5 6.7 7.7 7.2 7.3 8.6 26.8 25.6 21.6 12.7 35.4 9.8 21.9 26.9 7.4 27.2 11.8 15.5 40.1 25.8 18.3 18.4 60.5 23.8 33.2 14.8 19.6 28.5 22.9 26.2 21.4 29.5 12.1 68.0 12.4 21.2 22.8 17.5 15.3 16.8 22.8 28.8 27.5 8.3 18.7 30.3 10.6 15.4 20.3 22.0 12.1 6.8 23.6 17.4 1.8 14.0 30.1 20.3 41.2 9.5 19.2 25.3 18.6 25.9 14.3 22.8 16.5 19.3 29.2 55.0 26.3 21.9 24.1 47.4 61.8 7.5 8.5 25.2 28.2 16.8 19.7 24.5 GTF3C4 "KAT12, TFIIIC90" ENSG00000125484 "General transcription factor IIIC subunit 4" Q9UKN8 9 132670035-132694953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transcription "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069369 Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA069369: AB_2686130" "unprognostic (7.02e-2)" "unprognostic (9.01e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-2)" "unprognostic (1.58e-1)" "unprognostic (1.76e-1)" "unprognostic (4.77e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.99e-4)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" 4.9 4.4 4.3 4.6 5.1 6.9 8.5 9.5 4.4 7.3 3.3 5.4 4.0 6.7 5.5 6.7 6.6 5.3 5.9 4.5 5.2 6.1 5.4 5.8 5.0 3.5 5.2 4.0 10.3 6.2 9.5 3.3 6.4 4.5 6.2 5.5 5.6 7.4 5.8 5.9 9.9 3.6 6.2 3.8 4.6 5.8 8.4 4.9 8.2 9.6 8.1 6.6 5.1 3.9 4.4 15.2 21.7 25.8 22.5 12.3 14.4 20.0 15.1 18.4 19.6 14.4 25.4 10.9 22.7 9.8 18.6 18.1 33.8 39.8 23.6 21.1 15.4 19.1 19.0 28.9 10.8 12.8 28.6 12.4 11.4 17.6 20.4 26.1 11.6 16.8 15.1 32.7 11.4 14.0 24.6 17.8 13.3 33.1 22.2 21.4 17.6 31.1 20.6 14.3 12.5 36.3 24.6 25.9 25.8 15.9 15.8 35.4 12.1 17.8 32.9 18.7 15.1 21.6 4.9 12.3 25.1 13.5 17.8 20.7 0.0 0.3 0.2 0.5 0.3 0.4 0.5 0.4 0.6 0.2 0.4 0.5 0.5 0.3 0.5 0.2 0.5 0.4 0.2 4.3 5.1 9.5 4.4 4.5 5.2 3.5 5.2 4.0 4.5 3.8 4.9 4.4 9.9 19.2 11.5 2.3 7.8 30.7 6.9 6.9 21.6 15.5 19.1 14.7 14.6 1.5 6.7 3.7 14.6 7.5 9.0 6.6 7.9 8.3 6.5 21.5 26.2 11.6 13.1 8.2 3.2 6.3 7.5 13.0 8.6 17.7 1.3 17.1 10.0 8.6 6.3 20.2 3.1 8.1 10.2 7.6 9.3 3.7 19.0 6.3 3.6 1.9 7.1 11.9 7.2 1.0 2.1 5.8 7.0 19.2 10.7 11.6 3.8 6.6 16.2 16.9 0.0 18.8 10.9 16.7 13.8 22.1 40.1 6.4 8.8 18.2 9.0 6.4 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 4.0 3.8 3.4 5.3 3.9 4.2 6.3 8.8 3.1 4.7 3.6 3.9 3.2 4.5 5.1 5.7 5.2 3.6 3.3 2.7 3.7 4.9 5.5 4.6 6.7 4.7 4.1 2.7 10.0 5.8 5.5 4.3 3.5 5.6 5.4 4.7 3.3 8.3 4.3 6.1 8.4 4.2 4.3 2.9 4.8 4.1 6.0 3.6 5.5 13.9 4.2 7.3 5.3 5.0 4.7 12.4 22.2 10.8 14.4 12.4 11.1 20.4 12.9 12.2 19.2 14.5 24.9 24.1 29.9 11.2 11.7 20.8 33.5 32.8 14.6 15.4 18.4 12.3 16.4 19.5 13.1 14.9 29.7 12.8 9.9 19.5 19.7 27.5 7.5 12.7 22.1 30.6 11.4 16.1 26.3 20.6 15.9 26.2 35.4 22.2 21.4 19.3 34.6 17.5 11.4 18.8 13.5 23.4 20.2 18.0 12.2 42.8 8.4 11.1 32.5 15.0 18.7 19.8 5.5 18.8 23.5 12.0 18.2 25.2 0.0 1.1 1.2 3.1 1.6 2.4 2.1 2.9 2.4 2.5 2.7 3.6 2.7 0.2 2.0 1.1 1.6 2.0 1.7 3.4 3.9 8.8 3.1 2.7 3.7 4.7 4.1 2.7 5.6 2.9 3.6 4.7 3.3 6.4 6.0 16.6 7.2 5.6 4.5 3.0 9.1 4.3 5.9 8.1 4.4 0.0 10.2 7.3 4.2 5.7 4.7 3.6 1.9 6.2 4.1 3.9 6.6 3.6 24.6 1.7 9.7 5.4 6.8 4.4 4.1 4.6 1.3 6.1 2.9 4.1 5.2 1.7 13.9 5.8 6.1 2.9 1.8 3.0 18.0 2.9 1.8 5.6 4.5 1.7 8.2 26.7 17.1 5.9 1.2 13.2 5.7 5.8 0.7 7.1 5.7 3.7 0.0 4.1 3.4 14.0 13.7 8.8 6.3 3.0 5.0 5.7 6.1 3.5 BARHL1 ENSG00000125492 "BarH like homeobox 1" Q9BZE3 9 132582606-132590252 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 334 "brain: 34.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 102 "SCLC-21H: 16.9" "Group enriched" "Detected in some" 5 "cerebellum: 3.2;midbrain: 2.4;pons and medulla: 1.1" "Region enhanced" "Detected in many" "cerebellum: 5.8" HPA004809 Enhanced NA NA "HPA004809: AB_1078266" "unprognostic (2.29e-1)" "unprognostic (6.42e-2)" "unprognostic (8.07e-2)" "unprognostic (9.31e-2)" 0.0 0.0 0.5 0.0 2.4 0.0 0.0 19.5 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 23.6 8.3 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.4 19.5 6.2 0.0 3.5 23.6 8.3 0.0 34.3 0.1 3.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIR2DL1 "47.11, CD158A, cl-42, nkat1, p58.1" ENSG00000125498 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1" P43626 19 54769793-54784322 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 2.0" "Cell type enhanced" "Detected in some" "dendritic cells: 31.3;NK-cells: 13.4;T-cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.14e-1)" "unprognostic (9.82e-2)" "unprognostic (8.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.93e-1)" "unprognostic (1.55e-2)" "unprognostic (3.19e-4)" "unprognostic (4.11e-2)" "unprognostic (6.87e-2)" "unprognostic (1.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.61e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 PPP1R12C "AAVS1, DKFZP434D0412, LENG3, MBS85, p84, p85" ENSG00000125503 "Protein phosphatase 1 regulatory subunit 12C" Q9BZL4 19 55090914-55117637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043532 Approved NA NA 29000 "HPA043532: AB_10961273" "unprognostic (2.14e-1)" "unprognostic (1.27e-1)" "unprognostic (8.52e-3)" "unprognostic (7.92e-2)" "unprognostic (3.24e-2)" "unprognostic (2.78e-2)" "unprognostic (3.21e-3)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (1.20e-1)" "prognostic favorable (4.10e-5)" "unprognostic (9.60e-2)" "unprognostic (3.01e-3)" "unprognostic (8.36e-2)" "unprognostic (3.15e-1)" "unprognostic (3.01e-1)" "unprognostic (2.68e-3)" 101.7 67.8 78.4 50.0 71.0 56.3 97.0 63.4 103.6 158.7 77.9 232.2 61.7 202.4 26.2 81.3 144.5 26.4 226.1 78.5 69.2 96.2 86.5 107.9 45.1 84.9 74.5 73.1 105.4 87.0 36.8 109.1 37.1 79.0 139.1 19.6 15.5 60.9 58.2 43.7 74.4 137.1 58.9 59.1 140.0 133.3 152.0 81.9 29.1 86.5 22.5 23.3 175.1 102.3 72.4 52.9 66.7 36.2 43.8 39.8 24.1 84.0 58.8 41.9 35.3 38.9 24.1 37.6 77.9 25.0 33.8 36.0 49.7 12.6 23.2 12.0 63.6 120.7 52.0 67.5 40.2 82.0 38.1 90.1 37.8 29.0 35.1 22.4 29.2 39.7 39.8 40.3 87.1 32.6 32.7 45.4 55.3 26.2 34.8 67.6 62.0 29.9 31.4 32.4 89.2 47.0 37.4 42.1 35.7 37.9 17.9 22.9 76.6 82.9 86.0 41.5 43.1 62.3 43.0 37.7 42.8 78.4 77.5 54.2 0.0 1.5 2.6 1.1 1.2 0.8 1.3 1.0 0.9 0.9 2.5 0.8 1.1 1.6 0.6 2.4 1.5 0.7 0.7 78.4 71.0 63.4 103.6 78.5 69.2 84.9 74.5 73.1 79.0 59.1 81.9 72.4 28.2 22.4 15.5 19.9 9.6 11.5 5.1 4.6 1.8 31.3 11.4 12.2 50.3 8.6 8.6 11.0 22.9 6.2 20.4 31.9 1.9 8.4 19.4 9.2 25.4 23.2 5.3 6.5 15.1 15.1 10.3 18.6 33.1 15.1 6.3 96.2 23.6 17.4 15.7 37.0 16.7 18.7 8.2 24.4 16.5 9.1 17.1 20.2 17.8 12.2 14.2 19.1 11.3 10.6 16.2 13.3 20.1 25.6 13.0 7.6 17.1 7.9 7.8 21.7 39.5 15.6 45.5 19.7 13.4 8.9 8.2 10.1 13.2 28.5 13.2 8.7 MBOAT7 "BB1, hMBOA-7, LENG4, LPLAT" ENSG00000125505 "Membrane bound O-acyltransferase domain containing 7" Q96N66 19 54173412-54189882 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 109.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 9 "basophil: 157.3;eosinophil: 265.9;neutrophil: 239.1" "Lineage enriched" "Detected in all" 11 "granulocytes: 265.9" "Cell line enhanced" "Detected in many" "HMC-1: 216.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055967 Approved Approved Cytosol NA NA Cytosol "HPA055967: AB_2682990" "unprognostic (1.89e-2)" "unprognostic (2.60e-2)" "unprognostic (2.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.54e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (5.55e-6)" "prognostic unfavorable (5.13e-4)" "unprognostic (5.36e-2)" "unprognostic (2.31e-2)" "unprognostic (1.08e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (6.62e-5)" "unprognostic (1.31e-1)" "unprognostic (4.75e-2)" "unprognostic (3.95e-1)" "prognostic favorable (4.31e-4)" 13.5 109.3 14.1 13.6 14.9 13.2 13.8 0.3 21.6 19.0 2.1 22.8 27.3 19.2 6.6 20.8 20.3 9.3 11.9 16.8 21.9 19.1 16.2 23.8 4.9 25.7 12.9 17.6 23.2 21.2 19.0 23.0 6.9 20.2 17.5 5.4 1.0 18.8 20.4 7.9 21.0 25.5 4.5 7.1 26.8 20.1 36.6 18.9 3.3 16.0 1.1 2.3 32.8 18.2 19.7 66.8 43.2 3.8 50.8 21.0 15.4 57.1 90.5 42.6 32.9 49.2 22.1 64.3 11.3 46.5 34.4 10.9 111.9 0.3 26.1 9.0 16.1 54.6 12.8 30.0 12.6 18.9 29.0 216.2 31.0 17.9 17.3 9.8 44.1 46.0 11.0 51.6 42.2 9.2 32.2 10.9 22.7 22.0 21.1 60.1 28.4 7.3 24.9 47.0 71.1 2.3 14.3 57.3 37.0 16.3 4.2 34.5 2.8 73.1 49.4 16.0 12.1 40.8 17.4 31.0 6.4 66.1 25.8 27.9 157.3 22.5 265.9 2.2 11.8 3.3 1.8 3.2 1.7 24.8 1.5 1.1 1.7 239.1 7.8 7.0 7.0 1.9 8.6 14.1 14.9 0.3 21.6 16.8 21.9 25.7 12.9 17.6 20.2 7.1 18.9 19.7 11.8 12.8 26.4 11.4 11.3 13.9 66.4 29.2 14.8 15.4 31.1 19.8 8.4 31.5 23.2 44.1 6.2 43.5 15.2 88.8 5.9 52.2 1.1 28.7 22.1 18.5 42.5 13.9 18.7 33.1 52.2 16.3 10.7 26.4 76.8 25.3 15.0 22.7 32.2 30.3 13.6 49.6 16.2 36.8 38.1 4.3 19.3 52.5 8.8 8.4 48.9 24.6 3.1 5.5 9.3 28.6 43.0 15.4 9.3 44.5 101.1 14.5 28.5 8.5 39.5 7.7 19.6 5.1 15.0 17.9 21.6 51.6 23.0 46.3 46.6 47.2 SRMS "C20orf148, dJ697K14.1, PTK70, SRM" ENSG00000125508 "Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites" Q9H3Y6 20 63540810-63547504 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "stomach 1: 1.6" "Cell type enriched" "Detected in single" 4 "Gastric mucus-secreting cells: 3.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB044668, CAB044669, HPA073987" Uncertain Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments" "Actin filaments, Cytosol" "CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650" "unprognostic (2.26e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.62e-1)" "unprognostic (5.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.28e-1)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (7.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.73e-3)" "unprognostic (2.58e-3)" "unprognostic (4.75e-2)" "unprognostic (4.97e-2)" "unprognostic (2.54e-3)" 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.6 0.2 0.0 0.0 0.7 0.2 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.8 0.0 0.0 0.4 0.2 0.0 0.1 0.9 1.6 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 1.3 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 4.4 0.4 0.0 0.1 0.0 0.0 6.0 0.4 0.5 0.1 1.2 0.2 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPRL1 "KOR-3, NOCIR, NOPr, OOR, ORL1" ENSG00000125510 "Opioid related nociceptin receptor 1" P41146 20 64080082-64100643 "G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.6;testis: 6.8" "Cell type enhanced" "Detected in some" "Early spermatids: 13.4;Late spermatids: 30.8;monocytes: 6.5;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 3.9;eosinophil: 5.8;intermediate monocyte: 5.5;myeloid DC: 4.7;neutrophil: 4.9;non-classical monocyte: 12.4" "Group enriched" "Detected in many" 11 "dendritic cells: 4.7;granulocytes: 5.8;monocytes: 12.4" "Cell line enhanced" "Detected in some" "REH: 4.7;SCLC-21H: 9.4;U-937: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.03e-3)" "unprognostic (4.78e-2)" "unprognostic (4.35e-3)" "unprognostic (3.74e-1)" "unprognostic (4.13e-2)" "unprognostic (9.63e-2)" "unprognostic (2.13e-4)" "unprognostic (1.53e-1)" "unprognostic (1.67e-1)" "unprognostic (2.91e-1)" "unprognostic (2.66e-4)" "unprognostic (1.47e-1)" "unprognostic (1.12e-4)" "unprognostic (1.99e-2)" "unprognostic (4.17e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-3)" 1.0 1.4 1.3 1.2 1.5 1.5 1.0 0.0 2.0 1.0 0.0 0.5 0.3 0.5 0.3 0.4 0.7 0.5 0.7 1.6 3.7 0.6 0.3 1.4 1.0 0.7 1.8 1.7 0.3 1.6 0.2 1.7 0.9 0.7 1.0 0.1 0.2 1.5 0.3 0.2 0.4 1.4 0.3 0.5 4.6 0.6 6.8 2.7 0.5 0.6 0.0 0.8 0.6 0.6 1.8 0.0 0.6 0.8 3.5 2.5 0.8 0.5 0.2 0.3 0.1 0.3 0.2 0.8 1.3 0.4 0.6 2.7 0.0 0.1 0.0 0.0 0.9 0.0 1.2 0.0 0.2 0.1 3.5 0.6 0.8 0.2 0.0 0.1 0.2 1.3 1.7 0.3 1.2 0.0 0.0 0.3 2.1 0.3 0.4 1.4 4.7 0.0 0.2 0.0 0.0 9.4 2.7 0.0 0.0 0.0 1.4 0.3 3.4 0.3 0.3 0.2 0.0 0.0 0.1 0.7 2.3 0.4 8.7 0.4 0.0 3.9 5.8 0.2 5.5 0.3 0.6 0.3 0.1 4.7 0.7 0.2 0.0 4.9 0.0 12.4 0.4 0.4 2.2 1.3 1.5 0.0 2.0 1.6 3.7 0.7 1.8 1.7 0.7 0.5 2.7 1.8 1.1 0.0 1.1 2.6 2.8 0.8 0.1 0.0 0.6 1.4 0.7 0.8 1.3 0.0 1.3 0.0 0.0 0.0 0.6 0.1 0.0 0.2 13.4 0.3 0.7 0.9 0.0 0.0 6.2 0.0 0.1 0.6 0.0 0.2 1.3 2.7 1.4 0.0 2.8 3.3 1.9 0.0 0.0 5.5 0.2 30.8 0.0 5.0 0.0 2.8 6.5 0.3 3.1 1.0 0.6 0.2 0.0 0.0 0.6 0.2 0.0 0.2 0.3 0.2 6.6 0.5 0.4 1.4 1.1 0.0 0.1 0.0 0.8 0.3 0.1 0.0 SLC2A4RG "GEF, HDBP1, Si-1-2, Si-1-2-19" ENSG00000125520 "SLC2A4 regulator" Q9NR83 20 63739776-63744050 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 151.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 116.2;Proximal tubular cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063050 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA063050: AB_2684930" "unprognostic (2.89e-2)" "unprognostic (2.32e-1)" "unprognostic (1.84e-2)" "unprognostic (5.78e-2)" "unprognostic (2.07e-3)" "unprognostic (6.48e-3)" "unprognostic (2.70e-1)" "unprognostic (1.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-3)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-3)" "unprognostic (3.22e-1)" 54.5 38.2 7.4 3.1 7.4 10.3 45.4 6.2 12.9 40.4 6.7 44.5 1.6 39.6 4.2 48.0 35.3 3.4 50.4 7.2 7.4 67.1 151.9 31.1 5.0 8.0 7.0 6.3 46.2 28.7 5.7 23.2 2.9 6.8 50.6 1.5 2.3 27.5 10.6 88.9 59.2 25.8 3.3 7.3 35.8 33.7 24.4 6.9 6.4 32.4 18.9 3.0 50.6 40.9 7.3 20.5 26.4 12.2 11.0 7.6 14.9 11.9 16.6 16.4 43.8 15.2 49.0 34.0 4.3 23.1 12.1 18.9 24.1 6.1 20.0 7.6 13.5 11.0 4.3 19.4 25.8 16.2 10.5 8.9 17.4 29.0 11.8 9.5 8.7 12.8 3.9 15.8 4.7 21.3 37.0 5.9 29.8 5.3 21.9 59.6 29.4 21.8 10.5 17.3 7.8 10.8 19.0 35.4 16.0 4.5 4.6 37.9 33.7 11.0 43.4 22.7 25.2 13.1 12.8 27.0 7.3 18.1 12.4 11.8 0.0 0.0 0.2 0.9 0.0 0.4 0.1 0.9 0.5 0.1 0.0 0.7 0.7 0.0 0.3 0.1 0.2 1.1 0.1 7.4 7.4 6.2 12.9 7.2 7.4 8.0 7.0 6.3 6.8 7.3 6.9 7.3 35.9 9.6 21.2 21.5 16.0 24.5 25.0 19.3 19.4 10.1 44.7 61.5 21.3 37.1 11.2 42.3 10.4 30.7 60.1 18.3 78.2 8.2 9.2 16.3 57.1 22.2 2.4 55.4 5.5 10.3 16.6 49.7 12.8 32.4 3.8 52.6 19.6 116.2 14.7 10.1 4.5 17.5 14.2 13.5 12.7 4.3 28.9 14.6 3.6 5.6 11.7 33.5 13.4 8.0 7.1 20.3 7.8 34.6 16.9 14.9 10.5 160.8 6.1 6.5 32.9 26.1 32.9 1.1 6.4 29.3 37.8 8.6 46.3 77.0 15.0 18.3 NPBWR2 GPR8 ENSG00000125522 "Neuropeptides B and W receptor 2" P48146 20 64105820-64107171 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.44e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "testis: 108.9" "Cell type enhanced" "Detected in some" "Club cells: 1.3;Collecting duct cells: 1.8;Endometrial ciliated cells: 5.1;Respiratory ciliated cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "memory B-cell: 1.5;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 7 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;EFO-21: 2.6;HaCaT: 1.5;OE19: 1.8;SH-SY5Y: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome NA NA "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.4 0.1 0.6 0.3 0.2 0.5 0.6 0.1 0.3 0.8 0.3 0.3 0.1 0.4 2.4 0.2 1.3 0.3 0.2 0.1 1.0 0.6 0.1 0.9 0.6 0.4 0.4 0.0 0.4 0.1 0.0 1.0 0.1 0.3 0.6 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.0 0.4 1.0 0.4 108.9 0.4 0.3 0.5 0.0 0.4 0.7 0.6 0.2 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 5.2 0.3 2.6 0.0 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.6 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.1 1.8 0.4 0.0 0.0 0.0 0.9 0.0 0.2 3.3 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.2 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.1 0.3 0.1 1.0 0.4 0.4 0.0 0.3 0.4 0.4 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 6.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 BHLHE23 "bA305P22.3, Beta4, BHLHB4" ENSG00000125533 "Basic helix-loop-helix family member e23" Q8NDY6 20 63005927-63007035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "brain: 1.0" "Cell type enriched" "Detected in single" 32 "Cardiomyocytes: 3.3" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Region enriched" "Detected in single" 5 "medulla oblongata: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "MOLT-4: 13.9" "Not detected" "Not detected" HPA030575 Uncertain NA NA "HPA030575: AB_10601459" "unprognostic (1.74e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.9 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520765-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2997.4;Paneth cells: 2752.7;Proximal enterocytes: 2849.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "eosinophil: 26.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 26.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 206.2 72.8 157.6 71.7 158.8 80.2 239.5 154.0 264.3 273.2 84.5 278.7 82.1 219.6 44.2 627.2 187.2 41.2 364.3 129.1 161.6 422.4 136.0 245.5 42.5 179.6 164.6 105.6 199.2 199.6 47.5 198.3 30.6 196.3 368.1 61.2 25.8 436.0 94.3 441.9 448.2 168.5 53.9 178.6 118.0 301.3 130.3 172.3 32.4 251.9 64.7 47.7 266.3 414.1 236.7 287.2 87.8 57.9 118.5 65.4 107.9 185.4 169.1 54.1 217.5 85.2 162.8 166.3 60.7 222.8 115.2 83.2 294.3 29.5 196.0 35.5 110.5 58.5 24.8 83.0 31.9 175.3 0.2 124.3 106.5 384.9 55.3 76.4 72.7 86.5 74.9 104.5 138.9 81.1 394.9 288.7 2.7 63.3 228.1 494.5 132.0 132.2 125.7 159.8 117.4 197.1 150.9 170.3 272.6 124.4 39.1 390.7 168.8 147.3 184.1 206.9 245.8 143.5 108.9 93.3 41.1 130.7 70.9 122.6 2.3 3.0 26.0 5.7 3.6 4.7 5.0 5.1 5.4 3.4 5.8 4.3 5.2 1.2 3.0 5.7 4.0 5.7 5.7 157.6 158.8 154.0 264.3 129.1 161.6 179.6 164.6 105.6 196.3 178.6 172.3 236.7 328.1 314.1 220.3 15.7 462.8 574.5 714.7 1076.0 375.6 51.8 1282.8 1173.8 70.1 906.5 763.6 960.0 12.5 428.4 422.5 2528.3 2997.4 916.1 222.0 440.1 449.6 294.2 796.4 399.0 15.4 755.9 761.0 430.8 1120.8 520.2 337.8 293.3 376.3 224.2 600.6 50.5 12.5 1549.5 850.4 390.4 755.8 1154.3 371.9 366.4 1191.7 6.5 831.8 236.9 435.6 6.6 67.2 971.0 2752.7 288.5 280.4 1021.9 2849.8 1715.5 542.0 60.0 197.2 216.3 541.5 129.0 261.6 1559.8 932.1 414.1 541.7 158.5 1132.9 1492.7 IL1B "IL-1B, IL1-BETA, IL1F2" ENSG00000125538 "Interleukin 1 beta" P01584 2 112829751-112836816 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cytokine, Mitogen, Pyrogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 203.4;urinary bladder: 127.4" "Group enriched" "Detected in many" 11 "Langerhans cells: 1451.9;Macrophages: 1510.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 94.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 94.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 649.3;HBEC3-KT: 293.3;HMC-1: 235.1;hTEC/SVTERT24-B: 319.1;hTERT-RPE1: 277.0;U-87 MG: 571.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 2330 "unprognostic (1.55e-3)" "prognostic unfavorable (1.31e-4)" "unprognostic (2.75e-2)" "unprognostic (5.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.12e-2)" "unprognostic (2.63e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-1)" "unprognostic (3.63e-3)" "unprognostic (3.72e-2)" "unprognostic (5.57e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (1.29e-2)" "unprognostic (4.42e-2)" "unprognostic (5.09e-2)" "unprognostic (4.01e-2)" 44.3 7.7 3.2 54.1 2.8 203.4 2.1 3.5 4.9 3.7 4.5 8.2 3.1 7.4 2.0 3.4 4.2 19.1 2.1 2.8 15.1 4.3 9.1 17.5 9.6 5.6 3.2 2.7 0.9 4.5 3.1 2.6 7.9 5.2 6.2 6.6 0.4 3.9 1.8 0.1 0.6 3.5 9.3 4.7 17.9 25.7 1.1 4.0 9.5 2.6 7.1 12.9 127.4 1.0 7.6 6.3 0.1 0.2 0.0 0.4 0.0 0.0 2.1 649.3 3.1 6.5 0.0 0.0 0.0 18.0 0.5 11.3 14.7 0.0 293.3 39.2 0.0 0.0 29.5 0.4 0.0 2.2 0.0 235.1 1.1 8.9 319.1 103.5 277.0 0.0 0.1 0.0 0.8 0.6 0.0 0.0 2.9 0.1 1.2 26.2 1.0 0.0 0.0 0.0 48.2 0.0 0.0 1.7 0.0 2.5 0.0 0.0 2.8 0.0 15.3 0.2 0.7 0.5 0.1 0.0 0.2 571.5 14.0 22.7 1.7 12.3 4.4 0.0 19.5 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 94.1 0.2 7.7 0.0 0.0 3.4 3.2 2.8 3.5 4.9 2.8 15.1 5.6 3.2 2.7 5.2 4.7 4.0 7.6 23.8 9.6 28.2 0.0 14.1 30.8 5.4 25.4 0.0 0.2 8.2 13.3 4.8 0.0 16.2 1.8 0.0 1.5 7.5 2.8 0.0 33.2 0.3 4.9 5.0 20.0 0.0 58.9 0.0 0.6 2.6 8.1 44.4 8.4 41.7 0.0 1.4 0.4 108.1 0.0 0.0 12.7 14.2 130.5 1451.9 0.7 0.0 1510.7 23.2 1.9 7.9 0.3 0.0 0.0 0.0 2.9 10.0 0.0 9.3 4.7 0.2 0.7 8.6 0.3 0.0 1.5 4.3 0.0 0.4 8.3 20.3 4.4 6.3 0.0 1.9 6.1 PLGLB2 PLGP1 ENSG00000125551 "Plasminogen like B2" Q02325 2 87748087-87759476 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 163 "liver: 458.2" "Cell type enriched" "Detected in some" 17 "Hepatocytes: 76.3" "Cancer enriched" "Detected in single" 25 "liver cancer: 1.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Secreted to blood" NA NA "unprognostic (1.10e-2)" "unprognostic (8.78e-2)" "unprognostic (3.42e-2)" "unprognostic (7.03e-4)" "unprognostic (1.68e-2)" "unprognostic (3.77e-1)" "unprognostic (1.82e-2)" "unprognostic (5.74e-2)" "unprognostic (2.94e-1)" "unprognostic (5.04e-4)" "unprognostic (6.39e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-2)" "unprognostic (7.11e-2)" 0.3 0.8 1.0 0.5 0.7 0.5 0.3 1.8 0.9 0.6 0.1 0.3 0.2 0.6 0.6 0.6 0.7 0.2 0.6 0.8 0.2 0.8 458.2 0.3 0.9 0.5 0.2 0.8 0.5 1.3 0.4 0.9 0.4 1.4 0.7 0.3 2.8 0.4 0.4 0.6 1.0 0.5 0.2 0.1 0.9 0.5 1.0 0.2 0.8 0.5 0.5 0.7 0.3 0.2 1.0 0.0 0.1 1.2 0.3 0.4 0.5 0.4 0.6 0.4 0.1 0.2 0.1 0.3 0.7 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.5 1.2 0.0 0.1 0.5 0.2 0.5 0.3 0.1 0.2 1.0 0.4 0.7 0.0 0.1 0.4 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.4 0.0 0.0 0.7 0.2 0.2 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.4 0.3 0.5 1.2 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.0 1.0 0.7 1.8 0.9 0.8 0.2 0.5 0.2 0.8 1.4 0.1 0.2 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 76.3 0.1 0.0 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 137.9" "Cell type enriched" "Detected in some" 26 "Ionocytes: 73.2" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA 76700 "Nucleoplasm, Vesicles" "HPA054371: AB_2682465, HPA057950: AB_2683561" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.1 0.0 0.0 0.2 0.0 0.2 16.9 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.4 137.9 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.1 0.2 2.7 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.1 0.1 0.4 0.8 0.1 0.0 1.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.2 0.2 5.9 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 73.2 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.8 0.0 0.1 0.0 0.0 0.0 CHCHD5 "C2orf9, MGC11104, MIC14, MIX14" ENSG00000125611 "Coiled-coil-helix-coiled-coil-helix domain containing 5" Q9BSY4 2 112584240-112589275 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038263 Approved Approved Mitochondria NA NA Mitochondria "HPA038263: AB_10671525" "unprognostic (3.56e-2)" "unprognostic (3.41e-2)" "unprognostic (3.36e-2)" "unprognostic (4.57e-2)" "unprognostic (1.85e-1)" "unprognostic (7.75e-2)" "unprognostic (2.72e-1)" "unprognostic (7.18e-3)" "unprognostic (8.04e-2)" "unprognostic (4.96e-2)" "unprognostic (2.07e-1)" "unprognostic (4.95e-2)" "unprognostic (1.39e-2)" "unprognostic (3.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" 19.2 29.1 17.3 12.5 17.7 18.5 22.6 19.0 28.9 18.5 15.7 19.2 18.1 18.0 6.4 28.4 19.8 14.5 24.6 16.1 19.9 35.7 40.5 17.9 14.7 18.3 17.4 14.8 15.9 46.5 28.3 31.9 9.9 17.5 22.4 6.3 5.7 16.6 12.7 39.3 22.7 17.3 6.6 17.4 18.7 25.7 23.0 18.2 16.9 27.3 18.8 8.0 19.8 19.0 18.2 32.5 53.1 23.3 0.1 9.3 19.7 22.0 14.0 18.2 28.3 20.0 58.1 39.0 24.7 54.4 19.4 23.9 23.4 8.9 31.2 3.8 26.8 43.2 33.4 15.6 46.4 40.8 28.5 22.5 26.5 26.3 37.4 22.8 13.2 15.8 0.1 35.1 36.5 18.1 80.3 25.8 45.1 26.0 24.1 25.9 0.9 19.3 48.7 37.8 29.1 29.7 33.4 17.7 26.3 31.6 6.2 33.9 24.9 22.0 28.2 39.7 17.2 20.4 65.0 66.3 29.1 39.1 7.7 33.9 22.1 69.0 68.6 49.9 66.6 42.1 49.3 46.8 47.5 64.1 63.2 48.1 49.9 38.3 62.3 62.6 81.3 78.6 61.9 17.3 17.7 19.0 28.9 16.1 19.9 18.3 17.4 14.8 17.5 17.4 18.2 18.2 39.3 9.6 13.9 2.0 41.1 43.1 65.1 153.3 51.8 19.2 100.0 109.6 40.4 90.1 73.8 82.8 10.4 131.9 41.2 138.5 219.2 109.7 188.8 138.1 63.5 44.3 91.7 44.6 2.2 176.7 109.5 43.8 67.8 79.6 24.7 50.8 51.4 211.4 123.9 6.7 2.8 107.3 97.6 122.0 63.5 290.9 30.7 63.7 53.4 1.0 101.0 61.5 87.6 1.5 4.4 123.2 140.1 28.2 41.0 76.8 184.7 286.7 99.3 28.3 13.1 33.9 47.8 141.8 39.4 112.2 58.1 92.8 44.6 89.2 97.7 85.7 PAX8 ENSG00000125618 "Paired box 8" Q06710 2 113215997-113278921 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "kidney: 197.3;thyroid gland: 570.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1" "Group enriched" "Detected in many" 12 "endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 7 "EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2" "Region enriched" "Detected in some" 4 "pons and medulla: 5.5" "HPA030062, CAB055097, CAB061888, HPA064554" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283" "unprognostic (2.63e-3)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.24e-2)" "unprognostic (5.16e-5)" "unprognostic (1.56e-2)" "unprognostic (3.29e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (4.13e-2)" "unprognostic (4.00e-2)" "unprognostic (3.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.37e-1)" "unprognostic (8.93e-3)" "unprognostic (1.02e-1)" 2.0 6.1 1.9 0.6 1.4 0.5 1.7 0.1 1.2 14.7 1.6 1.8 0.6 8.9 33.2 2.2 37.8 3.6 2.1 1.1 1.9 197.3 1.2 1.6 1.7 4.5 1.4 0.4 1.7 1.0 1.4 1.4 1.9 2.9 1.1 0.9 1.5 1.9 26.4 0.5 1.8 2.4 0.8 3.2 0.8 1.4 2.5 2.0 0.5 570.1 0.3 1.1 2.1 1.0 2.2 9.4 0.8 0.4 0.0 0.4 0.2 3.0 2.6 8.0 0.7 1.2 5.7 1.6 1.7 79.7 0.6 50.0 0.1 1.6 2.6 0.7 3.9 0.0 1.5 0.7 3.4 0.9 0.0 0.0 2.3 0.3 0.6 1.9 9.9 0.1 0.0 1.3 6.2 2.5 1.8 1.0 3.8 0.5 2.2 5.5 0.0 0.6 2.1 193.2 14.4 1.5 0.0 10.4 0.1 5.6 0.0 0.0 3.5 2.7 13.8 0.5 2.6 7.2 1.2 4.6 0.6 11.9 2.0 0.0 0.7 1.0 0.0 0.1 0.6 0.4 1.3 0.4 0.3 0.9 0.5 0.7 0.4 0.2 0.6 0.4 0.3 0.2 0.4 1.9 1.4 0.1 1.2 1.1 1.9 4.5 1.4 0.4 2.9 3.2 2.0 2.2 1.3 3.2 2.0 0.7 4.1 0.6 1.9 1.8 7.4 0.6 2.0 1.4 0.9 5.7 3.4 246.5 0.0 2.4 1.6 9.5 46.9 8.5 1.6 114.0 21.8 1.4 4.8 3.0 0.8 2.9 2.4 1.6 4.1 228.2 0.0 1.0 1.1 0.3 5.2 0.0 0.8 3.2 2.0 2.6 2.1 3.9 5.0 5.6 0.0 0.0 2.0 4.0 1.0 0.5 0.2 29.2 7.4 0.4 0.5 1.6 6.3 128.1 0.6 0.9 6.6 3.6 1.7 6.2 7.3 12.5 0.9 0.8 3.1 0.4 3.7 2.2 INSIG2 ENSG00000125629 "Insulin induced gene 2" Q9Y5U4 2 118088452-118110997 "Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033861 Uncertain NA NA "CAB033861: AB_2249149" "unprognostic (3.84e-3)" "unprognostic (4.54e-3)" "unprognostic (1.84e-1)" "unprognostic (7.00e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-1)" "unprognostic (7.30e-2)" "unprognostic (7.41e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (2.19e-6)" "unprognostic (2.40e-1)" "prognostic unfavorable (4.11e-6)" "unprognostic (1.40e-1)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "unprognostic (3.75e-2)" 9.1 6.3 5.0 5.7 5.6 3.9 8.6 7.4 6.5 8.2 6.9 8.3 9.6 9.5 9.0 6.6 7.1 8.2 7.7 7.0 5.5 12.4 28.2 10.4 7.4 5.6 5.9 5.0 10.4 11.8 12.5 7.0 9.0 5.9 8.0 7.4 8.9 8.6 6.3 7.9 10.2 9.7 8.9 5.3 11.4 12.7 6.3 7.4 9.7 10.7 6.8 9.2 7.4 8.2 6.1 33.0 7.7 9.2 4.8 26.1 13.2 11.7 9.0 10.2 7.5 13.7 6.7 32.8 6.3 31.6 12.8 14.6 13.5 8.0 17.9 14.6 13.2 11.1 6.6 8.8 38.2 6.0 8.8 9.9 17.5 14.2 8.3 14.6 22.7 18.3 9.7 3.8 11.3 11.4 4.2 9.4 6.0 4.4 10.5 10.0 6.3 7.6 7.2 12.1 12.0 7.5 8.8 5.5 9.0 5.2 10.2 4.4 6.0 21.1 10.9 7.9 8.5 4.5 16.3 12.3 6.5 17.4 6.4 6.6 6.6 6.8 12.3 7.2 10.4 8.2 7.7 7.2 6.8 7.4 6.4 8.0 9.1 7.0 9.3 11.6 7.1 7.1 6.0 5.0 5.6 7.4 6.5 7.0 5.5 5.6 5.9 5.0 5.9 5.3 7.4 6.1 9.6 35.3 28.9 17.3 30.9 40.9 13.4 98.8 13.6 14.9 26.1 10.7 19.5 62.9 36.9 44.1 12.5 20.0 26.7 13.5 19.6 89.7 4.1 11.8 10.2 18.1 20.9 12.6 27.7 62.1 37.7 18.6 15.8 18.5 21.0 10.9 42.8 48.7 29.7 25.2 25.1 13.1 34.6 23.6 46.3 4.3 12.8 19.0 32.0 20.6 23.4 22.8 16.5 27.2 20.5 92.5 14.4 14.3 50.8 25.3 34.4 29.6 23.9 12.4 0.0 21.3 30.1 38.1 16.1 11.6 40.1 19.8 21.5 8.4 13.2 32.1 POLR1B "FLJ10816, FLJ21921, RPA135, RPA2, Rpo1-2" ENSG00000125630 "RNA polymerase I subunit B" Q9H9Y6 2 112541915-112579818 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 181.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037528 Supported "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA037528: AB_10671627" "unprognostic (1.66e-1)" "unprognostic (3.17e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (2.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "unprognostic (2.05e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (6.12e-2)" "unprognostic (1.29e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" 5.7 4.6 2.9 5.6 3.2 4.1 8.3 3.5 3.2 5.3 3.6 5.5 4.5 4.7 4.4 8.1 6.8 3.7 4.2 2.9 3.3 8.2 10.8 4.2 9.4 2.8 2.8 3.0 6.4 8.2 12.0 4.5 5.6 2.9 5.0 6.2 5.2 3.9 4.8 7.5 5.2 3.8 5.3 2.8 6.8 4.4 8.5 3.1 7.2 10.8 6.5 10.9 8.0 3.7 3.6 21.1 21.6 11.2 28.2 13.9 13.2 24.0 15.1 11.9 24.0 21.5 48.8 12.5 46.1 22.9 9.8 18.8 29.5 56.1 30.6 28.4 22.3 30.9 26.5 21.4 37.1 14.2 43.6 18.1 12.7 21.6 25.4 39.6 9.8 19.9 10.2 55.0 16.8 13.2 17.5 20.5 29.7 66.3 29.5 42.8 30.9 21.3 54.1 17.2 19.2 34.3 29.1 12.1 34.7 19.7 13.8 16.3 15.6 15.9 14.6 23.2 13.7 21.8 24.3 44.4 40.9 11.0 28.8 13.1 0.4 8.0 3.3 10.0 8.3 21.5 11.4 9.9 10.7 14.2 11.6 12.4 12.5 0.8 15.3 6.5 3.5 15.2 9.6 2.9 3.2 3.5 3.2 2.9 3.3 2.8 2.8 3.0 2.9 2.8 3.1 3.6 4.8 16.0 5.9 4.6 8.5 15.0 4.7 4.1 9.6 3.6 4.2 3.7 6.4 7.2 5.8 9.2 2.1 3.4 6.5 2.0 5.9 3.9 181.9 3.5 7.6 5.8 3.6 5.9 8.8 4.6 2.8 3.5 8.6 4.2 5.1 6.5 1.4 9.4 3.8 1.7 9.2 3.8 0.0 4.3 3.7 40.9 3.1 3.8 1.8 3.7 4.5 4.3 8.2 7.5 8.1 3.8 5.8 3.0 6.4 6.2 1.2 5.1 3.2 2.9 0.0 5.1 3.5 10.3 7.9 12.7 17.2 0.5 6.2 6.8 5.5 3.9 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA054183: AB_2682408" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.40e-2)" 9.2 14.6 9.5 10.5 8.8 21.9 9.7 9.8 12.2 8.6 14.3 10.7 12.1 8.3 9.9 7.5 9.3 7.2 18.1 8.6 9.5 9.9 7.9 11.9 10.4 9.6 9.2 8.4 13.4 13.1 16.0 16.2 8.2 10.4 7.7 10.7 26.2 9.1 8.5 13.0 11.1 12.9 8.2 8.6 12.2 9.2 12.1 11.1 10.2 12.0 10.4 10.2 8.6 8.2 10.1 18.7 8.1 22.0 19.4 31.2 21.3 18.5 21.8 14.2 14.0 14.3 17.7 11.7 15.9 14.5 17.1 24.9 15.8 12.8 11.2 18.1 20.8 13.0 20.1 15.5 23.9 13.7 22.1 22.0 14.6 11.5 21.9 25.9 19.4 15.0 18.9 11.1 11.0 15.8 8.1 14.0 23.8 9.9 13.4 13.0 17.6 17.2 10.7 11.5 19.6 17.4 10.3 14.2 10.6 15.1 19.6 8.9 13.5 21.2 23.9 20.0 20.4 15.3 14.3 16.0 24.7 13.8 16.1 14.2 2.9 1.6 1.8 2.1 2.1 2.0 1.6 1.5 1.8 1.2 1.4 2.0 1.7 1.7 1.7 1.3 0.5 0.7 1.0 9.5 8.8 9.8 12.2 8.6 9.5 9.6 9.2 8.4 10.4 8.6 11.1 10.1 17.4 19.2 28.2 61.0 28.6 17.6 14.6 11.2 9.6 32.0 12.4 10.0 43.0 7.2 17.5 1.8 47.9 12.6 31.9 21.5 9.8 24.0 4.5 14.9 15.2 16.5 16.7 9.9 57.1 16.7 8.5 14.7 11.7 17.0 15.2 25.1 12.8 6.0 15.2 20.2 60.6 11.4 10.2 16.3 15.9 10.6 13.7 19.9 3.6 32.8 19.9 13.8 20.6 53.3 37.9 32.0 11.9 14.3 19.4 13.9 17.1 9.4 16.3 36.0 6.6 21.4 15.0 46.0 31.1 10.1 16.1 12.9 24.3 12.8 14.0 15.0 PSD4 "EFA6B, TIC" ENSG00000125637 "Pleckstrin and Sec7 domain containing 4" Q8NDX1 2 113157325-113209396 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 51.2;Proximal enterocytes: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.8;NB-4: 9.3" "Low region specificity" "Detected in single" "HPA034722, HPA077847" Enhanced NA NA "HPA034722: AB_10669730, HPA077847: " "unprognostic (1.87e-3)" "unprognostic (1.32e-2)" "unprognostic (2.46e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-2)" "unprognostic (1.13e-3)" "prognostic favorable (9.91e-5)" "unprognostic (6.56e-2)" "unprognostic (4.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.00e-4)" "unprognostic (8.12e-2)" "unprognostic (2.41e-1)" "unprognostic (3.60e-3)" 1.3 13.8 1.3 3.1 1.2 3.7 3.9 0.4 1.2 1.8 0.9 4.2 2.1 0.7 4.0 10.9 1.8 1.3 0.8 1.0 1.6 4.4 21.3 5.9 4.0 0.9 0.7 1.0 0.5 11.7 3.0 3.4 0.9 1.0 8.8 2.0 0.5 11.4 1.2 0.7 9.0 17.8 0.4 1.0 23.5 12.5 1.5 1.2 6.0 10.2 0.3 4.0 3.7 4.2 1.2 5.7 1.0 0.3 0.1 0.0 0.0 6.1 0.4 2.2 0.4 0.5 1.5 8.1 9.8 1.2 0.2 1.7 7.4 0.0 2.0 0.1 8.3 0.1 4.1 0.8 2.2 0.1 6.9 6.9 0.1 1.9 0.2 0.5 0.9 0.0 3.8 3.9 4.1 0.0 3.2 7.1 9.3 0.1 1.8 1.1 0.1 0.1 4.3 0.4 1.4 0.5 0.0 0.7 5.1 0.0 0.2 1.6 5.6 0.1 0.3 0.2 0.2 1.6 5.0 4.0 3.0 0.9 3.3 0.1 1.7 0.9 1.7 2.0 0.6 1.7 1.0 1.5 1.8 0.6 1.2 1.7 1.9 3.9 2.4 0.7 1.5 1.1 1.4 1.3 1.2 0.4 1.2 1.0 1.6 0.9 0.7 1.0 1.0 1.0 1.2 1.2 0.9 19.2 12.0 7.5 28.6 12.7 10.4 7.6 13.1 0.3 22.5 11.2 1.8 11.5 5.8 33.1 0.0 20.7 41.6 39.1 0.0 21.3 0.3 9.0 1.6 2.1 7.2 13.0 0.9 23.6 11.2 3.0 31.1 20.4 3.8 2.9 2.9 51.2 12.1 3.3 1.7 10.7 4.1 13.8 17.0 0.9 0.9 14.3 1.8 2.8 13.8 10.1 47.4 2.5 0.2 23.1 17.8 0.0 18.3 15.8 50.3 7.1 4.6 0.4 0.0 3.0 1.7 0.2 1.1 17.4 15.8 7.5 28.2 1.7 18.6 11.1 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 206.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 164.2;Proximal enterocytes: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria NA NA Mitochondria "HPA009675: AB_2668252, HPA050883: AB_2681260" "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favorable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 29.1 38.4 143.6 12.1 206.0 0.8 18.2 80.1 198.3 29.9 71.1 78.6 39.6 42.2 24.2 65.3 36.9 21.6 79.7 206.1 103.3 44.8 38.8 24.2 9.3 118.5 100.6 127.9 33.9 24.4 59.3 22.4 4.7 138.4 35.3 49.5 41.6 69.5 40.4 91.7 33.0 40.9 66.1 81.2 12.0 41.7 9.6 104.9 7.3 61.2 78.9 31.5 56.3 31.4 114.8 58.2 22.9 32.2 101.9 42.3 18.6 14.9 17.0 26.4 31.0 37.2 58.2 37.1 32.2 40.0 41.3 34.1 48.0 66.3 39.0 24.3 0.1 58.6 23.2 46.7 46.2 39.2 1.6 52.5 53.3 33.4 27.6 12.0 62.9 32.8 34.7 68.8 39.4 6.2 41.6 20.7 32.8 23.6 61.0 71.1 10.0 8.8 49.4 83.3 10.2 2.4 31.9 11.7 70.8 30.0 34.8 37.1 50.1 11.7 9.8 41.8 2.6 11.2 7.3 10.7 28.3 4.5 54.2 15.6 0.5 0.0 0.0 2.0 0.0 0.4 1.0 1.1 0.9 0.2 0.4 1.5 1.4 0.0 0.3 0.0 0.4 1.3 0.4 143.6 206.0 80.1 198.3 206.1 103.3 118.5 100.6 127.9 138.4 81.2 104.9 114.8 6.2 9.6 20.9 11.8 7.0 10.5 8.8 11.5 12.0 13.1 18.9 15.6 39.5 47.1 10.0 46.0 8.4 1.4 4.5 164.2 19.6 54.7 15.9 8.2 6.4 8.0 13.8 1.3 24.7 28.5 1.8 10.2 12.8 17.5 7.0 17.9 16.1 38.0 2.7 8.4 17.9 34.5 10.2 3.0 2.6 71.2 19.0 1.4 17.8 12.2 1.0 28.7 4.1 17.1 12.6 55.5 57.9 29.3 17.6 13.6 106.8 28.7 6.4 22.0 13.1 12.1 12.7 0.5 4.6 34.1 23.3 0.8 5.2 39.5 34.2 30.3 PSPN PSP ENSG00000125650 Persephin O60542 19 6375148-6379058 "Predicted secreted proteins" "Growth factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 4.5" "Cell type enhanced" "Detected in many" "Early spermatids: 8.0;Late spermatids: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" CAB025366 Uncertain "Secreted in other tissues" NA NA "CAB025366: " "unprognostic (3.21e-1)" "unprognostic (3.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (3.67e-1)" "unprognostic (2.05e-2)" "unprognostic (5.80e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (6.27e-2)" "unprognostic (1.54e-6)" "unprognostic (5.39e-3)" "unprognostic (1.01e-3)" "unprognostic (4.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" 0.5 0.8 2.4 0.5 2.5 0.6 0.5 4.5 2.7 1.0 1.8 1.0 0.5 0.9 1.1 1.0 1.1 0.5 0.7 2.5 2.2 1.7 1.5 0.8 0.5 2.1 2.2 2.3 1.2 1.1 0.8 1.5 0.5 2.9 1.3 0.5 1.1 0.7 0.5 0.6 0.7 1.1 0.5 2.0 1.2 1.2 1.2 2.5 0.7 1.5 0.4 0.6 0.8 0.8 2.3 0.7 1.6 0.9 2.3 2.1 1.4 0.5 0.8 0.8 0.9 0.9 1.6 0.5 0.8 1.2 1.0 0.8 1.0 1.5 0.6 1.0 1.2 1.2 0.8 0.9 1.2 1.5 0.7 1.2 1.6 1.8 0.7 1.1 2.4 0.6 1.3 1.0 1.0 1.0 1.2 1.6 1.4 0.9 1.6 1.8 1.3 1.1 0.5 1.5 0.9 1.2 1.9 1.3 1.2 1.1 1.1 1.4 0.8 0.7 1.1 1.0 2.0 0.5 1.8 3.1 0.4 2.0 1.4 1.1 1.3 0.5 0.4 0.4 0.4 0.6 0.4 0.3 0.6 0.2 0.5 0.5 0.5 0.8 0.4 0.7 0.6 0.4 0.4 2.4 2.5 4.5 2.7 2.5 2.2 2.1 2.2 2.3 2.9 2.0 2.5 2.3 0.8 0.0 1.7 0.0 0.3 0.6 1.0 1.4 0.0 2.5 2.3 1.5 1.8 0.0 0.5 1.8 0.0 1.1 1.0 4.5 0.0 1.2 8.0 2.4 1.7 1.4 3.0 0.8 0.1 0.2 0.7 1.3 0.0 1.9 1.3 2.2 2.2 2.6 2.2 1.7 0.1 2.0 0.0 1.3 0.6 28.7 0.9 0.7 1.8 1.0 1.5 1.8 1.0 0.0 0.0 0.9 4.2 2.2 1.9 1.5 6.2 3.3 2.2 2.2 0.0 1.2 1.3 1.3 0.9 0.9 1.0 1.4 0.7 1.3 2.9 1.1 GTF2F1 "BTF4, RAP74, TF2F1, TFIIF" ENSG00000125651 "General transcription factor IIF subunit 1" P35269 19 6379572-6393981 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 228.3;Late spermatids: 391.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022793, HPA028707, HPA070752" Supported Enhanced "Nucleoplasm,Vesicles,Cell Junctions" NA NA Nucleoplasm "Vesicles, Cell Junctions" "HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163" "unprognostic (1.30e-2)" "unprognostic (6.05e-3)" "unprognostic (2.00e-1)" "prognostic favorable (8.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.46e-2)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.99e-2)" "unprognostic (6.45e-3)" "unprognostic (6.96e-2)" "prognostic favorable (9.80e-4)" "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.92e-2)" "unprognostic (4.25e-1)" 34.6 38.4 36.5 34.3 37.9 71.6 34.5 43.1 42.7 47.8 29.6 40.9 40.9 48.9 26.1 46.3 45.2 36.4 31.9 38.0 34.5 37.8 30.3 31.7 43.9 34.3 34.2 35.6 74.2 58.0 43.0 50.2 27.1 37.6 39.9 23.5 25.1 44.2 32.0 37.1 36.8 39.6 25.3 29.3 36.7 44.3 68.8 35.2 37.5 50.0 22.8 30.1 37.6 41.3 37.9 115.6 97.1 62.0 100.9 46.5 73.1 47.3 81.7 84.7 112.0 106.0 104.4 48.5 76.3 111.9 67.2 73.5 109.9 69.3 65.6 57.1 106.6 90.1 97.2 60.7 86.9 78.6 107.1 79.5 82.8 78.2 85.5 64.1 86.4 69.0 72.9 115.9 91.7 63.9 96.2 115.4 79.7 108.2 59.7 124.3 101.5 68.0 94.6 67.5 74.2 76.1 99.8 83.0 64.5 95.6 36.4 84.0 94.0 79.8 78.5 62.6 134.0 110.1 153.9 197.2 79.7 98.1 124.9 91.0 10.2 29.7 20.8 26.1 28.4 29.7 32.9 23.5 24.9 23.3 31.6 27.0 24.6 40.1 27.6 30.2 30.3 25.4 19.8 36.5 37.9 43.1 42.7 38.0 34.5 34.3 34.2 35.6 37.6 29.3 35.2 37.9 29.2 48.1 56.6 5.2 51.9 24.3 50.2 40.5 53.5 27.6 43.1 34.7 28.9 32.9 58.4 25.8 8.4 46.1 51.6 88.2 21.5 48.5 228.3 70.5 70.7 41.0 30.5 51.7 6.9 50.8 43.0 43.3 51.0 57.4 63.8 32.7 58.9 26.0 60.2 25.2 7.0 53.4 24.4 54.8 25.9 391.6 44.4 42.1 33.8 5.6 66.0 35.6 49.4 3.5 4.9 47.4 66.0 49.7 55.4 29.9 65.3 48.8 83.6 33.5 32.9 44.8 52.9 71.8 38.3 44.9 21.0 54.0 48.3 41.8 54.4 40.6 ALKBH7 "MGC10974, SPATA11" ENSG00000125652 "AlkB homolog 7" Q9BT30 19 6372794-6375250 "Predicted intracellular proteins" Necrosis "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 521.9" "Group enriched" "Detected in all" 4 "Early spermatids: 3004.6;Late spermatids: 8717.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008539, HPA039571, HPA039872" Approved Supported Mitochondria NA NA Mitochondria "HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710" "unprognostic (5.38e-2)" "unprognostic (3.58e-2)" "unprognostic (2.20e-1)" "unprognostic (1.15e-2)" "unprognostic (7.79e-2)" "unprognostic (3.56e-3)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (3.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.72e-3)" "unprognostic (1.54e-1)" "prognostic favorable (7.83e-6)" "unprognostic (7.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" 49.1 65.1 49.8 19.4 51.7 31.4 51.8 55.8 74.8 55.1 56.8 69.8 66.4 48.8 14.7 66.6 55.9 19.4 129.7 47.0 52.4 85.9 154.1 40.7 27.1 54.5 50.6 45.8 69.4 113.2 45.3 68.1 14.4 52.2 70.7 20.2 15.9 65.7 30.8 155.9 60.8 62.0 12.9 56.3 46.9 69.0 521.9 50.9 28.3 73.6 68.0 16.0 52.5 52.0 60.1 28.9 25.2 21.4 37.1 11.8 32.7 30.9 20.5 18.0 18.1 19.1 44.0 18.3 42.1 68.4 26.2 12.8 22.1 9.6 17.1 3.5 40.9 38.9 24.5 17.6 41.4 34.5 12.4 31.3 37.6 33.8 15.7 12.3 17.5 22.5 40.7 26.2 80.0 13.9 58.3 63.5 42.6 30.8 33.9 106.1 46.6 13.4 84.2 20.4 22.1 30.3 46.3 13.8 36.1 76.4 10.1 41.0 44.7 20.3 18.0 25.0 66.9 20.1 129.2 98.1 27.7 33.9 41.9 15.9 38.3 106.4 17.3 52.7 91.6 72.9 113.4 91.4 72.5 127.6 103.0 137.4 111.1 64.4 66.1 72.0 143.9 85.7 91.5 49.8 51.7 55.8 74.8 47.0 52.4 54.5 50.6 45.8 52.2 56.3 50.9 60.1 84.8 60.9 74.4 3.3 109.0 83.7 154.4 129.1 160.5 93.1 221.6 335.4 106.3 112.9 83.9 66.2 66.7 97.6 79.3 516.1 313.1 110.1 3004.6 76.1 73.0 84.8 220.4 54.0 2.4 245.2 149.6 88.0 77.5 85.1 66.0 108.3 113.2 302.0 196.8 42.1 3.5 400.4 71.2 168.6 96.2 8717.7 103.2 128.6 133.4 1.9 192.6 166.1 69.0 3.0 9.3 116.0 528.2 88.8 121.0 121.1 856.4 433.6 52.7 152.4 92.1 97.2 104.1 1180.3 76.7 171.2 100.6 108.9 87.4 143.4 410.5 215.6 CLPP ENSG00000125656 "Caseinolytic mitochondrial matrix peptidase proteolytic subunit" Q16740 19 6361531-6370242 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 229.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010649 Supported Supported Mitochondria NA NA 8500 Mitochondria "HPA010649: AB_1078538" "unprognostic (2.28e-1)" "unprognostic (7.14e-2)" "unprognostic (2.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.17e-2)" "unprognostic (1.15e-2)" "unprognostic (6.17e-3)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (6.97e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.86e-3)" 46.3 66.3 43.9 41.8 42.1 43.3 45.5 44.2 64.3 37.9 47.2 46.5 47.9 41.5 18.0 56.6 40.5 21.0 69.1 42.5 48.2 60.4 91.4 40.0 48.1 44.7 43.6 39.0 38.8 54.1 36.9 44.9 25.6 43.3 41.4 23.2 15.7 48.8 31.5 148.2 47.0 43.9 25.3 43.9 46.0 56.0 45.6 47.3 45.6 36.4 59.9 35.9 45.0 38.2 46.2 146.7 98.2 61.2 113.9 38.7 54.8 62.4 76.9 59.5 112.2 102.5 87.2 48.9 124.1 122.8 61.3 61.1 83.1 63.5 109.1 38.5 133.8 189.3 95.8 82.2 122.9 106.6 90.7 129.8 73.4 74.4 78.9 82.9 69.7 113.9 188.5 97.5 174.5 72.3 192.8 153.1 104.5 93.2 100.6 207.8 108.6 73.2 206.2 81.2 79.4 99.3 95.9 48.9 123.8 133.0 36.7 67.3 130.6 76.9 70.5 69.7 180.7 156.0 235.4 225.3 137.2 103.5 132.9 117.3 29.4 82.6 47.8 112.0 79.6 133.5 119.5 159.4 139.6 102.4 131.5 138.4 137.4 62.1 126.5 55.5 155.5 207.2 162.6 43.9 42.1 44.2 64.3 42.5 48.2 44.7 43.6 39.0 43.3 43.9 47.3 46.2 39.6 22.4 35.2 8.1 45.9 44.9 59.5 90.8 38.1 31.0 47.6 57.9 45.8 55.8 46.2 44.1 12.5 72.2 43.7 56.0 144.8 88.8 105.5 27.6 43.1 51.6 35.3 54.9 5.4 96.6 113.6 42.4 36.2 35.0 26.0 63.1 61.8 89.6 81.3 21.9 7.5 50.9 54.9 38.9 35.0 229.8 42.6 38.7 55.2 4.7 70.6 46.6 46.4 4.5 9.5 101.9 67.7 43.2 82.4 89.5 110.9 189.0 44.5 24.6 13.1 30.0 79.9 67.7 48.1 56.5 37.1 57.7 65.3 95.1 65.4 65.4 TNFSF9 "4-1BB-L, 4-1BBL" ENSG00000125657 "TNF superfamily member 9" P41273 19 6531026-6535924 "Plasma proteins, Predicted intracellular proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.9;vagina: 9.6" "Cell type enhanced" "Detected in many" "B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 85.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059857 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059857: AB_2684144" "unprognostic (2.21e-1)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "unprognostic (7.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-1)" "unprognostic (2.93e-2)" "unprognostic (2.41e-3)" "unprognostic (4.88e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (8.07e-3)" 1.7 0.6 3.4 1.0 2.8 3.8 0.8 3.4 7.6 4.8 2.4 1.2 0.3 0.3 0.3 9.9 1.1 1.0 0.6 3.6 3.4 0.9 0.4 4.9 1.1 3.5 2.7 3.3 0.5 0.3 0.5 0.3 0.9 3.2 0.3 1.8 0.3 1.5 0.1 0.7 1.3 1.2 0.4 2.9 2.2 0.6 3.4 3.2 0.5 0.4 0.3 0.7 0.7 9.6 6.3 10.7 13.4 0.2 4.8 2.5 6.0 0.4 1.5 4.8 3.6 17.1 0.3 18.0 11.3 6.8 3.0 0.0 19.2 5.4 2.3 0.9 0.0 2.6 1.8 18.4 4.4 0.4 0.3 85.8 1.0 10.1 20.1 5.5 2.6 0.6 1.6 10.9 0.2 1.3 1.5 0.9 1.8 1.8 0.7 9.5 1.2 0.0 2.8 22.9 0.4 0.0 0.0 29.8 1.7 5.0 0.6 1.2 16.4 6.2 0.0 9.6 26.0 0.0 26.9 10.2 20.9 10.2 5.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.4 2.8 3.4 7.6 3.6 3.4 3.5 2.7 3.3 3.2 2.9 3.2 6.3 11.3 0.0 4.5 0.0 57.5 2.7 0.3 4.3 6.2 0.2 4.0 3.8 8.1 0.0 1.6 0.0 0.0 0.1 51.6 4.3 0.0 0.3 0.1 5.7 3.9 6.8 14.2 0.0 2.2 0.2 0.0 12.6 23.0 9.2 8.9 0.6 1.8 0.0 4.5 0.0 2.5 3.4 2.0 1.9 15.9 0.0 0.0 22.5 3.6 0.0 1.6 0.8 0.0 1.5 2.9 0.8 4.9 0.0 17.2 0.9 0.2 0.1 0.9 0.2 0.0 2.5 7.5 0.1 0.4 12.7 1.3 0.1 31.5 0.9 5.7 0.3 GRIA3 "GluA3, GLUR3, GLURC, MRX94" ENSG00000125675 "Glutamate ionotropic receptor AMPA type subunit 3" P42263 X 123184153-123490915 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;retina: 18.0" "Group enriched" "Detected in some" 5 "Excitatory neurons: 468.4;Horizontal cells: 198.5;Inhibitory neurons: 396.3;Oligodendrocyte precursor cells: 385.0" "Cancer enriched" "Detected in some" 11 "glioma: 10.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 23.8;BJ hTERT+: 34.5;fHDF/TERT166: 45.9;U-2197: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058659, HPA073344" Enhanced "Intracellular and membrane" NA NA "HPA058659: AB_2683791, HPA073344: " "unprognostic (2.14e-2)" "unprognostic (6.00e-2)" "unprognostic (2.02e-2)" "unprognostic (2.94e-3)" "unprognostic (5.09e-2)" "unprognostic (4.29e-4)" "unprognostic (2.42e-1)" "unprognostic (6.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-3)" "unprognostic (1.31e-1)" "unprognostic (3.78e-3)" "unprognostic (8.05e-3)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" 0.8 10.4 17.7 0.3 28.2 0.1 1.4 4.0 33.8 6.8 0.0 0.7 0.3 2.1 3.7 0.4 1.6 1.2 2.1 31.8 14.5 2.5 7.7 0.3 0.5 6.0 7.9 26.8 4.2 1.7 0.0 1.0 0.4 8.2 1.7 0.8 18.0 0.2 1.9 0.2 0.5 0.5 1.9 5.9 0.1 2.0 0.7 7.4 0.2 0.2 0.1 0.8 0.6 2.9 23.3 0.0 0.0 0.0 0.0 2.2 0.4 0.0 23.8 34.5 0.4 0.9 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 6.6 0.0 15.1 0.2 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 28.2 4.0 33.8 31.8 14.5 6.0 7.9 26.8 8.2 5.9 7.4 23.3 0.1 0.0 0.0 27.4 0.0 0.3 0.0 0.8 0.6 13.6 0.2 0.0 1.6 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.1 0.3 8.7 0.3 0.0 0.0 468.4 0.2 0.1 6.4 1.1 0.2 0.0 0.1 0.4 6.1 0.1 198.5 396.3 0.0 0.0 0.0 1.5 0.3 9.3 0.2 1.8 14.0 0.0 1.9 0.0 385.0 67.6 0.3 0.0 4.1 0.0 0.4 0.0 6.2 0.1 3.8 0.0 0.2 4.5 0.0 0.1 0.0 1.0 0.1 0.1 0.7 0.0 0.0 THOC2 "CXorf3, dJ506G2.1, MRX12, MRX35, THO2" ENSG00000125676 "THO complex 2" Q8NI27 X 123600561-123733056 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047921 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA047921: AB_10960388" "unprognostic (2.12e-2)" "unprognostic (5.64e-2)" "unprognostic (3.49e-1)" "unprognostic (3.74e-2)" "unprognostic (2.22e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (6.29e-2)" "unprognostic (4.27e-3)" "unprognostic (6.43e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" 22.5 26.3 29.7 22.9 31.6 25.3 26.6 32.5 44.2 28.6 36.0 27.7 23.2 27.3 38.4 26.5 26.8 19.8 20.6 29.4 32.3 22.7 26.2 27.5 33.0 30.8 30.4 27.6 32.4 28.0 24.0 22.0 23.6 31.8 27.0 23.1 35.2 22.6 19.4 23.7 29.9 28.3 22.8 29.6 31.1 24.3 15.2 31.0 38.6 26.2 17.9 27.7 24.8 26.0 34.0 59.6 48.6 61.1 66.1 44.0 42.0 32.8 39.6 38.9 42.8 56.9 34.3 59.4 60.5 44.3 43.6 41.2 44.1 74.6 29.6 72.3 58.1 67.5 84.8 69.1 46.8 40.8 99.5 58.0 83.5 36.1 49.1 56.2 37.3 40.2 90.6 129.3 53.5 43.9 62.6 86.0 96.3 34.0 79.7 47.5 86.3 38.2 50.0 67.6 66.4 46.9 41.5 111.0 30.2 39.3 48.6 30.3 60.0 41.8 38.4 19.8 55.2 67.8 37.1 58.0 51.7 34.3 86.8 43.2 9.8 8.3 9.2 11.1 10.9 12.9 10.7 12.1 12.1 7.9 11.5 13.1 12.6 4.7 11.0 12.2 13.3 10.2 7.9 29.7 31.6 32.5 44.2 29.4 32.3 30.8 30.4 27.6 31.8 29.6 31.0 34.0 65.8 137.8 151.4 68.2 81.2 83.4 67.7 69.3 80.8 67.5 45.3 45.3 53.6 20.0 89.0 64.4 158.4 42.3 69.5 65.9 11.7 55.0 5.7 54.9 102.4 68.4 67.5 88.5 64.8 50.9 36.4 68.2 46.9 70.8 80.4 90.4 59.6 37.9 38.9 53.8 72.7 55.9 46.8 44.6 58.1 9.0 93.2 61.9 30.2 75.9 82.4 41.2 69.0 96.5 119.9 47.3 36.3 91.4 66.4 76.2 55.1 28.9 77.5 108.9 124.9 81.0 98.1 69.0 35.8 55.7 77.0 43.6 76.2 84.2 57.9 73.8 MED1 "CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2" ENSG00000125686 "Mediator complex subunit 1" Q15648 17 39404285-39451272 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 206.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017696, HPA052818" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB017696: AB_1128703, HPA052818: AB_2681962" "unprognostic (1.77e-1)" "unprognostic (1.63e-1)" "unprognostic (9.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.50e-1)" "unprognostic (7.86e-2)" "unprognostic (1.95e-3)" "unprognostic (4.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.78e-2)" "unprognostic (2.00e-1)" "unprognostic (5.94e-2)" "unprognostic (9.40e-2)" "unprognostic (5.79e-2)" 10.3 8.8 7.1 11.4 7.6 13.0 10.7 8.6 8.3 9.8 7.8 9.9 7.8 11.1 6.0 9.8 9.4 7.7 8.9 6.9 7.6 8.8 9.1 8.8 13.4 7.3 7.4 6.3 11.4 7.9 16.9 6.0 10.5 7.4 8.4 9.6 8.0 8.7 7.8 13.8 11.1 9.8 11.2 7.3 11.3 8.6 10.8 7.7 17.1 9.2 12.3 14.8 11.0 9.1 8.9 20.1 24.5 32.5 22.7 23.1 23.7 25.8 24.0 25.6 30.6 30.1 24.9 20.1 51.4 26.2 28.9 37.2 38.3 38.0 22.9 50.0 49.2 31.8 32.3 24.1 24.0 24.4 59.8 33.9 22.1 23.6 39.3 55.0 20.1 28.1 30.6 42.1 28.4 25.7 10.7 56.5 23.2 20.9 19.4 15.1 41.3 43.1 22.9 18.5 22.4 20.3 23.2 30.9 206.2 27.6 28.0 38.5 33.4 23.7 24.8 31.1 28.1 42.3 25.3 36.4 53.6 24.3 28.4 32.0 1.3 1.4 1.8 1.6 1.4 1.9 2.2 1.8 1.8 1.5 2.0 1.8 2.1 1.2 1.9 0.8 1.5 1.5 1.0 7.1 7.6 8.6 8.3 6.9 7.6 7.3 7.4 6.3 7.4 7.3 7.7 8.9 18.8 25.6 13.9 10.1 24.7 27.1 14.2 13.1 19.4 13.7 18.0 13.8 18.9 12.8 21.0 9.2 14.6 17.2 20.6 12.7 3.9 12.3 7.9 19.0 27.1 21.2 13.8 26.9 13.4 12.0 12.8 19.7 10.7 27.0 9.5 19.9 17.2 20.2 14.9 11.8 13.9 14.8 16.2 20.0 16.5 7.7 14.6 16.4 21.4 11.2 21.0 13.5 17.5 11.1 16.0 13.7 12.1 18.0 20.2 19.9 9.4 8.5 17.4 12.0 19.7 26.1 21.2 22.3 17.0 21.7 32.7 22.2 22.8 18.7 15.0 18.7 RPL23 "L23, rpL17" ENSG00000125691 "Ribosomal protein L23" P62829 17 38847860-38853764 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003373 Approved Supported Cytosol NA NA 130000 Cytosol "HPA003373: AB_1856436" "unprognostic (1.02e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.31e-2)" "unprognostic (5.62e-2)" "unprognostic (2.48e-2)" "unprognostic (9.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.02e-1)" "unprognostic (7.07e-2)" "unprognostic (8.01e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-5)" "unprognostic (1.18e-1)" "unprognostic (9.60e-2)" "unprognostic (6.46e-3)" "unprognostic (4.45e-1)" 2002.4 1421.8 882.8 981.1 895.5 2465.1 2555.9 888.9 1170.6 2058.7 962.7 1503.6 812.5 1510.1 1802.3 1692.4 1822.5 827.8 1242.3 861.7 948.1 1392.3 1239.1 1258.7 1950.1 926.1 905.1 842.2 3993.5 2117.6 1016.0 913.0 1096.6 934.6 1514.1 1219.7 516.7 1421.4 902.0 1916.9 2116.4 1301.6 1038.7 955.5 1620.9 1421.1 339.3 924.3 2017.0 1278.5 1631.9 2282.7 1605.0 1797.5 942.7 1912.8 1871.0 2422.1 2063.9 4227.9 5507.5 1695.5 1866.3 2802.6 2301.3 1716.5 2721.1 1652.1 4214.1 1806.8 2066.8 1701.9 3284.2 2131.0 3622.1 2803.5 1466.9 3178.0 1553.9 2573.8 3929.6 3170.2 4326.7 1561.7 5216.3 4409.6 2003.4 4154.8 4103.3 2475.7 2891.2 2507.1 2069.3 3000.0 1705.8 3818.5 4600.5 1778.3 2488.3 1131.0 2560.7 3549.4 4180.4 3262.5 2384.2 1643.0 2433.7 1001.5 1707.3 3998.7 3317.1 2828.9 5324.1 1746.6 1052.1 1617.9 1666.2 3155.0 1327.3 2217.4 3326.8 1613.0 2551.5 1388.0 568.8 1536.7 318.0 1179.7 1207.3 1463.1 2374.0 1868.0 1451.6 2065.6 2159.5 2473.1 2142.2 227.0 1404.4 1069.0 2578.5 1498.0 3233.2 882.8 895.5 888.9 1170.6 861.7 948.1 926.1 905.1 842.2 934.6 955.5 924.3 942.7 764.4 1012.8 1606.1 8.5 1481.6 2446.7 2204.6 1828.9 747.3 147.1 1240.8 1011.2 532.6 1243.9 1379.0 472.6 68.8 1809.9 1282.7 652.1 1352.0 1390.0 309.2 1084.8 2160.4 1122.6 919.7 808.5 11.3 2090.7 2633.3 985.1 306.3 1353.6 1350.3 1137.2 1572.1 1581.2 1666.5 58.9 10.9 1609.3 594.1 2477.5 2490.5 233.0 2682.2 1456.6 1108.1 11.2 2741.1 735.2 1365.6 5.0 11.5 1909.4 1437.5 1447.7 491.4 2347.2 799.6 2260.6 650.8 223.6 749.4 1743.9 1908.2 259.2 219.9 1022.2 3164.9 1904.2 1207.9 1159.8 1854.8 2378.9 ATG4C "APG4C, AUTL1, AUTL3, FLJ14867" ENSG00000125703 "Autophagy related 4C cysteine peptidase" Q96DT6 1 62784132-62865516 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.8" "Cell type enriched" "Detected in all" 7 "Oligodendrocytes: 449.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007049 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007049: AB_1845159" "unprognostic (1.28e-1)" "unprognostic (2.69e-1)" "prognostic favorable (9.83e-4)" "unprognostic (7.43e-2)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (3.76e-2)" "unprognostic (8.36e-2)" "unprognostic (1.83e-2)" "unprognostic (1.30e-1)" "unprognostic (3.77e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-2)" "unprognostic (1.81e-1)" "unprognostic (4.17e-2)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" 8.0 8.0 25.8 10.4 40.1 5.8 7.9 25.7 27.8 8.6 9.1 8.4 6.8 8.1 5.9 7.3 6.6 8.8 6.0 20.5 26.8 11.3 11.2 8.1 13.4 28.6 31.9 16.3 8.4 7.6 10.9 3.3 13.0 33.9 6.6 8.8 6.7 9.9 6.2 5.2 5.5 6.7 9.5 28.7 12.2 7.7 8.1 29.2 13.9 10.0 5.3 11.0 8.4 4.0 62.8 11.5 8.9 13.5 11.9 17.4 18.5 13.5 16.6 11.3 15.7 17.5 6.5 8.8 23.9 12.5 8.5 18.3 8.6 16.1 12.7 22.5 18.0 15.0 27.2 9.3 8.7 12.4 22.2 17.4 15.5 8.9 16.7 7.9 15.1 19.1 26.3 23.4 19.1 13.4 5.4 22.5 8.5 19.8 16.2 14.5 26.5 32.2 17.2 11.2 8.1 18.2 9.1 11.0 20.6 22.1 23.2 10.0 10.3 7.6 12.5 12.2 21.3 18.4 16.3 24.0 20.0 14.3 21.5 15.4 32.6 17.4 14.1 7.2 14.1 10.1 34.3 10.2 8.9 31.9 30.8 14.1 12.0 2.5 12.5 8.6 19.0 9.8 11.5 25.8 40.1 25.7 27.8 20.5 26.8 28.6 31.9 16.3 33.9 28.7 29.2 62.8 12.6 6.4 10.6 50.3 29.7 5.0 6.2 9.9 6.8 5.2 5.8 5.8 10.0 5.7 9.7 7.3 2.1 37.7 14.1 3.7 19.6 7.2 8.1 5.5 10.2 12.8 6.0 15.8 42.0 8.1 30.7 12.2 8.2 4.9 12.0 7.8 12.8 10.0 36.5 5.0 40.8 4.3 4.1 17.9 7.3 3.0 8.7 25.1 8.8 58.1 29.7 10.5 9.2 57.8 449.9 4.8 4.2 9.8 24.2 3.5 4.8 24.8 4.8 5.2 6.6 8.3 8.3 37.2 14.6 6.6 4.0 29.0 9.2 9.1 6.6 3.6 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.4" "Cell type enriched" "Detected in some" 4 "monocytes: 239.4" "Cancer enriched" "Detected in many" 4 "renal cancer: 24.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 44.2" "Group enriched" "Detected in many" 35 "B-cells: 24.2;T-cells: 44.2" "Cell line enhanced" "Detected in many" "SiHa: 189.2;THP-1: 157.3;U-251 MG: 234.2;U-266/70: 399.5;U-266/84: 312.7;U-698: 138.1" "Region enriched" "Detected in single" 25 "cerebellum: 11.3" "Low region specificity" "Detected in all" HPA046582 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 1.6 0.1 0.1 3.2 0.1 0.8 1.1 0.4 0.3 0.3 0.4 2.3 0.5 0.1 0.0 0.7 0.2 0.4 0.1 0.2 0.3 0.5 0.2 0.9 3.4 0.2 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.2 1.5 0.0 0.2 0.0 0.3 1.0 2.2 0.1 0.1 2.9 1.0 0.3 0.1 1.5 0.3 0.9 1.9 1.1 0.5 0.4 1.3 39.1 0.1 75.6 1.7 1.0 0.1 0.0 0.3 0.3 2.6 0.1 0.5 74.2 4.1 0.4 81.8 53.2 46.5 3.6 0.0 0.2 1.6 0.0 56.8 0.1 0.0 0.0 2.2 0.5 0.4 43.9 31.1 12.2 0.3 0.1 1.3 2.5 1.1 0.2 1.3 94.3 0.9 0.0 70.0 20.3 0.1 16.3 24.6 0.2 0.0 0.0 189.2 0.0 0.8 0.2 0.5 157.3 1.0 0.6 32.6 0.0 234.2 399.5 312.7 138.1 41.0 23.8 14.8 0.8 0.1 0.1 3.3 0.0 8.1 24.2 5.3 8.8 0.1 9.9 0.7 2.1 0.2 0.9 0.0 0.3 44.2 1.6 0.1 0.1 0.4 0.3 0.2 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.6 0.0 0.0 0.0 50.9 5.7 0.1 11.1 0.0 0.0 0.1 0.3 0.2 0.0 0.3 1.8 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.4 0.0 1.6 1.8 0.0 0.1 0.7 0.0 11.3 0.5 0.2 1.3 0.1 0.7 0.3 0.4 0.0 0.7 0.0 18.3 0.6 14.6 0.0 0.0 3.0 3.6 0.0 239.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 24.9 0.2 0.0 0.2 0.7 0.0 0.0 0.4 0.9 0.2 0.6 0.4 5.4 0.0 14.1 0.0 0.4 0.0 C3 "ARMD9, C3a, C3b, CPAMD1" ENSG00000125730 "Complement C3" P01024 19 6677704-6730562 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism" "Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "liver: 4800.7" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 4512.2" "Cancer enriched" "Detected in all" 5 "liver cancer: 1213.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "non-classical monocyte: 13.3" "Lineage enriched" "Detected in many" 4 "monocytes: 13.3" "Group enriched" "Detected in many" 7 "BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003563, CAB004209, HPA020432" Enhanced "Secreted to blood" NA NA 1260000000000 200000000000 "CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118" "unprognostic (3.26e-3)" "unprognostic (3.91e-1)" "unprognostic (3.92e-1)" "unprognostic (5.98e-3)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.99e-1)" "unprognostic (9.26e-2)" "unprognostic (5.80e-2)" "unprognostic (8.12e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.63e-2)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.88e-1)" 532.8 288.8 38.7 196.1 49.2 1.5 215.8 48.9 44.2 239.5 34.6 119.9 23.1 83.6 41.4 77.1 353.4 358.2 161.1 33.4 208.8 50.0 4800.7 177.5 68.7 146.6 73.5 21.3 230.0 184.2 18.0 21.9 17.8 107.3 35.7 77.3 11.8 156.9 57.9 36.9 50.8 157.8 124.2 85.4 7.2 108.8 41.5 84.8 34.4 93.2 52.4 127.5 366.8 102.1 170.5 65.0 23.0 0.0 0.1 10.8 36.0 74.7 5.2 357.8 6.8 12.6 3.6 49.5 1.9 738.6 0.3 54.2 46.6 0.2 43.1 6.9 24.0 0.5 3.1 31.2 795.3 16.3 6.2 9.1 534.8 12.8 60.8 27.3 9.5 0.0 0.0 2.1 0.8 0.2 1.0 0.6 1.6 1.5 0.7 0.1 0.4 5.0 0.3 32.1 6.2 0.5 0.5 209.5 0.1 0.5 0.1 17.2 8.8 3.5 5.7 7.4 4.8 3.6 1.6 4.8 4.5 75.1 4.5 0.3 1.7 1.3 0.6 0.3 2.5 0.2 0.5 0.2 0.1 0.7 0.5 0.2 0.2 3.0 1.3 13.3 0.5 0.1 0.9 38.7 49.2 48.9 44.2 33.4 208.8 146.6 73.5 21.3 107.3 85.4 84.8 170.5 36.4 76.9 473.9 0.7 29.4 27.5 14.7 141.5 0.6 0.7 19.5 23.4 14.5 783.5 422.5 16.5 0.0 1.4 2.0 0.2 5.9 494.1 45.9 23.0 63.5 26.2 0.0 209.9 0.4 136.7 1.4 482.2 17.9 57.7 5.1 0.1 124.9 4512.2 34.4 0.0 0.5 0.9 20.3 164.5 44.8 97.5 226.2 45.1 35.6 70.3 14.6 1.2 0.0 0.5 0.6 376.4 0.2 10.9 3.9 13.3 1.9 53.6 177.5 4.6 6.6 20.1 49.1 4.0 7.7 5.2 21.9 2.7 15.0 0.1 0.4 38.2 SH2D3A NSP1 ENSG00000125731 "SH2 domain containing 3A" Q9BRG2 19 6752160-6767463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 32.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4" "Not detected" "Not detected" "HPA035722, HPA064382" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA035722: AB_10670024, HPA064382: AB_2685251" "unprognostic (3.32e-2)" "unprognostic (5.48e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.96e-1)" "unprognostic (2.60e-3)" "unprognostic (3.63e-1)" "unprognostic (8.41e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.21e-4)" "prognostic favorable (1.42e-4)" "unprognostic (7.31e-2)" "unprognostic (1.74e-1)" "unprognostic (1.32e-3)" "unprognostic (1.81e-3)" 0.9 0.4 0.2 4.6 0.2 3.4 7.6 0.2 0.5 5.8 0.5 9.9 14.4 1.3 1.0 32.8 4.3 3.5 0.6 0.1 0.3 15.2 2.6 10.9 5.3 0.3 0.2 0.1 0.8 19.9 6.0 2.9 6.0 0.3 18.2 5.5 1.0 18.8 4.1 1.5 26.8 14.5 0.3 0.2 5.7 14.3 4.4 0.3 3.3 13.1 0.0 4.1 9.2 17.2 0.6 43.2 6.2 0.1 0.2 0.0 0.0 22.6 0.3 0.0 0.0 0.0 20.3 30.8 6.6 19.6 0.0 0.0 34.2 2.3 67.4 0.0 3.6 6.6 0.3 6.9 2.6 0.1 0.6 8.6 0.0 30.3 0.0 5.9 0.8 0.0 14.8 7.3 14.3 0.0 15.3 3.2 0.2 1.6 21.5 12.0 1.2 0.1 24.8 11.5 31.4 0.0 0.2 2.3 31.7 0.1 1.0 22.0 0.4 0.7 0.7 2.2 0.5 0.4 14.1 15.8 9.2 0.2 4.8 0.3 0.1 0.0 0.0 2.6 0.1 4.2 3.6 5.9 5.2 0.1 5.6 7.7 4.2 0.1 1.8 0.1 0.4 3.2 0.9 0.2 0.2 0.2 0.5 0.1 0.3 0.3 0.2 0.1 0.3 0.2 0.3 0.6 0.7 19.2 14.2 0.3 25.8 30.7 117.9 51.4 25.0 4.1 13.6 11.4 1.9 40.0 43.9 40.5 10.4 23.8 7.7 46.6 1.9 54.1 1.6 15.4 2.9 2.8 12.1 7.8 0.1 37.1 52.8 2.6 50.0 24.9 5.7 0.3 1.8 2.9 3.6 0.0 0.2 37.9 28.5 0.6 10.3 0.8 0.6 2.2 3.6 0.0 4.2 0.8 14.4 0.0 0.1 81.3 69.7 0.0 8.0 58.6 53.9 13.1 27.0 4.6 0.0 2.2 3.5 8.7 11.4 17.6 39.9 10.8 18.0 1.1 32.0 87.9 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751530 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 366.2" "Cell type enhanced" "Detected in many" "monocytes: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 26.4" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles NA NA 24000 Vesicles Nucleoplasm "HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244" "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favorable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 103.3 60.8 13.3 25.7 13.1 8.7 93.1 13.3 17.9 107.6 17.7 96.1 30.8 67.1 17.6 255.4 80.8 27.9 113.5 12.4 18.9 79.6 27.2 116.4 14.7 15.4 14.1 11.0 100.2 45.1 18.7 22.6 49.0 14.1 81.1 20.1 17.0 86.1 45.4 366.2 55.2 56.4 26.6 13.6 40.3 59.1 30.1 15.2 9.6 76.1 178.8 22.1 87.4 148.7 13.2 83.5 49.7 17.1 25.8 64.7 67.9 61.1 52.5 60.0 58.8 51.1 67.8 46.7 1.8 69.2 44.6 47.6 60.2 38.8 76.5 34.7 52.5 15.5 27.0 48.4 52.3 53.4 1.4 8.3 79.0 50.9 52.5 39.8 77.2 61.2 3.7 40.2 22.1 43.7 28.3 7.5 18.7 36.3 51.9 41.7 12.2 35.1 24.5 50.0 40.9 0.1 19.6 69.1 30.7 20.0 39.4 32.2 14.7 120.5 39.3 70.4 103.8 56.4 23.1 13.4 8.4 63.6 7.9 26.2 0.0 0.8 0.0 0.6 0.1 0.9 1.5 0.3 1.1 5.2 1.7 0.3 0.2 0.1 2.5 0.1 26.4 0.0 0.5 13.3 13.1 13.3 17.9 12.4 18.9 15.4 14.1 11.0 14.1 13.6 15.2 13.2 43.0 28.9 19.8 6.5 5.6 85.4 104.9 76.9 43.9 14.7 28.3 16.6 8.7 20.0 66.9 16.5 37.5 9.9 16.5 39.1 5.9 45.0 16.4 30.3 32.1 43.1 7.7 4.4 0.1 38.0 37.9 66.3 10.7 55.7 29.7 8.8 38.9 3.7 9.6 0.0 0.2 16.3 24.4 6.7 90.4 13.6 55.9 19.6 37.4 3.7 196.9 12.5 0.0 5.5 0.4 91.5 24.7 36.1 9.0 116.6 25.8 23.8 24.8 18.5 32.9 26.4 46.4 5.7 6.9 51.3 83.3 14.2 7.4 24.5 25.9 120.7 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 29.4 45.5 24.9 19.0 27.0 26.5 33.0 28.1 27.4 36.1 27.5 40.3 33.2 31.9 31.9 39.9 40.5 32.5 22.7 22.2 27.2 42.2 34.7 32.6 23.4 26.8 26.1 20.2 34.8 47.1 49.4 23.4 22.4 26.1 34.7 28.3 28.0 58.0 40.5 18.5 31.4 36.9 26.6 26.5 33.6 36.1 25.7 26.8 23.8 41.7 20.7 28.1 31.3 33.2 25.8 33.5 35.9 21.7 42.6 83.0 44.8 24.4 25.6 77.0 34.7 36.7 22.2 37.5 15.8 46.4 52.4 41.6 28.1 24.7 53.3 17.8 64.1 28.4 25.7 37.7 29.6 81.3 16.7 33.7 48.7 100.2 33.5 67.2 45.9 41.3 37.9 26.4 102.7 35.6 23.3 29.5 24.0 15.6 60.2 31.5 23.7 24.7 61.0 72.7 32.6 0.2 23.4 25.9 41.8 38.7 18.4 39.9 40.0 34.4 19.7 12.5 63.2 27.6 66.2 39.3 11.4 68.0 52.9 21.7 79.3 116.1 123.0 82.6 109.7 75.2 48.2 65.2 70.4 84.6 49.9 45.9 52.8 178.4 80.9 130.5 30.0 81.2 132.7 24.9 27.0 28.1 27.4 22.2 27.2 26.8 26.1 20.2 26.1 26.5 26.8 25.8 40.8 9.6 14.5 12.7 26.3 26.5 43.7 107.4 21.1 28.3 42.7 33.0 8.0 45.8 59.7 36.8 22.9 58.7 31.1 76.4 37.2 87.7 38.0 30.8 23.6 32.7 21.7 6.9 5.4 110.1 37.2 27.4 39.3 44.1 26.0 15.0 40.7 26.7 57.1 21.9 6.0 57.6 81.4 30.3 46.7 94.9 23.6 42.4 30.2 5.6 50.3 46.0 42.2 7.5 9.6 83.3 83.7 18.4 27.8 29.1 121.2 55.0 39.8 43.0 39.5 22.2 26.4 34.3 19.9 27.2 31.8 58.6 38.9 28.3 47.1 36.1 TNFSF14 "CD258, HVEM-L, LIGHT, LTg" ENSG00000125735 "TNF superfamily member 14" O43557 19 6661253-6670588 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 108.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 26.3;dendritic cells: 40.5;granulocytes: 26.1;Macrophages: 20.0;NK-cells: 26.8;T-cells: 43.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 199.7" "Group enriched" "Detected in all" 4 "granulocytes: 199.7;T-cells: 61.2" "Cell line enhanced" "Detected in some" "HDLM-2: 16.9;NB-4: 4.9;THP-1: 3.1;U-937: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA012700 Uncertain Approved Vesicles "Secreted to blood" NA NA 41000 Vesicles "HPA012700: AB_1852870" "unprognostic (2.78e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (3.82e-4)" "unprognostic (4.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (1.05e-2)" "unprognostic (9.23e-2)" "unprognostic (9.22e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (6.07e-13)" "unprognostic (1.09e-1)" "unprognostic (9.56e-3)" "unprognostic (1.75e-1)" "unprognostic (3.62e-2)" 14.5 1.7 2.2 3.2 1.5 1.9 2.7 0.8 5.9 1.9 2.7 2.6 1.8 0.9 0.3 1.8 9.8 1.2 2.9 1.0 8.9 1.3 108.8 4.9 2.6 1.4 1.3 0.6 5.2 4.5 0.0 1.1 0.2 1.7 2.0 1.3 0.2 2.3 0.2 0.5 0.6 6.0 1.2 1.0 3.2 2.3 0.6 2.7 1.1 2.8 0.6 2.0 4.1 2.3 5.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.5 0.0 0.0 0.0 16.9 0.0 0.0 0.2 1.1 0.0 0.5 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 10.4 0.0 140.9 17.6 115.3 41.8 4.0 61.2 0.4 17.7 34.5 6.9 1.9 2.8 15.0 199.7 30.7 0.5 0.7 15.9 12.8 2.2 1.5 0.8 5.9 1.0 8.9 1.4 1.3 0.6 1.7 1.0 2.7 5.1 0.7 9.6 26.3 0.0 1.6 2.9 0.7 0.9 0.0 0.0 1.1 0.8 0.8 15.7 8.2 0.0 0.0 0.1 40.5 0.0 0.0 4.1 1.2 4.8 2.6 0.9 0.0 0.4 0.1 3.8 0.2 12.4 1.1 18.1 26.1 0.2 1.8 15.8 12.8 0.0 0.1 0.2 0.0 3.4 12.3 0.0 0.3 20.0 3.6 1.0 5.8 0.0 26.8 0.0 0.1 6.0 0.0 0.0 4.8 0.6 0.0 0.4 2.8 0.0 0.0 1.4 1.0 0.2 0.3 0.3 3.3 0.0 43.7 0.0 0.0 0.4 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 50.6" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: AB_2682562" "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 398.3 122.8 1.6 119.4 3.8 437.8 92.7 29.3 50.6 151.6 4.6 38.0 25.0 47.1 4.0 189.3 408.0 350.0 45.8 8.6 30.9 35.0 86.3 114.5 68.2 1.3 1.5 1.3 276.7 127.4 46.5 27.5 58.2 2.0 119.6 79.1 10.8 77.5 29.9 3.4 154.1 63.6 356.5 0.6 22.0 105.3 8.9 1.0 153.6 319.0 82.0 1.6 216.0 11.1 11.4 0.4 0.6 0.1 0.3 1.2 0.3 1.8 2.3 1.0 0.7 0.7 0.5 1.0 2.0 0.4 1.5 11.4 0.8 0.5 1.6 0.5 0.3 0.7 0.6 0.8 0.4 0.8 1.1 13.3 0.5 8.1 1.7 1.9 0.4 0.9 2.3 0.8 6.8 0.2 0.2 0.2 1.2 0.4 1.0 0.4 0.5 0.1 1.4 0.6 1.3 3.1 0.4 1.4 9.6 1.2 1.9 0.5 0.8 0.1 0.5 0.6 1.1 0.7 5.1 0.8 0.5 1.1 0.8 1.3 0.9 1.2 1.0 0.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.1 1.6 3.8 29.3 50.6 8.6 30.9 1.3 1.5 1.3 2.0 0.6 1.0 11.4 1048.7 685.9 761.3 2.6 445.7 380.5 533.4 162.4 865.6 50.6 1627.1 1523.2 177.8 370.3 174.4 11.0 135.5 237.5 359.6 551.1 1.9 145.5 10.1 667.9 1204.4 442.6 877.0 68.6 1.3 74.2 301.9 788.2 911.3 1541.3 830.4 239.3 393.7 77.9 210.3 8.4 0.3 898.4 42.7 345.2 353.4 11.3 240.2 797.3 172.5 1.0 16.3 186.1 1.0 0.0 0.3 111.6 457.3 59.5 503.4 307.3 417.8 2.7 111.5 217.6 302.4 2234.0 608.8 3.3 4.5 476.3 380.9 396.9 481.8 174.2 616.5 208.5 OPA3 "FLJ22187, MGA3" ENSG00000125741 "Outer mitochondrial membrane lipid metabolism regulator OPA3" Q9H6K4 19 45527427-45602212 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 4.4 7.2 3.3 4.8 3.2 4.0 3.5 4.1 5.2 3.0 3.9 4.5 4.0 4.9 3.1 5.9 3.4 3.4 9.3 3.4 3.1 7.5 7.8 4.4 4.7 4.6 4.1 3.0 3.4 4.4 12.1 6.0 4.5 5.0 3.8 4.0 6.5 4.0 4.1 11.2 5.9 5.0 4.8 2.1 5.8 4.9 9.0 5.7 4.7 4.7 13.0 4.7 4.1 3.5 5.0 15.2 18.9 7.4 7.3 4.8 5.9 11.3 9.7 8.9 10.1 10.7 8.8 10.5 13.0 6.9 9.8 11.5 12.0 12.5 13.3 8.9 24.0 12.6 20.1 10.8 9.1 8.8 14.1 25.0 8.9 10.1 11.2 12.2 5.8 7.3 7.6 17.5 14.2 6.9 9.3 11.3 5.8 6.5 12.6 12.9 10.9 6.7 7.1 8.0 26.9 5.5 6.6 12.4 11.3 5.2 6.6 6.3 8.0 15.9 8.5 9.7 7.1 16.7 9.5 19.1 10.6 8.2 10.1 13.1 5.6 5.3 2.9 3.6 7.8 3.6 4.4 3.2 3.1 5.6 3.9 3.9 4.0 4.7 7.8 10.5 5.1 4.8 3.6 3.3 3.2 4.1 5.2 3.4 3.1 4.6 4.1 3.0 5.0 2.1 5.7 5.0 11.0 12.8 11.7 8.5 23.0 18.7 22.4 14.6 13.1 22.8 9.2 7.9 25.4 17.2 11.6 11.0 52.1 25.6 15.7 18.8 25.4 18.4 18.5 12.8 13.8 15.2 13.8 5.7 9.5 21.1 29.8 10.6 14.3 20.1 15.9 8.9 11.4 21.9 16.3 20.2 10.2 14.5 16.2 11.4 28.3 20.2 6.2 17.4 14.2 4.7 19.0 15.1 11.3 3.0 8.1 18.2 19.2 6.4 11.9 15.8 21.2 16.8 10.7 36.0 0.0 23.3 23.6 23.9 13.1 11.2 19.6 36.3 14.4 19.5 16.6 16.7 SNRPD2 "Sm-D2, SNRPD1" ENSG00000125743 "Small nuclear ribonucleoprotein D2 polypeptide" P62316 19 45687460-45692569 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041437 Supported Supported Cytosol NA NA 76000 Cytosol "HPA041437: AB_10795119" "unprognostic (1.48e-1)" "unprognostic (1.11e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-2)" "unprognostic (6.63e-2)" "unprognostic (6.84e-2)" "unprognostic (1.23e-3)" "unprognostic (2.08e-1)" "unprognostic (7.71e-2)" "unprognostic (3.50e-1)" "unprognostic (4.79e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.95e-1)" "unprognostic (6.57e-3)" "unprognostic (1.53e-1)" "unprognostic (7.12e-2)" 194.4 217.2 313.5 239.8 322.0 482.3 394.8 315.2 377.9 269.5 309.4 255.7 171.6 231.0 334.4 246.5 320.8 197.7 268.0 315.9 326.4 199.3 201.8 158.4 446.3 321.3 313.8 311.5 444.0 186.5 265.8 204.5 217.0 316.9 203.6 256.0 121.9 199.1 211.7 308.9 238.9 169.5 237.2 317.5 203.8 190.6 168.8 321.3 505.6 216.7 308.3 409.7 315.2 218.2 318.2 970.0 1429.6 863.8 905.4 843.8 797.5 475.5 630.8 777.8 933.3 974.0 814.6 582.4 1119.3 493.9 788.2 624.9 543.7 1180.4 1184.6 888.6 721.6 1428.6 1066.5 756.6 1040.6 585.1 1287.9 646.4 894.2 862.7 798.3 759.9 639.5 960.3 1111.6 996.6 713.1 765.9 1329.7 1274.7 1129.0 780.8 1758.5 776.2 848.1 890.0 896.5 782.0 1249.4 792.7 880.4 828.1 842.8 808.7 705.9 500.2 1378.5 614.2 422.3 694.7 397.5 1198.8 717.5 1949.8 1775.2 601.5 1087.8 691.3 306.6 525.1 275.0 810.3 500.5 1045.6 1309.4 1076.4 964.5 789.1 1155.8 1244.5 1083.7 62.7 885.6 393.8 876.0 1144.9 1776.3 313.5 322.0 315.2 377.9 315.9 326.4 321.3 313.8 311.5 316.9 317.5 321.3 318.2 150.6 147.4 211.1 8.1 407.6 470.5 564.5 724.2 463.9 43.1 361.2 650.5 443.3 233.1 372.3 329.2 22.9 607.0 294.3 318.8 665.2 368.8 563.3 190.9 310.2 225.3 310.2 315.9 7.9 350.7 787.7 305.2 199.8 198.2 266.0 284.4 232.3 265.4 475.4 37.0 8.3 492.0 376.4 269.9 470.6 1325.8 347.9 232.5 434.0 9.4 373.9 162.6 373.9 3.5 12.2 318.2 348.5 231.7 341.2 553.5 356.9 768.7 309.3 65.2 164.3 279.4 382.1 286.3 274.7 562.6 422.7 482.8 426.5 216.2 556.9 534.0 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485294-45497055 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "skeletal muscle: 514.7;tongue: 209.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 134.3;Extravillous trophoblasts: 145.7;Skeletal myocytes: 73.2;Syncytiotrophoblasts: 120.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.2;eosinophil: 2.6;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "dendritic cells: 1.6;granulocytes: 6.2" "Cell line enhanced" "Detected in many" "RH-30: 44.3;RT4: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: AB_2674375" "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 9.7 13.8 19.7 3.4 23.3 1.7 12.1 13.6 42.4 5.5 7.1 16.7 2.8 15.4 2.5 12.2 4.6 8.0 21.1 24.1 16.4 6.1 3.9 8.3 4.7 24.4 18.5 21.5 1.9 4.9 10.2 7.7 19.4 26.5 17.1 2.2 5.8 22.5 10.7 514.7 8.7 8.8 7.3 11.9 11.3 8.0 1.6 23.9 1.1 4.9 209.6 2.0 12.5 7.8 27.1 3.8 5.2 8.6 6.7 14.4 17.6 16.9 8.5 20.0 5.2 9.9 10.4 3.2 3.3 11.4 9.3 4.2 7.2 5.6 4.1 1.7 7.9 8.2 23.0 3.9 7.8 6.2 1.4 25.0 19.5 2.2 2.3 4.2 9.2 9.6 0.9 12.9 6.2 15.6 2.9 0.0 4.3 6.3 17.0 6.8 3.6 44.3 18.8 3.0 45.0 24.1 23.1 1.7 40.7 13.2 8.0 32.3 9.1 8.6 14.7 4.4 0.4 1.9 3.5 8.7 7.7 3.9 5.2 7.7 6.2 0.1 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.3 1.6 0.0 0.2 19.7 23.3 13.6 42.4 24.1 16.4 24.4 18.5 21.5 26.5 11.9 23.9 27.1 9.8 3.2 8.1 2.6 0.8 6.4 27.7 8.9 6.8 10.4 18.4 21.1 4.6 4.3 4.6 3.7 6.2 134.3 2.9 0.9 0.0 21.3 0.3 2.1 7.0 15.3 11.4 1.7 21.0 6.8 145.7 14.0 3.1 3.4 16.5 4.2 18.9 3.1 27.3 23.5 13.3 2.2 12.2 12.9 12.0 0.4 5.6 10.7 23.2 1.9 6.5 9.1 1.0 4.5 2.1 13.1 0.3 6.8 2.5 13.0 0.3 0.3 1.3 13.6 13.1 73.2 12.3 0.5 3.9 2.3 3.4 120.1 1.0 16.4 0.7 23.2 EML2 "ELP70, EMAP-2, EMAP2" ENSG00000125746 "EMAP like 2" O95834 19 45606994-45645602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 153.1;Syncytiotrophoblasts: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012757 Approved Approved Vesicles NA NA 180000 Vesicles "HPA012757: AB_1848145" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.81e-3)" "unprognostic (1.13e-1)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.85e-1)" "unprognostic (3.05e-3)" "unprognostic (3.72e-1)" "unprognostic (2.75e-3)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (9.44e-2)" "unprognostic (7.48e-2)" "unprognostic (7.03e-2)" 10.6 33.0 27.7 13.7 35.2 14.2 13.0 39.1 33.1 15.9 7.2 21.5 11.6 9.2 6.9 40.5 12.1 11.0 20.6 17.5 34.5 17.5 7.9 13.7 13.5 55.0 33.8 20.9 5.3 21.3 55.6 14.4 20.0 56.2 16.0 14.5 49.5 29.3 18.4 5.8 38.6 12.0 7.1 29.9 13.0 19.0 3.6 38.5 16.6 21.0 5.0 12.6 19.7 25.1 56.1 47.6 16.2 3.2 1.1 25.0 13.6 17.4 29.2 37.0 12.6 14.8 6.2 39.5 14.6 17.0 15.4 4.0 39.7 6.0 57.4 4.0 56.7 15.0 5.7 19.5 12.4 47.1 18.5 13.4 21.1 74.5 15.1 74.1 10.5 9.4 28.0 18.3 38.5 10.0 49.9 10.3 4.2 1.9 75.7 14.3 2.3 5.6 18.9 33.3 61.2 17.8 3.3 16.4 32.0 22.1 17.0 18.7 18.9 15.1 0.0 5.4 4.8 0.3 66.2 43.9 7.9 20.4 20.9 38.7 7.8 3.7 5.7 6.5 4.8 5.1 5.5 4.4 6.7 4.4 2.2 2.9 3.9 1.0 2.6 5.2 6.4 5.8 3.9 27.7 35.2 39.1 33.1 17.5 34.5 55.0 33.8 20.9 56.2 29.9 38.5 56.1 10.6 3.2 13.1 8.5 15.7 18.6 42.9 40.3 27.3 32.2 13.2 14.2 9.0 14.3 25.5 35.0 14.6 66.4 24.5 34.1 37.2 16.8 72.1 28.6 9.0 13.8 17.5 5.5 29.7 20.8 20.4 7.6 38.7 20.1 19.1 6.7 20.3 6.4 15.8 28.6 46.0 32.6 26.4 8.8 9.6 27.0 4.1 8.7 19.6 5.6 13.1 16.4 12.3 15.1 68.0 17.9 29.1 7.2 25.0 23.7 11.0 7.5 40.7 153.1 0.0 6.8 16.4 3.5 6.1 29.6 14.3 101.0 23.2 39.1 31.9 41.9 VASP ENSG00000125753 "Vasodilator stimulated phosphoprotein" P50552 19 45506579-45526983 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 443.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 52.7" "Group enriched" "Detected in all" 7 "granulocytes: 52.7;monocytes: 22.7" "Cell line enhanced" "Detected in all" "HMC-1: 270.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004612, HPA005724" Enhanced Supported "Plasma membrane,Cell Junctions,Focal adhesion sites" NA NA 32000000 "Plasma membrane, Cell Junctions, Focal adhesion sites" "CAB004612: AB_2213431, HPA005724: AB_1858721" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (4.70e-2)" "unprognostic (7.85e-3)" "unprognostic (8.31e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-2)" "unprognostic (3.64e-3)" "unprognostic (4.39e-1)" "prognostic unfavorable (5.91e-7)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.08e-2)" 48.5 24.8 10.3 75.8 8.4 94.8 42.8 8.8 10.8 37.7 12.5 87.5 62.5 89.8 6.0 37.8 54.9 27.3 33.4 7.0 11.5 30.8 27.5 58.7 49.1 11.6 9.0 4.7 22.7 20.8 10.8 17.2 31.8 12.1 44.1 20.6 1.9 30.9 39.5 12.6 32.7 64.1 36.9 12.5 107.9 71.1 14.8 12.5 25.1 27.8 8.6 32.3 72.2 39.3 16.7 68.9 66.3 20.6 35.6 10.2 17.4 50.5 70.2 52.8 47.4 40.9 30.1 142.0 31.2 55.7 56.4 31.3 60.6 6.2 69.5 15.9 87.0 14.8 183.7 32.3 55.4 56.6 68.1 270.1 26.8 38.2 44.5 28.5 38.3 71.1 25.8 112.1 67.5 29.4 53.7 30.3 58.7 36.0 65.1 44.5 21.6 12.6 12.2 40.9 216.2 23.0 16.3 83.6 41.7 48.2 13.0 45.7 115.2 107.0 74.7 74.4 24.7 112.4 32.8 43.3 54.7 52.4 82.3 92.3 13.3 8.5 52.7 4.1 13.9 2.8 3.4 3.3 3.9 5.5 3.3 2.1 2.5 34.5 4.0 22.7 2.1 2.6 5.8 10.3 8.4 8.8 10.8 7.0 11.5 11.6 9.0 4.7 12.1 12.5 12.5 16.7 80.9 16.0 19.5 2.9 99.4 98.3 95.6 48.8 37.0 6.9 53.5 57.0 19.0 48.6 41.5 33.1 27.1 67.1 85.9 202.3 17.6 138.6 3.2 33.9 30.5 77.0 114.7 20.0 2.6 98.2 443.6 26.7 81.6 58.1 83.1 17.4 48.5 15.8 160.1 6.7 3.4 159.3 44.7 132.5 232.0 3.8 26.1 192.9 49.8 10.3 162.9 13.2 185.3 2.0 2.3 212.5 245.5 49.2 38.2 73.4 134.6 20.4 18.6 14.7 131.5 46.5 89.4 18.9 15.5 38.7 77.7 140.9 95.7 21.0 129.5 144.8 SYMPK "SPK, SYM" ENSG00000125755 Symplekin Q92797 19 45815410-45863194 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 141.6;Late spermatids: 146.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041756, HPA042449" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA041756: AB_10963544, HPA042449: AB_2678003" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (2.59e-1)" "unprognostic (1.59e-2)" "unprognostic (3.11e-2)" "unprognostic (2.33e-3)" "unprognostic (9.93e-2)" "unprognostic (9.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.16e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (2.58e-1)" "unprognostic (6.38e-2)" 18.2 17.4 14.4 29.6 16.4 27.6 18.2 11.7 19.1 23.8 10.1 22.1 22.4 25.6 20.3 19.8 23.7 18.1 17.7 14.4 13.6 19.1 21.5 20.8 35.1 18.3 14.9 14.9 23.8 19.3 20.8 32.9 25.2 18.2 24.0 14.2 15.9 24.9 16.6 38.8 25.5 23.0 16.3 11.2 28.7 23.1 41.4 14.3 30.3 24.2 19.1 23.0 20.9 20.1 21.6 57.7 101.0 40.4 29.9 39.0 46.8 67.7 44.5 32.0 45.8 51.0 45.8 51.1 101.6 30.2 51.0 25.7 46.2 55.1 49.9 40.0 79.4 62.2 58.7 68.9 47.5 43.7 64.9 65.6 36.1 29.2 49.3 55.4 31.2 47.6 52.6 79.3 64.4 39.4 54.8 61.0 70.3 34.0 50.0 23.9 64.6 46.4 62.6 31.8 102.7 46.0 57.7 55.1 35.5 36.7 40.3 48.4 89.4 53.5 37.1 58.5 28.8 66.9 84.1 173.1 81.5 42.4 42.8 61.8 1.7 3.0 1.5 2.0 2.5 1.9 2.9 1.8 3.2 2.8 4.8 1.5 1.4 3.4 2.7 5.0 5.8 1.4 2.1 14.4 16.4 11.7 19.1 14.4 13.6 18.3 14.9 14.9 18.2 11.2 14.3 21.6 14.7 0.0 7.7 34.9 30.2 20.9 18.7 15.6 18.2 21.6 17.4 15.4 7.0 22.8 12.0 25.8 35.5 35.5 20.9 32.7 54.8 21.6 141.6 24.9 29.9 23.4 36.3 26.5 24.6 17.5 34.5 17.5 41.8 27.7 12.7 35.1 26.0 31.8 18.2 21.9 27.1 38.7 10.2 27.0 25.6 146.4 19.3 24.4 14.2 19.7 47.3 11.3 32.0 29.1 28.4 20.4 25.5 21.1 19.8 21.5 30.8 14.9 15.6 27.4 19.7 17.4 20.4 35.3 34.1 14.4 21.3 57.3 21.2 21.9 38.6 20.6 GPCPD1 "GDE5, GDPD6, KIAA1434" ENSG00000125772 "Glycerophosphocholine phosphodiesterase 1" Q9NPB8 20 5544439-5611006 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 76.1" "Cell type enhanced" "Detected in all" "Early spermatids: 208.7;Microglial cells: 291.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042987 Approved Nucleoplasm NA NA Nucleoplasm "HPA042987: AB_2678254" "unprognostic (2.25e-2)" "unprognostic (2.45e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.30e-4)" "unprognostic (2.93e-2)" "unprognostic (8.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (3.76e-2)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.56e-1)" "unprognostic (1.22e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-2)" 14.8 15.6 18.3 16.5 18.8 76.1 13.7 21.6 23.6 15.4 14.3 12.4 8.0 13.4 7.2 13.4 17.4 12.2 14.4 16.3 19.0 10.9 10.3 27.6 18.1 20.4 18.8 14.7 23.5 9.8 4.0 13.3 15.0 22.1 13.2 11.2 12.3 26.8 13.2 17.6 10.4 16.7 12.9 18.2 32.2 11.3 9.1 18.2 13.4 15.6 10.3 17.1 13.0 13.1 19.3 6.5 12.1 8.0 6.5 5.2 6.1 9.1 10.0 7.9 5.7 3.8 6.3 5.0 14.4 1.8 5.6 5.0 2.2 10.1 19.8 5.5 3.1 3.2 19.6 1.5 7.4 25.0 12.2 8.6 13.0 25.3 3.4 41.3 5.7 6.0 8.8 11.5 7.3 5.2 3.5 11.1 6.7 4.4 11.3 6.7 8.0 9.5 5.2 7.7 5.3 3.0 4.0 4.4 19.2 9.5 7.9 4.6 33.7 6.8 4.8 3.6 13.2 6.4 6.9 12.7 15.1 1.5 14.8 5.4 2.9 7.4 9.2 3.7 5.5 2.9 4.2 2.8 3.2 4.5 3.6 4.2 2.9 16.0 3.9 5.8 2.0 2.5 3.9 18.3 18.8 21.6 23.6 16.3 19.0 20.4 18.8 14.7 22.1 18.2 18.2 19.3 34.8 22.4 56.4 31.6 59.6 16.6 15.8 23.0 17.1 18.0 25.7 39.6 36.8 12.8 48.5 22.0 6.2 29.9 59.1 13.2 3.9 11.9 208.7 37.8 41.2 41.1 19.7 89.0 30.9 9.1 16.8 27.1 35.7 66.9 43.1 26.0 17.9 14.4 43.9 11.8 22.8 25.7 24.4 69.2 54.9 54.6 5.6 125.0 10.6 291.4 60.9 8.5 33.0 63.3 13.4 7.3 12.7 3.4 55.2 21.1 16.6 7.7 24.6 20.3 6.6 31.9 35.1 44.1 11.3 25.8 27.4 48.7 63.1 12.7 12.8 57.7 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329139 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 143.0;intestine: 138.1;stomach 1: 102.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.6;OE19: 57.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 7.1 3.5 18.3 10.2 18.9 0.7 7.0 14.7 24.5 14.5 13.5 86.6 138.1 5.8 9.1 143.0 4.4 42.2 4.0 18.0 17.7 15.9 18.3 21.1 1.3 16.2 16.4 18.3 3.5 15.3 2.5 3.9 3.3 15.9 6.5 56.0 1.1 30.0 2.5 2.8 61.8 134.1 3.6 15.0 3.1 102.7 5.6 17.6 1.5 14.7 1.5 13.8 38.6 50.3 16.4 10.9 0.5 1.4 0.5 5.8 5.1 0.9 3.2 6.3 2.8 2.7 2.3 18.6 1.1 2.1 1.2 2.0 8.2 0.5 15.5 1.4 0.4 1.0 0.9 0.6 1.5 5.8 1.1 1.2 1.8 10.8 2.2 2.2 6.0 9.6 2.0 1.5 0.7 1.1 2.6 1.7 3.0 1.3 57.3 0.7 1.6 0.7 2.2 1.2 14.4 2.4 1.9 1.5 9.3 3.6 0.6 0.4 0.9 6.5 1.5 0.6 2.8 1.2 2.8 2.7 1.1 0.7 4.1 0.9 0.1 0.8 1.9 0.9 0.3 0.7 0.2 1.2 0.9 1.0 0.4 1.0 1.8 0.8 0.9 0.6 0.7 2.3 0.7 18.3 18.9 14.7 24.5 18.0 17.7 16.2 16.4 18.3 15.9 15.0 17.6 16.4 15.6 16.0 4.2 0.0 4.1 55.7 112.0 198.1 3.4 1.0 4.9 4.8 0.8 72.9 172.6 16.5 0.0 1.8 1.0 782.5 27.4 114.5 17.1 25.8 11.7 14.1 35.9 0.0 0.0 209.7 1.1 4.6 201.8 85.4 8.9 1.0 7.1 5.1 0.9 1.7 0.0 150.8 156.6 1.9 6.4 1.9 1.5 1.8 8.8 0.0 2.3 1.0 2.1 0.0 0.0 755.4 948.5 0.0 0.7 107.0 470.3 1.8 89.6 0.9 0.0 1.7 9.9 5.0 7.6 31.1 95.6 1.6 3.5 2.0 109.2 641.9 PANK2 "C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN" ENSG00000125779 "Pantothenate kinase 2" Q9BZ23 20 3888839-3929887 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Coenzyme A biosynthesis" "Kinase, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008440 Approved Supported Cytosol NA NA Cytosol "HPA008440: AB_1079559" "unprognostic (4.50e-2)" "unprognostic (7.96e-3)" "unprognostic (2.26e-1)" "unprognostic (1.39e-2)" "unprognostic (1.68e-1)" "unprognostic (6.00e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.75e-1)" "unprognostic (3.39e-1)" "unprognostic (2.52e-1)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" "unprognostic (6.01e-3)" "unprognostic (1.73e-2)" "unprognostic (2.18e-3)" "unprognostic (2.63e-1)" "unprognostic (1.81e-1)" 13.2 12.4 15.8 16.9 14.9 21.1 12.3 16.4 16.2 12.0 15.5 11.5 8.5 11.1 11.4 20.2 16.4 12.2 8.8 16.6 15.1 15.8 18.5 14.2 18.6 14.0 15.6 15.5 13.0 10.4 11.0 9.0 15.4 14.4 12.1 14.3 10.4 12.0 10.8 9.7 11.8 11.7 13.9 14.3 15.0 9.1 26.2 15.3 17.0 15.5 11.3 22.2 15.7 10.0 14.9 39.3 29.4 33.7 18.6 39.3 32.6 15.0 25.6 34.2 38.3 48.3 40.8 25.4 34.6 10.6 34.9 70.2 34.9 34.7 57.3 49.3 8.8 9.8 47.4 22.7 80.2 33.3 33.6 15.9 28.7 26.4 39.7 28.7 17.0 36.0 23.3 34.7 30.5 42.5 11.7 30.0 30.3 28.8 22.9 19.5 20.3 46.0 22.4 26.2 45.7 36.2 16.7 30.0 44.3 78.1 32.6 23.6 28.1 24.6 47.7 17.8 60.7 43.3 14.0 50.8 23.3 15.0 30.7 34.2 3.0 10.5 3.4 3.6 11.1 3.5 3.8 3.7 3.4 8.5 4.5 4.1 3.4 5.9 6.8 9.4 3.0 5.9 4.0 15.8 14.9 16.4 16.2 16.6 15.1 14.0 15.6 15.5 14.4 14.3 15.3 14.9 23.8 19.2 11.7 23.8 29.2 25.5 17.5 12.0 41.5 22.0 15.8 17.3 9.8 7.2 13.4 14.7 25.0 29.4 38.6 14.4 23.5 19.4 83.1 24.1 20.6 26.7 20.3 42.7 28.6 17.8 36.0 21.1 24.5 24.1 7.6 20.1 26.0 14.0 33.8 35.3 25.3 12.7 10.2 52.8 37.9 17.3 21.1 34.3 19.6 29.0 55.0 14.1 35.0 23.1 17.7 15.9 12.8 22.6 33.2 20.9 15.1 20.6 20.2 21.1 6.6 14.1 23.1 54.6 25.9 37.7 24.3 18.6 31.6 21.2 15.0 20.0 TGM3 TGE ENSG00000125780 "Transglutaminase 3" Q08188 20 2296001-2341079 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "esophagus: 1852.8" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 46.2;Squamous epithelial cells: 22.5" "Cancer enriched" "Detected in many" 9 "head and neck cancer: 81.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 295 "neutrophil: 30.3" "Lineage enriched" "Detected in single" 303 "granulocytes: 30.3" "Cell line enriched" "Detected in single" 14 "EFO-21: 5.2" HPA004728 Approved NA NA 14000000 "HPA004728: AB_1080360" "unprognostic (7.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.18e-2)" "unprognostic (3.23e-3)" "unprognostic (4.27e-2)" "unprognostic (4.20e-2)" "unprognostic (8.62e-2)" "unprognostic (4.21e-2)" "unprognostic (1.50e-1)" "unprognostic (8.00e-2)" "unprognostic (4.88e-3)" "unprognostic (1.35e-1)" "unprognostic (7.78e-8)" "unprognostic (1.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (9.67e-2)" 0.4 0.3 0.2 0.2 0.0 1.5 4.0 0.0 0.1 26.1 0.0 0.3 0.0 0.2 0.8 1852.8 1.4 2.2 0.4 0.2 0.0 0.2 0.8 0.5 0.0 0.1 0.0 0.1 0.3 1.1 0.0 1.6 0.1 0.1 0.6 0.8 0.0 231.1 0.0 0.4 75.7 0.4 0.0 0.1 0.4 2.2 2.0 0.0 0.1 0.1 0.0 144.2 0.3 31.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.9 4.0 0.1 0.1 46.2 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.3 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.2 0.5 22.5 8.2 0.0 0.0 0.1 0.3 0.2 GNRH2 ENSG00000125787 "Gonadotropin releasing hormone 2" O43555 20 3043622-3045747 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Early spermatids: 1.2;Excitatory neurons: 2.0;Inhibitory neurons: 2.0;Late spermatids: 1.8;Oligodendrocytes: 1.3;Sertoli cells: 6.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/84: 3.8" "Low region specificity" "Detected in many" HPA004338 Uncertain "Secreted to blood" NA NA "HPA004338: AB_1079012" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (1.20e-2)" "unprognostic (2.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (7.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.47e-4)" "unprognostic (2.69e-1)" "unprognostic (2.98e-2)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" 0.4 0.5 2.0 0.6 1.6 0.3 0.3 4.1 2.1 0.4 0.6 0.2 0.2 0.5 0.6 0.3 0.9 0.5 0.4 2.4 1.0 0.7 2.0 0.3 0.4 1.2 1.1 1.6 2.2 0.1 0.2 0.9 0.2 1.7 1.9 0.1 0.3 0.8 0.8 0.1 0.1 0.2 0.0 0.2 0.3 1.0 1.4 1.1 0.1 1.1 0.0 0.0 0.3 0.3 1.7 0.5 0.5 1.4 1.8 0.8 0.2 0.2 0.3 0.0 0.2 0.3 0.9 0.3 0.7 0.0 0.1 0.5 1.5 0.5 0.5 0.4 0.5 1.6 0.6 0.6 1.1 0.0 0.0 0.9 1.1 1.1 1.1 0.0 0.2 0.4 1.2 0.7 0.2 0.6 0.5 0.3 1.2 0.6 0.0 0.0 0.4 0.2 0.4 0.2 1.3 2.1 0.9 0.1 1.2 0.7 0.6 1.3 0.6 0.0 0.8 0.3 0.7 0.8 0.5 3.8 0.4 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 4.1 2.1 2.4 1.0 1.2 1.1 1.6 1.7 0.2 1.1 1.7 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DEFB126 "bA530N10.1, C20orf8, DEFB-26" ENSG00000125788 "Defensin beta 126" Q9BYW3 20 142590-145751 "Disease related genes, Predicted secreted proteins" Fertilization "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 297 "epididymis: 1296.6" "Cell type enhanced" "Detected in single" "Prostatic glandular cells: 1.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.0;OE19: 3.4" "Secreted in male reproductive system" NA NA "unprognostic (1.16e-1)" "unprognostic (1.21e-1)" "unprognostic (3.16e-2)" "unprognostic (2.41e-2)" "unprognostic (2.32e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1296.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 3.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.6 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.1 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22580998-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 36.5;pancreas: 26.8;stomach 1: 31.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "midbrain: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "midbrain: 3.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: AB_2685736" "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favorable (6.28e-4)" "prognostic favorable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 14.3 0.0 7.3 3.8 2.1 0.0 0.1 4.4 4.0 0.0 0.0 0.0 0.1 36.5 13.8 0.0 0.1 2.3 0.0 0.0 26.8 0.0 0.0 0.0 0.1 0.3 9.6 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 31.3 0.4 0.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 19.3 0.0 0.0 1.2 0.0 0.0 28.8 0.0 0.0 0.0 0.0 10.3 0.0 12.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 22.7 24.7 0.0 0.0 0.0 0.8 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.4 0.0 0.0 96.1 78.0 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.1 0.3 0.3 47.1 12.5 0.0 0.0 0.0 0.0 21.7 0.0 25.6 0.1 30.8 2.6 0.1 28.1 0.0 0.0 37.0 0.0 0.3 37.8 27.1 4.5 0.0 0.7 63.7 0.0 0.0 0.0 87.2 6.1 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 24.4 6.8 0.0 0.2 1.0 1.0 0.0 10.0 0.0 0.0 0.0 0.2 4.1 0.2 0.0 0.0 0.0 1.0 0.0 28.7 0.1 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079360-23086324 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 138.7" "Cell type enhanced" "Detected in many" "Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5" "Group enriched" "Detected in many" 41 "dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" NA NA 550000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 82.1 12.0 3.0 43.9 3.0 16.6 41.3 2.9 5.9 24.1 7.8 13.7 9.9 18.0 6.1 19.2 23.6 40.1 30.9 2.8 7.7 15.5 16.5 65.1 14.2 5.5 3.8 1.9 6.2 13.3 10.9 6.6 138.7 4.9 11.4 12.2 1.4 9.8 11.0 24.4 11.0 14.6 43.9 4.0 23.6 13.1 4.6 6.7 9.4 21.5 34.7 10.7 41.7 12.9 6.8 0.2 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 346.0 0.0 0.9 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.9 0.2 27.8 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 105.3 442.2 0.0 0.1 0.1 0.5 0.0 0.0 0.3 0.0 593.5 0.1 0.0 25.8 0.4 0.3 16.8 0.0 0.0 0.2 0.1 9.1 0.0 0.0 0.0 27.8 0.1 7.5 1.2 0.5 9.9 3.0 3.0 2.9 5.9 2.8 7.7 5.5 3.8 1.9 4.9 4.0 6.7 6.8 321.5 3.2 7.4 0.0 2.4 15.0 1.0 0.0 6.2 0.0 1.0 1.8 14.3 5.7 3.7 0.0 0.0 0.2 5.0 0.0 0.0 0.5 0.4 0.4 0.7 309.2 0.0 1.3 0.0 0.0 0.5 9.8 0.5 0.4 5.1 0.0 162.8 1.9 19.9 0.0 0.2 0.0 0.0 156.4 52.5 0.8 1.8 102.4 8.8 4.7 131.8 0.2 6.2 0.0 0.1 0.1 0.0 27.8 2.1 4.1 0.0 0.3 3.0 0.1 19.7 5.7 8.0 0.0 0.2 1.6 10.1 0.4 2.4 3.0 0.0 4.0 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373062 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 5.6 18.9 10.6 5.6 11.0 31.8 5.1 12.0 11.2 6.1 9.7 5.8 3.9 6.5 5.3 4.4 6.6 5.5 12.5 10.3 11.6 6.7 6.5 6.0 5.2 11.1 11.6 9.4 9.3 5.3 6.8 7.9 6.4 10.9 5.9 4.1 10.6 5.0 6.9 9.5 4.7 4.9 5.7 11.5 5.4 5.4 13.4 12.9 5.5 7.1 8.1 4.4 5.9 4.6 11.3 8.2 14.2 8.9 9.0 10.3 10.0 7.1 9.8 9.0 9.9 9.2 10.9 6.4 16.6 8.5 8.5 19.3 14.3 10.3 13.2 11.2 2.8 6.7 15.4 6.0 14.7 13.4 9.3 9.0 10.1 9.6 10.7 16.3 13.8 6.7 11.4 10.6 25.2 14.3 10.9 14.5 11.6 6.6 11.5 19.3 9.5 21.3 11.6 7.4 8.2 13.7 7.8 8.7 15.4 20.9 7.3 10.2 13.4 8.7 16.0 9.2 12.1 10.6 20.5 9.0 14.4 4.7 41.8 8.8 0.0 1.6 0.8 0.7 0.9 0.5 1.0 1.0 1.0 1.6 0.6 0.9 1.0 1.2 0.5 1.2 1.3 0.3 0.9 10.6 11.0 12.0 11.2 10.3 11.6 11.1 11.6 9.4 10.9 11.5 12.9 11.3 9.8 6.4 9.6 5.5 12.6 10.8 3.1 3.8 8.6 12.6 6.0 6.9 19.7 1.5 4.7 3.7 18.8 4.9 8.7 3.9 7.9 3.6 18.9 10.4 9.7 8.4 5.4 4.0 6.6 3.3 3.2 8.3 7.1 17.8 13.9 8.2 2.2 5.2 8.7 6.7 7.6 4.2 4.1 13.2 28.8 27.5 9.3 23.9 1.8 1.0 2.5 10.3 5.2 4.5 5.6 4.0 4.6 8.2 11.6 3.2 2.8 3.8 7.7 13.4 0.0 8.8 11.5 20.7 8.9 7.6 8.4 5.6 7.9 14.0 3.7 1.8 PAX1 ENSG00000125813 "Paired box 1" P15863 20 21705659-21718486 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "parathyroid gland: 163.4" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 7.7" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SCLC-21H: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.74e-2)" "unprognostic (3.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.64e-2)" "unprognostic (1.04e-2)" "unprognostic (2.33e-2)" "unprognostic (4.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (8.08e-2)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 163.4 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.4 0.9 0.0 19.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.5 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "brain: 195.7;retina: 155.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 203.4;Cone photoreceptor cells: 66.7;Excitatory neurons: 68.8;Horizontal cells: 67.3;Late spermatids: 75.6;Rod photoreceptor cells: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 31.8;U-937: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol NA NA Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 6.7 24.6 75.5 5.3 113.6 10.7 6.5 68.7 139.8 10.1 20.5 8.9 5.1 7.5 8.9 7.4 9.5 4.8 6.5 105.1 112.0 7.2 7.4 8.4 5.9 101.7 80.1 105.0 13.4 6.7 7.8 18.7 8.8 109.8 8.1 6.8 155.5 6.9 6.0 6.4 7.6 8.1 6.0 47.3 8.8 7.1 9.0 91.0 6.1 9.1 3.2 4.4 8.3 9.5 195.7 5.8 3.7 6.0 6.2 6.6 6.1 8.5 7.4 4.0 5.9 5.1 4.4 5.1 8.6 8.6 4.4 4.3 7.3 7.8 5.0 7.1 2.8 5.8 9.4 5.4 10.5 7.8 7.0 5.4 6.1 6.5 4.2 5.2 5.4 4.4 8.6 8.0 11.0 9.4 4.0 7.2 6.4 2.6 4.7 6.7 4.8 4.9 6.5 7.7 6.2 31.8 10.1 4.3 4.1 7.1 8.7 4.2 4.4 5.2 5.6 4.1 6.2 5.4 8.0 6.7 3.8 2.9 32.9 5.7 2.5 0.5 0.0 1.9 0.5 0.6 0.6 0.8 0.9 0.8 1.2 0.7 1.2 0.6 0.6 0.9 0.6 1.0 0.9 75.5 113.6 68.7 139.8 105.1 112.0 101.7 80.1 105.0 109.8 47.3 91.0 195.7 4.1 12.8 6.5 30.0 6.6 8.7 5.6 4.1 6.2 203.4 4.2 2.9 6.0 7.2 6.8 14.7 66.7 7.0 5.9 3.6 0.0 3.3 39.9 4.4 5.8 7.5 10.2 2.5 68.8 1.4 5.4 7.4 3.1 3.8 11.4 14.3 9.7 5.5 5.2 67.3 63.8 2.7 14.2 7.2 10.2 75.6 9.0 4.0 10.6 24.4 7.9 20.5 15.5 38.2 37.2 2.9 1.8 9.1 4.7 6.4 9.2 3.6 6.1 84.8 6.6 5.4 5.5 13.4 11.2 3.9 8.4 6.2 6.5 9.3 4.2 4.6 CST8 "CRES, CTES5" ENSG00000125815 "Cystatin 8" O60676 20 23491101-23496010 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 203 "testis: 22.5" "Group enriched" "Detected in some" 128 "Early spermatids: 188.7;Late spermatids: 119.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-4 "NKX2.4, NKX2D" ENSG00000125816 "NK2 homeobox 4" Q9H2Z4 20 21395365-21397526 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 3.2;testis: 1.2" "Group enriched" "Detected in some" 24 "Cardiomyocytes: 1.3;Early spermatids: 3.0;Late spermatids: 2.7;Spermatocytes: 3.8;Spermatogonia: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "hypothalamus: 3.2;thalamus: 2.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.5;HEK 293: 5.1;SCLC-21H: 3.2;SK-MEL-30: 4.2;WM-115: 1.2" "Region enriched" "Detected in single" 23 "hypothalamus: 2.7" "Region enriched" "Detected in single" 11 "hypothalamus: 1.1" HPA074996 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA074996: AB_2686725" "unprognostic (3.77e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 4.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.1 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPB ENSG00000125817 "Centromere protein B" P07199 20 3783851-3786740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011626, HPA053507, HPA054405" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477" "unprognostic (2.01e-1)" "unprognostic (8.47e-3)" "unprognostic (2.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.40e-2)" "unprognostic (3.27e-2)" "unprognostic (3.57e-1)" "unprognostic (1.48e-3)" "unprognostic (7.93e-2)" "unprognostic (2.78e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" 42.3 40.2 123.6 20.6 119.9 15.1 40.6 106.7 110.7 41.0 75.8 49.7 21.6 45.8 11.1 42.6 36.5 15.4 48.5 97.8 101.3 33.7 42.6 36.3 17.6 129.8 120.7 87.4 36.9 41.1 26.3 29.8 15.4 131.3 40.3 12.7 4.0 35.3 24.3 95.8 53.5 35.1 19.6 129.4 36.2 44.7 10.8 122.3 17.8 35.2 43.6 13.8 48.6 34.2 128.1 111.9 140.4 27.1 58.1 56.2 44.4 17.4 78.2 56.4 49.1 39.5 57.5 78.1 38.7 24.0 72.9 77.0 88.3 21.7 88.9 24.6 55.5 37.1 82.3 51.5 51.4 65.2 27.0 26.7 50.5 46.9 70.5 45.0 38.5 42.5 49.2 53.9 23.8 42.4 183.2 81.1 61.8 34.0 62.7 165.4 66.8 3.6 28.3 52.2 67.6 66.2 49.4 64.7 89.7 62.4 12.2 56.7 59.1 73.2 84.9 45.8 74.1 121.3 28.5 44.1 22.5 29.8 95.2 56.9 0.0 1.7 0.6 1.9 1.7 1.3 1.0 1.3 1.2 1.3 1.4 1.1 1.4 0.2 1.7 1.1 1.7 0.4 1.1 123.6 119.9 106.7 110.7 97.8 101.3 129.8 120.7 87.4 131.3 129.4 122.3 128.1 30.2 6.4 19.5 2.3 6.8 13.9 5.7 11.2 15.9 18.3 23.8 23.1 16.5 30.0 11.6 14.7 10.4 6.2 17.2 48.0 3.9 18.9 1.2 12.7 21.5 24.7 20.4 12.0 2.6 29.8 7.9 14.6 15.8 18.1 7.6 24.0 17.9 25.6 22.7 21.9 4.5 27.1 6.1 25.7 12.3 7.5 21.8 15.3 17.8 3.7 17.3 31.1 12.3 1.5 3.8 31.0 25.4 25.9 5.7 12.5 28.4 8.7 10.8 13.0 13.1 22.4 21.9 1.1 1.5 17.4 14.1 4.5 11.8 46.5 26.9 7.4 PSMF1 PI31 ENSG00000125818 "Proteasome inhibitor subunit 1" Q92530 20 1113240-1189415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 15 "Early spermatids: 1242.7;Late spermatids: 4603.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041122, HPA041300" Approved Enhanced Cytosol NA NA 160000 Cytosol "HPA041122: AB_10805838, HPA041300: AB_10794370" "unprognostic (1.79e-2)" "unprognostic (8.96e-2)" "unprognostic (7.22e-2)" "unprognostic (3.88e-2)" "unprognostic (1.68e-3)" "unprognostic (1.43e-2)" "unprognostic (9.14e-3)" "unprognostic (1.56e-1)" "unprognostic (7.03e-2)" "unprognostic (4.71e-1)" "unprognostic (2.45e-1)" "unprognostic (7.41e-2)" "unprognostic (3.72e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-2)" "unprognostic (8.32e-2)" 48.8 38.1 30.6 42.2 30.6 54.2 43.8 31.2 35.9 42.5 30.1 46.4 44.6 42.8 28.0 48.2 38.1 27.1 48.8 29.7 30.8 39.7 73.2 43.8 41.2 34.0 30.3 27.6 44.2 57.3 43.5 35.5 26.5 33.0 33.6 32.0 33.2 39.1 32.8 129.5 45.4 43.2 37.2 29.1 38.6 44.4 108.5 33.6 41.6 38.1 84.3 40.2 42.6 39.4 34.3 141.5 126.4 29.7 70.3 63.8 66.5 50.8 83.8 64.9 76.1 67.2 118.2 96.4 71.2 56.1 90.3 79.3 123.8 78.9 143.3 95.1 42.3 47.0 99.1 20.8 217.0 83.7 120.6 33.2 67.9 82.3 85.3 132.7 45.9 83.2 55.3 101.5 138.8 62.9 75.4 156.3 107.9 42.6 81.4 79.2 74.5 62.2 118.6 67.7 117.9 75.4 52.4 92.3 159.1 77.3 28.5 108.8 43.3 96.8 95.3 63.8 111.3 115.6 85.9 185.5 77.5 41.8 81.3 74.7 123.8 65.2 123.3 49.8 80.2 57.8 73.2 66.2 54.4 66.3 69.0 59.7 52.8 71.7 58.5 83.0 37.8 81.6 69.4 30.6 30.6 31.2 35.9 29.7 30.8 34.0 30.3 27.6 33.0 29.1 33.6 34.3 48.7 35.3 44.2 34.0 58.3 41.2 59.1 81.0 33.0 32.7 40.5 41.5 55.4 31.5 44.8 40.5 4.2 68.0 48.8 51.9 82.2 102.5 1242.7 27.3 38.4 47.4 67.4 190.1 25.2 103.8 88.9 50.2 48.4 28.1 49.5 46.5 50.0 70.0 100.3 21.9 25.4 57.9 34.6 56.3 56.7 4603.4 77.3 58.2 51.6 34.7 76.1 64.3 55.6 22.1 38.1 99.4 75.3 88.8 66.8 69.0 103.3 80.7 32.4 33.1 118.3 36.7 65.0 97.4 90.7 52.1 48.6 74.0 55.0 73.0 62.6 68.8 NKX2-2 "NKX2.2, NKX2B" ENSG00000125820 "NK2 homeobox 2" O95096 20 21511017-21514064 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 35.6" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 166.1;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 73.1" "Group enriched" "Detected in many" 5 "glioma: 9.5;pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;T-47d: 4.9;U-138 MG: 17.1;U-2 OS: 3.6;WM-115: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003468 Approved NA NA "HPA003468: AB_1079490" "unprognostic (5.13e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" 0.0 0.0 10.8 0.0 21.5 0.0 0.0 18.9 13.1 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 7.5 12.9 0.0 0.0 0.0 0.0 23.9 20.4 5.4 0.0 4.9 0.0 7.5 0.0 24.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 20.4 0.0 2.5 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 17.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 21.5 18.9 13.1 7.5 12.9 23.9 20.4 5.4 24.1 20.4 18.3 35.6 0.1 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 166.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 56.8 73.1 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-aminoacyl-tRNA deacylase 1" Q8TEA8 20 18587942-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 350000 "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 21.9 21.3 7.0 3.7 7.1 4.6 21.7 7.1 7.7 18.3 7.0 15.7 2.7 19.8 4.9 26.8 18.7 3.2 16.9 7.1 7.3 25.7 10.9 16.2 4.1 7.5 7.3 6.7 17.7 20.6 7.8 34.1 3.4 7.3 13.9 4.2 6.7 22.1 3.1 29.3 26.8 13.8 4.1 6.8 15.4 16.3 19.3 7.3 2.1 19.5 6.8 4.6 17.2 19.6 7.4 10.1 15.7 15.8 16.2 8.8 12.2 9.1 4.3 12.3 10.5 11.3 10.0 11.4 0.1 4.1 13.6 13.9 5.3 13.1 25.0 10.4 6.8 3.2 10.2 4.0 18.7 22.8 9.4 8.2 10.2 22.4 11.8 42.1 8.7 16.5 3.0 7.0 22.5 15.3 24.9 1.7 23.8 11.0 13.5 9.9 0.0 16.6 11.1 16.6 8.2 16.6 13.0 4.4 20.4 23.6 7.1 12.3 9.2 10.2 14.3 3.8 17.7 14.5 5.5 10.2 4.6 8.6 13.9 11.1 1.7 0.7 0.4 1.8 1.0 0.8 1.1 0.6 1.0 1.5 0.7 0.5 0.5 0.9 1.4 1.0 0.2 0.4 0.6 7.0 7.1 7.1 7.7 7.1 7.3 7.5 7.3 6.7 7.3 6.8 7.3 7.4 35.5 35.3 24.0 32.0 26.8 23.6 40.9 48.3 22.2 42.4 27.9 33.0 18.8 28.6 23.1 42.3 2.1 26.7 24.7 9.9 43.0 71.9 38.4 16.2 33.1 36.4 23.3 22.1 41.9 87.4 37.8 29.9 13.7 17.8 42.5 24.6 35.7 11.2 47.8 43.7 60.6 23.5 28.5 23.5 35.9 21.8 18.0 27.1 42.7 12.2 42.8 58.2 38.1 53.3 52.2 90.6 19.1 19.5 24.6 50.6 9.3 73.8 22.8 34.9 0.0 30.1 27.5 93.5 124.2 33.2 35.7 12.4 35.5 42.7 26.8 31.9 CSTL1 "CTES1, dJ322G13.4" ENSG00000125823 "Cystatin like 1" Q9H114 20 23439685-23444930 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "testis: 4.4" "Group enriched" "Detected in some" 631 "Early spermatids: 51.3;Late spermatids: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (1.54e-1)" "unprognostic (3.25e-3)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (3.63e-1)" "unprognostic (2.97e-1)" "unprognostic (6.87e-2)" "unprognostic (2.35e-1)" "unprognostic (5.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RBCK1 "C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4" ENSG00000125826 "RANBP2-type and C3HC4-type zinc finger containing 1" Q9BYM8 20 407498-432139 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 255.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.94e-2)" "unprognostic (2.50e-1)" "unprognostic (1.62e-2)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.54e-3)" "unprognostic (1.15e-2)" "unprognostic (7.89e-2)" "unprognostic (3.44e-1)" "unprognostic (1.22e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.41e-9)" "unprognostic (5.87e-2)" "unprognostic (3.64e-2)" "unprognostic (3.33e-2)" "unprognostic (2.39e-3)" 39.1 69.1 19.7 29.1 21.4 25.9 39.0 23.9 32.6 48.8 15.5 49.1 34.9 47.4 14.0 55.5 45.1 19.6 38.6 18.1 21.1 52.9 109.8 48.1 28.4 25.6 20.2 15.7 53.9 55.8 30.3 64.6 23.0 21.3 56.4 17.9 12.3 42.3 26.5 38.9 42.0 57.3 19.4 17.6 66.7 50.7 35.1 20.0 44.1 47.1 18.4 18.2 46.0 47.2 26.0 64.0 88.4 21.9 37.2 44.3 54.7 44.9 34.2 55.0 56.2 73.4 53.7 74.1 29.2 51.3 70.7 103.5 62.7 29.4 151.0 19.0 21.7 29.8 30.2 23.9 140.9 185.3 28.4 21.5 83.1 255.7 43.0 173.2 68.2 50.8 109.8 29.6 55.0 40.7 33.2 61.5 69.9 18.4 77.4 73.0 40.3 21.8 37.3 72.7 57.5 41.3 35.9 24.1 122.4 140.7 25.0 73.3 64.2 31.0 54.5 27.0 33.2 46.5 44.4 61.6 35.6 24.5 61.4 39.0 56.5 48.8 85.4 61.9 71.3 43.5 48.1 48.0 63.1 43.6 46.8 38.7 45.2 135.6 52.4 83.9 72.1 55.7 52.7 19.7 21.4 23.9 32.6 18.1 21.1 25.6 20.2 15.7 21.3 17.6 20.0 26.0 69.4 32.1 39.8 40.8 54.4 44.5 77.1 96.2 49.5 15.3 65.4 66.7 19.9 64.3 48.2 57.0 16.7 88.7 72.6 111.4 62.6 111.7 58.9 40.4 45.3 59.3 61.7 43.8 15.8 116.2 102.4 52.3 50.0 54.3 43.8 62.9 57.1 139.3 66.8 16.8 17.8 122.8 46.8 69.8 44.2 163.3 65.9 57.2 42.7 23.4 69.1 45.1 106.1 22.1 24.3 108.5 161.0 47.8 30.5 98.8 185.2 74.5 39.0 29.0 46.0 56.9 51.9 32.6 29.3 69.0 40.2 94.7 71.0 110.6 74.2 120.3 TMX4 "DJ971N18.2, KIAA1162, PDIA14, TXNDC13" ENSG00000125827 "Thioredoxin related transmembrane protein 4" Q9H1E5 20 7977346-8019805 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 690.2;Late spermatids: 1524.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000399, HPA015752" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA000399: AB_1858471, HPA015752: AB_1858470" "unprognostic (3.93e-2)" "unprognostic (5.96e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-3)" "unprognostic (5.14e-2)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" "unprognostic (3.66e-1)" "unprognostic (2.96e-1)" "unprognostic (5.80e-3)" "unprognostic (3.16e-1)" "prognostic favorable (2.60e-5)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" 19.7 39.1 20.6 18.6 21.9 30.9 20.0 20.4 29.8 42.0 27.8 19.6 13.5 29.5 33.8 15.2 29.6 20.0 59.9 21.3 46.9 30.0 29.0 19.6 15.1 27.4 25.8 21.2 36.1 15.2 38.3 29.1 12.2 27.2 26.9 13.0 38.2 37.5 42.7 30.6 8.1 14.4 27.0 21.4 17.8 17.6 65.5 36.2 15.5 26.6 32.8 14.8 18.1 13.8 22.8 10.4 14.5 14.0 15.9 30.4 33.5 4.2 25.7 34.0 15.4 11.0 10.0 24.0 27.3 20.2 24.9 22.6 9.5 10.1 15.2 16.0 14.0 12.9 13.1 5.7 16.0 28.6 48.5 19.0 20.5 19.1 13.4 31.0 36.9 18.1 19.5 16.3 65.4 17.3 6.7 1.5 30.3 12.0 14.9 16.5 17.5 50.4 27.6 21.8 5.7 28.1 35.2 42.2 1.9 24.6 8.8 17.7 23.4 26.1 41.4 12.1 15.9 25.2 69.3 21.6 51.6 20.1 23.8 29.7 81.5 28.0 78.2 39.0 16.4 37.9 35.8 39.1 55.8 32.9 27.5 23.4 32.0 164.1 41.8 18.0 11.2 55.1 52.7 20.6 21.9 20.4 29.8 21.3 46.9 27.4 25.8 21.2 27.2 21.4 36.2 22.8 52.7 35.3 29.2 22.2 66.4 16.4 65.1 23.7 22.2 57.9 38.6 52.6 257.5 40.0 20.8 58.8 58.4 19.5 91.5 21.9 21.5 31.0 690.2 266.2 44.4 49.7 55.8 51.1 85.8 32.7 5.2 80.3 38.7 29.4 60.3 34.5 45.7 53.3 24.7 92.5 68.6 21.1 40.7 33.8 40.3 1524.7 77.0 55.1 46.2 20.6 37.5 85.7 64.9 38.7 38.4 24.7 20.4 56.1 72.9 45.3 31.1 23.8 29.4 99.0 32.9 136.4 43.1 178.7 39.7 30.9 15.6 8.2 99.2 28.2 24.6 30.4 CST11 "CST8L, CTES2, dJ322G13.6" ENSG00000125831 "Cystatin 11" Q9H112 20 23450403-23452876 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 473 "epididymis: 212.5" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Endometrial stromal cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053399 Enhanced "Secreted in male reproductive system" NA NA "HPA053399: AB_2682136" "unprognostic (9.42e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.3 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STK35 "bA550O8.2, CLIK1" ENSG00000125834 "Serine/threonine kinase 35" Q8TDR2 20 2101827-2177038 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 119.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 150.1;Early spermatids: 214.3;Horizontal cells: 294.4;Late spermatids: 821.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026452, HPA051673" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026452: AB_2671861, HPA051673: AB_2681569" "unprognostic (2.25e-2)" "unprognostic (2.97e-1)" "unprognostic (2.87e-2)" "unprognostic (1.30e-2)" "unprognostic (3.25e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (9.46e-6)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (3.05e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-1)" "unprognostic (4.39e-2)" "unprognostic (1.74e-1)" "unprognostic (4.67e-1)" "unprognostic (1.40e-1)" "unprognostic (4.99e-2)" 9.1 11.4 9.0 6.7 7.7 8.7 7.9 6.0 12.5 7.4 4.5 9.7 7.2 9.8 5.8 15.8 8.7 7.2 9.4 9.1 7.9 6.8 9.0 8.6 6.5 6.1 9.9 7.6 8.0 9.4 7.9 9.8 6.2 7.9 8.1 8.2 119.8 8.7 6.3 6.6 10.9 9.4 7.9 4.4 8.3 8.7 18.4 15.1 6.4 8.6 5.8 7.7 8.1 9.0 8.1 23.3 19.4 14.7 25.4 6.7 9.1 17.9 9.3 11.4 12.2 12.5 25.6 17.5 15.9 7.5 11.7 19.0 34.1 17.6 21.4 13.8 6.3 8.4 15.2 7.4 28.1 8.5 13.7 6.8 7.9 18.5 19.5 16.7 11.2 11.7 15.0 14.9 12.8 8.0 10.3 17.4 19.4 27.5 18.4 12.9 14.9 13.2 10.1 11.1 22.9 24.3 11.8 16.6 29.3 15.0 17.0 14.5 13.5 10.0 20.7 14.1 10.5 14.9 11.1 15.5 10.8 11.1 14.7 9.2 0.0 0.3 0.1 0.4 0.2 0.6 0.3 0.6 0.3 0.5 0.4 0.5 0.4 0.7 0.2 0.3 0.4 0.2 0.3 9.0 7.7 6.0 12.5 9.1 7.9 6.1 9.9 7.6 7.9 4.4 15.1 8.1 8.8 12.8 9.8 4.9 6.3 11.6 4.4 7.5 13.1 111.8 10.9 9.5 12.2 2.8 9.1 3.7 150.1 7.2 7.5 15.4 1.9 6.4 214.3 15.7 7.8 9.1 6.1 12.0 11.8 6.8 11.5 11.1 11.2 12.7 9.5 8.4 7.9 10.3 5.7 294.4 11.6 7.6 10.2 6.3 4.9 821.8 6.8 5.7 7.2 11.2 4.0 124.7 5.2 9.0 11.2 10.4 9.7 6.0 8.5 6.7 8.8 3.6 10.2 96.7 0.0 10.8 7.2 15.5 14.4 12.4 11.8 5.7 6.0 4.5 10.9 6.6 SNRPB "COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1" ENSG00000125835 "Small nuclear ribonucleoprotein polypeptides B and B1" P14678 20 2461634-2470853 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA003482, CAB009610, HPA067842" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (2.33e-1)" "unprognostic (3.14e-2)" "unprognostic (5.64e-2)" "unprognostic (2.73e-2)" "unprognostic (9.47e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.07e-5)" "unprognostic (5.11e-2)" "unprognostic (3.66e-1)" "unprognostic (4.66e-2)" "unprognostic (7.30e-2)" "unprognostic (4.20e-2)" "unprognostic (2.21e-1)" "unprognostic (2.79e-1)" "unprognostic (1.13e-1)" "unprognostic (9.18e-2)" "unprognostic (9.47e-2)" 110.1 111.4 43.1 111.7 43.6 348.4 112.5 48.2 54.9 97.8 46.1 102.7 103.6 120.4 67.3 178.5 94.5 63.3 81.8 43.6 45.6 96.7 92.6 112.6 168.1 45.1 43.1 43.3 94.6 78.6 83.8 73.1 83.6 44.4 88.6 87.3 25.2 100.5 63.0 113.6 148.4 110.1 86.6 46.4 140.1 101.5 83.8 44.8 170.4 77.7 60.4 155.2 110.4 109.8 47.1 782.5 1063.7 376.7 340.4 83.8 149.1 418.7 334.6 259.8 693.8 556.2 1209.6 555.7 588.8 210.6 203.2 556.7 567.8 370.7 636.2 350.3 239.7 658.6 400.5 190.0 1148.0 290.0 560.3 236.6 171.3 237.9 564.0 252.6 132.2 389.0 491.1 561.0 414.6 288.7 543.0 897.1 916.2 825.2 405.8 520.8 531.3 379.0 711.4 266.8 407.8 405.6 442.7 414.5 554.3 503.2 162.8 524.5 612.9 266.7 404.4 340.9 360.8 764.8 345.5 938.8 877.1 137.7 623.8 419.5 167.9 166.7 133.0 202.8 210.9 170.5 210.7 178.0 179.5 226.7 210.6 144.2 167.5 87.8 166.0 221.6 237.4 241.5 266.0 43.1 43.6 48.2 54.9 43.6 45.6 45.1 43.1 43.3 44.4 46.4 44.8 47.1 197.0 44.8 69.1 4.6 206.9 478.6 335.2 309.4 150.2 46.8 156.8 151.8 17.9 112.9 167.3 93.8 12.5 365.2 251.9 163.6 144.8 347.3 17.1 98.3 143.0 202.9 142.0 170.0 6.8 295.8 647.8 155.4 89.2 128.4 144.5 215.0 83.2 60.8 294.8 30.3 6.3 239.4 203.4 102.7 308.3 20.4 159.1 158.0 190.3 6.5 189.5 68.9 265.7 6.0 8.5 404.6 171.9 123.8 176.9 421.8 119.3 143.6 98.9 57.5 157.8 169.6 228.5 329.6 308.3 181.5 423.1 373.4 210.1 306.7 293.5 433.2 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 155.9" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 17.4 57.5 101.8 10.6 111.0 1.7 17.6 84.8 155.9 27.0 67.8 23.1 6.0 32.7 26.1 9.8 28.1 15.6 31.2 110.4 95.4 33.2 4.8 22.6 7.6 90.8 91.3 107.8 36.3 20.5 43.0 60.8 17.0 103.3 28.5 9.8 57.4 21.3 25.7 3.4 10.9 13.2 27.7 73.2 16.9 20.4 30.9 93.5 5.6 28.3 5.8 7.3 23.7 18.4 100.6 56.5 68.3 40.2 37.7 53.0 58.4 15.2 37.4 72.3 66.3 66.8 38.2 1.2 0.0 12.6 70.7 48.9 24.1 33.5 5.8 42.4 0.3 33.0 20.8 32.5 70.7 53.5 0.6 3.3 67.4 4.5 48.2 8.1 54.1 46.4 0.3 40.3 35.1 59.2 10.0 0.9 17.9 31.3 0.7 34.9 32.4 22.1 2.7 67.4 0.3 80.8 58.0 44.9 13.0 64.9 26.5 53.2 19.7 31.0 70.6 36.4 2.6 45.6 6.5 1.4 14.7 9.5 0.6 36.7 0.0 0.7 1.2 2.4 0.3 0.7 5.6 0.8 2.6 1.5 6.9 1.0 1.8 0.0 2.8 0.3 3.5 0.6 1.1 101.8 111.0 84.8 155.9 110.4 95.4 90.8 91.3 107.8 103.3 73.2 93.5 100.6 3.8 0.0 3.1 16.0 2.2 3.2 3.6 8.5 7.4 26.5 5.8 5.0 5.5 1.5 6.1 12.9 2.1 7.3 0.5 2.6 1.9 14.7 9.6 4.7 12.0 6.9 29.4 1.3 21.0 1.6 6.8 10.4 3.1 3.9 5.1 7.6 5.7 0.3 3.2 16.8 27.1 2.6 4.1 0.9 2.2 14.4 13.1 0.7 3.6 2.8 2.1 17.3 2.1 12.1 5.9 2.9 1.8 10.5 2.6 3.3 0.2 7.8 3.6 15.4 19.7 4.9 9.2 21.3 12.8 1.4 2.3 4.4 1.4 12.9 2.2 2.9 AP5S1 "C20orf29, FLJ11168" ENSG00000125843 "Adaptor related protein complex 5 subunit sigma 1" Q9NUS5 20 3820524-3828838 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034200, HPA043533, HPA048244" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328" "unprognostic (1.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (2.74e-2)" "unprognostic (1.34e-1)" "unprognostic (2.05e-2)" "unprognostic (5.49e-2)" "unprognostic (7.76e-2)" "unprognostic (1.33e-1)" "unprognostic (8.91e-2)" "unprognostic (5.15e-3)" "unprognostic (8.17e-2)" "prognostic favorable (5.53e-5)" "unprognostic (2.92e-1)" "unprognostic (1.62e-1)" "unprognostic (6.09e-3)" "unprognostic (5.08e-2)" 6.0 11.6 6.5 5.5 7.1 7.4 5.8 6.0 8.2 4.8 7.0 5.6 6.4 5.7 3.0 7.4 4.8 4.6 10.2 6.9 6.2 9.5 14.7 5.4 5.6 6.5 6.1 6.9 5.9 7.5 7.9 7.5 5.4 7.1 6.9 4.4 3.5 8.7 3.6 19.4 5.2 6.4 4.0 5.8 8.3 6.5 11.3 6.2 4.3 9.5 10.1 3.8 5.4 5.1 6.1 18.1 33.8 4.6 3.1 6.2 8.0 5.7 10.8 8.6 10.4 8.3 28.5 18.9 10.4 11.3 11.4 19.7 15.9 3.9 17.4 3.6 5.7 10.9 17.3 10.1 25.3 10.7 12.0 10.0 13.7 9.7 13.0 10.3 7.0 12.4 12.4 12.4 19.8 14.0 29.4 28.0 10.5 4.2 13.0 27.3 11.7 7.8 10.8 11.8 14.4 14.2 5.7 10.6 32.4 18.2 3.1 15.9 5.9 16.9 21.7 10.3 11.3 20.6 10.6 12.6 5.7 7.5 10.6 19.0 2.2 7.5 4.6 10.2 11.9 7.8 5.4 8.5 8.4 9.9 7.0 7.8 7.3 1.7 6.2 6.7 7.7 9.9 6.5 6.5 7.1 6.0 8.2 6.9 6.2 6.5 6.1 6.9 7.1 5.8 6.2 6.1 4.0 0.0 10.6 2.3 5.9 1.7 4.4 8.0 7.4 15.3 4.9 4.3 11.2 11.5 5.9 3.7 10.4 19.4 3.8 8.4 11.7 11.1 3.7 5.1 6.2 8.6 12.6 9.9 1.9 12.7 13.3 6.8 14.8 5.2 14.0 6.6 6.1 9.4 15.5 25.2 2.1 7.3 8.2 6.9 2.0 3.6 5.9 7.3 5.4 4.7 11.0 12.8 8.2 2.5 1.7 10.2 8.8 4.1 8.6 3.6 11.2 8.5 4.5 20.8 13.1 5.8 4.5 19.4 10.9 6.8 1.0 18.5 6.2 10.9 7.4 3.0 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 501.9" "Cell type enhanced" "Detected in all" "Distal enterocytes: 588.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 37.8;plasmacytoid DC: 44.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" NA NA 320000 "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favorable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.38e-4)" 59.8 72.9 29.2 63.4 38.1 28.3 55.0 39.1 29.9 69.7 48.6 99.2 76.8 60.0 55.5 68.4 45.5 72.2 53.9 24.9 46.8 62.7 220.8 80.9 28.5 49.9 40.8 19.1 48.7 501.9 72.9 63.9 108.8 42.0 67.1 66.6 17.8 230.2 63.9 22.1 41.9 83.4 46.4 38.6 58.1 124.2 48.8 37.5 14.5 131.6 14.9 27.2 58.2 55.7 48.5 173.5 121.0 35.7 80.4 160.3 172.2 186.2 264.3 221.3 110.0 148.2 271.2 159.3 66.5 87.3 252.2 113.4 170.4 38.7 215.4 89.1 30.9 29.7 76.2 34.9 283.6 229.4 29.0 93.0 228.9 63.8 178.7 104.3 161.7 109.7 23.4 32.6 62.9 167.6 78.8 11.4 65.5 41.6 383.3 115.8 20.1 94.2 231.3 93.0 58.4 18.2 13.7 151.1 353.2 108.4 75.0 62.0 43.5 198.7 232.7 85.9 122.1 88.5 114.6 93.6 21.6 88.1 30.7 121.1 11.7 8.4 37.8 4.3 5.5 3.2 1.0 1.4 2.6 4.6 1.4 1.4 1.6 7.8 10.7 8.4 44.4 1.5 3.1 29.2 38.1 39.1 29.9 24.9 46.8 49.9 40.8 19.1 42.0 38.6 37.5 48.5 146.8 96.1 197.1 15.0 72.5 59.1 92.3 90.3 55.2 21.9 127.0 76.3 46.4 144.4 158.2 95.6 31.3 262.0 180.6 588.9 45.0 199.7 47.2 117.5 228.4 155.8 97.0 31.6 3.0 414.6 235.8 219.7 294.6 322.8 118.9 78.1 118.9 279.9 117.4 25.2 4.9 507.9 50.8 62.0 85.7 44.3 127.1 91.6 71.2 17.8 75.1 144.3 79.3 23.1 27.6 357.7 452.3 83.1 570.6 145.6 221.6 57.2 121.8 35.5 32.9 165.1 169.8 77.5 139.9 73.2 55.8 532.9 56.9 114.6 329.3 218.5 BMP2 BMP2A ENSG00000125845 "Bone morphogenetic protein 2" P12643 20 6767686-6780246 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 155.9;Basal keratinocytes: 167.1;Distal enterocytes: 125.6;Suprabasal keratinocytes: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 31.6;HeLa: 19.6;hTERT-HME1: 17.8;RT4: 25.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA058610, CAB078457" Enhanced Vesicles "Secreted to blood" NA NA 24400 21000 Vesicles "CAB078457: AB_2532532, HPA058610: AB_2683777" "unprognostic (2.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.12e-2)" "unprognostic (3.56e-2)" "unprognostic (1.94e-2)" "unprognostic (2.48e-1)" "unprognostic (3.70e-3)" "unprognostic (3.12e-3)" "unprognostic (8.51e-2)" "unprognostic (8.46e-2)" "unprognostic (2.53e-3)" "unprognostic (5.39e-3)" "unprognostic (7.81e-2)" "unprognostic (3.76e-1)" "unprognostic (2.77e-1)" "unprognostic (3.01e-2)" "unprognostic (7.49e-2)" 18.7 1.6 1.3 4.0 1.4 1.6 6.1 1.4 2.0 5.2 1.0 15.3 6.7 5.2 0.6 5.6 3.8 16.3 3.7 1.8 3.0 3.9 5.9 19.0 2.0 1.9 2.1 0.9 2.8 9.2 3.3 2.3 11.6 2.4 1.9 13.7 1.4 2.1 1.2 2.3 9.3 9.8 2.6 1.5 12.5 20.9 0.5 1.8 0.4 19.1 2.7 1.8 17.4 6.4 1.9 0.1 0.3 0.0 0.0 0.5 0.2 0.0 0.8 3.4 0.0 0.0 31.6 0.1 0.0 0.5 1.1 0.0 10.5 6.2 2.7 0.0 0.0 5.5 0.0 19.6 0.1 1.5 0.0 0.8 0.2 9.2 0.0 17.8 4.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 6.0 0.8 3.7 0.8 6.2 0.1 0.4 2.3 25.0 1.1 1.6 7.3 0.0 0.0 5.5 0.0 6.5 1.5 1.8 2.7 0.0 0.9 0.3 0.9 0.0 3.0 1.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 1.4 1.4 2.0 1.8 3.0 1.9 2.1 0.9 2.4 1.5 1.8 1.9 9.4 80.1 155.9 0.3 1.1 167.1 45.1 11.0 70.0 0.4 1.4 2.2 4.7 42.9 10.5 1.8 0.0 0.1 3.8 125.6 0.0 23.3 0.3 1.7 34.8 24.1 11.3 0.0 1.1 9.8 0.2 20.2 33.6 3.0 8.8 1.9 41.4 3.4 3.6 0.0 3.5 23.8 0.0 2.9 16.8 0.2 5.9 2.9 8.8 2.8 0.6 6.2 0.0 8.5 1.4 33.5 60.3 0.0 1.3 47.5 28.3 2.1 0.8 0.2 19.7 36.5 48.8 0.0 0.3 43.1 119.3 0.1 2.1 4.3 48.2 43.3 ZNF133 "pHZ-13, pHZ-66, ZNF150" ENSG00000125846 "Zinc finger protein 133" P52736 20 18288283-18316996 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.1;Inhibitory neurons: 42.0;Oligodendrocyte precursor cells: 32.6;Oligodendrocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001493 Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA001493: AB_1080666" "unprognostic (9.09e-3)" "unprognostic (3.24e-1)" "unprognostic (8.27e-3)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.46e-6)" "unprognostic (6.01e-3)" "unprognostic (8.60e-2)" "unprognostic (4.17e-1)" "unprognostic (1.04e-3)" "unprognostic (7.36e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (1.52e-1)" 12.0 13.2 17.4 4.7 17.8 4.3 14.6 19.7 19.1 17.1 20.2 13.8 5.3 13.5 16.7 15.0 14.2 7.8 11.1 17.6 17.7 15.3 13.1 11.0 5.7 17.5 17.1 17.5 17.7 16.1 11.5 21.4 8.8 17.4 18.9 6.9 10.6 13.0 8.9 14.1 16.4 10.4 10.6 15.9 15.6 13.0 10.3 17.5 7.1 17.5 9.9 5.9 14.3 15.2 18.8 10.0 10.8 8.3 12.0 19.9 13.7 17.6 9.2 13.5 11.5 16.6 8.7 11.5 2.6 5.4 10.9 13.2 21.4 8.1 24.1 10.8 2.9 5.6 6.8 9.9 19.4 14.9 5.8 1.0 13.4 16.3 9.6 28.0 15.6 11.2 11.0 8.1 2.8 10.0 10.0 7.2 9.5 6.9 11.9 10.6 6.2 11.4 6.4 11.3 6.8 11.7 11.9 7.1 18.9 13.3 11.5 7.4 15.7 8.0 12.1 5.8 8.6 9.2 9.1 9.8 0.9 3.7 3.9 7.0 1.5 3.1 2.4 5.9 2.2 3.9 3.2 5.0 4.0 3.9 3.4 3.8 4.6 1.0 8.7 3.5 2.1 4.0 2.7 17.4 17.8 19.7 19.1 17.6 17.7 17.5 17.1 17.5 17.4 15.9 17.5 18.8 3.7 6.4 9.2 18.6 2.5 2.2 2.7 7.3 3.4 7.5 4.6 7.4 7.9 5.7 5.7 1.8 4.2 5.0 0.8 2.2 3.9 4.5 14.7 5.1 7.7 4.7 1.2 3.2 37.1 2.3 3.2 5.3 5.1 4.5 7.0 7.1 5.3 4.2 4.7 3.3 42.0 4.6 2.0 3.8 0.9 25.0 7.8 2.2 0.0 21.5 1.4 3.1 4.1 32.6 31.8 3.7 1.5 4.5 2.3 3.3 2.5 3.4 5.0 5.0 0.0 4.4 3.6 6.1 2.6 3.0 3.1 2.3 1.9 3.7 3.3 3.0 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322985-14337614 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: AB_2683016" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 2.3 3.7 1.7 0.8 3.5 0.0 2.3 7.2 5.9 3.2 1.1 1.4 11.9 2.3 3.1 1.6 2.4 5.0 0.4 5.5 2.2 23.4 7.0 17.9 0.1 0.4 2.1 2.5 10.7 1.2 8.2 1.0 1.8 2.0 8.2 0.8 1.6 1.2 14.1 2.0 6.4 2.3 1.4 0.6 0.7 9.8 1.2 2.4 7.4 5.2 0.7 0.3 8.0 2.1 3.3 0.0 12.2 27.5 0.0 0.0 0.0 0.0 2.7 0.8 0.1 0.0 15.3 5.6 0.0 0.9 0.6 0.0 8.0 0.0 8.3 0.1 0.0 1.8 0.0 0.4 0.3 2.4 0.0 0.0 4.6 51.3 0.0 9.7 0.0 0.1 0.2 0.0 0.2 5.3 0.4 3.7 0.0 8.9 6.2 0.1 0.1 0.2 0.0 17.3 3.6 0.5 5.7 0.0 0.0 9.2 15.5 0.5 0.0 0.0 0.0 1.8 0.1 0.7 0.0 0.0 0.0 0.2 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.5 7.2 5.9 5.5 2.2 0.4 2.1 2.5 2.0 0.6 2.4 3.3 0.3 218.0 156.5 2.3 0.5 8.7 168.3 26.1 55.8 23.9 4.4 6.5 1.2 24.3 73.1 22.0 6.2 0.5 0.0 2.2 13.7 23.6 0.2 0.7 1.7 1.9 11.3 0.0 27.2 14.9 0.0 8.7 37.8 0.7 5.1 5.0 2.9 8.5 0.2 6.7 39.3 2.5 2.0 0.3 0.7 0.5 3.7 1.3 5.4 1.9 1.6 0.6 0.0 26.2 3.9 10.0 3.0 0.4 0.1 24.9 3.5 49.2 13.4 3.3 0.0 25.0 1.8 0.0 0.1 5.9 16.6 0.0 0.8 1.4 1.5 18.3 OVOL2 "bA504H3.3, CHED, CHED1, HOVO2, ZNF339" ENSG00000125850 "Ovo like zinc finger 2" Q9BRP0 20 17956979-18059188 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 7.2;stomach 1: 8.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 24.4;Spermatocytes: 37.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.6;CACO-2: 4.1;CAPAN-2: 7.3;HaCaT: 5.4;OE19: 10.0;SCLC-21H: 8.3;SK-BR-3: 5.4" "Region enhanced" "Detected in many" "cerebral cortex: 10.3" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.9;hippocampal formation: 3.3" HPA038531 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038531: AB_10673012" "unprognostic (2.85e-2)" "unprognostic (5.13e-2)" "unprognostic (2.41e-2)" "unprognostic (7.35e-2)" "unprognostic (2.14e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.40e-1)" "unprognostic (2.61e-1)" "unprognostic (2.63e-2)" "unprognostic (1.62e-1)" "unprognostic (1.84e-4)" "unprognostic (4.77e-3)" "unprognostic (2.92e-1)" "unprognostic (2.57e-2)" "unprognostic (3.76e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 2.8 0.0 0.2 1.0 0.0 3.3 3.0 0.3 0.5 5.4 1.0 0.3 0.0 0.1 0.0 1.2 0.0 1.5 0.0 0.0 0.0 0.1 0.0 4.5 0.4 1.2 0.1 0.0 4.1 1.3 0.0 7.2 0.7 0.0 6.6 2.3 0.1 0.0 0.0 8.0 1.4 0.0 0.1 3.4 0.0 0.2 1.2 3.7 0.1 5.6 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.1 7.3 0.0 1.0 0.0 0.3 5.4 1.0 1.3 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 10.0 0.1 0.0 0.0 2.1 0.1 2.6 8.3 0.0 0.0 5.4 0.0 0.1 2.8 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 6.4 8.4 0.3 0.1 8.3 11.4 4.8 4.0 0.0 14.6 11.7 1.4 8.6 8.8 1.8 0.0 1.7 0.2 17.1 0.0 8.4 18.6 24.4 1.3 0.3 3.6 0.0 3.3 10.9 3.2 0.2 17.9 18.4 0.0 0.0 0.0 0.0 0.1 1.7 1.7 15.5 10.2 0.0 0.7 7.4 0.3 0.5 0.0 0.0 0.0 0.7 0.0 1.0 0.3 16.9 10.5 0.4 0.0 12.9 12.0 1.6 6.4 0.0 0.0 0.0 0.7 37.9 0.7 4.9 9.8 0.1 0.4 0.0 12.3 15.1 PCSK2 "NEC2, PC2, SPC2" ENSG00000125851 "Proprotein convertase subtilisin/kexin type 2" P16519 20 17226107-17484578 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 28.7;brain: 31.7;retina: 36.1;thyroid gland: 57.4" "Cell type enhanced" "Detected in many" "Early spermatids: 87.3;Excitatory neurons: 322.8;Horizontal cells: 132.9;Inhibitory neurons: 148.8;Melanocytes: 209.9;Muller glia cells: 452.7" "Cancer enriched" "Detected in many" 4 "thyroid cancer: 65.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 60.0;SCLC-21H: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049627 Approved Approved Vesicles "Secreted in other tissues" NA NA 18000 Vesicles "HPA049627: AB_2680835" "unprognostic (2.03e-3)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.07e-3)" "unprognostic (4.31e-1)" "unprognostic (5.88e-2)" "unprognostic (2.50e-3)" "unprognostic (2.14e-1)" "unprognostic (7.26e-5)" "unprognostic (2.29e-1)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-1)" 0.8 28.7 9.8 0.8 14.1 0.5 0.4 1.0 31.7 1.7 0.0 5.3 4.8 0.2 0.3 1.1 1.0 0.5 2.9 14.4 7.9 0.2 0.2 2.5 0.0 3.5 5.6 20.2 9.1 20.0 0.8 2.1 0.6 6.0 1.4 1.7 36.1 1.7 1.2 0.1 14.2 2.2 0.4 0.3 0.1 8.2 4.9 21.0 0.0 57.4 0.1 0.1 3.0 2.4 13.5 0.0 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 14.1 1.0 31.7 14.4 7.9 3.5 5.6 20.2 6.0 0.3 21.0 13.5 0.1 0.0 7.3 7.8 0.0 8.2 0.0 0.0 1.2 28.1 0.0 0.0 1.2 0.0 0.6 0.0 6.2 0.0 0.0 0.0 0.0 0.0 87.3 0.0 0.0 1.3 0.0 0.0 322.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 132.9 148.8 0.6 0.0 0.0 1.3 6.3 2.8 0.2 209.9 8.4 0.0 452.7 0.0 44.7 6.4 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.5 1.2 1.0 0.3 0.2 1.4 0.0 0.1 0.6 0.0 0.1 GFRA4 ENSG00000125861 "GDNF family receptor alpha 4" Q9GZZ7 20 3659248-3663399 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "thyroid gland: 1.1" "Cell type enhanced" "Detected in some" "Early spermatids: 1.6;Late spermatids: 3.2;Proximal tubular cells: 1.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.50e-2)" "unprognostic (2.36e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MKKS BBS6 ENSG00000125863 "McKusick-Kaufman syndrome" Q9NPJ1 20 10401009-10434222 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Chaperone "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041071, HPA044233" Enhanced Supported Centrosome NA NA Centrosome "HPA041071: AB_10960408, HPA044233: AB_10962986" "unprognostic (9.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (1.84e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.84e-5)" "unprognostic (5.54e-2)" "unprognostic (1.19e-1)" "unprognostic (2.58e-1)" "unprognostic (1.01e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.79e-9)" "unprognostic (3.69e-1)" "unprognostic (6.18e-2)" "unprognostic (1.63e-2)" "unprognostic (3.01e-1)" 11.6 13.4 16.0 6.7 17.4 1.9 12.5 18.7 19.4 14.5 19.2 18.4 17.4 12.7 13.9 12.8 13.2 12.8 19.5 17.1 17.9 29.1 26.2 10.0 8.5 16.8 16.7 16.3 14.0 12.5 25.7 14.9 9.7 17.6 15.1 19.6 23.0 13.1 15.5 25.7 8.8 14.7 14.5 15.4 11.9 14.1 16.4 16.9 12.3 17.7 40.9 10.8 14.5 13.4 18.4 18.9 23.3 21.7 32.9 23.3 20.9 6.7 12.7 14.4 16.6 13.3 7.7 9.6 16.2 5.3 12.4 30.0 25.0 27.6 25.1 20.6 2.9 10.4 37.1 5.8 20.9 15.8 23.4 7.5 18.5 47.5 16.0 31.7 28.0 13.5 14.8 18.8 11.7 19.7 7.1 22.3 14.2 15.6 60.8 16.4 13.2 21.5 14.5 25.7 8.6 33.0 20.9 11.9 61.3 29.7 14.5 16.8 15.5 6.3 14.6 12.4 17.8 23.3 8.6 36.3 6.9 12.1 24.3 15.3 19.5 16.0 13.4 11.7 14.2 13.8 11.3 13.0 9.9 16.8 7.8 15.1 14.1 7.9 11.9 16.9 10.8 11.0 16.4 16.0 17.4 18.7 19.4 17.1 17.9 16.8 16.7 16.3 17.6 15.4 16.9 18.4 15.0 3.2 17.9 20.5 29.8 33.9 56.5 143.1 39.9 39.1 11.5 13.7 225.7 118.7 67.0 9.2 12.5 101.6 50.3 116.4 68.4 27.0 95.4 14.7 11.5 41.2 71.2 43.5 30.2 19.8 83.4 40.1 37.8 11.5 22.8 9.1 57.5 182.4 127.1 69.0 36.1 90.0 89.5 62.5 67.5 41.7 62.4 34.5 49.8 11.2 51.1 70.7 55.6 25.6 24.7 17.6 92.9 63.9 31.5 87.4 99.6 47.4 54.7 40.1 52.6 43.9 51.5 229.1 73.6 86.4 42.8 96.9 23.5 13.0 100.7 75.5 BFSP1 "CP115, CP94, filensin, LIFL-H" ENSG00000125864 "Beaded filament structural protein 1" Q12934 20 17493905-17569220 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 5.7;NK-cells: 17.5;Spermatogonia: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.8;RPTEC TERT1: 19.5;SK-BR-3: 10.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "amygdala: 2.5;cerebral cortex: 3.2;hippocampal formation: 3.6" "HPA040748, HPA042038" Enhanced Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA040748: AB_10963786, HPA042038: AB_10964054" "unprognostic (2.24e-3)" "unprognostic (1.99e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.07e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-6)" "unprognostic (5.11e-2)" "unprognostic (5.53e-1)" "unprognostic (2.10e-4)" "unprognostic (1.75e-1)" "unprognostic (8.81e-2)" "unprognostic (3.35e-4)" "unprognostic (4.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.78e-2)" "unprognostic (7.50e-2)" 1.2 1.3 1.9 0.5 2.0 0.4 1.1 1.6 2.1 1.2 2.0 1.0 0.3 1.8 1.4 1.1 1.4 1.4 0.6 2.1 2.2 1.6 0.3 1.7 0.3 1.7 1.7 2.0 1.6 2.0 1.0 0.9 1.9 1.7 1.2 0.5 0.4 1.5 1.1 0.3 1.0 0.7 1.1 1.6 0.5 0.9 3.8 1.9 0.2 2.5 0.4 0.3 1.3 0.9 2.4 0.8 8.1 2.6 0.3 0.7 2.6 0.4 2.0 9.5 1.3 1.2 3.7 7.0 0.0 1.6 1.2 5.1 1.2 2.8 1.6 1.0 1.8 2.1 0.6 1.2 1.1 1.5 0.5 0.9 3.1 4.9 0.7 2.3 10.8 5.7 0.5 0.3 0.4 4.2 1.6 0.0 1.2 6.1 5.2 2.2 0.0 1.8 0.4 19.5 1.5 2.7 0.3 2.4 10.6 4.3 1.2 5.2 1.8 6.5 0.3 0.6 0.7 2.0 0.0 0.1 0.0 1.4 0.0 1.6 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.2 1.9 2.0 1.6 2.1 2.1 2.2 1.7 1.7 2.0 1.7 1.6 1.9 2.4 3.8 3.2 1.7 0.7 0.0 0.9 0.5 0.7 0.0 0.2 1.9 1.5 1.2 1.5 0.4 0.0 0.0 1.2 2.6 0.1 1.9 0.8 1.3 1.1 0.4 3.1 0.0 0.8 2.1 0.9 1.7 1.2 1.5 0.6 0.0 0.2 3.9 0.2 0.5 0.0 1.2 0.2 0.0 0.0 0.8 5.7 1.8 0.2 1.8 2.8 0.0 1.0 17.5 0.5 1.1 0.8 0.0 0.0 0.4 0.4 0.0 0.3 1.8 0.1 0.0 0.5 1.0 1.1 11.9 1.1 0.9 0.4 1.0 0.4 0.3 0.5 DSTN "ACTDP, ADF" ENSG00000125868 "Destrin, actin depolymerizing factor" P60981 20 17570075-17609919 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 1690.3;SK-BR-3: 1421.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037094 Approved NA NA 3700000 "CAB037094: AB_476911" "unprognostic (1.05e-3)" "unprognostic (1.61e-2)" "unprognostic (7.04e-2)" "unprognostic (2.20e-2)" "unprognostic (2.27e-1)" "unprognostic (1.51e-2)" "unprognostic (5.61e-3)" "unprognostic (1.74e-1)" "unprognostic (1.27e-1)" "unprognostic (8.18e-2)" "unprognostic (1.44e-1)" "unprognostic (2.56e-1)" "unprognostic (2.89e-3)" "unprognostic (6.05e-2)" "unprognostic (9.04e-2)" "unprognostic (5.56e-2)" "unprognostic (2.71e-3)" 269.8 234.8 146.3 137.9 161.9 53.8 289.9 153.3 179.4 319.7 185.9 855.0 137.4 641.4 299.7 540.6 453.8 300.0 409.3 158.4 161.9 271.5 142.4 318.6 60.7 156.7 161.7 144.0 238.8 271.1 181.5 128.1 163.6 163.4 564.1 309.7 115.0 277.0 765.4 88.0 216.4 288.0 701.0 163.8 75.8 490.9 82.7 155.6 48.3 275.4 112.4 79.6 710.3 315.4 177.3 323.0 431.3 161.5 160.5 399.8 391.5 303.8 397.7 616.4 248.1 221.7 200.4 348.6 50.1 97.7 587.8 458.5 305.3 149.4 606.5 281.9 28.0 125.5 131.9 247.2 295.3 426.2 102.9 86.5 357.9 563.1 239.3 275.9 609.0 360.6 85.4 63.4 65.7 468.1 251.7 42.2 121.6 110.4 1690.3 322.3 28.9 248.4 103.5 686.4 291.9 244.6 72.9 363.0 1421.1 441.9 263.7 654.3 55.9 345.3 294.9 93.2 324.1 276.8 39.7 52.2 134.6 139.9 43.8 250.8 33.8 17.6 59.2 55.9 32.2 46.8 11.9 56.9 52.0 22.1 9.0 37.0 47.0 11.8 48.8 46.4 51.1 46.7 45.3 146.3 161.9 153.3 179.4 158.4 161.9 156.7 161.7 144.0 163.4 163.8 155.6 177.3 372.8 1442.3 667.9 25.1 84.9 1151.6 697.0 796.7 542.4 101.5 925.2 762.2 1131.3 739.2 696.8 678.6 50.1 576.4 336.9 549.2 1457.6 1022.2 295.0 558.3 447.3 481.7 546.5 83.1 54.7 1468.6 1165.0 533.5 275.7 540.2 183.8 199.4 425.9 602.4 222.2 176.7 43.1 643.2 533.0 147.8 361.5 111.2 496.8 133.0 610.1 57.1 191.7 779.1 224.6 30.7 44.0 1018.6 572.8 1266.8 172.4 640.3 304.4 1491.4 912.0 153.1 1216.2 271.1 1745.4 390.0 298.9 515.2 1043.5 549.5 161.6 252.0 545.8 680.2 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 98.1;retina: 29.9" "Cell type enhanced" "Detected in many" "dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "plasmacytoid DC: 141.3" "Lineage enriched" "Detected in many" 31 "dendritic cells: 141.3" "Cell line enhanced" "Detected in some" "Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" Yes NA Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.3 4.4 45.6 1.5 98.1 2.3 0.9 15.3 50.5 8.9 9.0 1.8 1.2 4.8 6.3 0.4 10.7 3.1 0.3 39.4 36.6 0.8 0.2 0.9 5.7 48.2 21.4 35.9 22.1 1.2 0.7 6.3 0.1 48.5 2.3 1.2 29.9 1.1 3.8 0.1 0.5 1.3 3.9 30.8 1.8 1.4 0.9 31.9 1.5 0.9 0.2 5.3 0.7 1.2 48.1 0.1 0.2 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 469.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 86.4 0.0 0.0 0.1 0.4 0.0 169.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 21.1 0.3 4.2 1.7 0.0 0.0 0.3 0.2 4.5 0.0 0.1 9.5 0.5 0.0 0.0 0.4 0.0 0.0 141.3 0.0 2.4 45.6 98.1 15.3 50.5 39.4 36.6 48.2 21.4 35.9 48.5 30.8 31.9 48.1 0.5 0.0 1.1 6.2 3.4 0.1 0.0 0.0 0.0 12.3 0.3 4.3 0.3 0.0 0.0 0.0 8.4 0.0 78.4 0.0 0.0 0.8 5.4 0.2 0.7 0.8 0.0 0.0 10.0 0.0 0.0 8.4 0.0 0.7 0.0 22.2 0.0 0.0 1.3 60.6 38.9 0.0 0.0 0.6 0.8 7.5 0.6 3.5 3.6 4.7 5.4 3.9 0.0 13.0 1.5 0.4 0.0 0.0 5.5 0.5 0.0 0.0 0.0 5.7 0.0 0.3 13.9 0.6 1.1 0.0 0.0 0.0 0.9 23.2 0.1 0.0 SNRPB2 "Msl1, U2B''" ENSG00000125870 "Small nuclear ribonucleoprotein polypeptide B2" P08579 20 16729961-16742564 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 524.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 381.4;SK-MEL-30: 378.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050814, HPA076104" Supported Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA050814: AB_2681245, HPA076104: AB_2732301" "unprognostic (4.73e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (8.45e-2)" "unprognostic (8.36e-2)" "prognostic unfavorable (6.03e-7)" "unprognostic (4.23e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.06e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.14e-2)" "unprognostic (1.77e-1)" 27.7 27.9 25.1 31.2 26.6 54.4 31.3 25.3 36.0 22.2 27.6 25.4 24.5 29.3 35.5 21.0 24.6 22.1 25.2 26.1 26.3 42.6 30.4 22.3 43.6 25.9 26.2 24.5 29.4 18.4 27.2 22.8 28.9 25.9 22.1 26.8 11.3 21.3 21.8 30.5 16.7 24.8 27.3 26.5 28.7 23.6 22.8 25.9 37.7 25.9 27.5 36.9 29.2 20.0 28.4 76.0 73.3 94.3 59.1 46.1 57.8 104.7 73.4 60.9 78.0 76.1 84.6 83.5 121.0 56.0 63.0 119.2 69.3 74.9 85.5 111.0 40.0 62.8 111.8 22.4 157.4 53.9 132.0 73.8 57.6 56.0 71.5 55.6 58.1 74.4 81.3 93.8 53.6 80.6 79.2 152.5 159.6 84.2 381.4 97.0 86.1 113.1 84.9 76.9 50.8 49.8 142.3 54.5 147.6 378.7 69.4 93.8 106.5 63.7 71.0 71.2 64.4 122.7 46.9 102.8 134.7 33.7 77.8 157.1 51.8 29.4 47.4 27.3 38.6 35.8 31.5 34.7 31.5 31.6 29.1 30.0 33.4 12.8 31.7 40.5 45.9 48.0 29.9 25.1 26.6 25.3 36.0 26.1 26.3 25.9 26.2 24.5 25.9 26.5 25.9 28.4 125.9 44.8 58.0 6.2 128.6 89.1 186.9 238.2 60.3 30.7 93.8 118.5 67.4 107.2 126.5 93.8 0.0 281.4 150.1 79.6 215.2 165.9 163.3 105.3 150.3 124.6 93.3 131.7 12.9 169.2 288.3 120.8 50.0 120.5 132.5 103.2 140.3 139.3 227.3 48.8 14.3 133.3 152.5 157.9 124.6 35.1 172.7 120.5 110.3 8.4 195.4 77.7 153.5 15.1 21.5 169.4 102.7 155.7 91.2 143.8 94.9 524.6 107.2 25.1 98.6 118.7 147.5 192.4 130.4 60.8 96.0 376.9 150.1 94.7 127.7 170.2 MGME1 "bA504H3.4, C20orf72, DDK1" ENSG00000125871 "Mitochondrial genome maintenance exonuclease 1" Q9BQP7 20 17969018-17991122 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040913 Approved Supported Mitochondria NA Yes Mitochondria "HPA040913: AB_10962835" "unprognostic (5.81e-3)" "unprognostic (5.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-3)" "unprognostic (5.42e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (5.31e-2)" "unprognostic (7.05e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (8.70e-2)" "unprognostic (6.89e-2)" 6.1 14.5 7.5 11.8 8.2 16.1 18.6 8.1 9.6 7.3 7.9 11.5 13.5 5.3 10.5 13.2 6.3 7.4 10.9 7.3 8.1 12.4 14.5 7.7 20.0 8.5 8.2 6.8 5.9 8.9 7.9 4.7 12.9 8.6 7.6 13.6 7.9 9.1 7.5 21.5 34.4 12.0 6.7 8.5 17.8 9.4 10.8 7.8 20.0 12.0 12.3 21.0 8.9 9.6 9.5 44.7 51.0 41.0 38.7 16.5 29.0 54.9 36.8 27.1 34.8 47.4 63.4 44.7 53.4 20.3 16.4 39.6 64.9 43.1 55.1 52.7 19.9 34.7 34.7 29.6 97.2 12.3 22.9 56.2 17.6 37.3 52.3 27.4 16.3 28.2 26.0 48.0 33.3 70.7 33.4 40.5 29.9 36.3 26.8 44.0 30.5 91.4 50.8 30.1 32.3 31.6 26.1 26.1 62.8 57.7 33.2 59.7 15.5 22.8 59.1 48.1 29.8 40.3 24.6 59.6 45.3 15.2 17.3 44.7 57.5 15.2 44.6 8.1 14.9 10.9 21.0 10.5 10.9 12.6 24.2 7.5 6.9 14.4 16.7 15.0 19.5 17.1 8.4 7.5 8.2 8.1 9.6 7.3 8.1 8.5 8.2 6.8 8.6 8.5 7.8 9.5 10.6 0.0 10.0 19.9 24.6 46.4 15.7 12.7 40.9 7.9 19.9 39.4 12.6 15.7 11.9 7.3 8.4 22.9 21.0 14.3 39.2 13.1 9.8 11.2 15.6 11.9 7.2 52.6 3.1 10.2 25.9 8.1 5.1 13.3 48.0 25.5 20.0 9.9 31.4 8.4 2.9 12.1 6.1 34.4 15.4 5.5 8.4 18.8 21.4 9.4 16.4 11.4 28.8 17.6 12.6 10.4 10.6 5.7 13.2 12.3 31.0 26.5 5.9 10.0 13.1 10.3 10.8 38.6 47.0 20.5 46.9 18.1 14.9 27.1 19.0 12.8 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040546-6054060 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.8;lung: 9.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 3.9;Collecting duct cells: 1.8;Ductal cells: 3.8;Proximal tubular cells: 2.4" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enhanced" "Detected in single" "basal ganglia: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "RPTEC TERT1: 79.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 73000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 3.8 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.2 0.4 2.2 0.1 9.8 0.0 0.6 0.1 0.1 0.4 1.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.3 1.4 0.0 3.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 79.6 0.0 0.3 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.7 0.2 0.4 0.6 0.1 0.1 0.6 0.1 0.4 0.0 0.0 9.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TBC1D20 "C20orf140, dJ852M4.2" ENSG00000125875 "TBC1 domain family member 20" Q96BZ9 20 423596-462566 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 147.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043613 Approved NA NA "HPA043613: AB_10963930" "unprognostic (2.16e-3)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.14e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-3)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (2.54e-2)" "unprognostic (1.35e-2)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "unprognostic (2.97e-1)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (9.52e-2)" 16.9 21.7 21.8 7.6 23.7 7.1 16.1 22.9 22.6 18.3 17.7 17.5 8.7 17.5 15.7 19.1 16.3 11.9 15.8 20.5 22.3 14.4 13.5 18.2 10.7 23.4 23.9 19.4 17.5 14.9 21.4 18.0 17.6 22.6 17.9 11.9 7.8 17.0 19.0 20.5 19.7 14.6 20.6 23.4 16.2 15.5 10.0 23.9 14.7 15.2 23.8 13.0 19.7 17.0 23.8 18.5 12.6 18.2 15.9 75.9 39.3 16.3 19.8 39.1 27.7 29.4 11.8 9.6 8.4 4.6 43.7 35.2 18.1 18.8 20.2 26.8 4.9 4.9 13.4 4.0 27.3 45.7 13.1 7.1 35.2 38.3 15.4 14.4 29.9 17.7 14.4 14.8 17.7 30.7 4.5 12.1 15.5 10.6 23.7 11.0 12.0 17.2 10.4 18.7 12.0 15.8 12.8 22.2 39.9 53.5 20.0 14.1 27.9 19.9 25.0 8.9 22.2 14.3 9.7 19.0 7.7 13.4 14.0 15.9 3.0 0.6 0.7 1.8 0.5 1.2 0.8 1.2 2.1 0.6 0.7 1.1 1.8 1.5 0.9 0.4 0.6 0.8 0.7 21.8 23.7 22.9 22.6 20.5 22.3 23.4 23.9 19.4 22.6 23.4 23.9 23.8 23.0 12.8 13.6 16.3 22.6 18.5 13.6 11.3 23.3 29.3 22.4 14.4 16.8 24.3 11.1 14.7 12.5 16.5 28.9 29.6 11.7 23.8 48.9 21.3 26.9 20.7 16.1 48.6 16.2 30.3 25.1 23.0 17.9 16.2 11.4 14.4 25.4 19.7 19.7 26.9 19.2 17.9 8.2 17.6 16.4 147.2 29.5 18.6 14.2 14.0 13.2 21.4 43.3 11.6 15.2 22.5 20.7 35.3 30.0 21.2 19.4 17.0 17.1 19.4 19.7 22.1 18.3 33.1 34.7 15.3 18.9 50.9 24.0 19.6 15.7 27.9 ITPA "C20orf37, dJ794I6.3, HLC14-06-P" ENSG00000125877 "Inosine triphosphatase" Q9BY32 20 3208868-3223870 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022824, HPA073963" Approved Supported Nucleoplasm,Cytosol NA NA 120000 "Nucleoplasm, Cytosol" "HPA022824: AB_1851960, HPA073963: " "unprognostic (1.58e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-1)" "unprognostic (3.57e-1)" "unprognostic (4.63e-2)" "unprognostic (1.53e-2)" "prognostic unfavorable (2.54e-5)" "unprognostic (1.11e-2)" "unprognostic (1.68e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-1)" "unprognostic (1.94e-2)" "unprognostic (8.34e-2)" "unprognostic (3.63e-1)" "unprognostic (1.24e-1)" "unprognostic (1.84e-1)" 26.0 37.4 15.9 21.4 16.2 26.6 25.2 15.9 20.2 23.5 16.9 24.6 27.3 24.2 13.1 44.2 30.1 16.9 20.7 16.8 16.0 32.3 28.5 22.6 27.9 16.2 15.5 16.5 21.4 22.1 24.4 13.1 19.9 16.0 20.4 19.4 7.0 26.7 16.3 26.7 33.5 23.4 18.7 15.9 27.2 27.3 12.4 16.7 25.1 33.8 15.2 21.6 24.4 25.9 17.3 118.2 91.1 44.0 49.1 29.7 42.7 30.9 50.9 72.4 65.9 58.8 75.0 106.6 52.5 46.9 48.7 65.7 101.9 62.3 79.8 46.6 32.9 91.6 123.9 39.1 117.6 55.5 54.5 41.4 41.5 60.3 64.4 40.9 28.6 52.5 39.5 88.7 34.2 62.6 55.2 66.0 156.5 77.2 132.1 89.6 61.4 60.7 135.0 96.7 39.2 67.4 80.9 41.4 154.0 106.3 19.3 60.1 94.2 37.9 76.5 42.4 51.7 116.0 52.0 68.4 94.2 32.9 102.8 83.0 32.8 61.5 22.9 47.7 78.2 41.7 48.9 43.6 49.0 74.5 50.2 32.4 39.5 3.4 64.5 56.9 70.7 61.0 48.0 15.9 16.2 15.9 20.2 16.8 16.0 16.2 15.5 16.5 16.0 15.9 16.7 17.3 29.4 22.4 47.0 15.3 38.0 40.1 50.5 93.2 56.9 20.4 48.8 58.3 9.8 34.3 59.3 44.1 14.6 74.4 45.9 37.5 58.7 104.2 2.7 51.8 64.4 29.4 27.5 24.6 12.0 105.1 128.2 41.8 48.4 60.9 42.5 49.7 29.3 32.1 116.6 5.0 9.2 53.1 54.9 42.4 54.0 3.7 31.1 49.0 40.9 5.6 90.3 21.0 41.2 14.1 21.5 102.2 59.9 22.2 34.5 53.5 51.6 94.5 37.9 24.5 19.7 35.4 45.0 16.8 17.6 58.8 49.2 56.2 47.2 53.3 79.9 66.0 TCF15 "bHLHa40, EC2, PARAXIS" ENSG00000125878 "Transcription factor 15" Q12870 20 603797-610398 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 17.5;skeletal muscle: 13.3;tongue: 9.2" "Cell type enriched" "Detected in some" 6 "Adipocytes: 260.0" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 10.6;HMC-1: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050998, HPA060221" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA050998: AB_2681302, HPA060221: AB_2684225" "unprognostic (2.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.58e-2)" "unprognostic (3.55e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.57e-2)" "unprognostic (2.33e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.52e-1)" "unprognostic (9.43e-2)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (8.56e-2)" "unprognostic (5.11e-1)" "unprognostic (6.99e-2)" 5.8 0.6 1.5 0.1 1.1 0.0 4.6 1.2 1.4 0.2 0.9 1.2 0.1 0.8 0.0 0.3 0.4 0.1 17.5 1.1 1.2 0.7 0.2 0.6 0.1 1.3 1.3 1.0 0.2 0.3 0.1 0.4 3.3 1.4 0.3 0.0 0.0 0.6 0.0 13.3 0.2 0.5 0.2 1.2 0.0 0.6 2.0 1.5 0.0 0.5 9.2 0.0 0.9 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.9 10.6 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 1.5 0.0 1.3 0.0 3.0 0.0 1.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 1.2 1.4 1.1 1.2 1.3 1.3 1.0 1.4 1.2 1.5 1.3 260.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.6 0.5 0.6 1.0 15.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.7 0.2 0.2 41.2 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.6 0.0 0.1 7.1 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 2.8 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 13.1 3.7 23.3 2.3 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 OTOR "FDP, MIAL, MIAL1" ENSG00000125879 Otoraplin Q9NRC9 20 16748358-16770062 "Predicted secreted proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024335 Uncertain "Secreted in other tissues" NA NA "HPA024335: AB_1854838" "unprognostic (8.50e-3)" "unprognostic (9.56e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-1)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 12.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCM8 "C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC" ENSG00000125885 "Minichromosome maintenance 8 homologous recombination repair factor" Q9UJA3 20 5950652-5998977 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 71.8;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA045141, HPA066433" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045141: AB_2679230, HPA066433: " "unprognostic (6.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.43e-1)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (5.78e-2)" "prognostic unfavorable (9.30e-8)" "unprognostic (5.21e-2)" "unprognostic (5.14e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (6.74e-2)" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (3.47e-1)" 2.6 2.9 3.0 4.7 4.0 10.3 2.9 6.7 4.4 3.9 4.4 3.7 3.7 3.1 2.1 3.7 3.2 1.8 3.2 2.8 3.0 2.2 1.8 2.4 7.6 3.1 3.2 2.1 2.6 3.1 2.0 1.6 3.3 3.6 3.6 3.2 5.3 2.9 1.8 7.0 4.7 3.8 2.1 2.5 3.6 3.3 13.5 3.0 9.1 2.4 4.7 6.5 3.4 3.6 5.7 48.6 33.0 27.7 30.3 4.6 6.6 27.4 38.1 12.3 26.6 32.0 35.4 27.6 48.3 11.3 10.2 51.5 50.9 46.1 25.7 47.9 13.4 21.5 49.3 16.8 27.9 0.9 56.6 7.4 2.5 3.8 47.2 17.6 5.3 12.3 28.7 56.7 45.8 27.1 12.3 27.6 30.0 40.3 25.3 21.6 34.8 50.9 18.6 5.0 15.3 21.6 23.2 40.0 36.3 22.5 28.6 27.1 16.4 9.6 51.5 43.2 28.2 56.8 20.1 53.8 82.2 9.6 33.5 43.4 1.0 0.1 0.4 0.4 0.1 0.7 0.3 0.2 0.4 0.0 0.3 0.2 0.4 0.4 0.4 0.2 0.4 0.5 0.1 3.0 4.0 6.7 4.4 2.8 3.0 3.1 3.2 2.1 3.6 2.5 3.0 5.7 3.3 0.0 4.4 1.6 6.0 2.3 3.0 1.9 4.6 7.3 2.1 2.8 10.3 7.2 2.4 12.9 16.7 7.2 4.2 5.8 0.0 1.9 8.5 4.9 3.5 4.2 4.2 14.9 3.7 2.8 6.3 5.0 3.1 5.4 1.3 24.4 2.9 1.9 4.5 6.7 2.9 4.0 6.1 2.8 4.6 3.2 3.7 3.7 1.8 2.8 0.3 3.7 8.2 3.5 6.6 3.6 3.9 3.0 9.2 3.3 4.7 2.4 4.0 11.5 6.6 5.7 4.8 71.8 37.1 5.0 2.6 4.0 6.0 3.0 6.3 2.2 BANF2 "BAF-L, BAF2, BAFL, C20orf179, dJ803K15.1" ENSG00000125888 "BANF family member 2" Q9H503 20 17693672-17735871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 111.1" "Group enriched" "Detected in some" 163 "Early spermatids: 899.1;Late spermatids: 2850.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA042635 Approved NA NA "HPA042635: AB_10795707" "unprognostic (2.08e-1)" "unprognostic (9.15e-2)" "unprognostic (6.42e-3)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (3.42e-1)" "unprognostic (3.18e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.4 0.1 0.7 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.7 0.0 0.1 0.0 0.3 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 111.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 899.1 0.0 0.0 0.4 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2850.2 11.5 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 6.8 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 10.9 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 15.6;Horizontal cells: 18.5;Inhibitory neurons: 16.3;Paneth cells: 15.6;Proximal enterocytes: 21.1;Sertoli cells: 19.7;Smooth muscle cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.3;Hep G2: 9.2;K-562: 16.8;Karpas-707: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favorable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 5.7 2.0 16.4 1.0 14.2 0.2 5.0 8.8 19.6 1.8 7.3 3.3 18.4 2.0 0.8 4.0 7.4 4.0 10.7 11.6 14.0 3.8 4.7 27.8 2.0 17.1 11.9 14.0 1.0 2.0 7.1 10.2 17.4 17.1 3.2 1.8 3.9 6.4 15.9 5.2 8.6 23.3 2.0 8.0 2.8 4.1 4.1 14.1 0.3 4.1 2.2 1.2 1.2 2.1 15.6 0.0 4.4 2.5 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.3 0.6 0.1 0.9 0.0 2.7 0.3 3.4 0.4 0.1 0.0 4.2 1.1 0.0 9.2 0.0 0.0 1.2 0.0 0.9 0.0 0.1 0.1 0.1 0.6 16.8 7.1 0.0 0.0 0.1 0.0 3.0 1.2 0.3 0.0 0.2 0.0 0.7 0.6 0.5 1.9 0.1 0.0 0.1 0.9 0.0 0.0 1.7 0.0 2.9 0.0 0.1 2.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 14.2 8.8 19.6 11.6 14.0 17.1 11.9 14.0 17.1 8.0 14.1 15.6 3.7 0.0 0.0 0.7 0.1 0.3 0.7 0.9 0.6 10.5 2.2 1.0 2.3 0.0 0.2 0.0 0.0 0.2 0.2 1.0 0.0 0.5 1.0 0.2 0.1 3.3 15.6 0.0 9.7 0.2 1.8 0.8 2.6 0.1 0.0 0.5 4.6 0.8 0.0 18.5 16.3 9.9 2.0 0.6 0.7 0.7 0.0 1.4 1.8 1.9 1.0 0.5 0.0 0.0 1.1 0.9 15.6 0.0 0.1 0.7 21.1 0.6 1.2 4.0 19.7 0.4 13.3 0.2 2.7 0.2 0.9 1.4 0.2 0.3 3.9 0.3 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.6;skin 1: 66.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6" "Group enriched" "Detected in all" 9 "granulocytes: 543.5;monocytes: 248.6" "Cell line enhanced" "Detected in all" "SK-BR-3: 84.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 3.9 5.5 4.2 6.0 4.6 8.9 9.1 3.0 3.5 7.0 4.2 4.0 10.1 2.6 4.8 39.6 2.5 2.3 3.9 3.0 3.5 8.1 3.7 12.4 6.8 4.9 5.1 2.6 2.8 5.6 11.1 8.0 6.7 5.6 19.4 3.2 1.3 18.5 3.6 4.1 66.8 9.7 1.1 4.1 23.6 6.2 3.8 7.7 7.0 7.6 0.6 7.9 9.3 18.6 5.2 27.7 7.3 4.1 7.6 4.4 1.9 27.8 8.5 4.7 5.3 4.7 16.0 16.9 8.9 3.7 5.3 7.6 43.7 3.3 22.2 4.4 7.3 2.3 18.6 4.9 4.2 2.0 5.1 6.3 1.2 27.1 7.3 7.1 1.6 3.6 8.1 10.2 21.5 4.9 16.4 14.3 13.8 5.3 17.7 12.3 14.1 7.0 11.7 4.1 19.6 7.7 9.1 7.4 84.0 3.8 1.7 34.9 7.5 4.8 12.6 9.1 11.5 9.6 7.8 7.3 3.8 2.0 13.2 9.2 543.5 28.3 163.4 13.2 160.6 11.7 7.0 23.7 27.2 36.2 11.7 28.1 27.9 15.3 6.9 248.6 3.9 43.0 24.2 4.2 4.6 3.0 3.5 3.0 3.5 4.9 5.1 2.6 5.6 4.1 7.7 5.2 3.5 0.0 7.0 0.0 18.5 32.6 17.0 31.6 71.7 0.3 26.7 20.1 2.9 7.2 15.7 11.0 0.0 41.5 24.3 5.1 1.9 10.1 9.9 3.0 1.7 8.0 10.8 16.2 0.5 6.0 138.2 3.6 5.1 5.2 51.5 1.4 17.2 0.7 20.0 5.0 0.4 8.8 16.2 36.7 74.2 24.3 3.4 70.0 7.2 1.9 29.9 0.3 25.7 0.5 0.1 13.4 7.8 1.9 3.5 20.9 16.1 2.4 7.4 2.6 6.6 1.1 4.3 3.4 4.9 57.7 36.8 31.3 26.1 14.2 10.4 24.6 SIRPD "dJ576H24.4, PTPNS1L2" ENSG00000125900 "Signal regulatory protein delta" Q9H106 20 1534251-1557705 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 58.2" "Group enriched" "Detected in some" 118 "Early spermatids: 427.6;Late spermatids: 522.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "neutrophil: 37.2" "Group enriched" "Detected in many" 4 "granulocytes: 37.2;monocytes: 21.0" "Cell line enhanced" "Detected in some" "HL-60: 1.5;HMC-1: 1.9;NB-4: 2.6;THP-1: 5.6;U-937: 1.2" "Not detected" "Not detected" HPA042663 Enhanced "Secreted in male reproductive system" NA NA "HPA042663: AB_2678102" "unprognostic (4.91e-2)" "unprognostic (1.51e-2)" "unprognostic (3.01e-2)" "unprognostic (4.47e-1)" "unprognostic (2.49e-1)" "unprognostic (1.02e-1)" "unprognostic (1.48e-2)" "unprognostic (2.79e-1)" "unprognostic (3.66e-8)" "unprognostic (2.14e-1)" "unprognostic (3.32e-2)" "unprognostic (9.57e-3)" "unprognostic (2.44e-2)" 0.2 0.1 0.2 2.8 0.1 2.8 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.2 0.5 0.1 0.1 0.3 0.1 0.2 2.0 1.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.1 1.5 0.1 58.2 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.9 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 21.0 21.5 0.1 13.5 0.2 0.1 0.1 0.2 6.8 0.0 0.1 0.0 37.2 0.0 6.1 4.3 0.3 6.6 0.2 0.1 0.1 0.3 0.1 0.3 0.3 0.1 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 427.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 4.0 0.0 522.7 3.4 2.2 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPS26 "C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13" ENSG00000125901 "Mitochondrial ribosomal protein S26" Q9BYN8 20 3046052-3048250 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045472, HPA054610" Supported Supported Mitochondria NA NA Mitochondria "HPA045472: AB_10962052, HPA054610: AB_2682541" "unprognostic (1.53e-1)" "unprognostic (2.18e-1)" "unprognostic (3.71e-1)" "unprognostic (4.41e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (8.13e-3)" "unprognostic (3.14e-1)" "unprognostic (6.83e-2)" "unprognostic (8.21e-2)" "unprognostic (9.65e-3)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (3.77e-1)" "unprognostic (4.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.93e-3)" 34.6 70.0 60.1 17.2 60.1 18.3 38.6 62.4 70.1 41.6 60.5 47.2 27.1 41.2 35.1 49.0 42.8 11.4 58.6 58.1 63.0 61.0 104.9 28.1 19.3 63.9 61.4 59.1 48.4 50.4 39.2 65.3 19.5 62.4 56.8 18.9 14.3 41.3 30.6 57.1 46.1 36.0 20.0 59.0 35.2 45.8 21.5 62.3 18.4 51.5 25.9 21.1 49.0 38.6 61.9 119.0 157.5 34.7 63.6 37.3 28.4 91.0 45.4 30.6 51.4 39.2 138.9 53.0 117.7 56.3 23.7 67.0 109.9 69.6 94.1 29.9 30.2 149.0 53.6 60.8 234.6 51.9 85.2 25.3 32.0 72.0 42.7 64.2 35.7 38.7 68.9 88.1 27.0 31.1 103.6 88.4 149.6 170.8 89.9 154.0 96.4 60.0 126.5 51.2 78.9 108.9 140.7 52.0 171.7 109.2 34.3 77.4 47.5 36.2 33.2 52.6 60.0 84.9 120.0 169.0 72.6 21.6 70.7 37.8 36.1 64.2 33.0 68.6 77.5 87.9 114.4 76.3 74.6 87.5 104.9 87.3 74.9 5.1 97.0 63.6 53.3 65.9 73.2 60.1 60.1 62.4 70.1 58.1 63.0 63.9 61.4 59.1 62.4 59.0 62.3 61.9 50.9 16.0 26.8 18.3 61.4 82.0 62.9 113.7 86.6 40.0 87.4 136.5 64.6 54.3 61.5 55.2 35.5 188.1 50.2 72.6 209.4 77.6 4.3 56.9 70.8 43.1 55.1 49.2 20.3 54.8 117.5 57.6 60.1 50.3 14.0 94.0 32.5 120.0 81.1 47.1 20.3 104.1 103.7 23.6 37.5 10.6 69.0 29.2 67.6 5.6 35.3 88.5 56.7 18.1 19.3 52.6 62.0 61.7 46.2 115.3 108.6 239.8 44.4 45.4 59.2 47.3 66.8 60.8 68.7 101.9 92.2 78.5 44.8 164.6 124.2 54.0 DEFB129 "bA530N10.3, C20orf87, DEFB-29" ENSG00000125903 "Defensin beta 129" Q9H1M3 20 227258-229886 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 585 "epididymis: 1960.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.6;SH-SY5Y: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA014581 Enhanced "Secreted in male reproductive system" NA NA "HPA014581: AB_2732410" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1960.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.8;lymphoid tissue: 61.6" "Cell type enhanced" "Detected in some" "B-cells: 62.3;dendritic cells: 76.7;monocytes: 33.7;NK-cells: 140.1;T-cells: 64.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 24.0;HL-60: 32.2;NB-4: 31.7;REH: 89.2;U-937: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria NA NA Mitochondria "HPA060601: AB_2797261, HPA067232: AB_2797271" "prognostic favorable (3.13e-4)" "prognostic favorable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favorable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 3.8 1.0 0.3 10.8 0.2 19.8 2.8 0.1 2.1 0.9 0.7 1.5 1.2 0.9 0.0 2.3 2.3 1.0 1.3 0.2 0.2 1.7 1.7 12.0 16.7 0.3 0.2 0.1 0.3 0.7 0.1 0.3 1.4 0.6 1.4 0.2 0.0 1.2 0.1 0.6 0.8 13.7 0.5 0.2 61.6 5.0 0.2 0.5 4.9 2.9 0.7 4.8 2.8 1.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.9 0.3 0.0 0.0 0.3 0.0 0.1 0.0 24.0 0.0 10.2 0.2 0.0 0.0 32.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 31.7 0.0 0.3 0.0 89.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 3.5 0.0 30.4 0.0 53.2 28.3 81.0 31.1 32.5 27.2 32.3 37.9 29.9 20.4 39.3 31.6 30.2 120.8 16.3 44.7 18.1 67.6 21.6 0.3 0.2 0.1 2.1 0.2 0.2 0.3 0.2 0.1 0.6 0.2 0.5 0.3 6.3 3.2 4.6 0.0 62.3 1.3 0.2 0.8 0.0 0.0 0.4 0.3 0.4 1.5 1.9 1.8 0.0 0.2 76.7 0.2 0.0 0.1 0.1 0.4 0.1 4.1 0.0 17.0 0.0 0.2 0.2 0.5 3.1 0.3 5.7 0.0 6.8 0.8 25.2 0.0 0.0 0.0 0.0 27.6 8.3 0.0 0.0 27.8 1.8 0.0 33.7 0.0 140.1 0.0 0.0 0.1 0.0 0.0 27.7 0.3 0.0 0.3 2.7 0.0 0.0 0.5 0.3 0.0 0.0 0.1 1.4 0.0 64.0 0.0 0.0 0.6 NCLN "NET59, NICALIN" ENSG00000125912 Nicalin Q969V3 19 3185563-3209575 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006625 Approved Approved "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "HPA006625: AB_1079453" "unprognostic (4.32e-2)" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-4)" "unprognostic (8.55e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (9.38e-2)" "unprognostic (2.02e-2)" "unprognostic (1.26e-3)" "prognostic unfavorable (8.37e-5)" "prognostic favorable (8.82e-5)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" 23.5 62.9 17.7 16.4 16.6 33.5 22.5 16.1 25.4 23.3 11.5 29.3 31.4 26.1 4.4 31.3 23.6 6.9 25.4 20.2 14.3 26.2 60.3 33.4 12.8 18.1 17.1 16.5 22.2 54.0 11.1 23.7 7.5 17.5 29.2 8.7 3.6 23.1 8.1 29.5 25.5 36.1 8.6 15.3 43.1 30.0 22.0 18.3 8.6 24.6 10.6 6.6 26.5 21.9 18.5 70.8 74.2 21.6 60.3 20.3 15.4 55.4 84.5 33.2 57.5 45.5 103.6 36.8 43.3 67.0 49.4 37.8 87.2 24.7 57.1 12.7 57.4 61.3 31.7 46.2 73.2 41.1 56.8 51.3 29.0 36.2 46.4 24.7 15.2 31.7 41.7 84.1 41.4 25.6 59.3 48.9 64.1 59.3 43.2 63.6 77.8 23.2 71.9 36.5 42.6 45.3 47.1 31.1 56.2 50.3 10.3 38.3 61.9 47.6 45.4 45.8 77.3 100.4 59.0 58.1 36.0 51.1 71.5 72.7 1.4 13.4 9.8 7.1 13.1 5.8 5.4 4.3 7.9 9.2 4.5 4.6 6.2 7.6 4.8 5.6 18.8 4.2 9.6 17.7 16.6 16.1 25.4 20.2 14.3 18.1 17.1 16.5 17.5 15.3 18.3 18.5 15.3 16.0 14.7 12.1 19.8 8.3 9.4 18.2 5.7 15.1 15.6 11.9 10.2 15.7 14.8 11.0 10.4 20.4 26.0 71.0 3.9 31.0 15.0 11.3 15.6 14.3 12.6 12.4 13.6 37.4 49.3 14.9 30.5 17.4 15.9 31.1 12.8 43.8 39.3 23.5 14.6 41.2 14.2 18.8 9.2 49.1 9.3 18.1 14.2 8.4 19.2 5.8 14.4 9.0 10.3 35.8 45.3 9.1 51.7 22.0 75.7 11.7 10.5 13.2 13.1 11.8 16.9 13.6 20.1 12.4 12.5 17.0 12.0 115.1 72.7 14.2 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "epididymis: 1486.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 244.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049051: AB_2680612" "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favorable (6.10e-4)" "prognostic favorable (3.95e-4)" "unprognostic (2.99e-2)" 1.7 5.1 12.4 0.3 6.9 0.2 23.3 5.1 10.8 4.1 3.5 0.8 0.7 3.6 1486.5 0.3 1.5 0.0 0.6 6.5 42.8 5.1 0.4 0.6 0.3 8.5 9.7 6.7 1.5 1.6 0.0 211.5 0.0 17.1 11.3 0.2 4.6 0.8 3.0 0.4 0.6 1.0 8.1 4.2 0.4 1.0 201.5 23.7 0.2 8.0 0.4 0.1 0.5 1.0 10.7 0.4 0.3 2.2 57.1 2.5 0.0 2.1 0.0 0.5 0.4 0.3 0.1 0.6 0.0 0.2 0.0 0.6 0.0 20.5 1.4 0.1 6.1 8.0 0.9 0.4 0.0 0.0 0.2 10.4 1.1 0.8 0.5 1.0 0.2 0.2 0.2 2.5 0.0 0.4 0.8 0.2 4.4 3.3 0.0 3.6 0.1 3.6 3.2 0.1 0.4 25.8 12.5 0.4 5.1 244.4 0.2 1.4 1.0 0.0 0.2 1.9 0.4 0.8 0.2 0.5 0.2 0.5 0.4 5.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 6.9 5.1 10.8 6.5 42.8 8.5 9.7 6.7 17.1 4.2 23.7 10.7 2.2 0.0 0.0 0.0 0.0 0.1 1.0 0.4 0.0 5.6 87.4 47.6 0.4 1.5 0.1 3.7 6.2 0.1 0.3 0.3 0.0 0.1 20.4 0.5 0.8 1.0 1.2 0.0 0.7 0.8 0.1 0.7 0.0 0.3 0.0 31.0 0.4 0.1 0.1 0.0 1.5 0.2 0.0 0.0 0.7 58.4 7.5 0.8 3.6 1.9 0.1 1.7 0.0 0.0 0.1 0.4 33.8 3.0 0.0 19.3 0.7 0.3 0.0 3.8 13.1 1.2 3.2 12.6 6.8 0.0 0.0 0.0 0.1 0.5 0.5 1.0 HNRNPR "hnRNP-R, HNRPR" ENSG00000125944 "Heterogeneous nuclear ribonucleoprotein R" O43390 1 23303771-23344336 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011687, HPA026092" Supported Enhanced Nucleoplasm NA NA 470000 Nucleoplasm "CAB011687: AB_2295532, HPA026092: AB_1850885" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.92e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-3)" "unprognostic (3.28e-2)" "unprognostic (7.65e-2)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.14e-2)" "unprognostic (4.12e-1)" 49.6 48.3 18.0 49.1 21.3 57.1 49.4 25.8 23.1 54.3 21.1 44.4 33.9 66.6 26.0 55.3 53.1 29.2 38.9 17.9 21.5 31.6 27.4 48.0 58.4 19.9 19.3 16.8 62.1 34.2 42.6 34.2 50.4 20.6 35.3 43.6 40.6 47.1 32.1 56.3 49.0 47.0 45.1 19.9 42.2 39.2 31.2 19.3 72.5 43.9 27.9 60.5 48.7 50.6 26.5 161.7 103.9 200.9 123.5 70.0 73.6 103.6 102.7 118.0 178.3 123.0 73.2 113.4 202.3 52.1 141.4 88.9 89.5 211.0 143.9 208.5 142.3 161.4 192.5 131.0 121.9 68.4 224.2 125.1 74.8 86.7 141.5 113.4 73.3 112.9 153.0 185.4 139.9 119.2 98.3 268.3 71.6 111.6 105.3 103.4 196.9 186.5 144.1 96.5 88.7 137.3 132.6 141.8 116.0 88.7 109.5 98.6 102.6 121.0 102.6 133.4 123.8 129.5 81.3 149.0 276.8 71.9 200.7 117.7 21.7 35.9 44.9 49.0 47.2 51.7 41.4 45.0 47.7 45.8 41.6 48.0 45.5 12.8 53.9 48.1 30.0 58.4 46.6 18.0 21.3 25.8 23.1 17.9 21.5 19.9 19.3 16.8 20.6 19.9 19.3 26.5 112.0 118.6 109.1 29.0 132.7 127.6 207.1 139.0 95.6 127.8 89.1 78.0 72.3 84.4 138.0 88.3 43.8 253.0 125.8 60.2 92.0 126.6 22.9 110.5 183.8 129.3 116.4 150.4 28.6 126.5 274.4 135.3 92.2 146.2 172.0 171.4 61.8 73.1 106.6 126.2 32.6 107.8 138.4 77.7 92.4 17.2 120.9 98.8 83.6 36.5 147.7 159.9 112.3 63.3 60.6 125.2 64.1 116.6 144.3 208.5 59.6 76.9 114.5 111.1 85.5 159.1 170.2 170.4 148.3 136.4 129.9 206.7 136.5 157.3 116.8 182.4 ZNF436 "KIAA1710, Zfp46" ENSG00000125945 "Zinc finger protein 436" Q9C0F3 1 23359448-23369836 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.8;HSkMC: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043817 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043817: AB_10794774" "unprognostic (1.50e-1)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.10e-2)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.92e-1)" "unprognostic (9.51e-3)" "unprognostic (5.04e-2)" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (7.75e-3)" 10.0 14.9 4.7 2.4 5.1 1.4 9.9 5.6 5.4 8.4 4.7 7.7 3.1 10.0 8.1 16.6 7.0 5.6 7.2 5.2 5.3 4.0 3.7 4.3 2.7 6.4 5.1 5.0 15.6 7.0 5.3 4.4 4.2 5.9 9.6 3.1 4.7 14.7 5.1 6.6 12.4 5.6 6.2 5.6 7.1 6.1 8.0 5.1 3.6 9.1 6.2 3.6 10.5 10.3 6.9 3.8 2.4 8.6 4.5 9.1 18.8 4.1 3.4 4.6 4.3 5.0 1.4 3.3 2.6 3.8 4.9 2.8 4.8 15.0 5.7 4.6 3.2 3.3 2.8 5.3 2.2 3.6 1.2 1.9 34.9 8.0 3.6 4.1 7.8 6.2 3.1 3.4 1.8 4.5 1.8 2.9 2.1 0.3 1.7 3.8 3.8 3.6 2.5 3.4 9.5 3.9 4.9 9.6 4.7 3.7 2.9 2.6 1.4 5.0 3.7 2.7 2.9 1.9 2.8 3.6 2.1 2.9 2.3 2.9 0.0 0.7 0.7 0.7 0.8 0.7 0.4 0.5 0.8 1.1 0.5 0.8 0.7 0.5 2.6 0.8 0.1 0.9 0.6 4.7 5.1 5.6 5.4 5.2 5.3 6.4 5.1 5.0 5.9 5.6 5.1 6.9 7.8 0.0 0.5 2.6 2.0 5.2 1.6 1.9 22.2 4.1 6.9 5.0 6.4 1.5 1.6 5.5 6.2 3.8 2.6 3.5 0.0 2.9 2.3 5.0 8.5 14.0 3.6 1.7 4.2 4.9 1.8 9.6 2.0 7.8 0.0 9.4 3.3 3.1 2.1 10.1 3.3 4.6 2.0 1.9 3.8 1.5 9.9 2.1 5.4 0.0 4.5 9.3 2.1 2.5 3.1 3.6 5.9 11.7 2.1 3.3 4.0 2.8 2.4 2.4 0.0 4.5 4.5 5.5 6.9 22.1 9.7 2.9 2.4 7.9 3.1 2.0 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 390.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favorable (2.12e-4)" "unprognostic (6.03e-2)" 45.5 36.6 58.1 43.9 62.8 106.0 41.6 74.2 63.5 56.0 49.2 48.0 41.7 51.5 29.5 76.4 67.8 36.5 49.9 56.4 59.7 39.7 37.1 52.1 64.2 66.6 63.3 52.1 56.6 29.5 31.6 32.8 40.2 65.7 52.6 32.1 23.8 43.8 39.0 44.2 54.4 52.1 39.8 63.8 66.8 39.8 21.7 65.9 64.2 43.1 54.5 55.5 51.7 69.2 66.7 117.1 40.4 27.8 44.6 73.4 58.0 35.4 39.9 62.3 47.5 58.4 29.1 86.7 88.1 33.1 48.8 45.0 60.4 63.4 52.7 37.3 84.5 40.5 143.4 29.9 32.0 90.9 56.2 390.3 67.6 43.5 42.7 54.9 71.9 54.9 71.8 66.8 42.4 53.1 63.9 140.1 217.6 36.3 71.3 70.6 75.2 42.7 47.3 49.2 38.8 61.8 38.2 49.6 60.6 60.4 25.1 58.0 71.6 69.7 47.8 55.8 42.0 33.6 50.7 43.6 61.7 56.9 56.1 46.0 667.6 141.9 540.8 125.7 126.4 140.1 115.7 147.5 130.5 119.9 114.9 151.1 127.9 305.1 126.9 120.3 114.6 194.0 314.2 58.1 62.8 74.2 63.5 56.4 59.7 66.6 63.3 52.1 65.7 63.8 65.9 66.7 45.8 28.9 27.4 31.0 74.5 170.2 66.0 63.3 126.3 28.2 59.8 43.1 27.4 32.9 42.0 18.4 20.9 38.4 79.1 116.3 52.8 38.8 45.5 38.1 43.6 59.9 44.3 40.4 50.7 31.4 43.4 46.7 32.6 36.0 62.8 38.2 71.0 23.8 59.9 47.1 43.3 49.7 38.7 81.8 66.7 115.6 77.9 147.2 56.9 32.8 67.1 47.3 69.0 28.1 60.4 61.6 96.7 60.2 58.0 80.3 100.6 66.4 32.9 16.9 138.1 47.4 76.3 43.2 28.4 84.8 180.6 54.0 83.9 25.4 29.7 76.2 CHURC1-FNTB ENSG00000125954 "CHURC1-FNTB readthrough" 14 64914485-65061803 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Astrocytes: 11.1;Excitatory neurons: 10.4;Inhibitory neurons: 8.1;Microglial cells: 10.3;Oligodendrocyte precursor cells: 18.6;Oligodendrocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.2" CAB009260 Uncertain NA NA "CAB009260: AB_2294228" "unprognostic (9.48e-2)" "unprognostic (8.51e-2)" "unprognostic (4.96e-2)" "unprognostic (8.55e-3)" "unprognostic (1.48e-1)" "unprognostic (2.61e-1)" "unprognostic (5.74e-2)" "unprognostic (9.27e-3)" "unprognostic (9.98e-2)" "unprognostic (7.68e-5)" "unprognostic (2.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" 0.5 0.6 0.3 0.0 0.6 0.7 0.4 0.8 0.7 0.2 0.4 0.3 0.0 0.6 0.0 0.3 0.8 0.2 0.5 0.4 0.7 0.2 0.3 0.3 0.2 1.2 0.7 0.1 0.4 0.5 0.0 0.3 0.3 1.0 0.3 0.0 0.1 0.2 0.1 1.3 0.4 0.2 0.2 0.8 0.1 0.7 1.7 0.6 0.4 0.2 0.0 0.1 0.3 0.3 1.5 0.6 2.1 1.0 1.0 1.5 0.9 0.9 2.1 0.4 0.8 0.1 0.0 1.8 0.1 1.2 0.2 0.9 2.5 0.3 0.0 0.5 1.6 0.0 0.0 0.4 0.0 1.2 0.0 0.7 0.6 0.3 0.0 0.4 1.7 0.1 0.3 0.5 0.5 0.4 0.0 0.6 0.3 0.8 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 1.1 1.4 2.0 0.4 0.2 0.7 1.3 0.0 0.0 3.2 0.6 1.0 1.4 0.9 0.6 1.5 0.9 0.4 3.0 1.4 1.5 0.8 1.4 1.5 0.6 1.1 1.0 1.1 0.6 1.2 0.9 2.6 1.1 0.8 1.2 2.5 1.8 0.3 0.6 0.8 0.7 0.4 0.7 1.2 0.7 0.1 1.0 0.8 0.6 1.5 0.0 0.0 2.2 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.3 0.0 0.0 0.0 18.6 15.4 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ARMCX5 "FLJ12969, GASP5" ENSG00000125962 "Armadillo repeat containing X-linked 5" Q6P1M9 X 102599168-102604159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000996 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane" "HPA000996: AB_1078212" "unprognostic (7.71e-2)" "unprognostic (2.43e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (4.07e-2)" "prognostic favorable (6.58e-5)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (2.83e-1)" "unprognostic (3.28e-3)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (2.83e-1)" "unprognostic (5.24e-2)" 8.2 11.2 10.1 8.9 11.8 10.4 18.0 11.1 11.7 13.8 8.3 13.0 10.9 15.4 15.6 11.1 15.1 10.1 10.8 11.8 10.7 12.8 11.4 11.3 10.5 8.6 8.3 11.5 20.5 14.9 20.0 7.3 8.5 9.4 20.8 15.5 10.7 15.8 13.6 9.3 11.3 12.4 14.0 7.6 8.1 13.6 5.4 10.0 16.4 19.7 10.2 13.4 11.3 6.6 12.3 17.8 15.7 36.4 19.4 15.9 17.8 20.4 17.1 13.1 19.5 34.5 18.7 21.5 0.0 20.3 17.2 22.3 15.1 32.8 16.3 22.1 0.0 13.1 17.9 19.2 15.6 20.6 32.7 20.0 22.3 20.7 16.9 20.3 15.5 20.0 0.0 17.6 0.1 26.3 15.8 23.3 3.9 16.4 30.3 29.5 22.7 88.9 0.1 14.5 24.2 17.1 15.4 30.5 15.7 24.7 10.4 10.8 15.4 20.3 14.5 12.8 16.5 12.3 0.0 13.0 0.0 11.4 32.7 37.8 0.1 11.8 3.2 13.9 12.3 13.3 12.5 12.8 10.9 11.3 6.4 17.8 14.0 1.0 9.3 7.8 10.0 9.7 11.1 10.1 11.8 11.1 11.7 11.8 10.7 8.6 8.3 11.5 9.4 7.6 10.0 12.3 6.9 6.4 6.9 0.0 9.0 5.6 11.7 8.0 19.4 16.5 8.9 7.7 4.4 7.2 10.3 9.2 20.9 5.7 9.2 6.8 21.5 10.0 0.3 5.9 8.3 9.6 9.6 3.4 0.0 9.7 2.6 9.9 10.7 5.7 1.3 7.8 5.7 9.6 6.0 1.7 0.0 9.8 4.1 7.2 3.5 0.5 8.4 6.6 8.8 0.0 4.6 6.5 10.3 0.0 0.0 9.3 3.8 6.0 12.0 9.3 9.6 10.6 13.7 20.8 0.0 6.7 7.8 3.0 5.3 14.5 5.7 3.7 9.5 7.5 9.7 11.1 GDF5 "BMP14, CDMP1" ENSG00000125965 "Growth differentiation factor 5" P43026 20 35433347-35454746 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Chondrogenesis "Cytokine, Growth factor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 10.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.2;Basal prostatic cells: 1.0;granulocytes: 1.3" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.6;BJ hTERT+: 5.4;GAMG: 9.4;HHSteC: 5.8;HSkMC: 14.4;U-87 MG: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA015648 Uncertain "Secreted to blood" NA NA "HPA015648: AB_1849589" "unprognostic (4.59e-3)" "unprognostic (3.48e-2)" "unprognostic (5.53e-3)" "unprognostic (2.47e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (4.64e-1)" "unprognostic (2.17e-3)" "unprognostic (4.38e-2)" "unprognostic (1.40e-1)" "unprognostic (8.02e-2)" "unprognostic (2.77e-1)" "unprognostic (5.57e-3)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (1.38e-1)" "unprognostic (8.96e-3)" 0.9 0.1 0.1 0.0 0.3 0.0 0.6 0.1 0.4 0.3 0.3 1.2 0.0 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.6 0.2 0.0 2.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.9 0.1 0.0 10.0 1.2 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.6 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 17.6 0.1 2.8 5.4 0.4 1.0 0.0 0.0 0.0 0.0 4.5 9.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 14.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226690-35276998 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 37.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4" "Cancer enhanced" "Detected in many" "renal cancer: 11.4;testis cancer: 10.8" "Region enhanced" "Detected in all" "cerebellum: 37.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 51.5" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.7 1.0 6.5 0.5 5.8 0.7 0.6 37.8 8.5 0.7 3.5 0.6 2.2 1.3 0.1 0.3 2.2 0.6 0.6 6.5 6.1 7.6 0.5 4.7 0.4 4.8 8.0 6.4 0.4 5.9 0.3 3.8 0.2 15.5 1.7 0.2 2.5 0.6 4.3 0.3 1.2 1.4 2.0 3.1 0.4 0.6 0.4 7.8 0.0 0.7 0.1 0.0 0.4 0.3 5.6 0.6 36.3 0.1 0.2 0.2 0.0 1.0 1.9 2.3 3.8 2.0 56.0 9.7 0.0 15.8 2.5 1.2 0.6 8.5 0.0 1.6 0.2 0.3 1.9 1.2 0.6 0.0 0.1 0.4 0.2 0.2 0.1 0.1 1.0 0.1 0.1 0.1 0.5 0.4 0.5 0.1 0.2 13.6 0.1 2.4 0.1 0.2 0.0 24.6 0.1 14.1 9.7 2.5 0.7 0.3 2.9 0.5 0.3 0.6 7.4 17.7 1.8 0.7 0.3 0.2 0.1 1.6 0.2 1.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.5 5.8 37.8 8.5 6.5 6.1 4.8 8.0 6.4 15.5 3.1 7.8 5.6 0.3 16.0 1.5 5.2 0.0 0.1 0.2 0.0 0.0 3.9 0.2 0.8 0.5 8.6 1.3 1.8 0.0 0.1 0.1 0.7 5.9 8.5 0.6 0.8 0.3 1.4 0.0 0.0 24.6 0.9 0.1 0.6 0.0 0.5 0.0 0.1 0.4 0.4 0.0 15.2 38.4 0.1 0.0 0.6 0.0 0.0 0.3 0.1 1.8 10.3 0.0 0.2 0.0 12.5 12.0 1.9 0.1 0.0 0.0 0.4 2.3 11.4 0.0 0.4 0.0 0.2 0.2 0.1 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.1 NECAB3 "APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51" ENSG00000125967 "N-terminal EF-hand calcium binding protein 3" Q96P71 20 33657087-33674463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044785, HPA070595, HPA071786" Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186" "unprognostic (8.95e-2)" "unprognostic (1.45e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.44e-1)" "unprognostic (4.05e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.19e-5)" "unprognostic (3.13e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (6.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-1)" 10.1 56.4 19.1 2.2 19.8 1.5 10.5 18.0 32.8 11.4 17.4 14.4 13.7 9.2 6.9 9.0 11.0 4.5 39.1 20.4 18.4 13.3 13.4 11.2 2.3 21.1 17.5 20.1 41.6 19.2 17.6 10.4 3.9 23.3 27.4 4.4 6.6 13.7 7.9 60.8 6.8 10.7 3.8 14.5 6.5 30.7 10.6 22.6 1.9 19.4 32.0 1.7 14.7 10.1 21.0 8.2 7.1 5.1 10.5 4.0 7.8 24.6 11.2 4.2 7.1 6.2 33.2 5.3 9.1 26.2 6.6 16.7 9.7 5.3 3.3 2.6 3.2 7.7 8.7 30.7 39.3 10.5 2.1 8.0 9.7 4.8 6.6 2.1 7.6 4.8 4.8 12.6 4.8 9.3 12.5 3.3 8.6 2.2 8.7 17.5 9.7 13.3 15.9 6.6 6.1 32.4 9.0 26.1 28.7 12.0 5.6 36.6 10.4 4.0 8.6 12.4 11.3 12.7 17.7 7.8 17.1 16.9 4.0 3.8 0.0 1.3 1.8 0.3 1.3 0.9 0.2 0.6 0.3 1.2 0.9 0.4 0.1 0.0 1.2 3.5 0.0 1.6 0.6 19.1 19.8 18.0 32.8 20.4 18.4 21.1 17.5 20.1 23.3 14.5 22.6 21.0 5.4 16.0 45.5 14.7 4.1 3.1 6.5 2.7 8.6 19.4 20.5 11.6 29.9 10.0 5.9 5.5 8.4 20.6 3.8 22.5 33.2 3.7 93.1 5.7 7.2 2.4 19.9 4.0 13.0 7.5 26.1 12.5 26.5 5.4 3.8 14.0 2.2 9.1 8.9 8.4 14.5 16.2 4.1 6.0 6.2 54.0 26.4 5.5 12.4 1.0 3.6 18.2 2.1 6.0 4.5 4.4 15.1 23.7 11.7 14.2 45.9 12.2 3.8 20.8 6.6 9.2 12.1 20.5 20.6 9.3 3.1 20.7 5.4 23.9 20.0 10.0 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 160.3 89.2 51.4 20.3 51.4 9.1 142.5 51.0 59.7 107.0 72.6 99.8 79.1 116.9 4.8 343.2 147.6 35.4 255.3 44.3 121.5 128.3 155.4 206.4 14.1 67.9 52.7 37.5 67.4 42.7 8.2 169.1 46.1 56.7 204.2 26.6 5.1 59.0 150.9 54.3 97.7 155.5 12.3 52.9 80.4 163.8 16.5 66.7 5.9 269.0 38.1 6.3 354.1 208.6 50.2 76.1 245.3 2.7 49.3 31.2 14.1 187.6 314.1 12.6 56.9 6.2 130.5 111.4 0.6 509.6 84.3 67.2 500.2 40.1 17.9 8.6 6.2 25.6 41.5 229.2 425.3 42.3 0.9 2.2 57.4 69.7 0.3 4.3 93.5 35.0 27.6 94.0 2.3 110.4 99.8 11.4 1.8 172.7 336.5 515.3 0.9 200.8 4.2 11.1 206.1 93.5 87.4 261.3 91.9 2.4 128.8 57.0 7.6 188.5 151.3 300.0 49.0 216.1 5.6 6.3 5.2 176.2 39.5 21.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.1 0.1 0.2 0.0 0.0 0.1 51.4 51.4 51.0 59.7 44.3 121.5 67.9 52.7 37.5 56.7 52.9 66.7 50.2 1667.3 237.2 171.7 88.2 25.1 102.3 992.2 1443.4 406.3 2.7 98.6 114.3 35.1 112.9 685.1 228.1 4.2 129.9 46.3 594.3 37.2 584.1 5.7 794.1 450.1 907.7 572.7 49.9 0.6 535.5 493.7 195.3 675.3 707.6 22.2 8.9 2131.4 109.1 25.6 0.0 0.5 557.4 321.4 72.2 52.4 8.7 28.6 38.9 90.7 92.8 8.2 85.0 1.0 4.0 0.3 257.4 924.9 0.4 26.7 519.7 579.8 7.1 168.1 8.3 13.1 229.7 206.1 3.2 53.7 455.8 87.9 89.1 39.8 15.9 389.1 591.6 RALY "HNRPCL2, P542" ENSG00000125970 "RALY heterogeneous nuclear ribonucleoprotein" Q9UKM9 20 33993646-34108308 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040971, HPA043614" Enhanced Enhanced Nucleoplasm,Vesicles NA NA 9400 Nucleoplasm Vesicles "HPA040971: AB_2677230, HPA043614: AB_2678581" "unprognostic (2.06e-1)" "unprognostic (9.54e-3)" "unprognostic (3.72e-2)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.06e-1)" "unprognostic (1.27e-1)" "unprognostic (3.66e-1)" "unprognostic (4.20e-2)" "unprognostic (8.59e-2)" "unprognostic (3.29e-2)" "unprognostic (2.88e-2)" "unprognostic (8.61e-3)" "unprognostic (1.64e-2)" "unprognostic (8.80e-2)" 104.2 66.0 73.1 91.2 77.0 190.8 99.0 77.0 80.0 103.9 76.2 117.8 110.8 97.7 42.0 120.5 85.6 71.3 133.3 62.5 72.0 101.3 68.9 118.5 117.9 81.6 77.2 57.1 102.1 78.8 62.6 56.0 78.3 80.1 89.1 88.4 55.5 106.2 64.9 180.1 113.9 118.7 70.7 83.5 110.5 102.8 117.4 77.8 163.2 126.5 106.9 100.7 100.2 99.2 95.5 250.4 138.1 247.6 193.9 115.3 110.3 210.1 172.9 136.0 215.1 183.0 375.8 204.0 204.3 238.7 140.6 290.9 259.4 135.8 252.7 119.2 132.2 119.3 468.3 81.4 375.4 147.8 236.2 215.0 122.4 141.6 161.9 175.4 160.7 203.0 245.6 201.7 300.9 135.8 185.9 589.3 266.6 137.5 306.0 277.2 344.4 360.6 250.7 126.7 135.4 235.8 266.6 271.8 248.4 376.6 125.8 256.2 234.4 167.5 414.4 270.7 212.3 206.6 310.7 308.3 353.5 213.0 169.9 201.3 139.3 110.7 221.3 138.8 137.1 100.2 96.5 122.2 150.4 135.3 99.6 107.8 104.0 173.3 186.1 195.5 110.0 141.4 165.3 73.1 77.0 77.0 80.0 62.5 72.0 81.6 77.2 57.1 80.1 83.5 77.8 95.5 91.8 54.5 61.3 23.2 98.3 79.2 126.9 102.3 74.6 24.2 74.9 67.8 63.4 58.6 61.7 55.2 18.8 161.3 118.3 287.4 127.2 149.1 48.1 36.4 48.5 92.1 93.0 87.9 19.3 160.5 227.7 78.2 70.8 66.9 59.7 69.7 76.8 39.8 159.6 8.4 14.6 143.2 95.6 112.2 118.1 46.7 65.6 96.9 115.6 50.6 151.3 62.6 163.7 15.6 57.1 190.3 270.7 62.1 206.4 157.5 220.7 107.3 38.8 36.3 111.7 47.7 97.7 106.6 121.1 103.7 80.7 171.4 117.2 51.6 178.6 176.2 DYNLRB1 "DNCL2A, DNLC2A, ROBLD1" ENSG00000125971 "Dynein light chain roadblock-type 1" Q9NP97 20 34516414-34540958 "Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 781.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009845 Approved NA NA "CAB009845: AB_2093671" "unprognostic (2.23e-1)" "unprognostic (7.60e-3)" "unprognostic (5.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (9.10e-2)" "unprognostic (3.41e-2)" "unprognostic (7.79e-2)" "unprognostic (1.71e-1)" "unprognostic (2.11e-1)" "unprognostic (7.55e-2)" "unprognostic (1.32e-1)" "unprognostic (3.37e-2)" "unprognostic (2.00e-2)" "unprognostic (2.00e-1)" 169.8 210.1 426.5 97.7 439.3 114.6 165.1 415.5 557.1 162.9 402.2 202.3 114.8 194.6 206.6 156.6 200.2 118.1 278.3 441.8 436.6 267.8 123.0 170.9 124.9 442.7 429.4 427.6 155.1 116.0 224.8 205.9 155.9 447.2 182.5 129.5 173.2 143.3 172.3 224.6 220.5 157.8 160.0 413.5 144.2 168.0 67.1 426.2 155.7 176.0 226.5 136.2 193.0 160.1 455.3 244.4 317.6 259.4 207.3 307.5 294.9 175.4 264.1 393.5 399.2 340.7 853.3 231.1 135.6 327.4 402.0 385.5 215.3 282.2 391.6 265.9 164.5 198.8 463.2 286.8 679.1 345.7 217.5 249.6 251.4 250.4 320.2 245.7 306.2 282.2 255.8 195.1 249.0 415.5 313.4 314.7 427.4 148.6 284.7 345.2 158.6 359.6 220.2 618.7 160.8 264.2 273.9 382.9 631.9 359.4 249.2 362.5 240.7 251.9 500.8 122.4 351.2 295.8 208.8 310.3 157.3 430.1 186.7 225.0 225.4 112.5 221.2 88.0 123.1 88.8 144.2 145.6 117.2 128.8 127.3 101.4 102.1 111.4 132.4 144.3 161.2 238.7 135.0 426.5 439.3 415.5 557.1 441.8 436.6 442.7 429.4 427.6 447.2 413.5 426.2 455.3 188.4 169.9 106.5 26.1 107.9 146.8 176.8 215.9 100.2 105.4 136.0 200.3 125.5 170.1 157.4 292.4 58.4 297.8 112.9 283.9 481.3 264.4 34.0 266.4 139.5 170.9 226.7 98.2 34.7 223.4 211.4 149.1 85.1 208.5 159.0 149.8 162.4 104.1 287.9 80.8 30.0 284.6 256.3 127.8 131.5 51.0 234.9 139.1 193.9 19.7 236.2 435.8 148.3 20.1 61.4 317.5 379.3 240.3 117.0 240.4 388.9 781.8 253.1 127.6 203.8 101.8 210.8 65.6 77.2 106.3 150.0 342.3 124.9 90.9 160.5 184.3 C20orf173 dJ477O4.4 ENSG00000125975 "Chromosome 20 open reading frame 173" Q96LM9 20 35523186-35529652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 35.8" "Group enriched" "Detected in some" 76 "Early spermatids: 473.3;Late spermatids: 156.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA076859 Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA076859: " "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 473.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 156.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EIF2S2 "EIF2, EIF2beta, PPP1R67" ENSG00000125977 "Eukaryotic translation initiation factor 2 subunit beta" P20042 20 34088309-34112243 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034415, HPA041262, HPA041332" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 480000 "Endoplasmic reticulum" Nucleoli "CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417" "unprognostic (5.76e-3)" "unprognostic (7.12e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.02e-1)" "unprognostic (1.47e-3)" "prognostic unfavorable (3.23e-5)" "unprognostic (9.36e-3)" "unprognostic (2.39e-1)" "unprognostic (6.55e-3)" "unprognostic (3.04e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (9.64e-10)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-2)" 48.7 49.6 40.7 44.4 41.7 45.4 42.8 42.8 55.0 35.1 40.8 43.1 38.7 34.0 38.2 61.7 30.9 32.8 44.1 39.5 42.2 39.3 59.7 47.2 53.2 44.7 41.6 38.1 32.3 82.1 36.1 27.9 54.6 43.9 35.3 43.2 23.9 43.9 34.2 101.6 37.9 37.9 40.8 45.0 38.2 51.2 37.4 41.7 47.0 42.7 64.5 56.7 63.7 38.2 48.6 211.9 139.1 103.4 125.5 99.1 149.3 196.6 188.7 180.2 184.1 184.6 493.4 144.5 188.5 135.1 171.9 204.1 194.5 169.7 310.6 222.0 61.0 92.3 373.8 110.0 254.5 254.7 241.9 116.7 153.6 259.1 182.7 270.2 125.8 195.5 273.7 223.6 174.8 153.5 135.8 226.0 201.3 100.6 243.7 251.1 128.2 176.0 176.2 145.5 174.2 104.7 71.3 209.3 125.2 403.7 119.2 189.9 282.4 132.8 208.7 129.0 132.5 179.8 162.4 153.8 195.9 196.5 185.0 155.1 54.2 77.1 64.8 54.7 89.0 68.1 84.8 77.2 77.2 75.8 71.2 72.0 72.8 47.3 74.9 83.8 105.3 96.1 64.0 40.7 41.7 42.8 55.0 39.5 42.2 44.7 41.6 38.1 43.9 45.0 41.7 48.6 157.4 169.9 162.1 13.7 167.8 180.5 326.3 384.9 81.4 60.5 171.7 154.6 145.1 223.1 241.7 139.8 31.3 359.2 139.6 145.7 307.2 344.2 314.9 182.9 160.1 199.2 126.7 300.7 17.6 529.2 394.4 128.5 110.6 139.1 144.4 80.1 253.4 497.1 243.0 42.1 17.1 229.6 215.7 223.1 119.3 163.7 126.5 147.0 119.2 16.9 286.8 92.8 126.7 17.1 25.2 519.3 133.8 129.4 182.6 292.7 141.5 335.0 207.7 95.3 111.7 102.6 226.6 446.4 211.6 132.7 174.5 641.7 124.0 220.6 200.4 343.8 ERGIC3 "C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84" ENSG00000125991 "ERGIC and golgi 3" Q9Y282 20 35542038-35557634 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 711.0;Late spermatids: 708.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015242, HPA015968" Approved NA NA "HPA015242: AB_1848238, HPA015968: AB_1848239" "unprognostic (4.36e-2)" "unprognostic (3.43e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (2.20e-7)" "unprognostic (2.61e-1)" "unprognostic (2.90e-2)" "unprognostic (9.59e-2)" "unprognostic (8.59e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (9.81e-5)" "unprognostic (9.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (8.64e-2)" 121.7 168.9 125.7 78.4 124.7 165.9 176.6 126.8 182.1 162.8 175.0 156.0 125.4 128.6 460.9 148.1 328.3 136.3 119.3 124.4 136.5 144.9 182.4 116.1 100.2 128.9 128.3 121.8 189.9 272.6 189.5 87.6 152.6 127.4 127.0 192.7 67.6 198.5 143.6 104.4 152.6 111.3 143.8 127.0 109.1 163.4 213.3 130.5 121.0 201.6 96.0 155.9 155.4 138.7 129.0 173.2 317.5 161.8 282.4 553.6 417.1 210.1 234.4 503.7 378.3 374.0 726.9 354.2 127.4 214.4 495.4 332.8 249.5 137.7 371.9 279.0 62.8 252.5 272.6 221.1 453.2 285.2 240.1 193.2 462.8 578.1 235.1 298.7 432.5 251.1 163.0 189.8 399.3 307.0 379.1 191.4 354.0 93.4 645.1 305.1 143.1 378.8 365.5 315.6 298.7 155.4 225.5 353.4 286.0 284.7 159.8 276.5 389.0 209.8 429.5 169.0 178.0 208.1 164.7 107.0 102.5 461.2 126.4 235.5 98.5 188.7 106.7 117.9 182.2 143.3 157.9 139.2 130.4 228.7 146.6 136.0 139.9 62.0 150.7 158.9 226.6 177.0 237.8 125.7 124.7 126.8 182.1 124.4 136.5 128.9 128.3 121.8 127.4 127.0 130.5 129.0 48.1 35.3 79.9 14.4 107.1 184.2 209.7 289.4 150.2 27.1 194.3 150.2 37.1 153.0 190.7 62.5 18.8 476.5 80.6 224.5 117.4 210.6 711.0 215.5 99.4 101.8 112.6 93.2 8.9 269.8 490.7 122.7 114.7 77.5 78.0 94.7 146.3 146.4 208.1 16.8 10.1 246.9 152.5 148.2 192.5 708.4 105.3 100.4 190.3 8.4 126.7 76.8 82.4 8.0 13.6 185.0 283.1 94.0 344.1 189.8 213.4 207.5 340.2 31.3 118.3 100.5 122.0 415.9 170.5 172.6 200.6 589.4 86.8 111.3 264.6 292.3 ROMO1 "bA353C18.2, C20orf52, MTGMP" ENSG00000125995 "Reactive oxygen species modulator 1" P60602 20 35699272-35700984 "Predicted intracellular proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 1349.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012782 Uncertain NA NA "HPA012782: AB_1845685" "unprognostic (1.55e-1)" "unprognostic (3.86e-2)" "unprognostic (3.00e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (1.27e-3)" "unprognostic (5.84e-2)" "unprognostic (6.15e-2)" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (7.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (2.70e-1)" "unprognostic (1.35e-1)" "unprognostic (3.47e-2)" 126.0 187.3 137.7 72.2 140.9 113.3 126.9 147.5 218.0 110.4 152.3 128.6 100.7 113.9 82.3 187.0 103.7 51.3 229.3 137.0 151.2 189.1 207.9 100.7 79.9 144.4 139.6 134.9 112.2 135.9 123.4 164.9 63.5 143.0 127.5 66.9 33.3 135.1 80.3 261.7 122.1 106.0 52.2 144.8 105.5 127.0 122.5 146.5 103.2 123.5 170.4 59.8 109.6 120.7 148.8 304.5 493.7 164.5 202.1 125.3 169.2 269.2 165.7 196.2 256.6 251.0 1196.7 263.5 154.6 370.6 125.5 380.3 320.6 88.5 438.3 64.9 84.6 615.1 267.2 547.2 1349.5 259.4 166.6 134.7 216.2 204.3 182.1 133.1 118.5 209.7 285.9 224.6 309.7 124.7 966.0 373.0 456.6 251.8 327.6 867.8 246.5 319.0 342.3 246.9 516.1 229.3 236.0 288.6 546.5 306.6 150.0 502.6 353.8 172.5 425.0 240.1 281.1 279.8 504.6 481.5 409.3 371.0 130.9 249.7 602.8 590.1 459.5 398.5 511.9 378.4 587.2 408.8 393.7 573.0 523.1 346.7 384.9 330.0 391.8 486.2 1054.9 538.0 726.4 137.7 140.9 147.5 218.0 137.0 151.2 144.4 139.6 134.9 143.0 144.8 146.5 148.8 168.1 102.5 187.2 2.3 147.5 118.3 87.5 339.7 124.7 28.7 235.9 237.9 662.8 264.5 256.3 257.5 8.4 284.8 101.0 691.8 403.0 364.1 23.8 334.5 192.2 150.9 328.1 152.3 2.2 571.6 256.0 194.8 253.8 268.5 193.2 125.9 166.7 641.1 219.9 20.2 2.1 412.9 203.4 157.9 164.3 50.9 130.5 165.0 236.5 3.7 266.4 176.1 108.1 1.0 4.8 567.4 574.0 128.2 323.2 124.8 573.0 753.7 355.8 39.5 118.3 109.7 262.4 283.9 225.4 270.7 153.2 326.9 141.5 64.4 387.0 115.6 FAM83C "C20orf128, dJ614O4.7" ENSG00000125998 "Family with sequence similarity 83 member C" Q9BQN1 20 35285731-35292425 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 33.6;skin 1: 42.2;vagina: 15.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 27.9;Basal squamous epithelial cells: 17.6;Early spermatids: 11.8;Squamous epithelial cells: 26.1;Suprabasal keratinocytes: 64.2" "Cancer enhanced" "Detected in some" "cervical cancer: 9.9;head and neck cancer: 18.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034227, HPA049978" Uncertain NA NA "CAB034227: AB_1562876, HPA049978: AB_2680979" "unprognostic (3.76e-2)" "unprognostic (2.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (3.61e-1)" "unprognostic (1.57e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (9.17e-5)" "unprognostic (9.89e-3)" "unprognostic (1.71e-1)" "unprognostic (5.01e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 4.2 0.0 0.1 42.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 2.1 0.6 15.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 27.9 1.1 0.0 17.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.8 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.2 6.5 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.3 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 26.1 64.2 0.0 0.0 0.0 0.1 1.9 BPIFB1 "bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP" ENSG00000125999 "BPI fold containing family B member 1" Q8TDL5 20 33273480-33309871 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 571.7;salivary gland: 273.3;stomach 1: 516.9" "Cell type enriched" "Detected in many" 5 "Club cells: 5748.4" "Cancer enhanced" "Detected in many" "stomach cancer: 75.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3" "Region enriched" "Detected in single" 6 "olfactory bulb: 4.8" "Low region specificity" "Detected in many" HPA024256 Enhanced "Secreted in other tissues" NA NA 2700000 "HPA024256: AB_1845664" "unprognostic (2.42e-1)" "unprognostic (5.41e-2)" "unprognostic (3.67e-2)" "unprognostic (3.09e-1)" "unprognostic (6.72e-2)" "unprognostic (3.43e-2)" "unprognostic (9.37e-3)" "unprognostic (1.14e-1)" "unprognostic (2.82e-1)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (1.36e-7)" "unprognostic (3.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" 0.1 0.1 0.1 0.0 0.3 0.0 0.9 0.0 0.2 571.7 0.0 0.2 25.9 0.0 0.0 47.5 0.1 3.5 0.0 0.4 0.0 0.0 0.1 113.5 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 1.2 0.0 0.0 273.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 516.9 3.5 0.0 0.2 0.0 0.0 1.2 8.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 3.8 0.0 0.4 0.0 0.1 0.0 2.2 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 22.7 0.0 0.0 1.3 1.4 614.0 0.0 0.0 2.0 1.3 0.4 2.8 5748.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 63.6 0.4 0.1 1.1 0.0 0.0 0.2 0.2 0.1 3.0 31.1 0.6 3.8 0.0 0.4 0.1 0.2 0.0 0.1 0.0 1021.3 0.0 1.9 82.9 0.3 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.7 0.0 2.0 0.0 0.0 1027.4 0.0 0.0 0.4 305.5 5.8 0.8 11.6 0.4 0.1 1.0 0.0 0.0 95.9 CEP250 "C-NAP1, CEP2" ENSG00000126001 "Centrosomal protein 250" Q9BV73 20 35455164-35519280 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Cone-rod dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064875 Supported Centrosome NA NA Centrosome "HPA064875: AB_2685379" "unprognostic (6.35e-2)" "unprognostic (2.94e-1)" "unprognostic (2.31e-1)" "unprognostic (1.21e-3)" "unprognostic (1.99e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.60e-1)" "unprognostic (7.81e-2)" "unprognostic (3.47e-2)" "prognostic favorable (9.27e-6)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.97e-6)" "unprognostic (1.30e-1)" "unprognostic (6.40e-2)" "unprognostic (2.90e-3)" "unprognostic (4.57e-2)" 7.2 8.4 11.7 13.6 12.0 22.7 6.5 12.5 11.7 11.1 10.1 9.8 6.9 10.6 9.0 10.5 11.9 7.6 6.6 11.2 12.8 6.2 6.8 7.2 23.5 11.3 10.9 10.7 14.3 7.3 12.8 12.3 6.6 12.0 12.3 8.4 15.9 10.2 8.7 9.5 13.4 11.3 9.8 9.0 20.4 8.4 18.9 12.8 16.4 8.8 7.0 14.4 9.8 10.5 11.7 33.9 38.2 18.5 34.6 27.6 24.8 27.4 16.5 18.4 25.8 20.3 51.2 27.0 36.4 21.5 23.7 80.4 36.6 20.0 50.7 28.7 6.9 8.2 68.1 31.0 49.0 16.7 33.7 36.6 17.7 30.0 43.7 61.9 29.3 27.0 38.3 23.7 33.8 44.2 17.4 41.5 34.0 12.4 18.0 43.1 23.6 53.6 10.1 24.7 38.4 24.9 27.7 45.6 30.3 21.5 14.9 21.3 29.3 43.7 113.5 29.3 42.4 23.8 11.7 13.6 33.9 63.1 22.4 19.9 20.2 2.0 5.2 10.5 2.5 6.5 5.7 4.4 8.5 4.1 6.7 5.3 6.0 0.8 7.4 1.7 14.1 5.1 4.6 11.7 12.0 12.5 11.7 11.2 12.8 11.3 10.9 10.7 12.0 9.0 12.8 11.7 3.4 6.4 7.2 7.5 14.6 1.7 6.2 3.6 8.6 21.7 4.5 5.3 13.0 5.7 12.7 9.2 12.5 11.6 15.7 7.0 5.9 5.5 11.7 16.2 8.0 4.8 3.0 19.5 13.6 2.0 6.4 7.6 11.7 9.7 5.1 11.8 7.1 3.8 9.1 16.8 17.6 5.4 2.0 9.0 2.7 20.0 4.4 7.7 1.8 5.6 4.2 8.3 20.6 5.0 5.1 5.1 3.6 3.8 18.7 5.2 5.1 2.2 19.5 28.7 0.0 9.9 6.7 24.1 14.8 10.6 2.7 3.0 15.9 5.5 6.6 3.8 PLAGL2 ZNF900 ENSG00000126003 "PLAG1 like zinc finger 2" Q9UPG8 20 32192504-32207743 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32.5" "Cell type enhanced" "Detected in many" "Early spermatids: 56.7;Glandular and luminal cells: 47.7;Late spermatids: 159.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "intermediate monocyte: 18.3;non-classical monocyte: 34.8" "Lineage enriched" "Detected in many" 15 "monocytes: 34.8" "Cell line enhanced" "Detected in all" "CACO-2: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005900 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005900: AB_1079629" "unprognostic (9.40e-2)" "unprognostic (1.67e-1)" "unprognostic (6.95e-3)" "unprognostic (1.09e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-3)" "unprognostic (8.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-2)" "unprognostic (2.26e-1)" "unprognostic (3.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (7.90e-2)" "unprognostic (1.09e-1)" 4.0 3.2 4.3 6.7 5.0 32.5 4.7 4.7 5.1 4.9 6.3 7.8 10.5 6.0 5.3 12.9 9.4 4.1 4.9 4.9 5.3 4.9 4.3 6.6 7.7 4.2 4.0 3.8 7.8 6.1 8.5 5.6 3.9 4.2 5.4 8.0 13.1 6.8 5.5 10.3 7.4 13.0 7.2 3.6 6.3 7.3 16.5 3.9 9.0 4.9 8.4 10.8 5.7 6.1 4.0 19.4 10.9 28.5 10.4 10.4 8.0 17.8 7.5 11.9 16.0 14.5 82.3 9.5 19.8 10.1 7.8 22.4 18.6 35.7 17.3 21.0 11.9 16.1 80.3 9.4 39.8 12.7 35.5 17.0 9.7 15.1 12.9 9.1 7.5 11.7 20.7 28.7 17.5 8.5 10.8 39.2 24.4 13.4 14.8 12.4 25.0 36.8 12.6 6.9 14.6 12.9 14.2 18.5 9.9 16.1 16.5 14.9 42.8 8.8 19.3 20.5 14.0 15.5 47.5 28.5 25.1 11.2 73.5 12.1 2.2 3.6 0.9 0.7 18.3 1.4 1.4 1.0 1.5 2.2 1.0 1.2 0.7 0.9 0.5 34.8 0.6 0.8 2.5 4.3 5.0 4.7 5.1 4.9 5.3 4.2 4.0 3.8 4.2 3.6 3.9 4.0 4.3 12.8 21.1 2.0 6.0 7.5 13.5 6.2 10.8 7.4 8.6 6.5 4.2 2.8 12.2 1.8 31.3 3.2 8.1 13.1 3.9 3.8 56.7 26.1 9.1 5.2 10.7 10.3 4.5 5.2 3.1 5.7 8.2 47.7 2.5 6.4 7.1 3.8 6.0 3.3 3.8 12.4 2.0 8.9 7.8 159.8 2.5 11.9 0.0 4.7 11.1 6.3 0.0 1.5 4.9 6.2 8.9 7.2 7.9 15.0 29.3 3.4 6.8 21.3 6.6 7.1 4.1 11.8 10.8 21.2 11.6 4.1 7.4 6.2 16.7 21.7 MMP24OS MMP24-AS1 ENSG00000126005 "MMP24 opposite strand" A0A0U1RRL7 20 35201745-35278131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 167.3;Distal tubular cells: 403.0;Ductal cells: 225.8;Exocrine glandular cells: 205.2;Pancreatic endocrine cells: 278.9;Proximal tubular cells: 388.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" NA NA "unprognostic (6.31e-2)" "unprognostic (4.34e-2)" "unprognostic (1.14e-1)" "unprognostic (4.42e-2)" "unprognostic (5.73e-3)" "unprognostic (2.10e-1)" "unprognostic (1.72e-1)" "unprognostic (4.34e-3)" "unprognostic (5.75e-2)" "unprognostic (4.33e-1)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.47e-3)" "unprognostic (4.57e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-2)" "unprognostic (7.58e-2)" 50.1 51.6 31.5 15.4 25.7 26.2 38.4 22.4 41.1 31.4 34.0 30.3 27.3 31.6 10.0 49.1 27.6 15.6 30.5 26.4 22.5 69.0 45.2 31.7 12.3 32.9 24.1 18.1 33.2 36.7 15.1 50.5 9.3 34.7 37.5 19.3 4.2 35.2 18.6 25.1 38.3 29.3 11.6 17.0 24.5 32.0 20.1 33.3 11.0 27.8 8.9 10.0 31.4 36.7 33.1 3.3 22.6 1.6 10.2 21.8 39.2 12.3 44.3 31.1 37.4 58.4 15.5 27.1 11.4 22.5 30.6 25.8 14.6 5.9 46.7 31.1 19.2 27.1 36.0 8.4 6.5 13.4 13.9 30.1 36.6 41.3 21.0 29.7 13.1 16.2 12.1 11.0 24.2 53.2 17.1 47.8 20.5 7.1 9.2 29.0 20.8 11.1 23.2 35.2 12.5 10.7 13.3 31.5 72.3 35.5 22.2 31.8 8.4 37.4 65.5 5.4 25.1 23.0 10.1 3.2 4.6 35.5 6.2 21.8 2.9 2.1 7.5 2.3 3.2 2.2 1.8 1.5 1.6 1.6 2.4 1.5 2.2 6.7 0.9 5.5 2.3 0.6 0.8 31.5 25.7 22.4 41.1 26.4 22.5 32.9 24.1 18.1 34.7 17.0 33.3 33.1 49.1 22.4 28.6 0.0 14.9 0.0 0.0 0.0 0.0 0.0 98.3 99.8 0.0 0.0 14.2 167.3 0.0 46.8 58.1 0.0 403.0 225.8 0.0 85.3 45.2 16.4 0.0 0.0 0.0 205.2 80.2 26.0 0.0 65.5 7.6 44.5 0.0 0.0 110.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 98.8 0.0 0.0 0.0 0.0 278.9 0.0 0.0 11.7 0.0 0.0 388.2 9.5 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 75.4 22.5 68.2 0.0 0.0 GRPR "BB2, BB2R" ENSG00000126010 "Gastrin releasing peptide receptor" P30550 X 16123565-16153518 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "pancreas: 20.4" "Cell type enriched" "Detected in single" 15 "Inhibitory neurons: 6.3" "Cancer enriched" "Detected in some" 4 "breast cancer: 6.6" "Region enhanced" "Detected in single" "hypothalamus: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "PC-3: 29.2;T-47d: 38.2;U-138 MG: 51.5" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" HPA069604 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA069604: AB_2686158" "unprognostic (3.32e-2)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (2.87e-1)" "unprognostic (9.17e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (1.01e-1)" "unprognostic (3.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (5.59e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-1)" "unprognostic (2.86e-2)" 0.1 0.1 0.1 0.2 0.2 0.1 1.9 0.0 0.2 0.4 0.1 0.3 0.1 0.5 1.9 0.0 0.1 0.1 0.2 0.2 1.6 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 20.4 0.2 0.0 0.1 0.2 0.5 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.8 0.6 0.1 1.2 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.3 0.0 0.9 0.1 4.0 1.6 0.4 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.5 0.0 0.0 0.0 0.5 0.0 29.2 0.0 0.1 0.1 0.1 0.0 0.8 0.1 0.0 0.1 0.1 1.5 38.2 0.1 0.2 51.5 1.9 0.0 1.6 0.3 0.2 0.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 1.6 0.2 0.1 0.1 0.2 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KDM5C "DXS1272E, JARID1C, MRX13, SMCX, XE169" ENSG00000126012 "Lysine demethylase 5C" P41229 X 53191321-53225422 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038244, HPA046147" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038244: AB_2675911, HPA046147: AB_2679555" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (1.56e-2)" "unprognostic (7.10e-2)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.08e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.45e-2)" "unprognostic (1.58e-2)" "unprognostic (5.05e-3)" "unprognostic (1.96e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" 22.5 29.2 18.7 28.5 19.1 35.2 22.9 22.1 20.9 35.5 20.8 25.6 26.3 35.8 14.9 35.5 33.5 17.2 22.8 19.2 19.4 21.2 24.3 27.4 33.7 19.9 19.9 18.3 40.3 26.6 34.0 31.6 24.0 22.4 24.0 15.5 24.8 29.7 18.6 51.4 34.5 28.4 27.1 16.5 31.2 26.0 13.6 19.9 44.6 27.8 25.7 26.7 26.1 35.7 20.5 45.3 60.4 63.6 49.0 43.2 39.1 45.2 27.7 32.2 36.8 34.0 41.3 28.9 41.8 35.0 36.7 103.2 39.5 72.6 59.1 27.8 31.6 107.9 40.6 66.7 29.6 52.9 48.5 77.6 31.0 42.8 72.0 87.7 52.3 55.2 34.2 80.8 27.2 27.3 57.9 35.9 55.4 54.1 23.3 56.3 40.1 37.8 45.9 23.5 42.6 47.6 61.4 84.0 76.8 32.2 58.4 53.9 42.3 37.8 40.6 35.0 36.9 27.2 39.0 34.2 31.5 52.6 56.9 30.8 0.9 1.2 0.8 1.6 1.1 1.4 1.2 1.0 1.6 0.9 0.8 1.2 0.8 1.4 0.8 1.2 1.3 1.3 1.2 18.7 19.1 22.1 20.9 19.2 19.4 19.9 19.9 18.3 22.4 16.5 19.9 20.5 17.6 12.8 14.9 33.0 17.8 12.1 10.5 12.1 14.8 24.7 19.7 15.0 10.0 11.5 15.2 7.3 25.0 13.1 21.2 32.2 3.9 15.0 0.8 28.2 25.2 17.7 31.2 17.2 36.1 21.9 15.1 14.2 21.4 35.7 13.3 25.5 15.0 25.5 14.4 25.2 37.0 25.8 16.2 18.2 8.8 2.6 14.6 17.1 14.2 27.2 14.9 9.8 16.5 31.2 49.2 26.4 26.3 15.8 17.0 17.9 22.1 5.8 16.4 16.9 0.0 17.2 16.8 10.3 15.8 16.2 15.9 20.8 18.0 22.6 18.9 21.6 AMOT KIAA1071 ENSG00000126016 Angiomotin Q4VCS5 X 112774503-112840889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 146.8;tongue: 54.0" "Cell type enhanced" "Detected in many" "Astrocytes: 57.5;Collecting duct cells: 29.5;Cytotrophoblasts: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 22.5;HAP1: 25.1;OE19: 21.2;SuSa: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067290, HPA067853" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA067290: AB_2685819, HPA067853: AB_2732773" "unprognostic (1.08e-2)" "unprognostic (5.51e-2)" "unprognostic (2.38e-2)" "unprognostic (3.36e-1)" "unprognostic (3.20e-1)" "unprognostic (8.95e-2)" "unprognostic (3.82e-2)" "prognostic favorable (3.94e-4)" "unprognostic (4.46e-2)" "unprognostic (3.79e-1)" "unprognostic (2.17e-1)" "unprognostic (5.60e-2)" "prognostic favorable (4.21e-9)" "unprognostic (9.54e-2)" "unprognostic (2.59e-2)" "unprognostic (4.50e-2)" "unprognostic (6.44e-2)" 4.3 1.6 30.0 1.3 23.3 0.3 6.6 27.9 24.5 9.3 2.0 3.4 2.9 4.9 146.8 4.1 12.3 2.8 4.0 26.0 33.6 10.5 2.1 2.7 0.8 38.3 30.0 16.7 5.7 2.3 14.4 7.3 20.9 28.5 6.4 4.3 1.7 7.0 26.0 39.4 2.3 3.8 3.2 20.0 1.5 3.1 2.4 32.9 4.4 3.8 54.0 1.0 2.9 4.2 19.5 4.3 0.0 22.5 1.0 0.5 0.5 8.8 0.7 0.0 0.0 0.0 10.5 0.8 0.5 4.7 3.5 0.0 8.4 25.1 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.0 1.1 0.2 0.0 5.1 0.6 4.9 0.2 0.4 0.0 0.0 0.6 0.4 6.8 0.3 10.5 21.2 0.1 8.4 6.6 0.1 11.2 11.0 0.0 8.0 0.1 0.0 9.8 34.9 0.8 0.2 0.1 2.9 6.8 0.0 9.4 0.7 0.0 0.0 1.0 0.1 6.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 30.0 23.3 27.9 24.5 26.0 33.6 38.3 30.0 16.7 28.5 20.0 32.9 19.5 2.2 3.2 2.0 57.5 0.9 1.8 2.7 2.5 2.8 1.1 9.7 6.9 2.0 1.5 7.2 29.5 0.0 46.2 1.1 4.9 1.9 5.1 0.2 7.2 6.3 3.7 15.8 0.4 8.9 1.9 3.8 7.2 4.1 7.1 0.0 1.5 4.2 4.0 6.2 0.0 2.0 7.2 6.1 1.6 2.1 0.5 6.8 1.0 3.6 17.8 1.7 4.9 4.1 2.0 3.5 3.2 5.6 6.4 0.0 6.6 4.7 16.8 10.1 0.5 6.6 3.9 4.0 0.4 3.2 3.0 1.1 15.9 0.9 0.8 7.3 2.5 TMEM115 PL6 ENSG00000126062 "Transmembrane protein 115" Q12893 3 50354750-50359521 "Plasma proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006319, HPA015497" Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB006319: AB_425880, HPA015497: AB_1858076" "unprognostic (1.62e-2)" "unprognostic (2.37e-1)" "unprognostic (1.59e-2)" "unprognostic (1.65e-3)" "unprognostic (2.32e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.00e-2)" "unprognostic (6.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.75e-3)" "unprognostic (2.65e-2)" "prognostic favorable (1.04e-7)" "unprognostic (4.88e-3)" "unprognostic (3.00e-1)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" 29.0 34.6 21.9 12.1 22.3 11.8 28.9 22.7 26.7 24.8 23.9 29.7 23.6 33.5 17.8 27.4 26.5 15.7 30.3 21.6 21.3 28.9 32.6 26.8 11.4 24.0 22.5 21.3 25.6 30.1 32.3 20.5 23.0 23.0 31.0 12.9 6.8 29.3 20.8 27.4 41.8 27.3 17.1 21.7 24.5 31.4 17.1 23.2 10.9 34.8 18.4 9.7 28.3 25.8 22.5 26.6 31.9 20.4 33.6 56.9 45.2 26.4 40.3 59.3 50.2 38.3 24.0 30.4 12.9 33.1 53.1 46.2 27.8 24.7 32.7 14.1 23.9 42.9 19.5 27.8 32.9 79.7 21.4 27.2 68.4 41.6 41.5 30.1 43.3 38.6 15.7 21.3 21.7 37.9 24.5 14.8 33.8 36.4 17.4 49.9 7.2 16.3 28.8 38.3 24.7 22.7 48.7 24.5 26.9 34.5 17.8 22.3 22.4 40.4 45.3 22.8 48.1 42.9 32.0 19.9 7.3 41.6 23.3 30.5 52.5 27.9 41.4 26.5 25.1 17.5 18.2 17.5 21.2 23.2 18.5 18.7 18.2 37.9 27.3 24.5 26.1 24.1 23.8 21.9 22.3 22.7 26.7 21.6 21.3 24.0 22.5 21.3 23.0 21.7 23.2 22.5 24.0 16.0 12.4 4.2 14.3 30.2 19.7 26.1 29.6 17.1 25.3 24.9 7.0 25.8 15.8 11.0 6.2 58.8 15.9 39.9 3.9 44.7 1.1 17.9 17.2 22.9 15.7 18.5 2.9 26.5 42.2 31.5 20.4 16.3 11.4 23.6 26.0 19.5 36.3 18.5 3.7 26.6 28.5 11.4 12.4 1.2 29.2 15.5 10.6 2.8 20.4 25.7 13.4 6.6 4.4 35.6 32.5 25.2 18.8 33.8 43.9 26.9 14.3 15.1 26.3 19.3 26.5 17.0 8.0 17.5 34.9 92.8 14.3 36.4 24.9 25.6 PSMB2 HC7-I ENSG00000126067 "Proteasome 20S subunit beta 2" P49721 1 35599541-35641526 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026322, HPA026324" Approved Enhanced Nucleoplasm NA NA 9700000 Nucleoplasm "HPA026322: AB_1855821, HPA026324: AB_1855822" "unprognostic (3.54e-2)" "unprognostic (8.53e-2)" "unprognostic (1.63e-3)" "unprognostic (6.93e-2)" "unprognostic (6.41e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.49e-7)" "unprognostic (2.81e-2)" "unprognostic (5.23e-2)" "unprognostic (3.34e-3)" "unprognostic (7.87e-2)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.80e-6)" "unprognostic (1.65e-1)" "unprognostic (2.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" 26.5 29.5 10.2 14.0 10.7 21.9 25.2 10.1 11.7 22.4 9.6 24.5 13.0 27.1 11.6 32.0 22.0 9.2 25.6 10.8 10.7 22.7 46.2 25.8 16.0 10.4 10.1 10.7 21.2 25.5 11.3 19.8 15.3 11.0 20.2 12.8 12.2 22.5 10.9 63.6 31.1 23.4 13.5 10.1 25.6 24.4 15.7 10.1 20.7 18.8 14.9 16.9 23.1 24.1 12.2 68.8 42.4 45.5 32.2 23.3 27.9 55.5 31.8 36.6 63.2 51.1 51.6 79.3 68.8 71.3 37.6 38.6 41.2 59.3 53.4 54.5 54.5 54.1 63.4 44.5 50.1 41.4 66.1 34.7 30.4 33.4 77.0 36.8 25.9 50.8 54.1 76.6 37.7 41.9 30.7 85.5 50.1 59.3 29.7 44.0 52.3 47.5 48.7 45.3 35.9 39.8 30.1 36.0 34.5 52.1 50.3 24.9 29.3 35.2 32.0 37.5 30.9 76.5 31.8 55.0 66.9 49.9 70.4 55.6 20.5 23.6 18.2 19.6 30.3 19.9 22.3 19.3 20.6 26.4 18.5 14.0 17.3 8.8 23.6 35.4 27.4 26.3 26.1 10.2 10.7 10.1 11.7 10.8 10.7 10.4 10.1 10.7 11.0 10.1 10.1 12.2 110.8 64.1 68.9 6.2 80.4 111.1 145.2 298.5 50.7 48.0 65.8 95.1 59.8 67.2 145.0 66.2 16.7 406.6 83.6 72.4 144.8 286.2 118.0 95.4 78.8 115.9 98.3 78.7 20.8 227.3 341.0 101.3 61.2 75.9 35.4 109.6 85.6 158.1 222.6 58.9 20.9 96.9 187.2 92.7 70.3 22.8 100.6 94.1 76.5 15.9 184.1 68.4 87.6 17.1 23.4 252.0 76.6 91.4 141.7 186.0 108.5 221.7 126.8 50.4 92.1 66.8 291.4 224.4 144.0 80.4 111.5 442.1 81.4 123.9 111.7 178.9 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute RISC catalytic component 3" Q9H9G7 1 35930718-36072500 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 155.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA067849, HPA075436" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750" "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 3.3 2.8 4.7 2.6 7.5 7.5 2.9 6.6 6.0 3.2 6.8 2.7 1.4 3.0 3.2 2.7 2.8 1.9 3.0 4.2 5.9 2.4 4.3 3.5 3.0 8.2 7.2 3.1 3.7 2.9 3.3 6.2 3.5 8.9 3.2 2.0 5.1 2.6 2.2 3.2 3.8 2.6 2.7 7.1 2.8 2.8 5.6 7.8 3.3 3.2 4.4 3.2 3.0 3.0 14.2 6.6 4.4 5.5 4.4 7.5 4.6 6.7 5.2 5.4 7.9 8.4 4.9 7.2 7.2 6.5 5.4 9.1 5.3 5.9 3.8 10.5 9.9 3.7 8.8 8.3 3.7 4.0 8.5 7.2 2.2 3.4 11.4 7.2 3.1 6.8 7.4 9.8 10.2 7.0 2.5 6.5 4.6 9.6 3.4 7.8 7.5 7.4 7.1 2.5 6.2 6.7 4.2 9.4 2.3 3.3 8.3 3.5 3.5 5.4 5.5 13.9 4.9 6.4 5.6 10.5 9.9 2.8 5.4 5.4 9.8 4.3 13.2 4.9 4.1 3.1 6.5 3.1 3.4 4.8 6.4 4.4 4.3 13.0 5.4 6.1 4.2 3.4 2.3 4.7 7.5 6.6 6.0 4.2 5.9 8.2 7.2 3.1 8.9 7.1 7.8 14.2 32.2 86.6 43.2 80.6 32.6 38.7 35.9 17.8 35.3 69.1 26.1 17.8 19.1 17.2 23.0 25.8 112.6 11.8 36.6 13.2 0.0 15.8 56.0 26.6 43.0 33.8 46.7 18.7 103.8 12.2 14.8 42.3 19.9 35.6 55.9 31.6 36.8 24.7 16.4 42.1 101.1 16.0 20.3 31.7 45.1 76.7 37.9 29.7 23.2 70.3 36.9 35.2 27.8 141.8 155.9 17.3 9.1 41.3 24.7 41.1 15.0 8.8 17.5 89.6 19.7 64.4 29.9 37.5 22.1 20.0 33.5 12.9 35.3 31.0 17.5 27.9 UROD ENSG00000126088 "Uroporphyrinogen decarboxylase" P06132 1 45010950-45015575 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" "Decarboxylase, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Erythroid cells: 806.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 420.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027468, HPA028668, HPA030350" Uncertain Supported Nucleoplasm,Cytosol NA NA 2600000 "Nucleoplasm, Cytosol" "HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440" "unprognostic (5.90e-2)" "unprognostic (2.94e-2)" "unprognostic (2.49e-1)" "unprognostic (9.61e-2)" "unprognostic (7.94e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (6.75e-2)" "unprognostic (7.72e-3)" "unprognostic (3.92e-1)" "unprognostic (1.24e-1)" "unprognostic (4.68e-2)" "unprognostic (1.41e-1)" "unprognostic (8.73e-2)" "unprognostic (8.12e-2)" 52.2 121.1 69.8 25.8 70.1 200.6 48.7 68.9 79.9 41.1 72.0 42.6 29.5 47.3 55.2 34.5 49.6 31.1 71.3 69.3 71.9 58.5 101.7 35.1 35.5 69.4 70.2 67.2 51.6 45.5 116.0 42.9 39.7 69.2 35.4 30.4 24.9 61.9 44.6 76.6 30.9 31.0 55.2 69.4 38.1 38.8 45.1 71.0 44.4 54.5 84.5 36.4 40.6 33.0 71.2 66.0 42.5 67.0 89.1 113.4 107.7 31.8 87.4 209.8 163.9 125.2 59.9 32.3 46.4 82.3 122.8 116.3 31.1 127.2 153.6 116.9 42.9 133.4 245.4 95.4 200.7 132.4 79.0 42.6 115.1 97.6 154.1 132.3 121.8 208.9 92.9 420.8 48.5 157.6 53.5 49.9 62.9 104.1 51.5 145.9 76.5 96.5 69.9 141.7 54.4 73.9 57.3 89.1 63.9 134.3 73.7 50.8 77.6 137.5 96.9 71.6 34.2 130.5 49.4 60.1 38.1 141.0 117.6 47.2 72.3 111.9 65.5 57.4 81.5 58.8 84.9 69.2 56.7 149.7 81.9 63.6 58.0 20.1 87.4 50.9 102.3 88.7 122.1 69.8 70.1 68.9 79.9 69.3 71.9 69.4 70.2 67.2 69.2 69.4 71.0 71.2 25.8 44.8 38.0 7.8 25.4 22.9 35.8 101.4 43.9 27.3 31.0 37.1 74.4 41.5 45.3 27.6 16.7 98.6 22.1 21.4 90.1 73.5 8.1 20.3 30.7 42.7 18.0 806.8 9.4 63.7 54.6 57.1 17.3 21.2 52.6 20.4 38.6 98.5 101.8 13.5 6.7 20.2 73.2 37.9 29.4 16.2 79.6 38.5 48.0 5.6 103.6 89.7 24.7 7.1 7.3 51.2 23.7 56.1 36.8 15.9 32.7 134.5 32.9 25.3 39.5 29.4 75.0 37.3 42.3 31.6 24.7 49.8 23.3 72.7 20.9 29.1 ST3GAL3 "MRT12, SIAT6" ENSG00000126091 "ST3 beta-galactoside alpha-2,3-sialyltransferase 3" Q11203 1 43705824-43931165 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.8;tongue: 83.7" "Cell type enhanced" "Detected in many" "Astrocytes: 59.7;Excitatory neurons: 94.4;Granulosa cells: 52.5;Inhibitory neurons: 120.1;Microglial cells: 57.1;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051102 Uncertain "Intracellular and membrane" NA NA "HPA051102: AB_2681344" "unprognostic (8.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (3.20e-1)" "unprognostic (9.72e-2)" "unprognostic (7.01e-2)" "unprognostic (4.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (7.00e-2)" "unprognostic (3.68e-3)" "unprognostic (1.67e-2)" "unprognostic (1.30e-1)" "unprognostic (4.35e-1)" "unprognostic (6.60e-2)" 12.8 14.8 27.5 5.0 26.2 11.1 11.1 28.0 32.7 14.6 21.8 14.6 2.7 16.8 9.9 8.4 12.9 7.0 22.1 26.0 27.1 9.9 13.7 8.8 6.1 27.5 28.2 27.5 15.0 8.0 6.7 18.0 6.5 27.9 13.4 4.5 24.7 8.4 13.4 88.8 7.1 6.7 13.2 21.9 7.7 9.7 22.7 29.8 5.0 8.5 83.7 3.8 16.9 10.2 27.0 4.3 2.7 23.4 11.0 17.4 21.9 3.0 15.5 30.8 14.1 13.7 2.6 6.6 7.0 8.6 19.0 7.7 3.8 2.8 10.2 15.7 8.7 5.8 15.0 10.6 7.5 14.7 6.6 7.1 12.1 7.4 9.7 21.3 26.1 12.1 18.4 8.8 13.1 25.3 2.7 7.0 11.7 9.2 1.0 8.1 11.4 3.3 6.1 11.0 2.4 9.3 13.8 5.5 2.5 14.1 9.6 3.5 30.3 10.4 8.3 3.9 13.3 15.4 10.4 6.1 6.9 11.7 15.7 15.3 1.7 2.1 1.2 3.3 1.1 2.9 2.2 2.1 2.5 1.5 2.8 3.5 2.6 2.4 2.2 1.9 3.3 2.9 3.3 27.5 26.2 28.0 32.7 26.0 27.1 27.5 28.2 27.5 27.9 21.9 29.8 27.0 6.7 6.4 19.3 59.7 6.6 3.3 3.0 4.1 5.7 9.4 4.6 3.3 34.5 1.5 3.8 3.7 0.0 3.1 2.7 2.2 5.9 2.6 19.4 2.4 6.6 7.6 2.4 8.4 94.4 2.4 1.6 9.0 1.5 2.8 24.1 52.5 4.6 8.6 3.1 18.5 120.1 1.4 4.1 2.2 3.1 14.5 3.7 4.5 3.6 57.1 3.6 6.1 5.2 66.9 66.2 2.7 0.2 11.7 4.2 2.2 0.1 6.3 4.9 17.8 19.7 5.8 9.8 8.5 5.1 2.7 1.3 1.0 6.0 15.7 1.7 10.0 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 59.9" "Cell type enriched" "Detected in many" 5 "Late spermatids: 999.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "plasmacytoid DC: 99.4" "Lineage enriched" "Detected in all" 4 "dendritic cells: 99.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favorable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 12.9 12.1 4.9 4.5 7.9 6.7 12.2 6.0 8.4 6.9 4.9 11.0 16.5 9.0 6.9 6.0 7.1 6.2 13.1 4.9 6.3 18.1 59.9 10.6 4.1 7.8 7.8 4.3 10.7 8.4 6.4 10.1 4.0 8.4 7.2 7.0 7.2 7.3 3.3 7.6 6.6 14.7 4.2 5.7 6.3 10.2 35.2 7.2 3.3 8.0 3.7 2.1 7.5 6.1 14.8 12.9 14.7 13.0 9.6 16.6 12.5 15.6 3.8 11.1 7.2 10.5 4.7 39.9 4.1 11.8 3.6 27.4 11.5 3.6 7.8 3.8 6.5 9.2 4.7 6.0 22.7 16.5 3.7 16.6 14.8 11.9 14.4 3.1 7.9 4.0 9.1 2.0 5.1 4.3 7.7 4.5 11.2 7.6 9.9 8.5 6.8 1.8 40.0 21.6 13.4 9.0 8.7 4.1 15.7 21.3 9.3 4.8 9.9 1.7 5.3 8.8 7.5 4.7 3.7 4.7 2.3 13.6 9.6 6.3 14.1 12.9 6.3 7.3 23.1 6.3 13.9 7.4 6.3 6.6 14.8 3.5 4.5 1.4 7.8 16.2 99.4 8.1 7.6 4.9 7.9 6.0 8.4 4.9 6.3 7.8 7.8 4.3 8.4 5.7 7.2 14.8 10.9 6.4 12.0 8.1 3.5 1.7 9.5 24.2 1.8 6.9 9.0 7.6 35.5 10.0 20.4 20.2 4.2 14.5 9.5 53.1 45.0 18.6 188.3 14.0 4.6 8.5 14.4 10.1 2.9 25.7 15.5 6.9 8.2 5.7 6.3 8.6 10.0 93.0 34.3 18.5 3.6 22.6 44.7 12.6 0.7 999.9 9.0 14.0 8.8 1.9 3.8 17.1 5.2 3.0 4.8 17.5 51.3 12.4 2.6 8.9 74.3 45.9 32.8 13.8 26.3 3.7 10.6 15.6 13.2 3.9 2.3 9.3 3.7 8.3 18.0 12.7 HECTD3 FLJ21156 ENSG00000126107 "HECT domain E3 ubiquitin protein ligase 3" Q5T447 1 45002540-45011324 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.7;Proximal enterocytes: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027467 Approved NA NA "HPA027467: AB_10600710" "unprognostic (1.86e-1)" "unprognostic (1.19e-2)" "unprognostic (2.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.18e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.74e-2)" "unprognostic (2.92e-2)" "unprognostic (7.42e-2)" "unprognostic (2.47e-1)" "unprognostic (8.39e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.35e-1)" "prognostic favorable (1.85e-6)" "unprognostic (3.19e-1)" 21.6 24.7 19.6 12.4 20.1 15.1 20.1 20.1 20.0 16.9 17.9 28.4 47.6 18.3 16.2 26.6 13.9 12.4 15.0 19.7 19.7 19.5 30.8 14.1 16.6 21.3 19.8 19.3 19.7 37.3 27.0 12.0 14.3 22.1 14.9 26.4 7.5 34.3 15.8 40.2 28.1 40.7 15.0 19.7 20.3 22.8 13.7 19.8 12.9 17.2 24.2 14.5 20.5 19.1 21.9 22.1 19.8 12.4 20.1 42.5 26.5 24.3 20.6 31.2 22.3 25.2 28.7 6.8 10.3 17.1 34.1 50.0 20.2 29.7 21.5 20.0 19.3 22.8 16.6 28.4 24.9 37.2 13.0 26.8 28.6 36.5 38.4 14.8 23.2 50.4 17.8 38.0 11.3 28.9 18.8 16.6 10.6 17.1 24.9 29.6 19.5 22.7 15.0 33.2 25.7 29.7 12.4 27.9 47.8 25.5 31.1 15.5 12.0 38.0 25.7 20.4 32.2 23.9 14.4 18.3 5.8 41.3 14.0 12.9 10.7 8.0 8.0 7.3 10.9 6.3 6.0 6.1 6.5 7.3 3.3 5.0 6.1 2.8 4.0 6.3 5.5 6.7 6.5 19.6 20.1 20.1 20.0 19.7 19.7 21.3 19.8 19.3 22.1 19.7 19.8 21.9 6.9 3.2 8.2 7.2 5.6 3.8 2.2 3.1 8.6 5.2 8.5 6.2 6.0 8.6 5.8 5.5 6.2 7.1 9.2 33.7 1.9 10.3 1.2 4.0 7.5 7.0 2.4 20.6 5.4 15.5 14.2 7.0 21.4 8.1 6.3 6.4 6.4 14.1 13.6 6.7 5.0 15.1 0.0 15.3 2.9 2.3 14.6 7.8 3.6 4.7 10.2 3.1 5.2 2.0 4.7 13.2 28.1 9.8 9.1 2.8 44.8 6.9 1.4 6.2 6.6 4.5 6.7 4.5 7.4 9.7 6.1 6.0 7.1 13.5 14.9 2.3 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 433.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 14000 "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 67.7 49.8 322.1 42.6 331.8 50.7 63.5 309.3 346.5 70.2 254.8 74.1 26.4 72.1 44.3 66.5 65.6 38.8 94.4 340.3 329.0 35.9 30.2 66.6 44.6 401.2 343.5 327.2 63.4 43.4 48.9 87.4 46.3 433.4 47.5 34.6 160.0 54.7 47.6 124.4 67.0 49.2 58.5 336.8 49.4 54.4 45.9 345.4 40.6 49.0 72.1 47.8 67.1 70.4 383.9 57.0 74.2 138.6 76.3 92.6 102.8 65.5 129.5 105.4 118.6 81.7 64.0 60.8 75.8 65.2 139.3 53.2 93.0 85.8 69.6 112.0 89.9 43.9 41.6 92.8 66.1 106.8 83.4 79.5 73.4 109.3 89.6 112.1 126.5 104.2 52.8 63.5 83.7 104.4 94.6 56.9 74.0 45.6 90.1 140.4 53.0 60.6 38.2 74.7 122.5 165.1 93.5 105.7 52.7 90.2 85.9 47.9 40.1 152.7 88.4 43.5 123.1 74.1 65.9 50.0 83.3 101.7 47.7 97.0 5.5 4.6 9.8 7.3 4.6 6.6 5.0 6.5 7.8 5.1 6.8 5.7 5.0 5.0 3.1 6.5 7.6 7.0 2.9 322.1 331.8 309.3 346.5 340.3 329.0 401.2 343.5 327.2 433.4 336.8 345.4 383.9 45.2 44.8 32.6 92.4 24.3 26.0 45.1 30.1 13.6 140.8 18.7 19.7 39.3 15.7 21.5 20.2 52.1 22.6 29.5 17.9 9.8 42.9 8.0 30.8 41.8 45.5 44.9 13.2 84.1 30.7 30.6 37.4 27.0 43.2 33.6 31.5 39.3 18.9 30.5 138.0 80.8 24.3 28.5 19.9 23.8 17.0 38.5 24.4 39.2 73.1 36.3 45.4 20.6 57.3 89.8 71.2 17.3 48.2 26.2 46.6 15.8 5.1 23.8 106.1 26.3 46.4 46.8 64.8 83.3 20.1 17.6 42.1 30.8 17.1 17.5 38.4 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 8.9 6.1 7.3 8.8 10.4 32.2 9.4 6.7 7.7 12.7 10.1 10.3 7.0 10.5 1.7 14.0 11.0 6.7 8.2 5.1 7.7 8.0 7.8 12.2 15.5 13.3 8.6 3.3 12.8 9.9 1.7 8.7 5.2 9.7 13.5 7.6 4.5 12.8 3.4 12.5 39.3 12.8 2.8 7.4 21.5 9.1 13.9 7.9 10.0 10.6 2.5 11.1 9.7 12.5 13.2 32.4 58.4 31.5 38.5 2.8 7.9 57.0 35.5 11.6 48.9 52.3 32.4 50.3 51.8 29.5 7.5 38.4 50.3 34.6 52.4 29.9 31.3 36.1 50.6 31.6 30.4 4.9 45.3 30.8 6.0 5.2 43.2 26.7 10.4 20.2 51.3 31.8 30.4 25.2 70.7 79.6 35.8 26.4 47.1 42.0 63.7 45.7 19.8 10.5 44.2 31.1 25.7 41.3 21.7 14.3 17.4 34.6 35.0 17.5 25.1 28.9 80.0 38.8 26.2 25.8 63.7 15.6 36.9 38.4 0.7 0.5 0.9 1.0 0.9 1.0 1.1 0.8 0.8 0.5 0.9 0.8 0.5 0.3 0.7 0.7 0.4 0.6 1.3 7.3 10.4 6.7 7.7 5.1 7.7 13.3 8.6 3.3 9.7 7.4 7.9 13.2 2.2 0.0 0.0 2.6 2.5 1.5 1.9 2.1 1.8 1.7 3.2 3.6 0.2 2.8 2.5 0.0 2.1 10.2 1.8 6.9 1.9 1.5 0.7 1.9 2.2 2.0 1.2 7.4 2.6 1.8 6.1 1.2 0.5 2.0 0.0 4.7 0.4 0.3 4.4 3.3 1.0 7.4 0.0 0.0 2.0 1.8 0.3 1.5 0.0 1.0 1.5 1.7 2.1 1.5 1.4 1.7 2.6 1.2 4.4 1.6 0.7 0.2 1.7 2.3 0.0 2.6 1.2 3.1 5.8 2.8 1.3 3.1 2.0 4.2 8.3 1.2 TUBGCP3 "GCP3, SPBC98, Spc98p" ENSG00000126216 "Tubulin gamma complex associated protein 3" Q96CW5 13 112485011-112588205 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043913 Approved NA NA "HPA043913: AB_10963220" "unprognostic (6.12e-2)" "unprognostic (7.70e-3)" "unprognostic (1.94e-1)" "unprognostic (3.81e-1)" "unprognostic (6.86e-2)" "unprognostic (2.09e-1)" "unprognostic (6.26e-3)" "unprognostic (3.89e-2)" "unprognostic (8.70e-3)" "unprognostic (1.62e-2)" "unprognostic (3.98e-2)" "unprognostic (2.91e-2)" "unprognostic (1.23e-1)" "unprognostic (5.18e-2)" "unprognostic (8.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.38e-2)" 11.7 10.0 4.0 12.2 5.4 31.5 11.0 5.4 4.9 12.1 4.3 10.3 8.8 13.2 6.6 10.7 11.8 9.0 9.0 3.7 4.6 8.8 14.8 10.7 15.0 5.2 4.5 3.7 18.1 10.5 8.8 7.9 9.8 5.6 8.3 10.1 11.8 10.4 8.4 12.2 14.2 11.3 12.6 4.3 15.0 9.6 16.9 5.2 19.2 10.7 9.0 13.4 11.1 11.9 8.2 48.1 20.5 29.6 17.5 12.0 15.0 25.5 21.6 22.8 29.1 25.7 22.4 40.5 34.2 12.0 20.5 29.1 31.2 27.8 24.4 38.2 26.9 34.1 35.8 28.3 18.6 12.4 102.6 32.2 11.7 18.4 19.0 34.1 11.9 23.3 33.0 19.7 23.2 21.9 19.6 41.3 34.9 17.5 51.0 20.7 48.6 26.6 23.0 12.4 19.8 27.4 25.1 26.0 34.2 14.5 17.4 20.7 79.8 18.6 16.6 51.8 19.5 27.1 23.8 18.7 47.7 28.1 68.7 34.4 19.0 33.8 50.0 10.9 28.3 13.4 17.5 11.8 13.7 37.4 11.2 17.9 11.4 31.6 19.0 25.0 19.9 16.2 18.7 4.0 5.4 5.4 4.9 3.7 4.6 5.2 4.5 3.7 5.6 4.3 5.2 8.2 14.9 9.6 8.7 25.8 16.6 11.6 5.5 4.9 14.8 18.6 7.6 6.7 9.6 7.2 9.2 9.2 16.7 8.8 18.5 7.5 0.0 6.7 22.9 5.8 12.2 11.9 8.4 23.5 45.9 6.2 11.6 12.0 16.3 7.1 7.0 13.3 12.8 14.7 14.6 28.6 44.4 7.4 2.0 22.5 13.0 24.6 14.9 20.0 19.6 34.7 19.0 11.5 14.4 42.3 49.3 8.6 4.0 10.9 18.5 4.3 7.4 9.7 3.9 16.4 26.3 13.0 11.5 25.0 31.4 12.2 8.2 4.1 13.3 12.0 8.4 3.9 MCF2L "ARHGEF14, DBS, KIAA0362, OST" ENSG00000126217 "MCF.2 cell line derived transforming sequence like" O15068 13 112894378-113099742 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.7" "Cell type enhanced" "Detected in many" "Adipocytes: 138.3;Bipolar cells: 70.4;Cone photoreceptor cells: 127.2;Endothelial cells: 69.7;Microglial cells: 92.8;Oligodendrocytes: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 35.9;SCLC-21H: 65.3;SH-SY5Y: 29.0;SK-BR-3: 43.9;WM-115: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.56e-1)" "unprognostic (2.53e-2)" "unprognostic (8.86e-3)" "prognostic favorable (6.01e-4)" "unprognostic (9.07e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.02e-2)" "unprognostic (1.94e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.36e-5)" "unprognostic (1.17e-1)" "prognostic favorable (9.14e-6)" "unprognostic (2.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.24e-1)" "prognostic favorable (2.63e-5)" 41.6 7.7 53.5 6.3 40.5 0.9 39.8 118.7 69.1 16.1 3.7 17.7 11.4 19.6 5.1 14.2 17.9 13.5 37.0 37.2 32.9 17.4 7.8 19.2 6.8 53.2 45.0 30.5 4.8 19.0 10.4 44.8 8.4 72.1 17.2 13.8 20.1 33.0 8.5 16.6 25.0 18.9 7.2 29.6 3.6 18.2 2.1 53.8 7.2 27.9 16.4 6.0 15.2 17.0 75.9 0.0 1.6 14.9 4.8 0.5 0.9 2.1 0.0 0.0 0.0 0.0 3.8 2.2 0.1 3.7 1.5 2.5 0.3 3.8 0.0 0.0 0.0 7.4 4.3 0.2 9.1 0.5 0.2 3.1 1.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 14.4 5.6 0.5 2.6 4.0 35.9 0.0 0.2 15.0 7.9 5.9 23.6 65.3 29.0 0.0 43.9 0.1 2.4 26.0 0.1 0.6 0.1 12.5 5.4 0.0 7.5 0.4 2.3 23.9 1.0 60.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.4 53.5 40.5 118.7 69.1 37.2 32.9 53.2 45.0 30.5 72.1 29.6 53.8 75.9 138.3 0.0 8.4 4.6 2.6 5.5 3.4 1.5 8.0 70.4 12.9 10.0 44.3 12.8 4.6 9.2 127.2 0.0 1.2 10.8 7.9 5.6 0.4 9.9 1.6 69.7 26.5 0.0 58.5 2.6 0.2 7.1 23.0 18.7 1.3 11.2 13.6 3.4 1.4 38.7 60.9 54.6 8.2 2.2 4.6 1.5 0.6 2.5 8.8 92.8 0.1 5.4 0.0 40.7 75.0 1.7 9.8 1.2 3.0 4.2 4.0 10.4 7.2 23.9 0.0 5.2 11.9 0.7 2.7 4.2 9.1 0.1 2.1 0.5 7.4 4.1 F10 ENSG00000126218 "Coagulation factor X" P00742 13 113122799-113149529 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 161.4" "Cell type enhanced" "Detected in many" "Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2" "Cancer enriched" "Detected in many" 11 "liver cancer: 95.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted to blood" NA NA 13000000000 "unprognostic (4.18e-2)" "unprognostic (1.07e-1)" "unprognostic (7.62e-2)" "unprognostic (9.88e-2)" "unprognostic (9.44e-2)" "unprognostic (1.15e-2)" "unprognostic (4.90e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.24e-1)" "prognostic favorable (1.82e-5)" "unprognostic (6.39e-2)" "prognostic unfavorable (5.14e-5)" "unprognostic (6.60e-2)" "unprognostic (1.21e-1)" "unprognostic (3.87e-2)" "unprognostic (2.23e-3)" 18.1 8.6 1.2 1.5 1.1 0.0 11.8 2.4 2.0 44.6 1.8 5.3 11.0 13.3 16.6 8.9 24.1 11.0 24.9 1.0 1.7 4.1 161.4 14.5 3.2 2.2 1.4 0.9 28.1 7.1 0.2 4.5 4.4 2.4 12.9 2.0 0.9 5.1 7.2 6.8 17.2 12.0 2.7 1.1 3.3 8.7 10.2 1.4 1.4 8.3 6.7 1.3 12.0 26.1 2.1 0.1 0.0 2.5 0.4 8.0 8.1 0.1 14.4 11.5 0.8 0.3 12.7 0.1 0.1 0.5 13.1 1.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 59.6 11.5 0.0 0.3 8.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 1.5 0.1 0.0 0.3 0.0 1.3 0.2 0.3 0.1 0.0 0.0 0.2 1.0 27.9 0.1 0.5 0.1 0.6 0.6 0.1 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 2.4 2.0 1.0 1.7 2.2 1.4 0.9 2.4 1.1 1.4 2.1 7.0 0.0 0.0 1.3 0.6 15.7 0.1 0.0 0.0 1.1 0.4 0.3 9.1 4.3 0.0 1.8 0.0 0.6 0.0 0.1 0.0 0.1 2.9 1.9 45.9 3.8 17.9 2.7 1.3 0.0 0.4 113.6 6.1 1.0 1.3 2.2 7.9 195.1 1.4 6.7 1.4 5.0 0.0 4.8 25.0 9.6 215.9 1.3 19.6 5.6 0.6 4.5 0.0 0.5 0.1 0.3 6.5 236.2 0.0 0.3 28.3 6.4 0.0 1.2 52.6 14.5 40.9 2.3 1.2 0.5 15.3 1.1 1.9 2.4 2.2 0.4 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177536-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA069107: AB_2686088, HPA073074: AB_2686568" "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 22.2 29.2 17.1 15.9 17.8 15.6 23.1 19.5 18.9 26.9 18.5 23.0 12.2 23.2 23.2 19.4 26.1 17.2 38.0 17.2 17.5 18.3 24.0 18.8 26.0 16.9 17.2 17.4 34.0 24.1 19.3 22.8 15.7 17.5 24.9 18.6 10.8 24.0 19.4 29.3 18.6 20.3 22.0 17.2 24.9 24.6 45.7 17.9 24.7 21.0 24.7 23.2 24.1 22.6 19.2 62.9 26.3 39.1 34.7 70.2 52.3 27.4 47.2 70.7 64.4 59.1 51.9 57.7 50.2 30.7 64.5 81.6 38.8 62.9 42.8 71.2 44.3 62.1 64.8 68.1 45.9 70.0 110.4 25.5 43.3 46.6 40.4 71.1 51.4 51.3 68.5 50.4 19.9 73.6 30.3 59.4 77.9 38.9 115.1 33.2 53.4 43.4 48.0 58.8 31.3 52.0 31.9 29.5 72.2 55.9 39.3 39.9 133.4 33.5 19.0 68.7 27.9 36.2 30.4 30.4 70.4 65.3 74.1 44.2 28.2 25.5 20.0 68.9 34.4 81.6 39.7 58.0 72.5 26.0 39.5 52.2 54.6 3.9 22.6 33.2 24.8 64.7 54.7 17.1 17.8 19.5 18.9 17.2 17.5 16.9 17.2 17.4 17.5 17.2 17.9 19.2 26.5 19.2 16.7 16.3 28.4 21.5 29.1 37.8 17.6 23.6 25.5 32.3 27.8 21.5 23.7 14.7 16.7 30.2 38.5 7.8 27.4 22.8 52.8 26.8 35.7 26.2 7.8 32.8 43.6 13.8 24.7 33.8 18.8 21.7 10.8 39.0 18.9 18.4 20.2 37.0 33.7 15.6 16.2 18.2 14.0 18.1 41.3 17.2 16.0 26.2 24.0 19.0 38.1 25.1 40.4 18.1 15.8 40.6 16.8 46.3 13.6 23.6 30.4 23.8 19.7 37.4 30.9 204.4 72.7 17.6 24.7 31.1 43.7 33.0 20.1 25.3 PROZ PZ ENSG00000126231 "Protein Z, vitamin K dependent plasma glycoprotein" P22891 13 113158648-113172386 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 110.1" "Group enriched" "Detected in some" 52 "Hepatocytes: 63.5;Proximal tubular cells: 20.5" "Cancer enriched" "Detected in single" 27 "liver cancer: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;Hep G2: 3.6" "Not detected" "Not detected" HPA052006 Supported "Secreted to blood" NA NA 1720000000 650000000 "HPA052006: AB_2681691" "unprognostic (5.03e-2)" "unprognostic (4.05e-2)" "unprognostic (1.11e-1)" "unprognostic (2.36e-1)" "unprognostic (6.48e-2)" "unprognostic (1.39e-1)" "prognostic favorable (3.46e-4)" "unprognostic (4.10e-1)" "unprognostic (2.21e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (2.87e-1)" "unprognostic (9.83e-2)" "unprognostic (5.63e-2)" "unprognostic (1.41e-1)" "unprognostic (9.99e-2)" "unprognostic (2.51e-4)" 0.0 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.0 14.5 110.1 0.1 0.3 0.1 0.0 0.0 0.1 0.7 0.0 1.2 0.0 0.2 0.4 0.0 0.1 0.3 0.0 0.0 0.5 0.4 0.0 0.0 0.4 0.5 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.4 0.6 0.3 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.4 0.8 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.4 1.1 0.4 1.6 3.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 0.5 0.3 0.4 0.8 1.4 0.1 0.6 0.1 0.1 0.0 0.5 1.3 0.0 0.0 0.1 0.6 0.7 0.0 0.4 0.3 0.3 0.0 0.3 0.1 0.7 0.4 0.3 0.7 0.4 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 63.5 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 20.5 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 SLURP1 "ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM" ENSG00000126233 "Secreted LY6/PLAUR domain containing 1" P55000 8 142740949-142742406 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Cytokine "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 1047.6;skin 1: 730.8" "Group enriched" "Detected in some" 16 "Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 66.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050967 Approved "Secreted in other tissues" NA NA 7700000 "HPA050967: AB_2681293" "unprognostic (1.22e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.42e-2)" "unprognostic (1.84e-1)" "unprognostic (7.32e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-4)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (1.43e-1)" 0.7 0.6 0.1 0.0 0.0 0.0 11.4 0.8 0.4 50.2 0.0 0.2 0.0 0.2 0.0 1047.6 0.2 0.2 0.4 0.2 0.0 0.1 0.5 0.3 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.5 0.0 0.3 0.3 0.0 0.0 70.6 0.0 1.4 730.8 0.3 0.0 0.0 0.2 0.8 0.3 0.1 0.9 0.2 0.0 17.5 0.3 208.4 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.4 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.6 0.0 0.0 1.8 1.5 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 20.8 65.8 0.0 0.0 0.0 0.0 0.8 LRFN3 "FIGLER1, MGC2656, SALM4" ENSG00000126243 "Leucine rich repeat and fibronectin type III domain containing 3" Q9BTN0 19 35935358-35946624 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048923 Approved NA NA "HPA048923: AB_2680558" "unprognostic (1.88e-1)" "unprognostic (7.22e-3)" "unprognostic (1.82e-1)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (7.37e-2)" "unprognostic (8.14e-2)" "unprognostic (2.34e-3)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (3.49e-3)" "unprognostic (1.74e-1)" "prognostic favorable (8.46e-7)" "unprognostic (6.84e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-2)" "unprognostic (1.03e-1)" 5.9 6.9 3.2 1.8 2.6 0.1 6.4 3.2 5.5 9.2 0.0 6.5 3.2 10.5 1.0 7.1 7.6 1.9 6.3 3.4 0.7 6.3 8.2 5.1 1.2 2.3 1.3 2.8 11.8 8.0 3.4 13.0 1.6 2.2 8.1 1.6 2.1 6.8 3.4 8.1 5.8 6.4 2.9 0.0 5.6 6.6 5.0 1.7 1.0 6.1 1.9 1.1 7.5 8.0 1.5 8.8 10.4 5.4 7.8 10.9 5.8 2.0 3.8 5.7 4.3 4.3 1.9 4.3 5.6 7.3 5.3 5.2 3.2 2.3 5.0 2.5 9.8 3.7 0.6 2.1 1.9 4.0 0.3 7.8 6.2 6.7 2.5 2.7 5.2 5.0 6.7 1.5 8.1 3.9 6.4 4.1 0.2 3.5 7.4 4.5 5.6 3.0 0.1 3.0 3.5 6.1 7.3 5.6 4.3 3.2 2.8 3.2 2.5 5.7 8.9 7.0 7.6 6.0 2.7 3.1 0.2 7.8 3.0 6.2 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.4 0.5 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 3.2 2.6 3.2 5.5 3.4 0.7 2.3 1.3 2.8 2.2 0.0 1.7 1.5 5.3 0.0 0.0 0.7 0.9 1.1 3.2 1.9 1.8 7.5 2.0 2.3 11.0 1.5 0.9 3.7 2.1 0.4 0.7 5.9 0.0 3.9 0.5 2.1 2.7 3.0 3.0 0.0 4.3 4.3 2.0 4.0 4.6 2.5 0.0 5.7 8.9 4.6 2.1 8.4 4.2 3.5 4.1 1.0 0.5 1.5 4.4 0.5 0.0 2.8 0.3 4.9 2.1 4.0 1.7 4.3 6.6 7.5 0.6 3.9 6.7 2.5 1.0 5.5 6.6 4.0 3.0 0.2 1.7 1.9 1.1 0.1 1.8 3.3 3.6 2.0 IGFLR1 "FLJ22573, TMEM149, U2AF1L4" ENSG00000126246 "IGF like family receptor 1" Q9H665 19 35738801-35742453 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.3" "Cell type enhanced" "Detected in many" "dendritic cells: 29.9;granulocytes: 38.7;Langerhans cells: 33.7;Macrophages: 28.8;monocytes: 115.6;Plasma cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 899.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 899.7" "Cell line enhanced" "Detected in many" "HMC-1: 32.9;Karpas-707: 26.0;U-266/70: 34.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA012369, HPA070778" Uncertain Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA012369: AB_1858095, HPA070778: " "unprognostic (5.97e-3)" "prognostic favorable (6.55e-4)" "unprognostic (1.94e-1)" "unprognostic (5.42e-2)" "unprognostic (8.31e-3)" "unprognostic (2.34e-4)" "unprognostic (6.71e-2)" "unprognostic (1.74e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.59e-5)" "unprognostic (1.44e-3)" "unprognostic (3.52e-1)" "unprognostic (8.72e-12)" "unprognostic (2.74e-1)" "unprognostic (1.22e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-3)" 7.5 11.0 5.9 19.7 6.1 14.5 6.3 6.1 9.3 4.1 6.3 6.5 6.1 3.4 5.5 4.0 6.5 6.2 4.1 5.6 10.4 14.1 50.3 11.4 33.2 8.7 5.9 5.5 4.4 9.4 1.4 5.6 4.5 6.6 6.3 6.4 4.7 7.9 1.5 4.5 4.4 13.3 4.4 5.9 28.8 7.9 6.7 6.6 12.7 7.2 2.1 23.4 7.4 3.5 7.1 2.2 10.0 3.5 8.3 1.1 1.7 2.0 1.5 1.1 1.8 4.7 3.0 2.4 4.0 3.2 0.7 0.6 1.6 2.0 2.1 0.9 3.3 5.0 15.0 3.4 9.1 2.8 1.7 32.9 2.7 1.3 3.5 0.8 0.6 1.9 7.7 4.9 26.0 0.5 7.4 5.1 16.7 1.6 9.4 2.7 6.0 3.3 8.3 1.7 3.2 2.4 4.5 3.4 2.4 1.8 1.3 3.4 7.8 0.5 4.2 2.0 2.6 4.0 34.0 7.5 2.8 4.9 5.8 3.0 147.9 190.9 184.1 94.2 167.7 106.6 169.3 107.3 88.8 253.2 172.1 95.8 77.0 208.6 144.9 125.3 899.7 136.3 139.5 5.9 6.1 6.1 9.3 5.6 10.4 8.7 5.9 5.5 6.6 5.9 6.6 7.1 0.3 0.0 13.5 2.6 24.5 0.6 0.3 0.0 0.0 0.4 1.3 1.3 1.2 1.5 5.0 0.0 0.0 0.6 29.9 1.2 1.9 1.9 0.0 0.8 0.6 0.8 3.0 6.1 0.3 4.2 1.8 0.9 1.1 0.7 38.7 0.6 2.2 20.3 14.6 0.0 0.4 1.8 0.0 15.7 33.7 0.6 0.0 28.8 5.4 1.9 115.6 2.7 12.3 2.5 1.0 1.4 0.3 0.0 42.1 0.2 0.9 10.8 3.6 0.4 0.0 1.0 0.9 0.4 0.5 1.9 0.9 0.3 20.8 0.4 2.4 0.0 CAPNS1 "30K, CANP, CANPS, CAPN4, CDPS" ENSG00000126247 "Calpain small subunit 1" P04632 19 36139953-36150353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006872 Approved Approved Nucleoplasm,Cytosol NA NA 9000000 "Nucleoplasm, Cytosol" "HPA006872: AB_1078382" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.03e-1)" "unprognostic (2.82e-3)" "unprognostic (1.25e-3)" "unprognostic (2.04e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-1)" "unprognostic (5.53e-2)" "unprognostic (7.10e-3)" "unprognostic (1.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-2)" 419.7 360.8 345.3 173.0 356.7 237.8 374.8 341.0 511.1 339.9 334.7 351.0 265.6 306.1 195.5 767.8 309.3 199.6 582.2 357.7 376.1 491.4 275.8 400.2 168.8 377.1 360.1 348.4 269.8 253.0 333.6 320.4 148.5 390.6 360.0 290.4 137.4 378.0 284.0 495.4 206.4 344.2 292.5 338.8 366.5 313.7 275.7 372.3 202.7 332.7 376.8 277.4 357.8 405.9 383.1 395.2 977.6 240.0 342.7 566.3 683.0 48.2 315.8 673.4 631.3 488.1 223.3 572.2 141.9 463.7 1067.5 225.6 207.0 291.3 780.8 514.7 592.4 142.9 166.0 259.7 373.0 655.0 166.7 393.9 740.8 477.9 411.1 577.5 767.3 699.8 173.5 204.4 554.4 978.6 522.7 295.4 301.4 137.9 754.6 490.6 156.5 194.7 262.3 1208.8 368.7 159.1 199.4 385.1 532.0 155.5 279.4 308.6 261.4 460.6 555.5 424.3 188.1 318.7 198.4 277.6 126.8 630.4 225.9 480.8 24.8 50.1 22.6 44.4 75.6 28.5 29.4 30.9 36.4 46.1 32.3 18.7 25.2 25.2 24.6 83.4 58.7 34.7 21.1 345.3 356.7 341.0 511.1 357.7 376.1 377.1 360.1 348.4 390.6 338.8 372.3 383.1 172.7 125.0 98.6 10.4 49.3 30.7 76.2 69.1 29.6 21.1 91.7 75.1 149.5 130.1 85.9 163.7 0.0 74.9 107.1 250.1 62.6 226.3 102.9 168.5 118.3 136.6 107.8 47.3 13.4 251.3 87.8 83.3 66.8 234.4 63.4 84.7 157.1 78.4 155.1 16.8 11.9 220.3 52.9 244.6 86.9 230.2 93.2 130.5 39.2 15.9 208.4 78.2 109.2 6.6 21.9 254.2 187.5 76.0 50.2 98.0 243.5 135.3 74.6 33.1 46.0 64.3 92.9 120.1 6.5 109.1 28.8 70.1 62.8 132.2 165.6 112.4 PDCD2L MGC13096 ENSG00000126249 "Programmed cell death 2 like" Q9BRP1 19 34404399-34426168 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 24.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 35.7;Spermatogonia: 42.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052181 Approved Approved Mitochondria NA NA Mitochondria "HPA052181: AB_2681751" "unprognostic (5.39e-2)" "unprognostic (3.48e-1)" "unprognostic (1.51e-1)" "unprognostic (6.99e-2)" "unprognostic (1.07e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (8.78e-2)" "unprognostic (1.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.75e-1)" "unprognostic (1.72e-1)" "unprognostic (3.00e-2)" "unprognostic (5.98e-2)" 4.2 5.7 4.6 2.7 5.1 3.1 4.1 4.6 5.9 4.3 3.9 5.0 2.6 5.0 2.9 5.3 5.0 2.1 6.4 4.6 5.0 3.2 5.5 3.0 4.8 4.3 4.8 4.5 4.5 8.4 2.3 5.8 2.5 4.6 3.5 3.4 1.1 5.5 3.8 24.9 4.5 4.0 3.2 4.5 4.9 6.6 14.5 4.9 3.0 3.1 9.2 4.8 4.8 4.0 5.3 21.6 35.9 4.4 8.7 2.0 4.2 13.8 6.8 4.9 11.1 11.1 33.6 15.1 17.7 28.8 3.9 11.6 7.4 17.4 14.9 11.7 26.1 36.6 17.4 5.7 26.8 14.5 34.0 9.8 5.1 12.9 6.5 21.2 4.6 11.3 28.0 35.1 9.0 9.6 27.3 13.4 12.4 16.0 47.3 34.4 19.2 8.2 25.1 14.1 12.1 25.8 9.2 0.7 21.4 12.5 7.3 9.3 13.9 6.0 7.3 9.0 8.6 23.4 20.1 32.8 31.4 9.1 29.8 6.3 0.0 3.3 0.0 9.1 5.3 12.9 12.7 8.9 9.0 6.8 10.1 13.1 9.9 0.7 12.5 3.4 23.6 11.7 5.7 4.6 5.1 4.6 5.9 4.6 5.0 4.3 4.8 4.5 4.6 4.5 4.9 5.3 5.5 3.2 4.8 3.6 7.6 8.2 15.0 7.6 10.2 4.3 4.8 7.4 5.1 5.7 4.8 3.7 2.1 8.1 12.0 1.7 7.9 13.3 27.4 6.3 4.3 4.9 12.1 4.6 4.2 15.3 7.0 5.1 9.2 2.7 4.5 5.6 5.0 5.1 7.5 1.7 4.3 5.0 2.0 3.3 3.7 3.9 5.3 4.1 3.6 2.8 7.1 4.8 9.2 4.0 3.4 13.1 5.0 6.8 8.2 27.6 1.1 10.2 6.1 2.4 0.0 6.1 12.6 35.7 42.9 7.5 10.7 1.8 5.4 8.2 7.7 9.6 GPR42 "FFAR3L, GPR41L, GPR42P" ENSG00000126251 "G protein-coupled receptor 42" O15529 19 35370929-35372962 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.9;Kupffer cells: 1.9;Macrophages: 1.2;T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.73e-3)" "unprognostic (1.31e-4)" 0.4 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 384.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 55.1 48.4 32.1 24.7 35.7 38.5 54.8 38.2 41.9 56.1 28.0 56.7 27.7 65.7 12.1 59.0 54.3 11.9 55.7 32.1 33.4 54.2 54.5 46.9 24.3 40.9 35.1 29.9 55.3 39.9 23.3 41.8 23.4 35.4 55.6 10.8 9.2 44.5 25.1 76.6 65.4 46.7 14.7 35.6 52.1 50.1 41.9 35.8 26.2 50.3 21.8 15.7 58.4 51.2 40.1 115.6 176.5 38.8 52.9 34.6 27.0 104.8 77.2 41.8 88.3 69.0 105.0 72.8 63.7 137.8 49.4 48.2 46.6 44.8 54.0 26.0 165.6 80.0 87.8 57.7 87.5 88.8 78.5 81.1 38.6 42.3 65.4 36.0 28.4 48.8 65.3 92.9 50.8 40.5 130.5 99.9 103.1 44.4 103.1 71.9 107.7 52.9 63.8 43.0 52.6 50.5 73.3 87.8 71.5 62.4 21.1 57.0 122.0 76.2 63.1 86.4 84.4 136.6 123.0 140.7 99.1 60.9 73.8 90.2 98.8 79.6 124.5 82.8 95.6 70.9 76.2 67.8 83.1 94.3 81.3 59.4 67.1 73.9 79.3 94.5 87.6 82.6 73.3 32.1 35.7 38.2 41.9 32.1 33.4 40.9 35.1 29.9 35.4 35.6 35.8 40.1 56.5 38.5 24.6 4.6 38.4 51.9 52.6 94.3 43.9 23.3 31.2 37.5 14.7 40.0 57.4 53.3 12.5 197.9 47.0 67.2 74.3 78.0 38.4 41.0 35.4 50.9 52.1 43.8 2.3 90.4 101.5 47.0 38.7 41.6 51.4 46.0 46.8 31.6 91.2 10.1 2.6 56.4 54.9 31.1 60.9 16.3 58.1 40.9 53.4 2.8 63.0 46.5 27.8 3.5 5.8 80.6 48.9 63.2 43.7 31.8 72.3 78.0 44.5 19.8 52.6 34.5 92.4 71.9 52.9 36.2 43.5 384.3 44.9 44.3 64.7 45.4 KIRREL2 "DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1" ENSG00000126259 "Kirre like nephrin family adhesion molecule 2" Q6UWL6 19 35855861-35867136 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 70.6" "Cell type enriched" "Detected in some" 9 "Bipolar cells: 58.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA071587, HPA074326" Enhanced Supported "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA071587: AB_2732182, HPA074326: AB_2732251" "unprognostic (1.28e-2)" "unprognostic (1.80e-1)" "unprognostic (3.29e-2)" "unprognostic (3.16e-3)" "unprognostic (2.05e-3)" "unprognostic (2.29e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-3)" "unprognostic (3.30e-2)" "unprognostic (5.56e-2)" "unprognostic (4.85e-2)" "unprognostic (2.62e-2)" "unprognostic (2.43e-6)" "unprognostic (1.72e-1)" "unprognostic (4.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.62e-2)" 0.2 0.0 0.4 0.2 1.1 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.0 0.0 0.0 0.8 0.5 0.5 0.7 0.0 70.6 0.0 0.9 0.1 0.5 0.0 0.1 11.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.6 0.2 0.6 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.7 1.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 1.1 0.7 0.0 0.1 0.0 3.6 0.1 2.9 0.0 0.1 21.5 0.1 0.0 0.0 0.3 0.0 0.0 33.0 0.2 0.0 0.0 0.0 0.0 0.0 19.5 0.2 0.3 0.0 0.2 0.6 0.1 0.2 0.1 0.0 5.5 0.0 0.0 0.0 0.0 4.1 1.3 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.8 1.3 0.3 0.0 0.0 0.0 0.4 0.0 7.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.3 1.0 0.8 0.2 0.5 0.5 0.7 0.5 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 1.8 0.1 0.2 0.1 0.0 0.0 0.4 6.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.7 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.7 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 UBA2 "FLJ13058, HRIHFB2115, SAE2" ENSG00000126261 "Ubiquitin like modifier activating enzyme 2" Q9UBT2 19 34428352-34471251 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 269.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041436 Supported Supported Nucleoplasm NA NA 130000 Nucleoplasm "HPA041436: AB_2677479" "unprognostic (2.37e-1)" "unprognostic (3.17e-1)" "unprognostic (2.13e-2)" "unprognostic (1.36e-3)" "unprognostic (6.39e-3)" "unprognostic (8.72e-3)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.96e-2)" "unprognostic (2.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.58e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (2.11e-2)" "unprognostic (2.00e-1)" "unprognostic (1.88e-1)" 83.8 37.1 39.9 37.5 41.2 55.4 68.3 48.8 53.5 50.1 40.2 39.4 27.7 55.8 35.1 43.9 48.3 36.0 41.7 40.1 42.0 33.6 36.3 45.7 57.7 41.0 41.3 37.7 52.1 40.8 41.2 38.8 61.1 41.0 33.9 35.5 47.6 34.7 34.6 110.3 53.3 37.3 43.3 41.7 32.7 39.0 92.6 42.2 69.1 42.1 58.3 55.2 46.1 46.4 44.6 122.9 175.7 176.2 73.4 93.5 75.8 72.0 93.5 80.0 118.2 130.9 151.7 72.7 227.4 140.3 76.7 73.4 48.8 188.8 72.9 165.4 164.0 126.7 241.6 84.6 152.9 120.3 194.6 100.7 55.3 90.8 83.8 146.2 79.2 94.2 96.2 244.0 125.4 105.0 122.7 151.1 107.4 132.3 190.4 59.9 118.1 121.3 101.9 83.9 126.1 149.0 146.1 85.8 77.3 133.2 113.9 55.7 234.4 61.2 131.9 92.1 85.3 169.6 130.7 200.8 223.1 83.5 146.4 118.8 8.8 4.8 8.1 7.3 4.9 9.9 8.5 9.5 11.1 5.8 8.2 11.5 9.3 0.6 8.0 6.4 10.2 8.0 3.8 39.9 41.2 48.8 53.5 40.1 42.0 41.0 41.3 37.7 41.0 41.7 42.2 44.6 58.9 25.6 35.3 25.5 62.1 87.1 72.5 36.4 59.7 90.6 36.3 33.1 36.2 31.5 32.7 18.4 41.7 75.4 53.3 15.9 33.2 49.8 22.1 29.7 47.8 55.9 46.0 60.3 50.8 42.0 95.9 56.4 44.4 36.2 38.7 52.5 25.0 25.0 46.7 47.1 48.9 32.8 24.4 34.9 45.4 23.9 43.5 40.4 76.5 33.7 51.9 50.2 41.2 41.7 56.7 39.6 23.9 53.0 74.5 93.5 19.0 32.0 29.7 42.0 269.5 69.0 206.5 223.9 198.3 57.9 92.9 92.8 58.6 49.9 45.4 73.6 FFAR2 "FFA2R, GPR43" ENSG00000126262 "Free fatty acid receptor 2" O15552 19 35443907-35451767 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.5;lymphoid tissue: 22.4" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 24.1;Intestinal goblet cells: 8.9;Kupffer cells: 11.9;Macrophages: 15.4;Prostatic glandular cells: 7.7" "Cancer enhanced" "Detected in many" "prostate cancer: 6.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 25 "eosinophil: 85.0;neutrophil: 249.7" "Lineage enriched" "Detected in many" 38 "granulocytes: 249.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.9;OE19: 1.8;SK-BR-3: 1.1;THP-1: 1.2;U-937: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA023985 Approved NA NA "HPA023985: AB_1849302" "unprognostic (7.75e-3)" "unprognostic (5.65e-2)" "unprognostic (4.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (6.16e-2)" "unprognostic (2.04e-1)" "unprognostic (1.92e-2)" "unprognostic (9.04e-2)" "unprognostic (2.30e-2)" "unprognostic (4.60e-2)" "unprognostic (5.17e-4)" "unprognostic (1.48e-1)" "unprognostic (4.76e-2)" "unprognostic (9.42e-2)" "unprognostic (1.03e-2)" 3.4 0.3 0.2 17.9 0.4 20.5 2.3 0.2 0.4 0.1 0.6 0.8 3.3 0.1 0.0 1.3 1.0 1.4 0.8 0.3 0.3 0.3 1.5 7.6 0.1 0.5 0.3 0.3 0.0 0.6 0.4 0.1 1.6 0.5 1.1 0.7 0.1 0.7 0.0 0.2 1.1 4.6 1.3 0.2 22.4 1.2 0.1 0.4 0.7 0.4 3.7 0.7 6.1 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 1.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 3.1 2.1 85.0 0.0 5.6 0.0 0.1 0.0 0.0 0.9 0.2 0.0 0.0 249.7 0.0 6.5 0.1 0.0 0.7 0.2 0.4 0.2 0.4 0.3 0.3 0.5 0.3 0.3 0.5 0.2 0.4 0.9 5.6 0.0 3.2 0.0 0.6 0.1 0.4 0.3 0.0 0.0 0.2 0.3 0.4 0.0 2.7 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.2 0.0 0.1 0.8 24.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 5.1 0.0 0.4 0.0 5.0 0.0 0.0 8.9 2.0 11.9 2.6 0.1 0.0 15.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 7.7 1.1 0.0 2.2 0.0 0.0 0.4 2.4 0.1 0.2 0.0 0.6 0.1 1.3 0.1 0.6 1.5 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902529-35904377 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 255.9;lymphoid tissue: 116.6" "Cell type enhanced" "Detected in many" "dendritic cells: 993.2;Hofbauer cells: 571.1;Kupffer cells: 396.6;Langerhans cells: 584.5;Macrophages: 392.7;NK-cells: 1687.0;T-cells: 769.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 239.9;HL-60: 139.6;HMC-1: 154.3;THP-1: 177.8;U-937: 272.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Vesicles "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 27.0 9.6 11.9 54.1 12.8 255.9 14.3 12.3 18.6 8.2 16.9 12.8 11.4 8.3 4.8 5.5 9.9 11.6 7.6 11.5 17.4 10.3 14.6 40.7 68.6 15.1 13.1 9.9 5.7 6.8 2.5 9.6 24.9 15.3 9.5 8.7 2.2 10.8 8.3 4.3 6.5 28.4 11.3 15.9 116.6 15.6 3.5 17.1 60.2 8.0 3.0 38.2 16.6 8.1 17.9 0.9 0.0 0.3 0.5 1.1 0.0 0.3 1.9 1.1 0.0 0.6 0.8 1.2 26.9 1.7 2.0 0.4 0.9 0.0 0.2 0.0 0.6 0.0 239.9 0.5 0.7 0.9 139.6 154.3 1.6 0.3 0.0 0.0 0.7 0.0 14.8 2.1 33.4 0.4 0.4 16.9 54.7 0.3 0.3 0.7 0.8 0.5 2.0 0.4 0.1 0.9 0.4 1.3 0.7 0.9 0.2 0.5 177.8 0.5 1.4 1.8 0.2 0.2 1.6 1.1 39.5 1.4 272.2 0.3 124.7 725.8 105.8 1583.4 546.1 1172.3 78.6 664.6 1293.3 409.8 51.0 550.6 1108.0 196.1 1290.7 314.4 823.7 629.9 1421.2 11.9 12.8 12.3 18.6 11.5 17.4 15.1 13.1 9.9 15.3 15.9 17.1 17.9 12.3 6.4 43.3 0.0 85.3 28.6 1.3 1.7 2.8 0.4 11.4 12.8 1.2 15.7 7.1 9.2 0.0 3.8 993.2 1.8 0.0 2.8 1.3 4.0 2.5 18.3 0.0 84.2 0.1 1.2 4.7 9.5 14.8 5.5 240.4 0.3 21.0 14.3 571.1 1.7 0.1 0.9 2.0 396.6 584.5 3.0 2.1 392.7 44.4 5.6 309.9 0.7 1687.0 0.0 0.1 1.0 1.4 0.0 97.7 0.6 2.0 6.1 5.1 2.2 19.7 4.2 6.2 2.2 4.9 2.7 21.0 6.0 769.9 1.0 2.7 1.2 FFAR1 "FFA1R, GPR40" ENSG00000126266 "Free fatty acid receptor 1" O14842 19 35351552-35353862 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 2.9;brain: 4.8;ovary: 2.5;pancreas: 4.4" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;granulocytes: 1.3;Granulosa cells: 1.4" "Cancer enriched" "Detected in single" 13 "pancreatic cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.6" "Not detected" "Not detected" HPA048933 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA048933: " "unprognostic (9.49e-2)" "unprognostic (2.08e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" "unprognostic (4.46e-2)" "unprognostic (6.19e-2)" "unprognostic (9.56e-3)" 0.0 0.0 1.9 0.1 1.9 2.9 0.0 1.2 1.6 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 1.2 1.3 0.0 0.0 0.1 0.4 2.0 1.6 0.9 2.5 4.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.3 0.6 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.2 1.6 1.2 1.3 2.0 1.6 0.9 1.9 1.7 1.7 4.8 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.3 1.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648323-35658782 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 2475.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2710.8;Distal tubular cells: 2985.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria NA NA 150000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favorable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 325.2 213.6 735.3 208.5 738.3 469.3 374.8 774.9 943.5 293.4 744.6 604.6 430.8 199.1 639.5 413.8 332.6 248.0 1296.9 737.0 752.8 524.4 587.1 203.5 318.6 763.5 733.2 720.1 243.3 294.9 857.7 171.2 224.2 754.9 251.4 696.6 278.9 359.7 331.6 1480.9 266.9 354.2 345.8 729.5 194.9 339.9 107.9 751.8 430.3 272.9 2475.1 514.7 406.0 206.9 772.6 480.3 1219.5 479.2 649.4 665.5 701.3 455.3 383.4 641.0 684.8 686.4 1018.3 478.0 555.8 663.1 656.6 413.4 341.7 836.5 700.6 683.5 632.0 570.1 929.4 626.6 1014.1 521.1 835.0 454.9 800.2 906.5 619.5 361.1 606.3 690.4 577.8 616.9 783.0 714.9 1019.4 589.2 626.8 357.0 2445.6 811.5 502.1 525.9 930.4 1567.1 1035.9 434.4 484.5 615.9 1049.3 393.4 568.5 419.6 892.9 365.9 363.8 398.0 382.3 605.6 450.5 683.3 776.7 470.9 695.0 472.7 1138.1 1099.7 998.5 628.9 1228.5 607.0 1150.2 854.9 732.8 1140.2 956.3 839.9 744.3 1115.9 672.8 1178.4 1176.1 1138.3 2058.8 735.3 738.3 774.9 943.5 737.0 752.8 763.5 733.2 720.1 754.9 729.5 751.8 772.6 324.6 243.6 227.3 27.4 409.4 427.1 436.6 1071.1 373.3 143.5 498.4 615.2 2710.8 664.8 529.6 698.9 64.6 623.0 361.5 1496.0 2985.6 711.7 328.0 427.4 293.2 312.6 625.7 436.5 21.2 808.9 735.5 360.9 484.2 397.2 280.8 277.9 338.8 1270.7 1041.1 89.2 27.9 1277.1 736.5 800.2 705.9 942.4 327.7 582.7 748.8 18.7 807.7 351.1 435.6 16.1 31.6 863.0 1445.3 273.1 523.2 548.7 2291.0 2228.5 445.5 193.3 263.0 293.8 454.2 175.7 186.6 784.8 565.6 670.7 373.1 229.1 1277.5 717.0 KRT36 KRTHA6 ENSG00000126337 "Keratin 36" O76013 17 41486136-41492546 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 3.5;skin 1: 1.8" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;Late spermatids: 2.1;Prostatic glandular cells: 1.0;Spermatogonia: 2.4;Squamous epithelial cells: 2.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "Karpas-707: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 180000000 "unprognostic (4.39e-2)" "unprognostic (2.24e-3)" "unprognostic (9.85e-2)" "unprognostic (4.66e-1)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (7.19e-2)" "unprognostic (8.24e-2)" "unprognostic (8.50e-2)" "unprognostic (3.74e-1)" "unprognostic (6.66e-2)" "unprognostic (1.49e-1)" "unprognostic (7.11e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.2 0.0 3.5 0.0 0.0 1.7 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.3 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.8 0.0 2.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.4 2.0 0.0 0.0 0.0 0.1 0.2 0.9 THRA "AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3" ENSG00000126351 "Thyroid hormone receptor alpha" P10827 17 40058290-40093867 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.0" "Cell type enhanced" "Detected in many" "Muller glia cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009654, CAB023349" Approved Supported Cytosol NA NA Cytosol "CAB023349: AB_619577, HPA009654: AB_1854603" "unprognostic (2.75e-2)" "unprognostic (2.20e-1)" "unprognostic (6.64e-2)" "unprognostic (4.22e-2)" "unprognostic (8.78e-2)" "unprognostic (1.64e-1)" "unprognostic (3.41e-3)" "prognostic favorable (1.84e-4)" "unprognostic (1.47e-1)" "unprognostic (5.47e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-2)" "prognostic favorable (6.05e-8)" "unprognostic (3.05e-1)" "unprognostic (1.35e-1)" "unprognostic (4.21e-1)" "unprognostic (1.88e-3)" 40.5 44.0 182.3 12.1 215.3 23.2 39.2 143.2 220.0 65.2 92.0 56.7 31.4 50.3 22.2 19.3 58.2 26.1 64.4 172.3 174.6 34.2 10.3 32.5 9.8 156.0 155.6 175.0 91.6 31.6 30.2 50.4 17.3 149.9 34.8 19.0 35.7 27.6 35.9 91.6 49.5 36.5 34.9 143.5 14.0 48.4 18.9 154.8 12.9 32.9 53.3 6.3 45.4 46.3 163.0 4.9 37.6 11.5 28.9 77.4 28.2 4.2 19.3 23.0 19.6 18.2 31.5 27.2 5.6 31.3 37.6 8.7 11.4 22.6 11.7 10.6 2.1 21.6 10.4 44.5 13.4 26.0 16.9 11.2 45.1 9.5 18.4 7.1 45.4 26.6 16.7 21.2 5.2 16.5 7.1 22.8 27.4 10.6 24.6 11.8 32.1 22.7 27.6 6.4 3.3 19.5 17.7 14.8 23.3 33.7 17.5 27.3 19.5 18.7 19.4 18.9 17.7 5.9 11.9 9.0 3.4 12.0 19.1 10.6 0.2 0.3 1.9 2.0 0.1 0.8 0.2 0.8 1.2 0.3 0.4 1.4 1.7 1.1 2.1 0.3 0.6 1.0 0.7 182.3 215.3 143.2 220.0 172.3 174.6 156.0 155.6 175.0 149.9 143.5 154.8 163.0 32.2 19.2 7.3 27.1 6.2 10.6 28.1 3.3 31.3 76.4 19.6 21.2 45.4 38.6 2.7 33.1 20.9 0.8 16.5 37.9 50.9 12.3 1.1 20.5 29.5 20.8 25.1 17.9 19.1 14.8 1.4 36.8 29.0 12.1 14.0 23.1 24.7 13.8 11.6 62.2 24.2 22.6 6.1 10.6 5.1 2.7 51.6 8.6 19.6 8.4 5.1 95.2 37.0 15.6 26.5 6.9 14.6 49.7 3.9 17.2 58.8 29.9 7.5 22.5 19.7 84.7 44.4 0.3 27.3 14.6 10.4 0.3 18.1 16.3 39.9 13.8 CCR7 "BLR2, CD197, CDw197, CMKBR7, EBI1" ENSG00000126353 "C-C motif chemokine receptor 7" P32248 17 40553769-40565472 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.4;lymphoid tissue: 84.7" "Group enriched" "Detected in many" 4 "Langerhans cells: 415.0;monocytes: 1586.1;Syncytiotrophoblasts: 517.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in all" "naive CD4 T-cell: 4597.2" "Lineage enriched" "Detected in all" 4 "T-cells: 4597.2" "Cell line enriched" "Detected in some" 82 "HDLM-2: 1386.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003796, HPA031383, HPA074467" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693" "prognostic favorable (3.84e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.26e-3)" "unprognostic (1.32e-3)" "unprognostic (2.35e-3)" "prognostic favorable (7.61e-7)" "unprognostic (2.71e-4)" "unprognostic (2.58e-2)" "unprognostic (4.48e-2)" "unprognostic (4.68e-4)" "unprognostic (1.10e-2)" "unprognostic (3.11e-1)" "unprognostic (1.08e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.02e-1)" "unprognostic (7.95e-2)" 3.6 0.6 0.0 67.8 0.2 15.3 2.4 0.0 0.4 2.7 0.5 3.6 1.2 1.7 0.0 2.0 3.9 5.2 2.0 0.0 0.2 1.1 2.3 2.7 84.7 0.1 0.1 0.0 1.8 0.6 0.1 1.5 1.1 0.3 1.9 5.1 0.5 1.8 0.3 0.5 2.2 21.4 0.9 0.0 28.9 5.4 1.9 0.1 59.4 2.8 0.4 84.0 8.9 2.0 0.6 0.4 1.5 0.0 0.0 0.0 0.3 16.8 0.4 0.1 0.0 0.0 0.2 0.0 0.6 0.9 0.0 0.1 0.2 0.0 0.0 0.0 1386.6 0.1 0.0 0.2 0.5 0.0 3.9 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.3 0.8 0.2 0.0 0.4 1.2 3.0 0.1 0.0 0.0 4.5 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.2 1.0 0.6 1.6 0.0 0.4 0.1 1.6 0.7 7.5 0.9 9.0 1.9 0.1 0.0 25.6 6.5 4.2 61.1 3.5 69.2 794.6 996.2 285.4 4.2 1122.5 4597.2 2462.0 45.3 970.9 6.4 58.5 637.3 2489.9 0.0 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.1 0.6 1.2 0.0 3.7 0.0 201.4 5.0 1.5 0.0 0.0 0.0 0.7 0.4 0.3 0.0 1.3 1.8 0.0 143.8 9.5 0.0 0.0 0.6 0.3 0.5 0.3 1.0 0.0 0.4 0.0 8.3 24.2 1.6 1.1 0.4 2.5 0.0 0.4 0.0 12.8 0.0 0.0 0.0 0.0 0.0 415.0 0.2 0.0 75.7 16.0 0.0 1586.1 0.4 3.1 0.0 0.1 0.5 0.0 0.0 3.6 0.2 0.0 0.3 0.0 0.0 0.0 0.2 2.4 0.6 0.8 0.0 4.4 517.6 75.2 0.1 0.0 4.6 NR1D1 "ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL" ENSG00000126368 "Nuclear receptor subfamily 1 group D member 1" P20393 17 40092793-40100589 "Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 319.2" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.5" "Group enriched" "Detected in many" 6 "monocytes: 5.5;T-cells: 18.5" "Cell line enhanced" "Detected in all" "Karpas-707: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007935 Uncertain Supported "Nuclear bodies" NA Yes "Nuclear bodies" "HPA007935: AB_10601277" "unprognostic (1.38e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.53e-1)" "unprognostic (2.24e-2)" "unprognostic (1.05e-1)" "unprognostic (4.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.93e-3)" "unprognostic (9.93e-3)" "unprognostic (2.73e-1)" "unprognostic (9.15e-3)" "unprognostic (4.54e-3)" "unprognostic (2.49e-1)" "unprognostic (3.09e-1)" "unprognostic (1.34e-1)" 61.4 54.1 22.2 6.4 23.9 5.5 63.6 52.3 50.1 95.8 9.4 40.1 14.4 36.1 4.6 42.9 27.9 7.1 45.7 25.1 17.1 37.7 43.6 49.6 9.4 16.9 20.7 19.7 71.9 24.5 9.1 32.2 6.0 25.3 40.9 4.0 50.8 53.4 16.4 99.8 319.2 23.2 7.6 12.0 11.7 31.8 12.6 29.9 6.4 32.4 38.4 5.5 42.8 97.3 32.5 5.5 7.8 1.6 6.2 9.0 6.2 2.2 11.9 19.5 3.9 4.9 5.1 19.5 6.7 6.9 13.8 12.9 15.4 4.1 18.0 2.9 5.6 4.1 4.8 7.9 13.5 14.6 7.2 6.9 13.5 12.8 13.3 28.2 12.6 4.9 7.7 7.2 60.6 3.8 3.8 10.7 6.1 3.0 10.8 12.3 7.5 2.2 20.7 5.4 4.9 5.1 2.9 7.6 9.7 12.4 2.7 4.6 5.8 4.7 17.2 16.7 14.1 9.5 21.5 35.7 2.6 23.4 4.0 13.6 0.0 0.5 0.0 4.4 2.0 18.5 1.7 5.5 6.4 1.1 2.1 4.8 3.5 0.2 1.0 5.5 1.4 8.0 1.8 22.2 23.9 52.3 50.1 25.1 17.1 16.9 20.7 19.7 25.3 12.0 29.9 32.5 16.4 3.2 2.0 17.3 5.7 64.5 47.5 20.5 67.2 71.4 9.4 15.1 5.7 8.6 11.9 1.8 4.2 2.6 4.9 26.0 7.9 16.1 2.3 25.4 30.6 18.6 8.3 3.6 7.1 11.8 1.2 26.5 31.1 64.2 2.5 2.7 6.8 31.8 2.5 42.1 6.2 7.2 8.2 3.4 19.4 1.5 21.8 7.7 19.6 8.4 1.2 39.0 5.2 5.0 1.2 26.0 14.7 38.7 10.5 35.4 58.8 7.9 5.0 29.7 6.6 9.6 19.4 2.0 11.1 95.5 81.1 2.3 11.9 13.7 6.0 28.7 FRMD8 "FKSG44, FLJ90369, iTAP" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386621-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 129.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002861 Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Plasma membrane, Centriolar satellite" "Nucleoplasm, Cytosol" "HPA002861: AB_1078878" "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 19.9 17.7 10.0 11.9 10.9 13.1 19.9 11.8 14.7 17.6 9.3 13.2 11.8 14.7 5.3 37.6 15.9 11.7 16.2 12.2 19.8 16.4 13.5 23.7 15.7 12.1 11.5 8.9 12.3 23.2 4.0 11.7 10.5 11.5 16.0 6.8 1.7 18.2 6.6 14.9 33.7 24.0 6.7 10.2 41.1 13.5 18.2 10.5 11.2 17.9 5.2 13.7 14.7 26.6 16.0 17.8 22.1 8.7 20.4 23.0 12.0 15.6 20.1 18.1 16.7 12.7 21.2 28.5 21.9 41.9 27.6 11.6 30.3 11.3 16.9 7.0 38.8 10.6 29.9 21.5 11.7 12.4 16.9 44.8 14.9 13.2 15.7 8.2 8.9 26.6 23.2 25.5 23.5 18.3 23.9 26.6 24.6 10.2 13.0 28.7 33.7 16.6 25.2 13.5 21.8 18.9 14.0 15.0 60.1 47.7 7.7 22.0 13.7 23.6 18.4 19.7 26.1 12.3 41.0 22.5 20.4 16.0 10.7 129.8 1.1 12.4 17.7 13.1 13.2 14.1 12.5 9.6 16.7 11.3 9.6 8.8 9.8 23.0 8.2 19.6 13.4 10.8 12.3 10.0 10.9 11.8 14.7 12.2 19.8 12.1 11.5 8.9 11.5 10.2 10.5 16.0 30.3 3.2 5.8 2.0 20.5 54.3 22.5 17.7 6.2 5.4 15.4 12.6 7.4 12.8 13.8 12.9 0.0 6.4 25.8 29.3 7.9 21.0 22.3 20.1 12.1 24.8 13.1 24.0 13.4 29.1 15.5 13.0 10.7 23.1 14.0 27.3 37.5 11.0 16.0 5.0 4.9 20.5 8.2 20.2 68.7 4.6 6.2 18.7 19.6 10.3 21.6 4.3 18.6 5.0 10.3 33.8 14.0 7.2 11.9 28.1 32.8 4.6 14.3 4.5 6.6 11.4 14.4 5.3 9.6 24.9 83.5 11.4 21.9 35.2 14.6 35.7 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318121-64321811 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 2430.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Supported Mitochondria NA NA 6900000 Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 169.6 403.6 333.7 113.7 328.9 288.2 171.6 367.7 432.7 215.2 432.6 349.8 215.2 154.9 178.2 452.1 403.8 121.8 437.1 321.3 353.6 378.7 282.6 219.1 111.0 364.9 346.4 312.9 248.1 226.8 256.6 315.7 165.5 375.2 166.9 302.5 109.9 288.8 165.9 508.8 178.3 228.0 97.9 350.7 164.2 316.4 151.3 357.7 169.3 357.4 443.5 139.0 194.3 246.8 389.7 225.3 453.4 267.9 444.5 284.3 424.4 308.5 274.9 442.3 199.8 247.4 332.9 451.8 329.2 467.0 447.4 712.6 503.5 253.3 589.4 125.8 456.6 200.8 333.3 728.8 386.3 581.0 127.8 271.3 432.4 757.2 334.9 337.8 387.6 308.4 380.6 191.5 755.6 285.5 572.0 220.9 547.8 402.6 356.5 573.9 210.9 274.5 1178.8 760.1 442.9 224.7 424.9 230.8 506.8 818.8 254.3 370.5 283.3 298.3 281.8 258.6 326.7 123.1 383.1 490.8 392.4 340.7 253.7 223.6 703.9 465.4 630.7 251.0 432.9 218.3 393.5 229.0 205.1 369.8 409.0 224.5 225.9 802.3 368.5 399.0 487.9 297.1 639.6 333.7 328.9 367.7 432.7 321.3 353.6 364.9 346.4 312.9 375.2 350.7 357.7 389.7 213.7 266.0 463.4 17.6 182.1 326.5 760.2 1591.9 405.2 159.0 266.2 435.9 617.6 371.8 931.2 450.6 70.9 1122.2 185.8 846.1 1612.1 788.4 79.6 865.2 221.3 204.7 801.9 200.6 12.4 1039.2 1144.0 296.1 365.4 285.9 104.7 299.8 205.6 405.2 476.9 92.5 14.0 1041.6 1072.1 206.5 261.0 294.9 279.0 210.8 435.8 8.4 339.7 309.6 278.1 14.1 15.3 1487.3 641.3 226.8 288.9 401.3 922.4 1468.5 2430.7 150.3 197.2 176.2 433.1 150.2 333.9 482.8 257.7 978.9 165.2 713.3 1231.7 1077.1 BCL2L12 ENSG00000126453 "BCL2 like 12" Q9HB09 19 49665142-49673916 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020856 Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020856: AB_1845320" "unprognostic (2.59e-1)" "unprognostic (3.96e-2)" "unprognostic (2.24e-1)" "unprognostic (5.72e-2)" "unprognostic (3.64e-1)" "unprognostic (3.68e-2)" "unprognostic (6.80e-3)" "unprognostic (3.87e-3)" "unprognostic (6.12e-2)" "unprognostic (8.90e-2)" "unprognostic (1.60e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (8.75e-5)" "unprognostic (8.67e-2)" "unprognostic (3.62e-2)" "unprognostic (2.37e-1)" "unprognostic (2.56e-1)" 8.4 8.5 3.8 14.9 3.9 18.4 9.6 4.0 5.2 8.0 5.0 11.6 10.6 10.0 3.2 13.5 9.6 6.6 8.5 3.5 5.4 7.8 16.7 9.7 20.8 4.3 4.0 3.3 9.8 15.6 4.6 2.7 10.4 4.1 11.3 7.3 1.7 11.8 5.1 14.1 8.3 12.0 6.8 4.3 16.8 11.8 10.2 4.1 17.4 7.7 13.6 15.9 9.7 8.7 4.3 105.2 63.7 49.8 94.8 12.6 12.6 56.9 58.2 23.3 57.2 60.6 89.2 55.4 58.4 26.7 20.2 32.4 49.7 46.3 39.4 30.7 74.1 97.4 53.1 43.5 62.0 11.4 56.6 62.2 15.5 19.0 64.3 18.2 11.5 38.7 79.2 138.8 73.3 30.8 59.1 67.6 91.8 62.4 61.8 77.4 86.6 54.3 62.7 24.8 52.0 0.9 29.4 59.5 79.0 41.8 35.6 33.0 70.3 22.8 64.1 75.2 45.5 96.4 61.2 102.4 114.3 27.2 78.0 64.3 11.0 7.4 17.0 12.5 12.2 14.6 14.8 13.2 12.3 6.5 14.6 12.8 13.1 10.9 15.8 8.6 25.9 14.4 6.3 3.8 3.9 4.0 5.2 3.5 5.4 4.3 4.0 3.3 4.1 4.3 4.1 4.3 10.2 9.6 13.1 3.3 22.1 32.2 37.4 23.3 14.2 1.0 35.2 34.2 5.0 10.0 16.5 5.5 0.0 70.3 18.2 14.6 7.9 25.7 8.3 17.0 11.5 13.2 6.7 18.5 0.2 25.8 126.3 16.2 9.2 20.1 9.5 18.9 11.0 13.1 37.6 0.0 0.2 15.7 18.3 12.6 16.1 6.4 6.5 15.5 26.6 1.0 22.1 3.5 24.7 0.0 1.6 34.5 16.6 6.0 44.3 20.5 6.5 10.4 12.6 1.2 13.1 14.0 15.1 11.6 22.3 19.7 19.5 55.7 15.7 11.7 23.3 27.7 IRF3 ENSG00000126456 "Interferon regulatory factor 3" Q14653 19 49659569-49665875 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004895, CAB013018" Approved Supported Cytosol NA NA Cytosol "CAB013018: AB_2533904, HPA004895: AB_1851887" "unprognostic (5.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-3)" "unprognostic (1.59e-1)" "unprognostic (9.17e-2)" "unprognostic (9.60e-2)" "unprognostic (7.85e-3)" "unprognostic (7.91e-2)" "unprognostic (6.98e-2)" "unprognostic (5.52e-2)" "unprognostic (5.02e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (1.56e-7)" "unprognostic (1.61e-2)" "unprognostic (4.98e-1)" "unprognostic (3.47e-2)" "prognostic favorable (3.61e-4)" 32.2 33.9 23.8 21.0 23.2 25.1 34.1 23.6 36.2 45.7 23.9 36.5 19.0 37.3 10.3 37.6 40.1 19.7 31.9 22.6 26.0 40.6 42.8 40.1 43.0 24.4 23.1 21.9 44.5 36.9 12.1 37.2 21.3 24.7 47.1 11.5 5.9 35.0 23.0 18.1 40.7 53.4 14.5 23.7 74.5 38.6 16.1 25.1 30.1 43.4 9.5 24.4 40.6 41.4 24.8 82.2 88.3 30.1 44.7 22.6 35.3 68.1 35.1 52.8 59.8 77.7 62.6 93.8 47.7 39.4 32.9 49.8 66.2 32.5 91.0 26.1 66.0 57.6 44.7 33.8 58.2 25.5 33.1 43.9 33.9 63.6 79.2 23.8 30.5 47.9 60.9 50.4 50.7 32.3 79.9 53.4 94.2 36.0 82.3 80.7 60.8 29.4 83.8 43.7 69.2 16.7 21.7 64.5 69.6 35.9 29.5 30.6 64.4 33.6 35.0 32.7 26.7 46.0 69.4 76.9 47.9 40.1 77.2 35.7 25.4 27.6 50.3 58.6 29.3 52.8 37.8 57.1 55.0 22.0 37.9 49.5 45.2 35.1 46.3 36.0 30.2 81.0 39.5 23.8 23.2 23.6 36.2 22.6 26.0 24.4 23.1 21.9 24.7 23.7 25.1 24.8 42.5 25.6 33.9 16.0 51.3 54.2 35.6 58.4 29.0 33.0 40.1 39.2 7.9 35.8 51.9 40.5 29.2 78.2 57.6 83.6 19.6 39.4 3.7 30.4 29.5 33.1 44.9 40.0 3.9 46.5 92.0 30.4 76.0 37.0 77.3 33.8 38.6 25.7 39.0 16.8 5.6 70.5 46.8 32.2 29.9 8.9 41.0 33.9 30.2 10.3 71.1 37.9 122.6 7.1 10.8 46.8 60.0 35.7 70.4 26.7 74.8 25.8 45.4 47.7 32.9 23.1 28.2 13.7 15.9 23.2 45.6 49.3 69.2 30.9 63.8 30.1 PRMT1 "ANM1, HCP1, HRMT1L2" ENSG00000126457 "Protein arginine methyltransferase 1" Q99873 19 49675786-49689029 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 444.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022550, HPA069769, HPA072136" Supported Supported Nucleoplasm NA NA 8500 Nucleoplasm "CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490" "unprognostic (1.88e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-2)" "unprognostic (3.84e-1)" "unprognostic (4.13e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.04e-5)" "unprognostic (3.43e-2)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.05e-1)" "unprognostic (7.19e-3)" "unprognostic (2.21e-1)" "unprognostic (3.66e-2)" "unprognostic (4.73e-2)" "unprognostic (1.10e-2)" 74.1 103.0 58.5 76.9 58.4 65.5 77.4 62.9 75.3 106.2 53.6 81.8 55.6 116.4 44.9 91.4 110.7 50.3 150.6 60.1 64.9 72.7 62.3 77.2 94.8 61.6 60.9 57.5 107.6 66.8 66.2 101.9 65.8 64.3 77.7 45.9 71.9 68.2 74.6 244.9 74.2 72.4 74.7 61.0 92.4 70.0 79.0 65.2 80.3 71.5 164.6 85.2 93.4 82.3 64.4 262.5 584.9 396.5 481.7 105.4 118.7 208.4 163.7 283.1 461.8 394.0 439.5 202.2 425.9 119.0 193.4 181.1 188.0 337.3 345.8 200.1 333.7 580.5 311.5 156.4 484.6 256.8 378.7 214.2 166.7 169.3 259.2 369.0 154.8 277.1 338.3 334.0 293.2 182.5 394.1 493.2 467.0 420.5 324.9 375.6 344.8 319.9 388.8 264.0 540.9 440.0 342.4 188.9 193.2 103.4 126.9 146.8 220.6 173.9 269.9 262.5 125.4 398.6 280.0 457.4 429.3 165.7 271.0 289.8 25.0 76.8 37.5 104.0 93.8 129.6 198.9 95.4 111.0 131.5 171.6 105.2 103.3 14.8 162.3 71.9 158.9 97.7 132.5 58.5 58.4 62.9 75.3 60.1 64.9 61.6 60.9 57.5 64.3 61.0 65.2 64.4 169.7 3.2 10.3 15.7 112.4 207.0 228.7 444.9 123.5 228.9 71.3 96.8 17.2 40.0 117.3 44.1 106.3 195.6 74.4 45.1 127.2 204.0 5.4 88.9 124.5 167.8 115.2 38.3 9.8 135.2 177.5 101.7 51.5 87.5 54.7 154.2 109.6 22.1 104.1 129.5 15.8 74.5 227.9 27.0 125.7 19.4 104.1 52.9 112.1 15.9 149.4 119.3 57.7 14.6 20.2 125.6 45.6 89.1 117.8 263.0 35.2 87.5 62.8 168.7 92.1 89.7 236.3 66.8 121.8 94.9 158.8 235.2 76.8 200.7 105.0 183.2 RRAS R-Ras ENSG00000126458 "RAS related" P10301 19 49635292-49640143 "Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 215.6;Pancreatic endocrine cells: 150.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 20.9;non-classical monocyte: 25.0" "Lineage enriched" "Detected in many" 7 "monocytes: 25.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010160, HPA060364, CAB069439" Uncertain Approved Vesicles NA NA Vesicles "CAB010160: AB_2180086, CAB069439: AB_1622637, HPA060364: AB_2684264" "unprognostic (9.23e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (8.54e-2)" "unprognostic (4.55e-3)" "prognostic unfavorable (5.28e-4)" "unprognostic (2.16e-2)" "unprognostic (7.58e-2)" "unprognostic (1.39e-3)" "unprognostic (2.30e-2)" "prognostic unfavorable (1.54e-9)" "unprognostic (6.13e-2)" "unprognostic (3.42e-2)" "unprognostic (7.14e-3)" "unprognostic (2.74e-2)" 167.6 59.6 32.3 44.0 30.8 5.2 130.7 31.1 49.8 153.7 33.5 186.7 40.7 188.5 25.1 58.9 169.8 47.5 180.1 29.5 36.2 99.2 41.2 170.4 37.5 35.4 31.3 26.9 80.6 31.3 14.8 28.7 64.0 33.4 149.1 23.9 4.9 53.3 161.7 52.3 52.6 90.3 85.0 32.0 101.0 118.7 35.6 34.3 15.1 84.5 50.2 20.2 174.7 140.6 34.8 82.1 99.4 12.5 25.3 212.7 236.1 3.8 105.8 148.7 50.6 65.9 13.7 134.2 5.1 54.0 156.8 73.2 53.6 7.3 108.5 20.7 33.4 5.5 9.7 32.3 8.4 197.2 0.6 20.3 167.3 95.1 63.9 50.7 213.5 130.4 3.7 6.4 39.1 91.3 32.4 0.5 9.3 2.5 69.5 80.0 7.7 30.4 15.3 111.4 16.3 0.2 11.6 41.5 36.8 6.7 32.4 52.5 7.8 187.3 147.3 58.9 26.0 30.9 28.7 13.0 1.3 153.1 6.3 47.4 0.0 5.4 0.1 0.6 20.9 0.5 2.0 1.6 0.5 3.7 0.4 1.7 0.4 0.0 0.6 25.0 1.0 0.7 2.2 32.3 30.8 31.1 49.8 29.5 36.2 35.4 31.3 26.9 33.4 32.0 34.3 34.8 215.6 38.5 7.9 2.3 6.2 29.6 54.4 126.4 11.4 1.7 44.4 57.4 61.1 27.1 48.7 51.5 2.1 4.9 7.4 60.8 9.8 65.9 0.9 12.5 90.0 75.4 10.2 3.6 1.2 55.7 41.2 76.6 16.3 29.9 10.2 2.3 79.2 7.1 31.5 5.0 0.6 22.2 30.5 28.3 23.2 6.1 60.3 32.1 26.6 8.4 32.9 59.1 4.1 0.0 0.8 150.4 33.0 76.0 6.0 62.0 53.3 10.7 14.5 2.5 78.9 35.2 135.9 1.8 5.4 11.9 19.2 7.1 9.4 9.3 17.8 54.4 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591004 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 47.2;Proximal enterocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 1.1 0.4 1.0 1.2 1.0 0.1 7.1 1.3 2.6 5.0 0.6 8.5 12.2 1.5 13.0 13.6 5.0 4.3 0.9 0.9 1.0 10.9 6.4 3.9 0.9 1.2 1.0 0.9 0.3 13.2 28.7 15.7 2.2 1.1 6.2 7.8 0.1 11.4 9.1 0.9 12.8 11.1 1.2 1.0 1.0 9.8 0.9 1.0 2.3 13.5 0.1 3.9 6.7 5.6 1.1 11.1 0.4 0.3 0.9 1.3 0.0 4.6 0.2 0.0 0.4 0.4 2.2 14.9 0.7 1.6 0.1 0.3 8.5 0.3 8.5 0.4 1.1 1.2 0.5 0.8 0.7 0.9 0.4 1.1 0.9 7.4 0.3 0.3 0.7 3.4 0.9 0.2 0.8 0.0 2.4 0.2 0.7 0.6 18.0 1.4 0.2 0.3 8.7 6.5 11.7 2.4 0.3 1.3 13.3 0.1 1.0 14.4 0.2 0.6 0.8 0.7 0.4 0.1 5.1 18.7 0.5 0.2 0.3 0.4 0.0 0.2 0.1 0.4 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.2 0.5 0.0 0.2 1.2 0.2 0.1 1.0 1.0 1.3 2.6 0.9 1.0 1.2 1.0 0.9 1.1 1.0 1.0 1.1 6.4 6.4 13.4 0.7 3.4 4.1 11.6 20.2 29.6 2.2 21.5 22.6 0.9 8.6 14.2 12.9 2.1 13.0 4.1 47.2 3.9 31.9 0.7 10.8 4.1 6.4 16.2 1.3 0.5 33.2 6.5 1.6 16.8 16.1 2.5 2.3 1.1 6.8 2.3 5.0 0.4 18.0 8.2 1.9 1.2 0.4 0.3 3.3 1.8 1.9 8.2 0.9 2.1 2.0 0.4 27.4 29.4 0.0 4.4 14.5 46.3 15.5 8.8 4.1 0.0 0.8 3.9 1.9 2.1 23.3 4.7 12.7 4.1 4.6 20.7 14.6 SCAF1 "FLJ00034, SR-A1" ENSG00000126461 "SR-related CTD associated factor 1" Q9H7N4 19 49642209-49658642 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046828, HPA054593" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046828: AB_10961907, HPA054593: AB_2682536" "unprognostic (1.16e-1)" "unprognostic (3.08e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (3.38e-2)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (4.43e-3)" "unprognostic (4.11e-3)" "unprognostic (1.01e-1)" "unprognostic (8.30e-3)" "unprognostic (1.29e-2)" "unprognostic (3.52e-3)" "unprognostic (4.78e-2)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.18e-2)" 24.0 22.8 24.0 19.2 21.3 17.6 23.9 10.9 30.6 27.1 0.0 27.1 19.5 32.5 6.9 28.3 26.8 18.2 26.2 29.1 14.6 21.2 26.4 21.7 20.5 31.4 22.6 26.3 29.1 22.4 17.9 29.7 16.2 22.6 26.9 8.8 11.3 23.4 11.4 47.7 27.8 22.5 15.3 9.5 23.7 23.2 28.4 21.1 17.4 24.9 17.0 14.0 28.9 25.1 20.7 84.1 143.1 38.7 64.0 18.0 17.1 47.2 61.9 20.0 28.4 23.8 78.2 50.6 48.5 41.4 22.9 42.8 63.2 28.0 37.9 8.3 75.4 80.5 54.6 72.9 40.1 30.8 52.1 52.0 28.7 23.5 34.1 24.0 27.4 23.1 19.5 71.6 48.1 22.6 53.4 53.2 28.3 49.6 37.8 86.1 64.7 53.6 50.1 18.7 118.5 57.2 62.7 63.5 66.0 23.4 23.4 46.2 29.0 63.9 102.0 59.1 37.0 91.6 68.5 110.2 46.3 61.6 32.8 59.1 2.0 1.4 1.4 1.9 1.2 1.2 2.8 1.0 1.3 1.1 2.1 1.0 1.1 3.6 1.0 1.1 2.4 0.2 1.8 24.0 21.3 10.9 30.6 29.1 14.6 31.4 22.6 26.3 22.6 9.5 21.1 20.7 16.4 6.4 0.0 7.8 17.0 12.1 8.8 12.4 22.2 12.3 15.7 12.7 3.0 12.8 6.0 22.0 4.2 14.6 13.4 32.1 7.9 13.0 31.8 18.6 14.1 10.8 14.4 9.4 7.0 13.1 14.7 12.9 17.3 21.1 5.7 22.1 18.2 14.7 14.5 10.1 8.4 21.1 12.2 9.1 6.9 97.4 22.1 12.3 10.6 8.4 9.5 10.6 10.3 9.0 8.7 19.0 22.7 23.7 18.0 13.4 22.9 13.1 10.6 8.0 13.1 16.5 17.1 24.9 17.8 23.0 11.9 22.0 12.6 17.5 19.8 11.1 PRR12 KIAA1205 ENSG00000126464 "Proline rich 12" Q9ULL5 19 49591182-49626439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011959 Approved Approved Cytosol NA NA Cytosol "HPA011959: AB_10610286" "unprognostic (8.30e-2)" "unprognostic (8.64e-2)" "unprognostic (5.20e-3)" "unprognostic (5.04e-2)" "unprognostic (2.59e-1)" "unprognostic (1.05e-2)" "unprognostic (4.40e-3)" "unprognostic (5.00e-2)" "unprognostic (1.59e-1)" "unprognostic (1.25e-2)" "unprognostic (3.52e-3)" "unprognostic (8.59e-2)" "unprognostic (6.18e-2)" "unprognostic (2.00e-2)" "unprognostic (2.76e-1)" "unprognostic (9.32e-2)" "unprognostic (9.65e-3)" 10.6 12.7 8.0 7.2 4.9 5.5 11.9 5.4 11.4 14.9 0.0 13.3 6.3 16.8 2.0 12.4 14.5 3.1 10.2 6.6 1.2 10.2 6.9 10.3 7.9 4.2 1.7 3.5 16.4 11.4 4.7 23.0 4.6 6.9 13.2 2.2 4.5 13.1 7.5 14.9 21.1 12.8 3.5 1.0 15.0 12.9 7.5 1.9 7.5 15.8 3.4 4.2 14.2 13.2 4.0 15.4 23.4 12.6 14.0 5.6 5.0 10.0 9.5 4.6 5.2 4.1 9.0 8.9 15.5 7.9 6.8 4.9 14.0 5.8 8.3 1.7 13.2 17.3 16.0 12.4 9.0 4.0 15.1 23.0 6.4 8.2 5.9 3.9 6.3 5.8 9.2 11.1 8.9 4.6 11.6 17.1 18.2 17.9 7.8 21.5 22.2 9.8 5.8 4.7 19.0 10.0 18.6 13.8 12.8 6.7 5.0 9.0 11.0 13.9 18.0 17.2 6.8 15.7 11.4 14.4 10.4 11.2 8.6 11.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.0 4.9 5.4 11.4 6.6 1.2 4.2 1.7 3.5 6.9 1.0 1.9 4.0 8.8 6.4 2.6 9.8 8.1 4.0 1.3 8.2 8.6 7.7 8.1 6.5 2.9 7.2 3.6 12.9 4.2 5.5 8.7 5.8 1.9 4.1 1.1 5.1 8.8 5.5 10.2 2.5 9.3 7.5 3.3 5.6 8.6 7.1 10.2 9.6 6.8 2.9 6.4 5.0 11.9 6.6 4.1 7.5 2.8 2.1 14.0 5.8 3.6 8.4 3.3 3.6 5.2 10.6 8.8 13.4 5.7 14.7 6.0 1.9 6.6 2.5 6.5 3.6 13.1 7.3 5.5 2.7 6.8 6.9 7.7 1.1 7.5 6.9 6.9 1.5 TSKS "PPP1R161, TSSKS" ENSG00000126467 "Testis specific serine kinase substrate" Q9UJT2 19 49739753-49763306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 74 "testis: 120.9" "Group enriched" "Detected in some" 46 "Early spermatids: 887.3;Late spermatids: 1022.9" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.1;testis cancer: 2.2" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "NB-4: 11.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA045729 Enhanced NA NA "HPA045729: AB_10963430" "unprognostic (3.56e-1)" "unprognostic (3.75e-3)" "unprognostic (8.33e-2)" "unprognostic (1.67e-1)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-1)" "unprognostic (3.55e-1)" "unprognostic (1.54e-1)" "unprognostic (3.04e-2)" "unprognostic (2.44e-1)" "unprognostic (1.51e-8)" "unprognostic (7.89e-3)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-2)" 1.1 0.1 0.1 0.1 0.2 0.5 0.9 0.8 0.5 0.7 0.5 0.2 0.0 1.0 0.0 0.3 1.0 0.3 1.2 0.3 0.1 0.1 0.2 0.4 0.4 0.1 0.2 0.1 0.3 0.2 0.0 0.0 0.9 0.3 0.4 0.0 0.1 0.3 0.1 0.3 1.6 0.2 0.1 0.3 0.5 0.2 120.9 0.2 0.3 0.7 0.0 0.1 0.9 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 11.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.8 0.0 0.4 0.0 0.0 0.0 1.0 0.7 0.7 0.2 0.1 0.2 0.8 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.1 2.0 0.0 0.0 3.4 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 887.3 1.0 0.5 0.7 0.0 0.8 0.4 0.0 8.6 1.9 0.0 0.1 0.0 0.2 0.4 0.0 2.5 0.0 0.3 0.0 0.0 1.3 0.4 1022.9 9.6 1.5 0.0 1.0 0.2 1.2 1.0 0.5 0.5 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.3 20.5 8.4 0.7 1.4 6.7 0.5 0.2 0.0 0.1 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" 11 64103188-64119173 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.1;Excitatory neurons: 8.8;Inhibitory neurons: 16.1;Muller glia cells: 6.2;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 13.2" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;SCLC-21H: 5.4;SH-SY5Y: 13.5;THP-1: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054589 Uncertain NA NA "HPA054589: AB_2682533" "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.3 4.5 4.4 0.3 6.5 0.0 0.4 1.0 6.2 2.6 0.0 3.1 0.5 1.5 0.0 0.8 0.6 0.5 0.9 6.6 2.2 1.6 0.9 0.2 0.0 3.0 3.8 6.0 0.5 1.0 0.0 1.2 0.1 6.6 1.2 0.3 1.6 0.7 0.9 0.3 1.1 1.0 0.5 0.5 0.3 1.1 0.3 5.9 0.0 2.3 0.1 0.0 0.7 1.1 7.3 0.4 0.7 2.7 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.4 0.0 1.1 0.6 3.7 0.0 0.0 0.7 0.2 0.0 0.9 0.1 0.0 2.1 0.3 4.0 0.0 0.5 0.1 0.6 1.2 0.1 0.2 0.8 0.2 0.1 0.0 0.3 5.4 13.5 0.3 0.3 0.4 0.0 0.4 11.3 0.1 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.2 3.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 6.5 1.0 6.2 6.6 2.2 3.0 3.8 6.0 6.6 0.5 5.9 7.3 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 6.2 0.0 32.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASL ASAL ENSG00000126522 "Argininosuccinate lyase" P04424 7 66075800-66094697 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "liver: 399.7" "Cell type enhanced" "Detected in all" "Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1" "Cancer enhanced" "Detected in all" "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003696, HPA016646" Enhanced Approved Cytosol NA NA 12000000 Cytosol "CAB003696: AB_425316, HPA016646: AB_1845096" "unprognostic (2.95e-2)" "prognostic unfavorable (4.05e-6)" "unprognostic (4.83e-1)" "unprognostic (4.18e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (2.07e-1)" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (7.25e-2)" "unprognostic (4.95e-2)" "unprognostic (2.07e-2)" "unprognostic (3.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (8.40e-3)" 20.5 16.2 5.5 16.8 5.4 24.1 22.2 5.9 8.6 18.1 7.4 54.4 61.3 17.1 6.7 28.9 18.2 28.0 15.3 5.2 6.8 60.8 399.7 27.6 10.4 6.8 6.7 5.4 19.9 37.4 15.2 20.0 9.2 7.7 19.6 36.0 2.4 18.5 9.9 8.8 14.6 46.0 10.2 5.5 30.7 44.3 4.6 6.5 5.4 25.1 7.0 8.9 19.5 19.9 6.4 48.4 18.9 11.2 36.7 26.3 18.1 22.1 34.0 31.8 49.5 43.6 43.7 59.0 15.9 53.7 48.5 36.6 13.4 7.1 59.1 11.1 10.5 8.9 18.8 17.9 77.2 48.8 24.0 51.3 38.3 19.5 31.8 51.8 12.5 48.1 11.3 34.4 27.8 25.4 36.6 4.8 28.9 15.8 65.5 26.1 12.1 11.0 51.6 31.9 31.6 18.4 24.3 32.3 109.7 12.3 11.4 46.0 19.7 55.1 53.7 30.8 23.5 45.2 30.2 16.9 19.0 55.0 41.5 49.5 34.2 42.6 50.8 16.9 46.6 15.1 21.8 11.5 13.4 46.2 13.8 8.2 8.5 7.3 73.7 36.1 2.5 23.4 27.3 5.5 5.4 5.9 8.6 5.2 6.8 6.8 6.7 5.4 7.7 5.5 6.5 6.4 34.5 19.2 61.4 5.2 20.4 5.5 21.4 24.2 9.1 12.7 24.5 20.4 9.2 124.4 25.8 31.3 22.9 20.7 25.4 294.6 52.8 73.7 4.0 41.2 12.1 30.7 54.0 47.1 9.4 218.6 45.7 14.4 115.7 34.1 44.5 12.0 42.8 578.0 46.0 15.2 9.7 126.5 16.2 41.2 17.6 6.3 9.3 22.3 8.8 1.9 48.3 7.2 34.0 2.5 4.8 118.3 240.4 8.2 23.4 14.9 259.9 243.1 42.8 13.2 13.1 16.9 17.5 3.2 5.7 19.5 4.3 22.3 18.0 13.5 189.4 22.0 SBDS "CGI-97, FLJ10917, SDS, SWDS" ENSG00000126524 "SBDS ribosome maturation factor" Q9Y3A5 7 66987680-66995587 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2042.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028891 Approved Supported Nucleoplasm,Cytosol NA NA 190000 "Nucleoplasm, Cytosol" "HPA028891: AB_10601500" "prognostic unfavorable (1.49e-4)" "unprognostic (1.87e-2)" "unprognostic (5.73e-2)" "unprognostic (1.71e-3)" "unprognostic (8.06e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.07e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (6.99e-2)" "unprognostic (7.84e-3)" "unprognostic (4.59e-1)" "unprognostic (1.04e-2)" "unprognostic (9.38e-3)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (5.06e-3)" 140.4 108.5 145.6 58.4 159.2 158.6 114.7 158.9 167.6 91.5 129.6 127.0 128.9 118.2 84.1 129.8 100.0 85.6 240.3 143.9 159.0 118.9 127.8 114.8 44.1 165.7 155.8 135.8 90.9 90.0 146.2 88.1 107.1 164.4 108.9 112.7 91.1 81.4 123.7 377.1 91.2 115.1 129.3 165.5 57.8 105.5 61.3 154.6 39.1 108.0 265.6 53.0 114.9 91.4 179.3 168.3 68.9 59.9 54.6 212.7 157.9 67.0 281.4 225.4 206.1 157.1 143.1 83.0 62.2 209.7 253.5 136.3 80.1 101.7 164.3 219.4 59.8 136.4 31.1 125.9 86.6 188.9 78.1 40.8 144.0 215.1 157.0 269.8 105.9 129.2 39.7 227.2 65.0 324.2 100.0 41.8 112.4 67.2 227.3 165.9 31.3 132.6 129.3 218.1 73.6 91.7 63.7 142.3 235.5 194.3 131.0 176.2 64.8 176.4 276.5 96.7 142.5 205.4 40.6 51.4 141.0 95.7 125.5 157.4 75.5 33.2 61.4 64.7 37.7 81.7 62.8 82.7 75.2 33.4 59.9 104.4 85.7 13.0 51.8 35.1 45.4 80.2 62.2 145.6 159.2 158.9 167.6 143.9 159.0 165.7 155.8 135.8 164.4 165.5 154.6 179.3 169.9 304.5 128.0 10.7 101.6 464.2 466.2 213.2 145.7 73.7 118.5 154.0 286.6 108.7 160.3 92.0 12.5 130.5 98.0 270.9 262.2 177.4 583.0 93.0 131.2 153.2 101.9 51.3 12.5 165.7 232.1 197.7 96.8 128.2 150.0 29.7 138.5 102.1 107.0 58.9 15.3 221.9 142.4 47.2 238.1 2042.9 127.1 74.8 256.1 11.2 66.5 161.9 30.9 7.5 36.0 300.0 242.2 168.5 117.5 267.2 359.3 264.6 75.6 56.8 164.3 512.9 266.2 86.3 47.9 129.9 430.0 398.5 144.5 132.2 165.4 318.5 CSN1S1 "CASA, CSN1" ENSG00000126545 "Casein alpha s1" P47710 4 69931068-69946574 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Milk protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "breast: 1406.5" "Cell type enriched" "Detected in some" 47 "Breast glandular cells: 8261.0" "Cancer enriched" "Detected in some" 10 "breast cancer: 17.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035659, HPA057031" Enhanced "Secreted in female reproductive system" NA NA "HPA035659: AB_10696356, HPA057031: AB_2683315" "unprognostic (1.52e-2)" "unprognostic (1.01e-1)" 16.2 0.0 0.1 0.5 0.0 0.0 1406.5 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.4 1.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.3 0.1 28.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 8261.0 172.2 2.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.1 0.3 0.0 2.1 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.6 0.0 0.0 0.0 5.5 0.0 0.0 0.0 STATH STR ENSG00000126549 Statherin P02808 4 69995966-70002570 "Plasma proteins, Predicted secreted proteins, Transporters" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 925 "salivary gland: 9223.2" "Group enriched" "Detected in some" 9 "Breast glandular cells: 9.8;Early spermatids: 2.8" "Group enriched" "Detected in some" 14 "head and neck cancer: 3.5;lung cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044569 Enhanced "Secreted to digestive system" NA NA "HPA044569: AB_10966146" "unprognostic (2.00e-2)" 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.1 9.9 0.0 5.7 0.8 0.0 0.1 0.0 0.0 9223.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 9.8 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTN1 HIS1 ENSG00000126550 "Histatin 1" P15515 4 70050438-70058848 "Predicted secreted proteins, Transporters" Biomineralization "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2603 "salivary gland: 48795.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077315 Approved "Secreted to digestive system" NA NA "HPA077315: " "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 18.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 48795.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 STAT5A "MGF, STAT5" ENSG00000126561 "Signal transducer and activator of transcription 5A" P42229 17 42287547-42311943 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Lactation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 79.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 101.0;HEL: 153.5;HMC-1: 85.2;K-562: 262.4;MOLT-4: 163.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003860, HPA027873, HPA042128, HPA049883, HPA051156" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "prognostic favorable (5.87e-4)" "unprognostic (3.09e-3)" "unprognostic (2.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.43e-1)" "unprognostic (3.41e-3)" "unprognostic (2.15e-1)" "unprognostic (6.22e-2)" "unprognostic (3.33e-1)" "unprognostic (6.82e-3)" "unprognostic (2.76e-1)" "unprognostic (2.11e-1)" "unprognostic (3.85e-2)" "unprognostic (5.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" 79.6 40.9 4.5 29.1 5.7 52.6 49.2 5.7 5.3 18.9 6.9 21.3 8.7 17.9 5.7 10.0 19.2 14.0 13.6 3.7 8.7 14.0 8.1 23.6 37.8 8.2 6.9 3.0 22.7 12.3 2.4 10.6 7.4 7.2 15.5 9.2 1.2 15.9 13.8 24.0 17.1 22.6 14.4 6.8 30.0 14.1 4.9 7.8 24.7 13.4 13.9 27.3 24.3 15.6 8.6 3.9 4.9 0.5 0.0 35.7 17.5 0.4 2.1 8.6 4.0 2.3 0.0 3.7 0.3 9.0 8.5 0.2 0.3 0.8 0.3 1.1 101.0 0.0 153.5 9.3 1.3 15.5 13.5 85.2 36.8 2.1 1.7 2.0 0.0 12.3 2.0 262.4 0.1 2.3 0.1 163.5 64.7 1.4 2.5 0.0 4.5 1.1 13.8 1.1 2.6 0.3 0.0 10.0 3.9 17.8 0.9 2.5 13.9 7.2 8.0 2.6 3.9 0.1 0.2 0.1 0.0 1.0 25.4 2.5 9.8 15.1 7.9 10.3 18.6 14.4 8.2 18.3 15.2 18.7 6.6 18.0 15.0 18.3 17.4 24.9 6.6 14.5 12.9 4.5 5.7 5.7 5.3 3.7 8.7 8.2 6.9 3.0 7.2 6.8 7.8 8.6 14.0 0.0 10.6 2.6 18.7 7.4 3.8 4.5 5.7 2.9 35.8 24.5 29.6 5.7 3.4 5.5 0.0 1.2 17.7 5.5 5.9 5.0 0.4 7.2 5.2 21.2 0.0 33.2 0.2 13.6 2.9 15.3 5.1 11.9 22.8 6.8 6.1 3.3 21.4 0.0 1.3 4.2 0.0 24.5 41.3 3.5 32.6 31.8 8.8 5.6 41.0 3.9 8.2 2.5 5.0 9.6 8.1 41.0 12.5 12.2 1.8 14.4 8.4 0.7 6.6 13.7 10.2 0.0 0.9 4.4 7.7 1.4 29.2 7.7 6.5 7.0 WNK4 PRKWNK4 ENSG00000126562 "WNK lysine deficient protein kinase 4" Q96J92 17 42780610-42797066 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.0;intestine: 11.1;kidney: 17.8;prostate: 11.7" "Cell type enriched" "Detected in some" 4 "Distal tubular cells: 160.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016500 Approved NA NA "HPA016500: AB_10962984" "unprognostic (6.34e-3)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (2.48e-1)" "unprognostic (1.69e-1)" "unprognostic (5.84e-2)" "unprognostic (3.94e-1)" "unprognostic (2.08e-3)" "unprognostic (4.33e-3)" "unprognostic (7.70e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (1.43e-1)" "unprognostic (7.99e-2)" 0.6 0.0 0.9 1.1 1.0 0.0 2.9 1.1 3.3 0.4 0.3 8.9 1.9 0.2 0.7 9.0 0.4 0.0 0.1 1.9 3.8 17.8 0.2 0.1 0.1 1.2 0.9 0.2 4.3 0.2 0.0 1.2 0.0 0.9 11.7 11.1 0.6 1.8 1.1 0.0 0.3 3.7 0.4 0.9 0.1 3.4 0.2 1.0 0.0 0.0 0.3 0.1 0.2 0.4 1.1 2.1 1.2 0.6 0.0 0.7 0.2 4.8 11.9 4.8 4.5 1.3 0.7 1.0 0.6 6.8 32.6 1.2 0.0 0.2 0.3 8.6 0.6 1.8 0.1 0.0 4.7 7.4 0.3 0.7 3.9 1.4 6.4 2.1 2.1 0.3 0.4 36.8 1.3 0.0 1.0 0.0 1.1 0.3 2.0 8.2 0.6 1.2 0.0 0.0 0.5 0.0 0.2 0.1 0.2 1.7 4.1 2.4 2.7 34.1 0.3 3.1 0.5 0.4 6.2 5.3 1.2 0.0 2.1 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 1.1 3.3 1.9 3.8 1.2 0.9 0.2 0.9 0.9 1.0 1.1 0.2 0.0 0.6 0.0 0.5 0.0 0.2 0.0 0.6 0.2 7.1 4.1 1.0 1.5 0.6 7.3 0.0 0.0 0.3 8.0 160.4 0.0 0.0 5.1 1.1 0.2 13.1 0.0 0.2 0.2 0.2 0.1 3.1 6.7 4.5 0.1 0.7 0.0 0.0 0.0 0.2 40.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.4 0.0 3.6 0.9 1.0 2.9 0.5 0.0 0.2 0.5 0.8 0.8 12.1 0.4 0.0 0.2 0.0 13.1 0.3 BECN1 "ATG6, VPS30" ENSG00000126581 "Beclin 1" Q14457 17 42810134-42833350 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Autophagy, Cell cycle, Cell division, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003949, CAB010143, HPA028949" Supported Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "CAB010143: AB_626746, HPA003949: , HPA028949: AB_2672839" "unprognostic (1.97e-1)" "unprognostic (2.66e-2)" "unprognostic (9.97e-2)" "unprognostic (3.80e-3)" "unprognostic (1.46e-1)" "unprognostic (2.01e-2)" "unprognostic (5.16e-3)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.59e-2)" "unprognostic (4.33e-2)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (1.02e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" 45.7 41.8 32.1 42.2 31.9 51.2 44.3 31.7 38.2 36.0 35.0 71.0 57.1 31.8 48.1 49.9 36.4 34.7 59.4 32.2 33.0 48.3 44.0 39.9 48.3 31.6 32.1 30.2 26.9 39.8 42.1 20.6 26.4 32.2 42.6 65.4 26.7 36.3 41.7 96.7 36.7 50.6 44.8 32.7 40.1 53.5 24.4 32.6 41.8 37.0 78.3 56.6 49.7 29.9 32.8 47.4 79.0 27.9 48.7 95.7 56.8 54.9 95.1 104.2 69.5 73.8 61.4 61.9 68.9 69.3 118.9 70.0 52.7 48.9 85.3 123.4 105.0 59.4 58.0 74.9 105.5 71.4 111.0 114.3 76.8 99.1 69.4 66.0 61.8 90.2 75.4 50.5 67.1 86.4 40.1 66.1 61.1 29.0 88.5 40.6 56.3 100.6 69.3 74.1 88.6 33.5 34.9 52.0 43.5 100.7 61.4 72.0 92.9 121.6 82.8 38.8 57.0 99.7 103.8 84.8 57.4 84.3 54.0 106.7 154.1 133.2 122.1 103.1 152.1 105.1 112.6 114.4 111.6 120.2 123.7 96.4 100.2 191.0 107.8 144.2 75.7 180.1 171.8 32.1 31.9 31.7 38.2 32.2 33.0 31.6 32.1 30.2 32.2 32.7 32.6 32.8 43.7 38.5 46.1 11.8 38.7 29.7 26.7 40.1 39.3 12.3 38.3 22.7 6.0 30.0 39.1 12.9 10.4 23.5 37.8 59.5 58.7 46.2 18.2 35.0 28.3 33.9 28.3 36.2 12.1 69.6 32.3 23.1 42.3 31.5 43.1 20.5 31.4 46.2 38.8 21.9 11.7 60.2 30.5 65.4 36.8 11.9 21.5 43.1 42.7 3.7 67.2 26.9 50.4 5.5 9.8 53.6 45.4 26.7 51.2 37.8 49.1 40.3 51.7 13.4 26.3 25.6 36.0 31.6 14.9 44.9 37.6 38.0 39.8 33.8 51.1 46.7 PRKCG "MGC57564, PKCγ, PKCC, PKCG, SCA14" ENSG00000126583 "Protein kinase C gamma" P05129 19 53879190-53907652 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 93.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 22.6;Glandular and luminal cells: 5.1;Horizontal cells: 5.0;Inhibitory neurons: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;OE19: 4.0;SH-SY5Y: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054560 Enhanced NA NA "HPA054560: AB_2682523" "unprognostic (7.14e-2)" "unprognostic (5.42e-2)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.96e-2)" "unprognostic (4.46e-2)" "unprognostic (2.09e-1)" "unprognostic (2.64e-2)" "unprognostic (7.48e-3)" "unprognostic (2.68e-1)" "unprognostic (2.22e-7)" "unprognostic (2.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" 0.0 0.0 48.6 0.2 47.6 0.9 0.0 6.0 69.7 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.5 0.1 0.0 93.6 24.0 0.0 0.0 0.1 0.0 13.1 3.6 53.1 0.1 1.8 3.9 1.4 0.0 13.4 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.6 5.2 13.2 3.5 0.0 0.2 0.0 0.0 0.0 36.0 0.1 2.2 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.6 0.1 0.6 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.3 4.0 0.1 0.4 0.2 0.0 0.4 0.0 0.0 1.5 0.6 0.0 0.0 0.7 0.7 0.0 0.4 0.0 0.7 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.6 47.6 6.0 69.7 93.6 24.0 13.1 3.6 53.1 13.4 0.0 13.2 36.0 1.1 0.0 0.0 1.0 0.7 0.1 0.1 0.0 0.0 0.0 2.3 4.6 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 4.2 1.2 2.0 0.5 0.0 0.0 22.6 0.0 0.2 0.6 2.0 5.1 0.0 0.0 0.0 0.0 0.1 5.0 12.8 1.5 0.0 0.0 0.0 1.8 0.0 0.6 0.0 2.8 0.0 0.0 0.0 3.0 2.0 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.2 0.0 4.0 0.4 2.9 0.9 0.1 0.0 0.0 0.2 0.0 0.4 0.1 TRAP1 "HSP75, HSP90L" ENSG00000126602 "TNF receptor associated protein 1" Q12931 16 3651639-3717553 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041082, HPA044227" Enhanced Enhanced Mitochondria NA NA 1700000 Mitochondria "HPA041082: AB_2677291, HPA044227: AB_2678864" "unprognostic (1.18e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.80e-4)" "unprognostic (7.10e-2)" "unprognostic (6.80e-2)" "unprognostic (2.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.61e-2)" "unprognostic (8.58e-2)" "unprognostic (5.71e-3)" "unprognostic (1.54e-1)" "unprognostic (7.69e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "unprognostic (9.90e-2)" "unprognostic (3.82e-2)" 43.8 51.0 30.2 33.0 34.6 35.9 46.1 27.5 37.9 53.5 20.7 50.5 40.1 42.8 18.6 72.9 59.5 33.6 88.9 32.4 34.4 59.6 122.5 33.6 48.0 31.5 30.8 32.9 59.3 76.8 40.2 35.6 33.6 32.6 41.9 37.2 22.5 46.5 26.7 195.7 68.3 37.0 30.5 24.1 40.2 49.9 40.4 32.8 27.8 33.6 140.1 36.7 49.3 50.8 35.7 113.4 277.6 56.7 150.2 61.1 62.1 167.6 67.6 60.7 152.2 95.3 347.9 156.5 361.1 123.7 65.1 41.1 207.3 223.0 167.7 67.1 139.3 241.8 105.9 225.1 246.0 105.3 192.0 69.4 74.2 114.6 121.1 188.2 55.0 106.1 122.5 338.4 120.8 50.5 367.8 138.6 141.5 106.0 133.8 140.1 314.1 118.9 500.6 112.8 83.0 268.4 102.2 70.0 254.5 135.8 46.5 184.5 137.2 60.2 63.7 112.9 112.5 99.5 135.5 161.1 289.2 39.7 152.1 88.8 0.1 24.0 0.8 24.7 38.9 47.3 42.1 36.0 31.5 54.9 30.7 42.1 35.9 2.6 31.9 29.8 8.4 33.4 33.0 30.2 34.6 27.5 37.9 32.4 34.4 31.5 30.8 32.9 32.6 24.1 32.8 35.7 20.4 22.4 17.5 16.3 21.3 25.4 44.3 63.2 38.1 29.3 32.4 36.8 2.1 45.8 39.8 31.3 10.4 112.6 5.9 28.7 88.0 67.7 24.1 30.6 21.1 21.3 35.5 42.1 31.6 53.8 56.2 23.7 36.2 28.1 16.5 41.5 12.8 48.8 46.1 47.1 31.1 37.5 59.0 14.5 14.8 13.0 16.4 14.7 12.4 12.2 26.3 20.2 12.3 11.6 16.2 31.9 14.5 21.4 37.9 45.9 14.1 140.9 30.1 22.2 19.7 29.9 29.4 37.2 70.9 70.7 28.1 67.2 15.1 58.9 74.9 42.8 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 22.1;Peritubular cells: 33.8;Proximal tubular cells: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062755, HPA065406" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062755: , HPA065406: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 14.5 23.6 3.8 2.6 2.9 0.1 11.5 4.7 3.9 19.0 2.8 14.8 1.6 21.1 0.7 5.0 17.5 5.7 25.1 2.5 3.2 41.8 3.2 30.8 1.7 4.8 4.4 1.6 27.7 13.4 2.4 19.1 4.4 4.4 21.9 0.4 0.7 9.9 4.0 3.1 6.2 7.4 3.3 3.7 4.5 12.0 5.3 4.5 0.2 19.5 0.4 0.5 20.4 11.5 2.9 6.1 12.3 2.0 4.8 1.5 7.2 4.3 6.1 5.3 2.3 1.6 3.2 5.1 0.0 10.8 6.0 2.2 3.7 1.2 5.6 0.1 8.9 0.3 0.0 10.9 1.9 6.9 0.0 0.9 4.1 1.2 1.9 0.9 2.6 1.9 0.1 0.5 2.0 1.3 4.0 0.0 1.2 4.6 0.7 2.2 11.7 2.6 6.7 0.4 0.0 0.9 4.6 6.1 2.9 1.7 0.6 8.2 1.0 3.2 3.2 6.0 36.8 1.9 1.4 0.9 1.5 1.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 2.9 4.7 3.9 2.5 3.2 4.8 4.4 1.6 4.4 3.7 4.5 2.9 4.8 16.0 9.8 8.5 0.0 5.6 5.4 8.7 1.8 10.6 3.5 2.4 5.9 15.7 5.6 12.9 4.2 0.9 0.1 0.0 19.6 11.8 0.2 1.8 9.0 6.9 0.0 0.0 2.1 8.3 0.9 18.3 0.5 2.1 0.0 2.6 6.8 0.7 0.4 6.7 3.2 0.2 2.0 0.3 6.1 0.9 22.1 0.8 3.6 5.6 1.0 10.4 0.0 4.0 1.3 10.3 0.0 33.8 0.0 5.1 0.0 21.7 3.1 7.3 0.0 8.2 14.6 0.2 3.4 0.7 2.8 1.1 0.7 0.1 0.0 2.8 NSRP1 "CCDC55, DKFZP434K1421, NSrp70" ENSG00000126653 "Nuclear speckle splicing regulatory protein 1" Q9H0G5 17 30115521-30186475 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015593, HPA015603" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015593: AB_2072217, HPA015603: AB_1846157" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (5.45e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" "unprognostic (7.76e-2)" "unprognostic (1.83e-1)" "unprognostic (5.93e-3)" "unprognostic (6.12e-2)" "unprognostic (2.21e-1)" "unprognostic (3.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.43e-1)" 23.1 19.0 29.1 19.0 32.4 25.3 22.1 36.5 30.8 18.6 34.6 22.3 17.0 23.1 22.7 19.6 19.8 19.7 26.0 25.9 31.7 21.0 20.4 18.9 22.5 33.8 29.4 24.1 23.0 20.5 24.4 18.0 22.2 34.3 20.6 18.5 19.7 18.1 18.1 25.4 25.2 18.1 21.3 28.9 19.6 19.2 19.5 30.7 17.7 25.8 21.0 20.1 21.3 18.2 37.2 30.9 27.3 26.3 21.0 35.0 33.0 18.6 41.8 42.6 31.4 33.5 28.3 19.6 56.1 32.6 39.8 38.5 44.4 41.1 32.2 50.8 13.5 55.7 25.6 43.8 21.1 56.5 40.0 29.8 38.3 41.5 50.1 64.6 36.5 29.7 20.3 41.0 35.6 43.8 22.1 26.9 39.0 17.4 33.8 22.0 30.8 43.3 37.8 32.5 32.9 24.8 21.6 32.1 84.2 38.6 26.4 44.1 44.3 32.4 37.7 26.7 40.0 67.1 25.8 36.9 44.1 46.5 35.5 44.1 66.1 39.7 33.1 32.2 38.2 36.0 62.1 35.8 32.1 21.5 57.9 34.6 31.5 59.5 32.8 44.4 62.4 35.6 14.5 29.1 32.4 36.5 30.8 25.9 31.7 33.8 29.4 24.1 34.3 28.9 30.7 37.2 97.5 76.9 91.0 49.0 59.2 67.6 95.9 124.0 88.8 62.6 51.4 64.1 147.3 72.9 80.6 84.6 35.5 58.3 54.0 57.5 97.8 71.7 259.2 79.2 89.6 91.9 31.3 68.0 30.6 75.2 69.5 76.3 37.8 76.6 83.4 43.6 94.9 143.7 53.6 74.0 41.9 65.1 59.0 63.1 46.5 137.0 77.0 52.3 49.8 69.3 70.6 78.7 63.8 52.8 88.5 71.1 54.1 71.5 48.2 75.8 57.9 90.6 84.9 56.8 72.3 113.1 97.1 186.9 105.8 40.7 52.0 110.8 52.5 56.1 54.3 63.2 DNAJC8 SPF31 ENSG00000126698 "DnaJ heat shock protein family (Hsp40) member C8" O75937 1 28199456-28233029 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026275, HPA026283" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026275: AB_2671823, HPA026283: AB_10600907" "unprognostic (1.42e-1)" "unprognostic (2.44e-2)" "unprognostic (5.71e-2)" "prognostic favorable (6.95e-5)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.54e-1)" "unprognostic (3.07e-3)" "unprognostic (9.57e-2)" "unprognostic (3.93e-1)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "prognostic favorable (2.39e-4)" "unprognostic (4.84e-2)" 32.0 29.4 22.4 28.0 23.1 30.4 31.5 23.4 27.8 26.4 21.9 26.6 21.1 31.8 23.1 25.5 22.8 20.4 36.7 23.1 23.1 27.9 27.5 22.1 40.6 23.6 22.7 21.9 28.4 25.4 23.4 13.7 30.8 23.6 21.9 23.2 26.5 23.2 23.0 41.5 21.6 23.8 31.3 22.8 27.0 29.2 14.0 22.7 43.1 26.5 30.2 42.5 28.3 23.6 24.8 76.6 38.9 58.9 68.4 70.6 57.8 53.0 61.7 77.2 122.6 111.7 41.2 60.1 87.0 62.4 69.4 60.2 45.3 88.4 61.1 128.6 68.5 65.9 112.0 54.0 73.1 63.5 111.8 88.3 44.3 53.6 77.0 40.6 57.2 82.5 70.6 106.4 59.3 90.6 44.5 84.6 77.3 107.6 47.1 44.2 96.0 87.7 84.4 78.1 62.3 21.1 55.1 81.8 33.2 74.4 43.2 49.7 89.9 63.4 54.4 58.4 123.1 93.9 55.5 78.9 138.3 72.9 133.4 75.8 64.2 53.6 53.1 60.4 53.6 61.6 60.5 54.5 60.2 59.8 59.6 54.3 54.8 28.6 57.1 60.0 61.3 66.3 91.8 22.4 23.1 23.4 27.8 23.1 23.1 23.6 22.7 21.9 23.6 22.8 22.7 24.8 133.2 76.9 91.4 9.4 119.4 129.8 148.3 181.2 80.8 96.0 66.6 87.1 149.6 78.6 116.2 106.7 25.0 188.7 156.7 56.4 270.1 150.9 55.3 100.9 127.5 127.9 46.0 128.7 19.5 98.1 159.7 132.4 48.9 106.1 141.0 93.8 93.5 77.9 181.2 69.0 16.6 58.1 111.9 71.9 146.3 40.3 120.5 121.1 103.2 21.5 153.5 167.4 183.4 19.6 23.4 117.3 68.2 144.0 74.6 121.1 65.2 199.3 87.8 103.1 85.5 108.0 144.9 153.1 91.7 74.7 110.2 224.1 132.7 98.8 76.7 112.3 AHDC1 "DJ159A19.3, RP1-159A19.1" ENSG00000126705 "AT-hook DNA binding motif containing 1" Q5TGY3 1 27534035-27604431 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 31.3" "Low region specificity" "Detected in all" "HPA028648, HPA028685, HPA028691" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781" "unprognostic (1.96e-1)" "unprognostic (1.73e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.43e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (5.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" 11.0 24.5 10.0 3.9 7.6 2.5 12.7 10.7 11.4 22.5 0.0 13.0 2.7 27.0 2.2 36.1 19.7 3.4 17.4 8.4 5.4 10.2 7.7 12.1 3.3 4.9 8.2 8.0 22.9 8.5 2.1 18.9 4.7 6.3 12.1 1.1 2.7 17.0 7.0 30.6 30.0 7.8 5.3 2.2 16.7 11.4 9.8 7.5 6.4 21.1 15.7 2.0 15.3 24.4 4.5 10.5 9.5 13.0 6.9 4.1 6.7 13.2 9.6 6.8 6.5 5.3 3.7 9.5 1.6 6.9 6.5 3.9 10.3 1.4 12.5 1.9 3.9 5.0 8.3 9.0 5.0 3.8 2.2 4.1 6.3 5.0 4.6 2.9 6.7 3.4 4.8 10.0 1.1 11.1 5.1 7.2 11.8 9.5 2.6 11.5 31.3 15.7 0.8 4.4 1.4 22.3 8.6 6.8 10.8 2.7 4.4 5.3 1.9 6.6 11.2 9.2 8.4 3.0 3.3 2.4 1.6 9.5 6.5 6.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.1 10.0 7.6 10.7 11.4 8.4 5.4 4.9 8.2 8.0 6.3 2.2 7.5 4.5 20.3 6.4 5.2 39.2 5.8 49.5 9.1 25.3 41.5 33.4 37.9 44.4 14.5 4.3 14.4 18.4 0.0 11.5 23.0 10.3 3.9 10.4 0.8 13.2 33.0 19.7 9.7 3.4 26.4 13.7 4.3 24.5 15.8 14.1 0.0 5.5 17.2 11.7 14.2 35.3 19.9 5.5 6.1 3.5 24.8 4.1 51.9 5.8 16.0 16.9 3.6 12.8 14.4 21.6 8.1 16.2 4.5 63.6 5.6 11.6 4.3 4.3 17.7 2.0 39.5 46.2 20.9 4.6 6.8 61.6 56.1 5.6 10.5 67.5 6.6 13.6 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666064-27672212 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Cytotrophoblasts: 4084.0;Extravillous trophoblasts: 1291.2;Syncytiotrophoblasts: 4273.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 1349.9;BJ hTERT+ SV40 Large T+ RasG12V: 1570.7;EFO-21: 544.1;SK-MEL-30: 1075.0" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria NA NA Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 82.8 162.8 135.5 37.9 145.1 114.4 73.7 99.4 312.0 76.7 164.6 63.1 44.4 56.1 39.4 30.8 50.0 57.3 110.9 123.9 342.3 152.0 136.7 144.8 15.1 177.1 131.5 98.3 82.1 57.7 117.1 319.2 300.7 142.6 61.1 24.8 17.3 336.8 23.2 24.0 34.3 52.5 44.0 136.3 91.7 96.9 62.3 141.3 62.8 168.2 20.2 14.6 44.2 47.8 263.0 15.6 4.4 22.7 14.1 72.4 38.8 90.6 48.5 220.1 1349.9 1570.7 8.0 58.5 6.1 544.1 22.1 352.4 5.2 5.5 10.8 43.7 117.3 18.4 36.4 11.2 4.8 19.4 12.4 45.1 43.3 1.8 82.1 1.1 20.9 12.6 31.6 2.5 95.2 15.3 4.4 44.1 153.4 4.4 28.7 46.4 29.6 12.1 14.9 12.2 0.9 32.2 28.8 59.9 13.6 1075.0 6.7 6.9 46.5 21.7 12.6 19.3 9.4 8.4 113.5 68.1 4.4 24.6 105.3 35.8 193.3 265.8 252.0 128.7 374.6 127.9 57.3 128.2 118.0 117.6 47.0 132.7 130.9 506.8 102.0 259.4 12.8 172.9 113.2 135.5 145.1 99.4 312.0 123.9 342.3 177.1 131.5 98.3 142.6 136.3 141.3 263.0 158.0 141.1 74.4 5.2 26.1 23.5 19.8 39.3 29.0 15.2 17.5 14.4 12.9 54.3 42.2 64.4 10.4 4084.0 44.7 13.2 19.6 244.0 3.4 61.4 76.4 194.8 58.4 27.6 3.6 340.0 1291.2 149.3 21.4 91.8 63.3 186.3 82.8 40.4 685.3 3.3 7.4 60.5 67.1 71.8 49.1 11.5 110.6 169.4 71.2 24.4 93.8 95.1 46.4 16.1 3.9 214.2 11.7 204.7 96.0 48.2 16.9 32.7 89.3 5.6 111.7 60.9 63.1 7.9 1.6 5.8 22.4 4273.1 59.6 138.6 13.0 49.0 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148451-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.1;epididymis: 3.6;fallopian tube: 3.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HAP1: 6.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA000258, HPA001367" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.1 0.1 4.5 0.0 5.9 0.0 0.1 2.1 5.6 0.2 2.2 0.1 0.2 0.3 3.6 0.0 3.8 0.0 0.0 6.1 6.3 1.0 0.0 0.1 0.0 4.3 4.1 5.6 0.5 0.2 0.0 0.5 0.0 4.9 0.4 0.0 2.0 0.5 0.1 0.0 0.0 0.3 0.0 2.6 0.0 0.4 0.0 7.1 0.0 0.1 0.0 0.0 0.3 0.0 5.5 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.9 2.1 5.6 6.1 6.3 4.3 4.1 5.6 4.9 2.6 7.1 5.5 0.4 0.0 0.0 4.6 0.0 0.4 0.1 0.0 0.0 2.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 27.0 0.0 0.0 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.1 3.3 31.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 4.2 0.0 71.4 4.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 ZNF384 "CAGH1A, CIZ, NMP4, NP, TNRC1" ENSG00000126746 "Zinc finger protein 384" Q8TF68 12 6666477-6689572 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004051 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA004051: AB_1859228" "unprognostic (1.90e-1)" "unprognostic (5.11e-3)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (3.04e-2)" "unprognostic (1.87e-2)" "unprognostic (9.94e-2)" "unprognostic (1.35e-2)" "unprognostic (2.57e-2)" "unprognostic (3.51e-2)" "unprognostic (4.25e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.22e-1)" "unprognostic (2.06e-1)" "unprognostic (8.13e-2)" 30.6 33.4 21.7 36.5 22.7 60.4 31.0 26.7 26.6 38.7 22.5 33.3 35.4 41.0 25.3 28.2 36.1 26.4 26.2 21.9 21.7 27.2 26.5 28.9 36.3 23.9 22.0 19.7 46.7 30.1 35.0 32.8 32.8 22.6 32.1 33.0 30.4 30.1 30.3 37.1 32.0 37.1 38.1 20.7 40.5 31.2 32.0 22.2 47.1 38.7 32.6 37.9 37.1 31.1 25.0 35.4 66.2 79.9 53.7 55.2 38.9 107.1 50.0 46.4 47.3 50.3 73.3 73.6 82.9 18.5 56.4 68.5 46.6 59.8 45.9 53.6 150.8 54.0 94.9 93.0 38.6 38.9 91.2 67.5 43.0 43.6 58.3 90.1 88.9 41.5 57.4 50.6 27.9 52.4 54.8 82.6 58.3 155.0 64.1 28.7 81.0 85.4 32.2 41.9 93.6 24.8 80.4 51.8 68.4 44.1 133.5 18.0 74.5 51.9 51.6 71.4 40.9 59.6 38.5 39.6 149.9 51.0 32.4 60.0 3.7 8.5 15.4 16.4 9.8 13.4 9.7 10.7 13.4 11.5 8.0 10.2 11.6 14.4 17.0 15.3 7.6 14.5 8.3 21.7 22.7 26.7 26.6 21.9 21.7 23.9 22.0 19.7 22.6 20.7 22.2 25.0 19.2 0.0 8.7 17.3 12.5 7.9 2.6 4.4 12.0 6.0 11.1 11.9 2.6 10.0 4.7 1.8 10.4 6.7 17.9 16.5 0.0 4.6 4.3 10.2 12.9 10.7 3.6 8.0 10.3 5.0 6.8 8.2 12.8 13.5 5.7 14.7 8.9 8.3 7.0 0.0 10.4 11.8 2.0 16.6 6.0 2.7 8.4 8.6 5.4 6.5 9.9 6.1 7.2 9.0 11.8 6.8 14.4 8.6 11.4 4.8 10.6 4.3 5.6 7.8 0.0 9.3 9.3 7.1 6.5 10.7 9.8 7.3 13.2 9.0 13.4 4.6 EMG1 "C2F, Grcc2f, NEP1" ENSG00000126749 "EMG1 N1-specific pseudouridine methyltransferase" Q92979 12 6970913-6997428 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039304, HPA039666" Supported Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA039304: AB_2676432, HPA039666: AB_10672891" "unprognostic (1.23e-1)" "unprognostic (1.17e-1)" "unprognostic (6.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (2.12e-1)" "unprognostic (9.03e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (2.83e-6)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (6.75e-2)" "unprognostic (1.62e-1)" 16.3 18.2 12.6 15.4 13.9 12.7 17.5 13.9 20.4 14.3 15.1 13.6 11.2 14.6 13.7 20.4 16.2 4.7 19.7 12.5 14.2 15.3 23.0 16.0 13.5 14.1 13.7 12.1 14.0 13.7 9.5 12.9 8.6 13.8 15.9 9.8 9.4 13.7 6.1 21.4 16.7 14.1 7.4 14.1 18.3 14.8 10.0 14.1 12.4 15.8 12.9 12.9 16.2 14.2 15.0 55.5 53.7 20.5 25.2 15.8 11.5 84.7 40.1 17.9 31.2 21.2 106.4 57.6 55.4 14.7 25.1 56.8 39.8 18.9 46.1 35.2 40.1 30.6 76.8 51.7 99.6 20.3 79.0 47.8 18.5 27.2 45.5 51.8 16.2 13.9 38.6 38.6 12.1 29.8 65.3 41.4 48.3 169.6 45.4 28.0 56.3 41.2 44.0 20.0 68.8 11.9 35.7 42.2 43.9 41.4 57.5 12.0 57.8 29.2 32.4 42.6 26.8 92.9 14.6 17.9 97.7 34.8 33.7 52.8 15.5 44.1 22.3 60.7 66.4 63.3 85.3 63.6 67.6 51.2 88.0 74.4 69.1 6.2 60.9 86.4 55.8 68.1 81.3 12.6 13.9 13.9 20.4 12.5 14.2 14.1 13.7 12.1 13.8 14.1 14.1 15.0 30.1 16.0 41.3 1.3 34.0 36.6 92.2 79.1 25.0 14.7 29.0 36.8 0.0 24.3 60.9 42.3 8.4 107.3 22.8 18.1 49.0 75.3 9.6 23.1 24.8 32.3 9.6 16.0 1.3 66.8 121.0 31.8 11.7 22.7 60.9 27.7 23.2 35.9 65.4 16.8 1.4 25.7 71.2 25.0 29.3 15.5 37.9 27.7 28.4 1.9 45.1 24.5 43.3 2.0 2.7 75.7 19.8 25.9 17.3 69.0 25.1 81.1 54.0 16.0 39.5 29.2 86.5 28.9 59.7 28.4 39.9 74.3 30.6 46.4 35.7 75.8 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255392-48267444 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 6.9" "Group enriched" "Detected in some" 4 "Spermatocytes: 24.2;Spermatogonia: 30.2" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Daudi: 66.1;Karpas-707: 90.5;U-2197: 22.7" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.2 22.7 0.1 0.0 4.8 0.1 5.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 24.2 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UXT "ART-27, STAP1" ENSG00000126756 "Ubiquitously expressed prefoldin like chaperone" Q9UBK9 X 47651796-47659180 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Chaperone, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050499, HPA058400" Approved Supported "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA050499: AB_2681146, HPA058400: AB_2683706" "unprognostic (1.12e-1)" "unprognostic (3.85e-3)" "unprognostic (9.08e-2)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (2.31e-3)" "unprognostic (1.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (1.44e-1)" "unprognostic (8.11e-2)" "unprognostic (8.64e-2)" "unprognostic (4.09e-3)" 123.4 149.8 81.7 79.5 84.4 213.9 128.4 85.8 112.6 120.8 87.5 108.8 77.9 94.4 124.6 117.5 104.2 67.3 142.0 80.2 89.0 135.3 136.3 98.7 149.9 87.5 83.5 78.0 186.1 183.8 91.2 107.8 65.8 87.9 120.7 100.6 43.2 122.6 66.5 131.8 144.7 114.8 68.8 90.8 140.6 132.8 46.6 86.3 168.5 97.1 96.0 144.2 110.5 112.8 91.0 192.0 208.6 87.4 116.0 194.3 233.4 152.3 119.2 178.5 203.6 191.7 182.1 178.1 217.3 86.4 173.5 188.0 151.8 123.5 163.8 145.3 143.7 240.8 111.6 220.8 182.4 224.2 246.6 208.1 162.9 207.5 168.6 183.8 142.2 165.9 185.6 122.2 205.1 174.8 211.5 170.7 342.1 125.4 174.7 231.2 149.5 177.2 300.9 168.1 141.4 82.1 107.1 133.1 146.7 197.8 157.7 170.4 227.2 122.4 140.7 153.2 196.2 136.7 161.7 154.5 200.7 179.8 270.1 145.1 110.1 159.7 123.4 169.5 166.1 229.8 262.7 242.6 184.2 213.3 245.2 303.2 255.4 100.7 172.1 156.9 270.3 248.2 247.9 81.7 84.4 85.8 112.6 80.2 89.0 87.5 83.5 78.0 87.9 90.8 86.3 91.0 108.3 73.7 79.5 5.5 276.8 214.9 274.3 247.9 212.3 27.3 242.1 239.6 100.7 165.8 141.4 97.5 16.7 189.4 207.2 212.1 315.0 161.2 73.5 122.3 125.2 129.6 187.2 170.0 4.0 318.9 212.6 127.6 78.0 114.0 154.1 161.4 193.5 242.4 246.5 10.1 4.3 331.9 126.1 248.0 277.4 185.2 210.3 179.8 197.5 1.9 316.0 108.2 212.1 3.5 7.7 189.3 338.0 196.0 198.3 256.4 297.8 466.1 138.0 28.6 144.7 224.3 145.2 78.7 85.6 183.3 203.7 213.7 240.5 185.5 328.5 286.0 CFP PFC ENSG00000126759 "Complement factor properdin" P27918 X 47623172-47630305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 84.7;lymphoid tissue: 58.9" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 108.1;Kupffer cells: 356.7;Langerhans cells: 164.1;Macrophages: 177.3;monocytes: 473.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in all" 8 "classical monocyte: 1167.5;intermediate monocyte: 1273.6;myeloid DC: 994.5;neutrophil: 730.3;non-classical monocyte: 868.9" "Group enriched" "Detected in all" 46 "dendritic cells: 994.5;granulocytes: 730.3;monocytes: 1273.6" "Cell line enhanced" "Detected in some" "EFO-21: 20.7;HEL: 5.0;HMC-1: 5.5;NB-4: 10.7;U-937: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072644 Approved Vesicles "Secreted to blood" NA NA 6200000000 Vesicles "HPA072644: " "unprognostic (2.77e-3)" "unprognostic (2.21e-3)" "unprognostic (1.00e-1)" "unprognostic (2.15e-2)" "unprognostic (4.15e-2)" "unprognostic (9.66e-5)" "unprognostic (9.90e-3)" "unprognostic (1.30e-2)" "unprognostic (5.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (2.70e-1)" "unprognostic (1.97e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.62e-2)" "unprognostic (2.17e-1)" 6.1 1.9 0.3 20.7 0.3 84.7 2.1 0.3 0.6 0.6 0.4 1.9 1.3 1.0 0.2 1.6 3.4 2.2 1.9 0.5 0.1 0.8 12.1 9.4 11.8 0.1 0.1 0.3 0.7 0.8 0.1 0.8 0.9 0.1 0.7 0.9 0.2 1.0 0.2 1.0 1.5 3.8 5.3 0.0 58.9 1.5 0.6 0.0 5.2 0.9 0.7 4.4 4.9 0.7 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 20.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 5.0 0.2 0.0 0.1 1.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.0 10.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.2 1.0 0.0 0.1 0.5 0.1 0.4 0.4 0.1 0.1 7.2 0.0 131.5 1167.5 39.9 3.0 1273.6 2.3 6.7 15.1 1.8 994.5 2.6 21.8 8.1 730.3 12.3 868.9 30.9 14.1 1071.9 0.3 0.3 0.3 0.6 0.5 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.4 0.6 0.0 9.1 1.0 5.8 4.0 0.1 0.3 1.2 3.4 0.7 0.4 0.9 1.5 2.8 0.0 0.0 0.3 1.7 0.3 0.0 0.2 0.2 0.4 0.4 7.4 0.0 2.5 1.4 0.7 0.5 2.0 1.1 0.6 1.3 4.0 108.1 2.0 17.3 1.7 1.1 0.0 0.0 356.7 164.1 0.3 0.9 177.3 5.4 0.0 473.7 0.3 4.1 2.0 0.3 0.3 0.1 1.2 1.2 0.3 0.1 0.5 7.5 1.9 0.0 1.5 1.2 0.0 0.2 0.5 3.0 0.4 4.8 3.1 0.6 0.0 ELK1 ENSG00000126767 "ETS transcription factor ELK1" P19419 X 47635521-47650604 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Granulosa cells: 251.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003808, HPA036084, HPA064381" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250" "unprognostic (2.25e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (1.40e-2)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (2.59e-3)" "unprognostic (1.17e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (1.02e-1)" "unprognostic (2.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.67e-2)" 14.4 30.9 74.1 12.5 56.3 13.9 12.1 39.2 63.3 14.2 23.6 12.4 9.1 17.1 17.6 15.1 18.7 10.2 17.4 60.5 35.4 12.2 26.6 16.3 12.4 33.3 28.3 58.5 54.7 13.0 17.1 12.8 9.3 41.4 15.6 9.7 7.8 13.2 11.3 33.1 15.1 13.0 11.0 24.6 19.1 13.7 21.4 44.9 13.0 10.6 18.7 12.4 14.9 12.0 42.6 35.6 27.2 14.3 39.1 23.3 26.5 19.8 31.1 34.9 34.8 34.5 19.3 26.4 29.0 16.1 31.0 59.9 21.2 37.6 31.7 31.5 31.1 34.8 23.4 25.0 17.9 49.3 26.3 39.4 27.9 27.2 53.4 33.5 28.8 20.8 40.4 47.9 32.9 27.8 46.5 28.2 30.8 33.7 16.7 59.1 30.0 36.0 45.8 19.7 15.3 31.0 25.6 48.5 17.8 43.4 31.8 44.7 16.7 16.1 39.5 41.2 53.9 29.2 53.5 83.2 27.8 44.5 45.3 25.0 1.7 6.3 2.8 5.3 7.2 6.4 5.2 6.8 6.3 9.5 4.6 5.7 5.0 3.1 3.4 6.5 6.5 9.8 5.6 74.1 56.3 39.2 63.3 60.5 35.4 33.3 28.3 58.5 41.4 24.6 44.9 42.6 10.1 0.0 6.7 4.2 12.0 16.8 14.3 7.5 15.9 15.2 15.0 10.4 9.0 5.7 5.3 7.3 4.2 7.7 6.3 7.5 5.9 7.6 4.0 8.0 13.3 9.8 10.2 14.9 7.7 7.3 9.6 18.0 6.6 9.2 8.2 251.8 20.3 14.6 10.3 5.0 5.7 7.8 4.1 9.5 19.0 3.3 14.0 15.0 7.2 2.8 16.8 9.0 6.2 5.0 2.9 7.1 5.6 29.7 10.3 12.8 4.6 6.3 2.1 7.2 6.6 18.7 20.0 2.6 11.1 12.3 15.9 8.9 11.1 48.8 10.0 11.8 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favorable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favorable (7.88e-4)" 23.7 42.4 46.6 19.0 47.1 28.4 26.1 46.7 61.1 28.8 43.6 38.4 25.7 28.0 21.1 38.5 29.4 17.8 65.6 45.7 46.0 47.8 49.1 28.3 28.1 46.3 45.4 45.4 27.6 33.7 48.0 45.5 23.2 45.7 36.7 19.6 26.4 25.5 28.0 99.9 35.2 32.5 18.2 46.6 38.2 40.8 18.9 46.7 41.0 30.6 83.9 27.0 35.8 28.9 49.4 71.0 127.8 78.7 78.1 24.2 19.3 65.4 31.3 47.7 81.1 52.9 113.3 93.4 51.8 47.4 27.2 131.1 52.5 125.1 68.3 30.4 111.2 140.1 37.6 69.2 101.4 68.3 56.5 35.0 24.9 67.3 60.9 80.8 40.3 37.6 90.1 56.5 118.2 37.8 183.5 89.4 136.7 102.8 93.2 118.3 62.1 51.0 187.8 80.9 41.1 77.6 69.7 48.6 77.0 47.0 98.5 168.7 97.4 26.2 37.1 72.4 89.8 54.9 107.8 137.1 64.3 51.4 100.3 44.6 178.2 123.4 179.9 67.2 123.9 77.4 113.4 67.1 76.3 121.1 113.4 64.8 59.7 139.6 75.7 104.8 127.6 74.4 124.3 46.6 47.1 46.7 61.1 45.7 46.0 46.3 45.4 45.4 45.7 46.6 46.7 49.4 23.8 25.6 34.9 4.9 56.5 30.2 52.4 99.0 21.1 40.4 52.9 62.2 40.0 41.5 59.4 73.5 16.7 94.4 45.0 40.2 185.9 94.5 5.6 42.4 25.5 24.6 81.5 48.8 4.3 73.1 94.3 31.0 34.1 37.8 52.0 50.3 24.7 56.0 99.6 35.3 5.6 68.3 91.6 37.6 49.8 7.4 23.9 48.9 44.4 3.7 85.9 48.7 55.6 2.5 9.1 89.9 92.7 23.0 103.7 63.3 102.4 160.0 56.6 43.8 32.9 21.2 45.0 29.0 39.9 52.0 34.4 79.6 48.2 52.7 59.8 61.2 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 42.8;Endometrial ciliated cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol NA NA Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favorable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 7.7 9.2 5.0 6.4 4.7 7.5 8.2 6.9 4.8 10.2 10.3 6.0 5.0 12.6 7.1 5.7 13.2 8.4 11.2 3.6 7.1 12.4 6.7 7.3 7.1 5.0 5.5 3.5 16.4 6.5 11.5 12.0 8.6 4.3 11.8 6.7 18.4 7.2 8.6 12.4 7.3 6.2 10.3 5.0 7.5 6.2 11.1 5.0 11.7 9.8 5.7 7.1 6.7 7.9 6.0 85.2 14.3 25.2 17.3 19.2 22.2 11.1 28.5 44.1 31.2 38.3 15.0 26.1 14.8 11.6 23.7 26.0 11.1 16.6 16.2 51.7 20.8 7.9 25.0 10.1 9.7 39.7 25.0 17.7 18.5 10.2 23.0 38.3 24.3 14.9 34.8 12.5 21.2 48.2 11.5 35.9 8.0 12.7 9.7 17.4 20.9 31.8 6.4 15.8 11.7 17.9 21.8 25.5 9.2 18.2 13.4 22.7 11.1 30.7 66.4 52.8 16.7 20.5 7.1 7.4 19.6 26.1 8.5 33.2 3.4 4.1 3.3 4.8 4.3 6.5 4.1 3.4 4.2 4.4 2.8 3.7 4.4 2.1 8.4 5.2 4.4 3.8 3.4 5.0 4.7 6.9 4.8 3.6 7.1 5.0 5.5 3.5 4.3 5.0 5.0 6.0 22.3 16.0 29.9 0.0 18.2 0.0 0.0 0.0 0.0 0.0 19.9 17.5 0.0 0.0 19.2 25.8 0.0 18.3 42.8 0.0 17.6 18.4 0.0 82.0 37.4 14.0 0.0 0.0 0.0 13.1 8.3 13.6 0.0 27.0 15.2 33.9 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 18.5 0.0 0.0 14.4 34.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 19.4 14.5 33.8 0.0 0.0 ATG14 "ATG14L, KIAA0831" ENSG00000126775 "Autophagy related 14" Q6ZNE5 14 55366391-55411830 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037242 Uncertain NA NA "CAB037242: AB_1852353" "unprognostic (8.53e-2)" "unprognostic (1.84e-1)" "unprognostic (2.93e-2)" "unprognostic (5.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.61e-2)" "unprognostic (3.44e-2)" "unprognostic (2.92e-1)" "unprognostic (2.63e-1)" "unprognostic (8.49e-3)" "prognostic favorable (1.95e-4)" "unprognostic (1.70e-1)" "unprognostic (2.32e-1)" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" 6.1 6.7 5.5 4.6 6.7 29.2 6.4 7.1 6.8 7.4 5.3 6.2 5.3 7.7 2.0 7.0 5.6 5.8 8.0 5.9 5.6 6.3 4.9 5.4 4.6 6.2 5.9 5.7 8.1 4.9 8.1 3.4 6.3 6.5 5.7 3.8 8.9 6.0 6.6 16.2 8.6 5.0 6.1 5.9 5.6 4.8 7.8 5.9 5.1 6.5 10.5 5.4 6.4 6.7 8.8 8.2 5.7 4.8 7.0 8.3 9.9 10.4 7.5 13.1 7.1 8.5 5.1 9.6 3.2 6.3 7.3 3.6 8.7 5.6 2.9 10.2 5.2 3.7 4.7 7.5 6.7 8.4 5.8 6.4 6.8 8.7 6.0 5.4 11.3 6.7 5.6 4.8 7.1 6.7 6.5 4.0 6.7 8.8 3.6 7.4 4.0 12.3 2.4 3.4 5.3 5.8 6.5 11.2 6.5 7.8 5.7 6.4 2.3 8.0 11.1 8.3 5.6 3.8 4.1 4.7 3.5 6.9 3.2 5.9 2.7 2.5 1.1 2.4 1.8 2.0 2.5 2.4 2.4 1.6 2.8 2.6 2.7 0.8 5.9 1.6 2.4 2.0 1.7 5.5 6.7 7.1 6.8 5.9 5.6 6.2 5.9 5.7 6.5 5.9 5.9 8.8 22.5 19.2 27.6 17.3 20.0 17.5 7.3 7.5 30.7 14.9 27.3 22.0 39.1 11.5 15.8 11.0 8.4 10.0 17.3 15.2 19.6 11.6 7.5 21.8 30.0 19.0 19.7 49.9 28.0 7.9 7.8 22.6 12.2 35.1 25.9 16.1 15.7 12.7 7.2 3.3 27.8 10.8 8.2 12.2 9.2 5.8 14.3 14.4 14.2 12.2 14.1 12.6 16.5 24.1 44.5 11.9 12.4 16.6 16.9 9.8 10.3 17.2 10.2 23.1 13.1 22.5 21.2 21.3 53.2 20.8 26.0 14.4 17.2 11.4 8.3 11.2 KTN1 "CG1, KIAA0004, KNT" ENSG00000126777 "Kinectin 1" Q86UP2 14 55559072-55701526 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003178, CAB015331, HPA017876" Enhanced Enhanced "Endoplasmic reticulum" NA NA 55000 "Endoplasmic reticulum" "CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652" "unprognostic (7.00e-3)" "unprognostic (2.99e-2)" "unprognostic (8.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.83e-5)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.75e-1)" "unprognostic (1.21e-2)" "unprognostic (1.01e-1)" "unprognostic (9.08e-2)" "unprognostic (8.72e-2)" "prognostic favorable (1.01e-6)" "unprognostic (1.27e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" 82.3 78.5 98.6 53.3 105.9 36.4 82.4 101.8 107.2 61.9 159.2 98.3 43.8 58.6 97.9 73.4 53.7 59.1 121.7 90.3 98.2 105.0 107.4 67.6 62.3 105.6 103.4 81.7 64.5 67.8 144.1 67.9 70.0 107.4 78.2 91.7 129.1 74.2 74.2 381.7 138.7 53.6 60.8 106.2 53.8 61.6 146.4 105.5 55.2 108.7 284.1 61.5 114.2 55.7 119.2 200.5 133.4 100.3 106.5 132.8 127.3 140.2 159.7 127.3 97.2 85.2 89.4 233.9 152.8 213.4 166.7 102.7 347.2 122.5 138.2 162.7 251.9 65.2 109.1 223.0 174.4 126.3 160.3 83.3 119.1 124.6 122.1 208.4 208.3 161.9 122.2 107.4 88.1 189.0 154.6 141.3 95.0 76.8 91.1 194.3 109.6 258.2 73.5 244.8 307.0 122.4 100.0 245.8 113.2 143.2 201.7 115.3 101.7 230.0 193.9 250.4 100.0 151.2 38.9 55.9 110.4 229.4 93.4 109.5 117.0 42.7 48.0 56.2 40.3 54.7 95.6 69.4 65.8 44.0 106.6 71.1 62.1 29.6 64.9 52.6 185.8 48.4 16.0 98.6 105.9 101.8 107.2 90.3 98.2 105.6 103.4 81.7 107.4 106.2 105.5 119.2 363.1 307.7 239.8 72.5 171.7 654.5 285.8 215.6 270.9 206.5 460.6 348.7 852.7 270.2 214.7 428.6 360.7 155.1 194.9 575.2 31.3 249.7 721.9 351.3 186.6 345.0 224.0 165.3 93.9 304.0 199.1 211.9 95.3 298.1 134.9 384.5 295.9 401.7 116.8 326.4 112.1 226.4 207.5 181.3 261.6 377.9 248.5 168.9 172.5 104.9 194.3 449.2 142.2 90.0 139.8 341.2 325.7 441.6 184.6 283.5 152.6 109.3 319.3 400.9 335.2 333.5 292.1 694.3 386.4 217.8 723.0 164.7 168.3 162.4 282.4 328.0 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643421-60658259 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 48.2;salivary gland: 51.5;skeletal muscle: 120.5;tongue: 46.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 5.1 0.4 0.4 0.0 0.4 0.0 1.9 0.5 1.2 15.3 1.2 0.0 0.0 0.0 0.4 1.1 0.9 0.5 0.0 0.4 0.5 0.0 0.0 1.5 0.5 0.4 0.4 0.4 0.2 0.3 48.2 19.9 0.0 0.5 13.3 0.0 0.0 51.5 0.2 120.5 0.2 0.0 0.0 0.4 0.0 0.4 1.7 0.5 9.8 1.9 46.7 0.2 1.6 0.8 0.4 15.2 3.5 0.6 28.1 17.0 20.6 0.4 4.1 10.6 4.9 4.0 0.0 8.2 0.0 2.2 0.6 2.1 4.4 10.3 6.4 2.1 0.0 17.1 2.0 1.9 6.8 0.0 0.0 0.2 15.6 4.9 2.3 0.7 36.3 0.3 1.6 5.8 0.0 142.2 2.8 0.0 0.5 0.0 0.0 8.9 0.0 71.9 0.0 5.9 16.3 2.5 0.3 5.0 0.3 6.1 0.5 3.3 0.4 13.9 6.7 5.4 7.9 6.5 0.5 0.1 0.0 1.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 1.2 0.4 0.5 0.4 0.4 0.4 0.5 0.4 0.5 0.4 0.8 3.2 1.5 0.0 0.0 0.1 30.7 30.8 0.6 0.0 1.0 0.8 0.9 0.0 33.9 1.8 0.0 0.2 0.0 0.1 1.9 0.0 0.2 1.1 0.1 1.6 0.0 0.0 0.0 0.8 0.4 5.7 0.5 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.6 0.0 0.3 0.0 1.9 0.0 0.8 0.0 1.0 0.1 0.2 0.0 1.2 0.0 27.4 0.0 0.1 67.1 0.2 0.0 77.3 5.1 0.0 25.0 0.1 0.1 0.3 0.1 0.1 0.0 18.3 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293508 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 41.0;Astrocytes: 176.0;Endothelial cells: 72.5;Hepatic stellate cells: 41.4;Microglial cells: 35.6;Oligodendrocyte precursor cells: 43.2;Skeletal myocytes: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 63.8;HUVEC TERT2: 375.4;TIME: 100.9;WM-115: 106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 19.8 3.3 12.3 8.6 15.4 0.2 17.5 10.6 17.0 13.0 9.6 12.0 7.5 28.2 17.5 15.7 18.7 25.5 16.1 14.0 12.2 6.9 4.3 21.7 9.6 10.8 10.9 12.6 14.3 4.4 3.5 6.5 9.3 12.0 11.9 10.8 5.6 8.4 14.0 7.9 7.7 9.9 31.7 7.9 12.7 9.4 2.9 12.2 3.1 13.9 13.5 5.0 19.8 9.5 13.3 0.0 0.0 63.8 0.0 0.0 0.0 0.0 10.6 42.6 3.6 6.2 0.0 0.0 0.0 5.9 0.8 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.3 0.0 0.1 8.0 35.8 375.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 5.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 14.6 1.1 0.1 0.0 100.9 0.1 1.1 0.8 6.1 0.0 0.0 0.0 0.0 0.0 106.5 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 12.3 15.4 10.6 17.0 14.0 12.2 10.8 10.9 12.6 12.0 7.9 12.2 13.3 41.0 0.0 1.3 176.0 0.3 5.9 0.3 0.1 0.0 0.3 1.2 5.2 3.8 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.5 0.3 6.7 72.5 0.0 0.0 11.1 0.9 0.0 31.0 0.0 0.3 0.0 0.5 41.4 0.5 0.1 0.0 2.2 0.0 0.0 1.9 7.7 1.6 11.8 1.0 3.6 35.6 0.0 11.1 0.0 43.2 0.4 0.1 0.0 16.1 2.5 0.6 0.0 0.0 0.0 0.4 6.6 34.6 17.0 0.1 0.4 0.9 4.8 0.1 0.6 6.9 0.0 1.4 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191608 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 29.9;lymphoid tissue: 42.4;testis: 17.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 5.4" "Lineage enriched" "Detected in many" 5 "T-cells: 5.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 0.8 0.3 1.3 8.2 0.8 29.9 1.4 0.3 1.5 0.8 1.5 5.6 5.0 1.3 0.1 5.2 0.4 0.8 0.2 1.0 1.3 0.2 0.7 0.7 18.0 0.7 1.1 0.2 0.2 0.1 0.2 0.0 4.1 0.8 0.2 6.7 0.1 0.8 0.1 0.1 3.2 4.6 2.7 0.3 2.7 3.0 17.6 1.1 42.4 0.5 0.0 18.8 2.0 1.5 3.8 144.8 56.8 140.6 63.7 3.3 13.4 43.8 80.3 52.7 115.3 109.3 45.9 75.8 82.1 44.2 46.9 47.4 85.6 91.5 64.0 150.5 101.9 45.7 84.4 49.9 39.3 0.4 82.7 49.3 2.8 2.2 54.8 27.0 18.9 129.0 82.5 70.5 79.8 109.3 69.2 105.0 42.7 72.6 63.3 57.3 80.8 137.9 39.0 37.9 45.2 71.7 40.7 84.8 31.7 30.8 60.6 71.6 31.6 49.6 52.4 133.3 50.6 94.6 19.4 44.9 108.9 35.9 59.6 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 1.4 0.3 0.0 0.2 0.1 0.2 1.0 0.0 0.0 5.4 0.7 1.3 0.8 0.3 1.5 1.0 1.3 0.7 1.1 0.2 0.8 0.3 1.1 3.8 0.1 0.0 0.5 0.0 4.4 1.1 0.7 3.3 0.0 0.0 1.2 0.9 0.4 0.0 1.3 0.0 0.0 11.6 1.4 3.2 0.0 0.4 19.7 7.2 2.6 2.4 0.0 92.6 0.3 0.0 23.1 4.2 7.7 4.5 0.0 15.8 3.9 0.5 10.5 0.0 0.3 3.6 8.2 4.1 1.6 6.0 0.9 3.7 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.2 1.2 22.1 0.6 0.3 0.1 1.3 0.0 6.6 0.0 3.8 68.1 31.7 11.6 0.4 1.9 4.0 0.9 6.9 1.4 L3HYPDH "C14orf149, FLJ25436" ENSG00000126790 "Trans-L-3-hydroxyproline dehydratase" Q96EM0 14 59460363-59484408 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056694 Approved Uncertain Vesicles NA NA 49000 Vesicles "HPA056694: AB_2683210" "unprognostic (3.39e-2)" "unprognostic (5.55e-3)" "unprognostic (3.81e-2)" "unprognostic (5.86e-2)" "unprognostic (1.10e-1)" "unprognostic (5.06e-2)" "unprognostic (8.34e-2)" "unprognostic (1.16e-1)" "unprognostic (7.24e-2)" "unprognostic (9.50e-2)" "unprognostic (1.26e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 17.2 14.1 6.4 12.7 5.5 4.8 16.4 9.9 6.7 15.9 9.0 9.9 11.1 16.1 8.6 9.3 15.5 11.6 12.2 5.4 7.2 17.6 17.4 11.3 17.6 8.0 5.7 5.3 18.1 12.7 12.3 14.9 10.5 6.9 13.6 10.2 5.2 13.1 12.0 9.0 9.8 13.9 12.0 6.2 13.1 10.6 17.3 5.1 4.4 16.7 5.6 13.8 13.5 14.6 8.5 12.0 31.8 6.8 16.2 14.4 37.6 9.5 31.7 25.1 17.9 17.4 6.4 21.1 4.1 13.0 17.7 31.8 31.8 11.1 17.0 17.7 7.0 14.4 11.0 30.1 23.7 16.2 10.0 7.6 27.3 11.4 18.0 27.6 27.8 22.3 11.3 14.8 18.4 18.8 14.3 3.8 16.4 10.9 4.7 28.5 5.5 11.1 16.6 28.7 6.8 6.9 9.9 29.8 12.2 11.9 5.6 12.8 6.4 31.3 20.9 25.6 16.4 37.5 4.7 2.3 4.0 35.9 8.3 41.7 0.0 3.5 0.5 3.2 5.1 2.4 1.5 1.7 2.0 5.7 1.4 2.5 0.9 0.0 5.6 2.4 3.2 0.8 1.8 6.4 5.5 9.9 6.7 5.4 7.2 8.0 5.7 5.3 6.9 6.2 5.1 8.5 11.2 3.2 6.1 11.1 10.9 5.2 5.4 4.2 6.2 2.9 5.6 8.6 8.7 5.7 4.3 3.7 2.1 13.7 3.5 1.0 7.9 7.7 12.2 6.8 17.5 8.1 3.0 5.5 26.7 2.5 11.4 16.0 4.6 2.3 14.0 6.5 11.0 16.8 8.3 1.7 18.9 4.3 4.1 4.6 2.9 7.4 19.3 4.9 3.6 10.3 3.5 4.6 4.1 10.6 17.1 4.4 1.0 12.0 5.5 6.6 3.4 47.0 17.3 2.7 13.1 17.4 11.6 14.1 5.7 7.5 3.4 4.9 6.0 11.9 3.5 2.0 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 318.0;skeletal muscle: 172.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA 63000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: AB_2681854" "prognostic favorable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 9.0 6.6 78.2 7.6 146.0 0.8 6.5 140.1 128.1 9.8 77.7 71.9 5.6 52.0 18.7 42.6 17.1 5.4 40.1 82.6 107.0 37.8 4.2 14.3 3.9 170.3 122.5 62.1 5.6 8.9 7.9 15.3 62.0 159.2 10.9 9.6 1.2 16.5 4.5 172.0 31.5 29.8 29.0 124.8 20.3 18.6 121.9 124.8 3.0 2.7 61.1 5.0 43.2 16.2 318.0 30.4 75.4 11.4 0.2 8.1 0.7 114.4 42.3 99.0 16.6 27.3 2.9 52.9 7.4 16.8 46.4 3.6 33.6 0.0 2.2 10.1 4.3 5.8 0.1 4.0 0.2 7.9 0.2 10.0 3.7 1.7 2.4 0.1 4.1 1.1 0.5 0.0 6.0 8.4 13.5 0.5 0.4 8.4 11.7 9.1 6.0 0.0 0.1 26.1 4.6 101.4 5.8 1.8 3.7 0.1 3.9 2.9 3.1 1.6 0.3 0.2 3.7 0.2 7.6 0.2 0.2 9.2 0.1 11.4 0.3 0.0 0.0 0.5 0.1 0.0 0.2 0.4 0.2 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.0 1.0 0.1 78.2 146.0 140.1 128.1 82.6 107.0 170.3 122.5 62.1 159.2 124.8 124.8 318.0 74.7 0.0 5.2 18.6 21.1 54.0 31.2 35.1 342.0 1.9 37.5 57.1 39.1 5.7 8.8 132.4 0.0 42.5 30.8 29.2 238.7 8.3 35.7 56.4 63.8 59.6 28.1 0.0 0.5 5.6 509.9 40.7 83.6 54.5 13.3 1.4 32.2 0.8 15.7 0.0 1.1 63.4 24.4 3.1 25.7 27.3 8.7 24.0 30.2 6.5 0.0 14.2 0.0 2.5 157.4 5.5 15.6 7.5 7.1 7.5 8.5 1.5 4.6 2.4 26.3 48.6 66.2 578.6 77.1 175.8 42.3 75.9 29.8 4.5 12.9 11.3 ZBTB1 "KIAA0997, ZNF909" ENSG00000126804 "Zinc finger and BTB domain containing 1" Q9Y2K1 14 64503712-64533690 "Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050516, HPA054552, HPA075151" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050516: AB_2681153, HPA054552: , HPA075151: " "unprognostic (4.09e-1)" "unprognostic (3.68e-1)" "unprognostic (1.08e-1)" "unprognostic (9.51e-2)" "unprognostic (1.28e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.11e-3)" "unprognostic (9.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.00e-1)" "unprognostic (9.65e-2)" "unprognostic (6.63e-2)" "unprognostic (3.34e-2)" "unprognostic (6.26e-2)" "unprognostic (2.23e-1)" "unprognostic (2.58e-1)" "unprognostic (3.27e-2)" 24.2 15.3 15.1 29.1 18.0 83.8 26.1 17.0 18.6 20.9 20.3 20.1 17.0 20.6 27.1 16.0 25.0 21.4 16.3 15.6 15.3 18.1 22.3 22.5 44.4 17.7 16.7 12.8 21.7 17.9 21.0 18.2 24.2 17.3 24.5 22.4 21.0 18.7 18.1 22.8 35.0 24.1 19.5 18.3 35.1 21.2 12.5 18.4 38.9 28.1 21.5 36.1 22.1 20.3 21.0 56.2 18.4 40.5 25.4 41.1 49.3 41.5 23.8 35.4 22.0 27.9 17.9 38.7 53.5 23.2 33.8 17.2 38.4 19.9 23.6 30.0 79.7 13.5 26.1 35.9 15.1 25.8 21.9 36.7 63.7 40.6 15.3 22.6 48.3 25.8 33.8 13.1 35.7 41.2 42.5 38.0 22.0 16.9 28.8 27.5 33.7 25.0 20.7 38.3 67.1 28.2 22.6 38.9 29.0 32.7 39.0 27.9 27.9 34.4 36.6 24.7 17.7 16.7 44.6 20.6 59.6 36.9 20.6 24.5 42.5 13.6 23.1 18.8 13.1 21.4 14.8 16.6 20.9 14.6 14.3 16.8 20.8 10.4 19.9 19.1 9.1 25.6 16.4 15.1 18.0 17.0 18.6 15.6 15.3 17.7 16.7 12.8 17.3 18.3 18.4 21.0 19.8 16.0 12.7 65.6 56.9 31.7 17.0 29.7 40.9 11.5 14.4 13.7 11.9 8.6 22.3 9.2 12.5 8.0 115.7 9.2 9.8 13.2 83.0 40.0 41.5 24.7 22.1 20.8 40.6 8.6 13.7 26.5 19.9 30.2 28.5 18.8 19.2 8.4 15.2 6.7 58.1 12.1 30.5 23.0 73.5 38.0 15.8 50.5 30.2 58.1 13.8 7.7 22.6 40.2 96.3 16.2 8.3 18.4 48.3 15.2 6.0 6.6 27.8 8.4 6.6 20.4 27.9 2.2 4.5 23.7 24.2 7.8 78.7 23.5 10.9 19.2 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971441-60981170 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 7.3 5.5 3.5 4.5 4.0 4.8 9.9 6.2 4.2 6.6 3.2 6.8 5.7 7.0 7.8 7.7 7.5 5.2 4.2 3.5 4.4 7.0 6.8 5.1 6.1 2.9 3.4 3.4 10.0 6.8 10.6 3.5 7.0 3.8 6.9 6.0 5.2 7.7 4.8 7.6 6.8 4.6 7.1 3.1 4.7 5.8 17.4 3.7 6.2 7.3 7.2 5.8 6.8 3.9 3.9 49.7 12.5 17.9 25.0 15.5 23.6 19.4 18.2 14.0 19.1 15.2 9.8 28.7 25.2 19.9 13.3 14.3 22.3 22.9 26.4 25.0 25.3 11.5 18.6 8.1 10.2 25.1 33.2 9.9 18.3 25.1 17.4 25.4 17.0 17.0 21.6 24.5 8.8 28.3 18.7 17.1 16.8 16.4 19.4 20.3 5.4 41.5 21.4 16.3 16.7 22.1 21.6 20.2 20.1 16.6 15.4 33.5 19.7 16.1 22.1 26.7 15.7 17.5 5.3 10.8 11.6 15.6 7.2 21.0 0.1 3.2 0.7 2.4 5.5 3.3 4.9 3.4 3.5 3.0 4.1 3.8 3.4 0.3 1.4 5.9 5.2 4.5 2.5 3.5 4.0 6.2 4.2 3.5 4.4 2.9 3.4 3.4 3.8 3.1 3.7 3.9 7.0 6.4 10.9 3.9 4.5 6.4 19.5 15.9 9.6 5.7 6.3 10.0 8.0 1.5 19.6 11.0 4.2 12.8 5.7 3.2 1.9 7.7 221.8 8.2 17.4 9.2 5.4 10.7 5.4 7.5 12.4 12.4 9.7 8.1 6.3 12.1 8.6 7.0 10.9 3.3 6.7 8.3 8.2 6.2 7.6 50.2 11.1 6.0 7.2 3.7 4.1 12.2 1.0 9.0 6.3 8.2 4.8 7.5 4.7 8.2 3.9 11.1 14.9 5.4 13.1 14.7 9.5 23.3 12.6 11.1 4.3 19.2 5.2 14.4 7.6 10.6 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684216-63728065 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 61.8;Oligodendrocytes: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 43.8;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 7.6 10.7 6.7 6.1 7.1 3.0 6.5 7.1 7.8 6.4 5.1 6.6 3.8 7.5 6.2 4.9 5.8 5.5 4.7 6.6 7.2 16.0 19.7 6.9 13.4 7.8 7.3 6.3 5.9 12.8 10.3 5.6 12.1 7.7 7.4 5.3 4.1 4.8 4.0 4.2 3.7 8.9 4.9 8.5 9.4 5.5 5.4 7.3 5.9 5.8 2.6 13.0 5.9 6.8 9.5 19.7 6.2 3.0 8.6 10.7 9.9 35.9 15.7 10.9 9.6 10.7 2.7 10.9 43.8 4.5 8.0 8.0 20.3 4.8 9.3 15.3 17.3 5.7 4.0 3.4 4.4 13.1 7.3 12.2 7.3 14.7 8.4 13.2 9.7 4.6 8.2 2.3 1.2 14.1 7.3 8.6 0.1 2.1 3.2 13.1 2.1 8.4 3.5 15.2 9.7 1.8 5.0 11.0 10.2 8.4 9.2 13.3 2.6 5.2 13.2 9.1 9.5 7.9 10.1 6.5 57.4 9.7 0.0 5.8 6.9 0.2 1.7 0.5 1.4 0.5 1.8 0.5 0.3 0.3 0.4 0.8 0.6 0.2 0.3 2.1 0.1 1.3 0.3 6.7 7.1 7.1 7.8 6.6 7.2 7.8 7.3 6.3 7.7 8.5 7.3 9.5 5.3 12.8 16.2 22.2 22.6 9.7 6.1 4.1 8.0 4.0 9.4 5.2 3.8 24.3 3.2 51.5 0.0 23.4 10.9 11.9 0.0 6.0 2.4 6.3 12.1 6.5 18.6 9.7 32.6 9.1 27.0 12.8 3.1 10.1 11.4 5.0 6.1 43.6 23.7 10.1 38.5 10.2 2.0 61.8 20.1 1.2 6.2 18.6 17.8 21.5 6.8 8.2 2.1 31.7 60.0 13.2 13.5 17.0 5.7 8.1 3.2 22.7 2.6 5.4 6.6 8.1 11.3 7.4 3.5 4.6 13.5 33.0 10.4 10.3 10.3 5.6 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 174.0" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2" "Cell line enhanced" "Detected in many" "A-431: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" Yes No "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favorable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 24.8 3.5 32.4 10.8 76.6 16.4 23.7 38.5 51.6 32.6 41.0 35.3 13.1 68.1 5.0 46.2 38.4 22.8 17.4 33.4 44.3 36.2 36.6 14.4 5.7 66.1 58.6 18.5 34.0 33.2 17.1 6.8 29.5 91.1 24.4 15.7 3.0 29.4 37.9 9.8 45.0 13.3 26.7 34.8 26.8 22.5 5.7 62.6 4.7 23.9 7.4 4.9 32.4 39.4 174.0 78.4 36.5 29.8 45.3 3.1 0.0 49.0 8.7 10.4 13.8 11.0 38.9 34.3 0.0 15.3 8.6 4.8 74.6 20.3 69.7 4.7 0.2 16.7 35.1 48.3 9.2 4.0 1.3 16.1 3.9 39.6 2.9 24.4 22.9 9.1 0.3 0.0 0.4 4.6 37.5 0.1 32.0 10.0 21.2 37.0 0.4 14.7 5.5 37.0 58.0 9.9 18.0 17.7 26.7 25.1 27.5 29.0 8.0 16.6 6.0 59.8 0.3 12.3 0.1 0.2 0.1 0.6 3.7 10.7 9.0 3.0 18.2 16.2 1.5 11.1 0.0 5.0 7.3 1.0 0.0 0.5 3.6 24.0 9.4 1.0 0.0 1.7 5.3 32.4 76.6 38.5 51.6 33.4 44.3 66.1 58.6 18.5 91.1 34.8 62.6 174.0 3.1 3.2 6.2 15.0 0.7 19.4 19.4 15.1 21.6 5.5 16.0 9.8 7.8 12.8 6.0 47.8 0.0 7.9 14.5 24.7 11.7 26.7 0.9 18.6 18.5 4.0 34.7 0.4 1.0 20.6 9.5 7.4 14.3 23.6 1.3 1.9 3.6 10.1 5.5 0.0 3.2 26.9 18.3 6.5 8.0 1.5 7.5 2.7 5.4 6.5 4.6 9.1 45.3 10.6 90.9 35.3 16.7 25.6 2.8 16.1 2.3 9.5 4.0 0.8 26.3 5.1 25.3 0.2 1.6 25.6 21.5 2.6 9.0 10.5 13.2 32.2 PZP CPAMD6 ENSG00000126838 "PZP alpha-2-macroglobulin like" P20742 12 9148840-9208395 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 82.2" "Group enriched" "Detected in some" 4 "Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.0;liver cancer: 0.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Group enriched" "Detected in some" 9 "HeLa: 5.7;SiHa: 2.5" "HPA041403, HPA041471" Supported "Secreted to blood" NA NA 15000000000 "HPA041403: AB_10804003, HPA041471: AB_10795636" "unprognostic (8.48e-3)" "unprognostic (1.12e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-4)" "unprognostic (4.79e-1)" "unprognostic (3.50e-2)" "unprognostic (2.04e-4)" "unprognostic (4.57e-2)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-5)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (9.81e-3)" 0.2 0.0 5.7 0.0 0.9 0.1 0.2 1.6 0.9 0.1 0.4 0.0 0.0 1.3 0.1 0.0 1.2 0.0 0.4 0.7 1.9 0.1 82.2 0.8 0.0 2.2 3.9 0.2 0.0 0.0 0.0 0.1 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.6 0.0 2.3 3.9 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 1.6 0.9 0.7 1.9 2.2 3.9 0.2 4.1 1.4 3.9 1.3 1.9 3.2 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.6 0.0 2.7 0.0 2.1 0.0 1.4 0.0 0.0 0.0 26.2 4.7 0.2 2.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1.8 26.4 0.0 0.0 2.9 0.0 0.0 0.3 0.0 11.0 0.0 0.2 0.0 2.8 0.0 0.0 2.1 8.5 4.6 0.0 0.0 0.4 0.7 0.0 0.0 0.0 24.7 0.6 0.0 0.3 0.4 0.5 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 PRDM7 ZNF910 ENSG00000126856 "PR/SET domain 7" Q9NQW5 16 90056566-90092072 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.0" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 6.3;Spermatocytes: 14.3;Spermatogonia: 5.1" "Cancer enriched" "Detected in single" 30 "melanoma: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "REH: 3.8;SK-MEL-30: 2.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059944 Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA059944: AB_2684174" "unprognostic (3.98e-1)" "unprognostic (8.89e-2)" "unprognostic (8.02e-3)" "unprognostic (8.26e-2)" "unprognostic (9.01e-2)" "unprognostic (5.61e-3)" "unprognostic (1.05e-2)" "unprognostic (1.46e-1)" "unprognostic (5.73e-1)" "unprognostic (5.52e-4)" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (4.03e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.2 14.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RHOT1 "ARHT1, FLJ11040, MIRO-1, MIRO1" ENSG00000126858 "Ras homolog family member T1" Q8IXI2 17 32142454-32253374 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010687, CAB068223, CAB068224" Supported NA NA "CAB068223: AB_2665691, CAB068224: AB_2665692, HPA010687: AB_1079813" "unprognostic (3.28e-2)" "unprognostic (4.02e-3)" "unprognostic (6.85e-2)" "unprognostic (3.53e-1)" "unprognostic (1.57e-2)" "unprognostic (5.49e-2)" "unprognostic (1.59e-3)" "unprognostic (1.59e-2)" "unprognostic (7.02e-3)" "unprognostic (1.29e-1)" "unprognostic (1.38e-1)" "unprognostic (5.05e-1)" "unprognostic (1.01e-2)" "unprognostic (2.97e-2)" "unprognostic (2.58e-1)" "unprognostic (3.90e-1)" "unprognostic (4.08e-2)" 19.3 27.1 19.4 9.6 21.4 19.9 19.7 20.9 29.6 15.7 13.1 16.6 11.5 16.4 15.1 15.0 14.6 11.6 25.0 21.3 19.1 17.8 17.0 17.4 11.0 19.0 18.0 19.3 17.9 15.6 38.4 14.3 18.8 20.1 17.3 11.4 51.4 17.4 19.3 28.6 26.8 12.3 16.1 18.8 12.3 17.5 12.4 21.6 19.6 25.2 34.8 11.3 16.7 15.6 25.1 14.1 26.2 21.9 22.8 25.8 28.9 13.2 22.7 18.2 24.2 26.0 13.8 9.0 18.2 22.3 18.7 26.5 24.9 34.3 13.8 29.1 14.4 25.9 21.4 15.8 21.0 35.4 28.1 15.3 15.3 40.7 20.7 23.8 40.5 21.1 36.7 48.1 14.9 21.5 10.6 52.1 23.0 18.0 16.7 12.6 28.6 32.4 32.2 17.5 8.4 20.0 18.1 22.8 14.1 38.4 26.1 31.9 38.1 16.3 17.0 17.5 19.6 16.2 22.0 22.9 19.9 20.5 26.7 28.9 3.0 5.8 5.4 2.1 4.9 2.3 2.1 2.3 2.1 5.3 4.0 1.8 2.3 3.6 3.4 5.2 1.8 1.3 2.8 19.4 21.4 20.9 29.6 21.3 19.1 19.0 18.0 19.3 20.1 18.8 21.6 25.1 16.5 28.9 38.8 88.8 17.8 25.9 13.5 14.4 27.9 61.5 21.4 18.0 38.1 14.3 18.7 16.5 70.9 28.4 14.1 12.3 33.2 17.0 19.6 14.5 15.5 17.9 16.9 31.5 97.3 13.1 20.3 19.3 15.3 13.9 27.3 24.8 18.9 18.3 33.7 57.2 89.9 9.3 22.4 46.4 29.1 20.6 30.1 33.2 16.0 76.8 45.1 128.9 29.9 68.3 65.9 13.5 14.4 24.0 11.6 13.7 22.8 21.3 15.1 58.7 26.3 24.8 21.9 63.0 40.3 24.3 53.0 22.7 18.9 24.5 13.9 11.4 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31316410-31321749 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 168.7;choroid plexus: 70.3;lymphoid tissue: 106.0" "Cell type enhanced" "Detected in many" "granulocytes: 81.4;Hofbauer cells: 114.2;Kupffer cells: 240.6;Langerhans cells: 112.5;Macrophages: 112.0;monocytes: 195.8;NK-cells: 87.6;Oligodendrocytes: 218.9;T-cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 57.1;Karpas-707: 99.1;RPMI-8226: 160.7" "Low region specificity" "Detected in all" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA045033: AB_2679191, HPA057051: AB_2683321" "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 11.0 8.0 83.4 48.4 113.8 31.5 8.2 107.9 127.5 8.1 70.3 11.4 11.1 3.7 1.4 6.0 2.8 18.1 4.2 85.1 95.3 3.0 9.7 20.3 54.1 114.5 103.1 75.3 2.4 2.8 2.3 1.4 21.2 117.5 3.8 13.8 0.9 4.1 3.3 0.9 1.9 12.3 7.2 103.0 38.5 13.0 1.8 99.8 106.0 2.5 3.7 41.2 20.5 2.8 168.7 0.1 0.1 0.0 0.0 4.9 30.0 0.1 4.1 6.6 5.0 17.3 0.0 1.5 26.2 0.0 5.3 29.0 0.1 0.0 0.3 14.3 0.0 0.2 0.1 0.1 0.1 57.1 31.5 33.4 37.6 0.0 7.2 20.0 7.7 1.8 24.7 1.1 99.1 39.4 0.6 22.9 35.3 0.0 0.0 0.0 23.8 3.9 160.7 0.5 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 34.5 11.6 21.5 0.6 0.9 14.8 44.2 0.0 30.1 17.1 23.0 18.1 6.0 91.0 3.6 36.0 44.6 44.0 28.5 51.0 42.6 62.4 14.7 60.4 53.8 177.1 32.4 35.8 20.4 60.9 95.1 83.4 113.8 107.9 127.5 85.1 95.3 114.5 103.1 75.3 117.5 103.0 99.8 168.7 1.2 0.0 5.6 1.3 48.3 4.0 0.4 0.4 0.0 0.3 0.7 0.9 0.7 0.0 1.3 0.0 0.0 0.7 68.7 0.1 0.0 0.2 2.8 0.3 0.5 2.7 0.0 8.8 0.8 0.0 0.8 2.2 4.1 0.9 81.4 0.0 6.1 1.6 114.2 0.0 0.8 0.1 2.0 240.6 112.5 1.6 0.3 112.0 14.2 9.4 195.8 0.5 87.6 1.0 218.9 0.0 0.0 0.0 53.6 0.3 0.0 0.6 1.6 1.0 0.0 0.7 1.2 0.2 0.3 0.4 3.1 1.4 116.0 0.1 0.6 0.4 OMG OMGP ENSG00000126861 "Oligodendrocyte myelin glycoprotein" P23515 17 31272013-31297539 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 117.5;choroid plexus: 51.4" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 458.9;Respiratory ciliated cells: 708.8" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.5;glioma: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008206, HPA012693" Enhanced "Intracellular and membrane" NA NA "HPA008206: AB_1854240, HPA012693: AB_1854239" "unprognostic (8.05e-4)" "unprognostic (2.11e-2)" "unprognostic (1.27e-1)" "unprognostic (3.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.16e-2)" "unprognostic (1.63e-1)" "unprognostic (3.81e-2)" "unprognostic (9.54e-2)" "unprognostic (8.60e-2)" "unprognostic (7.03e-2)" "unprognostic (1.52e-1)" "unprognostic (3.96e-13)" "unprognostic (7.80e-3)" "unprognostic (6.00e-2)" "unprognostic (3.24e-1)" "unprognostic (2.42e-2)" 0.0 0.1 76.9 0.0 84.6 0.7 0.0 74.9 117.5 0.0 51.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 77.7 76.2 0.0 0.0 0.1 0.0 78.0 75.6 73.2 0.0 0.0 0.0 0.3 0.0 78.3 0.0 0.1 19.6 0.0 0.0 0.0 0.0 0.1 0.0 71.8 0.3 0.1 0.0 76.1 0.0 0.0 0.0 0.0 0.0 0.0 95.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.9 84.6 74.9 117.5 77.7 76.2 78.0 75.6 73.2 78.3 71.8 76.1 95.9 0.5 0.0 3.7 18.3 0.3 0.4 0.0 72.8 0.0 4.2 0.1 0.1 0.7 0.0 44.2 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 458.9 3.8 1.6 0.0 0.0 28.0 0.0 0.6 1.5 0.0 7.0 0.0 0.0 0.7 0.1 0.5 0.0 18.7 0.0 61.1 20.1 0.7 0.0 0.0 1.1 0.0 3.7 0.2 78.2 1.0 78.4 101.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 708.8 2.4 0.0 0.7 19.1 0.0 0.0 0.2 0.1 11.8 1.4 0.0 0.0 0.0 DYNC2I1 "CFAP163, DIC6, FAP163, FLJ10300, WDR60" ENSG00000126870 "Dynein 2 intermediate chain 1" Q8WVS4 7 158856558-158956747 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Adipocytes: 45.7;Cardiomyocytes: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020607, HPA021316" Approved Supported Centrosome NA NA Centrosome "HPA020607: AB_1858817, HPA021316: AB_2215577" "unprognostic (1.22e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" "unprognostic (9.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (5.88e-2)" "unprognostic (1.94e-1)" "unprognostic (3.58e-2)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" "unprognostic (9.23e-2)" "unprognostic (3.11e-2)" "unprognostic (1.41e-1)" "unprognostic (1.89e-1)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" 13.2 7.5 7.7 5.5 7.4 5.7 9.9 8.9 15.1 9.0 15.2 11.5 9.3 9.2 9.3 6.6 13.7 7.1 15.3 6.6 2.7 8.3 3.7 8.9 5.3 6.0 4.3 2.0 9.8 5.9 12.9 9.1 6.9 8.3 6.8 6.1 14.3 8.2 6.4 24.4 6.8 10.3 7.4 0.6 7.6 8.1 40.4 5.0 5.9 11.0 10.1 3.5 9.8 7.8 12.2 15.2 15.0 10.4 25.0 7.9 7.6 4.6 9.4 8.3 7.6 8.2 7.3 13.5 6.0 14.3 5.8 9.3 7.1 4.8 10.1 8.5 6.5 9.6 8.0 10.2 3.3 8.0 9.2 17.8 6.3 7.4 5.9 2.5 17.9 6.3 4.3 24.4 3.3 8.9 8.9 15.4 8.2 9.1 5.7 9.7 13.7 10.7 7.3 12.7 7.7 20.8 14.7 19.1 11.5 11.4 9.0 8.4 5.6 7.8 9.5 3.4 31.2 6.9 8.7 10.2 12.9 26.0 8.8 14.4 49.8 8.6 4.7 13.5 5.7 11.9 21.5 10.5 11.3 5.4 22.7 10.1 10.3 5.3 10.3 5.8 42.6 5.4 2.6 7.7 7.4 8.9 15.1 6.6 2.7 6.0 4.3 2.0 8.3 0.6 5.0 12.2 45.7 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.0 15.6 14.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 13.7 11.7 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.0 0.0 AIF1L "C9orf58, FLJ12783, IBA2" ENSG00000126878 "Allograft inflammatory factor 1 like" Q9BQI0 9 131096476-131123152 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 277.1;kidney: 263.5;lymphoid tissue: 208.6" "Group enriched" "Detected in many" 4 "Adipocytes: 122.9;Collecting duct cells: 356.8;Distal tubular cells: 289.5;Extravillous trophoblasts: 383.2;Proximal tubular cells: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 140.3;MCF7: 96.7;NTERA-2: 106.7;RPTEC TERT1: 299.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020522, HPA056852" Enhanced NA NA "HPA020522: AB_2670463, HPA056852: AB_2683256" "unprognostic (2.59e-2)" "unprognostic (1.83e-3)" "unprognostic (2.55e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-2)" "unprognostic (2.01e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.77e-1)" "unprognostic (4.39e-1)" "unprognostic (2.81e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.54e-6)" "unprognostic (2.48e-2)" "unprognostic (2.37e-1)" "unprognostic (1.38e-2)" "unprognostic (6.20e-2)" 45.1 4.9 221.3 4.7 227.5 2.3 40.2 217.0 247.5 14.9 144.9 6.8 1.4 13.6 9.4 106.6 10.9 8.4 27.5 180.8 238.9 263.5 1.6 12.3 1.9 247.4 243.3 160.1 5.1 6.5 81.3 18.4 24.0 277.1 6.6 5.7 6.9 32.4 36.9 14.7 14.7 8.0 10.1 215.0 208.6 9.1 6.5 222.9 4.0 92.8 22.1 5.8 9.2 35.6 269.8 0.5 2.2 140.3 24.1 0.0 0.0 59.5 0.0 0.3 0.1 0.3 26.8 11.3 0.0 63.5 0.0 3.0 13.5 21.2 1.5 0.8 0.3 30.0 15.7 7.4 51.4 0.3 0.1 7.6 1.2 6.6 0.5 0.7 0.4 6.7 39.3 10.6 0.1 0.0 96.7 9.3 1.9 106.7 9.0 10.1 0.2 1.9 39.6 299.9 8.5 54.3 8.7 7.4 60.0 20.4 82.7 57.6 0.9 0.9 3.8 10.2 0.5 30.8 0.4 0.5 0.4 6.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 221.3 227.5 217.0 247.5 180.8 238.9 247.4 243.3 160.1 277.1 215.0 222.9 269.8 122.9 0.0 0.0 5.9 2.8 4.1 2.1 1.5 1.2 0.1 45.0 29.5 6.6 0.0 3.5 356.8 0.0 4.5 1.3 0.8 289.5 1.5 1.0 4.1 3.5 35.0 3.6 0.0 0.3 0.8 383.2 15.5 0.5 15.0 0.0 10.1 33.5 0.0 7.0 0.0 0.3 2.1 2.0 0.3 2.0 3.5 37.6 2.3 67.6 21.5 0.0 15.1 0.0 8.0 36.3 2.9 0.3 59.0 0.0 7.7 0.0 201.5 0.6 0.2 0.0 3.3 10.3 0.2 5.3 4.4 2.4 21.1 1.7 29.9 1.3 2.0 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.2;testis: 32.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 3.0 2.0 3.1 13.9 5.2 21.9 1.7 3.1 5.6 1.4 1.4 2.4 2.8 1.5 0.3 1.7 1.3 3.1 24.2 4.2 3.2 1.6 1.5 6.1 24.7 4.7 3.4 2.0 1.4 1.1 1.2 1.2 5.3 4.6 1.5 1.7 4.7 2.7 0.9 54.2 1.2 9.0 1.9 4.0 21.8 3.8 32.1 3.7 21.3 1.6 20.4 15.1 3.5 1.1 4.5 0.7 0.3 2.5 5.6 1.7 0.5 39.3 0.3 0.3 0.5 0.2 0.3 0.2 17.1 0.2 0.3 0.8 0.1 16.0 0.2 0.1 4.4 1.4 38.6 0.6 0.3 0.6 38.7 1.5 0.4 0.8 0.0 0.1 0.5 22.2 10.8 13.8 4.7 0.5 6.0 1.7 60.7 2.6 0.3 0.6 4.0 2.3 23.7 0.2 0.1 1.5 2.1 2.3 0.8 2.4 0.9 1.4 53.5 0.6 2.3 2.4 1.3 0.1 3.4 1.9 9.7 0.3 35.9 0.6 0.5 9.7 17.6 9.2 12.6 7.4 14.2 8.9 10.1 6.0 15.9 11.0 9.3 9.8 3.1 9.9 2.7 9.5 8.7 3.1 5.2 3.1 5.6 4.2 3.2 4.7 3.4 2.0 4.6 4.0 3.7 4.5 3.2 0.0 1.5 0.0 15.5 0.9 0.0 0.0 0.0 55.7 0.4 0.5 17.6 0.0 0.0 1.8 0.0 1.1 19.0 0.0 0.0 0.1 90.6 0.1 0.2 6.8 0.0 3.4 5.0 0.0 37.6 3.1 0.5 0.1 1.3 167.2 6.4 0.5 25.7 0.0 1.7 0.0 0.0 21.7 10.6 120.3 5.0 14.8 1.8 15.9 15.6 0.8 30.9 1.0 0.1 0.1 0.0 3.4 12.0 0.0 0.0 0.2 0.0 1.8 0.0 0.6 6.3 2.2 1.2 0.0 0.9 1.4 17.4 1.0 0.0 0.1 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125586-131234663 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 125.2" "Cell type enhanced" "Detected in all" "Early spermatids: 281.4;Granulosa cells: 169.2;Kupffer cells: 274.8;Late spermatids: 404.3;monocytes: 224.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 425.3;neutrophil: 1259.6" "Group enriched" "Detected in all" 5 "granulocytes: 1259.6;monocytes: 425.3" "Cell line enhanced" "Detected in all" "K-562: 260.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 46000 "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 27.8 21.4 16.6 18.6 19.8 42.4 26.2 18.8 23.4 20.5 17.4 22.8 11.9 21.2 17.7 33.3 22.8 12.4 22.5 17.2 21.0 37.6 32.3 22.9 15.2 20.3 19.1 15.1 22.3 33.1 16.1 21.6 14.6 20.0 22.0 13.6 15.3 21.4 12.3 24.2 28.6 24.0 13.1 17.3 69.3 25.8 125.2 18.6 42.2 22.2 13.2 15.5 21.4 22.3 25.8 23.1 31.3 28.1 15.4 20.2 25.1 26.9 20.9 20.4 24.7 20.2 25.2 17.0 36.7 16.8 29.6 26.5 50.1 35.2 24.0 32.6 26.4 16.0 25.7 45.7 45.5 18.3 37.4 23.3 20.7 21.9 31.0 27.5 16.9 25.1 23.2 260.6 20.5 28.0 39.4 52.8 41.8 27.7 30.2 27.1 17.8 35.2 36.4 25.0 24.8 21.4 24.8 35.5 30.0 17.3 18.4 41.0 90.3 23.5 44.9 25.2 30.1 31.6 18.8 49.7 39.0 22.3 20.7 28.2 53.2 425.3 174.5 6.7 181.7 8.1 13.5 8.4 6.4 162.2 11.8 6.5 7.5 1259.6 10.2 154.8 16.9 5.2 211.2 16.6 19.8 18.8 23.4 17.2 21.0 20.3 19.1 15.1 20.0 17.3 18.6 25.8 24.3 19.2 17.9 46.7 27.8 8.7 11.3 11.4 20.5 31.0 14.7 14.6 21.3 10.0 15.6 23.9 45.9 13.2 31.2 18.6 9.8 10.4 281.4 17.3 20.1 18.6 20.4 20.4 39.7 15.2 11.8 17.8 20.4 18.8 8.8 169.2 21.4 14.5 81.2 16.8 41.1 16.6 22.4 274.8 35.3 404.3 23.3 120.6 10.6 50.6 224.1 14.9 33.0 41.2 75.8 13.8 7.7 20.3 23.4 14.3 15.0 9.1 19.8 32.3 6.6 24.4 36.3 90.8 49.8 16.5 10.9 10.9 22.4 23.0 17.6 11.3 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 5.4;testis: 10.5" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 77.3" "Cancer enhanced" "Detected in many" "melanoma: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: AB_2686402, HPA076586: " "prognostic unfavorable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.3 0.8 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.8 1.6 0.0 5.4 0.0 0.1 0.4 0.7 0.3 0.0 0.2 0.1 0.0 0.5 2.0 0.0 0.3 2.6 0.1 0.3 0.0 0.0 0.1 0.0 3.3 0.4 0.2 0.0 0.0 0.4 0.5 10.5 0.0 3.0 0.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 104.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.6 2.9 0.0 0.0 0.2 0.0 0.0 203.6 0.0 0.0 0.0 311.3 0.0 0.0 0.4 0.0 0.0 195.4 0.3 0.0 0.2 0.6 0.3 6.3 0.2 0.7 0.2 2.6 356.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.2 0.0 2.1 0.0 0.0 1.2 0.9 0.0 3.9 0.0 0.2 0.0 1.8 0.2 0.0 0.0 0.5 0.0 11.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.7 1.2 0.5 0.0 0.0 0.6 18.5 77.3 0.0 0.0 1.1 0.1 0.0 0.0 0.0 AVPR2 "DIR, DIR3, V2R" ENSG00000126895 "Arginine vasopressin receptor 2" P30518 X 153902531-153907166 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes insipidus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 5.3" "Group enriched" "Detected in some" 4 "Adipocytes: 48.0;Collecting duct cells: 49.7;Endothelial cells: 17.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "cerebellum: 3.4;pons: 1.5" "Group enriched" "Detected in some" 28 "intermediate monocyte: 3.6;non-classical monocyte: 3.2" "Lineage enriched" "Detected in single" 29 "monocytes: 3.6" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;SCLC-21H: 3.7;U-266/84: 3.7;U-698: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 6.8" NA NA "unprognostic (3.05e-2)" "unprognostic (5.62e-2)" "unprognostic (1.99e-4)" "unprognostic (2.50e-4)" "unprognostic (2.76e-1)" "unprognostic (7.10e-6)" "unprognostic (3.80e-3)" "unprognostic (1.17e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-2)" "unprognostic (4.21e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.08e-2)" "unprognostic (1.87e-1)" "unprognostic (4.38e-1)" "unprognostic (9.83e-2)" 5.3 0.2 0.1 0.2 0.2 0.8 3.1 3.4 0.1 1.0 0.5 0.7 0.6 0.9 0.1 0.6 1.6 1.0 4.0 0.1 0.0 2.8 0.0 1.3 1.0 0.1 0.2 0.0 0.2 0.6 0.7 0.1 0.2 1.5 0.7 0.2 0.0 0.7 0.6 3.1 1.5 0.8 0.8 0.3 0.3 0.7 0.2 0.2 0.5 0.9 4.0 0.3 0.8 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 3.2 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.1 1.2 0.6 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.8 1.0 0.1 0.0 0.0 1.4 0.6 1.4 0.0 0.0 3.7 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.6 3.7 3.6 0.0 0.9 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.1 0.2 3.4 0.1 0.1 0.0 0.1 0.2 0.0 1.5 0.3 0.2 0.2 48.0 3.2 1.3 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.0 0.0 49.7 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.6 0.8 0.0 0.0 0.1 1.3 0.0 0.1 0.5 0.0 0.1 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 63.6;Syncytiotrophoblasts: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "basophil: 218.6" "Lineage enriched" "Detected in all" 17 "granulocytes: 218.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favorable (4.53e-4)" "prognostic unfavorable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavorable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 23.5 23.0 6.1 13.2 5.7 34.3 21.2 6.3 8.0 26.6 5.7 21.8 14.0 29.8 18.6 31.4 23.0 21.5 23.3 5.4 6.7 19.8 10.4 22.9 15.2 6.8 6.3 4.7 41.2 23.0 9.7 18.9 21.3 6.8 23.1 8.4 2.0 17.6 15.8 18.5 41.3 18.8 13.6 6.3 19.4 19.0 9.0 7.0 9.9 20.8 9.5 11.3 32.1 26.3 7.2 66.4 27.0 7.3 38.3 25.2 27.6 48.9 49.2 29.2 32.5 32.3 25.0 31.8 51.0 91.1 46.8 41.3 55.9 24.4 24.7 8.6 32.7 11.8 15.9 36.0 20.3 47.0 19.0 24.9 34.8 28.1 29.9 15.8 28.5 22.6 8.7 17.6 48.6 21.6 90.0 10.2 17.0 5.9 32.4 54.9 16.8 19.9 38.8 24.7 24.2 6.8 12.0 29.8 55.4 13.0 8.5 17.9 15.0 29.5 38.0 23.9 89.6 63.2 34.3 35.6 52.8 40.9 39.6 20.2 218.6 4.5 21.1 12.9 6.5 9.6 5.3 8.5 9.2 3.9 5.2 6.0 5.9 6.1 8.8 5.6 9.5 6.4 6.3 6.1 5.7 6.3 8.0 5.4 6.7 6.8 6.3 4.7 6.8 6.3 7.0 7.2 13.3 3.2 7.0 2.3 21.1 22.6 27.1 15.2 50.7 2.8 13.7 11.8 4.0 15.7 7.3 18.4 6.2 49.5 17.4 22.1 7.9 17.8 3.6 13.0 14.8 15.8 10.2 11.1 1.6 19.4 63.6 21.2 13.7 21.0 12.7 15.8 16.8 2.3 19.4 3.3 1.4 15.5 4.1 8.4 19.6 1.2 27.1 22.7 3.6 1.0 13.2 3.0 23.7 1.5 1.6 20.9 16.0 13.2 19.8 14.1 17.2 10.4 6.9 1.9 6.6 12.1 14.3 1.9 2.9 45.5 27.8 103.0 24.5 5.4 11.7 23.5 MAP2K2 "MEK2, PRKMK2" ENSG00000126934 "Mitogen-activated protein kinase kinase 2" P36507 19 4090321-4124122 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 724.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003835, HPA051993" Supported Supported Cytosol NA NA 140000 Cytosol "CAB003835: AB_562312, HPA051993: AB_2681685" "unprognostic (4.39e-1)" "prognostic favorable (3.72e-4)" "unprognostic (4.24e-1)" "unprognostic (1.26e-3)" "unprognostic (2.58e-1)" "prognostic favorable (7.98e-4)" "unprognostic (2.08e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (1.32e-1)" "prognostic favorable (5.43e-5)" "unprognostic (2.91e-2)" "unprognostic (2.25e-1)" "unprognostic (4.90e-2)" 73.8 119.4 147.5 54.6 145.1 103.2 69.6 154.0 192.2 77.2 148.2 94.9 135.2 72.9 23.4 122.6 65.3 30.7 133.8 147.7 146.9 83.1 124.3 67.4 57.6 152.3 155.2 147.3 84.8 135.4 55.3 100.1 36.7 153.2 94.7 43.2 68.6 80.3 38.0 291.7 96.4 101.9 32.0 146.2 89.9 93.4 132.6 154.0 69.9 75.2 133.3 41.4 77.9 75.8 146.5 163.1 175.4 93.7 132.8 127.1 151.9 93.8 104.5 138.8 139.6 125.8 153.0 85.5 137.7 95.9 120.0 111.9 114.3 74.2 111.6 107.4 118.1 90.4 50.5 91.4 171.7 194.0 93.6 101.8 168.8 106.8 98.2 129.5 185.5 125.2 123.0 98.1 263.1 119.3 203.5 186.3 130.6 107.8 118.6 125.9 140.7 61.9 159.1 123.5 102.7 126.8 126.3 95.7 130.6 344.1 107.3 101.0 158.5 111.8 113.6 98.2 293.4 163.9 263.1 172.4 100.2 176.5 166.8 199.3 27.5 13.0 45.4 16.9 16.6 13.6 13.0 13.3 17.2 15.9 18.2 12.3 15.9 21.2 18.8 14.1 9.0 14.3 7.3 147.5 145.1 154.0 192.2 147.7 146.9 152.3 155.2 147.3 153.2 146.2 154.0 146.5 77.7 9.6 31.9 22.5 62.3 35.4 93.3 21.3 15.4 85.1 92.9 95.4 62.9 44.3 22.8 40.5 41.7 28.7 102.3 300.5 146.8 20.7 248.1 59.5 68.3 52.1 63.2 123.1 17.6 45.5 38.6 60.3 64.7 48.8 19.7 124.4 49.2 48.1 55.0 121.1 23.2 107.7 16.2 56.0 38.2 724.3 35.8 65.6 42.7 10.3 28.5 121.1 62.8 13.0 24.2 47.0 151.8 23.0 79.9 103.2 166.1 92.8 18.9 106.8 26.3 93.1 71.8 23.5 17.4 42.9 63.9 35.6 77.0 120.2 119.9 113.1 HNRNPH2 "FTP3, hnRNPH', HNRPH', HNRPH2" ENSG00000126945 "Heterogeneous nuclear ribonucleoprotein H2" P55795 X 101408222-101414133 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 302.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, CAB004436, HPA016884" Supported Enhanced Nucleoplasm NA NA 640000 Nucleoplasm "CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (5.48e-2)" "unprognostic (1.71e-2)" "unprognostic (3.83e-2)" "unprognostic (1.47e-2)" "unprognostic (3.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.22e-1)" "unprognostic (2.99e-1)" "prognostic favorable (7.37e-4)" "unprognostic (8.09e-2)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (6.68e-2)" 60.7 70.9 59.4 63.6 63.4 78.7 73.0 59.3 70.1 59.7 64.2 57.7 60.7 62.2 66.7 55.9 55.7 49.1 59.6 62.1 63.7 79.7 78.4 57.9 58.8 61.5 60.9 60.2 53.5 43.1 125.0 53.2 72.4 60.8 63.6 61.5 80.1 46.0 73.4 91.1 62.6 60.2 69.3 59.8 60.1 49.4 25.8 60.2 73.7 63.7 78.5 73.8 72.6 47.6 65.0 105.0 72.1 137.8 83.2 119.4 104.0 66.0 87.3 123.5 82.0 166.6 62.1 91.9 107.9 86.6 125.5 112.3 93.8 160.6 122.5 111.9 104.9 78.0 80.1 173.7 84.8 102.2 100.4 74.7 106.1 111.0 80.8 79.3 98.5 113.5 58.1 82.9 150.6 126.8 136.9 83.3 88.7 86.6 171.7 69.7 76.9 146.2 105.1 177.8 140.7 63.1 114.6 130.0 61.3 104.5 97.3 78.9 94.7 122.0 45.0 81.4 129.7 36.2 49.8 76.9 75.0 93.2 114.6 57.5 138.8 104.6 165.1 59.2 112.3 62.9 56.7 56.6 59.3 99.4 54.5 58.7 61.3 247.6 79.5 114.5 41.9 57.4 92.2 59.4 63.4 59.3 70.1 62.1 63.7 61.5 60.9 60.2 60.8 59.8 60.2 65.0 46.3 28.9 61.2 0.0 47.7 70.9 94.1 119.0 21.1 40.5 42.6 24.9 48.1 45.8 88.5 90.1 12.5 137.7 37.5 52.0 99.7 99.1 3.2 41.4 35.6 56.1 60.6 41.0 0.0 73.4 65.0 49.0 28.1 44.6 82.4 26.2 52.1 85.3 84.3 16.8 0.0 45.7 83.4 75.4 75.8 6.1 55.3 66.0 69.4 0.0 97.8 44.1 55.6 0.0 0.0 64.5 65.8 59.0 24.6 45.3 58.4 146.2 75.0 34.1 78.9 57.2 64.6 17.6 33.1 28.2 72.0 302.5 42.0 44.3 46.0 64.5 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing X-linked 1" Q9P291 X 101550547-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 74.9;ASC TERT1: 66.9;BJ hTERT+ SV40 Large T+ RasG12V: 78.2;LHCN-M2: 70.7;RH-30: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 24.1 34.3 17.6 8.9 19.7 3.1 22.1 16.2 22.1 31.5 19.4 24.6 7.0 30.7 21.4 11.5 25.4 17.7 33.1 18.7 20.1 13.8 4.0 16.7 5.5 17.2 17.9 19.1 48.8 12.9 17.0 26.1 15.0 18.6 24.5 7.6 12.1 14.2 23.2 27.9 10.7 12.1 21.4 16.2 14.2 14.9 6.0 18.1 6.4 16.5 25.7 3.5 23.4 21.9 19.5 2.1 0.6 16.0 0.0 74.9 66.9 0.2 25.5 49.7 31.4 78.2 0.0 0.4 0.0 21.3 39.3 34.2 2.1 0.0 3.7 17.7 0.1 0.0 14.9 5.1 0.0 39.6 0.0 0.2 56.5 4.8 23.8 0.0 25.9 19.2 0.0 0.3 0.3 70.7 1.0 0.0 0.1 23.1 0.0 0.2 0.0 87.8 0.1 21.6 0.0 15.8 13.1 0.0 0.3 45.9 4.4 2.5 11.0 25.6 18.9 10.0 55.5 0.3 0.0 0.3 0.0 18.6 0.0 12.1 0.0 3.3 0.4 0.0 3.1 0.5 0.0 0.4 0.3 7.7 0.2 1.1 2.7 0.1 1.8 0.9 4.0 0.8 1.6 17.6 19.7 16.2 22.1 18.7 20.1 17.2 17.9 19.1 18.6 16.2 18.1 19.5 27.6 25.6 7.4 8.5 0.7 33.1 22.9 5.0 18.2 32.2 19.1 17.4 59.7 7.2 4.1 23.9 6.2 1.6 3.7 0.6 13.7 21.1 0.3 10.4 23.2 29.9 5.4 4.2 9.5 7.1 2.6 53.2 9.2 11.2 24.1 20.0 20.7 0.8 27.9 21.9 11.8 2.2 2.0 9.5 33.4 2.0 47.2 17.5 58.7 4.7 5.7 36.0 0.0 11.1 8.4 5.6 0.1 44.4 0.4 20.6 0.6 13.6 3.6 13.9 46.0 60.6 39.9 1.6 0.7 3.8 21.7 2.6 2.3 35.6 2.5 7.5 TMEM35A "FLJ14084, NACHO, TMEM35, TUF-1" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078879-101096367 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9;seminal vesicle: 51.4" "Cell type enriched" "Detected in some" 5 "Theca cells: 37.5" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;HUVEC TERT2: 52.5;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.5 7.0 21.9 1.3 22.1 0.0 0.8 21.0 30.8 4.1 5.7 26.5 3.4 7.9 3.7 11.4 4.1 3.5 0.5 30.6 56.9 0.5 0.0 2.3 0.1 24.0 27.9 21.2 8.0 0.2 12.8 2.3 0.1 31.2 22.5 9.7 10.3 0.6 51.4 0.8 0.5 7.3 10.4 16.5 0.8 5.2 1.4 40.3 0.2 0.8 2.5 0.3 9.8 4.4 45.1 0.0 0.0 5.4 0.0 3.9 10.1 0.0 1.1 0.7 0.4 0.2 0.0 0.0 0.0 0.1 3.2 0.0 0.0 3.4 0.0 1.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 0.0 3.5 0.0 1.9 0.0 7.5 52.5 0.0 0.0 0.1 6.6 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 13.2 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 22.1 21.0 30.8 30.6 56.9 24.0 27.9 21.2 31.2 16.5 40.3 45.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 7.4 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.2 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 37.5 0.0 0.0 TIMM8A "DDP, DFN1, MTS" ENSG00000126953 "Translocase of inner mitochondrial membrane 8A" O60220 X 101345661-101348742 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Deafness, Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 102.2;Hepatocytes: 68.3;Suprabasal keratinocytes: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 217.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003628 Supported Supported Mitochondria NA NA 59000 Mitochondria "HPA003628: AB_1080284" "prognostic unfavorable (7.89e-5)" "unprognostic (1.36e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (8.87e-5)" "unprognostic (2.06e-1)" "unprognostic (9.28e-3)" "unprognostic (5.14e-3)" "unprognostic (8.32e-2)" "unprognostic (1.90e-2)" "unprognostic (1.86e-3)" "unprognostic (6.41e-2)" "unprognostic (8.57e-3)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (7.75e-2)" "unprognostic (1.70e-1)" "unprognostic (3.86e-2)" 5.1 5.7 4.7 6.6 4.7 6.9 7.7 5.4 5.3 4.4 4.8 7.2 6.7 4.2 4.8 7.1 5.6 3.6 11.0 4.8 5.6 9.2 25.5 3.1 8.2 4.8 5.7 4.2 6.0 5.3 6.8 1.9 6.3 4.9 6.5 7.6 5.0 6.1 3.8 10.1 6.5 6.4 4.8 5.2 4.6 4.3 3.2 5.3 6.8 6.6 14.1 8.8 6.5 3.2 4.8 31.5 30.0 17.1 33.8 13.3 15.0 20.3 23.5 11.4 20.0 40.6 26.4 21.3 38.0 29.7 17.8 36.5 27.7 46.2 24.5 33.3 17.7 29.9 62.8 44.7 46.5 12.7 39.9 217.8 15.0 21.5 30.0 18.8 9.6 19.7 15.9 51.0 40.8 26.8 50.7 18.3 39.1 55.3 46.4 49.3 30.2 31.1 44.9 18.3 21.1 22.7 20.9 28.6 22.8 22.5 18.8 19.1 19.3 14.2 27.5 31.5 40.6 26.1 18.7 50.8 45.9 14.6 53.8 22.2 1.2 3.8 0.2 4.9 5.8 7.0 12.1 6.8 7.2 4.6 11.9 10.3 8.4 0.4 5.2 3.1 11.7 3.8 4.3 4.7 4.7 5.4 5.3 4.8 5.6 4.8 5.7 4.2 4.9 5.2 5.3 4.8 7.0 3.2 4.4 1.3 10.7 102.2 39.6 27.6 31.9 7.6 11.2 16.8 25.8 5.7 14.1 11.0 6.2 38.4 8.7 7.5 39.2 13.5 0.7 9.0 10.8 10.2 8.4 27.4 2.8 10.9 47.6 13.0 7.1 7.3 16.5 9.3 5.3 68.3 21.1 3.3 2.8 8.6 22.4 7.2 13.9 0.5 6.5 7.5 14.2 1.9 5.0 5.4 3.1 1.0 0.7 15.4 6.7 2.6 13.8 36.2 8.0 39.9 9.1 8.5 0.0 9.6 16.7 2.9 10.9 27.7 88.5 36.7 6.9 12.4 18.0 27.8 ZC4H2 "HCA127, KIAA1166, MCS, MRXS4, WWS" ENSG00000126970 "Zinc finger C4H2-type containing" Q9NQZ6 X 64915802-65034713 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.4;Inhibitory neurons: 39.4;Oligodendrocyte precursor cells: 58.3;Oligodendrocytes: 59.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 37.3;REH: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049584 Approved Approved Vesicles,Microtubules NA NA "Vesicles, Microtubules" "HPA049584: AB_2680825" "unprognostic (9.55e-3)" "unprognostic (1.03e-1)" "unprognostic (4.40e-1)" "unprognostic (1.56e-1)" "unprognostic (7.29e-3)" "unprognostic (9.71e-2)" "unprognostic (1.64e-3)" "unprognostic (9.72e-2)" "unprognostic (2.98e-1)" "unprognostic (3.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.44e-2)" "unprognostic (1.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.51e-5)" "unprognostic (5.34e-2)" 4.2 6.3 7.3 2.5 7.4 2.5 4.1 7.2 8.1 5.8 6.8 8.1 3.9 7.1 4.3 3.4 6.2 3.7 5.2 7.2 7.9 5.2 5.4 3.5 2.8 7.5 7.6 7.1 7.3 3.6 11.9 8.7 0.9 7.8 5.3 4.4 5.1 4.4 5.8 1.8 3.7 5.3 8.0 7.1 4.3 6.4 1.0 7.5 8.0 5.4 2.0 2.6 5.4 4.1 7.7 0.0 1.5 23.4 11.0 0.2 0.0 3.7 4.4 9.3 6.3 11.5 2.2 8.8 4.4 2.5 3.9 0.0 0.1 10.4 4.0 6.2 0.0 9.5 7.4 3.3 3.2 1.4 6.8 2.2 4.7 3.3 2.9 6.5 9.5 11.5 25.1 2.4 9.9 7.5 0.0 20.2 0.0 37.3 4.2 10.2 29.8 11.3 0.2 6.5 0.0 0.0 16.8 0.0 0.1 0.9 13.9 2.0 1.3 7.2 3.2 6.7 0.3 0.0 1.8 0.2 14.9 9.9 6.2 0.0 0.0 0.7 0.0 1.7 1.0 3.0 2.6 2.4 2.4 0.9 1.9 3.9 2.4 0.0 2.1 0.2 2.4 1.2 1.4 7.3 7.4 7.2 8.1 7.2 7.9 7.5 7.6 7.1 7.8 7.1 7.5 7.7 2.9 3.2 0.0 20.5 6.6 0.6 2.0 1.9 1.8 3.8 1.5 2.2 4.0 4.3 1.8 1.8 4.2 0.1 1.2 1.9 1.9 7.7 0.6 1.7 3.0 4.5 3.6 3.4 37.4 5.7 0.8 4.0 3.6 0.5 2.5 5.2 5.0 4.1 1.1 0.0 39.4 1.9 8.2 0.9 0.0 0.8 7.2 0.8 0.0 22.5 0.5 5.1 2.1 58.3 59.0 4.7 2.2 8.6 1.5 1.0 3.8 5.6 0.6 1.6 13.1 2.8 4.1 0.6 0.5 1.8 0.6 0.0 1.9 4.5 3.3 1.0 CANX "CNX, IP90, P90" ENSG00000127022 Calnexin P27824 5 179678628-179731641 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 817.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 528.3;SK-MEL-30: 790.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004738, HPA009433, HPA009696" Enhanced Enhanced "Endoplasmic reticulum" NA NA 13000000 "Endoplasmic reticulum" "CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379" "unprognostic (6.56e-2)" "unprognostic (9.34e-3)" "prognostic favorable (1.38e-4)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" "unprognostic (1.41e-2)" "unprognostic (4.66e-3)" "unprognostic (8.57e-2)" "unprognostic (4.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.17e-3)" "unprognostic (4.48e-2)" "unprognostic (2.28e-1)" "unprognostic (1.87e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.15e-1)" 122.4 113.7 23.1 36.7 23.0 76.7 111.5 24.3 28.4 122.4 30.1 109.0 45.4 138.8 173.2 107.5 110.7 6.3 133.7 19.2 33.7 120.8 194.8 113.6 18.5 29.3 26.8 16.3 130.7 211.5 9.7 97.2 75.7 25.5 96.8 63.2 68.6 124.3 17.9 112.5 83.6 98.3 85.8 30.6 73.8 116.1 75.6 23.1 9.1 160.5 54.1 16.8 113.0 96.4 27.4 13.0 91.5 89.5 53.0 295.4 229.3 37.9 261.4 342.8 341.2 298.2 148.2 49.6 309.3 351.0 127.8 121.4 18.7 120.2 121.1 405.9 64.6 6.3 63.0 247.8 22.9 399.9 82.9 50.0 39.1 313.5 118.6 528.3 56.1 93.9 23.9 43.2 99.9 39.9 51.2 40.9 15.1 9.4 11.7 6.4 43.2 71.3 24.9 252.1 82.8 24.4 8.0 62.7 16.7 790.3 182.7 267.3 16.3 234.7 49.9 56.5 36.1 200.2 19.7 87.2 46.1 53.3 50.4 46.5 51.8 61.8 17.4 29.9 38.9 34.4 14.4 21.2 25.0 47.6 10.0 15.3 15.6 9.6 32.1 30.1 38.7 16.4 74.1 23.1 23.0 24.3 28.4 19.2 33.7 29.3 26.8 16.3 25.5 30.6 23.1 27.4 187.0 198.7 296.6 53.5 109.4 148.5 115.4 181.3 152.0 117.4 245.8 153.5 537.0 185.8 247.0 182.1 158.4 162.5 148.6 174.3 49.0 173.6 225.5 160.9 253.9 204.0 178.0 133.3 45.5 153.5 245.8 202.8 156.5 255.5 197.9 137.7 157.5 438.7 227.7 159.9 77.0 250.0 134.3 206.4 215.6 817.5 159.1 218.3 176.1 44.0 181.1 213.8 84.5 63.3 79.4 153.1 125.1 191.1 327.3 249.5 188.2 196.4 294.3 160.9 92.1 114.6 211.2 158.4 72.7 182.3 161.8 244.8 105.8 183.1 251.0 157.8 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324687 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 38.9 41.2 20.5 24.2 23.7 29.2 39.4 31.2 40.4 64.4 22.0 61.5 33.1 67.2 26.7 44.2 61.6 24.3 47.3 22.4 21.6 40.7 46.1 35.9 32.0 25.7 23.3 21.5 64.2 54.1 29.1 40.3 28.4 26.2 53.4 21.0 13.1 38.6 27.8 91.0 46.9 45.3 27.0 19.7 45.8 52.9 76.5 22.4 29.8 41.0 44.6 25.3 68.1 51.0 28.9 58.4 56.2 31.5 62.1 52.4 41.7 34.1 31.2 49.9 67.6 50.1 53.2 71.0 63.2 43.6 60.7 40.6 41.4 46.3 67.7 29.9 60.3 60.5 49.8 79.7 70.2 80.2 39.1 52.5 72.1 35.9 61.7 91.7 38.2 71.7 59.7 59.5 56.3 34.2 50.8 77.6 52.1 39.1 53.6 60.1 61.0 30.8 93.1 47.6 31.3 45.0 42.1 31.9 83.8 91.7 23.4 45.5 57.0 54.5 43.6 39.6 50.8 40.0 87.3 101.8 85.1 60.4 68.7 22.0 66.5 69.6 48.0 65.2 82.1 68.9 50.3 56.4 59.8 81.2 44.0 52.2 50.2 33.2 64.8 101.7 52.9 78.7 81.0 20.5 23.7 31.2 40.4 22.4 21.6 25.7 23.3 21.5 26.2 19.7 22.4 28.9 36.4 38.5 33.7 0.0 9.5 0.0 0.0 0.0 0.0 0.0 32.6 33.9 0.0 0.0 13.0 18.4 0.0 77.3 24.1 0.0 31.3 56.4 0.0 27.1 27.2 14.0 0.0 0.0 0.0 53.9 63.9 18.7 0.0 23.2 10.1 40.4 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 36.2 0.0 0.0 0.0 0.0 54.8 0.0 0.0 6.8 0.0 0.0 34.4 14.6 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 77.0 12.7 49.8 0.0 0.0 RGS13 ENSG00000127074 "Regulator of G protein signaling 13" O14921 1 192636138-192660311 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 48.4" "Cell type enriched" "Detected in some" 16 "granulocytes: 520.0" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 39 "basophil: 6.8" "Lineage enriched" "Detected in single" 39 "granulocytes: 6.8" "Cell line enriched" "Detected in some" 20 "Daudi: 47.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076656 Enhanced NA NA "HPA076656: " "unprognostic (1.99e-2)" "unprognostic (6.08e-3)" "unprognostic (3.25e-4)" "unprognostic (1.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.37e-5)" "unprognostic (1.93e-1)" "unprognostic (2.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (7.39e-2)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (3.42e-1)" "unprognostic (2.35e-1)" "unprognostic (6.86e-2)" "unprognostic (1.96e-1)" 0.5 0.0 0.0 9.6 0.0 0.7 2.3 0.0 0.0 1.6 0.0 2.3 3.1 1.0 0.7 1.7 0.3 3.7 0.1 0.0 0.0 0.0 0.0 4.0 48.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 1.6 0.0 0.3 0.6 0.0 0.3 5.7 1.2 0.0 0.3 2.1 0.1 0.0 1.3 0.0 0.2 35.4 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 30.8 0.0 4.8 1.9 2.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 1.3 0.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.0 0.0 0.3 7.1 0.0 0.2 0.0 0.0 0.9 12.2 0.0 520.0 0.0 0.0 0.0 0.3 0.0 0.6 0.6 0.0 0.6 7.1 0.0 0.0 3.8 7.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 3.9 1.7 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.3 0.0 7.9 0.5 1.6 0.1 IPPK "C9orf12, FLJ13163, INSP5K2, IP5K, IPK1" ENSG00000127080 "Inositol-pentakisphosphate 2-kinase" Q9H8X2 9 92613183-92670131 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 31.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020603 Uncertain Approved Cytosol NA NA Cytosol "HPA020603: AB_1851853" "unprognostic (3.51e-2)" "unprognostic (4.66e-2)" "unprognostic (6.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.63e-2)" "unprognostic (2.08e-1)" "unprognostic (4.88e-2)" "unprognostic (3.13e-2)" "unprognostic (4.40e-2)" "unprognostic (1.10e-1)" "unprognostic (2.68e-1)" "unprognostic (1.98e-1)" "unprognostic (6.26e-9)" "unprognostic (1.28e-2)" "unprognostic (4.23e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.28e-4)" 4.5 6.9 5.5 4.5 5.7 8.6 6.5 7.8 6.8 6.8 4.1 4.2 3.2 5.2 4.9 31.9 5.5 4.6 7.4 7.2 5.4 4.4 5.3 4.8 5.8 5.9 5.5 5.8 5.4 3.7 8.6 8.1 5.5 6.0 4.3 4.5 5.7 8.9 2.9 7.6 29.4 4.2 5.5 4.7 5.4 4.7 11.7 6.0 6.0 4.7 6.2 8.8 5.8 15.7 5.9 19.3 10.1 9.2 8.0 11.1 8.2 30.4 13.5 8.5 13.6 7.8 6.3 7.4 11.9 6.6 18.9 12.0 27.1 16.4 18.9 11.3 14.9 10.4 9.8 21.9 9.9 7.8 16.7 11.2 8.1 18.4 16.3 12.7 12.4 10.3 9.8 13.5 14.1 13.6 26.3 9.6 7.7 15.8 21.2 14.9 8.5 9.8 4.9 8.0 11.5 19.1 11.2 10.9 44.9 7.8 8.9 10.6 4.2 19.7 10.0 11.3 28.2 14.4 13.0 16.2 6.5 13.0 7.5 9.9 0.0 1.4 3.4 3.6 1.8 4.1 2.4 3.0 3.1 2.1 2.2 2.3 2.6 2.1 0.8 1.9 2.3 4.6 1.9 5.5 5.7 7.8 6.8 7.2 5.4 5.9 5.5 5.8 6.0 4.7 6.0 5.9 6.8 3.2 3.4 10.1 4.8 25.4 6.4 7.6 16.5 7.5 6.0 4.7 0.4 1.5 5.1 1.8 6.2 10.8 4.6 5.0 5.9 6.2 11.0 8.3 5.3 6.8 6.7 6.1 23.8 8.0 13.8 4.1 7.1 10.2 0.0 3.6 10.0 3.1 5.1 15.2 23.7 3.5 6.1 7.5 4.6 33.7 3.1 5.3 3.6 7.5 2.8 4.9 8.2 20.6 23.3 9.1 1.4 3.0 6.0 6.4 2.6 3.6 2.6 4.6 6.6 3.9 3.5 20.0 19.4 25.5 29.5 22.8 6.0 4.4 3.7 10.5 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92844182-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.7;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 2.0 2.3 1.9 2.0 2.8 4.1 2.3 9.6 3.2 2.6 0.5 1.6 1.3 2.4 1.8 1.3 2.1 1.6 1.6 1.8 3.0 2.5 1.9 2.0 2.5 2.7 2.7 1.5 3.1 1.3 3.6 2.1 2.8 4.0 2.3 1.8 5.4 1.5 2.0 1.1 1.3 1.6 2.2 2.4 2.9 2.1 1.7 3.2 2.6 3.1 2.3 2.8 2.1 1.9 4.0 3.1 3.6 4.7 3.0 2.4 3.0 0.0 2.4 3.8 4.2 4.4 1.2 2.2 2.5 2.1 1.9 2.9 5.0 3.5 3.7 4.4 4.2 1.5 2.2 3.1 2.4 3.7 1.9 3.7 3.3 2.7 4.7 4.9 3.2 3.9 2.8 2.4 10.6 4.5 2.9 2.7 0.8 4.0 3.4 1.7 2.2 5.8 1.9 2.3 3.4 3.2 3.0 4.3 1.2 2.4 3.5 0.2 1.5 3.7 3.7 3.7 2.0 1.8 3.9 2.1 1.5 2.4 1.5 3.1 0.6 1.2 2.8 2.4 1.8 3.1 1.8 2.6 2.1 1.1 2.6 3.4 3.2 0.7 2.4 1.6 1.3 2.2 1.5 1.9 2.8 9.6 3.2 1.8 3.0 2.7 2.7 1.5 4.0 2.4 3.2 4.0 6.2 0.0 1.5 9.8 13.2 0.1 0.7 1.1 6.8 5.0 1.6 0.9 2.2 0.0 4.7 1.8 0.0 1.2 6.3 0.9 1.9 1.3 0.7 1.3 4.4 4.9 0.0 3.4 17.7 0.4 1.2 4.3 5.6 1.3 2.5 3.6 0.7 0.6 0.8 5.0 22.6 1.4 4.1 0.6 0.4 0.9 0.6 2.7 0.0 12.2 1.2 3.1 5.2 27.2 19.1 0.7 1.6 1.5 5.8 0.6 0.9 1.5 4.1 3.8 0.0 3.7 4.8 0.8 0.7 3.9 0.1 0.7 9.3 3.3 0.7 0.6 OMD "osteoadherin, SLRR2C" ENSG00000127083 Osteomodulin Q99983 9 92412380-92424471 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Fibroblasts: 66.8;Hepatic stellate cells: 26.4;Leydig cells: 97.9;Peritubular cells: 110.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "ASC diff: 6.1;ASC TERT1: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069948 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Secreted in other tissues" NA NA 21000000 "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA069948: AB_2732144" "unprognostic (1.18e-1)" "unprognostic (2.33e-3)" "unprognostic (5.04e-2)" "unprognostic (2.26e-1)" "unprognostic (9.42e-2)" "unprognostic (1.87e-2)" "unprognostic (4.31e-3)" "unprognostic (6.42e-2)" "unprognostic (4.53e-1)" "unprognostic (3.89e-2)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-3)" "unprognostic (6.35e-2)" "unprognostic (2.84e-3)" "unprognostic (2.08e-3)" 10.8 7.0 3.0 0.3 3.2 0.3 12.7 3.5 4.8 15.6 7.3 4.3 0.8 7.7 7.6 4.3 9.5 8.2 17.3 2.8 2.7 1.9 1.1 4.6 0.9 3.5 3.0 2.5 12.2 1.7 0.8 3.9 2.8 3.4 5.0 1.9 0.1 2.2 3.5 1.3 3.1 3.3 8.5 2.8 0.4 4.4 3.1 2.9 0.9 9.0 11.4 2.8 5.6 4.0 2.7 0.0 0.0 0.0 0.0 6.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.4 0.4 0.4 0.0 0.3 0.6 0.5 0.2 0.2 0.1 0.3 0.5 0.4 3.0 3.2 3.5 4.8 2.8 2.7 3.5 3.0 2.5 3.4 2.8 2.9 2.7 4.4 0.0 0.0 0.0 0.3 2.7 0.4 0.1 0.0 0.9 0.1 0.1 1.3 4.3 0.6 1.8 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.3 11.4 7.8 0.0 0.0 1.7 0.0 0.2 66.8 2.0 0.3 0.0 0.1 26.4 0.0 0.3 0.0 1.5 0.0 0.0 0.3 3.3 3.2 97.9 0.2 1.8 9.4 0.0 0.0 0.0 1.0 1.6 0.0 0.0 110.2 0.8 0.2 0.0 0.1 0.0 1.6 0.0 2.2 2.9 0.2 0.1 0.3 2.7 0.0 0.4 0.1 0.0 0.2 FGD3 "FLJ00004, ZFYVE5" ENSG00000127084 "FYVE, RhoGEF and PH domain containing 3" Q5JSP0 9 92947523-93036236 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.8;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" "dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020963, HPA021018" Approved Approved Nucleoplasm,Cytosol NA NA 11000 "Nucleoplasm, Cytosol" "HPA020963: AB_2670542, HPA021018: AB_2670564" "unprognostic (5.66e-3)" "prognostic favorable (5.51e-4)" "unprognostic (5.05e-3)" "unprognostic (1.75e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.23e-7)" "unprognostic (2.26e-1)" "unprognostic (1.03e-2)" "unprognostic (2.61e-2)" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.32e-1)" "unprognostic (8.56e-2)" "unprognostic (3.96e-1)" "unprognostic (1.60e-1)" "unprognostic (9.66e-2)" "unprognostic (1.22e-2)" 4.8 1.3 1.7 22.1 1.6 39.8 3.5 1.8 4.4 1.4 3.4 3.1 3.1 1.1 0.4 2.5 2.2 4.6 1.6 1.5 3.3 4.3 2.0 10.3 31.0 3.4 2.3 1.1 1.4 7.6 0.4 0.7 3.6 2.9 1.7 2.3 0.0 4.9 1.5 1.2 3.1 11.4 2.7 2.9 29.8 4.3 6.6 2.8 32.7 3.3 2.2 17.7 8.2 3.5 4.4 13.3 0.2 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 16.0 9.1 11.3 0.6 0.0 0.1 8.4 0.6 0.0 0.0 19.7 0.1 17.4 0.1 0.6 0.0 4.8 43.9 0.0 0.3 0.0 0.0 0.0 0.0 18.8 0.7 61.4 0.0 22.8 20.7 20.4 0.4 4.3 1.1 20.1 0.0 16.3 0.1 33.5 1.2 0.4 0.0 14.4 0.4 0.4 5.8 21.4 0.0 0.0 0.6 0.1 0.1 6.2 6.6 5.4 3.1 10.3 0.0 142.9 50.6 139.6 49.5 63.4 49.9 28.6 51.4 46.6 37.5 36.9 50.1 44.7 178.2 39.1 99.2 16.8 48.4 74.0 1.7 1.6 1.8 4.4 1.5 3.3 3.4 2.3 1.1 2.9 2.9 2.8 4.4 1.7 22.4 9.2 0.0 25.3 0.8 0.6 0.4 0.6 0.1 5.8 1.8 2.5 4.3 2.3 9.2 0.0 2.9 41.8 0.4 0.0 7.2 66.1 1.2 0.2 2.1 1.8 11.8 0.6 0.2 3.2 0.9 0.0 0.6 19.6 3.7 1.8 0.8 15.5 0.0 1.6 0.6 0.0 22.3 6.2 99.0 0.3 20.7 1.8 12.2 20.1 0.4 69.0 5.0 0.5 0.4 0.1 0.4 15.8 0.1 0.0 0.7 0.3 3.9 0.0 0.3 0.8 1.6 2.4 0.5 1.0 4.5 47.3 0.1 0.4 0.5 HIVEP3 "FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C" ENSG00000127124 "HIVEP zinc finger 3" Q5T1R4 1 41506365-42035925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 6.7" "Group enriched" "Detected in many" 5 "Astrocytes: 83.9;Excitatory neurons: 219.6;Inhibitory neurons: 271.9;Microglial cells: 163.9;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 196.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 18.8;hTEC/SVTERT24-B: 9.5;Karpas-707: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005728 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA005728: AB_10612117" "unprognostic (2.87e-3)" "unprognostic (2.38e-2)" "unprognostic (4.65e-2)" "unprognostic (2.56e-1)" "unprognostic (1.55e-2)" "unprognostic (6.50e-2)" "unprognostic (2.70e-3)" "unprognostic (3.73e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (2.07e-8)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" 1.6 0.6 1.2 2.2 2.2 1.7 1.5 1.6 2.0 0.4 0.0 0.5 0.4 0.4 0.3 1.9 0.5 0.7 0.8 2.4 0.5 0.6 0.3 1.9 1.7 0.9 0.5 0.8 0.5 0.8 0.4 2.1 0.6 1.6 1.4 0.5 0.6 1.6 0.3 0.6 4.7 0.6 0.8 0.6 1.1 0.7 0.3 0.7 6.7 1.5 0.4 2.2 1.9 0.6 1.8 1.9 0.6 0.2 1.8 2.2 1.0 0.0 0.9 0.2 2.3 4.0 0.1 0.3 4.0 0.6 1.0 1.5 2.7 0.4 0.4 3.1 18.8 0.5 0.2 0.9 0.0 0.4 0.3 0.3 5.6 0.4 9.5 1.1 0.6 0.5 1.3 0.0 11.0 1.8 1.2 3.0 0.8 0.6 0.6 2.3 2.0 2.9 2.2 1.5 0.4 2.0 0.6 2.6 0.7 0.5 1.1 0.9 3.4 3.4 2.0 2.2 0.6 4.6 3.3 1.4 2.6 8.1 0.2 7.5 0.0 0.5 0.0 0.6 1.1 0.1 0.1 0.2 0.3 0.4 0.4 0.0 0.2 0.0 0.0 1.0 0.1 0.1 0.4 1.2 2.2 1.6 2.0 2.4 0.5 0.9 0.5 0.8 1.6 0.6 0.7 1.8 5.9 6.4 10.5 83.9 9.6 23.7 26.5 4.3 17.6 16.4 15.1 11.0 6.9 5.7 8.2 1.8 2.1 0.4 17.6 3.5 1.9 3.1 9.9 1.2 7.7 7.5 3.6 4.4 219.6 2.7 4.4 11.1 1.5 2.8 1.3 0.2 11.4 2.5 6.2 25.2 271.9 1.2 2.0 6.5 17.3 31.9 8.7 15.0 5.4 163.9 9.1 16.0 27.8 83.9 196.0 3.1 0.1 4.1 3.3 15.5 1.9 3.2 1.1 3.5 6.6 23.9 7.4 11.3 8.6 23.7 8.7 0.8 14.5 10.0 0.9 11.1 PPCS FLJ11838 ENSG00000127125 "Phosphopantothenoylcysteine synthetase" Q9HAB8 1 42456117-42473385 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 397.2;Proximal tubular cells: 316.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031361, HPA031363" Approved Approved Mitochondria NA NA 17000 Mitochondria "HPA031361: AB_10602150, HPA031363: AB_2673844" "unprognostic (1.49e-1)" "unprognostic (6.71e-2)" "unprognostic (8.15e-2)" "unprognostic (1.55e-1)" "unprognostic (3.84e-3)" "unprognostic (1.68e-2)" "prognostic unfavorable (5.96e-5)" "unprognostic (2.71e-1)" "unprognostic (7.79e-3)" "unprognostic (9.13e-3)" "unprognostic (3.24e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-2)" "unprognostic (6.45e-2)" "unprognostic (2.32e-1)" "unprognostic (2.80e-1)" "unprognostic (4.30e-2)" 50.9 63.2 31.9 34.9 31.7 27.3 65.6 32.8 34.9 44.5 38.2 64.1 58.6 36.1 71.7 48.8 32.0 43.5 42.9 31.6 35.4 88.9 100.5 40.2 43.8 33.8 31.3 29.8 30.5 67.4 60.3 28.0 38.3 32.2 52.7 58.6 22.6 59.8 44.6 46.3 46.5 56.9 29.3 35.2 42.5 65.2 15.2 33.3 28.1 65.4 40.8 38.5 43.7 40.5 35.3 83.4 34.3 17.2 28.8 52.3 55.0 72.1 40.7 43.3 49.1 44.2 30.7 93.3 22.6 80.7 46.2 30.3 48.8 11.5 62.5 40.3 66.2 35.1 39.9 34.7 31.3 72.5 39.9 69.4 48.8 98.9 35.8 62.4 58.2 48.3 29.9 16.9 17.0 50.5 47.3 20.4 40.1 22.6 70.0 49.8 22.6 18.8 45.3 106.2 70.7 23.0 25.0 47.9 113.2 129.4 50.2 56.7 167.8 31.1 28.2 41.1 42.9 46.5 58.6 37.3 17.5 12.6 44.4 61.0 298.8 231.5 325.6 114.5 245.4 135.2 171.5 141.1 128.0 195.9 182.4 149.5 132.9 159.5 185.6 237.2 135.8 160.9 262.8 31.9 31.7 32.8 34.9 31.6 35.4 33.8 31.3 29.8 32.2 35.2 33.3 35.3 61.0 57.7 84.1 5.9 62.6 23.3 42.3 99.4 42.7 12.1 91.3 100.2 104.3 84.4 90.8 64.4 6.2 172.2 52.6 129.2 397.2 96.5 3.5 66.7 43.9 48.7 31.3 29.0 7.4 136.8 131.0 52.9 61.7 59.3 57.0 52.8 44.6 120.1 107.4 11.8 7.0 124.9 103.7 84.4 44.3 4.6 60.6 76.3 81.8 6.5 127.0 64.8 79.3 8.0 8.7 98.5 125.2 63.6 41.8 51.7 159.7 316.3 63.2 28.0 26.3 26.2 48.9 10.3 20.8 66.3 36.2 134.6 62.5 103.2 101.2 60.1 EDN2 ET2 ENSG00000127129 "Endothelin 2" P20800 1 41478775-41484683 "Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.9;intestine: 17.5;vagina: 32.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 239.7;Basal respiratory cells: 137.3;Club cells: 146.1;Collecting duct cells: 69.9;Prostatic glandular cells: 62.5;Proximal enterocytes: 91.7" "Cancer enhanced" "Detected in many" "cervical cancer: 24.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;EFO-21: 35.9;HeLa: 13.0;SCLC-21H: 16.8;SK-BR-3: 41.2;U-2 OS: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA028459 Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA028459: AB_10602490" "unprognostic (2.71e-2)" "unprognostic (5.64e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" "unprognostic (5.44e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.81e-4)" "unprognostic (5.59e-2)" "unprognostic (1.28e-2)" "unprognostic (8.47e-2)" "unprognostic (1.76e-1)" "unprognostic (6.14e-2)" "unprognostic (3.85e-1)" 0.2 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 12.6 0.8 1.2 3.9 3.2 4.7 20.9 1.6 0.2 1.1 0.1 0.0 7.3 1.2 3.8 0.0 0.1 0.1 0.0 0.1 2.4 0.0 2.1 0.0 0.1 7.6 0.9 0.2 8.1 0.5 0.2 12.5 17.5 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.5 0.0 0.3 2.4 32.9 0.1 0.2 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 13.8 0.0 35.9 0.0 0.0 1.7 0.0 0.1 0.0 4.2 0.0 0.0 13.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.8 0.4 0.0 0.0 1.3 8.4 9.4 0.9 16.8 0.0 0.3 41.2 0.0 0.9 0.8 0.0 0.0 0.0 15.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 6.4 1.5 0.0 0.0 30.3 239.7 137.3 8.6 0.1 2.5 1.3 0.7 2.8 146.1 69.9 0.0 0.2 0.1 23.3 0.0 8.8 0.0 36.9 0.5 0.6 1.8 0.0 0.0 1.0 0.0 1.8 3.1 6.5 0.0 0.3 0.0 0.2 0.0 0.0 0.0 4.2 38.7 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 10.9 2.7 0.0 0.1 62.5 91.7 1.6 20.9 0.0 0.0 0.4 3.5 0.0 0.2 2.4 29.1 0.0 0.7 0.8 8.2 45.2 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "BAF chromatin remodeling complex subunit BCL11B" Q9C0K0 14 99169287-99272197 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 19.6;lymphoid tissue: 37.0;skin 1: 15.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0" "Lineage enriched" "Detected in single" 14 "T-cells: 4.6" "Group enriched" "Detected in some" 6 "JURKAT: 38.3;MOLT-4: 47.3" "Region enhanced" "Detected in many" "basal ganglia: 64.3" "Region enhanced" "Detected in many" "basal ganglia: 30.0" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favorable (7.48e-4)" 0.4 0.3 8.7 5.2 18.6 4.9 1.1 0.0 17.7 0.5 0.0 1.2 2.0 0.2 0.5 4.3 0.3 0.9 0.1 19.6 7.9 0.3 0.4 1.1 10.3 6.1 1.1 7.1 0.2 0.1 0.0 0.2 0.1 6.5 0.5 1.4 0.0 1.7 0.3 0.2 15.1 3.5 0.2 0.7 4.4 1.9 0.5 2.0 37.0 0.8 0.0 7.6 1.4 2.9 4.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 1.7 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.0 0.0 38.3 0.0 4.1 0.0 2.8 47.3 0.8 0.5 3.6 0.0 7.0 0.0 0.0 0.0 2.6 3.7 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.7 0.2 0.0 2.6 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.1 2.0 0.0 1.8 0.0 2.8 2.4 0.0 0.0 4.6 3.1 0.0 0.3 0.0 0.0 2.0 0.8 8.7 18.6 0.0 17.7 19.6 7.9 6.1 1.1 7.1 6.5 0.7 2.0 4.3 1.3 3.2 0.0 1.3 6.4 62.8 1.6 6.3 73.4 0.4 4.3 4.4 3.8 4.3 1.3 0.0 0.0 0.1 44.2 3.8 1.9 0.2 0.2 0.2 0.2 1.2 1.2 5.3 57.5 0.5 0.0 3.3 2.0 0.3 5.1 0.2 3.3 0.3 0.3 0.0 105.7 4.9 2.0 1.0 11.4 0.4 0.6 4.0 5.4 1.0 4.9 0.0 51.5 32.2 2.0 1.1 5.4 0.0 24.4 0.6 10.1 0.5 0.3 0.1 0.0 0.5 1.9 1.6 5.8 42.7 71.3 0.0 133.4 0.1 9.7 0.6 COX7C ENSG00000127184 "Cytochrome c oxidase subunit 7C" P15954 5 86617928-86620962 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2402.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 4586.0;Distal tubular cells: 4724.9;Proximal tubular cells: 5650.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046647 Approved NA NA 39000 "HPA046647: AB_2679736" "unprognostic (1.45e-1)" "unprognostic (1.74e-2)" "unprognostic (9.10e-2)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (1.04e-1)" "unprognostic (3.70e-1)" "unprognostic (4.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.23e-5)" "unprognostic (4.56e-2)" "unprognostic (2.06e-1)" "unprognostic (1.46e-1)" "unprognostic (4.46e-2)" 341.5 437.5 611.2 276.9 616.0 317.4 328.2 627.6 777.3 313.9 656.5 568.3 550.7 274.1 406.4 423.5 290.5 196.5 1412.5 613.2 651.2 688.8 626.4 245.5 317.1 628.5 620.8 603.1 396.0 385.4 788.0 405.5 197.9 619.2 308.0 402.0 238.7 463.7 255.5 2402.8 259.9 541.9 209.3 628.2 272.1 433.3 176.0 620.1 374.2 330.7 1613.6 322.5 347.3 317.6 617.7 576.6 687.2 595.1 1043.0 551.4 550.5 653.4 432.8 364.4 298.2 416.7 806.4 989.9 794.6 459.2 342.3 799.3 594.8 539.3 876.2 487.2 585.2 829.5 623.6 1006.0 844.4 458.9 732.2 692.1 648.0 745.3 377.5 518.0 841.6 486.3 687.0 392.7 860.9 443.7 1209.9 766.2 954.2 594.7 593.0 1958.6 728.4 654.3 1426.2 909.4 1129.8 700.4 518.2 406.7 946.9 973.0 646.9 963.0 1008.6 449.2 254.2 470.5 448.4 846.6 832.8 1056.8 903.4 652.5 860.4 491.6 344.5 526.0 414.6 399.1 558.3 500.0 682.6 620.5 497.6 668.6 567.2 648.4 579.2 52.3 404.7 538.3 619.0 606.5 996.5 611.2 616.0 627.6 777.3 613.2 651.2 628.5 620.8 603.1 619.2 628.2 620.1 617.7 408.8 512.8 732.9 33.0 879.5 723.5 946.8 1663.7 715.4 276.2 1141.9 1079.4 4586.0 1574.2 959.9 1213.8 156.4 1271.2 657.5 1604.6 4724.9 1314.8 1011.8 856.3 538.7 570.2 916.6 651.1 24.6 1506.3 878.3 605.7 677.3 706.8 618.0 814.7 809.2 2748.0 1388.3 230.5 30.2 1829.4 933.8 1457.0 904.7 488.5 985.7 785.3 1115.3 18.7 1443.9 714.6 782.7 15.1 25.9 1114.6 1964.4 720.7 617.5 975.5 3353.2 5650.8 734.8 313.3 598.2 662.7 740.8 927.7 381.9 1319.3 935.4 1320.8 826.7 634.8 2108.4 1356.3 TRAF2 "RNF117, TRAP3" ENSG00000127191 "TNF receptor associated factor 2" Q12933 9 136881912-136926607 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004603, HPA009972, HPA010634" Uncertain Enhanced Cytosol NA NA Cytosol "CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347" "unprognostic (7.77e-2)" "unprognostic (4.54e-3)" "prognostic unfavorable (9.32e-4)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (4.91e-2)" "unprognostic (7.23e-2)" "unprognostic (4.28e-2)" "unprognostic (7.39e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.80e-3)" "unprognostic (5.52e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" 8.2 8.0 19.0 13.9 16.2 16.3 9.1 19.2 22.2 10.4 13.4 10.5 10.0 8.4 4.1 15.5 8.4 6.1 9.6 19.9 14.3 10.4 15.2 9.7 20.3 17.5 15.0 13.7 7.4 8.0 4.9 10.1 8.3 21.3 12.6 5.5 4.2 11.6 8.4 8.6 12.1 12.1 6.3 15.4 16.9 9.7 17.9 17.6 18.0 14.2 5.2 14.9 11.1 11.6 25.8 25.4 76.3 20.2 18.0 5.6 8.8 39.5 20.5 11.1 29.2 19.8 47.5 44.5 31.2 25.8 12.8 39.3 65.0 27.9 33.3 11.8 47.9 22.8 23.6 76.2 30.0 8.3 23.5 23.4 6.6 9.9 23.7 13.4 10.9 13.9 28.5 40.5 34.5 13.2 36.6 38.3 33.6 33.1 57.4 33.9 35.8 31.1 42.7 18.0 19.6 32.9 15.4 25.6 58.9 23.7 22.5 42.4 27.2 15.7 37.8 24.2 24.6 34.8 14.3 25.2 31.2 13.3 19.2 28.5 2.0 4.8 9.1 12.3 5.8 17.8 15.2 13.4 15.6 6.5 12.3 10.7 13.2 4.2 14.0 12.0 14.8 24.0 8.3 19.0 16.2 19.2 22.2 19.9 14.3 17.5 15.0 13.7 21.3 15.4 17.6 25.8 7.9 0.0 6.4 7.5 12.5 11.9 14.1 18.1 4.0 6.9 8.3 7.0 7.5 12.8 8.7 5.5 0.0 19.4 7.4 23.3 3.9 19.2 3.2 4.4 4.3 11.0 11.4 9.0 5.6 12.8 28.9 6.9 9.7 6.1 10.2 11.8 4.2 4.1 13.3 18.5 4.5 16.1 6.1 2.2 8.7 4.1 3.4 6.2 14.2 2.8 32.7 4.5 11.3 2.5 5.7 20.8 6.2 7.9 11.3 20.0 15.6 6.3 5.6 9.8 19.7 4.1 7.4 17.5 23.8 5.3 12.8 17.8 13.9 6.5 15.4 10.0 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.3" "Cell type enhanced" "Detected in many" "Early spermatids: 146.2;Horizontal cells: 72.3;Late spermatids: 314.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 53.9;U-266/70: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: AB_2683638" "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 7.3 26.2 25.5 3.9 31.7 4.5 8.9 16.0 58.3 11.4 7.9 13.1 2.7 11.5 1.7 5.7 11.3 2.9 11.7 30.2 18.1 11.7 28.4 9.7 4.5 15.0 23.0 31.3 14.3 11.7 9.0 24.7 5.7 24.1 14.8 0.6 6.2 10.6 6.8 13.9 10.8 7.9 2.7 10.7 11.5 11.2 46.1 26.2 4.7 12.2 3.9 2.2 10.3 8.9 22.6 22.5 6.4 3.2 12.6 4.1 1.4 34.2 4.5 6.0 4.8 6.1 5.6 15.0 1.6 6.1 3.5 7.4 3.1 3.2 7.8 1.0 26.6 21.1 7.3 9.6 9.7 13.4 0.5 9.9 3.8 4.7 8.2 1.0 7.4 3.5 12.5 6.6 12.4 1.9 1.2 9.0 1.3 6.0 3.8 53.9 13.3 9.9 6.5 4.3 2.1 3.9 21.3 10.0 3.3 14.6 2.8 13.6 12.6 2.1 4.4 9.6 22.7 8.1 40.6 33.0 7.9 14.9 8.7 4.1 0.0 2.4 3.0 1.1 1.9 0.7 0.3 1.6 0.9 2.9 0.5 1.3 1.2 1.3 1.7 1.9 1.3 1.2 1.0 25.5 31.7 16.0 58.3 30.2 18.1 15.0 23.0 31.3 24.1 10.7 26.2 22.6 5.9 0.0 1.3 20.9 5.0 3.8 4.7 8.0 8.6 56.9 9.6 14.4 2.0 7.2 4.8 7.3 18.8 20.6 4.0 0.8 7.9 13.1 146.2 3.0 3.7 4.3 7.2 0.8 22.7 8.5 9.0 7.7 2.6 2.5 4.5 12.3 4.2 13.5 22.5 72.3 19.4 3.3 12.2 8.1 6.9 314.2 12.5 11.1 1.8 8.4 18.4 36.1 7.2 2.5 1.4 8.4 4.3 25.6 9.2 6.3 0.4 9.7 1.7 38.2 6.6 13.6 5.6 64.3 1.5 3.0 4.1 24.8 4.8 10.8 1.3 4.3 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217282-187291980 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 117.2;liver: 185.0" "Cell type enhanced" "Detected in some" "Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 133.3;BJ hTERT+: 498.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" No NA 8670000000 1900000000 "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favorable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 6.3 3.7 9.6 1.3 8.8 0.0 2.8 14.3 8.0 98.7 4.4 39.0 1.9 89.2 3.4 11.2 17.9 5.1 117.2 9.6 23.8 4.8 185.0 6.1 1.0 19.0 15.4 4.7 2.7 0.2 0.3 1.0 9.1 15.5 46.4 5.6 0.0 2.3 52.8 37.8 5.5 7.6 44.8 21.3 0.8 1.6 0.5 13.3 0.2 3.3 19.1 4.3 10.0 62.1 32.8 0.0 0.0 0.3 0.4 15.7 17.3 0.1 133.3 498.3 1.8 0.9 0.0 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.2 0.0 0.0 5.4 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 8.8 14.3 8.0 9.6 23.8 19.0 15.4 4.7 15.5 21.3 13.3 32.8 1.1 0.0 1.8 28.1 0.2 2.9 0.1 0.2 0.0 0.0 0.0 0.0 38.1 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.9 0.7 30.6 2.0 0.0 0.0 0.2 0.0 0.3 16.4 0.0 0.7 0.0 0.2 23.2 65.8 0.4 0.0 0.9 0.0 0.0 1.9 3.7 7.5 2.5 0.3 1.8 1.0 0.0 0.0 0.0 10.1 0.2 0.0 0.0 0.7 0.1 0.1 0.0 2.4 0.0 0.0 0.0 5.4 4.5 0.0 0.0 0.2 1.7 0.1 0.5 5.1 0.0 0.1 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193398967-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 65.1;parathyroid gland: 58.9;thyroid gland: 52.3" "Group enriched" "Detected in many" 4 "Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051932 Approved Nucleoplasm NA NA Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.1 0.3 18.9 0.2 19.6 0.2 23.0 19.5 23.2 1.4 24.8 2.0 0.3 0.1 65.1 20.3 2.4 4.6 0.1 18.8 25.8 0.4 0.6 27.5 0.4 24.1 18.2 14.8 0.3 5.3 58.9 4.8 0.1 24.4 0.1 3.5 2.6 7.2 2.4 0.5 17.0 0.3 0.1 13.3 0.3 9.6 0.5 18.9 0.3 52.3 0.0 4.8 0.1 6.8 15.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.9 19.6 19.5 23.2 18.8 25.8 24.1 18.2 14.8 24.4 13.3 18.9 15.5 0.2 64.1 30.5 409.4 1.1 0.1 0.0 1.7 0.0 1.6 6.1 3.6 0.4 11.5 15.3 0.0 0.0 1.2 0.5 1.6 0.0 3.3 0.4 4.0 0.7 0.1 0.0 0.0 5.8 0.2 0.1 0.2 17.3 6.4 1.3 0.3 1.4 0.1 0.2 1.7 10.9 1.9 0.0 0.3 0.5 1.0 0.0 0.5 1.8 13.1 0.0 0.5 0.0 163.3 20.6 1.3 1.7 0.4 0.2 0.0 0.0 0.4 8.5 1.0 0.0 0.1 0.2 0.7 1.5 2.2 1.6 0.7 0.9 0.1 2.2 0.1 PLAAT1 "A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1" ENSG00000127252 "Phospholipase A and acyltransferase 1" Q9HDD0 3 193241128-193277738 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "skeletal muscle: 90.9;testis: 74.2;tongue: 44.9" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 12.5" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051179 Uncertain Approved "Focal adhesion sites,Cytosol" No No "Focal adhesion sites" Cytosol "HPA051179: AB_2681375" "unprognostic (3.01e-2)" "unprognostic (4.21e-2)" "unprognostic (7.93e-3)" "unprognostic (4.82e-3)" "unprognostic (2.79e-1)" "unprognostic (1.87e-1)" "unprognostic (9.97e-3)" "unprognostic (9.68e-3)" "unprognostic (1.84e-1)" "unprognostic (3.55e-1)" "unprognostic (1.77e-4)" "unprognostic (5.09e-2)" "unprognostic (1.38e-5)" "unprognostic (1.61e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.98e-3)" "unprognostic (1.13e-2)" 0.9 2.5 4.7 0.2 5.0 0.1 1.8 3.6 5.8 0.4 0.8 0.4 0.0 0.9 5.9 6.6 0.5 0.2 8.8 5.1 5.5 0.5 0.1 0.2 0.0 4.4 4.2 5.1 0.2 1.4 2.1 2.2 0.1 3.9 0.1 0.1 9.1 2.1 0.7 90.9 3.2 0.3 1.3 2.0 0.2 0.8 74.2 4.0 2.3 7.1 44.9 0.3 0.3 0.4 5.4 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.1 0.0 0.2 0.0 5.3 0.0 12.9 0.4 0.6 0.0 5.6 6.9 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.0 0.4 23.8 0.0 10.7 0.0 3.7 0.0 22.0 4.1 1.5 3.3 0.0 2.1 6.5 0.1 0.1 0.0 13.3 0.0 18.6 0.1 0.0 0.0 7.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 4.7 5.0 3.6 5.8 5.1 5.5 4.4 4.2 5.1 3.9 2.0 4.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 HELB ENSG00000127311 "DNA helicase B" Q8NG08 12 66302493-66343643 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "dendritic cells: 32.8;T-cells: 43.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 2.7;HDLM-2: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052461 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA052461: " "unprognostic (1.33e-1)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (9.06e-3)" "unprognostic (8.65e-2)" "unprognostic (1.34e-2)" "unprognostic (2.00e-1)" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-6)" "unprognostic (3.97e-3)" "unprognostic (9.19e-4)" "unprognostic (1.93e-1)" "unprognostic (9.50e-3)" 0.6 0.3 0.1 0.4 0.1 1.0 0.7 0.1 0.2 0.5 0.2 0.7 0.0 0.4 0.0 0.6 0.5 0.1 0.4 0.1 0.4 0.6 1.2 1.1 0.5 0.4 0.1 0.0 0.8 0.9 0.1 1.2 0.0 0.3 0.8 0.1 0.1 0.8 0.0 0.2 0.5 1.3 0.1 0.3 1.8 0.8 0.4 0.2 0.4 0.7 0.0 0.3 0.5 0.6 0.6 0.4 2.7 0.2 0.6 0.1 0.1 0.5 0.6 0.1 0.6 1.2 0.6 1.5 1.0 0.9 0.1 0.9 0.8 0.5 0.2 0.3 2.6 0.2 0.8 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.2 0.1 1.3 0.6 1.1 0.4 1.1 0.0 0.2 0.0 1.1 0.5 0.2 1.0 0.2 0.0 0.0 0.1 0.3 1.7 0.2 0.4 0.4 0.3 1.7 0.2 0.2 0.5 0.3 0.5 1.2 1.0 0.5 0.1 0.9 0.4 4.5 0.8 5.8 2.6 0.5 4.2 0.4 4.9 3.9 1.7 0.7 5.1 4.1 0.7 3.5 0.2 0.6 5.6 1.0 0.1 0.1 0.1 0.2 0.1 0.4 0.4 0.1 0.0 0.3 0.3 0.2 0.6 14.7 0.0 7.5 1.3 14.0 0.6 2.5 0.6 10.8 3.2 10.3 9.8 4.0 0.0 6.6 0.0 12.5 3.0 32.8 4.3 1.9 1.7 0.5 12.6 11.5 9.9 4.8 6.1 7.7 1.1 2.5 5.7 11.7 20.9 2.5 10.3 4.6 2.8 3.3 13.5 5.2 5.6 2.0 5.5 3.3 0.8 3.4 10.3 3.6 20.6 8.0 2.4 14.4 0.0 16.2 2.4 3.0 0.7 21.7 5.8 5.9 3.2 3.4 6.5 0.0 11.3 8.0 1.2 1.5 5.2 1.7 2.5 43.5 9.2 6.4 1.8 RAP1B "DKFZp586H0723, K-REV, RAL1B" ENSG00000127314 "RAP1B, member of RAS oncogene family" P61224 12 68610855-68671901 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (1.47e-3)" "unprognostic (1.11e-1)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (7.23e-2)" "unprognostic (1.60e-3)" "unprognostic (1.48e-1)" "unprognostic (5.83e-2)" "unprognostic (1.80e-1)" "unprognostic (2.01e-2)" "unprognostic (2.86e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.08e-1)" "unprognostic (8.86e-2)" "unprognostic (7.86e-2)" "unprognostic (3.22e-1)" 157.5 108.5 50.9 168.0 55.1 280.5 119.2 60.2 64.8 90.5 68.5 127.6 85.0 121.4 70.3 87.1 79.4 130.8 62.6 50.9 74.9 108.3 142.3 136.1 213.5 60.6 56.2 46.5 69.9 79.5 74.7 52.4 134.1 61.2 85.8 112.5 58.1 70.6 137.2 49.9 73.4 122.0 147.7 55.9 154.6 105.3 90.4 57.4 164.0 89.9 57.9 182.5 200.0 84.5 68.8 199.9 133.1 153.2 131.2 317.6 253.1 140.2 414.9 252.1 269.5 203.5 178.9 130.2 280.0 232.8 580.5 124.2 113.4 146.5 202.9 379.8 496.2 125.7 725.2 156.7 120.9 370.8 282.0 407.1 254.8 203.3 289.5 346.0 218.6 298.7 232.1 261.2 445.6 272.0 127.9 265.4 361.7 173.9 86.8 191.3 235.8 181.9 211.1 204.9 488.3 59.6 93.3 209.1 124.8 206.1 174.7 160.3 327.2 330.4 243.0 108.9 275.6 229.9 227.1 452.4 342.3 224.7 191.8 212.3 399.1 215.4 205.7 340.1 407.0 221.2 154.1 206.1 297.6 196.2 140.3 222.2 303.4 149.8 469.5 464.3 99.0 186.2 820.8 50.9 55.1 60.2 64.8 50.9 74.9 60.6 56.2 46.5 61.2 55.9 57.4 68.8 210.9 80.1 79.9 41.1 166.2 294.4 72.4 150.9 70.6 14.0 73.3 61.0 14.7 37.1 108.9 80.9 22.9 35.5 373.9 176.1 109.5 157.9 99.6 78.5 154.3 132.4 189.5 104.7 45.0 130.8 75.2 123.4 52.0 119.6 147.8 60.5 85.3 32.7 78.5 33.7 46.8 93.5 95.6 111.3 437.6 44.6 38.8 273.1 188.5 105.9 257.3 28.6 362.5 45.8 67.8 186.0 215.6 36.5 228.4 61.4 72.3 182.2 104.0 23.3 6.6 40.3 204.8 46.3 50.2 78.9 297.8 154.5 256.9 123.2 92.2 92.4 IL22 "IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18" ENSG00000127318 "Interleukin 22" Q9GZX6 12 68248242-68253604 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 1.1;Langerhans cells: 3.4;T-cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 86900 "unprognostic (2.57e-1)" "unprognostic (4.24e-2)" 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 TSPAN8 "CO-029, TM4SF3" ENSG00000127324 "Tetraspanin 8" P19075 12 71125085-71441898 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 960.1;stomach 1: 636.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1688.5;Ductal cells: 943.3;Intestinal goblet cells: 886.7;Paneth cells: 2225.8;Proximal enterocytes: 3546.1;Undifferentiated cells: 1583.9" "Group enriched" "Detected in many" 4 "colorectal cancer: 283.9;pancreatic cancer: 156.9;stomach cancer: 194.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 2160.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA022273, CAB026009, HPA044337" Enhanced Approved Vesicles NA NA Vesicles "CAB026009: , HPA022273: , HPA044337: AB_2678899" "unprognostic (1.64e-1)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "unprognostic (6.40e-2)" "unprognostic (6.81e-2)" "unprognostic (7.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.01e-3)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.66e-5)" "unprognostic (1.88e-2)" "unprognostic (1.00e-1)" "unprognostic (2.97e-2)" "prognostic favorable (7.36e-5)" 11.2 9.8 2.9 128.1 5.8 0.0 17.2 7.0 5.6 28.9 2.8 960.1 924.3 12.6 11.8 5.6 13.5 210.1 3.1 2.8 4.7 58.1 53.6 23.2 4.7 11.5 6.3 2.3 42.1 60.5 0.4 2.5 2.0 10.1 165.3 870.3 0.3 77.0 10.9 64.2 11.6 855.3 39.6 11.0 0.3 636.7 5.8 5.5 1.1 6.5 12.5 3.8 11.1 4.0 17.3 0.0 0.7 0.0 0.0 5.2 0.8 2.8 0.0 0.0 0.0 0.0 48.8 3.1 0.0 0.2 0.0 0.6 6.5 0.0 0.0 0.0 0.2 0.1 0.0 52.2 3.3 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.3 0.0 0.2 3.0 0.3 2160.7 173.3 0.2 0.0 4.9 34.1 41.0 4.1 7.7 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.3 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 5.8 7.0 5.6 2.8 4.7 11.5 6.3 2.3 10.1 11.0 5.5 17.3 0.8 0.0 2.2 0.0 6.1 20.8 32.5 14.0 0.6 0.3 8.5 1.8 0.3 346.0 76.7 44.1 0.0 1.2 0.0 1688.5 127.2 943.3 34.5 3.7 4.5 3.8 174.1 0.0 0.1 654.9 0.6 37.3 645.3 44.8 4.5 0.0 2.2 26.0 0.2 0.0 0.1 886.7 16.2 2.2 29.1 17.9 44.1 2.6 64.0 0.0 7.8 10.3 0.0 0.5 14.3 325.0 2225.8 32.0 2.2 376.2 3546.1 2.5 30.2 0.6 0.0 7.7 23.6 0.5 1.0 2.7 13.5 1.1 5.8 10.7 1583.9 46.0 BEST3 "MGC13168, MGC40411, VMD2L3" ENSG00000127325 "Bestrophin 3" Q8N1M1 12 69643360-69699476 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 69.7;tongue: 56.3" "Cell type enhanced" "Detected in some" "Early spermatids: 10.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 70.4;Skeletal myocytes: 28.1" "Cancer enriched" "Detected in single" 9 "glioma: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "REH: 36.1;RPMI-8226: 38.4;U-698: 63.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA054582 Approved NA NA "HPA054582: AB_2682530" "unprognostic (1.53e-1)" "unprognostic (7.00e-2)" "unprognostic (9.83e-2)" "unprognostic (1.67e-2)" "unprognostic (5.15e-3)" "unprognostic (2.26e-3)" "unprognostic (7.30e-7)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (5.36e-2)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (4.82e-2)" "unprognostic (4.47e-2)" "unprognostic (3.03e-1)" 0.0 0.6 3.2 0.1 3.7 2.9 0.6 14.5 5.4 0.1 0.5 0.2 0.2 0.1 0.6 2.0 0.1 0.2 0.4 4.2 1.2 0.4 0.3 0.1 0.2 4.5 3.9 3.8 0.2 1.1 0.1 1.1 0.3 9.5 1.9 0.2 2.7 3.2 0.1 69.7 0.9 0.1 0.0 2.7 0.1 0.1 3.2 2.2 1.4 0.1 56.3 0.2 0.0 0.0 6.4 0.2 0.5 1.3 0.1 0.0 0.0 0.3 0.3 0.3 0.7 0.8 0.3 0.4 2.4 0.6 0.0 2.0 0.2 0.0 0.1 0.8 0.5 0.1 1.0 0.8 0.3 0.0 0.3 0.0 0.3 0.0 1.1 0.2 0.1 0.4 0.1 0.5 0.0 1.5 0.2 0.0 0.1 1.4 0.7 0.5 36.1 1.1 38.4 1.8 0.1 0.7 0.0 0.2 0.2 0.0 2.3 0.3 0.0 0.2 0.3 0.9 0.2 1.3 0.2 0.4 63.7 2.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 3.2 3.7 14.5 5.4 4.2 1.2 4.5 3.9 3.8 9.5 2.7 2.2 6.4 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 10.3 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 17.9 0.0 0.2 1.8 0.0 0.0 7.6 0.0 70.4 0.1 0.8 0.0 0.0 0.0 0.6 0.0 7.0 0.0 0.3 0.0 28.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 RAB3IP "FLJ22548, RABIN3, RABIN8" ENSG00000127328 "RAB3A interacting protein" Q96QF0 12 69738860-69823204 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 210.4;Early spermatids: 287.3;Late spermatids: 453.9;Oligodendrocyte precursor cells: 261.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039794 Uncertain Approved "Intermediate filaments" No No "Intermediate filaments" "HPA039794: AB_10960557" "unprognostic (4.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.66e-2)" "unprognostic (8.57e-2)" "unprognostic (3.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (7.10e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-1)" "prognostic favorable (5.68e-13)" "unprognostic (6.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "unprognostic (3.37e-1)" 3.7 16.0 21.1 6.5 21.5 25.8 20.1 76.6 18.6 8.5 42.6 21.9 19.3 5.5 44.6 8.7 15.3 15.2 18.4 19.0 18.8 48.9 16.7 15.1 13.7 25.6 23.2 14.4 3.2 23.0 27.1 20.4 12.1 32.9 21.0 22.8 89.3 12.9 9.8 9.8 11.3 22.6 4.9 14.8 6.9 18.5 75.4 18.8 12.8 16.3 14.4 15.4 11.9 4.8 30.4 44.1 23.5 14.3 22.9 6.9 3.1 41.0 4.3 9.9 16.9 22.6 67.3 19.1 34.1 13.9 2.3 21.9 33.0 14.7 22.9 29.0 51.7 25.6 25.3 8.4 32.9 6.4 29.9 15.4 7.4 23.3 15.6 52.4 17.5 24.8 44.4 12.1 30.3 9.6 46.8 30.3 12.8 35.7 46.1 25.7 35.3 22.2 35.9 55.1 53.5 56.7 10.2 16.7 28.0 6.4 57.0 47.6 11.1 7.4 7.2 18.3 3.0 20.3 14.2 63.4 156.9 17.5 18.3 11.2 1.8 5.2 7.2 4.2 1.9 8.5 9.2 7.5 6.8 5.6 8.6 9.3 9.1 6.9 7.8 2.3 5.1 12.6 4.4 21.1 21.5 76.6 18.6 19.0 18.8 25.6 23.2 14.4 32.9 14.8 18.8 30.4 4.0 60.9 51.1 19.6 17.7 23.6 55.6 28.8 19.4 210.4 44.6 13.0 50.2 85.8 48.8 51.5 110.5 21.7 6.4 33.1 37.2 64.6 287.3 79.7 5.2 8.7 40.8 14.1 22.6 31.8 8.2 6.4 39.3 119.7 2.5 19.3 7.1 16.5 3.5 28.6 186.1 39.3 46.8 1.9 7.5 453.9 4.4 8.0 5.4 9.4 16.6 96.6 4.1 261.9 104.1 51.1 38.6 3.8 25.9 77.9 46.1 82.1 54.4 95.8 6.6 31.8 12.3 48.9 37.7 24.2 29.8 8.5 15.1 3.5 45.8 76.7 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase receptor type B" P23467 12 70515870-70637440 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA 14000000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: AB_2685911" "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favorable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 26.9 9.5 16.7 4.7 12.1 0.1 18.9 12.5 14.5 12.9 14.4 11.0 7.5 12.4 4.4 6.8 10.9 14.8 23.4 9.9 15.6 22.7 16.8 36.0 3.2 17.5 14.3 7.2 4.0 6.2 7.9 4.8 32.9 16.4 6.3 11.2 1.5 3.3 8.1 17.2 3.8 9.3 18.3 10.8 30.3 6.2 2.5 16.3 3.0 14.9 39.2 3.4 7.8 5.3 15.2 4.4 0.3 1.9 0.2 0.0 0.1 0.9 0.9 4.2 2.2 5.2 0.1 3.4 1.7 24.3 0.6 0.4 15.2 0.2 0.7 7.8 1.3 0.7 0.4 1.7 1.1 0.2 0.7 0.0 0.1 0.7 6.1 0.0 19.7 61.4 0.0 3.6 1.0 1.3 0.0 0.1 0.0 2.3 4.4 0.9 0.1 1.6 0.9 11.3 1.8 0.0 0.8 1.6 0.0 3.5 0.4 0.0 1.5 90.3 0.9 0.9 0.4 5.4 1.1 0.9 0.8 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 12.1 12.5 14.5 9.9 15.6 17.5 14.3 7.2 16.4 10.8 16.3 15.2 215.9 0.0 13.2 2.0 3.1 3.7 0.8 1.0 0.0 7.1 0.9 0.9 12.3 11.5 1.3 3.7 0.0 0.0 2.0 12.8 0.0 1.5 4.6 2.2 0.7 211.5 0.0 16.0 52.5 0.9 0.0 7.3 1.5 4.0 25.2 0.5 504.0 4.7 0.4 5.0 68.8 6.4 0.0 20.0 4.6 3.0 1.2 1.2 5.4 164.9 0.0 0.4 0.0 2.5 2.9 12.2 11.1 0.0 0.1 0.8 3.2 0.1 0.2 0.9 0.0 6.4 5.2 0.7 0.7 0.9 1.6 0.0 1.0 1.8 6.8 0.7 DYRK2 ENSG00000127334 "Dual specificity tyrosine phosphorylation regulated kinase 2" Q92630 12 67648338-67665406 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 133.1;Horizontal cells: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027230, HPA056902" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027230: AB_1847925, HPA056902: AB_2683271" "unprognostic (5.86e-3)" "unprognostic (4.18e-1)" "unprognostic (4.08e-3)" "unprognostic (2.56e-3)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (7.83e-2)" "unprognostic (2.83e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (2.12e-2)" "unprognostic (2.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" 8.6 4.6 5.0 14.3 3.4 15.1 6.3 2.3 6.2 7.9 3.4 25.9 20.6 13.2 6.3 10.8 10.0 14.5 24.7 7.9 2.5 4.7 4.2 9.2 21.8 3.4 2.8 2.7 8.8 8.7 4.9 3.0 14.3 3.0 6.5 22.1 15.0 5.4 8.9 39.8 7.4 28.2 13.1 4.9 14.9 20.8 5.1 2.2 24.3 6.9 10.5 14.3 12.0 7.7 3.6 24.5 13.4 19.8 14.4 9.7 13.2 15.8 24.2 15.7 11.6 6.6 17.9 13.2 45.3 29.2 35.3 7.1 27.8 16.0 9.6 12.4 19.6 20.9 7.3 9.5 6.9 3.8 16.8 15.2 11.0 13.3 31.4 24.8 19.6 6.6 18.9 9.2 22.9 15.1 13.9 14.4 8.2 17.2 15.8 21.5 37.9 19.7 20.0 13.6 30.2 26.0 30.7 10.1 13.4 13.9 13.3 9.2 13.9 10.0 18.4 17.3 12.8 19.4 10.9 1.9 24.9 17.6 11.1 19.4 2.0 0.3 4.0 3.2 0.7 2.3 1.8 2.3 4.2 1.2 2.0 1.9 3.7 0.4 4.7 0.9 0.5 2.0 1.1 5.0 3.4 2.3 6.2 7.9 2.5 3.4 2.8 2.7 3.0 4.9 2.2 3.6 13.0 9.6 10.2 3.9 14.4 11.3 11.9 6.7 8.6 18.0 7.4 8.1 44.5 20.0 11.2 1.8 22.9 3.5 28.6 133.1 0.0 19.0 0.6 28.0 35.9 12.1 24.6 4.8 11.0 18.2 7.9 18.9 25.0 15.6 5.7 13.3 6.4 6.1 17.0 80.8 11.4 62.0 4.1 15.7 22.5 2.0 11.5 15.5 8.8 13.1 12.0 16.7 42.2 6.0 9.1 17.7 61.3 13.2 9.0 16.1 62.9 11.3 30.3 23.3 13.1 53.5 33.6 2.7 10.1 15.6 16.2 4.5 31.0 17.9 32.3 34.4 YEATS4 "GAS41, NuBI-1, YAF9" ENSG00000127337 "YEATS domain containing 4" O95619 12 69359710-69390870 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Spermatocytes: 364.9;Spermatogonia: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072532 Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA072532: AB_2686530" "unprognostic (7.23e-2)" "unprognostic (8.50e-3)" "unprognostic (2.05e-3)" "unprognostic (8.07e-3)" "unprognostic (1.64e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.77e-2)" "unprognostic (3.03e-3)" "unprognostic (1.80e-2)" "unprognostic (6.15e-2)" "unprognostic (2.13e-1)" "unprognostic (7.19e-2)" "unprognostic (8.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" 8.5 11.9 6.5 10.4 7.4 46.2 18.0 10.2 8.2 10.1 9.8 12.4 13.5 10.4 15.0 11.7 12.3 8.4 11.2 6.7 7.5 15.5 15.0 9.0 22.7 6.9 7.4 6.1 10.0 17.4 11.2 10.2 11.0 7.1 10.9 13.8 20.2 12.2 9.7 14.5 11.4 13.7 8.4 6.8 11.0 11.1 37.5 6.5 26.1 14.0 19.7 20.6 11.4 9.6 8.7 54.3 27.0 52.1 32.5 11.8 18.9 41.3 32.0 33.7 54.7 45.6 31.1 15.4 108.1 30.5 17.3 28.2 40.8 41.6 32.3 53.2 54.2 45.4 63.0 20.5 37.6 16.5 92.4 53.3 14.0 40.3 29.1 43.1 27.9 31.7 90.1 53.4 127.9 26.8 27.5 130.4 99.8 72.5 36.0 37.6 68.9 49.0 53.6 30.9 47.7 57.6 39.4 33.0 31.4 54.9 32.2 60.5 52.9 18.9 22.5 22.9 63.4 39.4 34.2 44.5 120.2 24.4 43.7 40.1 9.3 13.1 26.4 21.1 19.2 24.0 22.7 29.5 22.2 17.9 21.2 34.8 30.3 6.0 21.6 28.4 14.9 31.8 21.2 6.5 7.4 10.2 8.2 6.7 7.5 6.9 7.4 6.1 7.1 6.8 6.5 8.7 14.5 6.4 25.8 11.4 29.0 29.7 36.1 36.3 17.6 25.5 29.5 25.7 23.4 14.3 24.4 11.0 12.5 51.2 24.9 16.8 46.9 31.4 8.0 27.2 10.6 16.3 17.6 50.9 13.6 38.9 58.0 17.4 13.3 19.9 19.0 21.8 12.5 17.0 37.6 18.5 15.5 26.4 22.4 15.1 24.3 14.6 18.6 19.8 12.4 6.5 44.1 26.5 20.6 10.1 18.4 33.2 17.3 24.0 18.3 37.0 23.7 35.2 26.1 28.2 19.7 26.4 18.6 364.9 109.1 26.5 32.0 23.5 33.0 30.7 34.3 34.9 TAS2R3 T2R3 ENSG00000127362 "Taste 2 receptor member 3" Q9NYW6 7 141764097-141765197 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.11e-2)" "unprognostic (2.27e-1)" "unprognostic (4.40e-2)" "unprognostic (7.38e-2)" "unprognostic (4.04e-1)" "unprognostic (1.51e-2)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" 0.0 0.0 1.3 0.0 1.7 0.0 0.3 3.0 1.4 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.2 1.5 0.0 0.0 0.0 0.2 1.1 1.2 0.8 0.4 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.0 0.1 1.4 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 1.7 3.0 1.4 1.2 1.5 1.1 1.2 0.8 1.9 0.5 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R4 T2R4 ENSG00000127364 "Taste 2 receptor member 4" Q9NYW5 7 141776674-141781691 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 10.7;Bipolar cells: 9.3;Club cells: 6.8;granulocytes: 11.4;Horizontal cells: 8.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.15e-3)" "unprognostic (5.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-2)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (1.00e-2)" "unprognostic (3.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.06e-1)" "unprognostic (3.76e-3)" "unprognostic (6.15e-3)" "unprognostic (1.04e-5)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (9.87e-2)" "unprognostic (1.18e-1)" 0.3 0.4 1.5 0.1 1.7 0.1 0.6 3.1 1.6 0.8 0.4 0.6 0.0 0.7 0.9 0.6 0.9 0.1 0.4 1.4 1.3 0.5 0.5 0.4 0.2 1.3 1.5 1.2 1.3 0.8 0.1 1.2 0.1 1.8 0.6 0.2 1.1 0.7 0.1 0.6 1.0 0.9 0.1 1.0 0.9 0.6 0.5 1.4 0.1 0.9 0.1 0.2 0.5 0.7 1.7 0.1 0.2 0.2 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.7 0.1 0.2 0.4 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.7 3.1 1.6 1.4 1.3 1.3 1.5 1.2 1.8 1.0 1.4 1.7 0.9 3.2 10.7 0.0 1.3 0.0 1.3 0.0 0.0 9.3 1.2 0.9 0.3 1.5 6.8 1.8 6.2 1.2 1.6 0.5 0.0 0.5 0.3 0.5 0.8 1.5 1.2 0.0 0.2 0.5 0.4 1.8 0.0 0.4 11.4 2.9 3.3 0.7 0.7 8.4 0.2 0.5 0.0 0.8 0.0 0.0 0.6 1.5 0.0 0.0 2.2 2.4 4.1 0.0 0.2 0.6 1.4 1.5 1.4 2.1 1.3 0.3 2.9 2.9 0.0 1.9 0.6 1.9 1.0 0.4 0.0 0.8 1.4 0.5 0.9 0.4 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;NK-cells: 1.0;Oligodendrocyte precursor cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 5.3" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.4 0.7 1.5 0.8 1.6 0.2 1.7 2.5 1.7 3.1 0.5 1.4 0.5 1.9 2.8 1.4 2.9 0.5 1.0 1.1 1.4 1.3 1.0 1.4 0.7 1.3 1.4 1.1 3.8 1.7 0.3 2.7 0.6 1.6 2.0 0.6 1.6 1.9 0.5 1.4 4.3 1.9 0.6 1.0 1.8 1.3 1.8 1.2 0.7 1.8 0.3 0.7 1.6 2.4 2.1 0.2 0.1 0.7 0.3 0.4 1.3 0.8 0.3 0.3 0.2 0.4 1.1 0.2 0.6 0.4 0.1 0.0 0.1 0.8 0.4 0.1 0.3 0.8 0.2 0.6 1.4 0.4 0.9 0.6 1.1 5.3 0.6 1.4 1.5 0.5 0.7 1.4 0.2 0.0 0.9 0.3 2.1 0.7 0.1 0.1 0.1 0.0 1.5 0.2 0.3 1.0 0.6 0.2 0.2 0.1 0.8 0.0 0.2 0.1 0.5 0.3 0.3 0.6 0.9 0.2 0.7 0.4 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.5 1.6 2.5 1.7 1.1 1.4 1.3 1.4 1.1 1.6 1.0 1.2 2.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 CRYGN ENSG00000127377 "Crystallin gamma N" Q8WXF5 7 151428832-151440813 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "thyroid gland: 15.6" "Cell type enhanced" "Detected in some" "Astrocytes: 1.3;Breast myoepithelial cells: 1.1;Endometrial stromal cells: 1.4;Oligodendrocyte precursor cells: 1.0" "Cancer enriched" "Detected in some" 25 "thyroid cancer: 15.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Group enriched" "Detected in many" 5 "basal ganglia: 9.1;white matter: 11.4" "Not detected" "Not detected" HPA050788 Uncertain NA NA "HPA050788: AB_2681239" "unprognostic (1.69e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-3)" "unprognostic (5.50e-2)" "unprognostic (2.94e-5)" "unprognostic (2.49e-3)" "unprognostic (1.55e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (3.67e-2)" "unprognostic (1.39e-1)" "unprognostic (8.48e-2)" "unprognostic (8.93e-10)" "unprognostic (2.55e-4)" "unprognostic (2.71e-1)" "unprognostic (2.36e-2)" "unprognostic (3.36e-1)" 0.5 0.2 0.9 0.1 0.6 0.1 0.5 0.2 0.7 1.3 1.2 0.6 0.1 0.9 0.1 0.1 0.9 0.2 0.1 0.9 0.7 0.2 0.0 0.1 0.6 0.2 0.1 0.5 0.7 0.2 1.3 1.2 0.3 0.2 0.7 0.0 0.2 0.2 3.3 0.0 0.0 0.3 0.1 0.1 1.0 0.2 0.1 0.1 0.1 15.6 0.0 0.0 1.1 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.6 0.2 0.7 0.9 0.7 0.2 0.1 0.5 0.2 0.1 0.1 0.2 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150323263-150338156 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 80.6;Hep G2: 53.3;NTERA-2: 67.0" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favorable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 2.8 18.4 10.5 4.5 8.0 1.6 4.5 6.8 8.8 7.0 8.7 5.4 4.3 6.5 2.0 8.9 14.6 4.0 3.5 8.1 11.3 11.8 23.6 4.4 7.4 9.4 9.4 7.1 15.3 11.3 11.5 13.6 3.8 8.7 6.7 2.0 2.8 5.3 4.3 2.2 6.3 5.8 2.0 8.0 6.2 6.2 9.2 10.8 11.6 8.8 2.3 3.9 4.7 6.5 9.5 20.0 0.5 0.6 0.1 0.0 0.0 9.0 0.2 0.0 2.4 7.8 37.9 19.4 6.2 8.2 0.3 0.0 17.6 0.0 0.0 1.3 80.6 24.4 7.4 23.5 53.3 13.8 0.0 3.7 1.6 7.9 0.0 0.0 0.6 0.1 40.2 25.9 11.5 0.0 36.5 37.5 3.2 67.0 13.8 0.0 0.0 0.1 16.5 5.7 13.2 34.6 33.4 33.6 7.2 13.7 5.6 5.6 4.5 0.1 0.0 0.1 0.0 0.1 12.5 4.4 0.0 0.0 0.0 0.0 2.8 2.9 8.5 10.8 1.1 8.3 8.7 7.3 8.2 3.0 10.7 7.0 8.4 13.1 8.7 1.3 17.9 12.7 5.7 10.5 8.0 6.8 8.8 8.1 11.3 9.4 9.4 7.1 8.7 8.0 10.8 9.5 0.3 6.4 1.5 2.3 7.1 1.1 4.7 16.5 8.6 7.8 8.0 8.9 2.2 11.5 6.8 16.5 0.0 25.2 11.1 9.4 19.6 27.3 5.7 20.9 1.6 1.7 19.3 3.8 1.7 28.4 24.5 4.7 7.1 5.8 1.3 22.9 1.8 22.6 6.0 13.5 3.6 6.7 18.3 1.3 0.0 16.3 10.2 3.3 3.6 0.0 16.5 13.7 11.3 4.5 0.3 27.9 11.2 5.7 3.5 4.0 11.7 48.7 20.1 4.5 0.0 5.3 3.2 20.8 23.7 8.1 2.7 27.0 7.4 9.0 10.6 3.0 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933746 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "kidney: 4.3" "Cell type enriched" "Detected in some" 8 "Oligodendrocytes: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA063175 Uncertain NA NA "HPA063175: AB_2684954" "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.7 0.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 4.3 0.0 0.0 0.0 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.7 0.9 0.6 0.7 0.8 0.8 0.6 0.8 0.7 0.9 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IDUA "MPS1, MPSI" ENSG00000127415 Alpha-L-iduronidase P35475 4 986997-1004564 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025901, HPA046979, HPA054254" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 170000 Vesicles "CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429" "unprognostic (3.62e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (7.23e-2)" "unprognostic (1.45e-1)" "unprognostic (2.31e-2)" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.43e-2)" "unprognostic (1.89e-3)" "unprognostic (2.64e-2)" "unprognostic (4.61e-3)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "prognostic favorable (8.04e-5)" 12.7 17.7 3.5 2.2 3.0 2.9 16.2 8.0 7.6 17.2 2.8 9.3 3.7 15.5 2.5 10.0 16.4 3.7 9.5 3.8 1.7 15.9 13.7 14.0 3.6 3.2 1.4 3.2 17.2 21.2 2.8 17.3 1.7 5.6 18.7 1.8 1.8 16.7 4.5 3.7 8.3 14.4 2.0 0.5 19.0 17.2 5.7 2.3 3.4 17.1 0.7 1.3 12.2 14.0 3.9 1.8 0.4 0.0 1.1 12.7 3.6 5.3 10.7 8.5 1.2 1.7 0.6 6.4 0.8 10.7 5.0 1.0 0.5 0.1 0.3 0.4 6.1 0.6 1.0 0.8 0.1 5.8 0.8 4.6 9.3 3.1 0.6 0.0 3.4 1.0 0.7 0.6 0.0 1.6 0.0 2.2 2.5 0.8 11.9 5.5 2.7 0.0 1.1 3.5 0.9 0.1 3.3 0.3 0.0 5.7 1.3 1.2 2.3 9.3 9.0 1.6 2.6 1.2 29.0 1.4 0.4 7.8 3.3 1.8 0.0 1.5 0.0 1.4 1.2 1.8 0.1 1.1 0.9 1.8 0.2 1.3 0.7 0.0 1.5 1.7 1.1 0.6 0.5 3.5 3.0 8.0 7.6 3.8 1.7 3.2 1.4 3.2 5.6 0.5 2.3 3.9 8.7 6.4 5.0 4.9 5.2 3.6 11.5 1.1 8.6 2.0 8.5 9.1 2.6 1.5 1.5 7.3 4.2 0.4 4.3 5.0 0.0 1.6 0.9 4.1 9.0 4.9 10.7 1.3 4.4 2.4 1.7 13.4 16.8 6.0 2.5 8.2 6.1 2.6 6.5 0.0 2.9 4.2 0.0 5.0 3.6 0.9 19.6 7.3 5.4 1.0 1.6 1.1 4.1 5.5 3.3 1.4 6.9 10.5 15.7 7.7 6.9 1.4 1.4 2.1 0.0 5.5 4.4 3.7 1.6 4.7 1.8 0.4 5.6 4.7 4.3 7.9 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026898 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.1;non-classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-251 MG: 99.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026019, HPA068828" Approved Supported Vesicles No No Vesicles "CAB026019: , HPA068828: AB_2686043" "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 30.1 56.5 33.3 5.0 41.1 7.7 24.3 35.2 49.9 12.8 24.1 9.0 7.4 9.9 3.5 5.6 36.3 9.4 18.0 32.9 42.5 25.5 53.3 15.2 3.2 47.3 39.6 25.8 25.7 72.2 16.3 21.7 3.0 38.2 12.5 4.9 10.6 38.0 2.7 20.8 10.2 13.6 4.1 39.3 9.2 27.5 5.5 32.7 1.5 67.7 9.7 2.2 11.3 8.0 39.5 23.2 31.6 11.3 34.3 11.9 12.3 2.9 40.4 6.2 12.9 8.4 23.1 47.9 2.6 49.3 63.3 58.3 5.8 21.8 14.1 11.8 8.3 21.0 0.3 41.2 61.5 24.0 13.7 5.6 25.7 11.7 22.4 9.5 48.4 12.5 9.3 25.3 8.9 7.9 30.8 16.0 37.7 14.2 39.7 83.8 24.7 16.3 16.7 22.6 3.6 1.2 2.2 38.1 0.8 15.2 13.4 22.5 11.9 26.1 68.8 27.2 35.2 99.8 8.9 12.9 3.8 18.1 15.6 22.8 0.6 0.0 0.0 0.2 1.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 33.3 41.1 35.2 49.9 32.9 42.5 47.3 39.6 25.8 38.2 39.3 32.7 39.5 3.8 3.2 4.1 34.0 2.8 6.5 3.7 5.4 2.2 5.4 13.2 6.1 8.5 11.5 6.9 7.3 0.0 1.6 4.1 4.4 0.0 9.6 0.2 6.0 4.2 2.6 1.8 4.8 3.2 10.2 26.6 5.1 6.6 13.5 1.3 30.9 5.3 37.5 3.2 0.0 2.8 11.0 0.0 1.6 2.5 1.2 4.4 3.4 7.2 1.9 1.3 94.0 1.0 5.0 5.4 19.9 2.7 3.4 2.2 11.4 2.9 7.6 7.0 5.6 0.0 3.3 5.1 0.4 4.2 1.2 4.7 1.5 4.2 17.5 3.6 8.8 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA057160: AB_2683356" "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.1 28.4 9.9 8.2 10.6 13.0 17.7 12.6 24.8 14.7 8.7 15.5 9.0 17.5 6.1 14.4 15.1 10.1 18.9 10.5 10.2 16.4 33.8 16.3 16.2 12.2 11.2 10.1 12.3 23.5 9.3 31.1 7.5 13.2 19.2 3.6 10.3 21.6 8.8 19.9 17.1 17.7 6.5 8.1 26.3 19.5 13.3 9.9 9.0 21.1 4.5 6.1 16.2 13.6 10.2 4.9 9.5 5.1 7.0 23.7 12.3 11.8 13.0 8.6 7.3 10.8 4.2 20.5 4.0 7.5 12.8 12.8 8.4 4.7 9.5 3.1 9.2 11.9 8.3 14.9 4.3 13.7 4.6 14.8 17.5 11.3 6.4 4.3 5.1 4.6 8.1 8.2 30.0 6.4 16.2 11.3 17.4 3.2 5.8 24.8 7.5 3.1 11.5 7.0 5.0 14.0 12.9 8.6 5.5 7.8 2.5 24.3 11.3 6.6 13.7 3.0 16.8 9.1 23.0 5.9 7.4 13.2 9.4 11.3 36.8 32.2 27.2 20.6 41.1 13.3 19.4 17.3 15.5 29.4 21.6 12.6 17.6 27.8 17.0 39.7 47.1 18.5 21.2 9.9 10.6 12.6 24.8 10.5 10.2 12.2 11.2 10.1 13.2 8.1 9.9 10.2 17.0 12.8 8.9 26.8 20.7 6.2 8.1 21.0 12.5 26.8 15.2 14.4 10.4 8.6 17.1 14.7 4.2 24.1 19.2 13.7 1.9 8.8 6.1 11.6 12.2 10.2 16.2 3.0 42.8 11.4 10.1 16.6 17.9 11.3 7.0 10.8 10.8 24.5 15.2 47.1 37.8 9.6 34.6 14.5 9.1 4.0 12.5 15.8 19.6 15.0 9.6 38.6 15.5 25.1 29.1 7.9 16.1 16.1 16.7 6.1 16.6 8.0 13.6 28.7 13.1 10.1 12.3 24.0 14.1 12.3 7.7 18.9 15.3 29.2 7.6 8.4 AUNIP "AIBp, C1orf135, MGC2603" ENSG00000127423 "Aurora kinase A and ninein interacting protein" Q9H7T9 1 25831913-25859458 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 6.3;testis: 16.1" "Group enriched" "Detected in some" 5 "Early spermatids: 52.8;Late spermatids: 127.0;Spermatocytes: 54.9;Spermatogonia: 47.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA028730 Uncertain Supported Centrosome NA NA Centrosome "HPA028730: AB_10670830" "unprognostic (8.05e-2)" "unprognostic (1.98e-2)" "unprognostic (3.96e-3)" "prognostic unfavorable (3.94e-4)" "unprognostic (9.51e-2)" "unprognostic (8.86e-2)" "unprognostic (9.70e-6)" "unprognostic (5.00e-3)" "unprognostic (9.06e-3)" "unprognostic (4.59e-3)" "unprognostic (1.42e-3)" "unprognostic (1.12e-2)" "unprognostic (1.01e-6)" "unprognostic (3.61e-2)" "unprognostic (4.41e-2)" "unprognostic (4.70e-2)" "unprognostic (3.62e-1)" 0.2 1.0 0.6 0.9 0.5 6.3 0.4 0.9 0.9 0.2 0.0 0.7 0.9 0.3 0.5 1.4 0.2 0.2 0.5 0.7 0.2 0.3 0.5 0.3 1.2 0.4 0.1 0.5 0.2 0.2 0.0 0.4 1.8 0.5 0.3 0.9 0.9 0.3 0.1 0.7 0.5 0.8 0.3 0.0 0.7 0.5 16.1 0.1 1.3 0.2 0.0 1.7 0.3 0.6 0.8 19.8 5.6 8.8 11.3 0.4 0.6 8.5 11.1 5.1 22.0 17.9 4.7 15.0 19.0 8.3 4.0 7.7 15.7 23.9 10.8 17.6 11.0 17.7 42.0 8.8 7.3 0.2 20.7 18.3 0.5 5.3 13.5 9.2 1.7 5.0 14.7 25.7 9.5 6.2 10.5 15.2 17.3 15.2 13.1 6.6 12.4 16.3 12.1 6.9 6.4 12.3 5.9 15.4 17.5 12.4 9.7 6.3 10.8 2.1 6.5 9.7 13.5 10.0 3.6 7.6 14.2 4.5 34.3 10.6 1.5 0.7 0.5 0.1 1.0 0.1 0.2 0.2 0.2 0.6 0.3 0.2 0.3 0.5 0.3 0.6 0.4 0.8 0.3 0.6 0.5 0.9 0.9 0.7 0.2 0.4 0.1 0.5 0.5 0.0 0.1 0.8 0.1 0.0 0.0 1.6 0.3 0.4 0.1 1.4 0.6 0.0 0.3 0.6 1.4 0.0 0.2 0.0 2.1 8.9 0.3 0.2 0.0 0.4 52.8 0.3 0.4 0.5 0.0 13.0 3.8 0.5 11.1 0.7 0.0 0.3 0.0 1.4 0.0 0.0 2.1 0.0 1.7 0.5 0.0 0.3 1.2 127.0 2.1 0.7 0.0 0.0 1.1 0.2 0.0 1.5 0.8 0.6 0.0 0.7 1.1 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.5 54.9 47.4 1.7 0.4 7.4 0.5 0.4 1.0 0.2 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849689 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 782.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 120000 Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 55.2 90.8 120.8 31.4 127.9 48.5 52.8 118.2 202.9 58.6 85.3 72.3 36.8 62.2 7.3 60.0 64.3 13.2 96.2 129.9 125.4 70.5 63.7 49.5 26.6 134.2 123.4 131.8 55.0 43.9 28.4 69.7 20.7 145.0 75.3 9.4 20.8 39.9 22.2 91.3 53.4 49.4 16.8 102.0 54.2 61.6 99.2 126.7 42.7 45.2 33.7 12.5 68.0 52.8 155.9 116.8 104.5 75.4 70.8 25.8 22.9 45.1 85.3 35.7 60.9 58.3 97.5 36.1 72.0 132.0 31.7 63.8 58.4 52.2 49.6 19.3 153.9 223.5 187.0 137.2 85.5 41.9 88.0 105.0 31.5 33.5 39.5 18.7 45.7 49.9 124.1 86.1 105.4 37.3 81.0 133.7 338.6 72.8 47.8 156.8 120.6 79.4 121.2 44.5 56.4 95.1 112.4 82.0 40.5 96.6 30.8 51.9 104.3 87.3 85.6 68.3 133.6 139.1 135.0 137.0 97.1 90.9 111.3 107.2 280.9 181.0 397.6 170.1 202.0 159.8 165.5 165.5 171.8 171.4 176.5 130.5 146.0 114.0 192.2 195.8 316.9 245.5 214.7 120.8 127.9 118.2 202.9 129.9 125.4 134.2 123.4 131.8 145.0 102.0 126.7 155.9 73.8 28.9 20.5 11.1 48.8 48.3 65.7 153.9 23.3 77.3 56.1 62.0 79.6 44.3 67.4 62.5 12.5 119.4 81.3 82.3 164.4 101.5 270.5 75.9 57.6 65.6 99.9 78.9 41.3 108.6 98.1 66.5 38.7 40.6 63.5 83.6 56.4 45.8 140.7 60.6 39.2 70.6 160.7 54.7 75.2 782.4 90.1 60.6 124.5 20.6 131.6 87.9 138.0 11.6 24.3 113.7 81.2 129.8 74.3 68.9 97.0 143.8 104.5 76.0 65.7 52.3 98.6 186.7 94.7 54.0 65.9 55.0 77.8 81.8 69.2 58.5 FBXL12 "Fbl12, FLJ20188" ENSG00000127452 "F-box and leucine rich repeat protein 12" Q9NXK8 19 9810267-9827816 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002843 Approved Approved Mitochondria NA NA Mitochondria "HPA002843: AB_2666679" "unprognostic (7.65e-2)" "unprognostic (5.88e-2)" "unprognostic (7.72e-2)" "unprognostic (3.82e-2)" "unprognostic (8.21e-2)" "prognostic favorable (3.21e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.38e-3)" "unprognostic (1.49e-2)" "unprognostic (4.07e-3)" "unprognostic (9.28e-3)" "unprognostic (1.41e-1)" "unprognostic (1.36e-1)" "unprognostic (2.61e-1)" "unprognostic (4.77e-3)" 20.0 15.1 9.1 10.5 9.6 27.3 19.2 11.9 10.5 21.6 9.4 22.0 15.0 23.7 10.9 17.4 22.8 9.0 16.5 8.9 9.0 16.7 22.6 17.4 12.9 10.5 9.0 9.4 24.1 14.7 7.2 17.6 15.2 10.5 19.7 10.6 6.5 13.6 10.8 19.1 16.2 21.2 11.2 8.0 18.3 17.4 13.3 9.9 44.4 17.8 9.5 8.9 23.8 18.3 10.8 18.8 9.3 21.1 20.6 23.5 20.8 24.1 19.9 20.1 21.2 24.9 28.9 12.1 17.5 31.2 20.1 16.4 17.7 16.0 17.6 16.8 17.7 30.9 33.9 21.1 28.8 30.2 24.8 20.1 29.9 11.5 20.4 18.0 15.6 15.1 44.6 26.2 35.6 11.2 14.9 36.3 76.3 24.3 11.4 17.2 21.5 15.7 31.7 15.3 25.2 13.1 17.9 14.7 10.8 23.4 19.5 15.0 29.1 18.1 29.1 14.1 39.3 20.0 47.7 20.1 27.6 12.3 22.2 14.1 33.5 18.4 36.3 19.0 15.9 21.6 16.7 18.4 21.7 20.6 24.1 21.4 17.0 14.3 31.1 15.3 21.8 22.0 15.2 9.1 9.6 11.9 10.5 8.9 9.0 10.5 9.0 9.4 10.5 8.0 9.9 10.8 18.5 6.4 9.2 12.7 15.5 7.4 15.8 16.5 18.8 7.3 14.3 15.9 26.8 15.7 10.8 12.9 4.2 42.1 15.4 26.8 5.9 11.7 2.2 9.6 16.4 15.6 12.6 7.8 15.3 9.9 30.3 24.1 15.3 9.9 3.8 14.2 16.4 7.3 17.2 8.4 14.2 17.0 12.2 9.0 10.0 2.8 26.4 11.0 10.6 8.4 17.7 8.4 13.4 12.5 13.0 9.3 23.4 21.8 8.4 13.5 36.8 10.0 9.3 11.9 13.1 13.7 23.0 24.8 20.8 15.3 11.1 63.3 13.3 18.1 19.7 19.3 EMC1 KIAA0090 ENSG00000127463 "ER membrane protein complex subunit 1" Q8N766 1 19215660-19251527 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048904 Approved NA NA 14000 "HPA048904: AB_2680552" "unprognostic (9.46e-3)" "unprognostic (1.91e-3)" "unprognostic (1.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-3)" "prognostic unfavorable (8.56e-6)" "unprognostic (5.98e-2)" "unprognostic (1.69e-1)" "unprognostic (1.08e-1)" "unprognostic (4.96e-2)" "unprognostic (2.50e-1)" "unprognostic (3.02e-2)" "unprognostic (1.61e-1)" "unprognostic (1.54e-1)" "unprognostic (6.19e-2)" "prognostic unfavorable (1.43e-4)" 15.6 11.3 7.8 11.8 11.4 9.3 11.2 11.6 12.0 12.3 1.5 12.9 8.8 12.3 13.3 10.8 12.1 8.3 12.6 10.3 13.5 10.9 15.6 12.1 9.1 8.6 8.5 11.7 14.3 10.7 16.5 10.0 24.2 9.6 13.3 14.3 52.3 10.8 11.1 20.0 11.7 9.2 19.1 4.3 9.8 11.1 13.2 11.4 9.5 14.1 14.4 10.6 11.8 9.9 10.8 41.1 36.5 40.3 105.4 63.6 49.3 78.3 65.1 60.8 88.3 86.8 38.4 92.5 36.5 84.1 100.6 57.1 45.4 56.7 73.0 102.1 31.0 29.6 44.0 46.3 45.5 46.2 56.9 50.7 52.7 46.4 104.6 86.2 82.2 75.6 31.2 55.1 53.7 69.1 23.5 23.3 27.9 24.4 47.2 33.9 34.4 49.7 64.2 35.8 18.8 49.6 33.9 71.5 37.0 54.6 47.2 40.5 35.3 67.3 79.5 51.7 61.2 75.2 29.7 67.0 46.3 75.4 73.5 108.4 5.2 12.7 3.1 8.1 9.6 9.0 6.2 8.1 9.2 12.6 7.0 8.0 8.0 0.5 21.7 12.8 6.1 6.2 9.1 7.8 11.4 11.6 12.0 10.3 13.5 8.6 8.5 11.7 9.6 4.3 11.4 10.8 13.0 16.0 14.6 8.1 12.4 11.6 10.1 16.9 8.0 20.3 11.2 11.7 15.7 11.5 10.5 22.0 10.4 40.4 9.9 11.4 0.0 14.3 1.2 10.0 18.0 16.1 19.7 6.9 12.9 8.5 41.0 19.2 9.7 15.0 8.2 23.2 14.3 25.6 19.4 15.2 14.5 11.4 14.2 12.3 7.3 2.6 14.9 11.5 10.6 8.4 12.0 19.0 4.1 15.1 10.9 10.6 9.4 14.3 14.5 10.3 6.4 9.0 7.8 63.4 6.6 20.1 13.5 12.9 19.3 13.0 9.2 36.0 8.9 18.6 12.7 6.7 PLA2G5 ENSG00000127472 "Phospholipase A2 group V" P39877 1 20028179-20091911 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 112.5;ovary: 48.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 75.3;Cone photoreceptor cells: 70.9;Leydig cells: 81.4;Peritubular cells: 73.4;Sertoli cells: 263.0;Smooth muscle cells: 63.1" "Group enriched" "Detected in many" 5 "glioma: 13.0;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053361 Approved "Secreted in other tissues" NA NA "HPA053361: AB_2682127" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (5.68e-3)" "unprognostic (6.16e-2)" "unprognostic (2.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-3)" "unprognostic (6.00e-5)" "unprognostic (2.87e-2)" "unprognostic (3.00e-1)" "unprognostic (1.54e-1)" "unprognostic (4.97e-3)" 6.7 1.5 7.8 1.5 9.4 0.0 3.5 9.6 14.5 1.0 18.7 21.5 0.7 1.9 0.9 4.5 6.5 2.0 112.5 8.2 8.5 0.1 6.2 8.1 0.6 9.6 9.5 6.9 48.0 0.9 0.0 0.8 4.8 8.5 15.0 2.3 19.1 2.7 7.7 0.5 1.7 3.0 3.3 8.1 1.6 6.4 10.2 10.0 0.0 2.4 0.3 1.2 17.7 1.7 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 9.4 9.6 14.5 8.2 8.5 9.6 9.5 6.9 8.5 8.1 10.0 8.5 0.7 0.0 0.5 25.8 0.0 0.4 0.0 0.0 0.0 11.6 0.2 1.3 75.3 0.0 0.0 0.0 70.9 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.1 0.0 0.0 0.2 0.0 0.1 30.8 0.0 0.0 0.0 6.7 10.8 0.1 0.3 0.0 0.2 0.0 0.0 1.2 0.7 4.9 81.4 0.5 0.0 1.9 0.0 30.8 0.0 0.5 0.1 0.0 0.0 73.4 0.0 1.3 0.0 0.0 0.0 32.1 263.0 0.5 63.1 0.6 0.7 0.0 0.4 0.3 0.1 0.0 0.0 0.1 UBR4 "KIAA0462, KIAA1307, RBAF600, ZUBR1" ENSG00000127481 "Ubiquitin protein ligase E3 component n-recognin 4" Q5T4S7 1 19074510-19210266 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" "Calmodulin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 271.0;Suprabasal keratinocytes: 252.9;Urothelial cells: 236.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 39.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013394, HPA021046" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA 15000 Nucleoplasm "Centrosome, Cytosol" "HPA013394: , HPA021046: AB_1858578" "unprognostic (1.37e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" "unprognostic (2.02e-1)" "unprognostic (8.78e-2)" "unprognostic (9.77e-2)" "unprognostic (1.14e-3)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (9.14e-3)" "unprognostic (7.48e-2)" "unprognostic (2.53e-1)" "unprognostic (7.68e-3)" "unprognostic (4.30e-1)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.52e-1)" 54.0 63.3 44.5 23.2 44.7 80.5 50.2 36.7 47.0 56.3 45.8 63.4 21.1 62.2 36.0 55.9 52.8 29.9 55.1 43.9 44.4 74.9 83.4 72.6 25.9 49.1 44.3 45.6 75.9 53.9 35.8 71.3 27.7 48.6 67.7 22.9 44.9 48.4 27.3 130.2 154.9 60.2 26.3 34.5 63.3 71.2 106.1 44.2 34.9 57.0 45.4 25.9 90.7 59.7 48.1 61.4 60.7 53.5 39.7 97.6 50.0 46.2 46.5 48.8 49.5 44.7 97.2 51.3 36.6 42.3 61.7 43.3 40.8 42.3 46.3 46.0 30.6 37.5 83.8 63.3 64.1 68.6 51.9 53.4 45.0 57.9 100.8 96.3 48.1 54.9 63.7 58.5 32.9 47.6 43.6 24.7 62.9 43.5 124.3 33.6 34.0 41.7 31.0 44.7 35.2 37.7 37.4 55.0 31.1 39.9 48.6 21.7 40.4 85.9 57.4 36.1 69.0 52.8 38.8 25.2 41.5 39.3 79.3 50.3 39.8 28.7 4.7 4.9 5.9 4.2 7.4 4.4 2.9 14.2 4.0 3.9 3.7 15.4 4.4 2.1 6.5 3.4 8.3 44.5 44.7 36.7 47.0 43.9 44.4 49.1 44.3 45.6 48.6 34.5 44.2 48.1 28.1 35.3 37.6 85.5 30.3 271.0 124.6 28.9 28.5 57.5 22.1 23.9 19.1 37.1 30.4 31.3 152.2 24.7 34.2 31.6 13.7 41.3 21.4 39.8 32.0 30.8 17.5 48.4 58.9 40.9 17.0 32.2 44.9 50.4 19.6 32.9 31.1 94.1 63.2 79.1 61.8 29.2 12.2 43.0 48.7 28.7 30.7 46.4 49.8 34.7 64.4 28.8 21.6 51.8 44.5 61.0 16.7 35.7 26.4 59.1 57.9 135.6 39.1 48.5 19.7 28.3 30.1 44.8 21.0 28.0 252.9 33.9 32.7 34.5 20.1 236.5 HP1BP3 HP1-BP74 ENSG00000127483 "Heterochromatin protein 1 binding protein 3" Q5SSJ5 1 20740266-20787323 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028215, HPA054295" Supported Supported "Nuclear speckles" NA Yes 30000 "Nuclear speckles" "HPA028215: AB_10601021, HPA054295: AB_2682440" "unprognostic (3.90e-3)" "unprognostic (6.83e-2)" "unprognostic (7.69e-2)" "unprognostic (3.66e-2)" "unprognostic (1.31e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.97e-1)" "unprognostic (3.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.94e-2)" "unprognostic (9.50e-2)" "unprognostic (6.86e-2)" "unprognostic (1.65e-1)" "unprognostic (6.30e-2)" "unprognostic (1.27e-1)" "unprognostic (2.43e-2)" 88.2 79.6 66.6 76.9 80.8 143.0 80.8 74.8 77.9 136.9 68.1 100.2 71.9 117.6 63.5 95.6 97.6 76.0 76.4 68.7 74.9 84.3 67.0 84.8 92.2 72.2 68.0 68.1 136.7 75.0 98.9 61.3 86.6 70.0 82.0 89.0 97.3 83.8 75.0 114.9 87.5 94.6 101.2 68.5 90.0 83.8 55.0 71.9 135.8 107.2 79.4 91.0 94.7 115.2 112.1 207.3 106.1 261.6 157.5 152.3 172.8 157.3 230.2 182.4 156.7 163.1 97.6 232.0 208.2 113.4 176.6 108.4 171.9 136.7 125.5 199.8 306.5 124.7 296.2 230.5 85.4 98.1 209.7 181.7 135.1 90.6 159.0 208.5 193.0 160.5 245.1 169.9 251.8 180.1 64.2 323.5 93.0 69.3 152.6 126.3 250.4 255.0 219.2 113.6 66.6 175.0 180.0 279.8 112.9 181.2 132.9 117.3 138.7 196.4 176.2 164.2 180.7 139.2 144.0 194.2 246.7 150.2 213.0 204.0 102.4 55.3 202.6 57.1 45.0 59.7 70.8 61.9 62.1 52.2 58.4 80.4 54.5 66.1 63.3 54.9 59.5 71.6 49.0 66.6 80.8 74.8 77.9 68.7 74.9 72.2 68.0 68.1 70.0 68.5 71.9 112.1 129.4 150.6 156.2 96.9 112.1 130.4 137.4 81.6 159.9 117.8 116.6 108.7 161.4 94.4 94.5 104.8 54.2 87.6 144.7 105.6 154.6 87.0 40.8 85.3 184.6 136.8 103.7 214.6 98.3 93.4 70.7 161.9 98.8 128.2 137.8 131.8 129.2 101.0 72.6 80.8 93.7 113.4 83.4 100.7 104.1 22.3 172.7 116.9 113.8 130.2 111.2 119.5 127.7 142.7 189.9 113.0 90.1 162.5 162.0 124.6 91.7 110.7 54.6 97.6 157.8 145.2 148.3 141.3 110.1 201.8 134.5 92.9 151.9 116.2 115.3 118.4 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732392-14778560 "CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.5" "Group enriched" "Detected in many" 4 "granulocytes: 47.9;Kupffer cells: 69.4;Macrophages: 73.2;monocytes: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 70.0;eosinophil: 74.7;intermediate monocyte: 46.9;neutrophil: 55.7;non-classical monocyte: 89.9" "Group enriched" "Detected in many" 9 "granulocytes: 74.7;monocytes: 89.9" "Cell line enhanced" "Detected in many" "HEL: 11.8;HMC-1: 18.3;NB-4: 11.5;RPMI-8226: 8.4;U-937: 14.9" "Low region specificity" "Detected in many" HPA055200 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 4.9 1.5 0.9 19.5 1.3 7.0 1.8 1.1 1.7 0.9 1.3 1.4 1.9 0.7 0.7 0.9 0.9 2.5 0.4 0.8 2.0 1.2 2.0 4.2 3.0 2.3 1.3 0.7 0.1 0.8 1.2 0.5 1.6 2.0 1.1 1.9 0.6 1.0 2.8 0.6 2.1 2.3 1.6 1.0 15.8 1.5 0.4 1.6 2.4 0.6 1.0 2.3 5.4 0.9 2.0 0.3 1.2 0.1 0.2 0.0 0.3 1.2 0.9 1.3 0.0 0.0 0.2 0.2 0.1 0.1 0.7 2.3 1.9 0.3 0.1 0.0 0.2 0.2 11.8 3.8 0.2 0.5 4.3 18.3 0.9 1.6 4.1 0.6 0.1 0.1 1.0 2.7 0.4 1.3 0.5 1.5 11.5 0.4 0.8 0.2 0.1 1.5 8.4 0.0 0.3 0.0 0.2 2.4 2.0 0.4 0.2 0.3 5.4 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.2 1.1 14.9 0.6 70.0 13.9 74.7 0.2 46.9 0.2 0.2 0.2 0.1 9.3 0.3 0.1 0.2 55.7 3.3 89.9 1.9 0.1 7.3 0.9 1.3 1.1 1.7 0.8 2.0 2.3 1.3 0.7 2.0 1.0 1.6 2.0 0.6 3.2 7.7 0.7 1.9 0.0 4.8 0.0 0.6 0.8 1.6 1.5 0.8 0.0 2.5 0.0 0.0 0.2 12.8 0.0 0.0 0.0 2.0 0.7 3.5 1.8 1.2 3.8 0.9 0.0 0.5 1.9 1.1 0.9 47.9 0.1 0.7 0.5 12.8 0.0 1.2 0.1 0.0 69.4 0.0 2.5 0.0 73.2 0.0 0.0 49.2 0.0 2.1 0.5 12.0 0.0 0.2 0.4 2.1 2.4 0.1 0.1 2.2 0.9 0.0 2.0 1.5 0.3 0.5 0.6 0.0 0.4 3.0 0.1 0.1 3.0 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829398-16880353 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050329: AB_2681089" "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favorable (4.37e-4)" "prognostic unfavorable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 36.4 31.9 21.9 21.9 25.8 12.7 42.4 6.3 33.6 55.4 8.7 32.7 15.1 59.8 24.3 26.1 50.3 20.6 26.5 28.1 20.9 31.6 20.0 44.0 27.0 18.2 19.2 28.3 58.5 25.7 38.1 32.6 29.2 19.1 44.3 12.5 10.1 31.1 35.5 24.9 32.5 36.7 30.8 6.7 43.3 27.4 52.1 19.6 13.3 43.1 15.0 18.2 34.3 44.1 21.7 28.1 14.7 24.4 31.5 19.7 18.1 76.8 23.3 19.2 31.6 27.9 36.4 25.7 25.0 25.5 27.2 26.7 23.6 20.4 20.9 29.1 26.2 36.8 27.0 35.6 16.7 25.9 15.8 20.8 29.9 26.9 21.3 18.2 25.1 29.1 19.7 22.2 15.0 22.4 33.7 21.7 25.5 30.4 14.6 46.6 28.4 22.4 16.6 18.0 23.5 18.0 22.5 29.6 22.5 18.4 32.5 15.9 14.7 38.6 30.5 18.5 44.6 26.5 21.3 16.8 25.0 21.1 20.6 23.1 0.1 4.2 3.9 1.0 3.8 0.6 3.5 0.9 1.1 1.3 2.7 1.1 0.8 2.0 1.2 3.4 1.5 0.3 1.5 21.9 25.8 6.3 33.6 28.1 20.9 18.2 19.2 28.3 19.1 6.7 19.6 21.7 45.4 22.4 11.9 30.7 18.9 7.9 11.6 7.4 14.2 20.3 14.4 18.4 8.3 1.5 8.6 3.7 14.6 21.9 9.5 7.0 3.9 10.6 11.4 16.3 34.6 18.8 4.9 6.9 29.9 8.6 29.2 16.0 13.7 36.2 5.1 29.9 10.8 7.0 17.6 10.1 29.8 8.4 0.0 14.6 5.5 24.2 50.7 13.9 5.4 19.7 14.6 8.0 10.3 21.6 26.3 14.5 4.0 66.5 22.0 14.2 4.2 7.5 6.9 14.5 6.6 17.5 13.7 9.7 9.2 14.4 8.1 124.9 11.7 34.5 7.3 17.9 OR7A10 ENSG00000127515 "Olfactory receptor family 7 subfamily A member 10" O76100 19 14840466-14848922 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572415 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: AB_2684713" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 10.8 9.9 5.7 5.7 4.8 8.0 9.7 3.6 6.5 9.6 5.2 9.1 6.6 8.6 5.9 11.6 7.5 6.2 10.0 5.2 4.6 7.8 11.5 9.2 7.2 4.5 5.6 5.1 8.8 22.5 15.3 11.3 7.2 5.6 11.8 6.2 7.4 15.6 10.1 20.6 11.5 7.8 6.8 3.0 6.8 15.4 4.1 8.7 8.6 9.3 14.1 8.2 10.1 8.8 4.4 26.2 10.4 6.9 16.2 25.2 19.8 16.4 17.8 20.3 15.1 18.2 11.8 18.7 13.6 30.2 29.3 14.9 17.6 19.7 21.5 15.2 15.8 29.5 11.9 11.6 14.4 21.1 19.6 14.5 16.5 24.2 17.0 24.5 19.2 14.8 16.0 19.9 17.3 19.4 25.3 15.3 9.3 8.1 24.8 34.6 14.9 10.6 16.6 15.7 16.1 11.9 11.9 12.3 19.6 11.5 8.3 14.7 9.9 15.3 19.5 9.6 26.9 21.2 23.6 26.9 15.1 29.3 21.4 12.6 1.8 1.3 3.2 1.3 0.9 1.8 2.2 1.4 1.3 1.0 0.8 1.0 0.8 1.3 1.8 2.0 1.1 1.8 1.1 5.7 4.8 3.6 6.5 5.2 4.6 4.5 5.6 5.1 5.6 3.0 8.7 4.4 21.7 38.5 42.5 6.8 14.9 21.9 15.3 22.1 5.7 28.8 34.1 21.5 16.1 22.8 31.3 29.5 35.5 14.4 43.3 25.2 0.0 20.4 3.6 26.6 20.1 20.2 18.5 13.7 13.9 36.8 29.8 14.8 13.3 50.8 8.2 21.2 22.9 26.9 17.4 30.3 13.9 29.7 8.2 21.1 28.0 4.2 17.1 23.3 8.8 10.3 22.8 19.4 17.5 9.0 6.2 41.7 13.1 21.1 29.3 30.9 22.1 7.0 24.0 29.4 6.6 30.1 14.3 10.2 14.3 13.6 25.9 32.6 29.4 16.2 20.4 28.4 EPS15L1 eps15R ENSG00000127527 "Epidermal growth factor receptor pathway substrate 15 like 1" Q9UBC2 19 16355239-16472085 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019237, HPA055309" Approved Approved Vesicles NA NA 110000 Vesicles "HPA019237: AB_1848223, HPA055309: AB_2682780" "unprognostic (3.06e-2)" "unprognostic (3.33e-3)" "unprognostic (2.19e-1)" "unprognostic (6.45e-3)" "unprognostic (1.35e-1)" "unprognostic (8.64e-2)" "unprognostic (2.58e-3)" "unprognostic (5.12e-2)" "unprognostic (1.07e-3)" "unprognostic (7.54e-2)" "unprognostic (5.21e-2)" "unprognostic (1.81e-2)" "prognostic favorable (8.10e-5)" "unprognostic (2.47e-1)" "unprognostic (9.59e-2)" "unprognostic (2.14e-1)" "unprognostic (3.32e-1)" 15.3 17.8 30.7 11.9 29.2 23.9 14.4 33.8 40.8 20.3 18.8 16.0 8.3 18.3 6.0 25.4 18.8 9.7 40.0 32.6 25.8 20.4 18.1 14.8 14.0 26.5 30.7 24.7 19.3 15.6 18.3 22.8 14.1 28.8 19.7 9.3 14.1 15.0 13.0 68.2 23.2 14.4 14.2 21.2 19.9 17.0 23.1 39.3 11.9 17.7 25.9 13.1 17.8 19.8 25.3 27.3 12.8 25.8 20.4 27.4 21.1 40.3 17.8 14.9 28.8 25.1 15.3 18.2 29.2 30.4 26.1 22.8 26.6 36.3 20.8 25.1 15.8 36.8 24.7 17.4 29.8 27.7 22.8 26.7 17.6 21.1 31.9 22.3 28.6 23.6 24.5 20.1 31.2 24.5 53.9 25.4 32.5 17.7 36.4 41.7 32.2 12.5 24.3 19.8 27.9 23.3 15.3 18.6 17.5 17.7 19.2 58.3 21.3 24.5 18.2 12.2 57.3 31.4 8.8 19.4 27.7 20.2 31.9 24.5 53.5 11.9 35.9 11.1 12.0 10.5 20.8 9.8 12.0 9.2 19.3 10.1 7.8 56.2 19.1 14.4 8.6 10.7 9.0 30.7 29.2 33.8 40.8 32.6 25.8 26.5 30.7 24.7 28.8 21.2 39.3 25.3 10.8 9.6 9.8 62.3 22.1 16.6 14.0 12.0 12.0 30.7 9.5 8.1 20.4 7.2 10.9 9.2 50.1 21.7 30.8 11.7 9.8 11.0 74.9 10.7 13.0 11.8 11.3 13.9 49.7 5.7 19.7 16.0 16.3 12.1 12.0 22.3 11.0 8.2 20.0 11.8 63.4 10.7 24.4 10.6 14.8 15.1 18.6 13.8 3.6 30.9 13.0 9.9 34.0 36.2 35.6 9.3 9.1 20.3 18.7 15.0 9.0 12.9 14.7 25.9 19.7 20.3 13.9 18.5 16.7 22.3 24.4 10.9 15.8 18.7 9.8 22.2 KLF2 LKLF ENSG00000127528 "Kruppel like factor 2" Q9Y5W3 19 16324826-16328685 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 1043.3;B-cells: 691.8;dendritic cells: 542.9;Endothelial cells: 511.8;Gastric mucus-secreting cells: 561.7;NK-cells: 466.5;Plasma cells: 806.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.8;TIME: 67.8;U-266/70: 45.6;U-266/84: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055964 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055964: AB_2682989" "unprognostic (3.22e-3)" "unprognostic (1.89e-2)" "unprognostic (3.13e-2)" "unprognostic (1.72e-3)" "unprognostic (1.04e-1)" "unprognostic (7.91e-3)" "prognostic favorable (8.55e-4)" "unprognostic (1.74e-1)" "unprognostic (3.09e-2)" "unprognostic (4.28e-2)" "unprognostic (4.90e-1)" "unprognostic (1.52e-1)" "unprognostic (9.76e-3)" "unprognostic (7.80e-2)" "unprognostic (1.76e-1)" "unprognostic (3.50e-1)" "unprognostic (7.56e-2)" 145.5 27.4 27.6 62.1 19.0 90.7 109.3 14.1 18.6 50.1 18.1 49.2 9.6 62.0 2.5 32.4 106.9 14.8 98.5 12.5 17.3 41.6 13.5 111.8 45.8 26.9 19.1 5.9 153.9 12.6 5.7 29.1 22.6 27.7 42.2 5.1 0.6 36.0 6.9 52.5 61.4 45.0 19.7 11.9 71.4 73.7 18.4 25.3 13.1 53.9 20.7 8.3 87.7 64.3 26.5 7.5 1.8 0.1 1.6 0.4 1.0 2.9 16.6 1.8 5.5 1.8 0.1 24.0 0.7 3.7 6.7 0.9 2.5 0.5 0.0 1.5 0.6 2.0 0.0 1.4 0.2 4.2 0.0 12.1 1.2 0.2 1.4 0.3 7.1 10.9 14.7 0.5 15.4 2.4 0.4 1.5 3.2 0.2 7.3 2.2 0.5 4.3 26.8 0.2 0.3 0.5 0.2 0.9 12.3 10.4 0.1 0.5 8.6 67.8 12.9 9.4 1.0 23.8 45.6 49.3 1.6 5.7 0.0 5.8 63.2 8.3 25.1 42.7 32.9 34.9 44.7 56.6 43.9 3.3 47.5 53.5 44.4 79.5 28.7 29.1 0.6 59.4 20.5 27.6 19.0 14.1 18.6 12.5 17.3 26.9 19.1 5.9 27.7 11.9 25.3 26.5 1043.3 35.3 60.0 1.0 691.8 23.8 25.9 7.4 30.1 5.8 69.6 51.8 47.9 31.5 9.0 3.7 8.4 4.5 542.9 151.7 0.0 10.3 2.3 53.8 31.1 511.8 46.4 35.0 0.8 6.0 7.6 350.6 561.7 20.4 33.6 8.1 393.3 10.6 91.3 0.0 1.9 110.5 2.0 242.4 58.5 6.3 89.5 272.9 64.0 48.7 74.1 7.6 466.5 0.5 0.3 64.3 61.3 73.0 806.5 10.7 4.8 1.9 18.2 8.8 65.7 460.9 235.3 0.8 2.9 22.1 26.3 6.6 417.8 57.9 33.7 12.9 OR7C2 "OR19-18, OR7C3" ENSG00000127529 "Olfactory receptor family 7 subfamily C member 2" O60412 19 14941489-14942448 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047295 Uncertain NA NA "HPA047295: AB_2680013" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7C1 "OR19-5, OR7C4" ENSG00000127530 "Olfactory receptor family 7 subfamily C member 1" O76099 19 14789260-14835376 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 6.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.2;Club cells: 2.5;Glandular and luminal cells: 1.4;granulocytes: 1.3;Melanocytes: 1.8;Respiratory ciliated cells: 1.5" "Cancer enriched" "Detected in single" 9 "melanoma: 1.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA047127 Uncertain NA NA "HPA047127: AB_2679944" "unprognostic (7.68e-4)" "unprognostic (1.31e-1)" "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.39e-1)" "unprognostic (4.30e-2)" "unprognostic (6.11e-4)" "unprognostic (1.90e-1)" "unprognostic (6.80e-2)" "unprognostic (6.91e-2)" 0.1 0.7 0.4 0.2 0.4 0.6 0.4 0.7 0.7 0.1 0.1 0.0 0.2 0.1 1.8 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.4 0.4 0.3 0.1 0.1 6.0 1.7 0.1 0.5 0.8 0.0 0.5 0.2 0.8 1.3 0.8 0.1 0.0 0.0 0.2 0.1 1.9 0.3 0.1 0.2 0.0 0.1 0.0 0.2 0.9 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.3 0.3 0.6 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 1.6 0.1 0.5 0.1 0.0 0.1 0.4 0.4 0.7 0.7 0.3 0.2 0.4 0.4 0.3 0.5 0.0 0.3 0.9 0.1 0.0 3.2 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.1 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888999-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.5;lung: 33.7;thyroid gland: 19.4" "Cell type enriched" "Detected in some" 4 "Adipocytes: 110.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 30.7;HMC-1: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favorable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 18.5 2.6 0.7 1.5 0.8 1.3 18.1 1.6 0.9 1.1 1.1 3.3 1.6 1.6 1.6 1.5 1.5 2.8 3.9 0.7 0.5 9.7 0.5 33.7 2.3 0.5 0.5 0.6 0.8 9.4 1.1 2.7 1.1 1.0 1.4 1.3 1.3 1.3 0.5 3.2 2.7 4.9 1.0 0.0 1.3 5.1 1.7 1.0 0.4 19.4 0.6 0.9 2.0 1.3 1.4 0.3 0.3 0.8 0.4 0.1 0.2 0.9 0.4 0.1 0.2 0.2 0.5 0.8 0.6 0.6 0.3 0.3 0.6 0.2 0.3 0.3 0.4 0.4 30.7 1.3 0.5 0.2 0.3 11.6 0.0 0.1 0.3 0.2 0.4 0.9 0.6 2.5 1.1 0.2 0.5 0.4 2.9 0.4 0.4 0.3 0.3 0.2 1.0 0.3 0.6 0.5 0.3 0.3 0.2 0.1 0.7 0.6 2.0 1.2 0.6 0.6 0.4 0.3 0.5 0.4 0.6 0.3 0.5 0.4 3.3 0.9 0.7 0.9 0.4 0.8 1.6 1.0 0.8 0.3 1.8 1.4 1.3 2.2 1.8 0.6 1.7 0.8 1.4 0.7 0.8 1.6 0.9 0.7 0.5 0.5 0.5 0.6 1.0 0.0 1.0 1.4 110.4 0.0 1.1 0.0 0.3 0.4 0.3 0.3 0.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.9 27.5 0.0 0.8 0.0 0.5 0.0 2.7 0.0 0.2 7.0 0.3 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.0 0.4 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.0 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.4 0.5 0.1 0.3 0.2 0.3 UQCR11 "QCR10, UQCR" ENSG00000127540 "Ubiquinol-cytochrome c reductase, complex III subunit XI" O14957 19 1597169-1605473 "Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 314.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1792.1;Hepatocytes: 2200.3;Proximal enterocytes: 2007.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.90e-1)" "unprognostic (6.67e-3)" "unprognostic (1.78e-1)" "prognostic favorable (1.23e-4)" "unprognostic (5.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (5.42e-3)" "unprognostic (9.10e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.86e-4)" "unprognostic (1.03e-1)" "prognostic favorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (1.06e-2)" 64.1 80.9 62.3 20.8 65.7 40.1 61.0 65.4 104.5 45.6 62.8 88.6 60.3 46.8 18.6 72.2 44.0 25.2 266.9 62.4 63.3 104.0 137.5 49.1 27.7 63.5 64.5 60.6 35.8 49.9 47.2 63.2 24.3 64.0 62.5 23.1 13.9 54.3 31.2 314.8 49.6 63.1 22.8 62.5 61.4 77.8 24.8 69.4 24.3 53.1 110.6 19.5 61.4 51.9 65.7 68.9 75.7 34.7 74.5 60.8 40.7 79.9 54.3 45.4 55.5 48.8 121.5 47.3 47.4 51.8 41.8 12.3 46.8 55.5 61.0 26.5 65.0 163.1 40.6 87.3 114.0 60.6 66.1 57.9 62.8 62.6 35.2 41.6 28.6 50.8 66.9 94.8 73.1 36.2 111.5 67.7 72.4 94.8 59.2 176.0 40.4 36.2 148.9 74.6 158.4 69.6 65.9 39.3 86.4 99.7 27.9 59.3 65.1 66.7 44.3 30.0 129.9 57.7 110.4 101.2 54.4 82.6 69.9 64.8 619.6 421.3 521.9 282.7 367.9 287.1 390.0 341.7 316.6 360.5 333.8 324.3 314.1 496.7 273.7 354.9 448.4 407.7 872.4 62.3 65.7 65.4 104.5 62.4 63.3 63.5 64.5 60.6 64.0 62.5 69.4 65.7 300.4 269.2 379.1 20.5 287.6 0.0 189.6 0.0 206.6 135.2 715.6 798.8 1731.6 529.0 159.7 634.5 39.6 481.8 380.1 834.6 1792.1 665.4 178.2 290.5 220.2 282.4 452.6 451.6 17.8 811.6 632.1 262.0 342.0 243.5 199.3 152.6 463.3 2200.3 962.9 89.2 17.6 681.7 0.0 783.5 0.0 474.8 252.8 472.2 0.0 10.3 866.6 418.8 568.5 9.5 25.1 855.3 727.0 259.5 384.1 365.5 2007.4 1742.3 267.5 164.4 223.5 192.6 291.3 159.2 145.3 520.3 0.0 512.8 304.3 188.0 717.0 290.3 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984193-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 183.7;Early spermatids: 168.7;Proximal enterocytes: 371.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Secreted to blood" NA NA "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: AB_2685038" "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favorable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 17.3 21.4 19.5 13.9 18.5 18.3 17.9 21.0 23.3 13.9 17.2 31.8 43.1 16.8 6.7 17.6 16.1 13.6 25.8 18.7 19.5 22.0 46.3 15.4 21.0 21.0 19.9 17.9 11.3 54.2 29.8 18.2 12.3 20.5 19.8 25.6 7.8 29.1 13.3 41.3 14.6 45.6 11.0 18.5 22.1 24.9 38.8 21.1 10.6 16.0 30.6 17.1 19.6 12.9 21.2 27.2 44.1 35.6 29.2 14.7 28.9 43.5 28.6 31.2 44.2 35.6 63.7 46.1 15.2 39.7 24.2 25.7 39.8 27.3 42.4 27.9 44.7 46.6 20.9 44.3 73.4 26.6 32.1 37.9 18.9 32.5 38.8 34.6 27.8 21.1 32.7 33.0 51.3 32.6 66.1 34.9 33.9 54.9 23.9 39.7 74.5 26.8 50.7 45.5 21.9 30.5 28.9 39.3 91.2 34.5 18.2 43.4 33.6 19.1 42.8 45.0 24.0 54.3 79.1 48.3 45.7 14.2 21.5 36.7 3.8 16.2 13.4 11.2 13.9 11.4 23.5 14.9 18.5 11.6 17.8 13.6 9.5 1.4 10.7 17.4 5.1 24.9 10.6 19.5 18.5 21.0 23.3 18.7 19.5 21.0 19.9 17.9 20.5 18.5 21.1 21.2 18.0 3.2 6.7 2.3 32.5 15.9 19.9 21.1 17.6 10.8 32.7 27.6 17.4 27.1 16.6 9.2 0.0 43.4 23.0 183.7 35.2 44.0 168.7 24.0 11.4 17.9 27.2 17.0 3.4 80.8 57.8 17.7 16.8 18.7 12.7 22.8 20.7 59.1 45.9 8.4 3.2 60.3 26.4 39.3 24.8 123.7 17.4 24.7 23.2 1.0 39.6 12.6 39.1 1.5 3.3 57.3 100.3 12.4 39.6 21.7 371.7 84.6 33.3 11.5 13.1 15.8 18.5 41.9 26.7 17.3 14.8 37.5 27.4 26.7 68.7 26.0 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.2;Inhibitory neurons: 33.7;Spermatogonia: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.9;NK-cells: 2.0;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HDLM-2: 49.9;HMC-1: 30.3;Karpas-707: 25.8;SK-BR-3: 32.1;U-266/70: 40.2" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB034278: AB_2200905, HPA042842: AB_2678198" "unprognostic (8.89e-3)" "prognostic favorable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favorable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 0.2 9.5 68.8 2.9 89.2 0.9 0.3 36.5 107.4 0.5 13.6 4.5 1.3 0.2 0.0 0.5 0.4 0.4 0.8 78.4 83.4 3.5 0.3 1.0 3.3 85.5 102.2 99.8 0.6 0.8 7.4 12.4 1.7 104.3 0.8 1.1 9.6 1.2 0.1 0.1 0.6 5.9 0.7 33.1 2.5 2.3 5.6 126.1 0.5 0.4 0.0 3.8 0.4 1.3 148.5 0.9 4.0 3.7 0.5 0.4 0.4 4.5 1.9 3.1 1.5 1.2 6.3 2.9 6.2 1.4 1.4 4.1 3.5 4.1 0.5 0.4 49.9 2.9 0.1 5.9 3.1 2.1 0.0 30.3 0.9 0.2 0.1 1.0 7.2 0.4 1.9 17.9 25.8 0.7 4.7 0.3 0.3 19.0 0.7 1.8 0.0 0.5 4.9 2.4 0.1 8.6 10.7 4.4 32.1 0.4 2.0 4.5 0.4 0.7 0.9 14.5 0.1 0.7 40.2 5.0 7.2 0.6 5.5 0.6 0.0 0.3 0.0 0.3 0.1 0.8 1.2 0.6 1.1 0.3 1.9 0.7 0.3 0.0 2.0 0.3 0.0 0.6 0.4 68.8 89.2 36.5 107.4 78.4 83.4 85.5 102.2 99.8 104.3 33.1 126.1 148.5 0.1 0.0 0.6 3.3 5.0 0.3 0.8 0.6 1.2 5.0 0.2 0.3 5.4 0.0 0.6 0.0 2.1 0.5 2.1 0.9 1.9 2.0 0.8 0.0 0.1 0.5 0.0 0.0 24.2 0.5 0.8 1.2 0.5 0.1 1.3 1.4 0.0 0.0 0.3 6.7 33.7 0.5 0.0 0.6 0.4 0.5 0.0 0.5 0.0 1.9 2.7 1.1 2.1 2.5 3.5 1.2 0.0 0.0 2.3 5.5 0.1 0.1 0.9 2.1 0.0 0.1 0.3 3.0 8.6 0.4 0.3 3.1 2.9 0.4 0.3 1.7 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980479 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.9;testis: 57.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "T-reg: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 1.1 1.0 0.8 6.8 0.6 27.9 0.6 1.4 1.4 1.2 0.2 4.0 2.8 0.6 0.4 11.6 0.4 0.6 0.7 0.5 0.3 0.9 1.6 2.0 8.1 0.7 0.6 0.2 0.3 1.8 0.1 1.0 3.1 0.8 1.1 1.3 17.6 2.0 0.1 2.4 4.5 4.0 1.0 0.5 5.6 3.3 57.3 0.9 9.7 0.5 0.0 4.6 0.7 3.4 0.8 84.2 57.0 22.0 31.2 0.3 0.9 64.0 65.5 15.1 40.0 38.4 45.0 49.3 54.2 29.2 7.9 24.2 106.7 15.7 20.7 7.2 71.7 56.7 27.9 52.7 40.0 0.0 31.2 73.6 0.7 1.8 24.0 6.5 5.0 8.4 57.6 80.6 87.0 13.5 127.5 83.6 88.0 37.9 39.3 34.4 93.7 51.2 100.7 7.8 17.7 42.6 46.7 31.9 77.7 23.9 12.1 44.7 56.9 7.7 53.2 69.7 77.3 68.0 67.6 54.2 94.0 19.4 40.0 61.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.3 0.8 0.6 1.4 1.4 0.5 0.3 0.7 0.6 0.2 0.8 0.5 0.9 0.8 0.0 0.0 1.1 0.0 1.9 2.5 1.3 2.1 0.6 0.4 1.5 1.3 0.6 1.5 1.6 1.8 6.2 16.0 1.3 5.0 0.0 0.8 20.0 0.6 0.8 0.8 1.8 29.0 0.4 0.6 52.0 2.5 3.1 1.9 0.0 4.5 0.0 0.4 11.8 0.0 0.2 3.6 6.1 2.1 1.8 8.6 0.3 1.9 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.6 0.3 0.4 22.9 0.7 0.3 0.1 0.2 7.1 0.0 0.1 2.6 114.7 46.1 11.2 0.6 7.4 4.2 0.5 8.6 2.0 WFIKKN1 "C16orf12, RJD2, WFDC20A, WFIKKN" ENSG00000127578 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1" Q96NZ8 16 629239-634117 "Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Astrocytes: 4.9;Horizontal cells: 10.1;Melanocytes: 3.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.4;Hep G2: 1.0;NTERA-2: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA "unprognostic (3.12e-1)" "unprognostic (2.57e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-2)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (3.36e-2)" "unprognostic (4.45e-2)" "unprognostic (8.53e-2)" "unprognostic (2.43e-1)" "unprognostic (3.78e-3)" "unprognostic (1.19e-1)" "unprognostic (5.56e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (2.50e-3)" "unprognostic (4.70e-5)" 0.1 0.1 0.1 0.0 0.2 0.0 0.1 1.3 0.8 0.4 0.0 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.2 0.3 0.0 1.4 0.8 0.4 0.0 0.2 0.0 0.2 0.6 1.1 0.0 1.2 0.0 0.7 0.8 0.0 0.0 0.3 0.0 0.5 0.9 0.3 0.0 0.0 0.6 0.5 1.0 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.8 0.3 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.3 0.4 0.0 0.5 4.9 0.1 0.9 0.2 0.5 0.6 2.9 0.7 0.8 0.8 0.0 0.3 0.0 0.0 0.2 0.2 2.2 0.0 0.0 0.1 1.3 1.9 0.9 1.2 0.0 1.4 0.2 0.1 0.3 0.0 1.8 1.3 1.4 0.7 0.9 0.1 10.1 0.5 1.4 0.0 0.6 0.0 0.1 0.0 0.2 3.6 1.0 0.0 1.1 0.0 1.0 1.1 0.7 2.4 0.7 0.0 0.7 2.1 0.4 1.4 0.1 0.0 0.7 0.4 1.6 0.7 1.4 1.6 0.3 0.2 0.3 1.4 0.3 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 5.8 9.1 3.2 4.1 2.9 4.0 6.3 4.2 6.9 7.4 2.8 6.6 4.8 8.0 1.0 7.2 7.6 2.8 7.0 3.1 2.4 7.4 11.3 6.0 4.9 3.4 3.2 3.1 9.3 7.3 5.8 9.5 3.2 3.3 8.6 1.2 1.8 7.0 3.0 11.8 8.4 7.2 2.0 2.4 9.3 7.9 14.3 2.8 4.4 8.8 4.2 2.4 7.6 6.7 3.1 6.1 14.0 6.2 8.6 5.9 4.2 10.9 7.5 6.7 9.2 8.0 15.3 8.8 9.4 12.8 3.4 2.3 9.4 6.1 7.4 2.0 15.9 19.0 6.4 19.8 5.8 9.4 7.9 9.6 7.4 4.9 6.6 5.5 4.8 5.0 9.0 12.7 10.3 3.4 22.2 14.0 5.8 9.7 3.1 10.6 20.4 5.1 17.6 3.0 4.2 15.1 6.9 8.5 14.3 8.7 2.8 13.2 7.8 7.3 6.6 6.8 7.4 7.3 21.9 21.5 15.3 4.3 7.8 9.4 4.3 5.1 2.8 6.6 3.0 5.4 4.3 4.2 4.9 5.1 3.7 4.9 4.8 1.2 3.0 7.8 4.1 6.1 5.0 3.2 2.9 4.2 6.9 3.1 2.4 3.4 3.2 3.1 3.3 2.4 2.8 3.1 2.9 6.4 6.2 2.3 4.2 1.1 2.6 4.7 4.0 5.1 5.2 4.4 5.0 1.5 5.0 7.3 2.1 7.4 2.9 6.0 7.9 4.9 17.1 12.2 2.9 3.1 10.1 5.2 2.0 5.6 4.4 3.1 6.6 2.9 4.5 6.9 2.5 9.6 5.1 21.9 2.0 7.3 4.1 6.3 1.6 48.0 5.6 3.9 0.0 1.9 4.4 7.3 1.0 2.0 2.4 4.5 2.1 3.0 6.8 3.8 8.0 6.4 19.4 2.6 19.7 2.6 4.2 18.8 8.7 2.1 1.6 7.4 3.4 7.6 5.5 2.0 FBXL16 "C16orf22, Fbl16, MGC33974" ENSG00000127585 "F-box and leucine rich repeat protein 16" Q8N461 16 692498-705808 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 224.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 44.4;Excitatory neurons: 29.2;Horizontal cells: 32.0;Inhibitory neurons: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.4;GAMG: 12.3;MCF7: 15.5;SCLC-21H: 30.2;SH-SY5Y: 22.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 240.8;basal ganglia: 720.4;cerebral cortex: 384.6;hippocampal formation: 362.0" "HPA039504, HPA056354" Enhanced NA NA "HPA039504: AB_10794197, HPA056354: AB_2683105" "unprognostic (5.51e-2)" "unprognostic (3.39e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.58e-2)" "unprognostic (4.79e-3)" "unprognostic (1.83e-1)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.34e-5)" "unprognostic (1.62e-3)" "prognostic favorable (1.87e-4)" "unprognostic (1.90e-2)" "unprognostic (4.71e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-2)" 0.2 4.7 165.0 0.6 224.2 0.1 0.9 0.0 202.7 0.4 0.0 1.3 0.8 0.1 0.0 2.0 0.5 0.0 0.3 159.6 17.7 1.1 0.3 0.4 0.3 80.6 2.6 136.6 0.2 2.4 1.2 32.8 0.0 165.8 0.9 0.0 3.3 5.0 0.9 0.3 4.0 1.3 0.0 0.0 0.6 1.5 11.7 25.8 0.3 2.3 0.0 0.2 0.1 1.0 53.0 0.6 0.9 0.3 18.4 0.0 0.2 0.6 0.6 0.1 3.4 0.2 1.8 0.2 0.3 5.0 0.0 12.3 3.4 1.4 2.0 0.2 9.4 0.4 0.0 4.7 0.8 0.0 1.9 0.4 0.0 2.8 0.0 1.6 1.6 0.0 0.7 1.0 4.5 0.0 15.5 0.4 0.0 0.8 0.2 5.8 0.0 0.0 10.8 0.2 0.0 30.2 22.7 3.1 0.5 0.3 0.0 1.7 0.0 0.0 0.1 6.2 0.0 2.4 0.8 5.6 2.4 2.5 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 165.0 224.2 0.0 202.7 159.6 17.7 80.6 2.6 136.6 165.8 0.0 25.8 53.0 0.1 0.0 3.7 6.5 0.8 1.0 0.7 1.1 2.2 44.4 3.8 3.7 1.2 0.0 3.9 11.0 2.1 0.6 1.6 0.3 1.9 0.2 1.2 1.6 0.4 0.2 9.6 0.0 29.2 0.0 0.2 0.8 0.0 3.9 0.0 0.0 0.4 0.0 0.1 32.0 20.2 1.0 2.0 0.0 0.3 0.6 0.6 0.1 0.0 6.5 0.1 3.1 0.0 9.0 2.5 0.3 0.1 0.0 0.4 0.7 1.0 0.2 0.1 5.7 0.0 0.1 0.3 5.0 4.6 2.7 1.6 2.5 3.5 0.0 0.4 0.2 CHTF18 "C16orf41, C321D2.4, CHL12, Ctf18" ENSG00000127586 "Chromosome transmission fidelity factor 18" Q8WVB6 16 788046-800737 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.1;Extravillous trophoblasts: 19.6;Granulosa cells: 22.0;Spermatogonia: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 48.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA040976, HPA056209" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040976: AB_2677232, HPA056209: AB_2683066" "unprognostic (3.83e-2)" "unprognostic (4.97e-2)" "unprognostic (4.25e-2)" "unprognostic (9.35e-2)" "unprognostic (4.59e-2)" "unprognostic (3.02e-3)" "unprognostic (1.80e-3)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (4.00e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (1.43e-8)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.78e-4)" 2.5 2.2 0.6 1.2 0.4 6.9 3.3 0.5 1.5 4.2 0.0 2.7 1.9 3.2 0.0 5.1 3.2 0.6 1.7 0.5 0.4 2.5 2.4 2.8 1.4 0.5 0.3 0.5 4.9 2.9 0.1 2.5 1.2 0.5 3.4 0.3 0.3 2.7 0.6 2.0 3.9 4.0 0.3 0.0 5.8 3.0 11.8 0.4 1.8 3.2 0.3 0.3 3.1 3.7 0.3 14.4 7.0 5.5 4.5 0.5 0.4 48.3 8.9 2.4 4.4 3.0 12.5 10.8 16.1 8.9 1.5 2.3 15.7 1.2 6.8 0.0 9.2 20.1 7.1 8.6 6.4 0.0 4.4 13.4 0.2 0.8 4.2 2.2 0.6 3.7 16.4 10.9 5.2 1.1 27.7 17.4 16.6 7.2 3.3 8.3 31.1 14.0 21.2 1.5 4.1 7.2 9.2 6.4 14.1 4.8 0.6 10.3 10.8 2.4 6.5 23.5 11.8 12.2 12.3 4.3 9.1 2.0 6.5 11.5 2.5 0.2 0.0 0.7 1.0 0.4 0.1 0.3 0.6 0.4 0.2 0.4 0.1 0.1 0.7 0.6 0.2 0.4 0.2 0.6 0.4 0.5 1.5 0.5 0.4 0.5 0.3 0.5 0.5 0.0 0.4 0.3 4.3 3.2 4.2 2.6 3.5 5.4 3.3 2.7 5.7 23.1 4.1 5.5 4.6 0.0 3.0 1.8 2.1 15.2 4.3 7.1 1.9 2.9 1.2 4.2 4.9 2.4 6.6 14.3 2.3 3.9 19.6 3.9 10.2 8.8 4.5 22.0 3.3 2.4 6.4 6.7 1.8 5.3 0.0 2.6 5.8 1.3 1.8 2.9 0.0 2.8 0.3 2.4 2.1 1.5 2.8 1.8 1.0 1.5 5.7 1.4 0.9 1.0 2.5 7.0 0.0 3.2 3.5 13.6 21.2 4.5 2.0 8.6 3.4 5.0 7.4 3.2 GNG13 "G(gamma)13, h2-35" ENSG00000127588 "G protein subunit gamma 13" Q9P2W3 16 798041-800734 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 36 "brain: 46.4;retina: 56.3" "Cell type enriched" "Detected in some" 16 "Bipolar cells: 311.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebellum: 46.4;pons: 12.5;thalamus: 24.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 10.4;HEK 293: 9.0;HeLa: 6.5;MCF7: 12.9" "Region enhanced" "Detected in all" "cerebellum: 940.0" "Group enriched" "Detected in many" 6 "cerebellum: 37.7;olfactory bulb: 14.0" HPA046272 Enhanced NA NA "HPA046272: AB_10960062" "unprognostic (1.84e-1)" "unprognostic (2.75e-1)" "unprognostic (3.78e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-2)" "unprognostic (5.41e-2)" "unprognostic (8.47e-2)" "unprognostic (9.16e-3)" "unprognostic (4.04e-2)" "unprognostic (1.78e-1)" "unprognostic (6.77e-2)" "unprognostic (7.12e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" 0.0 0.0 3.1 0.1 0.6 0.2 0.0 46.4 4.6 0.0 0.0 0.7 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.0 0.0 0.1 0.9 6.5 0.1 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.1 56.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 24.0 0.6 0.0 0.0 0.1 0.0 0.0 4.9 0.2 3.6 0.5 1.1 0.0 0.0 0.8 1.0 0.0 0.0 0.0 10.4 0.3 1.1 0.3 0.0 0.1 1.6 0.0 0.0 0.0 1.2 9.0 1.3 6.5 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.8 0.0 12.9 1.3 0.7 1.2 0.1 1.0 2.8 2.8 0.6 0.0 1.5 0.9 0.8 0.9 0.3 0.2 0.3 0.7 0.1 0.0 1.3 1.2 1.7 0.3 0.4 2.5 4.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.6 46.4 4.6 0.7 1.9 0.9 6.5 0.1 12.5 0.0 24.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 311.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.5 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 MACF1 "ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF" ENSG00000127603 "Microtubule actin crosslinking factor 1" Q9UPN3 1 39081316-39487177 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" Actin-binding "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 1079.0;Cone photoreceptor cells: 779.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013713, HPA068064, HPA068103" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA 25000 "Plasma membrane, Cell Junctions, Actin filaments" "HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953" "unprognostic (2.71e-1)" "unprognostic (3.14e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (9.00e-2)" "unprognostic (6.19e-3)" "unprognostic (1.32e-1)" "unprognostic (7.40e-3)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.34e-1)" "unprognostic (3.98e-1)" "prognostic favorable (2.77e-5)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (8.57e-2)" "unprognostic (4.22e-2)" 67.2 63.0 177.4 27.9 193.9 36.5 55.1 177.8 183.1 65.4 127.4 114.4 18.8 131.4 49.1 46.8 92.8 46.8 127.8 164.7 163.1 79.8 64.3 185.2 36.2 194.3 183.4 150.3 93.4 51.6 97.7 69.8 34.9 201.0 68.8 25.3 122.2 58.1 42.0 73.7 118.8 63.1 54.7 165.6 85.6 71.9 50.6 188.8 39.7 73.9 55.7 23.0 81.0 63.2 190.1 48.1 54.9 66.7 29.3 53.8 47.3 29.8 62.2 79.4 38.0 33.7 34.3 56.5 24.4 64.6 84.0 62.1 30.6 12.5 45.7 51.2 43.5 33.1 34.0 43.4 56.5 66.0 30.8 15.9 37.0 46.5 105.1 54.3 83.5 104.7 52.0 63.2 25.7 137.0 16.0 23.3 52.7 95.8 20.0 31.7 38.5 89.6 4.5 206.0 50.8 38.2 38.6 24.9 17.2 62.5 76.3 7.5 37.9 115.1 61.6 48.5 28.8 101.9 19.4 19.7 28.8 101.0 32.6 55.2 7.5 1.3 3.8 12.2 2.7 5.9 2.2 5.8 7.8 1.8 3.8 4.7 6.1 1.3 6.5 2.9 2.5 3.0 2.0 177.4 193.9 177.8 183.1 164.7 163.1 194.3 183.4 150.3 201.0 165.6 188.8 190.1 135.3 150.6 128.2 1079.0 68.7 154.4 74.9 43.0 60.3 387.7 52.5 50.9 246.1 61.5 70.7 80.9 779.8 52.6 120.5 35.4 0.0 113.3 9.6 140.6 124.4 164.3 36.1 57.6 320.6 114.6 62.1 108.2 65.2 180.1 77.7 194.3 132.1 47.9 52.1 117.8 367.5 27.2 22.4 59.7 46.3 11.8 43.8 74.8 71.2 342.9 59.0 107.8 158.6 494.6 410.7 193.5 17.7 112.5 81.0 89.7 22.5 20.6 71.3 398.5 105.2 95.5 136.7 62.6 33.7 43.5 191.5 69.9 131.2 76.5 19.7 78.8 SMARCA4 "BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2" ENSG00000127616 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4" P51532 19 10960932-11079426 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 372.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004208, HPA048340" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim" NA NA Nucleoplasm "Nucleoli fibrillar center, Nucleoli rim" "CAB004208: AB_626762, HPA048340: " "unprognostic (2.68e-1)" "unprognostic (4.85e-2)" "unprognostic (1.71e-1)" "unprognostic (3.43e-3)" "unprognostic (1.40e-1)" "unprognostic (6.33e-3)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.19e-2)" "unprognostic (7.29e-2)" "unprognostic (1.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-2)" "unprognostic (6.80e-3)" "unprognostic (6.83e-3)" "unprognostic (5.44e-2)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 13.9 16.4 13.2 22.8 12.4 32.1 13.1 12.3 22.4 16.2 9.5 18.3 20.1 14.6 9.6 33.2 20.9 13.4 16.3 14.3 7.8 15.9 8.7 18.1 27.3 9.8 9.9 10.9 15.0 18.4 23.1 11.2 20.3 11.1 17.8 13.1 19.9 26.1 15.7 23.9 28.3 17.3 14.7 2.0 19.7 20.6 30.5 10.9 43.6 20.8 14.0 23.9 17.6 14.8 18.0 92.5 5.0 157.2 149.8 30.3 25.4 68.9 62.7 37.2 74.6 54.9 126.9 4.0 215.4 94.2 54.9 3.0 65.9 123.6 77.5 40.8 89.5 93.3 171.3 76.5 149.6 45.7 125.5 82.0 43.1 36.7 63.1 64.5 33.3 67.5 92.0 156.7 78.3 59.2 188.0 210.0 107.5 159.9 45.1 134.7 220.6 99.5 111.7 47.9 114.8 177.8 161.7 66.6 84.4 73.5 50.1 71.9 93.3 90.9 110.3 57.3 102.5 104.9 160.6 192.2 209.1 62.6 118.5 96.0 5.7 5.8 6.4 9.3 6.9 8.2 5.3 6.8 7.9 6.1 6.8 7.6 7.5 3.4 8.5 10.8 7.9 6.4 4.7 13.2 12.4 12.3 22.4 14.3 7.8 9.8 9.9 10.9 11.1 2.0 10.9 18.0 25.4 67.3 72.6 27.4 28.5 37.0 43.7 43.8 24.5 91.3 42.2 28.4 372.9 40.0 62.7 44.1 70.9 65.9 21.2 60.1 41.1 79.8 53.0 58.8 49.2 58.3 63.2 41.8 32.2 61.4 57.3 43.8 50.0 63.5 30.4 75.3 28.5 21.9 42.3 101.0 39.6 47.7 57.0 23.8 21.5 37.6 26.1 30.4 16.0 14.0 43.8 36.1 23.7 32.6 28.1 76.4 41.8 13.5 37.6 66.0 29.8 27.6 62.5 69.1 13.1 45.1 66.4 99.4 86.0 52.2 51.7 61.0 30.4 68.1 60.5 50.1 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153598 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7" "Cell line enhanced" "Detected in all" "T-47d: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071568 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071568: " "prognostic favorable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.74e-4)" "prognostic favorable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 11.7 19.6 7.1 9.0 8.1 13.6 16.9 13.4 10.0 23.1 4.2 13.7 6.6 18.5 6.7 17.1 20.3 4.8 14.8 8.2 4.6 10.5 21.4 12.6 11.8 8.0 7.0 7.4 17.9 13.8 6.6 18.5 9.5 8.6 25.8 3.0 14.8 14.2 7.5 32.5 21.2 13.9 4.9 3.9 22.3 12.7 16.3 7.5 8.9 29.6 8.4 7.2 13.6 18.4 10.3 16.1 5.5 12.8 15.4 7.3 7.2 25.7 7.9 5.8 6.8 8.5 9.6 4.4 22.4 8.2 9.1 5.5 8.9 7.8 9.3 4.2 10.1 19.9 7.5 9.9 8.0 13.6 7.6 16.7 11.2 9.9 5.6 4.7 12.3 9.3 12.4 18.7 13.3 6.2 8.3 8.8 11.5 11.3 5.8 13.6 14.7 9.7 19.0 6.8 10.5 23.7 18.1 10.3 11.2 12.5 12.3 61.5 19.7 13.5 10.1 5.7 12.5 8.0 36.5 16.4 17.1 20.0 15.1 6.0 1.5 0.6 1.9 0.3 0.2 0.2 4.2 0.2 0.2 0.3 5.1 0.4 0.5 4.7 0.8 0.3 1.7 0.4 0.3 7.1 8.1 13.4 10.0 8.2 4.6 8.0 7.0 7.4 8.6 3.9 7.5 10.3 15.3 6.4 10.4 18.9 73.2 7.4 14.1 10.8 7.4 72.5 36.1 22.2 15.3 10.0 9.4 7.3 98.0 25.7 25.5 15.3 7.9 10.5 17.0 25.4 18.7 16.4 8.4 9.4 33.6 7.6 26.2 14.6 26.5 30.2 8.2 34.3 15.4 30.9 9.0 74.0 30.6 16.7 16.2 14.2 7.8 12.1 18.3 15.8 10.6 27.2 17.0 23.5 19.6 29.7 28.7 18.0 14.1 23.3 23.9 19.3 7.4 6.6 11.7 69.2 6.6 23.1 13.7 25.2 9.1 14.1 15.3 24.1 13.9 29.7 9.5 12.9 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831712 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 156.9;Paneth cells: 146.3;Urothelial cells: 134.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042460, HPA055421" Approved Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240, HPA055421: " "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 12.5 6.4 4.0 6.8 4.4 15.1 11.3 2.4 7.5 11.4 2.5 11.7 14.6 9.3 1.1 45.9 9.5 7.1 9.7 4.5 3.5 13.8 20.3 16.6 6.9 4.2 3.4 3.2 7.4 10.4 2.9 6.1 4.5 3.8 9.5 3.3 0.4 13.6 3.3 19.8 20.4 14.6 3.3 3.9 12.0 15.8 1.8 4.4 2.6 8.3 4.1 4.4 10.2 17.5 4.3 34.9 6.7 0.1 5.8 4.9 6.2 3.1 11.2 11.4 8.8 9.8 6.9 12.2 23.5 6.2 12.9 8.8 23.1 3.2 11.8 3.4 25.4 6.2 5.9 13.7 6.7 13.5 2.1 14.7 10.1 14.4 11.0 8.0 6.8 9.2 8.1 12.9 4.9 4.8 13.0 6.0 1.2 1.0 6.2 26.5 13.2 1.4 15.4 8.0 10.7 4.6 8.5 6.9 20.4 11.4 0.0 9.2 4.9 18.5 10.7 7.3 27.4 17.1 19.6 18.5 16.7 12.5 8.1 8.4 6.8 4.1 1.8 1.7 5.4 1.5 3.4 1.7 2.0 3.6 2.8 1.1 0.7 1.2 1.2 7.1 2.5 2.1 5.1 4.0 4.4 2.4 7.5 4.5 3.5 4.2 3.4 3.2 3.8 3.9 4.4 4.3 10.5 6.4 9.6 3.9 12.4 69.3 67.0 20.0 23.9 0.9 19.4 13.6 2.5 21.5 18.5 5.5 0.0 6.3 3.7 156.9 7.9 29.9 0.1 27.0 7.6 14.4 29.2 4.2 3.9 17.5 11.7 11.0 42.3 56.2 10.8 4.6 11.7 13.4 12.8 1.7 3.2 39.2 10.2 14.0 52.6 0.3 3.7 22.1 14.2 1.9 17.7 0.8 7.2 3.0 1.4 51.8 146.3 5.3 18.6 57.5 55.8 9.2 16.3 0.2 6.6 4.6 5.8 0.3 1.4 27.3 71.2 3.4 9.8 3.4 26.2 134.3 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358528-82479239 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 160.3" "Group enriched" "Detected in many" 4 "Astrocytes: 68.2;Excitatory neurons: 63.2;Inhibitory neurons: 58.4;Microglial cells: 45.9;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Enhanced Uncertain "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 3.1 3.1 38.2 3.0 24.1 3.1 5.8 0.0 152.8 3.9 0.0 4.1 4.1 3.7 4.5 3.5 3.6 2.8 4.7 76.3 0.0 4.5 2.5 3.5 4.8 34.6 0.0 0.0 5.4 2.6 4.2 2.6 3.5 98.2 3.2 4.7 6.1 4.3 2.9 4.6 3.6 3.1 3.4 0.0 3.7 2.8 5.9 108.8 4.4 4.7 3.7 4.1 3.6 3.1 160.3 1.2 2.8 3.8 0.9 4.0 4.6 3.6 5.6 3.3 2.9 2.2 3.1 3.0 7.3 1.2 4.3 0.7 1.2 7.5 1.0 1.9 6.3 5.6 3.7 1.4 3.4 2.3 6.4 4.1 3.5 3.4 1.0 0.0 5.8 6.2 2.6 2.3 3.1 3.1 4.1 2.7 5.5 5.6 3.2 1.0 1.7 2.2 3.9 9.2 3.9 2.7 2.1 2.2 3.5 3.7 3.0 2.9 6.0 2.5 1.4 1.4 2.3 3.3 3.9 2.4 2.9 2.2 3.9 3.0 19.0 6.5 3.9 4.3 6.0 6.1 5.3 4.6 3.7 4.9 7.2 6.0 4.9 12.2 10.0 5.5 11.1 4.3 3.6 38.2 24.1 0.0 152.8 76.3 0.0 34.6 0.0 0.0 98.2 0.0 108.8 160.3 7.9 9.6 9.6 68.2 7.6 4.6 7.3 12.4 4.6 7.0 8.1 8.5 12.7 8.6 8.4 3.7 6.2 11.8 11.5 5.5 7.9 5.5 4.9 5.6 6.6 7.0 7.3 1.7 63.2 3.2 5.4 7.4 8.2 5.9 3.8 7.1 10.8 4.5 5.6 3.3 58.4 4.1 12.2 3.8 5.2 1.7 4.7 6.4 5.4 45.9 14.7 4.2 4.1 89.0 98.9 4.3 5.6 10.5 11.6 3.4 6.3 8.4 12.7 11.5 0.0 12.3 7.2 12.9 9.5 10.6 6.1 7.8 6.4 8.7 6.0 4.4 IL17B "IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7" ENSG00000127743 "Interleukin 17B" Q9UHF5 5 149371324-149404202 "Cancer-related genes, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 44.8;Peritubular cells: 13.2;Sertoli cells: 26.3;Smooth muscle cells: 7.6;Theca cells: 9.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "HEL: 1.3;Karpas-707: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042441 Uncertain "Secreted to blood" NA NA 75000 "HPA042441: AB_10797014" "unprognostic (2.83e-4)" "unprognostic (2.71e-2)" "unprognostic (4.90e-3)" "unprognostic (9.22e-2)" "unprognostic (7.43e-2)" "unprognostic (5.03e-2)" "unprognostic (9.62e-3)" "unprognostic (3.00e-1)" "unprognostic (1.80e-1)" "unprognostic (6.54e-2)" "unprognostic (9.30e-3)" "unprognostic (3.22e-1)" "unprognostic (6.98e-8)" "unprognostic (2.66e-1)" "unprognostic (1.53e-1)" "unprognostic (6.47e-2)" "unprognostic (1.10e-1)" 0.9 2.3 0.0 1.0 0.0 0.2 3.0 0.5 0.2 2.6 0.0 2.3 0.3 4.3 0.0 1.6 1.1 0.4 0.6 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 2.4 0.1 0.4 2.8 2.1 0.3 0.8 1.3 2.2 0.0 0.6 0.8 3.7 0.0 0.0 0.1 0.2 0.0 1.4 0.8 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.8 44.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.6 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 1.0 1.1 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.6 7.6 0.1 0.1 0.0 0.3 0.0 0.0 9.9 0.0 0.1 EMC6 "MGC2963, RAB5IFL, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668812-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 186.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA062681: AB_2684831" "unprognostic (2.21e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 32.5 58.7 34.6 14.8 34.7 30.6 31.6 37.6 40.5 24.5 37.3 40.1 20.2 29.3 11.4 49.7 27.3 5.2 77.4 33.4 36.8 53.6 76.4 29.4 13.4 35.7 34.0 32.6 23.5 44.6 18.7 27.9 13.6 34.9 33.3 10.4 17.4 35.7 10.7 186.5 36.4 35.5 9.1 36.9 38.1 47.8 63.8 35.2 15.7 29.9 61.3 12.7 33.1 30.7 36.6 92.8 88.6 38.1 40.1 26.9 21.4 73.2 64.7 31.4 51.7 47.5 54.1 33.8 57.6 91.6 30.3 45.9 87.2 44.5 45.6 37.2 56.0 166.2 41.9 65.4 76.2 38.7 29.3 41.6 27.1 50.6 47.8 33.2 40.9 39.8 68.0 53.4 40.6 38.6 56.2 60.5 86.2 55.0 55.9 99.1 55.7 35.5 55.3 74.2 25.9 31.3 56.7 53.1 41.2 75.6 37.8 48.0 31.1 44.2 43.3 54.4 65.9 96.5 39.5 47.1 38.4 67.7 38.0 53.3 91.6 83.1 87.1 66.1 83.8 61.1 74.6 73.6 73.4 72.7 72.0 75.2 68.5 62.8 56.5 60.7 114.3 92.5 87.4 34.6 34.7 37.6 40.5 33.4 36.8 35.7 34.0 32.6 34.9 36.9 35.2 36.6 40.1 16.0 25.9 9.4 60.3 89.0 127.1 144.2 42.1 41.8 82.9 87.8 0.2 82.9 74.8 58.8 35.5 118.4 68.1 55.7 166.3 126.2 252.2 90.0 42.7 56.6 51.4 46.7 7.4 142.8 148.6 40.8 48.4 58.0 55.2 59.8 47.5 148.7 102.5 33.7 8.4 74.7 105.8 57.1 49.6 176.1 38.5 56.6 67.6 3.7 83.3 125.9 77.2 5.5 17.9 164.8 71.6 34.3 81.9 179.9 84.6 203.8 82.2 52.9 39.5 43.3 111.7 151.0 91.6 81.1 101.9 129.0 52.7 65.0 72.6 169.5 OR1E2 "OR17-135, OR17-93, OR1E4" ENSG00000127780 "Olfactory receptor family 1 subfamily E member 2" P47887 17 3432870-3433841 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "brain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "white matter: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 METTL16 "METT10D, MGC3329" ENSG00000127804 "Methyltransferase like 16" Q86W50 17 2405562-2511891 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020352, HPA059798" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020352: AB_1853828, HPA059798: AB_2684128" "unprognostic (4.94e-3)" "unprognostic (2.86e-2)" "unprognostic (2.29e-2)" "unprognostic (5.66e-3)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (3.35e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-1)" "prognostic favorable (3.06e-4)" "unprognostic (5.35e-2)" "unprognostic (4.85e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-1)" "unprognostic (1.61e-1)" "unprognostic (2.68e-2)" 6.9 6.2 4.4 6.7 6.1 8.8 7.9 5.3 5.3 7.3 4.3 5.3 5.3 9.6 5.7 6.0 9.2 4.9 7.2 4.0 6.3 6.4 3.8 7.1 8.4 5.1 5.3 3.6 12.4 7.5 10.2 4.5 4.3 5.0 7.5 5.8 7.8 6.7 7.0 6.7 6.4 5.2 8.6 4.8 6.9 4.7 5.5 5.0 10.5 9.4 7.5 8.4 6.4 5.4 8.1 9.0 25.3 12.7 12.9 9.7 12.1 12.3 11.8 9.6 12.4 10.3 34.5 6.1 28.1 11.9 10.1 13.3 12.5 30.2 15.3 16.8 11.0 20.7 14.2 21.2 16.0 10.8 13.3 11.0 10.2 14.0 17.3 24.9 8.5 13.0 16.1 19.1 14.8 8.4 11.0 19.1 7.8 14.9 10.9 10.1 31.8 13.8 12.7 9.2 8.3 6.8 11.4 16.7 9.3 9.0 13.5 11.9 8.6 10.2 11.6 7.3 16.3 16.3 8.3 11.3 19.4 15.5 11.1 15.8 1.6 2.1 0.8 3.5 1.4 4.4 3.5 3.3 3.4 1.5 2.9 4.9 3.7 0.0 1.3 1.0 2.0 2.3 1.4 4.4 6.1 5.3 5.3 4.0 6.3 5.1 5.3 3.6 5.0 4.8 5.0 8.1 17.5 12.8 33.5 19.2 25.7 11.5 21.4 12.6 9.6 28.7 14.9 14.1 15.8 15.7 25.8 7.3 45.9 8.9 19.3 11.8 13.7 9.9 20.8 18.8 21.7 13.9 20.4 6.3 20.9 10.8 9.1 18.9 15.3 15.0 24.7 25.5 17.5 9.2 10.4 26.9 21.6 13.7 10.2 10.0 5.9 7.6 14.9 11.6 8.8 17.8 13.7 20.2 30.9 23.6 42.2 9.7 6.3 12.8 14.5 20.1 23.2 9.0 26.3 37.4 6.6 28.0 21.3 11.8 16.7 14.7 12.8 6.0 25.5 28.7 16.8 17.0 TUBA4A "FLJ30169, H2-ALPHA, TUBA1" ENSG00000127824 "Tubulin alpha 4a" P68366 2 219249710-219278170 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 363.6;tongue: 212.2" "Cell type enhanced" "Detected in many" "Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 265.9;HBEC3-KT: 439.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004621, CAB005887, HPA039247, HPA043684, HPA063394" Approved Enhanced Microtubules NA NA 130000000 Microtubules "CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (8.08e-2)" "unprognostic (2.31e-1)" "unprognostic (4.03e-2)" "unprognostic (2.56e-2)" "unprognostic (5.18e-3)" "unprognostic (3.99e-2)" "prognostic unfavorable (4.54e-6)" "unprognostic (1.52e-3)" "unprognostic (4.47e-1)" "unprognostic (8.85e-2)" "unprognostic (1.49e-2)" "unprognostic (5.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.70e-1)" "unprognostic (2.36e-1)" "unprognostic (7.38e-3)" "unprognostic (9.32e-2)" 11.8 41.7 23.1 34.4 50.7 108.1 16.6 25.6 135.3 16.9 8.9 33.2 18.8 9.9 10.2 85.4 12.7 13.6 70.4 43.9 32.9 31.8 29.7 26.9 57.2 39.1 19.3 35.7 13.0 18.3 34.9 23.3 5.1 47.0 19.9 28.1 39.6 47.3 22.7 363.6 162.7 35.8 12.9 4.6 57.2 30.9 32.6 25.4 17.0 12.4 212.2 64.0 22.8 57.7 67.3 106.0 90.0 0.0 0.3 9.1 6.9 0.3 16.2 49.7 2.8 1.9 20.4 106.7 144.2 172.2 11.7 172.7 265.9 49.3 439.9 3.9 81.7 0.7 184.2 154.5 15.4 7.3 60.9 60.8 6.7 158.0 23.7 49.2 27.4 17.3 2.4 20.5 91.3 100.6 4.3 0.3 107.9 32.3 83.2 107.4 6.5 139.0 84.5 129.7 7.5 85.8 1.5 213.2 18.7 0.7 1.8 8.0 50.9 12.3 49.8 27.4 58.4 56.7 38.0 48.8 171.4 183.3 116.4 2.5 141.7 63.3 170.2 107.1 45.7 110.1 124.9 150.3 142.8 20.9 95.5 140.2 138.4 331.2 82.0 71.9 3.8 143.8 270.9 23.1 50.7 25.6 135.3 43.9 32.9 39.1 19.3 35.7 47.0 4.6 25.4 67.3 55.3 44.8 47.1 16.3 160.6 181.8 201.2 235.3 68.9 123.3 42.3 51.6 60.9 28.6 62.0 49.7 77.2 0.7 311.6 87.3 140.8 199.3 423.0 9.8 3.3 36.5 107.9 56.2 34.8 205.6 0.5 11.5 40.8 26.1 15.8 0.1 36.0 33.0 6.0 67.3 22.5 141.9 48.8 15.3 54.9 823.0 16.8 159.5 78.2 9.4 27.8 38.6 50.4 10.6 10.6 613.5 51.2 7.5 202.3 46.7 87.5 137.5 11.1 72.9 0.0 21.1 408.5 5.7 5.0 130.6 244.5 2.5 290.1 1.4 58.9 113.0 VIL1 "D2S1471, VIL" ENSG00000127831 "Villin 1" P09327 2 218419121-218453295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Actin capping, Actin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "intestine: 439.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8" "Group enriched" "Detected in many" 4 "colorectal cancer: 56.4;stomach cancer: 23.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Group enriched" "Detected in some" 97 "CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002452, HPA006884, HPA006885" Enhanced Enhanced "Plasma membrane" NA NA 6800 "Plasma membrane" "CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.36e-1)" "unprognostic (3.03e-1)" "unprognostic (5.90e-2)" "unprognostic (2.44e-2)" "unprognostic (7.06e-2)" "unprognostic (4.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-3)" "unprognostic (3.90e-1)" "unprognostic (2.58e-1)" "unprognostic (4.79e-2)" "unprognostic (4.65e-2)" 0.5 1.1 0.0 10.4 0.1 0.3 0.8 0.3 0.2 0.7 0.0 177.5 398.6 0.5 0.0 0.9 0.7 28.4 0.8 0.0 0.0 26.2 31.7 0.7 0.3 0.0 0.1 0.0 1.1 29.6 0.0 1.4 0.3 0.1 1.0 185.7 0.0 0.6 0.5 0.4 1.0 439.9 8.2 0.0 1.2 6.9 2.0 0.0 0.0 0.6 0.0 0.0 0.8 0.9 0.2 0.0 1.5 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 762.5 0.5 0.1 5.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.3 365.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.1 0.0 1.7 0.8 321.9 0.0 0.0 0.0 1.4 0.0 0.2 0.3 0.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 4.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.3 0.8 0.4 0.1 0.0 1.8 0.3 0.6 0.5 24.3 0.1 0.0 2.1 0.3 0.8 243.8 3.9 12.3 1.9 1.3 0.9 0.4 113.6 3.2 0.7 42.9 0.2 0.8 6.6 1.6 8.9 0.3 0.7 32.6 0.1 1.7 0.5 143.6 0.0 2.2 1.5 0.5 0.0 5.1 0.0 0.0 0.2 0.5 0.0 0.0 0.3 10.9 216.2 0.0 0.3 0.9 558.5 35.1 0.0 1.2 0.0 1.7 0.7 0.8 0.8 0.6 0.9 0.3 1.5 0.0 161.8 0.3 AAMP ENSG00000127837 "Angio associated migratory cell protein" Q13685 2 218264129-218270178 "Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017717, HPA031868" Approved Supported Microtubules,Cytosol NA NA Microtubules Cytosol "CAB017717: , HPA031868: AB_2674078" "unprognostic (1.57e-1)" "unprognostic (6.12e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.39e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (8.94e-2)" "unprognostic (7.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (4.22e-2)" "unprognostic (5.51e-2)" "unprognostic (1.23e-3)" "unprognostic (5.26e-2)" "unprognostic (1.92e-1)" "unprognostic (9.09e-2)" 67.0 66.9 62.0 46.6 62.4 27.8 65.8 63.4 80.8 62.6 58.1 77.0 63.4 62.2 44.2 75.7 61.3 56.6 64.0 61.9 65.8 57.3 78.1 47.0 48.2 66.0 64.3 60.9 80.5 71.3 73.3 62.5 55.4 62.4 58.5 58.6 38.7 67.5 59.2 91.1 75.0 62.2 51.2 63.2 53.4 87.6 54.2 62.9 54.5 67.2 62.6 53.0 70.6 57.8 66.4 126.1 104.6 75.1 102.2 111.9 75.7 146.0 89.6 136.3 167.1 124.5 226.2 100.1 64.6 121.8 112.6 158.8 94.3 150.7 133.4 129.3 103.5 200.9 147.4 108.2 237.4 158.9 139.3 92.4 97.8 152.7 172.2 149.7 99.7 97.6 124.3 202.6 82.4 108.9 198.0 112.4 234.9 121.0 182.4 75.4 90.6 97.5 105.8 100.3 160.5 96.2 92.9 59.4 128.7 134.7 119.1 99.1 104.6 84.7 110.2 82.3 81.2 106.8 105.7 198.1 108.4 111.0 88.6 77.4 75.9 166.2 60.3 101.1 209.2 105.1 100.3 90.1 94.9 191.4 105.7 111.1 100.7 26.2 114.9 210.6 114.1 109.3 179.4 62.0 62.4 63.4 80.8 61.9 65.8 66.0 64.3 60.9 62.4 63.2 62.9 66.4 57.8 41.7 35.2 11.4 50.4 90.5 86.1 122.9 66.0 47.7 50.7 45.2 35.5 41.5 74.0 42.3 12.5 160.0 42.2 74.3 103.7 95.7 3.5 33.5 46.4 50.6 75.5 34.0 11.5 95.4 130.3 63.4 80.5 38.2 34.8 57.6 42.5 46.2 91.9 63.9 12.9 89.9 93.6 37.0 65.3 8.8 83.3 38.5 62.2 5.6 64.8 80.2 41.2 8.0 10.5 86.6 72.0 74.9 51.2 116.0 99.5 85.3 47.4 37.1 65.7 38.4 86.5 72.0 53.3 70.2 97.3 202.6 44.4 62.5 103.5 119.9 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, MR-1S, PDC, PKND1, TAHCCP2" ENSG00000127838 "PNKD metallo-beta-lactamase domain containing" Q8N490 2 218270392-218346793 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 508.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria NA NA Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 51.3 89.6 120.1 33.6 122.8 35.7 50.1 122.5 169.7 63.4 117.8 71.0 41.0 46.0 78.0 40.9 61.1 41.9 93.8 121.1 127.4 107.2 193.0 55.9 41.3 126.2 120.9 116.3 47.5 46.4 94.2 49.9 47.3 129.0 88.1 55.2 26.9 61.1 55.8 85.9 45.2 51.5 36.7 119.4 59.2 82.2 45.9 127.4 46.2 90.8 94.4 37.9 64.7 45.8 125.7 53.2 68.3 49.1 77.0 72.2 60.6 90.0 32.7 70.3 76.1 85.0 112.9 51.2 61.7 63.7 55.0 83.5 53.6 95.4 61.4 52.9 128.0 119.4 90.0 119.5 169.4 78.7 58.9 38.6 83.0 59.8 51.9 15.0 51.0 83.2 48.0 67.8 78.3 68.4 152.2 77.6 139.5 49.0 121.3 69.3 75.1 49.5 51.8 88.3 79.2 47.4 39.9 23.6 156.9 94.6 52.0 52.4 56.4 51.5 31.4 53.7 37.5 45.5 32.4 35.7 69.0 79.9 95.8 38.8 142.4 111.4 151.9 97.7 114.3 94.2 223.1 105.7 117.7 106.4 187.2 116.4 111.2 31.3 136.2 109.4 99.0 150.0 132.2 120.1 122.8 122.5 169.7 121.1 127.4 126.2 120.9 116.3 129.0 119.4 127.4 125.7 84.5 70.5 91.2 30.0 58.2 55.2 91.5 179.2 82.6 54.5 130.1 162.4 154.5 128.7 127.8 196.8 6.2 172.9 48.2 292.0 508.7 70.6 13.5 125.9 116.5 66.9 121.3 56.3 44.9 49.8 105.3 88.5 99.9 114.1 57.1 97.0 83.2 250.4 136.7 35.3 47.4 186.3 187.2 85.3 59.6 16.5 103.2 66.2 136.9 20.6 79.6 168.8 51.5 19.6 32.8 37.7 143.6 124.1 74.6 93.4 162.7 326.7 148.5 41.6 92.1 60.0 128.6 42.5 50.6 113.9 62.4 77.3 52.5 97.2 228.1 117.5 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 55.8;skin 1: 108.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 62.2;Microglial cells: 71.2;Respiratory ciliated cells: 62.4;Suprabasal keratinocytes: 80.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "hypothalamus: 27.3" "Immune cell enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 46.5;BJ hTERT+: 73.2;fHDF/TERT166: 55.9;Hep G2: 83.0;SK-MEL-30: 128.4;WM-115: 76.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favorable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favorable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.8 2.9 2.7 0.9 1.8 1.8 10.0 2.5 2.0 7.1 4.1 2.0 1.8 8.7 13.6 9.5 30.8 3.5 22.3 1.9 27.3 15.9 1.1 17.3 0.7 2.9 2.9 1.1 2.7 2.9 0.9 8.5 8.4 2.9 27.6 1.9 4.8 55.8 7.7 2.4 108.3 1.3 3.1 3.6 5.1 5.4 2.2 2.4 6.8 3.5 2.2 1.8 4.5 4.9 2.6 0.1 3.3 3.2 0.0 4.7 46.5 3.5 3.7 73.2 2.0 2.8 23.6 0.1 0.0 0.0 55.9 0.5 0.1 3.3 2.9 3.6 0.0 2.9 0.6 2.4 83.0 2.2 0.2 0.9 22.5 0.7 23.1 0.3 1.5 0.1 0.0 0.1 0.0 13.2 1.1 0.0 0.1 2.3 29.7 5.1 0.0 13.6 0.0 8.4 0.4 30.9 4.9 0.1 0.0 128.4 3.4 0.0 0.3 0.0 11.5 0.5 0.1 3.5 0.0 0.1 0.0 4.5 0.1 76.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 1.3 0.0 2.7 1.8 2.5 2.0 1.9 27.3 2.9 2.9 1.1 2.9 3.6 2.4 2.6 3.1 0.0 20.8 1.0 0.2 62.2 3.0 2.0 23.9 0.8 6.3 2.9 23.4 2.8 9.3 9.2 8.4 0.1 0.3 0.1 0.0 11.1 1.7 10.4 4.4 5.1 0.0 0.0 6.9 1.0 0.0 14.4 2.6 3.9 1.3 0.5 0.0 0.5 0.1 0.0 6.7 0.0 6.1 0.0 8.5 1.0 11.5 0.2 14.2 71.2 0.0 3.3 0.0 12.5 1.1 11.3 0.0 13.9 0.0 13.3 0.0 20.9 62.4 3.3 0.0 3.2 4.9 1.5 2.3 8.3 80.3 0.0 0.6 3.5 0.0 0.6 RNF6 DKFZp686P0776 ENSG00000127870 "Ring finger protein 6" Q9Y252 13 26132115-26222314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 99.1;Late spermatids: 191.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039343, HPA040048" Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA039343: AB_2676456, HPA040048: AB_10672969" "unprognostic (3.22e-1)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.45e-1)" "unprognostic (1.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.68e-2)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "unprognostic (7.63e-2)" "unprognostic (6.13e-2)" "unprognostic (1.39e-1)" "unprognostic (4.21e-2)" "unprognostic (2.70e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" 19.1 17.5 14.3 18.9 14.7 32.7 18.1 15.5 17.2 13.5 15.0 18.6 17.6 12.5 13.8 18.6 14.7 13.8 13.8 15.3 13.8 18.4 16.7 16.4 22.6 13.4 15.2 13.5 11.6 14.3 22.5 10.8 20.0 13.1 16.2 18.7 26.8 13.6 14.0 21.3 17.5 19.0 15.8 13.2 19.8 17.3 33.9 16.6 25.5 17.6 15.4 24.0 18.5 10.2 13.7 33.3 28.9 10.7 15.8 36.3 28.2 23.9 56.3 45.2 35.4 24.9 36.4 41.8 59.5 27.3 53.5 31.5 43.7 30.2 45.3 58.4 57.7 19.2 64.8 23.9 31.3 56.6 68.7 65.4 26.8 86.1 39.8 84.2 34.3 36.0 25.5 25.6 0.1 55.3 30.0 38.5 39.8 8.7 59.5 19.8 30.4 41.5 23.7 43.6 43.3 19.3 11.9 29.9 54.0 54.1 24.8 20.7 66.3 47.6 30.4 18.6 41.1 40.5 14.8 14.9 34.9 27.8 38.4 40.7 46.6 14.5 34.7 15.6 18.4 17.1 18.6 17.1 17.7 17.6 12.5 16.8 14.8 9.7 20.0 23.3 9.1 19.2 14.2 14.3 14.7 15.5 17.2 15.3 13.8 13.4 15.2 13.5 13.1 13.2 16.6 13.7 20.9 22.4 19.8 6.8 26.5 30.5 12.7 17.5 14.8 22.2 15.1 10.5 13.5 5.7 19.7 7.3 25.0 20.2 31.6 24.8 33.2 15.1 99.1 37.4 16.9 23.0 11.4 24.8 14.4 15.4 21.8 16.1 17.3 19.9 26.6 12.1 17.5 12.3 17.5 30.3 17.2 15.5 24.4 22.4 19.9 191.0 14.6 23.0 14.2 12.2 21.6 24.9 29.9 11.6 16.2 24.4 20.1 11.3 18.0 22.0 15.8 21.4 40.1 43.2 26.3 21.6 14.5 83.5 29.1 19.2 29.1 42.1 26.2 17.1 12.6 23.5 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362485-133373354 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1137.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 1476.3;Proximal tubular cells: 2336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria NA NA 1200000 Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favorable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 305.1 128.1 122.3 54.2 121.0 44.3 117.9 125.3 137.2 60.4 137.0 144.5 173.2 47.4 90.1 108.9 91.3 67.3 211.8 125.2 123.1 486.2 1137.9 48.9 52.8 124.1 121.7 120.5 72.0 97.6 99.6 74.9 74.3 123.1 102.9 105.6 40.2 164.8 124.4 297.1 68.7 154.9 59.9 124.5 48.8 85.2 53.0 125.5 40.3 89.3 274.0 59.5 88.2 58.3 130.9 185.1 229.2 120.4 303.4 173.0 111.4 110.5 132.2 175.9 183.2 154.1 509.5 174.0 139.2 111.9 151.4 94.4 167.7 160.2 136.1 132.0 107.4 281.2 138.5 128.1 367.2 145.0 180.4 93.5 124.5 115.9 121.2 153.6 160.8 165.1 98.3 127.8 117.4 181.6 443.9 90.7 352.0 84.4 289.8 272.1 152.8 146.4 74.6 227.8 236.0 78.1 123.4 137.0 224.1 178.9 69.4 174.8 171.5 132.1 81.3 115.9 169.9 177.4 87.0 58.8 159.8 192.4 98.8 68.7 96.1 184.7 86.8 105.5 212.2 137.6 178.7 117.8 115.8 242.6 148.9 119.3 115.8 19.8 166.0 168.1 104.9 123.0 233.0 122.3 121.0 125.3 137.2 125.2 123.1 124.1 121.7 120.5 123.1 124.5 125.5 130.9 99.2 44.8 82.7 16.3 60.5 68.2 86.9 271.8 62.6 57.0 98.5 119.6 255.2 210.1 161.5 174.7 6.2 470.2 34.0 298.6 565.4 162.8 29.9 148.9 92.7 71.4 131.7 72.2 11.6 101.1 163.5 92.5 87.7 226.4 91.2 120.0 88.5 1476.3 221.1 45.4 11.0 223.0 175.0 92.1 61.5 39.1 77.6 88.0 135.2 10.3 113.0 145.2 45.3 10.6 24.3 107.8 248.6 91.7 57.5 88.0 486.2 2336.5 93.2 55.2 85.5 57.0 98.8 52.9 66.1 125.2 76.3 299.1 62.5 220.0 317.2 127.8 ZNF835 BC37295_3 ENSG00000127903 "Zinc finger protein 835" Q9Y2P0 19 56661980-56671783 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.3;Cone photoreceptor cells: 8.4;Horizontal cells: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.6;EFO-21: 2.0;HEL: 1.7;NTERA-2: 4.8;SH-SY5Y: 2.4;U-266/84: 4.1" HPA051136 Uncertain Approved Microtubules NA NA Microtubules "HPA051136: AB_2681357" "unprognostic (3.15e-1)" "unprognostic (4.80e-2)" "unprognostic (4.89e-1)" "unprognostic (5.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-2)" "unprognostic (3.25e-2)" "unprognostic (3.39e-3)" "unprognostic (1.58e-5)" "unprognostic (6.65e-2)" "unprognostic (5.35e-4)" "unprognostic (2.33e-1)" "unprognostic (2.72e-4)" "unprognostic (5.31e-2)" "unprognostic (1.32e-1)" "unprognostic (9.29e-2)" "unprognostic (6.21e-2)" 1.5 1.4 2.2 1.1 2.3 0.3 1.0 3.9 3.4 1.7 0.3 1.8 0.3 2.1 0.8 0.9 1.9 0.5 2.2 2.3 1.7 0.9 0.2 0.8 1.2 2.1 1.9 2.4 4.3 0.9 2.3 1.5 0.6 2.5 1.3 0.2 1.5 1.9 1.4 2.2 0.3 0.8 0.9 1.4 1.8 0.8 0.4 2.1 0.3 1.6 1.3 1.0 1.8 1.0 2.9 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 4.1 0.2 0.0 0.0 0.0 1.8 0.3 0.3 0.3 0.2 0.7 1.7 1.3 0.8 0.5 2.1 2.2 1.5 0.5 1.6 0.3 1.5 0.7 0.8 2.2 2.3 3.9 3.4 2.3 1.7 2.1 1.9 2.4 2.5 1.4 2.1 2.9 1.5 3.2 0.0 2.0 1.1 0.0 0.1 0.0 0.0 5.3 0.5 0.6 3.1 0.0 0.6 0.0 8.4 1.1 0.6 0.0 0.0 0.4 0.0 0.2 1.6 1.2 0.0 0.8 1.7 0.5 0.4 1.7 0.0 0.1 0.0 3.6 1.8 0.1 0.3 16.8 2.3 0.0 0.0 0.3 0.5 0.0 2.1 0.6 0.0 0.0 0.8 3.5 4.1 3.0 2.4 0.1 0.0 3.4 0.2 0.1 0.0 0.8 0.0 3.1 0.0 0.5 1.1 0.0 0.6 0.0 0.1 0.3 0.2 1.7 0.0 0.1 AKAP9 "AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO" ENSG00000127914 "A-kinase anchoring protein 9" Q99996 7 91940840-92110673 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008548, CAB012909, HPA026109" Supported Enhanced "Golgi apparatus,Vesicles,Centrosome" NA NA "Golgi apparatus" "Vesicles, Centrosome" "CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688" "unprognostic (9.57e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (5.97e-3)" "unprognostic (1.20e-1)" "unprognostic (1.47e-1)" "unprognostic (4.75e-2)" "unprognostic (1.31e-2)" "unprognostic (1.28e-1)" "unprognostic (6.59e-2)" "unprognostic (7.59e-2)" "unprognostic (6.32e-2)" "prognostic favorable (2.10e-6)" "unprognostic (8.89e-2)" "unprognostic (1.73e-1)" "unprognostic (7.77e-2)" "unprognostic (3.96e-2)" 6.7 8.4 10.4 6.2 10.5 8.6 11.1 17.0 14.2 6.4 15.4 16.1 16.7 6.4 4.0 8.0 8.5 10.5 6.2 9.8 11.2 13.3 16.3 7.9 5.8 10.3 11.4 8.9 12.0 9.6 12.8 8.7 5.4 10.7 7.6 14.7 31.7 9.7 3.8 16.4 6.7 18.8 4.0 9.3 5.0 9.5 4.2 12.0 9.3 9.4 10.1 5.4 5.5 7.2 11.1 11.7 8.1 9.6 5.8 11.6 11.3 6.2 8.7 6.3 4.9 5.9 10.3 8.0 9.2 12.5 7.3 7.5 8.3 10.5 5.6 9.2 9.8 8.2 10.9 11.6 7.3 4.0 18.5 9.6 6.2 6.2 9.1 8.8 7.7 10.3 10.6 19.3 13.0 7.4 14.1 10.4 7.0 8.3 6.5 8.4 7.6 18.2 6.2 4.9 11.5 13.3 11.0 19.0 16.9 10.1 11.1 5.1 9.8 17.5 9.5 11.2 14.5 12.6 7.3 13.0 13.6 6.2 7.8 9.4 1.1 0.6 0.9 1.3 0.6 0.9 1.9 1.1 1.1 0.4 1.6 1.2 1.0 0.7 1.2 0.6 3.2 1.0 0.2 10.4 10.5 17.0 14.2 9.8 11.2 10.3 11.4 8.9 10.7 9.3 12.0 11.1 123.3 525.6 357.0 141.3 143.3 103.5 126.5 112.6 170.8 273.5 165.4 150.9 253.2 297.4 208.4 176.6 2230.9 141.4 201.5 293.4 101.8 131.0 22.5 392.3 157.7 115.9 185.1 129.4 142.6 92.6 81.9 123.5 152.9 185.0 136.6 386.1 98.2 153.5 57.2 360.1 182.6 350.8 136.3 78.3 88.4 17.5 173.4 101.6 58.7 115.2 121.5 155.7 119.4 169.9 187.1 102.4 218.9 135.8 193.5 91.4 298.5 47.2 506.3 1279.6 138.1 206.1 116.1 83.0 129.0 87.3 111.8 333.8 145.7 135.8 171.4 97.6 GNG11 GNGT11 ENSG00000127920 "G protein subunit gamma 11" P61952 7 93921735-93928610 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Adipocytes: 1903.6;Endothelial cells: 1236.2;Hepatic stellate cells: 994.2;Macrophages: 481.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 20.5;neutrophil: 9.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.5" "Cell line enhanced" "Detected in many" "EFO-21: 219.9;HUVEC TERT2: 349.6;SK-MEL-30: 221.8;TIME: 201.1;U-87 MG: 187.1" "Low region specificity" "Detected in all" HPA045255 Uncertain NA NA 3400000 "HPA045255: AB_10794781" "unprognostic (1.30e-1)" "unprognostic (8.04e-2)" "unprognostic (2.53e-1)" "unprognostic (4.89e-3)" "unprognostic (4.94e-2)" "unprognostic (2.63e-2)" "unprognostic (2.58e-2)" "unprognostic (3.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.91e-2)" "unprognostic (2.14e-3)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" "unprognostic (4.71e-3)" 71.8 16.9 14.3 8.2 13.7 2.6 65.0 14.1 22.2 24.0 13.6 20.4 6.8 27.0 11.0 11.0 33.8 15.6 40.9 13.5 13.9 25.9 12.2 40.1 7.9 14.4 13.9 12.5 57.1 8.8 4.5 9.3 86.6 14.3 16.0 6.4 1.6 9.2 18.1 15.6 11.1 16.2 16.9 14.2 39.3 16.1 3.4 15.6 19.2 29.3 18.8 3.6 28.2 18.6 14.6 0.2 34.2 67.2 31.0 51.2 40.0 0.0 34.8 67.7 19.0 26.7 0.1 2.9 0.0 219.9 17.5 79.9 0.5 0.5 3.2 23.8 0.2 2.0 11.0 35.9 0.0 81.8 0.0 0.1 13.4 0.1 61.0 6.0 78.7 349.6 0.0 0.1 0.2 85.9 0.0 0.1 0.1 5.8 0.0 10.4 32.5 7.6 0.1 41.3 0.0 0.1 67.2 0.0 0.2 221.8 8.6 144.4 2.4 201.1 93.4 10.4 68.3 3.9 0.0 0.2 0.7 187.1 0.0 81.8 20.5 0.7 0.3 0.1 0.1 0.2 2.3 0.0 0.0 1.0 2.0 0.2 0.0 9.8 0.0 0.1 3.7 0.1 50.2 14.3 13.7 14.1 22.2 13.5 13.9 14.4 13.9 12.5 14.3 14.2 15.6 14.6 1903.6 12.8 27.3 1.3 20.6 83.6 11.8 3.1 5.7 0.7 15.2 26.8 94.8 11.5 3.1 187.6 0.0 2.3 15.4 0.1 74.3 135.7 5.9 124.1 94.6 1236.2 0.0 40.6 0.0 5.7 12.9 207.3 0.5 236.4 2.5 12.7 994.2 11.1 17.0 0.0 0.0 0.3 18.3 55.9 89.5 17.0 82.3 481.1 188.5 26.2 49.6 9.2 41.2 0.5 0.2 4.3 0.0 86.9 8.0 11.0 0.0 12.9 1.7 4.7 151.2 115.5 165.0 1.9 7.6 2.7 65.8 23.8 15.9 109.9 0.0 4.5 SEM1 "C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1" ENSG00000127922 "SEM1 26S proteasome complex subunit" "P60896, Q6ZVN7" 7 96481626-96709891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 636.7;Endometrial ciliated cells: 571.3;Exocrine glandular cells: 537.4;Extravillous trophoblasts: 712.8;Pancreatic endocrine cells: 543.9;Proximal tubular cells: 533.4;Syncytiotrophoblasts: 872.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020429, HPA072648" Uncertain Approved Cytosol NA NA Cytosol "HPA020429: AB_1859527, HPA072648: AB_2686543" "unprognostic (5.41e-3)" "unprognostic (6.25e-2)" "unprognostic (1.62e-2)" "unprognostic (2.14e-3)" "unprognostic (1.24e-3)" "unprognostic (6.16e-3)" "unprognostic (4.29e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "prognostic favorable (2.52e-4)" "unprognostic (4.55e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.32e-1)" "unprognostic (2.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (8.00e-5)" 138.4 180.4 110.9 119.3 111.7 78.5 125.2 111.8 162.7 130.9 110.2 147.4 122.9 133.7 119.5 195.4 115.9 35.2 190.8 109.1 112.7 121.1 264.9 103.6 88.7 112.5 111.8 106.2 168.7 104.5 106.4 123.1 107.6 113.4 119.2 78.6 85.8 132.5 69.6 363.9 144.9 117.1 64.7 109.6 97.7 127.7 185.1 112.5 138.0 107.5 151.5 85.4 114.4 146.1 114.6 570.7 327.0 448.1 468.1 187.4 162.3 241.7 453.4 220.0 186.9 232.5 298.3 459.4 373.6 1096.4 222.8 575.9 288.2 379.5 306.5 263.6 437.4 285.9 448.3 505.7 472.5 171.2 670.0 321.4 208.4 233.7 279.8 283.7 291.4 253.8 438.4 592.4 444.7 193.0 716.9 760.9 942.6 607.0 572.4 297.3 291.6 576.4 441.1 273.2 555.6 367.8 463.6 845.0 701.6 497.9 681.4 200.6 502.2 525.6 365.3 641.2 683.1 575.0 278.3 818.9 1080.9 399.4 574.3 515.8 292.6 385.3 109.0 279.9 443.1 268.4 336.4 363.1 332.7 570.6 312.5 282.4 284.0 27.0 300.4 392.8 622.8 546.6 375.7 110.9 111.7 111.8 162.7 109.1 112.7 112.5 111.8 106.2 113.4 109.6 112.5 114.6 288.2 173.1 224.5 0.0 47.2 0.0 0.0 0.0 0.0 0.0 212.6 325.2 0.0 0.0 103.4 244.6 0.0 636.7 93.1 0.0 412.8 382.5 0.0 571.3 314.1 127.6 0.0 0.0 0.0 537.4 712.8 129.5 0.0 450.0 102.2 258.9 0.0 0.0 393.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 241.3 0.0 0.0 0.0 0.0 543.9 0.0 0.0 19.6 0.0 0.0 533.4 149.4 0.0 0.0 0.0 140.3 0.0 0.0 0.0 0.0 872.3 65.9 187.2 0.0 0.0 GNGT1 GNG1 ENSG00000127928 "G protein subunit gamma transducin 1" P63211 7 93591573-93911265 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 645 "retina: 1918.8" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 3097.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.4;HeLa: 3.4;SK-BR-3: 3.0;SuSa: 4.3;T-47d: 5.3;U-266/84: 4.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042721 Enhanced NA NA "HPA042721: AB_10806370" "unprognostic (1.30e-1)" "unprognostic (2.55e-4)" "unprognostic (3.32e-4)" "unprognostic (5.01e-2)" "unprognostic (2.54e-2)" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (4.55e-1)" "unprognostic (2.23e-4)" "unprognostic (1.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.2 1.5 0.1 0.4 0.0 0.0 0.0 2.9 0.3 0.0 0.0 1918.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.3 0.0 0.5 1.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.4 0.1 1.4 0.1 0.0 1.5 0.1 0.1 0.0 0.0 0.4 0.2 1.3 2.6 1.0 0.1 3.0 0.0 4.3 5.3 0.1 0.1 0.0 2.7 0.1 0.0 2.8 4.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.2 0.1 0.4 0.2 1.5 0.1 0.3 0.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 371.1 0.0 0.0 0.1 0.0 0.7 0.0 385.7 0.5 0.0 0.1 1.9 0.4 0.1 0.2 0.0 21.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.2 198.5 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 619.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.8 3097.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.1 0.0 0.1 0.0 0.0 HIP1 ILWEQ ENSG00000127946 "Huntingtin interacting protein 1" O00291 7 75533298-75738962 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation" "Actin-binding, Activator" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.9" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 9.5;eosinophil: 6.8;neutrophil: 6.8;NK-cell: 3.0;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013606, CAB015334, CAB016402, HPA017964" Enhanced Supported Vesicles NA NA Vesicles "CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719" "unprognostic (8.23e-2)" "unprognostic (1.22e-1)" "unprognostic (2.20e-2)" "unprognostic (1.64e-1)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "unprognostic (2.73e-3)" "unprognostic (1.03e-2)" "unprognostic (1.11e-2)" "unprognostic (2.02e-2)" "unprognostic (2.70e-2)" "unprognostic (7.98e-2)" "unprognostic (1.73e-3)" "unprognostic (9.67e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-2)" "unprognostic (1.09e-1)" 16.9 8.0 24.3 7.4 35.0 5.5 13.3 28.3 23.8 11.8 16.9 5.6 2.7 9.8 9.3 5.3 13.0 8.4 9.1 19.9 24.8 13.3 9.4 18.7 4.8 32.4 34.4 14.8 8.0 3.8 4.2 3.5 19.9 32.7 6.9 4.2 4.6 4.1 11.3 4.2 10.7 5.0 12.3 25.6 11.3 4.8 30.7 31.4 3.1 15.4 8.5 4.5 9.1 8.0 50.9 5.2 55.9 37.1 35.2 15.3 20.8 11.1 9.7 6.3 6.2 4.6 3.2 5.0 3.8 11.2 24.2 21.6 6.3 38.1 8.0 8.3 3.1 7.1 3.0 6.6 5.3 15.2 0.8 14.8 16.0 4.8 20.4 4.2 11.4 26.3 4.2 4.0 3.6 10.1 21.6 2.5 22.2 40.5 0.5 6.6 4.4 15.5 0.3 4.7 20.0 1.8 16.2 9.0 5.6 12.5 32.8 34.6 13.9 9.4 18.0 13.7 6.2 13.6 4.0 0.4 8.9 18.1 8.0 12.4 9.5 0.9 6.8 0.9 0.9 0.7 0.3 0.1 0.7 1.4 0.4 0.1 0.5 6.8 3.0 0.7 3.3 1.4 0.3 24.3 35.0 28.3 23.8 19.9 24.8 32.4 34.4 14.8 32.7 25.6 31.4 50.9 54.0 60.9 37.5 43.8 7.8 17.6 6.2 7.1 20.5 12.0 14.8 10.7 14.3 11.5 12.2 27.6 12.5 2.1 27.2 2.2 13.7 14.4 256.9 15.5 24.2 54.3 4.8 7.8 16.3 6.0 10.0 17.1 6.1 25.5 14.0 25.9 36.8 22.5 14.9 23.5 19.0 3.0 6.1 18.5 49.1 1373.3 22.4 24.1 10.6 45.9 9.4 14.3 21.6 336.3 313.7 3.1 7.7 24.8 18.4 4.2 0.3 2.6 1.3 9.4 85.5 25.9 44.8 12.1 5.6 5.6 9.1 0.8 13.5 7.7 3.3 3.5 PTPN12 "PTP-PEST, PTPG1" ENSG00000127947 "Protein tyrosine phosphatase non-receptor type 12" Q05209 7 77537295-77640069 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007097 Approved Approved "Plasma membrane,Cytosol" NA NA 770000 "Plasma membrane, Cytosol" "HPA007097: AB_1079689" "unprognostic (2.28e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.35e-1)" "unprognostic (3.35e-2)" "unprognostic (1.40e-3)" "unprognostic (4.48e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.29e-1)" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (4.99e-2)" "unprognostic (2.97e-1)" "unprognostic (1.81e-1)" "unprognostic (3.21e-1)" 60.1 30.4 26.8 44.3 28.0 70.6 50.7 31.2 31.9 40.5 30.7 40.7 19.1 39.0 18.8 38.9 39.9 40.5 37.2 26.3 38.2 28.1 31.2 65.6 27.7 30.0 28.9 20.5 34.9 20.2 21.2 22.1 75.3 32.0 26.6 28.0 31.1 24.0 33.5 24.8 37.2 30.0 40.5 28.7 53.2 27.3 30.3 32.8 34.2 31.3 44.9 27.7 47.2 39.9 36.6 72.4 43.5 100.6 51.8 69.1 71.7 54.2 73.3 93.0 56.6 80.0 21.6 109.9 8.6 23.2 86.3 123.6 50.2 34.2 73.4 113.3 21.2 19.2 44.9 44.2 88.4 67.7 25.8 28.8 59.0 80.3 123.2 157.6 101.0 121.6 2.1 54.9 12.2 182.6 49.4 3.6 71.9 81.7 97.6 49.2 15.1 80.6 4.5 97.6 38.5 12.5 66.6 90.4 81.5 73.4 172.2 39.5 93.9 89.3 121.4 73.1 45.0 141.3 12.6 7.4 22.2 71.6 65.9 215.7 3.6 4.1 6.8 3.1 2.8 1.3 2.3 1.1 2.6 3.8 1.0 0.6 3.3 9.5 13.3 5.3 0.3 1.6 2.7 26.8 28.0 31.2 31.9 26.3 38.2 30.0 28.9 20.5 32.0 28.7 32.8 36.6 139.3 70.5 56.2 30.0 18.2 68.8 60.0 55.9 23.9 16.7 40.9 26.3 41.3 28.6 46.4 20.2 8.4 40.0 89.0 31.2 3.9 42.1 3.5 43.9 62.4 114.4 12.1 16.6 65.8 39.6 58.7 54.6 21.4 87.2 14.5 21.7 119.2 24.6 50.1 35.3 58.0 21.7 28.5 82.0 121.3 6.7 46.6 96.1 35.6 93.7 54.9 66.9 163.7 70.4 67.3 75.0 21.4 47.0 17.6 62.0 10.9 19.2 23.2 15.2 65.7 127.9 66.8 51.2 71.4 29.8 101.4 72.1 27.3 24.4 23.3 104.8 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 315.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 328.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 12000 "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 53.9 199.0 18.6 32.3 16.9 18.0 45.1 13.0 18.8 42.2 13.9 36.2 106.2 32.4 29.6 54.1 50.6 37.4 38.4 19.3 44.9 37.9 315.9 55.4 20.1 21.5 16.9 15.2 52.7 44.9 78.3 71.9 46.6 16.4 32.1 22.1 12.8 30.2 114.1 56.6 43.3 93.2 28.5 15.3 44.1 41.9 25.7 27.3 38.4 132.5 68.7 23.4 37.0 42.6 16.6 59.6 133.0 57.0 106.3 212.9 79.8 98.0 24.4 79.3 44.7 62.3 100.7 257.0 56.1 21.9 53.1 151.8 28.3 76.0 38.4 19.6 48.1 57.9 26.0 36.9 189.4 146.5 26.2 45.5 163.9 47.4 59.2 43.2 36.3 42.3 27.1 79.1 24.0 40.8 90.9 29.0 49.4 71.7 92.9 74.8 41.0 37.6 61.1 50.0 72.8 59.3 57.4 65.4 328.4 91.0 32.6 94.0 44.2 38.6 41.7 45.8 63.6 48.7 23.8 38.3 39.0 59.3 39.8 54.9 65.9 42.6 60.4 20.6 39.6 17.1 11.0 17.5 19.4 45.6 11.2 17.1 14.7 53.8 25.9 30.2 12.5 19.3 36.6 18.6 16.9 13.0 18.8 19.3 44.9 21.5 16.9 15.2 16.4 15.3 27.3 16.6 34.3 38.5 39.7 23.2 17.1 17.1 29.4 172.3 13.1 31.4 20.5 14.0 10.9 54.3 201.4 73.5 12.5 99.9 26.0 97.7 1.9 65.0 27.6 62.1 28.0 27.1 19.8 11.8 10.1 29.4 95.0 40.1 67.8 46.6 24.7 121.4 32.2 489.2 67.8 15.2 17.1 41.7 124.1 35.2 16.1 9.5 75.8 47.3 12.4 11.2 20.5 25.9 12.3 11.6 8.8 27.9 102.0 112.5 17.0 20.7 274.2 31.7 178.6 23.0 65.7 32.7 46.9 21.3 30.8 18.2 14.6 193.2 25.4 647.6 44.5 45.9 FGL2 "pT49, T49" ENSG00000127951 "Fibrinogen like 2" Q14314 7 77193369-77199848 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 163.9" "Group enriched" "Detected in many" 4 "Kupffer cells: 466.3;Langerhans cells: 571.0;Macrophages: 430.3;monocytes: 463.1;Skeletal myocytes: 166.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 45 "classical monocyte: 256.5;eosinophil: 226.3;intermediate monocyte: 380.6;myeloid DC: 160.0;neutrophil: 294.7;non-classical monocyte: 379.8" "Group enriched" "Detected in all" 59 "dendritic cells: 160.0;granulocytes: 294.7;monocytes: 380.6" "Cell line enhanced" "Detected in some" "Karpas-707: 2.0;LHCN-M2: 2.9;NB-4: 2.9;RPTEC TERT1: 5.0;THP-1: 2.1;U-937: 5.0;WM-115: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021011, HPA026682" Enhanced "Secreted to blood" NA NA 38800000 7800000 "HPA021011: AB_1848532, HPA026682: AB_1848533" "unprognostic (9.80e-3)" "unprognostic (4.70e-3)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (1.00e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-2)" "unprognostic (3.49e-1)" "unprognostic (2.70e-1)" "unprognostic (3.19e-1)" "unprognostic (1.27e-1)" "unprognostic (1.19e-1)" "unprognostic (5.00e-2)" "unprognostic (1.91e-2)" "unprognostic (2.33e-1)" "unprognostic (7.01e-2)" 48.9 24.6 3.1 90.2 4.2 5.8 35.4 5.3 3.5 17.3 6.9 45.3 44.1 18.0 7.7 38.8 22.3 45.8 21.8 2.3 8.2 45.3 43.9 33.0 57.0 6.9 5.6 1.7 11.0 8.4 5.3 8.0 21.8 6.5 10.6 57.7 0.8 14.9 11.8 8.9 14.0 70.4 46.1 6.0 163.9 23.8 6.2 5.0 30.4 18.9 24.8 27.7 74.0 7.2 10.3 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.9 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.2 0.3 5.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 5.0 5.7 2.8 256.5 226.3 3.9 380.6 1.2 4.3 2.5 3.4 160.0 2.0 1.8 3.0 294.7 2.5 379.8 6.2 4.7 174.0 3.1 4.2 5.3 3.5 2.3 8.2 6.9 5.6 1.7 6.5 6.0 5.0 10.3 102.0 6.4 12.1 0.0 26.2 38.1 1.1 0.1 3.4 1.1 1.4 3.0 4.4 0.0 5.0 88.3 10.4 1.3 60.3 17.3 5.9 1.9 7.5 2.6 0.7 50.6 0.0 7.0 0.3 0.0 1.4 102.8 2.0 5.0 10.1 0.6 45.3 5.2 36.2 1.7 0.4 0.3 0.0 466.3 571.0 9.4 27.7 430.3 49.8 33.7 463.1 13.6 39.1 0.0 0.9 0.1 10.9 19.5 82.6 1.1 42.5 5.9 2.2 7.4 0.0 166.2 8.2 0.4 0.4 2.1 31.3 3.7 24.1 0.2 0.8 1.5 STYXL1 "DUSP24, MK-STYX" ENSG00000127952 "Serine/threonine/tyrosine interacting like 1" Q9Y6J8 7 75996338-76048004 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050261 Uncertain NA No "HPA050261: AB_2681066" "unprognostic (6.24e-2)" "unprognostic (1.12e-1)" "unprognostic (7.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.88e-3)" "unprognostic (9.33e-2)" "unprognostic (1.50e-3)" "unprognostic (4.77e-2)" "unprognostic (8.01e-2)" "unprognostic (4.02e-2)" "unprognostic (4.47e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (3.17e-2)" "unprognostic (2.28e-1)" "prognostic favorable (8.22e-4)" 8.6 15.5 20.8 11.6 21.0 15.2 17.6 20.2 26.7 15.4 22.7 16.1 11.3 10.6 20.9 19.0 28.9 9.9 11.5 20.6 19.6 15.5 19.5 12.0 16.2 20.4 19.9 20.5 15.3 22.7 16.4 12.0 17.4 21.3 16.6 20.6 13.2 16.3 10.2 10.6 20.5 9.2 14.5 19.2 14.5 14.9 22.1 21.1 13.3 14.9 9.7 21.8 14.4 13.5 23.9 50.3 26.2 20.3 27.2 31.4 33.6 21.1 22.1 31.3 35.1 34.7 30.6 44.2 11.7 10.9 29.4 55.6 21.6 33.3 44.3 50.5 37.4 14.5 14.2 12.2 27.5 44.3 19.9 24.7 33.2 51.0 42.1 104.8 45.0 34.5 17.4 46.4 34.1 31.8 40.8 7.9 84.6 17.1 48.2 62.5 30.1 16.9 31.1 45.2 32.2 26.5 27.6 20.7 46.7 57.6 50.4 51.5 38.0 17.3 29.9 12.6 33.3 31.8 36.6 24.9 39.5 26.7 37.5 47.8 70.8 52.9 50.0 23.8 48.2 26.3 36.3 22.5 26.6 42.1 29.7 19.8 22.2 44.9 49.7 47.0 28.1 41.4 34.1 20.8 21.0 20.2 26.7 20.6 19.6 20.4 19.9 20.5 21.3 19.2 21.1 23.9 7.7 22.4 13.2 16.6 10.7 7.4 14.8 24.2 13.1 6.7 17.9 18.5 18.1 10.0 31.4 11.0 0.0 34.8 7.3 24.6 39.2 15.6 91.4 42.7 10.2 11.1 20.3 9.0 18.8 25.6 24.5 9.4 18.3 19.7 10.8 13.9 11.7 18.2 30.9 3.3 11.6 29.1 24.4 21.0 9.6 62.1 11.5 19.7 3.6 11.2 31.1 20.2 9.2 8.0 15.8 23.9 40.3 10.1 23.0 17.0 14.6 25.2 60.7 10.4 6.6 7.6 9.0 39.3 12.6 13.0 9.9 45.0 10.8 9.5 18.8 17.9 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306894 "Enzymes, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 114.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 12 "neutrophil: 163.6" "Lineage enriched" "Detected in many" 12 "granulocytes: 163.6" "Group enriched" "Detected in some" 6 "HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA065201 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favorable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 114.7 46.6 0.9 32.0 0.8 7.2 69.2 2.6 2.0 19.2 14.7 11.7 3.8 18.0 7.9 15.6 36.4 22.9 23.3 1.3 0.8 7.2 24.5 68.1 7.2 0.9 0.7 1.2 4.4 10.7 16.2 13.1 15.5 1.6 60.5 9.3 1.9 27.1 10.7 13.5 17.7 10.7 29.6 0.3 5.4 10.6 13.6 0.7 7.9 53.6 16.7 5.1 34.6 22.9 1.4 4.9 0.0 0.1 0.1 0.1 1.9 0.3 0.0 0.3 0.0 0.1 0.1 23.6 0.1 0.1 0.0 0.4 18.7 0.1 0.0 0.1 0.0 0.1 0.1 7.9 0.1 0.1 0.1 0.2 122.1 0.1 0.4 0.9 0.0 0.0 0.1 0.3 0.4 0.0 3.0 0.1 0.5 0.1 1.0 0.0 0.2 0.1 0.3 0.0 0.3 0.2 0.2 119.7 9.9 0.0 0.1 0.8 0.0 0.1 0.4 0.3 166.4 0.1 0.1 0.1 0.1 0.2 0.9 0.2 0.4 13.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 163.6 0.2 0.1 0.3 0.0 3.2 0.9 0.8 2.6 2.0 1.3 0.8 0.9 0.7 1.2 1.6 0.3 0.7 1.4 77.2 54.5 402.5 0.0 0.8 9.4 5.8 8.6 1.8 1.8 21.6 8.3 9.1 0.0 152.8 0.0 2.1 0.4 1.1 0.4 0.0 14.6 23.8 14.6 20.5 14.7 0.0 0.0 0.5 9.6 10.6 39.8 1.1 51.2 16.4 0.0 15.4 0.7 2.8 0.0 0.8 0.2 16.2 7.2 7.4 10.9 114.9 12.2 5.4 6.5 19.0 2.7 0.0 1.0 0.1 18.6 0.0 9.1 0.2 49.3 0.1 0.1 72.8 0.3 460.2 9.6 255.3 0.9 0.3 1.5 18.8 10.9 3.1 57.7 0.2 16.6 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 79768028-80226181 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 220.0;Oligodendrocytes: 410.7;Suprabasal keratinocytes: 214.2;Syncytiotrophoblasts: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "NK-cell: 12.8" "Lineage enriched" "Detected in many" 6 "NK-cells: 12.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome NA NA 1600000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: AB_2677870" "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 46.8 26.4 9.2 2.6 18.7 0.4 35.2 14.0 17.9 15.2 4.6 22.8 4.8 14.9 0.7 19.9 11.0 3.2 7.7 11.4 15.0 19.0 15.3 15.3 2.0 18.4 15.8 8.7 17.2 4.6 1.3 11.0 13.7 20.3 8.8 2.6 1.5 10.5 3.0 6.3 48.3 10.0 4.1 16.5 5.9 17.8 13.1 15.2 1.3 14.3 2.9 1.5 24.9 20.1 37.3 2.2 18.6 10.5 0.0 14.5 7.9 9.1 14.3 7.2 5.5 8.7 0.0 3.4 0.0 4.5 9.3 5.1 2.6 7.0 9.5 5.4 0.0 11.9 10.4 12.9 1.2 14.8 1.8 0.0 12.0 19.9 4.1 9.5 4.4 3.5 0.0 0.0 0.1 7.7 0.6 0.0 0.1 6.1 0.2 11.0 8.6 5.2 7.8 15.7 7.0 12.5 9.2 13.5 0.0 10.3 5.4 2.0 0.3 13.0 21.8 15.6 5.1 4.4 0.0 0.0 0.2 6.1 1.2 10.2 1.3 0.4 0.4 0.1 0.4 0.0 0.0 0.1 0.1 1.9 0.1 1.1 0.5 0.3 12.8 1.0 0.2 0.1 0.4 9.2 18.7 14.0 17.9 11.4 15.0 18.4 15.8 8.7 20.3 16.5 15.2 37.3 121.1 19.2 13.8 11.4 0.9 220.0 20.6 81.6 35.3 3.9 7.0 7.7 6.7 21.5 42.3 29.5 0.0 83.6 1.3 11.1 88.0 7.2 1.7 23.2 58.5 31.5 19.9 4.2 71.4 3.8 84.6 35.9 4.6 40.3 30.3 43.9 17.5 20.0 10.0 26.9 77.4 7.8 36.7 1.0 28.6 7.0 33.5 3.9 103.2 4.7 2.9 49.1 0.0 53.3 410.7 9.4 6.3 74.4 1.2 17.4 0.9 18.4 36.8 5.0 111.7 10.6 70.8 9.7 45.7 31.9 214.2 183.5 2.9 2.9 10.7 19.2 PEX1 "ZWS, ZWS1" ENSG00000127980 "Peroxisomal biogenesis factor 1" O43933 7 92487020-92528520 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis, Protein transport, Transport" "Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020235 Approved Supported Peroxisomes NA NA Peroxisomes "HPA020235: AB_1855224" "unprognostic (4.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-2)" "unprognostic (1.53e-2)" "unprognostic (4.85e-1)" "unprognostic (2.41e-2)" "unprognostic (7.81e-2)" "unprognostic (9.79e-3)" "unprognostic (2.17e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-2)" "unprognostic (3.61e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.49e-1)" "unprognostic (5.35e-3)" "unprognostic (4.90e-2)" 5.6 6.9 2.8 6.1 5.1 4.1 8.7 5.0 4.5 6.5 2.7 8.6 6.7 6.8 11.3 6.1 5.6 4.7 8.9 2.8 3.7 14.3 13.2 5.4 6.9 4.2 3.9 2.3 6.8 8.9 11.8 6.3 4.2 4.5 7.9 9.6 13.3 9.2 7.1 9.2 8.0 8.2 5.5 3.3 6.0 8.2 6.8 3.6 8.0 8.7 10.0 6.8 5.6 5.8 6.6 8.3 8.9 14.4 24.6 8.9 7.6 13.0 5.4 7.1 6.3 9.1 5.5 8.7 12.2 12.0 6.3 9.6 8.4 11.0 9.9 10.0 12.7 9.7 5.8 9.5 7.0 6.2 10.6 6.4 8.2 8.6 9.4 12.7 8.0 9.9 12.6 21.9 17.2 10.1 15.5 21.3 10.4 10.0 12.3 8.3 15.0 16.0 15.3 8.8 12.0 10.6 17.1 12.4 34.3 10.8 20.2 7.1 4.4 8.1 6.0 8.1 23.0 5.7 18.9 15.9 16.7 5.7 6.2 9.8 0.8 1.1 1.8 2.5 1.8 2.5 3.0 2.6 2.8 1.2 2.8 2.9 3.3 0.9 4.7 2.2 0.7 2.8 1.1 2.8 5.1 5.0 4.5 2.8 3.7 4.2 3.9 2.3 4.5 3.3 3.6 6.6 14.2 28.9 18.4 26.1 14.1 5.9 8.4 8.1 10.8 43.5 11.7 12.6 29.7 5.7 13.1 5.5 35.5 9.0 13.6 17.2 9.8 6.6 7.3 22.6 14.7 11.6 13.9 12.4 30.0 7.5 3.9 11.6 21.9 14.2 8.8 20.5 8.2 14.2 5.4 40.4 45.7 12.0 8.2 7.6 3.1 4.8 14.3 8.4 7.2 13.1 12.7 14.2 14.4 23.6 55.2 6.0 11.3 15.1 11.6 9.6 16.5 19.2 32.4 42.9 6.6 15.5 12.6 36.6 14.4 11.2 7.7 8.3 12.0 11.8 15.2 7.7 MTERF1 MTERF ENSG00000127989 "Mitochondrial transcription termination factor 1" Q99551 7 91692008-91880702 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044894, HPA069560" Uncertain Supported Mitochondria NA NA Mitochondria "HPA044894: AB_10966284, HPA069560: AB_2686154" "unprognostic (5.57e-2)" "unprognostic (7.31e-2)" "unprognostic (2.15e-2)" "unprognostic (1.50e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (3.15e-3)" "unprognostic (1.25e-2)" "unprognostic (1.46e-3)" "unprognostic (7.62e-2)" "unprognostic (2.67e-1)" "unprognostic (5.19e-2)" "unprognostic (3.21e-2)" "unprognostic (1.14e-1)" "unprognostic (3.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" 4.7 6.1 3.9 8.0 5.3 10.1 9.3 4.9 5.5 5.4 4.0 7.6 7.0 7.1 7.6 7.3 6.0 5.4 6.0 4.3 4.7 8.4 11.3 5.3 14.1 4.5 4.1 4.0 8.4 5.9 6.6 5.1 7.1 5.1 6.2 7.9 6.5 7.6 5.9 5.1 6.3 6.9 6.2 4.0 9.8 8.2 6.7 4.4 11.5 7.5 9.0 13.4 5.8 5.9 7.0 17.3 15.0 13.3 9.0 12.2 13.9 12.6 14.2 14.3 15.8 19.6 16.9 17.7 36.8 11.9 11.0 21.3 15.2 21.3 13.4 23.9 1.9 14.5 16.1 17.2 13.4 11.6 29.3 15.7 17.2 16.3 15.8 18.5 11.4 12.9 8.1 31.2 15.0 18.1 22.2 31.5 27.0 22.2 20.1 16.5 9.3 19.2 23.4 15.8 17.5 12.8 23.4 13.9 30.1 29.0 24.3 10.9 19.4 9.5 18.4 22.2 25.4 14.9 19.4 21.9 48.7 13.0 9.4 26.9 46.0 12.9 18.5 14.6 11.2 18.5 22.0 19.2 21.9 14.1 23.9 26.1 20.7 6.2 16.1 13.5 11.2 20.1 15.1 3.9 5.3 4.9 5.5 4.3 4.7 4.5 4.1 4.0 5.1 4.0 4.4 7.0 5.5 9.6 10.6 6.2 10.5 0.0 3.9 0.0 14.8 0.0 5.3 6.7 5.3 5.7 2.5 3.7 0.0 9.3 8.0 3.4 5.9 5.9 1.5 4.5 7.0 4.9 1.2 8.2 7.9 5.2 6.3 6.2 7.7 4.0 5.1 8.3 6.4 9.6 5.1 0.0 7.2 2.6 0.0 6.0 0.0 2.1 6.8 5.9 0.0 5.6 7.1 0.0 10.3 8.0 15.2 4.1 3.1 7.2 12.6 3.9 7.2 8.2 1.5 0.0 13.1 5.0 5.3 14.0 10.5 6.3 0.0 4.5 8.0 8.5 4.1 2.7 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6" "Group enriched" "Detected in many" 4 "B-cells: 6.6;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 170000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 38.7 64.0 22.2 9.5 23.7 0.4 36.8 24.4 31.8 45.3 23.5 39.7 8.0 43.6 27.4 13.4 41.1 27.9 33.4 21.8 27.7 19.7 14.5 30.8 16.8 24.9 24.0 22.1 93.0 21.6 11.0 31.2 53.2 24.3 18.2 13.0 16.9 21.3 31.9 8.6 7.8 19.4 42.1 24.1 25.3 24.0 18.6 22.9 12.9 24.1 20.0 7.2 35.9 34.9 28.9 13.5 42.5 39.6 61.8 63.7 110.8 7.1 51.3 92.3 40.7 60.4 24.9 78.0 12.8 70.4 86.5 83.7 9.4 60.0 21.6 49.1 2.2 32.7 1.4 36.9 28.3 44.0 4.3 0.0 95.5 31.1 64.8 79.3 104.9 30.8 0.0 0.1 93.7 43.5 42.6 0.0 0.0 32.8 8.0 29.0 19.8 51.0 25.8 78.6 13.6 26.2 20.8 0.0 52.2 65.1 44.2 17.6 0.8 0.0 131.1 45.1 11.8 81.7 50.8 67.9 14.8 51.4 0.2 74.2 0.7 0.0 0.1 2.1 0.0 0.8 4.4 0.6 1.0 0.0 6.6 0.2 0.7 0.3 1.0 0.1 0.2 0.2 0.3 22.2 23.7 24.4 31.8 21.8 27.7 24.9 24.0 22.1 24.3 24.1 22.9 28.9 39.2 70.5 33.3 66.9 6.1 5.0 18.4 16.8 1.8 18.6 9.7 44.4 18.6 30.0 28.3 20.2 4.2 90.2 1.4 0.0 5.9 42.5 1.6 4.0 17.1 18.8 1.2 0.4 85.2 4.3 26.1 116.6 1.5 6.6 2.5 37.3 58.2 11.2 6.3 20.2 68.5 0.1 12.2 2.5 7.3 3.7 75.5 1.4 51.6 15.9 0.0 31.5 0.0 133.2 116.3 2.1 0.0 58.3 2.6 5.5 0.0 14.1 13.7 30.3 85.5 68.0 60.7 17.1 13.0 0.9 4.0 82.8 2.7 44.0 0.0 2.2 RBM48 "C7orf64, DKFZp564O0523, HSPC304" ENSG00000127993 "RNA binding motif protein 48" Q5RL73 7 92528773-92540481 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021777, HPA025306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021777: AB_1845763, HPA025306: AB_1845764" "unprognostic (2.79e-2)" "unprognostic (2.15e-1)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (2.81e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.86e-2)" "unprognostic (2.37e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-3)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (2.43e-2)" "unprognostic (8.04e-2)" 8.1 8.7 9.0 5.7 10.3 14.2 8.3 11.0 12.2 8.8 7.3 7.8 5.4 8.3 4.8 7.7 8.5 3.8 8.8 9.2 9.2 7.1 9.1 6.5 8.4 10.2 9.7 9.7 9.8 8.5 4.7 7.5 4.6 10.3 8.3 4.7 6.6 8.4 3.4 13.6 7.9 9.0 3.7 7.8 11.4 8.0 9.0 9.2 6.6 8.5 7.1 6.5 7.4 8.4 13.0 5.5 4.0 6.8 11.1 6.5 7.3 5.4 6.5 5.2 6.4 6.1 4.9 6.9 8.0 11.8 4.4 9.9 6.2 6.6 4.6 7.9 7.8 9.4 5.3 12.0 5.8 5.2 10.2 7.1 5.2 8.5 7.2 6.5 8.9 6.9 10.1 11.5 13.1 6.9 5.6 12.1 10.1 6.1 6.9 5.8 6.5 6.1 9.8 5.9 5.9 7.6 9.9 5.7 11.6 8.6 8.3 3.7 8.5 4.4 11.7 6.3 9.1 8.9 8.6 11.1 13.3 5.3 8.6 11.0 67.8 12.4 30.3 23.2 16.3 25.7 28.5 25.1 23.7 12.3 28.7 32.1 27.3 19.2 26.2 13.3 14.3 25.7 16.0 9.0 10.3 11.0 12.2 9.2 9.2 10.2 9.7 9.7 10.3 7.8 9.2 13.0 13.5 12.8 7.5 8.1 23.5 8.5 13.2 11.9 12.5 12.7 8.7 7.7 16.7 5.7 10.9 3.7 0.0 10.9 18.8 6.9 7.9 9.2 9.4 9.5 12.3 13.8 0.0 8.6 20.5 6.0 5.8 11.7 6.6 12.9 30.4 11.9 7.9 3.7 6.2 11.8 15.8 4.0 14.2 6.8 6.4 5.9 5.9 8.1 5.4 5.6 9.8 11.5 26.8 11.1 34.3 5.5 6.2 6.4 16.6 10.5 7.0 9.6 7.8 13.2 13.1 15.0 13.7 24.0 15.5 9.9 11.4 15.3 18.9 8.4 5.7 11.8 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.7;Inhibitory neurons: 108.5;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 11.2 25.6 11.2 9.7 14.8 6.1 15.8 11.9 13.5 11.4 5.1 16.7 6.5 14.2 14.7 6.4 11.1 10.0 17.3 15.1 15.6 12.5 9.1 11.4 12.6 9.6 11.0 9.9 16.6 9.9 13.9 8.7 12.4 11.9 14.0 19.5 22.3 20.4 9.5 14.3 3.8 6.2 11.1 8.7 10.7 7.4 13.3 13.6 11.3 16.2 19.7 10.8 9.2 4.4 15.8 5.5 10.4 34.7 12.9 10.4 12.3 5.9 7.2 12.8 7.9 10.2 6.5 13.2 13.9 18.5 9.8 14.1 3.0 8.8 2.5 15.4 22.2 7.1 12.3 8.5 11.9 8.8 20.5 0.0 11.4 9.2 7.2 10.3 15.4 12.6 16.0 6.7 29.3 19.6 8.0 28.5 11.6 17.7 7.7 8.2 19.3 28.0 10.8 15.9 14.9 13.1 44.5 11.4 20.7 7.4 24.9 5.4 12.8 6.7 19.6 15.5 16.2 10.6 28.0 28.1 28.5 10.7 4.7 12.9 0.0 0.2 0.0 0.6 0.2 1.6 0.6 0.9 0.8 0.4 0.5 0.9 0.7 0.0 0.6 0.2 0.3 0.6 0.2 11.2 14.8 11.9 13.5 15.1 15.6 9.6 11.0 9.9 11.9 8.7 13.6 15.8 26.2 28.9 26.3 76.0 15.4 4.6 5.8 5.8 4.0 56.4 14.4 12.8 21.1 17.2 12.8 20.2 18.8 14.2 14.6 29.7 3.9 5.1 3.4 18.0 13.1 16.4 7.2 4.6 93.7 5.6 5.7 14.6 5.1 9.9 10.2 23.7 16.1 13.3 8.8 67.3 108.5 30.2 2.0 9.8 5.5 7.0 11.5 10.8 24.9 61.8 7.1 23.3 10.3 122.6 170.3 6.8 11.8 9.8 9.2 10.0 0.6 10.8 18.1 31.4 19.7 41.2 12.2 9.6 12.8 4.7 4.5 16.8 12.2 25.8 19.5 4.5 ZNF780B ZNF779 ENSG00000128000 "Zinc finger protein 780B" Q9Y6R6 19 40028260-40056231 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 53.8;Excitatory neurons: 56.5;Inhibitory neurons: 59.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (3.28e-1)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (3.56e-3)" "unprognostic (5.54e-2)" "unprognostic (1.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.24e-2)" "unprognostic (4.59e-3)" "unprognostic (1.83e-3)" "unprognostic (1.33e-2)" "unprognostic (4.89e-3)" "unprognostic (4.71e-2)" "unprognostic (1.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-3)" 2.2 3.0 1.0 1.8 2.3 1.0 2.7 5.1 2.2 4.1 3.0 3.6 1.1 3.8 3.6 2.2 4.1 1.4 4.7 1.4 1.3 2.9 3.0 2.5 3.3 1.1 1.2 1.9 6.3 2.8 2.6 7.8 2.0 1.8 4.0 2.3 14.3 3.4 2.8 3.2 1.6 3.2 2.4 0.7 3.3 3.0 2.4 1.0 3.3 5.9 2.2 3.1 4.0 3.5 2.8 2.0 2.5 5.0 2.4 2.0 1.1 0.0 2.6 1.7 2.8 3.8 5.0 1.5 5.7 2.3 2.4 2.1 1.3 3.2 1.4 2.9 4.6 1.6 4.5 6.2 2.9 1.6 6.1 3.1 2.5 0.6 3.9 1.7 2.2 2.1 2.5 4.7 7.4 2.3 0.5 1.8 0.7 4.0 1.7 2.5 3.1 8.7 1.7 1.2 12.2 3.9 5.0 4.7 1.4 1.2 2.7 1.7 2.3 4.1 1.7 6.4 4.3 3.6 5.6 7.8 3.9 2.3 2.6 1.7 0.0 1.3 0.6 1.1 1.2 1.1 1.0 1.3 1.3 1.0 1.6 1.9 1.7 0.1 1.1 0.8 2.5 0.9 0.6 1.0 2.3 5.1 2.2 1.4 1.3 1.1 1.2 1.9 1.8 0.7 1.0 2.8 5.3 9.6 9.6 53.8 11.2 1.9 2.7 4.9 1.2 25.6 3.8 5.2 13.1 7.2 7.9 9.2 33.3 1.8 13.0 2.5 3.9 5.6 8.9 2.7 7.0 6.2 10.3 4.6 56.5 10.0 1.5 5.6 5.1 2.7 7.6 8.1 10.0 5.0 3.7 10.1 59.6 4.2 12.2 5.8 5.8 1.8 3.7 4.7 5.4 38.4 7.6 6.2 4.1 56.3 78.0 6.8 4.2 3.0 4.5 1.7 3.5 3.4 4.8 34.7 6.6 5.5 5.3 2.4 2.8 2.8 3.0 0.7 8.0 3.4 4.4 2.0 LRFN1 "KIAA1484, SALM2" ENSG00000128011 "Leucine rich repeat and fibronectin type III domain containing 1" Q9P244 19 39306566-39320863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 32.5;Cone photoreceptor cells: 8.4;NK-cells: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 16.9;HEK 293: 20.2;K-562: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.92e-3)" "unprognostic (2.00e-1)" "unprognostic (6.36e-4)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.87e-2)" "unprognostic (6.75e-2)" "unprognostic (4.25e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.45e-3)" "unprognostic (1.08e-1)" "unprognostic (0.00e+0)" "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.78e-1)" 1.1 0.5 4.4 0.6 4.6 0.5 1.2 2.6 8.5 1.3 0.0 1.0 0.4 1.9 0.5 0.7 1.2 0.1 0.4 4.9 2.5 0.5 0.8 1.9 0.4 3.1 1.6 6.0 0.8 3.0 0.7 0.9 0.2 3.0 1.0 0.1 1.1 1.0 0.1 0.1 1.1 1.3 0.2 0.0 4.0 1.1 0.7 2.5 1.1 0.9 0.0 0.2 0.5 0.7 3.2 1.2 5.4 0.1 4.7 0.0 0.0 5.6 0.2 0.0 0.3 0.1 16.9 0.6 0.5 2.2 0.0 1.3 0.3 2.1 0.1 0.2 0.5 20.2 0.8 0.8 0.7 0.1 0.3 4.4 0.3 0.2 0.1 0.0 0.4 0.1 6.1 8.9 0.5 0.0 2.8 2.3 2.7 2.3 1.7 5.5 7.5 0.0 1.8 0.0 0.2 1.5 8.0 1.9 3.5 1.4 0.4 1.7 1.8 0.3 1.9 6.6 1.6 0.2 0.8 0.3 2.0 0.1 1.0 0.6 0.4 0.0 0.9 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.6 0.4 0.2 0.1 0.0 0.0 4.4 4.6 2.6 8.5 4.9 2.5 3.1 1.6 6.0 3.0 0.0 2.5 3.2 1.9 0.0 0.0 2.0 0.5 0.8 0.2 0.0 0.0 32.5 1.4 1.5 0.8 1.5 0.0 0.0 8.4 0.7 3.3 0.1 0.0 0.2 0.1 0.0 0.4 1.3 0.0 0.4 5.6 0.7 0.4 0.8 0.0 0.0 0.0 3.2 2.9 1.0 1.0 3.3 5.7 0.0 0.0 3.5 1.4 0.1 0.0 1.9 0.0 1.9 3.7 6.3 11.3 3.5 0.6 0.2 0.0 2.6 0.5 0.7 0.0 0.1 0.0 2.6 0.0 0.0 0.3 1.2 0.8 0.5 0.4 0.8 2.9 1.6 0.0 0.2 ZFP36 "G0S24, NUP475, RNF162A, TIS11, TTP" ENSG00000128016 "ZFP36 ring finger protein" P26651 19 39406847-39409412 "Predicted intracellular proteins" "Host-virus interaction, mRNA transport, RNA-mediated gene silencing, Transport" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 2759.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 421.6" "Immune cell enhanced" "Detected in all" "neutrophil: 313.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 154.7;hTCEpi: 179.0;Karpas-707: 167.0;U-266/84: 149.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "spinal cord: 151.4" HPA006009 Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA006009: AB_1859030" "unprognostic (2.30e-2)" "unprognostic (2.27e-1)" "unprognostic (8.26e-2)" "unprognostic (6.76e-2)" "unprognostic (4.74e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.59e-2)" "unprognostic (5.20e-1)" "unprognostic (3.61e-3)" "unprognostic (9.44e-2)" "unprognostic (3.11e-1)" "unprognostic (4.20e-3)" "unprognostic (5.22e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (6.92e-3)" 1096.7 344.9 58.5 260.4 49.7 752.1 722.5 52.0 74.6 368.1 79.3 513.5 169.9 318.7 17.2 650.7 1288.4 524.6 436.3 34.9 421.6 287.3 465.9 1145.2 176.5 134.0 47.1 27.0 484.6 162.0 125.4 313.9 121.9 64.8 345.2 177.3 39.5 332.4 145.0 325.4 695.9 325.3 429.5 70.3 284.4 559.0 49.8 70.4 272.1 514.4 284.1 73.7 528.4 718.4 158.2 27.5 16.5 4.3 1.5 108.8 154.7 7.7 20.8 26.7 11.2 8.7 12.8 28.3 16.8 6.2 32.7 12.1 13.2 1.0 35.0 3.5 21.1 1.6 7.2 12.1 8.0 70.2 7.4 41.6 56.7 179.0 8.0 66.3 14.6 6.6 18.7 10.2 167.0 19.4 21.5 13.2 17.7 1.6 83.4 2.6 18.9 2.3 35.9 14.9 43.6 1.2 4.2 10.1 23.6 6.1 6.3 16.8 39.8 11.4 15.3 6.1 28.2 6.3 116.5 149.7 19.5 15.4 15.1 6.4 121.8 72.2 68.8 38.8 69.9 32.8 47.8 33.4 39.5 69.0 45.5 38.0 37.0 313.6 17.4 95.5 50.9 41.9 44.3 58.5 49.7 52.0 74.6 34.9 421.6 134.0 47.1 27.0 64.8 70.3 70.4 158.2 2759.0 419.9 864.0 7.5 686.2 1160.4 1543.0 789.3 2108.6 0.4 819.5 566.2 514.9 351.8 426.9 80.9 4.2 70.3 962.4 628.2 31.3 234.2 6.1 528.1 797.5 1208.6 631.9 109.2 0.4 105.6 95.5 2072.6 881.3 1055.0 690.7 45.7 668.6 206.4 703.1 1.7 0.2 608.3 250.3 669.9 2332.1 17.4 557.7 1189.0 631.5 24.4 125.6 55.0 94.7 0.0 1.6 156.4 907.8 139.5 1540.1 823.3 1060.8 60.2 298.5 7.1 769.2 878.2 1346.7 2.9 5.4 1641.6 1585.6 154.2 1193.0 87.1 366.5 639.9 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346213-55373100 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 79.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 12.3 12.1 10.5 2.6 11.5 3.8 12.3 11.1 12.5 11.9 9.5 6.3 3.8 6.8 4.2 26.3 5.6 10.4 9.0 11.0 11.1 8.6 14.6 10.6 2.5 11.5 11.4 10.7 3.2 20.4 7.0 6.0 4.0 11.3 7.5 4.2 1.5 16.5 2.9 6.3 14.9 7.1 2.6 10.9 6.9 9.8 3.3 11.0 6.1 7.7 5.5 6.0 10.1 14.8 13.0 9.7 4.3 10.3 10.1 29.4 20.4 5.6 10.4 9.3 2.4 5.4 6.5 19.5 21.2 11.7 11.0 11.1 7.0 5.3 7.9 3.9 6.6 17.1 12.3 5.2 15.8 9.2 23.7 6.1 17.6 14.5 5.4 5.3 7.8 14.4 38.5 21.2 47.7 21.1 10.8 36.0 10.3 13.0 53.2 9.3 11.4 3.3 14.0 12.8 7.9 16.0 9.1 10.7 79.6 8.3 9.0 9.4 17.9 8.3 25.0 4.7 2.0 8.1 28.6 15.8 7.9 34.1 29.5 25.9 25.6 35.8 11.7 16.1 56.5 18.6 12.5 12.0 15.2 30.2 12.7 10.2 14.4 1.8 8.6 59.5 61.7 12.5 23.1 10.5 11.5 11.1 12.5 11.0 11.1 11.5 11.4 10.7 11.3 10.9 11.0 13.0 25.4 9.6 15.9 4.6 7.8 13.6 13.3 245.5 5.2 4.9 43.8 29.3 5.3 34.3 245.2 5.5 4.2 27.0 21.2 12.2 3.9 93.4 3.2 51.2 31.0 19.6 12.0 14.9 11.1 105.4 106.0 16.2 13.3 105.9 14.0 6.7 17.5 18.6 63.4 10.1 17.1 22.6 57.0 32.4 34.1 0.5 1.8 27.6 24.9 4.7 31.3 21.9 18.6 8.5 23.4 155.5 10.0 5.7 16.8 17.5 9.4 18.4 195.0 3.9 13.1 13.3 28.2 3.5 20.1 32.7 29.7 7.5 7.2 15.4 23.3 108.6 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor Kazal type 2" P20155 4 56809860-56821742 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "epididymis: 5356.9" "Group enriched" "Detected in many" 10 "Early spermatids: 1217.2;Late spermatids: 1399.4;Spermatocytes: 1989.6" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "NK-cell: 146.4" "Lineage enriched" "Detected in many" 7 "NK-cells: 146.4" "Cell line enriched" "Detected in some" 4 "U-266/70: 90.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB020824, HPA026813" Enhanced "Secreted to blood" NA NA "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favorable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.5 0.1 0.2 1.1 0.2 13.6 1.4 0.1 0.7 0.7 1.5 2.8 1.9 0.3 5356.9 0.2 0.3 0.1 3.8 0.2 0.3 0.2 0.2 0.2 4.8 0.3 0.4 0.2 0.4 0.1 0.0 4.2 0.0 0.3 3.6 2.1 0.0 2.0 242.9 1.8 0.5 3.1 0.3 0.2 1.8 3.1 348.8 0.3 3.9 0.6 2.3 4.9 0.5 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.7 2.9 18.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 6.0 0.3 3.0 0.0 0.0 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 90.5 0.4 0.0 0.0 0.0 0.0 4.4 0.0 1.1 0.5 0.1 0.6 9.1 5.1 5.4 1.4 10.5 11.1 21.6 0.9 146.4 0.0 0.8 0.3 5.4 0.2 0.2 0.1 0.7 0.2 0.3 0.3 0.4 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.0 0.0 7.2 2.0 14.2 1.8 1.8 0.0 0.2 0.6 3.4 0.0 0.2 0.0 0.0 0.0 2.5 1.4 0.0 0.0 1217.2 0.2 0.1 1.6 1.8 32.4 0.3 0.0 0.3 0.8 0.5 0.2 1.3 0.3 0.0 0.0 0.1 0.0 0.2 10.4 0.0 0.0 3.6 1399.4 37.9 2.5 12.4 0.0 1.6 1.5 1.0 0.0 0.1 0.0 13.1 24.5 35.2 9.5 0.4 0.3 0.3 0.0 13.1 0.4 1.9 1989.6 149.9 0.1 0.3 0.0 16.8 0.0 2.6 2.6 RASL11B ENSG00000128045 "RAS like family 11 member B" Q9BPW5 4 52862317-52866835 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.8;ovary: 67.0" "Cell type enhanced" "Detected in many" "Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057803 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA057803: AB_2683533" "unprognostic (1.60e-1)" "unprognostic (1.95e-1)" "unprognostic (7.32e-3)" "unprognostic (1.19e-1)" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (1.22e-1)" "unprognostic (7.66e-2)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (9.71e-2)" "unprognostic (8.72e-2)" "unprognostic (7.20e-4)" "unprognostic (7.17e-2)" "unprognostic (1.35e-1)" "unprognostic (5.00e-6)" "unprognostic (1.10e-1)" 1.6 2.1 1.9 0.5 3.9 0.0 1.1 2.9 5.8 4.1 0.9 0.8 0.0 9.9 2.7 0.5 4.2 0.9 14.8 4.6 2.2 17.7 0.6 1.0 0.8 0.3 0.8 3.7 67.0 0.9 7.9 0.7 4.7 1.0 2.1 0.1 0.3 1.4 9.2 0.4 3.0 0.9 1.9 0.2 27.8 4.2 5.9 1.1 0.1 1.0 0.2 1.0 2.2 4.9 3.4 0.3 0.0 5.9 0.0 5.2 2.4 14.1 0.1 0.1 0.3 0.0 11.1 0.0 0.0 0.5 0.0 0.1 0.0 0.7 3.5 0.0 0.0 1.4 0.5 0.0 0.0 1.0 0.0 0.4 2.5 6.2 0.0 0.2 0.0 0.0 0.3 0.7 0.0 0.0 1.3 1.1 0.0 15.2 1.3 0.2 0.0 6.8 0.0 10.2 1.5 3.2 38.5 0.2 2.6 1.3 10.1 1.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.9 3.9 2.9 5.8 4.6 2.2 0.3 0.8 3.7 1.0 0.2 1.1 3.4 1.1 6.4 0.0 0.3 0.9 0.9 1.5 2.8 0.0 4.9 7.5 6.5 5.3 0.0 1.8 33.1 0.0 102.6 1.5 7.1 0.0 1.5 0.4 1.6 6.9 1.2 0.0 0.0 2.7 0.5 62.2 4.6 9.7 2.7 0.0 26.6 1.1 0.0 8.0 0.0 1.1 3.6 0.0 0.3 1.7 3.3 24.2 0.8 0.0 4.7 0.6 1.9 0.0 0.5 0.9 0.5 5.6 68.4 0.1 0.5 1.6 0.1 0.1 1.2 0.0 5.8 5.7 4.6 10.9 1.2 0.4 23.1 0.9 6.1 2.8 0.2 PAICS "ADE2H1, AIRC, PAIS" ENSG00000128050 "Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase" P22234 4 56435741-56464578 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Decarboxylase, Ligase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 157.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035895, HPA041538" Approved Approved Cytosol Yes No 490000 Cytosol "HPA035895: AB_10669660, HPA041538: AB_2677540" "unprognostic (2.59e-3)" "unprognostic (7.90e-3)" "unprognostic (3.84e-3)" "unprognostic (2.88e-2)" "unprognostic (9.85e-2)" "unprognostic (2.82e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.07e-3)" "unprognostic (1.23e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.48e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.11e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.16e-1)" 24.7 40.6 23.0 40.4 26.1 47.2 55.1 29.2 25.3 29.5 21.0 43.2 32.4 29.9 22.3 36.6 35.7 18.0 19.9 20.6 26.9 43.1 110.6 14.2 51.7 27.5 28.0 20.3 30.9 21.9 39.9 17.9 46.3 26.7 31.3 55.3 30.6 26.6 26.0 32.7 37.9 31.0 36.0 26.1 18.4 20.9 29.8 27.2 56.9 32.7 24.3 65.0 37.8 25.6 27.8 239.3 175.3 354.3 220.6 74.3 166.1 304.0 201.7 145.1 282.5 276.0 280.5 275.7 548.0 228.3 136.0 154.1 143.6 565.5 293.0 480.8 110.4 198.8 298.7 259.5 313.4 141.8 537.1 127.6 141.9 207.9 301.0 225.0 155.7 235.4 308.6 524.7 198.5 246.8 159.3 621.5 267.2 407.5 454.8 216.5 496.2 151.7 361.5 268.4 164.5 378.8 226.4 198.6 273.7 124.3 287.2 181.2 169.8 127.7 222.6 290.1 221.8 419.0 139.1 128.2 571.1 234.8 385.2 251.0 6.0 5.2 0.4 5.2 8.7 15.0 17.8 14.4 9.2 15.3 11.0 17.4 15.5 1.1 15.9 6.9 17.0 11.2 8.7 23.0 26.1 29.2 25.3 20.6 26.9 27.5 28.0 20.3 26.7 26.1 27.2 27.8 16.4 22.4 22.9 17.0 35.7 56.6 71.9 66.0 54.1 27.4 35.8 37.5 23.3 50.1 32.3 33.1 6.2 134.4 15.3 20.5 37.2 45.0 69.4 15.2 49.1 25.1 24.7 80.8 9.1 26.3 157.5 34.2 15.3 23.3 21.0 69.1 13.2 78.7 51.5 28.6 14.6 41.0 34.6 16.1 17.2 10.6 29.8 16.1 17.8 6.5 20.2 14.0 6.2 13.0 12.2 27.4 18.6 23.3 48.1 81.7 15.9 47.7 17.9 24.6 0.0 31.3 29.2 40.0 50.3 53.1 50.4 54.6 16.8 66.4 69.7 48.9 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078481-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6" "Cancer enhanced" "Detected in all" "renal cancer: 27.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 74.8;TIME: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004028, HPA073577" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 11000000 Vesicles "Nuclear membrane" "CAB004028: AB_2212507, HPA073577: " "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 31.9 11.8 3.7 4.3 3.9 0.0 26.3 3.0 4.3 13.8 9.7 5.8 2.3 39.8 2.9 4.1 18.0 5.7 16.8 2.5 6.6 15.5 9.2 23.7 2.9 4.1 3.9 1.4 5.2 6.3 8.6 11.1 31.1 4.0 11.8 1.0 16.5 5.4 10.1 6.6 5.4 7.6 7.6 3.4 4.5 8.4 1.8 4.8 1.0 34.7 4.7 1.0 8.7 7.6 3.7 0.0 0.0 4.4 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.5 0.0 0.0 0.9 0.0 0.0 0.4 0.2 74.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.9 3.0 4.3 2.5 6.6 4.1 3.9 1.4 4.0 3.4 4.8 3.7 157.8 0.0 4.9 0.0 1.4 2.5 0.5 0.1 1.8 11.7 1.3 2.5 9.4 1.5 18.4 0.0 0.0 0.1 0.8 0.0 0.0 0.5 0.8 0.4 2.6 143.8 0.0 2.7 0.1 0.0 0.1 8.3 0.0 0.8 2.5 0.0 158.1 3.3 0.4 0.0 1.3 0.0 0.0 10.6 2.1 0.9 0.0 1.2 7.2 7.5 0.0 206.6 0.0 0.0 6.1 0.5 0.0 0.4 1.3 0.5 0.0 0.0 3.9 7.9 0.0 0.9 7.5 0.3 0.9 0.8 2.7 0.1 0.6 1.6 0.0 1.4 PPAT "GPAT, PRAT" ENSG00000128059 "Phosphoribosyl pyrophosphate amidotransferase" Q06203 4 56393362-56435615 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Purine biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036091, HPA036092" Approved Approved "Midbody ring" Yes No 11000 "Midbody ring" "HPA036091: AB_2674936, HPA036092: AB_10603132" "unprognostic (5.11e-2)" "unprognostic (5.13e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (1.38e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (1.14e-8)" "unprognostic (6.74e-3)" "unprognostic (2.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.88e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.34e-4)" "unprognostic (1.41e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.09e-1)" 2.8 6.1 4.2 5.4 4.3 5.6 7.2 4.0 4.8 4.3 3.6 4.0 4.0 4.7 3.4 4.5 4.4 3.1 2.3 4.2 4.2 6.1 6.2 2.2 8.4 3.8 4.5 4.0 7.5 6.0 4.0 2.5 6.8 4.2 3.9 4.8 4.4 5.7 3.1 2.9 4.4 3.2 3.6 3.8 4.3 3.6 8.7 4.2 8.4 6.0 3.0 8.0 6.8 2.7 4.2 23.1 19.0 38.0 18.7 12.2 15.7 31.0 25.2 11.1 20.4 21.6 38.1 27.5 80.6 33.4 11.9 19.0 16.8 74.0 25.4 40.7 21.1 32.8 32.6 22.6 42.2 18.4 65.0 19.5 13.6 19.4 29.0 32.4 12.6 21.8 32.5 83.5 43.3 23.2 20.9 80.6 49.1 50.6 52.0 22.4 67.2 24.9 56.9 34.2 16.2 64.0 31.2 20.1 36.3 23.0 35.4 24.5 13.8 15.3 21.2 36.6 21.4 45.0 32.2 34.5 82.9 23.6 40.7 20.1 4.7 1.8 0.9 3.8 2.7 5.9 7.4 5.1 5.2 2.5 6.1 7.7 7.1 0.5 10.2 3.9 3.2 4.3 3.5 4.2 4.3 4.0 4.8 4.2 4.2 3.8 4.5 4.0 4.2 3.8 4.2 4.2 4.8 0.0 5.5 16.6 10.7 31.0 16.0 5.6 28.5 8.4 10.1 9.7 3.8 4.3 8.0 3.7 2.1 29.7 10.3 1.5 9.8 3.7 2.6 5.5 14.1 7.8 4.2 14.9 22.9 2.7 25.2 9.4 4.1 6.9 7.0 66.2 5.3 7.1 7.9 38.7 15.8 4.3 4.1 1.6 6.0 2.6 7.8 5.2 8.8 5.6 3.1 6.4 2.1 5.5 9.1 3.3 2.7 5.7 15.3 15.0 0.8 12.7 6.2 4.7 0.0 9.3 10.8 16.4 27.5 18.3 31.8 7.7 10.7 21.9 9.0 8.7 TUBGCP6 "DJ402G11.6, GCP6, KIAA1669" ENSG00000128159 "Tubulin gamma complex associated protein 6" Q96RT7 22 50217689-50245023 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043928 Approved NA NA "HPA043928: AB_10960352" "unprognostic (4.26e-2)" "unprognostic (1.62e-3)" "unprognostic (2.86e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.96e-3)" "unprognostic (2.73e-1)" "unprognostic (2.21e-2)" "unprognostic (2.67e-1)" "unprognostic (1.00e-2)" "prognostic favorable (5.75e-4)" "unprognostic (2.90e-3)" "unprognostic (1.90e-2)" "unprognostic (1.04e-2)" "unprognostic (9.71e-2)" "unprognostic (7.53e-2)" "prognostic favorable (3.18e-5)" 10.5 15.1 10.2 12.5 9.7 13.3 12.3 13.0 15.1 15.5 9.7 12.2 9.9 15.3 6.8 10.1 15.8 10.3 10.8 9.6 8.2 15.1 12.8 12.0 16.6 10.2 8.5 11.4 18.4 23.6 12.3 22.4 8.2 10.2 16.5 4.7 5.9 16.0 8.9 15.0 13.0 16.5 6.2 6.1 17.3 16.1 12.5 8.4 15.6 19.9 7.0 10.2 12.8 10.8 12.1 8.0 7.0 12.6 15.2 9.8 9.2 8.6 8.9 5.8 6.2 7.5 5.1 6.6 7.0 6.4 9.1 5.6 9.1 6.3 9.4 2.9 7.2 19.8 6.9 32.7 6.6 6.7 14.6 13.0 13.2 8.4 8.0 6.6 10.5 9.3 14.8 7.2 18.5 5.8 8.3 11.1 12.3 4.2 3.7 4.6 13.4 7.0 14.6 5.2 9.9 4.6 9.1 7.0 12.8 3.7 5.2 6.9 8.3 9.7 9.2 6.6 8.1 6.5 19.4 4.0 8.6 8.0 6.4 6.2 0.7 0.9 0.7 2.2 0.8 1.6 1.0 1.6 2.4 1.0 1.1 1.4 1.7 1.0 1.1 0.7 1.5 2.4 1.2 10.2 9.7 13.0 15.1 9.6 8.2 10.2 8.5 11.4 10.2 6.1 8.4 12.1 8.4 9.6 17.2 22.9 10.8 6.4 2.8 6.8 5.2 9.3 9.4 11.0 8.1 7.2 8.3 11.0 16.7 4.6 12.5 8.2 3.9 4.2 2.0 7.2 7.4 6.4 9.0 7.0 13.9 3.6 3.2 8.4 17.9 9.3 6.3 11.5 5.3 7.1 4.4 6.7 12.0 8.1 6.1 9.8 6.2 3.8 9.6 8.6 7.2 9.4 4.6 3.2 9.2 6.6 10.0 4.6 4.9 6.8 11.5 3.9 10.1 2.6 13.2 11.0 6.6 7.8 7.0 10.8 10.0 6.2 5.5 3.4 12.4 10.4 7.7 3.1 ADM2 "AM2, FLJ21135" ENSG00000128165 "Adrenomedullin 2" Q7Z4H4 22 50481543-50486440 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.1;pancreas: 15.6;thyroid gland: 11.7" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 10.0;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 7.1;Pancreatic endocrine cells: 9.4;Proximal enterocytes: 7.4;Proximal tubular cells: 28.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 37.1;hTCEpi: 23.8;Karpas-707: 38.2;SK-MEL-30: 25.9;U-266/70: 25.6" "Not detected" "Not detected" "Secreted to blood" NA NA 61300 "unprognostic (1.30e-2)" "unprognostic (4.96e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-1)" "unprognostic (3.15e-1)" "unprognostic (4.62e-3)" "unprognostic (7.26e-3)" "unprognostic (1.50e-1)" "unprognostic (3.44e-1)" "unprognostic (7.20e-2)" "unprognostic (9.41e-2)" "unprognostic (7.30e-3)" "unprognostic (1.17e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.06e-2)" 0.2 0.2 0.1 1.7 0.3 0.4 0.4 0.6 0.3 0.9 0.0 1.1 3.8 0.1 1.7 3.0 0.2 1.2 0.1 0.1 0.1 8.1 3.8 0.8 2.6 0.2 0.2 0.1 0.0 15.6 0.3 0.4 0.3 0.3 2.6 0.6 0.0 5.7 0.4 0.0 0.4 2.9 0.2 0.1 1.2 4.1 0.7 0.4 1.0 11.7 0.0 1.9 0.3 0.3 0.2 1.8 0.3 0.5 2.0 1.2 2.1 7.0 9.1 0.8 1.3 2.9 3.9 1.5 0.0 1.3 7.9 1.5 1.4 2.0 1.2 0.5 17.3 0.0 0.1 0.5 2.8 37.1 3.8 2.5 7.5 23.8 4.1 8.6 0.1 0.1 10.1 2.4 38.2 0.3 5.8 0.3 0.7 1.2 10.7 5.7 0.0 0.0 15.1 1.7 0.2 1.0 4.0 0.1 5.5 25.9 1.2 7.6 12.2 0.0 0.0 8.1 0.0 0.0 25.6 4.2 5.0 0.3 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.3 0.1 0.1 0.2 0.2 0.1 0.3 0.1 0.4 0.2 0.2 0.0 3.0 0.0 2.5 0.0 0.9 1.0 0.0 0.0 3.6 1.8 1.4 1.5 0.5 0.0 0.0 0.1 0.6 3.9 3.9 2.6 0.0 0.5 0.4 0.3 1.2 0.0 0.0 10.0 0.7 0.2 7.1 1.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 7.1 0.0 0.0 0.3 0.2 0.0 0.4 1.8 0.0 0.6 0.0 1.0 0.0 0.0 9.4 1.4 0.0 3.1 2.0 7.4 28.1 0.1 0.0 0.0 1.1 0.7 0.2 1.0 0.0 0.4 1.0 1.2 0.0 1.1 0.9 DGCR6L FLJ10666 ENSG00000128185 "DiGeorge syndrome critical region gene 6 like" Q9BY27 22 20314238-20320080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Late spermatids: 2787.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.91e-1)" "prognostic favorable (3.82e-5)" "unprognostic (2.74e-2)" "unprognostic (4.61e-3)" "unprognostic (3.97e-2)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "prognostic favorable (5.37e-4)" "unprognostic (1.44e-1)" "unprognostic (4.39e-2)" "unprognostic (3.29e-3)" "unprognostic (9.07e-3)" "unprognostic (6.72e-3)" "unprognostic (4.37e-2)" "unprognostic (2.91e-1)" "unprognostic (1.26e-1)" "unprognostic (2.97e-1)" 33.9 45.2 65.7 15.5 63.5 31.2 36.6 59.0 96.5 37.9 61.6 39.9 20.0 33.9 24.0 41.6 32.0 18.9 63.2 63.1 61.2 57.7 153.8 28.8 24.9 62.7 62.1 64.5 36.6 43.5 42.4 43.7 12.6 62.2 51.5 11.5 8.7 45.6 29.3 81.8 54.3 30.0 15.5 60.5 34.1 41.3 133.1 63.8 27.9 46.2 44.5 14.7 40.2 35.6 60.8 34.0 38.0 25.5 64.5 36.6 36.6 26.7 32.4 37.7 58.7 42.6 19.7 16.4 9.1 41.4 35.9 23.7 33.8 19.3 39.0 9.6 43.7 97.6 21.7 26.6 36.8 43.3 46.6 21.0 41.0 35.4 23.0 24.7 22.7 41.4 42.3 99.9 39.4 38.3 79.2 35.1 42.4 18.7 67.2 56.1 61.0 58.5 17.7 31.1 26.3 50.4 36.9 53.3 34.7 60.6 10.3 50.3 37.0 32.5 69.4 80.3 37.1 32.1 34.9 39.5 20.9 56.1 58.5 47.5 115.6 102.0 145.5 104.6 93.3 104.0 81.7 130.7 117.7 93.9 73.5 119.9 113.9 34.0 139.1 92.7 88.2 129.8 120.4 65.7 63.5 59.0 96.5 63.1 61.2 62.7 62.1 64.5 62.2 60.5 63.8 60.8 43.6 28.9 30.2 4.9 29.7 43.7 34.2 53.4 33.0 18.6 79.4 106.3 80.3 57.2 41.1 35.0 4.2 67.7 43.1 65.2 133.1 72.2 529.8 28.0 23.2 40.2 52.8 37.2 6.3 63.0 86.4 43.3 26.0 17.5 39.3 38.5 62.4 166.9 80.2 28.6 7.3 64.4 34.6 78.3 52.9 2787.0 70.2 41.7 56.9 1.9 55.5 58.2 95.8 6.0 7.9 51.7 58.5 70.7 44.2 26.2 166.0 164.5 42.5 24.9 46.0 23.6 47.2 117.3 91.0 62.3 60.9 21.9 56.7 36.2 69.0 33.9 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8 microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.3;Rod photoreceptor cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 5.3 4.4 5.3 6.1 4.6 7.8 4.8 8.8 5.0 6.2 4.0 6.8 5.0 8.5 3.6 7.1 6.9 4.8 5.2 4.7 4.4 4.7 4.5 5.3 6.4 4.7 4.6 3.9 8.5 6.2 6.5 5.2 11.7 6.9 5.5 5.0 6.6 7.2 5.7 14.9 7.5 6.8 6.1 4.8 5.9 6.1 15.3 4.9 9.6 6.1 9.4 6.0 6.8 5.8 5.7 22.7 15.7 20.1 11.9 7.7 12.4 25.5 21.3 12.6 14.1 9.9 17.0 11.3 20.1 11.6 20.0 9.4 21.4 18.4 17.8 12.2 19.7 27.4 21.7 17.4 14.0 20.3 40.7 17.5 10.0 21.6 14.8 10.7 12.9 12.6 12.1 78.7 14.1 16.5 14.6 24.7 12.1 19.4 16.5 11.8 29.0 21.2 6.8 8.5 20.9 22.3 14.3 19.4 11.3 13.0 12.0 10.9 17.2 18.8 20.5 17.1 13.0 21.9 7.8 11.5 19.9 15.3 18.2 20.3 0.0 1.1 0.6 2.0 0.9 1.5 0.7 0.9 2.1 1.3 0.6 0.9 1.2 0.2 1.6 3.6 1.5 1.2 1.5 5.3 4.6 8.8 5.0 4.7 4.4 4.7 4.6 3.9 6.9 4.8 4.9 5.7 8.1 6.4 7.9 11.8 6.0 9.6 5.2 6.8 10.2 37.1 9.1 8.0 4.2 11.5 7.3 5.5 39.6 13.6 6.9 9.6 0.0 6.1 61.3 5.5 8.3 10.2 7.3 10.3 12.4 10.2 11.2 7.3 12.8 7.3 3.8 19.2 9.7 14.4 5.3 43.7 12.7 10.3 4.1 8.4 6.5 39.2 18.3 5.0 5.4 6.5 7.2 10.9 11.3 9.5 14.0 10.9 5.8 10.5 9.3 8.6 6.2 3.4 8.1 60.7 6.6 9.7 8.1 25.2 17.5 10.4 9.2 13.5 9.3 15.1 9.7 5.6 ASPHD2 FLJ39838 ENSG00000128203 "Aspartate beta-hydroxylase domain containing 2" Q6ICH7 22 26429260-26445015 "Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 24.8;Early spermatids: 25.3;Late spermatids: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 5.3" "Group enriched" "Detected in many" 4 "dendritic cells: 2.4;monocytes: 5.3" "Cell line enhanced" "Detected in many" "Karpas-707: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000820 Uncertain NA NA "HPA000820: AB_1078231" "unprognostic (1.12e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-2)" "unprognostic (8.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (6.55e-2)" "unprognostic (9.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.11e-2)" 0.6 0.6 6.0 2.5 14.3 1.5 0.6 10.8 7.8 1.2 0.9 2.0 1.2 1.2 6.2 1.5 0.5 1.1 0.4 7.7 5.6 2.1 0.3 0.9 4.5 6.8 5.0 8.7 0.6 0.5 1.8 6.6 1.1 5.8 1.1 2.1 5.6 1.0 0.7 0.4 9.1 1.6 0.7 3.0 2.8 8.3 1.9 5.9 1.3 2.0 0.1 3.4 2.4 1.1 6.4 1.6 0.9 4.1 6.5 0.6 0.3 2.2 2.1 4.5 4.3 6.2 0.0 0.4 1.4 0.5 2.0 4.3 1.9 4.5 7.2 2.3 9.7 6.1 0.3 0.0 0.3 4.1 2.4 1.1 0.7 3.4 2.2 3.0 4.7 4.6 3.6 1.7 21.9 1.3 0.4 1.8 1.0 4.0 8.5 0.9 12.2 2.3 3.7 6.0 0.6 11.0 4.8 2.1 0.3 2.4 2.2 0.2 3.5 4.3 2.7 13.4 0.6 4.4 6.3 1.7 2.8 4.1 8.6 1.8 0.0 1.2 0.5 0.3 3.3 0.9 0.9 0.7 0.7 2.1 0.9 0.4 0.4 0.3 0.0 5.3 2.4 0.4 0.4 6.0 14.3 10.8 7.8 7.7 5.6 6.8 5.0 8.7 5.8 3.0 5.9 6.4 0.3 0.0 1.1 4.2 5.1 1.8 1.4 2.1 0.0 24.8 0.9 0.9 0.6 1.5 0.9 0.0 10.4 0.3 6.8 3.3 0.0 1.2 25.3 0.7 0.5 1.1 0.0 0.0 14.1 0.7 13.2 1.3 8.2 1.5 0.0 0.9 1.1 0.1 1.5 6.7 9.7 4.3 2.0 2.8 5.7 25.1 0.9 4.1 1.8 1.0 5.3 2.4 2.1 4.5 1.1 5.9 0.8 0.7 12.1 4.6 0.1 0.7 0.8 11.3 0.0 0.4 0.7 1.1 3.3 0.6 1.1 1.1 2.8 0.4 2.0 4.2 VPREB3 8HS20 ENSG00000128218 "V-set pre-B cell surrogate light chain 3" Q9UKI3 22 23752743-23754425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 51.9;intestine: 73.1;lymphoid tissue: 119.5" "Cell type enriched" "Detected in some" 12 "B-cells: 287.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 709 "memory B-cell: 753.3;naive B-cell: 803.7" "Lineage enriched" "Detected in many" 732 "B-cells: 803.7" "Group enriched" "Detected in some" 46 "Daudi: 263.3;REH: 309.9;U-698: 85.2" "Low region specificity" "Detected in single" HPA003041 Supported "Intracellular and membrane" NA NA "HPA003041: AB_1080577" "unprognostic (2.06e-3)" "unprognostic (4.75e-3)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.75e-2)" "unprognostic (4.79e-2)" "unprognostic (6.63e-3)" "unprognostic (9.15e-2)" "unprognostic (1.38e-2)" "unprognostic (4.93e-2)" "unprognostic (4.84e-2)" "unprognostic (8.44e-2)" "unprognostic (4.19e-2)" "unprognostic (1.18e-1)" "unprognostic (2.87e-1)" "unprognostic (4.12e-1)" 1.7 21.2 2.0 41.7 1.9 26.0 0.4 2.6 3.9 0.3 2.4 4.0 1.7 1.1 51.9 1.2 0.3 2.8 1.1 1.8 1.9 1.6 1.9 0.8 113.3 2.0 2.1 1.6 0.1 0.5 0.6 2.5 0.2 2.2 1.6 3.7 2.2 2.6 0.3 1.6 0.5 73.1 0.3 1.9 60.8 6.1 0.6 2.8 8.0 1.7 0.5 119.5 6.2 0.3 2.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.6 263.3 0.3 0.2 0.0 0.1 0.5 0.2 0.1 0.6 2.8 0.1 0.0 0.2 0.2 0.3 0.1 1.1 0.7 0.0 0.0 0.0 0.0 0.4 0.4 1.1 0.0 1.3 0.5 1.0 0.3 0.3 1.1 309.9 0.5 4.7 0.1 0.1 0.7 1.0 0.3 0.7 3.5 0.2 0.6 0.4 1.2 0.0 0.5 0.9 0.0 1.3 0.3 85.2 0.0 0.5 0.3 0.9 0.7 0.6 0.4 0.3 0.4 753.3 0.4 0.5 0.7 803.7 0.5 0.5 1.0 0.4 0.7 0.6 1.0 17.5 2.0 1.9 2.6 3.9 1.8 1.9 2.0 2.1 1.6 2.2 1.9 2.8 2.0 0.1 0.0 0.5 0.3 287.8 0.4 0.8 0.6 0.6 4.5 0.3 0.5 0.9 1.5 0.8 0.0 2.1 0.0 5.4 1.1 1.9 0.1 0.3 0.1 0.8 0.1 5.4 2.7 0.2 0.0 0.0 1.5 1.5 0.3 0.0 0.7 1.1 1.0 0.3 0.0 0.2 0.6 2.0 0.3 0.8 0.2 0.0 1.2 5.4 0.0 0.7 0.8 2.1 0.5 0.1 0.1 0.3 0.0 22.6 0.2 1.5 2.4 0.0 2.1 0.0 0.5 0.4 0.1 0.2 0.4 0.1 0.0 3.5 0.1 0.7 0.3 SDF2L1 "AP000553.C22.4, OTTHUMT00000075032" ENSG00000128228 "Stromal cell derived factor 2 like 1" Q9HCN8 22 21642302-21644299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 171.4" "Cell type enhanced" "Detected in all" "Plasma cells: 646.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 330.5" "Low region specificity" "Detected in all" HPA005638 Approved "Intracellular and membrane" NA NA "HPA005638: AB_1079888" "unprognostic (1.09e-1)" "unprognostic (2.76e-2)" "unprognostic (6.17e-2)" "prognostic favorable (4.98e-5)" "unprognostic (8.81e-3)" "unprognostic (2.29e-1)" "unprognostic (9.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.92e-2)" "unprognostic (6.88e-3)" "unprognostic (1.69e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (1.55e-1)" "unprognostic (1.70e-1)" "unprognostic (2.79e-2)" 24.5 40.7 13.6 31.4 13.2 26.1 23.8 14.4 18.9 24.6 19.2 31.1 25.2 33.3 21.9 31.1 30.0 5.7 39.8 12.7 18.4 44.0 171.4 36.2 17.1 16.7 14.4 11.3 16.2 95.4 10.1 77.9 11.8 16.0 33.0 9.9 1.4 48.4 11.6 17.4 19.2 36.0 7.2 15.0 68.8 41.3 35.3 20.1 9.7 90.6 1.8 12.0 33.5 21.7 15.7 77.3 64.6 15.9 53.4 9.2 11.9 99.6 66.5 16.6 31.4 34.5 66.8 44.9 70.1 59.4 16.0 50.7 62.2 29.8 45.9 8.5 51.4 179.7 53.3 70.1 147.5 52.8 53.7 89.6 8.9 19.6 29.4 30.6 10.9 31.1 37.1 330.5 175.8 13.4 146.4 52.8 76.4 17.6 82.8 110.3 48.6 36.4 58.9 22.2 57.0 33.8 52.2 33.6 56.8 36.5 12.5 54.5 62.9 35.9 16.6 92.1 55.7 41.4 160.6 70.7 52.0 32.7 62.1 49.8 114.0 98.9 44.6 173.3 106.8 130.2 131.8 109.2 156.8 72.6 124.9 86.5 102.7 29.8 101.0 102.2 218.5 126.9 106.3 13.6 13.2 14.4 18.9 12.7 18.4 16.7 14.4 11.3 16.0 15.0 20.1 15.7 52.3 25.6 28.5 2.6 164.7 114.2 125.1 89.0 16.5 5.6 80.2 57.8 35.8 62.9 50.3 49.7 35.5 94.7 98.0 194.2 25.4 121.2 52.3 59.3 47.7 58.0 186.1 51.1 1.5 177.5 342.9 64.6 53.0 65.0 111.3 19.0 61.4 286.2 224.1 5.0 2.2 344.8 48.8 68.7 205.4 31.4 32.3 85.9 211.7 6.5 69.4 62.0 145.2 4.0 4.6 175.5 169.6 16.6 646.4 203.8 129.8 96.5 40.9 13.0 39.5 26.2 53.0 276.5 218.9 23.9 112.5 168.1 85.1 37.5 188.1 129.4 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574665 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;intestine: 24.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 30.0;Muller glia cells: 35.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 53.6;Proximal enterocytes: 48.1;Proximal tubular cells: 24.6" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 27.6;CACO-2: 7.7;EFO-21: 14.6;K-562: 6.6;OE19: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 1.1 0.2 14.0 0.4 27.9 0.8 1.1 23.6 18.2 2.5 0.0 5.0 23.2 2.4 1.8 0.5 3.1 5.3 0.8 10.4 16.9 16.7 4.1 1.9 0.7 30.7 25.8 7.4 2.3 6.9 0.7 1.5 0.9 31.1 3.1 2.4 2.4 0.5 1.4 3.1 1.6 24.6 0.3 23.9 0.3 8.2 5.0 23.6 0.1 0.2 0.4 0.0 1.6 1.8 49.7 0.0 27.6 0.5 0.2 0.0 0.0 2.0 0.0 0.2 0.0 0.0 7.7 3.8 0.4 14.6 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.7 0.4 0.4 5.7 0.6 0.2 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.4 6.6 0.6 0.0 0.2 0.3 1.1 3.9 10.6 0.4 0.2 0.0 0.7 1.1 0.1 0.3 1.8 0.0 0.4 0.2 0.7 0.2 0.2 0.8 0.2 0.2 0.3 0.0 2.4 1.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.6 0.0 0.0 14.0 27.9 23.6 18.2 10.4 16.9 30.7 25.8 7.4 31.1 23.9 23.6 49.7 0.5 0.0 0.0 2.3 0.3 0.4 0.1 0.0 0.0 0.8 0.6 3.3 0.6 30.0 0.0 3.7 0.0 0.1 0.0 14.0 15.6 7.0 1.1 1.1 0.3 0.3 10.9 2.7 2.0 11.1 0.1 0.3 5.1 2.4 0.0 0.9 0.0 1.6 0.1 0.0 1.9 5.7 0.0 0.3 0.3 0.8 1.5 0.2 0.0 0.0 0.0 35.3 0.0 26.7 53.6 5.0 8.8 2.2 0.1 0.4 48.1 24.6 0.1 1.3 0.0 2.1 0.3 12.4 14.3 0.0 0.3 0.3 0.2 0.0 7.6 0.1 YWHAH YWHA1 ENSG00000128245 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta" Q04917 22 31944522-31957603 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 458.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025918 Uncertain NA NA 42000000 "CAB025918: " "unprognostic (3.77e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-2)" "unprognostic (1.86e-2)" "unprognostic (1.13e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.59e-5)" "unprognostic (8.62e-2)" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.40e-1)" "unprognostic (1.59e-1)" "unprognostic (5.60e-2)" "unprognostic (7.00e-2)" "unprognostic (6.81e-2)" 103.2 83.5 262.2 87.9 369.5 87.6 77.2 160.8 458.8 55.0 72.3 107.3 65.4 69.3 93.6 60.9 73.7 83.1 77.7 400.2 335.1 69.3 61.9 113.2 68.9 212.3 171.5 385.4 53.4 70.1 29.7 64.9 100.8 242.7 58.3 112.2 115.1 59.9 71.6 69.2 60.4 69.4 132.2 137.5 58.3 110.3 16.4 194.3 71.1 62.5 55.3 83.1 90.8 58.8 368.5 344.5 142.4 180.8 91.8 112.7 107.0 97.0 321.9 172.0 208.1 228.6 157.8 124.2 202.8 76.6 329.4 116.6 169.1 208.7 183.7 271.4 177.0 157.7 118.7 108.2 156.8 108.5 391.4 132.8 84.9 113.0 176.9 135.6 137.3 201.3 76.9 171.5 155.6 249.6 148.5 121.0 189.8 185.2 197.1 150.8 173.7 201.2 115.1 216.5 153.1 323.5 104.4 184.2 134.7 124.7 245.9 78.2 119.3 248.4 206.0 190.1 138.2 216.6 80.7 130.5 257.7 137.3 162.0 170.9 11.9 19.8 22.0 7.6 16.8 11.1 12.4 9.4 10.8 22.9 13.0 3.7 4.9 11.6 25.4 18.4 6.2 19.5 14.0 262.2 369.5 160.8 458.8 400.2 335.1 212.3 171.5 385.4 242.7 137.5 194.3 368.5 259.0 51.3 21.7 27.1 106.6 334.1 223.5 27.3 125.2 54.8 123.6 79.0 51.2 125.8 26.5 126.9 22.9 171.7 53.0 242.8 232.8 148.0 3.9 180.0 81.1 211.7 75.4 269.8 132.0 160.6 145.4 118.8 139.1 153.0 40.0 33.4 120.3 72.1 245.6 53.8 62.9 125.4 34.6 155.6 269.8 13.7 61.2 397.6 300.6 66.5 102.1 80.1 44.3 22.1 42.0 203.3 115.7 80.9 120.4 240.7 93.4 125.5 52.5 73.7 157.8 55.8 197.1 23.3 35.5 164.1 340.0 34.8 95.2 25.7 116.1 191.8 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.9;brain: 8.1;retina: 3.0" "Group enriched" "Detected in some" 7 "Early spermatids: 9.1;Hepatic stellate cells: 8.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 8.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.5;HMC-1: 2.7;Karpas-707: 3.0;SH-SY5Y: 3.7;SiHa: 1.8;THP-1: 3.5" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.1 2.9 0.5 0.2 1.0 0.1 0.0 0.0 8.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 2.5 1.7 0.0 1.1 0.0 0.3 0.0 1.2 1.2 2.5 0.1 0.2 0.3 0.1 1.3 1.3 0.0 3.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.5 0.5 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 1.8 0.0 0.0 0.1 0.0 3.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.5 1.0 0.0 8.1 2.5 1.7 0.0 1.2 1.2 1.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32205001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 8.6;prostate: 3.8" "Group enriched" "Detected in some" 4 "Excitatory neurons: 17.6;Inhibitory neurons: 8.6" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.0 0.6 2.5 0.0 3.5 0.4 0.0 0.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 0.0 0.1 0.0 0.1 3.1 2.6 3.1 0.3 0.0 0.0 0.1 0.0 4.7 3.8 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.7 8.6 3.5 3.6 3.1 2.6 3.1 4.7 1.0 3.8 6.7 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.7 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 GNAZ ENSG00000128266 "G protein subunit alpha z" P19086 22 23070519-23125032 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.0" "Cell type enhanced" "Detected in many" "Adipocytes: 32.1;Horizontal cells: 124.5;Rod photoreceptor cells: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.3;SCLC-21H: 39.0;SH-SY5Y: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003011 Enhanced Approved Vesicles NA NA 180000 Vesicles "HPA003011: AB_1078918" "unprognostic (7.61e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (3.45e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-3)" "unprognostic (1.68e-2)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (6.63e-2)" "unprognostic (2.82e-1)" "unprognostic (1.30e-1)" 8.5 6.7 31.8 2.8 35.1 1.6 8.4 29.0 38.0 5.1 25.5 10.5 1.8 10.2 2.8 5.1 10.3 11.3 1.9 36.3 27.9 1.8 0.5 1.4 1.8 32.9 32.9 34.5 9.0 1.6 7.5 24.3 0.3 32.8 8.5 1.6 33.3 1.9 17.3 1.4 1.3 3.2 12.0 29.8 4.7 11.6 4.4 30.3 0.5 1.5 2.1 1.2 8.0 3.6 37.8 0.1 2.0 6.8 14.3 0.0 0.0 0.4 9.2 18.3 8.9 6.0 0.1 0.1 17.7 0.6 0.8 12.2 0.3 8.4 0.3 6.4 2.2 7.0 1.1 10.2 13.1 0.6 0.0 1.4 0.0 0.3 0.2 0.5 2.2 0.2 1.0 0.2 5.4 0.2 6.4 0.1 0.1 4.1 0.5 5.5 0.1 6.8 2.7 0.1 0.1 39.0 24.0 2.0 4.4 1.9 0.8 1.9 0.2 0.0 7.2 8.2 2.0 0.2 6.6 12.0 9.2 3.7 0.6 2.8 0.9 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.6 0.0 0.0 2.0 31.8 35.1 29.0 38.0 36.3 27.9 32.9 32.9 34.5 32.8 29.8 30.3 37.8 32.1 3.2 0.0 4.9 0.7 0.3 0.3 0.4 0.0 12.6 0.8 1.7 1.6 7.2 0.7 3.7 8.4 0.0 0.7 0.3 0.0 2.0 1.5 1.6 0.5 5.0 4.8 2.7 11.0 1.6 0.0 1.1 1.5 0.4 0.0 2.1 2.2 0.4 0.1 124.5 11.0 0.3 2.0 0.0 1.7 2.1 4.1 18.6 1.8 1.0 1.2 19.3 1.0 2.0 16.5 0.7 0.0 4.1 0.1 0.3 0.1 0.9 1.3 37.7 0.0 9.0 2.1 2.0 4.2 0.0 0.4 0.0 0.6 0.9 0.2 0.1 MGAT3 GNT-III ENSG00000128268 "Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase" Q09327 22 39457012-39492194 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4;intestine: 28.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Bipolar cells: 30.7;Excitatory neurons: 25.1;Inhibitory neurons: 27.4;Oligodendrocytes: 45.7;Proximal enterocytes: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.4;eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.1;HMC-1: 56.0;OE19: 58.8;U-266/70: 73.6;U-266/84: 32.6;U-698: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017598 Approved "Intracellular and membrane" NA NA 170000 "HPA017598: AB_1853853" "unprognostic (1.41e-3)" "unprognostic (5.98e-3)" "unprognostic (4.79e-2)" "unprognostic (2.96e-1)" "unprognostic (2.76e-1)" "unprognostic (5.71e-3)" "unprognostic (8.92e-2)" "unprognostic (2.17e-1)" "unprognostic (4.35e-3)" "unprognostic (6.77e-2)" "unprognostic (8.12e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.04e-8)" "unprognostic (6.73e-2)" "unprognostic (1.46e-1)" "unprognostic (5.89e-2)" "unprognostic (4.92e-2)" 7.5 1.1 26.9 4.0 21.1 10.9 6.4 6.6 47.4 6.3 0.0 5.2 21.7 3.9 0.8 1.1 3.5 3.9 4.2 30.9 9.3 3.0 0.2 15.1 7.7 28.4 18.0 23.6 1.2 3.1 0.4 1.9 10.6 39.2 1.2 4.7 6.7 1.8 1.0 1.5 2.3 28.6 2.8 4.4 4.9 7.4 5.4 27.2 1.8 1.5 1.8 9.0 1.7 1.5 28.7 0.3 0.4 10.4 1.0 0.0 0.0 65.1 0.5 0.7 0.5 0.0 14.9 3.7 23.4 8.1 0.0 0.2 1.3 5.4 0.0 0.1 0.0 0.5 18.9 0.0 0.2 0.2 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 15.8 2.9 0.0 0.2 0.6 1.4 3.1 58.8 0.0 1.2 0.0 3.9 0.4 0.6 6.0 4.4 0.0 0.0 0.0 18.5 0.8 1.0 0.0 0.1 8.1 0.1 0.1 73.6 32.6 32.6 0.2 0.1 1.7 1.4 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.9 21.1 6.6 47.4 30.9 9.3 28.4 18.0 23.6 39.2 4.4 27.2 28.7 2.0 44.8 3.0 6.5 2.2 0.4 0.1 1.8 0.0 30.7 0.6 1.1 1.9 1.5 3.7 0.0 6.2 5.5 0.0 4.1 0.0 0.0 19.1 0.9 11.0 2.5 7.8 13.7 25.1 0.2 12.0 2.3 10.2 2.0 2.5 0.0 0.0 0.0 1.5 13.5 27.4 3.8 2.0 0.0 2.3 16.6 4.4 0.9 0.0 0.0 0.1 1.5 0.0 21.6 45.7 1.8 6.1 3.8 1.7 0.3 37.4 1.8 5.2 2.3 6.6 0.3 4.3 0.7 1.2 0.2 0.6 3.7 0.5 0.6 4.5 1.5 ADORA2A "ADORA2, RDC8" ENSG00000128271 "Adenosine A2a receptor" P29274 22 24417879-24442357 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.0;brain: 79.2;lymphoid tissue: 54.6" "Group enriched" "Detected in some" 6 "B-cells: 5.8;monocytes: 10.9;Plasma cells: 11.8;T-cells: 3.0" "Not detected" "Not detected" "Region enhanced" "Detected in all" "basal ganglia: 79.2" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 39.3;Karpas-707: 52.8;RPMI-8226: 41.1;SK-BR-3: 74.0;U-266/70: 52.8;U-266/84: 74.4;U-698: 55.0" "Region enriched" "Detected in many" 9 "basal ganglia: 399.8" "Region enriched" "Detected in many" 50 "basal ganglia: 142.2" "CAB001943, HPA065566, HPA075997" Enhanced Supported NA NA "CAB001943: , HPA065566: , HPA075997: AB_2732298" "unprognostic (7.30e-2)" "unprognostic (2.42e-2)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (1.88e-3)" "unprognostic (9.85e-2)" "unprognostic (3.63e-1)" "unprognostic (2.88e-2)" "unprognostic (4.57e-3)" "unprognostic (2.15e-3)" "unprognostic (1.87e-3)" "unprognostic (6.81e-4)" "unprognostic (1.50e-1)" "unprognostic (9.78e-3)" "unprognostic (1.30e-1)" "unprognostic (7.10e-3)" 2.8 5.4 11.6 13.7 79.2 41.0 2.5 9.6 16.4 3.9 7.3 3.9 6.7 3.0 1.7 2.0 3.8 3.1 11.1 10.9 15.0 11.6 14.7 14.7 20.6 23.0 9.5 9.3 3.9 2.3 0.2 6.7 1.8 28.8 5.5 1.0 2.2 3.2 1.7 2.5 1.6 7.1 0.9 8.7 15.3 4.0 3.1 14.8 54.6 4.3 1.4 10.5 5.4 3.4 10.5 0.5 0.9 1.0 0.3 0.4 0.3 1.0 0.7 23.2 1.3 2.4 4.5 0.3 39.3 2.6 0.7 2.4 1.0 2.4 0.0 0.0 4.7 6.6 0.7 0.2 5.6 0.4 0.8 18.7 0.2 0.2 7.2 0.0 0.5 8.2 5.8 0.3 52.8 0.0 0.7 14.0 4.2 1.6 5.0 0.1 0.6 1.7 41.1 0.1 0.3 3.9 21.6 1.1 74.0 0.3 1.1 0.8 3.7 0.5 2.2 3.7 0.5 0.4 52.8 74.4 55.0 11.5 13.6 0.3 9.6 2.1 11.6 20.0 6.5 46.9 21.9 37.4 39.2 2.6 38.3 51.5 42.4 32.6 6.3 23.1 2.9 54.0 27.1 11.6 79.2 9.6 16.4 10.9 15.0 23.0 9.5 9.3 28.8 8.7 14.8 10.5 0.0 0.0 0.5 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.6 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 ATF4 "CREB-2, TAXREB67, TXREB" ENSG00000128272 "Activating transcription factor 4" P18848 22 39519695-39522683 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011596 Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "CAB011596: AB_725569" "unprognostic (2.51e-2)" "unprognostic (7.36e-2)" "unprognostic (1.79e-1)" "unprognostic (1.09e-1)" "unprognostic (4.45e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (4.07e-4)" "unprognostic (4.43e-2)" "unprognostic (1.97e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.41e-1)" "prognostic unfavorable (9.77e-5)" "unprognostic (7.06e-2)" "unprognostic (9.78e-2)" "unprognostic (6.40e-2)" "unprognostic (1.95e-1)" 570.9 411.7 372.4 206.0 368.9 896.0 493.1 375.8 399.7 351.2 348.2 684.1 217.2 392.4 234.2 394.7 385.1 247.8 372.8 346.8 359.6 343.5 496.9 441.8 225.7 386.9 366.1 331.7 349.0 634.2 204.3 307.0 249.9 377.9 458.6 220.5 501.8 476.5 281.2 795.7 360.1 365.8 350.4 380.3 353.9 579.3 155.3 370.5 246.0 320.5 424.5 283.0 577.7 367.0 409.8 398.5 230.6 412.3 532.3 450.0 437.1 670.3 470.5 726.2 366.8 462.1 508.5 300.0 760.2 100.7 358.0 300.6 305.1 676.3 551.9 463.7 475.2 461.0 518.9 259.5 516.8 962.7 992.0 479.4 733.3 1172.0 654.3 973.2 658.2 365.8 825.3 560.4 790.7 288.6 241.8 599.2 713.8 354.8 828.1 288.3 612.0 268.5 793.5 491.0 328.0 605.3 254.3 214.8 559.3 1405.8 374.4 342.4 1191.5 290.4 221.5 645.9 250.8 323.8 1004.7 1100.7 888.7 244.9 497.5 506.3 46.5 36.9 24.8 20.0 31.6 26.4 37.9 27.6 26.5 44.3 28.7 28.6 26.6 17.8 26.8 34.9 27.0 31.6 28.8 372.4 368.9 375.8 399.7 346.8 359.6 386.9 366.1 331.7 377.9 380.3 370.5 409.8 201.0 169.9 176.0 19.2 181.8 443.9 344.3 171.2 205.5 120.5 286.8 211.5 167.9 143.0 148.7 44.1 93.8 140.1 156.9 357.9 66.5 200.9 20.9 154.2 122.8 229.9 266.7 140.4 19.2 765.1 309.0 198.0 184.5 191.7 223.0 119.0 146.7 190.9 112.7 69.0 16.6 371.4 101.7 174.3 348.4 21.1 185.1 215.7 238.3 22.5 239.5 94.7 92.7 16.6 34.7 396.0 335.7 206.9 223.7 378.5 265.0 85.8 92.3 311.3 335.2 306.5 279.0 72.3 61.5 155.3 335.7 218.4 175.5 115.0 284.5 401.1 A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692121-42721298 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 70.7;Proximal tubular cells: 91.0;Urothelial cells: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 38.7;ASC TERT1: 31.3;RPTEC TERT1: 27.1;TIME: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001141 Uncertain Mitochondria NA NA 22000 Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 36.9 14.4 5.2 6.2 4.8 4.1 31.5 4.2 8.1 28.8 7.7 25.5 4.5 28.4 3.3 30.8 29.4 4.4 71.0 5.0 9.1 51.2 4.3 26.2 6.8 6.6 4.5 3.8 7.8 6.2 1.2 16.8 9.1 4.4 35.4 1.7 0.3 36.4 21.5 19.5 19.9 18.3 7.0 4.6 16.3 26.8 6.3 6.2 1.6 25.3 6.3 5.1 38.4 38.5 6.1 1.2 13.6 0.0 0.0 38.7 31.3 20.1 5.5 5.8 1.2 2.1 4.3 2.2 13.6 9.4 9.7 6.7 1.3 12.9 6.5 0.2 0.0 2.7 0.3 21.1 0.5 11.5 0.0 0.9 18.6 1.8 5.5 0.9 1.8 4.7 0.0 0.1 0.0 5.1 19.0 0.0 0.0 1.6 0.9 3.3 0.0 3.0 1.4 27.1 23.4 0.2 0.0 16.9 0.3 0.0 2.4 10.6 1.6 29.3 0.0 2.6 24.3 7.3 2.8 13.1 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 5.2 4.8 4.2 8.1 5.0 9.1 6.6 4.5 3.8 4.4 4.6 6.2 6.1 47.1 0.0 0.5 0.3 1.6 9.2 28.9 70.7 0.0 0.1 4.2 1.5 15.8 1.5 41.2 18.4 0.0 48.7 0.4 0.2 13.7 23.1 0.7 11.1 10.3 43.7 0.0 10.7 0.1 1.1 35.3 43.8 2.6 17.4 1.3 0.2 30.7 0.2 5.3 0.0 0.1 0.0 14.2 1.0 11.8 4.4 46.3 4.0 7.2 7.5 30.0 0.8 0.0 0.5 0.0 3.6 0.0 30.1 0.1 40.1 0.0 91.0 12.1 0.6 39.5 7.6 29.3 0.6 0.6 1.2 8.8 9.4 1.5 19.9 0.1 74.7 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 25.1" "Cell type enhanced" "Detected in some" "Early spermatids: 2.6;Spermatocytes: 2.0;Spermatogonia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;NB-4: 2.2;U-266/70: 2.5;U-266/84: 2.6" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.1 0.1 0.0 0.2 0.1 1.4 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.1 0.6 0.1 0.2 0.0 0.5 0.7 0.0 0.1 0.1 0.2 0.3 0.0 2.4 0.5 0.0 0.5 1.3 0.3 0.0 0.0 0.7 0.1 25.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.4 1.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.8 0.0 0.4 0.6 2.2 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.2 0.8 0.1 0.0 0.2 0.6 0.2 0.0 0.2 0.0 0.0 0.4 0.1 0.0 2.5 2.6 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CDC42EP1 "Borg5, CEP1, MSE55" ENSG00000128283 "CDC42 effector protein 1" Q00587 22 37560480-37569405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;monocytes: 7.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006379, HPA076536" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA006379: AB_1078486, HPA076536: " "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.44e-1)" "unprognostic (3.79e-3)" "unprognostic (5.82e-2)" "unprognostic (4.06e-2)" "unprognostic (4.38e-2)" "unprognostic (5.57e-2)" "unprognostic (9.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.09e-3)" 64.5 91.9 49.0 16.8 87.2 1.6 58.5 75.1 59.5 62.8 12.2 42.6 31.4 71.3 4.1 93.9 61.5 41.2 50.1 40.4 63.9 50.6 134.2 65.7 11.4 84.2 92.3 24.6 61.4 163.0 16.7 19.0 32.1 94.5 41.8 14.5 2.7 103.5 24.1 13.2 70.8 33.0 19.7 66.4 26.4 157.1 23.8 72.1 2.7 33.9 11.2 10.5 38.7 70.2 140.1 125.2 35.4 15.1 67.9 23.7 40.2 73.3 69.9 41.0 78.9 54.3 87.8 15.9 0.2 24.2 81.4 25.4 95.0 17.8 35.1 26.0 15.5 60.7 0.5 33.9 53.6 167.7 0.3 0.6 74.9 52.1 65.0 61.5 63.1 59.2 0.1 78.9 0.7 33.0 42.6 0.3 0.5 13.6 96.5 79.6 0.4 27.5 2.4 27.9 1.9 0.4 2.6 51.2 112.3 112.4 20.6 50.3 11.0 91.6 163.9 98.2 80.0 98.6 0.2 0.8 0.3 65.3 0.7 135.6 0.4 7.3 0.0 0.1 1.9 0.1 0.0 0.1 0.1 2.4 0.3 0.0 0.2 0.2 0.4 0.1 0.3 0.0 3.4 49.0 87.2 75.1 59.5 40.4 63.9 84.2 92.3 24.6 94.5 66.4 72.1 140.1 62.4 6.4 19.5 2.3 1.8 46.9 87.2 51.4 21.1 0.1 59.2 31.8 3.5 134.4 41.1 12.9 0.0 98.2 2.0 41.6 1.9 245.6 3.7 4.3 20.0 54.7 11.5 0.0 0.1 226.0 110.3 32.1 133.0 9.0 2.5 1.7 69.7 35.6 13.2 1.7 0.2 66.6 30.5 5.9 29.3 1.7 39.4 5.3 21.4 4.7 8.9 12.8 0.0 2.0 42.7 266.2 45.8 35.3 0.6 122.4 17.5 11.4 14.7 0.3 39.5 22.8 49.5 2.0 0.6 55.9 52.0 112.2 2.2 7.0 61.1 161.3 APOL3 "APOLIII, CG12-1" ENSG00000128284 "Apolipoprotein L3" O95236 22 36140330-36166177 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 59.1;Endothelial cells: 69.8;Hepatic stellate cells: 69.7;Kupffer cells: 38.7;NK-cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.1;ASC TERT1: 54.1;HDLM-2: 25.6;Karpas-707: 59.0" "Intracellular and membrane" NA NA "prognostic favorable (6.82e-4)" "unprognostic (5.93e-3)" "unprognostic (6.79e-2)" "unprognostic (2.70e-2)" "unprognostic (2.22e-1)" "unprognostic (7.05e-2)" "unprognostic (6.30e-2)" "unprognostic (2.67e-1)" "unprognostic (8.94e-2)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (7.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" 50.9 12.4 10.6 25.7 10.0 10.2 44.1 8.9 12.3 16.6 9.3 16.0 15.1 18.9 12.4 12.1 24.6 14.4 26.9 8.8 9.3 19.1 40.3 42.3 43.7 12.2 10.1 7.3 9.7 6.4 3.5 8.5 16.5 10.2 18.5 11.5 0.6 15.8 15.1 16.7 17.7 21.9 16.2 8.8 48.0 12.4 2.9 11.9 18.3 25.4 19.8 20.9 17.7 19.6 10.3 4.3 0.0 0.0 0.1 34.1 54.1 1.8 1.8 10.2 3.1 7.0 0.0 9.5 2.1 0.4 5.0 4.6 0.7 0.0 1.3 1.9 25.6 0.0 9.2 1.3 2.1 18.3 0.1 2.6 11.4 0.0 9.0 0.4 2.1 22.1 2.0 0.2 59.0 1.1 0.1 11.7 0.3 0.1 0.0 0.5 16.9 0.0 1.3 0.3 3.0 0.2 0.1 6.0 4.2 0.1 0.0 0.0 1.2 16.2 1.5 0.6 1.7 0.5 15.6 10.8 0.1 3.7 3.5 1.5 8.3 19.1 0.8 16.9 23.4 27.3 9.7 14.4 17.5 15.4 8.0 13.4 14.3 2.3 18.5 24.6 0.5 14.7 17.2 10.6 10.0 8.9 12.3 8.8 9.3 12.2 10.1 7.3 10.2 8.8 11.9 10.3 59.1 3.2 8.6 1.6 21.1 5.0 4.3 3.9 2.2 0.0 5.8 4.2 7.9 8.6 4.3 3.7 0.0 1.9 16.0 0.3 0.0 2.5 0.9 1.8 4.7 69.8 0.0 20.6 0.0 1.6 1.2 18.8 7.1 1.3 9.5 2.0 69.7 20.6 6.9 0.0 0.0 7.5 2.0 38.7 10.6 1.4 24.2 19.6 3.6 9.4 29.2 0.7 46.4 0.0 0.0 3.0 0.1 9.8 15.3 10.4 5.3 2.8 4.2 0.3 13.1 3.2 10.1 0.2 0.3 4.1 4.1 0.8 31.5 4.3 2.3 4.7 MCHR1 "GPR24, MCH1R, SLC1" ENSG00000128285 "Melanin concentrating hormone receptor 1" Q99705 22 40678750-40682814 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;endometrium 1: 3.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.7;Hepatic stellate cells: 2.2;Inhibitory neurons: 4.3;Leydig cells: 2.8;Melanocytes: 8.8;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.0" "Group enriched" "Detected in some" 7 "glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;RH-30: 1.6;SuSa: 4.7;T-47d: 1.4;U-87 MG: 1.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 22.9" NA NA "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (2.45e-3)" "unprognostic (2.68e-1)" "unprognostic (2.84e-3)" "unprognostic (4.92e-3)" "unprognostic (4.51e-3)" "unprognostic (1.19e-2)" "unprognostic (1.58e-2)" "unprognostic (9.35e-4)" "unprognostic (3.05e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (1.49e-6)" "unprognostic (3.07e-2)" "unprognostic (5.40e-2)" "unprognostic (2.42e-1)" "unprognostic (3.91e-2)" 0.2 0.1 1.6 0.3 2.7 0.0 0.1 2.0 3.8 0.4 0.5 0.1 0.1 3.6 0.4 0.0 0.7 0.0 1.2 2.5 2.9 0.0 1.3 0.2 0.2 1.7 1.6 2.2 2.4 0.0 0.0 2.2 0.0 2.2 0.0 0.0 1.2 0.1 0.0 0.1 0.5 0.1 0.7 1.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.1 0.2 0.1 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.7 2.0 3.8 2.5 2.9 1.7 1.6 2.2 2.2 1.0 1.9 2.4 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.1 0.0 0.4 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.2 1.2 0.1 0.0 4.3 0.0 0.0 0.0 0.3 0.0 2.8 0.0 8.8 2.8 0.0 1.6 0.0 2.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TPST2 TANGO13B ENSG00000128294 "Tyrosylprotein sulfotransferase 2" O60704 22 26521996-26596717 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 402.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 171.0;NK-cells: 263.7;Plasma cells: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 158.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021054 Enhanced "Intracellular and membrane" NA NA 88000 "HPA021054: AB_1858221" "unprognostic (2.24e-1)" "unprognostic (1.70e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.08e-5)" "unprognostic (8.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-2)" "unprognostic (9.70e-2)" "unprognostic (3.18e-2)" "unprognostic (3.38e-1)" "unprognostic (2.70e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (2.34e-6)" "unprognostic (9.68e-2)" "unprognostic (9.21e-3)" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" 23.4 31.3 24.9 15.4 19.3 23.3 21.9 18.4 30.2 17.1 25.3 11.6 13.8 18.1 112.6 18.8 17.1 12.3 24.7 24.6 21.5 24.9 75.5 46.1 19.3 20.5 21.9 18.8 9.3 402.1 5.3 10.0 42.1 21.1 16.1 8.9 3.4 11.0 18.0 38.8 17.4 13.5 12.2 20.6 36.7 11.8 20.8 30.6 10.8 39.1 22.8 17.1 17.3 17.4 25.1 12.8 9.1 11.7 6.0 24.4 18.7 16.4 27.9 49.9 22.2 20.3 6.2 6.5 21.4 7.3 50.4 11.6 19.5 8.8 19.2 12.7 8.8 16.9 51.8 5.6 13.1 10.2 6.0 158.7 20.1 30.3 22.5 7.7 22.5 41.6 9.6 52.6 65.2 17.2 14.3 24.3 40.7 15.4 10.0 9.1 22.5 15.8 60.2 6.7 14.3 8.8 6.1 12.9 11.2 16.0 17.0 5.2 24.7 33.2 27.3 61.2 22.5 27.3 20.9 31.5 20.6 20.7 23.1 25.3 490.4 77.0 111.9 249.2 86.3 70.5 23.6 57.0 187.2 48.3 25.6 27.8 163.6 163.0 354.9 94.3 115.3 71.9 240.7 24.9 19.3 18.4 30.2 24.6 21.5 20.5 21.9 18.8 21.1 20.6 30.6 25.1 37.3 16.0 12.6 13.7 30.8 38.1 82.5 29.9 14.2 9.0 10.8 13.1 15.5 47.1 14.4 22.0 6.2 171.0 120.8 6.7 27.4 12.9 15.2 31.1 14.8 66.1 0.0 64.6 23.4 65.1 49.8 10.7 5.1 39.5 53.7 13.9 113.6 79.3 123.9 6.7 20.3 9.3 12.2 55.9 48.6 4.5 5.3 70.1 28.4 47.8 32.4 1.9 263.7 5.0 1.9 53.1 8.7 4.1 183.7 36.4 16.5 7.6 18.6 5.3 6.6 9.9 15.3 2.9 13.2 15.1 35.9 143.0 64.4 42.0 11.8 83.7 BAIAP2L2 "FLJ22582, pinkbar" ENSG00000128298 "BAR/IMD domain containing adaptor protein 2 like 2" Q6UXY1 22 38084652-38111015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 99.5;kidney: 41.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 68.2;Intestinal goblet cells: 58.4;Oligodendrocytes: 31.0;Paneth cells: 32.6;Proximal enterocytes: 125.8;Undifferentiated cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 14.1;OE19: 44.2;RPTEC TERT1: 27.3;SK-MEL-30: 38.4;WM-115: 29.8" "Region enhanced" "Detected in many" "olfactory bulb: 3.7" "Low region specificity" "Detected in many" HPA003043 Approved NA NA "HPA003043: AB_2227864" "unprognostic (2.15e-1)" "unprognostic (4.23e-2)" "unprognostic (9.82e-2)" "unprognostic (5.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (1.37e-3)" "unprognostic (2.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (1.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.23e-2)" "unprognostic (4.51e-2)" 2.3 1.1 2.6 2.8 2.6 0.1 1.8 2.1 6.2 3.1 2.3 23.9 99.5 2.1 0.4 9.8 1.9 15.1 0.8 2.7 2.3 41.6 3.8 0.9 0.3 2.3 2.3 2.6 1.5 2.7 0.1 3.5 0.2 2.4 2.6 12.8 0.4 1.9 0.3 1.2 2.3 82.3 0.8 2.2 1.4 8.6 5.9 2.2 0.6 3.1 0.1 0.4 1.2 3.4 3.3 0.2 12.3 0.0 0.0 0.3 1.9 1.5 3.0 0.0 0.0 0.2 9.6 0.8 0.2 4.6 2.7 0.0 1.6 0.0 0.4 0.0 0.3 0.4 0.9 0.0 14.1 0.6 0.0 0.8 0.3 0.7 7.0 0.5 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.6 0.3 1.1 44.2 0.0 0.4 0.0 0.8 27.3 0.1 0.2 0.2 0.0 5.3 38.4 0.1 0.3 0.2 0.1 0.1 0.4 0.0 0.0 0.9 0.1 0.2 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.6 2.1 6.2 2.7 2.3 2.3 2.3 2.6 2.4 2.2 2.2 3.3 0.2 0.0 0.0 7.8 0.5 0.8 0.2 1.0 1.2 2.8 0.3 0.3 1.1 17.2 0.2 0.0 2.1 0.3 0.2 68.2 1.9 0.6 0.7 2.2 3.8 0.3 27.6 0.0 17.2 0.0 1.2 0.8 21.9 12.8 0.0 0.5 0.4 0.9 0.5 6.7 13.1 58.4 0.0 0.3 0.2 0.5 1.2 0.2 5.4 5.6 0.1 0.2 1.0 7.5 31.0 5.4 32.6 1.2 0.3 0.2 125.8 19.1 0.1 1.4 0.0 0.2 1.3 1.3 4.4 1.4 1.1 0.4 0.5 0.3 41.4 0.5 MPST "MST, TST2, TUM1" ENSG00000128309 "Mercaptopyruvate sulfurtransferase" P25325 22 37019635-37029821 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 393.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001240 Enhanced Approved Mitochondria,Cytosol NA NA 2900000 Mitochondria Cytosol "HPA001240: AB_1079408" "unprognostic (7.18e-3)" "unprognostic (4.45e-1)" "unprognostic (1.80e-1)" "unprognostic (1.30e-3)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (7.07e-2)" "unprognostic (2.15e-1)" "unprognostic (2.22e-1)" "unprognostic (1.35e-1)" "unprognostic (2.25e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-3)" "unprognostic (3.98e-2)" "unprognostic (3.51e-1)" "unprognostic (2.52e-1)" "prognostic favorable (5.89e-4)" 56.3 57.7 21.3 10.1 27.4 36.8 51.5 25.0 31.2 38.4 25.6 77.4 107.5 35.0 0.6 92.2 43.2 16.7 59.0 19.1 20.6 70.4 393.9 43.9 8.9 30.1 23.8 17.2 82.4 107.3 4.8 14.8 9.1 27.1 45.7 17.2 0.5 43.9 9.7 90.4 81.8 93.8 7.0 23.3 22.3 70.9 52.1 26.5 4.5 25.0 23.3 6.1 48.7 62.8 30.3 44.0 50.4 24.2 50.0 27.8 17.2 38.1 23.4 20.6 24.8 33.2 48.6 18.9 68.7 33.0 16.7 16.7 29.9 20.9 33.8 3.6 41.4 119.2 26.5 21.3 115.6 87.5 29.0 35.6 30.0 64.2 16.1 15.1 22.8 50.6 33.1 48.0 19.3 7.0 33.8 2.6 97.5 45.7 56.7 52.2 73.6 28.8 51.9 25.5 14.0 12.4 92.9 15.6 23.9 46.6 12.2 26.0 45.6 39.8 21.3 60.1 23.9 16.0 33.3 16.8 21.0 7.7 34.7 11.1 48.5 71.9 54.7 31.0 27.5 42.4 24.9 20.1 26.4 104.0 25.0 2.7 10.4 21.9 87.8 12.7 16.3 44.3 35.4 21.3 27.4 25.0 31.2 19.1 20.6 30.1 23.8 17.2 27.1 23.3 26.5 30.3 21.3 35.3 61.9 14.7 25.1 81.6 80.4 120.3 70.6 4.5 81.4 83.4 29.4 243.1 70.0 60.7 0.0 61.9 20.3 553.6 133.1 146.4 191.1 38.5 46.8 42.6 108.6 122.6 1.1 148.3 119.1 52.8 87.1 72.5 17.2 140.3 108.5 578.6 77.5 3.3 1.9 363.1 85.5 84.6 77.6 115.1 91.0 62.7 58.7 3.7 60.7 24.8 56.7 4.5 14.9 117.9 621.4 84.7 65.7 77.7 1322.1 469.8 13.4 2.8 46.0 34.4 36.0 101.3 11.5 133.7 152.9 50.1 26.6 57.7 397.5 110.6 GALR3 ENSG00000128310 "Galanin receptor 3" O60755 22 37823382-37825485 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Glandular and luminal cells: 1.2;Late spermatids: 1.7;Paneth cells: 1.1;Theca cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-2)" "unprognostic (1.45e-2)" "unprognostic (4.60e-3)" "unprognostic (7.07e-2)" "unprognostic (7.63e-2)" "unprognostic (8.17e-2)" "unprognostic (4.18e-2)" "unprognostic (2.16e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-1)" "unprognostic (1.66e-2)" "unprognostic (7.37e-2)" "unprognostic (8.35e-2)" "unprognostic (4.45e-2)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.4 0.2 0.4 0.2 0.3 0.2 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.9 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.5 0.0 0.0 0.0 1.5 0.2 0.1 TST RDS ENSG00000128311 "Thiosulfate sulfurtransferase" Q16762 22 37010859-37020183 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 565.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 565.8;Hepatocytes: 414.9;Paneth cells: 463.4;Proximal enterocytes: 278.5;Proximal tubular cells: 254.5;Undifferentiated cells: 217.4" "Cancer enhanced" "Detected in all" "liver cancer: 177.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 25.0" "Group enriched" "Detected in all" 6 "dendritic cells: 25.0;granulocytes: 21.8;monocytes: 17.7" "Cell line enhanced" "Detected in many" "OE19: 264.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003044, HPA003643, CAB009546" Enhanced Supported Mitochondria NA NA 560000 Mitochondria "CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411" "unprognostic (3.09e-2)" "unprognostic (2.70e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-1)" "unprognostic (7.96e-3)" "unprognostic (4.38e-2)" "unprognostic (1.78e-1)" "prognostic favorable (7.59e-6)" "unprognostic (6.08e-3)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.04e-4)" 42.9 155.3 31.5 21.1 38.3 27.3 37.6 38.7 36.3 34.4 30.8 151.9 149.1 19.1 3.0 97.4 25.9 76.6 54.1 29.5 32.8 98.8 565.8 22.9 8.2 37.1 34.9 27.9 27.2 64.1 9.5 12.5 7.9 37.0 26.6 81.1 1.3 40.2 18.4 53.3 32.4 115.2 13.4 34.3 17.0 89.2 8.2 35.9 4.4 17.3 35.2 16.3 30.2 57.2 39.7 42.6 86.1 10.8 36.8 25.9 10.6 21.4 23.0 18.6 12.6 18.3 25.4 25.7 11.1 18.8 17.0 11.9 35.1 7.9 22.3 2.7 33.6 50.0 11.5 15.5 49.7 64.9 16.4 26.4 20.1 23.9 9.1 7.6 17.5 31.1 5.9 14.2 18.2 6.0 90.8 0.5 49.9 18.7 264.4 39.3 37.0 11.7 19.7 35.9 36.7 6.4 17.1 24.2 41.4 31.7 10.2 43.4 39.3 25.1 14.0 27.2 24.2 7.4 14.0 15.4 3.4 5.3 46.4 8.5 10.9 17.7 8.0 0.8 4.7 1.7 2.8 0.8 0.6 25.0 1.7 0.4 0.2 21.8 3.7 1.5 1.7 2.1 8.1 31.5 38.3 38.7 36.3 29.5 32.8 37.1 34.9 27.9 37.0 34.3 35.9 39.7 13.9 28.9 74.8 10.1 7.8 1.3 9.5 20.4 12.0 1.3 32.7 16.6 39.2 170.1 23.7 20.2 0.0 11.6 2.5 565.8 46.9 45.3 1.9 53.3 30.2 13.4 34.3 35.3 0.3 44.0 6.4 14.6 126.9 74.3 14.0 60.9 39.3 414.9 15.1 1.7 0.5 162.8 8.2 28.9 6.8 3.5 13.1 23.2 1.8 1.0 18.6 27.3 3.1 3.5 7.4 36.8 463.4 7.9 24.5 10.5 278.5 254.5 19.2 0.8 0.0 10.7 11.5 2.4 0.5 39.8 2.4 11.4 5.0 57.5 217.4 17.3 APOL5 APOLV ENSG00000128313 "Apolipoprotein L5" Q9BWW9 22 35717872-35729483 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.4;tongue: 2.0" "Cell type enhanced" "Detected in single" "Early spermatids: 1.1" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-698: 1.7" NA NA "unprognostic (2.23e-1)" "unprognostic (7.61e-4)" "unprognostic (9.34e-2)" "unprognostic (1.39e-2)" "unprognostic (3.23e-1)" "unprognostic (4.18e-2)" "unprognostic (4.37e-5)" "unprognostic (3.23e-2)" "unprognostic (2.78e-2)" "unprognostic (2.94e-2)" "unprognostic (1.59e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 IGLL1 "14.1, CD179B, IGL5, IGLL, IGVPB" ENSG00000128322 "Immunoglobulin lambda like polypeptide 1" P15814 22 23573125-23580302 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 70.5;testis: 25.4" "Group enriched" "Detected in some" 6 "Early spermatids: 78.0;Late spermatids: 140.7;Melanocytes: 119.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 0.5;lung cancer: 0.5;stomach cancer: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "memory B-cell: 12.0;naive B-cell: 14.8" "Lineage enriched" "Detected in many" 11 "B-cells: 14.8" "Cell line enriched" "Detected in some" 32 "REH: 787.7" "HPA051134, HPA071406" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 48000000000 "Endoplasmic reticulum" "HPA051134: AB_2681356, HPA071406: AB_2686393" "unprognostic (6.21e-2)" "unprognostic (5.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.91e-6)" "unprognostic (1.08e-1)" "unprognostic (5.27e-2)" "unprognostic (6.17e-3)" "unprognostic (5.89e-2)" "unprognostic (9.07e-2)" "unprognostic (1.99e-4)" "unprognostic (2.35e-2)" "unprognostic (5.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.2 0.3 0.2 70.5 0.0 0.3 0.4 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.1 1.4 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.2 25.4 0.2 10.2 0.0 0.0 1.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 24.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 14.3 2.6 0.0 0.0 0.0 787.7 0.3 17.3 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.1 6.2 0.0 0.0 0.3 0.3 0.0 0.6 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.8 0.2 0.2 0.3 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.9 0.0 78.0 0.2 0.3 0.3 0.0 10.5 0.3 0.0 0.4 0.6 0.0 0.5 0.0 0.2 0.7 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 140.7 1.2 0.4 119.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 6.2 0.0 0.0 0.0 1.5 0.3 17.1 0.6 0.0 0.3 0.0 17.9 0.1 0.0 0.2 APOL2 APOL-II ENSG00000128335 "Apolipoprotein L2" Q9BQE5 22 36226209-36239954 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 80.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001078, CAB026695" Supported NA NA 29000000 "CAB026695: , HPA001078: AB_10602432" "unprognostic (4.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.50e-2)" "unprognostic (4.26e-3)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.38e-2)" "unprognostic (7.39e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.22e-7)" "unprognostic (1.80e-1)" "unprognostic (6.79e-2)" "unprognostic (2.66e-2)" "prognostic favorable (5.06e-6)" 36.4 23.6 38.7 44.0 40.5 13.2 37.7 39.0 50.1 32.4 36.1 26.5 42.2 33.4 18.0 18.6 30.5 42.5 33.7 40.4 45.4 32.3 66.0 45.2 42.8 52.1 44.1 37.1 19.7 15.5 19.9 47.6 22.5 54.7 34.5 26.8 12.3 25.2 28.5 28.2 16.3 32.5 36.1 41.6 46.9 38.7 6.9 40.0 29.9 19.6 18.5 30.6 60.0 26.3 53.2 24.0 18.7 17.0 12.7 63.6 49.1 31.7 32.1 73.4 84.1 113.3 7.1 19.2 29.3 52.4 57.2 52.0 11.1 18.3 25.4 41.6 98.0 21.3 13.4 39.9 33.5 107.3 29.0 25.2 62.4 17.0 59.2 15.5 35.2 55.8 16.4 24.8 79.1 53.2 9.4 29.8 13.2 6.3 8.6 16.4 30.3 21.6 17.3 85.6 63.3 30.2 8.5 21.8 40.7 18.4 11.5 12.8 4.1 54.8 50.6 25.1 10.6 17.9 47.6 25.8 9.1 43.7 15.0 19.6 31.1 22.8 16.8 39.7 46.6 36.3 16.3 28.6 33.2 16.5 10.3 16.2 27.1 116.5 28.4 34.0 10.2 29.2 14.3 38.7 40.5 39.0 50.1 40.4 45.4 52.1 44.1 37.1 54.7 41.6 40.0 53.2 14.8 35.3 16.8 8.5 12.5 6.0 8.0 21.4 0.6 5.0 7.5 5.0 24.3 21.5 20.1 12.9 0.0 16.6 17.1 31.8 17.6 42.6 0.2 53.0 21.1 21.2 4.8 8.6 18.1 62.9 10.7 19.5 21.4 80.2 2.5 8.3 18.9 65.4 24.2 6.7 9.3 12.0 22.4 20.9 13.0 1.9 16.8 15.0 8.8 7.5 26.6 9.3 25.7 12.1 4.8 68.1 14.5 20.7 17.9 28.4 33.1 25.6 15.6 5.1 0.0 23.9 12.4 0.4 0.2 2.8 6.7 15.2 19.1 10.4 8.0 19.4 RAC2 EN-7 ENSG00000128340 "Rac family small GTPase 2" P15153 22 37225270-37244448 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 415.6;lymphoid tissue: 391.0" "Cell type enhanced" "Detected in many" "B-cells: 329.0;dendritic cells: 381.4;granulocytes: 520.5;NK-cells: 717.9;Plasma cells: 287.8;T-cells: 419.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 522.5;HL-60: 734.5;HMC-1: 1427.9;Karpas-707: 684.5;U-87 MG: 618.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022946, HPA047820" Enhanced NA Yes 3300000 "CAB022946: , HPA047820: AB_2680167" "prognostic favorable (1.03e-5)" "unprognostic (2.91e-1)" "unprognostic (3.21e-2)" "unprognostic (1.82e-3)" "unprognostic (6.74e-2)" "unprognostic (7.78e-2)" "unprognostic (3.47e-1)" "unprognostic (5.00e-2)" "unprognostic (8.52e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (3.81e-1)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.45e-1)" "unprognostic (1.75e-1)" "unprognostic (6.21e-2)" "unprognostic (1.50e-2)" 25.0 8.5 3.5 209.1 4.5 415.6 11.5 4.0 7.3 12.3 6.8 35.1 35.6 10.2 4.7 16.0 11.8 37.4 6.5 3.7 7.9 10.9 19.5 64.0 391.0 6.6 4.6 3.5 5.6 5.4 2.2 3.4 12.5 6.0 11.0 34.2 0.4 21.7 8.4 4.9 7.6 97.7 19.8 5.5 302.4 43.1 3.5 7.5 326.9 9.6 7.3 311.6 54.4 10.0 6.8 136.6 0.2 0.0 0.0 14.3 130.5 0.6 17.9 41.1 14.2 28.8 0.3 44.8 167.4 19.8 52.9 0.8 33.3 1.0 231.6 15.6 522.5 0.6 209.6 3.6 0.6 35.8 734.5 1427.9 96.4 32.3 25.1 84.3 0.9 239.7 159.1 50.5 684.5 1.9 0.2 218.9 291.2 2.8 13.1 87.2 72.3 0.7 193.8 22.6 0.1 2.0 0.6 0.9 23.0 2.7 0.8 9.7 391.8 258.7 0.6 23.5 1.0 2.0 307.0 171.4 176.6 618.6 316.5 35.1 1319.9 519.8 1602.2 972.1 695.5 731.5 761.7 768.6 858.9 494.0 672.8 584.3 759.8 1336.4 972.2 879.5 728.7 1163.4 1566.2 3.5 4.5 4.0 7.3 3.7 7.9 6.6 4.6 3.5 6.0 5.5 7.5 6.8 4.4 16.0 47.7 0.0 329.0 5.4 2.2 26.0 16.5 0.0 8.6 9.5 1.1 2.8 12.6 1.8 0.0 0.8 381.4 3.4 0.0 13.6 0.2 1.1 0.8 5.6 4.2 109.7 0.4 2.2 1.5 9.2 33.6 1.0 520.5 0.3 13.6 3.4 150.8 0.0 0.1 6.3 0.0 129.9 63.9 0.9 0.3 147.9 30.2 3.7 125.9 0.0 717.9 0.5 0.0 18.2 18.1 0.0 287.8 0.5 0.6 1.5 4.4 0.0 13.1 2.4 4.5 0.0 1.0 5.1 4.0 2.9 419.6 3.7 11.2 3.6 LIF "CDF, DIA, HILDA" ENSG00000128342 "LIF interleukin 6 family cytokine" P15018 22 30240453-30246759 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.1;urinary bladder: 91.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 95.5;Club cells: 56.3;Endometrial ciliated cells: 71.7;Fibroblasts: 51.9;Glandular and luminal cells: 192.9;granulocytes: 67.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "hypothalamus: 23.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 88.3;hTEC/SVTERT24-B: 113.0;hTERT-RPE1: 104.4;U-138 MG: 123.9;U-251 MG: 94.5;U-87 MG: 97.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018844, CAB025985" Uncertain Supported Cytosol "Secreted in other tissues" NA NA Cytosol "CAB025985: , HPA018844: AB_1852814" "unprognostic (1.28e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (8.79e-2)" "unprognostic (4.61e-2)" "unprognostic (7.36e-3)" "unprognostic (4.18e-3)" "unprognostic (1.17e-2)" "unprognostic (1.41e-2)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (6.78e-8)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (8.99e-2)" "unprognostic (4.71e-3)" 18.8 4.4 1.0 22.6 0.9 1.6 4.7 0.7 1.8 6.8 5.5 6.6 6.7 11.9 0.6 3.1 9.9 48.1 13.5 1.0 23.3 13.8 5.0 30.2 4.4 1.4 1.2 0.9 2.3 13.5 0.4 10.5 2.7 1.4 12.1 8.1 3.0 4.9 2.2 0.8 10.8 9.3 8.4 1.3 1.5 7.9 0.6 2.3 1.3 5.4 1.0 1.7 91.9 2.4 1.5 29.0 47.9 1.3 10.6 0.0 3.9 17.1 4.1 17.2 5.1 12.1 7.7 47.3 0.0 10.1 0.2 88.3 7.3 1.1 13.1 6.9 6.8 2.1 3.7 19.7 10.9 4.5 0.1 36.7 4.3 2.5 113.0 3.3 104.4 0.0 0.2 0.8 0.1 22.6 21.5 0.6 0.1 1.8 27.0 29.5 0.9 15.9 0.0 40.7 11.0 0.2 0.6 4.9 0.4 8.8 5.0 1.0 0.5 0.3 123.9 45.3 47.3 94.5 0.0 0.2 0.1 97.4 0.1 58.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.9 0.7 1.8 1.0 23.3 1.4 1.2 0.9 1.4 1.3 2.3 1.5 0.6 22.4 44.2 0.3 0.0 3.4 14.0 95.5 0.0 0.1 40.0 10.9 0.2 10.0 56.3 5.5 0.0 0.2 2.9 3.9 0.0 39.6 0.3 71.7 16.2 3.6 0.0 0.0 0.0 3.4 0.7 51.9 0.5 192.9 67.0 0.2 0.0 0.0 1.1 0.0 0.0 3.5 10.2 0.6 3.2 0.0 0.0 3.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 40.3 3.8 0.0 0.4 15.7 5.3 1.0 15.6 0.2 0.0 17.7 30.2 0.1 0.2 1.5 2.8 0.3 5.5 0.1 7.1 20.3 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 96.2" "Group enriched" "Detected in some" 7 "Early spermatids: 292.5;Late spermatids: 312.9;Spermatocytes: 241.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 31.8;U-138 MG: 31.4;U-87 MG: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm NA NA Nucleoplasm "HPA000650: AB_2732391" "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 2.9 2.6 4.2 5.6 7.8 3.1 0.8 8.6 4.0 1.6 3.4 2.4 2.9 8.4 1.3 14.1 12.5 6.4 5.2 4.2 5.5 2.3 0.4 5.0 3.6 10.2 9.7 0.7 2.5 8.7 1.1 4.9 5.4 10.0 5.1 0.1 3.5 10.4 0.2 5.7 26.2 3.8 0.1 8.8 2.3 9.0 96.2 8.4 0.2 8.3 0.0 0.1 6.3 1.2 15.6 6.6 5.3 11.1 10.3 0.2 0.4 13.7 18.4 0.5 0.5 0.7 6.3 5.9 3.5 5.0 0.4 11.7 31.8 0.4 0.1 0.6 6.7 13.4 2.0 4.6 4.3 0.5 5.4 4.4 0.4 0.2 2.2 0.2 15.4 0.1 2.6 2.3 2.0 0.1 4.1 0.3 3.2 1.6 6.6 4.6 6.0 16.1 1.3 0.1 29.4 5.6 4.0 8.2 3.2 10.3 17.5 3.6 7.3 27.8 31.4 10.2 25.1 10.0 4.6 2.0 1.6 46.9 2.5 18.3 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 7.8 8.6 4.0 4.2 5.5 10.2 9.7 0.7 10.0 8.8 8.4 15.6 0.2 0.0 2.4 1.3 0.0 0.3 0.1 1.8 0.0 0.2 0.3 0.8 0.1 1.5 1.9 0.0 0.0 0.1 0.1 0.1 1.9 0.4 292.5 16.8 0.6 0.6 0.0 0.0 0.5 0.4 0.1 0.5 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 312.9 6.8 0.5 0.0 1.0 0.0 2.2 0.0 1.0 5.6 0.3 0.0 5.3 0.0 0.1 0.0 1.8 37.8 1.2 0.0 0.5 0.4 241.3 5.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 APOBEC3A "ARP3, PHRBN" ENSG00000128383 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3A" P31941 22 38952741-38992778 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 94.8;lymphoid tissue: 48.7;urinary bladder: 24.6" "Cell type enriched" "Detected in many" 4 "Urothelial cells: 426.0" "Group enriched" "Detected in many" 4 "cervical cancer: 11.3;head and neck cancer: 15.8" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 1014.5" "Lineage enriched" "Detected in many" 8 "monocytes: 1014.5" "Not detected" "Not detected" "HPA043237, HPA056980, HPA066719" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (6.45e-3)" "unprognostic (1.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.21e-3)" "unprognostic (1.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.91e-1)" "unprognostic (1.91e-1)" "unprognostic (3.52e-1)" "unprognostic (2.59e-3)" "unprognostic (9.01e-3)" "unprognostic (2.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (4.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.91e-1)" 7.9 0.4 0.5 21.1 0.5 94.8 0.8 0.6 1.0 1.2 1.0 1.5 1.4 0.4 0.3 12.3 4.3 6.4 1.3 0.8 0.4 0.7 2.0 13.5 1.1 0.6 0.5 0.4 0.2 1.6 0.4 0.3 3.6 0.5 0.4 0.6 0.2 6.8 0.3 0.5 0.6 0.9 1.7 0.3 48.7 1.1 0.2 0.4 2.4 1.0 3.7 21.3 24.6 10.4 1.0 0.1 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.6 0.3 34.7 223.9 8.4 0.7 1014.5 1.5 3.1 0.6 0.7 10.4 0.8 0.7 0.7 121.7 0.9 298.5 1.3 1.0 149.1 0.5 0.5 0.6 1.0 0.8 0.4 0.6 0.5 0.4 0.5 0.3 0.4 1.0 0.7 28.9 33.6 0.0 0.5 1.3 16.0 1.8 0.0 0.6 0.7 0.3 0.1 0.0 24.1 1.8 4.2 0.3 0.2 17.5 0.0 0.1 0.6 0.5 0.2 1.4 0.0 8.0 0.0 0.2 0.3 6.3 0.0 0.6 25.9 0.3 0.7 0.4 14.9 0.0 0.0 0.0 2.0 18.8 41.4 0.1 0.3 91.3 16.0 0.0 17.9 0.8 2.1 0.0 0.0 1.3 27.4 0.4 15.6 6.7 4.5 0.2 10.7 0.8 0.0 1.0 1.2 0.1 0.4 48.7 6.8 0.3 3.1 0.2 1.7 426.0 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39055972 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.9" HPA073637 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favorable (8.28e-4)" 2.2 6.3 2.1 9.3 2.2 3.3 2.5 2.1 2.7 3.9 3.4 3.2 3.7 4.1 6.3 2.4 8.4 3.6 5.5 1.8 2.9 3.1 2.9 3.5 15.8 2.8 2.3 1.6 8.9 3.1 5.3 3.4 2.2 2.5 4.8 2.8 1.1 4.9 5.2 0.6 1.6 3.8 4.5 2.3 12.0 4.8 8.3 2.3 5.4 3.0 1.3 14.6 4.6 3.2 3.3 4.9 4.2 1.8 6.2 4.9 7.1 2.2 4.2 6.9 8.8 14.0 3.9 9.1 12.9 4.1 8.9 7.7 6.5 1.7 6.0 3.8 11.7 5.3 16.5 0.5 2.5 8.6 3.6 7.0 9.5 3.0 5.0 1.5 5.1 8.5 3.5 1.3 19.9 4.8 3.9 4.0 2.7 0.8 0.5 0.7 6.1 0.7 2.5 8.1 6.6 0.9 1.5 4.7 1.2 2.5 3.5 4.7 1.9 2.3 2.0 5.0 0.4 2.0 3.4 1.7 0.5 5.6 1.9 3.1 3.2 4.7 9.4 8.5 9.1 9.8 27.7 5.6 9.0 6.0 34.2 3.4 5.6 3.1 14.6 14.5 4.6 8.4 7.4 2.1 2.2 2.1 2.7 1.8 2.9 2.8 2.3 1.6 2.5 2.3 2.3 3.3 1.6 0.0 0.5 0.0 9.8 0.9 4.9 6.3 2.2 0.0 2.1 2.2 5.9 8.6 4.2 0.0 0.0 2.0 7.6 0.8 1.9 7.4 2.4 4.8 3.8 2.6 1.2 2.1 0.1 3.9 1.4 2.9 2.6 3.6 2.5 11.0 3.6 1.6 5.9 0.0 0.0 2.2 4.1 2.2 1.4 5.2 5.0 2.8 5.4 2.8 5.3 2.2 8.2 0.5 0.0 4.8 3.6 6.4 9.6 4.5 0.5 5.3 4.6 0.2 0.0 1.0 2.6 0.3 0.4 1.6 0.9 1.6 5.4 7.8 1.5 5.9 RIBC2 "C22orf11, DKFZp566F0546, FLJ25720" ENSG00000128408 "RIB43A domain with coiled-coils 2" Q9H4K1 22 45413693-45432509 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 11.6;fallopian tube: 9.8;testis: 30.9" "Cell type enhanced" "Detected in some" "Early spermatids: 218.6;Endometrial ciliated cells: 77.5;Late spermatids: 40.4;Respiratory ciliated cells: 101.4;Spermatocytes: 159.4" "Cancer enhanced" "Detected in many" "cervical cancer: 8.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 7.6;CAPAN-2: 7.7;MCF7: 9.2;SiHa: 13.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 14.9" HPA003210 Approved NA NA "HPA003210: AB_1078347" "unprognostic (2.55e-1)" "prognostic favorable (7.08e-8)" "unprognostic (3.58e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.71e-2)" "unprognostic (1.30e-3)" "unprognostic (9.51e-3)" "unprognostic (7.21e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (9.95e-5)" "unprognostic (1.41e-1)" "unprognostic (5.32e-2)" "unprognostic (7.91e-2)" "unprognostic (1.13e-1)" 0.0 0.1 5.0 0.6 0.8 1.9 0.2 0.9 0.6 0.9 11.6 0.5 0.3 0.6 0.4 0.7 9.8 0.4 0.0 0.6 1.9 0.1 0.0 0.8 0.4 2.0 2.2 0.0 0.2 0.2 1.3 1.4 0.3 1.5 0.6 0.3 0.2 0.2 0.1 0.0 0.9 0.5 0.2 2.3 0.1 0.5 30.9 0.8 0.6 0.5 0.0 0.4 0.1 0.5 2.2 5.9 4.0 0.6 0.0 0.0 0.0 0.5 7.6 0.6 1.5 2.1 4.2 7.7 0.0 1.8 0.7 0.0 6.8 0.0 0.0 1.1 0.0 0.2 0.0 5.7 0.2 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.8 0.9 0.0 0.0 0.5 9.2 4.0 2.0 0.9 0.1 2.2 4.5 0.0 0.0 2.1 0.8 3.9 0.0 13.0 2.6 0.0 0.4 4.8 2.8 0.4 0.0 0.0 4.6 0.0 2.2 2.3 0.0 0.0 1.2 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 5.0 0.8 0.9 0.6 0.6 1.9 2.0 2.2 0.0 1.5 2.3 0.8 2.2 0.2 0.0 0.0 0.0 0.1 0.3 0.8 3.6 0.0 0.0 0.6 0.8 0.2 1.5 7.7 0.0 0.0 1.5 0.4 0.8 1.9 0.1 218.6 77.5 1.8 0.3 0.0 4.0 0.9 0.0 0.6 0.9 0.5 2.5 0.0 0.6 0.0 0.0 1.1 0.0 0.3 1.8 12.2 0.0 0.4 40.4 1.2 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.4 0.1 0.0 101.4 3.6 0.0 0.0 1.9 159.4 22.2 1.2 0.1 0.3 0.4 0.1 1.1 0.3 KRT17 PCHC1 ENSG00000128422 "Keratin 17" Q04695 17 41619442-41624842 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 385.5;skin 1: 785.0;urinary bladder: 638.3" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 3317.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "hTCEpi: 20287.9;SiHa: 8539.7" "Not detected" "Not detected" "CAB000029, HPA000452, HPA000453, HPA000539, HPA045062" Enhanced Enhanced "Intermediate filaments" Yes No 610000000 "Intermediate filaments" "CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204" "prognostic favorable (4.44e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (3.65e-3)" "unprognostic (4.46e-2)" "unprognostic (4.34e-1)" "unprognostic (4.36e-3)" "unprognostic (1.32e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.86e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (2.20e-1)" "unprognostic (3.89e-1)" 3.1 0.4 3.9 0.8 4.7 2.9 385.5 3.2 5.8 61.7 3.9 1.9 0.8 4.4 14.3 323.0 6.9 2.0 1.6 6.0 3.2 3.0 0.6 9.9 0.3 3.5 3.3 3.8 1.0 2.6 0.5 6.7 7.1 3.5 133.5 0.3 0.3 265.4 117.2 0.9 785.0 0.6 1.0 3.1 0.4 2.3 4.5 3.1 144.0 1.6 0.0 98.6 638.3 214.1 4.4 212.5 0.2 0.0 0.0 0.8 0.9 48.8 1.9 0.4 2.8 2.7 16.8 1.9 1.0 14.7 0.2 0.4 2101.7 0.1 2129.1 1.9 0.3 1.6 2.0 910.8 2.0 0.5 1.9 2.2 0.4 20287.9 1.3 1539.9 0.0 1.0 0.0 1.0 1.5 0.4 0.7 0.7 0.3 0.4 237.2 0.0 0.7 3.1 1.7 0.8 770.5 0.3 0.2 8539.7 3.8 0.9 4.8 0.3 1.4 0.8 0.0 401.5 0.2 1.0 0.9 0.4 3.1 1.4 77.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 4.7 3.2 5.8 6.0 3.2 3.5 3.3 3.8 3.5 3.1 3.1 4.4 5.6 22.4 7.2 0.3 0.5 139.6 13196.1 338.0 327.8 0.2 158.4 792.8 0.1 0.0 415.8 36.8 0.0 21.5 3.8 0.9 0.0 567.7 0.4 116.9 13.5 54.5 1.8 0.0 3.2 202.1 148.5 87.9 0.0 134.1 3.8 0.0 0.0 0.0 3.8 20.2 0.5 0.6 36.7 0.0 14.1 1.6 2.1 37.5 10.6 3.7 6.7 0.0 0.0 0.5 1.4 1754.5 2.5 212.5 0.0 5931.6 0.1 0.4 100.1 0.0 0.0 0.9 101.0 0.3 0.4 48.2 124.3 5.7 60.8 3.1 0.8 8499.3 EMC4 "FLJ90746, MGC24415, PIG17, TMEM85" ENSG00000128463 "ER membrane protein complex subunit 4" Q5J8M3 15 34225013-34230156 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053440 Approved NA NA "HPA053440: AB_2682151" "unprognostic (8.99e-2)" "unprognostic (1.59e-1)" "unprognostic (7.68e-2)" "unprognostic (3.29e-2)" "unprognostic (9.23e-2)" "unprognostic (1.29e-3)" "unprognostic (3.25e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.52e-1)" "unprognostic (5.42e-2)" "unprognostic (4.20e-2)" "unprognostic (2.96e-1)" "unprognostic (1.97e-2)" 76.7 68.6 87.3 49.2 90.1 59.2 69.1 93.3 104.5 64.6 94.8 65.7 55.6 67.5 103.8 79.0 68.4 52.7 81.3 90.2 91.4 68.5 92.0 57.8 55.8 92.2 89.5 89.8 66.7 91.5 83.7 60.8 59.7 92.6 62.8 58.8 66.0 79.7 64.3 216.4 64.3 57.5 59.3 89.3 49.5 70.3 49.8 88.7 58.6 61.1 137.9 54.7 59.8 72.0 98.6 123.1 248.2 103.9 135.1 133.2 119.6 95.0 137.7 156.9 166.0 143.4 162.0 106.1 48.5 177.7 160.0 145.6 229.4 107.0 135.3 118.7 148.3 103.7 91.9 219.4 154.8 161.0 139.8 87.8 121.4 126.3 121.4 136.0 118.1 139.8 144.6 117.0 186.6 147.1 137.9 109.9 149.9 116.9 165.0 163.5 102.0 94.7 138.3 161.0 186.9 137.1 166.4 101.7 148.3 77.6 74.8 99.3 164.7 106.5 151.3 103.8 131.8 142.7 162.8 251.5 122.0 184.5 164.1 131.1 256.5 158.6 176.9 154.5 173.9 170.0 237.2 170.6 185.8 162.6 187.7 172.2 168.8 88.5 197.8 200.2 166.6 216.1 277.6 87.3 90.1 93.3 104.5 90.2 91.4 92.2 89.5 89.8 92.6 89.3 88.7 98.6 75.3 54.5 67.7 8.8 67.9 91.5 103.7 206.5 55.8 35.8 83.7 104.1 58.7 58.6 132.4 66.2 18.8 150.6 62.5 39.5 125.2 180.3 121.8 67.6 55.1 86.1 52.0 38.7 14.1 172.3 173.6 87.8 36.7 69.1 88.0 63.2 64.2 78.6 113.7 18.5 15.4 62.8 166.8 48.5 73.2 27.4 100.6 56.5 101.4 13.1 87.9 98.4 76.2 15.1 16.9 184.0 65.4 90.7 117.9 89.6 71.8 117.5 133.3 42.8 85.5 81.4 123.2 169.7 91.9 60.2 110.0 141.7 68.8 69.7 66.4 125.4 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell type enhanced" "Detected in some" "Astrocytes: 8.1;Bipolar cells: 6.6;Excitatory neurons: 19.6;Inhibitory neurons: 11.6;Muller glia cells: 7.6;Oligodendrocyte precursor cells: 13.6;Sertoli cells: 6.6" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.2;fHDF/TERT166: 6.2;SCLC-21H: 6.0;SH-SY5Y: 10.6;U-87 MG: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015970 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.1 5.5 20.1 1.5 21.0 0.1 1.9 34.9 25.8 3.1 8.4 8.0 1.9 3.1 4.6 1.7 3.3 2.8 3.3 24.8 17.5 1.9 1.0 2.8 0.7 14.6 16.4 21.9 2.4 1.3 0.0 5.5 0.5 21.6 12.4 2.8 1.5 1.2 2.1 1.4 1.9 7.0 2.2 12.3 3.0 2.5 2.3 15.8 0.2 2.2 1.3 0.2 8.4 3.2 24.0 0.0 0.0 0.1 0.4 1.4 5.2 0.2 0.3 1.2 0.1 0.0 0.2 0.0 0.0 0.1 6.2 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 4.2 0.0 0.1 2.1 0.2 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.4 0.1 0.2 0.2 0.0 0.0 6.0 10.6 0.1 0.0 0.0 1.4 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.1 0.0 0.0 34.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 21.0 34.9 25.8 24.8 17.5 14.6 16.4 21.9 21.6 12.3 15.8 24.0 1.1 0.0 0.0 8.1 0.0 1.0 0.0 0.2 0.0 6.6 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.2 0.3 0.5 0.0 0.0 19.6 0.0 0.0 3.3 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 11.6 0.2 0.0 0.6 0.4 0.2 0.0 0.3 0.0 4.7 0.1 7.6 1.0 13.6 3.3 0.0 1.4 3.8 0.0 0.2 0.5 0.0 0.1 0.7 6.6 1.4 1.5 1.7 0.7 0.3 1.0 0.3 0.2 0.0 0.1 0.1 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20008865-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 42.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA 9800 "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 11.6 9.7 30.4 7.3 31.4 23.8 9.3 23.1 44.7 5.6 22.5 15.3 9.9 12.9 4.8 9.3 8.3 14.9 4.5 41.7 18.3 4.7 1.2 5.8 5.3 29.5 25.3 15.8 16.8 4.8 3.3 6.4 3.6 38.5 6.2 10.1 6.1 6.3 5.0 5.2 3.7 10.6 9.5 21.2 13.6 10.4 23.0 28.1 3.0 5.2 2.8 5.2 4.6 4.3 42.5 26.2 37.3 15.7 7.2 14.7 6.9 29.1 10.0 12.4 12.4 21.4 67.6 17.1 1.5 45.3 11.4 24.3 21.1 10.7 33.4 3.7 12.8 18.5 14.5 34.4 10.5 4.9 1.3 5.6 10.6 36.9 10.2 24.9 46.8 0.0 4.4 1.0 15.1 10.4 24.0 0.3 5.3 14.5 17.0 6.3 11.8 49.5 23.6 32.2 11.4 7.1 6.9 75.7 35.6 13.9 62.2 26.3 9.1 0.3 0.5 21.1 0.9 30.8 5.4 11.7 0.9 19.1 12.6 6.5 42.1 15.8 33.0 2.2 8.4 3.2 1.8 1.5 3.4 26.6 1.4 1.0 1.4 11.1 13.0 7.9 4.6 0.6 5.5 30.4 31.4 23.1 44.7 41.7 18.3 29.5 25.3 15.8 38.5 21.2 28.1 42.5 28.7 22.4 14.7 170.4 5.7 5.5 12.5 22.0 10.8 7.4 5.8 4.7 10.3 7.2 21.1 18.4 68.8 5.5 10.2 56.8 9.8 30.9 100.0 40.1 44.1 13.1 7.7 82.5 217.1 36.3 11.5 18.6 34.1 64.1 116.4 29.5 3.9 0.2 22.0 0.0 220.8 54.8 12.2 12.4 15.9 54.5 5.0 29.0 21.4 187.4 84.7 13.6 11.3 125.2 317.8 67.7 24.7 44.8 7.0 19.7 25.2 3.6 18.1 31.4 59.2 7.3 81.3 73.8 68.9 5.9 2.6 2.2 10.0 87.8 27.4 21.5 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.8;skin 1: 57.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 17.7;Basal respiratory cells: 23.7;Exocrine glandular cells: 54.1;Fibroblasts: 11.5;Suprabasal keratinocytes: 31.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 140.1;hTERT-RPE1: 261.0;LHCN-M2: 284.2;U-2 OS: 151.0;U-87 MG: 272.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 390000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.5 4.4 0.4 0.4 0.6 0.1 3.6 0.5 1.4 7.3 0.5 0.0 0.0 0.2 0.3 21.8 0.4 0.1 0.6 0.6 1.3 0.6 0.1 0.4 0.3 1.1 0.6 0.4 0.1 12.9 0.0 0.5 2.0 1.0 0.2 0.0 0.2 6.8 0.0 0.3 57.5 0.2 0.8 0.8 3.3 0.4 0.4 1.0 0.8 0.0 0.0 0.9 0.0 12.7 1.1 95.3 5.0 0.3 0.3 0.7 1.5 0.1 74.6 140.1 74.9 18.5 0.7 8.1 0.1 14.3 31.9 75.2 5.5 0.0 41.3 76.7 0.4 0.3 0.0 33.3 2.1 1.8 0.3 0.2 1.0 65.2 6.7 9.4 261.0 0.3 0.1 0.0 0.2 284.2 0.2 0.0 0.0 0.8 0.4 11.1 0.3 75.4 0.1 34.5 4.0 0.2 0.0 49.9 23.3 0.5 28.0 0.5 0.4 57.3 18.1 151.0 6.2 7.4 0.2 0.2 0.1 272.7 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.5 1.4 0.6 1.3 1.1 0.6 0.4 1.0 0.8 1.0 1.1 0.0 3.2 0.5 0.0 0.0 17.7 0.5 23.7 0.6 0.0 4.2 2.8 0.3 0.0 8.5 0.0 0.0 5.6 0.1 0.0 0.0 0.5 0.4 0.4 0.2 0.3 0.0 0.0 0.4 54.1 1.2 11.5 0.0 2.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.3 3.6 1.0 0.6 0.0 0.0 0.0 0.5 7.9 0.0 0.0 0.0 0.9 0.0 0.1 2.9 0.0 0.0 1.3 0.4 0.1 0.7 10.0 31.0 9.4 0.1 0.0 0.0 1.6 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206407 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Group enriched" "Detected in many" 4 "Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: AB_2686407" "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 7.9 4.5 19.2 6.7 40.7 1.4 4.9 13.5 23.2 5.0 1.9 2.9 1.5 4.7 2.8 2.5 5.3 5.0 4.5 39.6 18.9 4.5 10.1 17.5 2.8 17.2 20.3 16.1 8.5 3.2 3.4 3.2 7.0 21.7 4.0 2.8 10.6 3.3 2.5 6.3 2.5 2.4 7.4 17.7 1.8 2.3 2.1 21.0 1.7 3.5 7.3 2.2 3.7 3.5 24.6 0.1 3.5 8.8 7.8 7.2 10.4 5.3 1.0 9.6 1.7 2.8 0.0 0.2 0.8 7.6 2.3 2.0 0.5 1.5 8.8 6.5 2.9 12.9 0.4 5.8 14.3 5.1 1.1 0.4 4.9 1.0 43.3 20.8 3.0 75.5 3.4 0.1 22.6 3.8 1.0 2.0 0.7 5.1 1.5 15.8 0.8 7.0 3.6 6.0 0.5 1.9 7.5 6.2 4.3 5.8 8.2 0.8 0.4 69.0 6.6 3.4 13.7 3.0 1.2 0.5 0.9 0.7 1.8 16.5 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.1 0.0 0.1 19.2 40.7 13.5 23.2 39.6 18.9 17.2 20.3 16.1 21.7 17.7 21.0 24.6 56.4 48.1 6.8 791.0 1.1 5.2 3.3 7.5 8.6 27.4 3.7 6.3 13.1 2.8 16.7 3.7 22.9 0.3 0.1 2.3 0.0 2.1 3.8 1.3 5.5 47.1 10.9 5.3 422.8 0.4 0.2 21.4 0.5 2.2 2.5 5.0 43.9 17.0 14.6 94.2 177.1 0.7 14.2 16.7 21.0 1.5 5.6 27.4 8.8 1568.3 6.1 5.4 0.0 434.3 815.3 1.2 8.0 8.2 0.2 8.2 0.0 1.8 12.2 11.4 13.1 4.2 5.8 0.6 1.9 2.3 2.7 0.0 0.6 26.2 1.5 1.8 POT1 "DKFZp586D211, hPot1" ENSG00000128513 "Protection of telomeres 1" Q9NUX5 7 124822386-124929983 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 41.5;Oligodendrocytes: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068538 Supported Nucleoplasm NA NA Nucleoplasm "HPA068538: AB_2686001" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (5.71e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-3)" "unprognostic (7.88e-2)" "unprognostic (2.26e-2)" "unprognostic (1.51e-1)" "unprognostic (2.48e-2)" "unprognostic (9.89e-2)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-2)" "unprognostic (4.77e-3)" "unprognostic (7.42e-2)" 5.6 5.7 3.4 5.8 3.9 4.2 10.5 4.0 3.8 8.0 4.2 5.7 4.6 9.6 6.2 4.5 8.1 6.1 6.3 3.5 4.1 9.8 10.0 6.1 8.9 4.0 4.1 2.8 10.2 5.3 9.8 6.4 7.0 4.2 7.1 6.4 9.9 3.9 6.7 3.3 4.1 4.2 7.3 4.2 8.2 5.8 13.9 3.6 13.1 13.1 4.5 9.7 7.8 4.5 6.4 24.0 6.9 14.0 9.9 9.2 16.2 10.3 12.1 14.9 14.3 19.7 7.3 25.9 24.4 8.5 11.1 23.6 9.5 14.8 15.0 21.7 21.4 17.5 18.9 10.3 3.2 15.4 22.6 12.4 13.1 13.6 12.8 21.8 14.5 16.6 10.1 38.1 51.9 15.0 4.1 29.8 12.5 17.4 13.2 14.1 19.1 14.0 27.5 9.9 9.8 13.9 16.6 18.7 19.8 15.6 20.3 8.0 12.3 8.4 14.3 5.5 19.1 17.1 23.2 27.0 39.8 20.4 23.6 22.7 0.6 2.2 1.0 2.3 2.3 4.3 3.2 2.6 3.0 2.5 2.5 4.3 3.0 0.4 3.7 1.8 2.2 2.8 1.9 3.4 3.9 4.0 3.8 3.5 4.1 4.0 4.1 2.8 4.2 4.2 3.6 6.4 9.7 6.4 4.1 36.9 10.1 4.6 6.7 5.5 13.1 9.2 7.1 7.1 8.8 8.6 3.6 12.9 10.4 7.0 8.0 1.5 19.6 5.0 19.3 4.3 6.9 7.1 9.0 16.0 34.7 4.5 8.0 6.9 8.2 4.2 3.8 9.4 7.1 10.5 6.3 8.4 41.5 4.0 2.0 10.9 7.0 8.3 8.7 8.7 16.0 24.4 5.6 12.6 4.1 37.2 66.8 3.8 1.7 4.5 7.6 2.8 0.8 11.2 4.9 10.0 0.0 5.4 6.3 35.2 14.4 7.6 2.6 4.5 8.5 4.8 4.9 3.5 TAS2R16 T2R16 ENSG00000128519 "Taste 2 receptor member 16" Q9NYV7 7 122994704-122995700 "G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP6V1F "ATP6S14, VATF, Vma7" ENSG00000128524 "ATPase H+ transporting V1 subunit F" Q16864 7 128862856-128865847 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1054.6;Hofbauer cells: 1132.8;Proximal tubular cells: 1076.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009529, HPA048700, HPA062011" Supported NA NA 26000 "CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656" "unprognostic (1.70e-1)" "unprognostic (1.61e-2)" "unprognostic (2.14e-2)" "unprognostic (3.26e-2)" "unprognostic (2.99e-2)" "unprognostic (8.46e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.28e-3)" "unprognostic (2.70e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (4.06e-1)" "prognostic favorable (2.49e-5)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (1.36e-2)" "unprognostic (7.33e-2)" 131.4 162.0 269.4 107.2 283.2 212.3 123.3 264.8 371.4 112.6 244.3 98.5 75.4 96.1 62.3 224.8 99.1 105.1 170.5 281.2 279.6 306.0 84.9 141.2 141.0 270.5 269.1 275.8 89.7 107.7 165.0 142.1 105.5 273.9 103.8 57.1 111.6 130.4 82.3 171.0 170.6 97.9 71.9 267.5 120.5 115.3 213.9 279.5 120.8 85.3 156.0 104.5 124.3 147.8 282.9 305.6 345.1 151.2 323.2 297.6 236.8 86.9 151.2 201.3 246.8 267.2 257.0 179.8 287.6 156.5 175.7 367.7 163.9 224.5 250.1 91.9 312.6 364.2 220.1 211.4 256.4 344.1 227.1 400.8 278.2 340.0 284.7 163.4 188.9 238.1 257.9 534.3 297.3 276.3 403.1 381.0 494.3 201.9 190.6 281.4 168.7 110.1 467.5 315.5 240.3 286.6 197.3 214.1 796.5 363.7 156.6 184.4 284.9 253.0 303.5 65.3 409.5 236.2 333.5 326.9 372.0 600.4 315.5 263.6 370.2 697.1 489.2 244.6 475.1 238.0 343.7 247.6 239.7 508.9 348.5 235.8 238.6 203.1 243.6 324.7 288.3 317.3 886.1 269.4 283.2 264.8 371.4 281.2 279.6 270.5 269.1 275.8 273.9 267.5 279.5 282.9 129.3 28.9 62.8 17.3 140.1 237.6 202.5 378.9 136.6 111.4 162.0 190.1 157.6 127.2 230.7 331.1 37.5 171.8 119.8 97.3 1054.6 241.0 574.0 128.6 96.3 163.1 113.2 63.1 27.0 222.2 289.0 155.1 78.5 131.0 275.1 114.0 124.6 112.0 1132.8 545.1 34.6 108.7 585.9 320.6 378.7 898.9 164.4 456.1 254.3 16.9 285.8 230.4 190.5 11.6 26.2 253.9 93.0 127.9 136.8 224.7 212.0 1076.3 200.2 96.4 85.5 69.7 168.9 399.6 102.0 328.4 326.6 401.4 136.3 184.5 98.9 362.7 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184144-118204035 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 25.1 19.3 6.2 22.6 8.2 45.2 25.9 16.6 7.5 20.5 6.2 20.8 15.6 20.1 16.7 24.6 18.8 9.3 19.2 6.3 7.0 19.3 18.7 21.4 29.1 7.4 7.5 5.9 20.0 25.1 8.5 16.4 10.1 9.3 21.0 14.3 16.8 22.9 7.9 21.8 21.3 26.2 8.3 6.9 31.2 21.5 17.5 7.1 18.4 22.3 7.8 27.7 20.1 20.7 10.5 37.2 21.2 53.7 43.6 11.3 19.4 25.3 36.1 26.4 19.2 21.5 16.8 35.6 70.0 78.9 13.4 51.5 28.2 23.1 16.3 18.6 35.9 27.7 49.5 63.3 48.6 29.2 63.9 59.1 20.8 19.6 24.6 25.8 17.7 19.6 55.8 45.8 71.2 26.1 13.2 142.9 155.6 43.6 28.9 26.0 40.8 32.0 53.3 20.3 27.8 28.2 41.6 29.2 83.0 89.1 36.9 17.3 72.7 17.4 36.9 27.7 56.3 51.2 69.9 52.0 101.1 29.1 66.9 61.5 65.3 46.5 45.5 61.8 66.7 59.8 68.0 67.8 75.6 51.5 58.0 64.6 67.5 15.4 43.9 65.7 93.2 74.2 39.5 6.2 8.2 16.6 7.5 6.3 7.0 7.4 7.5 5.9 9.3 6.9 7.1 10.5 108.5 25.6 58.6 15.0 130.3 0.0 93.6 0.0 82.6 41.5 71.8 92.1 43.5 74.4 35.3 62.5 47.9 133.2 141.2 76.8 90.1 101.2 54.6 76.1 92.8 79.6 86.4 83.1 19.5 172.0 193.6 69.0 66.3 76.4 101.4 87.1 88.5 75.3 139.8 42.1 22.4 99.1 0.0 148.9 0.0 19.1 97.3 102.2 0.0 36.5 184.9 52.6 158.6 23.6 39.1 144.8 109.0 76.0 95.6 108.6 83.6 106.8 36.5 42.0 85.5 65.3 66.2 135.3 117.8 106.7 0.0 120.8 121.1 76.1 100.7 121.2 CDHR3 "CDH28, FLJ23834, FLJ44366" ENSG00000128536 "Cadherin related family member 3" Q6ZTQ4 7 105876796-106036432 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "choroid plexus: 38.8;fallopian tube: 109.7" "Cell type enhanced" "Detected in many" "Astrocytes: 170.7;Endometrial ciliated cells: 136.4;Excitatory neurons: 70.2;Inhibitory neurons: 63.8;Respiratory ciliated cells: 358.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 5.7;Daudi: 6.5;WM-115: 4.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 11.8" HPA011218 Supported NA NA "HPA011218: AB_1078886" "unprognostic (4.38e-4)" "unprognostic (9.18e-2)" "unprognostic (8.16e-3)" "unprognostic (8.08e-3)" "unprognostic (5.23e-2)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.18e-1)" "unprognostic (2.77e-2)" "unprognostic (3.70e-3)" "unprognostic (3.51e-3)" 1.1 0.9 12.9 0.9 3.9 0.9 4.2 4.6 5.1 3.0 38.8 7.3 1.9 1.7 3.2 0.5 109.7 0.2 1.1 6.4 2.2 2.0 2.1 14.4 0.7 9.7 8.8 2.6 2.5 1.0 0.0 1.6 0.1 9.5 1.0 1.6 6.7 0.4 0.6 0.8 0.7 4.8 3.2 11.0 0.2 9.3 0.5 6.1 0.1 2.6 0.4 0.9 0.7 0.8 5.5 0.1 0.3 5.7 0.7 1.5 2.1 0.1 0.3 0.3 0.3 0.1 0.0 0.1 6.5 0.0 0.3 0.6 0.0 1.4 0.0 0.2 0.4 0.8 0.0 0.2 0.7 0.0 0.1 0.2 0.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 1.1 2.2 0.4 0.0 0.0 0.2 0.1 0.1 0.4 2.1 0.0 0.4 0.3 0.8 0.0 0.0 0.2 1.0 0.2 1.3 0.0 0.0 0.0 2.1 0.1 0.1 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.9 0.1 0.0 0.9 0.3 0.1 0.1 0.3 0.1 12.9 3.9 4.6 5.1 6.4 2.2 9.7 8.8 2.6 9.5 11.0 6.1 5.5 2.5 3.2 10.4 170.7 1.7 2.7 1.6 9.5 2.8 6.4 1.8 3.4 1.4 5.7 37.6 0.0 0.0 0.6 2.8 2.0 5.9 0.7 8.5 136.4 1.4 1.8 29.9 0.0 70.2 0.6 0.3 2.8 15.3 2.9 3.8 3.8 0.0 2.9 0.1 0.0 63.8 4.9 8.2 0.0 2.7 3.8 2.8 0.7 8.8 16.9 0.0 10.2 6.2 4.0 4.3 0.2 3.3 1.5 1.4 0.7 5.0 6.2 358.4 1.3 6.6 2.2 8.8 1.2 3.2 0.6 2.0 0.3 2.4 1.4 3.0 0.7 PRKRIP1 "C114, FLJ13902, KRBOX3" ENSG00000128563 "PRKR interacting protein 1" Q9H875 7 102363872-102426676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051146 Uncertain Supported "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA051146: AB_2681361" "unprognostic (4.78e-3)" "unprognostic (7.23e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (8.25e-2)" "unprognostic (2.99e-3)" "unprognostic (3.15e-2)" "unprognostic (1.99e-2)" "unprognostic (4.38e-3)" "unprognostic (1.57e-3)" "unprognostic (1.50e-2)" "unprognostic (2.61e-3)" "unprognostic (9.79e-3)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (4.88e-1)" "prognostic favorable (1.94e-4)" 12.2 16.4 13.7 7.2 13.7 16.7 12.9 16.6 18.0 15.4 12.6 12.9 8.7 13.8 3.5 11.8 14.3 5.7 9.7 13.7 14.1 15.5 12.2 9.7 12.6 14.5 14.0 13.3 14.8 11.7 11.7 15.5 7.1 14.7 15.6 3.7 4.2 12.2 6.9 12.4 18.4 12.5 5.1 13.0 18.4 13.6 19.2 13.9 12.2 14.6 7.5 7.7 13.7 13.2 14.6 17.0 12.4 11.8 17.3 5.4 7.7 17.6 13.1 9.0 21.1 17.8 20.3 14.7 17.6 20.3 11.2 15.0 19.2 9.0 12.9 10.7 20.1 19.1 7.3 12.3 11.9 13.3 10.3 10.3 5.5 12.4 16.2 10.9 11.3 10.7 19.9 21.1 26.3 13.1 33.7 34.4 46.7 18.3 15.1 14.7 24.8 11.5 27.5 11.3 7.2 13.5 25.9 19.5 29.2 20.1 11.8 15.1 20.0 12.7 21.6 26.0 23.3 20.5 36.0 26.7 31.6 18.3 18.4 29.4 3.8 10.1 18.3 11.5 10.0 10.7 14.0 11.5 12.9 7.8 13.0 14.2 12.4 20.7 12.9 13.6 14.1 9.6 10.0 13.7 13.7 16.6 18.0 13.7 14.1 14.5 14.0 13.3 14.7 13.0 13.9 14.6 23.4 32.1 21.8 0.0 31.4 13.4 19.0 14.8 20.5 23.1 21.1 19.3 23.8 14.3 23.0 16.5 31.3 27.5 31.7 13.7 31.3 24.8 77.8 29.6 26.0 21.4 16.3 21.8 0.0 25.1 26.7 21.3 16.3 32.0 22.8 27.1 15.0 14.1 27.6 23.5 0.0 13.8 8.2 13.8 16.9 92.5 17.1 19.2 12.4 0.0 22.1 25.3 20.6 0.0 0.0 29.5 9.8 16.6 28.6 22.4 14.6 26.6 27.1 21.5 32.9 29.2 27.0 88.4 47.6 20.8 17.6 41.9 30.4 24.2 12.0 19.4 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165569 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 887.1" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 128.3;Horizontal cells: 225.4" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Region enriched" "Detected in all" 5 "hypothalamus: 887.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1270000 3100000 "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavorable (4.25e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 2.2 3.2 41.1 0.8 65.0 0.1 0.1 6.4 174.3 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.0 0.0 22.8 887.1 2.7 0.0 0.1 0.0 181.5 45.2 39.5 0.1 16.3 0.0 118.0 0.0 113.8 0.1 0.0 2.2 0.0 0.0 0.0 0.7 0.3 0.2 16.6 0.1 1.9 0.9 49.2 0.0 0.6 0.0 0.0 0.0 0.1 155.0 2.2 1.1 1.1 9.5 0.0 0.0 10.3 0.9 0.0 0.0 0.0 2.4 0.9 0.1 3.1 0.0 1.4 1.4 0.5 0.1 0.0 1.0 0.7 0.3 0.0 0.9 0.1 0.6 4.4 0.1 0.2 0.2 0.7 0.0 0.0 0.1 3.7 2.3 0.0 23.4 0.1 2.4 17.6 1.0 2.3 0.8 0.0 0.1 0.3 0.1 14.1 172.0 0.3 0.9 511.5 1.1 0.4 0.3 0.0 0.4 85.9 0.0 2.0 0.1 0.8 4.7 13.5 0.4 141.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 65.0 6.4 174.3 22.8 887.1 181.5 45.2 39.5 113.8 16.6 49.2 155.0 1.7 0.0 0.0 3.6 0.9 1.5 1.0 0.0 1.2 22.0 0.9 0.6 2.9 0.0 0.0 0.0 0.0 1.5 1.0 1.3 29.4 0.3 0.1 0.4 0.4 0.9 128.3 0.0 22.7 0.0 8.4 0.3 3.1 0.5 0.0 1.4 0.0 0.0 0.6 225.4 37.7 4.5 0.0 0.0 0.4 0.6 0.6 0.7 0.0 11.2 0.0 2.1 0.0 4.0 4.8 5.9 2.8 0.0 0.9 4.3 2.7 1.2 0.0 5.0 0.0 0.1 0.8 0.2 4.3 0.6 2.3 1.4 0.5 5.4 2.3 0.6 PODXL "Gp200, PC, PCLP" ENSG00000128567 "Podocalyxin like" O00592 7 131500262-131558217 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 97.1" "Cell type enhanced" "Detected in many" "Adipocytes: 165.8;Cone photoreceptor cells: 87.6;Endothelial cells: 181.1;Glandular and luminal cells: 121.3;Microglial cells: 92.8;Rod photoreceptor cells: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 295.8;NTERA-2: 509.7;SuSa: 640.8;TIME: 474.0;U-251 MG: 226.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" NA NA 33000000 "Plasma membrane, Centriolar satellite" Vesicles "CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356" "unprognostic (1.26e-1)" "unprognostic (7.68e-2)" "unprognostic (8.28e-3)" "unprognostic (6.46e-3)" "unprognostic (5.16e-3)" "unprognostic (5.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (7.95e-3)" "unprognostic (3.52e-1)" "unprognostic (9.20e-3)" "unprognostic (3.40e-1)" "prognostic favorable (2.89e-4)" "unprognostic (2.56e-1)" "unprognostic (8.78e-3)" "unprognostic (3.55e-2)" "unprognostic (1.03e-1)" 21.0 6.9 36.9 9.0 25.3 0.3 22.2 24.3 34.7 26.2 21.4 8.5 5.2 27.7 5.7 8.2 49.4 14.6 29.4 24.3 23.4 97.1 3.0 32.1 5.7 29.9 26.7 16.1 6.2 26.2 19.0 1.1 29.6 31.9 8.8 8.7 68.4 16.2 19.0 15.5 4.9 6.2 29.1 20.3 5.7 5.6 2.4 36.7 3.7 28.8 26.3 6.2 9.7 1.0 39.9 50.9 18.9 42.6 16.3 0.5 0.0 2.6 5.4 4.2 16.9 6.1 121.4 83.1 0.3 109.7 295.8 57.1 34.9 34.3 0.7 15.3 5.4 17.3 0.2 115.0 2.7 1.1 4.2 4.0 0.2 0.4 50.5 0.8 9.4 146.3 1.5 10.5 1.8 16.9 18.0 0.5 1.3 509.7 10.0 43.6 16.2 73.1 15.8 1.6 16.6 34.3 8.9 34.7 7.0 0.2 640.8 4.1 2.2 474.0 6.8 26.6 72.5 226.1 2.5 4.5 1.2 27.1 20.1 48.4 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 25.3 24.3 34.7 24.3 23.4 29.9 26.7 16.1 31.9 20.3 36.7 39.9 165.8 6.4 9.9 3.6 2.4 5.2 0.9 14.0 0.6 9.7 33.3 20.7 22.9 4.3 25.4 27.6 87.6 0.8 1.0 1.0 0.0 4.6 0.8 44.8 13.0 181.1 2.4 2.7 9.4 18.3 0.4 9.2 1.1 121.3 2.5 2.2 65.0 1.0 0.4 5.0 3.3 12.9 4.1 0.9 9.6 1.3 4.7 2.6 5.4 92.8 0.7 10.6 0.0 7.1 3.1 42.7 0.8 0.4 4.3 3.6 0.7 0.8 10.3 188.4 0.0 6.3 8.4 0.3 1.1 1.3 3.1 0.7 3.3 1.9 2.7 5.8 FOXP2 "CAGH44, SPCH1, TNRC10" ENSG00000128573 "Forkhead box P2" O15409 7 114086327-114693772 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 186.8;Microglial cells: 288.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 21.0;RH-30: 37.3;THP-1: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000382, HPA000383, HPA001679" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415" "unprognostic (1.21e-1)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (8.83e-3)" "unprognostic (4.66e-1)" "unprognostic (3.69e-4)" "unprognostic (2.04e-2)" "unprognostic (6.22e-2)" "unprognostic (2.17e-1)" "unprognostic (6.70e-3)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (8.04e-2)" "unprognostic (4.16e-3)" "unprognostic (2.84e-1)" "unprognostic (9.81e-2)" "unprognostic (4.19e-2)" 1.7 1.4 2.0 1.9 1.6 0.4 2.0 0.0 11.5 3.8 0.0 13.7 2.5 8.1 1.7 6.2 3.4 3.6 1.2 4.7 0.9 1.7 2.5 1.5 1.0 2.2 7.5 0.4 9.8 4.6 0.6 0.9 0.5 2.6 2.2 5.2 3.2 2.8 1.4 3.3 3.7 3.2 7.7 0.2 0.5 4.3 1.3 3.9 0.2 4.9 1.8 0.7 6.2 4.4 6.3 0.4 3.2 21.0 0.0 4.9 6.2 1.3 3.5 3.6 0.7 0.4 1.6 0.3 0.3 0.8 1.2 0.1 0.5 0.8 0.0 0.1 0.2 7.0 8.0 4.6 6.6 0.0 0.5 0.5 1.3 0.8 0.1 0.0 1.3 0.0 0.0 1.8 3.0 0.8 1.5 1.8 1.2 1.1 0.4 1.0 0.6 37.3 7.9 0.5 8.6 5.1 2.2 0.0 1.3 1.1 1.2 1.0 11.9 1.6 1.3 0.6 2.0 0.7 6.3 0.7 1.0 1.5 0.8 0.6 9.7 5.5 11.4 5.9 7.4 5.8 10.1 6.4 6.3 6.7 8.2 6.5 7.4 5.5 6.6 6.3 16.6 10.7 20.5 2.0 1.6 0.0 11.5 4.7 0.9 2.2 7.5 0.4 2.6 0.2 3.9 6.3 0.5 0.0 8.2 5.5 0.0 30.7 2.9 5.5 48.3 0.1 1.8 1.3 1.6 10.0 7.3 3.7 2.1 0.1 0.0 4.8 0.0 0.1 9.7 0.1 1.2 1.9 4.2 0.0 186.8 5.4 0.0 20.6 1.1 0.0 0.0 16.2 8.2 11.7 0.2 13.5 6.4 11.5 2.0 1.6 5.6 6.2 5.3 0.4 3.6 288.6 0.0 27.7 0.0 5.5 4.6 1.3 18.5 0.7 0.6 2.3 8.6 3.8 11.3 1.3 0.0 25.5 1.7 2.4 1.4 25.3 25.6 0.3 0.3 4.2 11.5 4.0 STRIP2 "FAM40B, FAR11B, KIAA1170" ENSG00000128578 "Striatin interacting protein 2" Q9ULQ0 7 129434432-129488399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.1;choroid plexus: 67.7;skeletal muscle: 28.9" "Cell type enhanced" "Detected in many" "Astrocytes: 54.9;Cardiomyocytes: 49.5;Muller glia cells: 62.1;Oligodendrocyte precursor cells: 29.7;Spermatocytes: 79.1;Spermatogonia: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 44.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 102.5" HPA019657 Approved Approved Cytosol NA NA Cytosol "HPA019657: AB_1848399" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (2.11e-1)" "unprognostic (2.41e-1)" "unprognostic (4.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (6.78e-4)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (8.99e-2)" "unprognostic (1.95e-1)" "unprognostic (2.87e-6)" "prognostic favorable (5.41e-4)" "unprognostic (4.06e-2)" "unprognostic (5.34e-2)" "unprognostic (7.50e-2)" 0.4 2.3 3.4 1.6 33.1 3.7 0.5 3.7 9.2 0.3 67.7 0.6 0.5 0.4 0.3 1.1 0.2 0.8 9.4 4.7 6.5 4.8 0.5 1.0 2.4 7.7 8.9 5.8 0.7 0.9 0.1 8.2 0.9 16.2 1.1 0.9 22.3 1.4 0.1 28.9 0.9 0.9 0.5 0.9 1.2 0.7 14.3 8.7 1.3 0.5 19.6 1.7 0.7 0.4 2.2 15.4 6.5 5.9 9.3 2.3 2.0 25.5 6.1 7.7 10.2 9.8 3.6 8.5 6.4 0.8 2.6 33.2 16.9 6.4 5.5 15.4 37.6 5.3 4.9 11.5 3.7 1.5 3.1 25.0 2.4 1.9 17.3 10.6 16.8 17.8 5.7 21.7 3.8 39.7 0.8 8.2 7.8 5.7 3.3 13.4 5.4 10.9 1.2 3.7 5.7 1.3 1.3 14.2 1.0 3.1 4.4 1.8 7.6 6.4 5.9 5.8 44.7 18.0 3.6 2.5 7.6 39.4 7.9 8.5 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 3.4 33.1 3.7 9.2 4.7 6.5 7.7 8.9 5.8 16.2 0.9 8.7 2.2 0.4 3.2 1.1 54.9 0.8 0.3 0.3 0.3 0.0 10.5 0.5 0.4 49.5 0.0 0.3 0.0 2.1 0.7 0.8 2.1 0.0 0.9 5.7 0.2 0.9 1.1 0.0 9.1 18.6 3.8 3.8 3.2 2.0 0.4 7.6 1.0 0.4 0.2 0.8 1.7 16.7 1.0 0.0 0.3 0.3 9.9 0.6 2.1 1.8 7.5 7.8 62.1 0.0 29.7 1.0 5.0 4.4 0.7 1.4 0.6 0.1 13.7 0.8 3.5 0.0 2.3 0.9 79.1 37.1 0.5 0.1 0.3 1.3 0.5 0.8 0.6 IFT22 "DKFZp761N0823, FAP9, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101310914-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 577.5;Late spermatids: 1478.7;Spermatocytes: 357.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 92.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 12.4 22.2 20.5 3.7 20.6 2.9 14.5 18.8 25.9 17.3 24.9 17.3 2.9 21.2 23.1 8.6 28.1 12.2 23.0 20.4 21.3 35.6 7.9 13.2 4.1 19.4 19.2 19.3 19.7 18.6 30.1 31.3 2.8 19.1 18.2 3.4 41.8 14.8 6.5 26.6 9.9 7.5 5.9 20.1 4.7 15.0 77.0 19.3 10.2 24.6 19.8 3.6 17.3 11.6 19.0 26.1 38.6 20.7 47.9 17.1 14.5 4.6 8.6 4.8 10.6 7.9 15.4 19.3 3.1 22.1 17.8 41.1 16.6 12.2 12.7 8.2 6.2 16.4 0.6 16.4 15.8 12.6 8.7 4.9 14.9 10.9 25.2 5.9 36.5 10.4 18.2 11.2 3.4 12.6 92.5 15.6 16.3 21.6 19.5 17.4 14.4 13.1 5.3 20.1 15.8 22.3 37.0 25.3 21.0 13.7 33.5 16.3 6.6 10.6 33.1 24.6 64.0 18.0 3.1 10.3 7.5 21.7 2.5 17.3 1.4 0.8 0.9 4.0 1.7 3.8 7.5 4.8 3.6 1.6 5.9 4.3 4.4 1.1 5.8 3.3 4.7 2.0 2.3 20.5 20.6 18.8 25.9 20.4 21.3 19.4 19.2 19.3 19.1 20.1 19.3 19.0 12.0 25.6 14.3 6.5 11.9 0.0 25.1 0.0 22.2 26.6 35.5 54.4 42.9 55.8 19.2 49.7 54.2 19.7 2.3 4.0 138.9 73.9 577.5 176.0 32.1 17.0 18.5 17.4 7.2 36.9 17.3 28.3 12.8 28.0 9.5 37.9 21.8 10.7 17.7 32.0 5.3 13.1 0.0 2.7 0.0 1478.7 37.9 6.9 0.0 2.8 2.9 76.2 3.1 3.0 2.4 29.9 13.5 41.3 4.8 17.1 2.9 170.2 102.7 103.9 13.1 21.8 22.6 357.7 71.5 15.0 0.0 6.6 7.3 36.0 8.0 20.4 MKLN1 TWA2 ENSG00000128585 "Muskelin 1" Q9UL63 7 131110096-131496632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 455.1;Excitatory neurons: 336.5;Inhibitory neurons: 256.4;Oligodendrocyte precursor cells: 369.5;Oligodendrocytes: 332.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 9.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022817, HPA041810" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA022817: AB_1853974, HPA041810: AB_2677686" "unprognostic (1.97e-1)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.03e-1)" "unprognostic (4.20e-2)" "unprognostic (1.44e-3)" "unprognostic (4.58e-2)" "unprognostic (1.94e-2)" "unprognostic (1.97e-1)" "unprognostic (2.43e-3)" "unprognostic (1.55e-1)" "unprognostic (9.18e-3)" "unprognostic (1.70e-1)" "unprognostic (4.13e-1)" "unprognostic (1.13e-2)" "unprognostic (2.32e-1)" 12.7 12.2 20.0 7.0 22.1 9.2 13.7 24.1 19.6 10.9 18.2 7.6 9.1 10.2 11.9 7.6 12.0 7.2 9.0 17.1 35.2 14.0 14.8 7.7 8.9 21.7 22.7 15.5 13.9 7.8 10.1 4.6 11.7 24.1 16.2 7.4 22.2 11.4 13.5 10.6 9.7 8.5 9.0 19.4 8.7 8.5 9.5 21.8 8.7 11.4 13.6 7.7 7.2 5.4 22.3 14.1 16.0 13.6 13.8 32.8 29.6 8.5 13.3 30.7 14.8 18.8 7.3 11.9 14.6 9.0 16.7 29.3 9.5 14.4 13.1 24.2 14.5 7.0 6.2 13.1 8.5 15.7 10.4 8.7 17.7 8.8 20.6 10.0 15.9 13.7 8.8 23.3 10.2 18.6 5.2 12.3 11.1 15.5 11.4 8.3 7.7 16.0 10.1 16.4 8.1 7.0 15.2 25.7 25.7 12.9 14.1 5.0 12.9 14.1 11.5 6.5 21.1 11.0 24.7 10.0 24.6 39.6 12.3 17.2 1.2 0.7 1.4 1.1 0.9 0.8 0.9 1.1 0.9 0.8 1.6 1.7 1.4 9.5 0.7 1.3 1.2 0.7 0.5 20.0 22.1 24.1 19.6 17.1 35.2 21.7 22.7 15.5 24.1 19.4 21.8 22.3 54.4 51.3 43.7 455.1 42.6 44.1 29.3 22.9 31.9 49.7 34.6 21.5 24.9 38.6 27.4 46.0 70.9 17.3 37.6 33.2 7.9 23.0 5.7 30.5 60.4 50.5 37.1 38.9 336.5 23.7 17.4 46.3 36.7 46.9 34.2 42.9 64.2 78.3 21.7 53.8 256.4 29.4 28.5 41.9 52.1 7.8 68.0 35.1 35.6 210.8 44.9 44.1 26.8 369.5 332.5 27.1 36.5 84.2 40.2 49.3 38.7 31.4 25.9 64.9 85.5 64.3 56.9 41.1 28.0 28.9 45.9 14.8 37.9 35.9 28.4 39.1 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569867-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 350.9;Plasma cells: 409.3;Syncytiotrophoblasts: 569.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 116.5;Karpas-707: 109.3;U-266/70: 191.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 21.1 58.9 18.5 21.7 19.1 41.2 30.2 19.9 22.7 35.1 27.4 20.8 23.6 24.1 63.3 13.5 19.6 22.5 45.8 18.5 27.6 63.8 104.7 21.6 21.3 20.7 21.6 17.9 28.2 72.1 21.5 43.8 41.9 21.8 28.6 19.6 23.3 42.1 45.1 35.1 9.9 20.9 22.1 21.6 17.7 25.9 34.0 20.7 16.1 78.5 26.6 31.4 29.2 11.6 22.6 9.4 10.6 14.2 16.3 38.6 27.6 31.2 33.6 40.8 18.2 21.8 10.7 17.5 12.4 36.6 10.7 56.6 11.2 16.0 8.3 18.7 13.2 8.7 6.6 7.2 33.0 116.5 9.8 12.3 19.5 63.2 10.8 58.6 41.1 19.3 7.0 9.7 109.3 29.0 14.0 9.3 11.5 14.2 11.0 5.9 6.0 14.3 65.8 15.1 6.1 9.8 20.5 12.4 55.7 65.2 39.4 10.4 13.6 22.4 19.1 9.0 24.0 11.8 191.8 66.0 14.0 16.8 12.7 17.6 75.9 19.3 9.4 34.1 15.0 59.0 24.5 36.2 34.2 14.3 21.2 20.2 23.5 5.3 26.0 17.0 78.1 22.6 30.3 18.5 19.1 19.9 22.7 18.5 27.6 20.7 21.6 17.9 21.8 21.6 20.7 22.6 65.7 3.2 28.8 10.1 110.3 185.6 102.4 123.1 71.7 40.3 129.4 58.9 65.6 44.3 75.1 53.3 8.4 106.7 95.0 28.0 49.0 47.5 350.9 46.1 38.1 55.3 66.6 44.9 14.5 45.7 123.0 121.2 51.0 92.5 92.1 16.2 33.5 185.9 40.1 20.2 15.6 76.8 69.2 37.8 190.5 211.4 38.2 60.2 339.7 11.2 16.0 90.4 23.7 8.5 11.2 33.0 32.3 46.3 409.3 144.7 31.3 155.6 35.4 33.3 39.5 49.4 129.0 157.0 89.9 39.4 158.7 569.4 115.1 18.6 28.8 79.5 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830406-128859274 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 474.0;skeletal muscle: 1396.2;tongue: 446.5" "Cell type enriched" "Detected in many" 26 "Cardiomyocytes: 1892.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006135, HPA071007" Enhanced Supported "Plasma membrane,Cytosol" NA NA 26000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602, HPA071007: " "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (3.73e-5)" 13.1 3.5 6.6 26.1 10.0 0.0 6.0 12.3 9.1 16.3 5.7 153.0 9.5 97.4 4.6 40.6 35.7 13.9 474.0 4.8 18.7 2.8 1.1 12.7 0.6 50.9 10.2 1.9 9.4 2.1 3.3 1.6 2.4 24.9 71.7 9.9 0.5 16.6 101.7 1396.2 7.5 40.6 115.4 57.0 0.7 66.2 2.3 14.6 0.3 4.4 446.5 0.2 164.1 21.5 56.8 0.1 0.8 4.2 0.1 34.4 41.2 4.1 393.6 73.6 109.2 52.3 124.0 1.0 0.1 64.7 180.2 44.9 0.1 23.7 0.9 64.4 0.2 13.1 0.1 20.2 0.1 43.2 0.0 0.2 78.0 0.1 190.6 0.1 44.2 69.0 0.3 49.0 0.2 75.8 0.0 0.0 1.5 64.5 0.1 22.6 0.1 127.5 1.0 0.1 0.0 2.1 7.0 0.7 0.1 0.3 88.0 0.4 1.6 144.6 38.2 163.5 10.1 0.2 0.1 0.0 0.3 129.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 10.0 12.3 9.1 4.8 18.7 50.9 10.2 1.9 24.9 57.0 14.6 56.8 3.6 3.2 0.5 0.7 0.0 3.7 0.3 0.1 1.2 0.6 0.3 1.3 1892.3 0.0 1.9 1.8 0.0 0.4 0.2 0.5 0.0 0.7 0.4 1.8 5.0 31.4 0.0 0.0 0.2 0.2 3.0 31.6 0.0 2.9 0.0 0.6 1.8 0.0 0.9 0.0 1.1 0.3 0.0 0.0 6.9 0.9 5.3 0.5 5.4 0.0 0.0 0.1 0.0 0.0 5.8 2.6 0.1 10.5 1.2 2.7 0.0 1.1 0.0 0.2 0.0 71.8 38.1 0.3 1.0 0.2 4.5 1.9 1.0 0.1 0.2 1.0 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2" "Cell type enhanced" "Detected in many" "Club cells: 33.2;Cone photoreceptor cells: 27.1;Horizontal cells: 55.5;Respiratory ciliated cells: 53.0;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "neutrophil: 13.1" "Lineage enriched" "Detected in single" 20 "granulocytes: 13.1" "Group enriched" "Detected in some" 6 "AF22: 15.9;NTERA-2: 35.4;REH: 33.5;SCLC-21H: 18.2;SH-SY5Y: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" NA NA 2100000 "Golgi apparatus" "HPA051100: AB_2797241" "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.3 6.8 6.6 2.8 12.0 11.0 0.6 5.7 35.2 1.6 0.0 0.8 0.6 3.2 0.3 4.2 6.7 3.2 2.3 10.9 3.7 3.1 1.9 6.0 1.8 0.0 2.5 12.4 4.9 0.4 6.8 1.8 4.4 14.6 0.7 0.5 4.4 1.5 2.8 0.8 0.3 0.8 1.6 0.0 4.7 1.9 6.3 0.0 5.2 0.5 1.8 2.1 1.6 2.8 11.3 0.0 0.2 15.9 0.0 0.6 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.0 1.1 1.5 0.0 1.4 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 35.4 0.0 0.0 33.5 0.0 0.3 0.2 0.0 18.2 10.9 0.0 0.0 1.3 2.5 0.0 3.7 0.4 1.1 0.2 0.1 0.9 0.0 0.0 0.0 0.2 0.0 2.3 0.5 0.2 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.1 0.0 0.6 0.0 0.0 0.1 6.6 12.0 5.7 35.2 10.9 3.7 0.0 2.5 12.4 14.6 0.0 0.0 11.3 1.8 16.0 14.3 5.5 0.6 0.1 1.6 5.7 0.6 11.3 0.5 0.4 1.4 0.0 33.2 1.8 27.1 0.2 0.7 0.2 0.0 0.1 6.6 11.6 5.2 5.1 0.0 0.0 18.3 0.0 0.3 1.2 0.0 18.7 1.3 1.8 11.0 0.1 19.8 55.5 22.6 0.0 2.0 11.2 0.7 0.9 0.0 1.6 1.8 9.4 0.6 0.8 0.0 11.6 2.1 0.0 0.5 0.7 0.9 4.5 0.1 0.6 53.0 35.1 0.0 2.4 2.0 6.2 4.6 5.6 0.0 0.4 0.5 0.7 0.3 19.0 CALU ENSG00000128595 Calumenin O43852 7 128739292-128773400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 504.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 2467.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006018 Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 21000000 "Endoplasmic reticulum" "HPA006018: AB_1845934" "unprognostic (7.22e-3)" "unprognostic (1.16e-3)" "unprognostic (3.16e-1)" "unprognostic (8.86e-2)" "unprognostic (1.27e-1)" "unprognostic (9.52e-3)" "prognostic unfavorable (1.80e-4)" "unprognostic (1.05e-3)" "unprognostic (1.95e-1)" "unprognostic (1.38e-1)" "unprognostic (2.75e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.30e-11)" "unprognostic (3.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.60e-5)" 116.9 57.2 20.6 139.1 22.9 23.0 66.8 22.9 28.7 134.6 51.6 80.0 37.9 114.7 61.6 60.9 57.6 93.5 239.1 24.5 27.2 45.5 74.8 69.1 39.1 25.3 22.5 20.2 55.3 53.0 85.7 29.0 213.6 23.8 114.0 82.1 19.7 68.3 151.5 82.8 28.7 40.4 331.4 23.0 48.0 63.1 40.1 29.2 31.3 77.8 118.1 45.5 161.6 48.6 25.9 257.8 207.4 486.6 152.7 1348.5 1229.5 270.9 1821.7 1378.1 577.5 770.7 238.6 388.3 100.0 351.5 2467.8 850.4 144.9 258.2 318.2 826.5 80.6 138.2 136.6 283.7 295.0 657.1 187.2 254.3 930.5 223.6 868.3 370.6 904.4 537.3 116.4 237.9 172.8 1131.8 141.0 130.2 95.5 305.2 247.0 197.3 122.9 333.3 164.5 243.5 132.7 44.3 238.2 595.4 481.5 753.1 932.2 106.2 145.6 799.8 1706.6 234.2 1350.8 754.6 306.8 385.7 224.8 1478.6 223.6 1857.2 21.7 38.8 23.5 28.3 41.4 27.9 23.7 19.5 22.0 33.4 16.6 17.1 20.0 4.5 26.2 35.7 32.9 23.4 31.2 20.6 22.9 22.9 28.7 24.5 27.2 25.3 22.5 20.2 23.8 23.0 29.2 25.9 67.3 22.4 38.5 25.5 29.9 81.3 68.1 82.0 31.3 28.2 51.7 42.7 247.0 25.8 62.7 25.8 18.8 116.8 25.0 14.4 17.6 69.5 11.4 37.5 186.3 104.0 19.7 42.3 37.7 60.5 504.7 198.8 37.2 72.8 59.6 62.6 113.2 54.2 136.9 28.6 47.0 55.9 22.4 58.9 70.7 9.3 100.3 44.6 120.9 27.2 26.3 32.4 21.6 31.2 32.2 71.5 11.4 118.8 140.9 110.6 12.6 17.7 57.2 12.8 59.2 64.9 162.8 27.1 41.9 30.9 76.9 243.0 30.9 69.7 26.1 90.5 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 82.8;retina: 53.0;testis: 187.2" "Group enriched" "Detected in many" 4 "Early spermatids: 780.2;Late spermatids: 2032.0" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-87 MG: 30.5;U-937: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010646, HPA071015" Enhanced Approved Approved "Nuclear membrane,Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Nuclear membrane, Plasma membrane" "HPA010646: , HPA071015: AB_2686334" "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 1.6 3.7 39.2 1.9 28.6 0.8 1.7 46.0 42.6 5.2 9.8 14.5 1.6 9.4 2.2 1.8 3.3 2.2 5.7 27.1 33.8 0.6 0.3 1.1 2.7 33.6 57.2 25.0 2.8 0.8 1.7 6.5 1.4 33.3 12.2 3.1 53.0 1.6 13.7 4.4 0.9 4.9 11.7 37.5 1.5 4.6 187.2 82.8 5.3 1.3 4.0 1.7 13.2 4.0 33.4 1.1 1.5 11.7 7.9 6.3 5.4 2.0 4.7 6.0 4.6 4.3 1.8 1.0 6.5 0.5 6.2 18.4 2.5 7.8 0.9 4.3 17.2 7.7 10.7 3.1 0.0 2.2 1.5 22.2 6.0 0.8 5.0 0.4 4.1 2.7 10.0 4.0 6.0 1.9 2.3 8.0 3.4 16.3 0.1 5.1 19.5 2.3 2.9 0.3 2.4 7.4 20.4 2.9 3.3 5.1 4.1 0.3 3.1 2.4 7.4 4.2 3.7 3.5 3.4 1.6 6.1 30.5 46.2 1.9 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 39.2 28.6 46.0 42.6 27.1 33.8 33.6 57.2 25.0 33.3 37.5 82.8 33.4 1.6 0.0 0.5 11.4 1.1 0.5 0.9 0.1 1.8 306.0 0.6 3.8 7.5 1.5 0.7 0.0 98.0 0.1 2.2 0.0 0.0 0.7 780.2 0.3 2.2 2.0 0.0 0.4 23.3 1.5 0.3 2.6 1.5 0.1 0.0 1.9 1.1 0.0 6.8 40.4 48.0 0.1 0.0 0.6 1.6 2032.0 18.0 2.3 0.0 10.3 0.7 22.5 2.1 28.6 13.3 0.6 0.1 7.5 1.1 0.9 0.0 0.2 2.0 20.7 6.6 1.6 6.1 321.9 17.2 0.1 0.4 0.4 3.4 0.3 0.0 0.3 SMO "FZD11, SMOH" ENSG00000128602 "Smoothened, frizzled class receptor" Q99835 7 129188633-129213545 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 27.4;Granulosa cells: 13.0;Leydig cells: 20.8;Muller glia cells: 16.6;Peritubular cells: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 45.3;AN3-CA: 84.9;NTERA-2: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011446 Approved NA NA "CAB011446: " "unprognostic (2.48e-2)" "unprognostic (2.69e-2)" "unprognostic (7.09e-2)" "unprognostic (1.10e-1)" "unprognostic (8.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.38e-3)" "unprognostic (1.59e-1)" "unprognostic (1.17e-2)" "unprognostic (8.74e-3)" "unprognostic (1.62e-1)" "unprognostic (5.15e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-1)" "unprognostic (2.61e-2)" 4.3 6.1 9.0 2.6 9.2 0.4 5.5 9.5 9.7 26.2 16.0 7.9 2.5 19.3 18.8 12.1 14.6 8.4 7.3 8.1 13.2 15.4 24.1 3.7 2.3 12.1 11.2 6.7 28.5 6.3 16.2 19.4 2.6 9.1 20.2 2.1 2.1 11.6 12.4 3.8 17.3 5.7 8.1 11.1 2.8 6.4 5.7 9.6 4.5 9.2 3.7 2.1 9.1 16.9 8.8 1.6 18.2 45.3 84.9 1.1 0.2 14.3 5.2 6.7 10.1 5.8 13.8 0.1 0.0 13.9 10.4 22.8 28.3 27.4 1.5 3.9 0.0 23.0 9.4 0.0 22.5 5.5 0.4 0.0 16.2 11.0 3.3 0.0 19.9 5.8 24.9 1.5 0.0 3.1 0.0 24.4 0.1 64.2 0.0 5.3 35.1 19.7 0.0 5.2 0.0 1.3 30.2 0.0 0.0 12.3 16.8 11.1 5.8 0.0 0.7 14.1 17.6 10.1 0.6 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 9.2 9.5 9.7 8.1 13.2 12.1 11.2 6.7 9.1 11.1 9.6 8.8 0.4 0.0 0.0 27.4 0.2 1.9 2.3 3.9 2.8 0.7 3.3 5.2 1.4 2.8 3.8 11.0 0.0 0.3 0.4 0.0 1.9 3.4 0.4 1.0 8.6 0.6 0.0 0.0 1.4 1.1 0.3 7.6 0.0 1.3 0.0 13.0 1.4 8.4 4.2 0.0 0.8 0.1 2.0 1.6 1.8 1.3 20.8 1.0 0.0 3.7 0.6 16.6 0.0 4.5 0.5 1.3 0.1 21.8 0.0 2.7 0.0 3.9 0.7 0.4 6.6 3.5 3.9 0.0 2.0 3.3 2.8 0.5 0.1 6.9 0.6 0.7 IRF5 ENSG00000128604 "Interferon regulatory factor 5" Q13568 7 128937457-128950038 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 20.2;Hofbauer cells: 38.4;Kupffer cells: 34.5;Macrophages: 27.8;monocytes: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 17.6;dendritic cells: 43.6;monocytes: 53.1" "Cell line enhanced" "Detected in many" "HDLM-2: 124.3;RPMI-8226: 91.9;THP-1: 50.0;U-937: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046700, HPA076024" Enhanced NA NA "HPA046700: AB_2679761, HPA076024: " "unprognostic (4.01e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-1)" "unprognostic (1.57e-2)" "unprognostic (5.69e-3)" "unprognostic (1.49e-1)" "unprognostic (2.74e-1)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" "unprognostic (6.85e-2)" "unprognostic (1.53e-3)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (6.58e-2)" "unprognostic (3.20e-3)" 5.1 3.6 4.4 13.2 4.2 20.7 3.3 4.6 5.3 2.6 3.9 4.4 9.6 1.7 3.0 12.7 4.5 6.4 1.8 3.8 7.4 13.7 5.2 10.7 16.4 6.3 5.5 2.7 1.0 5.9 6.5 5.3 4.0 7.0 3.4 3.7 0.5 6.9 12.8 0.8 8.6 11.3 3.1 8.2 24.2 4.6 1.2 6.1 4.2 2.2 1.2 11.9 6.5 5.8 7.8 13.9 4.6 0.0 1.4 0.0 0.0 0.0 0.2 0.1 1.2 0.9 0.3 5.7 10.8 5.2 0.2 12.1 12.9 3.4 2.6 0.3 124.3 2.9 18.3 0.3 1.9 0.0 2.7 25.4 0.0 15.1 0.3 1.8 1.0 0.0 0.1 0.0 31.5 0.0 5.0 0.0 4.8 0.3 1.7 2.6 0.8 0.1 91.9 3.8 8.1 0.4 2.0 2.7 3.0 1.4 0.0 4.8 50.0 0.0 0.0 0.3 0.5 1.2 19.4 13.5 4.5 0.5 62.6 0.3 1.8 42.7 4.2 1.0 53.1 4.0 17.6 2.3 0.8 43.6 15.0 0.1 0.1 2.9 4.9 38.0 10.4 6.2 22.7 4.4 4.2 4.6 5.3 3.8 7.4 6.3 5.5 2.7 7.0 8.2 6.1 7.8 0.1 0.0 3.6 0.0 12.7 0.8 0.8 2.2 0.0 0.3 0.8 0.9 0.8 2.8 2.4 20.2 0.0 0.3 7.2 0.8 3.9 3.1 0.2 2.8 0.3 0.9 0.0 6.1 0.4 2.4 0.3 0.3 2.0 2.6 8.8 0.5 0.0 1.2 38.4 0.0 0.3 1.5 0.0 34.5 16.5 0.2 0.0 27.8 0.0 8.4 76.1 0.0 3.1 0.0 0.1 2.3 1.7 0.0 9.3 0.7 4.9 6.2 10.1 0.3 0.0 0.2 0.7 0.1 0.5 2.8 2.0 1.5 3.0 0.0 1.5 2.1 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102913000-102945111 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 76.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 31.3;Granulosa cells: 68.6;Leydig cells: 101.9;Peritubular cells: 31.6;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 94 "eosinophil: 9.9" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.9" "Cell line enriched" "Detected in many" 5 "LHCN-M2: 1237.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" Yes NA Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.30e-4)" 8.2 2.4 2.0 1.1 1.9 0.2 13.0 1.9 2.2 22.7 2.0 2.7 1.6 15.8 12.2 6.1 17.4 27.7 13.3 2.0 1.8 2.8 3.5 3.2 2.1 1.8 2.0 1.8 76.9 2.3 2.0 2.5 0.6 1.8 5.6 3.4 1.8 2.7 3.3 2.1 3.1 2.3 6.0 1.8 3.3 6.9 5.0 2.2 6.3 3.8 2.9 1.0 4.4 5.9 1.9 0.0 0.0 58.8 0.5 6.0 29.4 0.1 1.6 18.2 0.6 2.8 0.0 0.2 0.0 3.4 1.5 7.3 0.1 0.0 0.0 4.3 0.0 1.4 0.1 0.0 0.1 8.3 0.5 0.2 28.1 0.7 21.5 0.0 141.1 140.9 0.6 0.0 0.1 1237.5 0.0 0.1 0.4 3.1 0.1 0.1 0.1 244.0 0.2 0.2 0.1 1.3 1.3 0.1 0.0 0.1 0.1 0.0 1.7 11.8 0.2 1.5 15.2 2.3 1.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.9 1.9 2.2 2.0 1.8 1.8 2.0 1.8 1.8 1.8 2.2 1.9 3.6 0.0 1.1 4.6 0.2 0.9 0.2 0.9 0.0 3.7 0.7 0.8 1.1 0.0 0.5 1.8 2.1 0.3 0.3 0.0 0.0 1.7 3.5 2.7 15.3 4.4 0.0 0.0 6.9 0.4 0.2 31.3 1.1 4.6 1.3 68.6 6.1 0.5 0.4 0.0 8.7 0.1 2.0 0.0 2.7 2.9 101.9 0.5 5.4 10.3 0.6 0.6 0.0 2.5 5.3 0.2 0.3 31.6 0.0 0.3 0.1 0.3 0.1 2.2 65.7 16.1 17.8 0.6 0.5 0.4 0.6 0.0 0.9 6.6 0.2 0.2 KLHDC10 "KIAA0265, slim" ENSG00000128607 "Kelch domain containing 10" Q6PID8 7 130070534-130135705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020119 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020119: AB_2249467" "unprognostic (2.83e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (3.22e-1)" "unprognostic (1.80e-2)" "unprognostic (5.55e-2)" "unprognostic (8.70e-2)" "unprognostic (7.97e-2)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-2)" "unprognostic (8.22e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (1.64e-2)" 12.4 17.4 18.7 9.6 20.3 8.0 14.8 27.6 17.2 12.5 20.3 12.9 11.2 13.1 13.8 12.7 15.1 9.6 13.7 18.1 25.8 21.4 23.4 12.0 8.5 17.9 22.3 16.9 14.5 15.5 30.9 14.1 14.0 19.9 12.7 12.8 15.6 10.7 12.3 24.2 13.3 10.5 11.6 16.4 10.9 11.8 38.3 27.8 11.9 18.2 22.2 9.4 8.7 8.9 19.6 24.5 22.5 15.3 83.8 19.9 21.8 7.0 22.9 17.5 17.1 17.7 12.4 18.3 20.7 15.8 21.2 28.4 18.8 24.6 14.6 21.4 16.9 14.8 12.2 24.7 14.6 15.6 22.5 14.4 13.8 24.8 26.2 16.4 21.2 24.4 14.2 59.9 12.7 19.4 20.7 19.5 21.9 2.6 18.0 14.6 15.8 28.6 15.1 23.5 16.7 24.6 19.7 36.8 65.2 18.5 18.5 15.9 16.6 27.7 21.8 9.5 29.5 27.6 16.7 23.6 19.2 45.7 21.4 30.0 0.0 0.4 0.5 0.6 0.6 0.5 0.4 0.4 0.7 0.5 1.1 0.3 0.7 0.4 0.1 0.5 0.4 0.9 0.1 18.7 20.3 27.6 17.2 18.1 25.8 17.9 22.3 16.9 19.9 16.4 27.8 19.6 18.6 19.2 20.2 53.8 9.7 23.2 7.8 13.6 14.2 20.1 31.0 20.1 23.1 30.0 19.7 35.0 39.6 11.3 12.6 18.2 3.9 18.3 66.7 31.2 24.9 19.0 19.9 18.7 85.7 23.8 9.6 22.2 13.3 18.4 6.3 19.6 37.9 42.3 12.2 35.3 86.1 15.8 20.3 23.0 12.8 17.4 15.2 11.7 17.8 72.1 15.5 18.4 7.2 82.4 59.9 20.5 9.2 24.5 9.8 13.0 16.2 27.5 27.2 22.1 0.0 30.6 14.7 36.2 6.3 17.5 29.1 11.2 9.6 22.7 20.4 12.2 NDUFA5 "B13, CI-13kB, CI-13KD-B, NUFM, UQOR13" ENSG00000128609 "NADH:ubiquinone oxidoreductase subunit A5" Q16718 7 123536997-123557904 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 406.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 717.3;Distal tubular cells: 1070.2;Proximal tubular cells: 667.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043175 Supported NA NA 81000 "HPA043175: AB_10793992" "prognostic favorable (8.47e-5)" "unprognostic (4.00e-2)" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "unprognostic (4.90e-2)" "unprognostic (3.26e-1)" "unprognostic (2.23e-1)" "unprognostic (3.46e-2)" "unprognostic (1.81e-1)" "unprognostic (2.14e-2)" "unprognostic (1.37e-1)" "unprognostic (9.20e-2)" "prognostic favorable (3.99e-9)" "unprognostic (3.39e-1)" "unprognostic (1.59e-1)" "unprognostic (1.93e-1)" "unprognostic (2.73e-3)" 55.7 130.4 104.1 34.4 111.5 35.1 69.5 105.0 131.1 51.7 102.8 79.2 78.3 48.0 72.1 51.5 52.3 47.4 217.8 110.1 115.5 176.9 115.8 44.8 40.3 105.0 109.7 101.1 42.6 41.6 171.6 58.7 40.0 107.4 73.4 74.0 128.2 76.3 63.6 287.8 27.5 73.3 47.3 102.1 35.7 78.2 38.6 105.1 53.3 137.9 406.8 42.8 58.4 33.8 114.8 65.9 41.8 76.3 76.6 64.5 58.6 39.5 57.4 63.1 46.8 61.1 47.1 58.2 108.6 54.8 58.8 91.0 60.7 83.9 75.2 74.3 89.6 71.7 68.8 85.9 78.1 62.7 140.5 56.4 58.6 65.9 45.3 47.3 84.1 68.4 75.4 213.9 104.9 84.4 45.5 127.3 162.1 100.3 154.3 107.0 69.2 75.0 146.6 129.5 63.7 144.9 86.3 76.1 286.2 90.3 102.5 65.6 104.7 53.1 58.9 31.7 262.0 88.5 111.2 109.4 116.4 112.7 106.2 75.7 57.8 26.2 31.5 38.2 48.7 55.4 53.6 48.6 44.9 37.1 41.6 52.5 54.0 9.2 52.7 54.8 40.0 55.8 60.4 104.1 111.5 105.0 131.1 110.1 115.5 105.0 109.7 101.1 107.4 102.1 105.1 114.8 99.2 102.5 100.4 38.2 108.7 112.5 146.2 280.3 74.6 183.6 113.0 100.8 717.3 102.9 160.6 165.5 83.4 160.6 105.6 119.0 1070.2 132.2 359.6 123.4 91.1 91.8 138.0 91.1 65.2 89.6 156.8 110.5 108.6 128.6 88.7 59.2 66.0 170.6 109.6 127.9 48.5 168.6 295.0 67.2 92.5 77.5 90.1 94.9 202.7 19.7 65.7 264.6 77.2 32.2 29.2 86.2 130.9 112.1 82.0 107.1 210.2 667.6 158.6 214.7 118.3 97.4 133.7 179.0 99.0 94.7 110.2 158.4 102.3 116.9 172.2 147.0 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301303-122310691 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 80.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 5.1;Spermatocytes: 5.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "thalamus: 80.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 152.1;SCLC-21H: 66.0" "Region enriched" "Detected in some" 11 "hypothalamus: 11.7" "Region enriched" "Detected in single" 14 "hypothalamus: 7.4" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064639: AB_2685308, HPA073693: AB_2686626" "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.1 0.0 4.5 0.0 2.6 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 18.3 0.0 0.0 0.0 0.0 1.0 2.3 0.9 0.0 0.0 0.0 3.0 0.0 0.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 152.1 3.8 2.7 0.0 0.0 0.0 0.0 0.2 66.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 7.2 0.3 0.0 0.1 2.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 2.6 0.2 1.5 0.7 18.3 1.0 2.3 0.9 0.9 0.1 80.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772485-128775794 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "retina: 41.3" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "LHCN-M2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" Yes NA Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 41.3 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPS12 "RPMS12, RPS12, RPSM12" ENSG00000128626 "Mitochondrial ribosomal protein S12" O15235 19 38930944-38933168 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 287.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 226.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046775, HPA050633" Uncertain NA NA "HPA046775: AB_2679800, HPA050633: AB_2681195" "unprognostic (3.78e-1)" "unprognostic (8.43e-2)" "unprognostic (1.32e-1)" "unprognostic (2.15e-2)" "unprognostic (2.17e-2)" "unprognostic (5.98e-2)" "unprognostic (9.10e-3)" "unprognostic (6.95e-3)" "unprognostic (2.77e-2)" "unprognostic (5.25e-3)" "unprognostic (4.48e-2)" "unprognostic (7.94e-2)" "unprognostic (2.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (4.55e-2)" 24.7 43.8 14.5 11.5 14.3 14.6 24.0 16.4 20.4 18.4 14.3 28.2 18.4 20.9 4.1 45.5 19.5 4.6 65.6 14.6 15.2 51.7 72.4 20.6 11.0 15.2 14.9 14.0 17.5 32.5 14.0 15.1 6.1 15.4 24.6 6.5 2.4 26.4 8.0 54.1 32.4 27.5 5.4 15.6 32.9 41.4 19.6 16.2 8.3 19.2 17.5 7.6 25.0 23.5 16.1 56.5 226.3 9.9 27.5 12.9 14.1 34.8 33.4 21.0 34.7 30.2 93.4 43.8 60.1 62.4 17.2 26.8 30.4 28.3 53.8 9.2 53.2 64.4 45.0 37.8 62.1 41.4 48.4 39.2 29.1 35.3 30.2 15.3 12.8 32.4 39.4 48.9 32.5 20.7 104.5 54.2 39.4 23.1 81.4 94.4 50.8 33.1 60.5 32.2 73.6 28.9 32.3 32.3 86.1 35.4 8.9 43.0 41.2 29.5 30.7 35.7 45.8 65.7 39.7 40.4 54.4 48.0 52.1 36.4 42.6 76.1 33.1 72.5 91.9 71.9 91.8 66.3 62.0 96.5 92.2 57.1 63.6 9.6 69.1 72.9 110.7 76.8 91.6 14.5 14.3 16.4 20.4 14.6 15.2 15.2 14.9 14.0 15.4 15.6 16.2 16.1 32.1 22.4 26.7 3.6 54.5 91.9 72.6 126.2 64.3 17.7 67.2 73.8 59.8 82.9 56.5 66.2 22.9 120.1 61.5 99.6 287.6 111.6 34.2 30.1 44.5 43.2 51.8 61.0 3.9 114.0 161.4 41.8 65.2 42.0 27.8 56.9 27.5 143.2 101.5 23.5 4.8 116.6 71.2 55.5 52.8 72.5 37.3 47.4 53.4 1.9 103.7 23.6 97.9 4.5 5.0 129.4 59.0 32.7 72.5 127.4 151.2 220.9 31.3 25.9 32.9 27.5 48.6 21.0 32.1 91.8 107.3 103.0 43.9 121.8 163.7 101.6 MYO1B myr1 ENSG00000128641 "Myosin IB" O43795 2 191245185-191425389 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 257.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 330.2;Hepatocytes: 414.2;Sertoli cells: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 360.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013607, HPA060144" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA013607: AB_1854251, HPA060144: AB_2684211" "unprognostic (4.11e-3)" "unprognostic (7.36e-3)" "unprognostic (1.21e-1)" "unprognostic (4.83e-3)" "unprognostic (2.78e-1)" "unprognostic (1.59e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-2)" "unprognostic (3.25e-3)" "unprognostic (5.85e-2)" "unprognostic (4.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" 43.3 7.4 9.7 15.6 7.4 0.6 27.6 3.9 11.5 13.5 7.5 23.9 13.3 16.4 16.7 16.0 9.2 26.9 16.4 6.9 5.8 25.8 257.6 75.6 11.4 5.4 8.7 5.2 14.1 49.7 34.8 5.8 48.9 5.7 15.2 22.2 21.7 12.9 17.9 9.3 13.3 13.5 20.3 3.7 8.3 12.4 9.7 14.3 17.5 19.5 13.8 10.6 25.7 14.4 6.9 102.5 51.7 82.6 24.9 22.4 95.0 74.6 190.8 93.9 129.0 127.4 63.9 8.9 0.1 31.0 220.5 52.1 221.0 27.4 164.3 161.1 0.3 23.9 0.2 22.6 82.3 52.1 2.2 0.6 38.6 111.1 135.0 360.0 47.6 23.8 42.4 0.2 0.4 120.7 43.5 39.7 12.4 53.9 6.7 81.2 50.5 52.6 7.7 51.0 42.8 41.8 109.0 64.5 11.1 57.9 70.2 10.1 3.1 29.1 122.7 61.5 75.0 22.7 0.9 0.5 1.1 74.4 0.4 69.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.7 7.4 3.9 11.5 6.9 5.8 5.4 8.7 5.2 5.7 3.7 14.3 6.9 95.8 330.2 112.5 1.6 3.6 76.7 58.2 78.7 31.9 1.4 29.0 22.9 7.9 45.8 84.3 69.9 0.0 5.2 0.8 30.4 0.0 120.4 2.9 13.0 20.2 60.5 58.5 10.7 22.3 44.6 26.5 40.3 18.3 18.1 3.8 129.1 5.0 414.2 4.2 0.0 38.0 24.6 34.6 10.5 10.0 3.8 5.0 2.3 26.6 70.3 1.0 72.2 0.0 1.0 0.8 38.1 54.1 9.1 0.4 112.2 4.5 1.2 48.2 2.7 203.8 32.6 160.1 2.4 21.0 13.9 28.1 3.4 3.3 44.9 38.0 47.1 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188668-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;epididymis: 7.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 18.5;Distal enterocytes: 20.3;Distal tubular cells: 25.4;Endothelial cells: 18.8;Intestinal goblet cells: 20.6;Oligodendrocytes: 28.0;Proximal enterocytes: 22.0;Undifferentiated cells: 28.6" "Cancer enriched" "Detected in many" 5 "ovarian cancer: 6.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;Hep G2: 7.2;RPTEC TERT1: 21.3;RT4: 16.9;SCLC-21H: 5.7" "Region enriched" "Detected in single" 5 "pons and medulla: 1.1" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 1.6 0.2 4.1 0.5 5.3 0.0 1.6 6.1 4.7 0.3 1.4 2.9 0.3 0.4 7.6 0.5 4.9 0.7 0.1 2.3 4.1 6.5 0.0 3.3 0.4 16.7 6.5 1.7 0.4 0.2 0.0 0.0 0.0 9.1 1.0 2.0 0.0 0.2 2.6 0.1 0.5 3.3 0.3 8.7 1.1 0.4 1.7 5.7 0.1 0.1 0.3 0.1 2.2 0.4 11.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 6.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 7.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 21.3 16.9 5.7 1.0 0.0 0.0 1.2 0.8 0.0 0.0 3.9 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 5.3 6.1 4.7 2.3 4.1 16.7 6.5 1.7 9.1 8.7 5.7 11.3 14.2 3.2 18.5 0.0 0.1 4.2 0.2 0.0 0.0 0.0 0.9 1.3 0.1 0.0 2.5 7.3 0.0 0.0 0.1 20.3 25.4 0.0 0.1 0.2 0.2 18.8 6.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 5.6 0.4 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 28.0 0.1 13.2 0.4 0.9 0.7 22.0 3.2 0.0 0.0 0.0 0.6 1.1 3.4 9.5 0.3 2.6 0.0 0.5 0.5 28.6 2.7 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 42.5" "Cell type enhanced" "Detected in some" "Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1" "Region enriched" "Detected in single" 35 "pons and medulla: 3.5" "Group enriched" "Detected in some" 6 "medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" No NA Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: AB_2685083" "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 3.2 2.3 1.6 0.8 1.5 0.0 2.8 0.3 1.0 3.1 0.1 0.9 0.3 6.9 42.5 0.7 6.9 0.6 0.1 0.2 0.7 8.0 0.0 0.2 0.8 8.2 1.7 0.1 5.5 0.2 0.1 0.0 0.1 5.9 1.8 0.6 0.0 0.5 7.1 0.7 0.9 0.8 4.1 4.9 0.7 0.3 1.7 2.3 0.2 0.4 0.0 0.2 1.0 2.0 5.2 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 1.7 0.2 0.0 0.4 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.0 0.0 11.2 0.9 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 12.0 0.9 14.5 10.1 0.2 0.1 4.6 0.2 0.0 0.0 1.0 0.2 0.2 1.5 0.8 0.0 0.2 0.0 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.3 1.0 0.2 0.7 8.2 1.7 0.1 5.9 4.9 2.3 5.2 6.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.3 15.6 0.0 14.4 0.1 2.1 6.5 1.2 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.8 3.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.3 4.5 0.0 0.1 0.3 2.9 0.0 0.0 0.0 1.3 1.1 0.8 0.5 0.0 1.3 0.0 0.1 4.7 0.6 0.1 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 201.5;Spermatocytes: 247.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 20.6 37.8 34.8 15.3 36.2 9.3 27.3 35.0 47.1 19.7 37.4 31.5 23.0 18.8 39.7 38.4 29.2 14.7 48.9 35.5 37.9 46.8 31.1 15.8 14.3 36.8 34.5 34.1 21.3 26.6 48.5 29.7 26.0 36.0 26.6 35.9 47.7 20.6 22.8 75.1 22.1 20.3 25.9 35.8 15.7 24.6 64.9 36.7 18.3 20.6 71.5 21.0 25.4 24.9 38.0 52.2 31.0 60.8 37.8 40.0 45.9 58.3 54.5 52.0 49.8 58.3 53.1 55.8 66.4 91.4 49.1 79.9 34.5 67.1 67.6 67.9 66.6 49.4 63.9 39.1 94.9 62.7 98.9 20.7 51.1 83.5 52.2 89.1 60.3 72.0 64.3 86.8 50.2 59.6 47.4 34.9 102.9 58.3 101.8 45.5 0.0 44.0 60.8 142.4 93.3 87.0 74.4 45.7 60.9 120.7 116.4 33.7 64.0 63.5 49.2 43.5 52.1 57.9 55.4 62.1 79.8 61.1 49.7 60.8 8.0 9.3 4.1 9.6 15.8 13.1 18.9 12.4 11.1 14.8 13.7 14.9 15.4 0.0 19.6 14.4 12.1 16.9 9.9 34.8 36.2 35.0 47.1 35.5 37.9 36.8 34.5 34.1 36.0 35.8 36.7 38.0 34.4 19.2 22.6 50.6 20.8 31.1 36.2 130.9 37.5 0.0 38.2 43.8 69.2 31.5 63.6 57.0 0.0 78.8 11.1 38.8 201.5 51.8 22.3 60.9 25.7 31.4 41.5 19.5 106.0 39.5 63.3 30.2 28.1 33.9 43.1 25.7 16.4 33.7 47.8 0.0 106.3 47.7 103.7 21.7 15.7 18.8 35.4 19.6 35.6 43.1 26.1 0.0 12.3 93.5 180.2 49.8 26.1 32.7 23.1 48.2 39.6 106.3 63.8 0.0 39.5 24.9 52.4 247.8 127.1 56.5 41.9 65.0 18.8 55.8 52.6 53.7 PDE11A ENSG00000128655 "Phosphodiesterase 11A" Q9HCR9 2 177623244-178072777 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "Cushing syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 6.4;parathyroid gland: 9.8" "Cell type enhanced" "Detected in many" "Early spermatids: 37.0;Hepatocytes: 11.1;Late spermatids: 46.4;Oligodendrocytes: 14.9" "Cancer enhanced" "Detected in some" "prostate cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;fHDF/TERT166: 2.4;HAP1: 1.4;Hep G2: 2.8" HPA034560 Approved "Intracellular and membrane" NA NA "HPA034560: AB_10602140" "unprognostic (1.02e-1)" "unprognostic (4.73e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-3)" "unprognostic (2.34e-2)" "unprognostic (1.43e-2)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "unprognostic (3.91e-1)" "unprognostic (9.95e-2)" "unprognostic (2.80e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-4)" "unprognostic (1.64e-3)" 2.3 0.3 1.2 0.1 2.0 0.2 1.7 1.9 1.3 0.6 0.7 0.5 0.9 1.2 0.4 0.0 0.3 0.4 0.2 0.9 1.9 0.5 6.4 0.0 0.0 2.7 2.3 0.8 0.4 1.1 9.8 0.9 0.0 2.9 5.3 0.4 1.4 1.4 0.8 4.4 0.1 0.5 1.1 3.0 0.1 0.4 2.8 1.8 0.1 1.3 1.3 0.0 0.0 0.1 3.6 0.0 0.4 0.2 0.1 0.0 0.0 0.0 1.1 0.2 0.0 0.3 0.2 1.6 0.0 0.6 2.4 0.3 0.1 1.4 0.0 0.0 0.0 0.9 1.1 0.1 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.2 0.4 0.1 0.6 0.0 0.3 0.2 0.0 0.2 0.0 0.5 0.0 0.3 0.7 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 1.2 2.0 1.9 1.3 0.9 1.9 2.7 2.3 0.8 2.9 3.0 1.8 3.6 0.1 0.0 0.0 2.3 0.2 0.6 1.4 0.1 0.0 1.7 4.2 0.8 0.0 1.5 0.1 0.0 0.0 0.1 0.3 0.8 0.0 0.8 37.0 0.3 0.2 0.6 6.7 2.7 1.6 6.7 0.0 0.6 0.0 0.2 0.0 0.0 1.4 11.1 0.1 0.0 8.2 0.9 6.1 1.2 2.1 46.4 1.5 0.3 0.0 0.0 0.0 4.7 0.0 6.0 14.9 2.3 0.0 0.7 0.0 5.4 0.6 1.3 0.1 1.0 0.0 2.0 0.6 6.8 6.9 0.0 1.3 0.3 0.3 0.3 1.3 1.0 CHN1 "ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2" ENSG00000128656 "Chimerin 1" P15882 2 174798809-175005381 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 696.2;choroid plexus: 234.1" "Cell type enhanced" "Detected in many" "Astrocytes: 195.2;Excitatory neurons: 596.4;Inhibitory neurons: 111.7;Microglial cells: 97.4;Oligodendrocyte precursor cells: 149.8" "Cancer enhanced" "Detected in all" "glioma: 18.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 6.5;memory CD8 T-cell: 2.1;T-reg: 8.0" "Lineage enriched" "Detected in single" 18 "T-cells: 8.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 186.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036111 Approved Cytosol NA NA Cytosol "HPA036111: AB_10671241" "unprognostic (3.18e-3)" "unprognostic (4.19e-2)" "unprognostic (9.69e-2)" "unprognostic (3.42e-3)" "unprognostic (1.92e-1)" "unprognostic (2.65e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "unprognostic (3.71e-2)" "unprognostic (1.34e-2)" "unprognostic (5.29e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (7.31e-3)" "unprognostic (4.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.46e-2)" 10.7 13.5 361.4 7.4 498.1 0.8 10.5 251.6 696.2 9.3 234.1 8.4 3.4 8.0 38.6 7.0 6.6 11.2 15.2 514.7 381.1 4.8 2.1 19.8 21.7 279.2 294.7 468.9 5.8 4.2 43.7 36.6 39.0 344.7 17.2 5.1 39.8 3.2 9.7 2.7 3.8 7.6 13.2 244.1 5.6 7.1 21.4 296.8 3.1 10.3 3.7 18.8 8.8 6.8 478.0 0.4 17.4 57.6 16.3 14.7 67.4 0.4 45.6 186.7 65.1 97.0 0.3 5.4 0.5 1.6 71.8 39.9 2.0 68.0 1.9 30.3 1.3 32.9 11.1 20.1 3.8 34.4 6.4 1.7 53.6 1.9 31.6 11.1 16.1 33.6 30.0 0.7 1.9 57.2 11.8 29.3 2.5 71.7 2.6 23.7 8.2 70.3 0.8 0.9 0.6 71.3 76.3 41.3 0.5 7.3 36.0 3.2 2.2 10.1 26.8 3.9 9.8 20.6 6.4 33.7 0.7 6.7 0.4 6.6 0.4 0.1 0.1 0.3 0.1 0.8 0.2 6.5 2.1 0.0 0.1 1.3 0.4 0.4 0.2 0.2 0.3 8.0 1.0 361.4 498.1 251.6 696.2 514.7 381.1 279.2 294.7 468.9 344.7 244.1 296.8 478.0 15.4 3.2 1.9 195.2 1.6 4.5 0.3 0.0 0.0 85.1 7.3 1.4 6.2 1.5 2.6 3.7 27.1 1.2 0.5 0.1 0.0 0.3 24.1 5.3 5.6 17.9 2.4 0.0 596.4 0.6 1.1 28.4 2.0 3.6 0.0 5.1 10.4 0.5 2.7 77.4 111.7 0.0 0.0 0.0 4.0 23.2 3.1 0.9 7.2 97.4 0.0 59.1 0.0 149.8 88.1 0.6 0.0 5.3 1.3 0.6 0.0 0.3 1.0 14.1 13.1 23.8 27.3 17.8 23.6 0.1 3.7 2.1 12.5 5.1 0.2 0.3 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 66.9;parathyroid gland: 46.7;retina: 29.9" "Group enriched" "Detected in many" 8 "Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 20.1;HEL: 64.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 547.6" "CAB004415, HPA048871, HPA058412, CAB078176" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710" "unprognostic (1.28e-1)" "prognostic favorable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favorable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 0.2 3.0 22.7 0.0 29.7 3.3 0.1 16.4 32.6 0.8 0.0 0.0 0.0 1.6 4.3 0.4 0.2 0.1 0.0 15.4 66.9 4.9 0.1 0.2 0.1 13.7 40.0 24.3 0.2 0.2 46.7 5.0 0.4 13.5 0.8 0.1 29.9 0.1 0.3 0.0 0.1 0.1 0.0 6.3 0.1 0.0 3.2 24.4 0.8 0.1 0.0 0.2 0.6 0.4 14.0 18.2 0.7 0.0 7.3 0.0 0.0 0.1 0.4 0.0 2.6 1.7 4.6 6.7 0.0 0.9 0.5 2.9 20.1 2.3 0.6 1.6 2.8 13.4 64.5 6.0 0.2 0.0 0.3 1.1 0.0 5.5 0.0 2.3 0.6 0.1 0.5 17.0 0.3 0.8 1.5 0.0 0.0 8.1 9.7 6.7 1.0 4.6 0.4 8.5 9.4 6.7 2.1 12.6 0.0 3.5 0.6 0.2 0.0 0.0 12.0 1.7 2.4 7.0 0.0 0.0 0.1 11.5 3.2 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 29.7 16.4 32.6 15.4 66.9 13.7 40.0 24.3 13.5 6.3 24.4 14.0 0.0 0.0 0.0 14.7 0.0 0.3 2.1 7.7 2.2 32.5 0.1 0.1 1.3 0.0 3.6 0.0 10.4 0.0 0.0 0.2 7.9 4.5 5.6 4.4 0.4 0.4 3.0 5.5 2.6 5.6 0.1 0.2 0.0 2.9 0.0 5.5 0.0 0.0 4.0 5.0 392.8 0.3 2.0 0.8 0.4 6.2 0.6 0.5 0.0 7.5 0.0 4.9 0.0 146.8 7.6 2.9 0.0 0.0 0.1 0.9 0.0 0.0 4.7 6.0 0.0 0.0 1.2 4.4 7.7 0.6 0.1 0.5 0.0 0.1 0.1 0.4 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria NA NA Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favorable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 3.9 8.2 4.3 3.5 5.3 1.9 7.3 6.6 5.1 4.6 3.7 3.5 3.3 5.8 5.7 4.1 5.2 3.2 9.0 4.0 4.4 8.5 8.0 3.9 6.5 5.2 5.0 4.1 8.7 3.1 4.8 2.7 4.0 5.0 4.2 3.9 9.9 4.7 3.7 12.4 6.2 3.6 5.0 4.5 5.5 3.2 6.5 4.4 5.7 5.2 11.1 6.4 3.7 3.0 6.6 7.1 3.8 16.7 12.7 12.9 7.1 9.8 10.8 7.5 14.9 15.9 4.5 7.1 4.7 11.7 4.5 8.2 10.1 15.0 12.7 16.9 12.3 11.5 15.3 9.0 5.9 6.7 8.8 7.6 7.8 10.6 11.5 5.5 10.2 11.3 11.8 5.6 7.2 9.8 3.9 6.8 9.9 8.1 9.5 17.4 7.5 13.4 8.1 9.7 3.8 10.1 11.2 7.3 12.8 23.9 20.6 10.1 9.9 4.7 9.6 8.5 14.3 6.8 7.3 6.6 7.4 12.7 11.0 10.7 0.5 2.7 2.3 7.5 2.7 10.6 7.7 7.7 8.6 3.8 9.8 11.3 10.5 0.4 7.6 2.4 6.6 6.6 3.1 4.3 5.3 6.6 5.1 4.0 4.4 5.2 5.0 4.1 5.0 4.5 4.4 6.6 3.6 6.4 3.6 6.8 8.4 1.9 2.8 5.9 5.2 8.9 4.0 4.8 8.6 8.6 2.8 0.0 12.5 10.6 7.3 0.4 7.9 3.0 1.4 3.5 5.5 4.1 0.0 5.2 6.6 2.3 7.3 4.5 1.5 2.3 3.8 6.8 3.6 2.9 4.4 10.1 10.0 1.1 2.0 2.4 1.7 0.8 11.1 4.1 1.8 5.6 1.8 12.0 13.4 10.1 17.0 2.0 1.0 8.2 1.9 1.1 1.7 10.2 6.0 11.8 26.3 5.8 8.4 9.6 13.7 4.4 2.0 2.2 6.0 11.8 2.2 1.0 ORMDL1 ENSG00000128699 "ORMDL sphingolipid biosynthesis regulator 1" Q9P0S3 2 189770267-189784364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (1.45e-1)" "unprognostic (5.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (4.85e-3)" "unprognostic (1.86e-2)" "unprognostic (6.70e-3)" "prognostic favorable (3.04e-5)" "unprognostic (5.90e-3)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.84e-9)" "unprognostic (2.62e-1)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "prognostic favorable (1.49e-5)" 57.6 66.8 28.3 50.8 30.2 52.2 55.4 35.5 33.5 65.7 36.0 58.2 41.5 57.0 100.4 46.5 55.8 47.9 37.7 29.3 32.7 55.4 69.3 67.5 75.8 29.8 30.3 28.2 51.2 85.2 42.7 79.9 63.7 29.4 62.8 50.6 82.7 66.7 47.7 41.9 85.0 85.6 44.3 30.1 132.2 64.6 59.3 30.0 44.6 63.5 24.1 70.0 50.7 52.2 34.0 31.4 20.5 68.0 54.8 88.2 100.4 70.3 64.9 61.7 71.0 71.5 41.9 51.7 57.8 44.7 49.9 36.7 52.1 43.4 42.0 77.5 65.6 55.2 82.3 106.2 61.9 102.6 65.8 63.8 113.1 51.6 61.8 70.6 99.0 58.4 57.9 48.3 85.9 72.9 28.6 58.6 127.0 60.7 32.4 86.4 46.4 50.2 78.7 87.4 49.3 43.6 51.4 33.8 32.0 74.3 78.3 38.7 73.3 61.6 70.1 48.1 44.9 65.7 82.9 66.6 55.4 76.4 68.7 38.6 49.4 32.7 39.8 35.8 39.5 33.7 37.9 39.3 36.5 26.7 35.4 45.0 40.9 13.3 29.4 48.3 46.1 46.1 33.5 28.3 30.2 35.5 33.5 29.3 32.7 29.8 30.3 28.2 29.4 30.1 30.0 34.0 80.4 80.1 50.2 41.4 90.9 56.3 55.1 95.6 26.7 138.3 69.8 76.7 34.4 41.5 65.5 36.8 175.2 212.4 141.2 36.0 33.2 58.7 42.8 58.0 63.9 61.8 42.4 38.7 53.6 67.3 73.0 58.1 24.5 47.3 45.6 84.3 47.5 37.4 86.9 65.6 60.1 37.2 101.7 126.8 60.9 18.9 74.3 83.3 39.2 33.7 96.4 107.7 117.4 57.8 49.4 66.5 48.3 48.5 83.5 79.1 62.8 45.9 66.3 217.2 52.6 55.4 63.8 186.8 145.0 32.5 60.7 218.1 104.5 117.4 46.3 51.5 HAT1 KAT1 ENSG00000128708 "Histone acetyltransferase 1" O14929 2 171922448-171983686 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036788, CAB037191" Supported Supported Nucleoplasm NA NA 27000 Nucleoplasm "CAB037191: AB_477070, HPA036788: AB_10672267" "unprognostic (1.76e-1)" "unprognostic (1.01e-2)" "unprognostic (7.39e-3)" "unprognostic (8.24e-3)" "unprognostic (2.76e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.71e-2)" "unprognostic (9.08e-3)" "unprognostic (3.69e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (6.89e-2)" "unprognostic (1.80e-1)" "unprognostic (3.97e-2)" "unprognostic (6.69e-2)" 27.9 27.2 14.1 33.8 15.3 60.3 41.9 15.9 19.3 27.0 15.2 27.9 20.1 24.8 16.8 26.8 24.7 24.8 31.7 13.2 17.9 32.5 30.4 26.0 49.1 15.3 14.9 12.0 23.4 30.2 38.3 17.1 30.9 15.6 29.3 31.0 29.1 33.1 24.2 68.3 24.0 21.8 29.6 16.1 27.9 23.8 20.2 15.2 51.1 33.1 51.3 47.9 39.3 19.7 17.4 132.4 61.5 106.6 98.8 55.2 56.8 75.2 133.9 88.9 144.4 149.9 144.3 88.2 147.0 85.0 81.5 122.7 101.3 116.7 109.5 220.5 83.5 115.8 131.1 91.5 131.0 26.7 165.5 77.9 34.2 62.2 191.0 63.6 45.5 92.6 100.4 136.5 93.1 166.5 91.8 131.1 148.3 89.0 158.9 63.9 102.8 134.4 99.4 85.3 130.2 67.8 55.4 112.4 62.4 118.1 81.5 86.4 164.5 47.5 129.8 99.2 109.5 137.1 40.9 100.5 173.8 87.6 117.8 113.8 47.6 35.3 53.7 32.8 42.0 40.6 35.5 34.9 34.0 27.4 30.7 33.9 37.6 40.3 44.6 59.2 14.3 49.2 34.0 14.1 15.3 15.9 19.3 13.2 17.9 15.3 14.9 12.0 15.6 16.1 15.2 17.4 55.6 35.3 28.9 13.7 49.7 74.2 117.7 129.7 46.1 24.2 36.4 42.3 49.5 25.8 66.2 27.6 33.3 77.5 43.5 19.0 82.2 45.2 70.3 33.1 32.3 43.2 14.3 103.1 28.6 46.5 83.1 43.7 15.8 28.9 40.6 30.7 28.9 20.1 51.8 28.6 45.3 20.9 111.9 29.5 36.3 14.7 30.7 34.5 32.0 16.9 28.8 53.4 43.3 21.6 28.0 27.8 21.0 36.9 50.8 52.0 18.2 46.0 65.4 42.0 39.5 43.8 51.3 65.7 67.5 28.8 52.7 58.3 49.0 43.9 29.4 64.1 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122719-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 42.3;endometrium 1: 58.3" "Cell type enhanced" "Detected in many" "Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 80 "spinal cord: 8.0" HPA068683 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA068683: AB_2686018" "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favorable (9.58e-4)" "prognostic unfavorable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 8.9 6.5 0.0 1.3 0.0 0.0 14.0 0.0 0.0 42.3 0.0 18.3 0.1 58.3 14.9 3.5 16.2 0.9 0.1 0.0 0.0 33.6 0.1 0.7 2.4 0.5 0.0 0.0 11.1 0.3 0.3 0.0 0.5 0.1 32.5 3.0 0.0 1.2 8.1 1.6 5.6 3.0 15.3 0.6 2.4 0.5 5.6 0.1 0.5 1.4 0.2 0.8 6.1 35.6 0.8 0.1 0.0 0.0 0.0 0.5 0.4 0.2 1.6 1.1 1.3 1.1 0.0 0.0 0.0 11.3 1.6 0.8 7.6 0.1 0.0 0.9 0.0 16.1 0.0 0.8 0.0 0.1 0.0 0.0 3.6 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 19.0 7.1 4.3 21.7 5.5 0.0 13.2 1.1 0.0 0.0 16.9 0.0 3.6 5.3 6.0 0.0 0.0 0.0 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.1 0.8 38.4 0.0 0.0 0.0 0.4 2.4 1.9 0.0 0.0 0.0 0.8 0.5 0.7 0.0 0.0 23.9 0.0 0.0 1.0 8.5 37.2 0.0 0.2 0.8 10.9 39.2 7.8 0.0 0.0 0.0 0.2 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 3.0 1.3 34.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 26.7 0.0 1.1 0.0 3.0 0.0 0.0 39.5 1.9 3.3 2.2 1.4 0.1 1.8 0.0 1.1 13.9 3.8 0.8 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119937 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 19.1;endometrium 1: 36.2;vagina: 25.2" "Cell type enhanced" "Detected in some" "Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 66 "spinal cord: 6.6" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" No NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: AB_2685573" "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 1.5 0.1 0.0 0.5 0.0 0.0 2.7 0.0 0.0 19.1 0.0 11.1 0.0 36.2 0.6 0.5 4.1 0.1 0.0 0.0 0.0 16.0 0.0 0.1 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 16.9 5.8 0.0 0.1 6.7 0.1 1.5 0.1 18.3 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.2 2.2 25.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 4.2 6.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.1 12.0 0.0 0.0 0.5 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.9 0.0 32.3 0.0 11.8 3.1 18.4 0.0 0.1 2.2 0.0 0.0 2.7 0.0 2.1 1.0 14.4 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.0 0.0 0.0 0.0 0.0 0.9 6.2 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 14.7 0.0 0.0 0.1 10.6 15.6 0.0 0.0 1.2 25.3 13.5 24.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.8 0.2 1.8 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 1.1 0.0 0.2 0.0 4.4 2.9 HOXD11 "HOX4, HOX4F" ENSG00000128713 "Homeobox D11" P31277 2 176104216-176109754 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 7.1;prostate: 3.3;vagina: 4.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 26.7;Collecting duct cells: 22.0;Distal enterocytes: 22.8;Endometrial stromal cells: 29.0;Enteroendocrine cells: 20.6;Urothelial cells: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 21.9;RPTEC TERT1: 2.6;SCLC-21H: 6.1;U-251 MG: 4.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 40 "spinal cord: 3.9" HPA055155 Supported Nucleoplasm NA NA Nucleoplasm "HPA055155: AB_2682719" "unprognostic (1.99e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.05e-2)" "unprognostic (1.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (2.13e-2)" "unprognostic (6.73e-2)" "unprognostic (5.00e-2)" "unprognostic (2.11e-8)" "unprognostic (2.09e-3)" "unprognostic (2.49e-2)" "unprognostic (2.27e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 2.3 0.0 7.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 6.1 0.3 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.4 26.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.0 0.0 0.1 0.0 22.8 9.8 0.0 0.0 1.1 29.0 1.7 20.6 0.0 0.0 0.0 0.1 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.6 0.0 0.0 1.2 0.2 0.9 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 1.2 0.0 8.8 0.0 0.3 0.0 0.0 0.0 0.1 2.3 0.1 0.4 0.0 0.9 0.0 0.1 0.0 9.2 14.0 HOXD13 "HOX4I, SPD" ENSG00000128714 "Homeobox D13" P35453 2 176092721-176095944 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "cervix: 10.2;intestine: 9.1;prostate: 9.8;seminal vesicle: 16.5;vagina: 17.2" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 12.4;Distal enterocytes: 5.5;Enteroendocrine cells: 29.0;Intestinal goblet cells: 9.1;Paneth cells: 5.5;Prostatic glandular cells: 6.3;Undifferentiated cells: 9.9;Urothelial cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 18.4;HEK 293: 53.3;HL-60: 61.7;JURKAT: 16.7;NB-4: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA064064 Approved Nucleoplasm NA NA Nucleoplasm "HPA064064: AB_2685186" "unprognostic (2.04e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (2.52e-3)" "unprognostic (7.25e-2)" "unprognostic (2.08e-2)" "unprognostic (4.62e-2)" "unprognostic (1.77e-1)" "unprognostic (4.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.82e-4)" "unprognostic (4.95e-2)" "unprognostic (3.70e-2)" "unprognostic (9.98e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.2 0.0 9.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 7.7 0.0 0.0 16.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 2.2 4.7 0.0 0.0 0.0 0.0 0.0 5.1 0.0 18.4 0.0 2.8 0.0 53.3 8.3 0.0 0.0 0.0 61.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 3.9 0.0 0.0 0.0 0.0 36.3 1.9 0.0 3.0 0.0 0.2 0.0 0.0 0.4 15.2 3.7 3.8 0.0 8.9 0.2 0.0 0.0 0.0 1.8 0.0 0.8 5.1 0.0 0.0 0.0 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.9 0.0 0.1 0.1 29.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.4 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 9.9 6.7 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322179 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB017188: , HPA048389: AB_2680382, HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favorable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 5.1 5.7 1.7 2.4 2.7 4.1 5.0 1.1 3.2 5.4 2.5 8.2 2.7 7.6 1.7 5.3 6.1 2.2 7.2 2.0 1.7 3.7 3.7 5.2 2.3 2.2 2.0 1.6 8.3 6.1 5.5 6.3 2.7 2.6 4.4 2.9 5.4 4.9 2.9 14.3 5.3 6.2 3.7 0.5 4.4 6.4 4.8 2.9 4.4 5.9 9.4 2.4 5.6 5.0 6.1 8.5 16.5 11.2 4.7 9.2 6.9 3.2 6.0 7.1 7.6 7.3 8.6 1.1 8.5 7.2 10.4 11.5 8.5 12.0 5.9 5.6 5.2 7.8 54.0 20.2 2.9 3.5 12.8 4.1 5.7 4.5 9.0 11.2 4.9 10.2 7.0 21.2 3.4 7.3 3.9 2.9 4.3 3.4 6.4 7.1 10.2 16.0 0.7 2.6 18.2 12.3 7.1 14.6 4.1 4.5 5.8 4.8 14.8 15.3 14.0 9.2 5.5 9.1 2.2 3.3 7.7 6.5 5.9 7.6 0.1 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.0 0.1 0.1 0.6 0.2 0.1 1.7 2.7 1.1 3.2 2.0 1.7 2.2 2.0 1.6 2.6 0.5 2.9 6.1 56.2 22.4 23.5 68.9 34.3 16.4 15.3 18.1 27.9 107.9 39.1 31.2 66.6 21.5 23.6 64.4 148.0 25.9 28.5 31.8 1.9 28.7 13.0 35.0 55.8 73.3 28.1 67.9 88.9 30.4 15.5 34.3 43.3 29.6 3.8 135.0 38.9 36.7 19.0 122.8 82.9 32.1 16.2 22.3 20.7 15.8 56.2 22.1 69.4 84.3 26.9 41.0 45.3 65.9 89.7 36.6 30.8 52.3 56.6 20.5 31.1 19.8 19.6 142.9 65.7 46.0 43.2 72.5 66.4 38.3 21.0 17.8 30.0 62.7 35.5 11.5 SNRPN "HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN" ENSG00000128739 "Small nuclear ribonucleoprotein polypeptide N" P63162 15 24823637-24978723 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 457.8;Horizontal cells: 333.1;Proximal tubular cells: 300.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 789.5;SuSa: 505.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, HPA067842" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (9.91e-2)" "unprognostic (1.03e-3)" "unprognostic (2.79e-1)" "unprognostic (1.66e-2)" "unprognostic (3.71e-2)" "unprognostic (2.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.72e-2)" "unprognostic (9.44e-3)" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (6.59e-2)" "prognostic favorable (8.93e-8)" "unprognostic (4.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (6.74e-2)" 45.9 183.6 444.5 46.9 489.2 36.9 70.1 458.8 557.8 113.3 355.5 72.4 36.7 65.7 335.4 44.4 122.9 142.4 487.8 489.4 506.7 193.8 70.5 77.1 94.3 465.0 459.1 447.4 149.2 112.8 245.4 378.4 37.8 493.3 175.7 35.1 163.1 126.8 149.0 234.6 37.1 63.0 59.5 419.8 85.8 89.0 61.2 467.6 138.1 303.1 274.8 81.3 83.2 67.0 510.3 1.0 148.6 260.8 180.1 153.4 69.5 1.1 46.9 100.0 31.7 57.8 138.1 69.1 0.2 91.6 118.7 47.9 26.7 0.0 142.7 18.2 81.1 0.1 89.3 90.1 151.5 181.8 107.1 76.8 132.6 60.6 69.4 81.8 213.2 95.7 189.8 24.8 0.4 183.3 0.0 216.9 1.5 789.5 0.0 63.0 113.3 97.8 0.5 172.3 222.2 155.7 147.1 0.7 3.6 174.0 505.7 93.6 271.3 62.3 79.2 78.2 0.3 28.8 215.3 126.9 140.4 65.9 72.9 59.8 234.8 68.0 106.8 313.9 74.2 355.8 371.9 385.3 359.0 65.2 342.1 508.0 420.8 18.5 291.2 77.4 531.9 434.4 581.7 444.5 489.2 458.8 557.8 489.4 506.7 465.0 459.1 447.4 493.3 419.8 467.6 510.3 57.1 9.6 45.5 0.0 106.2 2.2 102.6 4.4 53.5 171.0 77.1 96.5 185.2 218.8 23.0 178.4 52.1 1.0 157.6 10.0 457.8 150.0 92.9 36.8 27.9 57.7 142.7 31.1 0.0 81.6 1.2 54.9 27.5 24.5 62.7 136.9 63.1 31.9 62.7 333.1 0.0 34.5 6.1 28.9 2.5 111.3 77.3 38.1 0.0 0.0 43.8 210.3 115.4 0.0 0.0 61.5 33.7 116.6 86.7 110.6 38.7 300.2 26.9 112.3 52.6 61.5 65.0 67.9 54.0 22.1 1.7 1.6 104.2 110.4 23.6 65.1 PSMG2 "CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1" ENSG00000128789 "Proteasome assembly chaperone 2" Q969U7 18 12658043-12725740 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 537.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 436.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041517, HPA046741" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA041517: AB_2677530, HPA046741: AB_2679780" "unprognostic (2.28e-2)" "unprognostic (9.44e-3)" "unprognostic (9.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.40e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.91e-2)" "unprognostic (2.27e-1)" "unprognostic (1.73e-1)" "unprognostic (9.04e-2)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (6.75e-3)" 63.3 50.7 46.6 45.2 46.8 92.7 65.8 50.0 55.2 52.3 47.1 56.3 48.7 49.5 68.1 64.0 48.1 53.7 47.8 46.4 49.0 57.7 66.2 44.7 65.6 47.9 47.8 45.5 61.1 56.3 31.3 32.0 53.3 47.5 42.9 61.0 25.3 46.9 48.4 51.3 55.0 48.2 53.4 49.1 44.1 54.1 90.5 47.3 68.2 50.1 39.8 64.2 64.4 52.5 52.2 82.6 51.3 58.2 74.0 100.1 142.5 75.0 81.3 115.7 131.1 147.8 89.1 84.6 90.6 64.6 86.2 108.3 49.8 93.7 99.9 112.2 48.6 52.4 50.1 43.0 101.8 100.7 170.7 78.7 116.8 76.0 80.7 107.6 81.3 92.5 78.7 77.4 112.9 102.4 83.0 109.9 226.1 46.2 436.4 67.8 78.8 87.5 130.2 121.0 106.3 69.6 52.5 77.5 88.1 78.1 56.3 75.8 136.2 63.5 148.9 203.3 131.3 89.4 101.1 142.9 111.1 90.1 88.5 63.3 84.9 89.3 87.6 65.3 95.1 77.6 70.3 84.0 74.8 80.5 62.5 74.6 72.2 30.9 73.9 111.6 65.7 108.2 91.7 46.6 46.8 50.0 55.2 46.4 49.0 47.9 47.8 45.5 47.5 49.1 47.3 52.2 96.1 51.3 50.1 42.7 76.4 91.0 98.8 145.2 80.8 25.1 81.4 99.2 36.0 82.9 80.9 82.8 22.9 183.0 80.9 70.8 154.6 110.5 537.7 59.8 75.8 83.9 68.6 97.2 50.1 110.8 140.3 99.3 59.1 53.3 60.9 74.9 101.7 53.1 147.6 25.2 50.3 87.8 54.9 133.0 88.7 140.8 134.2 100.2 72.9 26.2 130.7 63.8 50.4 34.7 38.5 103.2 84.2 97.0 67.1 126.1 120.6 193.8 68.7 21.4 85.5 78.4 89.8 344.9 216.8 119.5 90.1 186.3 78.8 122.3 103.6 130.7 TWSG1 TSG ENSG00000128791 "Twisted gastrulation BMP signaling modulator 1" Q9GZX9 18 9334767-9402420 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 141.2;Peritubular cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014898 Uncertain Supported Centrosome,Cytosol "Secreted - unknown location" No No 3500000 "Centrosome, Cytosol" "HPA014898: AB_1858467" "unprognostic (2.55e-1)" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (8.95e-3)" "unprognostic (2.92e-3)" "unprognostic (1.83e-1)" "unprognostic (8.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" 23.9 19.7 9.0 16.9 10.5 8.2 17.7 10.8 12.4 40.9 14.4 19.9 11.2 51.8 46.2 26.3 30.8 36.6 18.8 8.6 12.7 36.6 10.0 19.8 11.9 11.9 10.6 7.8 32.5 9.8 33.5 9.8 25.0 11.3 43.4 22.6 5.8 11.2 65.2 5.7 13.0 12.6 80.8 11.3 13.7 15.0 11.9 10.1 7.1 35.2 16.6 15.0 35.0 16.3 12.3 57.3 19.9 57.6 28.6 111.2 99.7 26.6 107.2 132.4 57.6 81.9 21.2 73.5 8.2 52.7 142.5 37.4 19.5 57.1 42.4 105.3 22.0 15.4 14.7 15.9 10.8 98.7 10.8 29.4 102.0 34.1 48.3 23.3 78.7 90.8 7.8 22.7 14.6 149.2 17.0 11.9 13.2 18.9 33.6 16.1 20.7 58.7 5.0 65.7 75.2 7.4 20.0 83.3 23.1 22.9 23.9 26.1 25.0 75.6 104.9 52.4 99.5 67.5 21.2 20.1 15.1 64.5 14.9 37.9 8.3 2.7 4.0 4.3 1.5 2.8 2.1 2.0 4.5 5.5 1.6 2.3 4.8 1.2 2.9 0.5 5.3 1.0 2.1 9.0 10.5 10.8 12.4 8.6 12.7 11.9 10.6 7.8 11.3 11.3 10.1 12.3 9.0 25.6 18.4 13.1 8.1 39.6 21.3 18.5 51.2 4.8 18.5 11.6 7.8 10.0 21.0 75.4 0.0 6.3 12.1 12.1 1.9 9.1 141.2 13.3 38.6 18.1 6.0 9.9 28.0 7.6 18.3 61.9 10.2 23.4 6.3 31.6 17.2 7.5 16.0 3.3 31.0 8.2 57.0 9.4 30.1 30.7 37.6 12.2 23.2 17.8 15.3 16.1 7.2 29.1 31.6 9.2 10.7 95.2 17.8 46.3 1.3 12.6 12.4 5.0 72.3 28.9 56.6 24.6 9.6 26.6 26.9 4.7 10.1 20.4 12.2 27.1 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446036-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in many" "Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.3 1.9 13.2 3.0 15.5 1.4 1.6 18.2 13.6 1.3 8.9 1.8 0.6 1.1 0.7 1.4 1.8 1.8 4.2 12.9 14.9 1.1 0.8 2.0 2.7 23.2 17.8 10.2 4.9 1.7 0.9 2.0 0.8 20.9 3.3 1.1 0.4 2.1 1.1 1.9 2.0 1.6 1.4 18.7 2.8 1.2 4.8 16.8 2.9 6.6 1.6 2.3 2.1 2.2 23.0 6.2 1.4 0.4 0.0 5.1 20.8 4.3 31.9 15.1 3.0 4.1 7.0 0.9 0.0 1.2 13.1 2.1 12.4 0.4 11.2 5.4 0.6 11.5 18.2 0.2 0.1 2.7 2.0 2.0 5.0 11.2 37.1 3.0 68.8 20.6 0.0 17.4 3.0 64.8 0.2 0.2 0.1 7.2 0.0 0.5 0.1 0.0 7.9 6.5 0.7 1.1 6.4 1.5 0.1 0.6 0.6 0.4 0.3 66.2 30.1 0.4 3.8 23.8 0.0 0.0 0.0 82.5 0.3 4.9 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 13.2 15.5 18.2 13.6 12.9 14.9 23.2 17.8 10.2 20.9 18.7 16.8 23.0 0.9 0.0 1.7 4.2 2.9 3.4 4.1 6.8 4.6 1.1 0.8 3.0 2.9 1.5 2.9 0.0 2.1 11.6 3.2 0.2 0.0 2.8 53.6 0.7 1.6 2.4 0.0 10.9 51.7 4.4 0.7 6.5 0.5 1.0 0.0 4.4 1.8 0.0 10.3 0.0 29.8 0.3 2.0 7.6 14.2 122.7 2.8 15.6 1.8 227.7 14.8 1.8 0.0 141.8 200.8 2.5 0.0 6.0 0.5 1.9 0.0 0.2 3.8 1.4 0.0 1.6 4.2 1.6 4.3 0.4 0.6 1.0 0.7 10.6 0.1 0.6 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.8;lymphoid tissue: 28.7" "Cell type enhanced" "Detected in some" "B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5" "Group enriched" "Detected in many" 7 "B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2" "Cell line enhanced" "Detected in some" "Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 1.9 0.7 2.9 12.2 3.3 11.8 1.4 4.4 4.9 1.1 3.8 1.9 1.5 0.8 1.9 1.4 0.7 3.3 0.6 3.1 5.1 0.8 1.3 5.3 28.7 5.7 4.5 2.0 0.6 1.0 0.4 0.3 1.2 6.2 0.8 1.9 0.1 1.3 0.6 0.7 2.6 7.5 1.7 6.3 17.5 2.3 3.8 5.1 12.4 0.6 0.4 24.1 3.1 0.3 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 56.3 0.0 6.5 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 25.0 0.0 0.0 3.0 0.0 0.0 2.8 0.0 14.3 0.0 0.1 11.3 21.2 0.0 0.0 10.2 0.0 1.3 32.5 0.0 1.1 2.9 3.3 4.4 4.9 3.1 5.1 5.7 4.5 2.0 6.2 6.3 5.1 7.4 0.2 0.0 1.1 2.0 44.7 0.4 0.1 0.0 0.0 0.0 0.1 0.4 1.3 0.0 0.6 1.8 0.0 0.1 29.9 0.0 1.9 0.0 47.2 0.0 0.1 0.3 0.0 0.4 0.7 0.0 0.2 1.1 0.0 0.0 5.7 0.0 0.0 0.0 13.0 0.0 0.4 0.1 0.0 12.9 30.6 17.7 0.3 24.6 1.8 81.5 16.4 0.0 0.0 1.0 0.5 0.0 0.0 0.4 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 2.9 0.5 0.2 0.3 0.3 1.5 0.0 0.3 0.1 EIF2AK4 "GCN2, KIAA1338" ENSG00000128829 "Eukaryotic translation initiation factor 2 alpha kinase 4" Q9P2K8 15 39934115-40035591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation" "Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 66.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011811 Approved Approved Cytosol NA NA Cytosol "HPA011811: AB_2668543" "unprognostic (3.10e-1)" "unprognostic (4.78e-3)" "unprognostic (5.97e-2)" "unprognostic (7.18e-2)" "unprognostic (1.05e-2)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-2)" "unprognostic (6.47e-2)" "unprognostic (2.31e-2)" "unprognostic (5.11e-3)" 20.3 14.8 21.8 12.3 22.9 18.9 17.8 26.6 23.9 14.3 17.9 15.7 11.4 30.8 15.5 16.1 16.2 17.2 17.9 21.3 21.9 13.3 21.5 17.0 17.0 21.1 20.2 21.4 17.3 14.3 17.8 24.3 19.2 22.5 19.9 13.1 13.3 14.0 11.6 19.0 19.2 11.4 15.7 19.1 15.8 15.3 9.0 22.4 13.2 22.0 11.1 11.7 17.4 12.5 29.1 37.1 17.5 30.3 46.3 49.0 81.7 28.9 51.0 58.1 40.8 40.0 25.2 15.6 19.6 25.9 69.3 54.7 38.6 41.1 61.4 56.6 92.8 20.4 41.6 30.8 30.7 42.1 25.6 27.8 65.3 41.2 39.0 69.8 57.3 58.0 40.5 31.3 18.1 81.7 12.3 21.7 34.6 18.8 32.8 38.2 25.4 42.2 33.1 51.4 24.7 16.1 24.4 36.4 22.2 32.3 29.5 30.7 43.4 61.6 54.3 40.9 27.3 33.6 24.6 47.8 6.0 38.1 34.4 77.4 11.6 10.8 8.6 6.8 14.1 5.7 7.1 7.6 7.9 17.6 9.2 8.3 8.2 3.3 8.5 20.5 66.5 5.8 4.9 21.8 22.9 26.6 23.9 21.3 21.9 21.1 20.2 21.4 22.5 19.1 22.4 29.1 47.9 16.0 31.1 28.7 29.3 12.0 27.5 17.8 43.3 29.9 45.0 45.2 32.3 32.9 21.4 16.5 12.5 37.5 32.2 21.1 13.7 23.7 1.5 19.3 52.7 35.3 14.4 37.4 42.7 25.4 34.8 36.5 23.4 27.0 24.1 35.0 22.9 27.8 30.7 28.6 53.9 25.9 12.2 33.7 55.4 4.3 42.3 52.1 32.0 29.0 41.1 30.4 16.5 30.2 26.3 47.6 16.2 39.9 115.6 30.7 6.4 18.2 12.9 23.9 46.0 43.6 35.6 8.6 29.8 47.0 14.5 15.2 18.2 64.0 29.6 18.4 MYO5C MGC74969 ENSG00000128833 "Myosin VC" Q9NQX4 15 52192322-52295804 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 68.5;Alveolar cells type 1: 131.4;Alveolar cells type 2: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 25.4;MCF7: 46.3;OE19: 41.2;RT4: 26.4;SK-BR-3: 34.0;T-47d: 40.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020790, HPA032115, HPA032116" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159" "unprognostic (1.85e-1)" "unprognostic (1.29e-1)" "unprognostic (3.49e-2)" "prognostic favorable (5.18e-5)" "unprognostic (2.94e-1)" "unprognostic (4.01e-2)" "unprognostic (2.07e-1)" "unprognostic (1.53e-1)" "unprognostic (4.53e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-3)" "unprognostic (4.82e-2)" "prognostic favorable (2.47e-5)" "prognostic favorable (5.82e-4)" "unprognostic (9.15e-2)" "unprognostic (2.34e-1)" "unprognostic (2.32e-1)" 9.7 1.5 5.1 2.8 3.2 0.8 13.3 7.9 3.8 14.2 14.6 14.1 5.3 4.2 12.9 7.1 11.6 6.9 1.6 2.5 6.9 5.5 3.4 13.9 2.0 4.9 3.2 1.8 1.6 27.6 13.8 7.3 2.5 5.5 10.4 17.8 1.7 21.3 4.4 2.2 4.5 5.2 4.0 9.9 3.5 19.6 4.7 4.1 2.0 18.0 2.6 2.5 4.4 4.5 5.9 21.4 25.4 3.5 0.0 0.0 0.1 3.0 0.0 0.3 0.1 0.0 3.9 8.8 1.2 5.3 0.1 0.2 3.4 5.3 7.4 0.0 1.1 8.4 0.1 17.3 15.7 0.0 0.0 0.2 0.0 7.2 0.0 6.8 3.6 5.6 0.9 0.0 0.3 0.1 46.3 1.3 0.2 1.4 41.2 12.0 17.6 2.1 10.6 19.5 26.4 3.5 3.9 1.6 34.0 0.0 5.4 40.9 0.0 0.0 0.0 0.2 0.0 3.3 0.7 0.7 2.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 5.1 3.2 7.9 3.8 2.5 6.9 4.9 3.2 1.8 5.5 9.9 4.1 5.9 68.5 131.4 84.5 3.9 1.5 0.6 20.5 10.2 2.2 0.4 22.4 10.9 4.9 18.6 47.1 22.0 0.0 2.3 0.3 26.5 3.9 21.1 2.8 34.1 4.8 26.1 5.4 2.1 29.3 29.6 1.5 3.7 41.3 50.4 3.8 5.1 2.5 5.1 0.9 0.0 3.9 47.1 22.4 0.8 3.1 3.2 1.8 1.4 7.2 14.0 0.1 5.6 1.0 8.0 2.8 39.0 21.5 0.4 2.7 28.1 2.1 1.3 49.8 0.5 0.0 1.3 1.5 9.0 5.9 14.1 1.4 0.7 1.6 2.0 25.8 38.7 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550717 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" No No "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102" "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favorable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favorable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favorable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 3.8 11.6 23.8 1.5 21.4 0.0 20.0 20.0 18.8 32.3 40.7 2.8 1.2 18.0 4.4 11.1 8.9 2.8 18.2 18.3 21.5 68.9 36.3 21.1 1.1 31.1 23.9 15.0 5.9 18.7 9.7 4.1 29.0 26.0 28.9 2.3 12.4 32.5 16.3 0.7 10.3 2.6 10.9 18.2 0.4 15.7 6.6 29.2 4.6 20.0 1.9 3.3 8.9 20.4 22.8 0.0 1.3 13.1 0.0 0.0 0.0 0.2 0.2 2.9 1.1 2.4 8.4 0.1 0.0 11.4 1.7 1.9 0.0 6.2 0.1 1.8 0.1 1.0 0.1 0.1 5.7 0.2 0.1 0.0 0.4 0.4 1.3 0.0 4.4 52.7 0.5 0.0 0.0 2.1 2.4 0.0 0.2 6.5 3.7 0.6 0.1 6.6 0.3 4.4 0.0 0.3 0.7 0.0 5.1 0.0 37.6 0.5 0.6 32.5 0.0 3.3 0.1 1.9 0.0 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 21.4 20.0 18.8 18.3 21.5 31.1 23.9 15.0 26.0 18.2 29.2 22.8 3.9 51.3 87.2 79.7 0.2 4.6 13.4 5.1 4.6 0.4 27.4 27.1 21.0 10.0 11.7 22.0 0.0 1.0 1.6 0.9 41.1 9.9 3.0 11.0 9.4 21.8 13.1 2.7 0.7 13.2 1.0 17.1 11.2 11.8 1.3 3.5 58.5 65.5 0.3 0.0 1.9 3.7 18.3 1.6 4.9 18.1 19.9 0.9 7.2 156.4 0.6 43.7 0.0 11.1 1.5 4.3 1.2 27.8 0.0 18.6 0.2 39.4 2.2 1.4 0.0 6.6 2.3 0.6 0.6 0.8 2.4 1.4 1.2 0.6 2.2 7.0 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751597-51816363 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 65.0" "Cell type enhanced" "Detected in many" "Astrocytes: 101.9;Excitatory neurons: 147.3;Horizontal cells: 87.5;Inhibitory neurons: 125.9;Oligodendrocyte precursor cells: 98.0;Oligodendrocytes: 94.1" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.1" "Group enriched" "Detected in all" 4 "granulocytes: 13.1;monocytes: 10.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favorable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.2 5.2 29.9 5.6 45.3 0.7 4.2 13.1 65.0 8.1 0.0 9.4 2.2 5.2 3.4 4.0 6.9 4.4 4.8 46.9 28.8 2.5 1.3 3.8 4.4 20.2 17.0 34.9 5.5 2.3 4.3 6.1 2.0 30.0 4.3 4.1 15.8 3.2 8.4 2.0 3.8 5.8 5.8 10.5 3.8 3.7 2.2 22.1 4.9 4.0 3.7 4.0 4.8 7.7 31.5 1.2 0.7 2.4 5.7 11.3 12.1 0.4 6.5 2.2 4.8 5.2 0.1 0.6 5.3 0.2 5.1 5.0 3.4 10.2 5.8 1.5 0.1 5.0 0.0 1.0 0.1 1.9 2.1 0.4 7.1 7.7 0.7 1.4 6.4 1.0 13.6 0.0 0.1 6.0 0.9 4.4 0.7 1.6 0.0 1.2 3.4 1.4 0.1 0.8 1.7 37.0 9.1 6.0 0.0 1.7 3.0 1.4 0.3 2.4 12.9 1.0 8.3 4.7 0.0 0.0 0.0 4.1 14.2 6.0 0.2 5.9 8.6 2.3 2.4 0.9 2.7 1.3 1.0 1.6 1.6 1.6 0.7 13.1 1.3 10.6 1.3 0.5 1.2 29.9 45.3 13.1 65.0 46.9 28.8 20.2 17.0 34.9 30.0 10.5 22.1 31.5 13.8 0.0 4.1 101.9 7.4 4.8 3.6 1.2 3.4 26.3 3.0 3.0 7.9 0.0 1.7 11.0 22.9 0.1 1.8 0.1 7.9 3.3 30.8 0.9 4.3 13.5 23.4 0.8 147.3 1.8 0.1 12.2 1.1 0.5 0.0 3.0 12.8 0.4 4.9 87.5 125.9 0.7 2.0 7.9 4.4 19.6 11.1 9.1 1.8 53.4 29.8 12.6 3.1 98.0 94.1 2.2 0.2 5.7 2.6 1.9 1.8 1.2 2.8 19.7 6.6 13.1 5.8 6.6 4.9 6.3 7.5 0.3 6.5 1.3 0.5 1.8 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738730-42920809 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.8;Inhibitory neurons: 185.1;Late spermatids: 146.2;Oligodendrocytes: 125.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: AB_2680923" "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 4.9 4.2 9.5 3.0 9.3 5.2 4.5 11.0 19.3 6.0 1.4 5.4 1.6 5.3 3.9 2.6 5.5 3.8 7.0 5.8 13.2 3.4 3.1 4.9 3.4 15.5 10.7 4.9 6.4 2.5 4.6 5.7 4.0 18.3 4.8 3.0 17.9 3.2 3.8 10.5 3.2 4.0 5.1 6.6 4.4 3.5 33.7 14.6 5.3 3.8 6.4 3.2 5.4 4.7 17.0 5.7 3.8 8.4 4.2 6.5 6.6 1.8 4.6 7.4 4.5 6.9 4.3 1.3 3.3 6.1 4.7 9.2 3.9 8.1 6.7 6.8 13.0 3.6 4.8 6.9 1.6 5.0 6.7 7.8 4.7 6.5 3.9 21.1 9.9 5.2 5.1 7.0 4.9 4.5 0.9 4.1 4.3 2.3 1.7 3.8 7.2 9.1 1.7 5.8 4.0 6.6 6.5 12.6 0.9 2.5 5.8 2.6 8.7 5.8 5.1 4.7 5.7 6.0 7.1 11.3 5.5 3.9 5.8 3.0 0.1 0.5 0.2 0.2 0.3 0.5 0.3 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.1 9.5 9.3 11.0 19.3 5.8 13.2 15.5 10.7 4.9 18.3 6.6 14.6 17.0 16.2 6.4 11.8 75.7 11.5 10.7 12.1 11.8 26.2 36.3 9.6 7.6 17.6 12.8 10.0 9.2 37.5 4.1 9.1 3.9 0.0 5.7 80.5 24.9 11.7 17.0 14.3 17.4 153.8 4.3 3.2 15.5 4.6 4.6 19.0 16.2 17.5 9.8 7.4 45.4 185.1 5.1 2.0 16.0 25.9 146.2 16.8 16.4 12.4 69.3 16.9 16.5 6.2 97.5 125.6 7.5 2.6 20.3 6.6 12.4 5.5 5.5 40.5 39.4 13.1 24.6 16.3 34.5 10.1 12.5 9.2 3.1 13.4 11.3 5.3 7.4 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772605-43777315 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.2;skin 1: 25.2" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 10.5;naive B-cell: 15.9" "Lineage enriched" "Detected in many" 7 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9" "Region enriched" "Detected in single" 11 "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes NA "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.5 0.9 1.0 9.8 0.9 0.2 5.3 0.9 1.1 1.6 3.9 8.0 14.3 0.6 1.1 4.5 3.9 0.7 0.5 1.0 1.3 1.5 0.7 1.6 50.1 1.0 0.9 0.9 1.7 0.4 1.6 0.5 3.7 1.0 2.0 12.4 0.1 2.2 1.0 0.4 25.2 13.0 1.0 0.9 1.0 1.8 16.3 1.1 1.5 0.7 1.9 58.2 0.7 0.8 0.9 2.1 0.2 0.6 1.1 4.9 1.2 0.4 0.2 1.3 2.8 3.1 0.0 1.3 73.8 0.1 1.2 0.1 13.7 1.3 0.7 1.4 1.6 7.3 0.4 2.6 4.6 1.0 0.1 0.0 1.4 12.3 0.7 0.2 0.2 1.1 0.4 0.2 0.0 0.7 4.0 1.5 1.4 0.1 28.5 2.4 0.8 0.0 0.0 1.8 0.0 9.5 0.0 1.7 21.5 0.0 0.3 39.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 149.9 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 10.5 0.6 0.1 0.0 15.9 1.1 0.2 0.0 0.1 0.0 2.2 0.6 0.6 1.0 0.9 0.9 1.1 1.0 1.3 1.0 0.9 0.9 1.0 0.9 1.1 0.9 0.1 0.0 0.0 0.0 2.2 0.4 0.1 0.2 5.2 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.3 1.2 0.0 0.1 1.8 0.4 0.1 0.2 0.0 0.4 0.1 0.7 0.0 0.5 4.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.5 0.0 0.0 0.5 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 6.5 0.1 3.1 0.0 0.0 0.2 0.4 0.2 0.2 21.0 1.0 0.3 0.1 0.1 2.3 0.2 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 15.3 20.7 16.2 17.2 15.2 20.4 15.6 14.4 18.2 15.0 17.0 17.5 17.1 14.7 17.5 9.4 18.4 18.0 18.3 18.5 17.0 17.7 13.1 14.3 29.0 16.6 17.6 16.3 25.2 18.0 20.1 13.7 21.4 18.0 14.0 20.0 15.2 13.1 15.0 15.6 10.3 15.0 15.5 16.1 21.7 18.2 8.4 17.1 19.6 21.1 11.2 26.1 19.4 12.2 17.3 15.4 10.8 14.1 22.8 28.8 29.9 8.4 12.0 17.8 20.9 21.8 16.4 20.9 5.6 32.9 18.0 30.2 28.3 13.8 13.8 14.8 35.0 16.2 62.6 18.1 20.6 19.6 24.0 31.5 25.4 14.1 16.3 11.0 19.8 26.7 22.0 35.0 36.9 16.1 13.3 11.2 20.4 5.6 35.3 13.6 19.1 18.5 19.1 39.6 36.3 15.8 15.5 17.9 18.5 9.3 16.6 19.6 43.4 29.8 19.5 17.0 34.1 17.5 21.1 21.1 18.4 20.7 37.2 27.8 58.2 32.4 33.9 32.6 34.2 25.9 147.1 35.6 35.3 43.0 167.2 35.8 30.7 34.0 29.1 35.7 57.6 50.6 42.1 16.2 15.2 14.4 18.2 18.5 17.0 16.6 17.6 16.3 18.0 16.1 17.1 17.3 32.1 12.8 13.4 0.0 24.6 0.0 0.0 0.0 0.0 0.0 18.6 20.8 0.0 0.0 9.9 20.2 0.0 80.5 19.6 0.0 29.4 27.0 0.0 22.7 13.7 10.2 0.0 0.0 0.0 29.2 32.5 11.3 0.0 14.4 6.3 15.5 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 10.3 0.0 0.0 0.0 0.0 38.3 0.0 0.0 7.8 0.0 0.0 30.0 12.4 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 81.4 10.1 35.0 0.0 0.0 INO80 "hINO80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex ATPase subunit" Q9ULG1 15 40978880-41116280 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 8.9 6.6 5.6 7.4 6.0 15.8 8.9 10.0 5.9 8.2 5.5 9.0 7.3 9.0 4.8 9.7 7.8 5.8 6.7 5.4 5.8 7.2 7.8 9.5 9.8 5.6 5.5 5.1 9.1 7.0 10.1 5.5 6.9 6.5 8.0 8.7 5.8 7.4 6.7 15.8 10.9 8.8 8.2 5.4 9.0 8.0 7.1 5.9 10.9 8.6 9.7 10.5 9.2 8.5 7.7 13.1 12.9 10.6 10.7 16.5 13.8 11.4 12.2 18.8 17.3 15.0 14.8 10.4 14.0 8.8 17.6 21.6 24.3 19.5 20.7 19.0 17.5 10.0 18.9 17.7 11.8 15.2 17.9 16.2 13.5 18.4 13.8 36.9 11.1 16.8 14.5 20.5 11.6 12.3 10.6 13.2 11.2 11.3 20.6 13.5 19.1 11.2 11.0 12.7 26.1 14.5 9.6 9.6 18.5 7.3 10.4 10.5 19.9 19.2 14.3 11.1 17.3 19.0 12.4 9.6 22.2 16.1 24.7 11.7 0.3 1.0 0.2 0.8 0.5 0.9 1.3 0.8 0.8 0.7 1.1 1.0 1.1 0.3 2.1 0.2 0.6 0.7 0.4 5.6 6.0 10.0 5.9 5.4 5.8 5.6 5.5 5.1 6.5 5.4 5.9 7.7 23.7 9.6 25.7 27.4 27.6 8.5 16.2 7.5 23.3 30.4 18.1 15.9 25.1 14.3 16.4 16.5 22.9 13.5 25.4 17.3 7.9 17.6 2.2 17.2 21.5 17.6 13.1 23.8 54.1 13.3 12.0 16.0 32.6 28.9 15.8 18.4 13.2 10.0 9.8 26.9 47.5 11.8 2.0 14.4 6.8 3.3 14.6 18.6 7.2 25.3 20.8 12.9 19.6 43.2 53.3 15.2 16.1 15.8 19.8 21.7 9.5 11.3 16.3 33.0 6.6 28.1 21.3 19.2 24.7 28.2 12.8 19.2 25.8 25.1 13.9 15.1 ICE2 "BRCC1, FLJ11896, NARG2" ENSG00000128915 "Interactor of little elongation complex ELL subunit 2" Q659A1 15 60419609-60479160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040058 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA040058: AB_10795686" "unprognostic (3.80e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (5.59e-3)" "unprognostic (8.78e-3)" "unprognostic (2.71e-1)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (8.39e-3)" "unprognostic (1.68e-1)" "unprognostic (3.45e-1)" "unprognostic (3.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (5.74e-2)" 5.5 5.5 3.0 6.3 3.9 5.6 8.5 4.5 3.8 5.1 5.6 4.9 4.5 8.1 5.6 6.6 6.4 6.6 5.4 2.6 3.6 6.6 7.1 4.9 9.2 3.7 3.4 2.3 10.0 6.3 34.9 4.2 7.9 3.9 6.7 7.2 4.9 6.0 5.5 4.4 5.0 5.4 6.5 4.0 7.7 5.3 6.8 3.2 12.8 9.4 5.1 9.9 6.2 3.7 6.7 14.7 25.5 21.1 20.3 15.6 16.9 11.0 8.5 13.1 13.3 14.4 20.0 10.6 25.5 18.3 9.2 25.2 27.2 28.3 11.4 18.3 30.9 12.6 25.8 17.4 11.8 8.4 28.8 17.6 8.5 13.6 11.0 19.7 17.7 22.2 24.9 39.9 23.3 16.7 6.3 22.9 7.6 26.3 26.8 17.1 27.1 16.7 22.4 10.7 18.0 23.8 22.8 12.0 12.2 15.1 24.8 19.7 14.6 10.5 18.4 16.0 15.8 26.5 11.0 31.6 37.7 12.1 32.4 17.4 4.0 4.5 5.3 5.7 6.3 9.7 7.6 7.0 7.6 5.9 10.5 9.3 9.1 0.7 4.2 5.8 4.9 8.1 6.0 3.0 3.9 4.5 3.8 2.6 3.6 3.7 3.4 2.3 3.9 4.0 3.2 6.7 32.5 19.2 19.6 34.6 30.6 0.0 20.4 0.0 16.5 31.3 24.4 27.7 20.2 15.7 17.3 20.2 39.6 22.7 32.4 8.8 21.5 12.2 15.5 25.6 27.5 25.1 19.2 28.0 39.9 10.4 14.9 21.1 25.0 21.8 29.8 70.6 29.6 20.6 14.0 30.3 42.6 16.1 0.0 16.8 0.0 17.4 25.4 21.1 0.0 49.6 25.3 19.6 25.7 49.3 83.6 14.6 13.7 17.7 15.9 23.0 11.6 18.1 19.7 33.3 0.0 31.4 17.5 22.1 34.8 21.3 0.0 14.6 31.3 39.3 19.4 19.2 DLL4 ENSG00000128917 "Delta like canonical Notch ligand 4" Q9NR61 15 40929340-40939073 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 70.7;Distal enterocytes: 24.2;Endothelial cells: 48.6;Hepatic stellate cells: 30.4;Intestinal goblet cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BJ hTERT+: 59.4;HUVEC TERT2: 15.7;SCLC-21H: 32.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023392 Uncertain NA NA "HPA023392: AB_1847740" "unprognostic (1.92e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (7.52e-2)" "unprognostic (4.71e-2)" "unprognostic (2.72e-1)" "unprognostic (4.16e-2)" "unprognostic (3.56e-2)" "unprognostic (1.60e-2)" "unprognostic (2.49e-1)" "unprognostic (2.73e-1)" "unprognostic (3.51e-2)" "unprognostic (6.10e-2)" "unprognostic (2.56e-3)" "unprognostic (9.92e-2)" "unprognostic (2.93e-1)" "unprognostic (1.51e-2)" "unprognostic (5.51e-3)" 24.1 2.6 8.3 2.9 5.2 0.3 21.4 5.9 7.1 7.9 5.8 6.9 4.0 8.8 1.0 3.8 7.7 3.7 19.3 5.1 5.4 9.7 3.5 22.7 5.0 6.5 5.9 3.8 4.1 3.0 2.9 5.7 19.9 6.7 7.9 3.0 0.9 4.3 2.7 10.1 5.2 6.9 4.3 5.7 4.6 4.8 1.5 7.3 5.0 15.5 10.7 1.7 8.8 7.6 7.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.9 59.4 0.2 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 15.7 0.0 0.4 1.1 0.1 0.1 0.0 0.6 0.0 0.9 0.0 1.4 0.5 1.6 0.0 0.1 32.5 0.0 0.3 0.7 0.0 0.0 0.0 3.5 0.9 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.2 5.9 7.1 5.1 5.4 6.5 5.9 3.8 6.7 5.7 7.3 7.7 70.7 0.0 2.7 0.0 1.7 1.3 0.2 0.2 4.0 4.9 1.6 2.8 3.2 1.5 0.9 0.0 0.0 1.5 0.2 24.2 0.0 0.2 0.2 1.9 0.7 48.6 17.4 0.0 0.9 0.2 0.6 3.1 13.3 2.6 2.5 0.0 30.4 0.1 0.2 0.0 0.6 36.3 6.1 1.6 0.8 0.3 0.0 0.8 1.8 11.2 0.0 0.2 0.0 0.5 0.5 0.2 16.7 0.0 3.5 2.3 9.2 0.0 0.2 1.4 0.0 0.9 3.8 0.8 2.0 1.0 1.6 1.9 0.4 0.4 12.0 0.6 ALDH1A2 RALDH2 ENSG00000128918 "Aldehyde dehydrogenase 1 family member A2" O94788 15 57953424-58497866 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 82.9;fallopian tube: 75.1" "Group enriched" "Detected in many" 4 "Early spermatids: 115.7;Endometrial stromal cells: 142.2;Late spermatids: 48.7;Microglial cells: 42.2;Spermatocytes: 78.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebral cortex: 12.8;hippocampal formation: 8.0" "Immune cell enriched" "Detected in some" 15 "neutrophil: 32.6" "Lineage enriched" "Detected in single" 62 "granulocytes: 32.6" "Group enriched" "Detected in some" 5 "AN3-CA: 402.4;HEK 293: 128.8;JURKAT: 387.2;K-562: 316.2;MOLT-4: 408.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010022 Approved NA NA "HPA010022: AB_1844723" "unprognostic (1.11e-2)" "unprognostic (2.52e-2)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" "unprognostic (1.44e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-4)" "unprognostic (1.08e-1)" "unprognostic (9.03e-3)" "unprognostic (6.92e-3)" "unprognostic (5.48e-2)" "unprognostic (6.19e-2)" "unprognostic (2.57e-3)" "unprognostic (3.18e-2)" "unprognostic (4.95e-2)" "unprognostic (1.99e-2)" "unprognostic (1.80e-3)" 13.8 3.9 1.0 3.0 1.1 4.0 6.0 1.8 12.8 52.7 5.2 1.3 0.7 82.9 7.8 2.4 75.1 24.2 18.9 8.0 1.1 19.7 2.6 7.8 0.6 1.6 1.0 0.8 24.2 3.2 30.0 14.7 5.3 2.3 21.2 0.7 6.0 2.0 53.8 10.8 1.5 1.3 32.1 1.5 4.4 0.8 58.1 1.8 2.8 1.4 3.0 0.4 4.0 13.0 1.6 1.2 0.0 0.0 402.4 0.0 0.0 0.1 0.0 5.7 0.6 1.3 0.0 0.3 0.4 3.9 0.0 0.1 1.0 11.8 0.0 0.7 0.0 128.8 0.0 2.7 0.7 0.3 0.0 3.0 2.3 0.0 0.0 0.0 0.0 21.4 387.2 316.2 0.0 0.0 0.0 408.5 0.1 0.7 11.2 19.6 0.0 0.8 0.0 70.7 2.0 0.8 0.1 0.4 0.4 1.9 0.4 0.2 0.1 0.9 0.3 1.0 3.8 0.0 0.3 0.0 0.0 0.2 0.2 0.1 2.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.3 0.0 0.0 0.0 1.0 1.1 1.8 12.8 8.0 1.1 1.6 1.0 0.8 2.3 1.5 1.8 1.6 13.1 6.4 13.9 0.0 0.0 0.6 1.9 0.2 0.0 1.1 1.1 0.9 2.4 20.0 3.4 7.3 0.0 0.3 0.1 5.2 13.7 11.6 115.7 6.8 142.2 7.6 0.0 0.0 5.8 0.4 0.3 17.6 0.0 3.6 1.3 0.3 10.8 17.4 2.2 0.0 9.6 0.1 0.0 1.6 0.8 48.7 5.3 3.0 1.8 42.2 0.7 10.1 0.0 0.0 1.2 0.7 0.3 5.3 0.0 1.3 0.3 0.3 1.4 0.3 0.0 8.3 3.3 78.9 14.7 0.2 0.4 0.5 1.0 0.1 0.7 1.3 MINDY2 "FAM63B, KIAA1164" ENSG00000128923 "MINDY lysine 48 deubiquitinase 2" Q8NBR6 15 58771192-58861900 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 72.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051103, HPA063669" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051103: AB_2681345, HPA063669: AB_2685082" "unprognostic (4.71e-2)" "unprognostic (8.92e-3)" "unprognostic (4.63e-2)" "unprognostic (4.13e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (8.60e-2)" "unprognostic (7.23e-2)" "unprognostic (7.09e-2)" "unprognostic (2.36e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.00e-8)" "unprognostic (2.53e-1)" "unprognostic (3.59e-1)" "unprognostic (6.76e-2)" "unprognostic (4.77e-2)" 9.4 5.5 9.8 5.7 10.3 3.8 6.7 15.6 10.3 7.0 9.2 4.8 3.6 7.2 4.7 7.2 6.9 6.4 10.9 8.7 11.8 10.2 3.5 7.8 4.1 11.4 11.7 7.7 6.9 3.4 7.4 4.9 9.0 10.6 8.9 3.9 16.5 5.0 6.1 3.4 7.2 3.6 8.5 10.5 6.1 4.9 3.9 12.0 5.9 9.7 9.0 3.7 8.0 5.3 11.1 10.9 5.3 7.3 4.4 10.7 19.7 11.5 9.8 20.8 3.0 4.3 8.4 5.4 5.6 10.5 11.8 5.3 10.3 13.4 7.9 4.6 5.6 4.9 7.8 5.7 7.6 6.6 5.9 6.9 8.7 12.9 3.5 8.0 11.3 7.4 5.9 13.7 6.1 7.1 1.4 7.4 4.4 15.7 1.4 2.7 3.3 21.0 6.0 8.9 12.1 6.7 4.9 7.1 10.0 17.9 15.3 3.0 12.5 8.7 4.2 3.7 72.5 4.3 5.4 8.3 5.4 9.4 9.5 10.2 3.0 0.7 1.3 1.1 0.6 2.1 0.9 1.0 1.3 0.2 1.6 0.8 1.2 1.4 0.8 1.4 1.1 0.9 0.5 9.8 10.3 15.6 10.3 8.7 11.8 11.4 11.7 7.7 10.6 10.5 12.0 11.1 65.2 147.4 39.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 43.8 44.8 0.0 0.0 18.0 82.8 0.0 65.2 27.5 0.0 46.9 44.4 0.0 66.4 46.8 19.8 0.0 0.0 0.0 21.2 108.7 21.7 0.0 73.2 11.4 11.6 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 32.4 0.0 0.0 7.5 0.0 0.0 14.2 28.4 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 53.2 11.3 17.6 0.0 0.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405485-40435947 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 135.0;Theca cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041391: AB_2677449, HPA044250: AB_2678875" "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favorable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 26.1 81.1 36.6 14.7 40.6 16.1 45.8 35.1 39.4 28.2 35.6 31.5 24.5 26.6 29.3 16.2 35.3 21.7 54.5 33.2 39.9 59.6 146.6 24.5 19.8 39.5 38.1 35.4 43.7 27.6 39.5 58.7 15.4 36.4 42.5 27.4 13.2 32.0 37.1 56.1 8.4 27.0 24.0 36.7 28.1 47.1 25.2 40.4 17.0 120.2 55.9 19.6 31.4 21.0 44.9 20.9 11.9 22.9 38.9 35.9 32.9 1.0 27.6 32.7 39.4 24.0 36.5 16.0 0.8 57.7 43.4 32.6 20.8 45.9 46.6 30.1 36.4 34.0 52.1 36.2 38.9 64.6 22.0 48.5 45.3 18.5 23.5 55.3 46.3 38.8 60.4 2.5 2.4 42.1 27.1 27.3 38.9 17.8 1.3 33.0 41.2 32.6 27.9 45.2 51.6 37.3 21.5 38.2 83.4 18.7 21.5 69.0 117.6 27.6 29.9 20.2 23.6 24.9 54.5 38.5 1.0 30.9 22.8 28.4 17.0 24.8 36.7 33.3 36.1 31.0 27.5 18.5 26.6 58.8 27.6 18.5 26.7 2.3 39.4 73.1 89.2 26.9 24.3 36.6 40.6 35.1 39.4 33.2 39.9 39.5 38.1 35.4 36.4 36.7 40.4 44.9 13.1 28.9 54.5 27.4 19.0 2.3 21.0 17.3 13.1 26.0 27.5 22.2 88.0 45.8 29.9 44.1 14.6 20.3 34.0 17.9 95.9 19.7 5.4 21.4 31.0 18.6 19.7 21.3 15.3 14.9 7.3 20.2 29.6 19.9 34.7 46.5 21.4 135.0 28.1 16.8 16.6 24.4 14.2 18.3 6.2 7.4 20.5 18.6 5.4 21.5 28.8 26.0 26.8 25.1 21.4 14.8 9.4 24.8 10.0 16.6 22.0 97.3 29.3 19.9 19.7 25.0 18.2 16.1 3.7 17.4 0.6 9.9 18.0 105.7 35.4 11.9 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin (SPAG5) binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.2;thyroid gland: 53.5" "Cell type enhanced" "Detected in many" "Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 8.1 6.3 6.5 8.2 7.8 14.2 14.4 8.5 8.6 5.2 5.4 8.0 9.3 6.4 12.4 9.1 5.8 4.4 7.2 7.7 7.2 7.3 12.1 5.9 14.7 6.9 7.1 7.2 5.1 5.1 8.4 5.7 10.8 7.1 6.9 10.5 9.1 10.4 7.3 12.3 6.2 6.3 10.3 7.1 7.2 10.3 64.2 6.8 25.9 53.5 12.5 16.2 5.6 5.6 8.4 103.4 47.5 92.7 61.0 20.1 30.9 48.1 69.9 54.0 141.0 123.3 102.6 44.2 39.7 34.8 47.3 112.1 115.7 100.0 64.8 126.5 70.8 48.8 117.7 107.4 65.2 18.9 63.8 58.6 16.1 36.5 71.3 70.6 34.5 80.3 97.6 86.3 66.8 120.0 52.2 55.6 51.2 58.6 87.7 71.2 56.4 69.7 45.7 49.7 42.3 89.9 62.5 58.3 63.3 15.1 55.8 66.5 45.3 41.6 67.5 68.8 69.7 98.3 56.5 98.6 70.5 41.8 84.0 56.5 13.2 17.6 17.4 7.9 24.3 6.8 9.5 5.7 7.0 18.4 11.2 5.4 5.5 9.7 9.8 47.8 12.7 9.4 7.1 6.5 7.8 8.5 8.6 7.7 7.2 6.9 7.1 7.2 7.1 7.1 6.8 8.4 2.4 9.6 1.1 2.6 4.1 2.2 2.9 7.6 3.4 8.2 4.2 3.4 7.3 1.5 5.4 0.0 8.4 25.2 2.5 1.9 3.9 8.5 328.2 5.9 4.9 3.7 2.4 34.3 5.1 9.3 40.8 5.2 5.6 4.4 1.3 16.9 3.6 8.0 21.6 5.0 4.9 5.3 14.2 9.8 2.0 600.1 9.0 8.2 3.6 4.7 8.0 8.5 6.2 2.0 4.3 12.3 0.5 7.2 12.6 4.9 2.8 5.8 7.2 8.5 0.0 3.7 6.5 145.7 19.2 7.0 1.4 21.1 5.1 8.5 6.4 3.0 DUT dUTPase ENSG00000128951 "Deoxyuridine triphosphatase" P33316 15 48331011-48343373 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 508.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054422, HPA060360" Enhanced Supported Nucleoplasm No Yes 31000 Nucleoplasm "HPA054422: AB_2682483, HPA060360: AB_2684262" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (7.89e-2)" "unprognostic (5.27e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (4.42e-3)" "unprognostic (1.87e-2)" "unprognostic (4.25e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-2)" "unprognostic (4.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-2)" "unprognostic (1.71e-2)" 71.7 65.8 58.0 62.3 61.2 164.3 77.1 58.9 77.8 88.0 62.8 66.9 29.6 77.5 50.1 72.6 78.3 33.9 69.5 55.9 61.0 64.6 54.1 58.6 98.6 60.5 59.0 58.2 86.8 53.7 48.7 80.6 45.5 59.9 78.4 47.5 49.5 67.1 48.8 58.4 65.7 67.0 40.8 59.4 82.8 62.0 57.8 59.2 112.4 89.9 53.4 88.6 69.7 78.6 65.9 196.1 60.2 143.9 137.1 98.4 104.0 85.3 202.1 128.1 182.8 224.6 69.8 131.0 539.3 106.0 112.0 149.4 262.1 152.4 138.4 177.6 383.4 157.2 442.2 151.8 96.1 54.8 469.0 202.0 64.4 92.1 123.9 65.0 117.8 123.3 316.6 244.0 297.6 136.5 79.3 422.4 548.7 90.7 197.4 114.5 338.6 313.9 570.0 120.8 130.4 207.2 210.1 150.0 119.6 184.4 145.5 169.6 368.6 103.0 190.1 183.1 228.3 269.7 238.1 534.3 532.5 143.6 789.4 213.4 32.5 50.3 46.8 52.9 53.1 68.7 94.8 94.7 84.6 74.0 90.0 97.4 64.3 30.9 60.5 68.4 85.3 94.3 71.4 58.0 61.2 58.9 77.8 55.9 61.0 60.5 59.0 58.2 59.9 59.4 59.2 65.9 153.6 54.5 38.9 39.8 126.8 179.6 212.0 222.4 131.5 48.3 158.0 205.5 120.1 95.8 118.5 104.8 14.6 221.8 103.9 62.8 203.5 94.3 36.8 67.2 123.5 123.0 96.1 418.8 36.5 46.5 286.8 147.9 76.5 86.0 84.4 118.3 101.4 77.6 174.5 82.4 32.1 98.4 105.8 87.7 112.6 31.5 184.8 92.0 154.7 23.4 89.5 106.3 95.8 23.6 45.1 45.4 58.8 177.6 192.3 133.2 27.2 256.4 59.6 40.9 157.8 167.1 154.0 508.7 270.0 206.4 168.5 97.1 124.4 82.3 195.4 181.2 CHAC1 MGC4504 ENSG00000128965 "ChaC glutathione specific gamma-glutamylcyclotransferase 1" Q9BUX1 15 40952962-40956512 "Enzymes, Predicted intracellular proteins" "Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 69.2;skeletal muscle: 68.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Exocrine glandular cells: 27.8;Gastric mucus-secreting cells: 33.6;Pancreatic endocrine cells: 19.3;Plasma cells: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 109.5;HHSteC: 80.7;hTCEpi: 130.8;SK-MEL-30: 95.0;U-266/70: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042708, HPA043505" Approved Approved Mitochondria NA NA Mitochondria "HPA042708: AB_2678125, HPA043505: AB_2678518" "unprognostic (6.04e-3)" "unprognostic (2.81e-2)" "unprognostic (7.47e-2)" "unprognostic (2.84e-3)" "unprognostic (6.57e-3)" "unprognostic (2.00e-2)" "unprognostic (5.59e-2)" "unprognostic (2.43e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (3.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.23e-7)" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-2)" "unprognostic (3.91e-2)" 4.5 0.6 18.6 1.4 12.7 1.8 0.9 12.2 24.7 1.2 7.9 1.9 2.0 0.8 1.6 23.5 1.7 1.8 2.3 16.9 14.4 3.1 11.6 2.0 0.9 14.8 15.6 11.8 0.7 69.2 1.4 1.9 0.8 16.2 1.3 0.8 1.1 5.2 1.0 68.9 1.1 1.4 0.8 15.8 1.0 14.9 0.8 23.8 0.5 1.5 11.8 3.0 4.3 3.7 17.2 9.1 6.0 1.5 27.2 4.3 3.2 11.1 53.5 109.5 5.8 15.5 15.1 2.2 2.8 4.1 4.8 17.2 6.0 12.0 4.4 4.1 10.4 2.5 2.5 1.6 0.0 80.7 7.3 0.1 36.1 130.8 17.1 23.2 1.8 5.4 62.3 7.7 12.5 4.8 5.5 5.3 0.1 4.9 31.0 21.3 4.8 0.1 12.8 3.0 3.5 5.3 7.9 1.6 9.5 95.0 3.3 3.6 51.1 1.8 1.3 16.1 1.5 9.4 81.1 19.0 11.0 4.8 10.3 12.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 18.6 12.7 12.2 24.7 16.9 14.4 14.8 15.6 11.8 16.2 15.8 23.8 17.2 6.2 0.0 2.0 0.3 3.1 2.8 3.8 11.5 3.4 2.6 2.2 2.4 4.6 4.3 6.5 0.0 2.1 0.3 2.6 8.0 35.2 6.4 0.1 1.8 0.4 2.7 3.5 3.2 1.3 27.8 0.3 0.6 33.6 2.1 0.0 0.4 1.8 0.7 0.4 0.0 1.5 8.0 6.1 0.3 1.5 0.0 0.3 0.8 5.4 0.0 1.0 0.5 0.0 0.5 0.2 19.3 2.3 0.0 21.4 6.5 0.8 0.3 3.3 0.4 0.0 0.3 3.2 1.1 1.1 1.5 4.3 3.4 1.6 0.5 4.8 14.6 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6 transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 181.8;Hofbauer cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: AB_2685604, HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 11.7 17.8 11.8 15.0 12.3 30.2 11.6 12.5 15.0 11.1 12.5 17.6 14.7 9.9 6.8 17.0 9.9 9.7 8.3 11.5 11.8 20.2 22.9 13.3 16.3 13.8 12.6 11.3 6.8 19.3 10.5 10.2 11.7 13.7 12.5 15.0 11.9 14.9 9.3 17.1 14.8 14.7 10.5 12.5 20.9 13.4 11.0 12.3 11.8 13.0 7.4 16.8 10.8 9.7 13.5 38.2 93.1 23.9 33.9 14.5 11.8 57.1 35.3 17.0 42.8 34.9 72.1 60.5 57.6 17.2 21.4 31.7 69.5 69.8 34.5 17.0 38.5 82.3 84.3 66.1 54.3 29.7 95.6 58.1 20.8 11.4 34.7 23.7 9.0 29.1 33.1 56.9 116.0 33.6 103.8 44.0 69.4 57.1 67.3 38.3 42.1 71.8 80.6 36.2 97.0 48.2 20.0 39.5 61.7 34.3 18.0 33.1 95.5 19.3 48.1 55.7 35.8 127.2 81.3 97.3 47.4 30.0 115.4 47.6 0.0 8.8 0.6 3.0 13.0 4.0 2.9 2.2 4.3 5.2 2.3 2.8 1.3 10.5 2.0 16.1 4.4 2.3 3.5 11.8 12.3 12.5 15.0 11.5 11.8 13.8 12.6 11.3 13.7 12.5 12.3 13.5 1.4 9.6 6.9 7.2 13.4 20.1 22.0 13.9 14.8 181.8 2.0 1.9 27.4 10.0 9.6 5.5 16.7 42.8 7.1 22.7 0.0 3.3 0.4 1.0 4.8 9.7 15.1 32.8 8.9 1.8 58.4 9.1 8.2 1.4 8.9 5.6 11.0 21.9 88.4 21.9 8.1 20.5 16.2 24.2 14.0 1.4 9.0 11.3 19.6 8.4 12.9 16.9 11.3 5.0 10.2 3.6 26.0 8.2 33.4 23.7 15.6 2.1 3.3 32.7 6.6 7.5 5.6 1.0 19.5 21.1 14.1 21.8 9.5 5.3 35.6 16.3 ARPP19 "ARPP-16, ARPP-19, ARPP16, ENSAL" ENSG00000128989 "CAMP regulated phosphoprotein 19" P56211 15 52547045-52569883 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 3587.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056851 Approved NA NA 270000 "HPA056851: AB_2683255" "unprognostic (2.83e-1)" "unprognostic (2.80e-1)" "unprognostic (3.44e-1)" "unprognostic (8.09e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (3.63e-2)" "unprognostic (2.33e-2)" "unprognostic (7.21e-2)" "unprognostic (5.67e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.40e-2)" "unprognostic (4.82e-2)" "unprognostic (3.05e-1)" "unprognostic (3.27e-1)" 61.7 52.2 128.7 39.0 241.9 104.2 46.7 117.9 169.9 38.4 80.7 36.9 29.2 48.3 36.7 52.6 33.7 39.6 82.1 163.0 139.9 57.0 42.6 45.5 48.7 132.1 123.6 150.2 46.6 46.7 110.1 39.0 57.5 144.7 39.8 36.2 57.9 32.0 41.2 242.6 30.7 30.9 58.6 141.8 44.1 38.9 85.4 144.6 53.4 57.9 172.1 52.1 55.9 30.3 157.6 115.1 126.3 178.2 81.3 69.8 77.6 91.7 103.8 88.7 75.9 76.9 111.7 56.6 120.2 110.3 75.0 110.3 100.4 126.1 116.7 98.2 412.3 59.9 138.0 126.0 99.9 59.4 131.8 99.3 74.0 116.1 78.5 128.2 90.0 119.8 115.3 86.2 224.4 113.9 129.0 126.4 51.6 110.1 81.0 63.8 134.1 102.6 243.3 108.2 146.7 179.4 145.2 76.6 99.2 102.6 194.4 99.2 89.0 109.4 120.3 86.1 87.0 151.1 104.4 289.8 154.8 84.9 116.8 116.7 53.5 38.5 88.1 47.7 44.5 47.4 69.9 50.0 57.4 32.5 50.8 47.9 53.1 63.8 65.6 55.6 41.5 80.2 53.9 128.7 241.9 117.9 169.9 163.0 139.9 132.1 123.6 150.2 144.7 141.8 144.6 157.6 90.8 64.1 59.4 33.6 93.9 215.7 190.7 142.2 55.8 54.3 107.3 72.5 156.5 61.5 96.1 62.5 20.9 75.7 100.3 46.2 135.0 88.9 743.5 66.3 60.4 83.0 84.6 63.3 133.2 67.9 94.2 73.7 43.3 104.4 62.1 58.5 80.7 93.1 72.3 85.8 33.9 45.6 81.4 81.7 211.9 3587.2 70.8 73.4 165.4 32.8 144.5 105.5 65.9 24.6 54.3 117.0 38.1 108.3 94.8 174.0 37.0 129.4 62.7 59.4 72.3 78.7 131.1 154.9 196.1 82.0 222.8 87.7 95.0 40.3 43.4 262.9 VPS13C "FLJ10381, FLJ20136, KIAA1421" ENSG00000129003 "Vacuolar protein sorting 13 homolog C" Q709C8 15 61852389-62060473 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 272.2;Oligodendrocytes: 291.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043507 Uncertain Approved Microtubules NA NA Microtubules "HPA043507: AB_10960840" "unprognostic (1.09e-2)" "unprognostic (5.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-2)" "unprognostic (5.90e-2)" "unprognostic (2.31e-2)" "unprognostic (3.92e-1)" "unprognostic (3.18e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (3.61e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-2)" "unprognostic (3.92e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (5.58e-3)" 9.4 8.4 5.6 13.4 13.1 10.6 9.7 10.3 9.1 11.8 5.0 9.0 6.9 12.1 7.7 4.2 9.5 9.1 6.8 4.7 8.0 9.0 7.3 11.0 17.8 12.6 9.5 4.5 17.1 8.7 12.4 5.5 8.0 13.6 8.0 9.2 19.0 8.1 6.2 7.1 5.7 7.8 9.5 8.5 17.9 12.9 6.1 8.7 14.7 11.6 12.9 15.2 9.2 3.5 24.8 8.2 13.9 5.2 5.5 22.8 20.1 6.1 6.4 25.4 6.2 7.5 5.8 5.3 27.9 7.4 12.5 11.6 9.3 18.8 7.2 5.5 20.1 3.4 28.3 7.9 5.4 11.3 13.7 17.6 14.3 4.8 6.7 13.9 14.0 19.2 28.1 8.9 19.5 9.9 3.5 8.1 5.4 3.4 8.7 3.7 19.0 16.1 7.5 10.5 32.5 7.7 9.4 11.5 6.6 7.0 9.1 7.2 19.9 28.9 14.0 7.8 8.5 8.2 9.8 9.4 16.3 11.1 28.8 6.8 3.7 4.2 2.5 3.3 3.1 2.8 4.9 2.7 2.7 3.0 5.3 3.0 2.5 1.1 2.2 5.4 5.9 2.3 1.2 5.6 13.1 10.3 9.1 4.7 8.0 12.6 9.5 4.5 13.6 8.5 8.7 24.8 92.5 67.3 61.6 161.6 108.5 18.6 32.3 33.1 26.7 84.9 41.8 24.5 75.2 25.8 83.2 57.0 146.0 14.8 141.1 16.7 9.8 36.7 6.4 92.9 79.6 57.3 53.0 30.7 182.8 29.6 8.3 56.2 83.1 118.9 89.7 51.8 43.2 22.7 31.3 124.5 272.2 29.9 44.7 71.0 58.1 7.3 50.4 107.2 35.6 148.9 118.5 29.6 84.5 217.1 291.3 26.7 21.0 51.6 83.9 25.2 21.6 12.3 113.1 84.5 32.9 86.5 66.9 20.8 20.4 5.9 23.3 8.2 98.8 88.2 23.9 28.3 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206079 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 92.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 184.3;non-classical monocyte: 216.9" "Lineage enriched" "Detected in many" 7 "monocytes: 216.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 5.3 5.2 2.5 14.7 2.4 4.6 3.2 3.6 3.8 9.3 10.2 70.8 92.7 3.3 1.4 2.1 19.5 18.8 1.1 2.8 3.0 29.4 15.1 5.2 3.9 2.5 2.7 2.5 1.7 7.0 0.9 3.6 5.4 2.8 6.2 65.4 4.3 2.2 4.4 3.4 4.8 76.6 7.4 2.1 5.9 15.7 3.3 2.5 4.5 1.6 0.7 4.0 3.5 2.3 2.9 3.4 11.6 7.9 4.8 1.6 1.7 5.7 2.2 2.3 4.8 3.0 22.1 29.8 3.7 3.0 1.9 3.7 15.1 18.2 2.8 2.0 3.3 16.9 6.7 21.6 7.9 3.5 5.8 14.7 1.6 4.4 1.8 3.4 3.0 5.9 10.8 6.2 3.9 0.7 10.2 14.5 12.6 8.5 24.1 3.4 30.1 8.1 8.2 1.3 6.0 4.4 4.3 3.5 3.2 9.9 3.1 2.8 12.6 3.5 5.0 4.5 9.2 8.7 14.4 9.4 10.0 3.3 14.9 2.2 0.1 43.7 0.2 0.1 184.3 0.6 0.6 0.6 0.2 29.1 0.1 0.5 0.3 21.3 0.0 216.9 1.4 0.4 18.3 2.5 2.4 3.6 3.8 2.8 3.0 2.5 2.7 2.5 2.8 2.1 2.5 2.9 1.3 0.0 1.5 3.3 0.7 1.5 0.8 2.8 1.8 11.1 0.4 0.1 0.3 12.8 15.8 3.7 0.0 0.5 0.3 49.2 0.0 2.5 6.5 9.4 0.6 6.4 7.7 1.3 3.8 4.3 0.5 3.2 31.6 0.4 0.0 0.4 5.0 8.1 3.9 8.4 4.0 17.1 0.0 11.7 1.5 0.5 3.7 8.1 0.0 4.7 3.9 2.0 2.1 3.0 3.4 3.0 39.3 6.8 2.4 1.1 36.2 25.4 107.8 3.1 0.0 1.1 0.7 0.0 0.4 1.3 2.0 0.1 1.2 0.1 21.1 1.1 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173710-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 204.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0" "Region enriched" "Detected in all" 5 "olfactory bulb: 118.0" "Region enriched" "Detected in all" 5 "spinal cord: 124.7" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 130000000 "Plasma membrane" "Golgi apparatus" "HPA040326: AB_2676928, HPA050811: AB_2681243" "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 78.5 17.7 3.9 5.6 8.2 0.0 67.5 1.1 11.9 204.0 9.7 57.2 5.7 182.9 19.1 17.2 79.4 38.9 49.3 3.9 11.9 20.8 8.2 38.1 10.0 4.5 3.1 3.5 172.3 10.2 2.1 44.9 10.3 3.2 51.8 5.3 0.3 33.9 23.1 18.7 40.1 31.6 26.6 1.5 33.3 32.8 15.0 3.5 3.4 63.9 19.9 5.3 64.0 112.8 5.2 0.0 1.5 0.1 0.0 62.7 33.5 0.2 10.2 0.1 0.0 0.0 0.0 4.0 0.0 0.6 148.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 25.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.5 5.8 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.4 7.6 0.1 0.1 1.1 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.2 1.1 11.9 3.9 11.9 4.5 3.1 3.5 3.2 1.5 3.5 5.2 10.3 0.0 1.3 0.7 0.1 11.7 0.1 0.2 0.0 0.1 4.8 3.9 3.9 1.5 0.7 0.0 0.0 1.3 0.8 0.0 0.0 0.2 2.4 7.2 193.5 14.0 0.0 0.0 1.9 0.2 1.4 154.5 2.0 4.2 0.0 0.0 7.5 0.0 3.8 0.0 0.2 0.0 0.0 0.0 16.2 6.1 214.9 2.6 12.4 34.7 0.0 0.2 0.0 0.5 0.7 0.8 0.0 159.9 0.0 0.1 0.0 0.1 1.5 0.5 26.3 7.0 49.8 0.7 0.7 1.3 8.8 1.0 2.6 7.0 0.0 0.2 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892433 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "U-2197: 40.4" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 1.7 2.2 5.1 1.4 5.6 0.1 1.9 6.5 7.4 2.4 3.0 2.2 2.4 2.1 1.8 2.0 3.2 1.5 4.8 4.6 5.7 3.0 2.1 1.8 1.0 5.6 6.0 4.4 3.7 1.9 5.2 1.8 1.8 5.9 3.0 1.9 10.9 1.9 3.1 2.3 1.3 1.3 2.0 5.3 0.9 3.0 3.5 6.6 0.9 3.6 2.3 0.9 2.7 1.4 6.1 7.3 12.6 7.7 9.8 4.1 5.0 0.1 13.5 6.1 11.4 13.5 2.0 9.5 0.0 8.2 3.8 14.3 11.3 16.2 3.7 10.2 0.0 8.3 2.6 6.2 0.9 2.0 0.7 5.2 1.6 5.1 6.5 6.2 7.9 5.8 0.0 0.9 0.0 8.3 5.7 0.0 2.9 11.2 5.2 5.3 0.0 9.9 0.3 5.1 5.9 8.6 8.9 9.3 3.9 6.5 7.5 4.6 6.3 4.3 7.9 5.6 40.4 9.6 3.4 4.3 0.0 5.0 0.9 11.6 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.4 4.2 0.0 0.2 0.1 5.1 5.6 6.5 7.4 4.6 5.7 5.6 6.0 4.4 5.9 5.3 6.6 6.1 3.5 0.0 0.5 0.0 0.5 1.8 4.1 2.4 1.2 17.5 2.0 2.0 6.1 1.5 2.0 11.0 0.0 0.2 0.0 2.5 9.8 3.0 12.6 5.5 1.9 2.7 3.0 0.4 3.0 1.1 0.3 2.4 1.1 1.1 0.0 2.1 1.4 1.8 1.3 1.7 4.0 1.5 8.2 0.6 1.0 7.8 2.5 0.7 0.0 0.0 0.1 5.2 0.0 1.0 4.7 0.8 5.3 4.9 1.2 2.2 0.6 6.8 5.4 4.6 0.0 1.5 2.9 19.3 2.7 2.6 1.4 0.1 0.2 1.8 2.9 4.2 LOXL1 "LOL, LOXL" ENSG00000129038 "Lysyl oxidase like 1" Q08397 15 73925989-73952137 "Disease related genes, Plasma proteins, Predicted secreted proteins" Oxidoreductase Glaucoma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 92.3;Extravillous trophoblasts: 145.8;Fibroblasts: 76.0;Smooth muscle cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 3.4" "Lineage enriched" "Detected in single" 34 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "BJ: 66.5;BJ hTERT+: 75.2;hTERT-RPE1: 73.7;U-87 MG: 61.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042111, HPA063583" Approved Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" No No 280000 "Endoplasmic reticulum" "HPA042111: AB_10794412, HPA063583: AB_2685050" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (9.52e-5)" "unprognostic (7.95e-2)" "unprognostic (2.49e-1)" "unprognostic (2.44e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (9.83e-2)" "unprognostic (1.14e-3)" "unprognostic (4.51e-2)" "unprognostic (5.81e-2)" "unprognostic (1.41e-2)" "unprognostic (9.76e-2)" 10.6 3.2 1.7 5.5 0.9 0.8 6.9 0.2 1.2 12.0 10.8 8.0 1.9 16.1 1.5 4.8 8.4 5.1 25.2 1.8 1.6 8.7 1.5 10.2 4.4 1.4 1.4 0.7 8.1 3.3 2.2 9.3 8.1 1.0 15.5 1.4 0.0 7.7 12.0 3.8 5.8 5.6 5.0 0.9 3.2 7.9 2.4 1.4 0.9 5.2 1.9 2.4 16.8 15.0 0.6 3.3 0.0 0.9 0.0 45.6 54.8 2.2 66.5 75.2 27.6 48.7 1.3 1.7 0.0 12.1 49.1 6.9 19.9 0.3 0.2 6.5 0.0 4.3 0.2 2.0 0.3 6.2 0.0 0.1 45.0 0.0 20.8 0.2 73.7 1.0 1.2 0.0 0.3 33.3 2.4 0.4 1.3 6.3 4.4 45.1 0.0 38.7 0.6 2.5 12.0 5.5 0.0 2.0 0.4 0.0 6.5 0.4 0.0 4.9 53.8 47.0 42.8 25.8 0.2 0.0 0.0 61.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.9 0.0 1.3 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 3.4 0.2 1.7 0.9 0.2 1.2 1.8 1.6 1.4 1.4 0.7 1.0 0.9 1.4 0.6 4.1 0.0 0.6 3.3 0.1 5.9 7.6 6.0 4.0 0.9 2.3 4.8 92.3 2.8 0.9 9.2 0.0 2.2 0.6 0.1 3.9 5.2 1.7 9.2 8.0 4.1 3.5 0.0 0.5 1.3 145.8 76.0 8.6 9.3 1.3 5.5 12.1 0.1 6.6 0.0 0.4 0.6 2.0 0.0 6.2 1.3 9.9 0.9 10.6 0.0 0.1 6.4 0.0 1.5 0.3 12.2 0.1 21.1 0.1 4.8 0.4 2.5 1.2 0.4 0.0 6.0 32.7 8.9 4.9 2.4 3.4 5.1 3.4 0.3 1.1 5.0 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597270-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Fibroblasts: 21.4;Proximal enterocytes: 19.1;Respiratory ciliated cells: 15.7" "Cancer enhanced" "Detected in many" "stomach cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 285.1" "Group enriched" "Detected in some" 7 "cerebellum: 4.7;pons and medulla: 1.5" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 7.6 1.4 0.6 1.0 0.2 0.8 5.6 0.3 0.4 0.6 0.7 1.8 15.9 3.7 1.7 1.5 2.0 6.6 5.1 0.4 0.3 1.1 1.0 8.1 2.1 0.4 0.4 0.1 1.0 2.6 0.0 6.8 0.2 0.2 0.5 1.3 0.6 7.1 2.0 0.5 8.5 13.1 2.2 0.4 1.6 10.3 0.4 0.1 0.5 1.4 1.0 1.7 4.7 1.1 0.3 0.2 0.0 0.2 0.2 19.9 10.7 0.1 47.7 285.1 2.8 7.9 0.2 0.4 3.3 0.0 29.9 0.2 0.1 0.0 0.0 1.8 1.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 1.3 0.0 0.0 4.9 0.1 0.2 0.6 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.0 0.5 0.1 0.7 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.4 0.4 0.3 0.4 0.4 0.1 0.2 0.4 0.1 0.3 1.6 38.5 1.1 0.7 0.1 6.5 0.6 1.3 0.0 1.6 0.3 0.3 0.7 1.5 2.3 5.5 6.2 0.2 0.1 1.1 0.0 0.2 2.9 2.9 0.6 3.9 0.0 0.0 0.6 12.1 0.1 21.4 10.7 0.6 0.0 0.7 9.7 0.2 0.4 1.7 0.5 0.8 0.0 0.3 5.1 0.4 2.1 0.3 1.8 1.9 6.8 0.9 0.0 0.0 0.3 5.1 0.1 2.6 0.5 0.4 19.1 3.0 15.7 3.4 0.0 1.3 2.6 0.1 0.1 0.6 6.5 0.3 0.5 12.5 3.7 1.2 ANAPC13 "APC13, DKFZP566D193, SWM1" ENSG00000129055 "Anaphase promoting complex subunit 13" Q9BS18 3 134477706-134486716 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 463.7;Proximal tubular cells: 373.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046114 Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA046114: AB_10961429" "unprognostic (2.84e-2)" "prognostic favorable (1.66e-4)" "unprognostic (2.98e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (3.57e-1)" "unprognostic (2.90e-1)" "unprognostic (2.28e-3)" "unprognostic (6.44e-2)" "unprognostic (4.36e-1)" "prognostic favorable (2.66e-7)" "unprognostic (3.10e-1)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.16e-1)" 57.2 74.0 59.2 29.3 60.7 30.3 66.6 62.5 69.2 49.5 76.1 40.5 35.5 47.2 115.4 35.4 48.6 48.5 99.4 60.2 67.0 122.4 87.5 45.8 39.1 64.3 64.3 57.6 52.6 50.5 77.9 64.2 51.5 65.1 60.6 46.3 63.1 54.2 54.9 87.8 38.4 34.1 48.6 62.8 40.4 54.8 29.6 62.7 36.1 96.5 68.6 36.9 51.8 33.6 63.2 91.9 56.2 87.4 74.9 144.7 191.6 67.5 116.0 106.4 83.4 77.9 70.6 52.9 61.9 244.8 172.2 100.1 53.0 82.6 83.6 119.9 31.7 37.7 63.3 43.2 119.3 104.6 104.2 43.5 127.7 90.3 83.5 155.1 93.4 130.9 59.3 85.9 51.2 266.9 117.3 53.5 103.1 59.8 157.7 54.5 42.6 68.5 113.7 165.3 56.0 35.4 58.0 103.2 37.8 107.4 92.8 94.2 101.6 91.9 115.2 47.0 164.1 52.2 56.2 65.6 127.3 71.4 57.4 100.9 112.9 96.6 86.5 52.7 108.2 69.7 86.1 78.7 69.9 91.8 68.9 94.2 80.7 236.4 67.6 111.4 70.1 72.9 84.8 59.2 60.7 62.5 69.2 60.2 67.0 64.3 64.3 57.6 65.1 62.8 62.7 63.2 46.6 35.3 47.0 3.6 41.7 42.1 47.6 72.2 47.8 41.0 60.8 49.9 112.8 67.2 41.7 84.6 12.5 95.8 26.8 22.1 463.7 51.5 42.5 38.1 39.5 51.8 40.8 26.3 7.0 53.8 96.6 57.2 38.2 28.9 18.9 34.5 53.6 64.5 78.7 20.2 8.3 40.6 77.3 71.3 48.8 104.6 50.7 43.8 97.8 6.5 33.4 85.0 42.2 4.0 6.3 39.5 42.6 44.0 46.0 74.7 54.6 373.4 49.3 38.3 19.7 26.6 58.5 46.2 64.2 44.3 50.6 70.3 35.4 59.5 35.4 52.9 MBD4 MED1 ENSG00000129071 "Methyl-CpG binding domain 4, DNA glycosylase" O95243 3 129430947-129440179 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002031 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA002031: AB_1079319" "unprognostic (2.70e-2)" "unprognostic (3.48e-3)" "unprognostic (1.18e-2)" "unprognostic (6.37e-2)" "unprognostic (4.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.70e-2)" "unprognostic (3.25e-2)" "unprognostic (2.02e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.73e-6)" "unprognostic (9.27e-2)" "unprognostic (1.59e-2)" "unprognostic (8.58e-2)" "unprognostic (3.35e-2)" 18.4 18.6 18.2 34.3 20.1 44.6 21.8 21.4 20.7 33.4 18.3 19.5 23.9 23.6 25.0 16.5 19.5 21.5 22.9 18.8 20.9 23.1 38.3 23.1 67.0 18.8 19.1 17.9 30.6 23.1 18.2 19.4 19.9 20.5 18.9 23.1 19.8 19.7 18.0 26.1 23.9 27.7 19.9 19.1 39.5 28.1 17.5 19.8 30.3 19.5 22.5 74.6 18.7 17.6 21.4 46.2 27.4 32.5 36.5 36.8 32.8 37.5 39.0 36.9 36.7 43.3 33.8 30.1 64.6 31.1 24.5 33.7 40.7 25.2 24.1 44.2 37.0 16.6 38.9 32.0 24.6 58.7 71.2 49.2 39.1 33.8 31.2 27.4 36.5 35.1 37.2 43.9 47.1 27.5 43.3 41.4 50.0 28.7 38.8 23.5 38.7 19.2 44.7 40.9 22.7 36.5 20.3 49.3 25.3 42.5 28.0 32.3 62.5 23.6 34.5 26.3 37.6 26.2 31.9 20.9 111.9 29.4 40.1 29.2 80.3 25.0 35.2 31.1 23.1 24.0 116.5 33.2 30.9 21.0 110.8 40.6 33.3 43.0 28.9 30.0 25.2 31.5 25.6 18.2 20.1 21.4 20.7 18.8 20.9 18.8 19.1 17.9 20.5 19.1 19.8 21.4 36.5 19.2 52.9 15.3 111.2 17.3 32.5 38.4 29.6 37.0 26.7 29.6 35.9 27.1 36.4 44.1 18.8 49.2 61.4 22.4 45.0 32.1 19.8 49.6 41.2 33.5 33.6 46.3 18.1 69.0 46.2 35.6 55.0 45.0 58.9 33.1 31.4 32.1 71.8 21.9 12.8 27.5 40.7 41.8 24.7 10.6 32.9 48.0 21.4 24.4 62.9 21.2 54.6 14.1 22.0 39.3 23.4 36.5 75.5 31.1 29.4 55.5 39.5 46.3 39.5 39.6 30.9 49.5 71.6 30.4 19.6 37.1 54.2 33.2 26.3 35.6 COPB1 COPB ENSG00000129083 "COPI coat complex subunit beta 1" P53618 11 14443440-14500027 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" NA NA 330000 "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258" "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.91e-4)" "prognostic unfavorable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 48.5 47.5 20.9 55.5 22.7 80.5 63.3 27.1 25.5 65.5 42.4 60.3 58.3 53.1 69.9 47.1 49.6 55.4 44.1 20.5 29.8 65.9 74.2 50.3 59.6 25.1 23.6 20.0 49.6 59.7 68.2 48.8 69.8 24.3 67.5 67.7 39.6 68.1 54.3 33.4 36.7 59.3 61.6 24.4 46.7 60.3 47.2 23.3 68.7 81.7 38.4 65.0 61.0 40.3 28.5 134.9 113.6 118.6 89.4 193.1 221.3 95.9 199.2 206.5 173.1 202.0 89.1 203.5 130.1 87.1 252.9 164.6 144.7 134.6 133.3 212.1 122.7 114.0 138.3 74.3 135.8 171.3 128.9 134.4 156.3 172.4 116.0 217.8 158.9 183.7 71.6 104.5 103.8 221.1 101.6 117.2 78.7 61.7 163.3 123.1 94.9 163.1 89.0 156.1 123.3 75.6 81.2 154.2 123.2 104.8 135.5 112.3 110.1 189.5 166.2 85.4 181.3 110.1 55.2 100.5 143.8 125.1 79.2 158.6 52.8 38.7 43.5 45.7 47.8 55.7 38.4 38.1 47.6 52.3 32.0 37.8 39.8 31.2 44.6 49.8 31.1 44.8 43.2 20.9 22.7 27.1 25.5 20.5 29.8 25.1 23.6 20.0 24.3 24.4 23.3 28.5 55.6 109.0 63.2 29.0 64.3 38.9 59.7 82.6 52.3 28.4 43.0 27.9 31.3 35.8 107.8 44.1 27.1 65.4 71.2 55.9 41.1 77.1 17.2 72.6 81.4 55.5 43.8 50.9 36.9 81.7 69.6 70.5 63.2 72.5 65.2 50.7 51.4 58.1 60.9 18.5 39.1 87.5 61.1 50.7 43.5 10.7 51.0 61.5 21.4 35.6 70.1 34.0 44.3 32.6 49.6 93.6 37.5 55.3 107.4 54.3 60.6 57.3 131.9 29.5 52.6 60.8 78.7 87.5 64.3 48.7 35.8 117.0 77.0 49.3 51.5 60.7 PSMA1 "HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30" ENSG00000129084 "Proteasome 20S subunit alpha 1" P25786 11 14504874-14643635 "Enzymes, Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033765, HPA037646, HPA043891, CAB079995" Supported Supported "Nucleoplasm,Nuclear bodies,Centrosome" NA NA 20000000 Nucleoplasm "Nuclear bodies, Centrosome" "CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718" "unprognostic (1.72e-2)" "unprognostic (4.97e-2)" "unprognostic (7.33e-2)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (6.66e-3)" "prognostic unfavorable (3.79e-5)" "unprognostic (3.28e-3)" "unprognostic (7.44e-2)" "unprognostic (3.43e-3)" "unprognostic (8.27e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (4.03e-11)" "unprognostic (1.93e-1)" "unprognostic (1.69e-1)" "unprognostic (4.66e-2)" "unprognostic (1.23e-2)" 88.0 86.3 52.9 95.7 57.4 137.0 97.2 54.9 68.8 77.4 59.2 93.4 97.3 81.4 108.9 95.6 80.1 80.3 141.8 57.1 61.8 99.3 140.3 78.2 115.9 55.9 56.0 54.1 80.1 55.0 79.2 50.8 113.9 57.2 82.4 102.9 63.8 75.0 86.6 170.0 81.2 86.8 96.9 56.8 76.2 76.4 56.7 58.9 123.3 89.2 154.0 110.8 112.2 56.5 61.9 408.8 279.8 227.8 275.7 223.7 225.5 193.3 232.9 305.2 348.3 283.9 244.2 500.1 349.5 262.1 248.6 315.4 303.1 259.3 290.1 328.3 344.0 389.6 220.4 190.5 326.1 291.0 355.3 277.5 217.8 171.6 188.9 390.7 252.7 347.0 271.6 398.9 283.4 315.2 277.8 334.0 319.5 191.6 340.5 414.1 223.3 336.1 217.5 313.0 304.7 188.2 119.3 246.6 273.9 229.0 233.8 164.4 222.9 272.0 226.2 222.9 402.7 295.4 123.3 366.1 319.9 334.8 291.1 296.6 115.5 191.2 47.5 97.7 139.8 128.0 104.1 110.8 109.7 243.3 95.3 98.5 94.4 36.3 145.1 137.5 138.7 154.9 235.8 52.9 57.4 54.9 68.8 57.1 61.8 55.9 56.0 54.1 57.2 56.8 58.9 61.9 119.0 83.3 90.2 64.3 101.7 142.9 231.2 365.7 76.2 50.3 105.7 125.9 0.0 82.9 176.1 88.3 18.8 469.5 135.3 49.2 256.3 228.5 75.5 84.0 94.0 135.5 40.1 163.9 56.8 233.1 370.6 128.5 66.8 79.8 78.2 134.7 95.3 127.9 292.9 57.2 66.3 63.6 231.9 161.8 170.5 36.3 116.5 153.6 144.1 122.7 263.7 111.6 168.9 64.8 35.3 223.2 88.6 127.5 112.1 209.1 135.0 257.1 115.1 54.8 85.5 99.2 129.8 174.9 80.1 114.3 151.9 627.3 130.7 137.2 97.1 248.1 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" Yes No 750000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favorable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.71e-4)" 64.7 65.1 25.9 43.4 29.0 51.9 58.0 29.4 27.4 92.1 43.9 68.1 90.0 58.0 65.4 47.2 103.5 71.2 30.6 24.3 37.4 94.2 95.6 72.2 50.6 34.9 29.7 22.5 60.2 92.6 116.7 32.1 45.9 31.8 80.0 69.8 11.1 70.1 77.8 22.5 47.9 75.0 58.2 30.0 57.5 93.5 24.0 29.1 58.1 92.1 21.6 51.8 57.7 44.0 35.7 352.3 102.9 46.0 211.8 214.4 147.5 68.9 114.5 156.1 92.6 114.5 57.2 278.0 57.1 96.5 162.4 90.4 172.3 27.4 131.3 61.1 90.6 42.9 36.4 63.5 54.2 138.4 89.7 108.7 116.8 124.5 83.7 143.3 186.9 137.7 101.4 116.4 236.6 151.3 76.8 77.2 115.7 63.5 272.0 52.2 61.5 45.4 359.0 127.7 39.1 54.0 65.6 142.4 294.2 140.9 98.9 294.5 144.5 115.2 85.6 121.1 211.1 98.6 160.8 130.8 84.0 139.7 165.7 283.2 58.1 60.3 22.0 71.1 80.5 90.9 59.8 70.9 71.8 72.3 49.1 75.3 75.2 4.4 49.0 90.3 132.6 82.7 90.2 25.9 29.0 29.4 27.4 24.3 37.4 34.9 29.7 22.5 31.8 30.0 29.1 35.7 44.0 57.7 30.5 20.5 47.3 33.8 44.1 46.1 39.9 25.7 57.9 25.4 10.4 87.2 31.0 90.1 14.6 44.5 85.3 45.1 19.6 95.3 3.8 93.1 70.2 43.7 59.3 41.7 21.2 55.7 96.7 54.7 55.5 78.9 54.5 47.0 51.0 91.3 68.1 43.7 24.4 61.8 22.4 79.8 38.7 8.0 69.6 50.4 53.4 14.0 73.0 23.8 70.0 10.6 24.2 48.4 64.6 47.4 65.0 50.7 91.8 45.6 34.5 13.5 52.6 41.6 44.1 31.6 28.6 52.8 41.9 46.7 52.7 58.7 85.8 42.7 PALLD "CGI-151, KIAA0992, SIH002" ENSG00000129116 "Palladin, cytoskeletal associated protein" Q8WX93 4 168497052-168928457 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 527.9;Cardiomyocytes: 591.7;Peritubular cells: 399.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 304.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035905, CAB070159" Enhanced Supported "Plasma membrane,Actin filaments,Mitochondria,Cytosol" No No 27000 "Actin filaments" "Plasma membrane, Mitochondria, Cytosol" "CAB070159: AB_1726016, HPA035905: AB_2674854" "unprognostic (3.59e-2)" "unprognostic (3.99e-1)" "unprognostic (2.55e-2)" "unprognostic (5.03e-3)" "unprognostic (2.51e-1)" "unprognostic (7.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.40e-2)" "unprognostic (3.57e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (3.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.28e-4)" 56.8 35.8 33.8 50.1 22.4 0.9 43.9 13.6 19.0 146.5 2.0 218.6 29.3 304.0 22.1 123.7 119.5 71.6 161.8 27.5 54.2 42.5 12.5 72.3 17.0 32.8 17.9 12.9 62.6 13.3 56.0 11.4 62.6 23.0 138.2 75.6 12.9 41.1 207.6 128.7 31.9 64.6 305.8 21.4 61.0 95.6 35.4 24.7 23.5 39.0 47.7 16.8 282.5 86.0 28.4 82.1 39.6 87.9 53.4 77.2 83.9 123.6 53.7 137.6 47.2 66.7 1.1 4.6 36.6 14.4 23.7 29.0 17.0 54.1 138.8 60.5 73.9 16.6 0.8 112.5 10.4 135.5 0.4 1.0 132.8 84.4 85.5 125.4 115.0 20.8 19.7 0.1 0.5 304.5 3.8 23.8 1.4 24.9 20.8 24.1 8.3 81.4 0.8 5.3 16.4 9.0 46.4 102.8 8.1 7.3 151.2 48.6 0.5 64.4 50.3 192.1 20.7 90.1 47.8 0.7 1.7 41.6 1.0 14.2 13.7 3.1 0.0 4.6 1.8 0.2 0.1 0.5 2.4 2.1 0.1 0.6 1.6 0.7 0.6 1.2 0.2 0.8 1.8 33.8 22.4 13.6 19.0 27.5 54.2 32.8 17.9 12.9 23.0 21.4 24.7 28.4 22.7 32.1 9.4 167.8 1.5 93.6 527.9 56.8 76.8 6.0 46.0 107.9 591.7 20.0 58.7 44.1 18.8 52.1 8.1 20.9 1.9 27.6 133.1 52.8 181.2 27.7 44.8 0.8 27.8 51.3 115.6 130.5 59.7 51.0 52.6 21.0 47.8 11.2 24.5 26.9 108.4 30.7 18.3 28.9 23.8 146.4 130.1 36.7 23.2 16.9 52.9 55.1 17.5 182.4 6.5 83.0 18.6 399.4 2.6 167.6 9.8 23.4 85.2 4.0 177.5 115.4 227.8 81.0 7.6 34.1 49.3 22.3 9.2 13.4 29.3 113.0 SPCS3 "FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W" ENSG00000129128 "Signal peptidase complex subunit 3" P61009 4 176319966-176332245 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 670.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 374.4" "Low region specificity" "Detected in all" HPA053180 Approved NA NA "HPA053180: AB_2682071" "unprognostic (4.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.20e-3)" "prognostic favorable (8.89e-6)" "unprognostic (1.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.79e-2)" "unprognostic (4.78e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.26e-1)" "unprognostic (4.92e-2)" "unprognostic (2.16e-2)" "unprognostic (1.44e-1)" 33.3 24.9 17.0 51.1 18.3 68.8 36.3 17.1 19.6 47.0 17.2 37.4 34.8 38.9 47.9 25.2 25.7 32.3 38.0 18.7 18.0 34.4 43.9 36.5 50.7 19.0 27.2 16.8 21.8 73.5 31.5 30.4 45.9 18.1 33.2 37.9 13.6 99.9 30.2 24.3 27.1 37.2 35.1 20.2 46.9 49.3 10.8 17.8 35.1 62.7 26.7 48.6 41.5 25.8 23.5 64.9 21.5 57.8 47.8 80.9 142.5 61.0 125.2 119.1 71.4 61.4 23.5 139.1 124.2 25.1 72.7 37.6 43.6 55.3 92.1 108.0 84.2 24.3 107.6 32.2 53.5 82.5 162.3 90.9 86.9 99.4 63.4 60.9 79.8 107.1 59.4 70.2 374.4 99.4 39.7 100.1 61.4 39.5 45.6 21.0 48.7 89.8 109.3 87.7 46.5 46.1 42.2 130.6 96.4 58.8 49.8 31.1 75.1 100.2 52.5 52.8 47.4 58.2 172.3 54.7 153.8 112.0 80.6 74.1 43.0 16.1 14.2 15.2 19.3 20.2 10.0 14.0 13.9 12.2 6.8 11.6 14.5 16.2 16.6 16.1 22.6 11.9 19.2 17.0 18.3 17.1 19.6 18.7 18.0 19.0 27.2 16.8 18.1 20.2 17.8 23.5 121.4 54.5 86.3 19.2 150.0 57.2 67.4 111.8 25.0 31.3 62.9 52.1 79.5 32.9 84.1 29.5 27.1 64.1 170.0 55.2 21.5 76.4 66.8 49.3 130.6 109.3 44.9 61.4 40.9 136.1 205.1 66.2 70.3 102.2 91.2 36.3 88.9 123.8 153.2 23.5 37.3 102.1 89.5 100.8 98.4 14.4 22.4 127.9 110.3 29.0 105.8 31.2 74.2 41.2 59.1 157.0 36.0 17.0 670.6 173.8 48.1 71.6 54.5 31.0 13.1 46.4 64.8 95.4 56.4 58.7 65.1 184.4 107.0 51.8 53.3 147.1 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 472.3;liver: 133.0" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 1623.0" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTCEpi: 13.7;RPTEC TERT1: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" NA NA 35000 Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 1.4 0.0 23.8 0.0 22.3 0.0 25.3 29.8 34.2 2.7 16.9 0.2 0.0 0.1 8.1 17.7 9.0 9.7 0.0 22.4 24.7 472.3 133.0 0.3 0.1 28.0 28.7 20.9 0.0 0.8 0.0 7.0 0.3 32.7 0.6 0.0 0.4 6.2 4.1 0.9 52.3 0.0 0.0 27.9 0.0 0.2 0.1 26.8 1.1 9.7 0.0 0.6 0.1 11.4 26.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 13.7 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.2 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 22.3 29.8 34.2 22.4 24.7 28.0 28.7 20.9 32.7 27.9 26.8 26.3 0.1 0.0 0.6 66.3 5.3 8.2 9.0 80.9 0.6 0.0 16.3 11.0 0.0 15.7 18.1 46.0 0.0 0.3 0.2 0.0 223.0 0.7 1.1 10.3 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.4 27.9 0.0 0.0 0.8 0.0 12.2 0.6 1.1 1.1 0.0 7.1 1.8 4.7 0.0 13.8 0.0 2.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 1623.0 9.4 0.4 0.0 0.0 1.4 0.0 0.6 16.9 35.8 0.3 5.0 0.0 0.0 2.6 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719571-17722136 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 36.4" "Group enriched" "Detected in some" 9 "Skeletal myocytes: 10.0;Spermatogonia: 3.8" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 461.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 461.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERGEF "DelGEF, Gnefr" ENSG00000129158 "Secretion regulating guanine nucleotide exchange factor" Q9UGK8 11 17788048-18013047 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 155.4;Excitatory neurons: 114.9;Inhibitory neurons: 123.9;Late spermatids: 258.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037811, HPA037812, HPA074086" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658" "unprognostic (2.67e-2)" "unprognostic (7.15e-2)" "unprognostic (7.00e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (5.67e-4)" "unprognostic (6.94e-2)" "unprognostic (1.30e-3)" "unprognostic (1.87e-1)" "unprognostic (3.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.74e-3)" "unprognostic (5.56e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.43e-1)" "unprognostic (1.24e-2)" "unprognostic (5.82e-2)" 15.9 17.6 36.5 9.4 39.0 6.4 16.5 51.7 45.0 19.0 33.5 21.0 7.5 17.0 18.6 12.6 16.6 10.0 17.2 40.6 40.8 19.7 14.1 14.1 10.8 38.8 44.8 37.5 27.7 23.3 17.2 37.1 5.7 42.6 21.4 12.4 22.7 15.3 18.2 22.9 19.5 14.0 16.5 35.4 12.9 19.9 5.0 40.4 12.4 28.0 21.9 13.6 21.7 17.8 41.4 10.8 13.2 10.6 22.3 19.1 18.6 7.2 9.0 18.3 9.5 12.0 8.5 3.7 9.5 11.0 12.2 26.1 14.5 37.3 27.6 7.5 21.0 37.7 15.3 10.6 36.3 21.5 13.5 16.6 17.7 27.4 4.8 20.4 28.6 10.5 20.8 9.2 17.6 15.2 16.0 14.0 30.0 8.9 33.7 16.2 18.3 13.0 10.0 21.2 16.1 27.1 5.9 15.8 16.1 17.1 21.1 7.2 12.1 6.2 8.9 12.1 13.1 10.2 12.3 16.1 12.9 15.5 15.4 10.2 15.6 21.3 17.1 34.5 17.6 28.6 25.5 35.5 25.8 26.1 18.7 34.8 30.5 2.3 22.4 17.5 10.5 41.4 25.9 36.5 39.0 51.7 45.0 40.6 40.8 38.8 44.8 37.5 42.6 35.4 40.4 41.4 12.7 6.4 6.8 58.4 14.3 26.5 25.3 30.5 15.9 14.1 18.5 20.8 11.6 10.0 13.6 11.0 2.1 6.4 14.4 7.8 39.2 17.1 155.4 3.3 5.1 9.0 48.5 7.4 114.9 24.5 12.5 14.4 4.6 5.2 14.5 26.7 12.5 14.7 14.3 11.8 123.9 14.7 34.6 17.8 14.9 258.3 19.6 9.3 21.4 44.0 12.9 31.7 17.5 82.9 46.5 14.0 9.8 21.4 11.6 18.7 12.3 46.0 7.6 10.9 6.6 13.3 16.9 9.0 7.6 8.7 20.2 3.1 18.2 15.6 13.0 20.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 46.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2" "Group enriched" "Detected in some" 5 "glioma: 1.1;testis cancer: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.1 0.8 0.9 0.1 2.9 0.9 0.2 40.9 46.7 0.9 0.0 0.3 0.3 0.3 0.0 0.2 0.1 0.2 0.1 4.9 6.4 0.1 0.2 0.1 0.2 7.9 4.9 4.2 0.2 0.4 0.0 2.2 0.0 15.5 0.2 0.1 7.0 0.3 0.0 0.5 0.5 0.3 0.0 0.0 0.2 0.3 1.4 13.5 0.1 0.3 1.2 0.0 0.3 0.5 19.8 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.9 0.0 0.1 0.2 1.1 0.3 1.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.2 0.2 0.4 0.7 0.0 0.0 0.4 3.7 0.4 0.0 0.2 3.5 2.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 1.0 0.1 0.0 0.2 0.3 0.4 0.2 0.2 0.4 3.2 0.3 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.0 0.5 0.2 0.2 1.4 0.2 0.3 0.3 0.1 0.1 0.9 2.9 40.9 46.7 4.9 6.4 7.9 4.9 4.2 15.5 0.0 13.5 19.8 0.2 0.0 0.0 5.5 1.1 0.0 0.2 0.0 0.0 79.6 0.3 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 9.5 0.2 0.5 0.4 7.7 0.0 48.2 0.2 0.0 0.3 0.0 0.3 0.0 2.8 0.0 0.0 0.0 1.7 120.2 0.0 0.0 0.0 0.0 10.2 0.3 0.2 0.0 7.5 0.6 1.5 0.0 16.1 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.7 0.0 0.2 0.5 6.1 5.0 0.0 0.0 0.0 0.6 1.8 0.0 0.0 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 21.5;intestine: 19.5;stomach 1: 15.1" "Cell type enriched" "Detected in many" 30 "Enteroendocrine cells: 1466.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Region enriched" "Detected in some" 10 "midbrain: 21.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Uncertain Uncertain Cytosol NA NA Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.5 0.1 0.3 1.2 0.4 1.1 1.3 0.3 0.4 0.5 4.2 9.1 10.2 0.9 0.9 0.2 0.9 0.1 0.3 0.4 2.1 0.3 0.2 0.8 0.5 0.3 21.5 0.3 0.7 0.5 0.1 3.1 0.2 0.5 1.5 19.5 1.8 0.5 0.1 0.4 1.5 11.3 0.2 0.2 0.7 15.1 0.9 0.6 0.4 0.5 0.1 0.7 0.4 0.4 0.4 0.1 0.0 0.5 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.6 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.5 0.2 0.4 1.0 0.7 0.3 1.1 0.0 1.5 0.3 0.0 0.6 0.0 0.2 0.1 0.2 0.8 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.9 0.0 0.1 0.4 0.1 0.5 0.0 0.1 0.3 0.0 0.3 0.4 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.3 0.4 0.4 2.1 0.3 21.5 0.3 0.5 0.2 0.6 0.4 1.4 0.0 0.0 1.0 1.1 0.4 0.4 0.5 0.0 14.9 1.9 1.0 0.8 0.0 0.1 5.5 2.1 0.2 0.6 1.7 0.0 0.2 0.8 0.1 0.6 0.7 1466.7 0.4 0.5 0.6 0.0 1.2 2.0 0.2 0.0 5.6 0.4 0.2 0.2 1.7 0.4 48.2 0.0 0.3 1.4 0.8 0.9 0.5 0.0 0.0 0.1 1.4 1.0 0.0 0.6 0.4 13.4 1.2 0.3 2.3 1.5 0.3 0.9 5.6 6.6 1.3 1.3 2.8 3.7 0.0 1.4 0.0 1.2 0.0 2.7 0.4 CSRP3 "CLP, CMD1M, MLP" ENSG00000129170 "Cysteine and glycine rich protein 3" P50461 11 19182030-19210571 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Actin-binding, Developmental protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2637.7;skeletal muscle: 1664.9;tongue: 584.1" "Cell type enriched" "Detected in some" 35 "Cardiomyocytes: 3433.6" "Cancer enriched" "Detected in some" 6 "head and neck cancer: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA042581 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 250000 Cytosol Nucleoplasm "HPA042581: AB_2678061" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-2)" "unprognostic (4.72e-2)" "unprognostic (5.99e-2)" "unprognostic (1.08e-1)" 0.3 0.2 0.2 0.0 0.1 0.1 2.8 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 39.9 0.0 0.5 2637.7 0.2 0.2 0.2 0.2 1.3 1.2 0.2 0.1 0.1 0.5 2.7 0.0 0.1 0.1 0.3 33.1 0.0 0.0 25.0 0.0 1664.9 0.3 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.7 584.1 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3433.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 28.8 0.0 0.0 0.3 6.0 0.0 79.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 95.5 32.7 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.3;lymphoid tissue: 11.9;skeletal muscle: 12.7" "Cell type enhanced" "Detected in some" "Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 0.3 0.1 0.0 2.8 0.0 14.3 0.5 0.1 0.2 1.0 0.0 4.0 3.8 0.4 0.0 4.9 0.9 0.4 2.1 0.0 0.0 0.1 0.4 0.3 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 5.1 0.0 0.9 0.2 12.7 3.0 3.0 0.6 0.0 1.3 5.7 1.7 0.0 11.9 0.1 0.4 7.4 1.8 1.3 0.4 23.3 7.2 7.1 9.8 0.4 1.1 31.7 13.0 3.7 15.3 16.4 25.4 7.8 23.5 5.5 4.3 9.0 20.2 17.2 1.6 13.5 15.9 14.9 8.0 4.1 7.1 0.0 12.7 19.2 0.3 0.1 3.1 1.0 0.9 21.0 17.2 17.6 22.1 6.3 11.6 25.8 16.6 6.9 26.3 10.1 26.9 12.8 16.0 6.6 16.8 6.0 7.0 5.5 11.3 1.3 4.0 7.7 13.7 4.2 7.3 9.0 18.3 11.8 7.7 16.2 30.6 9.0 24.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 1.1 0.1 1.3 0.0 0.0 0.3 0.1 3.8 0.0 0.5 0.0 0.0 0.9 0.8 2.5 0.0 0.0 0.4 3.3 0.8 0.8 1.2 34.1 0.1 0.0 1.7 1.0 10.2 3.3 0.0 3.1 0.0 0.0 2.4 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.2 0.0 9.7 0.1 0.4 0.2 5.6 0.0 0.0 1.5 0.9 4.0 3.1 10.0 0.3 0.3 2.2 0.5 6.3 0.9 DCTD ENSG00000129187 "DCMP deaminase" P32321 4 182890060-182917936 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035894 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035894: AB_10673488" "unprognostic (1.26e-1)" "unprognostic (9.80e-3)" "unprognostic (3.15e-2)" "unprognostic (3.78e-3)" "unprognostic (3.13e-3)" "unprognostic (2.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.59e-3)" "unprognostic (2.62e-2)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.20e-1)" "prognostic favorable (1.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-1)" 50.8 84.5 38.8 42.0 39.8 29.8 47.1 40.2 45.2 49.1 48.4 41.8 33.4 48.2 29.9 61.7 49.4 55.2 40.9 38.9 45.2 49.4 80.4 41.6 45.6 42.0 41.8 36.8 66.4 55.4 62.3 47.3 37.0 39.1 40.2 41.2 25.3 45.0 42.1 42.0 37.8 36.6 46.8 44.3 50.7 54.6 22.0 40.9 42.6 101.7 33.2 50.0 50.6 45.9 45.6 97.8 87.4 88.4 81.3 129.6 176.7 115.0 184.1 163.0 128.7 79.7 89.2 183.0 33.5 44.3 179.9 87.1 47.3 65.5 114.9 117.1 163.8 50.4 155.9 50.4 109.1 139.5 153.3 93.3 149.8 120.8 113.6 117.8 129.6 112.2 73.1 157.4 324.5 175.6 71.5 100.1 94.7 70.0 39.8 79.3 107.3 62.2 65.8 107.9 115.1 86.7 54.3 86.7 73.8 87.4 81.2 56.7 78.8 131.7 105.7 81.7 52.0 142.0 124.5 72.9 42.8 117.4 98.5 127.1 68.6 47.9 45.2 61.0 58.8 76.8 71.0 52.6 62.7 55.0 48.6 51.6 54.6 3.3 73.7 60.2 42.4 50.6 55.6 38.8 39.8 40.2 45.2 38.9 45.2 42.0 41.8 36.8 39.1 44.3 40.9 45.6 31.6 12.8 19.5 8.8 31.7 25.4 34.4 35.4 37.5 4.9 39.4 34.2 24.3 38.6 21.5 33.1 4.2 19.0 26.6 16.8 37.2 68.8 7.0 19.7 41.6 30.9 14.5 27.1 10.7 54.5 26.8 42.3 15.8 22.3 22.8 36.2 30.0 45.2 53.8 3.3 11.7 28.5 18.3 38.8 32.1 18.0 44.1 29.4 26.6 9.4 34.8 37.4 25.7 3.0 3.1 75.5 18.5 35.3 27.6 46.1 19.3 45.8 18.7 5.5 32.9 25.8 34.6 10.2 15.4 54.5 23.0 7.3 27.6 42.4 31.3 42.3 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box transcription factor 15" O60248 17 7588178-7590094 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.1;skin 1: 43.0" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 6.7;non-classical monocyte: 10.6" "Lineage enriched" "Detected in many" 5 "monocytes: 10.6" "Group enriched" "Detected in many" 8 "A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6" "Not detected" "Not detected" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 2.0 0.9 12.6 0.8 12.6 2.8 3.4 15.3 23.5 16.1 9.4 9.1 0.7 8.3 1.7 88.1 11.1 1.0 6.2 12.8 12.0 1.7 1.3 1.5 0.5 12.2 11.9 11.6 15.5 1.0 0.2 8.0 0.3 13.3 12.2 0.5 5.1 14.7 7.2 2.3 43.0 3.5 1.3 12.1 1.1 4.7 2.6 11.8 1.0 2.3 1.8 2.8 10.5 33.0 12.5 130.6 3.2 1.8 1.0 0.1 0.3 9.6 1.4 0.5 1.1 1.7 2.5 0.8 0.4 1.2 0.1 0.4 142.1 0.1 57.8 0.4 3.3 3.9 0.5 1.7 0.5 0.2 0.3 2.6 0.0 56.6 0.7 11.9 3.6 0.0 2.6 2.9 0.8 0.2 0.9 0.6 1.5 3.6 0.3 0.7 1.6 1.8 1.0 2.7 0.7 0.8 2.2 1.5 0.5 0.7 5.5 1.1 1.0 1.6 1.3 2.3 1.6 4.4 0.9 1.5 1.6 4.4 1.7 3.2 0.1 2.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 10.6 1.0 0.0 0.4 12.6 12.6 15.3 23.5 12.8 12.0 12.2 11.9 11.6 13.3 12.1 11.8 12.5 0.8 0.0 0.0 2.6 0.1 209.2 51.8 72.7 447.3 13.6 6.3 13.0 4.7 0.0 20.6 1.8 14.6 1.7 0.7 0.5 1.9 0.1 0.2 0.4 4.9 3.1 1.2 0.0 8.1 0.5 2.0 10.4 0.0 0.4 0.0 1.3 1.4 0.0 0.4 10.1 7.7 0.4 10.2 1.2 19.3 1.1 31.4 0.9 26.6 1.0 1.2 50.0 0.0 4.0 2.4 0.5 0.1 36.9 4.9 21.2 0.3 0.2 16.2 9.4 32.9 7.8 7.1 0.7 10.9 388.1 169.9 1.1 1.1 0.6 0.8 73.8 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444441-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 14.0" "Group enriched" "Detected in some" 6 "Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 161.8" "Region enhanced" "Detected in many" "white matter: 5.7" "Low region specificity" "Detected in single" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 0.4 2.5 0.3 1.3 0.1 2.5 0.8 1.0 0.4 0.5 0.0 3.3 3.0 0.8 0.0 3.3 0.3 0.8 0.2 0.1 0.1 0.3 0.3 0.7 1.5 0.2 0.1 0.1 0.8 0.2 0.1 0.1 0.6 0.4 0.3 4.1 0.4 0.7 0.1 0.0 2.7 3.1 2.0 0.0 6.0 1.2 0.3 0.1 14.0 0.4 0.0 2.1 1.3 1.3 0.4 42.1 54.1 161.8 73.1 1.5 4.5 12.6 47.9 29.8 78.6 52.5 32.8 17.9 0.0 18.8 39.8 39.9 29.9 82.6 21.6 41.9 64.6 33.9 0.1 33.8 41.2 0.2 1.7 48.9 2.4 1.5 32.2 12.4 8.0 24.8 36.8 10.1 23.0 49.9 30.5 9.2 0.5 70.9 34.0 37.8 74.9 64.8 29.6 12.9 6.4 36.5 51.3 41.7 42.5 39.1 20.4 19.9 4.0 11.9 59.9 48.4 36.0 80.7 8.2 31.5 0.2 23.6 20.4 94.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 1.0 0.1 0.0 0.3 0.3 0.3 0.1 1.0 0.4 0.1 0.1 0.2 0.1 0.1 0.4 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.4 1.2 0.6 0.0 0.0 0.0 0.0 0.6 5.5 0.0 0.7 1.3 21.5 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.0 0.0 RPAIN "hRIP, MGC4189, RIP" ENSG00000129197 "RPA interacting protein" Q86UA6 17 5419641-5432877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023924, HPA031526" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA023924: AB_10601890, HPA031526: AB_10601555" "unprognostic (1.68e-1)" "unprognostic (9.31e-3)" "unprognostic (2.32e-1)" "unprognostic (7.88e-2)" "unprognostic (5.41e-2)" "unprognostic (3.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.87e-3)" "unprognostic (3.98e-2)" "unprognostic (4.25e-3)" "prognostic favorable (5.20e-4)" "prognostic unfavorable (4.41e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.67e-2)" "unprognostic (1.00e-3)" 18.3 24.7 41.1 14.9 41.2 21.1 28.1 41.1 53.1 17.7 40.8 18.8 16.0 19.0 27.4 17.3 22.4 16.8 33.5 41.4 41.8 23.6 28.8 16.1 22.4 41.2 41.3 41.5 21.1 21.1 21.0 21.9 16.7 41.9 18.9 20.3 24.6 17.3 15.9 51.6 17.2 13.8 18.6 41.3 15.5 21.3 15.2 41.4 36.2 16.9 38.3 22.5 19.8 11.5 42.3 31.5 65.5 65.1 57.0 50.2 35.8 32.0 31.9 54.9 59.8 55.3 39.9 13.9 37.7 41.9 19.4 47.3 35.5 75.1 27.6 52.2 38.3 71.1 30.4 38.0 54.0 60.6 33.2 57.6 31.7 53.5 38.7 77.6 73.6 53.2 117.1 31.7 20.9 33.9 25.1 78.8 65.9 39.4 42.7 34.0 40.3 44.7 32.7 51.2 35.1 40.9 82.6 27.3 23.7 76.0 50.8 31.9 45.3 26.8 20.2 28.0 18.5 62.7 21.7 35.5 34.7 30.8 39.8 34.4 40.9 37.3 59.2 31.6 33.4 39.3 75.3 43.5 40.4 34.2 57.3 53.2 46.0 6.4 36.1 32.1 55.6 62.4 32.4 41.1 41.2 41.1 53.1 41.4 41.8 41.2 41.3 41.5 41.9 41.3 41.4 42.3 58.0 70.5 61.7 22.9 67.2 63.2 78.4 120.4 76.2 47.9 79.6 97.3 38.2 57.2 91.7 40.5 52.1 77.8 65.1 50.3 103.7 72.1 92.1 103.7 68.6 48.6 110.2 65.6 32.7 57.6 46.5 53.8 55.0 129.3 62.0 99.3 47.8 39.8 56.0 47.1 31.2 49.8 134.3 48.1 47.1 18.2 70.8 43.4 48.0 24.4 58.9 80.9 48.4 32.6 40.7 75.2 58.8 71.8 33.0 86.9 42.1 82.0 89.2 62.1 72.3 71.2 65.1 100.4 34.1 59.2 74.9 59.7 62.4 71.9 67.0 98.9 USP6 "HRP1, Tre-2, TRE17, Tre2, TRESMCR" ENSG00000129204 "Ubiquitin specific peptidase 6" P35125 17 5116032-5175034 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Calmodulin-binding, Hydrolase, Protease, Thiol protease" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 19.8;testis: 13.5" "Cell type enhanced" "Detected in many" "Early spermatids: 24.4;Spermatocytes: 26.9" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " "unprognostic (3.89e-2)" "unprognostic (3.79e-3)" "unprognostic (2.50e-1)" "unprognostic (1.85e-1)" "unprognostic (9.32e-2)" "unprognostic (3.50e-3)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (3.45e-2)" "unprognostic (2.46e-2)" "unprognostic (7.91e-4)" "unprognostic (6.28e-3)" "unprognostic (3.24e-4)" "unprognostic (3.75e-2)" "unprognostic (3.13e-1)" "unprognostic (2.71e-1)" "unprognostic (7.09e-4)" 0.4 0.3 0.9 0.2 0.5 0.1 0.7 0.3 0.5 0.8 1.3 0.6 0.0 0.9 0.7 0.2 0.6 0.5 0.4 0.4 0.3 0.6 0.1 0.4 0.3 0.9 0.3 0.3 2.6 0.3 0.0 0.6 0.5 1.0 0.6 0.3 2.5 0.5 0.5 19.8 0.6 0.3 0.9 0.2 0.4 0.2 13.5 0.4 0.0 0.9 0.6 0.2 0.3 0.5 0.9 0.1 0.1 0.3 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.4 0.3 0.1 0.1 0.0 0.3 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.5 0.3 0.5 0.4 0.3 0.9 0.3 0.3 1.0 0.2 0.4 0.9 2.0 6.4 10.8 0.0 0.4 10.8 1.0 1.1 0.0 8.5 4.0 3.8 1.6 5.7 3.5 3.7 12.5 0.6 1.0 0.1 3.9 0.0 24.4 1.1 2.1 3.0 0.0 5.3 1.2 0.0 0.8 1.8 0.0 1.4 0.0 1.2 3.6 3.2 2.7 1.7 1.0 0.0 0.0 5.4 6.4 13.5 1.8 3.1 3.6 2.8 3.2 5.1 0.0 0.0 2.9 0.1 0.1 2.6 0.1 2.1 0.0 3.2 4.0 12.3 6.6 5.9 1.7 26.9 11.5 0.0 10.4 0.7 1.1 0.9 0.2 1.1 SHBG "ABP, MGC126834, MGC138391, TEBG" ENSG00000129214 "Sex hormone binding globulin" P04278 17 7613946-7633382 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 63.9" "Cell type enhanced" "Detected in some" "Early spermatids: 51.6;Late spermatids: 124.5;Proximal enterocytes: 31.1" "Cancer enriched" "Detected in some" 28 "liver cancer: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.4;Hep G2: 3.0;HSkMC: 4.3" "Not detected" "Not detected" "Secreted to blood" NA NA 9100000000 "unprognostic (3.35e-3)" "unprognostic (6.47e-2)" "unprognostic (5.65e-2)" "unprognostic (2.35e-1)" "unprognostic (8.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.50e-1)" "unprognostic (2.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.32e-3)" "unprognostic (3.58e-3)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (7.83e-3)" "unprognostic (4.35e-1)" "unprognostic (5.50e-3)" "unprognostic (1.06e-1)" 0.7 1.3 1.7 0.0 1.5 0.1 0.4 1.5 2.0 0.6 1.5 0.2 5.3 0.5 0.9 0.2 0.6 0.3 0.6 1.6 1.5 3.5 63.9 0.3 0.1 1.6 1.4 1.4 0.7 0.4 0.5 0.7 0.3 1.6 0.5 0.2 0.9 0.2 0.4 0.8 0.1 7.1 0.2 1.5 0.4 0.3 12.5 1.5 0.2 0.8 0.8 0.1 0.3 0.2 1.6 0.1 2.4 2.4 0.3 4.4 2.0 0.1 0.6 0.9 0.9 0.5 0.9 0.3 0.0 0.5 0.8 1.2 0.3 0.1 0.1 0.5 0.1 0.3 0.0 0.6 3.0 1.4 0.0 0.1 4.3 0.3 1.6 0.8 0.8 0.1 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.1 0.3 1.8 0.0 0.2 0.8 0.4 0.0 0.8 0.4 0.0 0.0 0.2 0.3 0.3 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 1.5 2.0 1.6 1.5 1.6 1.4 1.4 1.6 1.5 1.5 1.6 0.2 0.0 0.0 0.7 0.5 0.0 0.3 0.1 0.0 0.4 0.5 0.6 0.5 0.0 0.2 0.0 0.0 0.4 0.0 0.2 5.9 0.5 51.6 0.4 0.6 0.1 0.0 0.0 1.0 0.2 0.1 0.4 0.0 0.2 0.0 0.6 1.1 13.8 0.3 0.0 0.9 1.3 2.0 0.8 0.0 124.5 0.9 0.5 0.0 0.0 0.0 2.4 0.0 0.5 0.6 0.1 1.3 0.7 0.0 0.3 31.1 12.8 0.4 1.3 6.6 0.2 0.3 7.2 0.8 0.0 0.0 0.3 0.1 1.1 0.5 0.3 PLD2 ENSG00000129219 "Phospholipase D2" O14939 17 4807152-4823434 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013397 Approved NA NA "HPA013397: AB_1855328" "unprognostic (1.87e-1)" "unprognostic (3.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (2.90e-2)" "unprognostic (3.85e-3)" "unprognostic (3.64e-1)" "unprognostic (6.15e-3)" "unprognostic (2.58e-3)" "unprognostic (1.25e-1)" "unprognostic (8.10e-3)" "unprognostic (1.08e-1)" "unprognostic (2.95e-1)" "unprognostic (1.91e-1)" "unprognostic (1.85e-1)" "unprognostic (5.48e-2)" 15.9 8.2 17.9 10.0 19.7 2.6 18.1 20.5 21.2 25.2 14.5 11.0 7.0 15.3 7.0 63.8 14.6 14.4 9.9 17.4 20.8 11.8 12.2 16.2 9.6 28.3 21.4 14.4 21.6 14.1 9.0 10.5 14.3 21.1 19.2 9.1 4.9 22.8 14.7 5.2 33.7 10.8 13.5 22.7 12.7 11.4 4.4 22.2 13.1 12.0 6.8 18.1 15.2 37.5 22.0 13.0 20.2 17.4 18.8 15.0 19.9 20.0 8.2 17.2 14.2 11.3 21.7 15.1 5.6 9.4 21.3 5.3 30.2 13.9 18.3 12.8 7.3 7.0 1.8 15.7 13.2 10.8 0.1 13.3 29.4 27.0 12.8 12.1 20.0 33.2 3.9 2.1 5.2 12.0 9.9 0.7 2.4 9.2 10.7 8.7 6.3 11.2 1.4 12.9 20.9 5.9 10.2 15.5 18.1 11.6 14.1 13.0 3.0 26.1 9.4 9.5 21.6 12.8 4.6 2.3 1.2 14.4 2.6 5.6 4.0 4.8 1.2 1.2 4.9 0.9 1.6 1.3 0.9 3.6 0.9 0.3 0.4 0.3 0.8 5.4 1.6 2.3 2.4 17.9 19.7 20.5 21.2 17.4 20.8 28.3 21.4 14.4 21.1 22.7 22.2 22.0 10.9 0.0 1.1 26.8 2.8 12.6 9.8 11.2 14.8 1.2 11.6 10.3 2.8 7.2 8.9 1.8 0.0 21.8 2.6 7.1 1.9 8.7 0.0 2.5 4.6 12.0 1.2 0.0 1.6 11.5 14.8 7.7 10.7 5.4 5.7 12.0 12.8 2.9 12.9 0.0 2.7 7.0 6.1 8.1 13.8 0.5 9.6 10.7 7.2 5.6 19.9 7.8 1.0 3.5 5.8 10.4 10.2 8.6 1.4 14.0 3.8 4.2 9.2 1.7 0.0 4.1 5.0 0.2 2.7 9.8 12.1 17.4 3.1 7.2 5.7 10.5 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 134 "retina: 843.2" "Cell type enriched" "Detected in some" 4 "Rod photoreceptor cells: 1926.4" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Region enriched" "Detected in single" 12 "midbrain: 6.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;OE19: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.0 0.0 0.3 0.1 0.3 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 6.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 843.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 2.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.3 0.1 0.5 0.2 6.2 0.1 0.3 0.0 0.3 0.4 0.0 3.2 1.1 0.0 0.0 0.8 1.0 0.0 0.0 139.2 0.1 0.0 0.6 0.0 1.4 0.0 412.8 0.1 0.1 0.2 0.0 0.0 7.8 0.4 0.2 8.5 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.4 0.0 0.1 1.4 0.0 0.1 65.6 0.2 0.2 0.0 0.3 1.1 1.3 0.0 0.3 1.8 0.0 0.0 256.1 0.0 0.5 0.1 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1926.4 0.0 1.8 0.3 0.4 0.2 0.0 0.4 0.3 0.4 0.1 0.0 1.7 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579491-7582111 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 361.1;lymphoid tissue: 373.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6" "Group enriched" "Detected in all" 11 "dendritic cells: 1378.6;monocytes: 3740.6" "Cell line enhanced" "Detected in all" "ASC diff: 472.0;U-87 MG: 751.0" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587" "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 140.8 79.1 9.2 238.1 13.6 268.6 73.3 8.9 33.7 57.2 22.4 89.7 282.1 27.0 9.1 127.5 43.5 162.5 38.1 5.2 40.9 49.7 158.0 361.1 219.1 37.1 23.7 2.1 19.5 22.3 14.3 9.0 174.5 24.6 13.2 92.8 4.9 53.1 19.9 23.2 22.0 242.2 79.8 19.6 373.9 88.3 15.4 43.8 44.6 22.9 21.5 84.9 150.7 51.1 83.4 243.4 48.6 3.2 3.5 472.0 177.6 2.1 75.6 203.9 97.8 113.4 10.1 71.3 2.9 84.2 220.8 174.6 10.6 1.2 47.6 65.9 2.2 9.0 38.8 13.2 59.0 42.0 19.2 207.8 57.1 9.8 205.4 150.4 162.6 26.3 4.3 15.7 24.2 95.5 2.2 1.7 17.2 2.8 63.1 36.0 3.3 4.5 144.4 20.9 10.9 1.6 3.0 63.2 31.3 72.1 2.2 1.6 146.1 82.4 123.7 8.0 125.7 100.1 1.4 2.1 1.9 751.0 46.4 64.0 243.5 3255.5 21.4 9.1 3655.9 11.1 80.2 4.1 6.2 817.3 59.0 5.8 5.1 219.4 18.7 3740.6 1378.6 6.5 3324.3 9.2 13.6 8.9 33.7 5.2 40.9 37.1 23.7 2.1 24.6 19.6 43.8 83.4 10.4 0.0 19.7 1.3 20.5 15.7 39.0 58.8 3.4 0.2 7.2 9.8 0.0 12.8 53.2 5.5 0.0 8.9 110.3 22.5 5.9 82.1 0.8 8.3 11.3 15.9 4.9 6.6 0.3 156.8 58.1 45.6 29.6 18.7 43.6 0.9 16.4 23.9 1820.4 0.0 0.4 15.8 16.2 701.2 341.5 2.1 6.5 791.2 39.2 5.6 179.2 0.3 7.2 0.0 0.1 121.0 86.1 1.9 8.5 33.3 335.3 50.2 20.6 1.0 26.3 8.7 11.7 0.5 1.2 12.4 14.3 33.4 10.8 0.5 28.9 99.9 TXNDC17 "MGC14353, TRP14, TXNL5" ENSG00000129235 "Thioredoxin domain containing 17" Q9BRA2 17 6640985-6644541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 184.4" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 785.8;Proximal tubular cells: 814.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022931 Approved NA NA 820000 "HPA022931: AB_1858479" "unprognostic (8.94e-2)" "unprognostic (6.03e-2)" "unprognostic (5.33e-2)" "unprognostic (2.97e-2)" "unprognostic (5.02e-2)" "unprognostic (5.06e-2)" "unprognostic (7.65e-3)" "unprognostic (3.88e-1)" "unprognostic (1.51e-2)" "unprognostic (2.21e-3)" "unprognostic (1.15e-2)" "unprognostic (9.97e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.86e-2)" "unprognostic (2.27e-1)" "unprognostic (3.09e-2)" "unprognostic (9.01e-2)" 26.0 45.7 17.8 22.8 18.4 21.9 28.3 18.6 24.2 26.0 18.9 54.6 57.3 20.6 40.6 184.4 16.3 27.2 29.4 18.5 20.1 62.5 70.3 23.4 22.3 18.7 18.3 17.3 13.5 40.7 24.8 27.8 15.1 18.6 32.4 45.1 7.5 47.9 14.7 21.9 26.2 39.2 20.6 18.9 42.2 54.9 15.6 18.7 26.0 20.9 10.2 27.2 69.4 59.0 19.5 130.8 154.4 62.1 134.1 38.1 54.4 29.1 65.4 56.4 59.2 57.0 84.8 44.0 27.8 62.4 50.6 62.3 200.0 67.6 223.5 73.2 93.0 109.3 33.1 138.6 153.3 43.3 54.1 70.7 55.1 83.6 72.7 72.3 58.2 79.8 88.2 45.1 13.3 83.1 91.8 55.1 69.7 90.3 91.9 123.9 53.2 41.4 69.5 126.7 253.3 28.8 74.9 65.9 66.7 54.6 42.1 63.3 48.2 59.8 48.8 61.7 55.7 117.2 20.0 47.8 43.1 98.9 56.9 57.1 77.2 105.0 93.6 35.3 117.3 37.2 54.9 41.7 42.4 115.8 47.5 32.2 37.8 180.9 35.5 120.9 109.3 66.9 56.7 17.8 18.4 18.6 24.2 18.5 20.1 18.7 18.3 17.3 18.6 18.9 18.7 19.5 91.8 93.0 157.2 3.9 66.9 189.3 185.3 785.8 330.6 18.1 141.5 162.6 110.3 175.8 236.4 125.0 2.1 180.7 76.6 560.2 389.4 326.8 362.5 110.0 81.6 99.6 135.1 70.7 3.9 451.8 291.6 84.9 181.0 126.9 50.0 92.2 88.2 371.7 245.0 40.4 3.6 316.4 221.8 114.9 83.7 303.2 74.9 118.9 113.8 1.9 170.2 86.8 80.3 4.0 5.3 534.5 378.6 67.0 112.5 169.9 420.3 814.9 142.9 26.8 26.3 58.5 103.9 34.6 116.4 500.1 143.3 104.9 67.7 151.0 332.1 300.0 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657770 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "brain: 327.6;retina: 620.1" "Group enriched" "Detected in many" 5 "Astrocytes: 207.3;Bipolar cells: 330.2;Cone photoreceptor cells: 250.2;Muller glia cells: 303.2;Rod photoreceptor cells: 226.1" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;HAP1: 2.9;K-562: 4.5;SuSa: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Supported NA NA 160000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favorable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 5.9 10.2 208.9 0.9 253.6 11.5 5.0 266.0 294.8 11.9 22.2 7.1 1.2 8.9 17.6 2.2 12.4 3.6 7.7 195.1 227.9 9.5 2.8 4.2 1.7 327.6 310.6 138.5 29.8 2.5 4.5 45.7 4.5 239.8 6.7 2.7 620.1 2.0 7.6 4.4 2.1 3.6 5.6 226.8 5.1 3.8 5.5 309.4 0.8 4.6 5.4 1.1 4.6 7.8 319.0 0.0 0.0 9.6 0.4 0.3 0.2 0.1 0.1 0.0 0.3 0.2 0.4 0.0 0.3 0.2 0.1 0.2 0.3 2.9 0.2 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.0 0.9 0.5 0.0 0.3 0.0 0.1 0.0 0.2 4.5 0.5 0.0 0.2 0.2 0.3 2.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.0 0.1 0.0 5.7 0.1 0.2 0.0 0.1 0.7 0.0 0.2 0.4 0.1 0.0 0.9 0.2 0.2 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 208.9 253.6 266.0 294.8 195.1 227.9 327.6 310.6 138.5 239.8 226.8 309.4 319.0 8.5 0.0 0.0 207.3 1.8 1.9 0.4 0.0 1.8 330.2 2.3 6.2 3.7 2.8 0.0 0.0 250.2 0.0 1.1 6.7 0.0 0.2 0.2 0.8 8.3 7.7 0.0 49.2 2.9 0.0 0.1 5.9 7.7 0.6 0.0 1.0 11.4 0.2 0.3 18.5 38.8 2.4 2.0 0.8 0.9 2.3 18.6 1.6 0.0 7.5 0.2 303.2 0.0 45.8 1.6 0.0 0.0 46.3 0.8 0.5 0.5 0.2 0.0 226.1 26.3 2.4 50.0 1.2 6.1 1.6 1.1 0.3 1.6 0.5 2.6 0.2 FXR2 FMR1L2 ENSG00000129245 "FMR1 autosomal homolog 2" P51116 17 7591230-7614897 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 121.9" "Cell type enhanced" "Detected in many" "Horizontal cells: 63.9;Rod photoreceptor cells: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011205, HPA022997" Supported Supported Cytosol NA NA Cytosol "CAB011205: AB_476964, HPA022997: AB_1849208" "unprognostic (9.57e-2)" "unprognostic (1.23e-1)" "unprognostic (5.15e-3)" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (7.56e-3)" "unprognostic (1.96e-1)" "unprognostic (3.50e-3)" "unprognostic (2.15e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.49e-6)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "unprognostic (2.64e-1)" "unprognostic (7.79e-2)" "unprognostic (7.67e-2)" 18.5 28.1 33.2 11.5 34.2 9.8 17.5 36.1 38.0 20.9 25.5 23.0 14.0 21.9 11.7 21.1 20.3 11.0 59.8 33.1 37.3 22.3 20.7 19.3 14.2 41.2 40.8 31.7 20.6 16.3 30.9 33.2 15.6 40.8 21.7 11.6 38.0 20.0 18.4 121.9 21.9 17.6 17.3 34.8 16.9 20.1 27.7 38.2 21.0 17.3 85.2 15.3 23.5 19.6 42.7 36.6 48.3 43.8 45.7 36.7 25.0 33.7 54.2 45.1 77.2 53.2 27.2 11.9 33.8 34.8 37.2 34.1 40.1 58.2 24.8 51.4 39.1 62.4 19.6 42.2 15.9 35.7 0.2 39.8 23.5 35.8 58.8 56.4 43.3 27.1 26.9 35.4 11.6 38.8 18.6 26.9 19.3 26.2 18.9 25.8 37.9 26.6 21.3 28.2 13.0 26.1 47.2 37.3 24.3 37.8 41.3 25.3 14.5 24.3 36.0 22.5 24.0 64.8 19.0 18.6 15.5 41.3 15.8 48.0 2.6 0.8 2.5 0.9 1.0 1.3 0.5 1.5 1.9 1.3 0.9 1.2 1.3 2.1 1.0 0.6 0.9 1.8 0.8 33.2 34.2 36.1 38.0 33.1 37.3 41.2 40.8 31.7 40.8 34.8 38.2 42.7 10.3 32.1 17.9 10.7 7.7 11.5 15.4 7.9 2.8 46.9 10.4 8.3 41.7 8.6 9.5 16.5 31.3 15.9 15.1 12.0 1.9 11.6 1.8 11.1 9.2 10.5 9.6 15.6 10.3 9.3 11.5 10.8 10.7 11.0 2.5 12.9 15.0 11.7 9.1 63.9 12.0 10.1 10.2 7.3 9.7 2.7 9.6 7.1 0.0 3.7 7.4 23.3 16.5 8.5 12.4 17.6 12.5 15.4 6.3 15.4 15.5 8.9 7.6 55.8 6.6 14.2 17.7 22.9 28.2 8.7 14.3 17.1 7.6 14.6 7.4 10.3 KIF1C "SAX2, SPAX2, SPG58" ENSG00000129250 "Kinesin family member 1C" O43896 17 4997950-5028401 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 246.9;choroid plexus: 158.7;heart muscle: 173.8;skeletal muscle: 566.3;tongue: 392.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 315.4;Distal enterocytes: 168.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024602, HPA045020" Approved NA NA "HPA024602: AB_1852480, HPA045020: AB_2679187" "unprognostic (3.89e-2)" "unprognostic (3.73e-2)" "unprognostic (2.70e-2)" "unprognostic (1.24e-2)" "unprognostic (3.74e-1)" "unprognostic (8.97e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-1)" "unprognostic (6.69e-2)" "unprognostic (8.31e-2)" "unprognostic (1.45e-1)" "unprognostic (4.90e-3)" "prognostic favorable (2.26e-9)" "unprognostic (1.10e-1)" "unprognostic (2.28e-1)" "unprognostic (1.41e-1)" "unprognostic (7.10e-3)" 55.1 18.8 243.8 25.3 232.3 6.4 36.7 203.0 211.6 31.7 158.7 57.1 53.8 44.8 7.9 76.4 31.7 28.3 173.8 180.4 191.1 38.2 46.8 50.0 10.0 237.5 231.5 161.8 24.3 52.0 55.5 10.6 18.8 240.0 36.7 33.5 4.3 38.6 37.1 566.3 49.2 51.8 36.7 222.5 26.7 51.6 17.9 219.3 11.4 39.0 392.6 16.9 51.8 37.6 246.9 104.1 97.6 32.2 69.4 74.5 44.5 51.0 80.8 64.3 63.2 38.3 70.7 24.5 16.6 46.7 127.2 41.2 105.3 58.4 107.2 44.6 40.2 68.7 12.0 124.1 57.4 50.7 4.9 34.6 46.0 109.9 85.2 58.0 59.6 87.2 14.5 45.9 28.4 62.6 61.5 14.7 8.0 25.1 68.1 63.4 15.1 54.1 17.2 55.7 71.9 7.8 15.3 114.2 63.0 34.9 30.6 62.0 14.9 185.5 84.8 63.7 62.2 99.3 10.8 9.9 8.9 62.6 20.9 43.0 0.5 0.4 0.7 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.4 0.2 0.2 1.2 0.3 0.2 0.2 0.3 0.1 243.8 232.3 203.0 211.6 180.4 191.1 237.5 231.5 161.8 240.0 222.5 219.3 246.9 24.8 54.5 50.6 6.5 6.8 16.8 19.0 25.6 12.5 12.5 24.8 14.2 315.4 48.6 28.1 25.8 0.0 14.8 6.5 168.9 19.6 32.2 71.6 13.0 15.1 37.8 14.4 4.4 5.7 43.1 14.0 21.9 51.0 29.3 12.7 21.6 37.1 82.7 16.1 23.5 7.3 77.3 12.2 18.5 11.0 32.1 16.8 11.9 16.0 10.3 16.1 7.7 6.2 4.5 5.0 63.0 83.8 42.5 11.4 44.1 92.9 42.9 18.4 5.8 6.6 35.0 35.1 18.7 23.6 21.3 20.2 23.3 7.9 12.4 65.4 36.6 MPDU1 "CDGIf, Lec35, PQLC5, SL15, SLC66A5" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 32.2 41.4 32.0 33.1 33.1 63.8 39.6 34.7 34.7 33.6 38.9 66.1 53.7 17.5 33.8 38.0 32.3 36.0 18.5 30.9 32.9 72.8 107.9 33.6 31.0 33.6 33.3 29.9 11.0 40.1 57.9 15.7 37.5 33.2 34.0 70.3 25.6 33.8 18.5 21.4 28.3 48.9 29.0 33.8 28.6 55.0 14.6 34.0 26.1 36.0 21.5 38.3 43.6 22.1 34.1 51.0 111.8 75.9 54.1 83.8 74.4 50.5 81.1 104.6 142.4 98.6 58.0 85.0 28.8 54.8 128.1 65.0 98.4 102.2 134.3 116.6 63.8 118.8 55.7 65.8 98.7 101.0 49.3 89.8 77.9 105.2 133.4 76.4 64.7 105.8 84.9 87.1 38.6 151.6 70.1 35.9 48.4 85.2 107.4 55.8 81.6 56.4 60.7 145.1 52.1 45.8 90.1 104.4 75.9 34.4 59.5 83.8 50.1 76.5 67.5 36.9 36.8 111.2 20.3 34.6 27.0 97.1 62.3 103.5 16.8 44.2 14.0 16.9 73.1 12.8 18.1 16.1 22.1 52.4 16.5 15.4 18.3 6.5 17.4 69.1 48.5 26.4 24.9 32.0 33.1 34.7 34.7 30.9 32.9 33.6 33.3 29.9 33.2 33.8 34.0 34.1 30.1 9.6 23.0 5.5 30.4 10.7 34.9 51.0 22.2 18.1 34.7 22.7 5.1 34.3 31.0 23.9 12.5 111.5 26.5 106.8 35.2 62.7 3.2 22.2 23.3 28.2 37.2 96.8 4.5 76.1 93.8 27.5 53.5 28.1 14.5 28.6 25.0 49.7 79.7 16.8 5.6 68.9 40.7 30.5 23.6 5.7 17.1 46.1 24.9 4.7 35.9 28.5 21.6 6.6 9.3 69.7 76.8 6.4 38.5 37.1 78.0 48.0 20.3 23.3 26.3 30.6 24.7 22.9 26.4 20.7 12.6 157.6 26.0 37.1 77.1 40.9 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 12.2 14.2 8.9 13.6 10.2 25.1 11.0 11.3 11.8 11.7 10.8 8.7 9.5 11.5 10.1 11.7 7.9 10.8 17.6 8.9 12.4 10.8 13.5 10.4 11.9 7.4 7.9 8.4 11.4 9.0 15.8 8.8 12.5 8.1 10.0 10.2 12.7 9.6 8.0 16.8 7.8 9.9 11.6 6.9 11.6 9.4 13.7 7.9 25.9 22.9 18.7 12.5 12.9 9.0 10.7 20.9 20.6 33.1 19.1 25.3 29.9 11.9 30.1 23.4 20.2 19.7 11.5 14.0 23.8 25.6 30.3 17.4 12.0 22.5 16.0 24.9 40.4 16.1 25.5 24.3 8.2 26.6 20.7 17.6 22.5 19.4 21.1 31.1 19.5 22.6 37.2 32.1 36.4 30.4 21.0 67.6 9.2 14.7 23.8 27.1 32.6 22.1 20.6 16.5 17.8 81.4 23.8 19.1 13.5 24.5 13.8 26.5 23.0 29.6 32.6 25.9 21.5 29.1 21.5 29.9 30.3 28.8 35.8 29.6 3.5 3.8 7.0 2.1 2.4 2.1 2.1 1.9 2.5 3.6 2.2 2.8 2.2 12.6 3.0 3.6 2.9 2.5 1.5 8.9 10.2 11.3 11.8 8.9 12.4 7.4 7.9 8.4 8.1 6.9 7.9 10.7 65.9 25.6 51.6 74.4 51.1 33.6 52.6 48.2 40.9 55.7 40.5 38.0 88.5 25.8 57.2 36.8 43.8 29.7 92.9 35.1 23.5 37.3 81.2 39.8 73.4 55.2 43.7 37.9 133.9 31.3 32.0 51.6 41.8 48.9 60.2 60.1 36.0 33.4 36.6 53.8 192.2 29.0 44.7 39.6 49.3 49.5 40.0 84.2 23.2 83.4 67.5 50.9 78.2 104.5 117.5 40.6 26.4 42.9 66.6 40.4 41.5 25.7 30.8 54.1 46.0 68.1 58.9 115.1 45.9 44.9 36.2 45.0 65.8 61.4 30.9 66.7 LRRC6 "CILD19, LRTP, tilB, TSLRP" ENSG00000129295 "Leucine rich repeat containing 6" Q86X45 8 132570416-132675592 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.5" "Cell type enhanced" "Detected in many" "Early spermatids: 228.5;Endometrial ciliated cells: 101.5;Excitatory neurons: 85.8;Inhibitory neurons: 67.1;Late spermatids: 62.1;Respiratory ciliated cells: 152.7;Spermatocytes: 102.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.5;RPTEC TERT1: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028058 Approved NA NA "HPA028058: AB_1853337" "unprognostic (1.53e-1)" "unprognostic (2.77e-1)" "unprognostic (6.91e-3)" "unprognostic (3.56e-2)" "unprognostic (2.50e-2)" "unprognostic (8.04e-3)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (7.39e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-1)" "unprognostic (9.51e-2)" "unprognostic (3.38e-2)" "unprognostic (8.42e-3)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.98e-4)" "unprognostic (4.17e-2)" 2.5 4.3 12.7 1.9 10.8 3.6 2.7 6.3 13.8 5.0 19.8 2.2 0.9 3.1 5.7 1.2 19.7 3.6 2.3 9.4 10.5 11.6 1.5 4.2 0.9 12.3 11.5 8.1 3.5 2.8 5.7 8.4 1.7 8.2 2.3 1.5 13.9 2.0 2.3 0.4 1.3 2.6 1.8 11.7 4.1 1.3 26.5 7.9 0.8 7.7 0.6 0.7 2.1 2.2 10.0 0.4 2.2 3.5 0.0 2.9 4.8 7.5 0.3 0.5 1.7 1.5 0.4 8.5 0.0 2.5 3.1 2.4 0.0 0.6 1.1 1.7 0.3 0.0 0.0 0.6 0.1 1.2 0.0 3.8 4.2 2.1 3.9 0.1 4.0 0.8 3.6 0.3 0.0 2.2 2.8 0.0 0.1 5.6 2.6 2.1 0.0 0.1 1.2 15.7 0.0 1.8 2.6 0.3 0.0 0.4 5.4 0.9 0.5 0.0 2.0 7.2 6.3 0.7 0.0 1.0 0.2 5.3 0.4 0.2 0.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.3 12.7 10.8 6.3 13.8 9.4 10.5 12.3 11.5 8.1 8.2 11.7 7.9 10.0 2.2 6.4 0.5 24.5 0.5 1.3 3.7 7.7 1.8 2.5 3.3 3.7 2.8 1.5 18.0 9.2 8.4 0.0 0.2 1.7 21.5 6.4 228.5 101.5 7.3 3.1 1.2 0.8 85.8 1.8 0.2 4.4 0.0 7.3 0.0 2.9 4.2 0.5 2.1 1.7 67.1 0.7 8.2 0.8 1.4 62.1 3.7 2.8 0.0 11.2 0.6 7.2 1.0 6.6 5.3 0.7 1.4 4.5 0.0 1.2 2.6 34.7 152.7 13.7 0.0 1.3 4.5 102.6 10.5 1.2 1.1 0.0 0.5 6.0 1.7 1.9 CCNT1 "CCNT, CYCT1, HIVE1" ENSG00000129315 "Cyclin T1" O60563 12 48688458-48716998 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004892, CAB009016, HPA072012" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: " "unprognostic (1.76e-3)" "unprognostic (3.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.76e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (5.78e-3)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.22e-1)" "unprognostic (3.43e-2)" "unprognostic (4.50e-2)" "unprognostic (1.92e-1)" 9.1 9.7 5.5 9.7 5.8 29.7 10.0 7.3 6.6 7.0 7.7 7.8 6.8 9.3 8.3 7.9 8.2 7.2 6.9 4.9 13.7 9.0 8.5 8.4 11.7 6.3 5.9 3.5 10.9 8.9 11.6 6.8 8.0 5.6 7.7 8.4 12.3 6.4 7.1 10.3 9.1 7.9 8.0 6.6 10.6 7.4 11.6 6.4 13.1 11.8 9.9 11.4 7.6 7.0 7.6 15.1 21.8 20.6 19.8 14.9 18.2 23.8 20.0 16.6 15.3 11.8 26.0 17.3 40.4 25.6 13.4 10.4 19.3 35.6 13.7 22.6 24.0 20.5 43.9 34.2 11.2 18.4 45.1 20.0 14.1 19.6 21.4 25.3 21.0 11.9 23.5 44.7 18.1 18.9 9.9 24.6 20.9 20.7 8.7 16.1 21.8 33.4 17.0 14.0 26.2 23.0 24.0 32.0 15.5 23.5 14.9 21.3 25.8 12.5 16.1 17.0 11.7 17.1 25.8 37.0 35.3 19.1 64.9 9.4 9.0 2.6 7.7 3.3 1.7 4.5 4.3 2.7 3.2 1.6 5.3 3.9 3.6 13.6 3.5 2.0 4.4 1.8 0.9 5.5 5.8 7.3 6.6 4.9 13.7 6.3 5.9 3.5 5.6 6.6 6.4 7.6 41.4 16.0 18.9 16.0 38.0 38.5 19.4 11.8 48.9 23.5 21.9 19.0 14.4 12.8 16.1 12.9 22.9 13.8 58.7 13.1 3.9 8.2 131.4 18.9 23.7 26.4 12.0 24.0 18.9 6.9 16.7 23.9 29.0 26.1 29.8 27.3 27.8 15.2 10.2 38.7 18.5 15.8 14.2 17.5 33.0 27.9 16.8 29.9 21.4 19.7 12.1 16.2 18.6 18.6 22.6 8.1 9.2 14.7 37.8 26.2 13.3 9.8 25.1 16.3 6.6 23.3 28.5 18.3 14.4 32.1 44.9 17.4 45.0 27.3 13.7 33.3 PUS7L DKFZP434G1415 ENSG00000129317 "Pseudouridine synthase 7 like" Q9H0K6 12 43718992-43758793 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056203, HPA058750" Uncertain Approved "Nucleoli,Nuclear speckles" NA NA "Nuclear speckles" Nucleoli "HPA056203: AB_2683064, HPA058750: AB_2683807" "unprognostic (3.41e-3)" "unprognostic (1.03e-1)" "unprognostic (2.51e-3)" "unprognostic (1.83e-1)" "unprognostic (3.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.87e-4)" "unprognostic (1.11e-1)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.49e-1)" "unprognostic (2.54e-2)" "unprognostic (1.80e-3)" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" 2.8 3.1 3.2 5.0 4.4 3.5 5.4 7.6 5.9 4.1 0.5 3.8 3.8 3.7 3.8 4.8 3.0 3.8 2.8 3.6 3.3 3.1 3.3 2.5 5.7 3.4 3.1 3.7 4.7 4.4 4.5 4.1 4.0 4.2 4.0 4.5 11.8 4.0 3.6 1.7 3.7 3.6 3.2 0.9 3.4 4.0 3.0 3.0 5.2 5.8 1.8 6.0 3.5 2.7 5.1 11.2 8.3 7.2 4.1 4.9 17.4 12.8 9.6 8.1 12.6 9.6 29.9 7.9 25.7 11.9 11.9 7.3 9.9 10.5 9.7 21.5 7.9 6.5 18.8 9.2 11.2 6.1 30.3 11.7 7.2 7.1 13.1 13.5 11.6 9.2 14.9 33.3 10.9 29.7 4.5 15.8 7.8 13.3 0.0 8.8 14.7 16.9 15.4 5.6 8.5 12.1 3.9 11.9 12.8 5.1 8.5 15.1 8.4 6.7 12.8 8.4 15.0 15.2 9.6 17.7 25.5 11.8 49.1 4.3 6.4 1.9 2.2 2.1 1.7 2.7 2.1 2.3 2.3 2.1 2.8 2.0 2.9 1.3 2.5 1.6 2.3 1.0 1.5 3.2 4.4 7.6 5.9 3.6 3.3 3.4 3.1 3.7 4.2 0.9 3.0 5.1 30.5 9.6 17.2 29.0 41.1 11.6 19.0 30.8 22.8 68.9 24.2 16.0 12.3 14.3 21.2 25.8 68.8 34.3 34.4 13.5 41.1 20.4 2.5 14.9 28.5 23.3 19.3 25.2 49.5 23.2 23.3 26.5 28.5 18.9 17.1 43.7 16.8 20.8 20.4 43.7 79.5 25.2 18.3 25.0 10.5 4.2 20.2 20.3 12.4 15.0 24.6 33.1 35.0 41.7 51.2 18.2 17.0 26.7 48.7 16.9 19.6 22.7 9.2 106.1 19.7 28.1 18.1 25.2 35.3 19.9 11.1 24.2 32.7 36.3 30.0 13.9 KRI1 FLJ12949 ENSG00000129347 "KRI1 homolog" Q8N9T8 19 10553085-10566031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 177.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043110, HPA043574" Approved Enhanced Nucleoli Yes No Nucleoli "HPA043110: AB_2678321, HPA043574: AB_2678561" "unprognostic (6.38e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (9.37e-4)" "unprognostic (6.70e-2)" "unprognostic (2.35e-2)" "unprognostic (5.10e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (4.89e-10)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.02e-1)" 12.4 11.6 11.1 20.2 11.6 17.2 12.7 11.5 11.9 15.9 12.0 13.6 10.1 13.9 7.6 17.0 14.5 7.1 11.3 10.8 11.1 11.0 13.7 11.3 22.5 11.8 11.6 10.1 15.0 15.8 10.3 13.5 8.8 13.0 15.7 7.5 34.1 13.1 8.8 22.4 20.8 17.5 7.4 10.7 22.5 12.6 16.2 11.6 30.8 14.7 9.8 15.2 16.0 16.1 12.7 37.7 17.6 23.6 35.0 13.2 14.3 16.6 34.0 16.1 21.6 20.2 27.1 13.6 55.7 39.2 14.1 18.4 29.1 30.3 27.3 23.9 60.2 67.1 177.2 39.6 18.1 23.4 69.6 61.7 17.7 21.7 31.8 31.4 18.4 13.9 33.2 50.4 56.4 18.7 33.5 72.7 104.3 38.2 30.3 45.0 30.0 30.7 28.4 18.1 32.6 39.2 18.2 40.2 23.4 25.7 20.7 29.5 50.0 16.8 27.9 23.0 74.4 71.9 38.7 48.5 39.7 23.2 56.3 41.6 2.2 4.9 2.9 11.9 5.7 11.0 7.4 7.9 9.7 6.8 8.3 8.7 9.5 0.8 10.3 3.0 16.0 6.5 4.8 11.1 11.6 11.5 11.9 10.8 11.1 11.8 11.6 10.1 13.0 10.7 11.6 12.7 8.9 16.0 25.5 6.2 20.4 13.5 11.4 12.2 40.9 15.4 6.4 9.5 8.6 8.6 17.5 14.7 39.6 11.4 15.0 9.5 1.9 8.5 4.6 9.0 17.6 11.0 9.6 26.1 4.0 7.5 8.9 11.0 16.3 10.4 19.6 12.3 10.4 9.0 8.0 11.8 3.7 10.1 8.2 12.5 6.1 5.8 8.4 10.5 8.8 5.6 9.2 11.6 24.7 6.0 7.7 5.6 7.6 9.1 17.4 10.8 9.0 5.0 16.0 55.0 0.0 13.5 9.3 25.3 16.8 28.1 13.8 4.5 26.8 9.0 12.7 8.2 ILF3 "DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1600000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 49.5 58.9 30.4 80.1 30.7 181.0 50.2 42.4 37.8 59.9 34.6 54.8 52.5 65.0 41.3 60.9 61.7 32.2 48.5 30.2 31.7 40.7 32.4 51.0 83.6 31.8 31.5 26.4 77.1 53.1 55.9 54.2 48.2 29.9 52.8 45.2 70.1 54.5 49.3 84.2 57.3 56.6 50.3 27.1 62.2 48.2 79.6 32.0 98.2 62.1 58.7 72.8 56.6 52.5 41.7 285.9 226.7 359.5 330.9 76.5 104.0 208.9 178.1 149.6 291.8 226.5 261.8 160.8 353.2 172.1 160.8 178.0 248.9 392.5 240.7 260.9 227.2 349.5 459.3 206.9 247.5 109.2 334.8 219.5 99.0 105.0 232.1 257.4 111.1 253.1 201.7 400.0 269.4 172.3 233.8 558.1 534.0 433.3 149.2 246.2 405.2 342.2 244.2 116.3 297.1 395.1 286.7 229.0 179.4 131.6 161.6 152.2 212.0 205.2 237.6 224.2 249.3 356.5 228.9 339.7 431.4 132.8 351.6 262.2 20.2 18.1 10.2 24.4 14.1 20.6 19.3 20.2 22.3 22.8 22.9 19.5 20.2 2.7 21.3 21.2 25.1 20.6 11.8 30.4 30.7 42.4 37.8 30.2 31.7 31.8 31.5 26.4 29.9 27.1 32.0 41.7 63.6 99.3 133.9 34.3 106.2 86.2 110.0 64.2 104.7 95.4 77.5 64.3 69.7 60.1 98.8 42.3 85.5 90.0 100.0 78.4 27.4 89.0 21.2 89.8 105.7 77.4 114.0 124.3 24.4 80.4 111.1 94.8 101.9 121.4 96.8 145.9 36.8 47.9 71.4 94.2 34.0 85.6 50.8 55.0 68.3 21.0 76.4 75.8 39.2 24.4 66.0 69.2 92.7 31.7 28.9 88.2 55.6 62.4 124.9 144.6 38.8 47.2 82.9 103.6 32.9 100.3 80.1 137.2 120.6 113.8 77.0 70.9 103.5 140.8 111.7 94.9 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644557 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 171.1;Extravillous trophoblasts: 257.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 333.2;SK-BR-3: 306.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: AB_2686314" "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favorable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 74.7 33.5 66.5 44.3 71.3 65.6 73.3 74.9 68.0 58.0 31.4 58.9 27.0 43.4 36.6 82.3 59.6 56.3 71.9 56.7 63.7 69.0 17.9 99.4 75.9 93.2 72.0 46.8 32.6 41.5 49.1 20.7 158.8 77.9 44.2 49.9 29.3 55.9 66.4 142.3 74.6 51.3 44.0 82.7 116.5 113.9 83.2 69.4 49.3 65.5 93.2 78.3 56.8 69.8 93.9 333.2 8.3 70.0 42.1 103.9 63.5 201.1 69.6 169.5 112.3 131.6 75.6 154.9 65.6 91.1 193.9 13.6 254.1 10.7 53.2 71.6 1.7 9.3 42.0 39.3 3.1 115.0 0.6 33.9 69.2 69.8 42.3 37.2 91.0 86.8 30.2 20.2 10.8 172.6 243.6 35.1 32.1 24.9 96.9 29.3 74.1 102.7 2.9 37.1 171.8 6.9 42.0 56.7 306.1 7.7 73.8 123.0 3.2 79.8 50.1 18.4 60.5 18.0 4.0 7.9 64.8 12.5 29.1 57.3 146.3 39.4 227.9 114.1 113.0 90.4 92.1 78.5 87.4 20.7 94.8 83.3 87.1 482.8 79.2 278.3 100.4 95.7 147.4 66.5 71.3 74.9 68.0 56.7 63.7 93.2 72.0 46.8 77.9 82.7 69.4 93.9 84.0 54.5 29.1 32.3 53.4 9.7 17.3 17.2 13.1 12.3 45.8 29.1 38.6 28.6 47.7 92.0 14.6 137.8 51.9 49.9 1.9 44.1 171.1 15.8 31.4 52.7 9.6 45.0 14.3 44.3 257.0 22.6 84.6 38.6 20.3 7.1 75.7 1.9 37.0 3.3 15.5 17.7 14.2 38.7 3.9 35.1 38.8 22.8 5.4 15.9 10.2 36.4 88.6 18.6 18.4 41.1 31.9 56.4 18.9 9.8 20.1 3.7 19.0 3.0 59.2 26.3 29.4 3.2 2.9 33.5 8.5 93.4 41.2 6.8 23.4 20.6 AP1M2 "AP1-mu2, HSMU1B, mu2" ENSG00000129354 "Adaptor related protein complex 1 subunit mu 2" Q9Y6Q5 19 10572671-10587315 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 162.0;Proximal tubular cells: 373.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 4.3;neutrophil: 7.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.6" "Cell line enhanced" "Detected in many" "CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA054999 Supported Vesicles NA NA Vesicles "HPA054999: AB_2682666" "unprognostic (8.31e-2)" "unprognostic (2.38e-1)" "unprognostic (1.87e-1)" "prognostic favorable (2.07e-4)" "unprognostic (2.07e-1)" "unprognostic (7.76e-2)" "unprognostic (2.11e-3)" "unprognostic (4.83e-2)" "unprognostic (1.93e-1)" "unprognostic (2.49e-2)" "unprognostic (2.65e-1)" "unprognostic (2.23e-2)" "prognostic favorable (3.73e-6)" "unprognostic (1.80e-2)" "unprognostic (8.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.06e-1)" 1.9 0.1 0.8 6.5 0.4 0.9 33.3 0.6 0.8 27.4 0.4 67.7 64.6 6.6 62.3 52.4 47.0 23.0 0.4 0.6 0.4 76.1 1.5 19.4 0.4 0.8 0.6 0.6 0.3 56.4 62.9 35.0 16.4 0.7 31.1 64.0 0.1 41.9 24.2 0.3 42.4 55.3 3.1 0.4 0.7 59.6 9.7 0.7 4.2 59.3 0.3 9.6 23.6 19.2 0.7 144.2 71.1 0.4 10.4 0.0 0.0 65.0 0.2 0.0 2.3 1.6 172.8 82.1 0.4 64.7 1.2 43.4 97.6 0.1 109.0 3.2 0.6 1.0 6.7 48.5 313.8 1.3 0.3 0.8 0.2 81.6 3.9 0.1 5.0 0.0 0.4 0.3 0.6 1.2 268.3 0.6 1.8 31.4 156.7 0.0 2.4 9.3 0.7 2.7 164.9 67.3 0.2 0.0 120.0 0.6 34.6 123.3 0.4 0.0 0.4 166.7 0.9 2.2 0.4 0.9 1.4 0.2 0.4 0.2 4.3 0.4 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.6 0.0 1.4 0.2 0.0 2.7 0.8 0.4 0.6 0.8 0.6 0.4 0.8 0.6 0.6 0.7 0.4 0.7 0.7 0.4 28.9 34.8 0.0 1.9 6.9 19.2 68.9 13.1 0.0 49.3 30.0 0.5 47.1 64.2 86.5 0.0 123.0 0.5 112.2 137.0 141.3 43.4 52.4 5.4 1.7 74.4 0.0 0.3 115.8 101.0 1.5 73.4 57.7 2.5 0.0 0.7 0.0 9.8 0.0 0.2 95.5 97.6 0.8 0.0 19.9 1.5 2.6 3.6 0.0 1.7 0.0 0.0 0.0 0.2 130.2 125.6 0.7 0.0 37.6 162.0 373.6 61.5 0.0 0.0 0.0 6.2 16.9 4.1 39.1 13.1 66.1 2.8 0.0 131.4 48.3 CDKN2D "INK4D, p19" ENSG00000129355 "Cyclin dependent kinase inhibitor 2D" P55273 19 10566460-10569059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 286.2" "Cell type enhanced" "Detected in all" "dendritic cells: 146.8;Erythroid cells: 116.6;Macrophages: 105.4;NK-cells: 155.5;Spermatocytes: 126.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 90.6;MOLT-4: 113.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011201, HPA043546" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB011201: AB_261049, HPA043546: AB_2678545" "unprognostic (3.08e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.57e-2)" "unprognostic (1.49e-2)" "unprognostic (3.29e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.08e-1)" "unprognostic (1.08e-2)" "unprognostic (6.55e-2)" "unprognostic (3.28e-1)" "unprognostic (1.50e-1)" "unprognostic (3.27e-3)" "unprognostic (9.90e-2)" "unprognostic (4.52e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" 12.6 9.8 62.9 13.4 67.4 286.2 9.6 46.4 87.6 8.6 40.8 13.2 6.4 7.0 3.1 14.4 11.1 6.5 15.1 65.9 62.2 11.3 7.2 31.0 24.1 55.7 56.6 71.3 7.1 5.8 3.4 15.8 8.2 60.5 8.0 5.6 16.5 7.4 4.1 19.9 17.6 14.6 7.9 47.1 42.7 9.5 38.9 57.5 78.7 6.2 16.1 16.2 11.3 13.0 63.8 30.8 4.8 15.1 10.0 8.0 12.2 3.8 19.8 23.2 21.4 18.8 6.1 7.3 8.5 6.4 21.1 21.6 6.4 5.2 5.1 7.7 34.3 12.6 90.6 5.8 10.2 9.2 9.2 70.2 5.1 16.2 11.0 8.2 17.7 6.1 52.6 3.8 72.3 21.5 4.3 113.9 48.3 3.0 23.4 22.7 18.4 14.7 5.1 9.7 2.6 21.3 11.2 14.0 10.4 15.2 2.8 9.4 24.0 4.7 25.2 12.9 42.1 30.1 44.9 16.5 15.8 26.7 15.5 18.4 143.5 17.7 79.7 30.2 23.2 24.2 56.7 24.9 34.1 17.4 50.0 23.3 27.4 139.9 41.1 35.6 51.0 22.5 31.8 62.9 67.4 46.4 87.6 65.9 62.2 55.7 56.6 71.3 60.5 47.1 57.5 63.8 35.2 6.4 7.0 4.6 65.2 23.2 13.7 17.1 38.7 32.4 11.1 15.2 9.2 5.7 8.2 5.5 12.5 4.8 146.8 11.8 9.8 7.7 21.2 26.9 10.2 29.3 7.2 116.6 18.5 4.9 8.4 11.0 3.6 16.7 21.0 4.8 26.7 3.8 10.4 47.1 14.8 6.4 36.7 42.2 47.7 13.7 7.2 105.4 30.2 1.9 46.4 22.2 155.5 1.0 8.2 14.2 9.4 6.0 9.2 11.4 5.0 5.1 10.9 37.1 19.7 8.3 25.8 126.0 83.7 38.6 33.1 4.9 63.4 4.5 6.9 23.8 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules No No "Nucleoli, Microtubules" "HPA067903: AB_2685921, HPA069795: AB_2686198" "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favorable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favorable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 53.4 39.3 71.6 13.5 98.3 0.3 45.4 94.9 82.4 34.8 60.6 37.0 32.9 31.7 22.8 38.3 29.0 38.2 86.4 64.7 79.7 26.4 57.3 40.7 9.1 98.6 92.8 53.7 51.8 99.1 65.7 23.1 70.6 101.5 32.1 39.5 57.4 50.3 24.9 107.2 26.0 33.7 38.5 86.0 16.3 42.6 12.3 92.3 23.0 27.6 168.9 14.6 36.2 31.2 153.3 21.9 115.7 18.5 100.1 0.1 0.6 33.2 1.1 7.8 0.6 2.3 8.7 7.8 2.8 8.5 0.0 4.8 22.2 30.8 10.9 1.1 15.8 13.2 0.0 19.2 55.8 6.6 0.0 0.4 9.1 16.4 2.4 33.3 0.0 296.8 7.7 0.0 43.3 0.1 5.7 4.4 5.7 26.5 44.1 2.9 0.1 17.0 11.5 5.9 44.4 9.2 2.2 14.8 26.6 84.7 11.0 19.2 0.3 61.4 0.1 24.0 0.1 0.2 5.9 3.5 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 71.6 98.3 94.9 82.4 64.7 79.7 98.6 92.8 53.7 101.5 86.0 92.3 153.3 408.9 70.5 281.0 139.1 2.9 21.0 56.4 38.9 58.1 0.0 42.7 31.6 141.6 55.8 88.4 20.2 0.0 23.8 1.6 58.5 11.7 50.1 18.5 71.4 53.8 154.5 15.0 0.0 6.1 174.2 40.0 83.8 94.8 144.2 9.5 7.6 29.3 71.2 58.2 0.0 81.8 47.3 22.4 4.1 16.1 24.5 76.4 9.0 28.4 174.3 2.7 0.0 2.1 39.2 469.2 56.5 19.1 57.2 15.3 77.9 52.4 10.4 49.4 0.0 19.7 69.7 60.1 2.4 8.3 45.3 20.3 54.0 7.1 79.8 49.3 81.3 KLK14 KLK-L6 ENSG00000129437 "Kallikrein related peptidase 14" Q9P0G3 19 51077495-51084245 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 9.8" "Cell type enhanced" "Detected in single" "Club cells: 2.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 10.7;HEK 293: 2.9;U-266/84: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB026228 Uncertain "Secreted in other tissues" NA NA "CAB026228: " "unprognostic (2.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.44e-2)" "unprognostic (2.60e-2)" "unprognostic (1.23e-1)" "unprognostic (6.12e-2)" "unprognostic (4.91e-2)" "unprognostic (5.79e-2)" "unprognostic (7.84e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (8.87e-2)" "unprognostic (2.04e-8)" "unprognostic (1.93e-1)" "unprognostic (3.74e-3)" "unprognostic (1.94e-2)" "unprognostic (8.08e-2)" 0.3 0.3 2.1 0.2 2.1 0.1 1.7 2.2 3.3 2.4 1.6 0.4 1.3 0.5 0.6 0.9 0.7 0.3 0.8 2.1 1.7 0.4 0.3 0.4 0.3 2.2 1.8 2.0 1.1 0.7 0.0 0.6 0.0 2.6 0.8 0.3 0.6 0.8 0.5 0.3 9.8 0.7 0.1 1.8 0.6 0.6 0.9 1.9 0.3 0.4 0.1 0.5 0.6 4.0 2.5 1.4 0.5 0.1 0.6 0.4 0.4 0.6 0.1 0.0 0.0 0.1 1.2 1.4 0.6 0.4 0.2 0.3 10.7 0.1 0.2 0.0 0.3 2.9 0.2 0.9 0.0 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.1 0.1 0.4 0.2 0.3 0.0 0.9 0.2 0.5 0.6 1.2 1.1 0.1 0.1 0.6 0.0 0.6 0.1 0.0 0.2 1.0 0.3 0.2 0.4 0.0 0.0 0.1 0.4 0.6 0.2 2.6 5.5 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.1 2.2 3.3 2.1 1.7 2.2 1.8 2.0 2.6 1.8 1.9 2.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC9 CD329 ENSG00000129450 "Sialic acid binding Ig like lectin 9" Q9Y336 19 51124906-51136651 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.8" "Cell type enhanced" "Detected in some" "Hofbauer cells: 42.1;Kupffer cells: 39.8;Langerhans cells: 13.4;Macrophages: 26.8;monocytes: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "classical monocyte: 198.9;intermediate monocyte: 182.5;myeloid DC: 169.1;neutrophil: 212.0;non-classical monocyte: 121.9" "Group enriched" "Detected in many" 13 "dendritic cells: 169.1;granulocytes: 212.0;monocytes: 198.9" "Group enriched" "Detected in some" 10 "Karpas-707: 23.4;RPMI-8226: 16.5" HPA010682 Uncertain NA NA 270000 "HPA010682: AB_1079968" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.03e-2)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (6.86e-2)" "unprognostic (5.10e-2)" "unprognostic (2.10e-1)" "unprognostic (1.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (7.03e-3)" "prognostic unfavorable (6.17e-5)" "unprognostic (6.56e-2)" "unprognostic (7.38e-3)" "unprognostic (2.95e-1)" "unprognostic (1.73e-1)" 8.1 5.4 2.2 18.0 2.9 9.1 1.9 2.6 4.6 1.4 3.7 2.1 1.7 0.9 0.2 0.9 2.6 5.0 1.7 2.2 10.3 1.4 5.5 8.3 5.1 5.6 3.4 1.7 3.2 1.2 4.1 0.9 7.9 4.5 1.1 2.4 0.3 1.5 0.9 0.4 0.5 2.2 6.5 4.2 20.8 1.4 1.7 5.5 1.4 0.9 1.4 2.5 5.4 0.8 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 23.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.0 1.5 0.0 17.3 198.9 1.6 15.2 182.5 8.6 0.2 2.5 5.8 169.1 0.1 0.6 2.7 212.0 3.1 121.9 9.2 0.9 84.9 2.2 2.9 2.6 4.6 2.2 10.3 5.6 3.4 1.7 4.5 4.2 5.5 5.4 0.1 0.0 0.5 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.3 0.0 0.0 0.2 2.7 0.0 0.0 0.0 1.8 0.0 0.1 1.1 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.1 5.3 0.8 42.1 0.0 0.2 0.0 0.0 39.8 13.4 0.4 5.0 26.8 0.0 5.6 10.4 0.0 7.2 0.0 0.1 0.0 0.0 2.2 0.4 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.1 0.0 0.1 0.0 0.1 0.3 1.3 2.8 0.0 0.0 KLK10 "NES1, PRSSL1" ENSG00000129451 "Kallikrein related peptidase 10" O43240 19 51012739-51020175 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Cell cycle" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 415.8;vagina: 192.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Basal respiratory cells: 61.4;Club cells: 113.9;Pancreatic endocrine cells: 74.8;Prostatic glandular cells: 68.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 97.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 67.2;HaCaT: 158.7;OE19: 68.1" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.6" "Not detected" "Not detected" "Secreted in other tissues" NA NA 2500000 "prognostic favorable (8.32e-4)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (4.26e-3)" "unprognostic (3.81e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-2)" "unprognostic (2.10e-2)" "unprognostic (3.94e-1)" "unprognostic (3.38e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (2.71e-2)" "unprognostic (2.46e-6)" "unprognostic (9.34e-2)" "unprognostic (7.81e-2)" "unprognostic (2.66e-3)" "unprognostic (1.52e-2)" 4.1 0.6 0.6 0.2 0.6 0.6 6.3 1.2 1.1 56.8 0.9 1.4 0.4 1.7 0.2 415.8 8.6 3.5 0.9 0.3 1.1 0.3 0.3 8.8 0.0 2.2 1.2 0.4 19.9 0.6 0.2 1.6 0.2 2.8 7.3 0.6 0.3 55.6 0.5 0.2 63.2 2.6 0.6 0.7 0.2 1.8 6.0 0.9 0.3 0.6 0.1 18.9 0.6 192.1 2.9 21.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 67.2 0.0 6.6 0.0 0.1 158.7 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 68.1 0.6 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.2 1.1 0.3 1.1 2.2 1.2 0.4 2.8 0.7 0.9 2.9 0.3 32.1 2.6 0.0 0.0 7.5 15.6 61.4 9.1 1.0 12.3 14.0 0.7 8.6 113.9 0.0 0.0 0.0 0.2 1.2 0.0 7.5 0.3 2.1 1.0 1.7 0.0 0.0 0.1 15.4 0.0 6.0 1.1 8.0 0.0 0.1 1.1 0.0 0.1 0.0 0.6 0.0 22.4 0.0 0.6 0.6 11.5 0.5 0.0 0.0 0.6 0.3 0.0 0.0 0.5 74.8 0.0 6.0 0.0 68.6 0.0 0.0 15.8 0.5 0.0 0.4 2.6 1.0 1.6 28.0 4.3 0.0 0.5 0.5 0.0 29.6 KLK8 "HNP, neuropsin, ovasin, PRSS19, TADG14" ENSG00000129455 "Kallikrein related peptidase 8" O60259 19 50996007-51002711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 118.9;skin 1: 85.7;vagina: 47.6" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 29.9;ovarian cancer: 30.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5" "Region enriched" "Detected in all" 5 "hippocampal formation: 36.1" "Region enhanced" "Detected in single" "basal ganglia: 1.2" "CAB019393, HPA035761" Enhanced Approved Vesicles "Secreted in other tissues" NA NA 3200000 Vesicles "CAB019393: , HPA035761: AB_2674769" "unprognostic (4.27e-3)" "unprognostic (2.59e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (5.46e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.10e-4)" "unprognostic (4.29e-2)" "unprognostic (4.66e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (6.17e-4)" 2.7 0.0 0.1 0.0 0.1 0.0 8.5 0.8 0.7 12.1 0.2 0.0 0.0 0.9 0.4 118.9 13.3 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 17.3 0.1 0.7 85.7 0.0 0.2 0.1 0.2 0.1 1.3 0.1 1.1 0.5 0.0 9.6 0.0 47.6 0.5 88.3 0.0 0.0 0.6 0.0 0.0 12.3 0.0 0.0 0.0 0.0 1.7 112.2 0.0 2.2 0.0 0.1 83.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 10.3 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.7 0.1 0.3 0.5 0.1 0.0 0.4 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.3 66.0 0.0 0.4 14.8 0.0 13.0 15.6 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.7 11.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 5.0 1.8 0.1 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 2.8 6.2 21.1 180.1 0.0 0.2 0.0 0.2 0.1 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469689-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 31.7 26.7 26.9 23.5 29.1 64.9 40.7 31.5 38.0 30.2 26.4 28.4 23.6 35.1 32.7 26.4 32.3 17.7 23.7 26.9 28.0 31.6 33.2 24.4 35.6 28.2 28.2 26.6 40.0 25.9 33.6 21.0 29.4 28.8 25.0 29.3 25.4 24.8 26.8 53.9 35.3 27.0 31.7 28.6 28.8 27.2 28.9 27.8 37.8 28.6 39.6 37.1 32.6 27.9 32.7 37.6 73.1 54.5 51.5 52.0 37.3 72.1 48.6 50.7 101.3 81.4 72.1 66.8 92.6 35.0 44.7 71.1 63.7 109.0 60.1 118.7 61.8 57.3 83.2 44.1 229.3 70.5 110.4 56.9 46.5 75.0 79.9 94.4 39.6 52.2 69.5 93.6 64.1 50.4 88.8 82.3 86.0 69.5 84.8 97.1 67.1 65.6 47.9 65.7 70.4 55.6 62.8 57.6 68.3 83.8 55.0 42.2 70.4 39.8 47.8 57.3 45.1 71.3 79.4 148.7 133.3 20.6 56.1 52.2 67.0 62.3 58.5 88.0 71.8 93.5 129.0 94.6 89.9 74.8 107.7 121.3 95.5 19.1 109.5 71.7 79.1 116.1 93.3 26.9 29.1 31.5 38.0 26.9 28.0 28.2 28.2 26.6 28.8 28.6 27.8 32.7 33.8 35.3 29.2 2.9 52.1 70.6 63.8 78.2 72.8 23.2 25.5 31.2 20.2 21.5 46.8 27.6 16.7 59.3 45.3 19.9 33.2 38.6 7.2 24.3 25.9 36.5 24.6 35.1 7.5 36.0 43.3 34.4 16.3 27.5 45.0 23.2 25.4 21.4 29.8 25.2 6.8 22.7 28.5 19.2 39.0 6.9 35.1 21.1 32.0 9.4 34.3 26.8 46.4 4.0 11.0 31.1 22.8 28.2 30.4 42.9 25.8 35.5 36.6 28.6 19.7 51.5 36.0 68.7 64.2 39.6 67.6 57.2 47.6 20.5 27.2 49.5 RIPK3 RIP3 ENSG00000129465 "Receptor interacting serine/threonine kinase 3" Q9Y572 14 24336025-24340022 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.5;Exocrine glandular cells: 35.2;Gastric mucus-secreting cells: 22.4;Paneth cells: 21.4;Proximal enterocytes: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.0;HDLM-2: 4.1;OE19: 10.1;SK-BR-3: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-2)" "unprognostic (1.11e-1)" "unprognostic (5.26e-3)" "unprognostic (9.58e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-2)" 8.1 1.8 0.8 5.7 0.7 5.0 8.1 0.7 1.4 5.0 0.9 9.6 10.3 3.2 1.5 12.0 3.8 5.5 3.8 0.7 0.9 4.3 1.7 8.1 7.8 1.1 0.8 0.5 0.7 7.9 0.8 1.2 3.2 1.0 3.4 11.1 0.0 9.0 1.5 1.6 6.5 18.5 2.1 0.9 18.7 10.7 1.1 0.9 3.6 10.8 1.3 7.7 5.5 7.5 1.1 0.0 0.0 0.0 0.0 2.4 2.7 0.0 0.6 3.4 0.0 0.0 0.1 7.0 0.1 1.7 0.3 0.0 1.6 0.0 0.1 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 1.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 10.1 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.0 11.1 0.0 0.0 1.9 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 1.7 3.3 4.2 3.7 5.1 3.9 2.1 3.1 3.7 3.3 2.4 1.6 2.3 1.9 2.7 6.0 1.6 6.1 2.9 0.8 0.7 0.7 1.4 0.7 0.9 1.1 0.8 0.5 1.0 0.9 0.9 1.1 5.5 3.2 9.1 0.0 5.7 1.5 1.4 5.8 1.8 0.0 2.0 0.9 0.7 2.8 4.7 3.7 0.0 0.3 9.6 38.5 3.9 8.1 0.1 3.2 0.8 4.2 6.1 1.3 0.0 35.2 0.4 1.9 22.4 5.4 12.6 0.0 0.7 0.0 12.7 0.0 0.0 14.4 4.1 9.5 1.6 0.3 0.0 7.7 3.6 1.9 11.6 0.0 10.3 0.0 0.0 17.8 21.4 0.0 5.5 0.5 22.5 0.1 3.7 0.0 0.0 0.2 1.0 0.0 0.3 3.9 1.4 0.3 8.3 0.1 8.0 3.3 ADCY4 AC4 ENSG00000129467 "Adenylate cyclase 4" Q8NFM4 14 24318349-24335093 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 2.9;TIME: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB005070, HPA048344" Approved NA NA "CAB005070: AB_2273639, HPA048344: AB_2680366" "unprognostic (5.59e-2)" "unprognostic (1.34e-1)" "unprognostic (3.47e-4)" "prognostic favorable (8.20e-4)" "unprognostic (4.06e-1)" "unprognostic (2.82e-3)" "unprognostic (1.75e-4)" "unprognostic (8.58e-2)" "unprognostic (2.51e-2)" "unprognostic (7.88e-2)" "unprognostic (6.77e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (8.02e-2)" "unprognostic (3.88e-2)" "unprognostic (1.57e-1)" "unprognostic (3.47e-2)" 16.7 2.6 2.5 2.3 1.8 0.0 16.2 1.8 2.8 9.1 1.8 3.8 0.9 8.9 0.5 3.7 8.3 2.9 12.0 1.6 1.7 7.5 1.5 10.0 1.6 2.3 2.0 1.2 2.4 2.3 1.0 1.7 10.0 2.1 5.3 0.7 0.0 3.8 1.4 4.3 4.4 4.5 1.9 2.0 10.0 3.7 1.1 2.7 0.4 7.7 2.8 0.8 5.9 6.7 1.9 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.1 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.5 1.8 1.8 2.8 1.6 1.7 2.3 2.0 1.2 2.1 2.0 2.7 1.9 90.9 0.0 1.8 0.3 1.0 3.6 0.4 0.3 3.4 0.0 1.5 1.5 10.6 0.0 0.9 1.8 0.0 0.2 1.6 2.9 0.0 1.2 1.3 0.5 1.1 74.6 1.2 0.4 0.2 3.1 0.1 4.7 7.1 0.6 1.3 0.0 50.3 0.2 1.4 1.7 0.2 7.9 0.0 5.0 3.1 6.9 0.0 1.5 7.2 12.2 2.5 0.9 1.0 0.0 0.0 2.1 3.8 0.0 1.4 0.4 2.4 0.0 1.1 0.2 6.6 1.7 5.7 0.3 0.8 0.6 2.8 0.0 1.6 0.5 2.1 0.2 RAB2B FLJ14824 ENSG00000129472 "RAB2B, member RAS oncogene family" Q8WUD1 14 21459020-21476960 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050292 Uncertain NA NA "HPA050292: AB_2681076" "unprognostic (7.56e-2)" "unprognostic (4.61e-2)" "unprognostic (2.98e-2)" "unprognostic (3.05e-3)" "unprognostic (1.75e-2)" "unprognostic (6.69e-2)" "unprognostic (8.86e-2)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (1.13e-1)" "unprognostic (1.66e-1)" "unprognostic (5.22e-3)" "unprognostic (1.49e-1)" "unprognostic (3.47e-1)" "unprognostic (3.21e-1)" "unprognostic (1.63e-1)" 11.6 11.7 17.4 7.5 18.8 19.0 12.2 19.5 19.7 11.9 16.9 11.6 7.9 10.8 15.0 8.9 11.4 8.5 10.0 17.4 20.5 10.3 13.2 11.1 9.4 20.1 19.2 17.6 13.9 11.6 10.6 14.3 9.8 21.1 13.8 8.3 18.0 10.1 10.0 7.0 11.6 11.2 10.5 18.5 12.4 10.1 10.3 20.0 10.7 14.6 8.3 10.3 10.8 10.6 22.2 6.1 9.5 20.2 14.2 15.1 16.5 10.8 12.5 15.2 12.1 16.5 5.1 11.7 8.8 9.1 13.4 13.5 8.4 12.9 7.8 17.0 22.2 6.3 10.4 6.3 17.0 18.7 14.8 18.8 17.0 11.7 14.9 12.8 17.5 17.8 15.6 6.7 12.4 18.3 4.6 11.3 11.3 11.0 8.9 11.4 14.2 19.8 5.1 12.8 6.9 14.6 17.6 17.9 6.7 14.2 18.9 5.5 6.0 19.9 12.0 10.8 9.4 7.4 15.6 17.4 12.6 5.3 5.1 16.7 12.1 2.9 7.8 6.0 3.8 6.8 5.4 6.5 6.5 3.6 4.8 5.0 6.7 3.2 6.1 5.4 10.6 7.1 3.5 17.4 18.8 19.5 19.7 17.4 20.5 20.1 19.2 17.6 21.1 18.5 20.0 22.2 16.5 9.6 15.0 12.1 15.7 19.8 14.4 11.2 22.2 11.8 16.9 11.4 8.3 7.2 8.3 12.9 25.0 10.0 22.5 11.6 1.9 6.6 32.1 10.6 11.1 14.6 21.4 17.0 13.1 5.1 8.8 12.5 10.7 13.6 19.0 13.5 15.4 24.1 11.4 20.2 13.0 8.5 12.2 22.7 16.6 54.5 10.2 12.5 26.6 12.2 13.1 8.2 12.3 16.1 19.6 6.4 5.7 10.9 27.1 14.8 9.9 9.9 9.2 15.0 0.0 13.3 12.0 16.7 14.9 14.9 18.2 15.7 17.6 9.4 7.3 12.6 BCL2L2 "BCL-W, KIAA0271, PPP1R51" ENSG00000129473 "BCL2 like 2" Q92843 14 23298790-23311751 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB040539, HPA048740" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB040539: , HPA048740: " "unprognostic (8.23e-3)" "unprognostic (9.85e-2)" "unprognostic (1.71e-2)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (1.64e-1)" "unprognostic (3.47e-3)" "unprognostic (1.53e-2)" "unprognostic (1.78e-1)" "unprognostic (2.91e-3)" "unprognostic (1.50e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.44e-1)" "unprognostic (2.00e-1)" "unprognostic (6.60e-2)" "unprognostic (5.38e-2)" 48.9 36.9 113.2 26.3 102.4 14.0 35.9 94.1 104.9 30.5 71.7 70.0 28.8 43.4 30.8 47.3 35.7 24.9 37.2 99.8 99.3 35.2 21.1 34.8 14.0 105.4 104.9 94.2 32.1 53.8 53.3 38.4 24.0 111.2 47.9 32.1 52.4 52.6 45.9 24.4 46.9 34.5 41.9 108.8 20.7 54.6 25.3 114.4 10.8 38.8 20.1 16.6 56.0 35.2 100.4 24.1 23.0 25.6 19.0 43.4 39.2 19.3 43.9 28.5 21.8 24.9 16.3 42.6 16.8 14.2 26.6 27.4 43.9 15.9 28.1 29.4 8.9 12.7 18.4 44.4 30.3 26.6 20.7 30.0 30.3 54.0 17.6 27.1 30.6 18.6 2.9 17.3 18.0 27.8 17.8 1.6 14.5 8.0 33.4 41.3 12.8 28.1 8.2 19.7 45.5 31.7 18.0 20.8 31.3 31.2 15.6 20.6 15.5 37.1 35.1 24.8 27.6 23.1 22.0 12.7 2.2 21.6 16.0 43.5 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.3 113.2 102.4 94.1 104.9 99.8 99.3 105.4 104.9 94.2 111.2 108.8 114.4 100.4 9.2 9.6 13.1 0.0 2.6 8.7 9.5 12.7 5.7 20.0 11.0 8.0 28.9 4.3 13.6 5.5 25.0 5.3 3.5 16.8 13.7 8.0 20.1 11.1 10.4 10.8 18.6 2.1 0.0 18.3 4.0 10.4 9.7 12.1 5.7 12.0 11.4 7.2 5.5 20.2 0.0 16.8 6.1 8.4 4.0 6.1 11.1 5.5 7.2 0.0 7.5 7.4 2.1 0.0 0.0 25.5 11.0 21.4 4.5 17.2 16.3 9.2 12.2 12.7 6.6 12.6 15.5 0.5 0.9 10.8 11.1 5.6 1.5 8.9 10.5 17.6 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971177-22982551 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 62.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 217.0;hTCEpi: 222.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" NA Yes "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 4.7 3.0 3.2 1.4 2.0 0.5 6.7 2.2 2.2 12.4 8.2 2.7 1.5 12.2 8.6 18.4 7.6 5.0 6.4 2.3 2.7 17.9 43.8 15.4 2.6 2.5 2.4 1.4 12.3 11.7 7.2 2.0 19.5 1.8 10.7 2.6 3.8 8.3 16.0 1.9 62.2 1.9 8.5 2.7 3.8 4.2 5.5 2.3 8.3 11.0 2.3 5.5 7.7 15.6 2.9 46.9 54.1 71.0 27.6 6.8 12.2 57.4 44.9 58.5 102.6 91.4 116.0 47.3 1.2 45.5 92.9 70.8 146.2 54.9 217.0 124.6 4.5 5.0 3.5 90.8 131.4 78.9 4.9 3.1 38.9 222.3 42.9 164.3 72.7 40.0 8.3 1.9 2.8 96.2 37.3 4.5 5.7 4.5 86.6 73.9 12.7 59.0 1.2 103.9 71.3 0.2 6.2 135.5 39.4 8.8 57.4 55.3 4.5 36.1 44.2 88.4 7.3 43.6 0.4 1.3 0.5 7.0 4.2 20.6 0.7 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.5 0.1 0.2 0.3 0.2 0.5 0.5 0.2 0.2 0.0 0.1 3.2 2.0 2.2 2.2 2.3 2.7 2.5 2.4 1.4 1.8 2.7 2.3 2.9 2.1 19.2 6.4 0.7 0.0 47.5 13.0 27.6 35.3 0.1 3.7 9.7 4.5 20.0 10.2 7.3 0.0 10.0 0.1 0.3 5.9 14.3 5.8 13.0 2.5 4.0 0.0 0.0 0.0 14.9 9.8 3.4 0.0 4.4 0.0 12.8 2.5 17.1 1.7 0.0 0.0 0.4 2.0 0.0 2.2 5.0 3.7 0.6 3.6 0.0 0.0 8.1 0.0 0.5 0.0 33.8 0.1 0.7 1.2 34.2 0.3 21.0 8.3 0.2 32.9 2.7 14.0 7.0 2.7 14.2 49.6 4.0 0.5 1.6 0.8 18.0 DTD2 "C14orf126, MGC9912" ENSG00000129480 "D-aminoacyl-tRNA deacylase 2" Q96FN9 14 31446036-31457506 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001117 Approved Approved Vesicles NA NA Vesicles "HPA001117: AB_2666204" "unprognostic (2.56e-3)" "unprognostic (9.38e-2)" "unprognostic (1.27e-3)" "unprognostic (3.24e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.04e-2)" "unprognostic (1.64e-1)" "unprognostic (8.74e-3)" "unprognostic (2.91e-1)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (5.74e-6)" 8.7 6.3 5.0 5.0 7.0 2.4 7.2 5.5 6.2 4.1 5.3 4.8 3.9 5.3 5.0 5.8 5.0 3.6 3.1 5.5 5.6 5.8 8.1 5.8 5.6 6.1 6.2 4.9 5.4 6.4 6.1 4.5 4.3 6.4 5.8 5.4 5.0 6.1 3.9 1.6 5.7 3.8 5.5 5.2 4.9 4.0 4.1 6.1 5.1 6.3 1.7 5.6 4.8 3.8 8.5 11.4 9.5 8.1 10.6 14.6 12.3 5.5 10.3 10.0 8.0 7.1 5.2 10.7 21.6 6.8 11.8 8.6 10.8 13.0 11.6 13.6 11.7 5.7 6.2 6.5 29.0 15.7 12.6 7.3 14.0 12.9 7.1 15.9 6.7 11.8 12.8 12.3 9.9 10.7 13.7 18.3 11.3 11.0 19.6 9.7 12.3 6.0 11.3 15.0 9.8 12.1 8.0 16.8 21.6 12.4 6.9 19.8 6.5 8.6 8.7 7.7 7.1 9.1 12.3 24.5 20.7 3.8 11.4 14.3 2.5 2.6 1.0 2.0 2.2 2.9 2.7 3.0 2.2 3.7 3.2 4.5 3.0 1.5 3.7 1.2 2.2 1.6 2.8 5.0 7.0 5.5 6.2 5.5 5.6 6.1 6.2 4.9 6.4 5.2 6.1 8.5 2.9 9.6 9.0 10.1 7.6 5.2 5.7 5.1 13.1 5.9 6.1 4.3 4.8 15.7 4.9 3.7 8.4 9.1 4.9 3.3 3.9 5.7 4.4 6.8 7.2 3.8 3.0 8.0 9.2 6.2 6.3 6.2 5.1 3.0 1.3 5.9 3.9 11.6 5.1 5.0 12.7 6.7 14.2 5.5 3.7 6.6 7.5 4.0 3.6 2.8 4.8 9.5 7.2 35.2 40.2 5.2 3.9 8.2 7.1 6.0 3.3 9.7 6.2 9.2 0.0 7.4 6.8 10.1 2.7 16.2 5.4 2.7 5.4 10.3 7.2 4.2 PARP2 "ADPRTL2, ARTD2" ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343615-20357904 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 15.2 21.3 21.9 10.8 23.8 27.0 17.7 23.5 31.7 18.1 18.6 16.9 12.9 21.1 18.0 14.7 17.7 10.1 16.3 23.9 22.6 15.6 17.3 13.6 14.6 21.6 21.3 22.9 23.1 18.1 11.2 21.1 13.0 23.2 14.0 14.2 26.7 14.3 13.6 32.7 19.1 14.3 16.0 20.6 16.6 16.4 24.0 21.5 12.0 16.8 27.3 18.0 13.9 15.4 23.8 55.5 39.5 59.7 45.3 19.4 18.4 43.4 60.2 32.5 74.8 91.8 36.8 51.3 40.4 26.5 19.0 64.8 50.1 78.3 27.5 87.8 32.4 38.3 37.2 46.6 63.3 17.3 77.9 20.4 12.5 23.0 45.5 51.1 20.5 38.5 48.0 39.2 53.4 52.3 33.5 40.1 33.0 33.0 62.8 60.0 49.7 79.7 26.5 30.0 28.2 41.3 28.3 65.3 36.8 17.9 37.4 34.2 25.8 26.6 45.3 68.1 31.5 48.1 49.3 67.7 53.4 19.0 33.3 51.4 1.9 5.0 0.5 8.9 4.8 11.7 6.8 8.4 7.9 5.5 4.1 9.0 8.6 0.1 7.6 2.6 5.6 5.3 4.8 21.9 23.8 23.5 31.7 23.9 22.6 21.6 21.3 22.9 23.2 20.6 21.5 23.8 12.1 25.6 6.5 7.2 9.5 6.5 10.5 16.1 18.8 29.2 7.4 10.0 14.0 5.7 19.9 7.3 12.5 25.8 10.2 4.5 7.9 12.8 9.3 9.9 13.3 11.0 4.8 30.3 17.6 8.7 22.2 11.6 7.7 11.3 8.2 18.4 6.8 10.1 11.9 30.3 15.5 5.0 14.2 4.6 5.1 9.8 11.5 6.6 8.8 9.4 4.2 20.7 6.2 6.0 9.3 10.1 4.5 17.0 19.1 4.5 5.3 7.4 28.0 23.2 6.6 9.8 18.5 20.9 41.5 11.3 4.8 14.9 6.2 16.7 7.4 7.0 HEATR5A "C14orf125, DKFZP434I1735" ENSG00000129493 "HEAT repeat containing 5A" Q86XA9 14 31291788-31420550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 120.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 120.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049539 Uncertain NA NA "HPA049539: AB_2680809" "unprognostic (2.63e-1)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (5.47e-3)" "unprognostic (3.97e-2)" "unprognostic (9.37e-2)" "unprognostic (8.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.11e-6)" "unprognostic (1.00e-1)" "unprognostic (5.93e-2)" "unprognostic (2.83e-2)" "unprognostic (6.00e-2)" 8.7 11.2 10.4 9.0 11.9 7.0 8.1 11.7 9.0 9.7 10.0 14.2 10.4 7.4 5.9 10.1 8.9 7.5 16.5 8.5 16.5 10.3 8.7 9.0 5.8 14.0 12.0 6.9 6.3 4.9 9.2 7.5 12.2 16.0 5.8 11.5 7.4 8.1 5.8 12.2 4.2 12.1 10.4 10.8 8.0 7.6 8.3 10.0 3.5 7.7 20.4 6.8 11.0 6.7 18.8 28.3 43.3 12.2 15.7 29.0 27.3 25.3 33.6 28.3 18.0 18.3 17.4 21.1 15.1 31.4 50.7 10.8 18.6 23.2 10.3 25.5 11.5 21.4 11.4 56.5 73.8 16.9 21.9 15.8 12.8 5.5 15.4 14.6 14.1 22.8 6.9 23.4 15.2 21.0 25.2 8.2 9.4 9.3 17.8 25.2 4.7 24.1 8.6 11.9 17.5 5.1 15.3 77.2 35.3 78.4 17.0 20.0 6.2 35.4 13.1 19.6 22.5 13.6 14.9 42.3 23.8 3.9 12.0 19.5 120.4 11.8 47.3 2.7 11.7 1.6 4.7 1.9 2.4 8.2 3.6 1.6 2.9 38.4 3.7 18.1 3.7 2.0 4.6 10.4 11.9 11.7 9.0 8.5 16.5 14.0 12.0 6.9 16.0 10.8 10.0 18.8 7.8 28.9 20.2 58.4 7.5 5.9 2.4 6.3 5.2 12.1 9.9 5.5 17.0 5.7 15.5 18.4 14.6 13.1 2.7 33.5 1.9 11.7 3.5 16.3 9.0 8.7 6.7 2.5 27.1 11.7 10.8 13.1 9.7 7.4 11.4 6.9 10.4 14.8 10.6 1.7 38.8 13.5 10.2 14.8 10.8 1.3 12.2 13.6 10.6 42.2 15.1 19.2 1.0 67.8 96.6 17.6 22.4 11.7 10.1 6.3 17.3 8.9 21.8 9.3 0.0 18.1 9.6 21.7 13.2 10.0 7.2 18.1 5.9 11.4 13.1 4.9 FOXA1 HNF3A ENSG00000129514 "Forkhead box A1" P55317 14 37589552-37596059 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 75.4;stomach 1: 28.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5" "Group enriched" "Detected in many" 5 "breast cancer: 80.0;prostate cancer: 127.0" "Region enhanced" "Detected in single" "midbrain: 3.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9" "Region enhanced" "Detected in some" "midbrain: 1.1" "Region enriched" "Detected in single" 6 "midbrain: 5.4" "CAB011595, HPA050505" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB011595: AB_2104842, HPA050505: AB_2681148" "unprognostic (1.61e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.78e-1)" "unprognostic (1.71e-1)" "unprognostic (3.01e-1)" "unprognostic (1.54e-2)" "unprognostic (6.30e-2)" "unprognostic (0.00e+0)" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.69e-2)" "prognostic favorable (1.00e-4)" 0.2 0.1 0.0 1.6 0.0 0.0 22.6 0.0 0.0 0.8 0.0 12.5 8.4 0.1 0.6 12.0 2.4 2.3 0.0 0.0 0.7 0.1 27.1 7.6 0.0 0.1 3.0 0.0 0.0 0.5 0.0 0.7 0.0 0.1 75.4 10.5 0.0 19.4 0.3 0.0 1.2 4.9 0.2 0.3 0.0 28.3 0.4 0.5 0.0 0.0 0.0 2.3 20.7 4.5 0.0 4.9 4.4 0.0 2.8 0.0 0.0 0.5 0.0 0.4 0.0 0.0 21.3 2.7 0.0 1.4 0.0 0.1 23.4 13.2 3.3 0.1 0.0 23.4 0.0 4.1 48.9 0.0 0.0 0.2 0.0 0.7 0.0 0.4 1.9 0.0 0.4 0.9 0.0 0.0 105.3 0.1 0.3 0.0 32.0 69.5 0.0 1.1 0.4 9.9 96.7 11.8 0.0 4.8 97.0 0.0 0.0 135.9 0.4 0.0 0.9 0.1 0.4 3.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 3.0 0.0 0.1 0.3 0.5 0.0 0.3 28.9 43.5 0.0 0.1 1.0 113.8 47.8 76.8 0.0 87.9 34.8 1.3 30.0 52.3 3.7 0.0 0.0 0.5 27.5 0.0 1.5 0.4 2.7 0.2 1.2 84.6 0.0 0.0 2.4 0.0 1.0 35.7 4.4 2.5 0.0 1.1 31.7 0.0 0.0 0.0 34.9 42.7 0.9 0.3 0.9 0.0 0.7 3.6 0.0 1.0 0.0 0.0 0.0 0.0 4.3 27.2 0.0 1.2 89.8 4.9 0.0 66.7 0.0 0.0 0.0 2.3 0.9 1.2 62.9 0.1 0.0 1.4 0.1 27.9 154.5 SNX6 ENSG00000129515 "Sorting nexin 6" Q9UNH7 14 34561093-34630160 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049374 Approved Supported Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" "HPA049374: AB_2680734" "unprognostic (1.89e-1)" "unprognostic (6.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.06e-2)" "unprognostic (1.12e-1)" "unprognostic (2.36e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.23e-1)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.91e-1)" "unprognostic (3.48e-2)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" 50.5 36.8 46.2 47.2 50.6 42.4 37.1 47.9 56.2 40.8 47.8 50.9 74.9 33.9 30.4 40.4 31.5 40.0 34.0 42.4 50.7 44.8 39.2 33.7 57.0 52.4 50.1 40.5 31.6 25.3 78.9 15.0 75.2 51.9 26.1 49.6 14.9 27.4 29.7 30.7 30.5 49.5 44.3 52.3 49.6 39.9 36.4 48.9 45.5 34.4 29.5 48.2 50.7 29.9 58.6 112.3 65.3 73.5 48.9 114.5 224.7 99.4 113.1 124.0 110.4 95.4 61.6 115.4 73.2 79.0 153.2 44.1 67.8 81.1 85.8 187.9 93.5 31.7 44.6 34.9 115.9 108.5 77.2 46.8 154.1 98.9 80.7 109.7 100.4 151.7 53.3 48.8 56.3 146.9 68.4 69.9 41.4 40.2 97.7 73.0 74.3 84.4 64.1 135.2 84.6 56.7 61.1 89.9 72.9 94.6 65.0 77.6 47.5 150.8 74.6 52.6 67.8 72.0 55.9 95.9 82.9 37.6 41.6 86.1 73.5 74.2 93.4 73.1 97.4 95.8 71.5 97.0 84.8 66.5 68.0 73.3 79.2 126.5 74.0 101.3 47.6 102.0 109.0 46.2 50.6 47.9 56.2 42.4 50.7 52.4 50.1 40.5 51.9 52.3 48.9 58.6 130.2 86.6 49.7 17.6 77.5 51.4 63.0 109.7 69.4 43.4 51.1 67.8 73.4 27.1 87.2 80.9 22.9 166.7 108.9 73.0 125.2 88.1 6.6 74.9 110.1 87.5 52.0 55.5 25.5 64.7 126.3 88.0 68.8 114.3 85.4 93.5 124.6 36.8 251.1 21.9 31.2 62.7 67.1 196.1 73.0 15.3 64.3 155.7 62.2 26.2 155.4 69.6 88.6 21.1 52.5 74.1 77.9 94.8 51.2 84.0 54.8 127.0 73.3 39.4 59.2 74.2 133.8 164.6 167.9 90.0 65.8 254.6 109.4 346.2 82.0 76.8 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515938-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 33.3 36.1 27.9 24.8 28.5 90.0 51.6 31.2 35.8 33.6 28.5 51.3 36.1 35.3 45.1 29.3 39.7 28.3 29.3 28.1 29.2 42.8 50.6 29.8 37.5 27.5 28.6 26.4 50.1 26.9 55.1 21.8 35.5 28.1 34.0 52.2 37.4 36.7 31.5 37.3 46.2 46.0 29.5 28.6 31.6 29.5 23.7 28.0 49.5 45.9 29.6 37.4 31.4 30.2 31.4 37.7 45.1 41.3 24.4 47.8 48.7 64.1 33.8 51.6 41.5 43.1 21.6 48.6 39.1 46.6 41.5 24.7 34.5 30.8 45.1 48.3 49.1 27.1 28.7 31.6 91.7 65.1 51.5 30.4 56.3 56.7 23.8 60.9 54.6 41.7 54.1 28.9 42.0 39.1 88.0 71.4 41.5 24.3 69.4 50.0 44.8 49.5 39.5 50.2 50.3 33.1 36.5 47.8 45.6 76.4 39.4 79.7 32.3 45.2 21.4 18.1 28.1 22.0 52.8 63.1 41.5 20.1 28.0 27.6 139.9 61.9 134.3 65.3 57.8 79.1 107.7 81.9 75.0 54.9 101.0 82.7 75.8 140.2 100.6 80.9 47.8 124.4 80.0 27.9 28.5 31.2 35.8 28.1 29.2 27.5 28.6 26.4 28.1 28.6 28.0 31.4 59.8 22.4 53.3 17.0 78.6 46.4 67.2 145.0 74.6 75.6 60.0 70.1 35.4 60.1 78.8 82.8 31.3 125.3 76.3 91.8 174.1 86.6 20.9 82.0 59.6 57.8 66.0 66.7 20.5 84.5 76.5 67.6 26.5 54.8 73.5 98.7 57.5 109.0 58.8 25.2 21.3 112.8 87.5 50.6 33.9 14.9 89.5 47.5 90.7 16.9 71.3 122.0 87.6 17.6 23.1 59.8 102.5 94.4 46.8 61.4 131.5 164.8 102.0 75.7 72.3 69.9 78.7 103.3 38.3 63.8 66.5 189.4 74.2 101.2 98.0 58.2 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924227-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 108.4;skin 1: 118.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 213.7;Cardiomyocytes: 105.8;Distal enterocytes: 135.5;Extravillous trophoblasts: 115.9;Suprabasal keratinocytes: 231.6" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in many" "RH-30: 44.6;RPTEC TERT1: 38.2;RT4: 122.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064895 Supported Cytosol NA NA Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 11.4 0.8 32.8 9.5 39.0 0.4 10.1 37.5 37.8 12.4 15.3 26.1 36.0 10.1 4.4 27.2 9.5 13.9 108.4 28.3 35.9 10.3 4.9 8.4 5.7 34.8 36.5 27.0 2.2 4.4 0.3 3.4 25.6 35.9 9.2 20.2 15.4 11.3 12.1 21.0 118.7 41.3 11.8 30.0 5.0 38.0 1.1 42.1 5.0 2.8 6.5 9.9 51.7 20.9 35.8 31.1 8.0 0.9 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 8.2 0.0 10.0 0.1 0.9 0.9 15.0 29.4 0.0 3.1 8.0 8.3 20.5 1.0 0.0 0.0 0.4 4.0 14.5 0.0 0.1 0.0 0.0 2.3 16.9 0.0 0.4 2.7 0.7 0.1 24.3 26.7 2.8 0.0 44.6 11.1 38.2 122.9 6.2 7.0 2.0 11.8 3.2 18.2 12.0 0.1 0.0 0.2 3.2 0.0 1.8 0.4 6.7 0.1 7.2 0.0 0.5 0.0 0.0 1.8 0.1 0.0 0.0 0.0 1.2 0.9 2.6 0.0 0.1 0.1 0.1 1.1 0.0 25.5 0.0 0.9 32.8 39.0 37.5 37.8 28.3 35.9 34.8 36.5 27.0 35.9 30.0 42.1 35.8 6.0 0.0 0.6 36.2 1.6 213.7 49.0 56.6 3.4 11.6 16.0 17.0 105.8 4.3 24.8 9.2 2.1 11.4 16.0 135.5 9.8 15.6 1.8 42.3 8.5 25.1 16.2 0.4 1.0 6.9 115.9 16.8 74.9 17.2 1.3 0.1 12.5 0.3 3.1 1.7 4.3 31.6 12.2 1.9 62.8 4.9 2.5 10.8 40.9 0.0 0.9 11.6 0.0 6.6 54.2 46.6 41.9 0.7 0.4 17.4 59.7 20.5 37.2 2.4 0.0 17.7 9.4 1.7 0.3 4.1 231.6 103.0 4.5 1.2 14.1 25.7 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.1" "Cell type enhanced" "Detected in many" "Granulosa cells: 145.1;monocytes: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 8.7 3.8 1.5 14.2 1.8 41.1 10.8 1.0 1.9 7.4 2.0 8.1 8.5 10.3 5.3 7.1 6.7 7.8 3.8 1.4 1.9 3.8 4.2 9.6 23.4 2.2 1.6 0.6 12.3 4.6 2.4 1.3 10.7 2.5 6.4 10.2 1.2 6.8 5.9 1.3 8.7 9.7 9.7 2.4 15.3 8.5 13.6 1.5 24.6 6.9 3.8 21.8 7.9 3.9 2.9 54.1 20.0 40.7 18.0 12.1 17.2 30.0 36.4 19.2 29.7 36.5 10.7 50.7 73.6 15.5 18.5 12.8 37.0 23.9 18.5 55.3 39.5 15.3 44.5 23.2 13.8 8.1 103.7 39.7 12.5 7.4 17.6 16.5 19.4 36.7 14.1 19.7 17.2 29.1 19.9 44.1 45.9 30.8 26.5 24.9 51.5 16.4 28.5 15.3 22.3 28.4 12.3 16.2 24.6 13.1 24.1 29.5 58.1 20.4 15.7 47.4 19.5 16.6 15.3 21.5 34.5 8.8 42.6 22.8 64.5 28.8 35.8 7.9 28.5 8.5 28.5 7.5 6.8 21.5 25.5 5.0 5.1 17.8 10.8 53.8 31.0 10.9 9.1 1.5 1.8 1.0 1.9 1.4 1.9 2.2 1.6 0.6 2.5 2.4 1.5 2.9 54.6 25.6 27.8 6.8 87.7 20.1 11.6 17.7 19.4 8.4 24.3 27.3 13.3 7.2 26.1 9.2 16.7 40.9 91.6 17.1 5.9 14.0 3.5 29.2 47.6 43.5 27.6 72.6 34.5 11.1 42.5 32.5 35.7 28.0 43.6 145.1 30.4 7.3 35.4 0.0 7.6 25.8 18.3 89.8 30.9 6.8 55.3 115.7 5.4 74.0 150.1 5.1 55.6 9.5 11.1 13.5 47.7 60.5 73.5 25.0 12.1 5.0 20.9 7.6 0.0 13.9 23.3 80.0 105.4 32.5 26.3 19.4 54.5 77.9 29.9 24.6 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24078662-24115010 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 75 "retina: 320.1" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 3720.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 4.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 0.8 2.5 1.6 0.5 1.4 0.5 1.0 2.3 2.2 1.1 0.4 0.9 1.1 1.1 0.7 1.1 1.0 0.9 2.2 1.4 1.3 2.8 3.6 1.1 1.0 2.1 1.6 1.1 1.2 1.7 2.0 2.4 0.3 1.9 1.5 0.4 320.1 1.0 0.7 2.5 0.7 1.4 0.3 1.5 2.1 1.3 4.2 1.5 1.2 2.7 1.4 0.7 1.1 0.8 1.6 0.3 1.2 1.6 1.6 0.3 0.2 0.4 0.3 0.3 0.5 0.3 0.7 0.5 1.2 0.4 0.5 1.0 0.5 0.6 0.3 0.2 0.6 0.5 0.7 0.6 2.2 0.6 1.4 1.6 0.4 0.5 0.2 0.7 0.7 0.5 2.2 0.7 1.2 0.3 0.9 1.2 0.6 1.8 1.8 0.9 1.2 1.5 0.0 0.4 1.3 1.7 1.2 0.8 0.7 0.8 4.8 0.9 1.5 0.4 1.1 0.5 0.1 0.7 3.6 1.9 1.5 0.3 0.9 1.1 0.2 0.3 1.3 0.2 0.4 0.1 1.0 0.2 0.4 0.3 0.7 0.8 0.6 0.1 0.5 0.3 0.4 0.2 0.3 1.6 1.4 2.3 2.2 1.4 1.3 2.1 1.6 1.1 1.9 1.5 1.5 1.6 1.4 0.0 0.5 5.5 6.2 0.8 1.6 0.1 1.2 434.4 2.0 1.9 2.1 0.0 0.7 7.3 431.6 1.4 3.2 1.5 13.7 0.6 2.7 1.3 0.7 24.1 1.8 3.2 1.8 1.1 0.9 0.7 2.6 1.0 0.0 0.7 0.7 3.3 2.0 250.7 2.6 1.7 0.0 1.3 0.4 4.2 1.2 1.4 1.8 0.0 1.1 636.4 5.2 2.0 4.4 0.3 5.3 1.9 1.7 2.0 5.6 6.7 0.1 3720.7 0.0 1.2 0.7 9.7 4.3 2.2 0.4 2.5 2.6 2.3 1.0 2.1 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20802855 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "pancreas: 9199.3" "Cell type enhanced" "Detected in many" "Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 9.7;myeloid DC: 20.3" "Group enriched" "Detected in many" 9 "dendritic cells: 20.3;monocytes: 9.7" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1100000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 663.2 506.1 381.8 132.5 494.8 6.2 356.3 448.9 502.9 205.7 392.4 382.0 178.3 140.6 113.0 195.7 234.1 410.0 348.4 394.9 483.2 252.7 54.9 782.7 189.4 521.5 462.3 349.5 192.3 9199.3 61.1 44.2 905.0 495.0 84.6 429.3 3.2 169.4 151.1 128.6 106.7 203.5 288.1 412.3 355.9 1012.5 985.1 450.6 179.2 120.7 283.1 69.4 378.2 108.8 573.7 0.0 1.4 0.5 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 6.7 0.0 0.3 1.7 0.0 2.2 0.6 0.0 1.4 0.0 0.1 0.1 5.3 0.1 0.8 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 286.8 0.0 31.4 0.4 0.0 0.0 0.3 2.0 1.2 67.4 0.0 0.2 0.1 1.5 0.2 114.2 1.2 1.4 0.0 0.8 0.3 2.0 0.3 0.1 179.3 0.0 2.7 1.8 0.3 0.6 0.1 0.1 4.6 0.1 3.8 1.6 9.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 20.3 0.1 0.0 0.0 0.1 0.0 0.0 5.0 0.0 2.4 381.8 494.8 448.9 502.9 394.9 483.2 521.5 462.3 349.5 495.0 412.3 450.6 573.7 826.6 929.5 818.4 1.6 11.1 35.6 1.0 1.9 15.9 0.1 6.2 11.7 59.8 27.1 174.0 16.5 0.0 12.9 5.7 261.8 0.0 8.8 20.0 3.8 1.9 581.7 48.7 28.0 0.5 315.2 14.6 58.4 821.1 3.4 25.2 103.8 650.3 7.9 1583.4 1.7 0.8 663.8 8.2 267.9 197.5 57.1 32.0 632.8 40.9 36.5 3.4 0.8 0.0 1.0 232.3 286.8 246.7 10.9 7.5 1.4 81.7 0.9 34.9 2.7 98.6 20.7 31.4 16.4 6.6 16.6 28.1 25.9 10.6 392.8 162.9 3.8 NEDD8 Nedd-8 ENSG00000129559 "NEDD8 ubiquitin like modifier" Q15843 14 24216857-24232367 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 990000 Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644" "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 170.3 226.2 162.7 72.1 166.9 91.8 158.0 162.6 220.9 149.8 157.4 162.6 56.4 148.8 133.8 203.7 132.4 51.5 267.5 165.9 170.1 197.1 177.1 149.0 81.9 166.7 163.0 161.5 139.2 111.8 291.5 145.1 85.0 166.7 134.8 89.6 75.2 140.4 86.3 296.7 183.0 129.9 98.5 161.5 165.9 148.0 78.5 165.1 126.9 133.9 198.9 114.0 153.3 158.8 172.7 166.9 292.7 223.8 159.9 255.2 223.2 165.6 218.7 237.4 259.5 237.5 204.6 196.1 142.1 126.9 317.1 212.3 169.2 230.8 349.5 365.6 201.9 139.7 150.2 272.9 710.7 220.8 251.8 151.6 237.0 231.8 217.2 172.0 239.1 317.3 162.3 139.3 161.5 409.4 380.3 203.4 241.1 166.1 303.7 335.8 141.3 176.9 146.1 302.7 322.1 96.7 221.7 188.3 192.6 168.4 229.5 117.6 199.2 230.3 145.4 144.9 184.9 198.5 187.9 322.7 210.6 102.6 146.2 139.6 461.6 277.3 459.9 214.7 302.8 235.5 311.9 246.0 241.0 276.3 273.4 229.8 233.1 299.8 233.7 310.5 369.7 327.3 526.6 162.7 166.9 162.6 220.9 165.9 170.1 166.7 163.0 161.5 166.7 161.5 165.1 172.7 276.4 144.2 156.8 0.0 182.1 277.9 227.5 644.7 166.8 101.0 263.4 301.5 464.7 215.9 301.5 310.8 47.9 525.7 237.0 267.8 594.8 344.9 72.6 201.8 189.4 259.5 212.4 220.7 0.0 406.9 625.0 246.0 108.1 195.4 218.6 228.7 222.0 431.5 576.3 106.0 0.0 286.4 362.2 288.7 345.5 77.3 272.1 255.4 268.6 0.0 394.0 275.0 346.1 0.0 0.0 449.8 311.5 275.7 161.3 254.4 340.2 845.8 279.7 95.9 210.4 178.7 318.4 150.0 196.9 252.1 386.6 419.5 216.0 289.8 291.8 275.5 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564907-22589224 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Uncertain "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 194.0 231.1 206.0 160.5 220.9 130.1 226.3 233.6 261.4 231.6 243.6 199.6 167.3 186.0 477.9 188.7 232.5 192.5 204.5 207.9 246.8 299.6 277.9 185.0 171.0 237.2 216.4 193.6 176.1 201.9 256.3 203.1 142.9 234.3 146.8 211.9 87.0 288.8 207.4 157.9 138.0 175.2 208.4 234.8 166.7 198.7 152.1 216.1 213.5 275.2 199.2 192.6 201.9 164.8 253.4 373.3 344.7 274.6 375.8 740.2 529.9 238.3 387.0 473.0 340.5 478.1 219.6 520.1 233.7 242.1 453.1 381.4 330.0 291.1 375.7 543.3 319.8 265.1 228.5 180.9 886.0 514.5 321.2 315.8 395.8 498.7 356.0 454.4 383.1 506.2 220.9 176.4 532.1 509.9 459.3 153.6 391.4 169.7 816.1 557.8 211.7 232.4 306.7 503.2 306.1 211.5 263.4 294.9 416.1 445.9 328.7 251.4 323.1 381.1 291.8 232.2 358.2 248.3 391.2 502.6 308.5 263.8 225.5 431.0 532.4 421.9 460.9 528.4 371.9 518.9 527.2 543.8 501.4 401.0 477.1 564.8 497.6 481.5 437.2 332.3 783.9 560.3 941.8 206.0 220.9 233.6 261.4 207.9 246.8 237.2 216.4 193.6 234.3 234.8 216.1 253.4 357.9 160.3 161.7 15.0 183.9 198.3 188.3 581.8 149.7 25.1 201.0 274.6 173.8 187.3 315.2 255.6 27.1 260.9 204.6 174.8 215.2 525.4 196.8 270.3 242.9 267.8 135.7 130.2 10.6 415.2 383.1 276.5 145.2 255.6 302.6 150.8 187.7 231.9 350.3 21.9 11.0 242.3 360.1 146.2 224.8 101.5 214.3 166.8 330.8 8.4 217.3 216.8 198.8 18.1 42.5 396.8 160.7 199.0 408.6 172.5 244.8 420.8 393.7 42.6 151.2 141.5 291.0 300.3 128.1 179.6 215.8 289.0 211.7 266.6 183.8 174.4 TEP1 "p240, TLP1, TP1, TROVE1, VAULT2" ENSG00000129566 "Telomerase associated protein 1" Q99973 14 20365667-20413501 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029206 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029206: AB_10601271" "unprognostic (4.53e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.58e-4)" "unprognostic (2.27e-1)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-2)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (6.18e-2)" "unprognostic (3.00e-1)" 9.4 7.8 3.0 12.2 4.1 5.1 8.8 2.7 4.0 7.4 5.9 17.6 28.3 6.9 7.3 6.9 7.2 10.8 6.0 2.7 5.5 6.6 6.6 11.1 15.2 5.1 3.4 1.4 6.3 6.3 13.8 5.8 6.7 4.6 7.9 18.1 5.0 8.4 6.4 10.4 7.8 15.7 9.8 3.6 14.9 9.6 2.3 4.7 10.3 8.2 5.1 15.2 7.5 7.9 9.6 9.2 4.2 4.1 4.5 26.1 9.9 7.3 6.8 6.0 4.0 5.1 8.7 10.2 8.1 4.2 17.0 7.3 9.3 3.5 13.6 6.8 7.8 3.5 9.5 9.4 5.7 7.5 8.0 16.1 14.1 11.8 6.5 5.2 17.1 15.2 6.7 3.1 5.8 14.0 5.4 4.7 5.8 1.8 28.4 3.6 12.2 10.2 2.8 13.2 13.8 1.2 1.9 5.4 12.8 4.2 11.8 6.5 4.9 20.1 15.5 10.6 4.9 1.9 12.9 6.9 5.1 3.7 6.9 5.5 3.6 2.3 0.0 1.0 2.8 1.0 1.7 0.5 1.0 0.8 2.4 0.5 0.6 4.5 0.5 2.9 5.4 0.6 0.3 3.0 4.1 2.7 4.0 2.7 5.5 5.1 3.4 1.4 4.6 3.6 4.7 9.6 3.7 9.6 14.1 13.1 8.4 2.8 4.8 3.1 2.8 0.3 3.2 2.8 3.2 8.6 5.6 1.8 2.1 2.0 14.3 23.9 1.9 4.8 0.2 2.9 4.2 5.8 4.2 2.1 1.9 5.1 2.5 3.4 25.5 4.2 10.8 2.6 8.2 4.9 6.4 0.0 2.1 12.8 0.0 10.4 4.6 1.3 5.0 10.2 5.4 16.9 12.9 2.6 7.2 4.5 3.9 6.0 12.8 3.8 8.4 5.1 21.8 3.8 12.2 2.6 0.0 5.1 6.1 0.0 0.6 2.4 1.4 1.9 5.0 2.2 8.3 4.9 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419313 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.1;HeLa: 36.5;RT4: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 8.7 4.5 5.3 3.3 5.6 3.6 5.3 4.2 4.7 4.1 7.7 4.0 2.7 4.3 12.8 10.2 7.5 13.9 9.2 6.1 4.0 11.8 3.3 7.8 3.3 5.9 4.7 2.8 5.8 5.0 8.1 0.5 9.4 4.6 5.8 4.8 16.1 7.2 5.5 4.2 8.9 3.5 2.8 4.6 4.7 5.7 6.2 4.8 3.6 13.6 4.3 3.6 5.2 2.3 4.9 0.8 5.5 14.3 1.5 0.0 0.0 2.9 2.1 0.0 0.0 0.0 3.0 12.3 6.2 30.1 0.0 0.8 7.4 1.1 6.9 0.0 1.0 5.0 9.8 36.5 2.0 0.1 2.6 3.1 0.0 3.0 0.0 0.0 1.6 9.2 1.7 1.9 5.6 0.0 1.8 4.6 3.5 2.7 1.2 1.1 2.3 10.7 1.3 8.4 21.6 11.8 6.1 10.7 5.2 4.5 9.8 15.9 1.4 15.7 0.7 2.4 1.9 4.4 5.6 1.3 4.6 1.4 5.2 0.8 0.5 0.2 0.1 2.0 0.3 1.1 1.4 0.6 0.6 0.2 1.6 0.9 1.8 0.2 0.1 0.5 0.1 0.6 0.5 5.3 5.6 4.2 4.7 6.1 4.0 5.9 4.7 2.8 4.6 4.6 4.8 4.9 55.9 28.9 7.7 17.3 4.7 6.0 16.8 11.2 13.6 5.0 11.2 4.7 8.3 64.3 24.2 14.7 4.2 7.4 4.5 8.5 11.7 15.0 20.8 19.7 3.1 35.2 1.2 2.1 28.6 7.5 0.7 8.4 7.1 17.1 8.8 11.9 34.6 1.7 2.7 1.7 31.8 6.3 16.2 4.6 2.1 23.0 1.8 1.8 3.6 56.2 3.2 8.2 14.4 164.4 65.4 14.1 10.9 1.9 6.5 13.7 1.9 30.4 39.5 32.1 0.0 8.7 6.0 1.8 9.1 16.0 8.1 2.5 3.7 2.2 7.5 19.1 CDO1 ENSG00000129596 "Cysteine dioxygenase type 1" Q16878 5 115804733-115816659 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 510.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7" "Group enriched" "Detected in many" 6 "glioma: 33.6;liver cancer: 74.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036573, HPA057503" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036573: AB_10696658, HPA057503: AB_2683451" "unprognostic (2.34e-2)" "unprognostic (3.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.91e-5)" "unprognostic (1.14e-3)" "unprognostic (2.63e-1)" "unprognostic (7.23e-2)" "unprognostic (9.28e-3)" "unprognostic (6.69e-2)" "unprognostic (1.58e-1)" "unprognostic (2.74e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-1)" "unprognostic (2.06e-2)" 120.4 18.3 26.8 3.3 28.7 0.2 36.2 26.4 31.4 9.0 94.8 4.2 0.7 8.4 141.5 3.6 13.8 10.6 18.0 28.0 29.6 3.2 510.9 11.8 6.7 24.3 26.4 27.6 26.1 14.3 0.7 20.8 35.5 25.5 9.1 1.8 16.1 7.2 73.5 8.5 3.0 4.0 6.3 24.6 3.8 4.1 15.7 26.8 1.3 9.7 20.1 3.1 8.1 5.8 26.5 0.0 0.0 48.1 0.0 57.9 22.3 0.2 1.4 0.4 4.6 4.5 0.0 0.0 0.0 0.0 0.6 17.2 0.1 17.1 0.0 6.6 0.1 8.5 1.7 0.0 1.4 0.2 0.1 0.0 8.5 0.0 0.7 0.0 1.2 6.3 0.0 0.0 0.0 5.5 0.0 1.2 0.2 17.8 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 11.0 0.1 0.0 0.0 4.0 0.0 5.4 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 26.8 28.7 26.4 31.4 28.0 29.6 24.3 26.4 27.6 25.5 24.6 26.8 26.5 4.1 0.0 1.3 6.8 0.7 0.8 0.8 0.0 0.6 27.3 1.0 7.1 3.4 0.0 0.0 1.8 6.2 329.4 0.3 0.0 0.0 9.9 6.0 0.3 7.1 3.1 1.8 2.7 12.2 0.2 17.0 27.8 0.0 0.3 0.0 7.5 33.9 149.5 23.4 1.7 16.4 0.0 0.0 5.7 1.6 15.0 91.0 0.6 1.8 1.0 0.6 31.4 0.0 5.5 3.1 0.3 0.0 37.6 0.0 0.9 0.0 2.0 0.0 3.8 13.1 7.3 3.9 1.6 1.4 0.5 1.3 481.9 0.9 104.7 0.0 0.1 REEP5 "C5orf18, D5S346, DP1, POB16, TB2, Yip2e" ENSG00000129625 "Receptor accessory protein 5" Q00765 5 112876385-112922289 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003895, HPA069960" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA069960: AB_2686221" "unprognostic (3.26e-3)" "unprognostic (2.60e-1)" "unprognostic (2.71e-1)" "prognostic favorable (5.23e-6)" "unprognostic (8.29e-2)" "unprognostic (1.44e-2)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.85e-1)" "unprognostic (3.75e-2)" "unprognostic (7.75e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.05e-5)" "unprognostic (2.88e-2)" "unprognostic (4.14e-2)" "unprognostic (1.83e-1)" "unprognostic (3.24e-2)" 77.6 106.5 106.4 50.9 110.6 27.5 131.9 102.9 125.1 87.8 84.3 67.3 57.4 58.9 121.1 52.6 65.3 61.3 134.5 112.5 120.0 149.4 125.3 81.1 48.6 118.8 116.6 112.1 72.9 124.1 141.8 41.8 67.2 125.4 99.8 58.6 82.2 149.0 85.0 115.3 59.6 58.6 55.5 104.2 54.8 70.8 28.6 124.7 32.4 241.5 100.4 57.1 73.9 49.5 139.3 101.7 90.9 29.7 72.5 136.0 115.9 104.7 102.2 92.6 96.4 103.4 74.9 138.1 42.5 179.6 105.1 112.5 107.5 66.8 138.9 88.5 190.6 116.4 42.8 56.3 63.5 126.8 36.9 77.4 81.3 136.0 82.2 78.0 94.5 113.7 38.7 26.0 84.5 121.3 100.0 15.7 60.7 43.4 73.5 75.3 22.4 84.3 116.6 229.1 108.4 56.9 43.1 148.5 244.6 99.8 75.5 287.3 58.9 142.4 83.4 32.0 126.5 126.4 97.6 126.2 33.8 142.6 65.4 47.8 224.4 222.9 234.3 140.1 249.5 149.4 175.7 112.7 133.9 189.0 149.2 52.5 94.6 253.0 112.7 316.2 133.6 177.9 236.4 106.4 110.6 102.9 125.1 112.5 120.0 118.8 116.6 112.1 125.4 104.2 124.7 139.3 141.2 166.7 102.3 30.0 131.1 93.0 177.7 291.6 89.4 83.5 225.3 188.1 217.3 145.8 213.7 195.0 89.6 296.0 138.4 77.0 82.2 275.1 231.5 111.8 97.0 130.5 118.0 34.9 78.6 414.1 352.8 182.3 65.7 141.6 108.9 76.0 118.2 197.0 267.1 87.5 95.0 127.5 256.3 135.0 159.9 42.0 116.2 168.8 206.3 36.5 188.6 97.2 101.0 44.7 71.5 316.5 141.1 133.9 271.6 225.3 134.1 146.1 170.6 80.0 111.7 92.6 253.0 162.8 63.9 118.1 101.6 489.8 123.7 100.3 104.5 214.8 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 285.9;Oligodendrocytes: 263.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" NA NA 28000 "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favorable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 25.5 42.6 15.0 16.5 23.5 12.6 25.4 16.9 22.2 29.0 23.4 35.4 30.7 28.0 31.5 19.3 26.5 29.1 45.1 21.3 22.9 48.2 45.8 27.7 13.6 14.0 14.3 18.1 28.3 27.5 56.5 15.8 41.0 16.6 29.6 33.4 33.6 22.0 29.1 24.0 13.0 27.0 29.3 12.7 19.5 28.5 37.0 18.1 17.3 43.6 24.8 16.8 24.7 13.9 18.7 22.2 24.8 44.0 31.1 84.1 65.0 54.1 50.7 72.9 45.6 24.3 14.2 51.8 25.9 70.4 63.5 30.9 31.9 21.6 33.0 44.9 11.8 17.0 14.0 22.0 33.2 39.4 32.7 59.6 48.3 55.6 23.3 30.1 96.3 44.4 24.2 40.3 33.5 58.3 21.1 20.2 16.3 14.5 27.4 24.5 31.0 43.4 66.5 60.2 15.9 21.9 30.8 46.0 53.6 24.0 43.7 23.7 29.9 43.0 48.9 23.7 26.3 20.7 47.6 66.7 48.4 48.9 20.6 39.2 17.9 33.9 33.4 16.0 33.0 15.2 16.6 19.0 17.7 25.8 17.2 20.7 17.4 21.2 23.8 33.1 17.5 26.1 29.2 15.0 23.5 16.9 22.2 21.3 22.9 14.0 14.3 18.1 16.6 12.7 18.1 18.7 38.9 51.3 28.1 165.9 37.2 38.4 43.4 81.3 27.9 50.8 32.6 23.2 56.8 50.1 62.2 82.8 47.9 100.6 32.3 79.3 9.8 60.5 129.0 33.0 28.7 37.8 61.9 27.8 250.7 52.4 86.4 48.5 41.8 35.0 8.2 54.5 39.3 68.7 50.9 40.4 285.9 43.2 73.2 53.8 30.0 32.0 35.1 41.9 28.4 146.1 45.4 39.4 38.1 214.6 263.5 45.3 37.0 61.3 60.1 35.3 65.2 49.6 54.5 47.4 78.9 30.1 49.8 93.7 98.3 25.5 30.3 114.0 29.9 66.0 38.1 37.4 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 18.4" "Cell type enhanced" "Detected in many" "Early spermatids: 33.8;Excitatory neurons: 9.8;Inhibitory neurons: 14.5;Late spermatids: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: AB_2681766" "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.8 0.7 5.6 0.7 4.1 1.7 1.1 6.4 7.1 1.7 2.8 1.4 0.3 1.1 0.7 2.1 1.7 0.3 1.4 4.7 3.9 1.4 2.3 1.7 0.6 6.1 4.3 4.1 1.3 1.9 0.6 1.8 1.0 8.2 2.1 0.6 2.7 3.6 0.5 1.2 1.3 1.1 0.4 3.6 1.1 1.2 18.4 6.1 0.5 4.4 0.5 0.5 1.0 1.7 7.1 0.8 1.6 2.9 3.3 1.5 1.4 1.4 1.4 0.3 1.0 0.3 0.5 0.3 4.2 0.5 0.9 0.8 0.3 4.0 0.7 1.3 1.1 2.2 0.4 1.2 3.7 0.8 0.6 1.9 1.3 0.6 1.2 0.1 2.0 1.3 1.2 2.3 0.8 0.3 2.5 2.3 0.5 1.2 1.0 3.2 4.9 2.5 0.1 0.5 1.5 2.7 2.7 0.7 0.4 1.7 2.9 1.2 1.7 1.2 0.8 3.1 4.1 1.7 1.1 1.1 0.4 0.9 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.1 6.4 7.1 4.7 3.9 6.1 4.3 4.1 8.2 3.6 6.1 7.1 0.8 0.0 0.0 6.5 0.8 0.1 0.4 0.2 0.0 0.7 1.5 1.8 1.7 5.7 0.3 1.8 0.0 0.7 0.1 0.7 0.0 0.9 33.8 1.4 0.9 0.9 0.0 0.4 9.8 0.0 1.1 0.3 2.0 1.6 0.0 3.7 0.0 0.5 0.2 1.7 14.5 0.5 0.0 0.6 0.4 9.1 0.9 0.3 1.8 5.6 0.6 1.9 1.0 5.5 5.4 0.4 0.2 0.7 0.9 0.3 0.2 0.8 1.1 2.3 0.0 0.9 1.0 5.0 1.5 0.6 0.3 0.4 0.4 0.1 0.6 0.3 FOXJ1 "FKHL13, HFH-4, HFH4" ENSG00000129654 "Forkhead box J1" Q92949 17 76136333-76141245 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 28.2;choroid plexus: 64.0;fallopian tube: 53.6" "Group enriched" "Detected in many" 8 "Endometrial ciliated cells: 234.7;Respiratory ciliated cells: 124.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 73.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 29.9;CAPAN-2: 25.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 43.1" HPA005714 Enhanced NA NA "HPA005714: AB_1078902" "prognostic favorable (9.39e-4)" "unprognostic (4.97e-3)" "unprognostic (1.22e-1)" "unprognostic (2.77e-3)" "unprognostic (1.19e-1)" "unprognostic (2.54e-3)" "unprognostic (1.71e-3)" "unprognostic (6.15e-2)" "unprognostic (1.00e-2)" "unprognostic (7.84e-3)" "unprognostic (1.43e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.49e-2)" "unprognostic (1.94e-1)" "unprognostic (2.27e-1)" "unprognostic (1.91e-1)" 0.0 0.0 14.9 0.1 12.3 0.3 0.0 18.0 10.9 3.6 64.0 0.6 0.3 2.2 0.5 0.3 53.6 0.0 0.0 14.1 24.6 2.3 0.0 10.5 0.0 27.9 24.6 5.5 0.2 0.9 0.0 2.2 0.0 23.0 0.5 0.2 0.4 0.1 2.6 0.4 0.8 0.2 0.0 23.9 0.0 0.6 16.8 27.8 0.2 3.0 0.0 0.0 0.9 0.1 28.2 0.0 0.5 1.7 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 3.1 25.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 12.3 18.0 10.9 14.1 24.6 27.9 24.6 5.5 23.0 23.9 27.8 28.2 2.2 9.6 3.1 1.0 2.3 0.8 1.0 4.4 0.0 0.4 5.6 4.2 0.9 1.5 12.0 9.2 4.2 0.2 4.8 1.0 0.0 0.6 21.4 234.7 4.5 0.7 1.8 3.0 0.0 0.0 0.6 1.6 4.1 10.7 1.3 0.1 0.4 0.0 0.1 0.0 0.1 3.2 4.1 0.6 0.0 19.1 0.3 1.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.8 0.4 1.3 0.5 0.2 3.5 124.0 8.7 0.0 1.8 3.5 20.7 2.0 0.8 0.9 0.3 3.5 1.1 2.3 0.7 SEC14L1 "PRELID4A, SEC14L" ENSG00000129657 "SEC14 like lipid binding 1" Q92503 17 77088749-77217101 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 355.0" "Lineage enriched" "Detected in all" 11 "granulocytes: 355.0" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 398.1;TIME: 251.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021463, HPA028703" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021463: AB_2670712, HPA028703: AB_10602300" "unprognostic (1.19e-1)" "unprognostic (8.61e-2)" "unprognostic (1.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (7.37e-2)" "unprognostic (1.21e-1)" "unprognostic (7.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (1.37e-1)" "unprognostic (1.33e-3)" "unprognostic (3.09e-1)" "unprognostic (4.30e-2)" 65.4 54.7 42.4 45.0 62.6 66.0 58.1 68.6 57.0 39.9 36.9 19.7 22.0 24.8 28.4 31.8 27.5 34.6 40.5 48.7 55.7 42.2 25.5 67.5 50.1 61.0 63.1 32.9 20.9 31.1 25.3 28.1 77.3 58.1 18.4 20.0 19.2 35.3 17.0 95.0 20.1 21.9 27.3 44.1 50.3 32.0 52.4 59.9 24.3 41.9 55.2 46.6 26.2 20.7 53.0 55.0 45.4 65.6 105.0 27.4 36.3 24.1 47.4 42.0 57.8 49.5 55.7 39.6 143.1 93.3 65.0 71.1 26.3 36.0 47.8 72.6 27.3 50.1 81.1 42.4 75.9 44.4 26.8 39.8 46.6 20.7 47.8 47.8 69.1 398.1 24.3 55.8 136.0 79.2 36.2 28.5 22.4 25.0 25.7 43.7 20.3 104.2 112.2 91.2 26.2 59.5 44.8 51.1 31.3 32.1 58.3 27.9 20.7 251.1 65.4 60.6 35.0 37.7 71.1 64.8 79.9 27.9 22.1 21.6 33.8 19.4 48.9 7.1 28.3 8.9 14.6 6.9 5.3 12.7 10.8 10.9 5.9 355.0 10.0 33.3 18.9 12.5 11.5 42.4 62.6 68.6 57.0 48.7 55.7 61.0 63.1 32.9 58.1 44.1 59.9 53.0 430.3 41.7 18.6 55.8 69.4 29.3 23.5 22.5 37.0 31.5 86.5 37.8 17.6 15.7 28.9 27.6 18.8 10.8 77.5 20.3 99.7 18.0 242.6 114.8 46.7 205.9 19.7 86.5 33.0 20.7 10.8 34.0 35.2 240.5 34.7 104.3 286.3 11.1 51.6 37.0 54.6 14.0 61.1 127.2 48.1 740.3 26.4 115.1 35.6 62.8 76.1 31.4 34.0 23.1 44.4 41.8 15.2 17.3 269.1 39.5 9.6 24.8 69.5 17.2 39.5 36.4 36.3 45.1 42.5 25.1 30.4 13.3 51.6 64.3 11.5 39.1 RHBDF2 "FLJ22341, iRhom2, RHBDL5, RHBDL6, TOC, TOCG" ENSG00000129667 "Rhomboid 5 homolog 2" Q6PJF5 17 76470891-76501790 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 58.4;Kupffer cells: 57.3;NK-cells: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 75.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018080 Uncertain NA NA "HPA018080: AB_2178634" "unprognostic (1.19e-1)" "unprognostic (8.71e-2)" "unprognostic (1.59e-2)" "unprognostic (5.11e-3)" "unprognostic (4.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (9.79e-3)" "unprognostic (2.55e-1)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.96e-11)" "unprognostic (5.24e-2)" "unprognostic (2.14e-2)" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" 17.1 10.2 5.5 31.5 7.0 29.9 13.7 9.9 8.1 7.8 11.7 7.6 6.6 7.4 1.6 24.1 10.2 10.4 9.3 6.7 16.2 10.9 6.4 25.0 27.8 20.7 11.1 1.4 8.1 19.7 3.2 5.4 9.8 19.1 9.2 4.4 3.0 11.7 2.7 13.6 28.4 26.8 6.4 15.9 42.5 10.6 3.0 22.5 6.5 12.4 3.2 21.5 11.1 15.8 23.6 38.3 43.3 1.3 10.7 0.4 1.1 30.1 8.6 26.9 6.7 9.1 13.3 45.0 41.5 28.6 10.9 39.0 29.9 7.3 40.8 6.2 7.1 13.6 2.8 3.5 21.8 25.6 1.8 5.9 4.5 20.2 18.1 20.7 15.4 20.3 5.9 4.3 18.3 4.6 30.7 4.3 4.7 6.7 25.7 26.1 10.3 0.4 75.3 17.8 14.0 9.2 12.6 9.9 28.7 38.7 8.5 24.7 11.4 32.4 0.6 14.4 0.7 11.0 44.3 22.6 33.7 24.3 11.2 27.1 6.3 13.4 4.3 8.0 13.1 5.5 12.7 2.1 5.8 6.5 7.4 1.5 3.6 10.2 4.9 12.2 10.0 1.1 8.8 5.5 7.0 9.9 8.1 6.7 16.2 20.7 11.1 1.4 19.1 15.9 22.5 23.6 22.3 6.4 6.9 2.3 58.4 17.6 15.3 35.0 8.0 4.2 4.7 5.5 3.3 18.6 19.2 3.7 2.1 1.0 47.1 2.0 0.0 21.3 0.5 4.2 0.8 15.3 1.8 1.3 0.6 9.8 2.2 4.7 7.7 6.6 0.0 15.4 7.9 3.4 37.6 0.0 0.5 4.1 6.1 57.3 42.7 0.7 0.9 48.8 10.6 38.4 40.1 1.1 64.9 1.0 0.1 14.2 4.8 0.4 36.5 20.4 1.9 1.8 16.2 1.4 6.6 3.6 3.2 0.7 7.1 9.9 29.3 1.6 22.3 2.8 7.8 20.4 AANAT SNAT ENSG00000129673 "Aralkylamine N-acetyltransferase" Q16613 17 76453351-76470117 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Melatonin biosynthesis" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 11.1;testis: 4.7" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 302.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;Daudi: 2.0;SCLC-21H: 3.2;U-266/70: 2.3;U-266/84: 2.7;U-698: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054321 Supported Cytosol "Intracellular and membrane" NA NA Cytosol "HPA054321: AB_2682449" "unprognostic (7.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.83e-2)" "unprognostic (2.03e-2)" "unprognostic (1.05e-2)" "unprognostic (3.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.61e-1)" "unprognostic (9.30e-2)" "unprognostic (4.19e-1)" "unprognostic (2.81e-7)" "unprognostic (1.04e-1)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (1.34e-2)" 0.1 0.2 0.5 1.6 0.6 1.3 0.1 0.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.7 0.1 0.7 0.5 0.2 0.0 0.2 1.5 1.9 3.0 0.1 0.2 0.2 0.0 0.3 0.0 1.8 0.1 0.0 11.1 0.1 0.0 0.1 1.4 0.4 0.0 0.9 1.0 0.2 4.7 1.6 0.0 0.4 0.0 0.1 0.2 0.1 1.9 0.5 2.5 0.3 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 1.7 2.0 0.3 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 1.0 0.2 0.3 0.0 0.1 0.6 0.8 0.2 0.1 0.1 1.1 0.0 0.0 3.2 0.2 0.0 0.1 0.8 0.3 1.5 0.3 0.0 0.0 0.9 0.1 0.0 2.3 2.7 3.6 0.6 0.2 0.4 0.7 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.5 0.6 0.7 0.7 0.7 0.5 1.9 3.0 0.1 1.8 0.9 1.6 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 302.1 0.1 0.4 0.3 0.0 0.0 0.0 12.5 0.3 0.2 0.0 0.0 0.0 7.5 0.2 0.1 0.6 1.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 6.7 0.6 0.1 0.0 0.3 0.0 19.4 0.3 0.1 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.0 30.2 0.0 0.0 0.0 3.1 1.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 ARHGEF6 "alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46" ENSG00000129675 "Rac/Cdc42 guanine nucleotide exchange factor 6" Q15052 X 136665547-136780932 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8" "Cancer enhanced" "Detected in all" "glioma: 24.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003578 Approved Approved Cytosol NA NA Cytosol "HPA003578: AB_1078203" "unprognostic (9.64e-2)" "unprognostic (3.47e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-2)" "unprognostic (7.28e-2)" "unprognostic (2.06e-3)" "unprognostic (9.08e-2)" "unprognostic (7.87e-3)" "unprognostic (4.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-3)" "unprognostic (5.29e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-3)" 44.4 16.3 22.2 30.8 22.9 31.7 23.7 26.3 19.7 10.8 12.8 11.7 7.5 13.0 5.3 7.6 7.0 17.5 33.2 24.8 24.4 6.7 8.6 25.8 42.1 27.6 26.7 14.2 16.7 3.9 10.3 6.3 47.3 26.8 7.9 11.2 4.6 8.8 8.9 69.4 6.2 14.5 16.7 28.9 39.8 12.4 3.8 26.6 51.9 5.7 55.2 39.9 14.4 8.8 31.6 1.1 0.0 5.1 0.0 11.2 28.5 0.1 1.6 9.5 1.5 8.2 0.0 0.0 5.5 2.3 8.0 7.8 0.8 6.1 0.0 1.5 28.1 2.0 117.6 0.1 0.0 4.2 153.7 532.0 30.9 0.1 5.4 0.1 10.1 3.0 152.7 0.5 22.1 20.4 0.2 70.6 88.4 4.9 0.0 2.3 26.6 37.2 0.1 1.6 29.5 0.3 6.7 0.2 1.2 4.0 2.6 3.5 61.2 0.5 7.6 1.2 9.3 7.2 3.6 0.1 57.3 35.1 158.2 10.1 57.2 16.4 71.3 13.8 18.9 16.0 6.2 15.4 11.3 19.1 5.4 13.7 12.3 9.1 12.4 16.1 6.0 21.5 15.3 22.2 22.9 26.3 19.7 24.8 24.4 27.6 26.7 14.2 26.8 28.9 26.6 31.6 18.1 6.4 8.9 57.1 22.4 1.1 0.9 0.8 1.2 0.8 16.1 10.8 60.0 0.0 2.4 1.8 0.0 0.3 23.6 0.1 1.9 0.6 12.0 0.9 2.4 13.2 0.0 11.3 20.6 1.8 0.4 10.7 5.6 1.6 193.9 128.2 12.5 2.5 15.2 13.5 21.6 0.4 0.0 46.5 25.1 35.8 14.9 40.3 3.6 77.8 36.1 4.7 36.0 48.2 4.3 0.7 0.0 14.7 12.8 0.4 0.0 0.2 2.2 0.3 13.1 33.5 18.5 0.7 0.7 0.6 1.7 0.4 40.5 30.1 0.1 0.7 MAP7D3 FLJ12649 ENSG00000129680 "MAP7 domain containing 3" Q8IWC1 X 136213220-136256482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 264.2;Late spermatids: 288.5;Spermatogonia: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035598, HPA058101" Approved Uncertain Centrosome,Cytosol NA NA Centrosome Cytosol "HPA035598: AB_10671108, HPA058101: AB_2683604" "unprognostic (2.89e-1)" "unprognostic (1.23e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (8.83e-3)" "unprognostic (3.77e-3)" "unprognostic (4.16e-5)" "unprognostic (5.35e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (9.91e-2)" "prognostic unfavorable (7.91e-4)" "unprognostic (2.04e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.38e-5)" 15.9 4.5 1.4 5.9 1.4 5.1 11.5 1.3 1.8 7.3 3.0 6.8 2.2 9.8 6.2 6.2 13.4 6.0 8.7 1.2 2.3 3.7 4.1 6.0 6.6 1.8 1.4 1.1 17.0 2.1 5.8 4.8 7.1 1.8 3.7 3.4 1.6 3.1 4.1 11.6 4.1 5.6 8.8 1.6 6.4 5.0 15.9 1.6 5.4 8.2 9.2 5.0 7.7 6.5 1.8 33.6 11.8 8.7 15.0 19.3 20.1 12.1 31.6 17.4 25.3 34.6 11.7 16.5 17.3 50.0 27.9 26.8 15.7 25.6 16.9 33.5 15.9 25.6 10.3 18.0 0.0 21.0 25.2 10.2 41.1 9.5 26.0 32.0 14.2 20.0 28.1 9.0 26.1 18.8 20.9 30.4 10.2 12.4 8.1 0.3 29.5 23.5 8.4 0.8 5.1 6.1 13.0 18.4 6.7 11.4 14.5 0.1 11.5 60.3 26.9 15.5 34.6 40.6 17.8 22.7 19.3 18.5 42.3 13.0 6.6 3.5 1.1 5.2 4.2 6.5 7.5 4.9 5.8 4.4 6.4 5.2 4.1 0.7 6.6 7.9 4.6 3.8 2.9 1.4 1.4 1.3 1.8 1.2 2.3 1.8 1.4 1.1 1.8 1.6 1.6 1.8 36.6 16.0 6.7 4.2 18.5 7.1 7.2 15.4 14.8 0.7 5.1 9.1 41.5 11.5 8.7 18.4 0.0 10.3 13.8 3.7 1.9 8.6 264.2 13.7 47.3 24.9 5.4 12.6 1.9 14.7 103.4 46.5 2.0 5.1 35.5 15.2 50.7 30.4 15.4 20.2 1.0 2.8 8.2 17.3 7.8 288.5 63.3 15.0 7.2 5.6 23.4 12.2 22.6 1.5 3.6 13.0 14.1 47.8 10.0 13.5 0.7 54.6 6.5 2.9 39.5 29.8 61.5 53.2 106.9 5.3 4.8 13.4 18.6 15.9 3.3 2.4 FGF13 "FGF2, FHF2, FLJ30672, LINC00889" ENSG00000129682 "Fibroblast growth factor 13" Q92913 X 138614727-139222777 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 49.8;skeletal muscle: 67.9;tongue: 52.8" "Cell type enriched" "Detected in many" 6 "Inhibitory neurons: 432.5" "Cancer enhanced" "Detected in some" "prostate cancer: 2.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.7" "Cell line enhanced" "Detected in many" "AF22: 43.0;fHDF/TERT166: 38.1;HAP1: 39.8;RPMI-8226: 34.4;U-2197: 69.3;WM-115: 37.5" "Low region specificity" "Detected in all" HPA002809 Supported Cytosol NA NA Cytosol "HPA002809: AB_1078855" "unprognostic (3.23e-1)" "unprognostic (3.13e-2)" "unprognostic (5.42e-2)" "unprognostic (1.42e-2)" "unprognostic (1.87e-1)" "unprognostic (2.87e-3)" "unprognostic (9.92e-3)" "unprognostic (2.97e-3)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (5.22e-3)" "unprognostic (6.79e-2)" "unprognostic (4.96e-4)" "unprognostic (4.36e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (7.48e-2)" 18.7 2.6 20.3 2.9 21.1 4.1 6.6 6.4 33.3 11.4 8.0 5.7 4.0 10.8 3.4 6.7 3.7 6.1 1.9 38.6 23.1 7.5 1.8 2.3 5.4 15.5 22.2 21.2 8.9 1.1 49.8 4.2 13.4 34.9 17.7 4.8 11.4 11.3 4.9 67.9 1.6 4.7 6.7 9.4 6.2 5.3 4.1 20.9 0.9 5.3 52.8 2.2 6.1 4.3 28.0 0.1 0.5 43.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.7 38.1 0.3 2.7 39.8 0.1 0.0 0.3 11.1 0.2 0.3 1.6 1.5 0.3 0.5 0.6 1.0 0.1 0.0 0.2 0.0 2.5 1.8 12.4 4.4 0.3 0.1 0.3 4.4 0.1 14.3 6.6 2.8 34.4 6.3 0.2 0.1 0.2 0.0 0.3 26.8 21.0 0.1 0.2 0.8 1.3 1.8 69.3 19.1 16.2 9.8 0.1 15.3 12.8 37.5 1.6 0.2 0.8 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 3.7 0.1 0.2 0.4 0.1 0.0 20.3 21.1 6.4 33.3 38.6 23.1 15.5 22.2 21.2 34.9 9.4 20.9 28.0 9.7 0.0 0.0 12.7 0.1 0.4 3.0 0.3 2.8 3.6 18.3 4.1 2.6 10.0 3.0 7.3 0.0 0.2 0.0 0.5 17.6 4.2 0.0 7.7 5.0 3.6 2.4 0.0 43.5 5.8 0.3 6.1 3.1 20.5 0.0 1.4 1.4 0.1 29.3 0.0 432.5 0.8 6.1 3.7 1.4 1.4 26.1 0.6 1.8 62.8 0.6 44.8 0.0 14.1 2.4 3.8 6.7 24.5 0.1 16.9 0.0 2.9 1.8 4.2 32.9 18.0 13.7 0.0 3.7 0.1 0.9 0.1 0.3 0.8 0.3 1.0 ASH2L "ASH2, ASH2L1, ASH2L2, Bre2" ENSG00000129691 "ASH2 like, histone lysine methyltransferase complex subunit" Q9UBL3 8 38105493-38144076 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 200.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042289 Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "HPA042289: AB_10795608" "unprognostic (9.39e-2)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (5.40e-3)" "unprognostic (2.87e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.10e-2)" "unprognostic (9.73e-3)" "prognostic favorable (4.25e-4)" "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.54e-1)" 29.2 19.0 18.9 18.0 21.5 31.9 21.6 20.4 21.6 20.0 15.8 22.7 18.3 22.2 17.3 24.1 20.3 17.5 21.5 20.6 19.8 23.5 23.8 18.7 28.1 18.0 17.7 18.9 26.4 17.8 25.0 12.1 22.2 17.7 20.0 22.5 21.9 20.8 21.2 32.7 20.5 18.4 24.4 16.5 19.1 22.3 41.7 19.3 34.0 21.3 28.0 28.6 18.7 16.2 19.9 45.6 23.3 39.8 39.8 26.3 34.0 49.8 44.1 45.7 53.5 47.0 24.9 21.1 51.4 38.2 37.1 27.2 27.5 49.0 24.8 50.4 20.3 22.4 200.3 22.9 51.7 39.4 32.0 41.3 28.6 22.9 25.0 27.7 28.1 43.9 48.0 138.2 40.0 53.7 26.1 91.9 40.7 51.7 39.3 15.6 38.2 42.9 23.4 28.9 33.1 18.3 32.4 33.5 22.5 38.4 37.1 27.4 40.4 33.5 35.3 35.0 50.4 37.6 37.8 48.7 44.9 35.2 44.7 49.7 39.9 23.0 55.9 16.8 26.8 18.1 19.6 18.8 20.0 27.7 19.2 19.3 18.4 19.2 26.1 25.8 15.8 21.3 21.6 18.9 21.5 20.4 21.6 20.6 19.8 18.0 17.7 18.9 17.7 16.5 19.3 19.9 11.1 12.8 15.8 18.3 14.3 6.9 9.3 13.3 10.8 12.9 9.6 8.0 18.1 8.6 15.9 12.9 10.4 37.0 15.9 11.5 7.9 21.2 10.8 12.7 13.2 14.0 10.8 62.1 19.7 28.7 37.2 17.3 8.6 10.8 19.6 38.2 12.8 11.9 24.2 6.7 21.4 11.6 12.2 17.2 5.7 13.0 23.3 17.0 23.2 15.9 29.2 17.8 19.6 17.6 16.5 21.3 8.9 20.7 8.4 6.2 12.8 17.1 18.0 15.5 13.1 14.6 20.7 69.6 33.9 11.6 6.8 30.9 11.9 37.3 10.9 7.4 TTI2 "C8orf41, FLJ23263" ENSG00000129696 "TELO2 interacting protein 2" Q6NXR4 8 33473386-33513185 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023523, HPA029823" Approved Enhanced Centrosome NA NA Centrosome "HPA023523: AB_1845776, HPA029823: AB_10602337" "unprognostic (6.30e-2)" "unprognostic (3.09e-2)" "unprognostic (9.34e-3)" "unprognostic (5.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" "unprognostic (4.25e-3)" "unprognostic (2.64e-1)" "unprognostic (3.10e-1)" "unprognostic (2.97e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.07e-2)" "unprognostic (2.05e-1)" "unprognostic (1.94e-1)" "unprognostic (9.35e-2)" 5.5 7.0 5.1 6.8 5.5 8.0 6.5 6.6 6.3 6.6 5.4 6.1 5.6 6.2 6.6 6.4 6.5 4.7 7.5 4.9 6.2 6.9 7.5 4.7 10.9 5.4 5.5 4.8 5.9 4.7 9.7 5.8 5.8 5.5 6.1 6.0 5.6 6.1 5.2 9.1 6.2 5.6 6.2 5.4 7.7 5.6 13.0 5.4 10.7 6.6 6.9 11.5 6.7 6.0 5.8 8.2 15.1 19.6 19.5 14.8 9.7 8.1 12.2 13.7 20.0 19.6 12.4 6.9 23.3 17.8 9.1 17.8 14.2 31.2 14.3 17.6 10.6 10.0 14.5 8.4 12.9 15.9 13.1 13.4 8.2 17.9 14.9 13.3 12.1 17.7 30.2 21.7 17.9 14.1 16.8 39.0 13.2 25.9 23.0 10.4 26.0 15.6 11.1 11.2 8.9 23.5 12.3 11.8 10.9 14.8 17.7 11.2 10.4 10.7 12.4 10.9 13.0 12.0 9.6 10.0 34.2 12.1 13.0 13.5 19.9 20.9 35.8 24.2 24.5 23.6 18.6 21.1 23.3 19.4 22.9 24.1 21.5 23.0 23.3 27.5 14.0 25.2 19.8 5.1 5.5 6.6 6.3 4.9 6.2 5.4 5.5 4.8 5.5 5.4 5.4 5.8 5.6 6.4 4.8 5.9 8.3 5.4 7.8 7.7 8.0 6.3 3.9 3.4 0.7 1.5 8.7 7.3 20.9 9.9 5.0 3.5 3.9 9.4 21.9 7.4 9.3 7.0 3.0 15.4 4.7 9.2 9.5 6.1 3.6 7.2 3.8 8.1 3.6 5.5 9.3 6.7 5.0 6.2 6.1 5.5 3.1 4.2 6.8 5.4 5.4 3.7 10.8 6.1 5.2 3.5 5.7 6.3 2.2 7.5 5.2 7.5 5.6 7.7 8.5 11.5 6.6 6.2 5.5 40.4 10.5 5.0 8.1 8.8 6.0 7.7 5.6 4.9 ART1 "ART2, ARTC1, CD296" ENSG00000129744 "ADP-ribosyltransferase 1" P52961 11 3645128-3664416 "CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 57 "skeletal muscle: 47.8;tongue: 37.1" "Cell type enhanced" "Detected in single" "Microglial cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051148 Uncertain NA NA "HPA051148: AB_2681363" "unprognostic (3.73e-1)" "unprognostic (4.58e-2)" "unprognostic (3.12e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 47.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 37.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.5 0.3 0.2 0.4 0.3 0.2 0.5 0.1 0.3 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA10 ENSG00000129749 "Cholinergic receptor nicotinic alpha 10 subunit" Q9GZZ6 11 3665587-3671384 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "skeletal muscle: 48.3" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 4.4;Ionocytes: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in some" 6 "olfactory bulb: 7.2" "Not detected" "Not detected" NA NA "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (4.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.50e-1)" "unprognostic (3.79e-2)" "unprognostic (2.74e-1)" "unprognostic (6.90e-5)" "unprognostic (4.35e-2)" "unprognostic (1.06e-5)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (2.32e-1)" "unprognostic (4.39e-3)" 0.5 0.7 1.0 0.5 0.9 0.3 0.4 1.2 1.2 0.7 0.9 0.7 0.5 0.6 0.3 0.7 0.8 0.1 0.7 0.9 0.8 1.0 1.6 0.8 0.4 0.9 0.9 0.9 0.8 0.7 0.1 1.4 0.2 1.0 1.5 0.1 0.7 0.8 0.1 48.3 0.5 0.9 0.1 0.6 1.9 0.8 1.1 0.8 0.4 1.1 0.1 0.2 0.6 0.4 0.7 0.5 0.5 0.7 1.0 0.3 0.1 0.5 0.6 0.1 0.4 0.4 0.4 0.9 0.9 0.3 0.3 0.3 1.1 0.5 0.3 0.3 0.6 1.8 0.2 1.7 0.1 0.4 0.2 0.9 0.3 0.3 0.3 0.1 0.2 0.2 1.1 0.7 0.2 0.3 0.1 0.5 1.5 1.0 0.9 0.7 1.0 0.3 0.1 0.3 0.7 0.6 0.3 0.3 0.3 0.5 0.6 0.2 1.1 0.2 0.6 0.8 0.4 0.7 0.2 0.6 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.0 0.9 1.2 1.2 0.9 0.8 0.9 0.9 0.9 1.0 0.6 0.8 0.7 1.5 0.0 0.5 1.3 0.5 1.8 0.6 0.5 0.0 1.6 2.2 3.6 1.3 0.0 0.4 0.0 0.0 0.4 0.4 0.9 0.0 0.2 1.4 2.1 0.9 0.9 0.0 0.0 1.3 0.4 0.3 0.4 2.0 4.4 0.0 0.8 1.1 1.2 0.6 1.7 1.3 0.9 4.1 0.6 0.7 0.8 0.3 1.1 1.8 2.8 0.6 1.2 0.0 1.0 0.6 0.4 0.2 0.4 0.4 0.8 0.6 0.0 2.1 0.8 0.0 3.1 0.9 0.4 0.5 0.1 1.1 0.3 0.6 0.7 0.8 0.7 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885775 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 208.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 155.1;non-classical monocyte: 376.4" "Lineage enriched" "Detected in many" 14 "monocytes: 376.4" "Cell line enhanced" "Detected in many" "EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 123.3 184.4 4.3 3.4 28.9 1.7 93.3 36.5 25.8 71.5 3.9 40.1 1.4 71.2 0.2 30.2 71.3 0.8 58.5 12.0 25.6 147.1 8.4 34.8 0.2 49.9 30.3 1.6 208.1 28.8 0.2 28.0 28.3 42.3 33.4 0.2 0.5 21.9 1.5 60.8 25.9 25.2 0.4 37.2 20.8 54.5 8.7 25.4 0.2 17.2 0.9 0.4 75.6 49.8 89.4 0.1 0.1 1.6 0.0 0.4 0.5 1.8 0.3 0.6 0.3 0.0 3.3 0.4 0.0 12.0 0.2 0.1 0.5 0.3 0.3 0.1 5.6 1.2 0.1 12.8 0.0 3.3 0.0 1.4 2.4 1.6 0.0 0.2 0.1 0.3 0.1 2.7 0.8 0.5 0.1 0.0 6.0 10.6 0.5 4.0 2.2 0.0 18.7 0.7 0.0 3.5 33.0 25.2 0.3 15.2 0.9 0.2 2.8 0.4 0.0 2.2 0.0 0.1 7.3 0.0 0.1 0.0 1.8 6.8 9.1 1.2 0.9 0.4 155.1 1.8 0.0 0.4 0.6 26.9 0.3 1.0 0.3 2.2 0.0 376.4 0.2 0.7 14.7 4.3 28.9 36.5 25.8 12.0 25.6 49.9 30.3 1.6 42.3 37.2 25.4 89.4 357.3 3.2 5.8 1.0 11.6 10.7 81.7 4.9 30.7 11.9 81.0 150.5 45.3 61.5 10.8 31.3 6.2 575.3 46.9 20.3 15.6 9.8 176.5 38.8 101.5 100.8 106.5 0.8 0.6 0.6 1531.7 141.0 17.9 56.2 0.0 31.2 74.6 4.0 91.0 8.4 1.2 25.0 12.2 23.5 23.2 276.4 74.3 54.9 35.6 4.7 14.1 68.3 0.0 3.5 65.7 4.3 4.2 44.4 12.9 64.6 4.0 78.5 7.5 27.4 32.9 238.3 71.4 2.1 3.5 17.3 11.8 2241.2 25.1 781.8 15.2 71.8 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186206 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.8;lymphoid tissue: 13.1;testis: 6.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.3 0.1 0.3 3.3 0.6 8.8 0.5 0.9 0.4 0.3 0.0 2.1 2.3 0.4 0.0 1.9 0.1 0.4 0.1 0.2 0.4 0.3 0.6 0.3 6.3 0.8 0.4 0.1 0.2 0.1 0.2 0.0 1.7 0.6 0.2 2.8 0.1 0.4 0.1 0.1 1.1 2.5 1.0 0.4 1.4 1.5 6.7 0.6 13.1 0.2 0.0 6.6 0.9 0.7 1.1 20.3 23.9 29.9 18.5 1.4 2.6 20.2 21.3 10.1 31.2 33.6 16.5 24.0 30.7 10.6 8.6 21.2 11.4 28.7 11.3 37.6 40.9 19.6 34.6 15.6 12.8 0.2 32.0 28.8 0.3 0.9 33.3 13.1 4.0 18.5 34.9 31.3 52.2 24.6 19.4 52.4 15.4 30.0 20.3 17.0 31.8 38.4 17.7 7.5 14.9 14.2 15.4 23.6 27.2 13.1 22.7 18.2 21.3 4.7 22.5 27.3 20.5 43.3 22.8 57.4 35.2 12.5 31.1 35.0 10.0 0.1 1.4 0.2 0.2 0.1 8.8 0.6 0.7 0.3 8.9 0.2 0.3 1.4 0.3 0.2 4.1 2.6 0.6 0.3 0.6 0.9 0.4 0.2 0.4 0.8 0.4 0.1 0.6 0.4 0.6 1.1 0.1 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.4 0.0 0.0 0.0 1.8 0.0 16.5 1.5 0.0 0.0 1.1 0.0 2.3 1.6 1.2 0.0 0.0 0.0 1.8 42.6 3.3 0.0 2.9 1.3 20.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.9 1.0 4.3 0.0 0.0 RPS4Y1 "MGC119100, MGC5070, RPS4Y, S4" ENSG00000129824 "Ribosomal protein S4 Y-linked 1" P22090 Y 2841602-2932000 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1273.9" "Cancer enhanced" "Detected in many" "prostate cancer: 187.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 1076.6;HSkMC: 1195.7;U-698: 1701.8" HPA000857 Approved NA NA "HPA000857: AB_1079849" "unprognostic (7.04e-2)" "unprognostic (2.21e-2)" "unprognostic (1.32e-3)" "unprognostic (3.93e-2)" "unprognostic (6.31e-2)" "unprognostic (7.35e-2)" "unprognostic (1.26e-2)" "unprognostic (1.75e-1)" "unprognostic (8.11e-2)" "unprognostic (5.87e-3)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (4.55e-2)" 249.1 241.9 161.5 81.4 164.4 229.1 236.8 151.8 343.5 0.2 152.1 199.5 80.6 0.4 304.6 179.0 0.3 131.0 179.3 165.6 155.9 251.7 175.6 177.8 59.6 167.1 151.3 150.3 0.9 330.1 117.8 116.6 117.3 179.4 299.7 260.9 84.1 180.0 227.5 298.0 228.8 190.0 0.2 153.9 204.3 223.7 103.4 184.5 0.0 174.2 386.1 256.0 216.9 0.6 240.4 2.8 270.9 0.0 0.1 0.2 0.8 383.9 452.8 783.0 697.8 586.5 0.5 0.0 1076.6 1.4 645.0 0.0 0.6 0.0 0.3 849.8 317.4 0.1 683.8 0.1 829.0 953.5 1.4 0.7 1195.7 784.4 0.0 0.0 0.0 0.6 97.3 1.7 0.0 717.3 0.4 615.0 1.9 0.6 0.0 0.9 0.6 342.6 163.5 658.9 507.6 391.3 1.2 1.0 1.0 1.3 252.6 0.7 481.4 579.5 263.3 4.5 0.9 451.8 410.9 1.1 1701.8 0.0 1.1 0.1 42.4 97.3 21.2 112.8 84.1 168.6 156.3 187.2 116.0 159.3 142.4 227.6 213.3 21.8 125.1 56.8 65.4 170.1 252.1 161.5 164.4 151.8 343.5 165.6 155.9 167.1 151.3 150.3 179.4 153.9 184.5 240.4 0.0 201.9 459.1 9.8 493.4 849.9 981.5 1273.9 537.3 115.3 0.0 0.0 109.8 343.1 479.2 215.2 41.7 568.8 126.2 24.6 471.6 302.8 13.7 0.0 0.0 354.9 99.5 292.5 10.9 8.3 368.5 281.0 208.5 0.0 354.6 0.0 476.2 51.1 281.6 53.8 9.4 159.2 256.3 426.3 758.3 52.3 809.3 248.7 588.7 11.2 407.2 321.0 472.7 5.0 6.4 213.6 56.1 431.8 202.7 816.8 115.7 893.6 314.5 153.4 276.1 292.4 214.8 103.3 227.3 594.7 989.7 464.4 523.1 0.0 183.8 904.0 VCY1B BPY1B ENSG00000129862 "Variable charge Y-linked 1B" O14598 Y 14056227-14056958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 576 "testis: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-266/70: 2.9" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCY "BPY1, VCY1, VCY1A" ENSG00000129864 "Variable charge Y-linked" O14598 Y 13985772-13986513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 131 "testis: 60.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY2B CDY ENSG00000129873 "Chromodomain Y-linked 2B" Q9Y6F7 Y 17878260-17880220 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171748-89195492 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 23.1;skeletal muscle: 57.5" "Cell type enriched" "Detected in some" 13 "Skeletal myocytes: 76.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 13 "cerebellum: 23.1;pons: 9.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 145.8" "Region enriched" "Detected in many" 7 "cerebellum: 15.7" "Region enriched" "Detected in some" 17 "cerebellum: 18.7" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" NA NA 870000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: AB_2686328" "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.1 1.3 0.4 0.0 0.1 1.2 0.0 0.2 1.5 0.0 0.1 0.8 9.6 0.4 0.0 0.0 0.9 0.0 57.5 0.1 0.0 0.0 0.2 1.2 0.2 0.6 0.1 0.0 0.0 5.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.7 0.0 0.1 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 31.5 0.1 0.0 0.1 0.0 0.2 0.3 0.0 145.8 0.3 0.0 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.1 0.6 0.0 0.1 0.1 1.2 0.0 9.6 0.2 0.1 0.6 0.2 0.0 2.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 1.0 0.1 1.2 0.0 0.1 0.0 0.3 0.7 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.2 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.0 76.1 0.4 1.5 5.5 0.0 0.0 0.1 0.2 0.8 0.1 0.1 KLF16 "BTEB4, DRRF, NSLP2" ENSG00000129911 "Kruppel like factor 16" Q9BXK1 19 1852399-1863579 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 58.7;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052481 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA052481: AB_2681845" "unprognostic (3.24e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "unprognostic (3.74e-2)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (9.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.92e-3)" "unprognostic (7.15e-2)" "unprognostic (3.23e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (5.85e-3)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (3.76e-2)" 7.0 8.7 33.2 6.6 40.1 13.2 5.7 0.8 37.3 4.7 0.2 8.0 8.6 9.0 1.7 16.2 7.6 3.0 7.1 36.6 13.7 9.3 14.6 10.4 4.5 18.2 5.2 28.7 5.8 6.4 2.8 15.4 3.5 21.3 6.4 2.6 12.0 8.1 2.0 3.0 13.7 10.0 3.0 5.3 15.3 7.2 9.7 10.4 3.3 4.5 0.7 3.1 6.7 6.6 12.2 29.8 15.5 7.7 16.2 4.5 5.4 16.9 22.4 5.0 9.1 8.1 12.5 12.9 22.0 18.8 14.5 8.3 27.1 11.9 20.1 5.7 33.8 20.9 22.9 8.1 15.0 10.2 22.0 37.2 8.1 11.9 15.1 18.7 11.1 8.0 14.3 28.6 16.6 7.7 22.5 20.6 27.3 25.4 19.5 22.1 31.8 7.2 24.3 9.7 10.0 33.7 28.4 7.8 11.9 27.1 7.1 11.2 27.4 19.4 14.8 22.6 34.1 30.8 23.3 29.0 25.2 15.3 18.7 15.9 1.3 1.2 1.3 0.8 1.1 0.9 1.2 0.9 0.5 1.0 1.6 0.8 0.6 2.7 0.1 1.1 5.2 1.3 0.7 33.2 40.1 0.8 37.3 36.6 13.7 18.2 5.2 28.7 21.3 5.3 10.4 12.2 13.3 0.0 5.8 2.6 10.7 26.8 12.1 6.6 11.4 58.7 30.9 19.6 2.0 7.2 5.5 3.7 22.9 3.7 24.6 38.8 1.9 6.2 49.2 18.6 9.0 10.6 32.9 8.6 2.8 8.1 2.8 6.3 8.2 19.3 4.5 6.8 10.0 15.4 13.4 15.2 1.8 22.6 4.1 10.7 12.5 37.0 5.0 12.7 12.4 5.6 9.6 12.3 1.0 1.5 1.2 12.8 24.9 3.4 8.2 13.2 19.7 6.1 7.7 53.0 0.0 11.6 8.0 1.6 4.3 17.9 27.1 4.0 13.2 7.0 20.6 13.5 PGAP6 "M83, TMEM6, TMEM8, TMEM8A" ENSG00000129925 "Post-glycosylphosphatidylinositol attachment to proteins 6" Q9HCN3 16 370788-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 36.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 129.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA051281: AB_2681418, HPA064673: AB_2685317" "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 22.2 25.7 11.7 18.2 13.1 30.3 20.3 8.9 17.8 15.9 11.4 32.6 31.7 19.3 25.0 32.1 17.8 16.5 32.7 10.3 10.5 55.8 58.0 36.5 17.1 11.6 10.3 8.6 12.3 103.7 19.5 29.0 35.1 13.0 30.5 10.4 5.6 41.2 12.6 36.4 10.6 38.8 8.9 9.1 36.3 54.4 63.8 12.4 11.8 28.2 10.2 8.0 23.6 14.5 14.1 12.7 32.8 18.4 33.9 24.7 22.1 36.7 35.5 36.6 17.7 25.3 129.2 57.9 13.4 47.1 34.5 27.3 17.8 8.4 39.2 4.9 38.5 31.1 22.1 23.1 74.8 56.9 16.9 40.4 25.7 11.6 27.4 7.9 18.0 41.4 14.8 36.2 20.1 22.6 78.2 23.9 33.2 29.2 20.1 12.9 51.0 21.0 31.2 28.8 32.0 21.9 25.2 19.8 19.7 106.3 9.6 35.7 33.4 61.1 50.2 53.6 35.2 19.2 40.3 21.6 27.0 25.5 17.8 32.5 7.1 7.6 10.1 10.7 8.6 8.3 2.5 8.1 8.3 3.9 2.6 10.7 8.0 36.0 1.5 6.1 4.2 6.6 5.7 11.7 13.1 8.9 17.8 10.3 10.5 11.6 10.3 8.6 13.0 9.1 12.4 14.1 11.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 63.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 7.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 100.2 1.4 0.0 0.0 0.0 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490821-3500674 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favorable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 7.0 8.8 15.6 4.4 17.8 9.0 6.8 17.9 18.4 6.1 9.4 8.2 17.9 7.6 0.5 11.1 6.8 1.2 11.2 14.2 15.1 11.1 11.0 6.4 3.2 20.1 18.8 12.9 6.5 8.6 2.5 8.5 2.2 19.1 7.6 1.0 1.3 7.0 2.1 19.1 10.5 11.6 1.3 16.9 7.9 8.8 8.2 16.6 2.1 6.0 2.2 1.6 8.4 6.9 23.4 18.6 22.4 3.1 7.1 1.6 2.0 15.0 17.4 3.6 8.0 6.5 31.9 7.6 15.3 13.2 2.4 7.5 19.3 4.6 6.1 1.5 21.5 24.5 15.1 13.3 37.7 6.7 20.7 19.9 2.3 5.7 8.2 3.3 2.8 4.3 15.6 34.1 16.4 3.7 22.3 20.3 23.3 19.1 7.1 29.2 25.4 7.6 21.3 5.3 11.1 20.0 15.5 12.7 10.8 18.4 1.3 15.0 11.0 9.9 10.9 14.4 29.0 31.7 21.9 17.4 20.1 12.4 46.6 12.7 1.2 6.7 2.4 7.6 8.1 9.4 11.1 10.1 14.9 11.0 16.5 14.1 12.3 0.4 10.0 8.9 14.1 13.2 5.9 15.6 17.8 17.9 18.4 14.2 15.1 20.1 18.8 12.9 19.1 16.9 16.6 23.4 9.5 6.4 2.2 2.0 15.5 23.6 22.6 13.2 12.5 17.2 12.4 10.0 7.7 11.5 7.1 5.5 10.4 30.9 7.6 27.9 21.5 22.2 8.6 10.9 7.9 13.2 13.1 23.2 4.9 21.3 29.9 13.6 16.3 7.8 13.4 10.5 11.7 10.0 21.6 25.2 5.1 17.6 24.4 7.9 9.3 23.8 14.0 9.3 19.6 1.9 16.9 12.7 15.5 4.5 30.0 24.7 17.2 15.1 16.0 28.4 10.8 28.9 4.6 12.4 0.0 16.2 13.6 12.6 12.7 14.5 27.6 34.8 12.1 13.6 27.2 18.7 MAU2 "KIAA0892, mau-2, MAU2L, MGC75361, SCC4" ENSG00000129933 "MAU2 sister chromatid cohesion factor" Q9Y6X3 19 19320829-19358754 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059897 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA059897: AB_2684154" "unprognostic (3.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.18e-1)" "unprognostic (9.57e-3)" "unprognostic (1.87e-1)" "prognostic favorable (3.90e-5)" "unprognostic (1.68e-2)" "unprognostic (3.49e-3)" "unprognostic (5.56e-3)" "unprognostic (3.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.28e-1)" "unprognostic (4.27e-3)" "unprognostic (2.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 15.1 16.1 15.2 12.7 18.3 21.4 15.9 16.1 17.8 18.9 14.8 16.7 13.2 18.6 11.9 20.3 18.5 10.7 17.7 14.3 15.6 15.3 14.4 14.3 14.8 19.6 17.1 14.2 23.6 16.7 13.5 21.2 12.4 18.4 17.7 7.6 10.9 15.7 12.2 36.3 21.0 16.6 11.3 16.3 22.4 15.1 19.8 16.8 17.6 17.1 17.8 12.1 16.7 17.3 25.8 13.6 10.4 18.0 16.1 14.5 15.1 24.9 12.7 12.9 16.8 15.1 14.8 18.9 16.9 26.7 13.7 8.5 15.9 15.5 12.8 7.8 9.0 39.3 13.0 16.5 13.2 16.8 23.7 19.5 16.7 14.4 12.1 13.8 17.4 16.3 15.0 18.0 20.3 11.3 15.5 24.3 32.5 15.8 18.7 29.1 27.1 11.6 18.2 11.8 17.6 26.0 23.8 15.7 16.2 16.1 9.1 14.0 32.9 14.8 25.9 6.0 25.7 19.3 26.1 23.5 16.9 12.8 24.8 19.9 3.1 5.8 4.3 6.0 5.0 6.8 4.6 5.3 5.7 5.1 4.5 5.6 5.4 10.4 6.5 11.1 4.9 5.4 6.1 15.2 18.3 16.1 17.8 14.3 15.6 19.6 17.1 14.2 18.4 16.3 16.8 25.8 16.4 19.2 18.3 33.6 17.3 6.2 5.5 8.5 18.8 30.4 13.1 15.2 19.1 11.5 10.5 11.0 54.2 10.4 16.4 15.8 3.9 8.2 9.7 16.5 17.0 13.4 14.4 17.4 26.1 9.4 7.1 13.0 15.8 14.5 10.1 26.0 14.6 8.6 8.8 50.5 31.8 11.9 4.1 13.8 6.4 12.3 15.2 13.9 10.6 14.0 15.4 12.0 20.6 26.7 55.3 11.8 10.7 13.9 12.8 10.5 13.7 6.2 21.0 29.3 6.6 17.2 14.8 31.9 12.6 11.8 9.7 15.2 13.6 21.1 13.1 8.6 SHC2 "SCK, SHCB, SLI" ENSG00000129946 "SHC adaptor protein 2" P98077 19 416583-460996 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 110.7" "Cell type enhanced" "Detected in many" "Adipocytes: 44.8;Hepatic stellate cells: 45.3;Hepatocytes: 56.7;Horizontal cells: 48.8;Oligodendrocyte precursor cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.9;HHSteC: 5.6;SCLC-21H: 12.6;SH-SY5Y: 11.4" HPA006136 Approved Approved Cytosol NA NA Cytosol "HPA006136: AB_1856827" "unprognostic (2.54e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (6.40e-2)" "unprognostic (1.64e-1)" "unprognostic (1.50e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.53e-4)" "unprognostic (4.45e-2)" "unprognostic (5.30e-2)" "unprognostic (1.99e-2)" "unprognostic (3.37e-1)" "unprognostic (8.86e-2)" "unprognostic (4.43e-2)" 13.6 20.0 17.0 1.6 12.6 0.1 17.7 5.7 31.4 25.2 1.5 17.5 6.4 24.4 2.0 5.0 23.8 11.0 17.0 12.9 26.0 12.3 64.3 17.4 1.7 21.6 14.0 15.3 14.2 110.7 7.1 48.4 7.6 16.8 32.9 0.4 1.2 24.7 5.2 5.1 9.1 10.7 2.9 9.9 26.8 21.6 9.7 20.4 0.3 33.0 1.2 0.3 10.1 11.8 13.4 0.0 0.1 0.4 0.1 0.0 0.0 0.6 0.5 2.5 0.3 0.0 0.0 0.4 0.0 4.9 0.0 1.2 0.4 1.1 0.0 0.0 1.1 1.7 0.0 0.0 2.8 5.6 0.0 1.9 0.3 0.0 0.0 0.0 2.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 1.9 0.0 12.6 11.4 0.0 0.0 0.0 2.3 0.3 2.0 0.0 0.5 3.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 12.6 5.7 31.4 12.9 26.0 21.6 14.0 15.3 16.8 9.9 20.4 13.4 44.8 6.4 8.8 33.3 0.5 1.9 2.0 0.8 0.6 11.4 11.3 10.0 9.9 18.6 1.5 0.0 2.1 0.1 0.9 0.1 0.0 25.2 2.5 2.8 4.9 16.6 8.4 2.7 22.1 38.5 0.1 9.5 3.6 4.1 0.0 15.4 45.3 56.7 0.9 48.8 33.1 3.5 6.1 5.3 1.7 7.2 9.0 0.4 8.8 15.0 1.0 29.5 0.0 49.8 28.4 21.1 0.1 11.3 0.2 11.3 0.3 0.4 1.4 3.5 0.0 4.5 13.8 14.7 11.0 0.4 3.1 0.0 1.0 1.6 0.9 3.7 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821955 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 9.9;brain: 23.5;fallopian tube: 11.2" "Cell type enriched" "Detected in some" 7 "Endometrial ciliated cells: 37.2" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 61.8;THP-1: 128.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.0 0.0 19.2 0.2 16.7 9.9 2.2 0.0 21.3 0.3 0.0 0.1 0.0 0.2 0.0 0.0 11.2 0.1 0.0 15.7 8.4 0.0 0.0 2.3 0.1 5.9 7.4 23.5 0.3 0.0 0.2 0.4 0.0 6.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.2 0.1 3.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.3 1.5 12.2 0.0 0.0 0.0 6.9 0.2 0.1 0.0 0.0 0.7 0.1 0.1 8.4 0.1 0.1 0.3 2.3 0.0 0.0 0.0 5.2 0.0 1.6 0.0 0.5 4.4 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.3 0.0 1.1 0.0 61.8 9.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 15.5 0.3 0.0 0.0 6.3 5.4 128.9 0.1 0.2 0.2 0.3 0.1 0.2 0.5 0.2 0.0 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 16.7 0.0 21.3 15.7 8.4 5.9 7.4 23.5 6.0 0.7 9.5 7.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 37.2 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.1 5.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 INS-IGF2 ENSG00000129965 "INS-IGF2 readthrough" F8WCM5 11 2132538-2161209 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "pancreas: 9.2" "Cell type enriched" "Detected in single" 11 "Hepatocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB019430 Enhanced "Secreted to digestive system" NA NA "CAB019430: AB_10691857" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD17A "C19orf27, FAM108A1, MGC5244" ENSG00000129968 "Abhydrolase domain containing 17A, depalmitoylase" Q96GS6 19 1876810-1885496 "Enzymes, Predicted intracellular proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 338.2;NK-cells: 383.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043270, HPA047226, HPA069225" Uncertain Approved "Nuclear speckles,Vesicles" NA NA Vesicles "Nuclear speckles" "HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: " "unprognostic (3.77e-2)" "unprognostic (1.85e-1)" "unprognostic (3.57e-2)" "prognostic favorable (1.73e-4)" "unprognostic (3.70e-2)" "prognostic favorable (6.46e-4)" "unprognostic (1.69e-2)" "unprognostic (1.92e-2)" "unprognostic (5.09e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.29e-2)" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.17e-1)" "unprognostic (1.60e-2)" 47.6 52.0 49.0 8.8 36.8 13.5 44.5 40.8 105.8 43.4 8.5 46.6 13.7 46.8 2.1 64.1 42.7 4.1 72.7 56.4 26.5 47.3 43.2 53.2 10.8 55.3 44.7 30.1 42.0 43.2 7.6 45.4 11.7 54.1 52.9 2.1 1.9 40.7 8.2 57.3 73.3 42.2 3.2 47.3 69.9 45.8 33.7 48.1 8.7 43.3 10.8 4.0 45.7 46.2 48.5 43.0 14.7 6.0 16.7 7.8 9.6 32.5 28.6 8.8 8.4 7.7 7.4 7.5 21.1 11.3 8.3 1.9 26.9 3.0 11.8 1.2 48.9 61.8 15.9 6.7 19.2 10.7 16.4 50.9 10.5 8.8 4.9 3.4 5.5 16.2 20.6 27.6 23.9 6.1 24.1 28.3 31.0 31.2 8.3 32.3 32.8 14.3 32.0 5.9 9.4 19.4 43.9 14.8 16.0 29.8 2.4 16.6 28.3 31.3 9.4 21.4 38.1 28.3 90.8 58.8 18.2 20.6 21.0 15.5 1.6 1.0 4.2 5.2 0.6 3.8 3.7 2.3 3.5 1.0 1.4 2.5 2.7 1.1 3.1 0.6 1.0 2.4 0.9 49.0 36.8 40.8 105.8 56.4 26.5 55.3 44.7 30.1 54.1 47.3 48.1 48.5 125.3 3.2 5.8 13.4 35.6 32.2 21.5 10.4 12.5 41.2 43.9 35.6 4.0 24.3 12.1 14.7 39.6 77.8 338.2 61.8 9.8 31.0 6.4 28.4 43.7 67.6 30.5 22.3 12.8 37.8 43.2 29.8 29.6 37.8 10.2 31.6 65.0 21.5 66.3 55.5 12.5 34.9 12.2 36.1 28.7 6.4 30.1 42.8 26.6 19.7 35.0 66.0 383.1 5.0 63.1 42.7 31.9 36.5 58.7 25.9 38.6 19.5 7.5 35.5 13.1 31.0 44.1 16.3 20.7 21.2 45.9 65.7 117.1 66.1 34.0 32.3 LBP BPIFD2 ENSG00000129988 "Lipopolysaccharide binding protein" P18428 20 38346482-38377013 "Plasma proteins, Predicted secreted proteins, Transporters" "Immunity, Innate immunity, Lipid transport, Transport" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "liver: 1349.5" "Cell type enriched" "Detected in some" 30 "Hepatocytes: 458.3" "Cancer enriched" "Detected in many" 20 "liver cancer: 356.7" "Region enhanced" "Detected in single" "medulla oblongata: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 10.7;HSkMC: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001508, CAB025905" Approved "Secreted to blood" NA NA 25000000000 1300000000 "CAB025905: , HPA001508: AB_1079241" "unprognostic (4.20e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (4.54e-2)" "unprognostic (2.47e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-2)" "unprognostic (5.50e-2)" "unprognostic (2.48e-3)" "unprognostic (6.15e-2)" "unprognostic (2.12e-1)" "unprognostic (7.93e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.62e-12)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" 58.8 0.5 0.0 24.4 0.1 0.5 6.6 0.0 0.1 2.6 0.0 0.4 0.0 2.7 0.0 0.1 0.6 0.2 1.9 0.0 0.0 8.5 1349.5 1.2 2.8 1.1 0.0 0.0 0.2 1.7 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.4 0.0 23.0 0.4 0.6 1.5 0.0 0.5 0.6 0.7 0.3 0.1 4.0 2.1 0.3 0.7 0.2 0.3 0.0 0.1 0.1 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 8.6 0.7 0.0 0.0 0.1 0.0 0.0 7.9 0.8 1.0 0.1 0.2 0.5 0.0 10.7 0.3 11.0 0.1 0.8 0.0 0.7 0.0 0.0 9.7 458.3 0.3 0.0 0.3 0.0 0.0 8.5 0.0 0.3 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.1 0.0 15.2 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 SYT5 ENSG00000129990 "Synaptotagmin 5" O00445 19 55171196-55180289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 68.6;pituitary gland: 59.7" "Cell type enhanced" "Detected in some" "Early spermatids: 15.4;Enteroendocrine cells: 57.6;Excitatory neurons: 20.3;Late spermatids: 41.4" "Cancer enhanced" "Detected in many" "pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 27.1;HMC-1: 60.2;K-562: 22.7;OE19: 95.7;SCLC-21H: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078390 Enhanced NA NA "HPA078390: AB_2732382" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (9.76e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (9.85e-2)" "unprognostic (3.24e-3)" "unprognostic (5.94e-2)" "unprognostic (1.36e-3)" "unprognostic (1.82e-1)" "prognostic favorable (5.54e-4)" "unprognostic (1.15e-3)" "unprognostic (3.71e-7)" "unprognostic (7.09e-2)" "unprognostic (5.21e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-1)" 0.2 9.8 35.5 1.9 43.4 0.5 0.1 0.6 68.6 0.8 0.3 1.7 1.3 0.1 0.0 0.2 0.2 0.2 0.1 48.7 43.4 0.1 0.1 0.2 0.2 14.0 14.2 51.0 0.0 2.6 0.7 59.7 0.0 21.2 0.1 0.7 4.4 0.0 0.0 0.1 0.8 1.1 0.5 5.2 0.1 1.9 5.4 24.0 0.2 0.1 0.0 0.3 0.1 0.3 40.1 0.2 0.2 0.4 0.4 0.9 0.0 0.3 0.6 0.0 0.0 0.9 0.0 1.1 1.7 27.1 0.0 0.8 0.7 0.0 0.0 0.0 0.3 0.1 0.3 0.2 0.1 1.1 0.1 60.2 0.7 0.2 0.0 0.1 0.0 0.5 0.5 22.7 3.8 0.0 0.6 0.5 0.0 0.1 95.7 3.8 0.1 0.4 0.3 0.0 0.1 15.9 7.1 0.0 1.1 0.9 0.0 0.5 0.1 0.1 1.4 1.3 1.7 0.1 0.2 1.4 0.9 0.5 0.1 0.3 1.4 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.5 0.2 0.1 0.1 0.9 0.3 0.1 0.2 0.1 0.1 35.5 43.4 0.6 68.6 48.7 43.4 14.0 14.2 51.0 21.2 5.2 24.0 40.1 0.2 0.0 0.0 3.3 1.0 0.6 0.1 1.4 0.0 2.8 0.1 0.6 1.1 0.0 0.4 0.0 4.2 0.0 1.0 0.8 0.0 0.3 15.4 9.1 0.3 0.1 57.6 2.7 20.3 0.4 0.1 0.3 5.6 0.2 0.0 0.7 0.4 0.0 0.2 6.7 11.9 0.8 4.1 0.6 0.0 41.4 0.3 0.1 0.0 3.7 0.1 0.4 0.0 1.5 2.5 0.9 0.1 0.4 0.1 0.1 2.1 0.0 4.0 0.4 0.0 0.0 0.7 8.2 7.6 0.0 0.1 0.0 1.0 0.2 0.6 0.4 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 417 "heart muscle: 7330.6" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 12618.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6" "Region enhanced" "Detected in many" "olfactory bulb: 10.9" "Low region specificity" "Detected in many" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol NA NA 2400000 Cytosol Vesicles "CAB009349: AB_793465, HPA046428: AB_2679661" "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 1.1 3.0 0.8 0.0 0.6 0.0 17.5 0.6 0.4 0.7 0.6 0.6 0.0 0.3 0.1 0.8 6.3 0.9 7330.6 0.4 0.2 0.9 1.1 7.4 1.7 0.5 1.1 0.2 1.5 2.3 0.2 0.6 1.0 1.4 2.4 0.0 0.2 1.3 0.0 6.6 1.2 0.7 0.0 1.1 0.4 0.7 3.7 0.4 0.2 1.5 2.4 0.0 0.4 0.6 0.3 1.2 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.0 0.3 1.8 6.3 0.0 1.1 1.1 1.2 0.3 0.0 0.0 13.0 3.0 0.0 1.9 0.5 0.0 20.3 0.0 0.6 0.1 0.3 0.1 0.1 0.8 39.1 0.8 0.0 0.6 0.2 0.0 0.7 54.6 0.5 1.9 0.4 0.1 1.8 0.0 0.1 2.2 0.0 0.0 0.2 0.0 2.8 9.5 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.6 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.6 0.4 0.4 0.2 0.5 1.1 0.2 1.4 1.1 0.4 0.3 0.1 0.0 0.0 0.0 0.2 6.9 0.0 0.8 13.6 0.0 1.0 0.9 12618.4 8.6 1.8 5.5 0.0 1.4 0.1 0.4 0.0 0.7 56.2 3.5 0.1 131.3 1.8 0.0 0.0 0.2 0.5 202.7 0.0 1.3 0.0 996.2 0.0 0.0 2.2 1.7 0.2 0.4 2.0 0.3 0.7 222.9 0.3 4.6 1.8 1.9 0.0 4.2 0.0 0.0 0.1 1.0 0.0 1.9 0.0 0.0 0.0 0.1 11.2 0.5 0.0 0.4 123.6 6.4 16.1 0.7 2.8 2.5 0.6 1.2 1.0 0.1 CBFA2T3 "ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4" ENSG00000129993 "CBFA2/RUNX1 partner transcriptional co-repressor 3" O75081 16 88874858-88977207 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3;lymphoid tissue: 29.8;pancreas: 27.5" "Cell type enhanced" "Detected in many" "Adipocytes: 24.8;B-cells: 26.2;dendritic cells: 25.7;Erythroid cells: 21.0;Intestinal goblet cells: 19.2;Langerhans cells: 23.3;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 33.3" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 64.2;K-562: 114.9;MCF7: 52.3;MOLT-4: 58.0;NB-4: 70.1;REH: 113.6;T-47d: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059931, HPA062423, HPA065890" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575" "unprognostic (2.47e-1)" "unprognostic (2.03e-2)" "unprognostic (9.24e-3)" "unprognostic (2.62e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.13e-3)" "unprognostic (1.69e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.30e-3)" "unprognostic (2.38e-1)" "unprognostic (7.04e-5)" "unprognostic (2.18e-1)" "unprognostic (4.08e-2)" "unprognostic (4.62e-2)" "unprognostic (9.35e-3)" 9.2 2.3 4.2 6.9 3.5 7.8 7.8 33.3 9.9 3.4 0.0 4.2 3.3 5.1 0.7 2.4 3.7 1.7 12.2 6.3 0.5 1.2 4.4 11.4 8.9 6.5 2.6 1.7 1.0 27.5 0.7 4.2 3.1 11.4 6.4 1.0 0.8 4.9 0.8 14.1 3.2 10.8 1.1 0.2 18.6 3.7 4.6 0.2 29.8 3.9 3.3 5.1 3.5 3.8 2.8 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.3 3.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.1 64.2 0.0 0.0 0.1 17.2 30.6 0.0 0.0 0.0 0.0 0.1 0.0 30.2 114.9 0.5 0.0 52.3 58.0 70.1 1.2 0.0 0.0 113.6 0.8 11.4 0.0 0.0 21.3 4.8 2.5 0.5 0.4 0.3 50.1 17.9 0.4 0.0 0.4 0.3 0.0 0.4 0.5 37.9 0.0 19.8 0.0 1.0 2.5 2.7 0.0 2.8 0.0 3.1 0.0 0.0 6.6 1.7 0.0 0.0 3.4 0.0 4.8 10.6 0.0 1.8 4.2 3.5 33.3 9.9 6.3 0.5 6.5 2.6 1.7 11.4 0.2 0.2 2.8 24.8 0.0 1.1 0.3 26.2 2.5 6.2 1.9 0.6 10.8 1.1 0.9 3.3 1.5 2.4 0.0 0.0 0.1 25.7 0.8 0.0 0.3 0.0 0.6 0.6 9.1 3.6 21.0 5.9 2.9 0.2 2.7 2.0 0.5 6.3 0.1 2.2 10.8 3.0 0.0 2.1 19.2 0.0 5.0 23.3 0.3 2.1 9.8 0.0 9.4 14.8 0.2 0.0 2.0 0.6 0.9 0.5 0.7 14.4 2.9 1.7 0.6 0.5 1.4 19.7 10.8 15.6 0.2 4.8 1.7 2.3 0.3 1.3 3.3 1.0 3.8 GAMT "PIG2, TP53I2" ENSG00000130005 "Guanidinoacetate N-methyltransferase" Q14353 19 1397026-1401570 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 620.1;skeletal muscle: 1246.7;tongue: 470.5" "Group enriched" "Detected in many" 4 "Hepatocytes: 718.3;Proximal tubular cells: 417.4" "Cancer enriched" "Detected in all" 5 "liver cancer: 173.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 176.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051806 Approved NA NA 420000 "HPA051806: AB_2681619" "unprognostic (3.25e-1)" "unprognostic (7.74e-3)" "unprognostic (3.22e-2)" "unprognostic (6.32e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (3.41e-2)" "unprognostic (7.10e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.54e-2)" 13.4 26.8 65.9 4.6 67.8 8.9 15.7 62.9 79.8 14.8 49.1 9.0 3.3 10.1 143.1 23.2 14.8 10.0 84.7 62.5 63.8 70.7 620.1 8.2 7.8 68.1 64.8 60.3 23.0 231.7 38.1 37.7 5.0 69.1 36.8 2.2 15.2 43.0 17.6 1246.7 29.4 6.5 4.6 64.8 10.8 32.1 55.4 65.8 25.0 22.4 470.5 4.4 13.0 15.4 90.3 21.6 24.1 25.2 56.9 30.9 37.3 34.3 25.2 41.2 31.8 28.7 54.8 15.1 11.3 17.2 30.0 3.8 9.1 39.8 15.5 8.5 81.5 46.2 34.9 20.3 176.7 18.2 0.7 11.5 41.8 5.5 33.8 0.1 44.0 6.9 43.0 50.6 26.6 52.6 22.1 103.9 12.0 28.6 10.7 75.4 103.1 22.3 81.4 38.1 19.5 8.4 58.5 1.9 14.3 32.0 16.1 65.3 48.1 12.2 34.6 35.6 1.9 11.6 119.0 24.8 19.5 32.2 46.1 40.7 3.7 2.5 15.3 18.8 3.4 27.3 22.0 26.3 23.8 11.2 32.3 40.6 30.8 1.5 18.2 6.1 47.3 15.8 14.9 65.9 67.8 62.9 79.8 62.5 63.8 68.1 64.8 60.3 69.1 64.8 65.8 90.3 9.2 0.0 7.2 5.5 18.0 58.9 42.1 57.8 116.7 41.0 60.3 99.9 99.3 127.2 12.9 16.5 56.3 35.7 15.4 0.8 92.0 39.9 5.2 6.5 7.4 9.2 7.2 35.8 7.4 33.6 41.2 30.9 10.2 4.0 4.5 43.3 18.9 718.3 81.7 18.5 10.1 1.5 6.1 29.5 13.3 16.0 83.9 13.9 32.0 3.7 4.7 57.3 10.3 4.0 36.7 13.5 0.1 139.5 12.5 24.1 0.1 417.4 6.1 61.7 32.9 77.8 47.1 4.3 22.6 42.1 42.9 12.0 19.7 31.1 3.3 23.2 PUDP "DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A" ENSG00000130021 "Pseudouridine 5'-phosphatase" Q08623 X 6667865-7148158 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000292, HPA072672" Approved Approved Nucleoplasm,Cytosol NA NA 14000 Nucleoplasm Cytosol "HPA000292: , HPA072672: AB_2732208" "unprognostic (1.84e-1)" "unprognostic (4.93e-2)" "unprognostic (5.15e-3)" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (5.63e-3)" "unprognostic (1.00e-3)" "unprognostic (3.22e-2)" "unprognostic (4.86e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.24e-1)" "unprognostic (3.06e-2)" "unprognostic (2.23e-1)" "unprognostic (2.92e-2)" "prognostic favorable (4.80e-4)" "unprognostic (3.42e-2)" 8.4 9.2 8.0 12.5 8.9 3.6 8.9 9.0 8.6 9.4 9.9 17.5 18.2 6.5 4.8 8.5 20.1 8.3 20.6 7.8 9.9 15.2 9.9 12.0 17.0 9.4 9.8 7.6 10.5 6.8 8.5 3.7 20.3 9.3 7.0 12.4 7.4 11.2 7.7 33.3 5.2 12.4 11.0 8.8 9.0 19.5 4.5 9.7 13.4 10.4 20.4 14.2 9.3 7.3 9.6 48.0 42.1 68.4 28.3 34.7 34.0 11.8 14.8 15.7 18.6 18.7 64.2 28.7 21.9 31.5 16.5 61.5 14.4 31.7 37.9 28.1 20.1 60.4 23.4 15.7 35.7 16.3 20.7 24.4 16.5 14.6 50.7 23.0 12.1 56.2 27.2 45.3 17.8 29.3 23.3 22.5 30.6 29.1 19.9 21.1 16.2 26.0 60.8 26.7 18.0 15.4 16.1 12.7 24.4 25.5 59.6 27.2 18.9 17.4 10.4 6.6 43.7 13.0 55.6 0.2 33.8 15.9 11.5 21.5 2.6 17.8 2.2 7.4 18.9 7.6 8.1 7.8 7.1 13.6 5.9 5.8 6.5 1.9 6.8 19.3 4.3 12.2 10.1 8.0 8.9 9.0 8.6 7.8 9.9 9.4 9.8 7.6 9.3 8.8 9.7 9.6 6.6 12.8 4.6 0.0 7.8 0.0 4.1 0.0 5.7 3.9 5.2 3.9 0.0 15.7 3.7 18.4 4.2 48.0 2.4 20.8 9.8 21.1 0.4 10.7 5.3 7.0 0.0 3.4 0.0 16.9 27.6 4.6 10.2 6.1 1.3 10.7 6.8 11.1 22.1 5.0 0.0 10.7 0.0 19.8 0.0 1.6 6.2 8.3 0.0 0.0 13.2 11.9 1.0 0.0 0.0 19.7 20.8 4.9 14.6 8.0 23.5 24.6 5.1 3.9 6.6 6.1 4.0 11.1 15.9 6.0 0.0 28.2 4.8 9.4 14.6 6.1 ERMARD "C6orf70, dJ266L20.3, FLJ11152" ENSG00000130023 "ER membrane associated RNA degradation" Q5T6L9 6 169751622-169781600 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 49.9;Late spermatids: 48.5;Spermatocytes: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041741 Approved Approved Cytosol NA NA Cytosol "HPA041741: AB_10804116" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (2.24e-2)" "unprognostic (7.41e-3)" "unprognostic (1.96e-1)" "unprognostic (8.14e-2)" "unprognostic (1.66e-3)" "unprognostic (4.74e-2)" "unprognostic (3.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.31e-2)" 12.2 14.7 6.4 8.5 7.4 10.2 13.2 5.8 6.8 13.3 5.8 10.7 6.4 13.9 20.6 10.6 13.3 7.8 6.8 5.7 7.0 11.8 18.8 9.8 14.0 7.6 6.6 5.5 17.5 11.5 6.9 15.5 7.5 7.0 12.8 7.5 14.7 11.1 8.7 15.0 18.8 13.8 6.5 6.9 17.4 10.9 22.3 6.4 10.0 13.3 2.5 13.7 11.3 10.9 9.5 5.1 7.5 9.7 14.8 6.9 11.4 5.1 5.3 7.7 5.0 6.3 2.0 8.3 8.0 4.8 6.5 6.1 13.3 4.0 10.3 4.4 8.6 4.4 11.5 9.9 3.0 13.7 16.1 7.6 13.4 10.4 6.1 15.5 12.8 3.4 14.0 8.0 11.4 6.5 7.7 6.8 14.4 3.2 5.7 5.4 7.5 6.0 13.0 6.2 4.0 3.8 7.0 9.0 9.0 4.9 6.3 7.1 12.8 5.3 5.7 3.4 9.1 6.5 13.1 17.5 6.7 7.2 9.7 6.6 1.6 4.2 1.8 5.2 7.9 5.2 5.1 6.0 5.9 4.4 6.0 4.7 4.4 0.4 5.2 9.7 3.7 7.6 3.9 6.4 7.4 5.8 6.8 5.7 7.0 7.6 6.6 5.5 7.0 6.9 6.4 9.5 8.5 3.2 11.1 20.2 6.2 4.1 4.4 7.7 5.2 12.0 5.9 5.1 2.8 5.7 7.7 5.5 10.4 12.2 4.7 3.0 11.7 9.8 49.9 10.8 9.4 5.0 6.0 4.6 9.3 8.5 8.3 7.0 5.6 6.9 2.5 11.7 7.9 10.1 5.9 5.0 11.8 2.9 6.1 5.7 4.4 48.5 4.4 6.1 3.6 8.4 5.6 14.6 5.2 17.1 20.7 5.3 2.4 4.5 4.4 2.5 5.7 9.5 15.5 10.8 6.6 5.5 5.8 37.8 18.0 5.5 3.1 7.1 4.7 10.3 3.4 3.4 PHF10 "BAF45a, FLJ10975, XAP135" ENSG00000130024 "PHD finger protein 10" Q8WUB8 6 169703902-169725566 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055649 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA055649: AB_2682875" "unprognostic (1.74e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (4.25e-2)" "unprognostic (4.45e-2)" "unprognostic (6.76e-3)" "prognostic unfavorable (3.42e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "prognostic favorable (1.12e-5)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.63e-1)" "unprognostic (6.82e-2)" "unprognostic (2.43e-1)" "unprognostic (2.76e-2)" 41.2 79.3 54.6 39.3 58.7 53.9 41.3 57.2 50.0 42.1 51.4 44.1 32.5 40.4 39.6 47.1 40.1 34.9 47.0 47.6 63.6 34.4 52.8 40.8 62.2 59.6 60.2 43.4 81.4 41.3 48.1 36.6 44.0 59.1 48.9 34.9 59.6 44.9 45.1 82.0 51.3 41.0 33.7 62.5 50.3 43.1 42.0 57.9 53.7 49.1 64.3 61.8 42.6 42.2 62.4 31.2 30.7 119.2 125.5 40.7 24.5 49.0 41.2 37.3 49.8 54.3 88.9 31.4 91.1 24.4 29.2 31.7 38.4 92.5 45.3 72.0 73.3 82.1 91.1 54.8 116.9 41.5 134.2 5.4 18.5 46.7 32.1 29.4 82.3 80.2 64.4 102.7 57.5 36.0 53.4 25.6 115.0 37.6 68.3 18.9 121.0 84.4 73.7 62.1 32.5 56.7 75.9 56.4 18.4 41.5 49.7 36.3 158.6 54.0 28.1 46.6 36.3 53.2 50.7 46.1 112.3 36.7 88.6 45.6 1.6 1.4 3.2 1.5 1.5 1.4 2.6 2.7 2.1 1.4 1.7 2.6 2.8 0.2 1.2 1.6 1.2 1.8 0.8 54.6 58.7 57.2 50.0 47.6 63.6 59.6 60.2 43.4 59.1 62.5 57.9 62.4 42.5 25.6 30.1 17.9 24.5 29.8 22.7 13.3 13.1 12.1 38.1 31.8 59.3 35.8 23.7 11.0 41.7 14.8 25.9 11.0 13.7 12.5 15.3 32.1 27.4 28.2 25.9 7.4 14.9 12.6 8.9 27.6 12.8 42.1 6.3 38.1 29.3 27.5 11.6 11.8 19.0 22.8 18.3 13.9 28.7 9.7 22.4 21.5 19.6 28.1 11.8 33.4 10.3 17.6 33.6 17.1 19.4 21.1 16.4 27.6 18.6 12.4 22.7 26.8 19.7 27.9 53.1 18.9 22.0 21.2 23.4 17.4 21.2 33.2 20.0 27.4 PRRG3 TMG3 ENSG00000130032 "Proline rich and Gla domain 3" Q9BZD7 X 151694607-151705924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;epididymis: 7.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 18.4;Excitatory neurons: 12.7;Fibroblasts: 15.2;Inhibitory neurons: 8.9;Langerhans cells: 22.4;Suprabasal keratinocytes: 22.6" "Cancer enhanced" "Detected in some" "stomach cancer: 1.3" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;SuSa: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060566 Uncertain NA NA "HPA060566: AB_2684321" "unprognostic (1.85e-1)" "unprognostic (1.21e-1)" "unprognostic (7.71e-2)" "unprognostic (1.77e-2)" "unprognostic (4.42e-4)" "unprognostic (7.24e-2)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" "unprognostic (5.11e-2)" "unprognostic (3.01e-2)" "unprognostic (2.26e-1)" "unprognostic (1.98e-2)" "unprognostic (7.69e-2)" "unprognostic (4.64e-2)" "unprognostic (1.57e-1)" "unprognostic (1.84e-2)" 1.9 0.2 6.1 0.2 9.4 0.2 1.8 0.0 11.5 5.0 0.3 1.0 0.1 1.7 7.5 2.3 0.9 2.0 1.3 7.2 5.2 0.4 0.0 1.2 0.1 2.1 2.8 9.3 2.1 0.1 0.2 1.5 0.8 3.5 0.6 0.6 0.7 1.7 0.2 2.4 1.5 0.4 1.4 0.0 1.7 0.6 0.3 5.9 1.2 0.9 2.0 0.2 1.1 2.7 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.2 0.3 0.2 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.6 0.5 0.4 0.3 0.2 0.2 6.1 9.4 0.0 11.5 7.2 5.2 2.1 2.8 9.3 3.5 0.0 5.9 7.6 7.4 0.0 0.0 0.7 0.1 18.4 0.4 0.0 2.8 0.1 0.6 1.7 4.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 3.9 0.0 0.0 0.2 0.7 5.7 0.0 0.0 12.7 0.0 0.0 15.2 0.0 0.5 0.0 0.5 1.4 0.2 0.1 0.0 8.9 0.0 0.0 0.0 22.4 0.0 0.3 0.3 7.2 1.0 0.0 0.1 0.0 1.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.3 0.0 3.1 2.1 0.0 0.1 0.2 22.6 0.0 1.3 0.3 0.0 0.3 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" Q9NY28 12 4720400-4851927 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 31.6;testis: 13.6" "Group enriched" "Detected in some" 6 "Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2" "Group enriched" "Detected in some" 4 "colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 23.4;U-266/84: 7.6" "Not detected" "Not detected" "HPA012638, HPA073461" Supported Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA No "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 0.3 0.6 3.4 1.9 3.4 0.0 0.6 3.0 5.1 0.3 2.3 14.1 5.7 0.3 0.1 0.1 0.6 0.0 1.9 3.8 2.9 0.4 0.2 0.3 0.2 3.7 3.4 3.1 0.7 0.2 0.0 2.8 0.1 4.3 0.4 31.6 0.2 0.4 0.3 0.1 0.2 12.7 0.9 3.1 0.5 0.5 13.6 3.5 0.0 0.2 0.0 0.0 0.4 0.3 4.2 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 23.4 0.0 0.0 0.0 0.1 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 3.4 3.4 3.0 5.1 3.8 2.9 3.7 3.4 3.1 4.3 3.1 3.5 4.2 0.1 6.4 0.5 1.3 0.5 0.0 0.0 0.1 0.6 2.1 0.1 2.3 4.5 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0 95.2 0.5 0.1 0.5 6.6 0.0 1.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 47.0 0.0 0.0 0.0 150.2 1.5 0.1 0.0 3.7 0.2 0.5 0.0 15.1 7.4 0.2 0.6 2.6 0.0 0.1 1.0 1.0 0.0 0.6 6.6 0.7 0.1 12.3 8.3 0.0 0.0 0.0 0.8 0.3 2.2 0.0 KCNA5 "HK2, HPCN1, Kv1.5" ENSG00000130037 "Potassium voltage-gated channel subfamily A member 5" P22460 12 5043879-5046788 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 43.1;heart muscle: 24.8" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 143.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 122 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 122 "dendritic cells: 12.2" "Cell line enriched" "Detected in single" 13 "NTERA-2: 4.2" "Low region specificity" "Detected in many" "HPA021516, CAB022562" Approved NA NA "CAB022562: , HPA021516: AB_2670732" "unprognostic (3.87e-1)" "unprognostic (9.91e-3)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (2.64e-1)" "unprognostic (7.06e-3)" "unprognostic (1.20e-1)" "unprognostic (4.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (2.37e-2)" "unprognostic (5.08e-3)" "unprognostic (6.73e-4)" "unprognostic (1.92e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (3.08e-2)" 2.3 0.5 3.4 0.2 4.9 0.1 1.4 2.9 3.5 0.7 43.1 3.1 0.3 1.5 0.4 4.9 1.9 0.8 24.8 6.3 7.3 1.1 0.2 2.8 0.2 3.5 5.4 2.4 2.4 1.3 0.0 7.2 2.0 2.8 0.6 0.5 7.6 0.3 0.9 3.9 0.3 1.2 0.5 4.4 0.5 3.7 0.2 4.4 0.1 1.3 4.8 0.4 3.6 1.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 3.4 4.9 2.9 3.5 6.3 7.3 3.5 5.4 2.4 2.8 4.4 4.4 4.6 0.7 0.0 0.0 0.3 1.6 0.9 0.0 0.0 0.0 143.1 0.0 0.0 20.9 0.0 0.0 0.0 2.1 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.1 2.9 3.5 0.0 0.3 0.0 0.0 3.7 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 3.7 0.1 1.9 0.0 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.0 13.1 3.5 29.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 CRACR2A "EFCAB4B, MGC4266" ENSG00000130038 "Calcium release activated channel regulator 2A" Q9BSW2 12 3606633-3764819 "Predicted intracellular proteins" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.1;intestine: 13.6;salivary gland: 39.0" "Cell type enhanced" "Detected in many" "dendritic cells: 14.9;Intestinal goblet cells: 46.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 29.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038686 Enhanced NA NA "HPA038686: AB_10671748" "unprognostic (6.78e-2)" "unprognostic (3.82e-2)" "unprognostic (3.96e-2)" "unprognostic (9.15e-2)" "unprognostic (1.40e-3)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-2)" "unprognostic (2.17e-2)" "unprognostic (5.47e-2)" "unprognostic (5.11e-2)" "prognostic favorable (2.85e-6)" "unprognostic (4.94e-3)" "unprognostic (2.01e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (5.04e-2)" 1.4 0.2 0.2 3.7 0.8 17.1 5.0 0.1 0.4 2.2 0.9 9.2 4.5 0.7 0.1 0.5 0.5 1.8 1.9 0.2 0.2 0.2 1.0 1.3 4.0 0.5 0.3 0.2 1.1 3.3 0.1 0.2 0.2 0.3 4.3 13.6 0.1 39.0 0.7 0.3 1.7 8.5 1.1 0.4 2.9 3.5 1.1 0.5 6.1 0.6 0.4 3.6 2.8 0.3 0.5 13.2 4.4 0.9 0.2 1.7 5.1 10.1 1.4 1.2 3.7 5.1 8.9 2.6 19.5 0.5 5.1 0.2 0.0 14.7 0.0 5.2 29.4 3.3 17.1 0.0 0.0 2.9 23.9 0.4 3.9 1.5 11.4 0.1 0.0 10.7 18.4 12.0 8.4 4.8 10.7 22.0 11.6 5.3 24.6 0.0 11.7 11.9 3.8 0.0 16.6 9.5 2.2 3.0 3.1 0.1 0.9 0.6 13.4 15.6 0.0 15.3 12.6 0.0 0.1 0.0 24.9 0.0 11.1 0.0 16.9 1.0 2.5 5.0 1.0 5.0 2.6 2.5 4.0 0.8 0.9 1.4 2.5 1.1 3.5 0.2 0.3 1.0 1.7 0.2 0.8 0.1 0.4 0.2 0.2 0.5 0.3 0.2 0.3 0.4 0.5 0.5 0.9 0.0 0.6 1.0 6.1 0.0 1.3 0.0 0.6 1.1 12.8 9.4 3.8 0.0 3.1 0.0 2.1 0.1 14.9 4.3 0.0 1.6 1.5 0.4 5.5 1.2 0.0 3.0 3.4 2.9 0.6 3.1 6.1 0.3 0.0 13.2 2.2 0.5 2.0 0.0 5.5 46.0 0.0 2.5 0.0 2.9 1.8 3.1 0.0 4.7 3.2 0.1 8.2 0.0 0.6 1.9 5.3 4.5 8.6 4.7 3.2 0.2 2.9 0.2 0.0 4.2 2.0 1.2 2.9 0.2 0.0 0.0 12.1 2.6 8.1 1.8 NXNL2 "C9orf121, RdCVF2" ENSG00000130045 "Nucleoredoxin like 2" Q5VZ03 9 88534033-88584274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 7.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045526 Uncertain Approved Cytosol NA NA Cytosol "HPA045526: AB_10961044" "prognostic favorable (6.53e-4)" "unprognostic (9.70e-2)" "unprognostic (4.78e-3)" "prognostic favorable (3.83e-8)" "unprognostic (2.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-4)" "unprognostic (1.92e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-3)" "unprognostic (5.58e-2)" "prognostic favorable (9.60e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-2)" 6.6 0.7 4.5 1.2 3.6 4.2 2.9 6.1 5.6 4.0 1.4 0.5 0.9 2.0 1.4 0.4 4.3 1.0 0.7 3.6 1.8 2.3 4.5 0.7 0.9 1.7 0.8 2.7 1.2 0.4 0.3 0.1 0.6 3.0 0.9 0.4 4.9 1.6 0.7 1.4 1.5 0.9 0.5 0.1 1.1 0.8 1.3 2.5 0.5 1.3 0.1 0.5 0.4 0.3 6.9 1.5 2.6 1.0 1.0 0.1 0.7 0.7 2.6 0.7 0.3 0.5 0.6 1.0 0.6 1.1 0.3 0.7 1.3 0.4 0.1 0.9 0.4 0.8 1.3 4.0 1.0 0.4 0.7 1.1 0.5 0.2 0.3 0.2 0.4 0.0 0.9 0.9 2.7 0.7 0.7 0.7 1.2 1.4 0.5 0.7 0.5 0.5 0.9 10.4 0.8 0.6 0.4 1.6 0.8 0.5 0.7 1.2 0.6 0.9 0.9 1.9 1.5 0.6 0.9 0.8 0.7 0.7 0.9 0.7 2.1 0.3 0.8 0.6 0.1 0.6 0.2 0.3 0.7 0.0 0.3 0.6 0.7 0.8 0.5 0.1 0.3 0.6 0.3 4.5 3.6 6.1 5.6 3.6 1.8 1.7 0.8 2.7 3.0 0.1 2.5 6.9 0.2 0.0 0.0 1.3 0.1 0.0 1.9 0.7 1.2 0.2 7.5 3.2 0.3 4.3 0.1 1.8 0.0 0.2 0.0 0.0 1.9 0.8 11.4 39.1 4.3 0.8 0.0 0.0 1.2 0.2 1.3 0.8 0.0 13.9 0.0 13.2 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 0.0 4.4 0.9 0.2 0.0 0.0 0.0 0.5 0.0 1.0 0.7 0.2 0.0 2.2 0.1 0.4 0.0 18.6 0.2 0.8 0.0 0.3 1.3 0.4 1.6 0.0 0.1 1.1 0.3 12.7 0.0 2.2 STARD8 "ARHGAP38, KIAA0189" ENSG00000130052 "StAR related lipid transfer domain containing 8" Q92502 X 68647666-68725842 "Metabolic proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 27.9;Endothelial cells: 26.5;Hepatic stellate cells: 18.5;Kupffer cells: 13.7;Langerhans cells: 14.9;Macrophages: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "classical monocyte: 1.6;intermediate monocyte: 3.2;myeloid DC: 3.4;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 18 "dendritic cells: 3.4;monocytes: 4.7" "Cell line enhanced" "Detected in many" "HEL: 16.0;K-562: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060788 Uncertain NA Yes "HPA060788: AB_2684365" "unprognostic (2.00e-1)" "unprognostic (8.98e-2)" "unprognostic (1.56e-3)" "unprognostic (4.94e-3)" "unprognostic (1.73e-1)" "unprognostic (2.61e-2)" "unprognostic (2.77e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-1)" "unprognostic (5.09e-3)" "unprognostic (9.72e-2)" "unprognostic (9.58e-2)" "unprognostic (5.19e-3)" "unprognostic (4.89e-3)" "unprognostic (9.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.07e-2)" 13.2 4.4 7.7 6.1 6.2 3.4 10.4 6.0 6.9 6.3 5.8 3.9 1.4 7.2 4.7 3.4 9.0 5.3 10.6 5.9 5.9 14.8 6.6 20.8 4.2 12.9 7.1 4.3 3.3 5.2 2.6 9.0 8.9 7.2 9.3 1.5 0.6 2.7 8.6 6.8 2.5 4.4 6.1 7.4 11.2 4.2 0.8 7.9 1.6 10.4 6.6 1.9 6.6 4.5 6.7 0.0 1.8 2.8 1.4 0.0 0.0 2.1 3.8 7.9 2.1 1.6 0.0 0.4 0.0 9.6 1.6 0.2 0.0 0.8 0.0 3.5 0.0 0.5 16.0 1.4 0.2 0.3 0.0 0.0 1.3 0.0 5.4 0.0 6.1 9.9 0.0 20.4 0.0 5.3 0.8 0.0 9.5 1.6 0.0 0.3 0.0 10.1 5.4 9.5 0.0 0.0 0.7 0.1 0.9 0.3 5.6 1.3 2.2 7.0 9.6 4.0 3.1 3.7 0.0 0.0 0.0 7.2 6.6 5.7 0.0 1.6 0.0 0.0 3.2 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 4.7 0.1 0.0 1.8 7.7 6.2 6.0 6.9 5.9 5.9 12.9 7.1 4.3 7.2 7.4 7.9 6.7 27.9 0.0 6.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.2 0.3 8.5 0.0 1.8 0.0 0.0 0.3 0.1 0.0 1.9 0.0 0.1 1.2 1.6 26.5 0.0 2.1 0.3 0.0 0.2 3.0 0.5 1.1 7.0 0.3 18.5 6.5 3.6 0.0 0.8 0.0 0.0 13.7 14.9 0.0 0.3 13.9 0.0 9.4 2.4 0.3 0.0 0.5 0.5 0.8 0.0 0.0 0.9 0.1 0.0 2.4 2.2 0.4 0.0 2.8 3.5 0.1 0.2 0.2 1.4 0.1 0.6 0.2 0.0 0.1 FAM155B "CXorf63, TED, TMEM28" ENSG00000130054 "Family with sequence similarity 155 member B" O75949 X 69504326-69532508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "heart muscle: 33.2" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 23.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036093 Uncertain NA NA "HPA036093: AB_10673613" "prognostic unfavorable (4.61e-5)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (5.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.49e-2)" "unprognostic (3.09e-4)" "unprognostic (7.07e-2)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (1.83e-4)" "prognostic favorable (6.63e-4)" "unprognostic (1.46e-2)" "unprognostic (3.50e-2)" "unprognostic (2.21e-1)" "unprognostic (8.21e-2)" 0.1 0.8 2.4 0.0 2.2 0.0 0.3 3.1 2.6 0.2 0.6 0.2 0.1 0.3 0.4 0.1 0.7 0.2 33.2 2.2 2.6 0.9 0.2 0.1 0.1 2.6 3.2 2.1 0.1 1.8 3.1 2.4 0.0 3.2 0.9 0.2 0.4 1.1 4.9 0.1 0.0 0.2 0.1 1.8 0.7 1.1 1.6 3.2 0.1 8.0 0.0 0.1 0.2 0.1 2.5 0.0 2.7 0.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.7 0.0 5.2 0.0 0.0 0.0 16.2 0.6 0.0 0.0 5.0 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.2 0.0 0.0 24.3 6.5 0.0 0.0 0.0 0.0 0.2 0.0 11.3 0.8 0.1 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 3.1 2.6 2.2 2.6 2.6 3.2 2.1 3.2 1.8 3.2 2.5 0.2 0.0 0.0 1.3 0.0 0.0 0.3 1.6 0.0 0.4 0.6 0.1 23.7 0.0 0.8 1.8 0.0 0.0 0.0 0.5 0.0 0.5 0.0 2.0 0.5 0.7 1.2 0.0 0.8 1.2 0.0 0.4 0.0 4.4 0.0 0.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.8 0.2 0.0 0.0 1.2 0.0 0.5 0.3 0.8 0.0 0.1 0.2 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 GDPD2 "FLJ20207, GDE3, OBDPF" ENSG00000130055 "Glycerophosphodiester phosphodiesterase domain containing 2" Q9HCC8 X 70423031-70433390 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 20.9;lymphoid tissue: 59.6;skin 1: 48.2" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 56.7;Distal enterocytes: 30.4;Muller glia cells: 29.9;Proximal enterocytes: 92.2" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 9.2;NTERA-2: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.53e-3)" "unprognostic (5.79e-2)" "unprognostic (5.37e-2)" "unprognostic (5.00e-7)" "unprognostic (3.15e-3)" "unprognostic (3.65e-2)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (1.19e-1)" "unprognostic (8.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.41e-2)" "unprognostic (5.52e-2)" "unprognostic (2.22e-1)" "unprognostic (8.91e-2)" 0.0 0.0 9.7 0.5 8.6 0.1 0.9 8.7 10.4 0.0 7.4 4.8 11.2 0.0 4.9 0.2 0.2 0.2 0.7 7.5 11.0 0.5 0.0 0.0 0.0 8.6 11.9 7.1 0.1 0.0 0.0 3.3 0.1 9.1 0.0 4.0 3.6 1.0 0.3 0.5 48.2 20.9 0.1 8.7 59.6 1.8 0.0 11.6 0.0 0.0 0.0 0.0 0.7 0.1 10.5 0.0 0.0 9.2 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 19.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.7 8.6 8.7 10.4 7.5 11.0 8.6 11.9 7.1 9.1 8.7 11.6 10.5 0.0 0.0 0.0 12.7 0.0 56.7 0.0 0.6 0.0 0.2 0.0 0.0 1.9 0.0 0.2 0.0 0.0 7.0 0.0 30.4 0.0 0.0 0.0 0.3 0.0 0.2 1.2 0.0 0.0 0.0 3.5 0.2 3.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 92.2 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 12.1 3.3 0.2 0.0 3.1 0.2 SAT1 "SAT, SSAT" ENSG00000130066 "Spermidine/spermine N1-acetyltransferase 1" P21673 X 23783173-23786226 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 8151.3;Langerhans cells: 13855.3;Prostatic glandular cells: 7419.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 3422.0;non-classical monocyte: 2519.0" "Group enriched" "Detected in all" 9 "granulocytes: 3422.0;monocytes: 2519.0" "Cell line enhanced" "Detected in all" "HBEC3-KT: 551.5;hTERT-HME1: 821.9;RPTEC TERT1: 694.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB047343, HPA055312, CAB069914" Supported NA NA "CAB047343: , CAB069914: AB_830224, HPA055312: AB_2682781" "unprognostic (4.19e-2)" "unprognostic (3.92e-2)" "unprognostic (6.41e-2)" "prognostic favorable (2.87e-4)" "unprognostic (8.58e-2)" "unprognostic (7.90e-3)" "unprognostic (8.52e-3)" "unprognostic (2.22e-2)" "unprognostic (2.81e-1)" "unprognostic (1.18e-1)" "unprognostic (8.38e-3)" "unprognostic (2.23e-1)" "unprognostic (7.58e-2)" "unprognostic (5.13e-2)" "unprognostic (1.61e-1)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 590.2 309.7 170.6 573.5 176.3 1498.8 457.9 168.3 281.9 340.7 224.7 315.3 636.6 322.0 172.3 410.7 325.5 606.1 445.6 172.2 341.2 682.6 892.4 1263.9 434.9 190.2 171.6 156.3 199.6 231.2 271.0 552.8 608.6 177.6 416.6 367.9 109.2 793.1 345.4 66.7 196.8 513.8 177.0 187.6 712.3 567.2 117.3 190.7 233.9 764.0 79.7 336.2 541.3 243.6 214.0 62.2 123.1 30.8 48.3 256.0 103.8 83.6 89.2 149.8 21.7 50.2 59.0 179.3 102.7 160.0 21.1 172.4 91.9 16.4 551.5 78.8 34.1 74.3 49.9 60.0 503.5 327.5 48.8 46.1 216.2 412.0 169.0 821.9 197.2 181.5 16.4 21.4 88.4 63.8 59.1 35.9 219.1 20.6 455.2 56.3 30.0 19.8 126.1 694.6 126.0 8.7 8.9 91.2 204.8 179.2 222.3 31.5 10.7 68.9 175.6 8.9 106.6 44.7 37.1 9.6 23.1 104.8 28.8 34.2 557.6 720.4 478.9 66.0 1930.3 41.6 125.3 77.4 53.8 324.8 79.1 45.9 53.3 3422.0 33.8 2519.0 161.2 231.5 742.5 170.6 176.3 168.3 281.9 172.2 341.2 190.2 171.6 156.3 177.6 187.6 190.7 214.0 798.0 734.0 1585.4 98.9 875.4 2435.0 3753.4 8151.3 1203.6 54.9 895.9 574.4 454.2 574.7 5509.5 829.4 116.7 853.1 409.5 1249.8 1189.5 5869.5 17.3 3940.5 859.6 1554.6 526.9 195.2 40.3 3065.2 1643.7 1211.3 1347.1 5651.2 870.6 110.6 558.3 994.1 2115.2 72.3 77.6 852.3 3733.2 4693.0 13855.3 55.2 165.3 5207.7 3922.0 213.6 5274.6 501.9 189.5 90.5 14.2 2774.1 1293.8 92.2 1091.8 7419.8 1851.7 2065.2 4274.2 114.4 151.2 765.7 857.5 31.6 14.7 1022.4 1468.3 2880.9 899.3 260.2 804.4 6549.5 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530183-54621521 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 4.6 3.6 2.0 7.1 3.3 8.9 4.8 2.6 2.6 4.9 3.0 4.8 3.9 4.8 3.7 5.8 4.8 4.7 7.2 2.6 4.6 4.5 4.0 5.0 7.6 3.0 3.6 1.7 3.8 5.1 5.8 2.3 5.6 3.6 3.7 6.1 3.8 4.0 4.4 7.1 5.7 4.8 7.4 2.8 7.0 5.3 2.3 3.0 8.4 8.6 7.8 8.5 6.8 3.5 5.2 20.7 49.1 9.5 20.9 10.2 8.3 15.2 9.8 8.7 13.4 9.9 43.4 16.6 26.9 21.3 18.2 15.1 18.7 34.6 14.9 19.0 15.9 16.4 30.0 34.0 17.2 7.9 42.6 26.0 10.0 7.1 31.0 17.4 5.7 13.4 16.4 19.2 27.0 14.0 36.5 25.5 11.8 29.6 13.0 26.7 27.7 23.9 27.8 10.3 28.8 17.1 8.4 39.7 24.3 11.7 20.9 30.9 11.4 20.0 22.6 22.1 21.8 18.4 19.9 25.7 35.9 12.8 34.6 27.8 23.6 14.4 15.0 16.5 12.8 15.0 15.1 14.8 13.8 11.1 16.0 10.6 11.7 19.2 21.5 15.0 10.2 9.3 12.5 2.0 3.3 2.6 2.6 2.6 4.6 3.0 3.6 1.7 3.6 2.8 3.0 5.2 9.2 12.8 18.5 14.4 15.3 1.3 3.6 3.9 9.6 10.2 6.1 3.9 8.5 8.6 11.8 3.7 12.5 7.1 14.1 7.4 3.9 9.4 0.4 8.2 17.2 9.4 3.5 12.0 14.8 8.7 6.4 7.4 10.7 9.6 10.8 10.9 7.1 4.6 4.9 8.4 14.8 4.7 8.2 9.4 4.2 0.0 5.6 9.4 0.0 14.0 12.0 3.4 25.7 16.1 23.2 9.8 3.9 3.0 10.0 4.2 6.8 5.3 7.8 9.3 6.6 8.5 7.1 1.1 7.7 6.6 2.0 5.5 11.9 9.5 7.6 3.6 SH3BP4 ENSG00000130147 "SH3 domain binding protein 4" Q9P0V3 2 234952017-235055714 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 84.2" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.0;plasmacytoid DC: 3.1" "Lineage enhanced" "Detected in single" "dendritic cells: 3.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037533, HPA037534" Uncertain NA NA "HPA037533: AB_10672903, HPA037534: AB_2675528" "unprognostic (2.16e-3)" "unprognostic (1.43e-1)" "unprognostic (2.83e-2)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (5.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (1.61e-1)" "unprognostic (4.30e-1)" "prognostic favorable (2.07e-6)" "unprognostic (2.86e-2)" "unprognostic (5.08e-2)" "unprognostic (6.91e-2)" "unprognostic (1.17e-2)" 11.9 9.1 17.4 5.8 20.8 1.1 35.7 20.9 13.8 21.0 18.6 13.9 17.3 12.6 14.6 7.8 17.7 19.2 10.3 13.8 15.2 18.4 26.4 13.3 2.3 20.4 20.2 10.7 22.7 61.8 5.9 4.1 18.4 21.0 20.5 13.8 2.5 84.2 17.0 9.6 15.7 11.2 13.7 16.7 5.6 25.8 10.3 18.4 4.7 11.2 9.5 3.8 9.4 7.6 27.5 49.3 30.6 77.7 5.8 33.8 22.4 35.2 70.2 66.6 54.6 48.8 23.5 28.8 0.0 19.0 140.4 126.8 26.1 22.6 47.2 64.8 0.2 10.3 0.0 39.5 64.1 55.8 0.0 0.1 43.9 69.9 76.6 41.4 52.4 58.7 0.1 0.4 0.2 81.4 37.8 0.1 0.2 42.5 56.2 16.8 0.0 16.0 9.3 50.0 9.9 47.9 19.3 15.8 101.4 42.7 55.2 11.9 0.2 47.2 59.8 52.2 47.1 45.7 0.0 0.1 0.2 55.6 0.1 89.2 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.1 17.4 20.8 20.9 13.8 13.8 15.2 20.4 20.2 10.7 21.0 16.7 18.4 27.5 23.5 3.2 9.1 4.2 1.0 14.8 50.2 15.6 14.2 2.3 37.3 18.0 6.6 18.6 22.5 7.3 6.2 8.7 3.9 6.0 9.8 24.7 3.4 21.4 10.9 22.9 6.6 1.3 0.7 24.8 29.9 11.7 14.8 29.2 1.3 10.0 17.2 26.8 2.1 3.3 1.4 9.1 16.2 1.4 13.1 4.9 8.1 10.9 24.9 20.6 2.6 1.3 0.0 18.1 52.4 39.6 6.3 9.4 0.2 96.9 0.8 1.9 20.7 0.7 0.0 1.9 12.4 0.8 2.8 8.8 11.1 37.1 0.5 5.5 18.0 30.4 MOSPD2 MGC26706 ENSG00000130150 "Motile sperm domain containing 2" Q8NHP6 X 14873421-14922327 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 53.4" "Group enriched" "Detected in all" 6 "granulocytes: 53.4;monocytes: 15.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003334 Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003334: AB_2146004" "unprognostic (2.74e-1)" "unprognostic (4.39e-2)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (7.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (8.91e-4)" "unprognostic (1.51e-1)" "unprognostic (7.24e-2)" "unprognostic (4.21e-3)" "unprognostic (1.00e-1)" "unprognostic (8.64e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-1)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (1.96e-2)" 8.4 6.9 8.5 10.8 19.7 8.2 8.6 20.8 22.3 10.8 1.7 6.7 8.3 8.9 7.5 13.2 6.9 11.6 5.2 14.7 13.7 8.7 9.6 14.4 11.6 26.2 16.3 11.8 10.6 5.4 6.6 3.6 15.6 22.9 7.1 7.3 7.4 6.7 6.9 2.4 19.5 7.8 8.6 13.6 14.1 8.1 4.0 16.7 8.8 15.2 4.5 10.0 8.7 8.1 49.2 9.4 13.4 9.6 4.9 33.1 20.8 9.4 22.8 21.4 16.2 19.2 7.0 11.1 13.0 6.1 39.0 25.0 15.4 12.6 9.8 20.7 9.0 11.1 4.5 12.5 5.5 20.4 8.6 10.0 19.0 13.5 14.4 19.0 15.6 14.4 12.7 5.8 12.5 15.3 4.5 7.9 7.0 6.6 8.7 12.0 8.2 12.7 10.6 13.2 6.2 3.0 6.9 17.1 7.8 38.5 36.8 6.6 12.7 14.9 13.9 5.6 48.9 8.8 7.6 9.7 8.1 18.3 6.6 20.3 11.8 14.7 6.6 2.7 14.4 3.3 2.1 3.0 2.2 5.1 3.1 3.2 3.4 53.4 5.4 15.8 1.6 3.6 5.8 8.5 19.7 20.8 22.3 14.7 13.7 26.2 16.3 11.8 22.9 13.6 16.7 49.2 18.3 22.4 18.2 16.3 15.5 8.5 7.3 5.7 14.8 7.3 10.2 8.3 6.0 11.5 10.9 22.0 6.2 15.5 12.6 9.1 9.8 7.0 5.8 20.3 10.6 14.4 12.6 6.7 17.2 6.1 9.4 14.3 12.2 16.6 7.6 8.7 18.9 8.2 21.8 6.7 17.2 6.7 10.2 28.9 7.1 24.3 10.5 32.7 10.6 23.4 32.5 8.0 8.2 14.1 125.8 6.9 5.7 15.1 12.6 6.7 7.8 11.4 15.4 4.7 13.1 11.6 13.4 9.9 7.9 16.8 12.8 23.5 10.3 11.4 6.4 6.7 DOCK6 "KIAA1395, ZIR1" ENSG00000130158 "Dedicator of cytokinesis 6" Q96HP0 19 11199295-11262524 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 70.3;Cardiomyocytes: 185.4;Endothelial cells: 64.8;Hepatic stellate cells: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 68.2;TIME: 68.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049423, HPA049424" Approved Supported Cytosol NA NA Cytosol "HPA049423: AB_2680760, HPA049424: AB_2680761" "unprognostic (2.69e-2)" "unprognostic (2.27e-1)" "unprognostic (9.51e-2)" "unprognostic (3.35e-2)" "unprognostic (4.72e-3)" "prognostic favorable (9.09e-4)" "unprognostic (2.54e-2)" "unprognostic (4.91e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (2.57e-1)" "unprognostic (7.89e-2)" "unprognostic (1.25e-3)" "unprognostic (2.76e-1)" "unprognostic (1.51e-1)" "unprognostic (5.41e-2)" "unprognostic (2.95e-1)" 29.7 9.9 8.4 5.4 5.7 0.4 27.8 4.7 9.7 15.4 6.0 15.8 14.4 14.8 4.7 16.9 11.7 12.1 24.4 4.5 5.0 24.5 13.3 46.7 5.0 7.4 6.9 2.4 12.1 14.6 5.5 11.9 15.1 7.3 15.0 6.3 1.8 11.5 7.6 15.3 25.2 15.6 7.2 5.1 14.7 16.0 5.9 11.6 2.2 29.2 9.3 2.6 14.3 16.7 7.6 14.6 8.9 9.9 8.1 7.3 10.5 15.9 4.2 6.9 4.1 6.3 16.9 11.2 0.9 25.4 7.1 3.9 8.3 4.3 22.3 2.5 12.4 7.0 2.8 2.2 12.8 11.8 4.3 13.7 8.1 13.0 7.5 17.0 7.9 68.2 0.3 15.7 0.0 9.1 32.7 0.1 14.7 12.5 13.2 16.6 0.9 6.7 14.0 6.8 20.0 0.6 17.6 4.2 4.2 7.6 6.5 4.9 7.6 68.8 7.5 7.8 17.1 7.6 1.2 0.2 14.1 6.3 3.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 5.7 4.7 9.7 4.5 5.0 7.4 6.9 2.4 7.3 5.1 11.6 7.6 70.3 3.2 12.6 6.8 0.9 6.5 6.2 8.5 4.6 1.4 4.3 3.8 185.4 5.7 11.3 25.8 0.0 0.3 0.9 15.6 1.9 5.4 3.5 3.9 8.9 64.8 12.1 0.0 2.9 6.8 1.3 19.6 35.2 7.2 5.1 4.7 55.3 5.6 4.6 0.0 5.9 15.9 8.2 2.5 4.4 1.3 22.4 1.6 3.6 35.6 0.0 4.6 0.0 7.1 3.5 11.9 10.9 9.4 1.9 8.4 11.9 1.9 9.2 2.6 19.7 8.4 30.8 1.5 4.3 7.4 11.5 0.5 1.2 7.8 9.7 9.0 ECSIT SITPEC ENSG00000130159 "ECSIT signaling integrator" Q9BQ95 19 11505929-11529172 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042979 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042979: AB_10964063" "unprognostic (9.88e-2)" "unprognostic (3.57e-3)" "unprognostic (2.93e-1)" "unprognostic (3.55e-3)" "unprognostic (2.27e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "unprognostic (1.24e-1)" "unprognostic (2.92e-1)" "unprognostic (2.18e-1)" "unprognostic (1.01e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.48e-9)" "unprognostic (2.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (5.95e-2)" 25.9 38.3 27.5 15.1 25.7 24.9 27.0 29.9 38.8 31.9 25.5 40.3 39.8 30.0 9.5 29.5 28.8 15.1 101.5 26.4 26.3 36.5 52.0 21.0 18.2 27.9 26.3 26.4 43.5 56.7 30.8 24.5 9.9 29.5 30.1 19.0 13.1 46.1 16.1 125.9 29.3 28.6 16.6 23.8 22.0 49.3 15.1 28.7 15.7 26.4 131.5 13.4 34.6 27.7 29.2 40.0 35.8 20.4 29.2 30.0 33.6 23.1 21.1 26.4 41.8 33.4 52.6 26.4 58.7 42.0 25.4 38.0 52.1 51.6 42.6 14.6 33.2 42.7 54.5 21.6 48.1 29.7 31.5 42.8 35.9 46.0 35.0 38.1 22.1 31.8 53.7 59.2 56.2 15.6 55.2 53.7 48.6 54.6 51.8 91.4 53.3 22.0 77.1 22.3 24.2 77.3 50.2 24.6 38.7 42.4 9.6 45.9 46.3 16.2 44.4 31.2 64.4 38.5 52.7 106.5 28.7 37.0 46.9 32.2 4.1 32.5 12.0 26.6 41.1 30.8 41.7 28.8 25.1 42.3 39.2 31.9 29.3 6.1 26.1 38.3 23.5 35.4 29.7 27.5 25.7 29.9 38.8 26.4 26.3 27.9 26.3 26.4 29.5 23.8 28.7 29.2 19.7 9.6 15.7 13.1 25.2 44.5 61.6 48.3 40.9 23.2 38.7 44.2 74.7 52.9 28.3 20.2 12.5 34.5 18.0 44.3 82.2 42.1 18.0 10.2 16.3 23.4 37.3 31.1 15.3 78.5 45.7 27.5 29.6 9.5 22.9 47.1 27.5 49.4 31.1 18.5 19.4 49.3 16.2 29.6 23.5 52.2 34.5 19.5 28.4 3.7 22.2 30.4 29.9 8.0 9.9 38.4 34.8 32.0 21.0 55.9 70.0 101.5 18.5 30.6 32.9 32.7 36.4 17.6 45.1 37.6 41.9 25.2 20.3 53.7 84.6 56.3 LDLR LDLCQ2 ENSG00000130164 "Low density lipoprotein receptor" P01130 19 11089462-11133820 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 397.4;Alveolar cells type 2: 468.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "basophil: 46.0" "Lineage enriched" "Detected in many" 9 "granulocytes: 46.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009647, HPA013159" Approved NA NA 23000000 "HPA009647: AB_1079243, HPA013159: AB_1852775" "unprognostic (4.39e-1)" "unprognostic (1.93e-3)" "unprognostic (2.52e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (6.71e-2)" "unprognostic (4.26e-2)" "unprognostic (3.73e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (6.60e-5)" "unprognostic (1.19e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.62e-1)" "unprognostic (2.78e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.43e-4)" 44.0 113.1 11.4 27.5 10.2 27.7 15.8 8.7 16.8 25.4 18.3 19.5 23.8 21.8 3.8 50.5 21.8 37.3 16.4 8.2 21.5 11.0 60.9 55.3 4.8 21.3 14.9 4.5 38.0 51.2 10.2 6.9 16.7 18.8 20.4 12.4 2.3 19.2 4.6 4.0 22.8 18.5 28.9 10.4 10.6 36.8 8.5 15.0 4.1 7.8 4.0 5.1 22.8 26.0 21.0 113.6 52.2 61.1 29.9 80.5 152.7 21.0 23.5 89.8 41.3 88.6 52.9 105.3 37.2 94.1 46.1 135.6 88.3 31.1 185.6 19.9 27.5 6.1 18.1 34.5 47.1 120.2 19.2 100.9 192.5 67.5 139.6 30.2 28.5 45.8 29.5 38.9 213.8 31.9 41.4 25.3 25.9 66.4 56.0 67.5 17.1 44.9 48.2 103.1 89.5 14.8 15.4 21.1 45.7 3.8 45.2 19.0 44.6 50.8 36.1 26.3 23.2 44.7 26.8 24.4 23.3 42.8 43.7 83.6 46.0 2.9 0.1 5.4 2.6 1.3 0.6 2.2 1.7 1.6 0.5 2.3 2.2 0.8 2.5 0.8 0.5 1.6 3.2 11.4 10.2 8.7 16.8 8.2 21.5 21.3 14.9 4.5 18.8 10.4 15.0 21.0 106.3 397.4 468.6 16.3 8.1 143.4 176.8 182.2 85.4 11.4 144.0 108.7 35.9 92.9 205.7 14.7 6.2 18.4 24.7 273.7 1.9 57.9 1.2 95.3 61.7 75.8 61.9 6.6 10.7 89.0 32.1 42.9 195.2 278.6 75.9 32.9 22.9 149.2 14.9 1.7 8.1 157.2 77.3 16.5 26.5 1.6 19.6 47.4 56.9 7.5 2.7 6.8 8.2 7.5 19.4 86.7 209.7 7.2 30.7 142.7 32.5 0.6 99.1 6.6 6.6 133.4 48.4 4.1 2.8 155.3 197.2 48.2 32.8 214.3 110.7 184.2 ELOF1 "ELF1, MGC4549" ENSG00000130165 "Elongation factor 1 homolog" P60002 19 11551147-11559236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 497.5;Late spermatids: 1414.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045606 Uncertain Approved Cytosol NA NA Cytosol "HPA045606: AB_10965133" "unprognostic (4.32e-2)" "prognostic favorable (1.83e-4)" "unprognostic (4.38e-3)" "unprognostic (3.39e-1)" "unprognostic (1.26e-1)" "unprognostic (3.29e-1)" "unprognostic (2.22e-2)" "unprognostic (2.65e-2)" "unprognostic (5.35e-2)" "unprognostic (4.90e-3)" "unprognostic (4.62e-2)" "unprognostic (1.26e-1)" "unprognostic (5.85e-2)" "unprognostic (2.93e-3)" "unprognostic (1.76e-2)" "unprognostic (7.09e-2)" "unprognostic (1.12e-2)" 39.9 66.2 72.9 33.6 76.8 62.7 41.1 87.7 95.9 61.4 81.3 52.4 31.5 69.5 43.8 51.8 60.8 29.7 52.8 75.9 83.7 55.3 80.9 41.2 45.7 71.9 75.5 71.2 60.8 80.4 49.0 74.9 25.8 79.1 64.6 25.2 22.4 56.9 45.5 58.4 47.5 49.4 35.1 70.0 56.5 66.9 206.8 79.5 47.5 47.8 48.2 38.9 53.6 48.1 96.6 138.7 94.7 63.7 88.0 78.0 78.5 32.8 87.2 73.0 117.1 117.6 94.4 37.1 88.1 83.5 79.3 76.3 63.5 78.2 121.2 81.2 70.2 79.6 110.8 61.8 90.5 87.6 72.5 72.9 76.8 88.7 103.6 74.8 83.7 57.9 82.8 156.1 111.8 71.0 177.8 108.2 84.1 166.1 69.9 172.3 79.2 54.5 93.2 97.6 63.2 80.2 101.4 70.3 83.6 85.2 58.1 70.2 57.5 40.6 120.3 45.5 127.6 133.0 129.0 188.5 75.1 112.1 101.0 61.5 99.6 130.4 144.2 99.5 128.8 92.5 195.5 104.0 93.5 115.0 160.4 92.8 83.4 87.1 106.1 147.3 189.4 153.0 146.4 72.9 76.8 87.7 95.9 75.9 83.7 71.9 75.5 71.2 79.1 70.0 79.5 96.6 15.4 16.0 23.9 7.8 50.5 84.9 53.4 74.7 43.9 24.7 47.9 39.2 31.9 50.1 37.7 33.1 8.4 83.6 52.3 59.9 105.7 80.1 497.5 38.9 30.3 32.4 60.3 67.8 10.0 103.0 80.8 42.2 19.4 20.2 22.2 29.5 44.3 37.0 76.7 15.2 10.3 47.1 59.0 53.0 68.9 1414.3 74.0 39.7 69.4 6.5 87.4 45.7 80.3 3.0 9.0 96.1 68.7 71.5 36.5 49.5 80.9 90.7 51.0 17.6 26.3 31.8 38.3 206.3 80.4 32.2 81.3 72.7 47.5 33.7 46.6 43.5 TSPAN16 "TM-8, TM4-B, TM4SF16" ENSG00000130167 "Tetraspanin 16" Q9UKR8 19 11296139-11326996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 135.7" "Cell type enriched" "Detected in some" 5 "Late spermatids: 4868.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "basophil: 16.6;eosinophil: 19.1;neutrophil: 37.4" "Lineage enriched" "Detected in many" 17 "granulocytes: 37.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA076551 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA076551: " "unprognostic (1.06e-1)" "unprognostic (2.82e-2)" "unprognostic (1.73e-2)" "unprognostic (4.74e-3)" "unprognostic (1.53e-1)" "unprognostic (2.06e-3)" "unprognostic (1.37e-1)" "unprognostic (2.21e-1)" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (8.69e-4)" "unprognostic (8.81e-8)" "unprognostic (1.98e-1)" "unprognostic (1.12e-1)" "unprognostic (1.95e-3)" "unprognostic (2.67e-1)" 0.0 0.0 0.3 0.2 0.1 5.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 135.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 16.6 2.2 19.1 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 37.4 0.0 0.4 0.0 0.0 0.3 0.3 0.1 0.2 0.4 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 892.5 0.0 0.1 1.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 4868.3 15.5 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.4 20.9 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANGPTL8 "C19orf80, RIFL, TD26" ENSG00000130173 "Angiopoietin like 8" Q6UXH0 19 11237450-11241943 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism" Hormone "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "liver: 413.1" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 151.2" "Cancer enriched" "Detected in some" 37 "liver cancer: 84.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "Hep G2: 37.0;MCF7: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042131 Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 836000 350000 "Golgi apparatus" Nucleoplasm "HPA042131: AB_10794413" "unprognostic (2.37e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (3.73e-1)" "unprognostic (2.80e-1)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (4.57e-1)" "unprognostic (1.75e-2)" 29.8 0.9 1.5 0.2 0.5 0.1 22.7 0.0 1.7 1.2 0.2 1.2 0.4 0.9 1.6 0.3 0.8 0.4 1.3 0.7 0.4 3.9 413.1 0.5 0.1 0.9 0.5 0.0 1.1 0.9 0.0 0.3 0.1 0.4 0.8 0.0 0.1 1.3 0.1 0.8 0.8 1.3 0.1 0.2 0.4 0.7 0.6 1.5 0.0 1.0 0.0 0.0 1.1 1.0 0.7 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 1.3 37.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 21.2 0.0 0.7 0.2 0.0 0.0 0.1 0.4 1.0 0.0 0.3 0.0 0.3 0.4 0.9 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 1.7 0.7 0.4 0.9 0.5 0.0 0.4 0.2 1.5 0.7 0.6 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.4 0.2 0.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 2.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 4.6 151.2 0.1 0.0 0.0 0.0 0.0 4.4 0.0 1.9 0.9 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.0 0.1 PRKCSH "G19P1, GIIB, PCLD, PLD1, VASAP-60" ENSG00000130175 "Protein kinase C substrate 80K-H" P14314 19 11435284-11450968 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004465, HPA041940, HPA043560" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 55000000 "Endoplasmic reticulum" "CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (2.45e-2)" "unprognostic (2.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.63e-2)" "unprognostic (2.52e-2)" "unprognostic (5.52e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-3)" "unprognostic (1.28e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (7.69e-4)" "unprognostic (1.63e-3)" "unprognostic (2.10e-1)" "unprognostic (3.44e-1)" "unprognostic (1.18e-1)" 114.6 108.5 70.8 81.9 77.7 171.1 118.6 78.8 98.3 144.9 83.3 112.9 121.1 124.0 114.0 107.4 127.3 92.8 85.8 70.5 77.5 108.3 161.2 106.4 94.0 81.8 77.8 62.2 198.5 187.8 117.2 119.3 109.7 79.9 109.4 99.9 47.0 147.1 98.7 75.4 130.3 122.7 79.2 74.2 112.1 125.9 89.2 76.0 84.7 136.7 45.3 87.0 110.9 123.7 82.7 274.8 216.7 211.6 391.5 351.2 426.4 241.5 305.5 387.6 331.5 302.7 328.3 327.5 204.4 478.1 409.2 165.4 283.4 226.3 309.6 292.1 193.3 173.5 178.0 269.4 268.8 258.0 263.0 236.4 404.5 228.6 312.5 261.4 425.6 232.8 210.1 204.8 422.4 289.0 470.1 187.9 322.1 485.0 129.7 283.3 201.8 215.3 505.6 223.2 260.1 146.9 291.5 282.3 280.4 280.5 200.8 292.5 296.7 263.6 437.1 198.2 416.0 361.0 471.9 575.3 132.3 330.1 276.8 306.5 38.8 47.2 45.1 37.9 36.2 42.6 35.9 31.8 36.4 36.1 38.7 30.2 33.1 56.3 32.8 41.2 75.7 37.5 39.5 70.8 77.7 78.8 98.3 70.5 77.5 81.8 77.8 62.2 79.9 74.2 76.0 82.7 45.2 12.8 16.9 15.3 65.1 41.8 72.2 90.0 39.9 18.2 56.9 47.5 10.5 71.4 44.9 64.4 33.3 174.9 54.6 152.0 33.2 88.7 18.1 47.4 65.0 52.0 58.8 40.6 12.3 127.5 189.1 62.6 70.3 67.2 41.9 104.5 60.3 86.4 93.4 10.1 12.5 123.2 65.1 80.0 43.4 55.9 78.6 59.3 53.4 14.0 81.4 59.8 61.8 6.0 39.0 89.0 132.8 72.6 91.4 45.9 187.8 62.7 32.7 30.2 39.5 39.8 52.0 36.8 55.2 49.5 37.8 143.5 55.5 84.2 128.2 66.6 CNN1 "Sm-Calp, SMCC" ENSG00000130176 "Calponin 1" P51911 19 11538767-11550323 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 1888.1;intestine: 1864.8;seminal vesicle: 1600.6;smooth muscle: 2227.2" "Group enriched" "Detected in many" 5 "Breast myoepithelial cells: 191.0;Early spermatids: 335.0;Late spermatids: 554.6;Peritubular cells: 221.2;Smooth muscle cells: 180.9" "Cancer enhanced" "Detected in all" "prostate cancer: 142.1;stomach cancer: 103.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 91.5;BJ hTERT+: 34.9;BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 64.6;HBF TERT88: 71.2;K-562: 35.8;SuSa: 72.5;U-2 OS: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000007, HPA014263" Enhanced Approved "Actin filaments" No No "Actin filaments" "CAB000007: AB_2082148, HPA014263: AB_1847039" "unprognostic (4.98e-3)" "unprognostic (1.01e-1)" "unprognostic (3.04e-3)" "unprognostic (1.95e-1)" "unprognostic (2.47e-1)" "unprognostic (4.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.76e-1)" "unprognostic (1.35e-1)" "unprognostic (7.06e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (5.43e-6)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (2.78e-3)" "unprognostic (6.11e-3)" 112.7 59.0 5.7 162.0 6.7 0.0 90.5 5.1 14.3 354.9 12.5 1864.8 137.5 1888.1 178.5 683.9 661.4 236.4 234.2 6.0 7.1 21.9 10.6 99.6 7.3 7.0 6.3 5.5 115.1 24.4 3.0 9.0 28.7 6.6 681.8 329.4 0.7 62.1 1600.6 21.9 48.8 435.0 2227.2 5.4 22.3 679.4 92.1 6.3 2.6 38.8 11.8 0.9 1398.2 308.3 5.9 0.1 1.3 5.9 1.0 0.6 0.2 3.2 91.5 34.9 48.0 64.6 27.9 0.0 0.4 2.7 26.1 4.4 0.3 0.0 0.0 71.2 0.0 0.2 0.1 0.1 2.3 2.5 0.0 0.4 3.0 0.1 28.7 0.1 1.6 0.0 0.0 35.8 0.0 0.0 0.0 0.3 3.8 2.9 0.0 0.7 0.2 0.6 3.8 0.0 0.0 0.1 1.3 0.1 0.2 0.2 72.5 0.1 0.1 0.4 0.4 34.6 1.2 1.2 0.1 0.4 0.1 3.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.7 6.7 5.1 14.3 6.0 7.1 7.0 6.3 5.5 6.6 5.4 6.3 5.9 2.4 0.0 0.0 0.0 0.2 4.8 4.1 1.6 0.6 0.0 4.2 191.0 51.4 0.0 0.3 1.8 0.0 0.8 0.7 0.0 0.0 14.5 335.0 3.1 20.7 2.4 0.0 0.0 0.5 0.4 1.0 21.5 0.5 0.7 0.0 0.5 6.8 0.0 2.3 0.0 0.3 0.0 0.0 0.0 9.4 554.6 8.4 0.9 3.6 2.8 0.6 0.5 0.0 0.0 0.1 0.9 0.0 221.2 0.0 4.0 0.0 0.4 0.4 0.0 39.5 1.1 180.9 8.3 19.5 0.4 7.1 0.7 1.1 0.7 0.0 1.1 CDC16 "ANAPC6, APC6, CUT9" ENSG00000130177 "Cell division cycle 16" Q13042 13 114234887-114272723 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042826 Approved NA NA "HPA042826: AB_10793987" "unprognostic (7.32e-2)" "unprognostic (1.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-3)" "unprognostic (1.50e-1)" "unprognostic (7.19e-3)" "unprognostic (6.82e-3)" "unprognostic (9.86e-2)" "unprognostic (7.64e-2)" "unprognostic (4.07e-1)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (1.99e-3)" "unprognostic (2.48e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-3)" "unprognostic (1.51e-2)" 37.2 36.9 54.2 24.9 55.0 25.9 39.3 54.9 69.8 44.1 58.3 35.6 27.0 37.8 50.7 33.3 45.8 24.1 33.8 54.2 55.0 34.5 50.2 32.0 35.7 55.6 55.9 53.7 41.9 48.5 33.6 39.7 35.0 56.2 39.3 38.0 43.2 31.9 32.2 42.0 42.3 35.5 39.5 55.0 44.7 38.5 42.4 54.7 43.2 35.6 37.8 39.9 37.7 36.2 58.4 75.4 42.1 63.1 65.8 78.5 98.7 36.0 76.3 63.0 78.7 75.6 38.9 60.7 68.0 28.7 104.8 75.4 41.6 56.6 72.5 104.2 42.7 65.9 56.8 53.7 39.8 83.8 104.6 76.4 72.2 78.5 53.7 69.0 77.8 76.8 35.7 48.7 26.1 109.7 34.6 45.7 49.2 71.1 129.0 38.8 22.2 32.6 41.3 94.0 50.9 61.2 58.8 42.3 68.8 130.0 106.8 53.3 126.0 61.7 34.8 61.4 27.8 46.6 38.2 32.3 72.2 83.3 63.0 47.5 2.3 2.9 3.3 3.3 3.2 3.1 8.4 2.3 4.3 4.4 6.8 2.5 2.7 0.7 11.2 2.6 6.1 4.7 2.2 54.2 55.0 54.9 69.8 54.2 55.0 55.6 55.9 53.7 56.2 55.0 54.7 58.4 27.2 38.5 30.3 69.2 24.7 17.8 21.7 23.0 17.1 17.1 20.4 20.7 37.4 24.3 39.7 35.0 25.0 38.1 24.0 13.6 23.5 34.4 34.6 63.3 25.9 27.1 19.7 45.0 41.6 37.2 33.8 33.5 30.1 31.3 26.6 30.4 28.2 32.6 34.7 13.5 39.3 31.0 16.2 22.0 12.9 29.1 26.4 24.9 23.2 23.4 27.3 23.0 19.6 45.8 65.3 33.0 12.9 29.0 24.9 26.2 19.2 28.7 71.0 23.3 26.3 31.6 23.5 53.9 49.5 21.4 19.0 24.9 21.8 31.3 23.8 18.0 ZSCAN10 ZNF206 ENSG00000130182 "Zinc finger and SCAN domain containing 10" Q96SZ4 16 3088890-3099295 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "brain: 1.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Cytotrophoblasts: 1.9" "Cancer enriched" "Detected in single" 207 "testis cancer: 19.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "NTERA-2: 56.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA076826 Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA076826: " "unprognostic (4.37e-2)" "unprognostic (5.13e-2)" "unprognostic (9.15e-2)" "unprognostic (6.65e-3)" "unprognostic (6.24e-2)" "unprognostic (7.60e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.72e-1)" "unprognostic (1.85e-11)" "unprognostic (5.98e-2)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 56.8 0.3 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 5.8 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.3 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.5 0.9 0.9 0.4 0.4 0.4 0.2 0.6 0.5 0.1 0.5 1.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 THEM6 "C8orf55, DSCD75" ENSG00000130193 "Thioesterase superfamily member 6" Q8WUY1 8 142727223-142736927 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.4;RT4: 114.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023255 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" NA NA "Nuclear speckles, Cytosol" "HPA023255: AB_1845782" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (9.10e-2)" "unprognostic (5.33e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-2)" "unprognostic (1.74e-2)" "unprognostic (6.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.44e-1)" "unprognostic (4.91e-2)" "unprognostic (6.76e-2)" "prognostic favorable (6.66e-7)" "unprognostic (7.02e-3)" "unprognostic (3.55e-2)" "unprognostic (2.39e-2)" "prognostic favorable (4.49e-4)" 13.0 17.4 13.4 4.4 12.5 5.3 15.7 12.7 18.4 9.0 10.0 10.7 11.6 7.0 3.5 21.1 9.5 7.4 14.4 14.6 13.1 21.5 47.4 10.7 6.5 19.1 13.4 13.0 4.4 23.3 15.8 12.6 8.4 16.0 12.6 5.2 1.4 16.5 10.4 12.5 15.9 11.7 3.5 13.1 11.1 15.7 3.8 14.4 6.9 14.3 7.3 4.1 17.3 11.6 13.3 28.5 23.1 3.5 23.9 10.9 3.8 16.6 14.3 11.8 21.5 14.9 14.2 41.5 11.9 31.8 5.4 8.0 64.4 10.2 31.0 3.5 9.9 28.2 9.1 12.3 28.9 11.9 5.3 9.2 5.5 10.9 4.2 6.0 4.3 18.4 16.6 4.3 5.9 3.7 82.4 21.7 1.3 5.4 53.0 74.5 24.9 2.4 27.4 25.9 114.0 53.1 20.8 21.9 64.7 18.6 3.2 31.9 4.3 10.7 9.2 6.7 26.8 2.5 3.8 5.6 5.2 9.5 25.7 11.6 7.2 4.9 2.6 10.9 9.2 16.6 5.1 11.6 14.1 4.7 6.7 13.6 12.9 0.7 11.1 9.0 3.6 11.6 9.1 13.4 12.5 12.7 18.4 14.6 13.1 19.1 13.4 13.0 16.0 13.1 14.4 13.3 35.4 9.6 5.8 6.2 6.7 3.6 7.5 5.7 2.8 10.4 24.7 25.3 7.4 11.5 7.8 18.4 6.2 18.3 11.5 16.6 5.9 13.7 3.3 5.5 3.0 14.6 31.8 11.6 11.3 11.6 10.1 4.8 7.7 9.0 0.0 6.6 19.2 20.8 11.4 16.8 7.8 13.5 6.1 3.1 1.4 15.7 2.8 3.9 5.4 2.8 2.3 13.5 16.5 11.6 7.3 9.4 9.0 4.1 3.7 10.7 29.0 16.2 2.4 11.3 0.0 6.1 4.3 2.7 5.7 18.4 7.7 3.4 10.3 8.2 22.4 25.1 NECTIN2 "CD112, HVEB, PRR2, PVRL2, PVRR2" ENSG00000130202 "Nectin cell adhesion molecule 2" Q92692 19 44846175-44889223 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 136.6;Ductal cells: 215.6;Exocrine glandular cells: 154.2;Glandular and luminal cells: 126.1;Pancreatic endocrine cells: 241.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 10.4" "Lineage enhanced" "Detected in many" "granulocytes: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012759, CAB026138, HPA073459" Enhanced Approved "Nucleoli fibrillar center,Cell Junctions" NA Yes 5900000 "Nucleoli fibrillar center, Cell Junctions" "CAB026138: , HPA012759: AB_1846227, HPA073459: " "unprognostic (3.30e-2)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (7.45e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" "unprognostic (6.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.97e-1)" "unprognostic (6.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (2.15e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-2)" "unprognostic (2.05e-1)" 59.5 79.7 32.2 32.4 27.6 15.9 66.6 29.6 34.6 41.8 41.0 39.9 55.8 45.4 58.7 76.9 44.3 53.0 64.6 28.3 52.6 79.7 119.5 73.5 15.9 35.0 31.2 25.8 42.0 55.4 62.0 39.4 77.8 32.0 69.8 33.2 16.9 63.1 30.6 20.3 50.7 47.9 31.6 30.1 58.6 76.0 66.3 33.7 7.0 57.9 17.8 25.6 56.4 49.7 34.4 73.8 89.3 118.3 140.6 59.3 35.8 123.7 62.6 83.9 120.4 136.6 194.8 171.0 0.6 79.2 79.0 61.1 98.5 106.6 55.6 91.7 3.2 53.2 43.0 30.8 128.6 145.0 0.7 117.9 64.9 22.5 56.2 44.8 123.2 149.3 3.0 71.1 0.7 59.2 146.4 0.6 5.6 92.8 249.8 27.7 4.3 37.7 3.2 139.5 100.1 5.4 15.2 74.9 127.0 28.7 210.4 97.2 47.1 140.1 31.3 105.5 23.7 48.6 9.0 25.8 0.6 57.3 10.0 83.0 1.8 2.0 10.4 0.0 0.7 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.8 0.0 0.4 0.3 0.0 0.7 32.2 27.6 29.6 34.6 28.3 52.6 35.0 31.2 25.8 32.0 30.1 33.7 34.4 136.6 35.3 31.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 108.4 54.9 0.0 0.0 6.8 58.8 0.0 109.3 2.6 0.0 3.9 215.6 0.0 73.8 66.3 58.8 0.0 0.0 0.0 154.2 97.8 30.4 0.0 126.1 3.8 75.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 80.1 0.0 0.0 0.0 0.0 241.8 0.0 0.0 0.1 0.0 0.0 27.1 3.6 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 101.8 2.2 58.3 0.0 0.0 APOE AD2 ENSG00000130203 "Apolipoprotein E" P02649 19 44905791-44909393 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Hyperlipidemia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 3482.3;liver: 6646.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 9363.4;Hofbauer cells: 6072.6;Muller glia cells: 9454.8;Peritubular cells: 4958.2;Proximal tubular cells: 8155.9;Theca cells: 7201.0" "Cancer enhanced" "Detected in all" "liver cancer: 3183.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1867.0;CACO-2: 466.1;Hep G2: 935.3;HSkMC: 1374.2;SK-MEL-30: 1956.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008363, HPA065539, HPA068768, CAB069921" Enhanced Approved Vesicles "Secreted to blood" NA NA 51800000000 29000000000 Vesicles "CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029" "unprognostic (8.98e-2)" "unprognostic (2.32e-2)" "unprognostic (2.49e-2)" "unprognostic (5.28e-2)" "unprognostic (3.77e-2)" "unprognostic (7.25e-2)" "unprognostic (5.22e-3)" "unprognostic (6.13e-2)" "unprognostic (5.06e-2)" "unprognostic (4.13e-1)" "unprognostic (5.78e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (7.76e-2)" "unprognostic (1.64e-1)" "unprognostic (1.12e-3)" "unprognostic (4.13e-2)" 526.6 3482.3 694.8 93.7 893.7 67.0 327.8 680.0 950.9 183.0 246.0 99.4 40.6 82.2 20.1 37.5 72.9 101.1 126.3 514.4 1127.5 1037.7 6646.6 261.1 355.2 869.7 859.4 381.4 512.4 42.2 34.8 111.7 103.1 751.5 45.8 23.1 88.4 81.1 10.9 31.4 328.9 167.3 12.7 836.0 625.9 84.1 141.6 843.8 58.3 147.6 10.5 46.4 94.3 136.7 762.5 3.2 5.2 9.5 2.6 1867.0 76.3 69.4 1.5 4.3 8.4 1.4 466.1 2.8 2.0 9.9 0.3 9.1 6.4 12.6 2.1 0.7 1.7 4.0 3.3 1.7 935.3 192.4 6.8 2.3 1374.2 2.5 14.8 1.3 15.6 1.0 0.7 124.9 2.8 1.2 3.3 1.9 2.5 243.2 3.0 1.3 2.6 8.0 1.8 2.8 0.9 5.6 2.4 4.5 1.4 1956.0 131.6 165.3 52.8 3.3 13.2 3.1 1.4 1.6 5.9 8.6 3.8 5.9 4.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 694.8 893.7 680.0 950.9 514.4 1127.5 869.7 859.4 381.4 751.5 836.0 843.8 762.5 136.7 0.0 8.2 444.0 66.1 935.2 12.3 18.3 67.7 81.7 86.7 565.8 2.2 450.4 5.2 228.1 41.7 46.3 6.0 2.2 682.9 1.8 73.6 33.8 936.6 140.2 0.0 331.6 1.1 0.7 43.8 860.7 3.6 22.9 174.4 103.6 208.9 9363.4 6072.6 38.7 2.1 0.6 4.1 718.0 292.6 355.3 2629.4 940.6 2481.3 60.9 70.3 9454.8 0.0 12.1 2.2 0.6 0.3 4958.2 7.2 15.0 0.2 8155.9 1.0 311.4 223.5 2958.4 345.5 14.8 12.8 15.1 1684.9 74.3 60.6 7201.0 1.7 4.7 TOMM40 "C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40" ENSG00000130204 "Translocase of outer mitochondrial membrane 40" O96008 19 44890569-44903689 "Predicted intracellular proteins, Transporters" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036231, HPA036232" Supported Enhanced Mitochondria,Cytosol NA NA 45000 Mitochondria Cytosol "HPA036231: AB_2675010, HPA036232: AB_2675011" "unprognostic (2.14e-1)" "unprognostic (9.58e-3)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (2.37e-1)" "unprognostic (2.17e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-2)" "unprognostic (7.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (5.86e-3)" "unprognostic (5.30e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-1)" 30.9 60.2 28.3 25.4 26.7 33.2 29.3 30.4 37.5 22.8 23.4 30.9 28.6 25.2 14.3 52.2 25.6 10.9 42.9 27.8 29.6 29.3 51.2 28.6 23.8 29.7 30.5 28.1 25.1 26.8 31.6 25.5 20.2 30.9 24.9 23.2 18.1 24.3 17.6 64.5 33.4 26.3 16.6 26.8 26.7 29.5 22.1 32.8 25.4 22.5 34.7 22.8 30.2 29.7 31.9 147.6 244.6 87.6 121.3 32.2 28.4 110.3 103.3 57.1 192.1 136.6 268.8 99.5 215.3 107.7 68.8 108.7 155.2 228.9 149.1 87.0 84.0 206.1 145.3 93.5 214.7 68.0 187.6 125.1 45.2 83.4 149.3 94.1 36.0 67.3 102.4 232.6 73.3 76.4 184.2 205.4 137.1 153.6 209.6 149.1 206.1 99.2 125.3 89.6 201.8 135.2 86.4 109.9 229.4 75.2 48.4 77.1 188.2 55.9 132.0 133.6 93.1 273.7 78.3 176.0 212.9 98.2 197.0 142.1 0.7 3.6 3.7 2.8 4.6 3.2 5.8 2.8 4.1 4.6 2.4 4.9 5.4 0.7 3.2 4.3 4.6 3.5 1.4 28.3 26.7 30.4 37.5 27.8 29.6 29.7 30.5 28.1 30.9 26.8 32.8 31.9 26.2 16.0 7.3 8.8 34.9 87.4 73.7 17.1 35.9 68.2 32.7 30.9 15.7 25.8 14.3 31.3 29.2 104.5 28.9 78.8 39.2 48.1 11.3 22.7 41.0 31.0 29.3 52.4 11.3 38.6 169.9 38.6 40.2 29.5 19.1 57.8 12.5 24.2 100.1 70.7 16.9 59.4 28.5 21.0 44.9 7.2 26.8 35.0 39.2 4.7 31.9 46.6 27.8 5.5 12.8 53.6 32.4 24.5 47.9 139.0 34.5 39.5 4.9 60.2 19.7 49.1 47.8 46.2 64.5 60.5 89.4 72.9 26.7 105.9 132.1 75.5 APOC1 ENSG00000130208 "Apolipoprotein C1" P02654 19 44914247-44919349 "Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 16364.8" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 33405.9" "Cancer enriched" "Detected in all" 21 "liver cancer: 3253.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "myeloid DC: 5.6" "Lineage enriched" "Detected in single" 12 "dendritic cells: 5.6" "Cell line enhanced" "Detected in many" "Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0" "Low region specificity" "Detected in all" HPA051518 Supported "Secreted to blood" NA NA 20300000000 15000000000 "HPA051518: AB_2681519" "unprognostic (3.51e-2)" "unprognostic (3.31e-3)" "unprognostic (1.14e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (1.15e-7)" "unprognostic (9.51e-3)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.52e-1)" "unprognostic (7.13e-3)" "unprognostic (3.48e-3)" "unprognostic (1.65e-1)" "unprognostic (2.01e-3)" "unprognostic (1.65e-1)" 57.2 2014.5 109.4 28.3 147.7 52.6 87.8 109.9 340.9 24.0 103.7 28.6 13.2 11.1 42.3 6.0 21.4 31.3 9.9 98.2 181.1 14.4 16364.8 292.4 141.3 156.0 163.0 91.5 56.9 21.6 16.4 23.8 42.0 130.9 14.5 16.8 15.3 35.8 2.2 22.5 49.1 49.5 4.0 135.3 257.0 22.9 18.8 152.6 37.8 36.6 6.2 34.2 23.7 11.4 149.3 2.7 26.5 12.0 5.0 37.1 38.2 111.5 1.3 1.7 4.8 7.3 55.6 49.9 8.4 9.4 1.0 3.2 1.8 15.6 1.9 2.3 0.4 63.5 36.8 4.2 576.4 32.9 27.5 18.1 332.9 2.8 4.8 1.8 9.2 1.3 1.8 151.6 0.8 1.7 3.6 1.5 2.0 112.4 10.4 5.6 6.2 16.0 0.8 7.3 2.0 5.3 3.3 18.9 0.3 268.0 37.7 2.2 98.4 4.2 0.4 1.7 0.2 1.7 4.5 5.4 8.2 0.7 7.4 2.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.3 109.4 147.7 109.9 340.9 98.2 181.1 156.0 163.0 91.5 130.9 135.3 152.6 149.3 22.9 115.4 214.4 2.3 40.6 17.0 4.1 5.8 6.2 2.5 49.8 92.8 0.8 453.2 55.8 1.8 0.0 31.7 1.6 2.4 49.0 4.6 1.2 6.6 128.4 68.9 2.4 768.8 0.3 4.0 341.3 93.0 19.4 5.0 142.6 30.6 432.6 33405.9 4789.8 0.0 0.5 3.2 4.1 867.7 27.3 22.8 270.9 620.5 30.2 3.7 124.5 276.0 0.0 0.0 0.0 3.2 0.3 259.5 1.3 4.2 0.6 16.6 24.4 9.9 19.7 1628.8 24.4 2.0 3.2 3.7 17.8 71.6 46.7 1226.7 2.1 5.0 GADD45G "CR6, DDIT2, GADD45gamma, GRP17" ENSG00000130222 "Growth arrest and DNA damage inducible gamma" O95257 9 89605012-89606555 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 369.0" "Cell type enriched" "Detected in many" 7 "Syncytiotrophoblasts: 1609.4" "Cancer enhanced" "Detected in all" "prostate cancer: 79.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 4.9" "Lineage enriched" "Detected in single" 24 "granulocytes: 4.9" "Group enriched" "Detected in many" 4 "HDLM-2: 116.8;SCLC-21H: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023606 Approved NA NA "HPA023606: AB_1849409" "unprognostic (5.84e-2)" "unprognostic (1.61e-2)" "unprognostic (1.08e-2)" "prognostic favorable (7.06e-4)" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.77e-3)" "unprognostic (3.75e-2)" "unprognostic (7.65e-3)" "unprognostic (4.16e-3)" "prognostic favorable (3.80e-5)" "unprognostic (1.11e-1)" "unprognostic (1.63e-2)" "unprognostic (4.95e-1)" "unprognostic (3.88e-2)" "unprognostic (3.41e-1)" "unprognostic (1.22e-1)" 18.3 144.6 9.9 3.9 14.6 14.8 24.8 18.5 19.6 114.1 7.4 24.8 6.0 53.6 1.9 13.2 26.7 2.9 212.1 9.2 16.9 24.5 369.0 27.1 1.6 11.1 12.9 7.5 74.9 79.1 28.8 128.5 25.5 10.8 75.0 1.5 3.1 19.9 10.5 140.1 32.8 19.8 7.4 10.4 6.7 44.8 30.1 13.7 2.4 20.8 23.7 0.6 30.9 39.1 11.2 3.1 0.0 16.0 0.0 0.0 0.0 21.1 1.1 0.0 0.1 0.0 2.6 0.3 0.0 2.5 0.0 0.8 2.3 5.3 0.1 0.0 116.8 1.0 0.3 0.3 0.0 0.8 0.0 0.4 0.4 2.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 4.9 0.2 1.1 14.7 2.7 0.2 1.2 4.7 1.2 0.2 0.7 58.6 13.4 1.1 6.3 0.1 3.0 2.5 0.1 2.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 9.9 14.6 18.5 19.6 9.2 16.9 11.1 12.9 7.5 10.8 10.4 13.7 11.2 124.2 6.4 53.7 4.6 15.4 28.6 50.9 9.9 40.5 43.9 118.2 215.3 196.8 62.9 22.5 11.0 6.2 80.7 46.6 21.6 92.0 18.3 2.1 40.7 98.3 48.8 54.8 6.6 1.1 43.4 12.1 138.9 97.3 29.3 19.6 24.7 11.0 215.2 57.0 3.3 2.2 55.9 50.8 12.4 121.1 9.0 84.5 77.6 35.6 2.8 11.7 35.7 0.0 0.0 1.1 20.4 11.1 45.5 13.2 88.9 24.9 40.6 23.5 22.0 131.5 90.9 144.4 3.6 2.0 95.5 19.6 1609.4 57.5 165.8 20.0 12.4 LRCH2 KIAA1495 ENSG00000130224 "Leucine rich repeats and calponin homology domain containing 2" Q5VUJ6 X 115110616-115234096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 23.8;Excitatory neurons: 24.4;Inhibitory neurons: 38.0;Oligodendrocyte precursor cells: 48.2;Oligodendrocytes: 32.0;Sertoli cells: 26.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 21.4;U-266/70: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003233, HPA076892" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA003233: AB_2265929, HPA076892: " "unprognostic (9.74e-2)" "unprognostic (9.48e-2)" "unprognostic (1.14e-2)" "unprognostic (4.22e-5)" "unprognostic (2.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (1.01e-2)" "unprognostic (1.84e-1)" "unprognostic (4.29e-5)" "unprognostic (1.09e-3)" "unprognostic (1.34e-1)" "unprognostic (7.75e-2)" "unprognostic (1.16e-2)" 2.6 4.4 4.5 1.4 4.6 0.0 2.0 4.8 4.8 5.0 1.4 6.1 0.5 5.2 2.1 1.6 3.4 2.6 2.4 4.3 6.4 1.1 0.2 2.8 0.7 3.8 4.3 4.1 7.1 0.5 0.3 4.5 7.6 3.9 8.4 1.9 3.7 0.5 7.4 0.5 0.5 2.0 5.1 3.5 1.8 2.0 2.1 5.7 0.5 2.3 1.5 0.2 5.0 3.3 4.9 0.0 0.0 6.4 4.7 6.4 5.3 0.0 4.3 9.2 4.1 9.3 0.0 0.0 0.1 0.1 5.7 3.2 0.3 21.4 0.0 6.2 0.0 5.8 0.0 0.0 0.0 5.1 0.0 0.1 3.1 0.0 1.6 0.3 10.8 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 6.2 0.0 4.6 0.0 5.1 0.6 0.0 8.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 2.5 0.1 6.0 14.0 2.5 0.0 1.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.6 4.8 4.8 4.3 6.4 3.8 4.3 4.1 3.9 3.5 5.7 4.9 9.3 3.2 12.3 23.8 0.0 0.6 0.1 0.0 0.6 6.9 0.1 0.3 7.5 0.0 0.0 1.8 0.0 0.1 0.0 0.0 1.9 0.0 9.1 0.1 5.9 6.7 0.0 0.0 24.4 0.0 0.2 6.3 0.0 0.1 0.0 8.4 2.9 0.0 0.6 1.7 38.0 0.0 0.0 0.0 1.0 2.9 8.7 0.1 1.8 9.4 0.0 6.4 0.0 48.2 32.0 0.0 0.0 6.4 0.0 1.2 0.0 0.0 0.0 2.5 26.3 3.6 7.8 5.4 2.9 0.0 0.1 0.3 0.2 5.7 0.0 0.1 DPP6 "DPL1, DPPX" ENSG00000130226 "Dipeptidyl peptidase like 6" P42658 7 153887097-154894285 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.6;endometrium 1: 58.7" "Group enriched" "Detected in many" 4 "Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8" "Cancer enriched" "Detected in some" 11 "glioma: 12.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "NTERA-2: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050509 Enhanced Supported NA NA "HPA050509: AB_2681150" "unprognostic (1.29e-1)" "unprognostic (3.55e-2)" "unprognostic (5.68e-2)" "unprognostic (5.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.28e-1)" "unprognostic (2.73e-1)" "unprognostic (5.83e-4)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.04e-3)" "unprognostic (2.94e-3)" "unprognostic (1.85e-4)" "unprognostic (1.05e-1)" "unprognostic (4.61e-3)" "unprognostic (6.11e-2)" 0.6 8.3 20.8 0.2 27.0 0.1 0.5 34.2 35.9 4.2 0.0 14.2 0.5 58.7 2.5 0.3 5.3 0.1 0.2 45.8 26.4 5.2 0.0 1.4 0.1 49.6 27.4 23.5 0.7 3.9 0.0 10.8 0.2 55.9 0.3 1.6 11.2 0.1 8.9 6.0 3.6 3.4 20.1 5.3 4.7 7.8 7.3 36.4 2.0 17.3 0.9 0.0 0.3 1.1 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 11.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.0 20.8 27.0 34.2 35.9 45.8 26.4 49.6 27.4 23.5 55.9 5.3 36.4 78.6 0.1 0.0 0.0 147.9 0.0 3.3 0.4 0.0 0.0 27.0 0.4 1.3 7.4 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 13.4 0.9 21.6 0.4 10.3 0.0 673.4 4.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 32.0 1195.9 0.4 0.0 0.0 0.0 18.4 1.2 0.2 16.0 22.5 0.0 17.1 0.0 1947.8 290.8 0.3 0.0 3.8 0.0 0.1 0.1 0.4 0.8 6.1 0.0 0.7 0.9 1.2 4.0 0.0 1.6 0.0 0.2 0.0 0.0 0.2 XPO7 "KIAA0745, RANBP16" ENSG00000130227 "Exportin 7" Q9UIA9 8 21919662-22006585 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043727, HPA048153" Uncertain NA NA 53000 "HPA043727: AB_2678638, HPA048153: AB_2680289" "unprognostic (6.30e-2)" "unprognostic (1.95e-2)" "prognostic favorable (2.29e-4)" "unprognostic (6.61e-3)" "unprognostic (1.81e-1)" "unprognostic (1.33e-2)" "unprognostic (1.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.18e-1)" "unprognostic (6.81e-3)" "unprognostic (9.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.76e-2)" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" 20.2 22.0 23.6 22.1 27.5 62.5 26.9 24.8 25.9 26.7 23.3 24.9 16.0 31.0 28.7 26.8 30.8 20.5 31.6 27.1 24.1 40.6 19.4 22.7 27.0 20.4 21.1 23.6 40.1 21.9 43.8 20.0 32.0 21.4 21.5 28.6 45.4 20.8 25.0 33.5 28.2 17.9 28.8 20.6 23.4 23.8 41.4 24.1 33.8 35.8 40.9 31.4 24.2 21.7 28.5 47.8 83.2 60.7 43.9 49.9 43.3 47.9 46.2 54.3 67.2 60.4 63.6 29.1 78.0 51.5 57.6 61.0 45.5 87.9 66.2 117.8 23.7 44.7 87.5 67.9 46.9 34.0 42.3 63.9 34.0 45.9 67.1 64.0 48.8 65.5 69.1 106.0 61.0 49.9 36.8 105.6 39.4 78.3 81.2 33.0 60.5 78.3 40.9 44.3 98.0 36.7 57.9 43.8 45.3 46.4 61.2 41.2 34.7 42.9 35.0 44.5 50.3 47.0 21.4 25.9 83.0 53.5 50.9 63.1 6.4 3.4 2.6 5.1 4.6 4.3 4.5 4.5 3.9 5.1 3.2 3.4 4.3 1.6 3.4 4.3 1.8 4.9 3.9 23.6 27.5 24.8 25.9 27.1 24.1 20.4 21.1 23.6 21.4 20.6 24.1 28.5 14.8 22.4 11.4 37.5 14.6 14.3 6.3 9.0 10.2 31.8 11.8 10.7 38.1 15.7 13.5 18.4 14.6 11.5 12.0 11.2 3.9 10.3 70.5 12.0 12.0 12.4 20.9 169.5 65.8 11.2 13.4 13.1 19.9 11.3 7.6 32.1 13.6 14.1 14.4 50.5 68.8 12.0 8.2 23.9 11.3 39.7 15.5 16.8 10.6 37.5 17.3 15.3 11.3 70.4 70.9 10.7 6.5 17.7 15.7 10.3 7.8 15.3 9.8 23.5 13.1 14.9 13.2 21.6 21.4 16.0 12.1 5.6 9.4 13.2 12.8 8.5 ACE2 ENSG00000130234 "Angiotensin I converting enzyme 2" Q9BYF1 X 15494566-15607236 "Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" "Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 66.1;intestine: 244.2;kidney: 88.4" "Cell type enriched" "Detected in many" 5 "Proximal enterocytes: 294.8" "Group enriched" "Detected in many" 4 "colorectal cancer: 13.9;renal cancer: 26.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028" Enhanced "Secreted to blood" NA NA 400000 "CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160" "unprognostic (1.40e-1)" "unprognostic (7.26e-2)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "unprognostic (2.51e-1)" "unprognostic (5.26e-2)" "prognostic favorable (4.21e-4)" "unprognostic (2.34e-2)" "unprognostic (6.74e-3)" "unprognostic (2.54e-3)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "prognostic favorable (2.12e-5)" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (2.11e-1)" "unprognostic (7.10e-2)" 6.1 0.5 0.2 1.4 0.2 0.6 4.4 0.5 0.3 0.6 1.7 10.0 184.9 0.5 0.6 1.8 1.6 66.1 43.1 0.2 0.3 88.4 5.8 0.8 0.4 0.3 0.2 0.1 1.9 2.5 1.5 0.1 1.2 0.3 0.4 6.0 0.3 1.4 4.1 0.7 0.3 244.2 0.5 0.2 0.1 2.7 50.2 0.2 0.5 4.5 0.5 0.2 0.8 1.2 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.8 0.1 0.0 0.2 0.2 0.2 0.3 0.4 0.3 0.0 0.3 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.5 1.2 1.2 0.0 0.0 0.3 0.2 0.5 0.2 0.4 0.2 0.9 0.0 0.4 0.0 1.9 0.4 0.4 0.1 0.0 0.0 0.3 0.4 0.1 0.5 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.5 0.3 0.2 0.3 0.3 0.2 0.1 0.3 0.2 0.2 0.3 0.4 0.0 0.5 1.3 1.4 0.1 0.5 5.0 0.0 0.0 1.6 0.0 11.2 55.8 2.6 0.0 0.0 4.2 0.1 22.9 3.9 1.2 0.5 1.1 0.3 1.0 7.2 0.0 0.8 0.8 0.3 4.6 0.0 0.6 0.0 3.9 0.0 0.9 0.8 0.0 0.8 8.2 0.0 0.0 0.0 1.4 8.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 5.1 6.0 0.0 1.0 294.8 48.8 2.0 0.0 19.7 0.0 8.9 1.1 1.0 0.0 0.1 12.7 0.3 0.1 10.6 2.2 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 9.9 9.6 12.0 5.5 10.9 8.8 12.4 10.3 17.8 13.7 5.5 13.6 14.0 10.8 2.6 17.8 12.4 5.4 11.5 11.8 10.5 12.2 13.4 9.1 6.3 17.1 9.8 11.2 12.6 18.8 8.4 11.7 2.4 11.7 13.5 4.8 1.7 14.1 5.9 3.3 24.7 15.5 3.3 10.7 11.9 14.5 9.1 11.8 4.7 11.5 2.5 3.9 12.8 14.7 12.3 15.6 16.3 1.9 9.4 2.0 6.8 8.2 8.8 7.3 8.5 8.9 2.8 11.0 13.9 9.7 5.2 3.0 7.5 3.7 6.3 1.4 22.6 7.6 4.6 2.9 6.5 9.0 3.9 8.1 6.6 13.0 4.3 7.8 4.7 5.0 22.5 12.9 15.0 5.1 17.2 5.9 3.1 1.4 25.5 17.5 11.6 3.9 8.4 10.4 8.0 3.3 9.6 8.8 15.6 5.6 0.9 11.8 12.3 6.7 3.8 10.4 11.9 10.7 16.1 8.8 6.1 9.9 9.2 6.2 0.0 1.9 10.8 2.4 2.7 3.2 2.0 4.2 3.4 2.6 6.5 3.3 2.6 1.7 3.0 2.7 1.0 3.9 1.4 12.0 10.9 10.3 17.8 11.8 10.5 17.1 9.8 11.2 11.7 10.7 11.8 12.3 19.8 9.6 8.9 3.6 17.5 21.5 22.3 23.7 14.8 15.1 21.1 26.3 5.4 10.0 21.2 23.9 12.5 11.8 22.1 41.4 21.5 22.2 6.4 18.2 9.1 12.0 25.7 9.7 11.7 32.9 10.9 13.9 17.9 18.0 15.2 8.6 11.4 12.5 11.0 11.8 9.5 32.4 22.4 13.2 18.2 2.4 18.6 14.3 23.2 2.8 14.4 14.6 34.0 5.5 8.5 23.8 42.8 18.4 12.7 12.2 100.4 22.6 22.4 12.5 13.1 13.5 13.8 37.4 37.4 22.3 29.8 6.2 21.8 12.9 34.8 23.4 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA 48000 Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: AB_2681266" "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favorable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favorable (2.12e-4)" 25.8 36.0 23.4 22.6 22.5 35.5 26.0 27.3 30.6 47.3 20.2 33.1 22.5 38.5 21.2 23.3 44.3 15.7 30.9 22.4 23.3 40.6 31.0 28.1 24.6 24.3 21.4 18.3 56.7 30.8 18.1 49.0 14.3 24.0 43.4 16.3 35.0 27.8 18.8 41.8 25.3 34.6 19.4 17.1 40.3 28.0 32.8 23.9 22.5 39.2 20.6 21.3 31.8 35.3 28.0 44.9 54.8 38.8 30.4 36.7 23.7 47.6 40.9 21.3 24.4 23.3 69.9 31.4 84.9 36.9 19.9 19.6 39.9 47.2 24.9 39.2 59.8 53.5 64.4 59.5 54.6 21.2 53.0 58.2 23.5 25.4 35.2 26.9 23.9 24.6 29.3 63.6 40.6 28.7 48.9 65.7 53.1 69.9 33.1 59.9 82.2 34.2 47.6 27.7 70.5 37.6 35.3 54.7 25.3 35.3 24.4 36.5 33.0 40.5 30.7 32.7 39.3 57.6 55.2 52.2 58.6 31.2 47.1 52.2 42.8 12.6 22.0 14.6 10.8 16.8 13.9 13.2 11.7 11.3 14.9 14.5 11.7 23.4 9.4 12.3 12.5 13.4 7.9 23.4 22.5 27.3 30.6 22.4 23.3 24.3 21.4 18.3 24.0 17.1 23.9 28.0 40.6 41.7 45.1 79.7 69.7 46.7 58.1 41.4 47.3 70.2 39.1 30.6 28.7 20.0 39.3 33.1 75.0 46.8 63.0 46.4 23.5 49.7 7.6 44.5 92.6 49.0 43.0 45.8 36.2 44.4 44.7 47.3 44.4 58.3 42.3 45.4 26.7 23.3 30.6 43.7 42.7 46.5 57.0 27.6 49.5 13.3 72.4 46.6 26.6 32.8 52.2 77.5 52.5 29.7 34.6 42.2 48.6 65.8 70.0 50.3 54.1 61.5 55.3 78.4 46.0 75.4 47.9 68.3 78.8 37.3 41.9 32.3 79.1 59.7 44.8 54.2 RPL36 "DKFZp566B023, L36" ENSG00000130255 "Ribosomal protein L36" Q9Y3U8 19 5674947-5691875 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 11665.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA047153 Supported Supported "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA047153: AB_2679958" "unprognostic (2.81e-2)" "unprognostic (5.70e-3)" "unprognostic (8.16e-2)" "unprognostic (6.28e-3)" "unprognostic (2.25e-2)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (5.48e-2)" "unprognostic (1.29e-1)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (7.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" 949.3 1542.0 537.6 570.5 527.1 1245.5 1123.2 499.8 825.7 1250.3 536.9 872.7 518.6 798.2 280.1 1393.5 1073.3 281.6 709.6 514.7 574.2 792.0 830.8 685.4 790.5 528.3 514.0 501.8 2581.3 2219.9 237.7 771.2 346.7 525.9 1163.4 285.3 136.1 1120.2 277.2 806.9 1783.7 871.9 216.6 536.2 1042.3 993.3 317.1 546.9 457.5 622.7 259.8 450.7 942.9 1214.8 547.3 1624.4 856.8 563.8 1439.8 676.2 1344.8 823.6 876.3 668.8 1021.0 840.8 1615.3 852.5 1173.9 1993.7 460.6 429.9 1130.5 516.6 1284.8 273.3 856.5 3892.1 744.2 839.2 1347.5 1732.2 1494.3 939.2 1304.3 1881.9 661.5 1160.1 829.4 856.6 1550.4 977.0 3630.2 553.6 1856.8 1934.9 2131.5 1915.2 955.3 2992.0 1187.0 608.1 3086.6 902.4 1141.2 1016.4 1276.6 521.4 1536.1 2592.7 259.3 1192.0 2488.2 811.2 603.9 762.9 875.4 1932.2 1609.3 1644.9 1795.1 1144.8 2480.1 859.7 649.8 1088.5 429.3 1239.7 894.7 1916.1 2491.9 2383.9 1779.7 1355.7 2443.4 2607.7 2240.3 143.2 1263.2 776.1 1337.7 2019.7 4662.9 537.6 527.1 499.8 825.7 514.7 574.2 528.3 514.0 501.8 525.9 536.2 546.9 547.3 2057.7 580.1 876.3 15.3 4029.9 6658.4 3062.7 4422.0 4306.5 233.8 7828.9 11665.5 326.1 1947.4 1831.0 1239.6 81.3 2834.0 2054.5 1783.8 2625.6 2857.3 568.5 1386.5 2987.3 2294.5 2048.6 1929.4 11.4 8143.9 4805.4 1873.1 2019.4 2045.2 1297.2 3141.8 3392.5 2952.1 2803.1 97.6 12.3 5548.2 1243.1 3831.3 4994.8 1712.7 3252.6 2108.4 3041.6 26.2 4068.5 1058.4 1988.7 10.1 18.4 5545.1 3883.8 1542.9 2258.4 3579.6 3704.5 3521.3 847.6 346.8 927.0 2285.6 1750.6 385.0 717.0 5107.2 9200.4 2783.1 3173.4 2031.0 4778.3 3290.7 ATP8B3 ATPIK ENSG00000130270 "ATPase phospholipid transporting 8B3" O60423 19 1782075-1812276 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 5.9;testis: 22.1" "Cell type enhanced" "Detected in many" "Early spermatids: 9.5;Late spermatids: 11.7;Spermatocytes: 20.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 12.5;Karpas-707: 22.4;U-266/70: 18.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (6.50e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.05e-5)" "unprognostic (6.66e-2)" "unprognostic (7.91e-2)" "unprognostic (1.86e-2)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (2.55e-3)" "unprognostic (1.28e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (4.80e-9)" "unprognostic (8.05e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-2)" "unprognostic (1.19e-1)" 0.4 1.9 0.3 0.6 0.2 5.9 0.4 0.2 0.4 0.6 0.2 0.3 0.3 1.2 0.3 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.6 0.5 0.7 0.3 0.2 0.2 0.6 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.1 0.6 0.4 0.8 0.2 3.3 0.2 22.1 0.4 2.4 0.5 0.3 0.8 0.4 0.6 0.5 0.8 6.3 0.7 0.9 0.7 0.6 0.0 2.5 3.7 2.4 2.2 0.1 2.5 2.7 2.7 1.9 0.3 0.2 0.5 0.1 1.1 2.7 0.1 0.8 3.2 1.2 0.2 1.7 12.5 0.3 0.2 0.0 2.5 3.7 0.6 8.0 2.1 22.4 4.0 0.3 1.7 5.0 0.2 0.3 2.9 2.7 0.5 0.3 3.4 0.1 0.0 0.8 0.7 0.0 0.4 0.6 0.7 8.0 5.9 0.1 4.7 0.9 2.6 18.5 9.8 0.7 4.7 8.0 3.1 0.0 0.9 0.8 0.8 3.1 0.3 0.0 0.5 0.5 0.5 0.0 0.2 0.7 0.3 1.1 0.9 0.2 1.3 0.6 0.3 0.2 0.2 0.4 0.2 0.3 0.3 0.2 0.2 0.3 0.2 0.4 0.5 1.5 0.0 0.6 1.0 0.5 0.8 0.5 0.9 4.6 2.4 1.0 1.8 1.6 4.3 0.3 0.0 2.1 0.1 1.2 0.1 0.0 1.0 9.5 3.9 1.8 2.1 0.0 0.8 0.6 0.2 1.2 2.0 0.5 5.1 1.3 3.9 4.6 0.8 1.4 0.0 0.5 0.1 0.0 4.1 1.9 11.7 0.3 2.0 1.8 1.0 1.1 0.7 2.1 0.5 0.2 0.2 0.0 0.4 0.9 0.3 0.5 0.1 0.2 0.7 0.0 0.3 0.7 20.9 3.7 2.5 1.4 0.4 2.7 4.2 0.1 0.2 GDF1 ENSG00000130283 "Growth differentiation factor 1" P27539 19 18868545-18896158 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 3.2;pituitary gland: 1.6;skeletal muscle: 4.0;testis: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;SH-SY5Y: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 0.0 0.1 1.6 0.0 2.1 0.0 0.1 1.9 2.8 0.2 0.4 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.4 1.6 2.0 0.0 0.0 0.0 0.0 2.2 1.8 1.3 0.4 0.1 0.0 1.6 0.0 1.9 0.2 0.0 0.0 0.1 0.0 4.0 0.0 0.1 0.0 1.6 0.0 0.2 4.9 2.4 0.0 0.1 0.0 0.0 0.3 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 1.9 2.8 1.6 2.0 2.2 1.8 1.3 1.9 1.6 2.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NCAN CSPG3 ENSG00000130287 Neurocan O14594 19 19211958-19252233 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 74.2" "Cell type enriched" "Detected in some" 6 "Astrocytes: 195.5" "Cancer enriched" "Detected in some" 57 "glioma: 71.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036814 Enhanced "Secreted in brain" NA NA 790000 "HPA036814: AB_10673666" "unprognostic (1.02e-2)" "unprognostic (2.84e-3)" "unprognostic (1.92e-1)" "unprognostic (1.56e-2)" "unprognostic (2.35e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "unprognostic (4.58e-3)" "unprognostic (4.38e-2)" "unprognostic (9.09e-6)" "unprognostic (1.10e-2)" "unprognostic (2.79e-2)" "unprognostic (2.91e-1)" "unprognostic (2.58e-2)" 0.0 0.1 52.5 0.0 50.6 0.0 0.0 15.0 74.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 39.5 0.0 0.0 0.0 0.0 38.7 35.7 47.7 0.0 0.0 0.0 0.3 0.0 44.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.9 58.3 0.1 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 50.6 15.0 74.2 55.4 39.5 38.7 35.7 47.7 44.0 20.4 58.3 51.4 0.0 0.0 0.0 195.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 15.5 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 8.4 0.0 0.5 0.0 29.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 KIF1A "ATSV, C2orf20, SPG30, UNC104" ENSG00000130294 "Kinesin family member 1A" Q12756 2 240713761-240824293 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 109.0;pancreas: 34.4;pituitary gland: 42.4;retina: 58.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 393.8;Cone photoreceptor cells: 419.1;Horizontal cells: 536.7;Muller glia cells: 116.4;Rod photoreceptor cells: 176.8" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 62.5;HAP1: 146.0;SCLC-21H: 276.0;SH-SY5Y: 52.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005442 Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA005442: AB_1079210" "unprognostic (1.19e-1)" "unprognostic (2.17e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (1.65e-1)" "unprognostic (4.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-2)" "unprognostic (2.06e-2)" "unprognostic (2.60e-1)" "unprognostic (2.54e-1)" "unprognostic (3.83e-2)" "unprognostic (1.96e-1)" "unprognostic (1.74e-3)" "unprognostic (3.90e-2)" 0.1 12.5 70.2 1.1 51.1 0.0 0.1 18.5 109.0 0.1 0.0 1.8 0.7 0.3 0.8 0.0 0.2 0.0 7.1 64.6 24.3 0.2 0.4 0.3 0.0 104.3 47.1 42.3 0.7 34.4 0.5 42.4 0.0 104.5 5.4 0.6 58.9 0.2 0.2 0.2 1.0 0.8 0.3 20.2 0.4 2.6 11.3 63.9 0.4 0.9 0.1 0.0 0.1 0.6 95.1 0.0 0.2 1.8 62.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 3.5 0.4 1.4 0.6 146.0 0.0 0.0 8.4 10.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.3 0.0 2.5 0.3 0.0 8.8 0.0 0.0 0.0 0.6 1.2 0.0 0.0 276.0 52.0 0.0 0.8 0.0 0.4 0.4 0.0 2.0 0.0 1.3 0.4 0.0 0.2 0.1 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.2 51.1 18.5 109.0 64.6 24.3 104.3 47.1 42.3 104.5 20.2 63.9 95.1 0.0 0.0 0.0 50.9 0.0 0.9 0.1 0.0 0.0 393.8 0.1 0.3 16.8 0.0 0.0 0.0 419.1 0.0 0.0 0.1 0.0 0.5 2.2 1.1 0.2 1.2 34.2 0.0 57.6 25.1 0.0 2.9 4.1 5.0 0.0 1.5 0.0 0.4 0.1 536.7 72.4 0.8 8.2 0.0 0.4 4.1 0.9 0.1 17.8 9.4 0.0 116.4 0.0 18.1 50.3 14.6 0.0 0.4 0.0 10.4 0.0 0.3 0.0 176.8 0.0 0.0 1.0 46.2 20.5 0.0 0.0 0.0 0.0 3.8 0.1 0.5 GTPBP3 "FLJ14700, GTPBG3, MSS1, MTGP1, THDF1" ENSG00000130299 "GTP binding protein 3, mitochondrial" Q969Y2 19 17334920-17342731 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042158 Approved Supported Mitochondria NA NA Mitochondria "HPA042158: AB_10964400" "unprognostic (1.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (3.08e-3)" "unprognostic (1.34e-1)" "unprognostic (2.18e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (6.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (2.81e-4)" "prognostic unfavorable (1.64e-4)" "unprognostic (4.94e-3)" "unprognostic (1.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.79e-1)" 7.7 13.7 6.7 5.1 5.8 4.9 9.2 5.7 6.9 10.5 5.6 8.3 5.5 8.6 1.8 13.2 9.7 2.2 7.9 6.1 6.8 9.1 14.2 7.6 6.6 8.4 6.5 6.0 10.3 12.3 5.3 8.9 3.4 8.8 10.5 2.9 4.1 10.3 3.9 9.3 15.0 9.5 2.8 5.8 12.8 9.4 3.0 7.0 3.6 8.8 3.2 4.4 9.0 10.5 7.7 19.7 11.6 10.6 13.8 3.5 3.3 51.2 9.1 3.8 8.2 8.0 16.2 15.6 29.8 22.8 3.4 5.8 17.2 13.5 7.8 6.7 24.9 62.6 17.8 18.4 21.4 4.6 19.3 11.2 3.4 11.2 7.6 9.7 5.7 6.6 20.9 34.6 13.0 4.2 15.7 23.2 17.2 22.4 12.2 51.5 27.4 8.2 28.3 7.6 8.8 24.7 22.0 9.8 14.9 12.9 7.0 13.2 7.9 7.2 12.6 11.3 28.0 16.3 21.9 36.7 35.4 10.0 25.0 9.8 0.4 2.3 0.4 4.8 3.2 4.0 3.0 4.5 4.3 3.6 4.1 4.9 4.6 0.7 5.2 1.7 6.7 3.3 2.8 6.7 5.8 5.7 6.9 6.1 6.8 8.4 6.5 6.0 8.8 5.8 7.0 7.7 10.5 3.2 5.3 11.8 10.8 17.1 9.3 11.4 13.6 20.3 14.9 14.9 7.2 4.3 6.1 5.5 31.3 21.4 10.2 5.9 7.9 12.5 0.3 5.2 7.7 9.7 3.0 12.0 6.2 10.9 25.3 9.0 9.2 7.9 2.5 15.7 8.6 9.8 10.1 11.8 9.4 9.7 12.2 5.6 7.7 0.2 11.8 6.2 10.6 2.8 8.6 8.3 12.3 8.0 8.3 10.8 7.5 13.5 18.0 9.7 9.1 7.1 5.9 20.7 6.6 7.2 10.8 2.9 4.6 11.5 17.5 8.3 12.6 15.9 13.2 6.4 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351450-17377342 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 439.8" "Group enriched" "Detected in many" 4 "Adipocytes: 439.2;Endothelial cells: 344.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 35.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 35.2" "Cell line enriched" "Detected in some" 27 "EFO-21: 549.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 273.0 51.6 2.3 55.1 2.5 1.7 212.3 2.2 4.5 87.4 17.2 80.1 87.4 90.7 5.2 49.3 84.0 140.5 61.0 2.6 10.0 120.4 6.9 31.3 51.0 3.0 2.6 2.0 16.8 96.9 99.4 64.8 49.2 3.3 69.0 22.5 0.0 78.6 38.3 33.0 58.1 104.1 51.0 3.2 168.0 117.6 4.4 2.5 19.1 439.8 13.0 16.3 105.2 81.5 4.6 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 549.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 9.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.1 20.0 0.0 2.3 0.1 0.3 0.5 2.2 2.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 35.2 0.0 0.6 2.3 2.5 2.2 4.5 2.6 10.0 3.0 2.6 2.0 3.3 3.2 2.5 4.6 439.2 6.4 0.0 0.3 0.7 22.9 1.0 0.0 8.0 0.0 2.7 3.3 3.7 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 1.7 3.6 0.4 0.3 344.9 0.0 0.4 0.4 2.5 0.1 48.9 0.0 0.3 0.0 0.4 79.6 0.2 1.8 0.0 0.3 0.0 0.0 3.5 28.8 0.8 0.0 5.5 23.2 6.5 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 7.6 1.5 0.0 0.0 0.0 0.1 0.0 1.4 6.1 0.5 0.7 2.9 16.8 0.1 1.4 0.7 0.0 2.3 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405630 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 514.0;ovary: 700.1" "Cell type enhanced" "Detected in many" "Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA017060, HPA073472" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 260000 "Golgi apparatus, Vesicles" "HPA017060: AB_1845467, HPA073472: " "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 182.2 514.0 80.4 96.4 77.9 104.7 154.2 72.1 126.7 90.2 74.8 84.5 47.9 59.1 60.0 40.7 250.2 110.4 90.1 74.2 81.3 158.8 229.7 142.6 129.1 84.2 73.9 68.9 700.1 26.5 13.9 57.3 204.7 78.6 89.4 33.6 2.0 78.3 106.2 46.6 23.8 110.0 76.7 80.8 240.4 84.8 35.7 83.3 124.6 54.4 51.3 66.3 83.7 89.4 91.3 327.0 0.5 0.9 145.6 0.0 1.0 49.6 1.3 24.9 459.5 615.0 150.5 286.1 252.2 338.2 197.6 14.6 1.3 212.9 23.9 14.3 279.1 1.8 3.6 525.7 149.8 256.7 120.1 304.7 1.3 0.0 153.0 0.1 4.4 119.0 6.0 146.3 603.4 0.0 89.5 57.7 208.6 158.0 0.1 407.9 105.5 0.8 530.7 110.1 1.5 0.6 1.4 325.5 12.3 410.5 12.3 243.1 166.3 1.5 1.9 11.4 0.5 3.3 308.3 439.3 168.0 1.3 470.8 2.2 229.7 345.3 125.3 171.4 385.5 163.0 115.2 143.2 160.0 283.8 146.5 114.8 132.6 113.3 353.2 359.3 421.7 143.3 367.9 80.4 77.9 72.1 126.7 74.2 81.3 84.2 73.9 68.9 78.6 80.8 83.3 91.3 1193.2 57.7 13.6 4.9 90.7 33.1 19.6 255.7 48.9 0.2 86.2 168.5 7.0 50.1 68.5 49.7 0.0 7.8 184.2 1.5 37.2 18.7 10.7 27.8 11.2 420.2 1.2 74.0 0.0 1.2 61.5 152.4 14.8 50.1 227.8 260.9 455.8 211.1 388.9 0.0 0.0 2.8 28.5 189.4 187.6 12.0 346.7 220.4 74.7 32.8 214.5 1.3 211.2 0.5 0.3 3.3 4.8 419.4 192.8 10.3 3.7 1.3 27.4 2.1 164.3 30.7 146.3 1.3 1.2 15.5 26.1 13.1 135.8 490.6 5.0 28.6 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Oligodendrocytes: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 27.7;SK-MEL-30: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: AB_2732311" "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favorable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 18.5 24.4 27.3 4.5 34.8 1.5 19.4 32.9 39.3 20.6 37.4 12.3 3.7 13.3 3.0 8.5 17.2 8.3 25.8 27.2 27.8 11.0 8.0 10.5 4.8 35.9 35.8 24.4 33.2 14.5 17.9 19.4 6.3 34.7 23.4 1.8 4.1 24.3 10.4 25.1 13.8 7.7 4.0 31.3 10.6 13.8 17.7 30.7 2.3 16.9 12.5 1.6 14.0 14.1 42.6 6.2 3.0 4.1 9.8 27.7 15.2 3.5 4.4 11.2 4.8 7.2 0.5 18.2 2.1 8.1 7.2 4.3 7.3 0.4 6.8 1.3 2.4 1.4 1.2 0.5 2.3 5.4 0.5 6.4 14.1 4.6 4.8 1.9 19.7 3.3 3.9 0.8 1.3 3.2 2.5 3.3 4.9 1.2 6.0 5.2 4.7 3.2 1.4 3.2 1.8 1.4 2.9 3.0 1.5 47.8 2.5 5.2 1.6 2.1 9.4 6.1 7.5 3.0 4.0 3.1 0.7 9.6 5.3 6.7 0.0 9.2 0.2 1.4 4.0 2.6 0.4 1.0 1.7 6.3 0.3 1.3 1.7 0.0 1.6 1.8 6.5 0.7 4.6 27.3 34.8 32.9 39.3 27.2 27.8 35.9 35.8 24.4 34.7 31.3 30.7 42.6 19.7 3.2 11.9 84.5 1.8 6.6 14.1 12.7 10.2 8.4 15.5 26.9 19.5 11.5 11.1 9.2 27.1 4.3 8.3 1.2 1.9 11.1 1.1 8.4 6.9 7.8 5.4 0.8 16.1 4.8 15.6 10.4 9.2 4.9 2.5 8.4 10.4 8.1 26.1 6.7 23.9 3.0 6.1 22.4 4.0 2.5 21.5 13.4 8.8 15.0 14.7 11.6 4.1 37.2 67.5 5.2 0.6 11.7 1.7 12.0 0.1 3.6 16.1 17.7 6.6 10.9 7.3 9.1 5.8 5.0 4.5 2.3 4.9 13.8 2.2 8.7 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase 5" Q96P11 7 73302516-73308826 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847" "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 13.0 11.7 9.4 9.8 10.2 33.6 14.2 10.6 13.0 15.3 8.2 17.8 9.0 18.9 3.2 17.8 15.7 4.2 15.8 8.7 9.8 15.0 16.3 12.2 14.3 11.8 9.7 8.3 13.1 24.2 6.7 12.9 6.1 10.8 15.7 4.3 3.2 14.8 6.4 38.2 19.6 17.8 6.2 10.6 24.6 16.4 20.9 9.8 13.1 13.7 8.2 9.5 18.8 14.9 12.3 34.7 46.4 12.3 29.3 4.8 6.3 48.4 15.3 9.1 23.6 25.3 63.0 24.3 55.3 10.6 7.7 34.6 28.9 23.7 15.2 8.1 36.6 57.0 20.7 35.8 36.4 20.0 45.9 26.0 8.3 25.7 20.0 17.3 5.2 3.1 40.4 71.0 12.7 10.8 83.2 39.3 91.6 52.1 24.9 34.9 48.9 9.5 79.8 10.1 17.1 33.2 54.6 27.9 72.5 36.4 12.8 47.9 37.1 5.3 0.2 34.8 34.7 11.1 49.6 73.8 80.8 0.5 65.6 2.5 23.7 21.5 24.0 19.6 19.6 15.7 32.2 22.3 20.4 25.0 46.2 31.0 26.5 27.4 26.8 14.8 31.5 26.9 23.2 9.4 10.2 10.6 13.0 8.7 9.8 11.8 9.7 8.3 10.8 10.6 9.8 12.3 11.1 6.4 7.4 14.4 38.2 17.0 20.0 32.8 14.8 27.5 23.0 25.0 20.4 27.1 21.3 36.8 12.5 37.7 27.3 18.3 37.2 35.8 17.4 18.1 12.7 8.9 3.6 19.1 9.2 33.0 48.9 17.2 21.4 15.5 26.6 50.5 5.3 21.0 36.6 32.0 9.3 18.3 26.4 21.0 10.8 21.6 29.2 20.2 21.4 3.7 39.9 13.2 36.0 10.1 12.1 29.1 20.5 20.7 24.9 12.6 28.4 25.1 21.8 23.1 6.6 20.8 16.8 64.2 56.7 15.1 21.3 21.8 24.9 16.2 23.1 14.3 USHBP1 "AIEBP, FLJ38709, MCC2" ENSG00000130307 "USH1 protein network component harmonin binding protein 1" Q8N6Y0 19 17249171-17282786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 41.5;Endothelial cells: 28.3;Hepatic stellate cells: 21.4;Ionocytes: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.9;HeLa: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052471 Uncertain NA NA "HPA052471: AB_2681843" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (2.91e-2)" "unprognostic (3.97e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-3)" "unprognostic (1.44e-3)" "unprognostic (3.94e-2)" "unprognostic (4.42e-3)" "unprognostic (2.52e-1)" "unprognostic (4.46e-3)" "unprognostic (5.12e-1)" "unprognostic (5.12e-2)" "unprognostic (1.16e-1)" "unprognostic (6.88e-2)" "unprognostic (8.45e-2)" "unprognostic (1.88e-1)" 8.3 1.9 4.1 1.6 4.0 2.9 8.3 5.9 5.2 2.8 3.4 1.9 1.9 3.6 1.2 1.3 3.1 1.8 8.6 4.3 3.5 4.5 1.2 7.0 2.6 4.0 3.7 3.2 1.4 4.9 0.8 1.3 5.6 4.4 2.3 0.5 1.1 2.0 0.9 6.3 2.1 2.3 1.3 2.3 3.5 1.8 1.0 4.8 0.5 4.5 4.8 0.5 2.8 2.3 4.5 0.6 0.9 1.7 0.4 0.0 0.0 10.9 0.3 0.0 0.0 0.0 1.9 0.9 2.9 3.4 0.0 0.1 1.2 0.1 0.2 0.0 0.7 1.3 0.7 5.0 1.1 0.0 2.4 2.4 0.3 0.0 0.2 0.2 0.6 3.2 1.1 1.4 1.5 0.0 0.1 0.4 2.4 1.3 0.3 2.7 1.4 0.2 0.7 0.0 1.3 1.1 0.7 0.7 0.7 0.2 0.9 1.3 0.9 1.9 1.8 0.5 1.5 1.0 2.6 0.9 2.8 0.6 1.5 0.6 2.0 0.4 0.7 0.7 0.3 0.6 0.6 0.6 0.7 0.1 1.0 0.9 0.8 1.6 0.7 0.2 0.8 0.8 0.5 4.1 4.0 5.9 5.2 4.3 3.5 4.0 3.7 3.2 4.4 2.3 4.8 4.5 41.5 3.2 0.5 0.7 0.0 0.5 0.9 0.1 0.6 0.3 0.5 0.1 6.7 0.0 0.7 0.0 0.0 1.1 3.1 0.2 0.0 0.1 0.7 0.7 0.8 28.3 0.0 0.0 0.4 0.6 0.9 0.9 0.0 1.5 1.3 0.1 21.4 0.3 0.1 0.0 0.5 0.2 20.3 0.6 1.2 0.2 0.6 0.3 5.4 6.5 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 1.3 0.1 1.7 0.0 2.2 1.5 0.2 0.4 0.2 1.0 4.5 0.7 0.3 0.0 0.8 COLGALT1 "FLJ22329, GLT25D1" ENSG00000130309 "Collagen beta(1-O)galactosyltransferase 1" Q8NBJ5 19 17555649-17583162 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 76.2;Hofbauer cells: 91.0;Kupffer cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047821 Approved Approved Vesicles "Intracellular and membrane" No No 9700 Vesicles "HPA047821: AB_2680168" "unprognostic (2.46e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.65e-5)" "unprognostic (2.92e-3)" "unprognostic (2.92e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (8.87e-2)" "prognostic unfavorable (3.83e-4)" 37.6 14.4 6.8 38.5 7.2 33.2 27.7 7.0 13.0 29.7 10.9 25.9 16.4 28.6 4.4 18.0 26.7 19.2 21.0 5.8 13.8 12.7 16.4 35.2 29.9 9.8 7.3 4.4 23.7 15.9 9.1 10.2 41.2 9.5 15.6 15.4 3.2 16.0 16.5 15.2 23.9 24.9 35.7 7.8 39.8 18.3 12.1 15.2 10.0 14.9 7.6 15.9 28.3 23.0 17.2 103.1 118.0 56.7 79.8 222.3 136.3 90.9 95.9 55.1 121.8 125.9 90.4 159.6 53.0 164.7 166.9 104.2 91.5 58.4 110.6 73.4 29.5 94.9 51.2 147.4 87.9 121.6 123.0 147.8 115.2 97.6 136.7 56.7 49.7 138.8 33.3 105.5 25.8 45.1 45.6 61.9 81.1 43.0 75.8 115.3 65.2 73.8 80.9 26.4 67.2 41.2 29.9 102.8 80.6 97.0 36.7 41.9 177.7 98.7 240.8 67.7 215.3 156.2 45.4 125.1 58.3 142.7 232.4 113.0 1.7 25.7 12.5 5.2 28.1 2.8 3.5 4.8 4.9 18.1 3.3 3.4 5.3 3.6 2.1 20.8 7.0 3.1 14.5 6.8 7.2 7.0 13.0 5.8 13.8 9.8 7.3 4.4 9.5 7.8 15.2 17.2 35.0 19.2 23.5 11.1 10.3 19.5 7.0 10.4 10.8 3.7 8.8 9.5 11.2 10.0 15.5 11.0 6.2 7.9 28.6 14.7 0.0 13.1 3.6 8.5 28.5 29.3 5.4 10.3 10.9 8.2 76.2 30.9 20.9 13.6 8.8 20.3 7.9 14.2 91.0 13.5 9.9 15.1 4.1 70.7 24.1 3.1 19.0 59.6 17.8 19.7 26.6 2.3 10.3 6.6 12.8 10.4 7.6 21.8 6.0 9.5 9.5 4.4 8.7 3.6 13.1 9.5 24.3 2.5 13.1 13.8 20.9 8.3 12.0 24.9 18.2 8.4 DDA1 "C19orf58, MGC2594, PCIA1" ENSG00000130311 "DET1 and DDB1 associated 1" Q9BW61 19 17309518-17323298 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 416.9;Syncytiotrophoblasts: 253.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042134, HPA055272" Approved Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA042134: AB_10794169, HPA055272: AB_2682767" "unprognostic (1.30e-1)" "unprognostic (6.35e-3)" "unprognostic (3.13e-2)" "unprognostic (1.49e-3)" "unprognostic (5.38e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-2)" "unprognostic (4.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (8.55e-2)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 7.7 11.6 14.5 5.2 13.2 7.1 7.9 11.1 20.0 7.7 9.1 10.7 5.8 8.7 3.4 11.0 8.5 4.1 10.2 13.4 12.4 9.9 10.9 9.7 6.2 12.8 13.3 13.6 7.4 6.9 6.1 8.1 8.1 13.5 10.1 4.8 3.9 8.8 5.4 9.5 12.9 11.3 4.2 11.6 10.0 10.2 10.2 13.6 7.4 8.0 5.1 4.8 9.4 8.0 12.2 15.6 13.5 10.1 8.2 10.5 7.5 15.6 10.1 13.0 15.4 14.1 12.0 13.8 6.0 13.7 10.6 7.3 13.2 7.5 15.0 7.8 9.9 19.4 7.2 11.1 11.5 12.5 8.3 14.2 11.5 17.5 9.3 8.7 9.5 9.1 13.9 8.9 10.7 8.4 7.8 17.5 12.7 11.7 16.0 22.3 11.0 7.8 10.3 12.6 11.5 10.4 15.2 7.3 17.8 9.5 6.1 9.0 11.6 13.7 10.6 8.7 26.9 14.6 12.8 18.2 8.6 23.3 14.4 10.6 3.0 3.8 6.4 4.2 4.3 3.6 3.7 3.5 4.2 3.2 3.2 3.9 3.9 4.0 3.4 3.8 6.8 4.8 3.4 14.5 13.2 11.1 20.0 13.4 12.4 12.8 13.3 13.6 13.5 11.6 13.6 12.2 24.4 28.9 14.1 13.4 26.3 54.6 38.6 84.0 30.1 18.4 41.8 30.5 17.1 11.5 54.2 27.6 12.5 140.5 38.5 70.4 39.2 77.2 416.9 48.6 32.8 26.4 20.3 29.9 10.4 46.4 152.8 26.8 34.7 53.7 38.7 25.2 20.3 26.3 65.0 13.5 9.8 43.4 54.9 22.4 36.8 130.3 22.4 34.2 30.2 7.5 57.2 34.1 58.7 4.5 10.8 139.6 79.9 27.1 31.8 41.4 47.4 55.1 43.7 19.0 19.7 19.5 36.0 107.7 40.0 36.8 61.8 253.5 34.2 31.5 28.6 89.5 MRPL34 "L34mt, MGC24974, MGC2633" ENSG00000130312 "Mitochondrial ribosomal protein L34" Q9BQ48 19 17292609-17306843 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 403.0;Proximal tubular cells: 414.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049276 Uncertain NA NA "HPA049276: AB_2680697" "unprognostic (1.21e-2)" "unprognostic (3.22e-2)" "unprognostic (4.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (4.27e-2)" "unprognostic (1.46e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-1)" "unprognostic (5.45e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.29e-6)" "unprognostic (2.44e-1)" "unprognostic (2.42e-1)" "unprognostic (1.23e-1)" "unprognostic (2.18e-2)" 66.9 116.4 62.5 27.7 62.0 26.4 65.3 66.5 72.7 48.5 86.9 100.1 72.1 59.2 23.7 63.3 46.0 17.8 147.3 60.4 66.8 125.6 196.6 47.5 28.9 62.5 61.2 56.3 41.3 70.0 92.6 74.7 20.5 60.7 55.8 30.1 31.9 65.9 40.6 212.5 58.8 76.4 18.4 63.1 56.2 88.5 94.4 69.2 38.4 62.0 140.8 21.9 64.5 51.0 61.5 91.9 55.3 35.4 45.4 88.2 48.7 132.1 45.4 47.7 36.6 44.8 53.6 64.2 115.2 126.7 25.2 50.7 73.6 57.1 53.5 25.9 171.3 198.5 81.4 87.2 119.2 78.7 89.2 103.9 56.6 71.2 38.0 52.1 38.9 57.8 95.5 119.6 136.4 35.7 86.7 113.4 187.4 97.6 147.2 293.8 97.9 52.0 160.9 107.9 68.6 84.1 136.7 42.6 67.2 105.9 37.0 58.7 74.3 49.0 52.7 32.8 151.6 87.4 186.5 305.3 129.0 65.4 161.7 49.1 169.6 162.3 159.5 172.4 177.0 192.5 204.0 203.5 177.3 178.1 211.0 197.5 172.2 52.3 141.7 107.0 233.6 210.8 276.7 62.5 62.0 66.5 72.7 60.4 66.8 62.5 61.2 56.3 60.7 63.1 69.2 61.5 64.4 35.3 41.4 13.7 51.7 60.7 33.0 128.5 74.0 50.2 81.7 108.2 153.4 91.5 64.6 82.8 20.9 118.5 94.1 138.9 403.0 88.5 57.6 48.1 46.7 54.2 68.3 45.5 16.1 68.8 112.1 55.6 60.1 45.4 39.3 37.1 59.6 290.3 172.4 42.1 16.7 125.4 134.3 70.1 55.9 31.9 82.0 61.4 81.8 6.5 90.0 45.0 97.9 6.0 12.8 64.7 99.1 91.7 80.3 45.7 219.5 414.8 42.3 49.7 72.3 48.1 69.7 233.1 14.9 93.2 72.0 78.3 62.0 109.5 130.6 36.7 PGLS 6PGL ENSG00000130313 6-phosphogluconolactonase O95336 19 17511636-17521288 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 244.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040744, HPA042032" Approved Supported Nucleoplasm,Cytosol NA NA 7200000 Nucleoplasm Cytosol "HPA040744: AB_2677111, HPA042032: AB_2677809" "unprognostic (3.68e-2)" "unprognostic (8.98e-3)" "unprognostic (1.25e-1)" "unprognostic (9.64e-3)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (2.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.30e-1)" "unprognostic (4.75e-3)" "unprognostic (2.39e-1)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (9.26e-3)" 65.2 86.6 26.5 20.2 27.8 40.9 61.5 29.6 42.2 51.7 30.1 46.7 26.4 43.0 13.4 108.3 45.0 17.0 32.2 25.0 31.5 64.6 76.2 46.9 27.4 31.7 26.5 22.8 60.2 89.0 28.8 43.3 17.3 29.4 57.8 16.2 3.7 66.6 19.2 18.1 81.4 49.4 16.0 31.2 74.2 55.1 23.4 32.2 26.5 58.8 11.7 20.7 50.5 63.1 33.7 68.7 62.2 38.7 26.3 57.6 94.8 70.6 45.4 76.5 46.4 59.5 29.7 104.0 74.4 50.0 74.9 33.1 46.6 21.9 73.6 14.5 37.3 80.9 35.3 28.0 54.1 97.8 38.7 38.6 111.8 100.5 27.9 83.9 48.3 63.3 29.4 40.7 18.7 58.5 77.2 84.6 108.6 50.6 72.9 244.0 57.3 23.3 49.9 64.3 56.3 47.3 56.0 28.3 33.2 70.3 21.1 47.9 69.7 57.2 47.9 12.9 96.0 26.6 31.4 23.9 32.2 68.2 97.5 48.0 73.0 163.5 194.6 55.3 185.4 44.9 61.5 49.5 50.1 185.0 71.4 45.4 46.1 158.8 72.5 180.2 137.2 57.3 102.7 26.5 27.8 29.6 42.2 25.0 31.5 31.7 26.5 22.8 29.4 31.2 32.2 33.7 93.7 28.9 38.3 7.2 84.8 64.5 94.5 132.5 100.2 22.2 128.9 177.8 8.9 110.1 89.4 47.8 16.7 122.4 98.8 194.0 111.6 177.5 35.5 89.4 99.7 72.0 133.0 48.4 3.5 208.8 169.6 94.2 82.0 90.9 25.4 163.7 99.2 94.0 263.4 26.9 4.9 147.0 75.3 306.5 142.4 70.8 90.7 208.2 74.7 8.4 325.3 79.4 139.0 8.0 11.8 175.7 211.6 69.2 40.4 107.6 263.1 211.1 66.7 28.1 52.6 51.4 103.9 28.7 25.8 210.7 96.2 105.2 85.2 178.3 173.4 143.5 LSM7 YNL147W ENSG00000130332 "LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9UK45 19 2321520-2328611 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041850 Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA041850: AB_10964065" "unprognostic (8.33e-2)" "prognostic favorable (3.28e-4)" "unprognostic (9.33e-2)" "prognostic favorable (4.19e-5)" "unprognostic (4.81e-2)" "unprognostic (2.90e-2)" "unprognostic (9.60e-3)" "unprognostic (9.65e-3)" "unprognostic (2.32e-1)" "unprognostic (2.65e-3)" "unprognostic (9.48e-3)" "unprognostic (8.45e-3)" "unprognostic (2.05e-3)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "prognostic favorable (6.96e-4)" 57.5 54.7 48.9 52.0 50.0 112.9 65.2 52.1 84.8 75.0 47.4 71.9 62.8 64.2 23.1 89.6 62.4 20.9 60.2 48.1 50.1 65.1 66.3 53.7 71.5 52.1 50.6 46.0 75.2 53.6 33.5 81.1 38.8 51.4 64.0 33.1 15.2 53.1 32.2 68.9 66.2 78.4 28.5 51.7 83.1 56.2 44.3 52.3 78.3 51.3 31.3 46.6 63.4 69.0 54.9 276.5 171.3 167.5 192.4 74.3 70.8 139.6 131.7 93.6 147.2 114.1 326.3 105.8 329.4 139.5 105.4 84.9 140.4 161.1 183.3 68.6 232.3 376.0 230.3 152.3 430.5 73.7 437.9 164.8 83.2 106.6 97.9 99.0 62.9 129.5 251.3 296.6 245.6 66.5 357.2 381.5 371.7 314.3 246.6 228.9 276.0 185.3 479.5 91.2 221.5 311.0 224.3 147.8 113.9 179.3 87.1 96.8 301.5 135.7 106.9 146.5 176.6 250.1 210.1 259.3 425.4 103.9 388.2 186.8 120.3 202.8 189.5 162.3 244.9 162.9 469.0 224.7 189.8 279.6 410.8 214.8 197.1 43.9 187.3 209.6 291.2 243.0 242.2 48.9 50.0 52.1 84.8 48.1 50.1 52.1 50.6 46.0 51.4 51.7 52.3 54.9 153.9 96.1 81.3 17.0 276.3 231.0 196.8 348.4 162.8 44.3 188.3 328.5 99.5 88.6 183.4 126.9 33.3 377.6 142.1 221.5 195.6 210.7 12.9 186.1 197.8 130.0 168.0 154.1 7.6 220.1 353.0 157.9 136.6 232.9 115.9 252.0 83.9 88.0 220.4 35.3 9.5 350.5 219.7 115.1 270.7 21.0 115.5 144.6 140.5 12.2 159.0 104.4 171.0 9.5 19.0 262.0 229.6 90.7 210.1 298.0 215.3 198.0 132.2 62.5 85.5 138.4 168.5 61.4 223.3 257.2 216.4 242.6 164.3 165.5 357.3 236.7 TULP4 "KIAA1397, TUSP" ENSG00000130338 "TUB like protein 4" Q9NRJ4 6 158232236-158511828 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.0" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005445 Approved NA NA "HPA005445: AB_1080421" "unprognostic (6.51e-3)" "unprognostic (1.83e-1)" "unprognostic (2.05e-1)" "unprognostic (1.39e-1)" "unprognostic (3.41e-1)" "unprognostic (9.77e-2)" "unprognostic (6.07e-2)" "unprognostic (1.55e-1)" "unprognostic (2.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.42e-2)" "unprognostic (3.04e-1)" "unprognostic (2.01e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" "unprognostic (9.65e-2)" 2.4 2.5 25.4 2.1 29.0 1.1 3.1 14.8 14.1 2.8 0.0 2.4 4.1 3.0 2.8 3.6 2.1 2.2 2.4 14.2 13.7 3.1 2.3 2.7 3.1 15.7 23.4 6.7 2.5 2.8 5.0 4.6 2.6 23.6 2.4 2.0 7.1 3.1 2.5 6.4 6.1 4.3 2.4 13.6 2.9 3.1 4.0 18.9 3.2 4.7 3.6 3.0 2.4 3.0 21.3 2.7 5.7 4.1 9.1 7.2 4.5 8.6 2.6 3.7 2.4 2.9 8.4 1.7 7.4 2.5 5.3 7.0 4.7 4.9 6.4 4.4 4.8 2.7 3.7 4.2 8.7 5.2 3.4 3.9 3.5 7.3 4.0 8.3 8.7 6.2 7.0 5.8 11.3 6.8 4.1 3.5 3.9 2.8 3.2 2.6 7.4 9.8 4.7 4.0 4.3 7.9 9.8 7.5 11.1 8.0 3.9 6.5 4.5 10.0 6.2 7.4 9.2 10.1 7.7 10.1 6.2 5.9 2.6 7.8 0.3 1.4 0.0 1.8 1.5 2.4 1.8 2.1 2.4 0.9 1.9 1.5 1.7 0.1 1.3 2.1 3.2 2.9 1.6 25.4 29.0 14.8 14.1 14.2 13.7 15.7 23.4 6.7 23.6 13.6 18.9 21.3 27.0 3.2 25.4 62.7 25.8 21.4 16.4 12.3 16.5 51.2 31.3 22.5 52.8 12.8 20.6 25.8 171.0 29.4 25.9 16.5 15.6 18.0 5.3 46.5 51.2 25.7 20.4 7.8 157.3 15.7 8.9 20.0 13.7 51.6 5.1 17.7 16.8 15.2 12.9 158.2 153.4 13.3 8.2 17.9 10.7 8.4 28.3 15.4 16.0 76.8 13.0 16.1 14.4 137.2 544.9 22.5 15.3 41.8 24.7 20.8 53.2 26.0 18.8 79.8 13.1 33.9 26.8 21.8 33.5 19.6 39.2 18.9 21.1 52.4 17.3 23.6 SNX9 "SDP1, SH3PX1, SH3PXD3A" ENSG00000130340 "Sorting nexin 9" Q9Y5X1 6 157700387-157945077 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 251.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 146.6;GAMG: 145.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031410, HPA057203" Approved Supported "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "HPA031410: AB_10603339, HPA057203: AB_2683368" "unprognostic (1.63e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (8.09e-2)" "unprognostic (1.40e-2)" "unprognostic (4.06e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.93e-2)" "unprognostic (4.99e-3)" "unprognostic (4.45e-2)" "unprognostic (2.42e-1)" "prognostic favorable (9.95e-4)" "unprognostic (2.14e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" 53.4 25.4 20.3 25.9 21.5 14.4 41.7 21.8 21.1 38.6 21.8 33.7 33.5 42.1 21.0 58.4 26.5 47.3 33.6 19.5 20.8 26.5 39.3 21.2 24.4 23.0 22.0 19.0 28.3 28.7 38.0 13.5 48.9 22.2 31.2 29.8 2.7 35.4 42.1 24.6 27.3 35.8 41.6 22.0 18.5 37.8 11.1 21.2 14.0 30.0 34.5 21.9 50.2 34.0 23.7 26.0 19.1 18.9 22.1 96.6 78.6 37.7 46.3 146.6 36.4 48.9 16.6 27.6 0.0 25.0 85.6 145.8 18.7 22.7 36.3 21.1 23.9 23.4 17.7 25.7 23.9 48.6 7.6 31.6 51.1 33.9 37.8 37.1 63.9 49.8 23.3 80.9 0.0 15.8 17.2 0.0 15.6 14.4 18.7 21.3 0.0 17.9 32.7 59.7 15.9 11.8 20.9 34.1 16.4 90.5 16.2 6.8 20.0 41.7 41.3 16.6 128.8 30.4 0.0 0.0 0.0 84.8 6.4 25.4 0.0 0.7 0.1 0.4 2.1 1.5 3.2 0.7 0.6 1.4 2.4 5.3 1.2 0.0 0.1 6.8 10.0 2.2 0.6 20.3 21.5 21.8 21.1 19.5 20.8 23.0 22.0 19.0 22.2 22.0 21.2 23.7 71.5 0.0 1.1 40.5 102.6 43.3 109.7 17.3 30.1 15.6 28.7 18.4 28.4 28.6 19.0 9.2 0.0 40.6 37.6 97.7 21.5 57.5 73.4 112.8 53.0 57.9 15.7 17.7 105.4 55.9 41.1 83.0 70.3 251.1 12.0 16.4 37.1 34.3 41.6 3.3 90.4 43.0 8.2 59.0 74.2 26.8 44.7 84.3 21.4 48.7 39.5 11.1 7.2 100.5 161.2 107.0 108.9 46.6 14.9 127.5 52.5 46.2 14.3 1.8 39.5 43.6 49.6 21.9 15.4 22.9 29.8 109.9 48.8 9.1 29.7 137.0 RTN4IP1 NIMP ENSG00000130347 "Reticulon 4 interacting protein 1" Q8WWV3 6 106570771-106629498 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036357 Approved NA NA "HPA036357: AB_10673128" "prognostic unfavorable (9.18e-6)" "unprognostic (5.87e-2)" "unprognostic (2.20e-3)" "unprognostic (2.88e-1)" "unprognostic (3.51e-2)" "unprognostic (3.71e-2)" "unprognostic (7.37e-3)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "unprognostic (3.35e-1)" "unprognostic (2.51e-2)" "unprognostic (1.72e-2)" "prognostic favorable (8.55e-6)" "unprognostic (1.62e-1)" "unprognostic (9.82e-2)" "unprognostic (3.71e-1)" "unprognostic (5.76e-2)" 2.5 6.9 2.9 3.1 3.1 1.8 3.3 3.4 3.9 2.6 3.2 6.1 4.9 2.7 5.5 4.2 2.7 1.7 12.1 2.8 2.8 6.4 7.4 2.0 4.7 2.8 2.7 2.9 2.2 3.2 5.3 4.6 2.2 3.0 2.7 6.1 6.0 4.6 2.8 15.7 2.9 4.5 2.9 2.4 4.2 5.9 5.6 2.8 3.0 4.0 15.5 6.2 2.9 2.9 3.6 7.6 10.8 7.3 12.6 5.9 3.5 8.6 5.0 7.0 7.7 7.4 17.4 4.1 11.6 7.6 6.5 15.1 10.8 13.0 10.7 12.1 8.1 7.4 12.1 8.4 14.0 6.1 12.5 8.1 5.2 8.3 10.3 6.7 4.7 6.9 16.3 21.7 4.7 8.5 11.3 4.7 14.4 9.1 10.7 7.9 16.1 13.3 8.8 12.4 8.1 7.1 5.7 4.7 12.3 11.2 7.5 15.5 8.0 3.6 4.4 6.1 8.8 8.9 3.5 5.7 24.8 11.5 18.1 9.6 0.1 4.6 2.2 3.2 5.1 3.3 11.4 4.4 3.4 10.7 16.0 4.0 3.9 0.8 6.5 3.7 5.6 8.2 3.3 2.9 3.1 3.4 3.9 2.8 2.8 2.8 2.7 2.9 3.0 2.4 2.8 3.6 1.6 0.0 2.8 7.8 8.1 0.8 1.9 6.4 0.6 5.5 2.8 1.7 18.4 4.3 3.1 1.8 8.4 12.5 1.3 5.2 27.4 6.7 8.5 7.6 2.0 2.1 4.2 1.3 15.6 8.6 15.0 2.1 4.1 4.2 2.5 3.6 2.5 5.5 7.3 0.0 17.2 3.0 10.2 5.4 1.8 3.4 0.6 3.6 0.0 8.4 0.9 3.7 1.0 6.6 17.5 4.9 3.0 1.9 4.2 1.2 3.3 14.5 5.4 6.2 13.1 2.1 2.5 11.9 16.7 4.1 1.0 5.6 2.8 5.6 6.4 2.0 QRSL1 "DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA" ENSG00000130348 "Glutaminyl-tRNA amidotransferase subunit QRSL1" Q9H0R6 6 106629578-106668417 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "memory B-cell: 86.4;naive B-cell: 71.0" "Lineage enriched" "Detected in all" 7 "B-cells: 86.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029585, HPA029587" Approved Approved Vesicles,Centrosome NA NA Vesicles Centrosome "HPA029585: AB_10599823, HPA029587: AB_10602311" "unprognostic (1.86e-3)" "unprognostic (5.58e-2)" "unprognostic (6.19e-3)" "unprognostic (3.45e-1)" "unprognostic (2.11e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (8.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.03e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.06e-1)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.46e-1)" 5.0 5.7 4.5 8.7 5.6 6.4 7.4 5.0 5.2 4.7 5.8 8.3 7.9 6.3 6.1 5.7 5.4 4.9 9.9 4.4 4.8 9.4 7.9 4.6 16.0 4.9 5.0 4.2 5.7 6.0 9.4 4.3 5.7 5.2 5.4 9.2 8.5 6.1 5.7 19.6 6.0 8.9 5.9 4.2 10.6 6.7 6.7 4.7 8.3 9.3 21.5 15.6 5.8 4.9 7.8 9.0 9.1 12.3 17.8 7.8 9.7 17.3 10.0 10.2 13.1 13.0 10.7 7.1 29.7 8.9 11.2 13.5 15.5 18.6 12.1 16.4 14.2 14.1 14.5 9.7 11.1 12.2 33.2 12.5 9.6 18.6 14.0 20.6 9.9 9.5 18.4 26.8 9.4 11.0 10.1 10.7 16.1 12.9 15.6 10.5 28.9 15.8 7.5 14.3 10.2 10.7 11.0 8.0 18.4 15.3 10.7 12.1 25.3 9.3 9.2 7.6 10.0 15.7 5.4 8.3 17.2 12.6 22.1 14.0 5.0 6.4 1.0 6.4 9.6 6.3 86.4 7.1 5.6 10.7 71.0 6.6 6.4 1.6 7.0 13.0 8.5 8.5 5.7 4.5 5.6 5.0 5.2 4.4 4.8 4.9 5.0 4.2 5.2 4.2 4.7 7.8 9.0 19.2 12.5 20.2 64.6 4.0 8.4 12.8 6.2 14.9 10.3 6.1 24.8 7.2 9.3 11.0 16.7 21.5 12.3 11.0 17.6 15.4 15.5 28.2 12.0 10.8 17.4 13.7 14.6 18.4 23.0 9.9 15.3 14.8 18.9 15.3 8.2 14.6 12.9 3.3 18.9 11.2 14.2 12.4 6.1 8.4 8.4 10.0 8.8 12.2 18.3 9.9 19.6 22.6 26.5 14.2 8.3 9.1 13.2 9.3 12.2 19.5 19.9 19.1 0.0 10.0 10.0 25.6 14.2 12.2 5.4 12.3 14.3 21.1 18.7 8.9 MTRES1 "C6orf203, HSPC230, PRED31" ENSG00000130349 "Mitochondrial transcription rescue factor 1" Q9P0P8 6 107028199-107051586 "Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 47.4;Cytotrophoblasts: 31.6;Extravillous trophoblasts: 14.3;Hofbauer cells: 24.3;Syncytiotrophoblasts: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049535 Approved NA NA "HPA049535: AB_2680808" "unprognostic (1.34e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (8.11e-2)" "unprognostic (2.71e-2)" "unprognostic (3.44e-2)" "unprognostic (1.89e-2)" "unprognostic (4.24e-2)" "unprognostic (1.05e-2)" "prognostic favorable (3.29e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.09e-5)" "unprognostic (2.64e-1)" "unprognostic (9.98e-2)" "unprognostic (3.19e-2)" "prognostic favorable (2.11e-5)" 14.6 33.4 23.9 8.9 24.2 5.6 12.7 25.5 36.0 10.9 25.7 18.7 17.6 11.5 19.2 14.9 11.2 8.3 29.2 23.9 24.0 25.4 28.9 7.9 11.4 23.9 24.2 23.6 11.3 13.8 14.1 12.2 8.9 24.4 11.2 18.0 12.4 16.2 11.8 42.2 10.9 15.0 10.2 23.6 13.2 15.5 9.6 24.0 10.5 16.5 37.1 12.3 13.4 11.5 24.8 11.6 7.1 21.5 30.5 39.1 33.6 8.9 24.1 19.1 15.7 20.2 4.6 8.7 31.8 17.6 17.5 17.2 16.1 15.4 20.9 21.6 25.9 11.5 19.5 7.0 7.7 26.0 23.0 10.2 24.3 29.2 13.6 19.6 21.1 22.3 24.5 22.7 23.8 33.5 15.9 10.5 34.3 10.3 36.9 12.0 19.0 17.8 14.7 41.0 16.2 13.6 14.1 11.9 15.6 22.5 16.0 12.6 40.7 17.4 10.6 10.3 13.4 13.0 5.0 7.8 17.2 18.5 35.6 22.7 1.4 14.9 14.2 16.0 15.9 16.7 20.6 18.4 17.8 21.1 19.6 25.0 21.8 1.7 20.3 14.6 21.0 26.5 13.6 23.9 24.2 25.5 36.0 23.9 24.0 23.9 24.2 23.6 24.4 23.6 24.0 24.8 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 31.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 14.3 5.6 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 18.2 0.2 0.0 0.0 0.0 RSPH3 "dJ111C20.1, RSHL2, RSP3" ENSG00000130363 "Radial spoke head 3" 6 158972871-159000202 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 149.3;Respiratory ciliated cells: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 10.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039109 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA039109: AB_10794423" "unprognostic (6.18e-3)" "unprognostic (3.62e-3)" "unprognostic (4.54e-2)" "unprognostic (6.20e-2)" "unprognostic (1.88e-1)" "unprognostic (9.18e-2)" "unprognostic (1.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.15e-1)" "unprognostic (6.74e-3)" "unprognostic (6.98e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (5.89e-2)" "unprognostic (1.67e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" 2.9 4.7 2.4 2.2 1.3 1.7 3.7 0.9 4.8 3.9 11.8 4.2 5.9 3.5 4.6 5.8 6.2 3.3 3.8 2.2 2.8 6.4 2.7 4.6 1.4 1.7 2.1 0.5 3.5 4.4 13.3 3.5 3.1 1.3 5.3 3.7 6.7 4.5 4.1 1.5 3.9 5.6 3.7 2.2 2.3 4.1 10.0 1.3 1.8 7.6 2.3 2.0 2.9 3.1 1.6 8.5 3.7 2.1 4.9 4.8 6.3 2.2 6.2 7.0 1.9 2.8 1.2 4.6 1.7 4.8 7.2 6.3 6.1 1.4 5.6 2.8 4.4 2.9 2.2 3.9 2.6 4.6 2.4 1.6 7.1 9.5 3.8 6.9 10.0 2.5 2.5 2.8 2.6 4.5 4.3 1.5 2.7 1.2 3.8 2.7 2.2 0.3 1.6 8.6 2.6 2.8 4.0 11.6 3.8 2.2 2.4 4.7 5.3 5.4 2.0 5.5 4.8 3.0 2.9 6.1 1.2 10.1 2.9 3.9 0.9 4.0 0.6 0.6 3.0 1.2 0.9 0.9 1.2 4.0 2.4 0.7 1.1 10.5 1.7 7.0 4.6 1.3 1.5 2.4 1.3 0.9 4.8 2.2 2.8 1.7 2.1 0.5 1.3 2.2 1.3 1.6 2.3 25.6 17.9 15.0 4.0 7.4 17.2 19.1 6.2 14.2 12.2 7.6 17.5 17.2 25.1 22.0 35.5 10.3 5.7 25.6 13.7 15.8 149.3 67.0 6.9 6.0 13.1 2.1 32.8 10.2 11.4 7.6 10.2 12.7 2.5 9.2 7.9 8.4 10.1 3.3 18.5 17.6 16.2 9.5 16.5 62.9 14.0 12.6 7.2 4.7 8.3 14.4 4.1 6.0 3.5 13.1 21.1 17.7 5.7 18.4 33.1 19.7 120.4 32.5 6.6 5.9 10.2 57.3 10.9 18.6 8.8 5.9 6.1 12.2 13.1 23.1 MAS1 ENSG00000130368 "MAS1 proto-oncogene, G protein-coupled receptor" P04201 6 159890988-159917447 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "brain: 8.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 5.2;hippocampal formation: 8.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HMC-1: 7.5" "Group enriched" "Detected in many" 22 "amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1" "Group enriched" "Detected in some" 4 "amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1" HPA079325 Uncertain NA NA "HPA079325: " "unprognostic (3.31e-1)" "unprognostic (2.25e-3)" "unprognostic (2.91e-1)" "unprognostic (2.22e-3)" "unprognostic (8.15e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (6.52e-2)" "unprognostic (1.48e-5)" "unprognostic (1.69e-1)" "unprognostic (7.67e-2)" "unprognostic (6.28e-1)" 0.0 0.0 1.6 0.0 0.7 0.3 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.0 5.2 8.4 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.6 0.3 3.2 0.6 0.0 2.0 0.0 1.4 0.0 0.0 1.2 0.1 0.3 0.8 0.0 0.6 0.0 2.1 0.2 0.2 0.0 0.0 0.0 0.1 0.4 0.3 0.8 0.0 0.0 0.1 0.0 0.3 0.7 0.0 0.3 0.0 0.4 1.1 0.4 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.7 0.0 0.0 0.5 0.7 1.0 0.0 0.0 0.1 0.0 0.7 0.0 1.4 0.0 0.3 0.0 2.1 0.0 1.3 1.0 0.4 0.5 0.0 0.0 0.3 0.5 0.2 0.2 1.9 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "testis: 130.5" "Group enriched" "Detected in some" 75 "Early spermatids: 533.6;Late spermatids: 1782.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Supported Cytosol NA NA Cytosol "HPA043421: AB_10794182, HPA051013: AB_2681311" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 130.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.2 0.3 0.1 0.7 0.2 0.0 0.5 0.2 0.2 1.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 533.6 0.0 0.1 0.6 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 1782.3 11.8 0.8 0.0 1.9 0.0 0.0 0.0 1.5 3.1 0.0 0.0 7.2 0.0 0.0 0.0 1.9 0.0 0.0 6.6 0.0 0.1 15.4 9.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 MLLT1 "ENL, LTG19, YEATS1" ENSG00000130382 "MLLT1 super elongation complex subunit" Q03111 19 6210381-6279975 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 570.1;Syncytiotrophoblasts: 1138.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031166 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA031166: AB_10601874" "unprognostic (3.21e-1)" "unprognostic (2.75e-3)" "unprognostic (4.84e-2)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "prognostic favorable (6.03e-5)" "unprognostic (1.30e-3)" "unprognostic (1.44e-2)" "unprognostic (1.56e-1)" "unprognostic (1.98e-1)" "unprognostic (3.93e-3)" "unprognostic (4.76e-2)" "unprognostic (3.65e-3)" "unprognostic (1.14e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.99e-3)" 28.3 22.6 31.4 16.6 29.2 8.8 26.6 29.6 36.6 40.0 23.4 34.4 12.3 40.8 13.4 25.8 43.0 9.9 33.0 34.6 23.9 25.6 37.8 33.8 11.0 24.4 26.0 24.4 48.1 27.1 21.1 29.1 42.9 26.0 41.2 5.6 13.6 24.2 15.8 35.0 30.3 24.5 13.4 17.9 27.2 30.2 16.9 26.8 12.0 37.1 12.8 7.6 37.7 29.0 25.5 49.5 23.8 28.7 34.1 22.0 19.0 33.3 29.9 19.3 24.7 25.1 39.5 16.2 35.6 38.1 39.4 27.6 30.2 22.9 29.4 14.6 30.2 35.9 44.3 66.0 30.1 42.2 29.0 39.0 30.7 25.2 23.6 19.1 27.1 28.2 31.5 43.6 40.4 16.4 27.1 49.8 27.8 35.0 24.6 49.5 42.3 21.4 28.7 13.4 30.1 49.7 45.2 30.9 33.8 37.8 14.1 30.6 34.1 29.8 34.3 26.5 53.7 41.8 49.1 41.0 28.0 39.6 49.3 49.9 0.1 0.8 0.2 0.7 1.2 0.9 0.5 0.4 0.7 0.6 0.5 0.4 0.5 2.0 0.8 1.5 2.0 0.2 0.7 31.4 29.2 29.6 36.6 34.6 23.9 24.4 26.0 24.4 26.0 17.9 26.8 25.5 20.5 22.4 32.7 12.1 5.2 0.1 13.2 0.0 2.8 29.8 13.6 13.5 23.4 5.7 8.6 12.9 18.8 570.1 11.1 5.8 7.9 12.6 27.5 34.8 21.7 21.7 4.9 1.3 10.8 16.6 38.6 14.8 13.3 14.5 10.1 16.2 23.6 18.9 60.9 58.9 13.3 9.9 0.0 15.6 0.0 57.8 19.0 12.1 0.0 11.2 13.2 35.6 10.3 8.0 16.7 13.0 3.6 18.4 8.6 17.8 8.4 6.9 4.4 15.8 26.3 20.7 11.0 10.6 5.7 7.2 0.1 1138.2 5.8 19.5 9.6 14.7 FUT5 FUC-TV ENSG00000130383 "Fucosyltransferase 5" Q11128 19 5865826-5870540 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.1" HPA046966 Uncertain NA NA "HPA046966: AB_2679879" "unprognostic (7.72e-2)" "unprognostic (3.59e-1)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 BMP15 GDF9B ENSG00000130385 "Bone morphogenetic protein 15" O95972 X 50910735-50916641 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Disease variant, Premature ovarian failure" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924" "prognostic unfavorable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 38.5 15.2 27.7 23.3 32.1 5.5 50.0 26.0 27.2 37.6 32.4 55.8 53.6 36.2 40.1 127.3 64.3 33.9 37.6 21.1 21.9 45.4 67.4 57.5 11.0 29.2 29.5 15.3 31.5 61.7 33.1 38.6 45.2 39.8 47.5 63.3 47.5 79.6 28.9 34.3 54.6 71.7 24.1 15.1 34.5 51.1 31.6 26.9 7.4 51.9 28.7 27.5 29.5 62.3 35.7 67.7 20.7 141.2 50.8 13.5 11.3 104.8 26.8 13.7 22.7 27.9 88.8 41.1 12.0 48.3 16.3 35.5 31.8 59.2 55.1 40.3 76.1 61.1 0.4 9.1 67.9 20.3 7.7 30.8 8.0 36.2 38.1 89.0 36.1 42.8 25.6 137.4 45.5 14.9 29.2 0.8 0.6 34.7 95.6 9.5 43.6 37.1 51.2 41.3 32.5 65.1 39.6 27.2 101.7 40.5 131.1 12.2 2.8 62.9 10.6 50.5 45.7 44.9 0.8 59.3 24.5 31.4 15.4 93.7 0.0 0.1 0.0 0.3 0.1 0.2 1.1 0.3 0.1 0.2 0.7 0.0 0.1 0.9 0.0 0.1 0.0 0.2 0.0 27.7 32.1 26.0 27.2 21.1 21.9 29.2 29.5 15.3 39.8 15.1 26.9 35.7 173.8 169.9 89.3 0.0 6.4 0.0 0.0 0.0 0.0 0.0 119.1 83.3 0.0 0.0 40.9 95.6 0.0 30.6 4.7 0.0 21.5 70.1 0.0 194.3 42.0 36.3 0.0 0.0 0.0 39.4 35.0 20.5 0.0 273.4 8.8 65.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 10.9 0.0 0.0 0.0 0.0 65.7 0.0 0.0 4.5 0.0 0.0 35.0 46.7 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 42.1 5.6 13.2 0.0 0.0 ACTN4 FSGS1 ENSG00000130402 "Actinin alpha 4" O43707 19 38647649-38731589 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 626.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 947.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001873, HPA006035" Supported Approved "Nuclear bodies,Actin filaments,Cytosol" NA NA 71000000 "Nuclear bodies, Actin filaments" Cytosol "HPA001873: AB_1078096, HPA006035: AB_1078095" "unprognostic (1.03e-1)" "unprognostic (6.34e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-2)" "unprognostic (2.37e-1)" "unprognostic (3.34e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.70e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.99e-1)" "prognostic favorable (5.25e-5)" "unprognostic (6.59e-2)" "unprognostic (1.91e-1)" "unprognostic (6.75e-3)" "unprognostic (6.52e-2)" 168.3 162.1 22.7 64.4 34.9 74.9 152.7 39.1 35.0 141.7 53.7 148.7 129.9 271.6 11.9 234.7 164.7 47.2 89.1 15.3 39.5 166.4 85.7 176.2 37.8 41.7 38.7 15.2 103.4 91.4 42.6 80.6 86.4 39.5 116.6 42.6 26.2 149.3 59.6 52.7 178.6 151.5 73.8 32.1 119.0 121.9 23.8 37.1 18.7 106.3 19.0 24.4 151.5 182.8 59.1 364.6 947.0 92.9 48.6 37.7 50.6 237.2 198.7 162.5 178.8 143.9 335.9 265.1 99.0 409.1 260.6 117.4 185.1 57.4 203.8 38.3 238.3 69.5 139.7 356.1 240.4 103.4 101.7 145.2 95.3 63.4 157.5 79.6 146.9 116.4 26.3 165.0 71.8 127.5 221.2 27.2 44.1 78.4 197.8 177.3 89.5 109.4 43.8 174.6 396.3 83.0 49.8 366.3 210.5 94.7 64.0 94.5 78.8 309.7 249.3 138.7 135.3 476.1 44.1 84.5 67.8 231.7 90.6 476.7 7.6 8.1 17.8 13.2 7.7 9.8 3.2 5.7 13.2 7.0 3.0 0.9 4.4 16.9 24.8 6.7 10.8 9.5 10.6 22.7 34.9 39.1 35.0 15.3 39.5 41.7 38.7 15.2 39.5 32.1 37.1 59.1 315.2 179.5 120.0 21.5 45.8 234.8 266.4 155.1 153.7 25.6 134.0 148.1 9.2 143.0 119.4 152.6 14.6 123.7 150.7 626.1 19.6 413.5 2.5 272.0 145.7 206.2 162.0 59.3 46.0 419.3 256.7 77.3 219.7 346.4 73.5 75.9 130.6 108.5 72.6 23.5 22.6 365.5 73.2 65.9 103.7 4.5 41.3 75.4 46.2 48.7 162.2 122.4 120.5 35.2 83.6 532.3 425.2 71.5 91.2 322.1 315.5 104.0 122.1 32.3 190.7 97.2 251.0 36.2 23.7 189.3 202.7 168.0 119.4 115.3 280.6 284.7 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 52.3" "Cell type enhanced" "Detected in many" "Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.1;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Cell line enhanced" "Detected in many" "Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.8 8.2 11.1 2.0 6.4 1.3 0.5 9.9 5.8 4.7 42.1 6.1 3.4 12.1 11.4 2.8 42.6 5.2 16.3 5.5 14.6 10.3 0.4 7.2 2.0 12.3 14.0 3.2 13.5 6.6 23.3 24.3 0.1 12.8 6.4 1.5 15.8 2.2 11.6 4.0 0.2 3.5 9.4 13.9 1.6 6.0 52.3 9.7 3.8 20.2 6.0 2.3 3.4 1.7 7.9 0.0 3.4 15.4 0.0 0.0 0.0 0.0 3.0 3.1 7.0 6.2 2.2 0.0 23.0 11.5 0.6 8.7 0.0 6.9 2.5 6.0 0.0 18.9 0.0 4.2 5.6 2.5 13.4 0.0 1.1 0.0 0.2 0.0 22.0 0.5 11.2 0.0 21.2 0.3 0.0 0.4 0.0 11.2 0.0 0.0 8.8 2.2 14.3 6.1 0.0 22.9 6.2 0.0 0.0 0.1 4.3 0.0 1.3 0.0 0.0 10.6 0.2 24.3 5.1 21.2 0.3 6.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.7 0.0 2.2 0.0 0.6 0.0 0.1 0.0 0.4 0.1 0.2 11.1 6.4 9.9 5.8 5.5 14.6 12.3 14.0 3.2 12.8 13.9 9.7 7.9 0.1 19.2 14.5 213.8 6.2 0.0 1.3 1.9 0.0 20.7 0.1 0.3 37.8 8.6 27.5 20.2 70.9 0.1 1.4 0.2 3.9 9.5 98.8 220.9 5.5 1.8 9.1 1.7 12.0 4.9 3.3 5.0 6.1 17.8 1.3 29.3 0.4 0.0 0.3 1.7 15.4 1.6 6.1 0.0 0.0 157.0 4.4 0.6 0.0 23.4 0.0 31.0 0.0 117.6 19.7 4.4 0.4 17.0 5.2 0.5 3.6 13.5 155.3 77.4 0.0 0.2 2.7 148.3 26.8 0.2 0.0 0.0 1.3 6.3 3.5 0.0 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025743 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 335.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756" "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favorable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 55.9 91.9 36.1 29.9 39.7 50.7 50.8 38.3 51.6 38.1 37.0 84.0 82.4 38.1 28.6 75.2 44.0 31.5 179.0 40.1 37.4 95.1 104.4 35.7 32.5 40.7 39.3 39.5 45.8 59.0 100.2 38.8 38.2 40.6 33.4 85.1 31.5 56.4 33.4 208.3 72.9 64.8 40.1 32.8 38.0 72.3 35.6 38.1 45.7 39.1 335.0 50.1 47.8 49.6 41.0 74.4 65.5 46.3 81.5 54.8 95.4 75.5 49.0 70.9 71.3 77.8 72.8 82.8 51.0 31.8 64.2 60.8 96.2 109.8 103.1 92.6 59.7 90.9 72.9 65.6 174.6 72.4 96.9 58.6 95.5 80.3 68.5 85.0 66.6 96.6 74.6 102.0 34.8 81.8 124.8 95.6 110.5 56.3 114.4 81.0 93.2 114.4 81.2 108.7 152.1 70.5 54.6 55.3 131.8 108.9 33.3 121.2 97.4 69.9 52.7 60.7 70.7 75.8 77.3 24.6 79.2 60.3 80.9 72.8 30.2 106.3 47.1 72.9 115.8 93.8 95.4 70.7 77.5 147.9 77.0 68.2 69.4 26.7 97.6 103.3 49.7 92.7 104.6 36.1 39.7 38.3 51.6 40.1 37.4 40.7 39.3 39.5 40.6 32.8 38.1 41.0 66.8 76.9 74.1 31.6 63.5 104.9 96.5 193.5 60.3 80.8 88.4 89.5 354.8 87.2 114.0 77.3 62.6 216.4 58.1 137.3 311.0 112.5 47.5 66.8 83.2 67.4 92.9 57.6 83.1 78.5 124.0 71.7 62.2 76.6 65.9 103.7 66.4 139.1 125.2 50.5 68.5 152.3 103.7 90.5 82.0 85.3 50.1 65.2 112.1 27.2 107.8 72.2 53.5 37.7 71.4 77.7 125.5 49.2 56.7 62.1 182.7 303.0 77.7 110.4 65.7 74.6 77.3 84.2 73.4 107.2 118.9 218.1 63.0 185.3 234.2 110.0 EPO EP ENSG00000130427 Erythropoietin P01588 7 100720468-100723700 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Erythrocyte maturation" Hormone "Cancer-related genes, Congenital erythrocytosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 47.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 2.9;Exocrine glandular cells: 4.2;Extravillous trophoblasts: 14.0;Hepatocytes: 19.5;Pancreatic endocrine cells: 3.7;Syncytiotrophoblasts: 2.9" "Group enriched" "Detected in many" 5 "liver cancer: 2.7;renal cancer: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 1.6;Hep G2: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB010336 Supported "Secreted to blood" NA NA 12300 "CAB010336: AB_2098408" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (1.08e-3)" "unprognostic (7.30e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.52e-2)" "unprognostic (5.16e-2)" "unprognostic (9.70e-2)" "unprognostic (2.44e-3)" "unprognostic (3.31e-1)" "prognostic unfavorable (2.18e-6)" "unprognostic (4.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.59e-2)" "unprognostic (3.34e-1)" 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.3 3.0 0.1 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.2 0.1 0.3 3.0 47.6 0.1 0.0 0.2 0.1 0.2 0.2 8.4 0.0 0.0 0.1 0.2 0.5 0.0 0.2 1.4 0.5 0.0 0.4 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 4.2 14.0 0.0 0.0 0.0 0.0 0.1 1.4 19.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 2.9 0.0 0.0 0.0 0.0 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394816 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 319.9" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 948.7;Hofbauer cells: 1088.1;Kupffer cells: 1035.5;monocytes: 1029.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 899.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Enhanced Supported Vesicles,Cytosol NA NA 13000000 "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 125.7 72.2 17.8 174.9 19.2 211.6 99.9 18.8 26.1 66.0 25.4 91.7 107.6 71.6 14.3 52.0 74.5 49.4 70.5 15.9 28.8 83.7 82.4 171.0 203.8 23.8 19.8 13.8 30.3 51.8 14.4 52.8 66.9 22.9 67.9 32.8 1.1 73.0 30.3 18.8 42.6 161.6 39.7 23.4 319.9 66.8 20.6 27.7 62.8 90.9 19.7 96.3 85.8 58.0 26.7 124.3 219.3 16.1 47.5 62.9 225.0 167.9 165.8 170.5 68.7 60.5 146.3 477.8 215.4 308.2 188.5 146.9 93.1 22.4 152.5 27.5 175.5 59.9 157.0 61.6 98.4 179.7 159.5 515.8 125.7 77.3 96.2 94.3 134.6 181.5 113.3 177.9 508.0 100.2 574.5 158.8 332.5 59.6 148.9 435.5 139.5 14.6 536.2 141.2 59.7 13.2 42.1 116.4 506.3 899.5 54.4 119.7 322.4 262.0 190.1 155.8 339.0 216.6 91.4 190.1 263.5 189.9 411.0 350.4 1026.1 2400.1 1973.2 770.3 2458.8 723.9 786.7 883.0 857.2 2054.4 699.1 510.2 680.0 1963.4 633.5 2382.6 1172.9 1315.9 4198.2 17.8 19.2 18.8 26.1 15.9 28.8 23.8 19.8 13.8 22.9 23.4 27.7 26.7 182.2 41.7 86.6 1.0 279.2 60.5 141.3 587.9 58.1 9.6 50.8 34.3 9.1 107.2 260.2 130.6 8.4 588.4 416.3 264.9 25.4 407.1 3.2 37.7 37.2 265.5 112.7 84.9 3.2 414.5 948.7 99.7 62.7 41.3 192.2 31.0 226.3 54.5 1088.1 1.7 2.3 97.6 203.4 1035.5 422.8 8.4 37.3 789.1 179.7 28.1 1029.7 21.4 498.5 0.5 1.6 405.1 268.7 18.0 154.0 132.4 516.0 110.9 214.0 14.7 92.1 29.5 238.5 2.7 15.5 26.3 37.1 303.2 324.4 20.4 161.1 187.6 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53991637-54012666 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skeletal muscle: 91.5;tongue: 30.2" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 107 "basophil: 13.3;eosinophil: 8.0" "Lineage enriched" "Detected in single" 133 "granulocytes: 13.3" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 23.6;HHSteC: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.9 0.1 0.5 0.0 0.0 0.4 1.0 0.2 0.2 0.1 0.2 0.2 0.0 0.3 8.8 0.0 0.0 0.6 0.8 0.0 0.0 2.2 0.0 0.8 1.1 0.2 0.0 0.0 2.9 1.9 0.0 0.8 0.4 0.0 0.2 1.0 0.0 91.5 0.0 0.2 0.0 1.2 0.1 0.3 2.4 0.4 0.0 0.0 30.2 0.1 0.0 0.0 0.5 0.0 12.7 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 23.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.6 0.0 0.1 0.1 0.0 0.0 0.0 1.9 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.1 1.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.2 0.0 2.8 0.0 0.0 0.0 3.5 0.1 0.2 0.0 0.0 13.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.4 1.0 0.6 0.8 0.8 1.1 0.2 0.8 1.2 0.4 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.1 0.0 0.0 2.3 0.1 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSWIM6 KIAA1577 ENSG00000130449 "Zinc finger SWIM-type containing 6" Q9HCJ5 5 61332258-61546172 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 500.1;Microglial cells: 365.4;Oligodendrocyte precursor cells: 765.6;Oligodendrocytes: 740.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035938 Uncertain Approved Cytosol NA NA Cytosol "HPA035938: AB_10672077" "unprognostic (2.22e-1)" "unprognostic (2.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.10e-1)" "unprognostic (2.70e-1)" "unprognostic (6.69e-2)" "unprognostic (2.00e-1)" "unprognostic (6.96e-3)" "unprognostic (6.16e-2)" "unprognostic (1.40e-2)" "unprognostic (2.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.68e-2)" "unprognostic (7.50e-3)" "unprognostic (1.11e-1)" "unprognostic (3.63e-1)" "unprognostic (1.99e-1)" 8.1 5.5 10.8 9.0 18.1 3.9 5.9 13.2 13.9 6.3 5.6 9.6 6.0 5.1 5.5 8.8 6.4 9.6 4.6 10.9 19.9 5.2 7.9 13.5 5.7 14.4 14.1 9.6 7.3 7.7 5.9 6.4 7.9 15.4 8.4 10.8 8.4 6.9 6.4 3.5 5.3 7.6 6.3 12.6 7.1 10.1 7.5 14.2 6.9 6.6 2.6 5.1 7.6 8.4 27.1 6.0 7.8 35.4 2.5 7.5 13.6 3.0 7.9 7.1 8.6 13.2 3.1 9.4 1.5 6.7 9.9 13.7 5.1 7.9 9.6 12.0 25.0 7.4 2.9 16.3 1.7 9.9 1.9 4.1 9.9 7.0 20.2 17.2 11.8 21.3 3.3 0.9 29.3 35.4 4.3 1.6 3.8 5.4 1.8 5.8 11.8 10.3 44.4 14.1 7.7 7.2 11.3 18.7 1.1 7.3 13.7 3.1 7.7 29.8 7.1 9.2 9.9 11.4 5.1 0.8 3.2 11.0 2.3 15.4 0.9 1.1 0.5 0.0 0.9 0.3 0.2 0.1 0.1 0.5 0.3 0.1 0.1 1.6 0.4 1.3 1.3 0.1 0.2 10.8 18.1 13.2 13.9 10.9 19.9 14.4 14.1 9.6 15.4 12.6 14.2 27.1 24.5 25.6 12.6 500.1 13.3 47.4 80.2 12.0 42.1 6.9 25.8 20.4 12.2 25.8 27.1 11.0 10.4 0.4 29.5 38.4 1.9 12.0 12.7 47.4 37.4 23.6 14.2 1.7 223.4 12.9 0.5 22.7 28.1 86.1 14.5 9.6 27.8 8.0 25.9 8.4 167.7 25.8 14.2 59.3 49.0 8.5 5.6 53.3 16.0 365.4 34.0 15.6 2.1 765.6 740.4 19.2 30.2 6.4 14.3 40.6 9.4 4.9 28.8 5.1 6.6 19.5 22.7 18.9 18.8 32.2 39.9 1.4 15.7 27.1 19.8 58.3 FCHO1 KIAA0290 ENSG00000130475 "FCH and mu domain containing endocytic adaptor 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.8;lymphoid tissue: 24.5" "Cell type enhanced" "Detected in many" "B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: AB_2684915" "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 1.8 1.9 22.3 14.8 31.3 20.4 1.5 19.0 28.4 0.9 9.7 2.5 3.3 1.3 1.4 1.1 1.5 4.3 0.8 21.5 22.1 0.9 2.2 3.8 24.5 27.3 26.7 18.7 1.7 0.7 1.1 3.9 1.1 29.6 1.1 2.3 3.4 1.4 0.8 0.7 20.0 8.1 1.7 17.9 15.6 3.4 4.4 27.6 17.8 1.0 0.8 17.6 3.1 1.0 57.8 0.9 11.9 7.5 5.2 0.2 0.2 7.5 1.1 0.3 0.3 0.5 1.5 1.4 62.4 17.1 0.5 1.4 2.3 3.7 2.3 0.2 27.6 2.1 4.9 1.4 6.4 0.6 15.7 10.2 0.1 0.3 0.0 0.4 0.4 1.6 30.2 24.9 28.9 0.0 17.4 36.2 27.8 3.6 14.7 28.7 30.2 0.2 43.3 0.2 1.2 1.3 2.5 0.3 5.9 0.9 0.9 6.0 15.4 1.3 0.1 4.1 0.9 0.4 18.2 9.0 33.4 0.9 38.5 0.5 13.2 9.6 10.1 7.0 14.3 6.0 12.4 7.9 6.3 14.5 12.3 7.4 6.1 37.8 6.4 11.5 15.3 7.6 7.4 22.3 31.3 19.0 28.4 21.5 22.1 27.3 26.7 18.7 29.6 17.9 27.6 57.8 0.4 0.0 1.5 0.7 16.8 0.0 0.4 0.2 0.6 7.8 2.0 4.3 0.9 2.8 0.4 1.8 0.0 2.9 19.1 2.0 0.0 0.5 1.5 0.8 0.2 2.4 1.2 2.5 15.0 0.0 4.6 2.5 1.5 1.0 9.5 2.9 2.5 0.0 6.8 0.0 13.0 1.7 0.0 8.7 14.3 0.7 2.5 11.0 1.8 6.5 12.3 0.1 13.4 3.0 46.9 2.1 0.5 8.6 4.5 0.3 0.1 0.1 0.7 0.8 0.0 0.2 0.6 0.9 5.5 0.2 0.6 0.8 9.8 12.2 1.8 0.3 UNC13A "KIAA1032, Munc13-1" ENSG00000130477 "Unc-13 homolog A" Q9UPW8 19 17601328-17688365 "Predicted intracellular proteins" "Differentiation, Exocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 26.2;pituitary gland: 32.5;retina: 19.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 43.9;Cone photoreceptor cells: 54.2;Excitatory neurons: 85.3;Horizontal cells: 119.5;Inhibitory neurons: 67.0" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 16.2;NTERA-2: 23.7;SCLC-21H: 38.9;SH-SY5Y: 9.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (4.96e-3)" "unprognostic (1.69e-1)" "unprognostic (3.98e-3)" "unprognostic (2.13e-3)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.89e-1)" "unprognostic (4.33e-3)" "unprognostic (1.40e-2)" "unprognostic (8.19e-3)" "unprognostic (1.94e-1)" "unprognostic (4.83e-2)" "unprognostic (2.14e-2)" "unprognostic (2.00e-1)" 0.1 2.6 5.8 0.4 16.6 0.0 0.0 0.0 26.2 0.3 0.0 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.0 17.9 10.0 0.3 0.0 0.2 0.3 1.8 1.2 20.8 0.2 1.4 0.1 32.5 0.2 5.9 0.1 0.2 19.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 2.0 0.8 0.7 1.6 0.1 0.2 0.0 0.3 0.1 0.1 10.9 0.0 2.4 2.0 0.4 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 2.4 0.6 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 16.2 0.0 0.0 0.0 1.5 0.4 0.0 0.1 2.0 0.1 0.0 0.2 0.0 0.0 23.7 0.2 0.6 0.6 0.0 0.3 0.0 0.0 38.9 9.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 16.6 0.0 26.2 17.9 10.0 1.8 1.2 20.8 5.9 0.0 1.6 10.9 0.2 0.0 0.0 6.5 0.0 0.3 0.3 0.1 0.0 43.9 0.1 0.3 2.1 0.0 0.0 0.0 54.2 0.0 0.2 0.3 0.0 1.5 0.0 0.1 0.2 1.0 8.4 0.0 85.3 0.2 0.0 1.5 0.0 0.5 0.0 0.4 0.0 0.0 0.2 119.5 67.0 0.0 2.0 0.0 0.3 0.1 0.0 0.2 0.0 3.7 1.6 3.3 0.0 18.1 2.8 1.1 0.0 1.5 0.0 0.4 0.0 0.1 0.0 22.7 0.0 0.6 0.6 0.2 1.8 0.0 0.0 0.0 0.0 1.8 0.5 0.3 MAP1S "BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1" ENSG00000130479 "Microtubule associated protein 1S" Q66K74 19 17719242-17734513 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.6" "Group enriched" "Detected in all" 4 "Early spermatids: 98.1;Late spermatids: 293.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050934, HPA054637" Approved Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Cell Junctions" "HPA050934: AB_2681281, HPA054637: AB_2682552" "unprognostic (8.47e-2)" "unprognostic (2.39e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.70e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (2.53e-1)" "unprognostic (6.17e-2)" "unprognostic (4.39e-2)" "prognostic favorable (2.65e-4)" "unprognostic (6.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (8.65e-2)" 20.2 14.0 36.4 8.8 37.2 11.3 19.3 25.3 83.6 18.2 19.2 20.3 7.8 25.0 5.4 12.0 19.3 8.0 17.4 38.5 28.9 15.5 12.5 23.7 9.1 33.6 30.8 38.7 21.7 15.7 5.5 22.2 9.8 33.0 17.5 2.4 2.8 19.9 6.6 32.7 11.9 17.9 3.7 28.5 18.5 20.2 75.3 29.7 6.2 16.2 5.4 4.0 21.8 14.7 35.6 30.1 43.2 12.4 16.9 10.4 15.4 34.0 18.3 8.8 10.9 12.3 61.3 16.0 17.3 33.8 11.4 12.8 15.3 10.5 14.5 4.6 21.8 61.1 15.1 36.3 39.2 22.1 16.8 20.9 16.7 8.3 16.7 10.5 7.9 22.6 12.5 24.2 9.5 6.0 39.0 20.8 42.0 28.7 17.1 50.8 33.3 10.2 17.5 14.8 43.4 23.0 26.5 10.7 14.8 18.9 9.0 9.9 17.8 37.3 19.7 18.2 40.7 27.2 18.1 23.3 17.4 23.7 26.7 25.1 18.5 22.6 25.9 15.7 22.2 15.1 15.7 12.3 15.6 25.9 15.5 10.1 13.9 31.4 13.0 17.9 21.2 12.2 19.0 36.4 37.2 25.3 83.6 38.5 28.9 33.6 30.8 38.7 33.0 28.5 29.7 35.6 11.1 3.2 7.5 4.2 14.7 10.3 14.0 13.1 13.1 11.1 12.3 8.6 5.5 15.7 12.1 3.7 8.4 21.7 14.0 30.9 3.9 22.2 98.1 12.9 11.5 18.5 20.4 3.8 8.4 17.2 16.9 12.3 19.4 26.9 10.2 12.0 20.7 4.8 26.1 40.4 5.5 16.6 12.2 18.7 25.1 293.2 22.4 20.7 1.8 2.8 17.4 8.1 8.2 4.5 7.1 24.2 15.8 31.6 8.8 14.9 19.0 5.9 6.2 6.3 13.1 7.7 13.0 25.9 21.4 5.4 3.3 33.8 11.3 8.1 18.3 13.7 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50545899-50551023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.2;parathyroid gland: 13.8" "Cell type enhanced" "Detected in some" "B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7" "Group enriched" "Detected in many" 4 "cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HMC-1: 97.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favorable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.2 0.2 0.1 2.1 0.2 1.1 0.3 0.1 0.1 0.5 0.1 0.3 0.4 0.2 0.3 0.4 0.1 0.3 0.0 0.2 0.3 3.6 0.4 0.7 2.3 0.3 0.2 0.1 0.0 0.1 13.8 1.0 0.1 0.2 0.4 0.1 0.0 1.3 0.2 0.0 0.3 1.1 0.1 0.2 2.7 0.5 0.2 0.3 5.2 2.0 0.0 1.3 1.6 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.8 0.0 0.8 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.0 0.2 97.7 0.1 1.2 0.0 0.2 0.1 0.0 0.0 0.0 11.6 0.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.3 0.0 0.1 1.1 1.1 0.1 2.0 1.9 1.4 1.9 2.1 2.6 0.9 1.3 2.3 2.0 0.2 0.7 1.4 0.3 2.0 1.5 0.1 0.2 0.1 0.1 0.2 0.3 0.3 0.2 0.1 0.2 0.2 0.3 0.3 0.0 0.0 0.6 0.0 5.2 0.1 0.0 1.6 0.0 0.0 3.0 1.4 0.5 0.0 1.6 5.5 0.0 0.0 2.5 0.1 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.7 0.1 0.2 0.5 0.3 5.7 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 5.2 1.2 0.0 0.0 2.7 0.0 0.0 21.1 0.0 10.3 0.0 0.0 1.3 0.0 0.0 2.8 0.1 0.0 0.3 1.6 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.2 PXDN "D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN" ENSG00000130508 Peroxidasin Q92626 2 1631887-1744852 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 79.1;Endometrial stromal cells: 99.4;Endothelial cells: 95.1;Hepatic stellate cells: 71.4;Skeletal myocytes: 120.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 323.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA012375 Approved "Secreted to extracellular matrix" NA NA 9100000 "HPA012375: AB_1855965" "unprognostic (4.37e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (8.16e-3)" "unprognostic (1.91e-1)" "unprognostic (1.92e-2)" "unprognostic (3.15e-3)" "unprognostic (6.50e-3)" "unprognostic (1.34e-2)" "unprognostic (6.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.18e-1)" "unprognostic (7.33e-3)" "unprognostic (5.54e-3)" 60.0 5.6 3.9 24.5 3.0 0.9 34.0 1.9 4.3 17.2 23.3 28.9 7.9 33.1 4.1 5.0 18.1 22.9 21.7 2.9 6.6 8.9 12.5 27.8 5.1 4.0 4.1 1.8 33.0 3.8 3.1 11.8 33.6 4.3 17.6 8.8 5.3 13.7 11.2 7.8 6.7 16.4 62.4 2.6 10.1 13.3 6.4 4.7 2.1 8.5 11.6 2.1 34.1 13.6 5.3 39.9 13.9 72.0 0.1 198.3 180.9 54.6 231.4 182.3 99.0 107.9 0.1 0.5 0.0 323.8 230.3 4.5 8.3 0.3 142.3 125.5 0.6 2.4 0.0 139.3 0.0 196.4 0.6 0.0 200.7 41.0 112.2 83.8 299.5 247.0 35.9 0.1 0.0 142.6 23.6 6.8 8.0 58.3 0.0 52.3 13.2 250.8 0.6 115.9 0.1 0.2 131.9 0.2 73.6 0.4 142.9 27.0 0.9 242.4 162.8 79.7 6.2 180.7 0.2 205.4 1.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 3.0 1.9 4.3 2.9 6.6 4.0 4.1 1.8 4.3 2.6 4.7 5.3 79.1 6.4 2.3 2.6 0.4 2.9 2.8 12.8 0.6 2.5 17.5 14.1 5.8 17.2 7.0 1.8 0.0 0.6 0.2 0.3 0.0 10.4 33.4 4.2 99.4 95.1 1.8 0.0 6.6 0.0 11.3 45.2 0.0 3.4 1.3 43.7 71.4 1.8 1.9 0.0 7.3 1.3 20.3 5.7 4.4 40.7 26.8 0.7 7.2 8.4 0.6 10.0 1.0 55.8 0.7 0.5 0.1 15.1 0.0 14.0 0.0 0.2 6.7 0.8 46.0 120.1 51.1 22.0 16.0 0.5 2.8 1.4 1.0 33.3 0.5 1.4 SSBP4 ENSG00000130511 "Single stranded DNA binding protein 4" Q9BWG4 19 18418864-18434562 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (2.81e-2)" "unprognostic (8.47e-3)" "unprognostic (4.94e-1)" "unprognostic (1.14e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-2)" "unprognostic (3.38e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-1)" "unprognostic (7.85e-2)" "prognostic favorable (1.01e-4)" "unprognostic (3.32e-2)" "prognostic unfavorable (2.04e-10)" "unprognostic (4.50e-2)" "unprognostic (1.97e-1)" "unprognostic (4.26e-2)" "unprognostic (1.05e-2)" 49.3 43.0 66.5 18.1 69.4 14.1 44.7 25.6 98.3 79.0 71.9 46.4 17.1 73.3 5.5 29.0 102.1 7.0 48.1 71.5 45.9 46.3 32.0 51.1 12.7 39.6 36.1 56.8 69.6 38.3 6.7 130.6 12.3 39.5 58.2 4.4 5.3 27.7 22.0 41.5 24.2 44.0 6.8 32.0 80.3 38.6 41.5 46.7 6.9 46.1 8.2 4.3 48.4 49.0 33.4 37.4 32.3 27.4 53.5 5.1 20.0 38.0 51.7 11.4 11.7 12.9 12.4 41.9 33.5 45.7 11.6 13.0 42.8 7.1 9.8 4.8 35.9 80.4 59.2 37.9 28.4 20.6 27.9 106.7 16.2 7.9 7.5 2.8 16.0 38.2 66.0 120.0 16.5 3.8 60.0 74.2 91.5 22.2 19.1 84.8 49.8 22.2 35.6 17.5 12.6 49.2 82.3 8.2 26.7 75.4 5.3 27.0 64.5 45.0 19.7 51.7 121.5 31.4 23.0 7.0 23.1 53.3 85.9 42.9 0.0 5.6 0.3 12.0 14.9 7.9 14.5 9.8 10.4 7.4 11.1 5.8 10.0 0.7 5.1 26.2 4.4 5.6 4.5 66.5 69.4 25.6 98.3 71.5 45.9 39.6 36.1 56.8 39.5 32.0 46.7 33.4 54.1 6.4 18.6 21.2 43.5 17.2 35.3 23.5 26.7 11.8 39.4 36.8 6.1 18.6 21.2 53.3 25.0 20.6 83.6 13.7 25.4 13.8 10.5 99.0 69.0 53.4 59.9 24.4 43.4 21.1 44.8 51.7 27.5 31.2 37.4 49.4 37.1 12.1 34.8 42.1 29.0 17.3 34.6 41.5 38.4 29.6 58.4 39.0 19.6 16.9 23.4 41.3 70.0 10.1 6.3 12.8 12.9 51.6 19.5 36.4 6.6 19.8 96.7 16.2 39.5 23.6 48.7 20.0 58.9 17.2 14.6 18.9 79.0 80.4 21.6 34.3 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 370.1;urinary bladder: 176.9" "Cell type enhanced" "Detected in many" "Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;monocytes: 1.2" "Cell line enhanced" "Detected in many" "BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1260000 960000 "Golgi apparatus" "CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168" "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 29.8 11.8 1.5 1.5 1.3 0.4 25.1 1.1 5.3 18.2 33.2 29.5 4.6 13.7 2.3 4.8 5.5 20.0 4.1 4.3 3.8 370.1 89.3 47.3 0.6 2.0 1.7 1.2 4.7 113.3 26.1 12.4 87.6 1.8 106.2 24.6 1.2 12.6 4.7 5.5 5.1 12.4 2.0 1.4 11.5 76.2 1.6 3.6 0.3 11.3 0.5 1.7 176.9 19.4 1.6 1.8 95.6 9.4 3.5 22.3 18.5 416.5 33.1 17.9 1.2 18.8 4.2 29.6 0.4 58.8 3.0 97.0 0.7 0.0 12.2 4.7 0.2 2.2 0.9 9.2 225.5 564.9 0.1 35.7 48.8 140.1 90.7 58.6 0.7 99.5 0.0 152.4 0.7 22.9 23.5 0.1 0.8 5.4 34.4 52.5 0.2 3.7 0.2 69.9 94.6 0.9 1.0 0.4 5.5 127.9 35.1 2.6 0.4 213.1 0.0 7.4 1.8 1.5 1.5 4.0 0.4 51.9 0.1 27.8 0.0 0.7 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.1 1.5 1.3 1.1 5.3 4.3 3.8 2.0 1.7 1.2 1.8 1.4 3.6 1.6 6.6 35.3 62.4 0.0 1.8 1.3 350.6 366.1 0.0 0.1 54.2 15.5 0.7 47.1 1160.8 259.3 0.0 60.6 0.4 176.0 33.2 316.9 0.0 166.8 35.4 31.9 84.8 0.0 0.1 381.9 263.4 52.9 224.8 261.8 29.2 0.2 2.5 7.0 33.8 0.0 0.1 357.6 453.7 1.6 3.7 0.0 0.9 14.1 3.6 0.0 9.9 0.5 1.0 0.0 0.0 440.4 146.6 1.5 1.3 780.2 22.9 85.7 681.4 0.6 0.0 9.5 46.7 0.7 0.5 1.3 1.7 4304.7 5.5 3.4 291.0 3294.2 PGPEP1 "Pcp, PGP, PGP-I, PGPI" ENSG00000130517 "Pyroglutamyl-peptidase I" Q9NXJ5 19 18340598-18369950 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 73.9;Proximal enterocytes: 88.2;Proximal tubular cells: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.4" "Cell line enhanced" "Detected in many" "HMC-1: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035368, HPA055277" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035368: AB_10601388, HPA055277: AB_2682770" "unprognostic (9.52e-3)" "unprognostic (1.37e-2)" "unprognostic (6.95e-2)" "unprognostic (5.74e-3)" "unprognostic (5.29e-2)" "unprognostic (6.60e-2)" "unprognostic (1.96e-2)" "unprognostic (2.11e-3)" "prognostic favorable (6.80e-4)" "unprognostic (2.79e-2)" "prognostic favorable (1.71e-4)" "unprognostic (4.81e-3)" "prognostic favorable (3.71e-8)" "unprognostic (1.12e-2)" "unprognostic (1.66e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-3)" 9.7 28.0 30.0 6.9 29.1 13.2 10.4 27.7 36.9 12.7 35.6 20.4 22.6 11.2 12.9 5.6 12.8 8.0 20.7 31.2 29.4 40.4 48.8 14.4 6.5 35.9 29.5 24.6 16.6 34.5 14.0 24.6 5.3 34.7 20.5 15.8 4.2 20.6 13.0 27.3 4.6 30.6 6.4 37.2 23.7 23.8 3.8 30.0 8.3 14.7 14.5 6.4 16.0 8.3 38.2 8.7 13.6 11.1 11.2 13.7 10.8 13.5 10.2 15.9 6.9 10.2 9.7 18.4 13.4 16.7 16.8 12.3 2.3 4.4 2.3 3.8 15.9 4.8 14.7 15.0 27.9 19.4 8.7 58.5 10.9 4.9 5.3 1.0 24.6 10.4 22.8 27.5 19.7 5.8 13.9 8.9 7.0 11.3 6.0 4.2 0.1 4.1 12.1 7.5 13.5 3.9 6.1 1.9 1.1 18.4 7.2 5.1 17.3 16.1 7.9 5.3 10.4 4.4 24.3 12.6 8.2 21.0 24.0 7.4 28.4 5.5 8.1 4.8 5.8 2.9 1.9 3.4 4.5 3.5 5.5 4.2 3.8 3.1 4.8 6.8 2.3 4.2 3.9 30.0 29.1 27.7 36.9 31.2 29.4 35.9 29.5 24.6 34.7 37.2 30.0 38.2 7.5 9.6 15.0 10.4 12.2 2.3 10.2 9.5 8.6 4.7 14.3 9.8 20.9 37.1 13.2 31.3 10.4 18.6 21.2 73.9 7.9 20.7 0.8 15.2 8.6 10.0 38.9 10.7 11.3 45.4 26.6 9.6 27.5 14.7 35.4 7.9 13.6 72.5 24.1 5.0 7.9 21.0 8.2 29.0 5.4 1.7 7.8 19.3 16.0 8.4 13.1 8.9 24.7 3.5 4.3 44.4 36.5 20.3 25.8 9.2 88.2 85.7 12.3 7.0 6.6 10.3 9.0 2.9 4.7 1.8 1.1 18.7 15.2 9.4 33.4 16.9 IQCN KIAA1683 ENSG00000130518 "IQ motif containing N" Q9H0B3 19 18257097-18274509 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.5;testis: 34.0" "Cell type enhanced" "Detected in many" "Adipocytes: 23.6;Alveolar cells type 2: 43.7;Breast glandular cells: 13.8;Breast myoepithelial cells: 17.5;dendritic cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042409 Enhanced NA NA "HPA042409: AB_10794421" "unprognostic (1.36e-3)" "unprognostic (5.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (2.15e-4)" "unprognostic (9.79e-2)" "unprognostic (9.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (1.64e-4)" "unprognostic (4.17e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (7.68e-2)" "unprognostic (1.30e-1)" "unprognostic (4.92e-3)" 1.3 0.7 8.5 0.7 7.7 3.2 1.8 16.2 16.5 3.0 5.9 1.0 0.4 3.2 2.0 0.9 3.2 0.9 0.4 7.6 7.7 1.0 1.0 2.0 1.2 8.0 7.8 7.1 3.9 1.4 0.7 2.7 0.3 9.9 1.5 0.8 2.1 1.1 0.8 1.5 2.3 1.4 1.5 6.8 2.0 1.2 34.0 7.6 1.0 3.0 0.1 0.5 0.7 1.5 12.1 0.0 2.2 0.3 1.3 0.5 1.0 0.3 0.3 0.2 0.0 0.1 0.3 0.7 0.5 0.2 0.7 0.3 0.0 0.0 0.2 0.0 0.6 0.1 0.8 1.0 0.4 0.1 0.1 0.2 0.5 0.0 0.2 0.4 1.2 0.2 0.1 0.0 0.6 0.0 0.9 0.2 0.3 0.2 0.6 0.0 0.2 0.0 0.2 0.3 0.3 1.0 0.2 0.1 0.1 0.5 0.7 0.7 0.2 0.0 0.1 0.1 0.7 0.0 0.3 0.2 0.2 0.4 0.0 0.0 0.5 0.3 0.2 0.3 0.1 0.1 0.4 0.3 0.1 0.1 0.6 0.3 0.2 1.7 0.4 0.1 0.6 0.2 0.1 8.5 7.7 16.2 16.5 7.6 7.7 8.0 7.8 7.1 9.9 6.8 7.6 12.1 23.6 3.2 43.7 0.0 5.8 0.0 0.0 0.0 0.0 0.0 13.8 17.5 0.0 0.0 1.3 1.8 0.0 1.5 22.3 0.0 0.0 2.7 0.0 6.7 4.5 1.4 0.0 0.0 0.0 0.9 0.5 2.8 0.0 10.2 5.1 4.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.3 2.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.8 8.5 4.2 0.0 0.0 LSM4 YER112W ENSG00000130520 "LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y4Z0 19 18306236-18323112 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 705.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040932 Uncertain Approved Vesicles NA NA Vesicles "HPA040932: AB_10795529" "unprognostic (2.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (7.42e-3)" "unprognostic (1.98e-1)" "unprognostic (4.09e-2)" "unprognostic (1.10e-3)" "unprognostic (9.80e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.34e-4)" "unprognostic (8.31e-3)" "unprognostic (1.25e-1)" "prognostic favorable (2.22e-4)" "unprognostic (2.51e-2)" "unprognostic (7.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.34e-1)" 55.1 131.6 93.9 32.1 97.3 63.4 55.5 95.5 112.5 50.7 102.2 75.0 58.1 52.1 36.6 101.3 53.2 17.5 92.5 96.5 96.1 119.0 123.8 61.4 41.7 94.9 98.6 94.0 51.0 57.9 49.0 73.0 35.8 98.5 64.8 45.6 33.4 55.6 40.0 150.3 68.2 77.7 27.6 91.6 71.7 79.0 127.8 99.4 79.6 62.7 90.1 39.2 62.6 60.2 97.0 294.3 151.2 252.3 226.2 95.4 91.4 291.8 132.2 113.6 167.9 158.7 137.0 305.5 172.0 274.5 139.0 152.5 192.3 276.4 274.5 127.1 201.1 524.0 156.1 247.0 167.5 94.9 148.9 89.2 83.3 160.5 156.9 182.9 94.2 139.6 248.6 333.0 172.3 177.3 479.7 411.0 321.6 327.1 419.2 475.4 229.4 112.0 320.5 212.9 102.0 283.8 264.9 113.0 141.3 204.2 174.8 140.4 157.8 81.0 98.0 113.2 244.3 250.5 160.2 147.7 204.4 131.4 289.3 170.4 171.5 223.2 163.8 148.3 258.5 182.5 163.5 158.3 154.4 252.8 164.5 169.7 171.4 18.4 220.4 205.6 359.0 166.9 283.9 93.9 97.3 95.5 112.5 96.5 96.1 94.9 98.6 94.0 98.5 91.6 99.4 97.0 76.8 28.9 38.8 7.5 85.1 67.4 92.4 183.1 46.7 72.0 141.7 134.9 53.2 74.4 90.5 115.8 14.6 270.4 95.8 179.1 299.3 196.7 280.8 102.8 55.1 75.7 124.4 109.8 11.5 182.1 489.1 67.9 68.8 96.9 117.4 115.7 54.3 89.3 288.4 58.9 11.1 194.5 154.6 85.4 129.0 705.7 62.4 109.1 104.9 7.5 243.2 115.6 130.7 7.1 13.4 159.3 205.5 47.4 98.3 153.1 225.3 347.7 94.6 73.0 46.0 38.5 80.7 203.1 378.6 125.5 71.9 170.5 87.7 174.2 237.1 119.9 JUND AP-1 ENSG00000130522 "JunD proto-oncogene, AP-1 transcription factor subunit" P17535 19 18279694-18281622 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 2129.8;dendritic cells: 1844.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005268, HPA063029" Supported Supported Nucleoplasm No No Nucleoplasm "CAB005268: AB_2130177, HPA063029: AB_2684925" "prognostic favorable (6.15e-5)" "unprognostic (4.18e-3)" "unprognostic (8.89e-2)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (6.39e-2)" "unprognostic (1.63e-2)" "unprognostic (6.35e-2)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-1)" "unprognostic (3.99e-1)" "unprognostic (5.37e-2)" "unprognostic (1.49e-1)" 240.7 190.8 180.6 39.2 183.4 432.7 259.5 156.1 201.4 160.0 151.4 180.0 63.5 188.2 37.9 119.3 294.1 30.2 195.6 176.2 185.4 149.0 213.6 229.3 29.0 252.5 200.8 177.9 427.7 179.8 40.7 258.4 45.5 188.8 160.4 33.3 26.0 113.7 34.1 81.7 238.4 162.6 58.0 173.4 101.3 203.1 98.2 169.6 58.7 156.1 37.4 16.0 130.6 148.9 254.5 84.2 35.3 33.3 37.9 25.9 28.8 150.5 35.0 40.8 19.2 25.4 38.3 72.9 42.1 39.4 34.8 31.1 46.1 8.2 8.3 9.5 84.6 75.9 62.7 30.3 84.9 58.6 29.5 81.4 27.8 33.7 20.0 25.9 44.5 15.3 18.8 86.5 119.8 5.2 113.6 89.9 92.5 69.7 22.7 50.6 32.7 20.9 94.0 27.8 13.1 184.2 75.1 41.7 45.4 122.0 37.5 38.6 43.9 54.7 11.8 54.8 74.4 20.9 171.3 73.8 36.3 41.5 44.7 27.9 10.5 6.5 6.8 4.9 8.2 3.8 8.4 6.4 4.5 4.9 8.7 4.5 5.0 19.7 4.8 8.3 11.3 5.7 2.4 180.6 183.4 156.1 201.4 176.2 185.4 252.5 200.8 177.9 188.8 173.4 169.6 254.5 2129.8 179.5 386.7 104.5 1176.8 317.1 400.4 76.0 188.4 129.8 1147.5 1419.1 158.8 291.7 84.4 257.5 79.2 78.5 1844.7 810.5 31.3 96.5 80.8 1026.0 1289.3 468.1 568.8 78.3 51.6 140.8 112.9 950.9 336.4 1561.4 257.7 514.1 338.4 436.1 100.1 139.7 41.0 569.6 67.1 332.7 506.0 59.2 123.3 847.7 249.1 65.6 91.7 625.2 27.8 44.7 132.0 154.4 464.2 88.8 734.5 253.6 538.1 65.4 90.4 174.3 131.5 1064.7 798.4 11.8 22.7 172.0 394.1 164.3 1158.2 448.7 297.4 232.7 HRC MGC133236 ENSG00000130528 "Histidine rich calcium binding protein" P23327 19 49151198-49155396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 45 "heart muscle: 557.3;skeletal muscle: 457.3;tongue: 246.8" "Cell type enriched" "Detected in some" 17 "Cardiomyocytes: 1182.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 5.8;HSkMC: 5.6;K-562: 8.0;THP-1: 13.9;U-266/84: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA004833 Enhanced "Intracellular and membrane" NA NA 100000 "HPA004833: AB_1079083" "unprognostic (1.06e-1)" "unprognostic (1.04e-3)" "unprognostic (1.46e-2)" "unprognostic (4.94e-2)" "unprognostic (5.66e-2)" "unprognostic (9.75e-3)" "unprognostic (3.44e-1)" "unprognostic (1.74e-1)" "unprognostic (4.09e-1)" "unprognostic (1.62e-1)" "unprognostic (7.41e-3)" "unprognostic (5.85e-3)" "unprognostic (4.04e-2)" "unprognostic (6.68e-2)" "unprognostic (1.07e-1)" "unprognostic (1.86e-1)" "unprognostic (1.46e-1)" 8.2 3.6 2.8 0.6 2.8 0.0 5.8 3.1 4.0 5.6 2.3 2.4 0.9 6.4 5.4 4.6 9.3 2.2 557.3 2.7 2.4 3.5 1.9 2.8 0.8 2.5 2.7 2.3 4.6 1.3 1.5 1.5 2.1 3.0 4.3 0.9 0.8 8.2 2.5 457.3 2.4 2.3 2.1 2.4 0.5 1.8 1.4 2.6 0.6 4.8 246.8 0.4 3.1 3.9 2.6 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 5.8 0.0 0.0 1.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 13.9 0.2 0.0 0.0 0.3 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.8 3.1 4.0 2.7 2.4 2.5 2.7 2.3 3.0 2.4 2.6 2.6 3.7 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 1.0 0.8 1.0 1182.5 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.3 1.7 11.0 1.2 0.0 0.0 0.2 0.0 20.9 0.0 0.5 0.0 0.0 0.7 0.6 0.1 3.3 0.1 2.8 0.0 0.0 1.1 0.4 8.4 0.3 3.6 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.4 8.2 0.1 0.2 0.5 0.0 0.0 0.2 65.7 8.7 44.2 0.0 0.2 0.1 0.1 0.1 0.2 2.8 1.5 0.2 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9" "Cancer enriched" "Detected in all" 4 "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3" "Cell line enhanced" "Detected in many" "OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041169: AB_2677343" "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favorable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 10.3 6.1 7.5 6.1 5.9 4.6 13.6 8.3 7.0 11.2 5.2 30.1 25.5 10.0 2.6 13.2 9.3 7.5 22.5 6.7 4.8 22.8 15.5 16.2 1.8 6.3 5.6 5.5 3.3 10.2 3.8 5.6 5.3 7.0 36.0 13.0 1.3 27.5 6.2 14.2 25.8 23.1 3.5 3.9 5.6 20.7 5.4 8.3 1.0 17.4 5.3 2.0 13.8 14.5 10.1 11.9 9.0 2.1 9.5 7.7 6.6 6.6 10.0 6.0 2.7 3.7 6.1 18.7 0.4 2.7 6.8 3.6 15.7 1.3 3.0 1.0 0.2 3.4 1.9 4.0 3.7 6.6 0.3 11.7 9.3 13.6 5.3 2.6 3.3 4.6 1.0 4.9 2.1 6.9 17.4 0.8 0.9 1.0 32.7 13.3 4.1 2.0 0.6 4.6 60.8 0.8 2.2 4.1 38.6 2.2 0.7 22.6 3.7 11.8 14.4 7.8 7.9 0.2 3.9 4.3 0.4 7.9 7.4 5.3 2.2 4.3 0.7 0.3 2.5 0.2 0.5 0.2 0.2 3.3 0.5 0.3 0.3 2.8 0.5 1.0 3.1 0.2 1.4 7.5 5.9 8.3 7.0 6.7 4.8 6.3 5.6 5.5 7.0 3.9 8.3 10.1 12.8 32.1 2.6 9.8 3.5 12.5 15.3 9.9 9.1 2.0 19.0 14.6 16.7 17.2 12.3 14.7 0.0 6.6 0.2 179.2 19.6 7.9 2.9 17.5 8.2 11.7 21.7 0.0 5.4 18.5 6.8 6.0 71.4 36.2 5.7 2.9 11.4 81.7 19.9 0.0 8.5 114.8 14.2 9.8 19.0 3.1 6.8 8.5 39.2 9.4 12.8 6.7 0.0 3.5 0.9 32.9 77.1 7.2 7.6 35.5 55.3 3.8 8.9 2.6 32.9 2.2 8.5 6.1 15.7 8.4 11.5 3.4 1.9 4.1 88.9 33.1 OR11H1 OR22-1 ENSG00000130538 "Olfactory receptor family 11 subfamily H member 1" 22 15528192-15529139 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SULT4A1 "hBR-STL-1, SULTX3" ENSG00000130540 "Sulfotransferase family 4A member 1" Q9BR01 22 43824509-43862513 "Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 86.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 23.0;Early spermatids: 23.7;Excitatory neurons: 53.1;Horizontal cells: 23.5;Inhibitory neurons: 55.2;Late spermatids: 29.4;Rod photoreceptor cells: 19.5" "Cancer enhanced" "Detected in many" "testis cancer: 6.3" "Region enhanced" "Detected in many" "cerebral cortex: 86.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003129 Enhanced NA NA "HPA003129: AB_1080130" "unprognostic (2.61e-3)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "unprognostic (6.30e-2)" "unprognostic (6.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.63e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-4)" "unprognostic (1.91e-2)" "unprognostic (6.10e-2)" "unprognostic (7.59e-4)" "unprognostic (7.89e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-3)" "unprognostic (8.34e-3)" 0.0 2.7 10.9 0.3 18.1 0.0 0.0 1.2 86.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.3 21.4 0.1 0.0 0.0 0.0 9.5 21.0 20.4 0.0 0.2 0.0 2.6 0.0 9.7 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.8 14.2 0.0 0.0 0.0 0.0 0.0 0.3 44.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 18.1 1.2 86.9 20.3 21.4 9.5 21.0 20.4 9.7 0.0 14.2 44.6 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.3 0.0 23.0 0.2 0.5 1.4 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 23.7 1.1 1.3 0.4 0.0 0.0 53.1 0.0 0.0 0.4 0.0 3.7 0.0 1.9 0.0 0.0 0.1 23.5 55.2 0.0 0.0 0.0 0.0 29.4 0.0 0.1 0.0 10.3 0.0 4.0 0.0 8.0 6.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 19.5 0.0 0.0 0.2 3.0 5.7 0.0 0.0 0.0 0.0 3.2 0.0 0.0 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069703-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Nucleoplasm, Intermediate filaments" "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 1.4 1.9 1.2 1.9 1.6 3.9 1.9 2.9 1.6 1.6 1.4 1.5 1.2 1.7 1.6 1.7 1.9 1.4 1.2 1.4 1.1 1.5 2.2 1.4 2.6 1.4 1.3 1.4 2.4 1.8 1.7 1.5 1.5 1.6 1.6 1.4 1.9 1.5 1.4 1.4 2.0 1.7 1.6 0.9 2.4 1.8 2.2 1.3 2.4 2.2 1.1 2.5 1.6 1.5 3.2 2.1 2.2 2.3 5.0 3.1 2.1 1.9 2.1 2.2 2.3 2.8 2.8 1.3 4.4 3.6 2.3 1.8 2.9 4.0 2.3 2.3 4.0 2.6 5.6 4.7 1.5 2.1 6.0 5.9 3.0 2.3 2.4 3.7 2.3 2.0 3.8 2.2 6.7 3.1 3.0 5.0 2.1 2.2 2.0 3.0 3.6 3.6 2.4 1.7 4.9 2.7 3.2 3.1 2.4 2.3 2.0 1.9 3.1 3.9 2.2 1.7 5.0 2.3 6.8 5.8 3.9 2.4 3.1 2.0 5.6 3.1 3.8 4.6 2.9 4.7 4.1 5.0 4.0 3.1 5.4 5.8 4.9 3.5 5.9 2.7 5.7 4.3 1.7 1.2 1.6 2.9 1.6 1.4 1.1 1.4 1.3 1.4 1.6 0.9 1.3 3.2 5.5 3.2 4.4 5.2 8.3 1.5 6.9 2.7 2.2 9.4 6.1 5.8 5.4 7.2 6.1 7.3 0.0 5.9 5.8 5.4 15.6 6.2 0.9 3.4 8.9 6.9 5.4 6.1 9.2 6.2 4.2 5.6 4.6 4.6 8.2 9.4 8.6 3.8 6.1 16.8 8.9 5.8 2.0 9.8 2.9 0.5 4.4 6.0 0.0 5.6 9.0 6.1 14.4 3.5 8.8 6.1 6.2 5.7 5.9 6.8 6.1 8.1 4.3 6.8 0.0 7.8 6.7 23.2 19.9 3.6 1.3 5.7 7.7 6.7 5.5 6.9 CRB3 MGC17303 ENSG00000130545 "Crumbs cell polarity complex component 3" Q9BUF7 19 6463777-6467221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 55.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 160.9;Pancreatic endocrine cells: 149.9;Paneth cells: 177.3;Suprabasal keratinocytes: 139.5;Urothelial cells: 243.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 9.2" "Group enriched" "Detected in many" 20 "B-cells: 3.1;T-cells: 9.2" "Cell line enhanced" "Detected in some" "A-431: 57.9;BEWO: 35.1;CACO-2: 38.1;HaCaT: 36.9;hTCEpi: 27.8;OE19: 33.1;SK-BR-3: 29.5;T-47d: 25.8" "Low region specificity" "Detected in many" HPA013835 Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA013835: AB_1847214" "unprognostic (3.25e-1)" "unprognostic (4.41e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.54e-4)" "unprognostic (1.24e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-2)" "unprognostic (1.86e-1)" "unprognostic (2.57e-2)" "unprognostic (4.98e-2)" "unprognostic (1.11e-1)" "prognostic favorable (0.00e+0)" "unprognostic (8.42e-3)" "unprognostic (1.96e-1)" "unprognostic (1.12e-2)" "prognostic favorable (8.06e-5)" 0.5 0.4 0.3 4.0 0.5 0.3 5.2 1.1 0.5 5.6 4.9 24.5 37.2 2.3 4.7 55.0 8.2 8.3 0.3 0.4 0.2 34.2 32.8 19.1 0.9 0.4 0.3 0.2 0.4 44.4 20.9 16.0 3.5 0.5 9.2 10.6 0.4 25.0 9.0 0.1 41.7 30.9 0.5 0.1 0.8 31.4 0.4 0.2 0.8 16.4 0.0 5.5 6.5 17.8 0.4 57.9 7.0 0.0 0.2 0.0 0.1 35.1 0.0 0.0 0.0 0.0 38.1 23.8 0.3 22.1 0.0 0.3 36.9 0.4 12.5 0.0 0.0 0.4 0.1 0.2 21.5 0.0 0.1 0.1 0.0 27.8 0.0 0.0 0.0 0.1 0.5 0.1 0.5 0.0 15.1 0.2 0.4 1.3 33.1 0.0 0.0 0.0 0.7 16.5 24.0 0.0 0.1 0.2 29.5 0.1 1.7 25.8 0.2 0.0 0.1 0.4 0.2 0.1 0.7 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.3 3.1 4.6 2.2 0.0 1.0 9.2 3.6 0.3 0.0 0.0 0.0 3.4 1.9 0.3 0.5 1.1 0.5 0.4 0.2 0.4 0.3 0.2 0.5 0.1 0.2 0.4 0.2 35.3 38.0 0.0 2.2 72.1 64.6 81.3 21.1 0.0 43.6 19.9 0.3 71.4 64.0 31.3 0.0 28.1 0.9 160.9 46.9 113.0 0.0 43.8 4.0 1.8 16.8 3.2 0.1 101.5 9.8 2.0 34.7 58.3 1.3 0.1 0.4 31.8 2.5 0.0 0.0 60.2 63.1 1.0 6.2 0.0 0.0 1.3 7.2 0.0 2.7 0.9 0.0 0.0 0.1 149.9 177.3 0.0 3.1 94.4 86.8 44.5 36.3 0.5 0.0 0.0 4.2 1.1 0.4 45.0 139.5 56.2 3.2 0.2 52.0 243.6 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121180 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 549.1;choroid plexus: 260.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6" "Group enriched" "Detected in many" 27 "dendritic cells: 2.6;monocytes: 2.8" "Cell line enhanced" "Detected in many" "HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 200000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 35.3 25.7 412.5 13.1 426.8 0.2 37.1 315.1 549.1 28.6 260.5 20.7 5.1 29.2 71.1 12.2 30.5 8.7 17.4 468.0 340.5 9.8 4.8 15.1 14.6 317.9 317.6 451.0 19.5 12.4 4.9 83.4 1.0 344.7 19.5 13.9 47.7 14.1 18.3 17.7 15.1 16.6 18.0 278.6 35.4 15.5 6.8 320.4 11.6 17.7 23.2 19.2 25.2 26.9 403.2 0.0 6.1 12.1 0.2 1.7 1.4 0.5 3.6 0.0 0.0 0.0 0.1 2.7 0.1 0.8 5.2 49.2 2.3 2.6 0.0 0.0 14.4 0.9 0.2 96.0 0.0 0.5 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.3 84.1 0.5 0.3 104.9 78.9 0.0 0.1 0.3 48.3 0.0 0.1 155.6 20.5 131.8 0.4 8.6 7.9 200.2 0.0 0.1 7.7 16.6 87.1 0.2 0.2 0.1 0.3 0.7 0.1 4.3 0.0 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 412.5 426.8 315.1 549.1 468.0 340.5 317.9 317.6 451.0 344.7 278.6 320.4 403.2 44.2 0.0 7.9 43.8 0.1 9.7 3.3 0.0 3.4 21.6 3.1 3.0 5.9 11.5 1.8 0.0 43.8 0.0 0.1 2.4 0.0 9.7 5.8 0.5 20.4 50.0 2.4 0.0 193.1 2.7 0.0 17.3 0.0 0.7 2.5 14.4 78.1 1.1 0.4 38.7 70.0 2.5 0.0 3.2 7.3 11.9 44.4 2.8 21.4 32.8 2.7 38.6 0.0 48.7 17.3 2.5 2.5 29.3 0.4 5.1 0.0 0.1 0.0 15.7 0.0 13.3 8.8 0.6 3.7 1.3 6.3 0.0 0.7 12.9 4.2 1.4 CAMSAP1 "DKFZp434F195, FLJ31228" ENSG00000130559 "Calmodulin regulated spectrin associated protein 1" Q5T5Y3 9 135808487-135907546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 106.4" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 339.9;Rod photoreceptor cells: 236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020527, HPA024161" Approved Supported "Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "HPA020527: , HPA024161: AB_1845967" "unprognostic (3.18e-3)" "unprognostic (4.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.57e-2)" "unprognostic (6.00e-2)" "unprognostic (1.43e-2)" "unprognostic (1.79e-3)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-2)" "prognostic favorable (3.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (2.66e-3)" 6.8 7.5 12.6 5.6 13.0 10.4 5.5 13.0 12.0 7.9 2.3 6.1 3.2 7.6 5.3 20.2 7.8 5.2 7.9 13.6 11.2 4.6 4.3 6.8 5.9 8.3 9.8 11.9 10.8 8.0 6.1 8.8 5.3 9.6 6.3 3.5 106.4 7.6 6.5 33.1 10.4 4.4 7.0 6.1 5.3 5.0 18.2 12.2 11.2 4.5 17.6 7.0 7.4 11.8 11.6 15.4 22.3 36.0 25.5 8.2 7.1 17.6 12.2 10.2 13.0 9.8 19.7 13.2 7.1 17.0 15.4 16.7 30.8 19.0 13.2 9.7 24.0 10.5 10.3 24.9 9.9 12.4 18.0 14.8 9.5 16.3 16.6 22.6 12.3 14.8 15.5 21.4 15.0 17.1 27.5 16.8 11.0 20.4 18.2 15.8 32.5 29.7 17.4 12.8 18.7 39.1 38.2 15.6 11.2 17.0 11.7 15.9 14.6 18.3 24.6 19.0 18.3 20.9 7.3 14.7 19.2 16.0 12.0 14.5 1.5 0.3 0.0 0.2 0.4 0.4 0.6 0.4 0.3 0.2 0.1 0.3 0.4 0.1 0.2 0.3 0.2 0.3 0.3 12.6 13.0 13.0 12.0 13.6 11.2 8.3 9.8 11.9 9.6 6.1 12.2 11.6 6.3 6.4 3.9 31.6 5.5 22.7 17.4 10.8 9.6 34.4 11.8 9.8 14.0 4.3 15.7 3.7 339.9 12.6 5.8 4.5 0.0 11.8 13.1 41.5 13.2 8.8 12.6 6.6 37.7 8.9 3.5 6.6 8.2 32.4 6.3 20.4 7.5 8.2 10.3 16.8 34.1 4.4 10.2 8.1 13.5 15.8 5.9 11.7 12.4 25.3 12.2 19.2 4.1 27.2 35.9 15.7 3.0 6.0 11.9 14.2 2.7 4.3 37.1 236.1 13.1 16.8 11.7 24.4 34.4 35.2 31.7 5.6 6.5 15.6 4.5 24.8 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961373 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 303.8;tongue: 172.5" "Cell type enhanced" "Detected in all" "Erythroid cells: 290.9;Late spermatids: 197.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 246.4;K-562: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 87000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favorable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 22.1 20.9 42.6 14.8 42.0 83.2 20.8 41.6 43.3 23.4 38.5 37.0 24.5 22.2 13.0 37.7 23.0 12.1 58.6 38.6 40.2 23.6 25.2 19.9 15.8 42.8 41.3 36.7 21.1 17.3 27.4 23.7 23.0 44.5 24.9 18.6 15.3 28.1 20.8 303.8 52.0 23.5 16.5 41.9 21.1 23.2 43.5 41.8 17.8 18.2 172.5 16.7 28.6 27.2 41.2 37.4 42.7 29.7 43.4 22.0 25.6 55.7 32.0 27.1 38.9 31.2 59.7 46.3 44.8 30.1 26.4 46.1 124.4 41.9 37.0 17.5 246.4 39.6 37.4 79.0 33.8 22.9 49.2 34.4 24.2 47.7 24.6 23.8 26.0 32.8 41.4 316.6 35.5 31.2 76.9 40.4 50.5 70.5 87.4 71.8 45.1 55.8 59.3 28.0 23.7 46.0 50.6 46.3 41.4 33.5 26.3 34.9 52.5 26.8 22.0 33.0 26.5 40.2 20.5 41.1 53.9 40.7 43.9 30.6 6.5 17.6 8.7 4.8 28.4 5.1 4.9 5.4 3.2 15.6 2.8 2.8 3.3 3.7 4.0 33.4 1.6 4.5 7.0 42.6 42.0 41.6 43.3 38.6 40.2 42.8 41.3 36.7 44.5 41.9 41.8 41.2 42.8 16.0 10.0 18.6 14.5 40.7 38.8 41.8 43.3 38.3 29.6 36.2 85.7 11.5 24.5 27.6 31.3 148.6 20.7 45.5 93.9 16.3 101.6 82.9 33.7 27.5 16.8 290.9 17.3 22.9 32.7 22.5 21.9 21.3 7.0 28.6 20.3 32.7 75.2 13.5 23.6 37.4 28.5 34.3 30.3 197.4 19.6 41.8 35.6 9.4 46.0 60.7 13.4 9.0 14.1 22.6 42.3 22.6 24.6 23.1 47.9 35.6 96.0 44.1 19.7 42.8 27.4 57.7 54.9 73.2 64.8 60.5 16.5 25.7 55.6 39.4 SAG "ARRESTIN, RP47" ENSG00000130561 "S-antigen visual arrestin" P10523 2 233307816-233347055 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital stationary night blindness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 475 "retina: 1478.8" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 6946.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA004946 Enhanced NA NA "HPA004946: AB_2667304" "unprognostic (4.76e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (3.95e-1)" "unprognostic (8.54e-2)" "unprognostic (2.89e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.54e-1)" "unprognostic (4.57e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-9)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-1)" "unprognostic (1.03e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1478.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 1.6 0.2 0.0 651.7 0.2 0.3 1.0 0.0 0.0 0.0 869.5 1.5 0.7 0.6 0.0 0.0 40.4 0.9 0.2 41.6 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 338.2 0.5 0.0 0.0 1.5 2.3 121.5 0.9 0.5 0.0 0.0 0.7 1191.9 0.0 0.5 0.2 0.0 0.0 0.0 0.4 1.2 0.9 0.0 0.2 6946.1 13.1 1.7 0.4 2.1 1.6 0.0 0.6 0.4 0.9 0.1 0.2 1.2 ZBTB46 "BTBD4, BZEL, FLJ13502, RINZF, ZNF340" ENSG00000130584 "Zinc finger and BTB domain containing 46" Q86UZ6 20 63743668-63832038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 28.6;Excitatory neurons: 26.0;Hepatic stellate cells: 28.9;Microglial cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013997, HPA048051" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013997: AB_1858961, HPA048051: " "unprognostic (1.11e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.13e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (9.33e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.17e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (3.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.70e-2)" "unprognostic (2.12e-1)" 7.7 5.0 4.7 2.3 4.7 1.2 7.6 13.0 5.5 6.5 4.1 2.5 1.2 7.3 4.5 2.1 7.8 2.5 8.6 4.2 5.1 9.2 4.7 5.9 3.5 4.1 3.8 4.3 12.3 3.2 2.2 10.0 4.1 6.8 4.6 0.7 4.1 2.9 2.6 3.7 2.3 3.5 1.8 3.2 16.8 2.8 3.9 4.6 1.3 9.8 3.8 1.2 3.5 3.4 4.2 1.6 0.6 6.9 1.9 0.4 0.8 3.6 0.4 2.7 0.4 0.2 1.8 4.7 0.2 7.2 0.1 1.5 1.2 0.4 0.1 0.4 0.5 1.7 0.3 1.0 3.3 1.8 0.5 1.0 0.4 0.1 0.1 0.0 0.8 0.8 0.2 2.4 0.5 1.5 4.1 0.1 9.7 1.0 1.9 2.4 1.8 2.4 2.9 0.5 1.1 7.2 1.7 0.7 3.9 0.5 3.8 4.0 5.7 0.1 4.1 2.4 1.7 0.6 1.2 3.3 0.4 0.2 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 4.7 13.0 5.5 4.2 5.1 4.1 3.8 4.3 6.8 3.2 4.6 4.2 28.6 0.0 1.1 14.4 0.8 0.4 1.3 2.0 1.2 4.7 2.6 2.0 10.8 1.5 2.8 1.8 18.8 4.3 0.6 1.0 0.0 1.6 0.6 1.5 11.2 14.5 1.2 4.0 26.0 0.6 0.9 5.1 0.0 1.6 2.5 0.1 28.9 0.3 3.0 1.7 6.9 0.0 4.1 3.8 14.6 2.3 8.1 4.2 1.8 45.0 1.7 3.9 0.0 12.1 2.0 2.3 0.1 8.6 0.5 2.6 0.2 1.3 1.7 10.1 0.0 2.2 8.0 0.7 1.9 0.3 0.4 3.7 0.5 13.4 0.2 2.0 HELZ2 "KIAA1769, PDIP1, PRIC285" ENSG00000130589 "Helicase with zinc finger 2" Q9BYK8 20 63558086-63574239 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 46.1;Urothelial cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 59.4;GAMG: 34.5;SK-MEL-30: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051267 Uncertain NA NA "HPA051267: " "unprognostic (1.86e-1)" "unprognostic (7.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.93e-3)" "unprognostic (1.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.36e-2)" "unprognostic (5.06e-2)" "unprognostic (1.52e-1)" "unprognostic (1.73e-2)" "unprognostic (3.61e-2)" "unprognostic (2.19e-3)" "unprognostic (3.95e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (9.76e-2)" "unprognostic (1.16e-1)" 6.0 4.2 5.3 5.7 3.9 15.8 5.6 2.1 2.3 4.6 1.9 5.2 3.8 4.2 0.6 7.4 5.1 3.1 6.1 1.6 5.5 5.1 7.8 10.0 4.8 5.7 2.8 0.8 3.9 5.9 0.8 5.2 2.3 3.8 4.7 0.9 0.1 12.3 1.1 1.8 4.6 6.3 1.0 2.7 12.4 7.6 1.2 4.4 3.0 6.0 0.9 1.8 3.9 4.0 7.6 10.0 3.7 1.2 3.7 2.2 2.8 7.1 3.5 5.2 59.4 23.0 10.1 12.4 0.2 7.5 1.3 34.5 15.3 0.7 3.6 2.3 3.7 1.7 0.2 4.6 3.5 4.8 0.3 23.4 3.5 2.5 4.3 0.7 1.3 2.8 0.2 1.8 4.1 0.7 9.9 1.1 10.2 1.9 2.6 11.4 2.2 2.0 3.9 1.7 11.4 0.9 3.3 10.9 0.7 25.4 0.7 3.4 3.0 4.5 5.7 8.4 4.7 3.6 5.2 0.7 0.2 6.2 1.6 5.2 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 5.3 3.9 2.1 2.3 1.6 5.5 5.7 2.8 0.8 3.8 2.7 4.4 7.6 24.7 9.6 6.0 0.3 10.5 8.7 22.7 8.8 4.6 1.0 8.8 5.5 4.5 8.6 12.1 9.2 0.0 2.1 15.9 26.0 0.0 8.8 0.1 11.6 9.6 24.9 30.9 3.2 0.1 7.7 13.4 11.6 26.0 17.5 0.0 46.1 10.4 6.0 3.5 0.0 0.3 19.5 4.1 4.3 17.1 0.0 7.2 10.8 3.6 4.7 7.0 1.7 24.7 1.0 0.4 20.4 20.7 2.2 6.4 28.9 17.9 0.8 9.6 2.7 6.6 12.2 9.9 0.7 0.3 5.1 8.4 1.9 14.7 17.7 14.5 47.4 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974116-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.6;T-cells: 3.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 1.6 3.4 5.9 4.0 7.5 2.4 2.9 10.6 10.1 2.1 3.1 2.9 4.4 0.8 1.6 13.9 3.3 2.2 3.8 5.6 4.6 8.6 5.7 2.7 6.6 4.7 4.6 5.9 0.4 5.2 3.1 3.5 1.9 6.3 5.6 2.1 3.1 5.7 1.6 1.2 7.6 5.4 0.8 3.3 6.6 6.3 3.6 5.1 4.3 3.7 1.1 6.2 3.7 5.9 5.1 8.2 0.0 2.6 0.2 0.6 0.8 0.1 2.6 2.1 5.2 2.4 7.8 15.5 0.5 5.3 1.3 0.3 11.0 2.6 3.2 2.6 16.6 5.4 2.7 8.8 11.8 1.1 13.8 21.3 0.7 5.8 2.8 0.5 3.7 2.4 5.7 6.7 6.5 1.0 6.3 6.2 12.8 4.2 11.7 12.3 8.7 0.1 14.6 8.6 14.1 2.9 6.2 1.8 14.9 3.4 1.1 10.1 6.8 2.3 1.6 3.7 0.1 0.4 1.3 1.0 4.7 5.0 11.0 1.5 0.0 0.1 0.3 2.7 0.1 1.4 1.6 1.7 1.6 0.3 0.6 3.1 3.4 0.0 0.6 0.3 0.5 1.4 1.1 5.9 7.5 10.6 10.1 5.6 4.6 4.7 4.6 5.9 6.3 3.3 5.1 5.1 1.9 3.2 0.0 5.2 3.5 1.0 2.3 3.9 0.0 5.7 4.9 4.3 2.4 0.0 3.6 9.2 2.1 3.0 5.1 2.5 1.9 3.2 0.0 2.3 0.4 1.9 4.9 2.1 5.1 3.4 0.5 0.3 5.1 3.3 0.0 3.3 2.5 1.1 1.2 0.0 5.8 4.4 4.1 1.0 0.4 0.2 0.0 0.9 1.8 0.0 2.1 2.9 8.2 1.5 0.0 8.4 1.8 0.0 0.5 3.0 4.1 3.5 3.0 3.3 0.0 0.1 0.9 0.5 1.3 6.4 1.8 2.7 4.7 0.4 2.5 3.9 LSP1 WP34 ENSG00000130592 "Lymphocyte specific protein 1" P33241 11 1850904-1892267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 226.5;lymphoid tissue: 246.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 492.2;Langerhans cells: 553.6;monocytes: 1505.6;NK-cells: 352.2;Plasma cells: 338.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 278.5;HDLM-2: 978.9;Karpas-707: 215.4;RPMI-8226: 500.2;U-937: 173.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017781, HPA019693" Enhanced NA NA 1600000 "CAB017781: , HPA019693: AB_1853387" "unprognostic (7.53e-3)" "prognostic favorable (3.56e-4)" "unprognostic (4.35e-2)" "prognostic favorable (2.54e-4)" "prognostic unfavorable (5.35e-4)" "unprognostic (1.43e-3)" "unprognostic (3.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.72e-1)" "unprognostic (1.03e-3)" "unprognostic (3.29e-1)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.20e-2)" 70.7 226.5 2.2 150.1 3.2 168.7 51.7 2.7 6.7 55.3 6.2 35.2 33.9 37.1 3.9 42.8 42.1 32.9 38.5 4.0 4.7 6.4 12.2 50.2 156.1 4.5 3.3 1.9 5.4 10.8 3.9 7.4 22.0 4.7 13.5 22.5 1.0 53.3 8.1 28.7 97.6 77.3 12.6 5.8 246.9 52.5 8.2 4.9 66.1 24.9 29.7 85.7 84.5 51.9 7.3 0.3 1.2 0.0 0.0 41.0 125.2 0.4 0.0 0.0 0.0 0.0 0.1 0.2 278.5 1.5 0.2 0.3 0.4 0.0 0.0 0.0 978.9 0.0 0.5 0.2 0.4 7.9 1.0 0.9 32.0 0.5 0.1 1.3 0.4 0.1 2.2 0.9 215.4 24.7 0.1 19.6 28.2 0.5 0.0 0.0 1.1 13.6 500.2 0.0 0.0 0.4 3.3 0.2 0.0 0.3 0.0 0.3 0.9 0.5 0.7 4.6 0.3 0.8 1.0 0.7 38.4 0.4 173.0 0.3 365.1 803.6 785.5 384.3 863.3 222.6 452.1 249.1 346.8 896.6 298.8 161.3 260.8 1574.3 279.6 888.2 669.7 491.4 1293.0 2.2 3.2 2.7 6.7 4.0 4.7 4.5 3.3 1.9 4.7 5.8 4.9 7.3 18.3 16.0 7.9 0.0 312.8 118.3 14.0 43.0 76.8 0.8 3.9 4.3 2.7 8.6 37.6 3.7 0.0 3.6 295.4 0.4 1.9 1.3 3.4 1.2 13.3 11.4 1.2 40.6 0.2 8.9 4.4 160.4 15.3 1.4 12.6 0.9 11.0 2.3 492.2 1.7 0.2 0.8 16.2 118.4 553.6 7.8 89.8 310.9 65.8 0.0 1505.6 0.2 352.2 0.5 0.1 1.4 1.4 30.1 338.4 1.1 1.2 12.9 36.6 1.0 0.0 182.1 15.9 0.4 1.3 16.7 114.7 6.4 310.1 92.7 3.2 67.3 TNNT3 "AMCD2B, DA2B, DKFZp779M2348, FSSV" ENSG00000130595 "Troponin T3, fast skeletal type" P45378 11 1919703-1938706 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 43 "skeletal muscle: 14039.2;tongue: 4547.7" "Cell type enriched" "Detected in many" 4 "Skeletal myocytes: 542.6" "Group enriched" "Detected in many" 9 "head and neck cancer: 28.8;urothelial cancer: 19.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 17 "basophil: 5.3" "Lineage enriched" "Detected in single" 17 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 21 "HSkMC: 24.0" "Region enhanced" "Detected in some" "olfactory bulb: 5.1" "Low region specificity" "Detected in single" "CAB002451, HPA037810, HPA056909" Enhanced NA NA 470000 "CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273" "unprognostic (1.01e-2)" "prognostic favorable (7.37e-4)" "unprognostic (2.17e-2)" "unprognostic (2.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.29e-2)" "unprognostic (4.53e-3)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (4.29e-3)" "unprognostic (3.53e-2)" "unprognostic (4.34e-1)" "unprognostic (1.42e-5)" "unprognostic (2.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-2)" "unprognostic (2.90e-2)" 27.8 2.4 0.2 1.4 0.4 1.5 20.2 0.2 0.4 12.4 0.1 4.5 0.2 6.6 2.8 63.0 14.6 1.9 126.5 0.3 0.2 0.7 1.4 3.7 1.4 0.2 0.1 0.2 1.7 2.3 0.3 2.5 41.7 0.2 20.8 0.5 0.0 217.8 3.1 14039.2 8.5 3.1 1.3 0.1 2.9 3.3 5.3 0.1 5.5 7.7 4547.7 2.1 20.4 12.1 0.2 0.0 0.0 0.0 0.0 0.5 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.2 0.4 0.3 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.2 33.1 0.0 1.9 0.0 0.8 2.9 3.9 5.9 2.2 0.0 0.4 0.3 17.8 0.0 10.1 0.0 0.0 24.5 1.5 0.0 0.0 0.1 0.3 2.4 0.3 33.9 0.0 0.0 0.1 0.0 6.7 42.0 0.0 0.1 0.0 3.0 0.0 0.0 2.7 0.0 0.0 0.0 6.1 0.0 2.3 2.5 110.9 2.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 94.8 0.3 0.2 0.0 0.0 42.5 0.0 0.0 542.6 11.2 0.1 0.6 2.9 3.4 18.3 2.0 0.7 0.0 17.1 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838981-1841680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "skeletal muscle: 8045.8;tongue: 2645.6" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 86.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 35.7;hTCEpi: 101.2" "Region enriched" "Detected in single" 6 "olfactory bulb: 5.1" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 110000 "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 2.3 1.8 0.3 1.1 0.3 6.1 8.0 0.3 0.6 0.9 0.4 1.2 0.3 0.8 0.3 67.4 0.9 5.6 1.5 0.3 0.3 0.7 1.6 7.9 1.6 0.4 0.3 0.3 0.7 8.8 0.0 0.9 3.0 0.4 14.1 0.2 0.0 217.9 3.2 8045.8 55.6 2.7 0.2 0.4 5.8 1.1 0.7 0.4 1.9 2.8 2645.6 1.0 27.7 3.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 35.7 1.0 0.2 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 8.1 101.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.1 0.0 0.1 1.2 2.4 0.0 1.0 0.0 1.0 0.0 0.7 0.0 0.0 12.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 13.8 5.8 53.3 0.1 12.5 0.1 3.8 0.0 0.0 8.0 4.8 0.0 0.0 39.7 0.4 17.6 86.4 0.0 2.5 0.3 0.3 0.3 0.6 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.5 1.2 3.2 4.4 0.0 9.1 25.1 2.6 1.8 15.4 0.0 0.5 23.7 5.6 21.5 3.0 0.0 0.0 33.8 15.7 0.1 0.0 1.4 0.0 1.4 0.2 2.0 0.0 0.0 0.0 0.6 449.4 2.4 1.1 0.1 10.8 0.4 0.4 0.3 39.6 0.0 0.0 0.0 2.0 18.8 10.7 0.0 0.3 25.9 0.0 0.0 16.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 4.2 0.1 0.0 0.2 13.2 0.0 0.0 598.7 2.4 0.0 0.6 2.7 6.5 87.2 1.9 4.3 0.0 0.9 COL5A1 ENSG00000130635 "Collagen type V alpha 1 chain" P20908 9 134641803-134844843 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Cancer-related genes, Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 140.8" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030769 Approved Approved Vesicles "Secreted to extracellular matrix" No No 15000000 Vesicles "HPA030769: AB_2673603" "unprognostic (7.77e-2)" "unprognostic (4.55e-3)" "unprognostic (2.22e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (8.07e-2)" "unprognostic (8.09e-2)" "unprognostic (2.38e-3)" "unprognostic (1.54e-2)" "unprognostic (5.03e-3)" "unprognostic (5.05e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.07e-12)" "unprognostic (2.02e-2)" "unprognostic (4.73e-2)" "unprognostic (1.65e-2)" "unprognostic (2.50e-3)" 39.7 12.1 1.5 39.5 1.2 1.0 20.1 2.0 4.5 140.8 5.0 56.3 13.7 119.2 11.2 23.4 60.2 78.2 28.6 1.2 3.0 7.0 7.6 36.0 5.6 4.2 2.8 0.9 52.3 7.1 6.8 6.6 96.6 1.3 44.1 16.5 3.1 9.4 29.2 10.3 24.8 22.2 90.5 2.3 17.7 31.7 6.2 3.8 2.3 10.1 7.3 2.9 52.1 63.9 1.3 0.6 16.7 13.0 20.7 192.2 202.4 7.9 446.6 89.0 73.6 78.6 0.2 0.3 0.0 95.3 414.6 39.8 5.6 0.0 0.1 21.3 0.1 1.0 0.3 297.0 0.1 265.8 0.2 2.7 200.0 0.2 71.1 5.6 0.0 89.2 0.1 0.1 1.2 39.5 4.1 0.3 0.9 7.6 0.0 8.5 15.7 50.3 1.8 0.1 0.1 5.3 2.5 290.0 1.8 0.2 173.7 0.6 0.2 152.6 154.4 61.9 190.4 93.7 0.3 0.2 0.4 121.6 0.1 26.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 2.0 4.5 1.2 3.0 4.2 2.8 0.9 1.3 2.3 3.8 1.3 7.9 0.0 1.8 0.7 0.3 14.5 3.5 0.8 3.4 8.5 0.8 2.7 9.0 0.0 0.0 1.8 2.1 6.4 0.3 0.0 1.9 2.2 5.5 4.2 141.1 8.8 0.0 0.0 6.6 0.0 12.3 134.9 1.5 4.8 0.0 1.2 21.8 0.0 8.9 0.0 1.2 0.0 0.0 0.3 15.3 15.6 61.2 1.5 7.2 12.2 0.0 6.4 0.0 5.5 0.3 1.3 0.0 38.7 0.3 1.0 0.0 0.3 0.0 1.2 52.6 78.3 57.5 0.5 0.8 0.6 7.7 10.4 2.6 11.7 0.0 0.4 ATXN10 "E46L, FLJ37990, SCA10" ENSG00000130638 "Ataxin 10" Q9UBB4 22 45671798-45845307 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049531 Approved Supported "Plasma membrane,Cytosol" NA NA 40000 Cytosol "Plasma membrane" "HPA049531: AB_2680806" "unprognostic (5.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (3.01e-2)" "unprognostic (7.50e-2)" "unprognostic (1.19e-3)" "unprognostic (3.18e-1)" "unprognostic (2.15e-2)" "unprognostic (5.07e-2)" "unprognostic (8.38e-2)" "unprognostic (3.51e-1)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (7.48e-2)" "unprognostic (6.98e-2)" 39.5 60.0 45.5 35.0 48.0 42.3 42.1 37.1 57.2 49.6 29.1 39.0 24.0 50.4 39.4 46.8 56.6 40.0 75.2 49.6 50.5 54.0 65.3 38.5 48.7 39.7 41.6 43.2 58.2 57.8 65.5 56.5 49.2 42.5 46.9 36.7 55.6 41.9 41.3 71.2 33.6 28.1 50.6 42.8 34.5 34.7 57.8 47.1 66.5 63.6 59.8 52.0 51.6 46.2 48.5 163.4 84.9 156.2 95.0 70.5 107.6 85.4 181.0 194.3 128.1 139.4 42.9 106.4 169.3 73.2 184.5 66.4 94.4 114.3 121.3 137.7 32.8 119.4 78.9 141.7 79.8 101.9 213.1 56.4 109.0 82.9 66.5 103.1 153.1 96.3 76.2 58.7 89.8 197.2 69.6 116.7 95.6 104.2 90.8 64.0 166.2 60.7 135.9 162.6 152.3 86.9 136.6 113.5 67.2 129.2 119.8 101.4 111.9 87.6 127.5 47.7 46.0 61.4 87.8 57.3 136.8 79.5 88.5 138.5 80.5 99.9 91.8 69.0 121.7 92.3 72.1 68.0 84.3 163.9 72.6 74.4 71.9 4.7 86.2 138.5 58.1 70.8 120.2 45.5 48.0 37.1 57.2 49.6 50.5 39.7 41.6 43.2 42.5 42.8 47.1 48.5 38.1 35.3 33.3 127.3 50.6 50.5 124.2 156.0 68.9 66.3 45.4 50.0 94.2 65.8 76.7 58.8 20.9 101.9 32.3 17.1 68.4 91.1 69.2 53.7 53.7 44.4 60.3 63.1 148.6 69.5 106.3 70.7 34.1 49.8 39.9 93.5 36.4 54.9 72.2 70.7 157.9 35.4 79.3 49.0 36.5 40.6 57.5 48.3 24.9 103.0 67.9 79.3 27.8 186.5 168.1 51.6 24.0 75.6 53.3 115.2 18.6 66.9 67.6 53.6 46.0 45.1 54.6 133.8 108.3 65.1 41.5 52.3 47.8 102.2 44.5 102.0 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278635-133312337 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.2 22.4 12.3 21.1 13.0 35.3 13.5 11.9 19.4 15.9 14.8 18.4 22.3 16.1 10.6 17.5 30.6 15.1 20.6 13.0 11.9 19.5 16.5 17.5 21.1 15.4 14.0 13.6 27.1 28.5 26.2 3.5 15.9 16.5 18.0 13.4 11.9 28.4 17.3 33.5 22.7 22.3 15.1 11.1 22.0 20.5 21.9 13.1 20.9 19.2 24.7 14.5 16.1 5.8 13.4 64.2 84.2 30.7 35.6 28.3 29.8 42.9 47.5 66.5 50.0 49.5 97.0 45.9 42.1 27.7 48.6 21.6 47.2 35.8 32.3 22.8 50.5 75.7 24.6 46.7 52.3 35.5 63.4 57.0 31.3 29.9 46.5 58.0 55.3 33.3 29.9 36.4 45.6 41.2 79.9 41.4 56.3 30.4 37.2 64.6 32.7 32.9 19.5 32.7 40.8 20.6 43.0 33.0 40.1 36.1 17.9 23.6 38.3 45.6 30.9 27.6 38.0 47.9 43.7 25.9 53.8 102.3 27.3 19.8 6.4 22.5 15.9 15.3 23.2 14.8 11.4 13.3 14.6 27.6 12.3 14.0 15.4 13.8 27.7 25.8 11.7 18.3 19.0 12.3 13.0 11.9 19.4 13.0 11.9 15.4 14.0 13.6 16.5 11.1 13.1 13.4 29.1 48.1 38.5 18.9 36.7 13.9 27.4 30.2 23.3 45.7 25.9 25.3 33.9 22.8 38.8 40.5 31.3 41.4 40.1 34.8 23.5 34.5 25.9 78.0 41.6 26.4 29.3 28.0 17.5 37.1 32.9 35.9 38.7 37.1 39.9 49.5 28.9 27.5 44.4 38.7 15.9 36.2 8.2 42.7 25.5 28.6 33.8 51.6 14.2 15.9 75.0 39.3 62.8 9.5 20.1 37.3 33.5 35.3 37.2 28.6 37.3 53.4 112.2 74.8 32.9 39.9 32.1 74.3 65.3 29.0 13.8 42.5 35.7 50.4 36.0 30.3 CALY "CALCYON, DRD1IP, NSG3" ENSG00000130643 "Calcyon neuron specific vesicular protein" Q9NYX4 10 133324072-133336935 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 184.4;pituitary gland: 168.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 155.7;Excitatory neurons: 72.6;Horizontal cells: 72.3;Inhibitory neurons: 128.5" "Cancer enriched" "Detected in some" 4 "pancreatic cancer: 7.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042283 Enhanced NA NA "HPA042283: AB_10794417" "unprognostic (1.43e-2)" "unprognostic (7.84e-2)" "unprognostic (3.77e-3)" "unprognostic (1.41e-2)" "unprognostic (7.32e-2)" "unprognostic (9.81e-3)" "unprognostic (2.56e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.23e-2)" "unprognostic (4.19e-10)" "unprognostic (8.04e-3)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" "unprognostic (1.63e-1)" 0.2 18.1 67.5 0.8 49.9 0.1 0.1 10.1 84.7 0.2 0.0 3.6 2.5 0.0 0.1 0.1 0.2 0.0 0.2 46.8 184.4 0.2 0.3 0.4 0.2 58.2 74.9 60.6 0.2 3.4 0.6 168.9 0.0 65.3 0.5 0.5 11.2 0.2 0.1 0.1 0.2 2.3 0.3 21.6 0.6 2.4 4.3 86.4 0.0 0.4 0.0 0.1 0.2 0.9 117.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.5 49.9 10.1 84.7 46.8 184.4 58.2 74.9 60.6 65.3 21.6 86.4 117.5 0.2 0.0 0.0 26.1 0.1 0.3 0.0 0.0 0.0 155.7 0.8 0.9 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 2.2 0.0 0.5 0.6 19.5 0.0 72.6 0.0 0.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.1 72.3 128.5 1.5 0.0 0.0 0.4 2.0 0.0 0.2 0.0 18.7 0.0 11.5 0.0 10.6 20.1 0.6 0.0 0.4 0.1 0.6 0.0 0.4 0.0 31.7 0.0 0.2 0.5 16.3 7.9 0.0 0.0 0.3 2.8 0.2 0.1 0.0 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 308 "liver: 10463.6" "Cell type enriched" "Detected in many" 58 "Hepatocytes: 6272.7" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5;myeloid DC: 6.2" "Group enriched" "Detected in many" 16 "dendritic cells: 6.2;T-cells: 2.5" "Cell line enhanced" "Detected in many" "HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 2.4 3.0 5.1 0.6 5.4 0.8 3.0 9.0 7.6 4.8 3.1 4.0 1.4 4.5 8.4 16.9 5.5 2.5 2.1 5.6 5.6 9.2 10463.6 2.6 2.0 6.2 5.8 4.7 4.2 12.5 0.6 4.1 1.4 6.8 5.4 1.2 11.6 3.6 6.2 2.8 14.0 2.2 2.2 5.1 7.3 6.8 3.7 6.2 1.8 4.0 0.9 33.9 3.5 3.3 7.5 0.1 0.0 0.3 1.0 3.5 1.9 0.7 1.6 4.5 0.0 0.3 0.0 2.7 1.4 0.2 0.5 0.0 11.0 0.0 0.2 0.4 0.3 1.5 1.8 0.2 1.3 0.6 8.9 8.9 1.0 0.2 0.0 0.7 1.9 0.0 3.1 0.6 0.4 1.0 0.7 0.6 24.0 6.4 4.3 0.4 0.4 6.1 0.0 2.0 0.0 0.0 0.0 4.2 0.0 0.6 0.2 0.3 0.9 0.0 1.4 0.4 2.3 1.0 2.2 1.0 3.0 1.5 7.4 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.1 0.6 6.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 5.1 5.4 9.0 7.6 5.6 5.6 6.2 5.8 4.7 6.8 5.1 6.2 7.5 0.8 0.0 1.1 5.5 9.2 2.3 0.2 0.7 0.6 5.7 0.6 0.5 2.8 48.6 1.9 0.0 2.1 0.0 0.4 0.1 0.0 1.6 2.1 0.6 0.8 4.6 0.0 67.6 6.7 1.3 0.1 1.1 1.5 0.5 1.3 0.7 67.1 6272.7 0.0 8.4 5.3 0.0 0.0 108.0 2.8 2.1 1.5 0.3 0.0 1.9 0.4 0.7 0.0 2.0 2.2 3.2 0.0 2.6 0.3 0.6 0.0 0.6 2.2 5.8 0.0 0.2 0.6 4.1 4.2 2.0 7.5 0.1 5.7 0.2 0.0 0.0 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459952-137550402 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.0;T-reg: 1.2" "Group enriched" "Detected in many" 4 "B-cells: 1.0;T-cells: 1.2" "Cell line enriched" "Detected in some" 22 "HMC-1: 83.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favorable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.5 7.1 4.7 2.2 4.8 2.1 11.4 1.6 8.7 16.4 1.1 9.9 2.3 12.4 1.0 2.7 13.1 3.7 6.5 6.1 2.7 6.2 14.1 4.8 4.4 4.5 2.1 4.3 21.6 18.1 2.0 9.0 0.6 4.3 22.6 1.4 1.4 16.1 2.7 17.4 13.8 8.4 1.6 1.9 7.0 16.5 2.6 2.8 1.4 17.5 3.4 1.4 10.6 7.7 4.5 0.1 1.0 0.2 0.3 0.8 0.5 0.4 0.8 0.8 0.2 0.2 0.1 0.5 0.6 0.8 0.4 0.4 0.3 0.1 0.0 0.0 1.6 0.9 0.8 1.0 0.3 0.5 0.4 83.7 1.2 0.1 0.3 0.0 1.4 0.1 0.1 0.1 2.3 0.1 1.6 0.2 1.6 0.0 1.2 0.9 2.0 1.3 2.8 0.1 0.3 1.6 0.4 0.1 0.6 0.3 0.2 3.7 1.2 0.6 0.0 0.1 0.4 0.1 0.8 0.2 0.2 1.2 0.8 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.2 1.0 0.3 0.2 0.0 0.0 0.0 0.1 1.2 0.2 4.7 4.8 1.6 8.7 6.1 2.7 4.5 2.1 4.3 4.3 1.9 2.8 4.5 3.0 9.6 5.9 56.2 4.8 1.5 1.1 0.9 2.2 2.5 6.5 8.3 3.9 4.3 2.6 1.8 6.2 0.2 2.1 6.6 0.0 0.7 0.5 1.7 4.8 1.2 17.3 0.8 23.6 0.0 0.3 3.6 12.2 3.8 7.0 1.2 2.5 10.2 2.6 5.0 21.5 9.2 0.0 4.5 1.0 0.6 4.4 1.2 0.0 9.4 1.3 2.5 1.0 11.6 21.0 0.6 7.1 1.9 1.6 2.5 3.8 1.0 1.6 9.6 0.0 2.3 2.1 3.1 4.0 0.9 3.3 0.0 2.3 0.6 2.0 0.7 HBZ "HBZ-T1, HBZ1" ENSG00000130656 "Hemoglobin subunit zeta" P02008 16 142728-154503 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 4.0;testis: 7.4" "Group enriched" "Detected in some" 4 "Erythroid cells: 82.9;Hofbauer cells: 192.0;Late spermatids: 275.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 80 "K-562: 2189.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063268, HPA064073, HPA071726" Approved Approved Nucleoplasm,Cytosol NA NA 80000000 Cytosol Nucleoplasm "HPA063268: , HPA064073: , HPA071726: AB_2732184" "unprognostic (3.56e-1)" "unprognostic (1.32e-1)" 0.5 0.0 0.3 0.0 0.3 4.0 0.6 0.1 0.8 0.4 0.6 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.4 0.1 0.1 0.2 0.5 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.2 0.7 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.1 7.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.1 4.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 27.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2189.0 0.2 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.8 0.4 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.3 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 40.0 0.0 0.1 3.7 0.0 82.9 0.5 0.0 42.4 1.8 0.0 0.0 0.0 0.1 0.4 0.0 192.0 0.0 0.3 0.0 0.0 0.3 0.3 275.5 0.6 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 6.6 1.9 4.8 1.3 1.8 0.0 0.1 10.4 0.1 0.0 0.1 0.0 PAK4 ENSG00000130669 "P21 (RAC1) activated kinase 4" O96013 19 39125770-39182816 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 154.7;MCF7: 172.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025747, CAB044670, HPA070175, HPA072220" Uncertain Supported "Plasma membrane,Cell Junctions" NA Yes "Plasma membrane, Cell Junctions" "CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (5.86e-2)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (8.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.13e-3)" "unprognostic (3.90e-2)" "unprognostic (4.04e-2)" "unprognostic (7.29e-2)" "prognostic unfavorable (9.85e-4)" "prognostic favorable (5.29e-5)" "unprognostic (2.39e-1)" "unprognostic (7.05e-2)" "unprognostic (2.02e-1)" "unprognostic (4.85e-2)" 11.5 20.2 14.3 8.1 15.1 5.4 22.3 11.8 18.5 25.4 11.0 24.5 27.7 20.8 9.4 44.2 23.6 7.5 15.0 11.5 11.5 37.2 26.4 39.9 4.5 15.8 14.7 9.0 24.4 32.1 16.4 30.8 16.5 16.6 41.1 8.1 5.9 42.8 11.1 14.1 39.1 25.3 5.8 9.9 13.9 25.5 35.3 12.9 5.5 29.5 4.3 5.5 20.4 30.7 15.0 62.8 154.7 22.7 34.8 7.1 7.5 68.1 29.3 11.7 19.3 19.4 102.1 51.9 14.3 43.3 18.7 25.2 22.7 12.6 23.2 7.2 38.0 35.4 16.9 27.5 50.4 11.3 17.5 23.6 9.0 10.2 18.1 12.9 12.6 25.5 21.4 34.3 11.0 11.8 172.7 18.6 18.9 41.4 55.2 36.7 18.5 17.9 10.9 19.0 67.9 72.2 49.9 29.8 130.6 33.6 11.7 58.1 28.4 42.8 32.6 55.6 37.8 53.0 12.3 12.9 11.9 39.9 10.3 39.9 0.3 0.7 1.2 0.6 0.3 0.8 0.5 0.7 1.1 0.9 0.6 0.5 0.5 0.5 0.9 0.6 0.8 0.9 0.7 14.3 15.1 11.8 18.5 11.5 11.5 15.8 14.7 9.0 16.6 9.9 12.9 15.0 5.1 0.0 1.5 9.4 3.9 14.4 15.9 13.8 9.6 18.8 34.2 21.7 2.0 20.0 9.1 18.4 25.0 42.6 4.4 47.5 31.3 20.5 4.1 19.5 8.5 15.0 44.9 5.0 3.9 19.7 67.4 8.8 23.9 23.3 5.7 21.6 10.0 13.3 9.6 21.9 4.2 33.8 28.5 5.3 4.1 6.4 11.8 3.6 7.2 8.4 11.2 13.6 8.2 9.5 13.5 21.8 44.2 10.5 5.8 21.7 39.5 14.4 13.7 13.4 0.0 8.5 7.5 10.4 24.0 20.1 18.8 65.4 6.0 22.3 33.9 24.3 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010663 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 7.3;pancreas: 16.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 39 "spinal cord: 3.9" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.5 0.3 0.3 0.1 0.0 0.2 0.4 0.0 0.0 3.8 7.3 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 16.5 0.0 2.7 0.0 0.9 0.3 3.0 0.0 1.1 0.0 0.0 0.1 6.1 0.0 0.6 0.0 2.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.4 5.8 0.0 17.2 0.0 0.0 12.7 0.0 0.0 0.1 0.0 7.6 2.5 1.4 16.2 0.0 0.5 0.3 3.0 2.3 1.3 2.2 13.2 0.0 1.5 3.6 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 6.1 5.7 2.9 0.0 10.1 0.9 0.2 0.0 1.7 1.1 0.0 2.5 37.6 6.5 0.6 19.3 0.0 2.5 2.2 0.4 0.1 5.4 4.4 0.0 0.0 0.0 0.0 0.0 5.3 2.9 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.5 0.1 1.3 0.3 0.0 0.9 0.6 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 1.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 4.4 1.3 0.1 0.0 0.1 25.1 0.0 0.0 3.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 19.7 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 3.1 7.0 0.0 0.4 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.8 0.0 0.0 0.0 0.2 0.0 13.6 0.0 ZNF337 dJ694B14.1 ENSG00000130684 "Zinc finger protein 337" Q9Y3M9 20 25673195-25696853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 26.4;Excitatory neurons: 30.4;Inhibitory neurons: 26.8;Oligodendrocyte precursor cells: 26.2;Oligodendrocytes: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044303, HPA064219" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA044303: AB_2678890, HPA064219: AB_2685215" "unprognostic (2.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-3)" "unprognostic (4.54e-3)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.34e-2)" "unprognostic (3.15e-2)" "unprognostic (9.36e-4)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.93e-2)" "unprognostic (8.82e-3)" 15.7 13.5 22.0 7.4 22.0 10.4 16.2 28.6 25.7 25.6 22.2 22.1 5.9 21.7 16.2 14.9 26.4 6.9 14.1 20.9 20.9 15.5 11.7 16.7 11.3 20.7 20.9 21.5 31.4 13.2 10.5 24.6 7.8 24.8 27.6 9.0 26.1 12.8 13.4 12.6 12.8 18.7 11.8 19.4 21.9 14.1 9.4 20.9 15.5 19.0 8.6 9.6 22.5 19.9 25.5 10.0 17.3 14.0 9.9 11.2 14.3 11.9 8.4 7.3 6.3 7.8 3.6 9.1 12.3 7.8 7.8 12.8 16.0 9.3 27.9 8.7 4.4 7.2 7.5 13.9 15.8 9.6 6.9 8.1 13.3 24.1 7.5 22.1 16.7 10.0 15.7 6.8 10.6 12.5 11.4 18.6 13.4 3.7 5.3 12.2 11.8 12.8 6.0 6.6 11.1 11.2 12.0 8.3 13.4 11.1 17.2 7.7 9.4 13.5 14.1 7.2 9.4 11.3 14.9 8.3 4.3 6.7 5.9 11.2 0.0 1.6 3.2 4.6 2.7 5.0 2.3 3.7 4.2 2.7 1.8 5.2 6.1 0.0 3.9 1.5 2.5 2.5 2.6 22.0 22.0 28.6 25.7 20.9 20.9 20.7 20.9 21.5 24.8 19.4 20.9 25.5 8.6 6.4 15.4 26.4 4.3 2.0 5.6 3.4 4.6 8.4 4.1 5.2 1.2 2.8 10.8 3.7 2.1 3.8 4.5 1.2 3.9 4.3 1.4 6.7 8.9 5.6 5.4 1.3 30.4 3.1 2.0 5.4 2.0 4.4 5.1 9.8 3.3 3.2 3.3 6.7 26.8 4.2 0.0 3.1 1.1 0.3 7.2 4.3 1.8 25.3 3.1 7.9 11.3 26.2 29.3 2.7 1.0 5.7 1.7 5.4 1.6 1.9 15.5 13.0 0.0 6.3 4.8 8.1 10.2 3.6 2.4 2.3 6.2 5.4 2.6 1.9 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234200-26278808 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.2;tongue: 66.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.7 3.6 4.1 5.4 8.3 21.0 3.8 5.2 7.2 3.3 3.6 4.6 3.4 3.2 3.2 8.7 2.8 2.7 23.9 4.4 6.9 6.0 5.8 4.8 6.9 7.7 7.5 4.0 3.3 5.1 8.9 6.1 3.2 9.6 3.0 6.1 14.2 5.3 2.4 134.2 9.9 5.3 3.7 3.9 6.3 4.8 31.4 6.5 13.7 7.9 66.5 7.9 3.2 6.3 14.7 29.6 12.5 30.2 22.6 7.3 8.9 52.5 18.8 11.5 31.9 28.5 17.4 28.2 34.3 20.1 9.2 14.6 25.5 41.0 14.4 29.9 23.5 20.9 49.7 31.9 19.4 6.6 46.2 43.8 3.8 13.7 24.9 16.4 12.8 14.5 47.7 57.4 39.9 19.2 9.8 38.7 35.2 23.0 17.4 20.8 39.8 31.3 29.7 10.4 5.5 41.4 16.7 24.5 19.8 15.7 21.5 14.5 26.4 14.3 17.1 26.7 19.3 24.7 30.0 48.4 38.9 9.8 65.2 27.5 5.0 6.4 19.2 3.5 6.1 2.8 2.6 2.6 2.7 4.9 1.8 2.2 3.5 0.6 2.3 7.4 2.1 3.6 3.6 4.1 8.3 5.2 7.2 4.4 6.9 7.7 7.5 4.0 9.6 3.9 6.5 14.7 1.0 0.0 2.2 3.6 2.7 6.9 4.0 2.5 6.2 11.2 3.7 2.9 29.0 1.5 3.7 5.5 12.5 3.4 5.1 6.9 7.9 1.7 1.0 3.4 2.3 2.0 1.8 16.8 12.8 1.3 3.9 2.3 3.6 4.9 2.5 9.1 1.4 3.1 4.8 0.0 9.9 3.7 2.0 5.0 3.7 2.9 1.5 4.3 1.8 4.7 4.0 1.8 2.1 3.0 28.8 2.7 3.4 0.4 4.4 2.5 2.3 1.1 2.0 11.1 0.0 2.4 2.3 40.9 34.2 8.6 6.1 41.7 3.4 2.3 4.5 4.5 TAF4 "TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135" ENSG00000130699 "TATA-box binding protein associated factor 4" O00268 20 61953469-62065810 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008599, CAB031484" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB031484: AB_671207, HPA008599: AB_1080183" "unprognostic (3.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-1)" "unprognostic (6.29e-2)" "unprognostic (3.14e-1)" "unprognostic (9.67e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (2.16e-1)" "unprognostic (1.91e-1)" "unprognostic (2.74e-1)" "unprognostic (3.34e-1)" "unprognostic (1.00e-3)" "unprognostic (4.39e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (3.92e-2)" "unprognostic (9.99e-2)" 4.9 5.4 1.6 2.1 1.1 2.9 5.1 2.8 1.6 6.2 0.1 6.1 2.6 6.4 0.5 6.2 5.7 0.9 4.4 1.0 0.5 5.2 7.6 5.0 1.8 1.8 0.9 0.6 9.9 7.0 1.3 4.4 1.5 1.8 5.2 0.9 1.6 4.8 1.2 8.8 6.6 6.3 1.1 0.3 6.0 5.9 10.1 1.1 2.7 5.3 1.7 1.1 5.7 5.8 1.9 6.6 6.1 3.6 4.2 1.6 1.2 7.3 3.2 1.4 5.2 2.8 20.5 5.4 5.3 8.1 1.7 3.9 8.4 3.2 3.8 2.2 4.6 4.7 12.3 7.1 9.5 1.7 5.9 10.7 0.9 3.4 2.4 2.4 1.5 2.1 6.5 10.1 4.6 0.9 7.1 16.7 7.2 5.3 4.7 8.6 15.3 8.3 5.7 1.7 6.1 6.1 5.3 9.8 10.2 3.4 2.6 6.3 7.2 2.6 6.7 9.7 6.8 6.0 6.4 6.4 8.5 4.0 3.5 4.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 1.1 2.8 1.6 1.0 0.5 1.8 0.9 0.6 1.8 0.3 1.1 1.9 5.6 6.4 14.1 13.1 4.7 7.6 3.2 4.5 4.6 8.8 8.3 4.4 7.3 5.7 4.4 5.5 2.1 5.6 6.1 11.6 0.0 5.7 21.1 7.4 5.8 7.1 3.6 10.8 16.3 3.8 5.0 5.7 8.6 11.3 1.3 7.9 6.4 12.6 5.9 15.2 17.3 9.9 12.2 11.0 5.5 7.0 9.3 7.1 3.6 15.0 10.5 3.9 5.2 17.6 22.1 6.0 10.1 10.5 4.3 8.0 9.8 4.9 7.4 9.1 6.6 5.4 6.2 8.6 13.1 7.6 9.7 8.3 7.5 5.2 9.9 5.6 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475995 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 11.3;stomach 1: 10.9;testis: 11.6;urinary bladder: 15.5" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 22.4;Hepatic stellate cells: 7.9;Intestinal goblet cells: 8.7;Proximal enterocytes: 38.8" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HEL: 2.9;K-562: 4.6;SiHa: 2.0;T-47d: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067583 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067583: AB_2685867" "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.1 11.3 3.5 0.3 0.1 9.6 1.4 1.9 0.0 0.0 3.9 0.7 2.0 0.0 0.0 0.0 0.0 0.7 0.1 3.4 0.4 0.4 0.0 5.5 0.0 0.0 0.3 0.3 0.0 0.2 10.1 0.7 0.0 0.0 10.9 11.6 0.0 0.0 0.6 0.2 0.0 15.5 1.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.2 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 2.0 0.0 0.0 0.8 4.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.2 1.7 22.4 0.2 0.0 0.0 7.9 0.0 0.3 0.0 0.0 8.7 0.0 0.0 0.3 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.1 0.0 0.1 0.0 0.0 0.0 3.4 0.0 RBBP8NL "C20orf151, dJ908M14.3" ENSG00000130701 "RBBP8 N-terminal like" Q8NC74 20 62410237-62427539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 51.2;Intestinal goblet cells: 58.0;Paneth cells: 54.5;Proximal enterocytes: 157.4;Undifferentiated cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.6;CACO-2: 27.5;MCF7: 11.5;SK-BR-3: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.99e-2)" "unprognostic (6.95e-3)" "unprognostic (2.71e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.27e-3)" "unprognostic (2.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (2.76e-1)" "unprognostic (2.15e-1)" "unprognostic (1.44e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.91e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.7 0.9 0.0 1.2 4.5 0.1 0.7 9.1 0.8 0.5 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 1.9 2.0 0.4 0.0 3.8 0.6 0.0 4.4 1.0 0.0 4.5 4.7 0.0 0.0 0.0 2.7 2.9 0.0 0.0 3.6 0.0 0.3 1.7 3.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 27.5 2.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 12.5 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.3 1.3 0.3 0.0 0.0 3.3 2.2 2.7 7.2 1.7 1.8 0.0 6.0 0.0 51.2 0.0 0.3 13.4 1.0 0.0 0.0 9.6 0.0 0.4 0.2 5.1 0.2 2.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 58.0 2.0 0.0 0.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 54.5 0.0 0.0 0.7 157.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.1 1.4 2.6 0.1 0.0 26.2 1.0 LAMA5 ENSG00000130702 "Laminin subunit alpha 5" O15230 20 62307955-62367312 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Cytotrophoblasts: 104.4;Glandular and luminal cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 114.9;CACO-2: 159.6;EFO-21: 114.4;HaCaT: 107.2;HeLa: 118.3;TIME: 138.4" "Low region specificity" "Detected in many" "HPA058389, CAB078157" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 1800000 Vesicles "CAB078157: AB_2665809, HPA058389: " "unprognostic (8.01e-2)" "unprognostic (2.47e-1)" "unprognostic (1.92e-2)" "unprognostic (3.42e-3)" "unprognostic (1.17e-1)" "unprognostic (9.90e-3)" "unprognostic (4.01e-3)" "unprognostic (5.45e-2)" "unprognostic (8.99e-2)" "unprognostic (1.34e-2)" "unprognostic (5.98e-3)" "unprognostic (2.98e-3)" "unprognostic (4.04e-2)" "unprognostic (9.86e-3)" "unprognostic (2.07e-1)" "unprognostic (9.76e-2)" "unprognostic (1.33e-2)" 26.6 11.9 6.2 5.1 1.4 1.3 27.2 12.2 7.0 25.1 16.5 49.1 5.4 31.6 1.2 24.7 32.1 8.0 23.0 2.4 3.8 32.6 13.3 44.3 3.0 3.0 2.2 0.0 9.4 14.0 4.8 12.2 20.2 6.3 37.0 1.2 0.6 17.9 15.5 11.1 36.3 20.1 7.3 0.7 14.1 25.3 4.6 8.0 2.7 28.9 2.8 1.9 32.8 30.5 2.5 15.1 114.9 2.2 14.8 2.7 31.0 85.9 4.2 2.2 3.3 0.6 159.6 59.1 1.3 114.4 0.1 3.6 107.2 3.1 45.8 0.2 0.3 6.5 3.8 118.3 46.1 9.9 0.0 16.6 1.6 29.6 7.9 8.0 5.7 15.0 0.0 7.0 1.7 0.0 22.3 0.1 0.4 7.3 19.3 65.9 0.2 1.4 12.8 28.6 70.3 1.1 44.5 63.2 62.2 1.2 11.6 62.0 0.9 138.4 1.6 41.2 0.7 18.9 0.8 0.2 0.6 31.7 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.2 1.4 12.2 7.0 2.4 3.8 3.0 2.2 0.0 6.3 0.7 8.0 2.5 60.2 76.9 37.1 19.9 6.9 17.1 16.0 56.8 52.9 3.6 16.7 20.8 20.5 12.8 43.9 38.6 8.4 104.4 3.9 0.6 0.0 28.6 4.3 35.5 11.7 49.6 2.4 6.1 5.9 4.5 23.3 13.0 6.1 82.0 2.5 0.9 18.9 12.7 13.1 3.3 12.7 0.3 14.2 0.6 5.4 1.3 9.9 2.2 1.8 10.3 1.1 8.2 1.0 3.5 1.3 13.2 0.1 19.5 8.5 21.9 0.0 12.2 49.6 1.8 26.3 11.0 39.4 0.6 1.7 23.4 12.6 57.3 2.2 1.7 0.6 27.5 OSBPL2 "DFNA67, KIAA0772, ORP-2" ENSG00000130703 "Oxysterol binding protein like 2" Q9H1P3 20 62231922-62296213 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 94.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 94.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041127, HPA042659" Uncertain Approved Cytosol NA NA Cytosol "HPA041127: AB_10962008, HPA042659: AB_10960683" "unprognostic (1.00e-3)" "unprognostic (7.20e-3)" "unprognostic (1.31e-1)" "unprognostic (6.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.73e-3)" "unprognostic (3.79e-2)" "unprognostic (9.60e-2)" "unprognostic (6.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.73e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.20e-5)" "unprognostic (3.86e-2)" "unprognostic (8.13e-2)" "unprognostic (4.00e-1)" "unprognostic (3.32e-2)" 14.4 15.3 21.3 13.5 21.6 33.2 19.1 39.4 21.8 18.6 18.8 24.5 23.0 14.1 15.9 41.1 15.8 20.2 25.7 17.7 20.4 18.2 18.1 16.3 14.4 23.5 25.3 15.6 15.9 40.1 26.7 26.6 13.8 24.0 20.0 22.9 14.6 25.1 19.0 18.1 42.7 21.8 17.6 20.6 25.1 28.1 15.0 30.6 17.4 22.1 12.0 20.6 23.3 30.0 20.2 23.9 17.0 19.6 18.3 19.4 19.1 18.5 14.2 27.9 46.6 32.1 61.0 24.1 11.5 37.1 28.4 41.8 40.7 18.9 42.4 25.7 13.7 17.7 30.6 21.5 31.2 19.0 11.8 26.6 17.7 61.0 20.8 23.3 22.1 19.1 29.4 20.3 21.2 13.5 19.4 17.2 19.8 6.4 43.5 15.0 15.9 23.5 15.3 23.6 48.2 25.6 16.7 25.7 48.2 24.3 25.9 32.1 21.0 13.2 23.2 17.0 24.7 17.3 24.5 37.4 17.5 25.7 8.4 14.9 16.1 9.2 34.5 13.0 11.7 11.4 13.7 10.5 13.7 9.9 10.9 9.5 11.4 94.6 16.8 9.9 7.1 17.5 10.9 21.3 21.6 39.4 21.8 17.7 20.4 23.5 25.3 15.6 24.0 20.6 30.6 20.2 27.1 16.0 18.3 17.3 16.5 20.1 24.8 24.4 14.2 18.9 24.7 16.6 61.2 15.7 28.2 11.0 6.2 13.4 21.6 44.5 31.3 22.7 33.0 22.6 12.0 18.1 16.3 24.2 13.9 20.1 14.8 17.8 42.8 34.2 10.8 19.2 12.8 14.1 12.3 18.5 21.7 29.6 22.4 11.1 8.0 17.4 17.4 14.3 8.8 10.3 16.8 18.2 27.8 9.0 15.5 39.8 37.0 13.2 21.9 38.8 30.2 14.1 34.3 15.9 13.1 14.8 13.1 22.8 11.1 25.2 27.8 37.1 18.5 12.0 25.7 58.7 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 372.5" "Cell type enhanced" "Detected in all" "Late spermatids: 1655.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 727.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 28000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 76.3 93.4 39.1 53.9 39.2 78.7 68.8 42.0 64.3 55.8 31.6 73.5 52.5 81.2 14.7 99.8 59.0 33.8 98.1 38.3 39.9 65.6 120.5 67.9 54.6 45.7 39.7 35.8 44.8 83.9 23.7 53.0 40.0 44.4 60.0 16.2 12.0 61.8 35.5 372.5 92.3 63.9 23.6 39.5 83.9 69.1 129.5 42.0 39.3 52.2 67.5 30.0 73.6 64.9 43.4 219.9 241.8 66.8 142.6 62.5 45.8 178.1 138.9 95.4 260.1 104.0 727.1 227.8 117.4 250.3 82.1 148.3 243.6 84.3 209.9 79.8 136.7 170.1 284.4 177.4 392.0 105.6 149.3 261.1 57.0 126.3 170.9 67.7 43.4 101.4 113.0 211.4 125.6 61.7 296.1 187.5 290.8 225.1 106.6 354.0 149.2 115.5 186.7 71.3 163.9 118.5 146.5 151.5 241.7 174.0 44.9 168.1 163.3 149.4 258.5 274.4 252.4 289.1 261.5 223.4 158.6 272.6 148.7 192.3 195.4 208.7 233.5 200.4 262.1 179.9 260.2 180.8 192.9 219.2 265.2 132.4 151.4 200.2 184.8 227.8 205.6 265.8 260.8 39.1 39.2 42.0 64.3 38.3 39.9 45.7 39.7 35.8 44.4 39.5 42.0 43.4 91.4 35.3 25.2 7.5 91.3 148.2 115.6 275.4 98.4 34.7 62.0 62.0 19.4 52.9 119.3 66.2 18.8 230.4 83.3 156.4 115.4 186.9 359.1 61.7 43.9 105.6 57.8 74.3 5.2 211.3 173.6 73.3 51.0 56.9 42.5 55.8 87.1 101.7 150.2 33.7 4.9 87.1 156.6 77.6 154.2 1655.0 72.4 89.8 97.8 3.7 126.5 73.0 83.4 4.0 8.5 247.5 129.7 86.9 118.2 145.7 118.6 139.0 96.2 31.7 65.7 49.9 177.0 135.2 204.2 108.0 148.0 423.0 86.1 57.5 95.2 144.6 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444961-130501274 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 1296.8;liver: 2054.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020896, HPA020934" Enhanced Supported Nucleoplasm,Cytosol No No 6400000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 197.0 148.1 28.6 51.7 28.0 0.2 169.6 23.9 31.2 65.0 64.2 158.7 125.6 112.2 125.9 51.5 167.7 111.2 61.1 28.9 34.6 1296.8 2054.4 53.3 7.5 39.7 36.2 25.3 57.7 69.0 11.5 45.3 51.0 41.1 56.7 169.5 6.9 120.4 133.9 75.0 132.4 196.4 61.8 25.9 20.1 53.7 36.2 34.6 7.9 93.2 72.0 15.8 291.5 67.1 29.0 124.5 11.9 13.7 23.1 88.4 223.1 43.6 146.2 893.9 28.2 85.5 52.5 34.0 0.4 95.9 300.2 8.2 850.4 59.9 5.2 19.5 21.7 27.1 0.3 18.3 137.3 305.4 18.3 1.6 148.2 817.8 45.4 81.2 0.3 1.1 384.0 5.3 530.6 28.8 619.8 7.2 262.7 19.2 635.9 26.7 1.7 15.4 1444.5 78.8 61.3 342.4 5.8 515.4 534.7 41.5 53.5 366.1 1061.5 0.4 11.3 68.3 2.3 13.0 88.1 91.5 32.1 219.0 137.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 28.6 28.0 23.9 31.2 28.9 34.6 39.7 36.2 25.3 41.1 25.9 34.6 29.0 72.1 25.6 28.6 2.6 21.3 70.5 55.7 179.8 53.5 0.1 23.7 17.3 5.4 138.7 104.4 47.8 0.0 178.5 0.4 398.7 133.1 116.5 1.2 4.7 30.5 68.0 12.0 93.7 2.2 110.5 8.9 21.5 20.4 6.2 5.7 55.5 65.7 1062.0 14.7 0.0 8.0 186.8 24.4 40.1 6.5 7.8 31.1 8.0 3.6 7.5 1.6 10.6 0.0 0.0 0.2 70.8 310.4 124.8 11.7 104.0 618.2 1408.9 32.7 0.4 0.0 18.7 13.4 1.4 2.6 23.5 17.5 144.1 11.5 62.0 165.6 413.2 PRDM12 PFM9 ENSG00000130711 "PR/SET domain 12" Q9H4Q4 9 130664594-130682986 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "brain: 2.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Excitatory neurons: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "RH-30: 19.1" "Region enriched" "Detected in some" 7 "basal ganglia: 10.9" "Group enriched" "Detected in some" 26 "basal ganglia: 3.8;hypothalamus: 1.3" HPA043143 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043143: AB_10806379" "unprognostic (3.25e-2)" "unprognostic (2.32e-1)" "unprognostic (3.40e-1)" "unprognostic (1.81e-4)" "unprognostic (7.90e-2)" "unprognostic (4.75e-3)" "unprognostic (2.48e-3)" "unprognostic (4.18e-2)" "unprognostic (4.61e-1)" "unprognostic (2.70e-1)" "unprognostic (6.43e-2)" "unprognostic (7.58e-2)" "unprognostic (4.03e-3)" "unprognostic (3.01e-2)" "unprognostic (4.79e-2)" "unprognostic (6.30e-4)" "unprognostic (1.40e-1)" 0.0 0.0 1.0 0.0 2.6 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.8 0.0 0.7 0.0 0.1 0.1 0.0 19.1 0.4 0.0 0.0 0.8 0.2 0.3 0.1 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.3 0.4 0.3 1.3 0.2 0.2 0.3 0.3 0.1 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 EXOSC2 "hRrp4p, p7, RRP4, Rrp4p" ENSG00000130713 "Exosome component 2" Q13868 9 130693721-130704894 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Deafness, Disease variant, Dwarfism, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021756, HPA021790" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA021756: AB_2670809, HPA021790: AB_1848320" "unprognostic (8.19e-2)" "unprognostic (1.93e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (8.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.48e-1)" "unprognostic (8.55e-2)" "unprognostic (1.20e-3)" "unprognostic (4.73e-2)" "unprognostic (6.57e-2)" "unprognostic (3.01e-1)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" 8.8 8.3 9.0 13.9 9.2 10.0 12.7 9.3 11.2 8.8 8.7 10.4 7.8 12.9 6.8 10.1 12.9 5.6 8.7 9.3 9.7 9.8 13.1 6.7 13.1 8.9 9.0 8.5 14.9 10.0 11.6 3.3 9.3 9.2 9.4 12.0 10.6 7.1 9.1 15.1 8.4 8.4 13.0 8.8 8.4 8.3 4.2 8.8 14.8 8.4 12.1 15.9 10.2 8.6 9.7 39.9 79.7 46.6 41.2 16.8 18.9 34.0 58.6 28.1 57.4 44.1 64.4 33.7 79.0 31.2 31.8 62.9 71.0 75.8 58.8 62.9 46.9 36.7 63.1 75.2 45.3 31.3 96.7 39.9 24.0 21.7 80.8 94.1 21.1 41.6 52.3 70.1 33.1 41.0 70.3 68.2 27.3 57.8 109.3 51.0 52.3 85.8 85.5 27.5 36.4 28.6 31.8 68.3 51.4 31.1 32.8 53.5 34.1 25.5 56.1 43.5 50.2 83.3 16.8 71.4 117.2 40.0 55.0 44.7 1.7 7.3 6.0 10.0 8.3 10.6 11.6 10.2 8.9 10.4 10.0 11.1 9.4 1.6 16.5 5.7 7.1 10.1 7.7 9.0 9.2 9.3 11.2 9.3 9.7 8.9 9.0 8.5 9.2 8.8 8.8 9.7 7.6 6.4 20.5 3.6 13.5 10.6 12.6 7.7 8.0 12.4 6.1 8.3 8.7 4.3 5.7 3.7 6.2 19.1 10.6 6.0 5.9 13.4 1.4 3.8 11.4 8.0 1.2 23.5 5.3 11.3 22.8 9.8 5.1 4.5 12.7 14.0 7.1 10.7 12.8 5.0 5.2 7.9 4.1 2.5 5.7 1.7 8.4 7.8 7.2 1.9 5.4 14.7 13.4 4.5 4.0 8.3 2.7 7.9 13.7 14.2 5.0 10.4 6.7 15.0 6.6 11.7 10.2 5.8 10.9 10.6 8.4 8.3 10.1 11.9 10.0 8.1 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502789-131523806 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 64.5;Spermatocytes: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 14.8 21.1 16.4 7.7 16.4 6.6 16.3 17.8 20.9 20.3 14.1 22.9 9.0 17.2 7.3 15.3 18.6 9.4 22.3 23.9 15.8 25.5 24.6 15.8 8.4 15.9 16.2 16.3 25.8 26.1 15.6 31.5 9.8 15.9 28.6 6.6 8.1 20.2 8.7 33.1 17.5 20.1 7.2 14.0 22.4 20.6 64.2 16.4 7.2 19.1 13.5 5.4 16.6 17.3 15.4 9.8 17.4 10.5 26.4 19.3 13.5 24.5 12.1 17.0 21.3 14.1 15.8 14.7 2.5 16.9 26.4 8.6 24.1 17.3 16.6 5.9 16.2 21.6 4.2 28.5 7.8 23.1 13.1 10.5 10.8 10.0 12.3 5.0 17.6 15.1 16.4 13.4 15.6 23.2 27.6 15.8 25.2 6.7 9.6 21.1 15.7 13.8 24.6 18.1 1.5 15.0 14.1 25.1 26.8 13.0 5.8 31.4 17.7 20.9 13.8 2.2 28.6 10.3 7.3 7.0 5.2 8.7 29.1 13.0 0.0 2.8 3.4 5.2 3.0 7.7 1.9 5.0 5.3 4.0 2.6 4.8 3.6 0.6 3.2 2.9 2.4 5.2 4.0 16.4 16.4 17.8 20.9 23.9 15.8 15.9 16.2 16.3 15.9 14.0 16.4 15.4 5.9 9.6 16.0 18.6 7.1 4.5 4.9 7.2 5.7 13.2 7.8 8.6 9.7 10.0 8.7 12.9 8.4 20.8 6.5 12.9 1.9 10.7 64.5 9.6 7.3 8.0 7.8 1.3 21.5 6.7 12.9 9.0 9.2 9.9 2.5 15.1 11.0 10.1 10.8 21.9 25.9 8.4 10.2 5.4 5.9 33.0 8.7 5.6 5.4 15.9 7.5 12.3 5.2 18.6 11.1 8.1 6.0 10.1 6.8 4.9 14.2 7.5 6.8 16.6 6.6 7.5 7.2 71.6 9.6 5.7 3.0 17.5 9.0 6.2 9.1 2.6 UCK1 "FLJ12255, URK1" ENSG00000130717 "Uridine-cytidine kinase 1" Q9HA47 9 131523801-131531264 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050969, HPA070526" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050969: AB_2681294, HPA070526: " "unprognostic (2.20e-1)" "prognostic favorable (3.19e-4)" "unprognostic (1.16e-2)" "unprognostic (1.74e-3)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.21e-7)" "unprognostic (5.11e-2)" "unprognostic (3.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.07e-1)" 20.4 25.5 39.3 10.3 40.5 16.5 20.5 40.1 45.5 19.9 36.4 23.0 11.9 20.4 18.8 21.4 20.0 12.3 25.7 37.8 39.2 29.3 53.2 17.4 15.2 41.3 41.0 36.7 22.4 30.1 22.7 24.4 14.4 39.6 27.1 9.3 13.6 25.8 17.4 44.3 18.4 18.1 11.3 40.0 21.1 25.1 20.6 40.6 17.7 23.6 27.0 11.6 21.1 17.3 40.9 13.9 30.0 33.9 43.8 23.6 16.7 28.9 22.0 32.1 37.0 28.0 30.1 12.4 15.0 12.9 26.4 28.9 26.3 31.9 28.0 15.8 27.7 29.8 14.0 46.3 19.2 33.6 23.2 19.9 18.8 25.8 29.9 21.6 22.4 23.0 36.3 17.9 11.2 27.6 55.2 31.9 11.8 40.4 27.0 29.6 30.1 52.5 25.1 24.1 13.0 45.7 28.9 31.8 23.9 34.3 15.4 46.6 13.5 17.1 40.9 20.7 25.7 21.7 22.7 31.3 19.4 20.3 16.0 29.1 2.1 5.5 9.0 7.3 7.2 9.8 7.4 8.5 6.4 5.2 8.0 11.3 5.6 3.6 7.0 2.6 5.9 12.0 5.6 39.3 40.5 40.1 45.5 37.8 39.2 41.3 41.0 36.7 39.6 40.0 40.6 40.9 13.6 16.0 5.0 7.8 12.4 14.3 10.3 9.9 12.5 18.0 16.2 20.1 14.0 4.3 6.2 14.7 8.4 33.8 12.0 20.4 29.4 22.7 21.9 9.0 10.2 14.3 12.1 3.0 4.7 26.2 17.5 15.7 6.6 9.2 2.5 16.2 13.2 20.5 26.4 26.9 6.1 11.6 16.2 10.0 13.4 33.3 17.7 14.0 16.0 4.7 20.4 22.0 9.2 2.0 6.0 18.6 12.3 19.9 8.0 14.3 21.1 31.6 3.1 13.1 19.7 12.4 17.2 32.8 33.4 11.8 12.5 25.7 10.0 14.9 14.8 8.5 FIBCD1 FLJ14810 ENSG00000130720 "Fibrinogen C domain containing 1" Q8N539 9 130902438-130939286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 10.0;brain: 22.7;parathyroid gland: 12.6;testis: 6.6" "Cell type enhanced" "Detected in some" "Early spermatids: 19.6;Exocrine glandular cells: 30.1;Intestinal goblet cells: 24.5;Ionocytes: 26.4;Late spermatids: 36.1;Pancreatic endocrine cells: 28.6;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 11 "monocytes: 1.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.7;MCF7: 32.8;OE19: 22.9;RPTEC TERT1: 24.4;THP-1: 12.5;U-2 OS: 14.1;U-251 MG: 13.5" "Group enriched" "Detected in many" 4 "basal ganglia: 17.6;hippocampal formation: 68.4" "Region enriched" "Detected in many" 5 "hippocampal formation: 57.3" HPA055353 Approved Approved "Cell Junctions" NA NA 19000000 "Cell Junctions" "HPA055353: AB_2682791" "unprognostic (1.18e-3)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (5.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.62e-1)" "unprognostic (4.16e-5)" "unprognostic (1.83e-3)" "unprognostic (3.14e-1)" "unprognostic (1.28e-1)" "unprognostic (2.05e-2)" "unprognostic (4.45e-2)" "unprognostic (1.42e-6)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (6.68e-3)" "unprognostic (2.77e-1)" 0.0 10.0 7.9 0.0 1.7 0.0 0.5 0.0 16.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.2 0.4 22.7 1.0 0.1 0.0 2.1 0.0 6.7 7.2 1.7 0.1 0.0 12.6 0.1 0.9 3.1 0.1 0.7 1.3 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.1 6.6 8.3 0.0 0.0 0.0 0.0 0.9 0.1 2.7 0.3 3.5 1.2 0.0 0.1 0.0 0.0 5.9 8.7 0.4 1.2 0.0 3.7 0.0 2.3 0.3 6.3 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.7 0.4 0.2 0.3 0.0 0.1 3.9 0.0 13.7 0.0 0.0 0.7 0.0 0.0 32.8 0.0 2.8 2.1 22.9 0.6 0.0 5.7 0.4 24.4 0.0 0.2 0.0 1.1 0.1 0.8 0.9 2.0 12.5 0.0 1.3 14.1 0.1 13.5 0.0 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 7.9 1.7 0.0 16.0 22.7 1.0 6.7 7.2 1.7 3.1 0.0 8.3 2.7 0.2 0.0 0.0 0.3 0.0 0.0 0.9 5.0 0.0 3.2 0.8 0.0 1.3 0.0 2.3 1.8 0.0 11.6 0.0 10.4 0.0 0.3 19.6 0.0 0.1 0.4 0.0 0.0 0.3 30.1 0.9 0.9 0.0 0.0 0.0 0.8 0.0 0.0 1.1 3.3 0.3 24.5 26.4 0.0 0.0 36.1 0.6 0.5 0.0 1.9 0.4 0.6 0.0 0.0 0.1 28.6 6.3 3.4 0.0 0.7 2.5 0.1 2.1 0.2 0.0 0.0 0.8 9.5 16.3 0.0 0.0 4.0 0.0 0.9 6.7 1.5 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555105 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 230000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 129.7 187.4 142.3 87.6 146.7 163.8 126.1 151.0 173.3 102.4 140.5 137.8 114.4 112.6 151.5 156.1 105.6 83.8 166.2 141.2 152.2 164.3 162.6 117.9 82.6 148.9 145.5 140.4 102.8 126.1 149.1 119.6 96.6 148.1 113.5 125.3 75.9 138.3 98.0 224.7 159.0 122.9 84.3 148.6 122.2 145.0 74.4 143.7 83.4 124.2 153.0 95.9 115.2 114.7 154.7 110.4 290.9 91.4 85.0 138.9 172.9 112.9 100.0 204.3 52.0 56.0 86.3 160.1 29.3 143.2 168.1 149.2 87.7 76.1 190.4 43.7 98.8 628.2 71.8 214.0 134.7 266.6 121.1 108.0 201.5 266.0 81.5 257.8 175.3 153.1 135.5 86.8 135.6 159.5 187.1 153.7 111.3 38.3 304.2 220.3 65.2 78.6 222.0 230.1 246.8 107.3 181.2 162.0 213.7 123.4 57.3 164.3 121.5 174.4 262.0 37.7 77.2 117.3 339.0 404.9 95.2 185.0 141.0 176.6 278.9 247.4 351.1 134.9 232.7 114.5 127.0 148.0 153.1 216.2 123.0 102.0 116.3 820.6 131.6 243.9 197.1 215.5 208.4 142.3 146.7 151.0 173.3 141.2 152.2 148.9 145.5 140.4 148.1 148.6 143.7 154.7 166.1 99.3 119.8 9.4 72.9 165.6 261.4 287.7 69.4 73.9 124.7 120.6 118.7 154.4 207.2 165.5 16.7 288.8 76.5 555.2 442.2 332.6 121.9 194.0 109.2 143.6 155.4 142.5 5.3 522.5 296.8 113.5 115.7 198.8 121.5 102.1 142.5 214.0 269.1 52.2 5.6 296.6 217.7 142.0 145.8 90.9 145.1 134.5 215.3 6.5 203.6 217.6 147.2 3.0 13.4 479.8 615.3 133.2 77.3 258.5 607.0 599.8 242.1 94.3 85.5 103.9 169.7 116.8 89.7 109.5 198.5 460.0 89.2 149.3 226.3 372.7 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558954 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 1197.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No 49000 Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 44.8 66.6 129.9 39.6 138.3 82.9 43.2 116.3 201.2 46.8 103.9 63.3 42.1 48.5 36.7 62.3 51.7 31.2 102.4 137.5 129.7 58.2 46.0 46.7 43.8 124.1 125.0 135.9 46.4 47.9 85.2 70.3 45.4 128.9 48.7 32.8 50.1 48.9 46.6 175.7 56.7 41.9 39.9 114.1 49.7 56.3 81.6 123.2 52.2 44.7 105.5 44.0 58.8 46.2 138.7 161.8 272.1 119.3 124.8 61.7 71.9 112.2 166.0 117.4 97.8 82.8 162.7 109.7 161.9 135.5 93.4 198.1 105.9 130.1 138.6 69.2 207.3 1197.4 235.5 163.7 113.7 154.4 197.3 192.9 82.1 107.1 145.9 167.3 102.6 117.8 146.3 119.6 179.4 127.3 158.2 177.2 223.7 87.1 155.1 306.5 171.7 106.7 204.5 111.6 166.8 239.5 205.5 133.1 149.7 163.3 41.6 94.4 188.4 105.2 333.4 80.5 110.6 281.3 262.3 411.9 169.6 206.0 177.6 220.5 6.7 3.6 4.2 3.0 2.6 2.2 2.8 3.2 3.2 2.8 3.8 3.3 2.2 10.1 1.7 2.7 6.7 2.9 1.9 129.9 138.3 116.3 201.2 137.5 129.7 124.1 125.0 135.9 128.9 114.1 123.2 138.7 75.1 6.4 13.0 14.7 32.7 40.4 36.3 15.9 6.2 100.0 74.5 81.3 38.5 20.0 11.6 18.4 20.9 21.0 72.9 63.9 7.9 17.3 25.7 89.6 68.0 40.1 41.2 39.8 22.9 30.6 22.4 38.9 21.9 63.3 19.7 103.3 28.5 38.0 35.4 109.4 20.8 43.8 20.3 27.0 33.5 34.0 17.4 42.5 35.6 15.9 21.1 142.3 14.4 8.5 17.9 41.8 21.4 13.9 35.4 59.1 37.9 33.9 18.6 81.1 26.3 41.5 55.4 27.1 7.9 17.0 56.8 52.5 41.0 156.1 41.6 56.2 TRIM28 "KAP1, PPP1R157, RNF96, TF1B, TIF1B" ENSG00000130726 "Tripartite motif containing 28" Q13263 19 58544064-58550722 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 2817.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010066, HPA064033" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 140000 Nucleoplasm "CAB010066: AB_2209905, HPA064033: AB_2685179" "unprognostic (2.76e-1)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.20e-2)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (4.92e-3)" "unprognostic (9.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.67e-2)" "unprognostic (7.34e-2)" "unprognostic (4.22e-1)" "unprognostic (3.28e-2)" 98.6 111.9 72.8 104.7 75.0 219.3 105.3 80.2 100.9 144.0 67.0 144.9 91.6 164.7 43.2 133.7 144.1 74.3 105.9 71.5 70.6 110.8 105.4 104.4 143.7 74.2 72.7 69.8 230.2 185.2 90.1 99.5 109.8 74.7 129.9 58.4 39.8 109.3 109.8 173.8 140.9 118.7 95.4 78.7 138.5 137.8 217.2 72.6 188.3 118.9 77.7 110.1 148.9 116.1 85.9 481.6 1080.4 491.9 365.1 218.9 186.5 616.5 321.5 291.1 311.4 237.0 732.8 375.0 562.5 196.1 270.7 492.8 317.7 590.5 480.5 163.6 281.3 2817.1 1012.8 407.6 537.7 254.4 640.9 577.5 252.4 248.2 385.9 274.9 220.1 301.3 597.7 507.1 259.4 284.8 705.0 756.5 640.8 372.8 443.6 637.5 761.9 340.9 550.2 260.8 730.6 517.1 403.4 343.9 359.3 170.7 131.9 273.2 493.1 272.4 643.1 273.2 148.6 562.5 397.7 665.7 604.7 293.0 432.9 418.6 1.9 9.7 8.2 12.8 11.1 17.2 15.9 18.0 17.4 13.7 19.1 22.8 20.5 4.3 24.9 7.9 21.2 12.4 10.1 72.8 75.0 80.2 100.9 71.5 70.6 74.2 72.7 69.8 74.7 78.7 72.6 85.9 60.8 12.8 18.6 18.3 51.0 64.2 60.2 34.7 47.3 61.8 86.6 87.5 9.5 51.5 29.0 33.1 27.1 61.2 72.4 88.3 23.5 44.8 96.9 70.7 53.3 49.7 64.6 46.7 10.3 56.3 61.6 48.3 65.7 80.2 21.6 136.3 35.7 31.9 46.9 55.5 12.6 79.4 14.2 36.5 70.7 110.6 65.9 48.3 28.4 6.5 32.8 49.8 19.6 10.6 18.2 56.3 50.0 41.3 43.5 52.1 47.3 36.3 28.7 34.1 59.2 69.3 61.6 158.7 83.1 58.0 60.7 56.1 54.5 80.9 94.1 45.6 METTL26 "C16orf13, MGC13114" ENSG00000130731 "Methyltransferase like 26" Q96S19 16 634427-636366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 172.6;Distal tubular cells: 168.3;Extravillous trophoblasts: 187.2;Proximal tubular cells: 289.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044004, HPA067414" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA044004: AB_10964777, HPA067414: " "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (3.35e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (6.27e-2)" "unprognostic (6.93e-2)" "unprognostic (6.21e-2)" "unprognostic (1.20e-1)" "unprognostic (4.71e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.73e-6)" "unprognostic (2.59e-1)" "unprognostic (1.37e-1)" "unprognostic (2.53e-1)" "unprognostic (2.72e-2)" 52.3 72.3 84.1 14.6 87.6 23.7 50.3 77.1 160.1 55.0 75.7 57.5 18.8 57.5 24.0 47.7 50.8 10.7 72.9 87.2 81.6 68.9 76.1 45.2 12.1 79.3 79.1 87.3 66.1 50.8 30.4 54.7 13.8 81.4 59.5 10.6 5.2 49.5 22.5 92.1 53.1 40.1 13.7 78.2 47.7 56.5 55.5 84.1 26.1 46.7 35.5 11.9 55.7 48.3 84.2 59.6 60.7 20.0 48.6 28.7 47.2 72.5 46.5 39.2 40.1 30.3 55.6 50.2 71.8 77.7 38.2 47.9 74.5 28.7 73.8 12.5 54.1 140.1 45.9 86.6 83.0 68.5 68.6 41.5 43.1 41.3 53.5 39.9 47.0 48.8 87.7 55.5 29.2 23.3 94.0 75.8 120.4 61.7 83.5 174.9 105.2 23.1 147.6 64.2 25.4 86.9 60.1 43.0 77.9 57.5 14.3 57.4 67.7 35.1 40.4 52.9 67.1 46.5 69.8 47.2 52.7 41.2 43.6 35.7 102.9 119.8 68.3 110.1 145.3 121.6 145.4 114.9 109.2 150.7 124.1 108.6 105.2 26.2 123.0 167.7 162.7 160.0 120.9 84.1 87.6 77.1 160.1 87.2 81.6 79.3 79.1 87.3 81.4 78.2 84.1 84.2 70.2 32.1 61.3 0.0 20.9 0.0 0.0 0.0 0.0 0.0 119.6 172.6 0.0 0.0 19.2 49.7 0.0 113.3 52.9 0.0 168.3 118.6 0.0 72.7 73.3 29.2 0.0 0.0 0.0 94.1 187.2 42.7 0.0 59.0 25.2 119.7 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 41.3 0.0 0.0 0.0 0.0 91.8 0.0 0.0 8.4 0.0 0.0 289.7 28.4 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 57.9 30.9 125.9 0.0 0.0 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" No No "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 29.2 43.8 16.7 16.0 16.7 29.8 34.4 18.2 26.8 41.3 25.0 31.3 32.1 38.4 27.0 51.4 35.5 30.6 29.3 17.1 17.4 41.0 56.5 33.1 16.9 20.1 17.4 15.0 39.9 115.3 33.7 109.0 39.2 18.8 40.6 15.9 6.5 106.6 23.8 25.1 33.9 30.1 14.3 15.7 27.9 39.5 77.4 17.3 14.5 47.9 10.4 11.3 32.9 39.9 18.2 64.9 22.3 17.5 25.4 40.0 38.9 30.1 48.9 71.6 36.6 52.9 68.1 51.6 12.8 80.2 56.2 16.7 49.8 11.9 47.6 9.5 41.7 43.2 24.2 27.3 39.1 62.1 42.5 49.3 35.7 33.6 24.7 35.4 47.7 26.2 31.1 31.6 69.2 22.9 109.4 27.4 42.7 29.4 44.3 55.2 22.8 14.1 65.3 33.0 30.2 45.4 22.2 35.2 56.4 48.8 15.3 51.7 60.1 39.1 41.6 15.3 60.2 36.7 96.7 42.5 24.2 65.1 72.9 43.9 39.2 18.8 9.3 13.3 21.3 10.4 16.3 10.4 12.3 22.3 9.5 9.3 13.3 3.1 12.1 19.4 34.1 12.6 10.4 16.7 16.7 18.2 26.8 17.1 17.4 20.1 17.4 15.0 18.8 15.7 17.3 18.2 20.5 16.0 21.2 2.6 16.0 6.8 41.6 22.4 17.1 19.4 46.9 37.8 0.5 27.1 27.3 35.0 16.7 109.5 20.6 31.9 27.4 69.3 131.1 23.0 20.1 19.2 43.3 17.2 6.4 80.7 114.1 36.0 33.6 29.3 21.6 22.5 22.5 23.0 38.7 18.5 6.7 69.4 14.2 15.3 5.2 34.6 35.1 20.5 5.4 5.6 21.1 23.8 16.5 3.5 3.3 50.3 47.7 25.6 55.4 51.6 52.5 27.0 26.1 16.4 6.6 20.0 21.9 159.1 16.6 22.6 7.0 174.3 13.9 27.9 50.6 50.0 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 103.9;Proximal enterocytes: 109.3;Spermatocytes: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 57.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA067683: AB_2685886" "unprognostic (2.85e-1)" "prognostic favorable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favorable (2.39e-7)" "prognostic favorable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 7.0 15.7 2.9 7.4 3.6 33.5 7.4 7.2 8.7 9.4 5.6 17.4 22.0 8.2 1.6 27.5 7.7 3.9 19.7 3.4 3.1 20.7 13.3 10.7 8.3 4.0 3.7 2.5 9.5 16.5 10.8 16.7 5.0 4.6 14.2 5.2 2.5 16.7 4.5 37.2 24.1 23.4 2.1 2.5 17.2 13.8 24.7 3.8 12.1 13.5 10.9 4.6 9.7 15.1 4.0 13.8 8.7 11.7 16.5 2.1 1.8 9.9 9.2 7.8 11.1 12.2 14.9 4.3 9.2 16.2 0.9 8.6 20.8 7.3 6.8 1.4 10.4 23.5 23.1 22.3 8.2 7.4 9.4 22.1 1.8 14.2 9.8 3.4 2.8 3.3 18.1 17.8 19.8 3.6 21.9 27.6 57.8 18.9 6.1 29.0 20.0 8.2 15.1 6.4 17.8 45.3 17.8 12.6 22.6 11.3 2.1 14.0 21.6 6.4 16.8 11.0 34.7 20.4 19.2 15.4 10.8 14.4 18.0 19.5 1.6 0.8 3.7 1.1 1.0 1.5 1.0 1.3 1.2 0.6 0.4 1.2 1.7 0.2 1.3 0.4 4.2 2.2 0.8 2.9 3.6 7.2 8.7 3.4 3.1 4.0 3.7 2.5 4.6 2.5 3.8 4.0 6.3 9.6 6.6 9.1 14.4 30.5 19.8 14.9 24.5 14.9 14.1 10.2 0.5 14.3 8.1 1.8 14.6 27.9 38.7 103.9 13.7 16.1 83.6 9.6 5.5 5.3 22.2 43.6 8.4 16.5 6.7 8.2 26.5 10.1 7.0 10.9 6.1 11.9 13.4 28.6 9.1 38.5 20.3 15.0 12.1 16.3 8.7 10.0 12.4 4.7 15.7 11.8 22.6 4.5 8.4 20.5 72.4 4.5 17.6 21.6 109.3 25.4 5.2 20.1 13.1 9.1 14.2 100.7 21.2 33.4 31.3 36.5 19.6 10.6 33.2 36.4 EIF2S3 "EIF2, EIF2G, EIF2gamma" ENSG00000130741 "Eukaryotic translation initiation factor 2 subunit gamma" P41091 X 24054946-24078810 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Disease variant, Epilepsy, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB012471 Approved NA NA "CAB012471: AB_873547" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (1.86e-1)" "unprognostic (5.27e-2)" "unprognostic (8.45e-2)" "unprognostic (1.46e-3)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (6.66e-3)" "unprognostic (6.94e-3)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.44e-6)" "unprognostic (4.88e-3)" "unprognostic (2.11e-1)" "unprognostic (1.02e-1)" "unprognostic (2.51e-1)" 66.1 52.2 33.7 72.4 36.0 76.9 83.8 37.2 36.1 78.4 47.4 62.5 67.0 84.6 45.4 63.1 80.6 53.8 57.7 32.7 38.8 70.2 75.2 51.2 114.2 37.0 36.8 30.6 132.5 95.6 50.0 30.3 46.8 35.9 52.1 67.0 47.3 70.3 42.1 67.2 72.4 53.4 75.0 37.6 72.7 67.3 18.7 34.7 98.5 70.5 52.3 112.5 67.0 66.2 42.2 261.0 256.0 110.3 182.7 113.5 235.5 73.2 142.3 127.4 114.8 130.6 290.8 174.3 449.5 141.0 104.9 251.9 165.1 344.7 271.3 140.8 147.8 203.7 177.2 467.8 164.3 126.2 304.0 219.4 206.9 169.2 129.6 269.7 152.9 166.2 176.0 275.4 176.0 127.7 124.8 170.6 278.8 268.2 118.1 146.5 169.5 215.2 271.4 155.4 241.5 60.2 130.8 232.3 224.7 239.8 205.5 289.6 205.1 140.2 97.1 66.7 177.3 125.3 156.6 322.4 240.9 120.9 193.1 113.7 64.4 141.1 27.9 84.9 151.9 147.8 156.0 148.8 113.9 123.9 120.6 187.5 156.6 51.2 106.3 132.6 97.4 124.2 127.2 33.7 36.0 37.2 36.1 32.7 38.8 37.0 36.8 30.6 35.9 37.6 34.7 42.2 76.5 44.8 54.5 48.0 187.6 126.6 98.0 51.8 145.1 25.3 128.4 91.2 49.1 74.4 49.0 40.5 25.0 59.6 127.5 35.2 111.6 67.9 0.5 67.3 109.4 67.5 44.9 92.5 19.0 57.6 122.1 72.3 78.5 90.9 100.8 84.6 84.3 58.8 89.1 20.2 20.1 65.0 32.6 138.9 91.9 3.5 67.7 109.7 55.2 36.5 134.5 30.4 78.2 23.6 31.4 59.5 68.9 61.3 99.3 70.2 72.3 135.2 40.6 33.3 72.3 85.0 87.4 10.2 21.9 130.7 151.2 71.0 117.9 76.2 100.4 92.9 TMEM160 FLJ20512 ENSG00000130748 "Transmembrane protein 160" Q9NX00 19 47045909-47048624 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 168.4;NB-4: 231.7;PC-3: 104.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055904 Uncertain NA NA "HPA055904: AB_2682965" "unprognostic (2.45e-3)" "unprognostic (1.69e-1)" "unprognostic (4.49e-1)" "unprognostic (1.09e-2)" "unprognostic (3.71e-1)" "unprognostic (7.39e-2)" "unprognostic (3.60e-1)" "unprognostic (3.20e-2)" "unprognostic (6.58e-2)" "unprognostic (2.86e-1)" "unprognostic (8.21e-3)" "unprognostic (3.76e-2)" "unprognostic (1.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.86e-2)" "unprognostic (1.37e-2)" 14.7 18.1 29.1 5.3 24.2 5.6 13.9 11.5 40.4 12.3 9.6 13.9 3.7 16.3 1.0 20.3 12.5 0.5 22.3 31.0 16.6 24.3 25.7 15.4 4.2 28.2 18.5 31.7 9.2 18.2 2.3 12.5 1.9 28.4 11.0 1.3 1.7 15.7 1.4 28.8 18.5 13.9 1.3 14.0 19.8 16.7 11.5 19.5 2.3 19.3 2.6 2.2 14.9 12.8 26.4 37.5 12.9 7.6 9.7 2.1 2.2 17.8 19.5 3.3 6.3 6.7 6.2 12.9 36.7 33.4 2.3 5.4 26.7 5.1 4.4 3.5 31.6 168.4 37.5 11.1 11.0 1.3 26.0 55.0 2.0 2.6 3.7 1.4 4.6 4.6 23.2 34.3 10.6 3.2 9.9 30.5 231.7 19.3 12.2 104.7 54.9 17.3 22.5 5.9 6.0 20.2 35.8 22.3 15.8 22.6 10.7 8.3 17.1 21.2 6.0 32.9 13.1 20.1 46.8 48.5 28.6 8.9 26.8 8.8 28.3 41.0 62.9 27.9 30.9 18.9 41.6 44.3 51.0 25.8 50.0 42.7 28.0 3.3 22.3 28.1 45.4 46.2 15.6 29.1 24.2 11.5 40.4 31.0 16.6 28.2 18.5 31.7 28.4 14.0 19.5 26.4 52.1 9.6 12.9 7.8 74.8 57.9 63.9 93.0 38.7 47.9 80.7 78.7 21.0 77.2 48.6 119.5 18.8 28.3 98.6 200.5 158.5 122.0 95.4 45.7 33.3 49.1 104.0 46.7 17.1 179.7 95.5 49.4 58.1 45.6 57.3 60.2 56.7 96.1 152.9 20.2 18.1 120.2 95.6 138.2 99.8 255.3 48.7 89.7 94.3 4.7 194.0 106.6 161.7 11.6 13.8 155.9 164.3 52.6 87.1 61.7 207.7 247.6 33.1 31.7 32.9 38.0 63.9 32.8 33.7 66.5 81.8 14.2 87.5 61.1 120.8 84.8 ZC3H4 "C19orf7, KIAA1064" ENSG00000130749 "Zinc finger CCCH-type containing 4" Q9UPT8 19 47064187-47113776 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040934, HPA041068" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040934: AB_10795495, HPA041068: AB_10796567" "unprognostic (8.02e-3)" "unprognostic (3.68e-3)" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (9.37e-2)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (2.93e-1)" "unprognostic (1.68e-2)" "unprognostic (1.53e-1)" "unprognostic (9.14e-2)" "unprognostic (3.00e-3)" "unprognostic (1.19e-1)" "unprognostic (5.90e-2)" "prognostic favorable (2.23e-4)" 7.7 7.8 12.1 8.4 11.0 5.6 8.1 11.9 9.7 9.7 3.7 10.0 6.8 11.6 3.3 11.6 9.2 3.8 7.9 9.7 8.5 7.0 10.5 6.9 9.1 12.9 11.2 7.8 10.7 10.8 4.8 9.8 3.8 12.4 9.2 4.1 5.3 8.4 4.7 10.5 10.3 10.4 4.8 9.6 12.6 9.1 11.3 10.9 9.7 9.5 5.3 6.3 9.7 8.9 10.7 14.4 22.2 13.5 19.3 7.4 4.6 13.7 11.3 6.4 10.4 7.0 15.9 15.8 30.3 8.2 7.7 6.4 24.5 5.9 16.1 6.6 18.8 9.6 21.6 13.9 12.2 6.4 20.7 22.1 7.8 4.4 9.6 7.6 5.6 8.6 18.4 21.2 11.2 6.9 25.2 23.6 34.9 20.1 9.7 7.4 36.5 11.6 13.7 8.0 23.2 16.4 23.1 17.3 14.3 8.6 6.5 15.0 16.6 15.2 14.1 13.7 9.1 16.1 14.5 12.7 26.4 11.0 16.6 20.5 2.6 0.9 1.5 2.2 1.6 2.3 2.1 1.9 2.3 1.2 1.9 1.7 1.9 2.7 2.3 1.6 3.0 1.3 0.6 12.1 11.0 11.9 9.7 9.7 8.5 12.9 11.2 7.8 12.4 9.6 10.9 10.7 19.4 3.2 13.1 10.7 16.6 22.3 6.2 8.4 6.8 23.8 18.0 10.0 12.8 28.6 11.7 20.2 14.6 6.6 14.7 20.0 9.8 10.8 18.0 13.0 16.0 14.7 19.2 20.0 8.8 11.6 7.4 12.7 9.7 18.2 12.6 17.5 19.2 16.5 12.9 16.8 9.9 18.4 8.2 28.3 20.0 6.8 16.8 18.9 7.2 13.1 23.3 14.3 17.5 12.5 17.6 10.9 14.6 9.8 8.2 9.7 15.1 11.5 12.6 23.8 6.6 16.0 13.8 15.6 9.8 14.7 22.4 8.6 16.1 9.8 17.1 7.5 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019837-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.0;skin 1: 7.7" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 16.7;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 28.3" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 9.9;Daudi: 10.2;HEK 293: 11.1;HMC-1: 9.0;NB-4: 18.1;U-266/84: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.5 0.4 2.5 0.3 1.2 0.2 0.7 0.1 6.0 0.3 0.9 0.3 0.0 0.1 0.0 1.0 0.6 0.0 0.7 4.8 1.6 1.4 0.6 0.4 0.5 2.5 1.7 1.8 0.2 0.6 0.0 1.3 0.1 3.7 0.4 0.0 0.6 0.4 0.0 0.1 7.7 0.5 0.1 0.4 2.8 2.7 0.6 1.1 0.1 0.5 0.0 0.3 0.4 0.7 2.4 0.2 2.4 0.3 0.5 0.2 0.2 0.0 9.9 0.3 0.1 0.4 0.7 0.5 10.2 2.2 8.1 0.4 0.2 2.1 0.2 0.1 0.7 11.1 0.8 1.2 2.5 0.0 5.5 9.0 0.9 0.4 0.0 0.1 0.6 0.2 1.3 3.5 0.8 1.3 0.9 0.4 18.1 2.4 0.4 1.7 0.9 0.4 0.8 0.6 0.6 0.7 0.6 0.8 0.3 2.4 0.8 2.1 1.7 0.1 0.2 0.9 0.1 0.2 5.4 11.5 2.2 1.2 1.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.2 0.1 6.0 4.8 1.6 2.5 1.7 1.8 3.7 0.4 1.1 2.4 0.1 0.0 0.6 1.6 1.1 0.8 1.4 1.1 1.8 0.7 2.2 2.5 1.1 0.0 1.1 0.0 16.7 0.0 0.1 0.3 0.0 0.6 0.1 0.4 0.2 0.2 1.2 2.7 5.7 0.4 0.1 0.5 27.0 0.4 0.0 0.7 0.0 0.1 0.3 0.0 28.3 1.4 2.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 5.4 0.0 2.0 1.2 1.0 0.2 0.0 2.6 1.5 0.0 0.9 2.0 5.4 0.0 0.1 1.1 0.4 2.1 2.2 2.3 0.0 1.2 0.1 0.6 1.2 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 582.6;lymphoid tissue: 464.9" "Cell type enhanced" "Detected in many" "Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 810000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favorable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 112.6 26.6 29.6 190.3 30.4 582.6 71.9 29.5 41.9 26.2 32.5 46.1 34.1 20.9 19.8 19.8 29.2 61.4 25.4 30.2 35.8 36.8 66.4 118.7 302.0 33.2 30.5 29.1 9.3 14.5 15.8 10.9 103.2 32.7 18.7 53.7 2.1 19.0 15.2 11.5 16.0 75.7 48.2 31.8 327.9 41.9 7.5 31.3 464.9 37.9 23.8 264.8 94.4 18.5 33.3 1.4 0.0 2.0 0.4 0.0 0.0 0.7 1.1 0.3 0.3 0.2 0.3 33.1 309.6 2.4 0.3 0.1 1.5 0.0 0.7 1.2 99.7 0.5 329.7 0.4 3.5 5.1 356.7 602.6 0.7 0.6 0.5 0.8 0.8 19.2 464.5 12.3 494.4 2.4 0.0 316.6 361.6 0.6 0.1 0.2 409.8 3.2 196.8 0.5 40.9 0.8 0.5 1.3 1.9 2.1 0.6 0.8 641.5 175.7 0.2 3.2 0.8 1.1 26.9 107.3 340.0 1.7 482.4 2.7 4389.0 1574.5 3622.3 720.9 1447.6 773.8 812.5 1058.2 894.4 1139.9 742.7 1044.5 858.2 5262.9 908.0 1686.2 459.6 1840.4 2617.7 29.6 30.4 29.5 41.9 30.2 35.8 33.2 30.5 29.1 32.7 31.8 31.3 33.3 304.3 28.9 97.6 0.0 211.7 18.6 4.4 0.3 2.8 0.0 4.2 9.4 3.2 11.5 17.3 0.0 0.0 3.6 273.5 0.9 0.0 1.1 11.8 0.6 2.2 176.4 0.0 119.4 0.5 0.7 4.0 18.2 9.7 0.8 238.0 0.3 272.4 11.8 467.5 0.0 0.4 0.3 2.0 523.4 343.2 30.4 1.8 409.6 74.7 1.9 409.4 0.7 423.3 0.5 0.3 0.3 0.0 0.4 216.8 1.1 0.3 4.6 8.9 0.3 46.0 4.2 26.4 8.6 3.3 1.4 14.8 5.5 370.6 2.3 1.1 4.1 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191426-40215575 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.9;Horizontal cells: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favorable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favorable (2.13e-4)" 6.8 8.4 23.4 2.3 17.6 1.9 6.6 0.0 47.6 7.7 0.0 7.4 2.0 8.0 0.3 5.4 6.7 1.8 10.3 36.1 3.6 7.4 5.3 6.7 2.3 6.5 1.6 21.4 7.4 7.0 3.3 14.4 1.6 9.8 8.1 0.6 1.4 6.0 2.0 17.0 7.1 6.4 1.8 0.0 8.1 7.2 11.2 4.8 1.8 7.0 4.4 0.9 7.3 6.7 12.5 6.3 7.2 2.2 5.2 2.0 1.2 6.2 4.3 2.0 1.9 1.9 1.7 1.7 5.7 4.4 1.4 4.6 1.9 0.8 2.2 0.2 10.9 6.8 1.4 3.3 1.7 3.8 1.2 3.4 1.1 5.0 2.0 1.4 2.0 1.7 7.6 5.5 9.1 0.5 3.7 4.5 2.2 2.6 2.0 4.7 5.8 2.3 3.4 1.7 3.8 7.4 10.7 4.9 1.7 10.0 1.3 2.4 2.2 2.9 4.9 4.8 7.3 8.3 12.7 7.7 2.6 5.7 2.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 17.6 0.0 47.6 36.1 3.6 6.5 1.6 21.4 9.8 0.0 4.8 12.5 5.6 0.0 0.0 6.5 4.2 1.5 1.8 1.1 1.2 14.9 2.9 2.4 2.8 5.7 0.5 7.3 8.4 0.9 3.3 2.4 0.0 2.5 2.8 2.4 3.6 3.6 4.2 5.3 18.9 4.3 0.8 2.6 5.6 3.8 0.0 10.3 3.9 3.2 2.5 23.5 15.9 1.7 0.0 1.6 2.9 7.6 3.1 2.7 1.8 9.4 2.5 5.7 4.1 9.0 12.4 3.7 2.9 4.9 1.5 2.5 1.7 3.1 0.6 7.7 6.6 4.5 4.0 4.1 1.8 1.8 2.7 1.4 4.4 3.2 2.4 2.0 ARHGEF16 "GEF16, NBR" ENSG00000130762 "Rho guanine nucleotide exchange factor 16" Q5VV41 1 3454665-3481113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 101.1;Extravillous trophoblasts: 55.6;Gastric mucus-secreting cells: 67.2;Intestinal goblet cells: 49.6;Paneth cells: 68.2;Proximal enterocytes: 72.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 56.4;MCF7: 32.4;OE19: 38.2;SK-BR-3: 34.9" "Region enhanced" "Detected in many" "olfactory bulb: 4.7" "Low region specificity" "Detected in many" HPA010609 Approved NA NA "HPA010609: AB_1845004" "unprognostic (1.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (4.31e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.82e-4)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.79e-2)" "unprognostic (5.39e-2)" "unprognostic (9.16e-2)" "prognostic favorable (1.24e-10)" "unprognostic (6.46e-2)" "unprognostic (2.86e-1)" "unprognostic (1.71e-2)" "unprognostic (3.29e-2)" 3.9 0.5 1.8 2.7 1.8 0.0 4.8 2.9 2.4 3.4 4.3 18.8 44.4 1.1 2.7 18.1 2.5 11.2 1.0 0.9 3.5 17.8 6.5 3.4 0.2 4.3 3.2 0.9 1.3 11.2 8.1 11.4 5.1 5.0 9.5 12.0 2.7 17.1 5.8 1.4 5.9 34.4 0.5 2.6 0.8 28.3 3.2 2.6 0.4 10.1 1.6 2.0 5.0 9.0 5.0 18.3 6.8 1.8 0.2 0.0 0.0 12.6 0.3 0.4 0.5 1.4 20.7 56.4 0.0 13.5 0.1 3.4 18.8 3.0 12.1 0.1 0.0 6.3 0.0 8.8 16.2 0.6 0.0 0.1 0.3 11.4 1.2 0.6 1.2 0.1 0.3 2.3 0.0 0.1 32.4 0.0 0.4 13.8 38.2 0.4 0.0 0.0 2.7 14.2 9.1 9.8 1.8 3.6 34.9 0.8 7.1 15.7 0.6 0.0 0.2 4.0 0.3 0.4 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 2.9 2.4 0.9 3.5 4.3 3.2 0.9 5.0 2.6 2.6 5.0 0.6 9.6 5.4 2.0 0.5 3.2 15.0 9.1 14.2 1.1 8.1 4.6 1.6 12.8 11.7 16.5 6.2 3.2 0.1 101.1 15.6 16.5 0.1 4.3 0.8 0.8 10.2 0.0 0.4 12.7 55.6 0.8 67.2 9.9 0.0 17.3 0.4 4.3 1.2 3.3 0.5 49.6 20.3 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.6 36.7 0.0 0.5 5.2 28.6 68.2 0.0 2.8 3.6 72.1 11.5 6.5 8.8 0.0 0.0 3.0 0.3 3.9 12.2 1.0 6.7 0.5 2.0 40.0 13.3 LRRC47 "KIAA1185, RP1-286D6.3" ENSG00000130764 "Leucine rich repeat containing 47" Q8N1G4 1 3778559-3796498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008512, HPA012018" Enhanced Approved "Nucleoli fibrillar center" NA NA 29000 "Nucleoli fibrillar center" "HPA008512: AB_1853324, HPA012018: AB_1853322" "unprognostic (2.25e-2)" "unprognostic (6.56e-2)" "unprognostic (6.24e-2)" "unprognostic (3.89e-2)" "unprognostic (2.86e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.49e-2)" "unprognostic (1.93e-2)" "prognostic favorable (2.75e-4)" "unprognostic (9.07e-2)" "unprognostic (4.81e-2)" "unprognostic (9.89e-2)" "unprognostic (2.25e-1)" 14.0 17.5 17.2 7.1 17.8 11.8 14.7 16.2 18.8 15.3 15.0 18.0 10.0 18.5 8.7 17.8 16.3 6.3 23.9 18.2 17.4 13.7 24.0 11.3 10.0 20.7 18.3 18.1 18.9 23.2 12.3 16.5 9.6 18.5 16.1 6.4 8.3 16.0 11.4 70.4 21.8 14.4 8.6 16.1 15.5 17.5 13.6 17.8 9.5 14.4 26.2 8.2 18.7 14.8 19.2 17.9 20.7 14.7 24.2 15.4 12.3 14.6 15.2 11.6 19.6 15.3 25.6 19.4 18.6 21.8 16.5 15.0 24.4 18.1 18.8 10.7 23.8 33.1 34.1 23.5 28.6 23.8 23.3 12.3 14.6 16.3 19.5 15.5 12.7 14.0 23.6 31.9 5.3 14.4 18.9 25.9 27.1 33.4 17.6 31.3 25.1 14.6 22.2 13.6 13.0 30.5 30.1 19.0 28.3 30.5 14.3 15.4 17.4 19.2 16.2 9.4 24.4 20.0 39.6 39.6 21.1 9.7 31.6 6.6 3.8 2.8 1.5 2.3 3.3 2.4 1.7 2.5 3.6 3.5 1.9 2.9 3.0 1.8 3.1 2.6 3.0 2.6 1.7 17.2 17.8 16.2 18.8 18.2 17.4 20.7 18.3 18.1 18.5 16.1 17.8 19.2 18.4 16.0 24.1 10.4 20.5 15.6 16.6 8.0 22.2 32.1 18.7 13.1 62.0 27.1 13.3 27.6 14.6 58.3 30.7 22.6 19.6 13.4 1.6 15.6 19.0 16.7 21.6 18.7 11.4 15.0 39.0 22.0 26.5 14.4 11.4 28.2 21.4 33.1 26.7 38.7 11.6 24.7 10.2 17.9 8.8 3.5 22.1 16.8 8.8 7.5 20.6 31.9 29.9 12.5 12.7 13.7 21.6 23.7 21.6 19.5 25.3 22.5 11.4 20.9 13.1 27.3 23.9 20.4 37.1 26.2 21.6 48.2 20.5 32.4 33.1 13.3 SESN2 "DKFZp761M0212, HI95, SES2, SEST2" ENSG00000130766 "Sestrin 2" P58004 1 28259518-28282491 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 46.5;SK-MEL-30: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018191 Uncertain Approved Cytosol NA NA Cytosol "HPA018191: AB_1856750" "unprognostic (7.05e-2)" "unprognostic (4.95e-3)" "unprognostic (1.43e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.78e-4)" "unprognostic (8.97e-2)" "unprognostic (2.50e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (2.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" 10.0 9.1 8.6 2.9 7.7 19.5 8.6 5.7 7.1 6.8 4.7 8.2 7.7 8.2 1.6 20.2 7.9 3.3 5.8 7.6 6.5 15.9 24.9 9.7 2.0 7.7 7.2 5.4 28.1 10.6 4.5 6.7 4.8 7.7 6.3 4.1 1.4 8.6 1.9 7.7 5.2 8.8 3.0 7.7 6.9 11.1 10.7 10.7 2.4 5.3 2.5 2.0 7.7 8.9 7.9 5.6 3.0 7.1 11.8 11.3 8.9 38.6 10.5 9.6 6.3 7.4 4.3 4.0 6.3 4.3 4.8 7.0 5.5 8.3 7.4 4.3 5.7 7.7 2.6 4.3 7.3 37.0 9.5 13.7 28.1 46.5 16.9 40.0 2.9 7.0 14.6 15.2 29.3 5.9 3.2 3.5 2.6 5.7 2.6 6.0 5.3 1.9 14.6 4.2 9.3 2.4 2.8 3.0 2.4 58.5 7.8 6.5 13.4 4.1 3.2 9.9 7.3 6.4 37.9 10.4 10.0 7.5 9.5 7.2 0.0 1.5 1.3 5.7 1.2 2.7 1.1 2.0 2.8 1.5 0.7 1.2 2.5 3.9 2.5 1.9 1.7 2.4 1.8 8.6 7.7 5.7 7.1 7.6 6.5 7.7 7.2 5.4 7.7 7.7 10.7 7.9 26.4 0.0 5.0 3.6 9.9 17.0 21.1 14.2 26.7 11.6 21.4 15.1 7.3 12.8 9.0 7.3 8.4 31.2 30.6 35.9 3.9 24.3 6.5 11.8 8.9 7.8 13.1 2.7 3.9 16.9 27.0 11.8 13.7 12.1 4.5 10.9 9.3 19.8 13.8 0.0 6.1 11.2 16.2 5.7 22.2 3.7 2.5 20.0 7.2 4.7 5.9 6.6 9.2 3.5 1.4 31.9 15.2 3.4 13.0 13.6 27.7 23.4 8.3 7.8 0.0 7.9 14.3 5.6 12.5 19.8 12.5 66.9 20.7 7.3 12.8 29.9 SMPDL3B ASML3B ENSG00000130768 "Sphingomyelin phosphodiesterase acid like 3B" Q92485 1 27935000-27959157 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.3;pancreas: 49.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.1;Ductal cells: 31.5;Paneth cells: 47.5;Proximal enterocytes: 37.4;Undifferentiated cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 6 "eosinophil: 3.3;myeloid DC: 1.3;neutrophil: 1.8" "Group enriched" "Detected in many" 7 "dendritic cells: 1.3;granulocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 46.0;CAPAN-2: 35.3;NTERA-2: 27.6;RPMI-8226: 30.1;SK-BR-3: 45.9;T-47d: 33.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA030561 Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 400000 Cytosol "Golgi apparatus" "HPA030561: AB_10604095" "unprognostic (1.22e-2)" "unprognostic (4.45e-1)" "unprognostic (4.58e-3)" "unprognostic (3.83e-2)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.50e-1)" "unprognostic (2.68e-1)" "unprognostic (3.95e-1)" "unprognostic (6.02e-2)" "unprognostic (1.64e-1)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.48e-1)" "unprognostic (4.40e-2)" "unprognostic (3.09e-3)" 0.8 0.3 0.4 2.2 0.6 2.0 5.8 2.5 0.6 2.8 1.7 22.4 24.3 1.9 15.9 1.1 7.1 2.2 0.2 1.1 0.5 5.2 0.4 6.7 1.2 0.4 0.4 0.7 0.2 49.8 7.9 1.0 0.3 1.4 3.7 23.8 0.1 12.6 0.5 0.0 0.9 14.3 1.0 0.5 1.7 16.6 0.7 0.6 0.5 14.1 0.0 3.1 2.2 0.4 0.6 5.4 2.5 0.0 0.3 0.0 0.0 46.0 0.0 1.1 0.6 3.4 12.1 35.3 1.7 8.3 0.0 0.7 5.9 3.8 3.2 0.5 0.0 23.6 7.9 0.5 3.0 0.0 2.6 0.0 0.2 2.9 7.0 0.4 1.0 1.0 0.3 1.0 0.4 0.0 19.5 0.1 0.8 27.6 4.1 4.3 0.5 0.2 30.1 24.6 9.5 23.4 0.5 0.0 45.9 1.3 4.7 33.3 1.4 0.0 0.0 7.6 0.1 0.0 0.3 12.9 0.6 0.8 0.0 0.1 0.1 0.1 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.2 0.1 0.0 1.8 0.3 0.0 0.0 0.0 0.1 0.4 0.6 2.5 0.6 1.1 0.5 0.4 0.4 0.7 1.4 0.5 0.6 0.6 0.1 9.6 17.9 0.0 2.3 0.1 2.7 4.0 0.0 0.0 15.0 6.5 0.4 1.5 13.8 9.2 0.0 2.5 0.5 38.1 0.0 31.5 0.4 2.2 0.3 1.1 20.4 1.3 0.8 23.3 0.2 0.2 18.3 5.6 0.0 2.0 0.4 0.0 0.3 0.0 0.1 21.6 10.2 0.0 0.4 0.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 1.0 0.0 21.7 47.5 0.0 16.6 3.7 37.4 8.7 2.7 0.0 0.0 0.0 0.8 0.0 0.2 0.6 0.1 7.7 0.8 0.1 31.2 3.0 ATP5IF1 "ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898" ENSG00000130770 "ATP synthase inhibitory factor subunit 1" Q9UII2 1 28236109-28246906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1035.0;Endometrial ciliated cells: 1524.2;Exocrine glandular cells: 672.1;Granulosa cells: 1030.6;Proximal tubular cells: 1502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027999 Supported Enhanced Mitochondria NA NA Mitochondria "HPA027999: AB_10600984" "unprognostic (2.80e-2)" "unprognostic (3.72e-2)" "unprognostic (2.95e-1)" "prognostic favorable (6.38e-8)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (6.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.40e-2)" "prognostic favorable (8.20e-4)" "unprognostic (5.94e-2)" "unprognostic (3.52e-1)" "unprognostic (6.15e-3)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (2.79e-1)" "unprognostic (1.48e-3)" 96.2 216.9 97.0 51.0 99.8 145.5 109.7 96.6 141.1 123.5 95.2 186.6 164.6 114.0 44.9 186.0 140.6 28.2 556.2 100.1 102.8 383.8 345.4 117.0 65.0 100.4 96.5 97.9 136.1 164.8 90.9 248.4 37.9 101.8 157.3 59.9 71.6 146.5 37.5 460.4 158.2 201.3 28.8 94.3 155.0 217.5 358.3 99.4 60.6 170.6 181.4 48.3 117.6 135.1 104.9 271.9 136.4 79.3 75.1 58.0 62.7 94.1 118.6 57.9 98.6 96.2 132.0 192.5 189.1 173.8 72.1 37.6 161.5 91.2 118.0 77.6 143.9 306.0 162.9 612.7 180.8 62.9 125.5 158.1 73.5 190.2 88.2 70.4 96.2 95.7 222.0 292.9 167.9 71.2 178.0 187.6 230.4 262.7 100.9 167.8 177.3 87.5 270.2 196.9 175.5 158.9 114.2 146.5 150.8 160.4 76.5 224.4 136.6 100.6 31.9 88.0 126.5 142.1 432.0 282.8 268.6 151.1 338.8 38.1 133.3 116.6 126.1 144.2 111.1 145.8 195.2 154.3 155.5 142.8 154.0 144.1 139.3 102.7 142.9 102.7 213.5 226.9 214.1 97.0 99.8 96.6 141.1 100.1 102.8 100.4 96.5 97.9 101.8 94.3 99.4 104.9 207.3 205.1 284.9 0.0 61.7 0.0 0.0 0.0 0.0 0.0 251.1 314.3 0.0 0.0 150.4 546.2 0.0 453.8 165.4 0.0 1035.0 396.6 0.0 1524.2 210.6 84.0 0.0 0.0 0.0 672.1 226.0 114.6 0.0 453.2 172.8 1030.6 0.0 0.0 372.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.6 0.0 0.0 123.0 0.0 0.0 0.0 0.0 550.3 0.0 0.0 30.3 0.0 0.0 1502.7 621.6 0.0 0.0 0.0 90.6 0.0 0.0 0.0 0.0 251.7 92.0 281.6 0.0 0.0 MED18 "FLJ20045, p28b, SRB5" ENSG00000130772 "Mediator complex subunit 18" Q9BUE0 1 28329002-28335965 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027429 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027429: AB_10610137" "unprognostic (2.72e-2)" "unprognostic (2.00e-1)" "unprognostic (2.78e-3)" "prognostic favorable (3.93e-4)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (4.30e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (7.49e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.38e-5)" "prognostic favorable (6.72e-4)" "unprognostic (9.20e-2)" "unprognostic (3.08e-2)" "unprognostic (7.69e-2)" 4.7 7.7 1.7 4.0 1.7 2.8 5.0 2.0 2.3 4.0 2.3 7.8 4.2 5.7 3.6 10.1 4.9 2.3 5.8 1.8 1.8 6.4 15.4 4.0 5.7 1.9 1.7 1.7 3.3 6.8 2.4 4.6 3.2 1.9 4.9 4.3 1.8 5.9 2.8 9.3 7.0 9.4 2.9 1.8 10.3 7.9 5.8 1.9 3.8 4.1 3.1 6.1 5.7 5.3 2.3 12.6 6.1 6.0 5.2 7.9 7.6 6.7 7.4 8.7 9.4 8.1 3.5 11.6 15.6 7.5 7.6 5.7 7.7 9.7 9.1 7.3 10.6 6.9 12.0 5.4 7.7 10.9 7.3 12.3 8.1 11.0 7.4 11.2 5.6 8.2 7.6 11.6 4.0 8.9 6.1 9.3 9.2 7.1 6.9 3.4 6.7 8.7 8.3 8.3 6.2 5.8 6.1 7.4 7.5 10.9 6.3 6.3 6.9 10.0 5.7 6.4 9.4 7.8 6.9 9.8 8.5 8.4 15.2 4.1 3.6 3.4 5.1 3.2 3.3 2.4 3.7 2.5 2.7 2.9 2.7 3.1 3.2 5.0 2.5 4.2 3.9 3.7 3.4 1.7 1.7 2.0 2.3 1.8 1.8 1.9 1.7 1.7 1.9 1.8 1.9 2.3 3.3 9.6 4.8 0.7 5.1 0.8 4.0 7.9 1.8 3.1 1.8 2.4 5.9 4.3 7.6 1.8 12.5 11.9 12.0 7.9 7.9 7.9 0.4 7.1 4.8 2.7 3.5 3.2 0.8 6.0 13.5 3.0 4.6 4.6 1.3 3.4 4.2 4.3 7.9 10.1 0.8 5.9 6.1 4.1 0.9 0.7 4.7 3.5 1.8 0.0 7.0 4.5 10.3 0.0 0.7 5.7 7.2 5.3 2.6 3.1 8.0 8.6 5.9 4.6 19.7 2.5 5.4 7.5 7.7 1.9 1.3 14.8 4.6 4.8 4.6 6.0 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 217.5;lymphoid tissue: 127.0" "Cell type enhanced" "Detected in many" "dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2" "Group enriched" "Detected in all" 6 "dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6" "Cell line enhanced" "Detected in many" "Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 31.0 10.7 11.6 73.5 14.1 217.5 12.8 15.1 15.8 7.3 15.0 14.8 10.2 5.8 3.9 8.0 10.3 23.8 5.9 13.1 21.4 9.1 19.2 46.2 48.3 23.3 14.7 9.4 3.4 5.4 2.7 4.9 18.9 19.0 5.5 10.2 0.9 11.2 3.9 3.5 4.3 28.4 15.6 16.7 127.0 12.4 22.5 16.8 16.1 11.1 4.6 30.1 27.2 6.4 24.3 9.1 0.3 3.4 0.5 11.4 15.6 1.5 1.9 20.0 28.7 40.2 1.3 2.4 12.8 1.2 6.6 15.9 1.3 5.2 1.2 4.6 1.7 1.2 18.0 0.4 2.3 22.3 23.0 27.8 7.9 0.3 14.8 0.1 1.5 11.1 1.0 24.7 135.9 2.1 6.1 0.9 20.1 11.8 0.3 1.8 4.1 12.8 23.2 8.6 0.3 0.2 5.0 0.1 0.8 26.2 2.1 0.3 20.2 6.9 1.7 0.2 5.6 0.3 98.4 6.1 0.8 32.3 62.1 0.5 41.7 403.3 341.0 71.9 441.4 66.1 41.5 53.1 60.2 309.6 21.8 45.6 48.2 498.1 61.9 454.6 125.2 56.4 380.7 11.6 14.1 15.1 15.8 13.1 21.4 23.3 14.7 9.4 19.0 16.7 16.8 24.3 2.2 3.2 20.0 0.3 42.6 3.2 1.1 2.7 0.6 0.4 1.0 0.6 0.7 2.8 8.7 0.0 0.0 0.8 87.5 0.3 0.0 0.9 2.3 4.5 1.8 6.8 10.7 6.1 6.2 8.3 1.3 1.8 1.1 6.4 13.3 7.1 3.6 1.3 62.6 0.0 0.7 0.2 36.7 135.9 59.9 5.2 0.6 125.4 17.8 6.5 144.8 0.1 54.6 0.5 14.7 8.7 0.0 0.4 57.3 3.0 0.0 0.4 3.2 0.2 0.0 21.9 2.1 1.8 2.9 0.1 1.1 2.5 21.2 3.0 0.8 5.0 CLIP1 "CLIP, CLIP-170, CLIP170, CYLN1, RSN" ENSG00000130779 "CAP-Gly domain containing linker protein 1" P30622 12 122271432-122422669 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 170.6" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 479.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004399, HPA026678" Approved Supported "Microtubule ends,Cytosol" NA NA 16000 "Microtubule ends, Cytosol" "CAB004399: AB_671001, HPA026678: AB_1846954" "unprognostic (1.18e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (2.51e-1)" "unprognostic (7.62e-2)" "unprognostic (2.31e-2)" "unprognostic (8.97e-2)" "unprognostic (3.26e-2)" "unprognostic (5.50e-2)" "unprognostic (2.63e-1)" "unprognostic (3.37e-1)" "unprognostic (2.52e-3)" 29.8 37.1 25.1 28.0 26.1 18.2 23.4 65.9 27.9 22.9 20.7 26.5 17.0 26.4 18.1 71.4 17.1 22.5 43.5 26.9 32.9 30.0 46.6 28.3 18.5 22.4 23.4 21.3 13.2 27.0 90.8 16.5 39.3 37.5 32.7 20.8 27.2 25.4 44.8 166.9 41.6 19.8 42.7 17.7 17.4 19.8 25.0 25.9 14.0 70.1 170.6 25.5 48.7 30.1 27.8 54.2 63.5 46.0 39.1 34.8 51.7 79.4 76.3 69.2 49.2 30.0 31.7 24.4 24.2 49.8 95.7 66.9 65.6 29.7 31.2 57.9 95.0 17.0 7.7 40.2 36.3 68.6 27.8 41.5 32.1 103.3 57.0 87.6 70.3 49.2 20.2 29.4 15.0 47.7 34.6 17.4 8.7 16.7 25.7 53.2 14.7 31.5 11.6 45.5 61.9 16.1 10.7 162.9 39.5 64.0 44.9 31.4 15.9 98.2 36.8 40.1 84.3 49.3 17.0 14.4 14.1 63.0 14.0 25.6 3.3 6.5 4.0 6.6 10.6 5.1 4.9 6.1 5.9 5.6 3.0 4.5 3.2 17.1 4.7 9.4 3.2 6.3 4.1 25.1 26.1 65.9 27.9 26.9 32.9 22.4 23.4 21.3 37.5 17.7 25.9 27.8 50.2 134.6 129.9 116.2 32.4 67.2 162.6 42.4 23.9 69.6 50.0 30.1 142.2 50.1 106.5 44.1 43.8 129.7 34.5 38.0 7.9 69.0 156.9 101.2 53.1 57.3 13.9 11.3 115.3 65.5 32.9 69.1 26.0 115.0 72.7 41.3 46.4 48.3 38.3 132.9 107.7 22.3 42.7 41.8 48.5 82.9 35.8 57.0 55.2 45.0 54.2 34.8 46.4 45.2 40.7 95.6 28.5 62.1 33.0 134.4 26.4 13.2 146.5 41.8 72.3 114.6 68.4 22.0 27.4 40.3 143.3 479.4 48.5 39.6 23.0 223.9 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774526-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 70.7" "Group enriched" "Detected in some" 13 "Early spermatids: 259.2;Late spermatids: 75.0;Spermatocytes: 188.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: AB_2683805" "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.4 1.4 0.2 1.4 0.2 0.1 0.9 1.6 0.3 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 1.4 0.6 0.1 0.1 0.1 0.3 0.8 0.7 1.8 0.1 0.1 0.3 0.7 0.0 1.1 0.1 0.1 1.4 0.1 0.1 0.7 0.4 0.2 0.1 0.6 0.6 0.1 70.7 0.7 0.2 0.1 0.3 0.3 0.1 0.1 2.2 0.1 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.3 0.1 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.3 0.9 0.1 0.0 0.0 0.6 0.8 0.1 0.3 0.4 0.1 0.1 0.0 0.7 0.3 0.2 0.4 0.1 0.0 1.2 0.1 0.0 0.5 0.8 0.2 0.0 0.2 0.1 0.5 0.0 0.0 0.3 0.4 0.2 0.0 0.6 0.1 0.2 2.9 0.1 0.1 0.3 0.3 0.2 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.3 0.0 1.4 1.4 0.9 1.6 1.4 0.6 0.8 0.7 1.8 1.1 0.6 0.7 2.2 0.5 0.0 0.0 9.1 2.1 0.5 0.2 0.1 0.6 1.4 0.4 0.5 1.0 0.0 0.0 0.0 4.2 0.1 0.6 0.1 0.0 0.3 259.2 0.5 0.4 0.4 0.0 0.0 11.7 0.2 0.6 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.1 1.7 8.1 0.2 0.0 0.3 1.7 75.0 3.1 1.3 1.8 3.7 0.2 0.5 1.0 5.0 8.0 0.1 0.0 2.6 0.3 0.5 0.1 0.0 0.0 1.3 13.1 0.5 0.2 188.2 2.9 0.4 0.9 0.0 0.3 0.2 0.3 0.2 HIP1R "FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655" ENSG00000130787 "Huntingtin interacting protein 1 related" O75146 12 122834453-122862961 "Cancer-related genes, Predicted intracellular proteins" Endocytosis Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 100.1" "Cell type enhanced" "Detected in many" "Astrocytes: 134.5;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 10.6" "Group enriched" "Detected in many" 8 "B-cells: 10.6;granulocytes: 2.9;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017187, HPA038135, HPA038136" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852" "unprognostic (4.52e-1)" "unprognostic (6.39e-2)" "unprognostic (7.07e-2)" "unprognostic (6.55e-3)" "unprognostic (8.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.02e-2)" "unprognostic (8.11e-2)" "unprognostic (6.37e-2)" "unprognostic (1.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.72e-2)" "prognostic favorable (6.50e-7)" "unprognostic (2.18e-2)" "unprognostic (2.84e-1)" "unprognostic (2.54e-3)" "prognostic favorable (7.26e-4)" 17.5 24.2 62.6 10.5 83.2 13.5 22.7 74.8 80.9 12.6 30.8 11.3 32.0 9.1 3.9 18.1 9.1 7.8 17.7 60.7 60.5 46.0 25.8 15.5 17.7 90.4 78.5 50.4 5.7 50.6 9.0 42.3 4.7 99.5 21.2 4.9 5.6 59.2 10.6 7.2 49.4 36.3 2.3 64.4 21.1 67.2 8.5 80.5 12.7 21.7 4.4 11.8 11.5 19.9 100.1 38.1 10.8 8.0 33.1 2.3 6.1 39.2 5.9 9.5 5.9 4.6 16.8 11.1 36.0 19.0 4.3 8.9 32.4 9.7 21.4 0.5 5.8 14.0 0.8 13.8 17.8 7.1 2.8 24.5 3.8 14.9 8.0 13.4 8.1 40.5 16.5 9.6 2.0 3.4 54.4 17.4 8.8 7.4 32.8 12.8 9.0 10.2 12.5 19.6 45.4 8.1 17.9 7.1 18.0 9.5 4.3 36.6 1.5 32.8 3.7 27.5 11.7 5.7 24.8 14.2 21.8 6.0 6.0 3.1 0.0 0.0 2.9 2.7 0.0 1.5 9.3 1.7 2.1 0.0 10.6 3.0 1.9 0.2 0.7 0.0 0.0 0.4 2.0 62.6 83.2 74.8 80.9 60.7 60.5 90.4 78.5 50.4 99.5 64.4 80.5 100.1 57.0 0.0 13.4 134.5 38.0 13.3 16.8 8.4 6.8 16.4 21.2 18.2 4.2 60.1 11.1 60.7 29.2 3.7 18.2 28.4 0.0 40.1 3.1 21.9 4.7 18.2 7.8 1.3 11.2 28.7 13.1 2.3 80.5 37.5 5.7 25.3 19.2 24.4 0.6 18.5 9.7 29.9 22.4 1.2 4.2 2.9 1.5 2.2 10.6 9.4 0.1 12.5 7.2 168.9 117.8 22.7 25.3 1.2 17.2 20.2 47.5 17.9 14.2 16.6 0.0 2.5 4.1 6.5 13.3 11.5 21.0 1.9 15.0 1.3 23.9 28.4 ZNF317 ENSG00000130803 "Zinc finger protein 317" Q96PQ6 19 9140397-9163424 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042075, HPA048625" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042075: AB_10796471, HPA048625: AB_2680464" "unprognostic (3.81e-1)" "unprognostic (3.11e-2)" "unprognostic (3.90e-1)" "unprognostic (1.63e-1)" "unprognostic (2.98e-2)" "unprognostic (6.07e-3)" "unprognostic (7.70e-2)" "unprognostic (6.17e-2)" "unprognostic (3.89e-2)" "unprognostic (1.72e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.67e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (3.36e-1)" "unprognostic (2.42e-3)" 15.3 17.6 21.6 10.3 22.2 26.4 14.8 22.8 34.4 14.9 22.5 17.2 11.3 16.5 11.6 17.5 15.6 8.4 14.5 21.8 21.9 18.1 21.3 14.3 14.3 21.8 22.0 21.1 16.5 19.7 12.5 15.9 9.2 22.4 17.9 10.5 13.1 13.7 9.7 14.7 22.5 18.0 10.4 21.7 24.9 18.5 6.7 22.3 15.2 14.7 12.8 15.5 17.9 15.3 23.2 17.4 14.6 15.7 21.0 15.7 14.9 13.6 14.3 22.3 19.2 23.2 16.6 9.2 29.5 17.9 15.3 22.8 17.2 25.7 24.7 24.8 24.4 34.5 26.6 13.3 18.4 20.9 27.8 26.0 17.9 32.2 21.9 38.1 16.6 17.0 25.8 24.8 33.6 19.6 14.6 34.8 88.3 29.0 18.4 30.9 24.4 19.8 23.6 17.0 29.4 27.0 18.6 19.9 17.4 22.7 13.7 13.1 28.7 15.1 13.6 12.3 31.2 19.3 42.0 42.8 33.3 13.1 24.2 17.8 19.4 14.8 16.1 13.0 15.5 20.5 20.8 17.3 15.2 15.0 16.4 16.4 17.9 9.0 22.8 13.4 13.6 22.5 14.2 21.6 22.2 22.8 34.4 21.8 21.9 21.8 22.0 21.1 22.4 21.7 22.3 23.2 5.7 9.6 13.4 6.8 11.8 7.4 7.1 4.4 6.2 8.3 8.9 6.7 7.3 7.2 9.4 5.5 6.2 5.6 12.6 9.5 3.9 5.3 0.7 8.9 9.0 7.6 7.2 9.1 6.1 6.4 5.2 7.9 12.2 13.1 13.9 8.1 6.4 10.1 8.0 8.4 7.4 8.6 6.1 15.9 6.2 1.4 3.7 10.1 5.4 7.5 8.1 4.6 8.2 10.6 9.3 8.5 4.7 3.8 10.5 9.5 5.8 9.8 9.4 5.3 0.0 5.7 5.4 2.4 1.0 7.0 6.5 10.9 10.3 7.7 9.6 11.7 PPAN "BXDC3, SSF, SSF1, SSF2" ENSG00000130810 "Peter pan homolog" Q9NQ55 19 10106362-10112012 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 243.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043265 Approved NA NA "HPA043265: AB_10793943" "unprognostic (1.91e-2)" "unprognostic (1.27e-1)" "unprognostic (7.97e-2)" "unprognostic (1.30e-1)" "unprognostic (4.93e-2)" "unprognostic (4.23e-2)" "unprognostic (9.47e-3)" "unprognostic (2.13e-1)" "unprognostic (3.80e-1)" "unprognostic (5.51e-2)" "unprognostic (3.10e-2)" "unprognostic (1.94e-2)" "unprognostic (2.01e-3)" "unprognostic (8.75e-3)" "unprognostic (7.52e-2)" "unprognostic (4.27e-2)" "unprognostic (2.92e-3)" 20.7 20.6 4.5 15.9 4.8 12.4 20.4 5.7 7.7 18.3 2.5 18.9 12.4 19.5 4.0 28.0 19.1 7.0 17.0 4.9 4.9 14.1 24.7 14.9 18.2 3.9 3.3 4.3 19.7 23.4 8.5 13.9 7.6 4.3 19.6 5.8 4.9 16.8 6.9 33.0 28.1 20.1 6.9 1.7 26.7 18.5 19.1 4.4 10.1 16.1 11.2 12.1 20.6 20.7 8.6 51.0 42.0 16.0 35.9 10.8 11.4 34.2 26.7 12.8 33.7 26.3 56.0 19.5 59.0 48.0 17.2 24.4 42.6 42.0 47.7 14.5 31.8 104.6 104.1 47.6 55.2 27.5 66.4 62.5 17.9 36.0 37.0 46.0 22.0 17.2 45.6 76.1 54.9 17.7 72.2 82.5 243.5 75.1 26.8 103.2 60.2 20.5 80.4 19.0 44.8 33.7 41.7 23.9 42.9 40.8 10.6 23.8 37.2 21.1 45.8 24.3 50.6 70.9 111.0 59.3 61.2 31.8 60.2 41.4 2.4 7.1 4.0 6.7 5.0 8.6 17.0 9.2 10.7 6.6 20.6 12.9 5.9 4.7 5.6 3.7 5.0 9.7 3.2 4.5 4.8 5.7 7.7 4.9 4.9 3.9 3.3 4.3 4.3 1.7 4.4 8.6 12.2 3.2 6.4 0.0 20.2 57.4 50.3 15.4 4.0 11.3 12.8 14.1 3.9 10.0 12.1 5.5 6.2 26.4 24.0 20.0 3.9 33.2 9.0 4.6 10.5 13.0 6.7 10.3 0.0 30.6 32.0 14.1 6.1 5.1 7.0 13.8 10.4 11.4 32.4 18.5 0.0 17.7 16.2 7.6 17.0 9.1 18.6 10.5 12.4 0.0 15.7 5.0 18.6 0.0 0.0 31.7 12.6 10.5 9.9 33.2 10.3 18.9 5.8 9.9 0.0 18.8 16.7 22.7 42.1 6.8 52.8 17.8 18.9 19.9 24.9 27.9 EIF3G "eIF3-delta, eIF3-p44, EIF3S4" ENSG00000130811 "Eukaryotic translation initiation factor 3 subunit G" O75821 19 10115014-10119918 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1509.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 1471.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041997 Approved Enhanced Cytosol NA NA 64000 Cytosol "HPA041997: AB_10804123" "unprognostic (1.80e-2)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "unprognostic (3.33e-2)" "unprognostic (2.22e-2)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.49e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.94e-4)" "unprognostic (4.90e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-1)" "unprognostic (2.40e-2)" "unprognostic (7.63e-2)" "unprognostic (1.91e-1)" "unprognostic (2.43e-1)" 187.3 154.4 84.2 97.8 86.2 129.0 189.6 88.4 111.2 210.4 85.1 189.9 95.8 192.2 61.9 145.4 191.4 68.7 193.8 78.1 87.2 153.7 135.4 136.5 126.4 89.8 84.7 73.5 282.4 327.2 117.2 120.5 91.5 89.4 173.5 54.8 25.0 183.7 103.2 534.2 213.8 149.2 74.4 90.8 170.3 209.3 177.7 92.3 126.0 140.4 223.1 99.6 185.1 173.3 93.5 211.5 175.5 130.1 174.9 170.8 216.6 169.2 175.6 242.3 269.0 247.7 289.2 111.1 214.9 245.1 210.8 121.9 158.4 159.7 265.0 111.1 196.0 491.8 379.8 179.0 293.2 283.7 303.8 192.7 262.7 191.0 191.6 181.0 172.2 195.7 263.1 349.2 249.6 164.3 282.3 333.2 1471.2 323.1 131.9 372.0 265.3 129.2 287.2 173.4 181.8 170.0 328.9 117.6 152.0 287.9 73.2 133.4 264.4 196.1 233.0 132.6 256.1 339.1 726.8 567.8 240.2 175.6 328.5 227.9 199.9 319.1 139.5 267.6 238.7 348.0 244.5 287.0 291.8 303.2 255.3 287.5 262.4 60.3 458.6 200.3 240.7 351.5 457.0 84.2 86.2 88.4 111.2 78.1 87.2 89.8 84.7 73.5 89.4 90.8 92.3 93.5 183.9 44.8 94.5 7.2 219.3 228.2 271.7 185.8 191.2 41.5 276.0 342.9 43.3 164.5 118.1 108.5 18.8 470.9 273.6 146.4 187.9 182.7 438.1 99.7 141.5 160.6 129.9 131.1 4.2 309.1 328.2 159.1 122.3 108.9 129.3 197.3 167.4 98.9 225.1 21.9 4.1 231.1 81.4 288.5 268.9 1509.3 237.9 198.9 145.9 4.7 351.7 85.5 557.1 6.6 10.8 205.3 198.8 177.1 192.6 241.0 277.0 320.1 100.6 56.6 164.3 189.9 243.8 221.1 142.4 152.9 238.7 527.2 261.5 209.6 235.4 263.2 ANGPTL6 "AGF, ARP5" ENSG00000130812 "Angiopoietin like 6" Q8NI99 19 10092338-10102796 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 30.4" "Cell type enhanced" "Detected in some" "B-cells: 4.1;Hepatic stellate cells: 5.7;Hepatocytes: 8.2;Smooth muscle cells: 15.8;Spermatogonia: 6.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HMC-1: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "Secreted to blood" NA NA 450000 23000000 "unprognostic (1.28e-1)" "unprognostic (2.18e-6)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-2)" "unprognostic (5.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.99e-2)" "unprognostic (1.23e-2)" "unprognostic (1.85e-1)" "unprognostic (2.26e-10)" "unprognostic (8.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-2)" "unprognostic (1.32e-1)" 0.3 0.3 1.7 2.1 0.9 2.9 0.3 1.0 1.1 0.2 0.4 0.5 0.7 0.1 0.2 0.3 0.7 0.4 0.1 0.8 1.2 0.3 30.4 0.5 3.4 1.7 1.0 0.7 0.3 1.1 0.1 0.4 2.2 1.4 0.2 0.4 0.1 0.2 0.0 0.0 0.3 3.6 0.2 1.5 3.4 1.6 1.6 1.3 0.8 0.3 0.0 3.3 0.5 0.2 3.1 0.3 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.2 0.0 0.1 7.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 2.0 0.2 0.2 0.0 0.5 58.9 0.0 0.2 0.1 0.1 0.3 0.0 0.6 0.4 0.3 0.0 0.0 1.3 4.7 0.2 0.4 1.1 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.5 0.0 0.0 5.0 0.0 0.1 0.1 0.0 0.0 5.1 1.4 2.9 0.2 0.7 0.7 0.0 0.3 0.0 0.6 0.4 0.4 0.7 0.4 0.4 0.1 0.9 0.2 0.4 0.0 0.4 0.2 0.1 0.5 0.2 1.7 0.9 1.0 1.1 0.8 1.2 1.7 1.0 0.7 1.4 1.5 1.3 3.1 0.3 0.0 0.0 0.0 4.1 0.3 0.1 0.4 0.0 0.1 0.4 0.3 0.4 2.8 0.3 0.0 0.0 0.2 1.7 0.1 1.9 0.3 0.3 0.0 0.3 0.2 0.0 0.4 0.9 0.0 0.2 2.5 0.5 0.1 0.0 0.1 5.7 8.2 2.3 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 2.1 0.0 0.2 0.5 0.2 0.2 0.0 0.1 15.8 0.5 6.3 0.0 0.0 0.3 1.0 0.9 0.1 0.1 SHFL "C19orf66, FLJ11286, IRAV, RyDEN, SFL" ENSG00000130813 "Shiftless antiviral inhibitor of ribosomal frameshifting" Q9NUL5 19 10086122-10093252 "Predicted intracellular proteins" "Antiviral defense" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 76.3" "Cell type enhanced" "Detected in some" "Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042001 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042001: AB_10794167" "prognostic favorable (4.04e-4)" "unprognostic (1.21e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (2.19e-2)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (6.57e-2)" "unprognostic (4.22e-3)" "unprognostic (2.34e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (8.96e-11)" "unprognostic (5.92e-2)" "unprognostic (1.81e-1)" "unprognostic (4.41e-3)" "prognostic favorable (1.35e-4)" 12.5 18.7 28.7 14.4 28.3 15.8 12.3 27.5 30.3 16.5 26.1 11.3 14.9 15.9 16.6 8.7 17.8 18.2 7.9 28.3 30.1 12.9 76.3 16.9 22.9 28.5 28.1 27.9 19.1 9.9 16.8 14.2 12.8 28.4 12.0 10.0 15.2 16.4 19.3 4.5 9.5 18.5 15.5 28.4 20.0 11.1 4.4 29.8 20.6 12.3 7.0 16.7 14.8 12.4 30.3 9.4 3.8 5.0 3.9 20.3 23.6 1.4 7.6 46.3 71.8 81.2 0.4 7.4 4.8 2.1 24.0 25.7 3.9 3.9 20.7 12.0 30.4 0.4 15.5 3.0 10.6 32.6 4.7 9.7 34.3 11.7 11.5 4.1 27.1 22.9 20.6 1.8 20.2 15.0 6.5 20.1 13.3 1.1 7.0 5.5 16.2 0.0 8.0 14.8 13.0 0.7 3.5 12.9 1.3 42.2 0.9 1.2 12.9 14.8 6.0 3.0 9.6 1.6 24.1 7.2 1.2 16.8 6.0 12.1 16.4 12.8 18.2 23.3 11.7 31.1 13.0 19.5 25.4 10.2 10.1 16.3 17.7 16.4 32.7 20.3 2.0 21.7 15.5 28.7 28.3 27.5 30.3 28.3 30.1 28.5 28.1 27.9 28.4 28.4 29.8 30.3 23.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 5.4 21.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 6.7 6.8 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 2.6 3.3 0.0 0.0 0.0 DNMT1 "CXXC9, DNMT, MCMT" ENSG00000130816 "DNA methyltransferase 1" P26358 19 10133342-10231286 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Deafness, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002694, CAB005876" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB005876: AB_731983, HPA002694: AB_1847810" "unprognostic (3.51e-1)" "unprognostic (1.20e-2)" "unprognostic (1.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.62e-1)" "unprognostic (7.59e-3)" "prognostic unfavorable (1.46e-4)" "unprognostic (2.90e-1)" "unprognostic (4.23e-3)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.28e-3)" "unprognostic (7.81e-3)" "unprognostic (1.73e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" 6.6 3.9 0.7 17.1 2.5 23.3 7.1 9.8 2.7 9.2 0.0 7.0 6.7 7.4 3.2 7.8 6.5 6.3 4.9 1.7 2.8 3.0 3.9 7.8 26.4 2.3 1.8 0.5 5.7 3.6 4.3 4.6 26.2 5.1 4.5 6.9 7.6 5.7 4.7 5.4 8.0 7.9 8.8 0.4 8.2 6.4 12.5 2.2 20.7 6.4 5.0 25.1 7.3 6.5 9.3 77.0 40.6 49.5 45.8 24.6 24.0 138.8 52.4 43.9 77.5 74.9 50.6 40.8 138.3 33.8 30.0 38.6 46.6 68.4 44.2 68.4 57.5 100.9 181.5 39.5 27.1 9.6 91.5 73.4 11.5 9.3 68.5 24.1 18.4 39.9 37.6 75.0 82.8 63.3 37.6 109.2 50.4 87.5 38.3 76.6 117.1 67.9 77.2 21.5 49.3 64.5 41.5 58.2 26.2 16.5 33.6 28.9 42.2 31.8 111.3 42.2 73.0 84.4 49.6 69.5 166.8 35.0 68.5 87.1 20.3 21.2 5.9 29.8 22.0 25.1 14.2 22.8 20.4 19.3 20.0 25.5 20.5 4.6 42.6 13.8 31.9 21.9 12.6 0.7 2.5 9.8 2.7 1.7 2.8 2.3 1.8 0.5 5.1 0.4 2.2 9.3 36.4 6.4 26.5 12.7 38.0 29.6 20.7 26.8 21.1 86.7 32.6 29.6 14.6 7.2 28.2 22.0 56.3 388.1 54.4 29.0 13.7 26.0 46.1 48.1 42.0 38.9 15.7 109.6 17.6 14.3 73.2 33.6 33.6 60.3 37.2 43.6 25.0 14.8 76.8 65.6 22.6 25.5 38.7 31.4 47.8 50.8 28.0 57.9 14.2 15.0 52.5 32.2 123.6 14.6 20.1 21.1 11.3 28.6 73.4 16.3 4.5 9.3 42.8 50.2 13.1 22.6 32.8 229.6 145.3 41.6 22.4 323.7 70.4 38.7 43.1 16.6 ZNF426 MGC2663 ENSG00000130818 "Zinc finger protein 426" Q9BUY5 19 9523223-9538645 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029342 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA029342: AB_10603007" "unprognostic (3.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (6.62e-2)" "prognostic favorable (3.74e-4)" "unprognostic (4.34e-2)" "unprognostic (1.77e-2)" "unprognostic (4.75e-3)" "unprognostic (1.05e-3)" "unprognostic (8.89e-3)" "unprognostic (7.41e-3)" "prognostic favorable (2.57e-6)" "unprognostic (1.05e-1)" "unprognostic (3.17e-2)" "unprognostic (2.49e-1)" "prognostic favorable (1.81e-4)" 5.1 3.3 3.1 4.0 4.1 5.7 7.0 5.5 3.4 5.5 4.9 3.5 2.8 7.6 4.6 20.8 5.8 4.3 5.4 3.2 4.4 4.3 2.2 5.1 4.1 3.2 3.5 2.9 9.3 4.4 6.4 2.4 5.6 3.6 6.0 3.9 5.1 4.0 5.4 3.7 4.1 3.0 7.8 3.4 4.7 3.7 4.8 3.4 5.8 6.8 5.5 5.8 4.7 5.9 6.1 5.7 1.8 11.2 11.8 7.4 9.7 6.2 7.1 10.8 9.4 11.4 2.4 2.5 5.7 5.6 6.9 6.6 4.8 11.7 8.4 14.0 2.7 9.0 23.7 9.5 4.3 6.7 0.7 7.4 12.4 7.1 10.5 15.0 10.2 10.2 9.7 9.6 0.5 9.1 0.3 13.7 11.4 14.0 1.3 4.4 7.4 13.9 5.9 5.1 14.7 6.3 8.5 12.1 4.3 9.7 9.5 6.0 5.5 8.3 13.2 7.7 6.0 7.7 6.4 9.7 4.8 1.9 0.3 9.6 10.0 3.2 6.1 8.8 4.5 7.8 7.6 6.8 8.7 3.8 6.5 10.0 9.3 6.7 7.8 6.3 3.4 7.1 3.4 3.1 4.1 5.5 3.4 3.2 4.4 3.2 3.5 2.9 3.6 3.4 3.4 6.1 15.0 28.9 26.5 3.3 13.2 3.4 15.6 3.2 12.5 24.8 17.1 14.6 10.1 5.7 12.4 7.3 20.9 12.8 13.4 3.8 21.5 10.9 33.5 11.5 14.2 16.4 3.6 12.6 5.4 4.2 10.2 12.4 5.1 15.5 28.4 22.4 14.3 3.0 7.6 37.0 3.9 4.2 12.2 8.9 1.6 8.2 17.1 8.2 3.6 5.6 11.2 20.1 15.5 4.5 4.7 6.9 5.1 22.2 6.7 13.3 4.7 5.4 14.6 22.0 6.6 17.9 13.2 12.2 11.8 14.7 2.8 14.2 12.1 12.3 6.3 17.9 SLC6A8 "CRTR, CT1" ENSG00000130821 "Solute carrier family 6 member 8" P48029 X 153687926-153696588 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 142.0;Distal enterocytes: 382.0;Proximal enterocytes: 235.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 155.8;AN3-CA: 151.3;SK-BR-3: 156.8" "Low region specificity" "Detected in all" NA NA "unprognostic (5.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.39e-2)" "unprognostic (9.98e-2)" "unprognostic (1.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (2.87e-1)" 31.9 67.1 78.9 9.1 102.3 34.7 24.1 82.0 80.2 16.6 43.8 68.3 51.8 32.7 13.1 55.1 17.5 31.5 119.5 77.7 82.6 82.0 4.5 9.2 1.9 99.1 95.9 66.6 12.5 20.1 45.9 21.6 36.5 107.7 31.5 30.8 35.0 52.7 36.2 168.0 45.4 76.5 20.9 77.9 13.3 31.1 38.8 89.6 12.0 8.3 76.2 3.0 41.6 36.8 121.0 155.8 6.7 39.5 151.3 14.7 9.9 10.2 22.2 37.7 28.7 35.5 20.1 2.1 0.2 17.0 27.9 33.6 54.3 85.3 78.0 17.0 2.7 83.3 0.6 50.6 59.7 50.0 1.2 10.1 20.9 16.5 27.3 103.3 50.7 14.9 0.9 37.3 2.4 15.7 9.3 0.8 3.6 47.0 30.9 67.0 7.6 5.2 2.1 30.8 29.5 56.0 64.2 33.8 156.8 107.9 9.8 30.9 23.9 14.1 45.2 73.1 58.2 66.5 5.2 3.0 1.8 105.5 4.5 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 78.9 102.3 82.0 80.2 77.7 82.6 99.1 95.9 66.6 107.7 77.9 89.6 121.0 5.9 0.0 1.9 14.0 2.7 23.2 14.3 91.1 13.1 142.0 19.6 18.4 106.9 21.5 55.6 5.5 110.5 15.3 2.8 382.0 3.9 4.6 1.5 21.4 38.9 6.5 25.9 23.4 8.2 22.2 37.7 8.8 6.1 16.1 4.5 14.4 3.9 0.9 4.9 119.5 9.9 44.2 38.7 1.9 5.7 3.7 9.0 4.1 24.9 2.8 3.2 19.0 0.0 9.0 23.7 47.5 101.1 8.2 0.8 28.3 235.8 53.3 31.3 49.3 32.9 15.6 19.0 2.9 3.9 16.9 15.6 90.8 2.9 1.5 20.7 18.6 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669733-153689010 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.0;intestine: 55.9;seminal vesicle: 38.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 40.9;Excitatory neurons: 29.0;Extravillous trophoblasts: 63.9;Granulosa cells: 46.9;Syncytiotrophoblasts: 49.5" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AN3-CA: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.2 1.2 41.0 1.9 50.9 0.0 0.6 6.8 49.2 1.1 5.3 55.9 3.4 6.5 1.8 14.1 4.1 2.6 5.3 51.0 39.5 1.9 0.2 0.6 0.0 21.5 20.0 53.0 0.9 0.3 0.5 1.8 2.0 25.2 17.3 3.8 8.0 0.4 38.0 2.0 1.7 13.6 15.9 11.8 0.2 16.0 8.8 51.7 1.5 0.3 0.3 0.1 27.7 2.2 32.4 0.3 0.1 0.4 33.9 0.0 0.0 3.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.4 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.3 0.4 0.3 0.2 0.7 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.7 0.0 0.1 2.7 0.9 0.3 0.4 0.0 0.2 1.2 0.0 0.2 0.2 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 50.9 6.8 49.2 51.0 39.5 21.5 20.0 53.0 25.2 11.8 51.7 32.4 0.0 0.0 0.0 18.9 0.0 0.6 0.4 40.9 0.0 21.6 0.3 0.9 3.0 0.0 18.0 0.0 22.9 13.5 0.1 1.7 0.0 0.4 0.3 0.3 4.4 0.3 0.0 0.0 29.0 0.4 63.9 0.5 0.0 0.3 0.0 46.9 0.0 0.0 2.4 0.0 24.2 1.1 12.2 0.0 0.0 0.8 0.0 0.3 1.8 1.0 0.0 3.2 0.0 11.1 13.2 2.9 0.1 0.4 0.0 0.3 20.3 0.4 2.6 19.4 0.0 0.0 4.0 0.6 0.9 0.0 0.6 49.5 0.1 0.6 0.4 1.0 DKC1 "Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101" ENSG00000130826 "Dyskerin pseudouridine synthase 1" O60832 X 154762742-154777689 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Isomerase, Ribonucleoprotein, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 707.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000166, HPA000447, HPA001022, CAB033086" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 34000 "Nucleoli fibrillar center" Nucleoplasm "CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175" "unprognostic (9.87e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.86e-1)" "prognostic unfavorable (2.94e-4)" "prognostic unfavorable (1.39e-5)" "unprognostic (7.02e-2)" "prognostic unfavorable (9.13e-4)" "unprognostic (2.53e-2)" "unprognostic (2.35e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (1.46e-9)" "unprognostic (5.28e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-1)" "unprognostic (2.55e-1)" 23.7 20.6 18.2 30.2 18.5 69.4 35.7 18.9 20.7 19.9 19.3 28.8 24.5 23.4 22.5 36.6 24.6 15.4 19.6 17.4 19.1 19.0 22.8 16.6 40.5 18.8 18.6 17.1 31.1 32.8 26.8 17.8 23.4 19.2 22.4 35.1 20.0 22.1 19.1 31.5 30.9 21.5 23.0 18.7 25.9 21.7 25.5 18.7 39.7 28.0 23.4 48.2 37.1 24.0 20.2 236.5 129.3 77.4 111.4 47.2 48.2 114.9 87.2 60.5 127.2 118.9 164.3 114.2 447.2 221.3 74.7 119.4 123.5 239.6 144.8 189.3 108.8 132.9 223.4 131.1 143.3 66.9 304.6 131.2 46.3 135.6 141.1 320.8 46.6 89.7 146.2 210.1 108.0 88.0 137.7 201.5 233.7 130.2 234.0 158.8 177.1 174.1 230.3 80.4 132.0 170.0 84.4 77.8 133.3 122.7 75.0 68.1 120.8 70.8 91.4 138.2 119.3 292.6 199.8 290.5 707.7 62.2 316.5 102.0 10.8 25.0 33.1 38.6 30.1 48.8 44.2 31.1 41.6 35.5 31.3 40.7 39.1 7.4 41.2 31.2 25.5 26.5 30.3 18.2 18.5 18.9 20.7 17.4 19.1 18.8 18.6 17.1 19.2 18.7 18.7 20.2 21.6 25.6 32.3 5.9 47.6 99.7 76.2 45.4 60.3 31.6 39.2 34.0 32.0 25.8 35.2 25.8 14.6 56.6 34.8 17.7 41.1 62.8 2.7 22.4 39.8 39.7 34.1 84.1 6.4 45.3 74.8 36.4 23.0 24.1 56.8 70.0 13.6 26.0 44.5 23.5 7.1 35.9 54.9 21.6 36.4 7.9 25.7 25.8 49.8 7.5 36.4 34.8 29.9 7.5 7.7 47.3 14.8 28.6 45.1 131.2 9.5 25.6 26.7 28.5 13.1 37.8 42.6 41.0 87.2 69.9 98.3 34.2 35.9 59.6 49.9 57.9 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 94000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: AB_2683872" "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.1 7.0 5.3 3.5 5.6 1.8 6.0 6.1 7.3 10.3 4.1 7.5 3.6 8.1 4.3 5.3 8.7 3.9 5.9 4.6 6.8 5.6 2.8 8.4 3.8 5.6 4.6 4.1 17.2 7.7 2.0 25.0 3.7 5.4 10.6 2.2 1.5 12.1 3.4 1.8 10.2 7.9 2.6 3.9 8.1 5.6 3.8 7.1 2.2 10.3 1.1 2.6 7.4 9.7 7.3 11.2 2.2 6.3 16.1 6.5 8.3 8.4 15.6 3.3 3.6 4.9 8.2 4.6 2.0 8.2 16.9 8.4 9.6 6.4 7.6 1.3 0.9 4.8 2.0 29.0 4.5 5.2 1.0 8.8 11.3 5.5 5.4 0.4 12.4 4.1 3.2 5.2 1.6 5.7 13.8 1.9 8.4 2.0 3.4 4.9 7.2 0.5 0.7 4.8 7.2 13.2 6.8 5.7 10.3 2.6 4.4 6.2 2.4 10.4 7.8 7.0 0.8 6.7 1.2 0.2 2.9 14.5 1.5 2.1 0.7 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.0 5.3 5.6 6.1 7.3 4.6 6.8 5.6 4.6 4.1 5.4 3.9 7.1 7.3 5.2 12.8 7.7 13.4 9.8 8.7 9.0 7.3 9.6 18.7 13.9 10.3 6.5 2.8 6.8 11.0 12.5 3.0 10.3 15.9 0.0 11.5 0.1 14.4 23.2 3.9 7.2 0.0 6.5 5.8 7.2 11.0 17.9 30.4 8.8 21.3 2.9 1.6 8.5 5.0 5.4 15.1 0.0 3.5 9.2 0.8 11.5 10.5 14.2 6.5 4.7 6.5 4.1 6.0 4.1 13.6 11.4 8.6 8.5 10.3 9.4 1.5 10.9 7.8 13.1 26.5 9.4 0.9 2.3 8.1 7.4 9.3 13.2 2.5 9.6 8.2 DUSP9 "MKP-4, MKP4" ENSG00000130829 "Dual specificity phosphatase 9" Q99956 X 153642492-153651326 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "kidney: 27.4;placenta: 73.2" "Group enriched" "Detected in some" 14 "Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1" "Cancer enhanced" "Detected in many" "liver cancer: 10.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "Hep G2: 372.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003336 Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003336: AB_1078709" "unprognostic (4.64e-2)" "unprognostic (6.48e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.52e-2)" "unprognostic (2.74e-3)" "unprognostic (9.36e-3)" "unprognostic (6.15e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-1)" "unprognostic (1.29e-2)" "unprognostic (1.38e-2)" "unprognostic (2.68e-7)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (5.52e-2)" 0.1 0.0 4.1 0.0 2.9 0.0 0.2 1.7 3.8 0.0 1.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 4.0 2.0 27.4 1.1 0.0 0.0 2.2 2.5 3.1 0.8 0.5 0.7 0.0 73.2 2.6 0.1 0.0 0.0 0.6 0.3 0.0 0.1 0.1 0.0 1.8 0.0 0.0 1.6 2.7 0.0 0.0 0.0 0.0 0.7 0.1 2.9 1.6 0.8 0.1 32.6 0.0 0.0 10.3 0.1 0.0 0.0 0.0 6.5 2.0 0.0 15.8 0.0 1.2 7.5 39.9 1.0 0.0 1.1 7.3 0.0 3.0 372.7 0.0 0.0 5.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 9.7 0.0 0.0 2.1 0.1 0.8 1.1 1.8 14.8 0.0 0.0 0.0 0.1 9.4 0.4 1.2 2.3 2.8 1.6 0.9 0.6 3.9 0.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.9 1.7 3.8 4.0 2.0 2.2 2.5 3.1 2.6 1.8 2.7 2.9 0.0 0.0 0.0 3.6 0.5 0.6 1.0 0.6 2.8 0.0 0.2 3.4 2.3 1.5 0.0 11.0 0.0 1171.5 0.0 0.0 727.8 0.1 0.0 0.1 0.1 3.1 0.0 0.0 0.7 0.0 84.0 6.1 0.0 0.0 0.0 3.8 0.0 0.9 84.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 0.0 0.8 0.0 3.2 0.4 0.0 0.0 0.0 0.4 0.8 8.9 0.2 0.0 1735.1 0.2 10.8 0.1 1.1 MPP1 "DXS552E, PEMP" ENSG00000130830 "Membrane palmitoylated protein 1" Q00013 X 154778684-154821007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 117.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 410.9;Erythroid cells: 393.8;Hofbauer cells: 291.9;Macrophages: 155.9;Syncytiotrophoblasts: 454.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 215.7;neutrophil: 202.1" "Group enriched" "Detected in all" 8 "dendritic cells: 57.7;granulocytes: 215.7;monocytes: 98.8" "Cell line enhanced" "Detected in many" "HEL: 218.0;REH: 136.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076675 Enhanced Supported "Plasma membrane,Centriolar satellite" NA NA 650000 "Plasma membrane" "Centriolar satellite" "HPA076675: " "unprognostic (2.15e-1)" "unprognostic (4.06e-2)" "unprognostic (4.52e-2)" "unprognostic (1.83e-3)" "unprognostic (7.14e-2)" "unprognostic (2.60e-2)" "unprognostic (7.47e-2)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (7.79e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-3)" "prognostic favorable (4.60e-6)" "unprognostic (6.69e-2)" "unprognostic (2.53e-2)" "unprognostic (4.68e-2)" "unprognostic (6.67e-3)" 24.4 27.4 21.5 27.4 22.2 117.8 16.7 25.9 28.6 11.7 21.4 16.9 59.9 13.5 5.4 10.6 15.9 24.5 26.2 22.1 24.3 43.3 37.8 28.6 25.1 27.1 22.1 19.7 10.7 34.9 30.9 9.8 87.3 30.9 15.7 17.8 10.7 23.9 18.3 29.5 10.0 47.7 19.9 22.7 41.2 11.9 7.2 24.7 73.4 14.1 27.5 12.6 21.5 10.1 28.6 41.4 8.3 18.7 18.7 19.0 20.1 59.5 15.3 23.3 25.3 30.8 23.7 3.7 32.8 29.3 17.1 67.9 4.6 21.6 6.9 19.9 34.9 38.0 218.0 5.7 25.3 28.6 44.4 121.4 19.4 9.0 28.2 7.0 25.9 58.5 42.1 96.1 5.3 28.7 0.2 102.6 60.3 1.9 3.8 28.2 136.0 4.8 15.5 14.8 3.3 4.7 7.5 12.7 1.2 13.3 18.5 3.2 25.8 26.6 23.2 12.5 51.8 41.7 36.6 52.9 12.5 32.7 61.7 11.1 49.7 95.6 215.7 5.1 76.6 6.0 7.8 5.9 5.7 57.7 2.7 15.4 7.9 202.1 10.1 98.8 15.5 3.5 79.1 21.5 22.2 25.9 28.6 22.1 24.3 27.1 22.1 19.7 30.9 22.7 24.7 28.6 18.3 3.2 11.2 8.1 6.3 8.7 4.8 0.2 8.0 10.2 7.1 5.1 17.0 41.5 6.2 7.3 4.2 410.9 6.9 16.3 21.5 11.7 0.6 3.5 5.7 18.9 11.5 393.8 16.1 2.8 27.0 11.4 1.1 6.4 90.6 9.6 11.7 10.6 291.9 16.8 17.1 4.4 0.0 104.7 30.2 2.4 8.7 155.9 10.6 15.9 52.5 15.4 9.2 6.0 5.9 3.7 4.1 13.2 8.1 3.1 57.4 66.3 2.2 8.2 0.0 8.6 10.3 0.7 6.8 6.4 6.0 454.4 9.9 14.5 5.8 1.2 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53519527-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 284.5;dendritic cells: 298.4;granulocytes: 241.9;Langerhans cells: 245.5;Macrophages: 241.4;T-cells: 303.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 79.7;RT4: 63.4" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm NA NA Nucleoplasm "HPA063157: AB_2684951" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" 33.3 125.9 13.5 18.7 13.4 46.7 19.4 48.0 27.4 19.1 22.3 12.8 4.8 20.4 10.7 7.6 47.0 22.8 27.4 14.0 91.1 13.8 12.4 43.8 10.4 24.9 14.2 11.4 120.4 21.2 17.2 75.3 55.0 15.9 24.5 8.5 41.6 11.1 22.6 18.9 13.2 10.9 14.3 11.7 10.7 15.5 20.2 23.6 12.3 16.8 9.4 8.8 29.1 16.6 20.3 0.2 11.3 22.5 26.0 15.0 10.7 38.3 16.2 13.7 12.0 21.4 11.8 5.7 7.9 4.2 9.4 5.4 6.6 16.4 12.1 21.4 0.1 79.7 11.8 18.8 7.5 10.9 6.8 15.4 12.4 6.9 13.2 4.8 6.2 5.6 13.9 0.5 3.0 11.4 7.6 16.5 15.1 9.5 0.2 15.5 20.2 13.5 9.6 5.9 63.4 14.3 15.7 7.1 18.8 4.5 43.2 4.1 6.7 5.6 17.0 15.1 10.0 11.1 37.7 28.2 17.8 0.2 1.0 13.9 0.8 5.7 8.2 9.6 4.7 15.2 8.9 10.5 9.7 4.3 10.3 15.6 10.2 0.7 6.1 9.8 4.8 11.7 5.9 13.5 13.4 48.0 27.4 14.0 91.1 24.9 14.2 11.4 15.9 11.7 23.6 20.3 37.4 19.2 56.2 13.1 284.5 44.7 21.1 10.9 95.6 56.2 28.6 44.7 20.5 35.8 15.2 77.3 29.2 38.2 298.4 1.6 9.8 4.0 125.7 51.0 18.9 36.8 23.4 7.4 36.3 4.0 33.7 96.7 52.5 79.3 241.9 14.5 13.6 3.8 62.1 30.3 39.9 4.8 14.2 46.8 245.5 84.8 24.2 241.4 46.2 15.0 5.9 33.8 11.3 17.6 24.9 2.4 2.7 19.5 141.7 15.9 3.9 4.4 12.4 38.3 0.0 44.0 151.4 39.2 23.5 15.8 50.6 44.5 303.9 14.0 5.2 12.3 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822557-76972901 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 2.4 2.3 3.4 2.3 5.0 5.0 2.4 8.7 4.1 3.0 0.0 2.5 1.9 3.2 2.8 2.5 3.0 2.0 2.2 3.1 2.8 2.0 2.1 2.1 2.7 3.0 2.5 1.7 4.3 2.8 3.1 3.6 2.2 3.2 2.6 1.5 2.4 2.7 2.3 2.6 4.1 2.5 2.1 1.7 2.3 2.8 6.9 2.9 4.1 2.7 3.1 2.4 2.6 2.9 4.9 2.5 2.4 4.7 3.4 3.7 3.4 1.9 1.8 2.6 2.9 2.4 2.3 2.3 3.6 0.9 2.5 3.2 4.6 3.0 2.8 2.5 3.8 3.1 3.4 3.9 2.8 2.1 5.7 3.7 3.4 3.1 2.8 4.4 3.4 3.0 5.5 3.3 2.9 3.1 2.2 6.9 3.2 2.5 0.6 2.6 4.3 4.9 2.4 2.4 3.8 2.6 2.8 3.6 2.2 2.5 2.2 2.5 3.9 3.2 5.3 2.0 1.3 2.9 2.0 3.0 4.4 3.6 3.0 3.9 0.7 2.0 3.9 3.1 1.9 3.0 5.9 2.3 2.1 1.4 4.4 2.6 2.7 2.1 1.9 1.8 2.8 2.7 0.9 3.4 5.0 8.7 4.1 3.1 2.8 3.0 2.5 1.7 3.2 1.7 2.9 4.9 9.3 9.6 7.9 39.5 11.9 7.1 8.5 5.4 10.8 15.3 8.0 7.6 9.5 12.8 6.7 7.3 10.4 8.4 12.9 5.6 1.9 5.4 6.9 10.8 12.6 9.3 6.0 12.8 37.7 3.9 7.2 8.8 9.2 10.5 1.3 15.8 10.0 6.8 6.0 25.2 25.3 5.0 6.1 7.2 7.2 6.0 10.5 8.7 7.2 16.9 8.4 9.7 9.2 41.7 39.7 4.7 3.1 7.2 9.1 6.8 5.9 3.0 10.9 15.9 6.6 14.2 10.4 26.7 26.2 8.8 8.4 6.0 12.4 7.8 5.7 6.3 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adipose tissue: 29.5;brain: 11.2;breast: 12.8" "Cell type enriched" "Detected in some" 4 "Astrocytes: 40.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 29.5 0.3 7.5 0.2 7.8 0.0 12.8 10.0 11.2 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.9 8.4 0.5 0.0 0.0 0.2 8.7 10.8 5.4 0.0 0.2 0.0 0.0 0.2 10.1 0.0 0.0 0.5 0.8 0.0 0.1 0.2 0.5 0.0 4.9 0.0 0.1 0.5 9.8 0.0 0.5 0.4 0.3 0.3 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 7.8 10.0 11.2 6.9 8.4 8.7 10.8 5.4 10.1 4.9 9.8 7.0 0.1 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 2.4 0.0 9.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 LRP3 "hLRp105, LRP-3" ENSG00000130881 "LDL receptor related protein 3" O75074 19 33177603-33208864 "Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.2;Muller glia cells: 29.9;Peritubular cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "THP-1: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041658 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA041658: " "unprognostic (3.10e-1)" "unprognostic (2.55e-2)" "unprognostic (3.25e-2)" "unprognostic (1.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (1.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.07e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.12e-7)" "unprognostic (1.34e-1)" "unprognostic (2.71e-3)" "unprognostic (4.36e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.32e-1)" 27.9 28.4 38.7 5.2 34.6 18.8 24.0 9.2 56.1 25.3 0.8 20.3 7.2 27.2 8.5 8.6 21.6 8.5 19.2 44.7 17.2 9.3 39.6 13.1 2.6 17.6 20.7 31.0 70.4 17.8 16.8 27.1 3.6 22.4 26.2 3.0 2.4 16.9 12.1 29.0 13.5 10.3 10.4 9.5 6.8 17.4 8.6 26.6 1.7 20.6 17.7 1.0 24.5 15.7 20.8 0.1 48.6 13.1 47.9 32.2 12.1 9.0 12.4 12.0 11.1 4.3 14.0 0.6 0.0 31.6 15.4 16.0 0.0 12.6 1.3 0.9 0.2 23.8 0.0 10.7 49.1 12.3 17.8 1.6 18.2 11.1 3.1 1.7 1.9 9.3 0.0 0.1 0.0 14.4 45.2 0.1 19.6 27.0 9.7 2.0 0.0 6.0 0.1 0.0 19.4 28.8 43.3 20.0 0.1 3.5 1.4 20.0 61.5 0.0 23.5 20.4 35.6 7.1 0.0 0.0 0.2 0.0 30.0 7.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 38.7 34.6 9.2 56.1 44.7 17.2 17.6 20.7 31.0 22.4 9.5 26.6 20.8 4.4 0.0 3.6 18.9 1.1 3.3 2.6 1.4 4.0 30.2 12.8 13.7 0.5 14.3 3.5 5.5 4.2 0.2 0.4 1.3 0.0 5.8 2.7 5.4 17.6 3.0 1.8 5.7 19.5 7.8 0.7 24.9 0.5 10.7 0.0 19.2 6.1 28.3 10.3 23.5 19.4 6.4 0.0 8.8 2.7 6.4 26.1 5.0 3.6 4.7 5.8 29.9 0.0 15.1 1.7 5.9 1.0 32.7 0.1 8.2 0.7 0.6 0.3 4.2 6.6 6.8 13.7 0.2 2.8 2.3 2.6 0.0 0.6 9.8 6.0 1.9 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123233385-123258079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 60.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.3 12.7 17.5 10.3 17.3 9.1 8.1 24.2 20.9 12.3 13.2 10.5 11.5 12.2 14.0 9.5 11.5 8.2 15.1 17.5 12.8 10.2 14.6 9.0 18.4 14.7 12.8 17.0 17.3 8.5 10.2 19.8 7.4 16.2 13.9 8.2 15.9 16.3 9.0 13.1 13.9 11.4 7.1 10.7 13.0 10.7 16.9 14.4 60.6 12.4 12.6 13.5 10.4 11.1 19.5 28.4 20.5 20.8 39.1 12.0 11.1 13.7 22.3 16.5 25.1 18.0 21.8 15.8 36.1 20.3 8.4 23.5 20.4 25.7 12.5 25.0 29.2 22.5 44.0 20.7 18.6 26.1 20.4 19.7 14.2 33.2 18.9 35.1 37.0 17.0 53.6 45.6 13.4 16.7 12.3 46.2 39.3 13.7 25.6 31.7 35.7 25.9 33.5 22.8 13.0 40.7 18.2 24.0 8.8 23.4 16.5 18.3 24.7 14.8 23.1 27.3 23.3 24.4 22.7 28.3 32.6 17.1 26.2 28.1 85.3 12.9 50.6 53.9 14.9 67.6 83.9 72.3 71.9 21.7 73.5 96.6 78.2 11.8 63.3 16.3 36.6 73.1 33.5 17.5 17.3 24.2 20.9 17.5 12.8 14.7 12.8 17.0 16.2 10.7 14.4 19.5 46.0 41.7 47.7 9.8 54.3 45.4 36.7 29.4 59.2 34.5 23.3 50.0 52.7 14.3 18.0 25.8 14.6 41.1 56.2 16.4 60.7 20.7 22.9 12.2 24.2 27.9 9.6 37.0 13.7 10.8 22.8 41.3 23.0 11.2 15.2 24.1 18.5 33.5 14.3 45.4 15.9 20.7 28.5 9.2 24.2 6.2 37.9 19.7 24.9 7.5 26.3 35.7 44.3 14.6 10.4 13.6 17.4 42.2 42.2 22.8 19.9 39.3 14.8 36.6 13.1 42.7 33.1 115.2 59.7 40.6 36.1 10.8 63.0 43.3 20.8 8.0 NOL11 DKFZP586L0724 ENSG00000130935 "Nucleolar protein 11" Q9H8H0 17 67717931-67744531 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022010 Supported Supported Nucleoli NA NA Nucleoli "HPA022010: AB_2267158" "unprognostic (6.81e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.00e-6)" "unprognostic (3.07e-3)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (2.59e-6)" "unprognostic (1.37e-2)" "unprognostic (1.25e-3)" "unprognostic (4.77e-3)" "unprognostic (8.74e-2)" "unprognostic (4.41e-3)" "unprognostic (6.55e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (8.44e-2)" "unprognostic (3.11e-1)" 12.6 8.2 5.4 14.5 6.0 21.0 16.5 10.1 13.1 14.9 6.4 15.0 12.3 15.2 12.8 15.0 14.7 12.8 12.4 5.4 6.0 15.6 19.1 9.8 23.1 6.2 6.7 4.9 14.9 14.5 15.7 3.4 17.9 6.9 12.0 15.6 10.4 9.5 11.4 15.6 12.0 11.0 15.8 5.9 12.7 10.3 11.6 6.2 19.9 15.3 17.2 24.7 18.6 6.1 9.4 54.3 63.4 45.7 29.6 21.1 25.3 52.2 37.1 28.6 71.0 58.5 53.5 36.2 86.5 26.8 36.4 47.1 38.4 112.9 54.0 105.7 26.8 92.7 57.9 36.3 48.3 24.7 74.8 34.0 19.8 34.2 52.7 36.9 20.7 67.8 39.1 96.6 25.8 58.8 49.2 89.1 29.6 50.6 61.0 74.4 63.6 101.4 59.8 31.0 57.6 39.4 37.8 32.8 84.7 40.3 63.3 60.5 44.0 26.5 64.3 44.7 21.7 75.7 16.2 45.5 93.7 26.4 54.8 37.6 12.8 6.3 4.6 9.7 7.6 10.4 10.6 10.2 11.9 8.9 13.0 16.4 11.9 0.8 13.1 7.7 6.5 11.8 9.4 5.4 6.0 10.1 13.1 5.4 6.0 6.2 6.7 4.9 6.9 5.9 6.2 9.4 25.5 28.9 18.6 10.4 33.7 33.4 38.9 30.5 27.9 21.9 15.8 11.8 18.6 21.5 27.8 9.2 14.6 45.4 33.8 13.1 11.7 23.5 1.7 17.1 28.9 26.0 27.5 24.2 11.3 17.8 37.1 25.0 20.4 18.7 24.1 31.9 16.8 25.3 20.3 25.2 11.4 16.8 26.4 11.8 11.8 4.3 20.8 15.7 17.8 8.4 19.5 15.8 21.6 13.0 16.3 16.6 9.2 19.2 17.4 24.9 12.2 28.6 24.8 32.7 6.6 25.9 21.8 30.2 35.0 26.8 33.2 33.0 32.0 27.0 21.9 25.4 UBE4B "E4, KIAA0684, UBOX3, UFD2" ENSG00000130939 "Ubiquitination factor E4B" O95155 1 10032832-10181239 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 99.9;Inhibitory neurons: 101.1;Oligodendrocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019219 Approved NA NA "HPA019219: AB_1858554" "unprognostic (5.32e-2)" "unprognostic (1.56e-1)" "unprognostic (3.74e-2)" "unprognostic (5.46e-2)" "unprognostic (7.19e-2)" "unprognostic (4.39e-2)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.53e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-1)" "unprognostic (4.26e-1)" "unprognostic (3.10e-1)" "unprognostic (1.86e-3)" "unprognostic (2.99e-1)" "unprognostic (3.99e-1)" "unprognostic (1.35e-1)" "unprognostic (1.76e-3)" 13.3 22.4 13.2 13.0 16.7 20.3 13.5 18.9 18.3 15.9 8.7 20.6 16.4 19.6 12.7 23.0 14.7 12.5 21.1 13.3 14.8 13.8 14.1 11.3 12.5 18.8 15.6 12.0 23.5 27.2 21.2 15.3 20.1 19.3 14.2 13.5 19.5 15.1 12.9 42.2 25.5 16.0 17.6 12.3 12.3 20.6 9.6 16.0 17.2 21.1 27.7 14.3 17.4 16.8 28.3 37.9 24.5 28.8 31.6 37.5 49.0 22.5 24.4 31.1 24.0 24.3 26.6 43.2 32.4 29.2 43.6 18.6 27.5 37.2 28.2 28.1 33.8 20.8 35.1 41.5 30.2 27.4 36.6 23.9 40.4 24.7 32.1 26.8 43.9 35.0 23.3 61.7 42.4 22.0 19.6 24.1 16.7 38.2 24.2 19.9 23.6 28.1 34.8 23.0 17.0 35.0 26.7 38.8 26.8 49.5 30.4 21.1 26.0 30.4 21.1 32.0 26.5 20.2 18.8 27.7 37.1 30.9 41.4 28.4 3.4 4.9 2.4 3.0 3.7 5.1 3.6 5.0 5.0 4.1 3.2 4.5 3.6 5.5 1.8 2.8 1.8 6.4 3.6 13.2 16.7 18.9 18.3 13.3 14.8 18.8 15.6 12.0 19.3 12.3 16.0 28.3 13.5 22.4 24.0 65.6 17.7 17.6 14.6 13.0 21.6 14.7 18.6 13.2 42.2 15.7 12.9 9.2 25.0 33.1 12.3 12.0 9.8 12.8 3.0 22.4 23.3 15.4 16.3 33.4 99.9 14.8 13.5 18.5 14.8 24.6 6.3 27.9 17.2 16.4 16.5 16.8 101.1 16.2 16.2 22.1 10.9 4.8 11.1 16.1 5.4 46.9 22.9 10.5 19.6 82.4 185.2 19.5 19.5 8.6 24.3 19.3 25.5 10.3 12.9 33.5 19.7 15.2 16.4 8.5 15.0 35.8 22.4 20.5 18.3 21.1 18.6 18.5 CASZ1 "castor, cst, FLJ20321, SRG, ZNF693" ENSG00000130940 "Castor zinc finger 1" Q86V15 1 10636604-10796650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 48.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 608.8;Horizontal cells: 138.0;Rod photoreceptor cells: 477.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 12.4;HDLM-2: 13.4;SCLC-21H: 19.8;SK-BR-3: 18.9" "Low region specificity" "Detected in some" "HPA028222, HPA029927" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028222: AB_10600106, HPA029927: AB_10601564" "unprognostic (1.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.67e-2)" "unprognostic (7.49e-3)" "unprognostic (4.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-4)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (1.03e-5)" "unprognostic (3.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-2)" "unprognostic (1.56e-1)" 2.1 2.0 0.7 2.2 0.8 4.7 7.1 0.1 0.9 4.5 2.1 17.3 12.1 7.9 0.8 15.4 5.6 2.7 17.9 0.2 2.0 6.8 2.8 11.4 1.3 1.0 3.0 0.2 1.0 6.1 0.2 2.1 1.8 0.7 18.4 3.3 35.4 20.0 5.8 34.6 48.5 11.7 3.3 1.4 2.2 17.4 1.7 0.4 1.3 3.4 5.9 2.0 10.8 11.7 0.7 12.4 1.0 2.2 2.2 0.0 0.0 0.5 0.4 0.1 0.4 0.4 2.6 2.8 0.5 2.5 0.5 1.0 10.5 2.3 2.4 0.2 13.4 4.1 0.8 2.0 2.8 0.3 1.4 3.8 0.1 8.7 0.1 0.8 0.0 0.4 1.9 0.0 0.0 0.1 6.6 0.7 8.9 0.2 6.4 0.6 1.0 1.5 0.1 2.0 5.0 19.8 1.8 3.2 18.9 0.3 0.8 10.1 1.3 0.1 0.0 1.6 1.0 0.2 0.0 0.0 1.3 0.1 3.8 0.2 0.6 0.0 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.4 0.6 0.8 0.0 0.1 0.7 0.8 0.1 0.9 0.2 2.0 1.0 3.0 0.2 0.7 1.4 0.4 0.7 12.9 28.9 21.7 1.6 6.1 33.0 20.1 21.2 30.7 12.7 57.9 30.4 25.2 17.2 17.8 14.7 608.8 0.7 15.3 60.4 3.9 14.1 0.6 41.8 5.6 14.4 41.3 1.3 1.6 8.9 1.2 2.3 57.6 66.7 4.5 4.5 5.0 5.1 1.1 138.0 0.9 39.1 16.2 0.3 5.1 1.6 0.0 1.8 1.8 1.9 6.7 28.4 9.2 0.5 0.3 18.1 40.8 6.8 6.1 33.4 46.3 1.1 41.2 477.7 0.0 6.8 5.1 2.5 3.5 31.0 61.2 0.7 7.6 1.5 27.1 27.6 PKDREJ ENSG00000130943 "Polycystin family receptor for egg jelly" Q9NTG1 22 46255663-46263343 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Cone photoreceptor cells: 4.2;Early spermatids: 2.5;Horizontal cells: 1.7;Late spermatids: 2.4;Spermatocytes: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034587 Enhanced NA NA "HPA034587: AB_10670570" "unprognostic (9.48e-3)" "unprognostic (1.09e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" "unprognostic (6.11e-2)" "unprognostic (5.06e-4)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (8.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-1)" "unprognostic (3.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.6 0.2 0.0 0.1 0.0 0.1 3.4 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.1 0.4 0.2 0.0 0.4 0.1 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 1.8 4.2 0.0 0.0 0.2 0.0 0.0 2.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.4 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.4 0.8 0.3 0.6 0.0 0.0 0.0 0.3 0.0 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302176 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease variant, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.2;testis: 37.0" "Group enriched" "Detected in some" 6 "Leydig cells: 108.1;Oligodendrocytes: 93.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.3;HEL: 1.0;U-2 OS: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Approved Vesicles NA NA Vesicles "HPA056833: AB_2683252" "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 1.4 0.8 3.8 0.2 4.9 0.0 1.7 4.1 5.6 2.5 3.3 2.5 0.5 1.5 1.0 0.7 3.6 0.2 1.9 3.7 4.5 4.6 15.2 1.8 0.0 5.1 4.8 3.8 1.5 4.2 0.0 1.7 0.1 5.2 3.3 0.1 0.7 1.1 0.1 0.5 0.9 3.7 0.0 4.2 0.9 1.4 37.0 4.8 0.1 10.0 0.1 0.0 1.6 1.8 6.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 4.9 4.1 5.6 3.7 4.5 5.1 4.8 3.8 5.2 4.2 4.8 6.0 0.0 0.0 0.0 15.3 0.2 0.0 0.1 0.8 0.0 0.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 4.0 0.2 0.0 0.4 1.8 0.0 0.5 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.5 0.0 0.0 0.4 14.4 108.1 1.1 0.0 4.7 0.1 0.6 0.0 1.0 93.2 0.2 0.1 12.8 0.0 0.1 0.6 0.0 0.5 0.2 0.0 0.1 0.5 1.9 1.8 0.0 0.3 0.1 0.0 0.0 0.3 0.0 NUTM2F "DKFZp434I1117, FAM22F" ENSG00000130950 "NUT family member 2F" A1L443 9 94318196-94328644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.9" "Cell type enhanced" "Detected in some" "Astrocytes: 10.4;Excitatory neurons: 42.9;Inhibitory neurons: 29.0;Microglial cells: 11.2;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NTERA-2: 1.3" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (1.40e-1)" "unprognostic (4.93e-3)" "unprognostic (4.16e-2)" "unprognostic (1.47e-1)" "unprognostic (9.26e-3)" "unprognostic (1.03e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (6.72e-3)" "unprognostic (8.48e-2)" "unprognostic (1.11e-2)" "unprognostic (5.14e-1)" "unprognostic (1.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 27.2 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450169-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.0" "Group enriched" "Detected in many" 10 "Early spermatids: 224.6;Late spermatids: 808.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055969, HPA062366" Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA055969: AB_2682991, HPA062366: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 18.5 12.9 67.8 7.1 69.8 1.8 17.0 58.6 76.0 16.2 45.5 15.4 3.1 13.6 7.1 7.6 13.6 8.9 24.8 65.8 67.3 26.7 7.7 10.9 8.4 70.4 67.1 63.6 15.8 6.6 13.0 22.7 3.6 71.4 12.6 4.2 16.2 6.2 11.2 16.9 9.1 10.4 9.8 63.0 7.5 12.6 44.3 67.6 4.6 13.8 13.5 5.4 18.5 13.1 72.6 14.8 16.6 20.6 22.3 44.7 37.9 14.6 19.5 21.8 14.5 15.7 24.9 24.0 7.5 9.4 29.4 45.9 10.6 17.4 3.7 11.6 9.0 10.3 2.9 7.8 42.0 22.7 0.7 3.0 15.5 6.7 16.5 13.0 21.9 10.4 8.4 3.4 21.6 26.4 15.2 0.3 4.6 9.6 20.5 15.8 7.6 17.9 0.3 24.8 6.4 13.0 8.8 10.6 6.2 32.5 15.2 4.5 3.2 17.8 19.8 4.6 36.6 16.8 13.2 14.0 3.3 15.9 5.9 29.8 0.0 0.0 0.0 0.5 0.1 0.5 1.9 1.6 1.3 0.0 1.1 1.1 1.1 0.1 0.4 0.3 0.0 1.3 0.2 67.8 69.8 58.6 76.0 65.8 67.3 70.4 67.1 63.6 71.4 63.0 67.6 72.6 22.2 0.0 7.4 27.1 5.9 11.5 10.8 0.9 4.0 22.6 3.8 6.9 11.0 14.3 5.5 18.4 0.0 2.5 5.5 0.9 17.6 4.7 224.6 7.3 9.0 14.6 13.1 0.8 47.4 5.8 7.4 13.3 1.5 8.1 1.3 13.0 15.0 6.3 6.6 23.5 33.2 0.9 4.1 1.3 9.3 808.8 13.7 6.0 17.8 10.3 2.7 22.2 3.1 18.6 37.5 6.3 0.0 23.7 5.1 10.0 1.1 43.7 1.8 15.6 6.6 5.8 26.4 26.8 15.4 0.9 8.0 1.4 13.3 3.0 1.3 6.0 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593824 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 760.7;tongue: 388.7" "Group enriched" "Detected in some" 7 "Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5" "Cancer enhanced" "Detected in some" "stomach cancer: 1.2" "Region enriched" "Detected in many" 4 "hippocampal formation: 6.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA012513, HPA077371" Enhanced Approved "Plasma membrane,Cytosol" NA NA 960000 "Plasma membrane, Cytosol" "HPA012513: AB_1848446, HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 0.1 0.9 0.1 0.1 0.0 0.0 0.2 1.2 1.4 0.0 55.3 0.3 5.3 0.0 0.0 8.2 0.0 0.1 0.2 6.2 0.0 0.2 0.2 0.4 0.4 0.6 1.1 0.0 0.0 4.4 50.2 0.0 0.1 0.1 1.3 0.0 0.0 4.2 3.3 760.7 0.1 0.9 0.0 0.9 0.0 36.4 1.4 1.2 0.2 0.3 388.7 1.0 0.3 0.0 0.0 0.3 1.3 0.0 1.4 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.2 1.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 2.9 2.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 2.8 0.6 0.0 0.1 0.2 0.1 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.6 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 1.4 6.2 0.0 0.6 1.1 0.0 0.1 0.9 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.5 1.3 0.0 0.0 11.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.2 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SLC35D2 "SQV7L, UGTrel8" ENSG00000130958 "Solute carrier family 35 member D2" Q76EJ3 9 96313444-96383711 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 117.2;Proximal enterocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 103.8;Hep G2: 132.3" HPA064047 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA064047: AB_2685182" "unprognostic (3.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.16e-2)" "unprognostic (3.17e-1)" "unprognostic (8.86e-3)" "unprognostic (4.25e-3)" "unprognostic (2.24e-2)" "unprognostic (4.12e-1)" "unprognostic (5.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-2)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.44e-1)" 13.7 8.9 15.6 14.5 20.5 11.5 16.5 18.7 20.7 16.6 14.4 49.6 65.7 15.1 12.2 13.8 14.8 20.8 12.3 14.9 25.1 32.4 56.9 19.4 12.5 26.4 21.2 12.7 17.4 31.6 16.5 7.3 25.7 23.0 14.3 46.9 4.3 13.1 11.1 4.0 9.3 66.4 14.0 19.0 10.1 43.5 7.2 19.2 7.5 29.7 6.9 11.8 17.3 13.2 29.1 33.2 27.6 15.8 30.2 20.3 37.3 27.9 14.7 30.2 21.6 17.5 60.4 103.8 0.6 24.5 13.5 49.9 47.6 22.2 21.8 18.7 16.4 16.8 11.3 9.8 132.3 32.5 0.1 0.0 32.2 27.6 16.3 48.7 51.0 46.7 0.0 22.3 0.4 23.7 27.2 0.3 0.1 13.2 67.5 28.5 0.1 0.0 0.0 54.4 21.3 5.5 35.9 11.9 24.8 68.5 53.3 16.4 24.7 41.3 14.5 16.2 21.2 13.8 0.0 0.9 0.1 30.2 0.1 20.4 1.2 0.9 0.6 1.3 1.1 1.6 0.7 2.1 2.9 1.2 0.9 0.7 1.4 0.1 1.8 2.1 0.2 3.9 0.5 15.6 20.5 18.7 20.7 14.9 25.1 26.4 21.2 12.7 23.0 19.0 19.2 29.1 14.5 9.6 11.0 12.1 4.3 5.2 8.9 2.1 1.8 1.1 15.1 13.1 7.2 27.1 4.6 12.9 2.1 28.1 12.9 61.7 11.7 8.1 0.2 21.0 14.0 12.6 9.6 1.3 0.8 24.5 45.1 9.5 20.4 31.6 4.5 20.0 13.2 43.2 20.5 1.7 1.1 42.0 4.1 23.0 9.7 0.6 10.8 17.7 17.8 20.6 8.9 10.2 7.2 11.1 117.2 25.4 43.5 6.0 6.3 15.5 67.0 23.6 6.7 3.6 13.1 6.8 11.2 1.4 4.4 8.6 5.4 26.5 14.6 7.0 34.9 17.9 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349309-37457292 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 229.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 79.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: AB_2686878" "unprognostic (8.82e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favorable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 8.7 3.7 14.8 2.2 25.5 0.2 5.2 23.0 21.4 4.4 7.4 4.1 2.9 4.3 1.5 4.1 2.6 8.9 6.4 14.7 18.6 10.6 7.9 5.5 1.7 25.8 23.6 11.2 4.2 1.6 1.2 1.4 8.2 26.0 3.4 4.1 1.5 2.9 7.9 16.1 2.1 3.0 5.5 23.3 2.9 2.4 1.5 21.7 1.5 8.4 7.9 1.0 5.6 3.8 41.8 32.3 7.2 5.6 5.6 18.7 15.4 2.4 14.1 17.6 4.7 8.2 17.1 20.2 0.0 21.8 10.4 8.9 10.7 15.6 10.0 8.3 0.1 5.2 5.2 7.7 5.7 22.6 0.0 7.2 23.2 8.1 9.1 7.7 9.4 24.8 0.0 2.6 0.1 16.5 2.4 0.1 0.1 6.8 5.1 13.4 0.0 13.1 0.0 79.2 1.7 0.0 0.1 9.7 15.6 6.1 15.3 0.1 3.5 17.6 7.5 4.2 14.2 4.1 0.0 0.1 0.0 7.3 0.0 7.3 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.8 25.5 23.0 21.4 14.7 18.6 25.8 23.6 11.2 26.0 23.3 21.7 41.8 29.7 6.4 4.2 15.7 0.0 11.3 4.8 7.6 5.2 2.2 5.3 5.3 8.1 15.7 2.7 33.1 0.0 7.0 0.2 7.6 7.9 6.8 0.7 3.3 12.9 18.4 3.0 0.0 23.3 3.1 14.9 9.6 4.6 9.2 1.3 3.9 17.9 16.3 4.8 18.5 10.8 5.7 14.2 4.1 5.3 0.4 4.7 1.4 3.6 31.9 0.8 2.2 0.0 12.5 229.8 18.7 7.5 2.6 0.0 9.1 4.3 9.4 2.9 0.5 6.6 8.3 8.4 2.5 4.2 5.2 6.3 10.4 0.4 3.5 4.8 8.1 UBA1 "A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X" ENSG00000130985 "Ubiquitin like modifier activating enzyme 1" P22314 X 47190861-47215128 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000289, HPA001506, CAB019435, CAB073410" Approved Supported Nucleoplasm NA NA 14000000 Nucleoplasm "CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305" "unprognostic (7.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" "unprognostic (2.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.10e-5)" "unprognostic (7.22e-2)" "unprognostic (2.42e-3)" "unprognostic (3.43e-2)" "unprognostic (8.50e-3)" "unprognostic (2.17e-3)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (5.38e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.21e-2)" 98.5 159.2 93.0 99.2 98.9 95.1 99.5 94.5 116.4 126.9 115.0 99.3 71.9 128.2 64.9 156.5 120.4 65.5 111.7 96.6 98.3 128.8 115.7 110.4 105.8 98.2 96.1 98.7 137.7 89.7 108.3 136.3 68.0 100.7 104.1 69.1 96.4 120.4 79.6 202.7 119.1 101.2 118.4 87.6 132.9 99.5 99.5 98.4 120.8 161.5 115.1 111.7 101.9 125.9 112.6 269.1 273.2 307.7 471.9 207.4 186.8 135.0 175.1 187.1 248.6 200.5 219.3 201.3 201.6 111.8 357.0 361.5 254.9 392.9 375.7 180.9 163.4 391.7 126.1 295.2 180.0 145.1 215.2 258.8 177.4 193.2 362.7 279.4 176.7 330.2 236.1 138.9 173.7 250.4 343.4 203.3 188.5 329.6 163.2 417.1 233.1 215.3 343.7 198.7 287.0 197.4 148.1 520.8 250.9 116.9 329.9 349.5 130.3 241.6 183.1 210.7 266.4 166.1 117.6 132.8 286.3 189.4 150.8 224.9 31.0 39.7 40.7 39.4 51.1 34.0 39.8 31.8 35.0 43.2 29.9 24.7 31.1 44.8 38.1 49.7 29.3 40.3 39.9 93.0 98.9 94.5 116.4 96.6 98.3 98.2 96.1 98.7 100.7 87.6 98.4 112.6 37.2 51.3 34.7 45.1 37.1 33.6 38.6 55.7 26.2 24.9 48.3 39.6 51.4 51.5 50.0 82.8 16.7 46.3 34.2 133.1 35.2 77.5 29.6 84.9 56.3 40.9 57.5 33.2 27.1 90.8 68.7 45.0 74.9 97.5 18.3 60.3 43.5 51.2 60.0 11.8 35.5 78.6 30.5 49.0 37.8 61.6 42.3 51.4 19.6 31.9 57.7 20.7 13.4 32.2 46.5 147.9 74.7 65.8 44.0 55.2 82.2 61.6 56.4 25.1 39.5 38.8 56.6 10.5 34.0 51.3 42.1 71.1 34.6 56.8 68.2 55.4 RGN "RC, SMP30" ENSG00000130988 Regucalcin Q15493 X 47078355-47093314 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 186.3;liver: 386.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4" "Cancer enriched" "Detected in many" 6 "liver cancer: 47.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029102, HPA029103, HPA029104" Enhanced Approved Cytosol NA NA 280000 Cytosol "HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: " "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (5.56e-3)" "unprognostic (8.22e-3)" "unprognostic (1.32e-2)" "prognostic favorable (7.55e-4)" "unprognostic (2.60e-3)" "unprognostic (2.23e-2)" "unprognostic (8.38e-2)" "unprognostic (3.37e-2)" "unprognostic (1.14e-2)" "prognostic favorable (5.10e-10)" "unprognostic (1.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.82e-2)" "unprognostic (5.22e-2)" 7.8 186.3 17.8 0.7 19.0 0.0 3.5 21.7 20.0 10.3 22.6 5.9 13.4 7.3 4.6 3.2 5.5 5.1 13.8 17.7 24.4 57.3 386.9 19.1 1.0 20.0 18.1 16.2 21.5 34.3 5.9 8.9 12.2 19.5 13.5 2.1 8.1 14.5 17.5 11.9 1.5 13.7 4.5 19.5 3.7 12.0 3.6 18.0 0.5 19.1 11.4 0.5 7.6 6.0 19.8 0.0 0.0 0.2 0.0 0.0 0.2 0.5 0.4 0.8 0.0 0.0 21.7 0.0 0.0 1.1 6.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 32.8 1.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 19.0 21.7 20.0 17.7 24.4 20.0 18.1 16.2 19.5 19.5 18.0 19.8 0.6 6.4 3.6 16.3 0.6 0.5 4.9 0.2 1.8 9.6 2.4 7.0 27.5 8.6 0.7 14.7 0.0 0.1 0.0 0.2 58.7 13.9 0.4 3.4 7.4 2.4 4.8 2.7 10.8 8.9 0.3 11.2 3.1 0.5 0.0 67.8 11.4 175.7 0.1 5.0 4.9 0.2 0.0 5.3 1.2 2.1 24.8 1.2 1.8 4.7 0.0 54.5 0.0 27.2 13.7 5.0 1.2 69.6 0.7 1.1 0.2 174.4 1.7 3.1 13.1 22.3 11.3 0.2 0.2 0.5 0.3 0.3 0.7 14.5 0.7 1.3 POLN ENSG00000130997 "DNA polymerase nu" Q7Z5Q5 4 2071918-2242121 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.4;testis: 2.6" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Excitatory neurons: 77.7;Inhibitory neurons: 42.7;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 26.8;Spermatocytes: 23.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "ASC diff: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035939, HPA035940" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035939: AB_2674875, HPA035940: AB_2674876" "unprognostic (8.52e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-2)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (1.45e-2)" "unprognostic (3.46e-1)" "unprognostic (2.70e-1)" "unprognostic (5.83e-2)" "unprognostic (2.23e-1)" "unprognostic (2.02e-3)" "unprognostic (1.25e-1)" "unprognostic (1.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" 2.4 0.6 0.4 0.0 0.3 0.0 1.0 0.3 0.6 0.3 0.0 0.2 0.1 0.3 0.7 0.1 0.4 0.3 0.3 0.4 0.0 0.3 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.1 0.4 0.1 0.3 0.6 0.0 0.2 0.5 0.2 0.4 0.3 0.3 0.1 0.0 0.3 0.3 2.6 0.0 0.1 0.3 0.1 0.1 0.2 0.2 0.4 0.0 0.6 0.0 0.3 1.7 0.5 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.6 0.4 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.4 2.4 0.0 0.0 32.3 1.0 0.9 1.0 0.6 0.6 4.2 3.0 1.5 3.6 1.5 1.7 0.0 0.0 0.2 0.6 0.2 3.9 0.4 8.3 4.2 2.0 1.9 4.8 0.8 77.7 1.0 0.3 2.0 1.5 2.1 0.0 5.5 3.3 1.1 0.7 3.3 42.7 0.0 2.0 1.3 1.0 14.1 4.4 1.3 0.0 15.0 0.7 2.5 1.0 22.1 26.8 0.5 1.1 3.8 1.5 1.0 0.3 0.8 1.9 3.8 0.0 2.9 1.1 23.4 10.4 0.5 1.6 0.0 1.8 4.1 0.3 1.3 PPIL4 ENSG00000131013 "Peptidylprolyl isomerase like 4" Q8WUA2 6 149504495-149546043 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031599, HPA031600" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031599: AB_2673950, HPA031600: AB_10600928" "unprognostic (6.12e-2)" "unprognostic (4.90e-2)" "unprognostic (3.85e-2)" "unprognostic (8.42e-2)" "unprognostic (7.53e-2)" "unprognostic (6.36e-3)" "unprognostic (2.91e-3)" "unprognostic (2.22e-1)" "unprognostic (4.22e-2)" "unprognostic (1.09e-1)" "unprognostic (2.38e-1)" "unprognostic (4.62e-2)" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (8.50e-2)" "unprognostic (7.94e-2)" 19.2 19.3 13.7 15.8 15.1 36.7 20.5 20.4 18.5 18.1 10.3 15.5 14.3 20.3 26.0 13.8 16.7 19.0 14.8 13.2 15.9 18.1 23.1 16.3 17.3 11.6 14.0 11.3 27.5 14.9 18.9 18.9 22.9 12.7 19.4 16.2 13.2 15.9 15.3 10.8 14.2 14.7 14.9 11.2 17.5 16.5 16.5 15.3 18.7 25.9 11.6 17.3 21.1 17.0 16.5 22.7 12.0 41.0 34.7 23.8 30.9 38.1 43.8 41.1 46.4 49.2 25.1 22.8 23.8 29.4 33.9 27.9 20.1 31.5 16.5 73.1 34.7 29.7 26.4 27.0 43.9 37.3 49.2 21.6 24.3 27.8 47.6 39.7 26.2 25.7 17.1 58.1 14.0 36.5 24.2 28.1 41.8 32.6 22.6 18.5 37.2 37.7 11.9 35.6 17.0 24.1 18.4 52.0 22.4 31.7 28.2 26.5 35.1 31.0 30.8 24.3 55.1 42.3 18.4 9.9 37.0 26.3 38.7 45.5 34.1 17.1 20.4 15.1 19.9 21.0 23.7 19.5 17.5 18.2 17.9 24.5 18.8 14.5 32.0 19.3 17.9 23.7 16.5 13.7 15.1 20.4 18.5 13.2 15.9 11.6 14.0 11.3 12.7 11.2 15.3 16.5 54.8 67.3 70.7 25.1 49.7 48.8 56.4 49.0 30.7 46.2 29.5 34.9 45.6 18.6 59.7 46.0 8.4 50.4 48.4 16.9 43.0 42.0 24.4 57.6 55.7 43.2 23.3 25.4 37.3 26.3 46.2 76.2 20.9 48.2 77.1 30.9 33.5 21.3 37.3 28.6 34.7 22.9 48.8 25.2 43.8 12.0 61.8 38.3 40.9 21.5 45.5 42.0 28.8 27.2 41.1 32.2 21.9 56.1 29.4 33.8 19.7 37.6 71.9 37.1 52.6 66.1 70.5 75.9 59.3 22.5 45.3 65.3 53.4 47.7 22.3 43.0 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942014-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.2" "Cell type enhanced" "Detected in many" "Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 12.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "SiHa: 66.7;U-2197: 47.4" "CAB018974, HPA066741" Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB018974: , HPA066741: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 1.1 0.8 1.5 0.6 1.8 1.8 0.7 1.7 2.9 0.5 1.0 0.2 0.2 0.1 0.1 6.2 0.2 0.5 1.7 3.2 1.3 1.2 0.5 3.5 0.3 1.9 1.4 1.8 0.0 0.4 0.6 0.5 1.6 2.0 0.2 0.1 0.2 0.7 0.1 0.3 0.4 0.2 0.7 1.1 0.2 0.3 1.5 1.3 0.7 1.2 0.7 0.8 1.5 1.7 2.1 19.9 1.8 0.5 6.1 1.1 5.6 3.3 20.1 11.8 20.6 16.8 7.4 11.0 0.0 29.9 23.0 29.6 13.9 7.6 18.4 11.8 9.1 3.9 1.1 2.8 0.0 7.1 0.0 1.5 2.7 13.9 18.3 8.0 16.7 11.9 16.6 2.5 0.0 15.4 13.9 1.8 0.0 0.0 3.6 10.2 3.0 4.5 0.0 29.0 5.7 0.6 0.0 66.7 1.4 1.9 3.2 1.8 8.5 18.8 13.5 17.1 47.4 23.5 0.0 0.1 0.9 19.2 10.7 9.9 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.8 1.5 0.0 0.0 0.3 1.8 0.0 0.4 0.0 0.0 1.7 0.5 1.5 1.8 1.7 2.9 3.2 1.3 1.9 1.4 1.8 2.0 1.1 1.3 2.1 28.9 0.0 1.3 0.0 1.2 3.7 6.5 17.9 7.4 0.0 1.3 4.4 0.3 0.0 9.4 1.8 0.0 0.0 12.1 0.5 0.0 7.5 7.0 0.3 0.5 9.1 0.0 0.0 3.0 8.8 0.5 3.0 1.1 0.2 0.0 0.1 7.1 0.2 2.2 0.0 0.7 0.3 2.0 0.8 2.1 8.0 0.0 3.1 1.8 0.0 0.0 0.4 4.1 0.5 0.3 4.5 0.0 0.0 1.4 1.4 0.0 0.1 1.4 0.0 0.0 1.0 4.2 3.1 7.0 11.8 2.8 0.0 11.0 0.6 0.4 5.2 AKAP12 "AKAP250, SSeCKS" ENSG00000131016 "A-kinase anchoring protein 12" Q02952 6 151239967-151358559 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4" "Cancer enhanced" "Detected in all" "testis cancer: 39.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 235 "basophil: 37.2" "Lineage enriched" "Detected in single" 235 "granulocytes: 37.2" "Cell line enhanced" "Detected in many" "REH: 193.0;TIME: 188.2;U-251 MG: 202.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006344, CAB026379, HPA056230" Enhanced Enhanced "Plasma membrane,Cytosol" No No 10000000 "Plasma membrane, Cytosol" "CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (9.90e-3)" "prognostic unfavorable (7.08e-4)" "unprognostic (2.61e-2)" "unprognostic (8.88e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (6.34e-5)" "unprognostic (1.34e-1)" "unprognostic (8.26e-3)" "unprognostic (2.59e-1)" "unprognostic (4.72e-2)" "unprognostic (4.51e-3)" "unprognostic (1.10e-3)" "unprognostic (3.51e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-2)" 86.9 16.2 21.8 17.3 18.2 2.2 60.2 101.3 58.6 19.4 6.8 48.7 8.6 31.4 9.4 18.8 31.5 31.7 35.6 15.4 54.6 32.2 30.8 44.7 7.0 59.4 33.9 14.3 88.6 10.9 1.7 23.5 38.6 64.3 23.3 13.3 110.3 6.6 21.0 12.0 8.7 25.1 43.3 11.2 14.5 25.8 100.9 57.4 6.0 22.3 14.6 3.4 33.3 21.4 70.9 7.8 37.8 53.2 0.1 98.2 145.9 18.8 43.9 23.7 19.3 19.4 0.9 141.6 0.0 17.1 33.2 160.4 1.0 102.2 32.5 17.2 50.2 37.6 0.6 40.8 35.6 10.9 0.0 9.6 104.0 0.0 81.9 4.3 25.4 127.8 0.6 9.8 0.9 70.7 0.5 0.3 0.1 33.3 0.1 43.9 193.0 2.3 0.2 110.2 6.3 37.9 22.0 14.1 0.5 24.9 74.6 2.8 0.5 188.2 2.6 34.0 110.4 202.9 0.4 0.1 0.2 63.2 0.1 37.4 37.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 18.2 101.3 58.6 15.4 54.6 59.4 33.9 14.3 64.3 11.2 57.4 70.9 352.6 12.8 16.2 34.3 6.8 19.6 19.6 63.2 1.2 14.5 1.2 3.9 12.1 5.7 31.1 51.5 2.1 2.4 0.9 1.2 1.9 107.0 101.4 14.2 195.4 278.4 1.8 3.2 75.8 6.7 10.1 270.0 3.6 31.6 64.2 14.7 194.5 4.8 26.9 0.0 33.3 0.7 4.1 15.7 45.4 116.3 39.7 13.9 58.7 37.5 0.6 583.0 1.0 59.8 5.1 322.1 1.1 110.6 6.7 49.5 0.0 89.4 6.0 31.0 98.6 208.3 243.0 325.4 33.0 1.6 11.4 10.0 5.1 9.3 2.5 105.3 SYNE1 "8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B" ENSG00000131018 "Spectrin repeat containing nuclear envelope protein 1" Q8NF91 6 152121684-152637801 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" Actin-binding "Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 150.2;choroid plexus: 156.8" "Cell type enhanced" "Detected in many" "Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "eosinophil: 56.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 56.8" "Cell line enhanced" "Detected in many" "U-2 OS: 29.8;U-266/70: 29.1" "Low region specificity" "Detected in all" HPA019113 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA 72000 "Nucleoplasm, Nuclear membrane" "HPA019113: AB_1857707" "unprognostic (9.99e-2)" "unprognostic (1.91e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-1)" "unprognostic (2.28e-1)" "unprognostic (9.58e-3)" "unprognostic (1.11e-1)" "unprognostic (3.55e-3)" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (8.87e-3)" "unprognostic (2.70e-1)" "unprognostic (4.14e-3)" "unprognostic (5.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" 14.7 17.9 61.8 7.6 64.5 54.1 14.6 150.2 72.3 16.9 156.8 14.0 2.3 19.3 23.9 5.7 26.6 8.0 28.6 94.8 54.2 34.9 14.7 31.6 17.3 55.3 58.3 56.7 44.9 20.7 23.8 57.2 4.4 69.0 17.1 6.2 66.9 5.1 12.7 28.2 19.7 11.5 13.2 40.6 33.2 21.8 17.8 55.0 24.2 45.1 16.6 13.5 16.4 13.0 53.3 0.2 5.8 3.7 4.4 5.7 12.1 1.5 14.7 6.9 3.4 6.0 1.3 0.2 13.5 0.7 7.5 11.2 0.3 1.6 3.8 3.5 11.6 4.0 5.2 4.1 4.0 12.8 1.1 2.7 7.9 0.8 7.5 14.9 9.2 6.8 6.9 0.0 14.2 9.2 0.7 2.4 0.2 0.9 1.3 2.2 2.9 8.1 3.5 15.7 0.2 2.6 3.9 2.7 0.8 9.8 3.7 0.8 0.5 9.0 16.3 29.8 5.9 7.6 29.1 12.5 23.3 8.8 2.9 4.6 10.2 2.3 56.8 11.8 1.8 7.9 6.9 10.3 13.4 1.8 8.2 9.7 10.9 1.6 9.9 3.9 1.5 13.2 3.5 61.8 64.5 150.2 72.3 94.8 54.2 55.3 58.3 56.7 69.0 40.6 55.0 53.3 139.7 166.7 215.2 550.1 29.1 12.7 5.4 3.0 3.4 332.1 4.9 9.7 117.2 7.2 53.1 44.1 200.1 0.9 132.9 0.4 3.9 24.0 11.5 132.0 118.2 127.5 3.0 11.6 494.6 7.7 14.2 79.6 7.7 17.8 15.2 13.1 90.0 21.8 8.0 138.0 482.6 11.5 2.0 10.1 15.0 12.6 33.2 16.0 16.0 315.7 12.8 27.3 210.1 256.4 108.6 4.2 0.1 39.9 79.6 5.1 0.0 17.8 146.7 145.5 26.3 145.8 85.6 3.9 5.7 2.2 9.7 1.2 74.7 62.2 0.4 2.2 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150061053-150069121 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 6.6;testis: 6.4" "Cell type enhanced" "Detected in single" "Gastric mucus-secreting cells: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" NA NA Vesicles "Centriolar satellite" "HPA056541: , HPA063007: AB_2684920" "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 1.3 1.2 1.8 0.7 2.1 0.7 1.0 1.7 2.7 0.6 0.7 0.8 1.1 1.0 0.9 1.5 2.0 1.3 0.8 1.8 1.1 1.7 1.0 1.5 0.5 1.2 1.1 1.6 0.8 0.7 0.9 0.1 0.9 1.6 0.7 0.8 0.8 0.4 0.5 6.6 1.1 0.5 0.5 0.5 0.6 1.9 6.4 1.2 0.5 5.0 0.4 0.9 1.1 0.5 2.7 6.2 2.0 6.5 7.3 1.6 11.9 2.3 6.1 2.6 7.2 8.0 11.0 5.1 0.2 11.8 9.9 10.9 8.3 17.7 20.5 7.7 3.7 7.8 0.6 2.9 0.5 2.5 0.1 1.1 10.2 3.5 15.0 8.1 6.9 9.7 0.2 0.5 0.8 6.3 7.0 0.3 0.5 3.1 2.6 14.8 6.2 5.9 0.3 17.5 12.4 1.2 0.5 12.2 8.2 3.0 3.4 2.5 1.7 5.6 1.2 9.8 20.5 13.3 0.3 0.2 4.1 9.6 3.7 5.1 0.8 0.2 0.2 2.2 0.2 2.9 0.8 1.5 2.4 0.2 0.5 0.8 1.2 1.0 0.6 0.2 0.3 2.3 0.4 1.8 2.1 1.7 2.7 1.8 1.1 1.2 1.1 1.6 1.6 0.5 1.2 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 LATS1 WARTS ENSG00000131023 "Large tumor suppressor kinase 1" O95835 6 149658153-149718105 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031804 Approved NA NA "HPA031804: AB_10601688" "unprognostic (4.02e-3)" "unprognostic (3.80e-3)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (2.09e-1)" "unprognostic (6.15e-3)" "unprognostic (1.29e-2)" "unprognostic (9.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (5.62e-2)" "unprognostic (1.92e-1)" "unprognostic (8.43e-2)" "unprognostic (2.63e-1)" "unprognostic (2.65e-1)" 8.2 8.1 5.6 8.6 5.8 15.5 9.3 11.8 7.1 10.2 5.9 7.1 7.2 12.2 7.5 8.3 9.8 7.8 5.3 6.0 5.2 7.8 7.9 9.1 9.9 5.3 5.4 4.5 15.7 6.9 11.8 5.3 8.9 7.0 11.1 8.6 11.1 8.8 7.8 6.4 9.2 7.8 10.8 4.6 10.3 7.8 6.3 5.0 11.9 8.9 8.2 8.5 9.1 7.3 8.4 8.7 6.8 13.7 19.8 12.9 16.6 10.7 11.3 11.4 11.8 11.7 11.1 7.3 14.0 11.1 15.7 9.4 11.8 18.3 12.0 18.5 12.9 14.7 28.1 8.2 9.9 11.9 26.5 19.8 11.3 19.1 13.5 22.7 12.2 14.8 12.1 35.3 13.9 11.9 10.4 13.8 11.0 8.5 8.0 6.5 13.6 16.4 6.5 11.0 12.2 9.3 14.7 16.1 11.5 8.4 9.3 12.0 22.9 18.7 9.5 14.8 11.4 18.2 11.6 13.5 15.8 8.7 14.8 14.3 8.2 3.0 4.8 5.9 5.3 5.3 3.8 4.5 5.0 3.3 4.7 3.8 5.1 2.0 3.0 8.9 2.8 4.8 2.4 5.6 5.8 11.8 7.1 6.0 5.2 5.3 5.4 4.5 7.0 4.6 5.0 8.4 21.1 12.8 21.3 33.0 21.9 16.3 11.2 9.7 27.9 20.3 15.2 10.2 9.6 12.8 12.5 7.3 18.8 8.5 18.7 15.3 1.9 7.5 23.0 14.1 23.4 16.2 16.8 17.7 51.4 6.6 11.4 19.7 20.9 17.1 14.0 19.8 21.0 13.3 11.0 13.5 48.0 12.6 6.1 14.7 11.6 6.9 13.7 16.6 14.2 32.8 15.0 10.7 10.3 54.8 64.0 9.9 11.5 25.9 21.9 15.4 13.6 6.6 12.8 22.0 19.7 28.8 15.1 8.8 9.6 18.8 18.0 13.1 23.3 13.8 11.7 11.8 EPS8L1 "DRC3, FLJ20258, MGC23164, MGC4642" ENSG00000131037 "EPS8 like 1" Q8TE68 19 55072020-55087923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 125.3;skin 1: 57.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 104.1;Gastric mucus-secreting cells: 108.1;Paneth cells: 110.2;Syncytiotrophoblasts: 428.0;Urothelial cells: 189.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 17.6;BEWO: 58.8;SK-BR-3: 19.6;T-47d: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041851, HPA043545" Uncertain Supported Cytosol NA NA Cytosol "HPA041851: AB_2677706, HPA043545: AB_2678544" "unprognostic (1.91e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (7.18e-2)" "unprognostic (9.33e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.43e-2)" "unprognostic (5.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.85e-3)" "unprognostic (5.04e-3)" "unprognostic (3.02e-1)" "unprognostic (5.41e-3)" "unprognostic (2.63e-1)" 2.2 0.2 0.1 0.9 0.1 0.1 4.1 0.0 0.1 14.5 0.0 2.7 2.3 1.5 0.0 125.3 14.9 0.9 0.5 0.0 0.1 10.4 0.7 3.9 0.0 0.1 0.1 0.0 0.5 5.6 2.1 2.1 5.4 0.1 9.3 0.6 0.0 20.5 2.5 0.5 57.7 2.0 0.0 0.2 0.6 27.2 0.6 0.2 0.1 17.6 0.0 1.6 2.7 37.4 0.2 17.6 0.7 0.6 0.4 0.0 0.0 58.8 1.5 0.1 0.0 0.1 7.6 13.7 0.3 3.4 0.0 0.1 9.7 0.4 2.1 0.0 0.3 1.6 1.3 0.6 0.5 0.2 2.6 10.8 0.0 3.6 0.0 0.0 0.0 0.0 1.2 6.2 0.1 0.0 8.0 0.9 2.6 0.8 12.7 0.0 0.1 0.0 5.4 2.7 3.6 0.2 3.8 1.0 19.6 0.8 0.6 28.9 3.2 1.3 0.0 0.7 0.0 0.0 2.4 3.1 1.6 3.3 0.9 2.0 1.1 0.2 2.3 0.3 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.3 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.2 4.0 9.6 6.1 0.3 0.8 2.0 28.4 39.5 8.6 0.0 16.3 15.1 2.6 8.6 92.2 31.3 0.0 55.1 4.0 104.1 13.7 20.4 1.6 29.1 6.3 10.7 3.0 0.0 0.1 10.2 26.8 4.7 108.1 41.7 10.2 5.4 10.0 0.1 8.9 0.0 0.1 39.0 24.4 1.9 3.4 4.5 1.2 2.6 21.4 0.0 5.2 0.2 6.2 0.0 0.1 94.5 110.2 0.7 1.0 48.7 12.7 1.1 53.6 0.6 26.3 0.5 21.6 1.6 3.6 6.6 4.0 428.0 2.8 0.3 22.1 189.4 LILRB2 "CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10" ENSG00000131042 "Leukocyte immunoglobulin like receptor B2" Q8N423 19 54273812-54281184 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 35.4;lung: 15.1;lymphoid tissue: 51.6" "Cell type enhanced" "Detected in some" "Kupffer cells: 150.7;Langerhans cells: 61.8;Macrophages: 147.3;monocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 61.6;intermediate monocyte: 132.3;neutrophil: 62.9;non-classical monocyte: 153.4" "Group enriched" "Detected in many" 6 "granulocytes: 62.9;monocytes: 153.4" "Not detected" "Not detected" NA NA 65000000 "unprognostic (1.23e-1)" "unprognostic (1.12e-2)" "unprognostic (3.21e-2)" "unprognostic (3.51e-2)" "unprognostic (6.21e-3)" "unprognostic (1.70e-2)" "unprognostic (1.44e-2)" "unprognostic (2.94e-1)" "unprognostic (1.08e-2)" "unprognostic (2.98e-2)" "unprognostic (2.64e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.45e-7)" "unprognostic (1.90e-2)" "unprognostic (4.68e-3)" "unprognostic (3.72e-1)" "unprognostic (9.73e-2)" 5.3 2.6 0.1 12.3 0.0 35.4 2.2 0.1 0.5 0.9 0.5 2.1 3.2 1.2 0.1 1.0 3.8 0.0 2.2 0.1 1.4 2.1 3.9 15.1 0.8 1.0 0.3 0.1 0.8 1.3 0.0 1.3 0.5 0.3 1.7 0.8 0.0 1.6 0.4 0.6 0.5 3.0 0.4 0.2 51.6 1.9 0.3 0.8 0.2 1.1 0.1 0.0 2.3 1.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 61.6 16.2 0.1 132.3 0.3 0.0 0.0 0.0 18.8 0.1 0.1 0.0 62.9 0.0 153.4 8.0 0.3 29.7 0.1 0.0 0.1 0.5 0.1 1.4 1.0 0.3 0.1 0.3 0.2 0.8 2.4 0.5 3.2 10.9 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.8 1.5 3.1 0.0 0.0 0.1 10.3 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.8 0.0 0.0 0.3 1.0 1.1 0.0 5.1 0.0 2.2 1.5 27.2 0.0 0.0 0.0 0.0 150.7 61.8 0.1 0.0 147.3 3.6 1.0 75.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.3 2.2 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.6 0.1 2.9 0.0 0.0 0.1 AAR2 "bA234K24.2, C20orf4" ENSG00000131043 "AAR2 splicing factor" Q9Y312 20 36236131-36270918 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034220, HPA048645" Uncertain Approved Cytosol NA NA Cytosol "CAB034220: AB_1564205, HPA048645: AB_2680475" "unprognostic (1.73e-1)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.54e-3)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.09e-2)" "unprognostic (6.84e-2)" "unprognostic (6.38e-2)" "unprognostic (3.79e-1)" "unprognostic (3.31e-1)" "unprognostic (4.61e-3)" "unprognostic (4.58e-2)" "unprognostic (5.85e-2)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" 21.8 27.0 14.9 14.4 16.2 22.5 21.9 16.0 15.6 19.9 18.5 24.1 15.3 25.8 25.3 18.0 23.4 16.6 18.9 14.7 15.5 18.0 23.7 19.4 17.7 16.3 15.7 14.6 22.8 18.7 25.7 10.1 17.7 15.9 20.1 17.5 7.5 18.2 21.3 23.6 25.6 19.1 28.2 16.4 18.2 23.2 16.5 15.7 26.4 18.0 20.9 20.1 26.0 16.3 17.7 26.9 30.7 28.8 33.2 48.9 32.4 22.9 25.4 33.7 58.1 45.7 69.2 35.0 18.2 35.6 36.9 44.8 36.6 46.6 48.2 35.8 17.0 28.2 57.9 19.3 43.3 36.9 39.5 27.9 39.6 68.7 41.5 31.5 29.4 36.3 36.0 36.8 34.3 32.4 32.0 56.0 48.9 25.1 39.1 49.5 30.7 48.3 42.4 33.0 19.6 33.2 36.1 37.8 100.7 32.8 26.2 57.1 42.8 26.6 54.9 34.3 33.0 32.2 31.1 42.3 34.6 39.9 26.3 29.7 60.6 46.2 41.6 43.0 49.4 43.2 32.5 40.0 41.4 49.1 35.5 50.0 43.0 8.9 58.4 58.1 39.8 50.2 57.4 14.9 16.2 16.0 15.6 14.7 15.5 16.3 15.7 14.6 15.9 16.4 15.7 17.7 11.7 6.4 12.5 4.6 10.8 5.7 10.6 11.8 6.8 4.4 10.3 9.5 6.8 11.5 8.4 9.2 8.4 21.3 10.9 7.1 11.7 19.7 2.8 6.9 8.9 11.9 11.4 14.7 6.3 21.0 14.3 12.7 6.6 6.6 15.9 10.8 11.4 11.8 15.0 15.2 7.1 10.5 12.2 15.0 2.5 3.1 11.1 8.5 10.6 3.7 12.3 6.1 14.4 5.0 9.9 17.3 7.6 15.1 7.5 11.3 8.4 8.0 11.1 3.5 6.6 9.8 13.9 17.0 14.5 9.0 7.5 18.6 7.9 15.3 8.7 8.9 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.8;choroid plexus: 8.7;epididymis: 2.6;fallopian tube: 6.2;testis: 5.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 20.8;Early spermatids: 39.3;Endometrial ciliated cells: 25.8;Late spermatids: 69.8;Oligodendrocytes: 28.0;Respiratory ciliated cells: 50.2" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.1 0.1 3.4 0.0 2.5 0.0 0.2 2.7 2.2 0.6 8.7 0.0 0.0 0.1 2.6 0.0 6.2 0.1 0.0 2.7 3.0 0.5 0.0 1.2 0.1 3.4 3.4 1.9 0.1 0.2 0.6 1.0 0.0 3.3 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 3.8 0.2 0.0 5.1 2.7 0.0 0.7 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.5 2.7 2.2 2.7 3.0 3.4 3.4 1.9 3.3 3.8 2.7 2.7 0.2 12.8 20.8 13.1 0.1 0.1 1.1 1.1 0.0 1.8 0.4 0.6 0.9 0.0 8.1 0.0 4.2 0.1 0.1 0.0 0.0 0.2 39.3 25.8 0.7 1.1 0.0 0.0 5.6 0.0 0.0 1.6 0.0 0.8 7.6 0.8 0.4 0.1 0.0 5.0 7.8 0.2 2.0 0.6 0.5 69.8 1.5 3.5 0.0 1.0 0.8 0.4 0.0 15.1 28.0 0.1 0.0 1.2 0.0 0.5 0.0 0.2 50.2 0.8 0.0 0.8 0.7 13.8 1.2 0.0 0.1 0.0 2.7 0.4 0.0 0.4 BPIFA2 "bA49G10.1, C20orf70, PSP, SPLUNC2" ENSG00000131050 "BPI fold containing family A member 2" Q96DR5 20 33161768-33181412 "Predicted secreted proteins" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1618 "salivary gland: 6917.3" "Cell type enriched" "Detected in some" 4 "Ionocytes: 649.0" "Group enriched" "Detected in some" 4 "lung cancer: 2.6;pancreatic cancer: 2.9;stomach cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.0;RT4: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA044006 Enhanced "Secreted to digestive system" NA NA "HPA044006: AB_10963580" "unprognostic (9.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (6.14e-4)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6917.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 49.3 0.0 0.0 0.0 0.0 0.2 0.0 145.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 649.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 17.3 0.0 0.0 0.0 8.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" NA NA 19000 "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavorable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 59.0 56.2 19.4 38.1 18.9 173.5 45.0 32.6 28.8 56.8 23.4 54.2 35.4 54.9 9.3 62.8 61.9 41.1 52.7 18.2 19.3 47.8 48.1 62.7 42.6 21.0 16.7 9.7 71.7 41.5 27.5 50.4 41.2 20.6 50.6 17.1 50.0 53.9 22.5 70.8 49.1 47.3 19.4 15.9 56.9 50.2 34.6 21.1 51.5 54.7 33.4 24.3 51.1 62.6 28.1 98.8 87.6 77.0 78.5 48.8 53.8 78.8 131.0 50.6 59.6 60.2 109.3 78.5 137.5 90.6 38.9 67.9 91.2 122.3 67.9 66.5 94.6 96.7 174.6 80.7 101.2 23.4 158.6 99.9 14.4 97.6 68.9 38.4 63.7 57.8 46.4 195.5 117.6 46.3 72.2 194.5 87.9 103.2 87.5 96.8 104.9 136.2 91.7 41.5 56.2 77.9 63.4 91.1 94.7 78.4 109.3 70.6 94.6 91.4 100.8 92.5 90.5 115.8 71.6 164.3 204.0 64.7 123.2 79.2 250.9 120.4 197.5 104.7 111.1 103.6 131.1 91.5 97.6 111.8 140.5 85.7 82.1 427.7 127.2 102.2 160.9 114.7 95.7 19.4 18.9 32.6 28.8 18.2 19.3 21.0 16.7 9.7 20.6 15.9 21.1 28.1 302.0 233.9 280.9 144.3 441.7 616.4 521.0 283.0 284.0 258.5 339.1 295.4 189.2 191.6 267.6 200.5 316.9 375.2 624.9 278.1 189.8 203.8 48.1 359.2 496.0 299.7 295.3 214.2 130.1 186.0 389.6 337.9 254.9 540.8 525.8 304.4 215.3 202.1 199.8 220.4 120.9 331.3 215.7 207.7 469.5 41.9 262.5 335.5 270.3 129.3 274.3 208.7 400.6 136.2 160.5 221.3 254.8 214.4 391.0 453.6 271.8 150.6 248.0 386.5 164.3 504.0 410.2 263.5 228.1 215.8 586.9 561.6 490.8 218.2 282.8 532.1 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637912-31645006 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 49.5;placenta: 116.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 414.2;Smooth muscle cells: 191.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "SH-SY5Y: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favorable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 18.9 1.1 6.6 1.7 6.4 0.0 16.0 6.4 9.2 4.8 6.2 4.4 2.0 7.5 4.0 5.4 5.0 10.7 33.1 6.3 6.5 3.6 1.1 49.5 4.8 6.7 6.8 6.0 2.9 2.3 9.4 2.2 116.4 6.9 10.2 2.7 1.1 3.6 4.8 8.8 4.7 5.9 7.1 6.4 1.7 4.3 1.5 6.6 1.8 14.8 19.6 3.0 7.8 6.8 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.4 6.4 9.2 6.3 6.5 6.7 6.8 6.0 6.9 6.4 6.6 6.4 55.0 0.0 0.0 0.0 0.5 6.4 0.3 0.0 2.2 0.4 0.9 1.9 2.7 0.0 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.2 0.1 0.7 23.5 0.0 0.0 0.0 0.0 0.3 9.5 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 7.5 0.7 3.7 0.5 8.8 2.8 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.7 414.2 4.6 191.6 0.1 1.0 0.8 6.7 2.5 1.0 1.0 0.0 0.3 BPIFA3 "bA49G10.4, C20orf71, SPLUNC3" ENSG00000131059 "BPI fold containing family A member 3" Q9BQP9 20 33217310-33227806 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 542 "testis: 54.1" "Cell type enriched" "Detected in some" 4 "Late spermatids: 3057.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062708 Enhanced "Secreted in male reproductive system" NA NA "HPA062708: AB_2684843" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 736.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3057.9 14.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 18.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780" "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favorable (3.93e-4)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 1.2 1.0 1.0 1.9 1.1 2.4 0.9 0.8 2.2 1.1 0.0 1.5 1.4 1.3 1.0 1.3 1.3 0.9 1.0 1.6 0.3 0.6 0.6 1.1 1.9 0.4 0.2 1.1 1.3 1.6 0.9 0.6 1.4 0.8 1.3 1.1 0.7 1.5 1.0 3.4 2.1 1.1 1.2 0.0 1.9 1.4 1.5 0.5 1.8 0.9 3.3 1.2 1.2 1.1 1.4 2.4 6.4 2.2 4.7 2.1 1.7 9.5 2.3 1.2 1.9 1.2 4.6 5.4 3.7 3.8 1.7 2.2 3.7 2.4 4.1 0.8 3.3 2.2 3.6 3.6 3.7 1.2 2.1 4.3 1.4 3.0 1.6 1.0 1.7 2.3 3.4 1.9 1.7 2.0 2.9 1.9 1.6 3.0 3.5 3.1 2.4 1.4 2.1 1.3 5.2 1.9 2.1 6.1 5.6 1.4 1.7 5.0 1.7 2.9 3.4 1.4 2.5 2.2 1.3 1.9 3.4 3.3 1.7 2.4 2.6 1.3 2.9 1.1 1.8 1.0 2.2 0.8 0.7 1.0 1.2 0.5 1.5 2.5 1.3 1.2 0.7 0.6 0.9 1.0 1.1 0.8 2.2 1.6 0.3 0.4 0.2 1.1 0.8 0.0 0.5 1.4 1.8 3.2 5.1 5.5 2.9 0.4 1.0 1.5 0.6 2.2 1.9 1.4 2.7 2.8 4.7 1.8 2.1 2.6 0.9 7.0 0.0 1.5 0.6 1.6 1.4 1.4 1.2 0.8 11.3 1.4 3.3 1.6 6.6 2.1 2.5 1.8 1.4 1.0 1.4 1.7 8.0 2.0 2.0 1.6 2.0 0.1 0.6 2.4 0.0 3.7 1.2 0.6 2.1 6.0 7.7 1.7 2.5 0.4 2.6 2.5 4.2 0.4 4.6 2.3 0.0 1.9 1.1 1.6 2.4 1.6 1.0 2.1 1.9 1.5 2.4 2.5 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872856 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 60.9;Inhibitory neurons: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles NA NA 1900000 Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: AB_2668816" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 12.4 13.9 32.7 11.9 36.6 5.6 15.5 42.3 43.7 24.6 46.0 18.2 16.1 19.4 29.3 10.2 21.3 18.3 22.5 39.6 32.7 22.4 16.9 14.5 18.4 34.6 31.6 39.3 24.3 27.3 23.1 40.8 13.8 35.3 25.0 15.0 22.9 31.1 22.8 68.1 18.0 20.3 15.0 20.7 15.5 22.3 10.2 34.4 15.9 29.1 13.9 13.7 19.9 18.2 40.0 5.2 7.7 38.5 39.5 29.7 26.4 34.2 21.7 21.9 17.5 26.0 40.6 25.5 0.0 25.1 17.1 17.8 3.6 16.8 9.5 11.5 1.8 29.9 15.9 16.0 21.3 26.5 0.8 24.9 38.5 10.6 19.7 9.1 52.2 1.5 20.3 12.0 2.8 12.2 9.1 4.2 8.1 8.9 9.1 3.8 0.1 26.3 25.9 25.3 7.7 22.4 26.1 11.2 17.6 28.2 14.4 13.5 14.2 0.6 59.8 23.6 5.7 12.6 29.6 4.2 1.9 70.4 1.5 22.4 1.4 2.8 1.5 6.9 2.0 2.0 6.1 5.8 2.6 2.5 5.4 11.5 8.2 0.3 3.0 0.7 1.4 5.1 1.8 32.7 36.6 42.3 43.7 39.6 32.7 34.6 31.6 39.3 35.3 20.7 34.4 40.0 2.0 3.2 2.7 23.2 6.4 7.4 18.1 14.8 9.1 40.2 9.6 5.8 1.9 32.9 11.1 18.4 12.5 24.2 2.2 14.2 0.0 16.1 3.2 3.3 7.6 2.1 10.8 1.7 60.9 5.6 12.3 14.0 23.4 4.5 2.5 9.0 1.4 12.1 4.5 40.4 58.0 15.2 38.7 3.2 4.4 1.8 12.5 3.2 10.6 17.8 2.8 9.7 4.1 31.2 25.5 6.3 17.8 7.9 1.9 9.3 11.9 6.1 7.2 19.3 6.6 16.0 9.4 13.9 15.5 5.7 4.3 16.8 7.2 17.0 17.9 13.9 DEFB118 "C20orf63, DEFB-18, dJ1018D12.3, ESC42" ENSG00000131068 "Defensin beta 118" Q96PH6 20 31368601-31373923 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9999 "epididymis: 999.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" HPA042634 Enhanced "Secreted in male reproductive system" NA NA "HPA042634: AB_10797505" "unprognostic (3.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 999.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 118.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 137.7;Hepatocytes: 138.9;Intestinal goblet cells: 100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 34.3" "Group enriched" "Detected in many" 5 "dendritic cells: 22.6;granulocytes: 34.3;monocytes: 21.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 132.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved NA NA 16000 "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 69.9 23.9 3.8 10.8 7.9 7.5 27.5 5.4 6.9 11.6 4.7 55.1 64.8 13.8 34.6 18.8 22.3 10.8 50.3 2.6 5.9 22.2 47.3 23.4 4.0 11.1 7.2 2.4 13.1 15.0 19.7 3.8 17.3 11.0 12.3 33.2 5.4 38.4 16.4 118.4 16.5 47.2 11.4 4.9 8.2 38.1 10.7 5.3 4.0 9.7 100.1 7.1 9.4 12.0 15.7 32.8 11.6 17.1 10.7 69.5 59.1 25.5 14.5 32.4 13.9 21.7 27.3 40.6 0.1 18.6 24.1 50.2 26.0 20.1 132.4 9.5 0.1 7.1 37.2 6.6 18.5 46.2 6.6 28.1 50.3 34.2 24.8 34.5 27.8 27.7 4.2 22.0 7.1 15.8 13.3 2.4 18.8 3.3 27.6 44.1 15.9 20.3 83.4 62.5 9.0 2.9 14.5 24.7 49.1 32.1 21.2 19.6 24.4 23.5 12.3 7.8 12.4 7.9 24.0 19.7 9.1 32.3 9.3 9.1 34.3 21.8 6.6 1.2 13.3 1.2 0.7 3.0 1.3 22.6 1.1 5.3 2.9 12.2 0.7 6.4 4.2 2.0 9.2 3.8 7.9 5.4 6.9 2.6 5.9 11.1 7.2 2.4 11.0 4.9 5.3 15.7 8.8 12.8 41.1 17.6 4.2 7.8 9.4 13.5 10.2 6.4 27.6 10.9 82.2 20.0 16.6 11.0 6.2 15.5 3.7 137.7 11.7 20.8 9.0 8.0 8.2 13.5 7.8 29.0 18.5 33.7 11.2 11.4 58.1 13.0 9.5 35.3 13.6 138.9 16.4 8.4 18.2 100.6 18.3 17.9 13.9 7.2 11.5 15.6 14.2 17.8 19.4 9.1 1.0 5.5 86.5 23.4 66.4 4.5 14.6 11.2 70.4 60.5 7.6 4.1 13.1 7.2 9.8 32.1 20.3 12.3 10.9 20.9 5.1 7.8 75.1 13.0 EDA2R "EDA-A2R, EDAA2R, TNFRSF27, XEDAR" ENSG00000131080 "Ectodysplasin A2 receptor" Q9HAV5 X 66595637-66639298 "Predicted membrane proteins" Differentiation "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 8.3;Microglial cells: 5.6;Oligodendrocytes: 6.4;Theca cells: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.3;HSkMC: 33.3;LHCN-M2: 31.8;SuSa: 25.2" "Not detected" "Not detected" HPA054522 Approved "Cell Junctions" NA NA "Cell Junctions" "HPA054522: AB_2682516" "unprognostic (1.31e-3)" "unprognostic (3.17e-3)" "unprognostic (2.19e-1)" "unprognostic (8.49e-3)" "unprognostic (4.15e-3)" "unprognostic (3.63e-3)" "unprognostic (2.48e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-1)" "unprognostic (7.17e-2)" "unprognostic (6.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (8.23e-2)" "unprognostic (4.92e-2)" "unprognostic (3.08e-1)" 1.9 5.8 1.8 0.5 2.5 0.0 3.1 2.1 2.2 5.9 3.7 2.2 0.3 5.8 4.2 2.4 4.4 3.3 2.1 1.9 2.1 1.2 0.8 2.6 0.5 2.7 2.3 1.5 7.5 3.2 3.0 3.4 1.1 3.0 4.1 5.0 0.7 2.5 5.4 2.5 1.3 1.1 5.3 2.3 1.2 0.8 1.4 2.2 2.6 5.7 0.9 0.5 2.4 4.3 3.8 0.0 16.4 15.0 0.0 21.0 24.3 0.2 22.5 24.0 2.1 3.3 0.0 0.0 8.3 0.0 14.6 0.0 0.1 0.0 8.6 7.3 0.0 7.8 0.0 0.5 11.0 3.7 0.0 0.1 33.3 20.0 16.4 15.1 20.2 0.5 0.4 0.8 8.4 31.8 1.9 0.4 0.0 5.6 0.0 0.0 0.0 2.0 0.0 1.5 0.0 0.0 2.7 0.0 0.0 0.0 25.2 0.5 0.3 17.3 0.0 12.0 0.0 0.2 0.0 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.5 2.1 2.2 1.9 2.1 2.7 2.3 1.5 3.0 2.3 2.2 3.8 0.5 3.2 0.0 0.7 0.8 0.3 1.0 1.5 2.8 0.1 1.2 1.7 0.5 1.5 1.4 1.8 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.5 1.2 0.6 1.2 0.0 0.0 0.6 1.3 2.5 0.5 0.2 0.0 8.3 0.7 0.0 0.2 0.0 0.3 0.5 2.0 0.0 0.3 0.0 1.8 0.1 1.8 5.6 0.0 1.5 1.0 2.0 6.4 0.6 0.3 0.4 0.0 1.1 0.2 0.4 1.0 0.0 0.0 3.6 1.6 0.0 0.2 0.7 0.6 0.7 0.6 5.0 0.5 0.6 ARHGEF9 "KIAA0424, PEM-2" ENSG00000131089 "Cdc42 guanine nucleotide exchange factor 9" O43307 X 63634967-63809274 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 88.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 184.3;Cone photoreceptor cells: 233.5;Rod photoreceptor cells: 320.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035419, HPA055291" Approved Supported Cytosol NA NA Cytosol "HPA035419: AB_10669859, HPA055291: AB_2682774" "unprognostic (3.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.02e-2)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.66e-1)" "unprognostic (1.98e-3)" "unprognostic (1.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.08e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.02e-5)" "unprognostic (4.56e-2)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (8.98e-2)" 7.8 15.8 22.4 6.5 40.4 4.1 10.7 5.3 51.2 8.5 4.7 13.8 16.0 9.4 7.2 11.3 7.7 8.0 36.2 46.9 28.5 13.3 5.7 6.4 6.3 13.6 14.0 35.1 16.4 5.3 15.1 15.8 5.9 22.9 14.0 14.4 88.9 6.3 14.7 5.9 9.1 13.6 17.3 5.8 7.0 9.0 2.8 20.9 9.5 8.3 9.0 7.4 14.4 6.6 28.5 6.3 9.7 20.2 10.3 7.6 11.1 1.2 12.3 11.8 12.8 9.8 0.6 6.8 14.1 8.7 8.0 10.8 0.2 8.4 14.5 15.1 18.5 6.6 13.7 4.5 0.6 4.5 6.7 4.2 12.2 6.9 5.9 18.5 11.9 7.1 14.8 1.5 20.8 14.0 10.0 12.6 3.3 16.4 6.2 12.1 22.9 48.2 13.5 7.8 6.0 0.1 5.1 5.6 9.8 6.7 8.4 7.5 8.9 3.4 7.1 6.4 34.6 5.1 7.8 6.5 10.2 8.7 10.7 5.1 0.8 1.4 1.3 4.5 2.0 3.2 2.2 2.7 3.1 2.2 2.9 3.3 2.9 1.1 8.4 1.4 1.8 2.6 1.9 22.4 40.4 5.3 51.2 46.9 28.5 13.6 14.0 35.1 22.9 5.8 20.9 28.5 9.2 9.6 11.4 59.4 20.3 5.7 6.5 8.7 12.5 184.3 26.0 17.4 45.9 7.2 10.0 11.0 233.5 5.0 19.4 18.2 13.7 6.3 2.0 6.5 9.8 10.8 20.9 3.8 105.9 8.8 1.4 11.8 24.5 6.0 14.5 20.0 11.7 10.7 10.5 82.4 90.5 16.0 12.2 5.7 6.3 6.2 15.5 8.2 14.2 33.7 3.8 29.9 34.0 89.0 50.5 7.9 14.5 15.4 12.4 4.3 19.1 17.3 9.3 320.8 0.0 12.7 22.0 1.9 3.4 11.2 6.0 4.4 21.8 39.6 21.8 6.1 C1QL1 "C1QRF, C1QTNF14, CRF, CTRP14" ENSG00000131094 "Complement C1q like 1" O75973 17 44959693-44968303 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 108.9" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 673.0" "Cancer enriched" "Detected in all" 7 "glioma: 116.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 34.8;SH-SY5Y: 24.8;U-2 OS: 89.0;U-251 MG: 28.1;U-87 MG: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (3.63e-3)" "unprognostic (3.15e-2)" "unprognostic (2.05e-2)" "unprognostic (7.65e-2)" "unprognostic (3.40e-3)" "unprognostic (2.34e-1)" "unprognostic (6.64e-3)" "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (1.31e-8)" "unprognostic (2.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.61e-2)" "unprognostic (3.04e-1)" 3.7 0.8 33.0 0.4 14.6 0.0 0.9 26.4 23.0 2.7 10.4 4.4 2.0 13.1 0.3 1.9 4.4 0.3 3.4 12.4 24.7 20.4 0.7 0.2 0.0 108.9 37.4 11.5 0.7 4.6 0.0 2.1 0.0 31.0 7.4 0.3 8.2 0.7 0.0 0.1 0.5 6.2 0.6 31.4 0.1 3.9 0.8 27.3 0.1 0.3 0.2 0.0 6.4 1.2 26.2 4.6 5.1 1.1 17.8 0.3 0.0 0.3 0.8 0.7 0.5 1.6 0.7 0.6 0.2 3.0 0.4 5.3 0.6 2.8 0.2 0.2 12.7 7.5 0.0 7.9 0.1 2.1 0.0 2.2 0.4 0.0 0.7 0.2 6.2 0.0 3.1 0.1 0.2 0.5 1.1 4.0 0.1 3.1 0.5 10.7 6.7 0.2 0.3 0.1 0.4 34.8 24.8 15.6 1.3 1.3 0.9 4.1 0.2 0.1 1.4 89.0 0.9 28.1 1.0 0.0 0.1 27.8 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 14.6 26.4 23.0 12.4 24.7 108.9 37.4 11.5 31.0 31.4 27.3 26.2 0.1 0.0 0.0 4.2 0.0 0.3 0.2 1.0 0.0 22.3 0.4 3.2 1.1 5.7 0.0 0.0 10.4 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.5 0.4 5.3 0.0 0.5 0.0 0.1 1.9 0.0 0.5 0.0 0.3 1.1 0.1 0.0 673.0 11.7 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 1.0 0.0 17.6 0.0 84.4 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.5 0.0 0.0 0.7 0.2 1.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903159-44916937 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 12855.4" "Cell type enriched" "Detected in some" 7 "Astrocytes: 381.9" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 6.2;NK-cells: 1.7" "Cell line enhanced" "Detected in many" "U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" No No 170000000 "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027" "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 1.8 1.8 4351.8 2.2 4622.7 14.3 3.5 5816.3 4926.6 1.3 1892.6 1.4 0.4 0.9 1.5 3.8 2.2 1.6 8.2 4465.1 8932.7 1.5 1.7 1.4 1.9 12855.4 6807.2 2981.1 2.1 1.6 1.6 34.2 0.7 8213.5 1.3 1.0 118.7 2.0 1.0 2.1 2.6 0.7 0.9 9813.6 1.5 1.5 1.4 8782.5 0.4 1.7 0.3 1.1 1.4 0.9 11334.3 1.0 0.7 1.2 2.3 0.0 0.4 0.2 1.0 1.2 1.5 1.2 1.3 1.5 2.2 1.9 0.5 0.9 2.7 1.4 0.4 1.8 3.0 1.1 1.4 2.1 0.9 0.0 0.2 2.2 0.1 0.8 1.0 0.0 1.7 0.0 2.3 0.7 5.3 0.8 1.3 1.9 2.6 1.6 0.1 3.3 0.7 0.7 1.2 0.7 0.6 1.6 1.8 0.1 1.7 0.2 1.0 1.2 1.2 0.7 1.2 0.9 1.1 2.0 0.7 1.6 1.6 6.1 2.0 2.7 1.5 0.8 0.3 0.3 0.6 0.2 0.2 0.2 0.4 0.1 0.5 0.3 0.4 6.2 1.7 0.5 0.5 0.2 0.2 4351.8 4622.7 5816.3 4926.6 4465.1 8932.7 12855.4 6807.2 2981.1 8213.5 9813.6 8782.5 11334.3 0.0 0.0 0.0 381.9 0.1 0.0 0.1 0.0 0.0 0.8 1.3 0.6 5.2 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.8 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.7 0.0 53.5 0.0 10.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 PYY PYY1 ENSG00000131096 "Peptide YY" P10082 17 43952738-44004469 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "intestine: 53.0" "Cell type enriched" "Detected in some" 96 "Enteroendocrine cells: 19377.2" "Group enriched" "Detected in many" 8 "endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.9" "Region enriched" "Detected in single" 14 "pons and medulla: 1.4" "Low region specificity" "Detected in single" "HPA010973, CAB016734" Enhanced "Secreted to blood" NA NA 87100 "CAB016734: AB_876471, HPA010973: AB_1855194" "unprognostic (8.17e-3)" "unprognostic (5.41e-2)" "unprognostic (9.93e-2)" "unprognostic (1.81e-3)" "unprognostic (2.48e-4)" "unprognostic (5.26e-2)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" "unprognostic (1.75e-2)" "unprognostic (1.54e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-1)" "unprognostic (5.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" 0.1 1.7 0.3 1.5 0.3 0.1 0.4 0.2 0.7 0.3 0.1 53.0 2.5 0.4 0.4 0.0 0.4 0.0 0.0 0.3 0.3 1.3 0.2 0.2 0.3 0.4 0.3 0.3 0.0 0.7 0.2 0.0 0.0 0.5 0.3 37.0 0.8 0.1 0.8 0.1 0.1 42.0 0.1 0.2 0.1 0.5 1.1 0.4 0.3 0.5 0.1 0.1 0.0 0.0 0.5 0.1 0.2 0.2 0.4 0.3 0.6 0.0 0.4 0.1 0.5 0.3 0.5 0.3 0.2 0.6 0.5 0.4 0.2 0.4 0.1 0.3 1.2 0.2 0.7 0.2 0.0 0.4 0.2 2.9 0.8 0.1 0.5 0.2 0.6 0.1 0.3 0.2 0.5 0.4 0.6 0.2 0.4 0.6 0.4 0.2 0.1 0.1 0.0 0.8 0.0 0.4 0.1 0.3 0.0 0.7 0.3 0.5 0.0 0.5 0.6 0.5 0.1 0.4 0.0 0.5 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.7 0.3 0.3 0.4 0.3 0.3 0.5 0.2 0.4 0.5 0.1 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 65.0 1.9 0.0 1.0 7.9 1.3 0.1 19377.2 0.0 3.5 0.0 0.1 0.0 0.0 18.9 8.9 0.1 0.0 0.0 0.0 0.0 3.3 199.9 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 35.5 0.0 0.0 0.0 20.7 0.1 0.0 0.0 0.0 0.0 0.1 2.3 4.3 0.0 0.1 0.0 1.0 0.0 36.8 0.0 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850476 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 115.6;placenta: 106.1" "Group enriched" "Detected in some" 5 "Sertoli cells: 762.6;Smooth muscle cells: 209.3" "Cancer enhanced" "Detected in all" "glioma: 9.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 11.4 0.5 66.3 0.7 64.9 0.5 8.8 64.7 115.6 8.4 59.7 3.2 2.1 10.0 11.7 5.0 5.3 11.4 27.3 63.1 65.4 3.4 0.6 39.0 2.6 67.1 65.3 61.3 3.0 3.2 8.0 1.4 106.1 66.4 9.6 1.1 2.3 1.5 6.5 14.6 2.0 4.4 11.4 62.5 0.1 3.7 1.5 66.2 1.8 5.1 31.1 1.4 4.3 4.4 66.1 0.2 0.6 0.0 0.7 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.3 0.2 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.7 0.1 0.8 0.5 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.7 0.5 0.0 0.3 0.7 0.7 0.4 0.3 0.3 0.8 0.4 1.0 0.0 0.5 0.7 0.3 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.6 0.2 0.4 0.5 0.4 1.2 0.6 0.5 1.1 0.7 1.7 0.6 0.2 1.2 1.0 0.4 0.2 0.7 0.9 1.2 0.3 0.9 0.7 0.0 0.7 0.1 0.3 0.8 0.5 66.3 64.9 64.7 115.6 63.1 65.4 67.1 65.3 61.3 66.4 62.5 66.2 66.1 88.9 0.0 0.5 0.0 0.3 3.4 0.6 0.3 0.0 0.5 1.2 2.8 11.0 0.0 1.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.2 0.7 70.2 0.0 0.0 0.7 0.0 0.2 4.4 0.0 0.3 0.0 0.0 0.7 0.1 0.8 1.7 0.6 0.0 0.0 0.0 3.9 0.6 0.3 1.6 0.0 2.8 0.0 1.0 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 762.6 9.5 209.3 0.0 0.3 0.7 2.4 0.3 0.8 32.3 0.0 0.7 ATP6V1E1 "ATP6E, ATP6E2, ATP6V1E, P31, Vma4" ENSG00000131100 "ATPase H+ transporting V1 subunit E1" P36543 22 17592136-17628749 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009528, CAB018699, HPA029196" Enhanced Approved Nucleoplasm NA NA 34000 Nucleoplasm "CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944" "unprognostic (1.53e-3)" "unprognostic (5.78e-3)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.17e-1)" "unprognostic (2.09e-1)" "unprognostic (3.37e-2)" "unprognostic (7.72e-3)" "prognostic favorable (4.18e-4)" "prognostic favorable (7.66e-8)" "unprognostic (3.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (2.75e-1)" 119.0 166.3 220.2 68.9 236.0 91.2 110.4 224.0 289.7 94.8 213.6 115.0 57.1 113.1 137.0 118.1 96.8 85.5 227.0 238.8 240.9 232.6 86.3 111.3 89.4 232.7 225.5 233.6 82.7 60.0 241.9 118.0 114.8 241.7 95.8 100.7 129.5 84.4 127.6 234.7 117.1 83.8 122.0 226.4 99.8 102.7 67.9 231.6 109.2 101.7 180.2 110.4 115.4 98.4 280.6 121.8 108.6 96.4 94.3 314.4 169.6 106.0 159.3 212.0 198.7 228.0 137.3 97.5 76.1 132.8 215.0 251.8 187.9 152.8 140.2 174.9 145.9 173.3 137.1 97.5 182.7 459.9 159.8 226.5 212.9 267.7 192.4 138.7 220.9 170.2 95.0 174.8 150.3 341.9 127.4 136.5 114.5 71.0 269.6 152.6 80.3 140.7 45.7 331.6 189.0 70.3 122.7 146.0 101.0 358.9 187.0 98.6 180.4 146.3 137.5 72.6 174.0 119.2 145.7 275.5 96.3 221.2 76.7 189.3 178.1 106.3 184.7 64.0 100.9 63.0 78.7 64.7 61.5 83.6 59.8 60.8 63.7 137.6 76.0 120.5 81.2 97.7 112.8 220.2 236.0 224.0 289.7 238.8 240.9 232.7 225.5 233.6 241.7 226.4 231.6 280.6 66.5 76.9 83.4 13.4 47.1 41.9 77.6 121.8 19.9 54.6 33.9 34.8 126.8 74.4 83.9 138.0 27.1 235.1 63.8 105.2 461.8 143.8 7.6 74.3 56.9 69.3 41.9 49.4 24.9 119.7 143.9 60.8 40.8 79.2 90.5 41.6 72.5 46.8 186.8 53.8 24.4 54.0 116.0 75.1 52.1 17.9 94.1 91.9 80.0 15.0 144.1 94.1 85.5 13.0 31.9 154.7 104.7 97.8 38.3 60.1 65.4 411.3 78.8 50.4 59.2 39.0 74.5 71.7 74.7 34.3 51.6 479.1 54.6 57.6 40.1 93.1 ZNF227 ENSG00000131115 "Zinc finger protein 227" Q86WZ6 19 44207547-44237268 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030573 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA030573: AB_10610702" "unprognostic (3.01e-2)" "unprognostic (1.79e-2)" "unprognostic (7.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.66e-2)" "unprognostic (8.05e-2)" "unprognostic (7.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.68e-3)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.21e-2)" "unprognostic (9.91e-2)" "prognostic favorable (2.64e-4)" 6.4 7.0 10.0 5.9 10.2 5.0 8.4 14.1 10.8 7.7 8.7 6.1 5.5 8.0 7.7 6.6 8.1 6.0 5.7 9.7 9.7 6.5 7.4 6.1 10.4 9.8 10.5 8.9 11.1 6.7 10.4 8.1 7.8 10.2 8.6 5.9 8.8 5.6 7.0 6.5 6.5 5.8 6.8 9.7 9.6 8.7 7.5 9.9 17.3 8.4 6.5 11.3 7.2 6.5 13.3 9.6 13.4 15.8 19.7 12.6 10.9 7.4 9.2 13.1 8.7 17.0 6.6 7.3 16.8 13.9 8.6 10.4 5.5 18.2 9.7 11.7 21.9 22.8 29.3 14.7 8.2 9.0 25.8 12.4 9.9 10.6 8.6 16.0 14.5 13.1 19.2 2.9 0.4 9.4 5.1 24.3 6.8 25.3 9.8 7.0 14.4 15.9 14.4 9.0 17.2 26.7 27.3 20.6 9.2 7.2 15.2 7.7 13.7 11.3 9.6 15.8 7.4 11.8 37.6 54.5 36.1 6.3 10.6 13.1 17.3 4.8 9.9 10.8 3.5 11.8 12.0 10.2 10.6 5.9 12.2 13.3 11.2 4.2 11.9 3.5 6.2 13.5 5.7 10.0 10.2 14.1 10.8 9.7 9.7 9.8 10.5 8.9 10.2 9.7 9.9 13.3 8.0 0.0 1.5 13.7 8.1 3.1 3.8 4.8 3.4 6.0 5.4 4.6 7.0 1.5 6.4 5.5 2.1 5.6 6.3 3.3 3.9 4.2 22.6 4.0 4.6 8.4 2.4 7.8 10.5 4.0 4.5 4.4 3.6 3.7 1.3 8.7 8.9 3.9 4.4 8.4 10.3 4.7 2.0 5.7 3.7 30.0 5.6 3.9 1.8 9.4 5.2 6.3 11.3 17.1 16.8 6.1 3.3 5.7 4.0 6.0 4.2 3.3 4.1 5.4 6.6 5.9 5.5 4.4 8.7 3.3 3.8 2.2 6.9 8.6 3.3 2.9 ZNF428 "C19orf37, MGC51082, Zfp428" ENSG00000131116 "Zinc finger protein 428" Q96B54 19 43607224-43619629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042596, HPA048072" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA042596: AB_2678070, HPA048072: AB_2680249" "unprognostic (2.45e-3)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "unprognostic (6.31e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (3.22e-2)" "unprognostic (2.32e-2)" "unprognostic (2.53e-1)" "unprognostic (6.67e-2)" "prognostic favorable (3.60e-5)" "unprognostic (3.85e-1)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-2)" "unprognostic (4.00e-1)" "unprognostic (2.74e-2)" 26.3 43.7 44.6 17.5 43.1 24.2 27.0 37.6 60.3 36.9 25.6 40.0 17.5 43.8 9.0 22.5 35.0 10.8 43.5 44.3 42.0 44.6 39.5 25.4 17.8 42.8 40.1 40.4 43.7 31.0 18.3 55.6 13.6 36.7 42.1 6.3 15.7 28.4 14.1 44.5 18.9 25.2 10.8 36.4 31.2 30.3 57.5 46.2 22.2 37.8 14.4 10.1 34.4 27.0 41.9 38.2 33.8 53.2 79.6 20.8 15.5 21.6 28.6 15.6 23.0 24.5 19.8 25.6 66.3 62.7 26.1 13.8 9.4 21.7 6.1 7.8 54.1 87.2 73.4 34.1 34.7 39.0 57.3 55.8 27.8 12.7 19.9 10.3 23.3 32.5 48.3 76.9 40.1 24.6 42.3 140.0 97.9 30.8 17.9 22.8 135.6 23.3 49.1 27.3 25.4 90.2 102.0 44.2 25.5 66.6 14.2 15.3 79.6 55.2 24.1 66.7 22.7 44.5 43.2 56.8 117.1 34.2 56.9 53.4 1.4 2.1 9.3 6.2 1.4 3.1 4.8 5.5 6.1 2.5 6.2 5.9 2.7 0.8 2.6 2.6 5.6 3.9 1.0 44.6 43.1 37.6 60.3 44.3 42.0 42.8 40.1 40.4 36.7 36.4 46.2 41.9 67.8 0.0 3.9 26.1 44.5 32.1 80.3 173.5 55.8 101.7 68.6 74.7 19.7 61.5 76.4 66.2 14.6 142.1 78.8 43.1 148.7 89.1 153.3 81.7 79.1 69.3 162.2 66.0 17.6 79.6 46.7 79.3 38.7 59.4 36.3 214.9 76.4 51.4 104.4 57.2 19.7 62.3 156.6 38.6 60.8 63.5 88.9 42.3 113.8 14.0 45.4 191.7 99.9 18.1 26.7 74.5 52.0 90.7 45.5 41.0 30.0 216.8 48.1 72.5 72.3 59.0 102.9 29.6 173.1 44.2 25.9 55.1 71.3 174.1 52.8 53.7 TEX101 "CT131, MGC4766, SGRG, SPATA44, TES101RP" ENSG00000131126 "Testis expressed 101" Q9BY14 19 43401496-43418597 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 118.6" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 909.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "cerebral cortex: 20.2" "Immune cell enriched" "Detected in single" 557 "basophil: 55.7" "Lineage enriched" "Detected in single" 557 "granulocytes: 55.7" "Cell line enhanced" "Detected in single" "THP-1: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA041915, HPA042513" Enhanced "Secreted in male reproductive system" NA NA "HPA041915: AB_10795268, HPA042513: AB_10795507" "unprognostic (2.50e-2)" "unprognostic (5.67e-4)" "unprognostic (2.64e-1)" "unprognostic (6.89e-2)" "unprognostic (1.87e-1)" "unprognostic (5.78e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (6.54e-2)" "unprognostic (4.06e-1)" "unprognostic (2.49e-2)" "unprognostic (1.67e-7)" "unprognostic (8.83e-2)" "unprognostic (2.24e-1)" "unprognostic (7.49e-2)" "unprognostic (7.04e-2)" 0.1 0.4 0.3 0.3 0.3 0.1 0.2 0.3 20.2 0.3 0.3 0.5 0.4 0.5 0.2 1.3 0.3 0.2 0.5 2.4 0.3 0.2 0.5 0.2 0.2 4.5 0.2 0.3 0.5 1.6 0.1 0.0 0.2 1.5 0.3 0.5 0.0 1.1 0.2 0.6 1.5 0.5 0.3 1.0 0.1 0.2 118.6 0.3 1.0 0.1 0.0 1.3 0.1 1.0 0.5 0.2 0.0 0.3 0.1 0.2 0.6 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.4 0.3 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.4 0.1 0.5 0.1 0.2 0.3 0.4 0.0 0.2 0.2 0.4 0.2 0.1 0.2 0.3 0.0 0.1 0.2 0.1 0.2 0.1 0.7 0.0 0.2 0.5 0.0 0.2 0.0 0.1 0.2 0.6 0.1 0.0 1.3 0.1 0.2 0.1 0.1 0.3 0.2 0.3 0.1 0.2 0.1 0.1 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 20.2 2.4 0.3 4.5 0.2 0.3 1.5 1.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.2 0.1 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.2 0.0 0.0 31.5 6.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 909.7 151.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF141 "D4S90, pHZ-44" ENSG00000131127 "Zinc finger protein 141" Q15928 4 337814-384868 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (6.88e-3)" "unprognostic (4.64e-2)" "unprognostic (2.60e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.47e-1)" "unprognostic (3.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.11e-1)" "unprognostic (5.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.71e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.76e-4)" 4.5 14.0 8.9 3.3 9.5 1.3 4.9 12.7 12.2 8.8 9.0 5.3 2.4 5.2 4.2 4.2 7.0 1.5 5.1 9.3 8.8 5.9 6.2 6.5 5.1 8.7 8.8 8.7 15.8 5.5 3.2 8.6 2.4 9.1 7.7 2.5 13.8 5.9 2.5 2.6 4.7 6.2 1.2 8.0 7.1 4.4 5.7 8.9 3.3 7.5 1.1 4.4 5.6 6.8 9.6 0.1 1.3 5.0 2.0 1.4 1.9 1.3 1.5 0.9 2.1 3.0 4.4 2.6 0.3 1.2 1.2 2.5 2.1 0.0 1.2 2.8 0.0 1.2 0.1 2.3 0.2 1.0 0.1 4.8 2.2 1.3 2.1 0.9 1.1 0.5 1.0 0.1 0.2 2.1 1.4 4.3 6.3 5.4 0.5 2.3 0.1 0.0 0.5 1.5 2.7 5.0 2.5 1.8 0.7 1.3 2.6 2.2 4.8 0.4 0.3 1.6 1.2 1.5 0.1 0.2 0.2 0.0 0.0 0.9 0.5 0.5 1.0 1.3 0.6 1.3 1.2 1.1 1.1 1.0 1.8 1.6 1.3 0.9 1.4 0.9 0.7 0.9 0.5 8.9 9.5 12.7 12.2 9.3 8.8 8.7 8.8 8.7 9.1 8.0 8.9 9.6 9.5 6.4 7.7 14.7 28.3 3.7 3.3 2.0 6.2 24.0 5.2 5.8 5.3 8.6 4.2 14.7 14.6 3.5 11.2 2.6 5.9 3.5 7.9 4.5 9.3 9.6 6.0 8.4 9.9 2.9 3.0 9.7 4.6 5.6 5.7 22.8 3.9 2.0 2.3 33.7 11.6 2.7 2.0 2.2 6.0 6.1 11.1 12.2 3.6 15.0 5.5 7.9 16.5 15.1 16.3 2.9 1.0 6.0 7.2 2.8 3.3 1.7 4.8 18.1 26.3 9.8 21.3 10.6 9.7 3.3 4.1 4.1 13.5 15.3 4.5 2.2 CCL25 "Ckb15, SCYA25, TECK" ENSG00000131142 "C-C motif chemokine ligand 25" O15444 19 8052318-8062660 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 1031 "intestine: 586.3;lymphoid tissue: 778.4" "Cell type enhanced" "Detected in some" "Intestinal goblet cells: 149.1;Proximal enterocytes: 774.7;Undifferentiated cells: 399.3" "Group enriched" "Detected in many" 4 "liver cancer: 25.4;stomach cancer: 33.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "NK-cell: 3.5" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 2.0;HEL: 2.1;NB-4: 2.6;REH: 6.1;RPMI-8226: 1.8;SH-SY5Y: 1.9" HPA055883 Approved "Secreted to blood" NA NA 183000000 "HPA055883: AB_2682955" "unprognostic (9.22e-3)" "unprognostic (3.13e-4)" "unprognostic (1.12e-1)" "unprognostic (1.29e-1)" "unprognostic (2.87e-1)" "unprognostic (9.30e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (8.85e-3)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-4)" "unprognostic (6.43e-2)" "unprognostic (3.86e-1)" "unprognostic (6.57e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.5 0.0 0.1 0.8 517.0 0.3 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.3 0.0 1.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 586.3 0.0 0.1 0.5 0.5 0.6 0.2 778.4 0.2 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.3 6.1 0.0 1.8 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.5 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.2 0.2 1.6 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 149.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 57.6 0.0 1.5 0.0 774.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 399.3 0.0 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807068 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria NA NA 55000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 434.0 396.7 890.8 234.6 893.8 588.3 441.5 909.0 979.4 343.0 892.1 653.1 591.3 304.4 483.0 602.0 358.9 249.1 1794.0 882.4 916.4 636.5 616.2 321.4 416.2 911.6 901.8 868.4 369.3 494.5 908.6 364.9 258.8 924.5 380.3 714.4 263.4 424.7 315.2 1346.0 536.3 533.9 304.1 891.6 409.2 655.6 192.6 914.9 484.3 364.5 2081.6 543.2 426.6 424.4 923.9 433.7 677.7 460.2 616.8 823.6 761.2 785.7 379.6 771.2 702.3 346.7 1170.2 636.6 698.6 454.2 610.5 389.9 855.1 657.2 765.3 622.2 238.7 678.1 392.9 554.8 1093.8 741.9 362.9 282.0 893.1 1162.8 579.2 786.0 739.1 746.4 563.6 672.3 280.4 602.5 1510.6 730.9 1116.7 623.0 954.1 796.3 816.9 287.5 616.7 1066.7 840.2 543.2 441.1 807.4 513.2 656.2 489.6 753.2 996.6 529.9 355.5 409.5 330.7 419.0 561.4 562.5 1646.3 542.4 702.2 410.6 633.9 1373.2 805.2 700.3 1199.6 868.1 1302.9 930.5 833.2 1480.8 1231.2 1169.3 968.8 513.9 840.6 1089.3 1105.6 1106.1 2815.9 890.8 893.8 909.0 979.4 882.4 916.4 911.6 901.8 868.4 924.5 891.6 914.9 923.9 552.0 275.7 398.1 45.1 925.3 1129.4 1242.3 2031.6 1121.8 280.2 1365.2 1553.2 3479.9 1086.6 942.3 632.7 131.3 1223.1 714.3 1863.5 2752.8 1091.1 539.4 480.5 468.0 629.7 1009.6 524.6 44.0 1316.2 1094.7 591.2 813.0 575.6 521.4 554.3 660.7 1314.7 1602.3 212.0 51.7 1782.5 1125.0 1488.5 1376.5 1155.4 498.9 1010.5 1145.5 35.6 1451.7 562.9 785.8 35.7 65.5 1463.7 1950.7 357.7 726.2 1370.7 3811.3 2936.3 545.4 349.9 355.0 481.8 678.0 358.6 321.7 1721.9 1361.7 1481.9 816.5 1020.3 2147.9 1941.7 EMC8 "C16orf2, C16orf4, COX4NB, FAM158B, NOC4" ENSG00000131148 "ER membrane protein complex subunit 8" O43402 16 85771758-85799608 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 230.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049476 Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum" "Golgi apparatus" "HPA049476: AB_2680784" "unprognostic (2.69e-1)" "unprognostic (2.62e-2)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.49e-4)" "unprognostic (1.30e-1)" "unprognostic (2.41e-1)" "unprognostic (2.67e-3)" "unprognostic (1.03e-1)" "unprognostic (6.91e-3)" "prognostic favorable (6.39e-4)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" 12.8 13.0 13.3 8.4 13.8 17.5 12.8 14.1 13.6 9.6 12.5 12.6 10.7 12.8 7.2 13.2 9.3 6.3 16.8 13.1 13.6 12.4 12.9 9.4 10.2 14.0 13.8 12.5 8.3 11.0 11.1 10.3 9.4 13.6 10.0 8.8 7.1 10.0 8.8 21.0 10.5 10.6 9.4 14.7 11.0 11.8 12.3 13.9 10.4 9.7 12.6 9.6 11.8 9.4 15.5 29.8 34.1 21.3 19.5 22.6 21.6 41.4 28.7 28.4 46.9 20.8 54.7 33.5 25.6 32.5 29.1 21.0 33.3 32.0 30.1 41.5 10.9 45.7 21.1 17.3 50.3 34.2 21.7 13.7 23.8 20.1 35.7 41.5 20.2 27.1 30.9 48.6 9.6 29.2 50.7 34.5 61.4 42.5 27.4 43.3 50.0 17.4 21.8 29.9 20.7 35.9 21.4 52.8 17.1 33.9 18.9 33.9 38.1 23.8 28.1 28.7 24.9 37.1 26.6 27.3 102.8 24.1 41.3 30.2 17.9 18.1 25.6 10.9 19.2 12.7 11.1 11.8 14.8 24.2 15.6 14.7 14.4 7.5 19.2 19.5 17.8 12.3 12.3 13.3 13.8 14.1 13.6 13.1 13.6 14.0 13.8 12.5 13.6 14.7 13.9 15.5 60.1 6.4 8.6 10.4 25.0 61.3 30.1 28.9 25.0 33.7 26.7 26.0 19.9 15.7 18.5 25.8 12.5 48.5 25.0 28.8 60.7 46.9 230.2 37.1 28.3 33.6 46.6 21.5 6.1 42.1 60.7 26.2 18.8 40.9 9.5 25.1 23.6 23.3 47.0 15.2 7.8 27.4 26.4 28.0 38.0 55.0 24.8 27.1 28.4 8.4 41.9 27.8 27.8 8.0 12.2 50.0 27.2 31.6 33.3 51.1 29.1 46.5 12.5 18.6 26.3 22.5 28.9 54.2 56.5 33.5 54.6 51.0 22.4 37.0 35.6 41.9 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 146.0;Syncytiotrophoblasts: 182.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 19.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 174.6;K-562: 205.4;T-47d: 200.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036365, HPA042090" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036365: AB_10601762, HPA042090: " "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favorable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 27.5 15.3 1.3 14.3 2.4 32.2 22.2 19.7 7.9 16.8 0.0 17.9 16.0 15.2 5.1 12.8 16.1 10.7 18.5 3.9 1.9 12.3 14.3 17.8 11.4 3.9 6.3 0.0 23.9 23.6 38.9 28.2 32.0 7.9 12.8 11.6 14.5 30.6 13.7 38.2 18.6 15.0 14.3 0.0 18.6 21.0 14.8 1.7 41.1 19.4 9.4 8.7 13.1 14.2 3.3 19.3 33.6 22.0 55.5 13.9 12.7 174.6 25.3 17.4 13.9 5.2 29.0 25.6 11.2 29.9 28.9 12.5 17.9 35.1 9.7 7.0 21.2 29.7 82.4 33.6 36.5 17.9 38.5 44.8 23.7 22.7 14.9 7.1 14.5 3.7 65.7 205.4 2.0 4.6 129.9 138.1 33.9 38.4 20.7 9.9 89.7 7.4 29.1 12.6 7.2 142.7 99.3 49.8 91.8 4.7 19.9 200.7 94.6 6.4 28.3 35.5 7.9 6.9 30.0 19.5 65.3 16.2 23.8 25.4 2.8 0.7 2.2 1.4 1.3 1.4 1.6 0.5 0.9 1.2 1.5 0.2 1.0 0.6 0.9 3.3 0.0 0.0 0.6 1.3 2.4 19.7 7.9 3.9 1.9 3.9 6.3 0.0 7.9 0.0 1.7 3.3 52.9 67.3 68.1 30.3 16.6 14.0 7.3 11.6 21.1 65.0 39.6 16.8 37.0 25.8 24.1 38.6 146.0 52.9 25.5 33.6 1.9 14.9 4.3 48.8 34.7 27.0 59.7 65.6 53.2 12.4 75.9 21.7 39.3 61.6 43.6 80.9 17.2 34.7 12.3 35.3 45.4 67.5 20.3 15.1 24.0 5.5 47.2 17.5 10.6 19.7 12.2 7.1 35.0 14.1 13.7 17.9 20.9 61.3 18.6 14.3 12.6 6.2 30.5 62.3 6.6 15.5 10.1 2.3 18.3 33.5 30.0 182.2 21.5 55.8 25.7 12.3 AC010531.1 ENSG00000131152 "Novel protein" 16 87302876-87334273 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.7;U-266/70: 3.4" HPA040850 Approved NA NA "HPA040850: AB_10794882" "unprognostic (1.44e-1)" "unprognostic (5.07e-2)" "unprognostic (3.15e-2)" "unprognostic (2.89e-1)" "unprognostic (1.69e-1)" "unprognostic (1.98e-1)" "unprognostic (4.72e-3)" "unprognostic (1.56e-1)" "unprognostic (9.65e-2)" "unprognostic (5.23e-2)" "unprognostic (1.61e-1)" "unprognostic (1.94e-1)" "unprognostic (9.21e-3)" "unprognostic (7.78e-2)" "unprognostic (2.14e-1)" "unprognostic (4.35e-2)" "unprognostic (3.72e-3)" 0.7 0.5 0.5 0.0 0.4 0.3 0.7 2.1 0.9 0.5 0.0 0.6 0.6 0.5 0.0 0.7 0.7 0.2 0.7 1.0 0.3 0.4 1.5 0.3 0.5 0.6 0.3 0.7 0.6 0.9 0.3 1.2 0.3 1.2 0.5 0.0 0.1 0.4 0.1 3.9 0.3 0.5 0.2 0.2 0.2 0.6 0.6 0.5 0.1 0.4 0.3 0.2 0.8 0.7 0.5 0.5 0.2 0.1 0.0 1.9 0.8 0.1 0.1 0.0 0.3 0.1 0.6 0.0 1.6 0.3 1.7 0.0 1.6 0.4 0.0 0.2 0.3 1.3 2.7 0.1 1.8 0.9 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.8 0.4 2.4 0.3 0.0 0.6 0.9 2.0 0.5 0.5 0.3 0.8 0.1 1.7 0.0 0.0 1.3 0.3 0.8 0.2 0.6 0.1 0.2 0.0 0.0 1.1 0.1 0.0 0.3 3.4 1.2 1.2 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.1 0.9 1.0 0.3 0.6 0.3 0.7 1.2 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GINS2 "Pfs2, PSF2" ENSG00000131153 "GINS complex subunit 2" Q9Y248 16 85676198-85690073 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8" "Cell type enhanced" "Detected in many" "Spermatocytes: 163.5;Spermatogonia: 148.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 271.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA057285 Uncertain Approved Nucleoplasm No Yes Nucleoplasm "HPA057285: AB_2683398" "unprognostic (3.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.04e-3)" "unprognostic (2.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.30e-1)" "unprognostic (2.45e-3)" "unprognostic (2.58e-2)" "unprognostic (1.67e-2)" "unprognostic (2.52e-3)" "unprognostic (2.19e-2)" "unprognostic (5.82e-3)" "unprognostic (5.70e-3)" "unprognostic (4.54e-2)" "unprognostic (6.30e-2)" "unprognostic (5.44e-3)" "unprognostic (1.60e-1)" 1.0 0.9 3.1 5.4 2.9 14.8 3.7 3.0 3.7 1.2 2.1 6.5 4.7 1.6 1.3 4.8 1.1 0.4 0.6 4.2 2.5 0.7 3.0 0.9 9.1 2.4 2.6 2.7 1.4 0.9 2.6 0.8 3.0 2.7 1.6 7.1 11.2 1.3 0.8 2.7 3.2 5.4 1.6 2.3 3.0 2.2 9.7 2.3 10.3 1.8 1.0 11.1 1.5 2.1 2.7 50.7 36.2 69.0 28.9 2.0 6.7 18.3 33.8 13.7 49.8 30.5 48.2 32.9 60.0 18.1 12.0 26.0 38.0 73.7 28.1 47.9 20.8 63.9 29.2 25.7 54.6 0.3 20.6 15.6 1.8 3.4 30.0 11.5 6.1 21.6 47.5 82.4 13.8 28.9 107.1 72.7 77.8 38.8 45.0 27.3 100.7 41.5 33.1 16.4 20.9 94.2 30.0 49.4 10.0 10.0 27.3 100.0 28.2 12.8 32.1 42.5 30.6 39.5 25.6 48.3 271.9 18.7 43.4 37.2 0.7 0.2 1.1 1.0 1.0 0.1 1.0 3.3 2.3 1.3 0.7 1.6 1.1 0.9 3.2 2.8 0.8 8.5 1.7 3.1 2.9 3.0 3.7 4.2 2.5 2.4 2.6 2.7 2.7 2.3 2.3 2.7 0.6 3.2 0.0 0.7 8.5 9.2 7.4 9.5 4.0 20.3 13.1 18.5 1.0 0.0 3.8 3.7 2.1 35.3 3.1 11.9 3.9 8.2 9.8 1.5 3.3 2.4 3.0 43.3 0.5 1.5 31.8 7.2 5.6 2.7 1.3 21.6 0.0 2.1 23.8 8.4 0.4 14.9 4.1 1.3 6.6 29.4 1.2 3.3 0.0 0.0 1.1 5.6 0.0 1.0 0.6 2.0 4.5 1.9 43.1 2.6 2.4 0.7 1.7 7.5 19.7 4.2 7.9 163.5 148.4 13.8 3.8 12.7 4.2 2.2 33.6 7.4 CHMP1A "CHMP1, KIAA0047, PCOLN3, PRSM1, Vps46A" ENSG00000131165 "Charged multivesicular body protein 1A" Q9HD42 16 89640816-89657738 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transcription, Transcription regulation, Transport" Repressor Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA006776 Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome, Cytosol" "HPA006776: AB_1078520" "unprognostic (7.12e-2)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" "unprognostic (7.29e-2)" "unprognostic (8.03e-3)" "unprognostic (1.28e-3)" "unprognostic (3.92e-3)" "unprognostic (2.42e-1)" "unprognostic (3.53e-1)" "unprognostic (2.21e-1)" "unprognostic (2.56e-1)" "unprognostic (7.98e-3)" "unprognostic (1.59e-2)" "unprognostic (4.19e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-1)" 29.5 31.5 42.6 21.3 41.0 31.7 29.6 37.7 53.9 32.6 33.2 39.4 38.2 36.1 17.1 65.9 31.8 25.1 30.7 43.1 38.4 36.9 30.8 28.9 27.7 41.9 40.3 41.2 25.3 25.9 30.6 25.0 24.9 39.1 33.8 23.2 5.4 32.1 22.3 50.4 47.9 42.8 22.6 40.2 31.8 34.3 37.5 40.8 30.8 28.5 26.2 24.5 35.9 37.2 40.5 70.5 66.3 29.5 46.2 42.2 38.2 75.3 53.0 54.3 79.3 38.7 97.1 111.5 37.7 53.2 70.1 52.9 88.3 52.6 69.7 36.7 34.2 82.7 31.0 23.4 108.5 57.8 23.0 31.7 54.7 75.6 74.6 33.8 42.7 41.2 46.2 69.9 18.2 45.6 141.4 55.1 88.3 58.1 78.6 63.5 60.1 58.3 39.8 60.4 43.0 52.7 70.8 103.5 34.3 38.1 27.5 117.6 48.5 63.1 52.7 61.6 65.3 45.8 52.1 59.1 51.1 88.1 54.9 62.5 66.7 51.6 108.9 54.4 62.7 42.0 36.3 43.6 50.1 44.2 33.4 27.5 33.4 86.0 49.8 82.3 49.4 58.5 64.1 42.6 41.0 37.7 53.9 43.1 38.4 41.9 40.3 41.2 39.1 40.2 40.8 40.5 31.1 32.1 23.6 17.3 27.5 23.8 24.5 28.8 13.1 24.6 33.9 27.6 16.8 28.6 26.6 31.3 8.4 57.7 43.2 147.3 37.2 55.3 56.4 27.2 26.3 28.3 44.3 16.2 8.8 59.5 74.4 26.9 36.2 35.0 27.9 33.0 23.2 31.1 47.6 43.7 7.9 57.7 30.5 30.4 23.8 125.5 20.5 28.3 23.2 11.2 62.8 36.3 43.3 11.1 9.5 84.7 121.6 24.0 14.8 31.7 109.6 40.9 22.4 20.5 26.3 17.1 27.1 45.4 33.3 26.3 32.5 66.2 28.6 28.8 58.2 36.5 SH3BGRL MGC117402 ENSG00000131171 "SH3 domain binding glutamate rich protein like" O75368 X 81202102-81298547 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051248 Approved Approved Vesicles NA NA 13000000 Vesicles "HPA051248: AB_2681405" "unprognostic (3.02e-3)" "unprognostic (4.25e-2)" "unprognostic (4.89e-2)" "unprognostic (3.15e-2)" "unprognostic (1.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.75e-1)" "unprognostic (1.73e-1)" 113.1 121.2 102.4 102.0 104.2 178.2 172.5 108.6 127.4 147.5 108.7 141.9 88.4 210.5 150.1 131.6 113.3 150.4 61.7 97.9 119.1 127.2 63.1 134.1 156.2 114.8 106.2 91.4 131.9 82.0 113.3 84.1 87.1 114.8 154.4 109.6 25.1 113.5 287.6 16.6 67.6 99.0 233.6 117.3 145.7 87.7 54.8 107.4 146.5 105.6 50.6 127.9 180.0 76.6 123.4 1.0 38.2 133.4 154.1 172.1 232.0 9.2 83.4 158.3 30.1 61.1 12.5 114.6 113.7 70.1 122.9 42.4 20.7 95.9 60.0 48.0 98.7 33.3 151.2 59.7 7.4 41.6 107.3 286.0 135.6 42.9 42.4 37.6 231.4 133.8 75.9 53.0 279.6 165.9 53.9 117.0 138.7 105.2 1.4 62.3 102.0 60.9 60.8 155.7 52.8 0.4 58.5 0.1 4.2 77.9 88.0 44.8 321.2 136.9 82.7 34.1 76.4 35.0 64.3 60.6 105.6 95.1 215.9 62.9 793.9 358.5 570.7 124.9 477.3 134.8 236.3 154.7 147.8 306.2 207.4 140.8 148.8 126.7 183.0 560.5 148.0 257.5 462.3 102.4 104.2 108.6 127.4 97.9 119.1 114.8 106.2 91.4 114.8 117.3 107.4 123.4 191.3 112.2 92.6 73.8 216.1 126.3 131.5 150.4 83.1 16.2 174.6 150.2 19.7 72.9 106.4 121.4 0.0 7.1 183.9 33.2 344.4 86.9 6.3 74.9 120.0 130.7 93.3 172.9 62.8 74.7 6.0 152.4 63.2 62.6 219.7 92.8 139.9 17.8 431.4 5.0 82.4 87.0 109.9 400.9 430.7 19.2 174.3 379.0 147.7 102.1 459.0 154.2 224.6 82.9 54.3 48.0 104.2 314.1 114.4 83.5 91.2 214.3 113.6 8.5 263.0 132.4 308.8 4.5 5.9 76.0 119.5 5.7 163.4 205.9 90.3 146.4 COX7B ENSG00000131174 "Cytochrome c oxidase subunit 7B" P24311 X 77899440-77907376 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1133.5;tongue: 763.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2237.0;Distal tubular cells: 2283.3;Proximal tubular cells: 1865.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058041 Uncertain NA NA "HPA058041: AB_2683587" "unprognostic (1.24e-2)" "unprognostic (1.76e-3)" "unprognostic (8.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (2.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.26e-1)" "unprognostic (8.10e-2)" "prognostic favorable (6.80e-6)" "unprognostic (8.58e-2)" "unprognostic (4.62e-1)" "unprognostic (6.38e-2)" "prognostic favorable (2.43e-4)" 100.0 95.7 201.6 75.2 202.9 207.4 82.3 218.3 379.8 46.6 224.7 178.1 184.1 50.7 95.3 72.7 55.8 42.4 329.9 203.6 212.6 224.6 183.0 46.1 64.9 204.3 204.7 196.8 39.1 49.5 304.0 21.4 54.1 206.5 62.1 160.0 185.7 94.3 66.5 1133.5 43.1 158.0 75.4 203.2 51.7 126.2 19.2 212.1 97.4 54.8 763.4 77.0 88.6 19.7 216.8 242.8 239.4 257.8 214.6 111.8 90.1 179.5 159.7 78.8 101.8 113.1 259.6 213.0 158.6 271.8 96.1 333.1 302.5 298.7 183.6 112.7 138.9 372.7 218.5 441.3 343.5 104.2 441.1 185.5 133.0 137.0 154.2 129.9 173.0 113.0 186.1 186.3 409.8 118.6 282.6 350.6 445.5 253.4 972.4 614.5 250.5 297.0 594.4 344.6 420.8 177.3 158.1 305.8 396.8 334.2 209.0 148.7 295.0 149.7 91.1 222.0 232.6 167.7 157.9 407.0 364.8 212.2 504.2 130.5 212.5 226.7 168.6 152.7 326.5 165.2 213.6 166.5 174.8 303.7 146.3 155.7 185.6 142.8 205.9 316.1 213.2 238.6 261.1 201.6 202.9 218.3 379.8 203.6 212.6 204.3 204.7 196.8 206.5 203.2 212.1 216.8 238.9 134.6 178.0 28.1 247.7 297.5 297.2 1151.7 225.9 111.4 204.5 244.9 2237.0 487.6 463.6 369.6 35.5 412.9 272.2 1219.8 2283.3 504.6 20.8 424.0 243.9 210.0 516.0 428.5 11.2 395.7 424.2 227.2 382.8 356.4 226.3 134.7 194.5 1179.5 718.3 47.1 14.8 922.1 734.5 438.9 432.1 43.1 199.4 368.3 538.9 10.3 488.1 214.0 258.5 12.5 19.5 425.5 1090.3 176.4 297.3 307.7 1516.9 1865.2 314.0 174.3 210.4 274.2 315.4 81.4 108.8 583.4 345.5 591.7 258.4 166.9 978.4 472.5 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "kidney: 156.8" "Cell type enriched" "Detected in some" 14 "Proximal tubular cells: 143.2" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "HEL: 2.4;U-937: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.3 0.0 0.0 0.2 0.0 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.1 F12 ENSG00000131187 "Coagulation factor XII" P00748 5 177402141-177409564 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 226 "liver: 609.5" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 523.0" "Cancer enriched" "Detected in many" 21 "liver cancer: 171.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;eosinophil: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 3.6;monocytes: 1.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA003825 Approved "Secreted to blood" NA NA 1040000 7000000000 "HPA003825: AB_1078790" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (2.93e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "prognostic favorable (4.63e-5)" "unprognostic (6.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (4.41e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (4.11e-2)" "unprognostic (3.69e-1)" "unprognostic (3.40e-6)" "unprognostic (6.48e-2)" 0.2 0.1 1.0 0.1 1.1 2.6 0.3 0.1 1.3 0.2 0.0 0.4 0.5 0.2 0.0 1.9 0.3 0.1 0.2 1.5 0.8 0.8 609.5 0.6 0.0 0.7 0.5 1.1 0.0 0.6 0.1 0.6 0.1 0.9 0.3 0.1 0.0 0.4 0.0 0.0 0.9 0.5 0.0 0.3 1.0 0.1 1.2 0.6 0.0 0.2 0.0 0.1 0.2 0.8 0.8 0.7 1.6 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.3 0.0 0.2 1.1 0.5 0.3 0.0 7.1 1.4 1.1 0.3 0.7 0.2 0.6 2.4 0.2 1.0 0.0 0.3 0.1 0.2 1.6 0.3 2.5 0.0 9.0 0.1 2.1 0.0 2.1 6.4 0.5 0.2 1.5 0.9 0.0 2.0 4.3 0.2 0.7 0.6 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.2 0.4 0.0 0.0 0.0 4.6 0.5 0.0 1.2 3.6 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.5 0.5 0.0 0.5 1.0 1.1 0.1 1.3 1.5 0.8 0.7 0.5 1.1 0.9 0.3 0.6 0.8 0.5 0.0 0.0 0.3 5.3 33.1 7.7 15.3 35.9 0.6 12.7 17.5 1.0 17.2 3.9 1.8 4.2 0.0 4.0 27.6 0.0 6.5 23.3 2.2 0.9 2.2 10.3 19.6 2.6 4.2 0.4 1.1 3.6 1.7 0.0 0.2 16.8 523.0 0.5 0.0 0.8 12.3 8.2 16.7 6.1 42.1 0.6 1.0 8.8 0.0 1.2 0.7 2.1 1.5 0.6 11.1 22.0 0.0 8.5 7.2 60.7 16.1 3.6 0.9 0.0 0.5 1.1 12.0 23.6 57.5 54.3 0.1 4.0 0.1 34.8 7.6 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 24.7;SK-MEL-30: 26.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046636 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: AB_2679730" "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.1 4.0 10.3 0.8 8.9 5.8 1.6 0.9 19.0 1.7 4.4 1.1 0.7 2.5 0.0 3.7 4.9 0.1 1.3 17.7 3.8 2.3 2.3 2.0 1.0 3.5 1.3 8.1 0.8 2.9 0.4 10.5 0.1 5.3 1.8 0.1 0.3 2.7 0.2 1.2 5.5 1.9 0.1 0.5 3.1 1.4 4.5 3.9 0.5 1.2 0.0 0.5 1.0 2.0 2.8 10.7 4.1 1.1 8.1 0.0 0.6 3.5 4.9 0.9 1.3 1.8 0.9 5.6 10.2 12.6 0.7 4.1 8.8 0.7 4.5 0.5 9.0 12.8 3.1 4.3 3.1 0.9 6.2 7.2 0.9 1.8 0.6 0.3 1.2 0.6 3.9 1.6 7.1 1.3 14.3 5.2 15.8 1.9 1.6 24.7 14.5 3.6 10.5 1.7 0.8 19.8 14.1 1.9 4.8 26.2 0.0 4.3 1.0 3.8 8.0 13.5 7.1 12.0 3.9 2.3 5.1 7.7 9.8 5.9 1.9 0.1 9.7 2.3 0.4 5.5 1.5 2.5 3.9 0.1 2.8 2.4 3.1 3.7 1.7 0.5 2.4 2.0 1.2 10.3 8.9 0.9 19.0 17.7 3.8 3.5 1.3 8.1 5.3 0.5 3.9 2.8 11.8 3.2 0.0 4.9 27.9 43.3 28.0 6.8 46.7 13.6 17.2 20.3 1.6 17.2 3.7 7.3 0.0 0.8 55.9 7.4 9.8 10.6 10.6 50.2 12.3 9.2 43.0 3.4 8.6 10.8 0.9 4.8 14.3 22.3 26.7 1.0 4.6 3.1 1.5 6.7 7.0 12.3 16.2 1.9 36.5 13.8 0.9 16.7 28.4 1.0 2.3 19.7 22.6 4.0 5.7 8.6 9.8 2.2 27.3 26.7 11.6 14.2 7.0 16.6 0.0 7.8 8.1 3.3 10.7 33.2 66.9 1.4 37.0 1.5 12.3 17.3 NFATC1 "NF-ATC, NFAT2, NFATc" ENSG00000131196 "Nuclear factor of activated T cells 1" O95644 18 79395856-79529325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 50.4;Skeletal myocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004513, HPA071732" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB004513: AB_628011, HPA071732: AB_2686439" "unprognostic (3.53e-2)" "unprognostic (2.16e-3)" "unprognostic (3.08e-3)" "unprognostic (3.40e-2)" "unprognostic (4.54e-2)" "unprognostic (2.79e-2)" "unprognostic (1.92e-1)" "unprognostic (4.85e-3)" "unprognostic (7.02e-2)" "unprognostic (8.37e-2)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (5.87e-2)" "unprognostic (1.38e-1)" "unprognostic (4.54e-2)" "unprognostic (5.04e-2)" "unprognostic (3.11e-3)" 12.0 4.7 7.0 11.8 5.1 3.9 10.7 5.9 4.3 6.0 23.8 8.1 3.1 7.8 0.9 3.0 8.1 10.1 14.0 4.0 8.1 4.8 2.7 13.7 21.4 8.3 5.1 2.1 7.2 7.1 4.1 3.5 4.1 6.0 6.4 1.5 0.5 6.4 2.9 33.0 10.5 13.3 3.3 7.8 18.8 5.5 8.6 7.1 8.4 7.7 9.4 13.6 7.1 6.1 11.1 0.0 4.0 1.9 3.6 3.3 3.6 6.9 2.4 0.3 0.6 0.3 0.3 3.6 22.0 1.5 3.2 5.6 0.4 9.9 0.0 0.8 15.3 8.0 15.4 0.9 0.1 7.3 4.9 8.2 4.3 0.0 1.2 0.1 0.0 12.2 9.0 12.5 4.5 2.4 8.4 12.8 1.7 3.5 2.9 2.6 4.0 2.5 5.0 1.8 1.6 0.0 0.0 3.2 2.6 5.6 4.2 3.2 19.7 11.4 5.0 20.9 0.0 0.3 0.1 0.1 60.2 0.0 6.6 9.3 1.8 3.4 7.5 4.0 9.1 4.2 7.6 6.2 5.5 3.1 10.0 5.2 3.7 2.9 2.1 13.6 3.0 5.0 4.7 7.0 5.1 5.9 4.3 4.0 8.1 8.3 5.1 2.1 6.0 7.8 7.1 11.1 19.4 0.0 6.0 13.4 50.4 37.2 30.0 7.0 6.2 0.1 19.2 13.5 8.4 5.7 8.1 0.0 0.0 0.3 11.8 0.1 0.0 5.7 12.1 10.6 5.4 25.2 0.0 5.9 0.2 4.0 7.2 24.3 8.6 16.1 31.8 1.2 39.3 0.6 12.3 0.0 0.2 0.0 2.0 12.6 35.4 20.3 8.4 21.9 10.6 9.4 6.9 2.5 13.4 4.0 1.3 4.9 0.0 9.8 8.9 12.0 0.0 0.5 4.4 0.1 0.0 52.1 14.2 11.4 13.2 1.5 29.7 0.5 29.4 2.1 0.1 7.7 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928790 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 59.2;placenta: 111.8" "Cell type enriched" "Detected in many" 11 "monocytes: 2612.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 14 "eosinophil: 465.0" "Lineage enriched" "Detected in many" 18 "granulocytes: 465.0" "Cell line enriched" "Detected in some" 7 "EFO-21: 61.8" "Region enriched" "Detected in many" 12 "basal ganglia: 34.1" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 5.0 0.7 0.5 40.9 0.4 0.7 2.0 0.4 0.8 7.3 0.9 5.3 10.4 10.3 1.2 1.4 2.7 6.2 1.1 0.3 0.6 1.7 2.4 26.1 59.2 0.6 0.4 0.3 1.2 1.2 0.2 0.1 111.8 0.5 2.1 8.3 1.3 1.9 3.0 8.2 1.3 8.5 2.5 0.4 23.2 5.9 1.1 0.6 31.5 4.0 0.6 31.8 9.2 0.5 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 7.6 4.8 0.3 0.8 0.0 61.8 0.0 3.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.1 8.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 9.1 0.2 0.2 0.0 0.3 0.0 32.5 1.3 465.0 0.1 1.4 0.1 0.2 0.1 0.0 26.4 0.3 0.1 0.2 4.9 0.1 0.1 0.3 0.1 1.2 0.5 0.4 0.4 0.8 0.3 0.6 0.6 0.4 0.3 0.5 0.4 0.6 0.6 24.9 0.0 0.5 0.7 4.4 0.4 0.2 18.3 0.0 0.0 0.5 0.1 0.3 0.0 76.0 0.0 0.0 0.0 0.3 8.3 0.0 4.4 3.7 70.1 23.0 6.9 0.0 0.0 0.2 8.1 0.0 0.3 0.0 223.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 2.0 3.7 28.1 1.8 0.0 13.6 0.0 0.0 2612.3 3.0 0.0 0.0 0.1 0.4 0.0 0.4 2.4 0.5 0.0 0.0 33.3 0.2 0.0 1.2 8.4 0.0 0.1 0.1 0.6 0.0 1.3 0.0 1.3 2.0 GJA9 "CX58, CX59, GJA10" ENSG00000131233 "Gap junction protein alpha 9" P57773 1 38874069-38881587 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "GAMG: 1.0" "Low region specificity" "Detected in all" HPA067850 Uncertain NA NA "HPA067850: AB_2685910" "unprognostic (2.00e-1)" "unprognostic (8.78e-2)" "unprognostic (4.55e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-2)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-2)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (4.11e-3)" "unprognostic (2.32e-2)" 0.1 0.1 0.4 0.0 0.4 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.0 0.0 0.1 1.3 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.7 0.2 0.2 0.4 0.2 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.2 0.8 0.5 0.0 0.2 0.0 0.0 0.2 0.3 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.1 0.5 0.2 0.1 1.3 0.3 0.1 0.7 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CAP1 CAP ENSG00000131236 "Cyclase associated actin cytoskeleton regulatory protein 1" Q01518 1 40040233-40072649 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 832.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 1954.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030124 Approved Approved Cytosol NA NA 73000000 Cytosol "HPA030124: AB_10600799" "unprognostic (1.80e-3)" "unprognostic (1.23e-3)" "unprognostic (5.68e-2)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.44e-6)" "unprognostic (5.37e-2)" "unprognostic (4.87e-1)" "unprognostic (1.98e-1)" "unprognostic (3.33e-3)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (1.39e-1)" "unprognostic (7.08e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" 176.7 97.7 81.2 277.5 92.2 317.8 138.7 89.4 96.1 120.3 87.2 225.8 145.0 208.9 101.2 198.0 135.4 136.5 77.4 83.5 98.1 131.9 125.4 183.3 268.9 100.5 89.5 81.2 88.4 68.4 116.0 63.3 185.7 96.2 105.9 212.4 64.0 118.4 141.5 48.5 116.8 166.4 238.7 100.7 207.9 149.1 75.7 89.8 188.5 107.7 56.5 329.0 233.4 131.5 101.8 435.9 185.1 216.4 134.8 310.6 290.5 338.9 749.8 437.7 398.9 399.9 272.5 440.1 339.5 295.7 598.7 275.7 267.1 265.8 535.7 548.1 461.6 164.9 520.2 188.7 216.8 286.4 326.9 1417.9 297.5 280.6 612.5 345.4 456.5 346.4 185.7 201.6 215.0 621.7 129.2 265.4 194.9 367.7 312.1 207.9 197.0 297.6 198.6 451.3 452.0 107.5 222.9 308.7 366.4 523.8 443.1 170.0 1954.7 628.9 347.3 317.9 188.0 641.4 178.9 381.8 301.0 451.5 353.8 466.9 1371.5 776.8 2592.7 665.8 1097.6 526.2 328.0 473.4 643.9 868.3 325.6 397.1 537.9 1560.4 479.8 1402.6 333.8 701.5 1838.4 81.2 92.2 89.4 96.1 83.5 98.1 100.5 89.5 81.2 96.2 100.7 89.8 101.8 132.5 121.8 90.9 17.6 179.0 112.3 149.0 236.2 48.9 40.8 81.8 89.9 15.7 80.1 161.8 114.0 27.1 212.9 206.9 372.1 111.6 364.1 411.3 94.5 109.8 163.2 76.1 73.4 22.3 272.3 439.6 107.9 74.5 182.9 229.1 70.9 167.0 77.0 426.0 42.1 16.7 180.2 142.4 411.6 333.3 480.3 88.0 390.8 99.6 25.3 606.5 160.9 315.1 13.0 30.4 832.7 202.0 176.8 117.1 130.7 159.7 142.1 105.6 49.5 164.3 68.9 207.1 118.0 67.9 97.2 132.8 237.8 238.0 74.8 151.5 221.4 PPT1 "CLN1, INCL, PPT" ENSG00000131238 "Palmitoyl-protein thioesterase 1" P50897 1 40072710-40097260 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7" "Group enriched" "Detected in all" 4 "dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 1082.7;THP-1: 1449.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021546 Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 240000 "Golgi apparatus, Vesicles" "HPA021546: AB_1855667" "unprognostic (5.02e-2)" "unprognostic (2.73e-1)" "unprognostic (1.64e-1)" "unprognostic (2.06e-3)" "unprognostic (6.68e-2)" "unprognostic (2.83e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.16e-2)" "unprognostic (2.39e-1)" "unprognostic (5.20e-3)" "unprognostic (1.75e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (2.08e-2)" 70.5 60.0 96.6 93.6 99.5 118.5 96.7 104.2 137.0 70.7 106.9 50.9 32.4 73.4 60.6 45.5 55.9 57.6 45.7 95.1 108.0 76.5 54.5 129.7 94.7 100.5 99.9 93.6 69.2 42.9 79.9 39.3 75.4 102.6 74.1 59.4 90.2 57.3 63.8 21.5 40.6 39.6 96.2 108.8 178.6 45.5 37.9 101.1 78.8 60.5 37.4 75.7 79.9 35.0 109.8 115.6 62.5 93.7 81.0 106.5 92.1 209.8 68.4 127.9 153.0 183.3 350.1 270.5 140.1 118.1 65.2 112.2 209.5 154.9 112.7 163.6 186.4 151.4 100.3 127.2 155.5 137.5 233.7 158.9 103.1 107.5 108.7 126.4 79.7 190.9 108.8 167.7 247.0 80.6 168.1 109.8 88.3 258.3 163.9 93.8 116.0 263.7 226.1 89.2 152.0 114.1 96.9 247.9 1082.7 298.6 111.7 199.3 1449.6 85.2 100.7 147.1 70.7 174.9 161.2 383.8 133.9 109.4 408.7 155.5 85.7 1254.3 624.2 122.2 1006.3 137.9 118.8 171.5 131.3 1091.1 118.6 227.0 168.3 683.9 100.3 815.7 101.8 204.1 1586.9 96.6 99.5 104.2 137.0 95.1 108.0 100.5 99.9 93.6 102.6 108.8 101.1 109.8 45.2 28.9 47.7 19.9 33.3 39.6 77.1 30.8 34.7 46.6 55.3 37.5 15.7 41.5 40.0 38.6 16.7 51.7 28.9 4.7 5.9 59.0 64.8 13.8 46.4 49.6 19.9 40.1 28.4 42.1 66.5 56.6 14.8 18.2 84.9 34.6 47.5 9.3 251.9 25.2 39.2 8.1 20.3 315.8 328.8 87.6 31.4 271.3 67.6 31.9 227.2 120.3 28.8 27.6 22.7 22.2 6.0 39.5 34.2 42.4 3.2 18.5 32.3 37.0 19.7 30.5 49.3 17.5 33.0 19.1 27.3 41.2 43.5 39.4 11.4 35.6 RAB11FIP4 "FLJ00131, KIAA1821, MGC11316, RAB11-FIP4" ENSG00000131242 "RAB11 family interacting protein 4" Q86YS3 17 31391675-31538211 "Predicted intracellular proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 80.6;testis: 49.2" "Cell type enhanced" "Detected in many" "Early spermatids: 334.6;Horizontal cells: 212.0;Late spermatids: 1251.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 78.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.7" "Cell line enhanced" "Detected in many" "BEWO: 64.3;Daudi: 36.8;Hep G2: 40.6;HMC-1: 41.5;RT4: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063203 Approved NA NA "HPA063203: AB_2684962" "unprognostic (2.11e-1)" "unprognostic (1.48e-1)" "prognostic favorable (2.70e-4)" "unprognostic (6.03e-3)" "unprognostic (4.29e-2)" "unprognostic (4.15e-2)" "unprognostic (1.11e-1)" "unprognostic (1.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.20e-1)" "unprognostic (1.16e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.74e-8)" "prognostic favorable (1.22e-4)" "unprognostic (3.00e-1)" "unprognostic (2.00e-2)" "unprognostic (4.13e-3)" 0.8 1.1 80.6 8.2 70.5 15.2 4.1 51.3 74.8 2.7 24.4 9.4 13.0 1.3 11.3 6.7 7.6 3.3 2.7 69.1 50.3 6.9 2.9 5.8 11.9 59.2 69.4 51.3 2.4 17.8 6.1 3.6 10.6 70.0 2.5 7.4 7.8 7.5 3.8 0.5 8.1 14.8 0.9 56.5 7.4 13.5 49.2 69.7 4.7 4.6 0.4 10.8 5.2 2.1 78.5 12.4 1.4 1.3 3.2 0.5 0.0 64.3 0.2 0.0 0.8 0.8 20.7 1.9 36.8 4.6 0.2 13.3 10.3 12.2 5.9 0.5 7.5 11.0 0.0 0.5 40.6 0.3 2.7 41.5 0.3 5.9 0.8 2.6 0.4 0.0 10.9 2.7 0.9 0.0 9.8 2.7 0.7 10.5 22.9 0.4 1.0 0.1 7.1 2.3 37.8 19.1 13.9 2.8 17.4 14.6 8.7 25.7 1.2 0.0 0.7 6.3 0.1 0.6 6.6 5.6 3.4 0.2 3.7 2.5 5.5 8.4 78.7 13.9 11.9 8.7 5.8 7.2 10.3 5.4 8.6 7.6 9.1 40.5 6.4 15.8 1.1 9.6 8.7 80.6 70.5 51.3 74.8 69.1 50.3 59.2 69.4 51.3 70.0 56.5 69.7 78.5 0.6 6.4 8.3 15.7 12.1 3.1 11.4 5.7 1.8 9.6 9.1 5.2 7.3 15.7 9.6 11.0 10.4 73.1 19.8 32.6 13.7 17.5 334.6 39.0 3.9 1.5 14.9 2.7 68.6 28.2 10.9 2.3 17.3 48.8 12.0 7.3 1.1 4.4 6.0 212.0 71.0 16.0 12.2 1.9 5.7 1251.4 5.3 6.3 10.6 1.9 11.1 53.7 26.8 13.6 72.3 24.8 20.2 4.9 7.0 11.1 25.9 12.4 18.1 7.4 0.0 3.1 2.7 8.3 9.7 4.4 3.0 50.3 15.2 0.2 21.1 15.4 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74582976-74614624 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.20e-1)" 10.6 11.9 9.6 10.5 12.1 41.6 10.6 6.1 9.7 10.1 9.7 6.3 6.0 9.5 5.7 8.8 8.4 9.7 8.9 10.4 13.5 10.1 8.4 12.2 9.0 8.1 8.7 8.8 10.7 7.6 11.8 10.4 9.9 9.8 9.9 6.6 10.8 7.5 7.2 9.7 9.0 6.1 9.3 6.6 9.4 7.5 6.6 10.8 11.1 11.8 8.7 9.5 8.5 8.0 13.2 23.7 24.2 22.8 18.7 20.1 22.5 22.4 22.4 26.0 19.9 24.4 18.9 24.4 12.8 25.4 28.6 26.7 19.9 45.9 26.7 30.1 11.7 23.9 22.7 43.2 10.7 17.4 34.6 38.6 21.7 14.4 28.2 46.5 15.6 23.3 20.9 19.9 22.9 24.6 18.1 26.0 16.8 35.0 12.9 22.5 24.3 48.0 21.5 16.1 28.6 16.4 19.5 42.3 19.0 24.5 20.4 11.2 24.9 31.0 23.4 23.1 24.8 19.6 12.0 24.6 20.3 25.5 33.1 23.2 22.8 6.0 5.9 3.1 7.5 3.1 3.0 3.9 3.8 4.9 3.3 4.2 3.8 11.5 5.3 5.6 2.6 4.8 3.2 9.6 12.1 6.1 9.7 10.4 13.5 8.1 8.7 8.8 9.8 6.6 10.8 13.2 44.8 16.0 17.0 13.4 22.4 35.8 29.6 16.1 23.3 13.8 18.3 13.5 30.5 18.6 20.4 25.8 14.6 16.3 27.6 10.3 11.7 13.7 7.9 32.3 35.3 30.1 23.2 12.8 19.2 10.7 21.5 27.7 27.0 41.0 38.0 24.6 21.0 14.8 18.2 21.9 18.9 10.6 10.2 20.7 34.1 4.4 9.9 29.1 17.8 15.9 12.7 13.2 12.3 11.1 16.4 14.8 8.5 18.8 16.3 25.5 6.8 12.0 25.2 14.6 6.6 31.1 24.1 9.7 18.2 21.6 38.8 26.3 22.0 19.0 11.4 37.2 CDX4 ENSG00000131264 "Caudal type homeobox 4" O14627 X 73447254-73455245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "skin 1: 1.1" "Cell type enhanced" "Detected in some" "Spermatogonia: 1.2;Suprabasal keratinocytes: 1.1" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043714, HPA056528" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA043714: , HPA056528: AB_2683166" "unprognostic (1.97e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 ABCB7 "ABC7, ASAT, Atm1p, EST140535" ENSG00000131269 "ATP binding cassette subfamily B member 7" O75027 X 75051048-75156732 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034982 Approved Approved Mitochondria NA NA Mitochondria "HPA034982: AB_10601010" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.83e-3)" "unprognostic (4.44e-3)" "unprognostic (1.33e-2)" "unprognostic (6.31e-2)" "unprognostic (4.39e-2)" "unprognostic (1.47e-1)" "unprognostic (2.17e-1)" "unprognostic (4.14e-2)" "unprognostic (2.55e-2)" "prognostic favorable (5.31e-6)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" 12.2 13.6 5.6 7.8 6.2 11.2 11.9 8.5 7.7 11.2 9.5 13.4 16.2 11.0 5.0 11.7 11.3 7.5 19.2 5.7 8.7 10.1 14.9 9.9 12.1 6.6 6.1 5.0 12.4 9.7 11.1 8.7 7.5 6.5 8.5 9.7 9.9 10.1 7.0 31.7 12.9 11.9 8.8 6.2 10.9 12.4 4.1 6.0 14.1 9.6 22.4 11.2 10.6 11.0 7.0 17.0 16.2 12.2 20.9 14.1 25.5 7.0 8.9 14.6 12.3 22.4 18.5 24.5 25.8 22.8 9.2 21.2 18.8 25.6 18.5 12.0 26.0 33.2 16.8 29.2 17.3 8.2 24.7 13.7 15.9 16.3 12.8 16.7 21.3 23.1 26.2 18.9 31.1 9.8 10.5 24.4 26.1 26.8 26.3 30.5 21.4 26.9 30.5 12.7 13.2 17.7 14.1 27.4 23.5 17.8 20.0 10.2 22.9 10.3 11.3 22.9 23.2 12.4 10.1 27.5 21.2 10.1 35.8 9.4 9.6 26.9 10.0 15.7 25.6 16.6 24.7 16.7 16.7 29.0 28.2 28.7 21.1 2.4 17.5 20.4 18.2 27.2 19.2 5.6 6.2 8.5 7.7 5.7 8.7 6.6 6.1 5.0 6.5 6.2 6.0 7.0 12.0 9.6 10.4 48.0 26.6 15.8 14.5 16.0 19.9 10.9 10.9 9.9 46.8 14.3 14.2 11.0 6.2 23.0 19.0 8.2 11.7 17.5 0.4 8.4 12.8 11.9 13.8 26.9 37.9 13.5 11.6 13.9 9.7 10.1 22.2 20.6 9.3 11.8 20.1 25.2 39.0 10.5 8.2 26.1 16.7 0.8 14.6 19.2 10.6 45.0 22.9 12.4 6.2 43.7 46.6 11.6 7.9 13.2 14.3 10.6 15.9 19.9 10.7 7.9 32.9 19.6 13.8 5.5 10.9 16.1 16.1 22.3 14.5 19.2 17.9 11.9 TRAF3 "CAP-1, CD40bp, CRAF1, LAP1, RNF118" ENSG00000131323 "TNF receptor associated factor 3" Q13114 14 102777449-102911500 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Immunity, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002933 Uncertain NA NA "HPA002933: AB_1080352" "unprognostic (4.06e-2)" "unprognostic (1.75e-2)" "unprognostic (2.08e-2)" "unprognostic (4.49e-3)" "unprognostic (5.25e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (1.31e-1)" "unprognostic (7.24e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.71e-1)" "unprognostic (3.13e-2)" "unprognostic (2.12e-1)" 6.6 4.3 8.8 18.9 8.6 20.7 4.8 6.1 14.6 3.8 7.8 8.0 7.8 5.8 2.3 6.7 6.8 6.2 6.3 14.3 10.1 5.4 6.5 7.4 21.1 9.9 9.2 6.2 3.3 4.5 7.3 8.4 4.0 10.4 5.1 6.4 4.5 4.8 5.8 5.7 6.8 10.7 6.5 8.2 12.1 6.7 10.7 11.5 9.5 6.2 3.3 16.0 8.8 4.8 13.3 25.3 26.4 14.8 9.7 7.5 11.4 23.4 19.1 19.0 19.1 16.7 13.3 36.7 18.6 22.5 19.2 25.8 14.9 20.4 20.4 19.1 50.2 13.9 18.2 11.7 10.3 12.0 21.4 54.5 11.4 13.9 13.1 18.3 10.9 13.9 27.8 18.2 57.4 11.8 23.6 46.2 12.6 8.0 10.7 19.2 25.5 19.8 11.7 16.8 29.3 38.3 13.8 19.8 14.1 13.0 6.6 13.1 24.2 29.9 18.0 14.8 48.0 27.8 42.2 51.7 36.0 20.5 10.8 21.8 3.3 5.1 1.8 2.9 4.0 2.4 10.0 4.2 2.6 3.6 9.5 3.0 2.1 3.8 2.4 2.5 5.9 3.8 5.0 8.8 8.6 6.1 14.6 14.3 10.1 9.9 9.2 6.2 10.4 8.2 11.5 13.3 4.2 6.4 8.9 54.5 43.3 12.2 20.4 20.0 18.2 42.6 9.1 6.9 8.0 10.0 13.8 0.0 6.2 5.3 12.8 14.9 3.9 15.8 9.7 20.2 13.5 8.6 17.4 2.1 108.3 17.8 11.7 11.2 8.6 12.2 8.2 3.5 1.4 5.3 12.9 15.2 63.1 15.8 10.2 8.7 29.5 7.6 1.8 20.3 17.8 23.4 18.1 5.4 8.2 63.8 43.6 22.6 5.9 6.4 42.1 28.8 16.9 8.3 19.2 11.0 0.0 12.2 8.4 14.2 33.2 12.7 12.6 3.4 21.9 1.5 11.3 24.9 HAUS8 "HICE1, MGC20533, NY-SAR-48" ENSG00000131351 "HAUS augmin like complex subunit 8" Q9BT25 19 17049729-17075625 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 40.4;Spermatogonia: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039406 Uncertain NA NA "HPA039406: AB_10794090" "unprognostic (1.14e-1)" "prognostic favorable (9.54e-4)" "unprognostic (8.73e-2)" "unprognostic (5.74e-2)" "unprognostic (1.65e-1)" "unprognostic (1.90e-2)" "unprognostic (1.74e-3)" "unprognostic (1.19e-1)" "unprognostic (1.04e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-2)" "unprognostic (1.34e-2)" "unprognostic (8.35e-13)" "unprognostic (7.46e-3)" "unprognostic (1.28e-1)" "unprognostic (2.75e-3)" "unprognostic (2.17e-3)" 3.6 4.6 1.3 7.6 1.2 11.6 3.3 1.7 1.4 2.0 1.0 5.6 5.1 2.8 2.5 3.0 2.3 2.7 2.9 1.2 1.3 1.6 4.7 3.1 14.7 1.4 1.2 1.3 2.5 1.9 2.5 1.8 5.5 1.4 2.3 5.1 1.0 2.8 2.7 3.4 3.8 4.7 2.9 1.1 7.0 3.6 10.8 1.3 9.6 2.4 2.6 14.5 3.6 1.9 1.4 29.8 19.2 28.5 29.5 5.2 5.0 58.1 29.5 14.7 44.4 44.0 29.9 19.0 59.8 29.7 12.9 12.7 28.3 29.2 14.7 33.4 34.6 32.6 37.3 20.1 20.7 2.9 24.9 34.2 1.5 3.9 27.8 9.2 4.7 17.8 27.4 31.8 27.5 24.9 37.6 42.2 28.5 29.5 34.0 36.7 38.5 29.8 24.7 10.5 21.2 26.7 16.1 27.8 17.0 15.5 18.2 19.5 21.5 11.2 27.8 18.7 48.6 40.4 14.9 21.3 40.6 15.2 47.5 25.2 0.2 5.1 5.6 5.4 15.0 5.9 12.0 6.4 7.0 3.6 11.0 8.6 5.7 3.3 7.7 14.2 4.4 11.1 5.1 1.3 1.2 1.7 1.4 1.2 1.3 1.4 1.2 1.3 1.4 1.1 1.3 1.4 3.2 3.2 2.8 1.0 12.0 6.6 13.5 10.2 6.2 2.9 4.4 5.2 4.5 7.2 5.1 1.8 2.1 25.1 6.2 8.5 5.9 7.2 12.6 3.7 5.9 3.8 0.0 18.1 2.0 7.8 25.4 7.8 1.5 4.6 4.5 7.8 4.6 4.2 12.1 1.7 2.3 7.9 14.2 8.5 12.1 3.2 5.9 12.2 10.6 2.8 6.4 2.6 5.2 2.0 3.2 7.0 3.0 3.8 4.4 5.5 5.3 3.0 3.5 6.3 6.6 4.2 6.1 40.4 47.0 4.7 4.5 9.9 7.5 5.6 6.5 5.1 ADGRE3 EMR3 ENSG00000131355 "Adhesion G protein-coupled receptor E3" Q9BY15 19 14619117-14690027 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2;lymphoid tissue: 6.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.4;Astrocytes: 2.0;Excitatory neurons: 1.9;granulocytes: 2.5;Inhibitory neurons: 2.4;Macrophages: 8.0;Microglial cells: 3.7;monocytes: 3.2;Oligodendrocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 281.6;eosinophil: 509.0;neutrophil: 489.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 509.0" "Cell line enriched" "Detected in some" 36 "HMC-1: 43.3" "Not detected" "Not detected" HPA015638 Uncertain "Secreted to blood" NA NA "HPA015638: AB_1848039" "unprognostic (2.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (5.69e-2)" "unprognostic (5.63e-2)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (8.07e-2)" "unprognostic (9.61e-2)" "unprognostic (9.11e-4)" "unprognostic (4.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.13e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 1.3 0.1 0.0 6.1 0.0 3.2 0.0 0.0 0.4 0.2 0.2 0.4 1.6 0.1 0.0 0.3 0.3 1.1 0.1 0.0 0.0 0.1 0.6 2.5 0.3 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.2 0.2 0.5 0.0 1.9 0.0 0.0 0.0 2.3 0.7 0.0 6.0 0.5 0.1 0.1 0.4 0.1 1.0 2.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 281.6 21.8 509.0 0.0 52.9 0.1 0.6 0.2 0.0 5.3 0.1 0.1 0.1 489.4 0.0 61.3 0.3 0.1 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 8.0 0.0 3.7 3.2 0.0 0.0 1.5 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 MRPS25 "DKFZp313H0817, FLJ00023, MRP-S25, RPMS25" ENSG00000131368 "Mitochondrial ribosomal protein S25" P82663 3 15042460-15065317 "Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 367.5;Late spermatids: 1316.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043490 Approved Supported Mitochondria NA NA Mitochondria "HPA043490: AB_10794888" "unprognostic (3.98e-2)" "unprognostic (5.36e-2)" "unprognostic (4.58e-3)" "unprognostic (1.24e-2)" "unprognostic (4.66e-2)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.93e-3)" "unprognostic (2.23e-1)" "unprognostic (2.10e-1)" "unprognostic (6.29e-2)" "unprognostic (2.68e-3)" "prognostic favorable (3.60e-7)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.91e-3)" 19.9 23.9 13.8 18.3 14.0 12.6 19.3 14.7 15.3 21.8 20.9 33.1 30.0 20.2 11.1 25.6 22.8 8.2 53.5 13.5 17.7 30.7 46.8 22.9 17.7 14.2 13.9 14.2 26.1 21.3 19.2 32.4 10.3 14.3 22.8 21.0 43.8 19.7 13.7 55.2 21.4 30.1 12.7 10.7 26.2 26.6 35.5 14.0 9.8 43.9 29.0 17.8 26.1 22.1 12.3 18.0 26.1 20.9 29.2 21.7 18.4 66.8 24.1 9.3 19.0 16.3 29.9 19.1 46.8 12.5 10.6 12.6 22.8 30.5 22.8 16.3 18.8 42.9 38.9 60.2 37.6 15.1 34.7 28.5 22.4 21.2 29.9 9.1 12.9 17.9 31.2 42.0 27.3 14.3 57.3 27.3 33.5 21.7 41.6 41.1 36.5 18.1 48.7 23.9 30.7 16.5 24.9 17.6 33.0 35.9 12.8 44.7 29.9 22.1 17.1 25.2 23.7 30.6 26.3 30.1 33.7 17.3 43.8 16.3 3.3 27.2 7.2 17.4 34.6 20.2 39.4 16.2 18.0 29.3 35.2 25.6 21.0 1.8 13.8 37.2 24.0 14.2 18.1 13.8 14.0 14.7 15.3 13.5 17.7 14.2 13.9 14.2 14.3 10.7 14.0 12.3 22.8 51.3 34.6 47.3 49.4 38.5 61.0 76.2 31.9 58.2 37.2 39.9 271.5 44.3 57.7 36.8 164.7 94.6 30.5 78.5 223.0 50.0 367.5 31.1 45.1 31.0 54.0 36.6 37.7 34.0 74.6 40.0 51.0 28.3 26.0 45.5 21.0 101.0 93.4 67.3 43.9 81.3 54.9 29.8 36.6 1316.8 46.0 35.3 37.4 8.4 41.0 25.7 43.3 32.2 29.3 47.4 49.5 30.1 41.6 74.4 152.8 201.6 40.7 106.2 72.3 35.6 43.0 139.1 30.0 56.1 48.6 72.7 28.4 97.4 125.8 73.9 SH3BP5 Sab ENSG00000131370 "SH3 domain binding protein 5" O60239 3 15254353-15341368 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 202.1" "Cell type enhanced" "Detected in many" "Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 349.3;MCF7: 118.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036445, HPA057988" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA036445: AB_10670106, HPA057988: AB_2683572" "unprognostic (1.28e-3)" "unprognostic (2.99e-2)" "unprognostic (9.50e-2)" "unprognostic (6.97e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.81e-3)" "unprognostic (4.80e-2)" "unprognostic (4.09e-2)" "unprognostic (2.76e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (4.76e-2)" "unprognostic (3.06e-2)" "unprognostic (4.34e-2)" "unprognostic (2.03e-1)" 78.7 202.1 20.7 35.5 22.5 73.3 72.6 39.2 25.5 68.3 21.2 24.4 15.8 78.2 13.6 27.1 86.4 46.1 17.9 25.4 24.3 52.9 17.4 73.9 60.4 23.4 22.3 21.2 117.2 16.0 48.3 36.0 41.2 25.5 25.2 8.5 27.7 50.3 34.5 72.3 24.2 27.3 37.6 23.6 31.1 16.2 31.2 23.8 37.7 51.5 19.2 36.0 33.3 51.0 34.5 27.4 16.5 6.4 14.1 53.1 46.8 349.3 13.6 10.9 9.3 10.4 10.8 13.4 21.3 6.2 40.8 16.1 3.6 2.9 14.2 5.9 19.5 12.8 15.7 72.3 1.9 21.9 4.4 8.6 36.9 9.3 41.6 7.9 34.2 116.0 31.3 18.4 8.5 10.3 118.1 57.6 23.2 13.6 3.5 20.6 1.1 27.2 115.6 8.8 53.5 16.8 7.8 18.6 19.2 21.7 21.6 18.1 10.9 84.3 22.8 29.5 21.9 12.0 3.3 7.6 15.2 44.7 16.3 31.5 8.1 7.8 9.1 52.9 2.5 15.9 19.1 24.1 36.1 8.9 24.3 12.9 16.6 13.9 25.4 4.6 3.9 11.1 20.4 20.7 22.5 39.2 25.5 25.4 24.3 23.4 22.3 21.2 25.5 23.6 23.8 34.5 195.9 0.0 16.3 2.3 115.2 17.0 6.0 8.2 11.4 41.3 23.5 32.1 0.7 5.7 13.9 68.0 14.6 12.5 73.7 0.6 3.9 2.7 192.2 13.1 33.0 150.7 2.4 7.0 49.5 8.7 356.3 97.5 3.6 13.7 2.5 28.1 165.0 7.0 33.1 65.6 38.4 2.5 12.2 87.2 133.3 97.8 49.0 113.1 33.8 26.2 33.3 5.1 167.9 12.5 60.6 3.2 1.1 118.5 67.1 8.5 4.7 36.2 7.5 44.4 6.6 56.8 13.4 3.0 4.5 14.2 12.1 173.2 51.5 81.6 1.4 10.2 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560699-15601852 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 117.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 117.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633" "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 14.6 12.1 8.2 8.2 8.3 11.7 14.7 11.0 10.6 9.2 8.0 10.1 57.1 8.4 16.7 7.6 10.9 8.8 11.1 8.1 7.6 26.2 52.2 9.8 14.2 8.3 7.7 8.0 7.5 15.3 20.2 7.9 7.9 8.0 10.9 12.1 12.4 9.2 9.2 17.8 10.4 27.9 9.5 8.0 11.5 13.3 26.9 7.6 14.1 20.5 10.7 14.6 10.4 6.4 10.5 15.1 28.6 8.2 30.7 13.4 12.4 82.3 14.2 22.0 26.6 26.3 27.3 14.3 14.6 9.7 18.7 10.5 10.4 18.7 25.3 23.8 13.6 36.4 25.4 17.7 24.7 20.3 30.5 23.1 13.7 16.2 37.9 16.6 8.3 31.4 18.3 24.0 21.2 22.9 28.7 14.0 12.6 19.7 19.7 29.7 14.4 21.5 19.6 26.4 20.2 9.6 12.3 22.4 19.0 25.2 12.8 8.5 25.4 22.5 14.1 14.6 17.4 24.7 27.2 50.9 28.5 27.1 26.4 17.2 117.3 16.0 18.3 14.4 20.1 21.2 15.4 15.5 18.0 16.0 21.2 14.8 16.1 3.4 24.1 24.2 10.2 19.8 13.0 8.2 8.3 11.0 10.6 8.1 7.6 8.3 7.7 8.0 8.0 8.0 7.6 10.5 12.4 9.6 17.3 34.9 22.1 10.3 12.0 13.5 20.5 19.3 9.1 10.2 6.4 14.3 15.6 11.0 29.2 27.2 15.7 6.1 13.7 16.0 66.6 12.6 6.0 12.3 9.1 8.2 67.4 25.2 18.0 12.0 11.2 5.4 13.3 12.7 8.9 24.3 13.2 13.5 55.8 7.5 10.2 9.3 8.1 56.8 23.3 8.8 12.4 25.3 19.3 24.8 8.2 40.7 38.8 14.5 11.2 15.4 21.4 9.0 41.9 39.7 29.8 38.3 6.6 9.0 11.2 51.1 24.4 8.6 7.1 18.9 19.4 15.1 10.6 7.9 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 18.1 17.5 13.3 17.1 19.5 25.5 18.8 17.0 15.5 20.3 7.8 13.6 10.9 17.8 12.2 16.9 22.7 19.4 15.9 13.1 17.8 20.1 14.8 18.1 23.3 19.6 17.5 11.6 28.3 18.5 25.9 8.6 17.7 20.8 14.1 14.1 11.0 14.2 16.6 9.4 14.1 13.9 18.5 19.5 24.2 14.0 19.1 16.7 20.4 30.3 11.4 23.4 14.9 10.1 29.4 26.3 28.8 23.2 22.0 45.0 65.5 25.4 27.6 39.7 17.7 15.3 14.0 23.2 48.5 29.1 56.3 27.1 8.0 20.6 33.6 36.6 43.0 7.9 46.6 11.1 16.5 28.8 45.7 39.0 42.6 39.3 38.5 23.2 39.8 40.9 28.3 29.6 43.6 43.5 17.6 22.5 10.5 19.1 16.8 30.0 48.9 29.6 34.7 26.3 20.0 8.8 41.0 52.5 12.2 18.6 21.7 34.6 37.6 44.7 48.7 21.6 25.6 30.4 25.2 36.6 46.7 37.5 42.3 46.5 11.7 8.1 11.9 5.8 6.5 7.5 10.3 4.4 4.2 9.2 11.3 3.2 3.8 10.4 4.3 6.3 5.8 5.2 4.8 13.3 19.5 17.0 15.5 13.1 17.8 19.6 17.5 11.6 20.8 19.5 16.7 29.4 40.4 16.0 35.0 226.6 56.0 18.4 20.0 15.8 42.7 20.3 23.0 19.9 18.6 25.8 27.8 14.7 10.4 17.1 28.9 9.2 5.9 17.7 64.1 19.6 28.9 30.7 13.1 31.3 333.2 9.9 16.7 32.5 20.4 28.2 18.9 31.5 34.6 19.9 21.4 35.3 350.5 13.4 10.2 35.6 22.9 40.2 30.7 34.9 14.2 324.2 23.2 26.6 32.0 341.8 565.6 12.3 9.1 30.5 20.7 9.8 13.7 15.9 16.3 22.3 6.6 34.0 20.4 20.7 25.5 28.4 17.0 8.2 30.0 35.5 14.5 17.6 CAPN7 PalBH ENSG00000131375 "Calpain 7" Q9Y6W3 3 15206152-15252916 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004745, HPA046617" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA004745: , HPA046617: AB_2679721" "unprognostic (2.70e-2)" "unprognostic (2.79e-1)" "prognostic favorable (4.85e-5)" "unprognostic (1.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.41e-2)" "unprognostic (2.22e-3)" "unprognostic (2.72e-1)" "unprognostic (1.42e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-2)" "unprognostic (1.12e-3)" "unprognostic (3.24e-2)" "unprognostic (7.84e-2)" "unprognostic (5.66e-2)" "unprognostic (1.05e-2)" 14.0 12.0 5.5 11.7 6.0 13.3 16.7 12.7 5.9 17.0 8.8 12.2 13.0 16.2 15.0 11.5 14.5 11.1 11.7 4.1 8.4 15.4 19.3 12.2 14.4 5.9 6.2 4.2 20.0 15.4 20.2 9.3 13.0 6.5 14.2 12.3 28.8 14.0 12.8 25.5 11.6 13.7 13.9 5.8 11.5 14.1 12.2 6.4 17.1 23.7 16.6 15.8 10.3 9.9 9.8 14.3 18.5 15.1 9.5 26.0 20.1 51.4 18.1 20.8 22.1 16.7 13.3 10.0 24.6 12.3 20.7 13.6 9.7 22.5 23.3 19.0 23.7 17.5 30.8 24.8 17.7 19.3 25.1 15.0 13.9 33.2 28.7 14.1 20.9 15.9 23.3 30.3 25.1 21.6 20.8 17.9 10.5 14.5 20.7 17.7 10.2 25.1 17.1 16.4 25.8 12.2 15.8 29.5 15.7 20.8 19.2 27.9 25.8 14.4 19.8 14.9 25.9 21.4 17.2 37.1 12.4 18.1 18.0 17.5 4.6 3.0 5.1 3.3 2.5 5.3 3.5 3.6 2.8 2.9 3.1 4.9 4.6 1.8 3.6 4.4 2.4 3.0 3.0 5.5 6.0 12.7 5.9 4.1 8.4 5.9 6.2 4.2 6.5 5.8 6.4 9.8 15.8 12.8 23.6 44.1 35.0 21.4 13.5 10.6 47.3 42.7 20.3 16.0 33.2 8.6 20.6 1.8 56.3 21.2 21.7 11.2 9.8 12.6 15.5 32.2 31.5 19.0 20.9 14.9 60.2 16.9 12.6 27.6 30.1 29.9 15.8 28.9 14.6 20.8 12.2 55.5 65.8 11.3 4.1 11.9 23.0 14.8 24.8 20.9 21.4 49.6 18.4 31.2 10.3 73.9 86.0 13.0 6.9 26.4 52.8 20.0 16.7 15.2 34.9 98.1 39.5 31.5 24.8 26.8 17.8 29.7 23.2 26.1 34.2 21.1 11.8 14.3 RFTN1 "FLJ23866, KIAA0084, MIG2, Raftlin" ENSG00000131378 "Raftlin, lipid raft linker 1" Q14699 3 16313574-16514026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 118.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 87.6;monocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048725 Approved NA NA "HPA048725: AB_2680502" "unprognostic (1.98e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-1)" "unprognostic (1.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (1.87e-1)" "unprognostic (7.55e-3)" "unprognostic (9.99e-3)" "unprognostic (7.24e-2)" "unprognostic (2.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.29e-7)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "unprognostic (2.88e-2)" "unprognostic (2.81e-1)" 57.7 11.3 18.9 45.1 19.0 13.4 33.4 14.0 21.8 28.1 17.1 13.8 9.4 36.9 4.9 14.7 26.2 15.5 36.2 17.9 24.8 18.5 25.0 47.3 118.0 23.4 15.6 17.3 30.7 4.8 9.1 7.5 51.4 16.1 16.5 14.3 11.5 11.3 10.4 25.8 15.4 22.9 31.6 13.1 45.9 11.9 7.1 14.3 73.9 53.9 26.8 118.4 26.5 14.6 18.3 0.1 2.9 5.3 0.0 151.7 75.7 7.7 38.8 65.9 19.3 15.6 21.5 1.0 122.9 18.6 71.2 4.3 0.6 0.1 51.4 25.5 177.5 9.0 19.8 4.9 0.3 78.6 14.7 10.8 111.3 3.4 60.7 19.0 67.5 40.5 19.8 0.5 0.4 47.0 6.6 31.3 5.0 3.5 0.0 1.4 29.6 60.8 15.0 8.0 0.1 0.1 132.6 1.3 1.3 7.2 7.4 0.2 12.2 59.9 47.3 23.0 47.8 16.8 0.4 0.5 82.5 22.0 38.6 19.2 56.0 19.6 13.2 35.3 46.4 18.1 16.3 27.2 37.6 33.6 32.0 18.4 27.8 1.2 80.1 81.7 25.8 60.4 38.3 18.9 19.0 14.0 21.8 17.9 24.8 23.4 15.6 17.3 16.1 13.1 14.3 18.3 37.9 22.4 40.0 8.1 51.2 6.5 0.3 2.3 0.0 3.2 0.7 1.5 14.3 5.7 6.9 0.0 0.0 6.2 61.1 0.1 0.0 7.2 38.0 2.6 51.8 34.4 1.2 10.3 87.6 0.9 1.1 32.4 3.1 2.0 24.7 2.1 36.0 7.2 10.5 0.0 16.5 0.0 0.0 17.6 63.6 12.2 18.6 27.0 10.6 19.7 143.8 37.2 64.9 3.0 2.4 0.9 0.1 8.6 43.2 0.6 0.0 0.4 3.3 3.2 0.0 28.2 35.2 2.8 2.4 0.8 5.1 2.5 39.5 12.6 0.3 0.4 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675141-14773036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 6.7" "Cell type enhanced" "Detected in some" "Astrocytes: 5.9;Early spermatids: 19.3;Excitatory neurons: 8.4;Inhibitory neurons: 6.9;Late spermatids: 34.6;Oligodendrocytes: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Daudi: 4.0;HEL: 8.2;U-698: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.4 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.4 0.1 0.2 0.3 0.0 0.1 0.4 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.2 0.1 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 34.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.5 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RBSN ZFYVE20 ENSG00000131381 "Rabenosyn, RAB effector" Q9H1K0 3 15070073-15099163 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044878 Approved Supported Vesicles NA NA Vesicles "HPA044878: AB_10967610" "unprognostic (6.76e-2)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.00e-1)" "unprognostic (8.06e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-3)" "unprognostic (1.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.90e-2)" "unprognostic (2.00e-2)" "unprognostic (9.34e-2)" "unprognostic (2.38e-3)" "unprognostic (4.45e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.78e-1)" 9.1 7.0 12.9 6.7 12.8 18.3 7.8 10.9 13.1 9.1 2.6 9.2 4.8 9.3 7.2 9.0 8.7 5.5 9.9 13.8 11.7 5.3 8.4 8.4 6.7 13.8 13.4 12.3 12.8 6.0 9.7 6.2 7.9 13.8 7.5 5.3 13.7 5.9 9.1 13.3 10.3 7.2 9.0 13.0 7.8 7.8 6.7 12.9 5.5 11.3 10.0 6.2 9.2 7.6 12.3 11.2 16.0 12.8 16.6 13.8 10.2 33.9 12.0 11.5 14.1 12.7 9.7 6.5 7.8 6.8 15.9 8.2 7.0 16.5 14.5 12.4 9.9 14.6 8.9 19.7 8.0 9.5 9.0 9.4 11.1 16.1 18.1 12.0 8.3 11.6 8.7 13.5 8.9 10.8 14.7 4.9 4.5 11.0 7.1 12.7 6.4 14.6 8.6 7.3 12.6 3.4 12.0 14.7 8.9 10.7 9.4 22.8 6.5 14.2 12.7 13.3 12.5 17.1 7.9 12.6 9.2 12.2 10.0 12.2 8.1 4.6 11.1 4.4 6.4 3.9 4.4 6.1 5.5 3.8 7.4 7.7 5.2 11.7 3.1 5.6 3.6 4.3 2.7 12.9 12.8 10.9 13.1 13.8 11.7 13.8 13.4 12.3 13.8 13.0 12.9 12.3 10.4 16.0 19.0 19.6 9.2 0.0 6.7 0.0 6.8 21.6 7.6 7.0 20.4 8.6 9.9 3.7 22.9 10.4 8.4 6.0 5.9 8.4 17.4 6.4 11.1 12.4 1.2 9.5 21.8 9.6 9.6 14.6 10.2 8.8 10.1 16.4 14.6 14.0 10.7 21.9 23.9 6.9 0.0 15.8 0.0 18.0 19.0 12.1 0.0 8.4 10.5 15.5 7.2 16.1 25.2 9.6 5.1 14.7 12.1 12.6 8.1 6.9 8.0 23.1 6.6 17.5 10.4 12.4 14.0 11.0 0.0 12.9 9.9 10.6 5.4 10.0 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174680-16231992 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 120.5;brain: 147.7" "Cell type enhanced" "Detected in many" "Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 40000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 120.5 4.9 47.6 1.7 56.3 2.7 88.0 67.1 46.4 10.7 15.8 21.3 3.0 11.5 12.0 12.5 25.2 5.7 17.3 50.4 92.1 11.7 4.0 9.5 4.1 138.5 61.2 28.1 22.5 3.6 2.4 3.6 32.6 140.7 6.0 4.0 13.5 25.7 4.7 36.6 34.5 21.4 7.0 106.4 12.4 15.4 9.2 65.7 4.0 18.4 35.6 1.3 33.3 23.0 147.7 0.4 1.3 0.9 1.0 133.0 128.8 0.3 3.4 2.5 0.4 1.3 0.0 0.5 0.5 1.9 7.8 2.3 0.8 0.5 1.4 2.0 0.6 1.4 1.1 1.9 0.0 7.4 1.5 0.4 102.8 0.0 1.2 1.8 2.4 2.8 0.7 0.2 3.0 1.1 1.9 0.0 2.1 0.5 0.8 1.1 0.3 1.1 24.1 0.5 0.5 0.4 0.3 0.4 1.0 0.6 0.6 0.7 1.8 3.9 0.6 4.3 26.8 0.6 1.4 5.1 1.4 2.5 0.4 0.4 0.5 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 47.6 56.3 67.1 46.4 50.4 92.1 138.5 61.2 28.1 140.7 106.4 65.7 147.7 103.9 0.0 1.7 34.6 0.1 0.5 0.4 0.0 0.0 3.8 1.1 0.9 2.8 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 26.6 0.5 3.3 26.9 0.0 0.0 4.9 0.0 0.1 24.7 0.0 1.0 1.3 0.1 41.7 1.8 0.1 0.0 3.9 0.0 0.0 0.8 2.1 16.7 1.8 0.5 0.0 22.5 0.1 47.4 0.0 5.0 69.3 0.2 0.0 0.7 1.8 2.1 0.0 0.1 0.0 3.2 0.0 7.3 2.1 25.5 0.5 0.1 0.9 0.0 0.2 0.3 0.0 0.3 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 55.3;retina: 69.1" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 59.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 59.2" "Cell line enhanced" "Detected in many" "HeLa: 66.6;RPTEC TERT1: 111.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.1 25.8 1.7 8.5 5.4 55.3 8.5 4.1 5.9 11.4 0.0 3.7 0.9 10.5 0.0 6.8 6.7 9.4 19.4 3.3 7.3 12.0 1.5 20.7 7.6 9.0 6.8 1.2 29.1 2.3 2.5 7.5 8.0 6.8 4.4 2.4 69.1 17.3 7.2 31.2 17.8 17.3 7.0 1.5 15.7 9.5 3.7 7.5 4.5 9.4 8.8 9.2 8.2 6.1 8.3 4.1 18.4 4.6 10.1 11.6 5.7 15.9 4.3 26.4 8.4 6.2 8.8 5.6 12.6 4.5 10.9 11.7 4.3 4.5 10.1 16.5 3.7 9.7 8.8 66.6 24.2 0.0 3.7 22.3 1.9 2.6 7.8 1.6 7.7 14.5 6.2 10.1 3.5 18.6 8.1 9.4 20.3 6.1 7.1 10.8 6.1 7.3 24.9 111.8 28.5 7.2 4.6 3.1 3.2 0.6 36.8 11.5 4.5 15.3 9.7 3.9 5.2 6.2 3.9 6.0 7.1 19.3 6.6 23.2 5.6 9.2 8.6 2.5 7.3 1.3 4.0 2.7 3.0 2.8 2.1 0.5 0.6 59.2 1.8 9.4 1.4 8.7 4.6 1.7 5.4 4.1 5.9 3.3 7.3 9.0 6.8 1.2 6.8 1.5 7.5 8.3 42.7 6.4 21.5 1.3 16.4 49.3 17.1 51.5 43.9 126.1 9.5 6.9 4.2 7.2 52.8 20.2 571.3 3.0 14.5 0.5 0.0 12.0 19.6 82.1 23.0 29.4 14.4 9.4 17.4 8.2 15.8 13.5 29.0 126.9 13.3 2.5 11.7 0.6 27.2 10.1 18.5 3.5 46.8 60.1 59.5 16.6 17.4 58.8 17.8 32.8 110.9 30.8 10.3 3.0 23.9 31.1 12.6 17.3 13.3 17.6 51.3 23.3 69.5 547.8 0.0 11.4 8.3 0.4 1.3 15.7 23.9 5.1 25.5 46.8 3.6 16.8 KCNC3 "Kv3.3, SCA13" ENSG00000131398 "Potassium voltage-gated channel subfamily C member 3" Q14003 19 50311937-50333515 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1;thyroid gland: 52.6" "Cell type enhanced" "Detected in many" "Collecting duct cells: 20.2;Endometrial ciliated cells: 23.9;Excitatory neurons: 15.6;Glandular and luminal cells: 16.3;Inhibitory neurons: 18.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebral cortex: 74.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;CAPAN-2: 7.2;HDLM-2: 7.0;HMC-1: 20.3;K-562: 7.0;SK-BR-3: 14.0;T-47d: 12.0;U-2 OS: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018041 Approved NA NA "HPA018041: AB_1855579" "unprognostic (8.05e-2)" "unprognostic (2.34e-2)" "unprognostic (3.01e-4)" "unprognostic (4.41e-2)" "unprognostic (3.84e-2)" "unprognostic (1.91e-2)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (3.94e-3)" "unprognostic (2.10e-5)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.68e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-2)" "unprognostic (1.19e-1)" 0.7 1.3 4.1 2.8 2.7 0.7 3.6 18.3 74.1 3.6 0.0 0.7 0.6 2.8 2.6 1.6 23.4 0.5 2.2 13.9 1.8 17.4 4.5 4.6 2.6 20.2 3.4 1.3 0.4 5.8 14.3 21.3 1.2 14.7 4.4 0.5 8.0 3.0 8.2 1.3 2.8 3.3 0.7 3.2 5.7 1.2 3.7 15.3 2.5 52.6 0.1 2.0 2.0 1.5 20.5 0.0 0.5 0.0 1.2 0.0 0.0 3.8 0.1 0.0 0.0 0.0 7.7 7.2 0.7 0.9 0.0 0.5 1.1 0.2 0.0 0.0 7.0 1.7 0.0 0.0 2.0 0.0 0.0 20.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 7.0 0.0 0.0 2.7 0.1 0.0 0.9 1.1 3.3 0.0 0.1 0.0 0.5 0.3 0.0 1.2 1.7 14.0 0.0 0.1 12.0 2.4 0.2 0.0 8.2 0.0 0.0 0.0 0.1 0.5 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 2.7 18.3 74.1 13.9 1.8 20.2 3.4 1.3 14.7 3.2 15.3 20.5 0.3 0.0 0.5 3.3 2.4 0.8 1.0 0.2 0.0 8.8 4.4 2.5 2.7 1.5 2.4 20.2 8.4 2.3 0.2 0.2 0.0 1.6 0.3 23.9 1.2 0.7 4.2 0.0 15.6 1.4 0.9 0.2 0.5 16.3 0.0 0.1 1.1 2.4 2.8 1.7 18.3 0.1 4.1 7.3 1.9 0.6 0.6 6.3 0.0 3.7 3.2 0.8 0.0 2.0 1.9 0.3 0.1 0.0 0.3 1.3 0.0 3.3 1.1 6.2 0.0 0.1 1.1 1.3 1.2 0.4 0.6 2.3 0.4 0.0 0.1 0.9 NAPSA "KAP, Kdap, NAP1, NAPA" ENSG00000131400 "Napsin A aspartic peptidase" O96009 19 50358477-50365830 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lung: 1085.0" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 3072.3" "Cancer enriched" "Detected in many" 18 "lung cancer: 249.9" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 8.7" "Group enriched" "Detected in many" 7 "B-cells: 4.3;dendritic cells: 8.7" "Cell line enriched" "Detected in some" 31 "U-698: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB009591, HPA045280, HPA047236, HPA047744" Enhanced "Secreted in other tissues" NA NA 1500000 "CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143" "unprognostic (5.36e-2)" "unprognostic (4.77e-2)" "unprognostic (1.64e-3)" "unprognostic (1.78e-1)" "unprognostic (1.93e-1)" "unprognostic (4.65e-2)" "unprognostic (1.02e-1)" "unprognostic (8.30e-3)" "unprognostic (2.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.76e-3)" "unprognostic (7.67e-3)" "prognostic favorable (1.21e-4)" "unprognostic (4.08e-4)" "unprognostic (3.29e-1)" "unprognostic (9.83e-3)" "unprognostic (7.26e-5)" 0.4 0.9 1.0 1.6 0.9 0.1 0.5 0.9 0.9 0.7 0.7 0.6 0.4 0.5 2.0 0.4 1.0 0.1 0.4 0.8 0.9 107.3 1.2 1085.0 1.2 0.9 0.9 0.8 2.2 1.0 0.2 0.6 0.4 0.9 1.0 0.4 0.4 0.6 1.0 0.2 1.0 1.6 0.1 0.8 1.1 0.9 1.9 0.9 0.4 1.7 0.0 0.5 0.4 0.7 1.1 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.3 0.2 0.0 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.4 1.3 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.7 0.2 0.5 0.2 0.3 0.4 0.6 0.0 0.2 1.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.4 0.2 0.0 0.1 1.0 0.0 0.2 0.4 42.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.9 0.0 4.3 0.2 0.3 2.6 1.7 0.4 0.4 0.5 0.4 0.7 8.7 0.0 1.1 1.0 0.9 0.9 0.9 0.8 0.9 0.9 0.9 0.8 0.9 0.8 0.9 1.1 0.3 522.4 3072.3 0.3 3.8 0.1 0.5 0.2 0.0 1.3 0.8 0.9 0.4 1.5 45.9 46.0 4.2 0.5 0.4 0.8 9.8 0.6 47.2 12.6 0.4 6.2 0.0 0.4 0.5 0.8 0.3 5.8 0.5 1.5 69.4 1.0 0.4 0.4 0.3 0.0 0.5 1.0 0.0 1.6 5.3 9.1 0.9 7.9 0.0 1.9 0.2 1.5 1.0 0.0 1.4 0.1 2.3 0.4 0.6 0.4 2.0 276.1 16.4 0.9 0.0 0.3 0.3 1.4 1.4 0.0 0.6 0.1 12.9 0.4 0.9 0.1 NR1H2 "LXR-b, LXRb, NER, NER-I, RIP15, UNR" ENSG00000131408 "Nuclear receptor subfamily 1 group H member 2" P55055 19 50329653-50383388 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005446, HPA056838, HPA070212" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234" "unprognostic (1.31e-1)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (1.34e-3)" "unprognostic (1.68e-1)" "unprognostic (5.24e-3)" "unprognostic (2.26e-2)" "unprognostic (9.69e-2)" "unprognostic (6.45e-2)" "unprognostic (5.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.88e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (5.12e-2)" "unprognostic (1.69e-3)" 59.9 61.9 38.5 37.5 38.1 144.6 58.4 36.4 53.7 61.3 34.7 69.7 43.5 67.8 10.9 56.5 64.2 28.6 78.2 33.5 37.7 64.3 61.5 67.0 34.2 48.3 39.8 30.1 57.4 50.2 32.4 40.9 26.5 42.0 64.3 12.0 9.4 47.3 38.2 133.2 60.7 55.6 20.5 38.1 57.2 60.7 32.1 40.6 21.6 57.0 37.0 16.8 77.8 58.8 40.6 56.2 124.1 12.1 32.4 34.5 36.4 42.0 75.8 53.4 38.4 41.7 25.8 48.9 34.8 67.1 39.4 31.7 46.8 7.8 34.1 9.5 89.9 57.6 32.5 41.8 26.4 63.7 58.2 84.0 34.8 45.2 39.3 27.3 37.7 33.4 24.7 51.7 65.4 20.8 53.2 39.3 40.5 25.5 32.2 94.4 22.8 35.8 57.2 30.4 54.3 14.9 50.6 50.9 54.0 46.7 6.6 37.9 42.5 53.9 54.3 45.3 58.4 66.8 82.5 79.3 26.4 108.6 36.5 53.8 159.1 123.9 232.4 90.4 125.4 89.3 112.3 89.9 86.2 121.3 117.7 90.8 81.4 194.8 85.9 146.4 103.9 89.0 129.3 38.5 38.1 36.4 53.7 33.5 37.7 48.3 39.8 30.1 42.0 38.1 40.6 40.6 50.7 28.9 30.7 3.6 70.7 43.0 89.3 53.2 32.5 37.9 33.4 27.3 29.6 37.1 31.1 31.3 14.6 64.5 57.0 82.1 64.6 63.6 15.5 31.9 19.5 50.0 20.8 58.9 5.9 72.6 53.3 40.2 37.2 33.8 50.2 25.1 36.8 20.7 51.3 37.0 5.5 45.5 46.8 37.0 48.3 9.5 45.4 54.5 60.5 4.7 65.2 46.8 65.9 0.5 6.9 74.3 89.6 53.4 47.5 91.0 93.5 61.8 21.7 25.4 39.5 45.5 50.2 34.6 25.9 27.9 45.7 140.0 54.8 27.7 35.7 109.0 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568435 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.2;cervix: 36.9;pituitary gland: 32.2" "Cell type enhanced" "Detected in some" "Astrocytes: 34.9;Bipolar cells: 19.6;Excitatory neurons: 32.1;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 48.9" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.7;HMC-1: 32.1;REH: 8.7;SH-SY5Y: 27.5;U-2 OS: 25.3;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain NA NA 2700000 "HPA058986: AB_2683871" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 2.6 5.3 48.8 0.9 28.8 0.0 2.1 15.0 56.2 36.9 0.0 2.8 0.8 16.3 0.1 1.9 10.1 1.2 1.7 42.8 20.6 1.2 1.3 5.9 1.3 45.6 43.4 39.1 5.1 0.8 0.2 32.2 4.2 38.8 3.4 0.1 1.6 0.8 1.0 0.7 1.2 3.3 1.3 10.6 0.8 2.9 2.4 31.0 0.0 2.6 0.1 0.5 5.9 13.1 32.6 0.0 0.5 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 4.9 0.0 0.7 0.1 0.1 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.0 0.1 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.5 0.0 1.0 0.1 0.0 8.2 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 27.5 0.0 0.0 5.7 0.2 0.0 0.3 0.0 0.0 25.3 0.0 0.0 0.6 0.1 0.1 0.1 0.3 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.8 28.8 15.0 56.2 42.8 20.6 45.6 43.4 39.1 38.8 10.6 31.0 32.6 0.7 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.5 0.9 0.0 0.0 32.1 0.0 0.0 1.3 0.0 0.1 0.0 0.2 0.7 0.0 0.1 10.1 38.5 0.0 0.0 0.0 0.3 2.2 2.8 0.0 0.0 2.8 0.0 1.6 0.0 29.7 48.9 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 5.8 4.8 8.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 PDLIM4 RIL ENSG00000131435 "PDZ and LIM domain 4" P50479 5 132257696-132273454 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 315.5;Prostatic glandular cells: 473.0;Skeletal myocytes: 225.2;Urothelial cells: 381.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 91.8;HBEC3-KT: 109.2;HHSteC: 103.7;hTEC/SVTERT24-B: 117.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011912 Uncertain Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA011912: AB_1856277" "unprognostic (1.36e-3)" "unprognostic (1.93e-1)" "unprognostic (1.62e-2)" "unprognostic (8.08e-3)" "unprognostic (4.70e-3)" "unprognostic (2.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.39e-1)" "unprognostic (1.34e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-2)" "unprognostic (4.20e-2)" "unprognostic (5.84e-3)" "unprognostic (1.13e-2)" "unprognostic (2.61e-1)" "unprognostic (3.57e-2)" "unprognostic (3.40e-3)" 21.9 6.6 12.2 18.7 12.3 0.7 34.8 17.7 17.9 35.1 17.7 75.6 7.0 91.5 17.9 50.4 48.7 20.7 36.3 14.1 59.2 17.9 1.2 10.6 4.5 26.7 15.8 8.3 28.7 6.6 5.0 28.4 8.1 18.4 50.7 4.8 2.7 47.8 28.4 5.5 59.6 27.5 43.3 20.0 6.8 32.4 6.4 17.7 6.6 14.3 2.6 10.2 59.9 39.5 20.4 46.6 0.0 9.7 0.1 13.2 36.7 3.3 12.9 6.3 12.9 4.2 0.0 4.3 0.3 8.6 68.4 65.8 91.8 0.0 109.2 6.1 0.2 5.1 0.0 0.0 2.2 103.7 0.0 0.3 46.5 7.8 117.6 43.7 45.9 74.0 0.0 20.2 0.1 57.6 0.0 0.0 0.3 3.4 0.0 28.1 2.2 66.4 0.2 29.0 0.0 0.0 39.0 29.7 0.0 0.0 7.7 0.1 4.8 47.9 46.3 49.9 48.4 72.9 0.1 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 12.3 17.7 17.9 14.1 59.2 26.7 15.8 8.3 18.4 20.0 17.7 20.4 10.1 0.0 4.4 5.5 0.7 105.7 315.5 183.8 76.2 0.5 38.2 149.5 6.8 0.0 57.0 14.7 2.1 5.1 0.8 0.6 107.6 121.5 14.2 21.1 81.0 69.8 16.8 0.0 0.7 9.9 14.4 85.1 6.1 17.9 4.5 10.7 21.0 0.3 6.6 0.0 0.6 16.6 61.1 0.3 32.5 15.8 36.4 3.4 165.4 3.7 1.0 17.7 0.0 0.0 0.3 105.7 154.6 27.4 0.0 473.0 5.6 8.9 138.3 0.7 26.3 225.2 53.8 9.9 13.9 47.8 82.8 22.8 4.2 2.0 5.5 381.7 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7;retina: 34.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 178.7;Horizontal cells: 185.1;Inhibitory neurons: 157.0;Spermatocytes: 147.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "basophil: 68.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 68.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 2.6 8.0 10.5 3.8 17.2 1.6 5.1 11.1 27.7 4.5 0.0 2.8 2.5 4.8 5.1 3.3 7.1 4.1 4.7 15.9 13.7 5.9 1.4 4.5 3.9 13.4 13.8 12.9 5.1 2.8 11.9 11.4 3.2 18.3 5.2 2.6 34.2 2.9 4.8 2.6 4.0 2.1 4.6 1.8 2.8 3.7 21.7 12.2 6.1 5.4 3.1 3.7 3.8 3.1 24.6 10.6 12.6 11.4 20.8 7.7 7.8 9.4 8.9 7.0 8.2 10.9 13.0 8.0 29.7 11.6 10.4 24.8 7.2 9.6 17.6 17.2 8.6 10.2 4.3 6.9 4.7 7.9 5.3 11.4 5.8 8.6 12.1 14.0 11.4 10.4 18.8 4.8 15.3 10.1 7.9 34.5 4.2 5.5 3.8 4.8 8.8 9.2 3.2 8.4 9.4 36.2 11.9 12.0 4.3 14.4 18.6 12.8 1.6 10.9 10.1 15.9 7.3 10.6 11.5 19.6 16.4 12.9 4.4 11.1 68.2 0.6 1.9 6.3 1.5 6.9 6.7 6.5 6.1 1.3 4.0 6.4 7.0 0.6 4.8 2.0 1.2 5.4 2.0 10.5 17.2 11.1 27.7 15.9 13.7 13.4 13.8 12.9 18.3 1.8 12.2 24.6 10.9 54.5 38.0 65.3 12.0 13.6 15.6 25.5 12.5 76.5 13.7 18.7 29.9 11.5 31.7 38.6 125.1 14.6 18.4 0.8 29.4 20.5 86.2 69.7 20.4 11.3 19.8 3.4 178.7 12.9 11.5 16.8 5.6 23.7 13.9 24.6 13.2 2.4 6.2 185.1 157.0 3.8 54.9 3.5 7.7 25.0 16.4 4.8 42.7 21.5 5.4 47.0 5.2 122.6 100.7 12.4 4.6 24.5 14.4 7.6 1.1 10.8 121.0 99.6 13.1 23.8 40.5 147.1 102.6 9.0 15.9 9.9 23.6 27.7 2.1 6.0 MGAT1 "GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT" ENSG00000131446 "Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" P26572 5 180784780-180815652 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 280.2;Syncytiotrophoblasts: 384.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017432 Approved NA NA 12000000 "HPA017432: AB_1853851" "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (3.38e-2)" "unprognostic (2.11e-1)" "unprognostic (3.91e-2)" "unprognostic (6.70e-2)" "unprognostic (4.39e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.98e-1)" "unprognostic (3.70e-3)" "unprognostic (6.44e-2)" "prognostic unfavorable (8.65e-4)" "unprognostic (4.15e-2)" "unprognostic (3.52e-2)" "unprognostic (5.68e-2)" "unprognostic (5.00e-2)" 131.3 67.3 45.0 66.4 39.9 61.1 114.6 38.6 53.6 70.5 64.6 67.4 50.7 75.8 28.5 104.0 86.5 40.2 94.2 35.5 47.3 63.6 148.1 114.3 69.1 52.2 40.4 29.2 75.7 116.3 20.5 62.1 67.8 47.7 76.1 30.4 29.4 82.7 37.5 61.6 72.0 82.9 41.3 43.0 141.0 78.8 36.7 55.3 38.7 96.9 36.0 42.6 85.8 72.9 59.5 58.3 58.2 30.9 66.3 149.6 68.7 111.0 130.1 154.4 77.4 96.7 79.4 45.6 50.2 77.3 122.3 78.2 68.8 17.0 190.8 46.1 271.6 47.6 44.2 34.1 61.7 72.8 40.6 137.6 79.7 91.5 63.1 62.9 53.6 67.9 34.2 26.1 84.7 70.9 78.3 38.9 55.2 29.6 37.5 72.0 46.2 44.5 66.8 30.9 67.3 27.2 32.1 54.6 56.5 115.7 27.2 43.8 68.5 72.9 94.7 44.7 42.7 61.1 165.9 149.2 44.7 77.6 78.9 49.8 93.0 228.6 104.6 83.5 186.7 91.6 48.3 60.2 70.3 161.7 42.0 51.4 59.1 152.2 70.4 149.4 152.9 75.3 235.1 45.0 39.9 38.6 53.6 35.5 47.3 52.2 40.4 29.2 47.7 43.0 55.3 59.5 157.8 48.1 31.1 9.8 57.7 61.2 44.6 52.8 50.1 20.7 41.5 29.7 18.4 44.3 32.7 29.5 56.3 94.9 114.7 43.8 37.2 49.0 31.7 26.2 34.2 94.2 49.8 47.6 7.5 79.0 280.2 80.5 33.6 48.7 30.4 27.2 125.7 88.1 200.5 63.9 8.5 54.9 20.3 195.5 142.1 43.2 62.7 234.9 81.8 26.2 112.1 18.9 87.6 8.0 14.6 54.0 34.7 76.0 169.7 76.9 57.2 22.5 20.4 78.8 32.9 72.1 51.5 26.8 22.5 46.8 63.9 384.9 59.3 43.7 36.7 56.8 GFPT2 GFAT2 ENSG00000131459 "Glutamine-fructose-6-phosphate transaminase 2" O94808 5 180300698-180353336 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 77.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 30.4;Fibroblasts: 77.9;Skeletal myocytes: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.5" "Lineage enriched" "Detected in single" 35 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "ASC diff: 119.1;ASC TERT1: 202.3;GAMG: 152.5;HSkMC: 130.7;hTEC/SVTERT24-B: 248.0;U-87 MG: 426.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056892, HPA059910" Uncertain Approved Vesicles NA NA Vesicles "HPA056892: AB_2683266, HPA059910: AB_2684157" "unprognostic (3.48e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.91e-2)" "unprognostic (1.08e-2)" "unprognostic (6.28e-2)" "unprognostic (3.39e-3)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (7.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.50e-2)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.58e-14)" "unprognostic (3.67e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.52e-3)" 77.4 7.1 17.0 18.7 15.3 0.1 23.2 19.1 19.2 23.9 14.1 15.0 1.6 16.1 7.7 5.8 36.2 16.6 25.5 15.5 33.4 6.6 2.1 25.5 2.9 28.6 15.3 13.6 33.7 12.5 4.7 5.1 6.5 23.8 15.8 3.3 2.9 7.1 8.3 4.7 8.0 11.4 11.4 19.6 2.0 14.7 8.7 16.3 1.2 10.9 7.1 3.5 38.7 18.1 22.4 0.1 27.7 21.5 28.0 119.1 202.3 2.3 3.5 0.7 2.3 0.8 0.7 0.1 0.0 1.4 23.2 152.5 0.4 11.8 0.2 1.4 2.6 4.2 0.0 13.7 0.0 49.4 0.0 0.2 130.7 1.0 248.0 0.7 41.7 40.7 1.0 0.0 0.4 107.7 4.2 0.1 0.0 45.7 0.3 12.3 0.6 0.2 0.0 0.0 0.0 1.0 1.6 43.0 0.8 1.4 25.0 1.9 0.3 19.5 67.9 10.7 44.3 52.2 0.1 0.1 0.0 426.7 0.0 1.5 0.0 0.0 0.0 0.7 0.0 3.5 0.0 0.3 1.2 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 17.0 15.3 19.1 19.2 15.5 33.4 28.6 15.3 13.6 23.8 19.6 16.3 22.4 4.1 3.2 4.8 13.4 0.8 7.4 0.4 0.2 3.4 0.0 3.2 6.3 3.0 5.7 3.2 1.8 0.0 1.1 3.5 0.4 1.9 1.0 5.7 2.0 30.4 1.9 0.0 0.0 20.0 0.8 0.5 77.9 6.6 1.9 1.3 0.4 1.4 0.0 0.5 0.0 12.1 0.5 0.0 0.3 9.6 3.5 10.2 1.7 8.8 4.7 0.0 6.1 0.0 10.6 6.5 0.4 0.0 18.8 2.5 1.7 0.0 0.4 1.5 0.1 0.0 27.3 17.6 10.1 8.3 1.7 4.3 2.7 8.9 0.0 0.1 0.6 TUBG1 "TUBG, TUBGCP1" ENSG00000131462 "Tubulin gamma 1" P23258 17 42609641-42615238 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 175.2" "Cell type enhanced" "Detected in all" "Early spermatids: 670.6;Erythroid cells: 286.9;Late spermatids: 560.5;Spermatocytes: 347.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004608 Enhanced NA Yes "CAB004608: AB_628417" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (1.79e-2)" "prognostic favorable (8.99e-4)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.08e-8)" "unprognostic (2.62e-3)" "unprognostic (5.67e-2)" "unprognostic (1.83e-1)" "unprognostic (3.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.48e-5)" "unprognostic (2.64e-1)" "unprognostic (3.52e-1)" "unprognostic (2.61e-3)" "unprognostic (1.97e-2)" 23.2 30.6 17.0 20.6 17.6 52.1 19.2 17.0 24.4 15.6 19.1 22.7 16.7 20.8 13.5 35.9 16.5 10.2 37.8 16.9 18.6 24.7 27.3 19.3 18.1 19.2 16.9 16.4 12.6 49.1 30.2 20.4 21.1 18.5 19.8 15.0 10.6 19.3 18.5 61.2 28.9 18.3 27.4 14.6 19.5 30.1 175.2 20.2 27.8 15.0 36.6 20.8 21.9 20.1 22.7 117.8 288.8 112.1 124.0 70.5 47.8 97.7 133.4 87.2 205.6 158.8 177.4 76.9 80.2 92.8 105.9 178.5 171.9 124.2 178.0 149.7 225.9 142.6 64.1 168.5 299.3 34.6 73.8 87.6 38.1 54.0 251.1 75.8 50.6 131.9 119.0 119.7 77.2 155.9 326.7 176.3 66.2 59.3 176.7 139.1 81.8 164.2 130.5 91.7 136.6 158.9 74.5 78.0 76.9 63.6 113.9 233.6 70.2 88.5 197.9 131.0 169.2 207.0 111.2 169.0 126.2 108.6 70.6 144.2 1.7 13.1 3.1 10.6 25.1 11.6 14.9 9.8 11.4 15.7 15.0 10.4 10.5 0.4 12.7 27.4 44.1 13.5 10.4 17.0 17.6 17.0 24.4 16.9 18.6 19.2 16.9 16.4 18.5 14.6 20.2 22.7 14.9 16.0 4.2 3.9 12.8 17.6 16.3 49.4 12.0 14.1 14.6 16.5 18.8 14.3 24.1 7.3 4.2 45.8 7.0 10.2 39.2 35.2 670.6 15.1 13.7 20.1 9.6 286.9 7.2 54.4 78.6 15.7 15.8 10.7 2.5 16.9 15.7 15.9 40.2 20.2 6.4 13.7 38.7 6.3 10.8 560.5 22.7 9.7 17.8 8.4 26.4 17.7 10.3 4.0 3.8 42.3 6.2 21.8 41.5 15.2 15.1 76.6 18.1 10.9 59.2 7.1 43.5 347.8 128.0 27.3 28.6 20.1 8.5 15.0 14.0 15.6 PSME3 "Ki, PA28-gamma, PA28G, REG-GAMMA" ENSG00000131467 "Proteasome activator subunit 3" P61289 17 42824385-42843760 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 253.8;Late spermatids: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008388, HPA012510" Supported Enhanced Nucleoplasm NA NA 460000 Nucleoplasm "CAB008388: AB_592552, HPA012510: AB_1855752" "unprognostic (4.22e-2)" "unprognostic (2.38e-2)" "unprognostic (1.63e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (8.30e-3)" "prognostic unfavorable (5.41e-5)" "unprognostic (6.02e-3)" "unprognostic (2.30e-1)" "unprognostic (1.26e-2)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (5.17e-2)" "unprognostic (4.09e-2)" "unprognostic (1.17e-1)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" 44.3 45.6 28.3 43.8 29.2 52.2 40.6 28.2 32.4 31.4 26.6 42.8 38.3 40.2 28.4 67.8 34.1 29.6 48.1 29.6 30.6 47.8 42.2 36.5 49.6 27.9 34.5 28.4 25.6 44.2 50.3 25.4 36.5 29.0 31.4 45.8 34.9 42.5 36.0 81.5 50.6 40.0 41.9 27.6 37.8 47.1 46.8 29.9 43.5 39.9 50.5 58.3 62.5 39.3 29.2 153.1 211.4 124.3 125.3 97.6 101.7 158.6 199.6 134.3 238.7 168.6 180.7 116.5 224.8 137.0 155.3 134.9 142.1 186.2 180.9 268.2 114.6 159.0 131.1 114.8 151.1 111.0 306.1 139.6 97.4 116.1 187.5 175.8 66.3 140.4 123.8 220.7 75.3 154.4 75.8 268.0 101.1 166.0 227.8 114.1 171.4 228.0 173.8 115.4 217.8 140.4 139.5 113.5 92.2 140.6 174.1 193.2 111.0 131.2 187.0 132.9 156.0 259.8 119.7 217.5 316.3 133.6 156.9 181.9 52.0 78.1 73.6 55.2 86.6 59.6 51.4 44.2 54.4 75.7 49.4 41.5 47.6 101.5 66.3 74.9 41.6 59.4 87.5 28.3 29.2 28.2 32.4 29.6 30.6 27.9 34.5 28.4 29.0 27.6 29.9 29.2 15.1 19.2 19.3 5.9 29.2 30.2 38.1 34.6 35.3 13.2 26.9 18.4 35.1 22.8 28.2 29.5 14.6 43.6 21.2 31.1 27.4 58.7 253.8 24.4 24.5 21.1 24.7 30.3 10.5 52.9 71.4 21.6 31.6 31.1 22.2 19.2 18.9 28.0 49.5 13.5 10.6 25.2 44.7 30.8 21.3 143.8 15.5 29.6 16.0 4.7 42.6 17.0 24.7 11.1 7.3 63.6 26.8 19.9 38.5 58.8 28.5 43.3 23.9 18.5 19.7 17.7 35.9 43.8 41.5 49.0 47.2 76.2 22.6 25.3 30.7 52.7 RPL27 L27 ENSG00000131469 "Ribosomal protein L27" P61353 17 42998273-43002959 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes, Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002649 Approved Enhanced Nucleoplasm,Nucleoli NA NA 170000 Nucleoli Nucleoplasm "HPA002649: AB_1079840" "unprognostic (8.53e-3)" "unprognostic (7.15e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-2)" "unprognostic (4.99e-2)" "unprognostic (4.31e-2)" "unprognostic (1.91e-3)" "unprognostic (7.32e-2)" "unprognostic (9.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.12e-2)" "unprognostic (3.86e-1)" "prognostic unfavorable (7.80e-8)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" 1874.0 1562.5 1094.6 1019.1 1095.7 2954.4 1979.8 1080.9 1525.0 1954.9 1116.3 1709.5 809.6 1563.4 1003.6 2000.1 1667.1 747.4 1419.0 1077.1 1126.6 1283.8 1327.7 1289.6 2015.8 1106.8 1093.4 1061.1 2620.6 2250.9 857.8 901.8 958.9 1103.8 1496.5 902.6 398.0 1544.0 757.0 2565.5 2678.5 1480.0 861.8 1111.4 1816.5 1572.5 412.6 1118.7 1697.9 1076.5 1523.5 1390.0 1664.9 1836.1 1119.7 2288.0 2867.0 1701.7 2480.6 2983.9 4422.4 2741.5 2594.6 2162.4 2777.2 1979.1 4107.0 1751.0 4309.7 2143.3 2087.9 1477.4 1948.8 2000.9 3363.7 2670.5 1996.4 4741.8 1694.3 2147.4 4431.8 3669.4 4908.1 1698.9 4175.7 2847.4 1867.0 2381.3 2795.0 2356.9 2241.9 3237.8 2584.2 2618.6 2253.4 4127.7 4153.0 2577.8 2634.0 1821.4 2841.1 4775.1 4927.8 2374.2 3092.9 1909.6 2094.8 1016.8 1982.1 4341.5 2299.8 3341.2 5076.5 2617.1 2021.7 1988.7 2497.2 3885.7 2219.6 4004.7 4327.4 1816.5 3030.7 2107.7 1007.1 1762.8 553.5 1773.1 1633.6 2518.3 3055.1 2633.3 2095.8 2115.1 2792.7 2987.8 2673.6 358.7 2155.7 1284.9 2726.2 2059.6 4601.4 1094.6 1095.7 1080.9 1525.0 1077.1 1126.6 1106.8 1093.4 1061.1 1103.8 1111.4 1118.7 1119.7 770.3 734.0 1103.9 11.1 2217.2 2530.2 2296.2 1759.2 941.8 138.9 1779.8 1725.0 725.8 1302.6 1175.0 518.6 89.6 2093.8 1873.8 948.5 1496.7 1822.6 435.6 524.0 1202.0 1245.7 912.0 1291.4 9.9 3028.9 3551.3 1025.1 510.7 660.9 991.3 983.7 1689.1 1859.0 2118.7 65.6 10.7 2016.4 671.4 2560.1 2977.0 1070.0 2434.3 1522.8 1426.5 22.5 3232.7 722.9 2669.4 7.5 16.3 2450.0 1585.4 1279.6 957.2 2462.7 1301.2 2383.0 574.6 230.6 867.8 1669.6 1874.7 384.8 476.4 1644.1 3371.3 2184.8 1833.0 1266.3 2175.4 2628.2 PSMC3IP "GT198, Hop2, HUMGT198A, TBPIP" ENSG00000131470 "PSMC3 interacting protein" Q9P2W1 17 42572310-42577831 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 113.3;Spermatogonia: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA044439 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA044439: AB_10964210" "unprognostic (2.98e-1)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (2.87e-1)" "unprognostic (6.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-7)" "unprognostic (6.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.47e-1)" "unprognostic (7.26e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (9.41e-4)" "unprognostic (6.03e-2)" "unprognostic (3.68e-1)" "unprognostic (1.39e-2)" "unprognostic (1.82e-1)" 3.4 1.4 8.9 2.5 8.9 8.3 3.8 8.9 10.4 3.3 8.0 3.2 1.3 3.8 3.8 3.0 6.3 1.4 1.8 8.0 8.4 2.0 0.8 2.4 3.9 9.3 9.0 7.8 3.4 2.2 7.6 1.5 4.2 9.5 3.7 3.0 7.3 1.5 3.9 1.6 3.1 1.7 5.2 9.3 1.9 2.4 23.9 9.1 7.4 1.8 2.4 5.5 2.9 2.9 9.3 21.1 29.0 48.3 34.9 11.0 15.0 11.0 80.4 23.7 63.4 78.3 28.6 12.9 21.1 17.6 22.2 27.6 29.9 36.9 28.8 73.0 31.0 30.0 13.5 66.1 35.0 1.6 46.3 14.4 5.3 6.4 101.5 34.2 9.4 18.8 28.3 44.5 38.2 56.6 21.8 33.3 28.0 30.0 23.9 26.8 32.3 50.7 20.6 14.8 16.6 65.1 40.6 32.1 11.8 34.7 24.3 28.3 20.3 8.8 70.5 41.1 55.2 128.6 30.0 54.1 30.8 32.8 21.2 79.7 0.0 0.0 0.9 0.7 0.2 0.9 1.1 0.4 0.7 0.0 0.3 0.1 0.4 0.9 0.1 0.3 2.8 0.7 0.1 8.9 8.9 8.9 10.4 8.0 8.4 9.3 9.0 7.8 9.5 9.3 9.1 9.3 6.0 3.2 3.7 2.3 6.4 5.4 2.7 3.7 0.0 5.9 4.8 5.2 0.9 4.3 2.8 3.7 10.4 15.6 3.7 1.4 0.0 4.5 12.8 11.1 5.8 4.4 0.0 19.8 1.1 3.3 19.1 5.5 1.5 5.0 1.3 7.7 2.9 2.2 7.4 0.0 1.2 1.2 4.1 3.0 2.6 13.1 5.3 2.4 5.4 2.8 5.8 4.6 3.1 1.0 1.5 2.0 0.3 8.6 6.5 2.0 0.2 2.2 14.9 13.9 19.7 8.6 16.0 113.3 44.6 3.2 4.1 5.2 2.7 2.5 2.5 1.7 AOC3 "HPAO, VAP-1, VAP1" ENSG00000131471 "Amine oxidase copper containing 3" Q16853 17 42851184-42858130 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 426.5" "Group enriched" "Detected in many" 4 "Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "ASC diff: 307.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA000980, CAB025797" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted - unknown location" NA NA 240000000 Cytosol "Golgi apparatus" "CAB025797: , HPA000980: AB_1078170" "unprognostic (2.20e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-1)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (4.00e-2)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (5.61e-2)" "unprognostic (1.67e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (6.98e-4)" 426.5 48.8 2.6 32.2 2.9 1.5 170.6 2.4 4.4 50.3 4.0 157.1 17.4 95.9 33.8 88.8 85.6 51.1 36.7 2.9 2.4 23.3 19.3 220.5 12.5 2.8 2.7 2.4 26.7 12.1 8.5 5.4 28.3 2.8 59.6 41.4 1.8 14.8 104.6 17.9 21.8 58.1 146.1 2.2 21.6 67.2 12.9 2.4 5.9 28.5 23.1 4.0 143.3 51.4 3.1 0.1 1.5 0.2 1.0 307.5 0.3 5.0 0.3 0.1 0.2 0.8 0.9 0.0 0.7 0.7 0.1 0.2 0.5 0.8 0.2 0.8 1.5 5.7 0.4 0.5 18.4 0.8 0.3 1.0 3.3 1.0 0.3 0.8 0.0 0.2 2.2 0.3 1.7 0.6 0.2 0.2 1.4 0.7 0.1 0.4 0.7 0.8 3.0 0.1 2.2 0.3 0.4 0.0 0.2 2.0 2.2 0.1 0.1 0.0 0.3 2.7 1.2 0.4 4.8 5.9 0.6 0.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 2.9 2.4 4.4 2.9 2.4 2.8 2.7 2.4 2.8 2.2 2.4 3.1 58.2 3.2 6.0 0.0 0.5 2.9 0.1 0.0 2.2 0.0 1.1 2.2 9.5 0.0 1.9 0.0 0.0 0.1 0.4 0.1 0.0 0.2 4.5 0.8 2.3 12.3 0.0 0.0 0.4 0.2 0.1 11.3 0.0 1.4 1.3 2.1 20.7 0.2 1.4 0.0 0.3 0.1 0.0 1.4 2.7 2.6 3.4 0.9 3.6 3.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 74.9 0.0 0.4 0.1 1.4 1.0 0.4 118.3 2.6 93.0 1.1 1.3 0.7 1.8 0.3 0.6 74.6 0.1 0.3 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866917-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported Nucleoplasm,Cytosol No No 3100000 Cytosol Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 58.1 30.4 26.0 44.3 25.7 35.0 47.1 32.3 46.4 33.4 20.3 35.8 49.8 34.6 35.0 30.7 36.3 31.4 27.4 25.0 47.0 48.0 27.7 35.6 43.1 66.3 43.5 23.4 21.5 46.7 37.7 22.6 42.8 66.7 63.1 36.0 23.4 39.4 28.8 15.5 27.9 44.1 42.9 34.6 39.5 39.2 32.4 44.6 48.8 31.0 15.0 40.6 37.0 29.4 66.8 127.1 423.2 194.8 168.8 296.1 274.4 178.3 174.0 188.0 213.7 266.3 217.9 141.8 204.7 108.8 245.2 200.6 197.2 253.9 298.0 177.8 184.9 243.0 117.3 228.3 227.5 136.9 191.9 147.1 219.8 88.3 376.9 75.6 140.0 228.7 155.0 147.4 158.5 180.4 130.0 317.8 107.6 127.6 84.8 75.7 205.2 236.2 262.2 221.0 222.4 364.7 200.2 124.5 382.8 133.7 167.6 229.4 181.0 248.4 165.7 135.5 169.0 291.0 91.9 127.0 193.0 280.3 145.7 137.5 32.2 29.2 36.5 30.9 30.9 29.1 21.6 24.4 27.7 33.0 18.3 18.1 20.3 14.6 24.0 39.8 19.1 34.3 33.8 26.0 25.7 32.3 46.4 25.0 47.0 66.3 43.5 23.4 66.7 34.6 44.6 66.8 28.2 28.9 26.2 12.4 20.5 25.0 10.0 25.4 12.5 12.1 38.6 21.6 12.6 31.5 21.0 23.9 4.2 22.6 25.9 26.7 11.7 33.8 73.3 31.6 35.3 33.4 65.9 34.3 10.9 33.6 46.5 28.9 23.4 29.2 15.2 28.7 41.4 53.0 31.0 18.5 14.7 54.0 20.3 39.0 25.9 17.5 61.8 27.6 32.0 16.9 42.9 7.6 25.7 11.6 13.6 42.9 16.2 51.1 17.4 35.9 40.4 87.0 31.1 9.4 13.1 17.6 25.7 17.9 36.0 21.6 33.0 22.2 25.1 49.0 22.2 15.5 VPS25 "DERP9, EAP20, MGC10540" ENSG00000131475 "Vacuolar protein sorting 25 homolog" Q9BRG1 17 42773449-42779599 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004978, HPA021992, HPA052217, HPA057284" Uncertain Supported Vesicles NA Yes Vesicles "CAB004978: AB_426095, HPA021992: , HPA052217: AB_2681765, HPA057284: AB_2683397" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-4)" "unprognostic (7.37e-2)" "unprognostic (7.57e-2)" "unprognostic (9.83e-3)" "unprognostic (2.76e-3)" "unprognostic (5.84e-2)" "unprognostic (1.25e-1)" "unprognostic (2.90e-1)" "unprognostic (8.10e-3)" "unprognostic (3.88e-1)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" 36.7 40.7 33.5 32.8 33.5 44.7 53.9 35.7 37.1 42.0 36.6 62.5 54.3 35.8 65.9 92.2 59.4 33.7 38.5 33.7 37.4 62.6 69.1 32.1 38.1 34.5 33.5 33.2 33.4 49.4 72.9 27.8 47.1 33.9 40.6 69.1 31.5 49.1 36.8 51.8 50.7 45.8 43.2 33.2 37.4 50.4 27.6 34.8 51.8 41.3 41.7 57.7 45.2 44.7 35.4 67.2 136.6 101.8 62.1 126.9 86.5 94.5 83.0 117.1 167.5 116.3 117.9 77.0 66.8 135.8 122.0 88.5 68.7 142.2 181.8 107.9 61.2 178.7 50.6 87.0 177.5 131.0 95.7 64.6 118.2 115.4 148.9 158.0 99.1 106.7 79.0 175.6 65.5 102.1 96.5 138.8 105.2 78.9 152.0 95.3 51.1 123.3 108.7 202.6 75.8 86.3 66.7 46.8 60.1 129.6 155.8 138.4 100.2 58.0 105.7 68.4 60.0 90.3 64.0 39.4 97.9 92.7 64.5 79.6 85.1 76.9 106.7 38.8 89.0 39.9 48.8 42.4 46.4 80.3 46.6 42.3 40.7 44.9 78.9 82.7 54.1 43.1 59.6 33.5 33.5 35.7 37.1 33.7 37.4 34.5 33.5 33.2 33.9 33.2 34.8 35.4 26.3 25.6 36.3 4.2 25.3 13.9 41.0 88.3 16.5 24.1 44.4 46.6 26.9 51.5 65.7 62.5 14.6 136.1 22.0 74.3 133.1 135.9 2.6 61.8 48.5 35.4 41.0 47.9 3.5 152.4 186.5 40.8 40.8 55.9 29.2 21.5 29.6 46.4 102.3 23.5 3.5 70.5 85.5 34.5 12.7 5.6 27.7 33.0 42.7 0.0 46.7 56.1 44.3 2.5 4.7 134.4 75.7 30.5 40.9 44.4 83.5 93.6 74.9 29.5 32.9 13.5 69.9 42.8 46.7 61.9 22.9 121.6 22.8 69.9 63.4 53.5 RAMP2 ENSG00000131477 "Receptor activity modifying protein 2" O60895 17 42758447-42763041 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Adipocytes: 1066.8;Endothelial cells: 562.9;Hepatic stellate cells: 344.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 21 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 21 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "ASC diff: 120.4;EFO-21: 80.5;HUVEC TERT2: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052020 Approved Vesicles NA NA Vesicles "HPA052020: AB_2681697" "unprognostic (8.64e-2)" "unprognostic (2.12e-2)" "unprognostic (8.03e-2)" "unprognostic (1.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (6.79e-2)" "unprognostic (1.28e-2)" "unprognostic (6.96e-3)" "unprognostic (4.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.25e-1)" 177.5 29.3 63.2 19.4 55.1 0.1 170.3 56.5 72.8 84.2 69.3 35.4 12.6 63.7 28.1 25.3 52.2 40.0 101.0 53.1 57.6 60.2 16.9 164.7 26.4 63.1 59.2 46.7 33.3 17.2 24.0 21.0 97.8 74.2 42.4 21.3 4.1 46.3 27.8 43.7 51.6 44.5 73.2 56.3 40.5 34.2 12.0 62.1 11.5 72.3 99.6 24.7 46.3 50.0 73.6 0.1 1.1 4.9 0.1 120.4 6.2 4.0 0.9 2.1 10.2 4.9 11.5 0.1 0.0 80.5 3.0 0.5 0.0 4.6 0.1 8.9 0.0 0.2 0.0 0.7 3.7 3.0 0.0 0.0 4.2 0.1 1.8 0.4 3.5 37.6 1.5 0.1 0.2 0.6 0.0 0.6 0.8 23.3 0.0 0.0 0.1 0.1 0.0 0.6 0.6 4.8 9.8 2.9 0.0 17.3 4.8 1.2 3.2 6.7 19.3 7.1 0.4 2.4 0.0 0.1 0.3 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 63.2 55.1 56.5 72.8 53.1 57.6 63.1 59.2 46.7 74.2 56.3 62.1 73.6 1066.8 0.0 5.7 1.6 6.2 34.4 5.4 0.9 9.6 0.6 24.0 24.8 2.2 0.0 1.0 3.7 0.0 1.1 3.7 0.1 3.9 0.6 1.6 22.2 52.8 562.9 4.2 0.0 0.2 0.7 1.7 126.9 3.1 38.5 0.0 1.4 344.8 1.3 3.4 0.0 1.0 0.2 20.3 8.4 40.5 3.6 38.8 4.1 23.2 45.0 2.6 15.5 0.0 1.5 0.3 0.0 0.0 21.8 5.2 4.8 0.0 1.0 0.1 1.8 6.6 10.5 26.3 26.6 59.1 2.6 27.6 1.5 4.0 14.0 0.1 4.3 AOC2 "DAO2, RAO" ENSG00000131480 "Amine oxidase copper containing 2" O75106 17 42844580-42850707 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "Early spermatids: 29.5" "Cancer enhanced" "Detected in some" "testis cancer: 3.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 11.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA057779 Uncertain "Intracellular and membrane" NA NA "HPA057779: " "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (5.10e-4)" "unprognostic (1.90e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (3.64e-2)" "unprognostic (2.16e-2)" "unprognostic (8.27e-3)" "unprognostic (4.55e-5)" "unprognostic (3.55e-2)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.47e-4)" 5.9 1.1 2.0 0.6 2.2 0.9 2.6 2.1 2.9 1.3 1.0 1.1 0.3 1.0 0.5 0.7 1.6 0.7 0.6 2.6 1.9 1.2 3.4 2.3 0.5 2.3 1.8 2.3 1.1 0.7 0.2 2.0 0.4 2.8 1.5 0.2 1.5 0.6 0.5 1.6 1.3 0.8 0.6 1.4 1.7 0.8 4.9 2.1 0.3 0.9 0.6 0.6 1.8 1.2 2.8 0.2 2.3 0.5 2.5 11.2 1.1 6.0 0.8 0.7 1.6 2.2 1.8 0.2 0.9 1.1 0.2 0.7 1.0 2.2 0.6 3.2 2.0 6.0 0.3 1.3 1.9 0.7 0.3 2.2 1.7 2.0 1.5 2.3 0.4 0.4 3.1 0.6 2.1 0.4 0.3 0.5 0.9 0.8 0.2 0.7 1.1 2.3 1.9 0.3 3.6 0.8 0.5 0.1 0.8 3.4 4.6 0.4 0.2 0.4 1.5 3.2 2.0 1.0 4.6 4.9 0.9 0.4 2.2 0.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 2.2 2.1 2.9 2.6 1.9 2.3 1.8 2.3 2.8 1.4 2.1 2.8 1.1 0.0 0.5 1.6 0.3 1.0 0.5 0.1 0.0 0.5 0.9 0.9 0.4 0.0 0.7 0.0 2.1 0.1 0.4 0.0 0.0 0.3 29.5 1.4 0.7 1.4 0.0 0.0 1.8 0.4 0.1 0.2 0.0 2.8 0.0 0.5 0.4 0.7 0.1 0.0 1.2 0.2 0.0 0.3 0.6 5.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 1.2 0.1 0.2 0.4 0.8 0.0 0.5 1.0 2.3 2.1 0.4 1.6 0.0 0.2 0.4 0.2 0.6 G6PC "G6PC1, G6PT, GSD1a" ENSG00000131482 "Glucose-6-phosphatase catalytic subunit" P35575 17 42900797-42914438 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 75.7;liver: 289.1" "Group enriched" "Detected in some" 4 "Hepatocytes: 246.2;Proximal enterocytes: 176.2" "Cancer enriched" "Detected in some" 72 "liver cancer: 151.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052324 Enhanced NA NA "HPA052324: AB_2681790" "unprognostic (4.23e-2)" "unprognostic (1.49e-2)" "prognostic favorable (5.42e-5)" "unprognostic (8.37e-2)" "prognostic favorable (3.79e-5)" "unprognostic (4.79e-2)" "unprognostic (6.46e-2)" "unprognostic (2.56e-3)" 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.4 0.2 0.0 0.2 0.1 19.8 0.0 0.1 0.0 0.0 4.1 0.0 0.2 0.2 75.7 289.1 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 30.2 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 28.6 0.0 1.8 0.0 0.0 0.0 0.0 1.9 0.7 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.5 246.2 0.1 0.0 0.0 2.1 0.0 3.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 176.2 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.2 NDUFA2 B8 ENSG00000131495 "NADH:ubiquinone oxidoreductase subunit A2" O43678 5 140638740-140647771 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1052.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035933 Approved NA NA "HPA035933: AB_10669661" "unprognostic (4.48e-1)" "prognostic favorable (6.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.96e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-3)" "unprognostic (4.01e-1)" "unprognostic (2.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.39e-3)" "unprognostic (1.84e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.78e-2)" "unprognostic (9.96e-2)" "unprognostic (4.22e-1)" "unprognostic (1.30e-3)" 76.8 129.0 128.3 52.8 128.3 96.8 67.9 135.7 157.4 49.6 134.6 81.7 91.0 44.2 79.7 74.1 50.8 46.3 167.7 125.7 133.6 145.3 146.3 53.7 66.6 130.8 128.9 126.4 55.4 82.2 100.7 79.7 47.7 130.2 69.3 61.5 52.2 103.1 47.2 286.5 51.9 86.8 31.9 133.8 73.2 91.5 80.3 130.7 78.9 64.7 235.1 48.6 56.0 51.7 138.4 131.1 202.5 91.3 195.9 113.6 84.5 117.8 76.6 69.0 99.4 120.4 328.1 149.5 125.4 191.2 65.9 122.9 103.7 88.4 153.9 57.1 120.6 226.6 80.1 170.6 248.3 67.7 138.7 102.6 100.6 116.6 65.4 47.5 84.3 101.2 111.8 86.9 194.4 93.1 204.9 168.4 285.9 97.5 152.8 203.6 144.7 110.4 212.7 167.5 146.4 119.6 99.4 104.7 292.2 221.8 81.9 269.7 216.3 70.1 113.9 84.8 96.3 125.9 214.2 339.4 190.1 132.3 152.8 65.0 195.0 304.6 311.5 133.1 270.1 137.4 222.0 141.1 143.0 258.1 178.0 127.0 135.6 255.8 156.8 219.9 273.3 205.6 322.8 128.3 128.3 135.7 157.4 125.7 133.6 130.8 128.9 126.4 130.2 133.8 130.7 138.4 138.4 109.0 125.4 10.4 127.5 97.8 116.4 311.1 105.3 87.4 182.2 203.5 314.4 200.1 199.7 244.6 37.5 294.1 168.0 499.6 815.9 187.8 526.6 194.5 114.1 115.8 193.2 222.2 6.5 220.4 231.0 115.9 122.9 171.9 92.5 121.2 169.6 516.1 291.9 53.8 7.7 337.9 258.4 251.3 144.6 435.1 165.0 168.0 190.3 5.6 265.1 227.3 211.2 5.5 12.9 194.7 474.4 153.4 151.8 153.8 682.9 1052.3 207.9 113.0 118.3 104.8 139.0 182.7 237.0 165.8 117.1 222.5 124.3 196.1 367.5 164.4 ANKHD1 "FLJ10042, FLJ11979, FLJ14127, FLJ20288, KIAA1085, MASK, MASK1" ENSG00000131503 "Ankyrin repeat and KH domain containing 1" Q8IWZ3 5 140401814-140539856 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA008718 Approved NA NA "HPA008718: AB_1078162" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.45e-1)" "unprognostic (2.78e-1)" "unprognostic (3.69e-2)" "unprognostic (1.39e-3)" "unprognostic (3.18e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-1)" "unprognostic (2.05e-2)" 37.6 43.7 26.1 37.4 31.2 74.7 39.9 35.8 41.3 45.1 32.9 38.6 32.0 41.6 48.7 44.9 41.7 25.2 35.7 26.2 32.8 37.0 54.7 40.7 41.6 28.8 30.3 25.1 52.8 61.1 38.2 42.8 28.8 30.3 37.3 33.5 40.8 42.8 28.0 71.9 49.7 46.7 26.3 26.9 48.8 42.2 30.9 28.4 49.2 47.2 28.2 41.8 36.6 44.3 38.5 58.6 56.5 69.8 95.9 44.3 42.8 74.0 32.4 35.1 45.0 56.0 138.1 51.6 86.5 50.6 29.8 91.6 58.5 67.4 63.4 58.2 65.3 65.1 67.8 77.7 77.3 43.8 132.6 64.3 37.5 41.7 61.9 75.5 31.0 49.3 61.5 69.4 91.5 34.6 62.6 70.4 70.6 42.5 36.7 56.9 89.3 87.1 60.6 23.8 74.2 58.5 40.7 73.1 74.6 75.4 33.6 77.3 69.5 46.4 48.8 28.3 49.5 53.8 83.6 88.5 108.3 38.0 85.3 35.2 25.2 8.2 10.4 10.5 6.3 9.3 10.5 10.6 10.9 7.2 9.2 9.4 9.7 17.9 15.6 8.8 11.3 7.8 3.4 26.1 31.2 35.8 41.3 26.2 32.8 28.8 30.3 25.1 30.3 26.9 28.4 38.5 13.0 12.8 45.5 0.0 34.7 18.6 18.6 7.2 44.9 13.6 9.0 7.5 5.4 18.6 20.5 9.2 16.7 12.0 17.7 10.7 3.9 11.8 13.2 7.9 8.0 13.5 4.2 21.0 0.0 19.2 13.5 13.7 27.5 11.7 12.7 8.3 15.0 10.9 13.0 11.8 0.0 10.1 8.2 19.8 20.8 4.2 10.8 19.7 17.8 0.0 18.5 8.4 11.3 0.0 0.0 13.8 12.1 9.1 41.6 14.0 12.5 5.2 16.3 13.2 19.7 15.3 12.9 31.6 31.6 39.2 21.6 30.8 31.2 6.5 11.8 21.5 DIAPH1 "DFNA1, hDIA1, LFHL1" ENSG00000131504 "Diaphanous related formin 1" O60610 5 141515016-141619055 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing Actin-binding "Cancer-related genes, Deafness, Disease variant, Epilepsy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 173.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 564.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004916, HPA076913" Approved Uncertain "Plasma membrane,Cytosol" NA NA 2000000 "Plasma membrane, Cytosol" "HPA004916: AB_1847668, HPA076913: " "unprognostic (6.79e-2)" "unprognostic (2.99e-1)" "unprognostic (2.12e-3)" "unprognostic (3.73e-2)" "unprognostic (4.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (4.54e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (7.81e-5)" "unprognostic (2.88e-3)" "prognostic favorable (1.29e-5)" "unprognostic (1.64e-2)" "unprognostic (1.84e-2)" "unprognostic (7.00e-2)" "unprognostic (1.65e-1)" 24.9 20.5 21.4 42.5 22.8 91.0 24.5 19.4 21.6 22.2 38.0 31.3 40.9 18.7 44.7 58.5 25.4 30.3 27.2 22.6 24.6 38.5 92.4 51.7 67.5 20.0 21.1 20.9 13.0 37.6 44.9 24.7 25.3 20.2 14.8 31.4 28.7 36.4 19.4 173.4 47.7 36.8 18.9 18.9 36.7 45.5 20.0 25.4 69.2 33.4 56.1 66.9 47.5 30.7 21.4 147.8 92.6 53.2 68.4 40.4 54.5 71.3 59.5 62.2 67.7 70.2 318.1 131.6 156.5 88.1 85.5 103.0 157.9 116.9 191.5 84.8 88.9 66.6 282.6 121.4 103.6 37.7 198.9 564.7 34.4 102.1 94.5 95.5 30.5 87.0 234.8 101.2 106.9 67.7 141.5 217.2 256.8 51.6 75.2 61.6 240.1 87.1 87.6 129.8 158.5 69.4 37.3 146.2 184.6 59.5 47.5 77.5 92.1 52.8 93.9 49.9 52.1 119.9 54.2 94.4 111.7 50.2 153.7 57.8 23.6 12.8 29.8 32.6 14.0 21.2 9.3 20.3 25.3 12.6 9.1 14.8 23.9 13.7 13.7 15.1 10.0 18.7 15.4 21.4 22.8 19.4 21.6 22.6 24.6 20.0 21.1 20.9 20.2 18.9 25.4 21.4 33.9 48.1 46.8 11.8 40.0 52.6 60.8 22.4 21.6 17.3 35.1 23.1 18.6 22.8 48.0 44.1 54.2 20.9 96.9 60.5 5.9 62.7 27.9 42.3 18.9 39.0 5.4 52.6 44.1 98.0 31.9 25.9 76.0 83.0 46.9 14.5 16.8 91.6 17.1 6.7 33.6 23.1 12.2 38.4 60.6 9.0 11.8 78.5 19.6 24.4 54.6 12.1 115.4 25.6 9.1 122.9 35.7 10.9 54.1 77.3 35.2 13.9 30.4 69.0 13.1 15.4 26.4 18.3 26.1 38.7 59.7 52.1 92.8 18.3 30.1 91.2 NDFIP1 "MGC10924, N4WBP5" ENSG00000131507 "Nedd4 family interacting protein 1" Q9BT67 5 142108779-142154440 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 678.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009682 Approved "Intracellular and membrane" NA NA "HPA009682: AB_1079455" "unprognostic (2.78e-2)" "unprognostic (1.62e-1)" "unprognostic (9.26e-2)" "unprognostic (5.66e-3)" "unprognostic (4.74e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (6.95e-2)" "unprognostic (4.96e-2)" "unprognostic (5.97e-2)" "unprognostic (1.74e-2)" "unprognostic (3.28e-1)" "unprognostic (4.46e-2)" "prognostic favorable (2.39e-7)" "unprognostic (9.18e-2)" "unprognostic (2.06e-1)" "unprognostic (6.23e-2)" "unprognostic (8.76e-2)" 62.7 82.4 85.9 34.1 103.8 26.4 56.9 72.3 101.6 55.2 75.7 40.7 49.8 45.7 137.1 30.5 46.8 45.8 55.6 97.7 104.9 95.6 121.2 50.1 39.3 78.5 83.8 94.7 62.0 65.0 153.9 52.1 45.6 84.0 68.3 38.7 165.5 100.4 64.1 46.2 25.5 48.0 41.2 78.1 56.9 50.8 41.1 91.8 42.3 104.3 41.3 35.1 48.8 31.4 109.6 53.3 35.2 61.8 83.6 128.2 72.5 41.4 56.6 59.1 48.0 54.6 39.5 87.3 4.8 115.0 62.2 66.4 51.9 39.6 59.6 56.2 61.2 48.8 69.2 30.8 28.7 55.8 38.3 23.9 55.8 55.3 33.8 43.6 68.4 55.9 54.0 23.4 83.3 60.1 27.4 42.9 12.0 33.2 52.0 33.4 16.1 34.2 122.1 119.1 56.0 65.0 67.3 61.9 91.7 88.3 46.0 64.7 37.6 64.5 58.7 22.1 48.0 56.8 53.6 65.8 22.0 62.1 24.9 45.6 70.4 32.1 26.4 22.9 39.9 29.2 12.8 40.6 28.2 37.0 10.4 80.9 63.9 19.5 23.5 40.1 11.2 50.6 62.4 85.9 103.8 72.3 101.6 97.7 104.9 78.5 83.8 94.7 84.0 78.1 91.8 109.6 100.3 57.7 62.6 74.7 76.4 111.5 176.4 133.4 82.0 196.4 134.3 68.5 70.0 143.0 101.4 154.5 141.8 146.9 94.0 98.0 140.8 207.4 20.2 69.5 91.5 103.7 137.6 184.9 189.5 145.3 263.8 164.1 62.7 118.2 60.2 365.2 116.0 169.8 154.1 318.0 184.9 81.9 177.0 205.9 154.9 15.4 116.5 137.0 170.7 69.3 176.1 300.6 87.6 114.1 125.4 179.8 100.5 156.9 107.6 262.6 198.5 173.0 67.7 322.9 131.5 74.3 149.3 26.6 33.2 71.1 101.3 191.5 156.4 678.1 83.3 256.2 UBE2D2 "UBC4, UbcH5B" ENSG00000131508 "Ubiquitin conjugating enzyme E2 D2" P62837 5 139526431-139628434 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.14e-1)" "unprognostic (2.75e-3)" "prognostic favorable (5.09e-5)" "prognostic favorable (5.90e-4)" "unprognostic (2.33e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (9.63e-7)" "unprognostic (7.41e-3)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (9.33e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (2.09e-5)" "unprognostic (8.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.20e-1)" "unprognostic (1.07e-1)" 76.8 60.4 78.7 67.5 82.5 107.8 73.3 81.1 84.9 84.9 67.5 107.8 46.9 73.4 103.5 89.7 95.8 50.2 87.2 78.6 86.4 76.1 83.3 77.7 84.2 82.8 82.0 74.5 64.9 67.1 73.4 62.8 66.1 82.7 57.5 93.7 77.8 61.5 73.0 192.1 77.9 71.0 75.0 85.0 79.9 70.8 136.8 83.5 129.2 61.8 128.5 141.4 80.5 73.4 88.6 175.9 113.9 194.3 137.0 127.9 161.7 125.4 179.6 165.5 204.7 238.6 292.0 160.6 247.8 229.1 185.7 254.0 108.8 192.6 300.2 272.5 162.4 113.7 140.1 115.0 172.1 249.9 136.9 119.7 129.9 152.0 204.9 301.8 177.4 221.8 159.5 125.0 203.1 192.9 175.5 215.3 197.2 108.1 60.4 124.0 162.7 198.1 179.6 220.4 202.0 177.5 117.0 157.1 198.7 309.4 413.4 125.2 121.6 148.9 156.4 87.6 132.5 223.5 146.0 260.0 343.8 112.3 223.2 128.0 44.1 57.0 115.9 57.7 53.7 62.1 89.2 82.1 80.9 63.3 90.7 102.5 90.3 90.7 65.1 66.2 106.1 110.8 58.0 78.7 82.5 81.1 84.9 78.6 86.4 82.8 82.0 74.5 82.7 85.0 83.5 88.6 137.1 32.1 69.8 35.9 215.4 171.8 182.3 204.8 112.7 76.3 124.8 146.9 96.4 124.4 96.5 68.0 81.3 181.4 205.8 158.0 215.2 208.4 637.0 457.2 94.2 131.0 123.4 148.8 62.0 178.4 228.0 104.8 77.5 230.9 138.8 119.4 109.9 80.6 178.0 94.2 54.4 120.8 142.4 136.4 203.4 550.0 104.4 150.8 152.9 49.6 189.5 170.7 234.8 38.2 65.7 228.7 127.1 93.6 237.3 234.8 123.8 200.9 63.9 105.1 118.3 102.2 171.2 459.7 152.5 149.4 203.7 249.6 217.1 111.7 160.4 247.1 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA 10000 "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 20.9 21.3 19.5 13.9 20.7 13.9 21.6 19.8 20.8 22.7 23.8 19.9 13.3 21.7 13.8 24.6 27.6 17.9 15.5 20.8 20.0 17.8 17.9 17.8 16.5 18.8 20.7 19.3 30.9 27.6 27.5 17.1 19.7 19.8 18.5 21.7 53.6 16.4 20.7 69.1 25.6 13.6 24.1 18.8 21.2 17.4 18.9 19.5 28.4 26.6 38.8 20.5 21.3 18.7 21.1 40.1 32.2 43.3 43.3 49.7 51.6 15.0 28.6 47.2 25.4 33.2 18.8 54.7 29.8 20.1 54.1 36.9 24.7 23.7 38.8 41.8 45.6 28.2 24.0 31.5 19.9 54.7 32.0 25.1 50.4 47.6 36.3 66.5 55.7 43.5 38.6 35.1 28.8 47.7 26.1 58.5 35.2 32.8 47.5 29.8 25.7 38.7 54.2 40.7 35.2 33.9 53.2 43.0 39.1 46.3 48.9 25.8 29.3 47.9 28.1 14.6 30.0 31.5 45.0 29.4 28.1 82.9 36.4 43.8 10.3 12.0 7.2 11.2 12.9 10.0 8.3 11.6 11.9 16.3 8.1 9.4 9.6 4.0 19.6 11.4 7.2 12.9 11.2 19.5 20.7 19.8 20.8 20.8 20.0 18.8 20.7 19.3 19.8 18.8 19.5 21.1 22.9 22.4 22.3 238.6 27.3 18.9 16.3 16.6 25.6 39.9 16.8 15.4 30.9 11.5 18.0 14.7 93.8 17.5 26.7 21.5 3.9 15.0 29.6 27.0 21.2 23.0 17.4 18.7 334.2 18.2 16.6 21.2 34.1 21.0 8.2 32.4 23.2 15.9 18.1 50.5 306.8 21.0 26.4 27.3 14.5 27.6 17.4 20.4 14.2 341.0 23.9 20.4 23.7 395.6 345.9 15.4 17.4 18.8 27.7 13.2 16.3 16.9 29.8 231.5 13.1 26.0 15.3 20.5 13.1 28.2 17.0 11.2 26.2 26.4 21.9 20.1 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292390-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 148.3;Cone photoreceptor cells: 104.3;Rod photoreceptor cells: 201.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA049317: AB_2680710, HPA058381: AB_2683699" "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 11.9 17.2 34.7 2.9 39.9 9.1 10.2 39.2 62.9 20.8 23.1 18.5 6.0 16.4 2.5 32.7 14.3 3.6 24.0 41.8 28.9 17.3 20.8 12.9 3.1 31.9 29.3 38.8 16.5 13.4 2.7 40.5 2.9 32.5 17.4 2.2 12.2 14.6 5.1 17.5 30.6 13.8 3.8 27.4 16.4 16.6 6.5 30.5 4.9 10.8 5.8 2.3 19.8 25.5 39.4 9.7 10.5 5.2 8.5 11.8 8.1 5.2 23.7 7.6 6.7 5.0 13.2 8.1 10.5 12.1 13.2 6.7 22.0 4.7 6.3 1.7 11.8 21.1 4.5 43.7 25.2 8.3 9.1 10.8 6.0 5.0 5.7 3.5 6.4 3.2 12.7 12.5 14.2 7.6 12.9 19.1 13.9 5.1 12.8 24.6 18.7 10.9 40.7 4.1 5.1 36.4 25.9 14.1 9.2 22.8 4.4 9.4 7.1 10.7 12.4 8.9 10.3 8.4 11.5 8.6 9.0 17.0 23.6 5.5 0.0 0.2 0.3 0.2 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.1 34.7 39.9 39.2 62.9 41.8 28.9 31.9 29.3 38.8 32.5 27.4 30.5 39.4 10.0 0.0 4.7 20.5 11.0 32.1 5.8 7.0 12.5 148.3 15.4 11.9 23.4 14.3 5.6 1.8 104.3 9.0 9.3 22.2 3.9 9.4 3.5 4.3 18.3 8.8 32.3 12.6 48.2 5.1 8.8 16.0 39.3 8.0 0.0 8.2 13.2 17.3 7.2 53.8 31.7 14.4 8.2 17.9 15.5 9.0 15.2 11.2 8.8 15.0 11.9 18.9 12.3 80.9 44.4 12.7 13.7 13.2 11.1 6.1 12.6 7.8 6.9 201.6 6.6 12.9 15.2 3.9 15.2 23.5 34.2 10.1 10.4 12.2 16.8 9.9 C1orf159 FLJ20584 ENSG00000131591 "Chromosome 1 open reading frame 159" Q96HA4 1 1081818-1116361 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.1" "Cell type enhanced" "Detected in many" "Early spermatids: 60.9;Late spermatids: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010019, HPA075399" Approved Approved "Nucleoli rim,Mitotic chromosome,Intermediate filaments" Yes No "Nucleoli rim, Mitotic chromosome" "Intermediate filaments" "HPA010019: AB_1078885, HPA075399: " "unprognostic (2.79e-1)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (9.58e-6)" "unprognostic (1.34e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" "unprognostic (9.29e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (1.77e-6)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.62e-4)" 3.5 4.8 9.2 1.6 6.7 2.4 3.9 0.7 10.0 4.9 2.2 5.6 1.8 4.3 1.1 8.7 4.9 2.3 4.3 9.0 2.0 6.6 6.8 4.0 1.8 6.3 2.4 9.6 4.4 3.7 0.7 5.3 1.4 5.9 7.0 0.6 1.6 4.6 2.3 2.2 4.9 4.2 0.5 0.5 5.5 6.1 23.1 3.4 1.8 4.5 0.3 0.9 5.6 5.9 8.0 15.7 12.0 5.6 10.0 1.5 1.6 13.3 9.0 2.1 7.8 5.1 6.5 14.7 4.3 10.8 2.8 6.4 12.2 2.5 7.1 2.2 8.6 18.2 3.1 19.6 7.0 3.6 5.5 7.3 3.2 2.8 3.3 1.6 2.3 3.8 6.4 18.6 3.1 2.8 11.9 10.2 13.2 4.7 5.9 19.7 12.0 6.7 8.5 4.7 4.7 11.8 16.1 6.8 12.2 7.6 1.6 7.8 6.5 5.2 8.3 8.8 11.9 9.2 5.6 8.3 7.8 6.8 14.9 6.5 8.1 2.6 1.4 2.6 2.6 2.8 2.5 2.5 3.0 1.7 2.2 2.5 2.6 0.5 2.7 1.8 2.2 0.9 2.3 9.2 6.7 0.7 10.0 9.0 2.0 6.3 2.4 9.6 5.9 0.5 3.4 8.0 6.3 0.0 7.7 20.2 3.4 7.5 3.6 6.2 4.6 5.9 8.9 6.6 2.3 5.7 7.1 9.2 4.2 5.0 4.9 13.6 1.9 8.2 60.9 8.6 8.2 4.4 4.2 5.2 26.5 7.0 14.0 4.2 20.4 9.0 5.7 9.0 3.3 5.3 3.9 13.5 21.8 7.4 6.1 1.0 4.8 124.1 2.8 3.9 3.6 2.8 6.0 3.2 9.2 10.6 24.5 7.8 3.5 1.5 6.9 5.1 3.4 1.8 10.4 8.2 0.0 3.5 4.8 18.3 6.8 4.2 7.0 4.9 4.6 4.4 9.4 4.9 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 183.3;salivary gland: 182.0;seminal vesicle: 211.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 6.6" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 13.5 2.3 0.5 3.6 1.6 0.1 87.7 0.8 1.4 47.1 0.8 12.4 3.6 40.4 183.3 12.8 59.6 54.8 22.2 0.6 0.1 5.8 109.4 16.3 3.4 0.8 0.6 0.2 2.9 9.2 48.5 4.4 5.3 1.2 17.3 11.1 0.9 182.0 211.1 12.8 98.2 4.6 30.3 0.2 1.2 48.7 10.4 0.1 1.6 35.7 33.3 4.1 6.8 12.9 1.5 140.2 5.3 0.3 4.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 207.9 0.0 2.5 0.0 0.3 254.0 0.0 0.7 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.1 0.0 1.0 0.5 0.3 1.1 182.2 19.6 0.3 0.0 0.7 0.0 0.2 7.3 0.2 0.1 43.1 0.8 1.4 16.2 0.5 0.5 0.3 1.1 0.0 3.5 0.1 0.3 0.2 0.2 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.8 1.4 0.6 0.1 0.8 0.6 0.2 1.2 0.2 0.1 1.5 7.2 0.0 0.0 0.7 0.4 17.7 21.5 4.2 0.0 0.0 30.5 70.2 3.5 17.2 2.0 0.0 0.0 1.3 0.2 0.4 0.0 4.1 54.9 10.0 27.5 5.6 0.0 2.7 0.7 0.0 0.6 4.2 36.7 18.5 4.5 0.0 3.3 141.3 0.2 0.0 20.4 13.3 0.0 1.6 3.0 75.1 1.8 0.7 5.4 2.8 0.0 0.8 0.0 1.5 0.7 1.0 0.5 1.5 0.3 22.6 0.0 0.7 0.3 0.4 46.0 1.1 52.5 1.4 2.3 1.4 46.7 4.1 0.7 0.1 0.4 20.9 PPFIA1 "LIP.1, LIPRIN" ENSG00000131626 "PTPRF interacting protein alpha 1" Q13136 11 70270690-70385312 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 190.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 261.2;SK-MEL-30: 156.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017032, HPA042271" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "CAB017032: , HPA042271: AB_2677923" "unprognostic (1.89e-1)" "unprognostic (1.28e-2)" "unprognostic (6.27e-2)" "unprognostic (9.92e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.58e-4)" "unprognostic (7.20e-3)" "unprognostic (2.20e-1)" "unprognostic (3.02e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.14e-1)" "prognostic favorable (3.76e-4)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (2.14e-2)" 26.9 14.8 16.7 16.2 17.2 20.8 17.8 15.8 17.6 12.6 20.2 18.4 14.1 18.1 13.8 16.6 12.2 22.3 14.6 15.3 34.0 16.5 15.1 20.0 15.8 24.8 18.0 11.4 15.2 16.0 18.1 13.3 24.3 21.7 12.5 15.9 15.1 13.6 14.1 31.9 18.1 16.3 17.6 17.9 15.4 13.6 26.5 18.9 15.8 23.5 27.0 14.1 17.2 12.2 22.5 261.2 30.4 31.8 22.5 33.1 20.3 34.9 30.0 24.4 40.8 26.0 66.8 22.8 25.8 39.6 27.3 39.4 38.3 30.7 28.3 35.9 15.5 21.5 19.7 34.3 24.7 33.4 26.2 22.1 24.9 46.8 53.1 44.6 31.4 27.9 21.3 33.1 19.9 37.3 30.8 19.3 17.7 19.7 59.5 34.3 20.6 80.2 22.2 20.6 32.9 31.9 21.5 45.2 59.1 156.6 36.0 37.5 31.2 30.0 38.0 29.8 54.3 32.4 24.7 15.8 37.3 28.2 20.1 43.0 0.0 1.6 1.1 0.8 1.2 1.2 1.5 1.2 1.1 1.3 1.0 0.9 0.6 5.0 0.4 3.5 1.7 1.2 0.6 16.7 17.2 15.8 17.6 15.3 34.0 24.8 18.0 11.4 21.7 17.9 18.9 22.5 33.0 25.6 53.5 114.6 19.3 27.4 26.4 14.2 30.1 39.1 32.8 24.1 27.2 20.0 25.1 18.4 31.3 44.2 14.2 39.3 11.7 21.8 190.4 28.7 44.4 31.4 26.9 24.8 57.8 20.3 13.7 33.3 25.5 45.4 8.8 94.3 20.7 25.2 25.2 33.7 52.8 19.8 16.2 35.5 28.8 97.7 27.7 40.4 21.4 38.4 28.8 71.8 17.5 47.7 56.4 36.2 24.7 25.6 23.6 36.7 19.2 22.7 27.1 45.8 19.7 45.4 30.0 60.7 61.9 36.1 33.1 74.3 22.2 42.2 25.1 37.2 TMEM204 "C16orf30, CLP24, FLJ20898" ENSG00000131634 "Transmembrane protein 204" Q9BSN7 16 1528688-1555580 "Predicted membrane proteins, Transporters" "Stress response" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 208.2;Endothelial cells: 95.9;Hepatic stellate cells: 133.2;Peritubular cells: 67.4;Sertoli cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 156.6" "Lineage enriched" "Detected in many" 5 "T-cells: 156.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.5;BJ: 16.5;BJ hTERT+: 21.2;fHDF/TERT166: 14.2;HHSteC: 36.9;HSkMC: 14.8;TIME: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014028 Approved NA NA "HPA014028: AB_2204906" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.81e-3)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (1.81e-2)" "prognostic favorable (4.76e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (8.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.04e-2)" "unprognostic (7.62e-3)" "unprognostic (5.11e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (2.53e-2)" 48.6 21.0 14.7 7.9 13.0 0.6 43.7 12.5 16.4 32.6 11.0 25.7 6.5 36.2 4.1 12.2 27.1 13.0 55.8 11.1 11.4 46.0 17.3 72.1 16.5 14.1 13.6 8.7 17.7 16.0 7.5 14.7 12.9 14.5 28.6 2.9 0.5 16.9 14.5 18.2 17.7 25.5 11.3 11.0 24.4 22.3 8.3 14.2 8.0 49.4 16.2 5.4 29.1 20.9 11.4 0.1 0.1 0.9 0.1 7.5 12.5 0.2 16.5 21.2 2.5 2.6 0.6 0.1 0.1 0.1 14.2 0.0 0.3 0.0 0.0 1.1 0.1 0.1 0.0 0.8 0.2 36.9 0.0 0.0 14.8 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.7 0.0 0.2 0.0 0.2 0.5 0.3 0.5 0.1 1.8 0.4 0.0 0.0 12.6 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 4.4 0.3 0.7 0.0 24.5 0.9 45.2 0.6 80.0 55.0 1.8 1.3 156.6 82.2 2.8 34.1 0.8 0.6 38.1 41.1 14.7 13.0 12.5 16.4 11.1 11.4 14.1 13.6 8.7 14.5 11.0 14.2 11.4 208.2 0.0 3.7 0.7 4.5 5.7 7.1 17.1 1.2 0.2 3.4 4.4 8.3 0.0 1.6 0.0 0.0 0.5 6.5 0.0 0.0 0.3 0.8 1.9 33.6 95.9 0.0 5.7 0.7 0.2 0.2 31.8 0.0 0.8 0.0 2.3 133.2 1.1 0.4 0.0 0.6 0.0 2.0 3.8 5.7 1.3 23.6 5.6 7.2 30.0 1.4 0.2 12.3 0.0 0.6 0.0 0.0 67.4 0.5 1.1 0.0 0.1 0.2 0.8 118.3 3.3 43.0 0.0 0.2 0.7 3.1 0.4 15.3 17.2 0.0 5.1 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2964216-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 4.1;skin 1: 6.8" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 14.1;Basal squamous epithelial cells: 23.3;Intestinal goblet cells: 14.0;Rod photoreceptor cells: 10.9;Spermatocytes: 9.7;Spermatogonia: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "HMC-1: 29.3;MCF7: 15.0;RPMI-8226: 28.8;T-47d: 14.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavorable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.0 0.1 0.7 0.3 0.7 0.7 0.1 0.0 0.9 0.7 0.0 0.2 0.1 0.1 0.1 2.0 0.3 0.1 0.0 1.2 0.0 0.1 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.6 1.3 0.0 4.1 0.4 0.0 0.3 6.8 0.6 0.0 0.0 0.2 0.2 1.7 0.0 2.1 0.0 0.0 0.8 0.0 0.5 0.8 1.8 1.1 0.4 10.2 0.0 0.0 1.5 0.6 0.0 0.0 0.0 4.2 1.5 7.8 2.1 0.0 1.1 8.6 1.3 0.7 0.0 1.1 1.2 0.5 2.9 2.6 0.0 0.6 29.3 0.2 0.0 0.0 0.1 0.9 0.0 0.8 3.3 2.9 0.0 15.0 1.8 3.5 2.9 3.0 2.2 4.7 11.8 28.8 0.1 0.3 2.9 1.8 2.0 4.7 5.2 0.4 14.9 2.8 0.2 0.9 12.2 1.0 0.7 5.3 1.3 4.7 0.4 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.7 0.0 0.9 1.2 0.0 0.3 0.1 0.1 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.3 1.4 14.1 0.9 0.3 23.3 0.4 1.0 0.9 0.9 0.0 0.0 0.0 6.2 0.2 0.0 1.1 0.0 0.1 0.7 0.4 0.1 0.1 0.0 0.0 0.4 2.7 1.8 0.1 0.0 0.9 4.5 0.0 0.0 0.0 0.1 0.0 0.1 14.0 0.0 0.0 0.6 0.6 0.0 0.2 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.2 1.3 0.0 0.1 2.1 0.5 0.0 0.0 10.9 0.0 0.0 0.3 9.7 18.0 1.2 5.5 0.1 0.6 0.0 0.5 0.4 THOC6 "fSAP35, MGC2655, WDR58" ENSG00000131652 "THO complex 6" Q86W42 16 3024027-3027755 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport" "Developmental protein, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 107.8;Extravillous trophoblasts: 121.1;Prostatic glandular cells: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052953 Uncertain Supported "Nucleoplasm,Nuclear speckles" No No "Nucleoplasm, Nuclear speckles" "HPA052953: AB_2681997" "unprognostic (2.07e-2)" "unprognostic (4.13e-3)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (7.82e-3)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (4.40e-4)" "unprognostic (3.59e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (9.43e-2)" 15.0 17.0 8.3 16.2 8.8 23.7 15.4 9.1 11.3 15.6 9.3 17.2 19.0 20.5 6.1 19.4 14.1 10.6 14.7 8.2 8.8 17.8 21.5 17.7 20.9 10.5 8.7 7.8 11.7 13.0 10.9 17.5 18.4 11.2 21.3 10.2 2.1 15.3 12.3 26.1 25.1 19.3 12.6 9.1 22.9 15.7 10.5 9.2 19.8 15.8 8.5 16.2 17.2 16.7 11.1 37.3 59.6 42.0 45.0 21.1 23.9 74.4 11.3 25.7 25.7 37.8 39.6 42.8 70.0 36.0 18.9 19.1 49.9 46.3 35.6 14.0 62.3 59.9 38.0 58.6 58.7 35.9 56.2 80.0 24.3 42.6 31.4 76.9 32.4 24.1 39.7 56.1 36.5 12.8 87.0 32.0 103.3 76.2 21.4 25.3 84.7 31.6 82.4 27.1 18.6 86.4 41.0 31.8 49.9 21.7 18.1 35.9 60.0 20.1 26.8 61.1 30.6 41.3 26.3 24.3 85.5 7.0 38.1 27.3 2.4 61.3 13.6 35.2 62.2 36.2 37.8 32.6 34.7 88.6 43.2 37.1 39.1 4.4 38.8 35.7 74.3 38.0 45.4 8.3 8.8 9.1 11.3 8.2 8.8 10.5 8.7 7.8 11.2 9.1 9.2 11.1 11.0 19.2 7.4 1.6 24.7 68.2 84.9 59.0 30.7 3.7 22.1 20.8 3.3 14.3 18.9 18.4 2.1 107.8 23.3 23.2 35.2 33.1 5.4 17.9 19.0 17.9 25.8 30.3 1.9 23.5 121.1 24.6 15.3 25.8 12.0 15.6 6.4 10.3 51.8 3.3 1.7 32.3 44.7 19.4 37.3 3.2 14.9 23.4 24.9 2.8 39.6 3.2 15.5 0.5 4.2 21.5 28.0 12.0 19.7 109.4 32.1 32.0 8.7 2.4 6.6 23.4 31.9 5.3 23.3 23.3 44.9 77.2 20.4 20.9 42.2 46.8 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 28.3 29.6 14.4 24.7 13.5 35.3 28.4 15.6 23.2 31.1 16.4 37.8 40.4 31.5 11.7 55.1 30.7 22.4 21.3 15.8 16.4 28.1 51.9 33.5 23.1 15.5 13.5 12.4 23.7 37.7 14.7 32.3 20.8 13.8 27.2 17.6 8.6 35.0 16.6 30.7 47.5 35.5 19.0 11.8 34.7 35.9 14.9 15.1 19.2 25.9 10.0 18.7 34.8 35.1 13.4 57.7 72.2 40.3 72.5 40.8 76.5 47.4 43.4 53.9 49.9 44.6 88.2 72.1 36.6 50.2 55.4 31.8 65.9 38.1 76.8 18.8 58.3 48.8 52.4 98.5 68.3 53.8 56.3 72.7 76.2 62.8 48.1 62.6 41.0 97.4 70.6 57.1 47.9 48.2 131.1 58.3 65.2 79.7 78.7 34.8 107.4 66.7 74.2 40.2 30.4 80.9 67.2 36.3 68.5 48.6 20.9 78.1 68.2 74.3 60.2 83.9 56.7 48.2 69.2 55.0 48.4 34.4 35.9 47.8 4.0 9.1 7.3 4.5 12.4 4.3 5.5 4.4 4.7 11.2 3.9 3.1 3.8 6.2 2.9 8.9 5.3 6.5 5.3 14.4 13.5 15.6 23.2 15.8 16.4 15.5 13.5 12.4 13.8 11.8 15.1 13.4 18.9 0.0 9.2 12.4 18.2 28.8 21.1 34.2 22.8 15.9 31.6 27.9 4.9 21.5 20.8 14.7 6.2 23.5 17.4 56.4 17.6 39.0 5.0 23.6 34.6 26.5 34.0 33.6 8.9 59.0 36.3 19.0 38.7 27.9 9.5 22.1 26.0 32.3 42.2 37.0 8.2 38.7 34.6 41.8 21.3 13.1 24.8 26.8 10.6 8.4 33.9 12.6 6.2 6.6 4.9 53.0 43.6 22.2 24.0 33.8 80.0 29.2 19.7 10.9 6.6 11.9 18.3 8.5 25.3 50.7 32.5 26.7 16.0 29.0 42.5 38.5 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951627-93955355 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "stomach 1: 167.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Early spermatids: 2.6;Fibroblasts: 2.9;Smooth muscle cells: 1.2" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 29.5;HMC-1: 69.8;NTERA-2: 20.7;THP-1: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA055858: AB_2682947" "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 7.8 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.8 0.4 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 15.2 1.5 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 167.9 3.9 0.0 0.0 1.0 0.5 0.4 0.0 0.0 0.0 0.0 2.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 4.3 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.4 20.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.3 5.8 0.0 28.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.9 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NINJ1 NIN1 ENSG00000131669 "Ninjurin 1" Q92982 9 93121496-93134251 "Predicted membrane proteins" "Angiogenesis, Cell adhesion, Cytolysis, Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 289.5" "Cell type enhanced" "Detected in many" "Hofbauer cells: 539.9;Langerhans cells: 741.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1668.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 1668.9" "Cell line enhanced" "Detected in many" "Hep G2: 197.5;MCF7: 191.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045063 Uncertain "Intracellular and membrane" NA NA "HPA045063: AB_10964133" "unprognostic (1.23e-2)" "unprognostic (8.25e-3)" "unprognostic (3.64e-3)" "unprognostic (1.40e-2)" "unprognostic (8.18e-2)" "unprognostic (1.28e-2)" "unprognostic (4.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.82e-2)" "unprognostic (9.06e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-2)" "unprognostic (9.45e-3)" "unprognostic (2.51e-1)" "unprognostic (2.69e-2)" "unprognostic (1.40e-3)" "unprognostic (7.46e-3)" 49.9 130.8 44.3 40.2 41.0 289.5 53.4 43.1 59.2 45.2 44.5 50.8 27.3 36.8 20.4 25.9 48.0 39.6 62.0 37.8 51.8 99.9 119.0 65.6 41.8 48.9 46.4 34.2 36.2 35.3 138.9 59.7 67.1 47.2 59.5 16.7 6.1 78.0 56.8 38.3 79.0 37.9 36.4 50.3 90.7 42.9 37.9 53.4 30.7 72.0 30.2 19.8 101.5 38.2 55.3 45.0 68.2 13.2 30.0 47.4 19.1 51.6 30.2 85.9 43.5 26.7 29.5 15.5 0.6 15.0 29.7 47.6 44.8 14.7 84.6 9.4 103.3 28.7 6.8 17.2 197.5 163.7 4.8 13.8 62.5 80.9 41.1 22.5 132.4 41.3 16.3 5.0 49.6 9.9 191.1 13.9 13.8 18.7 51.9 53.0 24.6 10.3 79.0 35.0 18.6 4.3 18.4 67.3 105.4 41.9 22.0 81.9 31.3 31.1 15.8 44.6 33.2 22.9 26.2 11.4 1.0 48.2 14.8 12.1 152.9 313.3 824.9 69.8 315.4 94.5 7.8 65.0 59.3 75.9 2.4 76.5 55.1 1668.9 44.7 355.8 10.7 73.8 219.1 44.3 41.0 43.1 59.2 37.8 51.8 48.9 46.4 34.2 47.2 50.3 53.4 55.3 15.7 28.9 41.6 6.5 24.3 114.6 75.8 273.0 130.3 1.8 117.8 96.6 31.6 62.9 80.7 40.5 0.0 128.3 45.8 19.4 129.1 95.2 3.9 22.9 20.9 46.9 18.0 3.0 3.4 101.7 78.3 64.9 20.9 24.5 47.0 13.8 23.6 48.5 539.9 1.7 3.9 21.3 111.9 176.9 741.7 21.1 42.0 278.1 147.7 18.7 214.9 76.1 33.0 3.0 1.7 68.7 23.7 72.6 32.5 60.3 75.5 240.6 18.8 3.8 13.1 45.7 53.3 0.9 11.4 36.3 135.7 73.3 54.7 4.5 19.7 76.9 CA6 ENSG00000131686 "Carbonic anhydrase 6" P23280 1 8945867-8975092 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 357 "salivary gland: 9472.7" "Group enriched" "Detected in some" 44 "Breast glandular cells: 77.9;Ionocytes: 99.7;Melanocytes: 179.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.6;naive CD8 T-cell: 16.4" "Lineage enriched" "Detected in many" 11 "T-cells: 16.4" "Cell line enhanced" "Detected in some" "Daudi: 1.7;U-2197: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028550, HPA028692" Enhanced "Secreted to digestive system" NA NA 24000000 "HPA028550: AB_10600105, HPA028692: AB_10601883" "unprognostic (2.54e-5)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.37e-1)" "unprognostic (2.90e-1)" "unprognostic (9.28e-2)" "unprognostic (2.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.73e-1)" "unprognostic (5.93e-2)" "unprognostic (4.41e-2)" "unprognostic (4.29e-5)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (2.35e-1)" 0.4 0.4 0.4 0.7 0.6 2.1 21.0 0.7 0.7 0.0 0.4 0.1 0.3 0.2 2.3 0.2 0.1 0.2 1.5 0.4 0.4 0.1 0.1 0.3 1.3 0.7 0.4 0.4 1.9 6.3 0.0 0.1 0.9 0.9 0.2 0.2 0.8 9472.7 0.0 0.4 26.4 0.5 0.0 0.1 1.2 0.4 0.3 0.6 1.2 0.3 0.0 1.0 0.1 0.0 1.8 0.2 0.0 0.2 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.4 1.7 0.1 0.1 0.4 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.5 0.5 0.0 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.4 0.0 0.2 0.2 0.4 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.6 0.3 1.3 0.2 0.4 0.1 0.4 0.1 0.4 0.4 1.4 0.3 0.2 0.3 0.2 0.3 0.3 0.7 2.7 0.0 0.5 5.6 16.4 1.3 0.4 0.2 0.3 0.3 1.6 0.4 0.6 0.7 0.7 0.4 0.4 0.7 0.4 0.4 0.9 0.1 0.6 1.8 0.2 0.0 0.0 0.0 0.1 0.1 0.1 1.4 0.0 0.0 77.9 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 99.7 0.0 1.3 0.2 0.0 0.2 179.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.5 0.0 0.0 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "hippocampal formation: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: AB_2685505" "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 2.7 2.2 1.0 2.3 0.8 3.7 2.7 0.0 2.0 2.7 1.9 2.2 2.1 2.9 2.3 2.0 7.9 2.1 1.8 3.1 0.3 2.2 1.3 3.1 2.3 0.2 0.2 0.6 2.9 2.5 2.7 7.9 1.6 0.3 2.2 1.2 2.4 2.2 2.3 2.2 5.0 2.2 2.3 0.0 2.2 2.0 5.3 0.1 2.6 6.7 1.9 1.1 2.1 2.5 0.6 7.8 4.8 5.4 4.3 4.7 6.8 4.1 3.9 3.9 5.3 4.2 4.1 6.5 4.0 9.6 4.6 3.6 7.4 2.7 6.6 2.7 5.1 7.3 3.4 8.1 4.1 3.7 6.5 5.1 5.6 3.2 6.3 3.9 3.4 3.8 9.4 6.2 4.1 2.4 5.9 8.3 7.1 1.0 4.0 5.5 7.1 3.4 6.5 2.6 1.0 17.0 5.5 6.1 4.5 6.5 2.3 6.0 7.2 3.7 7.6 3.2 13.0 4.8 5.0 7.0 4.2 3.4 8.3 2.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 1.0 0.8 0.0 2.0 3.1 0.3 0.2 0.2 0.6 0.3 0.0 0.1 0.6 3.2 0.0 1.1 24.2 1.3 4.0 1.2 1.8 3.4 7.3 3.0 3.6 3.1 4.3 3.9 3.7 33.3 0.6 2.2 2.1 1.9 1.6 2.0 10.2 3.3 2.9 3.6 3.2 47.1 1.8 0.5 3.5 4.1 3.0 0.0 4.0 1.8 1.5 2.0 5.0 30.8 2.2 2.0 3.5 3.7 1.4 4.1 2.4 10.6 14.0 1.8 6.3 2.1 10.6 17.3 2.1 2.2 2.2 2.6 1.8 1.1 1.9 10.9 18.2 6.6 1.6 2.7 11.6 6.5 1.9 5.3 1.1 1.7 4.0 1.7 1.1 MAP1B "MAP5, PPP1R102" ENSG00000131711 "Microtubule associated protein 1B" P46821 5 72107234-72209565 "Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 392.9;retina: 156.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2" "Cancer enriched" "Detected in all" 5 "glioma: 48.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 301.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009792, HPA022275" Enhanced Supported Enhanced Cytosol NA NA 180000 Cytosol "CAB009792: AB_2137420, HPA022275: AB_1853944" "unprognostic (9.96e-2)" "unprognostic (3.97e-2)" "unprognostic (1.57e-2)" "unprognostic (3.70e-1)" "unprognostic (4.67e-3)" "unprognostic (2.98e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (7.00e-2)" "unprognostic (4.78e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.90e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (8.22e-5)" 25.7 19.5 160.6 11.0 111.7 0.1 18.0 161.4 278.8 15.0 0.0 12.4 2.1 16.7 9.5 13.1 11.6 11.1 22.4 173.1 176.4 4.0 2.3 7.1 2.2 320.0 210.8 92.1 7.1 3.6 2.5 16.5 10.0 364.2 20.2 5.4 156.3 7.8 25.6 6.0 11.4 7.2 26.7 246.7 1.3 15.4 12.1 379.9 1.5 8.4 9.7 1.3 26.9 11.5 392.9 1.4 62.8 133.5 48.7 80.9 140.1 0.2 32.6 22.7 29.0 34.5 0.5 1.7 0.1 71.8 108.2 87.9 0.6 73.2 2.8 43.3 0.2 12.3 6.7 22.3 18.3 43.6 0.0 5.1 142.1 9.3 116.7 42.8 25.9 91.6 0.2 10.6 0.3 49.5 0.6 0.1 0.0 36.5 0.0 21.3 0.4 16.4 0.1 2.5 0.1 89.9 63.0 28.9 0.3 14.9 109.7 0.2 6.1 301.6 90.7 44.6 69.4 140.3 8.0 0.4 0.2 98.5 0.1 72.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 160.6 111.7 161.4 278.8 173.1 176.4 320.0 210.8 92.1 364.2 246.7 379.9 392.9 45.6 0.0 2.0 85.5 1.5 31.6 71.3 2.3 5.2 240.3 14.3 34.3 366.0 2.8 11.5 9.2 717.2 1.6 0.6 0.0 0.0 12.9 13.2 75.4 116.8 97.8 77.6 0.0 571.8 3.4 1.4 220.6 6.6 27.7 1.3 25.3 42.1 0.8 6.4 647.8 350.7 0.7 18.3 1.3 28.4 23.4 309.7 10.1 80.0 91.8 0.0 406.1 0.0 131.2 269.3 7.1 0.0 384.8 0.5 22.1 0.1 0.9 48.6 562.1 769.2 85.4 461.2 8.9 8.0 1.9 50.6 4.0 4.2 269.9 0.2 20.0 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158613-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 11.1" "Group enriched" "Detected in some" 22 "Spermatocytes: 6.6;Spermatogonia: 7.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "K-562: 100.5;NB-4: 69.9;THP-1: 27.9;U-266/84: 47.2" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.5 0.0 0.2 0.0 0.0 2.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 11.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.5 0.0 0.0 0.0 0.0 69.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.5 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.2 2.1 0.5 0.1 0.4 0.6 0.5 0.0 1.1 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727133-118794535 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.9;eosinophil: 12.2;myeloid DC: 17.2;neutrophil: 29.2" "Group enriched" "Detected in many" 7 "dendritic cells: 17.2;granulocytes: 29.2;monocytes: 10.9" "Cell line enhanced" "Detected in many" "HDLM-2: 181.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 17000000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 52.4 34.6 14.9 40.6 17.1 7.2 41.9 18.4 17.4 27.3 22.7 52.6 49.0 32.2 26.4 54.0 36.1 39.6 18.0 14.1 24.0 34.0 121.3 49.3 25.6 25.3 19.7 10.8 37.8 22.5 22.4 15.5 33.1 23.4 22.7 62.2 25.8 35.0 27.4 31.6 20.7 61.3 40.9 21.9 30.2 36.1 16.7 20.7 16.1 30.0 56.4 34.8 31.9 27.6 23.0 31.6 37.2 17.4 48.0 39.0 113.5 33.1 63.3 86.2 29.2 37.6 21.8 55.0 0.1 111.4 86.6 84.8 29.1 19.0 26.6 32.3 181.0 16.5 5.1 30.9 55.8 23.4 0.6 13.0 104.1 23.5 40.0 48.8 87.9 61.8 0.0 16.6 3.3 41.9 44.8 0.1 8.5 16.1 57.8 38.6 0.1 43.3 0.2 43.6 32.9 6.5 6.0 102.3 35.5 24.7 22.8 22.8 28.9 79.3 56.7 26.7 99.7 50.5 0.7 16.8 0.3 125.6 16.1 24.6 0.2 10.9 12.2 0.0 2.7 0.1 2.9 0.0 0.0 17.2 2.5 0.0 0.0 29.2 0.1 1.1 2.9 0.1 2.9 14.9 17.1 18.4 17.4 14.1 24.0 25.3 19.7 10.8 23.4 21.9 20.7 23.0 36.0 70.5 48.5 1.0 20.2 17.2 37.1 17.2 18.2 2.1 32.4 26.3 11.5 37.1 46.0 29.5 16.7 8.1 2.8 61.9 9.8 36.1 38.1 25.8 34.0 58.8 93.2 4.8 0.3 98.3 31.9 38.7 38.7 27.3 0.0 13.6 78.9 149.0 41.2 0.0 2.0 138.4 16.2 124.8 140.6 7.3 24.2 120.4 21.4 73.1 199.7 43.7 2.1 0.0 6.9 87.9 27.0 18.8 1.3 42.3 70.8 25.2 49.7 11.2 32.9 14.4 26.2 7.5 28.9 37.2 12.1 9.4 2.7 7.1 29.5 30.8 WDR44 "DKFZp686L20145, RAB11BP, RPH11, SYM-4" ENSG00000131725 "WD repeat domain 44" Q5JSH3 X 118346073-118449961 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038084, HPA046719" Approved Supported "Golgi apparatus" NA NA 1800000 "Golgi apparatus" "HPA038084: AB_10675626, HPA046719: AB_2679772" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-1)" "unprognostic (6.09e-2)" "unprognostic (1.91e-1)" "unprognostic (1.88e-2)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "unprognostic (4.98e-2)" "unprognostic (5.52e-2)" 8.5 7.3 7.0 8.3 9.5 6.1 6.3 8.5 7.6 8.1 3.4 6.3 8.4 7.8 6.7 11.4 5.9 11.9 8.4 7.7 7.4 6.1 12.9 7.9 9.4 7.2 7.1 5.7 7.7 6.8 10.2 5.2 7.3 6.9 7.6 6.2 8.5 5.6 10.6 9.8 5.1 7.8 10.5 6.7 8.2 8.7 9.9 7.3 10.7 7.0 9.0 9.3 10.1 6.9 10.6 16.4 9.4 10.0 5.8 16.7 13.6 5.5 25.2 17.6 17.9 25.2 6.4 18.4 4.6 14.4 18.1 15.1 12.6 19.7 12.0 20.6 18.6 8.8 18.5 23.3 4.2 11.5 11.7 12.4 8.1 12.6 17.0 11.4 18.2 16.1 8.5 14.8 15.8 17.3 8.0 9.2 6.9 18.1 12.3 15.1 7.2 8.6 7.2 14.6 10.3 4.3 6.7 23.9 8.3 7.9 17.7 7.4 8.3 20.5 13.3 5.1 18.2 14.4 5.9 10.0 6.5 11.2 13.7 9.1 8.0 3.2 7.3 5.4 4.9 5.5 3.6 4.4 5.4 5.1 3.2 5.1 5.6 2.0 7.2 5.5 3.7 7.1 4.0 7.0 9.5 8.5 7.6 7.7 7.4 7.2 7.1 5.7 6.9 6.7 7.3 10.6 14.3 22.4 15.0 18.3 11.0 14.8 7.2 6.3 9.1 8.9 7.6 6.3 11.4 10.0 6.2 12.9 10.4 2.3 9.9 9.6 1.9 5.2 0.4 10.9 10.8 12.0 1.2 5.0 35.2 5.3 2.2 11.1 14.3 17.8 8.8 9.8 5.7 16.7 8.6 1.7 41.2 5.2 4.1 13.6 17.7 1.3 7.2 17.2 7.2 40.3 10.3 7.5 11.3 35.2 89.6 11.0 5.8 11.3 12.1 10.2 6.2 4.2 9.1 7.0 26.3 9.3 11.1 17.5 17.6 12.3 9.2 1.2 14.7 5.7 4.6 7.4 CKMT2 SMTCK ENSG00000131730 "Creatine kinase, mitochondrial 2" P17540 5 81233320-81266398 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 48 "heart muscle: 1102.4;skeletal muscle: 1444.3;tongue: 2345.0" "Cell type enriched" "Detected in many" 20 "Cardiomyocytes: 814.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.1" "Cell line enhanced" "Detected in many" "BEWO: 3.5;T-47d: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051880 Enhanced NA NA 3000000 "HPA051880: AB_2681650" "unprognostic (3.64e-3)" "unprognostic (1.15e-1)" "unprognostic (2.82e-3)" "unprognostic (1.88e-2)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (1.73e-2)" "unprognostic (3.57e-2)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (5.34e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.75e-3)" 18.3 33.9 11.6 0.8 13.6 0.1 4.6 16.5 12.4 8.0 20.9 2.7 1.1 6.4 11.5 20.3 6.9 8.2 1102.4 10.4 12.8 14.7 1.0 2.5 1.3 15.6 15.7 8.5 10.3 7.7 15.9 4.6 0.7 15.8 13.2 0.7 1.6 26.5 13.2 1444.3 4.0 2.8 8.8 12.3 1.8 18.0 3.6 15.0 0.8 4.9 2345.0 0.4 4.2 4.1 17.0 0.3 0.7 0.8 1.3 1.9 0.4 3.5 0.1 0.0 0.0 0.0 2.4 0.2 1.4 0.4 0.0 1.0 0.0 0.0 0.0 0.0 1.5 2.4 0.1 1.0 3.2 2.6 0.6 0.2 0.8 0.0 0.0 0.0 0.3 0.0 2.1 0.3 0.5 0.0 2.2 1.2 0.2 1.0 0.0 0.7 0.6 1.0 0.1 0.0 0.0 1.4 1.0 1.2 0.3 1.4 1.5 6.3 0.3 0.7 0.4 1.2 0.7 0.2 0.2 0.1 1.3 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 11.6 13.6 16.5 12.4 10.4 12.8 15.6 15.7 8.5 15.8 12.3 15.0 17.0 1.8 0.0 0.5 40.1 0.0 0.1 0.4 0.0 1.2 0.9 0.9 0.8 814.1 7.2 0.6 12.9 0.0 0.1 0.0 0.1 37.2 1.7 25.1 13.6 3.5 9.8 0.0 0.0 11.4 0.6 0.4 16.2 6.6 27.8 0.0 0.8 0.0 0.0 0.1 0.0 18.1 0.3 0.0 0.0 0.0 2.2 7.2 0.3 3.6 23.4 0.0 1.4 0.0 4.5 9.1 0.4 0.0 15.1 0.0 0.3 0.3 0.6 0.7 1.0 0.0 11.6 15.0 1.0 0.4 0.1 0.1 0.3 0.8 23.7 2.5 0.2 ZCCHC9 "DKFZp761J139, PPP1R41" ENSG00000131732 "Zinc finger CCHC-type containing 9" Q8N567 5 81301587-81313297 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038404 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA038404: AB_10672744" "unprognostic (1.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-2)" "unprognostic (1.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.91e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.68e-2)" "unprognostic (5.20e-3)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 13.6 12.5 9.8 16.0 9.7 10.9 13.6 10.8 13.5 15.6 10.9 14.3 15.0 15.6 16.5 14.7 12.7 14.5 10.8 9.6 10.8 18.0 33.6 11.3 19.2 10.2 10.0 9.7 17.4 11.9 13.1 13.9 19.3 10.0 15.6 15.1 14.1 10.6 11.1 15.0 16.4 18.9 14.7 9.7 13.4 13.0 15.0 10.3 17.9 12.7 11.7 18.4 16.5 13.6 11.3 26.6 18.5 44.5 23.7 37.5 35.3 59.7 39.2 46.3 29.5 40.8 41.0 35.8 24.6 15.8 19.8 51.1 19.4 35.6 35.8 46.9 55.3 33.5 25.4 21.0 48.4 44.2 32.6 20.3 27.6 30.7 25.3 62.7 22.9 25.3 26.5 43.1 23.4 30.8 36.3 54.0 48.7 32.4 14.9 23.7 31.9 57.0 36.4 23.4 26.5 21.6 20.5 31.1 18.4 146.5 32.1 23.0 51.7 17.6 18.5 22.6 33.2 43.4 33.2 36.5 37.7 32.7 46.7 40.3 12.6 10.8 11.3 10.5 14.9 13.2 12.8 14.0 12.8 13.3 11.1 13.3 13.8 10.6 10.8 13.6 15.1 17.4 6.5 9.8 9.7 10.8 13.5 9.6 10.8 10.2 10.0 9.7 10.0 9.7 10.3 11.3 15.9 9.6 18.6 10.4 18.2 9.1 12.5 25.8 14.2 18.0 14.5 17.1 12.3 37.1 19.3 31.3 14.6 28.0 17.3 15.0 31.3 22.4 68.4 22.6 31.5 17.9 7.8 12.8 15.0 20.4 53.8 23.9 14.8 18.8 13.3 13.3 29.6 61.7 36.7 26.9 19.3 23.3 16.2 14.2 16.5 19.1 32.6 19.9 3.6 13.1 33.2 22.0 35.0 12.1 14.2 30.2 27.4 29.0 17.6 13.8 44.8 67.1 28.1 28.2 19.7 16.2 18.8 75.6 38.2 14.0 9.2 23.0 19.8 22.3 21.6 12.6 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 38.9" "Group enriched" "Detected in some" 8 "Early spermatids: 5.4;Late spermatids: 15.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ: 201.8" "Not detected" "Not detected" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles NA NA 170000000 "Nucleoplasm, Vesicles" "HPA055194: AB_2682733, HPA072208: AB_2686494" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.1 1.8 0.0 1.6 0.0 0.0 0.0 0.1 1.9 0.0 201.8 8.8 23.5 46.4 0.0 0.1 0.0 0.0 25.1 0.1 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.1 26.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.0 0.3 0.0 0.0 KRT33B "Ha-3II, KRTHA3B" ENSG00000131738 "Keratin 33B" Q14525 17 41363498-41369813 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "skin 1: 49.9" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 2.9;Ionocytes: 2.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "BJ: 4.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.1" HPA055194 Supported NA NA 350000000 "HPA055194: AB_2682733" "unprognostic (3.34e-2)" "unprognostic (5.19e-2)" "unprognostic (3.04e-1)" "unprognostic (1.55e-2)" "unprognostic (6.28e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 49.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 TNS4 CTEN ENSG00000131746 "Tensin 4" Q8IZW8 17 40475828-40501623 "Predicted intracellular proteins" Apoptosis Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 59.3;skin 1: 182.7;vagina: 75.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 133.4;Basal prostatic cells: 117.7;Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 77.4;Suprabasal keratinocytes: 65.5;Urothelial cells: 50.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 77.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 136.2;HBEC3-KT: 613.4;hTCEpi: 435.3;hTERT-HME1: 138.8;OE19: 125.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.16e-2)" "unprognostic (9.83e-2)" "unprognostic (1.01e-1)" "unprognostic (3.40e-2)" "unprognostic (3.68e-4)" "unprognostic (7.88e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.89e-1)" "unprognostic (8.02e-3)" "unprognostic (2.01e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-2)" "unprognostic (3.72e-1)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (7.08e-2)" 0.9 0.1 0.0 1.1 0.0 0.1 16.6 0.0 0.0 15.2 0.1 3.2 0.8 0.7 3.5 46.4 0.9 0.3 0.1 0.0 0.0 0.9 0.1 0.6 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 9.7 0.0 35.9 5.9 0.0 59.3 19.8 0.2 182.7 0.8 0.1 0.0 0.0 1.8 0.0 0.0 1.4 14.5 0.0 7.0 15.0 75.3 0.2 7.7 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 18.6 0.1 3.9 0.0 0.0 136.2 0.0 613.4 0.0 0.0 0.0 0.0 57.5 9.3 0.0 0.0 0.4 0.0 435.3 0.0 138.8 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.2 0.0 125.9 70.2 0.0 0.0 0.0 0.0 32.3 0.0 0.0 79.4 14.4 0.0 0.7 16.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 133.4 117.7 39.8 287.4 0.0 1.6 25.5 0.9 0.0 18.2 0.0 0.0 4.7 0.5 7.5 1.9 0.2 0.0 4.6 0.7 1.3 0.0 0.0 0.1 0.2 0.5 1.0 2.0 3.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.5 2.0 0.0 8.8 0.0 0.0 1.1 5.4 0.0 0.6 0.0 0.0 0.0 0.1 25.2 0.3 0.0 0.0 18.9 0.1 0.0 7.3 0.0 0.0 0.1 1.6 0.0 0.0 77.4 65.5 4.4 2.1 0.0 2.6 50.2 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388525-40417896 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 129.0;testis: 66.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 4.2;white matter: 8.0" "Low region specificity" "Detected in some" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.2 2.6 0.5 20.2 0.3 42.4 5.4 0.3 0.7 3.0 1.2 18.0 18.3 3.9 0.3 29.2 1.5 2.6 1.1 0.3 1.1 1.2 2.8 4.1 40.7 0.4 0.8 0.3 1.0 1.0 0.3 0.3 16.1 0.4 1.4 20.0 0.1 4.3 0.5 0.3 15.4 17.1 7.7 0.5 10.0 8.9 66.2 1.1 129.0 1.9 0.2 42.8 6.1 9.7 2.9 212.6 275.6 343.1 158.0 16.8 33.9 76.3 283.3 151.5 255.0 224.2 130.5 157.6 339.4 140.1 96.7 152.7 326.5 266.8 113.5 339.5 182.7 177.8 224.8 167.9 216.7 1.6 318.4 228.6 7.4 9.2 179.8 181.4 55.1 136.3 216.5 247.5 225.8 279.2 72.6 372.3 209.6 143.0 152.4 108.3 310.7 531.9 141.3 61.6 133.3 201.6 144.6 229.3 281.4 89.4 198.2 236.9 143.2 90.3 167.0 233.2 195.5 276.7 128.4 154.9 290.7 94.3 214.9 285.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.3 0.1 0.1 0.0 0.0 0.1 1.4 0.1 0.0 2.4 0.4 0.5 0.3 0.3 0.7 0.3 1.1 0.4 0.8 0.3 0.4 0.5 1.1 2.9 1.0 0.0 2.0 0.3 17.4 11.7 3.7 15.0 2.2 0.0 18.7 17.1 1.3 2.8 5.8 0.0 0.0 72.9 6.1 19.8 0.0 0.8 20.3 12.7 15.8 9.3 0.0 216.8 0.2 0.0 92.4 23.3 23.0 10.0 0.0 117.5 20.7 5.4 83.5 0.0 0.1 34.2 18.3 33.9 13.2 19.1 4.7 14.1 1.8 0.0 2.6 0.0 3.1 0.0 0.1 0.3 3.5 1.9 31.3 3.1 3.4 0.1 1.8 0.0 72.3 0.5 19.5 621.2 269.6 45.1 6.1 8.9 14.8 4.3 61.0 6.9 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637090-39664201 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 260.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 23.8 33.6 16.9 19.0 23.5 25.6 23.6 21.0 19.0 22.4 12.9 20.9 24.4 20.5 2.7 24.2 21.7 17.4 15.9 16.0 13.5 19.1 26.0 29.0 22.4 23.2 19.3 12.4 21.5 26.7 15.4 24.2 17.3 19.4 20.3 5.2 3.3 21.4 11.4 24.1 26.3 26.9 9.3 18.0 33.3 26.7 26.4 18.4 14.9 21.6 9.6 8.8 21.2 20.3 17.4 29.3 47.6 18.6 33.5 19.9 22.9 31.2 23.1 24.9 27.1 24.3 24.0 47.6 25.2 47.7 17.8 30.8 55.4 11.3 21.0 6.3 36.2 34.5 15.2 18.8 30.1 25.9 29.6 35.5 24.5 19.0 29.8 12.6 19.0 23.4 36.4 41.0 27.4 23.5 24.7 32.2 25.6 22.2 15.3 20.6 28.5 31.4 40.1 15.0 35.7 24.9 29.1 16.1 260.8 64.0 10.8 34.1 41.7 26.3 43.2 29.5 46.5 43.6 27.5 37.8 18.7 36.2 36.8 45.1 23.7 36.3 54.4 42.7 35.5 30.7 20.8 29.6 32.7 38.3 26.1 29.1 27.8 63.6 39.6 29.3 18.7 38.5 33.8 16.9 23.5 21.0 19.0 16.0 13.5 23.2 19.3 12.4 19.4 18.0 18.4 17.4 45.8 3.2 7.5 31.0 23.2 16.6 13.0 23.4 14.2 12.6 19.9 14.6 3.4 18.6 14.8 11.0 37.5 28.5 32.9 21.0 9.8 26.5 2.7 9.7 11.7 35.8 27.5 11.1 17.3 35.4 37.2 16.2 29.6 11.0 19.0 22.2 45.0 11.9 49.8 18.5 14.8 11.6 14.2 49.0 18.5 5.3 17.1 27.7 5.4 9.4 18.5 15.8 29.9 12.1 30.2 35.9 22.9 13.2 24.3 20.2 41.5 10.3 8.3 13.2 13.1 21.8 14.4 9.3 16.2 15.9 16.9 40.0 35.2 18.6 15.1 20.1 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309180-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 52.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 221.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058282, HPA071548" Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Actin filaments, Cytosol" "HPA058282: AB_2683666, HPA071548: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favorable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 42.7 21.2 3.3 28.6 4.5 60.2 37.5 6.5 15.0 42.9 6.1 29.5 28.7 32.4 10.8 15.0 41.0 41.7 35.0 6.5 18.5 24.2 42.7 58.9 16.5 4.9 2.7 3.5 41.1 14.8 11.4 30.8 25.9 3.2 30.1 13.4 18.5 20.8 21.5 63.1 24.3 32.5 28.8 1.4 42.0 23.1 29.1 3.8 10.1 27.1 17.5 11.9 30.6 30.4 3.9 18.0 41.9 11.8 20.5 23.4 35.9 12.5 14.9 21.8 21.5 13.6 28.6 15.1 9.6 22.7 33.2 18.9 51.1 14.2 33.9 12.0 77.5 21.4 26.6 21.2 29.8 37.0 9.4 81.3 48.2 10.0 22.7 29.2 75.8 30.9 8.4 17.6 20.2 23.7 221.5 6.4 34.2 10.7 16.2 13.3 12.9 71.3 37.0 12.2 14.4 5.4 40.5 31.0 124.8 42.1 11.7 119.1 36.6 35.8 25.3 45.3 44.2 15.4 48.7 16.9 8.3 38.4 18.7 77.1 26.3 8.9 34.6 3.2 14.6 5.1 2.0 3.6 3.8 12.4 1.7 1.5 2.8 52.6 5.9 19.5 3.8 3.1 5.0 3.3 4.5 6.5 15.0 6.5 18.5 4.9 2.7 3.5 3.2 1.4 3.8 3.9 35.6 3.2 7.0 2.3 43.4 19.5 25.6 8.4 18.8 23.2 35.4 17.5 3.8 10.0 5.5 7.3 6.2 2.2 36.9 41.2 13.7 16.7 60.5 20.7 22.0 28.4 9.6 5.7 5.4 19.2 5.8 28.5 10.7 18.4 35.5 13.9 26.0 28.8 12.3 3.3 2.6 13.1 6.1 45.4 65.5 66.2 41.7 56.9 28.4 2.8 26.1 11.8 6.2 4.0 0.3 22.0 33.1 23.0 21.0 13.4 70.9 17.7 4.9 10.2 32.9 42.1 26.7 3.6 7.6 7.1 18.9 5.2 31.7 6.5 16.5 19.3 PPP1R1B "DARPP-32, FLJ20940" ENSG00000131771 "Protein phosphatase 1 regulatory inhibitor subunit 1B" Q9UD71 17 39626740-39636626 "Metabolic proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 595.0;choroid plexus: 446.5;intestine: 213.4;salivary gland: 370.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 144.6;Distal tubular cells: 121.3;Intestinal goblet cells: 305.7;Melanocytes: 135.2;Paneth cells: 132.3;Undifferentiated cells: 423.7;Urothelial cells: 171.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 94.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "ASC diff: 7.6;CAPAN-2: 12.6;HSkMC: 31.7;OE19: 15.6;SCLC-21H: 27.4" "Region enriched" "Detected in all" 8 "basal ganglia: 1243.8" "Region enriched" "Detected in all" 26 "basal ganglia: 1534.8" "CAB004026, HPA048630, HPA061142" Approved Approved NA NA "CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438" "unprognostic (2.71e-1)" "unprognostic (4.09e-2)" "unprognostic (6.91e-3)" "unprognostic (2.42e-1)" "unprognostic (3.01e-1)" "unprognostic (7.69e-2)" "unprognostic (6.00e-3)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.13e-2)" "unprognostic (6.07e-2)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.52e-3)" "unprognostic (1.55e-1)" 94.6 30.5 263.2 20.0 595.0 0.4 74.7 252.4 311.4 20.1 446.5 213.4 84.2 4.5 5.5 4.8 28.6 2.0 2.2 233.9 312.9 16.2 0.5 15.4 0.1 292.5 259.6 229.5 11.4 76.3 0.5 15.1 0.0 458.7 63.2 205.3 6.2 370.1 90.6 1.0 49.3 69.3 10.9 214.1 0.1 40.2 16.0 281.4 0.2 0.6 0.0 0.3 19.1 11.5 224.4 0.0 0.0 0.0 0.0 7.6 4.4 0.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.9 15.6 0.9 0.0 0.0 0.6 0.0 0.0 27.4 0.6 0.0 1.5 0.0 2.4 0.6 1.1 0.0 0.0 1.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 263.2 595.0 252.4 311.4 233.9 312.9 292.5 259.6 229.5 458.7 214.1 281.4 224.4 1.0 0.0 34.7 33.3 1.3 1.3 117.1 0.4 0.6 0.6 93.5 84.3 1.1 0.0 0.2 1.8 0.0 0.0 2.4 144.6 121.3 28.7 0.8 46.6 0.9 1.6 96.7 0.0 5.3 3.3 0.0 2.8 13.3 3.2 4.5 0.0 4.2 0.0 0.2 0.0 1.6 305.7 2.0 0.0 0.8 3.2 34.5 1.2 135.2 0.0 0.0 29.8 0.0 1.0 0.5 0.8 132.3 5.7 0.0 84.3 40.4 0.7 0.1 1.3 0.0 1.2 1.7 0.9 3.7 1.2 0.4 0.0 1.9 0.0 423.7 171.5 KHDRBS3 "Etle, etoile, SALP, SLM-2, SLM2, T-STAR" ENSG00000131773 "KH RNA binding domain containing, signal transduction associated 3" O75525 8 135457456-135656722 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 159.1" "Cell type enhanced" "Detected in many" "Early spermatids: 364.5;Excitatory neurons: 828.6;Inhibitory neurons: 190.8;Microglial cells: 227.7;Oligodendrocyte precursor cells: 578.6;Spermatocytes: 276.1" "Cancer enhanced" "Detected in all" "glioma: 9.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "REH: 87.8;RPTEC TERT1: 76.0;WM-115: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000275, HPA000500, HPA000981" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (6.55e-3)" "unprognostic (2.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.31e-3)" "unprognostic (9.36e-2)" "unprognostic (2.00e-2)" "unprognostic (2.66e-1)" "unprognostic (1.91e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.16e-6)" "unprognostic (6.63e-2)" "unprognostic (7.85e-2)" "unprognostic (1.07e-1)" "unprognostic (1.33e-3)" 14.7 16.6 14.1 5.7 30.6 2.7 11.6 0.4 52.1 17.1 0.0 10.1 4.2 6.9 23.0 6.2 6.6 11.6 9.7 29.1 9.7 19.5 12.4 8.9 3.0 9.0 4.8 25.1 9.4 9.3 7.6 6.8 2.0 9.9 8.4 9.0 21.2 11.1 12.4 32.9 5.6 6.0 8.8 2.3 2.8 7.0 159.1 6.9 9.3 5.7 31.5 4.2 10.7 9.1 42.7 0.5 1.8 30.9 1.7 6.5 12.0 12.4 20.7 28.6 19.2 9.8 11.1 4.4 0.1 10.9 19.8 0.3 2.7 19.5 20.9 26.0 4.4 33.6 0.1 11.2 22.9 5.0 5.8 69.8 2.6 2.8 10.5 16.1 23.2 15.9 36.7 2.6 51.0 34.5 7.5 2.2 1.2 6.3 16.9 34.0 87.8 42.0 22.6 76.0 0.6 39.5 33.4 1.5 4.4 22.6 19.4 1.4 1.8 1.3 23.6 40.7 0.4 45.2 17.9 0.0 0.1 14.3 0.0 85.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 30.6 0.4 52.1 29.1 9.7 9.0 4.8 25.1 9.9 2.3 6.9 42.7 15.4 28.9 5.3 20.2 3.1 15.0 14.7 2.3 2.8 160.9 23.8 10.8 12.3 2.8 4.8 7.3 0.0 0.6 0.6 7.0 25.4 14.6 364.5 24.2 21.1 13.7 23.4 0.8 828.6 22.9 1.2 37.2 2.0 40.7 4.5 4.0 5.0 21.8 0.8 6.7 190.8 8.7 10.2 3.5 10.9 142.4 16.1 5.2 14.2 227.7 1.6 7.0 0.0 578.6 34.9 19.8 2.5 8.6 1.1 19.3 2.1 29.0 2.9 16.1 0.0 57.9 34.5 276.1 33.1 3.4 9.2 1.4 2.1 12.7 6.6 12.6 CHD1L ALC1 ENSG00000131778 "Chromodomain helicase DNA binding protein 1 like" Q86WJ1 1 147242654-147295765 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027789, HPA028670" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA027789: AB_10601099, HPA028670: AB_10601257" "unprognostic (1.07e-1)" "unprognostic (3.93e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-1)" "unprognostic (1.78e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.86e-2)" "unprognostic (7.83e-2)" "unprognostic (1.39e-2)" "unprognostic (4.97e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.31e-9)" "unprognostic (5.51e-2)" "unprognostic (3.52e-1)" "unprognostic (2.74e-2)" "unprognostic (1.16e-1)" 13.4 15.0 20.8 12.0 21.4 17.3 14.7 21.5 25.4 14.1 19.3 15.3 14.6 19.3 9.5 12.8 17.5 6.7 10.4 20.0 21.6 13.6 34.0 17.6 13.2 21.4 21.4 19.6 11.0 13.2 20.0 20.3 9.4 21.5 16.5 15.2 4.9 11.7 9.0 12.9 13.8 19.5 16.2 22.3 27.3 15.9 19.6 21.0 15.0 10.7 11.3 11.2 13.2 11.8 22.3 40.0 34.0 28.0 21.2 25.1 21.4 29.6 38.7 31.4 30.4 29.1 30.6 29.2 49.9 15.4 33.9 21.9 37.7 31.2 35.3 30.6 53.6 40.6 43.8 27.5 87.0 31.5 58.9 24.0 25.6 15.1 30.2 31.1 27.9 34.1 51.5 56.0 19.8 44.3 42.2 39.8 43.1 46.9 80.0 47.4 48.8 35.1 41.1 32.2 30.7 16.6 36.4 32.4 39.2 30.8 46.3 21.7 99.3 34.5 19.2 33.2 18.2 49.0 14.9 22.4 37.9 46.7 19.6 33.3 11.3 8.7 3.2 8.7 7.9 8.1 11.7 7.4 6.6 20.3 14.2 6.9 7.9 0.4 10.0 9.2 17.5 5.4 8.2 20.8 21.4 21.5 25.4 20.0 21.6 21.4 21.4 19.6 21.5 22.3 21.0 22.3 7.7 12.8 15.6 45.7 27.1 11.5 10.0 8.8 15.9 7.2 12.5 8.5 6.5 11.5 16.4 5.5 6.2 21.7 17.1 15.4 21.5 10.0 21.2 6.4 12.5 11.1 9.0 43.7 48.3 8.2 19.1 12.6 21.4 9.8 21.5 25.1 5.3 33.7 21.8 1.7 40.8 16.7 16.2 16.1 20.7 25.6 7.2 25.5 16.0 36.5 15.9 14.5 12.3 60.8 80.7 10.3 14.4 11.3 14.4 10.8 13.0 12.9 16.1 9.3 6.6 11.9 12.5 38.3 27.4 20.9 10.4 11.8 13.4 18.8 19.7 9.1 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918717 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017150, HPA050104" Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017150: , HPA050104: AB_2681017" "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.67e-4)" "prognostic favorable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 15.6 25.3 37.2 19.1 40.0 13.4 31.5 36.5 42.3 24.8 36.7 24.7 24.8 23.6 33.4 34.6 26.0 17.2 24.6 39.6 40.2 32.7 27.3 20.3 27.6 37.1 37.3 39.1 24.8 27.5 33.8 24.7 23.2 39.4 24.5 27.8 20.4 28.9 25.8 40.2 27.8 26.1 21.1 35.4 27.9 28.5 31.0 37.4 30.5 26.7 35.3 35.0 23.4 22.3 42.3 27.1 24.4 21.0 21.1 48.6 37.9 21.9 26.8 35.3 34.4 26.5 11.3 30.7 25.2 28.1 38.3 16.6 31.9 18.6 40.0 24.0 28.4 14.1 15.6 14.8 29.2 68.3 46.9 27.5 49.9 49.3 23.3 22.8 43.9 44.5 34.8 28.7 40.5 54.7 43.1 35.8 43.5 7.5 57.4 29.5 33.0 31.5 55.5 58.8 19.1 14.7 24.0 20.2 38.4 24.7 20.5 53.2 72.0 39.7 23.1 18.2 30.3 19.8 43.1 54.0 35.1 38.5 26.3 16.0 89.6 64.7 47.3 58.5 60.9 64.8 93.2 67.5 65.4 70.8 84.1 74.7 67.9 32.4 71.1 60.5 94.9 79.6 82.7 37.2 40.0 36.5 42.3 39.6 40.2 37.1 37.3 39.1 39.4 35.4 37.4 42.3 5.0 16.0 10.3 9.8 17.0 19.4 9.2 41.3 26.7 8.0 16.8 17.0 12.8 17.2 20.7 40.5 0.0 37.9 19.6 20.2 45.0 13.7 12.2 8.2 7.0 12.3 12.7 14.1 13.0 13.8 13.9 11.1 19.4 7.4 3.8 9.3 18.2 32.9 23.0 5.0 13.5 16.0 20.3 18.3 10.7 21.1 14.0 12.9 21.4 4.7 27.1 12.6 25.7 9.5 12.9 16.0 11.4 19.9 17.4 10.1 20.1 34.5 22.9 5.1 6.6 5.8 10.3 41.1 24.3 34.0 22.0 20.0 13.8 11.6 15.8 9.4 FMO5 ENSG00000131781 "Flavin containing dimethylaniline monoxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 688.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "Hep G2: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favorable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 3.1 5.8 2.9 5.2 3.5 2.0 46.6 4.3 4.1 7.9 1.0 41.7 71.9 2.8 6.9 1.2 3.6 16.0 2.2 2.5 3.5 52.0 688.9 27.4 4.0 4.7 4.9 2.0 4.1 48.5 68.9 6.8 2.4 5.4 9.8 47.0 0.9 33.0 4.1 0.8 11.3 74.5 3.6 3.7 4.1 121.0 5.3 3.5 1.1 2.0 1.4 2.5 3.9 1.5 6.2 0.1 1.1 0.6 0.1 2.8 0.8 0.9 0.7 0.5 0.3 0.8 0.7 2.4 0.4 0.8 0.8 0.2 0.4 0.0 0.0 0.0 1.4 0.2 1.6 0.1 41.7 0.9 1.4 9.0 1.3 0.2 0.4 0.0 0.4 0.6 0.2 0.1 0.1 1.5 1.4 0.2 0.7 2.8 5.3 0.8 0.4 0.5 0.4 3.4 0.6 0.5 0.3 0.9 2.8 1.3 1.3 2.1 10.4 1.1 0.0 0.3 0.9 0.0 0.3 0.0 0.3 1.1 0.5 0.3 7.0 12.9 4.1 2.0 5.9 0.3 4.7 0.5 0.6 5.4 8.5 0.3 1.3 1.3 1.2 1.8 2.5 1.6 3.9 2.9 3.5 4.3 4.1 2.5 3.5 4.7 4.9 2.0 5.4 3.7 3.5 6.2 2.8 9.6 64.2 11.1 6.4 1.7 3.9 0.9 1.8 2.0 17.5 6.7 1.9 133.0 10.4 14.7 0.0 1.5 1.7 60.8 7.9 7.5 7.7 2.5 1.8 2.7 6.7 4.8 8.2 5.9 1.1 2.9 24.5 6.1 5.7 9.8 5.0 265.4 4.0 3.3 6.4 34.4 4.1 10.0 2.3 4.5 2.8 4.6 28.4 10.3 5.3 0.2 4.1 10.1 17.5 7.0 29.0 1.5 0.4 5.6 108.8 69.2 18.1 1.3 0.0 2.2 1.0 5.9 0.9 1.3 1.6 1.4 2.6 6.6 20.7 6.4 PIAS3 "FLJ14651, ZMIZ5" ENSG00000131788 "Protein inhibitor of activated STAT 3" Q9Y6X2 1 145848522-145859836 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006389, HPA067383" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006389: AB_2667576, HPA067383: AB_2685828" "unprognostic (1.23e-1)" "unprognostic (2.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (2.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.50e-1)" "unprognostic (2.77e-3)" "unprognostic (5.06e-1)" "prognostic unfavorable (1.21e-7)" "unprognostic (5.14e-2)" "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (2.11e-2)" 19.7 11.6 10.4 12.9 9.8 4.9 23.5 9.2 12.3 34.3 11.9 20.4 7.6 32.3 8.0 37.6 37.5 12.2 17.2 9.9 11.4 13.8 7.3 18.0 9.1 11.3 10.9 9.1 23.6 13.2 14.5 15.5 10.8 10.7 21.8 8.1 9.8 29.4 21.3 26.0 33.1 14.7 23.8 9.9 13.4 21.9 11.2 11.6 13.6 15.0 14.6 18.1 29.3 35.2 10.4 34.6 23.5 23.8 21.1 35.9 67.3 14.5 31.8 43.6 35.5 39.3 19.3 22.2 17.8 33.6 54.8 15.0 35.0 12.4 50.4 29.9 19.4 18.3 8.2 15.9 10.4 35.8 14.7 38.8 55.2 32.3 32.9 18.6 45.6 52.0 15.8 13.2 24.0 74.7 57.6 15.8 7.8 37.0 97.3 37.7 24.6 16.2 11.7 28.2 20.5 8.1 37.9 30.7 16.9 15.5 27.0 78.0 22.1 80.7 47.2 34.8 31.7 20.9 32.6 15.7 11.5 45.8 10.9 23.9 8.9 9.1 10.7 10.6 8.7 11.4 5.4 6.7 11.6 6.8 3.6 6.2 6.0 2.2 15.2 12.5 8.4 8.1 7.0 10.4 9.8 9.2 12.3 9.9 11.4 11.3 10.9 9.1 10.7 9.9 11.6 10.4 14.7 22.4 11.5 8.5 8.6 10.7 7.9 15.4 19.4 10.2 16.2 16.5 0.9 4.3 22.8 16.5 12.5 3.7 10.0 2.1 1.9 7.9 2.3 29.4 14.8 12.3 4.2 2.1 4.2 7.7 7.3 11.9 13.3 19.1 10.8 4.9 13.2 3.8 5.2 10.1 3.9 6.2 12.2 4.4 7.0 3.9 14.3 4.1 5.4 7.5 13.1 4.2 8.2 6.6 7.4 12.7 2.0 13.2 4.8 9.2 2.1 1.8 37.6 11.8 26.3 7.0 13.6 4.0 11.4 19.9 16.3 4.0 8.6 6.0 2.8 10.4 PRKAB2 ENSG00000131791 "Protein kinase AMP-activated non-catalytic subunit beta 2" O43741 1 147155106-147172550 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.2;tongue: 104.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044342 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044342: AB_10966508" "prognostic unfavorable (4.55e-4)" "unprognostic (2.03e-2)" "unprognostic (1.84e-1)" "unprognostic (4.03e-2)" "unprognostic (9.59e-3)" "prognostic unfavorable (7.32e-4)" "unprognostic (6.30e-2)" "unprognostic (1.23e-1)" "unprognostic (3.06e-2)" "unprognostic (6.78e-2)" "unprognostic (4.65e-2)" "unprognostic (1.98e-1)" "unprognostic (5.34e-2)" "unprognostic (1.31e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (6.78e-7)" "unprognostic (4.78e-2)" 9.8 10.9 10.4 7.8 10.8 9.0 11.9 13.7 13.0 14.8 7.5 19.5 32.2 18.9 8.5 10.4 13.0 7.2 26.1 10.9 10.4 9.6 56.8 10.1 6.5 11.9 11.3 9.9 11.8 35.1 65.3 6.8 12.4 12.1 12.8 10.8 14.9 8.3 19.6 98.2 15.6 21.0 19.9 12.3 8.6 18.3 6.8 11.9 5.9 6.3 104.8 5.6 18.7 14.1 12.4 7.8 4.2 11.1 8.6 25.7 22.1 39.7 14.3 7.9 9.5 10.3 17.1 15.1 13.9 7.1 11.6 5.5 20.2 13.1 16.1 9.2 5.5 9.0 6.2 15.2 27.8 17.7 7.4 2.6 17.4 31.7 9.9 46.0 14.1 9.4 10.6 8.9 5.6 8.2 7.8 5.5 4.1 23.3 13.4 18.4 8.5 14.8 6.9 6.8 6.1 7.1 13.2 10.8 12.1 52.8 39.6 11.4 9.1 10.8 10.6 23.3 9.9 23.6 8.9 10.1 7.1 11.0 6.4 14.1 0.9 0.3 0.6 0.4 0.4 0.7 0.3 0.4 0.3 0.5 0.3 0.5 0.3 0.1 1.5 0.5 0.2 0.2 0.2 10.4 10.8 13.7 13.0 10.9 10.4 11.9 11.3 9.9 12.1 12.3 11.9 12.4 10.4 3.2 2.0 14.0 10.6 16.6 11.8 11.4 18.2 14.5 6.7 8.1 66.2 20.0 5.3 18.4 14.6 21.9 10.3 22.7 1.9 6.1 0.8 5.4 15.1 8.2 11.4 3.4 23.2 7.0 42.1 13.6 13.7 10.4 1.3 11.8 6.8 44.9 5.7 11.8 18.8 12.6 10.2 8.9 12.5 1.8 9.6 7.3 16.0 10.3 12.2 6.4 11.3 25.1 21.3 9.9 12.0 16.1 9.0 7.2 55.1 5.4 7.0 19.5 19.7 11.3 20.4 13.9 11.2 13.1 14.1 20.5 9.7 43.4 10.1 4.8 FSHB ENSG00000131808 "Follicle stimulating hormone subunit beta" P01225 11 30231014-30235261 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 422 "pituitary gland: 240.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB023410, HPA069703" Enhanced "Secreted to blood" NA NA 78000 "CAB023410: AB_324983, HPA069703: AB_2686176" "unprognostic (1.04e-1)" 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 240.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.2 0.1 0.1 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDHA1 PDHA ENSG00000131828 "Pyruvate dehydrogenase E1 subunit alpha 1" P08559 X 19343893-19361718 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 463.4;tongue: 777.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 479.9;Distal tubular cells: 354.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria "Intracellular and membrane" NA NA 100000 Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" "unprognostic (5.71e-3)" "unprognostic (2.46e-3)" "unprognostic (5.71e-2)" "unprognostic (3.36e-3)" "unprognostic (3.12e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-2)" "unprognostic (4.28e-1)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (6.90e-2)" "unprognostic (8.68e-2)" "prognostic favorable (1.13e-7)" "unprognostic (3.72e-2)" "unprognostic (3.03e-1)" "unprognostic (1.92e-2)" "unprognostic (9.06e-2)" 93.8 69.5 67.0 38.2 72.5 88.9 63.6 71.4 92.2 54.7 84.8 111.5 87.8 53.5 79.6 77.4 49.5 29.6 411.2 73.0 71.2 136.8 119.2 47.6 36.9 70.3 69.0 68.9 51.0 84.1 162.4 49.1 43.5 70.9 48.8 105.4 90.9 110.6 64.0 463.4 57.1 82.8 52.3 66.3 49.7 122.7 24.2 72.7 52.8 65.0 777.0 59.6 62.2 56.5 75.9 124.9 151.4 107.9 114.2 102.3 77.7 131.6 83.8 74.6 170.2 130.7 216.6 78.2 212.2 60.6 102.0 226.7 159.0 334.2 145.8 178.1 70.1 186.1 104.8 264.0 194.2 107.8 170.3 82.8 100.9 132.8 157.3 154.4 85.6 105.3 129.8 94.2 87.2 120.7 164.5 142.7 173.5 110.0 227.4 261.7 145.2 180.9 260.3 298.0 125.1 59.7 62.6 134.1 167.8 158.1 229.8 177.1 118.1 65.4 87.6 78.6 240.9 108.6 73.3 82.0 140.5 82.4 117.2 77.4 99.9 87.4 65.3 72.3 119.9 88.9 103.4 69.4 79.5 115.7 82.1 67.7 72.0 15.5 98.1 109.1 76.9 84.4 89.6 67.0 72.5 71.4 92.2 73.0 71.2 70.3 69.0 68.9 70.9 66.3 72.7 75.9 34.1 44.8 44.4 18.6 30.7 29.8 59.7 135.4 25.0 59.0 37.0 29.3 479.9 87.2 74.8 152.6 33.3 105.0 32.5 73.0 354.1 88.8 2.5 41.2 33.7 36.8 41.9 55.8 21.2 59.8 120.7 49.2 49.5 36.9 42.6 39.7 18.2 76.3 73.2 25.2 24.6 64.4 71.2 26.8 30.5 4.1 35.4 32.5 56.9 9.4 40.8 49.0 26.8 13.0 11.5 47.4 52.5 40.6 43.3 47.1 88.6 213.7 33.1 69.1 32.9 37.5 51.7 51.1 25.3 45.2 33.4 133.4 31.6 25.4 130.3 55.8 RAI2 ENSG00000131831 "Retinoic acid induced 2" Q9Y5P3 X 17800049-17861337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 41.9;Leydig cells: 49.0;Peritubular cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 10 "T-cells: 1.8" "Cell line enriched" "Detected in some" 10 "ASC diff: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051054 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051054: AB_2681328" "unprognostic (3.45e-2)" "unprognostic (9.61e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.31e-2)" "prognostic favorable (3.39e-14)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "unprognostic (1.82e-2)" "unprognostic (2.80e-2)" 44.0 17.5 9.9 8.4 9.5 0.2 47.6 8.4 12.0 54.6 7.8 27.0 6.8 67.4 10.0 15.6 72.4 24.9 30.9 8.9 8.6 14.4 3.9 28.8 9.7 9.2 8.1 9.0 51.3 14.4 10.9 19.5 7.9 9.1 32.1 8.2 9.0 14.0 32.1 12.6 18.6 23.2 30.4 7.6 4.6 28.5 6.0 9.4 5.1 21.7 17.3 9.6 39.3 44.1 9.1 0.0 0.0 0.2 0.0 104.3 10.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.7 0.2 0.6 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.1 1.9 0.0 0.6 0.0 0.0 0.0 5.8 0.0 1.1 1.4 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.8 0.0 0.1 0.0 0.0 0.0 0.1 9.9 9.5 8.4 12.0 8.9 8.6 9.2 8.1 9.0 9.1 7.6 9.4 9.1 25.0 12.8 4.5 2.0 0.0 4.1 9.3 0.0 0.6 14.0 13.4 10.4 13.0 12.8 0.6 22.0 0.0 0.1 0.3 0.3 5.9 8.2 0.3 25.0 16.5 15.2 27.6 0.0 10.5 9.8 0.1 24.8 7.7 41.9 0.0 9.7 10.8 0.1 0.5 26.9 17.9 0.7 0.0 0.0 4.2 3.3 49.0 0.9 5.4 14.0 0.6 20.5 0.0 5.0 0.4 4.9 17.5 70.7 0.1 7.9 1.3 1.9 4.4 3.0 0.0 21.0 8.7 0.4 2.7 0.5 2.8 0.0 1.3 0.2 1.6 5.1 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658706 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 121.5" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 107.0" "Cancer enhanced" "Detected in all" "prostate cancer: 81.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favorable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 21.5 48.0 13.5 13.7 14.2 6.1 60.6 12.8 15.6 21.5 22.5 30.8 27.5 14.5 39.2 25.6 17.4 15.4 51.4 12.2 18.6 74.0 121.5 13.5 18.0 14.5 13.3 11.7 14.4 24.8 33.0 14.2 14.3 14.6 48.7 36.3 12.3 28.4 20.8 34.7 19.7 20.9 11.8 16.5 15.8 26.0 8.7 15.1 14.3 45.0 35.7 21.7 27.3 15.1 18.8 38.5 52.4 21.4 82.5 22.4 23.0 36.9 16.4 29.4 35.7 25.7 91.1 46.9 90.4 62.8 25.9 28.0 30.8 37.8 58.8 44.3 47.6 45.6 48.2 24.7 100.5 39.2 24.4 42.8 29.5 30.1 32.6 25.8 15.8 31.7 24.9 63.2 31.6 24.9 103.0 0.3 42.9 29.0 33.2 27.2 46.3 64.5 130.9 92.5 66.9 32.9 36.7 80.1 111.8 38.8 10.1 92.7 59.6 22.7 14.4 22.1 26.1 49.9 22.4 46.2 54.6 23.7 66.3 36.6 2.0 8.4 1.9 6.5 13.5 8.5 9.7 8.4 7.4 19.4 9.9 8.3 9.1 1.3 14.7 8.1 8.1 12.1 8.3 13.5 14.2 12.8 15.6 12.2 18.6 14.5 13.3 11.7 14.6 16.5 15.1 18.8 9.1 16.0 23.6 27.4 26.8 13.3 17.5 20.2 22.2 12.6 54.9 28.3 61.5 20.0 22.3 16.5 6.2 48.5 17.6 26.3 21.5 20.6 4.3 94.0 24.0 15.1 29.5 13.9 22.2 18.2 23.0 13.1 30.1 107.0 12.7 22.7 9.7 93.1 18.0 3.3 21.6 22.8 8.2 12.1 11.2 9.8 13.7 14.0 12.4 11.2 17.9 15.4 20.6 30.2 28.0 15.3 17.0 20.3 27.2 29.6 23.6 59.1 17.7 10.8 6.6 15.2 9.0 4.2 12.0 35.9 13.8 63.6 17.9 30.9 33.9 20.9 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351271-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA050531: AB_2681160" "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favorable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 4.3 6.3 4.2 3.5 4.6 4.3 6.6 7.0 6.3 4.3 3.7 4.3 2.6 5.1 7.4 5.2 5.2 4.3 6.3 4.9 4.3 4.5 3.5 5.4 5.2 3.6 4.1 4.5 6.8 2.6 10.0 5.0 5.6 4.4 5.6 3.1 5.4 4.8 6.3 5.1 6.2 3.8 5.2 3.3 6.9 4.0 4.4 4.3 7.6 7.1 5.4 7.3 4.2 3.0 4.6 6.4 3.1 7.6 9.6 6.2 5.9 4.8 6.4 9.7 7.1 16.0 0.0 3.0 5.3 3.9 7.4 3.7 2.3 4.4 8.4 10.6 1.7 20.5 8.4 8.9 4.5 4.4 4.7 5.1 7.1 11.0 7.0 9.7 7.6 4.5 11.8 2.6 0.0 7.6 1.7 10.0 2.7 5.1 0.0 9.9 6.3 12.3 6.7 5.0 13.7 6.0 6.4 6.7 5.1 4.4 6.9 6.2 6.6 5.2 9.9 5.9 3.1 6.8 8.1 7.7 7.8 6.3 0.1 5.3 2.5 1.3 1.1 1.4 1.0 2.6 2.3 2.4 2.0 1.8 1.8 1.9 2.1 0.1 2.8 2.8 0.9 2.0 1.7 4.2 4.6 7.0 6.3 4.9 4.3 3.6 4.1 4.5 4.4 3.3 4.3 4.6 5.0 0.0 0.5 4.2 3.2 6.4 0.8 1.3 4.6 4.9 6.9 5.1 4.4 7.2 4.6 0.0 0.0 1.7 2.9 1.0 1.9 1.7 1.2 3.2 1.8 4.1 0.0 0.0 8.2 1.0 0.8 1.9 1.5 4.0 0.0 5.2 10.4 2.7 1.6 3.3 6.4 1.4 4.1 2.1 2.8 1.1 1.8 1.6 3.6 2.8 0.6 1.4 1.0 3.0 2.8 0.9 0.5 2.2 1.6 1.4 0.8 1.6 6.2 2.2 0.0 2.2 2.8 2.2 4.2 5.4 5.5 1.1 2.1 5.0 1.9 1.2 ZSCAN5A "MGC4161, ZNF495, ZSCAN5" ENSG00000131848 "Zinc finger and SCAN domain containing 5A" Q9BUG6 19 56219670-56368383 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.3" "Group enriched" "Detected in many" 6 "Early spermatids: 128.5;Late spermatids: 88.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (1.72e-1)" "unprognostic (3.19e-3)" "unprognostic (8.22e-4)" "unprognostic (1.65e-2)" "unprognostic (2.05e-3)" "unprognostic (6.99e-2)" "unprognostic (1.39e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" "unprognostic (2.42e-1)" "unprognostic (8.67e-4)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.10e-2)" "unprognostic (4.70e-2)" "unprognostic (6.15e-3)" "unprognostic (3.99e-3)" 2.7 3.2 3.4 3.6 3.8 2.6 2.8 3.4 3.5 3.4 4.5 3.8 3.9 3.7 2.0 3.1 7.1 2.6 3.8 3.5 3.3 3.6 2.6 3.1 2.9 3.5 3.5 3.0 3.6 2.6 3.9 3.3 2.1 3.8 3.0 4.5 2.3 3.2 2.4 4.2 4.3 3.5 4.0 3.1 2.8 2.6 25.3 3.3 4.5 3.3 3.5 3.4 3.8 3.2 3.3 5.9 5.0 7.1 8.6 5.7 3.6 10.4 3.4 7.2 10.3 6.1 10.1 3.4 10.6 2.7 6.0 6.1 7.0 9.2 7.3 9.2 3.0 19.4 13.0 3.4 10.2 4.5 14.5 14.0 2.8 11.0 10.1 4.6 2.1 7.5 8.2 5.3 4.7 3.2 7.2 3.5 8.0 12.8 5.2 13.1 5.5 10.7 6.1 4.3 10.9 6.9 6.9 9.1 6.9 3.6 4.0 3.0 13.2 4.1 8.9 8.9 4.7 11.4 7.7 21.1 7.2 11.5 14.2 3.5 3.7 6.5 4.4 4.2 7.2 6.4 3.3 4.4 3.2 7.5 1.9 5.7 3.0 0.5 1.3 4.5 9.3 1.2 3.7 3.4 3.8 3.4 3.5 3.5 3.3 3.5 3.5 3.0 3.8 3.1 3.3 3.3 3.3 0.0 4.2 2.3 5.3 4.8 5.8 6.0 6.2 4.9 6.4 5.0 17.4 0.0 5.0 0.0 8.4 3.0 5.6 4.3 11.7 5.0 128.5 10.5 3.4 4.1 7.8 5.5 0.6 5.1 3.5 5.5 5.1 4.9 2.5 2.8 4.6 6.8 6.5 3.3 0.3 4.0 8.2 7.3 3.0 88.5 2.5 5.2 0.0 0.0 3.0 7.8 2.1 0.5 0.3 4.4 1.0 2.6 4.0 4.5 4.5 6.0 12.4 10.8 0.0 6.5 3.3 14.7 16.5 4.2 3.7 7.0 3.4 3.3 5.2 3.3 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440153 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.0;Cone photoreceptor cells: 4.2;Early spermatids: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" NA NA Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favorable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 1.4 2.3 2.1 1.3 1.9 0.3 2.6 4.7 2.6 2.7 3.7 1.5 1.2 1.8 3.5 1.7 3.9 1.4 3.1 1.8 1.8 3.0 0.8 1.8 1.8 1.7 2.0 2.1 3.7 1.6 9.0 3.4 1.8 2.7 2.9 1.1 5.1 3.1 3.2 1.9 2.4 1.2 2.1 1.4 2.4 1.5 3.1 1.8 1.7 5.5 1.7 2.2 1.9 1.5 2.8 1.2 1.3 3.4 1.2 3.9 3.3 0.1 2.6 3.2 2.1 2.0 0.1 1.0 3.3 0.2 3.2 2.1 1.3 0.0 3.9 1.5 0.5 5.9 0.6 1.1 0.7 3.4 1.3 2.1 3.5 1.3 3.6 2.3 2.5 2.0 0.5 0.4 0.3 4.1 0.5 0.7 0.1 3.5 0.4 1.2 0.4 0.7 0.9 1.3 1.4 3.0 3.1 1.0 0.9 1.1 3.6 0.2 3.2 2.4 2.1 0.2 0.5 0.5 4.1 0.8 0.0 1.0 0.1 1.4 0.0 0.8 0.8 0.9 1.0 2.2 1.1 1.1 0.5 1.2 1.4 1.7 1.4 0.0 1.2 1.2 1.0 1.1 0.8 2.1 1.9 4.7 2.6 1.8 1.8 1.7 2.0 2.1 2.7 1.4 1.8 2.8 0.4 0.0 0.5 1.6 0.6 0.0 0.6 0.5 0.0 1.2 0.4 0.4 4.0 1.5 0.2 0.0 4.2 0.5 0.2 0.1 0.0 0.6 3.7 1.2 1.0 0.8 0.0 1.7 2.0 0.4 0.2 0.7 2.0 0.4 1.3 1.6 0.4 0.9 0.5 3.3 2.3 0.8 0.0 0.3 0.0 0.7 0.6 0.7 0.0 0.0 0.2 1.4 0.0 1.0 2.5 0.1 0.0 0.7 0.5 0.9 0.3 1.5 0.7 1.7 0.0 0.7 0.8 2.5 0.8 0.8 0.3 0.4 0.5 0.8 0.2 0.3 USP29 ENSG00000131864 "Ubiquitin specific peptidase 29" Q9HBJ7 19 57119138-57131926 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;testis: 5.0" "Group enriched" "Detected in some" 8 "Collecting duct cells: 1.8;Early spermatids: 2.2;Spermatocytes: 5.1;Spermatogonia: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA076515 Enhanced NA NA "HPA076515: " "unprognostic (1.32e-1)" 0.1 0.0 1.1 0.0 0.7 1.8 0.0 2.1 0.8 0.0 1.1 0.1 0.1 0.2 0.0 0.2 0.1 0.2 0.5 1.2 1.1 0.1 0.1 0.2 0.4 1.6 0.9 0.7 0.3 1.3 0.0 0.0 0.2 1.5 0.1 0.1 0.6 0.7 0.0 0.3 1.4 0.0 0.0 1.3 0.2 0.4 5.0 0.9 0.0 0.3 0.0 0.1 0.3 0.0 2.2 0.0 0.2 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.3 0.0 0.5 0.2 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.6 0.5 0.2 0.1 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.1 0.0 0.0 0.4 0.1 0.3 0.1 0.2 0.0 1.3 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 1.1 0.3 0.1 0.6 0.1 0.2 1.1 0.7 2.1 0.8 1.2 1.1 1.6 0.9 0.7 1.5 1.3 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 229.2;Glandular and luminal cells: 211.7;Pancreatic endocrine cells: 226.1;Syncytiotrophoblasts: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 606.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 606.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favorable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 61.3 76.1 30.3 48.8 32.3 51.1 55.5 33.4 40.2 50.6 38.5 83.2 80.7 42.3 76.2 56.1 45.0 45.9 61.6 29.6 32.8 49.1 85.4 60.1 49.6 35.0 32.6 28.7 41.9 104.5 51.5 44.9 58.1 34.7 54.1 88.0 29.0 74.4 49.6 71.6 47.8 82.8 43.3 34.0 59.2 67.8 93.4 32.3 24.3 56.3 49.1 53.6 61.2 45.7 36.1 45.3 68.8 61.2 54.5 129.8 91.1 52.4 136.4 100.2 89.8 90.2 82.3 105.0 33.6 49.6 117.5 150.8 125.1 66.6 59.7 58.6 63.5 91.8 57.2 62.5 86.8 206.5 43.5 63.9 80.2 166.3 60.3 177.7 70.7 68.1 44.3 58.3 369.0 97.4 71.7 31.7 67.6 46.8 169.9 45.7 41.6 50.1 74.7 90.7 104.2 34.5 88.5 93.0 85.7 193.8 79.9 64.0 96.2 73.6 84.0 57.1 116.4 103.3 272.5 246.3 49.9 92.2 50.8 104.2 134.4 66.4 81.2 94.1 84.0 91.1 62.2 71.4 101.1 58.6 51.4 53.7 79.6 23.1 95.6 100.1 606.9 71.4 63.7 30.3 32.3 33.4 40.2 29.6 32.8 35.0 32.6 28.7 34.7 34.0 32.3 36.1 164.0 118.6 108.6 0.0 47.8 0.0 0.0 0.0 0.0 0.0 172.5 129.4 0.0 0.0 64.4 154.5 0.0 125.9 87.7 0.0 31.3 183.9 0.0 127.0 165.2 53.3 0.0 0.0 0.0 189.3 229.2 91.6 0.0 211.7 30.3 53.5 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 92.0 0.0 0.0 0.0 0.0 226.1 0.0 0.0 101.0 0.0 0.0 73.0 56.9 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.0 303.7 40.4 100.9 0.0 0.0 CHSY1 "CSS1, KIAA0990" ENSG00000131873 "Chondroitin sulfate synthase 1" Q86X52 15 101175727-101252048 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 216.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (7.28e-2)" "unprognostic (6.39e-2)" "unprognostic (9.24e-2)" "unprognostic (1.55e-1)" "unprognostic (7.60e-2)" "unprognostic (9.51e-3)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (1.77e-1)" "unprognostic (1.32e-2)" "unprognostic (5.97e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.33e-5)" "unprognostic (3.44e-2)" "unprognostic (1.02e-1)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" 27.8 18.7 11.3 18.7 9.9 23.2 21.9 9.2 11.4 19.7 14.3 7.7 6.1 17.5 9.6 10.9 15.0 22.9 16.0 9.4 13.0 10.2 10.1 23.8 11.7 14.4 11.2 8.5 19.9 7.4 7.5 8.6 47.1 11.9 14.5 8.2 7.1 10.2 11.5 6.5 14.4 7.8 20.1 11.3 14.1 10.5 8.8 12.4 10.6 10.1 7.4 10.4 35.2 14.1 12.8 9.1 11.2 36.8 18.7 18.9 25.0 24.5 21.8 19.2 25.8 26.2 9.7 7.1 22.0 12.7 36.3 16.8 24.7 24.5 27.7 28.2 24.6 12.4 43.4 12.2 11.4 23.3 66.9 42.9 23.2 22.8 22.3 20.1 29.3 30.8 9.7 16.2 216.3 19.7 7.9 9.2 46.3 42.5 17.7 7.9 20.6 36.9 32.8 18.1 17.7 6.4 34.6 23.0 11.1 40.8 29.8 12.6 81.6 26.2 41.9 24.1 20.0 46.5 38.2 94.5 12.7 32.5 62.2 32.0 0.0 1.3 2.9 1.5 0.8 1.7 0.9 0.9 1.6 0.8 1.0 0.5 1.0 4.9 0.7 0.9 0.5 1.8 0.6 11.3 9.9 9.2 11.4 9.4 13.0 14.4 11.2 8.5 11.9 11.3 12.4 12.8 55.0 0.0 15.7 27.7 11.4 57.9 20.7 10.1 20.5 10.7 41.9 29.8 9.3 5.7 9.4 16.5 6.2 6.1 14.6 1.6 1.9 5.3 1.2 10.0 33.4 45.8 3.0 12.0 34.2 2.2 28.8 40.0 5.1 13.8 25.9 51.9 60.0 5.4 16.6 38.7 36.1 3.6 10.2 17.8 37.1 2.5 55.0 41.2 26.6 59.0 10.2 9.2 10.3 21.1 24.2 5.5 2.5 47.0 9.3 19.3 1.2 2.4 8.1 7.5 46.0 47.9 53.5 3.9 7.5 10.5 62.5 13.8 15.2 23.0 3.9 10.2 SNRPA1 "Lea1, U2A'" ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA 48000 Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: AB_2679394, HPA048499: AB_2680421" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favorable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 19.2 18.4 11.8 35.8 12.4 68.7 21.1 14.2 15.5 14.8 15.0 30.9 24.6 15.6 33.3 34.0 18.7 12.8 24.4 13.3 13.6 23.3 25.7 19.7 43.7 12.6 12.4 12.1 13.8 22.4 18.4 14.0 30.6 12.7 16.4 31.1 15.7 23.3 12.7 19.9 17.8 30.4 19.5 12.4 25.5 23.4 38.1 12.9 37.8 18.5 12.5 52.3 26.5 18.3 13.6 175.5 119.5 112.7 57.4 31.3 25.6 111.3 158.2 72.8 139.2 105.1 255.8 150.7 192.9 89.2 107.8 109.0 101.7 170.2 113.1 148.1 98.0 262.5 151.4 196.7 137.3 24.0 175.1 103.7 21.0 83.0 89.0 111.3 30.9 90.9 147.1 216.1 175.8 86.5 194.6 177.6 185.7 144.5 232.0 100.1 174.5 121.7 194.8 103.3 450.2 88.6 92.7 97.2 109.0 125.1 117.1 105.2 136.4 66.2 74.1 141.0 86.8 160.3 143.5 464.8 378.9 59.9 162.9 89.3 3.8 36.6 21.5 55.7 47.2 55.3 53.0 57.7 56.1 58.0 47.4 46.6 59.0 6.8 48.5 44.0 54.7 68.9 39.0 11.8 12.4 14.2 15.5 13.3 13.6 12.6 12.4 12.1 12.7 12.4 12.9 13.6 41.5 19.2 54.6 16.3 71.6 65.6 73.4 141.6 70.6 37.8 41.8 52.6 30.5 18.6 80.3 36.8 12.5 124.3 69.6 37.4 68.4 94.6 96.2 52.7 42.5 47.2 27.0 61.4 30.9 109.0 154.1 51.5 27.0 55.6 65.8 37.7 21.4 35.5 67.0 37.0 29.2 44.2 126.1 24.1 39.2 22.4 34.8 36.4 42.7 13.1 76.4 39.6 47.4 16.6 28.6 95.3 41.8 28.6 76.1 142.3 78.7 87.1 89.2 34.9 13.1 37.9 67.1 192.9 65.9 68.3 50.6 112.3 68.1 42.3 52.4 101.6 LLGL1 "DLG4, HUGL, HUGL-1, Lgl1, LLGL, Mgl1" ENSG00000131899 "LLGL scribble cell polarity complex component 1" Q15334 17 18225635-18244875 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022924 Enhanced NA NA "HPA022924: AB_1852926" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (1.88e-2)" "unprognostic (2.94e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.72e-4)" "unprognostic (7.71e-2)" "unprognostic (3.06e-1)" "unprognostic (7.18e-2)" "unprognostic (3.27e-3)" "unprognostic (8.99e-3)" "unprognostic (1.40e-1)" "unprognostic (6.02e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-2)" "unprognostic (2.40e-2)" 7.3 15.7 15.1 2.9 24.0 2.1 7.7 26.6 16.8 13.0 6.1 8.1 1.8 14.3 1.9 16.5 9.6 3.3 7.1 13.4 17.1 5.8 2.3 5.3 3.5 30.7 22.9 10.0 12.1 5.0 2.9 9.6 4.5 25.7 7.6 1.1 1.4 8.6 3.2 10.5 11.3 6.5 3.0 25.5 7.0 6.8 11.0 21.0 3.4 5.6 2.4 2.4 9.8 11.2 45.0 18.3 11.7 29.0 28.2 11.0 9.9 12.0 8.0 12.7 15.4 13.7 26.4 3.5 11.1 13.5 7.0 8.6 16.4 8.6 10.6 4.6 18.3 23.3 5.1 8.7 9.5 5.2 1.9 11.1 12.4 5.7 7.9 3.7 11.7 9.9 13.8 3.8 2.4 6.1 13.1 13.4 3.1 12.3 8.8 6.5 16.7 20.7 6.1 4.6 6.7 7.6 16.3 9.7 4.5 7.7 24.8 5.4 3.1 14.0 12.2 15.3 16.2 12.5 3.6 2.7 3.5 24.1 4.8 10.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 15.1 24.0 26.6 16.8 13.4 17.1 30.7 22.9 10.0 25.7 25.5 21.0 45.0 2.6 0.0 1.7 2.3 1.5 2.7 1.1 3.2 3.4 1.7 4.2 3.2 2.2 2.8 1.9 3.7 0.0 2.3 3.0 1.5 0.0 5.4 8.6 0.9 2.7 2.8 3.6 1.7 0.8 4.4 6.5 5.1 3.1 1.2 0.0 2.2 2.2 1.2 2.8 5.0 0.9 2.2 10.2 1.9 1.1 1.8 6.8 1.4 1.8 0.0 1.1 4.0 1.0 0.0 7.9 7.1 0.7 7.9 2.8 1.7 0.6 2.0 2.6 2.2 0.0 3.7 3.7 4.6 8.2 6.5 3.0 2.1 3.8 0.9 2.7 2.6 NR0B2 SHP ENSG00000131910 "Nuclear receptor subfamily 0 group B member 2" Q15466 1 26911489-26913975 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Receptor, Repressor" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 77.6;liver: 143.6" "Cell type enhanced" "Detected in some" "Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8" "Cancer enriched" "Detected in many" 5 "liver cancer: 52.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 33 "Hep G2: 78.2" "Region enriched" "Detected in single" 6 "cerebellum: 1.7" "Not detected" "Not detected" HPA003983 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003983: " "unprognostic (2.99e-2)" "unprognostic (1.86e-1)" "unprognostic (1.95e-3)" "unprognostic (4.68e-3)" "unprognostic (9.21e-2)" "unprognostic (8.22e-2)" "unprognostic (3.97e-2)" "unprognostic (2.44e-2)" "unprognostic (1.83e-1)" "unprognostic (3.09e-1)" "unprognostic (2.11e-2)" "unprognostic (6.74e-3)" "unprognostic (1.04e-1)" "unprognostic (2.03e-1)" "unprognostic (4.12e-3)" "unprognostic (1.10e-2)" 0.0 21.5 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 77.6 0.0 0.0 0.0 0.0 10.2 13.0 0.0 0.0 33.2 143.6 2.5 0.0 0.0 0.1 0.0 0.0 30.9 1.6 0.3 0.0 0.1 0.0 0.4 0.2 0.0 0.0 2.7 0.0 26.7 0.0 0.1 11.6 26.6 1.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 78.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.3 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 3.2 15.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 8.4 97.2 0.7 12.9 0.0 0.0 0.0 0.9 52.8 31.3 0.4 0.1 0.0 0.2 24.4 8.0 0.0 42.4 0.0 0.3 90.2 0.0 0.0 3.0 2.5 173.4 0.1 28.6 0.0 7.6 16.2 3.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.3 0.0 0.2 0.0 49.8 0.1 0.0 0.4 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.3 0.1 11.0 0.2 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410817-26429728 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 5.2" "Group enriched" "Detected in some" 43 "Early spermatids: 35.2;Late spermatids: 69.5" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 861.2;SuSa: 300.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" NA NA Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.0 0.0 0.3 0.0 0.3 0.2 0.0 1.0 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 5.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 84.3 0.5 0.0 0.0 62.7 0.1 0.0 0.0 0.0 2.0 0.5 0.0 0.1 0.0 0.0 0.2 11.6 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 861.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 300.9 27.2 0.2 0.1 0.4 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.3 1.0 0.3 0.1 0.1 0.2 0.2 0.1 0.4 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 69.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 1.1 0.4 1.2 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.2 THAP1 "4833431A01Rik, DYT6, FLJ10477" ENSG00000131931 "THAP domain containing 1" Q9NVV9 8 42836674-42843325 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" DNA-binding "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071310 Supported Nucleoplasm No No Nucleoplasm "HPA071310: AB_2686386" "unprognostic (8.99e-3)" "unprognostic (3.97e-3)" "unprognostic (7.15e-3)" "unprognostic (1.87e-2)" "unprognostic (2.55e-1)" "unprognostic (6.38e-2)" "unprognostic (1.20e-1)" "unprognostic (4.03e-1)" "unprognostic (3.91e-2)" "unprognostic (5.95e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-2)" "unprognostic (2.94e-2)" "unprognostic (1.28e-1)" "unprognostic (2.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.16e-2)" 7.4 5.8 5.4 7.0 5.4 8.3 7.5 7.8 7.6 6.3 5.5 6.1 6.0 7.0 6.2 6.3 7.3 5.2 8.9 5.5 5.2 7.1 8.8 5.5 9.5 6.1 5.6 5.4 8.3 4.7 8.0 3.8 7.0 6.2 5.7 5.5 5.7 6.2 5.8 12.5 4.1 5.8 6.8 5.8 6.4 5.1 9.5 6.0 11.6 8.7 12.6 8.5 6.6 3.7 6.9 10.5 9.3 8.5 8.2 12.7 14.3 10.2 14.2 10.8 12.8 11.7 8.0 13.2 12.8 11.3 10.5 19.0 10.7 14.0 12.0 16.2 12.4 10.3 12.5 8.1 9.4 15.6 10.4 12.7 11.3 17.7 14.1 18.2 12.4 16.5 17.1 14.1 14.7 15.1 6.4 25.1 12.1 16.8 16.9 7.4 11.2 15.2 10.2 13.9 7.8 6.9 8.1 15.5 9.7 20.2 11.2 13.5 11.6 10.0 11.2 8.3 15.0 14.3 11.9 14.0 12.2 11.2 13.6 12.4 23.8 18.6 30.8 19.9 16.7 21.6 20.4 23.1 22.1 19.9 17.8 26.9 21.5 22.0 19.3 18.0 9.8 32.5 18.8 5.4 5.4 7.8 7.6 5.5 5.2 6.1 5.6 5.4 6.2 5.8 6.0 6.9 17.2 9.6 9.4 3.6 20.1 13.5 9.4 16.6 26.7 10.5 12.3 11.4 21.5 7.2 12.6 5.5 0.0 20.5 17.5 7.7 23.5 17.5 35.6 16.1 16.2 15.5 14.3 18.3 5.2 11.3 23.8 14.5 2.6 13.3 16.5 8.6 10.4 12.1 15.2 23.5 5.3 8.8 28.5 11.6 9.2 17.9 11.5 13.4 7.2 2.8 20.2 15.6 30.9 5.5 4.9 10.6 4.0 13.9 18.5 10.8 14.1 22.9 13.1 11.0 0.0 12.9 17.0 32.6 45.8 21.1 13.8 8.1 24.6 12.8 9.6 8.2 RHPN2 ENSG00000131941 "Rhophilin Rho GTPase binding protein 2" Q8IUC4 19 32978592-33064888 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 61.0;Endometrial ciliated cells: 90.2;Gastric mucus-secreting cells: 94.8;Glandular and luminal cells: 108.8;Muller glia cells: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 52.4;OE19: 50.7;RPTEC TERT1: 52.9;SK-BR-3: 54.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051749 Uncertain NA NA "HPA051749: AB_2681589" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.08e-3)" "unprognostic (2.32e-1)" "unprognostic (5.07e-3)" "unprognostic (3.01e-3)" "unprognostic (1.26e-1)" "prognostic favorable (1.22e-8)" "unprognostic (3.74e-2)" "unprognostic (4.44e-2)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" 1.9 0.8 5.5 4.4 5.8 0.0 12.8 5.6 6.6 8.5 7.1 23.9 21.9 5.5 2.4 1.2 15.1 13.7 1.4 5.1 8.3 14.6 19.7 4.1 1.3 6.5 6.4 4.8 1.7 12.5 17.0 4.8 8.2 6.2 27.4 19.2 20.4 19.6 2.2 0.3 9.4 17.9 1.9 5.0 0.9 35.5 0.7 7.0 1.9 5.5 0.9 2.6 11.6 1.1 6.2 28.6 52.4 4.9 8.6 1.0 0.1 24.5 6.6 5.0 10.0 10.5 45.9 28.6 0.0 41.1 3.7 8.8 13.5 15.9 5.8 12.4 13.2 9.7 3.2 5.9 17.9 6.6 0.0 4.1 1.2 11.5 8.4 4.7 7.6 1.3 1.2 7.2 0.0 3.0 24.4 0.1 2.9 10.5 50.7 8.4 0.0 6.0 5.6 52.9 14.0 11.0 5.8 11.2 54.5 13.4 13.9 15.2 1.4 0.7 0.1 12.7 3.6 11.2 6.3 4.6 2.1 1.6 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 5.8 5.6 6.6 5.1 8.3 6.5 6.4 4.8 6.2 5.0 7.0 6.2 0.3 22.4 1.1 20.2 3.9 1.3 6.3 6.2 7.4 1.9 30.4 15.4 0.9 17.2 14.7 12.9 12.5 18.2 2.1 61.0 3.9 31.0 0.4 90.2 11.1 1.1 4.8 0.0 1.3 13.1 6.8 6.4 94.8 108.8 1.3 0.2 3.3 13.0 1.9 0.0 1.4 22.2 18.3 3.0 0.0 0.3 2.1 1.6 1.8 4.7 0.0 76.8 0.0 9.5 1.6 33.8 52.6 1.2 6.1 23.5 11.7 19.8 51.9 10.1 0.0 0.6 3.7 0.0 1.4 3.8 1.8 3.4 1.1 0.0 23.3 36.1 C19orf12 "DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43" ENSG00000131943 "Chromosome 19 open reading frame 12" Q9NSK7 19 29698886-29715789 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 120.0;tongue: 106.5" "Cell type enhanced" "Detected in all" "Hepatocytes: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046930 Approved Supported Cytosol NA NA Cytosol "HPA046930: AB_10962836" "unprognostic (1.76e-1)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.01e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.54e-1)" "unprognostic (9.94e-3)" "unprognostic (7.93e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (3.22e-1)" "unprognostic (1.22e-3)" 120.0 25.6 21.4 14.6 23.8 4.4 41.1 16.6 23.3 13.7 12.8 15.3 19.7 14.4 9.1 13.3 12.9 13.0 27.4 22.8 22.2 20.9 69.8 11.4 21.4 20.4 21.1 24.4 14.9 17.3 15.6 14.6 13.3 22.3 14.2 9.4 8.6 18.3 12.6 62.7 14.8 17.7 13.5 16.8 16.1 13.0 7.4 22.6 14.2 10.8 106.5 13.7 15.3 11.8 21.7 19.9 39.4 18.4 23.2 45.0 27.5 28.8 23.1 22.7 22.5 29.2 19.1 8.1 16.1 24.1 29.1 20.4 8.5 15.7 9.5 15.1 42.8 28.3 18.0 13.5 33.2 25.1 14.0 22.8 31.8 20.2 13.7 10.9 18.0 20.1 9.8 14.0 20.3 23.7 13.8 9.9 10.1 11.1 17.3 9.9 19.2 19.1 12.3 17.2 20.1 11.3 23.8 13.9 17.8 37.0 18.8 7.6 15.4 20.9 47.4 37.0 19.5 21.2 28.4 27.1 12.0 28.3 8.4 20.3 1.1 2.3 1.4 16.0 2.5 9.4 4.6 9.1 11.6 2.2 3.6 9.2 11.5 2.8 7.1 2.7 5.0 11.9 8.0 21.4 23.8 16.6 23.3 22.8 22.2 20.4 21.1 24.4 22.3 16.8 22.6 21.7 9.6 12.8 13.7 9.4 13.7 12.7 11.1 8.2 14.8 15.8 13.2 9.4 30.1 2.8 7.3 9.2 6.2 29.2 21.7 9.2 15.6 17.1 1.8 8.5 16.0 10.4 3.6 9.5 19.5 23.1 25.5 20.0 8.2 8.8 16.5 16.2 14.6 62.4 15.6 5.0 18.3 7.5 8.2 12.5 9.9 1.8 28.9 8.7 10.6 8.4 20.1 15.8 41.2 12.1 17.4 20.0 11.0 29.3 20.7 12.8 24.0 37.5 6.6 9.6 6.6 24.6 13.3 4.6 5.3 10.1 7.7 21.9 21.6 23.8 8.2 7.8 FAAP24 "C19orf40, FLJ46828, MGC32020" ENSG00000131944 "FA core complex associated protein 24" Q9BTP7 19 32972209-32978229 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 14.6;Spermatocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041168 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041168: AB_10960496" "unprognostic (1.18e-2)" "unprognostic (1.22e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (6.52e-2)" "unprognostic (2.73e-1)" "unprognostic (2.58e-3)" "unprognostic (3.76e-2)" "unprognostic (1.88e-2)" "unprognostic (3.98e-2)" "unprognostic (2.82e-3)" "unprognostic (3.54e-2)" "prognostic unfavorable (4.00e-7)" "unprognostic (4.37e-3)" "unprognostic (5.30e-1)" "unprognostic (2.31e-3)" "unprognostic (2.15e-1)" 1.5 1.4 0.9 2.6 0.8 3.6 1.8 1.1 1.0 1.0 1.2 1.7 1.8 1.3 2.4 1.8 1.4 2.3 0.6 0.8 0.6 0.9 1.4 1.4 3.1 1.0 0.6 0.7 2.5 0.9 0.4 0.8 1.6 1.1 4.9 2.5 0.5 1.2 1.1 0.5 2.8 2.2 1.5 0.5 2.4 1.4 6.3 0.8 2.6 1.8 0.2 3.5 1.5 1.2 2.3 6.0 15.0 5.7 9.3 3.2 6.3 4.9 7.7 8.2 14.5 18.8 10.3 9.7 7.0 11.2 3.2 11.4 4.2 11.7 5.9 11.5 19.4 5.4 15.3 5.8 7.6 1.7 5.2 7.5 3.5 3.5 9.0 5.3 2.3 5.9 11.2 8.2 7.1 11.1 6.7 11.6 7.1 2.6 8.7 6.7 10.2 5.1 3.9 2.9 3.6 5.9 4.9 8.7 9.9 6.1 6.2 6.6 13.7 3.5 14.2 6.6 6.2 7.2 5.5 12.4 9.6 10.1 11.9 9.6 15.3 5.7 8.8 3.2 6.9 3.8 6.4 4.0 4.9 3.6 6.2 3.6 5.2 13.9 7.1 7.8 6.9 5.6 3.2 0.9 0.8 1.1 1.0 0.8 0.6 1.0 0.6 0.7 1.1 0.5 0.8 2.3 1.7 3.2 1.1 0.0 3.0 0.0 3.3 0.0 1.8 1.5 3.9 3.6 0.5 2.8 1.3 3.7 2.1 11.1 6.5 1.2 1.9 1.6 7.2 4.4 3.0 2.1 1.2 7.4 0.0 8.0 14.6 3.1 0.5 6.3 1.3 7.1 3.6 0.4 8.2 5.0 0.0 2.4 0.0 5.1 0.0 12.3 3.4 3.5 0.0 0.0 7.0 0.6 2.1 0.0 0.0 4.2 2.4 3.4 2.6 3.2 3.5 1.0 0.0 1.0 0.0 2.7 2.2 22.6 8.3 2.7 0.0 5.1 2.5 5.8 2.7 2.6 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 7.4;choroid plexus: 10.3;testis: 8.2" "Cell type enhanced" "Detected in some" "Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.3 0.1 5.4 0.0 1.7 0.1 0.0 2.5 0.8 0.0 10.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 7.4 0.0 0.0 0.0 0.0 4.7 4.0 0.3 0.0 0.0 0.8 0.6 0.0 3.7 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.0 8.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.7 2.5 0.8 0.8 7.4 4.7 4.0 0.3 3.7 5.9 1.3 5.3 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.6 1.5 0.1 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 18.0 0.0 0.0 0.0 0.0 75.8 0.9 0.1 0.0 1.9 0.0 0.8 0.0 5.5 2.0 0.0 0.0 0.7 0.0 0.7 0.4 0.0 2.9 0.2 0.0 0.0 0.0 10.3 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 ACTR10 "ACTR11, Arp10, Arp11, HARP11" ENSG00000131966 "Actin related protein 10" Q9NZ32 14 58200080-58235636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000699 Approved "Vesicles,Plasma membrane,Focal adhesion sites" NA NA "Vesicles, Plasma membrane, Focal adhesion sites" "HPA000699: " "prognostic unfavorable (3.24e-4)" "unprognostic (4.61e-2)" "unprognostic (6.22e-3)" "unprognostic (2.03e-2)" "unprognostic (4.42e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.71e-5)" "unprognostic (3.20e-1)" "unprognostic (9.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.48e-8)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (2.43e-2)" "unprognostic (8.48e-2)" 11.9 18.1 25.7 3.2 25.8 5.4 12.6 26.9 41.9 14.3 27.7 12.7 2.7 10.3 5.1 16.5 12.8 4.3 20.3 25.7 26.3 18.1 18.7 10.8 4.2 26.1 26.2 26.0 15.9 17.6 8.8 20.5 6.4 26.1 14.6 4.4 5.5 10.4 4.7 10.3 12.0 11.4 6.2 25.5 14.9 13.3 10.9 26.1 5.4 13.8 4.2 4.4 12.1 14.0 26.2 4.1 2.6 4.6 1.8 15.3 7.3 2.3 3.1 3.6 4.9 6.1 3.5 4.8 6.3 4.5 6.7 3.0 4.2 6.2 4.5 7.2 3.3 15.3 2.4 4.6 6.9 13.0 4.3 3.4 9.7 6.8 4.5 8.5 4.3 6.7 3.6 2.1 5.0 10.3 11.3 5.7 16.2 2.3 4.0 20.8 4.0 8.0 3.7 9.1 5.2 2.6 2.9 5.9 4.9 16.9 5.2 8.4 7.1 5.4 5.3 11.3 4.9 2.8 2.9 2.0 7.1 5.8 3.3 3.2 15.7 5.4 8.6 6.2 7.3 9.2 6.1 7.0 6.2 4.3 4.1 7.2 7.5 7.8 5.9 8.5 4.8 5.5 4.0 25.7 25.8 26.9 41.9 25.7 26.3 26.1 26.2 26.0 26.1 25.5 26.1 26.2 68.3 60.9 44.2 28.7 39.9 53.3 66.4 125.7 34.1 71.4 35.8 43.3 77.0 42.9 75.1 51.5 29.2 110.1 46.4 59.6 125.2 81.2 8.7 40.3 46.7 54.4 33.6 60.0 48.6 59.6 76.9 73.4 32.1 29.7 43.7 49.6 47.8 31.8 77.8 57.2 47.3 48.1 105.8 32.0 38.4 11.6 88.3 47.2 74.7 23.4 52.8 101.4 35.0 40.2 54.6 75.0 29.1 80.1 34.7 59.1 56.3 111.7 67.7 72.0 78.9 54.5 96.6 116.4 60.4 45.7 64.4 156.0 46.1 81.3 41.3 54.6 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872053-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 6.2;retina: 15.7;skin 1: 10.6" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 188.1" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 1.0;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "thalamus: 2.1" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 0.5 0.0 2.5 0.1 4.9 1.6 1.3 0.1 2.6 0.0 0.7 0.7 0.0 0.3 0.0 0.2 1.0 0.1 0.1 1.2 1.8 0.2 0.0 0.3 0.1 0.7 4.9 1.8 0.0 0.0 0.2 0.1 0.1 1.5 0.0 1.0 15.7 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.6 6.2 0.3 0.1 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.5 4.9 0.1 2.6 1.2 1.8 0.7 4.9 1.8 1.5 0.0 6.2 3.5 2.4 0.0 0.0 0.3 0.1 0.4 0.1 1.5 0.0 3.4 0.1 0.1 1.9 0.0 5.0 1.8 2.1 0.1 0.0 2.2 0.0 0.0 7.7 2.5 0.2 0.7 0.0 0.0 9.9 0.0 0.0 0.7 0.0 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.0 4.1 0.0 0.0 5.8 1.2 0.1 0.0 0.0 0.0 188.1 0.0 1.0 4.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 26.4 18.1 0.0 0.1 1.2 0.3 0.2 0.0 1.4 0.3 0.1 0.0 1.8 0.2 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902826 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease variant, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.7;liver: 37.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 212.5;Hepatocytes: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 12.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 1.8 6.0 2.0 8.2 2.8 31.7 1.8 1.2 1.9 0.3 2.0 2.4 9.5 0.4 0.2 3.6 1.2 0.4 1.5 1.9 4.1 4.6 37.0 4.1 7.1 3.6 8.5 1.1 0.5 2.6 0.9 1.8 0.3 5.7 1.6 2.4 0.1 1.7 1.1 0.4 2.0 7.5 1.1 1.9 6.9 2.8 1.2 8.3 3.8 0.8 0.2 2.0 3.3 1.5 3.7 4.7 0.6 1.3 7.1 0.0 0.0 23.5 0.0 2.0 2.4 2.9 1.4 1.0 25.0 6.9 0.2 5.8 4.0 4.9 1.5 0.1 10.9 5.2 0.6 0.3 3.1 8.4 0.0 1.9 0.3 0.7 1.2 0.1 0.0 0.7 23.0 2.8 0.0 0.0 5.0 15.1 0.3 0.4 6.5 8.2 9.6 2.8 0.0 2.9 1.6 11.6 50.9 3.3 2.4 1.6 0.4 2.9 1.5 0.3 0.1 4.0 9.9 3.8 10.5 8.4 7.8 3.1 8.4 0.0 0.0 2.6 0.2 2.8 5.3 2.1 0.7 1.0 1.5 2.8 1.9 2.5 1.3 0.3 1.8 11.1 0.1 2.1 1.2 2.0 2.8 1.2 1.9 1.9 4.1 3.6 8.5 1.1 5.7 1.9 8.3 3.7 19.2 3.2 4.8 0.7 33.4 74.6 30.9 23.6 17.6 0.0 19.4 13.2 6.5 4.3 13.6 5.5 2.1 1.9 50.9 21.8 7.9 8.7 0.5 16.8 5.8 19.8 212.5 10.1 3.8 9.4 44.3 15.3 43.8 29.3 0.0 0.3 6.8 94.6 6.1 0.0 5.9 22.7 4.1 28.0 33.3 0.6 0.3 55.8 10.6 15.9 29.5 0.7 29.9 0.5 0.8 11.0 13.6 4.9 14.4 20.5 17.1 48.6 6.9 0.4 0.0 12.5 7.5 2.2 6.7 20.8 76.1 4.2 41.8 11.9 12.2 39.0 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145423 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 1205.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9" "Group enriched" "Detected in all" 13 "dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003162, CAB005191, HPA076528" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1900000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: " "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 350.1 72.6 95.4 221.9 95.3 350.0 325.9 94.7 149.3 334.2 91.9 1205.2 698.2 163.8 54.3 441.8 225.0 275.5 248.5 94.1 108.3 119.6 27.5 359.2 85.2 102.7 94.9 92.5 253.7 80.6 20.0 61.1 142.4 94.4 144.3 883.6 68.9 361.8 179.1 79.4 459.4 860.5 160.2 94.4 62.4 343.7 64.1 102.7 53.5 72.9 106.6 115.0 303.7 275.8 95.8 298.6 96.5 3.3 2.5 581.2 1169.3 344.9 226.7 496.2 64.0 113.2 225.4 968.0 0.7 121.3 272.8 114.6 289.0 6.1 245.4 37.5 357.1 4.4 1.0 104.7 103.8 446.8 1.0 1.1 363.4 375.2 73.9 152.8 145.1 101.5 0.7 1.4 283.1 148.8 218.5 1.3 74.4 5.6 1613.0 271.1 0.7 11.3 22.4 604.8 434.2 7.8 22.6 529.0 0.9 2329.1 16.2 242.8 31.4 180.5 297.8 41.5 112.0 4.4 154.0 535.6 2.8 426.8 18.6 31.8 18.5 651.4 32.4 15.7 544.6 99.7 11.5 58.4 44.2 397.8 4.7 2.5 8.3 28.7 24.2 441.2 9.6 251.9 449.6 95.4 95.3 94.7 149.3 94.1 108.3 102.7 94.9 92.5 94.4 94.4 102.7 95.8 1157.4 721.1 359.8 33.3 42.0 631.3 624.1 1278.9 241.9 2.9 307.3 478.7 218.2 258.7 1463.3 119.5 0.0 766.1 38.8 4097.0 673.1 605.9 21.7 636.2 742.7 397.8 173.4 578.1 0.2 1057.8 1051.7 666.3 281.4 846.8 580.5 6.3 64.6 2.3 1137.4 1.7 0.5 1733.8 1778.1 287.8 844.6 44.4 555.7 651.2 848.4 14.0 639.1 300.1 9.2 2.0 0.3 1289.6 3445.9 384.0 77.4 708.4 4397.2 81.3 1506.5 14.7 144.7 220.2 521.0 11.5 6.6 524.8 797.6 483.8 119.5 2.9 1880.1 1139.7 PODNL1 "FLJ23447, SLRR5B" ENSG00000132000 "Podocan like 1" Q6PEZ8 19 13931187-13953392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 13.4;Bipolar cells: 38.7;Leydig cells: 18.3;Peritubular cells: 38.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 6.6;HSkMC: 11.6;hTERT-RPE1: 18.8;SiHa: 9.7;U-2 OS: 6.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 11 "spinal cord: 18.9" HPA042807 Approved "Secreted - unknown location" NA NA "HPA042807: AB_10795514" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (8.08e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.61e-8)" "unprognostic (1.78e-1)" "unprognostic (1.86e-2)" "unprognostic (3.68e-1)" "unprognostic (2.02e-1)" "unprognostic (3.08e-3)" "unprognostic (4.37e-2)" "unprognostic (1.01e-1)" "unprognostic (0.00e+0)" "unprognostic (3.94e-3)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.49e-4)" 1.8 0.7 2.1 0.9 1.7 0.5 5.0 2.2 1.6 4.8 0.9 2.2 0.4 1.5 0.3 8.3 2.1 1.4 4.2 1.1 3.5 1.6 0.5 5.1 0.2 4.4 4.1 0.9 3.3 1.5 0.1 5.1 3.7 2.8 8.0 0.3 2.0 5.3 0.9 1.6 11.5 2.3 0.5 2.6 1.0 1.7 7.3 3.2 0.0 3.1 1.3 0.2 2.7 12.1 3.2 0.3 0.4 0.4 0.2 0.6 1.5 0.1 4.1 2.4 0.8 1.6 0.3 0.4 0.2 0.3 6.6 0.2 1.6 0.1 0.1 0.4 1.5 0.6 0.8 0.4 0.0 5.1 0.2 0.5 11.6 0.7 1.1 0.1 18.8 0.0 0.1 0.4 0.3 1.6 2.7 0.2 0.2 0.1 0.3 0.4 0.1 0.1 0.0 0.3 0.0 0.7 0.4 9.7 0.1 0.3 0.4 0.1 0.5 0.7 2.0 6.7 0.5 0.2 0.3 0.0 0.1 0.8 0.9 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 1.7 2.2 1.6 1.1 3.5 4.4 4.1 0.9 2.8 2.6 3.2 3.2 1.4 0.0 0.5 2.3 0.0 1.3 0.9 13.4 0.0 38.7 2.1 8.0 1.6 0.0 1.4 0.0 2.1 0.4 0.2 1.8 0.0 0.2 1.7 0.5 6.1 0.9 0.0 2.7 0.5 0.0 0.2 4.7 0.0 0.4 0.0 0.5 0.7 0.1 9.8 1.7 0.7 1.1 0.0 1.2 1.7 2.1 18.3 0.9 1.8 1.9 0.0 1.8 0.0 1.5 0.3 0.6 9.0 38.0 0.0 0.5 0.6 0.1 1.4 4.6 0.0 0.6 1.0 1.0 0.7 2.6 4.3 0.8 0.2 0.1 1.4 1.6 DNAJB1 "Hsp40, HSPF1, RSPH16B, Sis1" ENSG00000132002 "DnaJ heat shock protein family (Hsp40) member B1" P25685 19 14514769-14560391 "Cancer-related genes, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1149.7" "Cell type enhanced" "Detected in all" "Langerhans cells: 1392.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017450, HPA063247" Enhanced Supported Nucleoplasm NA Yes 23000 Nucleoplasm "CAB017450: AB_10631418, HPA063247: AB_2684971" "unprognostic (3.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.74e-2)" "unprognostic (3.83e-1)" "unprognostic (1.85e-1)" "unprognostic (7.91e-3)" "unprognostic (2.17e-1)" "prognostic favorable (5.96e-4)" "unprognostic (2.20e-2)" "unprognostic (4.44e-2)" "unprognostic (2.00e-2)" "unprognostic (6.77e-2)" 123.6 218.2 380.4 41.2 258.5 135.0 62.6 357.9 1149.7 114.3 275.8 86.8 35.5 54.4 41.1 443.5 75.9 185.3 164.7 534.4 265.2 193.4 232.2 288.5 42.3 338.9 270.0 232.3 233.9 90.6 67.0 149.5 124.4 401.0 74.5 48.9 81.9 110.6 128.3 51.7 107.6 63.2 54.9 275.8 105.4 150.4 150.6 385.1 108.3 98.0 209.9 77.2 134.8 259.9 582.4 192.5 212.5 80.8 81.7 146.8 114.1 45.6 125.9 99.9 210.4 158.8 126.3 106.7 54.8 135.4 121.0 135.5 144.9 169.1 96.7 150.3 55.0 76.1 86.7 115.0 275.6 94.6 57.9 78.5 61.0 237.5 85.3 73.4 114.7 71.6 35.7 131.2 471.6 123.6 130.5 102.2 60.1 80.4 285.9 228.3 73.7 106.3 121.7 101.8 62.4 67.0 51.1 121.1 233.7 127.1 90.8 60.3 60.6 64.7 156.4 98.0 184.1 264.8 193.5 141.7 65.7 114.4 109.2 151.1 68.8 92.4 116.2 171.6 159.0 184.8 93.7 244.5 214.9 76.0 92.0 281.6 219.9 137.6 125.1 172.2 45.1 270.9 322.6 380.4 258.5 357.9 1149.7 534.4 265.2 338.9 270.0 232.3 401.0 275.8 385.1 582.4 750.2 157.0 95.4 32.3 248.7 425.8 1142.1 148.0 719.3 60.9 468.8 476.4 367.1 72.9 118.6 23.9 118.9 135.6 214.2 459.6 41.1 132.8 491.8 374.8 339.3 397.3 407.3 60.0 10.2 162.6 199.3 661.2 408.7 552.8 339.4 100.2 86.7 59.9 158.1 52.2 8.9 420.1 81.4 85.1 1392.1 475.3 63.3 559.3 503.4 23.4 31.3 160.7 25.7 3.0 16.5 123.8 380.7 36.9 697.0 461.1 117.3 59.1 138.0 164.7 26.3 398.9 673.3 290.2 53.4 1186.0 478.9 274.9 948.4 104.8 393.7 606.2 ZSWIM4 FLJ12221 ENSG00000132003 "Zinc finger SWIM-type containing 4" Q9H7M6 19 13795460-13832230 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 16.8" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 34.2;Urothelial cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042084 Uncertain NA NA "HPA042084: AB_10795392" "unprognostic (3.29e-2)" "unprognostic (4.07e-1)" "unprognostic (4.15e-2)" "unprognostic (1.41e-3)" "unprognostic (4.78e-2)" "unprognostic (1.34e-3)" "unprognostic (4.25e-3)" "unprognostic (6.14e-2)" "unprognostic (5.36e-2)" "unprognostic (1.56e-2)" "unprognostic (1.78e-1)" "unprognostic (6.15e-2)" "prognostic unfavorable (7.85e-5)" "unprognostic (3.47e-1)" "unprognostic (4.95e-1)" "unprognostic (1.86e-1)" "unprognostic (8.63e-2)" 3.3 5.4 1.0 2.1 0.9 1.1 4.9 1.0 1.7 4.6 1.3 2.8 1.1 4.2 0.2 16.8 3.3 1.4 3.8 0.8 1.1 5.1 1.9 7.2 1.2 1.5 1.2 0.7 3.7 3.9 1.1 4.7 1.6 1.2 5.0 0.3 1.1 14.9 0.8 2.9 7.9 3.0 0.9 0.9 4.2 3.5 1.4 1.5 1.5 5.8 0.8 1.3 3.2 7.7 1.4 4.3 2.4 4.7 2.4 0.6 0.5 4.5 1.8 3.9 1.6 1.7 0.9 2.3 1.5 2.8 1.5 2.5 1.7 0.8 1.6 1.1 5.4 1.5 0.2 3.0 0.5 3.8 0.4 1.2 2.5 0.4 1.8 0.7 3.9 3.8 3.6 1.4 3.2 0.5 2.3 2.4 3.4 5.5 0.8 2.4 5.3 4.4 2.5 2.2 2.0 1.3 9.1 3.1 7.6 3.3 2.7 1.1 2.8 4.5 4.7 1.7 1.4 6.2 3.9 2.5 1.0 3.0 1.8 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.9 1.0 1.7 0.8 1.1 1.5 1.2 0.7 1.2 0.9 1.5 1.4 5.5 3.2 2.0 4.9 2.4 5.4 17.1 8.6 2.8 5.4 11.9 6.9 3.3 8.6 7.4 3.7 8.4 4.2 2.0 3.3 0.0 13.1 0.2 11.1 5.0 10.4 10.7 1.7 5.8 23.1 3.4 6.0 4.1 23.0 0.0 3.7 4.6 1.8 4.6 6.7 7.0 3.0 2.0 7.0 11.9 0.4 1.2 5.6 3.6 5.6 3.8 2.4 0.0 6.0 1.8 23.8 2.3 1.2 1.5 14.3 3.9 3.2 12.6 3.7 0.0 34.2 6.4 0.3 0.9 4.9 7.0 6.0 6.8 0.7 3.9 26.8 FBXW9 "Fbw9, MEC-15, MGC10870" ENSG00000132004 "F-box and WD repeat domain containing 9" Q5XUX1 19 12688053-12696631 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.6;Respiratory ciliated cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042087 Approved Approved Cytosol NA NA Cytosol "HPA042087: AB_10794168" "unprognostic (4.46e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-3)" "unprognostic (4.69e-3)" "unprognostic (4.91e-2)" "unprognostic (2.97e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (2.71e-2)" "unprognostic (4.02e-2)" "unprognostic (6.08e-3)" "unprognostic (8.04e-2)" "unprognostic (2.61e-1)" "unprognostic (8.42e-3)" 3.9 8.0 5.4 2.1 3.9 4.2 5.6 3.0 5.8 5.2 7.2 5.0 4.5 5.0 2.1 10.4 13.3 2.9 2.7 3.9 3.7 8.6 5.1 4.5 3.1 3.6 4.5 4.0 4.0 7.4 4.3 7.5 2.6 3.5 7.2 1.8 2.0 7.7 3.5 2.7 9.3 4.0 1.7 3.8 4.0 5.7 15.0 3.2 2.9 7.5 0.8 1.9 4.7 5.9 3.5 16.6 11.1 7.2 10.6 3.1 5.2 8.7 5.3 5.4 11.1 9.1 6.2 10.0 4.1 13.5 4.8 2.7 14.7 6.9 10.0 1.9 2.9 18.5 4.9 13.2 10.4 7.0 12.3 2.9 7.0 15.8 7.7 3.8 6.6 8.8 9.4 11.9 2.7 2.5 34.5 13.4 16.1 12.2 8.8 10.4 7.0 5.0 23.2 10.0 4.9 16.5 19.6 7.9 16.5 7.6 2.3 16.5 9.3 4.3 6.5 6.0 8.1 8.5 16.4 7.3 4.5 8.1 4.5 4.3 0.0 7.4 0.0 2.7 7.1 4.6 2.8 2.9 2.1 11.1 2.5 2.8 2.0 0.3 4.7 4.9 3.1 5.7 5.0 5.4 3.9 3.0 5.8 3.9 3.7 3.6 4.5 4.0 3.5 3.8 3.2 3.5 4.8 3.2 5.4 1.3 1.3 6.0 5.2 18.6 8.0 2.0 12.1 13.0 0.7 8.6 14.3 1.8 6.2 14.4 1.5 5.7 5.9 18.1 6.4 65.6 6.9 4.2 4.8 11.8 3.7 16.0 8.4 4.4 5.6 6.8 0.0 10.7 4.6 3.6 7.0 0.0 3.1 9.2 22.4 4.5 3.7 8.5 2.5 5.9 3.6 0.0 4.2 4.9 1.0 1.0 1.2 11.6 5.6 4.5 1.7 4.2 5.5 17.4 80.3 7.1 6.6 4.4 6.5 30.8 17.3 9.2 8.2 6.4 2.4 20.3 12.5 4.9 RFX1 EF-C ENSG00000132005 "Regulatory factor X1" P22670 19 13961530-14007039 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 144.2;Late spermatids: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048722, HPA052966" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA048722: AB_2680500, HPA052966: " "unprognostic (6.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.55e-3)" "unprognostic (2.63e-1)" "unprognostic (5.45e-2)" "prognostic favorable (2.42e-4)" "unprognostic (2.62e-1)" "unprognostic (1.71e-1)" "unprognostic (2.88e-1)" "unprognostic (1.61e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-2)" "unprognostic (2.96e-1)" "unprognostic (1.50e-1)" "unprognostic (1.56e-2)" 5.6 6.2 1.2 2.0 1.3 2.4 6.5 3.9 2.4 9.4 0.3 5.6 2.3 7.1 0.8 7.8 7.4 1.3 7.0 1.2 1.3 7.2 8.7 6.7 1.7 1.2 1.1 0.8 8.9 7.9 2.2 16.7 1.5 1.8 8.1 0.6 1.2 7.4 1.6 8.0 7.1 7.2 0.6 0.6 9.3 6.7 22.3 1.2 1.7 10.0 0.8 1.0 6.0 7.7 1.1 3.3 3.2 1.7 2.1 1.0 1.2 5.1 1.8 1.1 2.0 1.7 3.3 3.2 1.8 3.6 0.9 1.7 4.2 1.2 1.2 0.7 2.0 7.0 2.1 3.8 3.0 1.8 2.1 4.3 0.9 1.3 1.8 1.0 1.7 1.5 1.5 5.5 1.9 1.0 4.8 3.9 4.6 3.9 1.7 4.8 3.4 1.8 2.6 1.9 1.7 6.9 3.7 3.0 2.6 2.6 0.9 2.9 2.2 1.8 3.4 2.8 3.8 3.1 4.7 2.3 1.2 2.7 2.0 3.1 0.2 1.1 0.6 0.4 0.4 0.4 1.0 0.5 0.5 0.6 1.1 0.5 0.6 3.7 1.1 0.7 1.2 0.3 0.4 1.2 1.3 3.9 2.4 1.2 1.3 1.2 1.1 0.8 1.8 0.6 1.2 1.1 26.1 16.0 8.9 3.6 25.9 5.6 8.8 8.7 10.8 29.6 25.9 21.1 11.2 14.3 11.3 22.0 35.5 9.7 34.4 24.0 9.8 11.9 144.2 14.3 31.2 13.4 16.7 29.9 12.0 9.6 12.7 14.5 14.3 25.2 11.4 10.2 20.3 17.5 10.7 23.5 10.2 19.5 10.2 24.5 12.0 119.2 25.7 17.2 1.8 10.3 15.4 13.4 14.4 4.5 4.9 9.7 14.0 27.8 19.9 6.8 13.8 17.4 4.6 46.7 13.1 25.8 13.1 33.9 20.5 7.8 7.5 19.0 20.4 8.3 15.6 6.7 ZNF20 KOX13 ENSG00000132010 "Zinc finger protein 20" P17024 19 12092843-12140355 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 42.1;Late spermatids: 66.3;Respiratory ciliated cells: 29.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 22.9" "Group enriched" "Detected in all" 5 "granulocytes: 22.9;NK-cells: 6.8" "Low cell line specificity" "Detected in many" HPA020887 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020887: AB_2218842" "unprognostic (1.77e-2)" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-3)" "unprognostic (4.00e-2)" "unprognostic (1.08e-4)" "unprognostic (1.69e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (7.01e-2)" "unprognostic (9.23e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.21e-3)" 0.8 1.2 1.1 1.6 1.1 2.7 3.0 1.9 1.2 1.1 2.0 2.0 0.7 1.2 3.1 2.0 4.9 1.2 0.8 1.0 0.8 1.8 0.8 1.6 2.2 1.0 1.0 0.8 1.8 2.1 1.8 1.2 0.9 1.3 1.3 1.8 2.0 2.2 1.5 0.3 2.4 1.4 1.0 1.1 1.3 2.1 6.1 1.0 1.5 3.5 1.1 1.3 1.5 1.2 1.5 2.4 0.0 3.1 6.8 1.2 2.4 2.4 1.6 3.3 1.7 2.4 0.8 0.9 1.8 1.9 2.2 1.7 1.4 1.6 0.5 2.0 1.7 0.6 0.4 2.4 0.8 0.7 0.0 2.2 1.9 3.3 0.8 1.0 2.0 1.3 3.7 1.0 0.3 3.9 0.9 3.0 2.2 5.4 1.2 1.7 2.0 1.6 1.0 2.1 5.4 1.2 3.2 1.6 1.4 2.9 3.0 2.3 3.0 0.0 4.1 1.3 4.3 1.1 3.4 2.0 2.2 0.4 0.0 1.6 16.3 2.5 6.5 1.4 1.3 1.2 1.6 1.4 1.6 1.3 2.6 1.3 1.1 22.9 6.8 1.9 1.7 3.2 1.2 1.1 1.1 1.9 1.2 1.0 0.8 1.0 1.0 0.8 1.3 1.1 1.0 1.5 0.4 0.0 0.0 0.0 1.0 0.1 0.8 2.3 1.8 0.6 1.8 1.1 0.8 1.5 1.5 1.8 2.1 1.0 0.9 1.9 1.9 2.1 42.1 10.3 0.7 0.7 4.2 1.7 0.0 2.4 1.3 0.5 3.6 1.4 2.5 0.8 0.4 2.3 1.7 0.0 0.0 2.1 0.0 0.8 1.0 66.3 0.6 1.0 0.0 0.0 1.4 0.4 1.0 0.0 0.0 2.7 2.1 0.0 1.5 1.7 2.9 2.9 29.7 1.4 0.0 0.4 1.0 10.8 1.7 1.8 0.6 1.1 1.2 0.3 1.7 1.6 BRME1 "C19orf57, MEIOK21, MGC11271" ENSG00000132016 "Break repair meiotic recombinase recruitment factor 1" Q0VDD7 19 13882348-13906452 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 18.3" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044012, HPA054615" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044012: AB_10964782, HPA054615: AB_2682543" "unprognostic (1.71e-1)" "unprognostic (3.48e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (2.12e-1)" "prognostic favorable (5.14e-4)" "unprognostic (5.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.06e-1)" "unprognostic (1.36e-1)" "unprognostic (7.60e-2)" "unprognostic (4.43e-2)" "unprognostic (1.57e-4)" "unprognostic (1.21e-3)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (5.73e-2)" 1.2 0.8 2.0 0.8 2.1 1.9 2.3 3.7 2.8 2.7 1.4 3.0 3.2 1.3 1.4 6.1 2.3 0.4 0.7 2.1 1.7 1.1 1.9 1.1 0.7 2.1 2.0 2.1 2.3 7.0 0.6 1.4 0.4 2.6 2.4 1.2 1.7 2.4 0.7 1.0 5.9 5.6 0.5 1.8 1.3 1.7 18.3 2.1 0.4 1.2 0.2 0.8 1.7 4.5 2.6 5.9 0.1 4.3 2.4 1.2 0.2 2.8 1.6 0.6 1.9 1.8 3.7 0.8 6.5 8.9 0.7 1.1 2.9 1.3 0.5 0.6 1.0 2.8 2.8 2.7 0.1 0.3 1.4 5.9 0.2 0.4 1.2 0.2 0.3 0.4 3.5 1.9 2.5 0.6 1.9 5.3 3.0 0.6 2.0 4.4 5.8 1.6 0.3 0.7 1.4 3.8 1.4 6.3 1.1 1.8 0.3 1.2 1.3 0.0 3.5 1.9 8.0 0.4 4.5 1.0 3.5 2.1 4.5 5.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.2 2.0 2.1 3.7 2.8 2.1 1.7 2.1 2.0 2.1 2.6 1.8 2.1 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 DCAF15 "C19orf72, MGC99481" ENSG00000132017 "DDB1 and CUL4 associated factor 15" Q66K64 19 13952492-13961449 "Predicted intracellular proteins" "Immunity, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068351 Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA068351: AB_2685977" "unprognostic (6.91e-2)" "unprognostic (6.55e-3)" "unprognostic (3.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.95e-1)" "unprognostic (1.89e-2)" "unprognostic (1.83e-3)" "unprognostic (9.72e-2)" "unprognostic (8.03e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.97e-4)" "unprognostic (1.98e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (7.97e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" 16.0 10.8 5.7 10.4 5.7 20.7 18.3 6.7 8.0 18.5 4.3 16.3 7.0 17.1 4.3 24.2 16.9 4.5 17.6 5.7 5.2 16.3 14.0 18.8 13.7 5.4 4.8 5.4 15.7 13.8 7.2 16.7 7.4 5.6 17.1 5.3 3.6 16.2 5.3 23.1 30.4 23.6 5.1 4.6 33.7 14.1 45.0 5.1 14.7 17.1 8.7 10.9 15.7 21.8 4.9 18.9 11.5 29.5 16.2 3.1 4.5 13.5 12.7 8.8 26.1 25.9 20.4 7.9 17.3 14.4 12.3 15.4 16.7 18.9 12.0 9.2 21.0 33.8 21.3 21.0 21.4 6.5 17.8 30.2 5.9 10.9 19.3 8.6 9.4 13.1 27.4 22.9 24.8 11.6 28.7 32.0 33.0 35.2 12.7 17.8 29.2 10.4 11.8 14.1 14.3 18.8 19.3 11.4 8.1 10.7 12.1 10.5 22.7 9.2 17.8 13.1 28.3 24.1 17.4 20.7 18.3 11.4 25.8 15.6 0.2 0.3 0.9 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.4 0.1 0.3 0.6 0.1 0.2 0.4 0.6 0.2 5.7 5.7 6.7 8.0 5.7 5.2 5.4 4.8 5.4 5.6 4.6 5.1 4.9 19.5 0.0 0.0 6.8 19.7 4.8 10.5 6.9 8.6 17.3 8.9 10.7 2.9 10.0 3.8 9.2 8.4 13.7 24.4 9.6 1.9 11.0 5.0 7.0 7.8 10.9 7.7 9.4 5.2 10.3 15.1 7.5 13.7 7.0 1.3 15.0 7.1 3.4 15.7 15.2 3.4 5.7 4.1 8.1 7.0 9.5 18.3 14.3 1.8 8.4 13.8 9.2 16.5 7.1 5.5 9.9 9.6 12.0 18.3 6.4 4.5 4.7 3.9 13.9 6.6 6.0 7.9 35.6 19.9 10.0 9.8 13.8 21.2 10.4 7.9 8.9 CC2D1A "FLJ20241, Freud-1, MRT3" ENSG00000132024 "Coiled-coil and C2 domain containing 1A" Q6P1N0 19 13906201-13930879 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005436, CAB015220" Supported Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB015220: , HPA005436: AB_1078884" "unprognostic (8.66e-2)" "unprognostic (1.31e-2)" "unprognostic (2.55e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "prognostic favorable (7.02e-4)" "unprognostic (7.00e-2)" "unprognostic (1.59e-3)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (2.61e-3)" "unprognostic (4.07e-2)" "unprognostic (1.23e-3)" "unprognostic (6.67e-3)" "unprognostic (1.97e-1)" "unprognostic (9.22e-2)" "unprognostic (1.71e-2)" 16.2 16.6 9.1 3.8 9.0 3.7 21.4 7.7 18.2 19.3 7.6 29.9 16.4 16.3 2.1 33.5 20.0 2.9 18.9 9.6 9.1 21.6 27.1 16.1 3.2 9.2 9.1 8.9 18.9 34.6 7.9 32.0 3.1 9.7 26.0 4.7 4.1 27.6 5.3 28.6 35.3 33.3 3.4 7.3 17.9 24.9 16.1 9.7 2.6 20.8 4.0 3.1 21.4 25.0 8.8 22.0 8.5 2.3 9.9 5.1 3.1 9.3 6.9 8.1 10.2 10.4 14.5 6.8 11.2 11.4 6.1 6.4 15.2 5.3 10.1 3.3 17.0 30.9 5.2 11.0 6.9 9.0 4.1 15.2 4.7 12.5 7.2 4.3 6.5 7.2 11.5 6.4 8.5 3.4 22.4 11.6 12.1 7.1 18.5 16.7 11.2 6.3 8.9 6.5 16.3 10.2 7.1 9.8 13.3 12.2 1.6 10.4 9.8 6.3 8.3 4.4 20.9 8.9 15.2 7.3 6.6 10.8 14.3 7.8 0.5 0.3 0.8 0.4 0.7 0.1 0.2 0.2 0.2 0.4 0.1 0.0 0.2 0.1 0.2 0.5 0.3 0.3 0.3 9.1 9.0 7.7 18.2 9.6 9.1 9.2 9.1 8.9 9.7 7.3 9.7 8.8 20.6 9.6 8.3 23.8 12.6 9.1 14.2 15.6 19.4 66.6 19.2 64.6 8.4 21.5 16.5 11.0 93.8 22.3 11.7 103.4 9.8 22.0 2.2 10.1 6.7 13.2 33.5 18.7 38.4 27.7 10.7 10.5 63.7 11.3 17.7 29.3 12.8 12.4 14.5 30.3 43.3 46.6 24.4 12.2 13.0 6.5 64.3 11.3 7.2 10.3 16.3 15.6 23.7 31.2 24.1 26.0 77.6 87.3 12.3 13.0 97.9 6.8 16.7 93.2 13.1 8.0 9.3 10.2 12.4 24.8 13.8 21.3 14.8 16.1 64.3 18.8 RTBDN FLJ36353 ENSG00000132026 Retbindin Q9BSG5 19 12825478-12835428 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 290.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 350.3;Rod photoreceptor cells: 524.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.3;SH-SY5Y: 5.4;U-266/84: 23.1;U-87 MG: 4.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA052511 Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "HPA052511: AB_2797243" "unprognostic (4.55e-4)" "unprognostic (3.94e-3)" "unprognostic (2.18e-1)" "unprognostic (1.54e-4)" "unprognostic (3.33e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" "unprognostic (2.45e-2)" "unprognostic (2.02e-2)" "unprognostic (3.55e-1)" "unprognostic (6.48e-2)" "unprognostic (7.04e-3)" "unprognostic (7.66e-9)" "unprognostic (3.55e-2)" "unprognostic (1.00e-1)" "unprognostic (7.05e-2)" "unprognostic (2.24e-2)" 0.0 3.5 4.2 0.1 5.8 0.2 0.0 2.2 10.1 0.0 0.7 0.9 0.4 0.0 0.6 0.0 0.0 0.0 0.0 5.9 3.0 0.0 0.0 0.1 0.0 2.6 3.6 8.2 0.0 1.2 0.3 34.6 0.0 4.1 0.0 0.3 290.5 0.0 0.0 0.0 0.1 0.5 0.1 0.7 0.0 1.1 3.3 2.3 8.8 0.0 0.0 0.0 0.0 0.1 5.4 0.9 0.1 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.0 0.9 0.9 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.1 2.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 1.3 2.7 0.0 0.1 0.1 0.0 0.9 0.7 1.1 0.7 0.1 1.1 0.1 0.0 8.3 5.4 0.1 0.0 0.4 0.4 2.8 0.7 0.0 0.8 1.0 0.7 0.1 1.2 23.1 4.3 4.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 5.8 2.2 10.1 5.9 3.0 2.6 3.6 8.2 4.1 0.7 2.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 50.5 0.0 0.0 1.4 0.0 0.1 0.0 350.3 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 1.8 0.0 0.0 2.8 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 2.5 0.6 4.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 84.4 0.0 1.0 0.7 0.1 0.1 0.0 0.5 0.0 0.7 0.1 0.0 524.0 0.0 0.1 0.0 16.2 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992052-20012668 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.4;placenta: 11.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 38.5;Sertoli cells: 26.3" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "Hep G2: 143.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 1.7" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA 440000 "Endoplasmic reticulum, Golgi apparatus" "HPA051250: AB_2681406" "unprognostic (3.47e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.1 0.6 5.4 0.5 4.0 0.0 2.8 3.7 5.1 2.3 3.5 0.5 0.4 2.1 1.0 0.5 1.9 2.1 0.4 3.6 4.2 1.8 0.0 13.4 0.3 5.4 6.3 3.0 0.7 0.4 0.4 0.3 11.4 5.6 1.6 0.5 0.3 0.6 4.7 0.3 0.8 0.4 1.7 4.8 0.3 1.8 0.9 7.6 0.1 1.3 0.6 0.3 0.8 1.2 6.3 6.4 4.9 16.1 0.1 4.5 9.7 1.0 2.0 1.1 6.5 8.2 4.7 2.7 0.0 0.8 1.7 6.2 1.1 0.4 12.7 9.2 0.0 0.4 0.0 1.1 143.4 1.1 0.0 0.0 21.3 0.7 7.1 1.7 4.5 8.7 0.0 0.0 0.0 13.8 2.5 0.0 0.0 5.0 0.2 2.4 0.0 0.0 0.0 19.5 4.5 0.1 2.1 10.6 1.8 6.5 27.1 19.2 0.1 4.9 9.5 11.4 0.4 1.2 0.1 0.0 0.0 1.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.0 3.7 5.1 3.6 4.2 5.4 6.3 3.0 5.6 4.8 7.6 6.3 1.6 38.5 2.2 0.0 0.0 0.3 0.3 2.6 0.0 0.0 5.4 1.3 0.3 0.0 2.3 1.8 0.0 0.1 0.1 0.0 0.0 0.4 0.4 0.3 0.8 2.8 0.0 0.0 0.1 0.2 1.9 1.9 0.0 0.5 0.0 4.4 0.0 0.0 0.1 0.0 0.2 0.0 4.1 0.0 0.3 0.4 1.5 0.1 3.6 4.7 0.0 0.0 0.0 0.5 0.2 1.1 0.0 4.5 0.0 0.3 0.0 0.8 1.6 0.0 26.3 0.8 6.8 0.0 1.3 0.0 0.1 0.1 0.1 6.3 0.0 0.2 TRIM21 "RNF81, RO52, SSA1" ENSG00000132109 "Tripartite motif containing 21" P19474 11 4384897-4393702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004566, HPA005673" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB004566: AB_628286, HPA005673: AB_1080090" "prognostic favorable (4.83e-5)" "unprognostic (4.55e-2)" "unprognostic (3.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.20e-1)" "unprognostic (5.04e-2)" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (3.31e-1)" "unprognostic (1.82e-2)" "unprognostic (6.27e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.26e-6)" "unprognostic (9.12e-3)" 12.9 13.1 6.3 21.8 6.9 27.9 12.0 6.1 8.1 11.7 7.6 17.2 20.5 12.6 13.1 12.1 14.7 13.0 11.0 5.6 7.9 13.6 17.8 23.7 24.0 7.6 6.4 5.0 20.8 11.8 6.8 7.2 14.6 7.2 11.4 18.6 2.4 19.7 13.0 5.6 11.4 19.3 18.0 6.8 32.7 15.6 3.5 7.3 22.0 10.0 8.3 23.4 16.8 11.0 8.5 13.5 15.5 7.7 7.3 15.5 23.1 10.7 16.8 31.7 64.6 71.4 7.2 37.6 20.5 7.5 25.0 66.5 18.4 13.6 25.7 20.1 34.5 14.6 31.6 8.5 6.5 34.3 37.3 29.6 22.7 14.9 13.0 9.2 23.3 40.3 17.3 10.1 21.6 21.9 11.9 19.8 26.5 6.6 14.9 8.0 13.8 10.0 10.9 25.6 12.0 0.1 3.3 13.8 14.9 19.1 12.0 5.3 24.5 36.7 15.6 12.3 8.3 6.1 11.4 9.5 13.0 14.0 29.2 11.5 105.2 132.4 311.9 89.3 139.6 78.6 50.2 76.6 81.1 109.5 57.9 67.6 71.7 354.0 78.0 130.9 36.7 100.1 175.2 6.3 6.9 6.1 8.1 5.6 7.9 7.6 6.4 5.0 7.2 6.8 7.3 8.5 8.9 9.6 6.3 0.0 6.4 2.0 6.1 7.5 11.4 0.4 2.7 3.2 2.3 12.8 9.8 5.5 0.0 6.8 11.0 12.8 7.9 11.3 0.1 3.7 4.5 7.8 2.4 8.2 0.2 8.5 9.6 5.7 10.2 5.7 12.6 8.1 9.7 8.7 9.6 1.7 0.1 7.3 0.0 11.9 2.2 1.3 4.4 9.6 1.8 1.9 20.7 2.6 22.6 1.0 0.1 9.7 4.7 7.2 4.0 4.3 10.0 4.9 7.9 0.0 13.1 4.7 5.3 0.3 0.8 4.7 1.7 9.0 10.5 4.5 6.0 3.8 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295373-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.5" "Group enriched" "Detected in many" 5 "Early spermatids: 1475.4;Late spermatids: 4697.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 5.9" "Group enriched" "Detected in many" 4 "granulocytes: 3.6;monocytes: 5.9" "Cell line enhanced" "Detected in many" "AN3-CA: 12.9;ASC TERT1: 20.9;HSkMC: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: AB_2672532" "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.9 8.1 6.4 2.1 9.3 1.0 7.3 7.3 6.5 7.5 6.8 4.6 2.7 5.9 6.1 3.4 15.4 4.9 3.7 5.6 8.4 6.1 1.7 5.9 2.2 9.2 8.2 4.2 9.0 4.7 10.7 8.6 4.8 8.7 5.4 3.9 13.4 6.3 7.4 1.7 4.4 3.4 4.5 7.9 3.7 6.8 50.5 8.1 3.2 9.6 3.7 1.6 6.1 6.4 12.1 0.2 1.2 11.6 12.9 10.5 20.9 1.6 1.3 4.9 0.9 0.8 0.1 0.8 0.0 0.7 2.1 6.1 0.3 0.9 2.9 0.8 0.9 1.6 0.1 0.5 0.6 2.2 0.0 0.8 15.0 2.2 1.9 0.7 6.3 4.7 1.8 0.1 0.0 4.9 0.4 0.1 0.2 4.9 0.9 1.2 3.7 0.0 1.1 7.1 2.0 2.8 6.3 4.8 0.4 11.3 9.5 2.8 0.7 1.4 1.7 1.7 2.7 1.9 0.0 0.0 0.0 7.0 0.1 7.7 0.0 1.2 3.6 0.0 2.8 0.0 0.1 0.2 0.0 1.1 0.0 0.4 0.3 0.1 0.2 5.9 0.5 0.0 0.5 6.4 9.3 7.3 6.5 5.6 8.4 9.2 8.2 4.2 8.7 7.9 8.1 12.1 14.8 3.2 10.0 151.8 2.0 5.6 16.7 6.4 9.1 17.0 13.1 19.9 3.5 28.6 12.5 16.5 45.9 0.4 5.1 3.9 17.6 8.9 1475.4 77.3 18.9 10.5 9.6 2.1 43.9 10.2 0.6 29.8 35.2 9.0 16.5 5.0 16.1 2.4 5.1 32.0 35.0 5.7 12.2 17.9 9.2 4697.2 36.7 14.9 19.6 68.4 10.5 23.4 3.1 563.5 341.6 4.5 3.8 25.2 2.0 6.2 3.4 10.3 67.3 45.7 19.7 47.5 14.7 110.5 23.8 6.7 5.3 0.3 1.6 11.5 5.7 9.7 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303616 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 133.1;Syncytiotrophoblasts: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA051941: AB_2681669" "unprognostic (1.57e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 37.3 43.8 29.1 19.2 29.8 20.2 37.0 27.7 33.0 44.8 26.2 37.9 22.9 51.1 29.3 44.6 46.3 31.1 36.4 30.1 37.8 33.5 36.3 34.0 20.9 30.6 29.1 30.6 48.9 42.0 44.5 44.6 34.3 28.4 43.6 20.0 19.6 37.9 41.8 55.8 43.5 29.6 35.7 28.6 28.7 35.4 32.9 28.7 30.2 39.1 33.4 22.9 45.1 39.8 31.2 42.2 30.2 51.1 55.8 67.7 84.0 48.1 42.7 78.6 60.8 40.6 25.7 13.7 26.7 55.5 102.0 81.4 32.0 50.5 60.5 30.7 32.5 54.7 43.5 34.3 37.7 94.6 27.1 22.1 103.8 80.1 56.9 68.2 87.0 78.6 49.3 43.7 26.7 67.5 26.8 36.2 36.0 76.9 27.4 29.3 29.6 26.4 43.4 68.4 50.9 47.4 54.0 57.8 56.6 69.5 78.3 33.5 80.9 52.4 53.0 23.9 44.8 41.5 43.5 21.8 11.8 49.7 20.6 37.6 30.6 32.7 15.5 21.1 30.8 22.6 18.7 22.9 24.0 46.4 22.0 24.9 19.3 3.3 32.7 21.7 26.4 24.4 30.2 29.1 29.8 27.7 33.0 30.1 37.8 30.6 29.1 30.6 28.4 28.6 28.7 31.2 19.0 19.2 22.7 17.0 17.9 28.4 36.6 40.4 17.1 23.7 28.6 24.8 11.3 28.6 32.0 35.0 25.0 83.1 20.2 27.4 39.2 42.0 28.2 57.5 36.2 22.0 36.6 24.0 19.8 30.0 48.7 34.8 23.9 133.1 7.0 42.4 25.7 28.0 36.5 47.1 21.1 30.4 30.5 20.6 22.8 19.3 34.8 20.7 10.6 11.2 23.5 25.4 20.6 18.6 22.3 30.1 24.2 33.1 26.5 36.7 38.0 32.7 23.4 27.4 39.5 40.4 32.1 46.6 45.8 21.2 29.0 142.6 18.8 37.7 30.0 34.7 CCT6B "Cctz2, TSA303" ENSG00000132141 "Chaperonin containing TCP1 subunit 6B" Q92526 17 34927859-34981078 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "testis: 127.3" "Group enriched" "Detected in many" 27 "Early spermatids: 448.5;Late spermatids: 185.2;Spermatocytes: 490.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Uncertain Approved Cytosol NA NA Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "unprognostic (1.56e-1)" "unprognostic (1.72e-2)" "unprognostic (2.99e-3)" "unprognostic (6.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.12e-3)" "unprognostic (3.61e-2)" "unprognostic (1.75e-1)" "unprognostic (1.44e-3)" "unprognostic (9.56e-3)" "unprognostic (3.61e-2)" "unprognostic (4.82e-7)" "unprognostic (1.24e-1)" "unprognostic (4.30e-1)" "unprognostic (4.23e-4)" "unprognostic (1.49e-1)" 2.3 3.3 2.3 0.8 2.6 3.9 5.6 2.5 2.4 2.2 1.9 1.5 1.4 1.9 5.5 1.8 2.7 0.9 1.8 1.9 2.6 4.1 5.0 1.2 1.4 2.8 2.4 1.8 2.4 2.7 2.5 2.8 0.6 2.6 2.7 1.2 2.3 3.4 2.6 5.1 2.5 1.4 1.6 2.7 1.6 2.1 127.3 2.3 1.6 2.9 3.8 1.7 1.9 1.5 3.1 0.7 1.0 2.6 1.1 3.3 2.0 0.9 1.3 5.3 2.2 3.1 0.7 2.1 5.0 0.5 2.4 1.6 1.0 0.1 0.7 0.7 0.5 1.9 0.7 0.3 0.6 4.5 2.4 0.7 2.7 1.3 0.2 2.6 0.4 0.6 0.8 0.5 5.0 2.4 1.9 0.5 5.2 1.4 0.4 0.6 2.4 1.2 12.2 1.4 0.8 3.0 1.5 2.4 0.9 4.1 0.6 1.9 2.4 0.5 1.0 0.1 1.2 0.6 4.4 1.0 4.7 1.1 1.5 1.3 0.0 1.1 0.9 0.6 1.1 0.6 0.9 0.7 0.4 2.6 0.8 1.0 1.0 0.0 1.6 1.1 0.6 0.3 0.6 2.3 2.6 2.5 2.4 1.9 2.6 2.8 2.4 1.8 2.6 2.7 2.3 3.1 2.4 0.0 3.1 4.6 2.6 2.4 2.8 3.2 6.2 1.5 8.7 7.0 4.2 4.3 3.9 1.8 0.0 1.8 4.0 0.9 3.9 3.4 448.5 8.8 3.7 2.1 0.0 0.8 3.9 8.0 0.5 3.5 1.5 3.6 2.5 4.6 0.7 3.1 1.5 0.0 3.7 2.3 6.1 2.2 4.0 185.2 10.8 2.9 5.4 4.7 1.6 8.7 4.1 7.1 10.7 2.7 1.6 4.1 3.9 2.1 0.7 6.9 8.8 2.5 0.0 3.7 3.0 490.2 13.5 3.1 2.6 0.8 2.7 6.9 1.8 3.6 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favorable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 22.6 24.8 20.5 17.2 20.7 22.4 23.1 18.8 26.5 26.2 20.0 25.0 16.3 27.9 10.5 23.8 25.0 15.0 27.3 20.8 19.4 24.8 25.4 21.5 20.3 21.6 21.9 21.5 28.1 24.3 29.1 32.4 17.7 22.5 26.8 11.0 12.9 21.8 18.3 37.4 27.8 22.5 16.0 17.2 27.5 25.4 54.6 21.0 23.5 25.1 21.2 14.4 25.4 23.0 22.0 21.9 52.3 54.5 56.2 24.6 20.2 35.3 39.0 33.4 65.1 46.5 56.9 42.6 66.4 32.0 37.0 51.2 30.3 73.7 52.1 23.1 49.6 86.1 59.6 76.0 58.6 40.7 56.0 58.3 33.0 33.4 68.1 49.7 28.4 44.0 57.5 82.0 40.6 31.8 57.1 82.2 59.3 60.7 30.2 84.0 44.6 30.6 62.2 32.0 53.6 41.6 61.6 39.6 54.1 31.1 25.0 38.5 58.8 32.2 40.6 51.0 46.7 73.9 56.2 75.3 61.8 42.8 48.3 49.9 14.1 10.7 7.8 16.2 10.6 12.4 10.4 12.4 16.3 13.9 8.7 11.7 12.7 1.6 9.6 11.6 7.9 15.3 14.7 20.5 20.7 18.8 26.5 20.8 19.4 21.6 21.9 21.5 22.5 17.2 21.0 22.0 31.1 38.5 46.7 30.7 34.7 18.1 25.7 38.7 39.3 49.0 34.6 35.6 38.1 32.9 34.1 51.5 43.8 41.7 33.1 37.6 66.5 37.8 129.5 59.2 31.7 32.4 40.1 38.5 32.8 36.3 22.8 26.7 42.3 33.2 23.5 40.7 27.5 50.8 35.9 58.9 36.6 25.8 40.7 29.6 17.6 123.8 24.8 24.4 19.6 13.1 32.5 46.3 28.8 22.1 28.7 46.0 41.0 30.1 39.9 28.6 40.5 83.5 49.9 52.8 32.9 27.3 28.6 145.4 50.2 33.5 19.9 29.6 29.7 36.6 38.5 26.3 RAF1 "c-Raf, CRAF, Raf-1" ENSG00000132155 "Raf-1 proto-oncogene, serine/threonine kinase" P04049 3 12583601-12664125 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 175.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 175.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002639, HPA002640, CAB019291" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB019291: , HPA002639: , HPA002640: AB_1856047" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (5.92e-2)" "unprognostic (2.17e-3)" "unprognostic (6.51e-3)" "unprognostic (7.66e-3)" "unprognostic (2.66e-3)" "unprognostic (1.53e-2)" "unprognostic (2.72e-1)" "unprognostic (7.66e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-2)" "unprognostic (2.79e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (2.36e-2)" 41.8 34.5 35.8 34.1 37.3 78.1 39.5 41.9 36.3 45.8 39.4 44.1 40.9 46.0 34.3 55.9 43.6 31.2 89.5 36.2 37.6 47.1 69.5 45.1 36.6 37.5 36.4 35.2 52.4 51.1 64.2 28.5 39.4 36.8 42.2 42.4 37.7 39.9 38.4 196.5 55.7 43.7 45.9 36.8 48.7 56.0 27.0 37.1 53.2 49.2 123.6 48.1 46.5 46.6 39.1 49.9 57.9 85.5 66.6 74.3 59.6 168.0 73.9 129.1 100.1 112.5 46.6 41.3 52.7 34.6 120.1 51.6 31.9 93.4 67.5 103.8 91.4 70.2 72.0 69.4 42.9 74.2 70.1 64.7 55.3 67.8 102.3 82.0 67.6 73.1 78.2 52.6 136.0 98.3 88.6 91.1 47.8 86.5 64.0 76.4 72.6 75.7 66.4 60.9 76.9 26.1 56.2 61.1 59.8 40.9 66.1 99.1 91.5 51.1 65.6 62.5 55.7 85.0 103.3 178.4 112.3 57.2 80.4 73.9 40.4 32.7 62.5 22.3 32.6 22.5 19.5 21.9 22.3 30.3 20.4 21.9 22.8 175.1 29.8 34.2 13.5 28.3 28.2 35.8 37.3 41.9 36.3 36.2 37.6 37.5 36.4 35.2 36.8 36.8 37.1 39.1 28.5 22.4 37.6 47.7 36.1 34.4 35.2 22.1 27.9 56.7 27.5 22.6 29.0 35.8 25.7 27.6 66.7 40.0 41.5 31.3 13.7 25.6 8.8 33.2 37.1 32.7 29.3 46.7 46.1 37.0 46.8 32.3 27.5 43.8 34.2 78.7 36.0 41.2 28.6 43.7 52.9 31.0 30.5 39.3 43.4 4.6 39.1 34.7 26.6 44.0 49.5 31.9 51.5 65.4 64.0 35.5 29.9 41.3 43.3 46.9 47.3 20.1 31.2 81.9 32.9 56.2 39.1 28.3 33.6 31.8 43.5 62.3 40.8 35.6 31.2 47.1 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816201-10940714 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 121.3" "Cell type enhanced" "Detected in some" "Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.0 0.0 48.5 0.0 65.0 0.0 1.1 62.5 38.6 0.3 8.1 0.0 0.0 0.5 0.1 8.2 0.5 0.0 0.0 21.4 83.9 0.0 0.1 0.0 0.0 75.1 90.2 21.9 0.0 0.1 0.5 0.3 0.4 87.5 0.7 0.0 11.0 1.0 0.0 0.2 5.7 0.0 0.1 36.9 0.4 0.0 1.4 121.3 0.0 0.0 0.0 0.1 0.4 1.8 45.5 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.5 0.0 2.2 0.0 0.0 0.2 0.3 0.0 16.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.9 4.5 3.9 0.1 0.0 0.1 5.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 65.0 62.5 38.6 21.4 83.9 75.1 90.2 21.9 87.5 36.9 121.3 45.5 0.0 0.0 0.0 85.2 0.0 1.3 0.7 0.3 4.0 8.4 0.9 0.9 1.4 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 13.7 0.0 7.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 25.8 0.0 0.0 0.0 0.8 0.9 3.4 0.2 0.0 6.5 0.0 26.4 0.0 23.1 0.8 0.2 0.0 6.8 0.0 0.5 0.0 0.0 0.0 1.5 0.0 0.6 0.1 0.6 1.8 10.6 3.7 1.0 0.1 0.0 0.0 1.7 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 166.6" "Cell type enhanced" "Detected in many" "Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 166.6 3.9 4.5 8.7 3.5 3.0 75.0 3.5 5.7 8.2 1.7 49.2 23.8 7.0 1.2 6.2 7.1 10.6 12.7 4.4 3.5 14.4 17.3 28.7 4.9 4.2 3.6 3.0 14.6 2.8 8.0 0.5 44.0 3.8 5.6 41.0 1.0 5.8 1.7 5.2 5.8 15.2 8.8 5.7 12.1 35.8 7.0 3.5 4.1 13.3 8.2 2.2 68.3 9.2 5.1 44.0 38.6 0.0 0.2 198.7 113.7 247.5 3.7 44.7 5.4 2.1 7.8 111.6 0.0 0.1 4.0 72.9 17.3 14.4 0.7 1.0 106.4 20.3 0.0 8.1 10.3 51.8 0.2 0.1 118.9 9.7 9.8 37.5 20.6 0.7 1.0 0.0 0.0 8.3 11.0 0.1 0.8 0.7 99.2 112.0 0.0 0.0 0.2 30.6 157.5 0.1 1.2 18.8 6.7 2.2 6.7 0.0 34.2 35.0 7.8 10.6 4.6 0.2 0.0 0.1 0.3 3.2 0.5 1.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 3.5 3.5 5.7 4.4 3.5 4.2 3.6 3.0 3.8 5.7 3.5 5.1 284.1 3.2 7.2 1.6 0.6 1.0 50.5 0.4 4.6 0.9 1.9 2.8 9.2 1.5 2.5 5.5 0.0 110.4 1.8 93.4 1.9 1.1 4.9 5.2 1.4 26.1 8.4 0.0 39.3 0.7 217.8 12.3 83.1 20.8 8.9 232.9 25.7 3.4 49.9 0.0 74.1 21.3 0.0 19.4 4.8 2.2 4.1 19.1 3.6 38.4 1.8 0.6 0.0 6.6 1.2 17.3 84.1 0.0 1.6 42.1 17.0 14.3 1.5 0.2 13.1 1.9 31.3 10.9 22.8 4.6 1.1 88.9 2.2 0.8 24.5 239.6 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420322 "Metabolic proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.9;lymphoid tissue: 42.1" "Cell type enhanced" "Detected in many" "dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.7;U-266/84: 261.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved NA NA 78000 "HPA066888: AB_2685741" "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 1.8 5.2 5.1 23.4 5.2 53.9 5.4 7.0 5.6 2.3 4.2 6.5 7.4 2.6 8.5 7.2 4.1 4.6 2.2 4.4 5.7 8.8 20.0 7.6 41.6 5.4 6.1 4.4 1.2 13.1 9.7 13.6 6.5 5.7 5.4 5.6 4.8 6.4 2.9 5.2 5.7 22.3 2.4 5.0 32.8 8.6 9.3 5.4 42.1 8.2 1.8 29.2 5.8 2.3 6.8 41.5 72.0 34.8 90.8 0.0 0.0 138.1 0.6 0.0 8.6 0.4 37.2 66.3 167.7 55.6 0.1 3.9 23.8 77.5 0.0 3.2 135.9 57.9 65.2 81.1 39.6 0.0 210.8 22.7 0.0 0.0 0.0 0.0 6.3 0.1 124.1 102.5 174.9 0.0 103.8 112.6 83.4 40.2 12.8 14.8 0.2 0.2 232.7 16.9 38.4 39.8 39.8 51.3 67.7 21.0 15.5 64.8 172.6 0.5 0.1 11.7 0.2 31.8 176.1 261.0 144.9 0.1 116.0 0.3 0.0 2.5 0.9 7.3 3.2 5.8 5.4 5.2 7.2 5.4 3.1 4.3 5.8 0.1 5.5 2.0 5.6 4.8 3.7 5.1 5.2 7.0 5.6 4.4 5.7 5.4 6.1 4.4 5.7 5.0 5.4 6.8 0.7 16.0 5.4 16.6 37.3 1.7 1.3 0.5 0.0 25.4 9.6 5.3 11.6 8.6 4.1 5.5 14.6 17.6 57.7 2.9 3.9 5.7 19.2 4.3 1.0 1.0 8.3 41.8 17.9 4.4 5.6 1.1 3.6 8.3 5.1 70.0 3.6 17.0 16.7 35.3 23.4 8.8 4.1 11.3 4.9 23.5 0.6 14.9 1.8 10.3 16.7 3.0 69.0 30.2 17.7 2.6 0.8 0.4 43.7 2.6 2.1 4.5 3.0 19.4 0.0 2.1 1.1 6.4 10.0 3.5 2.4 4.9 37.2 17.8 11.5 1.9 FCRLA "FCRL, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595" ENSG00000132185 "Fc receptor like A" Q7L513 1 161706972-161714352 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 99.2" "Group enriched" "Detected in some" 6 "B-cells: 124.2;Melanocytes: 67.6" "Cancer enriched" "Detected in many" 21 "melanoma: 38.8" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "memory B-cell: 368.0;naive B-cell: 341.5" "Lineage enriched" "Detected in many" 10 "B-cells: 368.0" "Group enriched" "Detected in some" 6 "Daudi: 484.1;SK-MEL-30: 197.8;U-698: 260.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB016545 Enhanced "Intracellular and membrane" NA NA "CAB016545: AB_2247037" "unprognostic (5.46e-4)" "unprognostic (7.19e-2)" "unprognostic (3.69e-3)" "unprognostic (4.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.48e-4)" "unprognostic (1.45e-2)" "unprognostic (4.15e-3)" "unprognostic (8.66e-2)" "unprognostic (3.58e-4)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (6.84e-5)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (2.08e-2)" 0.8 0.2 0.5 23.7 0.4 4.1 0.5 1.1 0.7 0.3 0.3 2.6 0.9 0.4 0.7 0.6 0.2 1.1 0.6 0.5 0.6 0.3 0.4 0.6 69.0 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.3 0.5 0.8 2.8 0.3 2.3 0.1 0.3 1.2 19.2 0.4 0.1 38.9 4.2 0.2 0.4 7.8 0.5 0.3 99.2 3.4 0.1 0.5 0.7 0.0 0.0 0.0 0.4 0.4 0.0 2.7 7.4 0.2 0.5 0.0 0.0 484.1 0.2 7.0 0.0 0.1 0.0 0.7 0.8 1.8 0.0 0.5 0.0 0.0 0.0 0.2 2.0 0.4 0.5 2.4 0.4 0.1 0.0 0.0 0.9 26.7 0.1 0.0 0.1 0.3 0.1 0.0 0.1 4.0 8.3 52.4 0.0 0.1 0.0 0.0 0.3 0.1 197.8 0.0 0.0 0.2 0.5 0.6 0.7 0.5 0.5 0.7 0.3 260.5 2.9 0.3 44.3 0.4 0.3 0.2 0.8 0.0 0.1 368.0 0.2 0.4 0.4 341.5 0.2 0.1 0.6 0.2 0.2 38.4 0.2 17.0 0.5 0.4 1.1 0.7 0.5 0.6 0.4 0.2 0.5 0.5 0.1 0.4 0.5 0.0 0.0 0.6 0.0 124.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.7 67.6 0.0 0.4 0.0 1.0 0.5 0.1 0.3 0.1 0.0 14.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.4 0.0 1.6 0.0 0.1 0.0 HSD17B7 "PRAP, SDR37C1" ENSG00000132196 "Hydroxysteroid 17-beta dehydrogenase 7" P56937 1 162790702-162812817 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047496 Approved NA NA "HPA047496: AB_2680068" "unprognostic (2.93e-1)" "unprognostic (1.36e-2)" "unprognostic (6.03e-2)" "unprognostic (1.12e-1)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (2.57e-1)" "unprognostic (2.51e-2)" "unprognostic (1.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.47e-5)" "unprognostic (6.25e-2)" "unprognostic (1.90e-1)" "unprognostic (6.35e-2)" "unprognostic (3.17e-2)" 4.2 16.2 3.0 5.1 3.1 2.8 8.3 2.9 6.0 5.6 3.8 6.5 6.8 4.1 7.3 9.0 5.1 4.2 3.1 2.8 3.5 5.2 30.4 7.7 8.4 3.8 3.5 2.9 6.8 5.4 5.1 7.8 4.7 3.7 5.9 8.0 4.0 6.3 3.5 6.0 7.3 6.6 4.4 3.2 5.6 6.0 2.6 3.6 8.2 6.2 2.8 8.2 5.5 5.6 4.2 12.6 12.2 32.4 13.8 18.4 18.3 20.2 4.6 15.9 9.4 19.0 17.0 35.7 29.6 10.6 4.4 58.3 19.1 30.6 43.4 9.9 12.4 15.5 7.7 8.2 26.8 15.2 13.9 12.7 11.6 23.5 36.8 11.6 7.4 15.7 19.4 14.5 19.0 8.3 8.9 17.7 13.7 20.5 24.4 15.3 9.5 19.3 18.5 33.3 19.5 27.6 14.6 8.0 7.7 7.9 27.5 12.3 17.1 9.8 4.4 10.2 6.7 10.0 11.2 12.7 29.4 6.6 1.2 11.1 21.7 6.7 12.1 13.6 6.8 14.8 12.6 10.1 13.7 6.9 11.9 12.9 12.4 5.5 8.2 8.5 10.0 17.9 12.2 3.0 3.1 2.9 6.0 2.8 3.5 3.8 3.5 2.9 3.7 3.2 3.6 4.2 8.8 0.0 25.5 22.5 22.6 11.0 19.5 48.3 35.9 23.6 24.9 11.9 2.4 12.8 26.1 11.0 62.6 17.2 19.9 14.9 3.9 16.9 2.0 9.4 7.9 12.0 6.0 4.2 8.4 27.1 15.1 13.1 8.6 9.3 5.1 32.8 8.9 62.0 13.4 11.8 9.1 14.5 18.3 5.0 16.9 1.9 6.8 12.2 17.8 5.6 10.6 14.3 16.5 12.5 22.6 15.0 17.9 7.2 18.1 19.0 12.1 10.2 19.9 44.1 0.0 5.9 10.5 4.9 6.6 15.6 12.6 19.2 23.5 34.1 11.6 12.6 ENOSF1 "FUCD, HSRTSBETA, rTS, TYMSAS" ENSG00000132199 "Enolase superfamily member 1" Q7L5Y1 18 670318-712662 "Enzymes, Predicted intracellular proteins" "Isomerase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 216.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047829 Enhanced NA NA 7300 "HPA047829: AB_2680170" "prognostic favorable (2.27e-4)" "unprognostic (8.03e-2)" "unprognostic (2.02e-2)" "unprognostic (7.87e-3)" "unprognostic (1.85e-1)" "unprognostic (4.29e-2)" "unprognostic (6.48e-3)" "unprognostic (1.55e-2)" "unprognostic (3.50e-3)" "unprognostic (1.33e-3)" "unprognostic (2.44e-2)" "unprognostic (5.07e-3)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.36e-1)" "unprognostic (5.03e-2)" "unprognostic (1.31e-2)" 7.4 25.2 4.5 3.3 5.6 7.7 9.4 4.6 6.3 9.6 6.5 10.5 5.5 6.7 2.1 12.1 10.7 3.2 10.1 4.2 5.5 27.8 29.5 8.2 2.8 5.5 5.1 4.1 8.7 16.0 5.0 11.4 4.0 5.6 13.4 4.0 6.0 15.0 2.5 5.1 7.0 11.1 2.4 4.6 9.5 14.7 5.3 5.1 3.2 18.7 1.6 1.9 9.1 8.2 6.8 3.5 9.6 6.0 5.8 1.6 2.1 5.2 4.9 5.4 1.0 3.6 10.6 10.5 3.8 1.8 0.8 4.1 4.1 8.0 3.7 2.2 2.6 4.4 7.2 12.0 5.4 6.9 11.8 3.2 3.2 8.5 1.7 5.7 1.7 5.7 10.5 6.2 9.6 2.0 8.8 13.8 7.3 2.6 13.1 5.0 4.7 2.2 12.7 5.3 14.0 7.6 3.1 7.7 8.4 2.7 2.2 3.2 14.2 2.9 2.8 5.4 5.5 2.6 14.0 15.2 8.1 12.8 8.3 2.6 0.0 0.5 1.4 3.5 1.6 2.7 0.8 2.3 1.9 0.8 0.5 3.3 3.4 0.1 1.2 0.6 2.4 1.7 0.9 4.5 5.6 4.6 6.3 4.2 5.5 5.5 5.1 4.1 5.6 4.6 5.1 6.8 17.9 35.3 99.5 36.9 10.1 11.9 29.5 29.6 24.5 35.2 38.4 36.4 19.6 28.6 44.7 47.8 116.7 44.6 25.6 36.7 115.4 32.4 7.0 61.6 32.2 19.6 24.7 73.2 4.2 14.4 27.7 26.5 61.2 40.1 22.2 26.2 23.9 56.6 39.1 0.0 7.6 36.0 38.7 12.6 8.8 6.8 23.6 20.9 19.6 30.0 12.1 30.9 24.7 38.2 143.6 21.9 36.2 28.2 25.2 25.9 50.9 216.9 78.3 98.8 13.1 38.7 15.8 14.7 29.3 39.8 12.1 37.8 22.0 67.8 49.4 20.8 EMILIN2 "FLJ33200, FOAP-10" ENSG00000132205 "Elastin microfibril interfacer 2" Q9BXX0 18 2847006-2916003 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 76.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 25.7" HPA064576 Supported "Secreted to extracellular matrix" NA NA 840000 "HPA064576: AB_2732717" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (7.91e-3)" "unprognostic (1.11e-2)" "unprognostic (3.98e-3)" "unprognostic (9.91e-3)" "prognostic unfavorable (6.30e-4)" "unprognostic (2.01e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.49e-1)" "unprognostic (3.15e-3)" "unprognostic (3.72e-2)" "unprognostic (2.96e-1)" 13.1 1.3 1.5 17.4 2.2 11.4 5.1 4.7 2.6 5.4 3.4 2.8 1.6 6.4 0.8 2.5 4.7 5.9 6.8 0.8 4.8 0.8 1.5 12.0 2.4 8.0 4.6 0.6 5.9 1.4 76.5 0.4 22.1 5.2 1.0 3.3 0.1 2.3 1.2 0.8 2.5 2.2 8.5 7.1 3.9 1.6 1.8 5.6 2.9 1.6 2.4 2.1 8.1 4.0 11.5 0.2 0.4 2.9 0.0 48.2 19.9 37.8 7.9 0.0 1.4 2.4 5.6 0.1 0.0 0.6 19.3 0.5 0.1 1.0 0.0 2.6 0.0 2.6 0.5 0.2 0.4 1.6 37.8 60.6 26.1 0.0 1.5 0.0 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.1 10.4 4.9 0.4 0.1 0.1 2.5 0.0 0.1 0.2 0.4 0.2 0.2 0.3 1.4 25.7 0.0 36.7 0.4 0.0 5.2 46.7 0.4 0.0 0.0 0.0 3.1 9.1 1.0 5.5 1.1 0.3 0.4 0.8 0.3 0.2 0.4 0.3 1.1 0.3 0.2 0.4 1.1 1.5 0.7 0.7 0.3 0.4 1.5 2.2 4.7 2.6 0.8 4.8 8.0 4.6 0.6 5.2 7.1 5.6 11.5 6.8 3.2 6.7 0.0 13.7 5.7 3.3 0.5 0.6 0.1 2.8 3.0 15.7 1.5 5.3 3.7 0.0 4.7 14.5 2.8 1.9 2.7 2.3 19.3 98.0 8.8 3.0 6.7 0.5 1.1 11.9 31.4 5.6 46.0 46.3 5.7 2.9 0.5 61.1 0.0 1.2 4.9 0.0 52.9 99.7 2.3 15.2 97.5 5.4 2.8 51.0 0.0 7.2 11.1 9.1 2.4 7.9 1.2 2.7 3.5 1.5 1.7 4.0 0.2 0.0 2.3 8.7 4.9 5.5 0.4 4.0 2.9 9.6 14.7 5.1 2.8 SLX1A GIYD1 ENSG00000132207 "SLX1 homolog A, structure-specific endonuclease subunit" Q9BQ83 16 30193875-30197561 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 48.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (3.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.84e-1)" "unprognostic (5.60e-2)" "unprognostic (6.04e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-1)" "unprognostic (1.26e-6)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (3.86e-1)" 19.0 24.2 17.3 18.3 16.8 31.4 19.3 16.1 23.6 10.1 17.0 23.7 62.1 7.2 6.2 26.0 6.8 8.2 20.4 17.2 18.0 30.7 59.9 16.9 15.4 25.0 17.3 18.4 4.1 31.8 6.6 13.0 13.8 22.5 12.1 11.4 5.3 18.3 11.2 26.5 16.4 52.6 6.3 17.8 39.7 32.1 5.6 20.2 4.9 13.5 6.4 16.0 16.5 12.9 20.9 75.9 38.8 33.3 16.3 7.0 10.0 117.1 27.4 34.2 25.3 24.4 7.0 59.4 60.3 62.9 11.9 16.0 48.7 12.8 18.4 9.3 46.3 46.8 40.9 12.1 70.0 21.2 47.6 65.8 10.7 21.4 12.2 12.2 17.4 37.9 36.6 28.9 49.8 15.1 65.3 33.3 106.8 42.5 46.8 42.0 106.8 34.2 159.5 29.6 18.0 29.7 96.0 6.0 145.3 29.5 5.1 21.6 28.2 17.3 36.4 41.4 39.6 25.4 157.6 98.3 42.7 40.8 42.8 29.0 27.7 199.5 219.4 79.3 183.6 56.2 68.1 58.9 65.1 167.1 64.0 29.0 49.7 80.8 73.6 142.6 65.8 112.2 119.3 17.3 16.8 16.1 23.6 17.2 18.0 25.0 17.3 18.4 22.5 17.8 20.2 20.9 1.5 0.0 1.1 0.0 1.7 0.6 1.3 1.7 0.0 0.6 0.4 0.3 3.1 1.5 1.3 3.7 0.0 5.9 1.4 4.4 0.0 7.2 0.6 0.3 0.1 1.4 3.6 4.6 0.0 12.0 2.3 0.8 3.1 0.2 0.0 0.3 1.4 2.5 2.8 0.0 0.0 6.3 2.0 6.9 5.5 0.1 0.9 2.1 7.2 0.0 3.3 0.2 1.0 0.0 0.0 10.5 7.8 0.0 0.5 1.0 48.3 3.6 0.5 0.3 0.0 0.2 1.6 0.4 0.5 0.0 2.3 4.1 1.9 0.1 5.0 0.7 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favorable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 19.7 29.5 31.8 18.8 32.9 23.0 51.2 33.3 35.5 36.6 35.0 37.1 33.2 27.4 34.3 31.6 39.7 24.1 16.5 32.5 33.9 27.2 34.9 24.6 22.6 32.0 32.1 33.1 29.6 49.8 46.8 41.0 30.0 32.6 47.0 48.6 28.6 58.2 28.5 15.3 33.0 30.9 27.7 31.7 20.9 50.9 18.5 33.2 25.9 37.3 16.3 32.3 29.5 24.6 33.7 50.4 64.8 38.9 38.5 59.1 53.9 56.1 40.3 107.0 86.2 101.8 62.1 80.3 39.9 16.5 79.3 49.8 68.0 49.4 84.1 70.0 30.9 86.5 22.3 87.7 60.4 71.3 36.2 42.8 60.0 65.7 43.0 98.3 64.2 55.9 38.3 35.3 45.0 55.8 98.9 41.9 41.6 67.2 119.0 71.9 31.7 22.6 37.1 61.9 50.4 50.8 63.2 48.7 204.9 25.9 36.3 86.9 33.0 36.8 35.4 35.7 39.1 30.3 67.3 32.5 24.3 65.4 22.0 43.9 13.0 15.6 9.9 17.9 10.9 17.8 12.1 16.7 14.5 21.3 13.8 16.7 17.1 6.1 21.1 6.7 16.6 18.9 13.9 31.8 32.9 33.3 35.5 32.5 33.9 32.0 32.1 33.1 32.6 31.7 33.2 33.7 14.8 6.4 6.4 4.6 20.7 28.0 49.3 48.9 16.5 32.6 59.8 45.1 4.3 40.0 30.5 12.9 29.2 80.1 24.3 56.0 58.7 62.7 31.7 28.1 20.1 19.6 63.0 21.8 8.4 85.4 65.8 23.1 62.2 37.2 31.8 30.3 20.3 21.1 28.1 21.9 7.8 126.6 32.6 10.1 16.4 43.3 20.5 14.4 24.9 5.6 25.2 35.4 18.6 6.6 7.6 59.9 63.4 24.5 28.0 73.3 65.2 34.4 34.7 32.3 26.3 21.6 23.3 41.0 26.2 26.2 32.1 112.5 16.9 40.9 52.6 64.7 TRIM5 "RNF88, TRIM5alpha" ENSG00000132256 "Tripartite motif containing 5" Q9C035 11 5663195-5938619 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB013497, HPA023420, HPA023422" Approved Supported Cytosol NA NA Cytosol "CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379" "unprognostic (2.60e-1)" "unprognostic (9.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (4.74e-3)" "unprognostic (5.48e-3)" "unprognostic (5.82e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (8.54e-3)" "unprognostic (1.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (6.12e-2)" 7.7 10.9 2.5 8.2 2.5 3.8 8.1 2.3 2.5 11.4 7.3 7.0 7.5 11.8 18.6 7.8 9.5 6.9 5.6 2.1 6.2 6.7 12.9 11.9 8.5 4.0 3.4 1.3 11.5 13.4 4.2 3.9 9.7 3.5 8.6 7.8 1.9 14.1 9.2 1.9 5.5 8.6 11.4 2.8 10.5 7.8 8.4 3.4 9.5 9.6 4.0 9.0 8.3 8.7 3.5 7.7 15.4 19.2 12.4 24.0 22.5 5.4 18.0 35.0 37.3 50.0 13.8 13.5 5.5 13.3 18.8 27.6 13.0 18.4 25.8 14.9 9.6 5.1 15.2 10.4 9.5 20.2 11.5 15.3 15.4 22.7 10.5 31.3 22.9 52.8 8.9 16.9 12.2 32.1 4.2 7.7 5.3 7.7 11.7 8.1 14.3 4.7 1.5 23.7 14.4 0.5 1.1 11.8 18.4 6.8 20.7 9.3 6.6 43.3 13.9 20.2 3.6 4.2 9.4 7.9 1.9 10.9 6.8 15.4 10.7 7.6 11.6 3.6 7.8 3.0 3.1 2.8 2.8 9.4 2.6 1.8 3.7 7.7 4.1 8.0 7.0 2.2 4.1 2.5 2.5 2.3 2.5 2.1 6.2 4.0 3.4 1.3 3.5 2.8 3.4 3.5 14.2 6.4 14.0 4.9 8.7 5.2 9.5 9.7 9.6 0.2 8.3 6.5 4.9 2.8 13.4 11.0 0.0 7.8 16.4 5.5 5.9 10.6 5.0 8.6 12.6 14.8 1.2 8.4 3.0 8.8 10.5 12.4 6.1 12.5 0.0 11.9 15.4 13.9 6.4 0.0 1.4 9.7 4.1 12.2 7.1 3.8 7.8 10.8 3.6 19.7 10.8 7.0 14.4 3.0 1.0 8.1 4.9 7.5 6.7 10.1 7.4 6.3 3.7 0.1 19.7 6.5 10.9 5.2 3.3 7.0 5.4 7.8 7.5 20.6 7.5 9.9 CNGA4 "CNCA2, CNG5, CNGB2, OCNC2, OCNCb" ENSG00000132259 "Cyclic nucleotide gated channel subunit alpha 4" Q8IV77 11 6234765-6244479 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Ion channel, Ligand-gated ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 17.4;testis: 6.2" "Cell type enhanced" "Detected in some" "Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5" "Cancer enriched" "Detected in single" 6 "endometrial cancer: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074128 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA074128: " "unprognostic (1.11e-2)" "unprognostic (4.32e-2)" "unprognostic (2.69e-3)" "prognostic favorable (1.48e-4)" "unprognostic (4.96e-2)" "unprognostic (1.09e-1)" "unprognostic (2.01e-3)" "unprognostic (1.89e-1)" "unprognostic (8.51e-2)" "unprognostic (5.51e-2)" "unprognostic (1.83e-2)" "unprognostic (8.70e-2)" "unprognostic (1.03e-3)" "unprognostic (3.84e-2)" "unprognostic (3.47e-2)" "unprognostic (8.11e-2)" "unprognostic (3.55e-3)" 0.1 0.2 2.3 0.2 1.5 0.4 0.2 1.7 1.2 0.5 0.6 0.2 0.3 0.6 0.2 0.2 17.4 0.2 0.1 1.1 1.3 0.2 0.2 1.4 0.2 2.2 2.1 0.9 0.4 0.4 0.0 0.7 0.0 2.3 0.2 0.1 1.1 0.1 0.5 0.0 0.3 0.2 0.1 1.9 0.3 0.2 6.2 1.6 0.3 0.2 0.0 0.2 0.2 0.2 2.2 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.5 1.7 1.2 1.1 1.3 2.2 2.1 0.9 2.3 1.9 1.6 2.2 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689697-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 135.9;dendritic cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 54.4 21.5 13.3 102.3 19.2 91.2 51.2 16.7 24.2 43.0 26.8 36.4 25.4 51.1 70.8 37.4 49.7 79.3 22.8 14.9 18.2 21.4 73.1 84.2 140.1 16.2 16.4 13.6 60.8 17.4 8.1 12.7 21.7 16.4 43.7 53.9 11.1 66.0 53.1 13.6 18.3 53.9 52.6 11.2 144.3 39.8 15.5 12.3 102.1 21.9 40.9 121.7 62.2 22.8 29.3 2.8 1.2 13.9 2.4 88.6 174.6 5.0 53.3 93.9 89.8 209.9 1.7 8.6 111.9 13.0 80.2 20.6 10.5 34.0 56.4 10.7 2.0 0.0 6.4 5.6 1.4 107.8 18.2 11.4 190.6 54.3 18.7 9.6 124.5 128.7 1.0 2.3 4.7 111.6 1.5 54.1 16.9 40.3 0.5 4.9 62.6 3.4 2.3 51.1 14.9 1.4 2.7 4.5 4.5 2.1 56.8 4.5 17.9 153.6 56.4 29.8 2.5 2.4 4.9 4.4 11.2 67.7 28.9 7.2 108.7 118.5 79.6 109.0 143.3 145.9 149.4 118.4 117.2 138.7 158.2 106.5 102.7 103.1 61.3 181.1 177.0 197.9 181.9 13.3 19.2 16.7 24.2 14.9 18.2 16.2 16.4 13.6 16.4 11.2 12.3 29.3 54.4 67.3 57.7 2.0 135.9 12.6 17.0 42.5 56.3 0.5 17.7 14.0 6.0 7.2 60.5 29.5 0.0 1.5 113.9 4.7 5.9 11.2 0.3 16.1 27.0 40.5 4.2 16.8 4.9 8.0 4.7 36.2 20.9 23.8 17.7 5.4 33.5 4.3 18.7 1.7 0.3 9.0 30.5 87.1 46.6 2.0 36.1 67.8 5.4 52.5 59.0 6.4 83.4 1.0 0.5 5.4 6.3 30.1 18.8 9.9 4.4 3.3 52.5 1.0 13.1 35.1 24.4 0.6 0.3 14.1 8.7 2.3 89.3 13.0 5.0 18.8 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595072-6603616 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 10.8 10.2 12.3 5.9 12.4 18.6 10.6 12.4 15.0 12.7 11.0 17.4 6.8 11.1 9.8 11.5 10.6 3.4 14.3 11.9 12.1 11.4 21.7 9.3 8.6 12.6 12.6 11.7 9.4 10.1 5.4 8.3 6.1 13.1 15.9 6.6 7.7 7.5 8.9 9.5 12.7 10.4 6.3 12.7 14.3 12.2 10.8 12.7 6.9 10.7 4.1 8.5 17.0 11.2 13.5 12.3 12.0 4.7 6.1 9.6 8.3 6.7 6.2 7.7 14.0 13.1 12.4 14.1 17.1 6.0 5.9 10.3 12.1 13.6 10.9 14.7 8.3 19.5 8.1 14.0 14.3 11.0 14.8 10.8 7.1 14.0 6.7 12.1 9.2 14.7 8.0 16.3 9.7 11.2 15.2 14.5 22.0 11.6 21.4 10.7 12.8 3.8 3.9 13.4 9.7 7.2 8.4 8.9 18.0 10.7 7.7 9.8 12.9 7.6 13.2 6.1 13.0 12.2 10.8 10.5 16.7 11.2 14.8 8.7 26.3 10.0 10.4 11.5 10.7 11.2 9.1 11.3 10.7 13.0 11.9 11.0 11.7 3.9 13.6 11.8 9.9 11.9 9.0 12.3 12.4 12.4 15.0 11.9 12.1 12.6 12.6 11.7 13.1 12.7 12.7 13.5 17.0 22.4 15.0 37.2 19.6 23.2 18.5 13.3 14.2 17.3 14.1 11.7 20.7 8.6 14.7 9.2 14.6 23.5 20.7 12.2 11.7 19.0 7.4 13.7 22.8 16.4 7.2 37.7 45.0 15.9 21.2 15.5 21.4 14.0 17.7 14.7 12.5 23.5 18.9 3.3 32.6 16.2 12.2 9.4 13.4 13.6 13.1 13.1 8.8 21.5 18.4 14.2 22.6 27.2 34.6 22.7 18.2 9.8 15.2 15.8 13.7 29.8 10.3 30.5 0.0 15.3 20.0 23.7 18.0 18.3 27.1 20.0 17.7 25.2 17.3 15.0 TIMM10B "FXC1, TIM10B, Tim9b" ENSG00000132286 "Translocase of inner mitochondrial membrane 10B" Q9Y5J6 11 6481501-6484681 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052265 Approved NA NA "HPA052265: AB_2681778" "unprognostic (1.70e-1)" "unprognostic (2.00e-1)" "unprognostic (1.96e-2)" "unprognostic (3.06e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-1)" "unprognostic (2.15e-3)" "unprognostic (1.10e-3)" "unprognostic (8.72e-2)" "unprognostic (2.86e-1)" "unprognostic (6.78e-2)" "unprognostic (1.65e-1)" "prognostic favorable (3.19e-10)" "unprognostic (9.92e-2)" "unprognostic (3.84e-1)" "unprognostic (3.61e-1)" "unprognostic (2.42e-1)" 16.0 24.2 12.0 14.4 13.0 17.0 18.3 13.9 16.6 18.6 10.7 21.6 17.2 21.8 22.1 17.2 19.6 14.9 15.9 11.7 14.7 22.4 20.5 17.9 17.3 17.6 16.2 11.6 21.8 24.7 29.1 19.3 17.4 19.9 22.1 18.8 18.4 18.4 20.3 12.5 15.6 17.8 19.0 13.7 18.5 22.9 13.1 15.6 14.0 26.9 11.4 17.0 20.8 15.9 21.7 21.7 11.8 25.6 24.4 30.6 31.1 17.8 21.2 29.4 26.3 30.1 21.7 43.5 21.8 14.8 24.7 32.7 28.5 23.8 32.3 25.4 22.0 23.3 28.6 23.8 25.0 34.3 39.6 31.1 30.9 36.0 16.8 26.4 16.9 19.7 29.1 51.5 40.2 25.3 17.2 38.7 20.9 39.5 33.8 21.1 28.8 17.2 21.4 32.8 30.4 27.2 29.5 25.0 36.1 35.9 16.7 23.1 28.4 20.7 28.4 20.2 22.9 14.8 36.3 39.9 33.3 27.4 29.2 31.0 17.2 28.9 25.8 36.5 29.8 38.5 36.0 32.6 34.8 26.7 37.9 45.2 39.6 6.5 36.0 25.2 32.9 28.6 39.6 12.0 13.0 13.9 16.6 11.7 14.7 17.6 16.2 11.6 19.9 13.7 15.6 21.7 18.7 19.2 24.1 3.9 28.5 29.1 44.8 32.2 19.4 26.2 24.1 19.3 21.0 0.0 28.2 18.4 25.0 29.5 28.0 23.3 58.7 24.4 19.8 17.1 17.7 16.9 31.0 12.6 8.6 29.7 29.5 22.6 10.2 20.6 31.1 21.1 0.0 0.0 29.3 11.8 9.9 34.5 30.5 0.0 18.9 10.9 18.3 19.1 23.2 5.6 28.7 21.8 44.3 7.5 11.7 29.3 26.9 21.1 21.6 41.7 25.0 34.0 35.8 31.2 26.3 14.9 24.1 49.0 35.2 24.0 31.1 40.2 22.5 33.3 27.2 63.7 EFR3A KIAA0143 ENSG00000132294 "EFR3 homolog A" Q14156 8 131904093-132013642 "Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 122.7" "Cell type enhanced" "Detected in all" "Bipolar cells: 358.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022859, HPA023092, HPA023402" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031" "unprognostic (4.79e-2)" "unprognostic (6.54e-2)" "unprognostic (6.42e-2)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (3.44e-2)" "unprognostic (3.04e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-1)" "unprognostic (8.11e-2)" "unprognostic (5.89e-3)" "unprognostic (5.22e-2)" "unprognostic (3.46e-1)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.29e-1)" "unprognostic (2.21e-3)" 21.9 21.0 17.4 21.0 29.7 14.6 20.2 38.1 35.7 28.5 14.4 20.5 23.4 23.6 38.3 27.7 24.4 22.0 34.2 32.5 15.5 30.1 44.8 28.0 25.5 49.6 23.0 23.0 19.5 18.7 33.8 12.1 20.6 62.6 27.1 18.6 122.7 17.4 29.6 42.0 21.4 23.7 36.4 7.8 23.7 23.0 22.3 20.9 24.6 38.1 49.5 28.1 27.1 14.1 43.3 55.3 49.0 15.0 12.4 59.9 68.8 29.9 38.6 54.0 31.5 41.3 10.8 40.4 33.8 35.5 87.6 41.8 17.9 23.9 52.9 38.3 78.3 13.1 33.7 22.7 22.0 57.5 13.0 34.1 58.6 29.6 31.2 49.0 52.2 40.2 16.4 18.7 44.3 56.5 36.1 36.5 11.9 8.5 47.3 30.4 14.5 29.4 16.1 38.0 34.1 10.0 34.6 76.9 10.8 30.6 39.3 34.4 22.0 56.3 55.6 50.9 27.4 40.9 31.3 28.8 20.9 41.2 31.0 29.0 12.0 16.8 17.4 16.2 23.3 14.5 12.6 13.0 13.3 17.3 11.2 11.6 12.0 10.1 15.5 40.9 4.0 11.3 15.8 17.4 29.7 38.1 35.7 32.5 15.5 49.6 23.0 23.0 62.6 7.8 20.9 43.3 32.6 41.7 42.8 90.8 40.7 21.2 25.3 29.5 25.0 358.8 29.9 16.6 57.4 28.6 37.5 51.5 91.8 22.8 34.1 33.5 21.5 28.7 4.5 25.9 35.1 29.1 11.4 13.3 126.8 30.9 22.2 34.4 29.0 20.7 25.9 19.8 25.0 79.9 44.5 26.9 122.6 18.7 26.4 59.4 25.0 8.0 19.9 52.9 8.8 60.0 53.3 42.3 42.2 77.9 55.6 25.5 36.0 44.4 32.6 55.8 39.9 58.4 27.7 107.5 19.7 32.3 41.4 52.9 30.9 39.1 31.4 37.1 37.3 36.8 17.0 36.7 HHLA1 PLA2L ENSG00000132297 "HERV-H LTR-associating 1" C9JL84 8 132061486-132111159 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106223-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria NA NA Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favorable (6.86e-4)" 10.1 16.0 14.5 7.7 14.9 14.8 10.0 15.7 16.0 11.6 15.8 12.6 10.2 11.8 10.3 10.8 11.8 6.5 26.4 13.7 14.8 12.6 16.6 9.7 11.9 14.2 14.5 13.9 15.2 10.8 13.2 14.9 9.3 15.2 10.5 13.6 13.3 9.9 7.6 33.2 10.1 12.0 9.0 13.5 12.1 11.9 16.8 14.5 10.6 12.1 36.6 11.2 10.4 10.8 17.2 16.2 37.6 22.0 18.5 16.1 16.6 26.2 32.6 13.8 18.0 18.0 69.9 15.1 39.7 11.8 17.1 18.6 28.9 44.7 17.7 22.9 17.8 37.0 31.8 23.0 59.2 16.3 26.0 23.1 19.8 12.8 13.7 24.4 18.8 15.7 28.6 33.5 14.8 16.0 15.0 21.7 31.0 20.2 31.5 23.9 28.8 30.9 30.6 24.6 31.7 23.9 14.7 15.2 25.0 30.4 20.6 13.2 15.7 11.3 14.2 15.1 14.6 19.2 33.7 47.6 31.6 13.8 29.4 11.1 4.4 9.6 7.6 12.4 7.0 14.6 15.3 11.2 13.2 10.6 16.4 15.1 11.3 0.3 14.3 14.1 10.7 13.9 8.8 14.5 14.9 15.7 16.0 13.7 14.8 14.2 14.5 13.9 15.2 13.5 14.5 17.2 17.1 57.7 33.5 50.3 31.0 26.0 26.3 27.7 34.7 61.7 19.2 16.8 105.7 18.6 37.4 23.9 66.7 53.0 30.6 21.7 25.4 18.8 34.8 27.5 33.3 23.5 31.1 39.5 52.9 11.9 27.0 30.5 30.1 24.2 33.6 47.5 21.4 41.7 21.7 37.0 53.1 25.3 20.3 19.6 13.3 22.4 27.1 17.7 8.8 21.5 22.7 49.8 28.8 48.7 53.4 15.0 19.2 19.5 26.4 23.7 23.2 30.1 26.2 65.3 13.1 36.3 21.3 98.3 62.4 28.7 24.7 36.7 31.8 47.9 38.5 20.4 IMMT "HMP, Mic60, MICOS60, MINOS2, P87, P89" ENSG00000132305 "Inner membrane mitochondrial protein" Q16891 2 86143932-86195472 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 291.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 223.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022439, HPA036164, HPA036165" Supported Enhanced Mitochondria NA NA 220000 Mitochondria "CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980" "unprognostic (3.83e-3)" "unprognostic (1.56e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.40e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (5.66e-2)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (7.35e-2)" "unprognostic (2.21e-1)" "prognostic favorable (3.51e-6)" "unprognostic (2.06e-3)" "unprognostic (6.35e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" 41.0 83.0 30.3 35.2 32.1 40.6 36.8 33.0 39.3 29.2 39.2 57.6 58.0 35.3 27.9 43.7 31.2 27.4 159.8 31.5 33.7 81.7 65.6 32.8 44.7 34.5 34.7 29.9 28.3 48.9 90.9 36.3 37.0 35.0 29.6 58.6 42.8 38.2 35.4 202.8 37.5 47.0 39.2 28.6 45.2 56.4 49.6 32.2 52.8 35.8 291.4 47.5 41.8 34.0 36.4 115.6 111.2 99.2 45.6 93.7 88.3 101.5 80.5 85.6 108.0 98.7 160.7 89.1 175.7 78.9 87.7 87.7 83.4 128.9 118.4 131.8 71.4 105.9 139.0 65.6 192.0 95.7 135.9 91.1 100.6 84.0 101.7 119.5 67.2 124.7 99.7 138.4 96.7 105.1 99.0 135.6 140.8 117.8 175.1 88.2 89.9 211.2 158.7 122.5 128.3 119.3 89.0 82.9 124.0 126.3 77.4 70.7 94.6 93.6 76.0 83.6 112.0 101.8 76.6 104.1 119.9 86.9 158.8 94.4 12.1 29.2 12.2 23.5 34.0 20.7 15.9 20.6 19.3 32.9 13.7 18.3 22.3 3.8 20.8 33.2 17.2 23.2 25.4 30.3 32.1 33.0 39.3 31.5 33.7 34.5 34.7 29.9 35.0 28.6 32.2 36.4 29.3 54.5 49.2 31.3 42.1 23.3 34.9 51.6 30.1 40.9 21.6 19.7 223.0 24.3 57.3 40.5 33.3 94.9 49.6 57.9 133.1 59.9 152.4 26.5 34.0 38.3 56.0 76.1 41.6 52.8 73.9 36.3 39.8 26.8 48.0 55.6 35.7 64.2 70.9 23.5 46.5 46.2 38.7 49.4 28.3 158.9 27.7 48.9 17.8 26.2 80.6 30.2 52.5 29.1 44.1 43.3 36.3 36.9 56.4 28.6 59.8 92.6 41.8 42.5 6.6 39.7 58.2 100.7 54.6 41.1 24.9 98.5 45.6 118.6 68.0 33.6 MRPL35 ENSG00000132313 "Mitochondrial ribosomal protein L35" Q9NZE8 2 86199355-86213790 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043482 Uncertain "Intracellular and membrane" NA NA "HPA043482: AB_10959449" "unprognostic (3.68e-2)" "unprognostic (6.24e-2)" "unprognostic (9.14e-3)" "unprognostic (1.68e-2)" "unprognostic (9.38e-3)" "unprognostic (7.72e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (9.81e-2)" "unprognostic (1.76e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (1.66e-1)" "prognostic favorable (9.96e-6)" "unprognostic (1.94e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (2.52e-3)" 25.2 29.9 20.9 25.0 21.7 20.7 25.6 21.8 26.3 19.1 19.1 56.1 58.4 17.9 13.7 31.5 22.1 20.1 84.6 20.7 22.0 48.0 46.5 15.6 35.8 21.0 20.5 19.4 17.5 19.9 46.3 12.1 21.1 21.2 19.3 59.3 23.4 24.5 25.3 70.0 14.4 43.7 30.4 20.0 21.8 32.5 16.3 22.5 29.4 20.1 114.5 40.3 32.5 18.2 22.5 83.4 35.8 53.6 55.0 55.1 51.6 77.2 71.5 51.5 88.0 64.9 31.4 69.1 154.1 79.0 61.6 70.9 71.2 109.3 64.2 98.1 89.0 51.0 88.5 25.9 80.5 44.7 143.0 68.0 38.6 75.0 95.4 46.4 42.3 81.4 82.6 111.4 66.1 82.0 50.2 82.0 97.3 56.2 107.0 46.4 71.4 143.1 129.8 90.6 60.2 45.2 43.7 66.1 106.8 116.8 37.5 43.7 57.0 62.2 70.4 85.9 89.8 112.6 49.9 157.4 170.0 61.7 150.1 65.6 30.4 36.0 19.0 21.4 48.4 24.0 45.2 31.9 28.0 41.9 41.4 37.4 29.7 5.1 23.5 50.8 42.2 40.4 32.4 20.9 21.7 21.8 26.3 20.7 22.0 21.0 20.5 19.4 21.2 20.0 22.5 22.5 17.3 22.4 15.0 7.2 17.5 7.1 20.3 67.4 11.4 21.9 17.0 20.1 135.9 18.6 42.2 18.4 31.3 49.2 15.0 46.7 97.8 42.0 3.7 22.0 28.3 19.2 26.5 35.1 11.6 43.0 49.7 19.8 23.4 22.1 21.0 21.9 15.7 52.9 65.3 23.5 12.7 31.4 48.8 23.8 6.1 5.0 12.8 23.7 10.6 12.2 32.1 21.5 19.6 5.0 11.5 41.8 29.5 17.7 29.5 17.3 52.6 82.8 24.9 25.4 26.3 17.2 47.2 14.6 26.3 29.0 8.5 27.0 14.6 38.1 56.3 25.2 IQCA1 "DRC11, FLJ22527, IQCA" ENSG00000132321 "IQ motif containing with AAA domain 1" Q86XH1 2 236324147-236507535 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.4;choroid plexus: 21.7;thyroid gland: 19.4" "Cell type enhanced" "Detected in many" "Astrocytes: 180.9;Endometrial ciliated cells: 54.7;Respiratory ciliated cells: 115.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;HBEC3-KT: 3.3;HeLa: 3.8;hTERT-RPE1: 6.9;SuSa: 4.4;U-2 OS: 12.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 7.2" HPA057320 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA057320: " "unprognostic (1.73e-2)" "unprognostic (6.38e-2)" "unprognostic (3.75e-3)" "unprognostic (1.62e-2)" "unprognostic (6.27e-3)" "unprognostic (1.73e-2)" "unprognostic (3.23e-5)" "unprognostic (1.55e-1)" "unprognostic (7.23e-3)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.54e-4)" "unprognostic (1.19e-3)" "unprognostic (1.67e-3)" "unprognostic (1.91e-3)" "unprognostic (5.30e-2)" 1.1 1.2 24.5 0.4 25.7 0.0 1.8 20.5 46.4 1.2 21.7 0.2 0.1 1.7 5.4 0.7 11.1 1.7 0.4 22.3 19.9 3.8 0.1 2.7 0.4 21.8 24.4 18.2 2.4 1.3 1.4 10.4 0.2 21.1 1.5 0.1 2.2 1.2 1.3 0.0 0.2 0.3 0.5 14.6 3.1 0.5 4.6 19.6 2.9 19.4 0.0 0.6 1.7 1.0 17.2 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.3 0.1 0.0 0.0 3.2 0.0 1.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 3.8 0.0 0.1 0.0 0.0 0.2 1.7 0.0 0.0 6.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.1 0.0 12.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.2 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 24.5 25.7 20.5 46.4 22.3 19.9 21.8 24.4 18.2 21.1 14.6 19.6 17.2 2.8 16.0 12.6 180.9 0.4 0.5 7.8 26.9 1.8 26.2 1.7 14.1 1.3 11.5 26.7 3.7 16.7 0.5 0.0 0.0 0.0 10.8 24.0 54.7 5.2 10.4 0.0 0.0 26.0 1.5 5.6 3.3 0.5 9.8 1.3 6.7 2.2 0.0 0.3 0.0 11.6 0.0 16.2 0.0 0.0 14.5 2.1 0.4 0.0 9.4 0.0 0.5 1.0 4.5 2.4 1.2 0.0 6.0 0.3 1.7 0.0 11.7 115.7 2.3 0.0 0.8 2.2 31.0 28.3 0.8 0.3 0.3 0.8 1.9 0.0 3.1 ILKAP "DKFZP434J2031, FLJ10181, PPM1O" ENSG00000132323 "ILK associated serine/threonine phosphatase" Q9H0C8 2 238170402-238203708 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004752, HPA056099" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004752: AB_1851753, HPA056099: AB_2797255" "unprognostic (1.50e-1)" "unprognostic (1.62e-1)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.60e-1)" "unprognostic (3.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.37e-3)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.89e-6)" "unprognostic (6.24e-2)" "unprognostic (6.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.20e-1)" 19.7 17.6 25.6 15.2 25.9 29.3 19.7 27.2 27.1 26.2 23.1 27.4 14.7 25.4 15.4 23.4 23.6 8.7 23.6 24.5 25.4 22.4 26.4 18.8 20.6 25.5 24.9 24.2 24.8 20.8 13.2 26.7 13.0 25.2 25.5 13.1 13.1 17.5 14.6 41.8 21.6 23.5 16.3 25.2 26.1 21.6 23.2 25.3 18.1 24.1 18.4 18.3 26.8 22.0 28.2 40.5 25.6 36.9 36.3 28.1 18.6 37.9 41.5 27.9 40.9 35.4 23.7 20.9 25.8 10.5 30.1 48.8 33.8 48.1 34.4 41.2 46.6 49.8 66.7 26.0 52.7 43.3 43.7 50.3 19.6 23.3 43.6 43.6 20.2 31.1 34.0 52.4 16.1 35.4 48.1 43.4 58.0 34.8 37.4 25.9 52.6 75.6 23.7 30.4 18.8 54.1 26.7 28.2 29.6 68.9 27.9 23.3 43.7 28.9 39.7 36.7 53.5 45.1 28.6 31.4 46.7 32.5 47.3 34.3 43.4 19.8 27.1 28.2 25.6 25.4 24.7 24.9 26.4 27.7 24.0 28.8 22.9 7.3 24.8 21.4 20.9 30.7 23.0 25.6 25.9 27.2 27.1 24.5 25.4 25.5 24.9 24.2 25.2 25.2 25.3 28.2 27.7 12.8 22.0 43.8 35.4 27.0 29.1 30.8 25.0 28.9 19.4 21.6 23.1 17.2 19.6 25.8 29.2 41.2 51.5 22.4 43.0 27.9 8.1 17.1 20.6 21.5 19.1 64.2 37.7 28.5 43.7 26.7 29.0 16.1 33.7 43.5 22.1 19.2 34.4 38.7 33.2 24.0 16.2 17.0 22.0 12.6 28.3 24.0 30.2 25.3 34.0 25.1 57.7 36.7 72.2 24.8 16.2 29.3 33.6 29.7 24.1 33.4 19.3 28.6 32.9 29.2 47.4 54.4 70.8 29.2 28.7 40.4 36.6 23.0 27.4 23.5 PER2 KIAA0347 ENSG00000132326 "Period circadian regulator 2" O15055 2 238244044-238290102 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053136, HPA060510" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053136: , HPA060510: AB_2684298" "unprognostic (1.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.88e-2)" "unprognostic (9.28e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.29e-4)" "unprognostic (2.47e-2)" "unprognostic (2.17e-2)" "unprognostic (3.59e-3)" "unprognostic (3.59e-2)" "unprognostic (1.76e-2)" "unprognostic (2.13e-1)" "unprognostic (6.81e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (2.58e-1)" "unprognostic (5.22e-2)" 12.4 3.4 4.9 5.1 5.6 8.5 14.4 7.2 6.9 12.0 2.3 7.7 5.1 10.3 5.7 13.7 7.9 12.4 5.7 6.0 8.9 3.6 12.5 7.2 4.8 5.5 5.1 4.8 7.9 14.6 4.2 9.1 2.9 4.6 9.4 6.3 5.2 14.2 9.0 11.6 16.3 8.0 4.9 5.5 4.8 13.5 11.9 6.3 4.2 8.9 7.7 6.3 8.8 8.3 5.0 1.6 11.7 2.4 4.2 0.1 1.2 8.2 1.1 4.1 1.5 1.4 1.8 5.8 10.3 1.2 2.7 1.5 8.6 2.4 3.5 2.2 2.9 1.7 9.1 6.2 8.2 2.0 13.8 9.2 1.6 8.3 1.8 6.1 1.5 0.8 4.2 4.5 6.3 1.3 7.7 6.9 15.2 3.5 7.6 2.3 16.5 5.5 3.3 1.5 3.3 9.7 1.2 2.9 6.3 1.8 0.7 5.9 8.5 2.1 3.6 4.2 2.8 4.1 7.1 1.8 12.3 6.7 5.9 4.5 2.1 1.2 0.3 1.0 2.2 1.6 1.5 1.6 1.2 1.4 1.5 1.5 1.6 1.0 1.2 2.1 1.8 1.2 0.3 4.9 5.6 7.2 6.9 6.0 8.9 5.5 5.1 4.8 4.6 5.5 6.3 5.0 24.9 16.0 30.1 18.6 9.9 73.9 61.7 21.3 38.1 20.6 67.8 33.8 5.7 31.5 46.9 27.6 2.1 9.2 27.0 22.5 7.9 7.5 9.6 69.7 30.1 15.6 24.6 6.9 20.9 10.4 6.3 39.8 52.5 86.1 9.5 3.3 11.4 35.8 3.9 11.8 13.9 35.1 18.3 10.1 25.3 4.7 11.1 12.4 24.9 5.6 5.3 13.5 2.1 9.0 7.2 7.6 35.3 18.4 10.9 15.0 10.9 5.5 44.2 7.8 6.6 110.1 32.2 31.3 17.0 38.4 85.4 13.0 13.6 3.7 36.9 33.9 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912106 "FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 711.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5" "Cancer enhanced" "Detected in all" "prostate cancer: 152.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 18 "NK-cell: 70.1" "Lineage enriched" "Detected in many" 18 "NK-cells: 70.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 13.5 29.5 136.3 21.2 129.5 0.9 7.5 136.8 255.5 315.6 116.0 243.0 58.1 711.9 25.2 9.5 258.8 28.8 241.2 134.1 149.8 23.5 83.4 32.8 6.7 162.4 127.5 118.3 45.5 226.9 1.4 15.4 8.7 131.3 143.4 6.4 0.9 10.0 55.1 214.0 11.2 74.2 126.5 135.9 12.4 104.3 5.1 147.7 2.9 6.8 69.4 3.0 172.9 75.7 142.0 29.8 0.0 0.5 0.0 12.4 17.9 1.1 2.1 3.6 1.7 1.5 0.0 47.4 0.3 0.4 0.9 0.1 0.2 7.6 0.1 0.2 146.0 4.0 0.1 0.0 1.2 40.6 0.0 0.2 15.6 22.3 0.1 0.3 0.2 0.0 0.0 0.0 0.3 3.7 2.7 0.1 1.3 0.4 0.1 173.8 0.0 1.5 0.8 0.0 0.0 1.5 201.7 3.5 0.0 0.1 1.8 1.3 0.1 0.0 0.8 0.6 0.4 0.5 0.3 0.3 0.0 0.6 0.1 2.7 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.6 0.1 1.0 0.0 0.5 0.2 0.4 70.1 0.0 0.2 0.0 3.4 136.3 129.5 136.8 255.5 134.1 149.8 162.4 127.5 118.3 131.3 135.9 147.7 142.0 1.0 0.0 1.5 64.9 3.1 11.6 13.2 26.9 10.2 2.0 4.4 4.4 190.0 78.6 43.8 11.0 0.0 3.0 44.0 2.1 0.0 62.7 0.2 26.5 546.4 6.2 115.4 4.4 14.2 278.2 5.5 41.7 31.1 11.3 1.3 0.6 30.7 104.0 22.7 1.7 19.2 73.7 10.2 3.1 50.3 0.6 8.4 20.3 64.0 13.1 433.5 6.9 61.8 71.9 11.5 63.5 87.7 11.3 1.9 66.1 96.8 0.2 97.0 2.7 6.6 16.6 78.6 0.3 5.8 2.6 5.8 2.3 7.3 0.5 105.8 28.5 SCLY SCL ENSG00000132330 "Selenocysteine lyase" Q96I15 2 238060924-238099413 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.4" "Group enriched" "Detected in many" 13 "Early spermatids: 90.6;Late spermatids: 156.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020190, HPA055760" Uncertain Enhanced "Golgi apparatus" NA NA 300000 "Golgi apparatus" "HPA020190: , HPA055760: AB_2682910" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (8.65e-5)" "unprognostic (8.96e-2)" "unprognostic (9.85e-3)" "unprognostic (1.14e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-2)" "unprognostic (8.38e-2)" "unprognostic (3.98e-3)" "unprognostic (1.03e-2)" "unprognostic (1.02e-3)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "unprognostic (2.50e-3)" "unprognostic (1.98e-1)" 5.1 4.3 7.4 5.3 9.0 5.1 4.9 9.1 9.4 6.6 6.1 7.1 8.6 8.2 5.7 5.9 6.3 3.9 7.5 6.8 7.8 13.0 39.4 4.8 5.7 9.1 8.8 6.5 6.4 23.0 6.2 5.1 2.0 9.3 6.0 3.3 4.6 4.4 4.1 6.5 3.6 8.7 3.9 7.7 7.2 5.9 16.9 7.8 5.9 7.3 3.5 4.3 7.8 5.1 10.3 11.1 19.1 11.9 31.1 9.0 6.4 23.2 11.2 5.6 11.3 14.3 11.6 8.0 18.9 3.3 5.9 35.4 16.4 44.1 21.5 10.9 21.2 41.8 21.1 24.0 37.6 16.7 17.6 18.2 7.1 11.6 21.3 22.0 5.1 21.0 26.1 38.0 5.1 11.7 16.9 17.9 33.0 36.4 16.0 15.6 22.0 23.3 18.2 11.3 3.6 13.1 28.9 12.0 19.4 20.6 8.2 6.3 26.5 8.5 16.3 11.8 24.2 23.7 14.2 13.3 9.3 11.3 37.0 14.4 1.1 3.2 4.0 2.6 2.3 2.0 2.6 3.1 4.4 3.3 1.6 2.3 2.6 0.5 2.9 3.5 0.6 3.2 2.8 7.4 9.0 9.1 9.4 6.8 7.8 9.1 8.8 6.5 9.3 7.7 7.8 10.3 2.2 0.0 0.0 0.0 4.6 1.7 2.4 1.9 5.7 5.4 1.7 1.9 2.6 1.5 1.2 0.0 8.4 1.4 3.4 1.9 3.9 5.3 90.6 1.7 3.4 2.4 2.4 9.4 0.0 3.7 2.1 1.9 5.1 2.6 0.0 3.5 1.8 3.3 4.0 6.7 0.0 3.3 8.2 0.9 3.2 156.3 3.1 2.1 1.8 0.0 2.7 2.6 2.1 0.0 0.0 3.0 5.0 0.0 4.9 1.9 3.9 2.7 1.9 6.9 0.0 1.9 3.2 6.2 5.6 3.4 1.6 0.7 4.4 2.2 4.8 1.8 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase receptor type E" P23469 10 127907103-128085855 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 47.3" "Cell type enhanced" "Detected in many" "dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 634.6;plasmacytoid DC: 475.9" "Group enriched" "Detected in all" 12 "dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 13.7 16.8 14.9 25.5 9.9 47.3 6.7 6.8 14.1 3.9 8.4 9.3 9.6 3.5 2.6 7.9 4.9 10.3 9.1 15.1 13.0 3.5 4.4 16.2 16.5 12.8 10.6 9.5 1.6 2.7 2.8 5.1 7.8 11.5 3.5 9.4 1.0 5.9 2.5 1.3 4.7 13.0 7.5 12.3 20.8 7.5 2.6 11.3 8.7 5.5 3.1 9.9 12.8 4.5 13.7 4.3 0.9 0.5 0.0 2.5 0.4 7.5 0.1 0.0 1.6 3.6 1.7 25.1 3.3 2.6 2.1 5.2 2.3 2.1 12.2 0.7 4.0 1.9 0.4 1.4 0.0 4.1 16.2 11.6 0.8 6.9 6.1 12.1 38.6 41.6 10.3 0.0 1.9 2.6 4.0 4.9 32.5 0.2 4.6 1.5 19.1 2.6 6.4 6.8 18.0 0.0 2.5 7.4 1.3 0.3 1.8 0.6 20.1 79.5 1.7 1.8 7.8 8.9 0.9 1.3 4.6 11.3 12.5 0.0 174.3 175.4 147.2 36.6 64.5 22.3 7.7 16.5 25.1 97.9 8.3 11.5 19.6 634.6 31.6 54.9 475.9 26.7 43.3 14.9 9.9 6.8 14.1 15.1 13.0 12.8 10.6 9.5 11.5 12.3 11.3 13.7 25.0 83.3 57.2 22.5 26.2 59.5 54.3 42.4 15.9 5.2 14.2 23.6 20.3 8.6 23.7 3.7 0.0 43.2 256.6 15.7 0.0 3.7 2.1 3.6 10.6 78.0 6.7 10.3 112.7 4.4 67.4 17.5 10.7 7.7 31.6 3.7 47.5 2.3 57.5 0.0 191.6 15.8 18.3 166.7 307.9 2.5 0.6 276.3 24.9 165.8 139.5 0.0 150.4 247.3 93.4 49.2 13.3 0.4 38.5 21.3 13.9 2.2 7.8 0.9 0.0 86.0 12.8 0.5 1.9 20.4 64.6 17.0 59.3 9.2 11.7 40.3 RAN "ARA24, Gsp1, TC4" ENSG00000132341 "RAN, member RAS oncogene family" P62826 12 130872037-130877678 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063353 Enhanced Nucleoplasm No No 4000000 Nucleoplasm "HPA063353: " "unprognostic (2.22e-2)" "unprognostic (5.16e-2)" "unprognostic (2.30e-2)" "unprognostic (3.34e-2)" "unprognostic (1.75e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (9.99e-8)" "unprognostic (2.81e-3)" "unprognostic (1.28e-1)" "unprognostic (5.41e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (7.86e-5)" "prognostic unfavorable (1.46e-7)" "unprognostic (6.55e-2)" "unprognostic (2.79e-1)" "unprognostic (4.62e-1)" "unprognostic (3.16e-2)" 238.1 336.0 205.6 343.2 221.4 409.5 222.7 211.8 267.1 175.9 207.3 271.7 179.4 209.4 240.2 449.1 182.1 150.2 254.6 212.2 244.7 218.8 209.9 227.8 419.8 210.4 213.2 208.7 182.2 194.5 212.4 181.5 245.1 220.0 151.0 269.2 215.1 202.1 156.9 418.4 217.2 221.9 252.3 226.2 257.9 225.3 311.0 227.7 582.9 168.1 387.1 484.5 384.6 246.7 238.3 1391.5 1850.5 1580.8 921.6 707.0 868.2 1219.5 1770.2 926.2 1695.1 1163.1 2003.5 1434.2 2260.7 1169.3 1290.0 1067.9 877.0 2327.1 1854.5 1830.8 766.9 1831.5 1331.9 1318.9 2068.9 864.1 2347.9 1100.3 821.9 1129.3 1470.6 2111.6 1119.9 1671.0 1593.5 2013.6 656.5 1686.3 1688.2 2306.9 2810.1 1857.8 1429.2 2936.2 1773.9 1347.2 1274.4 1608.2 2377.1 1441.5 875.0 1018.5 920.7 1334.4 1299.9 1817.9 1666.5 1157.6 975.6 1495.0 998.8 1694.1 905.2 1605.1 3245.4 1002.2 1410.7 1390.4 285.0 398.0 275.5 501.5 489.3 614.6 726.4 682.5 581.4 531.7 593.3 611.5 585.9 80.7 500.4 481.0 506.9 768.0 1005.0 205.6 221.4 211.8 267.1 212.2 244.7 210.4 213.2 208.7 220.0 226.2 227.7 238.3 321.3 182.7 141.5 18.6 337.4 635.3 693.4 702.0 406.3 155.3 239.0 316.0 112.6 165.8 310.5 169.2 37.5 734.2 273.6 157.0 387.4 642.1 90.2 212.9 280.8 306.2 201.9 540.9 27.8 452.8 1266.0 379.6 181.0 201.3 194.0 273.1 143.8 181.6 624.5 139.7 25.8 300.5 349.9 171.7 424.1 148.1 213.4 239.7 332.6 9.4 417.0 287.5 219.4 19.6 23.5 596.4 189.1 230.9 418.2 954.8 167.2 423.2 214.3 141.6 164.3 286.0 600.8 746.4 571.6 578.0 547.0 613.1 332.3 451.9 403.6 621.0 PRKAA1 AMPKa1 ENSG00000132356 "Protein kinase AMP-activated catalytic subunit alpha 1" Q13131 5 40759379-40798374 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 292.5;Late spermatids: 478.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005050, HPA035409, HPA064946" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390" "unprognostic (2.07e-1)" "unprognostic (1.41e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (3.97e-1)" "unprognostic (1.05e-1)" "unprognostic (3.51e-2)" "unprognostic (7.53e-2)" "unprognostic (1.66e-2)" "unprognostic (2.88e-1)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (2.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-2)" 30.5 21.2 8.8 27.4 10.6 53.1 30.5 11.2 10.7 26.9 12.8 30.3 35.7 26.6 18.8 20.8 21.2 33.8 20.4 8.0 12.2 32.3 50.3 27.6 29.4 12.5 11.4 7.7 19.3 23.3 32.2 9.2 21.3 13.1 32.2 35.0 19.1 27.6 24.9 17.0 23.3 31.1 26.6 11.3 28.1 34.0 41.4 10.8 22.0 32.6 20.1 24.1 29.1 17.9 11.7 28.4 28.9 22.8 30.2 55.0 57.0 21.6 47.3 48.1 34.7 30.8 27.6 35.9 16.6 21.4 48.8 45.3 22.4 21.3 43.1 64.9 49.2 19.2 33.1 66.1 22.1 45.3 31.9 33.5 52.8 20.6 46.5 47.5 38.4 52.1 21.0 15.9 46.7 52.4 13.6 29.7 24.9 9.9 28.9 34.6 24.5 48.7 24.6 53.3 47.5 19.6 19.7 83.0 54.3 28.8 12.3 28.4 26.0 56.0 62.1 33.5 36.2 39.2 18.5 15.4 19.6 38.9 67.9 33.9 17.0 6.5 12.8 8.9 7.9 11.5 8.2 8.4 8.6 6.4 7.9 10.1 9.0 15.4 10.9 9.3 1.9 11.6 6.5 8.8 10.6 11.2 10.7 8.0 12.2 12.5 11.4 7.7 13.1 11.3 10.8 11.7 47.3 41.7 26.5 19.2 34.1 24.1 24.7 40.5 15.4 20.3 36.1 17.9 18.3 42.9 43.4 47.8 35.5 13.8 45.8 44.1 7.9 27.9 292.5 19.7 35.8 42.4 21.1 25.4 24.5 44.9 13.7 36.2 36.7 20.7 18.3 17.8 37.1 83.4 20.0 15.2 30.3 28.8 42.7 25.3 28.5 478.5 30.4 24.1 35.6 24.4 40.9 15.4 44.3 30.7 43.8 36.0 32.8 25.9 23.4 33.4 33.7 35.4 42.9 27.9 0.0 22.7 43.1 82.8 17.6 19.9 32.7 18.6 44.0 19.2 36.9 35.0 CARD6 CINCIN1 ENSG00000132357 "Caspase recruitment domain family member 6" Q9BX69 5 40841308-40860175 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 23.8;Gastric mucus-secreting cells: 26.5;Pancreatic endocrine cells: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 27.4" "Group enriched" "Detected in all" 5 "dendritic cells: 7.7;granulocytes: 27.4;monocytes: 13.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.5;HUVEC TERT2: 34.0;TIME: 36.9" "Low region specificity" "Detected in many" HPA036438 Uncertain NA NA "HPA036438: AB_10670105" "unprognostic (8.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.43e-1)" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (4.15e-2)" "unprognostic (3.12e-2)" "unprognostic (8.97e-2)" "unprognostic (1.50e-2)" "unprognostic (1.49e-1)" "unprognostic (9.37e-2)" "unprognostic (1.00e-1)" "unprognostic (2.93e-2)" "unprognostic (1.11e-2)" "unprognostic (8.88e-3)" 8.6 12.1 1.8 5.6 2.0 3.1 5.9 2.0 2.2 4.8 3.7 2.5 7.9 3.6 1.5 10.7 4.5 11.5 4.3 1.8 4.9 4.1 4.0 9.8 4.8 2.9 2.2 1.3 1.8 3.1 2.2 1.7 6.9 2.5 2.0 2.9 0.7 7.6 2.8 2.1 2.3 5.3 5.0 2.3 13.0 12.2 1.3 3.2 2.4 5.4 5.5 4.5 8.4 4.1 2.9 3.4 5.8 0.8 0.1 13.0 20.5 0.1 1.7 3.1 0.2 0.7 0.6 1.2 6.4 10.8 4.0 6.9 2.1 0.3 8.4 0.7 0.6 1.4 7.7 10.8 0.6 4.1 6.3 14.4 13.2 6.7 7.6 1.7 9.5 34.0 0.1 7.9 1.1 3.0 0.1 0.0 6.1 0.1 3.3 1.7 0.1 0.2 6.6 12.6 7.2 0.0 0.0 9.6 2.8 1.5 0.1 0.3 11.5 36.9 1.6 1.4 0.4 2.4 0.3 0.1 0.8 3.0 13.3 5.9 27.4 11.2 4.1 1.2 11.3 1.0 1.0 1.7 1.1 7.7 2.0 1.6 1.2 10.7 1.8 13.9 3.0 3.6 4.5 1.8 2.0 2.0 2.2 1.8 4.9 2.9 2.2 1.3 2.5 2.3 3.2 2.9 23.8 0.0 17.5 0.0 3.1 1.7 1.5 6.6 5.2 0.0 2.9 2.0 1.4 11.5 6.4 1.8 0.0 0.7 1.8 0.2 0.0 15.9 0.6 5.7 9.6 20.1 0.0 4.8 0.1 14.0 0.8 10.2 26.5 10.3 13.3 0.4 15.4 3.1 9.2 0.0 0.1 0.4 4.1 16.6 1.8 1.0 3.1 14.1 0.0 4.7 11.2 0.7 2.1 0.5 0.1 21.7 1.2 1.2 0.9 0.4 3.2 0.9 4.4 0.0 0.0 1.1 2.7 0.6 0.2 11.3 2.3 0.5 3.0 8.5 1.2 9.1 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037741 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.0;pancreas: 37.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 132.8;Inhibitory neurons: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" NA NA 21000 "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.8 6.5 6.0 4.1 13.1 28.0 4.5 1.2 10.8 3.5 0.0 7.9 8.7 4.1 1.1 3.2 8.2 4.0 14.7 18.3 3.9 5.3 0.6 3.6 2.9 0.1 0.7 9.5 4.6 37.6 4.2 5.1 5.0 3.7 3.8 8.1 7.2 11.0 4.8 0.8 3.1 8.3 3.4 0.0 4.0 22.6 3.2 0.4 2.8 2.5 2.0 2.5 2.0 2.5 11.8 8.1 9.9 1.9 8.1 0.0 0.0 15.9 10.7 5.0 1.3 1.2 21.9 3.5 3.0 2.9 1.4 13.5 11.0 6.4 20.0 0.4 0.0 6.9 3.7 14.1 9.9 1.9 0.8 3.9 0.5 17.0 5.5 13.9 7.2 0.2 3.7 21.4 1.4 0.0 9.1 3.1 2.0 11.7 3.9 9.5 13.4 6.9 7.8 5.9 4.1 21.6 52.3 15.5 15.8 6.9 7.4 7.8 2.3 2.4 9.1 14.3 1.6 9.1 0.0 0.0 1.2 0.5 6.9 15.1 0.9 1.4 2.1 2.8 2.7 1.1 0.2 0.9 2.1 1.0 0.2 0.1 1.0 4.2 1.9 3.9 1.7 1.0 1.4 6.0 13.1 1.2 10.8 18.3 3.9 0.1 0.7 9.5 3.7 0.0 0.4 11.8 1.5 6.4 2.5 13.7 5.6 2.0 6.6 1.8 1.2 23.6 9.9 7.6 20.2 11.5 2.8 12.9 33.3 7.5 27.2 15.2 9.8 6.0 6.1 9.2 6.8 1.6 48.1 0.8 132.8 12.0 6.0 2.2 18.8 9.2 6.3 3.0 3.6 0.8 3.4 37.0 67.9 21.7 8.2 11.1 4.3 8.3 1.8 11.0 3.6 47.8 12.0 2.1 35.0 8.0 4.2 12.4 24.1 1.5 6.4 16.5 5.7 0.8 4.2 4.6 0.0 7.9 2.5 0.4 3.4 2.8 0.4 3.4 8.2 1.5 14.0 11.3 CLUH "CLU1, KIAA0664" ENSG00000132361 "Clustered mitochondria homolog" O75153 17 2689386-2712663 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CACO-2: 266.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031505, HPA044346" Uncertain Supported "Nuclear bodies,Vesicles" NA NA 5500 Vesicles "Nuclear bodies" "HPA031505: AB_2673912, HPA044346: AB_10962153" "unprognostic (3.48e-2)" "unprognostic (3.97e-2)" "unprognostic (9.02e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (2.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.84e-1)" "unprognostic (2.69e-2)" "unprognostic (5.64e-2)" "unprognostic (5.11e-2)" "prognostic favorable (1.92e-5)" "unprognostic (4.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-2)" "unprognostic (6.26e-2)" 28.9 57.2 12.0 18.2 11.1 14.5 28.8 14.6 18.4 18.2 14.4 39.0 47.0 21.4 1.9 68.3 19.4 15.6 65.5 12.8 9.2 50.6 136.1 19.8 14.7 12.8 12.3 12.3 17.1 50.8 15.8 20.5 9.0 13.9 24.9 13.3 7.2 32.4 11.9 128.8 46.8 34.4 8.5 6.7 25.4 35.4 25.4 16.0 6.5 25.4 53.4 11.2 29.8 29.5 12.5 69.5 131.9 8.9 33.3 20.2 14.1 99.9 34.9 13.0 41.9 31.0 266.2 30.0 122.6 41.5 19.4 26.9 127.6 45.3 52.9 14.7 43.6 86.4 68.0 112.2 93.9 17.1 53.7 44.1 22.6 29.7 48.9 24.7 9.4 20.5 43.3 81.8 42.2 11.7 79.8 69.6 58.0 28.2 35.8 67.8 104.7 37.0 70.8 26.0 117.3 43.9 32.6 40.0 129.4 44.4 6.6 72.7 31.3 33.7 33.7 44.9 92.2 80.5 18.2 22.9 49.7 35.4 73.2 41.6 0.0 2.2 0.0 1.7 3.1 1.3 2.2 1.0 0.9 2.4 2.2 2.3 2.1 0.2 0.6 2.0 2.7 1.5 0.9 12.0 11.1 14.6 18.4 12.8 9.2 12.8 12.3 12.3 13.9 6.7 16.0 12.5 5.8 6.4 20.9 20.9 6.5 30.5 12.0 11.7 16.5 18.5 23.5 22.7 42.1 41.5 16.7 18.4 22.9 9.7 7.6 47.8 11.7 18.4 1.8 12.7 10.8 8.5 25.8 22.1 9.9 18.3 8.2 6.8 22.4 24.6 1.3 18.1 6.8 122.1 13.1 8.4 11.4 38.8 14.2 10.3 6.3 4.0 5.0 7.9 21.4 4.7 7.4 6.5 2.1 7.5 6.2 19.6 21.2 6.0 11.7 22.9 39.2 35.1 14.1 17.1 6.6 12.3 11.3 8.6 17.5 42.4 35.5 8.2 7.2 43.3 68.3 22.5 INPP5K SKIP ENSG00000132376 "Inositol polyphosphate-5-phosphatase K" Q9BT40 17 1494577-1516742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Congenital muscular dystrophy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 96.1;Late spermatids: 345.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.47e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.91e-2)" "prognostic favorable (2.33e-5)" "unprognostic (3.25e-1)" "unprognostic (9.22e-2)" "unprognostic (1.50e-1)" "unprognostic (7.50e-2)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.47e-6)" "unprognostic (4.71e-2)" "unprognostic (9.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.20e-2)" "unprognostic (4.28e-3)" "unprognostic (1.04e-1)" 33.0 15.3 24.2 13.0 24.3 34.9 29.4 23.8 30.4 18.7 53.0 19.0 10.3 17.2 13.2 18.0 15.4 10.8 24.9 28.3 24.1 16.9 15.1 27.5 18.8 25.7 25.4 24.0 18.0 22.0 13.8 14.9 18.8 26.0 19.8 12.8 16.0 18.2 13.1 40.8 29.1 19.6 12.1 24.3 23.0 19.3 20.6 24.7 26.0 30.7 25.4 19.9 18.4 18.0 25.5 14.9 24.0 9.2 18.4 22.5 13.2 12.1 12.0 23.6 15.8 19.6 15.7 9.1 14.6 23.2 22.2 12.5 19.4 22.1 9.6 14.3 35.3 33.0 8.6 18.1 5.9 31.3 7.9 17.0 16.2 24.0 15.8 16.1 10.0 25.3 25.3 9.4 25.9 10.6 12.5 24.5 7.1 3.9 23.9 14.6 19.0 6.7 14.6 12.8 10.3 7.1 18.0 10.2 21.6 24.3 13.0 17.9 7.3 16.2 13.6 13.3 19.8 16.8 12.9 23.4 7.4 14.7 9.1 17.3 104.3 42.2 74.3 48.7 41.9 39.7 27.5 44.5 50.2 36.2 24.4 37.5 41.1 74.7 42.3 66.6 27.0 75.1 62.5 24.2 24.3 23.8 30.4 28.3 24.1 25.7 25.4 24.0 26.0 24.3 24.7 25.5 26.1 32.1 14.1 8.5 20.6 30.0 15.7 10.8 18.8 7.8 15.6 12.2 35.8 8.6 11.0 23.9 2.1 13.9 27.5 26.0 13.7 19.4 96.1 10.3 6.9 27.0 17.4 25.2 5.4 24.3 16.4 15.5 13.3 17.4 19.7 7.7 28.5 10.2 11.9 20.2 5.9 17.3 14.2 18.4 19.0 345.7 11.5 13.8 32.0 2.8 37.1 23.1 27.8 2.5 7.0 27.1 23.4 7.5 18.0 13.3 33.2 11.2 6.4 7.9 19.7 12.6 15.3 35.5 20.4 18.1 30.3 31.1 27.2 5.8 13.5 17.4 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555386 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No 47000 Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 12.1 11.1 3.0 13.5 3.1 11.5 16.1 0.9 7.3 13.1 0.4 11.5 9.6 14.7 4.6 17.1 15.3 6.3 10.7 4.7 2.9 8.3 10.9 11.5 13.9 4.9 3.8 3.4 14.2 24.6 6.8 12.8 5.3 3.4 17.2 5.2 3.9 19.0 10.2 28.2 21.3 13.0 7.4 1.3 14.2 12.5 8.1 3.1 7.5 11.3 8.0 8.8 15.0 14.0 3.5 60.1 90.0 11.9 56.2 15.4 17.1 40.8 39.8 17.5 39.5 30.8 67.1 24.4 80.4 47.2 23.9 19.8 74.2 50.1 61.3 19.0 40.3 133.8 38.8 58.3 62.2 25.2 45.5 34.7 25.7 34.6 58.8 29.1 11.0 26.6 45.0 64.2 37.1 18.2 51.4 54.2 19.5 56.0 19.1 48.0 69.8 19.7 54.0 9.8 45.5 25.5 48.5 40.8 29.7 28.2 8.6 27.5 19.1 34.3 35.1 31.5 32.7 118.6 32.1 26.5 34.4 32.5 53.9 45.3 0.0 1.9 0.3 2.8 1.6 3.4 2.9 2.3 3.1 2.9 1.7 2.5 2.8 0.1 2.4 3.4 2.1 1.0 2.7 3.0 3.1 0.9 7.3 4.7 2.9 4.9 3.8 3.4 3.4 1.3 3.1 3.5 13.4 9.6 14.5 4.6 13.1 12.9 6.8 7.1 12.0 8.2 12.9 14.4 4.1 8.6 13.3 3.7 12.5 2.9 5.8 9.2 0.0 7.7 0.5 6.7 15.3 17.0 11.4 7.2 11.3 12.7 5.4 10.2 10.7 8.5 5.1 12.2 8.6 7.8 6.5 10.1 6.1 8.0 4.1 4.5 6.8 0.6 5.6 6.3 3.6 7.5 3.8 3.8 6.2 3.5 6.5 8.2 4.5 12.0 13.7 13.9 4.6 3.2 12.2 6.2 6.6 10.8 12.9 2.6 11.1 12.8 11.9 1.1 9.7 13.8 12.4 6.2 RPA1 "HSSB, REPA1, RF-A, RP-A, RPA70" ENSG00000132383 "Replication protein A1" P27694 17 1829702-1900082 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004563, HPA006914, HPA046497" Supported Enhanced Nucleoplasm NA NA 82000 Nucleoplasm "CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675" "unprognostic (1.84e-1)" "unprognostic (1.47e-2)" "unprognostic (7.38e-2)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (6.58e-3)" "prognostic unfavorable (9.00e-9)" "unprognostic (9.59e-2)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" "unprognostic (6.03e-3)" "unprognostic (1.75e-2)" "unprognostic (3.37e-2)" "unprognostic (2.19e-1)" "unprognostic (6.57e-2)" "unprognostic (2.62e-1)" "unprognostic (4.52e-2)" 19.5 17.9 14.5 22.7 16.0 22.2 20.9 18.4 16.5 21.5 15.7 19.9 21.0 23.0 17.6 23.6 25.7 15.7 27.0 14.6 18.4 14.8 17.3 17.3 36.1 15.5 16.3 13.8 32.1 15.4 19.1 14.9 17.1 17.5 22.4 17.3 22.6 22.0 22.0 52.8 26.1 20.8 22.1 17.4 22.0 17.1 14.6 15.6 38.0 23.4 34.6 38.1 22.3 19.8 19.3 93.5 90.7 77.9 76.2 35.3 35.9 88.1 73.5 40.7 85.1 87.7 132.0 41.2 128.4 68.1 41.3 34.9 83.4 93.4 58.3 93.5 86.3 116.3 77.8 113.6 51.0 23.4 57.7 65.5 29.9 37.0 84.1 36.2 30.1 62.9 77.0 75.8 72.4 60.2 47.8 127.3 33.7 63.5 58.2 53.2 173.8 44.0 72.1 37.3 62.3 34.9 54.7 103.9 35.1 63.8 52.0 75.1 43.4 56.2 66.5 56.7 75.3 113.9 19.8 56.5 76.0 46.5 88.6 82.2 43.2 25.0 54.5 53.1 36.4 54.2 51.2 55.1 53.0 30.2 35.8 53.0 48.4 11.9 80.8 47.8 31.7 56.7 60.5 14.5 16.0 18.4 16.5 14.6 18.4 15.5 16.3 13.8 17.5 17.4 15.6 19.3 14.9 9.6 14.7 12.4 24.3 29.6 16.3 22.4 17.6 19.2 25.1 21.0 23.7 22.8 14.4 40.5 4.2 69.4 27.0 13.5 5.9 20.6 18.9 13.4 16.6 21.7 15.6 67.6 12.2 19.8 68.9 23.2 7.7 14.2 33.7 25.0 25.4 24.2 46.1 37.0 14.0 19.3 26.4 49.1 14.6 42.4 32.3 35.1 28.4 14.0 37.6 39.7 35.0 12.1 18.2 15.0 7.2 34.6 23.0 14.1 24.6 11.7 19.4 19.5 0.0 19.2 21.5 14.7 21.8 24.3 29.1 43.5 30.3 15.6 23.1 11.7 SERPINF1 "EPC-1, PEDF, PIG35" ENSG00000132386 "Serpin family F member 1" P36955 17 1762029-1777565 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 1550.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7" "Cancer enhanced" "Detected in all" "liver cancer: 245.2" "Region enhanced" "Detected in all" "hippocampal formation: 93.8" "Immune cell enriched" "Detected in many" 18 "plasmacytoid DC: 1454.4" "Lineage enriched" "Detected in all" 121 "dendritic cells: 1454.4" "Group enriched" "Detected in many" 4 "ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005825 Uncertain "Secreted to blood" NA NA 9290000000 44000000000 "HPA005825: AB_1079921" "unprognostic (3.85e-1)" "prognostic favorable (5.49e-4)" "unprognostic (9.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.32e-3)" "unprognostic (2.33e-1)" "unprognostic (7.88e-2)" "unprognostic (5.92e-2)" "unprognostic (1.69e-1)" "unprognostic (4.18e-2)" "prognostic unfavorable (1.40e-8)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (4.53e-3)" "unprognostic (1.25e-3)" 532.5 58.0 14.6 125.3 16.6 12.0 494.4 21.8 33.6 537.0 1550.0 127.1 42.3 361.2 91.0 110.2 562.2 564.6 287.6 93.8 9.7 34.4 982.8 160.2 134.6 8.9 17.6 15.7 411.8 209.4 11.3 62.9 314.3 7.7 204.5 52.5 61.9 125.6 106.8 438.4 161.5 132.8 223.6 8.0 134.2 125.8 280.2 21.9 107.2 194.7 469.6 118.7 326.5 275.8 20.6 0.5 3.7 2.8 2.0 1232.0 956.3 20.4 56.8 49.8 0.6 0.0 9.7 0.5 2.3 1.9 71.8 0.3 3.2 86.0 4.4 0.0 0.6 46.0 1.0 1.2 606.0 410.6 1.1 1.1 1313.4 6.9 0.9 1.1 11.4 0.6 4.2 117.5 0.4 63.2 0.2 7.0 7.2 30.7 0.3 1.0 2.9 219.9 1.6 0.1 6.0 1.9 42.2 0.7 0.7 57.0 3.4 6.7 184.2 2.0 0.5 17.6 14.1 1.2 0.7 2.4 28.1 1.7 0.6 0.8 0.1 12.0 1.1 0.6 4.4 0.4 9.0 0.7 0.9 79.8 5.2 2.0 5.5 1.7 1.3 0.2 1454.4 0.8 14.2 14.6 16.6 21.8 33.6 93.8 9.7 8.9 17.6 15.7 7.7 8.0 21.9 20.6 59.0 3.2 10.4 0.3 10.8 95.0 238.0 697.8 27.9 59.3 6.7 71.2 12.1 11.5 167.7 1.8 223.1 795.6 226.1 0.0 0.0 0.3 11.2 12.5 372.4 26.2 0.0 19.2 5.3 24.5 98.7 951.9 11.2 6.7 22.9 1.7 28.2 765.0 151.6 3.3 2.6 0.0 366.2 60.4 262.6 53.0 1818.0 79.0 108.5 9.4 79.0 11.6 1.0 0.5 2.0 6.8 0.1 1045.7 7.0 155.5 0.2 27.3 105.5 39.1 19.7 193.3 202.8 12.7 8.7 4.5 78.6 534.8 14.3 10.2 0.3 47.7 UBE2G1 "UBC7, UBE2G" ENSG00000132388 "Ubiquitin conjugating enzyme E2 G1" P62253 17 4269259-4366628 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 212.2" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 286.0;Late spermatids: 248.3;Suprabasal keratinocytes: 239.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045681, HPA050551" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045681: AB_2679417, HPA050551: AB_2681171" "unprognostic (1.57e-3)" "unprognostic (1.94e-1)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "unprognostic (5.16e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (5.13e-2)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (3.97e-2)" "unprognostic (6.50e-2)" 21.2 19.2 18.8 25.6 22.8 31.8 20.3 22.5 23.4 19.6 14.0 33.5 22.7 22.9 14.9 52.6 16.5 16.1 34.9 18.6 20.4 27.3 30.6 15.7 39.1 22.9 21.5 15.5 15.7 18.6 21.6 9.8 19.1 24.0 22.8 24.4 17.7 21.2 21.0 212.2 27.7 23.8 27.5 23.4 20.9 22.0 23.4 22.5 25.2 16.2 84.8 46.8 24.7 32.4 28.7 54.5 57.8 52.7 38.9 42.2 44.3 74.9 51.7 41.4 48.2 42.1 40.0 27.0 84.5 52.8 51.2 39.4 57.2 66.3 48.1 77.2 44.8 53.9 31.7 28.6 45.9 41.3 46.5 57.4 38.0 70.3 45.8 66.1 33.8 65.6 55.8 56.5 88.9 40.1 24.3 59.4 42.5 58.2 40.1 29.6 76.1 27.9 78.1 56.4 35.1 22.7 42.3 48.9 41.8 41.6 77.4 41.1 29.9 49.6 48.1 36.8 57.0 58.7 34.3 43.8 118.9 36.9 42.8 37.7 13.3 15.8 39.0 22.2 16.8 29.9 34.1 28.3 29.1 20.2 24.4 28.3 28.9 28.1 32.5 18.6 14.8 28.9 21.8 18.8 22.8 22.5 23.4 18.6 20.4 22.9 21.5 15.5 24.0 23.4 22.5 28.7 28.3 22.4 14.4 31.3 70.6 286.0 36.5 47.8 111.5 18.8 47.0 31.0 67.6 27.1 32.2 25.8 6.2 47.0 47.8 41.4 82.2 30.9 139.5 36.7 25.7 35.5 38.4 26.5 47.9 26.7 59.6 31.1 32.6 39.9 21.0 13.9 31.1 62.3 48.1 15.2 46.3 38.3 44.7 36.5 81.1 248.3 19.6 35.7 67.6 30.9 43.1 28.7 36.0 36.2 84.4 43.0 30.4 21.1 154.3 65.7 40.4 75.6 35.4 17.1 6.6 25.9 43.5 70.8 50.8 85.3 239.7 66.8 58.2 13.8 30.1 54.0 EEFSEC "EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153481-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 71.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 12.4 8.3 0.2 0.2 0.1 0.1 12.6 0.1 0.6 14.0 0.1 10.8 0.0 15.7 0.0 12.4 14.0 0.1 21.1 0.2 0.2 14.3 22.0 9.7 2.2 0.4 0.1 0.1 12.4 11.8 3.0 8.9 1.6 0.2 12.2 0.6 0.5 9.8 2.0 24.2 16.4 10.8 0.0 0.1 13.5 11.1 19.4 0.3 0.1 9.9 0.0 1.2 12.8 12.4 0.4 0.5 0.1 4.1 1.7 0.1 0.2 0.5 0.0 0.3 0.2 0.2 0.3 6.9 15.2 0.1 3.8 12.3 1.1 0.4 0.1 0.1 0.3 0.3 0.0 0.1 0.1 5.7 0.3 0.3 0.1 0.1 4.0 0.1 0.2 0.3 0.0 0.1 0.2 3.5 0.2 7.9 0.4 0.4 0.1 0.1 0.3 0.2 1.0 0.0 0.0 0.3 10.4 0.0 17.7 15.4 0.3 9.6 0.7 0.0 0.1 0.0 0.2 0.2 0.4 0.7 0.4 0.1 0.4 0.2 0.4 6.3 6.1 5.0 6.0 3.9 5.4 4.4 4.4 8.7 3.9 4.0 5.0 0.0 7.5 4.8 3.7 5.7 4.3 0.2 0.1 0.1 0.6 0.2 0.2 0.4 0.1 0.1 0.2 0.1 0.3 0.4 9.4 0.0 6.0 15.0 17.2 6.4 9.3 9.1 7.4 7.8 6.9 8.6 10.1 8.6 4.4 16.5 2.1 22.3 15.7 6.4 15.6 7.9 27.7 3.1 12.5 8.2 11.4 5.9 25.3 7.1 18.3 10.0 10.2 4.5 28.5 10.0 8.9 14.8 14.6 13.5 36.6 11.7 18.3 7.9 8.2 71.6 13.1 11.4 12.4 28.1 9.8 9.3 17.5 45.8 27.1 5.6 2.7 8.6 17.1 9.4 8.6 25.7 2.7 8.2 26.3 9.0 9.1 27.9 16.9 10.8 9.9 29.7 13.7 11.9 10.6 6.0 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 197.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: AB_2685833" "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favorable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 26.5 42.4 42.2 31.8 41.5 16.0 27.9 39.7 43.2 19.4 47.0 26.7 23.0 21.1 23.1 34.3 23.7 17.1 30.7 42.1 43.3 44.2 27.6 24.6 30.0 49.5 44.2 39.0 28.9 19.7 42.3 27.3 24.0 43.8 24.8 26.5 18.7 32.0 20.4 52.1 49.9 26.2 23.1 44.0 35.2 59.0 30.2 46.8 40.5 19.3 41.7 27.2 20.0 22.4 44.6 34.5 36.8 40.4 45.5 32.8 27.4 24.5 27.0 29.3 24.7 21.1 38.3 69.8 54.9 15.6 32.5 62.8 24.5 68.4 61.7 30.0 15.5 22.2 91.8 23.8 40.4 22.7 42.0 197.9 21.3 85.8 23.4 38.3 31.5 23.5 51.2 88.6 19.3 30.2 22.3 64.9 42.5 54.9 41.1 40.8 80.2 53.2 59.9 36.8 23.9 61.6 44.0 22.4 24.1 84.3 31.2 33.3 39.4 23.7 27.2 20.5 24.0 40.3 36.7 91.6 55.7 25.4 53.2 26.6 2.6 13.2 5.6 8.6 8.2 13.1 8.1 9.3 9.3 10.7 8.3 6.9 6.6 40.6 8.6 3.9 11.5 11.9 10.8 42.2 41.5 39.7 43.2 42.1 43.3 49.5 44.2 39.0 43.8 44.0 46.8 44.6 8.4 6.4 17.7 22.5 15.5 9.1 7.0 15.8 15.9 10.2 21.1 16.3 4.6 10.0 14.8 14.7 14.6 12.5 16.3 17.7 19.6 11.5 68.0 12.3 10.3 7.8 6.6 7.2 25.6 10.2 7.1 9.5 14.8 11.9 7.6 18.9 8.2 24.4 26.0 25.2 25.1 15.7 10.2 33.6 8.7 41.0 7.2 27.8 19.6 27.2 24.4 13.4 16.5 51.8 27.0 11.8 14.2 8.6 15.4 12.9 12.8 19.8 10.7 6.6 0.0 12.7 7.1 17.7 18.0 19.8 11.9 16.4 16.3 12.5 19.9 10.1 TMEM128 MGC13159 ENSG00000132406 "Transmembrane protein 128" Q5BJH2 4 4235542-4248223 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044809 Uncertain NA NA "HPA044809: AB_10963539" "unprognostic (4.97e-2)" "unprognostic (4.32e-2)" "unprognostic (3.23e-2)" "unprognostic (3.65e-1)" "unprognostic (2.39e-1)" "unprognostic (2.10e-1)" "unprognostic (2.94e-2)" "unprognostic (8.81e-2)" "unprognostic (1.09e-1)" "unprognostic (9.11e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (2.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" 22.7 27.4 25.8 15.5 27.9 8.5 33.3 28.0 31.7 25.5 25.7 23.4 20.9 27.5 47.4 20.6 29.4 17.1 23.1 25.1 28.7 33.8 19.8 25.2 23.5 29.1 28.7 25.0 36.9 21.5 45.1 17.9 27.1 28.6 27.0 25.2 16.4 22.2 25.7 14.5 22.6 19.6 16.6 29.1 22.4 23.9 25.5 28.0 23.8 37.5 15.4 23.4 18.1 18.6 33.3 15.7 12.0 43.7 33.3 34.8 29.0 31.1 33.2 37.2 34.8 33.0 13.5 60.9 9.1 17.0 29.6 33.0 13.3 21.1 22.5 33.0 25.0 13.1 17.1 8.8 19.0 48.9 41.4 30.0 40.6 38.7 13.5 27.0 31.1 20.9 29.9 24.7 17.9 40.7 17.1 34.0 55.3 36.3 22.8 23.4 13.2 17.5 19.7 52.9 24.4 24.5 39.6 13.5 12.9 41.2 28.6 44.4 40.5 20.5 32.8 13.8 30.9 35.0 49.8 43.9 30.6 34.2 28.6 40.7 25.7 36.5 42.8 36.3 50.4 45.8 38.1 43.9 36.2 38.1 34.3 59.0 49.9 17.4 45.6 45.0 61.5 36.7 37.9 25.8 27.9 28.0 31.7 25.1 28.7 29.1 28.7 25.0 28.6 29.1 28.0 33.3 20.7 12.8 22.7 8.8 13.8 17.8 20.3 63.5 12.0 9.9 25.5 22.0 9.1 24.3 30.5 31.3 2.1 45.3 17.3 24.2 29.4 28.7 25.9 16.3 19.6 18.6 17.3 15.2 11.1 23.7 44.4 23.1 7.1 14.6 15.8 14.3 27.8 18.2 30.2 13.5 12.3 23.2 28.5 23.5 14.0 8.9 40.7 14.9 39.2 10.3 25.2 26.4 23.7 14.1 24.5 18.2 33.9 37.6 5.7 24.0 24.9 38.3 32.6 11.7 46.0 18.9 20.3 76.7 34.4 12.8 25.1 43.8 16.3 17.0 17.7 20.6 COQ3 bA9819.1 ENSG00000132423 "Coenzyme Q3, methyltransferase" Q9NZJ6 6 99369401-99394195 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 51.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 42.8;Distal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031273, HPA031274" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA031273: AB_10611107, HPA031274: AB_10602176" "unprognostic (1.81e-2)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (4.62e-2)" "unprognostic (2.41e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.40e-1)" "unprognostic (8.77e-2)" "unprognostic (9.78e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.86e-5)" "unprognostic (4.61e-2)" "unprognostic (1.81e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" 6.4 10.2 14.3 5.3 14.8 4.6 8.7 15.5 18.1 5.6 14.4 10.8 8.3 5.3 7.7 9.4 5.2 3.5 26.9 14.4 14.8 12.1 15.2 3.5 5.7 14.6 14.8 14.3 6.8 6.7 14.3 8.5 3.0 14.6 7.8 12.7 12.0 9.7 8.5 37.7 7.0 6.6 6.4 14.6 6.4 7.4 3.0 14.6 7.9 5.3 51.6 7.1 6.9 6.5 14.5 20.2 11.4 13.5 19.2 8.6 9.6 18.4 17.0 10.5 25.2 29.0 15.9 8.5 19.6 11.1 12.8 16.3 18.3 22.7 26.6 30.6 21.0 29.1 24.1 15.5 17.1 11.3 35.0 9.0 6.1 16.0 14.9 14.9 5.5 15.6 23.8 37.2 14.5 13.6 19.8 15.5 29.0 16.4 19.7 21.7 7.5 13.8 26.1 19.9 17.3 21.0 11.2 11.8 18.0 22.9 9.0 22.1 22.8 5.6 10.9 16.0 17.0 26.4 5.1 10.0 30.9 14.0 33.6 16.4 14.1 2.9 2.4 5.0 6.9 5.8 5.6 6.4 8.1 7.3 2.5 10.5 7.8 0.4 10.1 6.1 4.9 5.2 4.7 14.3 14.8 15.5 18.1 14.4 14.8 14.6 14.8 14.3 14.6 14.6 14.6 14.5 4.7 3.2 3.7 6.5 3.9 4.5 6.8 26.1 7.4 8.1 5.0 6.3 42.8 5.7 11.2 3.7 0.0 14.0 2.2 3.7 33.2 11.5 0.5 3.5 4.9 5.5 0.0 8.2 10.6 10.5 13.3 5.9 3.6 2.6 1.3 6.6 3.3 8.6 6.8 6.7 13.2 7.3 24.4 1.3 3.5 0.3 8.1 2.4 5.4 1.0 2.0 13.2 4.1 4.5 7.6 9.2 5.8 6.0 4.7 2.4 5.2 12.0 4.9 8.7 6.6 6.5 10.6 3.6 10.9 8.0 4.3 6.3 3.7 11.1 9.8 4.7 PNISR "bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130" ENSG00000132424 "PNN interacting serine and arginine rich protein" Q8TF01 6 99397629-99425331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038796, HPA075076" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA038796: AB_10672652, HPA075076: " "unprognostic (2.95e-1)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (9.72e-3)" "unprognostic (1.68e-2)" "unprognostic (8.55e-3)" "unprognostic (4.41e-2)" "unprognostic (1.58e-3)" "unprognostic (5.82e-2)" "unprognostic (4.32e-3)" "prognostic favorable (5.27e-4)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (3.43e-2)" "unprognostic (2.59e-1)" "unprognostic (8.89e-2)" "prognostic favorable (1.09e-4)" 66.7 69.4 59.4 52.4 60.4 107.7 75.9 78.6 90.6 100.8 65.8 97.1 51.8 80.3 94.4 52.2 94.0 38.6 76.6 56.6 51.5 67.4 62.7 75.1 79.4 60.1 55.7 51.7 124.0 66.5 38.7 112.8 36.7 61.7 92.0 49.8 103.0 77.2 48.6 90.1 61.5 94.9 49.8 51.4 91.4 77.7 39.7 58.1 51.9 115.5 31.5 55.4 82.3 81.0 62.7 26.7 19.5 98.8 72.0 35.3 46.8 45.8 44.1 22.8 25.6 29.9 33.3 49.2 85.8 26.6 25.3 28.7 41.9 49.3 33.3 45.2 75.0 48.8 52.6 105.0 30.6 22.2 73.0 67.9 51.8 50.0 27.4 37.5 95.7 34.2 44.8 59.3 52.5 31.3 25.2 31.8 71.2 55.2 24.5 15.3 62.1 29.6 32.4 47.1 47.1 43.4 51.9 21.7 23.6 35.3 75.4 32.8 58.6 45.0 25.2 28.9 25.7 37.2 35.9 24.3 70.5 37.5 68.3 27.0 12.3 10.8 11.9 12.5 6.4 13.0 19.3 12.0 10.4 5.0 25.8 17.9 16.6 30.0 23.5 7.7 19.6 12.4 3.7 59.4 60.4 78.6 90.6 56.6 51.5 60.1 55.7 51.7 61.7 51.4 58.1 62.7 175.8 185.9 237.6 356.2 375.8 195.3 357.3 250.5 165.6 546.2 143.9 192.5 121.2 137.2 215.7 178.4 446.2 158.3 336.4 152.4 74.3 130.8 17.0 132.2 185.7 210.7 247.8 194.4 241.5 104.5 102.1 240.1 100.9 140.5 190.5 344.5 135.7 109.4 99.7 498.0 257.4 129.6 199.4 128.0 236.8 47.9 593.3 152.1 167.2 193.9 261.6 223.6 375.9 270.4 252.6 133.1 176.2 441.2 209.8 293.6 205.8 58.6 179.6 419.9 249.8 288.7 236.3 342.6 181.3 115.5 173.6 180.9 283.8 363.3 151.3 352.4 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105157900-105180014 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 97.0;tongue: 29.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 42.8;Early spermatids: 88.0;Excitatory neurons: 16.6;Late spermatids: 18.2;Oligodendrocytes: 15.0;Skeletal myocytes: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.9;RH-30: 15.8;SH-SY5Y: 15.4;U-87 MG: 14.2;WM-115: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012514 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.5 0.3 6.2 0.3 7.3 0.0 0.2 6.3 9.3 0.4 5.3 1.8 0.1 0.9 1.5 1.9 0.4 0.7 20.9 7.0 6.6 0.0 0.0 0.1 0.1 7.1 7.1 5.7 0.2 0.1 0.1 4.4 0.7 7.0 0.8 0.0 0.5 1.3 0.3 97.0 0.1 0.5 0.0 7.1 0.0 3.2 4.0 6.6 0.0 0.2 29.8 0.0 1.3 0.4 10.5 1.3 1.6 0.5 0.2 2.7 6.8 0.6 2.9 2.5 4.5 5.2 0.0 1.6 0.1 1.1 5.5 25.9 0.0 1.7 1.5 3.6 0.0 4.1 0.0 1.1 0.0 0.1 0.0 0.0 2.3 0.3 7.5 1.0 1.4 0.3 0.1 3.4 7.0 12.8 0.0 0.0 1.5 3.0 0.0 6.3 0.5 15.8 0.0 0.0 0.0 7.5 15.4 0.0 0.1 11.5 1.4 0.0 6.2 6.5 3.4 0.0 2.1 10.7 0.0 0.0 0.0 14.2 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.3 6.3 9.3 7.0 6.6 7.1 7.1 5.7 7.0 7.1 6.6 10.5 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 42.8 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 88.0 1.5 1.0 0.4 0.0 0.0 16.6 0.0 1.2 2.0 0.0 5.6 0.0 0.1 0.0 0.0 0.3 0.0 4.9 0.0 2.0 0.0 0.0 18.2 0.6 0.7 0.0 2.8 2.0 0.0 0.0 0.5 15.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 32.0 3.5 2.9 5.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 SEC61G SSS1 ENSG00000132432 "SEC61 translocon subunit gamma" P60059 7 54752250-54759974 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enriched" "Detected in all" 5 "glioma: 333.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053196 Uncertain NA NA 37000 "HPA053196: AB_2682077" "unprognostic (1.39e-2)" "unprognostic (4.51e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.64e-7)" "prognostic unfavorable (3.85e-6)" "unprognostic (2.09e-2)" "unprognostic (2.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (6.60e-8)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (7.95e-3)" "unprognostic (8.43e-2)" 150.7 165.0 91.5 144.6 90.6 172.6 171.8 93.5 112.2 179.1 102.6 191.5 117.6 128.9 345.2 170.9 133.1 100.4 199.5 90.3 95.2 166.5 223.3 145.5 129.0 93.2 91.1 88.6 121.9 314.3 102.4 255.3 116.5 91.5 145.0 164.1 83.1 161.8 122.1 149.5 112.0 127.5 143.6 93.4 141.7 150.5 111.6 93.3 132.1 161.0 127.8 157.8 136.1 135.5 95.9 448.7 256.0 343.4 384.8 339.4 415.5 216.8 705.5 430.3 352.0 647.6 378.3 294.7 383.8 355.2 517.5 758.6 332.9 285.5 491.4 749.5 328.2 249.7 250.0 571.0 439.5 495.2 457.8 248.9 318.2 418.6 364.5 623.2 491.9 479.3 246.2 375.2 950.4 755.2 232.8 243.1 785.9 497.1 547.5 414.9 180.4 206.4 655.7 435.6 281.6 328.5 400.7 287.3 678.0 324.3 602.4 347.0 435.6 405.2 323.1 423.5 1273.5 526.0 385.8 392.5 737.5 672.8 256.9 639.4 294.5 135.4 119.7 145.8 141.0 201.1 144.6 166.5 156.3 154.9 105.5 116.8 140.5 45.1 124.5 156.1 696.8 168.7 136.4 91.5 90.6 93.5 112.2 90.3 95.2 93.2 91.1 88.6 91.5 93.4 93.3 95.9 258.9 99.3 139.0 10.4 318.3 378.8 264.8 1105.6 180.4 51.0 330.4 343.8 235.2 283.1 456.4 252.0 8.4 282.2 361.6 467.4 602.6 646.0 67.0 317.2 405.1 256.9 306.5 224.3 8.1 1006.7 775.2 325.7 311.4 524.7 147.2 190.2 267.0 706.0 472.5 23.5 13.1 735.0 506.6 333.3 450.8 46.8 251.0 258.2 498.0 13.1 537.4 166.1 292.5 6.6 12.5 814.2 476.0 222.7 962.7 544.6 544.6 652.0 343.1 45.4 111.7 229.4 500.1 287.6 233.4 290.4 463.9 507.3 257.1 192.2 423.4 362.5 LANCL2 "GPR69B, TASP" ENSG00000132434 "LanC like 2" Q9NS86 7 55365337-55433737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 52.5;Late spermatids: 55.3;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 67.3" "Group enriched" "Detected in all" 5 "glioma: 52.5;testis cancer: 19.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 8 "A-431: 144.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019711, HPA029535" Uncertain Supported Nucleoplasm,Cytosol NA NA 13000 "Nucleoplasm, Cytosol" "HPA019711: AB_1852699, HPA029535: AB_10602342" "unprognostic (1.11e-1)" "unprognostic (6.89e-2)" "unprognostic (7.28e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.89e-4)" "unprognostic (1.35e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.03e-6)" "unprognostic (4.58e-3)" "unprognostic (1.04e-2)" "unprognostic (3.94e-1)" "unprognostic (1.45e-1)" 3.9 6.2 18.0 2.6 19.6 4.0 5.9 12.3 19.3 5.8 9.3 4.8 5.2 10.5 5.1 4.1 5.4 3.8 4.2 21.7 15.5 6.0 5.0 3.1 3.5 13.5 13.6 17.7 9.2 4.7 9.3 6.1 4.0 13.7 5.8 4.7 8.5 4.7 6.5 7.1 5.5 5.0 6.7 13.3 3.7 4.5 6.2 14.3 4.7 6.6 5.2 2.9 3.9 4.1 18.1 144.8 4.9 9.7 6.6 2.9 5.0 5.4 6.4 7.6 9.7 8.2 5.0 4.1 10.1 5.9 9.3 9.7 6.4 5.2 3.5 5.9 4.4 10.4 3.6 3.8 5.1 5.1 11.2 6.4 9.0 3.7 7.2 2.3 5.1 4.8 4.7 6.4 6.4 9.1 4.4 2.9 5.2 18.8 3.9 6.1 4.3 4.5 5.0 6.3 11.3 16.9 16.0 9.3 13.6 3.9 3.6 5.6 11.8 8.1 6.1 8.3 11.6 12.5 6.1 7.8 10.6 4.8 2.5 11.8 0.1 1.5 0.3 1.0 1.9 1.7 1.1 1.3 1.5 1.9 1.0 1.2 1.0 0.2 1.5 1.4 1.5 2.6 1.1 18.0 19.6 12.3 19.3 21.7 15.5 13.5 13.6 17.7 13.7 13.3 14.3 18.1 3.0 3.2 8.9 28.7 5.9 4.0 6.3 5.5 5.7 8.9 6.8 6.7 9.4 10.0 5.1 11.0 6.2 12.5 5.1 8.8 5.9 7.1 52.5 6.7 11.2 5.4 12.6 12.6 41.7 12.2 12.1 16.3 5.1 7.7 11.4 10.2 7.1 10.0 7.7 15.2 39.6 9.1 4.1 7.3 4.8 55.3 9.0 5.4 0.0 8.4 9.5 10.8 6.2 52.8 67.3 7.8 7.6 7.5 5.1 5.5 9.8 27.7 7.7 7.6 0.0 19.4 5.9 22.7 17.8 7.5 3.8 19.0 4.3 12.8 9.7 6.0 FIGNL1 ENSG00000132436 "Fidgetin like 1" Q6PIW4 7 50444128-50542535 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA055542 Approved NA NA "HPA055542: AB_2682841" "unprognostic (4.62e-2)" "unprognostic (8.76e-2)" "unprognostic (3.99e-3)" "unprognostic (1.18e-2)" "unprognostic (1.18e-1)" "unprognostic (8.73e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.15e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (4.79e-2)" "prognostic unfavorable (9.54e-7)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" 4.5 4.2 4.5 8.5 5.9 8.7 8.8 6.6 5.2 5.5 2.2 6.3 6.9 8.6 4.8 9.1 4.8 4.6 3.9 4.6 4.8 3.5 4.7 3.4 10.4 4.8 4.6 4.5 11.4 2.8 3.8 2.6 5.3 5.1 6.0 6.5 9.7 3.9 4.5 6.5 8.7 6.4 10.0 4.3 7.8 4.3 7.3 5.1 10.3 3.7 8.1 13.4 3.6 4.9 6.1 12.9 25.8 33.0 36.1 7.4 13.3 21.1 43.8 22.3 46.0 50.9 40.6 28.5 49.1 22.9 13.1 38.3 43.6 35.3 21.9 73.0 42.0 26.5 21.8 53.7 14.2 4.5 52.5 33.4 6.1 10.7 30.4 15.6 7.3 48.8 22.1 51.5 30.0 35.3 19.1 32.1 38.8 30.2 48.6 30.4 29.8 28.5 17.9 14.3 32.7 37.6 29.2 16.3 35.5 16.6 15.4 34.8 17.4 19.0 0.1 19.2 55.9 36.4 50.5 56.5 38.1 14.7 47.2 73.4 0.0 1.1 0.8 1.7 2.0 3.0 3.4 2.0 3.4 1.2 4.0 3.0 2.9 0.6 3.8 6.1 1.2 4.1 1.5 4.5 5.9 6.6 5.2 4.6 4.8 4.8 4.6 4.5 5.1 4.3 5.1 6.1 3.4 0.0 0.5 3.9 7.8 4.1 1.9 3.2 8.6 10.8 4.3 3.9 17.2 2.8 2.3 1.8 6.2 7.0 6.0 1.7 3.9 3.0 1.1 3.3 5.6 4.4 0.0 17.9 11.0 1.2 9.8 5.7 2.6 6.0 2.5 21.3 3.9 2.1 4.6 10.1 7.6 1.3 4.1 2.9 4.2 1.4 11.5 2.9 3.6 4.7 4.4 6.0 7.2 6.6 11.1 2.3 2.8 9.4 8.6 0.7 1.5 2.2 0.8 14.9 0.0 6.0 4.3 27.6 20.4 7.7 3.0 1.4 5.5 9.9 4.0 1.2 DDC AADC ENSG00000132437 "Dopa decarboxylase" P20711 7 50458436-50565405 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 167.2;kidney: 317.9;retina: 177.1" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9" "Region enhanced" "Detected in many" "midbrain: 28.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "midbrain: 74.5;pons: 29.4" HPA017742 Enhanced Approved "Actin filaments" NA NA 120000 "Actin filaments" "HPA017742: AB_1847832" "unprognostic (1.04e-1)" "unprognostic (3.68e-2)" "unprognostic (2.57e-2)" "unprognostic (3.49e-5)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-1)" "unprognostic (5.15e-2)" "unprognostic (4.69e-2)" "unprognostic (5.44e-2)" "unprognostic (9.36e-3)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-1)" "unprognostic (3.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.16e-1)" 0.5 49.3 0.4 2.3 0.6 0.0 1.0 0.0 1.3 0.0 0.2 36.9 156.2 0.0 9.2 0.1 0.0 0.2 0.0 0.1 1.9 317.9 55.1 2.1 0.1 6.2 28.5 0.0 0.8 15.9 0.0 0.0 0.0 15.4 0.6 37.8 177.1 0.0 0.0 0.0 0.0 167.2 1.7 0.0 0.1 18.3 1.5 9.6 0.0 0.2 0.0 0.0 0.0 0.1 6.4 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 54.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 83.6 0.0 0.0 0.0 0.7 1.3 0.0 130.9 135.9 0.0 4.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 1.3 0.1 1.9 6.2 28.5 0.0 15.4 0.0 9.6 6.4 0.0 0.0 12.2 0.0 2.5 0.0 0.0 0.0 0.0 89.3 0.1 0.1 0.4 2.8 0.6 3.7 41.7 0.0 0.0 34.4 25.4 0.1 6.6 0.1 0.0 1.8 410.3 0.0 0.3 0.9 0.1 0.1 0.0 0.4 0.0 0.0 1.1 67.2 0.1 3.3 0.4 67.8 0.0 1.3 0.0 5.4 0.0 2.5 0.0 0.0 0.0 45.1 0.0 0.0 0.1 0.2 31.8 0.0 0.0 0.3 391.5 429.5 0.0 498.9 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.1 1.3 0.1 88.7 0.2 FTHL17 CT38 ENSG00000132446 "Ferritin heavy chain like 17" Q9BXU8 X 31071233-31072041 "Predicted intracellular proteins" "Iron storage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 4.0" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 18.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRSF1 ENSG00000132463 "G-rich RNA sequence binding factor 1" Q12849 4 70815783-70839897 "Predicted intracellular proteins" "mRNA processing, tRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 277.8" "Cell type enhanced" "Detected in all" "monocytes: 301.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036984, HPA036985" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA036984: AB_2675415, HPA036985: AB_10672785" "unprognostic (1.45e-3)" "unprognostic (1.82e-2)" "prognostic favorable (1.47e-5)" "unprognostic (8.63e-2)" "unprognostic (6.73e-2)" "unprognostic (4.15e-3)" "prognostic unfavorable (8.29e-5)" "unprognostic (1.94e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (7.68e-2)" "unprognostic (8.05e-2)" "prognostic favorable (2.72e-9)" "unprognostic (6.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-1)" "unprognostic (9.65e-3)" 38.3 61.8 42.8 37.2 42.3 23.9 38.0 48.1 45.4 36.6 58.0 55.1 43.5 32.8 34.3 42.4 43.4 35.5 81.5 44.8 47.7 56.3 54.9 35.9 47.7 45.2 45.6 39.3 38.8 62.5 49.2 21.7 44.2 46.3 40.2 63.3 25.7 84.6 35.6 277.8 31.4 41.7 40.4 45.7 34.9 51.3 33.1 44.1 76.7 46.1 156.4 54.2 50.7 26.0 50.5 116.9 78.1 90.0 94.5 93.5 108.1 128.3 138.2 87.3 102.3 83.5 80.5 117.1 167.6 102.9 143.7 53.0 43.4 161.3 108.6 135.9 91.3 52.8 88.4 75.2 112.4 115.1 130.8 48.7 91.9 102.2 103.6 71.6 123.0 106.9 91.9 102.6 94.7 144.2 124.9 217.4 92.0 96.3 127.1 80.9 88.2 139.8 71.6 126.1 144.0 93.4 84.0 65.3 183.6 234.3 104.7 79.8 63.3 98.4 95.1 99.7 79.4 88.7 78.1 66.2 106.4 78.6 83.6 94.5 12.7 17.4 7.7 10.1 12.3 12.2 7.4 14.6 15.5 28.1 6.1 14.4 12.6 2.0 20.0 15.2 27.2 13.3 8.4 42.8 42.3 48.1 45.4 44.8 47.7 45.2 45.6 39.3 46.3 45.7 44.1 50.5 27.8 32.1 36.6 19.6 38.0 50.0 53.7 32.9 48.3 18.2 37.7 28.3 135.5 40.0 30.4 27.6 25.0 106.2 57.4 52.9 74.3 70.3 7.6 53.8 40.4 33.0 69.0 41.2 35.1 61.3 141.3 41.2 65.2 44.5 17.2 60.2 35.0 50.9 63.2 28.6 30.5 73.5 36.7 66.3 53.7 6.7 34.8 45.4 62.2 24.4 301.5 23.8 41.2 21.6 28.0 60.1 46.7 39.1 58.7 65.9 47.1 74.1 27.6 19.6 19.7 38.4 46.2 35.0 61.8 69.7 50.4 77.2 45.1 99.0 89.3 67.0 ENAM AIH2 ENSG00000132464 Enamelin Q9NRM1 4 70628744-70646824 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 7.6;heart muscle: 6.6;kidney: 9.1;skeletal muscle: 4.9" "Group enriched" "Detected in some" 4 "Melanocytes: 33.8;Plasma cells: 13.4" "Group enriched" "Detected in some" 5 "pancreatic cancer: 0.6;renal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 1.2;U-266/84: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA 23000 "unprognostic (1.52e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.02e-2)" "unprognostic (2.78e-2)" "unprognostic (1.02e-1)" "unprognostic (7.94e-3)" "unprognostic (4.73e-2)" "unprognostic (2.06e-1)" "unprognostic (9.06e-4)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.81e-14)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 7.6 0.0 0.3 2.4 6.6 0.0 0.0 9.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.2 0.2 0.0 0.1 1.7 0.6 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.1 2.8 0.0 3.7 0.0 0.0 0.0 0.0 3.9 1.0 4.4 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.6 0.3 0.1 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 13.4 0.0 0.0 4.1 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.0 JCHAIN "IGCJ, IGJ, JCH" ENSG00000132465 "Joining chain of multimeric IgA and IgM" P01591 4 70655541-70681817 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 3057.6;intestine: 8055.6;stomach 1: 5969.9" "Cell type enriched" "Detected in many" 16 "Plasma cells: 101294.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 121 "memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1" "Group enriched" "Detected in all" 137 "B-cells: 4173.0;dendritic cells: 3578.1" "Cell line enhanced" "Detected in many" "Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034436, HPA044132" Enhanced "Secreted to blood" NA NA 2200000000 "CAB034436: AB_2233368, HPA044132: AB_2678826" "prognostic favorable (1.81e-6)" "unprognostic (1.45e-3)" "unprognostic (7.44e-3)" "unprognostic (1.82e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.56e-7)" "unprognostic (2.37e-2)" "unprognostic (2.70e-2)" "unprognostic (6.30e-2)" "unprognostic (2.64e-3)" "unprognostic (3.36e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (3.43e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.96e-1)" 131.4 77.3 0.9 1099.1 1.1 77.0 3057.6 0.6 3.0 207.0 3.1 8055.6 6201.6 95.2 25.2 660.3 116.0 497.0 45.9 0.6 6.5 43.6 117.8 625.7 1042.2 2.3 4.5 0.6 185.1 79.0 2.1 2.0 2.4 1.1 91.0 6487.5 0.3 2442.5 260.9 4.2 13.3 4312.7 202.2 6.8 826.5 5969.9 40.3 1.2 156.6 19.6 0.8 1761.7 1068.3 11.7 2.9 8.9 0.0 0.0 0.0 0.0 0.0 15.5 8.2 1.5 0.1 0.1 0.0 0.0 3953.8 3.3 12.7 0.1 6.6 0.0 0.0 0.6 2.1 0.0 3.3 0.0 0.0 0.0 3.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.4 2117.6 0.1 0.0 6.1 14.9 4.9 0.0 0.0 4.8 2.6 4469.2 0.0 0.0 3.3 15.7 3.7 2.6 2.7 0.0 0.8 6.8 3.9 9.9 11.8 4.9 6.3 8794.0 3519.2 4949.0 2.1 5.2 1.2 25.1 7.5 2.6 4.0 1.5 19.1 4173.0 2.5 3.8 6.6 2555.1 2.1 2.1 28.3 4.5 2.5 3578.1 2.6 1310.4 0.9 1.1 0.6 3.0 0.6 6.5 2.3 4.5 0.6 1.1 6.8 1.2 2.9 3.0 22.4 101.3 0.0 6154.9 0.0 28.2 0.0 8.6 0.0 11.7 1.9 2.2 15.7 8.1 0.0 0.0 0.1 700.0 5.1 0.0 0.0 0.5 0.0 0.1 38.1 7.3 139.0 0.0 0.0 0.1 48.8 228.8 0.0 79.5 0.1 66.4 24.6 0.3 0.0 0.0 5.3 0.0 35.8 0.0 0.3 0.0 42.0 0.0 0.0 3.9 0.0 6.2 0.0 0.0 0.0 5.1 0.0 101294.9 32.7 0.0 5.4 3.6 0.0 0.0 0.6 88.4 1.4 0.3 24.3 0.0 0.3 1487.8 0.0 3.5 0.6 ANKRD17 "FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16" ENSG00000132466 "Ankyrin repeat domain 17" O75179 4 73073376-73258798 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045024, HPA063731" Approved Supported "Nucleoplasm,Nuclear membrane" No No Nucleoplasm "Nuclear membrane" "HPA045024: AB_10964778, HPA063731: AB_2685106" "unprognostic (3.86e-3)" "unprognostic (3.59e-2)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-3)" "unprognostic (3.29e-2)" "unprognostic (3.10e-2)" "unprognostic (1.78e-1)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (3.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.13e-1)" "unprognostic (4.00e-2)" "unprognostic (4.07e-1)" 13.8 13.6 16.4 13.8 17.1 9.3 20.2 23.5 20.6 16.9 17.1 16.0 14.9 14.8 18.7 14.7 18.3 12.5 14.6 16.1 17.1 19.8 20.8 14.3 15.2 16.2 16.4 14.2 17.9 18.2 24.7 14.5 19.2 16.6 15.2 19.1 36.3 16.8 13.9 23.4 17.3 15.3 16.5 13.1 15.3 15.8 11.2 19.1 27.4 18.1 26.3 17.8 17.8 12.9 20.9 25.6 27.7 43.1 34.2 47.4 41.5 23.5 36.9 43.1 32.5 31.1 33.9 32.8 69.2 29.9 38.0 17.1 20.9 54.4 32.6 44.6 27.1 23.1 47.1 29.5 49.4 25.4 62.2 27.9 35.2 34.8 46.6 36.9 33.6 43.8 27.9 67.2 24.8 39.4 23.7 51.3 22.1 28.0 33.0 27.6 40.5 47.3 28.8 34.5 38.1 41.6 28.2 35.7 39.7 18.9 33.5 21.3 24.3 53.2 34.0 32.6 30.8 29.3 20.5 11.1 51.5 27.6 26.8 35.6 1.6 1.7 1.8 3.0 1.1 1.5 1.8 1.8 2.0 1.4 2.6 1.7 2.0 1.9 5.6 1.3 4.4 1.2 1.1 16.4 17.1 23.5 20.6 16.1 17.1 16.2 16.4 14.2 16.6 13.1 19.1 20.9 42.9 48.1 52.9 194.9 30.9 76.1 36.9 33.9 67.2 57.2 38.6 31.2 82.2 35.8 45.5 40.5 123.0 31.8 40.0 52.8 7.9 30.9 12.7 46.0 57.9 52.2 45.1 36.1 337.8 28.9 24.6 44.8 51.5 60.8 31.6 53.4 43.9 49.7 27.3 69.0 315.8 45.6 26.4 31.2 34.7 5.5 35.1 35.0 28.4 181.8 34.8 30.5 50.4 275.0 296.5 30.2 25.7 37.6 44.2 52.8 39.4 25.4 30.5 84.1 19.7 58.5 48.5 28.1 30.8 64.9 81.3 33.8 32.4 47.6 48.3 48.4 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3 small subunit processome component" Q9NQZ2 4 70688532-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: AB_2677488" "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 22.6 22.9 9.8 25.7 10.2 19.2 18.9 10.0 11.3 14.2 10.8 17.1 16.4 16.2 15.1 20.8 16.4 14.8 17.2 10.6 10.5 21.2 27.3 18.7 33.2 10.0 10.0 9.3 15.9 15.1 16.5 9.5 16.4 10.1 15.3 16.6 12.1 16.1 13.8 16.0 18.9 21.7 20.3 9.8 34.7 18.0 11.5 10.0 32.4 16.1 13.2 31.8 22.3 12.4 10.8 33.7 32.3 42.4 35.4 58.9 44.3 36.3 68.4 43.9 38.4 37.0 42.4 43.7 147.4 42.1 58.9 43.8 27.7 62.7 93.7 55.4 45.9 35.9 56.1 43.0 45.9 63.9 85.9 47.9 60.4 55.2 47.0 46.0 42.3 52.2 42.3 65.3 48.2 62.8 69.7 79.9 47.8 29.6 68.9 46.7 33.8 58.3 60.5 69.7 53.7 35.5 48.4 29.1 65.4 44.5 46.1 36.1 34.2 58.5 38.8 65.9 37.3 44.3 69.6 55.4 104.8 47.3 41.4 34.8 8.4 10.7 5.6 6.4 12.6 6.8 7.0 5.3 7.4 13.4 6.1 7.7 6.7 0.8 6.8 11.3 13.5 7.3 5.5 9.8 10.2 10.0 11.3 10.6 10.5 10.0 10.0 9.3 10.1 9.8 10.0 10.8 19.2 57.7 54.2 4.9 23.7 22.9 44.3 42.2 24.5 19.4 12.3 14.4 20.6 14.3 50.5 12.9 6.2 26.7 30.0 11.8 19.6 29.3 1.1 22.8 29.3 26.7 15.0 16.8 6.2 29.8 14.6 23.6 21.9 25.1 29.2 16.7 16.8 25.1 21.9 16.8 5.9 14.7 30.5 37.8 24.2 2.2 17.4 24.2 12.4 5.6 27.9 26.8 30.9 2.5 8.9 22.6 9.5 25.2 18.5 23.0 15.9 27.9 45.7 22.3 13.1 30.8 48.8 11.5 9.5 23.0 25.6 21.6 24.6 22.2 15.6 29.9 ITGB4 CD104 ENSG00000132470 "Integrin subunit beta 4" P16144 17 75721328-75757818 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 202.2;skin 1: 201.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 173.6;Distal enterocytes: 133.3;Gastric mucus-secreting cells: 165.1;Pancreatic endocrine cells: 284.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 897.3;HaCaT: 345.1;HBEC3-KT: 768.6;hTCEpi: 256.9;RT4: 254.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 37.4" "CAB002422, CAB005258, HPA036348, HPA036349" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 980000 "Plasma membrane, Cell Junctions" "CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078" "unprognostic (3.17e-3)" "unprognostic (3.52e-1)" "unprognostic (4.19e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.02e-1)" "unprognostic (2.23e-2)" "unprognostic (1.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" 32.7 5.3 71.5 12.5 71.3 1.6 67.1 67.5 92.5 55.6 63.9 71.4 57.5 24.2 3.7 102.1 44.2 20.2 19.4 69.4 95.8 18.3 5.7 18.6 4.5 91.8 79.6 53.2 8.6 24.7 2.9 21.3 35.7 69.0 86.1 15.8 8.8 202.2 18.7 6.9 201.6 76.2 6.5 90.5 77.5 80.6 4.9 76.1 4.1 17.8 6.0 7.3 58.9 99.6 89.2 172.7 148.5 0.3 2.1 0.4 1.3 199.2 0.7 0.6 0.5 0.9 16.1 897.3 0.1 31.5 0.3 1.3 345.1 1.0 768.6 0.5 0.7 0.6 0.9 39.6 17.0 1.2 0.2 1.8 1.1 256.9 0.6 159.2 18.0 5.5 0.6 0.5 15.7 0.1 95.8 2.0 2.0 1.0 92.8 127.8 2.7 4.4 2.2 204.8 254.9 0.2 1.9 4.9 15.2 2.2 5.3 63.9 1.5 16.9 4.6 7.8 0.7 1.9 5.6 2.1 0.7 2.0 0.8 2.7 0.0 0.2 0.0 0.4 0.4 1.1 0.7 0.1 0.5 0.0 2.0 0.4 0.3 0.7 0.0 0.0 4.6 0.8 0.4 71.5 71.3 67.5 92.5 69.4 95.8 91.8 79.6 53.2 69.0 90.5 76.1 89.2 26.9 12.8 2.2 50.3 1.4 49.5 45.1 173.6 67.2 0.3 21.2 36.6 7.5 25.8 38.9 23.9 2.1 89.8 1.8 133.3 1.9 33.3 0.4 61.3 5.7 26.8 9.6 0.8 0.7 28.8 20.2 5.2 165.1 60.2 2.5 1.1 17.9 0.4 9.4 0.0 0.7 59.2 18.3 0.3 5.4 0.4 3.7 1.9 12.4 1.9 0.1 34.4 0.0 1.5 0.7 284.4 68.4 1.5 2.6 17.1 94.0 2.6 53.3 1.0 0.0 1.2 5.0 1.1 8.2 28.1 13.1 111.1 1.8 0.5 60.1 42.0 WBP2 "GRAMD6, WBP-2" ENSG00000132471 "WW domain binding protein 2" Q969T9 17 75845699-75856507 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 321.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065682, HPA068819" Approved Supported Nucleoplasm,Cytosol No No 440000 "Nucleoplasm, Cytosol" "HPA065682: AB_2685530, HPA068819: AB_2686042" "unprognostic (1.74e-1)" "unprognostic (1.71e-2)" "unprognostic (3.17e-2)" "unprognostic (2.85e-1)" "unprognostic (8.39e-2)" "unprognostic (7.12e-2)" "unprognostic (8.89e-2)" "unprognostic (3.09e-1)" "unprognostic (2.68e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-3)" "unprognostic (6.18e-2)" "unprognostic (2.21e-1)" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "unprognostic (2.13e-2)" "unprognostic (1.76e-1)" 111.6 225.5 207.1 57.7 206.9 83.5 115.1 191.0 343.6 98.6 129.1 97.9 65.8 85.3 44.7 95.4 107.0 63.4 155.0 206.5 198.8 126.1 185.9 119.1 61.4 254.6 224.8 191.8 114.9 135.6 101.6 116.9 55.8 271.0 104.4 39.4 130.8 138.9 74.1 252.2 131.0 86.4 52.4 198.9 113.4 124.2 96.1 219.0 49.6 84.5 92.7 52.3 98.7 95.5 246.8 104.6 119.9 43.4 52.5 88.0 87.2 57.9 32.7 102.1 74.3 91.8 59.7 104.2 52.9 81.9 47.0 232.2 61.0 45.2 100.9 66.3 40.1 90.4 97.7 66.4 97.6 182.2 40.8 161.6 96.4 94.6 89.4 120.8 127.0 143.8 82.1 68.2 156.7 60.2 107.3 85.8 85.8 37.3 70.8 78.8 57.8 85.4 101.5 109.7 62.3 72.6 114.8 58.5 99.9 163.1 76.3 134.9 102.1 84.3 75.8 66.1 73.6 52.3 145.4 109.6 38.8 212.5 38.3 54.9 239.9 85.0 288.7 53.8 102.6 59.1 68.9 59.5 54.6 54.8 55.3 55.8 47.5 308.9 57.4 136.4 42.0 77.4 93.2 207.1 206.9 191.0 343.6 206.5 198.8 254.6 224.8 191.8 271.0 198.9 219.0 246.8 73.5 83.3 79.0 34.9 62.7 60.9 127.2 85.9 30.1 109.7 75.2 53.3 73.2 55.8 59.9 53.3 75.0 64.9 45.9 65.9 162.4 124.3 264.5 41.5 21.7 63.4 33.6 124.0 23.6 188.6 65.1 43.5 34.1 44.3 67.0 40.0 54.3 61.9 138.4 112.7 23.4 48.9 71.2 65.5 71.2 321.1 59.4 90.2 60.5 23.4 90.8 104.8 52.5 21.1 38.6 126.5 72.6 53.8 35.6 120.2 88.4 100.7 44.8 120.7 26.3 43.8 44.9 45.5 25.7 24.8 80.0 184.7 51.7 62.5 27.1 95.6 H3-3B "H3.3B, H3F3B" ENSG00000132475 "H3.3 histone B" P84243 17 75776434-75785893 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 4258.3" "Cell type enhanced" "Detected in some" "Adipocytes: 1321.3;Cytotrophoblasts: 1625.3;dendritic cells: 844.9;Extravillous trophoblasts: 1626.9;Hofbauer cells: 1908.9;Syncytiotrophoblasts: 3503.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 21089.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 21089.7" "Low cell line specificity" "Detected in all" "CAB037166, CAB037187, CAB037221, HPA042570" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056" "unprognostic (1.66e-1)" "unprognostic (8.42e-3)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.64e-1)" "unprognostic (5.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-3)" "unprognostic (9.20e-2)" "unprognostic (4.81e-2)" "unprognostic (2.33e-1)" "unprognostic (1.99e-1)" 566.1 373.0 220.5 537.2 250.2 4258.3 634.4 264.6 273.3 704.4 210.9 399.9 332.9 512.2 181.8 806.0 590.9 472.0 293.8 209.6 337.8 346.9 383.3 558.0 513.3 269.6 241.6 194.4 1176.6 582.9 343.9 360.3 430.7 243.3 351.1 225.2 302.4 523.4 239.3 335.2 1069.0 410.9 325.7 261.1 453.5 396.3 659.4 248.3 468.2 505.3 157.0 298.7 549.9 680.8 322.5 1386.5 1194.2 490.0 486.1 273.3 424.9 675.1 636.7 557.1 764.8 609.3 1290.7 952.6 683.6 593.1 373.2 539.5 530.0 390.5 881.0 432.0 375.9 883.0 612.8 668.2 1112.0 615.7 1029.2 755.0 467.3 534.2 785.6 1004.7 339.3 582.5 437.8 885.6 1193.0 399.4 2015.3 1492.3 859.5 394.8 442.8 1322.8 1091.7 894.2 746.6 607.3 803.5 988.1 1096.0 645.8 933.7 1402.2 259.3 734.2 1091.3 549.1 1359.7 1205.2 595.2 1721.1 1431.3 932.2 843.5 720.5 967.6 761.1 7991.0 3667.6 10060.5 2613.4 3365.8 2482.2 3199.5 2474.2 2478.9 3218.1 2813.7 2635.4 2173.4 21089.7 3240.7 3199.0 3294.6 2999.0 9615.0 220.5 250.2 264.6 273.3 209.6 337.8 269.6 241.6 194.4 243.3 261.1 248.3 322.5 1321.3 0.0 0.0 0.0 294.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 398.6 0.0 0.0 0.0 0.0 1625.3 844.9 0.0 0.0 0.0 0.0 0.0 0.0 172.3 0.0 0.0 0.0 0.0 1626.9 485.1 0.0 0.0 0.0 0.0 0.0 0.0 1908.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 257.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 314.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 377.9 0.0 0.0 0.0 0.0 3503.3 211.7 0.0 0.0 0.0 UNK "KIAA1753, ZC3H5, ZC3HDC5" ENSG00000132478 "Unk zinc finger" Q9C0B0 17 75784806-75825799 "Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.3;Spermatocytes: 120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023636, HPA027962" Uncertain Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytosol, Cytoplasmic bodies" "HPA023636: AB_10601774, HPA027962: AB_10611522" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (3.37e-1)" "unprognostic (1.04e-3)" "unprognostic (9.51e-2)" "prognostic favorable (2.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.11e-1)" "unprognostic (6.73e-2)" "unprognostic (9.78e-2)" "prognostic favorable (6.58e-5)" "unprognostic (5.31e-2)" "unprognostic (1.41e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.01e-2)" 11.4 11.8 7.2 8.6 7.6 8.5 13.7 8.0 9.4 20.7 7.8 12.3 6.8 18.4 4.1 13.8 17.7 5.4 10.3 6.0 6.0 11.8 12.9 10.2 10.7 8.0 7.0 5.7 22.3 14.9 9.9 20.3 5.9 7.7 16.1 3.4 5.7 14.3 6.5 9.2 18.1 14.3 4.8 6.1 21.3 11.5 9.4 7.1 10.2 17.1 4.2 5.3 14.1 15.4 10.8 9.3 14.7 16.0 13.6 5.0 4.6 13.0 6.1 6.6 6.7 8.2 5.4 10.5 19.8 5.2 6.6 11.1 8.4 8.1 7.3 3.1 10.3 26.6 12.4 12.8 11.6 6.7 9.6 15.2 9.1 4.4 5.8 6.2 7.6 8.9 14.0 6.5 9.6 5.4 18.6 21.4 13.2 6.9 6.5 9.6 22.4 16.0 10.1 6.3 9.8 14.7 28.8 7.9 11.0 22.0 8.0 13.4 14.7 6.5 15.9 8.6 7.1 7.9 16.4 5.1 11.0 11.5 6.1 10.0 0.0 0.2 0.1 0.5 0.1 0.4 0.2 0.2 0.3 0.1 0.7 0.4 0.4 0.0 0.2 0.2 0.4 0.3 0.4 7.2 7.6 8.0 9.4 6.0 6.0 8.0 7.0 5.7 7.7 6.1 7.1 10.8 12.7 16.0 17.0 33.6 25.4 15.2 17.3 19.3 10.2 26.4 16.5 14.7 11.2 11.5 21.3 3.7 14.6 9.1 18.9 11.4 3.9 15.3 130.3 14.7 11.8 13.3 16.8 10.9 15.4 22.9 15.8 14.1 15.8 9.1 19.0 15.6 7.9 6.0 14.3 21.9 21.1 13.3 38.7 10.8 14.3 22.6 19.0 10.1 26.6 28.1 10.8 22.5 18.6 27.2 26.0 21.3 12.7 10.5 24.4 12.9 7.0 6.1 24.0 24.4 19.7 15.1 15.5 120.5 73.5 13.0 21.9 17.2 19.1 10.5 14.0 13.9 TRIM47 "GOA, RNF100" ENSG00000132481 "Tripartite motif containing 47" Q96LD4 17 75874164-75878581 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 48.4;RPTEC TERT1: 36.0;U-266/70: 39.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014933 Uncertain Supported Cytosol NA NA Cytosol "HPA014933: AB_10603219" "prognostic favorable (6.54e-4)" "unprognostic (8.42e-2)" "unprognostic (1.42e-1)" "unprognostic (2.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (5.59e-5)" "unprognostic (2.08e-2)" "unprognostic (9.18e-3)" "unprognostic (2.74e-1)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.69e-5)" "unprognostic (3.94e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-2)" "unprognostic (9.98e-2)" 20.6 10.4 44.8 6.6 44.2 0.3 17.9 41.7 68.6 19.9 40.8 27.4 9.1 29.5 4.0 19.2 17.7 7.7 21.8 41.4 51.7 39.0 18.0 19.1 4.4 51.2 44.9 37.6 7.3 18.1 5.9 8.9 2.6 47.6 16.9 4.5 0.8 24.6 5.0 6.9 18.7 19.7 6.1 43.2 29.1 17.5 7.4 58.7 1.8 12.9 4.5 4.4 31.6 21.6 51.6 20.6 14.8 0.1 0.1 3.2 3.4 0.5 0.8 1.6 1.1 0.9 2.8 10.2 0.0 12.9 0.7 10.1 23.4 3.7 5.5 0.1 13.2 9.4 0.1 10.2 28.3 5.3 0.1 0.1 2.8 1.5 2.3 2.0 1.0 10.1 1.6 2.2 30.3 0.6 3.5 2.0 0.3 1.6 7.9 29.1 1.5 1.8 48.4 36.0 0.7 5.8 0.4 6.1 29.1 8.4 0.8 3.5 0.6 15.6 18.0 11.3 1.8 7.1 39.2 12.1 2.5 7.8 0.0 1.7 0.0 0.0 1.4 1.7 0.0 4.6 2.4 4.0 2.2 0.1 2.1 2.6 1.7 0.0 2.2 0.0 1.2 5.4 0.6 44.8 44.2 41.7 68.6 41.4 51.7 51.2 44.9 37.6 47.6 43.2 58.7 51.6 34.3 16.0 5.4 26.4 5.2 18.0 39.8 34.8 34.1 6.0 20.8 23.4 4.8 40.0 13.8 16.5 0.0 0.5 2.6 30.2 19.6 67.5 0.5 13.6 17.7 39.6 8.4 1.3 1.9 76.6 1.4 33.7 22.4 12.6 22.2 17.1 43.5 11.4 63.5 0.0 1.4 12.5 57.0 9.1 14.5 1.0 34.2 8.2 42.7 8.4 2.6 10.3 0.0 5.5 5.8 105.2 4.7 19.2 12.5 57.0 42.0 66.3 16.7 0.9 32.9 14.5 36.4 1.0 2.2 22.1 15.9 0.8 7.9 2.0 11.8 19.2 ZRANB2 "ZIS, ZIS1, ZIS2, ZNF265" ENSG00000132485 "Zinc finger RANBP2-type containing 2" O95218 1 71063291-71081289 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053960, HPA061949, HPA063298" Supported Enhanced Nucleoplasm NA Yes 13000 Nucleoplasm "HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979" "unprognostic (2.10e-1)" "unprognostic (7.54e-2)" "unprognostic (4.15e-3)" "unprognostic (8.11e-2)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (4.25e-3)" "unprognostic (1.24e-2)" "unprognostic (7.79e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (1.57e-8)" "unprognostic (3.96e-2)" "unprognostic (8.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-3)" 41.4 39.8 34.8 45.7 37.0 60.6 53.1 42.6 43.9 45.1 40.7 39.2 35.8 71.4 68.2 29.5 45.8 29.9 43.1 36.3 36.2 28.5 30.4 40.8 63.0 36.6 35.8 37.1 57.2 34.0 33.5 65.0 36.6 37.1 44.6 43.3 62.6 39.8 38.3 59.4 43.7 38.2 50.6 33.8 43.0 35.9 50.9 34.4 48.0 48.9 39.2 49.7 38.2 35.5 44.7 86.8 31.1 122.3 73.0 46.5 79.8 71.0 103.2 55.6 89.2 113.2 58.7 55.5 177.6 89.0 64.2 82.7 53.5 111.1 63.9 133.4 127.5 79.9 154.5 127.3 50.0 70.8 171.5 62.7 61.7 80.3 86.1 73.5 98.1 76.3 90.3 165.1 93.6 69.6 29.3 145.0 58.4 128.7 52.9 59.6 159.8 92.3 108.4 60.5 72.6 93.8 58.3 88.7 58.8 91.4 63.7 74.7 76.8 102.5 65.9 62.1 51.9 103.8 75.7 100.6 193.8 96.4 160.3 94.6 99.1 33.4 32.1 44.5 32.3 51.2 68.8 47.5 44.0 26.8 63.1 61.2 48.7 30.7 48.2 33.8 73.4 49.6 31.2 34.8 37.0 42.6 43.9 36.3 36.2 36.6 35.8 37.1 37.1 33.8 34.4 44.7 86.9 99.3 154.5 83.6 109.8 50.6 94.4 66.1 59.7 166.5 61.4 66.5 99.9 50.1 68.4 49.7 129.3 55.1 136.9 85.8 49.0 60.2 190.3 79.9 123.5 63.5 73.0 87.1 135.3 68.2 50.4 92.6 62.7 85.7 87.4 132.8 50.7 41.8 45.4 213.7 114.7 64.5 54.9 34.5 39.7 46.2 185.4 55.7 48.0 73.1 74.8 116.6 139.0 90.5 131.9 69.2 76.5 115.5 127.5 54.8 41.2 41.1 76.5 202.2 118.3 88.1 99.2 218.7 113.0 55.3 46.5 63.5 89.6 96.4 55.1 68.5 EIF5A "EIF-5A, EIF5A1, MGC104255, MGC99547" ENSG00000132507 "Eukaryotic translation initiation factor 5A" P63241 17 7306999-7312463 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005042, HPA061298, HPA074052" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: " "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (8.10e-2)" "unprognostic (2.80e-1)" "unprognostic (6.95e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (4.10e-1)" "unprognostic (4.11e-2)" "unprognostic (1.64e-2)" "unprognostic (8.25e-2)" "prognostic unfavorable (1.63e-5)" "unprognostic (3.53e-1)" "unprognostic (2.79e-1)" "unprognostic (6.01e-2)" "unprognostic (7.65e-2)" 273.4 311.9 82.5 139.6 82.7 223.4 242.7 83.8 99.8 189.7 76.6 225.3 114.0 208.0 86.6 580.6 189.7 74.3 285.8 87.6 89.8 233.4 499.6 246.6 136.1 86.9 85.6 83.8 162.5 297.4 80.4 168.0 97.2 88.5 190.7 126.9 48.0 232.7 66.2 576.8 397.1 209.2 107.0 87.2 229.2 228.6 203.2 87.9 123.7 183.1 161.7 155.6 223.2 284.1 97.8 838.2 958.6 275.8 570.6 220.8 270.2 427.1 546.2 360.7 730.1 501.6 583.6 343.3 749.7 350.9 451.4 300.3 572.3 610.0 777.8 665.9 466.2 987.2 477.9 710.1 750.6 388.6 324.0 431.7 302.5 374.9 587.8 736.0 259.1 501.4 232.0 673.8 192.2 527.3 496.2 388.6 523.3 525.8 477.2 498.0 412.0 320.5 732.4 464.6 393.8 340.5 431.8 330.0 469.4 360.8 212.3 327.2 258.4 427.7 567.6 379.5 326.2 896.4 168.8 229.9 443.6 515.1 527.2 642.2 146.8 137.6 102.0 157.4 193.1 187.5 154.5 153.1 137.2 215.9 149.1 139.6 144.6 62.0 195.1 186.5 225.0 156.7 200.3 82.5 82.7 83.8 99.8 87.6 89.8 86.9 85.6 83.8 88.5 87.2 87.9 97.8 180.1 54.5 37.9 6.2 241.9 349.0 67.9 226.5 378.5 88.3 258.8 138.7 77.8 125.8 72.7 62.5 14.6 324.3 200.3 316.0 74.3 317.3 153.8 136.4 255.2 176.6 150.6 456.1 6.8 239.8 633.8 199.6 172.8 187.8 138.4 87.3 105.7 236.4 296.8 50.5 7.0 317.4 83.4 133.6 283.1 112.9 100.6 151.9 263.3 4.7 245.0 122.2 216.3 2.0 11.5 322.0 223.7 81.3 386.7 507.1 229.3 127.1 41.3 65.0 92.1 160.7 262.1 200.4 82.6 572.0 313.7 428.4 179.3 290.7 384.7 207.0 KDM6B "JMJD3, KIAA0346" ENSG00000132510 "Lysine demethylase 6B" O15054 17 7834217-7854796 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Inflammatory response" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 393.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 3.6;neutrophil: 8.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 8.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037988 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA037988: AB_10672502" "unprognostic (3.43e-1)" "unprognostic (3.43e-1)" "unprognostic (1.09e-1)" "unprognostic (2.13e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.21e-1)" "unprognostic (2.43e-1)" "unprognostic (9.89e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.42e-2)" "prognostic favorable (6.07e-4)" "unprognostic (5.73e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.85e-1)" 21.2 13.4 3.5 20.2 3.0 35.9 12.7 10.4 20.4 12.0 3.6 15.3 14.4 14.1 3.4 13.7 17.2 15.7 17.1 3.1 24.2 14.7 15.4 27.7 8.1 4.2 3.3 1.3 30.0 17.3 8.0 21.9 6.9 4.8 14.6 4.1 6.3 12.1 6.3 12.5 15.3 17.6 5.6 1.9 20.8 17.8 16.2 3.8 16.6 16.0 8.3 4.7 20.0 12.5 6.1 4.9 7.0 12.5 19.0 4.6 3.4 16.2 3.8 5.4 2.7 2.8 9.3 3.6 11.4 4.5 3.0 3.9 12.2 5.8 5.1 1.6 4.7 4.5 5.3 6.7 6.2 13.0 7.2 15.6 5.3 8.0 6.1 5.1 7.2 4.8 11.8 8.8 4.8 1.2 7.7 10.6 6.5 6.4 4.9 3.9 11.9 2.9 3.2 5.1 7.7 6.6 21.4 4.8 11.5 10.3 7.3 6.4 8.9 2.3 4.0 7.1 7.0 5.5 5.6 1.2 3.9 5.3 4.2 8.1 3.6 0.6 1.1 0.3 0.4 0.3 0.3 0.2 0.1 0.3 0.5 0.3 0.4 8.9 0.1 0.2 0.7 0.1 0.4 3.5 3.0 10.4 20.4 3.1 24.2 4.2 3.3 1.3 4.8 1.9 3.8 6.1 135.5 25.6 33.6 6.2 158.8 214.4 122.2 30.8 156.0 45.2 113.7 70.9 10.8 42.9 32.4 7.3 31.3 15.1 127.6 47.8 1.9 28.0 29.2 88.2 67.1 80.5 79.9 8.4 9.0 25.1 15.9 85.4 73.4 181.6 178.6 44.8 34.2 22.7 23.4 38.7 10.9 62.5 18.3 50.4 393.1 10.7 16.4 219.2 56.9 4.7 25.6 13.2 9.2 5.5 1.9 58.4 49.1 13.9 70.7 99.6 53.9 9.8 20.5 17.1 19.7 181.2 83.0 20.1 19.3 138.1 188.0 52.0 104.1 22.0 46.2 86.6 CLEC10A "CD301, CLECSF13, CLECSF14, HML, HML2" ENSG00000132514 "C-type lectin domain containing 10A" Q8IUN9 17 7074537-7080307 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.7" "Group enriched" "Detected in some" 6 "Langerhans cells: 805.4;Macrophages: 213.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 12 "myeloid DC: 465.9" "Lineage enriched" "Detected in many" 12 "dendritic cells: 465.9" "Not detected" "Not detected" HPA021937 Approved NA NA "HPA021937: AB_1846905" "unprognostic (3.96e-3)" "unprognostic (1.71e-3)" "unprognostic (2.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.54e-2)" "prognostic favorable (1.26e-5)" "unprognostic (1.07e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.70e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.12e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (3.23e-1)" "unprognostic (3.65e-1)" 21.1 3.4 0.3 29.7 0.3 2.6 8.6 0.2 1.0 4.1 2.1 13.8 15.9 3.8 1.2 10.5 4.5 19.0 6.4 0.2 1.0 2.5 7.0 12.4 19.9 0.4 0.4 0.1 2.1 2.8 1.3 1.4 0.7 0.4 3.0 18.4 0.0 4.4 4.7 3.0 10.1 25.8 19.0 0.2 18.7 7.7 2.5 0.4 7.9 2.6 3.1 13.7 20.1 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 29.9 0.1 0.0 39.0 0.2 0.0 0.2 0.1 465.9 0.3 0.1 0.0 2.1 2.2 0.3 9.2 0.3 20.5 0.3 0.3 0.2 1.0 0.2 1.0 0.4 0.4 0.1 0.4 0.2 0.4 1.0 1.1 3.2 3.9 0.0 3.6 13.3 0.0 0.0 1.2 0.0 0.2 0.5 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.1 0.1 1.5 0.0 3.0 0.2 0.0 0.2 2.0 0.0 0.1 1.3 0.0 0.4 1.1 18.4 0.0 0.0 0.1 0.0 77.9 805.4 1.2 0.3 213.9 21.4 0.0 26.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.2 0.0 0.0 6.6 0.5 1.7 0.0 2.3 0.4 11.8 0.1 1.6 0.0 0.0 0.0 SLC52A1 "FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1" ENSG00000132517 "Solute carrier family 52 member 1" Q9NWF4 17 5032600-5052009 "Disease related genes, Metabolic proteins, Predicted membrane proteins" Transport "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 36.1;placenta: 18.5;skin 1: 11.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 820.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.4;BEWO: 1.9;EFO-21: 1.8;HMC-1: 4.6;SK-BR-3: 2.6;T-47d: 1.6" NA NA "unprognostic (8.81e-3)" "prognostic favorable (9.54e-4)" "unprognostic (9.34e-2)" "unprognostic (7.30e-4)" "unprognostic (6.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.82e-3)" "unprognostic (1.72e-1)" "unprognostic (2.36e-1)" "unprognostic (1.15e-1)" "unprognostic (7.19e-2)" "unprognostic (5.17e-5)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (4.07e-2)" "unprognostic (6.60e-2)" 0.1 0.1 0.2 0.1 0.2 0.5 0.5 0.6 0.4 0.5 0.1 1.0 36.1 0.2 0.3 1.0 0.9 0.3 0.1 0.4 0.0 0.1 0.1 0.4 0.2 0.2 0.0 0.3 0.1 0.3 0.6 0.1 18.5 0.3 1.0 0.5 0.2 0.4 0.6 0.3 11.2 23.7 0.1 0.1 0.4 0.3 0.5 0.2 0.6 0.3 0.0 0.2 1.1 0.7 0.5 0.1 2.4 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.3 0.3 0.0 0.1 0.1 1.8 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 4.6 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.4 2.6 0.0 0.0 1.6 0.7 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.6 0.4 0.4 0.0 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.1 0.0 0.5 0.0 0.0 1.1 1.6 2.0 0.6 0.0 0.2 0.5 0.7 0.0 0.9 0.0 0.0 185.7 0.1 4.1 0.0 0.0 0.2 1.7 0.1 0.6 1.2 0.0 0.0 0.0 15.3 1.2 0.0 0.5 0.0 0.3 2.2 0.0 15.7 0.0 0.1 6.6 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 76.4 0.1 7.7 0.0 0.0 0.2 0.1 2.0 2.1 2.3 1.7 820.1 0.3 0.1 2.6 1.5 GUCY2D "CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1" ENSG00000132518 "Guanylate cyclase 2D, retinal" Q02846 17 8002615-8020342 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "retina: 34.5" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 58.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 31 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 50 "dendritic cells: 8.0" "Cell line enriched" "Detected in some" 5 "JURKAT: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" NA NA "unprognostic (3.57e-4)" "unprognostic (5.05e-1)" "unprognostic (1.49e-1)" "unprognostic (9.75e-5)" "unprognostic (5.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.44e-2)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" "unprognostic (4.44e-1)" "unprognostic (7.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.46e-1)" "unprognostic (3.08e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 1.3 5.2 5.7 2.1 1.4 3.8 1.9 0.0 1.4 0.0 62.6 1.2 2.7 0.0 1.9 0.1 6.9 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.7 0.1 0.0 0.6 0.0 0.1 0.0 1.2 1.1 0.0 0.4 0.0 0.0 0.6 0.0 14.9 0.0 0.6 0.0 0.0 0.8 6.1 0.0 0.0 0.1 0.1 0.0 0.4 0.0 1.1 0.0 0.4 0.1 58.3 0.0 0.0 0.0 0.4 0.1 2.4 0.3 2.2 0.1 0.0 0.2 0.5 GPS2 ENSG00000132522 "G protein pathway suppressor 2" Q13227 17 7311324-7315564 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 279.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067540 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA067540: AB_2685860" "unprognostic (1.53e-2)" "unprognostic (3.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.71e-3)" "unprognostic (1.55e-1)" "unprognostic (1.53e-4)" "unprognostic (1.37e-2)" "unprognostic (1.33e-1)" "unprognostic (3.18e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.50e-5)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (6.87e-2)" "unprognostic (1.28e-3)" 42.2 48.1 31.7 15.6 31.4 27.1 40.0 31.5 38.0 40.1 29.2 44.3 14.7 39.9 14.3 38.4 37.1 13.3 58.7 31.1 31.6 50.1 33.6 34.3 17.3 33.1 31.5 30.1 39.8 39.3 24.6 34.0 14.0 33.4 35.6 17.3 12.1 39.7 17.1 156.1 49.9 34.8 15.7 30.5 34.9 40.3 103.5 32.3 21.8 34.9 53.4 20.2 44.3 37.6 33.1 28.1 60.6 24.9 26.4 36.5 20.2 21.2 20.1 26.7 45.2 39.0 39.2 16.1 32.0 15.5 31.1 32.3 42.1 25.4 42.4 31.5 37.9 34.8 30.1 62.2 53.0 26.4 19.1 37.1 19.3 31.2 59.0 17.1 19.5 26.0 29.7 18.8 8.6 43.2 25.8 38.2 21.2 24.6 29.3 22.8 29.5 30.8 34.1 36.4 32.1 23.5 39.5 35.6 23.6 28.9 21.4 23.6 18.6 15.9 23.0 20.5 28.2 48.9 25.0 37.0 21.0 30.3 23.2 38.1 78.3 47.2 82.7 53.5 59.8 49.5 81.6 56.6 58.5 39.5 63.8 51.9 47.8 79.1 41.5 67.7 66.0 81.2 58.1 31.7 31.4 31.5 38.0 31.1 31.6 33.1 31.5 30.1 33.4 30.5 32.3 33.1 29.1 12.8 10.8 19.9 36.9 15.8 11.5 11.4 29.0 29.9 19.2 17.8 1.2 17.2 16.6 20.2 66.7 13.5 55.7 52.4 25.4 21.7 100.3 15.0 22.6 18.9 16.8 29.9 15.0 26.8 11.1 14.9 25.5 17.5 19.0 23.4 11.4 10.6 10.3 38.7 12.5 23.2 6.1 14.1 25.0 279.3 21.1 21.1 19.6 13.1 21.6 15.5 41.2 10.6 17.1 19.5 35.9 15.4 42.2 8.4 42.2 25.7 14.6 44.8 19.7 17.4 18.8 37.4 42.9 18.1 16.9 19.6 39.0 17.1 21.8 9.1 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 174.2;Endothelial cells: 90.4;Microglial cells: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 81.8;BJ hTERT+ SV40 Large T+ RasG12V: 83.8;HHSteC: 35.3" "Low region specificity" "Detected in all" HPA057302 Approved Supported Nucleoplasm,Mitochondria Yes NA "Nucleoplasm, Mitochondria" "HPA057302: AB_2683405" "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 27.6 12.9 32.1 30.0 31.6 33.8 24.4 27.4 40.0 38.6 25.4 16.0 27.0 26.7 13.1 17.1 22.7 34.3 26.2 27.6 27.7 21.2 64.1 36.1 29.9 35.3 28.3 23.8 53.4 3.0 2.9 14.5 26.1 30.3 25.1 16.9 4.9 48.0 11.4 14.2 18.6 25.6 24.5 26.2 64.0 23.8 9.3 32.9 24.0 18.3 13.6 15.6 17.5 22.3 43.6 5.2 0.3 0.7 1.4 6.7 15.1 0.7 7.1 26.3 81.8 83.8 0.7 7.5 1.3 2.0 10.2 28.9 3.1 0.0 1.3 9.3 11.4 0.3 1.9 0.9 1.0 35.3 1.2 8.0 6.9 0.0 11.3 0.3 0.4 6.9 25.5 0.7 26.1 2.6 0.4 6.3 22.1 0.6 0.2 2.2 11.3 0.4 0.5 0.2 4.9 0.5 0.6 3.6 0.5 14.3 0.6 0.8 30.4 0.7 1.1 0.8 2.3 0.5 3.9 1.4 0.5 2.6 18.4 2.2 17.4 9.6 4.3 7.8 12.7 5.7 3.6 6.0 5.6 8.0 4.6 3.8 4.0 10.6 8.0 12.5 0.8 9.9 5.6 32.1 31.6 27.4 40.0 27.6 27.7 35.3 28.3 23.8 30.3 26.2 32.9 43.6 174.2 60.9 29.9 14.0 25.7 5.2 5.7 5.5 13.1 0.5 4.1 10.3 2.7 8.6 30.0 0.0 0.0 0.4 37.1 12.4 0.0 1.3 4.0 18.9 68.4 90.4 1.8 10.7 0.3 1.9 5.1 29.8 27.5 10.4 48.7 44.4 33.5 20.1 15.9 0.0 0.3 9.2 0.0 21.3 11.2 2.6 36.4 54.4 5.4 103.0 44.5 1.1 70.0 1.5 0.6 10.1 2.7 27.4 11.4 2.5 11.4 0.3 24.3 0.4 19.7 27.3 19.0 0.2 0.8 11.8 2.7 0.4 35.1 47.3 9.2 5.6 DLG4 "PSD-95, PSD95, SAP-90, SAP90" ENSG00000132535 "Discs large MAGUK scaffold protein 4" P78352 17 7187187-7219841 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 113.3;pituitary gland: 63.3;retina: 225.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 41.8;Cone photoreceptor cells: 102.2;Rod photoreceptor cells: 62.6" "Cancer enhanced" "Detected in all" "glioma: 13.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 40.0;hTERT-RPE1: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001999, CAB002000, HPA010122, HPA071006" Enhanced "Intracellular and membrane" NA NA "CAB001999: , CAB002000: , HPA010122: AB_1855169, HPA071006: " "unprognostic (7.08e-2)" "unprognostic (1.06e-2)" "unprognostic (3.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.23e-2)" "unprognostic (1.80e-1)" "unprognostic (7.18e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" "prognostic favorable (8.82e-6)" "unprognostic (3.45e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.12e-2)" "unprognostic (2.83e-2)" "unprognostic (3.68e-2)" "unprognostic (4.77e-3)" 10.4 19.3 47.7 9.4 56.1 3.6 10.0 36.7 113.3 22.9 0.0 14.9 5.0 23.3 6.9 6.4 20.9 10.9 15.8 95.9 27.1 10.3 7.1 14.8 4.4 28.0 2.7 66.7 30.6 6.3 7.3 63.3 8.9 31.4 16.7 3.5 225.1 7.2 12.9 6.2 4.4 8.5 11.2 0.0 14.1 10.4 19.0 12.4 8.7 11.1 2.9 2.9 13.5 16.6 42.7 0.5 15.2 29.4 9.1 8.4 14.6 1.5 14.1 12.5 10.8 11.3 0.7 4.0 2.4 6.4 12.1 1.6 1.8 1.1 6.7 3.3 17.6 6.0 9.4 35.1 1.4 8.0 0.3 40.0 17.5 0.9 7.7 11.0 45.5 11.5 10.1 3.1 10.1 15.2 1.0 9.3 5.1 3.8 0.8 1.6 10.5 1.6 1.0 6.6 0.3 12.4 10.5 0.4 0.8 2.6 7.0 6.5 7.2 16.4 30.6 12.6 7.4 7.8 1.5 0.9 2.1 19.3 6.9 8.5 0.4 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.0 0.1 47.7 56.1 36.7 113.3 95.9 27.1 28.0 2.7 66.7 31.4 0.0 12.4 42.7 3.4 0.0 1.5 14.0 1.5 2.7 2.2 1.8 6.2 41.8 4.8 3.7 3.2 1.5 2.2 3.7 102.2 0.6 3.3 0.4 0.0 0.9 1.8 2.4 9.5 7.0 15.0 0.8 22.8 0.2 0.4 5.5 2.0 3.2 7.0 3.4 10.0 2.2 3.9 20.2 17.5 0.8 4.1 11.0 10.3 1.3 7.2 7.8 3.6 8.4 5.5 11.1 0.0 4.5 4.2 0.2 0.1 10.1 0.2 1.7 1.3 0.3 3.0 62.6 0.0 1.4 4.5 6.5 2.9 3.2 1.8 0.5 1.1 6.8 0.5 1.1 RIDA "HRSP12, P14.5, PSP, UK114" ENSG00000132541 "Reactive intermediate imine deaminase A homolog" P52758 8 98102344-98117171 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "kidney: 500.8;liver: 1549.6" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1579.1" "Group enriched" "Detected in all" 5 "liver cancer: 162.2;renal cancer: 42.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 191.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022856, HPA023489" Enhanced NA NA 5000000 "HPA022856: AB_1858253, HPA023489: AB_1858252" "unprognostic (1.67e-2)" "unprognostic (3.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (4.16e-1)" "unprognostic (2.20e-2)" "prognostic favorable (9.61e-6)" "unprognostic (6.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.81e-1)" "unprognostic (4.46e-1)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-2)" "unprognostic (1.51e-2)" 50.6 48.8 92.0 11.5 95.0 7.6 19.2 95.1 132.8 11.3 82.8 24.7 30.8 8.4 22.9 14.4 9.5 22.9 32.6 88.7 93.9 500.8 1549.6 9.6 10.2 96.5 94.5 87.4 23.6 27.2 24.8 10.1 10.9 93.7 19.5 24.9 26.8 16.5 11.7 40.4 10.7 22.0 10.9 91.4 7.5 25.0 17.3 97.4 11.3 16.0 41.3 12.4 15.6 8.0 90.3 44.0 37.5 29.3 36.6 65.5 50.4 33.0 39.7 28.0 26.4 31.0 51.4 28.4 62.5 49.6 29.4 34.5 30.8 65.4 56.9 52.5 22.3 28.6 45.0 25.6 55.6 29.9 17.6 7.0 44.4 19.5 36.6 39.9 32.4 34.2 65.3 82.7 12.9 35.5 57.8 35.6 50.1 47.0 191.4 67.8 41.0 21.7 18.4 64.6 31.6 32.2 15.7 25.5 17.4 29.2 37.4 44.5 23.5 20.9 20.6 12.5 33.7 16.3 31.2 46.1 30.9 35.0 39.0 13.2 0.2 9.0 5.6 6.6 7.8 8.7 13.8 9.4 10.1 11.1 11.5 12.0 13.0 1.9 10.3 8.3 8.5 13.9 8.1 92.0 95.0 95.1 132.8 88.7 93.9 96.5 94.5 87.4 93.7 91.4 97.4 90.3 7.8 25.6 22.4 0.0 7.4 0.0 0.0 0.0 0.0 0.0 13.8 15.1 0.0 0.0 1.8 47.8 0.0 31.1 3.2 0.0 285.7 19.7 0.0 25.1 12.3 5.0 0.0 0.0 0.0 8.5 29.9 7.9 0.0 9.4 2.5 17.7 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 5.7 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.8 0.0 0.0 1579.1 5.8 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 14.4 6.3 22.3 0.0 0.0 VPS13B "CHS1, COH1" ENSG00000132549 "Vacuolar protein sorting 13 homolog B" Q7Z7G8 8 99013266-99877580 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 160.9;Excitatory neurons: 235.2;Inhibitory neurons: 253.2;Microglial cells: 204.2;Oligodendrocyte precursor cells: 217.1;Oligodendrocytes: 238.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043865 Approved "Cell Junctions" NA NA "Cell Junctions" "HPA043865: AB_2678704" "unprognostic (4.23e-2)" "unprognostic (1.98e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-3)" "unprognostic (5.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.65e-3)" "unprognostic (8.60e-2)" "unprognostic (5.95e-2)" "unprognostic (6.52e-2)" "unprognostic (5.19e-2)" "unprognostic (1.59e-1)" "unprognostic (8.93e-3)" "unprognostic (2.90e-1)" 4.0 3.0 2.3 4.4 3.4 13.5 4.8 4.4 3.3 5.5 7.7 3.6 2.4 7.2 3.8 4.4 5.0 4.5 2.2 1.8 3.0 3.8 3.1 3.5 4.9 2.8 2.5 1.5 8.2 3.4 6.9 2.3 4.1 2.9 4.9 3.7 6.0 3.2 4.1 2.9 4.1 3.0 5.5 1.8 4.2 3.6 4.9 3.6 7.2 4.7 4.4 5.0 4.6 3.7 5.1 8.6 6.1 7.2 5.3 13.3 15.9 3.6 5.4 9.9 5.3 7.0 3.6 4.3 4.8 6.9 9.3 3.9 3.9 5.0 5.0 9.6 7.7 4.6 10.3 6.5 2.8 4.3 5.0 7.4 10.3 4.6 8.5 12.2 7.4 7.6 7.9 7.9 12.4 6.1 5.3 10.5 2.9 2.3 8.9 2.2 8.3 5.1 9.1 3.5 8.0 2.1 6.0 8.4 4.0 4.0 6.4 7.2 5.6 10.8 7.9 7.4 7.1 4.6 5.0 6.2 12.7 6.0 7.9 5.6 3.0 1.2 2.8 1.2 1.0 1.1 3.3 1.0 0.9 0.5 1.6 1.7 1.1 6.1 0.7 2.3 0.6 1.4 0.5 2.3 3.4 4.4 3.3 1.8 3.0 2.8 2.5 1.5 2.9 1.8 3.6 5.1 15.5 19.2 12.2 160.9 24.2 8.8 7.6 9.2 15.4 15.1 8.9 7.6 12.8 10.0 11.9 3.7 37.5 4.9 21.6 7.3 0.0 4.9 8.6 10.9 42.7 11.5 9.0 22.9 235.2 4.6 4.0 18.2 28.1 12.7 3.8 10.4 6.4 5.2 6.5 11.8 253.2 11.9 8.2 15.6 11.3 9.6 27.7 17.8 7.2 204.2 15.0 9.4 17.5 217.1 238.1 4.0 11.0 20.7 19.2 6.2 9.8 2.9 8.2 12.9 0.0 15.7 14.7 23.9 7.3 13.0 9.7 4.2 19.5 14.6 7.4 5.7 RGS22 "CT145, DKFZP434I092, PRTD-NY2" ENSG00000132554 "Regulator of G protein signaling 22" Q8NE09 8 99960936-100131268 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 61.9" "Group enriched" "Detected in many" 8 "Early spermatids: 619.6;Late spermatids: 1623.3" "Cancer enhanced" "Detected in some" "breast cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053026 Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA "Nucleoli fibrillar center" "Actin filaments, Cytosol" "HPA053026: " "unprognostic (3.04e-2)" "unprognostic (2.62e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-1)" "unprognostic (3.47e-5)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (1.47e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-2)" "unprognostic (7.96e-3)" "unprognostic (1.98e-5)" "unprognostic (3.71e-2)" "unprognostic (1.31e-2)" "unprognostic (3.25e-3)" "unprognostic (8.36e-4)" 2.7 0.9 4.9 0.0 2.4 0.0 0.6 2.0 1.6 1.4 8.7 0.3 0.0 2.9 1.1 0.3 10.7 1.2 0.3 0.8 7.4 0.2 0.1 1.7 0.3 5.3 5.6 0.7 7.4 0.5 0.0 1.1 0.5 3.3 1.3 0.1 1.0 0.1 2.3 0.1 0.6 0.1 1.5 4.0 0.0 0.1 61.9 3.1 0.1 0.3 0.1 0.3 0.4 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.1 0.0 0.3 1.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 2.4 2.0 1.6 0.8 7.4 5.3 5.6 0.7 3.3 4.0 3.1 2.9 0.1 0.0 0.0 14.4 0.0 2.2 0.0 1.6 0.6 1.2 1.2 0.8 0.8 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 619.6 58.1 14.2 0.7 0.0 0.0 2.3 0.0 0.2 8.6 0.5 0.8 0.0 1.3 0.0 0.0 0.2 0.0 1.6 0.0 4.1 0.0 2.9 1623.3 131.4 0.4 0.0 6.5 0.0 10.9 0.0 20.1 2.5 0.0 0.0 62.8 0.0 0.0 0.0 0.0 77.2 0.2 0.0 0.4 1.6 70.9 11.1 0.1 2.0 0.8 0.4 8.3 0.0 0.1 MATN2 ENSG00000132561 "Matrilin 2" O00339 8 97868840-98036724 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Cell line enhanced" "Detected in many" "BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033879 Approved "Secreted to extracellular matrix" NA NA 1500000 "CAB033879: AB_2141502" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-1)" "unprognostic (4.98e-1)" "unprognostic (5.35e-2)" "unprognostic (7.18e-2)" "unprognostic (5.22e-2)" "unprognostic (2.77e-1)" "unprognostic (2.07e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (6.31e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (6.65e-2)" 54.9 51.5 25.7 30.4 22.5 1.8 44.1 20.3 23.4 189.1 19.9 68.2 59.0 148.3 102.5 33.1 47.3 40.5 66.9 21.3 34.0 36.2 24.8 15.3 18.1 25.6 26.6 17.1 117.4 11.4 28.2 9.9 179.4 29.9 105.8 58.4 46.1 43.0 173.5 4.0 63.3 81.3 98.9 22.3 5.9 23.9 31.5 24.1 5.0 273.9 28.7 15.5 103.9 140.4 32.7 24.1 10.8 23.3 2.5 60.7 3.6 15.0 72.5 17.6 78.6 106.7 13.0 8.4 0.1 7.0 29.2 3.5 114.4 2.3 4.4 100.6 0.0 2.9 0.8 6.1 0.9 14.0 0.0 0.0 13.6 9.5 16.1 0.8 22.1 0.5 1.3 0.1 0.2 4.1 11.2 0.0 0.7 7.1 0.3 3.7 0.0 2.4 11.4 5.7 5.3 16.0 1.5 11.5 0.2 19.8 67.3 10.9 1.4 0.6 5.2 31.5 16.1 11.0 0.9 0.2 0.2 18.8 0.4 5.9 0.0 0.1 0.1 0.2 0.4 5.2 0.0 0.7 0.9 0.8 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 25.7 22.5 20.3 23.4 21.3 34.0 25.6 26.6 17.1 29.9 22.3 24.1 32.7 27.8 3.2 1.3 11.1 0.3 37.3 10.1 6.2 80.2 6.3 3.8 45.8 29.1 18.6 3.0 16.5 54.2 1.2 0.2 20.6 0.0 9.9 86.0 4.2 22.6 32.4 23.4 3.2 6.4 0.0 1.1 113.1 5.1 5.0 0.0 43.5 201.0 11.0 1.6 0.0 11.5 25.4 0.0 5.0 7.7 108.6 103.5 0.9 28.4 19.7 2.0 8.1 0.0 86.0 59.8 3.2 18.2 258.8 0.0 6.5 118.7 3.4 1.6 52.9 13.1 97.2 17.1 2.5 2.6 7.3 8.5 2.5 2.0 297.5 27.4 1.8 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439057-138446969 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 152.8;choroid plexus: 67.4;pituitary gland: 54.9;retina: 61.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 47.3;Cone photoreceptor cells: 70.9;Excitatory neurons: 51.2;Horizontal cells: 48.8;Inhibitory neurons: 46.1;Muller glia cells: 29.8;Rod photoreceptor cells: 73.6" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 97.3;SCLC-21H: 40.5;SH-SY5Y: 46.1;U-87 MG: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031813: AB_2674054, HPA076571: " "prognostic favorable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavorable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favorable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 4.6 9.5 103.4 2.5 98.0 0.3 3.0 89.7 152.8 3.4 67.4 14.1 1.8 7.0 1.5 4.5 3.6 2.6 16.4 107.1 100.8 1.9 0.2 0.8 0.4 122.0 105.9 96.0 4.0 2.0 1.8 54.9 0.6 132.6 8.6 2.2 61.7 1.8 8.1 16.8 2.2 4.3 12.8 68.1 0.4 7.6 6.3 130.7 1.9 1.2 5.8 0.5 8.7 4.6 120.9 0.6 7.4 27.6 97.3 3.9 10.5 0.0 8.4 3.8 11.4 12.9 5.3 1.0 0.1 1.5 10.5 0.2 0.6 26.1 5.4 8.6 3.1 23.7 0.0 1.8 12.6 9.8 0.1 0.1 3.2 0.3 6.4 0.5 19.9 2.3 27.6 0.1 6.9 3.6 4.4 2.7 1.8 17.2 0.0 0.3 9.7 2.6 0.0 2.1 0.0 40.5 46.1 2.9 0.1 7.5 7.0 2.6 0.9 0.2 6.6 6.6 6.4 15.9 18.1 12.3 0.8 36.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 103.4 98.0 89.7 152.8 107.1 100.8 122.0 105.9 96.0 132.6 68.1 130.7 120.9 17.0 0.0 0.0 18.9 0.1 0.6 1.0 1.6 2.2 47.3 0.7 3.3 9.8 0.0 0.2 1.8 70.9 0.0 0.3 0.0 0.0 0.0 1.1 0.4 0.3 5.6 4.8 0.4 51.2 0.0 0.0 3.7 0.0 0.1 0.0 1.5 0.7 0.0 0.1 48.8 46.1 0.0 0.0 0.0 0.7 5.0 0.0 0.3 0.0 2.8 0.1 29.8 0.0 19.1 5.7 0.1 0.0 2.6 1.3 0.4 3.6 0.3 0.6 73.6 0.0 7.6 2.9 0.3 9.1 0.0 0.4 0.0 0.8 0.1 0.1 0.2 PCBD2 "DCOH2, DCOHM" ENSG00000132570 "Pterin-4 alpha-carbinolamine dehydratase 2" Q9H0N5 5 134905120-135007959 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 49.9;tongue: 43.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036428 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036428: AB_10670103" "unprognostic (3.70e-2)" "unprognostic (3.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (4.22e-1)" "unprognostic (6.43e-2)" "unprognostic (4.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.57e-2)" "unprognostic (6.34e-2)" "unprognostic (9.32e-3)" "unprognostic (1.50e-1)" 5.4 7.8 7.3 4.8 8.5 7.7 6.1 7.6 7.6 3.7 9.8 6.1 9.6 4.3 4.2 8.4 5.7 4.6 17.3 6.4 8.2 10.3 12.0 4.9 6.0 9.5 7.8 6.9 5.1 8.0 13.1 3.8 3.6 9.1 5.4 7.1 9.9 9.7 3.8 49.9 9.2 8.1 3.7 6.7 5.9 8.3 3.3 8.3 5.6 9.7 43.0 6.1 4.5 5.0 10.8 7.5 7.2 9.4 6.9 5.7 5.2 5.2 6.0 5.2 3.8 3.8 12.0 17.5 8.7 8.8 4.4 6.1 6.5 5.6 5.9 3.4 12.3 3.1 6.0 9.5 7.1 5.4 7.1 3.6 3.4 7.1 3.6 7.6 5.1 4.3 7.7 7.7 12.2 6.9 13.0 7.5 12.3 5.1 11.5 6.9 10.9 8.4 9.7 8.1 7.4 7.2 9.2 10.4 6.0 9.1 7.1 13.0 9.4 5.9 6.4 4.3 7.1 8.1 10.6 15.7 5.5 7.8 8.8 4.8 5.7 5.1 5.4 3.6 4.5 2.9 4.5 4.0 3.4 4.4 4.2 3.8 4.3 2.8 4.0 4.6 7.7 3.9 2.7 7.3 8.5 7.6 7.6 6.4 8.2 9.5 7.8 6.9 9.1 6.7 8.3 10.8 4.2 9.6 10.3 28.7 8.8 3.6 6.4 15.8 7.4 13.5 11.7 8.4 32.5 20.0 12.5 16.5 12.5 13.6 10.1 13.6 21.5 17.1 8.4 7.9 6.1 6.9 4.2 31.5 10.6 18.2 24.4 5.8 13.3 8.7 6.3 22.4 7.1 23.1 24.6 23.5 12.9 9.5 20.3 10.0 9.6 3.5 7.2 10.2 5.4 17.8 26.9 14.8 7.2 13.0 20.6 17.8 6.2 2.2 13.1 7.1 26.5 26.3 11.9 45.9 0.0 9.0 7.4 5.2 11.5 13.8 6.0 10.1 7.8 9.5 15.9 8.7 SDF2 ENSG00000132581 "Stromal cell derived factor 2" Q99470 17 28648346-28662189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 211.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042799 Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA042799: AB_10794533" "unprognostic (3.91e-1)" "unprognostic (2.79e-1)" "unprognostic (2.03e-1)" "unprognostic (5.77e-3)" "unprognostic (3.90e-2)" "unprognostic (1.88e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.28e-3)" "unprognostic (3.20e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.52e-1)" "unprognostic (1.79e-1)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (7.75e-3)" "unprognostic (6.61e-2)" 14.4 32.4 13.8 8.8 13.8 8.9 14.3 14.5 15.3 17.7 17.0 15.5 8.1 14.5 27.5 13.9 17.4 13.1 15.9 14.3 15.6 17.5 23.4 15.5 9.5 14.7 14.8 14.1 19.9 20.1 20.2 19.2 20.7 15.0 18.3 11.2 6.7 22.0 15.9 14.8 11.5 13.1 14.5 14.7 16.2 15.5 9.4 14.9 12.8 16.3 13.1 8.2 20.4 14.4 14.8 18.8 54.3 25.2 18.7 107.1 29.6 18.0 53.6 48.4 39.6 49.8 34.6 23.5 8.0 47.8 57.6 36.6 30.5 24.7 22.6 27.8 62.3 29.8 13.7 26.6 28.6 30.9 8.1 17.2 53.7 28.5 38.3 8.8 34.4 39.9 11.0 14.9 19.4 45.1 35.9 20.7 22.2 12.9 48.8 19.2 12.5 37.1 24.8 45.3 29.6 15.6 18.1 42.3 32.4 30.3 37.5 43.7 10.4 45.0 21.0 23.3 24.2 31.2 25.2 35.2 11.9 32.0 12.9 23.9 189.1 45.1 129.1 64.4 39.6 62.6 50.8 52.2 62.8 30.0 44.4 47.1 55.9 203.1 71.1 42.1 62.5 74.2 59.7 13.8 13.8 14.5 15.3 14.3 15.6 14.7 14.8 14.1 15.0 14.7 14.9 14.8 61.1 25.6 21.7 10.4 45.5 34.0 59.1 125.6 41.5 26.4 49.4 44.6 13.1 38.6 71.1 42.3 25.0 130.3 74.0 82.8 29.4 74.8 7.4 36.2 43.6 52.2 57.1 37.5 11.1 47.2 109.0 52.6 27.5 44.9 21.0 47.2 53.2 46.2 56.7 13.5 12.2 57.5 71.2 44.9 49.7 3.9 76.1 38.1 37.4 8.4 50.2 49.9 56.7 11.1 17.8 80.4 90.4 66.5 46.2 54.1 88.0 50.7 47.8 31.1 72.3 36.7 48.1 30.5 32.1 40.6 37.6 211.0 53.2 86.0 46.2 86.9 FLOT2 "ECS-1, ECS1, ESA, ESA1, M17S1" ENSG00000132589 "Flotillin 2" Q14254 17 28879335-28897733 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001396, CAB004395, HPA071038" Supported Supported "Vesicles,Plasma membrane" NA NA 170000 "Plasma membrane" Vesicles "CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: " "unprognostic (6.04e-2)" "unprognostic (8.76e-3)" "unprognostic (3.01e-1)" "unprognostic (8.92e-2)" "unprognostic (4.15e-3)" "unprognostic (2.17e-2)" "unprognostic (4.36e-3)" "unprognostic (2.12e-1)" "unprognostic (5.21e-2)" "unprognostic (1.20e-1)" "unprognostic (9.98e-2)" "unprognostic (2.80e-1)" "unprognostic (4.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (2.20e-2)" 59.5 46.8 34.8 57.3 35.0 98.0 56.7 24.6 48.0 43.2 40.9 55.0 21.2 39.4 21.4 69.9 47.2 27.2 54.6 37.6 37.3 71.6 99.2 60.0 68.8 44.0 34.3 35.4 38.0 39.1 30.2 22.5 58.9 38.8 68.4 27.4 20.5 62.2 52.0 52.1 38.4 53.5 35.7 33.2 123.7 45.0 10.5 39.2 48.3 40.0 44.5 64.1 79.4 50.0 42.9 55.5 90.8 69.6 60.2 33.6 44.2 76.6 42.5 57.9 60.9 71.3 96.0 45.7 76.9 79.3 47.6 42.0 63.3 76.5 69.7 25.9 245.5 91.4 92.7 80.5 70.3 43.6 76.8 15.2 53.3 53.6 49.3 66.9 64.1 97.4 21.8 89.0 65.6 28.9 83.5 21.2 54.0 61.4 48.6 24.6 32.6 70.6 189.3 92.0 166.9 61.9 103.3 99.8 69.6 77.5 66.7 72.3 136.3 81.5 21.4 38.2 35.2 65.0 36.5 68.2 39.5 59.9 72.3 40.7 171.9 106.0 213.2 98.8 96.6 72.6 98.5 74.6 84.5 144.3 118.1 55.3 69.0 415.2 78.5 110.2 38.8 97.6 143.2 34.8 35.0 24.6 48.0 37.6 37.3 44.0 34.3 35.4 38.8 33.2 39.2 42.9 34.2 22.4 21.9 12.7 46.8 12.6 27.1 20.6 29.6 6.9 24.9 30.1 32.9 22.8 16.5 20.2 10.4 96.6 20.5 29.0 15.6 39.3 13.0 25.8 13.2 37.0 25.8 49.2 17.0 31.1 68.9 14.8 23.0 27.6 6.3 15.6 48.9 45.1 44.4 5.0 19.2 25.9 10.2 43.3 22.6 42.3 10.8 31.1 8.8 22.5 75.2 10.7 35.0 16.1 11.0 32.2 16.5 8.6 27.8 14.8 14.8 26.7 19.1 12.4 19.7 7.1 13.4 1.6 6.9 42.4 9.2 37.1 32.5 4.2 32.0 26.7 ERAL1 HERA-B ENSG00000132591 "Era like 12S mitochondrial rRNA chaperone 1" O75616 17 28855010-28861061 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021425, HPA024423" Supported Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA021425: AB_1848228, HPA024423: AB_1848229" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (5.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.55e-1)" "unprognostic (8.37e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (8.20e-2)" "unprognostic (7.04e-2)" "unprognostic (2.70e-1)" "unprognostic (8.57e-3)" "unprognostic (5.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.49e-1)" "unprognostic (2.62e-1)" "unprognostic (5.79e-2)" 20.3 32.8 47.6 17.7 48.0 18.7 23.7 48.7 62.2 20.9 44.6 26.1 22.2 22.3 22.9 29.1 26.4 15.2 33.8 48.0 48.4 29.5 41.5 18.5 22.2 48.4 47.7 48.1 25.8 23.8 36.5 19.0 24.7 48.3 21.2 28.4 17.0 22.8 24.1 53.1 26.3 20.1 26.7 47.3 21.2 26.6 18.0 48.9 24.0 19.4 52.3 29.8 22.3 20.8 49.9 50.4 96.2 55.9 63.1 59.1 40.6 53.4 40.1 56.2 117.1 95.9 94.5 31.7 64.1 47.0 68.8 87.9 55.2 102.0 90.0 97.5 63.6 119.8 52.2 60.6 95.8 75.5 63.0 45.7 53.5 78.1 95.3 89.3 46.1 97.2 80.4 104.4 39.9 66.4 78.7 66.1 98.4 50.6 91.8 46.0 59.7 87.6 83.4 71.3 56.1 58.6 47.1 64.5 155.6 51.6 82.2 110.0 71.8 39.7 48.1 53.1 52.9 84.6 32.0 62.3 69.9 51.4 54.4 49.1 25.5 34.2 14.4 32.2 44.6 24.2 38.9 26.9 23.5 54.9 36.3 30.8 32.2 2.6 42.8 31.6 28.7 32.1 30.8 47.6 48.0 48.7 62.2 48.0 48.4 48.4 47.7 48.1 48.3 47.3 48.9 49.9 12.4 6.4 2.8 5.9 14.0 8.0 12.7 33.9 12.0 10.9 14.9 18.3 8.0 17.2 13.9 11.0 6.2 69.1 9.9 13.4 37.2 28.1 1.0 11.1 14.0 14.4 21.6 20.4 7.2 21.6 55.2 15.8 19.9 13.3 5.1 24.8 14.3 21.7 35.6 11.8 7.8 15.0 26.4 8.5 6.7 5.4 14.3 12.4 10.6 3.7 66.6 16.4 9.2 5.5 4.3 21.1 12.9 15.8 29.2 15.1 20.0 33.3 9.7 9.0 19.7 11.0 15.6 22.3 21.7 25.4 11.6 51.7 10.4 25.0 26.6 9.9 PRMT7 "FLJ10640, KIAA1933" ENSG00000132600 "Protein arginine methyltransferase 7" Q9NVM4 16 68310974-68358584 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044241 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA044241: AB_2678869" "unprognostic (9.33e-2)" "unprognostic (5.33e-2)" "unprognostic (1.52e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (4.12e-2)" "unprognostic (1.22e-1)" "unprognostic (3.74e-1)" "unprognostic (1.19e-1)" "unprognostic (4.74e-3)" "unprognostic (3.09e-2)" "unprognostic (7.72e-2)" "unprognostic (1.75e-1)" "unprognostic (9.23e-2)" "unprognostic (3.57e-1)" "unprognostic (1.31e-1)" 9.6 12.0 6.3 6.2 6.3 4.7 10.6 6.7 10.3 9.8 9.5 9.7 3.2 9.5 3.4 7.6 10.8 4.3 12.3 6.6 6.6 7.9 10.3 5.9 9.4 7.1 7.0 6.0 12.2 9.7 4.8 11.2 6.3 7.0 10.6 3.0 4.7 10.1 7.0 22.0 9.5 8.8 4.5 6.4 9.7 8.8 9.9 6.8 14.5 8.7 13.6 5.8 9.8 8.4 6.7 18.1 24.7 13.2 36.1 7.1 7.0 50.8 13.8 6.8 19.5 15.6 79.4 16.1 42.4 29.8 14.0 8.4 22.6 20.4 13.8 12.6 12.7 24.5 8.6 30.8 36.8 7.8 24.3 15.8 11.3 4.9 15.2 14.0 9.3 11.8 18.7 28.1 0.8 10.3 28.2 25.8 36.3 25.3 16.5 18.8 43.7 19.3 25.7 10.7 17.7 19.8 13.2 53.5 16.2 15.7 11.9 25.2 22.2 16.0 14.7 12.9 19.9 17.6 9.6 22.5 41.6 17.1 23.4 16.8 12.3 8.2 7.1 17.4 10.6 20.2 10.9 11.6 14.9 11.8 12.8 16.7 15.4 0.8 21.4 9.5 32.9 14.7 14.3 6.3 6.3 6.7 10.3 6.6 6.6 7.1 7.0 6.0 7.0 6.4 6.8 6.7 7.1 19.2 10.6 16.6 12.1 6.9 8.9 12.8 9.1 21.2 10.8 8.8 13.3 8.6 10.0 9.2 54.2 25.4 12.6 28.3 5.9 12.3 4.4 12.9 8.7 7.6 13.2 7.8 25.0 16.1 8.4 10.5 23.4 5.9 7.0 24.9 6.8 8.4 12.2 30.3 25.9 32.4 10.2 7.7 20.6 4.3 11.8 6.2 8.8 12.2 9.1 9.7 13.4 18.6 20.4 23.6 29.8 13.2 6.9 6.7 24.7 7.7 14.5 18.2 13.1 9.9 8.6 6.9 19.3 6.1 6.0 11.6 16.5 10.0 24.1 12.7 NIP7 "CGI-37, FLJ10296, HSPC031, KD93" ENSG00000132603 "Nucleolar pre-rRNA processing protein NIP7" Q9Y221 16 69337996-69343106 "Predicted intracellular proteins" "Ribosome biogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040856, HPA059850" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA040856: AB_2677171, HPA059850: AB_2684142" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.04e-3)" "unprognostic (1.37e-3)" "unprognostic (5.72e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (6.99e-2)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 18.0 14.3 7.4 18.1 7.8 26.5 16.1 8.0 8.2 11.5 9.3 16.8 14.6 11.4 14.3 17.4 12.3 13.0 7.8 8.1 7.8 13.4 17.4 10.7 23.8 7.8 7.7 7.1 7.4 10.4 11.5 5.2 14.6 8.4 9.9 16.3 3.5 8.6 9.0 8.7 12.8 12.1 14.3 8.3 13.2 11.6 12.4 8.0 21.6 11.3 9.9 27.1 25.1 8.7 8.8 57.9 39.7 31.2 43.0 44.0 38.5 48.8 52.7 40.6 87.8 62.7 66.7 61.6 105.5 57.1 48.3 36.5 60.1 63.7 80.0 112.5 28.9 51.2 53.8 27.0 83.6 42.6 118.1 34.0 42.2 63.1 83.1 88.7 25.7 50.5 60.7 115.1 17.5 62.3 69.8 78.6 81.9 94.4 50.9 47.7 108.6 34.3 95.7 54.6 38.8 41.3 57.8 107.8 31.0 59.8 35.0 44.3 72.4 43.5 63.5 54.7 49.5 97.0 54.4 45.0 250.2 37.9 69.4 63.4 16.7 12.7 9.8 28.4 14.9 29.9 28.9 25.2 33.3 22.8 21.1 23.3 30.1 4.3 24.8 21.4 20.7 28.9 16.9 7.4 7.8 8.0 8.2 8.1 7.8 7.8 7.7 7.1 8.4 8.3 8.0 8.8 28.2 3.2 12.7 3.9 33.7 53.7 58.1 34.6 45.5 8.8 21.7 18.3 5.5 14.3 21.1 20.2 16.7 33.2 33.2 14.7 21.5 35.9 43.8 24.5 32.0 28.3 3.0 37.9 5.1 26.1 36.5 24.0 11.2 23.2 17.7 20.5 18.2 12.1 24.8 11.8 4.5 12.7 30.5 12.2 19.2 41.4 17.1 14.7 19.6 1.9 18.3 9.2 35.0 3.0 6.4 37.5 16.6 17.3 15.6 46.2 14.6 28.9 25.6 8.1 13.1 35.2 25.9 40.7 43.8 43.0 52.6 25.6 33.2 36.2 20.8 42.2 TERF2 "TRBF2, TRF2" ENSG00000132604 "Telomeric repeat binding factor 2" Q15554 16 69355567-69408571 "Predicted intracellular proteins" "Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001907, HPA002735, CAB010451" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898" "unprognostic (2.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.13e-2)" "unprognostic (6.07e-2)" "unprognostic (3.45e-2)" "unprognostic (3.42e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.00e-1)" "unprognostic (5.79e-2)" "unprognostic (2.92e-1)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" 14.9 14.5 19.0 17.4 19.7 18.7 14.2 22.0 29.3 15.5 9.0 15.6 13.5 18.1 15.2 15.2 15.5 13.8 15.2 20.3 17.4 12.8 14.9 12.7 35.9 16.9 16.9 20.1 19.4 16.9 18.4 12.5 16.3 19.0 13.4 14.6 21.1 12.0 14.3 32.2 15.5 14.1 19.3 14.4 16.0 12.7 16.5 16.5 21.2 16.8 22.3 45.0 15.7 13.6 22.3 21.6 34.4 30.5 30.8 28.5 20.9 26.0 21.5 26.9 50.1 38.7 31.7 28.6 98.2 28.6 26.7 17.9 34.0 37.8 26.4 46.7 18.6 29.3 28.8 18.2 29.1 24.2 28.6 23.0 21.5 26.2 40.2 48.7 22.2 35.0 38.4 54.8 14.2 32.8 29.2 57.0 36.4 35.1 23.6 16.7 78.5 20.2 56.8 21.6 15.8 34.4 27.0 71.4 16.1 19.6 27.5 30.6 32.8 21.5 31.3 27.4 21.9 25.9 36.8 42.1 124.9 27.1 25.5 30.8 14.9 3.5 4.3 5.9 3.3 4.3 13.0 5.6 5.0 3.7 8.4 6.3 6.2 4.2 4.6 3.5 5.0 5.0 2.8 19.0 19.7 22.0 29.3 20.3 17.4 16.9 16.9 20.1 19.0 14.4 16.5 22.3 16.2 16.0 10.2 15.0 20.9 12.5 12.8 5.0 5.7 25.3 13.4 8.5 17.2 5.7 5.1 9.2 18.8 8.3 13.0 15.5 1.9 5.3 33.4 15.5 20.8 17.9 10.2 8.6 18.3 7.5 7.7 13.5 8.6 20.5 14.0 14.9 14.3 18.2 12.5 45.4 19.9 11.6 2.0 15.4 12.3 19.5 9.3 11.0 3.6 16.9 8.9 19.3 16.5 18.6 26.5 7.9 7.3 14.3 11.2 14.8 9.5 8.4 8.3 13.9 19.7 18.8 12.1 8.8 13.1 9.6 12.9 8.3 12.1 17.0 11.1 12.8 VPS4A "FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1" ENSG00000132612 "Vacuolar protein sorting 4 homolog A" Q9UN37 16 69311350-69326939 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018751, CAB034411, HPA060092" Approved Supported Midbody Yes NA Midbody "CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203" "unprognostic (2.60e-2)" "unprognostic (2.32e-2)" "unprognostic (1.26e-1)" "unprognostic (9.26e-2)" "unprognostic (4.03e-1)" "unprognostic (1.20e-1)" "unprognostic (2.55e-2)" "unprognostic (2.70e-2)" "unprognostic (4.63e-2)" "unprognostic (8.61e-2)" "unprognostic (3.91e-3)" "unprognostic (2.19e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.44e-2)" "unprognostic (1.46e-1)" "unprognostic (2.61e-1)" "unprognostic (6.79e-2)" 13.1 15.5 15.8 8.9 16.4 8.9 12.9 15.7 17.2 10.2 10.6 12.8 13.6 11.8 8.2 16.1 10.3 9.5 18.5 15.3 14.4 17.8 11.7 10.0 11.9 16.4 16.7 14.0 12.3 28.0 20.8 7.6 10.1 16.6 10.5 7.7 10.3 20.0 8.5 54.5 15.1 12.9 8.4 15.6 9.3 17.7 6.9 16.1 6.2 16.9 33.9 7.4 11.5 11.4 18.0 21.1 34.9 23.2 30.7 21.2 18.8 20.5 27.9 25.2 36.4 24.3 33.4 19.0 35.0 27.3 28.0 17.5 30.3 23.9 28.2 21.8 14.8 30.8 22.0 20.7 26.3 32.6 27.5 19.6 21.7 36.3 31.6 28.7 21.4 27.4 27.3 37.0 10.3 27.2 46.8 36.4 20.5 26.7 20.6 24.5 47.8 19.0 41.3 18.5 16.8 39.1 24.7 59.3 18.1 21.4 15.4 31.4 20.6 32.8 33.2 20.8 30.4 22.1 36.9 31.3 62.6 30.4 18.2 37.1 8.8 9.9 13.3 11.2 8.7 10.0 8.5 9.3 13.9 9.4 7.4 10.5 9.9 7.5 8.0 11.5 5.5 11.8 13.8 15.8 16.4 15.7 17.2 15.3 14.4 16.4 16.7 14.0 16.6 15.6 16.1 18.0 39.8 25.6 19.0 14.7 33.8 30.7 37.3 22.2 22.8 51.4 30.2 28.2 31.0 22.8 16.7 23.9 22.9 59.8 48.4 48.9 74.3 51.7 11.2 14.9 27.0 34.9 31.3 43.6 14.5 82.5 66.5 32.9 29.0 25.6 29.2 36.3 31.8 21.6 45.1 74.0 14.9 34.2 20.3 33.7 24.6 11.9 29.5 30.2 44.4 5.6 40.9 66.0 38.1 4.5 16.8 67.4 42.2 30.5 31.9 67.6 76.4 57.7 6.4 41.8 52.6 36.0 38.9 28.7 38.3 27.1 31.3 70.1 35.6 26.0 41.4 41.2 MTSS2 "ABBA, ABBA-1, LOC92154, MTSS1L" ENSG00000132613 "MTSS I-BAR domain containing 2" Q765P7 16 70661204-70686053 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 419.2" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 48.0" "Cancer enhanced" "Detected in all" "glioma: 26.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 299.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048531, HPA066469" Approved Supported "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA048531: AB_2680430, HPA066469: AB_2685671" "prognostic unfavorable (2.85e-4)" "unprognostic (8.85e-2)" "unprognostic (7.01e-2)" "unprognostic (5.99e-2)" "unprognostic (3.21e-1)" "unprognostic (2.98e-1)" "unprognostic (1.86e-1)" "unprognostic (1.82e-1)" "unprognostic (5.30e-2)" "unprognostic (1.31e-1)" "unprognostic (5.59e-3)" "unprognostic (3.88e-1)" "unprognostic (2.92e-3)" "unprognostic (9.87e-2)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.25e-2)" 32.0 40.8 291.8 21.0 247.2 9.5 27.1 278.1 281.2 64.9 78.7 66.2 14.4 79.6 6.2 51.2 47.8 29.3 33.6 289.7 278.5 25.0 106.8 47.7 10.2 419.2 257.5 160.8 35.9 13.8 12.9 25.2 36.3 288.0 42.4 8.3 25.8 30.9 37.4 81.9 32.1 27.7 60.5 246.5 58.8 30.1 10.9 318.9 42.9 21.4 30.1 8.0 47.0 46.4 268.6 67.2 157.4 38.9 40.4 31.6 31.2 146.4 98.8 122.0 83.0 68.5 63.8 41.9 0.8 34.6 155.5 33.0 136.9 42.5 43.2 31.5 1.2 56.9 23.2 137.7 299.9 278.1 35.0 1.1 129.3 92.6 38.6 133.0 35.7 27.6 35.0 88.8 1.4 74.8 164.1 33.4 177.8 34.2 22.6 33.1 70.6 72.5 0.4 72.4 99.0 91.1 61.0 210.5 90.6 27.2 36.6 69.9 67.2 41.9 64.3 72.6 59.0 62.7 23.4 6.4 1.2 58.3 1.0 22.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 291.8 247.2 278.1 281.2 289.7 278.5 419.2 257.5 160.8 288.0 246.5 318.9 268.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 48.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 HSPA12B "C20orf60, dJ1009E24.2" ENSG00000132622 "Heat shock protein family A (Hsp70) member 12B" Q96MM6 20 3732685-3753111 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 65.0;Endothelial cells: 50.1;Hepatic stellate cells: 16.1;Late spermatids: 16.8;Microglial cells: 15.0;Peritubular cells: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.9;EFO-21: 4.9;HUVEC TERT2: 9.5;TIME: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013659, HPA015639" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013659: AB_1234541, HPA015639: AB_1851192" "unprognostic (1.00e-1)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (6.99e-2)" "unprognostic (4.53e-2)" "unprognostic (2.09e-1)" "unprognostic (1.21e-1)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.07e-2)" "unprognostic (6.45e-2)" "unprognostic (8.74e-2)" "unprognostic (2.61e-2)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (4.05e-1)" "unprognostic (1.66e-2)" 23.0 4.1 8.7 3.0 7.5 1.4 23.2 6.0 7.9 15.1 4.4 6.4 1.8 12.6 1.2 4.2 10.4 4.8 19.5 5.9 6.4 9.1 1.7 20.8 1.7 7.5 7.3 4.6 8.3 2.6 1.5 2.9 11.4 6.9 4.9 1.3 0.4 5.4 1.9 12.5 7.0 6.2 4.0 5.8 25.5 5.2 5.3 9.2 0.8 9.2 10.3 0.9 10.3 10.3 8.4 0.5 1.7 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.9 0.1 0.2 4.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 2.6 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.4 9.5 0.4 0.3 0.2 0.0 1.0 0.4 0.9 1.0 0.0 0.8 1.8 0.2 0.5 0.0 0.0 0.9 0.7 0.3 0.2 0.1 0.1 0.2 0.5 5.3 0.1 2.2 0.7 0.4 0.4 0.3 0.5 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 8.7 7.5 6.0 7.9 5.9 6.4 7.5 7.3 4.6 6.9 5.8 9.2 8.4 65.0 0.0 0.0 0.3 0.4 1.9 0.1 0.0 0.0 0.5 0.7 0.3 5.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 9.8 0.2 3.2 50.1 0.0 0.0 0.5 0.0 0.2 10.5 0.0 0.1 0.0 0.1 16.1 0.3 0.5 0.0 0.4 0.0 0.0 1.4 2.5 16.8 7.5 0.2 0.0 15.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.2 2.0 3.5 1.7 0.3 1.1 0.4 0.3 0.7 0.0 0.2 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 14.1;testis: 14.7" "Group enriched" "Detected in many" 21 "Early spermatids: 323.1;Late spermatids: 383.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/84: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favorable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.11e-1)" 2.4 1.5 1.5 1.5 1.1 0.6 3.2 2.7 1.5 2.2 2.5 2.6 2.5 1.0 1.0 2.5 4.0 2.2 1.0 1.0 1.6 2.5 4.0 1.7 1.3 1.5 1.3 0.9 2.3 14.1 4.4 2.2 0.7 1.6 1.9 2.3 5.4 2.7 2.1 0.6 2.8 2.5 0.7 1.0 1.2 3.7 14.7 1.8 1.7 5.8 0.6 1.9 1.6 1.3 1.8 9.0 8.7 0.9 2.1 2.2 1.5 5.9 1.3 0.1 1.6 0.8 5.1 7.2 0.1 2.4 0.3 9.7 7.1 2.3 9.0 1.9 0.0 1.4 1.1 2.2 5.3 1.0 0.9 0.2 3.9 9.8 1.5 1.4 4.0 1.4 3.2 3.4 6.1 0.4 2.4 1.4 0.0 4.4 11.2 2.4 0.0 0.1 5.6 5.3 5.5 6.5 3.1 3.8 8.7 0.0 3.2 7.2 0.8 0.9 1.1 1.4 0.1 1.4 7.0 14.2 1.3 2.4 0.4 1.2 0.0 0.0 0.0 0.7 0.0 1.1 0.5 0.7 0.5 0.0 0.4 1.0 0.6 0.1 0.5 0.0 0.5 0.7 0.2 1.5 1.1 2.7 1.5 1.0 1.6 1.5 1.3 0.9 1.6 1.0 1.8 1.8 0.5 3.2 6.7 1.3 2.0 0.3 2.3 1.6 3.4 1.7 3.4 1.8 1.8 2.8 2.0 7.3 0.0 2.2 1.2 2.7 1.9 4.5 323.1 6.7 1.0 1.8 5.3 0.4 1.1 6.3 2.0 0.9 10.7 2.8 1.3 0.7 0.7 9.1 1.3 3.3 2.8 3.8 2.0 0.3 0.6 383.0 3.4 1.4 0.0 1.0 0.0 0.8 3.1 0.5 0.4 5.3 4.2 4.1 4.8 1.9 3.3 2.8 16.2 4.9 0.0 0.7 0.3 5.1 3.4 8.6 0.3 1.5 2.6 1.1 3.7 1.5 SCP2D1 "C20orf79, dJ1068E13.2, HSD22" ENSG00000132631 "SCP2 sterol binding domain containing 1" Q9UJQ7 20 18813783-18814378 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 568 "testis: 56.8" "Group enriched" "Detected in some" 163 "Early spermatids: 853.9;Late spermatids: 975.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 853.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 975.1 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCED1A "bA12M19.1, C20orf81, FAM113A, FLJ22376" ENSG00000132635 "PC-esterase domain containing 1A" Q9H1Q7 20 2835314-2841190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050816 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050816: AB_2681246" "unprognostic (3.20e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-3)" "unprognostic (1.90e-2)" "unprognostic (3.42e-1)" "unprognostic (6.91e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (1.00e-1)" "unprognostic (8.02e-2)" "unprognostic (2.99e-1)" "prognostic favorable (5.96e-5)" "unprognostic (1.03e-1)" "unprognostic (1.29e-2)" "unprognostic (4.10e-1)" "unprognostic (2.48e-1)" "unprognostic (7.30e-2)" "unprognostic (2.97e-3)" 38.7 44.6 62.5 31.1 61.9 22.4 35.8 57.3 74.7 58.6 65.4 30.9 24.8 40.3 27.4 32.0 53.8 26.3 26.4 58.3 59.5 61.2 58.3 43.0 37.1 63.7 59.9 57.1 63.9 41.6 40.5 63.8 23.5 62.5 66.5 12.7 18.4 35.3 19.9 13.6 19.2 48.1 21.2 58.1 82.5 41.5 26.1 60.7 23.7 87.0 9.1 24.4 40.9 42.9 68.1 31.2 39.1 39.4 21.6 39.8 54.5 29.1 29.2 32.5 29.7 32.2 27.3 54.5 9.1 20.0 19.5 49.5 50.3 9.3 27.1 13.7 45.4 31.0 36.0 49.9 38.7 32.2 6.8 11.6 73.0 56.0 36.3 48.4 42.7 21.7 45.3 28.9 40.1 22.2 20.9 4.9 45.5 44.3 23.3 25.4 24.7 13.3 18.9 33.7 24.7 37.2 57.4 29.8 37.1 51.7 24.9 48.0 23.2 21.6 29.1 20.4 30.4 14.0 69.0 36.5 2.6 7.1 24.8 35.1 3.6 8.2 3.5 11.0 7.3 10.9 9.8 6.7 9.8 9.2 9.8 12.1 11.0 0.6 16.1 7.7 8.0 4.8 8.3 62.5 61.9 57.3 74.7 58.3 59.5 63.7 59.9 57.1 62.5 58.1 60.7 68.1 9.9 16.0 19.8 16.0 13.8 4.0 10.6 8.6 30.1 11.9 12.7 13.2 4.9 8.6 10.5 9.2 10.4 5.1 12.8 6.0 13.7 5.0 0.7 12.4 32.3 11.7 8.4 7.2 4.8 2.1 2.5 15.4 22.4 10.1 0.0 18.1 11.0 14.0 6.9 11.8 6.9 9.1 6.1 9.5 6.8 3.0 9.0 12.8 1.8 8.4 5.1 9.6 5.2 8.0 11.6 4.0 8.5 2.2 11.4 6.6 8.6 12.4 8.5 12.4 6.6 7.1 12.3 13.2 7.4 15.1 3.7 3.4 12.2 17.6 7.5 8.3 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 20 "brain: 1734.8;retina: 496.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4" "Cancer enriched" "Detected in many" 4 "glioma: 28.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane" NA NA 9000 "Plasma membrane" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 1.1 44.0 286.2 4.1 532.6 0.2 4.5 747.0 1734.8 0.6 6.5 4.6 3.7 8.0 13.0 0.5 7.7 2.4 2.1 577.6 395.1 1.4 1.0 1.8 0.4 555.5 239.8 514.1 7.0 6.4 1.2 54.8 0.6 572.7 3.2 2.3 496.3 0.5 19.7 0.8 0.6 4.0 8.2 142.0 0.2 6.4 3.7 407.5 0.5 0.7 0.1 0.4 1.1 1.6 1274.2 0.0 4.7 3.9 0.0 0.4 0.1 0.0 2.0 0.0 4.8 1.4 0.0 0.0 0.0 4.3 0.0 3.4 0.8 0.6 0.0 9.6 0.5 0.3 0.0 6.8 0.7 3.5 0.0 0.5 4.4 0.0 3.9 0.0 10.7 0.0 2.8 0.0 23.8 1.6 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.0 0.1 0.9 0.0 78.2 46.6 0.7 0.1 0.0 2.4 0.0 6.5 0.0 5.0 6.8 0.0 2.3 0.1 12.9 0.1 56.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 286.2 532.6 747.0 1734.8 577.6 395.1 555.5 239.8 514.1 572.7 142.0 407.5 1274.2 0.5 0.0 0.0 117.2 0.0 0.8 1.4 0.1 0.0 559.2 0.2 1.3 0.5 8.6 0.0 0.0 106.3 0.0 0.2 0.0 0.0 0.2 16.3 0.1 0.7 5.2 43.5 0.0 1015.8 0.0 0.1 3.9 0.0 0.2 0.0 0.6 0.0 0.2 0.1 65.6 552.8 3.4 0.0 0.0 0.4 83.3 17.1 0.1 1.8 120.9 0.0 71.9 0.0 179.4 113.3 1.0 2.6 68.8 0.0 0.6 0.1 3.0 0.0 254.4 0.0 0.0 1.3 1.1 0.4 0.0 0.9 0.0 0.0 2.6 0.1 0.1 BTBD3 "dJ742J24.1, KIAA0952" ENSG00000132640 "BTB domain containing 3" Q9Y2F9 20 11890723-11926609 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.9" "Cell type enhanced" "Detected in all" "Endometrial stromal cells: 223.0;Oligodendrocytes: 254.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 241.1;HeLa: 186.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041424, HPA042048" Uncertain Supported Vesicles NA NA Vesicles "HPA041424: AB_10794667, HPA042048: AB_10796469" "unprognostic (3.93e-2)" "unprognostic (2.25e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-3)" "unprognostic (4.24e-3)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.51e-5)" "prognostic unfavorable (6.94e-4)" "unprognostic (4.87e-2)" "unprognostic (2.95e-1)" "unprognostic (1.07e-2)" "unprognostic (7.05e-2)" "unprognostic (6.66e-2)" "unprognostic (7.68e-3)" "unprognostic (1.67e-1)" "unprognostic (6.29e-2)" "unprognostic (1.37e-2)" 11.3 22.3 23.1 7.2 30.4 12.3 12.8 64.9 79.9 14.3 8.8 21.6 10.8 18.9 7.9 9.9 15.5 13.5 14.0 75.4 24.6 11.7 7.8 12.3 4.1 24.2 25.3 23.6 11.6 13.8 11.3 9.0 42.3 23.0 15.3 17.7 42.9 14.0 10.7 16.1 20.9 11.0 16.7 18.7 7.8 27.6 14.9 23.4 10.9 11.6 13.3 3.1 18.5 10.2 63.7 7.0 19.5 52.1 241.1 10.6 11.3 14.0 21.9 14.0 24.3 15.5 11.2 10.7 2.0 18.1 31.7 9.6 18.1 27.2 15.4 39.1 0.1 24.1 7.1 186.9 23.9 11.1 11.6 4.2 20.2 18.8 21.8 17.5 13.4 13.8 12.0 12.7 18.8 24.3 5.1 14.0 10.7 25.0 29.0 5.5 18.4 10.4 7.0 22.2 34.0 22.7 40.0 60.8 24.6 53.3 27.9 14.4 11.5 10.7 13.2 33.6 12.4 24.6 6.9 9.9 0.3 8.6 3.2 87.6 0.0 1.2 0.1 0.0 1.7 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.0 0.3 0.7 3.5 1.0 0.0 0.6 23.1 30.4 64.9 79.9 75.4 24.6 24.2 25.3 23.6 23.0 18.7 23.4 63.7 17.4 16.0 8.4 24.5 2.8 16.6 10.8 8.0 18.8 15.3 15.2 11.9 16.5 10.0 8.3 5.5 79.2 23.3 1.0 41.0 3.9 9.8 8.3 51.3 223.0 25.0 20.9 4.6 46.9 8.3 4.0 15.6 28.5 55.8 2.5 9.4 33.5 8.5 8.5 65.6 38.0 9.4 10.2 4.8 13.4 13.6 16.4 6.5 14.2 39.4 3.2 17.7 1.0 61.9 254.9 9.7 25.9 8.6 2.7 13.2 11.4 6.6 24.1 56.9 6.6 19.9 18.6 10.0 16.1 11.7 17.2 21.8 1.8 42.0 13.3 11.3 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 386.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes 170000 Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 31.5 47.6 24.3 86.0 26.7 386.5 51.5 27.5 29.9 41.8 27.7 89.9 71.4 38.5 31.2 81.9 39.4 35.1 30.9 23.1 28.9 44.1 55.8 37.8 170.1 26.1 26.1 22.8 38.0 33.1 42.7 25.3 70.4 26.4 32.5 94.6 94.9 40.6 38.6 28.1 63.3 73.5 48.3 27.1 54.4 54.4 62.9 24.7 222.0 42.4 27.0 138.4 51.5 42.6 31.5 769.1 591.4 585.0 253.7 136.1 126.6 409.5 491.6 288.3 453.7 640.0 465.3 594.2 773.4 155.7 177.5 395.2 558.8 350.7 594.4 413.2 231.7 386.8 543.7 207.8 1098.3 57.8 753.7 233.0 92.6 138.2 387.2 91.7 95.3 263.3 503.6 493.9 631.2 449.7 278.3 1450.6 829.3 439.9 592.0 322.9 787.9 514.1 622.5 208.5 441.1 500.8 339.4 345.1 524.6 351.9 213.9 371.2 378.0 177.2 324.3 373.3 461.5 572.0 317.2 981.6 1313.9 145.9 707.4 426.2 5.0 23.2 18.5 36.5 23.3 45.7 33.5 45.7 37.1 32.6 29.2 41.6 37.3 7.7 43.6 24.7 29.9 48.1 36.7 24.3 26.7 27.5 29.9 23.1 28.9 26.1 26.1 22.8 26.4 27.1 24.7 31.5 32.4 44.8 26.0 2.9 40.6 67.7 44.4 121.4 44.3 42.1 27.5 45.2 14.5 21.5 60.5 58.8 27.1 171.5 44.3 42.9 60.7 51.6 176.0 30.2 21.4 34.8 19.9 189.0 4.3 39.6 175.6 38.7 21.9 27.7 22.7 53.1 29.6 27.1 96.7 32.0 5.9 53.9 75.3 24.2 33.4 109.1 36.1 32.7 37.4 3.7 47.6 74.0 23.7 4.0 13.5 28.3 20.3 40.3 56.6 23.3 33.3 46.1 44.1 97.1 52.6 29.2 46.1 149.1 101.1 65.5 49.7 66.4 48.6 29.6 84.5 40.4 NXT1 "MTR2, P15" ENSG00000132661 "Nuclear transport factor 2 like export factor 1" Q9UKK6 20 23350791-23354771 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 235.3;Suprabasal keratinocytes: 253.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 200.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047471 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047471: AB_2680061" "unprognostic (6.44e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (2.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.89e-2)" "unprognostic (1.17e-1)" "unprognostic (6.89e-2)" "unprognostic (5.54e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.15e-7)" "unprognostic (2.07e-1)" "unprognostic (1.98e-1)" "unprognostic (9.11e-3)" "unprognostic (9.31e-2)" 21.5 14.3 10.2 12.6 10.1 47.2 20.7 10.7 11.8 18.4 11.0 15.1 7.0 18.0 16.8 19.8 23.0 10.2 14.8 9.6 13.7 14.8 13.8 19.1 13.8 10.8 10.5 9.4 24.1 12.6 9.7 18.0 13.1 11.1 15.0 10.2 9.5 12.9 11.8 11.7 20.7 13.9 15.1 11.1 17.7 15.4 17.7 11.7 18.5 14.5 9.6 18.4 21.7 17.0 10.9 46.3 50.6 29.9 31.4 20.7 20.0 27.9 27.7 31.0 44.3 44.5 33.7 44.2 55.0 40.3 27.7 73.0 52.8 35.6 72.6 43.3 26.5 33.2 40.5 10.4 60.4 30.9 43.6 29.5 17.9 47.6 42.8 60.4 17.5 35.7 39.5 54.7 52.6 34.7 60.1 90.7 76.4 25.2 82.3 110.9 61.9 48.4 64.7 27.0 38.5 48.4 28.4 25.4 66.7 53.3 18.2 37.5 50.1 22.7 44.6 36.9 37.7 54.1 35.9 37.2 64.0 12.6 200.8 33.9 43.6 46.7 34.5 80.2 68.7 99.2 141.5 80.4 84.3 69.5 131.4 97.9 88.3 11.5 107.9 51.1 113.5 62.1 87.8 10.2 10.1 10.7 11.8 9.6 13.7 10.8 10.5 9.4 11.1 11.1 11.7 10.9 63.4 16.0 13.1 1.0 67.0 235.3 141.0 82.9 132.1 10.1 73.1 91.4 7.6 17.2 36.1 20.2 4.2 75.4 64.7 8.2 41.1 39.7 20.3 34.0 39.3 62.1 18.7 41.9 1.5 31.2 77.1 63.7 5.6 37.8 76.2 23.5 27.5 13.4 45.3 11.8 2.2 23.9 59.0 16.6 141.2 12.8 51.6 36.9 108.5 1.9 23.9 24.5 35.0 2.5 2.8 41.3 11.0 40.3 46.0 111.3 8.3 24.1 24.0 18.3 6.6 89.5 70.5 89.6 76.4 87.4 253.5 40.2 66.7 27.8 27.9 118.1 POLR3F "C34, RPC39, RPC6" ENSG00000132664 "RNA polymerase III subunit F" Q9H1D9 20 18467389-18484646 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049441, HPA050173, HPA072298" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510" "unprognostic (4.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.55e-1)" "unprognostic (7.39e-2)" "prognostic unfavorable (8.87e-9)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "prognostic favorable (6.48e-4)" "unprognostic (3.04e-1)" "unprognostic (4.01e-1)" "unprognostic (3.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.88e-3)" "unprognostic (4.98e-3)" 6.7 6.6 10.9 6.4 11.7 9.9 9.6 13.9 13.4 6.1 10.3 5.3 5.0 8.1 9.6 7.1 6.9 5.7 9.9 11.6 11.5 8.5 6.5 6.2 7.4 10.9 11.0 10.9 8.3 6.0 7.7 3.3 7.6 11.8 7.1 6.1 21.3 5.8 6.6 11.0 7.4 4.4 7.2 10.4 6.3 5.5 9.2 10.9 7.0 11.1 9.6 7.2 6.9 3.0 11.7 12.9 12.6 14.9 15.9 9.5 11.7 22.7 19.0 13.2 23.8 19.3 14.0 12.1 12.0 10.0 14.2 21.3 20.0 20.8 21.2 27.2 8.1 11.0 8.5 7.1 18.6 12.4 22.8 11.9 10.6 14.0 32.2 18.0 13.1 12.9 9.4 19.4 11.7 19.0 15.8 17.3 21.1 17.2 14.3 29.1 11.8 29.4 12.7 13.0 9.1 27.3 17.2 13.9 24.2 32.2 14.0 13.6 15.5 10.1 26.0 13.4 16.2 27.8 11.2 38.0 11.7 10.7 11.0 19.5 0.4 3.0 1.3 2.7 3.7 4.5 3.1 3.6 2.7 3.7 1.7 3.5 3.6 0.8 3.7 3.0 2.7 3.7 2.7 10.9 11.7 13.9 13.4 11.6 11.5 10.9 11.0 10.9 11.8 10.4 10.9 11.7 7.3 9.6 4.8 9.8 8.0 8.9 3.7 5.7 10.2 18.3 6.6 5.8 8.3 2.8 5.1 1.8 10.4 10.7 8.5 3.5 9.8 8.8 42.7 8.5 6.7 9.0 6.7 8.2 21.7 6.8 12.1 7.0 4.6 4.8 5.7 8.8 7.1 4.6 7.6 11.8 19.4 4.4 4.1 9.2 6.7 7.7 6.2 5.9 5.4 10.3 10.4 17.5 12.3 15.1 13.0 7.7 1.9 10.1 9.0 4.3 2.9 12.2 11.3 19.3 13.1 8.3 8.3 28.1 22.9 8.4 11.4 7.3 8.0 11.3 4.3 3.2 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19757606-20002457 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 198.5;Microglial cells: 191.1;Oligodendrocyte precursor cells: 296.6;Oligodendrocytes: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favorable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 14.4 6.5 8.1 8.7 11.5 6.1 9.6 9.2 7.7 14.5 13.0 12.6 13.4 14.2 3.9 13.7 11.8 18.0 18.9 8.8 13.6 12.2 5.4 18.5 4.7 14.8 12.0 2.8 15.1 6.6 4.6 1.5 19.9 12.6 9.4 12.8 5.6 15.7 13.7 9.5 8.3 14.8 16.3 8.9 17.0 8.8 1.8 11.9 3.0 13.8 13.3 5.3 8.1 3.8 13.4 6.7 22.4 4.1 13.7 23.3 14.2 13.1 5.9 22.8 5.7 3.0 10.0 5.8 0.0 24.0 14.6 10.6 24.7 0.1 33.5 6.3 2.7 0.1 0.0 3.5 0.8 5.4 0.0 0.1 21.7 6.1 10.7 11.9 13.4 30.6 0.0 0.1 0.4 17.0 5.3 0.1 0.4 0.7 3.2 47.1 0.1 13.8 3.4 7.2 9.2 3.5 0.9 5.3 23.7 0.1 4.1 2.0 1.4 33.7 11.4 2.9 8.1 9.2 0.1 0.1 0.0 8.0 0.0 2.0 0.2 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.0 0.4 8.1 11.5 9.2 7.7 8.8 13.6 14.8 12.0 2.8 12.6 8.9 11.9 13.4 52.3 64.1 17.5 198.5 1.4 41.9 18.5 30.9 24.5 6.1 25.6 18.4 34.3 14.3 23.7 31.3 8.4 6.8 0.2 30.4 43.0 17.5 1.0 50.0 47.3 52.7 14.4 0.4 5.9 34.5 7.4 33.2 10.7 87.3 0.0 32.4 105.3 4.2 100.2 6.7 82.8 17.2 26.4 60.3 40.3 0.8 19.3 37.7 21.4 191.1 21.4 33.2 1.0 296.6 202.4 26.2 10.5 15.4 0.8 22.3 23.0 50.1 27.1 1.9 0.0 25.4 22.6 0.5 0.8 33.6 54.0 7.1 2.9 43.1 21.9 32.2 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase receptor type A" P18433 20 2864184-3039076 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favorable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 45.5 37.0 83.1 32.2 89.0 40.0 47.9 84.2 96.9 56.9 58.1 42.0 31.2 53.5 37.0 46.5 53.1 44.1 29.8 85.4 79.0 44.6 28.8 45.8 39.2 75.6 77.8 75.3 56.3 31.5 82.5 45.1 61.3 74.1 46.7 41.0 62.0 36.6 42.3 17.0 44.8 32.9 52.8 72.4 39.8 34.8 43.8 85.5 60.1 66.1 31.0 44.6 47.1 39.2 81.2 74.0 44.2 124.7 38.4 134.4 243.3 26.5 54.1 105.1 65.5 79.6 53.1 99.5 48.1 41.6 73.1 66.1 77.2 51.0 77.4 73.4 74.7 32.7 68.5 18.3 68.0 48.1 69.5 31.1 109.8 78.2 54.4 56.8 80.3 92.0 67.7 69.9 59.7 65.8 30.4 80.8 78.3 48.3 66.0 35.0 61.0 60.5 60.3 55.1 56.2 68.7 65.7 52.3 87.8 81.4 54.0 55.2 58.7 66.5 58.1 28.6 65.6 48.5 43.4 64.7 62.7 26.9 64.5 55.7 5.7 2.8 4.8 6.1 2.9 4.9 5.3 4.0 4.4 2.1 2.6 4.0 4.8 3.3 4.0 4.3 3.2 4.9 2.3 83.1 89.0 84.2 96.9 85.4 79.0 75.6 77.8 75.3 74.1 72.4 85.5 81.2 87.0 22.4 19.2 128.6 46.7 15.8 34.0 15.0 34.7 88.9 49.0 43.9 10.1 54.3 24.5 46.0 31.3 35.3 111.7 39.8 27.4 14.8 17.0 62.0 109.0 39.7 44.3 42.3 138.2 15.8 40.5 67.5 25.0 55.3 22.9 60.3 43.5 33.6 39.4 70.7 136.4 27.9 24.4 37.6 20.4 17.2 60.3 40.1 37.4 52.5 29.9 88.3 110.2 102.5 147.5 16.6 30.2 48.9 58.6 32.9 27.1 23.6 26.6 60.5 39.5 53.3 61.8 68.7 84.1 32.9 17.2 32.7 59.7 41.4 30.4 31.5 SSTR4 ENSG00000132671 "Somatostatin receptor 4" P31391 20 23035312-23039237 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "brain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064252 Uncertain NA NA "HPA064252: AB_2685227" 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.6 0.8 1.1 0.2 0.2 0.1 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 57.5 64.1 33.8 55.2 35.7 67.2 66.9 34.3 39.1 41.7 34.2 56.2 59.2 46.4 52.8 55.0 42.3 39.0 87.3 37.3 41.7 63.6 89.0 45.0 69.8 37.5 37.0 34.6 38.4 69.9 49.8 42.8 41.5 38.9 51.1 62.0 72.5 53.7 49.9 130.9 60.5 48.0 53.7 33.7 51.7 59.5 42.7 36.8 81.6 49.3 90.2 79.2 58.9 45.7 43.0 144.9 91.9 73.5 116.7 105.9 133.0 180.0 118.8 124.8 119.4 103.8 170.7 172.4 204.1 235.0 97.3 76.5 143.1 110.3 103.7 129.8 128.6 80.4 124.7 80.5 156.5 144.5 173.3 106.4 112.1 145.8 152.2 199.4 93.3 119.2 185.2 274.5 141.2 125.6 192.0 152.6 200.9 130.1 225.2 146.9 124.2 92.1 218.9 142.5 136.0 84.9 150.4 113.9 331.9 211.6 135.1 206.4 279.8 102.8 100.5 106.1 126.0 202.6 152.9 245.9 235.3 100.2 151.6 132.7 65.4 110.5 61.6 110.1 134.2 179.0 141.5 155.8 133.9 152.0 121.1 192.5 167.5 47.8 136.0 128.0 99.1 173.1 162.1 33.8 35.7 34.3 39.1 37.3 41.7 37.5 37.0 34.6 38.9 33.7 36.8 43.0 31.8 44.8 43.6 34.0 59.2 54.9 67.2 94.2 52.9 28.2 54.6 43.8 106.2 51.5 68.3 16.5 20.9 76.2 45.0 33.2 66.5 79.8 19.0 44.9 40.5 38.1 25.7 63.8 52.7 78.6 98.5 41.3 35.7 38.7 62.1 34.9 33.2 57.4 77.8 13.5 57.4 41.9 59.0 59.4 62.9 15.3 32.3 53.0 35.6 30.9 83.7 22.2 55.6 26.7 47.1 73.8 30.8 25.2 52.4 81.7 41.7 78.0 61.2 46.4 13.1 33.7 45.1 48.3 29.3 51.1 63.1 141.6 66.4 73.3 62.5 73.5 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein" Q9H310 1 156369211-156385219 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 9.6" "Group enriched" "Detected in some" 4 "Granulosa cells: 89.9;Theca cells: 91.3" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.6 1.9 0.0 0.0 0.0 0.2 0.0 2.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 22.0 0.0 0.0 0.0 0.0 19.6 0.3 10.3 0.3 0.0 0.1 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.1 0.0 89.9 0.0 10.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.8 2.3 0.4 0.0 0.4 0.0 0.0 91.3 0.0 0.1 KHDC4 "BLOM7, KIAA0907, SNORA80EHG" ENSG00000132680 "KH domain containing 4, pre-mRNA splicing factor" Q7Z7F0 1 155913045-155934413 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 57.0;Endometrial ciliated cells: 54.7;Glandular and luminal cells: 88.2;Granulosa cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008796 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA008796: AB_1079369" "unprognostic (6.31e-2)" "unprognostic (1.32e-1)" "unprognostic (4.52e-2)" "unprognostic (5.22e-3)" "unprognostic (7.68e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.79e-2)" "unprognostic (2.44e-2)" "unprognostic (7.88e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (3.87e-4)" "prognostic unfavorable (2.78e-10)" "unprognostic (1.04e-1)" "unprognostic (2.37e-1)" "unprognostic (9.10e-2)" "prognostic favorable (4.36e-5)" 26.0 29.7 21.7 22.5 23.0 12.0 31.0 28.4 25.3 42.4 22.8 34.5 23.2 32.4 45.6 29.0 33.8 15.1 27.8 21.9 26.2 35.5 30.4 34.4 29.1 22.4 23.4 21.8 48.1 33.0 18.6 44.9 23.4 24.1 39.5 27.6 55.9 38.6 20.9 40.1 31.8 36.8 15.6 22.7 38.0 37.9 24.9 22.6 27.4 33.9 21.5 29.9 37.4 36.5 26.2 27.6 20.7 43.2 26.2 22.6 31.6 26.6 23.2 18.4 34.6 35.5 21.6 59.6 34.0 25.2 13.3 24.7 49.5 40.0 16.4 34.0 27.2 83.5 30.7 70.8 26.0 15.9 36.3 25.4 20.7 42.4 24.3 18.8 40.8 25.2 38.2 37.4 37.9 31.8 13.3 35.1 35.6 47.7 26.0 29.4 41.0 23.3 30.1 30.7 14.7 29.9 29.7 17.2 17.9 25.1 35.2 37.6 60.5 21.2 33.3 23.2 10.9 31.7 61.3 28.4 30.1 24.0 33.5 25.7 4.1 1.5 3.0 2.1 2.0 2.8 2.7 2.3 2.8 1.5 2.6 2.9 2.7 1.9 2.4 3.0 1.6 2.0 1.0 21.7 23.0 28.4 25.3 21.9 26.2 22.4 23.4 21.8 24.1 22.7 22.6 26.2 19.4 12.8 19.2 0.0 10.3 0.0 0.0 0.0 0.0 0.0 35.2 23.5 0.0 0.0 12.4 57.0 0.0 26.5 25.7 0.0 3.9 11.2 0.0 54.7 20.0 9.5 0.0 0.0 0.0 7.2 20.0 11.0 0.0 88.2 6.3 48.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 13.5 0.0 0.0 0.0 0.0 18.7 0.0 0.0 8.3 0.0 0.0 7.9 12.4 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 30.8 10.5 34.4 0.0 0.0 ATP1A4 ATP1AL2 ENSG00000132681 "ATPase Na+/K+ transporting subunit alpha 4" Q13733 1 160151586-160186980 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 6.3;testis: 16.4;urinary bladder: 5.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 26.1;Early spermatids: 87.4;Extravillous trophoblasts: 14.4;Syncytiotrophoblasts: 38.2" "Group enriched" "Detected in some" 8 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 18.4;HDLM-2: 49.0;RT4: 57.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-1)" "unprognostic (4.01e-3)" "unprognostic (2.20e-1)" "unprognostic (1.94e-1)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (1.22e-1)" "unprognostic (7.48e-3)" "unprognostic (2.45e-1)" "unprognostic (8.77e-3)" "unprognostic (1.98e-2)" "unprognostic (3.17e-2)" "unprognostic (2.43e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.09e-2)" "prognostic favorable (2.20e-4)" 0.2 0.1 0.1 0.4 0.1 0.0 1.6 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.7 0.3 0.1 0.2 0.0 0.0 0.1 3.3 0.2 0.1 0.1 0.0 0.0 0.4 0.0 6.3 0.1 0.3 0.1 2.5 0.3 1.3 3.0 0.0 0.2 0.1 0.1 1.1 0.1 16.4 0.1 0.4 0.0 0.0 1.3 5.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.6 1.6 0.0 0.3 7.3 0.0 0.0 0.0 2.2 1.7 0.9 0.0 0.0 1.8 0.0 26.1 0.1 0.0 0.0 0.0 87.4 0.0 0.0 0.2 0.0 0.0 0.4 0.0 14.4 0.3 0.0 0.0 1.3 0.1 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.0 0.0 6.5 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 0.0 2.2 0.0 1.4 0.3 2.8 0.2 0.0 0.0 38.2 0.7 0.1 0.0 10.4 NES FLJ21841 ENSG00000132688 Nestin P48681 1 156668763-156677407 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 163.2" "Group enriched" "Detected in many" 4 "Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5" "Cancer enhanced" "Detected in all" "glioma: 147.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005889, HPA006286, HPA007007, HPA026111, CAB058692" Enhanced Enhanced "Intermediate filaments" No No 100000 "Intermediate filaments" "CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382" "unprognostic (7.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (1.36e-1)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (4.40e-2)" "unprognostic (7.56e-2)" "unprognostic (9.84e-2)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.02e-7)" "unprognostic (2.87e-1)" "unprognostic (2.48e-1)" "unprognostic (6.67e-2)" "unprognostic (8.11e-3)" 40.3 8.5 26.4 13.9 23.6 0.0 28.4 29.1 23.5 24.7 19.5 15.0 5.3 41.4 13.0 8.3 30.6 11.4 163.2 20.9 36.1 35.2 4.9 42.5 4.9 32.6 26.3 17.5 10.1 5.6 10.4 12.9 16.9 30.0 21.4 6.7 8.3 9.8 36.5 56.3 7.9 12.6 30.6 32.2 49.5 10.9 6.2 26.2 2.8 20.1 47.7 2.3 24.5 19.1 33.2 0.2 2.5 627.3 134.7 1.3 33.4 0.6 154.7 120.7 2.3 3.4 102.5 1.9 0.6 35.8 14.9 0.1 2.8 63.9 0.0 1.8 0.0 1.1 0.9 9.7 47.3 5.5 0.3 37.1 28.5 0.0 5.7 0.0 5.3 321.5 0.1 4.9 0.2 512.6 4.3 0.0 0.3 102.3 6.0 88.1 0.7 518.3 0.4 0.6 0.0 1.6 100.4 3.6 4.5 124.9 340.7 1.3 0.9 235.1 0.8 34.5 4.1 8.8 0.2 24.0 0.2 13.4 0.1 247.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 23.6 29.1 23.5 20.9 36.1 32.6 26.3 17.5 30.0 32.2 26.2 33.2 102.2 0.0 4.4 0.0 0.7 2.4 0.4 0.2 0.6 0.5 9.4 32.9 279.9 0.0 0.6 18.4 0.0 0.2 1.0 0.6 0.0 2.1 0.4 2.1 31.9 105.5 0.0 0.0 0.3 0.0 1.9 29.4 0.5 2.7 0.0 0.2 26.7 0.1 1.8 0.0 0.6 0.2 0.0 0.8 3.1 0.1 8.1 1.7 1.8 12.2 1.0 17.4 0.0 3.0 2.2 0.3 0.1 4.1 0.1 0.5 0.0 0.1 0.0 1.5 105.2 10.9 70.5 0.5 5.0 1.2 2.4 0.1 1.1 1.4 0.3 0.5 BCAN "BEHAB, CSPG7, MGC13038" ENSG00000132692 Brevican Q96GW7 1 156641390-156659532 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 166.0" "Group enriched" "Detected in some" 8 "Astrocytes: 136.1;Horizontal cells: 109.4;Melanocytes: 186.7;Oligodendrocyte precursor cells: 288.0" "Cancer enriched" "Detected in many" 5 "glioma: 348.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 24 "basophil: 7.8" "Lineage enriched" "Detected in single" 24 "granulocytes: 7.8" "Cell line enhanced" "Detected in many" "HDLM-2: 76.7;K-562: 108.3;U-266/70: 63.3;U-266/84: 133.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007865, CAB025862" Enhanced Supported "Secreted in brain" NA NA 120000 "CAB025862: , HPA007865: AB_1078299" "unprognostic (7.14e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (4.80e-2)" "unprognostic (6.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-2)" "unprognostic (9.47e-3)" "unprognostic (2.76e-2)" "unprognostic (8.54e-2)" "unprognostic (5.40e-1)" "unprognostic (1.90e-1)" 0.2 8.4 138.1 0.6 101.4 0.0 0.2 101.0 166.0 2.2 30.4 2.3 7.0 5.9 15.6 0.6 4.0 3.4 0.3 128.0 89.3 0.2 0.1 0.4 0.3 122.7 92.9 99.7 0.2 0.1 1.7 2.8 0.7 105.5 0.2 0.0 4.1 1.6 1.8 0.6 15.7 7.9 2.0 86.9 0.5 2.2 1.3 102.3 0.1 0.2 0.0 0.0 0.9 0.9 106.4 44.2 28.4 0.2 8.1 0.0 0.0 11.9 0.4 0.0 0.0 0.0 1.1 21.0 0.1 45.8 0.0 1.0 30.9 0.3 0.0 0.0 76.7 2.9 8.0 20.9 25.6 0.0 3.0 7.3 0.0 0.0 0.0 0.0 1.0 0.0 3.8 108.3 21.0 0.0 12.6 0.1 0.1 2.2 22.2 4.2 0.1 46.7 0.1 0.0 5.4 0.2 0.8 0.1 0.0 43.8 2.2 0.2 2.8 8.8 0.1 24.7 8.7 11.8 63.3 133.2 0.2 8.5 20.4 3.4 7.8 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.1 101.4 101.0 166.0 128.0 89.3 122.7 92.9 99.7 105.5 86.9 102.3 106.4 0.2 0.0 0.0 136.1 0.0 6.9 0.0 0.0 0.0 6.0 0.2 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 2.9 0.1 1.8 0.7 1.8 0.0 16.8 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.5 109.4 20.2 0.1 0.0 0.0 1.9 6.9 0.3 0.1 186.7 9.4 0.0 2.1 1.0 288.0 3.5 0.8 0.1 0.0 0.0 0.3 0.1 0.4 0.0 3.2 0.0 0.2 1.7 5.4 6.5 0.0 1.7 0.0 0.2 0.0 0.0 0.0 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "liver: 9465.6" "Group enriched" "Detected in some" 16 "Ductal cells: 1087.7;Hepatocytes: 4142.7" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" NA NA 2920000000 5200000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 3.4 0.7 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.3 0.0 3.1 0.0 0.5 0.4 112.7 0.5 0.0 0.0 0.7 9465.6 0.5 0.1 0.1 0.0 0.0 0.4 119.5 0.0 0.3 0.1 0.1 0.6 0.0 0.0 0.4 0.0 0.3 0.5 0.5 0.0 0.0 6.1 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.0 0.0 0.0 6.3 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.8 0.0 11.7 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 118.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1087.7 1.4 0.0 0.1 6.3 0.0 163.2 0.0 63.2 0.0 0.0 0.0 0.2 0.0 0.0 89.6 4142.7 0.1 0.0 0.0 0.0 0.0 98.8 0.3 0.7 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 ARHGEF11 "GTRAP48, KIAA0380, PDZ-RHOGEF" ENSG00000132694 "Rho guanine nucleotide exchange factor 11" O15085 1 156934840-157045742 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 68.6;Cone photoreceptor cells: 93.8;Excitatory neurons: 102.4;Inhibitory neurons: 122.5;Oligodendrocyte precursor cells: 78.4;Rod photoreceptor cells: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "WM-115: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011026, HPA012037, HPA014658" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428" "unprognostic (2.19e-1)" "unprognostic (9.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.17e-1)" "unprognostic (2.00e-1)" "unprognostic (4.94e-3)" "unprognostic (3.30e-2)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.72e-4)" "unprognostic (3.38e-1)" "unprognostic (2.41e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-1)" "unprognostic (1.08e-1)" "unprognostic (4.73e-2)" 11.0 11.0 9.6 9.5 7.8 4.4 8.2 3.1 21.8 10.1 0.4 11.9 13.2 12.1 9.7 11.6 10.4 10.3 12.2 9.2 7.9 7.3 6.4 11.5 5.3 10.9 10.0 6.5 13.3 10.0 25.2 12.3 11.2 14.4 9.2 11.3 17.7 8.6 11.7 12.4 10.1 15.0 13.4 2.8 9.4 10.8 19.4 16.7 3.6 13.2 11.3 5.7 10.5 8.2 11.3 13.5 26.6 22.0 16.9 28.5 14.6 25.0 13.4 19.4 20.0 14.6 17.9 14.0 1.8 22.6 23.0 15.3 14.4 15.0 13.5 10.8 19.6 9.3 6.7 15.9 11.5 16.4 13.7 23.0 22.7 14.4 18.3 14.2 14.9 14.5 5.7 11.1 1.2 13.3 17.4 3.5 7.2 27.6 21.0 16.0 0.5 10.9 7.4 9.5 21.9 4.2 25.1 28.3 22.6 23.3 18.8 20.3 30.3 22.4 20.6 12.9 18.3 13.7 18.7 12.2 1.3 13.1 1.8 69.7 0.0 0.4 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.9 0.0 0.4 0.0 0.0 0.2 9.6 7.8 3.1 21.8 9.2 7.9 10.9 10.0 6.5 14.4 2.8 16.7 11.3 6.2 3.2 4.2 68.6 0.5 1.1 2.8 0.4 0.0 48.0 5.0 5.8 15.3 7.2 1.6 1.8 93.8 1.8 0.0 26.0 1.9 1.1 8.6 7.7 10.9 5.0 5.4 0.4 102.4 1.6 0.6 5.5 10.2 7.8 8.9 6.6 5.3 5.2 4.0 21.9 122.5 7.3 0.0 8.8 3.9 10.5 4.7 7.1 1.8 37.5 6.8 9.7 0.0 78.4 47.2 1.2 10.8 4.5 2.9 4.0 10.6 1.3 1.4 58.7 0.0 6.7 6.9 3.1 4.8 1.8 2.0 1.5 0.9 9.2 9.8 3.3 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070504 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 426.7;skin 1: 209.7" "Cell type enhanced" "Detected in many" "Paneth cells: 249.6;Squamous epithelial cells: 300.6;Undifferentiated cells: 244.6;Urothelial cells: 232.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "BEWO: 120.9;CAPAN-2: 119.9;MCF7: 171.5;OE19: 392.3;RT4: 153.4;SK-BR-3: 243.3;T-47d: 227.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.4 0.1 0.1 10.3 0.1 0.1 52.6 0.2 0.3 39.4 0.0 87.0 73.6 7.4 37.8 426.7 48.0 26.7 0.1 0.0 0.0 30.2 1.7 39.5 0.4 0.1 0.1 0.0 0.4 57.6 69.5 27.7 12.5 0.1 36.6 78.9 0.0 106.1 28.6 0.9 209.7 66.1 3.8 0.1 0.2 81.6 0.3 0.1 10.2 51.1 0.0 44.3 70.5 149.5 0.3 93.3 0.0 0.0 0.0 0.0 0.0 120.9 0.0 0.0 0.0 0.0 90.4 119.9 0.0 0.1 0.0 0.0 109.5 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 105.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 171.5 0.0 0.4 4.8 392.3 0.0 0.1 0.0 0.3 0.0 153.4 13.3 0.0 0.0 243.3 0.3 21.1 227.9 0.4 0.0 0.2 0.2 0.0 0.2 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.0 0.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 1.2 28.9 41.0 0.0 1.5 55.1 102.9 113.9 74.0 0.0 121.4 137.7 0.1 94.4 98.7 86.5 0.0 102.1 2.3 197.8 166.3 170.4 0.0 58.6 6.4 2.6 85.4 0.0 0.1 150.3 30.0 2.3 96.4 66.2 5.7 0.0 0.0 0.4 7.3 0.0 0.1 208.5 89.5 0.0 5.8 0.0 0.3 2.1 21.4 0.0 3.6 0.0 0.0 0.0 0.1 197.3 249.6 0.0 0.3 114.0 195.9 35.5 66.3 0.0 0.0 0.0 6.8 0.2 1.1 300.6 154.7 80.3 2.7 0.0 244.6 232.3 HAPLN2 BRAL1 ENSG00000132702 "Hyaluronan and proteoglycan link protein 2" Q9GZV7 1 156619331-156625725 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "brain: 276.4" "Cell type enriched" "Detected in some" 6 "Oligodendrocytes: 202.1" "Cancer enriched" "Detected in some" 10 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045765 Enhanced "Secreted in brain" NA NA "HPA045765: AB_10964781" "unprognostic (3.19e-3)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-1)" "unprognostic (2.44e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-3)" "unprognostic (1.31e-1)" "unprognostic (8.25e-2)" "unprognostic (5.54e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-2)" "unprognostic (1.08e-1)" "unprognostic (2.25e-1)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 0.6 0.3 49.2 0.0 119.9 0.0 0.5 159.6 96.3 0.7 8.3 0.4 0.8 2.7 0.0 0.1 2.6 0.0 1.4 38.9 107.0 0.5 0.1 0.3 0.0 201.9 139.2 26.1 0.6 0.1 0.2 0.4 0.0 174.3 2.6 0.0 0.1 0.2 0.1 0.7 0.3 0.7 0.0 185.6 0.1 0.3 1.3 115.2 0.0 0.3 0.1 0.0 1.3 1.0 276.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 119.9 159.6 96.3 38.9 107.0 201.9 139.2 26.1 174.3 185.6 115.2 276.4 1.5 0.0 0.0 5.2 0.0 0.1 0.1 0.0 0.0 1.7 0.9 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.4 2.3 0.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 12.5 202.1 0.0 5.0 0.0 0.0 0.2 2.8 0.0 0.0 0.5 32.9 0.9 14.4 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 APCS "MGC88159, PTX2, SAP" ENSG00000132703 "Amyloid P component, serum" P02743 1 159587826-159588865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 76 "liver: 3659.1" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 4141.9" "Cancer enriched" "Detected in some" 25 "liver cancer: 826.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB007817, HPA053294" Supported "Secreted to blood" NA NA 27700000000 39000000000 "CAB007817: AB_598185, HPA053294: AB_2682104" "unprognostic (3.19e-3)" "unprognostic (2.30e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 48.1 0.1 0.0 0.0 1.2 3659.1 0.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 388.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 0.0 2.7 0.0 45.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 57.8 4141.9 0.0 0.0 0.0 0.0 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 FCRL2 "CD307b, FCRH2, IRTA4, SPAP1" ENSG00000132704 "Fc receptor like 2" Q96LA5 1 157745733-157777132 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "intestine: 21.1;lymphoid tissue: 34.6" "Group enriched" "Detected in some" 17 "B-cells: 84.7;Plasma cells: 40.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "memory B-cell: 29.7;naive B-cell: 18.4" "Lineage enriched" "Detected in single" 42 "B-cells: 29.7" "Group enriched" "Detected in some" 4 "Daudi: 12.9;U-698: 10.5" NA NA "unprognostic (3.94e-3)" "unprognostic (1.47e-3)" "unprognostic (3.49e-2)" "unprognostic (3.69e-3)" "unprognostic (5.11e-5)" "unprognostic (1.67e-2)" "unprognostic (4.77e-3)" "unprognostic (8.19e-2)" "unprognostic (8.66e-3)" "unprognostic (1.20e-2)" "unprognostic (4.19e-2)" "unprognostic (4.60e-7)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (7.92e-2)" "unprognostic (2.48e-1)" 0.4 0.0 0.2 12.5 0.2 2.6 0.4 0.0 0.4 0.2 0.0 2.2 2.2 0.1 0.1 0.4 0.1 1.0 0.4 0.1 0.1 0.4 0.5 0.8 24.3 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.3 2.7 0.2 1.0 0.0 0.0 0.2 21.1 0.1 0.2 34.6 1.7 0.3 0.2 1.7 0.6 0.0 26.0 1.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.7 0.0 10.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.4 0.1 0.1 0.3 0.1 0.0 0.3 0.2 0.2 0.8 0.0 0.0 1.1 0.0 84.7 0.3 0.5 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.3 1.3 0.0 0.7 0.6 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.0 3.6 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.1 0.0 40.4 0.3 0.0 0.1 0.1 0.0 0.0 1.2 0.6 0.0 0.2 0.0 0.4 0.1 1.9 0.0 0.1 0.4 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262549 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favorable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavorable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 60.5 63.1 35.4 47.5 43.2 55.1 61.1 49.8 55.4 55.1 43.0 64.8 57.1 60.9 76.8 50.7 59.4 54.0 75.9 35.0 34.2 55.8 104.2 51.4 61.0 46.4 39.1 33.6 62.7 80.9 86.4 66.8 45.5 47.7 54.1 41.0 107.6 61.1 53.7 221.8 67.7 62.3 44.4 33.8 66.2 67.8 41.0 40.0 68.1 78.6 119.4 51.5 61.6 50.2 54.0 54.2 62.5 72.0 64.8 86.3 65.5 63.7 62.7 81.8 49.5 42.2 69.8 89.6 56.3 112.1 67.2 34.6 64.8 34.6 57.4 31.0 134.9 69.0 63.4 99.7 54.1 69.3 52.9 80.3 74.6 58.9 44.2 60.8 55.3 73.5 73.1 60.6 98.4 46.0 50.0 71.7 54.5 52.7 70.1 62.6 69.2 41.8 115.5 57.7 87.6 49.0 47.3 101.8 113.1 68.2 68.9 104.9 82.0 95.1 60.7 31.5 38.6 58.7 169.8 124.9 94.3 68.7 49.6 51.2 32.9 21.5 22.0 31.5 19.7 29.6 28.5 27.0 29.2 17.5 30.4 29.4 27.0 24.9 30.4 28.4 22.0 30.4 19.2 35.4 43.2 49.8 55.4 35.0 34.2 46.4 39.1 33.6 47.7 33.8 40.0 54.0 21.4 57.7 54.9 57.5 35.4 18.4 16.3 17.3 38.7 44.6 27.5 21.8 54.2 30.0 30.5 25.8 64.6 30.9 26.4 20.4 62.6 23.9 3.6 26.6 18.9 26.4 25.1 48.4 53.7 21.6 21.0 28.9 35.2 21.4 34.1 21.2 21.4 77.6 23.8 40.4 49.5 19.2 20.3 29.8 18.9 4.3 28.0 24.2 14.2 39.4 27.6 38.1 18.6 58.8 93.1 19.2 13.6 32.7 45.3 16.3 29.0 38.1 40.5 60.5 13.1 29.5 26.6 28.0 20.4 35.1 24.2 44.3 36.5 25.6 18.8 12.5 SYT11 "DKFZp781D015, KIAA0080, MGC10881, MGC17226" ENSG00000132718 "Synaptotagmin 11" Q9BT88 1 155859567-155885199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 150.7;retina: 69.2" "Group enriched" "Detected in many" 4 "Astrocytes: 91.1;Bipolar cells: 78.4;Excitatory neurons: 83.5;Horizontal cells: 89.2;Inhibitory neurons: 104.5;Muller glia cells: 135.6;Oligodendrocyte precursor cells: 113.1;Oligodendrocytes: 133.2" "Cancer enriched" "Detected in all" 12 "glioma: 117.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 184.0;SCLC-21H: 72.7;SH-SY5Y: 79.2;U-87 MG: 87.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064091 Enhanced NA NA "HPA064091: AB_2685189" "unprognostic (1.83e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (2.14e-1)" "unprognostic (8.02e-3)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (3.93e-1)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-2)" "unprognostic (1.10e-1)" "unprognostic (2.22e-3)" 8.1 19.9 100.3 8.8 113.5 3.8 5.0 111.2 127.9 13.6 7.7 11.2 3.4 17.5 12.0 5.5 8.7 11.4 13.5 104.4 110.5 5.2 1.7 8.0 11.2 124.9 116.9 101.5 13.5 3.1 1.6 37.3 9.9 108.4 12.0 6.7 69.2 2.4 16.6 2.6 2.2 6.8 19.6 116.6 10.3 6.2 5.8 121.7 3.0 3.6 5.5 9.3 10.7 9.5 150.7 0.1 0.7 47.2 1.1 33.6 17.9 0.2 8.9 24.1 9.3 16.7 0.1 1.3 9.4 3.9 32.2 14.3 0.6 4.0 0.1 13.9 46.0 0.9 9.1 1.3 0.1 9.6 5.1 26.9 11.2 0.0 33.7 0.6 52.5 30.2 0.3 0.1 184.0 12.8 0.1 0.5 2.5 30.8 0.0 0.2 1.9 4.7 0.2 1.5 0.0 72.7 79.2 1.3 0.1 11.1 0.9 0.1 1.3 22.6 17.4 10.8 11.9 11.4 48.7 25.4 18.8 87.2 0.1 13.6 6.1 4.9 0.1 16.9 5.9 4.7 1.9 8.8 11.8 7.0 1.5 0.8 8.8 2.5 7.8 8.5 0.4 17.2 8.3 100.3 113.5 111.2 127.9 104.4 110.5 124.9 116.9 101.5 108.4 116.6 121.7 150.7 25.3 0.0 0.0 91.1 3.2 0.5 0.2 0.2 0.6 78.4 0.5 0.9 11.4 0.0 0.1 1.8 22.9 0.1 23.3 0.0 0.0 1.4 0.1 0.9 12.0 20.3 4.8 3.4 83.5 1.0 0.2 9.3 2.0 1.9 12.0 16.0 7.1 0.4 4.7 89.2 104.5 0.1 0.0 9.4 5.2 0.7 2.8 11.2 3.6 23.4 13.6 135.6 19.6 113.1 133.2 1.4 0.0 15.8 5.5 0.4 0.1 1.2 1.0 13.7 19.7 7.7 15.9 2.0 1.0 0.1 1.0 0.0 14.3 2.1 0.0 0.3 IGHMBP2 "CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7" ENSG00000132740 "Immunoglobulin mu DNA binding protein 2" P38935 11 68903863-68940602 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004092, HPA060994" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA004092: , HPA060994: AB_2684406" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (1.69e-1)" "unprognostic (3.59e-3)" "unprognostic (4.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.89e-4)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.29e-8)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" 5.1 4.0 0.9 2.5 1.2 6.0 5.5 0.7 1.7 6.7 0.1 9.7 1.5 7.9 0.6 5.5 6.7 1.7 4.7 1.3 0.8 4.4 6.3 5.2 3.3 0.8 0.5 1.1 6.1 5.3 2.8 4.0 2.0 0.8 6.3 1.5 1.4 6.5 3.1 8.5 7.5 6.3 2.7 0.4 5.8 6.3 15.5 0.7 4.3 5.0 3.8 1.8 6.3 5.9 1.1 5.1 7.3 4.0 7.4 3.6 3.1 5.2 5.8 3.9 7.8 4.6 14.5 7.0 7.3 9.7 3.3 6.9 8.0 5.8 4.9 1.8 8.3 6.2 6.6 9.6 5.6 5.5 6.5 7.4 1.8 4.9 9.2 4.6 4.5 4.6 11.1 10.6 4.6 2.3 5.1 11.1 8.9 2.3 7.9 10.3 9.4 5.7 7.6 3.3 5.9 8.6 5.4 7.4 6.1 16.6 3.0 9.3 6.0 6.6 5.3 3.8 7.7 6.6 6.0 6.3 6.9 5.3 6.1 5.1 0.0 2.0 0.8 1.5 1.8 1.3 1.0 0.9 1.0 1.8 0.6 0.5 0.7 0.6 0.1 1.1 0.3 0.6 1.3 0.9 1.2 0.7 1.7 1.3 0.8 0.8 0.5 1.1 0.8 0.4 0.7 1.1 6.6 6.4 7.7 7.5 5.7 5.7 3.8 3.5 6.2 9.1 5.6 3.8 6.3 8.6 6.1 1.8 20.9 4.9 10.2 6.0 1.9 5.1 94.6 7.0 8.1 6.4 3.0 9.3 7.4 5.1 4.4 5.5 6.1 14.0 7.0 10.7 3.3 6.1 5.8 11.8 6.4 4.1 2.0 3.5 4.3 46.9 7.8 7.2 1.8 5.6 7.3 6.6 9.2 6.0 5.2 6.5 8.4 7.2 5.8 7.5 3.9 2.9 3.8 10.1 0.0 5.1 10.1 51.6 7.1 5.3 6.7 6.7 8.0 4.6 7.1 6.3 ACY3 "ACY-3, HCBP1, MGC9740" ENSG00000132744 "Aminoacylase 3" Q96HD9 11 67642555-67650730 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.4;kidney: 56.8;liver: 34.1" "Group enriched" "Detected in many" 8 "Proximal enterocytes: 255.7;Proximal tubular cells: 437.6" "Cancer enhanced" "Detected in many" "renal cancer: 24.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 34.1" "Group enriched" "Detected in many" 5 "dendritic cells: 8.7;monocytes: 34.1" "Cell line enhanced" "Detected in some" "CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8" "Low region specificity" "Detected in all" "HPA039219, HPA048187" Enhanced NA NA 13000 "HPA039219: AB_10671872, HPA048187: AB_2680306" "unprognostic (8.37e-3)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (1.43e-1)" "unprognostic (7.37e-4)" "unprognostic (2.44e-3)" "unprognostic (1.15e-1)" "unprognostic (3.21e-1)" "unprognostic (2.63e-3)" "unprognostic (1.07e-1)" "unprognostic (8.24e-2)" "unprognostic (2.68e-2)" "unprognostic (1.48e-3)" 0.1 0.1 3.8 4.3 3.5 1.4 1.0 3.7 3.6 10.6 2.0 6.7 78.4 0.5 0.8 0.8 0.9 1.9 0.0 4.3 4.6 56.8 34.1 0.2 7.1 5.9 5.8 2.5 0.2 22.4 0.4 0.3 0.2 6.1 0.6 4.6 0.0 2.5 0.4 0.0 0.2 71.4 0.3 5.9 1.4 12.0 0.1 5.5 1.9 0.1 0.0 9.0 0.3 0.1 5.1 0.2 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.6 15.3 57.7 0.6 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.1 2.1 2.5 0.0 15.3 0.0 1.8 0.0 9.8 0.0 0.0 0.0 0.1 0.3 1.3 0.1 0.0 0.1 2.8 0.2 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 6.4 0.5 0.0 0.7 0.0 0.2 7.6 0.7 1.3 0.4 0.2 3.8 1.4 1.3 0.9 0.0 3.9 34.1 8.7 0.0 1.9 3.8 3.5 3.7 3.6 4.3 4.6 5.9 5.8 2.5 6.1 5.9 5.5 5.1 0.1 0.0 1.7 0.0 4.7 0.0 0.1 0.7 0.0 0.0 1.6 2.2 0.5 8.6 1.6 22.0 0.0 0.2 0.1 9.2 31.3 4.1 0.0 0.5 0.2 0.1 1.2 0.0 0.0 10.4 0.3 0.1 19.4 0.9 0.0 0.0 0.0 25.3 2.2 0.0 0.0 40.8 0.0 0.6 0.9 0.0 0.0 3.0 5.4 10.3 0.4 0.0 0.0 0.0 0.0 5.7 10.6 0.0 3.3 0.5 255.7 437.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.7 0.1 14.7 0.9 ALDH3B2 ALDH8 ENSG00000132746 "Aldehyde dehydrogenase 3 family member B2" P48448 11 67662160-67681224 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 73.7;esophagus: 153.4;skin 1: 122.8;vagina: 41.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 26.2;Endometrial ciliated cells: 12.6;Glandular and luminal cells: 28.1;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 14.8;Syncytiotrophoblasts: 14.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 71.9;SK-BR-3: 70.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045132 Approved NA NA "HPA045132: AB_10795993" "unprognostic (2.25e-1)" "unprognostic (2.41e-1)" "unprognostic (1.65e-1)" "unprognostic (8.65e-2)" "unprognostic (2.13e-1)" "unprognostic (6.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-2)" "unprognostic (2.59e-2)" "unprognostic (1.61e-1)" "unprognostic (1.15e-2)" "unprognostic (5.92e-2)" 0.2 0.0 0.1 0.1 0.0 0.2 73.7 0.0 0.0 7.9 0.0 0.1 0.1 0.8 6.8 153.4 4.6 0.3 0.1 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 5.3 0.1 3.2 0.0 3.3 0.1 0.5 17.4 4.9 0.3 122.8 0.0 0.1 0.0 0.0 0.3 0.1 0.0 2.5 0.0 0.0 21.3 8.4 41.4 0.0 0.2 0.0 0.1 0.1 0.0 0.0 7.9 0.0 0.0 0.1 0.0 1.3 3.5 3.3 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.9 6.8 0.0 0.1 9.0 0.0 0.0 0.0 1.9 0.0 13.0 0.0 0.1 0.0 70.7 0.1 0.4 15.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 1.7 1.2 4.9 1.2 0.0 26.2 7.2 0.4 0.0 7.3 5.5 0.0 10.6 0.2 0.0 1.9 1.1 0.0 12.6 2.6 0.2 0.0 0.0 0.1 0.2 10.6 0.2 0.0 28.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 53.3 14.8 14.6 0.2 0.0 0.0 7.6 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751520 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 53.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.6;Breast myoepithelial cells: 7.4;Endometrial ciliated cells: 31.5;Glandular and luminal cells: 27.0;Proximal tubular cells: 11.5" "Cancer enhanced" "Detected in many" "breast cancer: 6.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 11.9;T-47d: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA018539 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.6 1.0 0.6 7.5 4.3 0.6 0.7 0.6 0.6 2.3 1.4 0.7 0.7 1.6 1.7 0.4 0.2 0.5 0.7 2.9 0.4 0.4 1.3 1.1 0.7 0.7 0.9 1.1 2.1 2.4 0.3 1.3 2.3 3.0 1.5 1.9 1.1 0.0 0.6 1.4 0.4 0.4 1.3 0.9 53.0 0.7 2.1 1.1 0.1 1.1 0.4 0.9 1.0 7.2 3.1 1.3 0.1 0.0 0.0 3.5 1.6 0.8 2.2 1.0 0.9 7.1 2.9 1.6 0.3 0.0 3.4 1.0 1.4 1.7 3.0 2.5 2.1 1.0 0.0 0.0 1.5 11.9 0.0 3.8 0.1 2.2 3.0 0.7 3.4 4.5 5.4 0.3 4.8 0.8 4.2 7.3 3.3 3.1 1.9 0.4 0.8 2.6 0.1 4.4 4.7 0.0 1.5 0.0 3.7 23.8 10.0 2.7 0.2 0.5 0.2 0.1 2.1 2.0 2.8 0.1 4.2 1.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.6 0.6 0.6 0.7 0.5 0.7 1.1 0.7 0.7 1.3 0.4 0.7 1.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.6 7.4 0.0 0.0 0.6 0.0 0.0 1.8 0.7 0.0 5.9 6.3 0.0 31.5 2.6 0.3 0.0 0.0 0.0 4.0 4.7 0.3 0.0 27.0 2.5 4.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 0.0 0.0 11.5 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 1.1 0.2 0.0 0.0 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Metabolism of cobalamin associated C" Q9Y4U1 1 45500300-45513382 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 17.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 2.0 3.1 3.1 1.7 5.0 1.2 3.6 4.9 4.3 2.9 2.0 3.8 3.3 1.7 3.1 2.9 3.5 1.3 6.9 3.2 4.5 3.5 17.5 1.2 1.8 4.0 5.4 2.6 3.5 2.9 5.5 1.3 1.5 4.4 2.1 4.4 2.1 5.1 2.4 10.9 2.1 2.4 2.3 3.2 1.6 2.3 4.3 5.0 2.3 2.3 6.7 2.0 1.7 1.5 5.9 7.7 3.9 6.6 10.0 6.1 3.7 8.1 5.9 3.9 10.5 9.4 8.3 4.7 12.0 7.4 4.9 2.0 6.2 12.3 14.0 9.6 3.3 11.4 9.4 6.5 9.2 5.8 13.5 3.3 5.3 7.8 11.6 12.6 3.7 5.1 12.5 10.8 6.7 8.1 8.2 9.1 4.3 10.9 8.8 8.9 11.1 2.7 13.2 6.2 6.0 10.5 5.4 8.8 14.5 19.3 4.9 8.3 4.6 2.3 7.3 9.9 8.3 3.3 9.9 8.5 6.9 5.3 6.4 6.9 2.3 0.5 0.5 0.5 0.8 0.8 0.7 0.7 0.4 0.6 0.6 1.3 0.6 0.9 0.8 2.7 1.3 0.4 0.4 3.1 5.0 4.9 4.3 3.2 4.5 4.0 5.4 2.6 4.4 3.2 5.0 5.9 1.1 3.2 5.5 1.6 2.1 0.1 1.8 0.8 5.7 1.3 2.7 1.5 9.8 4.3 2.2 1.8 0.0 3.7 0.6 2.8 5.9 1.3 1.0 3.6 4.8 1.5 4.2 4.8 2.6 1.4 4.3 3.6 7.1 3.2 2.5 2.9 2.5 22.9 3.3 3.3 2.7 3.2 2.0 3.2 0.9 1.2 1.8 2.7 0.0 0.0 0.6 1.4 3.1 1.5 5.3 1.8 2.3 1.5 10.4 1.7 2.0 4.6 1.2 5.2 0.0 5.0 2.4 7.4 2.1 11.5 0.1 2.7 2.4 3.9 5.8 1.8 DPH2 DPH2L2 ENSG00000132768 "Diphthamide biosynthesis 2" Q9BQC3 1 43970000-43973369 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045796 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA045796: AB_2679456" "unprognostic (2.41e-1)" "unprognostic (1.15e-1)" "unprognostic (4.20e-3)" "unprognostic (9.13e-3)" "unprognostic (3.83e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.17e-8)" "unprognostic (1.38e-1)" "unprognostic (1.81e-1)" "unprognostic (3.72e-1)" "unprognostic (2.49e-1)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.37e-4)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (6.37e-2)" 7.7 11.6 8.0 10.9 8.3 7.0 8.0 7.7 10.3 6.8 7.5 9.8 7.4 7.7 6.1 11.9 8.3 5.5 10.4 7.8 7.4 9.4 12.7 7.2 12.5 7.7 7.9 7.6 7.3 16.0 10.3 8.9 6.6 8.0 8.2 9.3 3.5 9.6 6.7 33.0 10.6 9.1 8.9 7.2 11.8 9.8 7.2 8.1 8.9 7.4 17.1 11.0 12.5 6.8 8.2 25.0 28.5 12.2 26.8 9.2 9.6 41.6 13.0 13.9 32.9 26.9 36.1 23.8 41.4 21.4 13.3 17.0 28.1 41.7 36.8 18.4 28.0 36.1 42.4 36.1 37.9 24.1 49.9 23.4 14.9 40.6 39.2 21.0 10.0 23.2 32.0 55.4 23.1 16.8 28.6 44.6 28.3 86.3 40.5 31.4 37.6 28.2 67.4 20.6 19.5 42.8 49.3 17.2 43.1 32.6 16.3 18.2 34.3 15.4 16.1 36.7 28.6 52.4 55.3 98.7 43.0 14.2 55.0 24.1 0.0 6.6 0.4 6.1 9.4 9.0 8.3 6.4 6.5 10.1 8.8 6.4 9.3 0.6 10.3 4.8 8.4 6.6 6.3 8.0 8.3 7.7 10.3 7.8 7.4 7.7 7.9 7.6 8.0 7.2 8.1 8.2 5.8 0.0 4.8 5.2 14.4 22.9 13.2 8.9 8.6 6.8 10.3 10.0 9.3 7.2 5.2 1.8 10.4 14.8 8.8 4.8 5.9 16.5 0.3 4.0 5.6 7.6 12.0 6.3 6.9 18.8 16.2 6.2 8.6 4.3 4.5 6.9 2.5 5.7 8.6 3.3 6.5 8.1 4.1 3.7 7.1 1.0 8.4 4.4 5.4 0.0 9.2 4.4 12.3 4.0 6.9 15.2 3.0 3.8 11.5 23.6 3.8 9.0 6.0 6.0 0.0 6.5 8.0 9.4 24.9 10.3 27.1 8.6 6.9 12.7 13.7 9.0 TOE1 hCaf1z ENSG00000132773 "Target of EGR1, exonuclease" Q96GM8 1 45340052-45343973 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 36.6;Spermatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053775, HPA069119" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053775: AB_2682259, HPA069119: AB_2686090" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (7.15e-3)" "unprognostic (1.90e-2)" "unprognostic (3.33e-1)" "prognostic favorable (9.05e-4)" "prognostic unfavorable (6.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.84e-2)" "unprognostic (2.37e-2)" "unprognostic (6.03e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.71e-4)" "prognostic favorable (9.98e-4)" "unprognostic (1.81e-1)" "unprognostic (1.41e-2)" "unprognostic (2.08e-1)" 4.9 5.1 4.6 6.0 4.6 8.1 5.5 4.7 6.1 3.8 4.5 6.9 6.7 6.7 8.5 3.7 5.5 3.5 3.7 4.5 5.1 4.7 5.5 5.1 8.0 4.9 4.7 4.7 6.2 4.8 7.5 3.3 6.9 4.9 5.1 8.2 4.1 5.3 5.0 3.0 4.0 5.1 6.6 4.9 5.9 5.7 11.9 4.9 9.1 7.1 2.4 8.4 5.5 3.3 4.8 15.8 9.1 16.5 15.7 7.6 5.9 23.9 15.6 12.9 26.6 24.7 16.7 9.6 29.9 12.1 16.2 23.4 15.9 21.0 22.5 21.3 19.6 17.3 36.0 21.9 15.6 7.3 23.7 17.2 8.8 4.8 28.4 17.8 9.4 19.5 22.5 28.4 19.6 18.9 14.6 34.8 18.4 31.1 20.6 14.2 24.9 24.5 13.6 11.5 28.7 13.9 13.4 14.5 36.3 27.5 25.7 9.8 33.2 14.6 12.6 23.3 19.1 29.7 15.0 19.4 19.9 14.8 26.5 14.7 20.0 5.8 6.2 7.3 6.9 8.4 5.9 6.3 7.3 6.0 8.4 6.4 7.0 0.6 4.1 6.1 5.2 8.6 5.1 4.6 4.6 4.7 6.1 4.5 5.1 4.9 4.7 4.7 4.9 4.9 4.9 4.8 6.5 6.4 4.8 2.3 12.4 1.8 6.3 8.8 4.6 10.7 4.5 5.0 1.8 7.2 8.1 7.3 12.5 36.6 9.2 9.2 7.9 5.4 13.9 2.1 6.2 9.0 3.0 14.1 2.5 6.2 13.8 6.6 4.6 3.4 11.4 10.5 8.6 5.0 9.3 8.4 2.7 7.3 8.2 3.5 2.6 9.4 6.8 6.2 3.6 1.9 12.3 13.1 9.2 2.0 2.1 3.4 10.7 6.4 7.0 6.5 8.8 7.9 4.7 18.3 13.1 8.0 7.1 51.7 18.9 3.8 1.4 22.7 9.0 10.2 6.9 4.6 NASP "DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999" ENSG00000132780 "Nuclear autoantigenic sperm protein" P49321 1 45583846-45618904 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 476.2;Spermatogonia: 514.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028136, HPA030518, HPA030520" Enhanced Enhanced Nucleoplasm NA Yes 170000 Nucleoplasm "HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510" "unprognostic (5.59e-2)" "unprognostic (1.34e-3)" "unprognostic (5.02e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (5.36e-3)" "prognostic unfavorable (4.96e-6)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (1.91e-8)" "unprognostic (1.62e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" "unprognostic (5.32e-2)" 62.8 39.9 71.3 56.4 75.5 166.4 59.3 74.8 96.5 67.6 70.2 52.8 34.9 55.1 30.2 55.6 66.2 26.9 50.4 70.8 73.0 42.9 52.4 50.9 92.3 77.1 76.1 67.7 73.0 35.2 41.4 41.2 62.4 79.2 54.5 52.0 38.6 43.9 43.8 42.1 43.5 58.8 45.5 70.5 84.0 47.7 109.7 76.1 101.6 48.5 22.4 98.4 51.5 56.5 79.3 191.3 110.8 520.2 184.6 85.8 44.9 243.8 150.9 112.4 230.5 286.5 205.7 134.4 357.9 103.5 65.8 251.9 180.2 351.9 161.0 291.5 164.0 222.9 462.7 201.6 326.9 30.2 489.3 186.4 52.5 38.3 254.0 87.6 60.1 159.5 294.8 396.3 204.1 157.6 131.4 559.6 445.0 755.5 189.5 93.1 697.4 454.0 343.8 115.3 189.4 198.3 239.8 248.7 140.4 159.7 389.2 100.8 377.0 86.7 105.5 322.8 204.4 250.0 124.5 251.2 616.2 107.6 306.7 107.3 6.4 9.4 10.9 14.1 12.1 16.4 16.1 16.1 16.3 14.3 22.3 13.9 13.7 4.0 9.7 7.3 14.7 22.0 9.1 71.3 75.5 74.8 96.5 70.8 73.0 77.1 76.1 67.7 79.2 70.5 76.1 79.3 196.5 57.7 106.7 70.8 136.1 78.1 135.2 72.4 133.7 45.3 77.4 87.4 58.4 37.1 99.1 36.8 37.5 319.3 150.8 64.8 31.3 55.0 16.6 119.6 138.1 138.4 51.3 142.8 32.7 37.4 223.2 100.6 81.1 137.9 115.2 134.2 90.3 38.6 108.1 43.7 34.8 68.1 44.7 43.7 62.6 26.6 94.8 82.7 40.9 31.9 52.3 60.9 62.8 63.8 160.3 29.8 44.9 78.2 107.4 88.6 28.9 36.6 109.1 77.3 85.5 148.1 106.6 476.2 514.5 92.1 57.0 268.2 142.2 90.7 101.7 85.3 MUTYH MYH ENSG00000132781 "MutY DNA glycosylase" Q9UIF7 1 45329163-45340893 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA008732 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008732: AB_1854219" "unprognostic (6.30e-3)" "unprognostic (7.12e-2)" "unprognostic (6.29e-2)" "unprognostic (8.80e-2)" "unprognostic (3.43e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (4.76e-8)" "unprognostic (2.80e-2)" "unprognostic (7.12e-3)" "unprognostic (3.05e-2)" "unprognostic (7.80e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.25e-5)" "unprognostic (3.50e-3)" "unprognostic (1.62e-1)" "unprognostic (5.57e-2)" "unprognostic (5.49e-3)" 4.8 5.0 12.5 5.6 13.3 6.7 5.3 17.4 15.7 7.2 11.3 5.5 6.4 6.3 4.7 5.1 5.7 4.3 3.9 12.1 12.2 6.2 6.0 4.4 7.8 13.4 12.7 11.8 7.4 5.2 5.2 6.0 6.5 14.1 5.8 5.7 4.9 4.6 5.1 5.6 5.9 6.2 3.6 12.4 7.9 5.9 3.3 12.7 9.9 6.7 4.8 7.1 5.9 5.8 14.8 7.9 6.9 15.5 10.5 11.3 8.4 26.6 5.7 7.4 11.8 9.2 14.3 11.2 22.5 9.0 3.6 9.5 11.3 8.7 11.0 5.4 18.1 7.0 10.2 11.4 10.5 10.0 9.4 7.1 4.6 10.3 16.0 25.7 3.1 8.6 28.6 17.5 7.4 5.0 13.3 27.3 8.7 39.6 19.5 7.9 36.2 12.6 12.3 6.1 14.6 14.5 11.8 11.3 8.7 18.2 20.1 6.7 11.1 4.9 8.3 6.2 7.2 8.2 11.6 14.6 13.3 8.0 14.6 7.5 1.6 7.0 2.9 11.5 11.8 17.2 8.1 11.8 11.5 8.1 8.0 12.7 12.2 1.4 8.8 9.1 6.5 13.4 8.6 12.5 13.3 17.4 15.7 12.1 12.2 13.4 12.7 11.8 14.1 12.4 12.7 14.8 10.0 0.0 5.6 17.0 12.1 6.9 10.7 8.1 6.2 15.6 6.7 8.8 3.2 1.5 6.9 7.3 2.1 40.2 8.8 16.5 3.9 6.5 0.9 3.2 5.1 7.6 7.8 6.7 4.0 5.3 14.3 7.5 16.8 3.2 10.8 8.4 5.7 4.3 10.0 5.0 7.0 15.1 12.2 4.0 10.2 1.6 10.8 5.6 7.2 8.4 8.2 12.0 10.3 11.6 12.7 3.8 16.4 12.0 7.5 9.5 12.9 12.2 8.6 20.1 13.1 8.7 7.6 10.5 11.2 5.2 5.4 22.2 13.9 9.5 13.5 8.0 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 372.9;granulocytes: 263.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 308.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 25.3 16.9 22.2 27.6 23.5 42.1 24.0 22.6 25.0 23.3 24.4 28.1 21.9 28.0 31.4 23.6 25.5 19.9 31.7 22.8 23.2 23.1 47.1 25.6 39.7 23.7 23.0 20.6 27.4 17.4 19.9 18.4 22.3 22.7 23.6 23.4 19.0 18.7 30.9 33.6 25.3 25.4 30.8 22.0 54.5 35.1 43.6 23.1 40.5 17.3 21.1 41.6 26.0 20.5 24.6 66.7 60.3 56.7 44.6 40.3 32.8 89.2 41.9 43.7 98.0 86.0 224.8 52.4 73.9 59.6 42.7 94.4 69.8 77.1 98.6 105.3 36.1 38.0 243.0 33.2 110.2 41.8 77.4 308.0 35.1 58.9 55.6 54.8 34.1 59.8 103.8 66.8 29.6 53.5 54.9 127.0 101.4 51.4 74.9 85.8 87.9 109.1 56.3 42.9 55.0 45.1 53.6 72.5 102.3 75.4 52.3 50.6 61.1 44.5 97.4 58.0 64.9 68.8 34.1 46.6 85.5 68.5 48.6 52.7 267.9 77.7 103.3 51.0 103.0 49.1 88.9 49.9 53.8 110.3 83.4 49.8 53.6 16.9 79.9 109.6 86.9 66.2 71.3 22.2 23.5 22.6 25.0 22.8 23.2 23.7 23.0 20.6 22.7 22.0 23.1 24.6 28.6 28.9 26.4 21.2 40.0 22.8 32.9 40.7 13.1 26.1 13.0 13.2 39.8 17.2 34.1 18.4 18.8 147.8 40.4 21.1 37.2 34.8 372.9 24.2 24.9 32.5 20.9 43.7 31.6 34.7 69.4 28.7 48.4 21.6 263.6 34.4 44.3 45.2 49.3 18.5 35.6 27.3 42.7 36.0 35.5 131.2 34.2 44.5 26.6 14.0 89.8 32.1 40.2 30.7 39.8 31.9 21.5 33.4 21.6 22.3 34.7 43.1 26.1 25.8 19.7 25.4 48.0 79.4 45.2 10.7 22.4 52.9 38.8 23.7 24.2 20.6 LPIN3 "LIPN3L, SMP2" ENSG00000132793 "Lipin 3" Q9BQK8 20 41340821-41360582 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 214.9;Proximal enterocytes: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA051466, HPA052667, HPA070640" Approved Supported Cytosol NA NA Cytosol "HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288" "unprognostic (2.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (6.91e-3)" "unprognostic (4.26e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (4.29e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (5.60e-3)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (3.37e-3)" 17.2 7.3 5.1 3.7 5.2 0.3 18.2 4.3 6.8 17.4 7.2 18.4 42.0 14.2 13.2 32.4 17.8 5.9 15.7 5.1 5.9 31.2 30.2 9.2 2.2 5.4 4.5 4.5 14.6 15.3 10.4 12.7 3.6 4.8 19.9 13.4 1.3 17.1 9.7 3.3 40.9 32.7 6.0 5.0 5.7 12.4 3.3 4.9 2.0 27.2 2.5 3.2 13.4 26.4 5.7 12.4 12.0 0.7 7.1 18.6 28.8 9.1 7.5 10.3 9.0 12.1 22.3 10.7 0.6 9.1 16.7 9.5 30.6 3.6 19.6 5.6 0.3 6.9 0.6 19.8 11.5 3.0 0.0 8.1 20.8 24.3 15.3 5.9 10.4 2.3 0.3 3.2 0.4 11.3 26.5 0.1 0.3 1.0 7.6 12.1 0.1 0.2 0.9 30.9 15.5 0.9 0.2 10.0 12.6 6.4 5.6 14.8 6.2 0.7 0.6 2.9 10.1 0.1 5.8 3.3 0.1 0.2 0.1 0.6 0.8 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.6 2.3 0.3 0.2 0.1 0.1 5.1 5.2 4.3 6.8 5.1 5.9 5.4 4.5 4.5 4.8 5.0 4.9 5.7 7.2 6.4 12.3 12.1 0.8 14.4 8.2 10.0 3.4 0.0 12.7 11.3 0.8 10.0 6.0 11.0 0.0 2.8 0.2 44.4 5.9 8.7 21.6 10.0 12.5 3.2 14.9 2.7 1.0 3.8 3.5 9.4 19.9 33.1 1.3 16.2 5.0 44.1 3.3 0.0 0.3 21.9 4.1 2.2 6.0 214.9 3.1 1.0 10.6 8.4 0.0 5.2 0.0 1.0 0.2 6.4 28.4 2.6 0.1 3.8 76.9 11.8 4.2 0.5 32.9 8.8 8.2 1.0 2.7 4.7 12.6 2.6 1.0 5.2 23.2 4.8 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857614-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 7.6;Inhibitory neurons: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: AB_2682887, HPA060508: AB_2684297" "prognostic unfavorable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 1.3 2.9 2.2 2.0 2.3 0.7 1.8 2.9 2.5 1.8 1.5 2.2 2.5 1.9 2.8 1.8 2.1 1.5 2.0 2.2 2.3 1.8 2.3 1.9 3.4 2.1 2.1 2.3 2.8 1.5 2.2 1.9 1.7 2.4 1.9 2.4 3.3 1.8 1.6 1.4 2.2 2.4 1.8 2.0 3.2 1.9 3.2 2.2 3.6 1.9 2.4 3.9 1.7 1.4 2.4 1.7 1.4 4.1 2.4 4.9 3.5 2.4 2.6 3.1 4.7 4.6 5.9 2.6 5.3 8.8 2.2 2.3 2.8 5.9 2.8 3.5 3.3 2.5 5.1 2.6 3.8 5.9 2.9 6.7 3.2 3.1 3.6 2.2 5.0 4.1 4.6 4.8 2.5 3.6 8.5 4.0 5.8 1.6 3.9 5.6 3.9 3.8 4.0 1.3 1.0 5.4 2.7 4.2 4.8 3.3 3.1 2.3 7.6 4.1 4.7 1.5 1.8 1.6 5.4 3.0 3.4 4.0 3.4 1.5 1.0 1.1 1.6 1.3 1.5 2.8 2.1 1.5 2.0 1.9 1.8 1.4 1.9 0.8 1.7 4.8 1.1 2.4 1.1 2.2 2.3 2.9 2.5 2.2 2.3 2.1 2.1 2.3 2.4 2.0 2.2 2.4 1.6 3.2 1.1 4.6 4.1 0.4 0.3 0.7 0.6 4.4 1.1 1.0 1.3 0.0 0.5 1.8 0.0 1.3 1.4 2.8 0.0 1.2 0.5 0.6 1.2 1.8 2.4 0.8 7.6 1.4 0.6 1.4 1.5 1.0 0.0 5.2 2.2 0.8 1.0 0.0 9.2 1.1 0.0 1.3 1.4 0.7 0.3 1.1 0.0 6.5 0.6 2.8 0.0 7.1 7.0 0.6 0.3 1.2 2.6 0.2 2.0 1.2 0.5 4.3 0.0 1.3 1.2 2.4 4.3 1.3 0.3 0.8 3.1 4.7 0.9 0.4 RBM38 "dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D" ENSG00000132819 "RNA binding motif protein 38" Q9H0Z9 20 57391396-57409333 "Predicted intracellular proteins" "Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 137.6;skeletal muscle: 223.8" "Cell type enhanced" "Detected in many" "B-cells: 110.9;dendritic cells: 156.9;Erythroid cells: 280.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 95.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 140.6;U-698: 150.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB017036 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017036: " "unprognostic (1.03e-1)" "prognostic favorable (3.64e-7)" "unprognostic (3.71e-2)" "unprognostic (7.73e-3)" "unprognostic (4.16e-2)" "unprognostic (4.85e-2)" "unprognostic (1.53e-2)" "unprognostic (4.37e-3)" "unprognostic (3.04e-1)" "unprognostic (9.04e-3)" "unprognostic (3.90e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.13e-2)" "unprognostic (2.29e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.83e-1)" 11.4 10.8 4.8 26.9 6.1 137.6 12.9 11.3 10.4 16.8 13.8 71.9 8.8 38.8 0.9 16.9 29.1 5.1 62.3 4.3 9.7 16.2 16.6 21.2 43.7 7.0 6.9 1.1 28.0 10.9 1.9 12.3 5.5 7.2 27.2 4.2 0.6 19.8 12.0 223.8 9.1 40.1 8.7 4.6 66.3 23.1 38.4 6.4 26.8 9.5 33.0 12.3 43.3 13.7 6.4 20.1 20.4 9.7 25.1 0.0 1.6 56.3 6.5 1.6 13.5 3.5 84.2 20.6 140.6 54.1 1.9 13.2 18.3 8.0 8.0 2.1 29.0 34.5 118.0 7.6 52.6 6.0 57.8 54.2 1.9 3.8 5.7 1.1 1.9 9.2 52.5 100.9 24.6 1.6 87.8 42.7 58.5 36.9 10.7 25.5 82.0 23.6 114.2 10.1 9.2 40.9 26.3 15.2 50.5 24.7 8.7 28.3 79.4 17.0 4.4 42.6 6.0 27.6 60.1 86.8 150.7 1.1 40.3 4.2 0.0 0.5 2.2 3.1 1.8 1.9 3.2 2.5 2.1 1.0 3.3 3.0 2.8 0.7 3.5 1.7 1.3 4.7 2.1 4.8 6.1 11.3 10.4 4.3 9.7 7.0 6.9 1.1 7.2 4.6 6.4 6.4 13.9 3.2 5.2 10.1 110.9 9.1 28.3 7.9 13.6 1.0 15.8 21.0 42.5 8.6 6.6 1.8 0.0 1.9 156.9 41.6 9.8 6.2 4.2 54.2 5.2 11.9 62.8 280.4 2.5 5.0 5.8 8.8 12.2 21.5 8.8 31.5 10.4 6.0 9.6 0.0 1.3 56.4 12.2 8.1 18.9 4.0 4.4 27.6 1.8 2.8 5.8 12.8 54.6 4.5 4.6 5.9 35.4 6.0 52.8 18.8 2.8 16.4 22.5 1.4 6.6 20.6 7.6 2.4 13.2 9.1 8.4 2.3 81.0 13.3 34.0 18.5 VSTM2L "C20orf102, dJ1118M15.2" ENSG00000132821 "V-set and transmembrane domain containing 2 like" Q96N03 20 37903111-37945350 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.0;heart muscle: 50.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 25.2;Cholangiocytes: 61.5;Club cells: 28.7;Inhibitory neurons: 44.0;Respiratory ciliated cells: 83.0" "Group enriched" "Detected in all" 5 "lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 67.2;HDLM-2: 98.8;hTCEpi: 23.4;SH-SY5Y: 22.5;SK-BR-3: 81.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043832 Uncertain "Secreted - unknown location" NA NA "HPA043832: AB_10968449" "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.63e-5)" "unprognostic (4.96e-3)" "unprognostic (1.56e-1)" "unprognostic (1.83e-2)" "unprognostic (1.39e-1)" "unprognostic (1.52e-1)" "unprognostic (2.34e-3)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.85e-3)" "unprognostic (1.29e-3)" "unprognostic (1.68e-1)" "unprognostic (9.66e-2)" "prognostic unfavorable (8.14e-4)" 0.7 6.2 32.5 0.8 32.5 0.0 0.5 1.4 79.0 12.6 0.0 2.8 1.2 1.7 9.8 1.0 15.6 17.7 50.1 89.0 34.0 1.4 3.0 11.6 0.4 16.2 26.7 38.1 0.3 2.6 0.0 17.5 0.8 20.5 9.2 0.4 3.0 7.4 16.3 1.1 0.8 1.2 0.9 16.8 29.8 7.9 4.9 28.4 3.0 1.7 0.0 1.0 0.7 0.6 20.3 0.0 0.8 7.7 0.3 0.3 0.4 0.2 0.9 0.0 0.0 0.0 0.3 67.2 0.0 0.4 0.6 0.3 0.2 0.1 3.2 0.0 98.8 1.9 0.1 0.1 0.0 3.6 0.1 2.5 3.2 23.4 0.1 0.7 2.4 0.0 0.1 0.0 0.0 8.4 0.0 0.1 0.1 0.2 2.3 20.1 0.0 0.0 0.3 0.1 0.0 2.6 22.5 2.7 81.0 0.8 0.0 0.4 0.0 4.6 0.0 0.6 0.2 1.5 0.2 0.1 0.0 0.5 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 32.5 1.4 79.0 89.0 34.0 16.2 26.7 38.1 20.5 16.8 28.4 20.3 0.1 6.4 1.8 2.0 0.1 0.4 1.2 10.7 1.8 8.5 1.0 0.0 25.2 61.5 28.7 0.0 8.4 0.6 1.3 0.2 0.0 3.7 0.4 0.1 0.5 0.3 18.6 0.0 17.8 0.2 0.2 1.8 4.1 0.0 0.0 1.5 2.9 1.3 0.0 13.5 44.0 1.2 10.2 0.8 1.5 0.9 5.3 0.9 0.0 1.9 0.0 0.9 0.0 3.0 3.2 7.9 2.6 16.1 0.1 5.3 0.1 1.0 83.0 4.6 0.0 0.0 2.9 0.2 0.8 0.1 0.6 0.1 1.2 3.5 0.2 0.7 OSER1 "C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1" ENSG00000132823 "Oxidative stress responsive serine rich 1" Q9NX31 20 44195939-44210771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 842.5;Late spermatids: 2257.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045125 Approved Approved "Nucleoli,Nucleoli rim,Nuclear speckles" NA Yes "Nucleoli, Nucleoli rim, Nuclear speckles" "HPA045125: AB_10961629" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.18e-1)" "unprognostic (6.07e-2)" "unprognostic (8.44e-3)" "unprognostic (3.31e-1)" "unprognostic (1.14e-1)" "unprognostic (8.78e-2)" "unprognostic (8.01e-3)" "unprognostic (9.87e-2)" "unprognostic (3.96e-1)" "unprognostic (2.14e-1)" "unprognostic (2.45e-1)" "unprognostic (8.39e-2)" "unprognostic (1.06e-1)" 40.6 26.9 22.9 22.5 24.2 129.7 42.7 25.6 27.0 36.9 24.4 36.6 27.4 35.4 31.0 46.5 35.3 23.9 37.1 23.1 25.1 35.7 38.4 36.3 27.9 26.0 24.7 22.6 42.9 23.7 29.6 24.5 25.5 25.5 37.0 24.9 25.3 37.2 21.7 111.0 52.2 37.6 25.9 26.4 40.4 33.1 117.2 25.8 25.5 38.1 61.6 32.7 45.0 39.5 28.7 50.6 37.1 28.9 22.6 75.2 54.6 32.7 45.0 69.6 71.0 64.1 93.9 54.7 49.1 44.3 43.3 96.1 73.9 31.8 42.7 59.3 16.2 20.1 16.1 99.8 66.8 41.6 27.6 26.8 64.5 72.3 47.1 86.1 38.7 32.8 30.6 24.9 64.9 40.2 75.8 22.5 35.9 25.7 46.5 39.3 32.8 46.4 35.0 37.3 34.7 28.2 27.5 64.2 90.5 62.2 33.9 45.1 25.6 27.8 60.6 45.3 35.8 39.7 44.3 49.1 48.4 42.6 20.6 31.1 264.8 68.4 119.5 50.0 68.3 54.1 120.1 57.1 49.7 60.7 115.2 67.7 61.8 306.7 67.7 100.2 39.7 73.8 91.5 22.9 24.2 25.6 27.0 23.1 25.1 26.0 24.7 22.6 25.5 26.4 25.8 28.7 51.2 19.2 21.0 14.4 70.0 259.4 137.6 95.4 101.3 10.3 69.1 75.2 38.7 18.6 61.3 12.9 4.2 40.4 48.6 58.6 37.2 45.1 842.5 94.7 48.0 36.8 49.5 25.0 9.0 36.4 38.2 48.6 37.2 175.1 33.0 22.9 18.5 27.9 43.4 11.8 9.0 34.6 65.1 30.6 111.1 2257.1 40.7 55.2 76.5 5.6 84.2 31.0 30.9 5.0 12.5 49.3 87.7 35.3 40.6 91.4 68.1 33.5 36.9 14.8 19.7 47.0 45.6 194.8 71.7 50.4 198.5 173.6 55.2 22.3 47.5 119.4 SERINC3 "AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1" ENSG00000132824 "Serine incorporator 3" Q13530 20 44496221-44522085 "Predicted membrane proteins, Transporters" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 558.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048116 Uncertain NA NA "HPA048116: AB_2680269" "unprognostic (3.16e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (2.60e-1)" "unprognostic (2.74e-1)" "unprognostic (7.34e-2)" "unprognostic (1.85e-3)" "unprognostic (6.26e-2)" "unprognostic (7.41e-2)" "unprognostic (3.11e-1)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-3)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" 82.4 92.5 60.7 49.8 66.6 49.2 62.4 62.3 82.0 73.9 32.3 57.1 47.6 63.0 49.3 65.8 55.3 69.5 73.4 69.9 67.9 49.6 93.5 68.3 46.7 65.5 64.0 62.1 68.2 50.7 107.8 45.0 116.7 66.7 58.3 63.8 48.4 66.9 64.1 82.2 62.8 53.7 70.7 66.2 57.6 54.6 111.2 60.9 60.6 82.3 81.8 50.7 63.9 50.5 76.6 70.3 73.9 34.8 44.1 297.4 211.8 53.7 140.8 243.1 111.5 101.3 167.3 169.2 51.0 187.5 168.8 127.1 123.0 41.9 144.9 117.3 59.5 47.1 59.7 71.9 85.7 161.4 74.2 124.5 152.1 207.4 109.7 163.3 135.3 110.0 81.6 67.5 146.2 117.7 88.2 76.5 58.9 20.5 91.6 110.9 38.1 51.9 78.5 88.7 79.5 43.4 32.9 135.2 129.8 91.8 47.9 93.0 82.6 141.5 262.1 43.3 117.0 99.1 86.2 102.0 38.9 195.3 51.7 83.9 217.1 92.6 119.4 96.5 96.7 98.4 57.6 82.9 94.5 95.4 63.4 84.7 85.0 177.3 111.0 113.5 87.4 104.4 137.7 60.7 66.6 62.3 82.0 69.9 67.9 65.5 64.0 62.1 66.7 66.2 60.9 76.6 139.7 73.7 70.7 20.5 52.1 54.8 75.3 96.5 60.3 39.2 55.3 44.4 75.9 78.6 84.7 47.8 35.5 85.8 86.1 84.4 15.6 77.2 239.8 44.5 76.2 115.1 66.4 94.9 58.7 69.9 85.6 97.5 41.3 65.1 102.5 32.9 122.4 105.7 57.7 45.4 52.4 60.4 71.2 93.5 50.0 558.0 105.0 79.7 39.2 34.7 44.2 47.4 37.0 27.6 63.8 100.4 63.8 114.0 76.1 75.3 55.6 24.6 65.4 36.6 98.6 69.5 88.9 210.9 99.3 54.6 84.1 165.4 72.0 85.9 54.7 82.2 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936663-59940305 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.0" "Group enriched" "Detected in many" 4 "granulocytes: 3.0;monocytes: 1.8" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favorable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 3.7 2.9 6.3 4.8 6.6 6.3 3.8 7.2 6.9 4.2 4.4 3.5 5.3 3.7 3.4 5.8 3.5 3.0 5.5 6.4 6.3 4.2 1.1 3.5 3.9 7.5 6.5 5.3 4.6 3.5 5.2 2.8 5.4 7.0 6.3 3.0 2.1 4.4 5.7 7.2 4.2 5.1 3.8 6.7 4.9 5.4 1.9 6.9 3.3 3.7 9.8 5.1 3.5 3.6 6.6 5.1 3.1 2.1 4.3 4.6 4.8 17.3 6.6 7.1 7.9 3.8 4.9 6.8 2.1 8.0 5.5 4.9 14.7 4.3 4.7 5.1 5.0 3.4 5.6 4.2 2.6 4.2 2.3 15.2 3.4 12.7 2.8 2.4 4.2 4.4 1.4 1.0 0.5 5.1 7.9 1.9 7.5 1.5 9.6 7.3 2.4 0.9 3.3 5.3 8.1 4.0 2.4 8.2 24.6 7.4 3.9 9.0 8.2 4.7 4.6 1.9 4.9 1.1 1.7 4.5 0.5 3.5 8.1 2.9 0.3 0.7 3.0 0.4 0.3 0.3 0.3 0.3 0.3 0.5 0.2 0.3 0.2 1.8 0.4 1.8 0.2 0.4 0.2 6.3 6.6 7.2 6.9 6.4 6.3 7.5 6.5 5.3 7.0 6.7 6.9 6.6 10.4 9.6 0.5 12.4 3.3 1.3 4.6 2.6 4.6 7.8 5.7 4.2 6.7 7.2 4.3 5.5 2.1 14.3 4.5 4.0 5.9 1.9 0.4 3.0 4.9 8.6 1.8 1.3 0.9 3.1 6.4 3.3 3.1 3.4 5.7 3.9 9.7 0.4 5.2 13.5 2.4 3.6 0.0 9.8 2.6 1.3 3.1 7.4 5.4 1.0 8.7 11.0 13.4 2.5 1.8 3.5 6.1 4.5 3.7 6.7 6.7 6.2 4.3 11.4 6.6 5.7 4.9 0.4 3.6 4.7 3.1 4.9 5.6 5.1 3.8 9.5 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997564-79236038 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 18 "kidney: 171.0;liver: 286.1" "Cell type enhanced" "Detected in many" "Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria NA NA 680000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859" "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favorable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favorable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 8.4 4.5 1.5 0.3 1.7 0.0 2.2 1.5 1.6 1.4 2.8 1.0 0.2 2.8 12.3 1.4 1.3 2.1 1.4 1.5 2.8 171.0 286.1 0.4 0.2 1.8 1.9 1.5 2.2 1.8 0.6 2.9 0.1 1.7 1.8 0.4 1.5 0.4 1.8 2.4 0.6 0.6 1.7 1.3 0.1 1.0 2.3 2.2 0.3 4.9 1.5 0.3 1.3 0.5 1.6 0.0 0.0 0.0 0.3 0.3 0.8 0.3 0.2 3.6 0.8 1.4 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 7.6 1.9 0.0 0.0 1.7 2.1 2.2 1.6 1.5 0.0 0.8 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 1.5 1.6 1.5 2.8 1.8 1.9 1.5 1.7 1.3 2.2 1.6 1.3 0.0 1.1 19.9 2.9 0.1 0.5 1.0 1.8 1.9 1.4 1.8 1.0 2.8 0.8 9.2 2.1 0.3 1.9 0.7 19.6 0.4 40.6 2.6 5.0 1.2 1.2 6.1 5.8 0.7 0.1 2.7 3.6 2.7 0.0 4.1 1.8 104.2 0.1 0.0 1.5 1.2 4.1 1.6 0.4 33.1 2.5 1.7 0.0 4.7 0.2 4.3 3.1 4.5 3.3 0.8 1.4 2.6 4.5 0.9 1.6 83.9 4.7 3.7 0.0 1.7 0.7 4.9 5.3 1.8 0.3 0.3 2.9 4.4 0.9 0.8 BHMT2 ENSG00000132840 "Betaine--homocysteine S-methyltransferase 2" Q9H2M3 5 79069767-79090069 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "kidney: 336.2;liver: 433.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 95.9;Hepatocytes: 201.2;Proximal tubular cells: 408.6" "Group enriched" "Detected in many" 14 "liver cancer: 79.6;renal cancer: 52.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 17.5;Hep G2: 78.2;hTEC/SVTERT24-B: 46.0;U-87 MG: 18.6" "Not detected" "Not detected" HPA044573 Enhanced NA NA 1900000 "HPA044573: AB_10795044" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-2)" "unprognostic (3.76e-2)" "unprognostic (4.40e-2)" "unprognostic (2.90e-3)" "unprognostic (1.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.87e-2)" "unprognostic (2.45e-3)" "unprognostic (1.41e-2)" "unprognostic (1.02e-1)" "unprognostic (1.76e-2)" "unprognostic (5.05e-2)" "unprognostic (1.49e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-3)" 31.6 16.8 5.4 3.1 5.8 0.3 15.6 4.7 5.0 8.0 12.8 11.4 1.7 12.2 37.9 7.7 7.7 7.5 9.9 4.7 11.8 336.2 433.4 3.2 1.3 5.0 6.6 4.4 7.9 1.8 0.5 12.4 0.4 5.2 12.1 2.4 1.3 2.1 14.5 10.3 2.2 6.2 13.1 4.4 0.6 9.2 3.8 5.9 0.9 18.9 4.9 1.0 18.2 3.8 4.9 0.0 0.2 0.1 0.1 8.5 6.0 2.8 7.8 17.5 4.0 7.7 0.0 0.1 0.1 0.1 9.7 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.4 0.4 78.2 6.6 0.4 0.1 7.3 0.0 46.0 0.0 7.9 0.0 0.0 0.4 0.4 1.1 0.0 0.1 0.3 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.2 2.2 0.1 0.5 0.0 0.1 0.5 0.1 0.2 0.0 0.3 0.1 0.3 0.1 0.1 0.1 0.3 18.6 0.4 0.1 0.7 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.8 0.3 0.0 0.1 0.0 0.0 5.4 5.8 4.7 5.0 4.7 11.8 5.0 6.6 4.4 5.2 4.4 5.9 4.9 1.4 6.4 0.5 6.2 1.2 0.8 0.4 0.1 0.0 1.5 0.2 0.1 4.4 1.5 0.0 46.0 2.1 0.2 0.0 0.0 95.9 0.1 0.5 0.4 11.7 2.9 1.2 2.7 4.1 0.0 0.4 17.3 0.0 0.4 0.0 4.5 2.5 201.2 0.3 0.0 0.6 0.1 0.0 4.4 1.2 1.3 27.4 2.5 0.0 11.2 0.3 4.2 0.0 2.0 0.6 0.0 0.0 37.2 0.1 0.4 0.0 408.6 0.1 1.2 6.6 6.2 3.1 0.4 0.5 0.1 1.0 0.3 2.2 30.0 0.0 1.0 AP3B1 "ADTB3A, HPS2" ENSG00000132842 "Adaptor related protein complex 3 subunit beta 1" O00203 5 78002326-78294698 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038737, HPA045458" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 38000 Nucleoplasm "Golgi apparatus" "HPA038737: AB_10670788, HPA045458: AB_2679333" "unprognostic (9.14e-2)" "unprognostic (2.02e-1)" "prognostic favorable (1.37e-5)" "unprognostic (8.17e-2)" "unprognostic (2.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-3)" "unprognostic (7.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.97e-2)" "prognostic favorable (7.97e-6)" "unprognostic (1.65e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (3.39e-2)" 20.6 21.6 23.2 19.8 26.8 22.1 21.5 23.9 26.6 20.9 24.2 24.4 20.0 17.9 54.4 31.1 15.9 16.1 19.0 20.8 26.0 30.6 16.0 17.3 22.7 25.6 25.9 18.8 13.2 25.2 29.5 40.7 19.7 25.6 17.0 28.6 8.8 26.7 16.6 15.9 22.0 21.0 20.7 25.4 21.7 23.2 13.4 24.3 23.5 27.4 13.2 25.0 20.3 22.1 28.3 51.3 40.3 45.4 63.1 53.2 64.5 39.5 56.3 66.1 50.1 67.5 31.4 44.1 53.7 32.5 69.4 41.7 36.6 45.0 94.1 62.7 61.7 31.7 37.4 33.9 55.5 31.1 33.7 47.1 46.2 34.0 42.3 42.5 47.7 64.1 10.9 27.3 34.3 86.9 31.6 43.4 52.2 24.1 37.4 23.9 45.2 80.2 74.4 72.7 47.5 16.0 25.7 52.3 33.7 49.7 37.1 40.9 55.6 65.0 37.4 29.1 45.4 57.4 26.3 43.3 36.3 48.5 48.5 48.4 18.3 12.6 11.3 9.6 12.5 10.6 31.3 8.0 10.0 17.2 40.1 6.6 8.8 15.4 9.6 17.3 14.2 10.4 8.1 23.2 26.8 23.9 26.6 20.8 26.0 25.6 25.9 18.8 25.6 25.4 24.3 28.3 31.6 44.8 33.7 82.3 59.0 15.8 22.1 28.1 22.8 16.2 18.8 14.1 29.0 10.0 37.5 31.3 22.9 30.9 37.1 36.9 25.4 35.8 12.0 27.7 38.8 33.3 19.2 27.3 59.7 38.0 38.7 32.0 35.2 40.8 32.9 26.1 23.2 17.0 39.5 20.2 57.3 34.1 26.4 41.9 24.8 20.2 15.8 47.3 26.6 118.0 66.5 21.5 32.0 86.5 231.0 43.5 25.0 16.6 44.0 20.7 30.0 27.2 29.8 27.5 26.3 36.2 28.5 16.1 10.1 28.9 23.4 29.8 39.9 31.2 28.0 22.2 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087285 "Predicted intracellular proteins, Predicted secreted proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.7;JURKAT: 31.0;MOLT-4: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" Nucleoplasm "HPA055995: AB_2683000" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 10.1 3.3 9.3 1.9 13.0 2.7 8.8 10.2 9.9 6.7 7.6 4.1 3.9 10.3 7.4 2.4 7.0 3.6 4.6 8.4 10.3 10.1 10.8 5.1 1.9 16.7 12.8 6.7 8.0 7.6 8.5 3.9 2.4 19.2 5.1 4.3 3.9 6.0 6.6 2.8 2.5 3.4 8.8 11.6 3.6 6.5 1.9 12.2 4.8 11.3 3.8 1.9 3.0 3.7 17.8 5.2 4.2 5.4 29.7 22.1 1.5 0.3 1.7 5.0 2.6 6.9 9.1 2.4 0.0 10.9 3.4 1.1 0.6 2.9 1.8 2.3 1.7 5.8 4.0 9.1 10.4 13.1 5.5 1.5 24.6 6.8 1.3 5.1 4.2 8.3 31.0 0.0 11.0 1.6 5.2 29.4 0.8 3.5 1.4 2.5 12.1 10.3 1.7 12.3 2.0 5.9 12.4 6.1 5.0 8.7 2.1 7.5 3.8 3.3 2.3 4.5 5.1 7.0 8.0 8.2 11.5 3.6 10.4 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 9.3 13.0 10.2 9.9 8.4 10.3 16.7 12.8 6.7 19.2 11.6 12.2 17.8 10.5 0.0 2.8 8.1 1.7 1.3 3.8 0.3 4.0 8.4 13.5 13.6 10.7 12.8 2.0 12.9 12.5 1.5 2.0 3.1 17.6 4.1 3.3 16.5 13.5 11.7 16.2 5.0 3.3 6.0 0.3 9.3 11.7 12.5 1.3 20.2 12.1 31.8 9.6 3.3 8.5 5.3 0.0 13.6 4.9 2.2 17.7 9.0 7.2 5.6 5.1 13.8 3.1 16.1 18.3 2.7 3.4 11.3 1.4 5.6 1.9 17.2 0.1 17.0 0.0 21.4 7.7 1.5 3.4 2.2 1.4 0.3 1.2 25.6 7.1 1.8 PATJ "Cipp, INADL" ENSG00000132849 "PATJ crumbs cell polarity complex component" Q8NI35 1 61742477-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Alveolar cells type 2: 60.6;Club cells: 39.0;Collecting duct cells: 57.0;Endometrial ciliated cells: 55.7;Glandular and luminal cells: 98.3;Pancreatic endocrine cells: 47.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 73.1" "Immune cell enhanced" "Detected in many" "eosinophil: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 36.3;RPTEC TERT1: 30.3;RT4: 33.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 72.3" "HPA066352, HPA066960, HPA069079" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions" "Centriolar satellite, Cytosol" "HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079" "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favorable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 3.3 7.3 7.0 3.6 6.4 3.5 18.3 73.1 6.0 7.0 21.2 12.3 9.0 5.8 26.7 19.4 8.4 7.1 45.6 3.9 9.2 27.7 12.5 10.0 2.9 11.4 12.3 4.9 6.8 12.5 20.2 10.9 3.5 25.5 12.4 11.2 15.9 20.1 8.0 45.8 22.6 9.4 3.6 10.8 3.1 10.3 5.1 10.3 4.0 13.2 16.2 6.2 7.9 13.3 11.8 36.3 7.0 2.3 3.2 1.3 3.3 29.5 2.1 2.8 2.2 3.0 12.5 13.2 0.2 9.1 4.4 18.7 21.1 5.1 18.9 3.8 3.5 8.8 0.2 10.4 11.3 2.9 0.1 0.2 1.2 19.7 3.7 8.0 5.3 1.2 0.0 0.0 0.0 1.9 12.6 0.1 0.1 12.0 16.4 1.9 0.1 2.8 5.2 30.3 33.4 6.1 2.0 8.8 29.4 7.7 23.7 23.7 0.3 0.3 1.8 4.3 0.2 4.2 1.4 2.7 4.8 1.7 0.0 0.5 0.4 0.0 7.2 1.2 0.1 2.3 1.2 2.0 1.7 0.0 1.1 2.6 1.7 0.6 2.6 0.1 0.2 1.9 0.6 7.0 6.4 73.1 6.0 3.9 9.2 11.4 12.3 4.9 25.5 10.8 10.3 11.8 6.4 86.6 60.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 35.0 29.8 0.0 0.0 39.0 57.0 0.0 4.3 3.8 0.0 5.9 37.6 0.0 55.7 8.6 1.6 0.0 0.0 0.0 26.4 0.7 5.5 0.0 98.3 1.3 14.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 2.7 0.0 0.0 35.7 27.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 26.4 10.3 1.7 0.0 0.0 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236165-62319434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9;pancreas: 15.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 31.8;Exocrine glandular cells: 8.0;Extravillous trophoblasts: 19.0;Oligodendrocytes: 34.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.8;Hep G2: 13.4;SCLC-21H: 6.2;SuSa: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.8 0.6 2.9 0.5 5.4 0.0 2.7 9.8 4.0 0.3 0.3 1.0 0.4 0.2 0.7 0.2 0.3 0.5 0.3 1.0 6.3 1.4 3.0 2.5 0.0 16.1 12.5 0.7 0.3 15.3 5.7 0.1 10.9 22.9 1.5 1.0 1.0 8.5 0.6 0.2 0.4 0.3 0.2 6.2 0.8 2.0 0.9 6.2 0.8 0.3 0.8 0.1 0.2 0.5 13.9 0.0 0.0 1.1 0.0 0.0 0.0 31.8 0.1 0.0 0.1 0.0 4.8 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 2.4 13.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 1.0 0.6 0.0 27.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.9 5.4 9.8 4.0 1.0 6.3 16.1 12.5 0.7 22.9 6.2 6.2 13.9 0.1 0.0 0.0 1.3 0.0 0.0 2.4 0.4 0.6 0.3 0.5 7.0 0.9 0.0 0.0 0.0 0.0 31.8 0.0 0.5 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 2.3 8.0 19.0 0.9 0.0 0.1 0.0 0.1 0.4 1.5 2.3 0.0 2.3 1.4 0.0 0.0 0.0 0.3 0.0 0.4 1.8 1.0 0.0 0.1 0.0 0.5 34.3 0.4 0.2 3.8 0.0 0.0 0.0 0.8 0.0 0.5 0.0 1.2 4.2 0.0 1.0 0.2 0.0 5.5 0.1 0.0 1.0 0.1 ANGPTL3 ANGPT5 ENSG00000132855 "Angiopoietin like 3" Q9Y5C1 1 62597520-62606313 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Lipid metabolism" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 681.3" "Group enriched" "Detected in some" 12 "Hepatocytes: 567.6;Proximal tubular cells: 272.5" "Cancer enriched" "Detected in some" 39 "liver cancer: 94.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038097 Approved "Secreted to blood" NA NA 225000000 120000000 "HPA038097: AB_10675628" "unprognostic (2.29e-1)" "unprognostic (8.01e-2)" "unprognostic (2.51e-1)" "unprognostic (4.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (4.06e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-3)" "unprognostic (6.85e-3)" "unprognostic (2.89e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.09e-2)" "unprognostic (5.38e-2)" "unprognostic (7.62e-2)" 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 53.5 681.3 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.3 11.5 0.0 5.5 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.1 0.1 0.7 0.0 16.0 0.1 0.2 0.1 0.0 2.6 0.3 0.0 0.0 9.7 567.6 0.1 0.0 0.1 0.0 0.0 16.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 272.5 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.0 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267892-43277535 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 80.4;pituitary gland: 31.0;retina: 25.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1" "Group enriched" "Detected in some" 5 "glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 245.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.7 16.0 16.8 1.4 21.3 0.1 0.0 80.4 45.7 0.0 0.0 0.9 0.8 0.0 0.0 0.1 0.0 0.0 0.7 18.3 44.1 0.1 0.0 0.9 0.0 11.5 25.1 18.7 0.5 3.7 0.0 31.0 0.1 29.1 0.6 0.8 25.5 0.1 8.4 0.0 0.0 0.8 0.6 5.2 0.0 3.3 1.6 25.4 0.4 0.3 0.0 0.0 0.0 0.5 55.8 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 245.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 21.3 80.4 45.7 18.3 44.1 11.5 25.1 18.7 29.1 5.2 25.4 55.8 0.0 0.0 1.1 8.8 0.0 0.1 0.0 0.0 0.0 66.8 0.0 0.0 3.6 0.0 2.5 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 28.7 0.0 50.9 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.4 0.0 2.5 0.0 7.5 7.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.1 SLC14A2 "HUT2, UT2" ENSG00000132874 "Solute carrier family 14 member 2" Q15849 18 45212995-45683688 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.5;kidney: 3.2" "Cell type enriched" "Detected in many" 7 "Collecting duct cells: 77.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enriched" "Detected in single" 7 "U-266/70: 4.9" "Region enhanced" "Detected in many" "basal ganglia: 16.9" "Not detected" "Not detected" NA NA "unprognostic (2.33e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.54e-2)" "unprognostic (7.80e-2)" "unprognostic (1.11e-2)" "unprognostic (7.89e-3)" "unprognostic (3.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-3)" "unprognostic (8.96e-2)" "unprognostic (3.50e-3)" "unprognostic (1.20e-1)" "unprognostic (7.64e-2)" "unprognostic (7.52e-2)" "unprognostic (6.62e-2)" 1.5 1.1 0.2 0.2 0.2 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 3.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.7 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.2 4.9 0.2 0.1 0.2 0.7 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.3 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.4 6.4 9.6 5.2 0.7 0.6 0.9 0.3 0.0 1.1 0.4 0.3 0.9 0.0 1.9 77.3 2.1 0.3 0.6 0.3 0.0 0.0 1.3 0.2 0.3 0.9 0.0 0.0 8.8 0.0 0.5 2.4 0.0 0.3 3.8 0.1 1.1 0.0 0.4 1.7 10.6 0.5 0.0 0.3 2.0 1.4 0.6 0.8 1.8 2.8 0.2 0.9 1.0 6.6 1.0 0.1 1.2 0.7 0.1 0.5 4.9 0.2 1.5 2.0 0.0 0.4 0.2 0.3 0.4 0.0 0.1 0.8 1.0 0.2 0.2 0.5 FBXO44 "FBG3, FBX30, Fbx44, Fbxo6a, MGC14140" ENSG00000132879 "F-box protein 44" Q9H4M3 1 11654375-11663327 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 145.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 48.2;Inhibitory neurons: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003363 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003363: AB_1078831" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (9.59e-2)" "unprognostic (5.34e-2)" "unprognostic (2.82e-1)" "unprognostic (2.97e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-2)" "unprognostic (3.32e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.63e-4)" "unprognostic (2.57e-2)" "prognostic favorable (6.29e-5)" "unprognostic (1.34e-2)" "unprognostic (5.45e-1)" "unprognostic (1.77e-1)" "unprognostic (3.02e-3)" 16.5 37.4 105.1 12.6 116.4 8.3 27.1 110.5 145.6 37.9 71.8 22.7 20.1 21.1 13.5 23.9 32.7 14.6 30.0 118.7 108.0 49.6 40.3 22.5 25.4 105.1 99.7 117.9 32.3 41.7 45.9 91.2 3.1 107.4 55.0 4.2 18.2 35.5 19.6 11.5 41.4 27.9 8.0 80.0 38.9 30.3 29.2 110.7 10.2 50.6 8.9 14.1 26.4 37.1 113.4 14.9 23.3 8.2 31.6 11.8 12.4 10.9 11.0 13.9 12.1 10.7 17.0 26.6 0.3 25.7 12.4 20.6 3.3 16.5 37.4 5.0 16.1 21.1 0.4 14.0 27.9 16.2 0.2 2.0 15.9 24.7 11.4 8.7 24.9 9.6 27.4 8.5 3.5 3.1 8.8 24.2 2.4 8.7 12.9 16.5 9.8 0.1 4.8 19.7 5.2 24.8 20.7 29.7 11.3 51.1 10.1 20.4 12.9 12.1 8.8 21.4 12.2 9.1 23.1 13.9 9.3 19.7 5.9 21.0 1.8 2.3 0.7 13.0 2.7 10.0 11.0 8.6 9.8 3.8 11.5 11.6 7.9 1.8 1.8 3.0 5.7 8.6 7.4 105.1 116.4 110.5 145.6 118.7 108.0 105.1 99.7 117.9 107.4 80.0 110.7 113.4 3.4 0.0 7.4 27.1 18.3 18.4 12.5 20.1 25.0 21.5 15.7 18.0 4.3 8.6 10.1 16.5 14.6 1.3 18.3 1.2 31.3 7.8 4.5 2.3 4.4 4.3 4.2 1.3 48.2 6.5 2.5 12.3 7.7 2.1 3.8 10.7 8.6 5.4 6.1 40.4 50.1 1.9 14.2 5.3 11.4 13.7 23.0 5.8 10.6 6.5 4.7 15.6 16.5 22.1 18.2 7.0 1.7 29.0 9.7 10.8 1.7 11.9 5.4 7.2 0.0 6.4 6.6 11.1 6.7 7.6 17.0 0.8 18.2 4.5 2.9 5.9 CPLANE2 "C1orf89, MGC10731, RSG1" ENSG00000132881 "Ciliogenesis and planar polarity effector 2" Q9BU20 1 16231692-16237183 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Collecting duct cells: 7.3;Distal tubular cells: 3.9;Ductal cells: 2.4;Endometrial ciliated cells: 4.1;Extravillous trophoblasts: 2.3;Hofbauer cells: 2.4;Proximal tubular cells: 3.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028453 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028453: AB_10601692" "unprognostic (7.52e-2)" "unprognostic (3.22e-1)" "unprognostic (3.61e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-3)" "unprognostic (1.11e-1)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "prognostic favorable (1.36e-10)" "unprognostic (1.45e-2)" "unprognostic (2.36e-1)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" 2.0 6.0 9.3 2.4 8.7 3.9 2.2 4.5 7.4 3.3 2.4 3.0 2.5 4.6 1.4 5.2 6.7 2.3 4.9 8.7 10.4 4.2 3.2 2.3 2.9 8.8 10.3 8.2 5.6 5.0 6.2 6.6 1.9 7.4 3.1 1.9 2.3 4.9 4.1 1.9 4.4 2.4 1.7 4.8 3.7 4.0 6.3 10.8 2.9 6.1 1.8 2.4 4.0 2.4 5.6 4.5 12.1 3.6 12.0 2.4 4.3 3.3 5.0 3.2 4.0 1.7 4.4 6.7 9.7 9.7 2.8 7.8 3.6 6.6 6.4 0.4 14.7 5.6 4.8 11.1 0.9 5.9 3.2 8.4 2.3 5.4 4.6 4.1 4.0 3.8 7.3 17.8 3.7 3.3 5.5 3.5 2.4 0.9 4.8 4.7 8.8 0.4 7.8 3.4 2.8 8.7 5.8 1.9 3.0 4.7 2.7 9.0 3.0 3.8 1.1 1.9 2.3 1.6 10.1 4.1 5.7 3.1 7.0 6.7 0.0 0.5 1.9 2.2 1.6 2.8 1.2 1.3 0.6 1.0 1.3 1.3 0.9 0.4 1.4 1.1 0.3 1.5 0.6 9.3 8.7 4.5 7.4 8.7 10.4 8.8 10.3 8.2 7.4 4.8 10.8 5.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 7.3 0.0 2.0 0.7 0.0 3.9 2.4 0.0 4.1 0.9 0.3 0.0 0.0 0.0 0.9 2.3 0.4 0.0 1.5 0.0 1.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.4 1.4 0.0 0.0 CASP9 "APAF-3, ICE-LAP6, MCH6, PPP1R56" ENSG00000132906 "Caspase 9" P55211 1 15490832-15526534 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001473, CAB004348, HPA046488" Approved Approved Mitochondria NA NA Mitochondria "CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670" "prognostic favorable (5.91e-4)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (7.84e-2)" "unprognostic (1.93e-2)" "unprognostic (8.54e-3)" "unprognostic (1.90e-3)" "unprognostic (6.75e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-2)" "unprognostic (2.35e-1)" "unprognostic (3.21e-2)" "unprognostic (5.48e-2)" "prognostic favorable (1.67e-5)" 9.4 51.2 15.3 7.1 14.6 11.6 9.0 15.7 19.0 18.4 12.9 11.3 6.5 14.5 12.6 14.2 22.7 9.5 15.0 14.1 15.4 20.8 14.9 10.9 7.0 14.3 14.1 14.2 58.1 38.1 12.1 32.6 7.1 14.6 19.4 5.3 12.4 9.0 9.9 12.8 5.1 11.1 6.7 15.8 10.7 12.5 26.1 14.5 8.7 26.1 9.5 8.0 13.0 13.0 17.2 10.4 17.8 4.6 8.9 11.0 5.4 5.3 7.5 9.9 11.1 12.7 12.5 10.1 13.4 16.2 7.5 13.1 4.2 10.5 8.2 11.7 5.9 11.6 9.8 32.8 10.8 10.8 10.6 11.5 9.7 11.5 15.3 3.8 8.3 8.7 13.3 20.4 13.4 5.8 5.2 3.3 8.6 5.9 11.3 8.2 7.4 13.4 16.4 12.3 6.7 4.4 9.0 9.6 1.8 15.6 12.1 5.7 7.9 4.8 13.8 5.8 15.6 5.1 13.3 21.5 16.3 8.9 9.9 5.0 54.2 24.7 54.8 11.0 17.4 8.2 21.3 6.6 7.6 25.1 30.0 3.1 4.8 36.3 29.3 18.9 11.4 6.9 15.0 15.3 14.6 15.7 19.0 14.1 15.4 14.3 14.1 14.2 14.6 15.8 14.5 17.2 2.8 3.2 3.7 18.3 17.1 2.9 8.2 5.0 4.6 3.2 7.0 4.7 9.3 11.5 7.3 18.4 6.2 17.0 8.0 7.0 1.9 7.5 12.6 10.9 5.2 3.3 3.0 5.7 7.9 9.1 10.8 5.6 12.8 7.6 1.3 5.7 4.2 4.7 9.5 5.0 9.9 6.3 6.1 4.8 12.9 5.5 2.1 12.9 0.0 6.5 4.8 7.5 10.3 9.5 8.8 8.4 7.3 3.8 9.9 4.0 9.8 7.2 8.9 6.3 0.0 5.3 9.7 16.4 7.1 6.0 2.4 35.7 6.4 7.9 5.6 7.4 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391546-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 6.2" "Group enriched" "Detected in some" 13 "Gastric mucus-secreting cells: 5.1;Oligodendrocytes: 8.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 9.6" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.0 0.1 1.0 0.0 3.1 0.0 0.0 1.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 2.6 0.2 0.0 0.3 0.0 3.9 2.1 0.3 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.1 0.0 1.0 1.5 2.7 0.6 0.5 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 9.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.1 1.1 1.8 0.6 2.6 3.9 2.1 0.3 3.8 3.1 2.7 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DCTN4 ENSG00000132912 "Dynactin subunit 4" Q9UJW0 5 150708440-150759095 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017532, HPA038026" Uncertain Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "CAB017532: AB_1122152, HPA038026: AB_2675792" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.87e-3)" "unprognostic (7.82e-3)" "unprognostic (1.37e-2)" "unprognostic (2.08e-1)" "unprognostic (8.41e-2)" "unprognostic (1.38e-1)" "unprognostic (5.86e-2)" "unprognostic (9.68e-3)" "unprognostic (1.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.83e-1)" 26.8 32.1 30.6 16.7 32.0 57.0 30.4 32.6 36.6 21.5 25.4 19.1 19.4 24.4 31.0 23.7 21.2 19.3 25.6 31.6 34.8 23.5 26.8 21.5 14.1 34.2 31.1 31.0 29.7 38.4 28.9 20.7 31.6 35.6 27.6 21.8 59.2 18.5 25.2 47.9 22.9 17.1 25.3 26.9 15.1 21.9 28.3 31.4 20.2 29.6 37.1 17.3 20.1 16.3 42.9 25.2 29.3 53.1 87.5 62.8 60.9 43.2 43.1 43.9 52.7 51.9 55.6 30.5 24.9 58.5 53.1 46.2 29.4 67.3 51.6 63.3 48.3 52.5 31.6 32.3 33.8 57.3 38.9 42.5 61.8 45.0 45.9 82.5 53.2 37.4 30.4 48.9 30.3 68.3 26.0 23.6 20.5 26.2 30.1 47.3 20.5 32.1 27.8 38.7 42.4 117.8 49.5 46.0 62.0 66.9 34.0 59.8 51.0 40.8 56.8 30.3 37.7 47.2 26.3 36.8 14.3 65.6 51.2 48.1 3.2 11.2 11.1 5.0 7.8 5.2 4.8 5.7 5.1 11.0 3.8 5.3 6.5 16.1 3.2 6.8 5.1 4.6 5.7 30.6 32.0 32.6 36.6 31.6 34.8 34.2 31.1 31.0 35.6 26.9 31.4 42.9 19.3 48.1 29.2 43.4 29.4 17.7 13.2 12.6 52.3 20.8 33.7 21.3 37.2 32.9 13.7 16.5 20.9 22.4 26.8 23.2 11.7 11.8 2.6 23.9 32.7 19.7 37.7 47.3 41.3 16.5 18.0 26.0 40.8 32.2 12.6 32.4 20.7 39.4 31.5 30.3 43.7 27.2 16.2 48.8 19.1 4.7 22.1 35.7 12.4 35.6 20.7 26.4 9.2 46.8 56.2 18.4 19.7 19.2 27.0 17.4 14.7 22.7 20.6 31.9 13.1 15.0 19.5 18.4 24.0 38.6 20.5 29.7 26.2 23.7 19.5 17.9 PDE6A "PDEA, RP43" ENSG00000132915 "Phosphodiesterase 6A" P16499 5 149857953-149944793 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "retina: 1129.3" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 2946.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "CACO-2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016970, HPA074677" Enhanced NA NA "HPA016970: AB_1855125, HPA074677: AB_2732264" "unprognostic (6.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (4.39e-3)" "unprognostic (8.83e-2)" "unprognostic (6.54e-2)" "unprognostic (5.91e-3)" "unprognostic (1.77e-2)" "unprognostic (9.21e-2)" "unprognostic (7.57e-5)" "unprognostic (9.93e-2)" "unprognostic (3.08e-1)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" 0.1 0.7 0.5 0.2 0.5 0.9 0.2 1.4 0.8 0.0 0.1 1.2 0.2 0.1 16.5 0.9 0.2 0.2 0.2 0.4 0.3 0.1 0.1 0.3 0.1 0.5 0.3 0.4 0.2 0.2 0.2 1.7 0.1 0.7 0.3 0.9 1129.3 0.4 0.2 0.3 0.6 0.1 0.1 0.2 0.2 0.2 1.5 0.4 0.0 0.4 0.0 0.2 0.0 0.1 1.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 2.5 0.2 0.3 0.4 0.0 0.4 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.0 0.1 0.4 0.4 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.6 0.2 0.1 0.2 0.1 0.0 0.5 0.5 1.4 0.8 0.4 0.3 0.5 0.3 0.4 0.7 0.2 0.4 1.2 0.9 0.0 5.8 0.0 0.4 1.1 0.6 0.8 0.0 150.5 0.5 0.4 6.7 0.0 2.8 0.0 244.0 1.1 1.6 14.3 0.0 0.1 18.4 1.5 0.5 11.6 0.0 0.0 1.2 0.2 2.2 1.2 0.0 2.5 3.8 1.9 2.2 0.6 0.3 75.7 0.6 0.4 2.0 1.9 0.4 5.5 1.2 1.5 0.0 0.0 1.4 263.1 5.2 0.5 0.2 0.1 2.8 0.4 0.3 0.4 0.4 0.1 3.2 2946.4 0.0 1.0 1.2 2.3 0.8 5.4 0.6 2.9 1.5 2.2 2.7 0.2 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25371974-26025851 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 26.6;pituitary gland: 15.3;retina: 17.4" "Group enriched" "Detected in many" 6 "Excitatory neurons: 518.7;Inhibitory neurons: 727.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: AB_2676809" "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 0.1 2.1 3.9 0.3 6.3 0.0 0.6 7.8 21.1 0.1 0.0 0.3 0.3 0.7 1.8 0.0 0.0 0.1 0.1 7.0 7.9 0.3 0.0 0.8 0.6 11.6 6.5 6.9 0.2 0.6 0.0 15.3 0.2 12.8 0.1 0.2 17.4 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.3 0.6 2.9 8.8 1.0 0.1 0.1 0.2 0.2 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 19.9 0.1 0.0 0.0 0.0 0.6 0.5 9.8 0.0 0.0 1.7 0.1 3.9 0.0 2.0 0.0 0.7 0.0 2.7 0.9 0.2 0.0 3.2 0.0 0.2 0.2 0.1 0.2 0.0 0.4 0.2 0.0 1.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.1 3.9 6.3 7.8 21.1 7.0 7.9 11.6 6.5 6.9 12.8 0.0 8.8 26.6 0.7 0.0 12.2 9.4 0.8 1.0 0.2 0.3 0.0 21.5 1.5 0.3 2.5 1.5 0.4 0.0 95.9 1.5 0.4 0.0 0.0 0.3 39.0 1.2 23.6 2.6 0.0 0.8 518.7 0.0 0.4 1.7 1.1 0.9 5.1 3.7 0.0 0.0 3.2 21.9 727.7 0.0 0.0 0.0 0.7 30.3 0.9 0.3 0.0 9.4 0.0 7.2 1.0 88.4 24.7 0.0 0.0 1.2 0.1 0.2 0.0 1.3 0.3 91.6 13.1 0.3 0.8 19.8 12.5 0.0 0.4 1.1 1.8 10.1 0.1 0.1 MTUS2 "CAZIP, ICIS, KIAA0774, TIP150" ENSG00000132938 "Microtubule associated scaffold protein 2" Q5JR59 13 28820339-29505947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 50.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 548.4;Inhibitory neurons: 671.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 0.9" "Region enhanced" "Detected in many" "cerebral cortex: 10.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 13.2;HeLa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031473, HPA031474, HPA031475" Enhanced Supported "Microtubules,Cytokinetic bridge" Yes NA "Microtubules, Cytokinetic bridge" "HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442" "unprognostic (1.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.96e-1)" "unprognostic (3.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.22e-2)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (1.30e-3)" "unprognostic (3.45e-2)" "unprognostic (3.91e-5)" "unprognostic (2.51e-2)" "unprognostic (5.46e-2)" "unprognostic (5.93e-2)" "unprognostic (9.62e-2)" 0.1 0.2 0.3 0.1 2.0 0.1 0.1 1.4 10.6 0.6 1.6 0.6 0.1 1.5 0.0 0.3 0.9 0.1 50.7 1.6 1.4 0.1 0.9 0.1 0.6 0.4 0.9 1.9 7.6 4.8 0.0 6.2 0.0 1.7 0.3 0.2 4.6 1.0 0.1 0.1 0.2 0.5 1.2 0.4 0.5 1.4 1.2 1.0 0.2 0.5 0.1 0.1 1.3 0.2 3.1 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 13.2 0.4 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.0 0.0 2.3 1.6 0.1 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.0 1.4 10.6 1.6 1.4 0.4 0.9 1.9 1.7 0.4 1.0 3.1 0.1 0.0 0.5 10.4 0.1 0.5 0.7 0.1 0.0 0.0 0.3 0.4 145.8 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.4 0.3 1.0 0.7 0.0 0.8 548.4 0.6 0.0 5.9 0.0 1.1 0.0 1.2 0.4 0.5 0.1 0.0 671.8 0.7 0.0 0.0 0.8 3.3 0.9 0.2 1.8 15.0 0.1 0.0 0.0 18.1 16.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 3.6 0.0 0.0 1.6 1.0 0.1 4.1 1.8 0.1 0.3 0.3 19.6 0.0 1.1 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863649 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: AB_2670524" "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 7.1 7.9 2.9 7.2 3.4 12.3 8.0 3.5 3.4 6.8 3.8 5.6 6.3 7.7 8.7 7.6 5.4 9.3 5.5 2.5 3.6 6.6 7.0 6.7 10.3 4.1 3.4 2.0 6.8 5.5 5.5 4.8 7.2 3.5 8.2 6.3 9.1 5.8 5.6 6.3 7.9 6.7 6.9 3.3 7.6 7.4 23.6 3.4 10.2 8.7 7.8 9.0 7.2 5.9 5.3 8.5 4.4 9.6 7.7 6.5 10.3 3.6 7.8 12.2 12.5 10.3 10.6 16.5 11.8 8.4 11.2 15.5 7.9 7.1 9.3 14.0 9.5 5.7 22.1 7.9 7.4 21.0 15.9 11.4 12.5 11.0 6.8 12.7 12.8 12.7 7.6 9.0 10.0 12.0 21.4 11.9 16.4 5.2 11.0 6.4 13.2 12.3 4.6 10.5 9.4 9.0 8.2 10.1 8.2 27.4 10.2 12.7 13.7 10.6 6.8 5.1 9.2 5.8 15.9 7.7 17.6 6.8 6.9 11.2 16.1 5.4 8.6 8.7 5.2 9.3 9.9 9.9 8.5 5.7 8.6 7.7 8.2 10.7 8.0 7.4 7.8 8.9 4.2 2.9 3.4 3.5 3.4 2.5 3.6 4.1 3.4 2.0 3.5 3.3 3.4 5.3 34.1 28.9 17.3 33.0 35.7 24.3 20.8 20.3 43.9 29.7 27.4 26.8 16.2 22.8 18.9 11.0 18.8 17.9 32.4 10.7 7.9 15.5 16.0 24.0 24.0 21.3 27.6 22.3 36.2 10.5 9.6 24.4 19.9 25.4 33.6 19.6 15.0 7.9 11.4 28.6 35.8 11.9 24.4 12.9 24.0 20.8 22.7 23.9 21.4 26.2 17.0 15.2 16.5 30.7 52.9 14.2 16.9 18.4 20.7 16.8 10.7 11.2 10.4 30.3 32.9 27.2 24.7 92.7 51.1 56.5 21.7 8.3 38.3 15.5 11.4 32.9 USPL1 "bA121O19.1, C13orf22, D13S106E" ENSG00000132952 "Ubiquitin specific peptidase like 1" Q5W0Q7 13 30617693-30660770 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 135.8;Late spermatids: 306.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039342, HPA040172" Uncertain NA NA "HPA039342: AB_10795105, HPA040172: AB_10796447" "unprognostic (5.74e-2)" "unprognostic (6.26e-2)" "unprognostic (8.16e-2)" "unprognostic (4.29e-2)" "unprognostic (4.96e-2)" "unprognostic (3.65e-1)" "unprognostic (1.00e-2)" "unprognostic (1.65e-1)" "unprognostic (1.20e-1)" "unprognostic (6.79e-2)" "unprognostic (2.21e-2)" "unprognostic (1.27e-2)" "unprognostic (3.18e-1)" "unprognostic (2.68e-1)" "unprognostic (1.49e-1)" "unprognostic (3.78e-1)" "unprognostic (5.32e-3)" 11.6 9.9 8.5 8.6 8.8 24.3 11.4 11.5 12.7 9.8 9.2 10.5 6.4 10.9 7.2 7.4 10.1 6.3 7.5 9.7 8.7 9.1 15.8 11.9 13.0 8.7 8.9 8.0 13.3 12.2 4.8 9.0 8.3 8.9 11.0 6.6 15.7 9.1 6.6 9.5 9.8 13.8 6.3 8.9 18.8 10.0 19.6 9.0 9.4 11.0 8.4 11.6 10.7 9.7 11.7 4.5 6.5 14.7 9.5 7.5 9.0 6.2 10.1 7.9 9.8 7.9 9.1 11.5 10.1 5.0 8.6 12.8 9.1 16.2 6.1 14.4 8.5 6.6 12.6 10.4 8.0 6.7 12.1 9.6 6.8 10.7 7.2 10.1 14.2 14.2 10.9 12.4 6.6 10.8 3.9 17.3 25.3 12.6 15.0 4.2 15.3 11.3 9.5 7.9 3.0 13.0 11.7 5.5 6.4 9.5 11.3 7.1 15.1 9.0 6.8 6.7 9.2 7.9 6.7 6.3 14.5 3.9 8.7 13.6 3.1 3.8 3.7 3.5 2.8 5.0 5.3 3.4 3.7 3.5 5.7 4.7 4.3 1.8 4.5 2.3 2.6 4.2 3.1 8.5 8.8 11.5 12.7 9.7 8.7 8.7 8.9 8.0 8.9 8.9 9.0 11.7 17.6 16.0 9.8 17.3 30.2 4.5 6.6 4.5 17.1 10.1 9.0 8.4 18.2 5.7 7.4 7.3 16.7 4.3 18.6 6.3 3.9 5.1 135.8 9.3 19.6 13.9 14.3 9.5 19.6 4.5 5.9 13.7 13.7 12.1 1.3 9.4 11.0 6.9 7.0 15.2 23.0 11.7 6.1 10.1 15.4 306.1 6.8 18.2 3.6 19.7 6.9 8.9 10.3 21.6 26.8 5.5 5.6 5.3 24.2 8.5 5.7 3.5 6.4 12.0 6.6 13.1 12.6 16.4 8.8 15.5 3.8 3.1 18.2 10.1 8.8 5.0 XPO4 "FLJ13046, KIAA1721" ENSG00000132953 "Exportin 4" Q9C0E2 13 20777329-20903048 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053768 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053768: AB_2682254" "unprognostic (2.24e-1)" "unprognostic (1.20e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.67e-1)" "unprognostic (7.24e-3)" "unprognostic (9.50e-3)" "unprognostic (2.99e-1)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-2)" "unprognostic (2.42e-1)" 4.4 3.7 3.3 5.7 4.3 10.3 6.1 5.8 4.0 4.4 4.4 4.7 3.8 6.2 4.2 4.9 4.2 3.6 10.8 3.1 3.7 5.1 4.2 6.1 7.4 3.7 4.5 3.0 6.1 4.2 6.5 3.0 5.3 4.0 5.5 5.7 13.6 3.8 3.9 44.5 5.6 3.9 5.6 3.9 5.9 4.7 5.9 3.8 7.1 6.5 16.9 7.1 4.7 3.8 5.9 10.1 7.5 12.0 11.5 5.7 9.9 12.4 11.2 8.2 13.0 10.7 15.3 12.4 22.0 5.9 10.8 9.8 16.2 28.0 15.2 24.0 15.1 8.0 35.0 9.5 10.3 8.6 31.0 11.0 9.8 9.4 13.1 24.7 7.6 15.9 12.5 16.8 7.1 12.4 8.3 14.9 13.6 13.6 21.2 6.9 16.3 19.8 9.2 9.0 12.1 13.6 9.4 9.7 13.9 11.5 12.0 8.2 16.8 13.2 9.1 7.1 11.3 16.1 4.7 7.4 17.9 4.5 19.5 13.9 1.5 0.7 0.8 1.1 0.8 1.3 1.0 1.0 1.0 1.0 0.8 1.2 1.2 0.0 1.1 2.5 0.7 1.0 0.4 3.3 4.3 5.8 4.0 3.1 3.7 3.7 4.5 3.0 4.0 3.9 3.8 5.9 10.0 12.8 12.5 36.6 24.0 8.3 10.7 12.1 11.4 17.0 8.5 6.1 22.2 10.0 5.6 9.2 64.6 8.3 11.4 4.7 0.0 5.4 10.4 6.1 11.9 9.5 1.2 10.9 72.8 4.1 7.4 9.8 18.3 7.7 15.2 11.9 12.1 10.5 10.8 10.1 70.8 7.5 6.1 10.0 8.0 8.2 17.4 9.5 12.4 44.0 11.6 5.4 10.3 58.8 82.5 5.4 3.6 8.2 21.3 11.8 3.4 5.4 6.3 21.4 32.9 11.6 10.0 14.2 18.8 14.7 11.2 12.9 18.6 7.1 9.6 10.4 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 7.6" "Cell type enhanced" "Detected in some" "Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 4.8;Karpas-707: 1.3" HPA068342 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA068342: AB_2685976" "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.1 0.5 0.0 0.1 0.7 0.9 0.0 0.4 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.2 0.6 0.5 0.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.1 7.6 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.7 0.9 0.5 0.5 0.6 0.5 0.4 0.7 0.5 0.5 0.8 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.1 0.0 0.0 4.6 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 6.3 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.0 3.7 0.1 0.5 0.0 7.5 3.6 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 14.8 3.9 0.0 0.1 0.1 0.1 0.1 0.0 0.2 POMP "C13orf12, HSPC014, UMP1" ENSG00000132963 "Proteasome maturation protein" Q9Y244 13 28659104-28678959 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026995 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026995: AB_1845546" "unprognostic (2.00e-1)" "unprognostic (3.56e-2)" "unprognostic (2.26e-1)" "unprognostic (3.15e-1)" "unprognostic (8.58e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (2.71e-3)" "unprognostic (2.50e-2)" "unprognostic (9.90e-2)" "unprognostic (4.35e-2)" "unprognostic (4.83e-2)" "unprognostic (4.93e-1)" "unprognostic (1.39e-3)" "unprognostic (1.70e-2)" "unprognostic (9.41e-2)" "unprognostic (1.03e-2)" "unprognostic (9.81e-2)" 77.0 72.2 82.0 63.5 84.0 67.0 67.3 86.0 101.9 45.5 83.1 67.3 57.5 44.8 79.6 69.3 43.8 46.6 115.3 82.7 87.6 79.8 111.8 66.1 65.9 86.7 87.2 80.1 33.2 47.0 52.1 42.0 101.1 87.2 47.0 66.9 56.7 45.5 51.2 177.1 48.7 58.8 57.8 89.2 61.7 55.3 70.6 84.3 65.2 51.9 115.6 70.7 74.7 47.3 90.7 103.4 124.9 129.9 153.1 145.3 161.3 120.3 232.1 203.8 225.5 179.5 245.7 228.7 181.7 136.3 178.6 241.7 150.3 170.7 179.3 307.5 137.7 131.9 171.7 130.1 191.1 203.0 209.6 136.0 131.2 181.9 162.5 149.5 122.3 181.6 139.7 222.2 72.5 291.5 182.5 178.4 295.6 226.1 319.0 146.1 169.6 199.3 122.2 259.6 160.7 152.1 117.1 104.0 147.4 162.2 161.5 103.1 238.5 166.2 108.7 111.2 172.3 195.5 61.5 118.5 255.3 129.2 139.8 243.6 146.4 155.3 101.7 99.9 210.8 88.7 136.4 101.6 113.2 190.8 137.6 71.8 101.9 135.1 95.3 213.9 223.4 132.3 165.2 82.0 84.0 86.0 101.9 82.7 87.6 86.7 87.2 80.1 87.2 89.2 84.3 90.7 527.4 131.4 114.2 17.3 218.5 409.8 345.1 1106.2 124.1 110.1 194.3 229.9 806.2 204.5 523.9 239.1 54.2 660.4 255.5 410.0 600.7 566.3 1156.6 266.7 235.8 486.2 228.7 271.5 23.4 699.5 974.0 281.8 128.9 293.0 207.3 181.6 434.1 538.7 780.7 97.6 22.4 315.0 585.9 431.0 673.7 533.7 201.0 407.1 300.6 29.0 612.6 294.7 228.6 13.6 26.1 755.1 414.0 233.6 228.1 443.5 491.8 922.5 472.8 121.8 322.1 193.8 494.6 625.5 240.3 230.1 416.3 972.4 202.7 234.7 335.5 494.3 CDK8 K35 ENSG00000132964 "Cyclin dependent kinase 8" P49336 13 26254104-26405238 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 118.7;Inhibitory neurons: 175.4;Late spermatids: 100.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044721 Approved Nucleoplasm NA NA Nucleoplasm "HPA044721: AB_2679059" "unprognostic (3.28e-3)" "unprognostic (2.25e-3)" "unprognostic (2.08e-1)" "unprognostic (3.88e-3)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (5.00e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-3)" "unprognostic (2.12e-1)" "prognostic favorable (9.23e-4)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (6.37e-2)" 4.5 3.0 2.1 3.5 2.5 3.2 3.0 7.6 2.9 3.0 1.0 8.2 7.7 4.0 3.3 5.2 2.6 3.9 4.1 2.9 2.1 5.1 5.7 2.9 3.1 2.4 3.0 1.8 2.5 7.2 5.2 2.1 5.9 3.9 3.5 6.0 8.6 4.7 6.9 5.1 3.1 7.6 6.6 2.2 2.6 5.1 9.8 2.3 6.0 3.4 5.2 4.1 6.3 2.6 1.9 10.1 8.4 16.5 16.4 8.3 10.2 10.3 19.6 13.2 13.8 10.0 23.8 13.6 10.7 8.3 9.8 11.6 12.2 18.7 12.9 17.2 25.8 10.3 20.5 6.4 8.2 5.8 32.3 11.4 7.5 12.2 10.7 17.3 7.8 10.2 18.1 32.1 0.0 12.5 10.7 25.2 15.1 13.2 15.5 9.9 15.4 15.9 7.6 8.2 9.2 13.6 8.6 8.1 15.1 13.9 12.7 5.5 14.6 10.5 8.8 11.3 16.1 10.4 7.8 15.2 19.3 5.5 13.2 10.7 0.1 0.2 1.0 0.2 0.4 0.4 0.2 0.3 0.4 0.4 0.4 0.4 0.3 0.0 0.2 0.3 0.2 0.2 0.2 2.1 2.5 7.6 2.9 2.9 2.1 2.4 3.0 1.8 3.9 2.2 2.3 1.9 6.5 9.6 4.4 63.6 11.2 19.8 7.7 5.9 8.6 20.5 6.4 5.0 5.9 10.0 6.8 1.8 25.0 8.2 9.5 11.7 9.8 8.9 66.4 7.8 7.7 6.6 8.4 9.9 118.7 8.2 9.7 9.4 14.3 7.4 0.0 8.9 6.8 8.0 8.0 18.5 175.4 7.6 10.2 9.1 11.3 100.4 7.8 7.9 8.8 58.1 8.4 7.7 6.2 149.3 91.9 11.5 10.9 8.2 14.4 14.9 18.0 15.3 5.3 17.3 6.6 67.6 10.9 32.9 18.3 12.8 23.9 9.7 10.8 11.2 11.7 16.2 ALOX5AP FLAP ENSG00000132965 "Arachidonate 5-lipoxygenase activating protein" P20292 13 30713478-30764426 "Disease related genes, Predicted membrane proteins" "Leukotriene biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 491.8;lung: 184.9;lymphoid tissue: 139.7" "Cell type enhanced" "Detected in many" "dendritic cells: 691.3;granulocytes: 609.1;Hofbauer cells: 492.2;Langerhans cells: 335.4;Macrophages: 637.0;NK-cells: 280.2;T-cells: 368.6" "Cancer enhanced" "Detected in all" "glioma: 49.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 9703.9;eosinophil: 4033.4;neutrophil: 4968.7;plasmacytoid DC: 3555.3" "Group enriched" "Detected in all" 8 "dendritic cells: 3555.3;granulocytes: 9703.9" "Cell line enhanced" "Detected in many" "HDLM-2: 658.4;HL-60: 352.3;HMC-1: 1072.9;THP-1: 434.2;U-937: 321.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026592 Enhanced NA NA "HPA026592: AB_10601115" "unprognostic (1.17e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (4.64e-3)" "unprognostic (7.18e-2)" "unprognostic (7.10e-2)" "unprognostic (7.79e-2)" "unprognostic (1.04e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.83e-2)" "unprognostic (6.63e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-1)" 52.0 36.5 10.4 101.5 13.7 491.8 25.9 13.0 17.6 19.0 15.7 23.0 21.8 17.6 7.2 22.0 24.7 40.4 11.5 10.1 21.3 13.3 19.8 184.9 77.8 21.2 15.2 8.4 10.7 14.2 9.7 6.1 37.5 20.0 13.3 21.6 3.8 20.0 15.6 3.8 7.5 28.6 42.9 21.7 139.7 20.2 4.3 21.9 94.0 9.2 24.9 109.1 66.2 12.0 28.9 0.6 0.8 1.2 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 1.3 7.1 156.3 2.2 0.0 5.2 1.2 0.0 4.6 0.1 658.4 0.0 18.7 0.3 1.0 0.7 352.3 1072.9 0.8 0.2 0.1 37.9 8.1 1.4 33.3 0.1 3.2 1.9 0.1 19.8 12.7 0.0 0.0 0.2 3.2 3.9 12.4 1.4 0.3 10.2 0.1 0.2 0.3 0.9 2.3 0.0 434.2 1.1 0.0 3.2 0.3 2.6 66.2 0.5 103.8 1.0 321.1 1.4 9703.9 322.4 4033.4 546.0 17.2 808.3 477.9 536.4 449.0 198.5 489.2 271.6 260.7 4968.7 98.0 12.4 3555.3 843.9 775.2 10.4 13.7 13.0 17.6 10.1 21.3 21.2 15.2 8.4 20.0 21.7 21.9 28.9 3.5 41.7 102.0 0.0 117.6 23.7 2.6 1.8 1.2 0.0 3.3 9.1 4.1 10.0 23.7 0.0 0.0 3.1 691.3 4.0 15.6 2.3 5.6 14.3 0.7 17.2 26.4 27.1 0.4 1.0 4.0 11.2 21.4 0.7 609.1 1.9 7.1 1.8 492.2 0.0 0.4 2.0 4.1 144.3 335.4 4.5 4.7 637.0 42.7 13.1 217.1 0.1 280.2 0.5 0.3 6.4 3.1 4.1 31.1 1.5 7.3 2.0 11.1 0.1 32.9 4.4 4.0 0.4 1.1 1.7 24.7 4.9 368.6 0.0 2.0 1.4 WASF3 "KIAA0900, SCAR3, WAVE3" ENSG00000132970 "WASP family member 3" Q9UPY6 13 26557683-26688948 "Cancer-related genes, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.5;retina: 56.9" "Cell type enhanced" "Detected in many" "Astrocytes: 161.6;Early spermatids: 104.1;Horizontal cells: 82.4;Inhibitory neurons: 127.5;Oligodendrocyte precursor cells: 69.9" "Cancer enhanced" "Detected in all" "glioma: 14.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037086, HPA066228" Enhanced NA NA "CAB037086: AB_1080585, HPA066228: " "unprognostic (1.42e-1)" "unprognostic (3.65e-2)" "unprognostic (2.25e-1)" "unprognostic (7.57e-2)" "unprognostic (8.23e-2)" "unprognostic (3.34e-1)" "unprognostic (6.19e-2)" "unprognostic (8.37e-2)" "unprognostic (8.98e-2)" "unprognostic (2.99e-1)" "prognostic favorable (2.21e-4)" "unprognostic (8.86e-3)" "unprognostic (2.93e-3)" "unprognostic (6.35e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-3)" "unprognostic (9.18e-2)" 19.8 16.1 51.3 2.9 47.3 0.3 14.8 62.5 53.5 9.2 3.1 5.9 1.0 9.2 4.9 3.9 11.3 4.0 7.5 51.5 53.8 7.0 7.0 7.4 2.6 49.9 47.7 33.4 21.1 5.2 6.8 8.7 0.5 41.5 9.0 3.2 56.9 6.1 9.4 7.8 4.5 3.8 7.7 30.8 5.1 7.2 13.1 44.7 1.6 17.1 5.0 1.7 7.4 7.6 48.6 0.0 0.2 39.4 0.1 82.8 16.4 3.6 17.6 24.7 26.4 11.7 0.0 3.7 15.3 2.1 39.5 10.2 3.6 10.7 11.4 20.7 0.0 9.9 1.0 0.0 15.0 12.3 5.8 11.2 33.7 10.7 5.6 17.1 5.4 35.2 5.0 0.5 0.1 8.3 3.2 0.0 0.2 10.5 0.6 3.8 0.0 21.5 0.1 2.9 7.3 9.2 18.9 8.6 7.4 11.5 8.4 0.0 0.6 20.1 19.3 7.4 10.1 9.1 0.0 0.0 15.1 9.3 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 51.3 47.3 62.5 53.5 51.5 53.8 49.9 47.7 33.4 41.5 30.8 44.7 48.6 11.2 25.6 2.0 161.6 0.2 2.2 2.8 1.7 2.8 46.2 4.9 6.5 9.8 4.3 1.9 9.2 33.3 0.1 0.3 0.9 11.7 2.3 104.1 1.3 4.6 8.3 20.4 0.0 49.4 2.7 0.3 15.7 2.0 2.3 14.7 62.8 12.5 8.2 0.3 82.4 127.5 1.3 0.0 1.9 2.7 35.3 14.6 4.3 5.4 30.9 0.7 46.7 1.0 69.9 41.0 2.0 0.0 29.0 0.1 5.1 0.0 3.3 1.2 41.2 6.6 32.0 9.1 7.2 18.7 2.0 1.4 0.0 0.2 5.1 0.5 1.9 RNF17 "FLJ11045, Mmip-2, SPATA23, TDRD4" ENSG00000132972 "Ring finger protein 17" Q9BXT8 13 24764169-24879921 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 24.5" "Group enriched" "Detected in some" 7 "Early spermatids: 22.2;Late spermatids: 27.6;Spermatocytes: 67.0;Spermatogonia: 24.3" "Cancer enriched" "Detected in single" 41 "testis cancer: 4.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "olfactory bulb: 1.4" "HPA039699, HPA040111" Approved NA NA "HPA039699: AB_10795254, HPA040111: AB_10795414" "unprognostic (2.57e-1)" "unprognostic (1.87e-2)" "unprognostic (1.37e-1)" "unprognostic (4.44e-1)" "unprognostic (4.26e-1)" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (8.61e-2)" "unprognostic (5.04e-1)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 3.8 0.0 0.0 0.1 0.8 1.2 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 22.2 0.0 0.1 0.2 0.0 0.0 2.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 27.6 0.9 0.0 0.0 1.0 0.0 0.0 0.0 1.5 1.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 67.0 24.3 0.0 0.0 1.0 0.0 0.0 0.0 0.1 GPR12 "GPCR21, PPP1R84" ENSG00000132975 "G protein-coupled receptor 12" P47775 13 26755200-26760786 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.9;retina: 8.5;salivary gland: 3.0;skin 1: 4.9" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 9.7;Excitatory neurons: 9.5;Hofbauer cells: 17.6;Horizontal cells: 33.7;Inhibitory neurons: 15.7;Skeletal myocytes: 8.1" "Group enriched" "Detected in some" 7 "breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050972 Uncertain NA NA "HPA050972: AB_2681295" "unprognostic (2.37e-2)" "unprognostic (9.64e-3)" "unprognostic (3.75e-1)" "unprognostic (3.30e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (7.35e-2)" "unprognostic (5.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.40e-1)" 0.2 0.0 2.0 0.0 10.9 0.1 1.4 7.8 10.7 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 7.3 1.1 0.0 0.0 0.0 0.0 2.5 3.8 1.9 0.0 0.0 0.0 0.7 0.4 2.7 0.0 0.0 8.5 3.0 0.0 0.1 4.9 0.1 0.1 0.0 0.1 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 10.9 7.8 10.7 7.3 1.1 2.5 3.8 1.9 2.7 0.0 5.1 2.8 0.4 0.0 0.0 1.6 0.0 0.1 0.2 0.0 0.0 2.8 2.7 2.8 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.7 9.7 0.0 9.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 17.6 33.7 15.7 0.0 0.0 0.0 0.0 0.5 0.0 0.2 3.6 0.0 0.0 1.9 0.0 5.0 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 3.5 0.0 8.1 0.2 0.1 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.2 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.1;salivary gland: 17.6" "Group enriched" "Detected in many" 28 "Excitatory neurons: 802.9;Inhibitory neurons: 624.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 17.2;SH-SY5Y: 53.5;U-266/70: 21.7;U-266/84: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA024106: AB_1854211, HPA048036: AB_2680238" "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.2 0.4 2.7 0.8 7.1 0.2 0.8 0.0 8.3 0.4 0.0 5.2 1.4 1.9 0.4 7.5 0.8 0.7 0.4 6.9 5.5 1.1 0.4 1.1 0.1 0.2 0.0 11.1 4.8 10.7 0.5 0.5 0.8 2.5 1.1 2.9 1.7 17.6 3.0 0.0 1.1 1.5 4.1 0.0 0.7 5.1 2.5 2.4 0.1 2.0 0.1 0.1 7.1 0.4 4.9 0.0 0.1 0.4 0.4 0.0 0.0 0.9 0.6 0.1 0.3 0.1 0.0 0.0 0.0 2.1 0.0 0.0 5.8 0.6 3.8 2.7 0.0 3.7 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.1 9.1 0.9 1.4 0.0 0.0 4.6 4.6 9.1 0.0 1.1 17.2 0.7 0.8 0.1 53.5 0.0 0.1 0.1 4.0 1.8 0.0 0.3 2.3 0.8 0.1 0.5 21.7 16.3 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.7 7.1 0.0 8.3 6.9 5.5 0.2 0.0 11.1 2.5 0.0 2.4 4.9 6.1 0.0 3.7 6.2 0.0 0.0 2.1 0.0 0.6 19.0 4.6 3.2 1.2 0.0 0.8 0.0 0.0 3.2 0.3 11.0 1.9 0.4 19.6 0.1 0.1 3.0 3.5 4.6 802.9 17.3 0.7 3.9 11.7 0.2 1.3 7.5 4.2 0.3 0.5 0.0 624.0 6.0 0.0 0.0 0.0 3.9 0.0 0.2 7.2 22.5 0.0 0.3 0.0 8.5 11.2 2.6 25.3 0.4 0.2 2.5 2.2 1.4 1.6 0.6 0.0 0.2 1.1 12.9 3.0 0.2 0.0 0.5 0.1 0.8 15.5 0.2 MYH8 "MyHC-peri, MyHC-pn" ENSG00000133020 "Myosin heavy chain 8" P13535 17 10390322-10421950 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "esophagus: 16.0;lymphoid tissue: 10.8;skeletal muscle: 16.8;tongue: 10.1" "Group enriched" "Detected in some" 8 "Proximal tubular cells: 84.8;Skeletal myocytes: 52.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.7;renal cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HSkMC: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001349, CAB016527" Enhanced Uncertain "Focal adhesion sites" NA NA 53000000 "Focal adhesion sites" "CAB016527: AB_2147291, HPA001349: AB_1079437" "unprognostic (5.87e-2)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" "unprognostic (1.25e-2)" "unprognostic (2.29e-3)" "unprognostic (1.08e-1)" "unprognostic (5.02e-3)" "unprognostic (7.87e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 16.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 10.8 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 84.8 0.0 0.0 0.0 52.0 0.1 0.5 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 MYH10 NMMHCB ENSG00000133026 "Myosin heavy chain 10" P35580 17 8474207-8630761 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 216.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017180, HPA047541, HPA057198" Enhanced Supported "Actin filaments,Mitochondria,Cytosol" NA NA 28000000 "Actin filaments" "Mitochondria, Cytosol" "CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364" "unprognostic (4.67e-2)" "unprognostic (9.64e-3)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (2.40e-1)" "unprognostic (2.33e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (4.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-3)" "unprognostic (1.69e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.02e-2)" "unprognostic (2.73e-1)" "unprognostic (5.58e-2)" "prognostic unfavorable (6.42e-4)" 27.5 17.1 8.3 6.2 19.4 13.5 14.8 8.3 29.9 19.4 11.0 9.9 2.3 28.1 17.0 6.6 25.5 26.4 39.3 15.9 11.7 32.8 19.0 67.5 6.5 9.6 7.9 15.9 26.2 9.8 13.9 17.8 53.8 11.6 17.9 3.8 22.7 6.6 26.9 5.0 7.2 5.8 22.3 0.9 4.7 9.6 7.5 14.4 5.8 13.7 8.3 4.0 10.6 10.4 14.2 54.1 35.1 216.3 72.7 27.7 33.1 97.1 44.2 39.7 52.2 55.8 94.5 8.0 0.5 28.6 43.9 28.4 5.2 108.7 53.0 58.1 1.2 88.3 62.3 21.7 83.0 64.7 5.4 4.2 47.3 18.9 67.7 26.1 32.1 85.3 70.9 88.1 0.2 32.9 21.6 67.2 1.7 102.1 3.6 7.7 105.9 64.2 0.2 59.1 22.3 17.7 96.8 69.2 3.4 68.1 165.0 18.3 3.6 2.8 48.7 35.6 0.3 38.5 8.3 10.8 13.4 0.3 5.0 111.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.3 19.4 8.3 29.9 15.9 11.7 9.6 7.9 15.9 11.6 0.9 14.4 14.2 43.0 22.4 14.1 43.1 1.1 4.7 9.5 11.2 9.6 37.1 18.7 16.4 33.5 12.8 11.5 101.2 50.1 171.9 1.0 0.8 17.6 13.7 49.1 28.1 37.6 30.6 2.4 43.5 221.3 1.7 88.6 58.0 3.1 28.5 1.3 41.6 55.6 15.3 15.8 35.3 151.1 1.9 6.1 2.7 3.7 28.6 3.7 1.3 1.8 15.9 0.7 25.9 2.1 96.5 15.5 1.9 0.7 39.9 0.6 7.6 0.0 14.0 21.7 39.4 0.0 12.4 23.6 15.6 27.8 9.5 4.0 76.5 2.0 28.0 2.2 4.4 PEMT "PEMPT, PEMT2" ENSG00000133027 "Phosphatidylethanolamine N-methyltransferase" Q9UBM1 17 17505563-17591708 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 167.7;liver: 269.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 122.9;Hepatocytes: 220.1;Peritubular cells: 346.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042375, HPA073930" Approved Supported "Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Mitochondria" "Vesicles, Cytosol" "HPA042375: AB_10796905, HPA073930: " "unprognostic (1.39e-2)" "unprognostic (3.43e-1)" "unprognostic (2.43e-2)" "prognostic favorable (6.77e-6)" "unprognostic (2.85e-1)" "unprognostic (7.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (3.41e-2)" "unprognostic (5.47e-3)" "unprognostic (2.67e-1)" "unprognostic (8.63e-3)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (6.66e-2)" "unprognostic (7.60e-2)" 68.7 34.2 10.9 5.2 11.1 9.3 93.4 13.9 20.2 41.3 9.8 13.5 15.1 37.2 167.7 27.0 26.7 5.4 24.5 11.1 12.2 30.0 269.6 26.0 5.3 13.1 12.9 10.0 28.2 32.5 13.4 24.9 7.4 13.8 31.1 3.4 2.8 27.3 24.2 29.7 34.6 13.8 6.8 12.7 12.9 19.7 41.1 12.2 5.6 33.7 10.7 4.6 21.2 24.4 15.2 34.3 64.7 16.5 43.4 34.6 23.8 25.1 21.6 19.0 28.5 22.4 38.2 22.6 29.8 38.1 21.9 21.6 39.9 24.6 12.8 7.2 22.2 86.9 14.8 33.2 55.4 38.4 13.5 21.4 24.9 26.7 19.2 29.1 9.7 15.7 41.3 14.6 12.3 12.9 66.0 23.9 24.2 23.2 65.5 52.4 22.2 26.7 27.5 24.1 12.5 16.7 39.5 15.3 10.1 39.2 31.5 15.6 5.1 13.9 28.1 28.2 47.4 18.9 17.0 12.1 5.5 25.9 18.5 23.6 1.9 41.1 2.1 16.9 39.0 24.8 23.5 22.2 21.5 30.5 28.3 17.2 19.4 3.1 29.3 28.0 27.7 22.4 21.3 10.9 11.1 13.9 20.2 11.1 12.2 13.1 12.9 10.0 13.8 12.7 12.2 15.2 38.1 16.0 17.5 4.9 12.4 18.2 21.0 27.9 39.3 4.5 33.0 45.1 15.5 11.5 24.9 27.6 0.0 19.5 5.9 9.3 17.6 33.3 2.9 21.8 122.9 18.5 68.8 17.1 5.4 38.5 21.6 30.4 8.2 23.8 12.7 52.4 10.4 220.1 23.5 5.0 6.8 30.9 24.4 13.7 12.2 14.9 94.8 11.2 21.4 3.7 5.7 34.7 2.1 9.5 4.0 25.7 10.8 346.8 15.3 35.1 21.7 32.3 14.2 6.1 6.6 20.0 23.6 21.0 24.9 39.5 18.2 14.6 12.5 49.3 24.1 23.8 SCO1 SCOD1 ENSG00000133028 "Synthesis of cytochrome C oxidase 1" O75880 17 10672474-10698375 "Disease related genes, Human disease related genes, Predicted membrane proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 102.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021565, HPA021579" Enhanced NA NA "HPA021565: AB_1856631, HPA021579: AB_1856632" "unprognostic (6.11e-3)" "unprognostic (2.88e-1)" "unprognostic (5.12e-3)" "unprognostic (1.09e-2)" "unprognostic (1.92e-2)" "unprognostic (7.52e-2)" "unprognostic (5.01e-2)" "unprognostic (3.02e-2)" "unprognostic (7.09e-3)" "unprognostic (1.83e-2)" "unprognostic (2.43e-3)" "unprognostic (3.84e-2)" "prognostic favorable (9.69e-7)" "unprognostic (4.94e-3)" "unprognostic (3.54e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.12e-2)" 16.5 18.6 8.8 12.3 9.0 9.0 14.3 9.4 9.5 12.4 13.0 19.0 20.1 13.7 8.1 16.7 10.7 8.1 24.4 8.7 9.8 20.1 30.4 10.2 12.1 9.3 9.3 8.4 10.5 9.7 15.9 12.6 11.4 9.3 12.9 14.8 9.3 12.0 9.8 25.1 12.0 17.0 9.3 9.2 12.1 13.3 12.1 9.5 9.7 13.2 17.4 10.0 13.6 12.4 9.7 32.6 46.9 19.0 25.5 22.8 19.4 40.7 35.2 18.3 31.1 29.9 24.0 18.5 56.8 37.4 31.6 19.1 35.0 38.0 33.4 34.7 30.1 48.4 29.3 28.8 34.0 32.5 20.5 20.8 24.7 21.4 29.3 46.3 16.2 22.5 36.9 30.3 9.8 32.4 18.4 28.7 21.1 42.0 36.6 23.9 33.8 23.6 25.4 40.3 23.2 10.1 29.2 41.6 25.4 37.2 24.4 32.1 14.4 26.9 23.7 20.2 25.6 37.1 15.5 16.5 21.6 19.3 25.5 26.3 6.6 15.5 14.8 11.5 18.5 12.2 13.2 10.0 12.0 15.2 9.8 12.2 12.8 5.1 11.1 20.5 10.9 14.3 12.2 8.8 9.0 9.4 9.5 8.7 9.8 9.3 9.3 8.4 9.3 9.2 9.5 9.7 18.1 22.4 19.8 5.9 24.3 11.5 23.3 32.2 13.1 20.4 14.0 13.2 39.5 18.6 23.4 18.4 66.7 61.0 15.5 34.6 41.1 26.1 4.0 13.7 25.2 19.1 15.7 22.1 4.2 20.4 102.6 19.7 24.5 15.9 8.8 22.4 19.6 38.2 29.8 16.8 4.7 25.3 26.4 18.9 9.5 5.4 18.6 15.9 10.6 6.5 28.4 20.7 22.6 2.5 5.4 24.1 19.3 19.2 18.4 33.1 31.6 49.8 16.1 37.7 6.6 23.8 19.1 28.4 37.0 21.5 11.8 60.5 17.5 43.0 35.6 23.0 MPRIP "M-RIP, p116Rip, RHOIP3" ENSG00000133030 "Myosin phosphatase Rho interacting protein" Q6WCQ1 17 17042457-17217679 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 60.9" "Lineage enriched" "Detected in all" 6 "T-cells: 60.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022034, HPA022901" Enhanced Supported "Actin filaments,Cytosol" NA NA 29000 "Actin filaments" Cytosol "HPA022034: AB_1854093, HPA022901: AB_2297761" "unprognostic (1.92e-2)" "unprognostic (1.53e-3)" "unprognostic (5.81e-3)" "unprognostic (9.92e-3)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (5.18e-2)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (6.56e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" 123.5 110.9 162.9 75.5 203.0 68.7 103.6 157.4 177.8 126.8 108.1 114.9 79.3 174.1 84.5 152.9 121.5 74.4 212.6 179.1 141.1 113.9 130.2 145.8 81.1 164.0 155.1 144.7 91.1 138.7 97.4 116.9 71.1 168.0 113.9 60.5 59.5 83.8 92.7 169.6 94.4 104.1 134.7 138.0 103.1 142.4 100.0 160.1 90.5 140.6 85.3 77.5 134.2 136.5 165.0 328.5 241.7 103.6 85.1 107.2 79.3 146.0 155.2 117.6 131.9 96.9 189.2 242.3 129.3 151.0 251.4 108.9 292.1 133.4 227.3 139.3 127.7 69.8 70.3 216.9 68.6 72.3 38.6 49.4 76.8 133.4 149.9 114.0 189.8 138.9 97.9 43.5 73.1 213.3 113.0 158.1 131.9 46.6 324.2 275.9 127.6 162.4 48.9 101.6 155.3 57.3 94.4 174.7 144.2 81.4 414.0 68.8 60.3 130.8 118.4 128.0 321.3 280.2 51.6 45.0 61.1 221.3 69.1 297.7 2.4 2.5 3.5 8.5 1.9 18.3 9.3 34.8 14.4 2.4 6.9 24.8 12.1 1.1 4.5 1.8 10.0 60.9 9.9 162.9 203.0 157.4 177.8 179.1 141.1 164.0 155.1 144.7 168.0 138.0 160.1 165.0 75.9 32.1 48.0 87.1 22.2 27.0 27.9 22.7 12.5 104.6 26.2 29.2 59.9 31.5 30.6 25.8 81.3 25.9 32.9 46.9 3.9 31.8 28.5 43.7 47.4 62.1 22.7 25.0 94.0 28.7 36.2 39.7 72.4 79.4 16.5 51.3 37.9 21.7 12.3 97.6 75.6 17.3 26.4 14.3 18.6 32.4 29.2 17.7 32.0 43.1 13.5 31.3 17.5 73.4 84.4 92.4 26.4 43.2 19.0 40.2 27.9 9.2 30.6 49.3 78.9 71.0 110.4 24.3 31.4 22.4 27.4 31.7 35.0 49.4 27.1 103.0 CHI3L1 "GP39, YK-40, YKL40" ENSG00000133048 "Chitinase 3 like 1" P36222 1 203178931-203186704 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Inflammatory response" Antimicrobial "Asthma, Cancer-related genes, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 402.3;liver: 451.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5" "Cancer enriched" "Detected in all" 8 "glioma: 1313.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 495 "neutrophil: 470.4" "Lineage enriched" "Detected in single" 495 "granulocytes: 470.4" "Cell line enhanced" "Detected in some" "ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 10 "olfactory bulb: 16.0" HPA077365 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 25100000 180000000 "Golgi apparatus" Vesicles "HPA077365: " "unprognostic (2.11e-3)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.01e-3)" "unprognostic (8.81e-2)" "unprognostic (2.09e-1)" "unprognostic (1.48e-1)" "unprognostic (4.46e-2)" "unprognostic (1.30e-1)" "unprognostic (7.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-2)" "unprognostic (3.43e-2)" "unprognostic (1.14e-2)" "unprognostic (9.39e-3)" 61.6 2.1 71.6 140.2 85.6 234.6 63.3 64.4 120.3 21.1 62.4 5.4 0.4 19.7 1.0 14.5 23.6 3.0 9.6 57.1 402.3 59.3 451.5 38.7 32.6 247.0 112.3 52.8 6.7 13.9 0.2 135.6 10.2 145.2 13.9 2.0 51.4 100.3 0.9 21.2 65.9 17.0 6.9 85.2 14.0 9.8 1.0 153.1 12.5 15.2 1.0 37.2 98.7 9.2 136.5 0.8 0.0 0.0 0.3 322.9 712.9 0.0 0.0 0.2 0.0 0.0 75.3 0.2 0.1 1.2 0.4 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 8.3 0.3 0.3 637.0 0.0 1.9 0.3 30.8 0.0 0.0 0.0 1.0 0.2 0.3 0.0 5.8 2.7 0.0 0.0 0.0 0.1 15.4 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.2 0.0 1068.4 0.0 303.5 1.6 0.0 0.4 2.3 41.9 0.3 303.7 1.2 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 470.4 0.0 0.9 0.0 0.0 1.3 71.6 85.6 64.4 120.3 57.1 402.3 247.0 112.3 52.8 145.2 85.2 153.1 136.5 0.7 6.4 42.8 20.5 0.1 4.2 47.1 88.7 0.0 0.1 29.8 21.5 1.0 2.8 17.3 27.6 0.0 1.3 0.6 0.0 0.0 88.9 0.0 4.8 2.2 2.1 0.0 0.4 1.1 0.0 1.1 18.6 0.0 7.2 0.0 0.0 0.0 61.8 317.5 0.0 0.1 0.0 6.1 0.8 0.4 0.0 0.9 23.7 14.2 0.0 1.0 45.1 0.0 0.0 0.1 2.0 0.0 0.0 1.4 4.2 0.0 0.2 3.4 2.8 0.0 1.0 2.3 0.0 0.0 1.5 1.1 0.8 0.9 0.0 0.0 2.2 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175826 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 16.3;skeletal muscle: 74.8;tongue: 19.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Hofbauer cells: 1.0;Microglial cells: 1.0;Skeletal myocytes: 2.5" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 20.2" "Region enhanced" "Detected in many" "hypothalamus: 9.9" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.5" "Group enriched" "Detected in some" 5 "CACO-2: 30.6;HSkMC: 56.7;THP-1: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA 9700 "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.1 0.0 0.8 0.5 1.4 0.2 0.5 0.6 2.0 0.0 0.7 0.0 0.0 0.2 0.0 1.1 0.3 0.0 0.1 1.0 9.9 1.8 3.5 0.3 0.1 1.8 1.2 0.2 0.0 0.0 0.0 1.3 0.1 2.6 3.3 0.0 0.1 16.3 0.0 74.8 0.4 0.0 0.0 0.1 1.0 0.0 0.0 2.4 1.8 0.1 19.7 0.2 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.4 7.3 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 56.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.9 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.8 1.4 0.6 2.0 1.0 9.9 1.8 1.2 0.2 2.6 0.1 2.4 4.1 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 PIK3C2B "C2-PI3K, PI3K-C2beta" ENSG00000133056 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta" O00750 1 204422628-204494724 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.9" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 70.3;RT4: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030515, HPA050360" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030515: AB_10670043, HPA050360: AB_2681104" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.45e-1)" "unprognostic (2.19e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (3.35e-3)" "unprognostic (3.57e-3)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (5.36e-2)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "prognostic favorable (1.16e-4)" 12.1 3.6 6.5 15.3 19.1 5.0 9.7 5.9 15.6 6.6 1.8 16.0 14.5 8.5 4.8 13.0 6.5 8.1 10.0 7.9 9.6 6.2 4.9 17.4 23.6 21.5 17.9 3.0 3.0 5.3 3.3 3.3 12.9 33.7 6.3 13.1 3.0 7.3 5.4 21.1 21.4 15.0 10.0 5.4 13.7 19.1 1.9 21.2 22.5 8.1 10.9 22.3 11.0 10.8 41.9 7.5 14.8 12.9 11.9 7.4 0.6 70.3 0.9 2.9 2.8 2.1 8.8 19.2 12.7 2.7 1.7 2.5 18.3 7.7 5.2 1.1 7.7 2.1 0.3 30.1 3.3 0.4 4.5 9.3 0.9 5.4 0.7 0.4 1.1 19.1 12.6 4.7 8.3 0.2 16.7 15.4 12.8 11.8 29.3 9.3 16.6 3.3 2.4 3.5 75.6 14.1 7.8 26.0 35.9 8.4 4.7 16.1 2.4 0.7 0.4 4.5 1.3 0.2 8.9 2.6 16.4 0.5 6.7 1.9 0.0 0.1 0.0 0.5 0.0 0.5 1.5 0.6 0.4 0.1 3.2 0.3 0.3 0.2 0.8 0.0 0.0 1.2 0.2 6.5 19.1 5.9 15.6 7.9 9.6 21.5 17.9 3.0 33.7 5.4 21.2 41.9 26.7 0.0 12.2 16.0 15.3 3.8 2.1 7.9 1.2 16.6 5.3 4.4 6.9 5.7 6.9 3.7 0.0 4.4 3.3 29.2 0.0 1.8 0.6 2.0 2.5 26.1 9.6 0.0 14.3 3.4 4.4 4.5 28.5 2.4 32.4 8.5 31.1 5.5 4.2 15.2 22.8 23.8 2.0 1.6 5.1 0.7 1.2 2.9 3.6 27.2 2.3 2.7 4.1 23.6 111.5 4.7 14.5 7.5 4.9 2.4 14.6 2.1 9.1 1.0 0.0 7.7 3.3 0.1 1.5 8.1 8.0 2.2 5.0 9.4 15.5 13.8 DSTYK "DustyPK, KIAA0472, RIP5, RIPK5, SPG23" ENSG00000133059 "Dual serine/threonine and tyrosine protein kinase" Q6XUX3 1 205142505-205211702 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 89.2;Melanocytes: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044140 Approved NA NA "HPA044140: AB_10965031" "unprognostic (1.42e-2)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.66e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (3.26e-2)" "unprognostic (7.80e-2)" "unprognostic (1.93e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (8.73e-5)" 4.5 7.2 10.6 3.9 11.3 19.4 6.7 11.7 12.3 6.5 6.9 5.1 2.7 8.0 5.9 5.6 7.3 4.5 4.9 12.4 12.0 7.6 2.3 6.2 4.0 13.3 11.2 11.2 11.2 4.5 13.2 5.6 6.0 13.9 5.7 3.7 13.7 4.5 6.9 9.7 12.1 4.1 7.2 10.7 6.2 4.2 5.1 11.9 6.2 6.8 6.9 4.5 5.3 5.4 13.6 9.9 6.3 6.6 8.1 9.5 15.9 4.7 12.0 12.1 12.4 8.4 2.9 5.3 7.3 3.5 20.6 6.9 6.9 7.3 7.8 12.4 3.5 7.8 13.3 8.1 3.1 8.5 3.7 6.8 9.4 11.6 12.7 12.0 14.7 9.2 5.2 17.4 4.8 10.0 6.8 2.9 3.3 7.2 1.8 7.4 2.6 12.1 6.5 8.4 6.1 3.7 7.2 10.3 10.5 34.5 7.7 7.8 4.9 9.2 7.7 7.7 11.8 8.2 4.8 3.7 4.1 9.0 5.1 28.2 8.1 1.9 3.6 2.4 1.5 2.3 1.5 1.8 2.0 1.7 1.7 2.6 1.9 2.7 2.8 1.0 1.2 1.1 1.0 10.6 11.3 11.7 12.3 12.4 12.0 13.3 11.2 11.2 13.9 10.7 11.9 13.6 15.8 28.9 15.5 26.4 15.3 14.9 7.2 10.5 14.2 48.0 14.5 13.6 13.6 12.8 15.1 16.5 33.3 6.8 15.1 3.8 5.9 12.5 11.3 16.3 37.7 16.1 12.7 31.6 35.1 9.1 6.1 19.4 8.2 11.6 24.1 43.2 28.5 6.9 8.8 89.2 36.6 6.2 6.1 23.6 15.6 25.2 16.4 11.4 90.7 21.5 20.6 45.1 23.7 17.1 43.0 10.6 5.0 18.0 11.1 10.7 6.1 6.9 24.7 37.3 26.3 22.4 16.4 22.3 13.0 10.1 13.9 2.6 15.1 27.8 7.5 6.7 CHIT1 "CHI3, CHIT" ENSG00000133063 "Chitinase 1" Q13231 1 203212827-203273641 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 50.3;lung: 36.7;lymphoid tissue: 21.9" "Cell type enriched" "Detected in some" 10 "Hofbauer cells: 40.6" "Cancer enhanced" "Detected in many" "testis cancer: 31.9" "Region enriched" "Detected in some" 5 "cerebral cortex: 12.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010575, HPA074844" Enhanced "Secreted to blood" NA NA 26400000 57000000 "HPA010575: AB_1078512, HPA074844: " "unprognostic (5.80e-3)" "prognostic favorable (2.02e-4)" "unprognostic (2.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.87e-2)" "unprognostic (2.28e-2)" "unprognostic (7.55e-2)" "unprognostic (6.36e-3)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" 8.7 0.3 0.4 0.4 0.5 50.3 8.3 0.2 12.5 8.2 0.4 1.2 0.0 3.6 0.1 0.0 0.1 0.4 0.2 0.4 0.2 0.1 0.8 36.7 21.9 0.5 0.4 0.3 0.5 2.1 0.0 0.0 0.7 1.4 1.0 1.0 0.0 0.4 0.0 0.2 0.3 0.8 0.0 0.6 5.7 0.5 0.0 0.4 3.5 1.3 0.0 1.1 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.4 0.5 0.2 12.5 0.4 0.2 0.5 0.4 0.3 1.4 0.6 0.4 2.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789094-205813748 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.2;pancreas: 62.1;tongue: 76.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 175.0;Theca cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria NA NA Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 9.8 10.9 8.7 6.5 8.7 5.8 4.7 10.5 7.5 4.5 30.0 4.7 2.1 6.6 5.1 5.6 11.1 7.2 100.2 7.9 8.7 9.3 1.4 8.4 7.5 10.2 9.2 3.0 11.4 62.1 9.3 4.6 3.7 11.4 7.6 1.9 6.2 3.7 6.7 49.3 3.7 3.9 6.0 7.2 5.3 9.9 18.7 12.0 5.7 18.0 76.6 5.2 6.3 3.9 8.7 18.2 16.1 9.6 15.6 11.7 11.6 13.2 17.9 17.8 18.2 15.9 8.0 10.1 25.9 11.3 16.5 14.9 18.5 9.5 13.4 6.2 48.6 14.8 6.4 16.5 1.2 11.2 0.0 17.4 14.9 10.8 20.8 14.7 14.9 11.3 20.5 11.9 10.5 14.7 11.2 11.8 1.8 11.5 4.8 7.1 13.8 29.0 6.4 4.1 22.0 8.1 10.4 14.0 12.3 11.0 8.0 8.8 6.7 14.3 21.5 13.8 19.9 19.2 34.7 24.9 8.5 16.6 8.3 13.6 0.0 0.1 0.0 1.6 0.1 2.0 0.6 1.5 1.5 0.0 0.7 1.4 1.5 0.0 0.4 0.0 0.0 1.5 1.0 8.7 8.7 10.5 7.5 7.9 8.7 10.2 9.2 3.0 11.4 7.2 12.0 8.7 18.2 3.2 23.0 20.5 11.2 20.8 24.3 4.6 10.8 14.6 14.4 10.2 175.0 5.7 8.5 0.0 50.1 1.8 11.5 1.6 1.9 9.6 2.4 6.8 9.8 24.1 6.0 6.5 5.3 11.0 14.5 15.7 11.7 6.2 7.0 13.9 8.6 2.2 3.4 18.5 6.6 2.7 4.1 2.4 6.5 2.7 9.9 3.5 8.8 15.9 0.8 17.0 8.2 7.1 8.3 9.3 1.3 9.4 8.3 24.9 0.0 15.7 7.9 20.3 0.0 29.7 16.1 8.1 12.9 7.5 18.2 3.1 14.5 100.2 1.5 22.0 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193799-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6;pituitary gland: 17.7" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 9.0;Cardiomyocytes: 10.5;dendritic cells: 6.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "gdT-cell: 15.4;memory CD8 T-cell: 9.1;naive CD8 T-cell: 4.8" "Lineage enriched" "Detected in single" 37 "T-cells: 15.4" "Cell line enhanced" "Detected in some" "A549: 17.4;CAPAN-2: 15.4;HaCaT: 8.3;HeLa: 3.9" "Region enriched" "Detected in many" 9 "olfactory bulb: 24.4" "Low region specificity" "Detected in many" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.0 0.2 2.2 0.4 4.7 1.5 5.1 9.4 3.5 3.0 0.4 1.4 0.1 1.2 2.2 5.1 8.9 6.3 8.3 0.9 29.6 0.8 2.1 3.4 0.8 12.5 6.7 0.2 1.8 0.2 0.0 17.7 0.3 11.0 5.9 0.7 0.0 5.4 1.4 0.3 4.0 1.3 0.3 5.1 6.8 0.6 7.2 9.6 0.3 5.1 0.5 0.3 2.9 3.8 5.5 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 1.6 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 1.0 0.0 1.7 9.1 0.0 0.0 0.7 4.8 0.0 0.4 0.0 0.0 0.5 3.4 2.2 4.7 9.4 3.5 0.9 29.6 12.5 6.7 0.2 11.0 5.1 9.6 5.5 0.1 0.0 0.0 2.6 0.2 1.3 3.6 0.5 23.3 0.0 1.5 9.0 10.5 0.0 0.6 0.0 0.0 0.9 6.0 0.8 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.4 1.0 0.0 0.0 0.7 0.5 0.0 0.0 0.4 0.4 0.2 0.1 0.0 0.8 1.6 0.0 0.6 0.3 4.1 0.0 0.2 0.0 1.9 0.0 0.0 4.1 0.0 0.2 0.0 0.7 0.0 2.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 5.6 5.5 3.3 0.3 0.1 0.8 4.3 0.0 2.7 0.9 TMCC2 "FLJ38497, HUCEP11" ENSG00000133069 "Transmembrane and coiled-coil domain family 2" O75069 1 205227946-205285632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 88.8;brain: 43.7" "Cell type enriched" "Detected in many" 8 "Erythroid cells: 622.1" "Cancer enhanced" "Detected in many" "melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014254 Approved NA NA "HPA014254: AB_1851326" "unprognostic (2.59e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (2.61e-2)" "unprognostic (4.18e-1)" "unprognostic (5.59e-2)" "unprognostic (2.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.53e-1)" "unprognostic (5.08e-2)" "unprognostic (1.05e-5)" "unprognostic (3.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.99e-3)" "unprognostic (3.06e-2)" "unprognostic (4.01e-1)" "unprognostic (3.43e-3)" 1.2 2.6 21.8 0.4 17.2 88.8 0.9 14.7 43.7 1.7 0.0 1.9 0.3 1.6 0.0 0.7 2.1 0.3 2.5 22.1 11.1 1.4 0.7 3.1 0.3 31.4 22.6 4.6 3.1 0.5 3.1 5.0 5.4 37.4 1.1 0.1 8.5 0.9 0.3 3.6 1.7 0.9 0.5 20.9 16.2 0.9 2.0 21.4 0.7 1.3 1.6 0.2 1.2 1.6 29.8 1.9 0.9 1.7 3.8 0.7 0.2 0.9 2.4 1.0 2.3 1.8 0.3 0.2 1.8 0.4 0.6 6.3 3.2 1.1 0.5 0.7 5.7 4.2 7.5 0.5 0.1 0.3 0.3 3.5 0.4 0.1 1.2 0.0 2.0 0.3 1.7 4.0 2.4 0.9 0.1 0.0 0.9 4.1 0.0 5.2 2.8 4.3 9.1 0.4 0.1 32.0 4.3 0.2 0.0 8.0 1.5 0.7 0.4 0.8 1.5 2.5 3.9 2.7 4.9 2.1 1.2 1.3 0.6 9.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 21.8 17.2 14.7 43.7 22.1 11.1 31.4 22.6 4.6 37.4 20.9 21.4 29.8 1.9 0.0 0.0 6.2 0.4 1.0 0.4 1.2 0.0 34.4 0.2 0.0 4.6 0.0 0.3 1.8 10.4 0.1 0.3 0.0 0.0 1.6 1.5 3.7 0.8 2.5 3.5 622.1 7.9 0.0 0.2 1.0 0.0 1.9 0.0 7.4 3.9 0.0 0.9 40.4 10.1 0.1 0.0 0.6 6.1 0.8 1.2 13.1 3.6 2.8 7.8 17.7 0.0 2.5 73.0 0.2 0.0 0.4 0.8 0.1 0.0 0.2 0.9 43.2 0.0 1.8 2.8 1.1 4.8 0.4 0.9 0.0 0.7 0.8 0.1 0.1 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131382 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.8" "Group enriched" "Detected in many" 6 "Excitatory neurons: 970.6;Inhibitory neurons: 664.8" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 29.0;ASC TERT1: 27.3;fHDF/TERT166: 23.5;GAMG: 34.8;HAP1: 17.9;HSkMC: 25.5;NTERA-2: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265" "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 15.6 2.5 28.4 4.1 29.9 0.0 14.3 17.4 52.8 11.9 0.0 3.9 1.1 6.1 4.1 5.4 4.6 7.2 5.6 41.6 37.5 0.9 0.1 2.4 4.2 21.0 18.4 24.9 6.1 1.2 1.1 13.8 0.1 39.3 4.2 3.8 17.4 3.4 4.0 2.2 8.3 4.1 19.3 16.0 4.5 3.6 1.3 20.0 1.6 2.8 4.7 2.2 4.3 5.9 28.0 0.0 0.4 6.8 0.0 29.0 27.3 0.0 0.2 0.4 0.2 0.2 0.0 0.1 0.0 0.0 23.5 34.8 0.0 17.9 0.3 0.0 0.0 1.0 0.0 0.8 0.0 1.1 0.0 0.0 25.5 13.0 0.6 0.4 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 37.1 0.0 0.4 0.0 2.0 0.0 1.0 0.0 7.3 4.4 0.0 0.0 2.2 10.4 0.0 0.0 0.0 0.1 6.1 7.6 1.3 0.1 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 29.9 17.4 52.8 41.6 37.5 21.0 18.4 24.9 39.3 16.0 20.0 28.0 8.0 9.6 0.6 132.2 0.1 15.2 1.3 1.8 0.0 9.4 7.8 7.0 5.8 0.0 7.9 3.7 4.2 0.0 0.0 0.0 0.0 0.1 1.5 0.7 1.7 3.8 0.0 0.0 970.6 0.0 0.0 82.6 0.5 0.3 0.0 75.5 0.4 0.0 0.1 10.1 664.8 0.0 4.1 0.3 14.7 1.6 20.8 0.7 14.2 44.0 0.0 73.8 0.0 31.2 19.1 0.2 0.0 4.1 0.3 0.6 0.0 0.6 3.1 4.2 6.6 10.8 22.0 1.3 1.4 1.0 9.7 0.0 0.8 30.1 0.0 1.7 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442870 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.4;testis: 82.1" "Group enriched" "Detected in some" 5 "Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7" "Group enriched" "Detected in many" 4 "endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 103 "basophil: 49.2" "Lineage enriched" "Detected in single" 301 "granulocytes: 49.2" "Cell line enhanced" "Detected in many" "HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA060646: AB_2684336, HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.9 7.0 0.5 6.6 2.1 0.7 3.2 7.6 5.9 4.1 0.5 0.4 3.8 7.1 0.4 18.2 0.7 0.3 6.0 7.5 0.5 0.1 1.4 0.3 5.6 6.5 6.4 0.5 0.1 22.4 8.2 0.0 8.6 0.5 0.1 1.0 0.6 0.1 1.2 0.3 0.3 8.2 4.5 0.6 0.4 82.1 5.6 0.4 0.6 0.4 0.6 0.6 1.1 6.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 15.2 0.1 15.5 1.2 12.9 1.4 0.1 0.0 0.7 0.0 0.4 0.0 0.6 8.0 350.9 0.3 34.1 0.7 2.8 5.5 0.9 1.7 0.0 0.5 0.2 4.4 0.4 71.4 2.5 0.0 8.8 0.0 8.3 0.0 2.3 0.0 2.5 5.8 0.0 8.4 0.2 1.8 0.0 71.5 4.5 0.0 0.0 0.1 2.9 0.8 0.0 0.0 0.3 90.3 0.6 49.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.0 6.6 3.2 7.6 6.0 7.5 5.6 6.5 6.4 8.6 4.5 5.6 6.1 0.1 0.0 0.6 0.3 0.3 0.6 0.6 19.1 0.0 0.4 0.5 1.4 0.4 0.0 10.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 162.4 119.1 1.8 0.4 0.0 0.0 3.5 0.0 0.8 1.1 0.0 31.9 5.1 2.2 0.0 0.0 0.2 0.0 3.0 0.0 6.1 0.0 1.8 91.1 3.1 1.1 0.0 0.0 0.0 1.4 0.0 0.5 0.4 0.0 0.0 2.6 0.0 0.7 0.0 0.1 29.3 0.8 6.6 0.5 1.5 285.7 2.4 0.0 0.4 0.3 0.9 0.0 0.1 1.1 COG6 "COD2, KIAA1134" ENSG00000133103 "Component of oligomeric golgi complex 6" Q9Y2V7 13 39655627-39791665 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 123.1;Inhibitory neurons: 99.9;Oligodendrocyte precursor cells: 82.9;Oligodendrocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040410, HPA040441" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles, Golgi apparatus" "HPA040410: AB_10793964, HPA040441: AB_10794030" "unprognostic (2.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.85e-2)" "unprognostic (1.05e-2)" "unprognostic (4.81e-2)" "unprognostic (4.99e-2)" "unprognostic (6.81e-2)" "unprognostic (9.59e-2)" "unprognostic (3.66e-2)" "unprognostic (1.14e-1)" "unprognostic (9.07e-2)" "unprognostic (1.62e-1)" "unprognostic (6.60e-3)" "prognostic favorable (2.81e-4)" "unprognostic (4.87e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" 8.8 10.6 3.5 8.0 4.1 2.1 9.8 6.4 6.4 12.1 5.2 9.4 10.6 9.3 4.5 10.7 10.0 10.6 16.0 6.0 4.9 9.9 8.9 6.9 8.3 3.2 3.9 4.9 14.4 19.2 18.4 13.4 13.9 4.0 13.1 8.5 7.3 13.2 8.9 6.4 10.2 9.8 7.8 2.5 8.1 12.6 16.6 3.1 8.9 14.1 8.5 7.8 10.3 6.5 6.0 10.8 7.0 10.8 7.7 21.0 26.5 20.6 17.0 24.1 14.2 17.4 8.6 16.8 18.2 9.6 24.7 16.7 13.5 11.5 12.9 15.1 21.5 16.1 17.7 7.0 12.5 12.0 17.9 18.1 11.2 15.9 8.9 10.0 17.8 13.9 16.5 7.5 6.8 23.1 11.0 13.4 16.5 10.6 30.2 8.9 12.8 29.3 8.8 10.0 13.6 6.3 8.2 15.4 12.8 13.0 14.8 14.9 11.2 20.7 7.9 9.3 17.6 8.5 5.3 5.5 13.6 23.4 9.5 23.6 3.0 3.2 4.0 3.8 5.0 6.6 4.7 4.9 5.3 4.5 4.4 4.1 5.4 0.7 7.1 3.1 2.5 6.4 4.2 3.5 4.1 6.4 6.4 6.0 4.9 3.2 3.9 4.9 4.0 2.5 3.1 6.0 8.7 19.2 7.8 46.0 12.6 9.7 5.9 9.5 8.0 15.2 11.0 8.4 22.0 2.8 10.2 12.9 10.4 15.6 9.5 9.9 5.9 7.7 23.4 13.9 14.8 8.5 9.1 9.5 123.1 10.0 29.6 12.3 10.7 13.0 10.1 9.7 12.1 9.6 8.6 5.0 99.9 19.8 8.2 6.7 3.9 12.6 13.4 7.6 1.8 37.5 5.9 15.5 7.2 82.9 89.4 8.7 10.8 12.8 17.7 5.0 10.2 12.4 13.2 12.5 6.6 12.2 9.7 39.0 27.4 11.9 13.4 16.0 10.3 12.6 10.3 5.7 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 75.0;Proximal tubular cells: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 172.7" "Lineage enriched" "Detected in all" 7 "granulocytes: 172.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: AB_2676323" "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 42.7 48.8 42.2 18.1 47.9 23.8 32.8 49.2 49.4 49.6 46.7 29.5 12.8 42.8 67.7 24.8 44.9 37.8 25.9 41.0 50.0 48.8 20.0 27.2 15.9 47.6 46.1 38.4 64.1 14.7 29.8 29.8 40.2 47.3 35.0 13.5 43.6 17.5 36.8 33.8 18.4 15.5 53.3 48.3 31.0 21.2 27.8 45.0 16.8 35.9 34.0 11.3 35.8 30.2 57.2 0.1 22.4 59.5 0.0 127.9 106.6 42.4 54.1 81.3 53.7 52.8 0.1 0.0 0.0 32.9 65.9 98.2 31.2 81.4 38.0 57.5 4.4 46.9 69.4 28.3 14.6 128.0 72.8 134.3 106.2 59.5 44.4 61.9 131.7 79.6 18.7 30.6 11.9 97.5 5.2 21.7 120.8 30.0 0.0 7.8 0.0 99.4 2.5 62.5 28.2 6.2 14.5 46.3 18.3 58.9 85.3 10.5 84.7 66.8 40.0 20.1 55.9 32.2 14.2 0.2 0.1 44.6 61.8 71.0 172.7 22.1 30.1 13.5 21.7 13.1 10.1 18.6 5.4 15.7 9.7 24.5 13.1 35.0 14.2 23.8 19.3 4.8 18.1 42.2 47.9 49.2 49.4 41.0 50.0 47.6 46.1 38.4 47.3 48.3 45.0 57.2 43.5 35.3 51.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 30.8 30.1 0.0 0.0 40.2 27.6 0.0 52.7 18.6 0.0 66.5 26.2 0.0 59.4 62.6 15.9 0.0 0.0 0.0 15.0 59.7 39.8 0.0 38.1 58.0 75.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 16.8 0.0 0.0 3.5 0.0 0.0 90.4 65.6 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 64.3 10.8 59.2 0.0 0.0 RXFP2 "GPR106, GREAT, INSL3R, LGR8, RXFPR2" ENSG00000133105 "Relaxin family peptide receptor 2" Q8WXD0 13 31739526-31803389 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "Early spermatids: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "basal ganglia: 2.6" NA NA "unprognostic (1.77e-2)" 0.0 0.5 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPSTI1 "BRESI1, MGC29634" ENSG00000133106 "Epithelial stromal interaction 1" Q96J88 13 42886388-42992271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 168.1;monocytes: 144.2;Proximal enterocytes: 156.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 99.6;HDLM-2: 74.2;RPMI-8226: 35.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017362 Approved NA NA "HPA017362: AB_1848226" "unprognostic (2.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.80e-1)" "unprognostic (3.59e-2)" "unprognostic (2.35e-1)" "unprognostic (9.55e-2)" "unprognostic (2.31e-1)" "unprognostic (2.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.05e-3)" "unprognostic (8.13e-2)" 7.4 7.8 4.6 31.9 4.4 34.0 4.8 3.1 5.1 4.5 3.2 12.7 34.0 6.1 1.6 5.0 3.7 18.2 4.7 2.8 3.4 8.0 13.0 16.9 34.4 6.8 3.5 2.3 3.1 3.5 7.7 2.7 16.9 4.5 2.7 11.1 0.3 18.6 4.8 2.2 1.5 32.3 9.8 3.8 31.6 15.9 7.4 4.7 27.9 3.2 2.5 20.9 13.2 3.6 10.1 2.8 0.1 0.0 0.0 0.1 5.2 3.0 2.3 26.0 95.8 99.6 23.2 5.7 3.7 0.8 3.4 10.1 11.4 0.2 3.9 12.2 74.2 0.2 11.9 0.0 0.1 22.9 0.0 2.0 17.4 5.2 7.7 0.5 1.4 1.4 5.7 0.0 17.9 2.5 0.2 19.0 2.9 0.5 1.9 0.1 0.2 0.1 35.7 16.1 0.7 2.0 0.0 0.3 0.0 1.9 0.4 0.6 1.9 3.9 0.0 0.0 1.0 0.0 0.8 0.6 0.0 1.9 0.0 1.0 52.3 34.4 29.4 10.8 59.3 11.4 26.7 22.3 12.3 31.1 23.7 10.4 7.8 16.1 24.4 39.3 3.8 59.0 22.5 4.6 4.4 3.1 5.1 2.8 3.4 6.8 3.5 2.3 4.5 3.8 4.7 10.1 26.5 19.2 10.9 1.3 40.0 4.2 1.7 4.1 0.6 0.0 1.2 1.8 2.9 12.8 9.2 5.5 0.0 10.9 27.1 26.5 1.9 40.9 89.0 10.2 18.8 18.8 24.6 31.5 0.3 39.0 168.1 15.9 15.3 20.7 10.8 22.4 12.5 6.3 84.2 0.0 11.6 25.1 2.0 39.2 28.3 27.1 14.9 68.7 10.6 84.3 144.2 0.2 37.0 4.5 0.3 51.2 55.4 4.9 23.6 3.6 156.0 39.1 6.5 0.1 0.0 2.6 10.6 2.6 1.7 2.8 3.8 14.5 37.0 43.9 37.6 3.7 TRPC4 "HTRP4, TRP4" ENSG00000133107 "Transient receptor potential cation channel subfamily C member 4" Q9UBN4 13 37632063-37869802 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 12.0;seminal vesicle: 9.1;smooth muscle: 12.7" "Cell type enriched" "Detected in some" 4 "Inhibitory neurons: 133.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;BJ: 20.2;BJ hTERT+ SV40 Large T+: 9.1;fHDF/TERT166: 19.6;U-2197: 9.3" "Region enhanced" "Detected in many" "basal ganglia: 43.1" "Low region specificity" "Detected in all" NA NA "unprognostic (4.52e-4)" "unprognostic (9.99e-2)" "unprognostic (5.42e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (3.28e-1)" "unprognostic (1.60e-1)" "unprognostic (5.10e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-6)" "unprognostic (3.73e-3)" "unprognostic (1.93e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-2)" 0.8 0.4 3.4 0.8 7.3 0.0 0.3 0.1 3.4 2.1 0.0 2.2 0.4 12.0 0.8 0.1 1.3 3.3 0.9 4.4 3.7 1.5 0.2 3.4 0.1 0.9 2.2 2.2 2.7 1.3 0.2 0.2 1.3 0.7 6.7 0.6 0.2 0.2 9.1 0.2 0.1 1.0 12.7 0.5 0.2 2.0 0.1 1.8 0.0 0.7 0.2 0.0 1.6 1.6 1.2 0.0 0.0 8.7 0.0 1.2 2.6 0.0 20.2 2.9 9.1 4.4 0.0 0.3 0.0 0.0 19.6 3.1 0.0 0.1 0.0 4.2 0.0 0.1 0.0 0.4 0.0 3.1 0.0 0.0 1.3 0.0 2.6 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.2 0.1 9.3 1.8 4.7 1.2 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.3 0.1 3.4 4.4 3.7 0.9 2.2 2.2 0.7 0.5 1.8 1.2 0.3 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.3 12.3 0.6 0.0 0.0 32.0 0.0 0.0 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 133.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 15.0 0.0 0.0 0.0 2.5 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 7.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 POSTN "OSF-2, periostin, PN" ENSG00000133110 Periostin Q15063 13 37562583-37598844 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 208.9;stomach 1: 176.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5" "Cancer enhanced" "Detected in all" "breast cancer: 231.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "spinal cord: 87.9" HPA012306 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to extracellular matrix" NA NA 660000000 "Golgi apparatus" Nucleoplasm "HPA012306: AB_1854827" "unprognostic (7.73e-2)" "unprognostic (1.44e-3)" "unprognostic (2.19e-2)" "unprognostic (2.57e-2)" "unprognostic (4.73e-2)" "unprognostic (2.22e-2)" "unprognostic (4.19e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (3.05e-3)" "unprognostic (7.10e-2)" "unprognostic (1.32e-2)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.83e-7)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (8.32e-3)" 67.3 5.3 4.7 24.0 0.2 0.3 84.8 0.0 4.5 20.5 4.7 61.8 5.1 53.7 13.1 20.7 84.3 64.9 84.0 3.3 0.2 27.3 13.1 45.6 13.0 1.0 0.7 0.0 3.6 2.3 21.7 2.4 61.5 2.1 16.2 85.8 0.0 17.9 45.2 10.7 208.9 15.1 67.2 0.0 1.1 176.2 3.4 2.3 5.8 19.2 30.1 3.9 92.2 10.8 1.2 0.0 0.0 71.0 1.6 85.0 51.0 0.2 23.1 0.0 5.5 0.7 0.0 1.4 0.1 0.0 18.7 0.1 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 14.2 0.2 0.1 90.8 0.0 490.2 1.9 15.9 0.7 0.0 0.0 0.0 11.8 0.0 0.3 0.4 4.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.6 0.0 440.5 0.9 0.0 0.0 619.3 0.3 427.2 3.4 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.2 0.0 4.5 3.3 0.2 1.0 0.7 0.0 2.1 0.0 2.3 1.2 46.7 6.4 10.6 0.7 0.3 295.7 1.3 51.5 0.0 0.0 2.9 158.1 22.8 0.0 18.7 0.0 0.0 2.5 1.0 0.0 0.0 0.0 0.5 0.5 9.8 134.6 0.0 0.0 1.5 0.0 0.2 191.5 0.0 0.3 3.8 0.0 22.5 0.6 3.7 0.0 36.8 0.0 24.4 0.0 27.0 1.1 6.5 0.8 30.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.7 0.4 0.4 0.0 0.0 5.6 0.0 0.0 0.7 151.5 1.3 0.9 0.2 48.4 3.4 2.3 49.3 0.0 0.3 RFXAP ENSG00000133111 "Regulatory factor X associated protein" O00287 13 36819222-36829104 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding SCID "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032035 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA032035: AB_2674120" "unprognostic (2.03e-1)" "unprognostic (9.69e-2)" "unprognostic (7.40e-2)" "unprognostic (3.13e-1)" "unprognostic (5.14e-3)" "unprognostic (4.45e-3)" "unprognostic (1.15e-2)" "prognostic favorable (2.26e-5)" "unprognostic (1.45e-1)" "unprognostic (2.94e-1)" "prognostic favorable (4.18e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "prognostic favorable (4.91e-4)" "unprognostic (2.81e-2)" "unprognostic (4.09e-1)" "unprognostic (5.99e-3)" 4.2 3.4 4.3 5.0 5.0 6.0 4.7 7.4 5.3 6.4 3.1 4.4 3.1 6.8 5.2 3.0 5.9 4.1 3.5 4.5 4.4 3.3 2.6 4.3 6.8 4.1 4.6 4.6 7.1 4.6 6.3 4.7 3.8 5.2 5.3 4.2 5.5 4.9 3.9 4.3 3.5 4.5 5.8 4.2 5.1 4.2 6.6 4.1 8.3 5.9 3.0 5.5 4.0 3.8 5.0 7.4 1.8 10.4 14.7 3.8 5.2 6.7 5.9 6.2 10.9 6.7 5.2 5.9 32.3 4.8 5.4 9.6 6.7 10.8 3.6 12.2 24.4 17.9 15.5 8.6 10.2 6.9 28.7 10.9 4.8 6.3 5.3 4.0 3.1 8.3 24.4 9.0 6.4 3.3 3.6 28.8 20.5 11.1 6.4 3.2 24.9 19.3 9.8 4.6 4.5 8.5 10.6 5.7 3.8 4.7 6.3 3.9 16.9 6.5 2.8 6.1 9.8 5.5 6.0 5.3 24.2 7.9 19.6 4.5 0.0 0.0 0.5 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.3 0.2 0.0 4.3 5.0 7.4 5.3 4.5 4.4 4.1 4.6 4.6 5.2 4.2 4.1 5.0 6.6 3.2 3.9 11.1 10.4 3.6 3.3 2.5 7.4 14.5 4.9 4.4 3.6 1.5 2.7 3.7 2.1 6.4 11.1 2.0 15.6 4.2 5.3 4.3 7.5 7.0 7.2 16.0 26.4 5.5 2.8 9.8 4.6 3.0 10.2 10.9 7.9 2.2 3.1 23.5 27.5 2.8 2.0 1.9 7.4 4.1 11.1 4.1 7.2 7.5 5.5 20.8 17.5 11.1 23.9 2.8 2.5 10.9 6.4 1.5 3.3 1.4 2.2 18.0 6.6 13.1 10.0 20.1 25.8 2.8 2.0 1.2 11.7 8.2 3.6 0.8 TPT1 "fortilin, TCTP" ENSG00000133112 "Tumor protein, translationally-controlled 1" P13693 13 45333471-45341284 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 23456.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008364, HPA039437" Approved Supported Cytosol NA NA 1500000 Cytosol "CAB008364: AB_591904, HPA039437: AB_2676508" "prognostic favorable (5.90e-5)" "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "prognostic favorable (2.35e-4)" "unprognostic (3.25e-1)" "unprognostic (3.57e-2)" "unprognostic (8.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-3)" "unprognostic (4.56e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (1.47e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.31e-5)" "unprognostic (6.51e-2)" 5132.7 3826.1 2113.8 2998.2 2182.2 7082.2 4837.0 2132.5 2908.6 4855.4 2339.8 3730.0 3932.1 3495.5 5130.7 4777.7 3797.1 3801.6 4581.0 2026.8 2328.5 4795.0 6918.8 3647.2 5673.2 2266.6 2144.9 1915.9 7040.7 10736.0 2488.7 2615.6 4427.3 2292.4 3678.1 3418.1 1035.8 8547.6 2276.1 23456.2 3388.3 3929.3 2810.6 2351.8 3309.9 3574.1 828.4 2245.0 3946.4 4463.6 14008.5 4659.7 4905.3 4412.7 2340.5 1905.1 1684.0 2793.7 1836.1 8042.9 11121.9 3311.0 3946.8 6100.9 2460.2 2560.6 3800.8 4814.7 4011.0 3236.5 4125.5 1627.8 3232.7 2281.2 5785.6 3386.6 1869.7 2010.7 3227.6 1369.1 4278.1 8106.1 4451.8 4843.1 9204.7 11563.7 1572.6 9416.5 7957.8 5168.0 3360.7 2443.5 1080.9 5091.4 3449.9 5437.0 10564.3 3194.8 6358.1 1773.3 3370.4 2645.5 3062.6 6392.2 3916.9 1185.4 3165.1 1308.7 4147.6 6396.8 2827.9 2383.4 12710.0 3402.5 1129.5 1605.0 1855.4 2470.9 2644.9 2873.7 3842.4 3013.5 3486.9 899.6 1195.3 1271.4 617.3 1006.6 978.8 1830.5 1337.9 1874.2 1366.7 1138.9 1036.9 1944.6 1636.5 546.5 1513.4 929.3 1454.0 1812.0 3204.4 2113.8 2182.2 2132.5 2908.6 2026.8 2328.5 2266.6 2144.9 1915.9 2292.4 2351.8 2245.0 2340.5 4176.2 1593.0 3381.6 39.5 4868.3 3494.9 6406.7 2737.1 4501.1 371.9 5018.7 4187.9 2795.4 3154.1 2226.0 763.2 160.6 4470.7 5693.8 3799.1 3144.1 2527.2 1185.2 3111.2 5482.8 3928.3 2068.2 3074.8 44.9 5125.2 6375.7 3310.5 2398.6 5369.5 1842.3 4305.3 5062.0 4784.7 4614.9 213.7 39.1 5716.8 852.4 5939.9 3637.5 1381.9 6800.4 6005.9 1773.4 87.1 6495.9 2240.9 5186.5 25.1 50.5 5271.4 5556.8 3870.4 4453.2 6953.8 11028.2 9311.2 1156.1 656.2 2530.9 5300.1 3028.9 443.5 687.3 5411.6 3479.1 5749.6 5238.7 4437.6 5420.4 9158.8 GPALPP1 "AD029, bA245H20.2, KIAA1704, LSR7" ENSG00000133114 "GPALPP motifs containing 1" Q8IXQ4 13 44989529-45037669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038966, HPA058739" Approved Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA038966: AB_10672656, HPA058739: AB_2683804" "unprognostic (4.99e-2)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (8.81e-2)" "unprognostic (3.65e-2)" "unprognostic (2.63e-2)" "unprognostic (8.86e-2)" "unprognostic (6.08e-2)" "unprognostic (2.72e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" "unprognostic (4.56e-2)" "unprognostic (1.41e-3)" "unprognostic (3.37e-2)" "unprognostic (6.38e-2)" "unprognostic (5.88e-2)" "unprognostic (3.94e-2)" 5.7 6.6 2.4 3.3 2.6 6.5 5.4 4.7 3.6 6.8 0.7 5.8 3.1 6.7 3.1 5.9 6.2 2.1 5.2 2.7 1.9 5.7 5.0 5.3 4.4 1.5 1.6 2.2 8.1 4.9 1.8 6.1 3.7 2.5 5.8 2.9 5.7 5.4 2.6 4.3 4.4 5.2 2.7 0.3 5.6 5.7 5.3 1.6 3.2 6.1 1.8 3.6 6.5 6.5 3.7 4.7 3.8 6.2 4.6 2.6 5.3 6.3 6.1 3.8 6.1 5.8 7.8 9.1 10.9 4.3 4.1 5.8 9.6 6.6 5.1 5.7 9.2 9.2 8.1 6.3 5.4 3.9 10.9 4.5 3.3 2.9 4.8 3.2 3.7 4.9 8.5 7.2 2.4 4.0 5.5 11.0 9.3 5.7 11.9 4.4 11.0 5.3 4.5 3.5 4.6 3.2 5.1 5.8 4.0 3.5 4.5 4.0 11.0 7.9 4.0 3.3 4.6 5.1 4.0 4.0 11.5 4.1 6.7 5.2 2.4 3.9 6.7 4.0 3.1 3.2 4.8 4.1 2.7 4.4 6.2 4.7 4.2 2.9 4.0 3.3 5.7 3.1 2.5 2.4 2.6 4.7 3.6 2.7 1.9 1.5 1.6 2.2 2.5 0.3 1.6 3.7 18.5 32.1 34.2 26.1 19.1 7.1 15.6 11.6 15.4 24.4 13.7 13.6 16.2 15.7 22.3 23.9 18.8 27.9 19.6 6.8 23.5 13.0 7.0 15.2 26.1 17.3 18.0 14.7 65.0 13.3 13.1 19.0 9.2 17.2 21.5 27.7 16.8 17.3 15.5 23.5 57.3 11.3 12.2 14.2 7.6 5.1 26.8 12.9 12.4 24.4 15.6 18.5 29.9 53.3 42.6 11.4 11.1 26.7 10.5 10.0 10.7 21.0 22.3 26.1 26.3 20.1 23.1 48.7 26.7 16.7 9.2 18.2 16.2 22.9 12.6 11.8 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38990859 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 35.2" "Group enriched" "Detected in some" 19 "Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2" "Group enriched" "Detected in some" 4 "endometrial cancer: 2.4;lung cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "AF22: 17.5" "Region enriched" "Detected in many" 6 "olfactory bulb: 23.6" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA012892: AB_1857610, HPA071011: AB_2732169" "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favorable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.0 0.0 2.1 0.0 1.0 0.0 0.0 1.8 0.7 0.7 1.1 0.1 0.0 0.6 0.0 0.0 35.2 0.0 0.0 0.7 3.2 0.0 0.0 2.1 0.0 4.7 4.1 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.8 0.7 0.7 3.2 4.7 4.1 0.0 4.5 2.5 1.8 1.4 0.0 0.0 1.5 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.4 0.1 0.0 4.8 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.4 75.5 0.4 0.3 0.0 0.0 0.1 0.0 1.1 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 1.5 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 109.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.1 KL ENSG00000133116 Klotho Q9UEF7 13 33016423-33066143 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 129.9;parathyroid gland: 136.2" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 123.3" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HMC-1: 2.4;SK-BR-3: 4.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2" "Secreted to blood" NA NA 510000 "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favorable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favorable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 3.0 1.4 0.9 0.8 3.0 0.1 2.5 0.8 1.2 1.8 38.0 1.6 2.8 1.2 8.8 1.1 0.8 1.3 1.1 4.2 1.2 129.9 0.4 3.6 1.0 0.7 0.9 0.6 0.1 1.2 136.2 0.3 30.7 0.6 8.1 0.9 0.0 0.8 2.5 0.7 0.6 2.6 1.2 0.5 2.5 2.1 0.5 1.2 0.5 1.3 1.6 0.5 1.6 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.8 1.2 4.2 1.2 0.7 0.9 0.6 0.6 0.5 1.2 0.7 15.8 0.0 0.5 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.6 0.3 1.0 0.0 0.7 12.9 0.0 0.2 0.0 0.4 5.9 0.0 1.8 0.1 2.5 10.2 16.3 0.4 1.2 0.0 0.1 1.6 0.0 0.1 0.0 0.1 1.1 0.2 2.8 0.0 0.5 1.1 0.0 0.9 1.0 0.8 0.3 1.9 0.0 6.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 3.6 1.8 123.3 0.7 0.0 0.0 1.1 2.3 1.4 0.5 0.0 0.1 0.1 1.1 0.1 1.9 0.1 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818069-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 285.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles No Yes "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 5.3 13.9 2.8 13.0 2.5 19.7 12.9 8.9 2.7 5.8 2.0 9.1 8.5 10.7 4.3 6.8 8.3 4.7 6.1 2.8 2.7 5.2 7.5 5.4 24.5 2.6 2.9 2.6 7.8 4.8 5.1 2.7 10.9 3.7 6.4 11.7 5.9 5.5 4.1 3.5 7.6 8.0 7.7 2.9 6.7 6.6 12.9 2.7 24.3 6.6 4.5 23.5 5.7 4.6 2.8 49.0 51.1 86.4 69.5 6.5 10.0 47.5 66.6 29.2 85.5 73.7 63.0 72.2 179.8 26.8 25.3 53.2 72.5 111.6 45.9 112.0 71.5 68.9 105.0 54.4 68.0 7.5 127.2 48.3 9.8 5.8 74.5 49.9 14.1 28.9 63.7 75.1 44.2 51.4 56.1 108.8 58.1 104.2 101.2 42.1 40.3 103.4 41.1 25.4 42.7 45.1 79.2 49.4 65.3 33.4 45.7 52.2 66.8 15.5 45.1 49.7 57.1 70.9 24.9 36.7 285.3 32.4 73.7 86.6 1.5 4.4 7.2 3.2 6.1 3.7 5.8 3.9 3.3 6.1 5.5 5.0 4.5 0.9 2.5 5.3 2.5 6.3 3.1 2.8 2.5 8.9 2.7 2.8 2.7 2.6 2.9 2.6 3.7 2.9 2.7 2.8 9.3 9.6 6.2 5.9 11.2 12.2 6.9 6.9 7.4 16.5 8.9 10.5 7.5 1.5 8.6 3.7 8.4 29.6 5.1 3.0 3.9 7.3 8.4 7.0 7.9 9.4 6.1 43.8 30.2 8.9 39.3 7.5 3.1 7.7 1.3 17.8 8.9 7.2 11.9 8.4 20.3 4.3 4.1 6.7 4.0 7.9 6.2 6.5 8.8 34.7 6.4 5.4 1.0 33.7 18.0 5.4 1.5 4.5 21.0 2.7 1.1 5.4 3.8 12.2 6.6 7.9 29.8 52.6 43.2 9.2 7.0 16.4 6.6 9.2 10.1 3.3 STARD13 "ARHGAP37, DLC2, GT650, LINC00464" ENSG00000133121 "StAR related lipid transfer domain containing 13" Q9Y3M8 13 33103137-33350630 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Astrocytes: 212.5;Excitatory neurons: 120.7;Inhibitory neurons: 135.6;Microglial cells: 167.7;Oligodendrocyte precursor cells: 212.6;Oligodendrocytes: 470.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 50.2;TIME: 36.0;WM-115: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039535, HPA058867" Supported NA NA "HPA039535: AB_10965929, HPA058867: AB_2683839" "unprognostic (7.42e-2)" "unprognostic (6.71e-2)" "unprognostic (1.99e-1)" "unprognostic (4.99e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (7.13e-3)" "unprognostic (3.42e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (5.29e-2)" 16.2 11.0 8.8 5.7 12.5 0.4 11.2 9.1 11.3 15.3 14.0 21.5 4.8 14.9 5.3 7.3 10.5 10.9 11.7 12.8 10.9 6.4 6.2 12.6 2.6 11.1 11.9 8.3 7.3 10.9 17.0 4.3 24.8 15.0 9.1 6.8 1.8 6.5 8.2 5.5 5.1 7.1 15.8 9.5 7.5 11.3 2.8 11.2 1.5 20.6 6.4 1.4 14.1 9.6 13.8 11.4 1.6 3.4 2.4 6.8 16.0 0.6 21.2 26.2 17.4 10.8 0.9 4.0 0.1 2.8 10.2 10.7 10.4 1.5 7.5 22.0 10.0 3.6 5.2 3.9 5.2 5.7 0.0 4.6 13.3 4.3 19.7 24.0 9.7 17.1 0.1 0.0 1.7 50.2 3.3 0.0 0.0 2.2 1.2 5.7 0.2 16.6 0.1 10.6 3.2 0.1 5.5 3.2 8.0 2.6 3.0 18.5 4.7 36.0 8.7 9.3 22.0 11.0 2.9 0.0 0.1 7.0 0.1 40.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.8 12.5 9.1 11.3 12.8 10.9 11.1 11.9 8.3 15.0 9.5 11.2 13.8 30.5 28.9 15.1 212.5 0.1 2.4 2.8 1.1 4.0 5.3 8.6 5.1 19.8 7.2 2.0 9.2 0.0 9.4 4.2 11.8 0.0 7.7 1.2 5.5 26.6 18.4 6.7 0.0 120.7 2.2 3.7 18.8 10.7 6.4 5.1 6.2 17.9 10.7 16.7 5.0 135.6 4.4 0.0 8.8 6.8 1.4 7.2 10.8 14.2 167.7 0.8 1.1 0.0 212.6 470.9 5.5 4.3 7.5 4.7 4.4 3.4 2.1 6.3 0.4 13.1 15.6 33.1 0.1 0.3 1.0 2.3 7.5 0.6 31.1 5.4 1.5 IRS4 "IRS-4, PY160" ENSG00000133124 "Insulin receptor substrate 4" O14654 X 108719946-108736563 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.3;choroid plexus: 6.6;ovary: 4.7;pituitary gland: 5.3" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 2.9;Oligodendrocytes: 1.1" "Cancer enhanced" "Detected in some" "breast cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.4;NTERA-2: 1.3;RT4: 3.1;WM-115: 2.2" "Group enriched" "Detected in many" 5 "basal ganglia: 11.7;hypothalamus: 45.0" "Group enriched" "Detected in many" 5 "basal ganglia: 14.5;hypothalamus: 36.7" HPA017372 Uncertain NA NA "HPA017372: AB_2669600" "unprognostic (3.74e-3)" "unprognostic (3.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-1)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (9.28e-4)" "unprognostic (8.71e-2)" 0.0 0.0 3.6 0.0 1.3 0.0 0.0 0.0 0.6 1.0 6.6 0.0 0.0 1.4 0.5 0.0 0.2 0.0 0.0 1.4 10.3 0.0 0.0 0.0 0.0 2.1 2.3 0.5 4.7 0.0 0.0 5.3 0.0 2.2 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.9 0.0 0.2 0.0 7.6 3.8 1.8 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.6 1.4 10.3 2.1 2.3 0.5 2.2 0.9 7.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000212 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 80.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 13.6 31.2 24.5 7.9 37.9 11.9 12.4 47.6 53.7 11.3 17.6 8.6 10.5 11.6 16.5 9.7 10.4 10.2 5.6 30.4 30.0 10.9 21.2 8.9 5.6 17.9 20.4 31.9 17.6 15.2 11.8 6.2 80.5 28.2 12.5 10.9 22.5 11.0 11.6 20.4 18.8 10.1 11.5 2.4 6.0 8.5 20.3 14.4 5.6 10.3 10.4 7.0 7.6 11.2 57.3 29.8 121.0 11.4 26.4 35.0 40.3 60.5 28.7 30.8 14.6 18.3 64.6 13.1 3.7 14.2 30.5 23.9 22.5 39.8 25.5 17.1 4.6 23.0 6.4 40.7 27.1 25.6 4.7 13.9 20.8 24.3 19.6 28.6 85.7 13.1 4.1 3.9 41.4 32.7 26.7 10.7 6.4 8.9 82.0 45.2 4.2 22.9 4.3 47.0 23.3 9.2 11.5 35.4 33.9 23.0 15.9 19.7 5.0 12.6 22.5 21.4 44.7 15.7 11.1 16.2 11.5 24.0 3.8 16.2 8.3 1.5 1.8 1.9 1.3 1.7 1.7 1.9 1.5 0.7 2.7 2.1 1.7 3.7 1.5 1.7 2.5 1.5 0.4 24.5 37.9 47.6 53.7 30.4 30.0 17.9 20.4 31.9 28.2 2.4 14.4 57.3 8.6 131.4 130.4 6.2 5.1 17.5 19.1 4.9 21.1 5.4 11.5 9.5 3.0 10.0 61.8 5.5 4.2 329.8 10.4 3.6 21.5 9.9 0.9 6.2 11.5 13.6 1.8 0.4 4.2 7.4 28.2 33.4 10.2 15.5 66.3 10.3 7.5 24.0 23.4 1.7 6.5 10.5 6.1 2.1 5.0 1.8 11.1 8.2 12.4 3.7 0.3 6.7 3.1 15.1 8.7 7.5 6.7 11.7 5.8 16.4 4.4 12.7 62.2 7.2 26.3 16.9 12.0 9.9 26.6 19.7 16.1 257.8 11.9 10.1 10.1 11.8 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311007 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 196.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 418.7;Muller glia cells: 285.9;Proximal tubular cells: 201.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 52.7;NK-cells: 62.0;T-cells: 68.6" "Cell line enhanced" "Detected in many" "hTCEpi: 94.7;NTERA-2: 91.4;SCLC-21H: 135.2;SH-SY5Y: 61.4" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 3.3 74.3 132.2 6.9 142.1 13.8 19.6 125.4 168.6 15.2 103.9 10.2 3.5 27.8 124.9 10.0 15.6 7.6 16.3 140.6 149.3 53.1 2.6 12.8 14.3 125.5 127.0 136.4 63.3 35.8 124.2 196.1 8.1 131.0 24.4 6.1 84.2 26.9 21.2 9.2 16.4 14.2 8.8 118.9 18.7 16.9 43.5 136.8 21.2 104.3 11.6 17.1 8.8 10.8 145.2 0.0 2.8 11.3 0.1 0.2 0.0 45.5 0.3 6.1 7.7 11.3 8.4 3.8 0.0 31.6 0.0 55.4 2.0 0.1 9.4 6.6 0.1 25.4 1.4 1.4 0.4 46.0 0.1 25.4 2.8 94.7 3.7 29.1 17.8 0.5 33.6 17.4 0.7 1.0 4.2 20.1 0.2 91.4 0.0 8.4 0.1 0.0 0.2 3.8 3.7 135.2 61.4 5.9 1.4 22.2 10.7 11.2 0.1 0.0 0.1 9.0 0.3 2.1 30.8 21.6 0.1 15.3 0.0 1.3 13.4 0.4 1.1 21.8 0.4 31.0 52.7 43.8 25.7 1.6 42.3 68.6 50.0 1.4 62.0 0.1 10.0 33.7 18.4 132.2 142.1 125.4 168.6 140.6 149.3 125.5 127.0 136.4 131.0 118.9 136.8 145.2 3.7 16.0 68.5 15.0 41.6 31.6 95.6 17.4 100.7 184.7 65.8 145.5 27.0 60.1 43.4 114.0 43.8 72.2 20.9 5.0 418.7 47.5 17.9 11.6 3.3 13.7 100.5 9.4 56.7 42.7 19.9 13.1 23.0 17.0 12.7 87.6 3.6 0.9 7.0 121.1 53.0 29.6 16.2 0.3 5.3 69.4 15.8 4.6 26.6 7.5 2.5 285.9 27.8 35.2 25.8 19.8 8.4 22.2 16.5 64.5 3.7 201.3 9.0 120.5 6.6 32.0 11.4 16.8 5.8 25.7 26.7 63.8 30.2 22.3 22.3 51.1 RNF128 "FLJ23516, GRAIL" ENSG00000133135 "Ring finger protein 128" Q8TEB7 X 106693794-106797016 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.6;liver: 125.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 67.3;Cholangiocytes: 50.1;Distal enterocytes: 49.3;Gastric mucus-secreting cells: 54.6;Hepatocytes: 76.9;Proximal enterocytes: 85.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 41.9;CAPAN-2: 35.0;Hep G2: 30.6;OE19: 96.2;RPTEC TERT1: 30.5;RT4: 88.8;WM-115: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019675 Uncertain NA NA "HPA019675: AB_2670225" "unprognostic (1.78e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (1.88e-3)" "unprognostic (1.92e-4)" "unprognostic (2.14e-3)" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (1.55e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.07e-7)" "unprognostic (1.11e-2)" "unprognostic (7.61e-2)" "unprognostic (6.30e-2)" "unprognostic (5.30e-3)" 0.7 35.3 2.5 1.8 2.7 0.0 8.0 2.2 2.7 0.6 1.0 22.0 62.6 0.1 0.5 4.7 1.0 33.4 0.3 2.8 4.2 31.8 125.6 14.9 0.2 3.0 2.5 2.5 2.0 16.5 0.7 6.6 11.1 2.9 2.8 19.8 0.1 28.9 2.1 9.0 7.0 61.3 0.6 1.9 0.1 47.3 0.6 4.0 2.8 29.7 4.1 0.2 20.1 2.0 3.7 11.1 0.0 0.0 0.0 3.4 1.8 41.9 0.1 0.3 0.0 0.0 18.8 35.0 0.0 0.0 0.6 0.4 13.3 0.1 0.0 0.0 0.0 20.6 0.0 0.3 30.6 0.0 0.0 0.0 0.1 14.4 0.0 0.1 2.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.4 96.2 0.3 0.0 0.1 0.1 30.5 88.8 0.2 0.0 0.0 2.3 2.2 0.3 2.3 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 15.1 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.7 2.2 2.7 2.8 4.2 3.0 2.5 2.5 2.9 1.9 4.0 3.7 0.1 67.3 19.6 6.2 0.5 6.8 6.6 13.1 10.2 0.0 9.7 4.2 0.5 50.1 15.0 33.1 0.0 23.4 0.1 49.3 0.0 14.7 0.1 0.0 0.0 0.3 24.7 2.7 17.9 15.6 3.3 0.3 54.6 0.0 0.0 0.1 1.8 76.9 1.9 0.0 19.6 33.3 2.0 2.7 0.4 0.2 0.0 0.4 3.6 3.7 0.0 0.0 0.0 25.1 13.8 25.6 23.6 0.0 0.0 1.9 85.4 25.3 8.7 0.0 0.0 0.0 1.3 0.0 2.0 11.5 5.3 16.6 0.2 0.5 28.7 8.5 TBC1D8B "FLJ20298, GRAMD8B, RP11-321G1.1" ENSG00000133138 "TBC1 domain family member 8B" Q0IIM8 X 106802673-106876150 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 230.8;Alveolar cells type 2: 234.5;Club cells: 92.9;granulocytes: 113.0;Respiratory ciliated cells: 108.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023883, HPA027527" Enhanced Approved Cytosol NA NA Cytosol "HPA023883: AB_1857794, HPA027527: AB_2199395" "unprognostic (6.69e-2)" "unprognostic (1.06e-1)" "unprognostic (8.19e-2)" "unprognostic (4.69e-3)" "unprognostic (8.15e-2)" "unprognostic (6.97e-2)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (4.89e-2)" "unprognostic (3.32e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-1)" "unprognostic (9.97e-2)" "unprognostic (5.16e-2)" 4.5 19.8 6.7 4.2 12.7 5.2 4.7 15.8 21.1 7.0 13.0 6.4 7.9 5.4 10.0 3.0 4.0 7.0 3.4 8.9 7.1 8.4 12.1 4.5 2.7 4.7 6.5 7.5 6.4 9.1 8.7 6.4 4.5 8.7 6.9 7.4 9.6 7.8 6.4 3.1 4.2 9.6 5.1 0.5 3.2 11.1 8.5 3.4 1.7 8.9 1.6 2.0 4.5 2.5 25.1 14.7 4.6 1.8 7.1 21.9 30.9 7.9 16.3 16.9 2.8 8.5 8.1 12.6 5.1 12.9 16.6 11.6 7.6 5.9 8.2 7.2 2.5 6.5 7.1 6.4 7.7 5.7 1.8 2.6 13.7 6.5 6.0 2.9 17.2 7.9 4.1 2.4 8.3 10.0 7.4 4.6 2.7 9.2 21.6 7.3 2.0 3.9 2.1 7.9 10.7 3.3 2.7 13.4 9.7 6.0 9.1 11.0 2.2 10.0 10.4 11.2 13.9 6.0 7.6 8.4 1.3 20.2 1.5 13.1 2.1 0.8 0.4 0.7 0.4 0.5 0.7 0.6 0.5 0.2 1.4 0.4 0.5 1.9 0.5 0.4 1.0 0.2 0.1 6.7 12.7 15.8 21.1 8.9 7.1 4.7 6.5 7.5 8.7 0.5 3.4 25.1 7.0 230.8 234.5 1.0 2.2 2.4 7.8 8.4 7.4 4.1 6.9 3.3 2.6 4.3 92.9 7.3 4.2 2.8 0.6 9.5 7.9 8.8 0.9 4.9 12.5 19.2 4.8 1.3 8.3 9.3 3.0 25.2 21.9 6.8 113.0 4.8 3.3 13.5 1.7 0.0 7.5 15.1 6.1 2.2 0.4 2.2 9.0 12.7 3.6 14.0 1.0 1.8 1.0 13.6 25.4 6.1 9.2 8.6 0.2 8.0 14.0 12.1 108.3 3.6 0.0 8.3 5.7 3.6 3.2 3.5 1.4 2.6 9.4 31.4 10.1 10.3 TCEAL4 "FLJ21174, WEX7" ENSG00000133142 "Transcription elongation factor A like 4" Q96EI5 X 103576231-103587729 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Leydig cells: 1524.1;Peritubular cells: 1785.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.21e-1)" "unprognostic (2.21e-1)" "unprognostic (6.17e-3)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.08e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (4.16e-1)" "unprognostic (2.02e-2)" "unprognostic (7.49e-2)" "unprognostic (3.35e-2)" "unprognostic (5.46e-2)" "unprognostic (7.63e-2)" 158.3 215.0 175.4 44.7 175.0 28.4 157.5 171.2 206.6 498.3 211.9 167.7 32.7 718.5 253.6 114.7 431.7 87.6 153.6 175.0 171.6 144.6 112.3 168.7 30.7 182.1 175.5 169.1 863.0 98.9 135.7 181.8 113.1 182.8 321.1 50.0 78.2 89.7 265.1 96.8 142.5 112.8 279.9 175.3 126.7 160.6 119.9 176.0 31.0 136.0 82.2 30.5 427.1 281.3 187.9 153.8 115.2 96.1 85.7 330.5 196.1 96.4 165.0 165.3 101.5 118.2 49.6 112.0 37.9 178.5 181.5 242.6 96.8 107.3 120.2 122.9 0.6 72.4 51.7 179.9 65.0 291.9 0.4 41.2 262.6 182.4 84.5 193.7 253.3 149.2 52.7 0.7 39.9 303.9 376.5 56.5 2.8 87.6 3.6 136.8 55.5 162.8 7.5 155.3 186.4 97.3 95.6 265.4 64.1 224.0 112.0 102.3 25.1 185.3 100.6 39.8 257.3 68.9 11.7 71.7 1.7 138.7 0.7 104.6 12.3 28.5 1.0 12.8 15.3 18.4 36.4 17.5 13.7 37.7 22.8 15.9 16.8 1.1 24.7 11.9 11.8 57.0 13.6 175.4 175.0 171.2 206.6 175.0 171.6 182.1 175.5 169.1 182.8 175.3 176.0 187.9 131.6 112.2 159.1 20.9 28.8 130.0 305.9 170.2 117.3 88.5 169.2 191.4 278.7 114.4 130.8 198.6 14.6 222.8 11.7 19.6 385.4 156.6 11.7 117.0 459.5 143.2 104.2 28.6 19.5 95.2 331.5 202.4 46.4 178.9 116.9 167.0 231.0 218.6 148.4 90.9 21.1 44.9 91.6 61.7 80.5 65.2 1524.1 69.9 104.9 11.2 82.3 201.9 4.1 26.2 31.9 68.7 33.7 1785.5 23.3 195.5 7.6 297.2 81.0 60.5 361.6 120.3 192.8 34.8 58.5 91.1 104.3 94.3 29.7 144.7 39.4 135.8 BEX1 ENSG00000133169 "Brain expressed X-linked 1" Q9HBH7 X 103062651-103064171 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 384.5;pituitary gland: 402.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 354.2;Granulosa cells: 260.7;Horizontal cells: 363.4;Muller glia cells: 716.1;Rod photoreceptor cells: 142.2" "Cancer enhanced" "Detected in many" "glioma: 111.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 607.0;HBF TERT88: 680.4;HL-60: 1562.2;hTERT-RPE1: 1044.5;SCLC-21H: 465.3;U-937: 484.1" "HPA045384, HPA078630" Approved Approved Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "prognostic favorable (6.43e-4)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (2.94e-2)" "unprognostic (1.66e-1)" "unprognostic (7.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-2)" "unprognostic (5.28e-3)" "unprognostic (2.09e-1)" "prognostic favorable (8.16e-8)" "unprognostic (1.14e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.34e-2)" 1.4 84.6 244.1 3.8 275.1 43.1 2.5 215.1 301.7 4.7 155.9 8.3 5.0 15.7 56.0 0.8 21.6 1.3 11.9 276.0 384.5 8.4 4.2 2.8 1.2 237.9 252.8 275.4 20.4 72.2 112.9 402.3 0.4 250.5 6.7 4.4 174.5 2.3 3.6 0.6 0.8 6.4 4.8 206.5 2.5 8.6 93.6 261.7 3.6 26.2 0.8 0.4 0.8 2.9 284.1 0.7 0.0 37.6 0.1 0.0 0.1 1.1 21.6 0.0 412.1 607.0 0.0 0.1 0.1 0.8 158.1 130.0 0.4 0.0 0.5 680.4 0.2 1.2 129.2 0.0 85.2 6.9 1562.2 2.6 9.2 0.0 89.3 0.1 1044.5 0.1 120.8 0.2 0.2 84.6 0.0 294.7 0.2 337.9 97.8 62.0 0.2 0.7 7.6 0.0 0.3 465.3 266.6 0.5 0.6 1.9 5.9 0.3 432.4 0.0 0.1 140.2 1.1 16.7 71.9 2.9 0.7 54.4 484.1 27.2 0.4 0.2 3.4 0.3 0.0 0.3 0.5 0.9 0.5 0.0 1.0 1.4 0.6 0.5 0.9 0.2 0.1 0.4 0.7 244.1 275.1 215.1 301.7 276.0 384.5 237.9 252.8 275.4 250.5 206.5 261.7 284.1 1.1 0.0 0.5 16.3 1.2 8.7 11.1 0.0 1.2 354.2 7.2 32.5 9.6 31.5 0.7 5.5 39.6 0.2 0.2 0.4 72.4 6.1 12.1 1.4 0.6 5.3 79.6 0.8 64.6 13.8 0.2 3.9 8.2 2.8 0.0 260.7 30.4 1.2 1.4 363.4 56.1 6.9 10.2 4.0 1.2 31.8 8.1 2.2 7.2 12.2 1.5 716.1 0.0 32.6 20.9 6.3 3.3 2.6 0.0 7.5 0.8 19.5 0.0 142.2 0.0 15.9 14.4 38.5 13.8 0.0 6.5 0.5 2.0 0.2 3.5 1.7 FAM104A FLJ14775 ENSG00000133193 "Family with sequence similarity 104 member A" Q969W3 17 73207353-73236753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 45.1;testis: 154.2" "Group enriched" "Detected in all" 4 "Early spermatids: 1305.1;Late spermatids: 1771.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021459, HPA079514" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021459: AB_1848361, HPA079514: " "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-3)" "unprognostic (3.23e-2)" "unprognostic (2.28e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (2.12e-7)" "unprognostic (5.19e-2)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (4.20e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.26e-10)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" 15.7 11.8 13.0 14.2 12.9 45.1 15.4 17.0 14.1 14.5 11.4 14.8 12.7 11.8 12.6 18.0 11.2 10.5 11.8 12.9 12.3 10.5 14.0 13.0 18.0 12.0 11.9 11.9 12.3 15.1 12.3 16.2 17.9 13.1 14.2 12.5 14.1 12.4 11.2 17.2 21.4 12.9 11.3 11.6 17.1 21.9 154.2 12.3 21.0 11.9 12.1 17.1 13.5 14.9 13.6 41.8 33.5 16.7 31.0 24.7 23.1 54.1 33.4 34.7 35.9 36.9 28.3 26.3 24.3 26.7 32.2 35.0 26.0 21.4 24.3 38.7 28.6 28.7 35.4 29.1 43.5 32.9 31.1 58.1 24.6 31.6 31.9 23.2 23.7 42.6 28.8 28.0 39.6 43.6 28.5 55.7 21.5 22.9 30.7 42.5 30.1 46.3 23.5 27.6 33.7 27.3 36.1 19.6 28.2 36.7 31.0 39.4 31.8 29.8 42.3 49.1 29.1 39.4 38.5 41.5 29.8 37.9 33.7 31.9 72.4 49.4 87.7 57.1 44.6 55.5 53.5 69.6 65.7 48.8 55.8 50.1 60.9 81.9 68.9 49.8 31.7 128.5 82.5 13.0 12.9 17.0 14.1 12.9 12.3 12.0 11.9 11.9 13.1 11.6 12.3 13.6 37.1 9.6 10.2 7.5 24.2 57.0 20.7 42.3 17.6 17.7 22.5 21.1 5.6 22.8 26.9 22.0 6.2 122.3 23.0 20.8 31.3 32.7 1305.1 21.9 16.0 23.9 19.8 103.6 14.2 25.3 70.1 19.4 28.5 24.6 29.2 20.4 18.2 18.5 35.6 26.9 14.1 22.9 26.4 21.8 34.2 1771.9 35.1 25.5 24.9 10.3 32.2 20.2 33.0 10.6 11.3 32.1 20.1 24.0 30.4 32.8 26.4 18.9 27.4 19.7 6.6 14.8 43.7 277.3 60.7 29.9 65.8 324.9 32.7 21.3 20.7 51.8 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 205.3;Excitatory neurons: 107.7;Oligodendrocytes: 360.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 217.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm NA NA Nucleoplasm "HPA021455: AB_2670710" "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 12.8 7.8 13.4 10.9 25.1 21.4 17.6 22.8 16.2 15.0 9.6 24.3 20.5 5.5 15.9 15.6 9.2 11.1 4.9 14.3 16.4 13.5 39.7 11.0 8.9 25.7 23.7 9.5 3.4 29.5 4.8 2.9 8.8 22.7 7.7 24.3 2.3 30.6 8.1 4.5 12.8 23.0 7.4 19.5 8.0 48.6 6.9 23.7 5.6 36.4 3.6 12.5 12.6 9.4 35.3 20.5 36.8 4.3 17.2 30.7 24.8 24.4 21.6 19.0 9.7 13.0 13.7 90.7 25.4 21.5 22.1 15.4 17.2 6.2 10.9 14.8 27.6 12.8 23.8 9.9 16.3 18.3 25.4 217.5 21.2 20.3 20.1 11.6 10.6 10.1 13.1 12.6 31.0 12.4 28.9 16.3 55.1 3.5 62.4 15.6 10.9 16.3 21.5 16.0 20.9 10.2 13.8 11.6 84.7 12.7 16.8 58.4 34.9 8.5 19.0 17.7 16.3 13.4 24.9 12.2 17.9 30.8 50.6 11.1 19.3 39.9 26.0 16.7 40.4 10.9 16.7 12.5 12.5 37.9 9.8 8.8 12.1 6.6 22.6 33.1 26.8 17.1 18.1 13.4 25.1 22.8 16.2 14.3 16.4 25.7 23.7 9.5 22.7 19.5 23.7 35.3 4.9 0.0 6.3 205.3 7.6 4.5 5.3 5.6 10.2 2.6 13.7 5.5 2.3 4.3 8.6 3.7 0.0 5.6 6.9 15.8 0.0 9.4 18.5 5.6 3.6 4.0 8.4 9.9 107.7 14.1 17.4 4.7 29.0 9.5 29.9 7.9 3.6 30.1 26.3 5.0 32.1 79.0 10.2 21.0 5.6 66.7 4.1 14.4 10.6 64.6 19.6 4.1 8.2 22.6 360.3 9.1 20.5 3.4 15.1 6.0 24.8 11.5 7.8 1.6 13.1 2.6 7.1 2.0 2.9 10.3 4.4 4.9 5.4 4.4 18.3 7.5 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.5" "Cell type enhanced" "Detected in many" "Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" No No 380000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: AB_2686360" "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favorable (4.98e-4)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.2 1.6 1.7 9.3 3.3 0.5 1.6 3.6 5.0 2.6 0.0 22.8 21.2 1.8 1.9 0.6 4.4 3.7 2.0 2.4 4.7 1.9 0.4 1.8 2.9 4.9 4.1 1.3 10.6 3.9 6.1 3.0 4.1 4.4 2.0 23.5 3.0 1.6 3.1 0.2 0.8 22.0 3.4 3.6 2.4 1.7 1.8 4.3 1.2 7.4 0.3 1.7 4.5 1.0 8.2 43.4 17.2 17.2 27.7 1.6 1.5 0.0 10.0 0.5 27.3 5.7 6.3 16.6 0.6 20.2 4.0 86.5 39.6 10.8 52.8 7.7 0.1 4.1 0.0 1.9 0.1 16.5 0.0 4.3 5.3 17.5 48.7 0.3 25.4 74.2 2.4 1.8 0.1 5.7 6.4 1.1 0.3 4.0 49.0 11.2 5.3 18.0 0.8 14.7 4.0 18.0 19.3 17.4 0.7 0.2 1.5 1.1 0.5 79.2 11.5 29.6 29.4 69.5 0.0 0.2 0.1 21.8 0.9 0.5 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 3.3 3.6 5.0 2.4 4.7 4.9 4.1 1.3 4.4 3.6 4.3 8.2 0.4 3.2 0.0 5.5 0.3 0.8 1.7 20.5 0.0 15.4 0.1 0.1 1.3 7.2 8.6 0.0 0.0 0.5 0.1 24.3 0.0 45.1 2.6 1.0 0.8 1.2 48.7 0.0 34.1 8.0 2.8 5.0 1.1 2.4 0.0 0.5 0.4 0.4 9.6 6.7 32.3 61.1 6.1 7.6 1.4 0.8 0.9 7.2 0.0 21.5 0.7 18.4 0.0 5.5 76.3 63.7 12.6 0.7 0.3 2.3 5.5 0.2 1.7 1.8 0.0 0.6 2.1 0.5 3.5 0.0 0.4 1.1 0.3 0.2 97.2 1.1 SRRM1 "MGC39488, POP101, SRM160" ENSG00000133226 "Serine and arginine repetitive matrix 1" Q8IYB3 1 24631716-24673281 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049941, HPA058612" Supported Enhanced "Nuclear speckles" NA NA 20000 "Nuclear speckles" "HPA049941: AB_2680962, HPA058612: AB_2683778" "unprognostic (3.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-1)" "unprognostic (1.49e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.83e-2)" "unprognostic (1.80e-3)" "unprognostic (2.38e-1)" "unprognostic (9.27e-2)" "unprognostic (5.08e-3)" "unprognostic (4.52e-2)" "unprognostic (4.50e-2)" "unprognostic (2.77e-2)" "unprognostic (1.88e-1)" "unprognostic (3.46e-1)" 40.9 33.0 30.9 31.0 35.1 69.5 45.6 38.7 35.3 62.6 35.6 44.9 27.9 51.1 84.5 37.8 58.9 23.1 38.9 30.2 32.2 30.1 32.4 40.5 40.6 35.0 34.1 30.3 79.9 36.0 26.4 37.9 33.6 36.6 54.0 27.2 52.9 40.9 32.2 52.4 54.9 43.6 30.8 30.5 46.1 37.1 39.6 33.2 31.7 40.1 21.7 37.3 41.9 50.7 48.4 52.4 40.4 79.2 74.2 44.4 46.0 78.0 57.7 40.5 59.1 67.4 45.2 88.1 115.0 36.6 50.4 39.2 66.0 82.1 58.2 78.4 39.2 54.3 89.9 83.3 53.0 30.7 101.3 58.5 30.6 34.9 48.4 68.1 66.4 53.7 55.2 92.8 65.5 61.5 44.1 96.3 69.6 139.4 42.9 29.0 89.4 63.3 58.0 52.4 51.6 49.3 43.0 63.5 54.5 45.5 59.8 49.3 50.7 56.7 54.2 53.2 71.4 62.5 54.7 46.0 138.3 58.4 122.4 61.0 32.3 18.1 20.9 21.6 23.3 26.7 19.9 20.4 21.3 20.7 20.0 18.6 21.6 23.2 29.7 27.5 16.8 16.5 16.9 30.9 35.1 38.7 35.3 30.2 32.2 35.0 34.1 30.3 36.6 30.5 33.2 48.4 231.5 157.0 165.3 67.9 266.8 302.3 280.8 194.6 271.5 178.4 164.6 188.0 154.8 128.7 172.7 121.4 118.9 152.1 315.1 146.5 199.6 174.1 330.2 211.3 247.6 170.7 118.4 230.1 53.6 147.2 170.0 177.2 142.2 260.0 241.0 148.6 140.7 225.6 149.5 124.5 56.7 174.4 120.1 178.7 311.3 134.1 167.7 205.3 154.7 45.9 286.6 187.1 256.4 58.8 173.2 147.5 149.1 150.8 236.8 329.8 141.8 198.4 145.5 186.9 138.1 252.3 220.3 219.4 223.3 282.5 295.4 241.2 288.6 135.9 194.3 308.9 BTBD2 ENSG00000133243 "BTB domain containing 2" Q9BX70 19 1985438-2034881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.77e-2)" "unprognostic (1.41e-2)" "unprognostic (2.79e-2)" "unprognostic (5.42e-3)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (7.27e-2)" "unprognostic (1.20e-1)" "unprognostic (5.89e-2)" "unprognostic (8.77e-3)" "unprognostic (4.34e-2)" "unprognostic (2.10e-1)" "unprognostic (1.50e-2)" "unprognostic (2.51e-1)" "unprognostic (3.36e-1)" "unprognostic (7.35e-2)" 40.3 40.2 50.9 27.8 52.5 25.4 38.5 21.9 99.7 46.2 11.0 46.2 38.0 48.3 12.2 56.4 44.0 25.1 44.6 61.6 31.0 41.1 35.0 28.1 27.4 33.4 34.5 52.6 61.6 44.3 19.4 36.9 23.4 41.4 43.2 15.3 17.1 38.3 22.0 74.8 49.9 36.5 17.2 23.9 32.8 41.7 16.7 42.3 23.7 34.0 29.6 12.7 46.7 44.0 41.1 91.1 68.3 54.2 91.7 62.8 83.4 52.5 46.7 47.0 39.4 35.6 33.3 56.5 64.4 56.3 62.8 19.4 81.7 31.8 35.2 23.5 58.6 51.8 28.5 44.5 67.7 49.3 20.6 36.0 64.3 38.0 17.9 41.3 66.3 42.3 56.1 32.7 97.0 25.7 80.6 85.4 25.4 77.9 54.2 55.7 93.5 17.5 72.2 24.0 99.7 83.4 105.2 47.3 72.8 62.1 22.7 60.6 69.0 59.7 49.8 16.7 87.8 27.9 43.8 51.1 34.4 70.6 40.4 63.2 5.0 3.6 2.9 2.7 1.5 1.4 2.0 1.9 1.9 2.4 1.9 1.9 1.4 0.7 0.7 0.9 1.3 3.2 2.4 50.9 52.5 21.9 99.7 61.6 31.0 33.4 34.5 52.6 41.4 23.9 42.3 41.1 18.2 0.0 3.6 14.4 9.5 7.0 5.9 7.8 5.7 19.2 21.5 27.9 5.6 11.5 4.9 20.2 2.1 11.9 9.5 26.8 7.9 9.2 0.8 11.5 27.6 9.2 13.8 2.1 14.0 16.1 13.8 13.9 19.9 20.2 3.8 48.8 12.5 10.6 12.4 25.2 17.6 25.4 8.2 16.7 8.0 1.8 15.2 12.4 3.6 4.7 11.0 14.6 2.1 9.0 11.9 13.6 19.4 13.2 4.4 7.0 30.3 17.7 3.0 12.6 6.6 16.3 10.4 1.0 5.1 16.3 11.8 8.6 9.0 21.2 29.4 7.2 PRAM1 PML-RAR ENSG00000133246 "PML-RARA regulated adaptor molecule 1" Q96QH2 19 8490056-8502640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 97.8" "Group enriched" "Detected in many" 4 "Hofbauer cells: 30.0;Kupffer cells: 71.5;Macrophages: 49.0;monocytes: 70.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 95.4;intermediate monocyte: 101.3;myeloid DC: 58.6;neutrophil: 54.0;non-classical monocyte: 121.4" "Group enriched" "Detected in many" 7 "dendritic cells: 58.6;granulocytes: 54.0;monocytes: 121.4" "Cell line enhanced" "Detected in some" "HL-60: 23.3;NB-4: 19.4;THP-1: 39.4;U-937: 127.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045236, HPA050161" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA045236: AB_2679267, HPA050161: AB_2681036" "unprognostic (1.68e-2)" "unprognostic (3.79e-3)" "unprognostic (1.15e-2)" "unprognostic (3.91e-3)" "unprognostic (1.25e-1)" "unprognostic (6.54e-3)" "unprognostic (3.36e-1)" "unprognostic (1.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.28e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.73e-1)" "unprognostic (2.15e-3)" "unprognostic (2.72e-1)" "unprognostic (6.12e-3)" 1.7 1.5 1.4 11.0 3.1 97.8 1.2 2.1 2.9 1.9 0.6 0.9 2.7 1.4 0.2 0.8 2.0 2.0 0.8 1.3 4.9 1.0 2.6 9.9 1.3 6.7 4.2 0.3 1.4 1.2 0.3 1.7 1.0 5.7 3.3 0.5 0.8 1.4 0.4 0.6 1.5 2.9 2.2 3.3 12.9 1.1 1.0 4.9 1.0 1.7 0.3 0.4 1.2 1.3 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 23.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.1 19.4 0.2 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.4 0.3 0.0 0.1 0.1 0.1 0.7 0.8 0.3 0.0 127.6 0.0 2.8 95.4 3.3 0.2 101.3 0.3 0.1 0.1 0.2 58.6 0.0 0.0 0.4 54.0 11.5 121.4 3.0 0.1 41.9 1.4 3.1 2.1 2.9 1.3 4.9 6.7 4.2 0.3 5.7 3.3 4.9 5.0 0.3 6.4 5.0 1.3 0.9 0.4 1.1 0.3 0.0 3.2 0.4 1.0 0.8 4.3 3.2 0.0 0.0 0.3 3.1 0.1 0.0 0.0 0.0 0.3 0.4 1.3 0.0 3.8 0.9 0.0 0.4 0.5 0.0 0.3 2.5 0.6 2.9 0.2 30.0 1.7 1.1 0.2 2.0 71.5 2.0 0.4 0.6 49.0 0.0 12.2 70.1 0.4 3.1 0.0 1.6 0.0 0.0 1.5 0.3 0.3 0.0 0.2 0.2 1.3 0.0 0.5 0.2 0.2 1.8 0.4 0.1 0.3 1.9 1.1 0.0 0.8 KMT5C "MGC2705, SUV420H2" ENSG00000133247 "Lysine methyltransferase 5C" Q86Y97 19 55339853-55348121 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 47.9;Cone photoreceptor cells: 50.1;Horizontal cells: 67.3;Rod photoreceptor cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 20.7;SCLC-21H: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052294 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052294: AB_2681788" "unprognostic (4.02e-2)" "unprognostic (3.45e-2)" "unprognostic (2.92e-3)" "unprognostic (6.77e-3)" "unprognostic (2.48e-1)" "unprognostic (8.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (8.69e-2)" "unprognostic (3.04e-1)" "unprognostic (9.48e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.05e-8)" "unprognostic (7.39e-2)" "unprognostic (2.96e-1)" "unprognostic (9.41e-2)" "unprognostic (2.39e-2)" 3.5 5.9 4.3 1.3 5.1 5.1 4.6 5.4 6.2 5.5 3.3 5.3 3.6 5.0 0.9 4.8 8.7 1.1 4.3 4.1 4.1 5.2 5.1 5.4 1.5 5.0 4.9 3.6 6.4 5.9 1.3 11.2 1.9 5.5 6.8 0.9 2.6 5.3 1.3 2.8 8.0 5.1 0.8 4.1 5.7 4.8 7.2 5.1 1.9 4.6 0.6 0.9 4.7 4.6 6.0 6.2 4.1 4.1 3.3 0.8 1.0 10.5 1.8 0.7 0.6 1.5 2.8 5.1 6.2 2.2 1.3 0.3 3.1 2.8 2.2 0.7 5.5 20.7 4.2 3.7 3.0 1.4 2.7 5.7 1.0 2.9 1.9 1.0 1.4 1.3 6.5 12.4 3.6 0.7 7.1 8.6 6.4 7.0 3.8 6.0 12.3 4.7 6.2 1.0 1.5 19.3 8.2 0.9 4.9 2.4 2.6 5.3 3.7 1.4 2.1 4.4 0.9 1.3 9.8 5.2 4.1 1.2 6.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 5.1 5.4 6.2 4.1 4.1 5.0 4.9 3.6 5.5 4.1 5.1 6.0 3.3 6.4 4.1 0.0 4.9 0.0 13.5 0.0 7.4 47.9 11.8 9.3 0.0 8.6 3.1 3.7 50.1 31.1 13.3 7.5 1.9 6.6 2.3 27.4 7.5 3.9 7.3 18.9 0.0 2.9 20.4 5.4 16.3 18.0 2.5 11.1 6.1 1.1 9.6 67.3 0.0 15.0 0.0 5.1 0.0 2.4 7.5 6.2 0.0 0.0 2.2 19.9 8.2 0.0 0.0 8.7 11.9 6.4 9.8 10.6 21.1 2.7 3.6 49.7 6.6 5.4 3.0 21.0 30.5 6.5 0.0 19.8 13.0 23.0 11.3 11.8 ZNF414 "MGC15716, Zfp414" ENSG00000133250 "Zinc finger protein 414" Q96IQ9 19 8509678-8514167 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 93.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 40.5" "Low region specificity" "Detected in all" HPA053769 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053769: AB_2682255" "unprognostic (7.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.26e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.45e-1)" "prognostic favorable (1.67e-6)" "unprognostic (1.21e-1)" "unprognostic (2.32e-1)" "unprognostic (6.42e-2)" "unprognostic (7.29e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.08e-1)" "unprognostic (2.07e-2)" "unprognostic (3.84e-1)" "unprognostic (1.94e-1)" "unprognostic (1.91e-1)" "prognostic favorable (8.71e-4)" 13.6 19.8 4.2 5.3 4.7 9.2 16.0 3.8 12.4 21.5 0.0 15.6 8.0 23.4 1.3 18.4 17.4 1.9 15.5 4.5 3.0 17.3 21.0 11.5 6.3 6.0 4.7 2.3 22.6 15.0 3.4 21.5 3.8 7.8 24.1 1.1 2.1 15.1 4.5 18.2 21.0 15.7 1.9 2.9 19.4 14.6 20.8 4.7 4.3 22.7 2.7 2.0 17.3 18.1 9.9 9.2 7.8 4.2 6.8 1.1 2.6 9.2 6.9 2.6 4.4 3.9 6.9 4.4 12.5 19.3 2.1 3.2 12.5 1.4 5.6 0.6 11.4 31.0 7.9 7.2 8.3 5.9 7.0 10.3 4.8 4.0 3.6 1.3 2.4 1.9 7.8 10.7 18.0 2.7 11.3 15.7 40.5 12.5 2.4 22.0 18.1 2.2 12.8 3.1 7.5 14.4 22.3 7.5 5.7 6.6 0.8 10.8 8.1 7.1 12.8 6.5 18.7 8.9 26.0 11.8 10.0 10.2 5.8 7.1 1.4 0.5 0.3 0.6 0.4 0.3 0.8 0.9 0.9 0.5 0.8 0.8 0.8 1.6 0.8 0.7 1.2 0.4 0.4 4.2 4.7 3.8 12.4 4.5 3.0 6.0 4.7 2.3 7.8 2.9 4.7 9.9 9.7 0.0 1.1 4.2 11.8 11.9 13.5 6.9 26.2 18.3 12.1 14.7 2.1 11.5 2.5 3.7 10.4 28.8 15.8 14.3 15.6 3.9 27.1 5.7 9.2 8.2 22.2 9.2 3.6 5.3 22.8 11.8 17.3 8.0 4.5 15.0 13.2 10.9 13.1 11.8 3.6 14.6 2.0 12.7 7.6 93.4 20.5 11.6 8.8 3.7 8.8 20.4 11.3 4.0 6.5 4.6 16.0 16.1 9.3 9.1 16.2 17.6 1.4 21.9 13.1 11.5 10.0 21.3 38.3 18.0 12.1 31.5 12.8 19.0 13.2 9.8 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625573-670782 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "retina: 388.3" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 460.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol NA NA Cytosol "HPA054148: AB_2682401, HPA059929: AB_2684166" "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favorable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.9 2.2 12.0 5.6 23.4 8.5 4.2 9.6 21.7 2.5 2.1 1.7 1.2 2.8 4.1 1.7 10.3 3.7 5.9 11.3 17.4 5.0 1.0 4.7 14.5 24.6 20.7 7.9 2.8 1.8 8.3 4.2 3.1 31.3 2.8 1.3 388.3 3.8 3.0 1.1 2.2 3.1 2.5 10.8 10.2 2.9 4.4 26.6 12.3 12.1 0.1 9.3 3.8 1.4 41.1 0.1 0.0 1.2 0.5 0.3 0.4 0.4 0.0 0.1 0.8 2.0 0.0 0.1 0.3 11.5 0.3 0.9 0.1 2.5 0.6 0.0 0.1 0.0 1.0 0.3 0.1 5.8 0.2 0.4 0.7 0.0 3.5 0.0 0.8 1.1 17.3 0.1 1.0 0.1 0.3 31.3 0.1 9.4 0.7 0.0 16.8 0.2 0.2 2.1 1.3 20.2 11.9 0.0 0.3 0.1 4.2 0.6 0.0 0.4 0.2 1.2 0.2 0.4 7.7 24.0 0.3 0.3 0.3 0.2 16.8 5.4 0.9 14.0 7.7 12.6 12.8 9.3 9.8 8.5 21.4 14.6 15.8 1.4 14.4 8.1 18.2 15.5 9.4 12.0 23.4 9.6 21.7 11.3 17.4 24.6 20.7 7.9 31.3 10.8 26.6 41.1 0.5 3.2 5.0 4.2 6.4 0.4 2.1 1.2 2.8 20.7 3.9 2.4 4.4 0.0 3.5 0.0 83.4 0.1 8.4 0.2 1.9 6.9 0.4 7.0 2.2 2.9 1.8 7.4 40.3 0.6 0.3 1.3 1.5 2.5 3.8 5.4 2.2 0.0 11.3 11.8 27.3 0.5 4.1 5.1 1.4 0.3 1.5 3.3 3.6 4.7 6.2 31.1 7.2 10.1 33.9 0.8 0.2 1.5 7.5 1.9 0.0 8.4 11.2 460.1 0.0 1.6 1.1 4.3 11.0 1.9 0.3 0.3 5.9 3.5 0.4 1.3 HSPBP1 FES1 ENSG00000133265 "HSPA (Hsp70) binding protein 1" Q9NZL4 19 55262223-55280381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 270.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005865, HPA070398, HPA071444" Supported Approved Vesicles,Centrosome,Cytosol NA NA 19000 Cytosol "Vesicles, Centrosome" "CAB005865: AB_304116, HPA070398: , HPA071444: AB_2686396" "unprognostic (3.07e-2)" "unprognostic (6.36e-2)" "unprognostic (5.41e-2)" "unprognostic (8.05e-2)" "unprognostic (9.24e-2)" "unprognostic (1.43e-1)" "unprognostic (3.71e-3)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (1.52e-1)" "unprognostic (6.20e-3)" "unprognostic (7.23e-2)" "unprognostic (4.28e-3)" "unprognostic (2.44e-2)" "unprognostic (2.62e-1)" "unprognostic (9.45e-2)" "unprognostic (2.14e-2)" 22.9 29.2 36.7 14.6 43.0 16.7 25.7 37.8 60.9 29.9 27.3 33.7 15.8 39.6 5.3 42.4 38.7 6.3 43.5 36.2 35.1 35.3 38.3 24.1 12.4 35.0 35.4 40.1 34.6 27.6 19.0 27.0 8.4 35.7 29.5 6.8 7.4 25.4 10.5 47.3 33.8 24.2 8.1 33.6 21.2 29.1 32.8 35.2 9.6 27.4 17.0 8.2 33.6 30.0 34.3 86.9 150.0 27.1 38.6 15.3 14.3 78.8 44.3 17.8 45.0 38.3 85.5 57.7 56.1 42.1 24.3 27.0 59.0 33.1 43.9 11.6 48.4 270.8 74.9 48.2 79.7 34.1 72.3 38.1 18.5 39.4 44.6 20.9 19.4 22.5 46.5 61.6 31.1 15.8 80.3 65.4 64.2 95.6 75.2 125.8 63.7 41.7 121.0 30.4 54.8 71.0 108.0 54.2 54.2 46.9 14.4 41.7 56.4 29.8 50.3 55.0 29.4 83.1 48.4 126.9 60.0 57.6 62.6 56.6 2.0 25.7 7.2 39.1 45.4 40.9 53.9 42.2 44.7 52.9 64.3 42.1 41.1 1.7 44.2 39.6 29.3 43.3 25.1 36.7 43.0 37.8 60.9 36.2 35.1 35.0 35.4 40.1 35.7 33.6 35.2 34.3 11.8 9.6 11.5 5.5 15.6 26.8 39.7 55.5 29.6 15.9 20.1 20.8 13.2 34.3 35.1 35.0 6.2 48.0 11.6 46.4 72.4 62.5 13.4 69.4 15.2 18.5 22.6 18.1 8.6 46.1 57.0 22.0 25.5 13.4 10.8 20.0 10.4 23.9 39.1 13.5 11.6 31.7 44.7 11.3 13.7 16.0 19.6 11.9 17.8 3.7 28.2 14.9 21.6 6.0 7.3 42.6 44.4 17.7 27.3 29.5 25.5 62.5 119.8 14.8 26.3 24.2 31.9 39.0 28.8 27.9 29.5 37.5 17.1 16.6 58.9 35.2 CSNK1G2 CK1g2 ENSG00000133275 "Casein kinase 1 gamma 2" P78368 19 1941172-1981338 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 254.8;Late spermatids: 613.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034868, HPA056572" Uncertain Approved Vesicles NA NA Vesicles "HPA034868: AB_10671235, HPA056572: AB_2683178" "unprognostic (2.00e-1)" "unprognostic (2.15e-1)" "unprognostic (1.83e-1)" "unprognostic (2.42e-3)" "unprognostic (6.51e-3)" "unprognostic (2.27e-3)" "unprognostic (1.14e-3)" "unprognostic (2.00e-1)" "unprognostic (9.42e-2)" "unprognostic (5.78e-2)" "unprognostic (4.83e-3)" "unprognostic (4.09e-3)" "unprognostic (7.95e-2)" "unprognostic (4.65e-3)" "unprognostic (5.09e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-2)" 37.2 53.1 18.4 40.9 17.6 47.8 38.6 20.6 28.3 34.8 15.3 34.4 29.8 34.8 6.6 51.0 36.0 20.8 33.0 20.3 15.3 43.0 41.9 54.0 42.1 19.2 18.2 16.8 39.9 40.1 13.4 51.9 17.8 17.7 41.6 8.8 9.9 38.4 14.1 39.7 44.4 47.3 10.4 11.2 69.7 35.8 100.7 18.4 23.8 36.1 12.4 18.8 32.6 38.1 17.1 71.2 37.3 51.0 80.1 17.5 32.6 42.7 43.1 28.0 32.0 39.1 31.0 37.8 44.3 35.2 27.6 17.8 50.1 27.6 52.5 14.0 40.5 60.4 31.2 65.0 52.9 28.2 50.7 76.3 32.5 33.8 33.4 21.3 24.7 38.4 54.2 67.1 146.5 21.4 41.3 101.0 66.8 92.7 19.7 41.8 86.8 32.3 72.7 24.3 73.2 81.9 67.4 32.2 52.7 48.2 18.8 33.6 81.8 46.6 40.2 31.5 85.3 50.6 94.8 54.5 55.5 40.7 47.6 42.8 2.8 3.6 4.7 4.2 5.8 3.0 3.4 3.1 3.6 3.6 3.3 2.4 3.4 10.0 3.5 14.4 5.4 2.4 2.4 18.4 17.6 20.6 28.3 20.3 15.3 19.2 18.2 16.8 17.7 11.2 18.4 17.1 37.5 16.0 17.9 10.1 36.5 21.9 17.8 14.9 10.8 43.6 28.9 26.8 14.2 10.0 14.9 11.0 41.7 12.2 91.7 36.9 9.8 17.1 254.8 37.7 32.5 24.7 30.5 12.6 10.8 29.5 18.9 21.6 31.1 32.4 29.9 41.8 16.8 16.4 14.9 25.2 9.8 26.6 6.1 21.9 30.3 613.6 20.5 32.3 14.2 14.0 16.4 21.6 41.2 5.5 6.2 30.1 24.0 18.8 38.2 28.8 15.0 14.6 22.8 39.3 13.1 26.4 23.0 16.0 13.2 19.0 25.3 18.2 46.2 51.7 24.8 32.8 SLF1 "ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121" ENSG00000133302 "SMC5-SMC6 complex localization factor 1" Q9BQI6 5 94618669-94739436 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 142.1;Spermatogonia: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HeLa: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040793, HPA054213" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040793: AB_10796560, HPA054213: AB_2682419" "unprognostic (7.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.44e-3)" "unprognostic (1.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-5)" "unprognostic (1.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (6.57e-6)" "unprognostic (3.27e-2)" "unprognostic (2.83e-1)" "unprognostic (1.77e-1)" "unprognostic (8.32e-2)" 1.6 1.5 1.7 1.9 1.8 3.4 1.9 4.6 2.6 1.3 0.2 1.9 2.1 1.7 0.9 1.4 2.2 2.1 2.3 1.3 1.4 1.8 1.5 1.5 3.3 0.6 0.8 1.8 2.8 2.2 1.3 0.6 1.6 1.4 1.3 2.4 1.9 0.8 1.1 0.9 3.5 2.3 1.5 0.2 2.4 1.2 7.8 0.9 3.5 1.8 1.4 2.6 1.2 0.6 2.0 5.3 6.8 9.4 8.9 3.0 3.5 6.0 7.9 4.0 9.1 12.5 3.6 7.1 8.2 5.3 2.3 11.2 7.0 7.8 6.5 12.0 2.9 6.2 5.3 54.2 3.2 0.9 2.9 5.9 1.8 1.8 8.1 3.5 3.0 3.7 4.9 6.2 5.0 7.8 4.6 8.1 3.7 10.0 3.0 3.6 4.9 10.8 9.1 2.8 3.8 9.4 9.6 9.7 4.1 3.4 7.3 5.5 8.1 2.7 4.3 5.9 6.1 10.7 3.7 8.3 6.7 6.5 8.1 8.8 1.1 1.3 0.8 1.7 1.0 0.9 2.3 2.6 3.3 0.8 3.6 1.2 1.6 7.3 1.1 0.9 1.3 1.7 0.7 1.7 1.8 4.6 2.6 1.3 1.4 0.6 0.8 1.8 1.4 0.2 0.9 2.0 16.1 3.2 6.4 0.0 18.2 0.0 4.7 0.0 4.6 25.3 8.9 9.5 0.0 2.8 7.4 5.5 27.1 15.0 17.3 5.3 1.9 8.1 9.1 30.6 10.5 9.5 2.4 28.0 0.0 7.0 14.8 8.3 8.6 5.5 15.2 19.9 11.4 5.6 7.8 20.2 0.0 4.4 0.0 6.0 0.0 7.4 5.6 10.8 0.0 0.0 10.8 8.1 20.6 0.0 0.0 8.9 4.5 6.0 14.0 2.3 31.4 10.3 20.4 37.3 0.0 11.6 7.0 142.1 111.1 7.0 0.0 6.2 34.5 12.3 8.1 3.2 CNDP2 "CN2, CPGL, FLJ10830, HsT2298, PEPA" ENSG00000133313 "Carnosine dipeptidase 2" Q96KP4 18 74495816-74523454 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 458.7;RPMI-8226: 616.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026196, HPA036898, HPA036899" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 2600000 "Nucleoplasm, Cytosol" "CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371" "unprognostic (2.81e-2)" "unprognostic (9.96e-2)" "unprognostic (3.28e-1)" "unprognostic (1.19e-3)" "unprognostic (2.57e-2)" "unprognostic (5.06e-2)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.49e-1)" "unprognostic (9.31e-2)" "unprognostic (1.56e-3)" "unprognostic (1.15e-1)" "prognostic favorable (3.50e-6)" "unprognostic (2.37e-3)" "unprognostic (4.65e-3)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" 51.7 41.1 130.7 75.7 152.0 25.3 61.0 146.0 158.1 138.0 121.6 84.4 191.8 44.7 123.8 79.0 142.1 95.3 51.4 128.3 143.3 330.4 263.2 83.0 87.0 147.2 144.1 123.9 34.7 101.5 58.9 48.3 76.1 148.8 123.6 80.3 42.5 57.9 102.7 26.8 44.9 257.1 38.3 147.7 138.1 104.5 21.1 143.7 53.0 160.5 22.6 82.9 95.3 47.8 164.6 64.6 85.0 60.5 57.4 72.2 42.5 252.3 66.0 61.7 88.3 87.4 49.6 67.1 80.3 81.4 72.1 69.0 95.0 92.7 124.9 62.7 121.3 36.7 80.2 42.1 79.6 104.6 158.7 119.3 64.5 93.9 76.4 136.6 50.1 78.3 94.6 86.3 458.7 59.1 71.6 84.9 75.6 91.0 42.4 50.3 91.3 69.4 616.6 346.1 264.1 65.3 34.2 51.6 360.2 91.6 143.0 151.5 64.0 82.5 93.9 79.5 21.2 45.2 85.5 380.6 108.1 63.6 113.8 80.2 37.1 115.4 49.0 77.6 166.3 84.4 102.4 61.6 72.2 185.1 110.5 65.5 72.4 15.9 124.6 174.1 161.3 94.5 135.7 130.7 152.0 146.0 158.1 128.3 143.3 147.2 144.1 123.9 148.8 147.7 143.7 164.6 39.2 73.7 62.7 16.6 55.7 9.2 40.3 48.6 12.5 33.6 76.5 36.4 26.9 77.2 56.8 119.5 16.7 157.9 47.8 99.0 187.9 168.1 3.3 187.7 49.7 49.6 65.3 23.3 8.8 154.7 130.9 23.5 63.7 334.7 12.0 34.0 40.0 119.8 216.3 43.7 10.8 82.9 75.3 122.9 24.9 4.1 18.6 79.0 17.8 13.1 90.8 86.6 55.6 15.6 51.7 108.9 103.5 16.6 44.4 65.2 629.1 487.6 73.3 31.6 13.1 15.2 22.3 8.3 7.2 27.1 9.7 109.0 38.2 32.8 99.8 53.8 MACROD1 LRP16 ENSG00000133315 "Mono-ADP ribosylhydrolase 1" Q9BQ69 11 63998558-64166113 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 292.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 137.0;Proximal tubular cells: 333.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 73.8;RPMI-8226: 145.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041031, HPA071075" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041031: AB_10794435, HPA071075: AB_2686341" "unprognostic (1.19e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (6.03e-2)" "unprognostic (1.95e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-1)" "prognostic favorable (4.68e-6)" "unprognostic (2.45e-2)" "unprognostic (9.92e-2)" "unprognostic (2.36e-1)" "unprognostic (2.86e-2)" 13.2 14.3 5.0 1.3 4.4 2.9 17.5 5.2 12.8 15.1 4.0 20.4 5.7 13.9 1.0 18.8 15.5 2.2 77.3 4.8 5.9 54.3 50.6 10.4 1.1 6.9 5.7 4.4 21.7 50.0 4.1 11.9 1.6 7.4 19.8 1.4 1.2 30.4 5.6 292.4 24.2 10.8 1.1 4.8 6.5 27.5 4.7 6.5 1.0 32.2 59.4 0.5 17.5 17.0 5.9 12.7 5.7 1.9 10.2 1.7 1.0 10.9 7.5 3.2 5.3 5.1 5.3 33.2 44.9 25.4 0.6 2.6 29.8 1.9 0.1 0.6 3.6 21.9 16.8 23.3 29.7 6.1 13.8 1.8 2.5 3.4 0.6 1.7 4.5 1.8 14.7 15.2 8.5 1.1 73.8 20.1 45.1 5.5 4.3 24.4 18.7 11.5 145.4 1.8 0.7 15.7 31.2 5.7 40.3 41.4 0.2 29.8 1.0 2.9 4.9 7.4 7.0 0.8 17.8 3.1 7.4 3.4 13.4 4.6 0.0 0.0 0.0 0.4 0.2 0.4 0.1 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 5.0 4.4 5.2 12.8 4.8 5.9 6.9 5.7 4.4 7.4 4.8 6.5 5.9 19.4 0.0 4.6 6.8 7.1 28.0 39.8 7.5 57.5 15.1 46.2 45.0 32.5 30.0 8.6 42.3 0.0 35.6 1.3 34.6 137.0 20.8 7.1 19.0 13.3 11.9 22.9 8.0 7.1 40.4 16.1 15.9 20.9 22.7 0.0 41.6 9.7 45.3 11.7 11.8 12.4 55.2 8.2 6.9 5.1 26.8 24.8 7.2 39.2 4.7 2.4 16.9 1.0 13.6 6.9 19.2 35.2 14.3 12.9 37.6 23.0 333.4 3.1 20.6 19.7 55.7 19.1 8.2 32.5 46.3 37.1 23.9 6.1 18.8 67.9 49.8 WDR74 "FLJ10439, Nsa1" ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 563.1;choroid plexus: 634.2" "Cell type enriched" "Detected in all" 5 "Early spermatids: 616.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 21.4 21.9 304.3 20.7 261.2 128.2 21.4 480.5 302.4 18.9 634.2 19.6 17.3 21.0 14.7 26.0 22.5 11.5 19.5 252.0 157.1 17.9 28.7 15.0 30.9 210.7 221.9 145.1 25.8 31.1 15.2 11.5 18.5 335.4 19.7 16.6 33.9 25.2 13.9 59.8 31.4 17.8 17.2 261.5 30.3 22.2 15.5 270.7 62.9 28.7 25.6 24.1 25.1 19.1 563.1 64.2 76.2 28.8 49.4 22.9 31.4 85.9 35.8 37.5 73.6 49.1 108.8 77.0 111.6 97.6 28.5 59.0 84.1 88.8 69.0 56.8 72.7 64.2 55.5 84.1 97.5 65.9 112.3 36.0 30.9 75.7 47.8 153.9 24.8 36.1 80.5 126.1 32.5 33.7 120.6 106.7 178.7 117.1 70.9 96.7 108.9 49.9 193.6 52.7 35.6 65.7 72.1 40.8 84.1 115.4 27.8 58.8 83.1 28.0 44.4 52.4 98.3 88.2 81.0 120.3 137.1 47.5 68.3 57.2 40.1 140.9 11.7 40.2 61.4 49.7 66.0 42.1 38.6 105.0 121.5 56.8 52.0 51.0 93.2 44.9 154.3 52.4 47.8 304.3 261.2 480.5 302.4 252.0 157.1 210.7 221.9 145.1 335.4 261.5 270.7 563.1 36.8 38.5 67.9 1.6 112.5 104.5 47.2 45.7 60.9 15.2 37.6 57.0 2.0 40.0 108.7 16.5 16.7 55.2 57.9 32.0 43.0 42.8 616.0 22.4 34.0 41.7 41.0 26.5 3.6 40.5 53.8 39.1 65.2 32.4 43.6 23.5 20.7 34.0 37.9 3.3 3.0 32.1 20.3 33.1 69.2 97.1 32.9 45.0 30.2 1.0 22.4 15.4 45.3 2.0 2.8 39.8 24.2 21.4 74.3 50.3 44.8 54.0 32.0 11.4 19.7 53.0 89.3 19.4 31.4 50.3 109.3 34.8 66.3 30.4 41.5 39.8 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506052-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 79.0;breast: 41.7" "Cell type enhanced" "Detected in some" "granulocytes: 17.8;Macrophages: 13.3;monocytes: 2.5;Muller glia cells: 3.9" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 20 "eosinophil: 554.9" "Lineage enriched" "Detected in many" 20 "granulocytes: 554.9" "Group enriched" "Detected in some" 14 "ASC diff: 28.9;HL-60: 53.0;NB-4: 109.4;U-937: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021124 Approved Cytosol NA NA Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 79.0 0.8 0.1 2.7 0.2 18.5 41.7 0.1 0.2 0.1 0.4 0.8 0.5 0.2 0.0 0.2 1.0 1.7 2.1 0.1 0.2 0.3 0.3 1.0 0.1 0.2 0.2 0.1 0.2 0.6 0.0 0.0 0.1 0.2 0.4 0.6 1.9 4.5 0.7 0.5 0.9 2.1 1.0 0.2 1.1 0.9 0.0 0.2 0.3 0.7 1.5 0.0 1.1 0.3 0.2 0.0 0.0 0.0 0.0 28.9 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.8 53.0 3.3 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 109.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 112.2 0.0 15.5 28.1 554.9 0.2 3.3 0.2 0.0 0.0 0.0 7.5 0.1 0.1 0.1 5.7 0.2 0.5 0.7 0.3 17.3 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 17.8 0.0 1.1 0.1 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 13.3 0.0 0.0 2.5 3.9 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 RTN3 "ASYIP, HAP, NSPL2, NSPLII, RTN3-A1" ENSG00000133318 "Reticulon 3" O95197 11 63681446-63759891 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 591.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1074.7" "Group enriched" "Detected in all" 6 "granulocytes: 1074.7;monocytes: 400.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015649, HPA015650" Enhanced Supported "Endoplasmic reticulum" NA NA 130000 "Endoplasmic reticulum" "HPA015649: AB_1856498, HPA015650: AB_1856499" "unprognostic (8.11e-3)" "unprognostic (8.51e-2)" "unprognostic (3.61e-2)" "unprognostic (7.88e-3)" "unprognostic (1.41e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (5.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.87e-4)" "unprognostic (1.60e-2)" "unprognostic (2.54e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-2)" 209.3 82.6 346.4 54.6 448.1 109.5 94.1 362.8 518.9 88.3 218.9 89.0 54.5 63.1 81.9 56.1 89.3 56.8 58.0 433.8 413.4 93.7 88.2 78.5 36.3 424.0 373.8 417.2 48.5 91.9 110.7 81.6 62.7 442.3 53.8 80.6 196.1 140.0 76.9 70.8 104.0 65.7 80.7 343.3 52.1 57.5 47.0 406.4 54.2 177.0 44.0 48.9 56.3 54.6 591.7 157.5 113.8 134.0 128.4 242.3 170.9 53.4 139.3 147.5 120.5 128.4 99.6 338.1 184.2 231.7 210.0 115.7 157.2 194.0 68.7 157.5 149.5 103.5 236.5 151.3 70.4 201.1 212.8 182.4 113.5 199.2 146.7 162.3 200.7 165.2 158.9 136.2 290.1 107.4 129.2 113.4 235.2 156.7 127.3 127.3 148.4 93.8 342.9 239.7 87.5 282.7 164.0 226.2 245.3 271.5 95.4 271.1 172.7 155.2 71.3 95.6 251.1 108.4 183.4 169.9 145.6 274.7 173.8 77.2 441.0 400.1 487.7 41.4 187.6 44.8 28.6 41.6 41.3 130.8 19.4 30.1 32.7 1074.7 41.7 240.4 79.0 68.6 323.0 346.4 448.1 362.8 518.9 433.8 413.4 424.0 373.8 417.2 442.3 343.3 406.4 591.7 62.8 134.6 67.5 110.7 35.9 144.5 103.5 63.0 101.3 157.7 125.2 59.9 36.1 81.5 91.9 244.6 70.9 68.6 55.6 118.2 29.4 154.4 35.8 96.4 74.3 68.1 99.8 85.8 398.8 117.1 105.6 96.7 60.1 129.2 77.3 71.4 85.6 81.3 143.7 82.4 372.7 83.5 122.1 178.3 110.8 71.2 79.2 151.4 113.8 100.2 178.0 150.3 42.2 200.6 294.8 103.3 82.0 89.9 94.8 79.4 94.5 55.9 156.0 97.6 78.9 53.1 78.6 194.7 133.5 85.9 146.2 86.5 48.8 51.7 96.5 99.8 PLAAT4 "HRASLS4, PLAAT-4, RARRES3, RIG1, TIG3" ENSG00000133321 "Phospholipase A and acyltransferase 4" Q9UL19 11 63536808-63546462 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 20.0;dendritic cells: 75.8;Extravillous trophoblasts: 19.0;Hofbauer cells: 26.6;Syncytiotrophoblasts: 30.1;T-cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 223.6;RPTEC TERT1: 114.4;SK-BR-3: 169.0;U-266/70: 81.7" NA NA "prognostic favorable (1.35e-5)" "prognostic favorable (4.00e-4)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "unprognostic (6.91e-2)" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (6.26e-6)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (3.42e-1)" "unprognostic (2.11e-1)" "unprognostic (9.36e-3)" "unprognostic (2.64e-1)" 33.3 18.9 80.9 53.4 81.0 20.9 103.5 76.2 122.9 46.9 78.7 50.6 88.5 28.8 62.8 19.3 99.9 52.7 18.0 80.4 93.7 199.9 112.0 108.8 99.0 93.8 78.4 78.7 59.0 14.2 2.5 24.4 17.0 82.4 57.7 57.6 12.6 84.4 74.3 14.4 8.5 102.7 43.8 78.7 73.7 65.3 7.8 88.8 80.1 46.7 16.2 56.6 56.0 25.9 87.5 22.2 14.0 0.0 0.6 19.8 68.5 5.0 2.0 37.2 28.1 25.2 0.4 223.6 3.5 18.7 3.9 22.9 5.2 5.2 4.1 5.9 37.8 0.0 1.4 1.3 0.0 78.4 0.7 0.9 79.0 0.5 10.5 0.2 60.1 3.4 7.8 0.0 27.5 4.1 0.0 55.3 4.7 0.3 4.0 1.9 24.2 0.1 1.7 114.4 4.8 0.3 0.1 4.8 169.0 9.5 1.2 20.3 1.6 6.5 2.0 0.2 4.1 0.8 81.7 1.2 0.9 8.5 13.6 1.5 258.1 80.6 53.6 426.8 114.5 328.6 81.5 323.4 454.2 48.9 61.4 282.7 370.3 57.1 256.5 96.5 5.8 278.2 563.0 80.9 81.0 76.2 122.9 80.4 93.7 93.8 78.4 78.7 82.4 78.7 88.8 87.5 12.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 20.0 75.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 19.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 30.1 12.6 0.0 0.0 0.0 PLAAT2 "FLJ20556, HRASLS2, PLAAT-2" ENSG00000133328 "Phospholipase A and acyltransferase 2" Q9NWW9 11 63552770-63563379 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 68.6" "Cell type enhanced" "Detected in single" "dendritic cells: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 17.3;naive B-cell: 8.2" "Lineage enriched" "Detected in many" 10 "B-cells: 17.3" "Cell line enriched" "Detected in some" 8 "U-266/70: 128.9" HPA058997 Approved Approved Mitochondria NA NA Mitochondria "HPA058997: AB_2683874" "unprognostic (4.76e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.3 0.0 0.8 0.8 0.8 0.1 9.2 0.6 0.9 0.9 0.5 8.6 68.6 0.3 1.2 1.5 4.7 0.7 0.2 0.6 0.7 8.6 4.6 3.6 0.3 0.7 0.7 0.6 0.2 0.0 0.0 0.2 0.2 0.8 0.4 13.8 0.1 0.9 0.5 0.0 0.3 42.9 0.3 0.7 0.7 12.5 0.5 0.7 0.3 1.0 0.0 0.4 1.3 0.2 1.0 0.4 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 0.1 0.3 15.6 0.0 0.9 0.0 0.4 1.0 0.6 0.2 0.1 0.2 0.0 0.1 1.0 0.1 0.2 0.0 0.1 0.1 1.2 0.3 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.3 0.1 8.7 1.9 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.1 4.0 0.0 0.1 2.2 0.1 0.0 0.0 0.0 0.1 0.0 128.9 16.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.9 17.3 0.2 1.0 0.1 8.2 0.2 0.7 0.1 1.6 0.0 0.9 0.0 3.9 0.8 0.8 0.6 0.9 0.6 0.7 0.7 0.7 0.6 0.8 0.7 0.7 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 MYH11 "SMHC, SMMHC" ENSG00000133392 "Myosin heavy chain 11" P35749 16 15703135-15857028 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2272.9;seminal vesicle: 1681.4;urinary bladder: 2065.2" "Group enriched" "Detected in many" 8 "Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6" "Group enriched" "Detected in many" 5 "prostate cancer: 173.2;stomach cancer: 125.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "midbrain: 39.8" "CAB002302, HPA014539, HPA015310" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 23000000 "Plasma membrane, Cytosol" "CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (4.18e-2)" "unprognostic (9.21e-3)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "prognostic favorable (1.10e-5)" "unprognostic (1.41e-2)" "unprognostic (1.87e-1)" "unprognostic (3.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-3)" "unprognostic (4.06e-2)" "unprognostic (9.53e-2)" "unprognostic (5.00e-2)" "unprognostic (5.45e-3)" 134.5 39.0 5.0 110.1 11.4 0.2 79.1 5.1 14.7 352.1 28.4 2272.9 96.2 1083.7 221.6 766.8 611.4 252.8 52.9 4.8 5.8 20.8 9.3 109.9 9.5 12.3 8.0 3.9 145.2 10.8 2.9 11.7 68.7 6.3 769.4 295.8 0.4 84.0 1681.4 41.5 55.4 491.6 1062.7 5.5 46.4 839.5 61.4 6.0 3.0 46.4 34.9 5.4 2065.2 316.9 6.8 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.9 0.0 0.2 0.2 7.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 5.0 11.4 5.1 14.7 4.8 5.8 12.3 8.0 3.9 6.3 5.5 6.0 6.8 7.6 0.0 1.8 0.0 4.4 13.3 2.1 1.7 5.7 2.7 5.3 122.3 40.5 0.0 1.9 0.0 8.4 0.3 3.4 0.4 0.0 0.2 50.2 4.7 19.5 12.8 1.2 0.8 0.8 0.4 0.3 22.2 0.0 3.4 0.0 27.3 6.4 0.1 1.1 0.0 5.2 0.5 0.0 2.2 17.3 46.2 42.9 2.8 12.4 15.9 3.7 0.3 3.1 1.5 10.7 0.4 0.2 1669.7 2.4 5.6 0.1 0.2 2.5 1.9 624.5 4.3 964.6 3.1 8.8 3.5 18.6 0.0 5.7 34.7 0.4 2.6 CEP20 "C16orf63, DKFZp686N1651, FLJ31153, FOPNL, FOR20, PHSECRG2" ENSG00000133393 "Centrosomal protein 20" Q96NB1 16 15865719-15888625 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 11.2;Cardiomyocytes: 28.2;Cytotrophoblasts: 40.4;Extravillous trophoblasts: 27.1;Hofbauer cells: 21.1;Syncytiotrophoblasts: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040599 Supported Supported Centrosome NA NA Centrosome "HPA040599: AB_10794036" "unprognostic (1.10e-1)" "unprognostic (6.29e-2)" "unprognostic (1.16e-3)" "unprognostic (7.16e-2)" "unprognostic (2.45e-1)" "unprognostic (3.77e-2)" "unprognostic (2.23e-2)" "unprognostic (6.01e-2)" "unprognostic (1.72e-1)" "unprognostic (4.92e-1)" "unprognostic (4.35e-2)" "unprognostic (4.78e-1)" "unprognostic (6.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (5.45e-3)" 16.1 19.2 10.1 12.9 10.5 14.2 19.3 10.4 15.4 16.3 10.9 14.9 13.1 13.9 1.3 27.8 15.1 14.0 16.2 10.4 11.4 17.5 19.2 13.7 24.4 10.5 10.4 9.6 18.9 18.3 8.5 14.4 9.8 11.2 15.7 13.9 10.6 14.3 11.2 46.0 17.0 12.5 8.1 10.7 13.5 15.5 31.7 12.1 15.9 32.8 5.8 15.9 17.7 17.5 12.9 43.1 45.6 16.0 3.6 35.4 43.2 2.5 23.7 26.7 23.6 27.6 24.4 6.1 31.1 30.2 6.9 43.9 33.5 39.8 3.7 49.4 33.2 29.5 4.5 10.2 12.0 29.7 9.3 34.3 4.0 53.4 5.8 36.8 7.4 39.9 70.8 85.0 5.6 7.1 33.2 28.0 34.7 38.8 29.8 3.8 6.9 37.3 4.1 3.6 13.1 14.4 1.4 2.1 30.6 51.1 33.0 4.5 5.5 14.0 4.9 3.7 47.4 83.5 11.3 38.2 53.1 42.6 72.0 36.4 38.1 14.4 7.3 12.6 15.0 16.8 15.9 15.4 15.4 16.1 15.9 16.1 14.7 4.2 19.2 13.3 18.3 16.7 14.7 10.1 10.5 10.4 15.4 10.4 11.4 10.5 10.4 9.6 11.2 10.7 12.1 12.9 11.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 40.4 8.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 27.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 29.0 1.3 0.0 0.0 0.0 MED10 "L6, MGC5309, NUT2, TRG20" ENSG00000133398 "Mediator complex subunit 10" Q9BTT4 5 6371874-6378571 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042795, HPA054188" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042795: AB_10796679, HPA054188: AB_2682410" "unprognostic (2.33e-3)" "unprognostic (3.31e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.65e-5)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (4.92e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.85e-2)" "unprognostic (3.78e-2)" "unprognostic (3.11e-1)" "unprognostic (2.14e-1)" 26.2 20.8 31.9 22.5 34.4 55.9 24.1 31.9 38.2 18.9 29.1 30.2 19.8 20.5 24.3 27.3 20.1 20.7 31.6 35.6 36.4 21.3 22.9 20.5 35.8 33.5 34.7 32.5 20.7 27.3 22.4 18.3 21.0 35.5 21.2 12.8 8.6 21.7 22.5 34.2 27.2 24.1 20.4 34.0 23.6 24.6 17.7 35.9 27.0 20.2 20.4 22.9 26.7 22.4 35.9 55.0 59.8 23.5 43.9 36.3 40.2 66.7 67.9 61.1 70.6 51.7 91.4 43.5 70.8 53.3 57.5 101.7 40.3 40.7 50.3 63.6 116.6 46.6 47.0 94.0 46.5 111.9 56.7 39.8 46.1 65.1 66.7 95.4 43.6 57.5 39.9 69.8 41.3 55.3 68.7 84.2 86.2 40.2 38.0 154.4 47.6 41.6 29.6 48.6 57.3 44.7 66.3 128.8 53.1 106.2 29.2 36.9 50.6 63.5 70.6 77.7 65.5 73.5 65.5 70.1 102.4 63.4 89.5 53.8 127.4 42.3 94.6 75.0 47.1 92.6 98.2 93.9 81.8 36.5 88.6 101.7 85.7 31.6 76.1 52.0 67.5 93.1 109.2 31.9 34.4 31.9 38.2 35.6 36.4 33.5 34.7 32.5 35.5 34.0 35.9 35.9 108.3 22.4 21.7 11.1 96.7 92.0 87.8 142.0 58.1 68.0 49.8 68.8 46.9 34.3 56.3 46.0 29.2 81.9 116.2 38.6 58.7 103.2 5.5 43.5 50.5 74.7 44.2 46.3 28.3 92.0 78.5 67.9 35.2 50.8 51.4 58.0 75.7 23.0 64.5 74.0 18.8 56.2 95.6 30.7 61.9 11.8 70.2 44.4 62.2 13.1 96.9 55.1 133.9 12.5 21.0 148.4 52.2 45.1 72.5 108.0 68.7 51.9 53.1 49.1 32.9 51.1 71.5 63.7 83.8 53.4 70.5 79.4 105.8 68.0 45.8 88.6 PDZD2 "KIAA0300, PDZK3" ENSG00000133401 "PDZ domain containing 2" O15018 5 31639131-32110932 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 232.9;Excitatory neurons: 313.2;Oligodendrocyte precursor cells: 745.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.1;EFO-21: 4.5;SiHa: 11.6;SK-BR-3: 10.6;T-47d: 5.5" "Low region specificity" "Detected in all" "CAB020784, HPA036503, HPA036504, HPA064387, HPA076072" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: " "unprognostic (3.65e-2)" "unprognostic (4.06e-2)" "unprognostic (6.63e-2)" "unprognostic (5.42e-5)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (3.38e-2)" "unprognostic (2.45e-2)" "unprognostic (1.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-3)" "unprognostic (4.13e-2)" "unprognostic (6.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.79e-1)" 16.6 0.9 4.4 0.7 20.2 0.1 5.1 0.8 10.0 2.2 8.9 1.1 0.5 2.5 1.9 5.4 2.2 0.9 18.9 4.2 3.1 8.3 0.1 9.1 0.3 7.9 4.6 2.4 14.6 1.2 0.6 1.8 11.0 11.5 1.6 0.7 14.9 1.6 1.9 2.5 10.2 0.7 2.4 0.3 0.2 1.7 5.7 2.8 2.6 1.0 4.8 1.7 0.6 2.1 2.3 0.1 0.0 3.1 0.1 0.0 0.0 8.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 4.5 0.0 1.2 4.3 1.7 0.9 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 2.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.7 0.0 0.0 0.0 3.5 0.0 0.1 0.7 11.6 10.6 0.0 2.6 5.5 0.0 0.0 0.0 2.2 0.0 0.5 0.0 0.0 2.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 20.2 0.8 10.0 4.2 3.1 7.9 4.6 2.4 11.5 0.3 2.8 2.3 26.2 44.8 38.6 39.2 0.2 16.8 4.4 14.0 13.6 7.0 10.6 6.9 53.9 0.0 9.3 5.5 98.0 25.5 1.9 0.1 0.0 0.2 232.9 9.7 16.9 14.7 0.0 1.3 313.2 0.2 3.4 8.6 7.7 33.2 1.3 18.7 5.7 0.2 2.2 15.2 113.2 0.0 4.1 0.3 3.1 55.2 7.5 1.0 7.2 87.1 0.2 6.4 0.0 745.0 104.7 3.5 0.0 10.5 0.1 3.5 0.0 8.2 2.8 62.1 46.0 7.3 13.4 12.3 3.8 15.1 18.5 21.1 1.3 46.8 0.0 1.8 MORC2 "AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1" ENSG00000133422 "MORC family CW-type zinc finger 2" Q9Y6X9 22 30925130-30968774 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 16.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000436, HPA077137" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000436: AB_1079404, HPA077137: " "unprognostic (3.43e-2)" "unprognostic (1.71e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-2)" "unprognostic (6.15e-2)" "unprognostic (3.56e-3)" "unprognostic (2.89e-3)" "unprognostic (4.63e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-1)" "unprognostic (5.46e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.54e-8)" "unprognostic (5.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.02e-2)" "unprognostic (6.66e-3)" 14.8 14.5 7.3 7.1 7.4 6.7 16.8 9.3 8.3 20.5 6.9 18.3 5.3 18.2 6.9 17.1 18.9 5.4 18.7 7.2 7.3 15.3 27.1 14.7 9.0 7.3 7.5 6.8 20.2 20.3 7.5 16.8 7.5 7.6 21.9 6.0 5.9 14.9 7.7 27.0 19.5 15.8 7.8 7.2 19.7 16.3 45.5 7.7 8.1 15.7 10.3 7.4 21.4 18.7 7.9 19.2 12.2 20.2 23.3 21.4 18.3 15.5 15.6 12.9 16.1 16.7 17.5 10.2 26.9 11.7 14.3 9.4 17.2 17.7 6.9 18.2 15.5 23.8 20.5 12.4 15.3 15.6 18.1 19.8 15.3 12.1 15.1 18.9 12.0 14.0 9.5 26.3 19.0 17.2 23.7 16.2 17.9 23.0 23.9 12.6 31.5 12.8 22.9 12.5 19.1 20.5 17.2 18.8 21.9 8.8 19.6 16.2 21.2 16.3 17.8 18.7 14.3 12.3 15.0 19.0 22.2 10.3 9.1 13.3 0.8 1.6 1.0 12.0 2.9 10.0 2.3 15.1 9.6 1.6 2.1 15.2 11.0 0.3 1.8 3.3 3.2 16.5 5.2 7.3 7.4 9.3 8.3 7.2 7.3 7.3 7.5 6.8 7.6 7.2 7.7 7.9 8.7 0.0 4.6 14.0 4.5 7.4 7.3 3.9 6.2 7.9 8.8 9.1 4.6 2.8 6.2 11.0 10.4 8.4 5.9 6.0 3.9 7.3 30.8 6.1 7.8 7.3 9.0 8.6 9.5 8.0 11.4 6.2 4.1 6.0 1.3 8.9 5.7 8.8 5.4 13.5 11.7 4.8 6.1 3.8 4.1 10.3 7.8 4.5 7.2 10.3 2.8 4.1 6.2 11.1 8.8 11.7 4.1 10.1 3.2 11.6 4.6 3.7 3.8 10.4 19.7 7.7 7.7 26.6 24.1 6.0 9.2 6.3 7.8 7.0 7.3 5.6 LARGE1 "KIAA0609, LARGE" ENSG00000133424 "LARGE xylosyl- and glucuronyltransferase 1" O95461 22 33162226-33922841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 8.5;Alveolar cells type 2: 8.2;Ductal cells: 7.1;Endometrial stromal cells: 10.5;Exocrine glandular cells: 7.9;Glandular and luminal cells: 8.6;Hofbauer cells: 6.0;Pancreatic endocrine cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (7.77e-3)" "unprognostic (3.79e-1)" "unprognostic (1.74e-3)" "unprognostic (1.63e-1)" "unprognostic (1.48e-2)" "unprognostic (4.90e-2)" "unprognostic (1.39e-2)" "unprognostic (5.21e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-2)" "unprognostic (1.35e-2)" "unprognostic (7.12e-3)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-3)" 10.5 10.2 10.9 6.0 25.0 0.4 9.2 4.5 34.2 15.0 16.3 21.8 9.3 22.6 8.2 6.7 13.7 9.0 45.4 45.5 7.0 7.2 8.2 6.6 5.1 7.0 4.5 24.5 21.0 8.4 6.1 7.5 4.2 7.9 15.4 8.8 13.4 5.9 25.0 49.9 7.7 11.5 15.8 0.1 5.8 16.9 7.7 5.6 2.1 5.4 27.7 5.1 21.8 11.6 17.3 4.1 12.3 19.5 8.4 3.2 0.6 7.4 14.1 7.1 2.7 0.0 2.6 0.4 19.5 2.4 14.0 4.6 1.6 11.6 0.0 0.1 0.3 9.8 0.0 0.0 13.1 4.1 0.1 2.0 1.8 0.9 0.2 0.0 0.0 0.1 0.2 0.2 2.7 3.2 16.5 0.1 9.5 7.7 16.3 0.4 10.6 20.2 3.5 2.5 18.1 7.0 2.4 8.4 11.4 13.6 13.7 16.4 0.6 0.1 8.8 13.8 5.2 3.7 21.3 23.4 0.4 16.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 10.9 25.0 4.5 34.2 45.5 7.0 7.0 4.5 24.5 7.9 0.1 5.6 17.3 8.5 0.0 8.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 4.2 4.2 0.0 0.0 2.5 1.8 0.0 0.3 0.9 0.0 0.0 7.1 0.0 5.7 10.5 1.9 0.0 0.0 0.0 7.9 0.7 2.9 0.0 8.6 1.3 3.9 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.4 0.0 0.0 2.0 1.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.8 1.2 0.0 0.0 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B" P0CG30 22 23957414-23961195 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 82.5;breast: 310.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Hepatocytes: 27.6;Muller glia cells: 20.9;Peritubular cells: 28.6;Skeletal myocytes: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 57.0;HHSteC: 81.9;SK-MEL-30: 60.3;T-47d: 64.8" HPA000750 Uncertain Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favorable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 12.0 82.5 23.7 4.4 23.4 0.0 310.9 24.1 27.2 15.1 21.7 14.0 1.4 15.7 12.1 24.9 16.2 5.6 21.0 23.0 26.3 15.3 39.8 18.7 1.8 24.7 23.9 22.9 22.7 26.3 6.4 26.2 4.4 24.2 41.0 1.9 3.8 12.6 10.5 16.6 48.2 8.4 11.9 23.7 10.3 24.0 5.6 25.6 1.9 18.7 41.4 1.6 12.2 14.2 24.8 17.0 0.8 0.0 57.0 1.0 1.1 2.4 8.0 4.7 11.5 11.9 24.8 0.2 0.0 12.9 20.2 29.7 24.5 0.0 25.5 5.2 0.0 2.2 0.9 33.6 4.0 81.9 0.1 9.1 33.4 4.0 33.2 6.7 32.6 9.6 0.0 0.0 0.0 6.9 0.3 0.0 0.0 0.2 0.9 12.5 0.0 42.4 0.1 26.0 0.0 1.1 23.8 8.2 0.2 60.3 0.2 64.8 0.9 32.0 9.9 6.5 1.3 6.4 0.0 0.0 0.1 6.1 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 23.4 24.1 27.2 23.0 26.3 24.7 23.9 22.9 24.2 23.7 25.6 24.8 8.1 3.2 3.6 1.3 0.9 0.0 8.6 0.0 2.8 3.9 9.4 17.9 0.2 7.2 1.3 0.0 0.0 1.6 0.1 0.0 29.4 7.9 0.6 1.3 11.8 7.1 1.2 5.3 2.4 9.1 3.5 7.6 1.1 2.9 1.3 2.2 18.5 27.6 10.5 0.0 2.1 0.4 0.0 3.8 0.0 1.5 9.9 1.5 0.0 0.0 3.2 20.9 0.0 2.0 0.7 4.2 0.0 28.6 0.7 7.9 0.0 5.7 0.0 2.8 6.6 26.7 9.6 0.4 0.7 0.9 0.0 1.8 0.2 0.4 0.1 3.8 MYO18B BK125H2.1 ENSG00000133454 "Myosin XVIIIB" Q8IUG5 22 25742144-26031045 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 99.1;skeletal muscle: 264.8;tongue: 56.1" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 95.5;Early spermatids: 61.4;Late spermatids: 37.3;Skeletal myocytes: 32.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.8" "Region enhanced" "Detected in some" "thalamus: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 10.6;REH: 15.0;RH-30: 30.5;U-2 OS: 13.2;U-266/70: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA000953 Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA000953: AB_1079440" "unprognostic (3.28e-2)" "unprognostic (1.79e-1)" "unprognostic (1.86e-2)" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-2)" "unprognostic (5.93e-4)" "unprognostic (2.46e-1)" "unprognostic (1.22e-1)" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (2.96e-3)" "unprognostic (3.93e-7)" "unprognostic (1.14e-1)" "unprognostic (3.12e-1)" "unprognostic (5.06e-2)" "unprognostic (1.65e-1)" 0.1 0.1 0.3 0.1 1.1 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 99.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.9 0.1 0.0 0.1 0.0 0.2 0.0 0.2 1.0 0.0 0.0 2.7 0.0 264.8 0.4 0.0 0.0 0.1 0.0 1.5 10.3 2.0 1.9 0.1 56.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 5.3 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.0 4.0 0.0 0.4 1.6 0.0 0.0 0.0 15.0 30.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.2 0.0 0.0 9.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.2 0.1 0.3 0.3 0.9 0.1 0.2 0.1 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.2 1.2 0.0 0.0 1.8 0.0 0.0 1.7 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 37.3 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.7 0.9 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 298.2;Rod photoreceptor cells: 188.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 9.2" "Low region specificity" "Detected in all" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA042960: AB_2678241, HPA071184: AB_2686355" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favorable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 2.2 6.3 3.9 1.7 3.8 1.1 3.3 5.4 4.7 3.8 3.2 4.6 1.2 3.5 3.1 1.6 3.7 1.3 8.6 3.5 4.3 16.5 5.1 2.3 2.7 3.8 3.8 4.0 5.0 13.0 6.2 13.3 2.7 4.3 5.2 2.0 19.7 4.0 2.9 6.3 2.3 4.6 1.8 2.9 4.3 4.5 3.3 3.9 0.7 7.2 1.9 2.3 4.3 2.2 4.7 2.2 1.0 1.2 5.7 1.2 2.5 0.6 1.3 1.6 1.4 0.9 1.3 1.5 2.7 0.7 1.7 1.2 1.7 2.4 0.8 0.7 2.0 2.2 1.3 2.5 2.0 1.8 1.3 1.4 1.0 2.4 2.0 1.7 6.3 0.5 2.1 0.5 6.4 0.7 2.2 0.3 0.5 2.1 1.3 1.6 3.7 0.2 3.1 4.3 0.6 3.2 1.8 0.6 9.2 2.2 1.5 4.8 0.7 0.4 0.5 0.9 0.5 0.6 5.5 1.6 2.6 1.1 0.9 1.4 0.4 0.1 0.4 0.2 0.3 0.1 0.6 0.2 0.2 0.0 0.5 0.4 0.2 0.2 0.3 0.2 1.4 0.0 0.1 3.9 3.8 5.4 4.7 3.5 4.3 3.8 3.8 4.0 4.3 2.9 3.9 4.7 2.9 19.2 15.0 14.4 23.4 3.2 9.3 4.4 8.6 56.0 15.0 13.5 31.2 7.2 5.6 25.8 298.2 9.8 15.5 5.7 13.7 4.9 8.4 4.8 8.2 4.4 10.8 5.0 21.6 5.6 9.8 8.3 5.1 5.3 2.5 19.5 6.1 7.3 5.8 37.0 30.0 5.8 10.2 4.8 4.6 10.4 9.3 4.3 3.6 4.7 4.2 16.4 10.3 8.0 14.2 2.7 2.7 9.8 15.2 7.3 3.7 24.7 6.3 188.8 0.0 11.8 7.5 4.2 5.7 5.3 3.1 20.0 8.3 28.3 7.5 6.0 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180166-37199385 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 32.0;placenta: 29.9" "Cell type enriched" "Detected in many" 11 "Extravillous trophoblasts: 398.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 114.2;RT4: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 4.6 6.8 4.7 6.7 4.5 1.6 4.0 4.4 5.4 9.5 4.4 4.7 1.6 32.0 1.4 2.7 7.0 8.9 3.3 4.4 4.3 5.9 13.2 5.2 5.1 5.0 5.0 4.1 5.5 3.5 2.2 2.5 29.9 5.4 6.8 3.6 0.5 3.2 2.9 1.5 4.8 5.4 8.3 4.5 6.5 3.5 6.3 4.9 2.5 3.8 0.7 2.3 5.7 4.4 6.4 17.7 20.5 10.7 3.6 1.8 21.3 32.6 3.4 6.8 2.8 2.0 3.8 24.7 0.1 14.1 6.0 1.5 34.9 0.4 8.4 1.2 4.9 2.6 2.8 8.3 3.8 7.1 0.1 2.3 29.2 4.9 2.3 0.6 7.3 25.5 0.8 0.1 7.7 1.1 114.2 0.0 0.5 7.1 2.5 0.3 0.2 0.1 2.8 24.5 50.7 1.8 14.6 1.0 19.7 2.8 5.5 7.0 0.5 9.4 1.1 5.6 0.4 0.1 15.5 0.4 0.1 2.1 2.0 3.2 0.4 0.1 0.5 0.2 0.2 0.2 0.2 0.4 0.3 0.1 0.7 0.9 0.7 0.5 1.5 0.1 0.3 1.4 0.3 4.7 4.5 4.4 5.4 4.4 4.3 5.0 5.0 4.1 5.4 4.5 4.9 6.4 3.2 0.0 0.0 13.7 2.9 1.5 2.1 1.9 0.6 1.0 8.6 4.2 1.8 1.5 2.2 1.8 0.0 8.1 1.5 7.9 1.9 3.4 2.0 4.8 30.8 6.8 0.0 0.8 3.3 1.1 398.9 7.6 2.0 9.6 1.3 19.8 10.0 7.2 9.3 0.0 4.3 3.1 0.0 1.9 1.4 8.9 0.6 1.2 5.4 3.7 1.1 4.5 1.0 4.0 7.8 2.7 2.8 0.4 3.4 0.8 2.0 1.6 2.7 0.9 0.0 2.2 7.5 7.2 4.5 1.0 0.3 34.5 3.1 7.6 4.4 1.5 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 8.7;thyroid gland: 8.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Early spermatids: 5.6;Late spermatids: 18.7;Proximal tubular cells: 3.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;HeLa: 3.5;Karpas-707: 1.3;U-2197: 8.9" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles NA NA Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.7 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.1 0.0 0.1 1.5 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.2 1.0 0.1 0.0 8.6 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.6 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.3 0.3 8.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.1 0.1 0.2 0.0 3.2 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994954-40043534 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.4;testis: 41.1" "Cell type enhanced" "Detected in many" "Late spermatids: 68.1;Proximal enterocytes: 39.9;Suprabasal keratinocytes: 34.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 12.1;HaCaT: 12.8;HBEC3-KT: 15.5;hTCEpi: 37.9;hTERT-HME1: 11.8;OE19: 17.6;RT4: 18.6;SCLC-21H: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: AB_2685313" "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favorable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favorable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.2 0.1 0.2 0.5 0.1 1.2 4.8 0.3 0.2 1.4 0.1 5.0 3.2 0.2 2.5 20.4 1.2 0.5 2.0 0.2 0.1 4.0 2.9 0.2 0.0 0.1 0.1 0.1 0.3 13.6 5.4 1.2 0.1 0.2 9.1 3.2 0.4 8.3 6.7 0.1 17.7 7.6 0.1 0.0 0.0 6.8 41.1 0.2 0.9 5.9 0.2 1.1 2.6 7.1 0.3 8.3 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 12.1 2.3 0.0 0.0 0.0 0.0 12.8 0.0 15.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 37.9 0.0 11.8 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.1 2.1 17.6 0.0 0.0 0.0 0.1 0.3 18.6 39.8 0.0 0.3 3.4 0.0 1.3 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.5 28.7 14.5 18.0 23.9 1.2 19.1 10.4 5.2 12.8 7.4 23.9 0.0 0.2 0.0 33.1 3.9 9.6 28.4 6.2 0.5 1.0 13.1 0.4 0.2 15.1 0.2 1.0 10.7 6.5 1.3 0.2 0.0 2.2 0.2 0.0 0.2 21.0 14.2 0.6 2.9 68.1 1.8 0.5 1.8 0.0 0.0 0.9 0.0 0.5 0.1 12.5 21.6 2.2 0.2 16.3 39.9 5.9 6.4 0.6 0.0 1.1 1.3 12.4 1.8 30.6 34.5 1.4 0.8 0.4 15.6 17.8 SEC14L4 "dJ130H16.5, TAP3" ENSG00000133488 "SEC14 like lipid binding 4" Q9UDX3 22 30488902-30505711 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.2;liver: 19.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 6.9;Cholangiocytes: 11.5;Erythroid cells: 26.5;Hepatocytes: 22.8" "Cancer enhanced" "Detected in many" "liver cancer: 4.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" "Cell line enriched" "Detected in some" 4 "BEWO: 37.7" "Region enhanced" "Detected in single" "thalamus: 1.2" HPA069748 Approved Centrosome NA NA 82000 Centrosome "HPA069748: AB_2686187" "unprognostic (6.98e-4)" "unprognostic (2.72e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.07e-2)" "unprognostic (9.88e-2)" "unprognostic (4.93e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (1.88e-2)" "unprognostic (8.87e-2)" "unprognostic (4.06e-8)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "unprognostic (5.98e-2)" 0.0 0.9 0.3 0.1 0.4 8.2 0.2 0.3 0.4 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.2 19.4 4.5 0.1 0.4 0.3 0.1 0.2 0.2 3.4 0.1 0.2 0.5 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.2 0.5 4.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.3 7.1 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.3 2.5 0.0 0.1 0.0 0.1 0.1 0.2 0.1 9.2 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.3 0.4 0.2 0.2 0.4 0.3 0.1 0.5 0.2 0.2 0.4 0.3 22.4 6.9 0.7 0.1 0.1 0.5 0.3 0.0 0.4 0.2 0.3 0.7 11.5 1.4 1.8 0.0 0.1 1.3 0.0 0.0 0.5 0.7 1.8 0.2 0.2 0.0 26.5 0.4 0.0 0.4 0.3 0.0 0.2 1.3 0.2 0.4 22.8 0.1 1.7 0.4 0.2 0.0 0.3 0.3 0.1 0.6 0.4 0.0 0.0 0.1 5.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 4.3 0.9 0.0 0.9 0.1 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 GIMAP6 "FLJ22690, IAN6" ENSG00000133561 "GTPase, IMAP family member 6" Q6P9H5 7 150625375-150632648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 95.3;Endothelial cells: 83.5;Hepatic stellate cells: 92.1;Kupffer cells: 75.2;monocytes: 37.4;NK-cells: 91.6;T-cells: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "monocytes: 75.1;NK-cells: 217.3;T-cells: 127.2" "Cell line enhanced" "Detected in some" "HMC-1: 18.4;HUVEC TERT2: 124.9;MOLT-4: 43.3;TIME: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026715, HPA050740" Approved NA NA "HPA026715: AB_1849675, HPA050740: AB_2797239" "unprognostic (8.58e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.22e-1)" "prognostic favorable (2.91e-4)" "prognostic favorable (1.56e-4)" "unprognostic (2.88e-2)" "unprognostic (8.75e-2)" "unprognostic (8.87e-2)" "unprognostic (4.68e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (2.75e-1)" "unprognostic (2.48e-2)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" 42.4 9.5 9.6 34.2 9.3 2.5 22.0 9.5 10.7 15.1 8.8 12.1 13.7 19.5 7.4 8.5 17.0 14.8 29.4 7.7 9.6 12.5 12.8 39.1 50.6 11.2 10.1 6.4 5.8 5.2 8.0 3.3 32.5 10.6 6.5 12.3 0.6 7.8 10.1 24.9 6.4 18.8 26.0 9.9 64.5 11.7 3.2 13.0 29.6 14.4 35.0 34.2 16.7 6.6 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 6.3 0.0 0.0 0.0 0.4 18.4 0.1 0.0 0.0 0.0 0.0 124.9 0.5 0.0 4.6 0.0 0.0 43.3 5.4 0.0 0.0 0.0 4.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.8 35.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 13.0 0.0 11.6 58.1 2.1 112.9 75.1 127.2 0.4 104.3 120.2 22.1 0.3 108.3 103.0 8.0 217.3 60.2 0.7 105.7 163.5 9.6 9.3 9.5 10.7 7.7 9.6 11.2 10.1 6.4 10.6 9.9 13.0 11.0 95.3 0.0 1.1 0.0 3.1 3.8 0.1 0.0 0.6 0.0 1.1 1.0 7.4 0.0 0.0 0.0 0.0 0.2 24.5 0.1 0.0 0.0 0.4 0.1 0.2 83.5 0.0 19.4 0.0 0.2 0.3 3.4 0.0 0.2 2.5 0.3 92.1 1.7 30.6 0.0 0.0 0.1 0.0 75.2 6.5 2.2 1.2 20.0 1.8 13.1 37.4 0.1 91.6 0.0 0.1 0.1 0.0 0.0 2.9 0.1 0.0 0.2 0.7 0.4 0.0 2.6 2.2 0.3 0.1 0.4 3.1 0.4 41.2 1.2 0.0 0.3 GIMAP4 "FLJ11110, HIMAP4, IAN1, IMAP4" ENSG00000133574 "GTPase, IMAP family member 4" Q9NUV9 7 150567369-150573953 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 128.7" "Cell type enhanced" "Detected in many" "Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 26 "HUVEC TERT2: 326.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019135, HPA019137, HPA027198" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599" "unprognostic (5.03e-2)" "unprognostic (3.30e-3)" "unprognostic (4.08e-2)" "prognostic favorable (7.63e-4)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" "unprognostic (7.00e-2)" "unprognostic (2.40e-2)" "unprognostic (1.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.65e-1)" "unprognostic (3.32e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-1)" 46.5 18.5 14.3 75.8 15.8 4.3 32.0 16.0 21.4 19.9 17.8 21.4 16.6 23.3 9.7 12.1 18.9 24.8 31.1 13.8 17.6 17.5 30.2 51.2 128.7 17.5 15.7 12.7 7.8 6.7 9.7 6.1 49.1 17.7 10.3 22.6 1.5 11.3 13.5 17.6 8.5 25.2 38.6 17.3 116.6 18.2 4.2 18.4 30.8 21.3 48.5 85.8 31.4 11.7 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 326.4 3.4 0.1 0.3 0.0 0.0 0.4 0.2 0.4 0.0 0.0 12.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.5 370.2 5.2 325.8 390.9 404.2 3.0 408.0 402.8 122.1 1.3 424.3 361.9 339.7 263.4 320.4 5.3 312.1 776.9 14.3 15.8 16.0 21.4 13.8 17.6 17.5 15.7 12.7 17.7 17.3 18.4 19.4 182.3 3.2 12.4 0.3 7.3 6.8 0.2 0.0 3.4 0.1 2.2 4.7 9.9 5.7 1.8 11.0 0.0 0.6 82.6 0.0 0.0 0.2 0.6 0.3 0.4 195.2 0.0 9.7 0.5 0.2 0.8 9.0 2.0 0.3 6.3 0.0 222.0 3.7 96.4 0.0 0.1 0.0 0.0 197.2 20.9 1.7 5.0 110.0 10.6 18.7 176.0 0.2 344.0 0.0 0.1 0.1 0.0 0.0 14.7 0.4 0.0 1.9 0.7 0.4 13.1 3.9 7.9 0.0 0.8 1.1 6.1 0.8 186.2 0.8 0.0 0.3 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140672945-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favorable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 10.3 9.2 24.0 10.3 23.8 8.9 11.4 23.5 26.1 11.3 16.4 13.0 7.5 9.7 9.0 17.6 16.1 8.3 10.3 23.5 23.6 11.2 13.4 10.9 14.9 28.3 24.9 23.1 11.9 14.6 19.7 12.9 11.3 26.0 13.3 11.0 6.4 15.7 10.8 14.2 26.1 11.1 9.0 26.1 12.4 13.3 6.6 24.7 12.5 12.9 8.5 14.2 12.0 13.8 29.6 32.6 23.2 5.6 24.9 19.3 21.5 31.7 16.5 20.0 17.2 11.2 21.7 22.5 42.4 24.0 11.7 39.4 26.3 27.5 19.0 5.1 31.3 26.1 9.2 8.8 11.1 26.5 6.2 21.8 17.7 56.8 9.9 13.5 17.3 14.8 30.9 16.1 20.9 6.1 41.0 46.4 15.3 8.2 27.0 23.1 36.3 0.3 21.0 9.9 34.9 20.6 14.5 22.7 32.7 23.3 10.1 29.2 12.2 15.6 21.3 7.3 35.0 32.0 14.2 23.2 32.4 31.3 23.9 25.7 0.0 3.0 3.0 4.2 4.1 4.0 7.0 3.8 4.3 4.8 3.0 5.8 3.7 0.1 4.4 2.6 10.1 5.4 2.0 24.0 23.8 23.5 26.1 23.5 23.6 28.3 24.9 23.1 26.0 26.1 24.7 29.6 9.0 9.6 3.6 2.3 9.8 12.4 21.3 4.4 5.7 11.4 15.3 11.7 6.4 7.2 3.5 9.2 0.0 32.9 17.8 15.0 5.9 6.3 37.9 5.6 3.4 8.8 16.8 12.2 6.5 7.5 20.2 6.2 5.1 9.3 11.4 98.0 7.1 9.9 31.5 11.8 6.7 13.5 6.1 11.4 16.1 16.4 3.4 14.3 3.6 6.5 8.4 13.3 9.2 8.0 10.8 6.1 15.8 13.5 5.1 19.6 8.3 5.7 4.8 5.9 0.0 9.5 7.2 7.0 6.4 7.3 13.9 33.8 9.6 14.9 14.0 21.2 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453033-140479536 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 328.0;Erythroid cells: 424.2;Late spermatids: 340.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 129.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 39.9 37.1 52.1 48.4 52.6 204.4 48.3 54.4 56.2 43.4 51.1 98.8 69.9 47.1 43.7 49.4 51.7 37.9 65.2 52.4 55.5 48.3 43.0 47.3 50.1 57.6 52.3 51.0 57.0 58.6 67.3 42.6 43.4 60.9 49.1 80.9 59.1 57.0 44.8 84.7 51.7 66.3 43.9 52.5 53.1 54.4 124.3 55.6 47.5 47.3 59.0 56.9 46.1 39.3 63.3 96.5 72.3 55.6 83.1 86.5 75.5 78.2 64.6 83.3 49.8 57.2 30.0 98.8 69.4 98.4 63.4 99.2 45.7 63.2 71.2 62.8 138.0 55.6 72.1 43.5 55.9 69.4 62.5 107.1 75.4 105.1 56.2 52.8 81.9 50.8 46.9 58.0 84.8 49.1 82.6 73.4 114.2 143.3 80.7 53.6 52.4 47.4 107.6 80.8 109.2 76.6 79.1 80.8 108.5 120.6 81.6 53.3 53.5 71.9 34.9 27.4 85.8 59.8 200.2 159.2 60.9 99.3 96.1 73.3 58.6 22.5 100.4 15.4 21.3 18.0 33.6 29.5 23.0 18.0 32.9 39.9 25.5 42.5 31.1 26.5 6.0 35.3 15.3 52.1 52.6 54.4 56.2 52.4 55.5 57.6 52.3 51.0 60.9 52.5 55.6 63.3 28.4 51.3 37.2 13.4 76.8 82.1 66.6 57.1 57.5 61.5 60.9 36.2 57.7 67.2 71.1 42.3 35.5 75.8 54.0 172.1 103.7 69.8 328.0 58.4 30.6 34.2 97.3 424.2 28.9 67.8 96.6 43.3 38.7 65.7 37.4 79.5 45.7 45.0 59.5 119.5 28.0 107.7 89.5 95.9 93.3 340.6 66.5 86.3 69.4 22.5 119.0 61.4 92.7 15.1 22.1 57.6 140.3 62.4 41.8 101.2 112.4 54.4 70.0 46.4 46.0 34.7 53.3 303.0 60.1 62.4 95.5 138.0 62.9 39.6 103.5 145.9 AGAP3 CENTG3 ENSG00000133612 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 3" Q96P47 7 151085831-151144436 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012883 Approved NA NA "HPA012883: AB_1846533" "unprognostic (3.63e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (4.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (7.30e-2)" "unprognostic (2.89e-2)" "unprognostic (3.15e-3)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (1.55e-2)" "unprognostic (9.50e-3)" 43.8 43.2 90.0 14.9 98.3 7.2 47.6 44.2 188.1 79.7 25.3 46.9 17.9 58.1 11.2 65.2 55.7 15.6 49.3 107.3 66.9 34.8 54.1 73.2 13.1 78.8 62.1 105.8 72.5 57.2 24.4 101.3 19.2 80.4 65.3 8.0 12.5 45.8 18.5 46.5 67.5 38.9 14.8 38.5 38.1 42.3 20.1 70.2 5.5 47.9 13.9 8.5 55.3 66.6 97.5 44.1 34.8 30.7 67.6 28.5 22.7 47.2 33.9 31.9 26.0 22.8 34.1 44.9 0.9 42.7 19.8 31.8 60.8 21.8 47.7 8.3 51.4 67.6 39.4 38.0 46.8 40.0 26.7 15.5 22.9 58.2 21.1 22.1 41.3 39.0 16.7 71.8 31.0 15.4 115.6 11.2 123.6 57.5 34.9 38.4 27.6 21.2 62.4 32.7 106.4 91.5 76.4 26.0 8.1 83.9 21.5 22.5 40.3 37.8 35.1 11.7 43.3 42.3 39.5 19.0 0.6 69.3 45.1 44.8 0.0 2.7 0.2 0.9 1.8 0.7 1.9 1.3 1.6 1.2 0.2 0.9 0.5 0.2 2.0 0.5 0.0 0.2 1.5 90.0 98.3 44.2 188.1 107.3 66.9 78.8 62.1 105.8 80.4 38.5 70.2 97.5 24.3 28.9 25.3 24.2 2.4 21.3 14.1 17.7 22.8 53.7 14.7 23.4 21.5 10.0 16.8 3.7 8.4 8.8 6.4 16.2 0.0 5.8 0.4 13.5 19.4 21.9 7.2 1.3 45.4 10.5 1.6 16.0 7.7 15.6 17.2 34.6 13.9 19.0 19.5 57.2 38.0 11.1 8.2 17.9 47.5 2.8 11.8 24.1 12.4 26.2 8.9 13.2 1.0 16.6 38.5 21.6 3.2 11.7 5.5 14.8 17.8 6.5 11.8 15.1 13.1 12.3 9.8 0.7 13.6 22.6 18.6 3.1 6.6 20.2 11.8 11.7 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 32.8" "Cell type enhanced" "Detected in many" "Muller glia cells: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: AB_2681129" "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 4.1 6.1 6.0 5.0 6.1 4.0 5.4 3.9 10.4 9.1 1.7 7.1 1.5 9.7 2.3 5.7 7.0 4.4 32.8 6.7 4.3 7.1 2.6 4.8 4.7 7.7 4.9 6.1 8.9 7.7 6.0 25.4 2.3 5.5 9.0 1.3 4.9 13.0 5.7 6.4 6.7 5.3 6.4 2.6 6.9 7.5 6.8 6.4 3.9 6.2 4.2 3.7 8.2 7.6 6.6 8.0 4.9 9.5 20.0 4.2 4.1 8.3 4.2 5.1 6.6 7.5 0.5 2.1 2.4 8.6 5.3 13.3 7.8 7.2 14.0 3.3 11.1 13.7 4.4 7.5 4.7 5.2 0.0 12.0 9.2 6.5 4.6 2.5 7.8 6.1 13.0 18.4 2.5 3.4 3.2 11.7 6.8 11.4 3.7 4.7 12.2 3.8 1.3 5.1 6.3 7.5 12.7 6.4 18.3 4.5 4.3 3.2 6.8 6.2 8.0 3.4 0.0 5.8 11.7 4.1 10.7 4.7 7.6 8.5 0.0 0.7 0.1 1.4 0.7 0.9 0.6 0.7 0.8 1.0 1.3 1.2 1.0 0.5 0.1 1.6 1.4 1.6 0.7 6.0 6.1 3.9 10.4 6.7 4.3 7.7 4.9 6.1 5.5 2.6 6.4 6.6 2.0 0.0 3.2 9.4 1.9 1.8 2.6 2.7 4.6 7.9 4.4 3.9 10.3 5.7 1.6 3.7 4.2 1.2 4.8 0.0 0.0 4.9 0.6 0.8 2.0 1.6 0.0 0.4 6.9 2.7 2.3 3.0 2.6 0.9 0.0 6.3 1.4 1.2 5.2 8.4 6.5 0.1 0.0 2.8 0.9 1.2 4.1 1.8 0.0 1.9 1.6 11.7 2.1 5.5 3.3 1.3 0.0 3.4 1.1 3.0 0.0 1.8 1.6 4.2 6.6 2.8 2.2 1.8 3.5 1.2 1.8 1.2 2.8 3.0 0.1 1.9 ACTR3B "ARP11, ARP3beta" ENSG00000133627 "Actin related protein 3B" Q9P1U1 7 152759749-152855378 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast glandular cells: 58.1;Breast myoepithelial cells: 64.8;Excitatory neurons: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047016, HPA051683" Uncertain NA NA "HPA047016: AB_2679903, HPA051683: AB_2681573" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-1)" "unprognostic (7.34e-3)" "unprognostic (5.89e-2)" "unprognostic (5.72e-2)" "unprognostic (9.28e-3)" "unprognostic (6.11e-3)" "unprognostic (5.62e-2)" "prognostic favorable (1.66e-4)" "prognostic favorable (4.53e-4)" "unprognostic (4.14e-2)" "unprognostic (3.04e-1)" "unprognostic (7.48e-2)" 4.5 7.0 12.3 3.2 20.5 3.5 6.3 10.1 19.9 5.0 2.3 3.4 3.5 4.6 6.9 3.4 7.0 2.3 4.8 23.4 12.0 5.9 9.3 4.0 3.9 6.7 5.9 16.8 6.1 8.7 8.7 15.1 3.0 7.8 4.5 3.5 16.4 12.6 4.0 11.3 6.5 3.5 2.7 3.7 3.7 4.5 14.0 10.0 4.3 4.6 5.2 3.9 4.9 4.2 15.3 21.0 9.8 18.4 23.0 5.4 6.8 15.2 10.8 6.9 4.4 4.4 12.1 12.1 17.8 8.1 7.1 8.1 7.5 17.0 5.1 5.3 6.6 9.0 7.2 6.9 11.5 5.8 10.0 2.8 3.4 6.2 2.6 6.5 3.0 5.7 7.2 38.0 0.3 9.6 21.8 14.6 19.5 39.8 20.5 11.0 11.7 7.1 14.1 7.3 11.7 36.0 30.4 13.8 10.7 9.6 6.8 11.0 7.8 3.4 4.4 1.1 5.7 9.6 15.3 17.7 12.3 8.8 14.0 9.4 0.0 0.3 0.0 0.8 0.2 1.0 0.7 0.9 1.7 0.8 0.9 1.8 1.0 0.1 1.2 0.1 0.4 1.4 1.2 12.3 20.5 10.1 19.9 23.4 12.0 6.7 5.9 16.8 7.8 3.7 10.0 15.3 3.4 6.4 1.1 24.2 5.3 2.7 4.8 2.8 4.0 19.4 58.1 64.8 4.4 5.7 3.0 3.7 22.9 8.5 7.9 1.3 31.3 5.3 29.1 5.7 5.0 4.8 10.8 5.5 64.1 5.7 7.7 4.3 8.2 3.7 4.5 5.2 2.5 7.8 3.1 15.2 49.2 3.9 8.2 2.8 3.1 41.1 42.9 9.3 48.0 11.2 3.5 34.0 3.1 30.7 26.1 5.1 3.0 54.2 2.8 17.1 1.7 6.5 6.0 21.9 6.6 20.4 4.4 28.5 27.5 3.7 1.6 12.4 4.3 7.3 3.3 6.0 NTS ENSG00000133636 Neurotensin P30990 12 85874295-85882992 "Predicted secreted proteins" Vasoactive "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 167.2" "Cell type enriched" "Detected in some" 13 "Intestinal goblet cells: 1683.2" "Cancer enhanced" "Detected in many" "lung cancer: 155.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 205.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 154.3" "HPA026664, HPA071012" Enhanced Supported Vesicles "Secreted to digestive system" NA NA 1600000 Vesicles "HPA026664: AB_2671936, HPA071012: " "unprognostic (3.63e-1)" "prognostic favorable (9.94e-5)" "unprognostic (8.18e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-3)" "unprognostic (8.83e-2)" "unprognostic (1.74e-2)" "unprognostic (3.76e-2)" "unprognostic (1.30e-6)" "unprognostic (2.94e-2)" "unprognostic (2.25e-1)" "unprognostic (2.17e-1)" "unprognostic (7.48e-2)" 6.2 1.2 8.1 3.6 2.1 0.0 5.3 1.2 9.7 0.7 0.5 1.8 6.7 0.3 0.7 5.6 0.9 1.3 0.5 2.4 13.6 1.7 1.5 1.2 11.8 11.1 8.9 0.2 0.6 0.4 0.1 32.6 0.5 6.2 0.3 1.5 0.0 0.1 0.6 0.0 0.1 167.2 1.1 4.2 0.1 36.7 0.3 16.8 0.5 0.9 0.2 1.0 3.1 0.3 4.6 0.0 5.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 50.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 10.7 0.0 4.1 0.0 1.7 0.0 0.0 0.0 5.4 1.6 0.0 0.0 0.0 205.5 0.4 0.0 0.0 0.1 0.0 0.4 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.1 1.2 9.7 2.4 13.6 11.1 8.9 0.2 6.2 4.2 16.8 4.6 3.6 0.0 0.5 0.0 0.0 1.3 0.7 22.6 0.0 0.0 10.1 0.0 0.3 0.0 27.0 9.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 2.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 44.3 0.0 0.2 0.0 1.2 1683.2 2.0 0.3 2.6 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.5 15.0 0.0 0.0 2.5 120.8 0.0 3.5 0.0 0.0 0.0 0.9 0.8 0.1 1.2 2.3 0.1 1.3 0.0 8.1 60.4 BTG1 APRO2 ENSG00000133639 "BTG anti-proliferation factor 1" P62324 12 92140278-92145846 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 2751.6;Langerhans cells: 2893.3;Suprabasal keratinocytes: 3004.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 29.9" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005972 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005972: AB_1078303" "prognostic favorable (4.36e-5)" "unprognostic (1.43e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-3)" "unprognostic (1.10e-1)" "unprognostic (5.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.50e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (5.79e-2)" "unprognostic (9.81e-2)" 82.9 37.2 2.0 20.0 2.2 94.8 80.8 29.9 4.0 57.5 2.5 37.5 8.5 46.0 1.6 29.7 56.4 7.2 36.7 2.5 8.3 36.9 70.3 55.9 24.0 4.0 3.2 1.0 46.0 64.2 8.3 26.4 6.2 10.4 40.9 4.9 5.2 30.7 4.5 20.7 120.5 58.9 8.3 2.8 93.0 39.6 12.5 3.6 20.3 22.1 3.7 18.4 38.9 60.6 3.6 5.7 5.4 3.5 0.9 13.4 16.9 3.2 8.0 6.3 2.3 2.3 2.4 1.6 5.7 1.5 3.3 3.5 3.9 1.6 3.0 2.2 9.8 8.8 0.8 2.9 1.3 15.0 3.7 1.9 14.1 11.9 4.5 11.7 8.5 5.0 2.4 4.6 7.1 3.4 3.7 5.5 9.4 2.2 3.0 11.0 15.2 2.4 1.5 5.5 6.5 3.4 7.8 6.1 4.4 17.3 2.1 21.5 7.7 2.6 3.9 1.3 3.6 3.7 14.0 6.3 8.9 3.1 2.4 4.6 36.2 21.8 151.8 22.8 16.2 27.8 92.4 47.3 40.7 9.2 105.5 133.1 53.6 75.9 68.8 22.8 8.0 66.8 51.3 2.0 2.2 29.9 4.0 2.5 8.3 4.0 3.2 1.0 10.4 2.8 3.6 3.6 1186.6 96.1 185.4 12.1 2512.8 2751.6 1030.9 206.6 912.9 592.7 607.5 573.8 119.5 1009.4 140.4 174.7 196.0 412.8 1907.2 672.9 320.8 388.1 411.8 216.7 258.8 709.0 452.4 230.7 7.9 255.8 416.3 529.1 406.7 264.7 286.6 197.4 339.1 274.9 361.4 424.0 20.6 373.8 193.3 564.3 2893.3 213.7 287.1 1251.4 983.6 31.9 1241.2 877.6 1354.3 22.1 8.4 364.4 668.7 241.9 758.5 791.3 667.9 162.6 53.0 377.2 539.0 870.7 723.5 130.1 101.5 508.7 3004.2 1342.7 2354.0 786.4 410.9 1513.3 LRRIQ1 "FLJ12303, KIAA1801" ENSG00000133640 "Leucine rich repeats and IQ motif containing 1" Q96JM4 12 85036314-85264457 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 10.3;choroid plexus: 15.4;fallopian tube: 13.8;retina: 8.9;testis: 15.6" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 185.6;Early spermatids: 423.8;Endometrial ciliated cells: 287.5;Late spermatids: 248.1;Respiratory ciliated cells: 381.5;Rod photoreceptor cells: 257.6;Spermatocytes: 190.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.1;SH-SY5Y: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046162 Uncertain NA NA "HPA046162: AB_10963055" "unprognostic (3.55e-2)" "unprognostic (7.81e-2)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (1.01e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" "unprognostic (4.05e-3)" "unprognostic (1.52e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-2)" "unprognostic (6.98e-2)" "unprognostic (1.25e-3)" "unprognostic (3.35e-2)" "unprognostic (6.10e-3)" "unprognostic (1.64e-1)" 0.1 0.8 5.9 0.1 3.4 0.0 1.0 3.8 2.5 1.6 15.4 0.1 0.0 1.5 2.4 0.0 13.8 0.4 0.2 3.2 8.4 2.0 0.0 2.6 0.0 10.3 8.4 1.6 0.4 0.3 3.0 1.4 0.0 6.4 1.4 0.0 8.9 0.4 0.7 0.0 0.0 0.0 0.6 9.5 0.1 0.2 15.6 4.0 0.1 2.4 0.0 0.0 0.1 0.1 4.7 0.0 0.3 2.0 0.0 0.5 1.3 0.2 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.6 0.8 0.2 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.0 0.5 1.8 0.8 0.9 1.5 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.4 0.0 3.1 0.0 1.6 2.5 0.1 0.0 0.2 0.4 0.9 0.1 0.1 1.8 0.5 0.7 0.1 0.0 0.5 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 3.4 3.8 2.5 3.2 8.4 10.3 8.4 1.6 6.4 9.5 4.0 4.7 0.2 3.2 4.8 22.2 0.0 0.4 1.6 12.0 0.0 11.1 2.9 3.2 1.3 4.3 49.2 16.5 185.6 0.1 0.0 0.2 9.8 11.3 423.8 287.5 2.1 1.6 11.5 0.0 24.5 1.3 0.0 1.3 0.0 7.1 1.3 3.9 0.0 0.0 0.1 0.0 4.8 0.3 14.2 0.0 0.3 248.1 4.4 1.2 3.6 2.8 0.0 16.7 0.0 1.5 1.8 1.6 0.1 4.1 0.1 3.1 0.0 6.1 381.5 257.6 13.1 2.4 3.3 190.8 46.3 0.0 0.0 0.1 0.3 0.7 0.2 0.3 C12orf29 DKFZp434N2030 ENSG00000133641 "Chromosome 12 open reading frame 29" Q8N999 12 88033846-88050160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039663 Uncertain Approved Vesicles NA NA Vesicles "HPA039663: AB_10795253" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.80e-2)" "unprognostic (6.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.75e-3)" "unprognostic (4.72e-3)" "unprognostic (1.07e-2)" "unprognostic (1.84e-1)" "unprognostic (8.81e-2)" "unprognostic (6.49e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" 4.7 9.9 8.5 4.5 9.0 8.8 11.1 7.9 10.1 6.6 6.1 4.9 4.9 6.7 13.0 16.2 4.5 5.2 5.8 8.7 8.5 8.5 12.7 5.1 6.9 8.8 8.6 8.1 7.6 5.9 7.3 3.2 5.3 8.5 8.2 5.2 5.4 8.4 6.2 4.3 15.6 3.9 5.7 8.5 5.3 5.2 5.6 8.1 6.2 10.0 8.7 8.8 7.5 6.1 9.6 13.1 8.1 7.9 9.2 16.7 21.5 5.8 17.1 14.6 14.4 12.9 7.8 5.0 24.0 2.3 8.8 8.1 11.3 15.5 11.8 24.8 10.4 15.9 20.5 6.5 6.9 20.1 26.9 9.4 14.7 17.8 13.5 16.8 16.8 11.2 9.2 20.3 4.8 22.7 4.6 18.0 13.6 12.0 11.0 15.7 10.4 13.5 19.9 16.3 10.4 19.0 17.0 9.8 22.8 12.5 6.5 14.6 19.2 9.0 12.9 4.3 13.3 13.4 10.7 16.0 14.5 10.0 19.1 11.4 4.5 0.8 0.6 2.7 0.8 4.9 2.0 3.9 3.3 1.0 1.7 4.6 3.9 0.0 3.4 0.9 1.4 2.1 1.8 8.5 9.0 7.9 10.1 8.7 8.5 8.8 8.6 8.1 8.5 8.5 8.1 9.6 20.4 9.6 13.6 7.8 17.7 51.5 29.2 29.1 21.6 14.4 19.0 17.8 16.1 20.0 29.6 5.5 6.2 15.3 16.1 5.1 37.2 21.5 34.2 14.2 16.8 17.7 7.8 44.6 22.8 24.2 17.1 26.4 8.2 19.1 10.8 6.7 9.7 16.4 9.6 10.1 20.0 8.9 18.3 6.6 11.7 22.8 32.0 6.6 26.6 4.7 5.3 16.2 11.3 5.0 12.9 22.3 5.0 30.9 13.5 39.7 4.2 33.3 19.7 17.8 6.6 24.9 25.2 50.4 31.7 29.5 71.5 9.3 21.3 8.6 13.0 31.2 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 32.6 22.7 9.8 32.3 9.8 37.2 23.0 13.3 15.0 16.5 22.5 21.4 20.4 19.0 17.2 18.2 17.5 24.4 47.5 11.4 14.9 36.5 87.7 35.8 20.9 10.8 10.1 8.8 16.1 16.5 50.7 15.4 55.3 10.5 15.7 22.3 11.7 22.0 15.4 17.1 11.3 16.8 17.1 10.5 17.0 24.6 9.7 12.5 16.4 46.4 14.5 19.6 40.5 16.5 10.9 184.6 19.3 33.0 35.2 49.7 64.9 96.8 62.7 75.4 74.9 132.5 114.1 45.2 74.2 161.1 89.4 197.9 64.2 37.5 66.9 171.4 175.5 31.4 43.1 24.8 31.7 77.1 139.7 91.6 32.6 36.8 127.8 89.0 105.0 38.0 34.9 46.2 139.1 90.7 41.0 53.9 34.8 41.1 64.5 33.5 40.0 77.1 48.8 71.6 53.4 52.4 30.5 64.1 77.9 52.9 31.2 127.7 92.4 37.1 81.2 64.2 162.1 116.5 93.4 141.2 116.6 149.3 80.6 55.7 0.2 0.4 0.4 0.4 0.6 0.5 0.4 0.4 0.7 0.6 0.2 0.5 0.5 0.0 0.6 0.2 0.3 1.0 0.2 9.8 9.8 13.3 15.0 11.4 14.9 10.8 10.1 8.8 10.5 10.5 12.5 10.9 56.6 51.3 34.1 51.6 22.3 82.5 49.1 42.1 21.1 25.9 32.1 16.6 50.0 78.6 35.9 49.7 20.9 29.6 26.6 43.7 3.9 66.6 2.0 52.3 65.4 50.5 30.6 23.5 61.8 71.4 19.0 53.2 42.8 181.8 8.8 27.9 68.9 153.2 37.2 15.2 80.6 24.1 26.4 31.1 384.4 2.3 10.2 110.1 62.2 76.8 27.0 8.4 18.6 64.3 49.6 87.8 23.7 13.2 37.8 94.3 11.6 41.4 31.7 13.6 13.1 35.8 42.4 15.2 6.8 36.5 71.2 64.6 24.4 14.1 24.7 69.9 SFTPD "COLEC7, SFTP4, SP-D" ENSG00000133661 "Surfactant protein D" P35247 10 79937467-79982614 "Predicted secreted proteins" "Gaseous exchange, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lung: 512.4" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 2: 1863.1" "Cancer enriched" "Detected in many" 16 "lung cancer: 106.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 10.0;non-classical monocyte: 36.3" "Lineage enriched" "Detected in many" 18 "monocytes: 36.3" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HaCaT: 1.0;hTCEpi: 3.2;MCF7: 1.3;U-2197: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB004578, HPA044582, HPA056768" Enhanced "Secreted in other tissues" NA NA 8200000 "CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232" "unprognostic (3.81e-5)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (1.41e-2)" "unprognostic (4.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.66e-3)" "unprognostic (6.83e-2)" "unprognostic (3.85e-1)" "unprognostic (2.23e-1)" "unprognostic (5.29e-2)" "unprognostic (2.57e-1)" "unprognostic (4.70e-2)" "unprognostic (2.57e-2)" "unprognostic (2.38e-1)" "unprognostic (1.45e-1)" "unprognostic (8.86e-2)" 1.1 1.8 2.2 0.4 2.2 19.9 0.9 1.6 2.5 1.0 1.9 0.7 0.1 0.6 1.3 1.8 1.8 0.9 1.1 2.1 2.5 1.3 1.1 512.4 0.0 1.7 2.0 1.9 1.1 4.3 2.0 3.4 0.7 1.7 1.5 0.1 0.3 1.1 1.2 0.2 5.0 0.4 0.4 1.2 0.6 1.2 1.4 2.0 0.5 5.9 0.2 0.2 0.3 2.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 10.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.9 2.2 2.2 1.6 2.5 2.1 2.5 1.7 2.0 1.9 1.7 1.2 2.0 1.6 0.3 439.1 1863.1 1.0 0.2 0.9 1.3 7.8 1.2 1.7 1.4 1.8 0.7 0.0 38.0 5.5 0.0 0.1 0.0 0.0 1.9 1.4 7.4 0.6 0.1 1.5 0.0 0.0 4.9 5.8 3.0 4.4 0.0 0.9 20.2 1.6 0.4 0.7 0.1 0.0 3.5 0.0 0.0 0.0 2.7 12.2 1.2 2.9 0.0 1.9 0.6 2.8 0.0 0.0 0.6 2.0 0.1 0.4 0.0 0.8 0.0 0.2 9.6 0.5 0.0 1.8 0.4 0.4 0.3 0.6 1.8 0.1 4.3 0.1 0.1 0.6 DYDC2 "bA36D19.6, MGC16186" ENSG00000133665 "DPY30 domain containing 2" Q96IM9 10 80344745-80368073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "fallopian tube: 98.3" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 182.5;Respiratory ciliated cells: 324.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;NTERA-2: 3.2;SCLC-21H: 2.9;SH-SY5Y: 1.9;U-2197: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038006, HPA038007" Enhanced NA NA "HPA038006: AB_10672734, HPA038007: AB_2675783" "unprognostic (1.60e-3)" "unprognostic (7.35e-2)" "unprognostic (1.89e-2)" "unprognostic (9.26e-3)" "unprognostic (8.85e-2)" "unprognostic (3.26e-1)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (2.34e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-4)" "unprognostic (9.86e-2)" "unprognostic (5.40e-2)" 0.1 0.1 5.8 0.1 2.8 0.8 0.3 1.9 2.1 1.2 4.7 0.3 0.1 1.9 4.5 0.5 98.3 0.3 0.0 2.1 4.2 0.3 0.6 4.6 0.0 5.1 4.4 1.2 0.1 0.8 0.3 0.8 0.3 3.6 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 7.2 0.0 0.3 10.9 3.2 0.2 0.2 0.0 0.1 0.0 0.1 3.9 0.1 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.8 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.4 0.0 3.2 0.0 0.0 0.9 0.2 0.8 0.0 0.0 2.9 1.9 0.0 0.0 0.3 0.8 0.0 1.4 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.8 2.8 1.9 2.1 2.1 4.2 5.1 4.4 1.2 3.6 7.2 3.2 3.9 0.0 0.0 3.1 0.3 0.0 0.0 0.1 20.6 0.0 0.0 0.3 0.1 0.2 0.0 29.6 0.0 0.0 0.0 0.1 0.1 1.9 0.5 61.4 182.5 1.6 0.1 0.0 0.0 0.8 0.5 0.0 0.9 0.0 2.4 0.0 1.3 0.0 0.6 0.1 0.0 0.3 0.0 14.2 0.0 0.3 30.4 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.3 0.0 0.1 324.1 0.0 0.0 0.2 4.3 8.5 3.1 0.1 0.0 0.0 0.4 0.2 0.0 0.1 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA029105: AB_2672909, HPA072613: AB_2732205" "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 15.3 12.0 8.3 11.2 8.4 9.5 26.8 7.8 8.3 13.8 6.8 22.8 16.5 10.8 62.7 39.8 28.2 14.1 5.8 7.9 9.2 15.0 53.2 9.5 10.5 8.1 8.4 8.0 13.1 19.1 16.7 4.5 15.7 8.3 43.5 22.5 11.3 16.7 14.3 4.4 72.9 15.5 10.5 8.4 7.9 15.2 15.6 7.5 15.6 14.9 3.0 14.7 12.6 22.9 9.3 14.4 13.8 20.0 17.2 27.1 29.7 33.4 13.5 9.3 9.0 9.7 10.6 43.5 11.0 22.1 16.9 9.3 15.2 8.9 11.5 10.0 17.5 16.5 3.0 3.8 14.3 11.2 12.8 13.0 20.3 48.6 8.9 7.3 20.6 7.7 9.1 7.9 22.9 9.4 29.8 10.7 9.9 11.0 12.6 43.2 13.2 2.8 9.7 13.5 11.9 8.0 12.1 12.6 31.4 13.3 14.8 45.1 9.1 12.1 7.8 12.8 12.0 8.0 15.8 24.7 0.8 17.8 13.6 6.6 57.3 25.0 13.0 18.1 28.6 22.3 21.3 20.2 18.8 20.7 14.3 33.8 22.6 2.8 17.5 31.5 23.1 27.2 20.5 8.3 8.4 7.8 8.3 7.9 9.2 8.1 8.4 8.0 8.3 8.4 7.5 9.3 4.6 9.6 9.6 17.6 7.3 8.2 5.9 9.7 5.2 7.9 22.6 17.5 4.4 12.8 13.7 9.2 16.7 40.9 3.8 9.0 21.5 15.7 10.5 37.6 10.0 5.4 8.4 5.9 17.2 8.7 37.2 7.6 11.2 10.5 5.7 12.9 5.7 33.4 19.4 16.8 16.4 23.7 8.2 10.3 5.8 7.5 9.3 8.5 3.6 4.7 15.2 15.7 12.3 8.5 14.8 10.3 15.3 11.7 5.2 15.6 19.6 23.1 40.2 13.3 13.1 2.6 7.1 36.8 8.7 20.9 24.0 22.7 6.9 11.2 18.1 8.4 TMTC1 "ARG99, FLJ31400, FLJ41625, OLF" ENSG00000133687 "Transmembrane O-mannosyltransferase targeting cadherins 1" Q8IUR5 12 29500840-29784759 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 105.0;Astrocytes: 64.6;Excitatory neurons: 186.0;Inhibitory neurons: 200.5;Skeletal myocytes: 60.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 83.0;HSkMC: 56.9;hTERT-HME1: 103.8;LHCN-M2: 58.8;RH-30: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016720 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016720: AB_1858155" "unprognostic (1.67e-1)" "unprognostic (6.35e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.63e-3)" "unprognostic (4.53e-2)" "unprognostic (3.88e-2)" "unprognostic (8.36e-2)" "unprognostic (1.77e-1)" "unprognostic (8.90e-3)" "unprognostic (3.08e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.49e-4)" "unprognostic (5.89e-3)" "unprognostic (6.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.51e-3)" 37.1 14.2 15.0 5.2 20.2 0.2 16.9 7.8 14.3 12.0 16.4 10.1 3.2 9.1 3.0 6.8 14.4 7.1 15.6 18.6 19.8 14.9 2.5 8.8 2.8 12.3 22.1 12.3 9.4 2.6 28.2 10.8 2.9 12.9 6.9 6.0 2.6 4.5 8.8 18.6 3.8 6.5 13.3 6.8 42.8 8.3 2.5 22.4 7.0 4.8 31.5 2.1 12.2 8.3 9.7 0.0 0.0 15.3 0.0 47.7 31.6 0.1 14.7 33.1 4.3 3.4 0.0 0.2 0.1 7.4 10.0 17.6 0.0 0.5 0.2 0.2 0.3 4.6 0.0 41.5 0.7 83.0 2.1 0.0 56.9 5.6 40.3 103.8 12.2 2.2 0.0 0.0 2.2 58.8 0.0 0.0 0.0 11.1 0.2 20.8 0.0 122.4 2.1 0.0 0.3 1.2 1.2 1.7 0.0 4.1 5.4 0.0 0.8 6.2 3.7 2.4 2.3 12.5 19.6 0.0 0.0 27.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.0 20.2 7.8 14.3 18.6 19.8 12.3 22.1 12.3 12.9 6.8 22.4 9.7 105.0 3.2 0.6 64.6 0.9 3.3 1.0 6.1 11.4 12.1 1.3 10.4 32.3 0.0 2.4 3.7 0.0 0.1 0.0 0.0 0.0 0.1 29.6 7.7 16.2 57.9 0.0 0.0 186.0 0.0 0.0 17.5 2.0 7.0 0.0 4.3 54.7 5.4 0.5 0.0 200.5 0.2 0.0 17.7 4.2 7.5 8.1 4.9 10.6 30.9 0.5 0.5 0.0 9.5 5.7 0.0 0.0 18.4 0.3 4.0 0.1 0.7 6.0 1.3 46.0 60.3 24.9 2.4 1.7 1.3 2.0 1.9 1.0 21.9 0.0 0.4 KRAS "KRAS1, KRAS2" ENSG00000133703 "KRAS proto-oncogene, GTPase" P01116 12 25205246-25250936 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049830 Approved NA NA 3300000 "HPA049830: AB_2680903" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.86e-3)" "unprognostic (1.08e-2)" "unprognostic (7.39e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (3.74e-2)" "unprognostic (1.79e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (6.42e-2)" "prognostic favorable (2.75e-5)" "unprognostic (1.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.81e-2)" "unprognostic (9.97e-2)" 11.9 9.2 10.4 16.3 13.4 28.1 10.1 12.8 13.2 9.6 6.0 22.3 14.1 11.1 6.9 19.4 7.4 13.2 8.6 12.5 12.4 11.8 15.4 13.3 18.1 9.6 11.1 10.4 8.1 12.7 11.2 5.7 17.2 10.6 11.9 23.2 22.9 12.0 8.4 7.6 13.7 19.6 13.8 8.7 12.1 20.5 9.0 12.0 17.3 10.9 10.4 17.6 16.3 11.5 11.5 15.9 14.3 39.4 20.7 14.1 19.9 68.9 17.3 22.8 18.0 21.9 51.5 30.7 38.7 10.4 32.0 23.4 18.6 44.9 17.3 34.3 26.7 15.0 37.6 17.6 15.6 15.8 32.8 25.6 18.1 25.5 21.9 20.2 33.6 27.1 28.7 28.0 17.3 27.6 14.1 46.8 56.6 87.6 25.3 7.4 43.4 39.9 59.9 27.2 22.4 11.2 32.4 20.5 24.9 21.8 97.4 28.9 26.9 28.1 18.7 24.8 38.2 22.0 16.4 28.5 41.9 15.4 20.0 15.0 31.2 8.1 13.7 11.6 16.4 7.9 10.7 10.1 13.1 7.9 10.5 13.8 12.4 19.2 11.2 22.4 7.8 7.6 5.8 10.4 13.4 12.8 13.2 12.5 12.4 9.6 11.1 10.4 10.6 8.7 12.0 11.5 73.7 48.1 32.1 16.6 90.8 100.9 96.4 57.2 72.3 63.4 59.9 38.0 16.3 64.3 53.6 38.6 73.0 94.2 66.0 161.9 58.7 77.5 3.9 45.4 40.8 77.3 78.8 60.2 42.0 91.8 21.4 50.1 98.4 53.4 24.1 26.6 77.8 56.9 51.5 92.5 45.3 92.9 36.7 53.9 83.7 5.9 40.7 75.3 62.2 28.1 82.9 41.7 49.4 19.6 16.6 114.2 104.7 51.6 85.0 130.1 63.0 52.3 42.5 65.8 26.3 53.7 52.2 53.0 40.3 93.0 155.7 139.1 83.0 36.5 96.7 176.9 IPO8 "IMP8, RANBP8" ENSG00000133704 "Importin 8" O15397 12 30628988-30695869 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018439, HPA023765" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018439: AB_1851771, HPA023765: AB_1851773" "unprognostic (1.63e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (5.14e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.35e-4)" "unprognostic (2.66e-2)" "unprognostic (5.42e-2)" "unprognostic (1.20e-1)" "unprognostic (2.97e-1)" "unprognostic (1.38e-1)" "prognostic favorable (8.62e-5)" "unprognostic (9.75e-2)" "unprognostic (2.95e-1)" "unprognostic (3.14e-3)" "unprognostic (2.24e-1)" 20.3 21.8 18.7 23.3 22.4 16.6 22.4 26.4 20.8 22.3 27.1 29.7 26.9 24.1 17.2 24.4 17.3 21.6 16.8 19.3 21.9 32.5 34.9 23.3 28.3 23.1 20.5 18.8 26.8 28.0 52.3 15.7 22.7 20.6 22.0 32.5 23.0 19.9 25.6 18.7 24.5 23.9 27.1 19.8 25.4 24.3 24.8 22.0 29.5 32.0 21.8 27.7 24.1 15.6 23.7 41.2 46.8 44.3 32.9 40.9 46.8 62.3 44.4 42.5 34.9 40.6 32.9 41.8 52.9 38.1 54.8 37.0 25.8 49.7 48.4 50.5 62.0 35.1 43.1 56.0 29.8 26.8 63.3 32.8 37.8 29.8 55.5 47.1 62.5 58.5 36.4 39.2 38.7 49.9 21.0 47.6 39.3 86.7 56.5 18.1 38.5 93.1 42.7 43.6 55.5 27.3 33.7 46.6 33.7 25.0 78.6 53.8 22.7 52.4 33.2 29.0 72.3 39.3 38.0 54.9 78.4 40.6 37.4 58.7 3.4 1.9 2.4 1.9 2.5 2.8 2.4 2.1 2.0 1.4 3.2 2.2 3.0 2.5 2.6 2.6 1.4 2.8 1.3 18.7 22.4 26.4 20.8 19.3 21.9 23.1 20.5 18.8 20.6 19.8 22.0 23.7 18.4 9.6 21.0 22.2 17.3 9.6 6.7 6.3 12.5 13.4 12.2 7.4 20.3 8.6 16.6 11.0 12.5 11.8 13.5 17.2 3.9 10.1 51.5 14.3 17.5 17.5 6.7 14.5 38.8 14.0 6.8 13.4 16.8 14.2 12.0 25.0 21.0 25.1 16.1 8.4 35.0 13.8 8.2 24.8 10.8 11.9 8.7 17.4 8.8 30.9 16.7 12.7 18.6 59.8 35.7 14.1 8.1 13.2 17.5 7.6 15.0 15.7 9.9 14.3 13.1 17.0 14.8 17.4 5.2 23.4 9.2 17.9 13.6 11.1 14.8 9.0 LARS1 "FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS" ENSG00000133706 "Leucyl-tRNA synthetase 1" Q9P2J5 5 146110566-146182696 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036424, HPA040881" Supported Approved "Nuclear bodies,Cytosol" NA NA 110000 "Nuclear bodies, Cytosol" "HPA036424: AB_10670102, HPA040881: AB_2677185" "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-3)" "unprognostic (1.92e-1)" "unprognostic (2.69e-1)" "unprognostic (3.39e-1)" "prognostic unfavorable (3.78e-5)" "unprognostic (8.17e-2)" "unprognostic (2.72e-1)" "unprognostic (6.80e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.96e-2)" 32.6 37.3 42.3 26.9 44.0 20.4 46.8 44.7 49.3 34.0 45.4 33.2 18.6 34.2 35.7 35.3 35.1 18.8 37.0 42.4 47.0 32.5 25.8 26.6 30.0 44.3 44.5 39.8 37.5 50.1 35.0 37.3 22.4 44.1 35.9 35.2 35.0 40.4 28.5 71.2 31.3 28.4 33.7 44.4 36.0 30.1 24.1 44.6 33.0 35.0 59.3 35.1 35.9 31.2 48.0 56.1 59.5 65.9 125.9 88.0 95.7 102.5 45.5 57.8 71.4 92.4 66.1 59.8 67.8 32.7 91.2 72.6 52.9 107.2 116.5 106.4 45.2 88.2 65.5 76.0 58.5 122.7 101.4 51.9 83.7 153.6 92.0 173.3 73.2 87.7 108.0 67.4 121.3 83.4 56.9 102.8 116.1 126.8 63.8 86.8 75.0 62.0 101.9 73.6 44.1 77.7 97.3 50.2 111.6 221.2 76.6 103.1 159.3 63.4 61.2 44.3 56.7 89.4 79.3 82.3 86.3 89.8 164.1 79.1 1.1 11.8 5.4 14.5 19.2 19.6 18.9 16.6 14.9 21.2 15.5 21.2 21.9 0.7 19.2 16.7 16.6 19.6 14.9 42.3 44.0 44.7 49.3 42.4 47.0 44.3 44.5 39.8 44.1 44.4 44.6 48.0 26.8 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.7 0.0 0.0 0.0 0.0 39.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 40.3 16.6 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 33.0 2.8 0.0 0.0 0.0 SPINK5 "DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI" ENSG00000133710 "Serine peptidase inhibitor Kazal type 5" Q9NQ38 5 148025683-148137382 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 1024.4;lymphoid tissue: 295.4;skin 1: 320.8;vagina: 587.3" "Cell type enriched" "Detected in many" 4 "Squamous epithelial cells: 1622.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 45.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 14.7;HeLa: 22.7;Karpas-707: 19.3;SuSa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009067, HPA011351, CAB015347" Enhanced Enhanced Vesicles "Secreted in other tissues" NA NA 43000000 Vesicles "CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447" "unprognostic (9.66e-3)" "unprognostic (1.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.42e-3)" "unprognostic (2.45e-2)" "unprognostic (6.85e-2)" "unprognostic (1.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.92e-3)" "unprognostic (4.56e-1)" "unprognostic (2.44e-1)" "unprognostic (7.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.87e-2)" "unprognostic (2.59e-1)" 1.1 0.3 0.0 0.5 0.1 0.0 17.7 0.0 0.2 162.0 0.0 4.8 0.3 0.6 0.3 1024.4 0.4 1.8 1.7 0.1 0.0 0.8 0.4 2.0 0.1 0.1 0.1 0.0 0.3 0.8 1.0 2.0 2.4 0.2 1.3 10.7 0.0 146.2 0.5 1.8 320.8 0.7 0.5 0.0 0.3 5.0 1.6 0.1 9.2 2.2 1.1 295.4 0.7 587.3 0.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 1.8 0.0 0.0 14.7 0.0 1.3 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.9 19.3 0.0 2.1 0.0 0.0 2.6 2.0 0.3 0.0 0.0 0.0 0.0 5.7 2.8 0.0 0.6 0.0 0.0 6.6 4.6 0.0 0.0 0.0 0.1 0.0 0.0 5.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.3 5.7 9.6 45.4 0.3 0.2 53.7 1.5 331.1 102.4 0.0 4.2 3.4 1.2 34.3 115.6 0.0 0.0 1.9 0.0 177.9 0.0 0.2 11.0 2.5 0.7 12.9 4.2 0.0 0.7 1.3 2.1 2.6 17.9 4.8 1.3 0.0 7.9 0.2 0.1 0.0 0.8 33.8 16.2 0.8 2.1 3.8 0.6 0.7 3.6 2.8 0.0 0.0 0.0 2.0 1.2 7.6 60.3 0.0 3.7 0.7 0.0 0.0 9.4 0.0 0.0 0.2 2.4 1.3 4.6 1622.6 64.4 1.5 1.1 1.0 97.9 2.7 IMPA1 IMPA ENSG00000133731 "Inositol monophosphatase 1" P29218 8 81656914-81686331 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037489 Approved NA No 310000 "HPA037489: AB_10671757" "unprognostic (1.78e-1)" "unprognostic (3.59e-2)" "unprognostic (6.95e-3)" "unprognostic (2.15e-3)" "unprognostic (1.31e-1)" "unprognostic (6.27e-2)" "unprognostic (3.80e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-1)" "unprognostic (4.68e-2)" "unprognostic (7.78e-2)" "unprognostic (6.26e-2)" "unprognostic (2.52e-2)" "unprognostic (5.87e-2)" "unprognostic (1.84e-1)" "unprognostic (2.42e-1)" "unprognostic (5.41e-3)" 12.9 11.4 13.6 12.8 15.1 27.2 10.3 13.9 17.0 8.2 15.7 27.2 23.7 10.5 11.8 20.8 11.9 11.9 26.0 15.9 16.8 16.6 31.6 10.3 17.7 13.0 15.3 12.8 13.6 8.7 15.6 10.2 8.3 14.7 11.1 28.7 18.4 8.3 8.2 14.3 5.2 23.3 18.2 14.2 11.3 14.9 38.5 14.0 19.8 22.0 29.2 16.4 14.1 10.6 16.8 12.5 34.6 23.3 17.2 14.0 21.9 9.8 35.7 26.5 31.3 36.7 16.3 20.1 47.2 27.5 26.2 45.6 9.4 27.1 12.0 41.3 50.7 26.5 35.7 19.2 20.8 23.8 36.7 35.0 20.3 17.6 24.9 48.2 30.2 35.2 35.6 32.8 38.7 30.6 8.7 46.1 18.4 10.1 32.2 37.2 21.2 16.9 19.2 31.7 43.5 9.3 38.7 23.9 6.2 41.3 39.6 20.4 27.4 26.4 24.9 32.8 19.8 44.1 45.2 58.5 67.4 29.4 20.7 35.9 50.5 6.6 29.4 13.6 10.3 16.8 20.3 13.5 14.9 7.5 13.7 14.0 16.8 11.2 20.5 11.8 12.0 19.6 9.5 13.6 15.1 13.9 17.0 15.9 16.8 13.0 15.3 12.8 14.7 14.2 14.0 16.8 22.2 16.0 12.7 15.3 25.7 13.8 16.9 16.8 28.5 15.8 8.5 6.9 38.3 21.5 17.3 9.2 14.6 9.7 29.4 54.4 31.3 16.2 4.0 23.2 19.7 16.5 21.5 11.6 19.4 20.3 11.0 16.1 12.2 17.3 33.0 11.5 13.9 32.9 14.3 25.2 12.5 19.8 18.3 16.2 13.1 8.2 15.5 16.4 12.4 12.2 21.9 23.4 13.4 14.1 14.0 19.0 62.3 15.1 18.1 14.4 30.4 30.7 25.1 15.9 13.1 15.5 17.0 78.4 19.2 26.9 8.7 3.0 26.2 18.7 22.3 21.3 LRRCC1 "CLERC, KIAA1764, VFL1" ENSG00000133739 "Leucine rich repeat and coiled-coil centrosomal protein 1" Q9C099 8 85107215-85146080 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 33.8" "Group enriched" "Detected in all" 5 "Early spermatids: 192.2;Late spermatids: 166.0;Spermatocytes: 224.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012893, HPA075880" Uncertain Supported Centrosome NA NA Centrosome "HPA012893: AB_1852434, HPA075880: " "unprognostic (1.01e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-3)" "unprognostic (2.37e-2)" "unprognostic (7.67e-2)" "unprognostic (7.76e-2)" "unprognostic (1.47e-2)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.31e-1)" "unprognostic (4.45e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-2)" "unprognostic (2.43e-2)" "unprognostic (2.67e-2)" "unprognostic (7.37e-2)" "unprognostic (1.52e-1)" 5.0 4.9 6.8 3.9 7.5 7.4 6.5 7.1 9.0 4.9 5.7 9.0 6.8 6.3 3.9 3.8 4.5 4.2 3.4 6.5 7.1 5.5 4.0 5.3 4.9 7.7 7.3 5.8 8.1 3.7 3.8 1.8 2.1 7.7 5.1 9.1 3.0 2.7 5.1 0.8 5.9 6.5 4.6 7.3 4.4 6.0 33.8 7.2 6.6 8.8 2.0 3.7 4.4 4.2 8.0 7.3 1.6 13.4 3.1 6.3 5.6 10.4 7.4 4.8 1.6 2.9 3.5 10.2 5.4 1.2 4.6 8.6 9.8 16.0 4.5 2.6 41.9 1.4 21.2 4.0 5.4 1.9 8.1 5.5 3.1 1.2 4.6 1.0 3.0 1.8 13.7 24.1 4.8 8.5 2.6 24.9 6.3 4.6 28.0 3.3 18.2 8.3 3.7 4.5 5.5 1.7 4.5 3.7 7.1 2.8 8.6 15.8 17.5 2.4 6.3 8.5 6.8 10.3 6.4 6.9 10.5 5.1 20.6 12.5 0.0 0.2 0.0 0.4 0.3 0.2 0.4 0.3 0.5 0.8 0.2 0.4 0.7 0.0 0.7 0.3 0.5 1.1 0.1 6.8 7.5 7.1 9.0 6.5 7.1 7.7 7.3 5.8 7.7 7.3 7.2 8.0 12.2 32.1 32.8 6.5 5.8 9.3 11.8 7.7 13.1 7.2 11.3 9.8 12.6 11.5 22.1 25.8 12.5 8.0 9.9 9.3 33.2 7.7 192.2 14.1 12.6 12.0 7.8 33.6 5.3 7.6 11.7 13.9 12.8 8.1 15.2 13.1 11.4 6.8 6.9 25.2 8.3 14.4 2.0 4.1 8.7 166.0 10.2 10.1 5.4 5.6 6.3 10.8 12.3 22.1 13.8 2.9 5.9 14.3 9.1 5.6 7.7 7.9 20.7 5.0 19.7 13.3 15.5 224.3 38.3 14.1 6.5 1.1 6.5 9.8 20.6 10.8 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177154-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enhanced" "Detected in many" "B-cells: 23.7;Plasma cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.4;naive B-cell: 8.9" "Lineage enriched" "Detected in many" 9 "B-cells: 13.4" "Cell line enhanced" "Detected in many" "AF22: 82.6;Daudi: 158.0;U-698: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA055723: AB_2682897, HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 1.8 4.0 5.4 8.1 5.4 1.7 6.8 5.0 6.6 5.3 5.1 6.7 4.9 4.5 8.2 2.2 8.0 4.3 1.9 5.2 6.7 8.2 3.1 4.1 26.1 5.7 5.2 5.1 5.0 4.4 13.3 3.7 5.0 5.1 3.6 7.8 0.9 2.3 3.4 0.4 0.7 3.9 4.2 5.4 7.0 5.6 8.6 5.2 10.8 8.8 0.9 29.8 7.0 0.9 5.7 14.2 15.9 82.6 29.7 1.5 2.2 25.0 2.7 6.9 2.4 7.4 9.6 17.4 158.0 10.3 3.5 28.4 2.6 51.0 4.3 3.0 16.0 20.1 16.4 8.3 22.4 13.4 4.8 0.1 3.3 6.9 3.5 12.0 15.7 2.7 16.5 34.7 1.2 4.6 10.0 15.8 10.8 26.1 28.0 12.9 12.9 3.4 17.9 27.5 10.7 9.8 29.8 1.8 5.8 23.8 32.6 33.5 5.2 0.1 3.7 2.5 4.6 10.5 27.6 20.6 77.1 4.3 4.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 13.4 0.0 0.0 0.1 8.9 0.2 0.4 0.0 1.4 0.0 1.5 0.6 0.6 5.4 5.4 5.0 6.6 5.2 6.7 5.7 5.2 5.1 5.1 5.4 5.2 5.7 1.1 0.0 6.5 3.6 23.7 2.3 3.3 1.3 1.2 0.9 5.6 6.0 1.0 5.7 2.9 5.5 10.4 4.1 5.1 3.3 0.0 3.3 7.6 7.3 5.2 1.5 7.8 1.3 7.7 2.6 1.1 3.0 4.1 7.5 1.3 5.5 0.4 2.4 0.5 0.0 4.6 2.7 2.0 0.8 1.0 3.8 1.5 1.9 3.6 4.7 0.3 5.2 4.1 11.6 4.2 3.0 1.7 1.9 29.6 6.9 0.8 5.8 8.6 1.6 0.0 5.0 4.5 8.1 4.6 2.3 2.8 1.1 2.5 4.6 3.7 2.1 CA1 Car1 ENSG00000133742 "Carbonic anhydrase 1" P00915 8 85327608-85379014 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 55 "bone marrow: 1813.7;intestine: 2128.9" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 11487.3" "Group enriched" "Detected in some" 10 "colorectal cancer: 3.4;stomach cancer: 0.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 987 "HEL: 1022.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006558, CAB025790" Enhanced NA NA 4600000000 "CAB025790: , HPA006558: AB_1845989" "unprognostic (1.44e-1)" "unprognostic (7.56e-2)" "unprognostic (1.70e-1)" "unprognostic (3.57e-3)" "unprognostic (2.08e-2)" "unprognostic (1.66e-1)" "unprognostic (2.84e-2)" "unprognostic (2.03e-2)" "unprognostic (1.73e-2)" "unprognostic (6.12e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (5.61e-2)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" 1.2 0.4 0.7 0.5 0.3 1813.7 2.1 1.0 1.7 0.2 1.0 1032.7 0.2 1.6 0.1 0.7 2.2 0.3 1.4 0.2 2.1 1.9 6.8 6.0 0.2 0.4 0.6 0.2 0.4 0.3 0.1 1.9 20.8 0.5 0.4 2128.9 0.4 1.1 1.8 1.0 1.4 1.9 31.0 0.2 35.6 2.3 0.2 0.3 0.5 0.9 3.4 0.1 0.4 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1022.7 0.0 0.5 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.7 0.3 1.0 1.7 0.2 2.1 0.4 0.6 0.2 0.5 0.2 0.3 0.8 0.0 0.0 0.0 4.2 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 2565.3 0.0 0.0 0.5 0.1 0.0 0.5 45.8 11487.3 11.8 0.0 0.0 0.1 0.0 0.1 22.3 0.0 4.2 4.4 0.0 0.0 12.1 159.4 0.0 11.4 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 13.0 2.2 0.0 754.9 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.4 0.1 298.4 0.0 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 11.9 6.3 7.0 5.2 7.1 40.7 11.0 7.6 10.4 9.3 4.1 8.4 4.3 9.3 11.0 10.7 10.0 7.1 9.1 7.0 7.3 6.5 9.8 8.1 8.9 7.2 7.2 5.9 11.4 7.9 9.7 6.7 9.7 7.2 7.1 7.6 4.7 6.8 6.7 16.1 8.1 6.1 8.1 6.1 6.3 7.5 12.4 6.8 12.6 8.6 19.5 11.2 11.3 8.8 10.1 27.2 22.9 18.9 16.0 22.5 20.1 33.1 24.0 28.5 43.4 35.3 52.9 16.0 31.0 12.0 26.0 29.9 18.3 95.3 46.7 36.4 35.7 51.3 34.3 15.1 34.6 66.7 40.3 15.7 36.1 39.0 43.5 55.9 34.6 35.9 55.8 62.8 17.1 26.9 50.6 39.6 57.1 30.4 25.6 54.4 28.4 31.9 27.6 23.4 28.4 33.8 16.4 27.4 15.6 34.6 23.1 32.3 55.0 17.6 18.0 16.3 15.1 45.7 22.7 30.2 66.2 15.7 32.8 29.0 25.9 9.2 18.3 10.7 12.6 22.0 16.4 19.0 20.9 9.9 24.1 22.2 18.7 22.3 14.9 19.0 21.4 29.5 5.9 7.0 7.1 7.6 10.4 7.0 7.3 7.2 7.2 5.9 7.2 6.1 6.8 10.1 76.6 67.3 56.3 10.1 81.7 85.8 129.9 84.9 65.4 33.7 57.3 80.1 44.3 40.0 66.5 44.1 22.9 80.0 88.2 33.1 129.1 48.7 125.8 63.1 71.5 62.0 35.8 41.2 9.4 57.5 88.3 61.5 29.6 85.0 78.6 45.8 64.2 53.9 56.8 43.7 9.9 62.5 50.8 70.9 53.8 28.4 53.4 62.0 48.0 5.6 66.9 47.2 64.9 12.1 17.2 54.8 44.0 53.8 54.7 88.1 56.1 93.0 51.5 40.6 19.7 118.1 57.8 204.9 135.2 57.6 89.9 146.8 95.6 43.5 56.7 100.6 SWAP70 "KIAA0640, SWAP-70" ENSG00000133789 "Switching B cell complex subunit SWAP70" Q9UH65 11 9664077-9752993 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 80.6;naive B-cell: 84.8" "Group enriched" "Detected in all" 7 "B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6" "Cell line enhanced" "Detected in many" "Daudi: 161.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006810, HPA006929" Supported Supported "Plasma membrane,Actin filaments" NA NA 21000 "Plasma membrane" "Actin filaments" "HPA006810: AB_1857683, HPA006929: " "unprognostic (4.16e-2)" "unprognostic (7.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.67e-1)" "unprognostic (3.38e-2)" "unprognostic (3.16e-3)" "unprognostic (1.26e-1)" "unprognostic (4.04e-1)" "unprognostic (3.33e-1)" "unprognostic (1.75e-1)" "unprognostic (3.85e-2)" "unprognostic (2.79e-3)" "unprognostic (5.00e-2)" "unprognostic (1.14e-1)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 38.6 10.5 13.3 37.8 14.5 21.1 32.2 14.8 16.0 22.7 19.5 14.4 15.5 17.9 10.5 18.0 16.5 22.2 16.3 12.6 20.9 17.4 10.1 25.1 66.6 17.5 14.0 11.3 10.3 15.1 19.5 5.7 39.3 16.8 14.3 12.9 4.0 18.2 15.4 9.9 25.1 20.5 19.9 17.0 60.0 16.0 4.8 15.1 17.5 22.5 14.9 76.0 31.5 17.7 18.3 40.6 22.2 30.8 0.1 62.9 54.6 54.0 43.4 52.6 40.3 44.1 24.7 31.3 161.0 41.6 83.5 57.9 47.7 37.9 24.2 51.6 14.8 15.2 42.6 25.7 12.1 35.2 33.3 76.2 38.4 29.6 29.5 52.3 32.6 124.4 20.2 3.9 0.6 42.4 6.4 10.0 16.1 28.4 10.7 11.3 23.6 28.9 4.7 33.6 106.1 1.5 15.5 41.3 52.6 35.2 42.9 20.9 25.1 143.6 70.3 25.1 59.4 41.2 4.2 12.4 111.5 27.9 36.6 29.3 19.7 5.7 48.6 1.2 13.5 0.5 80.6 1.4 1.1 8.2 84.8 1.2 1.3 1.1 7.9 29.6 2.3 4.2 5.4 13.3 14.5 14.8 16.0 12.6 20.9 17.5 14.0 11.3 16.8 17.0 15.1 18.3 154.0 67.3 60.8 33.0 183.7 35.6 68.1 40.1 36.5 3.4 35.1 28.3 17.6 22.8 57.7 20.2 0.0 82.6 9.9 11.3 13.7 47.4 1.6 66.5 18.6 136.0 13.1 9.7 9.0 21.6 128.0 39.1 15.8 71.6 137.8 10.3 53.2 7.2 65.0 26.9 14.5 8.7 18.3 61.9 50.8 2.9 29.8 58.5 28.4 77.8 88.8 9.2 6.2 22.1 22.4 37.0 15.1 34.6 20.7 63.0 22.4 11.7 50.9 2.3 19.7 46.2 35.5 5.5 10.8 17.4 31.3 140.1 15.5 33.4 9.0 78.8 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 63.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 11.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: AB_2681282" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 14.8 13.4 3.2 5.2 5.1 7.4 14.2 5.0 8.4 10.1 2.8 11.7 5.3 11.6 1.7 10.6 11.6 4.1 9.5 5.0 2.6 7.3 19.6 15.2 5.9 2.0 2.8 3.8 19.9 10.4 1.5 12.4 4.5 2.5 8.6 4.1 23.6 12.8 3.4 27.2 17.4 12.5 5.6 1.7 11.7 10.9 11.0 4.4 14.3 19.1 8.2 6.5 9.4 11.6 7.4 8.2 9.0 7.5 4.0 15.0 9.0 5.7 9.5 8.1 8.6 9.7 3.7 10.9 0.1 2.6 5.2 10.4 3.4 5.3 10.3 7.7 13.6 6.3 3.9 6.6 1.8 23.7 1.8 16.2 10.1 21.3 3.7 14.1 5.9 6.2 12.6 2.5 14.9 6.9 4.7 4.7 0.9 1.6 5.4 4.3 5.1 11.4 3.4 5.7 1.8 1.2 12.2 6.1 0.7 7.6 7.1 5.7 7.0 11.5 6.2 6.8 20.3 5.5 4.1 12.0 0.0 6.4 4.1 8.3 4.3 8.3 17.9 18.1 9.0 25.2 2.6 16.8 15.6 8.4 3.1 9.4 11.1 24.5 14.1 8.9 1.1 11.1 10.7 3.2 5.1 5.0 8.4 5.0 2.6 2.0 2.8 3.8 2.5 1.7 4.4 7.4 4.9 25.6 21.0 49.9 9.0 30.8 13.4 7.3 10.2 28.3 6.1 5.0 8.8 10.0 11.1 1.8 16.7 17.6 34.8 8.6 17.6 6.8 1.5 6.1 14.2 6.6 1.2 3.0 63.6 6.4 2.2 10.3 11.7 12.9 2.5 6.9 10.8 22.9 8.2 30.3 30.5 4.6 4.1 14.0 12.3 4.2 12.8 11.9 3.6 18.7 13.1 18.8 32.0 34.2 11.9 8.3 9.3 19.9 11.5 8.0 13.5 11.3 5.3 30.9 13.1 6.6 10.7 4.7 5.4 9.4 32.4 6.3 33.0 4.7 4.5 12.0 LYVE1 "LYVE-1, XLKD1" ENSG00000133800 "Lymphatic vessel endothelial hyaluronan receptor 1" Q9Y5Y7 11 10556966-10611689 "Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 127.6;placenta: 150.6" "Group enriched" "Detected in many" 4 "Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HUVEC TERT2: 81.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "spinal cord: 1.8" "CAB025860, HPA042953" Supported NA NA 3300000000 "CAB025860: , HPA042953: AB_2678238" "unprognostic (9.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.53e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.98e-5)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 127.6 69.5 2.4 19.5 2.8 0.9 37.7 1.7 6.8 17.7 14.2 20.1 13.4 8.2 5.8 26.5 23.2 20.4 11.5 2.6 4.4 8.2 44.6 24.0 8.5 2.6 2.2 1.8 11.9 5.0 2.3 2.8 150.6 3.0 4.0 20.2 0.3 5.4 11.4 5.1 6.8 17.8 67.7 1.8 62.1 10.6 4.3 2.6 1.7 13.6 27.7 3.0 35.4 6.8 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 81.6 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 2.8 1.7 6.8 2.6 4.4 2.6 2.2 1.8 3.0 1.8 2.6 2.9 5.7 0.0 2.8 8.1 2.1 3.7 0.1 0.0 0.0 0.0 0.5 0.3 4.6 8.6 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 1.0 0.0 0.2 102.7 0.0 5.3 0.8 0.0 5.7 3.4 0.0 0.0 1.3 0.0 238.8 4.5 807.4 0.0 0.4 0.0 0.0 338.1 10.7 2.3 3.7 86.0 7.2 12.2 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.4 2.7 0.2 0.0 0.0 1.5 0.0 13.1 3.4 6.8 0.0 0.0 1.4 3.3 11.1 1.4 0.7 0.0 0.2 AMPD3 ENSG00000133805 "Adenosine monophosphate deaminase 3" Q01432 11 10308313-10507579 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.4;skeletal muscle: 73.9" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038662, HPA047408" Uncertain Approved "Nuclear membrane" NA NA 77000 "Nuclear membrane" "HPA038662: AB_2676136, HPA047408: AB_2680034" "unprognostic (2.24e-1)" "unprognostic (3.88e-3)" "unprognostic (1.44e-2)" "prognostic favorable (2.37e-4)" "unprognostic (1.89e-2)" "unprognostic (1.71e-3)" "unprognostic (2.91e-3)" "unprognostic (1.25e-1)" "unprognostic (7.83e-2)" "unprognostic (2.26e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-1)" "unprognostic (3.06e-2)" "unprognostic (7.07e-2)" "unprognostic (4.42e-2)" "unprognostic (2.98e-1)" "unprognostic (2.12e-2)" 3.6 19.7 11.4 20.9 22.3 63.4 3.0 19.4 13.7 5.4 10.6 4.9 6.6 4.2 4.1 7.7 11.2 6.5 3.0 10.4 20.2 6.5 1.9 7.0 17.8 21.4 20.6 7.6 2.6 3.4 24.2 18.3 4.1 21.2 7.4 6.7 7.6 6.4 3.6 73.9 15.8 7.9 4.4 16.5 12.2 6.7 1.8 20.3 14.1 3.7 9.4 20.4 9.8 8.0 30.8 14.1 2.0 0.5 0.2 7.1 5.0 0.8 12.4 44.2 3.0 3.1 6.9 34.6 5.1 1.2 5.7 11.9 8.6 0.2 11.8 8.8 12.7 0.5 12.5 1.8 1.0 2.4 17.2 36.0 18.5 17.9 6.0 7.7 7.5 1.4 8.3 19.4 5.3 10.1 0.5 10.2 22.3 1.6 1.1 12.2 3.7 15.9 18.2 0.6 11.5 5.1 2.6 2.7 0.4 0.8 1.0 0.4 5.8 3.4 13.7 0.2 9.6 0.5 4.8 2.9 5.5 15.7 16.9 0.3 9.5 6.4 19.4 2.2 3.9 5.4 7.7 3.3 2.6 4.2 5.3 3.6 2.5 8.4 3.8 1.7 2.7 2.1 2.8 11.4 22.3 19.4 13.7 10.4 20.2 21.4 20.6 7.6 21.2 16.5 20.3 30.8 0.5 0.0 3.9 5.2 14.3 12.5 10.6 8.1 4.0 23.6 1.6 1.8 6.3 5.7 9.8 14.7 2.1 0.9 1.6 1.9 17.6 2.9 7.3 14.0 1.7 1.6 10.2 20.2 11.9 1.6 1.5 8.1 3.1 2.9 12.0 0.9 1.1 0.7 14.5 0.0 7.0 3.9 20.3 15.2 7.6 20.6 0.9 18.3 3.6 28.1 14.0 6.5 1.0 5.0 111.8 6.3 3.0 0.0 1.7 26.5 4.9 0.8 24.2 1.3 0.0 12.3 1.9 0.4 0.6 2.2 12.5 1.2 6.6 0.3 2.2 16.8 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294219 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 224.6;Excitatory neurons: 244.9;Inhibitory neurons: 367.4;Microglial cells: 273.6;Oligodendrocyte precursor cells: 290.5;Oligodendrocytes: 228.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 105.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: AB_2681280" "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favorable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 13.5 7.7 8.8 6.3 8.1 4.0 9.3 6.5 7.4 15.4 5.4 9.4 6.8 11.4 9.2 11.7 10.3 10.5 9.0 6.9 11.6 13.9 9.6 7.5 3.9 7.5 6.6 3.8 18.2 5.1 17.2 4.7 14.4 6.8 10.7 10.6 15.1 9.4 11.5 4.8 7.4 6.6 11.0 6.5 7.8 9.6 10.9 6.6 6.2 16.9 9.0 4.2 11.3 8.2 8.4 15.1 12.1 20.8 15.0 27.1 35.4 105.4 11.6 20.9 13.1 18.2 9.1 18.1 5.8 6.2 20.6 19.1 9.8 12.5 9.8 22.9 6.2 8.6 2.5 9.1 11.9 10.6 5.6 8.0 17.5 12.3 6.6 25.8 20.2 21.8 12.1 5.1 5.2 15.8 4.3 8.1 1.5 9.1 13.5 13.3 7.5 14.5 7.6 11.9 13.4 6.9 15.4 15.7 22.4 10.0 10.6 6.7 4.0 24.4 23.1 11.5 24.3 9.5 1.7 4.6 8.0 17.4 2.7 17.0 0.0 0.7 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 1.1 0.3 1.6 0.1 0.1 0.2 8.8 8.1 6.5 7.4 6.9 11.6 7.5 6.6 3.8 6.8 6.5 6.6 8.4 50.2 44.8 83.9 224.6 16.4 25.5 43.4 24.1 27.3 35.1 16.4 14.5 31.4 22.8 30.8 16.5 75.0 13.8 14.6 20.3 3.9 13.9 18.3 17.8 31.1 40.9 43.8 11.4 244.9 8.8 12.9 40.0 40.8 30.1 21.5 41.7 49.6 16.6 18.6 37.0 367.4 16.2 24.4 55.0 34.1 9.2 51.0 44.8 30.2 273.6 37.6 12.0 29.9 290.5 228.4 13.5 21.2 27.1 9.5 56.5 14.5 13.1 38.3 71.6 26.3 44.0 34.8 24.5 17.4 30.6 30.7 13.8 20.6 25.9 20.1 47.4 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" O94851 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 193.5;Inhibitory neurons: 108.8;Late spermatids: 192.7;Peritubular cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 109.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.7 3.9 17.3 12.3 18.7 11.7 2.5 65.3 42.8 6.9 37.9 19.0 9.9 12.4 7.3 18.7 7.5 10.1 42.6 42.7 4.7 2.3 2.9 17.6 3.3 4.6 2.9 17.5 4.0 4.1 1.0 0.2 7.3 25.0 2.9 16.4 4.0 0.8 9.7 17.0 14.1 10.9 31.0 0.0 3.4 6.7 32.8 0.6 1.9 6.2 4.1 2.5 12.5 0.3 24.9 29.1 9.7 0.4 2.7 2.3 6.8 14.2 32.1 53.7 16.2 28.3 24.3 23.3 0.2 8.4 25.3 47.7 25.0 4.0 65.1 41.6 35.9 4.8 27.5 4.1 0.9 12.8 5.3 2.7 12.7 11.1 76.0 54.6 25.3 46.9 1.6 43.5 0.8 22.9 1.2 0.3 1.6 1.2 13.6 9.8 0.3 15.2 14.2 2.1 35.5 14.3 0.8 8.6 38.6 2.9 9.9 4.5 2.3 42.6 109.6 35.0 17.4 39.6 0.9 2.6 1.5 64.3 5.2 1.4 0.1 4.2 0.5 1.3 0.7 1.5 0.1 0.8 0.4 3.4 0.2 0.0 0.4 8.9 2.2 0.4 0.9 0.7 1.5 17.3 18.7 65.3 42.8 42.7 4.7 4.6 2.9 17.5 25.0 0.0 0.6 24.9 3.2 41.7 37.1 7.2 1.2 10.1 11.8 4.5 4.0 5.7 4.2 5.3 32.2 7.2 8.5 3.7 0.0 2.6 11.2 66.5 0.0 10.2 74.4 7.8 8.9 9.2 22.6 35.6 193.5 14.3 12.6 9.0 12.2 11.4 1.3 1.4 12.8 19.6 3.4 0.0 108.8 10.6 6.1 10.1 5.6 192.7 21.1 11.1 5.4 4.7 21.6 0.5 8.2 6.6 17.5 42.5 24.0 112.8 2.1 8.9 18.3 0.9 5.5 1.6 13.1 1.9 29.4 1.2 1.3 1.7 9.5 2.3 10.8 0.7 14.5 11.9 RRAS2 TC21 ENSG00000133818 "RAS related 2" P62070 11 14277922-14364506 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 11.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010420, HPA050942" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB010420: AB_2253855, HPA050942: AB_2681285" "unprognostic (6.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (7.80e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (4.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.50e-2)" "unprognostic (4.15e-1)" "unprognostic (9.02e-2)" "unprognostic (1.05e-1)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" 31.1 14.3 8.8 16.2 8.8 5.3 21.4 10.4 10.8 21.8 14.5 22.5 21.0 19.9 9.3 15.5 14.3 12.0 44.8 12.9 11.4 39.7 39.4 23.1 28.5 8.6 8.6 8.5 18.4 18.3 17.4 8.6 29.6 8.2 20.3 18.9 12.2 18.2 19.5 41.2 11.5 39.9 18.2 7.3 16.4 17.8 25.3 9.8 14.6 29.2 34.3 38.0 23.6 14.1 8.1 89.3 38.2 35.7 30.8 122.0 121.1 52.8 309.1 160.7 260.5 328.1 78.0 108.7 102.2 46.8 209.0 84.3 97.1 61.0 110.8 260.5 88.7 49.6 6.8 21.5 62.4 133.6 0.3 0.7 129.5 205.0 104.2 331.2 106.5 131.7 24.8 45.9 0.2 229.3 43.5 21.5 5.6 98.3 18.2 31.4 19.0 118.5 1.9 133.7 48.8 9.7 18.4 74.7 46.0 42.5 119.9 30.6 6.2 303.1 139.6 74.0 272.1 85.1 0.2 0.2 48.4 56.0 0.1 29.0 2.1 0.0 0.0 5.5 0.0 2.4 11.8 1.0 2.8 0.0 6.6 0.5 2.1 0.4 3.8 0.0 0.2 0.0 0.9 8.8 8.8 10.4 10.8 12.9 11.4 8.6 8.6 8.5 8.2 7.3 9.8 8.1 6.6 19.2 18.9 14.4 57.8 69.3 76.2 17.7 23.9 5.5 22.6 13.7 31.5 40.0 20.6 18.4 0.0 36.5 31.2 30.5 23.5 46.5 55.2 25.8 16.0 15.2 19.1 3.2 32.8 18.4 58.0 29.7 12.8 34.7 8.9 15.6 13.6 33.4 8.2 13.5 35.4 16.0 14.2 2.4 12.0 45.2 16.4 2.3 26.6 9.4 2.0 21.7 56.7 28.6 4.9 57.1 30.1 11.3 22.0 120.3 89.9 112.9 15.0 10.1 19.7 20.7 21.4 39.5 42.1 20.3 49.9 29.0 29.5 13.3 20.8 96.5 HSD17B4 "DBP, MFE-2, SDR8C1" ENSG00000133835 "Hydroxysteroid 17-beta dehydrogenase 4" P51659 5 119452473-119637199 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Oxidoreductase" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 322.7" "Cell type enhanced" "Detected in all" "Hepatocytes: 225.1;Oligodendrocytes: 221.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 75.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021302, HPA021311, HPA021479" Enhanced Enhanced Peroxisomes NA NA 450000 Peroxisomes "HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.21e-2)" "unprognostic (1.24e-2)" "unprognostic (3.12e-2)" "unprognostic (2.83e-3)" "unprognostic (5.47e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "prognostic favorable (6.31e-6)" "unprognostic (1.60e-1)" "unprognostic (8.26e-2)" "unprognostic (1.80e-1)" "unprognostic (6.65e-3)" 75.1 85.8 36.8 42.3 49.1 19.9 44.9 51.5 50.4 69.3 45.3 65.1 80.0 34.4 53.5 51.4 39.5 53.0 69.2 34.8 46.6 85.1 322.7 76.2 33.5 50.7 48.9 32.0 35.1 55.6 76.1 26.7 53.8 51.5 57.3 66.5 27.5 45.3 79.7 60.3 52.2 88.4 39.8 48.5 36.9 54.3 21.1 46.1 32.2 135.1 53.3 40.0 58.3 31.7 56.4 68.8 59.8 104.1 143.7 261.8 120.3 57.9 63.4 80.3 57.3 103.0 49.4 112.8 84.4 128.0 70.6 81.0 68.7 77.0 144.4 84.3 94.6 79.8 118.1 62.0 96.9 65.8 38.0 169.9 110.0 56.3 64.9 54.7 69.3 103.9 59.4 41.0 48.9 64.2 64.0 59.2 23.6 82.1 161.1 43.1 68.7 103.0 104.8 92.2 192.7 81.1 70.6 149.0 23.4 78.7 93.3 88.7 68.2 67.6 52.7 38.1 66.5 53.1 26.3 55.3 32.6 63.7 104.4 56.7 75.5 27.3 49.9 6.5 15.5 7.3 11.1 5.8 5.3 21.3 10.3 5.5 5.2 4.9 6.9 17.1 13.8 4.1 12.2 36.8 49.1 51.5 50.4 34.8 46.6 50.7 48.9 32.0 51.5 48.5 46.1 56.4 38.9 73.7 125.2 47.3 28.2 14.9 42.5 43.2 24.5 19.7 31.1 22.1 76.4 64.3 52.3 36.8 14.6 64.3 19.1 40.0 84.1 39.9 8.8 29.0 48.9 32.3 33.0 42.1 92.9 35.8 29.3 35.6 48.4 35.8 68.4 25.3 32.2 225.1 77.9 15.2 102.8 45.8 22.4 51.8 13.8 13.4 34.5 46.7 8.8 49.6 85.7 47.3 9.2 78.4 221.5 20.5 29.6 51.1 23.1 24.8 85.7 65.4 33.8 18.6 6.6 29.2 32.2 30.6 22.7 34.7 17.2 65.0 15.7 57.2 55.3 39.7 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609599-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 8.6 12.4 4.6 10.2 5.7 18.6 8.2 8.5 6.6 9.5 5.8 10.0 6.3 8.8 10.6 10.4 9.3 7.4 7.7 4.7 6.9 7.2 5.6 12.2 14.6 5.3 4.8 2.8 11.1 8.0 7.7 8.1 8.1 4.9 8.3 9.0 13.5 8.1 8.2 7.8 9.0 11.1 6.3 3.8 11.0 10.2 12.5 4.9 13.3 9.1 5.6 12.1 9.9 9.5 6.6 16.1 15.7 12.6 8.6 14.4 26.5 7.6 12.9 18.6 17.8 17.7 15.1 9.2 21.2 7.3 15.0 7.9 19.2 15.3 7.4 23.8 20.8 13.0 21.6 27.6 7.3 8.6 22.0 10.5 15.2 14.6 13.1 6.1 25.4 18.2 17.1 19.6 9.8 17.0 5.0 15.5 8.2 11.5 7.2 9.6 14.0 13.7 15.9 13.5 12.4 8.3 8.3 13.4 8.1 8.0 12.0 21.0 14.4 16.7 12.2 7.4 6.9 6.9 17.3 10.5 15.2 12.6 15.8 7.7 60.5 20.9 27.1 15.0 10.7 12.1 21.7 13.3 10.4 9.3 29.9 13.1 11.2 60.7 11.7 20.3 27.1 11.9 3.5 4.6 5.7 8.5 6.6 4.7 6.9 5.3 4.8 2.8 4.9 3.8 4.9 6.6 33.5 35.3 25.5 37.2 50.1 47.9 85.8 20.6 46.7 32.8 28.4 17.1 18.4 7.2 30.5 14.7 22.9 14.6 60.2 35.7 1.9 20.5 97.6 33.2 46.0 35.8 20.9 24.8 56.9 16.9 14.5 40.2 52.0 66.5 48.8 32.7 23.9 12.0 17.5 58.9 58.1 32.1 18.3 17.8 47.0 65.2 32.0 49.7 10.6 55.3 39.3 14.7 37.0 62.4 68.6 28.5 36.4 23.0 54.0 45.1 32.1 8.4 22.9 33.0 26.3 39.9 37.5 51.7 30.8 79.3 40.9 11.5 44.9 29.2 28.7 93.4 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913008 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 3.4;endometrium 1: 6.8;smooth muscle: 5.3;testis: 12.2" "Cell type enhanced" "Detected in some" "Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1" "Region enhanced" "Detected in single" "olfactory bulb: 2.2" "Low region specificity" "Detected in many" HPA036800 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.7 3.4 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.2 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.2 0.4 12.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.9 0.0 8.4 1.1 0.0 1.2 3.1 19.3 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.5 0.0 0.0 0.1 0.1 0.1 3.7 4.2 0.3 0.0 0.0 0.0 0.0 0.0 4.1 1.3 0.0 0.0 3.6 0.2 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.2 0.4 0.7 3.4 0.4 0.6 0.2 0.6 0.3 0.3 0.3 0.1 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.3 0.1 1.3 0.5 0.0 0.0 5.7 0.0 0.0 1.2 0.0 0.0 0.0 1.7 2.5 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 49.7 1.2 0.1 0.0 1.0 0.0 1.3 0.0 0.5 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.1 13.1 0.0 0.1 95.4 98.5 0.0 0.0 0.1 0.0 4.4 0.0 0.0 SARAF "MGC8721, TMEM66" ENSG00000133872 "Store-operated calcium entry associated regulatory factor" Q96BY9 8 30063003-30083208 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040400 Supported "Endoplasmic reticulum,Rods & Rings" NA NA 41000 "Endoplasmic reticulum" "Rods & Rings" "HPA040400: AB_2676962" "unprognostic (1.11e-1)" "unprognostic (4.78e-2)" "unprognostic (4.27e-3)" "unprognostic (1.38e-3)" "unprognostic (7.86e-3)" "unprognostic (1.91e-1)" "unprognostic (2.32e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.98e-1)" "unprognostic (1.74e-2)" "unprognostic (8.03e-2)" "unprognostic (6.70e-3)" "unprognostic (1.06e-2)" "unprognostic (5.09e-2)" "unprognostic (3.88e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-1)" 141.1 297.3 233.5 170.7 248.2 255.3 171.7 209.4 248.7 155.1 213.7 144.4 125.0 153.5 412.2 91.9 207.7 183.7 153.2 242.4 293.7 207.1 304.8 169.0 220.7 230.4 247.3 229.2 258.0 233.4 238.4 139.9 311.8 247.2 230.2 144.9 221.1 214.7 174.3 112.2 71.4 141.6 140.3 236.5 160.4 162.5 105.2 293.3 245.6 247.6 130.1 188.1 142.4 64.5 291.0 119.9 112.4 147.9 79.9 209.3 149.8 69.7 139.2 247.0 128.5 173.7 72.2 139.9 80.9 183.5 156.0 134.7 97.7 100.8 112.4 146.9 33.6 49.5 112.2 87.3 119.2 189.6 48.8 130.6 175.2 260.0 121.6 125.5 257.4 192.0 150.7 128.4 191.2 142.9 74.2 128.4 88.8 96.0 253.6 61.3 98.7 88.4 107.4 220.3 100.4 48.6 162.5 140.6 160.5 208.2 115.7 112.2 93.3 144.0 89.6 230.5 35.0 56.5 103.4 110.6 81.0 215.8 118.4 146.5 964.6 252.9 443.1 321.2 253.2 364.8 233.1 473.0 377.9 247.0 302.4 776.2 543.6 478.1 258.8 335.3 212.0 483.8 920.3 233.5 248.2 209.4 248.7 242.4 293.7 230.4 247.3 229.2 247.2 236.5 293.3 291.0 179.8 169.9 147.6 79.0 458.5 0.0 331.6 0.0 154.8 291.5 247.8 166.2 135.4 261.7 82.3 211.5 123.0 235.9 566.8 142.2 127.2 387.5 629.8 235.9 114.8 170.8 115.3 145.4 128.0 358.9 254.5 181.7 170.7 133.6 223.3 325.7 240.2 273.4 292.0 139.7 157.8 122.0 0.0 448.6 0.0 908.1 218.7 387.9 0.0 60.9 298.5 317.2 358.4 82.9 111.7 250.1 137.0 294.2 505.1 280.7 252.6 289.7 212.1 252.5 177.5 203.7 177.1 194.7 133.9 133.4 0.0 276.9 794.4 167.8 115.9 310.6 RNF122 FLJ12526 ENSG00000133874 "Ring finger protein 122" Q9H9V4 8 33547754-33567128 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 34.7;Glandular and luminal cells: 19.8;Plasma cells: 13.1;Skeletal myocytes: 13.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 11.1;hypothalamus: 39.6" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 83.7;Karpas-707: 53.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003888 Uncertain NA NA "HPA003888: AB_1079822" "unprognostic (2.36e-2)" "unprognostic (3.13e-1)" "unprognostic (2.09e-2)" "unprognostic (9.19e-3)" "unprognostic (2.46e-1)" "unprognostic (8.78e-3)" "unprognostic (1.71e-2)" "unprognostic (5.46e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (6.95e-2)" "prognostic favorable (5.37e-4)" "prognostic unfavorable (4.50e-7)" "unprognostic (4.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (7.15e-2)" 27.9 15.1 2.2 9.5 2.2 7.5 19.1 11.1 3.4 10.9 2.6 11.3 2.7 10.5 5.4 6.5 29.4 13.5 26.8 1.9 39.6 7.0 7.4 29.2 7.1 4.5 2.7 1.7 48.5 5.7 3.5 4.4 3.0 3.8 10.3 5.1 4.9 7.9 2.4 26.0 10.0 10.2 14.8 3.0 12.5 11.2 5.7 3.5 6.0 6.5 5.8 8.8 13.8 12.9 3.8 0.7 4.4 22.3 9.4 2.0 0.6 3.0 1.4 2.1 2.8 4.5 0.7 0.9 10.7 6.8 3.6 3.8 0.8 4.9 2.0 1.5 0.7 83.7 2.2 1.1 6.1 1.2 0.7 16.9 2.1 1.8 1.5 1.1 4.6 9.0 9.2 2.2 53.9 2.3 2.0 9.5 7.2 12.2 3.4 2.5 10.3 4.3 8.5 3.3 1.3 4.3 24.8 1.6 0.6 3.5 7.7 1.0 3.0 5.2 3.8 3.5 7.0 1.6 21.5 13.0 19.5 2.4 2.9 0.6 5.9 1.0 8.9 1.6 5.0 1.4 3.1 0.9 1.1 0.9 4.9 1.5 1.6 7.6 2.0 11.9 16.2 0.7 0.4 2.2 2.2 11.1 3.4 1.9 39.6 4.5 2.7 1.7 3.8 3.0 3.5 3.8 34.7 0.0 0.6 0.0 5.3 4.2 0.6 0.2 6.2 0.0 2.6 1.3 5.1 2.8 0.1 0.0 0.0 0.1 8.1 1.9 0.0 2.7 2.2 9.1 3.8 10.1 0.0 4.0 0.8 0.6 0.6 7.3 4.1 19.8 0.0 1.8 5.7 0.1 1.5 0.0 0.9 1.0 0.0 5.9 7.6 0.9 1.5 4.8 0.0 3.7 0.6 0.7 1.0 2.0 0.9 1.0 2.8 1.2 13.1 0.3 0.2 0.8 0.0 1.5 0.0 13.4 6.7 0.0 0.7 2.8 2.0 0.0 3.0 1.2 1.3 1.1 DUSP26 "DUSP24, MGC1136, NEAP" ENSG00000133878 "Dual specificity phosphatase 26" Q9BV47 8 33591330-33600023 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 425.3;tongue: 206.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2" "Cancer enhanced" "Detected in some" "glioma: 6.7;pancreatic cancer: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 97.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018221 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018221: AB_2669813" "unprognostic (2.77e-4)" "unprognostic (2.70e-2)" "unprognostic (2.70e-3)" "unprognostic (5.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.53e-2)" "unprognostic (2.81e-1)" "unprognostic (1.39e-1)" "unprognostic (4.10e-3)" "unprognostic (1.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (8.15e-2)" "unprognostic (5.80e-2)" 0.6 27.6 42.5 1.2 47.1 0.2 0.4 49.2 49.5 1.0 21.7 2.7 3.6 1.3 5.6 5.1 3.6 1.3 52.8 44.4 51.0 1.6 0.2 3.3 0.4 41.4 45.2 47.5 33.5 3.0 2.0 61.9 0.0 51.0 4.3 1.1 34.4 4.7 0.8 425.3 0.2 2.6 2.7 37.6 0.7 3.9 3.6 46.0 0.8 0.9 206.3 0.8 1.2 1.7 51.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 97.7 23.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.1 3.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 47.1 49.2 49.5 44.4 51.0 41.4 45.2 47.5 51.0 37.6 46.0 51.4 0.0 0.0 0.0 1.3 0.9 0.0 0.2 0.0 0.6 76.8 0.0 0.3 59.4 0.0 0.0 0.0 41.7 0.0 0.0 0.0 21.5 0.4 7.8 0.4 0.1 0.8 25.7 0.0 11.3 0.4 0.0 3.5 0.5 0.1 0.0 1.0 0.4 0.0 0.0 25.2 14.7 0.5 0.0 0.0 0.0 5.2 0.0 0.1 1.8 2.8 0.0 22.8 0.0 12.1 12.0 1.1 0.0 6.0 5.3 0.3 0.0 2.5 0.0 75.2 0.0 10.8 5.2 0.2 0.2 0.0 0.0 0.0 0.6 0.7 0.1 0.1 DPF2 "BAF45d, REQ, ubi-d4" ENSG00000133884 "Double PHD fingers 2" Q92785 11 65333852-65354262 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020880, HPA056786" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020880: AB_1847845, HPA056786: AB_2683235" "unprognostic (2.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.90e-3)" "unprognostic (1.40e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.04e-1)" "unprognostic (3.29e-2)" "unprognostic (3.07e-1)" "unprognostic (2.43e-1)" "unprognostic (1.33e-1)" "unprognostic (6.93e-2)" "unprognostic (3.04e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" 20.4 21.2 40.6 14.3 44.3 24.9 21.8 42.8 43.4 32.8 35.4 30.6 13.2 37.9 23.0 23.3 31.6 14.8 31.9 39.1 42.2 18.7 17.0 19.7 22.4 42.7 43.3 38.0 41.2 20.7 19.9 20.2 17.7 42.9 28.8 14.0 17.7 21.2 26.0 39.0 19.2 24.5 28.1 43.8 29.9 24.4 38.0 43.1 38.0 22.7 29.4 24.7 34.5 24.3 48.2 29.9 36.4 45.9 40.5 39.7 39.8 25.5 25.0 35.1 53.5 38.6 36.0 34.8 39.5 40.8 34.0 46.6 31.2 52.2 31.9 37.7 47.6 23.1 50.4 24.6 37.7 61.1 47.0 36.5 35.0 30.4 48.4 86.6 40.1 43.3 47.0 48.7 51.0 35.2 47.3 60.0 49.3 51.6 31.9 37.4 65.1 29.9 46.8 34.0 24.1 29.9 27.3 32.1 45.7 47.0 29.7 59.0 26.2 25.8 35.2 31.3 38.9 25.9 62.7 78.8 51.1 21.6 30.6 40.4 186.4 75.4 141.1 79.7 70.8 87.0 102.0 76.9 78.4 76.2 109.1 78.6 71.9 161.5 125.8 83.0 70.6 107.3 108.4 40.6 44.3 42.8 43.4 39.1 42.2 42.7 43.3 38.0 42.9 43.8 43.1 48.2 19.2 6.4 10.1 14.0 35.7 22.7 21.8 41.7 23.9 42.2 20.1 24.9 12.7 27.1 24.2 33.1 47.9 27.2 42.0 11.5 19.6 21.2 5.2 18.3 29.5 24.2 17.4 32.8 18.5 17.4 22.9 27.2 15.3 18.5 16.5 31.8 24.3 13.3 19.5 30.3 19.9 16.8 32.6 17.5 33.8 12.3 58.7 16.9 19.6 15.0 30.0 22.8 35.0 24.1 32.3 19.3 8.6 53.4 21.6 22.6 23.7 22.0 19.3 50.5 32.9 28.8 32.2 60.2 63.5 15.4 23.2 26.5 30.6 28.7 17.9 19.7 MEN1 ENSG00000133895 "Menin 1" O00255 11 64803510-64811294 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030342 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030342: AB_10610138" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.66e-1)" "unprognostic (2.59e-1)" "unprognostic (1.42e-2)" "unprognostic (4.96e-2)" "unprognostic (1.36e-1)" "unprognostic (7.39e-2)" "prognostic favorable (6.31e-5)" "unprognostic (1.40e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" 14.5 24.4 13.3 8.5 13.4 6.5 15.8 12.5 15.1 18.8 12.3 15.1 7.9 17.5 8.1 24.1 16.5 5.5 11.7 13.8 12.1 19.5 30.5 16.3 11.0 12.2 12.4 12.9 20.9 26.4 6.4 21.9 7.9 12.7 20.4 4.8 4.8 21.5 7.8 11.1 23.9 21.0 5.4 11.5 25.7 20.7 16.4 13.4 17.3 24.7 5.8 10.3 16.5 18.8 12.7 30.8 33.7 22.4 37.7 30.4 17.4 24.8 19.2 23.3 35.6 21.2 19.0 25.5 43.6 33.8 16.7 29.8 39.0 36.4 28.3 19.3 30.5 48.1 35.6 17.3 30.9 27.2 23.6 22.8 19.2 18.2 26.8 21.9 16.5 33.7 49.3 51.5 15.7 18.9 54.2 60.3 29.3 36.7 30.3 54.7 45.1 29.8 44.1 23.2 22.8 33.6 28.9 26.0 36.9 27.9 16.5 56.6 27.1 17.4 23.5 28.8 36.5 16.7 21.8 30.4 22.1 25.5 16.2 21.0 0.5 0.5 1.4 1.5 0.6 1.8 1.8 1.1 1.9 0.6 1.8 1.9 0.9 0.1 0.9 0.2 1.3 0.9 0.5 13.3 13.4 12.5 15.1 13.8 12.1 12.2 12.4 12.9 12.7 11.5 13.4 12.7 6.9 3.2 5.4 5.9 10.6 5.7 4.6 5.3 7.4 8.5 10.2 11.0 4.5 4.3 2.8 3.7 6.2 19.4 8.0 9.2 3.9 8.9 0.9 7.9 11.0 7.0 4.2 10.8 7.4 7.1 21.7 6.9 13.7 12.1 1.3 14.1 7.9 10.9 9.0 3.3 6.2 9.0 6.1 3.1 2.3 0.9 12.2 4.8 8.8 8.4 6.3 7.7 6.2 4.5 5.0 7.5 10.7 3.8 8.4 6.1 9.3 8.0 4.0 6.5 13.1 5.4 5.6 14.2 13.0 9.4 7.0 16.3 8.9 14.3 10.2 3.3 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75660876 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 152.0;Ductal cells: 95.4;Exocrine glandular cells: 110.3;Extravillous trophoblasts: 154.2;Syncytiotrophoblasts: 116.3;Theca cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043172 Approved NA NA "HPA043172: AB_10793942" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 9.2 28.0 23.8 9.2 23.4 13.3 17.5 24.4 26.5 14.1 24.1 16.6 21.8 15.1 41.0 34.9 17.1 12.0 13.7 24.3 24.2 18.6 70.7 22.8 11.6 25.4 25.0 22.7 20.2 16.2 30.0 17.5 15.1 25.2 21.4 15.6 19.6 20.1 13.9 10.4 23.8 14.7 14.7 24.9 8.4 13.7 47.5 25.4 10.3 21.7 11.4 14.7 12.6 20.2 27.3 39.2 21.6 42.7 33.5 28.6 53.1 26.6 15.6 48.2 29.9 51.0 33.8 91.4 16.6 22.3 19.6 59.7 42.4 38.5 67.0 34.0 31.2 25.4 17.8 20.5 48.4 41.4 19.7 25.5 66.5 56.7 42.9 23.8 24.0 35.3 44.7 16.0 39.3 20.9 77.7 30.2 21.8 41.8 62.5 34.7 23.9 28.7 33.0 99.8 50.5 36.6 20.1 39.2 33.5 24.1 37.8 56.1 28.3 25.1 16.1 32.0 15.8 15.8 25.3 32.5 36.1 25.7 28.5 27.7 33.5 12.3 20.0 40.0 12.7 39.5 39.4 43.1 41.8 29.8 34.5 39.1 38.5 6.6 31.8 13.2 38.4 42.7 31.9 23.8 23.4 24.4 26.5 24.3 24.2 25.4 25.0 22.7 25.2 24.9 25.4 27.3 18.8 22.4 57.5 0.0 9.3 0.0 0.0 0.0 0.0 0.0 74.7 57.7 0.0 0.0 11.2 60.7 0.0 152.0 23.6 0.0 49.0 95.4 0.0 43.4 11.5 18.0 0.0 0.0 0.0 110.3 154.2 21.4 0.0 30.3 5.1 63.2 0.0 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 37.7 0.0 0.0 0.0 0.0 76.9 0.0 0.0 3.5 0.0 0.0 47.1 18.2 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 116.3 12.4 121.2 0.0 0.0 GSC ENSG00000133937 "Goosecoid homeobox" P56915 14 94768223-94770113 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.1;breast: 6.8" "Cell type enhanced" "Detected in some" "Adipocytes: 3.5;Breast myoepithelial cells: 2.2;Ductal cells: 3.0;Exocrine glandular cells: 2.4;Fibroblasts: 9.2;Langerhans cells: 2.3;Skeletal myocytes: 2.6;Smooth muscle cells: 4.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "gdT-cell: 3.6" "Lineage enriched" "Detected in single" 18 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HEK 293: 2.0;MCF7: 3.2;REH: 3.3;SH-SY5Y: 3.5;T-47d: 2.5;U-251 MG: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB079923, CAB079924" Supported "Nucleoplasm,Nuclear speckles,Actin filaments" NA NA "Nucleoplasm, Nuclear speckles" "Actin filaments" "CAB079923: , CAB079924: " "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-2)" "unprognostic (5.11e-2)" "unprognostic (2.49e-1)" "unprognostic (3.70e-3)" "unprognostic (1.82e-3)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.28e-1)" "unprognostic (5.18e-10)" "unprognostic (4.96e-2)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.16e-1)" 3.1 0.0 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.4 0.0 0.7 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.6 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.9 0.5 1.2 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 1.6 2.2 0.1 0.3 0.2 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 1.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 2.4 0.0 9.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.2 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 2.6 4.6 0.0 1.2 0.0 0.9 0.0 0.4 0.0 0.0 0.1 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 165.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Collecting duct cells: 29.5;Cytotrophoblasts: 30.9;Endometrial ciliated cells: 29.4;Granulosa cells: 49.8;Hofbauer cells: 31.7;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 200.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 24.1 32.4 37.6 21.6 43.6 21.9 16.8 50.7 49.6 25.2 66.9 33.0 25.3 26.2 17.4 28.7 39.0 22.8 123.5 35.4 41.3 35.9 25.1 25.2 21.8 45.1 45.1 34.2 23.1 17.0 48.3 21.6 16.7 42.6 23.0 30.6 8.4 32.5 34.4 144.3 25.8 23.9 32.3 35.8 33.9 38.4 19.1 41.9 27.5 30.4 165.0 20.1 32.1 20.3 44.2 6.2 16.4 8.0 20.1 32.8 30.6 21.0 6.6 17.7 19.3 19.6 10.9 46.7 41.3 46.0 18.8 24.9 18.0 23.0 24.7 7.9 22.8 9.5 27.7 9.1 13.8 47.8 28.5 38.2 47.5 10.5 10.6 4.0 25.3 34.6 22.8 14.0 54.4 18.4 1.4 22.7 27.0 16.4 0.8 1.4 38.2 15.7 30.9 32.7 25.9 22.4 11.2 10.4 17.8 7.3 8.4 32.0 24.5 24.7 5.7 4.8 17.1 5.9 30.9 23.8 14.0 29.6 36.8 3.8 67.5 48.8 30.8 30.1 69.4 30.3 34.0 19.3 24.5 72.9 22.4 15.9 20.0 200.5 21.0 60.7 22.0 45.2 29.0 37.6 43.6 50.7 49.6 35.4 41.3 45.1 45.1 34.2 42.6 35.8 41.9 44.2 19.2 28.9 16.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 11.5 13.2 0.0 0.0 5.6 29.5 0.0 30.9 12.5 0.0 21.5 17.6 0.0 29.4 14.8 6.2 0.0 0.0 0.0 5.8 15.8 7.4 0.0 25.0 7.6 49.8 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 2.7 0.0 0.0 17.0 5.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 16.8 8.7 35.6 0.0 0.0 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;pituitary gland: 11.8" "Group enriched" "Detected in some" 4 "Excitatory neurons: 524.0;Inhibitory neurons: 463.6;Oligodendrocyte precursor cells: 270.4;Oligodendrocytes: 202.6" "Cancer enhanced" "Detected in some" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 4.3;SCLC-21H: 3.0;SH-SY5Y: 1.9;U-937: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 0.0 0.7 1.3 0.0 2.9 0.0 0.0 5.3 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.9 1.6 0.3 0.0 0.0 0.0 0.2 0.5 2.2 0.0 1.8 0.2 11.8 0.0 1.9 0.0 0.0 3.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 2.5 0.5 0.0 0.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.3 0.0 0.0 0.1 0.1 3.0 1.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.9 5.3 5.0 1.9 1.6 0.2 0.5 2.2 1.9 0.0 0.5 2.9 0.3 0.0 0.0 89.8 0.4 0.3 0.3 0.5 0.0 41.9 0.3 0.3 2.8 0.0 0.1 0.0 10.4 0.1 0.3 0.7 0.0 0.3 36.9 4.8 0.9 0.6 0.0 0.4 524.0 0.2 0.1 0.6 1.1 0.8 0.0 0.3 0.4 0.2 0.3 40.4 463.6 0.3 0.0 0.6 0.4 16.4 0.6 0.4 0.0 23.4 0.1 2.1 0.0 270.4 202.6 0.4 0.1 0.4 0.0 0.3 0.6 1.9 0.9 5.7 0.0 0.5 0.8 3.4 2.5 0.2 0.3 0.7 0.2 0.5 0.2 0.3 NUMB C14orf41 ENSG00000133961 "NUMB endocytic adaptor protein" P49757 14 73275107-73458617 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 290.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002874, CAB011478" Approved Enhanced "Cell Junctions" NA NA 12000 "Cell Junctions" "CAB011478: AB_443023, HPA002874: " "unprognostic (5.28e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-3)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (2.43e-1)" "unprognostic (9.49e-2)" "unprognostic (1.33e-2)" "unprognostic (4.08e-3)" "unprognostic (2.65e-3)" "unprognostic (4.14e-2)" "prognostic favorable (2.32e-6)" "unprognostic (9.12e-2)" "unprognostic (1.63e-1)" "unprognostic (3.92e-2)" "unprognostic (2.87e-1)" 35.1 26.1 17.6 38.1 19.6 35.9 33.3 19.6 23.4 34.1 22.7 46.8 47.0 35.9 26.1 40.3 39.3 42.1 28.7 21.1 22.0 41.7 52.5 53.2 24.9 21.9 19.5 17.9 34.2 37.6 40.8 20.3 44.8 19.7 29.8 42.6 20.6 37.1 31.9 21.2 32.6 47.8 37.9 18.2 40.8 37.1 20.4 19.8 27.8 39.3 24.3 31.1 40.8 34.2 23.6 70.2 46.9 33.3 30.2 65.8 99.6 45.3 64.9 87.2 51.2 54.1 57.0 86.0 31.9 39.7 80.7 37.8 45.2 39.8 66.6 77.2 48.9 22.2 25.5 28.2 37.3 69.7 23.7 57.5 56.0 70.3 126.2 74.8 56.2 112.3 49.2 47.0 37.1 65.6 62.9 43.3 32.8 15.4 78.9 50.1 27.6 46.7 21.6 71.2 105.3 13.6 35.3 81.0 54.2 33.4 55.9 81.3 34.5 108.8 76.2 42.7 49.3 28.2 30.9 38.9 29.2 153.1 27.4 34.3 91.9 93.3 96.8 12.6 76.4 13.2 22.6 12.7 14.0 68.7 21.4 12.9 11.8 290.3 12.8 102.8 12.8 17.9 64.5 17.6 19.6 19.6 23.4 21.1 22.0 21.9 19.5 17.9 19.7 18.2 19.8 23.6 54.4 64.1 49.0 108.4 53.6 42.8 27.7 38.6 42.1 30.7 38.4 26.0 22.0 44.3 50.0 55.2 81.3 26.0 29.9 59.3 25.4 27.9 11.9 68.2 35.0 59.2 40.7 22.9 151.1 26.4 31.0 37.5 43.8 56.6 24.1 26.3 52.1 51.0 42.6 15.2 78.8 39.4 36.7 91.5 109.7 8.1 45.1 94.1 46.2 141.5 117.3 42.6 39.1 62.4 81.8 46.9 39.3 36.9 40.9 37.1 64.7 43.2 56.9 46.4 26.3 22.8 29.7 59.2 32.7 35.6 46.5 34.3 25.6 16.7 37.5 44.6 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 10.8" "Cell type enhanced" "Detected in some" "Early spermatids: 22.9;Exocrine glandular cells: 10.9;Gastric mucus-secreting cells: 11.7;Glandular and luminal cells: 6.2;Pancreatic endocrine cells: 7.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;OE19: 1.3;U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA035134 Uncertain Vesicles NA NA Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.3 0.2 0.6 0.6 0.6 0.3 0.8 1.0 0.6 0.4 0.2 0.6 0.4 0.3 0.4 0.5 0.4 0.8 0.4 0.4 0.4 0.2 0.1 0.6 0.9 0.3 0.3 0.3 0.3 10.8 0.3 0.2 0.2 0.4 0.6 0.5 0.8 2.5 0.2 1.2 2.3 0.9 0.2 0.3 0.6 1.4 1.1 0.2 0.3 0.5 0.0 0.5 0.2 0.2 0.8 0.2 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 1.2 0.4 0.3 0.0 0.0 0.2 0.0 0.1 0.2 0.4 0.6 0.1 0.4 0.7 0.0 0.5 0.2 0.1 0.2 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.1 0.7 0.2 0.2 0.0 1.3 0.1 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 1.2 0.3 0.3 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.0 0.6 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.2 0.8 0.1 3.2 1.5 0.3 0.1 0.1 0.3 0.2 0.0 0.0 3.3 1.0 0.2 0.0 2.1 0.0 0.0 0.1 0.3 2.2 0.0 2.7 22.9 1.6 0.9 0.6 0.0 0.0 4.9 10.9 0.1 0.6 11.7 6.2 0.0 0.1 0.0 0.1 0.0 0.0 1.3 3.0 0.0 0.3 0.3 3.2 0.6 0.1 0.0 1.9 0.6 0.0 1.0 0.5 1.8 7.5 2.5 0.0 0.4 0.9 0.1 0.5 1.5 0.0 0.0 0.9 0.3 4.5 0.2 0.8 0.0 0.3 0.7 0.1 1.4 0.8 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.7" "Cell type enhanced" "Detected in single" "Spermatocytes: 2.7" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "NTERA-2: 50.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 1.7 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 COX16 "C14orf112, HSPC203" ENSG00000133983 "Cytochrome c oxidase assembly factor COX16" Q9P0S2 14 70325081-70416984 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 302.9;Ionocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria NA NA Mitochondria "HPA062659: AB_2684823" "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favorable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.6 27.4 20.9 18.4 21.1 23.0 28.0 21.2 29.4 16.6 23.3 26.8 30.4 12.9 27.3 17.2 17.4 19.6 24.6 21.0 22.1 29.6 40.8 16.8 21.9 22.0 21.0 20.6 17.3 43.8 27.1 12.8 14.4 21.3 20.9 22.3 24.5 22.1 13.8 84.8 17.6 27.0 10.6 21.8 19.1 33.7 17.8 22.4 21.0 23.6 44.9 19.2 19.5 12.7 23.5 100.2 31.2 65.9 56.0 26.7 36.0 48.3 55.0 37.1 38.9 34.7 19.2 93.5 26.2 36.6 33.8 33.5 41.8 27.6 35.5 48.9 18.9 27.5 36.9 31.3 22.1 16.1 35.9 48.7 36.1 25.1 24.0 23.0 41.5 34.2 69.2 20.8 54.6 39.0 49.6 85.4 43.8 68.3 83.3 44.5 57.6 53.2 37.0 46.2 49.0 57.8 46.0 46.2 102.4 53.9 42.2 87.4 69.1 42.5 50.2 111.6 55.4 40.6 57.6 38.9 48.2 75.4 19.1 61.1 48.6 33.8 8.0 24.2 38.0 29.2 45.7 34.5 29.1 36.3 39.8 32.3 34.8 2.5 45.6 38.3 55.7 43.6 44.0 20.9 21.1 21.2 29.4 21.0 22.1 22.0 21.0 20.6 21.3 21.8 22.4 23.5 22.0 51.3 53.9 0.0 45.0 84.4 9.4 302.9 70.6 8.2 29.7 18.8 7.1 32.9 162.2 23.9 2.1 14.8 22.9 23.8 52.8 47.1 2.7 43.6 21.3 28.5 31.2 46.0 0.0 64.8 20.2 36.0 99.4 62.1 33.5 7.4 31.8 57.7 18.2 1.7 0.0 35.8 187.2 34.6 89.3 4.6 18.3 40.0 96.0 0.0 26.3 25.2 25.7 0.0 0.0 59.1 27.0 15.8 99.3 11.2 42.5 48.6 137.1 10.0 6.6 13.6 27.5 15.4 21.0 125.7 100.7 10.9 39.8 7.3 39.4 14.4 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641916-70675366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.5" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 36.0;Respiratory ciliated cells: 38.1;Urothelial cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.2;Daudi: 15.9;RH-30: 21.3;SK-BR-3: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079473 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA079473: " "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 0.9 1.2 5.3 4.1 7.2 0.9 3.7 3.7 10.1 2.8 1.8 0.8 0.8 1.3 1.4 60.5 10.3 3.4 2.1 6.6 7.0 2.9 1.1 4.5 9.4 5.9 4.1 6.3 0.1 1.5 3.0 3.8 4.0 7.2 2.5 0.8 6.1 12.7 1.6 9.6 5.8 2.5 0.9 3.7 5.8 4.2 0.5 5.3 5.1 4.1 5.2 15.5 4.5 13.8 6.8 18.2 2.1 6.7 0.3 0.0 0.0 7.1 0.3 0.1 0.5 2.2 0.4 8.9 15.9 2.4 0.1 1.5 6.6 5.0 0.6 0.3 0.5 1.9 2.2 0.7 5.2 0.0 0.0 4.4 0.6 1.2 0.0 0.1 0.3 0.0 3.5 0.0 1.4 7.3 9.0 0.4 0.2 3.7 13.0 2.3 3.7 21.3 0.1 11.0 4.1 4.1 2.0 2.0 36.4 0.0 4.0 12.7 0.6 0.0 0.0 3.2 0.0 0.3 0.0 0.2 4.9 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.3 0.9 0.6 0.7 0.5 0.0 1.2 1.1 0.7 0.8 0.0 1.5 0.0 0.4 0.2 5.3 7.2 3.7 10.1 6.6 7.0 5.9 4.1 6.3 7.2 3.7 5.3 6.8 3.8 3.2 7.2 1.3 11.3 1.0 4.7 16.3 1.2 3.8 13.7 10.5 1.8 14.3 24.8 9.2 6.2 24.1 1.5 0.2 1.9 21.0 0.4 8.3 2.3 5.9 1.2 0.0 10.5 5.8 2.5 1.2 4.1 19.1 1.3 15.2 0.4 2.2 2.8 0.0 13.6 0.5 16.2 4.1 0.8 0.7 0.0 2.1 7.2 3.7 3.0 15.8 4.1 9.0 0.7 36.0 0.5 0.0 4.4 13.0 0.0 0.3 38.1 5.4 0.0 0.7 2.1 0.1 2.6 9.0 1.7 7.4 7.6 0.2 0.5 56.9 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 12.9 15.0 12.8 14.2 13.9 21.8 17.3 23.3 17.5 14.1 10.9 13.3 11.9 15.0 17.9 17.4 15.1 12.3 14.7 12.6 13.5 11.6 16.9 13.1 24.5 12.0 11.7 12.9 19.2 11.3 12.3 12.2 15.5 14.2 11.3 13.1 22.2 12.4 12.6 23.4 18.8 12.3 14.5 10.6 15.2 12.5 13.8 11.9 24.5 14.9 22.8 26.8 16.6 14.0 13.9 81.0 43.5 56.1 24.2 29.6 32.0 44.9 39.6 42.7 60.8 60.3 43.8 48.9 60.9 22.7 34.6 36.0 37.9 67.5 41.0 64.4 44.0 35.7 44.8 31.6 59.5 36.0 39.5 34.4 36.1 47.2 43.1 39.7 26.7 48.1 45.8 42.3 37.4 45.2 60.3 56.7 53.2 41.9 56.7 53.7 46.5 51.9 32.0 37.8 42.4 37.9 40.3 41.8 44.3 47.0 32.6 69.2 49.1 37.7 49.7 71.2 24.8 37.3 39.2 63.7 85.8 43.1 34.1 34.7 19.1 16.2 24.6 17.6 18.9 20.9 17.9 23.1 20.3 18.5 20.2 21.3 21.7 15.8 22.6 22.9 13.9 23.4 14.1 12.8 13.9 23.3 17.5 12.6 13.5 12.0 11.7 12.9 14.2 10.6 11.9 13.9 36.7 19.2 25.7 16.0 48.7 19.4 34.2 50.3 28.5 73.5 23.0 21.1 7.4 12.8 34.5 18.4 79.2 39.1 49.4 13.9 5.9 30.3 7.6 22.7 24.9 27.6 22.1 22.5 27.1 23.1 44.3 30.1 24.5 30.5 46.3 29.5 25.4 15.0 26.2 26.9 24.2 14.0 20.3 19.2 15.4 6.3 27.1 21.4 17.8 16.9 30.4 38.5 47.4 18.6 18.6 27.2 19.5 29.3 41.6 38.3 22.5 14.1 37.2 97.7 26.3 28.0 26.4 25.3 37.7 23.5 20.0 49.0 44.7 25.2 14.8 39.2 EIF2S1 "EIF-2alpha, EIF2, EIF2A" ENSG00000134001 "Eukaryotic translation initiation factor 2 subunit alpha" P05198 14 67360328-67386516 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011663, HPA064885" Supported Enhanced Cytosol NA NA 210000 Cytosol "CAB011663: AB_2096478, HPA064885: AB_2685382" "unprognostic (1.86e-2)" "unprognostic (8.33e-2)" "unprognostic (4.31e-2)" "unprognostic (2.46e-2)" "unprognostic (3.78e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (4.73e-7)" "unprognostic (4.14e-3)" "unprognostic (4.49e-1)" "unprognostic (1.68e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (2.95e-1)" "unprognostic (1.21e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-1)" "unprognostic (1.59e-2)" "prognostic unfavorable (7.11e-4)" 28.6 24.7 13.7 30.2 15.0 25.2 25.9 16.1 17.9 18.2 12.7 24.4 21.7 19.5 19.8 39.2 15.9 21.7 28.9 15.0 16.4 24.7 35.6 18.6 30.7 14.7 14.8 13.8 17.2 26.5 23.1 9.5 26.5 14.8 22.2 27.0 21.4 18.5 22.5 49.8 23.9 21.7 27.2 15.5 20.0 20.0 33.7 14.6 28.1 28.2 41.0 33.8 39.4 19.2 17.4 265.7 86.4 59.8 92.3 56.4 63.4 127.8 115.5 68.3 127.4 110.7 101.6 92.2 118.7 57.0 87.4 85.7 100.4 139.1 110.3 192.7 86.9 51.9 76.9 80.0 70.4 59.2 82.7 71.9 52.4 62.6 113.9 172.5 49.8 105.4 73.8 132.6 89.6 127.3 131.3 113.7 64.7 61.1 157.9 142.9 85.7 99.0 84.6 78.2 120.0 85.9 60.7 83.0 96.5 91.1 52.3 164.5 70.8 81.3 167.4 180.7 82.0 124.4 77.0 90.4 180.7 97.1 145.3 110.2 51.4 50.6 33.0 47.4 71.0 58.4 55.4 54.5 51.7 70.1 45.8 50.3 51.5 6.9 58.6 62.8 48.0 64.3 70.7 13.7 15.0 16.1 17.9 15.0 16.4 14.7 14.8 13.8 14.8 15.5 14.6 17.4 64.1 28.9 40.2 17.3 44.1 142.8 88.2 77.2 37.5 22.1 32.0 30.1 92.8 30.0 55.8 22.0 12.5 78.7 38.0 23.3 70.5 89.6 81.0 34.6 48.9 60.3 13.1 64.2 21.7 63.0 104.7 51.2 34.1 44.8 35.5 35.7 26.4 39.8 70.4 37.0 20.9 30.6 61.1 37.9 51.3 33.4 31.1 40.7 51.6 15.9 61.3 32.2 36.0 15.1 23.8 70.8 18.3 40.6 56.7 79.9 26.6 65.1 35.0 35.2 26.3 60.7 85.9 204.9 96.3 49.7 130.4 93.4 46.1 57.9 39.7 79.1 ADAM20 ENSG00000134007 "ADAM metallopeptidase domain 20" O43506 14 70522358-70535015 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 1.5;testis: 5.1" "Cell type enhanced" "Detected in some" "Astrocytes: 30.0;Early spermatids: 55.5;Excitatory neurons: 45.4;Inhibitory neurons: 37.4;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 23.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059377 Enhanced NA NA "HPA059377: AB_2683997" "unprognostic (4.13e-3)" "unprognostic (3.45e-2)" "unprognostic (1.14e-1)" "unprognostic (8.34e-2)" "unprognostic (2.06e-1)" "unprognostic (1.57e-2)" "unprognostic (5.61e-2)" "unprognostic (2.89e-2)" "unprognostic (1.58e-3)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.46e-3)" "unprognostic (2.64e-1)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (9.52e-3)" 0.1 0.0 0.5 0.0 0.6 0.0 0.1 1.5 1.3 0.2 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.6 0.1 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.5 1.3 0.4 0.6 0.2 0.2 0.5 0.5 0.0 0.3 0.5 0.2 0.0 0.0 30.0 0.0 0.3 0.1 0.1 0.0 4.1 0.3 0.3 0.5 0.0 0.1 0.0 4.2 0.1 0.3 0.2 0.0 0.3 55.5 0.2 0.2 0.4 0.0 0.0 45.4 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 3.3 37.4 0.0 0.0 0.0 0.0 8.2 0.3 0.1 0.0 12.2 0.1 0.3 0.0 23.1 23.9 0.2 0.0 0.7 0.1 0.5 0.0 0.0 0.4 3.5 0.0 0.5 0.3 5.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 LOXL2 "LOR, WS9-14" ENSG00000134013 "Lysyl oxidase like 2" Q9Y4K0 8 23296897-23425328 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Chromatin regulator, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 41.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 26.9;Endometrial stromal cells: 26.9;Endothelial cells: 33.1;Extravillous trophoblasts: 22.0;Fibroblasts: 22.9;Hepatic stellate cells: 19.6;Sertoli cells: 26.3;Smooth muscle cells: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 935.5;BJ hTERT+ SV40 Large T+ RasG12V: 517.3;fHDF/TERT166: 602.7;TIME: 510.7;U-87 MG: 905.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB025848, HPA036257, HPA056542" Approved Enhanced Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168" "unprognostic (9.48e-2)" "prognostic unfavorable (9.83e-6)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (5.55e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (2.91e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (9.05e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.91e-7)" "unprognostic (1.51e-2)" "unprognostic (7.07e-2)" "unprognostic (4.93e-2)" "unprognostic (3.68e-3)" 30.7 3.3 3.2 16.1 2.4 1.2 19.0 4.1 6.0 9.9 0.8 20.0 9.4 12.1 0.9 3.9 5.0 8.0 10.1 1.5 4.5 4.4 4.0 8.4 11.8 7.5 4.0 1.4 13.0 6.6 2.6 2.6 36.5 6.8 7.6 5.5 3.1 4.1 13.1 4.6 5.1 10.4 41.7 3.6 5.1 9.0 2.3 4.3 1.8 5.3 2.6 9.6 12.1 7.4 10.4 58.2 147.7 42.7 35.8 112.4 183.8 19.4 935.5 295.9 415.6 517.3 1.1 4.4 10.7 7.5 602.7 193.2 47.6 2.1 79.0 215.3 1.8 8.5 0.9 19.4 1.0 226.8 0.5 3.8 164.6 3.9 155.0 20.8 274.0 350.7 2.4 0.5 2.0 138.1 32.3 0.6 1.4 29.1 0.4 24.5 1.9 36.7 0.4 120.1 0.3 0.9 13.7 122.9 6.1 8.6 131.3 0.8 1.2 510.7 384.6 103.3 163.8 127.3 4.1 0.8 29.9 905.4 1.4 413.5 0.1 0.2 0.8 0.4 0.1 0.2 0.4 0.1 0.3 0.1 0.1 0.2 0.6 0.3 0.1 0.2 0.2 0.1 0.2 3.2 2.4 4.1 6.0 1.5 4.5 7.5 4.0 1.4 6.8 3.6 4.3 10.4 12.9 0.0 3.0 6.8 0.6 2.5 0.3 26.9 0.6 1.5 0.6 9.7 2.6 1.5 4.1 0.0 0.0 2.7 0.4 0.0 0.0 1.9 0.6 1.7 26.9 33.1 0.0 0.0 8.1 1.5 22.0 22.9 1.5 2.1 0.0 2.0 19.6 0.2 1.3 1.7 3.2 0.1 0.0 0.3 5.7 0.4 0.9 0.9 3.6 6.5 0.0 1.2 0.0 7.1 11.9 2.3 0.1 0.4 0.9 0.6 0.2 0.2 1.6 3.2 26.3 2.7 48.1 1.3 1.6 0.5 3.1 1.0 1.0 3.1 0.4 0.2 ELP3 "FLJ10422, KAT9" ENSG00000134014 "Elongator acetyltransferase complex subunit 3" Q9H9T3 8 28089673-28191156 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation, tRNA processing" "Acyltransferase, RNA-binding, Transferase, tRNA-binding" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 74.3;Glandular and luminal cells: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025297, HPA025812" Uncertain Enhanced Cytosol NA NA Cytosol "HPA025297: , HPA025812: AB_10601369" "unprognostic (1.29e-2)" "unprognostic (1.26e-2)" "prognostic favorable (9.25e-4)" "unprognostic (3.49e-3)" "unprognostic (5.73e-2)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.07e-2)" "unprognostic (7.66e-2)" "unprognostic (1.22e-2)" "unprognostic (3.89e-1)" "unprognostic (3.46e-2)" "prognostic favorable (1.31e-5)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" 13.8 13.1 17.6 11.1 19.4 6.6 16.8 19.3 20.5 26.3 14.3 13.9 9.8 22.8 11.4 12.3 16.2 15.5 14.8 19.2 20.9 17.6 21.2 12.2 16.4 18.4 18.0 18.1 16.2 11.0 17.0 11.7 12.1 18.9 13.5 15.8 12.5 9.9 19.4 28.2 11.7 11.2 15.0 17.5 13.9 10.8 14.3 19.4 14.8 18.5 26.8 19.6 13.7 10.7 19.9 34.5 36.3 26.1 21.7 28.9 27.8 17.6 17.7 26.6 31.9 31.2 23.9 14.7 60.0 24.6 27.7 31.3 21.5 26.3 34.3 41.2 11.2 12.4 38.0 21.9 41.3 27.7 21.4 27.5 32.7 48.4 24.4 36.5 26.2 32.4 41.3 46.2 34.8 32.9 20.9 47.3 30.1 28.9 29.5 12.0 34.4 24.4 24.2 33.8 25.5 13.6 25.5 18.1 14.4 28.4 21.3 29.2 24.2 25.7 23.6 35.2 26.8 26.5 14.4 25.9 45.2 26.7 24.7 26.8 20.2 16.1 12.9 25.0 22.2 28.7 17.9 21.8 26.0 18.3 21.2 18.7 22.1 3.8 25.0 27.0 17.3 23.5 19.1 17.6 19.4 19.3 20.5 19.2 20.9 18.4 18.0 18.1 18.9 17.5 19.4 19.9 8.8 3.2 12.7 26.4 14.4 2.7 7.1 10.2 10.8 8.5 6.8 8.9 16.6 7.2 11.1 7.3 22.9 15.1 12.5 6.3 7.9 12.5 7.4 74.3 25.0 10.1 1.2 9.4 32.2 9.9 14.8 9.5 9.7 125.2 8.2 12.8 10.4 19.0 14.9 15.2 38.7 7.0 0.0 13.2 4.0 4.8 8.4 9.6 1.8 31.9 9.6 8.7 24.7 49.3 45.9 9.3 11.3 10.1 11.0 7.6 9.9 13.1 10.6 12.2 0.0 9.5 8.4 20.2 17.7 6.9 2.4 10.4 13.7 15.6 10.5 5.4 PEBP4 "CORK1, hPEBP4, MGC22776" ENSG00000134020 "Phosphatidylethanolamine binding protein 4" Q96S96 8 22713251-23000000 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 385.9;skeletal muscle: 677.1;tongue: 586.5" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 109.0;Alveolar cells type 2: 177.3;Cardiomyocytes: 144.7;Muller glia cells: 198.7" "Group enriched" "Detected in many" 13 "lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA025064 Uncertain "Secreted in other tissues" NA NA 190000000 "HPA025064: AB_1855174" "unprognostic (1.34e-2)" "unprognostic (2.97e-2)" "unprognostic (4.11e-2)" "unprognostic (3.66e-1)" "unprognostic (3.35e-1)" "unprognostic (4.78e-2)" "unprognostic (1.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.60e-1)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "unprognostic (8.76e-3)" "unprognostic (9.70e-8)" "unprognostic (1.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.48e-1)" "unprognostic (4.59e-1)" 1.0 3.4 11.5 0.3 14.8 0.0 3.4 21.5 9.5 0.6 17.1 0.5 0.0 0.5 385.9 6.9 2.3 1.1 184.5 8.0 20.7 2.5 0.9 116.1 0.8 18.3 18.5 6.0 1.7 34.8 83.4 13.3 0.4 19.1 46.2 0.2 13.0 21.3 2.8 677.1 1.2 0.6 0.4 7.8 0.8 9.2 6.6 25.6 1.2 57.2 586.5 1.6 0.3 0.5 15.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 11.5 14.8 21.5 9.5 8.0 20.7 18.3 18.5 6.0 19.1 7.8 25.6 15.2 1.5 109.0 177.3 15.3 2.2 1.9 1.0 0.1 0.0 10.2 5.7 4.7 144.7 0.0 7.4 1.8 2.1 0.8 1.4 0.3 3.9 0.0 34.8 1.7 2.0 2.4 0.0 0.0 10.0 9.3 0.2 10.1 2.0 7.0 7.6 0.4 3.9 0.7 1.2 10.1 9.6 0.3 2.0 0.0 0.8 28.4 3.4 1.4 1.8 6.5 0.1 198.7 5.2 6.6 0.9 0.3 0.1 10.9 1.5 23.8 0.5 5.9 2.9 8.6 0.0 25.2 2.1 14.8 1.2 0.0 0.9 0.0 1.6 1.1 0.3 1.0 ADAMDEC1 M12.219 ENSG00000134028 "ADAM like decysin 1" O15204 8 24384285-24406013 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 428.4" "Cell type enhanced" "Detected in some" "Hofbauer cells: 14.8;Kupffer cells: 12.9;Macrophages: 25.5;monocytes: 5.2" "Cancer enhanced" "Detected in all" "testis cancer: 16.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "U-266/70: 10.7;U-266/84: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 28000000 "unprognostic (1.17e-2)" "unprognostic (1.80e-2)" "unprognostic (4.15e-3)" "unprognostic (3.60e-1)" "unprognostic (6.21e-2)" "unprognostic (3.84e-3)" "unprognostic (2.12e-1)" "unprognostic (2.90e-1)" "unprognostic (1.61e-1)" "unprognostic (5.99e-3)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (1.74e-2)" "unprognostic (2.06e-1)" "unprognostic (1.35e-2)" "unprognostic (3.66e-2)" "unprognostic (8.23e-2)" 0.5 0.5 0.1 52.6 0.0 0.3 0.6 0.0 0.8 0.4 0.0 217.4 191.1 0.9 0.2 0.9 0.1 3.2 0.4 0.2 0.0 0.2 0.1 1.6 73.9 0.2 0.1 0.0 0.1 0.2 0.0 0.0 7.8 0.4 0.8 314.5 0.0 0.7 0.4 0.0 0.4 428.4 11.7 0.1 5.8 5.9 0.3 0.2 5.7 0.3 0.0 27.4 20.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 10.7 2.7 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.8 0.0 1.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.2 0.0 0.2 0.1 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.1 0.0 0.0 12.9 2.0 0.0 0.0 25.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 CTIF KIAA0427 ENSG00000134030 "Cap binding complex dependent translation initiation factor" O43310 18 48539031-48863217 "Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 94.7;Excitatory neurons: 76.4;Inhibitory neurons: 80.6;Oligodendrocyte precursor cells: 75.9;Oligodendrocytes: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016865, HPA024801" Uncertain Supported Cytosol NA NA Cytosol "HPA016865: AB_1852311, HPA024801: AB_1852312" "unprognostic (5.84e-2)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.86e-2)" "unprognostic (1.95e-3)" "unprognostic (2.77e-3)" "unprognostic (1.35e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-1)" "unprognostic (2.34e-3)" "unprognostic (7.33e-3)" 32.1 20.2 13.8 3.3 13.0 2.0 24.5 9.5 22.7 13.8 0.3 19.6 2.5 21.6 2.6 11.5 16.4 7.6 23.2 15.2 14.9 10.8 25.0 14.4 1.4 19.3 17.9 13.8 28.3 9.9 4.6 12.5 4.3 19.7 14.0 1.6 7.5 11.1 5.5 16.0 12.9 10.0 7.0 7.4 6.8 19.7 7.4 18.3 1.4 10.8 4.3 1.0 26.3 12.7 19.0 3.2 3.4 4.5 5.8 11.3 6.0 2.5 15.9 13.2 12.4 11.2 3.5 1.9 0.0 3.5 22.0 5.2 6.7 3.3 9.0 5.3 0.0 2.7 1.4 7.9 8.4 21.6 2.6 4.5 8.4 14.5 7.8 13.8 8.9 8.9 4.1 4.0 9.8 8.0 1.7 0.9 2.0 2.2 3.4 2.8 1.6 5.2 4.2 3.7 4.3 9.6 9.7 5.6 6.0 4.5 3.8 3.8 3.1 18.1 11.4 10.5 3.4 2.9 3.3 4.2 0.0 10.1 1.6 5.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 13.0 9.5 22.7 15.2 14.9 19.3 17.9 13.8 19.7 7.4 18.3 19.0 7.3 35.3 3.7 94.7 1.9 3.3 2.1 3.5 2.8 25.6 11.2 8.4 16.0 5.7 5.6 7.3 16.7 1.9 0.8 4.6 7.9 5.1 11.1 1.7 7.7 8.5 3.5 0.4 76.4 4.8 2.8 13.1 7.1 3.6 4.5 19.5 7.5 23.0 4.2 11.8 80.6 3.5 4.1 6.4 2.7 19.3 25.1 5.0 3.6 30.0 1.5 3.6 3.1 75.9 59.7 5.7 2.7 50.8 4.8 3.0 5.9 5.8 4.7 8.8 6.6 8.8 9.4 2.3 1.8 3.5 2.3 1.2 0.7 34.7 3.3 3.3 MRO "B29, C18orf3, FLJ30140" ENSG00000134042 Maestro Q9BYG7 18 50795120-50825402 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 38.7;kidney: 24.3;testis: 29.2" "Cell type enhanced" "Detected in some" "Astrocytes: 30.0;Granulosa cells: 11.3;Hepatic stellate cells: 37.5;Kupffer cells: 13.0;Proximal enterocytes: 20.0;Proximal tubular cells: 16.0" "Cancer enriched" "Detected in some" 7 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 2.4;ASC TERT1: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022011 Approved NA NA "HPA022011: AB_2670880" "unprognostic (9.21e-5)" "unprognostic (5.22e-2)" "unprognostic (7.87e-3)" "unprognostic (1.45e-2)" "unprognostic (2.47e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.32e-1)" "unprognostic (4.71e-1)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (3.99e-3)" "unprognostic (6.06e-4)" 2.3 2.5 35.5 0.5 38.6 0.2 0.6 33.1 33.4 0.3 17.4 0.2 8.0 0.2 3.1 0.5 0.3 1.0 2.4 33.2 38.7 24.3 7.3 0.2 0.3 38.4 35.3 26.6 3.3 1.9 5.3 1.3 0.7 36.2 0.2 0.2 1.6 0.3 2.2 2.0 0.1 4.7 0.3 31.7 2.2 1.3 29.2 36.6 1.2 6.1 1.3 0.1 0.4 0.2 30.1 0.0 0.0 0.0 0.2 2.4 8.2 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.3 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 35.5 38.6 33.1 33.4 33.2 38.7 38.4 35.3 26.6 36.2 31.7 36.6 30.1 0.2 0.0 0.0 30.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.8 1.5 0.0 0.0 2.1 0.0 0.0 0.2 5.9 0.0 0.8 0.2 0.0 0.9 0.0 0.0 1.5 1.0 0.8 0.8 1.1 0.1 0.0 11.3 37.5 4.7 8.4 0.0 1.1 0.1 0.0 13.0 0.3 3.3 1.2 1.8 0.0 3.7 0.0 3.9 1.0 5.0 0.3 0.1 0.0 0.7 0.0 0.1 20.0 16.0 0.0 0.2 0.0 0.4 0.1 1.2 0.5 0.0 0.0 0.1 0.1 4.3 0.6 0.1 MBD2 ENSG00000134046 "Methyl-CpG binding domain protein 2" Q9UBB5 18 54151606-54224669 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037282, HPA067582, HPA067615" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872" "unprognostic (4.86e-2)" "unprognostic (7.21e-2)" "prognostic favorable (6.49e-4)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "unprognostic (2.47e-1)" "unprognostic (2.38e-3)" "unprognostic (2.35e-2)" "unprognostic (2.71e-2)" "unprognostic (2.36e-3)" "unprognostic (8.04e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-3)" "unprognostic (5.19e-2)" 27.1 10.6 6.6 19.4 8.3 20.5 20.1 9.5 9.5 14.2 7.2 17.4 12.1 11.4 16.0 29.8 11.4 11.6 14.1 6.8 8.8 16.7 17.0 16.5 32.3 7.6 8.3 6.3 11.5 17.5 16.6 9.3 19.0 8.2 13.5 16.6 14.4 19.5 15.3 15.6 25.6 15.6 12.0 7.1 21.3 14.1 31.8 7.5 20.3 31.2 16.9 35.5 21.2 20.3 8.0 29.1 13.2 23.2 11.7 27.3 23.0 22.5 26.5 33.9 30.6 26.6 8.5 15.8 68.7 13.1 42.1 13.5 45.1 20.1 36.6 33.4 50.2 11.1 10.2 20.4 18.3 28.2 32.7 17.7 20.2 40.3 23.5 34.1 20.3 35.9 20.7 8.0 62.0 28.0 14.0 33.1 18.1 24.2 11.3 17.2 21.8 13.9 27.9 44.5 29.9 25.6 10.8 21.0 21.1 14.7 30.3 10.9 16.3 31.2 31.1 14.1 10.9 24.4 65.1 38.3 52.5 27.4 27.4 19.0 0.0 1.4 0.7 0.6 2.6 0.9 0.7 0.7 1.0 0.8 1.3 0.3 0.6 1.2 0.2 5.0 0.7 1.5 0.4 6.6 8.3 9.5 9.5 6.8 8.8 7.6 8.3 6.3 8.2 7.1 7.5 8.0 71.1 28.9 21.0 30.3 44.9 49.3 37.3 21.2 13.1 19.3 46.0 35.3 35.8 24.3 23.0 33.1 16.7 14.3 57.6 51.2 7.9 26.3 1.9 62.1 48.9 38.0 16.3 22.7 42.5 58.4 49.4 32.7 21.9 103.3 8.2 32.0 32.2 25.2 30.3 21.9 38.3 35.9 10.2 142.6 38.7 4.8 25.1 82.2 26.6 43.1 69.3 45.9 8.2 32.2 49.5 54.3 28.0 26.4 53.7 51.5 35.7 23.5 30.0 27.0 26.3 39.0 35.2 6.5 6.1 54.6 62.5 18.3 47.7 43.0 38.7 79.5 IER3IP1 ENSG00000134049 "Immediate early response 3 interacting protein 1" Q9Y5U9 18 47152834-47176364 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Diabetes mellitus, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 357.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA010027 Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010027: AB_1079098" "unprognostic (6.13e-2)" "unprognostic (2.96e-2)" "unprognostic (3.82e-2)" "unprognostic (1.45e-2)" "unprognostic (1.11e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (6.47e-6)" "unprognostic (9.86e-2)" "unprognostic (5.13e-2)" "prognostic favorable (8.59e-4)" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (1.53e-3)" "unprognostic (8.55e-2)" "unprognostic (2.71e-2)" "unprognostic (8.75e-2)" "unprognostic (1.27e-3)" 13.8 17.3 8.8 11.9 9.0 14.7 14.3 11.8 10.1 10.6 11.5 14.2 17.1 11.3 11.0 12.1 9.1 10.3 17.1 8.8 9.4 31.6 19.7 12.4 11.5 9.4 9.1 8.7 11.7 13.8 19.3 15.6 11.0 9.8 14.1 13.1 14.2 15.2 7.9 31.4 13.9 15.8 9.6 8.9 11.2 16.0 9.4 9.4 11.2 16.0 21.9 10.7 14.0 11.1 9.4 27.1 15.3 22.9 20.5 30.5 33.8 15.9 62.7 30.5 30.6 32.2 12.5 22.7 26.5 19.3 28.1 25.0 32.3 21.8 22.1 33.2 43.5 19.5 23.3 23.0 38.2 32.5 70.5 33.2 26.8 27.7 27.6 20.6 28.9 26.7 23.7 19.4 39.7 33.0 15.0 25.1 33.7 11.6 11.5 18.4 24.7 35.9 37.9 31.2 26.0 26.4 29.4 21.5 18.1 38.8 16.4 18.0 40.1 38.7 45.2 23.3 22.0 34.7 56.9 66.4 27.9 35.3 44.4 37.2 15.9 17.2 16.1 25.0 16.6 22.2 18.9 21.1 21.5 16.6 20.9 19.6 20.8 1.9 17.3 17.5 34.5 23.6 19.3 8.8 9.0 11.8 10.1 8.8 9.4 9.4 9.1 8.7 9.8 8.9 9.4 9.4 80.8 86.6 51.8 7.8 58.9 0.0 64.6 0.0 73.4 48.0 96.0 51.4 63.1 97.2 19.2 51.5 8.4 104.9 61.3 35.6 140.8 124.3 18.4 49.5 47.7 70.8 37.6 51.3 15.7 138.9 126.3 76.2 57.6 55.6 13.9 40.0 83.6 138.8 108.9 40.4 17.4 69.1 0.0 63.6 0.0 13.3 84.8 54.8 0.0 12.2 79.4 69.6 86.5 16.1 19.1 139.3 50.1 48.5 158.8 117.3 125.0 357.0 26.2 48.0 52.6 40.4 61.6 163.3 158.9 88.1 0.0 177.2 54.4 36.7 62.2 109.4 MRPS36 "DC47, MRP-S36" ENSG00000134056 "Mitochondrial ribosomal protein S36" P82909 5 69217760-69230158 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 546.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035802, HPA056795" Supported Enhanced Mitochondria NA NA Mitochondria "HPA035802: AB_10600933, HPA056795: AB_2683237" "unprognostic (1.19e-1)" "unprognostic (6.78e-3)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (2.96e-3)" "unprognostic (1.99e-1)" "unprognostic (7.49e-2)" "unprognostic (1.49e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (3.90e-1)" "prognostic favorable (5.02e-6)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.84e-3)" 20.4 18.6 22.0 12.8 22.0 21.2 16.7 22.9 26.5 11.8 22.0 23.9 24.3 12.9 15.5 20.4 12.8 10.5 57.0 21.9 23.0 49.7 38.3 14.8 15.2 22.3 22.5 21.4 12.5 14.8 31.6 9.9 13.1 22.4 14.6 24.5 19.1 13.9 12.2 47.3 12.6 24.2 12.5 22.3 11.7 22.0 8.7 22.6 15.9 17.3 68.3 16.8 16.8 14.2 23.4 29.2 27.6 19.1 26.4 32.8 33.1 50.3 25.6 24.5 32.1 39.4 38.6 31.8 31.2 51.9 21.8 71.8 29.3 32.1 38.8 31.7 36.8 33.6 21.3 31.4 43.4 38.7 22.9 27.9 34.6 27.3 30.7 14.5 33.4 24.0 31.9 25.7 22.9 28.7 31.8 35.3 34.9 14.2 26.8 31.9 20.6 33.2 47.9 56.4 32.5 26.6 25.9 26.2 37.9 46.3 30.9 29.0 32.9 17.6 14.3 24.5 32.0 44.5 23.9 41.9 41.6 25.0 42.1 19.1 36.3 22.1 29.3 22.7 32.0 25.4 31.1 25.7 25.8 27.9 25.0 22.8 24.7 25.1 26.5 30.2 27.4 40.3 17.7 22.0 22.0 22.9 26.5 21.9 23.0 22.3 22.5 21.4 22.4 22.3 22.6 23.4 64.5 115.4 83.6 16.3 76.5 81.4 101.1 204.0 83.1 26.3 72.4 109.3 333.1 97.2 104.3 88.3 14.6 126.8 67.5 220.5 401.1 118.4 127.7 123.3 79.5 57.2 92.8 97.2 20.4 139.5 192.4 68.6 67.2 113.0 56.4 41.4 52.1 216.1 127.1 28.6 21.4 162.8 120.1 102.4 67.5 45.2 64.7 72.9 106.7 10.3 142.0 61.8 56.7 10.6 17.1 137.1 190.1 69.2 60.5 100.5 256.6 546.3 86.4 45.9 72.3 78.7 92.3 66.1 37.9 86.9 76.9 123.3 64.2 76.9 168.1 114.6 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167135-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3;lymphoid tissue: 76.9" "Cell type enriched" "Detected in many" 6 "Extravillous trophoblasts: 723.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 3.0;white matter: 8.3" "Not detected" "Not detected" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Yes Yes Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522" "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.54e-7)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 4.0 5.1 4.1 26.2 4.3 53.3 10.1 6.4 5.0 5.8 3.2 22.4 21.1 7.7 5.4 36.2 8.3 4.0 3.1 4.0 4.8 4.8 4.3 3.9 55.0 6.1 5.1 4.3 5.0 4.3 5.8 2.7 20.9 7.0 3.8 29.8 5.8 6.5 3.9 3.5 14.7 19.6 14.5 4.0 11.2 10.9 33.2 5.3 76.9 9.4 2.0 67.6 8.5 10.5 6.4 466.0 317.1 423.5 377.1 22.2 37.1 980.2 201.3 150.8 521.3 437.0 471.2 423.9 285.2 239.1 187.6 594.2 284.2 432.4 442.8 577.2 281.4 217.2 181.6 243.2 323.2 6.8 160.5 197.7 16.6 27.7 300.5 207.2 47.7 282.8 274.2 223.5 217.9 430.2 441.4 220.5 184.7 236.7 153.3 199.3 228.4 305.2 288.2 192.6 168.2 212.7 133.5 347.7 160.3 141.9 236.4 306.4 162.5 119.8 114.4 368.5 207.6 510.2 109.2 216.6 399.8 158.8 271.9 358.6 3.1 2.0 1.5 3.2 5.1 4.5 15.4 8.3 7.4 6.0 11.1 2.7 2.6 1.3 8.2 2.4 5.0 17.6 6.2 4.1 4.3 6.4 5.0 4.0 4.8 6.1 5.1 4.3 7.0 4.0 5.3 6.4 4.0 0.0 0.5 2.0 11.8 11.5 7.2 32.1 4.6 4.8 9.8 12.3 1.9 1.5 8.8 5.5 2.1 108.2 8.3 9.5 1.9 6.5 110.2 15.2 7.4 6.6 1.2 76.2 2.7 1.4 723.1 18.3 21.4 13.0 2.5 63.0 8.9 3.2 60.2 0.0 2.1 13.8 73.2 12.0 7.2 17.8 3.1 9.7 3.6 1.0 2.7 3.9 2.1 0.5 1.0 2.4 1.5 2.6 24.1 4.5 2.5 5.6 13.1 4.1 6.6 4.9 18.5 74.3 62.2 37.4 7.2 41.5 8.0 11.8 33.4 7.8 CDK7 "CAK, CAK1, CDKN7, MO15, STK1" ENSG00000134058 "Cyclin dependent kinase 7" P50613 5 69234795-69277430 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 121.0;Extravillous trophoblasts: 343.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 169.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004364, HPA007932, HPA008453, CAB079975" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Plasma membrane, Cytosol" "CAB004364: AB_627243, CAB079975: , HPA007932: AB_1078492, HPA008453: " "unprognostic (3.12e-2)" "unprognostic (1.23e-1)" "unprognostic (4.87e-2)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.49e-3)" "unprognostic (1.64e-2)" "unprognostic (7.77e-3)" "unprognostic (1.81e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (3.40e-2)" "prognostic unfavorable (9.42e-7)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-2)" 13.4 20.0 9.3 9.5 9.7 29.3 14.9 10.8 13.0 14.4 10.9 12.9 13.4 12.2 13.0 37.6 12.6 6.5 11.4 9.2 10.3 18.2 13.7 12.8 4.8 9.4 9.4 9.0 11.8 14.3 3.2 18.3 16.4 9.7 13.8 7.5 12.9 19.1 4.9 27.0 25.4 12.3 7.8 9.7 12.7 13.6 30.8 9.6 9.4 13.4 15.1 13.4 16.2 20.1 9.9 42.8 5.9 19.4 30.6 6.4 24.4 169.5 30.9 37.5 46.2 42.9 62.2 64.5 3.7 36.4 36.8 34.2 65.3 10.8 31.3 40.6 9.0 3.1 8.6 21.4 25.9 32.8 17.9 33.8 7.1 61.3 1.8 46.0 24.5 32.5 22.3 16.3 16.1 13.3 33.3 9.4 51.7 20.7 2.8 25.4 12.3 0.7 27.1 42.6 25.4 8.6 17.5 11.6 50.4 42.4 28.1 44.9 39.3 7.4 17.1 27.4 33.1 18.2 14.4 30.4 16.5 31.4 10.2 15.5 27.9 7.9 16.2 5.3 8.9 7.9 10.6 7.8 10.6 7.3 14.5 5.9 6.4 8.2 8.6 4.7 8.9 10.5 6.1 9.3 9.7 10.8 13.0 9.2 10.3 9.4 9.4 9.0 9.7 9.7 9.6 9.9 12.2 16.0 13.2 10.7 7.8 57.7 21.4 32.9 15.4 6.4 12.3 14.7 11.3 10.0 20.2 5.5 12.5 121.0 11.7 10.2 15.6 27.8 26.8 33.1 10.7 11.6 3.0 9.9 17.6 21.6 343.6 13.0 9.7 27.2 15.8 7.4 7.1 6.7 24.0 1.7 13.7 12.3 20.3 8.5 6.0 7.9 7.5 8.5 7.2 11.2 11.6 10.4 15.5 8.0 11.9 29.3 16.2 7.2 5.8 28.2 12.3 29.3 42.4 8.7 26.3 10.0 12.5 70.1 18.6 15.9 41.9 64.6 11.4 6.8 13.2 29.8 CD180 "LY64, Ly78, RP105" ENSG00000134061 "CD180 molecule" Q99467 5 67179613-67196799 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.5" "Cell type enhanced" "Detected in some" "B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory B-cell: 77.0;naive B-cell: 78.9" "Group enriched" "Detected in many" 25 "B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5" "Group enriched" "Detected in some" 10 "Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003740 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle" Yes NA "Plasma membrane" "Nucleoplasm, Nucleoli, Mitotic spindle" "HPA003740: AB_1078450" "unprognostic (9.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.81e-3)" "unprognostic (5.85e-3)" "unprognostic (2.25e-2)" "unprognostic (4.04e-3)" "unprognostic (1.09e-1)" "unprognostic (4.95e-2)" "unprognostic (5.83e-2)" "unprognostic (3.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.09e-1)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" 1.6 0.7 0.9 9.8 0.9 2.4 6.8 0.6 1.4 0.5 0.8 2.2 2.0 0.5 0.2 0.4 0.4 1.6 0.4 0.7 2.0 0.2 2.5 1.6 23.4 1.4 1.1 0.5 0.2 0.3 0.2 0.1 3.2 1.5 0.5 2.8 0.3 1.1 0.4 0.1 0.2 3.9 1.8 1.8 13.0 2.3 0.4 1.6 2.5 0.3 0.2 23.5 3.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 41.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.6 0.2 33.1 49.0 12.3 0.0 2.7 0.0 0.3 11.8 0.9 0.0 20.4 0.0 77.0 0.1 0.1 22.1 78.9 0.0 0.0 0.9 1.8 34.5 23.5 0.1 8.5 0.9 0.9 0.6 1.4 0.7 2.0 1.4 1.1 0.5 1.5 1.8 1.6 3.4 0.1 0.0 0.5 0.3 53.6 0.4 0.1 0.0 0.0 0.1 1.8 1.1 0.7 1.5 0.0 0.0 0.0 0.4 4.0 0.0 0.0 0.0 2.2 0.1 0.0 0.6 0.0 1.7 0.0 0.2 0.3 0.4 0.0 0.1 2.5 0.0 0.0 0.3 78.6 0.0 0.0 0.0 0.0 23.5 8.0 1.0 0.0 17.5 0.0 1.9 13.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 39.6 0.0 0.0 0.1 0.7 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.7 2.2 0.0 0.1 0.1 IRAK2 ENSG00000134070 "Interleukin 1 receptor associated kinase 2" O43187 3 10164919-10243745 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.5" "Cell type enhanced" "Detected in many" "Langerhans cells: 43.7;Oligodendrocytes: 34.3;Prostatic glandular cells: 23.4;Urothelial cells: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 33.2;BJ hTERT+: 35.2;CAPAN-2: 35.6;GAMG: 62.6;RT4: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013483, HPA050520" Uncertain Approved Vesicles NA NA Vesicles "CAB013483: , HPA050520: AB_2681154" "unprognostic (1.31e-1)" "unprognostic (2.04e-2)" "unprognostic (1.46e-2)" "unprognostic (4.61e-3)" "unprognostic (8.71e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.89e-2)" "unprognostic (8.01e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.24e-1)" "unprognostic (3.10e-2)" "unprognostic (7.22e-2)" "unprognostic (4.38e-2)" "unprognostic (3.91e-2)" "prognostic favorable (6.60e-5)" 5.7 3.6 3.7 6.1 4.0 23.5 4.7 3.9 7.3 2.4 2.6 2.0 2.0 2.1 0.7 7.2 1.8 4.4 1.8 3.4 4.6 3.3 10.9 10.5 3.8 5.4 4.3 3.3 1.0 1.9 1.0 1.2 2.2 5.8 3.3 1.7 1.5 3.6 1.8 17.2 4.9 5.5 1.4 4.3 4.5 3.4 1.3 4.4 4.0 3.1 4.3 11.6 16.2 4.5 8.3 2.7 7.6 0.3 1.0 8.1 6.7 33.2 2.9 35.2 4.7 4.5 3.6 35.6 0.1 0.9 4.3 62.6 0.8 0.8 9.0 6.3 2.3 2.5 0.8 1.7 9.9 3.9 0.0 1.1 4.1 1.5 17.3 22.4 12.4 9.7 0.3 1.8 10.7 5.7 0.1 0.0 1.8 0.3 4.2 7.5 1.7 0.0 0.6 10.3 49.2 0.5 0.3 3.3 0.1 0.3 0.8 0.8 1.7 10.1 10.7 0.9 6.5 7.0 3.6 11.3 2.1 22.9 4.7 1.9 0.2 1.0 0.1 5.8 0.7 6.0 4.2 1.7 3.3 1.0 3.2 1.2 3.0 2.1 7.4 0.2 0.0 0.7 2.2 3.7 4.0 3.9 7.3 3.4 4.6 5.4 4.3 3.3 5.8 4.3 4.4 8.3 3.9 0.0 4.1 1.6 8.3 8.0 20.8 9.9 5.2 0.9 1.6 1.3 2.0 0.0 6.1 0.0 0.0 0.2 3.8 1.3 0.0 9.8 4.1 4.3 2.4 12.3 0.0 0.0 6.3 4.2 0.7 4.3 7.7 16.7 0.0 0.1 0.7 4.8 3.4 0.0 7.0 0.7 4.1 2.9 43.7 1.5 0.9 20.9 5.4 13.1 1.9 2.1 7.2 7.1 34.3 15.7 0.3 0.0 7.4 23.4 2.6 1.1 1.3 0.0 0.0 4.2 2.0 0.7 0.9 4.7 7.4 1.0 3.9 0.2 0.5 30.4 CAMK1 "CaMKI, CaMKI-alpha" ENSG00000134072 "Calcium/calmodulin dependent protein kinase I" Q14012 3 9757347-9769992 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Differentiation, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 100.5" "Cell type enhanced" "Detected in many" "Adipocytes: 58.3;Hofbauer cells: 76.2;Macrophages: 71.2;Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "eosinophil: 280.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 280.5" "Cell line enriched" "Detected in many" 4 "HMC-1: 403.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031904, HPA051409" Approved Approved Cytosol NA NA 110000 Cytosol "CAB031904: AB_630964, HPA051409: AB_2681473" "unprognostic (4.43e-2)" "unprognostic (3.05e-1)" "unprognostic (1.68e-1)" "unprognostic (1.29e-1)" "unprognostic (1.11e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.53e-2)" "unprognostic (3.32e-1)" "unprognostic (9.74e-2)" "unprognostic (1.37e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "unprognostic (7.76e-2)" "unprognostic (1.72e-1)" "unprognostic (3.67e-2)" "unprognostic (3.01e-1)" 46.4 100.5 48.8 17.4 46.9 5.2 37.6 38.3 60.9 27.0 30.9 27.3 9.3 32.1 13.8 8.0 37.4 11.2 20.0 58.2 42.7 25.0 36.7 24.1 11.2 37.0 41.4 48.8 41.6 8.5 14.6 21.8 6.7 41.4 31.3 10.7 6.0 9.8 19.9 7.2 7.5 16.6 26.2 36.4 16.8 21.9 30.1 43.0 4.3 19.7 7.8 15.1 28.6 18.4 44.7 0.5 16.4 12.6 0.0 64.7 24.3 32.6 38.4 21.1 43.1 40.4 24.1 3.0 1.1 9.0 26.0 6.2 2.7 0.0 5.0 27.0 0.4 95.4 53.5 32.1 34.1 35.9 4.5 403.3 25.3 4.1 60.6 6.7 35.4 36.8 0.9 7.2 1.2 16.3 10.3 0.3 38.8 9.0 0.4 25.7 0.3 0.4 1.1 25.9 2.8 4.2 16.7 6.6 0.7 4.0 5.3 4.1 67.2 19.6 19.8 24.4 28.0 48.7 0.4 0.3 1.0 41.5 14.7 3.0 17.8 21.3 280.5 0.3 42.2 0.1 0.1 0.4 0.2 14.1 0.2 0.3 0.1 1.0 3.6 43.0 0.4 2.0 4.7 48.8 46.9 38.3 60.9 58.2 42.7 37.0 41.4 48.8 41.4 36.4 43.0 44.7 58.3 0.0 3.1 17.9 2.8 5.0 19.2 3.4 5.7 9.9 5.2 4.6 0.1 12.8 2.1 11.0 2.1 0.4 3.0 2.6 9.8 14.4 1.8 1.8 14.9 22.8 6.0 4.8 25.6 4.0 1.2 23.3 5.6 3.1 30.5 16.7 30.4 23.5 76.2 0.0 14.5 2.3 0.0 46.4 40.2 7.2 36.1 71.2 5.4 8.4 36.7 39.4 3.1 6.6 2.7 5.5 2.9 45.1 0.2 17.5 3.6 47.4 1.3 7.7 59.2 12.2 42.7 1.5 3.7 1.5 3.8 0.8 7.1 6.6 7.6 11.0 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362971-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol No No Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: AB_2674985" "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 14.6 15.7 10.2 15.2 11.7 33.3 18.2 12.9 11.6 18.2 12.9 19.3 17.0 16.5 16.8 21.1 14.9 13.7 24.8 10.2 13.9 20.2 23.6 14.3 19.0 12.1 11.0 9.2 14.8 15.6 26.0 12.2 15.2 12.3 19.7 19.2 22.2 16.0 18.1 27.1 13.7 14.4 14.5 12.3 14.4 14.2 59.9 11.3 18.5 23.3 26.7 17.8 16.5 9.7 14.9 40.0 53.0 36.4 18.7 46.5 44.4 146.3 47.2 38.3 47.1 35.8 40.2 41.0 41.0 35.8 43.5 74.1 26.0 66.4 48.3 47.9 45.6 39.1 51.0 51.2 35.3 44.8 66.0 35.3 36.2 53.7 55.7 58.1 38.0 31.5 65.1 80.2 58.2 62.9 55.3 78.9 27.2 69.3 44.0 50.1 49.4 62.7 57.9 29.7 60.4 15.5 48.9 39.6 27.5 43.5 37.2 45.2 42.1 22.8 45.0 38.9 54.9 53.1 73.1 186.7 129.2 55.0 60.5 65.7 19.1 17.8 17.6 20.5 23.4 26.2 17.2 17.6 21.9 20.8 20.0 28.0 21.5 3.6 17.7 29.0 20.5 18.4 14.1 10.2 11.7 12.9 11.6 10.2 13.9 12.1 11.0 9.2 12.3 12.3 11.3 14.9 14.9 25.6 21.8 10.1 14.0 10.7 29.3 42.6 16.5 21.6 19.5 23.2 45.3 17.2 34.6 22.0 16.7 34.7 13.1 10.0 52.8 39.2 270.0 19.2 26.8 14.9 3.0 9.7 9.7 29.4 28.4 22.3 12.2 20.9 28.4 21.9 13.2 25.3 27.4 38.7 13.2 15.5 38.7 14.8 6.8 145.3 20.5 18.0 12.4 9.4 20.2 31.4 18.6 18.1 12.5 28.2 9.8 25.9 16.2 32.6 10.9 32.6 20.1 35.2 6.6 28.5 24.5 183.5 52.9 18.9 12.9 27.5 18.4 49.2 20.0 20.9 VHL VHL1 ENSG00000134086 "Von Hippel-Lindau tumor suppressor" P40337 3 10141778-10153667 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031631, HPA031632, HPA068954" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: " "prognostic unfavorable (9.02e-5)" "unprognostic (1.10e-1)" "unprognostic (4.46e-3)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.55e-1)" "unprognostic (3.03e-2)" "unprognostic (4.36e-2)" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (2.51e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.46e-1)" "unprognostic (2.92e-2)" "unprognostic (1.28e-3)" 14.2 13.8 12.0 21.3 11.6 28.1 14.9 13.5 12.1 11.9 7.5 15.0 15.8 14.2 9.9 12.4 13.5 11.6 7.7 12.4 13.3 12.7 14.2 11.9 29.9 9.8 10.0 12.1 12.7 12.8 11.8 9.1 14.2 11.3 14.1 15.8 9.0 14.7 10.3 11.5 14.3 17.4 12.9 10.5 22.7 16.2 13.5 15.1 23.6 16.0 7.8 29.9 12.6 11.0 12.5 19.5 18.2 39.9 24.6 36.0 27.7 146.5 16.8 24.0 21.1 24.5 21.5 23.7 67.9 22.2 23.0 29.9 16.4 37.2 23.6 25.7 33.0 33.7 52.7 30.5 30.6 34.3 47.3 41.3 28.1 26.3 28.0 35.1 28.4 24.6 42.5 48.3 50.3 21.1 35.0 45.5 40.9 26.7 21.1 23.4 57.3 34.6 34.6 25.5 48.7 15.0 49.4 35.0 18.7 21.0 23.9 37.0 59.1 21.3 20.8 27.7 19.6 26.8 35.7 78.1 105.6 23.2 55.3 19.4 4.6 3.2 2.3 2.6 2.2 1.9 2.5 1.8 2.2 2.0 3.3 1.7 1.8 5.6 3.0 2.0 2.3 1.7 1.2 12.0 11.6 13.5 12.1 12.4 13.3 9.8 10.0 12.1 11.3 10.5 15.1 12.5 12.4 12.8 12.5 9.1 38.7 14.7 17.8 14.3 24.5 14.7 10.7 6.1 6.1 20.0 9.6 16.5 18.8 16.8 21.9 10.7 7.9 11.8 9.6 13.1 26.1 14.8 14.4 30.5 15.9 5.1 18.7 12.8 20.9 19.9 5.1 18.4 18.9 14.3 14.9 18.5 14.2 11.3 16.2 27.1 45.8 7.3 14.0 32.3 12.4 7.5 31.9 9.1 28.8 12.1 14.9 10.7 11.7 11.3 33.3 23.8 12.3 9.5 9.7 15.3 6.6 17.4 11.9 15.4 24.0 26.7 20.5 17.2 23.5 21.4 10.2 25.9 BHLHE40 "BHLHB2, Clast5, DEC1, SHARP2, STRA13" ENSG00000134107 "Basic helix-loop-helix family member e40" O14503 3 4979437-4985323 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 101.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028922 Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA028922: AB_2672828" "unprognostic (8.64e-3)" "unprognostic (5.21e-2)" "unprognostic (1.03e-2)" "unprognostic (1.39e-1)" "unprognostic (8.58e-3)" "unprognostic (7.95e-2)" "unprognostic (2.90e-1)" "unprognostic (2.88e-3)" "unprognostic (1.31e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (5.45e-2)" "unprognostic (3.36e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (5.95e-2)" "unprognostic (7.03e-3)" 152.3 99.8 34.9 53.4 33.4 189.9 201.7 35.2 50.8 100.5 36.5 57.0 31.1 68.2 34.9 356.0 62.0 101.3 117.8 34.6 71.7 151.1 189.5 113.0 52.8 51.1 38.1 29.3 76.6 80.5 68.1 93.4 72.8 37.3 98.9 47.9 119.3 118.3 32.8 253.8 205.9 43.0 65.7 36.0 27.1 43.9 14.2 48.9 41.0 83.4 47.2 51.1 173.8 274.5 39.7 40.4 53.4 0.1 14.7 30.8 23.8 78.6 7.5 19.7 7.7 30.2 3.4 39.7 0.2 19.6 14.2 118.9 31.5 6.6 108.0 13.2 488.2 4.7 9.8 39.6 11.9 29.7 25.5 192.8 55.1 63.3 88.9 25.4 53.4 30.0 1.7 53.9 228.4 20.3 28.4 3.9 10.8 2.9 45.6 87.1 0.7 17.6 23.0 74.4 7.9 0.8 1.7 132.6 34.2 40.0 45.9 78.6 38.8 39.7 30.4 29.3 28.9 50.0 175.9 82.8 1.6 218.0 19.8 15.3 101.4 9.7 54.5 24.7 4.9 24.9 7.7 13.1 16.6 15.2 4.5 2.9 10.1 14.3 54.9 0.5 19.9 0.9 11.9 34.9 33.4 35.2 50.8 34.6 71.7 51.1 38.1 29.3 37.3 36.0 48.9 39.7 172.5 67.3 191.3 32.3 24.9 165.4 112.8 330.5 373.3 15.4 136.6 74.7 65.0 40.0 297.7 46.0 0.0 32.0 159.8 52.9 11.7 75.2 0.3 210.2 69.6 161.6 10.7 2.5 36.6 72.5 89.3 102.6 68.3 386.7 439.2 0.5 75.0 56.5 38.3 10.1 4.5 32.6 136.3 52.1 354.0 1.7 7.2 117.9 108.5 27.2 42.9 95.1 44.3 11.1 3.3 138.8 37.9 3.8 38.0 61.1 8.8 23.1 102.1 11.5 6.6 55.3 94.4 0.2 0.4 517.2 262.0 158.4 97.8 0.3 24.4 129.4 ARL8B "ARL10C, FLJ10702, Gie1" ENSG00000134108 "ADP ribosylation factor like GTPase 8B" Q9NVJ2 3 5122249-5180911 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Langerhans cells: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038759, HPA040515, HPA045924" Approved NA NA "HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-2)" "unprognostic (3.59e-1)" "unprognostic (1.12e-1)" "unprognostic (3.08e-1)" "prognostic unfavorable (3.68e-6)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-2)" "unprognostic (6.27e-3)" "unprognostic (1.96e-1)" "prognostic favorable (4.84e-6)" "unprognostic (5.90e-3)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (1.95e-2)" 42.1 51.6 62.0 36.4 67.1 60.3 42.9 63.3 73.4 39.9 49.1 34.1 31.0 45.6 40.1 66.4 31.4 39.0 55.7 67.4 66.3 54.2 44.3 44.0 39.0 66.4 63.3 63.6 39.2 27.7 48.5 0.1 50.2 66.7 45.4 35.1 34.6 28.8 42.2 51.2 55.3 34.6 47.4 68.1 34.2 34.4 32.5 68.9 36.1 62.6 60.4 47.9 50.2 0.3 76.3 49.5 44.1 38.5 20.7 118.4 103.8 71.7 67.8 75.5 64.0 75.8 33.6 44.9 52.6 29.4 65.7 141.4 30.6 61.9 60.1 73.2 58.3 35.8 86.2 34.3 48.4 162.5 73.9 97.0 96.7 179.5 80.9 56.2 67.4 72.2 47.2 76.6 55.0 96.2 45.1 63.0 56.1 36.2 44.6 65.2 43.5 52.2 46.7 63.9 73.8 22.1 41.9 57.7 112.5 96.2 42.7 66.0 219.7 61.6 66.5 55.8 91.9 62.3 50.8 88.0 143.9 94.4 102.7 54.9 42.9 37.8 24.5 18.8 33.0 22.4 19.8 19.6 18.8 31.7 16.7 20.0 20.0 17.0 22.1 27.4 14.2 20.3 27.7 62.0 67.1 63.3 73.4 67.4 66.3 66.4 63.3 63.6 66.7 68.1 68.9 76.3 35.8 80.1 63.7 52.9 42.9 128.1 60.5 40.4 74.6 23.3 44.4 31.4 55.6 31.5 45.2 35.0 10.4 42.4 30.4 38.9 19.6 37.2 33.7 45.9 39.8 35.9 13.1 35.1 61.6 37.6 80.1 48.7 33.6 88.5 56.4 25.3 19.2 42.4 97.8 8.4 68.3 19.5 24.4 68.3 249.6 42.0 23.0 109.3 55.2 47.8 103.3 37.2 23.7 47.7 86.0 61.5 26.7 33.8 45.4 71.5 23.2 46.1 40.6 22.7 72.3 31.7 45.7 34.5 24.0 109.5 164.7 173.1 36.8 23.8 16.6 123.3 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219958 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 184.4;U-698: 162.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 11.3 11.4 5.3 31.6 6.6 67.1 14.6 3.9 7.4 11.3 5.2 15.8 14.2 12.1 12.7 16.8 10.8 12.3 6.9 5.4 12.2 12.6 59.8 30.0 41.8 6.7 5.0 5.5 13.3 25.1 17.4 9.4 14.2 5.3 12.6 17.1 5.6 13.4 10.8 5.7 16.7 18.8 12.6 5.3 24.6 17.9 10.6 6.7 79.8 17.8 5.4 42.9 16.9 13.3 6.1 18.0 17.8 11.1 11.1 14.3 31.6 35.1 28.8 38.8 19.5 25.5 8.2 23.4 95.9 15.2 28.6 42.3 13.9 12.1 39.8 29.6 184.4 7.1 32.7 16.9 18.7 66.2 39.0 91.8 28.7 47.4 41.6 45.5 26.4 39.2 122.1 8.7 128.2 24.4 10.6 78.9 14.9 5.6 8.2 13.4 113.2 19.6 90.0 22.4 37.0 1.4 14.5 20.8 29.6 44.4 9.8 15.2 123.3 38.7 37.2 25.7 32.1 33.6 75.1 49.4 162.3 61.8 37.1 31.8 2.9 2.6 3.1 4.0 3.7 5.7 6.7 5.9 4.4 3.3 4.4 5.2 4.1 3.0 2.1 4.6 7.5 6.7 2.0 5.3 6.6 3.9 7.4 5.4 12.2 6.7 5.0 5.5 5.3 5.3 6.7 6.1 11.8 60.9 100.7 10.7 51.1 20.6 7.0 15.5 10.2 5.3 17.2 11.0 3.1 20.0 19.9 16.5 10.4 10.0 29.1 23.8 0.0 7.0 14.4 11.4 14.8 12.6 8.4 12.6 17.4 12.2 32.8 11.3 20.9 20.0 23.5 8.1 12.8 76.2 17.0 1.7 15.4 26.4 14.2 32.9 194.0 63.1 8.4 44.3 16.0 14.0 43.1 3.3 12.3 11.1 10.3 15.2 4.7 9.1 135.5 12.5 16.1 8.5 11.0 4.0 0.0 9.4 13.6 7.8 5.5 23.1 27.3 40.9 25.5 5.1 12.3 20.7 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092658-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9;thyroid gland: 9.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.3;Excitatory neurons: 127.6;Inhibitory neurons: 75.9;Oligodendrocyte precursor cells: 52.8" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SH-SY5Y: 2.3;SuSa: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016645 Uncertain NA NA 4700000 "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.0 3.2 1.2 0.0 2.2 0.0 0.1 10.9 2.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 1.8 0.1 0.0 3.2 0.0 2.0 3.0 1.9 0.0 0.0 0.0 0.3 2.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 3.1 0.0 9.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.2 10.9 2.4 1.1 1.8 2.0 3.0 1.9 3.7 1.3 3.1 2.2 0.0 35.3 3.6 15.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 127.6 0.0 0.2 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 75.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 52.8 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.0 CHL1 "CALL, FLJ44930, L1CAM2, MGC132578" ENSG00000134121 "Cell adhesion molecule L1 like" O00533 3 196763-409417 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Cell type enhanced" "Detected in many" "Astrocytes: 223.6;Excitatory neurons: 423.8;Inhibitory neurons: 320.7;Oligodendrocyte precursor cells: 918.4" "Cancer enhanced" "Detected in many" "glioma: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 33 "memory B-cell: 2.7;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Group enriched" "Detected in some" 5 "SK-MEL-30: 91.8;WM-115: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003345, CAB026120" Enhanced "Secreted in brain" NA NA 5800000000 "CAB026120: , HPA003345: AB_1078516" "unprognostic (5.54e-2)" "unprognostic (2.08e-1)" "unprognostic (7.45e-2)" "unprognostic (7.14e-3)" "unprognostic (1.16e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-2)" "unprognostic (2.22e-1)" "unprognostic (5.14e-1)" "unprognostic (1.06e-1)" "unprognostic (7.81e-2)" "unprognostic (3.51e-1)" "prognostic favorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (6.07e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" 13.7 4.1 15.2 8.6 41.5 0.3 8.6 2.7 44.7 3.2 0.0 11.2 4.4 3.4 1.7 9.0 2.6 4.9 7.2 36.0 33.8 17.9 0.8 5.1 6.2 15.4 11.6 32.8 16.5 1.8 0.5 2.6 0.0 8.3 3.7 8.0 16.0 7.0 6.4 0.3 13.1 6.2 5.4 8.5 3.0 4.0 1.6 10.5 0.7 0.9 1.4 2.9 3.1 5.3 18.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 41.5 2.7 44.7 36.0 33.8 15.4 11.6 32.8 8.3 8.5 10.5 18.4 4.1 0.0 0.0 223.6 8.8 22.9 0.6 2.8 56.9 1.2 0.6 13.6 18.0 1.5 15.8 11.0 0.0 0.0 0.1 0.0 11.7 0.0 2.0 2.9 0.1 2.3 0.0 0.0 423.8 0.0 0.0 33.5 0.0 1.9 1.3 106.2 1.4 1.3 0.0 1.7 320.7 0.0 0.0 0.3 4.4 1.4 2.8 0.6 3.6 22.5 0.0 58.7 0.0 918.4 11.6 0.2 0.0 0.0 1.4 6.2 0.0 19.7 17.8 2.7 0.0 2.7 11.2 3.0 1.3 15.6 12.1 0.0 1.1 12.4 0.0 0.8 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 522.3;Cone photoreceptor cells: 254.4;Excitatory neurons: 164.7;Hepatic stellate cells: 207.4;Oligodendrocyte precursor cells: 262.4;Oligodendrocytes: 219.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "basophil: 2.9;eosinophil: 2.4" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 114.0;SH-SY5Y: 104.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 68.4;olfactory bulb: 177.4" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 7.8 22.1 19.8 5.3 49.5 0.0 7.4 13.1 23.8 18.3 2.3 24.7 20.8 37.4 4.1 14.3 23.5 17.9 15.8 17.1 24.6 10.9 6.9 8.5 3.4 22.2 27.6 17.6 21.3 13.5 3.5 16.5 8.6 19.2 38.0 6.5 19.0 57.3 21.8 0.7 4.3 8.4 36.6 19.5 7.7 14.2 1.6 11.0 11.2 5.5 9.5 3.4 25.9 13.6 21.5 13.3 12.0 15.3 43.6 16.7 20.6 3.6 28.3 15.6 32.9 18.4 17.2 10.8 7.6 0.7 114.0 20.8 22.4 26.9 7.2 18.1 10.9 17.3 58.8 15.8 13.9 28.6 17.5 57.2 27.3 6.3 22.3 6.6 43.2 19.1 2.8 20.1 0.1 6.4 14.3 0.1 6.7 0.2 15.8 3.9 0.0 11.1 4.1 0.0 25.7 11.9 104.0 10.8 7.1 8.0 16.5 3.4 13.3 27.3 37.6 4.6 10.1 12.1 7.5 8.1 14.6 44.3 9.7 9.6 2.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 49.5 13.1 23.8 17.1 24.6 22.2 27.6 17.6 19.2 19.5 11.0 21.5 6.5 0.0 7.3 522.3 3.4 17.5 97.3 14.1 79.1 43.8 21.0 16.3 23.9 77.2 11.4 1.8 254.4 23.3 1.0 1.0 0.0 58.4 15.2 10.5 17.1 67.2 1.8 5.3 164.7 27.1 10.0 61.7 25.5 0.8 63.3 14.9 207.4 9.6 3.4 3.3 5.0 0.4 30.5 6.5 6.1 7.4 47.8 1.1 8.8 21.5 0.6 10.7 0.0 262.4 219.7 25.7 0.3 41.3 1.8 38.3 1.4 0.1 26.5 135.9 32.9 14.7 46.4 3.6 3.1 23.8 6.1 4.5 2.3 31.2 1.0 54.1 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 91.7;Oligodendrocytes: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 7.8 7.5 3.7 4.9 5.0 5.5 10.9 4.6 5.1 6.7 3.5 6.8 6.2 7.9 10.8 9.7 8.2 6.0 10.3 3.7 6.6 10.5 8.2 5.4 5.3 6.4 4.2 3.4 9.8 14.4 8.7 5.9 8.1 4.6 5.8 7.1 9.0 6.8 6.2 10.9 9.8 6.6 6.5 4.3 6.3 6.8 6.0 3.8 7.1 10.9 7.0 7.5 8.1 7.2 5.8 16.9 8.9 14.7 12.5 2.6 11.7 14.3 6.2 10.8 14.7 7.6 11.9 15.5 5.2 14.8 5.7 17.9 19.0 17.2 17.9 17.5 4.1 10.7 19.6 9.9 18.9 15.3 10.6 12.1 9.9 22.2 5.9 28.5 9.0 14.4 11.0 21.8 20.6 13.6 6.6 13.0 9.8 13.0 25.4 8.1 16.0 13.7 7.2 12.9 21.0 10.7 10.4 11.6 12.8 10.7 8.5 44.6 14.4 4.4 14.2 13.8 14.4 10.0 18.2 31.3 13.4 12.3 17.7 13.9 0.0 6.7 0.3 6.0 6.7 7.7 8.9 8.1 8.4 6.7 6.3 10.3 9.3 0.3 14.7 6.2 5.8 5.8 4.5 3.7 5.0 4.6 5.1 3.7 6.6 6.4 4.2 3.4 4.6 4.3 3.8 5.8 15.9 16.0 7.5 91.7 18.7 31.0 20.0 19.8 24.5 29.2 12.0 16.6 15.8 18.6 17.2 9.2 39.6 26.7 9.3 7.5 13.7 16.3 2.2 10.7 13.7 10.0 5.4 16.8 28.0 24.1 23.5 12.0 21.4 13.3 3.8 21.1 5.7 7.4 17.5 18.5 47.0 7.4 14.2 10.3 12.9 3.3 14.0 9.8 16.0 44.0 14.3 15.0 11.3 71.9 101.5 18.7 7.1 6.8 6.9 8.9 13.4 19.9 7.6 24.2 0.0 18.9 14.0 9.8 14.0 21.2 23.2 22.6 9.9 21.9 10.5 13.4 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 128.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 128.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 22.2 12.3 18.0 23.1 19.1 16.4 21.1 25.9 22.1 19.1 22.5 20.0 16.1 20.9 19.2 40.3 16.9 16.0 13.5 17.5 14.9 14.1 17.7 18.6 17.7 17.7 16.5 17.8 14.5 14.2 14.6 12.2 32.7 19.3 17.1 21.4 31.4 14.7 13.7 13.3 31.7 15.8 25.6 15.3 18.8 17.9 18.2 16.6 15.3 12.6 13.1 20.5 18.0 28.0 27.1 37.1 31.5 49.7 33.4 39.5 39.0 37.0 49.6 30.0 38.7 38.4 17.8 19.9 17.6 31.2 32.2 54.5 47.5 24.9 28.5 45.8 36.9 12.6 31.8 34.6 21.6 27.0 33.9 33.1 23.6 40.8 26.1 51.3 39.7 70.6 45.4 34.3 36.7 53.1 17.6 21.4 27.4 35.8 47.4 25.0 32.3 30.3 16.1 35.9 49.5 28.1 24.8 30.1 21.9 14.7 49.2 27.0 38.8 40.4 51.9 26.7 46.8 39.7 21.5 32.5 37.1 46.5 35.7 38.9 62.8 18.2 29.7 18.4 17.3 23.3 23.9 19.6 18.8 20.7 25.6 21.5 19.2 128.5 13.2 11.5 28.4 17.9 12.0 18.0 19.1 25.9 22.1 17.5 14.9 17.7 16.5 17.8 19.3 15.3 16.6 27.1 59.7 38.5 25.2 83.9 41.7 41.3 65.2 60.5 34.7 57.0 42.1 43.1 12.8 24.3 51.6 25.8 52.1 58.6 42.3 30.6 33.2 59.1 75.4 40.5 53.3 47.0 23.9 39.8 104.3 54.5 86.2 38.8 39.3 50.8 44.9 68.7 37.9 20.8 39.1 67.3 96.7 35.6 52.9 27.6 48.8 59.2 31.7 36.2 32.0 64.6 49.9 53.1 27.8 86.0 114.4 105.3 37.4 33.1 41.1 116.8 21.4 41.6 49.6 44.7 59.2 52.2 45.3 47.8 44.3 45.0 54.3 179.5 39.7 31.6 39.1 132.6 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101862 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010029 Approved NA NA "HPA010029: AB_1078335" "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavorable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 65.9 87.4 76.0 48.8 79.3 75.9 59.1 83.3 93.7 47.6 89.5 61.9 52.6 50.0 105.3 48.1 46.3 50.8 71.1 75.0 87.0 91.5 104.7 54.9 44.1 80.1 79.5 74.4 43.5 79.7 94.0 55.1 78.0 81.6 62.8 65.5 67.8 60.5 57.5 91.7 56.2 47.2 59.3 82.8 42.8 58.2 77.6 81.3 40.4 71.7 71.5 46.6 63.6 44.4 88.6 68.1 185.7 62.2 84.2 249.3 143.3 69.3 190.4 199.3 174.8 181.0 170.6 79.7 40.4 187.4 189.5 181.3 128.9 94.7 96.3 128.5 99.7 96.5 99.4 273.6 147.3 229.1 101.2 135.0 155.1 181.5 125.0 178.7 117.3 110.3 75.9 99.5 259.9 170.7 79.8 54.5 115.2 58.1 157.2 122.3 69.5 76.2 140.3 187.3 119.1 107.2 78.2 114.0 151.8 97.7 75.5 110.0 161.2 94.9 185.8 71.6 123.7 144.4 172.4 219.7 86.2 187.8 153.3 154.8 316.0 161.1 178.1 139.7 184.2 136.9 137.0 138.6 144.0 150.6 102.9 100.4 124.1 143.8 122.7 206.2 242.6 195.8 196.4 76.0 79.3 83.3 93.7 75.0 87.0 80.1 79.5 74.4 81.6 82.8 81.3 88.6 65.5 28.9 36.1 20.2 51.7 86.9 56.8 194.6 40.9 58.6 44.0 50.3 92.9 54.3 117.9 103.0 45.9 127.5 92.1 56.5 39.2 124.4 117.3 52.4 66.2 67.3 45.6 48.0 15.5 172.4 153.4 90.1 32.6 52.6 45.1 40.2 60.3 78.6 112.6 30.3 17.8 57.6 146.5 65.2 60.1 81.6 90.1 61.2 103.2 12.2 70.9 112.4 40.2 17.6 27.7 137.9 63.0 104.2 97.1 61.3 72.5 90.8 94.5 62.9 118.3 65.4 136.5 257.9 57.4 43.1 86.4 160.1 65.8 100.4 61.3 55.2 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 9.5;skin 1: 4.1" "Group enriched" "Detected in some" 7 "Bipolar cells: 627.4;Melanocytes: 158.3" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 112 "SK-MEL-30: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.5 0.1 0.0 0.0 4.1 0.0 0.0 0.5 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.1 0.2 0.4 0.4 0.0 0.5 0.5 0.2 0.5 0.0 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 627.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 50.5 0.1 0.1 1.7 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 13.5 0.8 0.0 0.0 0.0 1.0 6.3 0.0 0.0 158.3 0.0 0.0 11.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 22.2 0.0 0.1 0.1 10.1 4.4 1.8 1.0 1.0 0.0 0.0 0.0 0.1 GNAT2 ACHM4 ENSG00000134183 "G protein subunit alpha transducin 2" P19087 1 109603091-109619929 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "retina: 79.5" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 2.3;eosinophil: 2.5;neutrophil: 3.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "CACO-2: 4.5;TIME: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.1 0.3 0.5 0.6 0.4 0.0 0.8 1.0 0.0 2.7 0.1 0.0 0.2 0.0 0.2 0.1 1.0 0.9 0.9 0.0 0.2 0.9 0.1 0.3 0.2 0.4 0.4 0.0 0.9 0.2 0.2 0.5 0.5 0.1 0.1 79.5 0.3 0.1 0.2 1.8 0.7 0.1 0.1 0.2 0.2 2.7 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.7 0.7 0.5 1.1 0.1 0.1 0.3 0.7 0.1 0.2 0.0 4.5 0.4 1.3 1.8 0.0 0.3 0.4 1.8 0.1 0.3 0.3 0.4 1.2 1.8 0.7 0.0 1.5 0.8 0.4 0.2 0.7 0.3 1.0 0.4 0.5 0.6 0.7 0.2 1.1 0.5 0.4 0.6 0.6 0.4 0.5 0.8 0.8 0.2 2.0 1.2 0.5 1.3 0.4 1.7 2.7 0.9 0.0 5.9 0.3 0.4 1.3 2.5 1.4 2.9 1.7 2.8 0.5 0.5 2.3 0.5 2.5 0.6 0.4 0.6 0.5 0.4 0.4 0.4 0.4 0.4 0.4 3.7 0.4 0.6 0.5 0.3 0.1 0.3 0.6 0.8 1.0 0.9 0.0 0.2 0.4 0.4 0.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.1 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.1 0.0 2.8 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GSTM1 "GST1, H-B, MU" ENSG00000134184 "Glutathione S-transferase mu 1" P09488 1 109687814-109709039 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 349.5;liver: 614.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.8;Cardiomyocytes: 6.0;Club cells: 6.7;Hepatocytes: 5.5;Kupffer cells: 7.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 63.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 87.0;HeLa: 96.1;HHSteC: 78.6;hTEC/SVTERT24-B: 73.0;HUVEC TERT2: 62.4;MOLT-4: 115.4;U-266/84: 64.4" "Low region specificity" "Detected in all" "CAB022669, CAB047357, HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" Yes NA Cytosol "Cytokinetic bridge" "CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (2.22e-2)" "unprognostic (5.35e-2)" "unprognostic (3.87e-3)" "unprognostic (3.20e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (6.55e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (4.72e-3)" 56.0 157.0 102.1 17.5 112.0 9.8 57.4 101.0 349.5 60.6 102.9 35.2 28.1 38.4 70.3 153.6 46.3 29.7 30.1 102.2 100.3 37.7 614.4 28.5 1.8 141.3 118.7 101.2 179.9 67.3 49.0 33.8 8.8 155.1 47.4 22.6 10.3 44.1 129.8 69.8 67.7 47.7 64.8 100.1 64.1 60.0 57.5 100.7 33.7 27.9 0.0 18.1 128.0 136.3 100.9 0.3 0.6 0.3 1.3 0.0 0.0 0.5 0.0 0.3 0.2 0.4 1.0 7.0 26.9 0.1 41.6 0.0 1.3 0.1 0.6 0.7 0.1 0.4 87.0 96.1 1.7 78.6 0.0 0.7 0.1 0.1 73.0 0.3 48.1 62.4 50.1 0.0 56.8 2.5 0.0 115.4 0.7 54.6 0.1 0.0 0.4 0.6 11.1 9.0 0.1 5.3 0.7 0.0 0.3 0.5 2.6 1.1 44.5 0.2 35.5 2.0 0.9 0.1 45.1 64.4 3.7 30.7 1.1 2.0 2.2 26.1 32.2 28.8 39.1 31.0 30.8 31.4 28.5 77.8 32.5 33.1 32.6 2.0 30.1 17.4 41.1 38.9 28.5 102.1 112.0 101.0 349.5 102.2 100.3 141.3 118.7 101.2 155.1 100.1 100.7 100.9 0.3 9.6 6.8 0.0 0.2 1.8 0.6 2.0 0.0 0.1 2.7 1.9 6.0 2.8 6.7 0.0 0.0 0.0 0.8 0.4 0.0 1.2 0.0 0.9 1.9 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 2.5 0.0 5.0 5.5 0.1 0.0 0.0 0.3 0.0 7.1 2.2 0.4 3.7 0.5 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.6 0.1 2.2 0.0 0.1 1.9 0.0 5.1 0.0 0.0 0.3 1.4 0.5 0.4 0.0 1.6 0.0 0.8 0.0 0.2 1.8 PRPF38B "FLJ10330, NET1" ENSG00000134186 "Pre-mRNA processing factor 38B" Q5VTL8 1 108692310-108702928 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053255 Approved NA NA "HPA053255: AB_2682093" "unprognostic (2.13e-3)" "unprognostic (9.66e-2)" "unprognostic (9.67e-2)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (3.28e-3)" "unprognostic (3.77e-3)" "unprognostic (9.49e-3)" "unprognostic (1.34e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (2.03e-4)" "unprognostic (6.97e-2)" "unprognostic (1.64e-1)" "unprognostic (1.42e-1)" "unprognostic (2.26e-1)" 24.2 21.7 20.9 35.7 21.7 63.5 24.3 31.6 23.4 22.1 20.4 24.2 24.6 23.4 15.9 24.6 22.5 18.9 18.6 20.4 21.7 20.2 25.2 26.4 45.9 24.7 21.6 17.7 23.9 31.3 16.6 22.6 24.2 23.8 23.5 21.6 25.1 26.1 15.0 25.8 22.9 34.9 15.5 21.4 43.4 24.7 14.8 22.5 37.8 26.1 16.1 31.4 23.3 22.9 25.1 57.5 22.5 52.0 33.8 29.2 23.3 47.8 59.3 22.7 27.7 29.6 43.4 26.7 77.4 31.4 18.8 19.1 52.2 48.5 30.9 40.7 45.2 51.0 60.4 83.7 41.0 28.7 83.4 49.5 16.1 42.5 28.6 56.2 37.3 23.2 35.9 75.0 56.6 29.4 42.7 61.6 67.4 56.8 26.1 40.4 61.6 99.3 32.8 26.7 47.0 49.4 35.5 40.8 47.3 58.1 32.2 24.1 53.6 38.8 54.0 41.0 43.9 51.2 52.6 35.4 71.0 47.5 61.9 57.7 24.3 19.8 27.1 23.9 19.5 24.8 19.6 21.8 19.3 23.3 23.9 19.9 20.2 30.0 31.9 17.7 27.5 24.6 13.5 20.9 21.7 31.6 23.4 20.4 21.7 24.7 21.6 17.7 23.8 21.4 22.5 25.1 81.7 105.8 143.8 38.5 166.5 246.8 199.4 79.9 90.0 96.1 87.6 69.0 60.7 105.8 120.5 60.7 135.5 86.3 227.0 88.7 13.7 79.5 34.3 62.1 117.2 101.4 95.0 88.1 27.7 66.2 104.1 85.5 61.2 96.4 103.1 72.5 88.5 59.8 78.3 37.0 30.1 110.7 61.1 127.8 203.1 19.3 99.1 131.0 104.9 63.7 138.1 50.7 242.0 39.7 65.0 75.7 81.2 85.0 139.3 172.6 81.3 17.3 73.9 74.3 46.0 89.5 108.1 96.1 62.3 102.6 265.0 87.7 222.3 98.4 131.7 234.7 REG4 "GISP, REG-IV, RELP" ENSG00000134193 "Regenerating family member 4" Q9BYZ8 1 119794017-119811580 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 668.2" "Cell type enriched" "Detected in some" 7 "Intestinal goblet cells: 3458.1" "Group enriched" "Detected in many" 21 "colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "naive CD8 T-cell: 24.6" "Lineage enriched" "Detected in single" 101 "T-cells: 24.6" "Cell line enriched" "Detected in some" 60 "OE19: 6164.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025867, HPA046555" Enhanced "Secreted to digestive system" NA NA 460000 "CAB025867: , HPA046555: AB_2679696" "unprognostic (3.22e-2)" "unprognostic (2.57e-1)" "unprognostic (2.86e-3)" "unprognostic (2.57e-1)" "unprognostic (6.52e-2)" "unprognostic (6.20e-3)" "unprognostic (1.11e-1)" "unprognostic (1.64e-2)" "unprognostic (7.10e-2)" "unprognostic (7.85e-2)" "unprognostic (2.99e-1)" "unprognostic (5.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-3)" 0.7 0.0 0.2 34.7 0.1 0.3 0.0 0.1 0.2 0.4 0.1 238.3 266.8 0.5 0.0 1.5 0.0 0.5 0.0 0.2 0.1 0.7 0.3 0.0 1.6 0.2 0.1 0.1 0.0 134.8 0.0 0.0 0.0 0.2 2.6 317.4 0.0 2.3 0.2 0.0 0.0 668.2 8.6 0.1 0.2 19.2 2.4 0.2 0.4 0.0 0.0 0.8 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.3 2.3 0.1 6164.0 102.7 0.0 0.0 0.8 0.0 29.2 0.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.8 24.6 0.2 0.0 0.0 0.0 0.0 2.5 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 10.8 0.0 0.0 0.0 441.8 0.0 0.0 1.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3458.1 0.0 0.0 0.0 25.9 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 140.0 0.0 0.1 3.8 178.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 2.9 0.1 52.0 0.2 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089503 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.8" "Cell type enhanced" "Detected in many" "Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 109.0;neutrophil: 109.8" "Group enriched" "Detected in many" 4 "granulocytes: 109.8;NK-cells: 86.2" "Cell line enhanced" "Detected in many" "EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9" "Region enhanced" "Detected in all" "white matter: 842.5" "Low region specificity" "Detected in many" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 7.2 1.8 3.3 10.1 1.9 21.0 4.6 1.0 2.2 9.1 3.0 40.9 5.4 47.8 7.5 14.8 22.3 7.5 7.5 1.1 3.5 8.4 0.8 6.6 1.4 4.7 3.8 1.2 2.9 2.9 10.3 2.1 3.0 5.9 15.6 12.1 2.1 3.0 28.5 2.8 1.8 11.0 43.1 2.2 3.9 13.9 1.1 5.9 2.7 2.7 5.3 1.2 24.9 8.1 4.4 15.1 0.3 1.2 0.0 0.0 0.2 0.1 2.1 1.0 2.4 3.8 3.1 9.5 0.0 58.8 3.5 3.3 2.2 1.9 0.0 2.7 3.1 1.2 0.5 1.1 0.0 0.2 0.1 0.0 0.0 0.4 0.7 0.0 16.9 0.1 11.1 0.0 0.9 0.0 0.8 8.2 1.3 13.8 3.2 1.6 0.1 0.8 0.0 0.4 5.8 3.0 4.5 3.5 1.6 0.2 8.2 0.3 0.6 0.2 0.2 5.7 0.4 14.1 12.5 0.4 0.1 0.1 26.9 6.9 109.0 9.1 55.8 17.4 0.2 5.6 0.6 20.5 22.6 4.1 0.3 3.4 17.0 109.8 86.2 0.1 3.8 3.3 13.1 3.3 1.9 1.0 2.2 1.1 3.5 4.7 3.8 1.2 5.9 2.2 5.9 4.4 18.7 0.0 0.6 0.3 1.4 8.0 23.2 10.9 1.8 2.5 1.5 7.6 9.6 0.0 4.4 11.0 0.0 1.4 19.9 0.1 0.0 35.3 12.2 14.3 0.9 16.3 39.4 3.0 2.8 2.4 4.3 4.0 0.5 16.3 0.0 2.0 6.4 0.0 0.7 0.0 5.4 1.3 4.1 0.6 3.7 4.6 0.6 3.0 3.6 2.8 2.7 0.0 40.2 1.5 0.2 10.9 0.0 3.0 3.3 30.0 0.0 1.3 10.7 0.4 6.6 1.4 16.2 0.1 0.9 0.2 2.7 0.3 17.2 0.1 1.4 21.6 TSHB ENSG00000134200 "Thyroid stimulating hormone subunit beta" P01222 1 115029826-115034302 "Human disease related genes, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2635 "pituitary gland: 1771.1" "Cell type enhanced" "Detected in single" "Late spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Not detected" "Not detected" "CAB022202, HPA042681" Enhanced "Secreted to blood" NA NA "CAB022202: , HPA042681: AB_2732500" "unprognostic (2.14e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" 0.1 0.6 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.4 0.2 0.0 0.4 0.2 0.0 0.0 0.3 0.0 1771.1 0.0 0.5 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.4 0.2 0.0 0.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSTM5 ENSG00000134201 "Glutathione S-transferase mu 5" P46439 1 109711780-109775428 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "breast: 939.1" "Group enriched" "Detected in many" 4 "Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 4 "dendritic cells: 3.9" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9" "HPA055972, HPA055973" Approved Uncertain "Cytokinetic bridge,Cytosol" Yes NA Cytosol "Cytokinetic bridge" "HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (1.46e-2)" "unprognostic (8.64e-3)" "unprognostic (5.58e-2)" "unprognostic (1.42e-1)" "unprognostic (5.34e-3)" "unprognostic (8.09e-2)" "unprognostic (9.64e-4)" "unprognostic (1.31e-2)" "unprognostic (1.44e-1)" "unprognostic (9.16e-2)" "unprognostic (3.31e-1)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (3.74e-2)" "unprognostic (4.39e-2)" "unprognostic (3.03e-3)" "unprognostic (1.40e-1)" 18.9 6.4 59.6 4.6 60.5 0.5 939.1 59.3 68.2 73.1 60.7 12.3 2.3 35.4 33.1 11.7 62.5 26.0 11.4 60.3 56.0 5.6 3.9 18.2 5.0 55.9 53.1 56.8 215.8 4.7 0.2 9.4 0.8 55.1 28.2 7.8 12.5 7.9 32.9 4.0 11.0 10.4 26.7 57.5 7.7 13.3 11.5 52.7 6.5 9.1 14.2 6.5 28.2 48.1 57.9 0.0 0.0 0.0 0.0 1.7 1.6 0.4 1.3 0.0 0.3 0.2 0.0 0.0 0.1 0.0 21.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 10.3 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.6 0.0 3.9 0.9 0.7 59.6 60.5 59.3 68.2 60.3 56.0 55.9 53.1 56.8 55.1 57.5 52.7 57.9 2.5 0.0 0.5 32.3 0.0 6.6 0.9 0.2 0.0 2.0 0.5 0.8 0.9 1.5 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 9.0 0.3 12.3 2.2 0.0 2.1 0.1 0.0 0.1 59.0 1.1 0.3 0.0 0.6 5.7 0.0 0.3 0.0 0.5 0.1 0.0 0.6 9.3 15.1 143.5 0.6 10.6 1.9 0.0 213.3 0.0 2.0 0.3 0.0 0.0 127.2 0.1 0.1 0.1 0.0 0.0 6.8 26.3 2.3 9.4 2.0 1.8 1.0 6.5 0.0 2.8 2.4 0.1 0.6 GSTM3 GST5 ENSG00000134202 "Glutathione S-transferase mu 3" P21266 1 109733932-109741038 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 381.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 802.2;Early spermatids: 2092.4;Late spermatids: 3843.4;Spermatocytes: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 3.4;gdT-cell: 3.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive CD4 T-cell: 7.8;naive CD8 T-cell: 4.3;T-reg: 1.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.4;T-cells: 7.8" "Cell line enhanced" "Detected in many" "SK-BR-3: 228.4;T-47d: 479.6;WM-115: 186.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017130, HPA035190, CAB040583, HPA055972" Enhanced Approved Cytosol NA NA 790000 Cytosol "CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992" "unprognostic (2.13e-2)" "unprognostic (2.76e-2)" "unprognostic (1.95e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.28e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-1)" "unprognostic (6.16e-3)" "unprognostic (1.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" "unprognostic (3.48e-2)" 33.5 39.4 52.4 11.1 56.4 3.3 84.4 46.5 69.7 53.1 94.8 36.6 47.2 32.4 245.3 54.0 35.4 47.5 75.1 51.9 56.7 189.8 20.2 23.8 6.2 50.6 51.2 52.4 121.4 101.8 41.4 33.9 21.7 51.0 47.9 20.1 21.2 22.8 167.4 66.4 57.7 28.0 58.9 52.7 14.2 76.9 381.3 52.7 13.3 58.4 51.7 7.9 57.5 53.7 54.7 0.2 6.9 49.3 0.1 64.5 39.9 8.5 54.3 9.4 58.2 56.2 21.8 1.9 0.1 30.8 27.8 40.1 2.6 10.0 22.3 80.5 0.3 14.9 50.8 152.1 33.9 69.5 0.0 115.2 40.3 27.0 87.8 0.1 63.5 73.1 61.9 4.7 0.6 26.6 30.0 14.5 1.2 5.3 0.2 93.1 0.4 31.9 2.3 16.3 117.1 86.1 46.0 112.5 228.4 10.5 14.1 479.6 75.3 57.9 0.8 20.9 59.6 36.3 7.7 13.1 0.2 0.6 0.1 186.9 0.3 0.1 3.4 3.1 0.1 0.8 0.3 3.9 2.2 0.1 0.2 7.8 4.3 0.9 0.7 0.1 0.5 1.9 1.5 52.4 56.4 46.5 69.7 51.9 56.7 50.6 51.2 52.4 51.0 52.7 52.7 54.7 22.2 6.4 11.5 18.3 7.0 143.5 97.2 104.4 50.1 17.5 196.1 176.8 88.0 50.1 35.9 222.5 6.2 16.3 8.7 17.3 802.2 88.0 2092.4 51.4 40.6 32.9 50.4 33.0 7.5 149.5 9.0 131.6 43.8 93.6 9.5 22.7 58.2 14.2 10.6 15.2 8.0 24.9 28.5 13.9 54.1 3843.4 385.5 15.1 60.5 2.8 3.5 247.5 2.1 14.6 1.7 126.4 32.5 276.1 3.4 53.7 116.9 38.9 5.4 19.2 190.7 23.8 94.4 1177.6 54.4 71.9 107.4 10.3 24.4 121.4 44.1 80.8 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153880 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.9;pancreas: 3.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.1;Early spermatids: 6.1;Excitatory neurons: 5.9;Late spermatids: 14.1;Microglial cells: 27.2;Oligodendrocyte precursor cells: 7.5" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 22.0;WM-115: 15.2" "Group enriched" "Detected in all" 7 "basal ganglia: 31.2;olfactory bulb: 71.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles NA NA Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.0 0.8 2.9 0.2 4.5 0.0 0.7 1.5 2.7 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.0 9.9 1.5 0.0 0.0 0.0 4.7 4.3 2.2 0.8 3.2 0.1 0.1 0.5 6.3 0.4 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.5 1.5 2.7 3.0 9.9 4.7 4.3 2.2 6.3 5.9 6.6 5.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 6.1 0.0 0.2 0.3 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 2.4 0.0 0.0 0.0 0.4 14.1 0.0 1.2 3.6 27.2 0.0 0.7 0.0 7.5 0.6 0.0 0.0 0.0 0.0 0.3 0.0 4.3 0.0 0.7 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.1 3.9 0.0 0.0 VAV3 ENSG00000134215 "Vav guanine nucleotide exchange factor 3" Q9UKW4 1 107571161-107965180 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 84.7" "Cell type enhanced" "Detected in many" "Astrocytes: 263.5;Basal squamous epithelial cells: 163.9;Syncytiotrophoblasts: 246.0" "Cancer enhanced" "Detected in all" "breast cancer: 28.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 52.8;RH-30: 61.7;RPTEC TERT1: 86.2;T-47d: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002012 Uncertain NA NA "CAB002012: " "unprognostic (4.80e-3)" "unprognostic (7.99e-3)" "unprognostic (5.31e-3)" "unprognostic (3.78e-3)" "unprognostic (1.15e-1)" "unprognostic (1.67e-3)" "unprognostic (6.84e-2)" "unprognostic (2.34e-2)" "unprognostic (3.39e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.60e-8)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-2)" "unprognostic (1.23e-2)" 3.2 1.7 4.1 10.9 4.1 19.5 34.5 5.6 6.4 5.8 13.4 41.6 9.4 4.5 4.0 35.2 3.8 2.6 1.5 2.4 2.9 84.7 2.4 4.1 10.5 4.1 7.1 2.4 0.5 17.5 1.5 1.4 34.6 4.3 4.3 51.3 7.4 7.4 11.6 0.9 49.4 15.4 3.6 1.5 11.3 7.3 5.2 9.4 8.9 10.0 1.2 16.7 12.9 16.2 3.7 0.0 12.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 3.5 16.9 0.6 0.2 0.0 0.0 4.5 17.4 5.8 10.2 0.0 16.3 6.5 0.0 36.6 0.0 1.1 0.0 0.0 8.5 0.0 13.3 0.2 5.7 34.2 4.2 5.0 0.2 1.2 52.8 61.7 0.4 86.2 29.5 2.8 2.6 16.4 7.2 0.3 1.5 107.2 29.7 1.2 0.6 0.0 0.1 0.6 8.0 3.3 0.5 13.0 26.1 1.2 4.7 0.6 0.7 2.1 0.5 1.1 1.7 0.6 1.0 2.6 2.0 0.1 1.4 1.7 2.1 0.2 1.6 2.6 0.7 4.1 4.1 5.6 6.4 2.4 2.9 4.1 7.1 2.4 4.3 1.5 9.4 3.7 7.3 0.0 1.7 263.5 37.0 11.7 10.3 13.3 163.9 15.0 48.5 21.5 2.4 5.7 17.8 51.5 2.1 108.8 91.0 87.3 117.4 7.9 55.7 11.2 1.1 9.6 21.1 11.3 38.2 0.0 25.6 3.1 2.6 5.8 7.6 0.0 10.0 0.2 23.6 0.0 77.7 29.1 4.1 15.7 10.6 40.1 0.3 22.1 3.6 23.4 13.3 3.8 69.0 36.2 2.4 0.1 47.2 0.4 32.7 2.1 25.2 79.6 12.3 28.4 6.6 51.1 1.6 1.3 3.0 108.7 21.0 246.0 30.3 8.8 45.9 4.7 CHIA "AMCase, CHIT2, TSA1902" ENSG00000134216 "Chitinase acidic" Q9BZP6 1 111290851-111320566 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "stomach 1: 330.2" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 34.6" "Group enriched" "Detected in some" 4 "lung cancer: 1.8;stomach cancer: 2.0;thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "ASC diff: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA059193 Approved "Intracellular and membrane" NA NA "HPA059193: AB_2683942" "unprognostic (8.00e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.99e-2)" "unprognostic (7.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.5 1.6 0.3 0.0 0.0 0.1 0.2 0.1 0.2 10.7 0.3 0.1 0.1 0.1 0.1 0.2 2.0 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 330.2 0.5 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 109.4;choroid plexus: 56.2;retina: 42.0" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 30.1;Oligodendrocytes: 95.2;Peritubular cells: 44.8;Rod photoreceptor cells: 71.0" "Cancer enriched" "Detected in all" 4 "glioma: 50.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 12.0" "Group enriched" "Detected in many" 11 "dendritic cells: 5.4;granulocytes: 7.1;monocytes: 12.0" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 3.5;cerebral cortex: 7.7;hippocampal formation: 5.7;white matter: 3.4" "Low region specificity" "Detected in all" HPA056561 Supported Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "HPA056561: AB_2683175" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 2.0 1.9 73.1 3.8 88.5 7.9 2.4 84.0 84.0 4.5 56.2 3.4 4.3 3.1 2.6 7.7 3.5 3.1 2.5 78.8 75.9 2.7 4.6 5.3 3.6 85.9 87.7 72.5 3.3 1.5 3.2 4.3 4.0 88.4 5.5 2.7 42.0 2.4 4.6 0.9 5.2 4.6 4.0 79.2 3.9 3.4 13.4 81.1 14.3 2.3 1.0 4.4 3.2 5.8 109.4 56.0 28.2 112.9 55.1 4.4 8.7 31.0 43.1 34.7 57.6 55.1 43.7 22.7 28.2 15.4 21.4 27.1 38.9 61.4 35.4 48.1 11.0 29.6 17.7 40.5 36.2 5.0 19.0 19.3 10.0 3.3 22.8 16.2 21.5 28.7 32.9 40.9 12.5 46.8 50.5 29.2 12.9 46.9 25.4 31.8 44.4 108.7 9.5 19.6 14.4 47.2 27.3 24.3 36.8 43.6 40.8 22.3 18.0 14.9 35.4 57.9 25.1 72.5 9.7 6.9 9.8 28.6 44.9 100.9 0.0 12.0 1.9 0.6 4.8 0.4 0.0 0.7 0.2 5.4 0.0 0.4 0.3 7.1 0.3 2.7 0.0 0.7 3.4 73.1 88.5 84.0 84.0 78.8 75.9 85.9 87.7 72.5 88.4 79.2 81.1 109.4 0.7 0.0 3.9 9.8 0.5 2.0 1.8 2.3 0.6 6.7 2.1 5.6 1.3 1.5 0.5 1.8 25.0 17.6 1.0 2.0 0.0 0.9 1.1 0.5 3.2 2.3 0.0 0.8 19.3 0.9 30.1 4.4 0.5 1.1 1.3 12.9 2.9 1.2 10.9 3.3 3.8 3.9 4.1 4.4 1.8 2.6 5.9 4.9 1.8 2.8 2.2 10.0 0.0 18.1 95.2 0.5 0.6 44.8 0.6 1.0 0.6 2.9 0.9 71.0 0.0 5.5 4.7 5.0 1.5 6.5 1.1 2.9 1.5 1.1 5.4 1.3 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119748002-119768905 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 2453.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3" "Cancer enriched" "Detected in many" 5 "liver cancer: 441.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "OE19: 113.6;RT4: 201.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Approved Mitochondria NA NA 830000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favorable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favorable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 1.1 0.3 0.0 7.4 0.0 0.0 224.6 0.0 0.0 0.1 4.2 370.2 167.1 1.4 0.4 4.4 0.4 4.3 21.7 0.0 0.0 65.5 2453.9 2.2 0.1 0.0 0.1 0.0 0.1 20.3 0.1 0.1 0.4 0.0 34.3 230.1 0.1 51.2 0.6 7.0 14.1 153.0 23.9 0.0 0.6 102.1 35.9 0.0 0.5 0.6 3.2 0.0 36.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 113.6 0.1 0.2 0.7 0.7 0.0 201.6 0.1 0.8 0.6 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 10.8 0.0 2.4 0.1 3.7 0.0 1.2 0.0 18.8 5.6 8.7 42.9 0.1 31.3 0.0 0.8 0.0 327.2 0.0 0.0 1.9 0.6 0.1 1.1 73.1 24.0 0.0 0.0 0.2 0.2 66.8 1.4 4.5 19.5 16.4 1118.3 0.2 0.0 0.0 226.8 0.0 26.1 0.7 3.9 1.5 0.2 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 177.7 0.0 0.0 6.3 12.4 0.9 0.0 0.0 6.6 0.0 0.1 0.4 0.5 1.9 0.3 9.4 2.2 0.1 282.3 26.5 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase non-receptor type 22" Q9Y2R2 1 113813811-113871753 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease variant, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.3;lymphoid tissue: 20.5" "Group enriched" "Detected in many" 4 "B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4" "Region enriched" "Detected in single" 11 "cerebellum: 5.3" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 2.0 1.5 0.2 11.6 0.3 38.3 2.3 0.5 0.7 1.8 0.8 4.1 6.5 1.1 1.1 1.7 0.9 4.8 0.5 0.2 0.5 0.6 2.0 7.5 20.5 0.6 0.3 0.1 0.6 1.4 0.3 0.3 0.8 0.4 1.0 4.3 0.4 1.3 0.6 0.3 0.9 8.7 1.6 0.4 13.4 5.3 1.4 0.6 20.2 0.7 0.2 13.6 4.3 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.9 0.4 0.0 0.7 0.0 0.4 69.3 0.1 0.2 0.0 0.0 0.0 0.1 0.5 6.5 0.0 10.0 0.0 0.0 0.2 27.7 21.1 5.7 0.0 2.8 0.2 5.1 10.6 17.2 0.1 15.7 10.3 0.2 20.1 15.7 0.0 0.1 0.0 1.2 6.7 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.0 5.0 16.0 0.3 0.4 0.5 29.2 6.6 37.5 11.1 28.4 0.1 15.8 4.8 25.0 17.0 1.3 20.1 9.9 8.4 13.6 8.7 7.4 5.0 12.1 2.4 11.0 0.6 5.2 14.5 7.3 0.2 0.3 0.5 0.7 0.2 0.5 0.6 0.3 0.1 0.4 0.4 0.6 0.7 2.2 0.0 6.5 0.7 67.4 2.5 0.2 0.0 1.2 0.7 2.2 2.4 0.8 0.0 0.2 1.8 2.1 0.1 176.0 2.2 0.0 0.1 0.4 0.7 0.5 1.7 0.0 16.6 3.2 0.6 0.3 2.2 12.8 1.0 27.8 0.0 0.4 0.5 7.1 0.0 2.5 1.2 0.0 17.3 26.8 1.0 0.0 26.4 3.6 2.8 14.4 0.0 108.1 0.0 1.7 0.5 0.8 0.0 79.6 0.3 4.3 0.1 2.2 0.5 13.1 0.6 1.4 0.4 0.6 0.3 2.7 0.1 151.2 0.0 2.2 0.3 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397918 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 282.9" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 447.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 9.2;non-classical monocyte: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 7170000 110000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 48.6 11.4 74.0 12.1 155.0 21.7 25.3 123.1 120.6 17.8 26.6 29.8 22.3 24.9 141.0 41.9 27.7 17.9 65.3 133.0 100.5 39.1 6.6 37.7 2.8 134.5 136.1 70.7 6.1 17.7 46.9 11.4 45.2 138.3 18.5 27.2 40.3 25.4 44.4 85.7 17.4 22.1 28.0 132.4 10.3 18.4 43.9 117.1 6.5 43.1 72.5 10.3 17.1 18.2 282.9 38.8 15.3 37.5 45.8 107.0 21.2 107.3 28.2 44.9 27.2 29.0 39.8 14.0 0.3 35.2 11.9 19.9 9.4 44.7 22.3 38.9 1.1 21.2 10.7 23.5 43.1 41.8 0.2 33.5 53.2 3.6 33.3 7.3 72.6 4.2 31.7 81.3 4.0 38.7 41.1 27.9 0.8 14.1 17.5 6.3 30.7 87.9 18.9 52.0 27.8 38.3 21.8 16.6 109.3 120.6 53.1 46.1 6.7 1.1 5.8 21.7 1.0 47.6 37.0 32.2 0.3 9.8 0.3 24.3 0.0 7.1 2.5 0.0 9.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.4 10.8 1.6 0.0 2.0 74.0 155.0 123.1 120.6 133.0 100.5 134.5 136.1 70.7 138.3 132.4 117.1 282.9 10.6 38.5 47.9 54.5 1.9 1.3 4.7 6.7 1.2 14.9 27.5 14.2 98.9 27.1 20.3 75.4 35.5 30.6 3.2 70.2 5.9 23.9 65.1 33.2 5.2 15.9 16.8 4.0 87.9 23.7 30.2 9.8 16.8 34.9 7.6 10.4 7.9 22.1 30.1 13.5 56.7 27.7 6.1 38.7 9.9 79.7 8.7 34.6 21.4 78.7 37.7 21.7 0.0 48.7 447.8 25.6 23.2 49.7 1.5 7.1 64.0 13.1 29.6 50.7 32.9 25.1 53.6 46.3 21.6 9.3 1.8 36.8 2.1 1.8 28.3 10.8 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Leydig cells: 80.2;Peritubular cells: 197.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.4;HSkMC: 8.0;SuSa: 3.4;TIME: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA Vesicles Nucleoplasm "HPA047274: AB_2732539, HPA066368: AB_2685664" "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 4.0 1.9 2.1 1.5 4.5 0.1 2.8 2.2 2.7 6.5 2.2 4.6 3.1 4.9 2.8 5.9 4.8 2.8 3.8 2.0 1.8 2.4 1.0 6.3 0.8 2.5 2.0 1.9 11.0 1.9 0.6 2.3 4.9 2.4 6.1 5.3 5.5 2.2 14.0 1.6 11.2 5.3 2.2 1.7 1.7 3.8 3.8 2.0 0.2 1.9 0.8 0.7 5.6 9.2 2.4 0.4 0.3 2.2 0.5 2.2 4.4 0.4 1.0 1.0 0.2 0.4 0.2 0.5 1.1 0.2 1.1 0.2 1.4 0.7 0.3 0.2 0.0 0.4 0.1 0.8 0.3 1.8 0.2 0.5 8.0 0.8 0.4 0.1 1.3 1.2 0.3 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.0 0.3 0.1 0.3 0.0 1.5 0.3 0.3 0.3 0.7 0.1 0.7 3.4 0.0 0.2 3.5 0.3 1.4 0.8 0.3 0.1 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.1 4.5 2.2 2.7 2.0 1.8 2.5 2.0 1.9 2.4 1.7 2.0 2.4 7.6 12.8 3.3 2.0 2.0 10.1 1.8 6.1 5.2 14.1 2.1 0.9 6.5 1.5 3.9 1.8 27.1 2.1 2.4 3.5 0.0 0.8 5.6 2.6 3.6 10.2 8.4 2.1 5.5 1.4 0.8 17.7 1.1 6.8 2.5 2.8 6.1 0.2 1.1 5.0 6.2 2.2 4.1 2.1 8.2 3.4 80.2 4.0 3.6 30.9 2.2 9.8 0.0 11.6 7.1 2.0 4.8 197.5 2.5 4.4 2.9 0.9 4.6 27.6 0.0 9.7 2.7 5.9 5.5 26.4 13.9 1.9 1.9 2.0 1.5 2.6 PTGFRN "CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6" ENSG00000134247 "Prostaglandin F2 receptor inhibitor" Q9P2B2 1 116909916-116990353 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 66.2;Cardiomyocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-87 MG: 146.8;WM-115: 111.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017074 Approved NA NA 340000 "HPA017074: AB_1855888" "unprognostic (1.18e-1)" "unprognostic (2.11e-3)" "unprognostic (3.03e-1)" "unprognostic (8.58e-2)" "unprognostic (3.20e-1)" "unprognostic (2.91e-2)" "unprognostic (1.48e-3)" "unprognostic (3.39e-2)" "unprognostic (1.76e-2)" "unprognostic (7.28e-2)" "unprognostic (2.77e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (4.15e-2)" 11.8 21.3 3.6 10.2 3.5 0.0 10.8 3.7 4.6 15.0 7.3 33.6 11.4 31.5 10.7 21.4 24.1 17.3 49.2 3.2 2.5 3.6 6.6 6.7 2.6 2.8 4.0 3.1 16.0 13.4 6.4 2.9 5.1 2.7 18.1 21.9 1.4 18.7 23.8 2.9 17.4 14.2 47.0 3.3 3.1 10.6 5.4 3.7 5.4 7.0 3.9 6.3 20.3 15.2 4.1 40.0 10.3 18.4 42.8 3.2 8.3 2.6 2.8 4.4 15.4 5.8 7.2 8.7 0.0 35.7 10.6 12.7 69.7 41.4 74.4 9.7 0.4 25.1 2.9 24.0 11.1 1.1 0.1 3.9 37.3 66.0 2.0 36.4 21.9 30.0 4.2 16.5 0.2 23.5 50.9 0.0 5.5 21.5 3.3 0.1 0.0 100.6 0.2 51.3 32.4 9.0 20.8 80.0 55.9 22.9 32.1 48.8 12.3 77.6 22.4 33.2 37.2 25.1 0.0 0.1 0.1 146.8 0.0 111.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 3.5 3.7 4.6 3.2 2.5 2.8 4.0 3.1 2.7 3.3 3.7 4.1 2.3 3.2 5.9 15.0 0.5 66.2 13.4 25.6 22.2 6.5 10.9 11.9 79.4 10.0 12.2 3.7 0.0 0.8 0.3 20.6 1.9 31.2 4.8 10.2 19.3 12.1 13.9 0.0 13.6 31.8 5.5 32.0 10.7 16.9 0.0 22.1 3.9 11.1 4.4 0.0 7.4 18.2 14.2 8.8 9.7 6.3 19.3 4.7 8.8 3.7 3.1 1.2 0.0 31.2 0.9 27.9 11.1 30.1 0.0 15.1 15.8 1.2 13.6 0.2 19.7 48.5 12.5 0.8 5.2 20.3 45.3 0.8 1.4 28.3 26.3 17.4 LAMTOR5 "HBXIP, MGC71071, XIP" ENSG00000134248 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5" O43504 1 110401249-110407942 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1113.2;Proximal tubular cells: 2532.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006812 Approved Supported Cytosol NA NA 150000 Cytosol "HPA006812: AB_1079040" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (3.54e-3)" "unprognostic (2.75e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.97e-2)" "unprognostic (7.58e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.80e-1)" "unprognostic (2.93e-1)" "unprognostic (1.65e-2)" "unprognostic (3.77e-2)" "unprognostic (3.80e-3)" "prognostic favorable (5.52e-4)" "unprognostic (6.66e-2)" 131.8 136.0 160.5 80.2 163.1 252.6 128.8 174.0 180.5 105.4 170.8 109.3 86.5 86.9 164.0 121.9 94.1 102.8 242.9 156.9 173.6 437.9 151.5 116.2 115.0 167.7 162.9 153.8 122.1 96.1 194.0 142.3 121.7 166.2 110.3 112.0 141.3 100.9 78.3 262.5 97.3 103.0 82.2 170.2 127.0 128.9 89.3 166.3 103.2 108.7 279.8 123.6 125.3 110.4 174.8 272.1 223.2 197.3 118.5 325.3 245.3 196.1 224.4 176.5 186.8 176.6 196.0 130.0 214.5 233.0 220.9 228.4 107.5 203.4 189.2 229.8 231.4 227.9 157.7 257.1 402.1 247.1 227.7 188.0 216.3 287.3 193.9 122.6 236.2 227.7 156.9 189.3 196.0 275.8 443.0 208.7 274.7 140.1 151.8 366.9 141.9 355.1 164.2 439.0 302.0 145.4 189.6 198.8 287.7 516.4 169.5 111.0 317.3 217.8 140.5 182.9 355.7 214.4 204.5 250.7 277.2 459.1 225.6 329.6 295.4 223.1 485.8 125.9 229.5 112.1 345.3 146.6 137.6 187.9 322.3 127.1 134.4 347.7 149.2 225.0 321.5 181.1 250.6 160.5 163.1 174.0 180.5 156.9 173.6 167.7 162.9 153.8 166.2 170.2 166.3 174.8 131.2 160.3 174.4 16.3 208.2 307.8 284.1 661.5 101.3 111.0 186.0 197.9 597.6 211.6 371.9 445.1 25.0 424.5 141.5 225.1 1113.2 389.2 67.5 215.8 141.8 193.1 222.3 158.9 15.4 331.0 370.7 194.0 99.9 191.1 146.4 97.0 133.9 311.9 424.8 89.2 17.6 302.6 449.6 154.4 189.2 112.8 264.7 175.3 350.4 18.7 320.9 297.9 137.0 9.5 23.3 403.9 296.4 239.2 100.6 360.9 315.4 2532.5 340.9 150.5 170.9 168.2 185.2 297.9 361.3 121.3 322.5 500.5 125.7 163.2 252.0 441.8 ADAM30 svph4 ENSG00000134249 "ADAM metallopeptidase domain 30" Q9UKF2 1 119893533-119896515 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 262 "testis: 26.1" "Group enriched" "Detected in some" 5 "Early spermatids: 77.4;Spermatocytes: 60.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026080 Uncertain NA NA "HPA026080: AB_1844581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.8 0.0 60.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NOTCH2 ENSG00000134250 "Notch receptor 2" Q04721 1 119911553-120100779 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048743 Approved Supported "Nucleoplasm,Plasma membrane" NA NA 160000000 "Nucleoplasm, Plasma membrane" "HPA048743: AB_2680508" "unprognostic (1.33e-1)" "unprognostic (1.43e-2)" "unprognostic (2.66e-1)" "unprognostic (1.40e-3)" "unprognostic (7.98e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (7.32e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.24e-4)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.86e-2)" "unprognostic (6.12e-3)" "unprognostic (1.55e-2)" "unprognostic (2.65e-2)" "unprognostic (1.12e-2)" "unprognostic (7.35e-3)" 27.3 13.0 15.6 20.5 12.2 13.8 25.0 13.4 15.7 31.3 20.2 14.5 5.4 21.4 21.0 25.1 25.9 18.6 11.6 15.9 56.5 11.0 19.7 20.4 16.8 20.6 16.6 7.0 34.2 20.3 12.2 5.5 25.2 15.5 20.6 13.7 19.4 17.2 22.4 6.5 32.6 12.0 26.8 16.3 25.5 10.6 25.6 18.0 15.4 21.4 9.0 18.0 19.2 24.3 15.0 54.2 17.7 27.0 20.7 108.5 92.7 26.6 39.7 54.8 51.8 55.8 16.3 14.2 1.4 32.6 75.3 46.2 20.1 42.8 35.3 82.5 64.0 27.2 32.1 45.7 1.6 40.5 32.7 8.0 75.5 22.5 155.2 103.7 78.4 26.9 14.5 0.8 65.3 63.7 59.2 13.9 9.2 34.6 5.0 19.6 9.1 94.2 36.1 27.3 33.4 1.1 13.4 54.5 50.0 27.9 53.4 28.0 11.7 97.0 67.0 45.8 102.7 63.1 27.9 16.8 16.5 98.7 29.5 65.2 15.0 14.9 22.9 1.4 7.3 1.4 39.0 1.6 0.9 23.7 33.3 3.1 2.0 8.9 2.4 10.5 12.3 3.8 4.4 15.6 12.2 13.4 15.7 15.9 56.5 20.6 16.6 7.0 15.5 16.3 18.0 15.0 4.6 35.3 19.5 125.4 36.6 46.3 56.6 14.8 31.3 3.3 38.1 25.3 16.0 24.3 28.5 18.4 6.2 1.6 26.0 6.2 0.0 46.8 17.7 33.8 21.9 5.4 6.1 18.3 4.2 12.9 8.9 67.8 5.1 61.1 15.8 78.3 3.9 41.5 32.7 3.3 22.6 7.9 20.3 74.7 78.2 12.6 55.0 76.6 39.2 43.1 79.3 46.2 15.5 75.4 0.6 26.8 105.5 85.4 14.2 37.2 3.2 4.9 16.4 10.5 19.7 83.6 34.0 10.0 4.3 75.1 88.9 1.6 18.5 22.0 15.8 66.9 TRIM45 "FLJ13181, RNF99" ENSG00000134253 "Tripartite motif containing 45" Q9H8W5 1 117111060-117122587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 29.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cardiomyocytes: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030266, HPA054308" Uncertain Supported "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA030266: AB_10795476, HPA054308: AB_2682445" "prognostic favorable (1.58e-4)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (3.49e-1)" "unprognostic (5.70e-2)" "unprognostic (9.66e-2)" "unprognostic (2.19e-3)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.43e-2)" "unprognostic (3.05e-1)" "unprognostic (5.45e-2)" "unprognostic (7.09e-2)" "unprognostic (3.90e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.27e-2)" 2.6 7.2 4.0 1.2 3.8 2.1 5.5 3.0 3.9 6.7 3.1 4.9 3.8 8.8 6.6 2.2 10.1 2.9 12.5 3.4 3.2 4.6 1.8 2.4 0.9 3.4 3.2 3.7 9.2 11.5 5.7 10.5 2.0 3.4 10.8 2.1 3.6 4.8 5.7 29.4 5.8 3.1 5.0 3.2 3.3 5.8 7.7 3.5 0.8 12.1 10.6 0.6 8.2 5.4 3.9 4.3 3.6 16.0 7.5 1.3 3.6 11.9 4.8 2.0 3.3 3.3 1.8 3.9 0.1 3.5 2.2 3.5 3.9 3.7 3.9 4.4 2.5 3.8 2.6 13.9 2.1 2.3 2.4 3.6 4.6 3.8 5.5 3.9 6.2 4.1 4.7 3.2 3.2 3.1 19.3 1.4 2.7 8.7 2.5 3.5 6.1 31.4 0.9 4.5 3.9 11.9 3.1 3.9 3.6 3.1 15.0 6.2 3.1 1.4 4.6 6.6 2.8 4.3 8.7 3.5 0.3 6.0 2.2 12.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 4.0 3.8 3.0 3.9 3.4 3.2 3.4 3.2 3.7 3.4 3.2 3.5 3.9 1.1 9.6 2.7 4.9 0.1 1.1 1.8 1.5 1.2 1.4 5.0 3.4 12.2 4.3 2.2 1.8 4.2 2.7 0.1 0.3 1.9 1.9 5.7 2.8 2.6 1.5 1.8 2.5 2.5 3.2 1.2 2.1 3.6 2.8 0.0 4.0 2.2 0.2 0.8 1.7 1.9 1.6 0.0 0.3 0.3 2.7 1.8 0.4 0.0 3.7 0.0 1.4 0.0 3.5 2.3 2.1 0.0 1.9 0.6 0.5 0.4 0.4 1.9 1.4 0.0 3.1 2.1 6.1 5.3 1.3 1.6 1.1 0.4 5.5 1.6 1.3 CEPT1 ENSG00000134255 "Choline/ethanolamine phosphotransferase 1" Q9Y6K0 1 111139627-111185104 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.47e-3)" "unprognostic (1.83e-2)" "prognostic favorable (4.96e-4)" "unprognostic (5.52e-2)" "unprognostic (1.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.54e-3)" "unprognostic (1.84e-1)" "unprognostic (9.20e-3)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.27e-2)" 20.9 18.1 15.5 20.4 15.7 5.5 12.1 16.1 19.6 11.1 16.4 12.1 17.2 12.6 16.1 13.4 14.1 13.4 6.8 15.1 16.8 20.1 36.5 13.4 32.0 16.6 17.0 14.4 19.4 10.7 18.8 6.1 17.2 16.4 10.9 15.5 8.1 17.6 9.6 9.3 15.2 18.4 12.8 17.4 27.9 14.7 9.0 15.8 20.4 16.9 10.9 23.1 17.0 10.0 18.5 27.3 10.0 11.6 11.3 44.8 22.0 28.1 29.5 16.5 13.4 16.0 8.7 30.0 32.1 31.7 15.2 17.0 32.6 16.7 22.9 18.9 24.1 26.4 14.0 16.3 19.6 29.9 33.4 19.3 18.1 42.8 9.8 46.1 25.4 18.0 32.8 30.9 20.5 17.6 19.8 34.6 32.9 18.0 43.2 20.3 18.4 36.8 26.3 22.0 17.0 15.2 8.2 27.1 40.2 33.2 22.4 21.8 35.5 15.8 21.7 13.6 47.4 20.0 18.5 21.6 24.9 29.2 29.6 42.0 4.4 10.0 5.8 7.9 18.3 10.3 17.9 8.7 8.2 12.1 17.8 10.0 11.0 2.5 8.7 27.5 9.3 8.3 7.4 15.5 15.7 16.1 19.6 15.1 16.8 16.6 17.0 14.4 16.4 17.4 15.8 18.5 11.5 35.3 14.9 20.9 45.5 13.0 16.5 30.8 13.6 25.1 11.1 6.2 3.6 17.2 26.9 36.8 35.5 30.1 16.7 20.7 5.9 13.4 1.9 15.8 16.9 12.3 10.2 21.4 42.4 8.1 19.7 15.2 12.2 11.1 19.0 15.2 19.6 37.8 28.3 28.6 49.2 15.0 20.3 52.1 13.9 3.7 14.6 26.0 16.0 42.2 24.7 10.0 34.0 47.3 59.5 8.5 19.9 17.0 18.5 16.0 26.1 15.2 29.2 29.3 13.1 9.9 10.1 17.1 14.7 13.0 15.3 19.0 17.2 19.1 14.4 15.4 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.6;intestine: 6.1;lung: 6.6" "Cell type enhanced" "Detected in some" "Kupffer cells: 6.7;Macrophages: 9.0;monocytes: 6.0;Oligodendrocyte precursor cells: 4.5;Sertoli cells: 6.6;Skeletal myocytes: 4.8;T-cells: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 92.7" "Group enriched" "Detected in many" 18 "dendritic cells: 32.6;granulocytes: 92.7;monocytes: 51.5" "Cell line enriched" "Detected in some" 8 "HMC-1: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049527, HPA057763" Approved Uncertain Mitochondria NA NA 630000 Mitochondria "HPA049527: , HPA057763: AB_2683519" "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.4 0.7 0.1 3.2 0.1 4.6 0.6 0.0 0.3 0.4 0.1 1.8 3.5 0.6 0.4 0.9 0.5 1.1 0.4 0.2 0.1 0.2 0.6 6.6 1.9 0.1 0.1 0.2 0.3 0.9 0.0 0.1 0.2 0.1 0.6 2.3 0.1 1.4 0.4 0.1 0.9 6.1 1.3 0.1 3.0 1.4 0.4 0.1 1.2 0.3 0.0 1.4 1.2 0.6 0.5 0.5 0.0 0.9 3.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 1.4 2.1 0.1 0.0 0.0 1.2 0.1 1.0 0.0 0.0 0.2 27.3 0.3 1.4 0.0 0.1 0.2 0.2 0.5 0.1 0.7 0.1 1.8 0.0 3.3 0.9 0.0 0.0 0.0 0.5 0.0 0.7 0.7 0.4 0.7 0.5 0.6 0.3 0.6 1.0 0.7 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.8 2.1 1.7 0.1 20.3 92.7 0.3 26.3 1.8 0.3 0.6 3.2 32.6 0.0 0.9 3.0 0.8 0.0 51.5 0.1 3.0 7.4 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.5 0.1 0.0 1.1 2.0 0.6 1.3 0.2 0.1 0.6 0.0 1.0 0.6 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.3 2.1 0.1 0.3 0.1 1.8 0.0 1.8 0.6 0.0 0.7 1.1 0.9 1.3 0.8 0.0 0.5 0.6 0.0 1.1 0.0 2.0 6.7 3.9 2.4 0.3 9.0 0.0 1.0 6.0 0.0 0.0 4.5 0.3 0.2 0.1 1.2 0.5 0.3 0.1 0.0 0.8 0.0 6.6 4.8 0.5 0.0 0.1 0.4 1.6 0.0 5.1 1.1 0.2 0.1 VTCN1 "B7-H4, B7H4, B7S1, B7x, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 101.9;fallopian tube: 32.9;pancreas: 30.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 244.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 15.4 0.0 0.0 0.4 4.6 5.1 0.4 32.9 5.1 0.2 0.0 0.1 17.5 1.1 0.7 0.0 0.0 0.0 0.0 0.1 30.3 0.0 0.1 0.9 0.0 3.0 0.0 0.0 22.2 7.9 0.2 2.6 0.0 0.1 0.0 0.0 3.7 1.1 0.1 0.1 0.0 0.0 0.0 3.2 0.1 0.0 1.0 0.1 1.7 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 7.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 4.2 0.1 1.2 0.0 0.0 244.8 0.1 29.9 14.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 2.5 6.9 0.0 0.0 62.3 18.4 1.1 0.0 22.6 55.2 0.0 3.4 1.1 0.0 0.0 83.6 2.5 42.7 4.4 0.6 0.0 0.0 0.8 34.2 1.4 0.4 0.0 79.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 6.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 11.3 0.0 0.0 0.0 1.6 0.0 0.3 8.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 3.0 0.5 0.0 0.0 4.8 NGF NGFB ENSG00000134259 "Nerve growth factor" P01138 1 115285904-115338770 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.5;ovary: 19.1" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 15.7;Leydig cells: 29.2;Sertoli cells: 118.3;Smooth muscle cells: 51.6" "Cancer enhanced" "Detected in many" "renal cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 87.9;BJ hTERT+ SV40 Large T+: 30.1;GAMG: 46.2;hTEC/SVTERT24-B: 29.8;hTERT-RPE1: 49.0;U-2197: 60.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted in other tissues" NA NA 40000 "unprognostic (7.55e-2)" "unprognostic (2.66e-2)" "unprognostic (1.53e-3)" "unprognostic (8.85e-2)" "unprognostic (4.12e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (5.30e-2)" "unprognostic (8.73e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.08e-7)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (7.99e-3)" "unprognostic (1.62e-4)" 8.8 2.5 1.8 1.6 1.8 0.0 4.1 1.4 2.1 6.4 2.6 4.0 0.1 8.9 1.4 1.2 13.3 1.7 18.5 1.8 2.1 4.8 4.1 1.7 0.5 2.0 1.8 1.8 19.1 0.8 0.4 2.8 1.1 2.0 2.6 0.6 0.1 2.2 1.0 0.9 0.9 2.1 4.0 1.5 3.7 2.1 1.1 1.9 0.2 3.4 1.1 0.1 5.6 5.1 2.0 0.0 0.3 0.0 0.0 1.8 0.1 0.0 87.9 9.9 30.1 21.9 0.0 0.0 0.0 1.9 21.1 46.2 3.6 0.0 0.6 13.8 0.0 0.2 0.0 0.6 0.0 12.1 0.0 0.0 0.1 0.6 29.8 21.6 49.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 3.0 0.0 1.3 0.0 1.2 0.0 0.0 0.0 1.1 0.3 1.6 0.6 0.0 3.9 0.0 0.0 0.8 1.8 3.7 60.0 3.5 0.0 0.0 0.0 3.6 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 1.4 2.1 1.8 2.1 2.0 1.8 1.8 2.0 1.5 1.9 2.0 0.4 0.0 0.0 0.3 0.0 3.1 0.5 3.9 0.0 0.0 0.1 1.5 0.7 1.5 0.2 0.0 0.0 3.0 0.0 0.0 0.0 5.6 0.2 0.2 0.8 0.8 0.0 0.0 0.3 0.0 1.3 7.3 0.0 0.3 0.0 0.0 4.2 0.0 0.1 0.0 15.7 0.0 2.0 0.0 1.7 0.4 29.2 0.2 1.8 1.9 0.0 0.0 0.0 12.1 0.5 0.1 0.0 6.0 0.0 0.6 0.0 0.0 0.1 0.0 118.3 0.8 51.6 0.3 1.0 0.0 2.3 2.5 0.6 0.0 0.0 0.3 AP4B1 "BETA-4, SPG47" ENSG00000134262 "Adaptor related protein complex 4 subunit beta 1" Q9Y6B7 1 113894194-113905201 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028162, HPA028652" Approved Approved Vesicles NA NA Vesicles "HPA028162: AB_10610976, HPA028652: AB_10601451" "unprognostic (8.90e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (8.60e-7)" "unprognostic (3.45e-2)" "unprognostic (1.54e-2)" "unprognostic (8.34e-3)" "unprognostic (1.55e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (3.73e-6)" "unprognostic (5.08e-3)" "unprognostic (7.88e-2)" "unprognostic (3.12e-1)" "unprognostic (1.55e-2)" 9.3 8.5 11.8 11.2 12.9 20.7 9.3 14.4 14.7 11.7 11.4 10.6 10.6 9.8 14.3 12.2 11.1 7.1 11.1 12.8 12.4 9.1 8.4 9.6 14.4 11.5 11.4 12.1 13.9 14.2 4.9 13.8 5.9 12.1 9.7 12.8 20.1 7.7 6.2 11.8 11.6 12.9 9.1 11.2 20.3 10.5 11.2 13.0 16.3 11.1 9.2 14.0 9.3 10.1 13.1 11.0 9.8 10.0 11.8 15.7 14.1 6.4 10.1 9.8 13.0 14.0 6.8 7.7 21.5 15.9 12.4 6.5 9.7 11.3 13.4 16.5 16.6 9.8 17.6 13.6 8.3 9.5 19.6 17.3 16.1 6.7 25.5 15.3 7.8 22.7 20.9 12.3 18.5 17.6 65.2 15.6 21.6 9.4 7.7 19.0 15.0 19.5 13.3 13.2 5.5 10.2 8.5 10.1 19.1 7.8 9.5 5.7 15.4 21.8 15.0 13.9 17.4 20.8 15.2 15.8 21.3 24.6 26.0 25.1 15.9 10.5 8.6 14.7 10.8 15.6 9.5 11.7 12.6 12.9 11.9 12.7 11.1 1.2 12.2 8.5 9.1 10.4 9.5 11.8 12.9 14.4 14.7 12.8 12.4 11.5 11.4 12.1 12.1 11.2 13.0 13.1 7.2 3.2 6.7 7.5 12.3 3.6 3.3 5.4 4.6 6.8 3.2 4.3 8.7 5.7 11.9 3.7 31.3 3.8 12.0 7.8 1.9 7.7 3.6 4.6 4.7 7.6 3.0 18.1 11.4 26.8 3.5 7.0 11.2 5.2 2.5 4.5 7.5 4.1 5.2 8.4 11.6 5.3 6.1 7.3 4.9 2.3 2.8 6.9 7.2 7.5 6.1 4.7 3.1 11.6 10.0 10.9 6.9 4.9 7.4 2.8 6.5 3.3 5.2 21.0 13.1 6.1 6.2 16.4 11.5 5.7 3.7 1.6 14.8 6.4 9.0 3.3 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552764 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane" NA NA 8800 "Plasma membrane" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favorable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.4 15.0 20.1 9.7 21.3 7.3 11.9 23.2 24.8 10.6 16.8 12.0 9.4 10.8 12.1 12.3 11.1 13.5 20.0 28.1 23.3 16.6 13.7 9.8 9.7 31.3 22.7 22.0 7.5 12.8 12.5 10.0 14.1 35.4 13.8 13.8 12.7 11.8 10.8 10.3 9.7 10.7 11.9 22.6 9.5 13.8 7.4 22.4 9.1 14.7 14.8 11.3 14.4 10.2 32.0 9.4 5.6 9.6 8.3 27.1 18.4 14.0 19.8 28.1 19.0 24.0 12.4 14.1 12.3 15.5 27.3 17.4 9.0 12.7 17.7 26.9 11.0 7.8 9.2 9.8 12.8 25.9 26.0 16.6 20.3 20.6 21.8 16.2 12.4 18.0 16.0 15.1 29.0 28.2 13.2 20.0 11.1 7.7 72.3 8.3 8.7 15.8 21.2 22.5 22.0 38.3 10.1 16.1 16.9 23.1 15.5 7.7 17.2 20.5 29.8 14.4 27.8 21.2 18.8 20.4 13.6 20.1 17.7 14.2 12.5 4.9 14.1 5.1 6.1 4.7 7.5 4.1 5.2 3.8 3.3 5.6 4.8 8.1 5.8 6.1 4.1 4.4 3.1 20.1 21.3 23.2 24.8 28.1 23.3 31.3 22.7 22.0 35.4 22.6 22.4 32.0 32.2 28.9 34.7 33.6 29.1 24.3 31.1 26.9 21.6 62.0 21.8 17.4 35.1 21.5 27.5 27.6 12.5 23.6 32.9 30.8 41.1 53.3 18.1 27.9 33.2 23.4 23.4 33.2 68.5 42.5 30.3 25.3 28.5 49.5 45.0 13.6 20.0 21.7 25.4 45.4 53.8 22.3 28.5 22.1 16.1 4.6 7.8 24.5 26.6 30.9 22.4 31.3 22.6 34.7 52.9 77.7 34.1 21.1 36.2 34.8 20.8 39.5 20.8 34.0 26.3 30.5 29.6 26.6 39.9 30.8 21.2 45.1 26.2 28.4 19.0 56.5 SPIRE1 "KIAA1135, spir-1" ENSG00000134278 "Spire type actin nucleation factor 1" Q08AE8 18 12446512-12658134 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 151.8;Early spermatids: 167.4;Excitatory neurons: 165.2;Inhibitory neurons: 155.9;Late spermatids: 321.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 97.3;U-2197: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040737, HPA040942" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040737: AB_10960987, HPA040942: AB_10960492" "unprognostic (3.39e-1)" "unprognostic (4.77e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (4.60e-1)" "unprognostic (3.66e-3)" "prognostic unfavorable (7.92e-4)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-1)" 7.3 17.6 25.3 3.9 25.4 1.0 9.1 25.5 28.1 8.7 9.8 6.0 1.7 7.7 5.5 7.3 5.3 7.3 20.9 25.2 22.8 10.8 5.0 10.9 2.8 23.7 23.3 22.6 8.1 5.2 17.6 6.1 6.5 23.7 8.4 3.2 14.8 9.0 8.0 20.8 7.5 3.2 8.4 24.4 4.5 5.6 33.9 27.7 3.5 13.3 19.5 4.0 9.1 5.8 28.6 19.0 8.2 17.7 19.7 19.5 17.3 0.9 20.1 20.7 19.4 18.4 0.9 4.1 8.9 22.2 26.0 32.2 4.1 24.0 18.0 24.4 13.4 11.9 5.5 16.9 10.7 40.0 3.9 13.6 12.0 33.4 33.6 97.3 22.4 26.3 3.0 14.2 0.2 29.1 25.2 1.0 5.2 7.5 6.7 20.2 0.0 21.8 19.0 23.5 25.5 25.9 10.6 21.8 17.9 45.3 7.9 5.7 11.7 32.3 32.0 9.5 75.4 24.1 6.6 0.7 0.6 25.6 2.4 8.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 25.3 25.4 25.5 28.1 25.2 22.8 23.7 23.3 22.6 23.7 24.4 27.7 28.6 10.1 25.6 43.2 151.8 0.5 3.7 9.7 8.3 1.2 60.5 15.6 12.3 28.5 7.2 13.6 12.9 8.4 0.1 2.5 0.5 21.5 8.2 167.4 5.7 25.6 10.7 3.0 0.8 165.2 4.9 0.9 13.0 2.0 7.9 15.8 11.5 5.3 4.6 14.2 26.9 155.9 3.7 0.0 17.2 5.3 321.5 5.9 12.9 17.8 30.9 2.3 15.5 0.0 93.5 91.2 11.7 0.1 10.9 1.1 23.1 0.2 1.0 8.4 13.2 19.7 20.0 15.4 17.4 17.5 2.0 2.3 0.5 2.2 16.7 0.1 16.8 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 337.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavorable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 26.2 30.8 21.4 35.2 24.0 52.3 33.6 24.6 26.8 27.9 23.0 29.2 23.4 31.2 32.2 28.4 28.5 28.8 36.0 23.3 23.1 30.3 30.8 28.3 58.9 19.3 20.7 23.1 34.4 19.4 26.1 23.1 30.1 21.6 26.3 32.0 26.1 26.1 28.6 34.4 26.1 29.1 34.2 19.7 36.5 26.0 56.6 23.0 53.3 27.7 31.5 59.6 37.4 22.6 24.0 60.7 54.7 63.5 53.4 56.0 61.3 55.8 68.3 79.1 71.8 59.1 89.1 74.3 99.0 86.4 74.6 33.9 53.6 66.2 72.4 87.6 87.3 68.9 159.5 53.8 81.9 58.8 190.4 88.0 74.4 71.9 57.5 54.6 80.3 89.5 87.3 79.2 76.0 78.9 46.3 107.8 111.7 55.0 166.0 54.2 90.4 73.7 93.3 111.7 50.7 44.7 66.0 61.1 48.7 60.1 60.7 75.1 90.7 63.1 41.5 74.5 39.9 60.7 87.4 129.9 163.3 69.8 337.5 27.7 51.7 23.9 44.1 32.7 26.7 39.4 44.3 41.9 44.5 43.8 35.8 37.9 38.1 14.9 44.6 25.9 41.5 61.5 22.6 21.4 24.0 24.6 26.8 23.3 23.1 19.3 20.7 23.1 21.6 19.7 23.0 24.0 28.9 41.7 51.8 46.0 78.4 75.8 68.1 116.9 44.9 60.2 30.8 31.0 32.5 40.0 70.7 42.3 29.2 88.1 77.4 31.8 37.2 62.3 243.3 47.5 56.1 48.1 33.6 58.5 128.7 68.3 75.4 47.0 24.5 60.7 57.0 238.1 36.0 35.5 52.9 37.0 93.2 35.8 71.2 40.6 65.4 76.7 58.4 49.1 64.0 49.6 92.9 46.3 72.1 64.3 85.0 71.4 42.1 52.3 63.4 46.4 45.8 55.6 58.6 60.5 52.6 44.6 47.9 120.3 58.8 50.3 59.1 44.2 81.8 84.0 42.4 50.7 FKBP11 FKBP19 ENSG00000134285 "FKBP prolyl isomerase 11" Q9NYL4 12 48921518-48926474 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 499.2" "Cell type enriched" "Detected in many" 4 "Plasma cells: 1153.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "MAIT T-cell: 188.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 332.6;Karpas-707: 315.1;OE19: 527.2" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome NA NA 170000 Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 19.3 17.7 4.2 60.7 4.1 34.8 34.9 3.5 5.0 42.7 5.4 57.8 71.4 17.5 87.1 16.3 19.3 25.7 10.5 3.7 10.5 13.9 59.9 24.1 55.9 4.8 4.7 4.1 13.9 499.2 4.7 47.6 15.7 4.8 29.1 53.8 2.1 161.6 33.0 2.4 7.4 56.3 26.4 3.5 77.0 71.3 6.2 8.5 16.6 23.1 0.5 78.0 49.7 17.5 4.8 13.6 24.7 3.0 4.5 116.0 141.3 3.8 123.2 183.3 128.0 154.5 78.3 88.3 192.8 2.2 226.8 1.1 60.6 31.6 60.4 77.0 39.1 7.7 6.6 24.7 0.3 332.6 3.2 3.3 165.0 109.8 99.2 171.4 67.2 75.4 53.1 3.0 315.1 49.9 44.7 26.3 5.1 7.4 527.2 33.9 76.5 3.3 280.7 21.0 2.3 35.0 10.6 36.6 66.5 24.4 4.0 2.0 7.0 49.2 21.0 2.8 2.1 2.3 132.3 122.2 108.1 16.1 3.9 33.0 6.0 1.0 2.8 115.7 1.3 188.3 50.5 80.5 92.7 1.9 25.7 38.8 69.9 4.1 26.7 1.1 39.3 33.4 36.3 4.2 4.1 3.5 5.0 3.7 10.5 4.8 4.7 4.1 4.8 3.5 8.5 4.8 22.3 16.0 19.1 5.2 229.8 28.3 56.0 48.6 39.3 5.5 45.0 43.3 2.3 30.0 42.8 9.2 39.6 21.5 130.9 23.1 7.9 23.7 18.4 19.2 117.8 32.3 25.1 20.6 5.3 171.7 80.7 64.1 31.6 31.0 12.7 34.0 40.4 96.6 10.9 1.7 3.7 227.7 16.2 15.1 26.1 17.4 27.7 10.1 272.1 0.0 8.0 1.8 158.6 1.5 1.8 59.8 14.3 13.9 1153.9 111.8 14.1 18.0 43.3 14.6 6.6 10.8 88.7 12.0 9.8 23.0 21.3 42.3 145.3 37.5 49.7 45.0 ARF3 ENSG00000134287 "ADP ribosylation factor 3" P61204 12 48935723-48957487 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.99e-2)" "unprognostic (2.40e-1)" "unprognostic (9.60e-2)" "unprognostic (1.58e-2)" "unprognostic (9.12e-3)" "unprognostic (2.25e-3)" "unprognostic (2.00e-3)" "unprognostic (1.24e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (3.88e-2)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" 63.7 74.0 101.6 80.6 159.4 67.3 53.7 60.4 152.3 67.5 36.7 98.9 58.2 60.3 71.7 80.2 59.7 47.0 42.2 158.1 134.3 86.4 46.3 71.7 51.0 73.9 86.2 147.1 47.7 46.7 139.2 75.8 59.1 90.2 55.7 89.9 78.7 55.5 59.7 17.0 68.8 65.9 72.6 71.9 61.2 55.8 49.3 120.1 73.9 70.2 16.9 70.4 65.4 51.4 105.0 212.1 305.2 131.0 116.7 106.5 77.4 124.8 137.8 173.0 158.5 136.4 407.0 272.1 168.6 201.4 151.2 124.4 171.7 182.9 186.8 142.4 206.8 94.2 274.5 243.0 118.3 66.5 212.1 213.5 87.4 145.2 172.8 102.3 172.1 170.9 111.8 170.4 89.0 137.1 256.7 158.1 116.7 185.4 338.5 162.4 150.4 75.0 111.6 173.3 265.7 134.7 122.7 148.6 171.2 129.7 144.4 290.1 167.1 238.8 117.3 187.1 74.2 87.3 86.0 210.4 123.0 154.7 162.0 68.4 5.7 39.0 27.7 13.5 25.2 10.6 13.1 15.6 16.8 52.1 12.7 8.4 9.8 54.8 18.7 17.1 40.2 14.0 21.3 101.6 159.4 60.4 152.3 158.1 134.3 73.9 86.2 147.1 90.2 71.9 120.1 105.0 35.8 25.6 33.2 19.6 31.4 60.3 41.5 92.2 61.5 34.5 60.2 40.6 10.1 54.3 47.4 99.3 10.4 56.4 54.4 228.4 66.5 114.8 49.9 41.3 31.8 55.0 70.8 26.5 44.3 90.7 119.8 42.7 34.1 48.9 27.9 59.5 57.5 48.7 132.8 43.7 36.8 71.5 75.3 86.9 81.2 101.9 40.7 79.9 44.4 18.7 128.1 57.4 50.4 14.6 20.6 103.2 176.3 37.2 37.6 60.5 78.9 143.3 45.8 24.1 32.9 24.0 52.3 52.6 63.8 61.6 65.8 69.0 31.3 43.2 67.3 56.7 TMEM106C MGC5576 ENSG00000134291 "Transmembrane protein 106C" Q9BVX2 12 47963569-47968878 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 244.8;Muller glia cells: 268.4;Paneth cells: 208.3;Proximal enterocytes: 385.7;Undifferentiated cells: 220.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 876.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047204 Enhanced NA Yes "HPA047204: AB_2679982" "unprognostic (1.63e-2)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.13e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.27e-8)" "unprognostic (1.05e-1)" "unprognostic (1.90e-2)" "unprognostic (1.52e-3)" "unprognostic (3.60e-1)" "unprognostic (7.29e-2)" "prognostic favorable (4.62e-4)" "unprognostic (1.12e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-2)" "unprognostic (1.83e-1)" 28.3 42.2 37.2 36.7 37.4 48.6 67.3 38.3 46.5 52.4 52.5 139.5 114.2 36.2 137.0 42.3 49.0 45.9 59.0 39.6 46.8 81.7 45.1 39.7 38.7 36.3 36.8 35.2 56.0 67.1 147.4 63.4 74.1 35.6 41.3 146.8 122.8 60.2 52.2 26.8 37.7 121.1 55.8 35.5 78.7 54.0 40.4 40.1 56.4 49.8 34.6 47.2 29.1 33.0 34.3 243.9 166.4 151.7 167.7 68.5 50.0 143.2 133.6 191.0 238.5 203.8 250.2 243.3 212.2 182.9 147.6 221.8 162.1 239.2 146.1 226.6 203.8 229.1 163.7 217.2 101.7 52.4 172.6 117.9 34.4 98.4 217.8 114.2 163.4 154.2 224.0 113.4 235.6 169.6 174.4 248.2 75.5 27.0 258.7 226.5 217.9 195.9 180.9 127.2 183.2 100.9 120.5 206.8 138.5 142.4 78.4 503.5 136.9 38.3 99.8 168.9 145.0 240.9 130.8 228.9 240.1 127.3 876.5 97.9 39.3 8.8 23.9 44.4 8.6 54.9 36.9 42.8 46.5 12.5 30.8 39.7 44.0 7.6 19.6 10.4 1.9 66.4 41.0 37.2 37.4 38.3 46.5 39.6 46.8 36.3 36.8 35.2 35.6 35.5 40.1 34.3 14.5 32.1 20.7 6.8 26.5 47.9 39.2 45.8 36.5 30.2 54.9 78.7 39.1 61.5 21.9 35.0 18.8 75.3 17.7 244.8 86.1 63.8 2.8 35.7 5.7 17.3 36.0 49.2 14.1 45.1 32.8 45.4 37.2 18.6 10.8 86.3 55.0 19.6 54.3 30.3 13.0 150.8 101.7 16.4 20.7 6.8 32.6 21.5 21.4 8.4 10.1 268.4 27.8 4.5 1.2 35.5 208.3 41.3 72.5 22.6 385.7 82.2 11.5 47.2 13.1 46.4 36.9 52.8 36.0 55.4 40.9 14.9 31.5 35.0 220.5 39.4 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358188-46372773 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 1118.3;Suprabasal keratinocytes: 1078.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 1198.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035180, HPA069672" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA035180: AB_10669901, HPA069672: " "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 113.8 114.1 40.6 72.2 51.3 96.3 89.4 58.5 50.5 92.5 34.8 57.4 33.9 93.7 38.9 109.1 84.4 132.4 59.2 38.5 53.3 65.4 309.9 118.1 67.7 56.2 49.4 34.8 131.3 75.3 92.2 28.1 163.5 57.3 53.2 50.2 27.2 77.9 43.5 109.4 206.1 54.9 116.7 54.5 76.0 63.5 25.6 55.6 101.3 63.7 176.2 78.8 99.8 88.7 91.1 83.7 179.9 157.6 444.1 356.7 347.7 118.1 382.8 921.2 313.0 254.0 108.2 151.2 0.1 504.2 627.9 215.3 271.1 107.9 335.1 299.1 67.0 61.0 105.8 208.7 339.9 548.8 88.0 108.7 357.2 718.4 199.5 1198.9 778.5 265.7 116.3 103.8 163.1 560.4 100.0 110.3 122.8 138.2 0.1 185.1 97.5 115.5 200.9 191.6 173.4 103.9 89.8 263.5 68.5 233.7 171.0 140.5 193.8 467.3 156.7 121.8 67.8 62.2 187.8 194.3 100.6 148.0 304.5 76.8 41.1 24.9 18.9 22.7 13.1 17.4 19.2 19.0 23.0 35.2 17.8 23.5 24.8 17.5 51.6 18.4 40.6 23.7 27.6 40.6 51.3 58.5 50.5 38.5 53.3 56.2 49.4 34.8 57.3 54.5 55.6 91.1 237.7 83.3 77.4 31.3 187.7 1118.3 134.1 262.8 653.9 40.5 315.7 252.2 153.6 108.7 123.9 57.0 70.9 53.8 292.3 114.6 5.9 41.2 5.5 228.5 245.0 234.7 76.7 109.0 54.6 51.1 49.3 219.1 328.2 464.0 81.6 138.3 227.7 265.9 54.0 53.8 58.9 175.0 130.2 143.3 303.6 12.4 263.2 193.8 250.8 59.0 52.6 74.3 70.0 42.3 136.2 79.4 83.5 85.0 322.2 181.7 67.4 24.4 50.3 68.7 282.7 184.8 339.5 6.7 15.5 532.6 1078.3 38.4 252.4 84.0 110.7 150.8 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583967-9630997 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286" Approved Supported Nucleoplasm,Cytosol NA NA 49000000 Cytosol Nucleoplasm "CAB010286: AB_2218221, HPA007925: AB_1844340" "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavorable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 138.2 142.4 210.3 107.0 233.8 179.9 155.2 227.5 239.4 160.7 167.4 149.3 120.5 185.9 142.9 188.8 137.6 123.6 220.7 223.1 248.7 141.3 117.2 120.3 133.1 229.1 225.2 211.0 164.7 203.2 132.9 113.8 124.2 228.8 162.5 134.3 144.9 121.2 141.5 53.9 118.0 117.2 178.9 220.6 90.5 128.6 145.9 222.6 149.5 138.9 62.6 142.3 145.8 163.2 298.7 316.1 465.2 412.0 400.3 316.6 434.5 385.7 421.6 412.3 432.5 360.2 352.9 269.3 404.4 214.0 608.5 451.3 288.5 462.8 459.7 553.6 1003.0 374.8 378.8 268.9 379.9 241.1 369.1 219.7 295.8 264.5 473.6 305.9 394.9 493.5 285.6 378.5 236.8 539.3 219.3 658.2 374.4 700.7 351.9 527.5 473.0 533.3 497.4 478.8 276.9 390.1 659.9 384.1 392.2 317.3 343.8 244.4 187.0 453.9 539.6 380.7 473.4 654.4 239.3 351.4 526.6 461.8 378.9 458.8 99.5 102.7 120.5 207.8 137.8 255.6 151.9 192.8 223.5 144.2 147.8 103.6 170.1 31.1 252.0 137.0 73.1 208.4 344.1 210.3 233.8 227.5 239.4 223.1 248.7 229.1 225.2 211.0 228.8 220.6 222.6 298.7 186.6 51.3 67.3 26.1 144.0 316.7 366.5 339.0 143.4 201.4 198.4 153.7 82.6 90.1 143.4 136.1 27.1 261.6 189.9 209.9 416.7 371.5 281.9 132.9 175.8 191.0 187.1 179.2 57.3 283.7 615.3 242.0 115.2 131.6 125.0 152.5 84.9 97.9 215.3 572.0 45.1 129.2 270.6 111.9 228.3 360.5 174.0 132.3 295.3 30.0 195.0 229.2 155.5 39.7 186.6 261.2 150.9 250.5 187.9 323.7 135.9 278.8 111.7 105.8 197.2 191.5 312.7 432.2 205.8 252.1 355.3 238.6 217.7 252.9 186.5 457.3 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Neurogenesis "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favorable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favorable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 21.4 21.8 22.4 14.6 39.3 24.6 19.8 34.2 34.2 22.5 21.1 17.2 11.5 29.6 15.5 15.2 16.7 17.9 22.1 23.0 31.4 22.3 15.8 23.8 13.2 41.9 32.9 22.0 38.0 18.9 43.2 17.0 21.6 41.0 20.1 16.7 38.3 14.6 18.2 14.6 16.8 13.9 23.8 38.8 17.2 16.7 10.7 33.7 21.8 20.2 16.9 12.4 16.8 18.1 75.0 13.5 21.3 41.8 26.8 51.4 33.9 21.9 26.2 21.6 16.4 15.0 21.5 13.5 25.2 26.1 39.4 31.5 22.5 37.9 16.1 24.0 36.4 25.7 22.7 15.9 22.6 36.3 23.6 29.9 35.3 24.9 26.1 33.7 25.1 25.9 21.6 44.7 30.8 29.2 14.8 24.2 12.7 22.7 22.3 18.8 22.7 30.7 12.7 21.7 25.4 35.4 59.3 20.8 20.7 23.6 21.7 13.3 26.6 34.4 36.1 19.0 36.6 28.5 22.4 21.1 33.5 21.1 31.2 28.1 4.1 3.4 4.2 3.6 3.9 2.6 1.9 2.6 3.0 2.7 1.8 2.7 3.1 5.3 3.2 4.6 1.8 2.4 2.2 22.4 39.3 34.2 34.2 23.0 31.4 41.9 32.9 22.0 41.0 38.8 33.7 75.0 57.1 99.3 115.7 129.6 25.2 32.8 27.6 25.1 19.9 86.2 31.3 25.0 40.2 25.8 48.6 29.5 139.7 21.5 35.0 33.9 0.0 33.3 1.3 32.3 77.8 51.8 43.3 36.4 108.3 23.6 10.0 55.0 39.8 53.1 35.4 144.0 47.8 30.9 28.8 154.8 149.2 23.4 44.7 52.7 46.0 5.9 69.6 45.9 24.9 60.9 44.2 60.5 34.0 162.3 322.2 29.0 29.8 65.5 27.3 25.7 24.5 10.5 34.4 58.0 6.6 65.4 54.2 28.1 23.4 26.4 29.5 10.9 40.2 52.1 23.9 36.0 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 120.6;skin 1: 88.4;vagina: 67.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Cytotrophoblasts: 61.9;Extravillous trophoblasts: 80.5;Suprabasal keratinocytes: 132.7;Syncytiotrophoblasts: 184.6;Urothelial cells: 104.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "eosinophil: 2.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "BEWO: 212.3;RT4: 41.4;SK-BR-3: 112.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 4.6 1.3 2.2 1.2 2.6 8.8 40.2 1.0 2.8 15.4 1.2 1.2 1.3 1.0 7.4 120.6 2.3 3.0 1.7 2.5 2.4 4.0 12.3 5.1 1.0 1.1 1.5 2.6 0.4 4.2 29.2 3.6 26.9 1.2 11.5 1.0 11.5 45.1 7.4 1.1 88.4 0.7 0.8 0.5 0.8 3.8 3.2 3.3 0.9 3.0 0.4 26.3 14.0 67.5 1.8 10.9 0.2 1.2 3.0 0.4 0.5 212.3 1.0 1.5 0.7 1.2 0.9 7.5 1.4 0.4 0.1 1.5 6.5 13.0 1.4 3.1 3.2 5.9 0.3 2.3 4.3 0.3 0.7 1.2 0.4 5.5 6.0 0.0 0.0 1.1 2.3 2.2 4.1 0.0 14.3 2.2 1.7 0.8 3.5 2.5 0.9 1.0 1.9 1.4 41.4 2.4 1.6 2.0 112.3 2.7 17.4 13.7 0.4 1.2 0.6 2.6 3.3 1.3 2.7 1.7 1.5 0.6 1.7 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 1.7 2.2 2.6 1.0 2.8 2.5 2.4 1.1 1.5 2.6 1.2 0.5 3.3 1.8 2.2 3.2 8.1 3.9 1.2 40.0 23.1 10.7 2.8 25.5 37.1 19.9 2.1 1.5 31.1 20.2 62.6 61.9 1.3 1.2 0.0 2.9 6.4 4.5 1.3 4.2 3.5 0.0 14.6 9.1 80.5 5.4 3.1 9.6 10.2 0.4 2.5 7.7 7.7 11.8 6.0 0.8 4.1 1.0 15.7 3.0 0.0 10.6 21.4 1.9 1.0 1.1 0.0 4.0 1.0 5.7 0.1 0.4 1.0 31.5 0.1 2.4 18.6 11.5 0.0 3.0 3.7 9.6 5.1 35.2 132.7 184.6 2.1 0.1 1.2 104.6 ROCK2 ENSG00000134318 "Rho associated coiled-coil containing protein kinase 2" O75116 2 11179759-11348330 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 280.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007459, CAB008666, HPA044109" Approved Supported Cytosol NA NA 710000 Cytosol "CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813" "unprognostic (4.55e-2)" "unprognostic (1.05e-2)" "unprognostic (4.18e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.71e-1)" "unprognostic (1.39e-2)" "unprognostic (2.72e-1)" "unprognostic (3.62e-2)" "unprognostic (6.66e-2)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.57e-5)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "unprognostic (2.52e-2)" "unprognostic (3.47e-2)" 36.8 9.4 8.2 13.7 13.8 6.9 22.5 21.1 15.3 18.8 3.0 22.8 16.9 22.2 10.4 16.3 13.7 15.7 17.1 13.2 6.7 14.6 16.6 17.0 10.2 4.3 6.6 8.5 19.2 11.8 12.9 5.9 25.1 6.9 17.5 26.5 13.6 14.7 18.3 30.6 8.2 19.4 28.2 3.3 16.6 14.3 7.9 8.2 8.5 14.0 29.1 8.9 21.2 11.1 11.9 17.5 41.7 33.8 33.2 59.7 41.6 21.6 40.4 37.7 25.8 27.1 39.8 37.2 21.9 23.4 64.5 31.3 18.9 24.7 23.4 40.6 31.2 14.7 43.8 70.6 79.7 21.4 24.7 12.1 32.6 14.6 31.9 22.6 21.0 42.0 11.9 38.6 8.6 38.8 14.8 18.2 12.7 18.8 36.9 25.3 21.7 74.2 7.0 14.0 48.8 15.9 16.9 79.6 27.4 27.4 25.5 11.3 13.6 57.3 52.9 38.2 21.2 36.0 6.8 8.9 18.8 22.8 28.2 75.4 0.9 0.4 0.4 0.6 0.4 0.7 0.3 0.4 0.4 0.3 0.5 0.4 0.4 0.6 0.8 0.4 0.6 0.4 0.2 8.2 13.8 21.1 15.3 13.2 6.7 4.3 6.6 8.5 6.9 3.3 8.2 11.9 114.5 115.4 79.1 81.3 16.0 39.9 43.0 15.3 21.1 35.7 33.5 41.1 107.0 37.1 53.1 22.0 58.4 26.3 20.4 97.7 1.9 27.1 11.0 53.6 141.2 90.3 21.2 22.5 280.4 39.5 19.1 64.0 18.3 55.3 29.0 36.9 56.0 43.1 19.6 80.8 158.1 92.2 10.2 20.3 27.0 4.9 43.8 30.4 23.2 107.7 20.6 38.4 15.5 99.0 66.9 39.1 43.6 78.6 16.2 53.5 45.3 15.7 32.7 48.5 131.5 70.0 118.5 30.3 24.6 19.9 27.8 31.5 18.5 34.2 54.8 40.7 RSAD2 "cig5, vig1, Viperin" ENSG00000134321 "Radical S-adenosyl methionine domain containing 2" Q8WXG1 2 6865557-6898239 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Lyase Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 21.1" "Cell type enhanced" "Detected in many" "Adipocytes: 35.6;Alveolar cells type 1: 35.3;Distal enterocytes: 72.3;Erythroid cells: 44.2;Paneth cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 30.7;eosinophil: 43.3;neutrophil: 25.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 43.3" "Group enriched" "Detected in some" 5 "BJ hTERT+ SV40 Large T+: 75.7;BJ hTERT+ SV40 Large T+ RasG12V: 117.6;HMC-1: 55.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041160, HPA049409" Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA041160: AB_10795489, HPA049409: AB_2680751" "unprognostic (8.91e-2)" "unprognostic (3.85e-2)" "unprognostic (7.89e-2)" "prognostic unfavorable (4.60e-4)" "unprognostic (3.27e-1)" "unprognostic (3.25e-1)" "unprognostic (1.95e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (3.66e-3)" "unprognostic (9.47e-3)" "unprognostic (4.06e-2)" "unprognostic (1.27e-2)" "unprognostic (3.98e-2)" "unprognostic (4.54e-3)" "unprognostic (4.47e-2)" "unprognostic (1.79e-1)" 4.3 2.4 4.1 4.1 4.7 13.8 3.0 2.3 3.8 4.1 4.7 5.2 3.6 2.1 2.1 1.5 2.8 5.6 5.7 2.8 3.4 2.7 3.5 8.4 2.9 5.0 3.1 2.4 2.2 1.5 1.1 4.0 6.6 4.9 1.7 3.0 1.1 21.1 2.0 5.7 0.8 3.0 4.5 2.8 10.1 6.3 2.0 3.2 7.5 1.8 7.7 1.8 2.6 1.4 12.8 0.2 0.0 0.2 0.1 0.0 0.5 0.9 0.0 1.2 75.7 117.6 0.0 2.5 1.1 0.1 0.0 11.6 1.2 0.0 0.0 0.2 0.2 0.0 17.8 0.1 0.0 0.1 0.0 55.7 0.1 0.0 5.7 0.0 0.0 0.0 2.6 1.6 1.0 0.0 0.1 7.0 1.5 0.2 0.0 0.4 0.3 0.0 0.1 0.1 1.1 0.1 0.3 0.1 0.1 3.6 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 1.4 1.5 0.0 0.1 1.2 0.4 30.7 4.9 43.3 2.3 7.5 2.8 0.3 2.6 2.2 2.7 0.4 3.7 3.0 25.2 2.5 7.0 0.3 1.3 2.7 4.1 4.7 2.3 3.8 2.8 3.4 5.0 3.1 2.4 4.9 2.8 3.2 12.8 35.6 35.3 3.9 3.9 1.5 0.5 3.3 2.4 1.2 0.8 1.0 0.6 5.2 2.8 3.2 0.0 2.1 0.6 1.9 72.3 0.0 3.8 1.3 19.2 3.1 21.7 9.0 44.2 12.6 6.2 0.8 3.8 34.7 16.1 23.5 8.3 8.9 0.6 9.5 0.0 13.2 2.6 6.1 1.6 2.2 1.1 1.5 8.5 0.0 21.5 7.0 6.3 6.2 17.1 0.9 7.7 107.7 2.2 1.7 4.1 1.7 0.1 13.4 0.7 0.0 2.5 2.8 0.4 0.5 1.2 0.3 2.9 3.6 1.7 1.0 7.4 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940550-15947007 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 9.6" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 84.2;Granulosa cells: 26.4" "Cancer enriched" "Detected in many" 5 "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 44.1;BEWO: 239.1;HMC-1: 57.3;NTERA-2: 91.3;RH-30: 63.3;SuSa: 40.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA057420: AB_2683434" "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.3 0.8 3.3 0.6 3.5 0.9 0.4 3.1 4.0 1.5 1.2 0.5 1.6 0.9 0.1 0.8 0.5 0.3 1.2 3.6 3.3 3.3 0.8 0.7 1.6 4.3 4.0 3.1 5.2 0.2 0.1 0.3 9.6 4.1 0.1 0.5 1.0 4.8 0.2 0.4 1.1 0.9 0.3 3.5 0.3 4.7 3.7 3.7 2.9 2.9 0.7 1.2 0.5 0.4 6.0 0.0 0.0 44.1 0.0 0.0 0.0 239.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 4.2 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 16.8 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.8 0.4 0.2 91.3 2.1 0.0 0.0 63.3 12.8 0.0 3.1 1.0 16.0 0.0 0.1 0.0 40.9 0.1 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.5 3.1 4.0 3.6 3.3 4.3 4.0 3.1 4.1 3.5 3.7 6.0 0.8 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 2.6 0.1 0.9 0.7 0.0 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.0 1.2 0.5 0.1 2.7 0.0 4.2 2.0 0.0 84.2 1.0 2.6 0.8 0.0 26.4 0.0 0.6 2.4 0.0 4.2 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.0 0.1 1.0 0.0 10.1 7.5 0.3 1.1 0.4 0.0 0.0 0.4 3.2 0.0 0.2 0.0 4.2 0.7 1.3 3.7 0.3 0.0 11.5 0.0 9.4 0.3 0.0 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.1;tongue: 138.5" "Cell type enriched" "Detected in all" 5 "Late spermatids: 1705.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 36.3 15.1 29.4 15.0 29.7 8.7 37.0 24.0 25.2 21.0 19.0 15.8 12.0 16.7 19.1 40.9 15.8 13.1 18.0 21.0 28.7 11.0 27.2 16.3 22.5 30.6 30.1 21.9 31.7 10.0 23.3 34.5 11.8 33.3 13.9 8.5 15.0 27.5 14.2 195.1 13.4 19.9 13.1 13.8 14.9 15.0 57.8 39.1 16.2 14.7 138.5 26.5 20.1 23.3 31.4 16.2 18.0 15.9 34.9 71.4 77.9 7.8 22.2 38.7 14.0 24.3 6.9 15.4 8.2 2.9 18.6 41.6 17.3 17.4 49.2 12.8 32.9 9.8 20.3 11.5 9.7 25.1 14.1 90.1 71.1 21.7 57.9 22.6 41.7 28.0 19.6 27.4 68.3 10.4 6.4 13.5 12.0 16.2 5.5 18.9 18.1 28.6 52.0 36.9 10.0 42.8 33.6 8.0 19.7 51.9 15.0 4.9 7.9 19.5 22.1 19.9 14.4 19.0 108.0 92.0 15.2 31.3 24.7 16.6 11.2 2.9 13.4 10.3 2.3 11.2 7.3 9.9 10.1 2.7 5.1 8.6 7.2 1.1 9.5 2.3 10.3 12.2 3.7 29.4 29.7 24.0 25.2 21.0 28.7 30.6 30.1 21.9 33.3 13.8 39.1 31.4 15.6 22.4 56.8 167.8 46.1 19.1 45.1 12.6 18.8 48.6 32.8 22.9 59.6 31.5 43.9 11.0 85.5 8.7 68.0 21.2 7.9 23.0 338.4 27.8 44.4 25.8 36.2 9.7 55.7 28.0 6.0 28.8 19.4 76.5 35.4 13.1 17.5 48.7 8.9 48.8 71.7 25.2 22.4 15.7 39.4 1705.8 119.0 25.5 17.8 21.5 15.4 14.7 66.9 41.7 43.5 36.5 29.7 179.8 76.0 34.9 5.4 4.8 52.0 49.0 32.9 32.4 18.4 20.6 19.7 5.5 11.9 12.3 73.2 26.6 16.3 31.3 CMPK2 "NDK, TYKi, UMP-CMPK2" ENSG00000134326 "Cytidine/uridine monophosphate kinase 2" Q5EBM0 2 6840570-6866635 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;salivary gland: 8.6" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 86.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "white matter: 14.6" "Immune cell enhanced" "Detected in many" "eosinophil: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 12.8;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HEL: 20.3;MOLT-4: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041430 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041430: AB_10796674" "unprognostic (2.37e-1)" "unprognostic (6.07e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.82e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-2)" "unprognostic (8.93e-2)" "unprognostic (6.63e-2)" "unprognostic (4.54e-3)" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (1.09e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (7.69e-2)" "unprognostic (4.32e-2)" 2.0 1.4 1.7 1.4 3.3 6.5 1.8 0.6 1.9 1.0 1.6 1.3 1.6 0.9 0.3 0.7 0.7 0.8 1.6 1.2 1.9 1.1 0.9 2.8 1.3 6.3 2.4 1.1 0.4 1.3 0.9 1.1 1.7 3.2 0.7 0.6 0.1 8.6 0.7 1.1 0.4 2.2 0.9 1.7 3.5 2.9 2.0 2.1 1.9 1.2 1.6 0.7 0.9 0.6 14.6 0.3 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.2 12.8 11.9 0.0 1.4 3.1 0.8 0.0 3.3 0.2 0.0 0.0 0.0 0.3 0.2 20.3 0.0 0.0 0.0 0.6 1.8 0.1 0.0 0.2 0.0 0.0 0.0 2.0 5.8 0.1 0.0 0.1 11.8 3.6 0.3 0.0 1.0 3.6 0.0 0.0 0.0 0.4 0.4 0.5 0.2 0.0 1.9 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.0 0.0 3.6 0.8 3.1 1.6 4.9 0.3 3.9 0.2 1.1 0.2 0.2 1.1 0.1 0.2 0.3 1.1 0.5 2.0 0.1 0.4 0.7 1.7 3.3 0.6 1.9 1.2 1.9 6.3 2.4 1.1 3.2 1.7 2.1 14.6 20.8 3.2 7.5 0.0 1.9 0.4 0.9 0.5 0.0 1.5 1.7 1.3 1.6 0.0 0.5 1.8 0.0 3.0 3.4 10.0 1.9 2.6 4.0 5.4 0.8 11.7 7.2 86.3 1.9 6.6 2.9 2.7 11.2 1.0 2.5 1.7 7.1 1.4 19.5 0.0 2.5 2.5 0.0 12.3 2.8 1.6 1.5 11.3 0.0 9.4 11.9 5.3 3.1 1.5 0.2 6.2 8.4 5.7 2.1 1.0 8.4 0.7 4.1 0.2 0.0 2.2 2.0 2.7 4.4 0.7 0.4 0.8 4.5 1.6 1.6 2.0 IAH1 ENSG00000134330 "Isoamyl acetate hydrolyzing esterase 1 (putative)" Q2TAA2 2 9473658-9496543 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 433.4;Late spermatids: 503.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040523, HPA076040" Approved Approved Nucleoplasm NA NA 240000 Nucleoplasm "HPA040523: AB_2677021, HPA076040: " "unprognostic (1.51e-2)" "unprognostic (1.19e-2)" "unprognostic (1.27e-1)" "unprognostic (9.41e-2)" "unprognostic (9.35e-2)" "unprognostic (2.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.28e-2)" "unprognostic (2.98e-2)" "unprognostic (5.40e-2)" "unprognostic (7.39e-2)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (2.42e-2)" "unprognostic (3.91e-2)" 38.8 47.9 28.0 17.0 29.2 27.6 34.3 33.1 37.6 32.7 31.8 37.3 20.2 30.6 31.6 26.9 28.5 23.2 52.2 27.8 30.5 39.6 46.4 31.5 27.2 28.5 28.1 28.6 35.9 23.4 45.9 31.3 24.4 29.4 26.8 29.4 22.5 22.5 29.6 43.4 22.7 26.5 27.6 27.9 26.1 30.1 66.3 29.3 28.8 29.1 73.3 31.2 30.9 30.2 32.5 41.0 40.8 4.7 0.5 73.4 140.7 0.9 33.4 76.8 48.7 46.4 0.5 44.2 21.1 17.6 106.7 35.2 27.8 15.4 32.2 48.5 81.2 26.8 26.7 16.1 27.5 139.6 0.1 21.2 85.1 92.9 36.6 42.6 93.6 49.2 37.8 0.4 13.3 100.1 39.4 106.6 4.2 6.4 53.6 20.6 26.0 0.1 6.1 79.4 21.1 29.0 56.2 26.0 37.2 52.6 2.4 37.9 46.4 38.6 38.7 17.0 17.5 52.6 10.6 0.7 8.2 53.4 16.6 44.3 33.3 38.0 31.9 30.2 35.3 33.8 38.5 35.2 34.6 49.6 32.7 27.2 30.9 23.0 37.6 42.8 52.4 46.0 25.6 28.0 29.2 33.1 37.6 27.8 30.5 28.5 28.1 28.6 29.4 27.9 29.3 32.5 44.4 32.1 26.2 25.1 53.7 89.9 100.5 92.4 21.6 33.6 41.3 51.2 45.4 52.9 40.1 49.7 12.5 74.2 65.0 36.2 92.0 68.9 433.4 49.9 56.9 30.1 25.7 41.4 43.2 76.9 109.8 73.5 16.8 50.1 36.8 74.0 36.4 53.1 87.4 42.1 35.1 28.6 42.7 78.2 95.2 503.0 93.8 66.3 92.5 19.7 116.8 44.0 80.3 23.1 44.4 90.5 37.3 73.0 38.5 75.6 68.0 138.8 42.7 57.4 98.6 82.8 75.2 243.2 48.8 41.4 95.8 44.5 64.9 87.0 47.5 89.5 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394560-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol NA NA 170000000 Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavorable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavorable (3.26e-8)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavorable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 419.5 361.1 57.5 140.7 69.0 186.3 333.2 53.2 72.4 179.7 67.5 279.3 159.5 152.3 44.2 454.2 190.9 76.1 339.6 63.8 92.2 363.9 735.2 244.1 98.0 74.7 71.6 62.2 151.0 173.0 26.8 96.7 114.8 85.4 171.6 118.6 447.7 269.6 82.6 955.3 450.7 299.0 125.4 59.5 186.7 182.7 96.0 72.6 116.4 182.3 504.8 147.6 268.5 317.0 118.1 1261.4 730.9 28.4 415.2 599.8 399.3 400.6 1186.1 1148.5 936.9 1366.4 324.5 196.6 909.3 380.3 1110.8 727.1 979.2 716.1 1715.1 2082.2 331.3 422.6 329.6 629.4 588.5 148.9 811.2 235.8 411.1 760.3 380.3 373.7 1670.8 550.8 292.3 462.8 431.7 1127.7 319.4 674.8 509.3 182.7 413.2 849.4 432.0 298.0 768.0 1546.6 284.5 220.5 279.3 642.7 518.6 230.8 431.4 241.7 192.9 546.9 1228.3 455.3 1094.7 14.3 348.0 545.1 899.4 1767.1 415.0 434.1 98.4 147.1 79.7 93.8 165.0 105.2 70.4 122.1 99.6 202.1 54.4 78.1 81.0 47.1 91.3 169.3 68.0 140.8 237.6 57.5 69.0 53.2 72.4 63.8 92.2 74.7 71.6 62.2 85.4 59.5 72.6 118.1 421.7 73.7 201.6 21.5 220.8 2198.1 475.6 2133.0 523.0 464.2 213.6 229.5 241.8 175.8 837.3 309.0 146.0 509.8 427.2 696.1 434.3 1293.9 204.4 180.0 317.4 492.8 45.6 123.2 38.7 1532.3 2086.2 544.4 163.6 485.8 262.9 205.3 205.6 514.4 659.3 514.8 33.5 285.1 649.0 224.4 1155.1 129.6 287.7 373.9 1177.5 20.6 973.4 444.2 170.0 9.5 12.6 1771.4 590.3 205.0 376.0 546.8 1765.0 682.5 178.1 481.4 190.7 251.6 706.3 195.5 44.0 422.9 1723.2 501.7 410.9 196.2 362.1 530.8 SAA2 ENSG00000134339 "Serum amyloid A2" P0DJI9 11 18239223-18248668 "Disease related genes, Predicted secreted proteins" "Acute phase" Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 36562.7" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 55342.6" "Cancer enriched" "Detected in many" 22 "liver cancer: 150.5" "Group enriched" "Detected in some" 6 "hypothalamus: 49.8;white matter: 19.9" "Immune cell enhanced" "Detected in some" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 27.8;EFO-21: 20.2;GAMG: 19.6;HaCaT: 25.0;HBEC3-KT: 55.4;HSkMC: 17.6" "Secreted to blood" NA NA 9200000000 "unprognostic (1.73e-3)" "unprognostic (4.42e-2)" "unprognostic (2.63e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-3)" "unprognostic (7.12e-2)" "unprognostic (7.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.57e-1)" "unprognostic (2.86e-2)" "unprognostic (2.78e-2)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (1.53e-1)" "unprognostic (9.72e-2)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" 567.4 17.1 0.0 139.1 0.2 0.5 324.2 0.4 0.7 279.3 0.6 7.9 0.9 1.0 0.2 22.3 21.3 14.2 6.3 0.2 49.8 12.4 36562.7 36.0 0.6 0.3 5.6 0.2 1.8 14.1 0.2 31.4 1.8 0.6 38.8 1.3 0.6 1810.9 1.6 223.0 20.6 21.1 6.6 0.0 20.2 18.3 2.1 5.9 16.4 6.7 0.2 6.9 22.6 7.9 19.9 27.8 0.1 0.2 0.2 1.0 0.0 3.6 0.1 0.8 0.1 0.3 0.0 12.1 0.1 20.2 0.2 19.6 25.0 0.0 55.4 0.1 1.2 0.0 1.0 0.5 0.0 7.8 0.8 0.1 17.6 7.4 0.0 8.9 0.6 0.2 0.0 0.0 0.9 1.5 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.7 0.0 12.4 1.3 0.3 0.0 1.7 8.5 0.1 0.5 0.4 0.5 0.2 0.2 1.2 0.5 1.2 0.5 0.3 1.7 0.1 1.1 0.3 1.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.1 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.4 0.7 0.2 49.8 0.3 5.6 0.2 0.6 0.0 5.9 19.9 7.6 0.0 1.5 0.0 184.4 1.0 5.6 4629.9 0.6 0.0 56.8 68.5 0.2 1052.3 4596.4 3.7 0.0 0.4 0.8 21.9 0.0 70.3 1.6 12.3 0.9 68.2 0.0 2356.0 0.0 34.4 2.3 2.0 0.0 13.5 0.0 0.0 1442.8 55342.6 0.4 0.0 0.0 1.1 1204.4 1502.7 0.0 0.5 0.0 0.6 8.8 0.0 1.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.1 34.5 2.9 0.1 11449.8 0.0 0.0 3.1 400.9 0.3 0.0 5.6 0.1 0.5 144.2 0.0 5.3 65.4 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26188842-26663289 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 45.9;epididymis: 57.9" "Cell type enriched" "Detected in some" 5 "Excitatory neurons: 201.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 45.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3" "Region enhanced" "Detected in all" "basal ganglia: 158.9" "Region enriched" "Detected in all" 7 "basal ganglia: 180.1" HPA041629 Uncertain NA NA "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 3.0 0.8 3.6 0.1 45.9 0.0 0.5 0.0 10.7 0.5 0.0 0.2 0.1 0.1 57.9 0.0 0.2 1.8 0.1 8.2 7.3 1.0 1.1 0.4 0.0 7.2 0.9 6.6 0.1 0.3 0.1 0.3 0.0 15.2 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.0 1.9 5.6 0.1 1.0 0.1 0.0 0.0 0.1 4.1 0.0 0.0 0.4 0.0 1.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.3 0.0 0.4 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 45.9 0.0 10.7 8.2 7.3 7.2 0.9 6.6 15.2 0.0 5.6 4.1 1.0 0.0 2.0 3.3 0.0 0.0 0.0 0.1 0.0 1.7 0.2 0.0 0.9 0.0 0.2 0.0 14.6 0.2 0.0 0.0 0.0 0.1 12.0 0.5 0.0 0.4 0.0 0.0 201.9 0.0 0.3 0.5 0.0 0.3 0.0 0.0 1.8 0.7 0.0 8.4 4.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 8.4 0.0 0.0 0.0 38.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 2.3 0.0 0.0 4.7 3.8 2.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 IL6ST "CD130, GP130, sGP130" ENSG00000134352 "Interleukin 6 signal transducer" P40189 5 55935095-55995022 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 580.3;Hepatic stellate cells: 808.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 16.7" "Lineage enriched" "Detected in many" 4 "T-cells: 16.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 151.3;BJ hTERT+: 175.2;HHSteC: 155.1;HSkMC: 135.1;TIME: 147.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010558, CAB025784" Approved Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 160000000 "Plasma membrane" "Golgi apparatus" "CAB025784: , HPA010558: AB_1078439" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (3.95e-2)" "unprognostic (8.93e-2)" "unprognostic (3.99e-2)" "unprognostic (5.18e-2)" "unprognostic (9.53e-3)" "unprognostic (1.89e-2)" "unprognostic (2.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (3.69e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" 62.9 46.4 30.6 14.2 33.1 9.7 51.8 33.3 37.0 42.6 29.9 30.6 4.2 35.5 18.6 18.6 34.5 23.8 32.1 26.1 43.8 27.7 78.3 53.7 16.0 40.9 31.5 23.6 37.2 22.1 39.9 22.7 102.6 37.8 32.9 14.4 28.8 32.2 30.2 41.4 17.6 31.3 28.9 40.0 35.0 28.0 9.0 29.8 23.8 40.8 35.0 16.3 38.0 35.4 46.7 14.4 35.6 9.4 18.8 75.5 151.3 22.3 54.5 175.2 44.1 62.4 40.5 16.3 1.1 33.7 52.5 71.6 7.8 9.8 19.2 84.1 1.6 8.5 4.6 20.1 14.2 155.1 0.4 6.2 135.1 11.1 103.1 42.7 43.6 101.8 1.9 3.7 51.0 47.0 2.9 0.7 0.8 1.5 1.8 10.1 1.1 22.5 14.4 22.5 12.1 3.8 5.9 26.6 5.7 19.7 13.7 29.5 3.1 147.8 12.4 10.1 44.5 24.6 14.6 8.2 0.5 28.9 1.1 31.1 0.0 3.9 0.1 0.7 3.4 0.3 0.8 3.7 0.8 2.1 0.4 16.7 4.8 0.6 0.8 0.5 1.9 4.1 4.0 30.6 33.1 33.3 37.0 26.1 43.8 40.9 31.5 23.6 37.8 40.0 29.8 46.7 221.6 134.6 149.8 59.4 30.0 103.9 98.0 60.6 71.2 56.5 202.4 81.3 81.5 124.4 105.4 68.0 35.5 77.9 33.1 34.5 7.9 85.3 12.3 76.4 227.6 256.2 19.8 41.1 25.7 62.0 75.5 285.5 59.1 580.3 32.9 58.6 808.5 219.8 56.0 16.8 70.0 34.1 46.8 93.7 99.1 16.7 105.9 60.3 80.0 188.3 45.8 190.8 7.2 75.4 64.2 80.8 35.6 130.5 100.6 163.9 33.6 52.2 80.3 39.3 98.6 158.7 150.3 54.4 38.6 44.9 83.5 101.8 75.5 228.7 17.1 106.1 FST FS ENSG00000134363 Follistatin P19883 5 53480626-53487134 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.2" "Cell type enriched" "Detected in many" 6 "Granulosa cells: 700.1" "Cancer enhanced" "Detected in all" "liver cancer: 45.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA016612, CAB026025" Approved Approved Vesicles "Secreted to blood" NA NA 1800000 Vesicles "CAB026025: , HPA016612: " "unprognostic (1.43e-1)" "unprognostic (6.50e-2)" "unprognostic (1.44e-1)" "unprognostic (7.73e-3)" "unprognostic (2.30e-1)" "unprognostic (1.50e-3)" "unprognostic (8.02e-2)" "unprognostic (2.32e-2)" "unprognostic (3.06e-1)" "unprognostic (1.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.44e-5)" "unprognostic (1.21e-3)" "unprognostic (2.48e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-1)" 21.9 6.3 0.8 3.0 0.7 0.4 15.3 0.4 0.8 6.2 0.7 8.4 1.8 4.3 3.7 6.6 11.9 7.2 7.7 1.9 1.5 2.8 69.2 8.3 1.6 1.9 1.0 0.7 10.0 2.6 0.5 5.9 24.3 1.0 15.7 3.0 0.3 11.4 10.9 9.2 17.5 8.8 4.8 0.6 0.3 11.2 5.0 1.1 2.3 4.1 7.8 13.0 40.8 7.6 0.9 20.0 1.8 33.7 0.0 38.6 13.5 55.4 76.3 351.1 46.4 45.4 0.3 0.2 0.0 0.6 19.9 2.3 292.3 0.0 191.3 32.7 0.8 0.2 4.0 1.7 31.3 20.4 0.3 206.5 31.0 0.5 84.5 55.0 31.3 40.0 0.0 0.0 0.6 29.7 0.1 0.1 1.6 52.1 0.0 558.2 4.2 43.6 0.0 0.0 31.9 0.5 0.1 3.1 0.2 2.0 83.9 0.3 0.3 0.2 124.1 35.3 13.2 11.1 0.4 0.1 0.1 14.8 4.1 116.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.7 0.4 0.8 1.9 1.5 1.9 1.0 0.7 1.0 0.6 1.1 0.9 5.2 0.0 1.1 0.0 1.0 20.0 31.5 64.4 13.1 0.0 0.9 23.4 11.4 0.0 8.3 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.4 0.1 3.4 2.9 0.0 0.0 0.1 4.6 14.8 107.7 3.6 0.1 0.0 700.1 1.1 57.2 1.8 0.0 0.7 0.0 2.0 0.8 16.4 1.5 3.1 1.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 11.3 0.2 37.1 0.0 0.1 1.6 0.0 13.1 29.6 33.3 0.3 12.2 4.0 4.7 6.0 2.0 0.3 0.0 51.8 CFHR4 "CFHL4, FHR-4, FHR4" ENSG00000134365 "Complement factor H related 4" Q92496 1 196888014-196918713 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 432 "liver: 125.0" "Cell type enriched" "Detected in some" 28 "Hepatocytes: 62.6" "Cancer enriched" "Detected in single" 145 "liver cancer: 13.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 170000000 "unprognostic (5.97e-1)" "prognostic favorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (4.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (4.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 125.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.2 62.6 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 NAV1 "DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1" ENSG00000134369 "Neuron navigator 1" Q8NEY1 1 201622885-201826969 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 169.1;Inhibitory neurons: 161.7;Oligodendrocyte precursor cells: 713.8;Oligodendrocytes: 224.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.4;myeloid DC: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 2.1;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "TIME: 187.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012302, HPA018127, HPA027887" Enhanced Approved Microtubules NA NA Microtubules "CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040" "unprognostic (2.14e-1)" "unprognostic (1.82e-1)" "unprognostic (4.12e-2)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-1)" "unprognostic (1.79e-1)" "unprognostic (3.45e-1)" "unprognostic (9.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.68e-1)" "unprognostic (8.24e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (3.45e-2)" "unprognostic (2.16e-1)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" 19.8 2.8 15.8 8.3 14.0 1.7 15.4 5.5 16.6 10.5 0.0 10.5 3.7 10.2 4.3 8.7 7.3 7.6 20.1 14.0 10.2 4.6 2.0 11.2 4.1 23.0 14.9 8.4 3.8 4.4 5.3 5.3 11.9 17.8 7.6 5.5 5.4 7.9 6.7 4.9 7.1 6.2 10.4 7.4 3.6 5.4 4.4 17.4 2.8 9.5 6.8 3.7 15.0 12.7 31.1 1.6 2.9 29.0 3.8 84.3 69.5 51.7 44.6 43.0 35.5 30.9 0.0 15.7 0.6 0.7 61.4 19.4 21.5 22.0 14.9 28.4 2.5 3.2 1.4 5.6 0.0 22.5 0.2 19.1 30.6 5.4 62.4 36.0 94.9 80.7 1.8 0.8 2.6 29.8 0.4 0.0 0.1 42.4 0.7 1.7 3.9 65.0 9.3 4.8 4.3 21.9 4.5 11.1 47.6 14.5 19.2 0.4 1.2 187.8 54.5 11.1 54.7 39.4 8.1 2.3 0.2 59.2 5.9 47.5 3.4 0.5 0.1 0.2 0.3 0.1 0.3 0.2 0.0 2.1 0.3 0.2 0.1 0.0 0.1 0.3 0.5 0.0 0.3 15.8 14.0 5.5 16.6 14.0 10.2 23.0 14.9 8.4 17.8 7.4 17.4 31.1 77.4 3.2 1.5 169.1 3.1 11.0 2.2 5.9 8.0 34.6 4.8 4.3 29.2 1.5 4.8 12.9 0.0 14.9 0.9 4.7 0.0 13.0 3.6 1.6 6.4 39.3 52.8 1.7 98.2 8.3 54.1 45.8 8.2 4.4 17.7 54.5 21.0 0.7 14.5 25.2 161.7 3.4 6.1 18.3 15.8 3.8 10.8 15.1 23.2 69.3 60.6 11.8 1.0 713.8 224.6 21.7 4.2 0.7 4.9 2.3 0.9 0.6 3.5 4.0 6.6 119.3 18.8 0.6 2.6 16.9 7.0 15.7 2.0 6.6 5.0 3.2 CDC73 "C1orf28, FIHP, HRPT1, HRPT2, parafibromin" ENSG00000134371 "Cell division cycle 73" Q6P1J9 1 193121983-193254815 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002326, CAB016359, HPA069324" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016359: AB_628102, HPA002326: , HPA069324: " "unprognostic (4.41e-2)" "unprognostic (6.22e-2)" "unprognostic (1.90e-2)" "unprognostic (5.30e-2)" "unprognostic (2.88e-3)" "unprognostic (3.53e-2)" "unprognostic (2.48e-3)" "unprognostic (5.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.40e-1)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (5.44e-3)" "unprognostic (3.47e-1)" "unprognostic (2.49e-1)" "unprognostic (6.73e-3)" "unprognostic (2.98e-3)" 10.8 9.6 6.5 7.3 7.1 8.9 10.8 6.8 7.4 11.2 5.5 9.0 5.7 10.4 8.6 8.5 7.2 5.9 9.5 5.4 9.8 10.5 9.3 8.0 7.5 7.9 7.4 4.5 11.6 6.4 13.0 5.6 9.5 8.1 15.3 9.1 10.2 7.7 9.8 12.3 6.9 7.7 10.4 8.9 8.6 7.0 5.9 7.2 10.7 13.2 5.6 7.9 9.8 8.6 9.3 9.3 2.4 16.6 11.5 18.3 18.9 4.9 6.7 16.1 19.5 16.4 6.5 12.3 10.5 5.2 20.4 8.8 10.7 16.8 14.9 24.7 6.1 4.1 7.3 8.1 7.2 16.1 16.0 11.6 13.7 16.0 14.9 17.7 20.6 17.8 11.1 8.1 14.2 28.8 3.5 13.9 9.2 11.9 21.9 2.5 10.6 7.0 15.0 26.6 8.2 3.9 12.3 8.6 26.8 22.3 21.0 18.3 14.0 9.2 19.3 2.2 16.4 12.6 12.2 7.2 7.6 11.9 10.2 30.1 2.2 0.5 0.7 0.8 1.0 1.2 0.9 1.1 0.6 0.6 0.5 1.4 1.2 0.3 1.3 0.8 1.0 0.9 0.4 6.5 7.1 6.8 7.4 5.4 9.8 7.9 7.4 4.5 8.1 8.9 7.2 9.3 44.5 35.3 25.4 54.5 44.9 37.2 35.6 38.4 36.5 30.4 24.4 21.8 44.5 25.8 27.2 33.1 35.5 25.0 48.0 18.2 33.2 37.5 19.7 24.6 39.6 38.0 11.4 40.8 71.9 32.2 42.0 39.1 28.1 30.8 41.1 17.6 25.4 17.2 31.6 21.9 76.4 15.8 34.6 27.4 49.1 8.5 33.5 38.3 28.4 54.4 46.0 35.2 41.2 78.4 112.3 35.5 16.9 36.1 50.3 34.9 19.2 36.3 20.6 36.7 26.3 49.0 48.3 55.6 33.0 36.8 34.9 38.0 44.4 30.3 18.6 27.9 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955503-201970664 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 265.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavorable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 30.8 48.7 34.0 35.8 34.4 37.1 29.6 34.8 36.8 27.6 37.6 35.6 31.7 26.0 41.4 32.2 21.1 19.1 72.8 35.0 36.2 42.6 81.2 23.9 31.1 34.2 34.5 32.8 18.7 23.6 56.3 25.0 31.6 34.4 25.2 38.3 33.5 23.2 28.7 86.9 20.8 24.1 35.6 34.5 25.1 29.4 19.8 34.6 30.5 38.5 95.7 36.1 43.2 23.4 36.0 89.1 88.9 78.5 94.9 64.5 67.2 132.5 138.4 98.0 110.5 98.4 104.8 89.7 122.5 49.7 118.6 81.1 69.2 145.3 82.4 118.3 90.4 90.7 67.7 119.1 99.7 66.7 145.5 69.5 78.0 89.8 113.2 93.9 79.5 117.4 75.4 173.1 66.7 131.7 56.9 78.9 78.3 99.6 88.3 47.0 76.5 91.4 152.6 136.2 83.1 118.0 83.2 84.6 213.5 130.7 98.7 118.5 97.0 95.2 73.6 78.7 86.7 146.4 99.9 115.9 102.3 78.4 109.2 84.2 18.5 32.0 29.2 21.7 44.5 28.6 30.3 23.5 28.1 50.1 23.6 22.4 26.2 7.7 29.7 46.7 33.6 37.0 32.2 34.0 34.4 34.8 36.8 35.0 36.2 34.2 34.5 32.8 34.4 34.5 34.6 36.0 31.7 38.5 37.2 9.4 54.7 92.2 100.2 123.3 34.1 24.1 43.2 36.2 129.5 37.1 73.0 38.6 35.5 115.2 44.2 38.8 137.0 94.5 69.7 40.1 55.2 46.0 34.0 36.6 18.1 86.0 187.0 55.9 40.2 48.1 55.2 37.9 32.9 168.0 114.8 35.3 17.4 58.1 81.4 44.0 177.7 32.0 33.5 52.8 53.4 4.7 80.4 49.4 26.8 6.6 14.9 109.4 30.4 38.4 98.6 85.0 37.2 131.8 55.8 31.7 26.3 46.6 75.3 42.6 61.5 60.6 98.9 265.6 46.2 62.9 58.3 118.1 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs cell polarity complex component 1" P82279 1 197268204-197478455 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Disease variant, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.8;retina: 75.4" "Cell type enhanced" "Detected in some" "Astrocytes: 469.5;Cone photoreceptor cells: 164.7;Inhibitory neurons: 130.1;Muller glia cells: 79.7;Oligodendrocyte precursor cells: 280.0;Oligodendrocytes: 105.6;Rod photoreceptor cells: 149.3" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 28 "basophil: 7.7" "Lineage enriched" "Detected in single" 28 "granulocytes: 7.7" "Cell line enriched" "Detected in some" 8 "HeLa: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA061250, HPA063127" Approved Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA061250: AB_2684458, HPA063127: AB_2684944" "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 0.1 0.1 21.8 0.0 17.1 0.4 0.1 19.6 20.7 0.0 9.2 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.2 15.7 15.1 0.1 0.0 0.1 0.1 18.2 15.9 14.9 0.7 0.4 0.0 2.2 0.0 16.3 0.0 0.0 75.4 0.0 0.0 0.7 0.0 0.0 0.0 19.4 0.0 0.2 2.9 14.4 0.0 0.2 0.5 0.0 0.0 0.0 20.9 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 21.8 17.1 19.6 20.7 15.7 15.1 18.2 15.9 14.9 16.3 19.4 14.4 20.9 0.0 0.0 0.0 469.5 0.0 0.3 0.2 0.3 0.0 15.0 0.2 0.1 1.1 0.0 0.2 0.0 164.7 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.7 0.0 11.6 53.2 0.0 0.0 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.7 130.1 0.0 2.0 0.0 0.5 1.6 1.8 0.0 0.0 24.4 0.0 79.7 0.0 280.0 105.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.9 149.3 0.0 0.2 0.1 1.8 0.3 0.0 0.3 0.0 0.1 0.2 0.0 0.0 CFHR5 "CFHL5, FHR-5, FHR5" ENSG00000134389 "Complement factor H related 5" Q9BXR6 1 196977556-197009678 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1689 "liver: 168.8" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 102.7" "Cancer enriched" "Detected in single" 396 "liver cancer: 57.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038915, HPA040726" Supported "Secreted to blood" NA NA 1900000000 "HPA038915: AB_2676269, HPA040726: AB_2677101" "unprognostic (9.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 102.7 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ERN2 IRE1b ENSG00000134398 "Endoplasmic reticulum to nucleus signaling 2" Q76MJ5 16 23690310-23713226 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix: 19.6;gallbladder: 17.1;intestine: 29.2;salivary gland: 23.0;stomach 1: 52.3" "Cell type enhanced" "Detected in some" "Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 17.0;pancreatic cancer: 19.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 43.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA076875 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Cytosol" "HPA076875: " "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (3.45e-1)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.13e-2)" "unprognostic (7.67e-4)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (7.34e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-9)" "unprognostic (1.48e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-3)" 0.1 0.4 0.2 3.0 0.2 0.0 0.1 0.5 0.4 19.6 0.2 29.2 13.0 0.0 0.0 0.9 0.4 17.1 0.0 0.1 0.2 0.1 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.9 0.0 0.2 0.0 0.2 3.5 23.2 0.0 23.0 0.1 0.0 0.2 12.5 0.9 0.0 0.0 52.3 0.1 0.1 0.0 0.0 0.0 0.0 4.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.5 0.4 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.0 1.1 0.0 0.8 0.0 1.5 6.8 0.0 0.0 0.0 0.0 0.5 20.0 38.4 0.0 0.0 0.5 0.0 80.2 0.0 2.3 0.1 0.5 0.2 0.1 10.8 0.0 0.2 1.9 0.0 0.1 193.7 1.6 4.5 0.1 0.0 0.0 0.1 0.0 0.1 143.9 6.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 33.1 37.2 0.0 0.5 1.3 6.1 0.1 16.9 0.0 0.0 1.7 1.6 0.0 0.2 0.0 0.0 0.1 0.4 0.0 70.9 11.1 RPS15A S15A ENSG00000134419 "Ribosomal protein S15a" P62244 16 18781295-18790383 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047103 Supported NA NA 210000 "HPA047103: AB_10959516" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.53e-2)" "unprognostic (6.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.19e-1)" "unprognostic (4.18e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.29e-7)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (6.32e-2)" 1904.1 1327.2 726.8 937.3 734.8 3599.8 4015.4 731.1 1056.5 2234.1 762.2 1632.8 854.7 1468.6 1510.8 1982.6 1844.6 975.1 1245.5 711.0 759.3 1228.8 1491.3 1288.9 2645.7 753.2 737.8 699.1 3703.3 2848.6 892.3 868.6 1072.7 753.8 1563.7 1303.6 512.8 1904.8 927.9 2309.2 2484.5 1645.0 935.7 762.1 1918.5 1619.7 475.2 757.4 2526.4 1221.0 1863.6 2086.7 1612.6 1995.8 771.5 1665.9 1632.7 2483.5 1708.0 3039.9 5447.7 1905.0 1623.5 2499.0 2223.5 1758.2 2282.2 1828.8 3795.4 3246.5 2258.0 820.6 1567.7 2367.9 3334.7 2557.8 1538.5 4026.8 1666.6 1734.7 5714.8 3899.2 2810.4 1310.7 5282.8 5288.0 1830.6 3782.4 3411.7 2803.0 2251.7 2437.4 2161.9 2389.3 3901.5 2848.5 3593.9 2324.8 2105.3 1704.5 3870.4 2300.4 4873.8 2757.3 1533.9 1781.7 1390.8 1259.1 2592.9 2737.5 1803.4 2342.6 4322.0 2001.0 1037.6 1004.2 1091.0 1617.6 1951.9 2709.1 3415.2 1339.3 2810.8 1215.2 519.8 1342.8 390.9 1643.8 974.2 2426.6 3134.0 2875.1 2323.1 1708.7 2591.0 3584.0 2850.7 215.0 1946.6 909.4 1602.5 2413.8 5373.8 726.8 734.8 731.1 1056.5 711.0 759.3 753.2 737.8 699.1 753.8 762.1 757.4 771.5 2629.8 1083.3 1663.6 11.4 6665.9 5978.3 5499.3 3924.8 5776.0 267.9 7331.7 10612.6 72.1 2372.0 2186.7 866.2 100.1 4677.6 4677.4 1392.4 2952.4 1975.3 1210.8 1172.7 3078.3 2808.5 2157.8 4096.4 11.0 3924.4 6676.0 2500.4 2125.4 1458.1 1587.3 3408.3 3436.1 3628.1 3635.3 119.5 11.6 4611.7 1194.2 5381.3 5449.1 622.7 5241.5 3453.2 2995.4 12.2 5190.0 1097.8 5097.9 13.6 16.0 2845.4 3571.7 2307.6 4358.8 5125.0 3359.1 4622.0 964.4 472.3 1393.7 3419.0 2181.1 798.5 662.3 7088.8 7535.8 4526.0 6066.2 2447.3 4984.8 5522.2 RAX RX ENSG00000134438 "Retina and anterior neural fold homeobox" Q9Y2V3 18 59267035-59274086 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 36 "brain: 10.4;pituitary gland: 6.6;retina: 16.1" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 493.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "hypothalamus: 10.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.8;SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (3.76e-3)" "unprognostic (2.28e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.46e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.6 0.0 0.4 0.1 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 10.4 0.0 0.2 0.0 0.4 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.9 0.0 0.0 1.3 0.0 0.0 0.0 83.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 493.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.7 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NARS1 NARS ENSG00000134440 "Asparaginyl-tRNA synthetase 1" O43776 18 57600656-57622213 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 221.3;Cytotrophoblasts: 116.0;Extravillous trophoblasts: 85.2;Hofbauer cells: 117.4;Syncytiotrophoblasts: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034257, HPA040017" Enhanced Supported Cytosol NA NA 76000 Cytosol "CAB034257: AB_2151043, HPA040017: AB_2676801" "unprognostic (9.85e-2)" "unprognostic (1.88e-1)" "unprognostic (3.86e-3)" "unprognostic (1.68e-1)" "unprognostic (2.61e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.23e-7)" "unprognostic (1.78e-1)" "unprognostic (1.48e-1)" "unprognostic (1.62e-2)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.73e-7)" "unprognostic (1.24e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" 67.8 66.6 59.7 62.7 62.5 49.2 69.0 65.6 83.7 58.0 64.9 109.7 88.1 53.2 67.1 64.8 59.0 56.5 95.7 61.1 65.6 136.3 76.2 52.2 53.2 64.9 62.8 54.5 45.8 63.7 126.3 33.4 56.6 69.8 69.0 100.4 68.8 69.4 66.0 128.4 50.0 72.6 66.1 61.9 47.2 80.1 33.0 68.7 59.7 95.8 131.8 67.9 78.7 42.2 68.6 215.1 133.2 129.6 199.1 172.8 130.7 202.5 302.5 161.7 179.2 215.4 100.3 97.0 270.7 136.2 208.7 172.1 241.7 211.0 191.6 259.0 127.5 75.5 217.8 105.4 171.8 299.9 433.0 212.5 146.0 331.2 233.8 245.8 130.6 154.6 169.4 246.5 201.6 200.9 86.2 172.4 111.9 189.6 145.1 118.6 139.8 154.5 229.9 340.3 224.4 140.9 147.6 153.1 184.0 309.4 137.3 108.8 242.6 179.7 190.5 127.7 78.8 215.8 449.1 559.2 260.3 175.1 285.7 227.7 50.9 108.5 38.8 41.8 92.6 50.9 52.6 43.3 44.7 71.7 51.4 58.2 52.6 34.4 43.6 76.8 64.0 49.4 74.9 59.7 62.5 65.6 83.7 61.1 65.6 64.9 62.8 54.5 69.8 61.9 68.7 68.6 26.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.3 0.0 0.0 0.0 0.0 116.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 85.2 23.1 0.0 0.0 0.0 0.0 0.0 0.0 117.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 158.6 3.5 0.0 0.0 0.0 GRP ENSG00000134443 "Gastrin releasing peptide" P07492 18 59220158-59230774 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5;lung: 9.1;stomach 1: 12.4" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 24.4;Early spermatids: 15.5;Ionocytes: 6.1;Late spermatids: 12.2;Sertoli cells: 6.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ hTERT+: 5.1;fHDF/TERT166: 6.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 24.9" "Secreted in other tissues" NA NA 340000 "unprognostic (3.91e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-3)" "unprognostic (3.21e-2)" "unprognostic (7.86e-3)" "unprognostic (3.01e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (1.79e-1)" "unprognostic (5.86e-4)" "unprognostic (2.65e-4)" "unprognostic (9.94e-2)" "unprognostic (6.99e-2)" "unprognostic (5.16e-2)" 0.3 0.2 3.0 0.2 2.4 0.0 2.6 1.0 5.0 0.1 2.3 1.7 0.1 0.3 0.4 0.0 0.0 0.3 0.0 5.9 5.5 0.0 0.0 9.1 0.0 2.8 7.5 1.6 0.0 1.2 7.1 3.9 0.0 2.7 2.7 0.1 0.5 0.0 0.1 0.0 0.3 0.7 1.2 1.8 0.3 12.4 2.4 6.0 0.1 6.1 0.0 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.0 0.4 0.0 6.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.4 1.0 5.0 5.9 5.5 2.8 7.5 1.6 2.7 1.8 6.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.2 0.0 0.0 0.4 24.4 0.1 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 2.0 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.3 12.2 0.3 0.1 0.0 4.7 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.1 6.6 0.0 0.2 1.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 4.2 RELCH "FLJ33841, HsT3308, HsT885, KIAA1468" ENSG00000134444 "RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing" Q9P260 18 62187255-62310249 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 7.7 8.9 9.0 9.7 11.4 14.3 12.0 11.9 10.3 9.9 7.8 11.6 9.6 8.5 11.9 25.6 7.8 7.9 7.3 10.1 9.9 9.7 7.9 8.1 11.9 8.7 8.8 9.5 8.3 8.3 10.3 11.0 8.2 9.0 12.2 14.6 16.5 12.6 8.9 6.8 20.8 10.9 6.3 7.7 11.3 12.8 5.3 9.3 10.9 9.6 5.9 13.3 10.1 16.4 10.3 9.7 8.7 10.4 10.0 10.8 12.7 11.1 17.0 14.1 15.0 16.5 4.5 8.8 6.6 8.6 15.1 9.8 19.7 14.9 10.2 18.3 6.0 9.3 5.6 9.7 10.4 9.6 10.8 7.4 9.4 12.3 12.8 7.8 12.3 10.3 6.2 4.2 6.5 15.9 5.7 6.7 9.3 6.0 6.5 7.3 8.2 13.0 7.9 17.1 19.1 14.7 7.8 10.2 14.9 8.9 13.4 7.7 11.6 12.9 15.9 5.0 6.9 8.6 19.0 3.7 6.4 11.2 11.4 13.0 1.4 1.0 1.2 1.1 0.8 0.8 0.8 1.0 1.0 1.0 0.9 1.1 1.3 1.7 1.1 0.7 0.7 1.3 0.6 9.0 11.4 11.9 10.3 10.1 9.9 8.7 8.8 9.5 9.0 7.7 9.3 10.3 7.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 6.5 8.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.6 1.1 0.0 0.0 0.0 FBH1 "Fbx18, FBXO18, FLJ14590" ENSG00000134452 "F-box DNA helicase 1" Q8NFZ0 10 5890203-5937594 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002844 Supported NA NA "HPA002844: AB_1078829" "unprognostic (3.14e-2)" "unprognostic (1.55e-1)" "unprognostic (6.35e-3)" "unprognostic (4.42e-2)" "unprognostic (3.37e-2)" "unprognostic (8.98e-3)" "prognostic unfavorable (7.73e-7)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" "unprognostic (3.37e-2)" "unprognostic (1.56e-2)" "unprognostic (2.23e-1)" "unprognostic (6.91e-3)" "unprognostic (3.69e-1)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (9.54e-2)" 27.6 39.1 16.8 23.0 19.2 24.8 27.1 16.8 18.3 32.2 23.5 30.3 24.9 34.6 21.5 24.2 36.7 23.2 41.2 16.5 17.7 25.3 29.0 27.8 27.8 17.2 17.3 16.5 31.0 22.0 28.8 26.3 26.8 17.1 28.9 24.4 15.0 24.5 26.0 30.5 30.0 30.0 30.4 17.0 35.6 27.9 24.9 17.9 40.6 25.4 27.7 27.4 29.0 27.3 18.1 31.8 34.0 31.3 34.4 70.4 46.3 28.1 35.9 24.6 34.8 38.8 40.4 28.3 29.6 23.0 52.5 16.7 46.3 42.6 38.2 31.3 32.2 31.5 28.6 27.3 34.8 48.2 14.2 26.4 58.2 36.4 44.2 19.4 44.0 59.7 39.7 50.9 30.4 37.3 48.1 34.5 20.9 14.3 54.7 18.9 37.6 14.8 49.9 34.0 25.5 17.7 26.6 36.8 33.1 50.8 35.7 33.7 28.5 37.9 22.1 24.7 59.1 28.1 30.9 26.1 16.3 29.8 20.7 15.8 0.0 2.1 3.3 1.9 1.7 1.3 3.0 2.0 2.5 2.0 4.1 2.5 1.8 1.3 4.6 1.3 4.0 6.2 1.7 16.8 19.2 16.8 18.3 16.5 17.7 17.2 17.3 16.5 17.1 17.0 17.9 18.1 22.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 15.6 16.1 0.0 0.0 0.0 7.3 0.0 20.3 9.3 0.0 21.5 16.8 0.0 11.4 19.0 7.1 0.0 0.0 0.0 15.1 19.4 9.8 0.0 14.9 0.0 23.6 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 18.3 0.0 0.0 3.2 0.0 0.0 20.9 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 32.0 4.4 27.9 0.0 0.0 RBM17 "MGC14439, SPF45" ENSG00000134453 "RNA binding motif protein 17" Q96I25 10 6089034-6117457 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037477, HPA037478" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037477: AB_10671372, HPA037478: AB_2675494" "unprognostic (8.55e-2)" "unprognostic (2.41e-1)" "unprognostic (3.11e-3)" "unprognostic (6.23e-2)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (4.57e-8)" "unprognostic (3.78e-2)" "unprognostic (6.39e-2)" "unprognostic (3.47e-3)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (1.82e-1)" "unprognostic (5.53e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-2)" 66.3 47.4 51.3 75.9 51.1 140.8 64.9 48.5 54.0 49.7 41.9 57.9 64.3 64.1 39.0 52.3 55.8 53.0 54.6 47.4 53.4 48.1 45.0 78.7 88.1 54.9 50.1 40.4 55.2 63.4 45.9 36.1 76.3 55.1 41.8 65.8 42.0 50.3 39.8 96.4 46.0 71.0 60.9 49.0 78.2 52.0 62.4 55.6 88.5 63.8 72.8 86.1 64.2 49.8 55.6 195.9 113.0 141.1 122.7 76.5 69.4 175.5 128.4 58.0 130.2 139.8 184.7 151.2 234.1 89.3 94.4 48.5 188.1 130.3 136.4 138.6 233.7 132.1 199.3 120.4 158.5 96.7 110.0 93.6 71.7 104.0 132.4 72.4 67.9 159.6 168.1 219.0 112.1 84.1 223.6 198.8 66.2 90.3 227.8 81.3 211.4 79.9 120.8 93.5 117.3 60.5 78.9 124.1 110.1 99.0 119.5 146.3 111.3 97.3 76.9 153.4 169.0 138.1 110.2 135.6 386.7 72.0 140.3 51.7 79.7 78.2 102.6 71.6 79.0 75.2 101.8 71.8 73.4 69.9 110.2 71.8 68.1 38.7 77.8 62.3 77.0 101.1 59.8 51.3 51.1 48.5 54.0 47.4 53.4 54.9 50.1 40.4 55.1 49.0 55.6 55.6 152.3 89.8 56.0 24.8 107.7 129.2 97.4 72.7 108.7 71.3 68.5 85.3 86.0 65.8 68.1 66.2 50.1 125.6 83.3 80.8 90.1 92.0 90.2 74.7 99.5 123.9 72.7 100.5 42.2 70.9 188.5 89.5 58.6 83.9 96.8 79.7 69.7 65.3 98.8 92.5 41.4 87.1 63.1 73.6 128.6 26.3 66.2 93.9 51.6 38.4 161.5 77.9 96.8 23.6 40.7 88.0 86.4 60.5 153.8 122.3 79.8 75.7 41.3 62.2 72.3 115.6 117.4 266.4 233.3 114.4 108.7 97.0 97.4 78.9 106.5 112.6 IL2RA "CD25, IDDM10, IL2R" ENSG00000134460 "Interleukin 2 receptor subunit alpha" P01589 10 6010689-6062370 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 19.1;lymphoid tissue: 17.6;urinary bladder: 11.3" "Group enriched" "Detected in some" 6 "granulocytes: 80.8;monocytes: 177.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "hypothalamus: 4.0" "Group enriched" "Detected in many" 8 "basophil: 175.9;T-reg: 248.0" "Group enriched" "Detected in many" 14 "granulocytes: 175.9;T-cells: 248.0" "Cell line enriched" "Detected in some" 59 "HDLM-2: 1113.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB002419, HPA054622" Enhanced NA NA 410000 "CAB002419: AB_563538, HPA054622: AB_2682546" "unprognostic (2.82e-1)" "unprognostic (8.10e-3)" "unprognostic (1.75e-2)" "unprognostic (5.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-3)" "unprognostic (2.78e-2)" "unprognostic (2.73e-1)" "unprognostic (5.03e-2)" "unprognostic (6.32e-2)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.08e-9)" "unprognostic (2.10e-2)" "unprognostic (4.66e-2)" "unprognostic (2.22e-1)" "unprognostic (5.10e-2)" 19.1 1.9 0.0 14.3 0.2 0.4 1.4 0.1 0.3 0.5 1.0 3.3 2.0 0.5 0.2 2.6 0.3 3.0 0.8 0.1 4.0 0.7 0.5 2.4 17.6 0.6 0.1 0.0 0.1 0.5 0.3 0.9 2.5 0.7 0.5 2.1 0.0 0.5 0.8 0.1 0.4 6.6 4.8 0.1 7.6 1.2 0.3 0.2 5.2 1.3 0.6 13.0 11.3 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1113.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 0.4 18.9 0.0 0.3 0.0 175.9 0.1 20.1 0.6 0.0 2.2 14.7 27.3 3.1 0.2 7.3 2.0 0.2 0.9 13.4 0.3 0.2 248.0 3.2 0.0 0.2 0.1 0.3 0.1 4.0 0.6 0.1 0.0 0.7 0.1 0.2 0.4 0.4 0.0 1.8 1.0 13.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.2 0.2 0.6 0.4 0.0 0.8 0.2 0.6 0.0 0.7 1.1 0.1 80.8 0.0 0.4 0.2 0.3 0.0 0.2 0.0 0.0 7.7 4.8 0.1 0.0 19.3 3.6 1.9 177.6 0.0 2.1 0.0 0.3 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.1 0.6 0.0 19.6 0.0 0.1 0.2 ANKRD16 DKFZP434N1511 ENSG00000134461 "Ankyrin repeat domain 16" Q6P6B7 10 5861616-5889906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 26.9;Inhibitory neurons: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037920, HPA037921" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA037920: AB_10671381, HPA037921: AB_2675740" "unprognostic (1.90e-1)" "unprognostic (1.67e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (1.73e-2)" "unprognostic (6.18e-3)" "unprognostic (9.96e-3)" "unprognostic (4.57e-2)" "unprognostic (3.05e-1)" "unprognostic (1.86e-2)" "prognostic favorable (1.98e-4)" "unprognostic (5.85e-2)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.06e-2)" "unprognostic (7.64e-2)" "unprognostic (9.53e-2)" "unprognostic (3.93e-2)" 3.6 4.0 5.0 2.3 5.3 1.9 4.2 5.5 7.9 6.3 2.7 3.6 3.2 5.2 4.9 3.7 5.8 2.6 3.1 5.2 4.3 3.3 4.2 3.0 3.1 5.2 5.1 5.9 6.3 4.1 5.8 4.0 1.7 5.4 4.1 2.5 4.4 4.0 3.1 3.9 6.8 3.2 3.2 3.7 3.2 6.6 8.8 4.8 3.8 3.7 2.6 3.3 4.3 4.5 5.5 8.3 9.8 4.5 9.2 4.6 3.4 6.6 2.5 1.9 4.4 3.8 12.1 4.3 8.8 3.5 4.2 1.6 8.5 5.5 6.4 2.0 3.1 8.6 5.5 4.8 11.1 5.9 3.4 3.8 5.3 4.8 4.0 3.1 3.5 4.9 9.0 7.5 2.6 3.1 11.5 12.7 5.8 3.7 11.2 6.9 9.6 2.9 18.1 5.0 5.3 2.7 6.0 5.2 6.4 6.0 3.6 8.9 6.9 3.2 2.6 3.4 5.8 3.5 14.7 7.1 5.8 5.4 3.3 2.9 0.3 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.2 0.4 0.4 0.1 0.1 0.4 0.1 0.5 0.2 0.1 5.0 5.3 5.5 7.9 5.2 4.3 5.2 5.1 5.9 5.4 3.7 4.8 5.5 5.3 3.2 1.3 14.7 5.9 4.7 7.8 1.4 4.6 14.1 7.0 6.0 2.8 10.0 1.8 3.7 6.2 4.7 3.0 2.4 13.7 2.1 8.4 7.8 9.8 4.2 4.2 5.5 25.1 2.2 3.6 10.2 4.1 4.4 0.0 13.0 3.3 3.8 3.3 26.9 28.4 3.1 0.0 1.0 3.3 14.6 5.6 3.2 3.6 5.6 3.6 8.8 1.0 12.5 16.2 1.0 1.3 3.8 11.3 7.3 5.2 8.3 1.0 14.4 0.0 8.5 4.5 13.0 7.8 6.5 5.7 1.5 3.5 10.5 5.2 3.7 ECHDC3 FLJ20909 ENSG00000134463 "Enoyl-CoA hydratase domain containing 3" Q96DC8 10 11742366-11764070 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 162.9;skeletal muscle: 129.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 81.2;Distal tubular cells: 144.8;Hepatocytes: 152.0;Proximal tubular cells: 209.9" "Cancer enhanced" "Detected in all" "liver cancer: 35.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 15.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 15.4" "Cell line enhanced" "Detected in many" "A-431: 52.9;BEWO: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038306 Enhanced NA NA 120000 "HPA038306: AB_10672586" "unprognostic (8.74e-2)" "unprognostic (1.69e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (5.07e-1)" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (3.53e-1)" "prognostic favorable (3.43e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (3.91e-4)" 72.3 29.5 2.4 3.3 2.2 7.0 53.3 2.3 2.5 12.9 14.8 5.8 1.8 11.1 2.3 23.0 11.2 1.8 52.9 2.4 4.0 62.3 162.9 17.6 3.8 2.9 2.5 2.3 10.6 30.0 1.8 10.9 8.0 2.7 13.9 3.7 2.0 28.9 13.8 129.4 21.3 6.1 4.5 2.5 15.8 26.8 14.4 3.0 2.9 18.0 60.6 5.5 9.4 18.0 3.5 52.9 7.6 0.1 0.0 0.0 0.0 28.7 6.3 0.0 4.6 4.0 19.1 0.4 0.0 5.8 14.1 1.3 12.5 11.9 1.9 2.0 0.1 0.5 0.0 7.6 0.0 20.5 0.0 7.4 14.1 11.8 4.8 0.0 0.4 9.3 0.0 19.6 0.0 1.4 7.3 0.0 0.2 13.3 0.1 0.0 16.3 0.0 0.0 3.6 0.0 5.5 8.4 0.0 13.1 0.0 16.5 20.5 2.6 2.8 0.0 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.6 2.9 1.7 15.4 0.0 0.6 0.0 0.2 0.1 0.5 1.7 1.7 0.3 0.0 3.6 0.5 0.7 0.6 0.0 0.3 2.4 2.2 2.3 2.5 2.4 4.0 2.9 2.5 2.3 2.7 2.5 3.0 3.5 2.7 19.2 11.8 0.0 3.6 4.5 13.8 2.7 0.0 0.9 16.7 27.2 42.2 17.2 6.4 16.5 2.1 81.2 0.1 1.3 144.8 33.6 4.0 2.3 5.9 3.5 0.0 1.7 0.3 29.8 32.9 6.0 16.3 4.6 0.0 49.5 4.6 152.0 13.1 0.0 0.2 0.6 6.1 14.1 2.2 6.3 2.8 10.6 8.8 1.0 6.8 13.1 0.0 0.0 0.5 13.6 1.2 3.4 6.4 26.1 0.9 209.9 0.4 2.7 19.7 12.0 12.0 22.1 9.6 0.4 5.7 28.9 1.5 4.9 1.9 6.8 IL15RA "CD215, IL-15RA" ENSG00000134470 "Interleukin 15 receptor subunit alpha" Q13261 10 5943639-5978187 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 39.1;Exocrine glandular cells: 55.2;Fibroblasts: 37.6;Hepatic stellate cells: 36.0;monocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 70.8;EFO-21: 41.3;HDLM-2: 78.5;HHSteC: 42.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 8 "cerebellum: 7.1" CAB026215 Approved "Secreted to blood" NA NA "CAB026215: " "unprognostic (2.86e-2)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (4.45e-2)" "unprognostic (7.87e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (2.67e-6)" "unprognostic (5.09e-3)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.18e-3)" "prognostic unfavorable (1.27e-12)" "unprognostic (4.43e-2)" "unprognostic (4.69e-2)" "unprognostic (4.08e-2)" "unprognostic (5.75e-2)" 18.4 7.5 3.5 20.6 3.9 11.8 18.5 3.2 4.6 21.6 4.8 12.4 16.4 15.1 4.6 11.6 19.0 23.4 17.2 2.8 6.7 9.0 19.7 44.9 21.5 5.5 3.9 1.9 3.7 11.6 2.2 4.6 16.2 4.7 10.5 11.0 0.3 8.1 5.3 7.1 11.3 15.8 12.2 4.4 15.3 16.5 3.3 5.6 5.7 12.2 10.3 11.7 26.0 12.8 4.8 16.8 2.4 0.0 0.7 21.5 4.9 4.3 8.6 18.4 10.7 11.4 0.3 70.8 1.9 41.3 16.0 6.0 15.6 2.0 12.1 2.4 78.5 3.5 2.0 4.9 1.2 42.7 0.9 0.6 4.1 4.2 6.0 0.2 4.4 29.1 1.3 20.5 23.5 0.3 9.3 3.6 8.9 0.4 6.7 6.8 10.0 0.0 13.4 2.8 1.3 0.1 0.1 12.9 1.4 0.6 0.2 6.1 8.0 10.8 0.5 1.3 30.1 11.2 20.5 6.2 0.4 4.9 12.4 0.7 10.2 26.0 6.6 18.9 32.8 29.1 10.8 14.7 19.7 7.1 6.4 6.1 11.0 7.5 11.5 21.0 0.1 17.7 12.8 3.5 3.9 3.2 4.6 2.8 6.7 5.5 3.9 1.9 4.7 4.4 5.6 4.8 25.2 6.4 5.0 1.3 6.0 5.7 5.7 9.9 4.6 0.0 4.4 3.0 5.8 22.8 3.3 0.0 0.0 0.6 4.2 5.8 0.0 39.1 1.7 5.1 23.0 21.0 5.4 19.8 3.3 55.2 1.6 37.6 9.7 6.7 3.8 0.1 36.0 8.7 6.6 0.0 0.9 6.8 2.0 14.7 5.5 2.1 5.0 7.3 3.6 12.2 55.0 0.0 4.1 1.0 0.3 35.5 13.3 0.7 22.2 20.1 9.3 0.1 3.4 0.0 0.0 7.1 6.4 0.2 0.4 4.6 6.5 0.1 7.8 0.0 9.3 6.8 CCNH "CycH, p34, p37" ENSG00000134480 "Cyclin H" P51946 5 87318416-87412930 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 281.5;Plasma cells: 219.9;Spermatocytes: 202.6;T-cells: 207.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019416, HPA044138" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB019416: AB_2259936, HPA044138: AB_2678828" "unprognostic (5.65e-2)" "unprognostic (3.94e-3)" "unprognostic (4.01e-3)" "unprognostic (4.12e-1)" "unprognostic (1.10e-1)" "unprognostic (9.30e-2)" "unprognostic (3.93e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (4.16e-2)" "unprognostic (2.27e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (1.48e-1)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (9.62e-2)" 37.0 26.8 7.0 18.9 8.1 38.7 29.2 15.2 11.5 18.2 7.9 16.1 17.7 15.0 24.4 17.9 17.8 24.9 19.7 8.8 14.8 24.8 37.8 26.0 24.3 8.3 7.7 8.3 27.1 23.2 30.2 27.3 15.7 8.4 26.8 20.1 11.5 20.6 18.5 29.4 15.5 16.8 15.8 7.9 18.5 17.8 54.5 7.3 37.2 27.1 22.8 26.1 27.5 18.4 10.7 62.6 26.6 27.1 18.1 39.3 27.5 28.1 44.4 54.8 73.8 101.2 46.7 35.0 40.5 15.8 66.4 77.7 31.1 32.5 67.5 68.4 42.9 39.9 73.1 44.8 46.4 69.3 61.9 57.6 37.0 25.4 38.6 93.8 37.8 65.6 38.7 50.0 70.7 61.7 35.1 42.4 49.5 11.6 15.7 99.4 34.5 63.3 60.9 62.5 32.8 27.8 18.1 23.3 21.7 53.8 16.3 51.7 46.8 45.6 70.9 29.3 41.9 39.4 25.1 23.9 63.4 45.6 55.7 33.6 49.3 37.7 58.8 26.4 47.2 37.4 36.7 35.4 34.8 44.5 32.0 34.4 36.2 28.0 35.4 50.2 26.1 44.8 36.9 7.0 8.1 15.2 11.5 8.8 14.8 8.3 7.7 8.3 8.4 7.9 7.3 10.7 67.5 35.3 33.7 15.0 111.2 37.3 64.3 55.1 40.5 29.0 30.1 24.3 13.2 20.0 37.7 18.4 16.7 21.0 154.2 14.7 41.1 40.1 281.5 28.0 25.2 37.6 24.0 33.7 28.3 34.5 25.6 52.5 41.3 24.2 57.1 19.9 30.0 19.9 45.3 18.5 43.7 15.2 36.7 67.9 73.4 41.4 29.5 125.2 48.0 20.6 25.5 44.9 41.2 20.1 23.5 31.1 15.8 25.2 219.9 31.7 27.0 53.8 34.4 32.9 52.6 43.3 120.0 202.6 48.3 22.3 34.5 30.1 207.8 35.7 19.4 41.0 HRH4 "AXOR35, GPCR105, GPRv53, H4R, HH4R" ENSG00000134489 "Histamine receptor H4" Q9H3N8 18 24460637-24479961 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Club cells: 1.3;Early spermatids: 1.2;granulocytes: 1.3;Late spermatids: 1.3;Melanocytes: 1.8;Spermatocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 123 "basophil: 212.9;eosinophil: 61.1" "Lineage enriched" "Detected in many" 191 "granulocytes: 212.9" "Cell line enhanced" "Detected in single" "HL-60: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035009 Uncertain NA NA "HPA035009: AB_10671507" "unprognostic (1.88e-1)" "unprognostic (2.62e-1)" "unprognostic (4.68e-2)" "unprognostic (9.83e-6)" "unprognostic (1.31e-2)" "unprognostic (3.61e-2)" "unprognostic (1.22e-1)" "unprognostic (8.96e-2)" "unprognostic (2.20e-1)" "unprognostic (3.30e-1)" "unprognostic (7.25e-2)" "unprognostic (2.91e-1)" "unprognostic (6.65e-7)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-4)" "unprognostic (7.70e-2)" 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.3 0.3 0.1 0.3 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.6 0.5 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.4 0.3 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 1.3 0.7 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.1 212.9 0.1 61.1 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.5 0.5 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.0 0.6 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.3 0.4 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.3 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.7 1.3 0.0 0.1 1.8 1.0 0.0 0.3 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.8 0.3 1.3 0.3 0.0 0.6 0.0 0.5 0.2 0.0 0.4 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.8;Oligodendrocyte precursor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "NK-cell: 6.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA029489: AB_2673067, HPA059922: AB_2684164" "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavorable (5.80e-4)" 2.1 0.6 0.4 1.8 0.9 1.1 2.3 0.0 1.5 1.8 0.6 1.7 1.5 2.0 1.6 1.7 1.7 1.6 1.5 1.2 0.7 1.1 1.7 1.4 1.4 0.1 0.1 0.9 1.6 1.3 2.4 1.1 2.3 0.2 0.9 2.2 0.3 1.2 0.9 1.0 0.8 1.1 3.0 0.0 1.5 1.4 0.6 0.3 1.0 2.2 0.9 1.5 1.6 1.0 0.9 3.2 4.5 1.2 4.1 5.5 5.3 3.5 1.6 1.9 1.9 3.8 1.3 7.6 13.1 3.4 2.7 6.6 6.0 2.9 7.8 5.3 1.4 1.5 2.4 4.5 3.7 3.3 2.7 2.1 5.3 6.5 6.3 6.6 4.1 6.6 6.3 5.5 4.1 5.3 4.6 2.6 0.5 1.8 10.6 2.9 1.9 5.8 11.2 2.6 1.9 4.6 4.3 7.1 3.2 4.2 4.3 4.0 0.8 3.0 10.3 2.4 3.6 3.9 8.4 8.1 5.3 5.1 8.4 7.2 1.2 0.5 0.0 0.9 2.2 1.3 1.3 0.2 0.9 2.0 2.2 0.8 1.2 0.0 6.0 0.8 0.7 1.2 1.1 0.4 0.9 0.0 1.5 1.2 0.7 0.1 0.1 0.9 0.2 0.0 0.3 0.9 3.7 0.0 6.9 4.9 3.5 2.8 3.3 3.9 4.0 1.0 16.1 7.9 1.4 1.5 5.2 3.7 4.2 8.3 4.7 1.8 0.0 2.3 0.0 2.4 4.6 2.5 1.2 3.8 70.8 2.2 8.7 3.9 7.1 3.2 2.5 4.2 3.3 3.8 3.1 10.1 16.0 4.0 6.1 0.6 2.9 0.3 1.8 2.4 1.8 11.2 1.4 1.0 5.2 21.6 9.9 3.0 3.1 1.2 5.7 4.6 2.0 3.3 8.3 1.3 0.0 4.2 3.0 1.4 5.5 6.2 4.4 4.7 2.1 4.2 2.3 2.9 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 106.4;Distal tubular cells: 117.4;Excitatory neurons: 283.7;Squamous epithelial cells: 109.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.6;HaCaT: 113.5;hTCEpi: 100.6;RPTEC TERT1: 97.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" Yes NA Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavorable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favorable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 6.3 16.6 24.4 2.7 37.3 0.6 32.7 17.6 41.2 17.4 12.3 8.4 4.2 14.3 22.8 51.0 50.7 8.5 19.5 31.5 24.6 29.0 3.5 5.6 2.8 19.2 16.0 30.6 15.3 7.5 12.1 10.9 11.5 19.1 21.8 10.7 18.5 20.1 22.8 5.1 61.6 3.7 12.6 12.7 3.9 10.4 6.0 15.7 17.7 20.1 7.0 14.4 13.2 37.2 32.5 17.5 55.1 106.6 11.6 61.8 9.7 13.4 14.3 21.5 22.0 21.9 5.1 19.1 2.9 52.2 30.5 18.0 113.5 20.5 30.6 20.6 2.2 8.7 3.1 10.2 8.2 11.1 1.7 4.7 16.7 100.6 6.2 41.4 28.0 21.0 24.1 1.3 1.2 16.0 24.5 16.3 5.2 10.5 57.1 27.1 8.5 5.7 2.3 97.8 25.2 10.3 40.5 20.7 27.5 8.7 61.3 24.1 4.0 11.7 24.4 6.8 4.8 15.0 4.8 4.1 0.4 8.7 11.0 36.8 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 37.3 17.6 41.2 31.5 24.6 19.2 16.0 30.6 19.1 12.7 15.7 32.5 3.0 3.2 4.1 80.0 0.7 31.7 55.9 17.2 106.4 5.0 27.3 29.7 13.9 8.6 15.0 25.8 8.4 45.5 0.8 6.2 117.4 8.3 28.0 47.0 7.8 2.9 1.2 0.8 283.7 3.6 7.6 5.5 7.1 42.4 0.0 66.3 2.5 1.7 4.4 21.9 66.1 4.3 20.3 0.8 1.7 12.0 5.3 1.2 23.2 16.9 0.4 21.4 1.0 81.4 42.1 11.8 2.4 3.0 6.6 36.4 0.4 10.7 29.3 5.9 0.0 2.7 6.2 1.8 5.1 109.0 44.5 33.2 1.0 6.3 4.0 51.2 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.6" "Cell type enhanced" "Detected in many" "Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 154.3;U-266/70: 216.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" "HPA073649: AB_2732233" "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favorable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 16.2 3.4 66.6 2.1 60.0 2.7 13.9 36.6 59.3 6.1 16.6 5.2 7.6 9.5 3.2 6.9 11.0 5.2 4.1 45.7 51.2 13.2 10.0 21.7 2.9 50.3 52.9 41.0 3.7 3.0 22.1 4.1 10.5 58.7 3.7 5.2 8.0 22.5 4.6 1.5 17.3 6.7 6.7 20.6 3.7 14.6 3.5 59.9 4.9 15.2 1.8 2.3 5.5 7.9 33.6 13.1 14.4 11.8 0.9 7.1 0.3 20.4 3.1 17.3 4.2 2.5 9.5 23.0 0.7 13.3 14.9 42.3 11.4 9.0 2.3 3.2 0.3 19.4 1.0 38.7 37.1 6.2 2.5 1.0 4.2 2.1 5.3 6.1 26.8 47.1 2.3 0.5 16.2 11.7 30.2 0.1 8.8 7.5 64.5 46.6 3.1 42.2 50.6 21.2 31.5 11.2 8.2 26.1 32.5 154.3 8.3 52.4 7.2 79.3 47.9 0.5 1.6 3.8 216.0 88.9 27.4 0.2 19.2 16.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 66.6 60.0 36.6 59.3 45.7 51.2 50.3 52.9 41.0 58.7 20.6 59.9 33.6 2.9 22.4 27.4 258.2 3.8 5.1 2.0 1.4 5.2 4.1 9.2 6.7 1.4 7.2 2.3 3.7 29.2 0.9 1.3 8.5 1.9 1.1 2.0 11.6 4.4 6.0 3.5 1.3 19.2 2.3 1.1 4.1 10.2 54.3 0.0 14.8 25.0 9.3 16.6 0.0 22.2 4.6 0.0 3.5 3.1 3.5 0.0 4.7 28.4 41.2 0.0 1.4 0.0 163.3 1.4 2.4 5.2 6.0 3.6 0.6 6.7 14.3 1.8 18.7 0.0 5.0 2.1 0.2 3.2 1.6 6.7 0.3 1.4 0.5 2.1 2.2 DOCK2 KIAA0209 ENSG00000134516 "Dedicator of cytokinesis 2" Q92608 5 169637268-170083382 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 62.2;lung: 16.5;lymphoid tissue: 51.9" "Cell type enhanced" "Detected in many" "B-cells: 53.3;dendritic cells: 78.1;Kupffer cells: 93.2;Macrophages: 78.0;Microglial cells: 173.3;monocytes: 72.5;T-cells: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 123.4;HDLM-2: 172.7;HL-60: 132.7;HMC-1: 135.8;MOLT-4: 94.5;U-698: 112.4;U-937: 85.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036469 Enhanced NA NA 46000 "HPA036469: AB_2675140" "unprognostic (3.45e-2)" "unprognostic (1.84e-2)" "unprognostic (3.90e-3)" "unprognostic (2.04e-2)" "unprognostic (1.03e-1)" "unprognostic (5.92e-3)" "unprognostic (3.47e-1)" "unprognostic (1.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-3)" "unprognostic (1.47e-1)" "unprognostic (2.22e-2)" "unprognostic (6.95e-2)" "unprognostic (7.24e-2)" 7.7 3.6 1.2 34.7 2.4 62.2 3.6 2.0 3.8 3.2 4.8 7.7 5.0 2.4 1.3 3.4 2.5 9.6 1.6 1.5 3.7 1.2 5.6 16.5 42.8 4.2 2.8 0.4 1.6 1.9 1.5 0.8 7.4 4.2 1.9 7.9 0.2 2.6 1.9 1.0 1.2 9.7 7.1 4.7 36.8 8.1 1.7 4.4 51.9 1.6 1.4 47.3 10.0 1.1 6.5 0.4 0.3 0.0 0.0 0.0 0.4 0.0 3.3 0.0 8.2 14.3 0.0 0.0 123.4 4.5 13.0 3.9 0.1 0.1 0.6 19.5 172.7 0.3 71.0 3.4 0.0 0.2 132.7 135.8 0.4 0.0 6.3 0.0 5.5 0.5 65.1 1.4 60.3 8.7 0.0 94.5 27.0 0.2 0.0 0.0 59.9 4.8 49.3 3.0 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.1 64.8 0.4 5.9 6.8 4.1 9.1 18.6 40.9 112.4 7.3 85.1 0.2 19.7 28.6 22.0 12.3 48.6 12.6 13.2 11.3 12.6 29.8 9.7 7.8 9.5 29.4 13.5 72.1 10.9 11.7 24.0 1.2 2.4 2.0 3.8 1.5 3.7 4.2 2.8 0.4 4.2 4.7 4.4 6.5 1.4 0.0 3.9 2.0 53.3 0.9 0.2 0.0 0.0 0.0 0.7 2.3 1.7 0.0 2.5 0.0 0.0 0.3 78.1 0.2 0.0 0.0 5.9 0.3 0.3 1.5 0.0 15.1 9.6 0.0 0.3 1.3 1.5 0.3 33.6 0.8 1.8 1.3 42.6 0.0 4.9 0.0 0.0 93.2 31.1 5.6 0.3 78.0 5.4 173.3 72.5 0.0 47.4 4.0 21.7 0.2 0.1 0.0 39.6 0.1 0.0 0.2 0.7 0.1 6.6 0.7 0.6 2.8 1.4 0.2 2.0 0.8 50.8 0.3 0.1 0.1 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196723-13219941 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 2273.2;vagina: 826.2" "Cell type enhanced" "Detected in many" "Adipocytes: 835.5;Basal keratinocytes: 694.1;Endothelial cells: 662.2;Squamous epithelial cells: 888.5;Suprabasal keratinocytes: 687.6;Urothelial cells: 1193.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "hypothalamus: 236.9" "Immune cell enriched" "Detected in single" 7 "myeloid DC: 3.4" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 1166.6;fHDF/TERT166: 861.7;HaCaT: 766.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "midbrain: 4.5;spinal cord: 16.0" HPA046912 Approved Vesicles NA NA Vesicles "HPA046912: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavorable (9.69e-8)" 541.5 42.4 20.9 64.5 19.9 20.9 168.1 20.1 28.7 237.9 18.8 101.7 39.9 62.1 12.6 2273.2 85.5 207.6 95.5 18.7 236.9 32.6 35.4 179.5 11.5 36.1 22.4 13.7 22.0 87.6 20.8 30.1 77.5 32.8 39.9 56.9 5.6 380.8 20.5 27.2 141.6 42.2 150.4 26.7 26.4 48.9 9.3 23.2 28.7 134.6 35.9 166.9 207.8 826.2 26.7 373.5 19.4 9.1 1.9 563.2 1166.6 1.5 269.6 489.4 135.7 172.3 2.7 612.6 2.2 187.3 861.7 60.0 766.6 10.8 35.7 182.9 7.2 0.8 1.2 61.9 0.2 135.6 2.6 2.1 369.8 50.9 432.7 126.4 107.3 316.8 0.2 2.0 6.2 325.4 1.6 0.8 8.3 6.6 69.8 62.3 1.0 37.1 3.4 396.4 4.4 0.3 0.3 120.1 17.4 211.9 69.9 3.1 2.2 349.8 302.2 106.7 287.0 146.8 1.5 4.1 2.5 441.2 2.2 363.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 20.9 19.9 20.1 28.7 18.7 236.9 36.1 22.4 13.7 32.8 26.7 23.2 26.7 835.5 205.1 88.5 8.1 3.7 694.1 362.3 34.8 223.7 0.1 316.5 91.7 12.9 27.1 166.8 18.4 0.0 1.2 7.6 481.5 15.6 28.7 0.8 76.0 167.6 662.2 47.6 0.0 0.9 4.4 1.8 470.5 62.2 160.3 50.4 0.1 157.1 2.2 39.8 0.0 0.4 13.5 6.1 37.1 481.2 2.1 69.6 105.8 473.2 7.5 7.0 2.4 0.0 0.5 0.2 62.2 343.0 109.4 12.7 413.0 48.6 0.5 60.2 0.4 6.6 202.1 170.1 1.1 0.9 888.5 687.6 1.1 23.0 5.1 26.6 1193.8 SOX5 "L-SOX5, MGC35153" ENSG00000134532 "SRY-box transcription factor 5" P35711 12 23529504-24562544 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.6" "Cell type enhanced" "Detected in many" "Astrocytes: 1531.5;Excitatory neurons: 615.9;Inhibitory neurons: 717.3;Oligodendrocyte precursor cells: 1437.1" "Cancer enhanced" "Detected in many" "melanoma: 3.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.5;naive B-cell: 1.3" "Lineage enriched" "Detected in single" 5 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 17.3;Daudi: 18.3;HDLM-2: 38.3;K-562: 17.0;WM-115: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060499 Supported Nucleoplasm NA NA Nucleoplasm "HPA060499: AB_2684294" "unprognostic (9.11e-4)" "unprognostic (4.64e-3)" "unprognostic (3.23e-1)" "unprognostic (6.83e-2)" "unprognostic (1.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.03e-3)" "unprognostic (1.36e-1)" "unprognostic (8.40e-2)" "unprognostic (1.70e-4)" "unprognostic (6.95e-2)" "unprognostic (4.53e-4)" "unprognostic (3.12e-3)" "unprognostic (2.37e-1)" "unprognostic (9.59e-2)" "unprognostic (2.75e-2)" 5.9 1.2 7.5 1.7 10.2 0.4 1.5 1.9 11.5 6.9 0.0 1.3 0.7 5.1 1.2 1.2 3.6 3.0 2.4 8.1 10.2 1.8 11.2 2.8 3.7 5.7 5.7 8.2 7.8 1.1 0.4 0.4 8.8 6.8 2.1 1.2 3.7 3.3 3.2 0.6 6.3 1.1 2.7 1.4 1.4 1.1 32.6 6.7 0.6 2.0 1.7 3.1 1.3 0.6 6.3 0.2 0.2 17.3 0.0 9.6 5.1 0.0 0.2 0.0 0.2 0.5 3.1 0.1 18.3 0.8 0.0 0.0 0.2 9.9 0.0 0.3 38.3 2.4 3.9 0.1 8.4 6.6 0.1 0.2 2.7 0.0 0.9 0.0 2.2 0.0 0.6 17.0 0.8 0.3 0.0 7.1 0.1 5.5 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.8 0.8 0.0 0.0 6.7 4.3 0.3 3.6 0.0 0.3 2.1 0.0 1.7 0.4 0.0 1.1 4.0 0.1 14.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 7.5 10.2 1.9 11.5 8.1 10.2 5.7 5.7 8.2 6.8 1.4 6.7 6.3 4.5 6.4 11.0 1531.5 3.7 13.3 0.1 0.0 1.8 11.9 1.0 1.3 4.0 1.5 3.1 3.7 0.0 0.1 0.0 0.0 0.0 0.2 198.7 18.7 55.7 4.0 5.4 0.4 615.9 0.0 0.2 11.3 1.5 21.2 1.3 13.3 3.6 22.0 0.3 0.0 717.3 0.0 0.0 0.8 1.9 208.6 10.2 0.8 12.4 279.2 5.7 17.9 0.0 1437.1 24.4 0.0 0.0 6.8 1.2 0.1 0.4 0.6 13.8 2.6 19.7 2.8 24.7 97.0 1.4 0.5 12.1 0.3 0.7 0.2 0.2 0.2 RERG MGC15754 ENSG00000134533 "RAS like estrogen regulated growth inhibitor" Q96A58 12 15107783-15348675 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 105.5" "Cell type enhanced" "Detected in many" "Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2" "Cancer enhanced" "Detected in all" "breast cancer: 19.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041387 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA041387: AB_10796669" "unprognostic (5.33e-2)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "prognostic unfavorable (7.56e-4)" "unprognostic (8.72e-2)" "unprognostic (9.42e-3)" "unprognostic (2.47e-1)" "unprognostic (2.38e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (5.07e-2)" "unprognostic (2.69e-1)" "unprognostic (7.16e-3)" "unprognostic (2.61e-3)" "unprognostic (3.30e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" 29.4 45.9 9.8 6.9 20.5 0.0 43.0 6.5 16.4 29.3 4.5 27.5 4.1 105.5 50.8 15.2 73.3 11.3 10.7 10.2 11.8 37.4 2.5 16.6 4.3 19.5 12.3 8.6 29.3 9.9 4.8 1.4 33.6 22.5 17.2 9.4 0.8 10.3 78.2 5.5 9.1 18.1 84.6 7.5 31.7 20.3 9.0 11.2 2.6 5.8 5.9 2.8 17.5 20.2 18.8 0.0 1.6 0.3 15.2 6.0 0.3 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.9 0.0 0.1 0.0 0.2 0.2 0.0 0.0 4.3 0.1 5.9 0.0 4.7 0.0 1.9 0.8 1.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 1.4 0.7 0.2 0.3 1.7 0.0 0.9 0.1 0.0 0.2 5.8 0.3 0.1 2.2 2.5 2.6 0.0 1.0 66.0 0.0 0.0 0.9 21.5 0.4 0.0 0.1 5.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 20.5 6.5 16.4 10.2 11.8 19.5 12.3 8.6 22.5 7.5 11.2 18.8 10.7 0.0 2.2 202.7 0.4 3.8 8.6 0.9 6.2 1.3 80.1 36.2 1.0 5.7 4.0 7.3 0.0 12.0 0.7 0.0 15.6 9.8 20.9 6.5 9.8 6.0 1.8 0.0 20.2 9.8 14.6 28.7 2.6 1.0 0.0 0.1 2.2 0.0 2.1 3.3 94.3 0.0 18.3 0.0 2.3 16.1 22.1 1.1 7.2 41.2 0.0 5.0 0.0 3.0 1.1 2.2 0.0 32.0 0.0 3.5 0.0 33.7 0.1 0.5 92.1 8.2 80.2 8.3 15.0 12.6 5.5 14.0 1.2 16.1 0.0 5.8 SLCO1B1 "LST-1, OATP-C, OATP1B1, SLC21A6" ENSG00000134538 "Solute carrier organic anion transporter family member 1B1" Q9Y6L6 12 21131194-21239796 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 613 "liver: 541.6" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 83.1" "Cancer enriched" "Detected in some" 96 "liver cancer: 52.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2" "HPA050892, HPA073093" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "HPA050892: AB_2681265, HPA073093: " "unprognostic (5.45e-1)" "unprognostic (1.82e-4)" "unprognostic (2.43e-3)" "unprognostic (1.96e-3)" "unprognostic (1.80e-1)" "unprognostic (2.41e-1)" "unprognostic (8.82e-2)" "unprognostic (5.63e-2)" "unprognostic (3.86e-2)" "unprognostic (3.49e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 541.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 83.1 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KLRD1 CD94 ENSG00000134539 "Killer cell lectin like receptor D1" Q13241 12 10226058-10329608 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.2" "Cell type enhanced" "Detected in many" "dendritic cells: 740.2;NK-cells: 1316.2;T-cells: 324.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 512.6;memory CD8 T-cell: 217.7;naive CD8 T-cell: 218.7;NK-cell: 737.5" "Group enriched" "Detected in many" 68 "NK-cells: 737.5;T-cells: 512.6" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA069688 Uncertain NA NA "HPA069688: AB_2686170" "unprognostic (3.75e-2)" "unprognostic (2.15e-3)" "unprognostic (4.95e-2)" "unprognostic (2.48e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-3)" "unprognostic (2.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.94e-3)" "unprognostic (4.53e-3)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.47e-3)" "unprognostic (1.78e-1)" "unprognostic (3.07e-1)" "unprognostic (3.06e-1)" "unprognostic (1.37e-2)" 1.6 1.4 1.0 2.8 1.3 8.5 1.9 2.0 2.3 1.2 0.0 1.6 1.8 1.2 1.5 1.3 1.1 1.6 1.1 1.7 0.6 0.7 4.2 4.8 6.8 0.8 0.2 1.2 1.1 2.2 0.5 4.7 1.3 1.4 0.7 0.9 1.3 1.3 0.6 1.2 0.9 3.4 0.7 0.1 17.2 2.1 1.3 0.4 0.5 1.2 0.2 4.0 2.1 0.8 3.2 0.2 0.1 0.2 0.4 0.4 0.2 0.2 0.7 0.0 0.0 0.2 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.0 0.2 0.0 0.5 0.5 0.4 0.7 0.1 0.5 0.3 0.2 0.1 0.5 0.1 0.3 0.3 0.1 0.3 0.3 1.2 0.0 0.5 0.3 0.3 0.3 0.2 0.4 0.1 0.4 0.3 0.2 0.3 0.6 0.2 0.2 0.6 0.1 0.9 0.2 0.6 0.3 0.5 0.9 0.4 0.1 0.5 0.5 0.3 0.7 0.2 0.4 1.7 0.8 1.1 512.6 2.0 58.1 0.8 3.5 217.7 1.6 0.8 1.3 218.7 9.2 737.5 1.5 2.1 1.3 163.0 1.0 1.3 2.0 2.3 1.7 0.6 0.8 0.2 1.2 1.4 0.1 0.4 3.2 7.4 0.0 10.5 1.3 5.8 0.5 1.2 0.2 0.6 0.7 1.7 1.0 2.7 7.2 1.9 0.0 6.2 1.8 740.2 0.4 0.0 0.6 9.0 1.1 1.2 7.7 0.0 24.0 3.1 0.0 1.0 4.5 10.7 1.8 2.5 0.4 15.0 4.3 0.7 1.7 2.0 0.2 0.0 18.3 1.2 12.6 0.3 7.0 5.4 4.7 5.1 0.3 1316.2 1.5 1.8 0.0 0.0 0.7 91.0 1.3 0.2 1.1 1.5 1.0 0.0 2.2 1.7 1.9 3.5 0.3 0.6 0.8 324.9 0.0 0.3 1.4 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 6.7" "Group enriched" "Detected in some" 8 "dendritic cells: 104.2;NK-cells: 254.3;T-cells: 100.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 229.2;NK-cell: 367.6" "Group enriched" "Detected in many" 46 "NK-cells: 367.6;T-cells: 229.2" "Cell line enhanced" "Detected in some" "HeLa: 5.6;Karpas-707: 1.9" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 0.7 0.5 0.8 2.2 0.9 5.4 2.0 0.6 1.4 0.7 0.5 1.8 1.4 3.1 1.5 1.4 0.9 2.0 0.7 0.9 1.3 0.3 1.8 3.4 3.2 1.6 1.1 0.6 0.7 0.8 0.3 0.3 2.2 1.4 0.7 2.1 1.2 1.2 0.4 0.4 1.1 2.7 0.9 0.7 6.7 4.4 1.0 1.2 1.1 0.7 0.0 2.5 1.0 0.6 2.1 0.2 0.8 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.4 0.8 0.0 0.6 0.1 0.0 0.2 1.6 0.1 0.3 1.4 0.5 0.4 0.2 1.0 5.6 0.0 0.0 0.3 0.1 0.5 0.0 0.1 0.0 0.0 0.4 0.3 0.6 1.9 0.4 0.0 0.1 1.4 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.1 1.7 0.1 0.0 1.3 0.2 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.4 0.0 1.9 0.3 0.2 229.2 0.3 29.1 0.6 0.1 40.1 0.3 0.2 0.3 33.2 6.4 367.6 0.6 0.4 0.1 28.6 0.8 0.9 0.6 1.4 0.9 1.3 1.6 1.1 0.6 1.4 0.7 1.2 2.1 1.2 0.0 0.6 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.9 1.3 0.5 1.5 0.0 0.0 0.0 0.1 104.2 0.8 0.0 0.1 1.3 0.3 0.4 0.4 1.8 11.2 0.2 0.0 0.0 0.6 3.1 0.4 0.0 0.0 3.9 0.9 0.1 1.7 0.1 2.8 0.0 4.0 0.4 0.4 0.6 2.0 5.4 0.0 1.4 0.0 254.3 1.0 0.0 0.0 1.2 1.2 17.6 0.1 0.6 0.6 0.0 2.0 0.0 0.1 0.8 1.1 0.6 0.5 0.1 0.1 100.2 0.0 0.5 0.4 SPX "C12orf39, MGC10946, NPQ, spexin" ENSG00000134548 "Spexin hormone" Q9BT56 12 21526296-21541249 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "adipose tissue: 112.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 86.1;Proximal tubular cells: 202.2" "Cancer enriched" "Detected in many" 5 "renal cancer: 13.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 17.5;HBEC3-KT: 8.9;hTERT-HME1: 12.4;SuSa: 14.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 17.1;hippocampal formation: 17.9;olfactory bulb: 7.5;pons: 8.0" "Secreted to blood" NA NA 2650000 "unprognostic (2.78e-2)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (1.81e-2)" "unprognostic (2.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (2.11e-2)" "unprognostic (5.89e-2)" "unprognostic (1.21e-2)" "unprognostic (1.95e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.37e-3)" "unprognostic (9.78e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" 112.4 0.1 9.4 0.1 9.8 0.4 4.2 9.6 24.4 0.0 8.0 0.1 0.0 1.4 0.6 0.2 0.2 0.1 2.8 9.0 11.9 26.6 2.3 0.6 0.2 9.4 11.9 8.1 0.0 20.9 0.4 0.0 17.9 22.3 0.0 0.0 1.7 6.9 0.5 2.0 0.0 0.3 0.1 8.8 0.4 0.5 0.2 10.5 3.0 20.3 8.9 0.1 0.0 0.0 13.3 0.0 0.5 0.8 0.0 3.0 1.2 0.0 0.0 0.1 0.1 1.2 17.5 0.0 0.7 0.3 0.0 0.3 0.0 0.0 8.9 1.6 0.0 0.0 4.7 0.0 0.1 1.8 0.0 0.0 5.7 0.9 0.3 12.4 0.2 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.7 0.0 2.0 0.2 5.1 0.0 0.0 0.0 0.1 0.0 1.7 14.6 0.0 0.2 0.3 0.0 5.3 0.0 0.4 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.4 9.8 9.6 24.4 9.0 11.9 9.4 11.9 8.1 22.3 8.8 10.5 13.3 1.4 0.0 0.0 1.3 1.3 0.0 0.1 0.0 0.0 3.0 0.7 0.9 28.9 0.0 0.0 25.8 0.0 0.0 0.1 0.0 86.1 0.4 0.0 0.5 0.3 0.6 0.0 0.0 0.0 19.1 0.0 1.7 0.0 2.5 0.0 0.0 0.7 0.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.9 13.7 0.0 0.0 1.2 4.9 4.1 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.0 202.2 0.0 0.5 0.0 2.4 0.9 0.0 1.8 0.0 0.0 0.4 1.0 0.1 0.0 0.1 PRH2 Pr ENSG00000134551 "Proline rich protein HaeIII subfamily 2" P02810 12 10929236-10934845 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 909 "salivary gland: 23243.3" "Group enriched" "Detected in some" 107 "Early spermatids: 35.5;Late spermatids: 136.2" "Cancer enriched" "Detected in some" 11 "head and neck cancer: 11.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 21000000 "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" "unprognostic (3.59e-1)" "unprognostic (1.25e-1)" "unprognostic (5.52e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.01e-2)" "unprognostic (7.37e-2)" "unprognostic (1.63e-5)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.26e-1)" "unprognostic (3.43e-2)" 0.0 0.1 0.6 0.0 0.9 1.8 0.1 1.1 1.1 0.1 0.0 0.0 0.0 0.1 0.0 19.4 0.0 0.0 4.7 0.7 0.6 0.0 0.4 5.0 0.0 1.2 0.9 0.3 4.4 25.5 0.0 0.3 2.6 1.5 0.1 0.0 0.6 23243.3 0.0 0.0 0.9 0.0 0.0 0.7 0.1 0.0 3.9 0.8 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 1.1 1.1 0.7 0.6 1.2 0.9 0.3 1.5 0.7 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 136.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856717-46918642 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 44.0;skin 1: 31.8" "Cell type enhanced" "Detected in many" "Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3" "Group enriched" "Detected in all" 4 "colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 21.3;SuSa: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 0.7 1.4 20.7 1.0 28.8 0.0 1.6 20.8 21.1 2.3 0.0 4.8 3.4 1.7 0.9 1.9 1.4 2.0 7.0 22.0 15.8 0.7 0.2 2.9 0.1 44.0 21.9 13.0 4.6 2.2 5.7 2.6 2.6 24.8 2.1 3.5 7.9 1.7 2.3 4.5 31.8 4.9 1.5 19.9 3.9 7.9 1.1 29.6 1.5 2.4 7.7 0.3 0.9 1.4 25.1 0.1 9.6 21.3 6.5 13.4 3.7 4.9 1.0 1.9 2.8 3.2 2.8 0.0 0.0 1.4 11.4 3.1 3.9 12.0 7.5 2.2 0.0 10.3 1.0 3.8 6.8 2.8 0.1 1.9 4.5 4.2 4.4 1.1 2.5 2.5 2.6 0.9 0.0 1.6 0.8 0.2 0.3 11.9 0.0 0.9 1.6 7.3 0.0 0.3 2.8 0.1 14.2 1.2 0.0 3.4 16.2 0.3 0.5 0.2 5.7 3.5 6.5 2.1 0.0 0.0 0.4 4.3 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 28.8 20.8 21.1 22.0 15.8 44.0 21.9 13.0 24.8 19.9 29.6 25.1 0.2 0.0 1.9 123.1 0.0 8.2 2.7 2.4 10.8 0.5 0.3 1.9 6.2 0.0 1.9 1.8 41.7 2.6 0.0 31.1 1.9 0.0 0.5 1.0 4.7 1.0 0.0 0.0 19.7 0.4 0.4 5.0 3.1 4.4 5.1 1.6 1.8 0.4 0.2 0.0 18.6 2.8 0.0 0.0 0.4 0.0 1.8 0.2 1.8 15.0 0.6 9.3 0.0 137.2 31.3 0.3 3.0 1.2 0.0 1.0 8.0 0.3 1.1 2.7 0.0 12.4 0.9 0.2 0.8 2.3 10.9 1.4 0.2 8.4 3.3 0.8 MYBPC3 "CMH4, cMyBP-C, FHC" ENSG00000134571 "Myosin binding protein C3" Q14896 11 47331406-47352702 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 460 "heart muscle: 1371.4" "Cell type enriched" "Detected in some" 42 "Cardiomyocytes: 1876.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-937: 6.4" "Region enriched" "Detected in some" 33 "cerebellum: 34.4" "Low region specificity" "Detected in many" "HPA040147, HPA043898" Enhanced NA NA 21000 "HPA040147: AB_2676861, HPA043898: AB_2678720" "unprognostic (1.06e-1)" "unprognostic (1.47e-6)" "unprognostic (2.17e-1)" "unprognostic (6.16e-2)" "unprognostic (3.00e-3)" "unprognostic (1.40e-4)" "unprognostic (7.47e-2)" "unprognostic (2.72e-2)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (9.53e-2)" "unprognostic (4.22e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (1.96e-1)" "unprognostic (4.15e-1)" "unprognostic (3.21e-2)" 0.4 2.9 0.0 0.7 0.0 1.5 0.8 0.2 0.4 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.4 1371.4 0.0 0.0 0.3 0.3 2.1 0.5 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.6 0.0 0.4 0.2 0.3 0.1 0.0 2.8 2.8 1.4 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.9 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1876.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 28.3 0.0 0.0 14.3 0.0 0.0 0.2 0.0 0.0 43.9 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.8 0.0 19.2 0.3 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.1 0.9 0.0 0.0 0.3 0.0 17.4 0.6 0.0 DDB2 "DDBB, FLJ34321, UV-DDB2, XPE" ENSG00000134574 "Damage specific DNA binding protein 2" Q92466 11 47214465-47239217 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 75.1;monocytes: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025912, HPA058406" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB025912: , HPA058406: AB_2683708" "prognostic favorable (7.29e-4)" "prognostic favorable (1.58e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.20e-4)" "unprognostic (4.29e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-2)" "unprognostic (6.18e-2)" "unprognostic (2.25e-1)" "unprognostic (3.58e-3)" "unprognostic (3.53e-1)" "unprognostic (1.94e-1)" "unprognostic (4.57e-3)" "unprognostic (1.21e-2)" "unprognostic (4.25e-2)" "unprognostic (9.82e-3)" "unprognostic (1.07e-1)" 11.1 22.7 2.4 8.3 2.8 11.7 13.6 3.2 3.6 12.3 3.2 12.9 7.7 12.9 11.8 25.1 17.7 12.6 6.8 2.4 2.3 4.4 27.3 12.3 14.8 3.2 2.5 2.0 11.7 14.5 4.8 4.7 6.9 3.8 9.7 15.1 2.3 14.5 11.8 6.3 47.1 10.3 14.0 2.7 11.4 9.5 4.6 3.0 23.7 5.5 7.0 17.1 11.3 14.2 3.5 23.7 62.3 25.9 19.3 16.6 32.7 29.9 26.0 58.8 32.0 37.1 10.1 14.1 56.6 5.3 23.2 23.6 40.8 14.6 51.8 15.7 14.5 27.5 13.3 55.7 46.7 15.8 15.9 34.4 43.4 58.0 15.9 35.2 10.2 94.2 14.7 3.5 27.0 52.7 44.4 60.4 7.7 8.4 31.1 22.3 30.3 5.6 30.6 13.5 22.7 13.2 16.7 31.2 8.7 8.1 30.8 56.1 5.5 41.2 96.8 44.1 21.3 12.6 27.6 22.4 12.5 37.0 20.2 35.9 9.8 12.8 20.2 19.3 18.4 18.8 18.3 20.1 18.8 10.4 14.5 14.8 15.7 3.7 14.1 15.8 0.3 47.7 15.9 2.4 2.8 3.2 3.6 2.4 2.3 3.2 2.5 2.0 3.8 2.7 3.0 3.5 13.8 16.0 22.2 7.8 25.1 38.9 39.7 28.1 75.1 5.0 18.0 25.8 7.8 11.5 16.3 5.5 10.4 3.6 21.3 11.1 9.8 12.5 1.5 5.2 8.1 19.5 7.7 19.1 6.6 13.8 9.0 16.0 18.3 9.5 22.8 31.2 15.0 16.6 17.5 1.7 1.4 12.6 16.2 17.5 12.8 2.1 19.0 16.8 19.6 24.4 135.5 9.6 35.0 1.0 10.6 19.9 9.8 10.5 34.1 8.9 15.7 7.7 13.9 12.8 0.0 12.1 14.0 3.1 8.6 34.5 30.3 1.5 34.3 25.4 16.5 26.5 ACP2 LAP ENSG00000134575 "Acid phosphatase 2, lysosomal" P11117 11 47239302-47248906 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 89.3;Hofbauer cells: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 69.9" "Lineage enriched" "Detected in all" 5 "monocytes: 69.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 12000 "unprognostic (5.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.90e-3)" "unprognostic (2.93e-1)" "unprognostic (6.16e-3)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (3.28e-3)" "unprognostic (2.64e-3)" "unprognostic (5.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (8.68e-3)" "unprognostic (1.57e-1)" 25.2 36.9 17.1 23.1 17.0 6.5 22.0 16.9 18.7 16.6 20.3 21.6 43.3 15.9 30.1 14.4 14.2 19.8 19.9 19.1 23.3 27.4 81.2 21.6 29.6 20.4 20.4 16.7 11.2 46.3 21.5 21.5 28.9 20.5 25.6 18.3 12.1 50.8 18.5 14.1 11.4 32.2 17.1 15.3 29.3 25.0 12.3 20.7 13.8 19.4 14.9 15.4 22.2 13.2 20.0 16.5 33.5 31.9 28.2 28.1 13.6 24.4 26.6 47.1 47.5 49.4 23.3 26.3 4.3 21.9 34.2 14.3 23.7 16.9 24.6 22.5 85.5 29.1 11.1 48.1 24.6 38.4 16.4 27.1 34.1 15.2 24.6 14.5 28.3 34.9 14.1 20.3 33.9 31.5 26.8 13.4 14.2 21.5 24.8 20.0 10.8 43.1 36.2 34.9 37.6 16.7 26.0 36.8 80.1 19.2 16.3 49.0 14.0 21.0 23.9 19.8 31.4 38.4 28.1 40.0 3.6 35.0 8.2 37.6 12.5 16.9 7.2 12.3 69.9 9.4 2.5 7.6 11.1 15.1 1.5 6.6 5.7 2.8 9.7 48.2 0.6 8.3 10.9 17.1 17.0 16.9 18.7 19.1 23.3 20.4 20.4 16.7 20.5 15.3 20.7 20.0 13.3 19.2 18.6 6.2 5.6 4.1 9.3 42.2 10.2 14.4 13.5 9.1 9.2 21.5 29.4 18.4 6.2 41.3 2.6 37.6 9.8 50.6 1.8 7.7 15.6 18.3 15.0 13.5 6.9 60.1 33.3 15.3 17.3 12.1 12.0 10.7 45.7 89.3 113.5 11.8 8.9 26.7 22.4 80.0 3.9 3.5 5.0 33.8 24.9 3.7 29.8 20.6 7.2 8.5 4.3 33.5 29.5 10.5 21.1 10.9 55.3 33.4 19.2 11.9 19.7 8.1 14.5 11.8 19.1 9.5 2.4 29.3 5.8 25.2 14.3 8.6 USP26 ENSG00000134588 "Ubiquitin specific peptidase 26" Q9BXU7 X 133024631-133097109 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "Spermatogonia: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000424, HPA027310, HPA079124" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000424: , HPA027310: , HPA079124: " "unprognostic (7.92e-4)" "unprognostic (3.59e-2)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RTL8C "CXX1, FAM127A, Mar8, MAR8C, Mart8, SIRH5" ENSG00000134590 "Retrotransposon Gag like 8C" A6ZKI3 X 135032355-135033546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 111.8;Distal tubular cells: 140.8;Endometrial stromal cells: 92.5;Extravillous trophoblasts: 99.6;Syncytiotrophoblasts: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.89e-2)" "unprognostic (2.50e-2)" "unprognostic (3.94e-3)" "prognostic unfavorable (2.69e-4)" "unprognostic (3.64e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.99e-4)" "unprognostic (8.76e-2)" "unprognostic (6.77e-2)" "unprognostic (5.65e-2)" "prognostic favorable (1.97e-4)" "unprognostic (2.06e-1)" "unprognostic (6.45e-2)" "unprognostic (9.02e-3)" "unprognostic (2.21e-1)" "unprognostic (6.13e-2)" "unprognostic (6.09e-3)" 167.7 206.1 159.1 37.5 174.7 10.3 142.4 154.9 307.7 180.9 89.2 162.0 23.1 207.3 27.4 202.8 168.0 45.4 387.0 164.7 166.6 174.5 78.1 135.5 20.4 177.2 164.2 165.6 195.3 62.2 38.6 229.8 60.9 183.8 185.5 20.4 34.6 102.1 82.2 241.2 98.7 94.0 96.8 147.6 83.6 122.2 58.3 168.3 20.0 118.6 189.5 15.6 165.7 170.5 171.8 68.6 79.1 78.0 113.1 270.2 310.9 55.1 178.6 137.7 101.9 140.0 65.9 25.5 0.0 218.1 237.1 120.2 69.7 72.1 71.5 38.1 45.9 114.6 18.0 139.2 37.4 160.0 0.0 35.4 337.8 93.6 115.5 29.4 132.6 123.2 0.0 29.1 0.2 172.8 130.8 0.3 50.0 32.3 29.3 147.1 0.0 82.6 0.7 107.9 31.4 58.2 138.8 61.6 46.0 86.6 39.7 29.7 31.5 150.1 141.0 51.4 344.4 131.9 21.7 17.8 0.4 196.0 17.9 76.9 28.1 73.4 67.6 44.1 90.7 34.1 23.2 35.8 45.9 53.4 33.9 41.7 47.5 18.2 49.2 77.9 58.0 39.8 41.8 159.1 174.7 154.9 307.7 164.7 166.6 177.2 164.2 165.6 183.8 147.6 168.3 171.8 48.1 38.5 23.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 33.1 31.1 0.0 0.0 16.7 36.8 0.0 111.8 7.9 0.0 140.8 42.3 0.0 27.5 92.5 24.3 0.0 0.0 0.0 26.3 99.6 58.6 0.0 47.6 18.9 35.3 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 27.9 0.0 0.0 0.0 0.0 39.3 0.0 0.0 1.9 0.0 0.0 67.3 10.2 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 94.0 5.2 45.9 0.0 0.0 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171962-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9;choroid plexus: 19.2" "Cell type enhanced" "Detected in many" "granulocytes: 22.9;Melanocytes: 12.4;NK-cells: 22.6;Oligodendrocytes: 23.5;T-cells: 12.9" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 111.4;Karpas-707: 126.8;U-266/70: 88.5;U-937: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles NA NA Vesicles "HPA059737: AB_2684115" "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 2.0 1.3 26.2 4.0 30.2 6.4 1.3 29.3 32.0 1.9 19.2 0.9 0.7 1.7 0.5 0.5 1.6 2.6 8.3 27.0 28.0 0.9 0.9 1.7 11.7 31.0 27.4 27.4 1.5 0.2 2.1 2.2 1.4 31.4 0.4 1.0 7.7 0.5 0.1 0.1 0.9 2.2 0.7 29.1 2.5 1.4 0.6 28.3 4.9 0.6 0.2 12.4 1.7 0.8 43.9 0.3 0.2 7.5 0.0 3.2 1.0 0.1 1.0 2.2 1.9 3.2 0.1 0.8 5.8 0.1 0.6 0.5 0.2 9.4 0.2 2.0 30.2 0.1 35.0 0.1 0.0 31.3 28.4 111.4 1.0 0.2 0.6 1.3 1.0 0.8 34.7 0.1 126.8 0.3 0.3 13.1 9.7 1.1 0.1 1.3 0.0 0.0 1.6 0.2 0.0 24.3 19.4 0.2 0.3 0.5 0.4 0.0 15.2 0.2 0.1 0.1 0.4 0.2 88.5 29.7 0.0 3.9 55.1 0.0 39.9 1.3 87.4 32.0 0.8 20.0 20.2 29.0 32.5 10.0 8.8 27.8 40.0 4.1 19.5 5.4 1.0 72.8 18.1 26.2 30.2 29.3 32.0 27.0 28.0 31.0 27.4 27.4 31.4 29.1 28.3 43.9 1.7 0.0 1.1 1.6 3.2 1.9 0.6 0.5 1.2 10.9 0.3 1.0 8.4 2.8 0.2 0.0 2.1 0.9 8.9 0.0 0.0 0.0 1.2 0.4 0.8 2.0 0.0 6.6 4.0 0.2 1.3 4.5 0.0 0.8 22.9 2.9 2.5 0.1 1.9 5.0 3.2 0.4 2.0 0.3 12.0 1.2 1.8 6.3 12.4 1.9 2.5 1.6 22.6 4.5 23.5 0.8 0.0 0.4 3.3 0.4 0.0 0.2 0.3 9.3 0.0 0.0 2.2 0.1 1.2 0.2 1.1 1.4 12.9 0.2 0.3 0.6 SOX3 PHP ENSG00000134595 "SRY-box transcription factor 3" P41225 X 140502985-140505069 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;fallopian tube: 9.3;testis: 2.3" "Group enriched" "Detected in some" 4 "Astrocytes: 2.9;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 2.0;Skeletal myocytes: 3.1;Spermatogonia: 1.9" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;HEK 293: 8.1;NTERA-2: 17.9;SuSa: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054720, HPA075003" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054720: AB_2682584, HPA075003: AB_2686727" "unprognostic (6.04e-2)" "unprognostic (3.75e-1)" "unprognostic (8.62e-3)" "unprognostic (8.03e-2)" "unprognostic (1.57e-1)" "unprognostic (5.27e-3)" 0.0 0.1 1.3 0.0 1.2 0.0 0.0 0.9 1.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.7 3.7 0.0 0.0 0.0 0.0 1.2 1.2 0.8 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 2.3 2.6 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.9 1.0 0.7 3.7 1.2 1.2 0.8 1.0 1.0 2.6 1.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 7.3 0.0 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.1 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein X-linked 2" Q9Y388 X 130401987-130413656 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.04e-4)" "prognostic favorable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 14.8 12.3 26.4 10.2 25.9 11.9 14.8 26.2 49.2 21.6 24.3 15.5 10.5 16.9 16.5 13.9 16.5 9.9 13.8 26.4 26.3 13.1 13.1 11.7 14.2 26.1 26.0 25.5 18.1 16.6 10.6 12.0 10.6 26.3 15.1 11.7 11.3 12.0 12.4 12.5 17.3 12.9 13.3 25.0 15.2 14.6 7.1 26.2 17.3 12.7 10.0 16.8 16.7 15.7 28.0 22.7 23.3 23.4 24.3 23.1 41.3 23.2 21.0 21.1 23.2 25.4 17.5 27.6 21.8 48.9 16.1 31.1 24.4 37.2 19.2 33.4 20.2 32.5 19.8 22.6 18.6 20.2 30.6 22.8 30.2 27.1 25.9 36.1 33.8 26.1 27.2 17.2 18.8 26.4 39.2 36.4 37.9 17.4 40.0 37.2 27.4 22.7 29.5 23.7 18.0 26.8 32.0 13.2 28.0 39.1 18.8 18.2 22.2 17.5 19.0 15.5 44.8 43.6 24.6 27.9 30.5 22.9 49.5 23.9 9.3 6.8 8.6 7.7 7.7 8.2 10.9 10.0 10.7 5.9 9.0 10.6 9.7 6.0 7.3 7.2 7.7 16.5 4.1 26.4 25.9 26.2 49.2 26.4 26.3 26.1 26.0 25.5 26.3 25.0 26.2 28.0 30.5 19.2 19.0 5.5 32.9 32.1 29.0 42.8 22.8 22.0 27.5 33.0 22.6 22.8 40.1 11.0 10.4 33.1 28.4 14.1 15.6 34.2 3.8 21.0 43.5 31.9 40.7 19.4 7.4 35.6 40.8 27.3 13.7 18.3 35.5 27.8 45.0 24.5 34.5 16.8 8.2 23.6 36.7 47.6 24.4 5.8 32.3 27.6 28.4 2.8 41.5 23.3 41.2 7.1 9.4 29.8 18.1 44.0 17.9 26.4 17.9 39.5 27.9 12.5 32.9 30.8 29.8 30.2 53.3 22.4 29.7 25.9 32.0 31.9 29.2 22.9 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023302-132075943 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 70.6;epididymis: 56.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 140.1;U-937: 144.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No 360000 Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 4.2 2.5 0.9 15.3 2.7 70.6 6.1 1.7 1.0 6.4 2.3 11.6 9.7 47.0 56.8 13.2 7.5 5.7 1.2 0.8 1.2 3.5 5.3 7.3 26.4 0.7 1.0 0.4 2.1 3.7 23.7 5.0 25.4 0.9 20.1 11.7 0.2 7.4 36.1 0.9 7.8 6.9 38.4 0.8 13.3 12.3 2.2 2.7 41.7 3.8 1.2 23.7 11.9 7.4 1.0 32.9 11.3 1.3 0.0 5.2 4.9 72.0 1.0 4.0 0.5 0.6 30.1 29.0 44.6 19.4 7.3 22.1 36.5 80.8 51.1 0.0 39.1 66.6 64.6 25.9 28.4 4.7 135.3 5.1 6.9 30.0 0.1 33.7 15.1 14.2 60.0 29.2 40.4 12.2 29.0 140.1 124.9 64.4 22.0 4.3 99.9 39.7 57.9 32.6 51.8 26.6 29.6 19.2 17.0 0.9 54.9 22.0 35.4 0.3 12.8 13.7 39.0 47.9 31.0 52.0 49.8 11.7 144.8 6.5 59.1 9.5 31.6 22.8 12.4 22.4 14.5 15.2 19.6 11.3 12.6 19.7 20.6 18.2 41.0 22.7 4.2 7.2 20.4 0.9 2.7 1.7 1.0 0.8 1.2 0.7 1.0 0.4 0.9 0.8 2.7 1.0 0.9 22.4 15.6 0.0 24.7 0.0 36.4 0.0 6.8 0.0 5.9 10.9 1.3 5.7 8.1 11.0 0.0 55.2 42.7 6.5 3.9 4.5 0.6 7.4 1.8 1.7 1.2 12.8 2.0 7.1 34.7 9.6 15.3 17.9 11.4 0.5 1.4 4.4 11.8 0.0 1.4 4.8 0.0 8.8 0.0 0.4 3.4 17.3 0.0 2.8 13.5 0.0 53.5 0.0 0.2 10.9 4.0 2.2 14.5 33.6 1.9 1.5 6.6 0.0 6.6 6.7 3.6 1.8 2.5 16.1 0.0 59.1 27.4 0.6 6.5 18.2 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.5" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 8.7;Spermatogonia: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 93.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036587, HPA036588, HPA057508" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 3.0 1.1 5.7 2.8 5.5 24.5 3.6 5.2 5.3 4.4 3.9 5.1 5.9 3.7 2.3 1.6 3.6 4.7 2.3 5.8 5.0 2.9 1.3 2.7 3.9 4.9 4.6 5.0 3.4 11.4 0.4 2.3 2.0 4.7 2.5 6.1 6.7 8.9 2.6 1.0 1.6 6.4 2.0 4.9 3.8 5.2 13.4 5.1 3.0 2.1 1.0 2.7 3.4 3.0 6.3 0.2 0.1 0.4 0.0 6.6 4.3 0.5 0.5 0.3 0.2 0.9 0.7 0.6 0.0 0.4 2.8 0.2 0.0 0.9 0.0 0.2 2.7 0.3 0.2 0.6 0.0 2.5 6.5 0.1 1.5 0.0 0.5 0.0 0.1 0.1 0.5 0.3 0.0 1.1 0.4 0.3 93.2 0.1 9.2 0.6 0.4 0.0 0.0 2.1 0.0 0.4 0.3 0.4 0.9 0.4 0.3 0.0 20.7 1.2 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.1 9.9 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.7 5.5 5.2 5.3 5.8 5.0 4.9 4.6 5.0 4.7 4.9 5.1 6.3 1.1 0.0 0.5 3.3 0.2 1.3 0.2 0.4 0.0 0.6 1.3 1.3 3.5 7.2 1.4 0.0 0.0 4.0 0.2 4.1 1.9 6.2 4.7 0.7 0.7 0.6 0.0 0.4 5.4 2.0 0.5 1.6 7.7 1.3 0.0 0.9 0.7 0.0 1.7 0.0 4.9 8.7 0.0 3.0 1.7 2.1 0.3 1.7 0.0 3.7 2.0 0.7 1.0 5.0 6.0 3.0 4.9 1.2 0.1 0.5 4.4 0.6 1.7 3.3 0.0 2.2 1.3 1.2 12.0 0.6 0.1 1.0 0.3 0.3 5.3 0.1 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969651-92985066 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.0;placenta: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "GAMG: 4.9;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA074024 Supported NA NA "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.0 0.0 2.1 0.0 2.9 0.0 0.0 1.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.0 0.0 0.0 0.0 0.0 2.3 1.7 0.8 0.0 0.0 0.0 0.0 1.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.9 1.4 1.0 2.0 4.0 2.3 1.7 0.8 2.7 2.5 1.3 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PUM1 "KIAA0099, PUMH1" ENSG00000134644 "Pumilio RNA binding family member 1" Q14671 1 30931506-31065991 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" RNA-binding "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027424, HPA027449" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA027424: AB_10602918, HPA027449: AB_2672281" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-3)" "unprognostic (1.10e-1)" "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" "unprognostic (2.44e-2)" "unprognostic (3.19e-3)" "unprognostic (4.42e-2)" "prognostic favorable (7.62e-8)" "unprognostic (1.57e-1)" "unprognostic (5.41e-2)" "unprognostic (1.19e-1)" "unprognostic (2.74e-1)" 27.2 26.2 35.1 22.7 37.3 52.5 32.2 38.7 38.1 28.3 30.8 26.9 22.7 32.5 29.5 25.9 35.3 22.9 28.8 35.7 40.1 29.0 26.1 25.9 26.4 29.7 33.3 31.8 40.6 27.8 39.6 19.3 32.6 30.1 27.6 29.7 38.7 30.5 28.2 46.5 32.3 22.8 31.9 27.7 25.9 26.5 18.5 42.7 35.5 35.2 38.6 26.4 27.4 26.3 34.1 33.7 43.7 70.4 44.7 54.1 46.5 48.2 39.3 47.9 40.3 45.5 46.0 56.6 39.3 40.2 53.8 25.2 48.2 58.3 43.4 51.4 33.2 50.8 42.8 50.7 56.0 37.9 52.6 39.2 50.0 53.3 53.5 56.1 52.8 55.6 36.9 60.0 36.1 46.5 28.1 51.6 37.8 72.2 42.0 30.2 53.1 48.0 42.3 58.7 50.0 58.0 44.0 54.5 41.7 47.6 77.6 42.1 39.3 58.5 33.2 29.8 44.7 39.7 28.8 28.3 42.5 29.7 38.3 43.0 44.1 31.3 24.8 31.0 30.3 31.7 23.9 27.5 30.3 32.0 21.1 31.0 32.0 19.6 37.9 34.5 18.5 35.9 31.0 35.1 37.3 38.7 38.1 35.7 40.1 29.7 33.3 31.8 30.1 27.7 42.7 34.1 66.6 73.7 58.8 85.2 56.9 90.2 53.8 41.2 56.3 54.6 63.2 58.7 80.7 61.5 46.3 36.8 79.2 52.6 66.4 56.4 23.5 44.0 32.2 139.8 98.0 61.5 104.7 34.3 87.0 36.4 42.4 56.8 55.0 154.6 18.3 105.1 43.2 61.0 34.0 33.7 87.5 65.6 24.4 78.3 49.8 21.5 72.1 50.4 17.8 102.1 56.6 41.6 69.0 111.6 101.7 58.1 45.0 80.5 41.7 84.6 28.8 49.2 42.7 59.2 32.9 81.6 65.5 36.4 24.4 62.9 93.6 78.0 50.5 63.6 75.8 95.5 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;testis: 9.8;urinary bladder: 9.6" "Cell type enhanced" "Detected in some" "Hofbauer cells: 13.2;Pancreatic endocrine cells: 30.9;Smooth muscle cells: 10.4;Spermatogonia: 13.1;Urothelial cells: 48.6" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "hypothalamus: 19.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 49.9;hTEC/SVTERT24-B: 51.5;RT4: 89.2;TIME: 46.2;U-87 MG: 84.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 2.3 0.4 1.6 3.1 1.7 0.1 1.6 1.2 3.5 2.7 2.2 0.4 0.9 2.2 0.3 0.3 1.2 0.9 0.1 1.3 19.7 0.3 0.1 7.3 0.1 7.8 2.3 0.8 0.3 0.0 0.0 1.5 0.3 2.9 1.6 0.5 0.0 0.3 0.1 0.1 0.2 0.9 1.4 2.2 1.9 0.9 9.8 9.4 0.2 0.3 0.0 0.0 9.6 0.9 6.4 29.8 0.8 0.1 0.1 0.5 4.0 1.4 37.7 49.9 35.8 23.7 0.5 1.7 0.5 5.0 42.7 14.7 3.9 0.0 0.7 11.2 0.1 0.1 0.0 5.8 0.2 1.7 0.0 0.6 17.7 0.6 51.5 1.7 28.9 24.4 2.0 0.7 0.6 21.5 0.1 0.2 0.0 0.7 0.4 0.8 0.0 3.8 0.0 0.1 89.2 0.0 0.0 0.9 0.2 2.6 1.2 21.6 0.0 46.2 37.4 3.9 24.6 14.3 0.2 0.3 0.1 84.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.1 1.6 1.7 1.2 3.5 1.3 19.7 7.8 2.3 0.8 2.9 2.2 9.4 6.4 0.2 0.0 3.7 0.3 0.0 0.1 6.5 4.5 0.0 0.0 0.3 0.1 0.5 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 8.3 0.3 1.7 0.6 2.3 1.8 0.0 0.4 9.8 0.6 1.0 0.0 5.9 1.3 0.2 0.4 0.0 13.2 0.0 0.1 0.0 0.0 0.6 0.2 0.5 0.0 5.7 0.0 0.0 0.1 0.0 0.0 0.0 1.6 30.9 0.0 0.4 0.1 2.5 0.0 0.1 0.3 0.0 0.0 5.1 10.4 0.0 13.1 0.0 0.0 0.3 0.4 0.1 0.0 48.6 YARS1 "tyrRS, YARS, YRS, YTS" ENSG00000134684 "Tyrosyl-tRNA synthetase 1" P54577 1 32775237-32817380 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017936, HPA018950, HPA018954" Enhanced Enhanced Cytosol No No 1400000 Cytosol "HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915" "unprognostic (4.05e-2)" "unprognostic (2.52e-1)" "unprognostic (4.21e-1)" "unprognostic (4.78e-2)" "unprognostic (9.54e-2)" "unprognostic (3.38e-3)" "prognostic unfavorable (6.97e-11)" "unprognostic (5.05e-2)" "unprognostic (6.29e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-3)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.02e-11)" "unprognostic (3.57e-3)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (6.57e-4)" 25.2 40.7 41.8 35.3 48.2 20.1 21.6 41.2 57.5 20.7 33.7 27.7 26.2 17.1 25.2 34.7 21.8 15.4 22.6 44.7 50.4 20.8 48.1 28.0 38.5 42.2 42.1 40.6 15.2 86.3 34.4 14.9 26.4 45.8 19.0 32.7 38.3 29.9 29.3 32.2 26.2 21.8 35.7 44.0 22.2 41.2 31.5 49.7 34.9 42.7 36.9 50.5 35.0 14.1 53.2 157.1 92.1 86.1 194.5 111.2 117.7 91.7 151.0 136.7 133.2 165.0 116.6 103.0 287.5 63.1 173.2 112.7 90.8 269.0 204.4 198.9 122.6 113.9 254.2 117.2 114.2 383.4 202.9 147.3 129.0 252.3 212.7 544.2 98.3 140.9 245.8 291.8 268.7 117.8 107.8 233.0 159.3 149.1 185.3 134.5 198.3 75.2 234.9 109.8 76.5 149.5 94.2 89.0 102.7 300.8 99.2 95.2 247.5 103.6 73.6 135.7 152.1 135.7 242.8 265.2 255.7 184.8 297.7 203.6 56.1 33.3 17.8 59.0 35.2 58.4 23.8 35.4 55.1 45.8 20.3 25.2 39.0 6.9 98.1 35.0 26.9 40.9 51.5 41.8 48.2 41.2 57.5 44.7 50.4 42.2 42.1 40.6 45.8 44.0 49.7 53.2 7.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 41.8 11.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 48.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 37.6 1.4 0.0 0.0 0.0 PHC2 "EDR2, HPH2" ENSG00000134686 "Polyhomeotic homolog 2" Q8IXK0 1 33323623-33431052 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 9 "neutrophil: 93.4" "Lineage enriched" "Detected in all" 11 "granulocytes: 93.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047403 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA047403: AB_10964220" "unprognostic (8.58e-3)" "unprognostic (2.10e-1)" "unprognostic (9.51e-2)" "unprognostic (3.69e-1)" "unprognostic (2.00e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (7.91e-2)" "unprognostic (3.08e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" 113.3 87.9 59.9 52.6 69.1 51.1 104.7 65.3 64.8 79.3 72.9 88.7 26.3 87.1 28.1 51.1 87.0 49.6 110.9 59.3 71.0 120.5 125.9 136.2 31.5 81.6 71.1 56.2 67.4 55.3 33.7 71.0 46.6 69.9 80.6 28.2 51.6 69.4 45.1 262.1 63.5 64.7 60.7 68.0 119.9 93.5 62.7 66.8 40.8 82.4 75.4 24.1 98.1 64.1 75.8 53.0 34.0 145.3 56.0 149.3 169.9 43.2 51.4 111.1 70.0 76.5 21.5 115.2 47.2 42.4 81.3 56.7 27.4 29.2 88.0 67.2 22.9 26.6 31.5 15.7 54.9 229.2 38.8 29.1 279.3 53.4 126.3 99.0 133.2 93.9 44.9 28.3 35.1 185.1 21.8 84.8 39.7 33.1 89.4 97.8 95.0 60.4 26.3 128.4 39.5 88.3 81.0 40.2 39.9 204.7 60.7 19.9 49.5 93.8 69.5 35.0 59.9 98.1 24.3 18.0 35.6 165.5 40.7 195.3 10.5 6.6 3.4 2.0 6.7 1.6 1.4 2.2 1.8 3.4 1.2 2.6 1.4 93.4 2.1 8.3 3.9 1.6 2.2 59.9 69.1 65.3 64.8 59.3 71.0 81.6 71.1 56.2 69.9 68.0 66.8 75.8 89.3 16.0 13.9 24.2 5.6 14.1 28.9 16.2 4.6 75.9 24.1 30.9 31.8 25.8 13.2 35.0 68.8 11.3 17.4 19.5 17.6 34.4 58.2 18.7 40.2 43.0 37.7 17.4 60.7 44.4 9.2 32.9 14.8 28.5 6.3 39.4 47.8 55.6 21.4 62.2 82.0 21.9 18.3 75.7 14.1 72.9 29.2 55.3 21.4 61.8 18.4 58.5 8.2 91.0 117.2 85.8 11.0 29.7 2.5 23.8 11.2 31.7 14.8 78.5 13.1 24.2 48.7 14.2 8.6 7.9 10.9 11.5 11.4 30.0 20.0 30.9 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692481-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.8;lymphoid tissue: 39.1;testis: 22.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.0 1.1 0.8 8.0 0.9 33.8 2.0 0.3 0.9 1.1 0.0 9.5 8.4 1.3 1.9 9.3 1.0 1.2 0.5 0.6 0.5 0.8 1.3 1.5 19.6 0.7 0.6 0.8 0.6 0.8 0.6 0.6 4.4 0.6 0.7 11.4 1.9 1.8 0.5 0.3 6.4 7.4 2.8 0.4 5.0 4.9 22.7 0.5 39.1 0.7 0.5 22.8 2.0 2.9 1.0 108.5 45.5 84.4 62.1 3.6 7.0 57.2 79.6 39.5 137.2 96.6 71.9 78.8 130.2 31.5 50.5 54.5 59.4 97.8 52.4 141.9 86.8 44.9 116.8 49.2 57.3 0.8 113.8 58.4 2.8 3.8 77.1 67.3 15.3 60.9 91.1 100.7 135.6 99.1 47.7 106.1 68.9 98.8 61.7 62.8 102.2 115.6 74.4 31.0 43.8 75.4 33.3 87.5 40.6 52.4 71.7 60.1 42.4 37.3 67.8 70.6 39.2 126.0 91.4 128.1 176.3 31.6 104.7 79.6 0.0 0.7 1.3 1.5 1.6 2.8 1.7 3.6 2.2 0.7 1.4 1.1 2.3 3.0 4.1 3.9 1.2 5.9 1.7 0.8 0.9 0.3 0.9 0.6 0.5 0.7 0.6 0.8 0.6 0.4 0.5 1.0 0.8 0.0 0.5 1.3 4.8 3.3 0.8 2.4 1.8 1.3 1.9 1.5 0.7 2.8 0.4 0.0 0.0 17.1 1.9 12.4 0.0 1.2 1.0 1.7 1.6 1.9 3.6 34.1 1.2 0.6 26.0 2.9 6.6 2.5 0.0 12.0 3.6 1.0 11.6 1.7 0.9 8.2 2.0 3.5 1.9 2.8 1.5 3.7 1.8 0.0 1.6 0.1 2.1 0.5 0.9 2.4 4.0 1.2 15.8 1.3 1.9 0.6 4.7 1.0 19.7 0.2 6.3 76.8 42.0 17.1 2.7 2.9 5.5 1.2 13.2 1.2 GNL2 "HUMAUANTIG, Ngp-1, Nog2, Nug2" ENSG00000134697 "G protein nucleolar 2" Q13823 1 37566816-37595937 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027163, HPA060026" Approved Enhanced "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA027163: AB_10601655, HPA060026: AB_2684191" "unprognostic (1.38e-2)" "unprognostic (5.23e-2)" "unprognostic (2.61e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.86e-9)" "unprognostic (2.28e-1)" "unprognostic (7.80e-2)" "prognostic favorable (7.89e-4)" "unprognostic (1.01e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (2.90e-11)" "unprognostic (3.36e-2)" "unprognostic (7.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.87e-1)" 26.0 22.6 11.5 25.0 12.5 50.3 30.7 12.9 13.6 21.1 14.1 23.0 18.0 23.0 24.6 26.6 20.3 19.6 21.4 11.3 15.2 17.3 31.9 22.9 26.8 13.4 12.5 10.6 20.5 21.0 21.1 19.5 23.7 13.1 18.3 25.8 11.8 23.3 14.4 51.0 29.8 18.8 24.6 12.9 19.7 22.1 30.5 13.1 26.4 16.2 29.2 33.0 35.5 21.4 14.6 66.5 33.5 63.9 66.4 49.8 57.1 102.9 98.6 68.5 89.3 90.4 92.6 75.2 107.8 62.7 73.5 50.8 60.6 105.1 80.5 121.1 62.6 83.5 108.4 66.4 74.5 66.5 143.3 73.7 36.2 72.6 122.4 144.3 42.7 65.2 47.1 146.8 74.6 87.3 58.2 77.7 85.9 165.8 48.2 65.9 81.8 114.7 121.8 75.0 70.7 76.9 71.1 74.2 73.4 73.1 93.8 52.7 82.5 53.0 59.1 83.9 127.2 138.6 69.9 67.8 185.8 68.3 113.2 77.3 23.2 28.1 24.4 22.5 36.3 26.0 28.1 21.0 24.6 39.8 21.1 21.9 21.2 2.8 33.5 35.3 29.0 28.2 21.7 11.5 12.5 12.9 13.6 11.3 15.2 13.4 12.5 10.6 13.1 12.9 13.1 14.6 18.5 16.0 48.1 6.5 29.7 63.3 84.3 37.2 27.3 8.8 17.5 14.5 21.9 12.8 63.3 7.3 10.4 37.2 27.8 18.2 27.4 52.9 54.0 27.2 31.0 28.1 17.3 17.7 6.4 62.3 49.4 40.8 23.9 29.7 48.1 29.5 11.0 18.3 32.0 6.7 5.3 27.3 24.4 17.9 29.6 13.5 23.9 27.7 8.8 8.4 31.7 21.1 25.7 3.5 5.7 51.5 21.9 19.2 32.4 68.3 15.7 18.8 54.4 9.6 0.0 44.8 34.8 46.7 45.6 29.5 52.8 46.1 28.3 20.6 27.5 56.5 AGO4 "EIF2C4, FLJ20033, hAGO4, KIAA1567" ENSG00000134698 "Argonaute RISC component 4" Q9HCK5 1 35808016-35857890 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 60.6;Inhibitory neurons: 72.0;Microglial cells: 63.7;Oligodendrocyte precursor cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012179, HPA067849" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Cytosol "CAB012179: , HPA067849: " "unprognostic (2.67e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (5.01e-2)" "unprognostic (1.76e-1)" "prognostic favorable (5.70e-5)" "unprognostic (3.92e-3)" "unprognostic (3.99e-3)" "unprognostic (2.32e-2)" "unprognostic (9.28e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-3)" "unprognostic (4.91e-3)" "unprognostic (4.96e-2)" "unprognostic (2.58e-1)" "unprognostic (3.96e-1)" "unprognostic (1.58e-2)" 8.2 4.9 7.5 8.9 7.6 20.6 7.7 9.0 7.8 8.4 9.1 8.5 4.8 9.0 6.6 7.4 7.3 6.3 10.0 7.2 7.7 5.1 7.5 11.5 7.1 7.7 7.3 6.6 7.0 8.7 6.5 5.8 9.0 7.6 8.2 6.4 18.2 8.5 6.2 13.4 20.2 7.9 9.9 7.1 14.3 9.7 7.3 7.6 7.4 5.6 11.9 6.9 8.2 8.6 7.8 6.0 1.5 11.3 6.5 5.8 6.6 5.7 4.5 4.4 4.6 5.3 0.8 9.0 9.6 6.0 6.6 4.7 2.4 4.9 3.6 4.3 10.7 4.5 4.9 4.2 2.8 5.5 5.6 7.2 4.3 7.6 2.5 3.8 8.8 7.9 11.5 3.7 3.7 6.2 0.9 9.1 6.2 3.7 3.8 2.7 9.0 10.1 1.2 4.5 7.4 5.0 7.3 4.1 3.7 12.7 9.6 3.0 24.6 9.5 3.5 1.7 3.6 3.4 5.4 1.8 1.4 4.3 7.0 3.2 1.3 2.7 3.0 0.8 1.5 1.4 0.6 0.7 1.1 2.0 0.4 0.3 0.4 7.5 0.6 1.4 0.4 0.2 0.8 7.5 7.6 9.0 7.8 7.2 7.7 7.7 7.3 6.6 7.6 7.1 7.6 7.8 16.4 19.2 21.7 54.9 6.7 9.8 4.7 5.4 9.6 28.2 8.5 7.1 21.8 12.8 9.2 11.0 22.9 4.2 17.9 5.5 1.9 5.6 2.0 12.7 9.4 11.6 12.6 5.0 60.6 5.6 4.7 7.2 10.7 10.9 2.5 11.4 22.1 11.5 13.5 6.7 72.0 8.4 2.0 42.3 10.0 1.6 5.0 28.9 3.6 63.7 33.6 6.5 6.2 87.4 54.8 14.4 11.7 5.7 4.3 9.0 10.0 1.5 10.3 32.2 19.7 6.8 8.5 11.3 1.6 5.9 12.8 4.1 10.3 3.6 5.7 6.7 HOOK1 HK1 ENSG00000134709 "Hook microtubule tethering protein 1" Q9UJC3 1 59814786-59876322 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 53.3" "Group enriched" "Detected in many" 5 "Early spermatids: 611.0;Late spermatids: 942.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 35.4;OE19: 24.4;RPTEC TERT1: 32.9;SK-BR-3: 32.1" "Low region specificity" "Detected in all" "HPA018537, HPA018820" Enhanced NA NA "HPA018537: AB_1850907, HPA018820: AB_1850910" "unprognostic (9.82e-3)" "unprognostic (4.29e-1)" "prognostic favorable (4.53e-6)" "unprognostic (4.26e-2)" "unprognostic (3.42e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.79e-1)" "unprognostic (5.55e-2)" "unprognostic (3.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (3.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-1)" 0.5 5.4 2.6 3.3 4.8 3.6 11.4 7.5 4.9 4.8 5.3 15.5 12.1 2.0 5.8 13.6 6.9 3.9 2.1 4.2 3.0 16.2 31.2 3.8 2.9 1.4 2.1 4.1 0.5 18.5 28.2 8.7 2.3 2.7 6.2 13.6 53.3 18.0 5.0 0.2 11.1 16.0 0.5 0.2 1.4 10.6 16.7 3.0 2.3 13.8 0.0 4.7 3.3 5.6 3.7 17.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 14.4 0.1 35.4 0.0 0.1 9.5 3.6 7.3 0.0 0.5 16.0 0.3 4.8 17.7 0.0 0.1 3.7 0.0 15.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 7.1 0.0 0.0 13.6 24.4 6.5 0.0 0.0 18.5 32.9 17.3 13.6 5.6 0.2 32.1 0.4 13.8 19.1 0.3 0.0 0.0 0.1 0.0 0.0 21.9 17.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 1.7 1.1 1.8 0.4 0.0 2.2 6.6 2.0 0.0 1.8 0.0 0.0 0.3 0.7 2.6 4.8 7.5 4.9 4.2 3.0 1.4 2.1 4.1 2.7 0.2 3.0 3.7 0.2 16.0 29.9 3.9 10.4 39.6 18.1 17.0 51.8 134.4 30.9 16.8 19.0 32.9 51.3 20.2 79.2 21.9 4.6 42.5 31.3 28.2 611.0 46.9 6.7 1.7 36.5 5.9 51.5 34.4 3.0 5.4 25.5 93.6 0.0 10.0 1.1 56.1 1.6 79.1 46.2 36.0 22.4 0.6 1.8 942.1 5.0 1.9 16.0 4.7 0.7 154.4 1.0 2.0 2.6 18.7 41.0 3.4 14.0 24.7 52.7 59.9 50.4 100.3 0.0 2.5 2.2 33.2 9.3 45.4 49.7 35.8 6.8 0.0 51.0 19.7 CYP2J2 ENSG00000134716 "Cytochrome P450 family 2 subfamily J member 2" P51589 1 59893308-59926773 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 90.6;intestine: 84.1;liver: 147.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 91.4;Cytotrophoblasts: 116.2;Hepatocytes: 58.3;Oligodendrocytes: 68.5;Proximal enterocytes: 134.6;Syncytiotrophoblasts: 240.9" "Cancer enhanced" "Detected in many" "renal cancer: 32.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "OE19: 16.9;RT4: 62.3;SK-BR-3: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.53e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-2)" "unprognostic (1.99e-2)" "unprognostic (2.51e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.84e-2)" "unprognostic (7.29e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (5.54e-7)" "unprognostic (4.96e-1)" "unprognostic (8.45e-2)" "unprognostic (4.25e-1)" "unprognostic (9.70e-2)" 0.6 0.4 18.8 1.2 22.0 0.1 9.4 24.3 19.2 1.3 9.4 19.2 34.4 1.0 0.8 13.2 0.9 2.0 90.6 15.0 19.2 3.0 147.4 1.4 0.2 20.6 21.4 14.8 0.0 2.2 0.0 0.9 22.5 19.6 3.3 21.5 3.5 14.7 0.7 25.5 8.9 84.1 1.8 18.2 0.1 4.7 0.6 25.1 0.5 0.1 6.5 0.7 5.9 3.6 22.6 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 2.7 0.1 1.2 0.3 2.8 0.0 0.8 0.0 3.5 0.9 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 3.2 0.0 0.0 1.5 16.9 2.6 0.0 6.3 0.0 3.4 62.3 0.9 3.8 0.1 16.4 0.6 0.1 4.1 0.0 0.0 2.2 2.5 0.0 0.9 1.9 0.1 0.0 0.5 0.0 6.9 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.3 0.2 0.0 0.4 2.9 2.6 0.0 0.4 0.0 0.6 0.0 0.4 18.8 22.0 24.3 19.2 15.0 19.2 20.6 21.4 14.8 19.6 18.2 25.1 22.6 0.0 3.2 4.1 35.6 0.7 0.4 1.7 5.5 7.4 0.0 5.1 3.0 91.4 11.5 28.9 0.0 0.0 116.2 0.1 26.4 0.0 9.5 22.7 3.1 1.7 1.3 9.0 0.0 0.1 0.9 9.3 2.3 4.1 7.7 0.0 1.5 0.0 58.3 7.0 0.0 0.4 18.7 6.1 0.8 0.3 23.3 0.0 0.2 0.0 1.9 0.6 12.5 0.0 29.7 68.5 2.0 18.1 0.0 0.3 1.5 134.6 2.5 20.1 0.9 0.0 0.7 1.0 0.3 0.2 7.3 2.3 240.9 0.2 0.4 24.1 2.1 BTF3L4 MGC23908 ENSG00000134717 "Basic transcription factor 3 like 4" Q96K17 1 52056199-52090716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067026 Approved Approved Nucleoplasm,Cytosol NA NA 59000 "Nucleoplasm, Cytosol" "HPA067026: AB_2685765" "unprognostic (6.12e-2)" "unprognostic (6.33e-2)" "unprognostic (5.09e-2)" "unprognostic (8.83e-3)" "unprognostic (1.42e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (6.73e-8)" "unprognostic (8.85e-2)" "unprognostic (5.59e-2)" "unprognostic (1.71e-3)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.43e-6)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (8.56e-2)" 45.0 52.4 31.0 30.6 32.4 61.5 44.1 31.4 38.2 31.7 31.9 22.9 14.6 36.7 30.9 36.3 36.8 24.1 40.5 32.2 34.9 35.4 41.2 26.5 36.9 34.4 34.6 31.0 53.4 38.6 42.4 31.3 37.7 35.5 29.5 23.9 31.6 30.2 24.7 70.6 35.8 18.7 35.1 33.9 28.3 27.9 34.3 34.1 49.6 43.5 59.5 41.1 42.7 30.1 40.8 99.8 23.7 113.5 59.6 60.4 76.4 117.3 96.1 96.3 108.0 115.2 43.8 50.8 92.3 93.9 68.3 127.1 56.6 111.1 75.0 137.0 64.4 77.7 105.8 41.0 65.5 163.8 118.2 70.0 79.2 101.0 100.2 140.1 89.1 86.9 75.1 81.5 57.0 98.0 42.1 82.6 69.9 202.7 76.7 51.2 53.6 132.1 109.8 105.3 78.6 89.1 100.6 112.5 102.8 141.7 124.8 92.8 124.8 64.0 60.5 65.4 78.4 114.8 98.9 176.3 89.4 52.2 90.0 77.9 70.3 74.2 70.9 29.7 78.9 40.2 49.9 42.8 31.0 72.9 49.7 49.1 38.2 31.6 49.7 70.9 34.3 62.6 64.3 31.0 32.4 31.4 38.2 32.2 34.9 34.4 34.6 31.0 35.5 33.9 34.1 40.8 60.4 35.3 22.3 17.0 76.0 107.7 91.7 153.6 65.4 43.6 81.2 75.6 44.7 52.9 82.2 69.9 33.3 111.1 45.9 18.7 168.3 106.0 115.3 82.9 83.6 55.1 52.2 114.9 30.8 80.1 137.6 77.2 44.4 73.3 22.8 128.2 56.0 81.0 129.3 38.7 32.9 33.8 120.1 127.8 92.9 25.4 72.4 87.4 78.2 27.2 86.5 62.0 49.4 29.7 39.5 72.7 26.3 55.7 58.7 135.9 23.4 162.9 75.7 33.2 59.2 73.7 106.3 97.1 31.1 108.5 160.3 145.8 56.0 114.9 34.8 106.7 TUT4 "KIAA0191, PAPD3, TENT3A, ZCCHC11" ENSG00000134744 "Terminal uridylyl transferase 4" Q5TAX3 1 52408282-52553487 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 20.7 34.6 30.3 18.5 29.0 26.8 21.6 44.7 36.5 33.5 28.8 23.6 8.8 27.6 23.9 19.4 31.1 15.5 25.7 27.6 32.7 23.1 31.5 22.3 34.5 28.8 29.2 26.1 46.7 31.4 29.7 41.9 21.3 31.6 26.4 11.3 85.6 20.9 16.6 60.5 32.9 31.1 16.0 27.1 35.3 22.4 47.3 31.9 32.8 31.7 30.3 29.7 23.3 26.7 34.4 24.4 22.7 55.3 37.3 21.1 27.1 36.4 20.0 31.0 30.3 34.9 23.6 12.5 50.6 23.0 30.0 49.1 19.7 41.6 22.6 38.7 39.7 36.5 53.7 30.0 49.7 35.0 59.4 29.1 31.9 49.4 32.6 40.0 38.6 21.4 35.7 44.7 25.6 25.7 0.3 60.1 42.7 39.8 12.5 27.5 51.3 55.3 39.3 33.4 20.0 28.7 26.8 31.8 14.1 32.9 62.3 19.4 31.5 18.1 23.2 30.6 21.1 26.2 52.7 74.0 71.8 15.5 32.0 17.0 83.7 9.7 34.8 26.1 4.0 19.3 49.0 27.3 21.6 5.1 50.2 33.1 22.0 37.6 25.3 3.7 61.9 23.3 5.1 30.3 29.0 44.7 36.5 27.6 32.7 28.8 29.2 26.1 31.6 27.1 31.9 34.4 52.2 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 36.1 41.4 0.0 0.0 0.0 47.8 0.0 53.6 64.9 0.0 15.6 28.5 0.0 59.5 96.1 14.3 0.0 0.0 0.0 17.0 19.1 18.8 0.0 46.7 0.0 70.7 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 9.8 0.0 0.0 0.0 0.0 19.6 0.0 0.0 30.2 0.0 0.0 22.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 36.9 28.2 57.3 0.0 0.0 PRPF38A "FLJ14936, Prp38" ENSG00000134748 "Pre-mRNA processing factor 38A" Q8NAV1 1 52404602-52420836 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053099, HPA058407" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053099: AB_2682044, HPA058407: AB_2683709" "unprognostic (1.29e-1)" "unprognostic (6.12e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.83e-2)" "unprognostic (7.84e-3)" "unprognostic (7.06e-2)" "unprognostic (1.62e-1)" "unprognostic (9.69e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (6.54e-3)" "unprognostic (3.35e-1)" "unprognostic (1.89e-1)" "unprognostic (2.82e-1)" 9.0 8.2 12.1 10.8 12.7 19.5 13.4 16.7 14.4 12.0 11.1 11.3 8.4 14.2 9.9 9.5 11.5 7.1 7.4 11.9 13.7 9.7 7.9 9.8 15.8 13.1 12.6 10.8 17.5 8.0 8.9 9.7 10.0 13.1 10.2 12.2 17.7 8.4 9.1 6.7 11.5 10.8 9.1 12.3 11.3 8.3 8.9 12.6 21.3 12.3 8.2 15.1 8.8 10.4 14.2 17.6 8.5 29.8 14.3 11.5 11.3 17.6 11.8 8.0 19.1 18.3 15.5 8.5 36.2 12.0 8.1 14.8 12.8 42.6 12.8 24.7 19.8 32.4 48.7 31.1 16.3 14.2 54.8 17.2 8.7 11.2 20.9 20.0 14.5 16.3 25.9 45.4 9.2 11.5 9.9 42.5 32.8 36.6 18.6 19.7 41.3 44.8 30.3 16.9 10.4 19.7 24.0 23.8 19.3 23.8 20.0 13.6 43.8 12.9 10.8 16.2 16.3 23.5 17.4 26.6 35.7 15.9 47.0 14.0 12.3 6.2 8.9 7.4 7.1 10.2 7.2 8.3 9.1 7.9 6.5 11.3 8.8 4.8 11.1 7.5 4.3 8.9 5.7 12.1 12.7 16.7 14.4 11.9 13.7 13.1 12.6 10.8 13.1 12.3 12.6 14.2 37.5 41.7 32.1 8.5 49.1 53.0 92.7 48.8 33.6 35.9 34.4 32.1 29.9 22.8 41.1 16.5 93.8 60.5 52.6 69.9 35.2 36.9 84.6 36.8 34.3 47.6 35.8 44.6 6.7 29.4 77.9 33.8 20.4 31.6 60.1 43.1 34.6 19.3 40.0 25.2 7.2 42.7 32.6 35.8 40.0 18.6 25.7 34.4 30.2 1.9 40.4 49.4 70.0 7.1 7.4 27.0 49.1 33.4 47.3 47.0 61.2 34.9 28.3 47.8 52.6 53.8 33.2 109.8 55.1 38.1 56.0 103.4 57.6 44.7 62.2 67.9 DSC2 "CDHF2, DSC3" ENSG00000134755 "Desmocollin 2" Q02487 18 31058840-31102522 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 165.6;vagina: 98.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 48.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "eosinophil: 28.9;neutrophil: 8.1" "Lineage enriched" "Detected in many" 14 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011911, HPA012615" Enhanced Supported "Plasma membrane,Cytosol" NA NA 24000000 "Plasma membrane" Cytosol "HPA011911: AB_1847618, HPA012615: AB_1847619" "unprognostic (3.28e-2)" "unprognostic (3.20e-1)" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (1.90e-1)" "unprognostic (3.04e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (7.66e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-3)" "unprognostic (2.10e-1)" "unprognostic (1.43e-3)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (3.01e-4)" 5.5 1.8 1.4 12.8 1.5 0.7 22.4 1.4 1.6 28.5 2.0 51.0 42.0 1.5 6.0 165.6 6.1 3.8 10.7 1.3 2.7 5.9 7.4 8.0 3.8 2.7 1.7 1.2 0.6 10.6 27.2 0.5 21.5 2.5 16.0 44.9 1.0 47.2 1.0 0.3 11.9 43.3 4.0 1.8 3.1 43.6 0.8 1.5 6.7 4.0 3.1 62.8 3.6 98.2 2.4 18.1 1.9 2.9 0.0 0.0 0.0 37.6 0.0 0.0 0.0 0.0 9.8 48.3 0.0 0.7 0.0 0.9 71.1 11.8 4.9 0.0 0.0 6.9 27.1 8.4 16.9 0.3 0.2 0.5 0.4 76.0 0.0 7.3 6.1 0.0 0.0 13.4 0.0 0.0 14.7 0.0 1.1 11.3 60.7 17.4 13.2 0.0 0.2 0.1 0.7 0.0 0.1 0.0 44.4 0.0 43.4 12.2 18.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 28.9 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.4 1.4 1.5 1.4 1.6 1.3 2.7 2.7 1.7 1.2 2.5 1.8 1.5 2.4 25.1 28.9 5.6 3.3 1.0 83.7 44.5 16.4 67.7 0.8 75.3 65.7 33.8 32.9 11.1 7.3 0.0 100.8 1.0 384.0 0.0 83.5 0.1 19.1 4.0 6.7 69.4 0.4 3.3 33.2 186.6 5.9 47.4 43.8 0.0 2.7 8.2 16.0 24.8 0.0 1.5 83.1 20.3 48.8 29.3 0.2 0.3 35.3 14.2 4.7 25.2 11.2 0.0 2.0 0.2 155.7 324.8 0.7 0.3 140.6 118.2 9.7 3.8 0.7 0.0 1.2 3.0 0.1 1.3 705.6 55.0 83.9 2.0 0.3 114.0 76.1 DSG3 CDHF6 ENSG00000134757 "Desmoglein 3" P32926 18 31447741-31478702 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 316.4;lymphoid tissue: 73.3;vagina: 120.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 197.6;Basal squamous epithelial cells: 101.9;Squamous epithelial cells: 470.6;Suprabasal keratinocytes: 206.4;Urothelial cells: 87.2" "Cancer enhanced" "Detected in many" "cervical cancer: 104.0;head and neck cancer: 183.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 53 "basophil: 8.2" "Lineage enriched" "Detected in single" 82 "granulocytes: 8.2" "Group enriched" "Detected in some" 7 "HaCaT: 204.4;hTCEpi: 494.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046864, HPA056863, CAB069880" Enhanced NA NA 190000 "CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260" "unprognostic (5.76e-3)" "unprognostic (6.99e-2)" "unprognostic (7.67e-2)" "unprognostic (7.79e-2)" "unprognostic (1.00e-2)" "unprognostic (4.08e-3)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "prognostic unfavorable (1.43e-5)" "unprognostic (8.26e-2)" "unprognostic (8.35e-7)" "unprognostic (8.85e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.90e-4)" 0.2 0.0 0.1 0.2 0.1 0.2 3.9 0.1 0.2 34.0 0.1 0.0 5.5 0.0 0.0 316.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.4 0.1 0.0 44.0 0.0 0.1 36.0 4.0 0.0 0.0 0.0 0.2 0.1 0.1 15.0 0.0 0.0 73.3 1.2 120.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 204.4 0.0 46.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 494.7 0.0 49.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.2 28.9 18.5 0.0 0.2 197.6 17.4 32.2 101.9 0.3 0.5 5.0 0.3 0.0 21.1 0.0 0.0 0.4 1.5 0.2 0.0 0.2 0.6 0.1 0.3 2.7 0.0 0.0 2.7 0.4 0.4 2.2 0.0 0.1 12.6 0.0 0.4 0.3 0.4 0.0 0.1 1.3 2.0 0.3 7.7 0.5 0.0 3.2 7.2 0.0 0.7 0.1 0.0 0.0 0.1 1.3 2.5 0.7 1.2 12.3 7.1 0.1 15.9 0.8 6.6 0.0 1.8 3.3 2.8 470.6 206.4 0.3 1.3 0.0 6.5 87.2 RNF138 "NARF, STRIN" ENSG00000134758 "Ring finger protein 138" Q8WVD3 18 32091874-32131561 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 96.9;testis: 120.3" "Group enriched" "Detected in many" 15 "Early spermatids: 982.8;Late spermatids: 3827.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041101 Approved Mitochondria NA NA Mitochondria "HPA041101: AB_10805837" "unprognostic (2.37e-2)" "unprognostic (4.63e-3)" "unprognostic (2.03e-3)" "unprognostic (1.01e-1)" "unprognostic (2.34e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-2)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (6.90e-2)" "unprognostic (1.27e-2)" "unprognostic (6.15e-2)" "unprognostic (9.52e-3)" "unprognostic (2.77e-1)" "unprognostic (9.58e-2)" "unprognostic (1.90e-1)" 13.8 7.4 8.4 17.6 10.1 96.9 14.6 15.1 12.0 12.5 11.3 23.7 16.9 14.5 8.6 15.0 19.6 13.7 6.0 8.2 11.4 9.8 21.8 13.4 24.4 9.2 9.9 7.2 15.0 16.5 11.3 7.6 15.5 10.3 10.6 20.4 9.0 10.0 8.0 7.0 8.9 17.4 11.7 9.0 21.7 14.3 120.3 9.3 29.2 11.9 6.9 19.9 13.4 8.7 13.8 28.3 16.4 66.4 33.2 8.5 17.5 37.6 28.3 15.8 34.7 39.8 19.4 19.3 67.9 34.3 18.6 22.3 28.9 35.1 31.9 47.1 37.7 58.8 53.5 19.2 24.1 33.3 149.3 45.3 17.1 31.3 38.3 53.8 19.9 35.9 59.3 74.7 27.0 22.7 26.6 101.1 66.5 74.4 48.4 22.6 102.5 41.7 39.3 31.9 20.7 75.0 37.5 37.7 21.7 30.1 30.2 14.0 62.2 27.8 41.5 30.5 10.3 32.2 44.4 64.5 117.9 22.6 81.6 41.5 25.0 64.4 63.3 25.0 48.7 32.2 34.6 54.5 35.9 62.5 39.2 102.8 66.9 64.7 42.8 42.0 26.6 44.3 68.3 8.4 10.1 15.1 12.0 8.2 11.4 9.2 9.9 7.2 10.3 9.0 9.3 13.8 27.9 16.0 19.7 15.3 65.9 69.3 33.7 11.8 71.2 6.7 32.4 18.0 8.3 24.3 16.8 16.5 0.0 28.3 51.6 43.0 17.6 17.6 982.8 35.6 20.4 29.4 29.9 48.8 25.9 18.4 21.6 21.3 26.0 28.7 22.8 8.4 22.5 16.8 24.8 8.4 28.0 20.8 20.3 25.5 52.3 3827.9 29.5 34.7 26.6 23.4 27.1 9.9 20.6 22.6 36.4 12.9 23.9 22.2 32.4 32.7 16.4 14.5 23.0 5.2 32.9 23.1 26.0 158.1 128.3 51.4 52.1 8.9 59.3 9.9 29.9 37.5 ELP2 "FLJ10879, STATIP1, StIP" ENSG00000134759 "Elongator acetyltransferase complex subunit 2" Q6IA86 18 36129444-36180557 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002996, CAB020835" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB020835: , HPA002996: AB_1857552" "unprognostic (5.51e-2)" "unprognostic (1.29e-1)" "prognostic favorable (5.41e-4)" "unprognostic (6.66e-3)" "unprognostic (4.33e-2)" "unprognostic (4.54e-1)" "unprognostic (2.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.92e-1)" "unprognostic (6.74e-3)" "unprognostic (7.31e-3)" "unprognostic (7.07e-2)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (3.05e-2)" "unprognostic (1.14e-1)" "unprognostic (8.97e-2)" 17.9 20.9 12.5 12.4 13.6 13.3 35.6 12.7 12.0 23.7 12.8 16.9 15.3 27.6 31.3 16.0 29.0 20.4 23.8 11.6 14.1 19.1 46.6 16.8 20.0 12.4 12.4 12.0 49.0 24.6 25.0 20.9 21.0 12.6 29.7 16.4 21.4 19.3 26.5 32.7 21.6 14.1 22.7 12.8 16.9 16.6 22.4 13.4 23.8 22.0 32.6 23.5 22.7 17.0 16.3 23.7 16.7 30.8 27.8 42.7 63.9 33.9 47.9 69.3 39.6 52.5 17.6 21.5 49.6 32.6 40.4 26.5 32.9 39.7 35.8 55.8 22.6 21.1 19.2 27.4 31.0 46.6 63.0 19.6 52.3 40.2 39.4 63.6 59.5 45.0 33.8 32.9 25.4 42.4 28.4 30.6 27.0 36.7 18.2 12.6 48.7 37.0 34.9 35.7 54.4 24.2 46.3 45.1 17.6 73.0 44.0 22.5 31.2 26.8 35.6 20.5 13.2 24.8 30.4 25.6 46.2 30.0 33.2 31.3 22.0 12.1 10.0 12.6 17.6 17.9 20.0 17.0 15.0 17.6 16.3 21.5 18.9 2.2 22.2 24.8 17.5 18.4 14.0 12.5 13.6 12.7 12.0 11.6 14.1 12.4 12.4 12.0 12.6 12.8 13.4 16.3 25.0 48.1 28.8 34.3 46.3 32.9 49.4 33.8 39.9 50.1 42.1 28.6 48.5 22.8 29.2 35.0 43.8 39.5 45.9 10.9 29.4 26.4 55.0 29.9 33.1 29.4 24.7 21.7 61.7 22.2 42.3 39.2 17.3 29.5 36.7 39.9 24.7 75.3 22.8 33.7 60.7 20.3 20.3 28.0 24.8 90.4 43.5 20.8 23.2 34.7 39.1 26.9 41.2 52.3 77.4 18.7 12.1 36.5 34.2 60.9 24.3 19.0 36.5 45.4 6.6 40.8 30.6 40.0 33.2 25.0 36.7 39.8 39.7 28.0 26.9 50.7 DSG1 "CDHF4, DSG" ENSG00000134760 "Desmoglein 1" Q02413 18 31318160-31359246 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "skin 1: 568.9" "Group enriched" "Detected in some" 25 "Basal keratinocytes: 117.4;Suprabasal keratinocytes: 315.7" "Group enriched" "Detected in many" 10 "head and neck cancer: 57.0;melanoma: 16.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "hTCEpi: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA022128, HPA074188" Enhanced NA NA 130000000 "HPA022128: AB_1847620, HPA074188: " "unprognostic (2.55e-2)" "unprognostic (8.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (5.22e-1)" "unprognostic (1.81e-2)" "unprognostic (1.57e-2)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (2.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-3)" "unprognostic (2.87e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.99e-4)" 0.3 0.0 0.0 0.0 0.0 0.2 25.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.1 1.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.7 0.0 2.0 568.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 2.1 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.4 0.0 0.0 0.6 0.0 3.3 0.9 1.7 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.1 0.0 0.0 8.6 3.5 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.2 6.5 315.7 0.0 0.2 0.0 0.1 0.0 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30989365-31042815 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 100.1;skin 1: 375.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 500.7;Basal squamous epithelial cells: 214.5;Squamous epithelial cells: 419.6;Suprabasal keratinocytes: 688.8" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 246.2;HBEC3-KT: 54.6;hTCEpi: 156.7;hTERT-HME1: 103.6;REH: 44.8" "Region enhanced" "Detected in some" "hippocampal formation: 3.3" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 6000000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645" "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.04e-5)" 2.5 0.1 0.1 0.5 0.0 0.2 12.7 0.1 0.1 11.6 0.0 0.3 0.4 0.1 1.2 100.1 1.4 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.4 0.2 3.4 0.2 12.6 0.0 6.1 0.1 0.1 19.7 1.3 1.0 375.6 0.3 0.5 0.0 0.0 0.1 0.1 0.0 7.7 0.1 0.0 24.9 3.6 48.8 0.1 17.2 1.8 0.2 0.0 0.1 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 246.2 0.0 54.6 0.0 0.1 14.6 0.9 4.7 0.4 9.7 0.1 0.2 10.2 156.7 0.0 103.6 19.6 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.9 0.1 21.8 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 1.1 0.3 0.0 500.7 62.0 49.5 214.5 0.0 3.1 8.0 1.3 0.0 30.3 0.0 0.0 73.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.3 2.4 0.0 0.3 0.0 14.2 4.6 0.0 0.1 0.0 0.1 0.0 0.0 5.3 0.0 0.3 0.2 12.2 0.0 34.8 0.0 0.0 0.6 39.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 32.1 0.0 0.1 10.2 0.0 0.0 0.0 3.4 0.1 0.1 419.6 688.8 25.0 2.3 0.0 0.1 89.1 DSC1 CDHF1 ENSG00000134765 "Desmocollin 1" Q08554 18 31129236-31162856 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 230.7" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 166.5" "Group enriched" "Detected in some" 17 "head and neck cancer: 7.3;melanoma: 4.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 2.7;naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 8 "T-cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA075379 Enhanced NA NA 27000000 "HPA075379: AB_2732290" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.48e-2)" "unprognostic (3.71e-2)" "unprognostic (8.19e-3)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (1.27e-1)" "unprognostic (1.78e-1)" "unprognostic (5.65e-6)" "unprognostic (5.08e-2)" "unprognostic (2.91e-1)" "unprognostic (6.99e-2)" "unprognostic (4.74e-5)" 0.1 0.0 0.0 0.1 0.0 0.2 9.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.7 230.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.7 2.6 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 14.1 0.3 0.0 2.2 0.9 0.1 0.4 29.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.4 0.0 0.0 3.6 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.5 166.5 0.4 0.6 0.0 0.0 0.3 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 475.8;choroid plexus: 134.8;heart muscle: 151.4;skeletal muscle: 168.5;tongue: 211.8" "Cell type enhanced" "Detected in many" "Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 11.7 6.7 267.6 5.5 259.5 0.8 9.7 271.8 262.2 5.4 134.8 16.3 3.9 8.1 20.7 23.1 11.8 9.5 151.4 264.9 441.6 2.4 2.2 6.6 2.3 475.8 295.8 208.1 7.1 18.2 2.4 10.9 4.1 357.1 23.8 7.7 20.0 11.4 25.5 168.5 2.4 8.4 19.6 310.3 4.9 6.8 6.2 346.1 0.5 12.4 211.8 2.0 32.3 5.2 356.5 0.7 0.5 17.3 0.0 9.5 25.1 2.6 3.2 14.8 0.6 1.7 3.8 0.2 0.1 8.9 1.9 15.3 1.1 2.1 7.5 1.8 0.0 10.7 0.1 0.9 5.7 7.1 0.2 0.2 19.2 1.8 11.9 4.5 14.2 6.7 0.1 2.4 1.9 3.8 37.7 0.1 0.2 42.0 0.6 8.1 0.1 7.7 24.1 0.9 0.3 51.9 6.9 0.0 1.7 4.9 23.8 21.8 6.3 0.5 16.7 9.9 0.3 5.2 1.3 2.0 1.0 52.5 0.0 8.4 1.0 0.7 0.0 0.8 0.0 1.1 0.8 1.5 1.1 3.5 0.7 1.6 1.3 0.3 0.8 0.0 0.1 4.3 1.0 267.6 259.5 271.8 262.2 264.9 441.6 475.8 295.8 208.1 357.1 310.3 346.1 356.5 5.1 0.0 1.1 1756.1 0.1 1.5 0.1 0.8 0.0 18.3 22.2 12.3 134.3 27.1 1.4 0.0 6.2 0.1 0.4 0.0 5.9 12.6 3.1 7.0 2.6 6.4 0.0 0.0 506.0 25.1 0.1 5.7 0.0 0.4 0.0 2.3 0.0 0.2 9.0 1.7 650.9 0.1 4.1 4.0 21.5 3.7 5.9 8.0 5.4 105.9 0.9 34.0 0.0 491.6 367.4 8.0 0.0 0.4 0.0 1.8 0.1 2.0 7.1 3.8 13.1 22.7 17.3 0.9 4.8 0.2 1.0 0.0 0.2 0.3 0.2 0.2 FHOD3 "FHOS2, FLJ22297, FLJ22717, KIAA1695" ENSG00000134775 "Formin homology 2 domain containing 3" Q2V2M9 18 36297714-36780055 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 147.1" "Cell type enhanced" "Detected in many" "Astrocytes: 104.5;Cone photoreceptor cells: 87.6;Excitatory neurons: 132.2;Granulosa cells: 84.9;Inhibitory neurons: 186.5;Oligodendrocyte precursor cells: 114.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.3;HDLM-2: 80.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021827, HPA024696" Uncertain "Intracellular and membrane" NA NA "HPA021827: AB_1848571, HPA024696: AB_1848573" "unprognostic (8.46e-2)" "unprognostic (8.76e-2)" "unprognostic (6.34e-2)" "unprognostic (3.44e-1)" "unprognostic (8.96e-2)" "unprognostic (8.30e-2)" "unprognostic (4.11e-4)" "unprognostic (2.73e-2)" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (2.16e-3)" "unprognostic (4.55e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.64e-2)" "unprognostic (4.10e-2)" "unprognostic (3.00e-3)" "unprognostic (1.20e-1)" 3.4 32.4 13.9 2.4 15.2 0.1 6.2 9.5 18.2 4.7 12.5 11.1 1.7 3.0 42.6 9.5 11.3 7.3 147.1 14.3 14.1 20.5 1.4 1.5 1.3 34.9 18.2 13.7 7.0 2.1 1.0 10.5 1.3 38.7 28.1 3.5 36.4 11.4 63.3 50.0 5.9 5.5 10.2 10.0 1.4 3.2 4.1 12.8 2.4 3.6 20.7 4.0 14.7 5.3 31.2 15.5 5.4 34.3 8.2 0.2 0.0 2.6 34.1 72.3 6.7 6.5 0.0 24.5 2.8 8.9 16.3 19.2 19.5 11.4 14.8 4.0 80.1 4.0 0.0 1.0 0.1 0.4 0.0 1.1 4.5 7.1 3.6 1.5 36.6 0.2 0.0 0.0 0.2 8.0 0.0 0.1 0.2 7.5 0.0 4.9 0.0 0.0 18.9 32.5 17.0 19.0 44.6 7.4 0.1 4.6 3.0 0.2 0.1 39.6 21.3 1.6 0.9 29.5 31.8 0.0 0.0 23.8 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 15.2 9.5 18.2 14.3 14.1 34.9 18.2 13.7 38.7 10.0 12.8 31.2 0.4 0.0 0.0 104.5 0.0 3.2 0.9 8.9 14.8 6.5 2.3 11.4 38.0 0.0 2.7 12.9 87.6 0.1 0.0 0.2 3.9 1.3 1.7 10.2 1.7 0.6 0.0 0.4 132.2 0.9 11.3 7.9 1.1 0.6 0.0 84.9 0.0 0.0 0.2 0.0 186.5 0.2 6.1 0.0 0.6 0.4 0.0 0.3 10.6 11.2 0.0 7.3 0.0 114.1 3.4 3.3 0.1 0.4 0.0 0.6 0.0 7.9 15.3 33.6 0.0 11.2 6.3 2.2 2.8 1.6 0.6 0.4 0.4 29.9 0.3 0.3 TPGS2 "C18orf10, DKFZP586M1523, HsT3006" ENSG00000134779 "Tubulin polyglutamylase complex subunit 2" Q68CL5 18 36777647-36829216 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 499.2;Late spermatids: 1012.6;Spermatocytes: 318.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 266.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040596, HPA040617" Uncertain NA NA "HPA040596: AB_10796458, HPA040617: AB_10794037" "unprognostic (6.51e-3)" "prognostic favorable (4.09e-4)" "unprognostic (5.82e-2)" "unprognostic (1.18e-1)" "unprognostic (5.05e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.78e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.93e-5)" "unprognostic (2.50e-2)" "unprognostic (1.33e-3)" "unprognostic (7.19e-3)" "unprognostic (2.51e-2)" "prognostic favorable (7.74e-4)" "unprognostic (4.03e-2)" "unprognostic (5.28e-2)" 43.7 53.2 67.2 29.8 70.7 70.8 40.6 68.6 71.9 45.2 144.9 40.5 27.5 37.8 32.8 57.4 55.2 43.9 59.3 69.8 77.1 46.6 27.5 49.0 39.1 77.5 87.6 68.5 68.2 35.5 41.4 23.2 35.7 86.0 34.5 41.4 58.9 32.9 35.1 16.6 46.8 34.8 48.8 68.9 25.1 32.2 204.8 72.7 102.2 50.1 22.3 65.1 54.6 38.0 86.6 142.4 109.6 208.8 183.2 102.3 111.0 87.6 152.7 207.6 210.6 252.9 53.2 99.6 138.8 104.0 307.5 133.5 138.1 173.9 215.3 246.9 182.2 59.0 97.2 186.5 145.8 104.9 126.5 83.1 148.9 110.0 188.0 96.6 202.5 253.6 142.1 143.1 100.0 279.9 84.0 202.2 74.0 126.8 62.8 70.9 149.4 192.8 169.6 235.3 136.8 146.5 160.3 229.8 59.4 67.6 181.4 114.1 120.6 143.0 210.6 78.1 30.3 123.6 126.5 129.4 164.4 170.3 101.3 120.9 266.1 44.0 89.5 44.2 50.3 44.4 44.7 51.4 46.2 45.1 31.5 38.5 43.5 13.5 52.3 61.0 35.8 94.3 52.8 67.2 70.7 68.6 71.9 69.8 77.1 77.5 87.6 68.5 86.0 68.9 72.7 86.6 26.2 44.8 34.7 9.4 23.7 28.9 39.3 87.8 25.6 21.5 38.2 42.5 19.7 54.3 64.1 25.8 8.4 81.2 25.6 13.9 72.4 123.2 499.2 68.8 27.1 32.0 19.8 125.8 27.1 77.2 144.5 41.3 25.0 50.7 19.0 41.6 36.8 21.7 85.8 8.4 30.9 24.5 69.2 29.9 32.4 1012.6 36.7 27.2 32.0 13.1 58.9 35.7 43.3 11.1 23.0 92.4 23.9 49.2 29.2 18.9 34.6 47.8 77.5 22.8 32.9 21.2 39.5 318.9 131.1 48.4 39.9 31.3 27.3 76.5 43.2 43.2 DAGLA "C11orf11, DAGLALPHA, KIAA0659, NSDDR" ENSG00000134780 "Diacylglycerol lipase alpha" Q9Y4D2 11 61680391-61747001 "Disease related genes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell type enhanced" "Detected in many" "Astrocytes: 12.7;Excitatory neurons: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.5;T-47d: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062497, CAB078793" Approved Supported NA NA "CAB078793: , HPA062497: AB_2684784" "unprognostic (2.53e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (1.23e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-4)" "unprognostic (2.22e-2)" "unprognostic (2.29e-3)" "unprognostic (3.99e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.14e-2)" 1.8 1.4 2.1 1.4 2.9 0.3 2.7 0.0 11.7 1.7 0.0 3.1 2.2 2.4 1.7 3.8 2.3 1.3 2.2 8.5 1.5 1.1 0.3 2.0 0.5 0.3 2.2 3.2 0.6 5.3 0.9 3.0 0.7 2.5 2.4 1.8 0.6 4.0 1.8 3.3 0.6 2.4 1.3 0.0 1.7 1.8 2.0 5.5 0.1 1.2 1.1 0.2 0.7 0.9 3.2 5.6 6.4 4.9 1.0 1.1 1.7 0.7 2.6 0.7 2.9 3.1 3.7 11.5 0.0 2.6 2.4 4.5 3.3 0.8 0.0 1.2 0.0 3.3 0.0 5.0 5.8 1.8 0.0 0.8 0.9 0.3 3.7 0.0 1.7 0.7 0.4 0.0 0.0 1.3 2.3 0.1 0.0 9.4 1.9 6.2 0.0 0.7 0.0 0.9 1.3 10.0 5.5 1.4 2.0 1.2 1.2 12.5 2.5 3.5 1.6 8.5 5.2 3.2 0.0 0.0 0.0 5.2 1.5 2.8 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 2.9 0.0 11.7 8.5 1.5 0.3 2.2 3.2 2.5 0.0 5.5 3.2 2.9 3.2 0.5 12.7 0.1 0.4 0.3 1.3 1.8 1.6 3.2 2.2 1.0 1.5 2.8 3.7 0.0 0.1 0.0 4.0 0.0 1.8 0.1 0.7 3.9 1.2 4.2 0.0 14.8 2.3 0.1 1.2 3.1 0.5 0.0 0.5 1.8 0.1 2.5 0.0 8.3 6.1 4.1 4.4 4.7 0.4 1.8 2.9 0.0 3.7 0.9 1.9 0.0 3.5 1.1 2.2 1.5 4.1 0.0 0.5 3.6 0.4 1.7 0.6 0.0 3.1 0.8 1.8 3.0 2.5 0.3 0.0 0.2 0.7 4.9 0.2 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 148.1" "Cell type enhanced" "Detected in many" "Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7" "Group enriched" "Detected in all" 4 "dendritic cells: 85.8;monocytes: 146.3" "Cell line enhanced" "Detected in many" "HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1" "Region enhanced" "Detected in many" "olfactory bulb: 10.3" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 61.1 16.9 6.6 35.1 5.4 58.5 50.7 6.0 8.5 34.2 8.6 21.5 8.4 28.3 4.6 35.1 30.3 28.7 33.0 5.7 7.7 9.5 148.1 47.3 26.7 6.9 5.7 3.6 24.5 13.8 3.9 5.0 14.4 7.0 14.6 11.9 0.9 35.5 7.6 15.7 31.0 20.8 25.7 7.0 20.9 20.3 4.7 9.4 23.5 76.9 13.5 29.2 31.0 28.4 9.7 289.2 0.0 16.0 0.4 52.9 76.9 0.7 22.0 93.0 31.6 54.1 0.0 61.4 165.0 9.8 52.0 16.3 161.8 47.0 28.8 63.3 1.0 0.2 257.3 93.0 0.0 106.6 513.8 428.4 231.7 0.9 306.5 3.5 22.9 89.7 75.0 299.8 154.4 123.7 0.6 108.6 328.2 24.3 0.0 5.3 221.8 3.3 570.9 76.1 0.0 38.0 0.0 62.2 1.4 263.5 1.5 24.1 77.3 48.1 1.5 81.4 209.2 62.5 0.3 0.9 41.3 187.3 183.2 532.1 15.2 105.7 23.4 19.6 127.0 22.2 9.6 13.5 26.8 85.8 7.1 10.4 10.5 9.0 3.9 146.3 85.7 26.5 60.7 6.6 5.4 6.0 8.5 5.7 7.7 6.9 5.7 3.6 7.0 7.0 9.4 9.7 19.8 16.0 49.1 1.6 6.1 46.8 7.4 30.8 48.3 0.5 8.0 14.2 3.7 28.6 26.1 1.8 0.0 0.6 11.9 0.3 0.0 75.5 1.0 1.0 3.1 33.0 0.0 38.3 0.1 6.4 5.0 33.4 2.0 3.0 67.0 2.9 14.3 61.7 73.7 0.0 0.2 0.6 16.2 21.0 74.6 1.7 9.9 47.0 30.2 8.4 10.2 0.6 3.1 8.5 0.8 9.4 0.5 12.4 22.5 14.5 0.0 0.1 4.9 0.1 65.7 15.5 22.0 0.7 1.1 13.6 17.6 0.8 11.8 12.3 1.2 3.0 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528464-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria NA NA 16000 Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 38.9 42.0 57.7 28.8 59.4 35.1 42.9 58.6 68.9 25.0 56.2 35.8 27.3 27.5 44.1 44.5 25.3 20.5 57.2 59.0 59.1 49.5 78.2 28.1 46.2 58.7 58.2 58.2 25.7 33.9 45.5 29.4 21.9 58.7 31.3 36.3 15.2 28.2 30.4 78.4 33.9 28.0 27.8 59.3 38.2 35.6 35.9 59.4 38.8 30.0 68.3 50.5 34.0 27.4 61.3 115.6 171.9 79.1 76.0 67.6 57.2 99.7 96.6 77.0 151.1 85.9 127.6 97.9 218.1 108.0 86.5 131.4 86.3 114.0 112.6 136.4 74.8 84.9 139.4 67.0 167.5 71.3 183.3 148.0 54.2 89.6 146.1 101.4 40.0 95.2 142.8 157.1 96.7 112.7 241.1 99.4 243.5 83.4 99.9 184.4 163.5 167.0 190.3 77.6 78.2 64.0 82.2 101.5 198.6 128.6 77.7 150.1 69.3 60.2 86.0 160.5 150.6 188.1 133.2 192.6 176.1 79.2 91.3 146.2 30.9 88.3 20.9 71.5 84.2 81.6 187.6 86.4 79.0 146.4 179.0 118.0 103.6 4.9 67.3 81.3 146.6 84.0 145.1 57.7 59.4 58.6 68.9 59.0 59.1 58.7 58.2 58.2 58.7 59.3 59.4 61.3 53.2 12.8 11.0 3.9 66.4 122.9 42.9 94.5 54.1 16.9 103.1 142.2 124.1 78.6 45.6 44.1 4.2 68.0 52.5 78.2 211.3 84.1 134.7 36.7 28.1 55.8 27.0 56.8 3.2 125.6 88.2 42.0 24.5 39.1 52.6 30.1 40.4 212.3 125.9 8.4 3.9 61.0 48.8 71.7 100.3 284.7 46.3 52.9 81.8 3.7 103.2 55.0 56.7 3.0 5.6 85.3 63.5 51.1 51.5 102.4 120.3 227.3 23.2 15.5 13.1 50.5 71.3 85.9 52.8 78.1 129.7 39.5 42.2 37.7 92.6 52.4 CBLIF "GIF, IF, IFMH, INF, TCN3" ENSG00000134812 "Cobalamin binding intrinsic factor" P27352 11 59829273-59845499 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2569 "stomach 1: 1591.0" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 11 "stomach cancer: 10.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039908, HPA040774" Enhanced "Secreted to digestive system" NA NA "HPA039908: AB_10796335, HPA040774: AB_10795626" "unprognostic (2.78e-4)" "unprognostic (1.04e-1)" "unprognostic (2.45e-1)" "unprognostic (3.59e-1)" "unprognostic (1.66e-1)" 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1591.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DHX34 "DDX34, KIAA0134" ENSG00000134815 "DExH-box helicase 34" Q14147 19 47349315-47382704 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 65.8;Spermatocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 11.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042159, HPA043558" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042159: AB_10963066, HPA043558: AB_10961262" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (8.63e-6)" "unprognostic (9.14e-2)" "unprognostic (4.74e-2)" "unprognostic (5.11e-2)" "unprognostic (4.76e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.16e-6)" "unprognostic (7.38e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (7.21e-3)" 5.0 6.8 6.7 5.7 5.9 11.4 5.9 5.9 9.6 9.0 5.5 5.8 3.7 6.8 2.3 7.6 8.0 2.6 5.5 6.1 5.3 6.8 10.2 8.6 4.2 6.3 5.1 5.4 10.4 6.9 3.1 9.1 3.3 8.1 8.2 2.0 2.9 5.9 3.6 7.5 7.4 5.8 3.0 4.9 12.1 5.6 22.3 6.2 3.8 8.4 2.3 2.9 7.8 7.6 11.0 10.8 27.8 6.7 13.1 5.7 3.9 12.7 8.4 2.8 8.5 7.6 17.8 10.3 16.5 8.3 4.7 9.1 15.4 9.3 11.1 4.3 13.8 25.4 17.3 16.1 13.7 6.4 13.5 7.1 5.0 8.8 14.3 8.0 5.4 5.7 7.4 29.2 6.9 5.7 12.8 13.5 33.6 13.9 14.0 16.4 14.6 5.3 10.0 4.6 14.3 11.9 7.3 10.3 10.1 6.8 7.5 9.2 8.6 6.5 9.9 12.7 6.3 15.0 10.5 15.5 15.1 7.9 9.7 11.8 1.0 1.8 0.7 1.0 1.8 1.0 0.9 0.8 1.5 1.7 1.1 1.2 0.5 11.7 0.8 1.5 1.3 0.6 1.1 6.7 5.9 5.9 9.6 6.1 5.3 6.3 5.1 5.4 8.1 4.9 6.2 11.0 1.8 6.4 5.8 8.5 4.4 7.5 5.7 2.4 4.0 8.1 5.4 3.0 3.6 2.8 3.5 7.3 2.1 4.9 8.6 4.2 0.0 4.8 26.1 5.9 4.4 3.6 3.6 4.2 11.0 3.3 5.7 3.6 6.6 7.3 3.8 10.5 2.9 6.6 7.6 0.0 10.1 4.7 4.1 8.2 18.1 65.8 5.3 13.3 1.8 2.8 5.4 1.6 1.0 7.1 10.4 3.6 2.2 4.9 3.5 7.4 4.1 1.9 6.0 5.7 6.6 3.4 4.0 39.1 16.9 4.3 7.2 5.1 3.9 4.3 6.3 6.4 APLNR "AGTRL1, APJ, APJR, FLJ90771" ENSG00000134817 "Apelin receptor" P35414 11 57233577-57237235 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 273.2;lymphoid tissue: 101.9;placenta: 88.8" "Group enriched" "Detected in some" 7 "Adipocytes: 67.6;Endothelial cells: 98.5" "Cancer enhanced" "Detected in all" "glioma: 50.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "AF22: 4.9;HEL: 4.3;K-562: 1.3;NTERA-2: 1.8;SuSa: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025842 Approved NA NA "CAB025842: " "unprognostic (5.06e-2)" "unprognostic (3.56e-1)" "unprognostic (2.70e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-1)" "unprognostic (6.68e-3)" "unprognostic (1.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (4.72e-1)" "unprognostic (1.77e-3)" "unprognostic (3.27e-2)" "unprognostic (8.13e-2)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" 17.5 3.7 49.7 9.5 50.2 0.2 10.7 62.2 46.1 2.3 25.5 5.4 4.6 3.5 0.3 4.2 1.2 13.1 21.5 52.3 128.3 5.8 18.7 8.1 9.7 273.2 80.9 40.0 0.7 2.0 2.9 2.5 88.8 87.2 1.0 6.1 0.0 3.6 1.9 15.3 7.2 4.2 10.0 104.3 101.9 3.2 1.5 106.2 4.2 9.6 10.9 4.2 6.3 1.7 136.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.7 50.2 62.2 46.1 52.3 128.3 273.2 80.9 40.0 87.2 104.3 106.2 136.0 67.6 0.0 0.0 6.5 0.6 2.3 0.1 0.0 0.0 0.0 0.5 0.6 3.2 1.5 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.3 0.3 98.5 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.5 0.0 0.0 10.4 0.0 0.2 0.0 0.0 0.0 0.0 0.8 2.6 0.2 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 2.7 0.0 0.0 0.3 3.1 0.1 0.2 2.7 0.0 0.1 FADS2 "D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13" ENSG00000134824 "Fatty acid desaturase 2" O95864 11 61792980-61867354 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 367.1" "Cell type enhanced" "Detected in many" "Astrocytes: 69.9;Endometrial stromal cells: 57.7;Hepatocytes: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 1141.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006741 Approved NA NA "HPA006741: AB_1078796" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" "unprognostic (4.33e-3)" "unprognostic (4.63e-2)" "unprognostic (2.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.35e-3)" "unprognostic (2.01e-1)" "unprognostic (4.21e-2)" "unprognostic (8.95e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (6.19e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.42e-4)" 23.6 367.1 137.4 35.0 126.3 28.2 60.2 132.1 136.1 67.8 137.8 19.4 32.2 87.0 28.0 10.7 34.9 20.4 23.9 126.8 154.0 14.7 127.7 33.7 16.6 170.9 174.9 102.5 29.3 9.9 80.6 51.2 40.9 147.1 98.5 13.4 41.9 24.5 190.5 12.4 81.5 16.0 126.3 139.2 11.6 14.2 28.1 190.8 34.4 10.4 8.8 31.4 24.8 28.1 131.0 14.6 492.6 655.8 345.0 551.3 1141.8 167.2 86.3 658.3 109.0 288.2 31.4 149.6 3.8 11.4 172.3 167.8 15.7 436.4 709.5 52.7 6.9 11.8 297.9 106.5 72.0 421.9 18.9 15.9 430.9 25.8 383.4 39.1 170.3 324.4 254.4 17.9 212.1 52.0 13.5 166.4 104.7 291.5 0.7 150.1 206.1 13.9 663.1 392.1 4.4 197.4 260.8 49.9 1.4 23.5 164.0 21.5 197.7 139.2 14.0 120.5 9.8 13.1 115.7 110.3 39.7 13.0 96.3 131.2 4.4 6.0 6.9 8.5 8.7 2.0 1.4 3.1 4.6 10.1 3.7 1.8 3.8 2.8 6.6 7.4 13.0 2.9 4.9 137.4 126.3 132.1 136.1 126.8 154.0 170.9 174.9 102.5 147.1 139.2 190.8 131.0 3.2 9.6 18.8 69.9 2.0 1.7 1.3 26.9 0.0 9.1 4.7 3.0 4.2 1.5 15.1 3.7 4.2 1.7 5.2 0.5 0.0 6.9 2.2 4.7 57.7 12.2 5.4 26.7 7.4 17.8 22.0 21.0 5.1 9.5 5.1 28.3 2.5 55.8 20.5 5.0 7.7 0.2 22.4 7.2 3.1 5.3 25.7 7.0 8.8 15.0 20.7 32.1 8.2 38.7 11.9 5.1 0.0 23.7 1.4 16.9 0.1 0.7 5.4 13.2 0.0 23.8 29.5 1.3 0.5 1.2 0.6 3.1 2.5 28.3 2.0 0.9 TMEM258 "C11orf10, Kud, Kuduk" ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 107.2 159.7 126.8 66.7 129.1 129.5 122.0 132.2 163.5 139.3 125.1 109.0 81.6 117.0 353.2 123.8 124.2 59.9 167.7 123.6 132.6 119.9 162.0 111.0 83.7 131.7 127.6 122.7 156.2 302.8 81.2 129.9 81.0 131.5 106.4 108.6 44.4 185.4 89.5 148.0 94.2 100.7 82.2 134.0 125.4 143.9 79.7 127.9 112.7 110.0 121.7 109.8 108.4 112.6 141.8 144.3 254.9 194.9 173.3 329.0 308.4 117.1 113.9 177.1 104.5 124.8 223.5 265.5 103.9 205.9 272.1 196.1 154.8 186.7 222.7 149.1 141.7 168.6 86.8 258.3 347.6 310.7 186.9 96.3 272.5 339.6 137.1 364.8 267.9 210.9 207.4 221.7 394.5 185.4 501.1 131.2 318.8 267.1 315.6 172.9 142.1 144.6 673.0 241.5 243.7 169.3 173.1 103.8 221.7 211.5 179.6 244.5 347.3 108.0 129.2 111.7 166.1 78.3 248.6 201.7 173.6 183.8 112.6 135.7 507.9 225.6 287.6 169.5 200.4 216.5 233.2 198.8 190.1 177.8 187.1 167.1 166.7 182.4 151.7 204.4 496.4 236.8 244.9 126.8 129.1 132.2 163.5 123.6 132.6 131.7 127.6 122.7 131.5 134.0 127.9 141.8 211.3 102.5 224.1 6.8 323.6 228.9 220.5 794.5 170.8 41.3 525.1 608.3 491.3 403.2 445.9 318.2 18.8 409.5 279.8 306.2 295.4 534.8 234.4 369.2 304.7 254.8 311.1 197.7 7.4 654.4 667.7 314.8 210.5 305.6 226.7 261.8 335.2 572.9 461.4 37.0 8.2 631.5 441.5 401.7 396.9 142.8 335.5 265.7 569.2 3.7 430.0 418.6 270.8 6.0 25.8 469.4 432.6 214.4 821.3 296.6 392.2 553.8 470.9 73.9 170.9 192.3 248.5 399.4 433.8 297.4 279.0 508.0 245.2 135.3 442.1 274.9 TCN1 "TC1, TCI" ENSG00000134827 "Transcobalamin 1" P20061 11 59852800-59866489 "Plasma proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "salivary gland: 782.7" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 52.0;Cholangiocytes: 62.9;Club cells: 94.9;Exocrine glandular cells: 372.3;Glandular and luminal cells: 84.7;Urothelial cells: 61.0" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 124.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 149 "basophil: 2374.2" "Lineage enriched" "Detected in many" 1592 "granulocytes: 2374.2" "Cell line enriched" "Detected in some" 21 "OE19: 159.0" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 4000000 "prognostic favorable (1.90e-4)" "unprognostic (1.17e-1)" "unprognostic (5.89e-2)" "unprognostic (3.61e-3)" "unprognostic (2.49e-2)" "unprognostic (5.28e-3)" "unprognostic (4.52e-3)" "unprognostic (3.11e-3)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (9.07e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.56e-8)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" 0.1 0.2 0.0 0.7 0.0 192.5 5.4 0.0 0.2 32.0 0.0 0.1 9.6 3.1 0.0 23.2 1.4 175.4 0.1 0.0 0.0 0.1 0.4 1.4 0.3 0.0 0.0 0.0 0.0 5.3 109.5 0.2 0.5 0.0 1.2 0.8 0.0 782.7 0.0 0.1 0.7 1.0 0.0 0.0 4.5 76.9 0.3 0.0 1.3 0.0 0.0 0.9 15.6 10.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 2.2 0.0 0.8 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 159.0 7.5 0.0 0.2 0.0 1.5 0.0 0.0 0.0 7.3 0.0 1.6 0.0 0.0 3.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 2374.2 0.0 0.3 0.0 0.1 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.4 15.9 0.1 1.4 0.1 0.3 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 19.2 52.0 0.0 0.0 21.9 4.2 0.2 62.9 94.9 23.9 0.0 0.0 0.5 0.3 0.0 23.7 0.4 2.2 8.0 0.4 0.0 0.0 0.1 372.3 0.0 0.1 3.6 84.7 0.0 0.0 0.0 0.3 0.2 0.0 0.1 1.2 12.2 0.6 0.3 0.0 0.3 0.9 0.0 0.0 0.7 0.0 0.0 0.5 0.0 46.5 0.0 0.0 0.1 5.0 0.0 0.3 11.7 0.0 0.0 0.0 2.5 0.0 0.0 6.0 0.1 0.0 0.5 0.0 0.2 61.0 C5AR2 "C5L2, GPR77" ENSG00000134830 "Complement component 5a receptor 2" Q9P296 19 47332175-47347329 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.3" "Cell type enhanced" "Detected in many" "Early spermatids: 14.4;Hepatic stellate cells: 23.9;Kupffer cells: 48.6;Macrophages: 34.5" "Cancer enhanced" "Detected in many" "breast cancer: 3.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 17.8;eosinophil: 11.9;neutrophil: 33.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.0" "Group enriched" "Detected in some" 4 "MCF7: 20.7;T-47d: 24.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA016629 Uncertain NA NA "HPA016629: AB_1849312" "unprognostic (5.00e-2)" "unprognostic (2.31e-2)" "unprognostic (4.33e-2)" "unprognostic (2.00e-6)" "unprognostic (2.88e-1)" "unprognostic (1.13e-2)" "unprognostic (1.02e-2)" "unprognostic (2.13e-1)" "unprognostic (2.25e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (6.05e-2)" "unprognostic (3.73e-5)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-3)" 3.9 1.2 1.1 4.2 0.8 5.9 2.2 1.0 2.6 1.0 1.5 1.2 0.4 0.7 0.4 0.6 2.4 0.7 1.4 2.1 0.9 1.2 1.9 6.6 0.9 1.2 0.4 0.7 0.6 0.8 0.1 0.9 2.2 0.9 0.4 0.4 0.4 1.2 0.3 0.3 1.3 1.5 1.0 0.4 14.3 1.1 3.2 0.6 0.3 0.9 0.4 3.2 1.2 1.4 1.2 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.4 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.1 5.2 0.1 0.0 0.8 1.5 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.4 0.0 20.7 0.1 2.4 0.2 0.0 0.1 0.3 0.1 2.7 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 24.8 0.3 0.2 0.8 0.2 0.5 0.1 0.3 0.3 0.9 0.8 1.4 0.1 17.8 2.7 11.9 0.3 2.3 0.4 0.3 0.2 0.2 0.6 0.4 0.2 0.2 33.0 0.3 4.4 0.3 0.6 0.7 1.1 0.8 1.0 2.6 2.1 0.9 1.2 0.4 0.7 0.9 0.4 0.6 1.2 0.6 3.2 1.9 0.3 1.1 0.4 2.8 0.1 0.0 1.3 4.7 2.8 1.6 2.8 2.6 1.8 2.1 0.1 1.7 0.0 0.0 0.0 14.4 0.5 0.5 1.7 0.0 3.2 0.6 0.0 0.2 2.1 0.0 1.1 1.3 6.1 23.9 1.2 8.3 0.0 0.1 0.0 0.0 48.6 4.6 3.0 0.0 34.5 0.0 1.0 8.3 0.3 1.0 0.0 0.1 0.0 0.0 0.4 1.3 2.0 0.0 0.3 0.8 4.2 0.0 4.0 1.0 0.2 0.4 0.1 0.9 0.1 1.3 4.1 0.0 1.9 TMEM165 "GDT1, TMPT27, TPARL" ENSG00000134851 "Transmembrane protein 165" Q9HC07 4 55395957-55453397 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 1021.6;Urothelial cells: 601.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038299, HPA062424" Supported Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA038299: AB_10675793, HPA062424: AB_2732682" "unprognostic (2.53e-2)" "unprognostic (1.08e-3)" "unprognostic (3.46e-3)" "unprognostic (7.07e-3)" "unprognostic (5.97e-2)" "unprognostic (9.84e-2)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.55e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.18e-8)" "unprognostic (9.05e-2)" "unprognostic (8.96e-2)" "unprognostic (2.72e-1)" "unprognostic (2.18e-2)" 46.2 61.8 50.5 43.0 77.6 11.3 35.5 68.3 68.1 46.3 45.6 32.7 32.3 34.4 31.4 56.3 31.9 46.4 36.9 47.9 73.6 42.0 19.5 53.2 32.9 92.4 81.4 41.5 22.5 40.4 32.6 24.1 61.0 94.5 38.1 33.6 15.1 40.7 30.9 17.3 26.4 28.1 40.3 69.6 37.3 39.5 13.8 72.7 24.3 38.1 17.4 42.9 79.6 43.1 125.8 74.6 30.4 47.1 50.2 143.5 105.4 50.0 138.6 212.7 98.0 106.7 34.2 108.3 76.9 98.3 85.9 56.2 53.8 50.0 56.8 98.9 43.8 46.4 66.0 50.1 66.6 89.1 92.1 75.1 109.1 72.7 55.9 37.3 82.4 113.2 25.6 112.8 47.8 116.5 54.5 73.0 76.5 51.7 97.8 70.6 52.0 35.5 42.1 148.6 70.2 48.3 64.7 69.8 261.0 85.8 46.3 41.2 65.3 98.3 83.1 49.6 37.0 102.5 44.4 38.5 48.3 98.9 77.2 67.9 23.7 40.4 26.0 15.2 35.7 17.0 19.0 14.3 17.8 36.5 11.5 12.1 14.4 28.6 18.1 35.9 28.4 18.3 30.2 50.5 77.6 68.3 68.1 47.9 73.6 92.4 81.4 41.5 94.5 69.6 72.7 125.8 119.6 54.5 52.4 42.7 87.9 245.1 277.8 295.0 147.4 50.6 85.8 42.7 32.2 71.4 214.9 79.1 81.3 112.5 97.7 42.4 17.6 171.1 32.1 123.6 99.1 108.0 50.4 79.1 58.2 163.5 157.2 110.4 76.0 173.8 21.0 57.6 113.8 18.4 105.7 28.6 71.5 69.4 77.3 97.9 145.7 24.7 58.7 109.5 88.9 59.0 117.5 53.2 123.6 71.4 1021.6 248.0 48.6 63.6 117.1 239.3 51.3 50.0 125.2 91.9 98.6 92.2 129.0 37.8 24.6 169.4 268.8 80.6 81.6 90.6 61.6 601.6 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55546909 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 5.5 6.2 3.6 4.2 4.5 1.4 5.9 9.3 5.7 8.0 5.3 5.2 4.9 6.9 5.7 9.3 5.4 4.4 7.6 4.5 4.1 6.6 5.6 4.6 2.9 3.3 4.2 3.6 6.2 5.1 10.4 5.5 5.6 4.2 6.3 5.7 11.7 4.6 6.2 9.8 6.9 5.7 7.2 3.0 4.6 7.0 14.2 3.6 3.1 10.2 9.3 3.7 5.7 6.8 5.2 20.0 9.1 7.5 11.6 11.8 11.5 3.6 18.7 16.4 12.9 12.7 5.1 14.8 5.1 9.9 22.8 10.3 15.9 9.5 15.4 23.2 6.9 3.1 4.4 9.4 6.7 10.3 7.0 4.7 6.7 15.8 18.8 18.7 10.4 13.1 4.6 10.1 10.1 21.3 10.6 4.0 4.1 5.0 16.3 9.4 2.5 8.7 3.3 11.0 10.9 7.6 6.2 13.5 16.7 8.9 6.2 5.7 4.2 17.1 18.4 19.5 6.0 26.6 9.1 7.5 3.1 15.6 5.8 14.6 0.0 0.7 0.2 0.7 0.7 1.3 0.4 0.9 0.8 1.1 0.7 0.4 0.6 0.2 0.9 0.7 0.5 0.9 0.4 3.6 4.5 9.3 5.7 4.5 4.1 3.3 4.2 3.6 4.2 3.0 3.6 5.2 32.2 41.7 27.7 49.3 15.2 31.1 21.8 28.5 27.9 63.4 21.5 14.9 55.2 14.3 27.4 14.7 43.8 11.3 11.9 21.5 1.9 13.6 34.5 34.2 39.9 32.1 39.7 3.8 95.9 16.5 6.8 28.0 25.0 32.0 3.8 16.6 28.9 27.7 11.6 33.7 114.6 18.5 18.3 17.0 26.1 16.9 23.9 16.9 10.6 70.3 14.0 26.7 19.6 82.0 93.1 28.3 13.2 36.1 18.5 34.0 29.6 19.7 25.2 41.4 13.1 36.5 28.2 64.9 72.5 55.1 37.5 5.2 14.0 21.7 15.6 51.6 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229280-54298245 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 191.9" "Group enriched" "Detected in many" 8 "Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 300000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 44.1 29.2 14.8 40.8 14.2 1.6 40.5 8.3 12.6 45.5 18.0 35.9 22.6 44.7 22.0 22.7 51.3 38.9 23.5 12.4 9.5 26.7 16.1 38.3 8.5 16.7 11.9 12.5 191.9 13.5 3.0 3.7 63.2 15.7 15.1 35.6 5.3 16.8 19.1 9.7 13.8 31.6 48.5 11.1 46.6 29.7 13.7 9.4 7.6 16.7 42.3 7.2 64.6 38.3 20.5 0.1 0.0 1.0 0.8 468.1 216.1 0.5 25.4 279.4 0.1 0.7 67.6 0.5 0.5 0.5 195.9 0.8 0.6 19.6 0.2 0.1 2.6 1.0 0.7 0.7 1.2 156.3 0.3 0.4 392.0 0.0 31.4 0.0 5.4 0.0 0.7 0.6 0.9 1.1 0.1 0.4 1.2 3.5 0.3 1.1 0.5 0.1 0.1 0.0 0.4 0.6 37.9 0.0 0.5 0.2 2.0 0.7 0.1 0.8 84.9 3.2 93.9 0.2 0.4 0.1 0.8 2.6 0.1 2.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.8 14.2 8.3 12.6 12.4 9.5 16.7 11.9 12.5 15.7 11.1 9.4 20.5 11.1 0.0 0.5 0.3 0.6 17.1 0.6 2.4 1.2 5.5 4.3 3.2 4.8 0.0 0.8 0.0 0.0 1.4 0.9 0.1 1.9 4.2 2.2 11.7 423.9 5.7 0.0 0.0 1.1 6.7 2.0 256.4 5.1 9.0 0.0 2.6 26.0 1.0 3.1 0.0 19.5 0.2 10.2 0.6 27.3 17.2 449.8 5.4 23.2 39.4 4.7 17.5 0.0 499.6 0.4 20.0 0.0 408.9 0.2 0.9 0.0 0.1 0.5 0.6 0.0 25.7 13.9 1.0 3.4 8.1 15.8 1.4 2.5 49.6 0.0 1.0 GGACT A2LD1 ENSG00000134864 "Gamma-glutamylamine cyclotransferase" Q9BVM4 13 100530164-100589528 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "kidney: 76.2" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "SCLC-21H: 133.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065320 Enhanced NA NA 110000 "HPA065320: AB_2685466" "unprognostic (1.93e-1)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (1.30e-3)" "unprognostic (9.12e-3)" "unprognostic (1.64e-2)" "unprognostic (1.58e-2)" "unprognostic (2.07e-2)" "unprognostic (7.41e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-2)" "unprognostic (2.45e-1)" "unprognostic (1.95e-2)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" 5.9 6.1 3.2 3.8 3.7 1.6 5.0 3.8 4.8 2.6 3.1 7.7 8.8 3.2 2.1 2.7 3.1 3.0 1.7 2.9 3.6 76.2 16.9 3.0 3.4 4.7 3.9 2.6 2.8 15.3 3.0 1.5 3.0 4.9 3.5 5.0 6.9 9.0 3.2 2.4 4.8 6.2 2.4 4.0 4.1 7.2 6.7 3.7 3.7 3.6 4.2 5.9 3.4 2.5 4.6 14.2 1.7 11.3 12.2 9.4 14.3 4.9 8.8 2.3 1.5 3.8 0.2 12.6 1.4 4.9 6.4 0.2 0.7 1.8 2.6 0.5 20.1 7.6 6.0 1.1 0.7 13.4 8.6 19.1 17.3 9.8 0.2 0.8 0.1 5.7 6.6 3.1 0.3 2.3 0.9 1.4 1.1 0.6 27.4 3.8 0.9 2.8 1.8 14.1 2.4 133.3 5.0 2.8 6.2 6.6 10.5 5.9 28.0 5.5 0.0 0.1 3.0 2.4 7.3 4.4 0.5 0.7 6.4 6.2 0.0 4.1 0.8 5.8 5.9 5.5 3.9 4.8 6.4 3.3 4.3 2.9 4.3 0.0 7.0 6.2 2.4 5.4 3.4 3.2 3.7 3.8 4.8 2.9 3.6 4.7 3.9 2.6 4.9 4.0 3.7 4.6 3.2 0.0 1.5 7.5 7.2 2.7 3.0 1.1 5.2 1.7 4.4 3.2 0.9 1.5 2.1 7.3 14.6 13.4 2.6 4.6 7.9 8.7 4.7 2.6 2.1 3.4 7.8 1.7 2.7 10.0 11.8 3.6 3.1 4.2 5.7 4.1 4.2 14.0 12.1 1.7 3.2 4.7 2.0 9.8 1.4 10.3 2.8 6.2 0.0 4.7 10.0 6.8 19.6 3.5 8.0 9.1 4.5 3.8 2.1 2.3 10.5 152.0 0.1 3.3 6.6 4.3 1.8 22.5 10.9 3.9 2.0 4.4 6.1 12.4 7.7 2.5 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513209 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 478.0" "Cell type enhanced" "Detected in many" "Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 1041.3;WM-115: 428.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010751, HPA029118, HPA069337" Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA 2700000 Vesicles "CAB010751: AB_476828, HPA029118: , HPA069337: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavorable (9.25e-4)" 242.6 51.6 16.0 104.4 2.0 0.6 154.8 2.2 9.9 101.8 14.6 208.0 29.8 221.3 10.5 52.2 124.0 85.0 111.2 16.7 9.4 72.3 19.2 183.3 23.0 6.8 4.9 3.1 52.4 32.9 25.8 17.6 478.0 8.6 122.3 19.1 2.8 35.3 96.6 45.0 38.8 84.8 228.9 3.2 122.4 97.2 15.8 10.2 8.0 75.5 21.7 7.2 187.8 75.0 13.5 88.9 45.7 218.7 0.6 213.7 99.0 312.8 307.9 97.4 167.3 76.1 2.5 0.7 0.6 1041.3 60.0 75.0 85.4 0.1 82.4 27.3 28.1 46.3 0.2 76.6 0.7 150.5 0.5 1.0 42.8 4.5 114.8 71.2 193.5 158.5 0.0 1.3 0.9 25.4 0.3 0.3 12.1 34.2 0.8 11.7 0.6 87.8 0.4 125.6 0.0 6.4 35.4 0.3 0.9 81.2 84.7 0.6 6.7 327.7 94.9 237.9 2.3 161.9 0.6 3.0 7.4 5.8 0.4 428.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 2.0 2.2 9.9 16.7 9.4 6.8 4.9 3.1 8.6 3.2 10.2 13.5 313.6 83.3 5.8 17.9 2.9 9.6 8.0 16.3 1.8 2.4 7.0 56.8 31.8 20.0 1.8 53.3 0.0 77.4 0.1 10.0 1.9 39.0 1.7 19.4 308.3 278.2 0.0 8.0 17.7 4.4 512.9 159.1 5.6 50.1 1.3 223.8 102.1 1.8 30.9 0.0 44.0 7.0 2.0 3.3 13.3 3.4 60.6 3.8 39.2 46.9 2.0 7.3 0.0 5.5 1.1 2.8 1.4 176.0 1.5 12.3 23.9 32.7 2.1 0.3 374.7 64.7 338.9 0.9 8.5 0.7 7.0 67.2 3.6 49.4 5.4 2.4 CLDN10 "CPETRL3, OSP-L" ENSG00000134873 "Claudin 10" P78369 13 95433604-95579759 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 79.2;pancreas: 218.3;salivary gland: 92.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 182.4;Cholangiocytes: 328.8;Club cells: 251.6;Ductal cells: 394.1;Glandular and luminal cells: 220.2;Proximal tubular cells: 285.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 1.3;neutrophil: 4.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 14.9;NTERA-2: 12.7;RPTEC TERT1: 29.0;SuSa: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012969, HPA042348" Enhanced NA NA "CAB012969: AB_2533386, HPA042348: AB_2677955" "unprognostic (6.45e-2)" "unprognostic (5.72e-2)" "unprognostic (3.35e-1)" "unprognostic (4.60e-2)" "unprognostic (4.73e-2)" "unprognostic (2.46e-3)" "unprognostic (6.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.91e-3)" "unprognostic (2.59e-3)" "unprognostic (7.93e-2)" "prognostic favorable (7.46e-5)" "unprognostic (1.11e-2)" "unprognostic (9.94e-2)" "prognostic favorable (2.13e-4)" "unprognostic (4.75e-3)" 0.7 0.1 29.0 0.0 27.3 3.3 3.1 24.7 46.2 30.6 20.9 0.3 1.1 9.4 21.0 7.9 19.4 25.8 0.4 28.9 26.2 79.2 3.8 2.1 0.0 24.3 25.6 27.8 0.9 218.3 0.4 3.1 0.8 24.6 1.3 0.4 2.8 92.3 0.4 0.1 16.4 0.2 0.4 23.5 0.7 0.9 1.5 26.4 0.5 0.2 0.7 27.6 0.6 0.4 27.4 0.0 0.0 0.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 2.7 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 1.9 0.0 0.0 2.9 0.0 0.1 0.0 0.5 14.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 12.7 0.2 0.0 0.0 0.1 0.0 29.0 0.0 0.2 0.1 0.0 0.0 0.0 73.3 0.7 1.8 0.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 29.0 27.3 24.7 46.2 28.9 26.2 24.3 25.6 27.8 24.6 23.5 26.4 27.4 0.6 0.0 0.0 93.4 1.0 0.3 5.5 182.4 0.0 0.3 22.6 5.0 0.8 328.8 251.6 99.3 0.0 15.0 0.4 0.0 135.0 394.1 3.4 83.2 28.5 4.2 0.0 0.0 0.6 82.5 7.9 1.4 0.0 220.2 0.0 0.1 1.1 0.4 1.9 0.0 1.6 0.0 77.3 0.3 0.3 2.5 0.0 2.8 69.4 4.7 1.6 78.7 0.0 33.7 0.4 103.1 0.0 0.4 0.1 22.1 0.0 285.9 43.3 3.8 6.6 0.2 16.8 12.2 19.9 1.5 0.6 23.1 2.2 0.5 0.0 5.0 DZIP1 "DZIP, KIAA0996" ENSG00000134874 "DAZ interacting zinc finger protein 1" Q86YF9 13 95578202-95644706 "Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054891, HPA057272" Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA054891: AB_2682631, HPA057272: AB_2683390" "unprognostic (6.74e-3)" "unprognostic (7.65e-2)" "unprognostic (1.94e-1)" "unprognostic (4.64e-3)" "unprognostic (4.82e-2)" "unprognostic (5.52e-3)" "unprognostic (6.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.34e-2)" "unprognostic (8.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.41e-3)" "unprognostic (1.48e-1)" "unprognostic (3.64e-2)" "unprognostic (3.89e-3)" 4.7 3.5 8.2 2.5 8.7 0.1 4.4 7.2 9.5 11.4 5.7 8.2 1.0 12.7 7.3 3.3 12.5 5.1 3.7 7.8 8.2 9.8 1.1 4.6 2.3 7.6 7.5 7.4 16.4 10.0 0.4 10.4 2.5 6.2 6.4 1.8 4.1 2.3 6.3 1.3 1.6 4.1 6.2 5.8 1.5 4.8 14.9 9.4 0.8 2.4 2.1 1.7 7.9 7.2 7.4 1.1 4.2 17.5 15.5 14.5 16.2 3.6 11.0 13.2 12.7 15.2 0.2 0.0 0.0 2.5 9.4 5.5 0.0 11.7 3.8 14.8 1.1 9.6 15.6 4.4 11.0 9.2 0.1 0.0 11.7 0.4 4.2 5.8 23.1 9.1 1.1 0.0 0.1 11.4 0.0 0.0 0.0 8.6 0.0 0.4 0.0 10.1 0.0 15.4 1.8 4.2 9.9 8.3 0.0 0.6 22.4 0.0 7.3 1.3 12.3 5.3 1.8 8.8 0.0 0.0 0.0 3.5 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.2 8.7 7.2 9.5 7.8 8.2 7.6 7.5 7.4 6.2 5.8 9.4 7.4 2.4 0.0 0.0 63.6 0.0 0.6 1.1 3.1 4.6 18.7 0.6 3.4 3.5 2.8 3.9 1.8 4.2 4.5 0.0 0.0 7.9 20.8 384.1 37.2 34.1 2.5 0.0 0.0 86.8 0.2 2.6 19.0 0.5 2.7 0.0 3.1 2.9 0.4 0.7 6.7 95.7 0.0 4.1 0.3 1.5 774.5 38.8 1.2 3.6 19.7 2.0 8.3 0.0 106.6 5.1 0.6 0.0 43.6 0.0 0.8 0.0 24.4 19.4 1.5 19.7 18.2 15.8 222.8 12.6 1.2 1.0 1.8 0.5 20.8 0.0 0.3 UBAC2 "FLJ30548, PHGDHL1, RP11-178C10.1" ENSG00000134882 "UBA domain containing 2" Q8NBM4 13 99200774-99386504 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013448 Approved Approved Cytosol NA NA Cytosol "HPA013448: AB_1855301" "unprognostic (7.04e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (7.30e-3)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" "unprognostic (9.48e-3)" "unprognostic (6.50e-3)" "unprognostic (1.58e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (6.44e-2)" "unprognostic (6.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.16e-1)" "unprognostic (6.08e-2)" "unprognostic (3.26e-2)" 15.5 13.4 8.2 18.4 8.5 19.7 20.2 6.6 8.8 21.5 8.7 21.7 31.0 20.1 18.1 28.9 27.8 22.8 27.5 8.8 8.4 22.1 27.9 17.1 25.6 9.4 8.9 7.1 19.3 17.5 30.3 2.8 29.6 8.7 18.6 23.1 7.7 26.0 17.4 39.3 30.8 23.5 19.8 10.2 21.0 17.9 26.4 10.0 29.5 30.3 39.2 27.5 24.1 8.6 8.6 51.8 26.8 22.4 33.9 52.2 62.8 56.3 25.9 73.3 40.3 36.4 29.2 108.7 19.9 43.8 34.8 27.0 49.2 28.8 41.1 22.0 33.8 33.7 37.2 16.9 22.5 48.7 48.2 28.1 45.9 54.9 24.6 71.0 54.6 38.8 39.6 31.1 13.3 31.6 14.3 32.1 15.3 32.6 104.0 27.0 27.6 24.9 15.2 32.7 29.6 25.2 40.3 21.0 67.8 41.4 39.4 41.5 148.7 30.3 21.9 19.0 20.1 29.5 16.3 12.0 6.6 42.9 71.9 38.3 64.6 53.7 41.9 61.3 57.3 87.3 48.1 53.8 62.6 46.2 55.2 73.6 74.5 48.8 84.6 57.5 57.3 40.2 88.1 8.2 8.5 6.6 8.8 8.8 8.4 9.4 8.9 7.1 8.7 10.2 10.0 8.6 28.7 6.4 19.1 58.8 45.3 27.1 26.0 41.7 40.5 27.3 31.2 24.3 23.8 21.5 29.4 23.9 27.1 111.6 48.5 37.3 23.5 44.1 26.0 24.5 21.7 26.4 8.4 31.3 110.9 34.9 84.6 31.6 19.4 21.9 22.2 34.3 17.9 29.1 48.5 32.0 103.0 30.1 40.7 39.1 121.4 22.0 35.1 88.4 30.2 81.5 35.7 48.8 69.0 82.0 73.3 29.0 32.6 50.8 11.7 48.7 48.0 22.6 31.6 21.2 32.9 24.7 32.1 66.2 35.1 31.7 33.1 132.4 66.0 54.4 39.1 34.4 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568137 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 34.8 25.7 21.3 4.6 21.7 11.1 36.6 23.1 23.8 43.0 17.2 39.1 3.5 43.5 6.3 31.1 47.4 2.9 31.0 20.9 19.4 28.5 23.1 46.7 6.7 19.1 19.2 20.4 50.8 29.6 3.7 34.4 6.1 20.6 35.0 4.8 8.7 35.3 4.5 28.7 30.7 43.0 6.4 18.7 41.1 38.5 23.8 20.5 7.0 36.6 7.6 5.7 35.9 37.9 21.7 10.5 9.4 26.0 6.4 9.0 4.6 9.1 10.2 6.5 9.1 6.6 16.8 8.3 21.5 6.1 9.2 8.4 6.9 17.4 9.9 11.4 24.5 12.3 18.8 9.2 11.6 9.3 36.0 8.2 5.0 6.8 6.9 7.2 9.2 8.1 13.0 13.4 11.4 11.4 7.7 16.4 13.9 18.6 23.6 4.0 17.3 19.7 8.9 10.6 7.3 7.0 13.8 9.9 12.7 6.1 17.6 5.8 27.0 9.2 7.5 6.2 5.9 10.0 11.1 14.2 27.4 10.6 15.6 6.7 44.6 24.2 17.2 15.4 17.7 14.1 30.2 13.5 12.1 17.1 32.4 15.3 14.6 45.7 18.8 14.8 34.2 15.7 12.8 21.3 21.7 23.1 23.8 20.9 19.4 19.1 19.2 20.4 20.6 18.7 20.5 21.7 342.0 141.1 230.6 198.8 242.0 261.7 268.5 179.3 186.1 222.7 153.9 104.0 88.3 90.1 204.9 114.0 135.5 141.9 329.3 195.3 99.7 120.7 42.0 201.2 308.3 298.1 187.7 160.3 208.8 113.2 137.7 204.7 355.7 290.6 168.7 331.2 280.2 81.5 101.3 304.5 155.6 218.5 148.5 90.7 186.2 34.0 255.1 142.1 128.1 161.1 182.1 223.3 301.8 200.6 367.2 145.0 173.8 217.7 194.9 251.0 153.7 58.6 190.7 271.2 216.9 179.6 196.8 199.8 125.9 164.1 262.3 185.2 257.8 280.7 193.1 316.0 BIVM FLJ20159 ENSG00000134897 "Basic, immunoglobulin-like variable motif containing" Q86UB2 13 102799119-102841533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 7.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA050126 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050126: AB_2681027" "unprognostic (8.86e-2)" "unprognostic (1.02e-1)" "unprognostic (3.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.19e-2)" "unprognostic (1.83e-3)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (6.89e-3)" "unprognostic (6.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.79e-2)" "unprognostic (2.73e-1)" "unprognostic (7.29e-2)" "unprognostic (3.33e-2)" 7.1 7.1 9.2 3.6 9.6 3.7 8.8 11.9 10.7 8.6 8.5 7.0 6.3 9.3 11.6 5.5 7.8 7.0 19.6 9.3 8.9 16.2 18.9 6.8 4.5 8.9 9.3 9.8 9.3 10.5 9.1 8.9 7.7 10.0 7.9 8.3 9.1 6.1 7.7 18.0 7.3 6.3 9.0 7.7 7.4 8.7 2.3 9.6 10.5 8.1 19.0 4.4 7.5 6.5 9.8 16.8 4.6 19.9 18.7 24.2 37.4 4.1 19.3 23.9 14.5 16.5 6.1 7.7 0.1 8.2 22.1 10.3 11.5 17.9 16.3 17.5 17.1 16.3 14.7 14.2 8.8 19.5 16.8 22.2 28.2 18.8 7.9 20.5 25.4 20.2 22.7 14.4 0.0 25.7 3.7 19.3 16.1 4.3 24.1 12.9 0.0 9.0 6.4 50.0 7.2 23.8 21.1 8.5 9.2 12.3 7.2 13.3 22.7 12.9 13.0 4.3 9.4 11.8 12.5 5.6 0.1 21.2 0.0 25.9 5.5 0.4 1.1 2.2 0.2 5.2 0.5 1.4 2.9 1.6 0.5 0.7 1.4 0.3 7.6 0.0 0.4 1.0 1.0 9.2 9.6 11.9 10.7 9.3 8.9 8.9 9.3 9.8 10.0 7.7 9.6 9.8 9.3 9.6 12.8 2.9 2.6 3.7 3.8 7.0 11.4 19.0 7.7 6.1 30.7 21.5 11.2 18.4 14.6 7.1 3.8 5.6 29.4 6.5 0.5 5.1 11.8 11.0 21.8 9.2 13.9 5.5 7.8 11.8 6.1 4.9 6.3 15.2 17.2 34.0 7.0 23.5 16.8 15.3 6.1 5.0 3.4 0.4 13.7 3.3 3.6 4.7 2.4 8.1 5.2 9.0 6.3 4.1 9.3 11.3 4.5 4.9 9.7 30.8 8.9 12.4 19.7 10.4 9.8 2.0 12.6 11.4 4.8 2.5 8.1 10.3 15.2 3.4 ERCC5 "ERCM2, XPGC" ENSG00000134899 "ERCC excision repair 5, endonuclease" P28715 13 102845831-102875995 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 60.7;Gastric mucus-secreting cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045845, HPA050374" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050374: AB_2681106" "unprognostic (1.28e-3)" "unprognostic (1.32e-3)" "unprognostic (1.86e-2)" "unprognostic (9.28e-3)" "unprognostic (6.19e-2)" "unprognostic (8.73e-2)" "unprognostic (1.23e-1)" "unprognostic (8.72e-2)" "unprognostic (2.52e-1)" "unprognostic (2.55e-1)" "unprognostic (7.77e-3)" "unprognostic (5.76e-3)" "prognostic unfavorable (2.96e-6)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "prognostic favorable (6.82e-4)" 14.2 11.2 7.8 11.0 8.2 16.4 14.7 9.1 11.9 12.3 10.0 14.6 20.3 9.3 13.5 10.8 9.8 10.9 9.9 8.0 7.8 12.7 21.9 12.9 15.3 8.6 7.9 6.9 12.6 11.4 12.4 3.7 11.4 9.0 11.8 14.5 12.8 10.6 10.9 9.6 13.4 17.3 9.7 7.7 15.3 16.5 7.1 8.1 21.5 13.6 10.9 16.7 11.3 3.9 8.4 21.5 10.5 15.4 7.4 34.4 30.5 8.9 24.5 31.1 13.6 16.7 10.8 37.9 19.3 10.4 23.4 9.4 23.8 14.3 19.6 10.1 19.4 9.7 16.6 23.7 13.3 15.9 50.9 26.3 26.1 19.2 15.7 25.6 19.6 23.1 23.4 9.5 16.5 23.9 8.0 18.7 23.5 7.7 30.2 9.9 14.9 10.9 17.9 19.3 15.7 9.0 14.1 12.6 25.0 8.8 13.6 13.9 43.4 21.4 7.5 5.5 3.7 13.1 16.1 5.0 9.4 41.3 20.7 10.9 19.2 11.9 20.4 16.2 15.0 14.6 8.9 17.1 19.8 14.3 8.8 18.4 18.2 3.5 20.5 21.1 7.4 20.7 17.7 7.8 8.2 9.1 11.9 8.0 7.8 8.6 7.9 6.9 9.0 7.7 8.1 8.4 2.2 3.2 9.5 0.0 22.2 7.1 4.7 11.5 16.5 0.0 2.0 2.0 28.6 14.3 14.0 0.0 0.0 9.6 7.3 17.6 0.0 1.6 60.7 2.4 4.8 8.6 4.9 24.8 0.0 1.2 7.5 11.0 44.9 2.1 19.0 1.7 13.2 21.2 10.5 0.0 0.0 22.3 10.2 17.2 6.5 28.3 22.1 14.0 7.2 0.0 12.6 0.0 19.6 0.0 0.0 1.7 16.7 15.8 21.5 4.0 26.6 1.5 11.4 0.0 19.7 10.6 6.7 11.6 6.3 19.1 7.0 5.7 31.3 1.7 18.2 5.0 TPP2 TPPII ENSG00000134900 "Tripeptidyl peptidase 2" P29144 13 102596986-102679958 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 9 "Early spermatids: 796.3;Late spermatids: 892.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021069, HPA049630" Approved Supported "Nuclear bodies,Cytosol" NA NA 280000 "Nuclear bodies, Cytosol" "HPA021069: AB_1858344, HPA049630: AB_2680836" "unprognostic (4.75e-2)" "unprognostic (4.78e-2)" "unprognostic (9.97e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-2)" "unprognostic (4.43e-2)" "unprognostic (2.45e-2)" "unprognostic (8.33e-3)" "unprognostic (5.02e-2)" "unprognostic (1.51e-1)" "unprognostic (3.12e-1)" "unprognostic (2.75e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.95e-2)" "unprognostic (3.43e-3)" 12.0 8.2 3.3 15.7 5.7 48.4 16.5 10.0 6.1 13.0 5.9 14.0 12.4 16.4 19.8 11.7 11.6 12.6 13.9 3.6 3.3 10.1 20.6 14.8 20.0 3.6 3.6 2.7 14.3 11.0 11.4 8.3 17.9 4.4 11.4 19.4 17.5 10.7 16.9 27.9 12.2 12.6 13.2 3.6 18.8 12.3 52.3 4.3 16.2 20.1 22.3 17.2 12.9 11.5 9.8 33.8 13.7 38.0 28.7 28.9 37.5 25.5 34.9 26.6 23.8 28.0 30.7 41.0 37.3 11.9 30.3 25.7 30.0 30.5 23.7 39.3 26.4 24.9 71.2 34.0 22.8 22.9 89.3 44.6 31.5 11.2 26.4 35.6 23.6 32.7 34.8 43.4 42.9 32.0 11.3 37.2 53.4 28.5 43.7 17.6 43.5 30.3 31.8 25.7 29.7 35.8 26.7 23.2 35.0 13.7 31.9 20.0 79.9 28.5 20.9 15.1 12.9 29.0 40.7 56.2 37.0 31.1 56.6 26.8 7.4 5.5 3.7 7.1 5.9 8.4 4.8 8.2 8.4 5.2 4.5 9.7 9.8 1.0 8.9 4.9 3.3 9.6 4.5 3.3 5.7 10.0 6.1 3.6 3.3 3.6 3.6 2.7 4.4 3.6 4.3 9.8 20.9 38.5 41.6 41.8 24.5 15.4 16.4 10.6 22.8 27.5 18.5 12.7 41.8 11.5 18.5 14.7 73.0 28.5 38.7 13.3 9.8 19.8 796.3 23.0 28.9 19.3 19.8 26.1 64.1 8.8 30.7 25.8 14.3 22.7 38.6 24.8 20.3 22.4 32.1 8.4 69.8 18.5 8.2 25.7 19.9 892.8 32.0 29.5 17.8 65.6 29.3 13.8 42.2 66.4 67.3 13.3 16.3 18.8 58.9 16.5 10.2 13.2 36.4 46.5 26.3 24.3 28.8 92.7 30.0 22.9 13.4 33.1 35.6 31.6 21.8 19.6 POGLUT2 "EP58, KDELC1, MGC5302" ENSG00000134901 "Protein O-glucosyltransferase 2" Q6UW63 13 102784281-102798976 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 6.0;Extravillous trophoblasts: 23.3;Fibroblasts: 3.8;Hofbauer cells: 3.3;Syncytiotrophoblasts: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.9" "Group enriched" "Detected in many" 5 "NK-cells: 3.9;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020780, HPA043946, HPA064398" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 44000 Nucleoplasm "CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256" "unprognostic (1.97e-2)" "unprognostic (2.34e-1)" "unprognostic (3.21e-1)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (6.68e-3)" "prognostic unfavorable (4.81e-4)" "unprognostic (4.34e-3)" "unprognostic (2.75e-2)" "unprognostic (7.26e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.11e-2)" "unprognostic (1.17e-1)" "unprognostic (2.46e-1)" "unprognostic (2.60e-3)" 4.0 2.3 1.6 3.1 2.3 1.6 3.3 2.3 2.5 5.3 1.8 3.0 1.3 11.2 4.3 2.6 4.3 8.2 4.0 1.7 1.8 4.6 7.8 3.4 2.4 2.0 2.0 1.7 6.6 1.6 2.8 2.1 12.3 2.1 2.8 2.8 3.4 1.8 4.2 0.8 2.3 2.1 12.6 1.7 3.7 2.4 1.5 2.0 1.9 2.9 2.5 1.9 6.1 3.2 2.9 8.1 6.0 36.8 35.5 37.0 28.5 9.0 21.4 16.4 19.5 33.5 17.1 11.5 0.0 16.7 17.6 10.0 13.3 26.6 10.9 19.5 3.4 22.1 9.8 16.3 18.8 32.1 25.4 34.5 27.0 12.3 14.8 14.2 29.1 43.0 12.3 16.3 0.0 10.5 9.0 11.4 20.8 23.5 11.5 17.9 0.0 26.3 9.5 53.7 0.7 5.5 33.7 21.0 5.6 12.3 30.5 16.1 10.9 13.3 12.8 9.3 14.7 21.6 7.4 14.4 0.0 25.2 0.0 22.6 0.0 0.0 0.0 1.4 0.0 2.4 0.2 0.7 1.1 0.6 0.0 0.2 0.7 0.0 3.9 0.0 0.0 0.9 0.2 1.6 2.3 2.3 2.5 1.7 1.8 2.0 2.0 1.7 2.1 1.7 2.0 2.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 23.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 CARS2 FLJ12118 ENSG00000134905 "Cysteinyl-tRNA synthetase 2, mitochondrial" Q9HA77 13 110641412-110713603 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 221.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-87 MG: 204.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041776 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA041776: AB_2677666" "unprognostic (2.34e-3)" "unprognostic (9.50e-2)" "unprognostic (6.62e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.98e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (7.82e-2)" "unprognostic (2.11e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.73e-2)" "unprognostic (3.42e-1)" "unprognostic (3.21e-1)" "unprognostic (1.71e-2)" 18.5 24.6 8.8 19.1 9.1 28.7 15.1 15.7 13.4 20.4 13.7 19.6 17.7 16.1 13.8 18.8 16.6 11.2 26.1 9.2 9.5 15.5 20.1 16.8 19.5 9.3 9.2 8.6 15.5 15.9 15.1 17.7 12.2 11.6 15.4 13.9 9.3 19.0 12.4 46.2 16.8 18.6 12.7 8.1 17.9 17.3 11.3 9.6 13.0 14.4 26.9 14.2 17.8 16.1 10.7 116.0 37.7 21.2 52.6 55.7 51.7 28.7 49.9 45.7 49.6 60.6 53.5 50.7 53.5 68.4 55.4 75.6 61.0 36.6 63.8 40.2 49.2 58.5 33.5 79.6 63.8 58.5 83.0 39.3 66.7 50.7 43.3 51.8 35.5 36.0 40.9 23.2 16.6 71.2 27.2 37.5 27.6 18.4 88.9 36.8 54.2 15.6 22.3 54.2 33.4 37.7 28.9 40.7 62.0 61.1 22.7 29.8 94.0 32.5 41.8 15.6 53.2 51.6 29.0 35.8 32.4 204.5 50.1 41.9 0.0 2.9 0.4 1.1 3.3 1.2 1.8 0.3 0.4 2.4 0.8 1.1 0.5 1.7 0.4 4.6 2.0 0.4 1.1 8.8 9.1 15.7 13.4 9.2 9.5 9.3 9.2 8.6 11.6 8.1 9.6 10.7 18.2 9.6 15.9 24.5 24.4 12.9 24.2 10.3 8.6 21.4 21.8 23.4 39.3 18.6 9.5 27.6 25.0 26.7 28.2 17.6 50.9 17.7 66.5 24.1 21.7 13.6 18.7 10.7 29.2 4.7 29.1 21.6 18.8 27.3 16.5 45.3 9.3 26.6 26.9 23.5 25.1 17.7 12.2 31.2 9.0 221.4 20.5 32.8 12.4 24.4 51.4 24.3 14.4 14.1 26.6 12.1 10.8 18.0 18.6 18.2 23.0 38.1 10.6 25.9 6.6 29.2 24.7 8.6 7.5 22.3 13.5 16.8 19.8 44.2 28.5 17.6 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.6 7.6 4.1 3.5 7.7 2.1 10.4 0.0 23.3 8.9 0.0 14.2 21.3 8.2 9.1 26.5 13.4 7.6 3.4 12.6 3.2 7.0 5.1 5.9 1.6 4.5 1.2 12.7 11.0 15.4 10.8 6.1 8.6 9.2 6.5 16.0 33.8 16.0 4.2 7.7 20.2 20.8 5.9 0.0 3.0 12.2 10.8 0.0 10.6 3.9 4.4 6.9 9.5 17.3 4.4 12.2 6.4 19.7 0.1 6.3 6.3 14.2 4.5 6.3 2.8 3.4 14.9 24.7 0.1 6.7 8.7 14.1 27.2 9.0 11.4 5.4 0.0 3.1 0.2 3.4 5.6 3.1 0.0 0.0 6.1 14.4 2.7 16.3 6.2 3.5 10.2 0.6 0.2 4.9 9.5 10.2 0.2 5.4 36.6 6.8 24.9 5.9 2.5 3.0 39.5 19.3 7.9 6.8 42.3 8.0 7.5 21.9 3.9 6.6 9.9 5.2 5.9 8.9 0.3 0.0 0.1 4.3 27.4 6.4 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.1 4.1 7.7 0.0 23.3 12.6 3.2 4.5 1.2 12.7 9.2 0.0 0.0 4.4 5.3 6.4 16.8 240.6 3.4 18.2 12.7 29.1 16.5 31.6 36.5 17.1 4.3 14.3 46.6 11.0 123.0 23.1 4.8 48.7 1.9 8.3 19.0 27.7 10.0 5.6 40.7 2.5 403.4 27.2 4.2 14.1 35.2 25.4 1.3 9.8 5.0 16.2 6.5 18.5 239.7 61.9 20.3 4.1 4.2 12.3 6.8 5.7 16.0 103.0 2.9 113.6 0.0 170.9 95.0 24.5 44.2 13.2 1.5 22.7 52.7 9.9 61.6 37.9 19.7 19.4 9.5 8.6 9.6 55.4 31.1 28.5 2.0 4.0 54.0 59.5 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3 oligosaccharyltransferase complex catalytic subunit A" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 394.6" "Cell type enhanced" "Detected in all" "Plasma cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved NA NA 23000 "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 38.8 39.6 14.3 45.0 16.9 32.1 56.4 17.8 17.0 85.6 27.4 54.5 42.6 61.3 141.6 30.4 56.8 39.8 38.8 13.7 25.4 46.2 69.6 39.4 33.2 19.1 17.2 12.9 68.6 69.6 394.6 29.3 64.4 19.0 56.7 60.1 40.4 80.8 78.0 18.6 31.8 42.4 59.4 17.4 34.7 51.9 44.9 16.1 35.1 84.7 24.6 49.2 50.8 33.6 22.7 113.1 99.5 123.7 173.6 230.1 176.4 133.8 198.5 238.5 158.6 196.6 304.2 294.3 143.6 236.2 297.3 222.4 202.7 173.5 176.2 208.5 114.8 90.0 341.0 63.7 215.1 254.4 208.4 153.6 138.4 125.8 219.5 424.5 186.1 182.2 63.9 147.1 210.6 205.4 82.7 84.4 65.6 78.6 221.8 106.0 98.9 107.1 221.5 173.7 170.1 77.5 66.2 142.9 229.3 72.5 144.9 267.8 148.1 164.5 227.7 82.0 97.6 159.7 66.3 82.4 109.6 87.4 206.3 184.7 96.2 46.7 36.6 56.1 45.4 77.9 42.8 53.7 52.0 65.2 32.1 37.1 44.4 15.7 52.8 41.8 158.3 44.0 47.5 14.3 16.9 17.8 17.0 13.7 25.4 19.1 17.2 12.9 19.0 17.4 16.1 22.7 17.4 28.9 25.0 6.8 20.8 16.2 14.3 40.3 12.5 11.6 15.2 9.8 23.3 27.1 29.1 16.5 20.9 45.4 21.7 16.1 1.9 30.1 10.6 22.9 51.0 17.3 15.6 19.6 7.6 27.2 73.4 33.0 26.0 57.0 17.1 29.0 32.2 38.5 30.7 1.7 8.9 37.3 20.3 23.6 31.9 5.4 21.5 17.3 24.9 9.4 12.6 13.2 11.3 11.6 10.9 28.6 12.2 18.8 91.9 19.3 15.6 13.6 23.6 15.1 19.7 23.1 32.8 33.5 13.1 21.9 14.8 45.6 14.6 22.3 26.9 13.9 ADAMTS8 "ADAM-TS8, FLJ41712, METH2" ENSG00000134917 "ADAM metallopeptidase with thrombospondin type 1 motif 8" Q9UP79 11 130404923-130428609 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.8" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 14.5;Endometrial stromal cells: 30.9;Glandular and luminal cells: 37.7;Skeletal myocytes: 26.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;HeLa: 1.3;HMC-1: 4.4;NTERA-2: 2.2;U-2 OS: 9.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066349 Approved "Secreted to extracellular matrix" NA NA 3600000 "HPA066349: AB_2685662" "unprognostic (4.76e-6)" "unprognostic (3.92e-2)" "unprognostic (6.13e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.41e-1)" "unprognostic (7.81e-2)" "unprognostic (3.09e-2)" "unprognostic (9.83e-2)" "unprognostic (1.09e-4)" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (4.66e-3)" "unprognostic (4.03e-3)" "unprognostic (5.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-1)" 1.8 0.1 1.4 10.2 1.7 0.0 0.7 0.0 3.4 1.5 0.0 5.2 1.1 3.1 1.0 3.0 2.2 1.6 1.4 2.9 0.5 0.2 0.0 27.8 0.1 1.2 0.2 3.1 0.4 0.7 0.0 0.2 2.7 0.7 2.7 0.5 0.0 0.5 5.0 0.5 0.3 2.1 4.2 0.0 0.4 5.4 0.3 0.5 0.0 0.2 0.5 0.0 4.3 0.9 1.8 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 1.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 3.4 2.9 0.5 1.2 0.2 3.1 0.7 0.0 0.5 1.8 1.3 0.0 0.6 1.0 0.0 0.4 0.4 0.1 0.0 2.4 2.3 3.9 9.1 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 14.5 30.9 0.6 0.0 0.0 7.4 0.0 0.0 6.6 0.0 37.7 1.3 1.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.7 0.5 0.0 0.1 1.8 2.8 0.0 0.1 1.0 0.5 5.9 0.0 0.0 1.5 0.0 0.5 0.0 0.1 2.6 0.2 0.0 26.9 5.7 0.1 0.3 0.1 0.1 0.0 0.6 0.1 0.0 0.0 ACRV1 "D11S4365, SP-10, SPACA2" ENSG00000134940 "Acrosomal vesicle protein 1" P26436 11 125671522-125680874 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 117.6" "Group enriched" "Detected in some" 48 "Early spermatids: 904.8;Late spermatids: 278.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 5.0;HEL: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038718, HPA038719" Enhanced "Secreted in male reproductive system" NA NA "HPA038718: AB_2676171, HPA038719: AB_10670787" "unprognostic (3.58e-2)" "unprognostic (8.68e-3)" "unprognostic (1.46e-1)" "unprognostic (6.18e-2)" "unprognostic (4.58e-2)" "unprognostic (7.91e-3)" "unprognostic (6.73e-4)" "unprognostic (1.76e-1)" "unprognostic (2.12e-3)" "unprognostic (8.39e-2)" "unprognostic (7.09e-2)" "unprognostic (2.90e-3)" "unprognostic (1.80e-8)" "unprognostic (5.26e-3)" "unprognostic (2.52e-1)" "unprognostic (1.95e-1)" "unprognostic (3.75e-1)" 0.0 0.0 1.7 0.1 1.9 0.2 0.1 1.4 2.1 0.0 1.3 0.1 0.1 0.1 3.5 0.0 0.1 0.0 0.0 1.7 1.8 0.0 0.0 0.0 0.4 1.6 1.8 1.8 0.0 0.0 0.0 0.2 0.1 1.8 0.2 0.0 0.2 0.0 0.7 0.0 0.1 0.1 0.2 1.5 0.0 0.0 117.6 1.8 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.3 1.2 5.0 3.2 0.0 0.0 1.0 1.5 0.0 0.1 0.0 1.8 1.7 2.7 0.6 0.0 0.7 0.4 0.0 0.0 0.3 1.9 0.9 5.0 0.6 0.9 0.1 2.5 1.1 0.0 0.0 0.0 0.2 0.2 0.0 0.8 1.4 2.0 0.4 0.7 2.7 3.4 1.1 0.5 1.0 2.3 1.2 0.5 0.0 0.5 0.6 0.8 0.6 0.1 0.1 0.9 0.9 0.6 0.5 1.7 1.1 0.2 0.3 0.9 1.2 1.3 0.2 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.9 1.4 2.1 1.7 1.8 1.6 1.8 1.8 1.8 1.5 1.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 904.8 0.8 0.1 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 278.8 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ETS1 "ETS-1, EWSR2, FLJ10768" ENSG00000134954 "ETS proto-oncogene 1, transcription factor" P14921 11 128458761-128587558 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Immunity, Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 331.8" "Cell type enhanced" "Detected in many" "Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 352.9;JURKAT: 362.3;U-698: 462.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002575, HPA063230" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002575: AB_563721, HPA063230: AB_2684965" "unprognostic (1.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.18e-3)" "unprognostic (6.22e-2)" "unprognostic (3.07e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.02e-1)" "unprognostic (3.08e-2)" "unprognostic (1.38e-1)" "unprognostic (5.48e-3)" 102.1 19.3 14.1 147.0 10.2 35.6 66.0 9.7 14.2 36.2 10.2 31.5 27.2 36.8 9.4 22.0 20.4 63.0 43.4 9.0 11.0 30.7 48.0 76.8 279.4 12.9 14.5 6.6 27.2 20.3 28.6 7.8 56.7 12.6 17.2 31.8 1.8 16.6 20.9 25.9 18.0 49.7 38.4 11.0 187.4 46.5 8.1 13.7 331.8 40.1 42.7 252.3 68.6 19.3 18.0 87.7 15.7 72.8 0.3 30.7 49.3 0.2 65.7 140.2 80.9 77.3 5.1 91.7 312.1 65.7 109.5 184.7 29.8 7.0 190.0 169.0 66.6 1.1 352.9 6.4 0.3 82.2 36.7 4.0 97.2 15.0 69.6 252.2 46.1 67.9 362.3 0.6 63.3 98.1 0.0 185.7 27.4 27.0 7.9 55.0 50.4 118.7 24.5 64.2 95.6 0.9 5.0 34.5 0.7 73.6 48.5 0.3 17.7 126.1 180.5 57.1 35.5 109.1 46.7 8.9 462.5 32.2 68.0 162.1 51.2 0.1 6.6 20.4 0.3 28.9 12.3 27.0 25.0 0.2 9.2 32.5 26.1 1.1 27.8 1.0 6.2 33.3 9.5 14.1 10.2 9.7 14.2 9.0 11.0 12.9 14.5 6.6 12.6 11.0 13.7 18.0 263.1 25.6 26.5 2.9 125.6 114.8 41.0 12.4 1.8 0.0 8.2 7.2 9.0 4.3 24.3 11.0 0.0 0.2 378.9 13.1 0.0 31.9 6.2 26.3 51.0 190.4 15.5 13.7 2.0 22.6 0.5 45.5 17.3 66.2 19.6 1.3 213.8 5.4 7.3 0.0 25.6 15.0 10.2 18.3 48.2 1.5 14.0 12.5 69.4 65.6 16.8 0.2 399.6 55.3 9.5 99.3 6.6 15.4 129.6 26.8 2.2 4.6 5.9 0.2 105.2 55.5 76.6 0.7 1.8 1.5 63.2 0.4 323.2 40.4 5.8 32.6 SLC37A2 FLJ00171 ENSG00000134955 "Solute carrier family 37 member 2" Q8TED4 11 125063302-125090516 "Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 79.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2" "Group enriched" "Detected in many" 9 "dendritic cells: 5.5;monocytes: 19.2" "Cell line enhanced" "Detected in many" "A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014948 Uncertain NA NA "HPA014948: AB_2190374" "unprognostic (8.47e-2)" "unprognostic (4.85e-1)" "unprognostic (9.64e-2)" "unprognostic (2.91e-2)" "unprognostic (7.88e-2)" "unprognostic (2.84e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-2)" "unprognostic (3.11e-1)" "unprognostic (6.61e-2)" "unprognostic (1.94e-3)" "unprognostic (1.66e-3)" "unprognostic (7.01e-2)" "unprognostic (3.24e-2)" 4.2 24.4 2.3 17.1 3.0 1.5 4.7 2.9 8.9 1.5 2.7 8.0 9.2 1.0 1.3 13.5 1.3 5.2 1.5 2.2 3.5 0.7 6.0 5.9 5.8 3.6 2.9 1.6 1.0 1.2 1.2 0.3 7.4 5.7 2.6 10.3 0.5 79.5 1.4 0.6 21.1 7.8 3.1 4.0 16.0 2.1 1.6 3.9 2.1 0.6 0.9 5.1 12.0 7.8 5.7 33.8 0.1 1.0 0.4 0.6 0.8 0.6 1.6 2.8 1.0 2.5 0.2 70.3 0.4 9.4 0.4 2.5 21.0 0.4 20.9 3.8 0.9 0.6 6.6 1.6 2.4 0.1 0.3 0.9 0.7 34.9 2.6 64.8 2.7 1.7 1.3 0.5 2.2 3.1 0.3 0.3 4.6 1.9 0.2 1.0 0.4 2.7 0.8 1.0 17.6 0.3 0.3 4.8 2.9 2.6 0.5 0.3 1.8 3.7 47.2 1.9 0.7 1.6 1.8 1.5 1.1 1.7 2.4 4.1 0.2 12.3 0.0 0.0 14.1 0.0 0.4 0.0 0.1 5.5 0.1 0.1 0.1 1.3 0.0 19.2 0.2 0.0 5.4 2.3 3.0 2.9 8.9 2.2 3.5 3.6 2.9 1.6 5.7 4.0 3.9 5.7 0.7 0.0 0.6 0.3 3.8 0.3 1.4 0.5 1.2 1.5 1.4 1.1 1.1 1.5 1.6 0.0 2.1 0.6 0.7 13.4 0.0 0.1 1.6 1.9 1.4 1.3 0.0 2.7 0.3 0.0 0.8 0.5 0.0 4.9 2.5 0.4 1.8 0.3 36.5 0.0 0.3 0.1 0.0 22.0 1.4 2.2 0.9 22.7 0.0 8.4 7.3 0.3 3.1 1.0 0.2 0.1 3.3 1.2 1.7 1.0 0.0 0.1 0.2 0.8 0.0 0.8 0.6 2.7 1.1 5.7 0.9 3.4 1.2 0.4 0.1 3.2 KLB ENSG00000134962 "Klotho beta" Q86Z14 4 39406930-39451533 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 19.8;liver: 17.9;pancreas: 6.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5" "Cancer enriched" "Detected in some" 16 "liver cancer: 11.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "ASC diff: 6.7;Hep G2: 25.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021136 Uncertain NA NA 320000 "HPA021136: AB_1852616" "unprognostic (1.03e-2)" "unprognostic (1.61e-2)" "unprognostic (4.67e-2)" "unprognostic (2.69e-1)" "unprognostic (4.30e-2)" "unprognostic (7.02e-3)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (6.99e-3)" "unprognostic (4.51e-3)" "unprognostic (3.02e-3)" "unprognostic (8.90e-3)" "unprognostic (1.73e-1)" "unprognostic (5.03e-2)" "unprognostic (4.53e-2)" "unprognostic (3.87e-2)" "unprognostic (3.09e-2)" 19.8 0.1 0.2 0.2 0.4 0.3 3.5 0.9 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.2 0.3 0.2 17.9 1.6 0.0 0.4 0.2 0.2 0.0 6.1 0.1 0.0 0.0 0.3 0.1 0.5 0.1 0.4 0.0 0.0 0.6 0.6 0.0 0.1 0.0 1.4 2.8 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 25.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.4 0.9 0.6 0.2 0.3 0.4 0.2 0.2 0.3 0.1 0.2 0.5 0.6 3.2 19.6 0.0 0.7 0.5 1.1 1.4 0.0 1.6 0.7 1.1 1.2 0.0 1.2 0.0 0.0 0.4 0.5 1.6 0.0 1.1 8.5 4.4 1.5 0.4 17.4 0.0 0.5 4.3 1.5 0.5 2.6 2.2 0.0 0.2 0.4 51.4 0.2 1.7 0.6 12.1 2.0 1.0 0.6 3.2 1.5 0.4 1.8 0.0 0.1 0.4 0.0 0.5 0.2 0.9 4.8 0.7 0.0 1.2 2.1 1.1 0.4 2.3 0.0 1.2 0.5 39.5 0.9 2.0 0.9 1.4 0.8 0.5 1.1 1.1 TMED7 "CGI-109, FLJ90481, p24g3, p24gamma3" ENSG00000134970 "Transmembrane p24 trafficking protein 7" Q9Y3B3 5 115613210-115632992 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008960, CAB025883" Supported NA NA 13000 "CAB025883: , HPA008960: AB_1080280" "unprognostic (1.40e-1)" "unprognostic (8.42e-2)" "unprognostic (1.45e-2)" "unprognostic (1.22e-1)" "unprognostic (2.04e-1)" "unprognostic (4.35e-2)" "unprognostic (1.27e-1)" "unprognostic (2.26e-3)" "unprognostic (2.02e-1)" "unprognostic (2.11e-2)" "unprognostic (6.15e-3)" "unprognostic (4.10e-2)" "unprognostic (6.82e-2)" "unprognostic (4.95e-2)" "unprognostic (3.06e-1)" "unprognostic (4.79e-2)" "unprognostic (1.22e-1)" 35.4 41.6 27.2 29.7 33.9 32.1 38.2 35.4 33.0 51.0 40.3 42.5 37.2 41.6 70.8 32.7 38.9 33.8 43.9 25.2 37.8 54.7 80.9 30.8 23.6 43.9 31.6 25.2 31.3 35.5 54.0 28.2 44.2 35.5 49.1 42.7 19.4 43.7 44.7 22.2 19.1 38.6 45.4 38.0 26.1 41.9 19.1 32.4 19.7 80.5 25.1 24.3 38.0 22.8 49.5 63.6 42.4 43.8 54.7 112.3 84.4 68.1 109.8 116.4 79.7 129.8 36.3 110.1 33.1 105.7 115.1 99.5 49.6 41.3 128.0 125.7 76.0 34.4 30.5 39.2 76.8 119.8 31.9 59.0 78.2 60.5 76.1 95.8 100.4 78.5 22.3 29.6 44.5 87.1 30.1 24.0 28.5 30.8 37.7 35.5 25.9 65.1 63.8 98.6 44.6 33.3 39.8 90.0 52.3 68.1 41.7 63.0 41.8 80.1 109.0 46.3 79.2 66.3 29.3 24.0 33.5 88.7 52.2 61.8 25.5 23.8 20.2 14.9 23.1 15.3 10.4 11.5 13.3 19.3 9.1 11.1 12.0 16.3 14.2 18.5 13.3 11.5 20.7 27.2 33.9 35.4 33.0 25.2 37.8 43.9 31.6 25.2 35.5 38.0 32.4 49.5 37.8 38.5 29.8 0.0 26.9 45.6 30.1 35.3 15.4 31.5 47.4 21.5 42.4 61.5 29.3 46.0 10.4 44.2 30.6 63.8 13.7 37.4 28.7 34.5 48.9 30.6 87.3 9.1 0.0 28.3 103.6 51.8 34.1 45.6 10.1 20.4 44.3 114.2 50.1 30.3 0.0 85.8 24.4 51.6 55.5 20.1 46.9 38.4 51.6 0.0 36.8 52.6 19.6 0.0 0.0 37.4 39.9 53.4 13.9 60.5 50.0 42.2 36.9 25.8 39.5 42.9 43.1 39.2 18.0 25.3 44.0 82.8 23.6 33.9 46.9 55.6 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC regulator of WNT signaling pathway" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" "Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013349, HPA013362" Supported Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA013349: AB_1844913, HPA013362: " "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 7.0 4.7 31.6 6.3 29.7 9.2 5.8 28.8 39.6 5.7 1.8 6.8 6.3 5.6 3.3 7.8 4.4 5.0 7.2 56.8 27.2 6.2 5.8 6.3 5.7 32.5 32.6 25.1 6.6 4.2 8.5 4.0 5.2 43.3 5.2 6.3 20.1 3.8 4.1 8.5 5.7 8.6 7.5 18.9 6.2 5.0 5.1 41.6 8.5 6.0 11.9 5.9 5.5 3.6 29.6 11.3 10.1 16.8 12.2 13.4 11.3 6.7 17.9 8.5 9.7 11.5 8.2 8.9 22.0 17.0 23.1 15.5 9.0 17.4 14.6 15.9 13.2 12.2 16.8 14.9 6.2 6.6 8.4 8.6 9.3 9.8 16.6 10.8 6.8 13.6 10.2 20.9 7.2 14.3 7.8 9.6 4.2 6.0 6.1 3.6 8.1 20.8 10.7 8.9 14.1 17.0 10.1 16.9 6.5 7.1 6.8 9.1 6.7 22.8 19.6 9.5 19.5 13.6 5.6 9.5 8.2 10.8 15.3 11.2 11.8 2.5 4.9 2.9 1.3 2.4 2.8 1.5 1.9 2.1 3.1 2.4 2.4 11.4 2.9 2.4 2.7 1.5 1.0 31.6 29.7 28.8 39.6 56.8 27.2 32.5 32.6 25.1 43.3 18.9 41.6 29.6 40.6 51.3 23.6 536.4 21.9 11.2 8.9 10.1 19.9 196.9 13.1 14.9 56.6 18.6 20.1 0.0 66.7 5.4 28.9 28.6 0.0 18.7 10.5 20.1 27.6 31.2 27.5 17.4 165.8 19.5 6.5 25.9 19.4 29.7 19.0 28.7 26.7 13.9 16.3 79.1 236.4 17.2 2.0 18.9 12.4 5.5 17.7 27.8 17.8 85.3 30.7 23.4 23.7 196.6 150.8 20.3 34.7 19.5 22.9 10.4 37.2 5.1 18.0 41.5 39.5 44.1 34.0 19.2 30.4 26.5 11.6 2.9 22.4 27.1 16.0 8.9 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 118.3;Excitatory neurons: 116.1;Theca cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 24.6;NK-cell: 6.9;plasmacytoid DC: 25.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 425.3;SH-SY5Y: 461.8" "Region enriched" "Detected in all" 5 "cerebellum: 1766.0" "Region enhanced" "Detected in all" "cerebellum: 219.5" HPA000545 Approved Approved Vesicles NA NA Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 19.1 57.0 46.1 19.6 53.2 37.0 29.6 144.6 72.2 32.5 54.0 23.5 17.0 85.6 18.0 23.2 18.4 65.9 71.5 57.4 49.4 50.0 51.1 27.9 17.5 47.5 54.3 47.6 42.2 9.9 8.5 13.4 120.8 65.8 53.2 25.5 108.4 36.4 72.9 181.6 22.2 16.9 55.0 42.3 37.3 25.9 12.8 47.3 169.7 18.8 119.2 18.6 27.7 16.9 58.5 0.6 7.1 425.3 91.5 20.2 46.6 20.3 140.9 83.9 135.7 221.0 0.8 2.8 73.1 44.6 71.3 18.9 0.3 91.0 5.2 69.4 29.5 13.0 57.5 35.2 77.6 28.1 77.0 0.8 45.6 22.5 129.5 44.5 318.6 154.2 81.4 0.6 7.4 143.4 1.6 308.3 53.7 244.1 0.2 33.3 326.3 173.4 19.9 52.2 1.6 96.9 461.8 31.6 2.2 2.9 224.2 17.7 210.6 31.1 163.7 54.1 80.8 15.8 34.6 29.3 92.3 35.6 159.8 32.8 0.0 4.0 0.0 0.0 2.2 0.0 1.6 0.1 0.2 24.6 1.1 1.2 1.6 0.1 6.9 1.0 25.1 0.0 2.2 46.1 53.2 144.6 72.2 57.4 49.4 47.5 54.3 47.6 65.8 42.3 47.3 58.5 20.8 6.4 30.8 43.1 3.6 18.1 1.6 4.5 14.2 66.9 12.4 22.6 33.4 8.6 5.7 12.9 87.6 118.3 12.9 2.5 33.2 14.4 2.5 5.4 69.1 38.9 21.6 52.2 116.1 5.5 18.6 31.7 31.1 7.4 5.1 69.9 27.5 10.1 35.5 20.2 51.4 9.3 42.7 10.0 19.0 1.0 8.4 14.9 14.2 17.8 11.5 14.9 5.2 37.2 4.6 8.2 2.0 23.3 0.9 0.7 1.2 61.0 0.5 29.0 13.1 25.4 51.8 0.8 12.6 11.9 12.6 31.5 3.2 150.8 11.3 0.2 WDR36 "GLC1G, TA-WDRP, UTP21" ENSG00000134987 "WD repeat domain 36" Q8NI36 5 111091716-111130502 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Sensory transduction, Vision" "Disease variant, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037796, HPA037797" Supported Supported Nucleoli NA NA Nucleoli "HPA037796: AB_2675673, HPA037797: AB_10672725" "unprognostic (2.14e-1)" "unprognostic (4.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (1.64e-1)" "unprognostic (9.79e-2)" "unprognostic (7.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.91e-2)" 9.2 6.3 3.8 9.5 3.9 10.0 10.2 5.1 4.5 7.5 4.6 7.1 6.5 9.0 6.7 8.0 6.8 7.3 6.1 4.1 4.4 7.6 14.2 6.3 11.4 4.2 4.3 3.6 10.2 6.4 7.4 4.5 7.6 4.1 8.3 8.2 4.7 6.0 7.0 9.2 10.2 6.9 7.6 4.0 8.9 7.4 6.3 4.3 9.2 9.8 7.2 12.1 9.9 6.2 4.7 17.0 14.9 13.7 36.6 24.7 32.2 19.2 14.6 13.9 19.5 27.9 19.1 19.7 53.8 17.0 12.2 22.7 19.2 26.8 33.8 34.8 15.9 15.7 26.6 17.2 19.5 26.3 25.6 38.8 19.2 21.4 34.6 37.5 36.5 20.3 18.4 32.3 18.1 25.8 14.3 31.7 24.9 18.3 16.8 15.6 25.6 29.9 42.4 18.1 19.3 24.3 19.5 18.6 15.2 22.4 15.0 15.2 21.3 19.1 28.1 15.6 20.0 30.5 18.1 14.0 48.6 22.4 37.9 22.2 0.3 2.5 1.0 3.3 3.3 3.8 2.7 3.0 3.7 4.0 2.4 4.3 3.6 0.1 3.3 5.0 2.1 3.8 2.6 3.8 3.9 5.1 4.5 4.1 4.4 4.2 4.3 3.6 4.1 4.0 4.3 4.7 17.2 19.2 13.8 15.3 26.0 61.1 15.4 18.3 113.3 9.9 14.5 12.1 15.6 18.6 19.6 16.5 6.2 9.4 15.4 5.3 7.9 9.5 5.1 10.6 26.0 20.4 6.0 20.6 30.5 13.8 9.9 20.7 13.7 16.2 14.0 16.9 12.5 35.1 14.7 11.8 24.8 12.9 16.2 24.1 16.0 4.2 8.7 18.2 21.4 20.6 18.3 5.7 16.5 27.6 22.3 9.9 6.4 11.3 27.5 20.8 5.3 11.3 12.3 8.6 19.7 20.2 17.3 18.5 17.8 42.3 57.8 5.3 18.0 18.1 13.4 11.2 OSTF1 "bA235O14.1, OSF, SH3P2" ENSG00000134996 "Osteoclast stimulating factor 1" Q92882 9 75088514-75147265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 329.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 302.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020514 Approved Supported Cytosol NA NA 580000 Cytosol "HPA020514: AB_2670461" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (7.54e-2)" "prognostic favorable (3.67e-5)" "unprognostic (1.36e-1)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-3)" "unprognostic (3.76e-1)" "unprognostic (7.89e-2)" "unprognostic (6.36e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" 44.7 37.3 28.2 66.3 34.5 56.9 35.2 31.5 37.5 25.8 28.4 42.9 38.5 22.9 38.5 105.6 20.2 43.1 32.3 28.5 32.7 35.0 58.1 56.9 75.5 31.3 32.6 27.4 16.2 19.6 72.7 19.3 70.5 32.5 22.9 46.2 12.4 38.8 19.8 9.6 63.6 48.2 29.1 30.6 87.8 41.0 18.2 29.8 48.2 29.2 16.2 85.7 55.8 54.3 35.1 69.1 16.0 7.7 11.2 45.4 41.7 81.3 71.9 46.9 26.9 24.4 8.2 50.8 70.9 35.3 59.2 34.6 111.8 12.9 51.9 77.0 302.0 16.0 39.3 24.8 42.5 36.7 71.5 141.6 29.1 49.2 31.6 21.8 23.7 91.2 59.4 13.4 158.4 65.4 35.9 107.5 44.8 14.5 161.5 30.8 20.1 52.3 63.0 57.0 97.1 6.5 0.6 53.1 74.1 36.2 58.2 97.4 79.9 86.4 55.8 19.4 108.3 30.8 30.1 52.5 26.7 67.1 81.9 46.4 359.5 177.7 464.8 158.6 199.3 169.6 101.2 110.5 131.5 148.7 87.4 62.1 109.8 495.2 168.4 256.8 110.6 163.0 283.0 28.2 34.5 31.5 37.5 28.5 32.7 31.3 32.6 27.4 32.5 30.6 29.8 35.1 113.4 22.4 24.4 8.1 90.8 82.2 61.2 78.2 61.5 2.9 38.6 23.2 7.8 28.6 51.2 33.1 6.2 125.5 162.1 64.8 76.3 49.7 11.9 42.8 59.4 60.5 27.2 23.3 32.0 52.3 252.9 42.1 31.1 51.1 137.6 4.2 71.7 32.2 233.1 10.1 12.6 31.9 69.2 167.4 181.5 6.0 23.9 155.7 76.5 43.1 329.9 6.0 268.8 30.2 67.3 60.5 97.7 15.4 83.2 34.1 64.1 63.0 27.3 8.6 19.7 15.9 45.0 6.7 17.8 141.4 114.5 133.9 163.8 37.6 38.2 91.6 RFK "FLJ11149, RIFK" ENSG00000135002 "Riboflavin kinase" Q969G6 9 76385526-76394517 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 352.0;Pancreatic endocrine cells: 220.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023259, CAB033887, HPA057163" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357" "unprognostic (1.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-3)" "unprognostic (8.61e-3)" "unprognostic (3.11e-1)" "unprognostic (1.39e-1)" "unprognostic (2.88e-1)" "unprognostic (1.02e-1)" "unprognostic (4.61e-2)" "unprognostic (1.22e-3)" "unprognostic (3.22e-2)" "unprognostic (1.83e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" 11.7 20.8 18.4 14.7 21.2 25.2 11.9 15.0 20.4 11.8 15.2 31.1 33.4 12.9 18.4 13.0 13.8 20.0 16.5 23.5 27.0 27.2 29.5 12.5 11.7 19.0 21.5 19.2 11.8 16.6 24.0 12.1 13.3 24.7 13.1 23.1 14.8 11.1 10.0 15.0 5.2 28.4 12.0 16.1 10.3 29.2 16.9 22.6 12.2 19.9 18.9 11.3 14.0 6.0 26.4 21.9 23.2 13.9 18.1 20.5 20.3 41.8 25.2 18.6 17.8 13.9 8.2 13.3 35.3 28.7 18.2 32.3 22.9 19.3 16.5 35.3 10.4 18.0 11.2 30.4 26.2 36.7 37.9 25.6 13.5 29.3 21.4 23.2 19.9 58.3 30.4 30.6 28.7 36.1 20.8 49.3 13.3 18.1 51.2 22.7 26.7 18.3 8.9 82.0 10.6 35.0 12.7 26.9 37.2 22.9 18.1 9.4 20.2 35.9 18.5 33.3 40.1 35.6 30.7 32.3 12.4 30.7 33.3 25.9 5.2 9.8 3.6 5.0 19.9 7.5 5.8 7.3 6.0 11.8 4.4 7.0 6.7 1.4 8.5 21.1 4.3 7.4 9.8 18.4 21.2 15.0 20.4 23.5 27.0 19.0 21.5 19.2 24.7 16.1 22.6 26.4 27.3 16.0 9.2 5.9 22.9 45.4 23.8 15.3 22.2 50.4 24.5 20.6 37.9 34.3 20.1 42.3 20.9 54.1 18.4 158.8 60.7 64.9 191.7 37.8 18.5 46.2 28.2 48.8 18.0 189.3 352.0 33.5 33.1 42.3 12.0 18.0 124.2 40.9 33.2 11.8 19.3 23.1 40.7 57.6 26.6 118.1 22.1 29.9 30.2 10.3 25.2 44.7 9.2 7.1 6.5 220.6 68.3 65.1 12.7 33.6 79.9 142.8 27.7 28.7 0.0 23.0 21.7 91.8 64.1 18.8 40.5 123.5 23.1 18.8 33.7 22.6 UBQLN1 "DA41, DSK2, PLIC-1, XDRP1" ENSG00000135018 "Ubiquilin 1" Q9UMX0 9 83659968-83707958 "Plasma proteins, Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037256, HPA054143" Supported Supported Nucleoplasm,Cytosol NA NA 200000 Nucleoplasm Cytosol "CAB037256: AB_1858556, HPA054143: AB_2682398" "unprognostic (4.72e-3)" "unprognostic (9.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (2.77e-2)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.80e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.07e-5)" "unprognostic (3.11e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-3)" "unprognostic (2.29e-2)" 50.5 50.3 43.1 44.0 49.5 85.7 42.8 45.1 48.1 41.1 33.2 44.6 39.7 43.5 39.1 51.2 37.2 37.3 63.6 49.6 51.3 55.7 74.6 39.3 51.5 50.6 51.0 42.9 36.4 50.9 72.8 28.8 50.8 51.4 45.8 41.7 56.3 34.8 47.2 126.8 42.0 40.0 47.5 49.0 38.0 42.8 42.4 49.4 70.0 45.7 73.6 65.6 53.9 35.5 57.7 154.5 137.8 101.9 77.9 83.4 89.3 164.0 140.8 125.4 147.7 111.3 56.8 105.5 153.9 86.6 120.0 137.0 172.0 141.8 101.7 152.7 79.7 66.0 95.1 97.9 90.3 111.7 116.6 98.3 74.7 127.1 124.1 172.4 92.8 112.8 72.6 102.7 105.7 124.6 91.0 160.8 66.6 132.6 147.5 126.3 117.6 113.7 80.4 98.7 65.0 90.4 101.2 130.9 131.7 102.0 100.2 64.6 84.2 111.8 92.2 84.9 154.2 143.6 146.1 222.0 74.7 139.4 85.1 114.1 34.9 21.2 22.6 19.8 31.4 19.3 19.0 16.9 18.2 24.2 19.6 16.9 18.5 22.7 31.8 30.7 10.5 24.2 20.5 43.1 49.5 45.1 48.1 49.6 51.3 50.6 51.0 42.9 51.4 49.0 49.4 57.7 39.5 35.3 42.2 29.4 53.9 103.2 66.2 43.0 42.7 58.4 41.2 28.3 76.7 31.5 46.8 22.0 20.9 59.9 38.9 49.9 19.6 55.1 37.9 47.7 50.9 42.8 51.4 51.8 61.9 53.5 86.9 42.2 32.1 74.9 50.1 33.6 25.7 73.4 52.1 75.7 58.7 41.5 42.7 51.2 87.5 18.3 24.5 52.4 42.7 41.2 46.5 31.0 39.1 33.2 67.9 70.4 36.5 27.8 56.2 68.8 48.9 39.6 33.4 34.1 39.5 33.4 42.9 74.1 50.5 45.2 92.5 164.3 47.7 28.9 41.1 84.0 NAA35 "bA379P1.1, FLJ21613, FLJ22643, MAK10" ENSG00000135040 "N-alpha-acetyltransferase 35, NatC auxiliary subunit" Q5VZE5 9 85941146-86025462 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021547 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA021547: AB_1853505" "unprognostic (5.87e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-3)" "unprognostic (9.25e-3)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.86e-1)" "unprognostic (5.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.30e-2)" "unprognostic (1.09e-1)" "unprognostic (2.36e-3)" "unprognostic (1.88e-1)" "unprognostic (4.34e-2)" "unprognostic (9.18e-2)" "unprognostic (1.07e-2)" 7.7 12.3 7.0 6.3 7.5 6.6 9.4 10.0 6.9 8.8 7.6 11.2 8.7 9.4 7.9 11.0 8.5 5.8 8.7 6.7 7.1 8.4 8.7 7.2 6.2 6.5 5.9 6.3 10.0 10.8 9.5 12.1 7.4 6.3 9.7 10.6 14.4 10.2 6.8 17.5 9.2 8.2 7.1 6.3 6.5 8.9 15.5 7.9 7.4 10.5 13.3 7.3 9.1 9.2 9.0 25.4 15.8 17.7 13.5 9.8 13.1 24.8 15.5 15.1 16.1 13.1 12.4 15.7 8.4 8.5 15.4 13.1 34.9 15.0 18.4 16.8 22.3 13.1 21.6 19.9 14.6 16.6 30.4 17.6 13.1 15.2 17.0 24.6 12.4 14.0 15.6 25.3 15.6 14.9 14.6 15.7 16.0 17.8 28.0 18.2 14.4 26.9 12.6 17.3 20.4 16.7 15.5 17.6 15.8 13.6 17.0 11.9 11.7 14.0 11.2 12.4 16.9 15.0 22.3 29.1 5.7 16.3 12.5 10.2 1.7 2.5 5.1 3.4 2.6 4.3 9.5 3.5 3.1 3.0 9.3 4.6 3.4 1.3 3.5 1.9 2.2 3.1 2.6 7.0 7.5 10.0 6.9 6.7 7.1 6.5 5.9 6.3 6.3 6.3 7.9 9.0 14.6 3.2 14.1 58.4 16.8 16.3 20.2 19.0 19.9 25.5 18.0 13.1 23.3 18.6 22.8 11.0 22.9 22.6 14.9 20.2 1.9 19.7 8.7 29.4 18.6 14.3 20.9 14.5 51.8 25.8 18.9 13.6 16.3 22.5 12.0 32.9 9.3 9.8 12.2 21.9 58.7 14.5 30.5 11.0 8.4 5.3 9.3 10.7 14.2 52.5 12.3 18.7 14.4 44.7 68.8 18.3 16.6 11.7 17.1 22.0 12.0 8.9 33.7 36.6 13.1 21.4 24.7 56.7 36.3 17.7 16.6 31.1 15.8 24.4 16.6 19.2 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946583-74952912 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 29.9;Cardiomyocytes: 45.0;Erythroid cells: 39.2;Spermatocytes: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA 230000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 4.7 2.1 7.6 4.4 7.3 6.3 4.4 7.2 9.7 4.0 5.3 5.9 8.4 3.7 1.5 3.9 3.1 1.6 2.8 7.4 7.3 2.6 3.2 2.1 4.7 7.7 7.5 7.2 2.7 2.4 2.9 3.1 3.7 7.9 2.7 5.2 8.0 2.2 2.5 3.1 2.2 11.4 2.7 8.0 3.9 2.6 11.9 7.7 4.4 2.1 2.5 4.8 4.2 4.2 9.0 29.6 6.3 16.3 6.6 6.5 8.2 30.2 23.0 7.1 15.7 16.8 1.8 9.0 26.5 6.7 5.8 26.2 8.6 12.9 1.3 24.9 36.0 19.9 14.1 11.2 11.3 5.2 17.2 21.5 4.1 8.5 8.7 6.2 6.3 4.9 19.1 20.3 17.5 20.7 8.3 30.3 19.9 19.2 15.4 19.2 28.0 12.8 6.5 6.7 7.1 17.7 7.8 10.1 8.5 7.3 14.3 10.3 13.1 6.4 14.1 15.9 19.5 20.4 33.2 26.7 17.0 10.7 19.0 15.5 0.6 0.1 2.1 0.3 0.1 0.1 0.8 0.3 0.3 0.1 0.5 0.7 0.4 0.1 0.0 0.2 0.3 0.4 0.1 7.6 7.3 7.2 9.7 7.4 7.3 7.7 7.5 7.2 7.9 8.0 7.7 9.0 29.9 3.2 0.5 2.3 5.8 2.4 4.4 1.1 3.4 9.7 6.0 6.2 45.0 0.0 0.6 3.7 8.4 20.9 3.2 13.4 1.9 3.3 12.0 2.9 6.2 12.1 1.2 39.2 5.8 3.1 24.9 5.9 2.6 6.4 0.0 3.1 8.2 3.8 11.3 1.7 4.6 7.9 0.0 4.2 3.7 2.9 4.4 3.5 1.8 6.5 2.6 4.8 2.1 1.5 4.0 2.5 7.3 5.3 4.2 5.4 20.3 2.2 1.0 16.4 0.0 3.8 5.8 42.2 10.6 7.1 5.3 12.3 4.8 9.2 17.0 3.9 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151865-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 7597.2" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 2816.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 3000000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 726.2 60.9 34.4 270.7 32.9 2151.1 447.2 28.4 44.8 503.8 36.9 128.9 64.7 117.2 59.2 7597.2 266.9 332.2 120.5 25.1 153.6 67.6 55.2 474.6 68.5 56.5 36.2 21.0 110.3 62.4 28.4 98.8 564.1 32.9 166.7 104.2 6.5 1559.9 156.4 48.0 198.8 89.4 263.7 42.6 80.3 91.0 18.0 39.5 110.9 208.6 89.9 1498.3 390.1 1548.8 42.1 960.2 1485.7 65.8 68.4 905.8 855.6 4.2 1614.6 1008.5 656.3 441.9 43.5 841.0 2.2 520.1 1426.5 1441.9 1147.7 142.6 984.1 516.8 541.6 10.3 73.2 398.5 1.4 719.4 160.9 34.7 495.7 800.6 664.7 1294.6 604.0 947.8 85.4 309.3 39.5 822.6 4.3 287.0 87.7 82.6 379.7 597.6 0.9 369.1 3.2 1495.9 200.4 1.0 0.7 556.6 14.7 377.9 862.7 3.5 24.3 1176.2 761.8 478.9 1058.2 845.1 6.8 2.0 3.6 1757.9 147.8 1171.2 2816.9 1237.6 2227.6 744.1 328.7 757.0 13.7 662.7 664.5 1513.3 3.3 190.7 348.5 128.4 443.6 324.0 53.2 134.5 2021.5 34.4 32.9 28.4 44.8 25.1 153.6 56.5 36.2 21.0 32.9 42.6 39.5 42.1 447.4 583.3 415.2 1.6 39.0 846.7 2486.8 2417.6 1748.3 0.1 225.0 417.1 22.5 58.6 2214.7 62.5 0.0 1543.4 602.1 32.2 0.0 167.4 8.2 2037.4 241.6 362.2 5.3 81.2 3.7 23.1 1747.7 732.0 86.6 1993.5 2550.6 0.1 136.7 6.5 593.8 0.0 0.1 20.8 1330.6 545.0 1190.3 7.3 222.4 901.7 307.7 29.0 575.0 0.2 319.3 0.5 0.6 733.2 5.5 9.4 140.4 1552.2 0.1 5.7 1996.9 0.0 65.7 728.2 413.3 2.3 4.0 3632.9 597.7 7071.8 1348.3 3.0 12.6 4808.1 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87724051-87731469 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 568.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 128.1;non-classical monocyte: 195.2" "Lineage enriched" "Detected in many" 12 "monocytes: 195.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 2305.0;HSkMC: 1061.0" "Low region specificity" "Detected in all" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 17000000 "Golgi apparatus, Vesicles" "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favorable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 224.0 87.3 52.4 137.2 58.0 85.6 111.0 56.6 68.0 64.6 69.5 96.8 40.1 109.1 82.3 33.6 109.3 85.8 111.2 50.4 97.1 209.2 336.3 156.2 101.9 58.3 55.5 49.1 97.2 62.4 152.3 70.1 568.3 57.6 68.8 59.4 32.6 78.2 92.6 72.5 37.0 57.6 126.3 56.3 125.4 72.0 80.8 100.0 33.3 76.8 80.5 49.8 211.8 48.4 66.7 88.1 423.0 32.6 55.3 514.0 2305.0 198.4 267.2 781.8 232.2 300.6 43.0 86.3 0.0 128.9 355.4 754.0 67.5 49.8 86.0 198.4 1.9 37.8 18.1 111.2 105.1 352.6 0.1 51.4 1061.0 138.9 373.7 134.9 186.6 194.9 0.0 162.5 0.7 326.6 115.6 0.5 9.9 67.7 128.6 77.5 21.6 21.5 0.6 158.6 39.0 42.8 50.6 62.1 133.5 312.3 177.9 14.5 97.9 296.9 190.8 104.7 750.6 125.9 18.5 84.1 0.9 692.6 0.2 67.9 0.3 13.5 0.6 0.3 128.1 0.0 0.0 6.6 0.1 7.9 0.1 16.7 1.3 0.5 0.2 195.2 0.3 1.7 10.1 52.4 58.0 56.6 68.0 50.4 97.1 58.3 55.5 49.1 57.6 56.3 100.0 66.7 86.1 41.7 52.9 15.3 11.2 37.7 82.1 58.0 15.4 43.8 12.2 33.4 96.8 87.2 46.4 75.4 18.8 1081.6 0.3 16.3 27.4 91.8 5.3 48.1 119.9 110.0 11.5 251.2 18.6 93.4 1012.3 261.7 10.2 27.6 29.7 63.6 580.4 122.6 1105.7 13.5 24.0 8.5 20.3 206.9 105.4 17.4 156.9 537.2 64.0 14.0 16.2 79.5 0.0 17.6 31.7 67.2 5.6 187.3 1.9 34.5 8.0 138.3 67.3 45.4 92.1 176.9 136.3 207.4 60.5 6.8 34.0 1543.6 10.8 30.8 11.7 44.8 CEMIP2 TMEM2 ENSG00000135048 "Cell migration inducing hyaluronidase 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 93.3;placenta: 80.3" "Cell type enhanced" "Detected in some" "Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 143.4;BEWO: 117.4;OE19: 144.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017080, HPA044889" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA 150000 "Plasma membrane" "Vesicles, Cytosol" "HPA017080: , HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 25.3 5.4 9.9 25.1 7.0 30.0 11.1 10.6 8.7 5.2 13.3 24.4 27.5 7.3 2.7 6.7 5.6 41.8 5.7 19.2 6.8 10.5 60.7 35.3 23.3 4.7 5.3 6.0 2.2 19.5 93.3 4.6 80.3 5.9 7.0 28.3 17.5 11.2 8.0 4.8 6.1 23.9 11.8 3.8 16.0 33.5 6.9 7.3 18.8 9.5 8.7 20.9 32.3 3.5 7.5 22.5 85.0 143.4 6.6 13.7 22.9 117.4 81.7 48.7 51.6 40.5 24.3 31.3 0.4 20.0 18.8 11.6 35.2 38.6 9.9 73.2 2.5 11.2 38.9 20.9 68.7 23.9 0.4 9.8 28.0 11.4 38.9 8.1 14.0 68.2 3.3 4.7 10.2 28.8 15.1 4.1 0.6 28.2 144.3 8.6 3.3 39.9 2.4 31.6 60.4 6.3 0.6 19.3 12.5 20.5 45.2 8.8 1.3 30.3 33.7 38.3 17.4 39.3 1.8 37.8 0.9 6.1 3.9 43.7 0.1 1.3 3.1 1.4 1.1 0.3 0.4 1.5 1.3 0.5 3.0 2.1 1.0 2.3 0.3 1.0 0.1 2.3 0.9 9.9 7.0 10.6 8.7 19.2 6.8 4.7 5.3 6.0 5.9 3.8 7.3 7.5 105.8 0.0 0.0 0.0 47.6 0.0 0.0 0.0 0.0 0.0 58.7 46.7 0.0 0.0 0.0 14.7 0.0 47.9 378.1 0.0 0.0 20.2 0.0 42.1 24.2 14.7 0.0 0.0 0.0 36.2 14.4 4.3 0.0 137.3 0.0 3.8 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 30.8 0.0 0.0 155.1 0.0 0.0 11.6 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 89.8 86.1 3.1 0.0 0.0 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 60.7;brain: 65.4;retina: 46.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.7;Inhibitory neurons: 163.0;Oligodendrocytes: 463.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057208, HPA071094" Approved Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA057208: AB_2683370, HPA071094: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 8.5 5.5 32.8 9.6 39.5 60.7 6.2 23.8 33.6 4.7 0.1 5.2 3.7 4.9 3.9 5.4 4.6 5.3 12.3 20.5 25.0 7.0 4.6 14.5 9.5 30.4 31.6 13.0 3.6 6.7 7.6 5.4 6.2 42.6 4.8 5.9 46.9 4.2 3.0 16.6 6.3 5.2 6.6 32.6 14.9 5.6 14.3 34.6 12.5 5.8 20.7 8.5 5.8 4.4 65.4 5.1 9.6 27.9 11.1 5.6 6.0 10.6 7.4 6.4 7.4 8.4 5.2 8.6 31.3 6.2 7.7 13.2 2.9 13.0 9.4 6.9 33.6 11.8 5.3 11.5 9.3 11.8 24.5 6.2 5.8 10.8 7.0 23.5 4.8 11.9 15.9 6.7 24.5 3.3 8.0 19.3 14.5 19.3 18.1 6.8 17.3 10.2 9.8 12.8 5.4 33.5 23.7 8.4 9.1 15.4 26.1 3.5 7.8 12.0 4.8 8.5 30.4 8.9 16.7 14.8 14.3 10.1 23.5 9.8 37.4 14.4 12.7 9.0 8.4 8.8 2.3 4.4 7.0 15.6 1.7 3.7 7.0 21.2 6.8 6.7 2.5 5.1 9.6 32.8 39.5 23.8 33.6 20.5 25.0 30.4 31.6 13.0 42.6 32.6 34.6 65.4 22.3 64.1 12.8 46.0 14.3 7.9 2.6 2.9 8.0 38.0 4.7 4.8 48.3 0.0 13.8 3.7 102.2 4.1 41.8 4.3 7.9 5.7 52.5 29.3 8.6 12.0 7.7 16.8 176.7 4.0 4.3 6.9 9.2 22.0 27.1 9.2 8.2 3.7 8.1 35.3 163.0 5.6 6.1 35.4 24.1 53.9 1.8 42.8 3.6 61.8 46.6 16.7 47.4 82.9 463.5 5.1 1.2 2.6 26.2 3.8 3.2 9.8 14.7 59.1 13.1 9.3 10.4 46.6 29.2 9.2 10.7 2.9 26.3 6.4 4.7 2.3 GOLM1 "bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73" ENSG00000135052 "Golgi membrane protein 1" Q8NBJ4 9 86026146-86100173 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 399.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6" "Cancer enhanced" "Detected in all" "prostate cancer: 343.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 372.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010638, HPA011929, CAB015341" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 81000000 "Golgi apparatus" "CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" "unprognostic (1.10e-1)" "prognostic favorable (8.14e-5)" "unprognostic (1.97e-1)" "unprognostic (4.40e-3)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.89e-3)" "unprognostic (2.81e-1)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" "unprognostic (5.59e-3)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (2.87e-3)" "unprognostic (1.23e-1)" 18.3 161.1 74.9 34.1 78.2 6.7 39.9 68.5 85.2 70.6 91.0 197.5 237.3 40.5 15.9 13.7 38.4 132.2 11.3 70.6 88.2 75.4 19.1 14.9 9.8 72.3 73.8 68.0 37.2 41.9 37.9 36.6 17.4 68.3 144.4 165.4 25.7 174.8 10.6 9.5 15.0 61.9 28.6 78.5 42.0 399.7 17.6 89.8 45.8 68.8 4.8 5.6 38.6 15.0 79.2 146.0 139.5 102.4 116.7 129.3 74.3 108.0 64.8 46.6 99.9 80.5 69.4 282.9 2.7 62.6 126.2 96.6 109.4 63.7 64.1 71.9 5.0 101.2 45.3 89.1 3.4 76.8 67.3 34.9 113.4 34.2 94.1 34.0 124.9 172.9 21.2 28.7 4.2 57.3 68.4 8.3 49.6 161.9 188.9 99.6 42.9 116.9 21.8 166.0 61.2 115.1 72.0 88.2 189.0 73.8 66.1 106.7 68.1 110.5 25.9 72.6 79.3 78.3 372.3 37.4 0.9 112.2 29.8 57.8 1.9 3.6 0.4 3.5 2.6 0.4 0.6 0.2 0.5 0.4 0.6 0.4 0.7 4.2 0.7 4.2 1.5 0.1 1.8 74.9 78.2 68.5 85.2 70.6 88.2 72.3 73.8 68.0 68.3 78.5 89.8 79.2 13.8 9.6 15.3 30.3 1.7 2.3 10.8 11.3 4.6 20.1 41.4 21.1 4.9 80.1 80.9 35.0 8.4 8.4 10.7 362.8 25.4 168.4 339.0 78.0 49.8 20.5 73.1 11.2 47.0 222.2 35.0 30.4 245.6 56.8 1.3 65.9 8.6 11.1 11.8 67.3 43.2 95.5 325.5 5.0 2.6 391.6 18.3 6.6 23.2 6.5 6.9 16.9 12.3 82.0 19.3 282.9 265.2 13.2 3.2 72.6 71.8 16.0 78.6 6.7 0.0 13.5 19.5 10.3 38.7 2.9 1.0 6.4 5.2 60.7 245.6 29.1 FAM189A2 "C9orf61, X123" ENSG00000135063 "Family with sequence similarity 189 member A2" Q15884 9 69324567-69392558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.8;thyroid gland: 58.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 157.0;Astrocytes: 256.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;NTERA-2: 5.1;RPTEC TERT1: 1.8;RT4: 2.3;SK-MEL-30: 5.0;SuSa: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029411, HPA057207" Approved NA NA "HPA029411: AB_10602338, HPA057207: AB_2683369" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.16e-6)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.09e-1)" "unprognostic (2.71e-3)" "unprognostic (7.84e-2)" "unprognostic (1.07e-2)" "prognostic favorable (1.75e-5)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-1)" 4.8 4.8 12.0 0.4 13.1 0.0 13.8 16.0 12.3 26.2 7.4 5.4 1.2 6.8 1.7 5.2 6.9 1.7 12.2 11.4 16.6 3.2 0.2 22.5 0.6 18.6 13.7 7.8 24.8 7.4 6.0 7.6 1.5 15.5 11.2 1.1 4.5 6.3 3.4 48.8 11.9 4.1 5.0 14.4 0.4 13.8 1.3 19.6 5.6 58.6 9.1 0.9 7.9 4.6 14.3 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.7 0.7 0.0 0.0 0.6 1.6 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.1 0.3 0.0 0.0 0.1 0.0 1.8 2.3 0.0 0.0 0.0 0.0 5.0 1.9 0.1 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 13.1 16.0 12.3 11.4 16.6 18.6 13.7 7.8 15.5 14.4 19.6 14.3 12.1 157.0 23.3 256.3 0.4 3.3 4.9 1.9 7.4 2.1 18.4 39.6 14.6 0.0 26.9 1.8 0.0 1.2 0.4 1.5 0.0 0.9 0.1 19.9 2.8 8.0 0.0 0.0 0.7 0.6 0.1 1.7 11.7 33.0 0.0 2.0 2.2 0.0 0.3 0.0 3.9 0.4 0.0 0.3 1.3 0.0 0.0 0.4 19.6 20.6 0.0 35.1 0.0 7.1 2.1 3.5 1.2 0.0 0.2 3.7 0.2 0.2 2.3 1.0 0.0 3.8 3.8 0.1 0.6 1.9 2.4 0.3 1.0 0.7 0.7 1.8 PSAT1 PSA ENSG00000135069 "Phosphoserine aminotransferase 1" Q9Y617 9 78297125-78330093 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 176.5;liver: 270.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 15.1" "Lineage enriched" "Detected in many" 5 "T-cells: 15.1" "Cell line enhanced" "Detected in many" "hTCEpi: 1170.1;SK-MEL-30: 752.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014882, CAB040567, HPA042924" Enhanced Enhanced Cytosol NA NA 2400000 Cytosol "CAB014882: , CAB040567: , HPA042924: AB_2678223" "unprognostic (8.26e-3)" "unprognostic (4.69e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.62e-5)" "unprognostic (4.05e-3)" "unprognostic (1.41e-1)" "unprognostic (2.21e-3)" "unprognostic (1.86e-1)" "unprognostic (9.85e-2)" "unprognostic (2.25e-2)" "unprognostic (4.53e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.87e-3)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (1.71e-1)" 6.1 66.4 126.8 7.4 127.9 2.1 5.2 137.3 176.5 3.7 97.9 6.0 5.5 4.4 62.1 33.4 35.0 1.7 2.3 128.0 135.2 138.0 270.1 5.2 9.4 131.9 127.0 118.7 5.7 130.2 9.8 7.6 3.0 132.2 10.1 5.6 6.2 19.4 4.1 0.6 57.6 4.6 3.3 134.3 6.0 19.6 10.5 126.9 30.3 30.5 0.5 12.5 7.3 11.3 167.7 222.8 146.0 121.1 215.6 35.1 41.2 284.7 184.3 130.4 91.8 170.6 38.2 41.9 143.2 79.8 416.9 82.9 215.3 209.1 203.6 136.4 141.2 73.9 49.2 60.8 293.3 322.0 277.6 84.6 131.1 1170.1 122.0 322.9 22.6 85.0 548.3 53.8 358.2 77.1 83.2 95.8 44.3 278.2 415.1 158.4 46.5 78.6 173.4 126.6 50.9 54.9 127.0 51.1 87.7 752.3 75.9 42.0 344.1 19.9 23.2 73.5 85.9 151.5 242.0 242.7 0.8 268.9 215.6 112.1 0.0 0.0 0.0 5.2 0.0 5.9 3.1 5.0 7.0 0.3 1.3 8.1 7.5 0.3 0.0 0.1 0.0 15.1 3.3 126.8 127.9 137.3 176.5 128.0 135.2 131.9 127.0 118.7 132.2 134.3 126.9 167.7 0.4 0.0 0.0 70.2 11.0 41.9 8.8 18.9 115.5 0.9 1.8 3.9 0.6 1.5 4.7 11.0 0.0 32.0 2.2 2.0 62.6 11.5 1.7 77.7 10.3 3.7 3.6 29.9 7.3 48.4 13.7 4.2 6.6 145.9 0.0 0.5 3.6 161.7 5.3 5.0 6.0 4.8 18.3 4.4 2.9 3.8 5.0 3.4 19.6 5.6 3.8 26.7 0.0 48.2 78.8 22.7 0.1 1.9 29.1 16.0 0.3 304.1 3.8 1.1 0.0 33.5 14.3 1.6 3.7 35.5 50.7 9.3 8.6 68.2 4.2 11.8 ISCA1 "HBLD2, hIscA, ISA1, MGC4276" ENSG00000135070 "Iron-sulfur cluster assembly 1" Q9BUE6 9 86264546-86283102 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 994.9;Erythroid cells: 315.5;Late spermatids: 804.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA042789 Uncertain NA NA "HPA042789: AB_10797022" "unprognostic (1.14e-1)" "unprognostic (5.84e-2)" "unprognostic (2.53e-3)" "unprognostic (6.91e-2)" "unprognostic (2.08e-1)" "unprognostic (1.00e-3)" "unprognostic (2.13e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (2.66e-1)" "prognostic favorable (3.83e-4)" "unprognostic (4.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.09e-2)" "unprognostic (3.31e-1)" 38.6 48.4 46.8 16.8 50.5 76.3 33.9 53.0 54.5 25.3 46.3 27.3 28.9 29.5 23.6 20.1 29.4 26.1 62.9 48.8 52.9 60.6 46.3 22.6 17.5 50.6 51.5 47.7 35.0 28.0 55.2 33.1 35.7 51.3 26.7 26.4 43.6 21.5 31.8 92.6 19.9 24.9 28.8 46.5 19.7 25.1 46.4 51.2 22.3 39.7 106.6 15.8 27.4 19.3 56.7 43.2 30.5 43.6 59.5 83.7 36.9 53.8 45.3 31.9 44.9 26.0 23.7 23.5 28.9 30.5 37.1 33.7 38.2 42.7 35.0 32.5 66.3 29.5 48.2 34.0 44.1 39.4 42.9 25.0 41.7 54.9 30.1 28.8 38.3 36.0 42.4 25.3 54.2 38.9 43.7 48.6 23.5 85.4 62.5 64.4 32.3 57.9 39.6 63.8 41.4 62.7 46.0 39.1 63.0 54.4 41.4 21.5 24.6 29.3 25.7 31.0 45.1 59.7 41.8 87.3 20.5 51.4 29.5 32.1 45.8 14.8 29.5 19.5 12.7 23.1 18.0 23.1 20.2 10.6 14.8 25.1 24.3 24.3 19.7 13.9 17.5 28.8 21.7 46.8 50.5 53.0 54.5 48.8 52.9 50.6 51.5 47.7 51.3 46.5 51.2 56.7 61.3 28.9 15.0 14.7 71.2 60.9 78.0 41.2 38.7 52.9 51.7 57.1 44.0 55.8 19.0 29.5 20.9 75.4 107.0 41.7 140.8 67.0 994.9 93.0 40.1 43.6 53.8 315.5 29.0 43.8 90.0 48.8 31.1 54.2 16.5 45.5 44.3 88.3 45.7 67.3 28.1 36.4 46.8 34.7 42.0 804.2 56.5 56.6 55.2 10.3 37.0 58.6 34.0 18.6 22.7 62.2 38.0 48.9 62.7 81.7 64.1 121.4 44.4 49.4 32.9 47.2 56.9 84.3 65.6 41.1 52.6 114.0 85.0 75.9 41.2 56.9 ADAM19 MLTNB ENSG00000135074 "ADAM metallopeptidase domain 19" Q9H013 5 157395534-157575775 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 56.7;Cone photoreceptor cells: 62.6;Extravillous trophoblasts: 81.8;Langerhans cells: 49.3;monocytes: 83.5;Plasma cells: 53.8;Rod photoreceptor cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 128.3;eosinophil: 139.9;memory B-cell: 50.8;naive B-cell: 53.5;neutrophil: 70.5;plasmacytoid DC: 66.8" "Group enriched" "Detected in many" 5 "B-cells: 53.5;dendritic cells: 66.8;granulocytes: 139.9" "Cell line enhanced" "Detected in many" "HDLM-2: 109.7;U-251 MG: 206.5" "Low region specificity" "Detected in all" HPA055537 Approved Vesicles NA NA 17000 Vesicles "HPA055537: AB_2797253" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (4.64e-2)" "unprognostic (1.81e-3)" "unprognostic (2.63e-1)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (2.80e-1)" "unprognostic (1.42e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.90e-12)" "unprognostic (1.44e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-2)" 4.9 3.6 2.4 24.2 3.2 7.8 2.8 4.6 4.6 4.6 0.9 17.6 5.8 8.0 2.6 5.1 7.5 9.0 19.1 2.8 3.4 2.1 9.6 13.3 29.2 5.1 4.6 3.2 3.5 0.9 0.1 1.8 13.2 5.8 7.6 6.8 22.8 1.9 6.4 6.6 1.3 18.9 16.5 3.2 22.8 9.7 1.6 4.2 7.5 4.2 2.9 30.4 18.9 5.3 5.5 38.8 6.0 11.5 0.1 0.8 0.7 73.7 45.0 16.0 27.5 20.5 19.9 30.7 19.9 2.4 23.4 5.7 32.4 1.8 2.9 24.9 109.7 1.1 0.1 3.3 2.7 6.5 0.1 0.0 5.2 0.1 21.5 4.3 32.7 31.5 0.0 5.7 2.8 59.4 0.0 0.0 0.1 12.3 0.0 19.3 0.6 65.9 16.8 2.9 0.6 5.2 3.5 0.0 15.9 2.3 45.3 0.2 0.6 48.7 29.6 31.7 6.8 206.5 11.8 0.4 69.6 6.7 0.1 13.5 128.3 13.1 139.9 1.5 1.2 3.5 50.8 14.4 3.3 4.2 53.5 0.4 0.4 70.5 0.4 0.1 66.8 16.6 9.2 2.4 3.2 4.6 4.6 2.8 3.4 5.1 4.6 3.2 5.8 3.2 4.2 5.5 1.5 6.4 0.6 2.0 56.7 2.2 0.1 1.2 0.0 37.7 0.5 0.4 5.6 0.0 0.7 3.7 62.6 1.1 22.0 0.1 0.0 0.5 4.1 0.5 6.8 5.6 0.0 1.7 24.2 1.5 81.8 6.5 0.5 0.2 0.0 0.3 4.2 7.5 1.7 15.2 21.2 0.1 0.0 9.0 49.3 1.3 5.6 12.4 1.8 10.3 83.5 2.4 1.0 13.0 28.7 2.2 0.1 7.9 53.8 0.2 0.0 0.1 0.1 43.9 6.6 12.3 13.3 0.0 1.1 2.5 1.4 8.3 24.0 1.7 0.3 0.2 HAVCR2 "CD366, FLJ14428, Tim-3, TIM3, TIMD3" ENSG00000135077 "Hepatitis A virus cellular receptor 2" Q8TDQ0 5 157085832-157142869 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 32.4" "Cell type enhanced" "Detected in many" "dendritic cells: 87.6;granulocytes: 80.6;Hofbauer cells: 148.3;Kupffer cells: 89.1;Langerhans cells: 67.8;Macrophages: 83.2;monocytes: 49.5;NK-cells: 70.0;Proximal tubular cells: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 53.8;intermediate monocyte: 57.9;myeloid DC: 137.9;NK-cell: 97.1;non-classical monocyte: 36.1" "Group enriched" "Detected in all" 6 "dendritic cells: 137.9;monocytes: 57.9;NK-cells: 97.1" "Cell line enhanced" "Detected in some" "ASC diff: 7.8;Daudi: 6.4;HDLM-2: 26.3;HMC-1: 6.0;RPMI-8226: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB026003 Enhanced NA NA 9900000 "CAB026003: " "unprognostic (2.50e-2)" "unprognostic (1.11e-2)" "unprognostic (5.18e-2)" "unprognostic (2.04e-3)" "unprognostic (3.79e-2)" "unprognostic (1.14e-1)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (8.48e-2)" "unprognostic (5.13e-2)" "unprognostic (7.83e-2)" "unprognostic (1.89e-1)" "unprognostic (1.83e-2)" "unprognostic (2.13e-1)" "unprognostic (1.34e-1)" 14.4 8.3 9.4 19.9 10.8 14.1 5.3 11.8 13.4 5.0 11.9 5.5 4.0 3.2 6.1 3.7 3.3 12.9 2.5 9.2 19.1 27.1 9.9 22.8 32.4 17.0 11.8 7.9 1.7 3.1 2.8 1.8 17.0 16.3 2.1 6.9 1.2 2.9 2.9 1.7 2.2 5.0 7.9 18.3 24.3 4.7 2.0 15.7 9.2 1.6 2.1 14.1 13.3 1.2 22.2 0.0 0.2 0.1 0.2 7.8 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 6.4 0.3 0.0 0.2 0.1 0.0 0.0 0.0 26.3 0.0 1.1 0.1 0.0 0.0 0.0 6.0 0.4 0.4 0.0 0.2 0.0 0.0 0.7 0.1 2.3 0.0 0.1 0.1 3.9 0.2 0.0 0.0 0.1 3.0 21.5 0.3 0.0 0.2 0.1 0.0 0.1 0.2 0.5 0.2 0.3 0.0 0.9 0.3 0.3 0.0 0.3 1.8 0.2 0.1 0.7 0.1 16.7 53.8 0.1 14.6 57.9 3.0 1.2 5.9 7.9 137.9 0.5 7.0 9.5 2.5 97.1 36.1 16.4 11.5 43.1 9.4 10.8 11.8 13.4 9.2 19.1 17.0 11.8 7.9 16.3 18.3 15.7 22.2 1.2 6.4 6.5 2.0 5.9 1.0 0.2 0.1 0.0 0.9 0.7 1.5 1.1 0.0 1.9 0.0 0.0 0.6 87.6 0.3 7.9 0.1 11.1 0.1 0.1 3.7 0.0 1.3 2.1 0.0 0.8 0.9 0.5 0.1 80.6 0.1 1.1 0.5 148.3 0.0 1.7 0.3 0.0 89.1 67.8 7.8 0.3 83.2 3.6 31.9 49.5 0.1 70.0 1.0 4.8 0.1 0.1 0.0 16.3 0.5 0.1 57.7 0.0 0.2 6.6 0.7 0.5 0.3 0.4 0.1 1.3 1.1 26.3 1.5 0.2 0.3 CCNJL FLJ14166 ENSG00000135083 "Cyclin J like" Q8IV13 5 160249083-160345396 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 23.4;Intestinal goblet cells: 28.5;Paneth cells: 26.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 16.8" "Group enriched" "Detected in some" 17 "neutrophil: 12.7;NK-cell: 4.2" "Group enriched" "Detected in many" 85 "granulocytes: 12.7;NK-cells: 4.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 49.8;RT4: 28.0;WM-115: 38.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049970 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049970: AB_2680974" "unprognostic (1.09e-2)" "unprognostic (2.36e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.79e-1)" "unprognostic (4.31e-2)" "unprognostic (1.60e-4)" "unprognostic (1.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.75e-2)" "unprognostic (6.27e-3)" "unprognostic (6.63e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.10e-4)" "prognostic favorable (8.02e-4)" 0.8 3.9 1.1 1.7 1.1 1.4 1.3 16.8 3.2 2.6 1.2 6.4 1.4 0.7 0.6 1.0 1.3 0.7 4.7 4.7 2.5 2.6 0.8 7.9 0.4 1.8 2.5 0.8 5.5 0.2 0.1 3.9 0.9 6.3 1.4 5.8 1.5 4.9 1.3 0.2 0.5 3.4 0.8 1.2 7.5 7.2 12.3 2.0 2.6 4.2 2.6 1.1 3.4 1.5 1.3 3.9 20.8 16.4 0.2 0.0 0.0 0.0 0.0 0.3 1.9 0.8 7.9 16.8 0.0 13.2 0.2 13.9 5.9 2.3 49.8 1.3 0.0 0.3 6.0 7.3 6.8 0.2 0.0 0.2 0.0 4.2 2.7 11.9 9.9 12.7 5.8 0.1 0.0 5.3 2.7 0.0 12.1 11.5 0.0 7.8 3.4 4.6 1.7 12.6 28.0 4.7 10.5 2.9 3.7 17.1 6.2 9.9 1.1 14.9 2.6 13.8 0.0 9.8 0.0 0.0 0.0 0.0 0.0 38.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 4.2 0.0 0.0 0.0 0.2 1.1 1.1 16.8 3.2 4.7 2.5 1.8 2.5 0.8 6.3 1.2 2.0 1.3 0.6 22.4 23.4 9.4 0.0 0.3 1.8 3.8 0.0 0.7 1.0 2.3 4.8 0.0 6.8 3.7 0.0 0.0 4.5 4.4 5.9 2.7 1.0 0.5 1.4 2.6 2.4 0.0 0.7 0.2 0.0 1.2 1.1 1.4 1.3 11.5 2.2 0.2 0.1 0.0 9.3 28.5 8.2 0.3 0.3 3.6 2.1 2.1 5.4 2.8 0.6 8.3 14.4 1.5 0.7 1.7 26.8 2.6 0.5 1.3 4.3 0.2 1.5 0.1 0.0 0.7 1.9 0.5 10.0 0.4 0.4 0.0 2.2 11.2 4.6 2.4 TAOK3 "DPK, JIK, MAP3K18" ENSG00000135090 "TAO kinase 3" Q9H2K8 12 118149801-118372907 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 400.6;Rod photoreceptor cells: 323.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 123.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017160 Approved Uncertain Mitochondria NA NA 520000 Mitochondria "HPA017160: AB_1851994" "unprognostic (3.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-1)" "unprognostic (3.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "unprognostic (7.38e-2)" "unprognostic (2.76e-2)" "unprognostic (8.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.08e-2)" "unprognostic (4.14e-3)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" 14.2 18.4 35.4 25.2 36.2 42.3 17.3 37.4 40.1 12.8 30.7 24.1 27.4 16.9 12.8 18.3 10.6 19.6 18.7 34.5 35.1 16.3 18.6 23.4 34.1 35.3 34.6 30.9 19.5 11.8 15.6 18.9 14.4 34.6 29.2 24.8 48.7 15.3 16.1 22.1 20.5 29.0 17.8 35.2 26.3 25.4 10.8 38.9 31.9 21.3 13.1 33.2 20.8 13.4 44.5 25.7 17.2 12.7 11.1 30.6 37.0 14.5 26.2 29.8 14.9 19.3 8.9 38.5 77.4 8.4 34.9 21.5 22.5 11.2 23.5 23.3 28.3 9.2 91.7 9.0 11.7 35.6 95.2 123.5 25.3 27.7 46.9 68.4 31.3 48.3 45.5 54.3 9.0 27.8 18.2 50.0 62.0 4.7 11.7 9.2 29.1 17.2 8.3 14.1 43.8 2.3 12.5 24.1 10.9 33.6 5.5 22.0 70.0 75.9 25.5 4.5 24.2 22.6 8.7 8.9 60.6 35.8 64.1 35.2 122.3 39.4 91.5 60.9 53.8 58.1 47.9 46.0 53.4 52.4 44.9 40.3 52.9 86.2 86.9 95.4 48.8 46.6 46.0 35.4 36.2 37.4 40.1 34.5 35.1 35.3 34.6 30.9 34.6 35.2 38.9 44.5 43.2 35.3 98.9 203.4 110.7 35.2 46.7 30.4 38.1 69.9 52.3 39.6 57.6 52.9 36.7 46.0 212.7 36.1 138.5 116.3 70.5 40.3 18.6 17.5 30.6 36.2 25.1 65.2 117.0 59.1 93.5 37.8 75.4 39.2 167.6 31.6 29.6 57.7 78.5 40.4 156.2 80.7 22.4 104.3 103.0 10.3 38.8 160.5 35.6 133.0 156.9 48.4 217.3 400.6 202.2 91.0 111.7 47.8 84.9 44.4 105.2 37.4 20.7 323.8 46.0 29.9 55.2 101.4 53.3 48.3 31.4 43.8 103.5 66.4 69.3 53.7 USP30 "FLJ40511, MGC10702" ENSG00000135093 "Ubiquitin specific peptidase 30" Q70CQ3 12 109023089-109088023 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 52.7;Oligodendrocytes: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016952 Approved NA NA "HPA016952: AB_1858680" "unprognostic (2.34e-1)" "unprognostic (1.57e-2)" "unprognostic (7.04e-2)" "unprognostic (9.91e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (1.91e-1)" "unprognostic (3.60e-3)" "unprognostic (1.98e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (1.07e-1)" "prognostic favorable (5.23e-6)" "unprognostic (2.49e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-3)" 8.5 8.9 2.1 7.4 5.2 10.7 6.5 2.6 5.4 6.6 1.0 10.2 11.5 7.9 4.7 5.6 8.1 6.0 6.9 2.3 3.3 9.2 16.4 6.8 8.8 4.6 4.1 2.2 12.5 8.7 14.6 4.2 5.1 4.0 6.9 8.4 10.8 7.7 6.7 10.1 6.6 11.2 6.3 2.6 8.0 6.5 13.9 3.8 6.3 8.3 8.7 4.5 4.3 3.3 13.2 5.3 4.1 10.7 9.2 7.3 8.3 5.9 5.9 7.8 6.8 5.9 4.9 3.9 13.6 4.8 5.9 6.1 5.6 9.4 6.3 7.7 16.0 11.7 4.2 3.8 7.1 7.8 8.7 4.6 10.1 7.4 5.9 6.0 17.5 8.0 13.8 6.8 6.1 5.9 6.3 13.8 5.0 3.2 6.3 11.3 14.7 7.6 8.1 5.4 6.4 9.7 8.6 8.0 5.6 6.3 7.8 14.5 6.8 5.5 5.9 3.3 5.9 3.7 16.0 14.4 19.3 6.5 5.0 6.9 14.0 8.4 16.2 17.5 14.0 20.2 17.3 14.7 16.8 5.6 17.0 15.2 14.1 5.1 23.3 11.7 15.2 14.4 7.4 2.1 5.2 2.6 5.4 2.3 3.3 4.6 4.1 2.2 4.0 2.6 3.8 13.2 3.9 0.0 4.6 10.7 2.5 2.0 2.2 4.1 6.2 9.1 4.8 4.1 8.6 10.0 5.6 5.5 8.4 5.7 3.4 14.3 0.0 4.7 27.3 3.6 3.8 3.6 6.7 5.7 18.8 5.7 4.2 4.4 1.5 3.2 0.0 11.8 4.2 18.3 5.7 6.7 22.7 8.4 0.0 3.5 1.4 52.7 3.7 2.2 1.8 7.5 3.5 6.9 4.1 16.6 41.8 5.3 5.6 3.8 6.7 1.9 13.3 7.3 5.2 14.9 13.1 5.2 3.5 26.1 5.6 4.7 3.3 7.3 3.4 5.0 9.9 2.7 SDS SDH ENSG00000135094 "Serine dehydratase" P20132 12 113392445-113426301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Gluconeogenesis Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 34 "liver: 1033.1" "Cell type enhanced" "Detected in some" "Hepatocytes: 364.6;Hofbauer cells: 199.4;Langerhans cells: 111.9;Macrophages: 93.7;monocytes: 97.6" "Cancer enriched" "Detected in all" 31 "liver cancer: 165.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "myeloid DC: 11.6" "Lineage enriched" "Detected in single" 15 "dendritic cells: 11.6" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;SK-BR-3: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039230 Uncertain Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA039230: AB_10674281" "unprognostic (1.31e-1)" "prognostic favorable (5.24e-4)" "unprognostic (6.37e-3)" "unprognostic (6.94e-2)" "unprognostic (9.19e-3)" "unprognostic (2.65e-2)" "unprognostic (2.35e-2)" "unprognostic (8.85e-2)" "unprognostic (1.79e-1)" "unprognostic (2.55e-1)" "unprognostic (4.89e-2)" "unprognostic (3.20e-1)" "unprognostic (4.08e-3)" "unprognostic (2.12e-1)" "unprognostic (2.07e-2)" "unprognostic (4.35e-1)" "unprognostic (2.99e-2)" 3.2 10.1 13.5 4.3 17.5 1.5 1.9 13.4 15.2 1.1 8.7 2.6 2.0 0.9 0.3 0.3 0.6 4.2 0.8 13.4 16.4 0.5 1033.1 6.3 0.8 30.4 17.9 10.2 0.5 1.0 0.8 1.1 2.9 16.7 1.1 2.3 3.1 2.7 0.1 0.8 0.2 2.0 0.5 10.4 1.7 2.9 0.5 19.3 0.4 1.0 0.0 0.3 3.8 0.3 12.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 1.0 0.2 0.0 0.3 0.5 0.2 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.2 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.5 0.1 0.1 1.1 0.0 0.4 13.5 17.5 13.4 15.2 13.4 16.4 30.4 17.9 10.2 16.7 10.4 19.3 12.9 0.2 0.0 0.6 15.0 5.1 2.4 0.4 0.0 0.0 0.2 0.4 1.5 0.5 17.2 0.0 0.0 0.0 0.8 0.3 0.1 0.0 2.8 0.0 0.1 0.2 1.3 0.0 29.5 0.1 0.4 1.3 0.6 0.0 0.1 0.0 0.1 18.9 364.6 199.4 0.0 0.1 0.0 0.0 45.1 111.9 0.0 0.0 93.7 1.8 0.0 97.6 1.9 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.0 0.3 0.6 0.0 0.0 0.4 3.1 2.5 2.4 0.8 0.0 0.1 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369164 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 105.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2;Early spermatids: 55.4;Late spermatids: 58.2;Muller glia cells: 82.4;Rod photoreceptor cells: 109.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 119.7;HAP1: 55.3;NTERA-2: 62.6;SCLC-21H: 88.4;SH-SY5Y: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favorable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.4 5.1 11.0 0.3 9.4 0.1 0.8 8.6 11.7 2.9 14.6 1.2 6.2 3.6 1.1 1.0 2.6 0.9 3.1 10.6 17.3 0.8 0.6 0.5 0.3 12.3 12.6 6.9 1.9 5.1 1.5 13.8 0.9 8.5 4.1 1.0 105.2 0.7 1.7 22.7 0.6 4.2 1.4 9.9 0.3 4.4 16.3 9.8 0.0 0.8 0.1 0.0 0.5 1.1 7.8 0.1 1.4 119.7 30.5 0.0 0.0 15.2 0.1 0.0 0.8 1.3 21.7 0.6 0.1 1.7 0.0 0.7 0.4 55.3 0.0 0.4 0.6 12.6 0.1 0.5 2.6 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 16.2 0.2 0.3 62.6 0.6 0.7 0.3 0.0 0.5 0.0 0.1 88.4 42.9 0.1 1.0 1.0 11.4 18.5 0.1 0.1 0.5 15.9 0.2 0.1 1.6 0.5 0.2 0.3 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 9.4 8.6 11.7 10.6 17.3 12.3 12.6 6.9 8.5 9.9 9.8 7.8 0.1 0.0 0.0 23.8 0.0 1.0 1.4 0.0 1.8 18.4 4.8 2.8 3.3 0.0 0.0 0.0 54.2 0.2 0.0 1.1 1.9 1.2 55.4 3.8 2.1 1.3 10.1 0.0 1.1 5.2 0.6 2.0 0.0 3.5 0.0 1.2 0.0 0.0 0.1 3.3 2.5 3.5 0.0 0.0 0.4 58.2 0.3 0.1 0.0 1.9 0.6 82.4 0.0 9.5 0.5 1.2 12.0 0.4 0.0 8.3 1.2 0.0 0.0 109.9 13.1 4.6 3.2 7.6 3.1 0.1 0.0 0.4 0.1 0.1 8.6 0.6 HNF1A "HNF1, LFB1, MODY3, TCF1" ENSG00000135100 "HNF1 homeobox A" 12 120978543-121002512 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 15.5;kidney: 16.2;liver: 35.0;pancreas: 9.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8" "Group enriched" "Detected in many" 4 "colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010430, HPA035231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB010430: AB_2116746, HPA035231: AB_2674528" "unprognostic (5.92e-3)" "unprognostic (8.47e-2)" "unprognostic (4.12e-3)" "unprognostic (6.18e-3)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (9.18e-2)" "unprognostic (9.18e-2)" "unprognostic (2.99e-1)" "unprognostic (2.01e-1)" "unprognostic (9.77e-3)" "unprognostic (5.21e-2)" "unprognostic (6.25e-3)" "unprognostic (5.55e-2)" "unprognostic (2.48e-1)" "unprognostic (6.93e-3)" 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 4.3 15.5 0.2 0.0 0.1 1.1 0.8 0.0 0.1 0.1 16.2 35.0 0.0 0.0 0.1 0.1 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.2 14.4 0.1 0.0 0.0 4.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 29.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.6 0.2 0.0 1.2 4.3 0.0 1.8 0.0 0.1 0.4 14.5 0.0 2.6 0.0 1.3 0.2 0.3 4.8 0.0 0.2 5.3 0.1 0.2 4.6 0.5 0.0 0.1 0.4 15.8 0.1 0.0 0.2 9.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.7 0.5 0.0 0.5 0.0 3.9 14.8 0.0 0.1 0.5 33.4 16.0 0.0 0.3 0.0 0.8 0.3 0.1 0.3 0.0 0.3 0.0 0.5 0.0 10.8 0.4 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141991-117190471 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 130.1" "Cell type enhanced" "Detected in all" "Peritubular cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 12.3 41.2 20.8 10.8 23.9 8.6 17.6 23.1 25.0 18.6 23.6 14.3 16.7 25.2 111.7 15.6 130.1 17.2 31.4 28.0 26.8 54.2 27.8 17.6 13.8 20.6 20.0 22.6 60.8 31.0 25.0 20.4 19.7 18.5 26.7 14.7 24.5 16.6 29.6 24.0 17.0 14.4 19.7 21.3 15.3 18.9 42.6 27.3 13.8 28.6 28.7 14.2 16.4 13.9 23.5 20.3 47.3 29.2 16.2 23.5 24.4 33.4 26.6 28.6 24.3 19.7 30.8 14.0 26.5 25.7 27.3 18.2 27.0 34.7 26.6 29.1 15.0 31.2 1.3 24.9 25.0 21.3 8.7 9.0 24.1 25.1 19.5 31.0 39.7 34.4 23.0 10.7 8.6 21.2 33.0 25.0 6.3 43.7 30.9 30.6 29.3 42.5 27.8 24.4 47.7 57.6 34.9 66.4 17.3 14.5 23.3 40.6 3.5 26.8 16.1 20.7 19.1 17.4 15.0 16.6 34.4 23.5 13.5 23.1 1.2 7.0 4.5 11.6 12.2 12.1 10.4 12.0 12.1 9.7 14.3 13.6 12.6 0.6 11.4 12.7 6.6 13.6 8.8 20.8 23.9 23.1 25.0 28.0 26.8 20.6 20.0 22.6 18.5 21.3 27.3 23.5 28.5 32.1 35.4 44.1 44.0 37.2 49.1 29.5 40.5 44.3 32.3 26.7 65.4 42.9 39.6 51.5 41.7 58.3 26.3 16.4 45.0 62.5 37.2 108.6 38.3 46.2 39.0 12.0 50.7 50.5 38.0 44.3 24.5 113.1 3.8 57.0 60.0 38.9 15.6 74.0 51.4 23.7 54.9 22.3 17.2 60.4 99.7 17.3 23.2 23.4 18.4 54.1 16.5 41.7 67.5 36.9 16.4 222.3 23.4 48.8 19.0 95.4 29.9 34.1 105.2 35.3 40.6 21.6 43.9 33.9 45.3 65.5 34.1 44.2 27.2 38.3 TBX3 "TBX3-ISO, UMS, XHL" ENSG00000135111 "T-box transcription factor 3" O15119 12 114670255-114684175 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 179.9" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 613.9" "Cancer enhanced" "Detected in all" "prostate cancer: 49.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 103.0;BJ hTERT+: 97.3;RT4: 129.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005799, HPA075876" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005799: AB_1857817, HPA075876: " "unprognostic (3.27e-1)" "unprognostic (2.64e-1)" "unprognostic (2.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.40e-2)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-3)" "unprognostic (1.09e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "prognostic favorable (3.28e-4)" 13.0 179.9 6.0 2.5 4.3 0.0 34.4 3.8 5.8 35.8 3.3 7.3 37.9 33.1 45.0 2.9 24.2 4.6 10.3 3.8 18.8 9.5 31.5 33.1 1.4 4.5 4.4 2.7 44.6 2.9 1.0 13.0 41.6 5.1 81.1 3.8 1.9 19.1 53.7 10.5 14.7 30.5 10.1 3.6 7.1 6.1 1.3 6.0 1.3 50.5 16.7 1.8 54.4 34.5 4.5 2.4 18.2 0.0 0.0 26.1 35.6 40.1 103.0 97.3 39.0 38.3 16.3 4.4 0.0 1.6 18.0 2.4 4.7 8.4 3.6 47.7 0.0 12.3 0.0 4.8 48.1 8.4 0.0 0.0 16.0 2.4 13.1 26.8 0.0 0.5 0.0 3.8 0.0 3.4 1.6 0.0 0.5 0.2 53.0 5.4 0.0 0.0 2.6 0.0 129.3 6.6 19.4 14.6 6.6 3.6 44.6 5.1 0.2 0.0 11.9 7.7 6.8 33.9 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 4.3 3.8 5.8 3.8 18.8 4.5 4.4 2.7 5.1 3.6 6.0 4.5 48.9 0.0 1.9 0.3 1.8 9.8 85.2 5.8 7.4 14.3 110.3 80.5 12.5 0.0 1.1 35.0 4.2 60.7 0.7 12.0 0.0 0.6 1.5 3.3 144.7 38.6 4.9 0.0 0.0 0.0 7.0 41.3 5.1 3.8 0.0 3.9 1.1 40.2 6.1 1.7 0.0 23.9 4.1 0.9 4.6 2.8 5.3 2.9 3.6 14.0 0.0 1.9 0.0 0.0 0.0 0.3 22.4 6.0 0.0 72.4 37.9 0.1 0.4 2.0 39.5 27.2 58.2 0.1 3.8 3.2 9.8 613.9 2.0 112.0 12.1 69.1 OASL "OASL1, p59OASL, TRIP14" ENSG00000135114 "2'-5'-oligoadenylate synthetase like" Q15646 12 121017763-121039242 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.0;stomach 1: 22.5" "Cell type enhanced" "Detected in many" "dendritic cells: 54.1;Distal enterocytes: 82.3;Gastric mucus-secreting cells: 97.9;Paneth cells: 71.4;T-cells: 43.9;Urothelial cells: 96.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 132.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 126.9;BJ hTERT+ SV40 Large T+ RasG12V: 66.2;GAMG: 35.3;hTEC/SVTERT24-B: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA001474 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001474: AB_1079518" "unprognostic (2.39e-2)" "unprognostic (7.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (1.62e-2)" "unprognostic (6.22e-2)" "unprognostic (5.93e-3)" "prognostic unfavorable (9.20e-4)" "unprognostic (4.61e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (3.17e-2)" 2.3 0.8 0.7 4.2 0.9 36.0 2.4 0.6 0.8 1.7 0.7 7.6 2.7 0.5 0.5 4.0 0.7 3.7 0.9 0.5 0.6 2.3 11.9 12.0 3.7 1.1 0.6 0.4 0.4 0.7 0.1 0.6 1.5 1.4 0.5 3.4 0.2 4.2 0.4 0.4 0.9 2.0 1.3 0.6 5.3 22.5 2.1 0.9 3.3 1.1 0.6 1.7 7.9 1.4 3.1 2.6 0.6 0.2 0.9 1.0 1.6 0.1 0.2 0.9 126.9 66.2 0.3 13.0 0.6 4.0 0.1 35.3 6.4 0.1 0.9 7.2 25.2 0.1 0.1 13.8 0.0 0.7 0.2 1.8 0.8 0.6 50.7 0.1 0.3 0.3 1.0 0.1 5.3 1.1 1.7 0.1 3.1 0.1 4.5 3.7 0.1 0.2 1.4 0.1 13.7 0.1 0.2 1.1 0.6 18.5 0.1 0.4 1.7 0.1 0.7 1.2 2.1 0.2 4.9 10.1 0.3 19.9 1.3 0.4 12.3 29.6 65.8 53.1 32.5 14.3 2.5 36.2 62.1 8.9 0.8 9.9 38.5 132.8 20.3 23.5 0.5 27.8 33.2 0.7 0.9 0.6 0.8 0.5 0.6 1.1 0.6 0.4 1.4 0.6 0.9 3.1 28.6 0.0 4.2 0.7 4.6 2.2 5.0 2.7 1.8 0.0 3.3 4.7 0.6 1.5 3.9 0.0 0.0 0.2 54.1 82.3 0.0 2.5 6.6 2.0 0.6 4.5 1.8 0.8 0.2 3.8 1.3 2.4 97.9 2.8 11.4 1.0 2.2 4.5 12.6 0.0 0.2 30.7 4.1 3.1 7.2 3.4 0.3 16.7 0.0 1.0 6.0 0.0 9.2 0.0 0.0 12.7 71.4 0.0 14.3 2.2 2.4 0.3 3.8 0.0 0.0 0.7 2.8 2.4 0.1 14.6 1.0 0.1 43.9 0.2 5.1 96.3 HRK DP5 ENSG00000135116 "Harakiri, BCL2 interacting protein" O00198 12 116856144-116881441 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;thyroid gland: 3.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 14.6;Early spermatids: 11.3;Endometrial ciliated cells: 10.3;Enteroendocrine cells: 11.3;Excitatory neurons: 9.5;Paneth cells: 10.1" "Cancer enhanced" "Detected in many" "melanoma: 2.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 30 "eosinophil: 1.3;memory B-cell: 3.6;naive B-cell: 3.9" "Group enriched" "Detected in many" 27 "B-cells: 3.9;granulocytes: 1.3" "Cell line enhanced" "Detected in some" "Daudi: 11.1;SCLC-21H: 9.1;SH-SY5Y: 7.8;SK-MEL-30: 22.0;U-698: 37.0" "Low region specificity" "Detected in all" CAB025973 Uncertain NA NA "CAB025973: " "unprognostic (9.38e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-3)" "unprognostic (2.54e-1)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.67e-2)" "unprognostic (1.10e-1)" "unprognostic (8.44e-3)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (7.24e-3)" "unprognostic (5.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.66e-1)" "unprognostic (9.42e-2)" 0.1 0.7 4.6 0.4 6.3 0.7 0.1 0.7 7.8 0.0 3.8 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.1 14.8 2.9 0.1 0.0 0.1 0.8 2.3 2.1 4.0 0.0 0.0 0.0 2.8 0.0 1.7 0.0 0.1 0.3 0.2 0.0 0.5 0.2 0.1 0.0 1.5 0.2 0.0 0.5 3.9 3.5 3.9 0.0 0.7 0.0 0.0 3.5 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.4 0.0 0.2 4.5 2.4 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 0.0 2.1 0.1 0.0 0.0 0.1 0.5 0.0 1.0 0.0 0.1 1.0 0.0 1.5 0.1 0.0 9.1 7.8 0.5 0.0 22.0 0.4 0.6 0.2 0.0 0.0 1.8 0.2 0.0 1.0 0.5 37.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 6.3 0.7 7.8 14.8 2.9 2.3 2.1 4.0 1.7 1.5 3.9 3.5 1.1 0.0 0.0 0.0 7.0 0.1 0.1 0.1 0.0 4.5 3.2 3.0 2.4 0.0 0.8 0.0 14.6 0.1 0.1 2.2 0.0 0.1 11.3 10.3 0.1 1.4 11.3 0.0 9.5 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.4 4.5 0.0 0.2 3.6 5.6 0.6 0.2 0.0 6.6 0.3 0.0 10.1 0.0 1.1 0.3 0.0 0.2 6.6 0.6 0.0 0.1 0.7 0.4 3.0 0.7 0.0 0.1 0.3 0.0 1.0 0.1 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.3;pituitary gland: 5.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.9;Early spermatids: 49.3;Excitatory neurons: 22.7;Inhibitory neurons: 28.7;Late spermatids: 56.4;Oligodendrocyte precursor cells: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/84: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA064161: AB_2685202" "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 0.4 1.0 8.6 0.6 10.2 1.1 0.2 6.0 14.3 0.2 2.8 0.3 0.5 0.2 0.8 0.4 0.3 0.4 0.3 11.1 9.2 0.6 0.1 0.3 1.1 11.5 8.7 10.7 0.4 0.2 0.4 5.1 1.0 12.8 0.2 0.3 5.0 0.6 0.2 0.6 0.6 0.5 0.2 4.3 0.8 0.3 3.7 8.9 1.4 0.5 0.1 1.3 0.2 0.1 12.2 1.3 7.3 2.9 9.8 0.1 0.1 6.8 0.5 0.5 1.6 1.2 3.3 1.2 6.5 1.9 0.1 2.2 1.3 7.8 0.6 0.9 7.0 4.6 1.1 5.5 2.4 1.1 0.5 4.9 0.2 0.1 3.6 0.8 0.9 0.3 4.4 8.0 2.1 0.1 4.0 7.6 1.1 4.5 1.9 1.3 4.1 1.5 3.4 2.0 1.2 5.0 4.8 1.8 0.8 1.9 2.6 5.0 1.7 0.4 1.0 4.5 2.2 2.5 3.6 14.9 8.5 4.0 0.5 0.6 1.1 0.2 0.2 0.3 0.1 0.1 0.7 0.3 0.3 0.1 0.8 0.6 0.7 0.7 0.5 0.3 0.7 0.2 0.2 8.6 10.2 6.0 14.3 11.1 9.2 11.5 8.7 10.7 12.8 4.3 8.9 12.2 0.9 0.0 0.5 11.8 2.2 0.0 0.3 0.2 0.0 17.9 0.7 0.3 1.2 1.5 0.2 7.3 16.7 3.1 0.3 0.5 0.0 0.9 49.3 0.7 0.3 1.9 4.2 0.4 22.7 0.2 3.0 0.6 1.1 0.6 0.0 3.8 0.4 0.2 2.2 10.1 28.7 0.8 2.0 1.9 0.8 56.4 0.6 0.7 1.8 3.7 1.0 5.5 0.0 18.6 7.0 0.6 0.1 1.5 2.0 0.2 0.6 1.0 1.4 10.3 0.0 0.7 0.9 3.8 5.2 0.2 0.0 1.6 0.5 1.1 0.8 0.2 P2RX4 P2X4 ENSG00000135124 "Purinergic receptor P2X 4" Q99571 12 121209861-121234106 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 135.3;Distal enterocytes: 133.7;Hofbauer cells: 129.5;Syncytiotrophoblasts: 155.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039494 Enhanced NA NA "HPA039494: AB_10969132" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" "unprognostic (5.43e-2)" "prognostic favorable (6.30e-10)" "unprognostic (2.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.06e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (7.71e-2)" "unprognostic (2.18e-1)" "unprognostic (1.81e-2)" "unprognostic (1.13e-1)" "unprognostic (6.06e-2)" "unprognostic (1.42e-2)" "unprognostic (4.76e-3)" 10.2 10.0 4.5 15.3 5.2 14.3 12.8 8.2 5.7 19.0 4.8 33.8 29.2 8.5 3.7 5.1 15.4 16.9 7.2 4.7 6.4 13.1 11.6 20.6 16.0 5.7 5.5 4.1 18.3 37.7 33.4 5.1 33.0 5.8 12.2 30.5 2.0 30.4 12.1 1.0 4.5 33.1 10.8 6.0 12.7 20.4 6.0 5.7 7.9 13.0 2.4 9.0 12.2 4.1 7.1 6.6 15.4 1.1 21.7 10.3 8.3 40.6 4.9 26.1 6.7 13.3 10.9 23.1 6.4 18.5 17.4 48.2 2.3 4.7 3.2 4.1 17.5 11.8 3.1 0.9 12.5 25.3 7.6 42.5 11.9 6.8 11.0 14.5 20.4 24.2 7.7 6.1 16.2 5.0 31.8 4.7 10.7 5.5 31.8 10.5 6.6 29.5 34.6 3.1 18.0 6.1 9.0 16.0 8.8 55.0 5.7 38.5 21.2 2.1 10.0 11.2 1.2 5.2 28.0 26.1 3.7 19.6 10.2 9.1 72.3 59.1 10.7 13.6 63.1 15.1 11.3 21.9 13.3 32.5 7.1 16.4 9.6 0.8 29.6 54.6 4.4 17.1 32.6 4.5 5.2 8.2 5.7 4.7 6.4 5.7 5.5 4.1 5.8 6.0 5.7 7.1 8.4 6.4 19.2 6.5 14.0 3.8 8.9 11.9 6.8 11.1 17.7 11.9 3.8 21.5 11.2 20.2 2.1 135.3 13.7 133.7 0.0 69.7 15.2 9.8 8.9 9.2 21.5 2.1 6.4 35.4 73.8 14.3 19.4 15.1 13.9 14.3 23.6 9.4 129.5 15.2 5.3 90.3 20.3 43.7 20.8 25.1 8.7 53.7 10.6 18.7 57.9 6.5 19.6 4.5 8.0 33.1 80.6 9.8 21.9 10.2 98.7 23.2 6.4 8.6 19.7 7.4 12.0 8.1 6.6 3.4 4.0 155.7 17.8 15.4 24.7 9.7 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 94.7;pituitary gland: 80.8;retina: 68.2" "Cell type enhanced" "Detected in some" "Collecting duct cells: 12.9;dendritic cells: 13.7;Distal tubular cells: 23.5;Plasma cells: 12.8;Proximal tubular cells: 27.3;T-cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 48.9;MCF7: 27.7;OE19: 25.2;SCLC-21H: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 11.5 2.8 7.6 10.9 9.2 3.0 2.9 5.5 13.5 4.2 0.1 3.3 4.1 0.7 37.8 36.1 4.3 4.2 1.7 8.2 8.4 94.7 5.7 6.1 24.0 6.1 3.8 9.7 1.1 7.7 2.5 80.8 1.1 6.9 4.9 3.2 68.2 8.4 1.0 0.5 59.0 7.4 0.6 1.2 7.2 21.1 41.1 6.0 18.4 24.6 0.0 15.7 3.1 21.6 7.4 3.5 10.6 0.6 0.0 0.9 0.0 12.6 0.0 0.0 0.0 0.0 9.5 5.9 16.8 4.4 0.0 9.1 7.9 1.3 1.6 0.0 1.2 1.7 0.1 4.7 18.3 0.0 2.1 17.1 0.0 48.9 0.0 0.6 0.0 0.0 14.1 0.5 2.1 0.0 27.7 12.3 0.2 21.1 25.2 5.0 1.3 0.9 4.5 6.2 8.4 30.8 2.2 3.6 9.7 2.6 5.1 22.4 8.3 0.0 0.1 2.9 0.0 0.2 4.2 17.1 6.5 0.6 2.4 1.7 0.3 0.0 0.0 1.2 0.0 0.4 0.1 1.2 1.0 0.0 0.1 0.9 0.7 0.0 0.0 0.3 0.0 0.2 0.2 7.6 9.2 5.5 13.5 8.2 8.4 6.1 3.8 9.7 6.9 1.2 6.0 7.4 0.6 0.0 1.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 2.8 2.2 0.0 0.0 1.3 12.9 0.0 1.0 13.7 0.0 23.5 1.1 0.0 3.1 1.0 0.1 0.0 0.0 0.0 3.5 0.6 2.7 0.0 7.7 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 12.8 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 17.6 0.7 0.0 0.0 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.9" "Group enriched" "Detected in many" 6 "Astrocytes: 48.3;Horizontal cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Daudi: 109.1;REH: 45.1;U-698: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: AB_2682769" "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 8.7 1.7 6.3 5.7 6.9 2.7 6.4 3.9 5.9 1.6 0.2 0.7 1.3 1.5 0.3 0.9 1.8 0.8 1.2 5.4 9.0 1.5 8.9 0.8 11.2 5.4 9.3 5.7 0.4 1.6 0.0 3.3 0.3 4.6 0.8 0.1 2.9 2.6 0.3 0.5 0.9 3.5 0.3 2.6 11.9 0.9 1.9 8.0 0.5 2.2 0.1 6.0 0.5 0.6 2.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 109.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.3 4.6 0.0 2.0 0.2 0.0 45.1 0.2 2.6 0.0 0.0 2.7 7.1 0.4 0.4 2.5 0.0 0.1 0.2 1.2 0.0 4.0 0.0 0.1 0.5 0.2 110.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 6.9 3.9 5.9 5.4 9.0 5.4 9.3 5.7 4.6 2.6 8.0 2.9 0.7 0.0 0.0 48.3 8.8 1.0 0.0 0.0 0.0 4.7 0.2 0.6 0.7 0.0 0.0 1.8 8.4 0.0 0.3 0.1 7.9 2.5 0.7 0.7 17.5 1.7 0.0 0.0 10.6 0.0 0.0 4.5 0.5 0.4 7.0 0.0 0.4 12.4 0.8 171.6 13.8 0.1 0.0 0.3 0.6 1.7 7.8 0.2 3.6 2.8 0.0 11.4 2.1 13.0 1.0 0.2 0.1 7.5 2.5 0.0 0.0 0.2 0.0 2.8 0.0 0.4 1.3 0.8 2.4 0.0 0.4 0.0 2.2 0.8 0.0 0.0 TRAFD1 FLN29 ENSG00000135148 "TRAF-type zinc finger domain containing 1" O14545 12 112125538-112153604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 117.6;Spermatocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039254, HPA039266" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039254: AB_10805358, HPA039266: AB_10795142" "unprognostic (7.80e-2)" "prognostic favorable (5.73e-4)" "unprognostic (6.12e-2)" "unprognostic (1.44e-1)" "unprognostic (9.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (1.07e-1)" "unprognostic (6.15e-2)" "unprognostic (3.33e-3)" "prognostic favorable (3.92e-5)" 16.7 14.7 17.1 30.7 22.4 30.4 20.5 22.0 19.3 19.4 24.6 33.2 16.8 16.9 15.7 32.2 15.5 17.8 22.5 16.2 20.4 14.4 13.6 26.5 37.5 23.4 21.4 16.1 18.8 11.9 15.8 11.7 19.2 23.6 22.1 20.8 18.9 19.1 20.0 13.0 35.8 20.5 26.1 22.0 31.6 17.3 29.3 21.6 32.9 13.9 11.5 40.7 30.1 21.9 32.0 23.8 26.2 41.8 40.8 28.8 27.3 22.1 27.2 38.8 36.5 29.4 29.5 21.9 27.4 22.6 28.9 15.7 49.0 42.0 26.3 24.2 47.3 40.1 44.4 37.7 16.3 50.0 27.1 67.7 34.4 43.5 27.1 35.7 37.2 32.6 16.6 50.1 16.9 23.6 41.2 31.5 39.0 35.4 27.8 31.8 43.8 25.6 46.8 24.3 89.5 36.4 27.3 57.4 55.7 15.1 30.8 35.8 38.7 22.1 17.2 12.2 17.1 14.3 40.3 36.2 29.3 18.5 21.6 19.1 323.7 96.1 226.1 45.1 86.8 30.1 56.7 43.1 40.3 50.1 60.2 39.4 36.6 188.2 70.8 93.1 33.5 63.7 101.2 17.1 22.4 22.0 19.3 16.2 20.4 23.4 21.4 16.1 23.6 22.0 21.6 32.0 10.7 19.2 13.1 6.8 12.4 12.2 7.4 18.5 30.7 7.0 14.7 11.8 10.9 5.7 18.9 12.9 25.0 20.1 8.5 15.4 5.9 21.3 1.7 9.0 14.3 11.3 15.6 9.0 8.4 20.8 15.6 15.1 15.3 7.5 12.0 10.0 7.9 5.7 14.8 15.2 12.2 10.3 30.5 11.9 9.9 3.7 11.8 14.0 7.2 7.5 117.6 9.9 19.6 10.6 28.6 25.8 15.5 12.8 8.7 22.7 13.0 6.3 10.2 10.9 0.0 5.6 8.8 75.6 36.0 22.0 15.2 26.4 14.0 10.0 9.4 14.4 DMTF1 "DMP1, DMTF, hDMP1, MRUL" ENSG00000135164 "Cyclin D binding myb like transcription factor 1" Q9Y222 7 87152409-87196337 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 176.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023846 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA023846: AB_1847779" "unprognostic (3.86e-2)" "unprognostic (1.88e-1)" "unprognostic (9.82e-2)" "unprognostic (8.54e-2)" "unprognostic (3.13e-1)" "unprognostic (2.26e-3)" "unprognostic (9.77e-3)" "unprognostic (2.53e-3)" "unprognostic (6.89e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (6.39e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-3)" 20.1 15.9 20.8 16.4 25.3 28.9 20.8 23.8 22.9 24.0 20.0 21.4 17.0 26.2 38.1 13.8 22.9 15.4 15.0 18.5 23.1 15.9 11.6 21.4 20.4 22.2 23.0 17.6 29.2 17.3 16.8 23.5 18.2 22.6 19.7 19.6 36.5 16.0 17.6 12.2 19.7 21.4 20.0 20.4 20.5 16.0 50.4 21.7 21.3 27.7 13.0 18.8 20.3 19.7 33.1 27.7 13.3 58.9 50.5 17.1 28.8 25.6 33.6 13.6 19.2 30.3 12.2 25.8 34.3 23.3 20.7 23.2 15.1 40.2 22.9 37.2 17.8 20.4 24.3 40.4 18.6 16.9 23.2 26.3 26.9 19.0 37.4 37.8 32.3 26.2 35.2 44.2 39.8 32.2 25.4 40.5 29.0 45.9 18.0 23.6 34.6 31.3 21.0 18.7 23.1 40.6 50.5 41.6 17.8 29.6 74.1 25.2 15.0 32.8 35.7 18.1 47.0 30.5 29.6 45.4 59.9 20.6 18.7 32.1 14.6 3.5 7.1 7.4 4.0 6.9 8.4 5.7 5.3 2.9 6.5 6.8 6.2 5.3 5.3 4.2 4.6 7.6 3.1 20.8 25.3 23.8 22.9 18.5 23.1 22.2 23.0 17.6 22.6 20.4 21.7 33.1 20.9 22.4 31.7 91.1 38.0 13.0 16.6 8.7 12.5 28.5 11.3 9.4 11.8 17.2 16.4 3.7 37.5 15.0 43.8 20.5 3.9 10.0 24.5 15.3 26.6 20.9 19.7 12.6 82.6 8.2 8.8 21.7 23.0 23.0 37.2 42.9 20.0 9.7 11.0 18.5 88.6 14.1 12.2 19.2 11.7 14.1 23.3 18.7 0.0 81.5 20.7 10.4 30.9 132.7 176.5 9.4 20.4 22.6 33.8 21.6 17.8 5.3 21.6 25.6 32.9 18.0 17.8 51.5 19.5 11.1 12.6 7.7 34.4 16.5 11.1 18.1 OCM2 ENSG00000135175 "Oncomodulin 2" P0CE71 7 97984684-97991169 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM243 "C7orf23, MGC4175, MM-TRAG" ENSG00000135185 "Transmembrane protein 243" Q9BU79 7 87196160-87220587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 192.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 150.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014918 Uncertain NA Yes "HPA014918: AB_2067447" "unprognostic (5.14e-3)" "unprognostic (7.27e-2)" "unprognostic (1.36e-1)" "unprognostic (3.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.50e-1)" "unprognostic (3.39e-2)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (4.58e-2)" "unprognostic (2.69e-1)" "unprognostic (6.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.32e-2)" "prognostic favorable (9.13e-4)" 27.9 16.5 18.7 31.3 17.5 28.7 27.0 17.9 22.5 31.1 22.3 18.8 25.1 22.1 39.0 18.3 28.2 22.8 15.1 19.1 24.8 36.0 8.7 53.1 68.7 17.7 17.4 16.4 35.7 35.3 20.5 22.6 32.8 17.6 25.1 17.5 5.8 32.3 24.4 5.2 20.7 39.2 16.2 19.1 44.6 27.6 11.0 19.6 27.7 70.4 8.2 80.9 23.2 27.3 18.8 35.7 21.1 20.7 25.8 48.5 54.0 49.7 28.5 42.9 20.9 38.2 29.7 42.1 76.1 61.1 28.7 37.9 33.4 19.8 28.6 27.7 32.5 52.7 1.2 38.5 63.2 38.0 27.7 5.7 36.0 28.3 16.1 32.2 40.0 31.6 39.3 3.6 39.8 28.7 58.7 34.9 4.5 23.4 4.1 28.9 68.0 62.0 105.1 61.0 27.3 22.7 20.4 21.2 43.4 33.0 35.7 16.2 4.9 17.0 35.2 30.9 90.2 25.1 56.1 52.2 150.0 32.2 25.3 21.0 53.3 34.8 23.9 45.3 38.3 65.6 181.9 81.6 57.4 61.5 170.8 135.6 95.5 15.7 67.7 25.6 129.4 79.7 38.8 18.7 17.5 17.9 22.5 19.1 24.8 17.7 17.4 16.4 17.6 19.1 19.6 18.8 45.0 25.6 109.4 6.5 192.9 42.7 44.0 55.7 31.9 6.1 40.0 42.4 1.0 34.3 32.9 22.0 39.6 111.8 102.2 8.1 52.8 26.2 139.6 41.6 21.3 41.6 7.3 13.9 14.8 42.5 43.8 44.7 21.9 18.9 2.5 25.6 32.9 3.4 48.9 11.8 13.9 23.5 14.2 66.5 62.4 23.0 83.0 45.6 51.6 22.5 43.7 8.8 50.4 6.6 6.1 24.3 24.5 59.0 144.9 51.4 34.6 70.0 34.6 12.2 46.0 24.6 19.8 16.8 43.2 23.6 38.1 33.5 85.1 29.3 39.7 43.7 CCDC146 "KIAA1505, MBO2" ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 34.3" "Cell type enhanced" "Detected in many" "Early spermatids: 308.3;Endometrial ciliated cells: 460.8;Oligodendrocyte precursor cells: 151.3;Respiratory ciliated cells: 417.9;Spermatocytes: 149.4" "Group enriched" "Detected in all" 4 "endometrial cancer: 8.8;ovarian cancer: 13.6;renal cancer: 15.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 14.3;neutrophil: 15.4" "Group enriched" "Detected in many" 4 "granulocytes: 15.4;NK-cells: 5.3;T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020082, HPA020105" Uncertain NA NA "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favorable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 2.2 1.1 11.0 2.5 4.0 1.7 2.4 4.1 2.6 4.1 15.8 3.4 2.5 4.6 2.5 3.6 34.3 3.2 1.8 2.2 7.3 4.2 1.8 5.3 3.0 10.4 9.1 1.0 3.3 2.5 4.0 3.9 1.9 7.3 3.7 2.8 14.6 4.2 2.3 1.1 9.5 2.8 3.0 11.4 3.7 3.4 21.7 5.4 3.1 7.7 1.6 2.7 3.1 3.9 6.8 0.6 0.9 2.7 1.4 1.7 1.7 0.3 0.7 0.6 0.7 1.1 0.0 4.6 1.4 0.1 0.2 2.6 0.9 0.4 0.8 1.1 1.9 0.3 1.8 1.5 0.8 0.5 1.8 1.3 0.8 1.3 1.2 0.2 2.2 0.6 1.4 0.0 1.4 0.1 0.2 1.5 2.9 0.3 0.6 0.6 4.0 0.4 0.2 2.8 0.5 2.0 1.3 1.0 0.9 0.6 0.8 0.8 0.6 0.9 1.0 0.4 1.4 0.4 2.7 4.5 1.2 2.3 2.7 2.3 0.9 0.6 14.3 4.4 0.9 3.0 1.2 1.9 3.1 0.8 0.2 1.2 2.0 15.4 5.3 0.4 2.0 1.6 0.8 11.0 4.0 4.1 2.6 2.2 7.3 10.4 9.1 1.0 7.3 11.4 5.4 6.8 6.9 3.2 9.7 34.0 3.6 7.1 2.6 16.9 6.2 8.6 2.7 4.6 32.0 2.8 56.9 5.5 62.6 1.2 9.3 2.8 21.5 3.2 308.3 460.8 11.1 4.8 1.8 0.4 49.0 1.6 0.7 15.4 6.1 106.0 6.3 6.1 23.6 0.8 1.6 5.0 48.8 1.4 24.4 3.5 7.1 52.4 12.2 4.5 5.4 50.6 2.0 12.1 20.6 151.3 62.8 1.7 5.2 6.4 3.7 5.8 2.9 30.1 417.9 55.1 6.6 15.6 11.6 149.4 10.8 5.5 3.4 2.5 8.6 7.2 4.0 5.4 TMEM60 "C7orf35, DC32" ENSG00000135211 "Transmembrane protein 60" Q9H2L4 7 77793728-77798434 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062625 Approved NA Yes "HPA062625: AB_2684811" "prognostic favorable (3.09e-4)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-3)" "unprognostic (3.91e-2)" "unprognostic (5.28e-3)" "unprognostic (2.73e-3)" "unprognostic (3.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (2.72e-2)" "unprognostic (9.44e-2)" "unprognostic (2.07e-3)" "unprognostic (4.43e-3)" 16.0 24.1 20.1 17.8 20.0 10.7 29.9 20.9 21.4 21.9 21.7 25.2 17.9 16.7 29.9 15.5 19.1 18.8 17.2 19.8 21.2 30.7 35.8 19.1 29.5 20.6 20.5 19.4 23.5 18.4 40.1 17.6 23.7 20.7 17.6 24.5 14.2 21.4 20.1 23.2 16.6 17.2 19.8 20.9 20.6 16.5 24.4 20.6 20.6 26.0 20.5 27.9 17.1 13.2 21.6 45.7 30.3 46.2 54.4 61.6 54.5 21.2 41.8 79.9 44.2 69.9 28.4 56.8 35.1 10.0 39.4 150.6 46.8 44.0 24.6 49.7 27.5 41.9 19.0 26.9 39.9 43.4 26.9 33.9 39.9 35.1 32.8 39.6 42.8 31.9 32.0 45.7 68.2 70.4 49.3 20.4 68.7 32.3 55.3 39.4 24.1 36.6 50.7 52.9 33.9 23.2 37.4 31.4 43.7 66.0 48.7 52.8 49.0 21.2 55.6 38.7 49.2 31.4 27.6 46.6 51.1 42.3 55.8 50.2 208.6 51.3 100.2 29.2 58.7 32.4 88.9 51.0 36.9 40.3 72.5 42.9 36.6 52.7 32.3 54.7 52.6 79.4 41.2 20.1 20.0 20.9 21.4 19.8 21.2 20.6 20.5 19.4 20.7 20.9 20.6 21.6 16.5 9.6 11.5 2.9 33.5 30.0 34.6 61.7 25.6 7.6 37.5 42.4 8.0 20.0 29.0 44.1 8.4 56.4 17.6 22.0 52.8 28.4 9.4 17.7 13.7 20.1 9.1 14.5 6.1 29.8 40.2 26.9 11.7 14.5 24.7 21.1 24.7 26.3 70.8 13.5 6.5 30.6 61.1 43.5 38.9 10.9 45.7 39.1 28.4 7.5 42.6 21.5 21.6 3.0 7.9 27.6 31.4 35.3 15.4 35.4 30.3 50.5 31.4 12.4 52.6 12.6 50.5 49.8 40.3 31.0 33.4 43.9 20.8 16.4 23.6 39.3 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1547.2" "Cell type enhanced" "Detected in many" "Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1" "Group enriched" "Detected in all" 46 "dendritic cells: 507.1;monocytes: 962.6" "Group enriched" "Detected in some" 4 "ASC diff: 322.6;HEL: 158.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 16.9" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 5300000 "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 1547.2 24.9 7.3 52.2 4.3 149.5 545.0 5.3 2.8 11.7 2.8 40.9 114.7 8.8 38.5 19.8 40.9 84.8 545.8 2.6 7.8 7.1 81.5 132.3 18.9 19.5 18.3 1.2 4.0 31.4 25.2 2.0 416.8 15.5 5.1 41.3 0.3 32.2 8.6 250.8 25.1 120.7 39.8 18.6 312.6 31.5 7.8 19.6 22.3 69.7 385.0 7.3 22.4 13.5 4.3 0.0 0.0 1.0 0.2 322.6 3.3 0.7 0.9 10.7 0.1 0.1 0.0 0.0 0.1 0.6 1.4 0.3 0.1 4.3 0.5 0.1 0.6 0.4 158.1 0.5 25.7 0.2 0.1 0.1 31.0 12.6 0.1 0.2 7.7 0.9 0.0 5.8 0.0 1.8 0.2 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.1 0.9 1.3 0.8 0.6 0.3 2.7 11.1 19.3 0.4 0.5 0.5 0.6 0.3 0.2 0.8 0.4 0.1 54.3 41.8 12.3 962.6 3.7 1.9 270.6 2.1 3.6 0.6 0.6 507.1 0.5 0.8 0.4 15.8 5.9 72.0 128.3 1.5 692.4 7.3 4.3 5.3 2.8 2.6 7.8 19.5 18.3 1.2 15.5 18.6 19.6 4.3 3219.2 6.4 63.1 0.0 7.9 7.4 0.2 3.0 0.6 0.2 189.9 24.8 623.1 4.3 9.8 7.3 0.0 10.1 55.0 0.0 0.0 0.2 11.7 5.0 5.9 303.3 0.0 419.5 6.3 0.0 11.1 69.6 1.1 38.4 15.2 0.6 406.2 9.0 1369.8 0.0 2.2 0.6 8.2 153.7 67.3 3.9 0.6 159.6 16.0 17.8 255.2 0.0 7.2 0.5 1.3 0.1 0.0 0.0 4.2 0.8 9.9 0.4 1.2 0.3 696.8 33.1 452.1 4.6 0.7 0.8 4.7 18.3 5.9 1.9 0.2 0.3 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951804 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 31.6;kidney: 20.4;liver: 13.4;pancreas: 16.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "Hep G2: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045108 Supported NA NA "HPA045108: AB_2679218" "prognostic favorable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favorable (6.07e-7)" "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 9.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 20.4 13.4 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 91.5 0.0 3.7 0.0 0.0 0.0 89.8 11.7 26.3 0.0 0.0 0.0 0.0 12.2 2.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 53.5 0.0 0.0 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 54.7 0.0 0.0 0.0 248.9 130.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 101.1 0.0 CSN2 CASB ENSG00000135222 "Casein beta" P05814 4 69955256-69961007 "Predicted secreted proteins" "Milk protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 94 "breast: 310.5" "Cell type enriched" "Detected in some" 97 "Breast glandular cells: 33136.9" "Cancer enriched" "Detected in single" 156 "breast cancer: 75.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041036 Supported "Secreted in female reproductive system" NA NA "HPA041036: AB_10793865" 0.0 0.0 0.0 0.0 0.0 0.0 310.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 113.1 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 33136.9 340.4 0.0 0.0 0.0 0.0 0.0 0.0 72.4 0.0 0.0 0.0 0.8 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 UGT2B28 ENSG00000135226 "UDP glucuronosyltransferase family 2 member B28" Q9BY64 4 69280475-69295050 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "breast: 200.4" "Cell type enriched" "Detected in single" 16 "Cholangiocytes: 10.0" "Cancer enriched" "Detected in single" 8 "breast cancer: 1.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Group enriched" "Detected in some" 10 "Daudi: 2.9;NB-4: 2.7" HPA045108 Uncertain "Intracellular and membrane" NA NA "HPA045108: AB_2679218" "unprognostic (1.81e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-3)" "unprognostic (1.51e-2)" "unprognostic (4.37e-5)" "unprognostic (9.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 200.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470417-108569666 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 28.0 47.8 26.0 18.0 26.3 83.7 20.4 24.0 29.9 19.6 23.7 14.3 11.9 18.1 17.9 21.3 11.7 21.6 25.5 25.6 30.6 30.3 34.9 17.6 18.2 25.9 25.4 23.9 14.8 14.0 28.7 16.6 26.8 26.8 18.1 15.3 24.6 12.0 17.9 36.2 15.1 10.8 21.1 26.5 17.8 15.7 15.6 25.1 18.8 24.5 35.0 22.2 29.4 12.8 28.6 28.6 12.8 22.1 19.7 47.7 32.7 32.4 26.6 47.2 21.6 35.8 12.4 16.0 15.9 33.1 26.4 43.4 10.6 37.9 17.1 32.6 24.2 10.1 11.0 19.3 9.1 34.8 7.6 21.7 29.8 31.7 29.2 26.9 23.4 29.5 17.7 13.0 44.5 27.2 18.9 18.0 18.3 9.8 17.9 17.8 6.5 23.3 34.3 25.9 35.9 18.3 25.3 25.8 27.4 32.7 27.7 11.6 12.6 24.2 35.1 15.7 52.8 15.0 37.4 41.5 23.9 33.4 11.4 23.2 21.9 29.8 26.2 14.6 32.8 17.8 28.6 14.2 14.6 29.2 27.3 15.4 14.7 24.5 22.9 43.4 11.6 19.1 22.9 26.0 26.3 24.0 29.9 25.6 30.6 25.9 25.4 23.9 26.8 26.5 25.1 28.6 64.5 41.7 49.3 66.3 91.3 92.9 124.0 42.2 55.2 64.0 45.7 35.9 49.7 8.6 51.2 23.9 18.8 58.0 72.7 44.3 93.9 32.0 52.3 124.9 67.3 57.1 57.1 50.7 42.4 37.8 37.5 76.6 45.3 236.1 71.7 19.0 23.2 44.3 32.2 32.0 42.9 27.8 67.1 45.5 90.0 47.4 32.0 113.8 55.2 23.4 43.5 42.9 18.6 38.2 41.3 29.6 38.6 39.5 76.8 80.1 16.7 41.0 62.0 32.5 19.7 88.9 63.9 18.6 23.1 60.5 135.7 130.2 69.1 43.7 22.9 122.7 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 165.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 170.8;Club cells: 140.2;Extravillous trophoblasts: 246.8;Ionocytes: 311.3;Syncytiotrophoblasts: 241.1" "Cancer enhanced" "Detected in all" "renal cancer: 72.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 67.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 116.1" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" NA NA "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavorable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 94.8 8.2 16.4 7.0 19.4 20.4 60.4 23.9 32.3 35.3 14.7 16.7 5.7 11.3 7.6 165.6 11.0 8.9 37.2 17.7 29.9 39.6 39.1 50.8 5.9 27.9 20.3 14.8 45.9 12.5 4.4 13.9 36.5 25.8 14.9 7.4 43.7 23.8 7.1 6.0 44.7 8.1 8.3 22.2 8.9 19.2 17.2 35.0 7.7 14.6 5.6 7.4 38.6 86.8 22.4 30.0 61.3 34.1 37.6 45.5 16.9 62.5 11.0 13.4 22.6 24.6 15.0 26.5 21.2 8.3 16.5 22.9 19.6 19.4 23.3 28.6 11.3 17.3 12.2 13.9 14.1 10.2 19.8 16.7 28.0 19.7 17.8 11.8 23.0 18.8 32.5 18.2 8.1 22.6 37.2 60.9 36.8 41.2 22.3 26.7 45.5 15.5 31.0 12.5 44.8 32.3 29.1 17.0 116.1 21.8 30.5 95.6 18.4 13.3 28.6 13.9 21.4 13.5 8.2 6.3 25.7 51.7 30.1 25.0 23.4 6.6 67.8 4.5 7.5 6.3 17.6 5.5 5.3 6.8 17.6 5.4 5.3 2.6 13.9 5.9 11.9 4.0 4.1 16.4 19.4 23.9 32.3 17.7 29.9 27.9 20.3 14.8 25.8 22.2 35.0 22.4 22.6 9.6 5.5 0.0 9.3 64.2 14.8 170.8 9.1 6.5 11.1 13.8 4.1 2.8 140.2 1.8 18.8 114.3 5.0 10.0 0.0 27.5 0.5 23.6 49.1 30.9 13.1 12.6 0.0 8.9 246.8 44.0 6.6 38.6 18.9 85.6 11.0 3.3 27.6 26.9 0.0 11.2 311.3 4.4 89.2 2.4 30.4 14.8 37.4 0.0 13.7 15.8 3.1 0.0 0.0 35.5 4.5 24.5 6.4 27.1 2.4 9.6 98.9 23.2 6.6 7.0 43.4 7.8 17.3 10.0 52.0 241.1 9.7 16.2 14.9 122.4 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "testis: 94.6" "Group enriched" "Detected in some" 93 "Early spermatids: 1122.8;Late spermatids: 2008.1" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "NTERA-2: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020636 Uncertain Cytosol No NA Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.4 0.9 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.1 0.0 0.7 0.9 0.7 0.0 0.1 0.0 0.5 0.0 0.6 0.2 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 94.6 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 1.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.4 0.9 0.7 0.6 0.7 0.9 0.7 0.6 0.4 0.5 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1122.8 0.2 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 2008.1 12.8 0.7 0.0 0.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 0.1 16.7 6.8 0.0 0.1 1.2 0.0 0.5 0.0 0.0 RINT1 "FLJ11785, RINT-1" ENSG00000135249 "RAD50 interactor 1" Q6NUQ1 7 105532169-105567677 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019875, HPA031646" Approved Approved "Golgi apparatus" Yes No "Golgi apparatus" "HPA019875: AB_1856283, HPA031646: AB_2673975" "unprognostic (1.58e-2)" "unprognostic (3.94e-2)" "unprognostic (9.00e-2)" "unprognostic (1.80e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-2)" "unprognostic (4.68e-3)" "unprognostic (1.33e-2)" "unprognostic (4.96e-3)" "unprognostic (2.41e-1)" "unprognostic (8.72e-2)" "unprognostic (5.35e-2)" "unprognostic (8.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (1.76e-1)" 7.4 6.1 2.6 9.1 2.7 15.3 10.1 6.6 3.4 8.3 4.6 8.2 9.5 8.7 7.3 11.5 8.0 6.7 8.3 2.7 3.0 9.4 10.6 6.7 13.6 2.8 2.7 2.5 8.1 11.7 9.7 5.4 8.8 3.5 7.9 9.3 10.4 11.4 6.2 16.9 8.7 7.1 6.5 2.4 8.9 9.8 11.2 2.6 10.0 8.8 13.4 13.8 8.5 5.8 3.8 28.8 23.5 12.1 27.8 18.8 24.9 15.9 27.2 19.2 26.4 29.6 27.4 18.4 31.6 31.3 24.1 29.4 19.0 22.5 21.0 34.7 17.0 25.9 18.3 26.1 18.5 14.5 38.9 17.8 17.9 16.4 28.1 16.3 20.3 29.1 16.3 39.5 23.2 30.3 46.9 29.3 28.6 26.1 23.8 23.1 17.5 20.5 45.4 14.2 23.6 20.5 22.4 28.9 47.7 20.6 20.9 19.4 12.5 20.3 30.2 24.0 83.1 34.8 46.6 59.7 61.4 20.0 31.8 34.6 4.4 3.9 4.4 6.7 5.8 11.6 9.0 9.8 9.2 6.0 7.8 8.6 9.4 0.7 9.1 4.8 4.0 10.5 6.2 2.6 2.7 6.6 3.4 2.7 3.0 2.8 2.7 2.5 3.5 2.4 2.6 3.8 6.7 3.2 9.8 10.4 12.4 6.6 9.6 7.7 8.6 5.8 5.9 5.3 10.5 1.5 9.4 3.7 8.4 11.2 13.4 6.0 9.8 8.1 10.8 9.0 6.4 6.8 5.4 4.6 25.6 6.3 10.3 9.4 12.2 5.5 10.1 7.5 4.2 5.1 7.3 6.7 26.0 5.8 10.2 5.6 3.4 6.2 8.7 5.2 5.4 9.4 5.7 7.8 7.2 9.0 18.2 6.7 4.0 9.8 17.9 6.5 5.5 6.8 18.1 8.9 6.6 8.3 8.0 29.2 12.4 8.3 7.7 12.0 10.8 7.5 6.4 8.3 SRPK2 SFRSK2 ENSG00000135250 "SRSF protein kinase 2" P78362 7 105110704-105399308 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.2" "Group enriched" "Detected in all" 4 "Early spermatids: 1275.7;Late spermatids: 2280.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 219.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 219.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015522, HPA020876" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015522: AB_1857479, HPA020876: AB_1857480" "unprognostic (9.75e-2)" "unprognostic (1.68e-2)" "unprognostic (1.12e-1)" "unprognostic (4.64e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (5.14e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" "unprognostic (2.31e-1)" "unprognostic (5.38e-2)" "unprognostic (7.95e-2)" "unprognostic (4.72e-2)" "unprognostic (2.87e-2)" "unprognostic (3.44e-1)" 14.4 16.3 27.2 15.1 31.0 10.8 18.5 20.4 46.0 16.4 1.1 13.4 11.5 18.2 15.9 16.6 14.8 16.1 14.8 30.9 27.4 14.0 14.3 12.9 18.0 30.4 28.3 28.0 17.4 14.8 15.2 13.0 17.3 33.8 18.9 15.0 24.4 15.3 14.5 11.4 24.6 11.5 18.4 23.1 18.0 16.4 109.2 30.1 41.7 15.7 11.9 20.7 18.4 11.7 48.7 36.9 24.0 37.3 74.5 39.3 43.8 21.0 35.4 40.8 34.5 39.9 18.9 30.5 23.4 43.7 45.8 38.5 21.6 38.3 37.3 43.7 40.5 33.2 33.1 21.8 16.5 45.1 31.8 47.1 30.6 67.5 29.2 54.6 33.0 59.8 54.4 33.0 92.2 38.5 69.3 118.3 23.9 31.1 20.8 25.9 37.9 41.3 51.1 49.5 56.1 54.8 37.8 40.1 59.0 37.7 49.1 22.1 21.8 39.7 62.9 45.9 60.8 33.4 100.6 106.6 56.5 24.8 32.3 48.1 50.3 30.2 103.3 41.4 21.0 24.8 45.0 31.1 31.6 27.3 44.0 29.3 33.6 219.5 38.7 25.1 23.6 38.6 25.2 27.2 31.0 20.4 46.0 30.9 27.4 30.4 28.3 28.0 33.8 23.1 30.1 48.7 35.8 28.9 29.5 128.9 62.9 212.9 60.6 68.1 49.5 76.9 45.2 40.0 23.3 28.6 41.5 23.9 50.1 52.4 87.1 16.6 27.4 52.9 1275.7 54.3 41.9 51.8 28.8 17.2 298.1 46.3 35.6 47.3 40.8 51.6 41.2 48.9 53.6 35.9 47.6 124.5 300.9 35.2 54.9 43.0 42.9 2280.6 76.7 39.2 58.7 168.6 57.0 73.7 103.0 172.4 399.8 36.4 24.4 95.9 54.8 100.7 15.7 25.9 54.2 67.6 46.0 40.3 59.1 198.8 66.0 36.7 103.3 64.4 58.2 61.4 26.1 67.9 KCP "CRIM2, FLJ33365, NET67" ENSG00000135253 "Kielin cysteine rich BMP regulator" Q6ZWJ8 7 128862042-128910719 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 9.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 53.3;Early spermatids: 23.1;Late spermatids: 28.7;Proximal enterocytes: 55.9" "Cancer enhanced" "Detected in many" "renal cancer: 5.5" "Group enriched" "Detected in some" 5 "cerebellum: 1.8;pons: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.3;HMC-1: 5.1;U-87 MG: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (6.12e-2)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (6.33e-3)" "unprognostic (2.14e-1)" "unprognostic (5.24e-3)" "unprognostic (2.01e-3)" "unprognostic (3.25e-3)" "unprognostic (9.59e-2)" "unprognostic (1.52e-1)" "unprognostic (2.20e-3)" "unprognostic (6.46e-2)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.84e-2)" "unprognostic (7.64e-3)" 1.1 0.1 0.0 0.2 0.0 0.0 0.3 1.8 0.0 0.6 0.0 0.1 0.4 0.0 0.0 1.6 0.5 1.0 0.1 0.0 0.0 9.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 1.1 0.3 0.0 0.0 0.4 2.2 0.1 0.2 1.0 0.0 0.0 0.2 0.6 0.2 0.3 0.0 0.5 0.2 0.0 0.2 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 9.3 0.2 1.3 0.0 0.1 0.6 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.8 0.1 0.0 5.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.3 0.0 0.9 12.8 3.4 0.3 1.9 0.0 0.9 0.0 1.2 3.0 0.6 0.9 0.8 0.0 3.7 53.3 2.1 0.2 0.9 2.1 0.0 0.3 23.1 2.1 1.3 0.8 2.4 0.0 0.4 0.2 4.1 2.0 3.1 2.9 2.5 0.2 2.2 0.3 1.0 3.3 2.6 5.3 0.0 1.3 0.0 28.7 1.2 3.1 0.0 0.0 0.1 0.4 2.1 0.0 0.2 4.3 1.9 0.4 1.9 0.3 55.9 6.4 0.0 1.3 0.0 7.3 1.7 6.3 3.7 2.1 0.0 1.4 2.2 0.5 9.2 4.1 TES "DKFZP586B2022, TESS-2, TESTIN" ENSG00000135269 "Testin LIM domain protein" Q9UGI8 7 116210506-116258783 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 199.0" "Cell type enhanced" "Detected in many" "Early spermatids: 386.6;Glandular and luminal cells: 283.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 230.0;hTCEpi: 263.6;SK-BR-3: 267.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015269, HPA018123" Approved Supported "Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol" NA NA 34000 "Focal adhesion sites, Cytosol" "Plasma membrane, Cell Junctions" "HPA015269: AB_1857899, HPA018123: AB_1857900" "unprognostic (9.81e-2)" "unprognostic (5.53e-3)" "unprognostic (4.79e-2)" "unprognostic (1.31e-1)" "unprognostic (4.01e-1)" "unprognostic (6.08e-3)" "unprognostic (1.84e-3)" "unprognostic (4.81e-3)" "unprognostic (8.81e-3)" "unprognostic (6.19e-3)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.60e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (2.36e-2)" "unprognostic (3.86e-1)" 29.5 7.3 3.2 54.9 2.4 44.5 32.5 3.3 3.3 29.3 9.2 101.6 41.5 106.8 21.9 58.7 45.6 37.7 14.2 2.1 5.2 19.3 10.2 41.4 50.0 5.4 3.3 1.8 7.4 21.0 15.4 5.7 25.8 3.2 55.7 69.6 13.5 34.5 199.0 5.1 23.4 47.9 148.8 3.0 30.2 52.5 40.2 4.2 33.8 67.0 9.0 51.7 87.9 41.5 4.2 115.9 24.0 27.0 0.2 11.7 29.7 62.3 58.9 28.9 10.9 10.6 60.4 126.2 0.0 230.0 41.7 1.3 116.9 14.4 87.3 26.4 57.3 46.0 11.5 53.1 30.5 69.9 53.6 0.2 66.4 263.6 37.7 95.0 74.9 31.1 0.0 11.9 39.5 3.0 24.4 0.2 0.7 17.8 134.0 67.4 0.2 0.4 46.0 110.9 44.0 12.4 113.4 85.5 267.1 68.2 77.6 0.3 21.5 52.3 0.6 1.5 86.2 0.7 92.6 48.9 1.3 7.4 27.2 89.3 274.7 79.2 221.5 150.2 132.1 144.7 104.6 113.4 137.6 86.9 95.5 111.0 127.6 41.6 205.1 170.5 20.7 130.4 162.8 3.2 2.4 3.3 3.3 2.1 5.2 5.4 3.3 1.8 3.2 3.0 4.2 4.2 40.8 243.6 47.0 0.0 60.4 200.4 196.2 64.8 60.3 2.2 62.2 57.0 16.1 47.1 81.7 36.8 12.5 23.2 121.3 140.8 21.5 110.7 386.6 176.7 29.9 49.0 50.6 17.7 0.1 112.3 78.1 23.6 84.1 283.9 18.9 54.1 25.7 11.9 15.4 1.7 0.1 100.7 34.6 58.0 119.0 112.5 1.8 78.0 28.4 10.3 77.6 24.7 201.8 0.0 0.3 196.8 112.1 0.4 76.3 102.4 65.3 13.6 68.1 13.9 6.6 9.0 42.3 19.1 10.6 55.9 122.7 29.1 79.2 8.8 79.7 135.9 MDFIC "HIC, MDFIC1" ENSG00000135272 "MyoD family inhibitor domain containing" Q9P1T7 7 114922359-115019202 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Muller glia cells: 139.7;Skeletal myocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 109.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030716 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA030716: AB_10671364" "unprognostic (1.24e-3)" "unprognostic (4.15e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.73e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (6.38e-3)" "unprognostic (3.68e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (6.13e-3)" "unprognostic (7.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.55e-1)" 45.3 17.5 5.4 22.7 4.6 11.2 14.6 5.7 5.4 21.3 23.3 10.7 7.3 20.8 5.1 17.3 12.3 13.3 24.8 4.2 12.8 12.7 13.4 23.5 32.4 12.2 8.6 3.1 16.3 5.1 16.8 4.6 20.4 8.6 10.3 10.4 21.3 15.9 11.2 27.9 10.4 9.4 17.8 13.7 33.9 10.6 1.8 6.6 17.4 19.5 14.4 30.3 16.6 8.3 9.6 0.1 13.2 18.3 0.1 37.8 52.0 7.1 69.9 83.9 15.9 19.8 0.4 41.7 9.8 0.8 46.4 25.4 7.7 5.7 12.2 27.1 34.0 12.3 0.0 16.8 0.0 19.5 22.2 14.2 43.7 11.5 35.7 11.1 40.2 10.7 9.7 0.0 66.8 54.2 0.2 0.1 1.8 14.8 0.6 15.6 0.2 53.5 21.5 16.2 16.9 0.7 0.0 30.5 28.3 32.5 24.7 9.0 19.7 30.2 58.2 16.4 109.1 34.1 27.5 0.1 0.2 40.8 0.1 50.9 0.2 0.9 0.6 1.8 1.2 2.8 2.3 4.1 3.6 1.5 2.4 2.3 2.1 0.0 1.6 1.8 5.5 3.5 0.7 5.4 4.6 5.7 5.4 4.2 12.8 12.2 8.6 3.1 8.6 13.7 6.6 9.6 61.3 16.0 26.1 32.7 41.5 9.4 7.0 2.2 17.6 0.5 13.1 10.2 24.8 24.3 12.2 14.7 0.0 7.5 58.1 1.5 9.8 2.3 2.5 9.4 12.7 42.8 0.0 1.7 27.2 2.9 5.3 25.8 5.6 1.3 2.5 29.9 59.6 18.6 21.9 0.0 5.4 2.7 0.0 55.6 34.0 1.3 4.4 41.1 37.4 55.3 22.0 139.7 21.6 6.6 0.8 9.2 2.0 2.6 63.2 6.6 0.1 5.1 15.1 5.0 6.6 131.8 13.8 0.2 1.0 20.0 13.8 3.7 70.6 38.2 4.6 10.2 MTO1 ENSG00000135297 "Mitochondrial tRNA translation optimization 1" Q9Y2Z2 6 73461578-73509236 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030230, HPA030232" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030230: AB_10598910, HPA030232: AB_10600891" "unprognostic (2.17e-2)" "unprognostic (5.29e-2)" "unprognostic (1.05e-2)" "unprognostic (3.22e-2)" "unprognostic (6.47e-2)" "unprognostic (8.58e-2)" "unprognostic (6.28e-2)" "unprognostic (5.48e-2)" "unprognostic (2.97e-1)" "unprognostic (2.12e-3)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" "unprognostic (1.64e-1)" 5.9 5.6 3.9 5.5 4.2 4.2 6.0 5.9 5.0 6.6 3.8 6.5 6.2 5.6 4.5 6.4 6.4 3.5 7.7 3.9 3.7 11.7 17.7 5.1 7.8 4.1 3.9 4.0 7.3 6.3 9.4 5.8 4.1 4.5 6.2 6.7 6.7 5.6 4.6 9.4 5.2 7.6 5.3 3.4 9.9 6.6 10.0 4.0 7.2 6.4 9.9 9.4 6.8 6.7 5.4 6.5 6.0 8.0 5.9 12.4 13.7 4.3 13.5 14.7 15.7 15.7 13.2 4.1 13.7 9.4 13.9 9.5 10.1 18.6 12.5 24.9 7.6 9.6 15.7 12.0 13.5 16.3 27.0 7.1 9.2 17.4 16.0 16.7 7.8 11.3 14.6 22.5 16.8 14.4 10.9 6.4 9.0 6.5 9.4 5.8 11.3 27.8 25.8 9.2 12.0 5.5 3.9 5.5 14.2 12.2 7.1 7.6 24.1 6.9 7.9 6.6 5.1 13.0 8.5 15.1 6.6 4.7 17.8 11.6 1.3 4.5 3.8 5.9 6.1 9.2 6.2 7.1 5.7 4.7 5.4 7.9 5.9 1.6 8.2 6.0 4.5 12.0 7.0 3.9 4.2 5.9 5.0 3.9 3.7 4.1 3.9 4.0 4.5 3.4 4.0 5.4 9.4 16.0 17.9 11.1 22.7 7.8 14.5 13.2 4.6 0.0 5.7 5.0 15.7 11.5 12.1 11.0 0.0 12.1 19.9 6.7 21.5 7.3 127.7 12.0 13.7 11.7 8.4 5.0 14.3 7.5 8.6 10.9 10.2 22.7 6.3 8.4 10.0 22.6 8.7 0.0 15.8 9.0 6.1 8.2 7.2 20.1 11.1 10.6 0.0 11.2 15.1 0.0 18.6 11.1 21.9 7.0 6.9 9.8 20.1 14.4 16.0 17.4 7.5 0.0 6.6 19.7 10.4 42.9 11.6 7.2 10.1 10.3 21.2 11.5 11.7 10.8 ADGRB3 "BAI3, KIAA0550" ENSG00000135298 "Adhesion G protein-coupled receptor B3" O60242 6 68635282-69389506 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 53.2;pituitary gland: 23.9" "Group enriched" "Detected in some" 10 "Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5" "Cancer enriched" "Detected in single" 10 "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 8.8;SH-SY5Y: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 8600 "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-3)" "unprognostic (3.27e-2)" "unprognostic (1.04e-1)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (5.08e-5)" "unprognostic (4.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-3)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (8.16e-3)" 0.7 3.9 12.1 0.8 26.5 0.0 0.6 53.2 30.8 1.3 0.0 3.2 0.4 2.2 0.9 0.7 1.0 0.9 1.8 28.3 12.7 0.5 0.5 1.7 0.0 2.5 2.9 26.6 1.6 0.3 0.1 23.9 0.1 14.8 1.0 1.3 7.1 1.2 1.4 0.3 0.4 1.4 3.3 0.0 0.6 1.3 1.9 13.9 0.1 0.9 1.4 0.0 2.6 1.4 21.6 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.0 1.2 1.0 0.0 0.0 8.8 19.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 12.1 26.5 53.2 30.8 28.3 12.7 2.5 2.9 26.6 14.8 0.0 13.9 21.6 3.1 0.0 0.0 1795.3 0.3 0.0 0.1 0.0 0.0 47.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.2 4.8 0.6 0.0 0.0 3843.1 0.0 0.0 2.1 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 2738.1 0.0 0.0 0.6 0.0 3.1 5.0 1.3 0.0 216.4 1.0 0.8 0.0 2036.3 1210.5 0.1 0.0 8.6 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.6 7.4 11.8 3.2 0.2 0.0 0.0 0.0 0.5 0.0 0.1 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433152-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 25.1" "Cell type enhanced" "Detected in many" "Astrocytes: 35.3;Granulosa cells: 53.9;Inhibitory neurons: 54.3;Oligodendrocyte precursor cells: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;BEWO: 44.9;HAP1: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles NA NA Vesicles "CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310" "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.5 1.8 14.5 2.6 17.3 1.4 3.7 25.1 10.4 5.0 9.5 2.2 0.7 5.2 1.8 4.2 9.2 4.8 7.9 14.0 18.7 4.9 4.1 5.0 2.3 10.7 9.5 15.1 12.9 3.9 6.5 3.4 3.7 9.6 2.6 0.9 3.1 5.2 1.7 3.9 1.4 1.5 4.1 9.6 1.8 2.2 5.3 20.0 3.8 4.7 3.1 1.8 3.6 2.8 9.4 0.0 2.0 15.1 6.6 0.1 0.7 44.9 0.2 0.2 0.1 1.0 0.5 1.2 0.0 1.5 0.0 7.0 0.0 15.2 8.2 0.6 0.1 10.0 5.5 0.0 0.5 0.2 0.0 2.0 1.0 2.3 0.0 0.0 0.0 1.6 1.4 0.4 3.6 0.0 1.9 0.2 0.6 4.4 0.6 1.5 5.7 0.0 0.0 2.9 8.0 9.5 3.6 1.2 10.7 4.6 9.0 3.1 3.5 0.0 2.3 0.9 0.2 1.3 0.5 0.1 0.0 0.4 0.0 1.8 0.0 0.1 0.9 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 14.5 17.3 25.1 10.4 14.0 18.7 10.7 9.5 15.1 9.6 9.6 20.0 9.4 6.8 16.0 19.4 35.3 1.6 0.9 5.6 4.7 10.2 0.9 4.4 4.6 5.7 11.5 6.4 1.8 12.5 3.6 1.3 0.1 11.7 5.9 2.6 12.0 2.9 5.7 1.8 1.7 23.8 11.2 10.8 7.2 5.6 3.9 10.8 53.9 5.0 2.8 2.6 0.0 54.3 0.0 8.2 2.6 2.1 6.1 9.6 2.5 3.6 25.3 2.9 7.2 3.1 32.6 6.6 5.1 0.1 27.8 4.0 2.5 0.0 4.1 8.2 1.7 6.6 3.4 5.2 5.3 5.3 4.3 1.1 1.9 1.5 4.3 0.0 4.9 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77460924-77463491 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.9;placenta: 6.7;stomach 1: 5.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HUVEC TERT2: 79.4;TIME: 35.1" "Region enriched" "Detected in all" 4 "basal ganglia: 38.6" "Region enhanced" "Detected in many" "basal ganglia: 11.7" HPA028808 Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Plasma membrane" "Endoplasmic reticulum" "HPA028808: AB_2672782" "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 0.8 0.6 1.9 0.4 5.7 0.0 0.2 0.0 3.9 0.7 0.0 0.1 0.1 0.5 0.0 0.0 0.5 0.5 0.0 1.2 1.2 0.3 0.0 0.4 0.0 1.2 1.8 1.2 0.4 0.1 0.0 0.2 6.7 1.3 0.2 0.1 0.3 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.0 5.0 0.5 6.9 0.0 0.2 0.3 0.0 1.3 0.5 1.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 3.5 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.4 0.2 0.6 2.2 1.4 79.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.7 0.0 3.9 1.2 1.2 1.2 1.8 1.2 1.3 0.1 6.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 32.9;Inhibitory neurons: 30.7;Oligodendrocyte precursor cells: 29.1;Spermatocytes: 38.8;Spermatogonia: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 1.2 1.1 11.0 0.6 10.9 0.2 0.9 11.1 13.7 2.1 8.4 1.3 0.1 1.7 1.2 1.0 2.5 1.0 2.8 10.9 11.0 0.6 0.1 0.8 1.3 11.1 10.7 10.3 3.0 2.7 2.2 7.6 0.5 10.9 2.0 0.4 3.8 0.6 1.3 1.1 0.4 0.8 0.9 10.6 0.7 1.6 8.4 10.8 2.2 2.4 1.4 1.4 1.5 1.6 10.9 3.2 4.6 0.9 2.4 4.2 4.8 2.2 6.1 6.0 9.3 13.7 4.4 2.5 6.9 2.3 2.7 4.8 3.1 6.4 1.3 7.1 6.5 4.6 4.6 4.2 0.0 5.4 2.3 0.1 6.2 2.7 9.3 2.6 3.9 2.1 7.1 3.4 8.0 3.8 7.7 0.5 2.1 4.2 0.6 9.1 1.0 0.0 5.5 1.5 0.1 11.1 2.4 3.6 0.2 0.3 3.0 0.1 6.8 0.1 2.0 4.2 1.2 6.6 13.5 8.8 4.9 0.1 1.9 0.7 1.9 0.1 0.0 2.1 0.0 1.3 1.2 1.3 2.4 0.4 0.8 1.0 1.6 0.0 1.4 0.0 1.3 2.8 1.1 11.0 10.9 11.1 13.7 10.9 11.0 11.1 10.7 10.3 10.9 10.6 10.8 10.9 0.3 0.0 1.5 8.5 2.8 0.8 3.4 5.4 2.8 9.6 2.0 6.5 2.8 0.0 2.1 3.7 2.1 1.7 4.7 0.3 1.9 0.9 12.0 4.6 2.8 0.4 0.0 1.3 32.9 3.7 0.4 3.6 8.2 0.8 0.0 5.8 0.0 0.0 0.5 13.5 30.7 0.7 2.0 0.0 0.4 15.2 2.1 0.3 3.6 2.8 0.7 16.1 3.1 29.1 11.2 3.2 0.2 3.4 6.8 2.0 0.1 0.2 1.4 7.2 19.7 1.9 2.0 38.8 20.9 1.0 0.6 0.1 2.5 2.7 1.1 0.8 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227643 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 141.3;Oligodendrocytes: 64.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite, Cytosol" "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 2.0 1.5 1.6 2.3 1.8 2.4 2.6 1.9 1.5 2.4 2.8 1.9 1.2 3.8 2.3 1.8 3.8 2.8 1.6 0.8 1.3 2.5 1.4 2.7 2.2 1.5 1.5 0.7 4.1 2.1 4.3 1.2 2.5 1.5 2.4 2.6 2.8 1.9 2.3 1.0 2.3 1.7 2.6 1.4 2.3 2.7 8.6 1.4 3.9 3.6 1.6 2.4 2.2 1.4 3.0 2.5 1.1 7.1 7.8 4.2 6.1 4.6 2.8 2.7 3.9 4.6 3.2 3.4 2.7 2.6 2.2 6.7 3.8 4.2 2.6 6.2 7.0 2.8 5.0 5.1 2.4 2.1 5.5 4.6 2.9 1.9 3.9 1.5 5.0 4.4 3.7 10.2 3.1 2.8 1.3 1.4 3.3 4.8 1.7 1.6 7.6 9.3 1.5 2.9 2.3 4.6 5.7 2.0 1.1 2.1 5.1 2.5 3.7 3.5 3.8 3.4 3.4 3.1 2.3 3.3 1.6 2.4 2.9 4.8 0.0 0.2 0.3 0.4 0.2 0.5 0.5 0.3 0.3 0.1 0.3 0.2 0.4 0.5 0.0 0.2 0.4 0.0 0.2 1.6 1.8 1.9 1.5 0.8 1.3 1.5 1.5 0.7 1.5 1.4 1.4 3.0 13.6 32.1 17.6 42.7 9.6 0.0 6.7 0.0 4.6 5.9 6.1 7.1 11.2 4.3 6.8 9.2 12.5 6.5 7.0 7.0 5.9 12.6 141.3 43.2 18.3 11.3 11.4 10.8 35.0 7.1 5.9 13.3 8.6 11.3 18.3 18.0 7.9 4.2 5.5 28.6 29.2 4.7 0.0 7.9 0.0 57.9 11.8 9.9 0.0 36.5 7.6 9.2 6.2 54.3 64.0 6.8 12.7 12.0 3.7 2.5 5.6 6.8 39.4 14.3 13.1 13.8 10.9 58.7 20.0 3.6 0.0 3.8 8.5 13.4 5.0 4.1 SYNCRIP "dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1" ENSG00000135316 "Synaptotagmin binding cytoplasmic RNA interacting protein" O60506 6 85607779-85644063 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010895, HPA041275, HPA069241" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA 1300000 Nucleoplasm "Vesicles, Cytosol" "CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: " "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (6.28e-5)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.86e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "unprognostic (4.11e-1)" 61.1 43.6 25.7 81.0 28.6 67.9 56.2 29.4 25.6 51.8 26.5 54.6 48.5 46.6 42.0 76.5 34.3 48.2 46.0 24.1 32.8 53.6 67.3 49.8 88.8 29.9 28.4 19.4 36.6 52.4 57.4 19.7 69.0 31.5 45.3 63.3 36.4 41.7 46.9 56.3 43.8 44.4 62.7 29.3 51.8 50.4 39.0 28.9 91.8 88.1 56.5 102.7 82.2 41.1 30.4 209.5 147.5 239.9 157.1 150.8 165.3 162.8 258.6 218.1 244.4 239.9 250.4 132.6 480.0 200.0 262.8 203.1 197.4 331.1 269.0 405.4 175.9 163.9 405.4 152.8 165.2 130.3 497.6 177.7 141.8 179.6 276.4 272.1 138.4 254.9 133.2 451.5 210.0 295.1 243.5 255.2 218.9 231.5 209.4 153.2 364.7 345.5 209.9 236.2 307.1 239.5 184.6 188.5 180.8 128.6 137.2 150.8 360.9 247.4 165.8 142.7 189.8 374.2 138.0 260.5 275.4 165.4 328.7 251.4 1.8 24.7 8.8 30.6 36.2 30.0 21.9 27.1 27.5 37.7 21.2 23.4 27.7 3.0 36.1 41.1 29.0 31.6 24.6 25.7 28.6 29.4 25.6 24.1 32.8 29.9 28.4 19.4 31.5 29.3 28.9 30.4 106.9 115.4 119.5 26.4 73.0 148.2 160.9 124.4 83.6 44.5 89.0 82.8 88.9 52.9 126.7 46.0 16.7 101.3 97.2 50.4 54.8 120.7 117.6 105.1 156.2 100.7 56.7 65.6 24.0 99.6 133.3 101.8 79.5 152.1 61.4 81.6 57.5 81.4 96.9 62.2 24.3 78.0 79.3 71.1 67.1 28.7 73.7 92.9 53.4 31.9 90.7 45.1 57.7 32.2 40.9 130.0 45.7 64.3 97.4 133.0 47.7 80.7 84.6 42.2 19.7 158.6 131.8 93.7 65.8 142.4 141.6 118.1 81.6 85.8 106.7 159.8 SNX14 RGS-PX2 ENSG00000135317 "Sorting nexin 14" Q9Y5W7 6 85505496-85594156 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017639 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017639: AB_1857345" "unprognostic (1.16e-2)" "unprognostic (3.29e-2)" "unprognostic (2.19e-2)" "unprognostic (1.52e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (1.57e-2)" "unprognostic (3.14e-2)" "unprognostic (2.37e-2)" "unprognostic (1.10e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (4.72e-3)" 27.5 40.2 42.2 23.2 42.6 31.7 42.1 46.5 61.4 31.1 50.0 40.1 30.1 23.7 57.8 24.5 28.4 28.5 24.6 42.1 48.4 54.9 70.2 40.0 32.8 42.2 43.3 42.9 27.0 44.0 47.5 36.5 36.5 44.9 33.5 35.4 47.6 28.1 31.1 16.5 28.8 32.0 22.6 42.2 37.7 45.7 87.8 44.3 19.1 40.8 13.0 29.0 35.5 24.9 45.8 46.1 27.3 44.5 64.9 98.3 71.6 46.0 58.0 78.5 44.2 67.5 49.0 75.4 60.3 69.8 74.4 85.9 60.7 30.5 58.8 69.4 53.3 18.0 66.1 36.4 75.1 80.9 62.4 65.0 63.0 43.7 52.0 51.6 81.1 79.4 23.2 67.7 50.4 96.9 52.1 4.4 117.0 18.3 72.1 31.1 26.2 90.6 29.1 107.1 82.7 19.8 44.5 35.0 76.6 56.3 57.9 47.9 108.9 71.6 35.4 21.8 44.1 60.3 50.4 87.0 22.8 71.3 72.2 71.8 36.7 21.5 33.0 19.9 33.6 14.7 13.3 13.4 18.1 26.2 14.7 12.0 15.0 9.9 22.9 40.9 7.9 16.7 15.7 42.2 42.6 46.5 61.4 42.1 48.4 42.2 43.3 42.9 44.9 42.2 44.3 45.8 28.5 93.0 47.2 76.4 25.3 14.7 18.7 32.8 15.9 36.4 23.3 15.1 16.9 15.7 39.1 22.0 56.3 50.4 32.6 30.7 5.9 31.7 87.1 37.3 22.2 26.9 31.8 13.2 115.2 41.6 31.9 23.1 37.8 32.5 31.6 36.0 26.0 28.7 35.4 15.2 124.4 26.1 65.1 37.7 22.3 21.6 19.6 33.4 28.4 63.7 43.1 26.1 41.2 85.5 91.0 34.4 22.0 29.3 23.8 15.7 31.9 25.1 58.9 40.7 19.7 26.2 33.0 173.0 14.9 15.9 14.8 56.5 26.4 26.5 28.6 17.7 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 113.5;retina: 95.2" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 33.0;naive CD8 T-cell: 30.7" "Group enriched" "Detected in many" 41 "B-cells: 33.0;T-cells: 30.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 3000000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 20.9 6.0 10.3 12.0 10.6 0.6 14.3 12.0 12.8 113.5 17.1 29.7 40.5 49.9 6.4 8.6 20.9 17.3 6.8 9.0 22.4 17.4 55.2 6.9 9.7 12.9 13.3 8.7 39.6 1.8 1.9 11.9 25.6 12.6 13.4 32.3 95.2 6.7 34.6 2.1 6.1 21.1 74.5 14.0 13.1 8.1 10.4 12.1 5.3 24.0 9.9 11.4 15.9 28.7 13.6 48.9 26.0 42.9 0.8 95.1 302.4 0.4 306.1 332.7 147.5 275.2 0.4 469.6 0.0 107.3 270.2 379.0 24.5 0.1 308.0 348.8 0.8 0.1 0.1 7.3 6.0 47.5 0.2 0.7 77.4 3.7 302.0 191.3 807.8 124.9 0.3 0.3 1.4 934.3 8.3 0.0 0.2 0.8 8.2 34.6 1.5 9.5 1.3 323.1 21.8 0.3 5.5 3.8 18.8 104.9 2.2 0.4 8.3 546.2 120.6 0.9 152.9 506.8 22.7 15.3 0.5 821.7 0.4 385.3 0.0 0.0 0.5 3.7 0.0 6.4 23.7 4.2 11.7 0.0 33.0 4.1 30.7 0.5 0.7 0.0 0.1 1.7 6.4 10.3 10.6 12.0 12.8 9.0 22.4 12.9 13.3 8.7 12.6 14.0 12.1 13.6 6.4 0.0 5.8 36.9 21.6 5.2 1.7 6.1 2.8 4.4 1.2 0.3 1.7 27.1 4.8 1.8 10.4 0.6 2.2 49.2 3.9 3.8 0.6 19.3 20.8 20.5 0.0 0.0 1.6 4.1 2.5 39.4 11.2 58.0 0.0 0.1 49.6 33.7 1.3 0.0 2.1 27.7 0.0 3.5 8.2 1.3 13.1 2.1 7.2 11.2 0.5 9.1 0.0 61.3 0.7 124.8 46.0 25.6 3.6 1.5 8.3 27.6 4.8 81.6 0.0 3.3 9.6 0.0 0.3 0.6 4.8 15.2 5.0 0.1 18.0 9.6 MRAP2 "bA51G5.2, C6orf117" ENSG00000135324 "Melanocortin 2 receptor accessory protein 2" Q96G30 6 84033772-84090881 "Disease related genes, Human disease related genes, Predicted membrane proteins" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 56.5;Inhibitory neurons: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "K-562: 91.7;SCLC-21H: 30.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (3.82e-4)" "unprognostic (7.11e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.66e-4)" "unprognostic (8.80e-3)" "unprognostic (3.15e-1)" "unprognostic (9.85e-2)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-3)" "unprognostic (1.41e-2)" "unprognostic (4.47e-1)" "unprognostic (6.02e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (4.50e-3)" "unprognostic (9.12e-2)" 1.0 7.3 11.2 1.3 12.2 0.1 1.6 8.0 17.6 2.6 5.8 5.4 3.8 2.5 1.1 1.5 8.6 1.9 0.8 11.0 13.1 3.5 0.2 0.9 0.5 10.3 10.4 11.6 4.6 4.3 0.1 3.7 0.2 9.5 6.2 5.2 2.1 6.9 7.8 1.3 1.9 4.0 1.1 6.2 8.7 7.7 2.8 24.5 0.9 0.6 0.5 1.7 0.8 2.2 15.4 0.0 2.5 0.9 0.0 0.3 1.4 0.1 0.9 0.0 1.5 0.2 1.2 0.1 0.2 0.1 9.6 3.2 0.0 1.7 0.4 0.1 0.8 0.8 3.1 0.2 0.4 0.0 0.7 0.2 0.4 1.3 0.1 0.0 0.1 5.7 0.1 91.7 0.1 0.4 0.0 0.0 0.0 2.1 0.0 0.4 0.1 5.0 0.0 5.3 1.6 30.1 10.2 0.2 0.0 1.5 1.1 0.2 2.6 0.4 0.5 0.4 5.0 1.2 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.2 12.2 8.0 17.6 11.0 13.1 10.3 10.4 11.6 9.5 6.2 24.5 15.4 0.8 0.0 0.5 3.3 0.0 1.8 7.8 1.7 0.6 1.2 0.8 1.0 0.2 1.5 2.1 12.9 0.0 0.1 0.1 6.4 1.9 4.3 2.8 5.1 0.5 2.3 0.0 0.0 56.5 5.3 0.0 1.1 13.7 2.4 0.0 1.8 4.2 0.0 0.0 0.0 33.5 11.3 0.0 0.0 0.4 4.8 4.1 0.2 0.0 2.8 0.0 0.4 0.0 3.5 4.0 0.6 6.4 5.3 0.0 2.8 2.3 0.0 4.5 0.5 0.0 8.1 2.4 0.2 4.7 2.7 1.0 0.0 0.1 1.8 6.8 4.7 EPHA7 Hek11 ENSG00000135333 "EPH receptor A7" Q15375 6 93240020-93419687 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 19.7;parathyroid gland: 70.4" "Group enriched" "Detected in some" 8 "Excitatory neurons: 138.6;Inhibitory neurons: 172.0" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 12.0;HEK 293: 35.1;RH-30: 31.7;THP-1: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010496 Approved "Intracellular and membrane" NA NA 660000 "CAB010496: AB_2099673" "unprognostic (3.34e-1)" "unprognostic (7.82e-2)" "unprognostic (1.41e-1)" "unprognostic (9.32e-2)" "unprognostic (1.19e-1)" "unprognostic (3.56e-2)" "unprognostic (1.62e-2)" "unprognostic (4.07e-1)" "unprognostic (4.16e-2)" "unprognostic (3.19e-2)" "unprognostic (5.69e-2)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-1)" "unprognostic (1.56e-2)" "unprognostic (4.82e-2)" 0.2 0.0 0.7 0.4 3.5 0.0 1.2 3.6 5.3 1.3 0.6 19.7 1.5 0.9 0.2 0.2 0.5 2.3 3.6 5.1 3.2 6.0 0.0 0.2 0.0 1.3 2.4 1.4 1.9 0.1 70.4 1.2 0.4 1.5 9.8 2.5 1.8 5.5 0.9 0.1 0.2 4.5 2.1 0.1 3.9 10.4 0.9 0.8 0.0 0.1 0.1 0.0 8.3 1.8 1.5 0.0 0.5 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 35.1 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.0 1.0 5.4 31.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.6 5.3 5.1 3.2 1.3 2.4 1.4 1.5 0.1 0.8 1.5 0.2 0.0 0.0 4.2 0.0 0.4 0.4 0.0 0.6 18.5 3.1 1.8 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 13.1 1.3 1.4 1.8 0.0 0.0 138.6 0.0 0.0 5.9 0.0 3.8 0.0 3.7 0.0 0.0 0.1 11.8 172.0 0.0 0.0 0.0 0.4 3.3 0.9 0.1 0.0 11.2 0.0 0.4 0.0 4.5 8.3 0.1 0.0 0.0 0.0 0.4 0.0 11.8 0.0 1.0 0.0 0.2 0.5 0.2 1.1 0.2 1.0 0.0 0.2 0.9 0.0 0.1 AKIRIN2 "C6orf166, dJ486L4.2, FLJ10342" ENSG00000135334 "Akirin 2" Q53H80 6 87674860-87702233 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA064239 Supported Nucleoplasm No Yes Nucleoplasm "HPA064239: AB_2685222" "unprognostic (9.65e-2)" "unprognostic (2.56e-1)" "unprognostic (8.25e-2)" "unprognostic (8.09e-2)" "unprognostic (3.58e-1)" "unprognostic (1.87e-2)" "unprognostic (1.07e-1)" "unprognostic (5.38e-2)" "unprognostic (6.17e-2)" "unprognostic (6.60e-3)" "unprognostic (1.62e-2)" "unprognostic (2.56e-1)" "unprognostic (1.48e-2)" "unprognostic (9.62e-2)" "unprognostic (9.55e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" 33.2 37.4 29.7 24.0 33.6 71.1 26.2 28.2 37.9 21.2 28.2 19.5 12.8 24.8 23.9 33.5 22.8 15.4 29.2 34.4 31.8 20.1 31.5 33.5 28.6 30.0 29.5 30.5 25.8 13.3 17.9 23.6 18.7 27.9 17.1 12.6 29.9 24.7 11.8 98.2 22.2 23.1 16.6 33.8 49.4 17.0 24.3 33.6 31.5 17.4 42.9 30.5 23.4 25.3 31.4 23.9 24.7 71.0 40.1 43.1 29.6 41.4 41.1 25.7 33.2 32.3 39.7 18.0 62.2 44.1 42.1 55.1 36.2 39.1 29.6 37.9 79.2 48.5 36.3 21.8 89.7 47.1 31.4 30.2 34.6 29.9 41.0 40.2 32.5 36.6 24.3 71.2 42.2 43.5 30.7 9.9 64.9 51.0 20.3 38.1 38.7 50.2 25.7 41.7 20.8 53.0 50.3 24.9 14.8 44.2 40.1 17.9 73.9 47.6 27.5 18.8 23.5 54.6 40.9 48.4 38.8 30.4 40.2 45.1 76.1 57.8 64.8 28.1 73.2 29.2 41.6 27.4 27.6 55.0 32.6 21.4 23.1 144.4 36.6 75.6 75.1 39.1 35.0 29.7 33.6 28.2 37.9 34.4 31.8 30.0 29.5 30.5 27.9 33.8 33.6 31.4 49.9 25.6 19.8 10.4 88.2 96.5 192.2 101.9 80.8 13.0 31.8 28.8 22.5 35.8 43.7 18.4 8.4 45.1 94.4 17.1 45.0 30.9 58.0 44.9 34.3 45.6 12.1 45.4 15.6 14.7 71.0 51.1 16.3 39.9 33.6 47.2 44.6 29.9 77.0 11.8 14.8 10.9 69.2 104.4 167.0 100.9 35.8 142.8 74.7 19.7 46.7 80.5 33.0 17.6 15.1 29.6 21.7 28.2 69.4 119.7 19.0 53.5 17.9 17.0 6.6 62.2 39.9 70.6 63.0 92.6 92.9 136.5 99.5 54.2 12.6 191.0 ORC3 "IMAGE50150, LATHEO, ORC3L" ENSG00000135336 "Origin recognition complex subunit 3" Q9UBD5 6 87590067-87667453 "Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039553, HPA053748" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA039553: AB_2676566, HPA053748: AB_2682247" "unprognostic (9.38e-3)" "unprognostic (2.38e-1)" "unprognostic (3.74e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (8.63e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (2.15e-1)" "unprognostic (1.16e-1)" "unprognostic (2.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "unprognostic (3.38e-3)" "unprognostic (1.09e-1)" 11.9 18.1 13.9 9.9 14.8 8.9 16.0 19.1 18.0 11.0 12.1 9.4 6.8 13.8 16.4 9.1 15.4 9.6 20.5 14.5 15.0 14.7 15.9 10.9 13.9 14.7 14.4 14.3 20.2 9.7 19.6 13.3 12.8 14.7 12.4 10.7 34.1 9.1 11.6 21.9 10.6 8.9 11.0 13.5 10.9 8.5 26.0 14.4 20.7 16.2 20.7 13.3 10.9 9.5 17.8 16.5 22.9 39.1 30.6 31.0 32.2 29.4 32.9 30.4 38.5 53.0 31.6 20.0 32.3 44.6 22.9 33.0 28.5 45.1 27.3 52.4 40.6 31.3 30.8 30.5 33.3 16.9 34.6 9.7 29.6 20.1 43.5 38.6 21.4 23.7 34.2 71.5 33.8 37.5 22.2 13.7 18.4 28.5 24.3 24.3 33.5 53.5 20.4 30.8 24.6 27.8 20.4 25.9 15.7 26.2 41.4 20.9 29.9 19.6 19.1 18.5 39.1 39.7 16.1 38.0 22.4 25.3 34.7 29.9 22.5 10.1 11.5 12.6 17.1 18.7 17.7 17.7 15.7 8.6 15.2 21.9 18.5 7.0 19.4 22.4 11.0 18.8 12.7 13.9 14.8 19.1 18.0 14.5 15.0 14.7 14.4 14.3 14.7 13.5 14.4 17.8 17.8 12.8 13.4 36.2 21.6 5.0 11.0 16.0 5.7 18.7 9.2 11.0 36.3 11.5 15.7 7.3 12.5 23.4 13.6 14.2 21.5 10.8 61.2 21.2 19.8 10.9 10.3 12.0 56.2 10.3 24.5 17.5 11.7 15.1 12.0 23.7 12.1 9.5 20.0 6.7 68.0 12.5 10.2 8.8 3.9 26.7 18.6 13.1 8.8 37.5 12.4 20.2 10.3 41.7 44.8 10.5 12.1 15.4 23.9 10.0 58.3 31.4 21.4 28.1 13.1 21.6 17.1 67.8 34.6 8.7 4.4 14.6 17.0 20.0 14.2 8.3 LCA5 C6orf152 ENSG00000135338 "Lebercilin LCA5" Q86VQ0 6 79484991-79537458 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 89.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029053, HPA029055" Supported NA NA "HPA029053: AB_10602020, HPA029055: AB_2672889" "unprognostic (8.96e-2)" "unprognostic (1.04e-1)" "unprognostic (3.06e-2)" "unprognostic (2.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.34e-3)" "unprognostic (6.83e-2)" "unprognostic (2.73e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (7.09e-3)" "unprognostic (1.39e-1)" "unprognostic (5.39e-2)" "unprognostic (3.21e-2)" 3.2 1.9 4.8 1.6 4.4 3.6 4.9 4.5 5.4 4.2 14.4 2.0 1.0 5.5 3.7 3.0 9.7 3.1 2.4 6.4 8.9 2.9 1.2 4.1 1.5 5.2 5.4 3.9 7.3 2.5 17.3 3.7 3.3 5.1 3.9 1.6 13.9 5.6 4.8 1.2 0.9 1.4 4.2 6.6 1.7 1.6 7.0 4.0 1.1 6.4 2.0 1.0 3.5 2.8 6.5 1.7 1.3 3.9 2.2 4.8 5.3 1.7 3.0 3.6 1.8 3.7 9.9 1.9 0.4 3.9 2.4 3.4 1.8 2.9 1.8 3.3 0.0 2.2 14.6 1.9 1.4 5.0 0.3 1.2 5.0 2.0 3.1 4.0 7.0 5.6 0.1 2.3 0.9 3.0 0.0 0.0 0.0 1.1 1.0 1.5 0.0 6.8 0.7 3.9 0.5 2.9 3.5 2.7 0.4 1.9 4.8 0.3 0.8 3.9 1.9 2.2 0.6 2.6 3.7 1.4 0.0 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.4 4.5 5.4 6.4 8.9 5.2 5.4 3.9 5.1 6.6 4.0 6.5 6.7 16.0 11.5 17.0 1.1 1.0 12.5 5.9 11.4 12.4 6.5 15.2 5.1 11.5 17.5 11.0 22.9 8.0 0.1 0.1 0.0 15.9 17.3 52.6 8.6 14.4 2.4 4.6 32.8 4.9 3.6 12.0 0.5 3.7 1.3 6.3 9.3 0.1 1.1 10.1 16.2 0.3 8.2 1.3 0.9 5.3 18.0 1.0 3.6 4.7 0.2 13.4 0.0 24.6 21.9 7.1 0.1 15.8 1.6 6.2 0.1 3.3 89.7 30.4 6.6 14.0 12.1 18.0 11.4 5.5 1.0 12.3 1.2 8.4 0.6 9.5 MAP3K7 "MEKK7, TAK1" ENSG00000135341 "Mitogen-activated protein kinase kinase kinase 7" O43318 6 90513573-90587072 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007633, HPA075335" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear speckles, Plasma membrane" "HPA007633: AB_1079359, HPA075335: " "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (9.77e-2)" "unprognostic (6.51e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (2.56e-3)" "unprognostic (4.76e-2)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (1.17e-1)" 11.9 12.6 14.6 12.6 16.5 8.7 14.4 17.0 17.2 14.4 13.4 10.6 9.3 16.7 16.7 10.7 11.1 12.9 17.0 15.9 16.6 11.5 11.7 10.5 16.5 16.3 17.0 14.1 15.9 9.8 16.5 13.1 17.5 17.0 15.0 11.0 23.7 12.2 13.5 17.0 14.0 9.9 14.1 16.2 17.8 10.9 10.0 15.4 21.0 14.8 18.6 17.0 14.4 12.3 23.8 16.7 14.4 41.3 35.6 29.5 39.1 29.0 32.7 37.7 28.8 36.1 18.6 15.5 36.9 20.4 35.6 25.6 17.3 26.3 25.5 48.7 19.0 27.7 32.9 19.9 24.9 30.8 36.9 24.4 32.5 30.5 28.2 34.2 33.1 27.4 31.8 67.0 29.3 41.8 20.3 17.2 31.2 34.0 25.7 18.0 29.3 73.9 18.0 24.2 18.4 20.8 29.5 22.9 15.6 24.8 32.2 15.5 64.7 26.5 23.3 14.7 21.6 30.9 25.9 24.7 15.8 35.7 39.7 35.0 18.2 11.5 18.4 12.8 15.9 14.5 13.0 12.3 12.5 14.6 9.9 13.7 13.4 11.5 17.9 17.6 8.9 20.8 13.4 14.6 16.5 17.0 17.2 15.9 16.6 16.3 17.0 14.1 17.0 16.2 15.4 23.8 16.1 16.0 26.9 47.0 24.3 36.3 20.8 19.5 21.6 23.3 17.9 12.3 31.0 14.3 16.9 16.5 27.1 31.8 17.8 12.4 7.9 17.6 3.6 10.9 19.8 21.2 12.1 14.1 85.7 20.9 34.6 23.2 16.3 14.8 13.9 25.9 25.7 20.7 24.3 28.6 63.8 13.7 20.3 27.3 24.6 3.2 26.8 21.7 21.4 36.5 35.2 19.6 16.5 50.8 137.2 20.1 9.1 41.0 18.8 30.1 11.1 16.6 21.4 21.5 19.7 28.0 18.5 25.9 24.9 21.3 37.2 48.4 22.7 18.1 15.1 24.8 CGA "FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA" ENSG00000135346 "Glycoprotein hormones, alpha polypeptide" P01215 6 87085498-87095106 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pituitary gland: 4423.7" "Cell type enriched" "Detected in some" 15 "Syncytiotrophoblasts: 85317.2" "Cancer enhanced" "Detected in many" "breast cancer: 10.9;testis cancer: 13.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "BEWO: 776.1;SuSa: 1437.9" "Region enriched" "Detected in many" 6 "hypothalamus: 22.2" "Region enriched" "Detected in many" 40 "hypothalamus: 82.2" "CAB023350, HPA029698" Enhanced "Secreted to blood" NA NA "CAB023350: AB_617281, HPA029698: AB_2673153" "unprognostic (1.66e-1)" "unprognostic (2.10e-1)" "unprognostic (3.22e-5)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.69e-2)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (4.32e-2)" "unprognostic (8.32e-2)" "unprognostic (9.15e-3)" 0.5 4.1 0.2 0.1 0.5 2.0 0.1 0.5 0.6 0.0 0.3 0.3 0.5 1.0 1.2 1.2 0.1 0.2 1.2 0.2 0.6 2.7 2.0 0.7 0.3 1.6 1.0 0.3 0.5 1.3 19.0 4423.7 732.2 1.0 2.7 0.3 0.3 0.5 1.1 3.3 1.9 0.3 3.4 0.2 1.1 38.4 0.5 0.6 0.8 0.5 0.0 0.3 0.4 0.2 1.3 0.0 1.0 0.0 0.1 0.0 0.0 776.1 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 4.2 1.8 0.3 40.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.2 0.1 0.0 0.3 0.0 0.1 1.0 0.6 0.1 22.6 0.0 1437.9 0.1 0.0 0.0 0.9 0.2 0.4 0.3 3.1 0.4 0.5 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.3 0.1 0.4 0.2 0.4 0.6 0.2 0.3 0.4 0.1 0.0 0.2 0.5 0.5 0.6 0.2 0.6 1.6 1.0 0.3 1.0 0.2 0.6 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 1.9 0.0 0.0 7.3 0.0 1414.2 0.1 0.0 0.0 0.0 0.2 20.2 1.1 22.9 1.8 0.0 0.2 0.0 5400.7 65.5 0.0 28.4 0.0 0.0 0.0 0.0 625.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 85317.2 6.0 0.0 0.2 9.9 GJA10 CX62 ENSG00000135355 "Gap junction protein alpha 10" Q969M2 6 89894469-89921760 "Predicted membrane proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 92 "Horizontal cells: 18.5" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA021145 Uncertain NA NA "HPA021145: AB_2670600" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.0;intestine: 35.1;lymphoid tissue: 36.7" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 302.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge, Cytosol" "HPA070174: AB_2686231" "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.71e-8)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 3.2 1.6 13.7 9.0 24.5 4.8 2.7 21.2 13.9 11.5 2.9 35.1 3.3 2.8 2.0 1.4 6.3 7.2 2.1 8.3 18.7 3.6 2.9 13.7 9.4 35.2 23.1 4.4 12.9 1.2 0.9 2.7 3.6 30.1 2.4 28.1 0.7 7.8 2.0 0.9 1.6 12.3 6.0 29.9 36.7 3.5 1.5 22.1 3.4 3.3 0.7 3.4 4.3 3.9 47.0 0.0 5.5 10.3 0.2 1.4 0.0 0.1 13.2 8.9 25.7 27.2 0.0 0.2 0.1 4.4 15.7 5.9 0.5 2.1 5.9 12.9 5.0 3.7 1.5 35.5 0.0 3.5 0.0 55.7 3.8 9.0 2.3 57.9 25.2 9.4 0.0 0.0 0.1 13.6 3.3 0.7 0.1 0.8 0.1 2.3 4.1 1.1 1.1 27.0 6.9 0.0 0.4 40.1 0.0 2.2 6.5 0.0 0.6 7.8 22.3 6.8 0.0 16.4 0.2 0.0 0.0 9.7 1.5 6.7 36.1 2.0 24.9 34.6 21.4 8.2 0.0 12.2 29.7 2.5 1.6 2.6 18.0 11.8 9.6 24.6 7.7 0.0 15.4 13.7 24.5 21.2 13.9 8.3 18.7 35.2 23.1 4.4 30.1 29.9 22.1 47.0 2.1 19.2 4.2 17.6 0.7 0.4 0.2 5.0 0.0 0.1 1.9 0.9 0.9 1.5 6.8 7.3 0.0 0.2 25.9 44.3 1.9 1.3 17.6 1.5 0.8 7.7 1.8 7.0 1.8 2.2 0.1 2.1 1.1 2.5 5.1 0.5 22.5 0.4 8.8 0.0 1.1 22.7 10.2 11.7 0.7 54.9 0.6 5.4 0.0 16.9 4.7 1.2 58.7 31.7 302.0 3.9 37.0 0.4 4.2 0.7 13.2 0.5 9.0 0.2 6.6 1.8 2.6 0.3 0.6 0.4 0.6 0.3 14.5 0.9 17.5 0.5 LMO2 "RBTN2, RBTNL1, RHOM2, TTG2" ENSG00000135363 "LIM domain only 2" P25791 11 33858576-33892076 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6" "Cancer enhanced" "Detected in all" "glioma: 30.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016258, HPA029285, HPA070901, HPA070910" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: " "unprognostic (1.60e-1)" "unprognostic (1.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.14e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.73e-3)" "unprognostic (8.95e-2)" "unprognostic (5.76e-2)" "unprognostic (7.86e-3)" "unprognostic (3.69e-1)" "unprognostic (7.10e-2)" "unprognostic (9.65e-2)" "unprognostic (3.90e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" 15.1 5.9 16.8 11.5 12.6 28.0 12.6 13.8 16.8 8.1 14.7 4.7 4.6 6.5 0.7 6.8 8.4 5.5 4.4 14.0 18.2 12.9 2.3 18.4 19.6 19.4 14.4 7.6 3.5 2.6 2.3 8.6 6.5 16.2 5.7 1.5 0.6 5.4 2.5 23.6 4.8 6.6 4.8 16.2 19.2 3.9 1.7 19.6 1.8 12.4 4.7 8.5 5.9 7.3 17.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 2.2 1.3 12.8 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.4 71.8 0.0 0.0 0.3 72.7 18.5 0.0 0.0 0.0 0.0 0.0 10.2 0.0 60.9 0.0 0.0 0.3 5.1 27.3 0.9 0.0 0.0 15.3 0.8 0.2 0.0 0.8 4.3 0.0 0.3 0.5 0.1 0.2 0.0 81.6 0.9 0.0 0.2 1.7 0.0 0.0 0.2 0.6 4.7 29.2 0.3 0.6 0.5 1.5 0.0 1.4 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.7 0.0 1.7 0.1 0.0 0.2 16.8 12.6 13.8 16.8 14.0 18.2 19.4 14.4 7.6 16.2 16.2 19.6 17.5 109.2 3.2 7.1 8.5 6.6 8.4 7.9 8.0 0.6 1.6 2.8 9.5 2.8 8.6 1.7 5.5 2.1 0.4 1.0 0.8 0.0 3.0 0.5 40.5 11.0 144.6 0.0 103.7 1.3 2.0 3.2 9.8 0.0 39.6 7.6 0.9 167.4 1.7 39.1 0.0 3.8 0.2 2.0 65.0 56.8 1.2 4.1 54.1 10.6 64.6 47.5 1.1 4.1 5.0 1.0 1.0 1.9 0.0 3.0 5.4 0.0 8.8 5.0 2.6 0.0 17.3 3.6 0.3 7.9 0.8 6.0 21.5 1.9 12.4 0.5 25.1 PHF21A "BHC80, BM-006, KIAA1696" ENSG00000135365 "PHD finger protein 21A" Q96BD5 11 45929319-46121454 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 172.4;Excitatory neurons: 171.0;Inhibitory neurons: 140.0;Microglial cells: 138.7;Oligodendrocyte precursor cells: 250.3;Oligodendrocytes: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 34.9;neutrophil: 31.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 34.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023253, HPA023580" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023253: , HPA023580: AB_10962727" "unprognostic (5.30e-3)" "unprognostic (8.93e-2)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.93e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (2.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (1.25e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (2.59e-8)" "unprognostic (1.89e-1)" "unprognostic (1.97e-1)" "unprognostic (9.53e-2)" "unprognostic (1.21e-1)" 12.9 17.6 20.5 20.7 24.8 29.1 11.1 41.2 24.4 12.1 7.0 14.7 7.1 17.4 10.7 11.5 13.0 12.7 17.5 14.9 19.7 7.9 8.1 17.4 16.9 19.1 18.6 12.8 24.3 8.7 16.6 12.9 13.2 20.9 12.2 9.6 16.8 10.0 11.4 15.5 13.6 10.5 16.8 14.7 17.6 10.1 23.9 25.2 18.0 12.9 13.0 14.9 14.1 11.7 28.4 7.3 19.1 36.8 35.6 14.8 22.5 4.9 14.6 25.4 12.3 20.5 3.7 11.2 30.4 10.3 14.2 19.3 8.2 22.0 9.4 12.4 34.0 15.3 17.2 19.9 7.7 17.6 12.5 25.9 20.6 21.3 7.1 20.2 30.2 18.4 21.1 21.0 48.2 14.5 6.9 13.6 20.6 31.9 9.3 11.3 22.8 18.2 10.4 12.6 12.2 24.1 31.7 21.6 10.9 16.0 23.6 19.7 23.5 18.8 20.2 16.3 16.9 12.0 52.5 46.2 20.8 16.1 13.6 16.3 34.9 7.8 4.1 6.1 3.9 5.1 5.0 4.7 5.4 4.3 4.2 2.8 4.8 31.3 5.6 7.2 2.9 6.0 4.1 20.5 24.8 41.2 24.4 14.9 19.7 19.1 18.6 12.8 20.9 14.7 25.2 28.4 13.9 12.8 17.7 172.4 25.2 10.3 8.8 11.2 22.2 25.5 11.8 12.1 25.7 10.0 10.5 3.7 27.1 4.3 26.1 4.8 1.9 10.0 9.0 10.3 26.8 15.0 23.4 18.7 171.0 6.3 3.4 18.3 12.8 11.1 16.5 30.1 12.5 5.5 10.0 15.2 140.0 6.8 4.1 25.4 12.4 8.2 26.1 23.9 10.6 138.7 35.6 7.9 37.0 250.3 231.3 5.5 6.5 14.7 21.8 7.6 5.6 3.9 15.4 23.3 13.1 18.6 18.8 16.9 16.9 19.0 8.8 4.2 19.5 19.2 6.2 5.7 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105617-34147670 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 19.6 24.4 15.4 17.5 15.7 20.6 19.8 14.8 17.6 19.6 13.1 16.9 10.3 20.2 13.9 25.9 19.4 9.5 17.4 15.4 15.0 16.1 22.5 15.1 23.5 14.5 13.3 15.5 23.3 25.5 17.0 17.7 15.2 15.1 19.6 15.7 16.4 16.8 12.3 25.0 29.0 17.6 15.7 11.3 22.9 18.9 22.2 14.2 19.6 17.4 12.6 27.7 20.5 20.7 17.2 40.0 55.5 29.3 62.0 34.2 30.2 33.6 38.8 28.5 48.4 38.4 62.6 22.6 127.6 28.3 33.0 41.8 59.5 110.5 59.4 59.5 35.9 70.2 58.0 44.5 58.9 31.0 147.3 40.7 31.1 40.0 31.5 88.3 22.8 37.4 60.6 128.6 43.5 40.8 76.0 120.5 65.7 41.9 69.3 65.7 89.3 98.0 53.7 27.8 68.5 43.1 32.6 52.3 54.9 23.6 28.2 55.0 41.0 30.5 42.8 34.0 63.7 72.8 47.0 61.0 120.3 43.3 60.0 43.4 0.7 8.3 2.8 11.7 13.7 15.5 12.2 12.6 13.4 15.5 10.6 12.7 13.2 0.9 15.0 12.9 11.6 12.0 9.1 15.4 15.7 14.8 17.6 15.4 15.0 14.5 13.3 15.5 15.1 11.3 14.2 17.2 8.5 6.4 20.7 10.4 12.7 12.2 11.3 6.9 12.5 12.2 8.8 10.2 12.6 7.2 15.1 14.7 12.5 18.1 8.0 5.8 5.9 9.2 6.1 10.1 18.3 10.9 7.2 21.0 22.8 9.6 13.4 14.5 5.6 12.2 5.1 17.3 5.7 7.5 12.0 11.8 21.7 8.9 4.1 5.5 4.4 3.4 9.3 8.5 1.8 6.5 12.9 5.3 7.2 11.6 16.0 8.7 3.5 13.2 9.8 14.8 3.7 5.8 10.6 11.0 13.1 19.6 8.4 20.5 21.6 13.1 13.8 14.4 11.0 19.7 14.3 7.6 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34663288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 290.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.9 1.1 1.1 14.8 1.6 0.2 201.5 1.5 1.0 121.8 1.1 100.2 42.6 14.0 95.8 202.6 130.7 32.5 0.3 1.0 2.5 26.0 1.4 23.6 1.5 2.9 2.3 0.3 0.2 41.5 18.6 0.7 0.1 2.7 83.4 127.5 0.8 290.2 154.8 0.2 54.1 34.4 3.5 3.1 1.2 60.1 0.7 2.2 1.3 2.5 0.0 67.9 51.2 79.8 5.2 46.5 26.8 0.0 0.3 0.0 0.0 0.8 0.0 3.9 0.0 0.2 0.4 138.4 0.1 17.1 0.0 0.2 95.7 0.0 107.6 0.5 0.1 0.2 0.0 1.5 0.2 0.0 0.2 0.0 0.0 41.7 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.1 0.8 0.2 132.9 1.0 0.0 0.1 1.0 20.2 214.8 0.0 0.2 0.5 14.8 0.2 0.0 213.5 0.5 0.0 0.2 1.2 5.1 0.4 0.5 0.2 0.3 0.3 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.6 1.5 1.0 1.0 2.5 2.9 2.3 0.3 2.7 3.1 2.2 5.2 0.8 48.1 97.2 1.3 0.6 109.6 400.8 271.6 133.1 0.0 123.0 51.9 0.9 60.1 323.3 55.2 0.0 0.1 1.1 62.7 15.6 77.8 14.2 229.6 17.7 4.0 23.3 0.0 0.7 86.5 0.0 3.2 53.5 281.8 1.3 0.0 0.0 0.4 0.1 0.0 0.0 82.8 116.0 0.0 17.7 1.0 0.0 5.1 12.4 0.0 5.6 3.8 0.0 0.0 2.4 104.8 30.2 0.0 1.2 173.1 14.1 0.3 204.6 0.0 0.0 0.0 9.6 0.4 0.1 251.1 170.1 1.4 4.9 0.0 74.5 397.3 ELF5 ENSG00000135374 "E74 like ETS transcription factor 5" Q9UKW6 11 34478791-34525193 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 152.8;salivary gland: 148.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 40.3;Breast glandular cells: 143.2;Breast myoepithelial cells: 57.1;Collecting duct cells: 101.2;Cytotrophoblasts: 26.9" "Cancer enhanced" "Detected in many" "breast cancer: 8.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "RT4: 30.2;T-47d: 56.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062706 Approved Nucleoplasm NA NA Nucleoplasm "HPA062706: AB_2684841" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (7.55e-2)" "unprognostic (3.31e-2)" "unprognostic (2.41e-4)" "unprognostic (6.90e-2)" "unprognostic (3.93e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (8.15e-2)" "unprognostic (3.15e-2)" "unprognostic (1.78e-3)" "unprognostic (3.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.86e-1)" 0.2 0.0 0.2 0.0 0.1 0.2 152.8 0.2 0.2 0.4 0.4 0.0 2.1 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.0 17.2 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 2.6 0.0 0.0 148.9 30.6 0.0 6.3 0.0 0.0 0.0 1.1 0.6 0.2 0.0 0.6 0.0 0.0 2.5 5.8 2.3 0.2 0.1 0.0 0.0 0.1 0.0 0.5 3.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 30.2 0.0 0.0 0.0 5.1 0.0 0.1 56.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 3.2 40.3 0.0 1.1 0.3 1.9 0.9 0.0 0.0 143.2 57.1 0.4 0.0 9.7 101.2 0.0 26.9 1.4 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.0 1.9 0.4 0.1 0.0 0.5 17.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.4 4.8 0.0 0.0 0.2 0.9 2.5 0.2 0.0 0.1 11.5 0.6 0.0 0.0 6.5 PRRG4 TMG4 ENSG00000135378 "Proline rich and Gla domain 4" Q9BZD6 11 32829927-32858120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 124.3;Basal squamous epithelial cells: 145.1;Prostatic glandular cells: 153.9;Squamous epithelial cells: 141.8;Suprabasal keratinocytes: 141.5;Urothelial cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "neutrophil: 11.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "HaCaT: 52.7;hTCEpi: 28.0;SK-BR-3: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009040, HPA024566" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA009040: AB_1079694, HPA024566: AB_2237712" "unprognostic (3.30e-1)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (6.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.06e-1)" "unprognostic (4.13e-1)" "unprognostic (3.24e-2)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (2.26e-3)" "unprognostic (3.16e-2)" "unprognostic (1.99e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-2)" 1.1 1.6 0.7 2.0 0.9 4.6 7.2 0.7 1.2 7.6 2.4 7.0 7.6 1.4 6.1 23.6 5.4 3.4 0.9 0.7 1.5 13.5 22.8 6.5 1.1 0.9 0.7 0.5 0.3 4.0 3.0 2.8 5.9 1.1 6.4 6.4 0.2 10.1 6.0 1.1 21.0 7.4 0.9 0.9 3.0 5.5 0.5 1.1 3.6 5.6 1.4 6.7 6.9 13.9 1.2 13.2 0.4 0.1 0.1 0.3 0.0 5.4 0.1 6.5 1.5 2.6 6.2 12.7 0.1 0.4 0.0 3.3 52.7 1.3 3.2 0.4 0.4 8.7 2.7 1.8 0.4 0.0 0.9 2.4 0.4 28.0 0.5 0.1 2.2 0.0 0.0 0.0 0.7 0.5 5.9 1.1 6.0 0.6 10.7 1.5 0.1 0.0 1.6 9.6 16.5 1.8 0.1 8.8 22.0 2.8 1.6 16.0 12.8 0.1 0.6 0.8 2.9 1.3 5.8 4.3 0.1 1.6 7.5 2.5 0.8 2.3 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 11.9 0.2 0.8 0.2 0.1 0.5 0.7 0.9 0.7 1.2 0.7 1.5 0.9 0.7 0.5 1.1 0.9 1.1 1.2 4.2 28.9 23.0 1.0 2.8 124.3 92.5 53.6 145.1 0.1 43.0 21.1 1.0 95.8 33.9 47.8 0.0 24.4 1.7 46.8 7.9 31.5 0.7 75.5 7.4 10.2 13.8 2.5 0.3 36.3 16.8 3.6 25.0 81.9 0.0 6.0 8.9 57.1 8.1 1.7 0.3 34.7 24.4 50.0 15.4 0.3 0.3 12.6 12.4 4.7 40.2 0.1 0.0 1.0 0.1 26.4 19.5 1.5 6.9 153.9 48.3 21.4 51.1 0.2 6.6 2.5 8.8 2.4 4.1 141.8 141.5 82.0 2.6 0.2 47.0 167.4 CAPRIN1 "caprin-1, GPIAP1, M11S1, RNG105" ENSG00000135387 "Cell cycle associated protein 1" Q14444 11 34051731-34102610 "Predicted intracellular proteins" Differentiation "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 483.0;Late spermatids: 289.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018126, HPA063617" Approved Enhanced Cytosol NA NA 43000 Cytosol "HPA018126: AB_1849929, HPA063617: AB_2685062" "unprognostic (3.79e-1)" "unprognostic (3.85e-2)" "unprognostic (3.51e-3)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (8.67e-8)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-3)" "unprognostic (2.90e-1)" "unprognostic (2.87e-2)" "unprognostic (2.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" 45.6 30.9 27.0 42.6 28.1 70.9 57.4 26.0 30.0 57.3 22.3 49.3 46.4 53.2 30.8 47.6 62.3 42.0 45.3 29.2 41.6 50.3 40.2 43.7 43.3 28.7 26.2 23.3 61.0 47.9 60.4 21.8 54.3 27.8 46.1 61.1 59.2 38.9 54.0 45.7 30.1 41.5 66.7 31.3 40.4 42.5 124.0 28.4 78.3 53.8 54.5 63.1 59.4 32.1 35.9 134.7 168.8 245.6 137.2 180.9 182.5 117.5 168.0 175.8 202.4 188.2 154.9 80.8 211.1 104.9 213.9 169.4 173.1 311.9 204.3 244.9 134.7 155.5 174.1 153.3 131.9 109.4 282.0 122.8 164.0 109.2 129.1 236.3 174.7 204.2 153.7 228.1 103.6 211.3 114.5 243.7 55.8 114.8 155.3 150.6 191.8 339.2 93.7 120.4 263.1 155.5 147.7 202.6 101.1 88.8 150.5 183.5 104.4 205.3 172.7 116.4 167.9 190.8 110.9 175.5 238.7 117.2 116.3 191.7 25.0 33.3 13.9 18.8 39.7 27.3 19.4 20.9 23.2 39.0 17.8 21.6 21.1 13.5 30.7 43.4 18.2 28.1 31.0 27.0 28.1 26.0 30.0 29.2 41.6 28.7 26.2 23.3 27.8 31.3 28.4 35.9 42.1 35.3 43.5 37.9 46.0 77.8 45.5 51.5 68.9 38.1 63.7 43.9 55.4 24.3 37.2 64.4 18.8 46.7 47.2 46.0 31.3 56.6 483.0 90.0 116.5 52.1 71.8 79.0 37.4 60.1 60.2 54.6 65.7 132.2 17.1 63.1 39.7 46.1 57.2 25.2 38.8 51.1 54.9 75.8 72.3 289.3 47.8 57.9 39.2 37.5 57.0 36.7 35.0 44.2 53.1 71.3 40.4 72.6 83.0 72.7 42.9 47.4 49.5 32.3 39.5 40.4 64.3 201.7 74.8 93.2 72.9 45.8 46.5 53.9 65.5 77.7 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1335.2;Breast myoepithelial cells: 1873.6;Distal tubular cells: 1762.9;Hofbauer cells: 1076.1;Proximal tubular cells: 2061.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved NA NA "HPA051469: AB_2681496" "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 252.9 300.6 492.3 242.2 510.8 449.4 490.4 501.0 579.2 341.2 494.0 448.3 387.1 281.7 467.8 343.6 538.4 298.8 766.7 479.3 516.8 441.5 473.3 245.8 409.8 508.6 491.7 468.1 491.5 503.4 507.2 19.1 267.5 509.0 325.0 557.0 278.3 487.2 287.6 1418.8 348.2 325.2 364.3 515.2 298.4 314.9 128.1 502.3 458.1 316.9 1460.1 544.7 369.0 15.3 523.6 325.4 684.8 701.3 640.3 478.0 1162.4 330.7 278.3 630.3 824.5 561.2 236.2 745.1 392.9 668.3 554.8 263.9 304.7 914.6 652.8 729.3 660.9 1096.7 1068.7 515.2 495.7 1034.1 819.7 508.5 1297.4 956.8 797.0 1315.9 1313.7 1078.7 468.0 776.8 1116.6 852.6 857.0 842.8 1996.5 603.6 681.5 756.7 838.3 665.2 981.9 1019.4 407.0 365.8 669.0 376.5 431.6 974.2 610.1 1403.7 1473.7 512.5 396.4 542.2 307.5 441.4 577.6 537.6 288.1 589.9 863.0 620.2 367.7 977.3 281.8 645.6 924.4 710.5 1119.6 826.1 693.6 1324.3 974.6 896.6 755.0 214.2 769.1 849.6 1023.6 955.8 1565.2 492.3 510.8 501.0 579.2 479.3 516.8 508.6 491.7 468.1 509.0 515.2 502.3 523.6 412.1 182.7 266.7 0.0 167.8 0.0 0.0 0.0 0.0 0.0 1335.2 1873.6 0.0 0.0 177.0 527.8 0.0 732.4 297.0 0.0 1762.9 470.7 0.0 529.1 446.9 190.2 0.0 0.0 0.0 676.5 777.5 222.2 0.0 454.1 224.5 715.4 0.0 0.0 1076.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.0 0.0 0.0 380.9 0.0 0.0 0.0 0.0 392.7 0.0 0.0 52.8 0.0 0.0 2061.3 215.7 0.0 0.0 0.0 248.9 0.0 0.0 0.0 0.0 507.7 182.6 802.8 0.0 0.0 DNAJC14 "DNAJ, DRIP78, FLJ32792, HDJ3, LIP6" ENSG00000135392 "DnaJ heat shock protein family (Hsp40) member C14" Q6Y2X3 12 55820960-55830824 "Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017653 Approved NA NA "HPA017653: AB_1847799" "unprognostic (2.54e-2)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.90e-1)" "unprognostic (6.04e-2)" "unprognostic (3.14e-2)" "unprognostic (6.91e-3)" "unprognostic (6.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.63e-1)" "unprognostic (4.34e-2)" "unprognostic (3.89e-3)" "unprognostic (4.73e-2)" "unprognostic (7.98e-2)" "unprognostic (9.17e-2)" "unprognostic (8.92e-2)" 14.2 13.3 15.0 15.5 15.4 16.5 15.8 14.1 14.7 16.1 14.7 14.4 13.9 15.5 17.1 11.4 17.6 12.7 12.3 14.8 14.9 16.6 17.0 15.4 17.0 14.7 15.4 13.8 12.9 13.6 24.8 11.6 16.3 15.6 14.9 15.1 12.4 15.7 13.6 11.3 13.3 15.1 16.3 14.8 17.7 14.7 18.8 15.3 23.8 17.9 11.4 19.2 14.3 10.5 17.0 25.0 29.7 31.9 32.3 31.3 29.5 36.1 27.6 35.8 35.2 25.5 24.2 41.5 31.5 51.9 31.4 24.3 26.9 28.7 34.4 32.1 50.8 20.6 43.6 28.0 20.4 32.4 26.5 35.9 26.5 28.3 35.4 32.8 52.4 38.7 45.7 34.0 36.4 40.6 29.5 48.8 26.3 25.1 24.8 24.8 39.6 28.5 27.6 32.4 21.3 43.1 40.2 22.2 30.5 21.0 30.6 64.1 40.1 33.6 33.2 30.6 31.2 22.6 43.7 40.7 27.7 33.7 24.1 42.1 14.8 9.5 16.1 12.9 8.4 10.2 10.3 9.6 11.6 9.1 7.4 8.4 10.5 7.8 11.3 11.5 11.6 8.4 11.1 15.0 15.4 14.1 14.7 14.8 14.9 14.7 15.4 13.8 15.6 14.8 15.3 17.0 9.2 6.4 7.7 1.6 6.8 4.0 4.0 8.1 5.7 7.1 7.5 4.2 0.8 7.2 9.0 11.0 10.4 10.0 6.7 9.6 3.9 9.8 4.5 7.1 7.7 8.1 7.2 10.8 3.9 7.7 14.1 6.4 7.7 6.8 1.3 9.7 5.3 7.4 9.8 1.7 3.8 5.2 0.0 12.5 10.7 4.7 9.6 9.2 7.2 3.7 8.6 7.9 13.4 1.5 5.5 9.3 7.7 9.1 8.5 5.6 8.0 7.5 6.9 5.2 6.6 7.4 11.5 6.8 10.0 5.1 4.1 13.0 6.3 7.7 7.2 3.5 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 1857.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 4897.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356, HPA073506" Supported Supported Vesicles "Intracellular and membrane" NA NA Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: " "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 952.2 889.3 493.2 462.0 505.8 754.0 776.2 520.6 722.8 714.1 589.9 791.0 398.1 861.8 1505.1 399.3 653.0 612.4 1025.9 491.6 629.9 627.3 569.7 889.9 327.7 551.5 515.3 479.1 651.3 837.0 529.2 490.4 593.0 528.2 524.5 743.2 271.5 878.8 552.6 926.8 381.9 564.0 751.0 527.7 602.5 797.3 226.1 545.0 195.1 663.1 592.6 287.3 843.3 544.3 560.5 481.0 669.0 432.6 430.8 4897.7 2932.4 577.5 1914.8 3104.6 979.2 1048.9 750.3 939.2 120.5 581.2 2608.7 787.7 436.3 301.7 732.6 1197.9 372.5 248.7 760.9 542.8 443.3 2006.7 338.5 1699.0 2315.1 639.7 1164.8 979.2 2305.1 1052.2 64.6 386.8 936.3 3062.5 626.3 64.1 439.5 395.7 1062.7 880.7 146.0 949.3 345.7 1699.3 1433.6 170.1 425.8 528.3 392.5 3348.6 630.4 546.4 1089.6 948.0 710.1 514.8 984.9 649.8 377.3 239.3 92.5 2023.9 208.1 1326.3 1279.9 610.3 1857.5 323.2 458.8 235.2 111.0 126.9 260.0 473.0 73.9 55.9 186.0 656.0 733.0 320.4 309.8 121.6 850.4 493.2 505.8 520.6 722.8 491.6 629.9 551.5 515.3 479.1 528.2 527.7 545.0 560.5 798.7 512.8 689.0 28.1 147.6 567.2 1382.5 3135.4 155.4 190.3 606.5 601.1 820.9 836.4 1789.7 875.4 152.2 608.3 322.0 1083.4 232.8 2621.2 16.7 446.7 766.7 916.3 581.1 97.0 8.8 3429.0 2756.5 1538.0 371.1 727.3 1030.0 531.6 739.6 423.9 3372.5 33.7 9.3 1251.6 1715.1 854.6 1698.3 65.5 1727.3 1146.7 1993.9 11.2 575.7 893.8 487.1 21.1 26.5 3437.4 1394.0 1157.0 326.9 2039.2 878.1 794.2 1012.6 258.8 1255.6 1845.2 1278.7 43.8 68.9 137.1 400.5 2708.1 310.4 645.8 761.6 1868.9 PRPH "NEF4, PRPH1" ENSG00000135406 Peripherin P41219 12 49293252-49298686 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.7;intestine: 17.5" "Group enriched" "Detected in some" 6 "Early spermatids: 327.5;Late spermatids: 920.2" "Group enriched" "Detected in some" 4 "endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5" "Region enhanced" "Detected in many" "pons: 53.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 367.0" "Group enriched" "Detected in many" 4 "hypothalamus: 19.4;pons and medulla: 35.1" "Region enriched" "Detected in many" 8 "spinal cord: 256.8" "CAB002437, HPA039277, HPA063887" Enhanced NA NA "CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142" "unprognostic (1.73e-2)" "unprognostic (3.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.04e-3)" "unprognostic (1.88e-2)" "unprognostic (6.29e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.38e-2)" "unprognostic (1.24e-1)" "unprognostic (4.25e-3)" "unprognostic (3.63e-2)" "unprognostic (5.73e-2)" "unprognostic (4.86e-3)" "unprognostic (6.36e-5)" 3.0 14.6 2.2 7.6 4.3 0.0 1.8 0.5 7.2 3.1 0.3 17.5 4.8 0.8 0.1 0.5 3.1 0.6 0.8 0.8 4.5 0.3 0.1 0.9 0.2 37.9 5.2 0.9 0.7 1.3 0.1 2.9 0.3 53.7 2.3 2.1 1.5 0.5 1.5 0.4 0.9 9.0 2.0 9.2 1.2 5.2 13.3 1.9 0.1 0.5 0.2 0.1 1.5 8.4 18.0 0.0 0.7 0.0 367.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.7 1.6 0.4 1.3 0.2 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.7 0.0 0.2 2.0 0.0 2.2 0.4 0.0 1.6 86.6 1.5 0.2 0.8 0.0 0.0 1.7 0.1 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.3 0.5 7.2 0.8 4.5 37.9 5.2 0.9 53.7 9.2 1.9 18.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 10.8 0.3 0.8 0.4 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 327.5 0.5 0.1 1.4 92.3 0.0 0.1 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 25.2 0.1 1.0 0.0 0.0 0.9 920.2 5.9 0.7 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.8 0.1 38.1 0.0 0.1 14.1 96.1 19.4 0.3 0.4 0.0 0.1 0.0 0.5 0.2 AVIL "ADVIL, DOC6, FLJ12386, p92" ENSG00000135407 Advillin O75366 12 57797376-57818704 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 9.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 28.3;Gastric mucus-secreting cells: 23.9" "Cancer enriched" "Detected in all" 5 "glioma: 9.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Cell line enhanced" "Detected in some" "Daudi: 4.6;RH-30: 8.5;U-266/84: 3.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA058864 Approved NA NA "HPA058864: AB_2683838" "unprognostic (3.86e-2)" "unprognostic (9.86e-3)" "unprognostic (4.36e-2)" "unprognostic (3.38e-3)" "unprognostic (1.36e-1)" "unprognostic (7.79e-4)" "unprognostic (1.42e-1)" "unprognostic (7.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.02e-2)" "unprognostic (1.04e-2)" "unprognostic (1.07e-2)" "unprognostic (2.57e-4)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (3.29e-1)" "prognostic favorable (2.71e-4)" 1.3 3.6 2.0 1.5 3.5 0.7 1.3 7.8 2.5 1.2 2.2 2.8 3.0 1.0 3.2 0.6 1.3 1.9 1.5 2.2 2.0 1.6 1.7 1.5 0.7 2.2 2.1 2.1 1.6 3.8 0.3 1.9 1.4 3.3 1.5 1.6 4.9 1.7 1.3 9.4 5.6 3.4 1.2 1.1 1.3 1.1 0.8 2.2 1.0 2.9 1.5 0.8 1.2 1.0 3.3 0.3 0.4 2.9 2.0 0.7 1.3 0.2 0.2 0.1 0.0 0.2 0.0 1.0 4.6 0.4 0.4 0.0 1.6 0.1 0.0 0.3 0.0 1.4 0.5 1.3 0.9 0.3 1.9 0.0 0.9 0.7 0.1 0.4 0.1 0.4 0.4 0.3 1.9 0.0 0.4 0.0 2.0 0.2 0.0 1.0 0.1 8.5 0.3 0.2 0.9 0.6 0.0 0.4 0.3 1.0 0.6 0.6 0.0 0.2 1.2 0.1 0.9 0.0 0.9 3.5 0.5 0.5 0.3 0.3 0.2 0.8 1.4 0.6 0.4 0.7 0.6 1.1 0.5 0.3 1.1 1.0 0.8 5.0 0.4 0.5 0.8 0.3 0.0 2.0 3.5 7.8 2.5 2.2 2.0 2.2 2.1 2.1 3.3 1.1 2.2 3.3 5.3 3.2 7.7 15.0 3.4 2.9 3.7 3.6 4.0 28.3 8.8 7.4 1.2 5.7 4.6 3.7 18.8 1.3 1.3 11.9 0.0 4.7 6.0 6.1 5.4 5.0 7.7 2.7 13.4 6.0 1.0 5.4 23.9 11.1 1.3 2.0 12.8 2.8 2.2 8.4 8.5 3.4 10.2 3.3 3.1 2.8 4.1 2.6 3.6 5.6 3.4 11.3 5.2 5.5 7.0 4.5 3.7 0.7 1.3 4.9 2.9 1.1 3.2 21.6 6.6 8.8 4.1 1.4 2.7 2.5 4.1 2.9 2.7 5.8 4.1 2.7 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431672 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 41.8;ovary: 33.4" "Group enriched" "Detected in some" 4 "granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "HEL: 40.1;K-562: 22.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 11 "hippocampal formation: 9.4" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 41.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.5 0.0 0.2 0.0 0.9 0.4 0.0 0.0 0.0 0.0 33.4 12.6 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.2 0.1 0.1 0.0 0.0 5.8 0.7 9.2 0.3 0.0 0.0 1.8 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 40.1 0.0 0.8 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 3.5 2.6 0.0 0.1 1.5 0.0 4.2 0.1 2.1 0.1 2.7 0.0 0.1 26.0 36.1 11.4 0.3 0.1 0.0 0.0 0.0 0.0 1.2 0.0 2.5 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.3 0.0 0.0 0.3 0.8 94.9 0.1 0.0 LACRT LACRITIN ENSG00000135413 Lacritin Q9GZZ8 12 54630811-54634895 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "salivary gland: 13.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 304 "breast cancer: 15.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 230000 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GDF11 "BMP-11, BMP11" ENSG00000135414 "Growth differentiation factor 11" O95390 12 55743122-55757264 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.0;retina: 21.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 76.6;Cone photoreceptor cells: 77.2;Horizontal cells: 57.2;Rod photoreceptor cells: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 127.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060985, HPA069609" Approved Approved Vesicles "Secreted to blood" No No 46400 340000 Vesicles "HPA060985: AB_2684403, HPA069609: AB_2686159" "unprognostic (5.21e-2)" "unprognostic (1.62e-1)" "unprognostic (3.20e-2)" "unprognostic (2.41e-2)" "unprognostic (2.78e-2)" "unprognostic (3.39e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (8.96e-3)" "unprognostic (1.23e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.69e-1)" "unprognostic (1.62e-2)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" "unprognostic (9.48e-2)" 3.1 4.0 26.0 3.8 17.9 1.8 2.3 17.9 16.8 6.7 14.3 4.4 1.7 7.7 2.0 2.4 5.1 4.7 7.3 18.3 20.7 2.8 1.3 3.7 2.9 24.6 23.8 14.7 5.7 3.0 2.9 4.7 2.0 20.4 6.1 1.6 21.8 4.9 9.5 1.8 1.4 3.7 4.6 18.7 5.6 2.7 1.1 22.0 4.7 3.6 2.1 1.8 6.0 3.5 20.8 4.9 7.6 32.8 18.6 24.4 17.8 8.2 10.1 9.5 12.5 10.7 26.0 2.1 9.5 13.0 10.5 5.9 4.6 25.0 18.0 4.3 18.2 22.7 11.7 12.3 4.1 4.9 9.8 127.7 17.2 1.0 18.3 5.2 14.0 16.4 12.7 13.2 30.1 16.0 9.2 16.0 8.5 26.4 0.3 18.9 25.1 8.9 5.9 7.7 6.6 22.2 13.6 6.2 2.8 2.6 13.3 10.7 10.7 10.1 15.0 22.9 11.9 7.4 8.1 2.6 4.9 8.0 9.7 10.8 0.2 0.2 0.5 1.2 0.1 1.0 0.7 0.7 0.7 0.2 0.7 0.6 0.8 0.3 0.2 0.4 0.7 0.5 0.1 26.0 17.9 17.9 16.8 18.3 20.7 24.6 23.8 14.7 20.4 18.7 22.0 20.8 8.4 0.0 1.1 19.2 10.9 0.5 9.8 0.6 4.0 76.6 6.3 6.6 25.6 1.5 0.9 0.0 77.2 3.6 16.6 1.5 0.0 5.0 0.6 9.9 35.2 8.0 10.7 11.1 4.3 1.4 5.3 13.3 3.1 18.0 5.7 7.6 6.4 0.2 1.6 57.2 10.8 1.9 0.0 1.9 0.7 0.8 9.0 4.4 3.6 1.9 4.1 30.6 22.6 17.1 3.2 3.3 4.1 5.7 4.1 9.8 3.4 0.5 0.1 53.1 13.1 31.1 18.1 2.9 4.1 3.0 0.9 4.7 18.9 7.2 2.2 6.2 GLS2 "GA, GLS, hLGA, LGA" ENSG00000135423 "Glutaminase 2" Q9UI32 12 56470944-56488414 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 206.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 41.3;Hepatocytes: 54.9;Inhibitory neurons: 31.6" "Cancer enriched" "Detected in single" 4 "liver cancer: 1.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Cell line enhanced" "Detected in some" "A-431: 7.6;Daudi: 42.8;Hep G2: 7.4;SCLC-21H: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038608 Uncertain NA NA "HPA038608: AB_10673176" "unprognostic (5.59e-2)" "unprognostic (1.51e-2)" "unprognostic (8.73e-2)" "unprognostic (7.15e-2)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "unprognostic (3.27e-3)" "unprognostic (1.98e-6)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.29e-2)" "unprognostic (1.52e-1)" "unprognostic (5.65e-5)" "unprognostic (1.42e-2)" "unprognostic (2.59e-1)" "unprognostic (9.02e-2)" "unprognostic (4.44e-2)" 0.2 1.6 3.0 0.2 3.8 0.1 1.3 5.1 12.2 0.4 0.1 0.6 0.3 0.9 2.3 1.5 4.1 0.2 0.2 3.7 4.3 2.0 206.6 1.4 0.9 5.1 2.4 5.6 0.8 21.4 5.6 5.8 0.0 6.0 1.4 1.6 11.3 1.5 2.3 0.0 2.8 0.6 0.5 0.4 0.5 1.5 0.6 1.8 1.3 1.4 0.0 1.5 0.6 0.7 8.9 7.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 4.3 1.2 42.8 0.5 0.0 0.0 0.8 0.0 6.5 0.0 0.0 6.0 0.0 0.4 7.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 3.2 1.2 0.5 0.0 0.1 6.6 3.9 3.4 12.6 0.5 1.3 0.3 0.0 1.0 4.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.8 1.7 0.4 0.0 0.3 1.8 2.2 0.0 0.0 0.0 0.0 0.5 0.7 3.0 3.8 5.1 12.2 3.7 4.3 5.1 2.4 5.6 6.0 0.4 1.8 8.9 0.2 0.0 2.7 5.5 2.3 1.7 4.8 4.6 10.8 10.7 0.9 1.7 0.0 0.0 4.5 0.0 6.2 0.2 0.1 0.1 7.9 0.5 0.0 0.3 0.2 0.5 1.2 8.0 41.3 2.0 0.0 0.5 1.1 0.2 1.3 0.3 2.5 54.9 0.1 3.3 31.6 0.1 0.0 1.6 0.7 0.0 0.9 0.1 1.8 3.7 0.2 3.1 0.0 8.0 3.3 0.7 0.1 0.0 0.9 1.3 0.0 0.6 1.7 10.2 0.0 0.3 0.2 0.6 1.5 5.5 1.1 0.3 1.1 0.0 0.3 1.3 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 264.8" "Group enriched" "Detected in many" 6 "Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 309.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" NA NA 1200000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favorable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (9.59e-5)" 134.6 8.3 16.3 18.7 16.9 1.8 69.6 14.3 28.4 28.1 14.2 71.5 17.8 45.9 12.5 24.1 56.6 31.1 159.3 32.7 20.1 11.5 10.3 15.7 6.5 18.5 16.1 11.7 19.2 5.2 6.2 12.7 1.9 20.6 34.2 9.0 2.4 15.0 37.7 264.8 14.4 27.6 96.1 15.7 10.2 35.5 9.0 18.9 3.4 26.3 155.4 3.3 46.9 25.7 19.5 0.2 4.1 7.5 12.3 66.5 13.4 0.7 5.4 8.7 11.7 11.8 8.4 6.5 2.3 7.4 3.4 0.9 1.1 5.1 0.3 10.0 0.2 3.8 0.8 2.8 3.2 0.5 0.3 2.7 19.1 0.2 64.2 0.3 309.1 0.2 2.2 0.9 1.6 37.8 5.3 0.3 3.1 20.9 1.7 0.4 0.1 28.7 0.6 0.2 0.2 0.9 2.8 0.6 0.2 48.0 4.0 0.9 13.9 0.0 1.3 12.4 0.8 8.4 3.2 2.2 0.9 57.8 8.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.3 16.9 14.3 28.4 32.7 20.1 18.5 16.1 11.7 20.6 15.7 18.9 19.5 11.9 0.0 0.0 87.5 0.3 1.9 0.5 0.1 0.6 2.4 1.2 3.4 124.5 2.8 0.0 1.8 4.2 0.0 0.3 0.7 0.0 0.3 0.3 1.1 1.2 9.5 7.7 0.4 17.6 0.0 0.1 5.0 0.5 1.1 0.0 6.2 0.7 1.4 0.6 0.0 9.4 1.8 0.0 1.9 2.7 0.1 6.5 2.2 3.6 9.4 0.0 3.4 0.0 6.6 3.7 0.3 0.1 6.4 0.1 0.8 2.6 0.8 0.1 0.6 164.3 65.8 110.6 4.1 2.9 0.7 2.3 0.1 0.5 0.3 0.9 0.3 TESPA1 "ITPRID3, KIAA0748" ENSG00000135426 "Thymocyte expressed, positive selection associated 1" A2RU30 12 54948015-54984762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;lymphoid tissue: 75.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 202.7;granulocytes: 120.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HEL: 247.1;HMC-1: 187.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058823, HPA079222" Approved Supported Cytosol NA NA Cytosol "HPA058823: AB_2683828, HPA079222: " "unprognostic (1.98e-5)" "unprognostic (3.70e-4)" "unprognostic (3.87e-4)" "unprognostic (1.13e-3)" "unprognostic (3.20e-2)" "unprognostic (4.55e-4)" "unprognostic (2.29e-3)" "unprognostic (5.34e-4)" "unprognostic (3.83e-4)" "unprognostic (1.35e-2)" "unprognostic (3.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.50e-2)" "unprognostic (4.11e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" 1.2 0.5 28.3 14.0 39.1 14.7 1.8 19.3 81.9 1.9 20.1 3.7 3.1 2.4 4.9 1.9 1.3 4.9 1.0 39.8 26.2 0.8 1.0 5.8 36.7 21.0 22.7 34.2 7.0 0.9 0.7 0.6 0.5 27.9 1.5 4.8 1.0 1.4 1.1 1.4 1.0 7.6 2.1 18.4 13.6 3.9 0.9 22.3 75.9 1.1 0.6 36.7 4.0 1.1 49.5 0.2 0.4 0.6 0.4 0.7 0.7 3.2 0.0 0.7 0.2 0.3 0.0 0.4 17.5 0.2 0.7 0.6 0.4 0.7 0.4 0.3 20.0 0.6 247.1 0.8 0.3 0.6 13.6 187.7 0.5 0.4 0.4 0.7 0.5 0.0 41.5 1.0 16.3 0.4 0.4 39.1 1.5 0.5 0.2 0.2 9.3 0.3 2.7 0.6 0.9 0.5 0.2 0.6 0.1 0.5 0.7 0.2 3.6 0.3 0.4 0.4 0.2 0.2 11.1 0.4 12.0 1.7 4.0 0.4 43.1 1.4 1.6 38.3 1.3 43.5 17.9 126.0 57.5 16.0 15.0 175.8 98.8 3.1 57.2 1.5 5.6 92.6 64.5 28.3 39.1 19.3 81.9 39.8 26.2 21.0 22.7 34.2 27.9 18.4 22.3 49.5 0.7 0.0 4.3 10.1 9.9 0.5 0.0 0.0 0.0 0.0 0.2 0.3 1.5 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 32.4 202.7 0.0 0.0 1.3 0.0 0.1 120.1 0.0 0.4 0.5 0.1 0.0 2.5 0.0 0.0 1.3 1.6 0.0 0.9 4.6 1.8 2.8 3.3 0.0 25.7 7.1 5.1 0.0 0.0 1.2 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.0 0.0 0.2 0.0 0.3 0.0 37.0 0.8 0.1 0.0 FAM186B "C12orf25, DKFZP434J0113" ENSG00000135436 "Family with sequence similarity 186 member B" Q8IYM0 12 49582885-49605639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 46.4" "Group enriched" "Detected in some" 17 "Early spermatids: 85.1;Late spermatids: 101.5;Spermatocytes: 38.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039736, HPA040028" Uncertain NA NA "HPA039736: AB_10795295, HPA040028: AB_10795684" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.94e-1)" "unprognostic (3.00e-1)" "unprognostic (5.55e-2)" "unprognostic (1.53e-1)" "unprognostic (3.37e-3)" "unprognostic (1.44e-1)" "unprognostic (4.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-5)" "unprognostic (1.56e-1)" "unprognostic (6.18e-2)" "unprognostic (2.10e-5)" "unprognostic (7.23e-2)" 0.2 0.5 0.4 0.5 0.4 0.5 0.3 0.8 0.6 0.3 0.0 0.2 0.3 0.3 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.5 0.8 0.2 0.6 0.6 0.2 0.4 0.8 1.6 0.9 0.3 0.1 0.9 0.3 0.1 0.6 0.4 0.2 0.6 1.2 0.3 0.1 0.1 0.3 0.4 46.4 0.2 0.1 1.0 0.3 0.2 0.3 0.3 0.5 0.3 1.4 0.1 0.4 0.1 0.0 0.7 0.0 0.1 0.0 0.1 1.8 0.5 1.0 0.3 0.1 0.3 0.5 0.2 0.2 0.1 0.3 0.4 0.6 0.9 0.2 0.1 1.1 0.3 0.0 0.3 0.2 0.7 0.1 0.1 0.4 1.0 0.8 0.2 1.0 0.1 0.1 0.2 0.4 0.5 0.4 0.1 0.4 0.5 0.4 1.1 0.3 0.5 0.2 0.8 0.3 0.6 0.5 0.5 0.1 0.5 0.4 0.3 0.5 0.4 1.8 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.8 0.6 0.4 0.2 0.6 0.2 0.4 0.9 0.1 0.2 0.5 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 85.1 0.2 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 101.5 1.2 0.2 0.0 1.0 0.0 0.1 0.0 0.0 1.0 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.5 0.2 38.2 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RDH5 "HSD17B9, RDH1, SDR9C5" ENSG00000135437 "Retinol dehydrogenase 5" Q92781 12 55720367-55724705 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sensory transduction, Steroid metabolism, Vision" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 95.3;liver: 59.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Proximal enterocytes: 49.9;Rod photoreceptor cells: 62.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 28.5;ASC TERT1: 24.3;hTEC/SVTERT24-B: 15.3;hTERT-RPE1: 24.5;LHCN-M2: 15.4;U-87 MG: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063345 Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA063345: AB_2684992" "unprognostic (1.04e-2)" "unprognostic (6.45e-2)" "unprognostic (1.80e-1)" "unprognostic (2.67e-1)" "unprognostic (3.66e-2)" "unprognostic (1.48e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.35e-2)" "unprognostic (4.04e-2)" "unprognostic (4.05e-1)" "unprognostic (1.26e-3)" "unprognostic (7.63e-2)" "unprognostic (8.79e-2)" "unprognostic (3.46e-2)" "unprognostic (2.12e-3)" "unprognostic (3.27e-2)" 95.3 1.9 1.8 4.1 2.1 1.0 34.5 2.0 2.6 2.4 3.0 13.1 18.7 4.3 7.9 3.2 4.6 4.3 8.9 1.7 3.2 8.8 59.4 1.9 1.9 2.5 2.0 1.5 2.1 3.6 0.3 1.8 0.6 2.3 4.4 4.4 3.3 3.3 2.3 6.1 2.5 15.6 19.7 2.3 2.2 5.9 2.4 2.2 0.9 2.7 7.7 0.8 5.6 2.3 3.2 0.7 1.4 0.8 0.5 28.5 24.3 0.6 3.8 4.2 0.7 1.4 0.5 7.9 1.0 0.7 2.1 0.2 0.3 0.3 0.1 0.6 1.0 1.3 0.1 2.0 2.1 0.8 0.1 0.3 10.5 1.0 15.3 0.1 24.5 0.3 0.5 0.2 1.3 15.4 0.7 0.4 0.2 0.3 3.7 2.3 0.6 0.4 0.5 0.2 0.8 0.2 1.1 0.2 0.5 3.4 0.2 0.7 0.6 0.5 1.5 1.5 1.1 0.9 1.1 0.5 0.2 26.7 0.4 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.2 0.5 0.2 0.0 0.2 0.0 0.2 0.3 0.2 0.5 0.0 0.0 1.8 2.1 2.0 2.6 1.7 3.2 2.5 2.0 1.5 2.3 2.3 2.2 3.2 2.5 9.6 2.2 0.0 4.6 1.9 4.5 3.9 0.6 24.3 2.7 5.0 3.9 10.0 2.4 1.8 62.6 2.2 5.3 23.5 1.9 2.1 0.8 1.8 2.9 3.7 11.5 0.0 0.0 2.6 1.2 3.9 11.2 1.5 0.0 4.9 3.6 18.4 0.6 16.8 0.0 10.3 0.0 4.5 7.9 2.3 13.4 2.3 5.4 0.0 4.7 8.2 12.3 0.0 0.0 3.6 18.6 6.8 0.7 3.2 49.9 13.0 4.7 62.9 13.1 14.0 9.3 3.9 6.4 0.8 1.7 1.5 4.8 5.3 15.9 3.1 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 235.4" "Cell type enhanced" "Detected in many" "dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" Yes NA "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 6.3 2.5 96.1 10.1 77.9 14.6 1.8 1.4 235.4 0.8 0.0 2.2 3.0 2.0 0.3 2.3 1.0 4.3 13.3 178.5 13.1 0.8 1.1 3.4 17.0 18.9 1.3 97.2 1.5 3.7 1.8 7.6 2.5 40.0 1.9 1.5 4.7 2.3 0.8 15.2 3.2 5.8 1.0 0.0 11.5 3.3 1.0 11.3 15.1 2.5 10.0 11.4 3.2 1.0 50.0 7.3 10.5 19.8 5.8 0.0 0.0 11.3 4.8 0.9 0.1 0.5 1.2 6.6 18.4 1.5 0.0 3.6 4.4 0.1 0.2 0.0 20.3 3.1 20.5 1.6 3.4 0.1 21.2 40.3 0.0 0.0 0.1 0.1 8.4 0.0 21.3 0.0 39.8 0.0 12.6 37.4 13.5 3.2 2.3 10.6 15.5 98.8 13.4 0.0 6.0 5.6 20.5 2.6 3.6 4.3 0.1 2.6 14.8 11.2 5.5 9.0 10.5 3.6 16.8 10.9 9.4 9.8 13.9 9.4 3.8 0.5 0.6 2.7 0.8 2.9 1.2 2.8 3.0 0.8 0.8 1.1 1.7 3.8 1.4 0.4 0.8 4.2 1.1 96.1 77.9 1.4 235.4 178.5 13.1 18.9 1.3 97.2 40.0 0.0 11.3 50.0 3.6 3.2 1.1 0.0 5.7 0.0 0.3 0.0 0.0 10.0 0.8 0.5 5.8 1.5 0.6 0.0 0.0 0.1 16.4 0.2 0.0 0.1 0.4 0.1 0.7 4.2 0.0 2.1 22.2 0.0 0.2 0.9 2.0 0.2 2.5 0.0 1.1 0.1 1.3 8.4 12.3 0.5 0.0 2.2 1.1 1.1 0.0 3.0 0.0 1.9 3.9 0.5 17.5 5.0 1.2 0.1 0.1 0.7 11.4 0.3 0.3 0.1 0.0 2.3 32.9 2.2 16.2 0.8 0.4 0.2 0.4 0.0 16.4 0.3 0.2 0.0 BLOC1S1 "BLOS1, BORCS1, GCN5L1" ENSG00000135441 "Biogenesis of lysosomal organelles complex 1 subunit 1" P78537 12 55716037-55720087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 1180.5;Proximal tubular cells: 719.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021381 Approved NA NA "HPA021381: AB_2228026" "unprognostic (1.27e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (1.59e-1)" "unprognostic (6.77e-2)" "unprognostic (2.22e-1)" "prognostic favorable (2.19e-4)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.83e-2)" 122.8 169.9 253.7 82.2 260.3 225.7 113.5 267.2 296.3 89.4 253.6 177.7 146.6 119.9 152.4 178.6 134.5 77.7 157.6 255.7 272.7 196.2 221.1 114.0 108.4 264.1 260.4 250.1 94.3 111.0 177.1 110.5 72.2 263.8 114.1 169.0 82.4 108.2 77.8 312.3 115.4 156.7 100.5 266.2 176.3 166.2 55.4 263.1 148.1 119.8 202.9 112.6 126.3 107.0 278.5 134.9 258.3 133.7 113.3 170.6 217.1 75.7 93.7 154.4 112.9 111.8 148.5 267.3 148.6 166.5 194.6 95.2 91.7 70.8 132.4 110.9 142.5 160.5 84.6 220.5 224.9 163.6 104.5 177.7 139.8 137.3 108.2 83.1 145.8 152.4 172.0 77.5 221.0 183.3 294.0 164.3 123.8 84.6 219.1 134.2 110.9 129.9 163.3 182.9 164.2 85.1 141.6 85.1 86.0 150.5 93.2 177.5 169.2 114.2 87.2 142.7 96.5 74.0 99.4 126.2 134.6 158.8 97.2 121.8 612.0 471.8 746.5 238.6 543.1 162.2 345.1 224.4 239.8 486.6 326.5 160.9 201.1 631.4 221.7 586.1 409.0 318.2 637.9 253.7 260.3 267.2 296.3 255.7 272.7 264.1 260.4 250.1 263.8 266.2 263.1 278.5 155.2 16.0 20.7 0.0 110.4 83.1 120.0 143.2 61.5 51.6 123.8 158.5 37.6 160.2 92.0 160.0 25.0 98.1 159.5 439.5 369.8 207.3 53.7 123.9 60.6 92.1 99.5 191.3 0.0 320.7 182.3 105.1 103.0 88.6 20.2 77.9 122.4 378.7 430.7 30.3 0.0 266.8 179.0 403.1 213.2 213.9 134.2 238.6 176.1 0.0 347.9 192.0 230.7 0.0 0.0 291.0 409.3 98.9 66.9 122.6 1180.5 719.6 114.2 92.9 78.9 133.9 208.5 46.9 55.0 86.6 88.9 73.2 111.5 77.4 256.7 180.7 KRT85 "Hb-5, KRTHB5" ENSG00000135443 "Keratin 85" P78386 12 52360006-52367481 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "skin 1: 111.6" "Group enriched" "Detected in some" 12 "Early spermatids: 6.2;Late spermatids: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "A549: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA049778 Supported NA NA 110000000 "HPA049778: AB_2680877" "unprognostic (1.36e-2)" "unprognostic (3.93e-1)" "unprognostic (7.27e-3)" "unprognostic (5.71e-2)" "unprognostic (2.36e-1)" "unprognostic (4.72e-2)" "unprognostic (9.22e-4)" "unprognostic (1.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.38e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 111.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "glioma: 175.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497" "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 68.1 88.6 34.0 53.2 36.4 72.6 77.4 37.0 37.2 81.8 34.9 63.2 40.6 98.2 64.7 57.6 70.0 57.6 59.4 32.6 37.2 59.0 51.9 58.5 67.3 36.3 36.3 32.4 98.1 71.5 64.1 68.2 52.8 35.5 53.2 63.9 14.6 54.9 54.6 48.6 59.1 47.6 81.1 36.9 51.9 55.2 24.3 36.4 68.3 66.6 53.2 71.1 72.2 61.2 37.0 207.1 235.7 295.7 268.0 253.7 220.7 210.4 116.1 347.9 468.5 385.7 338.2 189.1 297.4 200.2 173.6 293.2 158.0 396.3 2594.8 354.9 150.9 209.0 275.4 149.5 237.9 297.0 309.7 182.5 221.5 180.9 294.2 326.7 326.4 304.8 280.0 301.3 242.7 2819.4 304.9 296.7 256.5 347.0 208.0 249.8 267.3 8902.5 272.1 147.2 320.6 271.2 251.7 205.3 150.2 310.0 195.1 202.8 380.7 146.1 233.6 217.0 265.8 233.1 122.2 206.1 450.8 214.1 291.3 286.9 9.5 46.5 10.3 79.6 65.6 81.8 93.5 70.0 72.5 66.7 90.0 93.0 84.4 4.4 56.6 41.9 84.9 57.0 73.6 34.0 36.4 37.0 37.2 32.6 37.2 36.3 36.3 32.4 35.5 36.9 36.4 37.0 47.1 22.4 30.8 7.8 40.0 89.7 78.6 83.4 74.0 15.9 67.2 82.2 0.7 51.5 35.3 47.8 10.4 82.9 26.1 15.9 70.5 93.1 13.5 14.9 77.7 50.8 45.6 98.0 5.2 62.5 134.5 79.4 28.5 22.6 69.1 60.2 39.7 35.8 132.9 18.5 6.7 42.2 40.7 25.1 44.1 8.0 64.0 31.2 53.4 6.5 41.9 51.4 29.9 5.5 8.0 48.3 18.9 63.2 57.8 113.9 14.0 80.9 7.4 17.9 32.9 62.1 61.9 32.1 48.3 74.5 86.1 46.8 32.3 78.8 78.7 49.4 PPP1R1A ENSG00000135447 "Protein phosphatase 1 regulatory inhibitor subunit 1A" Q13522 12 54575387-54588659 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 243.4;skeletal muscle: 839.5;tongue: 273.5" "Cell type enriched" "Detected in many" 4 "Distal tubular cells: 1348.0" "Cancer enhanced" "Detected in many" "liver cancer: 17.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007811, HPA041542" Approved NA NA "CAB007811: AB_598171, HPA041542: AB_2677542" "unprognostic (6.39e-3)" "unprognostic (2.61e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.19e-3)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.04e-2)" "unprognostic (2.71e-3)" "unprognostic (1.76e-3)" "unprognostic (2.88e-3)" "unprognostic (7.68e-3)" "unprognostic (2.17e-1)" "unprognostic (8.49e-3)" "unprognostic (7.49e-2)" 243.4 2.6 36.1 1.1 60.4 0.3 171.2 25.7 45.0 1.5 19.5 21.6 3.1 2.2 0.7 10.4 3.9 1.5 108.1 38.1 41.2 93.3 139.2 1.0 0.5 37.1 31.3 35.1 7.8 14.3 21.0 1.8 0.0 41.2 8.0 1.8 14.7 9.8 3.2 839.5 6.2 13.3 3.3 23.7 0.5 28.0 2.2 28.5 0.2 2.6 273.5 0.5 5.4 1.5 33.3 0.0 0.0 3.9 0.0 8.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 5.4 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 29.4 0.0 0.0 0.0 0.0 0.2 32.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 60.4 25.7 45.0 38.1 41.2 37.1 31.3 35.1 41.2 23.7 28.5 33.3 7.9 0.0 0.0 3.3 3.4 0.1 0.0 0.0 0.0 2.2 23.7 40.6 300.7 5.7 0.0 18.4 0.0 0.0 0.5 0.0 1348.0 3.5 1.6 10.4 0.5 4.6 2.4 2.7 3.1 0.4 0.1 24.5 0.0 13.8 0.0 21.0 6.4 218.4 0.6 112.7 1.8 2.1 0.0 3.8 0.0 1.9 1.2 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.5 2.5 0.1 1.2 0.0 0.3 0.5 156.8 0.0 2.8 0.0 19.2 21.6 0.2 5.9 0.0 0.3 0.0 0.9 4.2 2.0 0.2 TROAP TASTIN ENSG00000135451 "Trophinin associated protein" Q12815 12 49323236-49331731 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.5;lymphoid tissue: 37.1;testis: 29.4" "Cell type enhanced" "Detected in many" "Early spermatids: 71.5;Erythroid cells: 75.6;Late spermatids: 70.2;Spermatocytes: 29.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 8.6" "Lineage enriched" "Detected in many" 4 "T-cells: 8.6" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA044102 Uncertain NA Yes "HPA044102: AB_10963691" "unprognostic (1.47e-1)" "unprognostic (2.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.92e-3)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.43e-3)" "unprognostic (2.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.08e-3)" "unprognostic (3.51e-2)" "unprognostic (0.00e+0)" "unprognostic (1.80e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (5.17e-2)" 1.3 1.5 0.2 7.3 0.3 51.5 1.4 0.1 0.7 1.6 0.2 6.8 9.0 1.2 0.6 13.6 0.7 0.8 0.7 0.2 0.3 0.9 1.6 2.4 11.3 0.5 0.3 0.2 0.8 0.9 0.7 0.4 5.2 0.3 0.9 9.3 0.6 2.5 0.4 0.3 7.7 7.6 2.8 0.3 7.1 5.4 29.4 0.4 37.1 0.8 0.3 14.7 1.9 5.4 0.6 95.9 73.9 92.4 69.7 2.8 6.2 71.2 45.4 43.4 129.5 73.1 163.7 73.5 64.6 21.9 33.7 70.7 74.6 70.4 44.0 75.7 51.9 101.8 90.9 120.4 53.7 1.9 66.5 93.8 1.5 6.0 86.9 59.8 21.1 75.1 68.0 57.2 108.9 52.7 123.0 122.9 101.8 43.4 269.3 110.2 62.5 78.6 83.9 31.7 35.0 59.9 41.0 56.0 107.4 32.7 53.6 88.2 50.1 25.0 33.5 91.2 69.4 124.8 58.3 68.8 83.0 32.3 73.8 38.4 0.2 0.0 0.1 0.1 0.0 0.2 1.4 2.1 2.3 0.3 1.4 0.1 0.5 0.0 2.0 0.1 0.0 8.6 0.5 0.2 0.3 0.1 0.7 0.2 0.3 0.5 0.3 0.2 0.3 0.3 0.4 0.6 0.1 0.0 0.0 0.0 4.6 3.8 1.5 2.8 1.2 0.6 2.1 2.8 0.5 0.0 1.8 0.0 0.0 14.1 1.0 3.7 0.0 0.7 71.5 1.9 1.3 1.9 1.2 75.6 0.0 0.7 23.6 3.3 10.2 2.7 0.0 16.0 5.7 1.1 15.7 0.0 0.0 7.9 10.2 6.7 3.7 70.2 1.8 4.0 1.8 0.0 0.9 0.0 6.2 0.0 0.0 0.8 1.8 0.4 17.0 1.1 0.7 0.1 0.2 0.4 0.0 0.7 3.5 29.1 9.3 15.6 2.0 4.0 2.5 0.9 12.7 3.6 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750219 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enriched" "Detected in all" 4 "glioma: 54.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 23.1 30.0 9.8 11.3 11.3 5.6 23.3 11.3 15.7 26.0 11.7 20.2 16.6 26.4 13.4 20.6 26.1 21.1 26.5 10.0 14.2 24.8 21.0 23.0 11.9 11.7 10.8 9.7 25.8 25.5 33.0 24.6 12.6 11.2 22.3 10.8 30.0 25.8 13.7 21.1 18.1 18.7 8.5 11.8 20.9 23.2 8.0 10.8 9.9 30.5 21.4 8.8 21.2 20.3 13.8 9.5 23.4 21.1 5.4 44.3 24.0 13.5 15.8 11.7 4.6 5.1 16.7 46.4 7.6 32.7 29.0 9.4 17.5 5.7 26.7 10.7 23.1 15.4 10.7 18.7 6.6 45.2 10.6 17.9 29.6 30.2 13.7 30.3 22.1 14.6 4.6 7.5 19.9 19.6 19.4 9.2 5.9 4.3 18.3 7.0 10.5 139.8 20.0 15.7 19.0 6.6 16.7 15.6 21.3 10.5 4.5 41.1 15.8 27.6 11.3 9.5 5.6 7.4 28.9 8.1 4.1 32.7 6.3 19.2 25.4 26.3 16.4 35.8 28.6 34.8 31.1 28.5 30.7 27.6 31.0 28.3 26.2 5.8 35.4 42.0 58.3 22.1 33.0 9.8 11.3 11.3 15.7 10.0 14.2 11.7 10.8 9.7 11.2 11.8 10.8 13.8 37.1 48.1 32.4 8.1 23.8 11.2 46.4 37.4 22.2 43.2 32.0 27.4 5.1 20.0 31.4 31.3 41.7 20.9 29.8 19.9 9.8 37.6 1.2 18.5 32.5 26.7 26.5 8.2 9.1 39.0 15.2 31.7 11.7 20.4 45.0 28.9 22.1 21.6 22.4 21.9 9.1 21.6 32.6 18.0 16.4 1.8 25.7 24.2 32.0 8.4 21.6 62.7 35.0 11.1 13.3 37.6 20.3 17.3 18.4 30.5 30.6 18.1 27.9 60.4 19.7 22.3 31.9 9.2 7.7 16.1 12.6 24.5 20.4 35.3 19.4 31.8 B4GALNT1 "beta1-4GalNAc-T, GALGT, SPG26" ENSG00000135454 "Beta-1,4-N-acetyl-galactosaminyltransferase 1" Q00973 12 57623409-57633239 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5" "Cancer enriched" "Detected in many" 6 "glioma: 10.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008968 Enhanced "Intracellular and membrane" NA NA 35000 "HPA008968: AB_1078253" "unprognostic (3.18e-1)" "unprognostic (8.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.33e-3)" "unprognostic (2.54e-1)" "unprognostic (2.70e-3)" "unprognostic (3.73e-5)" "unprognostic (1.26e-2)" "unprognostic (1.72e-1)" "unprognostic (2.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.18e-14)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (1.44e-2)" "unprognostic (4.92e-4)" 1.9 1.2 31.6 1.9 35.4 0.0 0.7 35.3 53.7 1.1 7.6 2.1 0.5 2.1 2.7 0.7 0.8 1.1 2.9 41.2 27.8 0.4 0.4 0.7 0.6 23.1 19.2 36.4 0.3 0.3 0.3 1.8 0.4 27.9 2.6 1.3 4.3 1.8 5.1 9.6 0.6 1.2 2.5 13.1 0.6 0.9 0.7 26.4 0.3 1.2 7.3 1.0 1.3 1.6 35.9 7.5 38.2 18.2 38.7 0.3 0.1 0.4 3.0 11.3 19.0 17.5 2.8 21.9 3.0 47.9 13.2 35.9 3.3 15.3 2.1 5.2 67.4 2.6 1.8 10.1 9.9 0.4 3.1 4.1 0.1 0.9 11.0 0.5 6.7 0.2 11.4 8.7 34.8 2.4 13.5 2.5 0.1 13.0 0.9 7.7 0.1 27.1 8.0 0.1 0.1 34.9 12.3 3.1 1.1 0.4 0.9 7.0 3.3 0.0 22.8 28.1 24.0 26.1 37.0 34.0 2.6 28.9 2.3 45.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.6 35.4 35.3 53.7 41.2 27.8 23.1 19.2 36.4 27.9 13.1 26.4 35.9 0.8 0.0 0.0 2.6 0.0 0.4 0.0 0.0 0.0 10.0 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 1.0 0.8 0.0 0.0 22.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 21.9 13.4 0.0 0.0 0.0 0.3 0.7 2.8 0.1 3.6 2.8 2.6 0.7 0.0 4.5 2.7 0.5 0.0 3.0 0.0 0.1 0.0 0.2 0.0 2.6 6.6 0.6 7.5 1.6 4.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093656-51173135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.0;Inhibitory neurons: 75.9;Microglial cells: 69.3;Oligodendrocyte precursor cells: 79.4;Oligodendrocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA070247: AB_2686239" "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 16.8 13.0 13.2 18.7 15.0 9.9 17.1 14.6 16.5 18.6 11.4 17.2 15.0 18.1 16.2 13.6 19.7 13.6 17.9 13.9 14.4 16.2 11.4 13.6 21.2 13.4 13.8 13.1 18.8 13.9 25.2 14.3 18.9 13.7 18.7 20.5 32.4 16.4 15.2 26.9 14.4 15.2 18.3 13.2 18.6 15.3 9.2 13.4 27.5 17.2 22.3 26.2 15.6 13.5 17.8 17.3 29.5 43.0 40.4 25.2 31.3 64.1 30.7 18.6 29.8 17.4 52.4 37.6 1.5 27.9 29.4 21.9 33.8 56.0 35.2 29.4 35.5 28.3 47.4 26.6 23.8 20.3 57.9 48.4 21.3 33.3 29.4 47.8 34.0 28.4 15.1 54.1 0.1 32.0 0.0 55.2 39.5 64.0 39.9 55.3 41.2 23.6 0.4 39.2 39.4 41.1 36.0 38.8 34.6 28.1 41.7 13.0 49.0 24.3 27.1 27.9 27.8 28.4 30.8 53.3 0.1 25.8 35.3 19.5 7.4 6.1 6.6 2.3 5.4 3.8 2.8 2.4 2.6 5.6 1.8 3.1 2.4 2.1 6.9 7.2 2.2 3.8 3.3 13.2 15.0 14.6 16.5 13.9 14.4 13.4 13.8 13.1 13.7 13.2 13.4 17.8 9.3 9.6 16.4 57.8 11.0 6.6 6.9 10.7 9.1 21.6 11.5 10.5 23.8 8.6 8.7 12.9 20.9 13.2 19.6 11.4 5.9 9.2 0.8 11.0 14.1 10.2 10.8 5.9 73.0 7.7 10.5 9.7 10.7 14.6 10.8 22.5 12.5 9.3 13.7 10.1 75.9 13.2 10.2 21.1 10.8 0.7 12.2 17.0 10.6 69.3 36.8 9.8 24.7 79.4 103.6 12.2 11.0 10.9 7.3 11.1 8.7 9.4 9.2 27.3 0.0 14.0 13.1 6.7 11.3 9.9 5.3 16.7 10.7 12.2 13.4 6.4 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266890-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "heart muscle: 125.6;skeletal muscle: 283.4;tongue: 391.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 120.5;Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: AB_2686061" "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavorable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favorable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favorable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 6.9 33.6 17.3 3.6 17.8 4.7 7.3 18.8 19.9 8.7 20.8 8.2 3.2 10.1 16.3 9.1 10.9 6.4 125.6 17.3 18.5 17.1 37.3 6.8 7.8 17.9 19.1 16.5 10.3 18.1 15.8 25.6 2.8 17.7 12.0 5.1 26.2 12.7 9.9 283.4 4.9 9.8 7.3 17.2 12.3 8.9 6.8 18.6 8.0 10.4 391.0 9.0 8.5 6.8 17.5 3.7 15.2 14.4 9.4 8.1 8.0 6.0 5.2 12.5 18.3 18.2 11.9 5.6 21.5 11.3 13.3 5.1 3.5 16.8 3.0 10.9 3.2 17.0 10.2 14.1 12.4 11.0 8.1 5.9 8.4 4.9 13.6 5.3 11.4 9.8 14.9 6.8 8.8 17.1 5.1 11.7 29.1 12.0 2.7 8.7 24.2 15.6 14.5 10.1 2.2 20.5 22.0 18.1 3.8 5.8 10.6 5.8 8.9 6.9 3.4 10.0 9.5 5.3 18.1 20.4 10.8 10.2 7.6 2.6 14.1 1.1 1.1 7.4 1.0 7.4 12.7 7.0 7.8 1.7 6.8 8.3 8.1 0.4 5.8 0.9 6.9 5.1 3.9 17.3 17.8 18.8 19.9 17.3 18.5 17.9 19.1 16.5 17.7 17.2 18.6 17.5 8.1 3.2 7.2 12.4 20.8 13.4 13.0 2.3 15.4 17.9 8.4 12.7 120.5 7.2 3.2 11.0 16.7 5.8 32.0 2.0 52.8 2.8 0.2 13.7 6.3 9.6 16.2 4.2 3.9 4.6 6.8 10.9 6.6 5.1 4.5 8.2 3.6 15.2 5.2 32.0 6.2 3.4 4.1 2.5 12.1 1.7 8.4 4.5 12.4 3.7 2.5 26.5 13.4 4.5 2.3 2.7 2.5 17.0 18.6 4.4 3.1 18.1 11.0 32.3 39.5 22.1 14.0 4.0 22.2 4.9 10.5 3.0 19.5 10.4 4.4 5.9 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 358.7;parathyroid gland: 99.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 4.0 42.0 148.3 4.9 188.6 0.0 1.8 103.8 358.7 6.5 0.0 7.3 2.2 10.0 8.1 4.2 14.4 10.3 26.3 184.3 157.4 2.1 0.4 2.2 3.7 216.0 150.4 197.5 3.9 2.4 99.0 42.4 0.2 232.0 14.3 3.5 72.9 2.7 9.1 1.2 0.9 6.4 12.3 78.6 1.9 4.3 30.7 206.6 1.9 1.8 1.2 2.9 9.6 10.6 275.3 0.0 0.5 0.5 0.7 2.7 1.7 0.1 0.7 3.6 0.7 0.4 0.4 0.0 0.0 0.1 5.1 0.2 0.3 1.5 0.0 0.4 0.0 0.0 2.9 0.0 0.0 12.2 0.1 0.1 1.1 0.2 2.7 0.0 0.0 0.0 0.3 1.6 0.4 0.7 0.0 0.1 0.0 0.1 16.7 0.0 0.0 0.2 0.0 0.0 0.0 4.4 6.7 0.0 0.2 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.1 0.1 0.4 0.0 0.0 38.5 0.0 0.4 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.1 148.3 188.6 103.8 358.7 184.3 157.4 216.0 150.4 197.5 232.0 78.6 206.6 275.3 0.2 0.0 0.0 31.0 0.0 0.3 0.3 0.7 0.6 141.9 2.3 2.3 1.1 0.0 0.4 0.0 2.1 0.0 0.3 0.1 0.0 0.1 202.2 0.1 0.5 0.7 0.0 0.0 77.6 0.2 0.1 16.7 1.1 0.0 26.1 0.0 0.0 0.0 0.4 232.2 105.1 2.2 12.2 0.0 0.4 52.0 5.0 0.5 0.0 13.1 0.0 35.6 0.0 45.2 55.5 0.1 0.0 5.3 0.3 0.5 0.0 0.4 0.0 20.2 0.0 0.9 0.7 4.8 5.8 0.5 0.3 0.1 0.5 0.4 0.7 0.3 PAN2 "hPAN2, KIAA0710, USP52" ENSG00000135473 "Poly(A) specific ribonuclease subunit PAN2" Q504Q3 12 56316223-56334053 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (9.10e-3)" "unprognostic (1.03e-1)" "unprognostic (7.28e-2)" "unprognostic (7.35e-3)" "unprognostic (3.80e-1)" "unprognostic (1.74e-3)" "unprognostic (4.23e-3)" "prognostic unfavorable (2.77e-4)" "unprognostic (4.19e-1)" "unprognostic (3.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" 6.4 8.8 4.3 5.9 5.6 7.5 7.5 5.4 6.0 7.9 6.3 7.3 10.0 9.2 14.2 5.0 9.7 6.7 7.0 3.9 4.6 7.7 16.1 7.4 8.5 5.0 4.9 3.5 12.8 10.0 14.2 11.7 8.3 5.4 6.7 8.3 16.1 8.0 8.2 7.0 8.4 8.8 7.6 4.7 10.1 9.6 13.6 4.9 16.9 14.9 6.8 10.1 7.1 6.8 7.7 4.3 6.4 15.5 4.9 13.3 15.0 10.1 3.2 4.4 7.1 3.2 3.9 8.3 11.8 12.2 6.3 3.8 8.8 18.6 12.3 4.0 5.2 8.8 15.1 6.6 3.8 11.7 3.3 7.8 14.0 16.3 7.6 22.0 18.7 5.4 24.2 10.3 28.4 4.2 9.4 11.3 7.9 5.2 7.2 4.2 9.7 11.0 21.5 7.0 3.4 12.1 11.0 6.2 7.9 8.0 17.2 10.2 6.4 2.3 7.0 7.0 3.3 3.0 23.9 10.3 7.8 8.7 6.8 6.2 3.2 3.3 1.3 1.3 4.4 1.9 1.6 1.1 1.9 4.2 1.3 2.2 2.7 0.2 2.3 2.2 1.7 1.7 2.0 4.3 5.6 5.4 6.0 3.9 4.6 5.0 4.9 3.5 5.4 4.7 4.9 7.7 9.7 9.6 17.0 19.2 11.1 5.1 5.4 3.8 6.8 27.4 9.5 10.2 9.8 2.8 8.3 5.5 27.1 8.2 7.9 5.4 1.9 3.7 1.8 8.6 9.4 9.4 14.4 13.3 11.0 2.2 4.8 7.2 18.3 13.7 6.3 15.0 10.4 18.3 5.4 15.2 13.9 10.8 4.1 7.0 5.0 2.6 11.1 8.2 1.8 9.4 5.2 7.3 3.1 10.1 32.1 2.8 8.7 6.4 9.2 4.1 7.3 3.5 13.4 17.1 6.6 11.4 6.9 26.9 7.6 7.1 3.8 5.1 6.6 12.6 9.5 3.6 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.6;esophagus: 15.5;lymphoid tissue: 10.8" "Cell type enhanced" "Detected in many" "Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.4 0.2 0.0 2.4 0.0 8.6 0.5 0.0 0.0 1.7 0.0 1.6 4.0 0.2 0.0 15.5 0.2 0.4 0.1 0.0 0.0 0.9 0.6 0.4 4.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 1.5 0.0 2.0 0.1 0.0 2.6 4.4 0.7 0.0 1.0 0.9 6.3 0.0 10.8 0.1 0.0 5.0 0.6 5.9 0.1 27.8 23.6 27.6 21.1 0.6 1.9 17.5 15.9 8.6 28.8 19.2 15.8 22.7 49.9 9.5 6.8 17.4 20.2 32.6 9.9 14.3 13.7 32.8 30.6 24.1 11.1 0.1 19.5 25.2 0.6 0.6 15.5 7.6 2.8 15.4 22.2 42.6 41.0 9.1 29.2 30.6 16.4 22.5 14.5 12.9 29.3 30.2 21.4 4.2 11.6 18.9 15.8 11.9 20.4 10.1 13.0 36.9 12.7 8.2 14.5 27.2 11.9 25.5 32.5 29.7 31.9 8.2 19.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.3 0.6 0.9 0.3 0.5 0.6 0.0 1.0 1.3 0.9 0.0 0.4 3.7 0.0 1.9 0.6 2.7 0.0 0.2 0.8 0.2 0.8 1.0 3.5 1.3 0.7 0.0 2.3 1.1 3.6 0.7 0.0 4.4 0.7 6.8 2.6 0.0 0.4 2.7 22.4 0.6 2.1 1.2 0.0 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.5 1.5 1.3 0.4 2.1 0.4 22.6 6.6 0.2 0.0 0.0 0.4 0.9 5.5 4.1 7.4 0.6 0.3 0.4 0.1 2.8 0.4 KRT7 "CK7, K2C7, K7, SCL" ENSG00000135480 "Keratin 7" P08729 12 52232520-52252186 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 913.2;thyroid gland: 598.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 560.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 4 "monocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000028, HPA007272, HPA007315, CAB079970" Enhanced Approved "Intermediate filaments,Cytosol" NA NA 1300000000 "Intermediate filaments" Cytosol "CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: " "unprognostic (2.71e-3)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (1.27e-1)" "unprognostic (5.44e-3)" "unprognostic (2.74e-1)" "prognostic unfavorable (9.42e-5)" "prognostic unfavorable (7.78e-5)" "unprognostic (4.54e-2)" "prognostic favorable (2.77e-9)" "unprognostic (2.82e-1)" "unprognostic (1.43e-2)" "unprognostic (3.28e-1)" "unprognostic (3.98e-3)" 15.9 0.7 0.0 1.4 0.0 0.3 275.6 0.0 0.3 48.9 0.4 1.4 0.4 13.0 15.3 92.4 76.6 83.2 3.7 0.0 0.8 101.4 14.3 328.0 1.7 0.3 0.0 0.0 2.4 57.8 5.6 12.1 267.3 0.3 58.6 0.7 0.3 913.2 215.1 1.7 72.0 1.3 0.4 0.1 0.8 18.0 0.8 0.1 3.4 598.3 2.0 6.8 393.4 20.2 0.5 4.9 2418.2 0.6 1.7 2.8 0.0 2737.9 509.6 0.6 261.3 23.6 7.6 1683.1 0.3 1.4 176.3 0.8 1871.6 0.2 6225.3 13.3 3.0 0.0 2.2 1179.8 8.0 57.4 1.5 1.5 1.3 380.7 1.3 2433.8 1.0 267.4 0.0 0.7 2.2 0.1 13.7 1.8 3.7 7.6 1.1 2.6 2.0 4.8 38.6 1520.5 7463.2 3.5 2.4 5833.6 3363.4 0.0 27.5 130.3 0.0 2028.2 1.9 3.7 2.4 1.1 1.8 0.4 2.0 2.0 1.6 1.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.3 0.1 0.1 0.5 8.1 653.9 109.4 0.0 2.5 3.6 1172.6 173.6 8.0 0.0 451.3 426.3 0.8 724.9 684.8 360.5 0.0 1756.7 8.9 2.2 135.0 2931.3 16.1 106.2 20.4 30.6 6.6 0.0 0.1 2143.5 4196.1 29.9 14.3 253.2 3.8 0.1 4.2 2.9 189.9 0.0 0.0 3.5 954.2 3.4 4.6 140.0 3.7 11.0 131.6 0.0 35.6 0.0 0.0 0.0 0.0 6163.7 0.3 0.4 1.4 2386.6 0.2 8.5 249.2 0.0 0.0 7.6 72.1 0.6 1.3 35.3 2.3 1442.5 9.2 0.0 4.4 1900.8 ZC3H10 "FLJ14451, ZC3HDC10" ENSG00000135482 "Zinc finger CCCH-type containing 10" Q96K80 12 56118260-56127514 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039236, HPA062265" Uncertain Approved Vesicles NA NA Vesicles "HPA039236: AB_10795463, HPA062265: AB_2684730" "unprognostic (1.19e-1)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (7.39e-2)" "unprognostic (2.27e-1)" "unprognostic (3.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-2)" "unprognostic (2.07e-2)" "unprognostic (2.80e-1)" "unprognostic (1.31e-5)" "unprognostic (4.42e-2)" "unprognostic (2.69e-2)" "unprognostic (6.45e-2)" "unprognostic (1.40e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-1)" 2.7 3.1 1.8 3.0 2.5 1.4 2.6 3.1 2.4 3.6 1.0 3.1 1.7 4.0 2.2 2.0 3.3 1.7 2.5 1.8 1.8 2.3 2.9 2.4 2.9 2.6 2.4 1.5 4.1 3.7 2.5 2.4 2.0 2.6 2.6 1.3 4.0 2.9 2.5 5.1 2.3 2.3 2.1 2.0 3.9 2.4 8.8 2.3 3.0 2.7 3.1 2.2 3.4 2.7 3.9 3.3 5.8 4.6 3.6 5.5 3.7 3.5 3.9 2.6 2.3 1.8 1.6 1.9 3.7 6.3 2.8 1.3 4.4 2.4 1.4 1.5 6.3 6.1 5.5 5.8 1.7 3.4 5.4 3.3 2.4 3.1 2.7 3.1 4.3 3.5 4.2 2.9 6.5 3.1 2.4 5.6 2.1 3.1 1.9 4.7 5.5 5.0 3.4 1.9 1.6 4.4 4.3 2.3 3.4 3.5 3.4 5.6 4.5 5.0 2.2 5.1 4.3 2.9 5.4 3.7 2.0 2.9 2.4 5.4 3.6 5.0 5.9 4.7 6.0 4.9 3.6 3.7 4.1 5.3 3.9 3.7 3.6 3.6 8.0 10.5 2.4 2.0 3.7 1.8 2.5 3.1 2.4 1.8 1.8 2.6 2.4 1.5 2.6 2.0 2.3 3.9 4.2 0.0 4.2 1.3 5.6 0.8 2.5 1.3 1.8 9.0 3.2 2.2 3.0 5.7 0.8 7.3 20.9 6.3 5.9 7.1 15.6 5.3 47.6 2.2 4.3 5.1 1.2 5.2 0.6 3.0 2.7 3.3 1.1 2.6 2.5 5.9 6.8 3.0 5.3 13.5 0.9 3.8 2.0 7.4 1.6 9.5 5.3 4.0 3.6 1.0 10.6 9.2 9.2 0.0 1.5 3.3 2.3 5.3 1.6 2.3 6.0 4.7 2.7 17.3 0.0 6.2 5.3 16.2 15.5 1.9 1.7 6.4 3.2 5.1 3.9 1.4 HNRNPA1 "ALS20, hnRNP-A1, HNRPA1" ENSG00000135486 "Heterogeneous nuclear ribonucleoprotein A1" P09651 12 54280193-54287088 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001609, HPA001666, HPA005812, HPA007185, CAB010894" Supported Enhanced Nucleoplasm NA NA 9300000 Nucleoplasm "CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768" "unprognostic (1.38e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-2)" "unprognostic (5.98e-3)" "unprognostic (2.82e-2)" "unprognostic (2.46e-1)" "unprognostic (1.22e-2)" "unprognostic (9.71e-2)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (3.72e-2)" "unprognostic (3.51e-2)" "unprognostic (6.88e-3)" "unprognostic (2.32e-2)" "unprognostic (1.14e-1)" "unprognostic (1.48e-1)" "unprognostic (9.54e-3)" 492.9 414.2 362.6 532.9 380.9 1097.0 647.1 370.7 384.9 737.1 350.5 547.5 451.5 631.2 479.0 514.4 594.3 216.6 378.4 343.0 366.4 430.0 279.2 383.9 691.4 375.9 369.1 329.4 1422.8 561.3 362.6 329.8 451.7 382.7 462.8 450.2 263.5 402.2 413.5 441.0 467.7 440.0 385.4 400.4 437.9 434.5 170.4 382.6 1020.3 399.6 176.0 831.6 518.1 585.8 395.4 1246.7 815.8 2072.5 1717.3 550.5 1057.0 1204.0 911.9 1405.6 1311.7 1153.1 1225.4 1306.6 3183.8 983.8 671.8 354.7 1045.9 1486.5 1393.4 1425.5 1216.4 1041.7 1700.0 1156.1 2250.0 320.4 2712.4 1078.2 845.2 568.3 642.9 1056.1 868.7 1408.6 1474.7 1930.7 1215.3 968.2 1244.6 2969.1 2880.9 2571.8 844.0 675.9 2911.7 1588.9 1574.1 1239.4 1395.0 1260.4 1739.0 758.0 1675.2 1392.3 1031.6 1010.9 1744.5 1063.1 781.6 1164.2 820.6 1395.1 1185.7 1349.3 2249.7 572.5 1646.7 744.0 140.4 423.5 165.9 572.8 513.1 893.3 576.5 746.2 657.5 704.5 501.8 851.2 810.1 41.0 823.3 437.7 556.5 683.4 1333.2 362.6 380.9 370.7 384.9 343.0 366.4 375.9 369.1 329.4 382.7 400.4 382.6 395.4 372.4 304.5 521.4 20.9 1018.9 1416.1 1039.8 1252.9 900.9 254.1 745.1 541.3 166.2 697.7 612.0 294.3 93.8 2076.2 900.8 407.3 739.6 1296.2 181.5 304.7 706.7 624.8 824.0 1032.4 16.5 2124.2 2894.5 600.5 458.7 400.7 528.9 790.7 562.2 183.1 1006.9 109.4 18.3 1130.9 459.8 863.9 1048.2 115.6 1050.7 609.2 588.7 21.5 1374.4 411.0 1304.9 23.1 34.1 1162.7 731.2 741.8 702.2 696.8 693.2 838.6 288.3 195.2 453.6 714.5 704.1 217.0 338.1 1030.6 1261.9 2178.8 958.6 690.9 1543.8 897.8 ACVR1B "ActRIB, ACVRLK4, ALK4, SKR2" ENSG00000135503 "Activin A receptor type 1B" P36896 12 51951699-51997078 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026126, HPA063761" Approved Approved Cytosol NA NA Cytosol "CAB026126: , HPA063761: AB_2685115" "unprognostic (8.66e-2)" "unprognostic (5.72e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.68e-2)" "unprognostic (5.29e-2)" "unprognostic (2.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.52e-2)" "unprognostic (9.02e-2)" "unprognostic (6.60e-2)" "unprognostic (8.96e-2)" "unprognostic (4.79e-2)" 16.6 10.4 15.7 10.1 21.0 13.7 13.3 14.0 23.6 12.3 10.1 24.8 28.4 8.9 18.2 21.1 15.4 12.4 9.6 20.4 15.6 34.7 30.1 14.9 6.5 13.1 14.6 21.9 9.5 41.1 53.1 14.8 11.2 15.1 14.1 24.7 17.5 33.0 15.5 13.2 44.5 26.3 8.1 9.4 8.9 25.1 15.8 16.8 7.7 11.6 8.9 7.5 12.7 18.9 18.5 11.4 24.3 18.6 10.3 20.9 16.2 10.5 12.6 14.2 13.1 9.9 49.5 17.1 5.0 17.2 13.8 14.6 19.6 17.8 15.2 13.5 7.3 21.0 12.3 5.9 15.6 23.8 19.9 43.8 32.0 19.4 14.8 18.6 13.9 18.7 17.7 13.3 14.9 11.8 23.2 19.1 17.2 18.0 24.0 8.5 10.2 14.4 6.4 37.2 17.0 23.5 19.5 13.6 19.2 9.0 13.1 21.1 12.8 12.0 9.0 13.6 10.2 6.1 9.0 6.8 6.7 9.7 9.4 11.8 2.5 1.2 3.9 0.3 1.8 0.5 0.0 0.3 0.3 0.7 0.2 0.8 0.4 1.0 0.0 2.2 0.3 0.5 0.3 15.7 21.0 14.0 23.6 20.4 15.6 13.1 14.6 21.9 15.1 9.4 16.8 18.5 8.0 3.2 13.4 8.1 2.9 18.6 10.1 9.2 23.3 45.3 11.3 8.6 5.9 17.2 12.0 25.8 29.2 0.7 2.0 49.7 3.9 17.7 2.9 12.3 8.1 10.9 24.6 0.8 34.8 14.4 0.8 12.6 19.9 9.0 11.4 9.4 17.9 24.4 4.0 37.0 30.2 28.7 2.0 16.7 5.3 8.4 9.9 10.0 7.2 9.4 10.1 8.8 1.0 21.6 11.3 13.3 22.1 9.4 2.3 15.1 31.8 17.0 15.8 24.5 6.6 17.5 12.2 3.8 16.5 17.7 25.3 0.5 4.6 5.6 24.7 15.5 OS9 "ERLEC2, OS-9" ENSG00000135506 "OS9 endoplasmic reticulum lectin" Q13438 12 57693955-57721557 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 3551.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011518, HPA013694" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 10000 "Endoplasmic reticulum" "CAB011518: AB_776918, HPA013694: AB_1854812" "unprognostic (1.67e-2)" "unprognostic (4.20e-1)" "unprognostic (3.93e-2)" "unprognostic (1.50e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-3)" "unprognostic (4.78e-2)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (1.64e-1)" "unprognostic (5.67e-3)" "unprognostic (2.23e-1)" "unprognostic (1.83e-2)" "unprognostic (2.78e-1)" "unprognostic (1.67e-2)" "unprognostic (4.81e-2)" "unprognostic (2.21e-2)" 152.3 93.9 61.7 119.7 60.2 150.4 114.4 61.6 61.9 136.8 91.4 159.5 151.3 102.0 142.6 106.0 110.5 107.2 100.0 58.3 70.1 115.9 266.6 131.1 90.4 64.8 60.9 54.7 125.8 272.3 173.0 72.1 142.5 63.0 117.4 133.9 76.2 190.6 103.0 60.1 120.7 144.4 111.2 60.9 106.8 138.4 39.3 67.3 73.3 130.6 66.1 95.0 120.8 104.4 62.8 86.8 170.8 86.2 214.4 440.4 295.6 190.5 211.9 268.4 153.4 154.6 180.2 274.5 110.0 345.3 255.2 118.5 152.9 81.3 137.5 121.2 142.0 97.6 124.0 115.3 164.8 287.1 196.9 307.3 273.7 217.6 150.7 152.6 529.4 258.6 71.7 96.0 427.9 162.2 149.5 53.7 239.7 97.7 172.0 121.2 69.8 3551.9 281.5 116.5 210.6 88.4 116.4 300.3 205.5 176.6 158.1 245.4 381.0 238.9 206.0 122.3 140.4 136.4 253.4 234.6 112.9 173.8 141.6 290.4 175.7 241.2 274.6 72.9 213.0 68.5 50.5 61.1 65.0 172.6 54.3 46.8 54.1 246.4 58.8 182.4 149.0 74.4 218.9 61.7 60.2 61.6 61.9 58.3 70.1 64.8 60.9 54.7 63.0 60.9 67.3 62.8 83.3 86.6 116.7 22.2 65.8 57.7 85.4 103.3 43.9 44.1 61.2 46.6 14.1 80.1 111.8 73.5 77.2 142.4 64.5 153.0 9.8 144.8 6.7 34.0 73.3 90.2 103.6 53.4 19.5 110.1 124.6 113.6 65.7 60.0 91.1 61.6 81.4 161.1 144.8 50.5 27.0 167.3 107.8 121.1 99.1 10.7 113.4 106.1 119.2 29.0 125.0 87.2 53.5 23.6 24.4 94.7 155.4 79.0 141.1 56.5 154.0 53.9 74.0 50.9 92.1 68.3 66.9 38.1 46.4 51.3 51.6 197.7 59.5 64.9 102.4 65.0 MIP "AQP0, LIM1, MP26" ENSG00000135517 "Major intrinsic protein of lens fiber" P30301 12 56449502-56469166 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Transport, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 2.6;Horizontal cells: 1.7;Late spermatids: 2.8;Spermatocytes: 7.3;Spermatogonia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014940 Supported NA NA "HPA014940: AB_2669122" "unprognostic (6.48e-2)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (7.14e-2)" "unprognostic (3.96e-2)" "unprognostic (2.90e-3)" "unprognostic (1.72e-1)" "unprognostic (3.47e-1)" "unprognostic (1.51e-5)" "unprognostic (4.56e-3)" "unprognostic (6.75e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-2)" "unprognostic (3.27e-1)" "unprognostic (2.62e-1)" "unprognostic (8.82e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.6 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.1 0.2 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 7.3 1.6 0.0 0.0 0.3 0.0 0.3 0.0 0.1 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539030-49558337 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 39.7;pituitary gland: 25.9" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.2 2.9 27.1 0.0 22.0 0.2 0.6 0.0 39.7 0.6 0.0 0.2 0.1 0.6 0.1 0.1 5.9 0.3 0.6 27.3 5.2 3.4 0.3 1.0 0.5 4.8 2.4 29.5 0.3 1.3 2.6 25.9 0.0 13.6 0.7 0.0 0.0 0.3 0.4 0.1 0.2 0.3 0.0 0.0 1.4 0.3 2.8 2.9 0.2 1.3 0.0 0.2 0.1 0.3 22.5 0.4 5.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.2 1.7 0.6 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 9.1 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 27.1 22.0 0.0 39.7 27.3 5.2 4.8 2.4 29.5 13.6 0.0 2.9 22.5 0.1 0.0 0.5 4.9 0.0 0.1 0.2 0.5 0.0 0.1 0.1 2.0 1.0 5.7 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 6.0 11.4 0.4 0.1 2.4 0.0 58.2 0.0 0.1 0.6 0.0 0.5 0.0 2.4 0.7 0.0 0.0 1.7 19.2 0.0 0.0 0.6 0.5 10.6 0.3 0.6 0.0 1.0 0.7 0.4 2.1 6.0 2.6 0.1 0.1 1.2 0.1 0.0 0.0 0.2 10.9 0.3 0.0 0.4 0.3 1.1 3.4 0.0 0.3 0.0 0.7 0.0 0.2 0.0 LTV1 "C6orf93, dJ468K18.4, FLJ14909" ENSG00000135521 "LTV1 ribosome biogenesis factor" Q96GA3 6 143843338-143863812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030159, HPA030160, HPA030161" Approved Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001" "unprognostic (2.26e-2)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (5.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "prognostic unfavorable (4.95e-5)" "unprognostic (7.09e-2)" "unprognostic (2.16e-1)" "unprognostic (1.55e-2)" "unprognostic (1.26e-1)" "unprognostic (4.70e-2)" "prognostic unfavorable (6.01e-13)" "unprognostic (2.94e-1)" "unprognostic (6.83e-2)" "unprognostic (8.62e-3)" "unprognostic (1.41e-1)" 24.6 22.8 13.8 22.6 14.7 53.0 24.4 14.7 16.5 18.6 13.8 19.8 15.9 22.4 15.8 23.5 19.5 12.5 17.9 14.0 14.0 14.0 24.8 19.2 26.4 14.4 14.2 12.9 21.4 23.7 14.3 14.1 19.8 14.5 17.7 20.7 10.4 18.1 17.5 37.2 27.5 20.2 21.2 14.0 22.4 20.8 20.9 14.2 16.9 17.1 18.6 25.8 23.3 19.6 16.1 42.5 39.0 45.3 101.4 32.9 39.7 52.5 64.5 47.2 69.7 55.2 63.6 21.6 88.7 50.6 58.7 76.5 46.8 76.3 63.2 96.8 51.2 74.4 175.8 45.1 98.4 57.9 219.0 97.8 45.1 45.5 77.7 84.4 28.7 49.0 51.1 170.3 57.2 54.4 71.7 75.2 92.8 53.6 48.5 42.5 64.1 85.6 40.1 51.9 58.1 40.0 48.2 65.8 53.8 62.3 41.1 30.2 138.1 44.7 44.4 51.6 100.0 120.0 70.9 93.6 118.9 44.5 112.3 63.8 2.0 16.7 7.3 18.9 21.8 20.6 28.6 19.6 20.5 25.3 24.5 21.5 24.9 0.5 36.0 19.5 30.7 18.7 14.2 13.8 14.7 14.7 16.5 14.0 14.0 14.4 14.2 12.9 14.5 14.0 14.2 16.1 19.8 6.4 34.1 9.1 22.1 25.6 22.3 28.8 13.1 9.9 10.8 15.7 25.6 10.0 28.3 7.3 2.1 25.5 22.1 9.0 13.7 29.4 25.0 11.5 29.0 20.6 19.7 18.3 13.7 28.7 30.5 27.6 12.8 14.0 24.7 17.6 11.4 18.0 27.9 11.8 14.2 13.3 38.7 13.1 14.8 10.7 25.7 17.0 5.4 10.3 33.6 9.9 23.7 13.6 13.7 29.9 10.4 27.4 17.6 21.9 6.9 17.3 24.1 10.2 6.6 29.0 24.5 57.5 62.5 18.9 32.1 16.3 16.2 57.8 19.7 16.3 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 134.8" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1501.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol NA NA Cytosol Microtubules "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favorable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.7 8.5 42.0 4.9 78.4 4.9 13.2 52.8 62.4 6.1 1.1 24.8 29.2 2.4 19.6 15.9 10.0 8.3 1.4 42.0 45.3 32.9 17.4 7.1 1.5 71.1 70.5 25.4 1.5 25.4 25.1 12.1 6.9 79.6 20.1 23.4 57.8 20.4 6.5 0.8 17.3 26.9 2.4 59.1 1.8 18.9 27.6 65.7 5.1 16.3 0.2 5.1 12.1 9.7 134.8 25.6 39.2 0.3 0.1 0.2 0.2 40.4 0.7 1.2 0.4 0.7 59.8 26.3 0.1 5.3 0.8 6.7 38.2 11.1 34.6 0.7 0.2 24.6 26.6 69.2 0.5 0.3 26.1 3.0 0.1 31.5 0.2 2.4 1.0 0.2 2.0 18.4 0.6 0.1 88.5 0.2 2.6 5.2 55.3 5.7 0.1 1.0 4.8 23.6 68.4 24.4 5.2 27.4 51.7 0.6 9.1 20.5 2.6 0.5 0.1 1.9 0.4 1.7 4.6 6.4 0.2 0.5 10.1 0.7 2.8 2.3 0.0 0.0 1.6 0.3 1.4 0.5 0.0 5.7 1.6 0.1 0.0 12.2 0.7 3.1 0.0 0.2 0.7 42.0 78.4 52.8 62.4 42.0 45.3 71.1 70.5 25.4 79.6 59.1 65.7 134.8 4.0 57.7 51.4 117.2 1.9 28.2 48.7 21.7 33.6 367.0 29.5 18.4 3.0 28.6 42.9 18.4 146.0 33.1 0.7 67.9 31.3 35.8 293.9 30.4 5.9 4.9 117.7 35.1 217.1 49.0 23.1 4.4 42.8 60.8 0.0 1.2 0.7 37.0 16.3 304.5 258.6 81.5 22.4 3.2 8.5 53.1 6.8 6.2 17.8 15.0 3.2 50.9 0.0 26.2 1501.2 37.2 51.9 3.4 4.4 56.6 60.7 81.8 56.0 104.7 19.7 2.0 5.2 37.5 23.4 49.0 30.4 76.2 3.4 2.8 64.2 62.8 CD164 "DFNA66, MGC-24, MUC-24" ENSG00000135535 "CD164 molecule" Q04900 6 109366514-109382467 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010636 Uncertain "Intracellular and membrane" NA NA "HPA010636: AB_1078447" "unprognostic (1.23e-2)" "unprognostic (1.61e-2)" "unprognostic (3.89e-2)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (1.97e-3)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (8.88e-2)" "unprognostic (1.38e-1)" "unprognostic (7.11e-2)" "unprognostic (1.29e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "unprognostic (1.51e-1)" 263.2 124.8 54.2 120.2 62.1 215.8 213.3 68.0 70.2 152.3 78.4 267.3 254.3 118.1 163.3 95.9 125.9 160.8 92.6 50.4 78.0 300.9 258.9 123.0 139.0 76.0 66.5 46.1 127.5 125.2 221.0 90.2 191.7 73.6 147.3 273.1 36.7 306.4 113.7 96.8 89.9 279.9 117.1 65.7 122.1 275.3 114.6 61.1 133.3 363.6 92.6 124.0 155.6 76.6 80.1 130.0 73.0 34.6 242.9 503.0 496.6 235.7 230.8 304.0 213.7 308.0 148.1 194.9 105.7 218.0 261.5 198.0 125.4 136.9 152.7 315.4 220.1 144.5 177.8 72.0 173.9 294.9 209.5 399.0 384.6 279.7 211.3 186.5 270.3 196.9 86.9 178.9 279.9 287.8 141.1 191.5 251.2 52.9 273.1 119.6 126.3 109.0 135.1 292.2 180.5 40.2 80.9 144.6 184.0 348.6 168.0 167.7 265.0 205.6 138.8 99.1 199.5 188.6 96.3 147.4 121.2 244.0 242.8 147.2 349.0 192.3 167.0 166.8 198.6 175.0 126.2 135.2 155.1 189.7 111.0 138.0 150.1 128.5 255.2 197.5 214.1 192.9 413.8 54.2 62.1 68.0 70.2 50.4 78.0 76.0 66.5 46.1 73.6 65.7 61.1 80.1 76.5 163.5 78.9 22.5 168.1 200.1 180.2 149.6 128.7 33.8 251.1 123.3 70.9 174.5 153.5 281.4 25.0 244.9 372.7 600.0 93.9 178.8 103.8 111.9 109.2 89.2 166.5 92.8 22.1 136.8 407.2 176.3 175.8 151.2 128.6 76.7 98.2 177.4 311.9 33.7 16.4 427.3 215.7 360.4 223.9 97.3 158.8 237.3 247.3 38.4 147.1 113.3 266.8 15.6 83.1 177.6 430.0 182.1 173.6 230.3 425.5 348.0 351.2 44.4 124.9 110.0 138.1 160.5 184.4 143.0 231.0 674.5 165.9 87.7 285.0 334.7 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294991-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 1.8 2.1 2.2 1.3 2.8 2.2 2.2 2.2 3.0 1.7 2.4 2.6 4.3 1.5 1.9 1.6 2.3 1.5 4.6 2.0 2.0 5.1 3.7 1.7 1.9 2.3 2.3 2.0 1.7 2.1 5.4 1.6 2.2 2.4 1.7 3.2 3.1 1.8 1.7 3.7 1.1 3.0 1.7 1.8 2.1 2.8 10.8 2.8 2.3 3.0 4.1 2.1 1.7 1.2 3.4 2.7 1.4 3.4 6.1 3.5 5.1 3.3 3.0 4.4 4.8 4.7 5.7 3.3 4.8 3.8 4.7 5.8 1.5 4.4 4.5 5.4 2.8 2.6 5.7 1.8 6.6 3.5 5.3 2.7 4.7 3.6 3.6 5.8 3.1 2.6 3.5 5.9 2.2 4.5 2.6 0.9 4.8 2.2 4.6 2.8 3.3 4.6 2.8 6.1 2.9 3.7 3.2 2.4 3.5 6.4 4.5 2.8 9.8 3.2 2.9 0.7 2.6 3.4 1.5 2.6 3.7 3.6 6.0 4.5 0.0 1.6 2.8 1.0 1.2 1.3 2.5 1.5 1.9 1.4 3.4 2.1 1.4 0.4 2.4 4.3 1.6 2.3 0.7 2.2 2.8 2.2 3.0 2.0 2.0 2.3 2.3 2.0 2.4 1.8 2.8 3.4 2.4 0.0 4.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 5.0 3.7 0.0 6.4 1.1 0.0 9.8 3.1 0.0 2.6 2.6 2.2 0.0 0.0 0.0 3.8 4.6 1.2 0.0 1.8 2.5 5.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 6.3 5.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.2 0.9 4.5 0.0 0.0 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.4" "Cell type enriched" "Detected in many" 4 "Astrocytes: 502.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.6;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 46.2;TIME: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: AB_2673271" "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 4.1 1.2 15.8 2.4 14.3 0.3 2.5 11.3 10.5 1.6 14.8 13.3 16.0 1.2 4.7 10.4 1.0 3.0 15.8 15.1 10.6 5.9 15.0 12.9 1.0 16.3 14.1 4.7 0.6 3.3 2.1 1.1 4.3 16.5 0.8 11.5 2.7 3.5 0.5 0.5 11.5 23.4 3.3 8.5 2.6 7.9 0.4 14.8 0.6 1.4 0.8 2.1 2.7 4.5 6.6 5.5 4.7 32.8 13.8 9.4 11.4 12.2 4.8 2.3 1.7 1.6 6.2 3.1 0.0 6.0 4.1 3.1 12.3 20.0 12.5 0.9 0.4 13.4 3.4 2.2 46.2 13.8 12.4 2.3 16.7 7.0 0.9 14.1 1.8 23.3 1.9 0.0 1.8 7.2 10.7 1.3 1.0 13.1 3.1 8.8 14.1 3.4 1.0 11.2 13.7 12.4 0.0 5.1 10.3 33.4 21.5 3.3 3.9 64.3 4.6 4.5 4.6 13.3 1.2 2.7 0.0 0.4 5.0 25.5 0.4 1.2 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.2 15.8 14.3 11.3 10.5 15.1 10.6 16.3 14.1 4.7 16.5 8.5 14.8 6.6 6.2 60.9 66.9 502.1 0.5 42.8 3.1 6.6 4.0 0.6 4.1 6.0 22.7 15.7 9.9 29.5 29.2 14.2 0.1 84.1 9.8 3.7 1.1 19.0 1.8 9.3 20.3 2.7 3.3 3.6 3.5 15.6 16.8 16.9 8.8 1.5 26.4 38.1 4.5 37.0 2.9 32.3 6.1 9.4 7.1 0.4 0.6 7.5 21.4 104.0 0.6 15.4 0.0 79.9 2.3 3.9 43.0 0.0 0.1 5.4 87.3 15.8 22.0 1.4 6.6 2.3 4.7 0.0 1.1 7.7 49.2 43.4 1.8 0.8 45.4 10.5 AHI1 "FLJ20069, JBTS3, ORF1" ENSG00000135541 "Abelson helper integration site 1" Q8N157 6 135283407-135498434 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation" "Developmental protein" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 1121.7;Excitatory neurons: 633.2;Inhibitory neurons: 655.2;Rod photoreceptor cells: 1631.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031698, HPA046684" Approved Approved Centrosome NA NA Centrosome "HPA031698: AB_2673997, HPA046684: AB_2679752" "unprognostic (4.00e-2)" "unprognostic (2.86e-1)" "unprognostic (8.13e-2)" "unprognostic (1.02e-1)" "unprognostic (3.17e-2)" "unprognostic (2.18e-2)" "unprognostic (2.70e-3)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (4.58e-2)" "prognostic favorable (7.51e-5)" "unprognostic (2.81e-2)" "prognostic unfavorable (4.07e-9)" "unprognostic (2.49e-2)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" "unprognostic (6.19e-3)" 5.6 9.5 6.7 2.8 5.0 1.8 5.9 12.5 11.0 7.6 5.1 6.3 1.9 7.9 6.2 3.9 8.6 3.3 5.1 4.2 12.3 5.1 5.4 6.5 1.9 5.7 4.5 3.3 10.7 9.2 7.1 29.9 3.3 6.4 9.4 3.9 27.4 6.7 5.8 5.5 4.4 4.8 5.1 1.3 2.8 7.0 13.4 13.7 3.6 7.3 3.4 1.9 7.1 6.3 13.2 4.8 6.7 7.9 8.8 11.6 15.0 3.0 9.3 11.7 8.3 14.5 1.7 3.4 6.8 4.6 9.1 8.4 3.2 6.3 1.7 12.5 6.2 6.3 2.5 15.0 4.2 6.0 14.5 2.8 6.2 3.4 12.7 5.1 15.3 8.8 8.1 14.8 0.6 14.0 4.4 4.4 1.7 5.9 2.8 4.9 6.8 4.3 2.7 3.4 3.0 12.2 6.5 12.2 3.9 5.6 5.3 3.2 7.1 6.9 6.9 8.7 11.3 8.2 6.7 11.0 3.5 8.5 2.3 12.7 11.1 2.5 0.1 6.0 0.8 3.4 11.5 5.7 6.0 3.6 14.1 4.3 5.6 0.2 6.4 0.8 21.9 3.3 0.9 6.7 5.0 12.5 11.0 4.2 12.3 5.7 4.5 3.3 6.4 1.3 13.7 13.2 32.7 38.5 93.8 162.6 35.6 28.7 38.2 11.2 37.0 296.1 41.1 38.6 26.7 25.8 35.1 58.8 1121.7 25.8 64.0 43.9 13.7 29.5 327.4 92.7 65.1 43.8 101.8 10.7 633.2 44.4 18.2 66.8 61.7 50.7 58.3 49.8 21.0 17.5 13.3 329.7 655.2 52.4 24.4 6.5 19.3 375.4 67.7 20.7 32.0 89.9 9.0 93.4 11.3 171.9 272.1 22.5 43.1 65.1 36.6 30.5 7.1 13.6 65.2 1631.4 52.6 81.6 37.6 137.4 127.1 18.1 22.6 28.6 38.6 52.8 42.5 24.9 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors, Transporters" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 5.1 0.9 8.4 1.0 11.3 0.1 5.8 9.6 7.3 7.1 5.0 2.4 1.3 7.6 16.5 1.8 13.6 1.8 18.4 7.1 9.5 2.1 5.4 3.2 0.5 14.4 8.9 5.6 7.2 3.4 2.7 5.6 3.7 10.6 2.1 1.3 5.8 2.0 2.7 16.4 2.0 2.1 1.7 13.4 1.9 2.1 6.6 10.5 0.7 3.1 4.9 0.6 2.7 4.7 11.3 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.5 7.1 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.6 0.0 0.4 0.0 0.0 3.2 0.0 0.3 0.5 0.6 0.9 0.0 0.1 2.3 0.0 0.0 0.0 6.6 3.2 1.9 0.0 14.8 0.3 0.0 0.1 0.8 17.6 0.3 0.1 0.6 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.4 11.3 9.6 7.3 7.1 9.5 14.4 8.9 5.6 10.6 13.4 10.5 11.3 2.8 3.2 1.1 12.4 0.7 3.8 0.5 8.7 3.4 0.4 9.8 5.7 21.5 0.0 2.7 0.0 8.4 0.0 1.4 0.1 9.8 0.1 49.9 46.1 4.2 6.0 0.0 2.7 0.1 1.8 0.1 3.3 1.1 36.8 0.0 73.9 1.8 8.0 0.1 1.7 0.4 0.0 2.0 0.8 3.0 80.6 6.5 0.6 3.6 5.6 0.0 34.8 3.1 2.5 23.4 1.1 0.1 23.3 3.1 0.3 0.0 6.4 5.4 5.2 52.6 17.5 41.8 16.2 15.1 7.7 2.0 0.0 2.0 2.8 0.1 0.3 PKIB PRKACN2 ENSG00000135549 "CAMP-dependent protein kinase inhibitor beta" Q9C010 6 122471917-122726373 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.4;intestine: 91.6;parathyroid gland: 64.2;placenta: 61.0" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8" "Cancer enhanced" "Detected in all" "breast cancer: 16.3" "Region enriched" "Detected in all" 4 "cerebellum: 69.4" "Immune cell enriched" "Detected in some" 11 "myeloid DC: 34.8" "Lineage enriched" "Detected in many" 11 "dendritic cells: 34.8" "Cell line enhanced" "Detected in many" "AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7" "Region enhanced" "Detected in all" "cerebellum: 63.0" "Region enhanced" "Detected in all" "cerebellum: 45.0" HPA030156 Approved NA NA "HPA030156: AB_10602816" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (9.45e-2)" "prognostic unfavorable (4.72e-7)" "unprognostic (1.94e-2)" "unprognostic (5.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (2.47e-7)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" 2.2 5.9 5.2 9.1 4.7 0.2 23.5 69.4 6.5 4.9 4.4 91.6 15.7 3.4 3.4 5.3 5.5 5.8 0.5 6.3 6.3 2.8 8.3 4.2 2.2 12.3 8.6 4.2 0.8 6.3 64.2 22.3 61.0 16.9 6.2 63.0 56.5 8.5 2.4 0.7 9.2 28.6 3.9 4.3 3.3 34.7 4.2 8.0 3.8 1.1 0.6 4.2 5.5 1.3 12.3 0.1 2.8 71.8 0.3 0.6 0.3 62.4 0.0 0.8 0.3 1.2 0.4 3.0 0.0 0.4 0.0 3.8 0.3 0.0 1.5 0.8 0.4 3.7 1.2 3.9 1.7 0.2 0.0 12.3 0.3 1.2 1.2 15.3 34.0 0.3 0.5 22.3 0.4 0.2 84.9 0.3 0.4 29.6 91.2 112.5 0.6 10.8 0.4 187.1 10.6 157.7 0.2 0.0 17.1 2.0 39.4 12.0 1.8 5.7 0.2 47.3 0.2 6.2 0.2 0.3 0.2 46.7 1.5 0.4 0.0 0.6 0.0 0.0 3.2 0.7 0.0 0.0 0.0 34.8 0.1 0.4 0.1 0.1 1.9 0.3 0.5 0.4 0.7 5.2 4.7 69.4 6.5 6.3 6.3 12.3 8.6 4.2 16.9 4.3 8.0 12.3 3.0 3.2 3.9 17.0 4.6 19.8 2.3 2.5 2.8 23.6 94.8 53.3 0.3 2.8 10.2 1.8 4.2 542.7 0.9 750.2 19.6 22.6 106.0 5.3 1.6 3.9 98.0 4.0 5.5 35.8 420.5 6.9 52.0 5.5 38.7 0.3 1.1 3.8 53.1 6.7 15.5 94.9 14.2 75.5 251.9 251.1 1.2 51.2 44.4 9.4 25.5 15.2 0.0 6.0 8.5 50.4 355.4 0.4 1.2 13.8 255.0 26.9 58.3 54.8 6.6 0.3 2.7 3.3 5.8 12.4 17.0 959.8 3.5 0.2 92.9 8.3 TAAR5 PNR ENSG00000135569 "Trace amine associated receptor 5" O14804 6 132588673-132589686 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051703 Uncertain NA NA "HPA051703: AB_2681580" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;testis: 1.4" "Cell type enhanced" "Detected in some" "Astrocytes: 3.3;Early spermatids: 7.0;Excitatory neurons: 2.3;Inhibitory neurons: 4.5;Late spermatids: 2.1;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 2.5;Spermatocytes: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026665 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.8 1.1 0.6 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.1 0.5 0.2 1.5 0.8 1.1 0.6 0.7 0.7 0.4 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440724-109443919 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.4" "Cell type enhanced" "Detected in many" "Early spermatids: 179.4;Late spermatids: 359.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favorable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favorable (1.70e-4)" 6.4 8.9 7.8 8.7 7.2 12.8 10.6 9.4 7.7 10.8 13.3 12.8 13.6 7.1 15.6 24.7 21.6 8.8 6.6 7.3 7.4 12.3 7.6 9.8 13.4 7.1 7.3 6.7 8.2 17.9 22.3 11.2 6.0 7.2 13.3 12.7 6.5 15.7 5.9 4.2 21.8 12.4 5.0 8.0 13.4 14.3 53.4 7.0 10.4 13.5 1.7 17.2 10.5 14.5 8.7 13.1 14.8 7.7 12.2 13.2 7.1 25.5 4.3 15.7 10.5 9.8 14.0 10.3 7.1 9.0 9.3 22.1 16.4 7.8 18.7 6.3 9.1 20.5 8.2 15.9 8.7 11.0 9.1 9.4 7.7 21.3 9.3 18.4 11.8 9.8 12.4 16.3 12.2 5.3 18.7 14.8 19.7 2.1 17.3 7.5 10.4 3.6 7.7 19.3 21.8 10.1 8.4 8.2 24.9 19.3 6.2 7.9 17.2 6.3 4.7 6.8 3.8 16.3 8.3 2.3 4.6 9.1 8.6 8.5 6.2 9.0 10.8 6.9 8.6 7.8 14.4 7.8 8.2 11.2 20.4 5.6 5.9 2.5 7.3 7.8 14.3 8.2 6.0 7.8 7.2 9.4 7.7 7.3 7.4 7.1 7.3 6.7 7.2 8.0 7.0 8.7 3.9 12.8 7.2 1.6 15.9 9.8 12.9 13.8 8.6 1.3 8.9 6.7 2.1 7.2 11.8 12.9 4.2 10.3 9.1 26.1 1.9 19.2 179.4 28.4 4.0 4.4 8.4 4.2 1.4 19.8 18.5 6.1 25.0 4.3 0.0 3.5 3.6 3.6 9.5 0.0 0.5 27.1 14.2 4.1 11.2 359.7 9.3 7.2 8.8 2.8 9.9 3.7 6.2 0.0 1.7 15.4 27.7 9.1 9.8 15.0 37.5 9.3 67.1 4.9 13.1 3.1 5.8 69.9 10.9 13.8 18.6 17.0 7.6 8.7 17.8 16.9 MICAL1 "DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL" ENSG00000135596 "Microtubule associated monooxygenase, calponin and LIM domain containing 1" Q8TDZ2 6 109444062-109465968 "Enzymes, Predicted intracellular proteins" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 148.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030175, HPA030176, HPA030178" Approved NA NA "HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824" "unprognostic (1.07e-2)" "unprognostic (1.86e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-1)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (1.52e-2)" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "unprognostic (1.94e-1)" "prognostic favorable (2.63e-7)" "unprognostic (2.31e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (2.05e-1)" "unprognostic (3.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.22e-1)" 19.0 6.3 17.5 27.8 18.9 66.5 14.3 17.6 25.8 42.4 17.0 15.8 38.1 29.8 2.5 11.9 33.0 14.8 10.6 17.8 19.7 18.8 5.5 35.5 33.1 20.0 18.2 17.6 13.7 8.7 9.2 18.0 10.8 21.7 31.1 10.2 6.3 11.1 19.0 5.2 15.5 43.6 9.2 18.6 57.1 18.5 18.9 20.1 18.5 12.8 4.0 16.7 62.7 31.0 20.3 4.1 5.1 15.8 0.2 55.9 43.6 10.7 31.3 22.0 6.7 11.0 7.3 4.7 23.2 6.6 33.1 19.4 5.4 9.6 12.3 2.8 20.3 4.0 9.9 12.0 11.5 22.8 6.5 0.3 25.7 6.2 15.5 12.6 25.2 20.0 14.0 2.7 40.2 40.6 5.1 8.0 36.0 9.9 5.5 5.4 21.9 10.0 3.3 15.0 10.0 5.3 28.1 2.9 2.7 50.4 10.0 4.9 148.8 21.6 16.7 5.9 9.8 12.2 29.7 9.6 20.8 13.9 21.4 12.3 14.6 7.3 13.6 6.5 13.2 3.9 3.5 6.4 5.2 12.8 5.1 4.3 3.1 9.3 5.1 14.2 14.4 9.4 6.8 17.5 18.9 17.6 25.8 17.8 19.7 20.0 18.2 17.6 21.7 18.6 20.1 20.3 5.3 44.8 14.4 3.3 26.2 6.1 1.3 2.3 1.2 3.4 2.5 3.6 4.4 0.0 4.2 1.8 4.2 1.3 31.0 24.9 1.9 7.8 13.2 2.0 29.8 5.9 32.2 4.6 13.8 6.5 10.9 9.7 76.9 2.4 15.2 3.1 4.6 0.3 32.2 0.0 12.9 34.9 6.1 28.3 44.5 23.1 20.8 34.7 16.0 8.4 34.0 2.2 21.6 12.5 4.2 11.6 27.6 37.6 15.4 1.3 49.6 4.6 10.7 18.3 0.0 31.6 27.3 7.9 9.5 0.7 4.8 4.8 22.5 2.9 13.9 1.5 REPS1 ENSG00000135597 "RALBP1 associated Eps domain containing 1" Q96D71 6 138903493-138988261 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029961, HPA029962" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA029961: AB_10603233, HPA029962: AB_2673269" "unprognostic (1.72e-3)" "unprognostic (9.61e-2)" "unprognostic (5.82e-3)" "unprognostic (2.77e-2)" "unprognostic (6.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (9.47e-4)" "unprognostic (3.79e-1)" "unprognostic (2.49e-1)" "unprognostic (9.71e-3)" "unprognostic (4.29e-3)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.27e-1)" "unprognostic (3.83e-2)" "unprognostic (2.69e-2)" 13.5 12.0 26.0 15.0 26.6 23.4 23.8 29.2 37.1 17.8 16.7 17.5 15.6 22.1 40.6 28.3 18.5 14.1 24.1 28.9 24.2 17.5 31.5 15.3 19.5 27.0 24.6 24.5 21.3 18.9 41.3 32.0 17.3 23.3 16.0 17.5 39.1 26.3 16.3 17.6 30.2 16.5 19.7 22.7 22.2 18.3 35.9 27.4 36.3 17.9 12.8 22.4 19.6 20.3 26.7 29.3 22.6 42.3 53.1 23.4 41.6 46.2 27.8 30.7 31.9 38.2 54.1 24.8 35.2 22.9 38.9 38.0 33.6 48.7 42.0 42.1 37.6 41.9 29.6 12.9 32.9 35.3 94.6 45.9 34.1 33.7 58.6 70.3 30.2 33.5 51.2 40.2 35.1 41.4 49.4 53.9 51.3 40.4 37.4 21.3 62.4 26.0 20.0 26.5 43.6 37.7 37.2 25.7 38.7 38.0 62.0 18.6 64.4 32.9 17.8 29.6 48.5 38.8 34.4 33.7 49.2 21.1 38.3 26.4 5.9 1.3 1.9 2.2 4.0 3.8 3.0 2.9 3.2 1.9 1.6 2.9 3.6 0.7 2.9 4.5 3.5 3.3 1.2 26.0 26.6 29.2 37.1 28.9 24.2 27.0 24.6 24.5 23.3 22.7 27.4 26.7 11.8 19.2 7.4 207.3 18.0 13.4 11.7 7.9 22.2 12.6 13.7 9.5 28.4 10.0 12.2 5.5 16.7 25.6 18.9 11.9 7.9 7.8 13.7 17.5 9.7 10.3 6.0 5.0 114.3 7.1 28.3 11.5 16.3 23.3 15.9 14.4 15.7 43.8 13.3 13.5 138.1 12.8 6.1 24.0 10.3 7.7 7.2 17.2 5.4 47.8 10.5 36.8 15.5 99.5 71.2 8.9 14.7 8.6 23.9 11.2 13.5 8.6 16.5 14.4 19.7 16.8 10.9 41.7 33.8 26.4 14.9 28.6 18.7 7.6 15.2 18.1 STX11 ENSG00000135604 "Syntaxin 11" O75558 6 144150517-144191939 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 57.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 7 "basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0" "Group enriched" "Detected in all" 8 "dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0" "Cell line enhanced" "Detected in some" "HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007992 Approved NA NA 1100000 "HPA007992: AB_1857620" "unprognostic (1.30e-3)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-2)" "unprognostic (3.73e-2)" "unprognostic (8.96e-2)" "unprognostic (3.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (8.65e-2)" "unprognostic (1.36e-1)" "unprognostic (4.47e-3)" "unprognostic (7.07e-2)" "unprognostic (3.91e-2)" "unprognostic (8.50e-3)" "unprognostic (1.07e-1)" 20.6 4.5 0.6 5.8 0.7 57.0 14.6 0.6 1.2 1.5 1.2 2.8 1.0 1.4 0.3 5.1 2.6 2.1 5.8 0.7 1.0 3.2 3.2 21.5 5.6 0.9 0.6 0.5 0.9 1.1 0.6 2.1 2.4 0.9 1.3 0.9 0.2 2.1 0.3 2.5 7.8 3.3 2.0 0.7 14.2 2.0 1.1 0.9 1.8 7.5 0.9 3.6 4.0 3.3 1.1 0.4 0.1 0.1 3.9 0.2 0.3 0.6 0.4 0.3 0.4 0.7 0.1 0.4 0.1 0.4 0.6 0.7 0.6 0.0 0.1 0.2 17.2 0.6 3.0 0.6 0.1 1.0 0.9 0.5 0.0 0.0 0.2 0.1 0.2 4.3 0.8 0.1 10.1 0.5 0.2 0.4 0.9 0.0 0.0 0.3 0.1 6.9 0.6 0.0 1.9 0.2 0.1 1.2 0.1 1.7 0.3 0.1 3.8 8.3 0.2 1.0 0.4 0.3 11.6 4.6 0.1 0.2 2.1 0.4 22.6 68.4 43.5 6.0 81.1 3.8 1.4 2.7 5.1 25.4 2.4 1.0 3.0 81.7 3.2 87.0 2.7 8.3 43.9 0.6 0.7 0.6 1.2 0.7 1.0 0.9 0.6 0.5 0.9 0.7 0.9 1.1 41.9 54.5 10.7 0.0 16.6 85.0 11.3 6.3 3.4 0.0 11.1 4.6 4.5 4.3 6.6 1.8 0.0 0.9 38.1 0.1 0.0 6.4 0.4 3.7 0.7 23.7 3.5 6.1 0.1 2.6 5.7 11.2 0.5 5.0 90.3 0.2 8.2 1.4 30.1 0.0 0.1 0.4 2.0 73.7 271.6 1.2 0.6 158.0 44.4 2.8 85.5 0.0 21.6 0.0 0.1 6.1 3.3 0.0 63.1 14.4 0.0 0.1 10.7 0.1 0.0 46.6 9.7 3.0 3.8 11.2 154.6 28.0 36.6 3.2 0.6 33.3 TEC PSCTK4 ENSG00000135605 "Tec protein tyrosine kinase" P42680 4 48135783-48269838 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 20.7;eosinophil: 13.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 20.7" "Cell line enhanced" "Detected in many" "HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005733, HPA024657" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA005733: AB_1857878, HPA024657: AB_2671637" "unprognostic (7.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.41e-2)" "unprognostic (4.07e-3)" "unprognostic (4.21e-2)" "unprognostic (8.57e-2)" "unprognostic (3.14e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-2)" "prognostic favorable (7.12e-4)" "unprognostic (7.46e-3)" "unprognostic (7.83e-2)" "unprognostic (1.01e-4)" "unprognostic (4.24e-2)" "unprognostic (2.16e-1)" "unprognostic (7.39e-2)" "unprognostic (4.96e-3)" 0.9 1.7 0.3 2.1 0.2 6.2 1.4 0.1 0.5 0.9 1.3 1.3 1.6 1.1 4.3 3.4 1.9 1.2 1.3 0.1 0.3 1.1 2.5 2.1 3.1 0.9 0.4 0.0 0.4 0.8 1.2 0.6 1.1 1.2 0.5 1.4 1.9 2.3 1.0 0.6 3.6 1.5 0.8 0.3 1.7 1.1 1.2 0.6 2.1 1.3 0.5 3.3 1.0 1.6 1.0 3.0 0.8 0.0 0.0 0.0 0.0 0.1 0.5 2.2 1.3 2.7 0.0 2.2 1.9 2.0 0.0 0.1 0.6 1.1 0.0 1.8 0.1 0.8 13.5 1.0 0.1 0.0 2.2 20.3 0.0 0.3 1.7 0.0 1.4 0.0 0.6 7.5 0.5 4.1 1.0 1.3 4.9 0.4 1.4 0.8 3.1 2.7 0.0 3.4 0.9 0.0 0.2 0.6 0.3 0.5 1.1 0.7 4.2 0.0 0.0 0.0 2.8 0.0 20.3 15.4 2.6 0.0 3.0 0.1 20.7 0.6 13.3 0.1 0.7 0.3 1.0 0.2 0.5 1.5 0.7 0.5 0.5 0.5 3.6 0.1 0.1 0.1 0.4 0.3 0.2 0.1 0.5 0.1 0.3 0.9 0.4 0.0 1.2 0.3 0.6 1.0 0.6 6.4 6.8 0.7 6.8 2.5 1.7 0.2 2.8 0.9 1.7 1.1 1.8 7.2 2.6 0.0 0.0 1.5 3.3 2.1 0.0 1.7 6.4 13.9 1.5 1.2 3.0 12.6 6.7 1.1 0.1 0.8 0.0 25.1 19.6 0.7 0.0 2.9 4.9 0.0 1.6 1.4 4.1 4.6 1.8 2.6 0.0 5.9 1.8 10.3 1.7 6.6 0.0 0.5 0.2 1.0 0.6 0.4 15.4 1.3 3.0 2.0 0.2 3.1 6.6 1.8 0.8 0.7 1.4 9.8 3.0 0.8 3.4 0.3 2.1 1.6 PRADC1 "C2orf7, hPAP21, MGC13004, PAP21" ENSG00000135617 "Protease associated domain containing 1" Q9BSG0 2 73228010-73233239 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 127.8" "Cell type enhanced" "Detected in all" "Late spermatids: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051066 Approved "Secreted to blood" NA NA "HPA051066: AB_2681333" "unprognostic (2.94e-1)" "unprognostic (1.93e-2)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (9.23e-2)" "unprognostic (3.93e-2)" "unprognostic (8.54e-2)" "unprognostic (9.08e-3)" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (1.09e-3)" "unprognostic (9.99e-3)" "unprognostic (3.56e-2)" "unprognostic (2.96e-1)" "unprognostic (4.89e-1)" "unprognostic (1.93e-1)" "unprognostic (9.23e-2)" 22.0 36.2 44.5 9.9 45.2 8.8 19.5 46.3 51.0 13.9 49.5 27.6 25.4 12.7 16.4 26.0 11.4 9.9 88.6 43.7 44.6 27.1 72.1 12.9 9.3 45.9 45.3 42.2 11.1 41.9 21.3 23.3 8.3 45.6 19.5 21.6 15.7 29.4 14.8 127.8 20.7 22.2 14.9 44.6 23.8 27.3 31.6 45.5 11.1 18.1 108.1 10.0 23.3 16.4 44.4 21.7 16.6 16.2 31.3 49.3 19.2 22.6 37.8 15.1 32.5 18.7 46.6 20.6 23.3 20.2 38.0 29.3 19.5 25.8 22.7 23.0 36.2 28.2 36.7 21.4 35.2 15.3 20.3 33.7 25.0 13.5 29.2 15.4 9.4 30.5 39.0 32.4 46.1 37.8 41.9 51.7 34.0 5.2 93.7 74.2 31.0 68.6 71.8 18.6 19.0 34.5 12.3 18.1 42.5 15.7 17.3 22.5 15.7 18.9 37.6 16.6 32.9 31.8 52.2 43.9 22.3 24.0 39.6 15.7 15.6 35.0 35.4 24.8 84.3 20.1 17.5 23.8 23.6 36.3 21.8 22.3 19.5 5.0 39.2 105.3 73.3 31.1 48.2 44.5 45.2 46.3 51.0 43.7 44.6 45.9 45.3 42.2 45.6 44.6 45.5 44.4 21.7 9.6 4.6 10.1 11.0 15.6 11.3 34.5 4.6 15.2 23.3 23.9 62.6 15.7 20.0 14.7 8.4 25.7 25.4 44.7 72.4 23.3 57.3 12.1 9.3 17.7 32.3 4.2 6.9 46.9 47.2 20.4 13.7 6.0 28.6 4.8 30.7 63.0 49.1 11.8 6.9 47.7 44.7 25.5 14.0 144.3 16.8 19.3 16.0 1.9 7.2 31.4 21.6 6.0 7.0 23.2 31.2 16.1 29.2 10.7 101.4 65.2 15.8 28.3 32.9 19.1 19.1 61.5 21.1 30.1 24.0 13.5 9.7 27.2 50.2 15.4 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.5;Inhibitory neurons: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 2.9 2.3 5.0 0.9 7.1 0.4 3.3 3.0 8.1 4.0 0.0 2.3 0.5 3.6 1.7 1.3 3.3 0.8 2.5 7.7 5.9 3.1 1.0 2.6 1.5 4.5 1.6 7.6 5.4 2.6 3.0 7.3 0.9 4.2 3.2 1.0 4.7 2.8 1.4 1.4 1.8 2.2 1.6 1.0 2.6 2.3 4.1 5.5 1.2 3.1 1.4 1.4 2.6 3.2 4.7 6.1 3.4 3.7 5.5 5.8 3.3 2.6 3.9 8.9 7.4 6.5 1.4 3.3 2.3 5.0 6.2 14.4 1.9 6.7 5.7 7.5 5.3 7.0 4.4 1.4 3.8 2.3 1.0 5.4 2.6 6.0 4.9 2.4 14.1 2.9 4.4 0.2 0.2 4.8 2.1 3.3 0.8 2.6 2.7 4.0 0.0 5.4 0.0 6.0 2.6 2.9 5.8 7.0 1.8 6.5 5.0 2.6 0.7 4.9 11.5 5.8 2.9 7.1 5.2 5.6 0.3 13.4 0.3 5.6 0.3 0.1 0.7 1.9 0.0 1.2 1.1 1.1 1.7 0.0 0.8 1.1 1.3 0.3 1.0 0.2 0.0 0.9 0.8 5.0 7.1 3.0 8.1 7.7 5.9 4.5 1.6 7.6 4.2 1.0 5.5 4.7 2.2 0.0 6.5 4.9 2.7 0.4 1.8 1.8 2.2 8.8 1.8 2.5 2.4 5.7 4.8 5.5 12.5 0.8 1.4 0.7 1.9 2.1 3.2 0.6 0.6 2.2 7.2 0.8 44.5 1.6 2.4 3.3 1.5 1.0 2.5 3.0 3.3 0.6 0.8 11.8 22.7 0.6 2.0 0.0 0.7 3.7 0.9 0.7 0.0 4.7 1.5 3.3 4.1 4.5 5.8 2.7 1.4 1.5 0.7 1.3 0.4 0.3 1.3 6.7 6.6 3.1 1.4 5.6 11.2 0.5 0.4 0.4 3.5 0.5 1.0 1.6 CCT7 "Ccth, Nip7-1" ENSG00000135624 "Chaperonin containing TCP1 subunit 7" Q99832 2 73233420-73253021 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 393.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008425 Approved Approved Cytosol NA NA 1900000 Cytosol "HPA008425: AB_1078428" "unprognostic (5.02e-3)" "unprognostic (9.51e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (4.60e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.37e-3)" "unprognostic (8.76e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" "unprognostic (3.78e-1)" "unprognostic (1.41e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-3)" "unprognostic (3.12e-2)" 106.6 152.1 108.0 109.5 110.8 94.2 112.5 115.3 111.8 106.9 120.3 107.9 85.5 124.0 118.1 120.6 134.5 69.6 153.4 108.6 114.5 112.9 115.0 84.2 127.5 114.2 110.9 104.4 141.6 115.2 135.8 97.8 102.2 114.1 116.2 124.4 84.4 92.9 111.8 254.5 102.6 89.0 148.8 115.0 99.5 107.7 164.3 112.1 154.4 88.2 243.3 159.8 121.1 101.9 121.3 396.3 641.9 361.8 393.0 259.1 211.7 460.7 348.6 311.8 573.6 359.0 1054.5 272.1 760.3 219.0 365.9 529.3 328.2 816.6 533.8 635.9 420.7 722.9 516.2 403.2 755.3 287.5 614.9 367.5 328.9 297.7 565.9 683.3 301.4 521.0 444.7 650.2 265.8 488.7 613.6 686.5 776.1 519.1 540.6 455.8 614.8 927.2 535.0 411.6 374.7 512.4 315.9 302.6 411.0 406.7 333.6 235.2 331.4 339.7 390.9 464.3 245.7 679.7 298.1 341.1 709.2 319.4 686.1 435.6 157.7 131.4 78.1 190.8 178.8 211.3 216.6 193.5 191.4 202.0 208.8 208.9 195.3 39.5 192.1 209.8 203.7 186.0 299.3 108.0 110.8 115.3 111.8 108.6 114.5 114.2 110.9 104.4 114.1 115.0 112.1 121.3 77.7 57.7 45.6 12.4 87.5 69.1 149.7 161.5 55.8 81.1 63.8 77.1 99.2 68.6 96.7 58.8 18.8 190.2 74.3 54.8 109.5 148.2 393.0 99.8 96.4 91.6 75.3 77.8 10.8 139.0 213.2 94.8 57.1 58.1 73.6 108.2 61.8 69.3 133.6 82.4 13.3 102.2 118.0 58.8 58.1 246.3 104.7 57.3 74.7 10.3 98.9 125.5 74.2 12.1 15.0 134.1 60.3 107.2 112.3 156.0 67.3 133.2 108.2 88.6 72.3 91.8 126.7 288.9 127.8 71.1 73.6 166.5 77.2 190.6 127.6 112.5 EGR4 "NGFI-C, PAT133" ENSG00000135625 "Early growth response 4" Q05215 2 73290929-73293701 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 53.5" "Cell type enriched" "Detected in many" 6 "Enteroendocrine cells: 99.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 53.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HMC-1: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028983 Enhanced NA NA "HPA028983: AB_10603665" "unprognostic (7.75e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-4)" "unprognostic (2.43e-3)" "unprognostic (2.68e-2)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (5.20e-2)" "unprognostic (4.00e-1)" "unprognostic (2.29e-4)" "unprognostic (2.41e-1)" "unprognostic (1.75e-2)" "unprognostic (3.20e-2)" "unprognostic (1.77e-1)" "unprognostic (1.21e-2)" "unprognostic (4.07e-3)" 0.2 0.1 2.5 0.1 5.1 0.1 0.0 24.6 53.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.0 3.8 0.0 0.0 0.0 0.0 1.5 2.3 1.8 0.0 0.0 0.0 3.5 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 5.1 24.6 53.5 18.0 3.8 1.5 2.3 1.8 4.1 0.0 1.3 10.4 1.3 0.0 0.0 0.0 2.6 2.7 13.2 0.6 0.6 3.0 6.8 7.2 1.2 0.0 0.2 0.0 0.0 0.1 5.0 0.4 0.0 0.2 0.0 2.9 7.0 1.0 99.5 0.0 3.8 1.0 0.3 0.7 5.1 15.9 8.9 16.1 0.0 0.0 0.2 0.0 0.5 0.6 2.0 0.6 5.3 0.6 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 1.1 0.0 1.0 10.8 0.0 0.0 0.1 0.8 0.0 0.2 5.7 0.2 13.2 1.7 2.3 0.8 1.5 3.4 0.8 0.2 RAB11FIP5 "GAF1, KIAA0857, pp75, RIP11" ENSG00000135631 "RAB11 family interacting protein 5" Q9BXF6 2 73073382-73156721 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 45.1" "Cell type enhanced" "Detected in many" "Early spermatids: 86.2;Late spermatids: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036406, HPA036407" Enhanced Enhanced "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA036406: AB_2675105, HPA036407: AB_10669778" "unprognostic (1.49e-1)" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.58e-3)" "unprognostic (4.08e-3)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (3.23e-3)" "unprognostic (1.45e-1)" "prognostic favorable (2.26e-5)" "unprognostic (1.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "unprognostic (9.66e-3)" 7.1 5.4 6.7 2.3 3.5 0.5 7.6 2.0 18.2 6.7 0.0 6.0 2.0 10.7 1.5 5.9 7.5 3.7 6.6 4.8 4.5 11.6 2.3 6.8 1.0 15.1 5.6 4.5 7.0 7.5 12.3 5.5 1.7 15.6 5.2 0.9 0.8 7.6 3.3 11.6 7.3 3.4 3.2 3.1 14.4 6.0 45.1 14.3 0.4 5.2 3.0 0.9 6.7 5.8 16.8 20.0 8.8 0.6 6.2 6.7 7.9 11.1 28.6 15.9 10.1 8.0 6.9 4.4 0.0 15.3 16.3 10.7 8.1 4.1 8.6 4.4 38.1 11.1 7.8 4.0 4.2 7.8 0.0 1.4 9.5 8.9 12.5 8.3 9.3 13.5 3.6 6.0 3.6 7.1 0.6 0.1 0.2 4.8 3.2 15.0 7.1 7.8 18.3 8.7 2.7 2.8 2.9 10.0 3.3 4.3 2.1 2.2 0.5 35.4 24.4 13.2 17.3 15.0 13.8 4.3 0.1 18.0 8.5 2.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 6.7 3.5 2.0 18.2 4.8 4.5 15.1 5.6 4.5 15.6 3.1 14.3 16.8 12.1 6.4 3.6 4.6 1.3 25.5 8.3 6.7 12.5 4.4 13.0 6.9 12.0 12.8 3.7 20.2 0.0 1.2 5.5 7.7 27.4 12.1 86.2 6.1 3.2 20.4 1.8 0.0 11.1 18.4 12.2 9.0 3.1 12.8 0.0 34.5 16.8 6.1 2.1 6.7 11.5 2.5 2.0 1.3 8.1 171.6 14.3 1.9 8.8 7.5 1.0 7.4 1.0 1.0 1.3 22.7 2.7 8.6 6.1 13.4 0.4 46.9 5.0 2.6 26.3 7.2 6.2 39.8 6.6 5.1 17.6 14.8 4.5 6.4 4.6 16.4 SMYD5 "NN8-4AG, RAI15, RRG1, ZMYND23" ENSG00000135632 "SMYD family member 5" Q6GMV2 2 73214222-73227221 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015514, HPA049002" Uncertain Approved Mitochondria NA NA Mitochondria "HPA015514: AB_2669205, HPA049002: AB_2680595" "unprognostic (1.75e-1)" "unprognostic (3.39e-1)" "unprognostic (5.22e-2)" "unprognostic (6.66e-3)" "unprognostic (3.86e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.58e-7)" "unprognostic (1.28e-1)" "unprognostic (1.60e-2)" "unprognostic (3.84e-2)" "unprognostic (3.84e-1)" "unprognostic (2.49e-1)" "unprognostic (3.03e-2)" "unprognostic (3.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (2.40e-1)" 13.0 19.3 27.8 12.2 28.0 11.7 14.9 24.6 30.8 15.4 21.9 11.8 7.4 14.5 19.6 14.3 19.7 7.3 17.7 28.5 28.3 16.2 15.3 9.9 13.2 28.7 27.3 27.9 28.5 18.6 18.0 15.5 13.2 29.3 15.5 11.4 13.1 12.3 13.6 17.8 14.3 12.5 14.7 25.7 16.4 11.4 17.6 26.9 8.3 14.4 13.1 16.1 17.6 13.2 28.1 24.3 45.2 27.0 25.9 19.3 28.4 45.7 22.8 23.0 43.4 26.6 59.4 24.4 43.1 20.9 38.6 52.1 24.4 42.2 49.4 39.1 26.3 29.7 41.8 19.5 65.9 26.0 41.5 16.5 24.0 31.4 39.7 47.3 19.2 26.7 33.9 44.9 20.2 27.9 34.1 38.8 27.1 42.2 50.8 36.3 25.6 50.6 35.5 28.6 34.6 17.4 25.9 20.7 30.7 26.4 24.4 25.0 14.7 18.5 29.7 46.3 36.5 38.1 22.0 17.7 38.2 33.5 35.2 24.3 0.0 1.4 0.0 5.1 3.9 11.1 6.0 7.0 6.8 3.2 6.2 7.0 7.7 0.0 4.5 4.3 3.0 3.1 4.5 27.8 28.0 24.6 30.8 28.5 28.3 28.7 27.3 27.9 29.3 25.7 26.9 28.1 4.1 3.2 5.6 5.2 5.6 5.1 3.9 2.3 1.8 10.2 5.4 6.7 7.2 2.8 4.4 5.5 4.2 9.0 3.4 2.4 1.9 8.5 0.5 2.8 4.2 4.9 0.0 9.5 5.0 8.8 10.4 4.5 2.6 3.7 7.0 9.5 2.9 4.8 5.9 5.0 5.2 4.4 4.1 2.4 2.5 2.9 2.8 2.7 5.4 2.8 3.7 4.0 4.1 1.5 3.5 5.6 1.5 3.0 3.1 5.0 1.3 8.1 1.3 5.3 6.6 4.0 4.6 6.7 11.1 5.7 3.4 4.8 4.5 4.6 5.6 3.6 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.3" "Cell type enhanced" "Detected in many" "Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 7 "neutrophil: 27.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 27.0" "Group enriched" "Detected in many" 5 "hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 10.2 1.8 2.7 11.6 1.1 31.9 4.3 3.8 6.5 1.9 2.1 5.2 2.1 2.4 0.5 7.5 3.3 4.6 16.9 0.3 2.8 3.6 6.5 8.3 3.7 12.4 4.5 0.5 1.3 1.5 2.4 1.5 21.3 13.5 3.4 2.5 0.5 1.3 4.8 96.3 1.0 3.1 10.3 1.8 21.5 2.5 1.1 7.5 2.3 4.7 32.6 0.9 7.0 1.9 9.5 1.1 0.0 3.3 3.0 0.0 0.0 6.1 0.1 0.8 2.2 1.5 0.4 1.0 0.0 12.1 0.1 3.4 2.5 0.0 1.2 1.1 0.0 0.0 0.2 0.2 0.0 0.3 0.1 0.0 1.5 0.0 2.3 10.6 31.9 85.5 0.2 8.4 0.0 75.3 0.0 0.0 5.8 8.1 0.0 0.9 0.0 78.5 0.0 2.6 0.2 0.0 0.0 4.1 0.7 0.1 7.9 0.3 0.8 58.1 0.3 3.8 0.2 1.1 0.0 0.0 0.0 0.0 13.3 0.0 0.0 4.1 0.1 0.5 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 27.0 0.4 0.1 0.0 0.0 1.4 2.7 1.1 3.8 6.5 0.3 2.8 12.4 4.5 0.5 13.5 1.8 7.5 9.5 30.5 3.2 8.1 1.0 1.0 2.4 0.0 0.1 0.0 1.1 0.3 0.6 24.0 0.0 1.3 0.0 0.0 8.1 0.7 0.1 0.0 0.4 4.8 0.7 1.3 43.7 0.0 2.7 34.7 0.2 3.8 2.2 0.0 9.3 2.5 0.3 32.2 13.4 11.4 0.0 13.0 0.2 0.0 27.1 3.0 6.0 0.6 10.2 0.0 16.9 5.8 0.1 0.0 2.5 62.7 0.1 0.0 0.7 0.1 0.2 0.0 2.1 0.7 0.2 6.6 5.2 5.5 0.6 1.1 0.1 1.6 66.2 1.1 0.9 0.0 0.1 CCDC142 FLJ14397 ENSG00000135637 "Coiled-coil domain containing 142" Q17RM4 2 74471986-74483408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 28.3;Respiratory ciliated cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056946 Approved NA NA "HPA056946: AB_2683282" "unprognostic (2.00e-1)" "unprognostic (3.25e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.73e-1)" "unprognostic (1.69e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.05e-2)" "unprognostic (5.15e-2)" "unprognostic (2.44e-2)" "unprognostic (5.65e-3)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.71e-7)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "unprognostic (5.31e-3)" 1.8 2.6 3.0 2.4 2.8 1.5 1.9 5.0 3.2 2.6 3.2 2.4 4.4 2.6 1.4 2.5 2.4 1.3 1.8 2.7 2.5 2.2 4.7 1.8 2.6 3.3 2.6 2.8 2.7 2.2 2.8 2.9 1.2 3.7 2.9 1.9 1.3 2.5 2.0 1.5 2.6 3.3 1.5 2.4 3.3 2.4 3.2 2.8 2.5 2.4 1.2 2.2 2.3 2.0 4.0 2.7 2.1 4.3 3.4 2.8 2.7 7.5 4.0 2.4 3.2 2.4 6.3 3.8 3.2 2.6 2.5 3.9 4.8 2.8 3.1 2.1 4.5 8.9 5.6 7.7 4.6 1.2 3.6 4.2 1.9 2.1 5.0 2.1 4.1 2.5 3.8 2.6 2.2 3.0 2.3 4.8 3.6 4.1 4.7 5.3 5.7 7.8 2.9 1.9 3.9 5.5 3.4 3.1 6.4 3.5 3.1 4.3 2.5 2.1 6.3 4.0 4.4 4.9 6.6 3.1 3.2 2.9 1.9 3.7 6.3 3.0 5.9 5.1 1.8 4.1 3.3 2.9 3.6 1.6 5.3 4.6 3.8 2.4 4.7 3.8 2.9 1.4 1.1 3.0 2.8 5.0 3.2 2.7 2.5 3.3 2.6 2.8 3.7 2.4 2.8 4.0 2.5 9.6 28.3 3.3 6.1 3.2 2.4 1.4 1.8 16.4 2.8 2.0 4.1 2.8 16.2 0.0 18.8 3.1 6.1 6.2 1.9 2.7 1.1 1.3 4.2 5.6 6.0 4.8 3.3 2.0 2.2 6.7 4.1 1.8 18.3 8.6 6.8 2.1 2.0 5.0 3.6 5.3 0.0 3.3 3.0 0.4 7.5 5.8 0.0 5.6 4.2 11.5 16.5 2.5 2.4 1.5 5.7 6.0 4.6 1.7 14.0 1.3 31.2 22.9 0.0 6.1 4.0 8.1 5.0 1.2 3.0 1.9 7.7 5.9 6.3 2.0 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.5;kidney: 36.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7" "Cancer enriched" "Detected in some" 5 "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 12.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.1 0.1 0.4 0.0 1.9 0.0 0.0 0.0 12.5 0.0 0.0 0.2 0.8 0.0 0.7 0.1 0.0 0.0 0.0 4.4 0.0 36.3 0.2 0.0 0.0 0.0 0.2 1.8 0.0 0.3 6.0 0.2 0.0 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.3 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 12.5 4.4 0.0 0.0 0.2 1.8 5.9 0.0 0.0 2.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 55.2 0.0 0.1 0.0 1.2 5.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 35.7 0.0 0.0 0.0 0.0 0.0 1.5 5.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366290-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 15.0;brain: 54.5;choroid plexus: 24.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 95.7;Hepatic stellate cells: 37.1;Inhibitory neurons: 45.0;Oligodendrocytes: 86.9" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 7.7;RH-30: 8.2;RT4: 9.3;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072287 Enhanced Approved Approved Cytosol NA NA Cytosol "HPA072287: AB_2686507" "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 2.3 15.0 37.7 1.1 42.9 0.2 2.0 34.7 42.6 3.0 24.5 6.4 1.0 1.8 1.1 1.0 1.7 1.4 4.0 41.1 42.9 3.6 0.5 6.2 1.3 42.7 37.2 37.9 2.7 0.5 0.2 1.9 2.5 39.6 3.2 1.2 2.0 1.8 2.1 2.4 2.6 3.1 1.2 34.2 1.2 2.2 2.1 38.3 1.3 2.1 1.5 1.0 2.6 2.6 54.5 0.0 0.3 4.9 2.7 0.3 0.2 0.5 0.6 0.9 0.2 0.7 0.2 1.8 2.4 0.3 0.0 1.0 0.0 5.3 0.8 0.2 1.1 3.1 1.3 1.1 2.9 0.0 0.1 0.1 1.4 0.1 0.0 0.0 0.5 0.2 3.5 0.0 0.0 0.9 0.7 1.8 0.4 7.7 0.1 5.6 2.6 8.2 0.2 0.2 9.3 2.4 2.9 0.7 0.9 0.0 7.3 2.7 0.1 0.1 0.3 1.3 0.1 0.3 1.7 0.0 2.5 0.4 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.1 37.7 42.9 34.7 42.6 41.1 42.9 42.7 37.2 37.9 39.6 34.2 38.3 54.5 8.5 0.0 0.6 2.6 1.1 3.2 0.2 0.4 0.6 23.1 2.8 1.9 4.3 0.0 0.2 23.9 0.0 0.2 2.1 0.1 0.0 0.1 0.9 4.7 1.1 8.7 0.0 3.2 95.7 0.0 0.4 9.6 0.0 3.4 0.0 7.2 37.1 0.7 1.2 0.0 45.0 0.4 0.0 10.8 2.6 2.2 6.5 2.9 1.8 20.6 0.7 1.5 0.0 13.6 86.9 0.0 0.0 18.0 0.2 0.8 0.0 9.7 0.0 3.0 0.0 12.8 5.1 2.2 7.8 0.2 5.5 0.3 1.4 14.0 0.5 0.0 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 177.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 297.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 297.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 300000 Cytosol "Nucleoplasm, Nuclear bodies" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 26.4 21.7 4.3 29.7 4.6 177.8 23.1 12.1 7.1 16.2 10.3 17.4 13.9 14.7 9.2 19.9 18.0 13.8 19.6 4.8 6.0 13.2 27.4 31.7 33.6 5.1 4.6 3.2 26.9 19.8 15.0 14.0 18.6 5.9 14.4 16.8 46.2 19.8 8.4 35.8 29.7 24.8 12.7 4.8 44.7 18.9 30.5 5.0 26.7 17.2 14.9 25.1 18.3 19.6 6.5 18.3 16.5 14.2 17.7 25.7 25.1 27.0 29.0 21.2 22.3 16.1 19.6 21.6 15.5 16.6 17.8 10.1 18.5 18.4 23.1 27.6 18.5 15.0 25.2 15.1 14.1 18.8 35.6 61.8 15.0 19.2 27.2 20.7 20.7 26.1 16.3 80.8 36.0 20.0 23.5 26.4 19.3 25.4 16.5 24.0 17.2 19.1 32.3 17.9 22.8 17.9 8.9 30.9 21.6 17.3 17.4 34.7 18.8 37.2 21.2 22.2 32.0 18.2 16.4 24.0 21.9 25.7 26.7 23.5 163.4 60.0 64.3 13.5 31.1 14.9 28.5 19.6 14.0 23.7 20.5 23.5 13.8 297.9 14.7 26.8 26.6 58.8 26.1 4.3 4.6 12.1 7.1 4.8 6.0 5.1 4.6 3.2 5.9 4.8 5.0 6.5 57.1 38.5 36.4 68.6 130.3 58.8 40.8 26.2 40.5 54.9 32.3 28.1 74.9 21.5 48.9 23.9 110.5 31.7 142.5 50.2 11.7 36.4 172.2 26.3 46.5 45.4 42.0 248.3 124.8 41.5 43.3 52.5 57.6 38.9 88.6 53.5 21.0 45.3 46.2 42.1 104.2 33.2 12.2 101.3 97.6 172.0 61.8 120.6 53.4 135.9 195.8 25.6 90.6 100.0 108.8 55.1 47.6 29.3 94.3 36.0 30.9 25.9 31.9 151.5 39.5 66.1 60.5 83.7 43.3 49.3 77.0 65.8 130.0 27.0 29.5 60.8 GNS ENSG00000135677 "Glucosamine (N-acetyl)-6-sulfatase" P15586 12 64713445-64759431 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 198.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 228.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013695, CAB026011, HPA048508" Enhanced "Intracellular and membrane" NA NA 510000 "CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423" "unprognostic (8.07e-2)" "unprognostic (2.39e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (9.33e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (1.26e-1)" "unprognostic (4.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.04e-2)" "unprognostic (3.30e-2)" "unprognostic (3.28e-3)" "unprognostic (1.42e-1)" "unprognostic (3.77e-2)" "unprognostic (1.09e-1)" "unprognostic (3.04e-1)" 107.1 176.2 18.1 56.9 19.4 25.6 52.3 21.3 21.6 59.4 71.0 35.7 34.9 49.9 38.9 26.5 44.2 64.2 53.3 17.1 35.7 133.2 56.6 72.1 41.4 30.6 22.1 16.0 64.8 24.3 77.4 23.2 80.9 24.6 38.8 37.3 25.3 33.1 48.1 30.4 24.6 41.8 69.8 23.7 51.6 34.9 32.0 26.2 20.7 73.5 29.3 27.1 64.3 27.8 29.0 41.0 61.3 50.7 81.4 240.0 145.2 108.8 92.0 213.5 108.4 117.1 55.9 53.3 17.4 117.0 117.8 133.3 33.1 49.1 52.6 119.5 51.4 36.6 41.4 45.4 36.4 109.3 30.6 346.2 139.6 62.9 111.5 49.3 342.0 200.1 24.7 28.8 117.2 156.8 32.6 8.1 17.9 19.4 102.8 53.2 23.8 77.3 53.7 91.5 116.2 33.7 37.3 119.6 56.6 82.4 65.8 102.2 40.4 185.1 104.5 54.8 101.8 54.4 112.1 143.4 14.9 151.1 58.4 72.1 51.7 136.9 27.5 29.3 158.4 21.9 13.0 15.9 22.6 78.2 10.0 16.4 16.4 56.6 18.4 228.5 19.3 13.0 101.9 18.1 19.4 21.3 21.6 17.1 35.7 30.6 22.1 16.0 24.6 23.7 26.2 29.0 52.6 48.1 31.7 19.2 11.0 16.6 8.4 14.8 11.4 10.5 28.4 17.0 59.9 22.8 24.2 103.0 18.8 24.3 18.8 24.2 1.9 36.2 24.4 26.5 25.5 50.6 41.9 15.4 25.0 15.1 19.7 40.2 12.2 32.9 48.1 36.3 58.5 57.9 81.0 16.8 31.3 16.6 18.3 198.8 46.5 24.5 34.8 107.8 16.0 27.2 79.0 20.1 13.4 15.1 19.9 20.0 15.7 37.2 16.0 17.2 60.9 64.3 42.8 7.5 6.6 23.1 24.9 11.3 7.8 10.5 12.9 29.1 13.2 30.0 18.2 19.2 CPM ENSG00000135678 "Carboxypeptidase M" P14384 12 68842197-68971570 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 157.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 359.0;Alveolar cells type 2: 362.2;Kupffer cells: 368.5;Sertoli cells: 762.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 21.0;intermediate monocyte: 14.5;myeloid DC: 16.6;non-classical monocyte: 7.4" "Group enriched" "Detected in many" 5 "dendritic cells: 16.6;monocytes: 21.0" "Group enriched" "Detected in many" 4 "ASC diff: 71.1;ASC TERT1: 50.0;HSkMC: 91.2;SiHa: 68.9;THP-1: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002657, HPA077243" Enhanced Uncertain Vesicles NA NA 7100000 Vesicles "HPA002657: AB_1078398, HPA077243: " "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.00e-4)" "unprognostic (4.58e-2)" "unprognostic (8.61e-2)" "unprognostic (1.57e-2)" "unprognostic (2.01e-1)" "unprognostic (8.42e-2)" "unprognostic (1.40e-1)" "unprognostic (1.35e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-3)" "unprognostic (8.58e-2)" "unprognostic (6.85e-2)" "unprognostic (2.59e-2)" "unprognostic (1.06e-1)" 157.5 11.6 5.9 14.5 11.6 3.5 40.5 8.9 22.9 14.5 4.5 33.8 4.4 24.1 0.9 10.2 16.3 16.3 4.4 6.0 13.5 41.7 26.7 59.9 16.3 15.3 10.5 3.0 18.2 13.1 12.1 1.0 70.7 16.5 14.8 26.8 6.8 4.1 2.9 5.9 19.9 6.0 6.4 7.5 19.6 15.5 5.4 11.1 4.4 7.5 9.8 10.5 9.4 5.7 23.3 0.1 4.0 0.1 0.0 71.1 50.0 0.7 9.8 1.1 1.7 2.3 3.2 4.1 0.5 9.6 1.4 4.1 0.0 1.4 2.7 4.1 0.1 2.7 0.0 15.1 0.3 0.4 1.2 1.9 91.2 0.6 1.0 2.0 8.6 0.0 0.3 0.0 0.1 7.3 1.7 0.0 0.7 1.7 0.0 5.2 3.1 0.6 0.0 7.2 5.9 0.4 0.2 68.9 10.7 7.9 5.5 1.2 26.5 0.2 1.2 7.5 0.5 0.2 0.4 0.5 13.1 4.3 13.1 5.9 0.6 21.0 0.1 0.2 14.5 0.0 1.8 1.5 0.1 16.6 3.5 0.9 0.2 1.6 0.5 7.4 1.1 1.9 7.3 5.9 11.6 8.9 22.9 6.0 13.5 15.3 10.5 3.0 16.5 7.5 11.1 23.3 83.3 359.0 362.2 34.6 4.9 12.4 3.5 6.1 0.6 3.3 7.8 8.9 2.6 135.8 70.1 51.5 0.0 32.3 1.1 97.5 29.4 57.9 16.6 100.9 8.3 29.0 10.8 3.6 1.2 212.5 59.9 14.1 4.6 237.1 112.5 6.7 73.9 36.6 134.6 0.0 1.3 28.7 0.0 368.5 36.3 17.5 105.0 202.2 10.6 19.7 23.3 68.9 1.0 23.1 161.8 68.0 65.9 79.0 2.4 38.7 1.9 63.7 16.4 5.7 762.6 7.2 126.9 0.6 3.9 2.4 9.9 172.4 14.5 46.3 32.7 2.8 MDM2 "HDM2, MGC5370" ENSG00000135679 "MDM2 proto-oncogene" Q00987 12 68808177-68850686 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 504.6;U-698: 517.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000086, CAB016303, CAB079977" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: " "unprognostic (1.16e-1)" "prognostic favorable (3.23e-4)" "unprognostic (6.16e-2)" "prognostic favorable (4.51e-7)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.77e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (3.23e-1)" "unprognostic (1.80e-3)" "unprognostic (2.36e-1)" "unprognostic (4.22e-2)" "unprognostic (4.59e-2)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (8.95e-2)" 14.1 11.7 4.6 10.5 8.7 28.9 12.0 7.1 7.7 14.0 22.6 20.9 6.4 9.6 7.2 13.1 14.2 12.1 6.8 3.1 7.4 9.6 27.2 14.4 13.9 7.6 7.8 2.5 10.9 14.4 11.0 5.0 16.6 9.5 11.4 22.2 14.3 9.7 11.6 18.8 10.9 7.6 12.5 5.6 11.5 10.1 6.6 7.4 15.7 15.6 13.0 17.2 15.2 10.9 11.7 18.7 42.1 43.5 22.6 55.9 51.5 223.4 49.7 50.3 26.2 41.5 26.8 8.4 188.6 13.5 34.7 7.3 11.0 31.4 504.6 42.1 51.0 22.0 35.3 36.0 115.0 55.7 32.6 31.0 77.8 46.5 101.5 69.4 26.9 73.7 32.1 37.1 45.4 50.8 28.0 43.1 10.7 36.9 10.1 8.2 149.4 31.7 16.2 16.0 146.0 34.3 20.2 32.0 25.0 11.3 88.8 58.3 21.4 82.3 20.2 38.0 16.8 18.5 68.2 47.7 517.6 31.3 12.8 81.2 6.1 5.4 5.2 4.1 4.1 3.7 4.7 3.5 4.1 3.0 5.4 3.6 3.5 19.2 3.7 7.2 3.9 4.1 3.6 4.6 8.7 7.1 7.7 3.1 7.4 7.6 7.8 2.5 9.5 5.6 7.4 11.7 23.1 32.1 56.3 26.1 36.4 15.6 30.5 42.6 22.8 26.8 21.4 17.1 20.9 24.3 75.8 25.8 33.3 47.5 32.1 19.3 13.7 19.5 2.5 257.4 34.5 22.0 25.1 29.9 28.8 24.2 28.0 31.9 28.5 74.8 32.9 33.2 15.7 45.0 18.3 30.3 32.9 23.4 32.6 49.0 25.0 2.9 19.3 44.9 12.4 37.5 35.4 27.8 10.3 25.6 71.8 22.4 20.1 15.1 117.7 39.8 15.8 21.3 141.7 35.3 19.7 30.0 32.4 17.3 20.0 59.5 22.0 94.3 31.8 49.4 20.9 82.0 KLHL36 "C16orf44, FLJ12543" ENSG00000135686 "Kelch like family member 36" Q8N4N3 16 84648511-84667686 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023423 Approved Approved Cytosol NA NA Cytosol "HPA023423: AB_10962985" "unprognostic (6.50e-2)" "unprognostic (2.41e-2)" "unprognostic (2.35e-1)" "unprognostic (5.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (2.90e-1)" "unprognostic (5.25e-2)" "unprognostic (2.59e-2)" "prognostic favorable (9.81e-5)" "unprognostic (3.79e-3)" "prognostic favorable (5.52e-10)" "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (8.47e-2)" "unprognostic (1.67e-3)" 9.4 6.4 6.3 6.1 6.2 13.5 7.8 4.1 7.1 5.6 9.3 6.7 6.9 6.7 2.1 9.0 6.9 3.9 8.7 8.9 5.2 6.9 11.3 8.7 7.8 6.2 4.3 5.6 8.8 11.5 8.9 6.2 4.6 4.1 6.6 3.3 1.9 7.7 5.4 5.1 8.1 9.1 4.0 3.6 9.4 8.5 13.9 5.8 4.4 8.9 4.5 4.9 8.2 7.1 3.8 18.9 19.9 5.0 11.9 5.4 8.8 18.9 13.9 9.7 5.8 2.8 17.3 12.7 13.2 18.2 11.3 5.9 20.6 5.5 13.4 4.0 8.1 8.0 4.4 6.7 10.9 7.2 5.4 12.2 8.4 11.2 6.7 8.3 8.6 8.7 4.3 14.3 2.1 6.0 28.7 0.8 8.3 7.6 8.1 8.2 18.1 5.8 6.3 11.1 17.2 5.9 4.4 16.6 4.7 8.8 6.0 17.7 16.6 16.9 7.6 12.9 8.2 8.7 7.1 10.2 22.7 10.3 7.3 22.2 3.5 2.7 6.3 3.2 1.7 2.8 4.5 5.9 4.7 3.7 3.7 6.9 5.0 3.2 2.3 2.0 3.4 3.4 2.8 6.3 6.2 4.1 7.1 8.9 5.2 6.2 4.3 5.6 4.1 3.6 5.8 3.8 18.5 19.2 16.2 8.5 24.6 15.9 45.3 23.9 15.9 25.8 23.3 15.7 26.5 32.9 16.8 22.0 35.5 23.7 19.3 28.3 5.9 24.5 41.4 13.8 12.3 19.6 18.6 6.5 11.8 14.5 11.7 20.9 16.3 21.4 7.0 22.7 19.2 21.9 19.3 26.9 10.6 23.3 26.4 21.2 17.6 14.7 23.3 18.0 21.4 15.9 22.4 10.5 18.6 7.5 8.5 22.8 20.0 25.2 10.8 56.0 37.0 28.1 16.3 23.0 32.9 21.7 24.9 21.7 6.1 19.3 17.6 19.3 26.8 12.8 21.3 39.8 BCO1 "BCDO, BCDO1, BCMO, BCMO1, FLJ10730" ENSG00000135697 "Beta-carotene oxygenase 1" Q9HAY6 16 81238689-81291142 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 14.7" "Cell type enhanced" "Detected in some" "Astrocytes: 6.2;Distal enterocytes: 4.8;Excitatory neurons: 8.0;Intestinal goblet cells: 5.5;Proximal enterocytes: 13.6;Proximal tubular cells: 8.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 11.5;EFO-21: 8.7;HAP1: 3.3;NTERA-2: 4.6;RPTEC TERT1: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043811 Uncertain "Actin filaments,Centriolar satellite" NA NA "Actin filaments, Centriolar satellite" "HPA043811: AB_10962487" "unprognostic (2.78e-1)" "unprognostic (3.88e-3)" "unprognostic (2.61e-1)" "unprognostic (3.32e-1)" "unprognostic (4.05e-2)" "unprognostic (8.01e-4)" "unprognostic (1.65e-1)" "unprognostic (2.99e-2)" "unprognostic (1.58e-3)" "unprognostic (7.26e-2)" "unprognostic (2.97e-2)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.48e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 0.0 0.0 2.0 0.2 1.5 0.0 0.1 0.1 1.5 0.2 4.3 2.6 9.4 0.6 0.2 0.3 0.5 1.2 0.0 2.8 0.2 3.5 0.8 0.2 0.0 0.5 1.0 1.0 0.9 0.3 0.0 0.7 0.0 0.7 0.5 3.0 0.2 0.5 1.5 0.1 0.3 14.7 0.3 0.1 0.0 1.9 0.1 0.8 0.2 0.1 0.0 0.0 0.2 0.4 0.9 0.0 11.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 2.3 0.0 8.7 0.0 0.3 0.1 3.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.6 0.8 0.0 0.0 0.0 0.0 8.6 0.3 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.5 0.1 1.5 2.8 0.2 0.5 1.0 1.0 0.7 0.1 0.8 0.9 0.0 0.0 0.0 6.2 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.5 0.0 4.8 0.0 0.6 0.1 0.9 1.1 0.1 1.2 0.0 8.0 0.0 0.0 0.2 0.0 4.0 0.0 0.1 0.4 0.3 0.1 0.0 3.7 5.5 0.0 0.0 0.0 0.3 1.5 0.1 0.0 1.0 0.0 0.0 0.0 2.5 1.0 0.6 2.1 1.2 0.0 0.1 13.6 8.8 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.7 0.0 0.3 0.1 0.0 3.0 0.7 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170224 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavorable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favorable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 19.0 21.5 26.7 25.8 29.0 20.1 73.2 31.2 33.1 23.8 21.4 23.0 13.9 26.1 22.5 36.5 16.0 16.6 13.5 28.9 28.2 16.3 16.0 18.9 24.9 24.0 24.9 28.0 13.5 9.0 16.3 21.5 24.6 26.8 15.4 25.2 31.9 26.3 13.1 18.2 40.4 16.0 23.0 23.2 16.8 15.8 14.2 27.2 20.9 11.7 17.7 26.5 35.0 21.2 30.5 67.8 36.2 79.0 38.9 37.7 52.7 43.5 71.1 84.7 60.6 29.3 58.5 38.4 55.2 42.0 39.2 44.7 69.2 76.2 73.6 80.8 41.3 49.9 44.5 31.2 106.5 37.5 111.9 65.9 33.6 64.7 36.2 102.8 30.5 70.6 75.7 106.2 15.3 93.4 54.8 86.5 131.2 72.4 83.4 49.5 105.5 36.6 36.5 55.3 69.8 54.1 23.3 119.6 52.5 53.6 32.4 92.2 68.6 56.0 56.5 56.3 50.2 51.3 22.4 58.0 217.9 51.0 89.9 73.2 26.1 38.3 36.9 38.2 46.5 48.5 35.6 38.7 39.9 44.9 29.2 41.1 38.8 4.9 33.1 33.8 27.2 44.3 28.3 26.7 29.0 31.2 33.1 28.9 28.2 24.0 24.9 28.0 26.8 23.2 27.2 30.5 13.2 19.2 38.3 20.5 22.9 38.7 40.3 123.9 19.4 14.5 74.3 50.0 31.5 14.3 66.2 20.2 10.4 56.9 23.0 21.7 50.9 45.2 6.5 13.9 18.5 19.3 9.0 23.1 38.5 28.1 46.1 31.4 15.8 22.0 18.3 21.9 20.0 19.0 49.6 20.2 35.6 20.7 40.7 29.1 42.7 7.5 11.1 55.9 32.0 12.2 56.0 61.1 34.0 29.7 17.1 56.4 28.4 10.1 22.3 38.6 12.2 46.5 32.7 24.5 19.7 15.4 30.1 36.9 57.5 30.6 54.0 32.8 27.4 26.3 34.0 48.1 CHST5 "FLJ22167, I-GLCNAC-6-ST" ENSG00000135702 "Carbohydrate sulfotransferase 5" Q9GZS9 16 75528535-75535247 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 85.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 5.2;Intestinal goblet cells: 3.7;Paneth cells: 8.1;Proximal enterocytes: 11.6;Undifferentiated cells: 2.6" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.4;stomach cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.5" "HPA043804, HPA068029" Enhanced "Intracellular and membrane" NA NA "HPA043804: AB_10960563, HPA068029: " "unprognostic (6.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.99e-3)" "unprognostic (1.03e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-2)" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (2.09e-2)" "unprognostic (9.03e-3)" "unprognostic (4.27e-2)" "unprognostic (2.05e-3)" "unprognostic (3.56e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 0.1 0.2 3.0 1.3 1.9 0.6 0.4 2.0 2.3 0.3 1.8 46.5 85.8 0.4 0.3 0.2 1.1 0.2 0.3 2.4 1.0 0.2 0.1 0.3 0.3 1.7 1.6 2.2 0.5 0.1 0.4 0.7 0.2 1.3 0.3 55.8 1.5 0.1 0.4 7.7 0.2 76.3 1.0 1.9 0.4 4.8 0.7 1.2 0.3 0.3 0.8 0.1 0.2 0.1 1.7 0.1 0.3 0.4 0.5 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.2 0.6 0.4 0.2 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.5 0.0 0.2 0.6 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.4 0.0 0.9 0.2 1.3 0.3 0.0 1.5 0.2 0.1 0.9 0.5 0.1 0.7 1.2 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.5 0.3 0.9 0.1 0.2 0.7 0.0 0.3 0.1 0.3 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.2 0.2 0.1 0.0 3.0 1.9 2.0 2.3 2.4 1.0 1.7 1.6 2.2 1.3 1.9 1.2 1.7 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.3 0.0 0.0 2.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 2.0 0.6 0.0 8.1 0.0 0.0 0.0 11.6 0.0 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.6" "Cell type enhanced" "Detected in many" "Early spermatids: 50.2;Excitatory neurons: 53.5;Inhibitory neurons: 53.3;Late spermatids: 199.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 25.8;monocytes: 23.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol NA NA 67000 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favorable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.4 11.4 18.6 10.0 35.9 17.3 2.5 33.5 63.6 7.0 0.0 9.7 4.7 5.2 2.7 7.8 3.3 4.7 4.6 35.0 16.2 3.5 2.5 7.5 6.0 14.0 7.2 38.7 2.7 15.4 4.1 32.9 3.9 16.2 9.3 6.2 9.3 7.0 4.9 10.3 10.7 6.8 5.7 0.1 8.2 10.9 5.9 6.9 2.8 2.4 3.7 6.6 15.0 6.4 28.2 6.7 7.1 4.7 6.8 8.6 6.4 1.2 6.6 10.4 9.2 5.3 3.2 3.1 2.2 2.8 8.0 5.6 5.8 4.4 10.5 5.7 4.9 3.6 4.3 1.9 1.7 4.1 0.5 5.9 11.9 5.5 10.6 1.4 3.9 5.0 4.6 19.1 5.4 8.3 10.5 0.8 1.8 4.6 7.8 5.6 0.8 6.0 1.4 8.7 4.8 13.7 2.1 7.7 12.7 3.1 4.7 10.3 1.3 10.0 5.7 4.3 8.7 2.3 8.4 1.6 4.8 7.5 3.3 6.2 24.6 11.1 17.9 1.4 13.4 0.4 0.0 0.9 0.9 4.1 0.1 0.8 0.9 25.8 1.3 23.9 5.9 0.3 5.3 18.6 35.9 33.5 63.6 35.0 16.2 14.0 7.2 38.7 16.2 0.1 6.9 28.2 0.9 6.4 5.8 7.5 2.6 4.0 7.8 12.4 2.2 17.9 2.7 1.1 8.3 2.8 15.3 1.8 6.2 0.6 8.0 16.0 0.0 2.8 50.2 2.8 7.5 3.3 11.4 0.4 53.5 4.7 0.8 6.9 10.7 4.9 2.5 1.7 3.3 2.9 6.9 48.8 53.3 8.6 10.2 21.5 4.6 199.5 16.1 30.9 3.6 11.2 24.5 3.1 3.1 8.5 7.0 9.1 7.2 26.7 16.5 15.0 4.8 1.8 23.9 5.4 0.0 5.4 3.4 4.1 4.1 1.2 4.4 3.4 4.6 4.8 5.2 29.8 DYNC1LI2 DNCLI2 ENSG00000135720 "Dynein cytoplasmic 1 light intermediate chain 2" O43237 16 66720893-66751609 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 288.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049538, HPA057201" Approved Approved Centrosome,Cytosol NA NA 21000 Centrosome Cytosol "HPA049538: , HPA057201: AB_2683366" "unprognostic (6.03e-2)" "unprognostic (2.40e-2)" "unprognostic (8.28e-2)" "unprognostic (1.57e-2)" "unprognostic (5.35e-2)" "unprognostic (2.80e-1)" "unprognostic (7.58e-2)" "unprognostic (3.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (4.77e-2)" "unprognostic (1.92e-1)" "unprognostic (7.70e-3)" "unprognostic (1.34e-1)" 61.4 45.3 277.9 39.5 271.1 42.8 44.5 248.7 271.1 46.6 174.2 63.5 43.7 51.2 40.9 51.1 38.0 49.1 59.9 225.5 239.9 43.3 29.3 46.3 27.2 270.5 267.8 202.0 45.9 45.1 66.2 35.9 47.2 270.4 53.1 61.7 37.7 49.1 50.4 42.7 51.7 44.9 65.5 286.9 36.6 50.7 34.4 261.2 24.8 62.2 50.3 29.1 46.1 41.1 288.5 52.5 54.0 79.1 71.0 100.1 98.3 71.6 84.5 67.1 67.5 87.0 73.4 50.6 21.9 64.6 83.3 49.1 74.1 61.2 60.4 98.2 14.9 43.9 27.0 68.1 70.6 55.5 29.0 38.5 64.8 80.6 77.8 53.4 94.3 96.2 22.4 44.4 28.0 88.8 37.5 18.1 37.5 47.5 58.4 93.0 39.4 166.3 26.5 67.2 73.3 78.8 54.9 152.1 32.6 100.6 56.5 39.7 28.8 123.2 86.9 43.3 43.0 58.2 35.3 27.4 43.0 74.6 27.7 55.8 13.6 16.6 16.6 12.3 9.9 14.2 4.8 10.4 10.2 12.2 9.4 8.7 8.4 15.7 9.3 14.5 7.6 11.4 8.7 277.9 271.1 248.7 271.1 225.5 239.9 270.5 267.8 202.0 270.4 286.9 261.2 288.5 117.9 102.5 120.4 44.1 29.5 66.2 63.1 66.1 52.3 82.5 54.8 51.2 48.3 54.3 93.8 27.6 33.3 61.3 47.2 114.0 7.9 85.7 112.6 77.6 68.5 97.6 106.1 28.4 50.9 58.1 62.0 66.7 52.5 87.4 36.7 87.5 62.4 33.3 30.6 107.7 45.4 78.6 65.1 39.9 53.7 66.8 63.3 36.8 69.4 34.7 37.8 116.0 35.0 51.3 106.9 101.7 56.7 80.5 37.3 83.6 60.0 49.4 105.0 61.4 118.3 93.4 87.0 103.0 51.1 53.6 69.9 84.8 32.2 61.2 66.7 95.8 FBXL8 Fbl8 ENSG00000135722 "F-box and leucine rich repeat protein 8" Q96CD0 16 67159932-67164570 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035587, HPA035588" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035587: AB_2674690, HPA035588: AB_10670023" "unprognostic (1.31e-1)" "unprognostic (1.95e-1)" "unprognostic (3.57e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.79e-1)" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (9.14e-2)" "unprognostic (1.21e-1)" "unprognostic (4.67e-1)" "unprognostic (1.06e-2)" "unprognostic (2.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.68e-1)" "unprognostic (3.88e-2)" "unprognostic (1.47e-1)" "unprognostic (7.17e-3)" 12.0 24.2 2.9 5.4 3.3 3.4 18.5 5.0 5.4 17.6 1.7 13.1 9.8 17.2 2.5 15.7 20.5 2.3 10.9 3.5 2.6 14.7 16.8 14.7 4.3 5.0 3.3 3.5 16.3 53.9 4.9 25.1 5.8 4.3 35.8 6.4 2.2 36.1 2.6 11.3 27.4 12.3 2.5 2.1 13.7 22.8 4.3 3.1 2.1 21.0 1.2 2.7 12.8 15.0 8.6 5.9 7.2 1.1 9.7 5.2 9.2 25.0 4.9 4.0 4.0 4.0 6.8 16.0 4.6 7.4 4.6 4.0 19.9 2.9 4.8 1.1 11.9 11.7 4.7 17.2 7.5 3.7 2.7 18.1 6.9 5.2 4.2 3.4 11.6 2.6 12.6 9.3 10.1 2.8 16.8 3.9 10.4 0.6 5.4 17.6 12.7 3.3 22.4 6.1 8.1 10.2 9.5 12.4 6.4 3.3 2.9 31.7 6.2 6.3 10.0 11.5 23.4 4.4 43.4 10.4 6.0 11.0 8.7 6.1 5.1 4.7 4.9 3.8 2.2 3.4 1.6 10.7 5.0 2.4 1.7 2.3 2.4 6.4 5.8 2.0 4.3 4.0 3.1 2.9 3.3 5.0 5.4 3.5 2.6 5.0 3.3 3.5 4.3 2.1 3.1 8.6 3.4 0.0 3.1 0.0 2.8 3.2 4.4 3.4 17.1 1.7 5.0 4.3 0.9 7.2 5.1 5.5 8.4 2.8 6.0 7.6 1.9 6.9 0.1 3.3 3.4 3.2 6.7 0.4 0.2 8.0 3.1 4.6 18.8 3.7 0.0 4.7 1.8 4.4 2.8 5.0 0.1 10.4 2.0 1.9 2.9 0.5 9.3 2.9 10.6 0.0 7.7 1.9 8.2 0.0 1.1 9.3 5.2 5.7 4.6 5.4 10.6 6.2 4.1 4.7 6.6 2.4 4.2 0.1 1.0 7.2 4.4 1.5 4.2 8.4 9.0 5.6 FHOD1 FHOS ENSG00000135723 "Formin homology 2 domain containing 1" Q9Y613 16 67229387-67247481 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 88.9;skeletal muscle: 128.2" "Cell type enhanced" "Detected in many" "granulocytes: 40.6;Theca cells: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HMC-1: 112.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024468 Approved Supported Cytosol NA NA 1300000 Cytosol "HPA024468: AB_1848568" "unprognostic (6.53e-3)" "prognostic unfavorable (9.57e-4)" "unprognostic (5.42e-2)" "unprognostic (2.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-1)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.27e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-3)" "unprognostic (4.70e-2)" 16.4 17.1 3.5 9.7 3.3 6.3 13.3 3.2 4.0 9.6 4.2 7.7 6.0 8.6 1.6 4.6 8.0 5.6 9.6 3.0 3.4 10.0 3.3 26.8 8.5 3.5 3.7 2.7 14.8 7.8 3.8 5.5 9.0 3.6 8.9 4.3 0.3 8.5 3.9 128.2 5.8 9.7 5.9 3.8 88.9 7.3 5.0 4.0 4.1 16.9 30.1 6.0 7.5 6.7 4.2 12.0 31.6 11.8 9.8 46.1 27.9 39.2 24.9 19.8 27.2 26.3 22.3 15.7 14.1 17.5 18.0 8.8 14.7 13.5 20.0 13.5 11.3 21.7 63.1 13.9 24.5 12.2 26.3 112.1 34.8 2.6 42.2 4.1 24.3 43.0 19.9 32.9 9.3 17.6 41.0 18.1 48.3 17.6 11.0 10.0 20.3 25.9 33.8 8.7 4.9 3.7 19.2 38.2 22.4 22.5 11.7 23.8 21.1 51.6 37.4 22.0 24.0 20.3 29.9 32.0 20.7 76.1 24.7 34.7 0.3 0.7 0.1 0.2 0.2 0.3 0.0 0.3 0.2 0.4 0.1 0.1 0.1 0.5 0.3 0.2 0.2 0.3 0.6 3.5 3.3 3.2 4.0 3.0 3.4 3.5 3.7 2.7 3.6 3.8 4.0 4.2 18.0 12.8 21.6 4.6 7.2 5.7 1.8 2.0 3.4 1.8 11.5 8.0 13.8 10.0 5.9 5.5 8.4 8.7 11.4 16.9 0.0 3.6 1.1 3.5 8.1 22.3 9.1 8.6 2.5 5.9 4.7 10.9 5.6 4.7 40.6 12.0 25.0 0.8 17.1 1.7 2.2 13.1 2.0 20.3 19.7 1.1 10.5 19.8 3.6 17.8 18.9 2.9 10.3 2.0 0.6 7.4 6.1 10.9 7.1 3.1 6.3 1.4 3.9 1.2 26.3 4.2 15.7 19.0 12.3 5.6 3.7 1.9 13.3 40.3 13.8 1.7 CCDC102A MGC10992 ENSG00000135736 "Coiled-coil domain containing 102A" Q96A19 16 57512181-57536571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Peritubular cells: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040598, HPA040958" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA040598: AB_10794035, HPA040958: AB_10794156" "unprognostic (3.46e-2)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.01e-3)" "unprognostic (7.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.38e-1)" "unprognostic (5.24e-3)" "unprognostic (8.40e-3)" "unprognostic (4.08e-1)" "unprognostic (2.75e-1)" "unprognostic (2.37e-1)" "unprognostic (8.42e-3)" 4.9 3.8 2.4 2.7 1.4 0.5 4.9 1.8 2.4 10.6 3.7 8.2 2.3 11.1 1.1 3.6 8.9 1.5 6.2 1.5 3.0 5.2 1.5 4.5 3.0 2.3 2.0 0.9 8.1 3.4 1.5 2.3 2.5 1.8 8.4 0.5 0.1 4.0 3.9 1.6 4.8 4.8 2.4 2.0 5.1 4.8 3.0 2.7 1.6 5.8 0.5 1.7 12.0 8.3 2.9 6.6 7.9 3.0 4.3 1.0 1.4 6.2 4.2 2.3 2.4 1.2 3.2 7.5 6.0 16.4 1.3 3.2 4.8 1.5 2.2 0.9 4.9 6.8 0.8 3.8 1.3 3.7 0.4 7.7 3.5 1.4 2.0 0.5 5.2 1.9 2.1 4.6 0.0 0.8 2.7 5.4 5.3 7.1 0.7 14.6 4.8 3.4 2.4 3.0 1.0 0.5 7.8 6.6 2.1 3.2 1.1 4.5 2.9 5.2 4.4 14.5 0.4 3.8 6.9 2.7 2.2 2.5 2.1 7.4 0.0 0.0 0.0 1.1 0.0 0.9 0.9 0.2 1.2 0.0 0.5 0.5 0.8 0.1 0.6 0.0 0.3 0.0 0.2 2.4 1.4 1.8 2.4 1.5 3.0 2.3 2.0 0.9 1.8 2.0 2.7 2.9 8.8 0.0 3.0 0.7 8.2 12.9 8.0 2.4 14.8 0.0 4.9 10.3 3.1 5.7 2.2 7.3 0.0 1.6 16.3 0.5 9.8 1.9 0.6 6.0 8.5 10.6 0.0 3.4 0.0 0.9 1.1 13.2 2.0 1.8 0.0 14.6 7.1 0.9 0.3 0.0 0.1 1.0 0.0 0.6 2.8 1.3 19.6 1.5 1.8 1.0 0.5 3.5 18.6 0.0 0.0 0.9 0.1 34.6 18.8 10.6 1.1 10.5 3.1 0.2 19.7 10.8 11.8 2.8 8.9 2.3 5.7 0.3 10.5 3.3 1.0 3.2 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272191 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.5;lymphoid tissue: 17.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 11.1;Horizontal cells: 16.8;Inhibitory neurons: 12.2;Oligodendrocyte precursor cells: 7.1;Spermatocytes: 17.2;Theca cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 0.8 0.6 4.2 0.3 5.8 0.1 1.0 5.2 6.5 0.7 2.6 0.4 0.4 0.4 1.0 0.2 0.5 0.6 1.2 4.6 3.9 0.8 0.2 1.4 0.8 4.7 4.5 4.4 1.2 0.6 0.1 0.8 0.6 5.4 1.0 0.3 1.2 0.8 0.3 1.8 1.5 0.5 0.1 3.5 17.6 0.6 3.2 4.2 0.1 0.8 0.7 0.4 0.4 0.5 4.8 0.3 2.9 2.6 0.9 4.7 3.2 0.3 1.1 4.1 2.4 2.2 0.1 2.0 0.0 0.6 1.2 1.2 0.1 0.6 0.4 1.0 0.8 0.8 2.1 0.5 0.7 0.5 1.0 4.7 3.8 1.0 1.5 0.2 4.5 1.0 0.9 0.5 1.3 1.6 1.7 0.0 0.2 1.5 0.2 0.2 0.0 0.5 0.7 0.4 0.5 1.6 0.9 2.4 0.1 1.2 0.6 1.1 0.2 0.8 6.4 0.9 1.1 0.4 2.4 0.5 1.3 4.5 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.2 5.8 5.2 6.5 4.6 3.9 4.7 4.5 4.4 5.4 3.5 4.2 4.8 0.6 3.2 2.8 4.2 0.4 0.6 0.2 0.1 1.2 3.4 1.8 1.3 1.5 1.5 0.2 0.0 0.0 0.3 0.1 0.5 0.0 0.3 1.8 0.2 0.8 0.8 1.2 0.0 11.1 0.2 0.1 0.7 0.0 0.9 0.0 0.9 1.4 0.0 0.1 16.8 12.2 0.3 0.0 0.0 0.4 0.7 0.3 0.5 0.0 1.9 0.6 0.3 0.0 7.1 2.6 0.5 0.1 2.2 0.0 0.5 0.2 0.0 0.7 0.9 0.0 0.6 1.4 17.2 4.6 0.3 0.9 0.0 0.3 6.8 0.3 0.2 AGT SERPINA8 ENSG00000135744 Angiotensinogen P01019 1 230690776-230745576 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 1616.8" "Group enriched" "Detected in many" 9 "Cholangiocytes: 985.1;Hepatocytes: 2244.9" "Cancer enriched" "Detected in all" 4 "liver cancer: 1163.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 646.2;THP-1: 243.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025798 Supported "Secreted to blood" NA NA 5940000 65000000000 "CAB025798: " "unprognostic (7.77e-2)" "unprognostic (4.46e-1)" "unprognostic (2.15e-2)" "unprognostic (2.07e-2)" "unprognostic (2.67e-1)" "unprognostic (3.61e-2)" "unprognostic (5.75e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-2)" "unprognostic (4.46e-2)" "unprognostic (4.32e-3)" "unprognostic (6.70e-2)" "unprognostic (9.28e-2)" "unprognostic (4.42e-3)" "unprognostic (2.17e-1)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" 8.2 14.7 229.9 2.6 232.1 0.4 4.5 265.2 245.5 9.8 121.2 4.6 2.5 3.2 1.9 2.6 6.1 93.5 142.6 218.4 230.1 51.3 1616.8 5.1 1.0 326.7 249.7 164.9 3.5 8.0 6.1 26.0 0.7 277.5 16.4 3.6 26.6 4.9 2.3 44.0 1.6 9.8 5.9 310.3 1.3 5.0 4.2 265.3 1.7 13.3 26.0 0.1 7.1 4.6 299.1 0.2 0.4 0.2 0.2 15.6 0.0 0.9 0.6 0.2 0.0 0.0 80.6 0.1 0.3 0.7 0.2 0.7 0.7 0.0 0.0 0.0 11.4 0.2 0.2 0.3 646.2 1.9 1.0 0.5 26.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 5.5 0.7 0.0 0.2 0.6 0.6 0.1 0.2 0.3 2.4 0.1 0.1 0.3 0.9 0.6 0.4 0.1 5.5 0.1 0.0 243.6 0.1 0.4 1.3 0.4 1.2 3.5 47.0 0.4 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 229.9 232.1 265.2 245.5 218.4 230.1 326.7 249.7 164.9 277.5 310.3 265.3 299.1 0.8 0.0 1.7 140.0 11.3 0.6 1.1 0.0 0.0 4.7 0.8 0.3 60.0 985.1 0.6 3.7 35.5 0.1 0.0 0.0 25.4 169.8 62.2 0.3 0.4 5.5 0.0 50.8 0.3 10.0 0.2 27.2 0.5 0.1 0.0 0.0 39.3 2244.9 2.1 3.3 1.5 1.1 0.0 56.9 0.4 48.5 4.1 0.9 8.8 5.6 0.6 75.1 0.0 3.5 6.8 13.7 1.2 3.4 0.0 26.2 24.2 146.9 0.1 49.8 13.1 7.2 94.1 0.4 0.4 0.0 0.0 0.7 3.9 0.0 0.4 1.9 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex 2" A6NKB5 1 232983435-233295725 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 9.3;Endometrial stromal cells: 8.8;Glandular and luminal cells: 11.1;Granulosa cells: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 3.7 2.1 8.1 2.5 8.7 2.2 3.8 6.5 15.1 3.7 0.0 2.1 1.5 3.1 6.7 3.6 4.3 3.9 1.2 14.9 5.7 4.4 0.6 2.5 5.1 2.3 5.2 7.6 7.2 4.5 3.6 15.0 1.0 5.2 4.7 2.2 11.6 4.7 3.7 3.1 4.3 5.2 2.4 0.2 3.9 3.4 2.8 5.5 3.3 5.7 0.6 3.7 4.7 5.1 7.1 5.1 12.0 6.4 0.1 10.3 11.1 1.9 3.0 8.6 3.1 5.3 3.9 6.0 10.5 6.8 8.1 11.1 8.2 2.9 8.5 7.1 8.9 8.7 0.1 6.6 0.0 4.6 3.5 2.0 8.5 7.4 6.0 23.6 10.3 5.8 7.7 0.0 5.5 3.0 3.0 9.8 0.2 20.7 4.2 7.2 0.1 1.7 1.5 5.5 7.7 11.0 9.2 4.4 1.8 1.8 3.6 4.3 0.9 2.2 8.4 5.4 9.6 9.9 6.5 7.3 0.1 7.7 3.8 9.9 0.3 0.2 0.1 0.7 0.1 0.5 0.3 0.6 0.7 0.5 0.3 0.2 0.5 0.1 0.2 0.1 0.1 0.7 0.3 8.1 8.7 6.5 15.1 14.9 5.7 2.3 5.2 7.6 5.2 0.2 5.5 7.1 7.0 9.6 5.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 6.9 7.4 0.0 0.0 6.8 12.9 0.0 0.4 5.8 0.0 7.9 6.4 0.0 9.3 8.8 1.1 0.0 0.0 0.0 3.3 1.6 3.6 0.0 11.1 1.3 8.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.7 0.0 0.0 1.7 4.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 6.5 4.3 0.0 0.0 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614106-233672514 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 157.8;Horizontal cells: 200.2;Prostatic glandular cells: 222.9;Urothelial cells: 371.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 69 "plasmacytoid DC: 6.9" "Lineage enriched" "Detected in single" 69 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "HeLa: 64.7;SCLC-21H: 62.5;U-266/70: 137.3;U-266/84: 134.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 117.0" "HPA016049, CAB022588" Approved Approved Vesicles NA NA Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 2.5 4.2 21.4 3.0 23.7 0.3 5.7 57.9 26.7 6.8 43.5 15.8 17.1 6.1 31.2 21.0 11.0 12.2 27.0 27.8 26.6 9.3 12.3 4.4 1.0 27.5 23.0 24.9 7.3 5.5 16.3 22.3 6.8 30.2 6.5 14.0 18.7 15.3 11.4 0.4 12.6 12.7 3.9 20.4 0.9 38.4 0.9 21.8 0.5 7.3 0.9 4.4 11.6 14.5 29.8 33.2 18.3 0.1 0.0 0.0 0.0 50.2 8.8 0.0 0.0 0.0 0.0 52.9 0.0 20.7 6.8 7.3 47.1 8.9 15.2 0.0 0.1 15.8 0.0 64.7 0.0 0.5 0.0 1.8 3.9 17.0 0.0 12.4 1.1 0.2 17.7 7.9 15.0 0.0 12.6 12.2 0.1 10.9 38.5 41.0 0.0 2.7 3.7 16.0 28.4 62.5 11.8 33.5 14.3 0.0 1.0 4.1 0.1 0.0 0.1 25.8 0.0 1.0 137.3 134.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 21.4 23.7 57.9 26.7 27.8 26.6 27.5 23.0 24.9 30.2 20.4 21.8 29.8 0.4 9.6 22.9 5.9 0.6 63.3 136.7 32.6 3.4 2.9 23.0 6.0 54.7 12.8 44.6 18.4 4.2 0.5 3.0 91.0 1.9 29.2 1.1 52.7 26.4 3.5 29.3 0.0 157.8 48.3 14.0 31.2 50.4 89.3 0.0 15.0 0.0 8.9 0.6 200.2 61.0 56.3 24.4 0.3 4.4 0.2 1.5 1.0 10.6 12.2 0.0 72.6 0.0 36.2 73.2 96.3 82.4 0.0 0.2 222.9 10.6 8.8 42.9 5.1 0.0 2.3 6.9 0.6 3.2 19.1 47.6 0.8 1.4 0.5 31.2 371.6 URB2 "KIAA0133, NET10, NPA2" ENSG00000135763 "URB2 ribosome biogenesis homolog" Q14146 1 229626247-229660200 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008902, HPA046788" Uncertain Enhanced Nucleoli NA NA Nucleoli "HPA008902: AB_2213805, HPA046788: AB_2679807" "unprognostic (1.26e-1)" "unprognostic (4.03e-3)" "unprognostic (2.16e-2)" "unprognostic (3.63e-2)" "unprognostic (1.79e-1)" "unprognostic (2.48e-1)" "unprognostic (5.53e-3)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-3)" "unprognostic (7.81e-2)" "unprognostic (2.72e-1)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" 5.0 2.8 2.0 3.9 2.4 4.6 3.3 2.5 2.4 2.1 1.7 2.7 2.2 3.2 1.8 3.7 2.8 2.6 2.4 1.9 2.2 1.6 2.9 2.1 4.5 2.5 2.6 1.6 2.9 4.7 2.5 4.4 3.4 2.5 2.0 2.4 2.6 2.3 1.8 6.9 3.0 2.5 3.3 2.5 3.0 2.7 5.8 2.2 4.7 2.2 4.6 4.8 4.9 2.3 3.0 13.6 20.1 12.8 17.2 7.9 6.5 39.1 10.6 6.6 16.1 12.1 20.1 10.4 28.0 11.9 7.6 8.6 18.3 32.0 13.0 14.6 13.8 30.4 17.5 16.8 11.9 7.5 25.8 14.5 6.4 9.3 16.0 12.4 4.1 7.8 16.2 37.7 12.7 10.1 10.7 29.0 12.6 43.1 24.1 13.2 32.0 18.2 27.9 7.1 17.0 19.1 23.4 12.5 12.9 10.6 4.4 14.6 14.6 8.6 13.1 16.6 16.8 30.8 13.9 14.4 41.6 7.0 19.0 24.4 0.1 0.9 0.2 1.2 1.7 2.2 0.8 1.1 1.4 1.1 1.0 1.6 1.3 0.1 0.8 0.6 0.7 1.4 1.4 2.0 2.4 2.5 2.4 1.9 2.2 2.5 2.6 1.6 2.5 2.5 2.2 3.0 5.4 0.0 1.1 3.6 6.0 10.1 8.6 1.8 4.0 6.4 5.1 4.3 2.7 1.5 2.6 5.5 29.2 5.3 4.5 2.0 0.0 2.4 0.4 2.8 5.0 4.6 6.6 6.9 7.1 2.7 11.7 3.6 4.1 3.2 0.0 3.5 3.9 3.7 2.8 3.3 7.2 2.5 4.1 1.3 2.7 0.9 2.1 2.8 5.4 6.5 2.7 2.6 2.1 10.1 7.0 2.7 0.8 3.4 4.4 8.7 0.6 2.3 1.3 16.7 0.0 11.6 4.0 8.0 4.0 5.5 9.1 3.3 4.2 3.1 3.1 5.5 EGLN1 "C1orf12, HIFPH2, PHD2, SM-20, ZMYND6" ENSG00000135766 "Egl-9 family hypoxia inducible factor 1" Q9GZT9 1 231363751-231422287 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Congenital erythrocytosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 192.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 29.1" "Lineage enriched" "Detected in many" 15 "granulocytes: 29.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022129 Approved NA NA "HPA022129: AB_1848046" "unprognostic (4.20e-1)" "prognostic unfavorable (2.99e-7)" "unprognostic (8.86e-2)" "unprognostic (1.26e-1)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.20e-1)" "unprognostic (3.87e-3)" "unprognostic (1.91e-1)" "unprognostic (3.99e-1)" "unprognostic (6.63e-2)" "unprognostic (9.71e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-1)" "unprognostic (5.65e-2)" "unprognostic (1.81e-2)" 33.1 35.9 41.4 18.3 44.2 20.2 24.1 42.8 43.5 26.5 34.9 30.3 34.3 31.1 24.7 33.9 24.4 28.5 59.3 42.7 41.4 39.2 56.9 19.3 21.2 46.1 42.8 38.2 37.8 40.3 39.3 9.4 43.0 41.8 24.1 26.4 50.3 22.2 30.6 192.2 49.0 35.8 27.8 44.9 27.8 19.2 17.3 44.9 16.8 25.8 154.8 21.5 27.3 12.1 45.5 54.2 59.9 17.5 33.7 44.8 29.4 15.8 22.7 42.2 36.3 49.4 41.3 48.0 15.5 41.7 42.4 31.7 25.1 26.8 30.1 61.0 18.6 42.5 6.7 23.5 37.7 31.5 38.5 8.1 25.4 27.5 24.9 34.2 58.6 49.3 18.5 33.9 37.9 38.3 12.2 8.9 14.4 18.4 33.4 21.0 20.0 21.7 22.7 48.0 23.4 15.9 45.3 32.9 41.4 83.1 11.2 22.4 112.8 54.3 44.3 20.8 40.5 47.2 65.7 46.4 14.7 60.4 14.0 59.4 4.2 0.5 3.1 1.2 1.0 0.7 0.7 0.9 0.8 0.8 0.7 1.0 1.8 29.1 1.6 1.8 0.7 0.5 0.4 41.4 44.2 42.8 43.5 42.7 41.4 46.1 42.8 38.2 41.8 44.9 44.9 45.5 64.7 19.2 23.2 36.6 19.8 58.5 15.0 10.7 33.0 32.3 19.4 13.3 111.9 67.2 11.6 18.4 37.5 16.2 16.6 57.6 35.2 37.8 1.2 18.5 20.2 60.6 12.7 8.2 43.9 36.2 34.2 25.9 15.3 21.2 10.1 55.6 28.9 70.6 16.9 62.2 52.6 24.6 16.2 24.1 45.3 5.0 16.1 29.8 26.6 44.0 19.0 56.9 12.3 46.3 48.3 36.6 30.9 23.0 23.9 15.1 43.2 52.3 13.5 44.0 19.7 36.4 36.6 13.1 20.9 24.9 57.5 10.4 24.9 16.0 23.5 21.3 CAPN9 "GC36, nCL-4" ENSG00000135773 "Calpain 9" O14815 1 230747384-230802003 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 22.4;stomach 1: 60.8" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 25.6;Gastric mucus-secreting cells: 93.8;Intestinal goblet cells: 71.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 7.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "OE19: 10.7;SCLC-21H: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020398, CAB033483, HPA062050" Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: " "unprognostic (2.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.60e-2)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.49e-2)" "unprognostic (3.36e-2)" "unprognostic (2.30e-2)" "unprognostic (4.61e-2)" "unprognostic (3.44e-2)" "unprognostic (9.10e-2)" "unprognostic (1.60e-1)" "unprognostic (5.97e-5)" "unprognostic (1.51e-1)" "unprognostic (2.08e-1)" "unprognostic (4.60e-2)" "unprognostic (2.16e-1)" 0.0 0.6 1.4 0.9 1.9 0.0 0.4 1.2 1.4 0.4 0.0 13.8 6.7 0.2 0.5 0.2 2.5 0.6 0.4 0.9 0.9 0.0 0.0 7.6 0.0 2.5 2.2 0.3 0.6 0.2 1.1 0.0 0.0 2.1 0.6 22.4 5.1 11.4 0.1 0.2 0.1 11.8 0.5 2.0 0.0 60.8 0.2 1.6 0.1 0.1 0.1 0.0 2.1 0.1 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.5 10.7 0.0 0.4 0.0 0.0 0.0 0.1 14.7 0.0 0.0 0.4 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.9 1.2 1.4 0.9 0.9 2.5 2.2 0.3 2.1 2.0 1.6 3.3 0.0 25.6 3.0 0.3 0.1 0.0 0.6 0.7 0.0 0.0 0.6 0.3 6.0 0.0 3.2 0.0 0.0 0.1 0.0 4.1 0.0 0.2 5.2 1.5 0.1 0.1 3.0 0.0 0.4 0.2 0.0 0.4 93.8 0.5 2.5 0.1 0.0 0.0 0.1 0.0 0.4 71.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.6 1.7 5.0 0.0 0.2 0.5 3.3 0.1 8.2 1.7 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.1 1.5 COG2 LDLC ENSG00000135775 "Component of oligomeric golgi complex 2" Q14746 1 230642481-230693982 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 71.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076994 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA076994: AB_2686823" "unprognostic (2.21e-1)" "unprognostic (7.35e-2)" "prognostic favorable (9.76e-4)" "unprognostic (2.91e-1)" "unprognostic (1.32e-3)" "unprognostic (3.59e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-1)" "unprognostic (2.18e-1)" "unprognostic (5.87e-2)" "unprognostic (6.83e-3)" "unprognostic (1.08e-1)" "unprognostic (2.73e-2)" "unprognostic (2.61e-1)" "unprognostic (4.44e-2)" "unprognostic (2.18e-2)" "unprognostic (5.62e-2)" 9.7 22.2 11.0 11.1 11.7 9.2 13.0 15.0 13.2 13.2 12.8 19.1 13.6 10.1 13.9 9.0 14.3 11.0 17.4 10.1 11.7 16.8 10.0 10.1 16.4 11.5 11.6 9.7 10.1 14.2 71.8 8.6 9.0 11.1 12.2 22.9 11.0 12.9 11.0 20.2 11.8 13.5 11.8 11.4 15.2 14.5 11.0 11.4 16.8 15.1 20.0 16.4 11.2 9.2 12.5 15.6 18.0 21.1 20.4 20.6 16.0 30.7 13.2 20.4 21.4 18.6 24.2 23.2 47.6 20.2 18.1 13.8 22.8 20.1 23.6 20.3 38.8 39.8 16.8 17.0 24.9 25.4 43.6 25.1 21.7 25.6 13.6 19.5 13.7 18.0 29.1 29.5 25.8 17.4 12.5 39.7 21.2 30.5 47.1 33.1 33.8 33.8 56.7 22.1 22.8 21.7 29.7 15.5 27.9 30.5 9.4 33.6 41.9 15.3 10.3 9.5 12.8 25.9 31.7 28.3 37.7 17.2 17.7 22.1 18.7 15.7 20.5 16.0 19.4 18.5 13.9 15.1 15.5 18.1 15.2 21.6 19.0 0.8 22.9 29.4 9.1 13.5 18.2 11.0 11.7 15.0 13.2 10.1 11.7 11.5 11.6 9.7 11.1 11.4 11.4 12.5 12.5 22.4 19.5 22.9 21.0 5.2 6.1 7.8 8.6 16.1 12.3 10.8 25.9 20.0 15.1 12.9 29.2 13.1 19.6 19.8 27.4 18.7 19.3 17.6 15.2 10.7 18.6 14.9 22.3 23.3 11.8 10.8 15.8 10.7 23.4 14.2 11.0 14.1 14.0 25.2 20.5 37.1 12.2 20.1 6.0 6.4 11.5 12.3 7.2 17.8 19.0 20.5 21.6 23.1 22.6 18.0 12.8 14.7 13.0 9.0 15.2 20.3 28.9 42.9 13.1 13.9 13.3 23.3 25.2 10.0 4.8 9.2 18.4 21.0 21.6 6.0 ABCB10 "EST20237, M-ABC2, MTABC2" ENSG00000135776 "ATP binding cassette subfamily B member 10" Q9NRK6 1 229516582-229558707 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.7" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HL-60: 101.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB044063, CAB044065, HPA055175" Uncertain NA NA "CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727" "unprognostic (1.00e-1)" "unprognostic (1.29e-2)" "unprognostic (5.56e-3)" "unprognostic (5.64e-2)" "unprognostic (2.04e-1)" "unprognostic (8.06e-3)" "unprognostic (9.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.15e-2)" "unprognostic (5.61e-2)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (8.32e-2)" "unprognostic (2.58e-1)" "unprognostic (3.83e-1)" "unprognostic (5.29e-2)" "unprognostic (3.37e-2)" 9.0 6.0 5.0 9.0 5.4 60.7 8.0 7.2 6.5 6.8 5.4 11.2 17.3 6.9 4.7 8.4 8.0 6.8 7.9 4.9 5.1 9.9 19.1 8.9 11.1 5.3 5.4 5.2 5.5 7.4 9.5 3.5 11.4 5.6 8.5 11.4 6.4 6.8 7.4 13.0 8.2 14.0 9.3 4.9 8.7 10.2 3.8 5.8 8.2 7.6 11.0 9.7 8.5 6.4 6.3 25.1 14.6 11.9 9.8 19.9 17.1 51.6 22.5 16.8 20.0 18.1 15.1 18.7 27.3 20.1 20.7 8.2 21.1 25.8 18.6 20.1 18.7 32.5 30.0 12.2 19.3 14.2 101.9 16.1 11.8 15.7 12.2 14.1 12.1 21.9 47.9 65.2 61.0 20.8 7.9 26.1 57.9 15.9 28.8 12.3 23.4 23.5 29.0 16.2 15.9 8.8 13.3 17.6 19.4 28.6 7.3 15.0 35.0 17.0 21.5 13.5 13.5 31.2 14.9 11.9 23.7 11.3 17.5 13.8 0.5 0.6 0.8 0.7 0.8 1.0 0.5 0.9 1.1 0.8 0.6 0.8 1.0 0.1 0.4 0.6 0.9 0.8 0.3 5.0 5.4 7.2 6.5 4.9 5.1 5.3 5.4 5.2 5.6 4.9 5.8 6.3 6.9 9.6 2.0 16.0 3.8 3.2 2.7 4.3 3.4 6.8 6.4 4.2 11.5 5.7 5.5 0.0 12.5 6.5 7.9 13.5 1.9 4.6 0.2 6.3 8.7 6.5 10.2 170.0 21.9 5.3 10.4 5.0 6.1 6.0 5.7 3.5 8.6 19.2 9.1 10.1 27.3 10.6 2.0 13.3 6.6 0.5 5.0 8.3 8.8 10.3 16.8 3.6 4.1 31.2 30.3 4.7 8.8 4.5 5.5 8.4 13.5 4.9 12.1 4.8 6.6 5.4 6.8 4.2 4.5 8.3 5.1 3.6 5.9 2.8 11.5 3.7 NTPCR "C1orf57, HCR-NTPase, MGC13186, THEP1" ENSG00000135778 "Nucleoside-triphosphatase, cancer-related" Q9BSD7 1 232950605-232983882 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028125, HPA054304" Uncertain Approved Cytosol NA NA Cytosol "HPA028125: AB_10601091, HPA054304: AB_2682443" "unprognostic (2.67e-1)" "unprognostic (2.28e-2)" "unprognostic (1.63e-2)" "unprognostic (7.59e-2)" "unprognostic (5.85e-3)" "unprognostic (1.04e-1)" "unprognostic (8.70e-3)" "unprognostic (2.12e-1)" "unprognostic (6.00e-2)" "unprognostic (5.03e-3)" "unprognostic (4.78e-2)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.74e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (6.37e-3)" 2.8 4.0 10.0 2.0 9.4 0.8 3.7 8.4 9.8 5.0 10.2 4.4 2.0 4.2 3.8 3.3 4.7 3.3 4.6 9.3 10.4 3.6 2.8 3.5 2.9 11.3 9.9 8.3 5.3 5.9 5.3 4.3 2.6 12.2 4.2 4.3 8.1 3.4 4.1 13.7 4.3 3.9 4.1 9.8 3.4 3.0 2.3 10.2 3.6 4.4 11.9 2.8 3.9 4.2 9.7 2.0 4.9 5.4 2.7 4.0 5.2 0.1 1.3 4.3 4.0 5.5 3.5 2.3 3.1 2.9 2.7 2.2 2.6 3.7 5.0 4.4 2.3 6.9 0.9 3.4 4.5 4.1 1.7 1.8 6.9 9.4 3.9 3.9 4.0 3.3 5.8 2.8 4.6 4.8 1.5 4.4 4.4 5.4 4.0 5.7 2.9 3.5 4.6 5.9 2.4 4.7 7.8 1.9 1.6 1.9 4.0 4.0 3.8 2.5 3.3 2.7 3.6 3.7 5.2 4.6 3.5 3.9 4.1 4.9 0.3 0.5 0.2 0.6 0.6 0.7 0.5 0.9 0.3 0.4 0.6 1.2 1.0 0.9 0.5 0.5 0.1 1.1 0.4 10.0 9.4 8.4 9.8 9.3 10.4 11.3 9.9 8.3 12.2 9.8 10.2 9.7 45.5 19.2 21.1 24.8 16.9 19.4 37.3 85.3 24.5 15.8 31.5 34.8 63.9 38.6 36.3 25.8 27.1 68.9 16.1 37.3 93.9 62.2 47.7 27.3 29.4 29.1 25.8 15.8 16.1 64.5 59.1 33.1 16.3 27.7 16.5 44.9 23.9 34.3 42.3 10.1 16.1 50.0 75.3 22.8 17.3 27.3 20.2 21.2 23.2 15.0 30.1 41.0 47.4 16.1 20.8 46.5 31.2 30.5 12.2 40.1 66.0 82.0 27.2 21.8 13.1 21.3 27.7 86.5 40.4 40.1 23.9 28.0 16.5 67.9 66.5 41.6 TAF5L PAF65B ENSG00000135801 "TATA-box binding protein associated factor 5 like" O75529 1 229593121-229626047 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067941 Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA067941: AB_2685929" "unprognostic (3.41e-1)" "unprognostic (1.34e-1)" "unprognostic (3.39e-2)" "unprognostic (1.93e-1)" "unprognostic (7.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-1)" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (5.17e-3)" "unprognostic (8.16e-3)" "unprognostic (1.91e-3)" "unprognostic (3.21e-1)" "unprognostic (2.99e-1)" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" 16.5 6.4 7.3 10.6 8.4 22.9 10.6 8.6 8.3 9.3 5.2 12.5 10.7 9.2 6.0 10.7 9.6 11.8 8.5 7.4 7.6 6.6 15.5 11.3 14.1 8.4 8.3 6.7 9.4 8.5 9.3 3.9 14.1 9.0 9.2 12.6 10.2 8.3 8.8 14.3 7.3 9.9 11.5 7.8 11.5 9.6 5.6 8.0 14.4 10.6 12.8 10.9 14.2 5.2 9.6 30.2 17.1 23.6 19.8 16.1 16.6 62.4 20.1 23.5 24.3 22.4 23.3 23.9 33.7 20.8 21.4 15.7 24.9 26.4 24.2 22.9 25.5 38.3 26.4 17.7 14.8 17.9 35.3 29.3 18.6 22.9 24.0 20.3 9.4 23.7 34.8 36.1 29.7 22.8 14.6 39.9 18.5 34.1 33.3 13.2 35.0 26.8 34.9 16.6 27.2 23.9 29.4 17.2 22.9 27.9 8.7 27.4 35.6 21.2 20.1 24.7 27.2 42.6 16.1 13.3 37.9 15.4 21.1 32.3 0.0 0.2 0.0 0.4 0.2 0.5 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.0 0.5 0.3 0.1 0.4 0.2 7.3 8.4 8.6 8.3 7.4 7.6 8.4 8.3 6.7 9.0 7.8 8.0 9.6 15.9 3.2 9.4 19.2 8.2 5.7 4.8 2.9 6.2 5.5 8.4 5.3 7.3 5.7 7.1 3.7 12.5 11.0 14.6 12.3 1.9 4.2 3.4 11.0 8.9 8.0 12.0 7.6 11.7 8.3 32.8 7.0 6.1 12.7 0.0 6.1 6.8 13.6 9.6 6.7 15.7 10.2 6.1 6.3 8.4 4.7 4.7 10.9 5.4 13.1 11.8 3.8 4.1 22.1 24.0 6.9 8.3 4.1 10.2 6.6 6.9 3.0 5.1 9.0 13.1 15.4 11.5 6.0 4.6 9.6 5.3 10.4 8.8 5.6 9.9 7.2 GLUL GLNS ENSG00000135821 "Glutamate-ammonia ligase" P15104 1 182378098-182392206 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Ligase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1455.4" "Group enriched" "Detected in all" 4 "Late spermatids: 8544.2;Muller glia cells: 6247.0" "Cancer enhanced" "Detected in all" "liver cancer: 365.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 656.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 656.8" "Cell line enhanced" "Detected in many" "ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007316, HPA007571, CAB008636" Approved Supported "Plasma membrane,Mitochondria,Cytosol" NA NA 150000 "Mitochondria, Cytosol" "Plasma membrane" "CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980" "prognostic favorable (4.81e-4)" "unprognostic (1.52e-3)" "unprognostic (3.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.25e-1)" "unprognostic (9.52e-2)" "unprognostic (7.58e-2)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (8.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.38e-2)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" "unprognostic (5.55e-2)" "unprognostic (4.53e-3)" 760.3 76.7 757.6 158.3 794.5 235.0 578.3 775.1 1074.3 162.8 663.1 154.0 24.6 117.7 116.7 220.7 226.2 106.3 119.9 740.8 848.8 65.3 283.0 223.6 75.9 929.5 841.8 735.1 305.6 206.4 32.6 71.1 178.0 842.4 104.3 93.4 898.9 235.4 96.9 1455.4 219.7 149.5 125.2 771.6 218.1 653.5 87.9 829.5 97.8 259.8 476.2 104.1 187.0 294.5 880.0 26.4 10.8 117.2 0.2 1150.8 807.6 86.0 44.1 141.7 25.9 23.4 64.1 26.7 22.4 46.3 85.5 23.8 59.3 51.8 309.4 21.5 61.2 143.3 296.5 47.6 124.8 61.1 132.6 227.2 702.1 363.3 32.9 384.6 39.1 52.8 71.7 254.3 13.3 92.6 15.0 208.2 126.5 87.3 36.8 55.0 74.3 31.3 38.6 45.8 114.0 79.7 52.5 12.4 157.3 17.4 93.3 153.1 165.9 39.7 0.9 1.9 0.8 10.1 4.8 3.4 0.4 22.3 73.9 5.0 396.5 153.4 409.4 42.3 145.8 17.6 11.5 29.9 35.5 80.0 17.8 15.3 25.3 656.8 27.2 130.5 43.7 13.0 172.0 757.6 794.5 775.1 1074.3 740.8 848.8 929.5 841.8 735.1 842.4 771.6 829.5 880.0 127.8 125.0 173.8 599.4 37.6 134.7 533.8 1190.7 260.0 105.6 166.6 99.1 216.2 171.6 855.3 82.8 52.1 161.7 113.4 118.3 74.3 124.2 1491.3 140.2 150.0 191.5 325.9 319.7 3.4 116.6 65.9 404.4 388.4 124.6 786.3 88.0 152.8 597.1 798.0 43.7 22.0 256.7 451.6 907.2 614.1 8544.2 487.4 687.4 136.9 74.9 112.7 6247.0 42.2 38.2 330.0 108.1 105.3 375.0 38.7 421.0 10.3 46.6 569.9 176.0 92.1 481.5 218.5 48.2 63.6 186.5 128.3 235.3 108.6 53.3 173.3 1420.5 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 9.6 7.5 15.0 11.3 16.0 2.7 9.3 17.1 17.3 9.4 13.6 8.0 7.5 8.3 7.7 17.6 7.5 7.2 5.4 16.3 15.3 8.6 4.8 11.4 11.0 14.7 14.6 14.5 8.2 4.2 7.5 4.6 11.6 14.8 7.2 8.2 8.1 8.0 6.8 4.1 12.9 7.7 8.8 15.0 9.4 8.0 5.6 14.9 17.4 11.5 5.0 14.2 14.4 11.3 17.6 16.9 18.6 18.0 24.1 18.5 21.7 30.3 21.2 27.3 16.4 13.9 17.4 16.5 17.0 28.7 23.4 10.2 29.4 16.5 37.4 19.0 12.3 12.1 11.4 14.2 17.2 18.4 16.4 14.1 19.9 33.6 27.6 28.3 29.3 33.6 15.7 21.3 11.8 22.0 24.2 15.9 15.4 28.2 21.0 9.2 13.7 22.0 24.7 19.6 41.7 25.5 27.0 22.2 42.3 23.9 30.7 25.8 14.9 28.0 22.4 11.8 21.2 17.3 19.8 11.8 12.3 11.0 15.8 13.5 2.6 1.6 2.1 0.7 1.3 0.8 0.7 1.1 1.1 2.2 0.7 1.4 0.9 1.4 0.2 1.1 0.7 1.4 0.6 15.0 16.0 17.1 17.3 16.3 15.3 14.7 14.6 14.5 14.8 15.0 14.9 17.6 13.9 16.0 18.6 32.3 11.8 48.9 21.3 19.0 41.5 12.8 16.0 11.7 6.4 2.8 13.7 18.4 6.2 25.7 15.8 10.5 11.7 10.7 8.9 19.4 16.6 23.0 23.4 16.0 54.7 9.8 24.9 12.7 19.4 22.7 12.0 12.7 14.6 4.8 26.4 8.4 38.0 11.1 16.2 26.1 28.0 11.8 8.4 31.9 7.2 23.4 25.2 6.7 15.5 50.3 30.7 14.9 13.9 13.2 10.0 22.2 10.2 11.5 13.3 11.4 6.6 8.2 12.2 5.6 15.4 47.8 37.6 20.5 14.0 16.4 10.6 22.8 RGS8 "MGC119067, MGC119068, MGC119069" ENSG00000135824 "Regulator of G protein signaling 8" P57771 1 182641816-182684576 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 58.5;retina: 34.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 65.6;Early spermatids: 11.7;Inhibitory neurons: 18.0;Late spermatids: 22.1;Theca cells: 14.0" "Group enriched" "Detected in some" 13 "glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.7;Daudi: 2.1;SCLC-21H: 15.9;U-698: 3.3" "Region enhanced" "Detected in all" "cerebellum: 425.5" "Low region specificity" "Detected in many" HPA076764 Enhanced NA NA "HPA076764: AB_2732321" "unprognostic (6.75e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (9.29e-5)" "unprognostic (2.60e-1)" "unprognostic (2.37e-1)" "unprognostic (9.29e-3)" "unprognostic (1.16e-1)" "unprognostic (3.78e-1)" "unprognostic (2.40e-1)" "unprognostic (3.23e-2)" "unprognostic (7.08e-2)" "unprognostic (2.98e-2)" "unprognostic (6.37e-2)" "unprognostic (1.02e-1)" 0.0 1.1 15.7 0.0 40.6 0.0 0.0 13.4 12.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 19.1 0.0 0.0 0.0 0.1 23.6 30.3 7.1 0.4 0.0 0.0 1.4 0.0 27.7 0.0 0.0 34.7 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 3.0 58.5 0.0 6.7 0.0 0.3 0.0 0.0 36.9 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 40.6 13.4 12.8 3.6 19.1 23.6 30.3 7.1 27.7 1.0 58.5 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 18.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.0 14.0 0.0 0.0 RNASEL "PRCA1, RNS4" ENSG00000135828 "Ribonuclease L" Q05823 1 182573634-182589256 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002633, CAB010906" Approved Supported Cytosol NA NA Cytosol "CAB010906: AB_477444, HPA002633: AB_1856314" "unprognostic (3.46e-2)" "unprognostic (9.10e-2)" "unprognostic (7.74e-2)" "unprognostic (1.13e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.81e-1)" 5.6 6.5 3.0 8.9 3.5 3.6 6.0 3.3 3.9 6.7 3.5 8.1 7.1 6.6 9.7 6.2 5.2 7.0 3.4 2.8 3.5 6.3 3.6 7.0 9.7 3.3 3.4 2.6 11.4 3.2 7.9 5.4 6.9 3.7 7.3 9.1 5.7 5.0 8.3 2.0 5.5 8.1 7.2 2.4 9.0 7.9 2.2 3.1 8.1 9.1 4.5 9.9 6.1 6.4 4.4 2.6 3.6 1.5 0.6 7.9 13.7 2.8 4.9 6.1 4.9 4.5 2.1 5.6 5.6 8.4 5.6 2.2 4.7 3.6 5.1 1.9 4.5 3.1 6.6 1.3 0.3 4.1 12.4 12.5 9.8 11.4 2.6 0.7 3.1 2.1 8.2 2.4 4.2 4.3 3.8 3.6 5.1 1.2 8.4 1.0 5.3 1.2 2.9 5.2 3.4 0.7 0.2 4.4 5.3 4.3 3.9 5.4 13.6 2.8 2.5 2.0 2.7 2.7 3.7 1.3 0.7 4.0 7.5 3.8 41.7 14.8 53.1 9.4 15.8 12.4 10.3 11.1 10.1 12.4 7.9 17.3 12.8 55.3 10.9 30.3 14.7 10.0 10.5 3.0 3.5 3.3 3.9 2.8 3.5 3.3 3.4 2.6 3.7 2.4 3.1 4.4 4.5 6.4 4.2 5.2 6.5 1.0 2.9 4.9 1.2 4.3 2.8 2.4 1.3 1.5 9.0 3.7 4.2 4.2 8.2 14.8 7.9 6.7 0.0 2.5 9.6 5.1 2.4 4.8 4.2 1.8 3.7 6.4 7.7 3.4 5.7 5.5 3.9 1.6 6.2 1.7 6.6 9.3 8.2 9.7 1.2 0.8 2.8 5.8 0.0 1.9 7.3 8.7 5.2 6.0 3.6 2.2 3.2 6.4 2.7 3.5 7.2 7.3 9.1 6.1 19.7 5.8 5.2 0.4 0.9 4.5 1.0 2.6 7.5 12.1 4.0 4.6 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839347-182887982 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 360000 Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 39.0 30.8 12.9 47.8 15.2 132.5 53.7 18.4 19.8 44.1 15.7 40.6 32.9 49.8 33.3 32.5 46.3 31.4 28.7 12.5 18.7 50.4 37.2 38.9 57.4 14.5 14.2 11.1 53.3 30.7 68.7 21.2 45.0 15.2 39.9 47.6 67.0 32.8 44.7 30.5 31.4 36.6 51.2 15.2 41.2 34.8 50.9 14.1 89.5 48.5 38.1 70.7 54.5 30.2 24.6 165.7 158.8 223.0 122.3 113.7 87.8 219.2 143.5 130.3 203.6 137.0 175.8 124.2 264.3 133.7 129.6 121.7 138.8 342.6 155.2 225.7 108.3 169.5 176.4 121.0 119.6 62.5 258.3 115.0 78.6 75.8 200.4 53.4 91.6 161.7 132.9 281.8 91.9 165.1 142.3 263.6 61.1 282.8 173.9 96.8 236.0 208.0 151.0 127.0 187.8 160.0 183.2 203.2 125.0 83.2 186.4 148.4 140.9 127.6 125.3 138.8 128.9 195.9 93.6 167.2 305.0 79.0 137.0 174.5 7.7 21.3 16.1 23.4 22.5 26.2 20.5 19.8 21.1 29.9 16.6 21.6 23.7 8.0 20.0 19.7 14.2 20.1 21.2 12.9 15.2 18.4 19.8 12.5 18.7 14.5 14.2 11.1 15.2 15.2 14.1 24.6 43.6 41.7 74.1 59.1 54.5 53.7 61.2 42.7 38.7 59.6 43.3 38.9 43.9 30.0 60.8 51.5 52.1 50.9 70.2 38.6 19.6 49.0 26.8 79.2 67.4 50.7 53.8 74.5 49.4 50.8 47.5 48.0 37.8 109.8 44.9 67.7 36.0 28.0 40.8 28.6 55.5 40.9 30.5 35.4 35.1 45.8 60.3 44.7 30.2 55.3 55.9 42.7 42.2 55.3 70.3 52.3 28.0 47.0 52.4 48.3 35.4 38.0 67.7 77.1 39.5 73.9 54.1 69.9 68.2 51.7 47.2 49.5 59.2 60.9 54.4 55.4 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180912897-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 25.5" "Group enriched" "Detected in many" 13 "Bipolar cells: 95.3;Cone photoreceptor cells: 131.3;Rod photoreceptor cells: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SH-SY5Y: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.7 1.2 3.4 1.3 3.5 0.4 4.0 14.0 6.1 6.8 3.7 6.3 2.4 8.1 1.3 3.5 6.2 2.5 6.9 4.8 2.1 4.8 0.5 3.7 1.2 3.4 3.7 3.5 5.9 1.8 0.3 1.8 2.8 7.0 4.8 0.6 25.5 3.3 2.1 2.0 2.4 2.9 3.1 2.5 2.6 3.3 1.7 2.8 0.3 6.1 0.4 0.4 7.4 4.3 4.7 1.7 0.8 1.4 3.0 4.3 10.5 4.8 3.3 3.8 1.6 0.9 1.6 1.7 0.7 3.0 4.1 0.8 3.2 0.3 0.1 0.5 0.9 1.3 2.4 0.6 2.2 5.9 1.5 1.7 5.0 0.1 0.2 0.1 2.7 2.2 2.5 2.1 1.1 1.4 1.4 2.1 0.6 3.3 0.5 0.4 1.1 17.8 2.5 2.6 1.6 12.2 44.7 1.0 1.1 7.3 1.4 1.3 2.1 5.2 3.4 2.5 4.0 1.3 2.3 3.2 1.6 0.4 1.2 2.3 1.3 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 3.4 3.5 14.0 6.1 4.8 2.1 3.4 3.7 3.5 7.0 2.5 2.8 4.7 1.0 0.0 1.8 9.8 0.5 0.4 0.8 0.8 0.6 95.3 0.5 0.6 3.5 1.5 1.3 1.8 131.3 0.3 0.5 0.0 1.9 0.4 4.6 0.8 3.6 2.1 0.0 0.0 5.0 0.2 0.4 3.3 0.0 2.2 1.3 1.6 1.8 0.1 1.8 3.3 1.5 0.0 0.0 0.3 0.4 1.8 7.8 0.5 3.6 1.0 1.0 10.0 0.0 4.5 1.4 0.7 0.0 5.7 0.1 0.4 0.2 1.8 0.1 176.0 6.6 8.4 2.4 0.6 0.6 0.2 0.3 0.3 0.4 0.6 0.1 0.0 CEP350 "CAP350, KIAA0480" ENSG00000135837 "Centrosomal protein 350" Q5VT06 1 179954773-180114875 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 835.2;Late spermatids: 824.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028355, HPA028357, HPA030845, CAB079754" Enhanced Enhanced Centrosome NA NA Centrosome "CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633" "unprognostic (9.52e-2)" "unprognostic (1.18e-1)" "unprognostic (2.78e-1)" "unprognostic (4.20e-2)" "unprognostic (3.68e-2)" "unprognostic (7.12e-3)" "unprognostic (5.17e-3)" "unprognostic (2.85e-1)" "unprognostic (3.65e-3)" "unprognostic (3.84e-2)" "unprognostic (4.86e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.22e-1)" "unprognostic (8.38e-2)" "unprognostic (1.46e-2)" "unprognostic (1.13e-1)" 10.7 7.1 10.2 11.6 21.2 24.8 11.5 21.0 14.3 9.2 7.8 11.3 9.4 8.7 7.6 9.4 8.4 8.8 7.8 8.0 13.6 9.0 10.5 8.0 15.6 16.8 17.0 6.9 14.1 10.7 17.0 7.5 10.0 16.0 7.8 11.3 21.1 7.5 9.3 31.6 11.9 11.7 8.4 13.5 11.8 11.1 25.2 14.3 24.2 11.4 37.2 14.1 10.6 8.7 26.1 23.8 16.4 21.2 7.5 17.6 16.2 20.0 15.8 21.0 13.2 14.5 18.7 13.8 26.0 16.8 14.2 11.4 28.8 16.1 9.0 17.2 25.9 11.4 18.6 20.6 11.9 19.2 37.1 16.7 16.3 13.7 17.3 22.5 9.7 16.4 24.4 36.9 19.5 14.3 17.2 21.9 10.4 19.8 23.0 4.3 18.9 23.4 20.3 9.3 48.2 14.8 15.9 26.2 17.3 29.7 14.9 19.0 32.8 16.8 18.7 13.0 16.7 16.9 33.5 46.2 49.9 8.7 15.9 28.6 1.4 2.1 5.0 2.9 1.9 3.3 2.3 2.1 1.8 1.7 3.7 2.2 1.9 3.8 1.9 1.7 3.4 3.4 0.8 10.2 21.2 21.0 14.3 8.0 13.6 16.8 17.0 6.9 16.0 13.5 14.3 26.1 63.6 118.6 67.4 138.4 75.9 38.0 28.4 23.9 45.5 56.8 34.3 27.4 84.3 37.1 42.2 12.9 85.5 19.7 76.4 35.3 5.9 23.3 835.2 61.0 59.5 49.4 46.2 81.4 108.3 38.9 23.9 47.5 47.9 53.6 29.7 42.9 74.6 28.4 29.4 62.2 121.3 29.3 22.4 72.3 60.9 824.3 53.7 79.0 19.6 89.0 101.0 36.2 70.0 121.2 172.9 37.2 22.4 42.2 100.1 37.5 52.0 11.8 57.3 56.4 26.3 74.0 51.3 233.9 45.0 48.5 46.7 26.3 75.2 40.7 29.5 40.0 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 52.8;placenta: 45.6" "Cell type enhanced" "Detected in many" "Astrocytes: 170.1;Cytotrophoblasts: 123.1;Hofbauer cells: 481.5;Kupffer cells: 148.8;Microglial cells: 125.5;Proximal tubular cells: 141.0;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 423.2" "Group enriched" "Detected in many" 34 "granulocytes: 423.2;monocytes: 128.4" "Cell line enhanced" "Detected in many" "HEL: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" NA NA 190000 Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 12.8 5.8 15.5 19.4 18.3 19.1 5.5 19.9 23.1 4.3 12.1 7.0 2.8 1.8 30.2 10.1 3.4 13.1 2.6 11.8 16.8 52.8 21.0 14.6 32.7 17.4 17.8 10.1 1.4 2.9 3.3 1.7 45.6 19.5 2.4 9.2 2.0 4.2 6.2 1.7 8.5 4.4 7.6 16.5 28.9 5.0 5.1 21.5 6.3 2.7 2.8 14.8 15.6 5.2 18.6 3.4 0.6 1.0 0.0 2.8 2.8 0.9 1.1 2.1 1.2 0.6 0.0 1.4 9.0 1.5 0.0 0.0 1.3 1.9 2.4 0.3 0.0 1.5 14.2 0.4 0.1 1.5 5.4 8.1 2.2 9.1 0.2 0.0 0.1 0.1 10.1 10.9 13.8 2.1 1.1 0.3 3.5 11.0 7.0 1.1 1.4 0.7 11.0 0.2 7.4 3.1 4.6 5.0 0.3 4.7 1.1 2.9 8.7 0.2 1.1 2.4 0.7 0.1 9.8 12.7 9.0 2.4 9.5 3.6 25.5 128.4 104.1 5.5 118.2 4.8 1.8 4.5 4.9 7.6 6.3 3.5 4.9 423.2 0.3 96.6 1.5 8.1 65.4 15.5 18.3 19.9 23.1 11.8 16.8 17.4 17.8 10.1 19.5 16.5 21.5 18.6 2.9 0.0 5.5 170.1 4.9 6.1 4.0 8.6 1.8 7.6 1.5 4.4 2.9 2.8 4.8 7.3 2.1 123.1 2.2 2.3 19.6 1.2 19.1 0.4 0.6 3.5 1.8 45.5 7.5 2.4 6.1 2.5 3.1 0.2 5.7 0.5 72.8 3.9 481.5 6.7 13.5 1.4 6.1 148.8 11.5 27.0 0.9 91.7 10.6 125.5 40.1 2.8 5.2 22.1 21.0 1.3 0.3 0.4 0.7 1.6 0.9 141.0 1.7 2.8 0.0 1.7 1.7 16.5 8.9 16.5 7.1 107.4 3.1 3.4 1.6 4.3 NIBAN1 "C1orf24, FAM129A, GIG39, NIBAN" ENSG00000135842 "Niban apoptosis regulator 1" Q9BZQ8 1 184790724-184974508 "Cancer-related genes, Predicted intracellular proteins" "Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 165.7" "Cell type enriched" "Detected in some" 13 "Cardiomyocytes: 692.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 72.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 72.1" "Cell line enhanced" "Detected in many" "HDLM-2: 83.8;Karpas-707: 85.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028172, HPA028231, HPA028657" Approved Supported "Plasma membrane,Cytosol" NA NA 120000 "Plasma membrane, Cytosol" "HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680" "unprognostic (4.61e-3)" "unprognostic (3.45e-2)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (2.77e-1)" "unprognostic (3.87e-1)" "unprognostic (3.23e-2)" "unprognostic (1.30e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (4.12e-1)" "unprognostic (1.32e-1)" "unprognostic (2.94e-3)" "unprognostic (9.01e-3)" "unprognostic (4.38e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (4.52e-4)" 18.3 7.9 1.5 39.2 2.0 8.9 24.3 1.7 3.0 14.9 4.9 71.0 8.6 24.4 6.2 61.8 22.3 28.0 165.7 1.6 3.5 3.3 2.8 18.2 11.4 4.0 2.0 1.4 4.9 86.4 4.3 2.1 6.3 3.0 60.1 16.0 0.8 101.4 43.5 61.5 7.9 18.7 41.4 2.6 12.4 59.4 1.9 2.5 12.3 15.4 41.6 17.4 106.7 14.7 3.9 42.0 0.5 0.2 0.1 28.0 42.2 1.6 21.1 42.9 17.7 22.3 0.0 17.3 0.0 13.6 54.2 4.6 46.0 2.4 1.5 28.4 83.8 3.2 17.5 8.2 0.0 65.2 57.2 19.1 39.1 65.3 52.1 62.4 12.6 0.1 6.3 4.2 85.5 0.5 0.2 1.9 10.0 11.1 0.0 4.3 13.3 9.9 0.8 24.5 0.8 2.3 2.1 0.4 0.1 29.9 7.0 9.0 17.9 3.3 35.0 0.1 6.3 43.5 71.1 30.2 8.7 68.8 23.4 35.3 20.4 3.6 10.9 5.1 2.1 4.4 1.0 4.7 5.0 5.2 0.3 0.4 1.8 72.1 5.7 0.8 0.5 11.9 2.2 1.5 2.0 1.7 3.0 1.6 3.5 4.0 2.0 1.4 3.0 2.6 2.5 3.9 20.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 692.7 0.0 0.0 0.0 0.0 0.4 52.8 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.2 24.7 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.4 27.4 0.0 0.0 0.0 PIGC ENSG00000135845 "Phosphatidylinositol glycan anchor biosynthesis class C" Q92535 1 172370189-172444086 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036663 Uncertain NA NA "HPA036663: AB_10669912" "unprognostic (3.35e-1)" "unprognostic (3.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (2.65e-1)" "unprognostic (3.72e-3)" "prognostic unfavorable (4.49e-4)" "unprognostic (7.25e-2)" "unprognostic (2.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.43e-8)" "unprognostic (1.09e-1)" "unprognostic (1.77e-1)" "unprognostic (6.04e-2)" "unprognostic (1.90e-1)" 17.5 20.9 13.4 13.2 13.8 27.4 22.0 14.2 16.3 20.8 14.4 20.3 15.6 24.5 39.2 16.7 23.7 18.2 14.5 13.7 14.9 17.1 16.2 15.1 19.9 14.8 14.0 13.7 22.6 26.1 19.8 18.2 20.3 15.1 16.5 19.5 17.8 20.9 17.6 13.7 40.6 21.7 19.1 14.1 20.5 19.8 18.5 14.2 27.9 15.4 11.2 21.1 18.9 18.9 15.1 33.3 28.1 37.2 25.5 27.8 25.0 27.8 21.1 23.5 35.6 30.9 25.6 47.6 17.7 30.4 25.4 28.3 35.0 24.6 30.8 28.6 39.5 28.4 21.8 25.5 31.9 30.6 44.9 27.4 37.4 36.0 25.6 27.9 27.7 23.0 33.5 33.5 32.9 29.2 17.3 34.4 40.1 38.5 67.4 38.7 27.9 30.3 31.9 55.5 24.1 19.5 37.1 30.5 35.6 50.3 52.4 31.9 31.6 21.0 22.6 37.8 28.0 22.8 21.8 33.1 27.6 16.2 29.0 43.9 71.5 28.1 55.6 35.4 26.9 29.8 37.2 40.6 37.4 24.3 33.8 60.1 43.4 18.2 51.6 29.5 24.1 40.0 40.9 13.4 13.8 14.2 16.3 13.7 14.9 14.8 14.0 13.7 15.1 14.1 14.2 15.1 19.4 9.6 10.3 0.0 24.2 13.5 19.7 31.2 18.2 15.7 20.9 29.5 20.7 17.2 17.7 29.5 8.4 61.6 23.9 20.6 33.2 31.9 78.2 15.2 19.3 20.0 7.8 58.9 0.0 41.1 50.9 31.0 15.8 18.6 7.6 21.6 22.9 15.4 35.3 20.2 0.0 19.6 32.6 23.7 16.9 80.8 47.2 20.0 26.6 0.0 27.6 30.1 42.2 0.0 0.0 34.8 27.6 40.6 12.4 14.2 25.2 20.9 20.1 17.9 32.9 22.2 18.7 30.0 18.8 17.7 19.0 23.7 29.1 21.5 18.9 15.5 LAMC1 LAMB2 ENSG00000135862 "Laminin subunit gamma 1" P11047 1 183023420-183145592 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 233.7" "Cell type enhanced" "Detected in many" "Fibroblasts: 187.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1582.4;ASC TERT1: 863.5;HSkMC: 980.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001908, HPA001909, CAB004486, CAB078163" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to extracellular matrix" NA NA 100000000 "Endoplasmic reticulum, Plasma membrane" "CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230" "unprognostic (1.46e-1)" "unprognostic (1.05e-2)" "unprognostic (8.30e-2)" "unprognostic (8.84e-3)" "unprognostic (3.75e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-2)" "unprognostic (2.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-3)" "unprognostic (1.10e-3)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.85e-5)" 117.7 16.6 7.0 35.2 7.2 1.2 79.9 9.1 7.2 55.6 13.9 65.9 16.1 63.7 19.5 44.9 64.4 55.1 61.3 7.2 36.3 19.6 13.9 59.3 15.4 6.9 7.3 5.1 36.4 19.3 20.1 9.5 233.7 6.8 31.6 34.6 3.8 28.3 51.4 50.9 37.4 49.3 103.3 6.1 8.5 51.5 18.9 7.8 14.9 40.6 60.6 12.1 67.4 48.1 6.9 52.5 83.5 268.4 76.7 1582.4 863.5 405.0 374.8 373.0 147.8 87.1 249.4 58.2 18.8 168.6 180.8 87.9 127.4 51.7 99.2 112.7 0.6 52.6 0.9 71.1 91.3 248.1 16.6 8.9 980.4 52.2 177.0 138.7 262.7 261.0 0.2 0.6 55.5 182.5 22.8 0.2 17.4 109.3 96.0 15.7 13.5 226.2 9.9 237.6 137.0 17.6 50.1 98.9 0.7 95.6 459.0 21.2 43.6 486.5 179.1 70.0 168.2 95.4 21.6 0.3 12.4 148.7 12.3 177.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.0 7.2 9.1 7.2 7.2 36.3 6.9 7.3 5.1 6.8 6.1 7.8 6.9 81.2 35.3 21.6 32.7 8.1 31.4 46.1 44.4 35.9 3.1 7.1 17.4 57.5 27.1 21.0 36.8 4.2 101.9 0.2 1.6 1.9 59.2 5.7 32.5 58.5 80.9 1.2 0.0 69.2 23.3 69.0 187.8 8.6 78.5 2.5 53.0 26.7 19.1 18.7 1.7 50.0 2.4 18.3 10.7 20.6 6.8 120.9 4.5 33.8 106.8 6.0 2.2 1.0 35.2 2.5 44.7 2.6 62.4 11.0 59.9 0.5 12.4 14.8 0.7 72.3 73.9 102.1 17.6 36.8 17.0 16.9 72.1 2.8 74.4 3.5 25.8 RC3H1 "KIAA2025, RNF198, roquin, RP5-1198E17.5" ENSG00000135870 "Ring finger and CCCH-type domains 1" Q5TC82 1 173931084-174022357 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027428, HPA027434, HPA027448" Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683" "unprognostic (6.91e-2)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" "unprognostic (2.33e-2)" "unprognostic (7.73e-2)" "unprognostic (1.61e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (5.25e-2)" "unprognostic (2.15e-1)" "unprognostic (3.43e-3)" "unprognostic (6.83e-3)" 4.8 3.8 3.0 4.3 4.7 19.8 5.3 15.2 5.0 4.7 10.6 5.2 3.5 4.5 4.0 6.2 4.9 4.0 4.6 3.3 5.7 3.9 5.9 6.0 4.9 4.3 3.7 2.6 5.1 4.8 3.9 4.6 4.4 6.4 4.2 4.3 8.1 4.4 3.6 10.7 7.4 5.6 3.7 2.4 6.8 4.6 5.3 4.0 5.0 5.0 10.4 5.6 4.6 5.1 7.4 6.6 9.1 4.9 7.7 9.2 7.1 6.8 4.4 6.3 5.0 4.4 8.4 7.3 9.4 7.7 7.2 3.9 6.2 7.5 6.3 7.0 6.6 1.8 8.1 6.8 7.0 5.6 10.7 9.1 6.8 4.8 7.3 4.9 4.6 7.9 4.5 9.4 5.6 6.2 5.0 6.5 9.6 8.5 6.1 1.0 7.0 8.8 6.9 8.9 12.7 5.9 5.3 8.4 10.7 4.3 8.2 7.2 10.7 11.4 6.5 6.5 5.6 5.8 6.9 7.5 11.8 4.4 4.8 6.7 3.4 1.9 2.7 1.1 1.9 1.2 1.5 1.1 1.3 1.0 1.8 1.5 1.3 6.4 1.4 2.6 0.8 0.9 0.7 3.0 4.7 15.2 5.0 3.3 5.7 4.3 3.7 2.6 6.4 2.4 4.0 7.4 39.8 41.7 34.5 32.0 49.4 34.4 17.3 14.1 60.9 35.6 53.6 28.3 25.7 25.8 20.0 23.9 81.3 10.6 70.2 37.4 9.8 25.4 13.3 77.5 45.9 32.0 34.2 30.7 46.8 18.9 8.2 34.9 68.8 82.9 15.8 20.3 34.2 36.3 11.5 38.7 43.5 28.9 16.2 37.2 48.2 8.1 15.8 38.5 30.2 40.3 33.0 22.7 30.9 42.3 68.2 24.8 22.1 10.5 52.2 38.3 25.1 9.8 30.2 47.3 19.7 39.0 31.5 35.8 14.0 66.8 40.9 11.6 41.4 16.1 25.9 38.5 GPR55 ENSG00000135898 "G protein-coupled receptor 55" Q9Y2T6 2 230907318-230961066 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;lymphoid tissue: 4.5;testis: 4.7" "Cell type enhanced" "Detected in some" "B-cells: 2.1;Enteroendocrine cells: 1.8;Excitatory neurons: 2.3;Langerhans cells: 3.1;Plasma cells: 2.4;T-cells: 4.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 3.7" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.88e-4)" "unprognostic (2.60e-2)" "unprognostic (2.27e-1)" "unprognostic (4.24e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-4)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "unprognostic (4.37e-2)" "unprognostic (3.18e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-2)" "unprognostic (4.26e-1)" 0.2 0.0 0.3 1.8 3.7 0.2 0.5 0.0 0.6 0.1 0.0 0.8 1.3 0.1 0.0 0.5 0.1 0.5 0.1 0.4 0.8 0.0 0.2 0.5 2.9 0.7 0.1 0.3 0.0 0.0 0.0 0.4 0.0 1.2 0.1 0.9 0.0 1.0 0.2 0.0 0.4 2.2 0.1 0.0 4.2 0.7 4.7 0.8 2.0 0.1 0.0 4.5 0.9 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 2.1 0.0 0.6 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.8 32.0 0.0 0.0 0.2 0.9 0.7 0.0 1.0 0.1 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 6.0 0.0 0.0 2.3 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.3 0.1 1.9 0.1 0.9 0.2 0.9 0.1 0.7 1.3 1.7 0.3 3.7 0.0 0.6 0.4 0.8 0.7 0.1 0.3 1.2 0.0 0.8 0.3 0.0 0.0 0.0 0.3 2.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.8 0.0 0.0 0.1 1.8 0.0 2.3 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.4 0.0 0.1 0.0 0.1 1.4 0.0 0.3 3.1 0.9 0.0 1.2 0.0 1.0 0.9 0.0 1.0 0.5 0.1 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.2 0.1 0.2 0.1 SP110 "IFI41, IFI75" ENSG00000135899 "SP110 nuclear body protein" Q9HB58 2 230165186-230225729 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 54.1" "Cell type enhanced" "Detected in many" "B-cells: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 99.3" "Low region specificity" "Detected in all" HPA058554 Supported Nucleoplasm No No Nucleoplasm "HPA058554: AB_2683754" "unprognostic (9.72e-2)" "unprognostic (1.15e-2)" "unprognostic (5.02e-2)" "unprognostic (8.33e-4)" "unprognostic (2.93e-1)" "unprognostic (1.80e-1)" "unprognostic (6.65e-2)" "unprognostic (9.44e-2)" "unprognostic (9.68e-2)" "unprognostic (1.46e-2)" "unprognostic (4.11e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.38e-1)" "unprognostic (2.66e-2)" "unprognostic (2.99e-3)" "unprognostic (9.50e-3)" 14.1 7.4 9.2 38.8 10.3 30.1 11.9 9.4 10.9 11.6 12.8 12.7 12.0 10.6 8.0 9.3 9.6 18.1 7.8 8.1 11.9 8.2 14.9 21.2 54.1 12.3 9.9 6.4 16.6 8.0 9.8 5.3 17.6 11.4 9.7 14.2 2.1 17.2 7.6 5.8 7.8 17.8 13.5 9.9 50.2 13.0 3.1 10.8 36.0 7.5 8.5 50.6 19.1 9.4 16.6 8.3 4.4 2.7 4.7 14.2 23.6 8.3 14.8 30.8 70.3 99.3 0.2 12.7 34.5 13.8 15.8 67.0 5.1 9.0 23.0 25.7 30.5 6.0 14.9 6.2 8.9 14.5 22.1 17.1 32.7 11.8 20.8 27.4 13.2 25.3 23.6 5.3 12.1 20.6 4.9 33.0 43.5 8.6 4.2 5.1 20.1 25.4 12.8 56.2 11.1 0.5 5.7 5.7 12.7 32.7 0.9 9.6 18.5 18.8 12.9 7.9 3.2 7.5 12.9 4.6 16.2 14.4 20.6 10.7 92.2 49.7 124.4 55.2 85.8 47.8 142.8 53.5 50.5 44.1 135.8 54.1 58.7 268.6 56.9 143.4 84.4 70.7 48.5 9.2 10.3 9.4 10.9 8.1 11.9 12.3 9.9 6.4 11.4 9.9 10.8 16.6 77.8 44.8 23.8 17.3 141.7 9.9 5.2 25.7 16.5 0.4 21.6 19.3 3.7 7.2 19.6 11.0 0.0 3.8 84.0 17.0 13.7 19.9 5.2 17.2 21.3 28.6 6.7 9.7 1.1 28.5 12.7 22.8 9.2 20.1 38.0 21.2 26.4 6.2 26.9 0.0 2.1 11.4 73.2 47.4 25.8 4.2 11.8 62.3 19.6 42.2 56.7 9.7 59.8 19.6 18.2 26.0 11.6 10.1 35.7 3.5 10.7 14.4 21.0 4.9 6.6 8.6 16.2 4.8 2.3 9.8 10.1 4.7 68.8 23.5 6.1 3.0 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957463-223967714 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria" NA NA Mitochondria "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA038147: AB_10671521, HPA038148: AB_2675863" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favorable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 27.1 16.3 15.1 17.5 45.8 17.8 17.1 20.4 13.0 18.5 22.0 19.5 12.8 13.3 18.1 16.4 17.6 34.2 16.9 18.9 37.8 39.7 12.7 32.8 16.3 16.3 16.3 15.4 17.6 19.9 11.7 20.2 16.6 15.4 23.2 10.1 16.3 13.3 43.0 15.5 18.1 14.6 17.2 18.0 16.4 18.4 17.5 21.6 16.4 41.0 26.7 17.2 11.6 17.9 27.3 22.6 33.1 38.3 30.6 36.1 52.4 30.0 33.6 48.0 50.4 81.0 33.4 41.1 31.9 26.0 43.9 35.3 54.5 41.5 44.1 39.0 38.7 45.0 24.0 64.4 44.9 50.0 33.1 42.5 50.9 29.1 38.7 40.4 47.8 41.4 43.7 31.6 38.9 31.9 37.8 62.9 49.4 54.8 23.6 43.8 40.6 25.5 64.3 22.8 45.0 25.7 22.0 49.0 74.8 48.6 41.4 71.2 31.5 31.8 24.7 27.3 24.5 34.5 25.9 58.7 32.2 47.4 35.6 55.7 44.5 35.3 28.5 44.8 36.5 45.9 30.4 34.4 42.2 42.3 36.5 32.3 58.1 33.8 41.2 33.9 33.7 36.3 16.3 17.5 17.1 20.4 16.9 18.9 16.3 16.3 16.3 16.6 17.2 17.5 17.9 11.7 6.4 13.1 3.9 31.3 17.8 27.4 52.6 23.9 17.3 15.6 17.4 10.4 27.1 30.0 27.6 0.0 95.3 29.5 25.0 82.2 45.3 8.1 17.1 22.3 20.7 13.1 26.5 6.5 35.1 64.8 24.9 14.3 26.6 18.4 22.0 20.7 51.5 46.6 11.8 6.9 22.0 48.8 33.3 14.5 7.9 18.0 25.4 33.8 4.7 35.3 16.5 20.6 7.5 9.7 37.2 18.1 18.0 24.8 21.7 23.6 106.1 25.6 12.7 19.7 14.2 18.8 41.1 56.3 22.8 16.6 48.7 20.9 40.9 28.3 37.6 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 58.1" "Group enriched" "Detected in some" 10 "Muller glia cells: 4.0;Skeletal myocytes: 4.4" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 49 "RH-30: 99.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 6.3 0.7 0.0 58.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199887-222298998 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease variant, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;salivary gland: 4.8;skeletal muscle: 3.7;skin 1: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 14.4;Late spermatids: 34.8;Melanocytes: 33.8;Skeletal myocytes: 12.8" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 9.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;HBF TERT88: 8.0;RH-30: 17.5;SK-MEL-30: 29.1" "Group enriched" "Detected in some" 7 "cerebellum: 3.4;midbrain: 1.4;pons and medulla: 1.3" "Region enhanced" "Detected in many" "midbrain: 7.7" "HPA063659, HPA069000" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063659: AB_2685080, HPA069000: AB_2686067" "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.3 0.0 0.3 0.0 0.6 0.0 1.0 4.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 4.8 0.0 3.7 2.9 0.0 0.0 2.3 0.0 0.0 1.1 1.0 0.0 0.0 0.8 0.1 0.0 0.1 5.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 6.0 6.5 9.0 10.6 0.0 0.7 0.0 0.0 4.4 0.2 0.0 0.0 0.0 8.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 6.9 0.1 0.0 0.0 0.0 17.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 29.1 7.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.5 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 4.5 0.4 0.0 0.2 3.5 2.1 0.0 3.4 2.3 1.0 5.3 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 34.8 0.9 0.1 33.8 1.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.4 5.6 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042468 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.9;lymphoid tissue: 32.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1806.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058106: AB_2683606" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.4 8.3 24.3 19.0 44.8 10.3 3.9 31.6 32.8 8.7 10.1 6.4 4.1 3.2 1.1 3.2 2.4 6.4 1.5 26.7 32.4 3.2 5.6 7.7 28.1 42.1 38.9 15.8 17.8 1.7 2.0 1.0 2.3 44.5 1.7 6.6 5.7 2.5 1.7 1.2 5.1 12.6 4.4 31.6 30.0 6.7 2.2 35.9 32.4 2.8 0.8 20.1 6.5 4.4 83.9 0.0 21.4 6.7 0.0 8.5 17.9 0.0 45.5 36.8 21.3 15.8 0.0 0.0 0.6 0.1 28.9 73.4 0.5 0.0 0.1 16.9 52.7 0.0 0.6 4.5 0.0 0.3 4.4 2.1 4.3 0.4 31.0 12.0 8.3 21.4 7.0 0.1 42.1 36.4 2.1 8.0 6.1 2.6 0.0 5.0 10.5 9.8 6.2 1.1 0.1 0.4 5.5 0.0 0.0 4.8 1.2 1.4 20.0 48.2 22.8 5.7 10.9 15.6 0.0 0.0 0.0 32.2 29.6 10.1 3.0 3.3 0.2 6.5 9.2 6.6 7.2 10.9 9.1 6.9 4.5 10.5 9.3 0.1 14.3 11.8 2.8 8.4 4.5 24.3 44.8 31.6 32.8 26.7 32.4 42.1 38.9 15.8 44.5 31.6 35.9 83.9 3.7 3.2 9.1 4.2 47.1 4.7 0.6 0.3 8.0 7.9 0.8 4.3 1.2 0.0 2.5 5.5 0.0 0.3 39.5 0.8 1.9 0.1 3.2 0.2 2.3 3.2 2.4 5.5 8.0 0.0 0.2 4.9 5.1 0.5 36.7 64.0 2.5 1.4 30.6 97.6 244.2 3.8 0.0 54.2 39.7 2.8 0.6 51.0 8.8 201.4 38.3 1.2 38.1 400.6 1806.0 0.2 0.3 0.0 43.5 0.5 0.2 0.3 2.6 1.8 13.1 2.5 18.9 0.3 1.1 2.1 4.1 0.8 75.1 31.4 2.5 0.7 TTLL4 KIAA0173 ENSG00000135912 "Tubulin tyrosine ligase like 4" Q14679 2 218710835-218755416 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.4;Muller glia cells: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027091, HPA050252" Approved Approved Mitochondria NA NA Mitochondria "HPA027091: AB_10601828, HPA050252: AB_2681064" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.64e-1)" "unprognostic (1.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.83e-3)" "unprognostic (2.96e-2)" "unprognostic (1.21e-1)" "unprognostic (7.52e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (6.63e-12)" "unprognostic (9.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" "unprognostic (5.29e-3)" 4.0 7.2 9.4 8.4 9.8 5.9 6.4 8.5 9.4 5.2 18.4 5.6 5.7 4.8 3.6 6.9 7.4 4.2 4.2 7.3 9.8 4.4 6.0 6.9 6.2 10.4 10.3 6.4 4.5 7.2 5.2 6.7 8.1 10.2 6.7 6.5 15.3 6.9 3.7 5.7 8.2 5.9 5.3 8.6 5.7 8.9 25.7 9.5 5.8 3.9 2.9 9.0 5.3 6.3 11.2 18.4 12.3 32.3 16.4 8.1 6.3 43.5 12.2 9.8 19.8 16.8 52.6 21.4 14.4 10.1 9.5 18.9 19.0 34.3 16.9 23.0 16.3 27.3 18.5 19.0 50.2 11.5 23.6 13.1 10.4 10.1 17.7 19.9 8.5 19.0 16.0 53.8 22.2 11.0 10.7 13.1 15.3 36.4 13.5 8.1 29.4 14.6 18.9 19.7 14.5 12.9 12.7 9.3 13.7 23.9 48.9 11.1 12.0 7.6 17.6 17.9 11.3 11.7 11.2 10.1 32.4 9.2 14.5 23.4 0.1 12.6 0.8 3.1 6.0 2.9 3.9 2.3 2.3 7.3 3.5 1.5 1.4 14.5 2.1 8.8 4.3 1.3 5.1 9.4 9.8 8.5 9.4 7.3 9.8 10.4 10.3 6.4 10.2 8.6 9.5 11.2 1.6 3.2 5.8 28.4 3.1 4.6 12.3 3.2 4.6 6.6 4.5 5.1 3.5 5.7 4.2 7.3 27.1 6.8 3.0 2.4 0.0 6.0 39.4 7.8 3.1 3.7 5.4 6.5 3.9 3.9 8.0 4.8 10.2 5.3 1.3 4.2 1.8 2.6 7.8 3.3 4.8 4.7 4.1 5.5 2.9 16.1 3.1 9.4 3.6 15.9 10.4 72.7 5.2 11.1 20.8 5.8 2.5 1.5 2.8 15.2 2.9 1.8 7.5 12.7 0.0 3.3 3.1 18.3 12.7 4.2 4.1 5.7 2.5 2.1 5.1 11.4 USP37 KIAA1594 ENSG00000135913 "Ubiquitin specific peptidase 37" Q86T82 2 218450251-218568351 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 119.4;Late spermatids: 145.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045160 Approved Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA045160: AB_10795620" "unprognostic (7.00e-2)" "unprognostic (2.29e-1)" "unprognostic (8.83e-2)" "unprognostic (9.19e-4)" "unprognostic (1.83e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.66e-3)" "unprognostic (1.17e-1)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (3.82e-2)" "unprognostic (3.26e-1)" "unprognostic (2.87e-1)" "unprognostic (6.69e-2)" "unprognostic (6.41e-3)" 2.7 4.2 3.8 4.5 5.4 11.9 4.7 8.5 5.2 3.7 2.1 3.1 3.0 4.3 7.5 4.0 3.4 3.6 2.4 3.8 3.3 2.9 3.8 3.0 6.0 3.5 3.6 3.6 6.0 3.0 4.0 1.4 4.1 4.5 3.6 3.5 9.1 4.0 3.0 2.9 3.9 3.3 3.2 2.4 3.9 3.4 12.8 3.6 6.4 5.0 4.3 4.9 3.7 2.3 8.7 9.6 6.9 14.2 11.0 3.6 4.4 12.1 7.1 5.1 12.2 13.6 13.1 7.4 8.7 7.5 5.6 9.3 8.9 15.7 8.0 13.4 12.0 8.3 23.5 13.6 8.7 4.1 15.6 11.3 2.4 4.7 12.9 9.2 4.5 5.3 15.0 17.3 16.2 7.8 7.2 20.1 10.6 12.2 6.2 5.9 16.0 21.3 8.0 4.2 11.2 15.5 8.4 11.5 5.6 7.2 13.6 6.4 10.8 6.8 13.7 12.0 7.7 9.5 11.0 10.4 17.6 7.4 11.2 9.5 4.2 2.0 3.8 3.1 2.3 3.2 2.5 2.6 2.7 2.1 3.2 4.0 2.6 1.6 3.2 2.2 2.9 3.6 1.2 3.8 5.4 8.5 5.2 3.8 3.3 3.5 3.6 3.6 4.5 2.4 3.6 8.7 12.8 0.0 11.0 34.3 16.5 19.5 7.0 7.1 22.2 14.7 14.4 10.2 4.9 4.3 9.6 7.3 27.1 8.4 13.4 5.5 0.0 5.8 119.4 13.3 11.8 14.2 10.3 16.6 47.4 2.3 6.6 13.2 9.2 16.4 5.1 16.2 12.5 11.0 7.8 15.2 40.0 8.9 4.1 8.5 22.9 145.5 9.9 17.2 21.4 27.2 10.2 9.1 10.3 35.2 60.5 4.9 7.4 9.8 14.6 12.1 7.1 4.2 11.1 19.9 6.6 12.7 21.6 60.8 31.4 13.6 20.6 7.3 19.7 10.9 7.6 7.1 HTR2B "5-HT(2B), 5-HT2B" ENSG00000135914 "5-hydroxytryptamine receptor 2B" P41595 2 231108230-231125042 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 17.5;cervix: 21.7;endometrium 1: 19.0;smooth muscle: 16.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Endometrial stromal cells: 17.7;Endothelial cells: 4.1;Hepatic stellate cells: 5.7;Microglial cells: 4.7;monocytes: 6.2;Peritubular cells: 5.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "basophil: 1.8;T-reg: 1.0" "Group enriched" "Detected in many" 15 "granulocytes: 1.8;T-cells: 1.0" "Group enriched" "Detected in some" 4 "HHSteC: 8.7;HSkMC: 16.5;SK-MEL-30: 32.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012867, HPA063658" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012867: AB_1856710, HPA063658: AB_2685079" "unprognostic (1.86e-1)" "unprognostic (3.55e-2)" "unprognostic (1.20e-3)" "unprognostic (1.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.15e-4)" "unprognostic (3.59e-1)" "unprognostic (2.17e-2)" "unprognostic (1.42e-3)" "unprognostic (7.44e-4)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" 0.9 17.5 0.3 1.5 0.4 1.2 0.8 0.9 0.7 21.7 1.2 6.8 1.5 19.0 11.9 0.7 2.4 1.3 4.3 0.4 0.2 3.4 3.6 0.9 1.0 0.4 0.4 0.2 0.8 0.2 0.6 0.3 4.1 0.4 0.3 2.1 0.2 0.5 1.4 0.1 0.1 4.9 16.9 0.2 0.4 4.6 0.4 0.4 1.2 3.2 0.3 0.8 2.2 0.8 0.5 0.2 0.3 0.0 0.1 0.5 4.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.7 0.1 0.3 16.5 0.0 0.0 0.0 0.0 3.2 1.4 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 32.7 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.4 0.9 0.7 0.4 0.2 0.4 0.4 0.2 0.4 0.2 0.4 0.5 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.2 0.0 4.2 0.1 0.1 0.0 0.0 0.0 0.2 1.5 17.7 4.1 0.0 0.0 0.7 0.7 0.1 0.8 0.0 3.4 0.0 0.1 5.7 1.5 3.4 1.7 0.9 0.0 0.0 0.8 0.0 0.2 0.6 2.2 0.0 4.7 6.2 0.0 1.0 0.5 0.6 0.2 0.0 5.3 0.0 0.0 0.0 0.0 2.0 0.7 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.3 0.2 0.3 0.0 0.2 ITM2C "BRI3, BRICD2C, E25, hRPC.1050_D_4, ITM3" ENSG00000135916 "Integral membrane protein 2C" Q9NQX7 2 230864639-230879248 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1114.8;intestine: 714.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2610.8;Intestinal goblet cells: 884.1;Paneth cells: 2076.6;Plasma cells: 1010.4;Undifferentiated cells: 843.5" "Cancer enhanced" "Detected in all" "glioma: 496.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "plasmacytoid DC: 2464.2" "Lineage enriched" "Detected in all" 8 "dendritic cells: 2464.2" "Cell line enhanced" "Detected in many" "EFO-21: 517.7;NB-4: 599.8;RPMI-8226: 482.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 29000 "unprognostic (2.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.74e-1)" "unprognostic (6.03e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.52e-2)" 42.9 89.8 788.7 117.1 755.8 110.6 31.6 663.7 1114.8 110.5 483.0 714.2 80.9 104.4 40.3 85.2 59.1 54.4 50.3 784.6 886.8 178.6 37.0 45.7 78.8 896.9 836.3 711.2 78.8 81.0 106.4 290.6 109.7 751.4 104.3 544.1 119.3 72.9 111.3 22.7 19.6 332.0 96.2 841.4 118.5 88.2 22.3 913.0 180.2 53.4 34.1 72.7 125.3 75.5 778.1 34.1 67.0 215.6 170.6 27.2 15.3 68.8 176.0 191.6 92.5 144.2 89.7 46.8 0.4 517.7 126.3 94.9 16.8 127.2 25.6 58.1 328.3 109.0 44.7 33.6 119.1 96.0 81.1 180.9 131.4 24.7 83.6 8.2 33.8 3.5 76.8 43.6 108.3 35.5 53.0 59.3 599.8 263.5 184.0 58.8 85.2 37.0 482.9 123.5 200.8 11.8 329.4 85.8 10.3 207.4 220.7 17.0 455.6 2.9 39.6 114.4 70.5 50.0 0.7 9.1 4.6 124.6 70.1 336.5 76.5 3.6 291.0 12.5 1.8 33.2 185.2 39.7 33.1 68.9 94.7 38.1 31.6 6.9 52.0 0.6 2464.2 64.2 50.0 788.7 755.8 663.7 1114.8 784.6 886.8 896.9 836.3 711.2 751.4 841.4 913.0 778.1 26.3 6.4 10.8 155.7 167.8 24.1 49.7 9.3 29.0 428.1 24.4 40.0 20.5 61.5 16.5 138.0 252.3 95.7 483.6 2610.8 27.4 123.0 0.8 43.0 34.0 36.2 408.3 8.4 49.3 39.5 63.4 94.9 21.4 45.6 183.9 41.6 16.4 14.8 80.1 101.0 63.3 884.1 12.2 7.5 108.9 3.4 54.3 26.0 202.7 27.2 70.9 225.9 3.1 107.5 17.8 46.2 2076.6 69.2 1010.4 52.9 666.0 23.7 16.5 101.1 138.1 30.9 108.6 4.8 20.5 3.8 14.9 57.6 75.3 37.9 843.5 97.7 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718028 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.1;breast: 28.7;placenta: 24.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 47.1 0.6 5.5 1.9 3.6 1.2 28.7 4.5 4.5 0.4 1.4 2.7 9.2 0.5 0.1 0.7 0.5 5.8 0.6 3.8 4.7 2.2 13.9 4.2 0.8 5.3 4.6 3.0 0.9 1.7 0.1 0.2 24.3 5.5 0.3 1.8 2.3 1.1 0.1 0.9 1.6 5.7 0.4 4.0 0.6 0.5 0.5 6.2 0.2 0.4 0.8 0.4 1.0 0.4 4.3 0.3 0.9 0.2 0.8 13.9 0.3 6.2 0.1 0.2 0.2 0.6 20.2 0.4 0.2 0.1 0.1 4.6 0.4 0.6 0.5 0.8 0.0 1.0 0.1 1.1 0.8 1.8 0.2 0.1 3.4 0.4 0.1 0.8 0.3 0.0 0.3 0.1 0.6 0.0 1.6 0.1 0.5 3.0 0.7 0.1 0.3 0.1 0.2 0.2 0.2 0.9 0.1 0.3 1.9 0.5 2.6 0.2 0.2 0.6 0.4 0.4 4.1 0.4 0.1 0.1 0.6 1.4 0.2 0.5 6.8 0.8 1.0 0.4 0.6 0.3 0.8 0.4 0.4 0.2 1.3 0.5 0.5 3.3 2.2 0.7 1.0 0.2 0.3 5.5 3.6 4.5 4.5 3.8 4.7 5.3 4.6 3.0 5.5 4.0 6.2 4.3 0.2 9.6 5.1 2.3 0.0 0.0 0.5 0.0 0.6 5.3 0.2 0.1 0.4 5.7 0.0 1.8 0.0 65.4 0.1 5.7 1.9 4.4 0.3 0.1 0.0 2.6 1.2 0.0 0.4 0.0 7.4 3.2 0.0 0.1 0.0 0.3 0.0 13.1 5.1 0.0 0.9 1.6 0.0 0.6 0.0 0.7 0.3 0.9 0.0 25.3 0.0 0.8 0.0 4.5 0.3 0.4 1.0 0.0 0.1 0.4 9.3 3.0 0.0 0.2 0.0 1.7 1.6 0.0 0.3 0.0 0.0 160.6 0.2 0.1 6.5 0.4 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975045-224039318 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "placenta: 1101.0" "Cell type enriched" "Detected in many" 8 "Granulosa cells: 4466.0" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2" "Group enriched" "Detected in many" 15 "NK-cells: 23.2;T-cells: 12.9" "Cell line enhanced" "Detected in many" "BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000277 Approved "Golgi apparatus" "Secreted in female reproductive system" NA NA 910000 "Golgi apparatus" "HPA000277: " "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.48e-5)" 28.2 20.0 126.6 76.4 119.9 6.5 14.5 134.8 159.9 28.4 78.3 22.8 28.5 17.6 5.7 36.5 20.9 46.4 74.6 117.1 140.7 36.3 10.9 14.6 31.1 161.1 149.1 116.3 146.9 8.6 3.4 8.8 1101.0 131.6 26.6 22.0 5.4 12.7 7.6 6.7 11.3 27.3 120.8 144.2 31.2 9.0 58.1 143.1 17.2 26.3 10.9 44.3 148.3 27.9 134.7 3.1 83.8 29.4 32.6 1172.5 438.7 4.4 1492.9 851.5 118.1 112.7 4.8 7.0 0.4 32.5 6425.1 188.0 5.0 3.5 102.5 101.0 0.6 26.8 16.6 49.9 22.7 57.7 12.8 1.5 128.3 68.5 342.0 505.6 304.6 9.0 5.4 0.5 1.9 412.1 4.5 2.3 3.9 56.2 31.8 92.3 10.3 25.2 64.5 1100.2 97.5 43.0 7.1 284.4 0.5 2966.9 385.2 1.2 6.4 1056.5 692.5 96.6 214.4 72.7 6.3 13.3 0.8 443.5 11.1 2183.6 0.0 0.0 0.0 0.7 0.0 0.5 0.8 0.6 0.6 0.0 1.2 12.9 6.8 0.5 23.2 0.0 0.2 0.7 2.7 126.6 119.9 134.8 159.9 117.1 140.7 161.1 149.1 116.3 131.6 144.2 143.1 134.7 13.5 0.0 1.1 233.1 3.1 23.3 16.0 132.2 351.7 5.3 7.9 8.5 5.3 0.0 4.6 7.3 0.0 106.1 11.3 19.5 11.7 13.0 2.6 5.3 17.7 20.9 24.0 23.1 86.1 33.2 524.3 556.7 5.6 5.9 2.5 4466.0 23.2 0.0 45.5 0.0 11.4 4.7 0.0 0.8 26.9 9.9 401.4 9.7 142.3 23.4 3.5 2.5 2.1 199.6 13.5 22.1 14.9 98.9 5.6 27.2 2.0 146.2 1.7 3.5 13.1 5.2 146.6 4.2 70.9 34.8 14.5 133.9 10.7 18.9 3.1 7.2 DNAJB2 "CMT2T, HSJ1, HSPF3" ENSG00000135924 "DnaJ heat shock protein family (Hsp40) member B2" P25686 2 219279342-219286898 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 368.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036268 Approved Enhanced "Nuclear membrane" NA NA 9900 "Nuclear membrane" "HPA036268: AB_10670793" "unprognostic (2.02e-2)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (2.53e-2)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (1.45e-3)" "unprognostic (5.11e-2)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-3)" "unprognostic (7.03e-2)" "unprognostic (4.09e-2)" "unprognostic (4.64e-2)" "unprognostic (1.96e-2)" "unprognostic (5.98e-2)" "unprognostic (5.62e-3)" 42.2 107.8 290.7 17.8 290.5 26.8 46.1 274.6 325.9 60.4 232.4 45.6 23.4 46.6 45.6 54.5 48.6 26.9 72.7 267.3 266.9 81.5 72.6 46.2 26.3 285.6 282.7 257.2 65.5 85.5 54.8 113.0 27.3 291.6 74.6 15.9 64.5 62.8 35.8 136.7 108.2 36.3 16.0 282.9 47.1 55.3 86.7 283.8 28.7 71.6 57.0 20.7 53.2 59.5 368.5 34.9 14.2 21.9 20.7 45.6 22.1 29.3 32.8 27.2 29.0 24.2 66.2 21.3 21.4 39.7 31.6 66.3 49.1 27.9 36.3 16.3 45.3 12.2 41.7 28.0 32.0 30.8 7.1 36.5 21.3 103.3 31.8 38.4 51.3 12.9 23.5 7.4 23.7 21.4 18.0 13.0 8.4 12.9 30.2 26.4 13.4 17.9 13.5 31.7 24.5 20.6 26.0 38.0 38.4 64.9 57.5 28.6 14.9 17.5 41.6 82.3 12.0 28.6 26.2 8.4 35.0 42.8 6.5 31.1 0.0 0.4 2.1 0.7 0.4 0.6 0.5 0.7 0.6 0.2 1.7 1.0 0.9 0.4 1.3 1.2 0.6 1.0 0.4 290.7 290.5 274.6 325.9 267.3 266.9 285.6 282.7 257.2 291.6 282.9 283.8 368.5 24.6 19.2 31.4 35.6 30.9 28.6 40.9 17.1 9.1 97.9 61.9 33.9 77.4 25.8 18.0 38.6 56.3 36.1 24.0 41.5 78.2 60.0 43.8 43.5 16.2 22.3 53.7 69.9 17.9 33.5 34.7 27.5 22.4 27.9 24.8 22.1 20.7 20.5 28.2 80.8 26.5 47.5 10.2 19.7 28.2 70.9 36.4 28.0 32.0 11.2 21.6 84.8 15.5 16.6 144.2 68.9 23.6 39.1 28.5 39.8 31.7 56.5 39.0 87.3 19.7 27.3 28.3 56.5 20.6 18.9 50.4 69.0 30.2 23.1 25.5 25.8 WNT10A ENSG00000135925 "Wnt family member 10A" Q9GZT5 2 218880852-218899581 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 7.0;skin 1: 8.9" "Cell type enhanced" "Detected in many" "B-cells: 12.2;Basal keratinocytes: 17.1;Basal respiratory cells: 15.5;Basal squamous epithelial cells: 30.1;Bipolar cells: 16.2;dendritic cells: 16.4;Plasma cells: 30.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.9" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 50.8;HaCaT: 140.1;HDLM-2: 58.7;RPTEC TERT1: 29.2;U-266/70: 69.0" "Region enhanced" "Detected in many" "cerebral cortex: 5.2" "Region enhanced" "Detected in single" "basal ganglia: 2.1" HPA013898 Uncertain "Secreted to extracellular matrix" NA NA "HPA013898: AB_1858847" "unprognostic (2.99e-4)" "unprognostic (4.31e-2)" "unprognostic (8.55e-2)" "unprognostic (1.17e-3)" "unprognostic (2.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.04e-1)" "unprognostic (6.34e-2)" "unprognostic (2.23e-3)" "unprognostic (9.52e-2)" "unprognostic (6.64e-9)" "unprognostic (1.22e-1)" "unprognostic (1.72e-1)" "unprognostic (4.89e-3)" "unprognostic (1.82e-1)" 0.3 0.2 0.5 1.0 1.1 0.5 0.5 0.3 1.3 0.8 0.2 1.6 3.8 0.0 0.4 7.0 1.2 0.3 0.1 1.3 0.5 1.4 0.2 0.7 2.5 0.7 0.6 0.5 0.2 0.1 0.0 4.4 3.4 0.5 1.7 1.1 1.4 2.5 1.0 0.0 8.9 2.1 0.0 0.3 2.0 2.5 0.4 0.8 1.1 0.2 0.0 1.9 2.7 2.9 0.7 15.8 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 50.8 2.8 10.4 0.0 3.8 140.1 0.0 0.1 0.0 58.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 10.5 29.2 0.4 0.0 0.4 0.3 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 69.0 1.1 1.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 6.2 1.0 0.0 0.5 1.1 0.3 1.3 1.3 0.5 0.7 0.6 0.5 0.5 0.3 0.8 0.7 0.2 0.0 0.0 0.3 12.2 17.1 8.2 15.5 30.1 16.2 0.5 1.3 1.4 0.0 1.1 9.2 2.1 1.2 16.4 0.0 0.0 0.3 1.2 0.3 0.1 0.2 0.0 0.4 1.3 0.0 0.4 1.9 0.5 0.2 0.0 0.0 0.0 0.2 0.1 0.0 1.9 0.0 2.0 0.0 1.3 0.1 0.6 1.0 7.2 0.0 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.0 30.4 2.5 0.0 0.3 0.6 1.5 0.0 0.1 0.8 0.9 0.6 5.2 4.7 0.1 9.8 0.0 0.2 3.2 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274197-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 281.2;Pancreatic endocrine cells: 294.3;Syncytiotrophoblasts: 282.1;Urothelial cells: 299.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 573.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles NA NA Vesicles "HPA012093: AB_1858056, HPA070824: AB_2686317" "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favorable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 233.1 121.9 122.2 84.8 130.4 97.0 166.9 128.1 124.6 125.0 116.6 144.4 154.0 120.7 93.8 336.1 98.2 136.7 122.2 109.7 143.7 123.8 172.2 176.6 55.9 196.8 145.9 103.9 94.3 242.3 126.6 50.6 174.2 148.8 98.5 142.1 15.3 156.5 90.4 221.2 181.9 176.0 128.3 142.5 66.5 214.2 25.6 145.8 42.3 159.4 186.8 107.7 174.6 216.9 148.9 183.9 66.4 3.5 47.1 404.3 170.6 188.7 175.5 217.9 103.4 117.7 169.8 449.0 40.6 123.3 263.0 194.6 305.3 59.8 399.9 100.4 151.0 23.5 264.6 41.8 205.6 183.3 2.4 252.4 161.1 370.7 210.4 265.6 108.4 111.8 6.7 169.0 75.0 182.9 6.1 2.8 46.5 2.5 382.3 60.4 5.7 28.3 33.1 142.1 573.4 2.2 3.1 58.0 214.7 122.8 36.6 56.3 39.8 168.4 182.4 50.1 84.9 64.8 35.9 45.2 17.7 179.9 41.0 105.5 352.9 136.4 298.5 107.9 172.7 91.8 77.1 98.0 89.1 93.3 61.9 64.3 70.2 167.1 66.7 221.9 25.9 116.1 190.1 122.2 130.4 128.1 124.6 109.7 143.7 196.8 145.9 103.9 148.8 142.5 145.8 148.9 47.6 73.7 25.6 20.9 37.2 81.7 96.9 85.0 51.2 2.0 28.8 26.0 26.4 78.6 66.9 69.9 0.0 139.1 51.8 266.8 13.7 175.5 0.6 45.6 42.6 50.8 22.7 66.3 2.4 281.2 146.8 61.9 110.6 78.4 50.0 16.1 28.9 50.4 104.9 0.0 2.5 67.9 52.9 45.1 50.2 2.8 54.0 69.6 46.2 14.0 22.0 22.9 48.4 5.0 35.2 294.3 177.3 59.5 30.3 151.8 204.4 37.7 34.8 1.9 13.1 35.7 45.0 1.4 12.5 86.5 101.2 282.1 41.3 9.9 69.1 299.8 CYP27A1 "CP27, CTX, CYP27" ENSG00000135929 "Cytochrome P450 family 27 subfamily A member 1" Q02318 2 218781749-218815293 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "liver: 599.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3" "Group enriched" "Detected in all" 4 "liver cancer: 176.9;melanoma: 85.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 151.5;neutrophil: 126.3" "Group enriched" "Detected in many" 21 "granulocytes: 126.3;monocytes: 151.5" "Cell line enhanced" "Detected in many" "Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059155 Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA059155: AB_2683933" "prognostic favorable (1.05e-4)" "unprognostic (4.21e-2)" "unprognostic (2.34e-1)" "unprognostic (1.83e-3)" "unprognostic (3.71e-3)" "unprognostic (1.31e-2)" "prognostic favorable (8.62e-6)" "unprognostic (6.04e-2)" "unprognostic (1.73e-1)" "unprognostic (4.04e-1)" "unprognostic (1.25e-3)" "unprognostic (8.76e-3)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (7.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 22.6 50.7 45.5 15.8 57.6 1.3 22.0 58.4 59.8 26.8 71.5 26.5 78.5 20.0 11.7 12.0 34.3 19.2 24.7 42.8 52.2 46.9 599.2 72.4 24.8 64.1 57.4 39.5 32.9 8.4 18.7 29.8 6.3 61.0 42.2 20.9 22.7 40.7 29.8 38.3 17.4 82.6 13.3 58.4 13.1 13.9 12.7 55.1 23.8 12.7 49.6 28.2 24.5 23.4 70.8 0.2 0.0 2.7 0.2 4.6 3.3 0.4 1.9 11.7 3.9 7.8 13.7 0.8 0.0 4.3 7.6 0.2 0.1 0.0 0.0 1.7 1.4 1.0 0.0 0.4 299.6 16.2 0.4 0.3 54.7 0.5 0.1 0.0 12.8 5.9 0.0 0.3 0.1 8.3 0.0 0.0 0.2 2.3 0.3 0.5 0.1 2.4 0.5 78.5 0.2 0.2 0.2 0.1 0.0 103.6 2.4 1.6 2.2 5.9 0.0 0.2 0.1 6.0 0.0 0.0 0.1 0.1 0.3 42.9 0.0 151.5 0.4 0.2 17.1 0.3 0.7 0.2 0.5 6.5 0.0 0.1 0.0 126.3 0.0 1.2 0.8 0.0 44.1 45.5 57.6 58.4 59.8 42.8 52.2 64.1 57.4 39.5 61.0 58.4 55.1 70.8 10.6 3.2 28.9 33.6 0.9 5.2 52.4 8.5 21.6 15.3 12.7 18.8 5.1 17.2 11.3 3.7 27.1 0.7 0.5 37.0 9.8 12.1 1.0 12.6 4.3 10.3 24.5 8.4 2.2 12.0 0.7 35.4 2.6 14.8 2.5 1.9 19.6 404.3 148.9 10.1 3.9 20.0 4.1 18.2 5.1 1.0 47.5 104.3 49.8 15.0 92.4 28.7 0.0 26.7 108.5 9.7 44.0 26.7 0.0 43.3 206.3 76.9 21.4 14.1 0.0 12.8 7.2 0.7 0.1 3.2 3.1 1.2 2.3 1.2 30.3 20.4 EIF4E2 "4EHP, EIF4EL3, IF4e" ENSG00000135930 "Eukaryotic translation initiation factor 4E family member 2" O60573 2 232550674-232583644 "Predicted intracellular proteins" "Protein biosynthesis, RNA-mediated gene silencing, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 302.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019253, HPA077074" Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019253: AB_1848092, HPA077074: " "unprognostic (3.44e-2)" "unprognostic (2.70e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-2)" "unprognostic (1.63e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.42e-1)" "unprognostic (5.62e-3)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" "unprognostic (1.21e-2)" "unprognostic (1.36e-2)" "unprognostic (7.74e-2)" "unprognostic (3.34e-3)" "unprognostic (1.88e-1)" "unprognostic (9.38e-2)" 41.2 36.2 28.5 52.9 29.2 58.9 43.5 29.9 34.6 35.7 27.7 68.1 51.1 42.0 37.2 52.3 33.5 43.2 36.0 29.0 30.7 64.5 94.0 45.6 49.6 30.6 29.7 29.1 33.9 41.2 36.5 24.7 57.4 31.9 35.1 77.9 34.7 39.1 32.1 154.6 50.6 53.0 56.6 28.7 42.9 51.5 42.5 29.9 42.3 36.5 63.1 62.4 47.8 34.6 33.1 104.9 99.5 108.7 79.3 83.4 110.2 161.9 144.9 88.3 101.9 107.8 109.8 100.3 109.0 39.0 151.6 116.7 88.6 128.2 131.2 128.9 98.6 122.0 146.6 97.4 149.9 98.8 213.0 130.7 103.1 98.1 105.5 78.5 102.8 172.1 53.0 139.0 34.7 118.7 201.4 83.1 171.0 174.3 124.1 83.5 73.2 231.7 72.3 209.6 133.2 98.7 135.5 77.0 86.6 95.3 117.2 81.3 145.3 148.6 88.3 114.9 96.6 106.1 67.3 71.0 139.8 100.0 109.4 78.9 299.2 205.7 194.4 63.6 220.0 51.4 62.2 65.8 67.7 179.3 60.5 55.1 56.1 132.1 70.7 205.9 70.9 114.7 155.5 28.5 29.2 29.9 34.6 29.0 30.7 30.6 29.7 29.1 31.9 28.7 29.9 33.1 37.2 41.7 57.3 11.8 40.1 38.0 78.2 127.4 31.3 19.8 41.5 49.3 36.9 65.8 85.4 35.0 18.8 142.0 53.6 109.1 74.3 164.5 129.6 45.6 63.1 46.9 66.0 50.7 20.0 151.5 204.3 60.2 48.9 68.6 43.7 47.2 50.0 119.9 125.4 20.2 19.3 111.3 120.1 90.8 87.5 302.4 38.2 72.6 30.2 10.3 135.8 29.3 51.5 12.1 29.7 159.8 109.3 38.7 51.8 96.8 139.1 170.8 58.8 22.3 26.3 38.8 118.5 68.4 56.0 59.7 51.1 182.5 42.7 92.3 87.9 120.4 ARMC9 "ARM, FLJ12584, KIAA1868, KU-MEL-1" ENSG00000135931 "Armadillo repeat containing 9" Q7Z3E5 2 231198546-231376848 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 72.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 310.6;Excitatory neurons: 112.5;monocytes: 116.4;Rod photoreceptor cells: 202.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 275.2;SK-MEL-30: 222.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019041, HPA026671" Approved NA NA "HPA019041: AB_1845035, HPA026671: AB_1845036" "unprognostic (2.90e-1)" "unprognostic (2.86e-1)" "unprognostic (5.35e-2)" "unprognostic (6.26e-2)" "unprognostic (1.99e-2)" "unprognostic (5.57e-2)" "unprognostic (7.20e-4)" "unprognostic (1.58e-2)" "unprognostic (4.85e-2)" "unprognostic (7.17e-3)" "unprognostic (4.14e-1)" "unprognostic (9.15e-2)" "unprognostic (7.43e-2)" "unprognostic (1.30e-2)" "unprognostic (4.19e-2)" "unprognostic (5.57e-2)" "prognostic unfavorable (7.66e-5)" 2.1 15.2 3.5 5.4 5.3 1.9 3.3 1.1 13.5 4.8 39.0 11.3 1.7 19.6 5.6 4.2 8.8 7.8 2.1 5.9 1.6 5.2 0.9 7.2 1.6 1.6 2.4 5.7 9.5 3.7 10.9 11.2 5.7 3.5 5.5 5.2 72.1 3.2 6.6 1.0 2.6 6.6 23.7 0.0 1.1 9.0 9.5 0.8 3.1 7.6 1.1 2.1 6.9 2.7 3.8 21.2 10.8 20.3 15.1 14.5 23.7 8.3 23.3 275.2 28.6 35.8 3.1 10.3 2.7 11.0 68.3 46.6 12.2 24.8 22.7 25.0 1.7 15.2 1.5 14.0 11.6 41.3 5.0 5.1 63.8 8.8 38.3 13.7 73.3 21.7 12.2 4.7 0.6 46.0 29.9 6.3 6.9 44.4 7.7 12.0 7.8 18.2 0.3 30.6 6.9 15.6 32.2 9.3 25.2 222.7 17.8 9.7 5.4 22.6 17.6 10.9 10.0 10.4 24.8 6.2 1.3 33.9 1.0 17.7 1.1 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.3 0.2 0.3 0.3 0.3 0.5 2.6 0.2 0.3 0.2 0.2 3.5 5.3 1.1 13.5 5.9 1.6 1.6 2.4 5.7 3.5 0.0 0.8 3.8 1.3 3.2 36.1 25.8 1.4 1.8 5.6 6.8 1.2 24.0 5.1 5.7 3.3 2.8 7.5 3.7 310.6 4.8 0.1 4.0 1.9 7.3 69.5 25.1 22.3 4.9 7.8 1.3 112.5 17.3 3.0 7.2 3.6 4.1 3.8 6.6 2.5 1.0 10.6 1.7 62.7 6.0 0.0 0.3 2.4 23.8 14.0 6.6 19.6 17.8 116.4 16.7 1.0 25.6 14.1 11.5 1.8 21.4 1.1 1.9 0.7 5.1 31.3 202.4 6.6 5.3 6.4 36.7 15.7 0.6 0.9 2.2 1.3 6.3 10.0 2.1 CAB39 "CGI-66, MO25" ENSG00000135932 "Calcium binding protein 39" Q9Y376 2 230712842-230821075 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 190.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037112, HPA076632" Approved Approved Nucleoli,Cytosol NA NA 100000 Nucleoli Cytosol "CAB037112: AB_1078367, HPA076632: " "unprognostic (4.36e-3)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" "unprognostic (1.71e-1)" "unprognostic (3.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.50e-2)" "unprognostic (2.84e-2)" "unprognostic (9.16e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (1.04e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.59e-1)" "unprognostic (2.92e-1)" "unprognostic (8.93e-2)" "unprognostic (1.36e-1)" 44.1 31.3 33.0 55.7 36.1 51.4 29.9 34.3 40.4 26.5 33.8 54.3 48.4 31.0 35.3 56.4 30.2 41.7 56.1 36.3 36.0 54.6 38.9 40.3 58.4 38.5 37.9 30.5 29.5 33.4 42.8 17.2 35.8 39.4 40.2 56.5 46.0 34.7 31.5 190.3 34.5 51.6 40.8 38.8 38.4 46.6 41.7 35.2 45.5 37.6 129.0 59.6 49.8 30.8 41.1 131.6 30.0 39.8 34.0 48.2 59.8 45.3 73.7 91.8 45.4 47.2 36.6 140.0 33.8 56.5 64.5 76.5 59.1 44.8 138.5 91.9 142.1 35.1 90.5 36.9 39.5 40.9 126.6 100.8 42.5 79.1 58.5 128.4 51.8 57.1 46.1 153.9 30.3 43.8 45.6 59.1 77.9 39.8 53.4 52.0 67.8 59.3 33.5 84.6 104.9 43.2 26.4 55.2 68.2 59.9 44.7 16.9 72.4 73.1 63.9 24.3 68.2 61.0 39.0 31.8 53.8 45.4 72.4 53.4 4.0 3.6 6.0 4.7 4.4 4.8 3.0 5.8 6.1 3.0 2.4 4.7 6.5 10.3 9.3 4.3 2.2 6.2 2.4 33.0 36.1 34.3 40.4 36.3 36.0 38.5 37.9 30.5 39.4 38.8 35.2 41.1 41.6 64.1 37.5 42.1 29.6 97.8 44.2 23.0 23.3 14.4 28.3 18.9 69.1 17.2 30.5 51.5 33.3 20.8 32.3 162.5 29.4 26.0 12.0 41.4 25.2 29.6 20.4 32.0 85.1 32.7 18.7 24.1 28.5 39.5 20.3 16.6 28.2 29.3 56.8 28.6 69.3 48.5 24.4 81.2 72.4 13.5 17.4 66.2 30.2 93.7 49.6 39.6 29.9 58.8 64.3 72.3 62.4 32.0 37.0 84.4 54.6 39.8 55.6 40.5 13.1 27.5 27.3 30.8 29.5 31.2 85.1 23.1 52.0 18.9 34.8 88.6 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646062-97648383 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1345.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3614.3;Distal tubular cells: 3621.5;Proximal enterocytes: 2795.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria NA NA 230000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.73e-4)" 189.7 254.9 308.1 43.2 313.6 114.2 180.2 350.4 439.5 131.7 316.7 297.4 165.7 125.7 73.0 286.9 138.0 32.9 1016.0 296.2 329.4 410.3 375.8 121.5 40.7 323.4 318.0 301.1 139.6 167.0 236.1 170.3 47.5 320.3 159.6 114.5 75.1 198.3 90.9 1345.4 209.0 213.7 51.6 319.2 154.5 292.9 102.0 333.6 65.0 186.6 712.1 54.7 181.3 180.6 334.9 144.9 165.5 106.8 169.7 115.9 105.8 428.3 180.0 100.8 118.3 130.5 459.9 148.7 240.8 377.3 116.5 188.4 217.9 117.5 181.8 56.4 188.7 493.2 324.2 166.6 559.8 220.3 310.6 231.2 193.8 161.6 113.4 91.2 125.4 104.4 187.8 243.6 115.5 94.0 360.0 203.5 450.0 196.6 257.2 854.3 194.9 170.6 368.8 167.5 227.9 202.2 210.3 175.0 225.0 374.8 146.0 115.7 345.5 186.9 107.5 181.4 174.4 118.7 265.8 274.7 183.1 194.9 264.5 113.5 1086.6 1062.7 933.1 458.0 1057.0 445.1 801.5 547.4 481.8 990.1 666.0 528.0 468.8 1016.6 469.6 926.3 677.6 783.4 1543.0 308.1 313.6 350.4 439.5 296.2 329.4 323.4 318.0 301.1 320.3 319.2 333.6 334.9 461.0 221.2 256.0 33.3 292.7 386.6 629.5 1166.0 377.9 239.1 433.2 536.2 3614.3 567.6 618.5 800.0 227.2 736.0 257.4 1960.0 3621.5 599.5 207.5 399.4 300.8 380.0 740.3 308.8 27.3 604.1 897.1 391.6 616.7 439.7 330.6 392.2 361.3 1234.9 875.0 141.3 33.7 1430.5 1043.6 485.2 651.9 360.8 351.6 456.6 912.4 30.0 711.7 461.5 314.1 15.6 39.4 505.4 1836.0 304.6 353.3 468.2 2795.9 2663.5 485.4 386.3 447.0 340.2 569.9 265.2 310.7 944.2 479.9 613.2 291.9 455.7 1576.9 915.9 REV1 REV1L ENSG00000135945 "REV1 DNA directed polymerase" Q9UBZ9 2 99400475-99490035 "Predicted intracellular proteins" "DNA damage, DNA repair, DNA synthesis" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044534, HPA051036" Uncertain Approved Cytosol NA NA Cytosol "HPA044534: AB_2678975, HPA051036: AB_2681319" "unprognostic (3.05e-1)" "unprognostic (3.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (7.87e-3)" "unprognostic (1.30e-3)" "unprognostic (3.56e-3)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (3.17e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-3)" 9.7 11.7 7.6 6.1 7.9 7.1 11.3 13.6 9.7 11.4 9.7 8.9 6.1 14.3 17.4 10.6 11.5 7.9 11.8 7.7 8.3 8.8 10.1 11.3 10.0 7.6 8.2 7.5 12.2 6.9 8.9 10.5 7.4 8.4 11.3 9.3 12.3 9.4 12.1 15.9 10.4 9.0 10.2 7.4 9.5 8.3 9.7 8.1 9.8 10.4 23.9 10.1 10.6 11.6 8.8 7.9 2.0 12.4 4.7 9.5 9.3 13.0 8.6 10.8 9.9 11.3 4.6 7.5 15.9 6.7 9.2 10.4 10.9 9.3 11.5 15.3 7.0 5.8 8.1 7.7 10.5 10.6 10.6 16.5 9.1 13.7 8.9 13.0 11.1 12.9 8.1 9.4 5.3 11.1 5.2 11.2 19.0 8.9 5.1 5.2 17.4 8.8 7.0 12.3 13.4 8.0 8.5 7.6 6.4 11.2 13.3 6.6 15.2 9.1 11.7 9.7 4.9 5.7 7.2 7.8 12.8 4.8 13.4 9.2 0.0 0.2 0.0 0.3 0.2 0.2 0.1 0.5 0.4 0.3 0.4 0.9 0.7 0.1 0.3 0.1 0.1 0.3 0.1 7.6 7.9 13.6 9.7 7.7 8.3 7.6 8.2 7.5 8.4 7.4 8.1 8.8 45.3 70.5 61.9 59.4 27.7 48.3 57.5 37.8 58.6 84.2 21.7 20.4 52.5 20.0 38.6 22.0 39.6 32.9 17.5 24.1 5.9 18.4 29.2 41.6 32.8 31.6 17.5 35.7 71.3 18.1 20.0 33.8 31.6 30.0 25.3 32.4 23.6 18.0 19.1 82.4 78.2 16.3 26.4 17.6 28.3 21.6 27.1 20.6 19.6 53.4 27.3 36.7 14.4 60.3 77.0 16.4 25.6 46.3 23.3 51.0 30.0 12.5 33.7 57.2 26.3 51.2 28.8 52.1 53.8 36.3 35.5 35.2 26.8 39.7 19.3 63.5 TSGA10 "CEP4L, CT79" ENSG00000135951 "Testis specific 10" Q9BZW7 2 98997261-99154964 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 52.0" "Cell type enhanced" "Detected in all" "Early spermatids: 458.9;Late spermatids: 294.2;Oligodendrocytes: 144.9;Spermatocytes: 206.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036879 Approved Cytosol NA NA Cytosol "HPA036879: AB_10671715" "unprognostic (1.71e-3)" "unprognostic (6.68e-2)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (3.69e-2)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-5)" "unprognostic (2.32e-1)" "unprognostic (2.82e-6)" "unprognostic (1.06e-2)" "unprognostic (9.91e-3)" "unprognostic (9.79e-2)" "unprognostic (8.37e-4)" 1.1 1.0 3.2 0.7 1.8 0.7 1.4 2.1 1.9 1.3 3.2 0.9 1.0 1.1 1.6 0.6 12.7 1.1 0.1 1.8 1.7 2.0 0.5 1.7 1.0 3.3 2.8 1.3 0.6 1.7 1.6 2.5 0.4 2.7 1.0 1.3 2.6 1.1 0.6 0.1 1.9 0.6 0.3 3.4 0.8 1.4 52.0 2.0 1.1 3.1 0.2 0.8 0.6 0.4 3.8 0.8 0.2 1.2 0.5 0.6 0.7 0.9 0.0 0.1 0.3 0.2 0.2 0.8 0.7 0.2 0.0 0.5 0.2 0.2 0.2 0.3 1.0 0.8 0.1 0.0 0.3 0.0 0.5 1.7 0.9 1.0 0.1 0.1 0.7 0.0 0.9 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.2 0.3 0.1 0.2 4.2 0.7 1.7 0.2 0.9 0.7 0.2 1.3 0.2 0.3 0.4 0.2 0.4 0.0 0.1 0.6 0.3 0.3 0.3 1.0 0.4 0.1 0.2 0.2 0.6 0.0 0.7 0.7 0.7 0.8 0.0 0.8 1.1 0.7 0.0 1.0 0.0 0.4 0.7 0.3 3.2 1.8 2.1 1.9 1.8 1.7 3.3 2.8 1.3 2.7 3.4 2.0 3.8 3.1 3.2 9.2 35.3 13.3 3.6 10.3 8.6 6.2 19.3 13.9 15.4 7.1 17.2 14.5 23.9 29.2 9.7 5.6 4.7 25.4 8.4 458.9 80.6 4.5 4.0 15.5 8.6 73.4 10.5 4.3 5.8 8.6 10.9 5.1 5.3 4.2 7.1 4.6 20.2 57.9 6.7 12.2 3.1 1.4 294.2 11.1 5.1 1.8 23.4 4.5 21.1 15.5 27.6 144.9 4.7 12.2 9.8 8.1 7.8 8.0 12.9 107.9 36.6 6.6 5.7 6.2 206.8 36.6 5.6 4.4 9.3 8.9 5.9 8.4 7.9 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102714630-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA055293: AB_2682775, HPA061859: AB_2684627" "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 2.8 2.2 1.5 2.9 1.3 4.1 2.7 4.4 2.0 3.7 1.7 6.4 8.8 1.8 2.9 4.5 1.8 2.3 1.4 1.9 1.7 4.7 10.6 2.3 3.2 1.5 1.9 1.1 2.4 9.3 4.1 3.4 2.4 2.3 2.6 5.9 2.4 5.0 3.1 1.3 2.9 7.3 1.9 1.4 2.7 4.8 1.2 1.8 4.6 2.9 1.2 3.6 3.3 2.2 1.4 3.1 2.4 3.0 5.2 3.6 1.6 6.1 1.9 1.9 2.8 2.8 8.6 4.1 2.7 3.1 1.2 4.3 4.7 4.8 1.8 1.8 11.5 4.4 4.5 3.1 10.9 3.0 3.6 6.2 1.6 6.1 1.7 0.9 2.9 1.8 8.8 2.7 1.3 1.4 2.9 3.7 7.2 2.3 7.4 3.1 2.8 4.9 2.8 5.9 9.4 5.8 4.1 1.7 6.1 6.9 3.2 2.3 5.7 1.3 1.9 4.0 3.2 2.7 3.6 2.9 1.8 2.1 8.4 2.6 1.3 0.3 1.5 1.2 0.6 0.9 0.8 0.9 0.8 0.6 0.6 0.9 1.1 1.0 1.0 0.5 1.2 0.7 0.7 1.5 1.3 4.4 2.0 1.9 1.7 1.5 1.9 1.1 2.3 1.4 1.8 1.4 1.6 0.0 1.5 1.0 4.1 3.3 3.2 3.7 2.8 1.5 4.1 1.3 3.1 1.5 5.4 7.3 4.2 8.2 4.3 15.9 0.0 5.8 12.8 3.3 2.0 1.6 3.0 1.7 5.4 8.6 9.1 3.3 7.1 5.3 3.8 3.0 1.4 11.5 4.8 0.0 12.2 8.7 10.2 2.9 1.4 4.5 0.9 2.6 0.0 1.9 4.3 1.4 7.2 4.0 1.3 11.4 8.0 1.2 8.9 4.2 10.4 3.6 3.9 2.8 6.6 2.1 2.4 1.0 5.3 4.3 4.4 11.5 5.1 3.1 7.2 8.2 TMEM127 "FLJ20507, FLJ22257" ENSG00000135956 "Transmembrane protein 127" O75204 2 96248514-96265997 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-3)" "unprognostic (2.67e-1)" "unprognostic (1.72e-2)" "unprognostic (6.51e-2)" "unprognostic (5.82e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.59e-4)" "unprognostic (6.73e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (7.50e-2)" "unprognostic (2.17e-1)" "prognostic favorable (6.69e-5)" "unprognostic (3.59e-1)" "unprognostic (1.52e-1)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" 28.2 34.9 25.0 28.7 23.6 53.5 25.8 19.8 29.4 31.0 16.4 34.7 32.9 30.3 21.6 40.4 25.5 32.6 68.4 25.1 23.0 28.9 35.7 31.9 21.5 23.5 25.2 24.4 32.2 28.7 73.7 29.6 27.0 24.4 26.3 30.8 27.9 40.0 42.8 26.1 31.4 35.0 35.4 21.9 35.0 28.1 10.3 29.3 19.2 26.4 30.9 25.6 38.9 28.0 24.3 28.8 38.0 19.9 30.7 86.0 43.3 36.7 36.9 65.9 38.6 35.2 37.9 40.0 17.9 52.8 73.3 67.8 45.1 23.1 34.2 26.8 36.1 17.8 31.2 17.6 37.5 55.4 26.7 54.0 52.7 48.0 48.0 35.3 51.4 44.5 12.1 19.5 37.6 39.8 32.8 17.6 16.8 27.3 33.9 40.4 16.4 25.0 26.9 42.9 48.7 22.3 23.4 27.1 63.8 31.3 40.2 23.6 28.2 52.5 63.9 36.2 55.9 25.8 28.2 29.6 14.1 42.6 30.9 34.7 3.9 6.3 8.2 2.8 6.6 3.0 1.8 2.1 3.0 4.3 1.9 1.6 2.2 14.3 1.5 5.3 2.5 1.6 3.2 25.0 23.6 19.8 29.4 25.1 23.0 23.5 25.2 24.4 24.4 21.9 29.3 24.3 24.8 19.2 15.3 7.2 13.4 17.2 16.6 14.5 12.0 22.1 20.0 12.8 39.6 22.8 20.2 27.6 27.1 11.4 19.3 88.2 15.6 29.7 5.2 16.4 15.1 23.1 16.3 9.0 12.9 34.8 13.1 16.7 14.8 28.8 13.9 13.6 29.6 35.7 37.7 21.9 15.7 26.7 12.2 59.8 33.2 5.8 13.7 34.0 16.0 5.6 41.9 7.8 15.5 8.0 6.6 41.0 35.1 17.0 13.0 23.1 43.9 13.3 15.7 16.9 6.6 18.5 19.4 9.1 2.9 12.6 23.3 24.2 14.3 15.9 18.6 34.1 EDAR "DL, ED1R, ED3, ED5, EDA1R, EDA3" ENSG00000135960 "Ectodysplasin A receptor" Q9UNE0 2 108894471-108989372 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein, Receptor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 3.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 3.4;Macrophages: 1.1;Squamous epithelial cells: 5.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 7.5;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 75 "T-cells: 7.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.7;HaCaT: 10.2;OE19: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042292 Approved NA NA "HPA042292: AB_10794648" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.22e-2)" "unprognostic (1.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.21e-2)" "unprognostic (2.30e-1)" "unprognostic (2.53e-2)" "unprognostic (3.70e-1)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (8.83e-7)" "unprognostic (9.21e-2)" "unprognostic (5.61e-2)" "unprognostic (2.29e-1)" "unprognostic (5.03e-3)" 0.0 0.0 0.1 0.9 0.0 0.3 0.2 0.0 0.2 0.4 0.0 1.3 1.1 0.5 0.2 3.6 0.2 0.9 0.0 0.1 0.1 0.7 1.0 0.2 1.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 2.0 0.0 0.6 0.1 0.0 1.4 1.0 0.0 0.0 0.2 0.9 0.1 0.0 1.2 0.0 0.0 1.2 1.5 1.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.7 0.0 0.4 0.0 0.0 10.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 7.5 3.7 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.4 0.0 0.1 0.6 0.5 0.0 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.7 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.8 0.0 0.3 0.8 TGFBRAP1 "TRAP-1, TRAP1, VPS3" ENSG00000135966 "Transforming growth factor beta receptor associated protein 1" Q8WUH2 2 105264391-105329735 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037672, HPA038397" Approved Approved Vesicles NA NA Vesicles "HPA037672: AB_2675597, HPA038397: AB_10669782" "unprognostic (1.66e-1)" "unprognostic (1.58e-2)" "unprognostic (8.99e-2)" "unprognostic (4.49e-3)" "unprognostic (3.02e-2)" "unprognostic (6.77e-2)" "unprognostic (5.63e-3)" "unprognostic (9.15e-2)" "unprognostic (2.25e-1)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (8.30e-2)" "unprognostic (8.82e-2)" "unprognostic (3.89e-1)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-2)" 8.5 8.2 5.8 8.0 6.1 22.9 8.1 6.0 6.9 6.6 7.0 8.1 7.3 7.9 5.4 8.3 7.1 6.0 6.7 6.7 5.4 6.7 5.1 7.5 9.4 6.1 6.3 6.4 7.7 10.0 11.5 5.2 10.5 6.4 8.4 8.2 6.2 8.4 9.4 11.9 10.7 8.0 9.0 5.7 8.6 13.6 2.5 6.3 9.2 11.0 7.8 8.4 7.8 6.7 7.0 22.5 17.5 12.5 15.5 13.3 10.5 25.4 16.0 21.8 26.6 25.3 25.9 13.6 22.7 16.9 18.2 27.1 13.5 22.4 38.1 21.9 24.3 23.8 30.7 13.8 20.7 12.1 28.6 22.4 12.7 22.5 22.2 19.6 14.1 28.7 19.5 28.0 10.9 32.6 14.9 20.4 18.3 15.9 15.4 14.5 22.9 19.8 33.0 16.4 27.3 24.7 16.5 13.2 26.1 25.8 9.0 13.1 17.5 20.8 16.7 25.4 14.1 16.4 11.3 14.8 24.7 11.9 19.6 35.3 0.4 0.8 1.1 1.8 0.7 1.5 0.6 1.2 1.0 0.6 1.0 0.7 1.1 0.3 0.9 0.5 1.0 0.9 0.7 5.8 6.1 6.0 6.9 6.7 5.4 6.1 6.3 6.4 6.4 5.7 6.3 7.0 13.7 6.4 9.5 10.4 8.1 8.0 3.5 5.6 9.1 12.4 8.8 9.3 5.9 5.7 7.1 5.5 16.7 12.4 8.9 7.5 1.9 5.4 0.1 5.2 7.0 10.6 11.3 11.3 17.0 10.8 4.8 8.5 9.7 8.3 2.5 10.8 13.9 6.7 12.9 15.2 14.8 8.2 8.2 13.8 4.4 0.5 7.5 9.9 3.6 17.8 9.5 9.0 11.3 8.5 13.5 8.3 5.2 8.2 7.6 7.7 5.8 7.3 2.7 7.2 26.3 15.8 8.1 0.4 1.2 11.5 13.1 7.4 8.8 11.1 9.2 3.1 GCC2 "GCC185, KIAA0336" ENSG00000135968 "GRIP and coiled-coil domain containing 2" Q8IWJ2 2 108449191-108509415 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035849, HPA035850" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035849: AB_10671941, HPA035850: AB_2674821" "unprognostic (1.35e-1)" "unprognostic (1.29e-2)" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.59e-1)" "unprognostic (3.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.53e-2)" "unprognostic (6.53e-3)" "unprognostic (3.99e-1)" "unprognostic (4.71e-1)" "unprognostic (9.61e-2)" "unprognostic (1.64e-2)" 9.1 12.9 4.1 17.8 5.0 25.5 17.6 0.7 6.3 12.6 22.5 19.4 21.9 15.4 42.1 7.6 15.1 21.5 8.5 3.7 5.6 16.8 10.8 14.9 21.7 3.6 3.5 2.6 15.6 12.6 15.1 4.1 13.8 3.2 19.8 21.0 17.4 15.4 17.3 2.3 8.0 23.1 9.5 2.5 19.0 26.7 16.7 2.3 19.1 20.7 9.5 16.5 14.2 3.7 6.5 12.5 10.4 12.6 5.5 14.2 22.6 27.4 17.6 26.8 9.2 12.9 18.4 17.2 14.9 22.3 16.0 16.7 10.4 10.0 14.1 15.8 16.9 13.6 18.7 16.3 15.8 12.7 26.4 14.3 29.1 13.3 23.1 16.3 20.0 13.6 13.9 25.3 12.4 17.4 7.1 13.6 18.1 21.9 11.5 12.0 11.7 17.9 16.1 12.2 20.1 13.6 12.5 21.1 16.7 18.7 18.2 8.3 12.8 21.3 13.3 20.2 12.4 6.7 18.0 26.9 18.2 17.2 7.0 9.8 47.3 8.9 25.9 25.5 8.0 25.1 27.0 28.2 27.8 7.3 24.3 38.2 33.5 35.6 14.9 17.6 31.8 23.0 8.2 4.1 5.0 0.7 6.3 3.7 5.6 3.6 3.5 2.6 3.2 2.5 2.3 6.5 92.6 150.6 103.3 44.1 125.2 23.8 68.6 54.8 29.6 155.9 60.3 57.5 85.6 75.8 95.7 104.8 139.7 44.2 157.6 152.1 50.9 114.5 73.9 253.3 85.1 68.1 85.6 39.5 104.9 81.6 56.3 74.2 65.7 118.6 82.2 113.9 65.0 36.7 37.0 70.7 73.6 152.6 52.9 49.8 39.3 39.9 71.4 66.0 33.8 62.8 88.5 59.0 134.9 50.8 66.1 116.1 125.2 82.8 108.7 91.7 134.0 63.1 259.7 127.2 52.6 61.4 66.2 163.0 120.7 21.0 17.5 65.0 139.1 138.0 88.3 114.5 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105038069-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Supported Mitochondria No No Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 17.3 33.8 23.1 18.0 24.5 24.8 23.6 25.6 26.7 18.3 26.8 30.0 29.8 20.9 19.4 24.0 24.4 13.5 64.7 23.2 24.9 33.0 32.1 15.6 24.9 25.5 24.8 23.0 31.1 24.4 33.1 19.7 13.0 25.7 23.6 33.6 22.5 23.5 21.8 99.5 22.1 23.6 20.0 24.3 18.7 26.1 33.8 24.5 31.0 21.6 97.9 27.3 20.4 18.1 26.8 68.2 28.9 59.4 55.1 30.6 31.5 69.6 42.6 40.6 66.2 59.2 155.0 46.4 70.6 41.1 33.9 68.9 59.8 118.0 62.1 69.9 44.0 77.5 69.7 42.4 94.4 51.0 52.2 29.9 37.9 41.5 54.6 45.4 38.3 51.6 84.8 101.5 35.9 45.7 54.9 70.6 68.6 93.9 57.4 62.6 88.9 50.9 98.3 83.2 47.3 51.4 30.9 49.4 71.5 59.9 58.0 58.9 52.2 34.0 38.8 78.2 38.9 46.6 32.6 41.5 56.3 33.6 79.1 33.3 21.7 23.8 10.1 39.3 31.5 43.3 44.4 43.0 41.7 43.0 35.3 42.9 42.4 2.8 46.0 39.9 32.1 49.9 31.7 23.1 24.5 25.6 26.7 23.2 24.9 25.5 24.8 23.0 25.7 24.3 24.5 26.8 18.2 22.4 28.2 28.1 21.0 19.5 25.3 56.4 22.2 24.7 15.4 22.2 110.2 22.8 30.4 22.0 12.5 39.9 29.1 17.7 107.6 40.7 51.7 35.9 18.6 22.5 19.7 47.5 43.4 42.7 40.7 21.2 18.8 12.9 22.8 34.6 18.2 31.2 28.8 8.4 54.2 27.9 24.4 15.2 9.9 14.6 23.9 15.9 30.2 17.8 26.2 21.2 29.9 49.3 69.4 22.6 18.3 27.1 25.0 17.4 23.1 72.3 42.1 32.0 39.5 24.8 28.1 112.8 40.7 23.4 13.2 20.4 25.2 62.9 40.5 19.0 GPR45 "PSP24, PSP24A" ENSG00000135973 "G protein-coupled receptor 45" Q9Y5Y3 2 105241743-105243467 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Group enriched" "Detected in some" 51 "Early spermatids: 4.2;Late spermatids: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 1.3;U-2 OS: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055940 Uncertain NA NA "HPA055940: AB_2682977" "unprognostic (3.80e-3)" "unprognostic (5.92e-2)" "unprognostic (2.19e-3)" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.13e-1)" "unprognostic (3.96e-1)" "unprognostic (1.61e-3)" "unprognostic (1.11e-2)" "unprognostic (3.13e-4)" "unprognostic (2.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.7 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.9 0.7 1.1 0.7 0.4 0.5 0.5 0.2 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf49 "asw, MGC5509" ENSG00000135974 "Chromosome 2 open reading frame 49" Q9BVC5 2 105337532-105349211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043846, HPA060814" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA043846: AB_2678698, HPA060814: AB_2684372" "unprognostic (4.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.06e-1)" "unprognostic (6.16e-3)" "unprognostic (2.57e-3)" "unprognostic (8.75e-3)" "unprognostic (1.89e-3)" "unprognostic (6.51e-2)" "unprognostic (5.01e-2)" "unprognostic (2.07e-1)" "unprognostic (2.56e-1)" "unprognostic (5.94e-2)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.04e-2)" 11.4 9.4 10.2 10.7 12.1 19.5 11.2 12.7 13.0 12.6 7.5 9.2 9.5 14.8 7.9 11.9 12.5 9.6 15.5 9.8 11.2 8.8 10.2 8.6 12.7 11.3 12.2 8.4 20.1 11.1 10.6 5.5 12.1 12.0 11.3 10.0 25.2 9.1 11.1 20.1 9.6 10.2 12.3 11.6 11.1 13.9 13.1 11.3 16.2 12.7 21.2 13.5 11.4 10.6 14.6 20.0 13.9 17.2 17.5 19.4 23.6 30.7 19.6 20.6 17.0 23.3 30.7 19.5 23.3 23.9 17.1 45.6 18.7 23.9 16.7 22.2 30.6 18.1 25.3 11.6 23.8 23.6 21.3 20.1 17.1 28.7 24.0 21.6 24.3 15.8 18.1 35.9 18.7 24.3 15.4 25.9 24.5 22.6 13.5 16.8 17.1 25.4 27.1 19.2 18.9 20.3 16.2 17.3 15.5 23.8 19.2 15.2 23.8 25.4 17.9 25.1 13.0 16.1 23.6 20.5 24.6 18.1 21.3 17.6 15.4 13.2 12.0 9.0 8.3 8.9 14.5 10.1 9.0 9.2 17.6 11.0 9.3 17.8 9.2 11.9 19.1 12.7 6.7 10.2 12.1 12.7 13.0 9.8 11.2 11.3 12.2 8.4 12.0 11.6 11.3 14.6 27.0 16.0 14.3 7.5 26.3 29.1 13.4 21.8 15.4 37.1 24.8 22.9 30.9 18.6 22.0 25.8 29.2 21.2 31.6 16.5 25.4 22.9 40.6 43.1 34.7 19.3 11.3 21.2 10.8 18.2 26.5 22.8 12.8 33.9 16.5 18.1 19.6 22.4 16.1 23.5 11.2 22.5 12.2 18.5 13.5 35.8 27.7 15.5 7.2 10.3 21.1 39.6 28.8 7.1 15.8 21.0 17.5 29.0 19.0 16.2 21.8 22.3 36.1 44.3 19.7 17.3 19.8 45.8 28.1 13.7 24.7 36.8 22.4 16.6 14.8 15.8 ANKRD36 UNQ2430 ENSG00000135976 "Ankyrin repeat domain 36" A6QL64 2 97113153-97264521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2;retina: 20.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 240.8;Inhibitory neurons: 255.3;Oligodendrocyte precursor cells: 155.3;Oligodendrocytes: 217.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (4.24e-3)" "unprognostic (7.59e-2)" "unprognostic (6.15e-3)" "unprognostic (9.86e-2)" "unprognostic (9.83e-3)" "unprognostic (5.25e-3)" "unprognostic (5.65e-2)" "unprognostic (1.49e-2)" "unprognostic (4.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (9.14e-7)" "unprognostic (1.67e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.75e-1)" 1.8 1.6 5.0 2.8 8.4 11.9 3.3 25.2 7.8 2.0 0.3 1.8 1.8 3.7 4.2 1.0 2.1 2.0 1.1 6.0 4.7 1.0 0.6 2.4 3.0 8.0 6.3 4.5 4.5 1.9 1.8 1.9 1.3 10.3 2.3 2.6 20.5 2.2 1.4 0.7 3.3 1.8 2.3 1.8 3.4 2.8 7.1 5.1 3.2 2.1 0.5 2.2 1.4 1.8 10.2 4.4 1.4 3.9 2.4 0.9 2.1 1.5 2.1 1.3 1.5 1.5 1.3 2.3 5.5 1.0 1.4 1.2 2.9 1.4 1.9 1.3 2.9 2.4 4.7 6.4 2.4 0.4 3.8 1.9 1.4 0.9 1.2 1.9 2.2 2.9 8.9 3.6 10.1 0.8 1.0 4.4 4.4 0.9 0.4 2.8 5.0 1.9 2.2 0.8 2.3 3.3 2.2 2.3 1.3 0.7 1.5 1.4 1.9 3.9 4.2 3.8 4.1 2.3 6.5 2.8 5.1 2.2 4.5 1.0 9.2 2.2 3.1 7.2 1.0 7.4 9.2 7.1 6.1 0.9 8.1 7.2 7.5 3.3 4.9 2.3 10.1 6.6 2.0 5.0 8.4 25.2 7.8 6.0 4.7 8.0 6.3 4.5 10.3 1.8 5.1 10.2 16.9 44.8 27.4 85.5 27.8 15.7 8.4 28.2 14.2 51.0 9.0 11.2 26.2 2.8 31.5 7.3 75.0 1.4 38.2 4.9 0.0 7.1 70.7 39.6 22.2 19.3 13.8 14.3 240.8 18.6 5.6 19.5 84.6 19.3 26.6 39.4 11.7 1.1 5.1 21.9 255.3 10.5 12.2 3.8 26.2 14.3 26.1 10.2 39.2 46.9 6.1 9.3 26.8 155.3 217.7 9.5 3.6 18.0 56.3 5.9 2.2 2.7 43.2 65.0 0.0 36.4 20.7 123.4 22.1 9.8 9.2 0.4 39.6 9.1 8.1 14.1 EPC2 DKFZP566F2124 ENSG00000135999 "Enhancer of polycomb homolog 2" Q52LR7 2 148644440-148787569 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 125.7;Oligodendrocytes: 99.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036759 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036759: AB_10672365" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (2.83e-3)" "unprognostic (2.59e-2)" "unprognostic (1.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.47e-2)" "unprognostic (3.86e-2)" "unprognostic (2.29e-1)" "unprognostic (6.21e-2)" "unprognostic (5.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.54e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" 16.5 14.1 11.0 13.7 11.2 50.7 17.3 22.7 13.8 17.8 8.8 12.1 9.8 25.8 14.2 12.3 15.4 15.5 15.6 10.3 14.2 13.0 12.8 14.7 18.1 10.5 11.4 9.0 32.1 9.9 12.2 9.9 18.6 12.8 16.4 14.0 14.1 11.6 15.7 16.0 11.7 10.6 19.2 10.3 16.1 12.1 14.3 11.4 23.3 19.5 18.7 16.0 15.8 14.2 15.1 9.2 7.0 23.8 14.8 15.7 19.5 17.9 15.9 21.4 25.3 21.2 14.1 12.0 19.8 7.8 18.7 10.9 12.1 20.7 12.7 31.1 17.6 15.4 38.9 11.0 19.8 16.0 29.7 22.7 20.5 22.1 25.8 25.3 15.6 15.9 15.9 20.9 33.4 16.0 14.7 20.2 19.8 24.3 8.7 13.6 20.7 22.1 18.2 12.7 25.6 32.5 23.6 19.6 12.0 29.8 16.6 7.7 25.8 19.2 20.2 17.7 14.0 13.6 20.3 17.0 25.0 16.0 17.4 21.9 0.1 0.9 1.2 0.9 0.7 1.3 0.8 1.4 0.8 0.9 0.8 1.5 1.1 4.5 0.3 2.0 1.0 1.4 0.5 11.0 11.2 22.7 13.8 10.3 14.2 10.5 11.4 9.0 12.8 10.3 11.4 15.1 24.2 25.6 13.6 60.1 21.1 14.0 26.4 4.8 4.0 19.6 15.4 17.1 22.0 8.6 15.1 9.2 6.2 11.3 27.5 8.4 3.9 9.1 28.5 23.5 25.9 17.0 18.0 15.8 79.2 8.8 11.7 20.7 8.6 27.3 6.3 15.6 7.9 5.0 8.6 8.4 75.3 9.2 2.0 16.1 10.2 5.5 23.9 17.7 12.4 70.3 11.3 14.1 20.6 125.7 99.3 9.3 9.1 23.0 10.7 20.3 6.3 6.7 9.8 15.7 13.1 44.4 25.4 19.3 18.6 7.8 15.6 20.1 25.2 16.3 8.1 23.6 ARHGEF4 "ASEF, KIAA1112, STM6" ENSG00000136002 "Rho guanine nucleotide exchange factor 4" Q9NR80 2 130836914-131047263 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8;skin 1: 40.1" "Cell type enhanced" "Detected in many" "Astrocytes: 333.3;Excitatory neurons: 83.0;Inhibitory neurons: 83.5;Oligodendrocyte precursor cells: 143.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Group enriched" "Detected in many" 12 "dendritic cells: 1.0;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HaCaT: 39.9;hTCEpi: 78.9;REH: 20.3;SCLC-21H: 52.9" HPA018267 Approved NA NA "HPA018267: AB_1845006" "unprognostic (2.30e-3)" "unprognostic (8.84e-2)" "unprognostic (5.32e-2)" "unprognostic (1.18e-2)" "unprognostic (4.44e-1)" "unprognostic (2.60e-2)" "unprognostic (4.69e-2)" "unprognostic (2.14e-2)" "unprognostic (8.97e-2)" "unprognostic (1.29e-1)" "unprognostic (7.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.68e-2)" "prognostic favorable (7.00e-4)" "unprognostic (3.93e-3)" "unprognostic (9.71e-3)" 5.7 5.1 50.6 1.0 50.0 0.0 2.2 31.3 67.8 6.5 22.4 5.0 0.2 2.9 1.7 34.3 8.4 2.9 1.3 61.3 36.6 0.4 0.9 3.1 0.3 45.3 36.1 46.0 7.9 18.0 2.5 15.5 0.2 42.2 5.2 0.8 10.3 5.8 9.4 9.1 40.1 1.4 4.1 35.5 0.2 3.1 5.2 40.9 1.9 6.1 2.6 2.5 4.6 20.1 43.9 4.8 2.0 0.9 16.6 0.1 0.0 0.4 5.3 0.3 0.3 0.2 0.9 1.5 0.0 0.5 2.1 3.6 39.9 2.4 10.5 0.0 0.0 2.2 0.0 7.0 0.0 0.6 0.0 0.1 0.0 78.9 1.2 5.8 0.1 0.1 0.1 0.0 0.0 0.0 2.5 0.0 0.0 5.8 0.7 7.2 20.3 0.2 0.8 3.2 0.1 52.9 7.0 0.8 8.3 0.6 1.6 0.5 0.5 0.0 0.0 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.5 0.0 0.0 0.5 1.4 0.0 0.0 0.0 1.0 0.5 0.1 50.6 50.0 31.3 67.8 61.3 36.6 45.3 36.1 46.0 42.2 35.5 40.9 43.9 0.1 25.6 0.0 333.3 0.0 17.3 1.2 4.8 15.4 18.8 0.9 5.5 3.2 1.5 2.9 0.0 37.5 1.0 2.9 0.3 0.0 0.8 10.9 7.5 1.0 0.5 0.0 2.7 83.0 0.0 0.3 3.5 2.6 5.4 0.0 3.1 0.7 0.4 0.4 28.6 83.5 0.9 0.0 0.6 2.4 8.2 5.0 0.3 5.4 11.2 0.7 3.7 0.0 143.7 28.3 1.5 0.0 10.9 0.0 1.2 0.3 0.9 6.6 13.9 0.0 3.1 1.1 1.1 4.2 17.4 19.9 0.3 0.8 0.4 0.4 0.8 ISCU "hnifU, ISU2, NIFUN" ENSG00000136003 "Iron-sulfur cluster assembly enzyme" Q9H1K1 12 108562582-108569368 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1430.2;Late spermatids: 969.5;Proximal tubular cells: 1315.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006329, HPA038602, HPA057592" Approved Supported Cytosol NA NA Cytosol "CAB006329: AB_425907, HPA038602: AB_2676109, HPA057592: AB_2683478" "unprognostic (1.72e-1)" "prognostic favorable (4.90e-7)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (2.43e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (6.69e-3)" "unprognostic (1.14e-1)" "unprognostic (1.84e-1)" "unprognostic (1.28e-3)" "unprognostic (2.49e-2)" "prognostic favorable (2.73e-7)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-3)" "prognostic favorable (6.12e-4)" 174.2 390.8 182.4 90.6 192.1 99.0 168.2 215.3 221.0 175.7 217.4 192.9 89.6 171.6 150.1 91.9 143.8 107.4 453.6 186.4 228.2 339.7 120.9 139.5 140.0 229.3 193.0 180.8 170.7 107.1 288.5 230.7 112.1 223.9 151.8 113.1 59.4 124.7 198.0 425.8 110.3 143.9 123.3 192.1 165.2 170.6 124.2 193.1 152.9 186.0 384.9 139.5 180.5 134.6 251.4 47.5 113.8 78.9 47.3 277.4 211.6 191.7 92.8 152.2 69.7 65.7 84.9 66.0 47.4 77.9 128.5 74.6 67.5 76.2 106.8 62.5 147.2 82.0 51.8 60.7 190.6 161.5 124.4 59.0 206.6 234.3 75.4 149.3 176.8 107.7 100.7 98.3 148.8 147.8 102.9 98.1 225.4 76.4 70.9 165.7 64.0 52.5 205.3 204.5 134.6 67.4 62.4 67.5 39.7 108.7 98.3 102.2 99.4 92.3 70.3 59.0 56.8 47.8 175.9 207.8 146.3 109.5 91.8 72.4 478.2 182.1 567.9 224.5 200.5 269.2 564.4 292.6 292.7 128.4 516.7 366.2 305.0 554.2 207.5 239.3 225.2 334.2 400.8 182.4 192.1 215.3 221.0 186.4 228.2 229.3 193.0 180.8 223.9 192.1 193.1 251.4 129.8 76.9 158.9 19.9 206.3 98.1 148.6 227.0 98.4 46.2 137.5 212.3 674.1 145.8 148.6 233.6 10.4 453.7 142.2 120.1 1430.2 154.3 433.2 78.1 76.5 140.8 75.0 165.5 52.6 149.8 164.0 165.5 64.2 37.1 116.5 89.1 126.0 112.3 263.0 45.4 53.7 117.6 193.3 140.1 110.2 969.5 202.0 129.9 249.1 23.4 502.4 167.9 163.7 14.6 26.0 141.3 96.3 308.4 299.4 171.8 235.9 1315.1 160.4 45.8 223.5 97.4 158.1 294.5 242.1 92.6 93.1 475.2 153.6 154.2 139.8 177.7 ALDH1L2 "FLJ38508, mtFDH" ENSG00000136010 "Aldehyde dehydrogenase 1 family member L2" Q3SY69 12 105019784-105107643 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "pancreas: 41.0;salivary gland: 13.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 23.1;Inhibitory neurons: 24.0;Oligodendrocyte precursor cells: 25.1;Plasma cells: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 62.8;ASC TERT1: 85.2;fHDF/TERT166: 102.4;HHSteC: 55.6;HSkMC: 69.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039481, HPA059282" Approved Enhanced Mitochondria No No Mitochondria "HPA039481: AB_10795465, HPA059282: AB_2732633" "unprognostic (5.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.76e-1)" "unprognostic (8.86e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-1)" "unprognostic (5.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-8)" "unprognostic (3.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.53e-3)" "unprognostic (2.52e-5)" 3.7 0.6 1.4 3.1 1.2 0.6 2.4 2.3 1.6 5.4 0.6 2.2 2.6 2.0 1.0 1.3 1.5 2.8 1.8 1.3 1.8 0.4 0.2 1.8 1.0 1.5 1.3 0.9 0.6 41.0 0.6 1.3 1.1 1.9 3.7 2.3 0.7 13.1 4.6 0.8 0.8 1.4 4.2 1.8 0.7 3.4 1.1 1.7 0.5 2.1 1.2 1.7 3.4 1.5 2.5 13.0 1.3 0.7 27.3 62.8 85.2 1.6 40.8 26.0 5.2 13.5 1.6 0.0 0.0 1.6 102.4 0.2 0.1 0.1 1.0 6.5 0.0 0.3 0.8 0.1 3.4 55.6 5.3 0.1 69.7 3.1 13.6 25.2 0.0 3.0 0.2 2.1 37.7 10.6 0.0 0.0 0.3 1.6 0.0 0.3 0.0 0.1 4.3 0.0 0.0 9.4 4.5 0.0 8.3 20.5 0.4 6.0 44.0 0.3 3.9 3.8 0.0 2.2 45.5 12.8 0.1 16.2 19.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.2 2.3 1.6 1.3 1.8 1.5 1.3 0.9 1.9 1.8 1.7 2.5 1.4 0.0 0.6 3.3 2.6 0.5 0.1 0.7 0.0 1.7 0.3 1.1 1.6 0.0 0.2 0.0 0.0 0.2 1.5 0.1 0.0 0.3 4.1 0.7 8.5 0.9 0.0 0.0 23.1 9.8 0.6 10.5 1.5 1.6 0.0 0.1 1.1 0.0 0.4 5.0 24.0 0.0 0.0 0.6 1.7 5.9 3.7 1.0 5.4 1.0 4.0 1.3 0.0 25.1 8.5 3.7 0.0 6.8 14.6 0.4 0.0 0.1 0.2 0.8 0.0 3.6 8.4 1.7 0.1 0.0 0.6 0.3 0.9 0.1 0.1 0.2 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766719 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 66.4" "Cell type enriched" "Detected in some" 11 "Hepatic stellate cells: 145.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 11.5;HaCaT: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026871, HPA072699" Enhanced Supported Cytosol NA NA 1200000 Cytosol "HPA026871: AB_1857536, HPA072699: " "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.9 0.2 0.9 0.9 0.6 0.7 0.9 0.2 0.7 1.0 0.0 2.1 0.3 0.9 1.5 0.8 1.3 1.0 0.3 1.2 0.1 0.2 14.8 0.5 3.9 0.4 0.2 0.4 0.6 0.3 0.0 0.3 0.3 0.6 0.4 0.4 0.3 0.4 0.0 0.2 0.3 0.6 0.2 0.2 66.4 0.4 2.2 0.4 0.0 1.1 0.0 0.4 0.8 0.5 0.3 0.2 0.5 0.5 0.1 0.0 0.0 11.5 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.8 0.3 0.7 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.1 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.6 0.2 0.0 0.4 0.6 0.3 0.0 0.8 0.1 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.7 1.2 0.1 0.4 0.2 0.4 0.6 0.2 0.4 0.3 0.2 0.0 0.0 0.7 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.8 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.1 0.0 0.0 4.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 145.6 4.1 0.1 0.0 1.9 0.0 0.0 11.6 0.7 12.2 0.3 0.0 0.0 1.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 USP44 FLJ14528 ENSG00000136014 "Ubiquitin specific peptidase 44" Q9H0E7 12 95516560-95551476 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.4" "Cell type enriched" "Detected in many" 4 "Early spermatids: 482.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.0" "Group enriched" "Detected in some" 4 "cerebellum: 7.0;pons: 2.5" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 6.1" "Group enriched" "Detected in many" 41 "B-cells: 4.6;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HEL: 26.4;JURKAT: 58.4;NTERA-2: 138.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA026543 Approved "Nucleoli fibrillar center,Microtubules" NA NA "Nucleoli fibrillar center, Microtubules" "HPA026543: AB_1858692" "unprognostic (2.12e-2)" "unprognostic (1.14e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-3)" "unprognostic (1.83e-4)" "unprognostic (7.18e-4)" "unprognostic (5.55e-2)" "unprognostic (1.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.97e-2)" "unprognostic (8.12e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-1)" "unprognostic (7.41e-2)" "unprognostic (7.07e-2)" 0.7 0.6 0.6 1.0 0.7 0.3 0.9 7.0 0.9 0.8 0.1 0.9 0.3 1.3 0.7 0.4 1.2 0.8 0.5 0.5 0.8 1.4 0.1 3.9 1.1 0.7 1.1 0.4 0.9 2.4 1.7 1.3 0.1 2.5 0.7 0.4 1.7 1.1 1.6 0.2 0.3 0.9 0.9 0.5 1.6 0.6 24.4 0.5 3.7 1.3 0.3 1.2 0.5 0.5 1.0 0.2 0.4 11.4 0.0 0.1 0.1 0.4 1.1 3.3 1.4 0.5 0.0 0.1 0.1 3.4 0.0 0.0 0.1 0.0 0.0 1.9 0.0 5.8 26.4 0.0 0.0 5.8 10.8 0.5 0.1 0.0 0.8 0.0 0.6 0.6 58.4 4.3 0.0 0.0 0.0 13.9 0.1 138.3 0.0 0.0 0.0 0.0 0.0 2.4 0.8 8.8 5.9 0.0 0.0 0.1 13.2 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.6 0.0 1.0 0.3 0.0 0.0 0.0 1.1 0.0 2.4 4.6 1.7 1.5 0.0 3.7 6.1 4.0 0.1 0.1 0.0 0.0 0.2 1.0 0.6 0.7 7.0 0.9 0.5 0.8 0.7 1.1 0.4 2.5 0.5 0.5 1.0 1.9 12.8 31.0 1.3 5.7 1.0 3.4 0.3 4.6 8.6 1.5 3.2 1.8 0.0 3.8 7.3 6.2 2.8 0.6 0.1 0.0 4.4 482.2 0.9 2.2 2.5 0.0 0.4 5.1 3.1 0.5 3.5 1.1 1.8 0.0 10.6 1.8 0.0 0.1 0.0 16.2 0.0 0.0 0.3 1.0 116.6 5.6 0.8 3.6 1.9 0.6 2.4 1.0 15.6 4.0 0.9 0.1 3.4 1.1 5.0 0.1 1.0 0.3 9.5 6.6 2.9 3.7 77.6 6.7 0.6 0.9 1.1 3.2 2.5 0.1 1.9 SCYL2 "CVAK104, KIAA1360" ENSG00000136021 "SCY1 like pseudokinase 2" Q6P3W7 12 100267140-100341715 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021050 Approved NA NA "HPA021050: AB_1846175" "unprognostic (7.01e-3)" "unprognostic (3.04e-2)" "unprognostic (4.34e-3)" "unprognostic (4.01e-2)" "unprognostic (3.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.27e-2)" "unprognostic (8.19e-2)" "unprognostic (5.32e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-2)" "unprognostic (1.93e-2)" "unprognostic (4.44e-1)" "unprognostic (2.72e-1)" "unprognostic (3.46e-1)" "unprognostic (1.60e-1)" "unprognostic (2.18e-1)" 13.5 13.5 6.8 16.6 8.0 21.7 16.9 10.7 9.5 14.1 8.5 23.1 20.4 14.6 21.1 22.3 11.0 16.3 15.0 7.8 8.4 21.4 28.9 17.4 15.1 6.5 6.5 7.0 8.9 18.0 21.1 13.0 21.2 6.9 17.2 27.2 16.8 15.8 16.1 15.8 13.8 17.2 17.5 7.2 14.8 16.6 14.7 7.6 19.2 15.8 19.2 20.0 21.7 11.6 7.6 37.7 29.0 45.8 37.7 28.8 31.1 43.2 38.0 42.8 34.8 29.6 28.1 19.4 23.4 17.7 46.9 23.7 32.1 36.4 27.8 40.6 36.5 24.2 76.0 18.5 20.3 25.7 36.2 72.8 23.1 42.5 39.5 44.9 41.3 44.4 26.0 40.8 19.7 37.4 29.2 29.2 31.7 28.6 21.7 32.6 23.4 33.6 22.7 31.6 61.1 28.3 25.3 43.0 44.2 36.2 48.2 64.9 27.8 41.7 29.7 17.2 27.8 24.8 22.6 32.1 28.3 14.6 24.6 34.4 12.3 5.2 10.0 4.0 6.5 5.1 3.3 4.2 3.8 6.6 2.3 4.5 4.9 6.7 8.6 5.7 2.0 6.2 4.0 6.8 8.0 10.7 9.5 7.8 8.4 6.5 6.5 7.0 6.9 7.2 7.6 7.6 24.4 16.0 35.2 37.9 20.4 35.9 21.3 17.4 33.0 16.8 29.6 17.1 30.1 7.2 26.8 20.2 27.1 31.3 22.7 44.1 5.9 16.8 8.5 24.4 19.1 24.8 21.7 28.6 50.3 21.7 22.2 20.2 37.8 31.2 27.9 15.1 16.4 37.1 25.1 15.2 54.1 30.6 12.2 34.6 47.4 4.7 13.4 29.2 16.0 44.0 27.5 10.9 17.5 64.3 47.2 24.0 32.1 15.4 22.2 36.8 16.2 26.3 18.3 16.2 0.0 13.1 20.9 24.9 12.0 36.8 34.7 59.4 22.6 19.2 33.6 52.8 CKAP4 "CLIMP-63, ERGIC-63, P63" ENSG00000136026 "Cytoskeleton associated protein 4" Q07065 12 106237881-106304279 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Intestinal goblet cells: 198.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 106.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 106.8" "Cell line enhanced" "Detected in many" "BJ: 549.7;BJ hTERT+: 687.6;fHDF/TERT166: 834.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000278, HPA000792" Enhanced NA NA 560000 "HPA000278: AB_1078527, HPA000792: AB_1078526" "unprognostic (5.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (7.13e-2)" "unprognostic (2.44e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (6.61e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (5.02e-2)" "unprognostic (9.66e-3)" "unprognostic (1.95e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.20e-3)" "unprognostic (6.97e-2)" "unprognostic (1.29e-2)" "unprognostic (3.66e-2)" 26.2 40.3 15.1 35.0 15.4 101.5 22.0 14.6 15.6 49.9 25.4 43.3 19.5 40.9 59.7 71.9 31.5 26.5 40.3 14.3 19.1 18.7 30.7 33.8 10.6 18.2 16.0 14.4 30.9 41.5 26.4 20.4 52.2 17.3 38.0 46.3 19.0 57.9 37.2 14.7 39.5 19.1 47.1 15.9 25.3 52.8 10.0 19.2 7.9 20.0 13.6 23.0 51.8 40.9 18.6 86.8 106.7 126.5 138.3 240.6 212.5 73.2 549.7 687.6 262.7 300.1 45.6 19.4 5.6 98.0 834.0 89.3 153.1 93.5 83.5 187.5 3.0 54.1 0.1 56.5 89.9 179.2 0.4 1.7 205.5 111.9 223.5 159.9 331.9 311.7 6.5 0.6 11.0 253.0 29.1 4.4 3.1 73.8 45.6 127.9 40.1 91.0 7.5 80.5 76.9 41.5 46.0 98.0 65.9 54.4 112.9 73.9 39.3 268.9 205.8 112.2 86.3 157.9 29.0 0.3 60.2 148.5 10.9 184.5 106.8 18.8 22.5 1.1 6.8 1.6 9.5 1.7 1.0 5.8 4.1 2.2 2.0 30.1 0.2 11.3 0.2 0.5 7.1 15.1 15.4 14.6 15.6 14.3 19.1 18.2 16.0 14.4 17.3 15.9 19.2 18.6 17.7 22.4 26.5 9.1 26.3 54.8 37.9 63.2 56.3 11.8 37.6 34.4 43.2 35.8 33.4 23.9 10.4 26.9 2.8 43.0 5.9 37.8 1.1 38.6 103.1 33.8 41.4 1.3 5.8 87.7 107.0 92.9 51.5 139.9 19.1 62.8 43.2 52.3 20.1 47.1 11.2 198.7 16.2 31.8 16.8 2.7 68.3 33.1 33.8 8.4 59.9 23.4 2.1 7.5 1.6 52.4 22.9 61.3 144.5 92.0 3.9 9.2 13.3 23.3 13.1 45.1 52.3 4.9 12.6 122.3 71.9 26.4 6.7 73.3 69.0 46.7 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148577-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 57.0;Macrophages: 62.5;Melanocytes: 96.0;monocytes: 53.8" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.4" "Group enriched" "Detected in all" 4 "granulocytes: 16.4;monocytes: 8.6" "Cell line enhanced" "Detected in many" "HAP1: 33.3;Karpas-707: 25.8;SK-MEL-30: 41.4;U-266/70: 64.3;U-266/84: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066899 Approved Mitochondria NA NA 150000 Mitochondria "HPA066899: AB_2685743" "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.1 8.9 7.9 20.7 8.0 17.5 4.8 10.0 7.0 8.6 4.6 5.8 4.1 7.0 2.7 3.9 4.8 10.3 1.9 7.5 12.3 4.1 2.5 11.5 16.3 4.8 8.6 7.5 15.0 2.4 0.9 4.1 9.5 4.7 2.3 6.6 2.2 2.4 4.6 4.0 8.4 5.6 6.9 6.3 19.9 4.6 15.3 15.4 5.8 3.4 4.1 13.1 9.5 3.9 7.4 1.1 0.4 2.7 0.5 1.5 1.2 0.4 1.3 1.8 1.7 5.1 9.1 0.1 21.8 0.1 2.0 1.6 0.1 33.3 1.4 1.2 15.3 0.7 1.2 0.6 6.1 17.7 4.5 7.2 17.7 0.0 1.9 0.8 2.3 0.0 2.0 0.6 25.8 0.5 0.3 1.0 2.4 5.5 0.2 1.2 3.6 1.0 12.1 0.1 1.7 2.2 1.6 0.3 0.2 41.4 6.3 0.1 3.7 0.7 0.6 2.3 0.2 0.8 64.3 73.3 1.4 0.4 11.7 1.4 0.0 3.6 15.1 1.6 6.1 1.7 2.6 1.7 1.9 2.9 1.7 1.6 1.6 16.4 1.1 8.6 1.1 1.3 2.0 7.9 8.0 10.0 7.0 7.5 12.3 4.8 8.6 7.5 4.7 6.3 15.4 7.4 4.9 3.2 2.4 9.8 17.9 6.1 0.3 0.3 1.2 3.6 3.2 2.5 8.1 1.5 0.2 0.0 0.0 0.2 5.6 1.2 1.9 0.2 9.4 3.2 14.9 4.3 19.8 26.1 36.1 0.5 0.2 16.0 1.1 1.6 16.5 29.8 6.1 1.6 18.8 0.0 57.0 1.8 0.0 39.4 13.8 6.2 1.5 62.5 96.0 40.3 53.8 0.3 3.1 34.2 12.6 0.3 1.8 3.4 24.4 0.2 0.1 3.4 2.3 0.5 6.6 2.8 2.5 3.0 1.1 0.7 1.6 0.1 9.4 4.8 1.9 0.3 APPL2 "DIP13B, FLJ10659" ENSG00000136044 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2" Q8NEU8 12 105173297-105236203 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 171.2;Microglial cells: 112.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 21.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 177.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039688, HPA043925" Approved NA NA 45000 "HPA039688: AB_2676626, HPA043925: AB_2678733" "unprognostic (3.46e-1)" "unprognostic (4.21e-1)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.54e-2)" "unprognostic (2.41e-2)" "unprognostic (6.66e-3)" "unprognostic (8.43e-2)" "unprognostic (5.50e-2)" "unprognostic (5.71e-3)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "prognostic favorable (7.65e-4)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" "unprognostic (9.32e-2)" 30.9 29.5 31.9 18.7 34.2 37.4 35.5 38.7 35.8 31.7 28.9 54.6 39.1 26.5 19.1 23.5 20.9 34.7 16.4 29.7 34.6 20.9 16.2 18.6 22.8 35.2 32.0 26.5 29.1 24.0 23.4 19.8 23.3 34.9 39.2 55.2 33.8 22.3 27.2 14.6 67.1 58.1 22.3 33.5 23.1 32.0 36.9 32.3 20.2 16.3 12.9 17.9 16.7 28.0 38.2 15.5 23.2 37.8 22.9 111.9 80.5 27.6 114.4 110.1 40.0 24.3 27.7 11.8 13.5 21.6 177.9 15.3 18.1 19.2 24.6 49.0 6.8 16.6 7.4 11.4 12.4 18.1 5.5 7.4 42.6 22.9 31.6 35.4 77.4 17.2 18.2 8.4 17.5 90.9 20.9 10.6 17.6 27.8 33.1 33.1 8.3 24.9 25.3 33.4 31.9 25.7 48.1 38.4 17.0 19.3 26.6 28.3 10.1 16.7 61.7 14.8 30.4 19.4 15.9 13.7 9.9 39.6 7.3 34.4 0.2 4.7 10.7 1.6 3.7 1.3 0.4 0.6 0.9 3.2 2.8 0.9 1.4 21.1 4.6 6.2 1.0 2.3 1.7 31.9 34.2 38.7 35.8 29.7 34.6 35.2 32.0 26.5 34.9 33.5 32.3 38.2 16.0 19.2 13.2 95.3 6.1 12.7 13.0 6.5 12.0 30.6 18.0 14.1 13.2 28.6 10.6 11.0 10.4 19.9 12.1 171.2 5.9 24.2 6.8 33.8 23.0 15.7 30.0 2.5 50.2 18.9 19.0 22.8 15.8 20.7 8.2 46.0 16.4 6.5 30.3 10.1 51.8 40.0 12.2 23.3 8.3 8.6 23.6 18.9 16.0 112.4 10.3 39.9 10.3 91.5 75.1 26.4 38.1 21.8 6.0 29.4 101.5 16.6 56.2 16.2 19.7 18.9 13.2 15.6 23.7 14.3 19.0 23.1 8.0 25.0 17.5 14.2 PWP1 IEF-SSP-9502 ENSG00000136045 "PWP1 homolog, endonuclein" Q13610 12 107685799-107713162 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038708 Approved "Nucleoli rim,Golgi apparatus" Yes No "Nucleoli rim" "Golgi apparatus" "HPA038708: AB_2676163" "unprognostic (7.06e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.65e-4)" "prognostic unfavorable (1.40e-5)" "unprognostic (1.97e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.00e-1)" "unprognostic (6.95e-2)" "unprognostic (6.13e-2)" "unprognostic (1.10e-2)" 28.9 21.1 19.2 26.7 20.1 32.2 34.1 20.0 23.8 24.5 28.4 25.0 17.9 30.6 25.0 29.0 24.9 20.6 17.5 19.5 20.6 30.7 32.5 21.6 32.3 18.8 19.0 19.2 33.1 26.0 33.2 18.0 29.8 21.3 25.4 26.2 27.2 24.6 27.8 23.1 28.7 21.9 32.6 18.9 23.9 23.3 30.3 19.6 33.5 26.1 17.8 37.7 31.7 24.7 20.3 71.0 86.9 51.8 49.4 70.9 77.2 68.5 72.9 81.9 100.8 84.8 88.5 32.9 108.8 38.4 112.9 68.4 60.7 70.8 77.0 99.2 54.7 80.6 82.9 50.5 103.2 72.7 101.8 56.9 70.2 69.1 93.5 83.0 79.0 119.8 66.0 110.8 29.8 109.1 78.3 71.6 99.3 62.0 64.8 141.2 58.3 61.2 101.4 62.7 98.3 58.4 46.9 59.6 42.4 104.1 64.8 75.3 49.7 94.9 76.7 38.9 63.0 84.1 42.5 62.8 84.9 34.3 55.3 68.7 29.4 20.8 16.2 41.7 27.8 37.8 68.5 40.6 43.9 35.0 64.1 34.5 47.9 6.6 44.2 34.4 47.3 48.6 29.7 19.2 20.1 20.0 23.8 19.5 20.6 18.8 19.0 19.2 21.3 18.9 19.6 20.3 44.1 41.7 38.1 13.7 80.1 48.4 52.3 70.6 36.5 50.4 41.0 41.3 22.1 25.8 48.9 27.6 37.5 69.1 48.4 14.6 58.7 69.7 24.4 34.5 47.3 52.0 21.0 52.2 15.6 63.0 74.5 51.6 30.5 35.8 57.6 41.5 43.5 52.0 46.2 33.7 19.0 31.9 26.4 34.3 28.0 11.1 50.4 33.2 30.2 4.7 75.2 41.4 38.1 15.1 16.7 68.0 19.8 44.0 46.0 50.2 24.5 70.8 42.8 46.2 26.3 41.8 50.9 124.3 79.2 41.9 49.7 45.7 44.0 45.8 34.1 40.5 DRAM1 "DRAM, FLJ11259" ENSG00000136048 "DNA damage regulated autophagy modulator 1" Q8N682 12 101877580-102012130 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 95.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 321.8;Early spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "BJ hTERT+: 532.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.82e-2)" "unprognostic (1.80e-1)" "unprognostic (7.19e-2)" "prognostic favorable (6.52e-8)" "unprognostic (1.15e-2)" "unprognostic (2.35e-3)" "unprognostic (1.29e-3)" "unprognostic (1.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (6.17e-3)" "unprognostic (5.02e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (3.58e-2)" "unprognostic (2.07e-2)" 14.5 15.6 3.0 19.1 3.7 37.2 11.4 4.8 4.2 9.0 7.9 9.7 7.1 10.2 5.3 10.8 9.5 16.9 8.0 3.2 11.5 23.9 7.9 95.0 18.3 4.4 3.3 3.0 7.4 8.5 6.2 5.9 20.2 3.3 9.2 9.5 4.4 11.2 7.3 4.8 9.1 9.4 12.7 3.2 11.5 15.8 5.0 4.3 9.4 7.5 5.5 10.5 37.5 7.9 5.3 10.6 20.5 7.4 2.3 93.4 21.4 40.4 77.2 532.4 76.2 118.3 6.9 19.8 1.9 8.5 128.2 29.4 15.5 1.9 32.2 104.8 11.3 6.2 2.6 17.5 27.2 43.1 3.0 5.5 25.5 14.0 26.8 28.7 65.1 41.5 2.4 9.5 3.6 20.0 8.3 1.8 9.0 5.1 26.3 4.9 3.4 5.4 1.9 80.9 49.4 1.4 1.6 42.8 4.8 20.5 20.3 14.9 11.7 25.3 53.3 9.5 9.3 14.2 10.7 5.3 1.4 17.9 26.8 14.2 10.2 9.0 6.0 1.6 10.2 2.0 2.7 1.3 1.8 3.1 1.4 0.9 1.1 8.6 3.3 5.8 0.8 1.9 2.8 3.0 3.7 4.8 4.2 3.2 11.5 4.4 3.3 3.0 3.3 3.2 4.3 5.3 17.2 54.5 321.8 4.9 10.7 20.9 21.5 42.4 28.5 1.6 12.8 8.0 4.3 10.0 25.2 29.5 0.0 28.1 5.0 1.3 1.9 11.4 145.0 12.7 30.8 16.5 0.0 11.3 0.5 21.4 30.9 30.5 10.2 15.6 24.1 3.2 10.0 2.0 60.6 0.0 4.7 1.6 14.2 40.5 31.1 80.6 14.0 51.9 8.8 3.7 24.6 3.2 5.2 10.1 0.6 21.7 0.3 10.5 30.9 34.2 0.3 23.4 7.4 0.2 13.1 14.4 9.9 1.2 4.5 3.2 6.1 22.0 6.4 7.3 1.2 22.1 WASHC4 "KIAA1033, SWIP" ENSG00000136051 "WASH complex subunit 4" Q2M389 12 105107324-105169130 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045666, HPA046737" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045666: AB_2679411, HPA046737: AB_2679778" "unprognostic (2.68e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.85e-2)" "unprognostic (2.76e-1)" "unprognostic (1.10e-1)" "unprognostic (4.41e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-2)" "unprognostic (3.14e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (2.96e-1)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" 22.6 21.3 10.2 31.2 14.3 24.0 21.0 14.7 11.9 20.9 13.3 16.3 15.4 20.3 20.1 15.3 13.2 22.8 14.4 9.8 16.0 23.7 30.0 20.4 44.3 18.8 14.6 7.3 23.0 18.5 20.6 8.6 30.8 18.0 19.3 18.6 15.6 16.3 16.0 12.3 31.4 18.5 20.0 15.2 33.2 18.0 12.2 13.8 18.2 22.3 14.3 39.8 17.8 12.7 23.3 24.0 28.2 24.6 18.2 56.3 56.6 29.5 36.5 41.5 41.7 38.0 20.2 13.5 53.4 19.8 61.0 26.5 21.9 21.5 22.3 33.5 19.2 15.3 11.1 25.6 16.8 38.4 30.9 20.5 45.7 25.7 37.3 30.4 45.1 68.7 18.1 22.1 18.6 45.9 12.1 17.1 32.6 30.1 16.8 23.5 32.7 32.8 16.6 55.6 27.5 15.4 19.0 37.7 26.4 37.9 31.0 19.6 32.9 84.1 49.8 13.6 32.1 23.9 23.3 23.9 42.7 35.4 26.1 51.4 21.3 15.1 9.2 3.0 18.4 4.4 16.2 4.7 4.1 11.9 12.9 4.9 4.7 16.7 8.0 34.2 5.8 3.5 6.9 10.2 14.3 14.7 11.9 9.8 16.0 18.8 14.6 7.3 18.0 15.2 13.8 23.3 37.5 35.3 24.3 0.0 25.3 0.0 0.0 0.0 0.0 0.0 16.4 11.0 0.0 0.0 11.8 44.1 0.0 24.1 17.5 0.0 19.6 25.8 0.0 23.8 48.3 18.0 0.0 0.0 0.0 22.1 28.0 14.6 0.0 31.7 26.5 30.7 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 24.2 0.0 0.0 5.2 0.0 0.0 41.8 17.5 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 32.0 8.9 29.1 0.0 0.0 SLC41A2 DKFZP434K0427 ENSG00000136052 "Solute carrier family 41 member 2" Q96JW4 12 104802553-104958744 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 115.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 100.6;Hepatocytes: 51.6;Inhibitory neurons: 93.8;Oligodendrocyte precursor cells: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "myeloid DC: 4.1;plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 15 "dendritic cells: 12.2" "Cell line enhanced" "Detected in many" "HDLM-2: 56.2;SK-BR-3: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038658 Approved NA NA "HPA038658: AB_10671747" "unprognostic (7.19e-2)" "unprognostic (4.38e-3)" "unprognostic (1.94e-2)" "unprognostic (2.38e-1)" "unprognostic (6.06e-3)" "unprognostic (3.05e-2)" "prognostic favorable (9.94e-4)" "unprognostic (1.35e-1)" "unprognostic (3.68e-1)" "unprognostic (3.65e-1)" "unprognostic (4.20e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (1.50e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "unprognostic (5.30e-2)" 8.7 8.8 5.0 8.2 7.1 1.3 10.4 7.5 7.4 9.5 8.5 21.2 31.7 4.6 16.0 2.0 3.2 14.5 1.8 5.0 11.8 8.3 115.9 6.6 4.8 2.7 4.5 7.7 5.3 18.5 8.7 6.3 3.8 4.1 3.3 15.3 1.9 14.3 9.5 0.7 1.4 28.0 8.7 0.5 3.3 37.5 8.5 7.8 2.8 12.2 1.6 4.8 5.6 1.6 4.5 11.6 25.6 0.9 5.3 21.0 15.2 9.9 7.9 12.9 5.4 9.1 16.1 10.8 4.7 8.4 15.8 19.8 1.1 5.7 2.6 10.1 56.2 14.4 0.4 9.6 7.3 4.6 1.8 6.2 5.2 2.1 5.8 1.6 11.7 7.0 3.1 0.3 11.9 0.9 5.3 2.3 0.1 2.4 20.6 8.2 1.0 11.0 11.2 21.5 0.3 10.1 2.6 13.5 44.5 2.2 3.9 17.3 0.1 2.0 8.2 5.8 8.7 9.0 14.1 19.1 6.2 13.0 0.9 5.7 0.2 0.2 0.0 0.1 0.1 0.8 0.5 0.1 0.1 4.1 0.2 0.3 0.1 0.2 0.3 0.0 12.2 0.1 0.3 5.0 7.1 7.5 7.4 5.0 11.8 2.7 4.5 7.7 4.1 0.5 7.8 4.5 3.8 19.2 9.6 16.6 4.5 2.4 3.2 1.8 1.8 2.6 6.3 2.3 0.8 25.8 6.5 7.3 0.0 1.7 4.4 34.0 0.0 27.9 29.5 6.4 2.5 2.5 1.2 0.0 100.6 38.5 19.7 12.3 29.0 16.7 0.0 0.4 1.8 51.6 5.3 5.0 93.8 9.8 2.0 2.9 33.2 5.9 2.1 8.5 0.0 10.3 18.7 1.8 1.0 55.3 5.2 29.9 9.2 6.4 6.9 4.9 37.0 7.4 3.1 0.1 0.0 4.7 4.8 6.4 4.3 0.2 2.3 9.0 2.2 0.5 11.8 4.9 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 62.5;stomach 1: 98.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.0;OE19: 78.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 5.3 3.7 8.0 11.1 8.2 12.7 6.5 6.4 10.7 8.9 6.2 47.3 62.5 5.8 1.6 7.3 6.8 15.8 5.5 8.2 7.4 5.3 1.4 7.8 9.9 8.2 8.2 7.4 6.9 3.5 1.2 5.2 4.1 7.5 16.2 26.9 1.2 5.8 4.1 1.3 9.1 62.2 4.2 7.4 11.9 98.4 5.4 7.5 10.3 7.5 1.4 6.4 17.7 7.5 7.0 8.2 0.1 0.2 0.4 2.8 2.2 0.8 2.3 1.9 2.3 2.2 6.1 25.0 3.9 3.5 1.6 0.0 1.9 1.8 0.2 0.5 0.8 0.0 7.3 0.1 0.6 3.4 7.7 9.5 3.3 2.2 2.2 0.0 0.0 4.5 16.1 7.3 2.3 2.6 0.1 12.4 8.7 0.2 78.4 0.0 4.8 0.0 2.0 0.8 9.8 0.1 0.3 0.0 0.5 1.8 0.0 0.7 12.4 2.8 1.0 0.3 3.0 0.0 1.4 3.1 1.2 0.6 10.9 5.0 0.0 3.2 0.0 6.8 2.0 7.4 3.5 4.4 3.9 2.1 4.6 5.6 4.2 0.1 3.4 1.4 3.8 5.8 4.1 8.0 8.2 6.4 10.7 8.2 7.4 8.2 8.2 7.4 7.5 7.4 7.5 7.0 4.9 9.6 7.4 10.4 7.2 2.3 5.7 25.5 6.8 0.9 3.3 2.9 1.9 8.6 46.1 0.0 0.0 3.0 13.3 221.7 0.0 3.4 6.2 1.5 2.7 4.5 9.6 6.1 5.5 16.9 3.4 6.7 192.7 1.5 8.2 6.1 5.3 0.3 2.4 1.7 3.0 64.4 14.2 1.9 2.4 19.9 3.7 4.0 1.8 3.7 4.2 28.1 7.2 2.5 1.2 38.7 139.0 2.6 4.4 6.2 165.6 1.6 40.5 0.8 0.0 4.3 7.1 5.4 3.4 3.1 1.4 1.0 8.1 5.6 50.5 33.4 FLNB "ABP-278, FH1, FLN1L, LRS1, TABP, TAP" ENSG00000136068 "Filamin B" O75369 3 58008400-58172251 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Differentiation, Myogenesis" "Actin-binding, Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 17.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 523.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004747, HPA004886, CAB019322" Enhanced Supported "Golgi apparatus,Plasma membrane,Actin filaments,Cytosol" NA NA 20000000 "Plasma membrane" "Golgi apparatus, Actin filaments, Cytosol" "CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600" "unprognostic (1.29e-2)" "unprognostic (1.08e-2)" "unprognostic (5.97e-2)" "unprognostic (6.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.05e-1)" "unprognostic (6.52e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (8.45e-5)" "unprognostic (9.23e-2)" "prognostic favorable (3.45e-6)" "unprognostic (4.38e-2)" "unprognostic (1.36e-1)" "unprognostic (6.65e-3)" "unprognostic (2.33e-1)" 71.2 63.6 49.8 22.5 54.1 7.5 91.2 55.7 51.0 44.7 61.7 107.1 53.3 76.2 121.3 58.2 76.5 19.8 39.4 44.5 54.0 78.6 72.0 50.3 24.6 63.1 55.5 40.7 69.5 83.9 60.4 38.4 48.4 56.1 125.4 75.1 10.3 64.5 51.9 16.5 91.8 93.5 36.5 54.6 55.7 70.8 30.6 55.1 75.4 91.8 17.9 24.0 115.7 59.1 62.5 134.4 225.0 22.3 32.9 14.8 25.0 385.7 49.0 39.3 106.6 108.4 227.1 223.1 21.9 18.1 172.9 172.8 215.9 42.1 311.5 103.0 121.6 20.8 18.4 192.7 110.5 107.8 16.2 63.1 40.2 132.1 148.5 448.3 125.2 365.4 94.7 30.9 6.6 67.0 29.2 49.3 38.5 34.5 146.6 192.1 21.6 5.8 18.7 143.8 224.6 24.7 23.1 247.3 132.6 27.4 160.9 110.3 44.6 523.3 27.8 84.5 334.1 175.6 4.8 1.7 17.0 102.2 29.2 29.9 10.1 0.3 5.0 0.5 0.8 2.7 4.1 1.7 0.8 1.4 1.6 5.1 3.8 0.2 7.3 1.5 17.9 2.0 1.5 49.8 54.1 55.7 51.0 44.5 54.0 63.1 55.5 40.7 56.1 54.6 55.1 62.5 133.7 51.3 30.2 3.9 11.0 50.6 42.9 73.2 29.0 3.3 86.6 43.4 10.0 57.2 62.0 47.8 39.6 28.7 36.8 344.9 0.0 93.8 15.6 103.6 24.4 92.9 49.2 10.3 34.1 67.1 207.1 28.8 88.7 133.8 24.7 34.4 151.3 52.0 14.6 1.7 34.3 82.8 38.7 11.3 12.2 22.4 16.1 11.1 5.4 22.5 11.6 9.1 2.1 25.1 40.9 385.7 161.0 27.8 3.4 115.2 157.3 6.5 76.1 10.6 0.0 4.4 25.9 4.4 6.9 46.4 51.7 49.8 9.9 84.6 93.0 88.4 NEK3 "HSPK36, MGC29949" ENSG00000136098 "NIMA related kinase 3" P51956 13 52132639-52159861 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 87.0;Spermatocytes: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019062, HPA043230" Enhanced Approved Microtubules NA NA Microtubules "HPA019062: AB_2670037, HPA043230: AB_2678374" "unprognostic (8.97e-2)" "unprognostic (2.54e-2)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (2.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.71e-1)" "unprognostic (2.31e-1)" "unprognostic (1.31e-1)" "unprognostic (4.30e-3)" "unprognostic (1.16e-3)" "unprognostic (1.70e-2)" "unprognostic (1.17e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (4.15e-2)" "unprognostic (5.34e-2)" 10.7 3.9 14.2 6.3 19.2 8.7 10.7 13.6 22.0 10.2 13.0 16.4 9.4 10.0 6.9 4.2 8.8 7.4 7.7 14.3 16.6 9.3 7.3 9.1 5.1 18.8 19.2 11.8 8.3 8.4 3.8 5.2 17.5 20.7 8.3 17.0 4.7 7.0 5.1 6.0 7.2 12.8 8.6 13.9 8.1 6.7 18.3 17.0 3.2 6.4 3.3 5.4 8.4 7.4 28.0 0.3 2.7 20.2 11.4 6.2 10.8 0.3 6.5 6.2 7.6 8.3 8.6 11.1 0.0 0.4 8.4 6.3 1.5 0.4 4.8 4.8 15.1 11.8 1.9 2.7 23.0 7.6 19.4 10.9 7.2 9.5 4.2 17.6 5.6 13.5 1.0 3.1 7.1 9.0 5.1 1.1 23.4 19.7 4.4 0.5 0.5 1.7 7.6 11.4 1.9 2.2 14.0 2.9 6.4 12.8 19.6 2.5 26.3 12.2 1.0 5.9 6.0 6.7 7.5 2.5 13.1 1.8 6.8 10.8 7.1 6.3 5.1 1.6 5.8 1.0 3.6 1.9 1.0 6.7 1.9 1.4 0.4 0.4 1.6 1.2 5.8 2.9 1.4 14.2 19.2 13.6 22.0 14.3 16.6 18.8 19.2 11.8 20.7 13.9 17.0 28.0 28.8 6.4 6.5 9.1 5.9 2.8 4.4 2.8 5.7 3.9 5.5 6.7 7.7 5.7 5.8 7.3 0.0 13.0 8.3 20.1 13.7 7.9 11.5 9.8 14.0 22.7 6.0 3.4 0.6 17.3 14.4 8.7 10.2 11.0 10.1 11.6 18.2 7.4 19.1 3.3 3.4 13.7 6.1 12.4 8.1 4.6 7.2 10.4 12.4 18.7 25.4 3.0 7.2 9.0 87.0 15.6 17.9 6.8 6.0 3.3 22.4 6.8 7.1 5.8 0.0 7.1 9.0 49.7 25.5 3.5 3.4 4.8 4.0 3.9 20.1 5.2 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 26.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.0 0.0 6.4 0.0 13.9 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 6.2 0.0 0.0 0.0 0.0 2.3 3.4 10.5 0.0 0.0 0.0 1.4 0.0 2.7 1.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.9 1.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.9 0.0 21.3 26.2 6.2 2.3 3.4 10.5 2.7 1.6 0.8 1.1 0.1 0.0 0.0 5.9 0.0 0.1 2.1 0.0 0.0 18.2 0.4 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.6 0.0 0.1 0.0 0.0 24.8 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 18.6 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 3.7 0.0 25.8 0.0 2.5 2.2 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.4 0.1 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.1 VPS36 "C13orf9, CGI-145, Eap45" ENSG00000136100 "Vacuolar protein sorting 36 homolog" Q86VN1 13 52412602-52450634 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039734, HPA043947" Approved Supported "Vesicles,Lysosomes,Plasma membrane,Cell Junctions" NA NA "Vesicles, Lysosomes" "Plasma membrane, Cell Junctions" "HPA039734: AB_2676652, HPA043947: AB_2678744" "unprognostic (2.43e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-1)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-1)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" "unprognostic (3.96e-3)" "unprognostic (1.19e-2)" "unprognostic (9.37e-2)" "unprognostic (5.57e-2)" "prognostic favorable (9.91e-6)" "unprognostic (6.47e-3)" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (9.83e-2)" 17.2 15.3 12.1 16.9 12.9 8.6 26.4 15.4 17.6 18.5 11.0 24.7 27.9 18.8 12.3 23.9 16.9 16.8 24.2 12.9 11.4 25.6 23.8 20.1 19.6 13.7 12.8 11.4 18.0 18.0 23.5 11.1 25.2 14.3 22.0 27.7 43.4 25.4 18.5 23.6 51.6 28.0 20.8 11.3 24.3 18.3 4.1 13.2 22.5 22.7 26.4 20.9 19.0 21.5 14.3 7.3 11.8 20.4 13.5 21.1 29.3 17.8 16.7 12.5 16.1 9.6 14.3 22.9 25.5 8.6 23.8 10.6 20.1 16.6 19.7 18.0 19.3 16.0 30.2 18.7 12.8 25.3 40.2 31.4 20.5 37.9 11.2 18.0 18.0 16.6 33.6 22.7 21.8 31.8 9.6 30.4 40.6 19.5 29.0 6.3 31.0 11.9 15.9 28.7 18.9 10.4 22.0 11.9 27.3 25.9 24.0 15.9 67.1 26.3 10.3 12.6 10.3 19.1 16.3 22.0 26.8 10.6 28.4 24.7 15.6 14.6 12.3 12.3 16.3 19.8 15.3 13.5 15.4 15.6 13.0 12.2 13.1 3.6 21.6 22.7 16.3 16.0 13.7 12.1 12.9 15.4 17.6 12.9 11.4 13.7 12.8 11.4 14.3 11.3 13.2 14.3 54.2 83.3 51.5 41.1 49.9 42.8 48.9 57.6 62.0 132.2 51.6 72.8 80.8 38.6 47.7 33.1 120.9 60.2 83.4 62.6 68.4 35.4 1.2 28.0 45.9 55.7 49.8 31.1 57.0 29.3 43.0 46.6 36.7 37.0 44.3 44.9 38.2 54.0 43.8 52.2 54.6 64.1 40.7 44.0 29.1 3.7 49.7 47.1 28.4 36.5 60.8 39.8 59.8 44.7 40.7 29.8 63.0 52.3 55.0 65.4 77.4 78.5 33.2 265.8 46.0 52.7 76.1 15.3 25.9 83.5 58.2 38.2 48.2 40.6 58.6 45.4 RNASEH2B "AGS2, DLEU8, FLJ11712" ENSG00000136104 "Ribonuclease H2 subunit B" Q5TBB1 13 50909747-51024120 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 133.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 351.0;NB-4: 259.8;REH: 286.0;THP-1: 258.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040084, HPA041469" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040084: AB_10697714, HPA041469: AB_2677496" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (2.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-1)" "unprognostic (8.33e-2)" "unprognostic (2.79e-2)" "unprognostic (2.50e-2)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (2.54e-8)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" 17.9 14.9 14.7 28.9 14.8 58.9 19.7 16.1 16.0 16.1 11.0 22.6 16.8 19.0 14.2 17.8 25.1 17.3 25.4 13.3 13.2 14.9 15.2 20.6 46.0 13.7 13.4 12.6 21.4 25.9 17.2 8.4 19.7 14.1 19.4 22.2 4.7 20.3 21.8 24.0 13.6 20.0 27.1 14.2 26.5 19.3 17.4 15.3 133.8 27.7 6.0 38.7 23.1 9.5 16.3 41.1 33.1 17.6 37.5 22.9 45.9 41.7 28.6 32.4 40.6 34.0 43.1 61.2 114.4 17.8 29.4 38.4 38.2 55.8 26.1 48.4 42.2 47.1 102.7 22.4 25.4 31.2 191.2 66.0 17.9 33.4 35.9 31.8 36.8 36.3 238.0 58.7 52.7 55.4 19.2 351.0 259.8 57.9 87.2 25.7 286.0 51.4 77.7 30.6 23.6 38.8 56.8 34.4 12.6 38.0 22.8 19.7 258.7 25.6 36.0 30.1 42.7 64.3 69.8 50.3 135.6 9.5 140.6 43.1 3.5 37.5 17.8 31.6 43.3 35.7 104.2 61.9 51.4 55.1 86.4 54.4 51.9 6.1 38.0 38.3 94.0 107.5 54.1 14.7 14.8 16.1 16.0 13.3 13.2 13.7 13.4 12.6 14.1 14.2 15.3 16.3 21.2 38.5 23.8 17.6 85.8 18.7 30.5 43.7 22.2 14.1 31.1 35.8 47.4 18.6 27.4 16.5 6.2 40.7 92.3 9.7 29.4 41.7 74.0 30.1 33.2 14.9 12.1 107.7 31.1 50.5 55.7 26.7 13.7 18.2 52.6 62.0 16.4 15.1 97.3 1.7 35.4 21.8 24.4 59.0 22.0 38.2 27.7 50.4 16.0 45.0 86.4 11.7 45.3 44.2 59.5 24.7 9.9 29.7 75.6 34.5 12.1 28.4 37.3 6.2 13.1 21.8 28.9 91.4 44.3 26.9 21.0 17.9 56.5 36.9 35.4 29.3 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA008410, HPA027821" Enhanced Enhanced "Microtubules,Mitotic spindle,Centrosome" Yes Yes "Microtubules, Mitotic spindle" Centrosome "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavorable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 6.0 6.5 3.4 10.0 3.8 68.4 5.7 10.9 5.2 3.0 1.4 9.0 12.2 5.2 4.4 10.5 3.5 4.1 6.1 3.6 4.3 5.2 4.1 5.3 19.6 4.3 4.1 2.9 3.2 1.5 4.4 4.6 10.7 5.3 5.6 9.6 7.7 4.6 4.3 2.9 14.0 9.5 8.6 3.6 9.5 5.5 32.8 3.8 34.0 6.3 3.4 20.3 7.2 5.0 5.8 77.6 40.0 155.7 76.4 19.7 19.5 39.6 124.7 70.7 137.4 87.2 59.7 92.3 142.5 19.3 89.2 65.7 86.2 107.6 61.7 188.8 103.0 90.4 129.8 42.6 41.4 8.6 129.7 50.4 14.5 24.6 64.5 83.3 41.2 84.0 62.0 55.3 58.1 152.8 36.0 91.2 64.8 92.2 116.6 42.4 86.2 88.6 62.6 42.1 40.9 47.6 62.4 68.9 49.0 37.1 78.7 54.4 61.7 56.7 38.7 60.9 62.0 124.1 33.4 56.3 173.9 27.3 67.3 105.7 86.0 14.1 22.0 10.3 21.0 9.3 25.3 15.7 12.8 15.8 33.0 12.0 10.4 4.3 5.8 28.7 32.8 33.6 10.0 3.4 3.8 10.9 5.2 3.6 4.3 4.3 4.1 2.9 5.3 3.6 3.8 5.8 6.7 6.4 2.8 5.2 41.2 15.0 4.5 32.8 22.2 13.1 11.2 13.2 10.8 2.8 11.4 1.8 6.2 44.3 30.9 7.5 9.8 4.9 41.3 19.4 16.1 12.7 7.2 122.9 10.3 6.0 38.1 12.1 10.7 10.1 16.5 88.6 17.5 5.5 31.8 1.7 12.4 13.6 20.3 24.5 13.7 51.7 7.5 18.5 0.0 6.5 22.9 12.9 5.2 3.5 2.0 2.6 4.6 17.0 30.8 3.7 6.3 9.4 3.7 6.6 6.6 7.6 12.1 151.7 87.5 41.3 15.3 10.0 27.1 29.6 17.9 3.9 CNMD "BRICD3, CHM-I, CHM1, LECT1, MYETS1" ENSG00000136110 Chondromodulin O75829 13 52703264-52739820 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.8;retina: 8.4;salivary gland: 6.8" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 35 "NTERA-2: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010510 Uncertain "Secreted to extracellular matrix" NA NA 9500 "HPA010510: AB_10602021" "unprognostic (7.52e-3)" "unprognostic (1.34e-1)" "unprognostic (7.36e-2)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (3.22e-1)" "unprognostic (2.84e-2)" "unprognostic (2.63e-2)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-1)" 0.0 0.0 1.7 0.0 4.8 0.0 0.0 2.1 2.5 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 2.3 0.0 0.0 1.6 0.0 2.3 2.2 1.7 0.0 0.3 0.0 1.0 0.1 2.5 0.5 0.0 8.4 6.8 0.0 0.1 0.0 0.1 0.0 2.5 0.3 0.0 1.8 2.3 0.1 3.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 4.8 2.1 2.5 1.8 2.3 2.3 2.2 1.7 2.5 2.5 2.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TBC1D4 "AS160, DKFZp779C0666, KIAA0603" ENSG00000136111 "TBC1 domain family member 4" O60343 13 75283503-75482169 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "GTPase activation" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.5" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 157.7;Microglial cells: 307.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 25.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 84.7;HUVEC TERT2: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040145, HPA059885" Approved Supported Cytosol NA NA Cytosol "HPA040145: AB_2676860, HPA059885: AB_2684152" "unprognostic (5.44e-3)" "unprognostic (5.23e-1)" "unprognostic (9.85e-2)" "unprognostic (1.39e-1)" "unprognostic (2.78e-2)" "unprognostic (9.54e-3)" "unprognostic (1.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.87e-1)" "unprognostic (5.02e-2)" "unprognostic (7.53e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.07e-11)" "unprognostic (6.40e-2)" "unprognostic (3.16e-1)" "unprognostic (8.88e-2)" "unprognostic (3.45e-1)" 14.9 71.2 15.7 15.9 11.7 3.4 20.3 12.9 15.4 9.8 8.2 8.8 4.6 8.6 18.6 9.5 10.8 14.2 30.9 10.8 13.9 25.4 11.8 12.0 34.5 14.8 12.4 8.3 45.2 15.1 22.3 5.3 20.9 17.1 12.4 10.5 1.6 27.9 4.3 83.5 21.6 10.4 10.3 11.5 21.2 11.1 5.3 18.5 10.8 24.5 55.4 32.9 8.5 9.3 13.4 12.9 14.9 9.2 0.6 21.3 22.8 12.0 11.0 5.8 8.7 9.6 84.7 15.5 2.7 2.4 15.7 4.2 12.0 23.4 11.0 9.0 42.6 24.3 41.5 19.8 25.9 5.4 20.0 0.5 25.0 19.7 9.7 22.4 14.9 61.6 46.0 12.0 1.3 10.0 6.2 29.4 3.6 12.9 24.7 8.8 26.4 8.7 15.2 8.5 9.3 16.9 5.2 4.8 14.6 8.0 4.8 5.0 0.7 26.2 9.8 12.1 5.2 13.0 0.7 0.1 0.3 17.4 18.5 14.7 5.0 0.4 0.0 0.7 0.1 0.0 0.6 11.2 2.5 0.6 0.5 10.4 4.9 0.5 0.5 0.1 9.9 25.0 2.3 15.7 11.7 12.9 15.4 10.8 13.9 14.8 12.4 8.3 17.1 11.5 18.5 13.4 17.8 6.4 29.1 32.3 2.6 36.2 10.0 2.0 19.9 1.6 33.1 41.1 81.4 10.0 6.1 14.7 0.0 10.8 32.4 8.0 15.6 12.3 25.5 14.3 17.7 32.6 21.0 5.0 78.0 7.4 9.7 17.3 7.1 8.7 5.1 81.5 26.0 19.4 26.6 1.7 157.7 10.7 24.4 24.8 25.8 5.2 3.7 12.9 21.4 307.3 33.6 0.4 1.0 40.7 5.1 4.9 2.9 7.2 2.1 16.4 3.4 10.8 3.9 0.6 6.6 24.8 21.6 2.4 7.7 24.2 44.2 4.9 25.2 8.1 15.5 10.6 THSD1 TMTSP ENSG00000136114 "Thrombospondin type 1 domain containing 1" Q9NS62 13 52377167-52416373 "Disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 22.0;Astrocytes: 25.5;Basal respiratory cells: 16.5;Endothelial cells: 29.9;Hepatic stellate cells: 17.2;Microglial cells: 17.8;Spermatocytes: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 19.9;HBEC3-KT: 19.9;hTCEpi: 19.0;hTERT-HME1: 19.5;HUVEC TERT2: 40.6;LHCN-M2: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012611, CAB020796" Uncertain Supported Cytosol "Intracellular and membrane" No No 1400000 Cytosol "CAB020796: , HPA012611: AB_1857990" "unprognostic (1.21e-1)" "unprognostic (7.54e-3)" "unprognostic (3.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-1)" "unprognostic (6.10e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-3)" "unprognostic (8.44e-2)" "unprognostic (1.31e-1)" "unprognostic (3.35e-2)" "unprognostic (4.90e-2)" 8.4 2.0 7.5 1.0 6.7 0.2 8.8 5.2 8.6 5.1 4.5 2.7 0.7 5.2 2.8 3.1 5.1 3.3 7.0 7.9 5.4 2.5 2.2 11.6 2.1 5.6 5.2 6.9 2.1 1.4 1.4 3.5 11.4 5.8 4.2 1.4 6.9 3.9 2.0 4.6 6.3 2.7 4.8 5.1 5.9 2.1 2.1 5.5 1.4 5.0 10.5 1.6 3.9 4.5 6.3 0.9 3.9 0.5 3.5 3.1 10.3 0.8 8.4 4.1 3.2 5.1 0.1 0.7 0.3 1.0 19.9 3.1 4.4 0.0 19.9 4.9 9.3 2.9 0.5 0.0 0.0 1.9 2.1 0.6 4.1 19.0 15.4 19.5 1.8 40.6 1.2 0.0 0.3 18.6 0.0 0.7 0.4 0.3 0.2 0.9 0.6 4.3 0.0 4.5 0.2 0.1 0.7 0.2 0.1 0.8 0.2 0.4 0.3 9.6 1.0 1.7 0.0 6.3 0.6 0.1 0.1 1.8 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 6.7 5.2 8.6 7.9 5.4 5.6 5.2 6.9 5.8 5.1 5.5 6.3 22.0 0.0 1.1 25.5 0.9 1.5 1.1 16.5 0.6 8.0 1.5 3.0 3.1 0.0 1.8 1.8 2.1 5.4 3.6 0.3 3.9 0.3 1.4 0.8 1.0 29.9 0.0 0.0 3.5 0.6 1.8 6.4 1.1 0.7 0.0 1.5 17.2 2.0 3.1 0.0 3.1 0.3 0.0 1.6 1.6 0.6 3.4 0.6 5.4 17.8 0.4 1.2 1.0 3.0 0.9 0.4 0.2 3.8 0.6 1.8 0.4 0.8 1.3 3.2 6.6 4.4 2.3 18.5 10.1 1.0 1.6 3.4 0.9 0.6 0.3 0.4 BORA "C13orf34, FLJ22624" ENSG00000136122 "BORA aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 13.5;Sertoli cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 1.6 1.3 1.3 4.3 1.4 6.0 2.4 1.5 1.7 1.5 2.0 4.3 4.4 1.3 1.5 3.5 1.4 1.4 1.0 1.3 1.5 1.4 1.8 1.8 7.6 1.8 1.4 1.1 1.2 1.7 0.5 1.9 2.3 1.6 1.8 5.0 3.5 2.0 1.0 1.1 4.2 3.5 1.7 1.3 4.2 3.3 4.0 1.4 8.2 1.9 0.9 6.8 2.2 2.3 1.6 32.5 8.5 19.6 14.7 2.4 2.4 11.6 9.8 8.6 17.9 18.1 20.6 17.2 23.8 6.4 6.4 10.3 15.0 17.1 11.5 22.1 20.9 12.3 28.7 11.4 15.8 1.7 54.2 17.1 1.9 2.6 8.9 15.1 5.0 14.6 22.8 12.7 10.7 14.6 9.8 20.8 21.8 10.8 36.8 6.0 16.4 12.3 10.6 6.5 10.0 6.9 7.0 12.0 12.8 10.2 15.0 6.4 24.6 4.8 5.8 9.7 8.3 16.3 6.9 7.0 14.8 16.3 24.8 13.9 1.3 1.1 0.5 1.9 1.9 2.3 1.6 1.8 2.0 1.9 1.9 1.6 2.5 0.1 1.8 1.2 1.4 1.9 1.1 1.3 1.4 1.5 1.7 1.3 1.5 1.8 1.4 1.1 1.6 1.3 1.4 1.6 1.6 3.2 2.8 3.6 5.4 0.6 1.3 2.2 3.4 1.7 1.4 1.3 0.3 1.5 2.1 1.8 2.1 7.5 3.9 3.1 0.0 1.9 12.6 2.2 2.3 1.4 0.0 13.5 4.3 2.6 11.5 1.7 3.6 2.4 1.3 5.1 1.8 0.4 4.6 8.4 3.1 2.7 0.0 2.8 1.5 2.7 0.9 2.8 0.0 3.7 3.5 1.1 4.1 2.5 7.3 1.7 2.2 1.2 5.2 1.2 3.2 0.8 2.7 2.3 13.1 1.6 1.5 11.8 4.3 3.4 1.1 2.9 4.1 1.5 5.8 1.4 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 89.2;Inhibitory neurons: 117.6;Microglial cells: 183.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 14.8 5.1 5.4 10.8 4.7 9.0 14.7 35.7 6.2 16.1 5.2 12.7 8.0 16.4 7.7 10.1 11.9 12.7 8.4 5.7 6.0 15.0 12.3 13.9 16.4 6.3 8.3 3.5 10.2 5.6 5.5 5.9 18.4 17.1 10.8 10.1 10.3 10.1 12.1 4.0 16.9 11.7 17.7 7.5 14.7 13.1 4.7 6.8 18.7 6.6 7.5 15.8 13.7 9.8 8.1 7.4 10.4 9.2 9.6 6.6 12.5 23.6 12.4 16.1 15.0 14.2 23.5 12.3 23.4 3.4 11.7 9.8 10.4 7.1 12.5 21.6 24.2 6.6 21.0 4.3 11.1 8.2 13.8 34.5 7.9 9.7 13.9 16.8 12.3 13.1 15.6 4.2 6.9 11.2 14.2 14.8 17.3 5.2 46.3 5.5 8.0 10.0 6.3 28.1 7.5 14.5 14.6 7.0 6.8 18.8 16.2 5.3 18.3 12.5 8.8 6.0 11.0 11.9 1.3 3.7 10.6 10.3 11.9 10.8 0.6 0.9 0.9 1.5 0.7 0.8 2.2 1.1 1.0 0.8 2.7 0.8 0.9 0.3 2.5 0.5 1.0 0.8 0.9 5.4 4.7 35.7 6.2 5.7 6.0 6.3 8.3 3.5 17.1 7.5 6.8 8.1 61.5 6.4 6.1 24.8 26.7 37.5 10.5 6.2 27.3 8.3 12.0 11.8 7.2 17.2 6.5 22.0 22.9 13.4 8.4 6.8 9.8 8.3 1.6 5.4 6.5 32.5 1.8 9.9 89.2 4.2 12.7 14.3 18.8 13.7 27.9 2.8 17.5 9.3 13.4 3.3 117.6 10.6 8.2 16.9 30.7 2.1 13.1 12.3 30.2 183.6 8.4 5.5 8.2 64.8 9.7 13.5 5.5 17.0 12.4 12.9 8.0 8.4 2.6 8.5 13.1 15.6 18.6 1.7 4.1 15.9 33.2 9.7 14.7 15.3 7.8 9.2 SUCLA2 LINC00444 ENSG00000136143 "Succinate-CoA ligase ADP-forming subunit beta" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 234.3;tongue: 274.3" "Cell type enhanced" "Detected in all" "Early spermatids: 256.2;Late spermatids: 314.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria NA NA Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.22e-4)" 54.3 41.0 31.6 20.3 34.3 13.7 39.1 39.0 40.7 32.7 35.4 37.4 58.7 27.5 25.0 33.4 24.9 20.4 101.1 33.4 40.9 78.2 29.3 18.3 22.2 33.8 34.6 32.0 31.2 25.6 71.9 20.5 28.3 35.4 36.1 36.7 44.6 34.2 31.6 234.3 20.5 45.1 33.4 34.1 20.0 29.9 18.0 37.1 31.0 36.8 274.3 24.1 26.3 25.6 40.0 44.9 49.5 60.6 37.1 68.4 51.3 38.9 64.8 72.4 66.9 44.5 91.3 47.9 61.3 49.3 63.9 39.9 60.0 81.9 61.9 81.6 59.8 75.9 69.2 45.8 58.0 47.6 69.9 38.9 48.4 71.2 45.3 52.6 54.4 49.0 70.7 47.7 21.1 65.8 31.4 73.1 80.8 64.4 150.2 64.7 60.9 55.4 49.3 94.4 41.9 34.7 41.2 54.5 49.3 39.1 66.5 43.8 60.8 39.0 36.2 24.1 53.0 45.7 23.0 37.4 72.7 22.8 50.9 54.8 12.6 50.2 27.8 34.4 53.7 41.9 34.6 38.0 42.2 62.5 33.1 47.7 47.5 8.8 51.8 46.1 49.8 46.6 36.5 31.6 34.3 39.0 40.7 33.4 40.9 33.8 34.6 32.0 35.4 34.1 37.1 40.0 20.8 25.6 16.8 17.6 20.1 32.4 37.7 57.5 21.1 44.8 28.9 26.5 148.8 17.2 40.2 31.3 12.5 48.7 18.1 29.1 164.4 32.3 256.2 50.9 32.0 22.0 19.2 21.0 37.0 17.8 42.7 37.7 19.9 52.6 33.7 25.2 16.1 14.7 29.9 45.4 39.0 19.5 71.2 16.7 20.4 314.2 37.0 21.7 42.7 21.5 24.9 43.3 13.4 26.2 38.2 20.2 30.6 46.3 22.1 35.9 62.3 127.4 29.9 42.4 39.5 33.3 50.0 36.3 29.0 22.8 31.7 52.1 19.7 47.3 30.4 39.0 RCBTB1 "CLLD7, CLLL7, FLJ10716" ENSG00000136144 "RCC1 and BTB domain containing protein 1" Q8NDN9 13 49531946-49585558 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Cone photoreceptor cells: 64.6;Oligodendrocyte precursor cells: 75.4;Oligodendrocytes: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056783 Approved Nucleoplasm NA NA Nucleoplasm "HPA056783: AB_2683234" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (1.49e-1)" "unprognostic (5.70e-2)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (7.52e-2)" "prognostic favorable (5.51e-5)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.17e-3)" "unprognostic (1.52e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.29e-1)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (5.49e-2)" 11.0 22.9 26.1 9.9 31.3 14.5 13.3 28.8 29.7 9.3 23.4 6.9 6.5 16.9 20.3 5.7 13.2 9.9 16.4 24.2 32.3 19.2 9.0 13.4 14.9 30.4 30.3 22.1 7.7 11.4 49.0 14.6 13.2 29.5 11.3 8.7 50.0 8.0 19.3 7.8 8.4 8.1 14.8 30.0 15.0 10.8 9.3 29.3 19.7 44.6 16.1 11.4 9.6 6.8 33.5 5.7 12.9 27.8 25.3 36.2 31.4 16.2 21.2 21.0 15.7 16.1 10.9 14.0 19.3 4.6 17.5 13.6 7.9 20.8 32.6 26.9 28.5 16.2 23.1 10.7 28.1 43.5 18.6 17.6 28.1 19.6 13.1 20.8 20.7 27.7 37.3 10.4 8.2 31.9 5.3 27.1 10.8 29.0 19.1 7.8 34.8 20.9 12.3 19.6 15.3 14.6 19.4 10.8 8.2 21.7 23.4 11.0 13.3 19.7 11.8 9.5 24.8 10.5 8.4 10.9 31.1 10.5 18.3 16.9 17.1 6.0 6.4 2.7 7.4 3.3 4.5 4.5 2.2 7.6 2.8 2.8 2.7 3.0 2.8 8.9 1.0 9.1 3.5 26.1 31.3 28.8 29.7 24.2 32.3 30.4 30.3 22.1 29.5 30.0 29.3 33.5 6.9 44.8 10.8 11.8 6.7 3.7 2.5 2.8 20.5 10.2 7.4 4.4 18.9 8.6 9.3 1.8 64.6 3.0 5.3 1.5 7.9 7.4 0.4 6.3 16.3 10.4 16.2 8.0 13.0 5.0 3.5 4.7 3.6 5.8 2.5 12.1 6.4 7.8 8.8 10.1 13.9 2.9 2.0 14.1 5.5 0.7 3.4 9.0 8.8 23.4 8.3 6.0 3.1 75.4 76.8 5.0 0.7 5.7 6.3 3.5 0.7 12.8 10.3 37.7 39.5 3.1 10.2 1.9 6.0 2.3 2.4 1.1 6.4 35.4 2.1 2.3 MED4 "DRIP36, HSPC126, TRAP36, VDRIP" ENSG00000136146 "Mediator complex subunit 4" Q9NPJ6 13 48053323-48095131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006232 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006232: AB_1079351" "unprognostic (1.10e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-1)" "unprognostic (2.80e-1)" "unprognostic (5.79e-1)" "unprognostic (2.56e-2)" "unprognostic (4.09e-1)" "unprognostic (7.97e-2)" "unprognostic (7.34e-3)" "unprognostic (3.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-3)" "unprognostic (6.54e-3)" "unprognostic (1.94e-2)" "unprognostic (1.84e-1)" 44.6 34.4 29.2 34.3 29.0 79.3 47.2 36.3 35.4 37.5 27.8 41.7 41.0 40.7 43.8 41.4 31.5 33.2 49.9 28.6 29.6 38.8 51.8 37.2 47.1 28.3 28.6 27.6 32.2 27.6 43.6 31.7 45.9 29.8 37.1 46.8 41.7 33.8 38.8 58.3 39.8 41.5 43.5 28.3 36.2 34.2 56.4 28.8 64.3 41.5 59.0 56.0 43.8 36.1 31.1 40.2 25.8 86.1 47.8 55.8 71.4 59.5 57.1 70.9 66.8 47.1 49.3 66.9 65.2 16.0 60.5 41.3 59.6 63.1 54.2 86.7 85.0 51.9 85.6 49.5 77.6 51.7 128.1 76.4 49.6 75.2 39.7 58.2 65.2 63.1 64.8 61.9 40.7 75.5 40.6 121.3 121.4 85.4 128.2 33.5 87.4 58.3 52.9 87.0 61.7 38.0 61.2 46.5 57.8 63.4 55.5 49.3 94.6 51.1 37.5 43.4 47.0 52.7 39.2 61.7 100.2 32.2 65.9 72.6 105.0 65.5 106.3 74.6 70.0 82.6 65.4 84.2 76.6 64.5 58.0 80.4 77.0 69.8 86.6 74.3 58.5 101.6 91.2 29.2 29.0 36.3 35.4 28.6 29.6 28.3 28.6 27.6 29.8 28.3 28.8 31.1 71.3 96.1 53.4 12.7 71.1 91.3 72.8 164.9 34.7 51.5 48.1 42.9 100.8 60.1 116.5 57.0 16.7 116.4 96.0 51.7 152.6 79.4 87.9 46.4 69.8 73.8 26.9 106.9 24.7 63.4 104.4 74.1 31.6 60.5 98.1 43.9 59.3 66.8 70.3 37.0 20.1 51.2 124.1 51.9 65.4 185.6 76.7 51.2 78.2 14.0 136.6 65.2 102.0 20.1 20.4 66.8 67.4 77.5 46.5 69.7 66.1 100.1 62.8 50.2 52.6 58.7 78.7 141.4 162.8 48.6 97.3 134.9 79.4 61.1 56.9 71.5 PHF11 "BCAP, IGER, NY-REN-34" ENSG00000136147 "PHD finger protein 11" Q9UIL8 13 49495610-49528981 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA016566 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA016566: AB_2669387" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.98e-6)" "unprognostic (3.49e-3)" "unprognostic (6.29e-2)" "unprognostic (5.50e-2)" "unprognostic (6.91e-2)" "unprognostic (3.05e-2)" "unprognostic (1.64e-1)" "unprognostic (2.37e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (4.46e-7)" "unprognostic (9.81e-2)" "unprognostic (5.36e-3)" "unprognostic (1.05e-1)" "prognostic favorable (3.46e-4)" 28.1 39.8 17.0 33.7 18.5 37.4 32.6 18.1 23.7 27.7 19.2 26.1 25.6 24.2 28.7 23.4 23.2 26.6 20.9 16.5 21.1 26.4 22.5 29.1 43.8 20.4 18.4 15.1 22.8 25.3 16.7 16.2 24.1 20.2 26.5 22.2 9.2 40.0 24.9 13.5 27.4 27.9 27.5 18.9 39.6 29.1 13.5 18.7 31.9 34.7 11.4 39.7 28.6 27.6 22.6 12.0 4.9 1.7 0.0 23.5 44.4 14.7 28.5 32.5 40.0 42.1 0.0 28.3 29.2 7.7 32.1 26.5 8.2 10.4 9.8 23.6 59.2 8.8 14.5 9.5 12.8 29.1 10.5 21.5 27.0 15.4 16.2 9.0 16.4 26.0 23.6 3.1 12.4 30.3 9.8 33.7 24.8 5.6 7.8 3.3 32.2 0.0 8.9 36.5 21.8 1.0 0.2 7.6 15.9 0.4 2.1 9.3 23.6 23.2 9.7 3.8 14.0 8.2 8.9 4.9 18.1 20.0 14.9 14.9 26.3 42.4 31.0 42.3 54.1 49.1 40.7 53.6 50.6 39.9 35.0 43.1 48.5 51.3 30.0 51.4 34.8 78.0 42.6 17.0 18.5 18.1 23.7 16.5 21.1 20.4 18.4 15.1 20.2 18.9 18.7 22.6 48.0 16.0 28.7 15.7 48.2 22.6 35.1 41.0 29.0 4.4 26.8 25.4 19.5 27.1 40.3 36.8 0.0 26.1 54.6 15.2 35.2 41.1 35.9 38.3 48.9 35.0 4.2 18.5 11.1 42.3 46.4 32.6 23.0 34.9 24.0 30.3 31.1 22.3 41.9 11.8 11.7 15.6 26.4 40.9 31.5 56.3 32.0 46.6 12.4 27.2 66.8 17.0 58.7 16.1 23.9 38.5 8.5 31.6 35.7 35.4 21.4 29.2 63.4 5.0 46.0 26.5 28.7 24.2 6.0 27.1 20.2 21.1 60.4 23.1 15.8 35.8 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536701 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: AB_2732585" "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 10.7 15.2 7.5 9.4 8.2 11.9 15.8 10.8 9.4 14.9 10.7 16.4 12.7 13.2 16.9 12.5 12.3 9.5 12.0 7.9 8.1 12.4 29.8 10.5 10.8 7.4 7.5 7.8 15.3 21.0 12.4 15.1 13.1 8.1 18.9 19.1 10.1 18.2 12.5 11.5 13.2 13.3 12.2 6.9 12.5 14.8 9.8 8.1 12.3 17.2 9.8 11.0 12.8 13.2 9.9 8.3 7.4 13.9 12.6 17.9 20.4 13.2 13.5 19.1 15.4 12.8 10.8 14.9 11.3 5.9 16.2 11.4 17.7 11.6 13.7 23.3 8.9 9.3 12.7 9.2 19.2 22.1 18.8 11.7 15.4 20.3 10.3 36.1 18.6 15.2 11.0 8.3 6.8 18.7 12.9 10.5 17.6 11.4 41.5 8.7 12.1 8.1 10.6 14.4 13.4 6.9 12.5 8.7 17.1 18.2 13.1 11.7 19.3 14.4 7.4 5.7 13.9 8.7 9.4 5.4 11.7 14.2 9.4 13.5 3.5 1.9 3.6 3.4 2.2 3.6 2.2 2.6 2.9 1.4 2.3 2.9 2.7 1.7 2.5 1.3 3.4 3.0 1.7 7.5 8.2 10.8 9.4 7.9 8.1 7.4 7.5 7.8 8.1 6.9 8.1 9.9 15.8 9.6 31.4 23.2 18.9 15.8 15.2 13.1 14.2 9.7 22.0 17.9 19.7 24.3 19.8 12.9 14.6 14.2 35.5 32.5 15.6 11.6 24.1 15.0 20.1 16.7 22.2 11.4 39.3 37.9 18.8 14.3 26.0 30.8 17.1 22.4 18.9 72.8 10.8 10.1 34.7 54.5 6.1 20.9 9.0 9.0 14.0 13.3 10.6 22.5 13.2 7.6 15.5 34.2 36.9 22.7 32.8 13.5 31.3 26.6 29.4 17.3 11.7 11.2 6.6 12.8 11.7 12.7 8.9 17.7 16.1 32.8 21.2 21.7 24.4 37.3 LMO7 "FBX20, FBXO20, KIAA0858" ENSG00000136153 "LIM domain 7" Q8WWI1 13 75620434-75859870 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 251.2" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 1682.7;Urothelial cells: 435.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 13.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 343.4;fHDF/TERT166: 568.2;LHCN-M2: 525.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 20.8;basal ganglia: 32.8;cerebral cortex: 26.6;hippocampal formation: 33.8" "HPA020923, HPA050184" Enhanced Supported "Actin filaments,Cytosol" NA NA 8200 "Actin filaments" Cytosol "HPA020923: AB_1852963, HPA050184: AB_2681045" "unprognostic (2.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.57e-2)" "unprognostic (1.97e-1)" "unprognostic (1.52e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.14e-1)" "prognostic favorable (7.75e-12)" "unprognostic (2.49e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (8.33e-2)" 4.0 5.4 8.7 10.7 17.6 4.2 9.4 0.0 25.7 11.5 4.6 47.8 66.9 5.7 12.2 155.2 14.6 43.7 251.2 13.8 4.2 44.5 62.5 180.2 11.1 3.4 1.1 10.5 18.8 25.7 11.9 6.5 41.7 7.6 27.5 32.8 4.9 32.7 15.2 144.9 21.0 80.4 8.0 0.0 5.1 63.2 18.4 2.7 57.4 54.0 100.4 37.4 24.8 38.7 15.9 77.8 43.6 1.7 1.3 86.5 61.4 14.9 343.4 168.3 85.4 91.6 107.4 97.8 6.6 25.7 568.2 21.2 73.5 18.9 16.6 97.8 105.4 4.5 47.8 229.2 102.2 25.0 15.3 24.0 42.0 31.1 37.0 42.3 207.9 36.2 14.7 1.7 0.5 525.9 30.4 11.6 6.4 2.2 119.6 65.0 7.2 159.5 1.6 36.0 18.1 5.4 11.6 62.2 10.8 13.8 8.6 14.0 11.3 55.6 208.7 38.7 25.4 84.9 22.6 18.4 27.8 61.6 17.0 97.0 4.5 0.2 2.7 0.6 0.5 0.9 1.1 3.2 1.0 0.4 2.3 13.6 8.6 0.1 0.6 0.4 1.1 1.4 2.6 8.7 17.6 0.0 25.7 13.8 4.2 3.4 1.1 10.5 7.6 0.0 2.7 15.9 1.5 1682.7 279.7 22.2 4.3 24.0 74.7 59.9 72.8 6.8 10.5 13.2 362.6 51.5 317.2 62.5 2.1 45.5 3.6 378.5 15.6 81.5 6.2 92.0 19.0 9.0 71.2 3.6 162.3 37.8 8.7 38.0 276.3 244.4 20.3 9.5 6.1 72.7 6.0 6.7 82.5 96.6 67.1 3.5 4.4 8.0 42.0 6.4 16.0 39.4 2.8 1.9 3.1 30.7 48.4 228.8 351.2 42.5 2.1 344.9 213.8 15.5 199.5 10.5 13.1 27.2 18.1 11.2 6.3 100.9 45.3 17.0 12.9 2.5 75.2 435.7 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 388.6;skin 1: 305.2;vagina: 122.6" "Cell type enriched" "Detected in many" 12 "Alveolar cells type 1: 679.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 17.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (1.73e-5)" 1.7 0.1 0.0 0.1 0.1 0.1 19.7 0.1 0.1 33.5 0.0 1.2 0.0 0.1 0.1 388.6 0.4 0.1 0.1 0.0 0.0 0.4 0.1 60.4 0.0 0.1 0.2 0.0 0.2 0.2 0.3 0.5 0.8 0.2 0.1 2.0 0.1 58.3 0.0 1.5 305.2 0.1 0.0 0.0 0.0 0.6 2.4 0.1 0.5 2.2 0.0 77.4 0.1 122.6 0.2 16.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 1.8 0.0 0.0 54.6 0.0 25.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 74.2 14.9 0.0 0.0 0.0 107.2 0.0 2.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.2 0.1 679.5 31.6 0.0 0.0 10.7 0.1 12.9 0.0 0.0 0.0 0.0 0.2 0.0 49.7 0.0 0.0 0.3 0.0 0.7 0.0 3.2 6.6 0.7 0.1 0.2 0.0 0.0 0.2 0.2 0.0 2.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 7.8 8.2 0.0 1.1 20.9 0.0 0.3 1.8 0.0 0.0 1.6 0.0 1.0 1.7 45.5 0.2 0.0 0.0 0.1 0.0 0.1 7.1 0.0 0.0 0.0 1.2 7.9 5.0 48.8 55.8 0.1 0.3 0.8 0.1 2.7 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48232612-48270357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Amyloidosis, Deafness, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4375.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 4375.2" "Cell line enhanced" "Detected in all" "HMC-1: 731.2;RPTEC TERT1: 1718.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 5800000 "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: AB_2686480" "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favorable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 514.7 370.9 336.9 174.1 340.6 126.7 327.1 375.4 493.4 419.6 450.3 262.6 291.8 392.5 1182.1 403.1 308.1 259.8 342.4 361.6 473.0 1318.4 394.4 379.4 238.7 378.7 356.7 280.4 511.7 181.1 235.7 292.8 578.6 350.9 315.2 193.3 175.9 412.0 389.8 166.3 391.4 289.8 234.5 415.0 439.0 315.6 122.4 384.5 190.0 389.7 208.0 189.0 307.9 405.6 449.5 67.6 51.8 73.1 116.3 348.5 254.5 119.2 215.0 202.2 87.5 100.6 29.1 248.3 16.6 168.8 121.6 48.5 214.1 61.3 107.0 107.4 69.9 147.3 137.9 29.0 99.0 138.5 140.6 731.2 113.4 149.1 45.1 62.0 375.7 131.2 78.3 24.5 90.9 174.8 29.6 200.4 310.1 266.0 116.5 103.6 100.1 100.5 73.6 1718.9 268.6 26.2 119.5 154.5 110.2 111.0 306.0 74.0 119.4 180.5 62.9 73.8 95.7 85.4 72.9 59.6 2.5 78.0 75.3 155.3 3091.4 864.5 2737.9 387.4 661.3 512.5 235.3 523.1 476.4 428.9 245.3 551.3 466.8 4375.2 356.5 692.7 196.2 563.4 1723.5 336.9 340.6 375.4 493.4 361.6 473.0 378.7 356.7 280.4 350.9 415.0 384.5 449.5 1380.0 695.5 300.4 174.6 408.6 862.4 1661.1 2606.2 1006.2 653.1 460.1 573.5 384.8 722.0 1121.9 1991.8 187.7 1164.3 448.2 754.2 545.9 910.2 23.6 751.8 802.2 1166.2 283.3 307.0 114.2 682.9 2362.8 1334.0 302.8 1177.2 578.0 421.2 1319.7 557.3 2117.8 353.3 142.6 503.2 1129.1 1569.8 900.6 76.7 1867.0 1381.5 681.3 252.0 1415.7 1634.9 425.3 174.4 237.9 515.7 788.3 2011.6 445.4 922.5 1259.3 2748.9 795.6 219.4 1222.7 602.4 1022.9 143.6 256.4 1384.6 1149.6 1471.5 723.2 665.5 440.9 1613.4 SPRY2 hSPRY2 ENSG00000136158 "Sprouty RTK signaling antagonist 2" O43597 13 80335976-80341126 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 267.9;SK-MEL-30: 156.9;WM-115: 136.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037205, HPA042198" Approved Supported "Actin filaments,Microtubules" NA NA "Actin filaments, Microtubules" "CAB037205: AB_261923, HPA042198: AB_2677896" "unprognostic (9.37e-3)" "unprognostic (3.71e-2)" "unprognostic (1.10e-1)" "unprognostic (9.12e-3)" "unprognostic (3.80e-2)" "unprognostic (8.99e-2)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.53e-1)" "unprognostic (4.28e-2)" "unprognostic (1.56e-2)" "unprognostic (9.89e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.86e-2)" 69.7 24.4 37.7 11.9 37.7 29.8 66.7 54.1 43.0 29.7 27.9 38.6 17.8 29.6 15.4 20.2 47.1 30.3 45.6 38.5 62.7 17.7 28.1 31.8 9.0 50.4 41.1 35.5 17.0 27.6 10.3 17.4 14.0 40.8 26.4 27.5 34.5 35.1 19.1 39.4 26.3 25.7 23.7 42.8 31.1 26.1 4.1 39.4 11.4 27.4 41.8 4.9 27.2 31.1 44.7 1.8 7.6 84.2 267.9 108.4 70.6 5.8 69.3 31.1 15.3 18.2 34.9 10.3 0.0 11.6 28.5 10.6 6.7 4.8 13.9 17.0 0.1 15.3 12.0 4.5 8.9 24.9 63.4 4.8 31.8 14.6 26.1 63.3 95.6 29.9 13.0 4.4 0.3 35.0 1.5 8.6 28.8 33.7 23.6 19.6 25.6 112.0 0.2 28.8 11.7 1.0 46.7 5.7 3.1 156.9 32.9 6.3 56.0 44.3 14.3 5.6 30.3 13.6 0.1 0.1 0.0 97.6 23.9 136.9 0.0 0.0 2.1 0.3 0.0 0.1 0.4 0.0 0.8 0.9 0.0 0.0 0.1 0.0 4.1 0.0 0.1 0.0 0.1 37.7 37.7 54.1 43.0 38.5 62.7 50.4 41.1 35.5 40.8 42.8 39.4 44.7 48.5 25.6 29.3 59.4 2.9 43.5 38.0 12.5 53.5 5.9 12.4 21.3 20.5 18.6 6.3 1.8 6.2 8.7 12.1 33.4 5.9 11.3 0.3 25.2 17.6 22.3 12.0 8.4 22.1 8.0 2.9 65.9 11.2 41.7 16.4 7.2 32.5 17.0 10.9 8.4 15.3 36.1 4.1 27.3 10.7 1.5 29.5 12.2 14.2 15.9 0.8 68.5 3.1 39.7 17.6 18.0 33.7 5.7 1.7 23.1 7.2 8.3 4.8 23.3 26.3 57.7 67.6 0.1 1.5 16.2 29.1 9.6 11.1 8.5 27.6 11.9 NUDT15 "FLJ10956, MTH2" ENSG00000136159 "Nudix hydrolase 15" Q9NV35 13 48037726-48047221 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038968, HPA038969" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA038968: AB_10697402, HPA038969: AB_2676295" "unprognostic (9.48e-2)" "unprognostic (5.91e-3)" "unprognostic (2.64e-2)" "unprognostic (9.00e-3)" "unprognostic (4.99e-2)" "unprognostic (2.50e-3)" "unprognostic (2.29e-2)" "unprognostic (7.47e-3)" "prognostic unfavorable (1.25e-5)" "unprognostic (1.04e-1)" "unprognostic (8.50e-2)" "unprognostic (3.69e-1)" "unprognostic (4.63e-2)" "unprognostic (1.84e-3)" "unprognostic (3.35e-1)" "unprognostic (9.58e-2)" "unprognostic (8.93e-3)" 12.3 13.1 7.5 10.2 7.5 18.1 16.6 8.8 8.8 13.0 7.1 20.3 20.9 9.8 14.0 16.4 11.7 9.1 11.1 7.2 8.9 17.3 14.2 9.2 7.6 7.6 7.7 7.1 8.6 9.5 8.3 9.5 12.8 8.2 15.3 22.3 10.4 12.2 10.1 12.0 8.8 16.5 10.6 7.1 5.5 13.1 10.8 7.8 10.8 13.5 18.8 10.4 13.0 10.4 8.6 47.5 28.4 52.4 23.1 21.2 30.3 37.8 37.7 35.8 41.3 39.7 42.1 45.2 34.6 20.7 30.3 36.7 54.3 51.3 56.1 63.4 18.3 41.8 34.1 28.0 46.2 19.8 52.0 31.2 20.9 35.3 33.3 46.7 18.4 45.3 34.5 30.7 13.5 67.2 23.2 40.5 48.4 83.0 72.8 32.2 27.6 33.8 22.7 46.2 35.8 31.4 33.1 25.6 43.8 30.3 44.7 22.5 38.7 23.0 28.5 34.7 36.2 53.3 6.9 12.5 43.6 14.8 40.1 47.4 1.6 4.8 3.5 2.9 6.9 2.9 3.1 4.6 3.6 4.9 2.6 5.3 5.8 1.0 2.8 4.8 3.7 3.4 2.7 7.5 7.5 8.8 8.8 7.2 8.9 7.6 7.7 7.1 8.2 7.1 7.8 8.6 12.0 12.8 15.7 0.7 14.7 16.6 34.6 18.1 19.9 9.2 14.0 11.6 12.5 12.8 20.7 7.3 2.1 36.2 12.6 30.4 49.0 17.3 16.7 45.7 20.4 15.1 8.4 10.5 3.9 17.6 79.4 12.8 18.3 39.5 9.5 8.7 7.5 17.4 16.8 38.7 3.1 23.5 26.4 7.8 10.5 9.3 16.8 11.4 10.6 1.9 10.3 10.8 6.2 0.5 3.0 16.4 18.3 12.4 16.8 41.9 18.9 40.8 13.6 9.0 0.0 9.5 17.1 8.9 34.4 34.9 20.5 38.0 13.2 15.3 31.9 42.0 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease variant, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 124.0;placenta: 128.9" "Cell type enhanced" "Detected in many" "Adipocytes: 120.5;Astrocytes: 126.3;Hepatic stellate cells: 112.5;Melanocytes: 110.3;Muller glia cells: 116.2;Sertoli cells: 216.9;Skeletal myocytes: 81.3;Smooth muscle cells: 102.1" "Cancer enhanced" "Detected in all" "melanoma: 127.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 68.0;ASC diff: 50.5;SK-MEL-30: 66.0;U-266/70: 40.7;WM-115: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 54.7 41.6 34.9 19.7 47.1 0.9 40.1 48.8 26.7 16.0 7.3 13.1 20.2 13.2 3.7 8.3 14.2 15.0 27.8 28.6 124.0 33.3 51.3 51.6 10.5 71.3 58.6 22.2 4.8 11.5 15.4 9.6 128.9 52.9 25.6 13.3 18.1 27.2 7.0 11.4 12.1 22.1 13.0 90.4 16.9 10.7 2.3 60.5 4.1 32.1 19.0 4.7 23.8 15.6 82.3 5.7 0.0 68.0 0.0 50.5 2.0 1.0 0.0 0.1 0.0 0.0 25.9 0.0 0.0 2.6 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 3.5 0.0 0.2 13.2 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.2 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.1 0.5 0.1 0.0 66.0 8.9 0.0 0.3 0.3 0.6 0.1 0.0 0.4 40.7 24.9 0.1 1.2 0.0 131.8 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 34.9 47.1 48.8 26.7 28.6 124.0 71.3 58.6 22.2 52.9 90.4 60.5 82.3 120.5 12.8 51.0 126.3 0.2 14.8 1.0 0.0 1.2 5.8 1.2 2.8 10.8 0.0 2.5 0.0 6.2 14.7 0.3 0.1 0.0 0.0 2.9 2.9 20.7 73.3 0.0 0.0 1.3 0.0 13.9 51.1 1.1 35.9 6.3 2.1 112.5 1.1 13.4 0.0 1.6 0.0 0.0 18.7 10.6 2.2 79.9 5.2 110.3 6.5 0.1 116.2 0.0 48.2 0.9 0.1 0.0 2.6 0.1 2.6 0.0 0.1 1.5 4.4 216.9 81.3 102.1 0.4 2.1 0.2 7.2 5.7 1.6 2.5 0.0 1.5 RCBTB2 CHC1L ENSG00000136161 "RCC1 and BTB domain containing protein 2" O95199 13 48488963-48533256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "MOLT-4: 278.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040242 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040242: AB_10795362" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (8.47e-2)" "unprognostic (9.47e-3)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-1)" "unprognostic (5.40e-3)" "unprognostic (8.28e-3)" "unprognostic (1.20e-1)" "unprognostic (4.85e-2)" "unprognostic (3.60e-1)" "prognostic favorable (2.45e-4)" "unprognostic (1.06e-2)" "unprognostic (8.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.98e-1)" 13.0 11.2 10.5 13.0 11.6 5.2 10.8 12.1 14.1 15.7 17.2 8.2 5.3 15.1 12.4 13.1 13.1 12.4 12.1 10.0 18.8 16.8 9.5 10.6 11.4 12.4 12.2 9.2 20.1 6.9 6.7 13.5 17.8 12.7 13.6 8.1 8.4 23.5 20.1 7.0 5.5 7.3 13.8 13.9 17.6 8.9 7.2 12.0 11.9 27.7 10.9 10.8 11.6 12.5 15.3 1.5 1.2 22.0 1.4 17.1 15.1 0.0 6.8 8.4 4.0 3.0 0.8 1.4 4.7 5.0 10.7 2.7 3.1 3.2 2.8 4.6 5.7 4.3 12.2 3.2 1.2 6.6 5.6 7.4 15.6 6.5 5.3 2.6 9.2 12.3 29.8 0.9 7.1 14.6 0.5 278.7 15.6 12.3 0.5 3.7 23.9 2.2 20.3 7.5 3.7 5.1 4.3 5.3 1.1 8.7 9.1 0.5 14.2 10.3 4.6 2.0 1.2 2.7 0.3 0.4 5.7 2.7 12.5 9.1 4.6 39.8 4.6 14.0 28.8 8.7 1.1 11.4 14.2 27.1 1.1 6.6 10.2 55.0 15.5 27.9 0.5 15.5 20.5 10.5 11.6 12.1 14.1 10.0 18.8 12.4 12.2 9.2 12.7 13.9 12.0 15.3 23.1 3.2 3.3 9.1 5.5 6.1 11.6 9.5 21.1 1.9 4.9 9.3 16.1 4.3 9.8 5.5 2.1 1.4 20.7 1.3 7.9 1.2 9.0 5.1 6.6 19.7 8.3 6.1 12.3 0.8 1.4 11.6 2.6 5.0 8.8 9.9 24.7 5.2 25.0 1.7 17.0 2.2 2.0 26.6 24.4 8.1 9.3 30.6 8.8 66.5 38.3 33.7 24.7 6.6 13.2 1.3 1.6 14.3 17.4 6.0 0.7 11.2 6.9 4.9 13.1 14.9 14.1 9.6 4.4 12.6 5.7 1.0 24.0 11.9 2.4 6.7 LCP1 "CP64, L-PLASTIN, LC64P, PLS2" ENSG00000136167 "Lymphocyte cytosolic protein 1" P13796 13 46125920-46211871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 715.5;epididymis: 406.3;lymphoid tissue: 610.0" "Cell type enhanced" "Detected in many" "dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019493, CAB020673" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 1800000000 "Plasma membrane, Cytosol" "Actin filaments" "CAB020673: , HPA019493: AB_1855457" "unprognostic (2.79e-2)" "unprognostic (8.20e-3)" "unprognostic (1.19e-2)" "unprognostic (3.95e-3)" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (2.70e-1)" "unprognostic (4.99e-2)" "unprognostic (6.70e-3)" "unprognostic (2.54e-1)" "unprognostic (5.47e-2)" "unprognostic (3.63e-1)" "unprognostic (3.32e-3)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (7.50e-2)" "unprognostic (2.92e-1)" 86.7 31.4 11.0 400.5 13.1 715.5 44.4 13.6 27.3 28.7 25.2 55.2 42.7 27.6 406.3 29.7 21.7 77.1 14.7 11.2 22.7 13.3 89.7 175.3 568.1 19.5 16.8 9.1 10.1 12.3 12.7 4.3 67.7 20.0 186.1 71.9 5.0 44.8 24.5 7.2 40.9 62.8 60.9 26.1 378.4 53.7 33.5 20.4 504.4 23.8 18.0 610.0 134.3 7.8 22.9 36.1 0.2 1.9 0.0 0.0 0.0 409.8 0.1 1.2 3.9 2.9 237.4 1.4 875.8 179.5 0.0 249.1 1.7 0.1 0.6 3.9 799.3 202.9 187.6 0.4 1.1 0.9 850.7 861.7 2.3 0.1 1.4 1.2 0.3 0.0 792.7 100.4 569.7 0.0 2.8 624.8 789.2 1.0 0.4 8.2 451.6 1.6 638.2 0.0 233.8 2.8 7.5 1.9 91.8 6.4 25.0 6.4 840.5 3.1 22.0 13.6 1.5 25.5 135.3 292.5 1105.7 17.0 530.9 3.6 1007.3 1559.5 810.8 915.7 1806.2 822.0 342.3 539.6 761.2 1134.5 251.6 330.2 560.5 1908.6 650.6 1826.1 297.5 598.1 3644.2 11.0 13.1 13.6 27.3 11.2 22.7 19.5 16.8 9.1 20.0 26.1 20.4 22.9 7.4 32.1 73.2 0.3 185.2 12.0 1.2 0.0 1.8 0.4 10.3 11.7 4.2 5.7 18.0 3.7 0.0 9.8 438.4 0.2 0.0 16.9 113.1 4.7 42.8 9.6 1.2 63.9 0.5 16.3 68.3 10.9 19.9 7.0 309.1 0.7 12.5 24.0 264.4 0.0 0.5 0.5 0.0 401.2 337.6 290.9 1.2 466.1 23.2 17.8 535.7 23.7 471.7 0.5 1.5 6.8 2.4 1.9 102.4 42.0 0.1 1.5 13.8 1.2 0.0 3.1 6.2 2.7 1.6 2.2 11.8 13.5 375.3 0.5 0.4 4.0 SETDB2 "C13orf4, CLLD8, CLLL8, KMT1F" ENSG00000136169 "SET domain bifurcated histone lysine methyltransferase 2" Q96T68 13 49444374-49495003 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012190, HPA071677" Approved Approved Nucleoplasm No No Nucleoplasm "CAB012190: AB_2186195, HPA071677: AB_2686430" "unprognostic (1.77e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-2)" "unprognostic (4.20e-1)" "unprognostic (3.70e-3)" "unprognostic (3.74e-2)" "unprognostic (3.44e-3)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.09e-3)" "unprognostic (7.95e-2)" "prognostic favorable (1.92e-7)" "unprognostic (2.83e-2)" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" 5.3 9.0 4.3 10.5 4.9 8.3 11.2 6.0 5.8 7.5 6.4 7.6 6.4 9.1 6.1 6.0 6.4 7.8 10.6 4.7 4.4 8.2 8.0 8.2 16.9 3.8 4.2 4.0 16.2 7.2 7.9 3.9 6.4 4.1 7.7 9.4 9.6 8.3 6.9 2.6 7.8 7.2 7.6 4.0 13.2 8.1 15.4 5.1 10.2 11.2 5.4 14.0 6.5 4.8 5.8 3.0 2.0 6.0 6.2 8.3 9.3 3.0 8.4 10.5 7.4 6.9 12.5 7.1 37.1 1.6 5.5 5.5 6.0 6.4 5.7 7.2 8.5 5.6 12.9 5.7 7.6 11.7 19.9 7.1 7.3 10.2 5.6 18.5 8.0 6.3 11.8 5.7 5.0 6.8 2.6 7.6 14.8 3.2 7.9 4.8 14.6 7.5 8.0 6.8 2.8 3.1 3.5 3.7 5.2 18.2 5.1 4.4 17.0 3.8 7.0 2.5 9.4 3.4 6.1 8.9 19.4 2.2 15.9 3.3 3.0 2.7 3.3 4.2 3.6 3.6 5.4 4.4 4.4 4.9 5.5 6.1 4.7 0.9 5.1 3.0 3.4 6.5 2.8 4.3 4.9 6.0 5.8 4.7 4.4 3.8 4.2 4.0 4.1 4.0 5.1 5.8 7.8 28.9 13.3 18.6 26.9 6.9 5.7 3.9 7.4 14.4 8.0 7.4 23.2 10.0 8.0 5.5 27.1 5.6 17.0 9.7 9.8 4.0 22.1 8.6 14.7 8.8 11.5 8.8 32.9 4.2 3.3 8.5 9.7 6.8 6.3 18.8 6.4 7.6 17.1 13.5 30.4 7.0 6.1 21.5 19.8 16.5 9.9 26.4 14.2 15.9 13.8 11.0 20.6 24.1 21.5 3.6 3.7 8.2 28.9 3.5 6.7 5.5 9.8 28.1 0.0 7.5 7.7 25.5 13.1 9.2 6.0 2.9 17.3 30.7 8.6 2.5 SCRN1 KIAA0193 ENSG00000136193 "Secernin 1" Q12765 7 29920104-29990289 "Enzymes, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 158.6" "Cell type enhanced" "Detected in many" "Muller glia cells: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 326.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024517 Enhanced Approved Cytosol No No 160000 Cytosol "HPA024517: AB_2184811" "prognostic unfavorable (8.32e-4)" "prognostic unfavorable (8.46e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.00e-5)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (1.13e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.15e-5)" "unprognostic (2.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (2.60e-4)" 13.6 28.1 120.1 13.2 124.4 8.2 14.4 133.3 118.8 22.4 57.1 22.4 6.5 27.6 16.3 19.1 26.2 16.7 20.0 115.6 123.1 23.9 2.6 16.6 14.4 118.5 158.6 109.2 32.7 37.0 55.0 34.3 16.0 119.1 28.1 10.5 103.4 18.1 37.5 2.4 11.2 15.9 34.6 125.3 10.8 19.4 23.2 116.8 29.1 13.7 11.1 21.7 22.2 17.9 136.6 106.3 75.0 119.9 48.6 83.1 126.9 0.5 97.0 128.8 102.5 110.0 87.1 81.8 13.0 83.7 124.7 227.3 46.7 137.7 41.2 148.9 0.6 29.0 43.8 49.7 56.6 105.9 0.3 0.5 106.5 58.1 93.5 49.6 139.4 95.9 28.0 0.5 33.3 146.6 59.5 15.5 0.1 109.4 0.2 79.6 0.3 127.7 1.1 71.7 51.5 43.7 103.1 99.9 64.1 112.5 149.7 86.3 6.9 106.7 132.2 113.3 1.7 123.7 10.8 177.0 1.1 62.4 0.5 326.5 3.7 3.4 10.3 0.9 14.1 10.7 14.0 0.2 1.0 10.9 7.6 0.7 1.4 0.5 7.1 25.4 10.8 0.0 3.5 120.1 124.4 133.3 118.8 115.6 123.1 118.5 158.6 109.2 119.1 125.3 116.8 136.6 5.9 28.9 14.1 42.7 15.4 3.1 12.6 14.0 14.2 66.9 7.6 5.2 15.8 20.0 22.3 33.1 45.9 0.4 16.2 1.1 15.6 24.1 61.1 7.3 11.9 10.9 12.1 2.5 52.0 25.1 1.9 17.2 5.6 6.7 8.2 22.9 1.8 0.3 5.4 69.0 51.4 0.7 14.2 8.8 13.9 68.1 13.7 11.1 7.2 16.9 11.5 80.8 12.3 31.2 35.6 21.2 17.3 21.1 12.5 17.4 0.1 2.8 29.2 41.1 6.6 9.6 11.9 3.1 11.0 5.1 1.7 1.0 2.8 8.5 1.2 22.3 C7orf25 MGC2821 ENSG00000136197 "Chromosome 7 open reading frame 25" Q9BPX7 7 42908726-42912305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Cone photoreceptor cells: 4.2;Excitatory neurons: 4.6;Inhibitory neurons: 4.7;Oligodendrocytes: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 36.6" "Lineage enriched" "Detected in all" 15 "granulocytes: 36.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020120, HPA049635" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020120: AB_1845755, HPA049635: AB_2680837" "unprognostic (6.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-2)" "unprognostic (4.83e-2)" "unprognostic (1.13e-3)" "unprognostic (2.23e-2)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (1.66e-2)" "unprognostic (1.73e-1)" "unprognostic (5.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.26e-1)" "unprognostic (2.66e-1)" "unprognostic (3.87e-2)" "unprognostic (3.05e-3)" 1.5 1.7 2.4 0.6 2.7 0.7 2.0 2.5 4.3 1.6 1.2 1.6 0.5 1.7 3.2 1.6 2.1 1.9 2.1 2.5 2.7 2.7 1.6 1.5 1.7 2.9 2.7 2.1 2.2 1.7 3.1 1.4 2.1 3.4 2.6 1.0 1.9 1.6 2.8 1.7 1.4 1.2 1.9 1.8 1.8 1.9 3.7 3.0 1.7 2.7 1.9 1.3 1.2 0.9 4.4 2.7 8.5 2.2 3.7 2.9 2.0 2.5 5.9 2.0 3.4 3.0 4.9 3.9 7.4 3.7 5.2 4.3 4.1 1.7 5.0 4.2 3.3 7.3 4.0 8.2 3.2 6.2 3.2 2.2 2.9 3.4 3.3 3.3 1.4 2.6 4.8 5.0 1.5 3.3 6.1 1.7 2.5 3.0 1.7 9.8 1.7 2.8 3.7 2.1 6.9 2.8 3.9 8.3 2.9 2.7 3.3 3.3 2.1 7.3 3.6 3.8 4.3 3.3 4.0 9.1 2.2 3.7 3.5 8.3 36.6 1.6 15.7 1.5 2.0 2.3 2.2 1.0 1.5 1.0 1.6 1.6 1.7 8.8 2.2 2.3 0.8 0.8 1.1 2.4 2.7 2.5 4.3 2.5 2.7 2.9 2.7 2.1 3.4 1.8 3.0 4.4 0.4 0.0 1.1 2.3 0.7 0.3 0.4 0.1 0.6 0.9 0.4 0.5 0.6 0.0 0.1 3.7 4.2 0.7 0.3 0.1 1.9 0.9 0.1 0.4 0.6 0.7 0.0 0.4 4.6 1.1 0.4 0.6 0.0 0.2 0.0 0.6 1.1 0.5 0.2 0.0 4.7 0.2 0.0 0.0 0.4 0.3 0.6 1.2 0.0 2.8 0.3 0.7 2.1 3.0 7.9 0.9 0.3 0.7 0.2 0.3 0.7 1.5 1.0 0.4 0.0 0.3 0.8 1.7 1.3 0.4 0.4 0.8 0.5 1.0 0.2 0.1 TNS3 "FLJ13732, H_NH0549I23.2, TEM6, TENS1" ENSG00000136205 "Tensin 3" Q68CZ2 7 47275154-47582558 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Oligodendrocyte precursor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 4.0;intermediate monocyte: 3.2;memory B-cell: 2.3;myeloid DC: 2.6;naive B-cell: 1.9;non-classical monocyte: 3.2;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 7 "B-cells: 2.3;dendritic cells: 3.7;monocytes: 4.0" "Cell line enhanced" "Detected in many" "A549: 266.7;LHCN-M2: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055338, HPA056015" Approved Enhanced "Focal adhesion sites" NA NA 8100 "Focal adhesion sites" "HPA055338: AB_2682789, HPA056015: AB_2683010" "unprognostic (1.46e-1)" "unprognostic (2.97e-2)" "unprognostic (1.34e-1)" "unprognostic (7.02e-2)" "unprognostic (9.04e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (8.00e-2)" "unprognostic (3.77e-2)" "unprognostic (3.70e-1)" "unprognostic (6.60e-2)" "prognostic favorable (5.21e-4)" "unprognostic (3.13e-2)" "unprognostic (4.41e-2)" "unprognostic (3.20e-2)" "unprognostic (9.09e-3)" 29.8 35.6 51.7 24.0 50.9 6.3 21.1 53.9 52.1 26.5 52.8 18.5 18.9 24.8 6.6 6.5 22.1 21.5 23.4 51.4 60.1 50.2 52.0 41.1 37.0 75.6 55.7 41.8 38.6 57.5 31.0 10.5 57.2 64.6 16.5 17.1 9.2 48.9 16.1 22.2 13.5 24.1 16.7 59.0 42.4 30.6 9.5 65.0 8.3 30.1 15.1 19.5 16.3 16.7 66.5 26.5 266.7 15.9 27.7 35.6 28.8 50.6 23.6 133.8 22.7 34.7 60.5 34.7 13.4 40.9 86.4 84.8 49.4 25.9 38.6 20.6 0.2 1.6 37.4 37.3 32.3 36.8 0.1 0.4 28.7 16.3 13.0 20.7 147.3 18.1 0.0 0.1 80.6 170.0 16.4 0.1 0.8 15.4 38.1 31.5 12.1 38.7 44.5 77.5 53.0 1.5 32.3 46.5 9.3 26.9 79.6 35.2 27.6 72.6 35.0 27.1 0.4 36.5 51.7 72.4 30.6 8.7 26.0 129.6 0.2 4.0 0.0 0.0 3.2 0.1 2.3 0.0 0.0 2.6 1.9 0.0 0.0 0.5 0.0 3.2 3.7 0.0 1.4 51.7 50.9 53.9 52.1 51.4 60.1 75.6 55.7 41.8 64.6 59.0 65.0 66.5 8.5 67.3 15.8 90.8 10.9 4.8 6.5 26.3 14.2 1.6 8.5 10.3 23.9 35.8 18.8 31.3 0.0 27.7 7.1 41.3 1.9 15.5 11.8 19.8 11.0 12.4 15.0 6.3 2.4 18.4 59.2 14.9 18.3 23.2 0.0 11.4 31.4 40.3 77.4 0.0 6.4 14.0 10.2 41.3 8.4 18.5 6.2 28.9 16.0 76.8 23.1 35.2 1.0 150.8 3.7 23.8 9.9 15.4 5.3 10.5 33.6 14.1 11.1 1.4 26.3 45.5 21.8 2.2 3.0 1.5 3.3 30.0 3.5 20.1 17.0 3.2 SPDYE1 "Ringo1, SPDYE, WBSCR19" ENSG00000136206 "Speedy/RINGO cell cycle regulator family member E1" Q8NFV5 7 43997897-44010122 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 7.3" "Group enriched" "Detected in some" 9 "Early spermatids: 54.5;Late spermatids: 56.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (2.16e-1)" "unprognostic (1.44e-1)" "unprognostic (3.98e-2)" "unprognostic (6.20e-2)" "unprognostic (1.22e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "unprognostic (8.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.69e-2)" "unprognostic (1.95e-6)" "unprognostic (2.68e-1)" "unprognostic (2.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.19e-2)" 0.2 0.3 0.6 0.9 0.8 2.0 0.2 1.0 1.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.1 0.3 0.2 0.8 0.2 0.2 0.2 0.2 0.8 0.7 0.3 0.0 0.3 0.3 0.0 0.2 0.2 1.3 0.2 0.0 1.0 0.6 0.0 2.5 1.7 0.6 0.0 0.0 0.8 0.5 7.3 0.7 0.0 0.5 0.0 0.0 0.2 0.2 1.7 1.1 0.9 1.1 1.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.8 0.6 1.1 0.6 0.0 0.4 1.7 0.0 0.0 0.0 0.8 0.9 0.5 2.8 0.5 0.0 1.9 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1.6 2.7 0.0 1.3 0.7 1.1 1.0 0.6 0.4 1.6 0.4 0.7 0.0 1.2 0.8 0.7 1.7 0.4 0.2 1.4 0.7 0.2 1.0 1.5 1.2 0.6 1.4 1.5 1.0 1.0 0.7 1.3 1.7 1.5 0.5 0.7 0.5 0.6 0.7 0.5 0.5 0.2 0.3 0.8 0.4 0.5 1.0 0.3 0.4 0.7 0.2 0.3 0.6 0.8 1.0 1.0 0.8 0.2 0.7 0.3 0.0 1.3 0.0 0.7 1.7 0.5 0.0 1.1 4.2 0.2 0.4 0.0 0.2 0.0 1.1 0.1 0.0 1.2 0.0 1.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 54.5 1.0 1.1 0.5 0.0 0.0 6.0 0.0 0.1 0.4 0.5 0.9 1.3 0.1 0.0 0.1 0.1 1.7 4.8 0.1 0.0 0.3 0.3 56.5 0.3 0.3 0.0 1.0 0.1 0.4 0.0 4.0 4.3 0.0 0.0 0.4 0.6 0.0 0.0 0.1 0.0 2.1 0.0 0.5 0.6 0.7 0.2 0.0 0.3 0.1 0.4 0.1 0.1 0.0 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403588-2448484 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 960000 "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 16.2 13.4 3.9 5.1 3.7 6.2 15.1 7.0 5.1 15.5 0.3 12.4 5.5 17.9 0.6 8.0 16.0 1.2 14.7 9.1 2.8 11.2 7.2 14.6 2.9 9.3 5.4 2.0 11.7 11.8 1.5 17.8 2.9 6.0 13.7 0.6 1.2 10.4 2.8 8.4 15.5 10.6 1.4 3.8 24.6 11.2 9.2 6.2 1.4 14.3 0.9 1.0 13.2 13.2 4.7 9.5 9.1 2.7 10.0 3.8 2.3 29.5 17.2 4.2 4.2 5.7 9.0 3.2 8.5 31.6 2.7 10.3 7.1 1.6 2.2 0.8 11.2 17.7 5.9 7.0 9.9 2.6 19.4 60.1 4.8 0.9 3.8 0.5 3.3 4.2 11.5 15.1 25.0 1.2 6.8 19.8 57.4 19.1 1.3 14.4 7.1 7.6 42.1 1.2 3.8 6.8 28.7 8.4 4.5 4.0 2.0 6.6 22.3 13.0 9.6 26.5 20.0 15.2 88.9 37.1 3.9 7.8 8.8 17.9 59.1 10.4 53.2 87.6 9.1 54.4 14.7 30.0 71.4 20.4 18.3 12.6 37.8 3.1 121.6 3.9 64.9 33.0 22.9 3.9 3.7 7.0 5.1 9.1 2.8 9.3 5.4 2.0 6.0 3.8 6.2 4.7 36.8 16.0 50.5 9.1 32.8 18.1 35.5 24.3 18.8 45.6 18.0 13.0 8.3 15.7 30.5 18.4 66.7 104.5 158.7 6.2 1.9 22.4 6.7 4.7 21.1 59.4 12.7 37.0 11.0 15.3 15.0 37.0 6.1 6.4 38.0 13.4 152.8 7.2 24.8 47.1 12.3 9.1 24.4 26.4 22.9 5.8 95.7 21.2 21.4 10.3 21.3 15.1 368.7 14.1 9.5 13.3 6.7 67.7 107.8 18.4 16.2 9.5 15.2 50.5 19.7 25.6 17.9 37.8 30.6 9.2 15.3 133.5 93.2 18.4 12.2 13.1 IGF2BP3 "CT98, IMP-3, IMP3" ENSG00000136231 "Insulin like growth factor 2 mRNA binding protein 3" O00425 7 23310209-23470491 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.4;placenta: 29.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 84.8;Early spermatids: 40.8;Extravillous trophoblasts: 93.4;Hofbauer cells: 38.5;Late spermatids: 24.1;Syncytiotrophoblasts: 78.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 170.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002037, HPA076951" Enhanced Supported Cytosol NA NA 27000 Cytosol "HPA002037: AB_1851483, HPA076951: " "unprognostic (5.72e-2)" "unprognostic (3.12e-1)" "unprognostic (7.25e-2)" "unprognostic (3.56e-3)" "unprognostic (1.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.64e-3)" "unprognostic (3.18e-2)" "unprognostic (2.60e-3)" "unprognostic (3.67e-1)" "unprognostic (1.02e-5)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (1.43e-1)" "unprognostic (7.95e-2)" "unprognostic (2.87e-4)" "unprognostic (7.51e-3)" 0.3 0.0 0.7 0.8 0.3 0.6 0.1 0.2 0.5 0.1 0.0 0.1 0.0 0.0 0.8 2.1 0.9 0.2 0.0 0.3 0.0 0.0 0.5 0.5 4.3 0.1 0.0 0.2 0.0 0.6 0.3 0.0 29.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 5.1 0.2 1.6 0.8 0.1 7.4 0.2 0.2 0.2 48.7 14.0 104.5 31.0 16.2 42.8 63.7 8.1 35.7 19.6 24.2 45.0 37.4 36.4 42.1 21.3 86.4 31.2 45.8 35.2 34.2 5.9 18.3 19.3 38.1 37.9 50.3 35.5 13.1 44.1 24.2 15.0 6.3 114.7 170.0 20.0 89.5 0.2 47.8 0.0 21.6 23.5 83.0 36.6 43.3 33.2 34.8 47.1 38.4 4.2 27.4 59.6 4.8 0.3 38.9 118.3 0.0 6.6 68.9 18.6 1.2 40.6 21.0 0.0 15.8 56.7 73.8 38.6 72.8 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.7 0.3 0.2 0.5 0.3 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.2 0.2 0.0 0.0 1.0 2.8 0.3 0.7 0.3 0.0 0.5 0.0 0.0 0.5 0.0 0.3 0.0 0.0 84.8 1.4 0.1 0.0 1.2 40.8 5.4 0.2 1.7 0.0 0.0 2.0 0.2 93.4 3.5 0.0 1.5 3.8 0.1 1.1 0.2 38.5 1.7 12.9 0.0 0.0 0.8 0.6 24.1 2.1 11.3 3.6 5.6 2.9 0.2 2.1 1.5 1.8 1.0 0.0 0.0 2.1 0.2 0.0 0.1 2.6 1.6 0.0 0.4 7.7 6.8 3.5 0.7 0.4 78.5 0.3 0.0 0.0 0.6 GPNMB "HGFIN, NMB" ENSG00000136235 "Glycoprotein nmb" Q14956 7 23235967-23275108 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 585.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 327.1;Fibroblasts: 285.8;Hofbauer cells: 814.1;Macrophages: 328.9;Melanocytes: 597.7;Suprabasal keratinocytes: 359.7" "Cancer enhanced" "Detected in all" "melanoma: 354.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.1;intermediate monocyte: 3.9" "Lineage enriched" "Detected in single" 6 "monocytes: 3.9" "Cell line enriched" "Detected in many" 6 "ASC diff: 5015.0" "Region enhanced" "Detected in many" "olfactory bulb: 9.7" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 33000000 "unprognostic (3.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.65e-2)" "unprognostic (1.82e-1)" "unprognostic (5.14e-2)" "unprognostic (4.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.89e-2)" "unprognostic (7.13e-2)" "unprognostic (2.79e-1)" "unprognostic (2.83e-1)" "unprognostic (6.40e-2)" "unprognostic (2.08e-3)" "unprognostic (1.24e-2)" "unprognostic (3.46e-2)" "unprognostic (4.82e-1)" "unprognostic (6.95e-2)" 147.3 26.1 26.4 42.1 28.8 6.6 137.0 24.7 71.5 306.5 73.0 78.9 22.7 182.4 44.2 112.9 73.4 273.1 326.7 25.9 36.5 33.0 52.9 217.8 170.4 31.0 26.7 25.1 78.4 20.8 15.4 12.9 149.9 34.2 30.7 93.8 3.0 66.7 56.3 15.5 585.8 48.9 152.8 39.5 32.2 37.4 26.4 36.4 90.4 51.9 73.1 104.3 192.7 152.3 56.5 19.2 0.8 0.1 0.6 5015.0 908.0 0.4 33.6 564.1 27.9 116.2 0.2 0.8 0.7 1.4 109.5 49.1 118.3 0.7 0.7 14.2 1.3 1.3 0.1 0.9 2.5 61.5 1.5 0.6 630.3 134.8 46.3 4.7 734.9 0.3 1.4 0.3 0.6 150.2 3.5 0.7 0.7 0.6 0.5 0.5 0.4 1.4 7.6 71.2 443.4 2.4 0.6 0.1 175.6 841.5 1.3 2.3 2.8 0.1 163.0 17.8 297.8 5.5 5.1 8.6 1.2 56.3 2.6 166.1 0.6 2.1 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.1 0.4 0.0 0.5 26.4 28.8 24.7 71.5 25.9 36.5 31.0 26.7 25.1 34.2 39.5 36.4 56.5 18.0 19.2 24.3 0.3 3.2 327.1 7.1 58.5 150.2 0.4 6.6 24.5 204.2 2.8 16.0 75.4 0.0 7.2 2.2 0.1 3.9 0.6 3.0 2.5 44.0 15.0 0.0 0.0 0.5 0.8 4.6 285.8 12.2 2.5 22.7 0.1 4.6 5.1 814.1 1.7 1.2 0.0 12.2 188.4 100.7 5.5 129.8 328.9 597.7 12.2 3.2 0.2 1.0 55.8 0.1 0.6 0.0 108.0 10.2 1.9 0.0 1.2 3.4 0.6 0.0 20.6 53.4 3.9 1.4 65.3 359.7 28.9 5.7 0.1 0.0 11.9 RAPGEF5 "GFR, KIAA0277, MR-GEF" ENSG00000136237 "Rap guanine nucleotide exchange factor 5" Q92565 7 22118236-22357154 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 164.4;parathyroid gland: 390.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057821, HPA076772" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA057821: AB_2683538, HPA076772: AB_2686814" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (5.22e-2)" "prognostic favorable (3.52e-5)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-1)" "unprognostic (3.76e-2)" "unprognostic (6.36e-3)" "unprognostic (6.57e-2)" "unprognostic (2.55e-1)" "unprognostic (8.26e-3)" 21.2 12.8 37.6 7.1 83.8 0.9 16.6 74.7 68.4 8.7 12.7 9.6 7.6 8.8 4.9 14.0 8.4 17.0 17.0 55.0 60.6 16.9 22.0 37.8 14.4 109.2 79.3 34.9 6.5 20.3 390.5 7.5 67.8 100.0 5.2 11.1 4.2 7.7 5.7 5.1 9.3 8.4 12.2 111.3 51.3 7.0 6.4 71.0 15.8 11.8 11.2 10.8 9.4 12.0 164.4 2.8 0.0 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 5.5 1.4 21.1 1.1 0.3 0.7 13.0 2.8 1.9 0.0 0.0 4.2 0.3 0.0 5.4 0.1 0.0 0.1 0.5 2.4 1.3 0.7 0.7 45.0 5.9 4.8 0.1 0.0 1.2 3.0 0.1 3.6 5.4 4.0 5.2 0.0 7.4 4.2 1.9 34.1 9.0 0.5 6.0 0.1 0.7 3.0 0.1 25.8 0.0 1.0 0.4 1.1 10.9 2.5 37.4 0.5 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.6 83.8 74.7 68.4 55.0 60.6 109.2 79.3 34.9 100.0 111.3 71.0 164.4 125.5 9.6 16.5 13.4 3.1 11.0 4.2 2.4 86.0 30.6 8.8 5.5 10.0 15.7 3.8 0.0 0.0 0.3 0.6 16.0 1.9 6.5 61.5 3.3 1.2 70.1 7.2 0.4 504.6 7.0 0.1 5.3 16.3 10.8 8.2 0.1 86.0 6.3 0.2 23.5 193.4 18.3 2.0 3.1 2.0 65.2 1.8 0.9 7.2 138.7 0.0 0.6 0.0 28.1 640.8 5.0 20.3 4.9 12.9 3.0 18.1 0.3 0.5 1.6 85.5 1.4 21.5 1.2 1.6 19.8 11.2 0.3 2.4 1.9 10.1 4.4 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374527-6403967 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 1980.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3900000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 152.8 109.1 254.0 97.7 264.0 95.3 147.7 260.1 288.9 143.6 229.3 192.3 168.9 152.1 151.2 319.4 146.4 127.0 130.6 255.7 262.4 151.9 137.3 148.8 97.2 266.6 262.6 241.8 137.0 93.0 152.3 78.1 181.7 263.9 123.9 201.5 52.7 139.0 146.4 181.0 190.8 163.3 180.9 279.3 97.5 162.0 52.1 263.7 116.4 128.4 142.3 171.0 207.2 190.2 280.9 519.9 230.9 233.0 255.1 270.1 341.8 138.6 284.9 348.0 371.6 375.8 227.3 474.8 145.5 179.7 400.9 384.2 359.4 251.5 345.9 471.9 68.3 207.8 146.6 171.7 166.5 323.7 134.0 114.6 229.7 302.8 268.4 297.6 281.7 333.4 141.3 266.2 111.7 406.4 377.3 74.0 312.4 419.1 261.9 272.3 129.2 236.9 214.6 481.7 322.7 175.8 295.9 201.7 726.1 241.4 264.7 409.6 396.3 341.8 242.4 364.3 300.7 334.5 84.1 99.5 135.4 223.9 250.9 470.6 31.0 117.3 63.0 23.8 83.0 15.1 46.8 26.8 30.9 112.8 49.9 33.0 21.8 168.6 26.1 83.5 64.5 46.1 47.0 254.0 264.0 260.1 288.9 255.7 262.4 266.6 262.6 241.8 263.9 279.3 263.7 280.9 755.4 147.4 123.6 28.7 155.9 934.1 981.6 232.1 429.2 90.4 485.3 593.8 200.6 484.7 164.8 356.8 25.0 802.8 224.1 920.9 536.1 183.5 77.6 388.7 362.9 641.2 336.7 313.3 43.3 174.2 1064.1 415.9 305.3 422.8 130.9 325.4 580.8 367.1 832.0 146.4 35.3 632.9 179.0 811.3 1066.7 58.8 476.3 705.7 458.9 66.5 607.2 341.1 191.6 23.1 56.7 299.1 754.4 472.8 212.2 1495.5 816.4 832.0 214.1 64.2 479.9 346.6 466.6 216.6 373.1 774.5 1148.6 845.4 180.0 353.6 573.7 1980.7 KDELR2 "ELP-1, ERD2.2" ENSG00000136240 "KDEL endoplasmic reticulum protein retention receptor 2" P33947 7 6445953-6484190 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 786.7;Extravillous trophoblasts: 944.9;Syncytiotrophoblasts: 759.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016459 Approved NA NA "HPA016459: AB_1852180" "unprognostic (2.16e-3)" "unprognostic (1.34e-3)" "unprognostic (1.77e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (5.40e-5)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.85e-2)" "unprognostic (7.05e-2)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (2.33e-2)" "unprognostic (5.42e-1)" "prognostic unfavorable (6.79e-8)" "unprognostic (7.72e-2)" "unprognostic (1.80e-1)" "unprognostic (4.29e-2)" "unprognostic (2.71e-2)" 84.7 71.3 31.7 67.7 32.9 25.8 85.5 34.9 35.8 133.6 52.0 134.1 118.7 83.7 120.3 63.9 68.9 85.8 66.1 31.0 39.4 82.1 231.5 73.8 36.6 35.2 33.7 29.5 65.5 100.4 68.8 71.2 149.6 34.6 107.9 145.6 23.8 104.7 85.0 40.8 52.8 120.1 107.2 35.3 44.5 157.0 64.5 34.7 25.1 99.2 44.8 52.5 92.5 59.1 36.6 280.7 121.6 116.4 223.0 558.2 512.4 116.0 415.2 374.8 236.5 353.8 197.0 180.6 44.7 113.0 591.3 352.8 245.8 169.9 173.1 365.1 24.6 97.6 55.0 120.0 271.6 338.4 84.0 72.4 327.8 171.8 230.7 272.3 263.8 217.5 42.2 123.4 128.2 325.4 234.7 25.8 80.9 112.8 358.0 181.5 61.5 180.6 117.6 190.6 116.2 108.5 130.2 172.7 304.6 135.2 177.8 252.3 144.7 189.0 180.0 262.4 439.6 223.4 93.9 84.4 76.8 299.5 162.8 525.7 77.8 72.0 77.0 47.6 74.8 61.0 44.0 49.0 52.5 72.0 43.6 39.4 43.3 47.2 43.5 77.8 127.3 49.1 56.9 31.7 32.9 34.9 35.8 31.0 39.4 35.2 33.7 29.5 34.6 35.3 34.7 36.6 110.2 25.6 71.0 17.9 109.7 192.2 175.5 239.0 67.7 26.7 141.6 82.4 60.6 117.2 159.5 62.5 12.5 417.9 86.9 261.0 35.2 217.2 786.7 59.2 152.5 136.4 114.3 100.1 22.5 323.5 944.9 262.9 170.2 121.4 68.6 75.7 119.6 377.8 300.9 32.0 29.5 492.7 89.5 91.7 210.8 115.9 151.3 112.4 177.9 37.5 99.2 31.2 58.7 29.7 24.5 224.8 232.9 121.9 486.7 427.2 244.1 113.5 87.7 31.2 72.3 89.4 177.1 527.9 149.8 122.4 198.9 759.9 73.2 136.1 279.6 319.1 NUP42 "CG1, H_RG271G13.9, hCG1, NLP_1, NUPL2" ENSG00000136243 "Nucleoporin 42" O15504 7 23181841-23201011 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 7.7;Cardiomyocytes: 20.3;Cytotrophoblasts: 17.1;dendritic cells: 10.5;Extravillous trophoblasts: 11.6;Hofbauer cells: 28.1;Syncytiotrophoblasts: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049036, HPA057251" Supported Nucleoplasm No No Nucleoplasm "HPA049036: , HPA057251: " "unprognostic (3.81e-2)" "unprognostic (2.53e-1)" "unprognostic (3.97e-1)" "unprognostic (3.87e-1)" "unprognostic (4.16e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-3)" "unprognostic (2.16e-1)" "unprognostic (1.09e-2)" "unprognostic (1.42e-2)" "unprognostic (1.30e-3)" "unprognostic (2.07e-2)" "unprognostic (4.74e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-3)" "unprognostic (3.59e-1)" "unprognostic (1.32e-2)" 10.9 14.9 14.9 10.9 10.2 20.7 11.5 20.2 15.9 11.3 16.4 11.2 15.0 14.3 15.2 13.7 13.0 13.2 19.8 12.2 9.0 15.3 14.1 10.0 21.8 13.0 10.0 15.2 12.2 6.3 17.2 6.4 8.6 13.8 12.2 14.5 8.3 10.8 10.2 11.7 16.5 12.5 15.2 5.3 16.0 11.7 19.1 11.4 19.5 14.5 9.0 18.4 13.3 7.8 24.3 31.1 14.0 21.5 44.5 21.3 25.0 17.8 23.1 16.6 25.2 26.4 21.2 31.9 52.4 22.0 16.1 54.1 41.6 37.9 17.2 32.6 15.9 39.0 32.0 36.5 21.7 24.6 67.4 47.1 11.6 25.5 21.8 14.5 20.4 29.0 22.0 58.9 31.4 25.5 7.7 32.5 54.6 45.1 38.4 21.9 31.6 19.0 40.5 27.1 21.6 33.2 31.2 22.9 14.0 44.9 41.2 17.0 86.3 21.6 16.5 21.8 28.3 39.7 44.9 64.8 52.3 17.6 46.7 44.4 33.2 10.3 8.1 11.0 10.1 10.7 18.8 12.8 12.1 15.0 13.6 10.6 12.7 8.0 17.8 9.3 14.4 16.2 11.1 14.9 10.2 20.2 15.9 12.2 9.0 13.0 10.0 15.2 13.8 5.3 11.4 24.3 7.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 17.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 11.6 5.2 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 6.6 1.3 0.0 0.0 0.0 IL6 "BSF2, HGF, HSF, IFNB2, IL-6" ENSG00000136244 "Interleukin 6" P05231 7 22725884-22732002 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cytokine, Growth factor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 284.0" "Group enriched" "Detected in many" 4 "Adipocytes: 188.5;Endometrial ciliated cells: 163.9;Endothelial cells: 287.4;Fibroblasts: 593.3;Glandular and luminal cells: 322.2;Smooth muscle cells: 449.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 9 "hypothalamus: 74.1" "Group enriched" "Detected in some" 44 "memory B-cell: 3.9;naive B-cell: 4.8" "Lineage enriched" "Detected in single" 48 "B-cells: 4.8" "Group enriched" "Detected in many" 4 "BJ hTERT+: 2214.7;GAMG: 1447.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB023406, CAB072821" Supported Approved Vesicles "Secreted to blood" NA NA 5700 Vesicles "CAB023406: AB_617317, CAB072821: " "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (3.59e-2)" "unprognostic (9.88e-3)" "unprognostic (1.35e-1)" "unprognostic (3.07e-3)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.10e-11)" "unprognostic (2.45e-3)" "unprognostic (2.10e-1)" "unprognostic (4.31e-2)" "unprognostic (7.80e-2)" 116.4 14.1 4.2 31.1 3.8 47.2 31.5 3.8 5.9 4.7 8.7 15.5 2.0 5.8 0.0 35.2 19.1 41.9 37.8 3.8 74.1 8.5 13.1 115.9 9.2 4.6 4.1 5.0 6.2 19.7 10.1 38.6 11.4 4.6 16.7 17.4 1.4 12.1 2.1 7.8 7.2 8.4 19.7 4.1 7.1 18.2 1.2 4.6 6.4 14.3 4.1 3.7 284.0 5.8 8.5 0.1 0.0 0.0 0.0 0.7 2.2 7.5 8.9 2214.7 43.2 151.0 0.0 0.6 0.2 71.6 15.2 1447.6 1.7 0.0 0.3 59.9 94.2 0.2 0.0 3.7 0.0 47.3 0.0 0.6 5.6 0.0 413.8 63.1 44.2 18.2 0.0 10.6 0.5 1.9 0.1 0.0 0.3 1.6 0.7 0.5 0.0 0.0 0.0 124.2 0.0 0.0 0.0 144.5 0.1 0.6 7.9 0.1 0.1 14.5 15.2 1.4 28.2 4.7 0.0 27.8 0.4 98.5 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 3.8 3.8 5.9 3.8 74.1 4.6 4.1 5.0 4.6 4.1 4.6 8.5 188.5 6.4 22.7 0.0 27.0 44.6 3.4 28.5 1.8 0.1 1.4 1.1 1.4 0.0 17.7 3.7 0.0 1.1 0.4 0.1 0.0 9.8 0.4 163.9 44.6 287.4 0.0 0.0 0.0 2.8 4.0 593.3 0.0 322.2 6.3 0.0 3.6 0.1 4.1 0.0 0.0 0.0 0.0 9.3 76.5 0.2 0.0 27.4 40.9 2.8 4.2 0.0 0.0 0.0 0.1 4.3 0.1 0.0 0.9 16.4 0.0 0.0 8.1 0.0 0.0 28.9 449.0 0.0 0.1 0.4 33.4 1.4 8.6 0.2 0.0 20.6 ZDHHC4 "FLJ10479, ZNF374" ENSG00000136247 "Zinc finger DHHC-type palmitoyltransferase 4" Q9NPG8 7 6577434-6589374 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032124 Approved NA NA "HPA032124: AB_10610699" "unprognostic (1.07e-1)" "prognostic unfavorable (9.35e-4)" "unprognostic (6.82e-2)" "unprognostic (8.36e-2)" "unprognostic (3.66e-1)" "prognostic unfavorable (3.95e-6)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (4.60e-2)" "unprognostic (1.52e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.18e-7)" "unprognostic (8.75e-2)" "unprognostic (9.41e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (8.94e-4)" 24.8 31.3 16.9 16.3 17.7 19.0 24.5 18.9 18.9 24.6 19.4 33.1 19.3 28.2 34.5 19.7 31.3 23.5 26.5 16.7 20.3 33.9 36.0 22.1 20.8 19.1 19.6 15.7 27.9 38.2 33.3 24.1 18.7 19.7 25.5 21.1 19.5 32.5 25.7 54.9 13.5 22.7 24.9 18.4 18.1 33.2 34.1 19.6 18.8 37.1 44.1 19.5 29.5 18.9 19.1 50.7 35.0 11.7 68.8 60.8 41.4 52.4 26.2 6.5 31.2 44.3 44.3 69.7 29.9 40.1 51.3 66.2 44.2 40.8 25.7 33.2 16.8 24.0 31.4 37.8 48.6 47.8 39.8 36.6 45.2 37.6 24.1 0.0 40.8 27.9 51.8 72.4 40.3 43.5 59.2 22.1 39.6 59.4 45.0 28.1 29.4 57.5 40.3 25.9 43.7 26.9 68.7 35.5 11.8 51.7 60.4 43.1 45.8 18.7 40.6 54.9 39.2 39.3 62.1 58.7 66.7 21.6 50.0 56.5 56.3 25.0 44.8 24.1 31.9 24.8 38.8 25.1 27.3 28.1 36.0 31.4 31.1 2.9 28.7 26.5 113.9 24.5 29.3 16.9 17.7 18.9 18.9 16.7 20.3 19.1 19.6 15.7 19.7 18.4 19.6 19.1 11.7 38.5 20.1 2.9 23.3 11.3 46.5 63.4 24.5 30.2 42.1 34.7 4.4 57.2 42.4 35.0 10.4 69.0 46.1 12.1 86.1 60.5 3.0 24.1 22.1 14.3 32.4 26.5 4.6 66.4 69.4 26.0 20.9 20.3 10.2 25.9 25.0 47.3 55.3 21.9 5.4 21.2 42.7 36.5 18.2 3.5 18.0 24.8 21.4 2.8 35.3 71.8 28.8 5.0 6.7 54.6 21.4 32.7 34.2 39.5 27.2 71.9 32.5 24.6 13.1 20.9 25.6 70.2 69.7 19.2 9.2 48.8 19.0 40.6 27.5 39.5 AOAH ENSG00000136250 "Acyloxyacyl hydrolase" P28039 7 36512941-36724549 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.7;lymphoid tissue: 65.5" "Cell type enhanced" "Detected in many" "dendritic cells: 77.9;Kupffer cells: 119.7;Macrophages: 77.1;Microglial cells: 233.3;monocytes: 67.5;NK-cells: 90.6;T-cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 298.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "GAMG: 4.8;NB-4: 26.5;THP-1: 20.2;U-937: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021666, HPA026716" Approved Uncertain Vesicles "Secreted to blood" NA NA Vesicles "HPA021666: AB_2670799, HPA026716: AB_2671960" "unprognostic (3.55e-2)" "unprognostic (4.03e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-1)" "unprognostic (6.06e-2)" "unprognostic (4.78e-2)" "unprognostic (2.40e-1)" "unprognostic (3.14e-3)" "unprognostic (5.42e-2)" "unprognostic (6.02e-2)" "unprognostic (3.36e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-3)" "unprognostic (1.75e-1)" "unprognostic (1.92e-3)" "unprognostic (2.38e-1)" "unprognostic (1.35e-1)" 7.6 5.1 2.2 34.1 3.3 43.7 3.8 2.3 4.4 5.7 6.6 10.5 9.6 2.9 1.5 3.3 3.6 15.8 2.0 1.9 4.2 2.0 13.3 12.8 35.3 6.6 3.1 1.1 2.6 1.5 1.5 0.9 11.3 4.9 2.6 13.5 0.8 3.8 2.8 0.5 0.8 12.2 9.4 4.1 65.5 7.1 1.3 4.3 14.0 1.8 0.9 15.2 14.0 1.3 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.6 0.0 0.0 0.0 3.8 0.0 0.3 0.1 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 26.5 0.1 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.9 0.0 1.8 298.5 97.8 43.6 251.9 9.0 2.6 2.2 30.7 183.1 0.3 4.8 37.3 97.9 106.8 113.2 2.7 0.7 207.3 2.2 3.3 2.3 4.4 1.9 4.2 6.6 3.1 1.1 4.9 4.1 4.3 7.8 1.3 0.0 9.6 1.3 3.6 0.8 0.1 0.0 0.0 1.1 0.6 1.7 0.5 1.5 2.5 0.0 0.0 0.2 77.9 9.2 1.9 0.3 0.6 0.4 0.3 1.4 15.5 16.0 12.4 0.0 0.2 3.1 2.6 0.4 5.1 0.7 2.5 0.9 32.8 0.0 8.1 0.3 0.0 119.7 20.3 1.2 0.0 77.1 0.0 233.3 67.5 2.8 90.6 12.1 38.6 0.0 3.8 0.4 13.6 0.1 0.3 0.5 0.7 0.3 0.0 0.3 0.5 0.0 0.1 0.4 0.3 0.1 54.1 0.6 0.9 0.2 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 268.0;skeletal muscle: 371.2;tongue: 261.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 278.2;Extravillous trophoblasts: 875.6;Syncytiotrophoblasts: 762.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 25.5 18.3 8.0 27.0 10.7 46.1 50.2 8.2 14.4 16.2 11.1 51.7 29.2 18.6 10.0 42.9 20.3 17.3 268.0 10.6 8.7 17.0 18.5 20.1 30.2 6.6 7.6 10.9 16.1 30.3 6.8 10.5 81.1 7.7 19.4 57.4 88.8 24.0 34.6 371.2 56.0 30.3 39.4 6.4 16.7 50.7 11.7 7.8 33.3 36.8 261.2 38.7 60.1 26.4 10.9 91.7 81.3 138.2 201.7 67.5 118.3 125.7 126.0 156.3 117.6 124.9 201.8 129.7 208.0 143.7 96.9 87.6 181.6 164.8 141.5 152.0 27.8 99.8 129.6 84.4 117.0 70.5 180.3 79.1 90.6 74.6 104.0 187.7 92.4 171.6 149.7 251.9 43.5 96.9 105.0 90.0 210.4 143.9 259.5 174.1 111.0 91.2 216.6 113.4 152.6 179.9 106.8 50.8 419.9 67.7 156.7 187.8 149.5 97.6 93.1 119.1 141.5 136.3 89.5 92.8 288.1 45.5 220.6 340.3 2.6 46.0 5.0 27.3 55.2 44.6 44.6 39.8 36.9 98.8 42.9 56.8 47.1 2.1 56.8 41.6 38.5 31.8 44.0 8.0 10.7 8.2 14.4 10.6 8.7 6.6 7.6 10.9 7.7 6.4 7.8 10.9 32.8 22.4 60.5 3.9 30.0 57.6 69.9 60.5 82.6 55.9 52.3 57.0 278.2 17.2 53.9 47.8 64.6 214.3 26.8 42.4 58.7 47.5 9.8 31.9 43.2 42.9 30.5 63.5 48.6 65.6 875.6 43.5 110.1 40.6 21.0 33.3 8.9 13.7 65.0 6.7 32.0 49.5 61.1 33.4 46.0 6.4 12.2 30.7 24.9 12.2 47.5 19.7 19.6 19.1 17.9 47.0 42.9 9.8 31.9 52.0 19.2 20.8 32.6 106.4 6.6 30.2 54.2 11.3 4.1 99.6 51.6 762.9 29.3 52.6 90.6 79.0 DGKB "DAGK2, DGK, DGK-BETA, KIAA0718" ENSG00000136267 "Diacylglycerol kinase beta" Q9Y6T7 7 14145049-14974777 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 23.1" "Group enriched" "Detected in some" 8 "Excitatory neurons: 937.7;Inhibitory neurons: 576.6;Oligodendrocyte precursor cells: 254.3" "Cancer enriched" "Detected in single" 11 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;fHDF/TERT166: 2.6;SCLC-21H: 1.3;U-266/70: 3.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 192.8" HPA020321 Supported NA NA "HPA020321: " "unprognostic (9.89e-2)" "unprognostic (9.72e-5)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.32e-2)" "unprognostic (3.37e-1)" "unprognostic (7.34e-2)" "unprognostic (5.91e-2)" "unprognostic (6.19e-2)" "unprognostic (8.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (5.98e-2)" "unprognostic (2.37e-3)" "unprognostic (6.13e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-4)" 0.2 2.6 4.2 0.2 23.1 0.0 0.1 0.0 12.6 2.4 0.0 1.0 0.0 3.3 0.0 0.5 1.6 0.3 0.4 7.8 10.6 1.1 0.2 0.0 0.0 3.9 0.2 3.1 0.0 0.1 0.0 0.7 0.0 9.3 0.2 0.5 2.0 0.0 0.1 0.3 0.0 0.5 1.4 0.0 0.0 0.6 0.1 3.0 0.1 0.1 1.4 0.0 0.6 0.3 2.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 23.1 0.0 12.6 7.8 10.6 3.9 0.2 3.1 9.3 0.0 3.0 2.1 0.4 0.0 0.0 70.5 0.0 0.1 0.3 0.0 0.0 26.4 0.0 0.0 1.6 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.2 5.3 0.7 0.0 0.0 937.7 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.0 576.6 0.0 0.0 0.0 0.5 1.9 1.2 0.1 1.8 43.1 0.0 0.1 0.0 254.3 17.3 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 1.6 6.6 0.5 4.9 0.2 0.5 0.1 0.4 0.0 0.1 0.1 0.0 0.3 TBRG4 "Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948" ENSG00000136270 "Transforming growth factor beta regulator 4" Q969Z0 7 45100100-45112047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020582, HPA050430" Approved Enhanced Mitochondria NA NA 23000 Mitochondria "HPA020582: AB_1857804, HPA050430: AB_2681125" "unprognostic (2.22e-1)" "unprognostic (4.75e-2)" "unprognostic (1.19e-1)" "unprognostic (3.46e-3)" "unprognostic (1.41e-2)" "unprognostic (9.29e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (3.15e-2)" "unprognostic (1.86e-1)" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (1.25e-2)" "unprognostic (3.66e-3)" "unprognostic (3.91e-2)" "unprognostic (3.84e-2)" "unprognostic (3.30e-1)" "unprognostic (1.52e-1)" 23.5 29.7 18.7 23.2 20.3 23.2 24.2 21.7 21.6 21.9 21.3 32.9 29.7 23.3 8.0 36.1 21.4 12.0 46.5 18.8 20.5 29.8 43.6 19.2 25.8 21.4 20.3 18.8 24.2 21.5 22.1 17.5 19.6 21.8 24.7 18.9 6.7 24.3 15.7 83.7 31.9 28.8 15.8 20.7 28.8 26.4 34.7 21.4 22.1 19.1 66.8 18.1 29.6 25.7 23.7 49.4 113.1 35.7 77.3 31.5 28.9 70.2 39.2 35.9 74.6 61.5 123.8 67.5 93.8 58.7 39.9 103.3 125.6 82.6 89.3 37.6 49.0 77.8 64.5 73.6 84.4 51.6 74.5 63.4 39.7 81.7 71.2 50.7 26.7 46.6 79.3 181.1 46.0 46.2 84.5 75.9 168.0 111.0 110.6 88.6 65.9 45.3 136.2 44.1 50.4 69.9 65.6 40.4 218.8 77.6 45.6 97.7 120.4 36.4 54.6 65.7 33.9 64.8 81.0 87.6 137.5 50.1 104.9 125.7 17.3 23.8 20.6 31.1 44.3 29.5 27.9 25.6 30.0 35.9 20.9 34.5 33.3 1.9 18.1 39.5 13.6 27.2 33.0 18.7 20.3 21.7 21.6 18.8 20.5 21.4 20.3 18.8 21.8 20.7 21.4 23.7 13.3 3.2 16.3 9.4 21.0 35.1 33.2 39.8 15.4 15.1 17.0 15.0 28.0 15.7 24.1 20.2 0.0 61.5 18.4 32.9 43.0 31.1 24.6 12.5 13.8 14.2 22.2 14.3 6.5 18.3 72.5 17.9 24.5 16.9 14.0 25.4 10.4 31.8 34.5 11.8 7.1 32.5 36.7 12.3 17.8 19.6 16.4 18.0 17.8 3.7 34.6 14.7 14.4 4.5 8.4 29.5 28.0 11.7 17.9 33.8 33.5 47.4 11.2 14.2 13.1 17.1 25.5 72.4 33.0 17.0 29.3 47.9 19.2 44.7 53.3 30.2 DDX56 NOH61 ENSG00000136271 "DEAD-box helicase 56" Q9NY93 7 44565804-44575051 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019749, CAB037320" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes NA Nucleoli "Mitotic chromosome" "CAB037320: , HPA019749: AB_1847579" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-2)" "unprognostic (1.93e-1)" "unprognostic (6.08e-3)" "unprognostic (2.12e-3)" "prognostic unfavorable (1.38e-5)" "unprognostic (5.17e-2)" "unprognostic (2.76e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-2)" "unprognostic (6.01e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (2.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 21.5 22.0 24.6 21.7 25.3 16.7 17.3 25.1 29.3 19.4 24.2 18.8 21.0 15.5 17.4 26.1 27.5 16.0 20.4 24.9 25.6 16.3 30.4 15.8 29.6 25.5 24.9 24.1 22.3 28.5 27.3 8.0 20.2 25.2 18.3 15.8 7.3 24.8 20.4 27.6 32.5 16.6 21.4 25.2 19.7 21.0 10.5 24.9 24.7 23.7 21.6 27.3 28.7 7.4 25.6 69.5 118.8 32.0 70.0 36.6 40.3 62.3 60.9 43.7 107.6 83.9 139.2 90.7 109.8 65.0 59.4 143.5 111.4 70.9 97.5 38.5 45.9 99.2 64.3 90.9 86.1 59.9 77.0 66.4 57.9 78.8 105.8 82.2 35.5 62.0 55.8 150.2 42.8 78.3 103.7 67.3 104.4 108.8 127.8 103.6 70.7 54.3 76.7 69.8 65.4 68.8 90.6 64.2 199.4 58.9 21.3 120.6 105.5 52.4 71.0 86.0 52.6 155.1 88.7 135.0 167.1 75.2 115.1 146.1 36.3 50.8 21.1 37.6 66.3 47.7 48.3 40.9 41.6 63.8 55.0 49.2 38.7 3.6 63.2 67.7 34.8 44.9 59.7 24.6 25.3 25.1 29.3 24.9 25.6 25.5 24.9 24.1 25.2 25.2 24.9 25.6 21.5 16.0 29.0 13.1 22.8 17.1 23.9 45.1 21.1 26.6 18.4 14.7 12.3 11.5 40.3 22.0 14.6 57.0 19.1 29.0 27.4 39.4 41.4 21.0 21.1 26.4 18.5 35.8 6.1 32.3 48.5 24.6 30.5 20.6 28.5 35.3 16.8 30.1 35.4 6.7 8.0 24.9 38.7 13.2 17.5 37.5 21.1 17.9 14.2 3.7 28.8 22.4 23.7 6.6 6.2 37.5 18.8 19.9 18.2 24.8 37.2 63.0 31.8 26.9 13.1 22.4 25.1 36.2 25.6 30.1 19.9 47.2 23.6 40.3 36.8 21.3 HUS1 ENSG00000136273 "HUS1 checkpoint clamp component" O60921 7 47963288-47979615 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026787 Approved NA NA "HPA026787: AB_10601431" "unprognostic (1.87e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (2.65e-1)" "unprognostic (1.73e-3)" "unprognostic (6.93e-3)" "unprognostic (8.83e-3)" "prognostic unfavorable (9.54e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.96e-3)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (4.19e-2)" "unprognostic (3.89e-2)" 6.0 8.5 4.6 5.7 4.9 8.4 5.3 5.4 7.5 5.4 6.1 7.4 6.9 5.8 5.7 8.5 4.2 4.2 6.5 4.5 4.9 7.2 11.3 6.4 7.5 5.0 5.0 4.2 5.5 6.3 9.8 6.4 7.6 5.1 5.3 8.7 3.5 6.1 4.2 11.2 4.4 5.4 7.9 4.7 5.3 4.3 3.6 5.5 7.0 6.3 7.0 7.7 6.9 6.1 5.5 8.8 16.7 10.7 18.2 9.8 10.0 9.0 20.2 8.4 11.1 10.2 11.8 10.8 9.3 10.2 15.5 57.4 13.6 11.9 15.8 24.3 10.5 8.2 5.2 16.5 9.5 10.3 9.5 12.4 7.0 20.2 12.8 7.0 9.1 18.8 8.4 10.1 10.5 31.8 11.7 13.0 24.8 13.2 15.7 15.2 8.1 7.9 14.7 15.8 24.1 14.6 18.8 13.4 19.8 9.9 20.3 15.3 22.6 9.4 22.1 15.0 31.9 23.0 8.3 19.6 17.2 17.6 17.6 35.4 18.6 14.2 8.2 12.6 13.4 12.7 9.1 11.9 13.7 12.6 10.0 12.5 12.9 3.3 14.9 9.0 14.9 14.1 9.5 4.6 4.9 5.4 7.5 4.5 4.9 5.0 5.0 4.2 5.1 4.7 5.5 5.5 20.0 3.2 6.2 4.2 22.8 9.7 16.2 12.7 11.4 11.3 9.0 7.1 16.8 4.3 13.2 11.0 10.4 17.9 18.6 26.1 21.5 17.1 29.6 11.0 17.5 16.5 6.7 8.6 5.9 14.7 31.1 11.2 7.1 16.1 23.5 14.3 10.0 16.7 23.7 13.5 6.2 10.8 14.2 12.8 17.7 48.2 9.3 23.3 17.8 8.4 20.0 8.1 15.5 6.6 8.2 18.6 37.9 11.7 15.8 10.7 16.5 15.8 7.4 14.9 0.0 12.6 10.7 12.8 6.7 11.7 7.2 31.9 20.8 11.0 9.4 15.0 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080437-45088969 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 79.8;pituitary gland: 24.5" "Cell type enhanced" "Detected in many" "Horizontal cells: 32.0;Oligodendrocytes: 23.1;Peritubular cells: 12.0" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 33.4;SCLC-21H: 25.6;SH-SY5Y: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020981, HPA079208" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020981: AB_2670549, HPA079208: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 3.2 5.2 25.1 1.2 42.3 0.1 3.2 45.5 34.3 5.9 0.0 6.5 0.7 8.0 0.8 2.0 5.5 1.8 4.4 22.0 31.4 2.2 0.2 2.5 0.7 52.9 44.7 16.7 8.9 1.0 0.9 24.5 1.9 73.6 4.3 0.8 3.7 1.7 3.0 1.2 1.6 3.0 4.4 36.2 1.6 4.0 3.7 44.0 0.3 1.3 1.0 0.3 5.1 4.7 79.8 0.0 0.0 2.5 0.1 1.6 0.7 0.1 2.9 3.5 7.7 4.8 0.2 0.1 0.0 2.2 5.1 33.4 0.2 2.2 1.9 2.7 0.0 0.8 0.0 1.7 0.0 1.8 0.0 0.0 1.6 0.0 3.3 0.3 4.1 2.4 0.0 0.0 3.5 2.0 0.0 0.0 0.0 2.3 0.0 2.2 0.0 0.9 0.0 0.3 0.0 25.6 17.7 0.0 0.1 0.1 6.7 0.0 0.1 0.9 0.0 0.0 0.2 0.5 1.8 1.0 0.0 1.5 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 25.1 42.3 45.5 34.3 22.0 31.4 52.9 44.7 16.7 73.6 36.2 44.0 79.8 0.3 0.0 0.0 6.8 0.0 0.6 3.5 0.9 1.2 5.5 0.4 1.8 6.0 0.0 0.2 1.8 0.0 0.1 0.4 0.1 0.0 0.6 2.9 0.5 3.1 0.9 1.2 0.0 4.4 0.2 0.1 3.9 1.1 1.2 1.3 3.9 0.7 0.0 0.1 32.0 5.2 0.0 0.0 0.0 0.0 4.9 6.8 0.7 1.8 1.9 1.0 2.7 0.0 3.0 23.1 0.1 0.0 12.0 0.1 2.3 0.0 0.4 0.8 2.8 6.6 5.3 4.2 1.5 1.4 0.2 0.1 0.1 0.3 9.6 0.1 0.9 DBNL "ABP1, HIP-55, SH3P7" ENSG00000136279 "Drebrin like" Q9UJU6 7 44044640-44069456 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Endocytosis, Immunity, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 338.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020265, HPA027735" Enhanced Supported "Vesicles,Plasma membrane" NA NA 3500000 "Vesicles, Plasma membrane" "HPA020265: AB_1850723, HPA027735: AB_10603790" "unprognostic (9.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (2.25e-1)" "unprognostic (6.18e-3)" "unprognostic (1.83e-1)" "unprognostic (5.88e-2)" "unprognostic (8.92e-2)" "unprognostic (5.76e-3)" "unprognostic (5.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (1.46e-1)" "unprognostic (9.51e-2)" 55.7 52.0 40.3 63.3 41.8 77.3 51.7 38.5 50.8 60.2 35.8 55.0 35.0 56.5 20.4 190.5 48.2 47.6 43.3 42.1 40.5 49.9 51.5 58.3 100.4 42.9 41.2 40.7 38.3 44.7 38.7 48.1 35.2 42.8 57.5 30.9 9.4 58.0 38.4 34.6 57.8 65.2 45.2 40.8 120.4 55.1 21.0 41.0 65.4 47.9 16.5 89.8 60.8 92.7 41.2 57.6 89.1 60.5 56.6 77.0 49.7 46.0 95.9 93.6 111.5 91.5 90.0 82.5 132.3 70.0 126.1 133.6 101.9 35.6 130.6 40.7 70.6 38.9 51.9 73.8 52.4 78.5 75.8 70.3 46.6 53.3 107.1 35.2 71.5 74.1 83.9 63.8 49.3 105.5 91.5 136.5 85.3 43.1 72.9 73.0 69.4 48.1 64.5 69.8 90.5 65.6 89.8 69.6 121.5 24.4 43.8 94.0 99.4 121.1 82.7 75.5 49.5 113.6 102.7 49.4 81.2 78.3 83.2 183.8 263.3 377.1 295.0 190.3 422.7 148.3 253.9 138.0 155.0 362.5 261.7 136.5 145.1 357.4 192.4 437.9 376.6 183.1 558.8 40.3 41.8 38.5 50.8 42.1 40.5 42.9 41.2 40.7 42.8 40.8 41.0 41.2 49.9 44.8 36.2 10.7 105.4 17.6 34.1 62.9 19.4 33.0 26.7 24.0 30.6 25.8 42.2 31.3 35.5 78.9 101.6 58.5 45.0 87.0 10.3 30.7 39.3 44.8 37.8 45.8 7.4 73.2 146.4 39.3 54.6 50.7 65.9 42.3 32.5 22.5 176.0 40.4 6.7 50.0 38.7 129.6 48.6 10.6 37.0 113.4 55.2 7.5 338.3 42.5 112.3 5.5 11.4 105.9 74.0 33.8 50.2 31.5 49.0 33.6 21.6 38.6 6.6 29.0 54.6 24.4 12.8 64.4 26.7 87.3 69.5 51.9 44.0 51.1 CCM2 "C7orf22, MGC4607, OSM" ENSG00000136280 "CCM2 scaffold protein" Q9BSQ5 7 44999475-45076469 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 140.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020273, HPA021669, HPA065815" Supported Enhanced Mitochondria NA NA Mitochondria "HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562" "unprognostic (4.30e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.17e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.37e-3)" "unprognostic (3.92e-1)" "unprognostic (2.65e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.03e-1)" "prognostic unfavorable (5.06e-7)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (2.81e-2)" "unprognostic (2.48e-1)" 31.0 41.0 63.8 25.4 67.7 15.6 26.8 56.4 89.8 19.1 46.6 28.4 13.4 20.5 6.4 22.6 19.1 11.6 33.1 60.7 60.1 24.2 86.7 29.4 43.9 63.9 61.4 58.5 16.2 26.8 21.5 30.7 14.6 65.1 24.0 10.9 9.4 18.9 14.6 48.6 21.0 27.8 17.1 56.3 55.0 24.2 30.6 69.9 45.8 18.9 37.2 29.8 27.4 20.2 66.4 38.7 41.8 24.4 49.2 45.5 39.8 17.7 45.9 37.3 32.0 43.3 30.6 39.3 53.7 34.5 58.5 101.8 49.5 15.3 58.9 21.4 61.0 29.7 23.3 34.0 22.1 39.9 9.9 61.5 44.7 38.0 56.3 24.0 30.0 59.2 76.8 27.5 42.1 64.7 58.2 47.9 131.6 28.4 32.3 46.1 25.7 14.2 43.9 33.1 36.8 46.9 36.8 37.5 29.2 20.9 31.7 33.3 45.7 45.1 43.4 36.4 44.2 44.8 75.9 64.0 109.2 42.3 35.7 53.4 108.1 33.5 105.8 52.2 40.2 35.2 42.0 62.3 57.4 23.6 43.6 58.9 44.1 103.9 60.9 47.7 23.8 167.1 40.2 63.8 67.7 56.4 89.8 60.7 60.1 63.9 61.4 58.5 65.1 56.3 69.9 66.4 28.7 19.2 19.4 26.1 57.5 46.8 22.6 27.6 54.7 19.0 13.5 24.6 13.0 20.0 18.8 14.7 4.2 28.3 53.7 30.5 25.4 30.2 6.9 6.0 14.3 26.7 15.6 13.7 33.3 38.5 35.8 25.0 11.2 7.4 36.1 23.8 30.4 56.5 49.3 82.4 24.9 15.2 12.2 47.9 51.1 12.8 21.1 47.7 33.8 56.2 140.0 34.1 122.6 20.1 51.7 45.3 11.4 20.3 69.1 40.4 13.6 22.9 8.0 14.4 19.7 16.2 29.6 15.3 37.8 16.8 23.0 10.4 55.7 36.9 15.2 19.7 MYO1G HA-2 ENSG00000136286 "Myosin IG" B0I1T2 7 44962662-44979088 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.0;lymphoid tissue: 27.4" "Cell type enhanced" "Detected in many" "dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA021252 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA021252: AB_1854254" "unprognostic (2.74e-2)" "prognostic favorable (8.26e-4)" "unprognostic (5.20e-3)" "unprognostic (9.91e-3)" "unprognostic (1.27e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (4.54e-3)" "unprognostic (6.47e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (8.71e-8)" "unprognostic (3.20e-1)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (7.92e-2)" 2.2 0.8 0.4 16.7 0.3 44.0 1.0 0.3 0.7 0.8 0.3 2.0 3.4 0.7 0.3 1.5 1.2 3.6 0.7 0.2 1.1 0.9 1.3 12.1 25.3 1.3 0.4 0.2 0.3 0.7 0.1 0.5 1.2 0.7 1.1 1.8 0.0 2.3 0.7 0.3 0.9 7.8 2.8 0.6 19.1 3.3 0.4 1.2 27.4 1.6 0.4 14.9 6.2 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 52.6 0.0 64.1 2.7 0.0 0.0 39.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 97.3 52.1 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 57.3 0.0 41.5 58.3 18.5 61.5 95.5 38.4 27.7 40.5 55.6 42.7 18.9 14.1 29.6 6.0 23.9 129.8 4.5 79.9 79.9 0.4 0.3 0.3 0.7 0.2 1.1 1.3 0.4 0.2 0.7 0.6 1.2 0.9 0.9 3.2 7.7 0.0 55.7 2.8 0.4 0.0 0.0 0.2 1.2 1.3 1.1 1.5 1.3 0.0 0.0 0.2 81.3 0.2 0.0 0.3 0.6 0.3 0.5 1.0 0.0 6.3 0.1 1.1 0.3 2.3 2.0 0.6 30.4 0.4 2.2 1.4 10.5 3.3 0.0 0.2 0.0 58.7 65.1 1.6 0.0 74.2 3.6 0.0 392.2 0.3 252.4 0.5 0.0 0.2 0.1 0.4 33.4 0.4 0.0 0.6 0.7 0.2 6.6 2.0 1.4 3.8 1.2 0.2 1.7 0.1 87.1 1.2 0.1 0.2 TTYH3 KIAA1691 ENSG00000136295 "Tweety family member 3" Q9C0H2 7 2631986-2664802 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 135.0;Kupffer cells: 85.0;Melanocytes: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 10.0;non-classical monocyte: 8.4" "Lineage enriched" "Detected in many" 4 "monocytes: 10.0" "Cell line enhanced" "Detected in all" "U-2 OS: 205.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053520 Uncertain NA NA 55000 "HPA053520: AB_2682176" "unprognostic (2.53e-2)" "unprognostic (6.65e-3)" "unprognostic (3.86e-3)" "unprognostic (1.35e-1)" "unprognostic (5.25e-2)" "unprognostic (7.42e-2)" "prognostic unfavorable (2.53e-5)" "unprognostic (5.53e-2)" "unprognostic (1.96e-1)" "unprognostic (8.59e-3)" "unprognostic (5.40e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.58e-5)" "unprognostic (7.90e-2)" "unprognostic (5.45e-2)" "unprognostic (1.03e-1)" "unprognostic (8.85e-2)" 23.2 29.7 30.5 31.0 27.1 11.9 16.4 34.4 39.6 18.0 2.9 14.6 20.1 18.8 1.9 7.8 16.8 18.5 12.1 23.8 8.5 42.7 37.7 25.8 19.5 13.7 17.6 26.9 15.1 9.6 4.7 14.3 24.0 14.0 21.1 6.8 5.4 25.6 7.3 3.9 12.1 27.9 10.7 5.9 41.1 13.4 14.5 25.4 11.8 21.8 1.7 7.4 14.8 11.5 13.0 43.8 84.9 88.0 123.7 24.2 21.7 98.5 69.4 61.8 29.8 34.9 35.3 30.9 3.6 82.4 66.1 78.8 19.3 12.7 31.5 8.4 5.9 42.9 21.8 17.9 98.7 32.3 4.5 13.2 52.0 15.1 32.0 8.3 55.5 99.4 21.6 6.7 4.7 20.1 25.5 16.1 47.0 112.7 61.7 32.9 66.3 63.7 4.1 47.0 47.0 36.8 185.1 42.8 8.2 40.3 58.1 22.3 117.5 117.9 69.3 205.4 40.9 78.6 8.0 5.3 12.1 50.0 16.1 152.7 0.0 4.9 1.5 0.2 10.0 0.2 0.3 0.1 0.1 2.2 0.3 0.3 0.0 0.5 0.3 8.4 1.0 0.2 3.4 30.5 27.1 34.4 39.6 23.8 8.5 13.7 17.6 26.9 14.0 5.9 25.4 13.0 8.6 0.0 4.2 38.5 4.8 6.5 1.8 12.9 2.2 9.0 10.2 7.1 2.7 18.6 8.8 9.2 4.2 1.8 2.9 9.6 3.9 20.3 0.5 2.8 12.8 21.0 7.8 1.7 22.4 5.2 28.8 9.0 7.1 6.0 2.5 19.4 15.4 21.1 135.0 30.3 25.4 20.5 8.2 85.0 32.6 5.2 8.1 52.4 56.9 17.8 30.7 4.0 2.1 8.5 6.1 20.2 2.7 3.8 1.5 5.0 28.3 32.2 3.8 2.2 6.6 2.2 8.0 1.7 2.3 1.2 3.7 2.5 3.8 4.9 11.2 3.1 MMD2 PAQR10 ENSG00000136297 "Monocyte to macrophage differentiation associated 2" Q8IY49 7 4905989-4959213 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 25.9;retina: 6.2;testis: 7.1" "Group enriched" "Detected in some" 14 "Astrocytes: 253.4;Oligodendrocyte precursor cells: 121.2" "Cancer enriched" "Detected in single" 59 "glioma: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.32e-1)" "unprognostic (1.53e-2)" "unprognostic (5.03e-2)" "unprognostic (2.03e-1)" 0.0 0.2 21.4 0.0 23.2 0.0 0.0 8.2 16.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 20.3 0.0 0.0 0.0 0.0 25.9 19.8 13.5 0.1 0.0 0.0 3.2 0.0 21.6 0.0 0.0 6.2 0.1 0.1 0.0 0.0 0.1 0.0 13.1 0.0 0.0 7.1 24.9 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 23.2 8.2 16.5 21.6 20.3 25.9 19.8 13.5 21.6 13.1 24.9 16.2 0.0 0.0 0.0 253.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 13.1 0.0 2.6 0.0 121.2 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CIDEB ENSG00000136305 "Cell death inducing DFFA like effector b" Q9UHD4 14 24305096-24311430 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 313.3" "Group enriched" "Detected in many" 5 "Hepatocytes: 258.9;Proximal enterocytes: 301.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 21.5;HEL: 11.0;Hep G2: 24.0;HL-60: 15.5;Karpas-707: 10.6;U-266/84: 14.8;U-937: 17.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA001272 Approved NA NA "HPA001272: AB_2666255" "unprognostic (2.62e-2)" "unprognostic (6.55e-2)" "unprognostic (2.62e-3)" "unprognostic (9.35e-2)" "unprognostic (2.38e-3)" "unprognostic (1.83e-2)" "unprognostic (1.57e-1)" "unprognostic (8.48e-4)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (3.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.43e-2)" "unprognostic (6.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.64e-1)" 12.0 37.5 1.6 5.6 1.6 12.4 11.7 2.3 2.3 14.7 2.1 9.8 71.2 8.7 4.5 35.7 13.0 3.9 7.1 1.5 2.1 30.7 313.3 10.6 4.9 1.9 1.9 1.4 25.6 19.4 1.9 12.3 2.0 1.9 11.3 3.5 0.2 14.3 4.8 2.5 21.9 58.6 4.1 2.0 89.6 8.1 2.2 2.3 3.6 7.7 1.3 7.3 8.7 20.2 1.8 0.0 0.0 0.0 0.0 1.4 0.6 0.2 0.4 0.1 0.2 0.1 1.4 0.5 0.0 0.0 0.6 0.0 2.0 0.0 0.2 0.0 21.5 0.0 11.0 0.0 24.0 0.1 15.5 0.0 0.5 0.0 0.0 0.0 0.0 4.8 0.0 0.0 10.6 0.0 0.0 0.1 7.3 0.0 5.6 0.0 1.8 0.1 5.5 0.0 0.7 4.5 0.0 5.9 0.1 0.0 0.1 0.0 5.3 0.2 0.0 0.0 0.0 0.0 8.4 14.8 0.1 0.0 17.9 0.0 0.9 5.2 6.9 3.4 1.8 3.2 0.5 2.2 2.1 5.2 0.4 1.4 1.7 2.9 5.2 0.9 1.3 1.3 2.0 1.6 1.6 2.3 2.3 1.5 2.1 1.9 1.9 1.4 1.9 2.0 2.3 1.8 8.8 0.0 1.7 0.0 6.9 7.0 6.4 5.6 29.6 0.4 4.6 5.6 0.0 11.5 3.3 1.8 2.1 0.1 15.0 14.4 9.8 1.5 0.1 4.3 2.0 7.0 1.8 13.0 0.0 9.6 0.2 4.0 5.1 1.2 8.8 0.3 12.5 258.9 7.9 0.0 0.1 11.7 8.2 30.5 2.6 0.5 6.2 13.2 5.4 1.0 8.8 0.6 21.6 0.0 0.1 15.4 24.4 3.0 7.2 0.7 301.5 51.6 10.5 0.6 0.0 0.9 2.8 0.2 2.3 33.4 6.1 0.3 11.1 3.6 8.6 1.8 TTC5 Strap ENSG00000136319 "Tetratricopeptide repeat domain 5" Q8N0Z6 14 20256558-20305960 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045008, HPA054198" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045008: AB_10960209, HPA054198: AB_2682414" "unprognostic (2.19e-3)" "unprognostic (1.00e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.39e-2)" "unprognostic (6.48e-2)" "unprognostic (8.15e-2)" "unprognostic (6.82e-2)" "unprognostic (4.68e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.54e-4)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (5.07e-2)" 2.1 2.8 2.9 1.9 2.9 2.9 3.9 2.2 3.1 3.1 4.1 2.2 2.2 3.1 3.2 2.3 5.8 2.2 1.8 2.5 2.9 3.6 1.4 2.6 3.2 2.2 2.5 2.4 3.0 1.9 6.2 2.1 2.5 2.2 3.8 2.3 2.6 2.3 3.0 0.7 3.4 1.6 2.9 1.7 2.4 2.5 2.5 3.5 2.6 5.0 2.3 3.1 2.3 1.7 2.7 3.4 5.4 6.5 0.7 4.7 6.8 3.5 4.3 5.0 6.4 6.6 2.4 7.6 7.2 2.7 4.5 3.3 2.8 6.4 3.0 9.8 6.3 2.4 5.9 2.2 4.3 4.8 11.0 3.5 4.2 6.7 5.6 7.2 5.8 6.3 5.1 4.3 3.5 6.3 4.6 6.5 4.6 5.5 5.6 5.2 3.4 4.8 5.2 5.6 3.5 2.2 4.3 4.9 5.1 3.0 2.6 4.0 5.3 6.6 2.5 4.1 3.4 2.3 5.0 4.7 8.9 2.0 4.6 6.0 1.3 2.0 2.9 2.7 2.0 2.3 2.7 2.0 2.2 2.2 3.0 2.1 2.5 0.8 3.0 2.9 1.6 2.7 2.0 2.9 2.9 2.2 3.1 2.5 2.9 2.2 2.5 2.4 2.2 1.7 3.5 2.7 13.9 12.8 7.2 6.5 15.2 6.4 9.4 21.5 13.6 15.5 9.4 12.8 4.3 12.8 9.8 18.4 16.7 20.4 12.2 2.3 11.7 10.6 1.6 27.7 13.4 12.3 9.0 6.7 18.2 6.5 12.4 12.5 8.6 7.9 12.0 16.0 10.8 6.4 15.4 5.0 12.4 6.9 18.3 11.2 6.8 3.4 10.2 10.5 7.2 6.5 11.5 12.4 19.6 11.6 8.7 6.4 5.0 9.8 7.8 4.6 8.6 13.1 32.8 19.4 6.6 14.1 11.6 26.6 36.1 8.8 8.7 4.7 12.7 14.6 8.3 5.3 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580004-36582614 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;esophagus: 2.6;testis: 8.0" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;PC-3: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.0 0.0 0.9 0.0 1.0 0.0 0.0 1.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.0 1.9 1.2 0.1 0.0 0.0 0.1 1.1 0.0 2.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 8.0 1.9 0.0 1.4 0.0 0.0 0.0 0.0 4.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 3.6 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 1.2 0.6 0.2 2.1 1.9 1.2 0.1 2.2 2.8 1.9 4.9 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.9 6.8 0.0 1.0 1.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.4 0.4 0.0 0.0 0.0 0.0 0.4 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lung: 53.5;thyroid gland: 173.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Group enriched" "Detected in many" 4 "hypothalamus: 19.8;thalamus: 10.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SCLC-21H: 78.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.2;hypothalamus: 10.2" "Group enriched" "Detected in some" 13 "basal ganglia: 4.3;hypothalamus: 10.4" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.0 0.1 3.7 0.0 1.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.0 53.5 0.0 0.5 0.2 0.5 0.1 0.1 0.0 12.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 10.6 0.0 173.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 78.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.9 0.0 3.2 0.0 19.8 0.5 0.2 0.5 1.5 0.0 10.6 0.1 0.0 137.8 124.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520857-23556192 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;testis: 7.4" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;SuSa: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 0.4 0.7 2.0 0.5 5.2 0.1 0.4 10.5 5.5 0.3 0.0 0.5 0.1 0.7 0.4 0.2 2.2 0.4 0.3 3.5 0.0 1.1 0.2 0.5 0.3 2.5 0.6 2.1 0.5 0.5 1.7 3.4 0.2 5.3 0.6 0.2 3.1 0.4 1.2 0.7 0.5 0.3 0.6 0.0 0.2 0.4 7.4 0.9 0.2 0.7 0.5 0.2 0.3 0.2 2.6 0.1 3.1 2.4 4.8 1.6 0.2 0.1 0.7 0.2 0.3 1.2 0.3 0.2 0.2 0.3 0.0 0.3 0.1 1.2 0.1 0.5 2.2 0.8 2.5 0.0 0.6 0.2 0.4 1.7 0.3 0.1 0.5 0.1 1.3 0.3 2.1 0.4 0.4 0.1 0.8 0.3 0.3 2.9 0.3 0.7 1.4 0.0 0.0 1.3 1.2 2.7 1.7 0.4 0.6 0.1 3.6 1.0 0.6 0.1 0.0 1.2 0.7 0.3 0.3 1.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 5.2 10.5 5.5 3.5 0.0 2.5 0.6 2.1 5.3 0.0 0.9 2.6 0.5 0.0 1.1 22.5 0.7 0.1 0.6 1.1 0.0 9.0 2.2 2.3 2.5 0.0 2.4 1.8 0.0 0.3 0.1 0.6 1.9 2.8 38.9 12.2 0.6 1.1 6.7 0.0 31.0 2.4 0.0 1.4 2.0 2.5 0.0 3.2 0.7 0.2 1.0 8.4 20.0 0.7 2.0 1.0 1.9 19.1 0.6 0.8 0.0 4.7 1.0 2.7 0.0 27.2 20.8 1.2 1.2 0.4 0.1 1.4 0.4 1.4 9.8 3.8 0.0 2.5 1.3 16.5 1.2 0.7 0.0 0.3 0.4 0.2 0.6 0.3 MTHFS HsT19268 ENSG00000136371 "Methenyltetrahydrofolate synthetase" P49914 15 79833585-79897379 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 255.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 134.1" "Group enriched" "Detected in all" 5 "granulocytes: 134.1;monocytes: 49.1" "Low cell line specificity" "Detected in many" "HPA008067, HPA054177" Approved Supported Cytosol NA NA 13000 Cytosol "HPA008067: AB_1078882, HPA054177: AB_2682405" "unprognostic (4.57e-2)" "unprognostic (9.76e-2)" "unprognostic (6.11e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (9.13e-3)" "prognostic favorable (1.29e-6)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "unprognostic (6.18e-3)" "unprognostic (2.91e-2)" "unprognostic (2.76e-1)" "prognostic favorable (2.04e-4)" "unprognostic (1.36e-1)" "unprognostic (2.85e-1)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" 19.7 20.0 8.9 4.7 8.9 5.0 19.1 10.2 12.8 9.9 8.3 11.8 13.8 9.1 10.4 10.2 9.4 7.1 17.1 8.7 9.4 52.4 255.4 17.9 6.4 9.4 9.3 8.9 8.7 33.0 26.5 21.7 8.4 9.8 19.7 6.5 6.0 13.7 5.5 20.3 5.7 14.6 6.2 9.9 15.1 19.6 12.2 9.3 10.7 16.0 11.2 10.8 12.5 10.0 9.8 12.6 35.8 5.0 2.6 15.8 12.0 11.9 8.8 13.0 16.4 10.5 34.5 22.4 15.1 25.1 15.5 15.0 19.5 31.9 10.7 15.4 14.7 28.4 14.8 22.9 39.8 25.3 7.8 0.8 17.5 27.8 8.1 23.0 19.6 7.4 16.0 28.8 12.0 17.4 36.0 10.2 36.1 15.6 51.4 17.0 10.8 17.2 25.8 35.1 34.3 8.9 4.8 25.1 14.2 43.8 20.0 17.3 13.0 3.3 5.7 11.1 3.6 7.1 6.8 20.2 17.8 3.3 25.9 6.2 17.5 25.7 73.5 9.4 35.3 12.4 13.5 13.7 12.9 12.3 11.1 16.5 12.6 134.1 17.8 49.1 13.3 15.7 19.1 8.9 8.9 10.2 12.8 8.7 9.4 9.4 9.3 8.9 9.8 9.9 9.3 9.8 11.3 19.2 44.0 0.0 20.7 10.7 9.9 63.0 35.9 0.0 25.5 32.5 0.7 58.6 34.3 22.0 0.0 68.1 10.1 10.0 64.6 55.8 2.2 11.9 7.8 10.5 17.6 36.6 0.0 75.7 37.1 13.5 39.8 11.0 8.8 7.2 21.8 205.5 45.7 0.0 0.0 18.7 24.4 22.1 34.8 3.8 13.7 29.3 21.4 0.0 150.8 0.0 35.0 0.0 0.0 75.3 35.9 15.8 13.3 13.3 101.7 201.6 29.9 0.0 13.1 8.4 10.5 6.7 8.5 21.1 8.1 253.8 22.2 9.2 24.9 7.7 ADAMTS7 "ADAM-TS7, DKFZp434H204" ENSG00000136378 "ADAM metallopeptidase with thrombospondin type 1 motif 7" Q9UKP4 15 78759206-78811464 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.2" "Cell type enriched" "Detected in some" 4 "Theca cells: 44.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "HMC-1: 259.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA045284, HPA048453" Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA045284: AB_2679285, HPA048453: AB_2680399" "unprognostic (5.94e-3)" "unprognostic (9.94e-3)" "unprognostic (2.76e-2)" "unprognostic (7.09e-2)" "unprognostic (3.38e-1)" "unprognostic (1.93e-1)" "unprognostic (5.88e-4)" "unprognostic (3.34e-3)" "unprognostic (2.89e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-2)" "unprognostic (3.79e-1)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (8.86e-2)" 6.2 5.3 0.4 1.8 0.3 0.1 3.9 0.2 0.5 6.0 0.5 3.5 1.1 7.2 0.1 0.9 2.3 2.3 21.2 0.3 0.5 2.2 1.1 6.4 0.9 0.4 0.4 0.1 6.2 0.6 0.4 0.8 2.1 0.4 1.8 0.2 0.5 1.3 0.5 1.1 1.6 2.7 1.4 0.1 5.2 2.2 4.1 0.5 0.2 2.1 0.5 0.2 3.0 2.6 0.4 0.0 1.1 16.5 7.5 6.9 8.2 20.9 3.7 1.3 1.0 0.6 0.0 0.1 0.0 4.8 0.4 1.0 0.4 0.4 2.0 0.0 0.3 0.6 2.1 0.5 0.1 6.9 0.0 259.9 3.3 2.0 1.9 1.0 5.3 24.0 0.0 0.3 0.7 5.6 0.0 0.1 4.9 4.7 0.0 1.4 17.3 7.7 0.3 0.5 0.9 0.3 23.9 4.8 0.0 0.6 4.0 3.2 0.4 29.8 9.4 1.0 3.3 0.0 0.1 0.0 0.0 1.6 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.5 0.3 0.5 0.4 0.4 0.1 0.4 0.1 0.5 0.4 7.5 0.0 0.0 3.6 0.3 0.4 0.2 0.7 0.0 0.3 0.1 0.5 9.8 0.0 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.1 4.9 0.8 7.5 10.5 0.0 0.0 0.1 0.0 0.3 10.1 0.5 0.9 3.8 7.2 2.9 0.3 0.7 0.0 0.2 0.0 2.0 0.0 0.8 2.7 1.5 0.1 1.8 1.0 0.1 1.3 0.0 9.5 1.4 0.3 0.0 1.9 0.0 0.3 0.0 0.1 0.3 0.1 0.0 3.7 5.0 2.6 2.0 0.2 0.1 0.3 0.5 44.9 0.1 0.3 ABHD17C FAM108C1 ENSG00000136379 "Abhydrolase domain containing 17C, depalmitoylase" Q6PCB6 15 80679684-80755621 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 201.4;Intestinal goblet cells: 103.7;Urothelial cells: 86.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 127.1;RT4: 102.6;SK-MEL-30: 119.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048890 Uncertain NA NA "HPA048890: AB_2680546" "unprognostic (3.60e-1)" "unprognostic (5.07e-2)" "unprognostic (1.58e-1)" "unprognostic (2.19e-2)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.59e-2)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (2.59e-2)" "unprognostic (5.08e-3)" "unprognostic (2.87e-1)" "unprognostic (1.23e-3)" "unprognostic (5.75e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.89e-3)" 2.6 4.8 18.2 10.4 17.3 6.0 11.8 15.2 18.6 19.4 13.8 65.9 23.5 6.1 2.2 46.9 11.0 6.3 4.3 19.7 17.7 14.7 5.7 19.7 7.3 16.9 16.9 17.2 2.0 8.0 7.1 6.0 4.7 15.3 18.2 56.8 17.0 23.8 3.5 1.8 18.8 30.9 5.6 16.8 8.2 36.4 5.2 16.9 5.7 8.1 2.8 23.2 29.0 21.4 16.4 26.4 24.7 15.7 19.8 5.7 11.6 26.8 24.9 93.0 20.7 20.0 20.6 57.7 8.7 9.9 26.4 14.7 52.7 44.1 23.0 18.5 62.0 25.0 0.1 17.7 22.1 9.9 8.0 12.3 24.9 27.1 15.0 7.4 17.9 22.6 9.1 0.2 10.8 12.1 73.3 0.7 0.8 23.3 127.1 9.2 17.4 13.4 24.5 17.0 102.6 13.9 5.7 19.8 33.7 119.9 6.8 16.8 13.5 7.7 12.8 10.5 14.1 22.4 0.8 0.3 8.6 8.3 71.6 14.3 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 18.2 17.3 15.2 18.6 19.7 17.7 16.9 16.9 17.2 15.3 16.8 16.9 16.4 2.0 12.8 12.5 32.3 1.4 7.1 13.2 14.3 9.6 4.8 15.7 9.4 5.3 17.2 11.1 7.3 8.4 2.2 2.8 201.4 45.0 6.5 0.3 13.4 7.8 6.9 14.5 0.8 18.4 8.9 5.8 3.1 39.8 35.4 0.0 3.0 6.4 6.0 1.1 10.1 20.1 103.7 10.2 1.3 1.5 0.7 1.2 5.9 8.8 6.5 1.4 4.8 0.0 12.1 3.1 28.1 58.6 0.0 2.4 34.5 46.3 5.6 10.5 22.4 0.0 1.0 2.0 0.7 6.0 19.3 22.7 1.0 2.6 19.6 53.2 86.1 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501453 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064" "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 17.3 25.4 7.3 18.4 8.2 27.9 19.0 17.0 9.4 15.3 8.3 17.5 18.0 18.1 11.9 15.4 14.8 15.0 12.6 7.8 10.3 18.5 23.3 15.1 23.0 7.4 8.5 6.6 22.2 11.5 17.9 8.3 22.0 9.2 16.7 20.5 19.5 10.7 15.6 19.0 14.5 18.6 16.2 7.0 25.0 16.6 15.3 9.0 29.9 28.9 23.7 21.0 13.5 11.8 8.1 19.9 34.9 52.8 33.2 45.5 29.7 35.5 33.3 26.0 29.7 26.9 34.6 33.8 73.1 22.1 28.0 20.3 37.8 124.7 33.2 26.1 23.4 43.0 63.6 35.0 24.4 23.8 69.4 65.7 31.5 22.4 22.9 27.7 30.2 35.4 42.6 67.9 25.4 25.5 29.7 42.8 35.2 69.1 24.1 12.4 49.6 53.0 20.8 32.4 54.2 31.7 47.3 45.1 31.4 35.7 59.2 29.5 59.7 28.9 30.3 20.8 16.8 29.2 31.5 74.8 41.7 21.8 63.1 22.2 3.8 2.5 2.0 2.4 3.3 3.1 2.7 2.6 2.4 3.5 2.6 2.5 3.5 2.8 3.0 2.6 4.0 2.3 1.4 7.3 8.2 17.0 9.4 7.8 10.3 7.4 8.5 6.6 9.2 7.0 9.0 8.1 24.3 22.4 40.7 33.0 37.5 14.1 16.6 19.3 14.8 55.6 23.1 18.4 24.9 25.8 26.1 23.9 66.7 35.0 56.2 45.3 0.0 19.9 18.1 19.3 38.2 26.6 31.9 42.3 52.3 19.6 23.7 27.7 32.1 21.2 17.7 66.2 38.9 41.8 26.1 79.1 55.6 31.0 18.3 61.3 18.4 10.8 32.9 37.7 14.2 28.1 52.9 22.4 54.6 50.3 49.0 26.3 49.8 30.5 28.5 33.7 49.1 19.6 25.7 51.1 6.6 29.5 23.2 33.9 29.6 24.5 18.6 30.6 33.9 56.3 36.0 29.6 ALPK3 "KIAA1330, MAK, Midori" ENSG00000136383 "Alpha kinase 3" Q96L96 15 84817356-84873479 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 54.5;skeletal muscle: 197.4;tongue: 59.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 64.1;Exocrine glandular cells: 20.5;Skeletal myocytes: 51.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.3;HDLM-2: 10.7;HUVEC TERT2: 15.5;LHCN-M2: 21.2;NTERA-2: 12.9;RH-30: 37.7;THP-1: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA026558 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026558: AB_1844774" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (4.61e-2)" "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.74e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.95e-7)" "unprognostic (1.76e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (4.87e-2)" 12.6 9.7 2.2 1.0 1.6 0.1 4.5 1.1 2.0 2.1 8.7 5.6 0.6 1.5 5.5 3.0 1.7 1.8 54.5 1.4 3.4 8.5 6.0 5.6 0.6 2.0 3.3 0.9 0.8 7.8 11.3 26.3 2.5 3.1 2.5 0.8 2.5 2.7 1.3 197.4 0.7 2.1 3.2 1.8 0.5 5.2 1.0 3.0 0.6 3.6 59.6 0.4 3.6 1.4 4.0 1.8 0.1 0.1 0.2 0.3 0.1 14.3 0.0 0.0 0.0 0.1 0.1 6.3 0.0 0.4 0.0 0.1 1.1 0.0 0.0 0.1 10.7 1.7 1.8 0.3 0.0 0.2 0.0 0.1 1.3 0.2 0.0 0.0 0.1 15.5 0.1 0.0 0.1 21.2 0.9 0.0 0.2 12.9 0.3 0.1 0.0 37.7 0.2 0.0 4.0 0.0 0.2 0.0 2.0 0.1 1.9 0.1 9.6 0.3 0.1 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.6 1.1 2.0 1.4 3.4 2.0 3.3 0.9 3.1 1.8 3.0 4.0 3.3 6.4 2.7 2.6 0.2 0.9 0.1 0.6 1.2 4.1 1.3 0.8 64.1 17.2 2.4 9.2 16.7 0.3 0.2 0.5 0.0 2.9 0.3 11.5 1.0 8.7 9.1 0.0 3.0 20.5 0.7 3.8 0.5 8.9 1.3 8.7 1.8 1.7 10.2 0.0 3.4 0.3 0.0 0.3 12.0 0.0 0.0 5.2 3.6 9.4 4.7 1.0 1.0 0.5 0.3 10.4 1.2 0.0 1.5 0.7 0.1 2.2 4.2 3.4 0.0 51.9 8.4 0.5 3.2 0.2 0.1 0.7 0.5 0.2 0.3 1.6 TM6SF1 ENSG00000136404 "Transmembrane 6 superfamily member 1" Q9BZW5 15 83107572-83144854 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 47.7" "Cell type enhanced" "Detected in many" "Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 195.8" "Cell line enhanced" "Detected in some" "HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016051, HPA056857" Uncertain NA NA "HPA016051: AB_2203924, HPA056857: AB_2683259" "unprognostic (8.09e-2)" "unprognostic (1.31e-1)" "unprognostic (2.87e-2)" "unprognostic (4.67e-1)" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (6.46e-2)" "unprognostic (3.52e-3)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.80e-1)" "unprognostic (2.55e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.15e-2)" "unprognostic (4.65e-3)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" 6.5 4.0 7.2 5.3 8.1 5.4 4.6 9.9 8.5 3.3 8.6 2.7 2.0 2.9 2.2 3.1 2.9 3.7 9.6 7.3 8.1 1.9 2.3 10.8 5.7 8.8 7.7 7.1 1.7 1.2 1.9 0.9 7.9 8.7 2.1 2.6 2.8 2.9 1.3 47.7 1.8 2.7 3.9 9.0 6.2 2.1 3.7 7.4 2.2 10.5 22.0 3.0 3.9 1.5 9.4 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.3 5.6 0.0 0.2 0.0 0.3 0.1 1.0 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.3 23.2 0.0 0.0 49.6 1.6 0.1 0.2 0.0 0.0 0.1 0.3 27.7 36.4 0.9 0.0 0.4 0.0 0.0 3.0 0.6 0.0 0.0 0.0 4.2 0.0 0.1 0.4 1.2 0.3 0.2 0.0 1.9 0.5 0.0 14.9 68.3 0.6 0.9 0.1 0.3 2.1 0.0 17.0 0.1 3.4 0.1 76.6 31.7 195.8 5.0 13.4 0.0 0.3 0.5 0.8 18.9 0.9 0.1 0.8 118.1 5.0 6.4 2.6 0.0 11.8 7.2 8.1 9.9 8.5 7.3 8.1 8.8 7.7 7.1 8.7 9.0 7.4 9.4 30.5 0.0 6.0 2.9 0.9 2.4 0.1 0.4 0.6 1.6 0.5 1.8 1.2 1.5 0.8 0.0 0.0 0.3 7.5 0.0 0.0 0.2 13.1 0.6 0.2 16.7 0.0 4.4 18.7 2.0 0.4 1.5 0.0 0.3 44.4 0.0 7.9 0.1 50.9 0.0 22.4 0.0 0.0 37.8 46.4 7.4 0.9 45.9 3.6 46.9 19.4 0.5 16.5 2.0 1.9 0.4 0.0 0.0 0.7 0.1 0.0 0.0 1.4 1.3 0.0 1.4 0.6 13.1 7.5 0.1 1.7 0.3 4.2 0.1 0.0 0.1 CIB2 "DFNB48, KIP2, USH1J" ENSG00000136425 "Calcium and integrin binding family member 2" O75838 15 78104606-78131535 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.3" "Group enriched" "Detected in many" 4 "Early spermatids: 73.1;Late spermatids: 269.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "plasmacytoid DC: 18.7" "Lineage enriched" "Detected in single" 48 "dendritic cells: 18.7" "Cell line enhanced" "Detected in many" "AN3-CA: 44.0;GAMG: 39.0;HAP1: 38.6;SCLC-21H: 38.8;SH-SY5Y: 40.1;SuSa: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036697 Approved NA NA "HPA036697: AB_10672475" "unprognostic (5.77e-2)" "unprognostic (1.83e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.46e-1)" "unprognostic (2.57e-1)" "unprognostic (1.11e-2)" "unprognostic (6.73e-3)" "unprognostic (1.66e-1)" "unprognostic (9.94e-3)" "unprognostic (3.18e-1)" "unprognostic (7.49e-2)" "prognostic favorable (6.16e-4)" "unprognostic (9.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 7.0 12.2 15.1 3.2 14.3 1.6 4.8 13.5 23.1 12.8 11.4 9.2 18.9 9.2 3.1 4.0 5.7 2.8 30.1 15.5 15.8 8.3 1.2 3.0 3.6 17.8 15.8 13.8 7.4 5.9 13.5 10.5 3.8 15.9 10.5 7.2 5.1 8.2 8.8 11.5 6.3 24.8 6.7 14.7 3.0 3.9 23.5 14.2 48.3 4.0 1.9 6.5 8.7 7.8 18.4 3.5 8.6 24.2 44.0 1.1 1.4 18.1 2.4 0.9 2.0 4.2 0.0 9.6 0.4 4.8 11.3 39.0 1.9 38.6 7.7 0.6 21.7 26.8 2.6 1.6 1.4 4.3 0.0 3.4 2.1 3.2 3.5 2.0 5.0 4.2 13.0 9.1 0.2 3.7 0.7 1.1 0.4 31.1 1.2 0.3 16.9 0.1 1.0 2.8 0.7 38.8 40.1 5.9 3.1 3.5 49.2 0.6 2.6 0.3 0.1 20.3 2.2 0.3 0.4 0.4 6.7 1.0 0.1 5.4 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 18.7 0.0 0.2 15.1 14.3 13.5 23.1 15.5 15.8 17.8 15.8 13.8 15.9 14.7 14.2 18.4 11.0 0.0 0.0 1.6 3.6 5.5 26.6 2.3 1.8 2.9 3.4 12.6 11.4 1.5 0.5 1.8 6.2 19.4 17.3 14.9 9.8 3.0 73.1 1.6 8.1 3.0 3.0 3.0 1.6 1.1 15.5 9.5 2.0 1.5 0.0 10.7 2.5 0.4 2.8 5.0 3.9 25.1 2.0 0.6 1.4 269.9 3.4 2.3 7.2 1.0 0.1 18.1 1.0 2.5 0.4 1.5 16.2 2.6 1.7 12.3 35.9 10.6 0.2 2.2 6.6 11.5 4.9 10.0 17.5 0.4 3.1 9.3 2.5 18.0 11.1 11.5 CALCOCO2 "MGC17318, NDP52" ENSG00000136436 "Calcium binding and coiled-coil domain 2" Q13137 17 48831018-48866522 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 1127.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022989, HPA023019, HPA023195" Enhanced Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916" "unprognostic (3.71e-1)" "unprognostic (2.87e-1)" "unprognostic (3.84e-2)" "unprognostic (3.37e-2)" "unprognostic (4.90e-2)" "unprognostic (4.46e-2)" "unprognostic (2.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.88e-1)" "unprognostic (2.15e-1)" "unprognostic (2.41e-1)" "unprognostic (4.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.06e-1)" "unprognostic (3.80e-2)" "unprognostic (7.57e-2)" "unprognostic (5.65e-2)" 119.0 59.7 36.1 55.8 43.4 63.4 96.1 42.6 51.2 80.0 72.0 102.0 68.7 69.8 61.6 89.4 82.9 66.8 127.1 34.8 56.7 76.4 121.3 92.2 53.6 49.4 46.0 30.3 87.3 57.1 77.4 47.0 63.8 48.3 56.1 102.5 77.1 53.0 73.1 159.7 66.8 76.1 88.6 41.3 69.4 72.1 137.5 42.4 75.1 76.0 171.9 67.7 81.6 77.6 52.9 126.0 79.4 33.1 64.0 241.2 173.7 95.0 120.2 160.0 135.9 151.3 150.8 80.6 42.5 117.0 146.5 115.9 68.2 81.4 101.7 162.6 193.3 66.9 40.7 48.0 59.1 276.8 137.4 196.8 258.1 148.1 144.3 103.9 129.0 101.3 130.7 74.9 124.3 119.2 36.8 119.5 73.6 10.3 278.9 97.7 77.8 161.7 81.0 52.2 39.2 13.1 27.9 37.6 24.3 106.0 66.6 154.2 76.5 97.7 147.1 44.9 91.0 85.8 110.4 165.1 30.0 89.2 69.0 61.4 108.9 115.1 115.5 56.6 121.5 54.2 54.1 49.9 58.9 67.1 46.7 50.5 55.8 132.8 105.0 132.3 33.6 107.2 89.7 36.1 43.4 42.6 51.2 34.8 56.7 49.4 46.0 30.3 48.3 41.3 42.4 52.9 166.2 115.4 98.1 20.5 42.1 36.6 73.3 40.9 40.9 16.8 34.7 32.4 169.1 37.1 48.4 33.1 50.1 50.2 48.6 124.5 37.2 47.2 1127.4 37.4 89.7 104.6 50.4 40.8 31.0 42.2 45.3 79.1 31.6 44.0 100.0 29.8 110.3 58.9 27.6 8.4 21.2 44.7 24.4 119.2 54.3 233.3 70.2 70.7 26.6 28.1 57.4 45.9 64.9 26.7 27.3 37.7 54.6 74.1 56.2 57.6 81.5 48.9 28.4 72.7 72.3 69.6 76.2 152.5 32.7 55.6 46.9 81.3 54.6 96.3 66.1 66.1 RSAD1 "FLJ11164, HemW" ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478860-50485974 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967, HPA024459" Approved Approved "Mitotic chromosome,Mitochondria" Yes NA Mitochondria "Mitotic chromosome" "HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: " "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 22.8 41.7 37.2 16.5 40.1 12.9 23.7 40.6 43.7 37.0 35.7 24.4 17.2 24.4 17.6 17.5 24.7 12.6 35.3 37.4 37.3 41.1 44.4 21.3 20.0 37.6 38.1 38.0 32.0 49.3 27.7 23.8 12.5 38.6 25.4 17.8 21.4 27.5 15.1 66.5 22.1 24.1 14.5 37.5 32.1 32.8 14.3 38.5 18.5 29.4 57.5 17.9 26.3 23.8 39.0 13.0 43.2 20.3 33.7 34.0 27.6 7.2 22.2 21.6 27.9 23.5 43.0 16.1 34.9 48.0 15.6 27.6 12.1 23.2 31.0 23.9 38.9 42.0 47.0 20.5 42.4 23.7 28.6 31.7 20.2 33.7 18.6 35.7 23.0 27.5 84.1 36.9 32.3 23.7 30.3 48.1 20.9 8.2 54.6 45.9 19.6 23.2 31.6 34.0 19.4 11.1 37.9 5.7 26.3 29.7 25.6 39.6 28.7 19.6 29.0 30.8 22.3 26.4 50.0 37.6 13.5 21.8 40.3 20.6 1.1 4.2 3.8 8.5 4.4 8.5 4.5 7.3 8.4 4.9 6.9 9.4 9.5 0.0 6.6 4.2 5.4 6.2 5.7 37.2 40.1 40.6 43.7 37.4 37.3 37.6 38.1 38.0 38.6 37.5 38.5 39.0 15.1 3.2 13.1 18.3 16.0 10.1 4.4 7.2 19.4 14.8 12.1 12.8 29.4 12.8 7.7 16.5 2.1 21.4 24.1 10.8 23.5 14.4 8.8 5.3 10.4 12.4 25.2 12.0 24.0 29.5 11.1 13.1 12.2 7.4 3.8 15.8 10.0 18.5 16.1 8.4 21.5 11.7 8.2 7.2 6.1 7.4 15.5 9.6 17.8 16.9 12.5 32.1 19.6 13.6 12.4 11.8 6.2 10.9 18.7 6.5 11.1 11.1 3.8 7.8 13.1 16.0 11.3 11.5 21.9 10.6 9.9 10.1 18.7 43.6 12.9 3.4 NMT1 NMT ENSG00000136448 "N-myristoyltransferase 1" P30419 17 44957992-45109016 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 344.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022949, HPA022963" Supported Supported "Plasma membrane,Cytosol" NA NA 94000 Cytosol "Plasma membrane" "HPA022949: AB_1854534, HPA022963: AB_1854535" "unprognostic (1.40e-1)" "unprognostic (2.87e-1)" "unprognostic (1.30e-2)" "unprognostic (6.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (4.96e-3)" "unprognostic (3.86e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (3.77e-3)" "unprognostic (1.01e-2)" "unprognostic (4.89e-2)" "unprognostic (4.17e-3)" "unprognostic (9.45e-2)" 28.5 32.0 32.5 22.5 35.7 19.6 26.1 29.4 43.8 24.8 26.1 24.9 23.8 26.6 15.9 29.1 27.9 20.5 28.4 35.5 33.4 27.6 39.8 26.7 33.9 33.2 32.8 35.0 26.5 22.4 38.1 23.5 36.9 32.0 24.7 29.4 25.9 32.4 27.9 45.0 24.1 26.6 33.2 31.8 28.6 24.7 25.1 34.3 35.6 31.0 48.0 39.8 33.3 23.7 34.4 51.5 88.8 53.7 42.3 82.9 75.0 60.6 41.4 87.6 115.9 101.0 83.9 57.0 54.0 86.2 80.4 78.4 51.5 94.5 92.3 132.9 117.9 73.3 49.0 60.7 84.4 53.7 71.0 62.6 66.4 64.1 79.1 69.2 64.1 87.1 60.9 81.8 38.1 63.1 49.2 76.2 31.7 42.4 151.5 87.8 57.5 67.2 52.2 73.6 78.8 39.2 32.9 33.0 30.2 38.0 112.8 73.1 46.0 50.1 69.9 49.5 55.8 68.1 41.4 61.0 69.9 64.5 44.5 56.4 34.9 49.4 20.0 23.8 33.3 19.9 42.3 19.9 20.1 26.2 31.0 23.7 18.8 26.5 21.1 27.6 115.5 25.7 11.8 32.5 35.7 29.4 43.8 35.5 33.4 33.2 32.8 35.0 32.0 31.8 34.3 34.4 50.1 38.5 29.5 49.3 53.8 13.9 15.4 48.8 24.5 97.8 74.1 57.1 46.5 97.2 33.6 69.9 116.7 73.7 87.5 48.7 78.2 69.4 31.1 51.5 63.1 46.4 50.9 72.0 30.3 71.2 61.9 39.6 21.9 62.3 22.8 28.1 85.3 344.4 47.6 129.5 30.7 43.0 28.5 86.5 15.9 12.2 55.0 34.6 10.6 18.7 97.9 41.5 59.8 20.1 19.3 67.9 52.0 51.1 31.0 15.3 84.1 108.1 24.0 123.5 59.2 16.1 46.3 67.6 35.5 20.5 14.1 81.8 40.1 25.4 68.6 18.6 MYCBPAP "AMAP-1, DKFZp434N1415" ENSG00000136449 "MYCBP associated protein" Q8TBZ2 17 50508384-50531501 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 65.6" "Cell type enhanced" "Detected in many" "Early spermatids: 224.2;Late spermatids: 145.2;Respiratory ciliated cells: 40.4;Spermatocytes: 69.9;Theca cells: 54.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;JURKAT: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023257, HPA024405" Enhanced Approved Vesicles NA NA Vesicles "HPA023257: AB_2671126, HPA024405: " "unprognostic (2.05e-2)" "unprognostic (1.79e-2)" "unprognostic (9.13e-3)" "unprognostic (3.98e-5)" "unprognostic (8.62e-4)" "unprognostic (3.65e-2)" "unprognostic (1.52e-3)" "unprognostic (1.61e-1)" "unprognostic (2.38e-3)" "unprognostic (1.11e-1)" "unprognostic (7.32e-4)" "unprognostic (2.52e-1)" "unprognostic (1.39e-4)" "unprognostic (7.15e-2)" "unprognostic (1.97e-1)" "unprognostic (7.37e-2)" "unprognostic (2.02e-2)" 0.7 0.8 2.6 0.6 1.8 1.3 0.4 2.4 3.4 1.2 2.9 0.4 0.2 0.9 1.1 0.8 5.4 1.1 0.6 1.4 1.0 0.4 0.2 1.6 1.0 2.8 2.2 1.2 2.5 0.2 0.4 0.9 0.3 1.8 1.0 0.4 1.1 0.8 1.3 1.2 1.0 0.3 0.9 1.8 0.6 0.4 65.6 1.8 1.0 0.8 0.3 0.6 0.3 0.5 2.3 0.1 0.8 0.3 0.3 0.8 0.4 0.8 0.7 0.3 0.2 0.2 0.4 2.0 0.2 0.1 0.2 0.8 0.3 0.1 0.9 0.2 4.4 0.2 1.3 1.3 0.4 0.7 0.1 0.2 1.2 0.2 0.4 1.8 0.8 0.6 3.8 0.2 0.4 0.6 0.1 0.2 0.3 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 0.6 1.6 0.3 0.2 0.1 0.5 0.3 0.8 2.0 0.3 0.4 0.1 0.1 2.3 0.8 0.1 0.5 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 2.6 1.8 2.4 3.4 1.4 1.0 2.8 2.2 1.2 1.8 1.8 1.8 2.3 0.3 0.0 1.7 7.2 0.7 0.1 1.4 0.7 0.0 3.6 0.4 0.3 0.9 0.0 6.5 1.8 0.0 2.4 1.7 0.4 0.0 0.1 224.2 18.6 1.2 1.1 0.0 3.6 2.5 0.4 0.3 2.0 0.0 0.6 0.0 5.6 0.0 0.0 0.4 0.0 2.2 1.8 0.0 0.6 0.5 145.2 6.8 0.6 0.0 2.8 0.0 4.3 3.1 0.5 1.0 0.1 0.1 3.8 0.6 1.1 1.4 0.2 40.4 0.5 0.0 2.7 1.4 69.9 7.6 0.1 0.4 0.1 1.4 54.9 0.4 0.8 SRSF1 "ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a" ENSG00000136450 "Serine and arginine rich splicing factor 1" Q07955 17 58000919-58007346 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013073, HPA061301" Supported Supported Nucleoplasm NA NA 980000 Nucleoplasm "CAB013073: AB_2533079, HPA061301: AB_2684474" "unprognostic (9.86e-2)" "prognostic favorable (7.00e-4)" "prognostic favorable (4.56e-5)" "unprognostic (8.11e-2)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "prognostic unfavorable (1.64e-6)" "unprognostic (8.28e-2)" "unprognostic (2.60e-3)" "unprognostic (3.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (1.59e-2)" 64.7 81.7 46.6 84.7 49.9 55.2 63.3 55.0 49.9 77.9 54.8 75.6 70.3 79.7 70.6 84.7 74.2 42.9 61.4 45.3 55.5 62.2 72.0 61.3 107.9 47.2 48.9 43.2 79.0 59.1 73.6 69.7 65.3 47.3 70.8 77.8 61.0 68.0 57.9 71.8 57.6 74.0 60.2 51.8 73.2 69.6 39.2 49.6 105.5 73.3 52.0 120.6 69.9 74.2 53.5 211.4 157.1 264.9 153.3 72.3 67.3 164.6 187.0 102.9 177.9 167.8 195.9 180.6 352.0 121.1 129.8 134.3 178.9 298.4 192.6 325.5 196.8 176.1 263.0 202.2 220.9 83.2 292.4 169.9 56.3 90.5 164.6 168.3 84.3 145.1 131.9 291.0 166.9 181.2 162.6 370.2 258.4 246.5 191.7 160.9 349.4 216.1 217.1 176.6 177.5 192.4 206.8 142.5 128.6 139.5 142.0 180.8 220.5 139.3 158.6 197.0 122.7 258.8 149.7 217.3 333.3 150.1 272.2 193.8 23.9 48.3 32.5 38.9 64.4 38.6 35.7 30.7 37.1 71.1 24.9 32.8 33.3 22.0 48.1 45.1 40.5 36.9 45.2 46.6 49.9 55.0 49.9 45.3 55.5 47.2 48.9 43.2 47.3 51.8 49.6 53.5 74.1 35.3 48.3 66.0 89.1 133.7 130.0 53.1 96.2 62.9 73.1 58.0 31.3 41.5 48.6 44.1 31.3 70.3 68.1 57.5 70.5 68.2 57.8 44.9 59.2 66.2 65.8 93.2 33.0 60.1 116.6 74.7 53.5 59.3 59.6 92.2 44.6 46.3 59.1 52.2 51.8 76.2 52.9 54.0 73.5 34.0 84.2 52.3 55.2 36.5 60.7 43.5 80.3 56.3 59.2 61.4 84.9 60.2 73.3 102.8 76.3 56.4 43.4 83.1 105.2 87.7 89.5 74.6 58.0 86.6 137.5 60.9 69.4 57.3 93.3 120.6 VEZF1 "DB1, ZNF161" ENSG00000136451 "Vascular endothelial zinc finger 1" Q14119 17 57971547-57988259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027520, HPA048315" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027520: AB_10602680, HPA048315: AB_2680353" "unprognostic (7.24e-2)" "unprognostic (3.18e-1)" "prognostic favorable (6.14e-5)" "unprognostic (2.12e-2)" "unprognostic (3.85e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.71e-2)" "unprognostic (1.65e-1)" "unprognostic (4.72e-2)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (3.28e-3)" "unprognostic (1.45e-1)" "unprognostic (7.67e-2)" "unprognostic (8.67e-2)" "unprognostic (3.03e-2)" 22.1 29.3 20.9 18.8 31.5 57.1 24.3 27.5 24.3 29.8 24.8 34.7 19.3 37.9 16.1 25.1 38.0 25.3 28.7 19.8 26.7 26.4 16.7 28.7 22.0 30.2 28.5 14.7 32.3 25.9 25.0 20.6 26.6 30.0 29.5 23.3 71.1 27.7 27.4 66.3 15.8 24.5 33.3 24.9 24.2 26.2 19.1 27.8 35.2 37.8 44.9 20.3 33.0 24.4 48.3 42.5 48.1 93.8 30.1 22.9 32.4 28.9 35.1 50.9 44.7 41.0 22.9 44.4 20.6 55.3 40.3 41.6 23.7 38.1 40.7 60.3 58.2 23.7 41.7 39.5 25.6 27.1 36.0 33.6 23.0 47.6 29.9 52.1 59.3 42.2 29.5 30.9 28.9 44.2 15.3 58.0 20.0 30.5 38.4 48.7 43.4 68.9 16.9 25.6 40.9 36.6 63.2 32.3 15.3 51.8 39.3 90.3 33.1 40.2 59.7 59.3 37.5 56.1 30.9 26.3 33.9 40.5 30.4 76.3 31.6 15.2 30.1 17.9 19.0 18.0 12.8 13.8 19.3 18.6 14.3 18.0 16.2 25.2 30.7 33.9 17.2 14.3 16.4 20.9 31.5 27.5 24.3 19.8 26.7 30.2 28.5 14.7 30.0 24.9 27.8 48.3 44.4 83.3 60.9 29.0 32.2 36.2 39.5 25.8 70.0 73.6 42.6 37.6 111.0 40.0 41.5 25.8 66.7 16.3 49.5 24.9 25.4 36.2 28.9 73.5 41.4 44.6 49.0 23.8 8.1 36.5 19.2 48.6 23.4 64.3 57.0 44.4 34.2 18.3 22.6 33.7 14.5 29.7 24.4 34.9 48.5 36.6 36.1 36.5 42.7 19.7 39.4 44.5 34.0 43.2 81.9 30.9 21.1 27.8 20.2 48.3 21.1 23.8 63.0 65.7 52.6 102.8 60.5 42.1 24.5 36.0 21.0 19.8 34.3 21.8 26.7 35.3 CHAD SLRR4A ENSG00000136457 Chondroadherin O15335 17 50464496-50468906 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.5;pancreas: 32.8" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6" "Group enriched" "Detected in many" 5 "breast cancer: 23.7;liver cancer: 10.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 53 "memory B-cell: 21.5;naive B-cell: 8.0" "Lineage enriched" "Detected in single" 76 "B-cells: 21.5" "Cell line enhanced" "Detected in some" "RT4: 4.0;SCLC-21H: 8.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA018241 Enhanced "Secreted to extracellular matrix" NA NA 22000000 "HPA018241: AB_1846612" "prognostic favorable (7.68e-4)" "unprognostic (4.34e-2)" "unprognostic (1.24e-1)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (3.06e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.51e-2)" "unprognostic (4.75e-2)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.52e-1)" "unprognostic (1.84e-2)" "unprognostic (1.51e-3)" "unprognostic (1.41e-3)" 1.5 14.2 7.2 0.7 8.0 0.3 9.7 16.9 7.4 21.9 5.1 4.1 7.7 0.5 0.1 1.8 0.8 1.5 1.2 6.6 6.8 2.3 36.5 1.7 0.6 7.5 6.7 6.4 3.2 32.8 0.0 1.3 0.5 9.6 1.9 4.0 0.5 21.5 0.2 14.7 8.6 10.4 0.1 6.1 1.2 10.8 1.2 6.7 0.2 4.2 0.9 0.2 1.3 1.6 6.8 1.0 0.8 0.7 0.6 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.5 0.8 0.1 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.6 0.7 1.2 0.7 1.5 0.0 0.4 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.1 0.3 0.0 0.5 0.0 0.7 0.1 0.1 0.7 0.9 0.1 1.5 0.0 4.0 8.5 0.2 0.1 0.3 0.0 0.3 0.3 0.2 0.9 2.1 0.4 0.1 0.0 1.4 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 7.2 8.0 16.9 7.4 6.6 6.8 7.5 6.7 6.4 9.6 6.1 6.7 6.8 0.0 0.0 0.0 1.3 1.0 0.3 0.2 0.3 0.0 0.0 4.6 2.4 0.2 1.5 0.2 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.2 4.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 5.5 0.1 0.0 2.5 0.0 1.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.4 TACO1 CCDC44 ENSG00000136463 "Translational activator of cytochrome c oxidase I" Q9BSH4 17 63600882-63608365 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" Activator "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 87.9;Proximal enterocytes: 81.2;Proximal tubular cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021626, HPA021643, HPA024294" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150" "unprognostic (1.26e-1)" "unprognostic (2.92e-2)" "unprognostic (4.55e-3)" "unprognostic (9.82e-2)" "unprognostic (1.30e-1)" "unprognostic (9.30e-3)" "unprognostic (2.83e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (7.38e-2)" "prognostic favorable (3.73e-4)" "unprognostic (1.35e-1)" "unprognostic (4.12e-3)" "unprognostic (5.21e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" 12.9 18.8 16.8 8.2 16.7 8.4 11.0 18.7 18.4 8.7 16.8 17.5 19.0 11.2 9.7 13.5 9.4 5.6 34.4 16.2 17.2 30.3 69.8 7.8 10.5 17.4 17.3 15.5 8.4 12.1 18.3 9.6 8.4 17.4 9.6 16.3 9.5 11.5 9.2 62.1 11.3 16.9 9.8 16.5 11.6 15.3 12.2 17.7 10.0 9.5 56.4 12.3 11.9 9.3 17.7 39.6 61.2 19.4 20.2 16.5 23.5 25.7 28.5 26.8 56.2 44.4 40.5 23.2 32.6 21.2 33.1 38.9 35.8 43.0 41.5 52.6 17.3 58.1 32.0 29.8 72.3 45.5 38.3 21.7 29.0 28.6 48.5 51.1 20.9 29.6 24.2 44.4 24.1 26.6 71.6 44.7 28.7 16.8 42.5 62.9 28.1 47.7 40.8 33.2 27.6 29.5 32.4 19.6 64.0 55.3 25.3 53.3 29.1 26.4 39.9 29.9 27.5 50.7 25.9 27.2 38.7 30.4 26.0 29.6 2.2 9.4 9.0 9.8 8.5 10.7 7.5 13.7 9.7 10.6 9.9 12.4 10.3 1.4 17.8 7.4 7.0 10.2 9.4 16.8 16.7 18.7 18.4 16.2 17.2 17.4 17.3 15.5 17.4 16.5 17.7 17.7 9.8 3.2 6.3 2.6 12.0 2.5 8.0 21.1 8.6 8.2 7.8 10.9 54.0 17.2 11.5 14.7 2.1 32.1 8.2 32.9 54.8 29.1 15.3 8.0 11.4 14.2 13.8 17.4 4.0 27.4 28.9 14.1 16.8 6.4 9.5 16.2 8.6 87.9 26.3 6.7 3.9 21.7 12.2 10.7 3.9 46.0 11.8 9.2 10.6 2.8 22.0 15.5 14.4 1.5 3.2 30.0 25.8 11.3 10.7 11.6 81.2 109.7 9.1 13.4 19.7 10.7 14.6 26.8 13.9 18.6 4.3 19.8 10.1 40.7 32.8 7.1 TEX2 "HT008, KIAA1738, TMEM96" ENSG00000136478 "Testis expressed 2" Q8IWB9 17 64147227-64263260 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5;Late spermatids: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 20.6" "Lineage enriched" "Detected in many" 6 "dendritic cells: 20.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020648, HPA057116" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020648: AB_1857908, HPA057116: AB_2683341" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "prognostic favorable (3.90e-6)" "unprognostic (1.69e-2)" "unprognostic (3.84e-2)" "unprognostic (8.34e-2)" "unprognostic (6.97e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-2)" "unprognostic (1.11e-1)" "unprognostic (7.97e-2)" "unprognostic (7.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.53e-3)" "unprognostic (5.59e-3)" 16.8 24.5 40.8 7.4 46.9 18.9 19.8 40.1 38.3 17.9 31.7 12.4 10.3 14.9 11.5 17.4 13.6 16.9 27.5 40.6 46.8 18.6 33.4 15.1 6.3 45.8 48.0 36.3 15.8 29.6 31.8 11.3 9.9 45.7 16.4 13.6 23.2 19.6 17.1 45.5 15.6 10.3 14.8 42.6 12.8 13.3 54.0 45.1 9.0 40.5 42.2 6.9 10.6 11.2 45.2 32.6 15.2 9.5 19.5 44.7 26.3 11.5 44.1 49.7 39.2 27.0 14.2 7.8 11.3 11.0 55.9 24.3 15.5 17.0 53.3 44.7 16.6 11.6 76.3 9.9 27.0 16.7 22.5 12.2 19.3 29.0 26.7 54.3 27.5 19.1 18.8 21.3 13.6 29.8 36.1 20.5 10.4 5.4 25.3 26.9 12.6 85.8 16.1 22.7 14.9 14.4 24.0 21.9 55.9 24.3 52.2 26.4 19.0 22.6 36.5 21.1 28.5 25.8 14.0 20.1 7.2 14.5 21.0 33.6 0.0 3.1 0.9 1.5 1.0 1.7 0.3 1.7 1.8 2.9 0.6 1.7 1.7 0.3 3.3 2.0 20.6 1.3 1.8 40.8 46.9 40.1 38.3 40.6 46.8 45.8 48.0 36.3 45.7 42.6 45.1 45.2 8.1 3.2 8.1 27.4 3.4 8.8 6.8 5.1 16.5 4.2 17.6 13.7 33.3 8.6 6.2 12.9 6.2 2.5 14.7 10.7 1.9 4.7 53.5 6.0 10.5 8.8 12.1 15.4 41.6 8.3 2.0 7.4 16.3 4.2 3.8 12.2 8.6 30.4 12.0 10.1 35.6 11.3 6.1 11.5 3.7 52.9 6.5 9.2 7.2 17.8 2.9 7.2 1.0 33.2 39.3 6.5 4.6 12.8 10.1 7.1 7.1 8.3 8.2 17.3 0.0 12.6 7.4 22.5 8.8 14.6 8.9 1.4 3.6 9.4 10.9 5.4 DCAF7 "HAN11, SWAN-1, WDR68" ENSG00000136485 "DDB1 and CUL4 associated factor 7" P61962 17 63550477-63594279 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022948, HPA022962" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022948: AB_1858820, HPA022962: AB_1858821" "unprognostic (7.75e-2)" "unprognostic (3.31e-1)" "unprognostic (1.37e-3)" "unprognostic (3.78e-2)" "unprognostic (1.03e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.86e-1)" "unprognostic (2.28e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.40e-2)" "unprognostic (1.97e-1)" "unprognostic (9.95e-2)" "unprognostic (4.18e-2)" 12.5 13.7 22.6 22.8 22.7 9.1 15.7 20.7 21.3 20.0 17.9 24.2 26.2 16.9 19.0 17.7 19.4 16.8 18.2 22.2 23.3 26.8 14.4 21.8 29.3 24.1 22.8 19.6 16.6 18.6 37.7 12.5 27.0 22.7 22.1 26.0 30.1 18.3 23.5 13.4 14.1 25.2 19.1 25.4 25.6 21.0 14.9 22.8 37.5 22.3 15.5 32.7 22.5 12.9 23.9 33.2 46.4 79.6 51.0 26.9 22.2 20.9 32.6 28.7 35.3 29.7 34.2 35.2 61.2 25.7 32.7 36.9 34.7 67.0 45.8 45.0 23.7 42.7 79.9 29.3 40.3 27.7 89.7 44.4 18.6 29.7 20.6 46.8 42.5 55.8 50.9 85.7 27.8 45.3 40.9 97.7 43.0 25.9 57.5 61.7 77.1 94.5 34.9 51.4 49.7 76.4 141.0 29.4 56.2 38.9 70.0 41.5 72.1 59.3 58.0 26.4 29.6 54.4 28.9 39.6 32.2 33.0 57.1 35.2 10.9 11.3 12.6 11.2 13.1 9.0 8.1 7.7 8.7 10.6 8.3 6.9 7.5 4.7 8.9 16.2 7.8 5.9 8.6 22.6 22.7 20.7 21.3 22.2 23.3 24.1 22.8 19.6 22.7 25.4 22.8 23.9 28.5 44.8 45.9 30.3 57.4 31.4 30.5 49.8 46.7 55.4 29.3 25.1 30.8 38.6 38.1 68.0 77.2 51.7 49.0 47.2 23.5 50.1 95.5 30.5 38.0 43.1 72.0 62.6 42.3 45.2 47.7 33.8 31.1 30.1 60.2 67.1 48.9 40.2 55.4 65.6 41.1 49.0 52.9 64.3 45.2 27.6 35.1 61.9 26.6 43.1 72.9 53.1 69.0 36.2 40.5 55.0 41.2 38.0 45.0 45.3 67.7 52.0 43.7 54.0 59.2 23.2 35.8 96.5 35.0 51.6 34.8 21.6 53.1 49.8 57.2 47.6 GH2 "GH-V, GHL, GHV, hGH-V" ENSG00000136487 "Growth hormone 2" P01242 17 63880215-63881944 "Cancer-related genes, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 79 "pituitary gland: 103.2;placenta: 128.6" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 8.6;Syncytiotrophoblasts: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "BEWO: 8.4" HPA043715 Supported "Secreted to blood" NA NA 4200000 "HPA043715: AB_2678632" "unprognostic (1.02e-1)" 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 23.7 0.0 0.0 0.0 0.0 CSH1 "CSA, CSMT, FLJ75407, hCS-A, PL" ENSG00000136488 "Chorionic somatomammotropin hormone 1" P0DML2 17 63894909-63896661 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 247 "placenta: 9877.3" "Group enriched" "Detected in some" 24 "Extravillous trophoblasts: 542.0;Syncytiotrophoblasts: 1092.3" "Cancer enriched" "Detected in single" 8 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 11.8;SuSa: 17.0" "CAB026374, HPA043715" Enhanced "Secreted to blood" NA NA "CAB026374: , HPA043715: AB_2678632" "unprognostic (6.99e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 6.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.7 4.0 0.0 0.2 9877.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 39.9 0.0 26.3 20.1 0.1 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 542.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1092.3 0.0 0.0 0.0 0.0 LIMD2 MGC10986 ENSG00000136490 "LIM domain containing 2" Q9BT23 17 63695888-63701172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 113.1;lymphoid tissue: 224.0" "Cell type enhanced" "Detected in many" "B-cells: 436.9;dendritic cells: 306.6;Kupffer cells: 216.1;monocytes: 188.2;NK-cells: 510.9;T-cells: 264.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 243.0;NB-4: 171.7;SH-SY5Y: 163.3;THP-1: 127.6;U-698: 260.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062432, HPA075172" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062432: , HPA075172: " "unprognostic (2.90e-3)" "unprognostic (2.89e-3)" "unprognostic (6.34e-2)" "unprognostic (6.53e-2)" "unprognostic (8.72e-2)" "unprognostic (2.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.67e-2)" "unprognostic (6.68e-2)" "unprognostic (2.01e-2)" "unprognostic (1.20e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.36e-11)" "unprognostic (1.21e-1)" "unprognostic (2.21e-1)" "unprognostic (2.26e-2)" "unprognostic (6.08e-2)" 12.2 8.0 22.6 107.9 25.8 113.1 8.2 15.6 35.6 11.1 16.7 10.7 13.7 7.9 2.1 6.5 9.0 17.7 8.8 26.1 21.2 13.2 10.5 25.0 224.0 21.2 19.0 22.5 7.1 7.2 3.3 10.8 15.7 20.1 16.5 9.5 1.0 13.0 5.6 3.1 6.7 61.5 9.2 19.8 172.1 20.7 14.1 18.6 112.4 9.4 3.5 151.0 20.4 8.3 22.4 0.8 7.7 92.9 22.9 0.8 2.4 2.3 2.6 1.4 9.4 6.4 4.2 1.9 243.0 20.5 11.6 9.4 3.9 20.4 0.9 2.6 84.3 8.7 72.4 1.8 20.6 17.6 95.2 7.6 22.8 1.0 9.6 0.3 11.0 25.5 16.5 6.7 13.8 10.7 1.3 84.7 171.7 50.3 0.0 4.4 34.6 37.4 43.6 13.1 1.0 111.2 163.3 11.8 0.2 22.2 23.9 0.6 127.6 32.2 12.8 28.1 0.7 3.4 2.9 1.0 260.4 1.4 13.3 22.7 2144.2 601.8 1434.7 368.9 716.3 364.8 688.5 512.2 432.9 609.8 855.0 679.3 496.3 1248.9 553.2 783.9 230.5 664.2 991.4 22.6 25.8 15.6 35.6 26.1 21.2 21.2 19.0 22.5 20.1 19.8 18.6 22.4 11.0 0.0 4.6 0.7 436.9 7.5 7.7 20.5 2.2 1.9 5.0 7.2 1.0 4.3 8.6 11.0 4.2 1.6 306.6 1.1 5.9 20.5 18.8 2.3 14.2 23.6 22.2 99.2 18.7 8.9 3.6 10.1 5.6 4.2 53.3 15.7 30.4 2.0 137.6 3.3 2.2 2.1 26.4 216.1 93.9 57.5 3.4 148.0 37.4 12.2 188.2 8.4 510.9 3.5 2.9 19.8 4.7 4.9 154.3 17.7 0.4 3.7 2.4 1.1 6.6 2.9 30.5 7.8 7.5 1.1 6.0 1.5 264.3 4.7 2.5 4.3 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61679139-61863528 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.3;lymphoid tissue: 6.0;testis: 7.1" "Group enriched" "Detected in many" 12 "Early spermatids: 186.2;Late spermatids: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 88.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 0.3 0.3 0.7 1.7 0.9 7.3 0.9 1.3 1.1 0.2 0.0 1.7 2.1 0.8 0.4 1.5 0.3 0.6 0.1 0.7 0.3 0.3 1.6 0.4 2.8 0.6 0.2 0.7 1.1 0.3 0.1 0.0 0.8 0.7 0.4 1.9 0.5 0.4 0.2 0.1 2.0 1.9 0.9 0.0 0.7 0.9 7.1 0.3 6.0 0.3 0.1 3.3 0.7 0.6 1.2 26.6 9.4 25.0 14.1 0.9 2.1 5.5 23.6 13.3 24.6 31.8 9.5 8.0 14.9 5.2 4.9 7.7 9.2 12.8 4.5 33.3 3.8 15.8 15.5 14.4 10.5 0.2 20.3 8.8 0.6 0.4 20.2 5.1 3.4 5.0 14.8 11.6 10.5 14.4 88.9 32.5 6.7 5.3 5.9 7.3 19.7 50.1 7.1 3.0 12.8 10.0 24.2 9.4 3.0 3.3 9.1 8.3 7.3 4.5 36.9 26.5 13.5 26.6 6.3 13.3 16.6 7.3 9.3 8.8 1.0 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.1 0.1 0.6 0.4 0.2 0.3 0.1 0.1 0.1 1.0 0.1 0.7 0.9 1.3 1.1 0.7 0.3 0.6 0.2 0.7 0.7 0.0 0.3 1.2 0.2 0.0 0.5 1.0 1.6 2.3 1.3 0.8 0.6 0.3 1.1 1.8 0.6 0.0 4.0 0.0 0.0 2.0 2.0 1.8 0.0 0.3 186.2 0.7 1.7 0.8 0.0 7.4 4.6 0.2 3.0 2.0 2.0 1.6 0.0 15.5 0.4 3.4 1.7 0.0 3.3 1.8 0.0 0.8 1.1 194.1 1.2 1.0 3.6 2.8 0.6 0.2 1.0 1.5 1.0 0.8 0.1 1.2 4.8 0.4 1.4 0.2 0.8 0.2 0.0 2.5 1.8 12.1 6.0 2.9 0.4 0.3 2.3 2.1 4.7 0.7 KAT7 "HBO1, HBOA, MYST2, ZC2HC7" ENSG00000136504 "Lysine acetyltransferase 7" O95251 17 49788648-49835026 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044470, HPA071116" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044470: AB_10965785, HPA071116: " "unprognostic (1.30e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-3)" "unprognostic (2.20e-2)" "unprognostic (7.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (1.36e-1)" "unprognostic (6.26e-2)" "unprognostic (1.44e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-3)" "unprognostic (2.75e-1)" "unprognostic (5.03e-2)" "unprognostic (6.23e-2)" "unprognostic (7.68e-2)" 16.1 14.3 13.9 8.2 16.5 41.2 16.7 22.6 21.7 20.1 13.3 18.8 7.2 22.8 12.4 20.6 20.4 6.7 22.2 15.1 14.5 16.5 11.8 14.6 10.5 13.6 12.3 15.3 21.1 12.5 23.7 17.2 10.1 15.4 17.6 10.1 19.4 17.9 14.1 38.1 24.7 16.1 12.5 9.1 16.0 16.1 38.9 13.7 17.5 21.2 20.3 13.7 22.7 19.1 18.3 17.1 22.6 22.5 17.3 10.1 14.3 27.2 11.2 16.5 24.7 18.7 35.9 11.5 17.8 21.8 13.7 24.7 16.7 23.0 12.8 32.5 18.6 20.3 20.7 14.8 17.8 15.0 21.6 17.2 13.3 16.6 21.1 25.3 14.4 22.7 16.0 23.6 18.9 27.4 28.8 26.4 23.2 79.0 38.4 20.2 20.6 34.7 18.2 12.8 17.6 25.7 15.7 7.6 9.2 14.9 40.5 38.6 22.9 8.8 24.5 13.3 16.0 19.4 21.4 32.7 23.3 17.3 13.6 23.3 17.1 6.8 9.5 8.3 5.4 10.6 5.8 7.8 8.5 7.0 6.1 9.3 8.5 10.1 11.7 7.1 4.3 8.5 7.9 13.9 16.5 22.6 21.7 15.1 14.5 13.6 12.3 15.3 15.4 9.1 13.7 18.3 16.0 25.6 21.3 9.4 23.6 16.8 11.7 10.1 25.0 32.6 18.5 16.6 28.5 20.0 15.6 27.6 31.3 22.7 27.6 11.7 9.8 11.9 23.1 22.4 21.0 18.7 25.1 25.4 14.8 7.5 14.5 15.3 15.3 29.9 24.1 18.2 15.4 10.4 13.3 45.4 16.7 13.4 12.2 22.6 13.2 16.5 16.8 15.9 14.2 10.3 19.1 16.5 25.7 13.0 18.3 10.0 8.9 18.4 18.6 15.4 12.8 10.2 18.6 25.1 39.5 21.2 24.2 73.7 31.6 17.9 20.0 33.8 28.4 15.2 12.1 10.2 RTP4 "IFRG28, Z3CXXC4" ENSG00000136514 "Receptor transporter protein 4" Q96DX8 3 187368385-187372076 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 33.2;Ductal cells: 46.4;Urothelial cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.9;GAMG: 14.2;HDLM-2: 12.3;Karpas-707: 9.7;REH: 9.9;SK-MEL-30: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064887, HPA071189" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA064887: AB_2685383, HPA071189: AB_2686357" "unprognostic (1.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.30e-1)" "unprognostic (1.44e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.78e-1)" "unprognostic (1.18e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.34e-1)" "unprognostic (5.49e-2)" "unprognostic (3.44e-2)" "unprognostic (2.95e-2)" "prognostic favorable (4.35e-4)" "prognostic favorable (1.45e-4)" 2.1 2.7 2.5 5.1 2.7 1.1 6.0 2.4 3.1 4.8 2.3 6.0 9.2 4.3 3.3 1.9 10.9 6.2 3.2 2.2 2.7 3.6 6.1 7.0 8.2 2.9 2.6 2.1 4.0 2.5 0.6 1.1 2.2 3.0 4.1 6.1 0.2 10.8 5.2 1.0 2.4 8.3 4.5 2.7 8.6 8.1 1.0 2.7 9.2 1.9 2.3 5.9 8.3 2.8 3.9 3.1 0.0 0.0 0.0 1.4 4.9 0.1 0.0 1.2 2.0 1.8 0.0 10.9 1.4 0.0 1.3 14.2 3.6 0.0 0.1 0.0 12.3 0.0 0.0 0.0 0.1 1.8 0.0 2.7 1.2 0.0 0.4 0.0 0.4 0.4 0.3 0.0 9.7 0.0 0.0 7.3 0.0 0.0 0.0 0.0 9.9 0.0 8.0 2.6 7.9 0.0 0.0 0.0 0.2 19.7 0.1 0.0 4.9 0.2 0.1 0.2 0.0 0.1 7.8 2.6 0.1 0.0 2.7 6.0 7.0 8.3 5.9 11.5 10.2 11.5 6.2 9.1 10.5 7.1 5.3 6.9 8.2 2.3 14.9 13.2 0.2 19.8 6.7 2.5 2.7 2.4 3.1 2.2 2.7 2.9 2.6 2.1 3.0 2.7 2.7 3.9 7.4 6.4 4.5 0.3 4.3 1.7 33.2 10.5 1.8 0.0 4.0 5.5 0.7 11.5 11.3 5.5 0.0 0.1 4.2 6.0 15.6 46.4 0.0 13.6 4.3 9.6 9.1 0.4 0.0 9.8 0.5 4.2 10.7 6.1 1.3 1.6 10.8 4.5 5.5 0.0 0.1 9.6 6.1 7.8 2.5 0.0 2.1 6.4 1.8 1.9 8.9 3.7 25.7 1.0 0.7 16.9 9.4 4.9 2.0 12.9 17.9 3.1 24.6 0.1 0.0 1.3 3.0 0.1 0.1 1.3 1.3 0.3 8.3 12.0 7.8 52.6 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562886-179588407 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 243.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671, HPA063149" Supported Enhanced Nucleoplasm,Cytosol NA NA 18000 Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 19.0 20.6 9.1 23.7 10.4 18.0 33.3 10.8 12.5 24.8 11.3 31.4 24.9 27.8 26.1 25.5 25.2 15.7 18.8 8.6 10.9 22.5 22.0 19.2 32.2 11.1 10.4 8.1 32.2 20.8 24.5 13.2 23.7 11.2 21.5 38.2 16.4 21.5 21.6 12.4 27.0 24.0 26.5 10.4 20.1 22.5 63.1 9.7 46.5 20.7 14.0 41.8 25.0 20.8 12.7 196.4 59.5 142.2 75.7 53.4 58.0 111.7 78.1 60.2 142.3 119.8 126.6 94.8 154.0 136.8 73.5 164.7 88.7 126.3 95.7 174.6 156.7 105.0 125.5 58.2 101.9 61.0 157.4 75.2 40.7 96.1 91.5 76.6 44.5 82.5 90.7 100.1 85.1 103.6 135.6 140.1 96.8 127.6 178.0 129.5 128.7 118.0 284.4 113.4 76.2 116.9 83.2 119.1 118.5 125.2 71.2 231.5 128.8 62.5 101.0 87.1 104.1 237.8 54.6 86.5 231.3 55.6 165.0 113.5 5.7 19.3 14.7 24.5 25.5 32.4 29.2 27.8 28.5 34.1 24.1 30.2 31.3 2.6 26.7 30.1 19.3 39.1 24.3 9.1 10.4 10.8 12.5 8.6 10.9 11.1 10.4 8.1 11.2 10.4 9.7 12.7 31.1 22.4 23.1 6.2 27.1 47.2 48.0 60.4 29.0 6.1 24.5 23.9 6.7 30.0 38.1 27.6 8.4 51.2 21.6 13.4 35.2 51.1 53.5 27.1 28.8 26.7 30.5 62.3 2.8 44.7 67.5 28.1 23.4 20.8 14.5 31.0 13.6 16.8 34.9 0.0 3.8 26.7 48.8 17.1 18.7 17.7 32.3 15.4 30.2 3.7 27.1 16.7 18.6 6.6 19.0 38.8 18.8 30.1 25.8 45.4 18.2 25.8 35.6 14.9 26.3 25.0 49.0 243.2 92.1 42.7 45.9 30.6 21.6 35.1 40.4 38.5 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 243.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 61.6 89.1 39.4 29.3 41.8 19.7 48.2 42.7 57.7 36.1 52.4 62.4 75.8 30.5 15.8 57.2 33.7 29.0 179.1 41.1 42.8 90.5 74.6 34.7 36.4 40.8 40.1 40.0 42.3 52.7 67.2 40.5 27.2 42.3 32.8 36.4 22.9 44.0 20.4 243.7 41.4 57.5 22.5 39.1 46.6 64.3 42.6 43.5 31.6 41.9 168.4 25.0 46.6 41.9 42.6 96.5 23.2 51.2 66.8 52.3 66.0 75.6 58.5 42.0 48.1 50.7 79.8 53.4 72.7 193.4 32.7 119.5 89.9 48.9 47.4 38.9 182.5 43.1 90.4 31.2 44.8 52.3 97.9 64.0 64.9 60.7 31.2 51.0 61.0 62.8 62.1 71.2 98.7 51.8 68.8 55.8 60.5 80.2 138.7 80.8 64.2 63.3 205.1 82.5 46.8 41.1 62.4 34.9 169.9 126.7 36.2 265.9 151.2 64.5 46.6 47.8 61.7 139.9 158.0 193.6 122.5 75.8 91.7 67.9 94.6 104.5 49.9 43.8 127.8 64.5 90.2 60.0 51.6 145.5 67.2 59.8 62.9 18.9 48.1 154.8 81.0 84.0 105.6 39.4 41.8 42.7 57.7 41.1 42.8 40.8 40.1 40.0 42.3 39.1 43.5 42.6 113.6 48.1 48.5 17.3 90.2 85.1 115.2 374.4 73.4 45.9 121.0 138.6 362.3 88.6 164.3 88.3 33.3 234.0 54.5 115.9 508.7 132.5 162.6 118.4 79.0 89.2 117.5 75.3 16.1 105.7 150.0 87.1 77.5 62.9 93.8 120.1 105.7 118.3 253.5 40.4 22.6 196.0 266.5 261.3 133.0 28.9 81.1 133.6 135.2 15.9 180.0 107.2 70.0 19.6 25.8 81.5 163.4 70.0 75.0 89.8 293.5 462.8 157.9 73.4 72.3 87.1 98.5 265.7 128.3 105.9 88.7 230.0 72.9 257.4 268.8 163.4 MRPL47 "CGI-204, NCM1" ENSG00000136522 "Mitochondrial ribosomal protein L47" Q9HD33 3 179588285-179604649 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 399.7;Spermatocytes: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037553, HPA047779" Approved Supported Mitochondria NA NA Mitochondria "HPA037553: AB_10671375, HPA047779: AB_2680154" "unprognostic (6.37e-2)" "prognostic favorable (6.44e-4)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (1.53e-1)" "unprognostic (8.55e-3)" "unprognostic (1.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.58e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-2)" "unprognostic (1.29e-2)" "unprognostic (5.64e-2)" "unprognostic (3.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.71e-1)" "unprognostic (8.84e-2)" 25.3 35.1 32.1 24.2 32.7 49.2 27.5 35.3 41.4 19.0 34.8 32.4 23.9 23.2 23.0 32.1 19.1 18.7 52.2 30.6 35.6 41.1 35.8 20.3 30.2 33.6 33.2 29.7 16.7 17.6 34.1 24.2 22.4 34.1 20.8 32.1 26.9 21.3 19.0 53.0 21.2 22.8 24.9 34.5 24.5 26.5 53.5 33.9 33.6 21.2 57.5 30.7 32.3 21.8 35.5 128.6 48.6 83.0 76.7 51.5 53.5 95.2 73.2 65.1 112.3 93.2 198.6 51.8 104.7 140.6 62.5 137.2 94.5 103.5 76.9 120.5 121.0 90.9 99.8 46.1 112.5 99.8 182.2 54.2 49.6 65.7 83.4 84.7 53.1 77.2 95.9 59.5 81.4 88.1 98.9 98.4 168.4 144.3 115.4 114.6 102.7 81.1 175.3 120.4 79.6 71.8 83.5 80.7 128.6 151.2 61.9 198.6 136.6 61.6 60.7 87.4 77.1 204.5 102.1 182.4 229.3 70.7 147.4 75.8 38.2 32.4 44.2 31.7 43.8 32.2 35.1 35.1 34.7 48.4 31.8 30.4 31.7 8.5 41.5 54.4 41.9 48.9 35.8 32.1 32.7 35.3 41.4 30.6 35.6 33.6 33.2 29.7 34.1 34.5 33.9 35.5 45.3 22.4 21.7 5.5 51.4 74.9 82.0 179.7 38.7 20.2 36.4 33.4 89.7 54.3 78.6 57.0 10.4 100.0 61.2 46.3 258.2 112.3 399.7 72.8 56.0 55.5 54.9 62.9 7.1 115.9 109.6 51.8 36.2 50.0 56.4 34.0 44.3 62.5 99.3 10.1 9.2 52.8 105.8 42.4 55.7 95.4 42.9 53.5 48.0 4.7 80.3 43.4 39.1 7.1 12.4 118.7 53.6 49.2 54.6 72.6 45.2 201.7 85.5 26.0 59.2 57.9 68.2 301.2 54.0 52.2 70.5 104.1 57.8 102.3 71.9 83.8 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185914558-185938103 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 444.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol NA NA 62000 Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396" "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favorable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 38.5 41.7 19.2 35.6 21.1 46.6 30.5 24.4 31.4 25.4 26.9 42.1 21.7 31.6 26.5 39.0 27.3 16.1 28.5 20.6 21.7 31.9 37.8 21.7 39.0 23.7 19.1 18.4 25.7 28.5 29.1 20.5 26.6 21.2 26.1 25.1 18.6 27.2 18.6 34.4 25.3 27.2 25.4 18.2 36.5 31.4 22.6 21.9 48.1 23.4 23.4 44.2 29.0 27.0 27.3 145.0 44.2 135.0 67.8 30.3 27.3 78.2 101.5 71.1 117.5 90.2 75.3 67.6 124.5 134.4 53.2 79.5 94.1 140.9 104.5 120.9 117.5 89.6 122.0 40.1 92.7 42.4 133.3 101.1 26.5 44.3 75.1 51.0 36.5 90.4 63.5 120.4 81.6 79.6 66.4 344.9 164.1 191.3 113.0 85.5 201.1 109.4 147.5 94.3 58.9 98.0 104.0 73.3 90.1 117.8 66.5 101.1 138.0 52.7 81.3 110.8 68.2 170.1 159.6 444.0 272.0 78.0 151.0 130.6 84.1 39.2 33.0 36.3 33.1 32.8 71.2 36.1 34.0 35.3 64.0 45.0 40.9 44.0 41.3 39.6 73.2 36.4 21.5 19.2 21.1 24.4 31.4 20.6 21.7 23.7 19.1 18.4 21.2 18.2 21.9 27.3 236.3 64.1 122.0 46.4 201.7 258.4 196.9 136.6 157.1 107.8 206.0 148.2 67.2 140.2 104.0 69.9 196.0 188.9 196.6 156.2 72.4 126.8 156.9 152.7 284.5 181.6 227.6 233.4 49.7 109.5 230.7 147.2 92.2 274.6 197.6 155.9 189.9 93.0 174.6 72.3 53.7 259.8 85.5 280.7 283.1 46.6 127.7 228.1 135.2 74.0 196.9 115.5 167.9 78.4 67.0 97.5 129.1 117.4 152.1 218.3 121.2 59.1 66.7 219.5 105.2 177.0 214.7 168.2 151.5 141.3 260.7 214.9 212.6 89.4 232.4 163.7 SCN2A "HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2" ENSG00000136531 "Sodium voltage-gated channel alpha subunit 2" Q99250 2 165194993-165392310 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 26.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 440.4;Inhibitory neurons: 364.7;Oligodendrocyte precursor cells: 246.3" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 2.1;U-138 MG: 3.4;U-266/84: 8.1;U-87 MG: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022567 Enhanced NA NA "CAB022567: " "unprognostic (1.16e-1)" "unprognostic (3.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.97e-1)" "unprognostic (8.62e-3)" "unprognostic (1.18e-1)" "unprognostic (7.25e-3)" "unprognostic (1.40e-1)" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (4.88e-2)" "unprognostic (2.14e-1)" 0.1 1.3 8.6 0.1 17.2 0.0 0.8 26.7 22.1 0.2 0.0 0.1 0.2 0.5 1.0 0.0 0.1 0.8 0.1 17.9 15.6 3.5 0.1 0.2 0.0 0.0 3.4 17.3 0.2 0.1 0.0 3.8 0.1 1.9 0.1 0.1 4.7 0.2 0.4 0.0 0.0 0.3 0.6 0.0 0.1 0.3 0.3 1.9 0.3 0.0 0.0 0.0 0.1 0.3 8.7 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 1.7 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.3 0.0 0.1 2.1 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.9 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.4 0.2 0.2 0.0 0.3 8.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 17.2 26.7 22.1 17.9 15.6 0.0 3.4 17.3 1.9 0.0 1.9 8.7 0.1 0.0 1.7 18.3 0.5 0.3 0.1 0.2 0.0 49.8 0.3 4.7 0.8 0.0 0.0 11.0 47.9 0.1 0.2 0.0 5.9 0.2 1.6 0.1 2.3 0.3 0.0 0.0 440.4 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.2 364.7 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 60.9 0.0 3.4 0.0 246.3 17.0 0.3 0.0 6.0 0.0 0.0 0.0 0.3 0.0 4.3 0.0 0.0 0.6 0.0 0.9 0.1 0.1 0.0 0.4 1.0 0.0 0.0 TBR1 ENSG00000136535 "T-box brain transcription factor 1" Q16650 2 161416297-161425870 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "brain: 28.1" "Group enriched" "Detected in some" 5 "Early spermatids: 32.3;Late spermatids: 65.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 44.6;basal ganglia: 28.3;cerebral cortex: 70.8;hippocampal formation: 45.7;white matter: 43.9" "Region enhanced" "Detected in many" "cerebral cortex: 66.9" "HPA051256, HPA078644, HPA078657" Enhanced Supported NA NA "HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388" "unprognostic (3.08e-2)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-2)" "unprognostic (7.43e-3)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.39e-9)" "unprognostic (5.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.37e-2)" 0.0 0.0 6.0 0.0 22.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 1.0 0.0 0.0 0.0 0.0 7.2 2.1 16.3 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 22.0 0.0 28.1 13.2 1.0 7.2 2.1 16.3 8.1 0.0 0.0 19.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 32.3 0.2 0.3 0.4 0.0 0.0 9.3 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 65.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.3 0.2 0.5 1.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 MARCHF7 "AXOT, MARCH-VII, MARCH7, RNF177" ENSG00000136536 "Membrane associated ring-CH-type finger 7" Q9H992 2 159712457-159771027 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 33.3;Cardiomyocytes: 88.4;Cytotrophoblasts: 36.2;dendritic cells: 28.2;Extravillous trophoblasts: 38.8;Hofbauer cells: 34.0;Syncytiotrophoblasts: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014275, HPA022152" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014275: AB_10599820, HPA022152: AB_10601107" "unprognostic (2.42e-1)" "unprognostic (2.24e-1)" "unprognostic (1.02e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (3.17e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.84e-4)" "unprognostic (1.41e-3)" "unprognostic (1.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 38.7 30.3 18.4 38.3 22.6 43.6 48.7 34.2 21.7 38.9 27.1 33.5 30.3 45.4 34.5 67.9 37.8 38.4 49.4 17.7 25.8 33.1 40.4 38.6 48.3 19.7 20.3 17.3 47.9 22.5 36.9 22.9 47.3 21.4 38.5 37.3 38.3 27.1 36.6 55.7 38.9 30.2 51.1 17.4 45.4 33.8 62.6 18.5 61.3 48.0 44.4 52.6 39.4 37.8 23.7 50.3 35.3 88.7 40.7 61.9 81.9 89.1 83.9 81.1 82.5 73.9 70.9 57.5 71.0 36.8 84.2 46.8 61.3 55.4 74.5 102.9 75.9 43.2 96.0 53.8 53.3 60.7 79.9 72.6 72.7 83.0 99.5 86.5 92.5 99.3 50.7 75.6 65.6 82.9 44.2 52.4 73.8 84.6 54.6 47.3 75.0 64.5 59.3 74.6 112.1 51.9 48.6 65.6 48.2 67.0 94.3 56.9 94.4 93.5 86.9 51.9 53.9 47.2 51.5 61.0 96.8 54.1 46.8 84.0 83.5 28.8 59.6 28.6 29.5 33.3 27.6 30.4 32.4 27.6 26.4 36.3 35.9 127.5 39.4 43.4 22.3 34.3 30.9 18.4 22.6 34.2 21.7 17.7 25.8 19.7 20.3 17.3 21.4 17.4 18.5 23.7 33.3 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.4 0.0 0.0 0.0 0.0 36.2 28.2 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 38.8 13.5 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 44.2 5.8 0.0 0.0 0.0 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318631-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "brain: 533.8;choroid plexus: 175.1" "Cell type enriched" "Detected in some" 51 "Oligodendrocytes: 290.9" "Cancer enriched" "Detected in some" 4 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HAP1: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favorable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 0.7 0.2 273.7 2.3 365.4 18.9 0.5 340.6 341.5 0.4 175.1 0.8 0.5 0.4 0.1 0.5 0.4 0.8 0.3 243.3 284.7 0.5 0.5 2.4 3.4 404.1 353.9 195.2 0.2 0.3 0.0 0.4 0.1 417.0 0.3 0.9 0.6 1.7 0.3 0.4 0.7 3.8 0.3 331.8 4.8 1.3 0.5 342.4 1.6 0.4 0.0 3.1 0.7 0.3 533.8 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.3 0.0 1.9 0.0 0.3 25.3 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 3.5 0.4 0.2 0.7 2.3 0.2 0.1 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.5 0.0 0.1 0.0 0.3 0.6 1.2 0.0 0.2 0.1 0.3 0.6 3.4 2.5 0.6 1.7 0.9 0.9 0.5 0.3 0.3 0.4 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.3 0.3 0.6 0.5 0.2 0.3 0.2 0.1 273.7 365.4 340.6 341.5 243.3 284.7 404.1 353.9 195.2 417.0 331.8 342.4 533.8 0.1 0.0 1.3 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.8 0.2 0.0 1.2 0.9 0.1 0.0 2.2 0.0 1.9 1.1 0.0 3.1 2.0 290.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257705-157318491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.7;lung: 10.3;stomach 1: 12.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 1300000 "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.1 0.0 0.0 0.7 0.0 0.6 1.1 3.7 0.3 0.7 4.2 10.7 2.3 0.1 0.1 4.5 0.0 2.7 0.4 0.4 0.2 0.0 0.0 10.3 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.6 0.0 0.8 0.7 13.7 0.1 8.3 0.1 0.0 0.3 4.1 0.4 0.0 0.1 12.9 0.2 0.1 0.1 0.1 0.1 1.7 4.5 4.6 0.2 45.3 4.8 0.0 0.0 2.0 17.0 0.0 29.8 53.5 0.5 1.1 1.9 24.4 0.0 0.1 64.5 0.0 51.8 0.9 10.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.9 0.0 0.0 0.0 30.7 0.0 52.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 25.4 0.3 0.6 0.1 0.0 0.1 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.4 0.2 0.1 0.2 0.0 0.8 0.0 0.1 0.2 0.1 157.0 36.1 0.0 0.1 0.8 13.3 20.2 6.2 0.0 0.5 2.8 0.5 2.8 32.9 0.0 0.0 0.0 0.2 48.3 0.0 1.2 6.9 1.2 0.0 0.6 2.4 5.2 0.8 3.2 0.0 2.1 35.7 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 75.5 6.1 0.0 0.7 0.5 0.0 0.3 3.6 0.0 1.6 0.0 0.0 0.0 0.1 53.5 26.4 0.0 1.4 40.1 3.1 0.2 10.0 0.0 0.0 0.5 1.2 2.6 0.5 4.5 0.1 0.0 0.3 0.0 22.7 115.1 SCN7A "NaG, Nav2.1, Nav2.2, SCN6A" ENSG00000136546 "Sodium voltage-gated channel alpha subunit 7" Q01118 2 166403573-166611482 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 45.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Group enriched" "Detected in some" 5 "HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 7.6" HPA072715 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA072715: " "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (9.72e-2)" "unprognostic (7.43e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-1)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (5.21e-2)" "unprognostic (6.84e-3)" "unprognostic (6.88e-2)" "unprognostic (1.27e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-2)" "unprognostic (1.47e-2)" "unprognostic (1.35e-1)" "unprognostic (1.22e-4)" 4.6 8.7 3.0 3.4 2.7 0.3 10.3 0.1 1.7 6.5 0.0 25.4 3.4 9.1 6.4 10.2 11.0 3.8 17.9 1.0 5.5 1.8 1.2 27.8 0.5 4.0 3.5 1.7 45.8 4.9 0.8 1.0 12.4 4.0 11.1 8.5 10.7 6.2 10.2 7.3 2.4 6.9 7.7 1.8 3.2 7.8 5.7 7.7 3.3 1.3 15.1 0.4 4.8 7.2 3.5 0.1 0.1 0.7 0.9 0.2 0.0 0.8 0.7 0.0 1.3 0.0 0.6 0.2 0.4 0.1 0.0 0.3 0.3 0.1 0.1 0.0 7.9 0.5 0.2 1.5 0.6 0.0 0.2 4.5 0.0 0.0 0.4 0.1 0.4 0.0 0.4 1.2 5.8 0.0 1.0 0.8 0.5 1.1 0.3 0.3 0.0 0.5 0.0 0.1 0.8 0.2 0.4 0.3 15.4 0.0 0.3 0.4 0.1 0.4 0.2 1.0 0.7 0.4 1.0 0.3 1.1 0.2 0.2 0.4 1.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.8 3.0 2.7 0.1 1.7 1.0 5.5 4.0 3.5 1.7 4.0 1.8 7.7 3.5 1.4 0.0 1.1 1.0 0.0 0.3 0.2 0.0 5.7 21.5 0.2 0.3 16.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.9 0.0 2.4 0.0 0.3 4.1 0.0 0.0 7.7 0.0 0.0 102.0 0.0 0.0 15.9 0.1 9.3 0.0 0.2 0.0 20.9 0.0 0.0 0.0 1.2 4.1 100.9 1.8 5.4 14.0 0.0 4.9 0.0 14.1 0.3 0.1 0.0 159.9 1.2 0.5 0.0 0.5 0.0 1.8 151.2 16.7 26.1 0.5 1.2 1.7 1.1 0.0 0.2 0.3 0.0 0.3 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236230 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601" "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 43.2 36.6 20.9 46.6 23.9 85.0 58.3 22.7 24.9 30.8 27.2 32.7 28.2 31.0 27.3 30.1 35.3 43.4 27.3 20.3 30.4 29.4 67.0 40.0 53.2 24.7 25.3 18.8 31.1 23.1 28.0 19.9 37.2 24.0 24.8 36.1 32.4 26.8 24.9 52.7 26.9 29.3 32.7 22.8 43.6 30.5 22.5 22.8 42.5 36.7 43.6 51.9 49.4 25.2 25.7 39.2 24.5 31.7 36.3 91.3 124.9 45.2 58.0 86.4 39.3 57.7 30.8 50.5 53.1 38.7 67.6 28.2 27.5 19.2 43.4 59.5 126.6 20.5 29.8 22.5 79.1 72.4 51.1 32.2 98.3 66.6 59.6 46.6 73.5 101.7 32.0 30.5 68.7 77.7 29.3 31.4 50.7 18.2 40.9 21.5 17.9 45.5 35.2 86.3 62.1 26.4 30.7 37.4 40.6 60.4 43.2 17.5 64.9 108.2 50.4 29.3 25.7 34.0 46.6 46.1 80.9 66.9 40.3 40.8 122.2 71.4 97.1 36.0 78.5 55.9 63.8 58.8 53.1 66.5 66.7 39.9 39.6 189.4 42.4 94.0 43.4 100.7 55.0 20.9 23.9 22.7 24.9 20.3 30.4 24.7 25.3 18.8 24.0 22.8 22.8 25.7 34.7 57.7 79.6 82.3 108.9 59.9 106.3 82.7 21.6 32.7 73.0 71.5 27.3 42.9 69.2 46.0 12.5 43.1 54.8 50.4 60.7 58.8 18.0 47.2 42.3 46.7 47.4 63.8 49.9 40.5 82.9 67.8 28.5 52.4 59.5 17.0 28.2 58.1 45.6 21.9 60.9 29.3 71.2 71.5 194.0 10.0 52.8 106.8 72.9 120.9 177.7 33.5 40.2 63.3 87.4 56.0 43.9 26.4 57.1 81.8 34.4 46.5 66.2 37.4 26.3 52.1 40.3 54.3 33.9 29.3 60.9 134.9 109.3 33.0 32.2 158.4 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564599 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 39.4;lymphoid tissue: 47.1" "Cell type enriched" "Detected in some" 11 "B-cells: 116.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory B-cell: 183.4;naive B-cell: 131.5" "Lineage enriched" "Detected in many" 5 "B-cells: 183.4" "Cell line enhanced" "Detected in some" "Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB005093, HPA069571" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB005093: AB_2274756, HPA069571: AB_2732137" "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.3 0.1 0.0 9.2 0.0 2.7 0.2 0.0 0.0 0.0 0.0 1.5 0.5 0.1 0.0 1.2 0.2 0.5 0.0 0.0 0.0 1.1 0.7 0.8 30.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.7 0.0 0.8 0.0 0.3 0.0 39.4 0.1 0.0 47.1 2.1 0.1 0.0 2.5 1.2 0.0 28.2 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 29.9 0.0 38.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 5.4 10.2 48.6 22.7 0.0 0.0 0.2 0.1 0.2 2.0 0.0 37.9 183.4 1.4 4.6 0.1 131.5 0.9 0.4 0.7 0.1 0.1 17.5 1.8 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 116.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 4.0 0.1 0.1 0.0 GATA4 ENSG00000136574 "GATA binding protein 4" P43694 8 11676959-11760002 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 85.8;ovary: 96.2;pancreas: 53.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1" "Cancer enhanced" "Detected in many" "stomach cancer: 21.8;testis cancer: 12.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013125, HPA073899" Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "CAB013125: AB_2533804, HPA073899: AB_2686641" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (8.68e-4)" "unprognostic (2.66e-3)" "unprognostic (1.71e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-2)" "unprognostic (5.47e-2)" "unprognostic (2.55e-1)" "unprognostic (2.78e-2)" "unprognostic (2.49e-1)" "unprognostic (1.67e-8)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.29e-2)" 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.4 0.2 0.0 0.0 2.3 4.0 85.8 0.0 0.0 0.0 36.9 0.2 0.0 0.0 0.0 0.0 96.2 53.9 0.0 0.1 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.1 35.5 32.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.7 20.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.2 1.3 0.0 0.0 1.5 20.5 0.0 0.0 0.1 3.9 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 16.1 0.0 0.1 6.1 0.0 0.0 0.1 33.7 0.2 12.0 61.2 0.0 0.0 158.4 57.8 12.1 0.6 0.0 0.1 0.8 0.0 2.8 0.0 37.0 41.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 41.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 5.3 2.4 2.2 0.0 0.0 0.8 0.1 80.1 0.9 0.0 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008472, HPA014233" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008472: AB_1856933, HPA014233: " "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 12.0 12.1 7.4 19.0 8.5 23.3 9.1 10.5 13.0 9.5 15.4 10.5 13.9 12.1 8.3 9.3 6.4 21.3 9.3 7.4 17.0 10.4 15.7 16.2 13.9 11.2 11.7 6.1 9.3 9.7 5.7 11.1 14.1 11.6 11.7 9.8 9.7 7.5 9.0 11.1 5.9 14.3 10.6 14.7 7.3 16.0 13.2 11.4 9.3 11.4 21.6 18.6 14.8 8.9 12.1 19.9 24.0 15.6 10.4 20.0 8.7 29.1 19.6 13.6 13.8 10.6 4.9 42.2 24.9 60.5 18.2 23.1 44.8 9.9 9.0 21.3 43.6 9.2 32.8 24.8 11.0 17.8 13.7 17.4 15.3 8.8 19.9 15.0 42.9 34.1 2.4 14.7 27.9 28.4 21.3 5.9 4.5 61.2 21.8 8.1 13.6 52.8 5.0 20.8 31.7 11.5 14.1 48.3 47.4 10.3 31.6 32.2 14.2 66.1 38.2 35.9 33.0 37.1 36.2 18.6 47.3 14.3 7.1 18.3 3.1 3.4 1.8 1.3 8.3 1.8 3.6 1.1 1.7 2.4 4.4 1.9 2.0 4.0 2.8 10.3 1.6 0.5 1.9 7.4 8.5 10.5 13.0 7.4 17.0 11.2 11.7 6.1 11.6 14.7 11.4 12.1 104.1 73.7 72.8 21.2 142.1 72.7 88.8 52.5 67.7 25.6 79.3 38.1 12.4 21.5 70.4 35.0 54.2 14.8 124.9 45.9 15.6 56.7 115.7 118.4 80.9 86.0 23.8 3.0 48.6 111.4 58.3 100.6 93.8 102.0 204.8 46.3 72.5 32.0 26.3 53.8 21.6 62.4 22.4 65.4 85.2 35.8 37.9 121.7 35.6 60.0 42.1 12.7 14.4 26.2 27.5 176.5 29.1 68.1 104.3 43.5 41.3 45.9 82.1 30.5 26.3 143.6 63.6 53.9 37.6 61.3 96.0 41.2 81.5 17.5 31.3 117.8 EPRS1 "EARS, EPRS, GLUPRORS, PARS, QARS, QPRS" ENSG00000136628 "Glutamyl-prolyl-tRNA synthetase 1" P07814 1 219968600-220046530 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding" "Disease variant, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026490, HPA030052" Enhanced Enhanced Cytosol NA NA 360000 Cytosol "HPA026490: AB_1855979, HPA030052: AB_10601466" "prognostic unfavorable (7.25e-4)" "unprognostic (1.19e-2)" "unprognostic (3.94e-2)" "unprognostic (2.60e-2)" "unprognostic (7.98e-3)" "unprognostic (1.12e-2)" "unprognostic (3.41e-3)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.30e-1)" "unprognostic (7.13e-2)" "unprognostic (5.12e-2)" "unprognostic (2.32e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.62e-4)" 29.1 25.0 18.6 34.7 19.8 26.9 36.1 22.5 25.0 30.8 17.6 36.5 28.0 25.8 25.4 30.9 26.4 20.8 32.1 17.8 20.4 31.9 28.1 24.6 36.7 22.1 20.1 16.6 35.0 49.4 54.9 22.7 24.0 22.5 23.8 39.4 44.1 84.1 26.7 52.6 29.1 29.9 32.8 21.7 27.7 36.3 20.7 21.2 35.1 43.4 56.4 42.9 30.7 18.8 27.9 125.9 78.4 55.7 152.3 114.9 126.7 138.0 160.1 111.7 102.1 113.4 93.3 98.1 239.3 86.7 170.4 41.3 130.3 140.9 129.4 136.2 117.9 88.9 130.2 97.6 80.2 125.1 217.6 106.7 92.1 161.7 130.3 161.6 84.8 113.4 113.2 228.0 182.9 100.8 61.8 94.7 53.1 107.4 146.8 159.6 98.5 98.0 236.2 92.8 54.4 128.6 101.3 93.7 152.6 166.5 78.9 141.2 235.1 101.1 48.3 88.1 149.6 151.1 122.8 150.1 197.1 111.4 153.9 156.4 8.8 17.8 10.0 19.7 24.6 27.8 21.0 19.7 22.1 23.2 18.5 22.0 22.9 0.6 22.5 22.1 7.6 20.8 17.2 18.6 19.8 22.5 25.0 17.8 20.4 22.1 20.1 16.6 22.5 21.7 21.2 27.9 22.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.7 0.0 0.0 0.0 0.0 40.8 14.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 59.3 17.1 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 36.5 2.6 0.0 0.0 0.0 HLX "HB24, HLX1" ENSG00000136630 "H2.0 like homeobox" Q14774 1 220879431-220885059 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 87.3" "Cell type enhanced" "Detected in many" "Adipocytes: 35.7;Endothelial cells: 32.5;Hepatic stellate cells: 47.5;Hofbauer cells: 34.1;Kupffer cells: 24.8;Langerhans cells: 23.5;monocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 65.1;neutrophil: 55.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 65.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 32.4;THP-1: 100.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005968 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005968: AB_1079066" "unprognostic (6.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.57e-2)" "unprognostic (9.19e-3)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (5.14e-3)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" "unprognostic (3.19e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.28e-6)" "unprognostic (8.44e-3)" "unprognostic (3.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" 30.5 4.8 1.3 10.4 1.1 87.3 18.7 1.2 2.0 7.0 1.4 34.5 4.9 5.5 0.5 3.9 9.4 9.7 15.9 1.7 3.3 6.4 22.0 23.3 8.6 1.6 1.3 0.7 4.2 4.3 1.3 3.1 13.9 1.7 6.4 2.0 0.0 3.5 0.4 9.3 7.6 19.0 5.6 1.5 15.8 5.3 1.8 2.0 2.1 9.6 4.2 2.4 11.1 8.9 2.8 0.0 2.1 0.0 3.2 9.2 14.7 3.0 11.4 18.9 12.8 10.6 0.2 0.3 0.0 0.1 6.8 2.5 0.0 0.5 0.0 5.3 3.0 5.9 0.0 1.1 0.3 15.1 3.9 0.8 15.4 0.2 14.7 0.8 1.1 5.7 0.0 4.0 0.0 1.6 0.0 0.0 10.3 0.3 0.0 5.2 0.3 9.0 0.1 0.8 0.1 0.0 2.4 0.7 0.0 32.4 0.1 0.0 100.4 1.8 8.7 0.0 1.3 9.3 0.0 0.0 0.0 14.1 12.3 3.6 65.1 10.4 22.3 0.0 3.4 0.0 5.7 0.0 0.0 13.0 2.7 0.0 0.0 55.9 0.7 0.7 8.7 0.4 3.3 1.3 1.1 1.2 2.0 1.7 3.3 1.6 1.3 0.7 1.7 1.5 2.0 2.8 35.7 9.6 5.3 1.0 4.3 2.8 0.1 0.0 0.6 0.1 0.5 1.3 5.7 0.0 0.0 0.0 0.0 0.6 3.0 0.4 0.0 0.5 0.5 0.2 2.6 32.5 0.0 8.4 0.3 0.4 0.7 8.4 0.5 0.3 3.8 0.1 47.5 10.8 34.1 0.0 0.2 0.3 0.0 24.8 23.5 0.4 2.5 17.8 0.0 4.7 44.2 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.2 0.2 0.0 0.1 0.0 0.0 6.6 7.5 10.6 0.1 2.2 0.3 3.1 0.4 1.1 0.4 0.3 0.4 VPS45 "h-vps45, H1, VPS45A, VPS45B" ENSG00000136631 "Vacuolar protein sorting 45 homolog" Q9NRW7 1 150067279-150145329 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.8;Late spermatids: 267.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027425, HPA027441" Uncertain Approved Microtubules NA NA Microtubules "HPA027425: AB_10599415, HPA027441: AB_10602284" "unprognostic (1.57e-1)" "unprognostic (2.75e-1)" "unprognostic (2.03e-1)" "unprognostic (5.51e-2)" "unprognostic (1.56e-2)" "unprognostic (8.36e-3)" "prognostic unfavorable (6.57e-6)" "unprognostic (4.76e-2)" "unprognostic (2.94e-2)" "unprognostic (2.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.49e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-2)" 19.3 27.0 32.2 12.1 34.2 6.7 18.0 40.2 43.3 20.3 28.1 19.7 12.7 18.8 22.7 16.9 16.3 13.8 39.0 33.5 34.2 21.3 12.6 15.5 13.6 31.1 32.2 33.1 14.1 11.2 26.6 19.2 17.4 32.7 19.0 17.4 29.4 14.5 20.3 19.5 16.4 15.5 25.5 31.3 16.3 17.5 11.1 31.7 17.2 20.0 16.8 15.4 18.6 16.0 32.6 31.5 24.3 40.9 27.0 37.1 29.4 19.0 44.7 23.7 45.3 37.4 17.7 26.1 19.3 26.5 37.0 19.9 26.0 42.4 27.0 49.0 38.7 31.1 24.6 33.5 16.8 24.7 17.6 30.2 25.8 24.8 43.5 22.8 29.7 37.1 38.6 34.4 28.3 40.0 53.5 34.7 17.5 28.4 28.7 38.4 23.7 41.9 27.4 31.2 30.0 28.5 59.7 34.9 29.8 46.9 46.2 48.9 45.6 32.6 20.8 25.1 18.7 31.3 21.3 49.4 18.9 30.9 24.4 30.2 23.6 26.6 4.7 16.0 28.0 15.0 15.6 13.6 15.1 25.9 12.8 13.2 13.9 2.5 14.1 19.9 14.6 16.8 18.4 32.2 34.2 40.2 43.3 33.5 34.2 31.1 32.2 33.1 32.7 31.3 31.7 32.6 9.4 12.8 14.0 85.8 11.9 7.4 8.2 12.7 13.1 20.9 11.0 10.2 44.0 8.6 11.0 16.5 18.8 20.9 12.5 8.3 7.9 12.3 202.8 9.7 14.2 10.4 7.8 4.6 79.4 7.2 9.5 14.7 12.8 10.1 6.3 24.6 12.1 7.2 19.0 30.3 90.2 8.1 14.2 18.0 8.6 267.9 21.5 13.6 10.6 45.9 19.7 17.9 6.2 92.5 59.5 11.4 11.6 14.7 8.4 6.4 13.6 9.2 11.5 23.8 32.9 7.3 17.1 18.1 15.1 11.6 7.7 14.8 11.2 21.2 9.7 7.9 IL10 "CSIF, IL-10, IL10A, TGIF" ENSG00000136634 "Interleukin 10" P22301 1 206767602-206774541 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 6.7;lymphoid tissue: 7.7" "Group enriched" "Detected in some" 4 "Hofbauer cells: 28.3;Kupffer cells: 44.4;Langerhans cells: 35.5;Macrophages: 99.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.1;intermediate monocyte: 1.8" "Lineage enriched" "Detected in single" 6 "monocytes: 2.1" "Group enriched" "Detected in some" 11 "HMC-1: 14.6;U-266/70: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013120, HPA071391" Approved "Secreted to blood" NA NA 5670 "CAB013120: , HPA071391: " "unprognostic (3.65e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.20e-1)" "unprognostic (2.63e-3)" "unprognostic (2.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (4.26e-1)" "unprognostic (8.01e-2)" "unprognostic (4.00e-1)" "unprognostic (4.66e-4)" "unprognostic (7.11e-2)" "unprognostic (1.93e-2)" "unprognostic (2.73e-1)" "unprognostic (1.96e-2)" 6.7 2.1 0.3 7.7 0.4 3.3 0.7 0.3 0.7 0.8 1.3 1.0 0.8 0.3 0.1 1.5 1.4 3.6 0.8 0.3 1.5 0.2 1.6 1.5 5.7 0.9 0.4 0.2 0.4 0.1 0.2 0.4 1.9 0.7 0.4 1.3 0.0 0.2 0.7 0.0 0.1 1.1 3.1 0.6 4.9 0.8 0.8 2.8 2.9 0.2 1.2 2.1 3.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.2 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.4 0.3 0.4 0.3 0.7 0.3 1.5 0.9 0.4 0.2 0.7 0.6 2.8 1.4 0.5 0.0 1.9 0.0 5.6 1.0 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 1.3 0.0 0.0 0.1 1.3 0.0 0.0 0.0 6.9 0.1 0.2 1.9 0.0 0.4 0.0 0.0 0.1 0.8 1.1 0.2 1.3 0.0 0.7 0.5 28.3 0.0 0.0 0.0 0.0 44.4 35.5 2.9 0.0 99.5 1.8 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.9 0.3 0.0 0.0 0.0 0.4 0.0 0.9 0.8 0.0 0.2 0.7 1.1 0.1 12.9 0.0 0.0 0.4 KCTD3 NY-REN-45 ENSG00000136636 "Potassium channel tetramerization domain containing 3" Q9Y597 1 215567304-215621807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "T-47d: 227.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015142 Approved Approved Cytosol NA NA Cytosol "HPA015142: AB_1852174" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (5.46e-3)" "unprognostic (3.91e-2)" "unprognostic (3.67e-2)" "unprognostic (6.00e-2)" "unprognostic (3.39e-1)" "unprognostic (1.20e-2)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.49e-1)" "prognostic unfavorable (8.94e-6)" "unprognostic (2.30e-2)" "unprognostic (2.55e-1)" "unprognostic (4.27e-1)" "unprognostic (3.31e-3)" 35.4 78.0 21.2 12.0 27.3 16.1 67.9 36.9 23.4 24.0 19.5 28.9 45.9 23.9 27.6 39.0 19.5 28.0 13.2 21.9 25.7 27.9 72.4 17.2 8.7 30.0 27.1 18.8 23.7 33.0 37.0 12.1 29.9 29.3 38.8 28.6 40.1 28.0 29.9 15.3 19.0 49.9 29.1 27.1 11.7 26.9 20.2 24.2 11.4 27.8 24.0 11.0 24.1 31.0 35.4 52.8 37.2 41.6 24.1 34.3 57.5 57.1 42.8 40.0 37.1 38.5 33.0 85.6 14.6 23.4 45.0 11.1 50.3 44.1 43.4 42.5 8.2 45.8 26.3 71.0 46.3 28.3 26.9 5.1 53.5 30.0 47.0 35.5 46.7 34.6 19.8 51.8 13.9 41.1 45.6 11.7 13.8 69.9 76.2 47.0 17.7 58.8 56.9 42.8 35.2 48.7 54.0 65.9 95.0 36.6 52.1 227.5 34.3 31.1 36.8 36.4 46.1 49.4 12.5 18.2 5.3 29.0 14.1 28.5 0.5 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.4 0.5 0.2 0.2 0.7 0.5 0.2 0.6 0.1 0.2 21.2 27.3 36.9 23.4 21.9 25.7 30.0 27.1 18.8 29.3 27.1 24.2 35.4 26.5 9.6 11.6 41.4 2.4 18.0 25.2 9.4 19.4 31.7 60.0 31.9 13.3 40.0 17.6 11.0 18.8 27.2 4.6 15.5 23.5 26.6 1.3 14.0 29.8 20.6 39.6 19.3 53.5 20.7 15.7 30.3 21.4 19.6 5.1 30.7 16.1 60.5 8.0 18.5 62.9 40.6 14.2 9.3 8.4 3.2 27.7 7.9 16.0 33.7 5.5 24.0 0.0 53.3 106.7 16.5 19.1 22.6 4.6 21.9 50.1 28.3 14.4 24.2 26.3 41.8 20.4 6.3 14.6 45.2 17.6 17.5 2.5 32.0 33.0 38.3 RPS6KC1 "humS6PKh1, RSKL1" ENSG00000136643 "Ribosomal protein S6 kinase C1" Q96S38 1 213051233-213274774 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 86.2;Excitatory neurons: 273.2;Inhibitory neurons: 151.2;Microglial cells: 101.2;Oligodendrocyte precursor cells: 116.6;Oligodendrocytes: 137.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 16.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026531, HPA031565" Approved Supported Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" "HPA026531: AB_10601497, HPA031565: AB_2673935" "unprognostic (3.90e-2)" "unprognostic (5.90e-2)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (2.42e-1)" "unprognostic (9.81e-2)" "unprognostic (1.32e-2)" "unprognostic (1.64e-1)" "unprognostic (4.10e-2)" "unprognostic (3.34e-1)" "unprognostic (4.18e-1)" "unprognostic (5.11e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (8.10e-2)" "unprognostic (5.48e-2)" "unprognostic (2.98e-2)" "unprognostic (4.44e-2)" 8.4 8.9 11.0 7.2 12.9 4.9 7.3 9.4 14.2 8.9 6.2 6.3 6.3 9.5 5.3 6.8 7.7 7.8 6.5 13.4 10.7 6.4 7.5 7.2 5.3 10.2 10.9 12.3 9.2 9.3 10.3 4.6 8.5 10.5 11.6 6.6 9.4 6.8 11.4 10.1 4.3 6.0 12.8 10.4 8.0 8.7 19.5 11.0 5.5 6.9 11.7 5.4 8.2 4.7 14.6 11.0 9.3 15.0 16.3 15.0 21.6 13.2 14.1 20.7 21.5 24.6 7.7 11.9 6.9 9.3 21.4 14.1 8.9 18.3 11.6 16.2 14.7 6.7 18.7 10.9 10.5 13.6 11.9 21.4 14.3 9.8 18.8 10.2 17.9 18.2 6.7 24.6 10.5 22.3 6.3 5.0 3.9 21.8 9.8 10.4 5.9 14.1 6.8 9.7 10.9 8.7 22.6 15.3 11.9 20.6 25.5 17.1 4.9 17.0 14.6 13.3 16.9 9.3 6.1 12.6 5.2 6.2 4.5 15.2 16.8 4.5 3.5 2.5 6.4 2.1 2.4 2.0 2.2 8.5 1.6 1.3 3.0 0.5 3.8 6.7 1.0 1.6 2.2 11.0 12.9 9.4 14.2 13.4 10.7 10.2 10.9 12.3 10.5 10.4 11.0 14.6 10.1 9.6 5.8 86.2 8.8 2.9 2.7 4.5 7.4 17.4 6.6 5.6 9.6 7.2 4.3 0.0 14.6 3.5 7.7 4.8 0.0 5.2 33.6 7.4 12.1 9.9 3.6 12.4 273.2 8.0 4.0 10.1 15.3 9.9 7.6 16.6 7.9 9.3 7.1 20.2 151.2 3.3 6.1 11.4 7.7 45.2 11.1 15.1 7.2 101.2 13.1 5.6 10.3 116.6 137.6 6.6 2.1 7.5 8.1 5.4 4.4 5.7 4.7 20.0 13.1 13.7 9.1 19.6 19.6 9.1 4.4 3.8 10.4 6.1 4.3 3.2 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 110.3;Suprabasal keratinocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 4.6 8.3 6.0 5.4 6.4 1.5 7.1 7.3 7.5 8.3 7.0 7.3 2.3 7.0 7.2 9.5 4.6 4.5 14.6 6.6 6.8 13.9 10.6 4.1 3.2 6.2 6.1 5.7 5.5 5.6 16.3 8.9 5.9 6.4 6.5 6.0 6.4 8.2 7.5 26.3 4.3 4.6 8.2 5.9 4.9 6.5 2.0 6.0 6.9 9.7 24.1 4.7 8.8 5.4 6.7 16.1 9.7 9.8 11.2 25.7 11.8 19.2 11.9 7.4 9.1 12.0 16.0 9.6 20.7 36.2 12.8 42.1 13.2 10.8 13.2 12.0 7.5 28.9 17.4 16.8 29.8 8.6 8.1 7.8 11.1 8.1 13.4 8.1 17.7 17.1 11.1 10.1 22.2 13.4 17.1 23.3 24.2 11.9 30.2 20.7 10.9 26.6 54.6 24.6 25.1 28.0 8.0 31.4 4.6 5.1 33.7 14.5 21.6 20.8 7.7 10.7 4.8 11.9 8.5 38.2 10.5 12.8 44.5 19.3 15.6 67.7 35.6 12.1 68.4 13.2 17.9 18.2 14.3 65.3 22.7 15.3 14.1 18.5 20.2 56.2 16.2 27.0 52.9 6.0 6.4 7.3 7.5 6.6 6.8 6.2 6.1 5.7 6.4 5.9 6.0 6.7 5.6 9.6 20.5 11.8 32.5 110.3 12.8 24.5 62.6 10.5 15.9 14.9 49.6 18.6 20.0 14.7 16.7 17.6 7.1 7.2 39.2 29.6 18.6 10.3 7.1 11.9 2.4 23.7 27.3 14.3 13.2 16.4 23.0 11.1 15.8 9.5 6.1 11.4 9.0 13.5 25.8 11.4 16.2 9.4 62.5 18.4 10.8 20.0 26.6 21.5 53.8 10.9 2.1 15.6 24.9 12.7 14.1 17.3 78.7 14.9 13.7 33.9 26.4 14.0 0.0 9.6 17.1 21.7 13.6 61.0 120.0 25.9 18.4 11.6 17.3 12.2 IL36G "IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1" ENSG00000136688 "Interleukin 36 gamma" Q9NZH8 2 112973203-112985658 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 14.4;lymphoid tissue: 39.7;skin 1: 26.5" "Group enriched" "Detected in some" 6 "Basal respiratory cells: 136.0;Club cells: 36.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 36.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;HaCaT: 1.0" "Not detected" "Not detected" HPA068168 Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 11000 Cytosol "Nucleoplasm, Plasma membrane" "HPA068168: " "unprognostic (1.56e-2)" "unprognostic (2.88e-1)" "unprognostic (7.27e-2)" "unprognostic (3.15e-2)" "unprognostic (4.91e-2)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (3.68e-1)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (5.79e-2)" "unprognostic (5.58e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 3.9 0.2 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 39.7 0.8 3.6 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.0 1.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 136.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.7 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 3.9 0.0 0.0 0.0 1.3 0.2 0.0 1.7 13.2 0.0 0.0 0.0 0.0 7.8 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 1985.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 184.4;Hofbauer cells: 306.0;Langerhans cells: 292.6;Squamous epithelial cells: 469.7;Suprabasal keratinocytes: 336.6;Urothelial cells: 464.9" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "classical monocyte: 63.8;myeloid DC: 61.7;neutrophil: 240.2" "Group enriched" "Detected in many" 694 "dendritic cells: 61.7;granulocytes: 240.2;monocytes: 63.8" "Cell line enhanced" "Detected in some" "A-431: 59.1;HaCaT: 112.3;RT4: 106.6;THP-1: 27.3" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 45000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 13.1 2.1 0.4 47.2 0.3 235.6 9.1 0.4 1.2 133.1 1.1 4.4 10.8 2.5 3.0 1985.5 2.1 17.1 2.0 0.3 0.5 1.4 250.6 20.3 1.4 0.4 0.4 0.2 0.9 1.8 2.0 2.4 21.3 0.5 2.4 4.0 0.0 289.4 7.5 0.8 123.1 8.8 4.0 0.3 14.8 45.9 6.5 1.1 5.3 6.4 3.0 314.4 187.5 468.8 1.5 59.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.9 0.0 0.2 0.0 0.6 0.2 0.2 0.0 1.1 112.3 0.0 3.3 0.0 0.1 0.0 0.3 0.0 17.3 0.0 0.3 20.3 0.0 14.3 0.7 0.0 2.0 0.0 0.0 0.3 0.3 0.0 0.5 0.1 14.7 0.0 13.2 0.0 0.0 0.1 0.1 0.0 106.6 0.0 0.0 0.1 0.8 0.1 0.0 0.0 27.3 0.3 1.4 0.0 0.7 0.1 0.6 0.1 0.2 10.3 10.5 0.3 0.0 63.8 1.9 0.0 27.7 0.0 0.1 0.0 0.0 61.7 0.1 0.1 0.1 240.2 0.0 13.7 0.8 0.1 19.8 0.4 0.3 0.4 1.2 0.3 0.5 0.4 0.4 0.2 0.5 0.3 1.1 1.5 1.7 6.4 7.7 0.0 4.1 184.4 81.3 151.8 56.9 0.0 4.9 3.4 0.4 11.5 60.6 3.7 0.0 1.8 0.2 6.5 0.0 27.5 34.8 7.8 1.4 4.8 0.0 3.2 0.3 28.0 2.9 11.0 44.4 23.6 10.1 0.0 3.3 53.0 306.0 0.0 0.2 1.1 6.1 39.8 292.6 93.3 0.6 111.1 24.9 0.0 22.6 0.0 2.1 0.5 0.2 149.9 0.1 0.4 2.8 58.4 9.3 0.2 20.2 0.0 0.0 0.3 3.8 0.8 0.2 469.7 336.6 4.5 3.3 0.0 3.2 464.9 IL36A "FIL1, FIL1E, IL-1F6, IL1(EPSILON), IL1F6, MGC129552, MGC129553" ENSG00000136694 "Interleukin 36 alpha" Q9UHA7 2 113005459-113008044 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "esophagus: 415.1;lymphoid tissue: 116.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 8.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;MOLT-4: 1.2;U-266/70: 1.2" "Not detected" "Not detected" "Secreted to blood" NA NA 327000 "unprognostic (1.37e-1)" "unprognostic (9.66e-3)" "unprognostic (5.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 415.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 116.4 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL36RN "FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840" ENSG00000136695 "Interleukin 36 receptor antagonist" Q9UBH0 2 113058638-113065382 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 26.7;lymphoid tissue: 44.0;skin 1: 51.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 8.9;Extravillous trophoblasts: 2.0;Syncytiotrophoblasts: 3.8" "Cancer enriched" "Detected in some" 7 "head and neck cancer: 25.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "BEWO: 26.6;GAMG: 11.1;U-87 MG: 19.9" "Not detected" "Not detected" "Secreted to blood" NA NA 107000 "unprognostic (3.88e-3)" "unprognostic (3.16e-1)" "unprognostic (2.88e-1)" "unprognostic (4.29e-1)" "unprognostic (8.68e-3)" "unprognostic (9.80e-2)" "unprognostic (2.48e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" "unprognostic (5.37e-2)" "unprognostic (3.85e-3)" "unprognostic (4.23e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.5 0.0 0.0 0.0 0.0 4.6 0.0 0.1 51.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 44.0 0.0 9.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 1.1 0.3 0.0 0.0 11.1 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.8 0.0 0.0 0.0 0.7 IL36B "FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882" ENSG00000136696 "Interleukin 36 beta" Q9NZH7 2 113022089-113052867 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 2.2;lymphoid tissue: 3.8;skin 1: 7.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "GAMG: 71.8;U-87 MG: 73.3" "Not detected" "Not detected" HPA035664 Uncertain "Secreted to blood" NA NA 15300 "HPA035664: AB_10669672" "unprognostic (8.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.56e-2)" "unprognostic (1.06e-1)" "unprognostic (3.77e-2)" "unprognostic (2.40e-3)" "unprognostic (2.05e-1)" "unprognostic (7.10e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 1.4 0.0 0.0 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL1F10 "FKSG75, IL-1F10, IL-1HY2, IL1-theta, MGC11983, MGC119832, MGC119833" ENSG00000136697 "Interleukin 1 family member 10" Q8WWZ1 2 113067970-113075843 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "lymphoid tissue: 2.8;skin 1: 11.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 222000 "unprognostic (3.89e-1)" "unprognostic (6.25e-2)" "unprognostic (1.48e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CFC1 "CRYPTIC, HTX2" ENSG00000136698 "Cripto, FRL-1, cryptic family 1" P0CG37 2 130592165-130599575 "Disease related genes, Human disease related genes, Predicted secreted proteins" Gastrulation "Developmental protein" "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;pancreas: 30.9;pituitary gland: 59.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 14.9;Enteroendocrine cells: 20.5" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "RPMI-8226: 12.1;SCLC-21H: 6.7;SuSa: 4.0" HPA041773 Uncertain "Secreted - unknown location" NA NA "HPA041773: AB_2677664" "unprognostic (6.65e-2)" "unprognostic (2.19e-3)" "unprognostic (1.11e-3)" "unprognostic (2.01e-1)" 0.8 0.6 4.7 0.0 2.0 0.0 0.0 2.7 3.2 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.5 0.0 0.9 1.1 17.9 0.0 0.0 0.1 0.0 3.8 4.1 1.6 0.0 30.9 0.0 59.8 0.0 4.2 7.3 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 10.8 0.6 6.5 5.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 2.0 2.7 3.2 1.1 17.9 3.8 4.1 1.6 4.2 4.1 6.5 5.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 20.5 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA Yes "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 9.8 10.9 4.0 11.2 4.2 25.6 10.9 4.2 6.3 15.2 2.1 11.8 9.5 15.7 5.0 13.9 16.0 9.3 11.8 3.5 5.1 8.7 9.3 10.7 15.8 6.8 4.1 3.2 14.8 13.5 15.3 22.9 15.0 5.5 11.9 11.2 4.8 13.0 11.9 13.4 13.2 11.6 13.0 2.5 11.3 10.4 17.9 4.9 20.0 16.1 12.1 15.8 11.9 12.4 9.6 89.1 41.5 46.2 39.2 29.1 21.8 58.7 41.5 42.0 76.3 62.8 119.2 47.0 56.2 41.2 49.9 36.3 43.8 64.0 64.4 40.4 72.7 61.2 60.5 36.2 90.1 31.2 68.5 34.7 25.6 39.4 77.0 27.2 21.1 44.9 51.4 82.2 40.8 40.7 44.3 72.2 32.0 77.0 40.1 56.4 74.3 44.2 59.0 27.0 38.6 66.8 36.3 42.8 54.5 22.7 24.9 37.8 34.8 32.8 57.0 49.3 33.0 49.4 34.3 44.0 79.2 51.4 38.7 44.0 1.8 9.2 14.8 12.9 11.2 14.3 8.9 9.6 11.6 9.6 9.1 9.0 10.5 4.3 12.1 8.1 6.0 9.2 10.4 4.0 4.2 4.2 6.3 3.5 5.1 6.8 4.1 3.2 5.5 2.5 4.9 9.6 17.4 3.2 11.3 4.9 20.8 15.0 9.1 8.8 12.0 19.8 21.5 23.0 3.9 5.7 8.0 7.3 12.5 23.8 16.4 7.9 9.8 9.2 22.7 16.0 19.7 12.0 13.1 21.2 6.9 12.2 26.5 12.2 18.8 26.3 6.3 29.0 10.4 17.3 14.1 15.2 6.7 12.8 4.1 13.2 7.7 41.7 14.6 10.2 16.0 1.0 8.8 9.9 11.3 7.5 10.4 11.8 10.5 18.4 27.0 9.4 7.7 5.9 9.9 16.0 0.0 14.1 12.8 25.0 25.6 18.7 20.6 15.6 15.6 16.0 15.2 9.6 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701027-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: AB_2679686" "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 19.6 16.2 16.8 18.7 18.3 17.5 20.6 36.0 19.0 24.2 19.6 20.8 14.8 20.1 14.5 21.0 21.7 11.9 18.6 16.8 17.2 20.0 28.2 19.0 22.2 15.8 18.0 15.9 28.1 20.3 19.3 23.2 17.0 21.9 22.2 15.3 24.7 19.4 13.0 21.4 26.5 22.3 15.2 14.8 28.1 18.7 20.8 17.0 31.2 24.4 21.5 24.1 20.1 23.0 20.8 40.3 22.3 38.2 31.2 22.3 22.9 39.0 36.0 28.5 37.3 35.2 52.1 30.3 50.5 39.0 24.0 34.4 31.8 43.6 30.5 48.6 46.5 26.0 48.9 28.2 56.6 25.1 59.7 35.1 22.4 31.7 35.9 30.3 26.7 32.4 45.0 41.5 44.4 26.6 25.1 62.3 43.7 46.5 25.9 24.6 43.1 38.6 40.4 21.5 51.6 35.5 27.5 32.3 29.6 26.0 35.7 23.0 34.4 29.8 29.3 42.6 33.0 31.1 42.8 70.5 96.4 23.9 23.4 27.8 35.7 20.6 35.1 24.9 22.7 25.8 30.5 25.2 24.2 27.4 28.3 26.6 25.7 14.1 34.7 25.0 19.7 34.4 18.5 16.8 18.3 36.0 19.0 16.8 17.2 15.8 18.0 15.9 21.9 14.8 17.0 20.8 63.0 35.3 45.0 47.3 77.9 110.0 77.3 83.8 51.2 50.7 41.3 41.4 46.5 64.3 51.5 36.8 64.6 80.7 74.7 31.4 46.9 48.1 42.4 38.3 39.8 55.0 39.4 35.9 66.2 44.8 87.9 49.3 40.8 47.4 64.7 49.8 43.2 72.5 49.5 60.6 68.9 36.6 75.3 42.0 82.0 25.2 50.4 50.8 76.5 45.0 69.2 32.2 64.9 73.4 83.5 38.9 37.0 50.4 110.1 51.2 42.3 56.7 35.6 61.3 46.0 48.8 71.3 113.3 81.2 53.7 115.8 110.5 79.2 59.7 43.2 65.5 CCDC115 "ccp1, FLJ30131, MGC12981" ENSG00000136710 "Coiled-coil domain containing 115" Q96NT0 2 130337933-130342699 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034598 Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA034598: AB_10601697" "prognostic favorable (7.59e-4)" "unprognostic (1.28e-2)" "unprognostic (1.10e-3)" "unprognostic (6.80e-3)" "unprognostic (3.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (8.13e-3)" "unprognostic (2.63e-1)" "unprognostic (4.29e-1)" "unprognostic (2.87e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (7.83e-2)" "unprognostic (2.16e-1)" "unprognostic (3.16e-2)" 24.5 25.3 26.8 18.2 27.3 25.0 25.7 28.1 29.2 33.4 23.4 23.9 21.4 29.7 32.6 31.4 30.2 20.0 18.6 26.5 28.1 29.9 17.9 26.8 30.0 28.9 27.6 27.2 41.9 20.3 40.6 23.1 13.9 28.2 24.2 19.5 15.9 29.4 27.9 13.0 38.8 24.4 17.8 27.0 26.3 24.3 10.5 27.2 23.5 30.6 12.4 26.3 27.1 28.3 29.3 22.5 10.5 13.3 8.1 27.2 30.7 16.3 10.5 28.2 22.4 26.1 24.4 48.5 25.7 36.6 18.3 11.4 20.7 10.8 19.2 16.1 33.4 20.2 20.2 5.4 27.3 22.7 20.8 40.2 26.2 44.2 14.6 8.1 21.8 23.7 24.3 19.8 22.6 27.7 20.7 38.5 37.5 17.2 11.2 26.4 29.4 14.2 24.1 18.8 18.6 12.4 22.8 12.3 22.4 24.2 8.7 24.5 25.3 18.6 10.1 10.4 18.5 8.3 12.4 13.0 19.7 22.9 22.1 13.5 129.9 94.6 154.8 80.8 136.0 71.8 96.3 85.1 85.8 95.2 98.9 81.1 74.8 33.3 80.6 174.9 73.8 103.6 132.8 26.8 27.3 28.1 29.2 26.5 28.1 28.9 27.6 27.2 28.2 27.0 27.2 29.3 37.5 19.2 28.3 3.6 43.6 51.9 42.3 104.2 40.5 25.9 43.3 41.9 13.9 35.8 50.8 77.3 10.4 76.7 35.1 29.9 105.7 47.4 1.4 14.5 16.9 30.8 27.6 13.5 8.7 42.7 36.6 30.6 21.4 20.3 53.3 22.7 33.2 21.4 63.5 23.5 12.3 35.6 99.7 45.5 60.7 4.5 42.6 49.4 53.4 5.6 97.3 48.4 49.4 10.1 12.2 27.5 49.1 52.3 16.9 14.9 51.9 65.9 24.3 27.6 46.0 29.2 31.7 9.0 24.0 42.4 70.0 26.4 51.3 39.1 41.6 30.0 SAP130 FLJ12761 ENSG00000136715 "Sin3A associated protein 130" Q9H0E3 2 127941217-128028120 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.7" "Cell type enhanced" "Detected in many" "Early spermatids: 71.5;Late spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034664 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA034664: AB_10603238" "unprognostic (2.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.33e-1)" "unprognostic (5.45e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (2.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (3.92e-2)" "unprognostic (6.77e-2)" "unprognostic (3.75e-2)" "unprognostic (5.26e-2)" "unprognostic (4.41e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" 8.5 8.7 7.6 8.7 7.9 21.9 8.3 7.8 10.2 10.5 4.1 10.3 8.4 10.5 9.3 10.5 9.7 7.2 8.3 7.5 6.9 7.2 8.4 8.1 10.1 6.8 7.7 6.9 11.3 8.8 12.5 14.6 9.1 6.7 8.8 9.7 8.7 9.2 8.0 12.0 12.5 9.8 10.3 4.4 8.6 9.8 47.7 7.2 14.9 8.9 13.1 12.7 9.5 10.4 8.1 35.3 18.9 35.3 28.6 22.9 15.7 38.5 22.0 21.4 33.4 26.2 45.1 14.4 29.4 19.3 25.0 17.4 24.0 39.3 22.7 34.5 16.3 25.2 29.2 16.7 35.9 27.5 25.5 22.2 14.8 16.7 44.1 27.5 17.6 27.0 24.4 35.9 21.1 28.2 39.3 35.6 20.0 36.6 20.7 21.1 24.3 29.0 19.6 17.9 30.7 18.5 22.3 23.2 21.7 13.6 22.1 16.4 17.3 23.2 32.1 34.5 30.1 23.6 29.3 31.2 34.3 26.4 17.0 21.0 2.3 4.2 4.6 5.3 2.7 4.0 2.0 3.8 3.5 3.4 5.0 2.7 3.1 14.0 3.6 8.6 6.2 2.7 3.8 7.6 7.9 7.8 10.2 7.5 6.9 6.8 7.7 6.9 6.7 4.4 7.2 8.1 5.4 0.0 10.9 29.0 7.9 7.9 2.3 3.2 5.7 5.2 6.5 5.3 15.2 2.8 3.1 1.8 8.4 11.9 9.4 13.1 0.0 4.9 71.5 4.6 8.6 6.2 6.7 11.6 25.4 4.7 12.8 5.2 8.6 8.7 1.3 5.3 5.3 5.8 7.8 8.4 28.9 7.0 4.1 8.4 6.3 44.2 8.4 7.0 5.4 16.9 4.9 5.0 6.2 26.2 31.0 6.1 7.8 8.2 13.2 4.9 6.5 3.4 4.0 5.8 6.6 4.4 5.5 31.0 17.9 9.2 10.4 19.3 7.6 3.7 7.8 4.3 BIN1 "AMPH2, AMPHL, SH3P9" ENSG00000136717 "Bridging integrator 1" O00499 2 127048027-127107288 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 2125.5;tongue: 810.3" "Cell type enhanced" "Detected in all" "Hofbauer cells: 164.9;NK-cells: 176.1;Oligodendrocytes: 186.4;Proximal tubular cells: 255.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 186.6;MAIT T-cell: 163.9;memory B-cell: 165.9;memory CD4 T-cell: 192.1;memory CD8 T-cell: 187.4;naive B-cell: 181.2;naive CD4 T-cell: 177.1;naive CD8 T-cell: 171.1;NK-cell: 178.9;T-reg: 249.8" "Group enriched" "Detected in all" 9 "B-cells: 181.2;NK-cells: 178.9;T-cells: 249.8" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001945, HPA003894, HPA005437" Enhanced Supported Cytosol NA NA 430000 Cytosol "CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284" "unprognostic (2.20e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" "unprognostic (9.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-3)" "unprognostic (1.26e-2)" "unprognostic (2.57e-1)" "unprognostic (2.41e-3)" "unprognostic (3.22e-3)" 44.0 94.0 166.9 26.0 223.2 12.1 37.6 155.8 194.7 52.0 89.1 32.4 17.6 39.0 16.9 33.8 54.0 22.8 13.9 172.1 169.0 82.3 35.0 22.9 41.4 202.2 192.0 162.0 34.6 21.7 19.7 41.3 23.7 204.0 58.6 13.2 54.1 43.0 24.2 2125.5 13.5 31.7 19.7 155.1 55.2 45.4 10.4 198.2 18.5 28.8 810.3 27.8 89.8 36.9 311.0 52.0 27.9 32.8 39.3 95.9 76.5 11.4 15.3 33.1 35.8 23.4 107.6 31.3 0.0 46.0 28.9 20.8 6.8 14.6 25.0 9.5 5.9 4.1 15.1 46.9 7.1 86.2 0.2 2.8 70.2 6.1 77.3 14.0 46.4 49.1 5.1 3.2 1.6 44.8 1.1 4.9 43.3 24.8 114.2 31.4 11.8 36.3 4.8 126.7 0.1 22.4 61.9 55.5 21.2 17.7 34.7 1.3 9.7 59.3 40.9 39.9 52.8 52.1 1.3 1.4 0.3 60.3 2.6 19.2 1.2 3.1 0.6 186.6 2.0 163.9 165.9 192.1 187.4 15.1 181.2 177.1 171.1 6.0 178.9 3.2 21.5 249.8 133.5 166.9 223.2 155.8 194.7 172.1 169.0 202.2 192.0 162.0 204.0 155.1 198.2 311.0 15.6 9.6 10.0 10.7 80.1 18.6 10.0 3.3 1.2 144.1 10.7 9.1 5.6 44.3 5.5 14.7 125.1 1.8 98.3 18.6 37.2 15.2 16.1 11.7 46.2 21.9 46.0 11.6 36.9 29.4 4.2 68.7 29.0 19.0 2.5 28.7 15.0 18.3 164.9 30.3 47.2 28.0 10.2 27.0 62.3 55.8 78.6 50.1 23.2 58.1 10.4 25.3 176.1 11.6 186.4 16.7 18.1 30.5 14.6 26.2 14.3 255.7 1.4 133.4 13.1 75.7 28.8 2.6 10.9 1.6 8.9 2.9 98.2 40.0 50.1 9.8 IMP4 "BXDC4, MGC19606" ENSG00000136718 "IMP U3 small nucleolar ribonucleoprotein 4" Q96G21 2 130342877-130347967 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 303.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066222, HPA066673" Enhanced Nucleoli NA NA Nucleoli "HPA066222: AB_2685638, HPA066673: AB_2685701" "unprognostic (8.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.00e-1)" "unprognostic (2.55e-1)" "unprognostic (3.70e-3)" "unprognostic (2.18e-3)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.33e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.28e-2)" "unprognostic (5.08e-2)" "unprognostic (4.47e-2)" "unprognostic (1.09e-1)" "unprognostic (6.10e-2)" 28.2 25.6 12.4 20.8 11.8 21.0 25.8 12.2 13.9 14.8 7.4 20.7 20.1 18.1 6.4 20.7 14.0 12.5 33.3 10.4 12.1 19.8 48.1 17.9 24.7 15.5 14.6 9.5 12.2 45.8 13.0 11.5 11.6 13.3 15.5 7.3 3.6 32.1 12.1 70.6 18.3 18.7 11.8 13.6 17.4 24.7 11.9 15.7 7.3 11.5 25.7 12.3 23.5 15.8 13.8 88.7 87.1 11.1 59.2 13.5 22.7 61.5 60.8 30.2 54.1 39.8 184.5 55.0 303.2 71.5 30.2 36.0 56.6 64.5 66.5 25.9 64.2 66.0 100.3 33.2 143.8 70.7 99.7 51.8 28.1 48.0 71.9 37.6 10.9 38.5 68.7 103.1 58.8 26.5 157.0 63.2 57.1 85.4 53.0 106.3 73.1 39.4 134.4 27.0 61.0 57.9 51.8 41.3 124.0 62.9 7.2 52.7 47.0 47.5 69.8 74.3 75.2 109.0 77.5 87.8 235.4 56.5 56.5 98.9 12.3 72.7 23.9 71.5 82.6 66.1 115.9 62.7 62.6 84.1 99.7 64.8 64.6 8.0 90.8 79.4 91.5 68.9 89.2 12.4 11.8 12.2 13.9 10.4 12.1 15.5 14.6 9.5 13.3 13.6 15.7 13.8 41.4 16.0 24.8 3.3 65.5 106.6 79.3 67.0 58.6 21.9 49.5 46.4 53.7 58.6 46.5 44.1 4.2 63.6 52.3 43.4 101.8 96.4 24.2 19.6 27.3 48.6 54.5 32.6 4.2 110.3 100.5 43.2 45.9 22.3 46.3 26.8 29.6 89.1 76.5 16.8 4.8 49.8 52.9 36.5 54.0 69.9 30.7 37.5 78.2 1.0 66.1 18.9 33.0 4.5 5.0 83.7 54.2 25.6 82.4 148.6 55.5 144.6 22.9 25.5 26.3 43.7 51.6 32.7 48.3 57.6 110.4 49.3 45.9 62.1 77.5 79.2 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318868 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Transferase "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 75.4;Granulosa cells: 285.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "EFO-21: 131.2;HMC-1: 206.6;SCLC-21H: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044586 Approved Nucleoplasm "Intracellular and membrane" NA NA 72000 Nucleoplasm "HPA044586: AB_10963057" "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 14.2 63.9 32.9 8.9 31.9 5.1 16.2 23.2 44.5 15.7 9.8 15.4 8.7 12.4 6.2 34.4 17.7 21.1 15.5 31.8 23.6 43.3 47.2 17.2 8.5 30.7 31.9 31.5 26.6 31.1 8.9 15.3 12.1 33.5 28.4 7.0 26.6 26.2 23.0 36.5 25.9 15.2 6.5 27.0 32.4 12.8 25.2 35.7 14.7 14.4 18.8 7.4 19.6 23.3 29.0 12.5 17.4 46.0 26.5 17.5 32.5 24.7 15.1 19.1 14.8 8.1 9.0 8.0 11.9 131.2 19.4 6.9 32.5 17.5 29.1 5.5 19.9 18.1 10.5 6.4 87.9 21.1 18.4 206.6 43.9 33.9 11.9 3.6 4.9 8.0 31.8 6.7 12.1 5.4 25.7 49.6 81.0 55.3 4.7 10.7 16.1 12.6 61.9 13.4 36.3 112.9 28.4 12.1 30.1 6.7 30.6 12.2 6.9 9.6 13.1 28.9 49.1 12.3 7.2 7.6 2.7 7.9 13.0 9.7 3.0 0.7 0.6 1.0 0.4 0.1 0.7 0.4 0.6 0.5 0.7 0.4 0.4 0.2 0.2 1.5 2.3 0.2 0.6 32.9 31.9 23.2 44.5 31.8 23.6 30.7 31.9 31.5 33.5 27.0 35.7 29.0 9.5 25.6 8.9 20.9 4.9 16.2 11.2 16.1 14.8 9.4 15.1 12.8 7.3 10.0 10.3 75.4 31.3 9.7 7.3 22.3 5.9 15.4 0.9 22.9 11.5 12.6 3.0 6.9 24.2 5.8 36.9 12.6 4.1 39.7 57.0 285.6 30.0 23.8 10.7 21.9 20.3 6.5 8.2 14.2 9.2 3.3 11.8 9.1 7.2 5.6 6.7 8.2 1.0 6.6 10.4 6.6 12.0 17.0 3.2 9.7 6.9 3.3 8.7 32.8 6.6 7.6 9.4 1.1 3.1 18.3 17.0 23.3 3.5 27.1 3.7 8.9 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 4000000 Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 8.1 8.5 3.8 13.8 4.5 22.0 7.6 4.5 6.6 9.1 4.8 12.6 9.1 7.4 20.1 8.1 6.5 6.6 7.9 4.0 4.4 8.2 15.0 8.5 12.4 4.5 4.2 3.5 5.1 14.9 8.8 6.5 8.8 4.5 8.8 10.1 9.8 8.7 6.3 13.3 8.9 10.3 6.3 3.6 9.4 10.8 6.5 4.4 11.8 10.5 13.1 12.7 7.6 6.6 5.4 34.8 11.8 22.0 47.6 28.0 22.3 34.3 39.4 16.7 12.7 11.3 26.0 24.9 49.4 15.4 28.3 11.3 25.3 16.8 16.8 25.5 31.5 8.2 43.4 14.9 82.3 28.0 58.6 25.9 16.3 13.0 25.4 23.0 25.0 29.8 19.8 28.4 25.6 26.9 24.4 23.5 33.5 39.5 24.0 12.4 19.2 21.3 20.9 23.8 25.2 11.7 17.4 27.3 36.0 24.4 22.5 14.4 40.2 43.1 34.6 24.4 20.1 28.4 27.3 40.4 22.3 29.3 31.4 32.6 3.8 2.5 2.5 2.3 2.5 2.3 1.6 1.9 2.1 1.9 3.3 1.6 2.3 3.7 1.9 2.5 3.1 1.6 1.4 3.8 4.5 4.5 6.6 4.0 4.4 4.5 4.2 3.5 4.5 3.6 4.4 5.4 14.6 35.3 24.7 24.8 14.3 8.2 6.4 11.1 5.7 19.8 11.2 7.1 16.7 12.8 20.7 3.7 22.9 10.5 22.1 21.5 1.9 14.0 9.2 18.4 27.7 16.5 22.8 31.5 40.6 19.5 20.1 16.6 21.9 22.2 11.4 20.8 17.9 39.7 16.6 20.2 37.6 21.9 8.2 25.4 16.4 2.3 14.9 20.0 14.2 32.8 26.0 7.5 15.5 31.2 46.5 19.4 10.4 13.5 31.5 13.3 25.3 8.4 12.7 20.2 6.6 18.5 13.3 10.0 8.5 9.4 10.7 10.8 18.9 16.0 22.8 10.1 GYPC "CD236, CD236R, Ge, GPC, GYPD" ENSG00000136732 "Glycophorin C (Gerbich blood group)" P04921 2 126656133-126696667 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 444.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 1728.6;Hofbauer cells: 488.7" "Cancer enhanced" "Detected in all" "melanoma: 66.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 433.1;K-562: 362.1;SK-MEL-30: 668.4;U-266/70: 363.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008965, CAB009445" Enhanced Supported "Plasma membrane" NA NA 970000 "Plasma membrane" "CAB009445: AB_2116251, HPA008965: AB_1078455" "unprognostic (1.63e-2)" "unprognostic (7.14e-3)" "unprognostic (8.39e-2)" "unprognostic (3.31e-3)" "unprognostic (4.19e-2)" "unprognostic (1.69e-2)" "unprognostic (8.82e-2)" "unprognostic (3.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (8.00e-3)" 173.8 73.6 17.3 52.0 17.9 444.7 110.2 17.8 31.1 73.0 28.7 70.2 18.4 62.8 20.3 42.7 69.0 56.8 138.1 16.5 22.4 49.8 18.6 102.3 111.5 22.2 18.1 14.6 92.3 35.1 9.7 17.1 50.8 21.0 46.9 19.5 10.4 26.6 56.6 214.8 33.2 53.3 56.4 21.9 99.3 41.4 7.4 21.1 60.2 33.5 205.9 76.5 73.6 54.9 21.3 1.3 0.0 152.0 0.2 116.1 100.5 0.2 24.0 186.4 28.9 84.9 0.0 0.2 0.6 0.4 69.6 107.6 0.3 85.7 0.1 9.5 79.7 0.0 279.0 0.0 0.0 433.1 99.0 0.7 237.4 0.0 23.1 0.1 2.3 1.0 190.4 362.1 214.6 70.5 0.0 0.1 148.9 46.7 0.0 0.4 18.1 12.1 0.4 11.8 0.0 0.2 0.0 0.3 0.0 668.4 20.7 0.0 258.5 65.7 107.3 1.0 7.3 1.2 363.9 257.4 0.5 51.4 135.8 99.3 0.8 28.6 2.2 153.1 40.3 172.2 95.8 136.7 186.5 50.0 102.6 190.5 188.3 21.9 81.1 24.7 27.1 179.4 119.0 17.3 17.9 17.8 31.1 16.5 22.4 22.2 18.1 14.6 21.0 21.9 21.1 21.3 260.7 6.4 7.7 0.7 152.7 38.0 3.4 17.0 43.3 0.6 14.6 110.5 34.9 84.4 6.0 14.7 2.1 4.9 194.0 0.0 135.0 202.9 1.6 3.6 99.8 157.2 0.0 1728.6 0.4 4.9 6.9 170.5 10.2 2.5 22.9 23.3 229.2 6.2 488.7 0.0 0.5 1.1 0.0 118.0 108.5 4.9 87.3 134.9 305.9 15.0 98.0 5.1 204.9 6.0 0.1 6.0 0.4 69.2 250.9 9.4 0.0 8.1 1.7 2.6 59.2 65.8 88.6 0.2 0.7 41.9 26.6 9.0 228.0 31.8 1.6 2.9 STAM STAM1 ENSG00000136738 "Signal transducing adaptor molecule" Q92783 10 17644151-17716824 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 76.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034399, HPA043882" Supported Supported Vesicles NA NA 82000 Vesicles "CAB034399: AB_2197486, HPA043882: AB_2678713" "unprognostic (1.09e-2)" "unprognostic (8.32e-2)" "unprognostic (1.10e-1)" "unprognostic (3.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.44e-6)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (8.58e-2)" "unprognostic (1.37e-2)" "unprognostic (8.39e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.02e-1)" 10.2 13.4 8.1 6.9 9.7 53.6 9.0 14.5 12.1 9.9 4.6 7.7 8.3 9.1 5.8 12.3 7.8 9.2 18.2 10.3 9.1 10.3 7.0 11.0 7.6 10.9 9.4 8.6 11.5 10.5 10.4 7.5 8.6 10.8 8.8 7.7 11.3 8.6 6.1 24.7 10.0 7.4 8.6 9.0 6.9 11.5 8.2 9.5 13.2 10.9 10.2 7.5 11.0 9.1 15.4 34.8 19.8 30.8 14.2 30.1 21.9 10.3 45.1 19.8 41.0 33.1 25.9 31.7 9.1 7.2 33.9 31.7 18.2 27.6 21.1 35.0 10.9 12.7 86.3 15.3 43.1 31.8 6.5 43.7 22.7 27.0 33.6 28.3 26.6 19.8 56.3 30.1 10.5 43.8 10.4 35.7 5.6 14.7 19.7 10.2 18.0 29.0 11.9 17.5 11.2 13.0 19.2 24.6 16.7 34.6 24.1 27.5 9.4 26.6 23.9 24.5 42.7 21.1 6.6 11.5 15.6 25.6 9.6 15.6 47.5 7.5 12.5 5.9 8.2 5.6 5.4 12.8 6.2 9.6 3.1 8.8 7.1 5.9 17.3 7.5 5.5 76.5 6.4 8.1 9.7 14.5 12.1 10.3 9.1 10.9 9.4 8.6 10.8 9.0 9.5 15.4 13.2 12.8 23.4 15.7 14.1 22.9 5.3 16.2 23.9 19.7 9.4 8.9 30.0 5.7 14.0 16.5 10.4 10.2 24.3 6.4 5.9 15.1 3.5 16.3 22.3 11.0 11.4 56.8 31.7 13.4 10.5 23.5 15.8 25.9 31.6 13.0 10.4 7.8 15.5 10.1 36.9 7.8 2.0 10.4 16.3 3.5 9.6 15.6 19.6 39.4 8.4 13.7 10.3 31.7 59.4 29.9 8.0 6.0 20.8 10.1 5.7 15.6 14.0 14.5 26.3 22.3 12.6 22.1 14.6 21.8 21.0 24.6 27.6 18.4 8.1 8.5 GAD2 GAD65 ENSG00000136750 "Glutamate decarboxylase 2" Q05329 10 26216665-26304558 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 36.4;retina: 9.6" "Cell type enriched" "Detected in some" 13 "Inhibitory neurons: 293.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SCLC-21H: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044637, CAB078177" Enhanced NA NA "CAB078177: AB_2665779, HPA044637: AB_10794053" "unprognostic (8.67e-2)" "unprognostic (1.11e-1)" "unprognostic (4.93e-2)" "unprognostic (2.52e-5)" "unprognostic (5.44e-2)" "unprognostic (8.08e-2)" 0.0 0.0 12.0 0.0 36.4 0.0 0.0 7.3 15.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 29.2 0.0 0.0 0.0 0.0 10.5 13.9 7.3 0.0 3.6 0.0 0.4 0.0 7.4 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.1 0.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 36.4 7.3 15.6 5.4 29.2 10.5 13.9 7.3 7.4 1.8 15.3 5.2 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 1.8 0.0 1.6 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 293.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.6 0.0 0.3 0.0 2.0 6.1 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABI1 "ABI-1, E3B1, SSH3BP1" ENSG00000136754 "Abl interactor 1" Q8IZP0 10 26746593-26861087 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 278.2;Suprabasal keratinocytes: 270.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008375, HPA068407" Approved Approved "Plasma membrane,Cell Junctions" NA NA 440000 "Plasma membrane, Cell Junctions" "CAB008375: AB_592744, HPA068407: AB_2685983" "unprognostic (2.83e-3)" "unprognostic (8.69e-2)" "unprognostic (1.12e-1)" "unprognostic (3.96e-1)" "unprognostic (2.51e-2)" "unprognostic (9.24e-3)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (6.04e-2)" "unprognostic (4.38e-1)" "unprognostic (2.40e-2)" "unprognostic (5.48e-2)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" 26.6 16.4 29.7 35.4 29.7 84.5 30.1 29.6 39.2 26.0 23.2 32.3 32.7 23.9 19.4 53.4 24.0 25.1 16.5 35.8 30.6 27.8 25.1 28.4 48.5 26.7 28.0 27.2 26.8 20.1 20.3 13.0 28.5 26.9 21.0 33.3 19.1 33.2 19.2 20.2 43.2 34.4 24.1 27.4 32.6 32.1 14.4 28.4 44.9 22.8 19.8 54.1 35.0 36.8 29.0 55.0 28.6 21.1 21.9 34.4 39.5 34.1 50.9 31.2 35.0 37.5 33.7 61.7 101.1 23.2 51.7 23.0 57.7 28.0 37.0 41.0 65.2 24.2 44.5 18.0 29.0 23.6 23.2 43.9 28.1 54.6 35.3 21.8 41.5 43.7 33.5 30.7 67.2 40.5 25.4 49.8 26.0 18.8 37.5 13.5 51.4 41.2 69.2 48.0 22.9 17.1 18.5 41.3 44.5 46.8 29.4 27.7 35.5 50.6 27.3 33.2 34.4 25.5 15.0 24.0 108.7 38.7 61.1 17.4 77.3 35.5 91.4 42.1 43.2 40.8 57.2 40.9 48.5 39.4 47.7 37.7 41.7 64.3 35.8 45.4 34.1 76.5 57.2 29.7 29.7 29.6 39.2 35.8 30.6 26.7 28.0 27.2 26.9 27.4 28.4 29.0 44.4 41.7 37.7 278.2 89.3 246.2 127.9 74.0 123.5 9.6 40.5 26.5 23.2 38.6 73.5 25.8 2.1 36.4 75.7 69.7 13.7 56.3 11.3 72.1 41.3 41.9 44.9 43.8 81.6 52.1 46.9 45.9 42.3 111.5 57.7 22.3 32.9 25.6 75.8 16.8 133.7 54.9 83.4 80.5 116.3 5.7 22.1 92.1 92.5 106.8 89.8 48.2 73.2 128.7 47.4 82.2 52.1 22.2 56.8 132.5 52.7 39.0 86.2 10.0 32.9 29.8 40.3 14.7 10.8 109.6 270.6 77.2 71.0 27.2 41.3 195.4 YME1L1 YME1L ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110111-27155266 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 49.3 53.1 16.6 52.2 17.7 96.0 48.0 22.7 21.8 52.8 35.9 52.7 46.4 50.8 53.8 59.7 44.1 46.4 62.0 17.9 28.9 54.5 66.1 40.1 57.0 17.9 17.8 14.2 51.3 52.4 55.0 33.5 61.6 18.4 48.8 52.9 42.3 45.1 44.9 112.4 40.4 46.7 49.7 15.8 46.8 49.2 51.6 19.1 66.5 62.8 98.6 63.0 57.4 35.3 23.8 146.6 105.3 125.5 62.0 118.3 123.9 100.7 143.3 79.7 139.7 157.6 143.3 171.9 152.1 90.8 154.8 100.5 135.6 152.8 122.6 152.9 143.4 89.0 144.4 91.0 98.3 124.6 100.4 114.5 104.7 143.3 123.4 121.6 122.5 146.7 138.8 173.8 150.5 154.4 95.1 189.1 53.7 97.4 119.3 49.4 160.4 199.7 143.0 107.7 68.2 95.6 121.9 138.4 105.2 138.9 102.8 101.5 115.1 146.9 83.4 117.3 140.8 126.7 75.1 121.9 196.1 119.4 178.8 65.8 195.0 146.4 165.4 147.5 128.5 149.4 143.0 142.4 138.8 121.9 149.7 129.3 136.8 204.0 135.6 143.1 222.6 156.7 155.5 16.6 17.7 22.7 21.8 17.9 28.9 17.9 17.8 14.2 18.4 15.8 19.1 23.8 105.4 67.3 81.8 40.5 108.3 70.1 96.7 55.6 92.2 53.1 76.8 90.9 103.6 32.9 66.4 29.5 83.4 61.2 121.0 179.4 15.6 52.2 62.3 141.4 152.5 86.1 50.3 63.1 67.0 48.6 74.4 101.1 136.6 224.3 110.8 75.0 58.5 70.0 73.2 50.5 68.1 121.2 32.6 98.9 133.2 27.0 57.8 125.4 56.9 41.2 63.7 63.8 47.4 66.9 75.2 66.8 109.3 43.2 93.8 83.7 156.5 47.3 70.1 65.7 72.3 156.6 94.5 143.4 57.4 92.5 64.9 94.8 122.1 102.2 104.4 75.0 DNAJC1 "DNAJL1, ERdj1, MTJ1" ENSG00000136770 "DnaJ heat shock protein family (Hsp40) member C1" Q96KC8 10 21756548-22003769 "Predicted membrane proteins, Transcription factors" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013432 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013432: AB_1847797" "unprognostic (7.00e-2)" "unprognostic (9.81e-2)" "unprognostic (3.61e-1)" "unprognostic (5.12e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (3.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.46e-2)" "unprognostic (1.09e-1)" "unprognostic (9.36e-2)" "prognostic favorable (2.33e-4)" "unprognostic (4.44e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-2)" "unprognostic (2.22e-2)" 16.7 17.1 10.5 16.5 11.6 18.5 20.2 11.4 13.2 17.8 15.1 20.8 28.5 15.7 13.5 16.4 14.3 17.9 14.9 9.7 16.7 23.2 37.2 24.2 15.7 12.7 11.7 9.3 14.2 38.9 46.0 19.8 20.1 12.5 24.0 18.9 7.2 41.1 16.5 12.8 13.9 22.6 15.9 12.2 15.4 28.8 9.5 12.4 13.2 29.3 11.3 13.1 26.7 15.4 13.8 38.5 24.5 53.9 20.1 49.3 34.9 23.4 50.9 22.1 20.8 32.7 33.8 33.1 16.9 21.9 31.2 31.2 36.1 12.3 25.7 11.5 88.6 41.1 40.3 18.8 20.3 119.5 3.0 16.5 35.8 46.5 24.7 28.3 30.4 27.8 16.4 42.7 93.6 23.8 39.2 9.6 12.9 7.1 33.2 20.3 13.8 18.8 62.3 29.1 9.1 11.3 17.1 37.7 62.2 38.1 58.7 19.8 42.8 42.7 20.3 43.5 34.4 29.3 29.8 10.0 11.7 30.3 126.1 12.3 11.8 16.6 7.0 36.2 16.6 36.5 8.4 20.2 29.1 15.3 12.3 12.9 16.5 9.3 34.2 30.9 39.6 15.8 15.0 10.5 11.6 11.4 13.2 9.7 16.7 12.7 11.7 9.3 12.5 12.2 12.4 13.8 56.4 35.3 26.9 73.4 46.7 38.7 64.8 26.6 30.1 27.9 67.9 76.1 16.9 57.2 31.0 31.3 45.9 16.7 92.9 52.4 27.4 73.6 47.6 40.9 74.6 54.7 38.3 49.0 134.4 74.2 92.6 67.4 59.7 58.3 41.8 14.3 52.8 84.5 55.0 38.7 77.1 75.8 28.5 43.7 52.5 19.6 94.8 44.2 67.6 112.4 46.9 37.4 99.9 91.5 137.7 80.6 49.2 67.0 202.7 71.2 57.9 80.1 23.9 149.1 59.2 49.3 56.7 232.2 109.5 45.3 44.2 35.3 81.5 41.0 55.8 71.9 NIPSNAP3A "DKFZp564D177, FLJ13953, HSPC299, MGC14553" ENSG00000136783 "Nipsnap homolog 3A" Q9UFN0 9 104747683-104760120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 103.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042491 Approved NA NA 13000 "HPA042491: AB_2678023" "unprognostic (1.03e-1)" "unprognostic (9.13e-2)" "unprognostic (7.40e-2)" "unprognostic (3.52e-2)" "unprognostic (3.59e-1)" "unprognostic (1.59e-1)" "unprognostic (1.64e-1)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (2.32e-1)" "unprognostic (2.59e-1)" "unprognostic (1.49e-2)" "unprognostic (1.91e-3)" "unprognostic (2.92e-1)" "unprognostic (1.41e-1)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 27.9 39.3 20.6 15.2 20.8 40.6 28.3 22.4 25.7 26.6 19.7 38.7 25.7 19.7 19.8 25.5 20.5 16.4 31.5 20.8 23.1 29.9 51.5 23.0 17.3 26.8 23.0 20.1 14.0 12.9 15.2 18.1 33.4 23.7 21.6 39.3 8.7 14.3 21.7 13.6 21.4 24.5 25.7 24.7 22.9 29.7 15.8 21.8 20.7 23.4 17.8 17.3 21.0 19.6 29.5 18.8 16.3 9.4 8.5 16.9 29.9 19.5 57.9 22.4 56.6 48.0 19.0 29.8 29.8 24.2 47.7 17.4 31.9 30.5 25.2 30.7 17.4 28.3 52.5 22.3 22.0 30.6 65.3 38.8 36.2 65.5 23.5 17.6 31.7 64.7 44.0 56.3 19.2 44.2 40.3 54.4 37.1 10.6 44.9 29.1 42.8 32.9 30.1 49.8 11.1 32.4 21.4 36.4 22.8 16.7 26.0 55.0 55.4 47.1 28.9 16.8 30.9 17.2 13.5 16.8 16.2 29.4 55.1 15.9 43.0 51.5 36.2 11.5 63.7 14.2 19.5 11.6 12.7 88.5 13.8 14.2 14.0 3.5 32.5 56.7 45.3 12.7 38.2 20.6 20.8 22.4 25.7 20.8 23.1 26.8 23.0 20.1 23.7 24.7 21.8 29.5 23.7 22.4 15.5 3.9 16.2 28.2 18.8 55.6 18.2 7.9 18.1 16.3 13.3 22.8 34.9 29.5 2.1 37.9 14.4 27.4 103.7 28.1 3.8 30.9 14.4 22.5 25.2 47.3 9.9 27.6 31.2 18.4 16.3 30.7 52.0 19.9 24.3 45.5 84.9 3.3 9.8 35.5 46.8 40.5 48.1 4.3 19.0 37.5 37.4 8.4 68.9 9.7 13.4 3.0 15.7 28.1 17.5 21.8 9.5 11.6 21.0 52.9 26.2 6.0 26.3 6.9 24.5 13.0 13.7 41.4 38.8 30.8 11.3 40.2 35.3 22.2 LRRC8A "FLJ10337, KIAA1437, LRRC8, SWELL1" ENSG00000136802 "Leucine rich repeat containing 8 VRAC subunit A" Q8IWT6 9 128882133-128918039 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 192.0;Prostatic glandular cells: 207.0;Urothelial cells: 328.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 163.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.33e-2)" "unprognostic (3.88e-2)" "unprognostic (1.88e-3)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "unprognostic (4.38e-3)" "unprognostic (4.29e-2)" "unprognostic (1.19e-3)" "unprognostic (2.44e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (3.53e-1)" "prognostic favorable (5.27e-5)" "unprognostic (3.69e-1)" "unprognostic (8.77e-2)" "unprognostic (3.93e-3)" "unprognostic (1.02e-2)" 31.0 17.5 63.2 16.4 60.6 17.4 27.5 64.3 77.8 26.7 39.3 26.9 9.8 36.6 7.4 72.2 23.7 23.5 29.1 52.3 60.3 18.2 29.2 42.8 9.4 69.4 70.3 46.0 18.9 21.4 32.6 13.8 23.3 63.9 29.5 8.6 13.5 28.3 25.7 14.1 35.4 17.4 29.4 59.1 16.3 25.2 11.9 73.4 10.0 25.8 18.6 10.2 33.0 44.5 51.8 35.1 54.2 32.0 27.5 73.6 28.3 40.4 39.8 26.2 24.1 17.1 24.1 73.2 12.8 43.6 43.3 30.1 163.8 19.9 87.5 11.3 13.1 16.4 11.5 33.4 29.2 49.8 13.8 20.3 22.1 60.9 42.7 50.8 48.6 84.1 17.5 25.8 12.4 31.8 30.3 15.6 13.2 95.9 58.3 58.4 21.4 37.0 20.6 37.9 17.3 19.2 39.9 44.4 27.3 15.8 23.9 19.9 10.2 149.4 69.9 30.2 29.9 58.8 14.4 36.5 15.5 38.7 10.3 41.3 0.7 0.7 1.9 3.9 1.1 1.8 1.2 1.9 2.5 1.0 0.9 1.9 1.8 1.4 3.5 0.3 1.6 3.5 1.0 63.2 60.6 64.3 77.8 52.3 60.3 69.4 70.3 46.0 63.9 59.1 73.4 51.8 98.8 16.0 15.6 57.1 7.5 105.7 192.0 91.6 113.3 13.1 38.3 29.2 31.3 17.2 73.6 7.3 6.2 13.8 17.4 31.9 0.0 28.9 6.9 22.0 50.5 57.4 16.1 13.7 11.8 21.2 17.6 27.5 24.5 47.0 6.3 35.1 55.6 16.5 6.1 25.2 14.2 28.7 24.4 5.0 17.4 4.5 23.0 9.9 26.6 12.2 5.1 41.3 36.0 8.5 9.7 78.1 23.0 44.4 13.5 207.0 10.9 8.1 33.2 10.2 65.7 38.2 35.2 3.2 8.6 91.6 145.1 20.8 15.5 9.6 14.5 328.5 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790792 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 44.0 61.3 46.3 23.9 45.7 47.4 40.7 43.3 54.2 51.9 36.7 42.8 19.8 49.7 21.3 35.7 66.1 23.9 38.4 53.3 43.7 44.7 65.6 47.6 35.4 47.0 44.5 47.3 89.2 44.8 19.4 67.5 18.9 45.1 44.5 12.3 11.2 30.0 23.5 28.6 37.6 41.2 19.3 44.3 66.1 37.7 44.6 45.0 32.2 42.5 17.2 21.0 39.2 40.8 45.5 22.5 40.5 24.9 27.6 27.6 21.4 32.1 22.9 33.3 23.4 20.9 30.3 25.0 39.5 25.7 26.0 32.1 44.2 16.5 37.3 8.9 34.8 19.0 37.1 45.2 25.3 40.2 36.3 56.5 37.9 44.5 24.8 27.7 30.0 48.5 34.8 32.6 51.7 21.2 60.1 39.5 54.5 55.0 34.3 41.9 112.2 21.2 57.0 34.2 24.9 24.5 29.2 34.5 35.8 20.9 19.3 45.0 33.9 56.4 27.8 30.9 24.1 22.3 92.5 76.4 34.7 26.1 24.4 25.9 4.1 3.7 5.8 10.3 5.1 10.1 3.6 5.7 8.3 4.8 6.6 6.3 7.9 5.4 22.4 7.5 9.9 4.4 3.6 46.3 45.7 43.3 54.2 53.3 43.7 47.0 44.5 47.3 45.1 44.3 45.0 45.5 43.1 12.8 12.4 39.8 27.1 24.1 27.6 15.8 18.8 13.9 17.9 10.9 14.1 20.0 10.8 11.0 2.1 22.5 28.5 17.1 15.6 31.3 4.4 26.4 22.7 35.6 19.2 15.4 18.1 37.2 22.3 23.0 24.5 25.3 25.3 18.1 33.5 26.4 23.3 25.2 17.0 12.7 8.2 18.8 23.4 6.2 19.6 24.2 16.0 22.5 44.7 17.5 33.0 12.5 16.8 32.9 13.7 31.2 22.2 28.9 14.5 16.7 20.4 7.9 0.0 21.6 22.1 8.9 22.9 19.9 22.0 51.3 24.7 54.5 13.7 31.4 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243810-110256507 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 1067.3" "Cell type enriched" "Detected in all" 4 "monocytes: 15775.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 1642.2;granulocytes: 1355.4" "Cell line enhanced" "Detected in all" "OE19: 3836.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 16000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favorable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 140.0 128.8 164.7 146.7 168.3 370.7 220.8 166.7 227.3 151.2 157.7 459.5 352.4 132.1 169.9 1067.3 242.8 143.4 88.9 167.4 176.9 434.6 439.6 159.8 132.6 176.1 171.5 165.6 84.5 120.1 73.6 61.6 106.7 175.5 114.6 439.1 46.6 394.9 130.1 85.5 242.1 335.0 141.5 171.4 106.3 224.5 36.9 165.5 263.7 94.6 77.0 210.1 220.1 232.7 180.0 672.9 920.0 238.7 265.6 601.0 782.3 352.7 792.5 756.2 555.6 419.4 606.8 785.6 598.9 331.5 754.7 1181.3 1464.8 351.0 1081.1 544.6 887.6 778.5 298.2 804.7 1061.8 684.7 747.2 864.2 556.2 703.5 809.0 607.8 504.7 498.7 369.7 515.9 553.1 775.4 557.1 621.9 1119.7 505.4 3836.3 1110.5 256.6 810.3 696.3 721.7 479.4 520.9 183.7 860.0 687.5 572.7 458.6 661.2 508.6 587.9 556.4 357.3 1050.2 1006.1 271.4 872.5 512.7 804.8 654.4 789.5 484.8 311.2 1355.4 169.2 195.5 165.2 154.2 237.7 207.3 475.7 75.9 87.4 129.3 1212.7 195.0 131.6 1642.2 337.0 279.2 164.7 168.3 166.7 227.3 167.4 176.9 176.1 171.5 165.6 175.5 171.4 165.5 180.0 458.7 391.0 298.2 12.4 165.9 1304.5 1072.4 3654.4 435.4 38.0 514.2 752.8 108.5 418.9 1810.0 263.0 20.9 637.2 443.0 1297.7 972.4 1172.8 31.2 1560.7 1465.0 587.0 556.4 388.4 18.2 1341.7 993.1 526.8 662.1 775.9 268.6 247.1 216.0 842.8 571.8 28.6 18.3 1111.2 2191.1 286.1 1752.9 31.6 403.2 682.7 763.1 10.3 15775.8 86.3 128.8 7.5 21.9 1994.7 1227.7 285.5 388.5 2151.2 1439.2 3670.6 1516.8 34.8 144.7 211.8 557.8 10.6 76.3 2725.7 1491.0 468.2 266.6 879.4 1621.8 1742.1 ODF2 "CT134, ODF84" ENSG00000136811 "Outer dense fiber of sperm tails 2" Q5BJF6 9 128455186-128501292 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 320.1" "Cell type enriched" "Detected in all" 4 "Late spermatids: 8228.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001874, HPA048841" Enhanced Supported Vesicles,Centrosome NA NA Centrosome Vesicles "HPA001874: AB_1079522, HPA048841: AB_2680536" "unprognostic (4.54e-3)" "unprognostic (9.91e-2)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (6.11e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-1)" "unprognostic (1.79e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.93e-2)" "unprognostic (9.23e-3)" "unprognostic (1.47e-1)" "unprognostic (1.62e-1)" "unprognostic (7.65e-2)" 14.3 11.9 12.1 22.3 11.2 31.3 14.3 19.5 14.8 19.9 36.1 14.5 10.4 22.1 11.1 12.5 22.8 13.4 14.5 12.4 12.6 11.2 16.5 14.6 25.8 13.1 14.6 9.5 15.2 13.3 15.4 31.0 16.0 14.7 16.2 15.3 15.0 13.0 14.9 9.0 19.5 13.8 20.7 11.2 20.7 13.8 320.1 13.1 35.1 13.3 5.4 26.8 17.2 14.6 12.0 44.2 52.2 85.3 97.7 33.3 39.6 68.6 72.3 33.7 58.9 30.8 51.8 31.6 78.6 26.7 59.2 45.7 112.7 62.9 43.1 59.4 52.2 29.3 69.8 84.9 43.8 19.3 76.2 84.5 32.8 26.9 62.6 43.9 36.5 52.0 58.8 83.9 42.9 56.3 134.9 81.5 92.7 33.4 89.7 37.2 73.6 82.0 60.9 30.7 33.6 51.2 43.6 67.8 64.0 22.9 38.3 59.8 54.8 49.9 73.1 44.6 84.9 71.7 79.6 123.9 55.9 33.4 68.4 64.8 21.6 9.2 10.3 11.4 13.4 13.6 8.2 10.2 12.2 8.8 7.0 7.2 9.3 3.0 12.0 17.8 8.3 8.1 10.1 12.1 11.2 19.5 14.8 12.4 12.6 13.1 14.6 9.5 14.7 11.2 13.1 12.0 14.2 6.4 6.8 9.8 14.4 16.7 16.7 7.4 19.9 9.8 11.2 9.5 10.6 11.5 8.5 7.3 10.4 13.1 13.7 4.6 11.7 10.6 1914.4 39.4 16.3 18.3 3.6 29.8 18.5 9.0 16.8 14.0 10.2 13.4 19.6 10.1 8.2 9.6 12.4 8.4 16.6 10.9 12.2 10.2 14.9 8228.0 42.6 12.9 10.6 12.2 11.1 8.6 9.2 14.1 9.8 7.4 3.2 33.8 16.1 16.1 3.0 6.9 46.6 8.9 13.1 11.1 16.7 268.1 58.3 13.8 13.2 33.2 16.8 11.4 7.6 12.9 ECPAS "ECM29, FLJ22036, KIAA0368" ENSG00000136813 "Ecm29 proteasome adaptor and scaffold" Q5VYK3 9 111360692-111484745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 247.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021646, HPA059795" Uncertain Approved Nucleoplasm Yes No 5400 Nucleoplasm "HPA021646: AB_2670788, HPA059795: AB_2684127" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (7.42e-2)" "unprognostic (5.72e-2)" "unprognostic (3.81e-1)" "unprognostic (1.79e-1)" "unprognostic (1.80e-2)" "unprognostic (5.12e-2)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (9.99e-2)" "unprognostic (1.67e-1)" "unprognostic (3.72e-3)" "unprognostic (2.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" "unprognostic (1.05e-1)" 42.0 34.3 29.6 23.8 42.8 28.9 32.1 33.9 53.3 31.4 31.4 32.5 32.4 28.6 23.8 28.9 26.7 20.0 40.6 52.5 33.5 28.8 28.4 31.3 21.7 31.6 32.4 35.0 33.3 38.7 40.9 32.9 24.2 32.4 34.6 29.8 28.6 32.3 25.9 247.0 32.3 29.8 28.8 24.8 22.6 31.5 35.9 29.7 16.4 32.7 98.0 21.4 31.9 31.2 39.3 58.9 53.1 35.0 37.7 81.6 81.1 57.5 70.8 60.4 57.0 39.1 49.7 35.6 59.3 32.5 62.6 46.5 83.7 45.1 47.4 52.7 65.4 28.3 36.6 64.5 72.0 60.4 68.9 38.2 74.2 48.8 57.3 84.4 64.6 58.8 14.7 85.4 81.1 47.1 49.5 0.3 39.9 68.6 74.7 44.1 33.4 107.2 35.7 48.9 52.2 66.7 31.7 60.5 64.1 46.2 37.6 50.5 36.4 64.7 38.1 43.6 57.5 65.5 71.2 144.9 71.3 55.7 27.8 36.0 2.7 5.8 1.9 4.6 6.0 5.3 3.9 4.7 5.3 8.1 4.2 2.8 4.9 1.7 4.8 4.5 3.6 4.1 2.9 29.6 42.8 33.9 53.3 52.5 33.5 31.6 32.4 35.0 32.4 24.8 29.7 39.3 24.6 57.7 63.9 0.0 5.3 0.0 0.0 0.0 0.0 0.0 19.0 14.7 0.0 0.0 32.8 12.9 0.0 17.3 11.6 0.0 9.8 21.0 0.0 19.3 32.0 12.1 0.0 0.0 0.0 21.7 11.4 12.5 0.0 26.2 24.0 30.6 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 25.7 0.0 0.0 4.9 0.0 0.0 14.4 24.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 20.2 6.5 29.2 0.0 0.0 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803157-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Uncertain "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA 140000 "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 11.3 10.1 8.5 13.3 8.5 14.4 8.8 11.9 8.7 8.4 9.2 20.4 11.4 9.2 7.0 10.3 7.8 13.4 8.7 8.2 9.2 8.6 18.6 11.8 11.1 8.8 8.6 8.4 7.6 12.7 11.8 7.4 14.3 9.5 11.1 22.8 6.0 10.4 9.3 10.6 11.9 14.2 12.7 8.3 9.4 12.0 10.3 9.2 10.8 10.8 10.0 9.5 16.0 8.5 9.0 11.7 26.5 10.9 29.0 53.2 39.4 25.0 40.8 26.7 27.6 27.2 22.0 26.1 8.3 25.2 40.7 43.0 46.4 11.9 16.9 28.2 30.4 12.3 7.2 21.5 15.8 22.8 13.8 31.1 22.6 29.3 39.6 19.4 20.4 24.9 21.5 25.6 18.8 26.2 32.9 19.2 21.8 22.9 54.8 20.1 7.8 18.9 25.3 21.3 12.1 15.0 17.2 26.0 30.4 16.6 19.5 43.7 13.5 22.7 51.9 24.5 62.4 35.7 13.6 53.9 7.0 28.6 17.9 36.0 8.7 13.3 20.2 12.6 16.0 13.0 4.0 10.0 11.2 6.9 4.7 7.3 7.3 16.4 8.8 10.1 4.2 10.5 9.9 8.5 8.5 11.9 8.7 8.2 9.2 8.8 8.6 8.4 9.5 8.3 9.2 9.0 9.5 9.6 2.4 6.5 11.7 6.5 5.9 7.3 12.5 2.7 6.9 5.6 5.5 5.7 6.1 5.5 4.2 10.8 16.1 15.3 0.0 9.7 13.3 5.0 6.7 8.2 19.2 3.4 13.9 13.7 17.7 10.5 17.9 5.7 4.5 4.0 9.7 13.3 12.0 6.7 15.6 16.2 4.1 5.4 5.0 15.1 4.4 12.1 3.6 4.7 12.3 4.7 16.5 14.6 10.5 12.6 6.7 5.7 14.5 10.1 10.7 3.7 9.4 2.7 19.7 6.8 13.0 22.7 5.4 10.4 5.4 15.2 12.2 4.6 10.5 11.2 C9orf78 "CSU2, HCA59, HSPC220" ENSG00000136819 "Chromosome 9 open reading frame 78" Q9NZ63 9 129827290-129835863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 414.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021216, HPA021232, HPA021242" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838" "unprognostic (1.00e-1)" "unprognostic (4.23e-3)" "unprognostic (1.03e-2)" "unprognostic (1.83e-1)" "unprognostic (3.35e-2)" "unprognostic (7.03e-2)" "unprognostic (3.50e-2)" "unprognostic (6.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.26e-1)" "unprognostic (1.13e-2)" "unprognostic (1.43e-2)" "prognostic favorable (3.49e-7)" "unprognostic (5.34e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 36.4 37.2 56.3 33.7 58.0 114.6 36.0 56.5 62.8 34.8 53.4 39.8 27.5 36.4 35.7 37.2 32.7 31.6 37.9 57.1 57.3 48.3 61.5 29.9 50.0 57.9 57.9 54.4 36.7 38.6 29.4 29.7 28.1 58.3 35.8 33.9 20.8 35.8 31.1 68.2 41.1 37.4 29.3 57.1 37.6 36.8 33.5 58.5 61.0 38.2 36.8 44.7 41.3 34.6 59.0 36.0 36.3 36.9 59.8 66.4 44.4 44.4 51.7 41.0 44.7 32.5 37.0 38.3 57.9 41.6 60.5 72.6 71.8 52.8 41.9 36.9 57.2 37.8 92.1 63.6 40.8 42.7 131.5 91.1 39.2 78.2 56.5 47.9 44.2 42.9 242.6 235.4 68.3 57.3 87.4 175.0 160.3 53.2 143.9 81.4 47.8 57.1 117.8 46.3 24.9 31.6 60.0 76.2 73.0 63.3 35.8 63.9 88.6 47.2 68.5 50.1 68.2 63.6 30.2 94.6 89.9 57.1 105.1 57.3 164.4 82.1 219.5 150.2 131.0 150.4 105.3 156.0 164.3 69.7 106.5 174.8 159.8 63.8 147.9 172.7 82.7 184.6 138.6 56.3 58.0 56.5 62.8 57.1 57.3 57.9 57.9 54.4 58.3 57.1 58.5 59.0 55.7 89.8 84.6 7.8 93.9 78.1 64.8 60.2 55.2 39.8 57.3 58.5 55.5 57.2 81.6 57.0 37.5 71.9 160.1 60.7 125.2 65.1 58.8 46.7 57.7 58.4 84.4 414.9 12.5 89.6 78.3 55.4 39.3 41.1 134.1 34.8 45.7 83.3 66.3 32.0 12.8 64.5 109.9 66.6 78.2 17.7 59.0 75.0 72.9 8.4 102.6 62.3 178.2 5.0 9.9 65.7 44.0 60.9 73.9 68.4 102.8 183.4 72.8 35.1 78.9 59.9 68.0 119.8 117.7 63.2 85.0 67.6 172.4 45.3 58.0 55.9 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141419 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.9" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No 26000 Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 5.2 4.1 2.8 11.4 4.0 18.5 6.7 4.4 3.4 7.5 1.8 8.3 7.6 6.1 2.6 7.4 4.7 4.0 8.0 2.6 4.1 6.4 4.8 4.6 16.1 4.6 4.0 2.1 4.7 3.5 5.7 1.5 7.0 4.3 4.3 8.9 5.7 3.2 4.8 2.2 7.5 7.7 5.5 3.7 7.2 6.2 12.1 3.6 25.9 7.6 5.5 16.0 4.9 3.2 5.2 59.3 45.0 49.4 45.9 10.3 14.9 46.2 53.5 25.4 46.9 39.4 39.3 44.9 112.6 25.2 27.7 40.5 97.6 72.3 34.8 63.2 71.6 30.3 67.9 68.8 25.5 2.7 41.5 65.6 9.8 7.0 63.7 25.7 15.9 33.7 71.2 55.8 89.8 43.0 28.9 109.1 21.3 42.9 47.6 34.8 72.0 141.3 42.2 20.1 21.1 46.5 35.9 63.8 29.6 15.5 20.5 59.5 28.0 27.1 56.8 59.1 79.3 67.9 32.6 118.2 64.6 36.8 59.8 70.3 15.0 2.2 2.5 4.8 5.9 5.4 7.3 4.4 4.8 2.6 7.9 5.0 5.8 0.3 7.0 7.4 4.4 6.0 2.4 2.8 4.0 4.4 3.4 2.6 4.1 4.6 4.0 2.1 4.3 3.7 3.6 5.2 19.6 25.6 11.9 6.5 19.9 27.3 16.4 27.6 11.4 39.7 16.6 19.3 45.1 7.2 17.8 16.5 8.4 54.3 15.2 13.7 35.2 18.9 40.0 114.6 21.6 21.4 4.9 95.3 10.2 20.4 93.8 20.2 13.3 16.0 22.2 40.4 21.0 7.6 44.3 28.6 15.5 14.6 26.4 19.8 19.8 24.7 18.6 22.9 7.2 7.5 19.8 15.6 22.6 5.5 18.4 15.6 6.3 12.4 40.9 7.3 10.3 15.0 12.0 19.1 13.1 25.1 37.7 84.5 93.5 27.4 23.2 25.9 18.1 28.1 35.0 14.2 KLF4 "EZF, GKLF" ENSG00000136826 "Kruppel like factor 4" O43474 9 107484852-107490482 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 240.7" "Cell type enhanced" "Detected in many" "Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.0;non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002926 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002926: AB_1852541" "unprognostic (2.06e-1)" "unprognostic (1.42e-2)" "unprognostic (1.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-3)" "unprognostic (3.44e-2)" "unprognostic (6.49e-2)" "unprognostic (3.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" "unprognostic (8.32e-2)" 74.2 24.1 6.7 21.2 5.3 51.0 64.4 5.1 7.4 53.7 6.1 88.1 28.6 16.1 5.7 103.0 43.4 44.6 28.2 4.6 6.5 6.3 12.5 45.2 5.6 5.8 5.9 3.7 29.2 7.1 5.7 5.0 32.6 5.7 16.9 96.9 0.8 27.7 7.7 14.3 240.7 40.8 40.9 4.8 24.3 58.5 17.9 7.5 17.2 25.4 23.4 14.6 44.4 59.4 5.0 13.3 3.9 0.6 0.1 16.6 39.2 5.2 4.4 27.6 6.7 8.1 1.0 18.0 0.0 0.6 6.9 23.7 8.7 6.1 3.9 3.0 0.0 2.2 0.0 7.5 0.3 21.6 0.0 0.0 5.0 84.4 14.0 54.5 1.5 0.6 0.2 0.6 0.0 4.1 7.3 0.0 1.4 4.1 47.2 25.2 0.3 1.6 0.2 2.3 3.7 0.4 0.2 4.0 11.8 15.2 12.7 1.3 5.4 3.5 3.6 0.1 111.5 2.1 0.2 0.1 0.0 3.4 2.6 6.8 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 1.0 0.2 0.0 0.1 6.7 5.3 5.1 7.4 4.6 6.5 5.8 5.9 3.7 5.7 4.8 7.5 5.0 1054.7 12.8 41.1 0.3 32.2 436.0 284.3 143.0 832.1 0.5 206.7 205.0 70.3 35.8 71.5 1.8 8.4 49.1 15.0 789.2 1.9 24.4 263.1 154.1 216.0 336.6 123.8 4.8 0.0 38.7 75.5 463.2 537.2 297.4 54.7 4.7 216.0 4.6 89.9 0.0 0.2 710.9 83.4 232.9 282.0 163.0 143.8 401.0 206.3 16.9 36.8 2.0 0.0 0.0 0.0 49.3 540.9 60.5 38.3 187.3 198.0 2.1 46.4 2.0 39.5 463.7 130.0 21.6 15.9 639.9 674.0 107.9 26.8 63.5 332.6 236.8 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812942-129824244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 20000 "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: AB_2681382" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 21.1 24.4 14.2 20.8 15.1 34.8 19.7 15.1 17.8 18.7 14.3 20.9 16.7 20.5 20.1 14.5 17.4 20.8 16.9 15.5 15.5 20.7 36.2 19.6 23.1 14.0 14.4 14.5 17.3 19.6 19.6 14.4 23.7 14.5 21.5 22.5 9.9 17.2 23.3 16.5 17.7 19.0 25.7 14.7 19.0 18.3 9.3 15.4 26.6 24.0 15.0 19.2 28.8 15.7 16.1 33.7 49.5 35.9 41.5 53.1 51.3 47.4 76.7 94.5 67.0 57.2 32.3 48.2 41.0 44.0 99.7 46.0 77.2 34.7 50.8 54.7 65.7 32.9 36.9 49.8 32.3 66.9 82.1 65.5 69.8 50.7 63.5 45.6 61.5 73.2 65.3 66.5 32.3 74.6 84.3 58.9 79.3 53.8 39.2 55.6 30.5 56.5 41.9 54.9 42.4 27.0 47.6 79.3 30.7 43.3 40.1 61.6 63.4 65.1 66.1 37.7 49.6 59.6 36.6 87.0 37.7 49.0 46.9 54.3 95.5 72.8 141.3 57.4 68.5 48.1 45.5 48.4 52.1 61.4 33.5 40.9 42.4 72.7 68.6 58.3 56.5 59.1 78.9 14.2 15.1 15.1 17.8 15.5 15.5 14.0 14.4 14.5 14.5 14.7 15.4 16.1 25.0 9.6 11.8 5.5 17.5 17.6 16.6 39.5 12.0 11.2 16.5 15.9 9.9 18.6 24.4 14.7 2.1 47.9 39.3 18.7 15.6 42.1 0.7 12.5 18.8 24.2 19.2 30.5 6.3 49.9 65.7 25.0 13.7 15.0 22.2 23.4 16.1 22.7 45.2 21.9 6.4 17.8 26.4 19.1 22.4 1.3 12.8 27.9 14.2 3.7 47.6 18.5 35.0 9.5 6.6 40.1 18.9 15.4 23.7 24.7 21.0 17.0 14.9 9.2 32.9 15.2 24.3 7.3 10.1 9.3 18.5 53.4 25.5 23.4 15.4 19.6 RALGPS1 "KIAA0351, RALGEF2, RALGPS1A" ENSG00000136828 "Ral GEF with PH domain and SH3 binding motif 1" Q5JS13 9 126914774-127223166 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 87.8;Cone photoreceptor cells: 104.3;Excitatory neurons: 105.6;Inhibitory neurons: 164.4;Oligodendrocytes: 161.3;Rod photoreceptor cells: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014749 Uncertain NA NA "HPA014749: " "unprognostic (3.49e-2)" "unprognostic (3.35e-2)" "unprognostic (4.14e-2)" "unprognostic (2.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.10e-2)" "unprognostic (1.09e-1)" "unprognostic (6.69e-3)" "unprognostic (3.47e-1)" "unprognostic (4.68e-2)" "unprognostic (5.02e-3)" "unprognostic (3.49e-1)" "prognostic favorable (6.20e-11)" "unprognostic (4.79e-2)" "unprognostic (7.68e-2)" "unprognostic (3.75e-2)" "unprognostic (3.24e-3)" 3.3 3.4 13.6 3.8 13.4 3.3 6.7 18.2 16.8 5.3 4.6 10.9 30.9 4.7 9.4 7.7 8.6 6.4 13.2 13.4 14.0 11.5 2.8 6.5 4.4 18.7 16.5 13.5 4.1 11.4 16.0 18.9 3.9 20.1 8.0 13.2 30.9 13.2 8.3 9.5 9.9 29.3 4.6 12.7 5.3 18.3 10.7 15.6 4.8 13.9 6.1 6.4 8.6 5.9 22.0 3.5 3.1 8.1 8.0 1.5 1.1 8.8 1.1 1.1 1.7 2.4 8.6 5.8 5.8 0.8 1.4 10.3 12.0 2.5 1.4 1.0 2.3 4.9 0.4 4.3 1.5 1.2 1.0 6.3 0.7 4.9 0.8 1.0 1.4 2.8 13.3 0.8 5.8 0.4 6.5 1.1 0.9 2.2 33.6 2.7 3.9 1.9 11.2 3.4 8.6 7.4 11.1 3.4 10.5 2.5 5.6 9.5 0.5 1.3 0.7 2.4 1.6 1.3 10.5 10.8 3.0 3.2 1.0 1.2 0.0 0.1 0.7 0.1 0.0 0.2 2.3 0.3 0.2 0.0 0.7 0.1 0.1 0.9 0.8 0.1 0.7 0.1 0.1 13.6 13.4 18.2 16.8 13.4 14.0 18.7 16.5 13.5 20.1 12.7 15.6 22.0 6.2 6.4 4.1 87.8 11.2 2.7 4.4 3.6 2.2 36.8 8.5 5.1 10.2 17.2 10.2 11.0 104.3 9.6 3.6 18.8 5.9 6.1 27.6 11.8 2.6 2.3 7.8 0.0 105.6 6.4 1.0 3.2 34.7 7.2 0.0 6.5 3.3 2.1 2.6 45.4 164.4 16.8 12.2 2.5 2.8 41.4 1.5 2.7 1.8 31.9 3.5 12.4 8.2 68.3 161.3 8.9 14.7 3.8 5.5 6.2 56.9 3.9 13.4 119.0 6.6 5.8 3.2 31.3 12.3 11.6 4.7 4.0 4.7 4.4 17.8 9.1 NIBAN2 "bA356B19.6, C9orf88, DKFZP434H0820, FAM129B, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Niban apoptosis regulator 2" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 611.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 73.6;Extravillous trophoblasts: 40.5;Hofbauer cells: 23.0;Syncytiotrophoblasts: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1500000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 45.0 108.3 27.1 37.0 22.8 27.6 42.4 23.4 24.6 75.6 39.7 69.2 51.2 39.2 12.7 611.5 39.8 40.0 39.6 20.2 46.1 50.0 16.9 122.9 6.7 45.9 30.6 16.4 31.8 143.8 26.5 34.3 85.5 32.6 67.0 30.6 2.7 143.3 32.5 13.7 110.4 54.3 22.2 36.5 32.4 84.0 11.1 32.4 5.7 111.5 11.4 54.1 69.0 191.2 31.7 134.0 149.8 29.9 39.3 87.9 170.1 138.2 259.1 238.5 140.1 86.4 48.2 143.7 0.4 100.4 295.5 172.9 217.5 25.9 192.2 45.9 25.2 27.5 22.8 218.9 50.4 173.1 1.0 62.0 187.3 118.3 231.4 80.8 256.8 213.6 8.4 43.5 1.2 269.8 157.3 1.6 37.6 30.9 228.0 194.4 16.0 99.9 70.1 120.5 105.6 47.4 22.1 212.3 149.0 93.4 42.1 98.2 7.5 279.9 143.1 62.4 182.2 218.0 2.5 5.1 0.6 403.3 21.6 271.1 0.2 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 27.1 22.8 23.4 24.6 20.2 46.1 45.9 30.6 16.4 32.6 36.5 32.4 31.7 12.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 73.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 40.5 4.2 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 120.9 0.1 0.0 0.0 0.0 OR1J1 hg32 ENSG00000136834 "Olfactory receptor family 1 subfamily J member 1" Q8NGS3 9 122476958-122477926 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.33e-2)" "unprognostic (2.86e-2)" "unprognostic (3.08e-2)" "unprognostic (9.41e-2)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C9 ENSG00000136839 "Olfactory receptor family 13 subfamily C member 9" Q8NGT0 9 104617248-104618204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA078297 Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA078297: " 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.3 0.3 0.1 0.5 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917041 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 67.8;Erythroid cells: 112.2;Plasma cells: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "plasmacytoid DC: 233.9" "Lineage enriched" "Detected in all" 9 "dendritic cells: 233.9" "Cell line enhanced" "Detected in many" "HDLM-2: 105.3;RPMI-8226: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 19.0 17.1 9.6 10.7 9.1 40.3 16.7 10.5 15.3 17.7 10.8 18.2 15.0 18.6 6.4 15.3 19.4 8.7 32.9 10.1 8.7 20.4 9.1 27.9 14.1 10.0 8.5 8.5 25.3 72.6 7.5 21.0 5.4 9.7 13.7 6.7 1.0 11.9 15.4 24.6 9.3 19.5 7.6 8.7 37.5 15.3 5.4 8.9 6.0 11.4 10.3 9.5 18.0 14.8 8.5 9.5 15.9 4.1 20.1 27.4 20.8 3.0 16.3 17.6 16.2 9.4 9.1 17.0 60.2 24.0 20.2 22.8 23.0 8.2 17.2 2.7 105.3 7.2 19.3 48.8 34.2 33.3 1.6 19.1 25.6 18.0 14.4 12.9 13.1 43.2 11.4 14.0 38.9 7.8 4.4 3.8 2.2 4.6 30.7 38.9 18.3 10.5 149.6 16.5 0.5 33.8 7.8 23.6 49.8 3.0 1.3 10.3 12.2 31.3 13.1 15.2 41.3 25.8 63.5 35.0 18.8 26.2 8.4 1.9 3.7 9.0 0.3 11.1 8.0 12.3 25.1 6.9 13.3 11.3 18.6 8.6 11.9 1.1 18.9 14.5 233.9 13.3 10.2 9.6 9.1 10.5 15.3 10.1 8.7 10.0 8.5 8.5 9.7 8.7 8.9 8.5 15.0 9.6 26.5 2.3 35.5 2.2 12.2 21.1 8.6 3.1 5.2 4.8 12.2 10.0 9.9 1.8 0.0 1.1 48.1 27.0 1.9 16.1 0.2 2.5 13.8 14.8 67.8 112.2 3.7 14.1 15.6 10.7 6.6 2.6 8.2 7.1 12.1 1.9 23.0 0.0 4.9 16.6 8.2 13.3 10.0 0.6 17.4 9.2 7.2 1.9 11.2 15.0 11.3 2.0 1.0 9.3 9.1 42.9 93.9 12.8 17.1 20.6 5.1 1.9 13.1 9.2 10.9 0.3 1.5 9.3 3.1 4.5 10.2 34.0 13.0 10.6 TMOD1 "D9S57E, ETMOD, TMOD" ENSG00000136842 "Tropomodulin 1" P28289 9 97501180-97601743 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 252.4;tongue: 258.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 60.0;Erythroid cells: 138.9;Horizontal cells: 102.6" "Group enriched" "Detected in many" 4 "glioma: 21.6;ovarian cancer: 17.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 38.0;HDLM-2: 155.7;K-562: 53.3;SH-SY5Y: 157.4" "Low region specificity" "Detected in all" HPA051202 Enhanced NA NA 9400 "HPA051202: AB_2681387" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-3)" "unprognostic (1.95e-1)" "unprognostic (1.08e-1)" "unprognostic (2.62e-3)" "unprognostic (2.82e-1)" "unprognostic (3.09e-1)" "unprognostic (2.09e-1)" "unprognostic (2.91e-1)" "unprognostic (1.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (2.02e-1)" "unprognostic (4.88e-5)" 17.9 65.7 18.2 4.5 20.9 24.4 15.9 26.5 22.2 45.5 18.1 25.7 4.2 54.7 5.6 17.5 27.6 7.5 145.5 18.9 31.0 9.2 28.8 15.6 2.6 21.8 14.3 19.5 51.7 23.2 14.0 31.9 2.6 18.6 17.3 6.3 9.3 10.5 9.2 252.4 6.5 12.3 36.6 20.0 3.6 18.6 2.9 14.6 1.0 22.0 258.1 2.4 38.6 25.7 24.3 5.4 1.4 0.0 0.7 6.3 0.6 1.9 1.0 9.1 0.1 0.2 1.2 1.6 0.1 38.0 0.1 8.5 0.4 1.6 0.0 0.0 155.7 5.6 7.4 8.8 0.6 0.2 0.1 12.5 0.5 0.0 0.4 0.0 0.1 0.7 0.2 53.3 0.1 0.1 2.3 0.0 1.0 2.0 1.5 0.6 0.0 5.1 0.1 0.0 1.1 0.6 157.4 4.8 0.1 2.7 2.1 2.0 7.7 0.8 0.0 5.7 4.3 1.1 19.1 4.1 0.2 7.0 5.1 8.4 0.8 0.3 0.5 1.2 0.3 1.1 1.2 1.0 0.7 0.5 2.0 0.6 0.7 0.0 0.7 0.4 0.1 2.2 1.1 18.2 20.9 26.5 22.2 18.9 31.0 21.8 14.3 19.5 18.6 20.0 14.6 24.3 4.7 6.4 4.2 2.3 1.9 2.3 1.0 0.0 0.0 1.1 1.6 1.3 60.0 4.3 0.0 0.0 6.2 0.2 1.1 0.0 0.0 0.3 0.8 10.2 14.5 13.0 3.0 138.9 27.6 6.5 0.4 12.8 4.6 27.7 10.8 0.1 27.5 20.2 0.9 102.6 19.3 0.4 0.0 13.7 4.2 0.6 10.2 6.5 17.8 6.5 0.1 2.2 0.0 31.2 5.9 4.7 0.0 6.8 0.4 2.1 0.0 0.2 0.0 1.3 19.7 8.8 23.9 2.6 6.8 0.2 1.0 0.1 3.2 0.1 0.1 0.9 DAB2IP "AF9Q34, AIP1, DIP1/2, KIAA1743" ENSG00000136848 "DAB2 interacting protein" Q5VWQ8 9 121567057-121785530 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell cycle, Growth regulation, Immunity, Inflammatory response, Innate immunity, Stress response, Unfolded protein response" "Developmental protein, GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 81.7;HDLM-2: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.82e-2)" "unprognostic (2.79e-1)" "unprognostic (2.62e-2)" "unprognostic (4.99e-3)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.08e-1)" "unprognostic (1.49e-2)" "unprognostic (3.09e-1)" "unprognostic (1.87e-1)" "prognostic favorable (4.00e-15)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.81e-2)" 23.3 17.9 24.1 11.4 36.9 0.3 28.5 80.5 35.8 20.9 12.6 38.4 18.6 41.9 5.6 26.2 22.0 14.0 29.9 27.0 20.1 33.7 13.6 29.8 3.9 30.9 24.9 21.2 29.3 19.3 10.0 15.4 14.6 36.3 25.0 14.9 11.8 38.7 24.1 47.8 26.5 21.5 22.1 18.8 23.7 30.3 23.2 27.5 8.6 19.3 18.1 3.3 23.8 20.7 21.2 18.2 21.0 17.5 16.0 3.4 2.6 28.7 13.9 32.5 10.3 5.9 15.2 15.3 0.0 17.1 13.5 14.5 81.7 16.3 47.6 2.6 64.6 9.9 0.3 22.9 27.4 4.8 2.8 0.1 1.4 32.4 3.6 7.1 9.4 16.0 1.6 0.3 0.2 3.4 18.5 13.1 3.9 19.0 54.2 6.9 6.1 12.5 28.6 10.6 27.3 17.7 33.2 7.5 47.6 25.9 10.1 52.9 2.3 16.2 12.2 16.0 4.0 11.1 0.2 0.3 1.2 1.4 0.5 14.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 36.9 80.5 35.8 27.0 20.1 30.9 24.9 21.2 36.3 18.8 27.5 21.2 39.4 44.8 11.7 21.9 1.1 5.0 18.9 20.8 21.1 20.6 16.3 22.5 23.7 30.0 12.6 11.0 0.0 6.0 0.6 49.4 9.8 35.6 5.8 19.2 13.9 29.3 6.0 0.0 31.0 32.1 9.9 11.4 14.3 33.9 0.0 18.8 14.6 11.0 1.1 15.2 20.0 17.2 16.2 0.3 2.1 8.6 12.8 1.2 14.2 22.5 0.7 41.9 0.0 23.6 10.7 40.6 11.7 9.8 1.2 24.0 18.4 8.3 5.7 2.7 6.6 16.9 21.7 5.3 13.1 15.5 2.8 26.5 2.0 14.7 23.9 19.2 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 172.4;pituitary gland: 66.9;retina: 216.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6" "Cancer enhanced" "Detected in all" "melanoma: 39.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 144.1;SK-MEL-30: 131.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol NA NA 29000 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.47e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favorable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 27.7 29.0 16.7 7.9 38.6 1.1 21.1 45.5 172.4 21.0 0.0 13.3 5.6 24.4 7.2 10.5 32.6 11.5 24.2 49.8 73.6 14.0 3.1 32.4 6.1 59.2 21.3 52.7 25.4 25.0 15.1 66.9 14.2 69.0 10.6 8.5 216.0 15.8 10.5 9.1 11.2 9.3 21.2 0.0 10.5 13.4 9.2 17.4 5.8 20.2 9.3 7.1 15.6 16.5 130.1 13.2 27.1 25.5 28.8 56.6 48.3 23.2 45.0 22.9 26.6 23.3 1.5 15.4 13.1 24.2 29.7 74.2 4.7 22.6 28.1 32.7 29.8 15.4 17.1 69.7 4.9 28.5 1.8 14.6 36.6 15.4 70.0 33.7 42.6 32.2 43.4 17.8 19.6 45.5 24.5 12.5 5.2 21.5 21.4 35.9 7.5 12.1 31.3 22.0 0.6 144.1 69.9 72.9 37.2 131.9 22.5 5.8 5.6 47.5 30.0 15.1 59.9 17.4 40.2 73.2 17.4 59.2 18.9 28.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.9 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.2 16.7 38.6 45.5 172.4 49.8 73.6 59.2 21.3 52.7 69.0 0.0 17.4 130.1 24.3 25.6 70.7 34.0 1.2 11.6 10.1 8.4 12.5 131.0 10.5 8.0 15.2 1.5 9.2 3.7 156.4 2.7 1.1 0.5 7.9 13.1 2.2 8.3 14.7 28.9 45.6 4.0 243.2 8.4 5.9 18.7 3.1 7.0 5.1 5.0 26.7 1.4 4.4 84.1 157.5 10.2 8.2 2.5 5.6 2.2 20.5 3.0 10.6 45.0 0.6 27.0 0.0 61.3 39.0 5.3 0.0 44.4 1.6 10.8 0.1 8.9 15.9 155.6 13.1 9.5 11.2 40.6 16.9 2.9 7.5 24.5 2.3 17.7 0.9 7.1 SLC2A8 "GLUT8, GLUTX1" ENSG00000136856 "Solute carrier family 2 member 8" Q9NY64 9 127397138-127408424 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 145.8;Endometrial stromal cells: 86.5;Late spermatids: 310.1;Spermatocytes: 98.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 75.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 75.9" "Cell line enhanced" "Detected in many" "CACO-2: 122.9;Hep G2: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011935 Uncertain Approved Vesicles NA NA Vesicles "HPA011935: AB_1849760" "unprognostic (6.49e-2)" "prognostic favorable (2.57e-6)" "unprognostic (9.13e-2)" "unprognostic (1.85e-3)" "unprognostic (4.23e-2)" "unprognostic (9.43e-3)" "unprognostic (2.62e-1)" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.36e-1)" "prognostic favorable (9.86e-6)" "unprognostic (1.70e-1)" "prognostic favorable (6.55e-6)" "unprognostic (4.25e-2)" "unprognostic (3.55e-1)" "unprognostic (1.59e-3)" "unprognostic (2.04e-3)" 14.9 47.3 22.9 7.5 23.3 3.4 13.2 21.7 21.7 18.7 14.9 31.7 15.9 16.7 13.5 12.1 11.2 6.5 16.2 20.8 19.3 15.4 41.3 11.6 7.5 23.4 23.3 18.8 12.1 12.5 6.4 10.0 11.7 25.3 18.0 5.4 3.2 10.3 11.7 33.4 13.8 15.6 6.1 23.1 16.8 23.3 64.7 22.6 1.6 14.9 12.8 3.7 61.1 12.9 23.6 4.9 18.8 8.4 18.5 0.0 0.0 26.3 7.4 4.9 11.5 6.9 122.9 4.5 7.5 16.3 3.9 18.4 25.4 10.1 11.7 2.9 7.2 16.2 1.1 15.4 73.3 10.5 0.0 7.8 0.2 10.6 1.1 4.7 5.7 9.0 10.2 8.1 16.4 4.7 35.1 0.0 0.2 13.4 27.1 29.4 2.9 11.5 20.7 11.0 50.6 13.8 9.6 17.6 29.8 6.6 10.6 19.2 4.3 7.9 0.0 11.7 0.8 16.7 49.7 50.6 11.3 7.8 0.0 8.9 0.0 7.0 16.6 10.4 13.5 7.7 5.0 3.3 7.1 10.6 4.7 0.7 2.5 0.5 3.3 12.5 75.9 15.0 4.7 22.9 23.3 21.7 21.7 20.8 19.3 23.4 23.3 18.8 25.3 23.1 22.6 23.6 10.8 9.6 8.4 6.2 6.4 11.1 7.4 8.5 9.6 9.5 12.2 10.7 7.6 8.6 7.8 5.5 10.4 78.3 24.5 12.5 15.6 15.6 145.8 6.0 86.5 10.2 12.1 7.0 7.7 16.7 12.8 11.0 10.7 8.0 7.0 15.9 12.1 26.8 75.0 6.7 7.7 14.9 2.0 16.7 8.5 310.1 10.8 14.9 26.6 2.8 7.2 13.4 13.4 2.0 5.4 17.4 22.3 11.7 8.5 14.1 35.0 14.0 5.3 8.4 13.1 11.6 8.6 98.7 15.5 8.7 10.5 67.3 5.9 9.3 19.8 5.8 ANGPTL2 "ARP2, HARP" ENSG00000136859 "Angiopoietin like 2" Q9UKU9 9 127087348-127122635 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 47.4;Endothelial cells: 34.6;Fibroblasts: 99.7;Oligodendrocyte precursor cells: 35.2;Skeletal myocytes: 39.3;Smooth muscle cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 140.4;ASC TERT1: 94.9;BJ hTERT+: 205.9;HSkMC: 98.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040933, HPA041299" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 2510000 2200000 "Golgi apparatus" "HPA040933: AB_10795530, HPA041299: AB_10794552" "unprognostic (5.46e-2)" "unprognostic (4.96e-3)" "unprognostic (1.11e-2)" "unprognostic (2.07e-2)" "unprognostic (8.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.79e-2)" "unprognostic (2.04e-2)" "unprognostic (3.31e-1)" "unprognostic (1.17e-3)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (4.15e-2)" 107.5 11.6 7.2 33.8 11.9 0.2 71.8 15.5 8.4 54.1 11.1 58.2 15.3 73.5 13.8 21.9 31.7 67.6 69.9 6.7 9.2 8.3 14.9 22.7 8.2 12.4 12.7 4.7 44.6 5.6 4.1 3.4 21.6 12.7 24.9 18.1 0.9 18.2 27.4 58.1 24.9 28.0 64.0 10.5 49.6 29.1 4.4 12.5 4.8 15.8 36.9 9.0 59.9 49.6 15.2 0.0 0.0 17.4 0.0 140.4 94.9 9.4 8.1 205.9 9.2 8.5 0.0 0.0 0.0 7.0 21.4 1.8 0.1 1.7 0.0 4.8 0.1 0.0 0.0 0.1 0.5 30.3 0.1 0.0 98.2 0.0 20.0 0.0 28.7 27.6 2.3 0.0 0.1 6.3 0.0 0.2 4.3 18.4 0.0 1.0 16.5 27.3 1.6 2.2 0.0 9.3 10.1 0.0 0.0 0.0 3.3 0.0 0.0 8.8 35.5 4.5 50.4 0.0 0.0 0.1 0.0 37.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 11.9 15.5 8.4 6.7 9.2 12.4 12.7 4.7 12.7 10.5 12.5 15.2 47.4 9.6 2.4 1.0 0.1 14.3 7.0 0.2 3.4 14.4 0.6 6.6 16.6 0.0 0.1 0.0 2.1 1.0 0.5 0.1 0.0 0.2 1.6 1.4 20.2 34.6 0.0 0.0 0.6 0.0 0.8 99.7 1.1 1.0 0.0 2.9 5.0 0.0 1.4 0.0 1.5 0.0 0.0 0.0 17.4 1.5 20.8 0.8 7.2 1.9 0.0 1.9 0.0 35.2 19.2 1.2 0.0 6.4 0.0 1.7 0.0 2.4 1.6 0.8 0.0 39.3 43.5 1.0 0.0 1.4 11.1 2.6 1.7 1.1 0.0 0.6 CDK5RAP2 "C48, CEP215, FLJ10867, MCPH3" ENSG00000136861 "CDK5 regulatory subunit associated protein 2" Q96SN8 9 120388869-120580170 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035820, HPA035821, HPA046529, CAB079753" Approved Enhanced "Cell Junctions,Centrosome" NA NA Centrosome "Cell Junctions" "CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688" "unprognostic (7.72e-2)" "unprognostic (2.04e-2)" "unprognostic (2.84e-2)" "unprognostic (4.48e-2)" "unprognostic (6.63e-2)" "unprognostic (6.88e-2)" "unprognostic (6.70e-3)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (7.36e-2)" "unprognostic (2.26e-2)" "unprognostic (1.88e-1)" "unprognostic (4.94e-2)" "unprognostic (2.36e-1)" "unprognostic (3.33e-2)" "unprognostic (7.41e-2)" 10.2 11.8 12.0 9.9 16.7 24.6 14.6 14.1 12.9 14.3 19.2 13.1 5.6 11.6 7.8 12.3 12.0 9.3 17.2 11.9 13.7 7.6 15.8 10.7 15.2 15.4 16.0 9.9 17.2 9.6 13.4 12.3 8.7 16.1 13.8 8.7 13.0 22.4 10.6 48.3 15.9 11.1 10.5 13.9 11.6 13.1 21.0 14.4 21.1 11.7 29.9 14.8 12.6 11.2 16.8 19.6 33.8 45.9 27.8 19.3 28.4 24.6 24.6 18.9 27.3 25.4 26.8 25.1 36.3 11.1 24.3 18.7 42.1 36.5 28.3 26.1 29.3 14.7 31.0 62.1 47.7 18.1 38.5 19.9 51.4 18.5 24.3 31.8 20.6 24.1 43.0 29.2 30.6 36.4 44.2 41.8 24.7 42.6 41.5 25.3 40.3 54.5 17.1 19.5 15.4 29.9 34.3 42.9 23.3 28.8 19.7 54.6 26.3 16.1 23.6 25.7 28.0 28.4 22.2 33.4 39.7 24.6 24.4 50.8 15.7 1.7 3.0 3.4 1.7 3.3 5.0 3.2 3.2 1.0 5.8 2.6 2.7 2.4 4.0 4.7 2.2 2.9 1.8 12.0 16.7 14.1 12.9 11.9 13.7 15.4 16.0 9.9 16.1 13.9 14.4 16.8 11.6 28.9 39.5 64.9 21.2 7.0 13.5 11.9 13.1 23.7 18.0 17.5 53.8 15.7 19.3 1.8 16.7 13.2 25.8 12.3 7.9 12.6 37.5 24.8 18.1 13.7 8.4 35.3 43.2 14.3 12.7 20.4 10.7 23.7 17.1 41.4 8.6 22.2 10.8 18.5 38.4 12.1 18.3 9.4 8.6 30.6 22.1 25.8 12.4 26.2 13.2 20.4 24.7 66.9 148.7 11.8 8.1 23.3 27.7 9.5 5.6 4.6 35.0 28.9 32.9 43.6 22.3 58.4 36.4 17.8 6.8 7.3 23.1 23.0 11.6 7.7 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038377-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 15.5;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 2.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA049112: AB_2680637" "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favorable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 1.5 1.7 2.3 1.3 3.0 0.2 2.8 4.5 2.6 2.6 0.7 1.3 0.8 4.5 1.8 1.2 2.5 1.4 1.5 2.0 2.7 2.3 0.6 1.3 1.2 2.5 2.4 2.2 7.2 1.3 2.9 3.8 1.3 2.6 2.5 1.1 6.3 0.9 1.9 1.4 1.3 1.1 2.5 2.3 2.1 1.2 2.2 2.8 1.2 2.9 2.0 1.3 1.8 1.6 4.2 0.6 1.7 7.2 6.0 3.9 7.5 3.7 2.3 3.4 2.5 2.1 0.0 1.7 4.2 1.8 2.4 3.3 1.5 0.0 0.9 3.9 5.2 0.8 0.2 3.5 1.9 2.1 0.0 0.8 2.1 0.7 3.0 5.8 6.1 1.4 0.0 0.4 3.6 5.2 0.0 0.0 0.0 7.4 4.4 0.0 0.0 10.0 0.6 1.9 0.0 6.1 5.8 7.1 1.5 1.4 3.5 6.0 0.0 0.6 5.8 2.5 6.9 3.5 1.4 2.9 0.0 4.5 0.1 3.6 0.1 0.0 0.0 0.9 0.2 0.7 0.9 0.8 0.9 0.3 0.4 0.6 0.9 0.1 0.7 0.0 0.0 2.4 0.3 2.3 3.0 4.5 2.6 2.0 2.7 2.5 2.4 2.2 2.6 2.3 2.8 4.2 3.4 0.0 0.5 5.5 2.1 0.3 0.9 1.3 2.2 10.3 1.4 2.8 8.0 0.0 0.5 0.0 6.2 0.8 1.6 0.1 3.9 1.6 1.0 0.6 4.9 3.2 1.2 0.0 9.2 0.9 1.6 3.8 2.6 0.6 5.7 2.5 2.5 1.3 0.5 6.7 15.5 0.6 4.1 0.3 0.3 0.2 2.1 0.8 0.0 3.7 0.5 3.4 3.1 23.6 29.7 0.4 1.3 2.2 1.1 0.5 0.1 3.1 0.4 6.0 6.6 6.4 4.2 5.6 3.2 2.7 0.0 0.1 1.3 2.6 0.3 0.4 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150976-113164140 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "parathyroid gland: 576.6;salivary gland: 412.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 12 "classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3" "Group enriched" "Detected in all" 47 "dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3" "Cell line enhanced" "Detected in many" "ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" NA NA "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 48.7 16.9 57.5 18.6 77.7 20.3 24.7 76.1 78.5 7.3 45.1 11.0 10.9 4.4 16.8 9.3 7.0 8.7 8.7 54.5 67.8 28.0 33.7 27.6 16.2 80.0 76.2 49.6 5.1 19.4 576.6 2.6 23.8 76.5 4.4 12.2 0.8 412.6 43.0 16.8 47.2 17.3 10.9 79.1 33.0 11.9 13.9 72.0 12.2 6.3 14.7 17.7 13.4 10.8 118.2 7.8 3.1 1.3 1.7 54.4 22.3 6.5 4.0 13.9 12.8 12.3 2.4 1.5 0.3 0.5 9.1 7.9 37.7 5.1 31.0 12.0 2.2 1.3 0.1 1.2 3.3 20.7 1.9 0.8 25.3 85.0 30.0 57.7 1.8 6.9 3.0 1.4 2.6 68.9 6.5 1.6 0.7 0.4 1.8 2.6 0.2 39.3 0.0 4.5 4.2 0.9 2.5 6.9 36.4 1.4 0.8 8.6 2.5 2.4 2.0 1.9 13.7 3.2 2.1 5.0 0.1 12.5 3.2 2.0 5.1 226.0 24.0 4.3 331.9 6.5 1.2 4.9 5.2 134.6 1.0 3.8 3.9 355.8 1.0 423.3 2.1 3.0 104.9 57.5 77.7 76.1 78.5 54.5 67.8 80.0 76.2 49.6 76.5 79.1 72.0 118.2 13.8 9.6 9.2 2.3 7.0 37.1 6.4 37.7 13.6 7.0 15.3 10.8 0.6 4.3 10.9 1.8 35.5 96.4 3.6 12.8 3.9 13.5 4.1 23.5 4.9 6.4 3.5 0.4 2.1 7.7 9.0 14.4 3.6 8.4 0.0 2.7 12.8 18.1 57.2 6.7 1.8 4.5 10.2 145.6 65.6 4.6 15.8 101.3 0.0 4.7 84.1 6.9 3.1 0.5 113.7 18.5 11.0 9.4 9.1 10.2 51.3 18.2 14.8 9.1 19.7 8.7 7.8 31.0 5.2 3.3 38.4 43.1 7.9 4.6 5.7 7.6 SLC31A1 "COPT1, CTR1, hCTR1" ENSG00000136868 "Solute carrier family 31 member 1" O15431 9 113221544-113264492 "Metabolic proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 108.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 20.9;intermediate monocyte: 26.8;myeloid DC: 16.3;neutrophil: 8.2;non-classical monocyte: 31.0" "Group enriched" "Detected in all" 4 "dendritic cells: 16.3;granulocytes: 8.2;monocytes: 31.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013810 Approved NA NA "HPA013810: AB_1857095" "unprognostic (1.22e-2)" "unprognostic (1.74e-1)" "unprognostic (4.29e-2)" "unprognostic (5.48e-3)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" "unprognostic (7.58e-2)" "unprognostic (2.30e-1)" "unprognostic (2.51e-1)" "unprognostic (7.18e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (1.22e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.51e-2)" 11.6 24.2 5.8 11.2 6.0 11.8 12.9 6.5 6.5 20.8 22.1 16.5 45.5 7.2 13.8 12.1 6.6 9.7 7.5 6.9 7.4 28.9 108.5 17.9 6.4 6.9 7.1 4.9 5.0 19.3 15.4 5.9 13.6 9.4 21.4 17.2 7.2 67.1 12.9 3.6 18.5 37.7 10.1 6.5 7.7 19.6 6.4 6.9 5.5 11.0 5.9 12.5 14.4 6.6 6.9 22.1 23.4 18.7 41.4 42.0 29.8 68.8 38.3 58.0 26.0 30.1 33.5 18.8 17.2 15.2 33.0 32.9 53.3 35.8 21.8 29.0 15.2 19.9 14.2 18.7 37.6 102.3 26.1 20.6 36.1 48.3 33.6 54.6 17.4 24.0 19.6 32.8 30.9 24.8 23.6 17.9 13.2 30.4 84.2 26.0 18.3 49.1 17.2 23.6 27.2 17.7 23.1 37.0 73.0 101.5 26.2 37.2 22.0 22.3 19.3 11.9 39.1 23.2 18.5 40.5 23.6 31.9 24.2 23.1 3.0 20.9 2.5 2.3 26.8 3.2 1.7 1.6 2.4 16.3 1.5 1.8 1.7 8.2 4.4 31.0 2.3 1.8 7.6 5.8 6.0 6.5 6.5 6.9 7.4 6.9 7.1 4.9 9.4 6.5 6.9 6.9 8.0 35.3 33.5 7.5 6.6 15.2 10.6 27.4 10.2 12.6 21.4 14.9 7.4 21.5 50.8 5.5 33.3 16.5 6.9 40.2 9.8 18.3 0.3 16.2 15.6 11.6 9.0 25.4 16.8 27.2 24.1 16.0 15.3 14.5 5.1 11.4 11.4 97.1 43.4 6.7 17.0 18.9 42.7 39.4 19.9 0.9 6.2 40.3 12.4 20.6 21.8 12.2 4.1 16.1 12.3 22.3 11.1 7.2 16.1 28.9 61.7 24.7 30.1 11.2 6.6 8.4 15.2 24.4 30.7 15.1 15.8 22.4 5.5 15.2 19.9 22.6 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724735 "CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 86.8" "Group enriched" "Detected in many" 33 "dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6" "Cell line enhanced" "Detected in many" "Karpas-707: 60.0;TIME: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: AB_2680662" "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favorable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 31.4 11.1 13.1 26.0 14.3 22.4 12.1 12.5 10.4 6.6 4.8 6.8 4.3 5.6 1.2 4.8 4.9 10.9 8.4 10.9 15.7 6.9 16.8 16.4 13.2 15.2 13.3 6.3 6.1 2.7 2.5 2.1 24.1 14.7 4.7 7.4 2.9 6.1 3.2 3.2 3.4 5.8 10.9 15.0 32.8 4.4 1.5 11.4 3.6 5.6 12.1 7.8 13.4 2.8 11.1 0.0 0.0 25.5 0.0 11.1 23.0 0.1 10.2 17.9 2.5 1.5 0.0 2.6 3.6 0.5 26.7 7.5 0.1 0.0 2.2 3.7 0.0 0.0 5.7 5.1 0.4 8.1 19.1 0.1 14.2 0.0 5.4 0.7 22.5 31.4 0.0 0.0 60.0 29.2 0.0 0.0 2.9 3.1 2.4 1.2 0.0 28.0 19.8 0.9 28.9 0.0 0.1 6.4 0.0 1.0 2.2 0.0 10.4 43.5 1.4 18.4 0.1 4.8 0.0 0.0 0.0 0.9 19.1 15.2 64.0 64.9 21.5 0.1 57.5 0.0 1.7 0.1 0.0 22.4 0.5 0.0 0.0 86.8 0.1 65.6 0.9 0.0 25.5 13.1 14.3 12.5 10.4 10.9 15.7 15.2 13.3 6.3 14.7 15.0 11.4 11.1 38.6 0.0 5.0 50.9 2.3 0.8 0.3 0.1 0.6 0.2 3.5 1.0 2.9 2.8 2.9 0.0 0.0 0.3 0.1 1.6 0.0 0.1 0.1 3.5 29.2 31.6 0.0 1.3 0.2 0.2 0.2 11.5 1.5 6.8 15.8 1.2 62.8 1.9 38.2 0.0 0.2 2.0 0.0 106.0 8.6 0.4 0.0 64.5 1.8 26.2 54.0 8.8 2.1 7.5 0.3 0.5 6.1 0.0 0.1 0.1 0.0 0.4 3.7 1.3 6.6 5.5 4.5 0.1 0.3 0.3 0.0 0.8 0.9 3.1 1.2 3.3 ZNF189 ENSG00000136870 "Zinc finger protein 189" O75820 9 101398873-101410660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 86.7" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034814 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA034814: AB_10601030" "unprognostic (3.87e-2)" "unprognostic (3.47e-1)" "unprognostic (5.30e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.26e-2)" "unprognostic (3.59e-3)" "unprognostic (1.70e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "prognostic favorable (5.32e-4)" "unprognostic (3.31e-1)" "unprognostic (4.58e-1)" "unprognostic (1.86e-2)" "unprognostic (6.57e-2)" 24.4 21.8 17.8 9.5 23.5 4.0 16.4 20.4 26.3 12.6 15.7 10.1 12.4 13.9 86.7 7.5 10.6 23.5 14.8 27.6 17.7 14.8 18.7 9.6 10.8 18.8 18.4 18.6 16.1 31.6 14.4 19.9 8.9 19.0 14.1 10.3 12.8 9.9 11.7 16.6 6.0 12.4 13.4 20.2 12.8 12.8 13.9 19.2 11.3 13.4 16.9 15.3 8.5 7.0 29.2 7.4 6.0 19.1 14.0 16.7 11.6 9.1 10.3 15.8 11.9 10.2 12.7 5.7 9.9 6.8 12.5 12.4 14.1 9.6 9.8 10.5 13.1 6.6 10.8 9.6 27.3 12.4 11.5 9.1 14.2 13.3 10.6 16.3 16.3 15.0 11.9 13.0 13.9 17.7 4.1 13.8 4.9 13.8 16.2 6.7 9.7 27.3 7.6 11.4 8.4 19.7 12.4 11.2 7.6 11.4 12.5 6.3 14.3 12.6 11.6 8.4 9.6 8.1 13.1 21.7 4.7 10.0 4.4 12.0 0.5 0.8 1.4 0.7 1.0 0.7 0.9 1.2 1.5 0.7 1.0 1.4 1.2 0.4 1.3 0.8 0.5 0.6 0.6 17.8 23.5 20.4 26.3 27.6 17.7 18.8 18.4 18.6 19.0 20.2 19.2 29.2 7.5 9.6 6.4 11.1 9.7 9.8 8.2 4.9 8.0 7.4 8.9 6.5 22.2 25.8 11.9 1.8 4.2 4.6 6.4 6.2 9.8 7.2 3.1 5.2 8.7 9.4 5.4 6.5 29.1 18.0 2.1 9.0 6.1 5.4 9.5 9.8 8.9 9.0 5.5 8.4 17.4 6.3 8.2 14.4 7.6 3.1 11.1 9.6 7.2 11.2 3.9 6.8 6.2 17.1 124.9 7.2 6.7 10.9 4.9 6.2 7.2 14.5 8.2 3.9 13.1 10.6 8.9 7.0 3.6 9.1 6.5 1.9 6.2 7.8 5.9 5.2 ALDOB ENSG00000136872 "Aldolase, fructose-bisphosphate B" P05062 9 101420560-101449664 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 27 "intestine: 5784.2;kidney: 7248.0;liver: 11251.9" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0" "Cancer enriched" "Detected in many" 31 "liver cancer: 1414.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA002198, CAB020827" Enhanced NA NA 560000000 "CAB020827: , HPA002198: AB_1078129" "unprognostic (6.58e-3)" "unprognostic (2.83e-1)" "unprognostic (1.43e-3)" "unprognostic (1.03e-1)" "unprognostic (8.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.44e-3)" "unprognostic (4.34e-2)" "unprognostic (4.57e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (7.48e-2)" "unprognostic (1.66e-2)" "unprognostic (2.02e-1)" "unprognostic (2.58e-1)" "unprognostic (5.19e-2)" "unprognostic (1.96e-2)" 3.4 1.5 0.4 17.1 0.8 0.0 0.7 0.9 2.3 0.1 0.0 30.4 4110.7 2.9 1.0 0.7 0.4 178.6 1.0 2.3 0.1 7248.0 11251.9 0.5 4.9 0.1 0.1 0.4 0.5 295.1 0.0 5.7 0.4 0.4 2.1 5.6 0.3 0.3 0.0 0.4 0.4 5784.2 7.1 0.1 2.0 34.6 1.1 0.1 0.7 0.3 0.0 0.8 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.5 0.0 4.5 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 2.2 0.0 1.0 0.0 6.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.3 21.0 0.4 0.5 0.0 0.3 4.6 28.6 0.0 0.0 4.3 20.6 2.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 1.0 7.1 0.3 0.5 0.7 2.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.9 2.3 2.3 0.1 0.1 0.1 0.4 0.4 0.1 0.1 0.3 0.0 0.0 0.0 0.3 39.4 0.0 0.0 0.3 0.0 1.1 0.0 0.0 1.1 308.8 0.8 150.8 0.0 0.0 0.0 13.5 620.3 4.9 0.0 0.0 0.4 3.6 0.0 50.8 0.5 253.3 0.1 0.0 0.0 0.3 0.0 0.0 49.2 3225.4 0.2 3.3 0.2 464.9 0.0 66.2 0.0 0.0 0.0 38.1 0.0 0.0 3.6 0.3 0.0 0.0 0.3 182.1 997.4 0.0 0.1 0.0 20078.3 7956.0 0.2 0.6 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.3 20.6 0.2 412.7 0.0 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906654-99974534 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 9.4 9.5 7.9 9.4 8.8 11.4 12.4 12.7 8.8 9.6 9.6 9.6 9.0 10.9 10.9 12.1 8.0 8.6 8.2 8.0 7.1 9.8 18.5 9.4 9.3 7.7 7.8 7.8 11.0 12.2 11.1 7.7 10.8 8.3 12.5 9.9 11.0 12.9 11.4 16.8 17.7 9.5 10.6 6.9 10.6 11.0 7.9 7.8 11.5 13.4 13.1 10.3 7.8 9.9 11.2 12.9 12.4 11.2 13.0 14.0 13.2 22.3 9.7 13.1 10.1 8.4 14.1 15.8 25.2 9.2 9.5 17.7 14.1 9.6 13.6 7.1 21.3 7.7 16.0 16.3 8.3 15.9 22.5 5.3 12.2 15.9 10.9 15.7 11.7 12.0 21.9 22.4 12.5 8.2 15.4 14.5 8.4 10.0 15.3 8.8 10.8 20.3 10.5 13.7 15.5 6.2 11.9 19.1 13.3 10.2 7.0 13.8 6.9 9.1 6.5 9.9 11.1 8.3 18.5 24.4 4.8 9.2 9.5 6.9 18.6 3.6 7.3 6.4 3.9 9.1 6.3 7.7 7.2 4.6 5.1 8.8 8.4 4.0 14.5 8.2 2.8 4.6 4.6 7.9 8.8 12.7 8.8 8.0 7.1 7.7 7.8 7.8 8.3 6.9 7.8 11.2 25.1 16.0 32.6 35.6 26.2 10.6 19.2 13.9 34.7 14.9 20.1 20.6 19.1 14.3 19.4 23.9 20.9 24.7 21.5 10.7 29.4 19.0 67.2 13.5 21.6 18.7 25.2 26.9 41.9 19.4 19.5 18.0 28.1 15.6 26.0 24.0 18.5 25.0 10.4 10.1 40.5 15.7 20.3 12.7 10.6 36.7 25.7 17.1 8.8 45.0 24.8 21.8 24.7 48.7 47.4 15.7 18.1 18.0 24.4 30.9 17.8 21.1 19.6 13.5 39.5 19.6 20.2 33.6 18.1 27.3 12.1 27.4 26.6 27.0 16.2 18.3 PRPF4 "HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60" ENSG00000136875 "Pre-mRNA processing factor 4" O43172 9 113275642-113294009 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021794, HPA022248" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA021794: AB_1855772, HPA022248: AB_1855773" "unprognostic (1.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.69e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (9.35e-4)" "unprognostic (1.95e-2)" "unprognostic (6.57e-2)" "unprognostic (3.14e-2)" "unprognostic (5.00e-2)" "unprognostic (6.76e-3)" "unprognostic (2.18e-3)" "unprognostic (4.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.42e-1)" "unprognostic (1.57e-2)" 11.4 14.8 9.5 15.3 10.1 15.3 13.5 10.9 11.0 11.2 9.2 10.8 10.0 13.7 19.6 15.0 12.4 10.4 10.0 9.8 12.0 15.6 16.3 9.5 15.7 9.6 9.7 10.0 15.0 14.6 25.6 12.3 12.6 10.1 13.5 12.4 13.2 11.3 11.2 18.2 14.7 9.9 13.3 9.5 11.7 10.3 11.7 9.6 17.1 10.3 15.3 17.7 16.9 11.4 10.2 36.6 61.3 40.3 44.4 27.8 28.6 40.4 56.1 28.1 60.2 44.2 60.4 33.4 76.5 32.5 30.3 62.2 81.8 84.9 48.8 66.2 54.2 32.1 39.1 50.4 43.7 25.2 68.0 34.2 20.7 32.7 63.1 59.9 22.6 28.9 41.8 67.5 40.9 51.2 57.3 65.1 47.9 63.9 94.2 66.5 59.4 95.9 51.4 26.0 28.9 52.7 35.5 82.9 44.0 26.0 32.0 68.3 35.0 29.8 49.1 37.3 63.0 72.4 52.1 153.1 73.3 37.6 42.9 63.8 27.4 16.2 16.1 14.7 19.4 17.1 17.1 14.4 13.3 20.4 17.4 14.5 14.6 5.2 18.4 24.6 13.4 14.6 14.8 9.5 10.1 10.9 11.0 9.8 12.0 9.6 9.7 10.0 10.1 9.5 9.6 10.2 15.7 9.6 18.4 6.8 23.7 15.7 17.6 10.4 18.8 22.9 12.7 14.6 12.9 12.8 15.2 18.4 18.8 27.7 26.6 5.8 25.4 18.6 17.2 17.5 24.7 12.6 17.5 20.0 8.6 16.9 34.5 16.4 10.2 21.9 19.0 21.5 6.4 9.9 18.4 28.6 8.3 13.0 10.2 13.5 17.8 13.0 11.5 20.5 5.4 2.8 27.3 22.7 18.6 4.0 5.7 15.5 9.6 10.9 15.7 20.6 8.1 16.9 14.3 24.1 0.0 16.9 17.5 28.6 21.0 21.4 18.8 21.5 20.0 24.7 14.0 16.9 FPGS ENSG00000136877 "Folylpolyglutamate synthase" Q05932 9 127794597-127814327 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050488 Approved "Intracellular and membrane" NA NA "HPA050488: AB_2681143" "unprognostic (6.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-1)" "prognostic favorable (9.08e-4)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (6.25e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (6.97e-2)" "unprognostic (1.76e-1)" "unprognostic (8.54e-3)" "unprognostic (2.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.55e-2)" 37.2 49.5 8.7 15.7 9.4 19.9 32.9 9.5 9.4 24.1 9.3 19.5 10.6 29.9 8.5 22.3 35.8 9.2 30.7 8.4 10.3 24.9 66.6 30.9 17.9 10.6 9.7 7.7 55.8 28.2 10.3 18.2 7.8 10.5 26.9 6.9 2.2 20.5 11.7 48.6 14.9 23.0 9.4 10.1 30.2 26.0 13.0 9.3 13.5 22.3 19.1 13.4 25.8 18.3 10.4 36.2 24.4 14.2 29.7 21.2 23.1 42.6 28.0 33.0 34.4 28.0 26.4 56.7 44.4 35.8 38.9 24.4 67.0 17.7 39.4 11.4 48.5 22.6 34.5 30.4 32.1 50.5 64.2 28.1 32.2 21.2 34.7 43.8 29.4 43.3 41.6 39.8 27.7 36.2 45.8 56.6 47.8 39.9 39.2 74.0 116.0 23.0 77.7 52.2 29.3 20.5 35.0 80.1 38.6 5.8 5.7 23.7 26.8 65.4 18.6 26.0 54.1 56.8 31.0 14.2 36.0 40.7 29.4 26.7 0.2 15.4 2.3 38.8 23.9 35.1 23.2 22.9 34.0 30.8 27.6 18.5 25.2 0.8 43.6 23.9 38.9 26.6 22.4 8.7 9.4 9.5 9.4 8.4 10.3 10.6 9.7 7.7 10.5 10.1 9.3 10.4 11.3 22.4 28.1 8.8 28.6 10.5 23.7 31.1 8.6 5.5 15.7 13.3 19.5 34.3 21.6 9.2 14.6 15.5 21.8 11.6 11.7 49.6 5.0 18.0 19.9 18.7 22.9 26.7 5.8 52.9 22.0 18.0 31.6 23.9 31.0 14.6 19.2 73.2 29.8 5.0 6.4 13.8 16.2 19.5 18.4 2.2 19.0 18.9 8.8 4.7 46.2 6.5 22.6 6.0 6.2 66.9 9.9 7.2 32.7 30.8 22.1 20.1 11.2 8.5 13.1 21.9 15.2 6.0 16.0 19.9 8.8 14.8 22.2 14.5 24.2 36.5 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881828 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (2.48e-4)" "prognostic favorable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favorable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favorable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.4 12.1 7.2 13.7 7.3 22.8 8.4 4.2 8.2 12.0 2.4 11.7 8.3 12.6 4.3 8.0 12.2 7.8 7.6 6.9 8.5 7.6 7.5 8.5 18.4 9.7 8.3 7.5 13.7 11.0 8.5 18.5 6.8 7.9 15.0 4.9 6.8 11.5 13.3 11.0 11.9 12.6 8.3 4.2 14.0 10.0 10.1 7.8 32.6 18.9 7.6 11.9 15.0 10.2 8.2 6.0 5.8 10.0 13.4 12.8 10.8 14.1 9.5 7.9 7.1 4.9 4.7 6.5 8.1 8.0 9.3 8.0 14.7 6.0 6.7 2.9 43.4 7.9 14.9 17.0 3.3 8.8 14.2 10.6 9.6 9.8 9.3 7.0 12.4 7.7 95.9 60.2 9.9 4.4 15.9 56.4 33.6 7.9 12.7 13.6 9.4 11.2 14.0 5.5 6.5 2.2 11.0 11.0 13.9 9.1 5.9 14.4 19.9 11.5 7.8 3.5 10.5 6.3 9.7 15.3 5.7 15.5 18.6 7.4 1.0 1.9 5.4 8.6 1.5 9.1 3.7 8.7 8.3 2.6 3.4 9.8 8.9 2.8 10.0 1.5 2.1 11.5 6.3 7.2 7.3 4.2 8.2 6.9 8.5 9.7 8.3 7.5 7.9 4.2 7.8 8.2 3.0 9.6 6.9 16.3 9.2 2.8 2.2 2.5 4.0 7.8 6.4 8.0 7.7 4.3 3.0 1.8 4.2 5.9 9.4 6.2 3.9 2.4 2.1 4.1 6.3 4.3 8.4 12.8 17.0 4.0 2.5 4.6 8.2 5.7 1.3 6.8 6.4 6.1 3.3 10.1 21.1 4.6 4.1 1.6 3.8 3.3 6.2 6.0 3.6 11.2 3.1 5.3 11.3 9.5 14.3 2.7 5.0 4.9 6.7 3.0 4.1 2.9 5.0 6.3 0.0 4.3 5.7 12.1 6.0 4.8 2.0 6.2 19.3 2.9 5.2 1.6 BAAT BAT ENSG00000136881 "Bile acid-CoA:amino acid N-acyltransferase" Q14032 9 101354182-101385400 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Serine esterase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "liver: 727.0" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 996.7" "Cancer enriched" "Detected in many" 42 "liver cancer: 181.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.4;CACO-2: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021251, HPA021330" Enhanced Uncertain Vesicles NA NA 520000 Vesicles "HPA021251: AB_1845247, HPA021330: AB_2670674" "unprognostic (2.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.97e-2)" "unprognostic (9.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.68e-2)" "prognostic favorable (4.97e-4)" "unprognostic (2.14e-2)" "unprognostic (6.19e-2)" "unprognostic (4.43e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.24e-7)" "unprognostic (1.74e-1)" "unprognostic (2.12e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 0.1 0.0 0.3 0.0 0.5 1.2 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.6 0.1 0.5 0.3 0.3 727.0 0.4 0.0 0.4 0.4 0.3 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 3.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.4 0.8 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.0 0.5 0.3 0.4 0.4 0.3 0.5 0.0 0.3 0.7 0.3 0.0 0.0 0.7 2.4 0.0 0.1 0.0 0.0 1.1 0.3 0.1 0.7 91.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.1 0.7 0.0 16.0 9.7 0.2 0.0 0.1 0.0 0.1 0.0 0.0 12.1 996.7 0.0 0.0 7.2 0.0 0.0 18.2 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.0 3.0 0.9 1.8 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.5 0.1 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.4 0.0 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 131.3;pancreas: 86.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020192, HPA024127" Uncertain Uncertain "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.1 0.0 2.1 1.1 1.7 0.0 25.5 0.3 3.6 6.4 2.2 5.0 25.7 4.2 1.1 0.2 8.1 24.9 0.2 2.0 0.7 131.3 27.9 1.6 0.5 0.6 1.0 2.0 0.7 86.1 0.8 0.6 1.1 0.8 7.1 4.3 0.1 3.7 4.9 0.0 1.3 16.2 0.4 0.1 0.2 11.1 2.4 0.9 1.3 32.1 0.0 0.1 0.2 0.3 1.5 0.0 4.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.6 0.2 0.0 5.2 0.0 0.6 0.0 0.2 0.1 0.2 0.0 0.9 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.0 0.0 0.4 0.1 17.2 0.6 0.0 0.0 0.1 44.8 0.2 6.6 0.1 0.0 0.9 0.0 0.2 4.5 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.7 0.3 3.6 2.0 0.7 0.6 1.0 2.0 0.8 0.1 0.9 1.5 0.1 0.0 4.4 0.0 1.3 0.0 0.9 0.6 0.0 0.0 20.3 10.8 0.4 105.8 0.0 90.1 0.0 0.1 0.0 7.9 80.3 43.3 7.0 8.3 1.5 0.3 64.1 0.0 0.7 11.8 9.3 0.4 14.8 15.6 0.0 0.0 0.0 10.2 0.3 0.0 0.3 22.0 0.0 0.3 0.0 14.7 0.6 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.1 5.7 21.3 0.0 0.0 2.2 60.3 79.1 0.0 0.0 0.0 0.0 0.3 3.2 7.9 0.0 0.0 0.5 0.9 0.3 28.9 0.5 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587706-114598915 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli NA NA 96000 Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: AB_2678217" "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favorable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 78.8 141.4 78.9 81.2 78.6 132.5 109.5 81.5 101.9 81.5 91.7 70.4 60.0 93.1 178.9 133.6 71.9 65.2 92.3 79.4 84.5 136.9 127.0 85.6 116.4 82.6 85.7 77.6 107.1 73.1 174.4 136.1 92.0 84.9 133.8 66.1 92.0 112.8 55.6 125.1 94.1 69.7 61.1 79.0 94.7 122.1 76.1 82.0 105.1 100.1 114.0 101.6 107.8 94.8 88.0 83.6 71.0 153.2 38.8 111.0 84.5 148.3 125.2 86.6 88.5 63.4 92.3 94.8 74.2 106.8 80.0 183.2 179.0 105.6 84.6 79.3 63.2 73.8 72.3 84.4 143.4 156.8 173.1 135.1 105.2 227.9 72.7 87.3 104.1 91.0 123.1 136.0 164.4 131.6 159.0 164.6 113.6 187.0 222.2 126.8 159.0 95.0 126.7 195.2 128.4 113.8 156.3 159.7 284.0 487.6 143.9 235.0 202.5 118.9 80.1 68.9 132.3 142.0 213.6 474.5 139.6 106.8 97.2 112.0 490.1 327.8 495.0 212.6 331.2 264.9 549.6 288.8 255.8 255.0 501.7 374.7 305.5 405.4 255.4 348.4 401.5 398.9 756.7 78.9 78.6 81.5 101.9 79.4 84.5 82.6 85.7 77.6 84.9 79.0 82.0 88.0 230.6 160.3 176.6 19.6 353.9 519.0 492.9 1068.9 277.7 170.5 470.4 494.1 151.6 163.0 629.7 331.1 41.7 346.1 268.2 198.5 970.5 374.1 85.7 381.6 223.8 227.7 360.7 157.6 35.0 263.6 336.5 247.0 231.4 594.9 267.4 156.8 219.2 337.1 548.1 164.9 37.4 346.8 1133.2 350.1 517.8 60.3 306.0 382.4 494.5 20.6 699.7 360.9 261.6 20.1 22.9 430.5 218.1 250.9 255.0 686.5 176.7 1021.5 426.3 158.6 236.7 155.6 393.0 400.6 326.7 361.4 576.7 757.4 304.0 280.3 201.6 852.2 TEX10 "bA208F1.2, FLJ20287, Ipi1" ENSG00000136891 "Testis expressed 10" Q9NXF1 9 100302077-100352942 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045434 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045434: AB_10965650" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" "unprognostic (1.21e-1)" "unprognostic (8.28e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (2.43e-2)" "unprognostic (3.74e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-1)" "unprognostic (7.39e-2)" "unprognostic (3.27e-1)" "unprognostic (2.66e-3)" "unprognostic (9.63e-3)" 8.4 7.1 3.9 8.7 4.5 12.3 10.0 7.4 5.3 9.5 5.3 6.8 5.3 11.3 8.2 9.2 10.3 8.7 6.5 4.3 5.7 6.4 7.0 6.4 14.4 4.1 4.4 4.1 11.5 5.8 8.2 5.4 19.0 4.3 7.6 6.9 5.6 7.0 7.5 16.1 12.1 6.6 8.9 4.2 8.0 6.5 22.5 5.0 22.5 8.5 11.7 13.7 10.9 8.8 5.7 26.5 28.5 36.6 41.3 13.2 23.1 56.6 32.7 33.7 41.8 38.7 29.5 30.4 74.6 17.2 21.4 38.3 35.2 52.9 42.1 48.6 30.2 23.3 40.6 17.5 25.8 28.2 59.6 29.1 20.3 23.3 42.5 44.6 20.3 23.1 26.0 46.3 23.8 54.5 41.5 44.0 38.1 75.4 51.1 33.9 42.1 62.2 22.8 30.8 17.0 32.3 27.4 17.9 29.3 29.4 22.4 12.2 17.3 23.6 27.5 24.5 37.3 30.9 16.7 30.6 29.9 28.1 26.3 29.4 18.1 7.4 2.6 9.1 8.9 9.7 12.2 9.0 9.1 9.1 12.9 9.7 11.5 1.8 10.7 6.9 5.3 11.4 7.0 3.9 4.5 7.4 5.3 4.3 5.7 4.1 4.4 4.1 4.3 4.2 5.0 5.7 8.6 3.2 9.3 10.7 14.7 22.2 10.6 8.4 20.5 7.8 10.8 8.1 15.4 0.0 13.0 9.2 12.5 53.5 9.6 3.8 3.9 7.7 13.9 11.0 15.8 10.9 5.3 11.1 24.1 8.8 15.7 14.7 5.1 21.9 17.1 13.9 5.0 7.9 9.8 8.4 23.3 5.7 2.0 4.1 8.1 11.4 8.7 8.1 17.8 18.7 7.8 3.4 7.2 21.1 23.9 7.5 5.6 7.9 7.1 9.7 3.0 4.5 5.6 6.5 0.0 14.5 14.7 33.0 33.4 12.9 22.6 46.1 10.3 12.0 6.9 9.5 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 5.3;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: AB_2732270" "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 2.7 6.1 4.6 0.3 5.8 0.0 4.5 11.7 6.2 6.0 2.1 2.3 1.8 7.5 5.3 4.4 5.5 3.7 11.4 7.0 5.1 2.2 1.8 2.4 1.3 4.7 4.9 5.5 4.5 2.1 6.6 2.0 1.4 6.6 6.3 1.9 1.3 5.1 4.1 1.5 2.8 1.9 6.8 3.1 1.8 1.8 2.9 4.4 0.6 5.8 1.9 1.3 4.6 3.3 11.4 0.5 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.3 0.1 1.0 1.2 0.3 0.0 1.0 0.1 0.4 0.6 1.8 0.0 0.1 0.0 0.8 0.0 1.9 1.2 0.4 0.4 0.1 0.1 1.5 0.0 0.0 1.5 0.7 1.9 0.8 0.7 0.1 0.5 0.0 0.3 0.4 5.3 1.6 0.1 1.1 3.4 1.9 2.5 1.2 3.9 0.8 2.7 0.4 0.6 0.9 0.0 0.0 0.2 1.0 0.0 0.4 2.3 2.4 1.0 0.4 0.5 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 4.6 5.8 11.7 6.2 7.0 5.1 4.7 4.9 5.5 6.6 3.1 4.4 11.4 1.3 0.0 0.0 77.1 0.5 2.7 1.7 0.4 2.8 8.0 3.1 4.3 6.8 4.3 2.0 3.7 0.0 0.6 0.2 0.9 1.9 0.3 2.2 1.0 21.1 1.5 1.2 0.4 178.4 0.6 0.1 4.8 5.6 1.2 0.0 2.4 1.8 2.5 0.8 1.7 184.7 0.8 0.0 1.3 1.9 1.0 7.5 1.3 1.8 48.7 0.0 4.0 0.0 45.2 165.3 0.4 1.6 3.4 0.5 3.3 0.6 1.8 0.1 1.0 0.0 7.1 4.0 3.5 3.9 2.7 2.0 0.3 0.7 1.0 0.8 1.2 MRPL50 "FLJ20493, MRP-L50" ENSG00000136897 "Mitochondrial ribosomal protein L50" Q8N5N7 9 101387633-101398618 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 203.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022925 Approved Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA022925: AB_1854117" "unprognostic (6.17e-2)" "unprognostic (6.03e-2)" "unprognostic (4.65e-2)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "unprognostic (1.27e-2)" "unprognostic (5.75e-3)" "unprognostic (1.59e-1)" "unprognostic (1.55e-1)" "unprognostic (6.99e-2)" "unprognostic (1.19e-2)" "unprognostic (3.46e-2)" "prognostic favorable (1.21e-10)" "unprognostic (7.06e-2)" "unprognostic (2.39e-1)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" 9.7 16.1 11.0 8.3 11.9 4.1 11.9 16.4 13.6 7.9 10.2 8.2 8.7 7.8 12.8 7.1 8.1 7.3 14.7 11.3 11.7 13.4 14.1 7.2 11.1 10.6 11.9 10.6 12.0 12.0 13.2 9.0 8.3 11.6 9.9 8.7 19.1 8.5 8.1 11.0 5.8 8.3 7.2 10.9 9.5 10.2 6.6 11.3 8.6 9.2 15.1 11.7 10.4 5.7 12.1 12.6 14.9 23.3 13.6 16.0 17.0 16.5 16.0 15.2 17.3 14.6 20.4 12.3 30.6 10.1 12.5 21.3 28.4 23.0 19.2 18.6 18.6 13.7 15.0 16.4 59.0 17.2 27.5 13.9 14.0 21.9 14.0 25.5 13.0 15.9 15.9 32.1 16.1 17.8 20.7 17.0 20.3 25.6 73.9 20.2 17.1 33.1 19.2 25.8 13.7 22.4 16.6 17.0 16.9 18.5 15.9 11.9 17.0 13.2 11.8 17.6 20.7 15.4 12.0 38.0 12.8 15.0 16.0 16.9 9.8 12.5 9.9 13.9 15.2 16.8 20.6 19.3 16.0 16.3 19.5 22.4 20.3 2.2 14.7 15.9 13.0 23.1 16.8 11.0 11.9 16.4 13.6 11.3 11.7 10.6 11.9 10.6 11.6 10.9 11.3 12.1 33.0 16.0 20.8 11.4 46.4 90.5 133.6 203.4 51.2 19.1 31.0 31.9 76.0 35.8 86.9 57.0 12.5 74.8 29.3 15.3 152.6 66.8 10.4 31.4 33.6 41.0 19.8 30.1 12.5 69.4 73.8 46.9 23.4 25.7 44.5 24.0 32.2 43.9 51.9 5.0 15.1 28.0 162.8 25.9 50.6 7.4 34.2 28.3 30.2 5.6 32.1 21.9 27.8 8.0 17.2 66.8 32.7 40.6 39.4 112.8 26.4 186.5 67.4 18.2 46.0 37.6 52.4 44.7 39.3 41.6 99.3 76.5 43.2 63.1 34.3 130.4 DPM2 "MGC111193, MGC21559" ENSG00000136908 "Dolichyl-phosphate mannosyltransferase subunit 2, regulatory" O94777 9 127935099-127937854 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 202.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064623 Approved NA NA "HPA064623: AB_2685303" "unprognostic (8.30e-3)" "unprognostic (1.07e-2)" "unprognostic (9.84e-3)" "prognostic favorable (2.20e-4)" "unprognostic (3.67e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.91e-1)" "unprognostic (1.37e-1)" "unprognostic (6.62e-2)" "unprognostic (5.55e-3)" "unprognostic (1.35e-1)" "unprognostic (1.51e-2)" "unprognostic (5.71e-3)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" 21.6 20.8 50.7 19.5 49.7 39.9 27.7 46.9 67.3 31.7 45.7 27.9 24.2 18.1 38.4 25.7 43.4 19.8 16.1 52.4 48.1 22.2 29.9 29.5 24.2 49.5 51.3 48.3 20.8 59.1 53.9 12.3 27.2 49.7 24.7 25.9 13.4 50.6 27.1 8.3 29.8 20.3 28.6 46.5 18.7 40.2 15.5 49.9 26.8 38.6 12.1 29.5 25.2 9.7 48.8 49.5 85.5 42.1 57.2 75.1 59.4 40.6 61.3 55.7 63.9 44.2 58.1 79.7 38.8 38.0 90.1 91.8 85.4 47.3 88.1 31.2 71.7 74.5 46.4 98.5 66.1 88.8 75.4 51.1 57.5 78.0 93.5 101.2 44.9 65.8 67.2 106.2 84.9 76.7 161.8 55.8 78.0 79.1 169.7 79.4 43.0 54.6 212.7 79.1 28.8 39.3 95.8 63.8 75.4 53.0 27.3 95.1 48.2 43.5 56.1 43.4 72.0 64.5 93.3 134.4 32.5 113.1 52.8 76.6 52.3 67.8 57.6 86.6 75.7 72.8 99.3 62.1 75.9 77.3 94.3 47.8 61.6 28.1 77.5 73.0 88.5 55.2 60.9 50.7 49.7 46.9 67.3 52.4 48.1 49.5 51.3 48.3 49.7 46.5 49.9 48.8 29.9 28.9 42.5 6.5 27.5 27.0 34.1 58.2 18.8 25.3 52.4 57.7 12.4 38.6 42.8 40.5 16.7 86.9 25.1 40.6 45.0 61.2 9.6 28.3 39.9 33.1 32.4 202.7 9.7 59.4 105.8 38.6 44.9 33.5 29.2 31.1 33.9 33.2 83.7 38.7 9.2 53.6 42.7 25.0 22.1 11.6 26.4 30.0 32.0 7.5 49.8 35.0 39.1 6.0 10.0 58.7 36.2 20.3 62.0 64.5 44.5 47.3 24.9 22.1 6.6 16.6 32.5 19.1 22.5 36.8 34.5 65.0 28.5 41.2 43.8 40.7 WDR38 ENSG00000136918 "WD repeat domain 38" Q5JTN6 9 124853417-124857890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 78.4" "Cell type enhanced" "Detected in some" "Early spermatids: 26.9;Endometrial ciliated cells: 93.3;Late spermatids: 92.6;Respiratory ciliated cells: 127.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 12.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056607 Approved Vesicles NA NA Vesicles "HPA056607: AB_2683188" "unprognostic (5.66e-3)" "unprognostic (2.15e-3)" "unprognostic (1.51e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.14e-1)" "unprognostic (2.17e-3)" "unprognostic (4.29e-3)" "unprognostic (7.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.82e-1)" "unprognostic (1.38e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-5)" "unprognostic (1.01e-1)" "unprognostic (3.25e-2)" "unprognostic (6.36e-2)" "unprognostic (4.42e-2)" 0.0 0.0 5.3 0.0 2.5 0.0 0.0 3.9 1.3 1.3 13.6 0.0 0.0 0.7 0.0 0.0 78.4 0.0 0.1 1.9 6.5 0.1 0.0 5.2 0.0 6.9 7.6 0.8 0.0 0.0 0.0 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 7.9 0.0 0.0 7.6 3.6 0.1 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 2.5 3.9 1.3 1.9 6.5 6.9 7.6 0.8 6.1 7.9 3.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 26.9 93.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.0 92.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 127.9 0.0 0.0 0.0 2.8 1.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 TSTD2 "C9orf97, PP4189" ENSG00000136925 "Thiosulfate sulfurtransferase like domain containing 2" Q5T7W7 9 97600080-97633368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022537, HPA024241, HPA064304" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238" "unprognostic (7.24e-2)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-2)" "unprognostic (1.38e-1)" "unprognostic (7.07e-2)" "unprognostic (1.10e-1)" "unprognostic (1.23e-3)" "unprognostic (9.67e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.75e-4)" "unprognostic (2.21e-2)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 6.0 5.7 3.5 5.3 4.2 2.5 8.2 3.8 5.1 8.6 3.3 7.1 4.7 8.3 7.5 6.2 7.3 7.2 10.0 3.1 4.8 8.0 9.6 7.4 6.5 3.8 4.0 2.8 7.3 10.4 10.2 4.6 7.7 4.0 7.7 7.4 10.4 6.8 8.3 9.2 6.1 4.3 8.7 4.1 6.1 6.2 8.0 4.1 9.0 10.5 13.0 8.2 7.6 3.8 5.4 13.6 10.7 17.3 11.3 11.1 9.2 15.1 8.7 10.7 12.0 12.3 10.9 4.7 14.4 4.1 11.6 14.5 19.0 15.3 9.3 13.3 10.0 6.7 10.1 12.6 8.8 14.4 15.0 13.3 12.3 15.4 11.8 21.0 11.2 9.5 15.0 18.0 10.7 10.6 7.6 17.7 8.2 13.5 17.8 10.6 14.5 24.9 7.7 8.9 6.6 12.3 9.7 11.3 8.0 10.4 13.4 6.1 8.3 9.8 11.1 10.1 12.5 10.0 15.8 21.2 7.5 8.8 7.3 7.7 4.3 2.9 3.9 4.4 5.0 7.3 4.1 4.3 5.4 4.8 4.5 4.8 4.7 1.0 8.6 4.0 2.0 2.6 3.9 3.5 4.2 3.8 5.1 3.1 4.8 3.8 4.0 2.8 4.0 4.1 4.1 5.4 11.4 19.2 15.3 23.8 11.7 1.7 4.3 5.7 7.4 27.8 11.1 9.9 17.5 11.5 16.9 1.8 25.0 7.6 12.3 11.1 17.6 8.7 17.9 11.3 17.2 7.8 19.2 12.4 26.0 7.5 3.9 11.3 10.2 10.6 20.8 8.5 5.0 13.4 5.3 21.9 31.5 5.3 4.1 5.4 3.1 9.6 8.1 5.9 5.4 15.0 6.5 13.0 7.2 36.7 36.4 9.2 6.5 10.5 9.5 5.2 4.5 8.9 16.2 23.9 19.7 13.9 9.4 18.8 24.8 7.6 4.1 10.9 9.3 7.6 6.3 3.8 GABBR2 "GABABR2, GPR51, GPRC3B, HG20" ENSG00000136928 "Gamma-aminobutyric acid type B receptor subunit 2" O75899 9 98288109-98708935 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 90.5" "Group enriched" "Detected in some" 4 "Excitatory neurons: 386.5;Inhibitory neurons: 395.1" "Group enriched" "Detected in many" 10 "glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 14.6;fHDF/TERT166: 7.3;HUVEC TERT2: 29.5;U-138 MG: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013820, HPA031684, CAB079065" Enhanced Approved NA NA "CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993" "unprognostic (2.00e-1)" "unprognostic (7.56e-2)" "unprognostic (3.75e-1)" "unprognostic (3.09e-5)" "unprognostic (2.52e-1)" "unprognostic (1.16e-1)" "unprognostic (2.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (4.43e-2)" "unprognostic (1.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.76e-2)" "unprognostic (3.52e-2)" "unprognostic (1.91e-1)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" 0.0 3.6 16.3 0.2 39.7 0.0 0.0 10.1 90.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 33.0 17.8 0.0 0.0 0.3 0.0 12.1 19.6 42.1 0.0 0.1 0.2 0.6 0.1 20.2 0.0 0.0 8.6 0.0 0.1 2.9 0.1 0.0 0.1 0.4 0.0 0.2 0.6 40.7 0.0 1.4 0.5 0.2 0.5 0.0 36.2 0.0 0.0 0.0 0.0 0.1 0.1 1.2 14.6 2.9 3.0 5.5 0.1 0.1 0.0 0.9 7.3 0.6 0.0 0.1 0.2 1.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.9 0.2 0.0 29.5 0.0 0.3 0.1 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 4.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 1.2 11.5 0.7 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 16.3 39.7 10.1 90.5 33.0 17.8 12.1 19.6 42.1 20.2 0.4 40.7 36.2 0.1 0.0 0.0 14.0 0.0 0.1 0.0 0.0 0.0 86.4 0.5 0.1 1.9 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 90.3 0.1 0.0 0.6 0.0 0.0 386.5 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 395.1 0.0 0.0 0.0 0.0 34.5 0.3 0.1 1.8 11.2 0.0 1.8 0.0 26.2 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.3 1.3 0.7 0.9 0.0 0.1 0.4 0.0 0.3 0.1 0.0 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 248.8" "Group enriched" "Detected in some" 27 "Early spermatids: 1329.5;Erythroid cells: 1206.7;Late spermatids: 1439.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.1" "Group enriched" "Detected in many" 28 "granulocytes: 2.2;NK-cells: 2.0;T-cells: 5.1" "Cell line enriched" "Detected in some" 5 "K-562: 290.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.1 0.0 0.1 0.8 0.1 248.8 0.0 0.2 0.4 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.6 1.0 1.5 0.5 0.1 0.1 0.0 0.2 0.0 0.1 6.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.1 0.0 0.0 3.2 0.2 51.0 0.1 12.7 0.2 0.1 1.5 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.3 64.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.2 290.9 0.3 0.0 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.2 0.0 1.5 0.5 1.8 0.0 0.0 0.1 2.2 0.1 0.0 0.2 0.0 0.5 0.0 1.5 0.7 0.1 0.0 5.1 2.1 0.6 2.0 0.0 0.0 0.9 2.7 0.1 0.1 0.2 0.4 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.2 0.4 0.1 0.0 0.0 1329.5 0.2 0.0 0.5 0.0 1206.7 0.4 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.7 0.7 1.0 0.0 0.2 0.0 0.0 1.6 0.0 1439.7 5.9 47.4 1.8 0.0 2.1 0.0 4.1 0.0 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.1 10.0 4.4 0.0 0.0 0.5 2.3 0.0 0.0 0.0 PSMB7 Z ENSG00000136930 "Proteasome 20S subunit beta 7" Q99436 9 124353465-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No 2100000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA052408: AB_2681820, HPA054902: AB_2682635" "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 115.4 181.9 137.8 104.9 143.3 191.4 123.9 140.0 146.0 97.4 127.0 102.5 99.6 103.7 148.3 140.2 95.5 88.0 186.8 140.5 141.3 152.3 224.7 92.2 113.6 143.4 143.9 133.7 102.4 143.4 144.6 75.3 121.2 142.6 95.6 108.8 81.8 115.3 75.7 280.1 164.2 99.1 93.5 139.1 92.4 116.2 156.4 141.0 149.0 92.2 207.1 125.6 111.5 105.1 141.2 344.4 411.7 275.8 336.4 190.4 224.8 396.1 325.3 447.6 461.7 315.1 546.3 327.1 389.2 256.8 307.4 457.2 480.2 346.7 345.4 420.0 375.0 299.3 245.3 673.3 460.0 428.5 491.6 234.3 270.8 299.6 483.7 478.5 355.1 394.3 345.5 507.9 269.8 362.4 600.0 355.9 329.5 409.7 519.6 581.5 309.8 411.4 457.2 331.5 221.9 323.7 263.6 310.4 394.0 498.4 268.7 454.8 212.7 315.9 297.5 240.7 384.9 499.0 289.9 873.7 394.9 498.1 297.8 429.1 162.7 201.5 154.5 128.3 211.4 138.9 177.8 145.7 142.5 221.1 159.7 138.2 135.9 87.0 185.3 206.8 187.5 226.0 264.8 137.8 143.3 140.0 146.0 140.5 141.3 143.4 143.9 133.7 142.6 139.1 141.0 141.2 73.1 76.9 77.6 26.1 88.0 194.1 184.4 309.1 39.9 41.5 113.9 97.5 147.3 134.4 150.0 69.9 22.9 441.4 83.0 146.9 330.6 351.3 404.6 105.7 93.8 123.8 141.2 93.8 38.4 392.7 356.7 112.3 52.5 90.3 104.6 130.8 107.1 277.3 237.2 33.7 31.9 162.5 160.7 122.1 148.4 472.8 139.1 92.5 199.3 33.7 168.5 119.7 113.3 30.7 44.8 393.6 143.7 125.3 69.9 158.0 173.6 484.7 135.7 61.6 85.5 133.8 221.2 330.6 190.4 60.4 218.9 488.7 81.4 135.8 181.2 201.3 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507420 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 189.9;lymphoid tissue: 144.0" "Group enriched" "Detected in some" 8 "Granulosa cells: 47.9;Theca cells: 180.1" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Region enriched" "Detected in some" 9 "thalamus: 12.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 82.9;Hep G2: 59.2;K-562: 20.6" "Region enriched" "Detected in single" 52 "hypothalamus: 5.2" "Region enriched" "Detected in single" 8 "hypothalamus: 1.2" HPA079181 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.0 189.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 36.1 0.0 0.0 21.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 144.0 0.1 14.2 12.2 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 82.9 0.0 59.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.0 0.0 0.1 0.1 0.1 12.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 180.1 0.0 0.0 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922516 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021281: AB_2670649, HPA052197: AB_2681758" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favorable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 7.3 9.4 7.1 11.5 7.8 16.5 13.8 7.6 7.9 9.1 8.5 7.3 7.0 9.1 11.9 7.9 10.5 7.5 6.6 6.2 7.5 10.0 11.4 9.3 14.7 8.3 6.9 5.9 9.1 9.7 11.7 7.9 7.6 7.4 9.6 8.1 5.6 9.6 7.8 7.3 10.4 9.4 6.4 7.6 12.0 9.4 12.1 7.1 13.9 18.6 7.9 14.1 7.1 6.6 9.7 19.4 12.1 6.5 8.0 8.1 6.7 11.2 9.7 11.0 15.3 11.6 16.9 14.0 12.1 6.4 9.7 17.1 18.0 10.6 7.6 11.8 14.6 8.4 10.0 14.8 15.3 16.7 19.4 15.8 11.7 17.0 8.5 6.9 9.2 6.9 9.5 16.0 15.3 10.7 28.1 8.3 13.3 9.1 20.7 13.4 9.8 14.5 8.7 14.5 15.5 11.5 10.1 7.1 15.4 16.6 5.5 6.8 10.5 10.6 8.4 8.5 17.7 15.0 16.3 12.6 6.1 9.0 9.8 7.7 44.4 21.1 49.4 20.4 23.4 25.4 19.4 30.8 24.6 22.6 28.8 39.7 27.9 32.4 22.9 16.1 13.1 35.1 20.1 7.1 7.8 7.6 7.9 6.2 7.5 8.3 6.9 5.9 7.4 7.6 7.1 9.7 7.5 12.8 5.3 0.0 16.7 0.0 14.6 0.0 10.2 9.1 7.3 7.6 0.0 4.3 6.8 5.5 0.0 8.9 17.5 3.5 7.9 9.1 30.6 9.3 5.4 4.9 2.4 6.9 0.0 9.6 6.9 6.0 9.2 7.1 0.0 4.1 5.3 7.3 10.8 6.7 0.0 5.6 0.0 10.7 0.0 18.3 5.0 9.7 0.0 0.0 10.7 12.1 8.2 0.0 0.0 10.3 5.7 7.2 12.0 6.1 4.9 9.9 5.8 4.9 6.6 8.6 5.2 16.7 13.3 7.8 0.0 18.3 14.6 6.6 3.9 8.1 RABEPK "bA65N13.1, RAB9P40" ENSG00000136933 "Rab9 effector protein with kelch motifs" Q7Z6M1 9 125200542-125234161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023920, HPA067106" Supported Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA023920: AB_1856023, HPA067106: " "unprognostic (8.72e-2)" "unprognostic (1.29e-1)" "unprognostic (1.76e-2)" "unprognostic (1.58e-1)" "unprognostic (3.24e-2)" "unprognostic (2.70e-2)" "unprognostic (3.47e-2)" "unprognostic (3.47e-2)" "unprognostic (9.74e-2)" "unprognostic (4.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (8.25e-2)" "unprognostic (2.69e-1)" 17.0 15.1 27.0 14.7 29.4 11.8 16.5 26.9 32.8 15.5 25.0 16.3 11.6 15.2 17.1 16.2 15.5 10.7 14.4 26.9 28.7 13.9 59.2 12.3 14.0 28.1 28.0 27.5 13.2 14.5 15.0 19.9 12.0 28.2 14.2 14.9 15.8 10.8 13.2 15.2 16.4 11.5 16.6 26.8 12.9 13.6 16.2 28.3 15.0 11.8 13.7 13.9 17.4 15.4 28.9 24.6 57.2 21.3 39.2 34.0 41.0 39.4 33.3 32.5 38.7 30.6 68.6 24.0 73.5 29.1 45.5 38.2 64.8 54.2 41.3 38.0 42.6 45.1 32.6 52.7 105.2 30.4 62.3 21.7 30.0 49.0 55.3 59.1 23.5 41.8 45.3 71.8 20.6 37.5 66.8 44.5 42.2 43.0 96.7 51.2 62.0 41.2 81.5 31.4 18.8 50.3 25.5 34.3 23.8 39.2 21.1 48.3 26.5 36.1 26.7 26.3 61.8 58.8 27.4 65.5 51.2 34.3 40.1 40.7 27.8 19.6 23.2 24.0 16.6 22.1 23.8 34.4 23.6 21.6 20.6 38.2 28.2 27.9 23.0 17.3 20.6 38.8 23.8 27.0 29.4 26.9 32.8 26.9 28.7 28.1 28.0 27.5 28.2 26.8 28.3 28.9 9.9 0.0 11.3 13.1 9.9 14.5 17.2 23.4 28.5 12.1 9.1 11.2 9.5 10.0 8.5 5.5 8.4 36.1 7.8 8.7 25.4 13.9 85.2 8.6 11.9 13.1 2.4 13.5 25.2 13.3 32.2 17.4 10.2 8.5 5.1 10.4 10.0 54.8 20.9 13.5 24.0 11.9 10.2 7.7 10.8 19.2 16.1 7.4 8.8 6.5 31.6 12.0 14.4 9.0 17.2 10.0 4.9 18.8 16.8 24.9 9.2 23.2 8.0 17.1 0.0 13.5 13.5 7.0 11.2 20.0 12.9 12.7 13.0 13.1 15.9 15.6 GOLGA1 "golgin-97, MGC33154" ENSG00000136935 "Golgin A1" Q92805 9 124878275-124948492 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013065, HPA044329, HPA050555" Supported Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174" "unprognostic (5.44e-2)" "unprognostic (9.35e-2)" "unprognostic (6.92e-2)" "prognostic favorable (2.21e-4)" "unprognostic (9.34e-2)" "unprognostic (4.43e-1)" "unprognostic (4.40e-2)" "unprognostic (6.03e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-3)" "unprognostic (3.06e-1)" "unprognostic (6.28e-3)" "unprognostic (4.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.24e-3)" "unprognostic (2.52e-2)" 8.2 9.5 5.4 8.8 7.0 5.9 7.9 6.0 6.3 7.8 7.0 10.2 10.2 8.9 5.9 10.0 7.8 7.7 10.3 5.0 7.0 6.9 9.6 7.6 7.6 6.4 6.3 4.9 8.1 10.9 9.2 8.1 5.6 7.0 8.4 9.4 38.1 8.5 8.3 13.4 10.9 9.7 8.7 6.2 8.6 8.7 15.3 6.8 5.4 8.2 9.6 7.5 10.4 8.2 9.1 8.4 14.7 8.6 9.1 14.7 13.0 11.0 13.5 14.3 14.0 10.2 9.7 9.6 5.6 6.5 15.0 10.8 21.2 7.1 11.4 10.2 8.0 7.0 5.9 20.5 12.9 16.9 7.1 13.7 8.8 8.1 13.5 16.3 9.9 12.7 7.0 9.8 9.4 10.0 17.5 5.1 8.0 3.2 19.7 13.5 3.2 12.7 12.3 7.0 11.3 5.0 9.5 16.2 13.0 8.5 7.6 25.1 5.0 14.8 13.0 7.2 16.8 12.6 11.4 19.6 6.5 16.3 7.4 13.8 8.1 3.4 4.3 4.2 3.5 3.4 3.0 2.6 4.5 3.3 3.5 2.7 2.5 7.6 3.2 2.8 4.6 2.7 1.3 5.4 7.0 6.0 6.3 5.0 7.0 6.4 6.3 4.9 7.0 6.2 6.8 9.1 11.8 6.4 14.4 32.3 8.1 2.0 4.2 5.8 6.2 16.3 10.2 10.2 21.0 7.2 10.8 5.5 64.6 6.8 11.5 11.7 3.9 9.5 16.2 10.4 13.6 10.0 5.4 5.0 31.7 8.9 4.9 7.8 10.7 8.8 15.8 14.6 10.8 14.8 6.6 18.5 31.4 9.7 12.2 7.3 4.2 9.8 5.9 9.3 8.8 20.6 10.1 15.2 9.2 27.2 34.3 9.0 2.7 9.1 11.1 4.5 7.8 6.1 17.8 38.0 6.6 15.4 12.3 50.1 21.4 11.0 4.3 8.6 9.1 10.9 8.8 4.0 XPA "XP1, XPAC" ENSG00000136936 "XPA, DNA damage recognition and repair factor" P23025 9 97674909-97697340 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000155, HPA056856" Supported Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "CAB000155: , HPA056856: AB_2683258" "unprognostic (8.76e-2)" "unprognostic (1.05e-3)" "unprognostic (1.60e-1)" "unprognostic (2.30e-2)" "unprognostic (4.17e-1)" "unprognostic (1.84e-1)" "unprognostic (5.26e-2)" "unprognostic (2.38e-1)" "unprognostic (3.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.97e-3)" "unprognostic (9.55e-3)" "prognostic favorable (4.28e-5)" "unprognostic (2.19e-2)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (1.17e-1)" 15.2 13.5 10.9 9.6 11.3 9.2 13.5 12.9 15.5 13.6 11.5 18.8 16.0 14.1 11.1 15.1 13.2 9.8 10.0 10.9 10.7 18.6 19.0 11.4 14.1 12.2 10.9 9.9 13.1 11.9 18.9 10.0 9.8 13.0 14.9 10.0 10.7 12.6 12.8 19.7 12.6 13.2 12.1 10.1 12.6 21.7 5.2 11.7 11.1 23.8 8.7 17.4 15.5 13.6 11.5 35.5 8.2 11.9 14.8 14.3 13.7 8.2 9.4 14.9 16.9 11.4 21.4 28.9 19.9 8.9 10.5 11.3 17.4 9.6 11.4 14.1 13.7 19.2 15.7 17.7 12.0 15.5 18.7 18.2 12.0 12.0 7.9 8.0 11.4 19.1 16.1 22.0 15.2 9.4 11.0 24.4 22.5 8.2 33.5 13.5 24.6 25.4 17.0 27.0 13.7 16.7 16.7 13.4 10.3 12.7 9.0 14.9 11.1 12.0 5.9 14.8 23.4 20.6 26.5 22.7 12.3 14.6 13.2 11.8 12.8 21.6 22.6 25.5 23.0 30.1 34.4 27.9 25.0 23.0 40.5 33.5 29.0 2.6 35.2 29.7 39.8 33.1 19.6 10.9 11.3 12.9 15.5 10.9 10.7 12.2 10.9 9.9 13.0 10.1 11.7 11.5 32.4 25.6 37.8 49.0 36.1 17.3 23.3 39.3 31.9 101.4 24.8 31.9 36.2 45.8 39.7 22.0 81.3 32.1 47.2 10.6 121.3 36.3 1.7 22.5 29.1 30.4 22.3 11.1 49.3 38.3 9.7 31.3 22.4 17.2 30.9 28.0 28.2 48.7 36.0 84.1 63.5 24.6 30.5 27.7 20.7 4.0 44.1 24.5 14.2 40.3 49.6 87.0 64.9 74.9 96.0 29.3 19.2 47.4 26.2 18.9 32.1 55.5 28.6 97.5 32.9 38.3 39.4 18.2 17.9 28.5 18.8 14.0 34.9 36.4 24.2 23.5 NCBP1 "CBP80, NCBP, Sto1" ENSG00000136937 "Nuclear cap binding protein subunit 1" Q09161 9 97633668-97673748 "Predicted intracellular proteins, Transporters" "mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042411, HPA049031" Enhanced Supported Nucleoplasm,Cytosol NA NA 25000 Cytosol Nucleoplasm "HPA042411: AB_2677985, HPA049031: AB_2680606" "unprognostic (4.76e-3)" "unprognostic (2.16e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (3.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.11e-2)" "unprognostic (3.84e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-2)" 11.0 11.2 12.2 16.2 14.3 29.8 11.9 28.2 13.9 10.5 12.5 15.5 12.8 11.8 10.0 12.4 8.9 11.5 12.3 12.0 12.7 11.1 16.8 9.7 19.9 10.9 11.3 11.2 12.9 13.3 10.2 10.6 14.7 19.0 12.3 18.1 30.9 10.8 10.3 18.8 15.9 12.7 11.5 10.7 13.5 13.1 17.1 10.8 21.5 15.9 15.0 18.8 14.1 10.7 17.5 57.7 40.6 44.2 41.0 30.8 30.9 41.6 41.2 25.9 40.1 37.4 54.7 30.2 49.0 17.9 41.1 38.5 62.1 72.3 51.6 57.3 33.8 22.2 45.8 58.5 34.4 30.0 60.8 43.2 23.5 25.0 47.3 35.8 28.5 42.4 35.4 68.6 27.0 68.5 43.5 44.3 33.5 46.4 85.4 39.8 41.9 100.4 20.4 33.0 42.9 55.2 35.4 44.2 38.5 23.5 37.9 23.7 38.7 35.2 31.1 28.0 61.9 44.5 21.7 34.3 25.7 27.3 48.6 40.9 14.0 10.0 9.4 7.2 13.4 8.0 5.3 7.7 7.2 12.7 6.5 6.6 8.0 2.9 12.7 13.9 4.5 7.9 7.4 12.2 14.3 28.2 13.9 12.0 12.7 10.9 11.3 11.2 19.0 10.7 10.8 17.5 9.8 6.4 11.1 34.9 13.9 13.6 6.8 9.3 13.1 21.9 7.9 5.6 23.4 10.0 13.7 9.2 20.9 13.7 9.7 16.0 3.9 8.9 20.3 12.2 16.7 10.4 9.1 21.4 26.1 6.9 15.0 11.7 17.3 13.2 8.2 12.8 7.1 16.5 11.3 21.9 25.5 12.1 14.2 12.0 9.6 9.8 6.5 12.0 5.4 12.2 15.8 8.9 11.3 20.1 24.4 9.7 7.8 7.5 15.9 7.9 9.0 5.3 15.1 23.4 6.6 10.4 11.2 29.4 14.1 14.3 7.4 14.4 15.0 9.5 10.9 8.4 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983341-98015943 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 709.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 570000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 142.6 77.7 170.1 125.2 168.7 368.8 139.8 156.3 169.8 154.7 134.3 143.1 96.0 117.1 105.6 142.0 128.3 61.0 87.3 137.8 152.3 86.6 104.3 123.4 224.5 192.7 170.6 120.1 169.9 157.8 69.2 68.7 111.4 185.3 99.5 119.8 46.6 111.5 72.1 110.5 142.5 128.3 78.7 185.9 124.8 133.0 60.1 171.2 274.0 97.7 51.1 250.4 133.6 147.8 194.8 659.7 347.4 378.6 318.4 208.1 365.2 344.4 332.6 292.4 349.2 291.9 438.3 313.1 798.2 194.2 224.6 266.3 423.9 516.1 375.2 397.1 523.0 290.9 692.4 289.1 478.4 266.9 1201.9 386.8 278.7 268.8 280.9 574.0 283.2 307.9 701.5 1359.2 548.8 272.6 875.7 913.5 1062.0 148.2 638.8 341.2 537.8 589.5 381.7 228.8 269.9 304.2 265.8 390.4 376.2 364.5 185.3 213.2 444.0 377.0 226.5 367.3 288.3 355.5 493.2 601.3 469.1 209.7 472.7 432.1 91.3 83.6 118.8 65.2 95.5 89.3 106.1 122.5 92.8 100.5 93.0 143.8 112.1 34.2 74.1 149.7 96.4 162.5 85.3 170.1 168.7 156.3 169.8 137.8 152.3 192.7 170.6 120.1 185.3 185.9 171.2 194.8 127.9 86.6 101.8 7.8 227.7 180.7 201.3 180.0 208.9 61.1 100.4 126.0 85.8 112.9 120.7 75.4 25.0 345.5 159.5 159.1 97.8 144.9 114.9 73.8 176.3 146.9 149.9 709.4 5.8 171.6 537.9 121.9 123.3 117.5 119.7 247.9 159.5 96.6 284.7 119.5 6.2 242.2 75.3 310.6 152.0 95.2 146.3 222.5 128.1 14.0 263.5 68.9 149.3 8.0 18.8 137.1 151.1 145.2 266.5 260.6 177.7 101.9 56.3 42.1 151.2 113.4 189.4 204.3 339.0 243.0 154.1 333.1 217.6 188.9 302.7 234.1 OR1L4 "OR1L5, OR9-E" ENSG00000136939 "Olfactory receptor family 1 subfamily L member 4" Q8NGR5 9 122723990-122724925 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDCL "DKFZp564M1863, PhLP" ENSG00000136940 "Phosducin like" Q13371 9 122798389-122828588 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021571, HPA021647, CAB026473" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115" "unprognostic (3.51e-2)" "unprognostic (4.11e-2)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.39e-1)" "unprognostic (8.74e-3)" "unprognostic (1.77e-1)" "unprognostic (3.13e-2)" "unprognostic (1.49e-2)" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "prognostic favorable (7.00e-4)" "unprognostic (9.84e-2)" "unprognostic (1.35e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-1)" 11.1 8.8 7.4 10.5 9.4 19.6 13.1 8.6 8.8 12.2 8.2 10.3 9.4 13.5 7.8 9.9 10.4 9.6 8.9 7.0 9.2 8.9 6.4 13.3 13.3 9.8 8.9 5.5 10.0 6.9 11.1 5.0 14.2 10.7 11.2 10.6 12.5 12.9 9.3 5.9 10.7 9.2 11.4 8.3 12.8 10.7 6.7 9.1 13.2 11.7 6.9 12.4 9.3 7.6 11.2 16.9 23.2 38.4 14.4 34.1 22.5 21.4 23.1 23.8 20.9 21.2 15.2 21.9 28.1 18.7 27.5 23.0 32.3 24.1 22.6 22.7 28.0 12.1 29.2 30.1 25.3 17.4 24.6 55.3 19.7 15.8 20.7 10.3 19.3 43.3 17.6 29.7 16.1 23.1 25.8 27.1 22.2 28.4 28.8 17.6 27.8 36.5 20.9 25.6 0.0 30.8 27.4 31.3 17.3 13.8 25.1 26.5 16.8 48.4 19.4 23.0 28.4 22.8 12.0 26.7 30.5 16.6 19.6 19.0 30.4 13.8 23.9 15.2 12.5 16.2 12.7 18.2 14.1 14.5 16.0 18.5 16.4 11.4 19.8 21.8 17.0 31.3 13.4 7.4 9.4 8.6 8.8 7.0 9.2 9.8 8.9 5.5 10.7 8.3 9.1 11.2 43.0 9.6 9.2 5.2 16.7 24.2 14.7 25.4 25.6 42.6 19.9 16.0 5.7 14.3 13.4 20.2 22.9 27.6 29.1 12.9 9.8 20.7 5.5 29.9 22.3 37.5 12.6 50.5 5.8 18.0 27.3 26.7 9.7 36.3 57.1 14.4 31.8 7.6 24.9 40.4 8.2 19.0 24.4 22.6 15.7 4.1 23.0 19.3 19.6 10.3 30.4 36.1 20.6 6.6 15.4 16.5 13.2 17.0 18.2 15.8 9.1 15.3 21.9 38.2 19.7 15.8 21.6 14.5 21.9 25.8 23.2 31.9 25.9 19.9 13.5 16.5 RPL35 L35 ENSG00000136942 "Ribosomal protein L35" P42766 9 124857880-124861981 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006047 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA006047: AB_1856443" "unprognostic (1.16e-2)" "unprognostic (5.42e-3)" "unprognostic (3.04e-2)" "unprognostic (3.69e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" "unprognostic (2.67e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-3)" "unprognostic (6.58e-2)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" 1845.0 1520.9 1311.9 982.7 1316.6 2752.3 1976.8 1275.0 1794.5 2012.0 1269.1 1613.8 816.8 1354.9 800.9 2561.2 1708.9 846.5 1366.0 1261.6 1376.6 1387.5 1760.6 1282.3 2006.5 1336.1 1301.1 1230.6 3036.4 3441.8 860.4 1235.1 749.9 1328.9 1723.8 715.3 276.1 1826.9 743.5 2573.7 2922.4 1394.8 723.8 1352.1 1722.7 1580.2 674.6 1360.2 1583.8 1360.3 1603.6 1392.2 1669.2 2098.3 1360.2 2104.6 3225.4 1780.5 2469.8 1923.1 4033.9 2443.2 1626.3 2589.3 3295.8 2235.0 5370.0 2030.1 3127.8 1631.9 1836.1 1970.9 3986.3 2097.6 3578.7 1209.0 1929.9 3742.5 1266.5 4071.9 3541.9 3433.2 2856.0 1626.0 3759.1 5481.9 1973.9 3480.3 1809.7 2473.6 2927.1 2775.1 3857.2 2523.6 6848.9 3384.5 6510.7 3362.5 6272.1 4016.6 2849.6 2744.6 7026.2 2896.8 2469.0 2412.8 1946.7 1466.3 3452.9 3423.3 876.8 3508.4 4592.6 1269.5 1472.5 1558.9 2578.9 3357.6 2151.5 5523.9 4935.8 2059.7 2982.8 2523.1 753.7 1769.0 695.2 2322.2 1602.3 3101.1 4455.5 3086.5 2676.2 2564.2 4099.1 3218.0 2834.7 221.1 2414.5 1352.2 3650.6 2715.7 7293.7 1311.9 1316.6 1275.0 1794.5 1261.6 1376.6 1336.1 1301.1 1230.6 1328.9 1352.1 1360.2 1360.2 1202.7 637.8 1152.6 15.3 3024.6 5507.5 4326.2 3639.5 1752.9 221.3 4389.9 4459.0 750.7 1732.9 1653.3 1134.8 85.5 2799.3 2227.9 1319.7 2701.9 2347.8 1562.9 826.5 1969.5 1751.1 1298.1 2073.6 9.0 6137.7 4495.9 1544.5 976.6 1135.5 1308.1 2164.6 2362.3 3182.4 2826.7 109.4 9.7 3044.7 1249.2 3375.2 4877.3 6025.8 2777.4 1833.7 2821.1 11.2 3348.5 925.7 2482.0 9.5 16.2 3542.4 2346.8 1285.2 1756.4 4196.5 2319.0 3772.0 618.9 410.0 992.7 2309.7 3771.2 790.9 905.5 3017.8 7263.3 2464.8 2473.5 1760.1 3346.1 3998.4 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029677-97156556 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 649.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 4 "plasmacytoid DC: 15.1" "Lineage enriched" "Detected in many" 4 "dendritic cells: 15.1" "Group enriched" "Detected in many" 8 "BEWO: 592.6;SuSa: 739.0" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 370000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavorable (2.39e-4)" 0.2 0.2 0.8 0.3 0.8 0.3 5.9 1.1 1.3 43.5 0.9 3.0 1.1 2.8 1.8 20.0 1.3 0.5 0.1 0.7 0.9 21.5 0.2 0.9 0.1 0.9 0.8 0.7 0.2 2.2 1.4 1.6 17.0 0.8 0.7 3.2 17.3 9.5 0.1 0.7 48.5 0.4 0.8 0.8 0.2 2.8 66.4 0.8 649.5 1.3 0.1 6.0 0.4 20.3 1.2 37.1 5.2 12.1 33.1 0.6 0.0 592.6 0.5 0.0 7.1 4.7 81.0 37.7 0.3 2.8 0.5 50.5 67.2 58.8 43.9 9.7 0.1 4.4 0.8 1.9 3.1 0.2 0.1 3.3 0.0 9.2 1.5 0.8 0.9 2.4 8.5 0.5 0.2 14.4 15.2 0.9 0.3 76.2 78.9 10.7 0.0 27.3 0.1 11.4 3.7 2.4 3.6 39.1 13.1 13.2 739.0 21.1 3.2 0.0 1.0 23.6 0.2 3.5 5.7 20.6 0.8 1.6 0.4 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.0 0.2 3.3 0.0 15.1 0.0 0.1 0.8 0.8 1.1 1.3 0.7 0.9 0.9 0.8 0.7 0.8 0.8 0.8 1.2 0.9 0.0 1.1 0.3 0.9 30.3 13.0 63.7 19.9 4.6 13.1 9.9 1.3 0.0 17.4 1.8 10.4 122.3 6.9 4.7 1.9 1.8 2.6 15.0 2.9 1.8 1.8 0.0 0.6 0.8 153.0 3.2 0.0 24.0 0.0 54.2 0.4 0.0 13.6 0.0 0.9 1.5 10.2 0.8 3.0 8.2 4.1 2.4 0.0 0.0 0.2 6.5 0.0 0.0 3.5 0.5 10.5 1.2 0.0 8.1 0.1 22.1 4.2 36.6 6.6 1.4 3.6 46.7 33.7 8.2 11.9 67.3 0.5 0.7 4.2 8.4 LMX1B NPS1 ENSG00000136944 "LIM homeobox transcription factor 1 beta" O60663 9 126613928-126701032 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;salivary gland: 18.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1" "Cancer enriched" "Detected in some" 14 "breast cancer: 12.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1" "Region enhanced" "Detected in some" "pons and medulla: 2.3" "Region enhanced" "Detected in many" "midbrain: 5.0" "HPA073716, HPA075656" Approved Nucleoplasm NA NA Nucleoplasm "HPA073716: AB_2686630, HPA075656: " "unprognostic (4.17e-1)" "unprognostic (4.72e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.73e-1)" "unprognostic (1.50e-4)" "unprognostic (1.86e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-1)" "unprognostic (2.26e-1)" "unprognostic (1.34e-2)" "unprognostic (3.51e-3)" "unprognostic (1.63e-5)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-6)" "unprognostic (1.13e-2)" 0.4 0.0 0.2 0.0 0.5 0.1 4.1 0.3 4.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.3 3.5 0.0 0.1 0.0 4.0 7.8 0.0 0.0 0.2 1.1 0.2 0.0 2.2 0.0 0.0 0.0 18.7 0.0 0.1 1.9 0.1 0.0 3.8 0.0 0.1 1.4 1.8 0.0 0.4 0.0 0.0 0.0 0.0 2.1 1.2 0.6 0.3 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.3 0.0 2.5 0.6 3.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 10.4 0.0 0.0 2.4 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.2 0.1 8.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 4.3 1.0 1.3 4.0 7.8 0.0 2.2 3.8 1.8 2.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.3 7.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 1.6 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ARPC5L "ARC16-2, MGC3038" ENSG00000136950 "Actin related protein 2/3 complex subunit 5 like" Q9BPX5 9 124862130-124877733 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 576.3;Late spermatids: 975.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 415.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022013 Approved NA NA 97000 "HPA022013: AB_1845045" "unprognostic (2.10e-1)" "unprognostic (3.40e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-2)" "unprognostic (9.04e-3)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.48e-2)" "unprognostic (9.37e-2)" "unprognostic (6.80e-2)" "unprognostic (4.30e-1)" "unprognostic (2.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.99e-2)" "unprognostic (4.35e-1)" "unprognostic (7.55e-3)" "unprognostic (3.58e-1)" 35.4 60.8 49.8 27.9 53.6 52.3 33.0 48.8 57.9 24.7 44.9 37.0 25.8 24.0 22.9 91.4 21.2 19.4 54.8 54.3 52.9 42.6 60.1 48.0 45.0 49.5 50.3 52.3 15.2 28.7 22.9 44.5 24.4 51.1 28.0 26.4 14.5 37.6 17.1 70.9 68.3 34.6 18.2 48.5 58.1 43.9 79.7 51.1 24.7 28.0 41.9 48.8 34.3 46.9 52.8 86.2 45.5 38.3 44.9 31.6 45.6 93.5 87.5 48.1 65.9 46.0 94.2 72.9 78.3 51.4 53.5 48.4 124.2 60.4 77.2 62.1 86.8 47.1 41.3 109.5 55.7 50.6 90.8 50.6 35.6 91.1 58.6 63.8 40.4 76.5 47.4 112.0 209.3 69.8 125.3 52.3 86.8 90.1 134.8 114.3 83.2 66.3 228.1 64.2 59.9 56.0 45.3 58.6 74.6 75.5 41.9 105.4 89.0 85.0 55.1 64.7 81.9 123.3 138.0 415.8 103.7 65.3 69.0 53.2 10.2 15.5 20.7 73.3 13.7 71.7 67.3 43.3 77.5 27.1 64.6 31.8 50.3 8.7 86.5 16.1 54.4 54.8 24.3 49.8 53.6 48.8 57.9 54.3 52.9 49.5 50.3 52.3 51.1 48.5 51.1 52.8 79.4 57.7 64.4 5.2 98.7 354.2 149.9 135.5 101.3 25.6 92.5 79.4 80.5 71.4 90.8 68.0 2.1 152.2 143.9 104.9 131.0 126.9 576.3 79.8 38.4 119.5 65.7 37.6 17.4 164.6 163.9 49.0 69.8 78.7 37.4 42.6 75.0 83.5 95.2 25.2 10.9 83.8 101.7 32.1 147.3 975.1 41.3 48.9 90.7 5.6 55.7 72.3 267.7 6.0 9.9 270.2 92.5 48.5 150.8 182.0 77.2 98.2 77.5 25.6 26.3 31.3 71.1 246.1 124.3 156.4 418.5 213.7 137.2 66.5 99.9 267.8 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 382.3;choroid plexus: 615.9" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1041.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 53.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 53.8" "Cell line enhanced" "Detected in many" "AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1200000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 99.3 47.1 95.6 62.6 193.1 2.7 90.5 180.3 157.8 49.9 615.9 27.3 68.1 140.5 20.4 9.1 56.2 40.3 10.0 109.2 142.0 77.3 28.7 43.1 110.7 229.1 168.0 78.0 15.3 16.1 20.4 11.9 254.4 220.6 26.6 32.6 7.0 10.0 27.6 9.0 17.7 46.2 85.9 163.5 51.9 27.2 31.6 155.9 21.0 10.9 24.1 86.5 45.5 18.2 382.3 0.0 0.0 111.4 0.0 147.7 312.5 0.4 103.2 188.9 43.9 42.1 0.0 0.0 0.1 1.3 124.2 0.1 0.3 2.3 0.0 31.3 8.7 3.4 0.0 0.2 3.1 67.0 0.0 0.5 144.7 1.3 89.3 4.3 0.6 0.5 0.1 0.1 18.1 2.5 0.0 0.1 0.7 4.4 0.0 0.5 0.1 0.1 0.6 0.3 0.0 1.1 2.2 0.1 0.4 0.2 4.2 0.1 0.0 0.0 89.6 1.9 108.6 0.9 0.9 0.0 0.0 75.0 0.8 2.4 53.8 0.2 9.5 0.0 0.1 0.1 0.4 0.5 0.0 1.0 0.1 3.0 1.1 0.5 0.4 0.2 6.8 0.0 0.6 95.6 193.1 180.3 157.8 109.2 142.0 229.1 168.0 78.0 220.6 163.5 155.9 382.3 231.4 12.8 3.6 2.0 1.8 10.6 0.5 0.0 19.9 1.9 2.1 2.8 1.8 35.8 0.6 1.8 0.0 5.2 4.9 0.3 1.9 0.1 83.9 12.7 8.8 79.9 54.0 0.8 2.5 0.0 2.2 76.9 3.6 1.4 6.3 0.4 31.1 0.8 65.8 0.0 4.2 3.3 0.0 18.6 14.9 9.5 3.1 16.2 46.2 6.5 0.1 6.4 0.0 16.6 1041.6 0.7 2.6 3.4 1.9 0.1 4.2 47.6 3.7 1.2 0.0 3.1 9.6 1.7 0.4 7.8 5.3 6.4 1.7 1.1 2.8 1.4 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119855894 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 24.6;Extravillous trophoblasts: 17.6;Spermatogonia: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA023780: AB_2671311, HPA024401: AB_2671557" "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.92e-6)" "prognostic unfavorable (3.93e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 1.8 1.8 1.4 3.7 1.7 6.2 2.4 2.3 2.0 2.7 1.3 2.7 2.4 2.4 1.3 2.4 1.6 1.1 1.5 1.5 1.6 0.9 1.2 1.5 7.1 1.7 1.7 1.3 1.5 2.8 0.5 0.5 2.3 1.9 1.9 3.6 0.3 3.8 1.2 2.1 2.6 2.4 2.8 1.7 1.3 1.7 2.6 1.6 10.0 1.0 3.4 5.7 1.5 2.1 1.9 34.3 16.6 32.1 29.4 4.6 8.3 13.8 23.1 4.7 16.3 16.9 15.2 20.4 61.7 19.7 6.9 10.1 24.8 36.7 14.4 17.5 42.2 33.3 78.7 16.2 17.9 1.5 31.2 26.4 3.8 2.2 20.1 9.7 3.8 4.7 40.5 27.2 26.9 19.9 33.8 82.4 19.2 47.2 90.4 41.2 29.1 30.4 29.9 12.7 21.3 28.7 17.6 12.4 96.7 15.8 25.0 18.1 17.0 3.2 17.7 48.0 17.2 33.9 36.5 58.2 65.4 9.0 49.2 26.2 0.0 0.0 0.0 0.9 0.0 0.7 0.3 0.2 0.4 0.0 0.1 0.1 0.3 0.0 0.8 0.0 0.2 0.3 0.2 1.4 1.7 2.3 2.0 1.5 1.6 1.7 1.7 1.3 1.9 1.7 1.6 1.9 4.7 0.0 0.5 2.6 1.2 3.4 2.2 2.1 4.6 0.7 2.2 3.2 0.8 1.5 0.2 0.0 0.0 7.9 1.6 1.0 0.0 1.6 0.1 0.8 2.8 3.0 0.0 24.6 6.4 2.4 17.6 4.3 1.5 1.3 4.5 3.7 4.6 0.9 4.7 0.0 5.2 1.2 2.0 1.0 1.2 0.2 1.2 0.9 3.6 1.0 0.0 1.5 1.0 7.5 5.3 0.5 0.3 2.6 5.2 1.7 0.2 1.5 1.7 0.3 0.0 2.3 3.3 1.1 18.8 6.0 3.3 1.4 3.0 2.0 3.8 1.5 DERL1 "DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577" ENSG00000136986 "Derlin 1" Q9BUN8 8 123013170-123042302 "Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 225.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 825.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016562, CAB037269" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB037269: AB_609868, HPA016562: AB_1847611" "prognostic unfavorable (2.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (9.48e-2)" "unprognostic (4.21e-3)" "unprognostic (2.76e-1)" "unprognostic (1.28e-3)" "unprognostic (4.42e-2)" "unprognostic (5.38e-2)" "unprognostic (1.41e-3)" "unprognostic (4.35e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-3)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" 69.7 48.1 15.6 54.2 16.9 105.0 34.4 20.6 18.1 26.8 25.4 50.5 48.3 29.6 31.7 35.8 29.7 33.2 36.8 18.2 20.6 31.1 78.2 37.4 49.1 16.2 16.9 17.7 38.5 31.8 27.1 23.2 28.2 16.3 27.2 43.2 29.9 29.9 29.0 73.9 23.8 47.4 34.7 16.9 40.3 38.9 32.4 17.4 27.4 42.7 49.5 56.0 42.2 22.7 18.9 130.8 93.9 55.7 72.6 98.3 72.8 47.1 108.9 72.1 68.7 85.1 59.7 126.9 150.7 129.8 87.4 81.2 107.0 51.8 69.3 97.4 174.9 57.6 157.2 62.9 51.6 89.2 62.2 111.0 66.9 87.8 76.0 89.8 62.5 62.8 60.6 95.9 193.7 78.7 254.8 68.5 39.4 42.1 166.4 82.5 68.3 46.2 252.1 182.2 92.1 60.5 89.8 109.9 825.1 68.6 59.6 97.3 55.4 74.2 82.2 154.1 74.1 102.1 239.5 444.6 136.5 135.4 76.4 79.4 73.1 60.7 72.6 89.3 75.7 93.0 69.8 59.5 74.0 49.5 56.1 41.0 64.0 42.1 77.8 77.9 56.6 80.0 83.3 15.6 16.9 20.6 18.1 18.2 20.6 16.2 16.9 17.7 16.3 16.9 17.4 18.9 38.6 32.1 25.9 12.4 78.3 42.3 41.8 57.3 26.7 22.6 38.3 21.3 28.1 17.2 44.8 29.5 20.9 41.0 67.6 43.3 9.8 87.7 85.5 18.9 32.3 39.2 30.5 41.0 11.5 75.4 71.4 43.8 26.5 31.2 42.6 24.0 39.3 75.9 68.0 18.5 12.8 62.2 42.7 49.4 44.2 19.9 24.5 45.6 60.5 14.0 47.6 25.5 59.8 17.6 19.1 68.4 40.6 25.6 225.0 63.7 56.6 28.0 31.3 25.6 46.0 32.7 77.6 75.4 40.3 41.0 50.7 78.0 69.8 34.8 37.5 64.4 MYC "bHLHe39, c-Myc, MYCC" ENSG00000136997 "MYC proto-oncogene, bHLH transcription factor" P01106 8 127735434-127742951 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1013.3;Basal prostatic cells: 1080.5;Basal squamous epithelial cells: 1270.8;Squamous epithelial cells: 768.8;Suprabasal keratinocytes: 1070.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 1069.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000084, CAB010307, HPA055893, HPA066556" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691" "unprognostic (1.45e-2)" "unprognostic (4.00e-3)" "unprognostic (3.94e-3)" "unprognostic (2.41e-3)" "unprognostic (8.14e-2)" "unprognostic (3.36e-3)" "unprognostic (5.80e-2)" "unprognostic (4.94e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.19e-3)" "unprognostic (9.86e-3)" "prognostic unfavorable (5.49e-8)" "unprognostic (7.85e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (4.96e-5)" 171.1 60.4 2.7 62.9 2.7 54.2 116.8 3.7 3.9 43.7 5.1 57.2 30.9 54.3 3.9 100.3 169.0 84.0 38.4 2.3 12.5 16.4 65.5 47.4 49.8 9.1 4.4 1.7 100.8 103.9 7.0 12.4 33.7 7.2 32.9 37.1 0.7 42.5 14.2 51.0 230.2 49.0 55.2 4.9 60.5 71.2 12.6 4.8 47.7 27.2 15.9 39.5 63.8 97.1 4.8 56.8 89.3 9.3 100.9 166.6 209.8 28.4 72.2 31.6 87.5 72.7 137.0 150.2 587.3 86.4 43.0 82.4 122.2 383.8 226.5 67.8 128.9 167.0 370.7 189.5 203.6 150.0 282.0 52.0 138.8 560.4 55.5 490.8 74.8 104.3 217.3 549.8 315.5 49.7 151.9 394.4 616.9 27.4 273.2 204.0 203.7 46.1 1069.6 79.2 61.9 660.7 64.9 32.6 270.7 195.9 17.5 106.4 172.2 120.5 63.4 71.6 49.7 87.2 5.5 8.7 275.9 55.3 286.2 30.8 3.0 39.5 0.7 31.5 36.0 161.5 92.0 114.3 67.4 33.5 71.4 195.2 128.0 4.1 85.5 26.9 1.4 95.6 88.9 2.7 2.7 3.7 3.9 2.3 12.5 9.1 4.4 1.7 7.2 4.9 4.8 4.8 218.0 57.7 70.4 0.7 108.0 1013.3 1080.5 278.9 1270.8 0.6 251.3 207.3 10.9 44.3 98.4 12.9 0.0 20.6 20.9 23.0 1.9 78.3 1.0 43.9 224.5 158.0 12.5 189.1 1.6 43.6 61.2 337.9 46.4 72.0 57.0 47.6 141.0 25.8 26.9 0.0 1.1 67.8 97.6 43.7 133.1 3.9 98.8 23.3 168.9 1.0 17.0 1.4 5.2 0.0 0.2 66.5 40.4 67.4 45.7 364.8 4.8 13.3 21.5 0.3 46.0 458.5 349.1 0.6 0.6 768.8 1070.1 5.9 75.0 56.0 117.7 409.4 CCN3 "IGFBP9, NOV" ENSG00000136999 "Cellular communication network factor 3" P48745 8 119416446-119424434 "Plasma proteins, Predicted secreted proteins, Transporters" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 44 "adrenal gland: 1115.9" "Cell type enhanced" "Detected in some" "Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6" "Cancer enriched" "Detected in all" 4 "melanoma: 62.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 116 "eosinophil: 64.8;neutrophil: 30.8" "Lineage enriched" "Detected in single" 157 "granulocytes: 64.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2" "Group enriched" "Detected in all" 6 "amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0" "Region enriched" "Detected in all" 6 "spinal cord: 114.6" "HPA018449, HPA019684, CAB034423" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 269000000 2800000 Vesicles "CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190" "unprognostic (5.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.36e-3)" "unprognostic (1.30e-3)" "unprognostic (9.35e-3)" "unprognostic (4.92e-1)" "unprognostic (8.10e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.67e-1)" "unprognostic (3.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.74e-3)" "unprognostic (1.51e-1)" "unprognostic (1.98e-1)" "unprognostic (2.72e-2)" 23.9 1115.9 6.5 3.6 11.9 1.8 8.2 6.7 12.5 11.3 9.1 6.5 3.9 8.7 6.3 5.6 9.0 6.3 18.3 16.4 10.0 6.9 1.1 6.9 2.3 5.7 5.8 8.7 3.1 6.8 9.5 22.0 0.6 5.4 23.0 7.1 1.2 2.7 20.2 4.7 12.6 4.5 8.5 7.3 1.6 4.9 3.7 6.2 1.0 25.5 7.3 1.9 4.4 8.1 6.7 0.1 3.1 1.7 0.0 11.1 2.9 0.1 16.9 125.0 14.9 8.6 0.0 0.3 0.0 12.9 21.2 11.6 10.5 0.6 0.0 5.1 0.0 0.3 0.0 9.1 0.0 0.4 0.0 0.0 0.6 0.1 5.7 0.6 38.1 0.4 0.0 0.0 0.0 0.8 0.7 0.0 0.1 0.2 1.2 24.9 0.1 0.0 0.0 15.8 0.1 3.9 0.1 6.3 0.1 24.2 0.0 0.0 0.0 0.0 10.6 15.8 128.2 3.5 0.0 0.0 0.0 16.7 5.4 12.5 0.0 0.3 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.1 6.5 11.9 6.7 12.5 16.4 10.0 5.7 5.8 8.7 5.4 7.3 6.2 6.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 IL33 "C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV" ENSG00000137033 "Interleukin 33" O95760 9 6215786-6257983 "Predicted intracellular proteins, Predicted secreted proteins" Transcription Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 121.8" "Cell type enhanced" "Detected in many" "Endothelial cells: 141.8;Fibroblasts: 87.5;Hepatic stellate cells: 499.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 53.6;U-2197: 162.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007057, HPA022899, HPA024426" Supported Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA Nucleoplasm Vesicles "CAB007057: , HPA022899: , HPA024426: AB_1845820" "prognostic favorable (4.42e-4)" "unprognostic (8.36e-2)" "unprognostic (5.67e-3)" "unprognostic (7.67e-3)" "unprognostic (4.27e-1)" "unprognostic (1.63e-1)" "unprognostic (2.59e-3)" "unprognostic (2.66e-3)" "unprognostic (3.18e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (8.08e-2)" "unprognostic (1.58e-3)" "unprognostic (4.70e-3)" "unprognostic (4.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.85e-3)" 39.1 16.9 9.1 45.0 8.0 0.2 27.5 6.9 12.2 56.6 7.5 19.1 8.8 50.5 16.1 24.8 26.1 33.7 38.0 8.6 12.7 5.1 37.0 53.5 47.5 7.6 8.3 7.9 5.0 3.5 3.7 5.7 61.6 7.4 30.2 19.5 2.0 19.1 31.8 6.2 44.4 15.8 51.3 8.0 20.7 33.8 5.9 9.4 13.2 12.7 13.9 43.4 121.8 21.4 8.7 0.0 0.0 0.0 0.0 0.3 1.4 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.1 16.9 0.3 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.7 0.3 0.4 53.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 162.9 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 8.0 6.9 12.2 8.6 12.7 7.6 8.3 7.9 7.4 8.0 9.4 8.7 63.5 6.4 7.2 39.5 1.0 24.2 17.0 73.9 27.3 0.0 9.4 4.1 5.8 4.3 77.8 0.0 0.0 0.0 0.1 2.2 0.0 3.0 0.5 12.4 7.1 141.8 10.7 8.0 0.2 7.9 0.0 87.5 48.4 20.6 1.3 0.0 499.4 5.0 0.1 0.0 0.1 0.2 2.0 20.8 10.2 1.6 20.5 1.7 1.8 1.0 0.0 9.5 0.0 0.5 0.1 12.1 0.2 12.4 0.2 5.2 0.0 0.0 62.1 0.1 0.0 65.5 11.5 0.0 0.4 3.3 48.4 0.1 1.2 0.1 1.1 4.9 DMAC1 "C9orf123, MGC4730, TMEM261" ENSG00000137038 "Distal membrane arm assembly complex 1" Q96GE9 9 7796500-7888380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 500.8;Hofbauer cells: 221.7;Proximal tubular cells: 254.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA014585 Approved NA NA "HPA014585: AB_1845803" "unprognostic (1.48e-2)" "unprognostic (3.74e-2)" "unprognostic (7.23e-3)" "prognostic favorable (4.15e-4)" "unprognostic (2.78e-2)" "unprognostic (2.79e-3)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (3.26e-3)" "unprognostic (3.65e-1)" "prognostic favorable (1.96e-11)" "unprognostic (1.75e-1)" "unprognostic (4.19e-1)" "unprognostic (2.35e-1)" "unprognostic (7.41e-2)" 10.7 12.0 15.1 7.7 17.3 6.2 12.5 17.3 21.2 9.4 9.3 12.6 9.9 10.1 11.9 9.4 11.1 6.4 23.9 15.9 16.5 14.0 10.2 7.3 10.0 15.4 16.3 17.2 13.3 9.2 22.0 12.4 8.2 16.5 12.0 10.0 9.1 14.5 11.8 43.5 8.5 9.2 8.2 13.9 10.5 10.8 7.1 15.8 20.8 11.9 30.1 9.0 11.6 8.4 18.3 18.5 21.8 19.7 12.3 15.4 19.1 13.3 11.0 7.7 11.5 10.4 9.9 11.3 27.1 5.6 9.8 15.0 9.8 21.2 18.8 11.6 16.2 24.3 49.3 32.7 31.8 15.6 17.2 6.7 24.1 13.2 9.1 13.9 10.6 11.0 24.3 9.2 5.6 12.2 15.7 25.1 39.7 17.5 15.6 10.5 19.0 11.1 16.4 13.2 17.6 31.5 17.6 12.0 8.0 14.1 13.5 10.5 10.5 14.0 8.8 14.2 11.6 7.7 7.0 12.0 14.5 7.4 14.3 9.0 2.0 10.1 4.5 11.5 12.2 17.4 26.5 15.7 12.3 12.6 22.5 20.5 16.5 1.6 20.8 9.8 13.1 19.9 19.6 15.1 17.3 17.3 21.2 15.9 16.5 15.4 16.3 17.2 16.5 13.9 15.8 18.3 42.2 70.5 48.5 0.0 15.7 0.0 0.0 0.0 0.0 0.0 69.5 81.5 0.0 0.0 24.1 101.2 0.0 113.6 13.9 0.0 500.8 94.2 0.0 81.4 64.3 30.0 0.0 0.0 0.0 90.7 96.3 32.8 0.0 58.6 27.8 127.7 0.0 0.0 221.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 25.8 0.0 0.0 0.0 0.0 62.4 0.0 0.0 3.1 0.0 0.0 254.7 70.7 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 55.4 17.3 79.3 0.0 0.0 RANBP6 ENSG00000137040 "RAN binding protein 6" O60518 9 6011025-6015625 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043748, HPA052684" Approved Supported Vesicles NA NA Vesicles "HPA043748: AB_10796796, HPA052684: AB_2681913" "unprognostic (1.47e-2)" "unprognostic (8.86e-2)" "unprognostic (1.70e-1)" "unprognostic (6.01e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.89e-2)" "prognostic favorable (1.34e-7)" "unprognostic (2.42e-1)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (2.61e-1)" 8.7 11.5 9.2 13.1 10.2 31.3 11.5 12.5 12.3 7.8 17.5 7.2 7.6 8.9 7.1 7.9 7.4 7.7 12.5 10.2 12.3 13.5 15.3 8.4 17.1 12.1 11.1 9.4 9.6 7.9 13.7 5.1 9.0 13.1 9.8 7.1 21.8 8.7 8.5 16.4 10.0 8.7 10.4 10.6 13.2 11.2 5.9 11.3 19.8 12.1 16.3 16.3 8.8 5.6 14.7 25.1 13.6 27.2 23.4 23.6 18.6 14.6 30.9 21.9 26.8 21.6 7.5 7.7 33.5 8.4 24.7 13.1 14.0 24.2 28.2 29.7 80.1 13.9 88.3 53.0 15.6 13.9 34.2 17.9 20.2 15.2 16.5 16.3 21.1 31.3 30.1 6.9 27.3 25.8 8.4 24.3 54.8 12.3 9.0 11.0 25.6 16.7 15.7 28.1 17.6 13.2 19.9 14.7 11.0 8.7 22.3 17.7 23.0 37.6 25.1 14.9 12.4 29.4 16.3 27.8 31.5 14.4 19.8 9.3 5.1 4.5 3.7 2.6 6.3 2.5 2.5 3.8 2.8 2.7 1.9 4.4 4.2 1.3 2.8 5.2 3.1 5.2 2.9 9.2 10.2 12.5 12.3 10.2 12.3 12.1 11.1 9.4 13.1 10.6 11.3 14.7 11.3 9.6 8.1 8.8 11.5 10.3 6.6 10.1 13.1 18.0 8.1 5.6 24.4 8.6 16.3 11.0 2.1 8.8 12.0 4.1 7.9 8.6 1.6 12.2 16.5 13.1 9.5 8.6 15.9 10.9 4.1 8.3 16.8 17.7 10.8 10.1 10.0 13.7 4.4 11.8 19.0 3.2 2.0 10.5 6.0 1.2 6.5 7.2 1.8 8.4 7.2 15.9 9.2 3.0 20.5 7.5 3.8 6.8 11.8 5.7 1.8 12.5 8.7 23.1 0.0 11.6 10.2 10.1 9.3 9.8 9.5 6.6 13.3 12.7 4.8 7.3 POLR1E "FLJ13390, FLJ13970, PAF53, PRAF1, RPA49" ENSG00000137054 "RNA polymerase I subunit E" Q9GZS1 9 37485948-37503697 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022527, HPA052400" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA022527: AB_1854924, HPA052400: AB_2681815" "prognostic favorable (2.27e-4)" "unprognostic (2.09e-1)" "unprognostic (9.90e-3)" "unprognostic (1.10e-2)" "unprognostic (7.16e-3)" "unprognostic (2.07e-1)" "unprognostic (1.09e-2)" "unprognostic (7.14e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.80e-1)" "unprognostic (2.48e-1)" "unprognostic (1.07e-1)" "unprognostic (4.96e-2)" "unprognostic (5.23e-1)" "unprognostic (1.58e-1)" "unprognostic (4.24e-2)" 19.8 15.4 9.3 14.8 9.5 13.2 24.2 9.5 8.7 22.0 7.2 15.1 8.5 24.5 15.0 14.0 20.2 12.7 18.6 8.6 11.2 7.8 29.9 12.0 19.5 9.2 9.4 7.7 42.7 28.2 11.6 9.5 8.4 9.6 14.1 11.0 9.0 18.1 17.5 19.3 15.7 11.0 22.7 10.4 11.0 15.1 9.2 9.4 17.2 13.8 10.6 21.8 18.0 17.1 10.5 58.5 53.7 29.0 46.2 53.2 67.8 18.9 50.6 19.5 51.2 45.0 46.4 18.9 84.1 23.8 58.5 34.9 23.8 71.5 60.0 64.2 81.9 33.6 40.4 68.0 33.3 39.7 78.2 27.5 72.7 20.9 100.4 85.7 32.2 26.5 46.0 107.5 36.0 45.6 28.0 54.5 26.8 51.7 39.7 43.5 47.8 26.7 40.5 26.7 21.4 41.3 33.9 33.7 26.7 43.8 23.8 26.0 51.4 18.3 60.3 91.9 52.3 102.2 19.5 29.6 87.7 20.8 48.8 51.2 0.0 3.5 2.2 14.2 6.0 22.7 10.1 13.5 14.5 5.6 11.5 16.6 14.7 1.1 13.1 5.2 3.9 8.0 7.5 9.3 9.5 9.5 8.7 8.6 11.2 9.2 9.4 7.7 9.6 10.4 9.4 10.5 7.2 0.0 8.4 1.6 20.4 28.3 23.7 10.9 21.1 7.0 13.2 15.2 8.6 14.3 7.4 0.0 4.2 15.6 20.0 4.3 7.9 13.8 5.6 5.4 20.1 7.1 1.8 15.4 1.8 21.6 21.4 16.1 8.6 6.7 8.8 14.0 3.9 18.7 7.4 3.3 2.4 7.7 6.1 10.3 8.0 10.7 14.9 8.1 5.4 3.7 9.2 9.2 12.3 1.5 2.1 14.1 3.0 15.1 28.3 23.6 3.1 5.9 4.1 6.9 0.0 22.1 15.9 20.6 23.5 14.0 17.8 8.3 23.7 31.9 11.9 12.7 PLAA "DOA1, FLJ11281, FLJ12699, PLA2P, PLAP" ENSG00000137055 "Phospholipase A2 activating protein" Q9Y263 9 26903372-26947242 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005035, HPA020994, HPA020996" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 12000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (4.00e-3)" "unprognostic (5.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (4.50e-3)" "unprognostic (2.48e-1)" "unprognostic (5.54e-2)" "prognostic favorable (7.87e-4)" "unprognostic (3.24e-2)" "unprognostic (1.44e-1)" "unprognostic (9.29e-3)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (1.39e-2)" "unprognostic (5.10e-1)" 16.1 17.0 7.5 16.3 8.9 42.4 12.7 9.0 11.3 11.4 9.1 15.3 13.7 17.7 13.5 19.0 9.9 13.1 18.9 9.4 8.9 15.5 21.7 12.9 15.1 8.2 8.1 8.4 11.1 12.1 17.1 8.0 16.1 8.8 13.0 16.1 14.2 11.0 12.6 50.7 12.0 12.7 19.4 7.6 13.4 12.8 20.6 8.1 18.2 16.1 29.4 18.3 14.8 11.3 10.1 64.6 37.0 46.1 46.3 30.4 38.2 34.6 58.4 33.1 43.9 42.2 13.1 29.8 56.9 48.0 45.0 30.6 25.1 45.8 46.0 47.7 75.7 19.1 35.2 57.9 25.5 30.9 28.8 46.3 34.4 27.0 53.2 38.8 33.0 44.3 41.7 22.1 56.6 47.6 26.6 56.3 28.1 66.8 33.2 31.6 39.4 28.7 34.4 33.5 37.6 29.2 49.9 31.3 36.5 19.1 44.8 25.5 22.5 54.3 0.2 53.8 28.5 48.3 18.4 43.7 59.5 30.8 40.4 23.4 21.9 12.7 21.0 11.0 18.2 12.6 14.3 11.5 11.4 13.1 11.9 10.3 12.0 11.4 14.9 21.2 6.6 18.0 9.6 7.5 8.9 9.0 11.3 9.4 8.9 8.2 8.1 8.4 8.8 7.6 8.1 10.1 10.8 16.0 11.2 18.3 18.8 11.0 11.3 14.6 17.1 9.1 7.5 6.6 23.8 5.7 16.1 9.2 0.0 24.9 14.9 11.9 9.8 17.6 27.7 10.2 12.3 17.1 9.6 25.9 31.9 16.2 26.6 11.5 15.8 14.7 40.6 13.2 12.5 10.7 20.7 5.0 30.8 8.6 14.2 15.8 8.2 6.6 8.7 17.5 1.8 21.5 15.9 9.5 16.5 24.6 32.1 15.2 8.7 8.2 23.1 10.6 11.0 12.3 12.7 6.7 19.7 13.0 34.1 28.1 24.9 20.9 9.5 49.3 18.3 21.5 12.6 11.6 IL11RA ENSG00000137070 "Interleukin 11 receptor subunit alpha" Q14626 9 34650702-34661902 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Craniosynostosis, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 57.8;Late spermatids: 97.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.8;HSkMC: 38.2" "Low region specificity" "Detected in all" "HPA013162, CAB032830, HPA036652" Supported "Secreted to blood" NA NA "CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229" "unprognostic (7.76e-2)" "unprognostic (7.63e-2)" "unprognostic (1.05e-1)" "unprognostic (6.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.52e-2)" "unprognostic (1.89e-2)" "unprognostic (4.02e-1)" "unprognostic (1.28e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (2.14e-1)" "unprognostic (1.51e-1)" "unprognostic (2.93e-2)" "unprognostic (8.71e-2)" 26.1 14.9 18.6 15.7 20.7 13.8 30.5 22.5 24.0 40.1 16.3 47.8 21.9 33.2 12.3 16.5 37.1 19.6 60.3 19.0 20.6 21.8 51.2 22.8 32.2 19.8 19.8 18.0 38.3 13.0 29.4 22.0 10.4 20.6 30.6 11.5 18.9 26.3 15.8 30.3 61.7 38.2 19.8 18.5 33.5 26.2 18.5 19.1 17.1 48.4 28.8 21.3 32.4 34.4 21.3 2.5 5.5 11.7 11.7 16.5 28.9 5.5 13.8 19.1 8.8 11.9 2.0 4.6 2.6 3.7 36.8 3.3 5.0 3.4 5.0 3.5 23.8 9.2 7.9 23.4 1.0 8.4 2.7 4.3 38.2 6.1 4.9 1.7 11.9 5.6 16.4 3.3 5.4 11.3 1.6 3.6 18.6 2.5 2.0 3.7 5.6 2.3 2.7 2.9 2.5 3.4 12.3 1.7 3.7 5.3 6.1 10.1 10.2 5.2 4.1 10.0 3.2 0.0 3.7 2.6 1.0 10.9 3.1 20.1 2.1 1.0 0.0 1.4 1.4 2.1 0.8 2.7 2.2 1.3 1.0 2.5 1.8 0.3 1.0 0.3 0.5 1.7 1.7 18.6 20.7 22.5 24.0 19.0 20.6 19.8 19.8 18.0 20.6 18.5 19.1 21.3 15.8 3.2 14.3 26.8 2.6 17.5 5.8 3.6 6.2 19.6 6.4 25.1 37.9 1.5 3.6 3.7 14.6 11.3 5.1 3.7 0.0 1.9 18.3 0.7 4.4 15.2 9.1 0.8 4.3 0.7 4.1 42.7 3.1 1.3 0.0 57.8 17.5 32.1 4.6 23.5 9.0 5.0 0.0 3.5 19.6 97.2 11.1 3.6 32.0 4.7 2.6 15.2 6.2 5.0 7.3 0.3 4.3 5.7 2.4 2.9 7.0 2.4 1.4 9.0 0.0 32.9 8.9 4.6 21.6 1.4 14.1 12.4 6.0 12.2 5.2 1.7 UBAP2 "bA176F3.5, FLJ22435, KIAA1491" ENSG00000137073 "Ubiquitin associated protein 2" Q5T6F2 9 33921693-34048949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021684 Approved Approved Cytosol NA NA Cytosol "HPA021684: AB_2211887" "unprognostic (2.71e-1)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "prognostic favorable (8.59e-4)" "unprognostic (1.75e-1)" "unprognostic (9.76e-3)" "prognostic favorable (1.95e-4)" "unprognostic (8.06e-2)" "unprognostic (2.39e-1)" "unprognostic (2.95e-1)" "unprognostic (8.77e-2)" 11.9 26.0 13.0 8.2 12.6 17.3 12.9 17.8 13.6 14.4 5.7 13.5 8.7 13.1 8.8 19.3 11.5 6.7 13.6 10.5 8.9 13.0 11.2 13.3 10.4 11.6 9.8 8.0 15.3 15.5 9.4 11.1 11.9 11.8 14.4 12.2 10.0 13.2 6.8 38.2 22.0 10.9 10.4 7.4 11.0 14.1 32.7 11.9 14.1 15.9 20.7 12.2 12.7 15.3 13.5 40.5 36.5 25.9 32.9 25.2 22.0 31.2 31.8 19.6 32.1 31.0 49.9 21.0 46.8 9.8 26.7 24.7 23.1 43.9 34.9 35.5 34.8 21.5 26.2 47.2 55.0 20.5 59.6 40.3 20.4 28.8 40.8 28.2 16.7 26.3 28.3 36.5 37.6 29.4 26.9 44.6 100.4 27.7 22.6 28.5 34.1 16.0 29.9 31.2 30.1 26.5 18.4 37.6 30.3 9.4 25.8 26.9 26.3 30.9 19.0 25.5 22.8 35.7 14.5 32.3 49.3 20.9 22.5 48.3 1.6 2.7 3.0 2.2 3.1 4.7 2.7 2.7 3.2 3.1 1.4 2.4 3.3 1.6 4.5 7.2 4.1 3.3 2.3 13.0 12.6 17.8 13.6 10.5 8.9 11.6 9.8 8.0 11.8 7.4 11.9 13.5 23.8 54.5 23.1 56.8 15.0 28.2 23.8 21.0 27.3 28.7 25.3 26.2 59.9 8.6 32.4 12.9 60.5 44.4 24.7 28.1 3.9 20.0 102.8 52.5 30.3 28.6 25.1 20.8 46.8 19.8 36.3 23.7 32.6 68.8 14.5 36.2 11.7 14.0 16.6 16.8 48.3 30.4 14.2 17.0 21.4 85.0 30.4 17.1 26.6 33.7 19.0 12.5 16.5 50.8 46.3 27.0 26.8 24.5 28.4 24.9 12.3 15.9 24.1 27.0 26.3 27.4 22.6 81.0 70.4 25.9 31.1 72.9 22.3 68.4 29.6 23.7 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32886601-33025130 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 9.5 14.9 15.2 7.0 15.1 11.1 10.5 15.2 20.4 8.9 14.3 10.3 8.7 8.6 7.7 14.8 9.0 4.9 9.4 15.2 15.9 11.9 15.8 9.4 8.2 15.1 15.0 14.6 8.6 9.6 12.2 7.6 7.9 15.5 9.7 11.3 8.0 9.1 6.6 9.9 15.0 8.4 8.7 15.1 9.0 9.8 14.8 15.3 9.4 7.1 6.9 11.1 10.5 9.7 15.4 36.2 26.1 18.4 17.1 19.0 17.4 25.6 24.8 26.0 28.7 31.5 35.1 12.7 27.8 14.6 21.1 18.4 19.4 33.7 32.8 35.1 39.2 11.2 17.9 32.5 37.8 24.4 29.4 15.1 23.8 36.3 32.5 37.9 16.9 26.8 20.2 27.0 24.2 26.0 15.6 24.4 43.2 33.5 24.4 29.0 21.2 14.4 21.5 25.2 21.2 15.6 11.1 21.4 18.0 15.5 17.9 23.0 11.4 17.7 16.2 21.1 29.9 25.0 11.1 21.2 27.5 23.4 23.8 13.2 3.3 14.7 13.4 12.2 15.6 15.2 16.3 12.8 14.6 17.6 16.1 16.0 12.1 5.9 23.1 21.7 15.2 17.3 16.1 15.2 15.1 15.2 20.4 15.2 15.9 15.1 15.0 14.6 15.5 15.1 15.3 15.4 14.8 19.2 29.0 31.3 16.9 16.7 23.1 32.9 22.2 15.2 17.9 17.0 14.9 21.5 23.1 9.2 10.4 27.7 15.1 12.6 29.4 25.3 55.6 19.7 18.3 13.3 16.8 20.0 27.3 28.2 27.7 15.6 19.4 18.1 16.5 17.8 8.9 21.4 18.8 13.5 29.0 15.3 34.6 14.7 9.9 48.7 13.4 15.0 14.2 15.9 19.3 18.3 15.5 23.6 43.0 31.9 6.8 10.5 28.3 24.0 13.9 31.7 25.4 16.6 13.1 13.5 20.2 42.2 26.9 25.8 21.2 27.9 15.9 20.5 16.3 23.1 RNF38 ENSG00000137075 "Ring finger protein 38" Q9H0F5 9 36336396-36487548 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 11 "Early spermatids: 503.1;Late spermatids: 1314.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015853 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015853: AB_1856365" "unprognostic (2.26e-1)" "unprognostic (2.49e-1)" "unprognostic (1.53e-1)" "unprognostic (8.16e-2)" "unprognostic (6.49e-2)" "unprognostic (3.65e-3)" "unprognostic (3.30e-3)" "unprognostic (1.64e-2)" "unprognostic (1.58e-1)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "prognostic favorable (2.90e-6)" "unprognostic (3.88e-2)" "unprognostic (5.94e-2)" "unprognostic (1.46e-1)" "unprognostic (5.39e-2)" 15.7 12.0 10.4 13.4 11.8 38.1 17.3 16.5 15.2 17.5 6.6 17.2 10.6 23.7 19.8 16.0 18.0 11.9 15.9 11.5 10.5 19.4 11.3 19.0 18.5 10.0 10.5 9.2 37.1 20.7 15.9 6.7 20.6 11.1 17.8 15.9 24.1 14.2 19.3 12.8 12.1 13.5 23.1 8.6 19.7 10.8 69.0 11.0 21.5 22.8 19.8 18.7 16.8 13.0 11.1 14.4 8.0 30.5 18.2 13.7 12.6 29.8 8.8 11.0 10.6 13.8 13.8 7.8 21.6 9.1 17.1 14.0 5.5 19.6 10.3 16.3 19.3 8.4 26.2 11.6 13.6 10.6 19.4 22.9 13.0 10.9 13.4 12.9 17.6 27.4 21.0 5.5 20.2 17.4 5.0 20.1 10.2 20.5 9.5 5.7 18.3 13.8 12.0 18.1 16.4 12.7 13.6 10.0 9.9 10.0 35.5 9.6 19.6 27.2 10.1 15.2 6.0 10.6 13.2 29.6 15.0 9.2 16.1 13.2 10.7 2.9 5.0 4.4 2.7 3.6 3.5 4.0 4.7 2.7 3.7 4.2 4.3 5.3 5.9 2.8 2.2 5.9 3.1 10.4 11.8 16.5 15.2 11.5 10.5 10.0 10.5 9.2 11.1 8.6 11.0 11.1 32.8 12.8 11.7 80.6 16.8 17.3 10.9 8.7 14.8 16.5 21.9 15.2 15.9 10.0 11.5 7.3 18.8 13.2 29.9 19.6 9.8 11.2 503.1 13.1 14.6 25.0 16.8 9.0 71.2 12.0 11.9 14.4 14.8 16.7 6.3 20.5 24.7 16.6 11.4 26.9 72.8 12.8 10.2 27.0 23.7 1314.3 32.9 19.0 19.6 82.4 19.5 19.3 20.6 53.3 81.5 14.5 6.8 39.9 18.6 23.9 10.4 16.5 10.1 23.2 13.1 19.3 20.9 40.4 20.2 14.4 14.9 14.9 23.3 13.2 14.3 17.5 TLN1 "ILWEQ, TLN" ENSG00000137076 "Talin 1" Q9Y490 9 35696948-35732195 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Macrophages: 323.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002006, HPA004748" Supported Supported "Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol" NA NA 1300000000 "Focal adhesion sites, Cytosol" "Plasma membrane, Centriolar satellite" "CAB002006: , HPA004748: AB_1857760" "unprognostic (9.71e-2)" "unprognostic (2.02e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (1.96e-1)" "unprognostic (5.55e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-2)" "unprognostic (5.07e-2)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "prognostic favorable (7.21e-4)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (7.83e-2)" "unprognostic (8.83e-3)" 126.9 63.2 30.9 85.5 37.8 79.9 80.1 37.6 27.4 80.0 45.1 149.8 36.9 153.1 25.5 78.7 103.8 53.7 80.9 23.4 45.0 47.4 42.7 92.6 63.6 48.3 39.0 17.5 66.6 33.4 41.9 37.0 71.0 43.9 73.2 41.8 7.8 42.9 112.5 71.5 43.5 78.5 146.7 39.8 90.4 92.6 23.5 39.4 61.7 49.4 56.3 53.1 149.0 66.8 42.1 63.4 103.8 62.7 86.9 210.8 158.7 71.4 171.2 186.8 162.9 146.4 86.3 27.4 76.5 55.5 319.0 103.0 33.3 74.2 106.9 118.3 172.8 48.0 173.0 132.1 77.4 130.6 105.8 276.2 193.4 50.2 240.1 112.7 223.7 253.4 64.7 60.2 76.0 218.5 27.8 71.5 27.8 51.3 28.4 78.8 95.0 36.6 44.8 81.4 49.8 14.1 59.6 83.7 46.3 53.4 56.5 39.3 72.6 308.5 257.8 99.6 80.0 140.6 26.2 27.6 51.7 199.9 55.9 238.4 6.0 5.9 7.3 5.4 6.1 4.4 2.6 3.1 4.1 4.3 2.3 1.4 3.1 10.0 4.1 8.1 5.4 2.3 6.9 30.9 37.8 37.6 27.4 23.4 45.0 48.3 39.0 17.5 43.9 39.8 39.4 42.1 123.2 109.0 66.9 11.4 99.8 40.1 69.4 43.5 42.7 11.7 40.3 61.3 134.1 31.5 55.7 53.3 10.4 44.3 186.3 43.8 23.5 94.3 47.2 36.0 156.9 106.8 34.1 127.0 7.7 61.9 82.6 103.9 51.0 73.0 206.6 72.0 93.9 54.7 112.4 15.2 7.6 29.0 26.4 196.9 91.0 26.4 99.4 323.4 23.2 21.5 174.1 33.0 288.4 4.5 9.1 107.7 33.2 128.6 61.4 58.4 40.6 62.8 34.3 17.6 203.8 126.5 267.9 32.0 28.5 47.4 26.6 58.8 143.8 89.4 28.9 46.4 CCL21 "6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4" ENSG00000137077 "C-C motif chemokine ligand 21" O00585 9 34709005-34710136 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 2748.4" "Cell type enriched" "Detected in many" 8 "Endothelial cells: 1213.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;K-562: 1.2" "Low region specificity" "Detected in some" HPA051210 Enhanced "Secreted to blood" NA NA 198000 920000 "HPA051210: AB_2681390" "unprognostic (3.06e-3)" "unprognostic (7.19e-3)" "unprognostic (9.89e-2)" "unprognostic (5.50e-2)" "unprognostic (4.51e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" "unprognostic (8.07e-2)" "unprognostic (4.15e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (8.99e-3)" "unprognostic (3.50e-3)" "unprognostic (1.58e-1)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 175.3 47.4 0.1 272.1 0.2 0.0 182.5 0.1 0.3 155.9 0.7 109.8 46.7 76.3 34.4 129.2 255.5 81.5 33.5 0.2 0.1 74.3 66.6 198.1 2748.4 0.4 0.1 0.2 34.1 15.4 0.9 2.5 1.8 0.2 38.5 137.0 0.0 21.7 19.2 6.9 45.9 503.0 69.6 0.0 339.8 61.4 10.4 0.1 29.1 523.8 30.9 1007.3 74.7 51.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.1 0.2 58.4 22.4 53.3 0.0 1.9 145.3 2.4 3.8 1.8 0.0 13.5 4.3 10.1 0.0 13.0 1.8 0.0 0.2 1.4 0.2 0.0 10.0 5.7 0.1 0.3 1213.6 0.0 2.7 0.0 3.6 0.2 22.9 0.0 0.2 11.4 0.0 107.1 0.5 0.6 0.0 0.0 2.1 0.0 1.8 148.8 11.0 0.6 6.5 144.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 29.6 1.5 0.0 0.0 10.2 0.0 0.0 3.4 120.0 0.2 0.3 11.5 137.7 0.3 9.2 0.0 0.0 0.4 SIT1 SIT ENSG00000137078 "Signaling threshold regulating transmembrane adaptor 1" Q9Y3P8 9 35649295-35650950 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 96.2" "Cell type enhanced" "Detected in some" "B-cells: 78.9;dendritic cells: 31.2;Plasma cells: 19.8;T-cells: 86.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 46 "gdT-cell: 119.1;MAIT T-cell: 202.7;memory B-cell: 213.6;memory CD4 T-cell: 249.2;memory CD8 T-cell: 223.4;naive B-cell: 192.1;naive CD4 T-cell: 170.4;naive CD8 T-cell: 169.5;plasmacytoid DC: 203.1;T-reg: 352.4" "Group enriched" "Detected in many" 56 "B-cells: 213.6;dendritic cells: 203.1;T-cells: 352.4" "Group enriched" "Detected in some" 5 "Daudi: 113.1;HDLM-2: 70.6;JURKAT: 58.7;U-698: 104.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA018506 Enhanced NA NA "HPA018506: AB_2669896" "unprognostic (4.28e-3)" "prognostic favorable (6.56e-4)" "unprognostic (8.01e-3)" "prognostic favorable (1.94e-6)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-4)" "unprognostic (1.75e-2)" "unprognostic (9.34e-3)" "prognostic favorable (8.17e-4)" "unprognostic (2.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.23e-1)" "unprognostic (1.47e-1)" "unprognostic (8.87e-2)" "unprognostic (6.34e-2)" 0.9 0.8 0.1 19.3 0.1 1.9 0.9 0.0 0.2 0.5 0.2 2.4 2.9 0.5 1.1 0.9 0.5 1.7 0.5 0.1 0.1 0.5 0.7 2.8 51.0 0.2 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.6 2.3 0.0 2.6 0.3 0.3 0.7 13.3 0.6 0.1 23.8 4.7 0.2 0.4 96.2 0.8 0.1 32.8 3.7 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 70.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.1 0.0 0.0 0.0 19.1 0.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.1 0.0 0.0 104.4 0.0 0.0 0.0 1.4 1.3 0.7 119.1 0.8 202.7 213.6 249.2 223.4 1.8 192.1 170.4 169.5 4.5 0.8 0.8 203.1 352.4 123.9 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.3 0.9 0.0 0.0 0.0 78.9 5.6 0.0 0.0 1.2 0.0 1.0 1.0 0.2 1.5 0.0 0.0 0.0 0.0 31.2 0.7 0.0 0.0 0.0 0.1 0.1 0.6 0.0 2.7 0.0 0.0 1.9 0.9 2.0 0.0 0.0 0.0 1.4 0.2 5.3 0.0 0.0 0.0 0.0 2.7 7.4 0.0 0.0 3.4 5.4 0.0 2.5 0.0 4.1 0.0 0.0 0.1 0.1 0.0 19.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.5 3.7 0.3 86.8 0.0 0.3 0.0 IFNA21 IFN-alphaI ENSG00000137080 "Interferon alpha 21" P01568 9 21165637-21166660 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRT1 "CT154, DMT1" ENSG00000137090 "Doublesex and mab-3 related transcription factor 1" Q9Y5R6 9 841690-969090 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 27.1" "Group enriched" "Detected in some" 5 "Early spermatids: 44.0;Spermatogonia: 153.2" "Cancer enriched" "Detected in some" 9 "testis cancer: 5.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA027850 Enhanced NA NA "HPA027850: AB_10600868" "unprognostic (3.23e-1)" "unprognostic (1.91e-1)" "unprognostic (9.75e-4)" "unprognostic (1.34e-1)" "unprognostic (2.50e-1)" "unprognostic (3.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (5.60e-2)" "unprognostic (3.06e-2)" "unprognostic (1.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 17.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.9 153.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAJB5 Hsc40 ENSG00000137094 "DnaJ heat shock protein family (Hsp40) member B5" O75953 9 34989641-34998900 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 166.0;tongue: 220.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 42.9;Smooth muscle cells: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 5.5;neutrophil: 5.2" "Group enriched" "Detected in many" 5 "dendritic cells: 5.5;granulocytes: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023818, HPA050794" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023818: AB_1847793, HPA050794: AB_2681241" "unprognostic (1.41e-2)" "unprognostic (3.87e-1)" "unprognostic (2.53e-3)" "unprognostic (5.21e-2)" "unprognostic (1.86e-1)" "unprognostic (3.54e-2)" "unprognostic (7.31e-2)" "unprognostic (2.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-1)" "unprognostic (4.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.00e-3)" 14.9 12.7 18.1 11.1 18.5 1.5 8.8 22.2 27.6 14.0 14.8 46.7 7.8 56.5 12.0 32.8 29.9 12.8 65.4 22.8 24.7 8.5 4.4 12.4 4.7 20.5 20.8 17.4 8.7 6.1 4.1 25.5 2.4 20.2 27.8 12.3 10.2 6.4 52.6 166.0 4.4 18.1 64.8 18.3 12.3 27.1 16.1 19.1 5.8 11.0 220.4 5.1 34.0 11.6 19.3 4.7 3.8 23.7 12.7 13.6 10.4 2.6 20.1 14.5 30.3 26.8 2.8 1.0 4.5 4.9 22.2 31.7 0.6 9.1 15.8 25.5 6.4 2.9 1.6 5.6 1.3 15.6 0.5 14.2 15.2 1.1 18.0 8.9 13.4 19.6 8.3 0.4 9.3 24.7 3.3 7.8 6.7 11.2 2.1 8.1 6.0 24.4 2.5 4.4 0.4 10.1 16.4 10.8 0.6 2.4 20.2 3.8 1.4 8.8 14.4 31.4 7.6 6.3 3.4 2.5 3.3 16.6 1.8 15.9 0.0 1.0 0.0 0.2 0.3 0.9 0.4 0.2 0.0 5.5 0.2 0.3 0.7 5.2 0.4 0.1 0.1 1.0 0.5 18.1 18.5 22.2 27.6 22.8 24.7 20.5 20.8 17.4 20.2 18.3 19.1 19.3 1.9 6.4 1.5 8.5 0.9 2.0 2.3 4.7 1.8 6.0 1.7 1.4 42.9 1.5 1.8 0.0 6.2 0.1 0.5 0.5 0.0 2.8 8.0 1.7 4.8 4.5 0.0 0.0 4.9 3.4 0.7 6.7 2.0 2.2 0.0 1.7 3.6 1.2 4.7 1.7 3.3 0.3 2.0 1.9 11.1 6.7 1.5 3.6 5.4 1.9 1.2 12.0 2.1 6.6 3.2 4.3 0.0 7.9 0.7 1.5 1.6 4.4 1.0 2.7 6.6 14.7 16.8 6.3 1.3 1.8 3.0 0.8 1.4 1.5 0.3 0.7 SPAG8 "BS-84, CT142, HSD-1, hSMP-1, SPAG3" ENSG00000137098 "Sperm associated antigen 8" Q99932 9 35808045-35812272 "Predicted intracellular proteins" "Cell cycle, Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 13.0;fallopian tube: 14.3;testis: 10.4" "Cell type enhanced" "Detected in many" "Early spermatids: 51.2;Endometrial ciliated cells: 75.7;Late spermatids: 26.5;Respiratory ciliated cells: 123.3;Spermatocytes: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "ASC diff: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068012 Enhanced NA NA "HPA068012: AB_2685941" "unprognostic (1.01e-4)" "unprognostic (3.52e-3)" "unprognostic (6.36e-3)" "prognostic favorable (2.15e-4)" "unprognostic (2.62e-1)" "unprognostic (5.04e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-2)" "unprognostic (1.59e-1)" "unprognostic (4.65e-2)" "unprognostic (1.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (5.41e-2)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-3)" 0.2 0.6 2.2 0.2 0.9 0.3 0.3 2.0 1.1 1.0 13.0 0.6 0.4 0.7 1.0 0.2 14.3 0.6 1.7 1.4 2.5 0.7 0.1 1.3 0.4 3.2 2.4 0.2 1.3 0.3 1.0 2.5 0.2 2.6 0.7 0.1 0.2 0.3 0.4 0.4 0.2 0.3 0.2 2.0 0.6 0.4 10.4 1.1 0.7 1.4 0.8 0.3 0.5 0.3 1.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.3 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 0.1 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.4 0.2 0.6 0.3 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.2 1.4 0.7 0.0 0.6 0.4 0.2 0.0 0.4 0.6 1.1 0.4 0.3 0.8 0.0 0.9 0.0 0.0 1.0 0.4 2.2 0.9 2.0 1.1 1.4 2.5 3.2 2.4 0.2 2.6 2.0 1.1 1.0 1.0 0.0 1.5 8.1 1.0 0.4 1.0 6.3 0.0 4.9 0.8 1.8 3.6 0.0 10.4 5.5 8.4 0.3 1.0 0.0 1.9 0.4 51.2 75.7 1.1 1.0 3.0 0.4 4.4 0.0 0.1 1.4 0.5 1.4 1.3 0.7 1.1 0.1 1.0 3.3 4.7 0.0 8.2 0.3 0.9 26.5 1.5 1.9 0.0 1.0 1.9 5.7 0.0 3.0 7.0 0.1 0.0 1.2 0.9 0.6 0.1 1.6 123.3 8.5 0.0 1.5 4.5 58.8 3.1 0.0 0.6 0.1 1.1 1.4 0.1 0.3 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 70.8 88.6 91.7 34.0 99.3 108.2 72.8 91.0 124.4 77.6 85.2 71.7 42.4 73.5 47.2 99.3 67.0 39.0 118.4 98.0 97.2 88.9 67.5 61.4 48.4 92.5 92.4 95.3 79.3 77.1 95.2 109.2 41.1 94.8 68.7 39.4 57.5 69.8 51.9 153.9 110.9 51.6 54.1 87.2 59.1 76.2 36.5 94.2 82.1 72.1 115.4 59.5 70.1 79.9 93.2 147.1 120.7 110.1 115.6 95.1 132.3 45.1 122.7 112.8 166.4 130.2 77.7 53.8 67.0 74.6 161.8 58.4 57.4 101.0 128.3 105.6 211.9 126.5 44.9 202.9 68.5 102.6 118.8 131.3 117.5 109.4 115.6 75.0 81.4 111.1 123.6 54.2 135.3 147.4 120.9 151.4 320.0 33.4 61.0 192.7 75.2 59.7 93.4 81.5 51.2 36.5 93.3 90.9 82.7 48.0 32.2 110.6 134.5 102.7 104.6 84.1 120.1 121.0 90.6 126.0 45.5 164.1 68.6 217.4 235.2 131.1 187.4 99.9 139.4 92.1 88.4 106.0 106.8 133.8 94.7 83.6 98.9 114.4 102.2 150.3 136.1 179.1 152.5 91.7 99.3 91.0 124.4 98.0 97.2 92.5 92.4 95.3 94.8 87.2 94.2 93.2 103.7 32.1 38.3 13.1 61.3 101.6 111.8 180.7 82.0 83.2 97.3 146.9 86.1 77.2 91.8 80.9 25.0 128.8 105.6 74.1 207.4 127.5 14.3 78.6 98.8 79.2 74.7 115.7 16.8 154.6 111.9 97.9 56.6 67.1 87.5 82.4 88.5 84.9 133.8 74.0 16.2 64.9 91.6 88.8 99.0 21.1 103.5 76.8 149.4 5.6 94.9 212.9 125.7 7.5 16.8 126.7 84.5 122.6 89.1 54.7 89.0 240.2 95.0 96.7 59.2 82.0 150.5 82.2 72.9 109.9 142.6 99.7 95.7 143.2 61.6 96.6 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609979-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 65.6" "Cell type enhanced" "Detected in many" "B-cells: 95.6;dendritic cells: 18.3;Hofbauer cells: 18.7;Kupffer cells: 25.6;Macrophages: 21.1;NK-cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "memory B-cell: 232.9;naive B-cell: 413.5" "Lineage enriched" "Detected in all" 20 "B-cells: 413.5" "Cell line enhanced" "Detected in some" "Daudi: 21.4;Karpas-707: 14.5;REH: 7.8;U-698: 44.4" "Region enriched" "Detected in single" 7 "basal ganglia: 4.1" "Low region specificity" "Detected in single" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: AB_2679039" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 4.5 2.3 2.6 20.8 2.7 6.7 1.7 2.7 5.1 1.4 4.6 1.9 1.3 1.1 4.8 0.6 1.2 4.1 0.7 2.5 3.2 2.0 6.0 2.8 65.6 3.4 2.6 2.4 0.8 2.2 1.1 2.6 3.4 3.3 1.5 1.3 0.4 1.6 0.7 0.6 2.0 8.5 1.6 2.6 54.1 2.6 0.8 3.6 7.0 2.5 0.0 50.6 4.2 0.9 3.2 0.1 0.0 0.6 0.5 0.9 5.2 0.1 0.3 0.1 0.4 0.7 0.0 0.2 21.4 0.1 0.3 0.1 0.0 0.0 0.1 0.5 1.8 0.4 0.6 0.2 0.0 0.5 0.3 4.1 1.5 0.0 0.2 0.4 0.9 0.0 4.9 0.0 14.5 1.1 0.0 0.3 2.7 0.2 0.0 0.1 7.8 0.0 5.5 0.0 0.0 0.3 0.5 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.7 0.2 0.2 0.0 0.3 0.3 44.4 0.8 0.5 0.0 0.6 2.0 0.3 3.1 3.5 4.3 232.9 1.5 2.2 20.2 413.5 0.7 2.4 1.4 10.6 0.5 11.0 1.7 14.8 2.6 2.7 2.7 5.1 2.5 3.2 3.4 2.6 2.4 3.3 2.6 3.6 3.2 0.7 0.0 0.6 5.9 95.6 1.0 0.5 0.9 0.6 0.0 1.3 1.3 1.1 1.5 0.4 3.7 0.0 0.2 18.3 0.7 0.0 0.8 0.2 0.4 0.6 0.9 1.8 2.7 1.0 0.7 0.3 0.9 1.1 0.4 0.0 0.8 0.7 0.2 18.7 0.0 1.2 0.2 0.0 25.6 14.6 0.3 0.9 21.1 0.0 0.0 3.0 0.6 19.6 2.0 4.4 1.1 0.0 0.4 2.7 0.5 0.6 0.7 1.3 0.7 0.0 0.5 0.9 1.1 1.7 0.2 1.1 0.3 5.9 0.5 0.4 0.4 TMEM8B "C9orf127, FP588, LINC00950, NAG-5, NGX6, NGX6a" ENSG00000137103 "Transmembrane protein 8B" A6NDV4 9 35814451-35865518 "Predicted membrane proteins, Transporters" "Cell adhesion, Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 36.1;Granulosa cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 51.2" "Lineage enriched" "Detected in many" 24 "dendritic cells: 51.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052130, HPA062701" Approved Approved Vesicles NA NA Vesicles "HPA052130: AB_2681740, HPA062701: AB_2684839" "unprognostic (5.54e-2)" "unprognostic (3.32e-1)" "unprognostic (3.96e-1)" "unprognostic (3.53e-2)" "unprognostic (3.81e-1)" "unprognostic (1.42e-1)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (2.97e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.14e-4)" "unprognostic (5.93e-2)" "prognostic favorable (1.89e-15)" "unprognostic (8.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" 10.2 21.3 19.1 3.2 15.3 1.8 12.4 10.6 20.2 21.8 2.6 17.2 5.1 20.3 6.2 5.7 21.0 6.7 15.3 19.5 13.0 15.3 6.4 10.3 3.6 13.6 14.6 16.6 33.9 11.9 17.9 30.8 4.5 13.5 24.1 5.5 7.8 18.2 14.3 12.9 9.3 9.6 7.0 11.6 8.6 17.8 19.2 18.4 5.3 22.9 9.7 2.6 19.4 15.8 12.8 3.1 3.4 11.7 9.2 12.9 10.7 1.4 2.8 5.5 3.1 3.8 1.4 0.8 2.5 6.5 7.7 9.1 1.2 3.1 4.7 2.5 1.9 5.2 0.7 2.5 3.4 9.1 0.2 0.2 10.1 6.1 3.2 3.4 10.0 1.8 11.5 1.2 6.9 5.5 1.2 6.6 1.4 1.6 2.7 4.6 7.2 2.4 6.2 3.3 1.5 2.8 8.1 4.3 1.8 4.1 3.8 3.2 1.1 2.9 7.3 2.2 7.2 1.1 8.6 2.8 2.8 6.7 1.2 4.6 0.7 2.1 0.2 0.5 0.1 0.3 0.6 0.4 0.4 8.2 0.5 0.4 0.4 0.9 0.7 0.1 51.2 0.2 1.3 19.1 15.3 10.6 20.2 19.5 13.0 13.6 14.6 16.6 13.5 11.6 18.4 12.8 4.4 12.8 12.2 18.9 3.3 4.5 9.1 8.1 8.0 4.1 12.1 11.4 11.7 10.0 9.1 14.7 2.1 34.1 36.1 8.2 1.9 5.7 25.4 7.7 8.4 3.2 6.7 0.8 12.4 4.0 9.2 9.2 11.2 6.3 1.3 47.3 1.8 4.0 3.2 1.7 13.0 7.0 12.2 1.3 11.2 14.0 14.6 5.3 10.6 10.3 3.6 9.1 2.1 12.1 7.2 3.6 8.0 19.5 2.6 9.0 3.0 4.5 7.5 5.3 6.6 7.1 8.7 8.6 5.2 1.9 1.6 13.0 3.6 8.1 7.8 10.0 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 657.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 864.6;Proximal tubular cells: 817.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022971, HPA078575" Enhanced Approved Nucleoplasm,Cytosol NA NA 2700000 Cytosol Nucleoplasm "HPA022971: AB_1849975, HPA078575: " "prognostic favorable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 58.3 144.3 71.0 35.8 81.7 40.8 56.2 82.2 74.9 51.9 73.1 57.9 64.0 59.0 63.1 63.1 51.4 37.0 98.5 68.0 74.7 158.0 657.8 43.3 56.3 75.5 75.6 64.3 63.9 64.7 49.5 36.0 35.5 77.6 51.2 35.8 21.0 75.4 46.9 170.1 63.4 51.8 43.2 75.6 42.0 61.2 38.2 77.5 35.0 43.8 147.7 52.0 53.4 52.3 88.6 111.7 157.7 87.5 81.0 80.1 86.4 87.7 86.2 114.3 115.8 125.2 60.3 47.2 106.5 50.0 105.3 85.8 49.3 51.7 113.5 69.3 140.3 62.8 61.6 144.1 107.5 124.3 58.7 61.6 104.2 97.2 67.6 87.4 98.0 102.2 67.5 116.1 42.9 104.2 85.3 58.9 60.8 53.5 101.1 67.5 55.4 62.1 59.1 155.9 63.0 36.3 64.3 74.4 143.8 84.1 79.1 80.1 75.7 109.7 63.5 100.4 44.0 76.9 33.1 27.4 70.8 90.8 33.5 95.7 45.0 64.7 33.9 39.3 66.9 32.7 61.6 40.8 44.6 70.3 65.6 39.6 33.9 14.5 64.5 56.7 63.4 57.8 52.0 71.0 81.7 82.2 74.9 68.0 74.7 75.5 75.6 64.3 77.6 75.6 77.5 88.6 50.7 57.7 30.2 24.2 37.5 43.3 52.5 87.3 41.5 39.0 53.7 65.7 103.7 177.3 53.8 51.5 20.9 152.6 33.9 65.3 248.4 78.0 14.9 38.4 65.4 47.9 62.2 54.7 10.3 89.0 93.0 67.7 52.0 44.8 50.1 93.3 67.5 864.6 110.8 23.5 11.0 79.7 71.2 82.9 45.8 16.0 74.6 49.2 80.0 14.0 71.1 102.8 33.0 16.1 44.9 73.8 56.9 98.6 30.1 46.4 135.6 817.7 36.0 29.1 78.9 54.3 71.8 22.3 19.0 74.6 56.3 88.9 32.5 233.3 80.9 48.1 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392702-38398661 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 174.0;smooth muscle: 129.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 183.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Mitochondria,Cytosol NA NA 500000 Mitochondria "Nucleoplasm, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 21.4 10.5 3.2 31.7 3.2 3.0 9.0 4.3 4.2 7.9 6.6 50.1 23.1 58.1 5.8 33.0 35.2 29.3 14.8 3.0 4.9 59.8 174.0 7.3 5.1 3.8 3.5 3.6 12.7 11.3 8.6 2.5 5.2 4.6 37.3 35.9 1.6 11.2 55.0 56.3 5.2 25.0 129.2 3.5 7.2 28.5 8.4 4.3 5.1 15.5 36.2 5.7 85.8 10.6 4.3 72.2 65.5 19.8 31.8 27.6 32.5 15.8 33.6 16.9 27.8 28.3 44.2 13.7 45.2 19.7 47.4 42.0 10.0 66.0 71.4 27.4 50.8 28.5 22.4 44.7 132.2 20.0 36.0 24.0 39.0 15.3 22.6 19.5 56.6 26.8 10.6 65.6 42.8 42.8 27.3 0.1 14.4 59.1 183.3 29.0 14.9 119.9 34.5 25.1 31.7 43.3 19.9 25.7 16.7 19.4 20.6 15.9 27.9 18.2 31.9 52.4 26.9 42.5 6.5 13.2 17.8 16.4 36.0 22.1 0.3 4.2 0.2 6.7 9.2 9.6 5.5 6.5 6.1 9.5 2.6 5.1 6.2 1.0 8.0 11.9 1.2 5.0 5.3 3.2 3.2 4.3 4.2 3.0 4.9 3.8 3.5 3.6 4.6 3.5 4.3 4.3 3.3 9.6 1.7 0.0 3.7 1.0 5.7 9.4 2.2 1.2 3.7 4.2 6.6 85.8 3.8 16.5 2.1 2.0 1.2 12.8 17.6 64.1 0.6 2.3 6.4 4.7 15.6 12.8 0.5 6.9 46.6 6.6 8.2 3.4 8.9 12.8 8.9 128.1 7.2 0.0 1.1 25.5 6.1 4.1 2.4 2.2 6.5 4.2 0.0 0.0 5.5 2.1 0.0 0.5 0.5 15.0 7.7 6.8 3.7 6.1 10.3 165.0 0.3 0.7 0.0 6.0 16.1 0.6 0.8 2.1 1.0 1.8 3.3 91.7 71.7 2.8 HINT2 ENSG00000137133 "Histidine triad nucleotide binding protein 2" Q9BX68 9 35812960-35815354 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 633.9;Hepatocytes: 457.4;Proximal tubular cells: 578.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020961, HPA059109" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA 110000 Mitochondria "HPA020961: AB_1850715, HPA059109: AB_2683906" "unprognostic (9.64e-3)" "unprognostic (1.53e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (3.97e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.71e-3)" "unprognostic (2.87e-2)" "prognostic favorable (2.97e-9)" "unprognostic (4.29e-2)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (1.72e-1)" 48.7 80.1 41.7 15.6 42.8 27.2 48.9 45.4 47.1 23.0 39.5 40.6 35.2 26.1 49.0 27.7 30.2 15.1 74.0 39.4 47.0 91.5 170.6 30.5 21.2 43.0 42.5 38.1 19.4 66.4 73.2 41.5 17.7 42.3 34.2 34.6 20.6 40.0 26.4 80.9 33.6 34.5 20.3 43.2 34.1 57.4 30.1 45.1 39.2 38.7 86.3 24.0 30.8 24.4 43.4 30.3 76.1 47.1 45.6 29.0 24.3 33.2 27.8 39.2 42.3 46.1 49.9 31.1 39.9 31.7 25.3 59.8 29.3 21.2 40.9 44.1 87.8 40.7 42.2 64.1 45.8 68.1 25.1 40.0 27.3 36.8 40.2 64.8 16.7 33.2 91.4 25.5 117.4 34.0 60.3 61.3 31.3 21.4 70.0 138.7 60.8 33.1 53.6 61.5 21.5 38.4 46.4 36.0 42.7 49.6 27.5 45.9 44.6 16.5 22.0 37.7 30.4 35.7 107.0 127.3 57.4 49.8 32.2 36.2 41.0 77.5 4.7 68.9 58.5 62.4 98.9 73.7 69.8 113.4 96.7 56.4 58.6 7.6 66.8 56.9 246.1 107.3 81.2 41.7 42.8 45.4 47.1 39.4 47.0 43.0 42.5 38.1 42.3 43.2 45.1 43.4 49.3 22.4 17.5 5.2 57.9 45.4 63.4 137.6 49.5 39.8 99.1 105.8 115.1 130.1 68.3 80.9 20.9 154.9 69.3 148.2 633.9 115.5 67.3 83.9 28.6 47.8 96.0 100.8 1.7 172.1 71.7 53.2 52.5 44.6 18.4 43.5 63.1 457.4 113.9 20.2 2.5 127.4 126.1 61.1 51.4 128.0 40.4 47.7 120.9 1.9 74.1 123.7 87.6 1.5 4.5 85.6 157.5 44.8 77.7 40.7 181.4 578.1 105.1 45.5 46.0 54.2 72.6 38.4 77.4 64.7 45.9 56.8 51.0 85.1 126.7 84.8 ARHGEF39 "C9orf100, FLJ14642" ENSG00000137135 "Rho guanine nucleotide exchange factor 39" Q8N4T4 9 35658875-35675866 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 98.2;Erythroid cells: 16.6;Extravillous trophoblasts: 19.5;Late spermatids: 36.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 2.7" "Low region specificity" "Detected in all" HPA061299 Uncertain NA Yes "HPA061299: AB_2684473" "unprognostic (2.93e-1)" "unprognostic (3.90e-1)" "unprognostic (3.31e-2)" "unprognostic (3.40e-2)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (3.60e-2)" "unprognostic (8.55e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.14e-1)" "unprognostic (9.75e-2)" "unprognostic (6.04e-9)" "unprognostic (3.31e-3)" "unprognostic (3.38e-1)" "unprognostic (5.14e-2)" "unprognostic (1.46e-1)" 2.4 1.8 0.0 1.6 0.1 1.9 2.3 0.9 0.2 1.8 0.2 3.5 2.1 2.5 0.1 1.5 2.0 0.8 1.9 0.1 0.1 1.2 1.2 1.8 2.1 0.1 0.1 0.1 1.2 1.7 0.0 0.9 0.7 0.4 2.5 1.1 1.5 1.0 0.2 0.7 1.2 2.3 0.3 0.0 2.0 3.0 1.1 0.1 1.6 1.2 0.0 1.3 3.1 1.7 0.2 5.2 7.7 7.4 3.6 0.0 0.2 4.9 3.7 1.4 3.3 2.9 8.7 4.0 3.2 2.2 0.5 4.6 3.8 3.7 2.2 1.3 9.5 5.8 5.1 11.3 3.3 0.0 4.3 7.5 0.2 0.2 1.6 0.9 1.0 1.2 4.6 3.6 2.9 1.4 2.6 1.1 2.4 4.7 3.7 2.5 4.4 5.7 1.9 1.2 2.2 5.2 2.1 1.9 4.1 1.0 3.0 6.1 2.5 0.7 2.3 7.4 2.7 2.7 2.8 3.7 1.4 1.4 2.3 5.1 0.3 0.2 0.2 0.5 0.1 0.7 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.2 0.4 0.2 0.1 0.4 0.1 0.0 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.7 0.0 0.0 0.0 2.1 2.7 1.4 1.6 0.6 2.1 1.6 3.4 1.4 1.5 1.0 1.8 0.0 8.1 3.6 1.7 0.0 1.0 98.2 0.6 1.6 1.3 3.5 16.6 0.4 0.8 19.5 2.0 14.8 1.1 0.0 4.1 1.8 0.5 5.3 0.0 0.5 4.1 0.0 2.5 5.0 36.1 0.9 2.0 5.4 0.0 0.4 1.6 3.1 0.5 0.3 0.5 0.3 0.4 2.6 1.2 1.5 0.3 1.2 2.4 0.0 2.6 3.3 3.3 5.4 3.5 2.0 1.9 3.1 0.5 6.9 0.8 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38406528-38424454 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "thyroid gland: 16.6" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;Excitatory neurons: 2.5;Hofbauer cells: 1.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 2.5;Spermatogonia: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 360.4;NTERA-2: 104.2;RH-30: 97.5;SCLC-21H: 334.3;SH-SY5Y: 332.6;SuSa: 241.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 0.8 1.5 2.2 0.6 3.9 0.5 0.1 3.2 2.8 0.2 1.3 0.5 0.9 0.7 0.1 0.3 0.3 0.6 0.6 2.7 1.9 0.2 0.3 0.8 0.2 1.6 2.3 2.4 0.1 0.9 0.0 1.1 0.6 2.2 0.4 0.3 0.3 0.1 1.6 0.2 0.2 0.6 1.1 0.9 0.1 1.6 2.1 2.4 2.9 16.6 0.0 0.1 0.5 0.1 2.4 0.0 8.6 360.4 0.4 0.0 0.0 0.2 2.4 0.0 0.5 0.3 0.1 0.2 0.1 1.3 0.3 0.0 0.1 44.0 0.0 0.5 0.0 2.7 0.1 1.2 0.2 0.0 1.7 1.2 0.4 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.2 2.5 0.1 0.3 0.2 104.2 0.5 0.7 0.1 97.5 0.9 0.0 0.2 334.3 332.6 6.4 0.5 0.0 241.3 2.3 2.3 0.4 0.1 7.7 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.0 2.2 3.9 3.2 2.8 2.7 1.9 1.6 2.3 2.4 2.2 0.9 2.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.3 0.6 0.1 0.0 1.8 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 DENND4C "bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF" ENSG00000137145 "DENN domain containing 4C" Q5VZ89 9 19230435-19374281 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 120.9;Oligodendrocyte precursor cells: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014917, HPA015096" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA014917: AB_2261659, HPA015096: AB_1845831" "unprognostic (4.57e-2)" "unprognostic (1.73e-2)" "unprognostic (6.81e-2)" "unprognostic (1.71e-1)" "unprognostic (1.87e-2)" "unprognostic (1.48e-1)" "unprognostic (2.43e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.51e-5)" "unprognostic (3.27e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" 19.9 12.0 5.7 9.3 7.0 10.7 21.9 14.3 6.8 15.8 8.1 17.5 25.4 17.3 14.4 14.6 16.5 13.9 12.0 5.5 9.4 14.1 15.3 18.1 11.9 5.8 6.4 3.6 21.6 13.0 19.2 8.8 19.8 7.0 16.3 20.0 11.9 15.2 13.5 10.7 29.9 22.6 14.7 6.0 12.8 20.0 11.3 7.0 17.8 17.5 12.5 11.3 16.8 16.1 6.7 17.7 17.5 11.7 15.3 26.6 28.5 21.4 10.0 14.9 10.2 13.7 8.4 11.6 7.5 8.3 13.6 11.8 9.4 13.7 9.4 12.0 47.2 7.8 34.4 18.5 10.4 13.4 8.3 18.8 11.7 18.7 9.0 15.5 21.6 20.2 9.9 9.4 8.5 13.1 7.4 13.8 18.8 9.0 24.7 8.5 12.6 6.6 10.9 29.2 34.1 10.9 8.5 8.4 20.1 7.4 11.0 12.1 11.3 18.5 8.9 5.2 10.0 10.5 5.8 14.9 4.0 7.7 7.6 5.2 8.3 1.6 1.9 5.4 0.8 7.0 1.7 4.6 5.5 3.1 2.3 4.3 5.0 0.9 6.4 0.9 3.2 3.8 2.4 5.7 7.0 14.3 6.8 5.5 9.4 5.8 6.4 3.6 7.0 6.0 7.0 6.7 28.6 9.6 11.5 85.8 21.3 51.2 16.7 18.0 65.4 20.9 16.0 11.0 12.4 14.3 21.6 16.5 60.5 29.4 22.6 26.6 1.9 9.8 7.7 12.7 15.5 22.9 19.8 9.7 78.6 12.5 13.5 24.0 47.4 20.4 27.1 24.8 51.0 11.5 19.0 23.5 87.2 22.6 24.4 23.9 22.0 5.2 18.6 32.2 21.4 120.9 8.5 13.6 27.8 107.1 69.1 12.1 20.9 20.3 14.1 19.4 26.4 4.9 21.6 16.3 0.0 19.5 16.2 3.3 6.8 30.9 49.3 16.1 28.2 12.0 23.3 23.2 RPS6 S6 ENSG00000137154 "Ribosomal protein S6" P62753 9 19375715-19380236 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 16920.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004027, HPA031153" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 320000 "Endoplasmic reticulum, Cytosol" "CAB004027: AB_2238583, HPA031153: AB_10602245" "unprognostic (3.95e-3)" "unprognostic (2.08e-1)" "unprognostic (6.34e-2)" "prognostic favorable (4.12e-4)" "unprognostic (1.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" "unprognostic (2.76e-1)" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (8.36e-3)" "unprognostic (2.06e-3)" 2357.1 1540.3 1255.9 1496.7 1304.3 4022.6 3101.0 1227.2 1892.8 2691.2 1241.7 2039.9 1498.5 2024.9 1873.5 2810.8 2211.5 935.5 1427.1 1162.1 1301.8 1809.4 1341.7 1533.3 2985.3 1307.6 1255.6 1127.2 4593.4 3849.4 1078.4 1438.5 1017.3 1316.7 2269.7 1658.7 722.6 2084.9 978.6 1762.3 3341.0 1945.3 1133.9 1335.5 2048.8 2140.4 703.0 1303.9 2363.0 1677.1 1261.8 2514.2 2398.4 2559.8 1366.6 3146.0 2013.7 2004.4 2363.6 3318.8 5075.0 2399.4 2066.1 2675.8 2423.3 2011.5 1686.4 1409.3 7139.0 1986.4 1988.0 859.3 1500.9 2274.1 3180.3 2611.8 3750.0 2173.6 4721.4 2328.7 3106.0 4041.3 2533.2 2256.0 4248.4 5692.5 1620.0 4727.2 3469.1 2964.4 3160.6 2022.8 2830.1 2653.9 1886.9 5406.2 16920.1 3772.8 2466.3 1354.6 4159.9 2025.5 3447.5 3412.7 2646.9 1993.2 2674.3 781.7 3280.0 4564.1 1597.1 2139.0 9080.4 2194.5 1386.6 1486.6 1453.3 3293.5 1324.9 2750.6 4935.9 939.6 3747.0 829.8 1125.0 2374.7 735.3 3116.0 2085.1 5427.4 7104.3 5693.8 4240.7 4059.2 6035.0 7515.6 6032.8 374.2 4153.1 1946.8 3766.4 4744.0 14744.9 1255.9 1304.3 1227.2 1892.8 1162.1 1301.8 1307.6 1255.6 1127.2 1316.7 1335.5 1303.9 1366.6 1666.2 1653.8 3379.0 28.7 5653.1 9735.5 13864.1 9387.7 4797.6 270.6 10286.6 10100.4 820.4 2965.4 5237.5 1276.3 127.2 5414.0 3535.8 1396.0 5791.2 3073.2 2516.7 1356.0 3150.4 3882.7 2052.9 3987.8 23.0 6777.1 9231.6 2652.7 1988.8 1730.0 3234.5 2265.7 4298.1 2248.6 4065.7 75.7 23.7 4887.3 2541.0 4150.7 6491.3 7208.8 4631.0 3029.8 4605.0 37.5 5131.6 1404.2 4136.0 25.1 42.9 4532.4 4207.9 2423.4 2549.8 11104.9 2807.8 6997.6 2168.7 461.5 1485.7 4699.9 4234.9 1260.7 962.3 6520.0 12082.7 5409.2 4876.4 2935.1 6434.2 12610.3 CNPY3 "CAG4A, TNRC5" ENSG00000137161 "Canopy FGF signaling regulator 3" Q9BT09 6 42929192-42939294 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" Chaperone "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 248.5;Kupffer cells: 233.3;monocytes: 207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016560 Uncertain "Intracellular and membrane" NA NA 4100000 "HPA016560: AB_1858173" "unprognostic (5.26e-3)" "unprognostic (6.63e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (8.15e-2)" "unprognostic (3.12e-1)" "unprognostic (1.79e-1)" "unprognostic (5.70e-3)" "unprognostic (5.11e-2)" "unprognostic (4.77e-2)" "unprognostic (1.94e-2)" "unprognostic (2.26e-3)" "unprognostic (4.54e-2)" "prognostic unfavorable (9.85e-6)" "unprognostic (2.34e-1)" "unprognostic (1.93e-2)" "unprognostic (2.21e-2)" "unprognostic (2.98e-3)" 35.7 31.7 58.8 64.9 58.7 145.9 33.1 58.9 73.4 40.0 68.8 31.2 31.1 37.8 32.6 23.6 50.2 38.2 28.9 58.9 66.0 30.8 65.2 45.8 79.2 68.0 59.8 54.0 49.0 90.8 29.3 42.0 48.0 65.6 45.5 29.9 24.1 32.8 34.1 11.0 21.8 50.5 42.4 67.8 106.0 37.0 47.0 62.6 116.9 34.4 16.9 69.8 43.7 30.2 76.8 78.2 75.6 72.8 157.0 118.4 44.8 73.5 60.3 78.9 79.1 91.0 85.2 57.0 82.1 91.0 102.9 170.8 63.7 54.7 68.7 48.2 82.7 61.6 88.6 65.2 134.0 70.0 155.7 173.3 54.3 41.7 61.2 67.4 113.9 72.4 77.6 73.3 157.3 51.9 147.9 141.4 188.8 59.1 367.3 42.1 97.2 50.6 123.2 79.6 58.6 78.5 68.9 37.7 38.6 134.4 93.4 49.8 334.6 54.6 82.7 82.9 30.9 66.0 107.0 78.9 115.0 34.2 178.6 70.9 212.7 483.3 249.0 115.2 336.3 110.9 267.3 101.1 126.1 407.0 258.7 112.6 115.1 852.8 132.3 327.2 696.4 102.2 404.5 58.8 58.7 58.9 73.4 58.9 66.0 68.0 59.8 54.0 65.6 67.8 62.6 76.8 32.3 12.8 11.1 4.2 132.1 22.8 32.1 41.1 31.9 41.6 25.6 29.7 16.9 22.8 26.2 23.9 14.6 51.1 176.5 16.7 7.9 47.4 61.0 25.9 24.2 36.7 55.3 47.9 5.1 34.1 180.8 33.9 20.9 31.8 46.3 81.5 42.1 58.9 248.5 1.7 6.7 31.1 34.6 233.3 61.7 81.7 33.5 184.3 30.2 18.7 207.0 20.8 62.8 4.5 6.6 27.9 34.9 30.1 70.7 50.8 38.4 18.1 32.8 11.1 19.7 12.6 28.0 72.3 39.9 23.9 17.0 36.1 64.1 39.8 36.5 37.9 FOXP4 FLJ40908 ENSG00000137166 "Forkhead box P4" Q8IVH2 6 41546381-41602384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 40.2;Gastric mucus-secreting cells: 56.6;Intestinal goblet cells: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "CACO-2: 113.9;OE19: 118.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007176 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007176: AB_1078911" "unprognostic (8.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.17e-6)" "unprognostic (3.20e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.13e-2)" "unprognostic (7.86e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-3)" "unprognostic (9.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-2)" 15.7 10.7 8.3 11.1 5.1 4.9 18.8 2.7 10.5 29.1 2.0 21.8 20.1 32.7 2.1 15.5 16.4 9.2 19.0 9.4 6.1 19.9 28.8 17.5 9.6 12.4 7.7 4.6 16.8 35.1 6.3 20.1 5.1 11.2 33.8 6.0 2.9 31.9 10.4 14.4 12.6 18.9 9.2 2.9 8.1 50.5 28.1 10.7 6.9 32.2 4.4 6.0 17.0 15.8 10.7 25.8 36.2 41.2 45.7 7.1 2.5 44.0 14.5 6.8 11.2 7.8 113.9 8.0 29.9 25.7 7.8 33.3 19.3 11.4 13.2 4.1 25.1 20.7 24.2 20.1 74.9 14.1 15.1 19.3 6.6 14.1 10.4 5.6 15.8 10.9 17.6 30.2 11.6 5.0 70.5 17.5 22.4 10.8 118.6 11.7 19.3 13.8 20.9 8.6 22.2 11.9 17.0 15.2 35.4 23.3 10.5 20.0 35.3 17.0 15.1 37.3 24.0 24.0 9.1 6.2 40.9 12.3 25.8 14.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 8.3 5.1 2.7 10.5 9.4 6.1 12.4 7.7 4.6 11.2 2.9 10.7 10.7 1.1 0.0 11.7 4.6 6.2 9.2 5.8 5.1 2.8 5.2 19.2 15.2 21.0 7.2 4.8 5.5 2.1 2.6 4.3 22.0 0.0 8.7 26.9 6.3 1.9 3.4 40.2 0.8 2.5 16.1 3.4 4.6 56.6 9.5 3.8 15.0 13.6 21.0 4.1 0.0 1.9 41.7 8.2 4.2 7.0 21.0 4.1 4.4 1.8 1.0 5.4 1.2 7.2 6.6 3.5 20.9 20.3 8.6 3.6 14.7 15.8 8.8 3.4 2.7 13.1 4.8 8.4 2.2 13.1 7.6 7.7 4.4 4.0 0.6 17.4 10.2 PPIL1 CYPL1 ENSG00000137168 "Peptidylprolyl isomerase like 1" Q9Y3C6 6 36854827-36874803 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062916 Supported Nucleoli NA NA 21000 Nucleoli "HPA062916: AB_2684904" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-3)" "unprognostic (1.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (2.01e-1)" "unprognostic (3.37e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.58e-2)" "unprognostic (5.49e-2)" "unprognostic (8.99e-2)" "unprognostic (1.30e-1)" "unprognostic (2.30e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-2)" 12.5 21.9 20.1 19.3 20.6 11.5 18.6 21.7 27.6 15.2 21.8 14.8 13.4 15.9 19.3 17.2 23.2 10.8 43.2 19.1 23.6 19.1 21.7 10.6 22.1 21.6 20.5 18.4 17.8 14.5 21.9 12.1 22.5 22.1 17.0 17.8 29.3 19.7 17.8 18.6 9.6 11.4 23.1 21.4 9.6 13.0 23.4 20.9 18.8 33.5 20.9 24.8 20.7 8.1 22.2 69.2 50.0 111.2 78.5 19.7 31.5 77.5 60.9 41.0 82.7 70.0 89.7 39.7 87.7 75.5 41.9 105.5 55.4 135.1 92.7 96.2 81.3 114.6 102.7 33.6 147.7 53.5 89.3 40.8 24.7 48.7 62.3 118.9 31.8 75.5 79.1 202.4 48.0 63.3 71.2 101.9 69.8 92.3 108.5 57.9 79.4 100.2 92.0 63.2 53.5 140.0 68.5 41.8 51.4 102.5 83.5 76.3 100.2 44.0 66.7 69.0 58.5 98.8 57.0 145.2 153.0 23.7 183.7 139.4 1.6 4.8 1.3 14.7 6.2 19.7 10.3 12.1 13.9 9.2 7.4 13.4 15.9 1.2 7.3 3.4 7.8 10.2 9.8 20.1 20.6 21.7 27.6 19.1 23.6 21.6 20.5 18.4 22.1 21.4 20.9 22.2 5.7 6.4 7.5 2.9 10.8 3.1 18.6 12.2 5.7 16.9 9.0 10.5 45.8 8.6 8.3 5.5 4.2 58.7 6.6 3.3 23.5 25.7 32.0 10.3 14.2 12.3 3.6 22.7 6.5 20.3 72.3 12.2 7.7 7.7 10.8 16.3 5.0 8.2 30.1 16.8 8.6 11.4 4.1 3.3 3.6 11.7 6.8 6.4 7.2 1.9 9.2 41.0 11.3 7.5 5.4 22.1 5.5 12.4 15.0 13.5 3.3 17.1 13.5 15.5 6.6 6.1 12.8 25.7 51.0 10.6 4.5 25.3 9.2 21.1 11.9 8.6 KLC4 "bA387M24.3, KNSL8" ENSG00000137171 "Kinesin light chain 4" Q9NSK0 6 43040777-43075095 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.6" "Cell type enhanced" "Detected in all" "Distal enterocytes: 81.9;Hepatocytes: 67.8;Paneth cells: 70.4;Proximal enterocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030168, HPA030169" Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA030168: AB_10599285, HPA030169: AB_10601105" "unprognostic (2.96e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" "unprognostic (3.67e-2)" "unprognostic (5.63e-3)" "unprognostic (6.36e-3)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.30e-1)" "unprognostic (1.47e-2)" "unprognostic (9.22e-2)" "prognostic favorable (6.99e-6)" "unprognostic (2.08e-1)" "unprognostic (3.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" 11.8 17.4 19.5 11.3 19.4 12.5 13.5 21.0 22.9 16.0 17.4 41.5 73.2 15.2 23.3 11.0 17.9 18.0 25.3 18.8 18.9 24.4 90.6 16.7 13.6 21.0 19.4 18.2 19.9 18.0 28.9 24.3 12.3 21.2 17.1 34.5 24.1 20.1 15.9 23.2 17.6 64.2 14.1 17.7 12.6 32.1 25.0 19.4 17.2 19.8 23.0 11.2 17.4 13.0 20.9 7.5 6.0 15.9 18.9 15.0 14.7 13.7 5.5 8.5 9.5 15.6 9.8 11.5 9.9 19.7 13.4 12.6 12.3 15.8 14.9 7.2 10.0 19.1 11.4 18.2 44.0 14.5 5.4 9.1 19.3 18.2 11.8 10.8 29.8 12.1 20.5 7.9 12.8 8.0 13.0 16.2 12.2 6.1 65.4 7.9 12.6 9.0 19.3 14.3 6.5 26.7 12.8 10.3 9.6 20.3 14.9 16.4 15.0 10.2 10.6 12.8 5.4 5.9 25.8 9.9 24.1 5.8 8.5 3.9 2.6 2.6 3.2 2.6 2.6 3.4 3.7 3.7 2.5 3.0 3.2 4.5 3.3 6.5 4.9 2.6 8.7 4.5 2.3 19.5 19.4 21.0 22.9 18.8 18.9 21.0 19.4 18.2 21.2 17.7 19.4 20.9 4.1 16.0 14.4 23.5 4.3 3.7 9.2 12.5 15.9 21.8 8.0 8.8 10.6 20.0 10.8 14.7 29.2 11.8 11.4 81.9 19.6 8.7 13.4 8.9 3.8 5.8 22.3 9.3 17.2 9.8 4.9 5.9 33.6 7.9 7.0 12.2 7.5 67.8 6.5 11.8 24.2 35.3 10.2 5.7 2.9 6.5 10.2 3.6 3.6 6.5 5.3 16.3 4.1 10.6 9.7 7.6 70.4 6.8 7.4 5.0 143.4 23.5 19.0 28.0 13.1 6.0 5.5 27.3 15.6 9.4 4.5 13.5 5.3 6.2 44.0 6.6 KIF13A bA500C11.2 ENSG00000137177 "Kinesin family member 13A" Q9H1H9 6 17759183-17987635 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 105.5" "Group enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 831.4;Oligodendrocytes: 453.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029253, HPA029254" Uncertain NA NA "HPA029253: AB_10611115, HPA029254: AB_10602094" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (1.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.06e-4)" "unprognostic (2.96e-1)" "unprognostic (8.40e-3)" "unprognostic (1.44e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (2.64e-3)" "unprognostic (1.77e-2)" "unprognostic (3.17e-1)" "unprognostic (1.14e-1)" "unprognostic (4.44e-2)" 24.3 20.1 24.4 10.4 29.1 19.5 21.5 27.0 24.0 20.2 30.3 26.0 27.7 25.6 13.2 20.3 19.1 17.9 48.2 21.4 24.2 14.2 16.1 25.5 5.3 28.4 26.9 19.4 20.4 14.8 21.4 11.9 12.0 26.7 23.9 25.6 21.8 17.4 18.8 105.5 28.8 23.7 22.6 23.6 8.1 14.6 8.7 24.6 8.4 28.1 73.1 7.4 30.2 24.5 35.1 24.8 18.0 21.3 13.1 28.4 27.0 25.3 33.6 57.0 28.9 29.5 6.5 5.9 0.2 26.3 58.4 36.5 24.3 16.3 42.6 36.2 2.5 9.8 10.6 44.9 32.1 18.9 0.4 10.3 21.5 34.9 31.3 47.1 37.2 23.8 0.1 39.5 0.3 31.8 10.0 0.1 1.5 16.9 5.7 11.0 12.6 29.1 0.2 18.1 62.1 5.8 11.5 27.7 20.6 38.4 36.7 29.9 1.5 16.8 52.6 15.2 17.4 31.8 0.2 0.1 0.2 18.9 0.8 39.2 2.1 1.3 1.2 0.0 1.1 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 5.9 0.1 0.5 0.1 0.0 0.2 24.4 29.1 27.0 24.0 21.4 24.2 28.4 26.9 19.4 26.7 23.6 24.6 35.1 29.9 35.3 44.4 149.5 4.3 57.2 39.6 9.2 21.1 32.9 20.5 23.1 67.7 17.2 12.8 20.2 18.8 4.1 2.8 20.3 11.7 5.9 20.9 14.5 27.9 28.6 12.5 20.4 134.4 8.7 4.0 24.0 13.7 16.5 5.1 9.7 15.4 25.5 11.9 5.0 42.2 27.2 6.1 22.3 14.7 10.5 15.5 18.9 17.8 105.9 21.1 37.6 5.2 831.4 453.8 9.2 27.4 24.8 0.6 38.4 18.2 10.9 23.5 26.8 26.3 32.7 35.3 6.8 14.9 8.1 45.6 9.0 2.2 2.9 32.7 38.0 ZSCAN9 "PRD51, ZNF193" ENSG00000137185 "Zinc finger and SCAN domain containing 9" O15535 6 28224886-28233487 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054512, HPA059951" Uncertain Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054512: AB_2682511, HPA059951: AB_2684176" "unprognostic (1.67e-1)" "unprognostic (5.32e-2)" "unprognostic (2.68e-1)" "unprognostic (2.04e-1)" "unprognostic (1.32e-2)" "unprognostic (5.24e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.69e-2)" "unprognostic (4.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.55e-2)" "unprognostic (6.14e-3)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.74e-2)" "unprognostic (1.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.16e-5)" 9.3 11.3 11.5 9.0 12.7 10.8 14.1 15.1 13.9 13.3 14.3 13.1 9.3 14.3 13.6 7.9 11.5 9.5 10.6 11.4 12.8 12.8 9.3 10.2 8.7 13.3 12.7 10.4 14.4 12.2 11.6 14.3 11.3 13.1 14.7 15.0 17.5 11.7 11.9 9.2 6.4 13.0 11.8 12.4 16.4 11.9 21.1 12.7 4.4 13.3 8.0 10.4 12.1 10.4 13.7 11.2 7.7 25.7 30.9 9.8 10.6 8.9 13.5 11.3 12.9 14.4 7.1 5.5 0.1 19.9 8.5 12.5 7.7 12.3 12.5 14.6 7.5 10.6 17.1 16.8 13.1 12.4 20.4 13.1 9.1 19.1 10.9 16.6 19.5 16.9 0.0 25.8 9.3 19.2 6.5 0.1 33.4 9.5 5.0 8.6 10.5 17.9 11.7 16.3 15.4 22.3 30.0 11.8 8.8 16.3 19.1 10.9 13.8 13.9 26.2 18.0 6.3 23.2 20.8 22.5 4.5 5.4 24.6 15.4 4.3 3.5 5.1 3.5 1.8 2.9 4.7 1.2 2.7 5.0 4.0 0.4 0.7 1.3 11.7 0.9 2.6 0.9 2.2 11.5 12.7 15.1 13.9 11.4 12.8 13.3 12.7 10.4 13.1 12.4 12.7 13.7 6.1 9.6 3.6 5.9 4.4 0.9 5.3 8.0 0.6 7.3 5.5 4.3 5.1 12.8 10.2 3.7 0.0 5.1 5.3 3.8 1.9 8.5 21.5 2.5 4.9 6.5 5.4 4.0 4.5 6.4 3.1 5.3 2.0 3.6 5.7 7.3 5.7 2.4 5.4 6.7 4.7 6.9 4.1 5.3 4.6 5.1 3.7 5.0 3.6 10.3 3.1 4.8 4.1 8.0 10.0 6.1 6.1 4.9 3.6 3.5 4.9 3.8 4.8 6.6 6.6 5.0 5.3 23.7 15.8 3.1 1.1 12.0 2.3 5.8 6.7 2.5 PIM1 PIM ENSG00000137193 "Pim-1 proto-oncogene, serine/threonine kinase" P11309 6 37170152-37175428 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 220.9;esophagus: 203.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 321.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 321.3" "Cell line enhanced" "Detected in all" "HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003941, CAB017040" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "CAB017040: , HPA003941: AB_1079618" "unprognostic (1.25e-2)" "unprognostic (4.77e-1)" "unprognostic (3.61e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (4.64e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (7.32e-2)" "unprognostic (2.14e-3)" "unprognostic (8.16e-3)" "unprognostic (1.04e-1)" "unprognostic (5.26e-3)" "unprognostic (2.90e-1)" 91.3 14.5 10.0 42.7 9.3 220.9 46.6 10.9 11.9 54.9 11.1 40.5 39.6 46.6 2.7 203.1 67.0 53.0 49.0 8.2 16.8 27.0 58.5 50.3 38.9 15.9 11.9 8.2 60.9 20.6 3.4 14.9 29.1 13.2 22.7 17.9 8.3 41.5 7.5 36.5 110.6 44.7 38.4 12.3 62.2 40.6 10.7 12.4 26.8 22.9 5.9 27.0 102.6 114.2 14.0 19.1 7.9 12.1 6.7 27.2 14.5 141.9 6.7 20.3 13.5 21.5 28.3 26.2 38.3 10.4 8.0 30.2 21.7 12.7 20.1 12.3 174.4 8.4 219.9 8.7 37.0 27.9 3.8 391.5 49.0 24.5 12.4 8.3 14.9 4.0 9.2 192.7 59.7 2.2 5.0 12.3 19.9 22.7 35.4 12.1 29.7 22.0 45.7 3.9 114.4 58.8 11.9 14.7 1.7 3.8 27.9 3.2 6.5 7.4 7.8 23.3 35.6 8.5 28.0 15.9 735.7 3.4 55.3 8.1 321.3 8.0 113.5 60.3 7.3 77.7 7.1 53.4 53.8 6.3 5.2 47.1 36.9 61.7 39.8 4.2 1.9 41.3 42.1 10.0 9.3 10.9 11.9 8.2 16.8 15.9 11.9 8.2 13.2 12.3 12.4 14.0 41.1 22.4 16.0 2.9 35.1 127.8 166.5 63.3 26.7 4.9 9.6 5.3 36.0 18.6 37.6 9.2 0.0 36.5 55.0 50.4 5.9 40.6 4.8 40.3 125.8 33.3 37.1 368.2 2.4 17.2 121.8 67.4 26.0 92.0 49.3 27.5 11.0 33.8 53.6 15.2 2.2 12.4 44.7 44.3 47.4 12.4 8.1 53.9 44.4 4.7 72.3 7.6 112.3 1.0 0.9 60.7 34.2 3.0 190.1 109.6 51.1 17.2 12.9 1.7 0.0 34.2 41.3 14.5 33.9 92.8 228.6 80.7 118.0 1.1 7.8 455.2 GMPR ENSG00000137198 "Guanosine monophosphate reductase" P36959 6 16238587-16295549 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 361.5;tongue: 206.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5" "Cancer enhanced" "Detected in all" "melanoma: 95.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9" "Group enriched" "Detected in all" 6 "granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6" "Cell line enhanced" "Detected in many" "HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA021476" Uncertain NA NA 950000 "HPA000904: AB_1078998, HPA021476: AB_1849858" "unprognostic (2.74e-1)" "unprognostic (1.05e-1)" "unprognostic (2.14e-1)" "unprognostic (4.97e-3)" "unprognostic (3.52e-2)" "unprognostic (1.05e-1)" "unprognostic (3.06e-1)" "prognostic favorable (8.07e-4)" "unprognostic (4.12e-1)" "prognostic favorable (2.06e-4)" "unprognostic (3.15e-1)" "unprognostic (2.86e-1)" "prognostic favorable (2.94e-5)" "unprognostic (3.01e-1)" "unprognostic (1.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.17e-1)" 7.8 23.5 26.3 2.8 27.7 30.0 6.6 35.8 21.7 5.8 32.3 12.0 2.7 13.4 16.7 5.4 57.4 3.7 85.5 18.1 39.7 25.6 6.0 9.2 2.5 35.4 32.8 16.3 38.4 18.5 14.3 25.1 7.8 33.1 63.7 3.4 2.2 21.7 9.1 361.5 10.7 6.0 10.0 36.4 12.6 36.8 52.7 39.5 6.6 4.4 206.8 1.6 5.2 3.7 36.6 0.0 0.0 0.3 0.0 2.7 2.1 0.1 3.9 15.7 27.2 55.2 1.6 0.4 0.0 8.8 6.0 19.1 0.1 6.7 0.8 4.5 0.0 5.0 193.1 0.1 0.0 11.8 0.8 314.7 3.7 2.8 8.5 0.0 22.2 49.5 0.7 43.9 0.3 4.8 3.8 0.2 4.1 2.0 0.2 7.5 0.0 41.9 0.0 36.1 5.4 9.4 1.2 1.9 3.2 74.4 12.1 3.0 1.4 12.5 0.4 0.2 1.3 7.5 2.3 0.0 0.0 0.9 20.3 21.8 14.9 3.3 0.4 0.7 5.0 1.2 0.2 0.1 0.5 1.5 1.5 0.0 0.2 3.3 9.6 1.7 1.5 0.0 16.0 26.3 27.7 35.8 21.7 18.1 39.7 35.4 32.8 16.3 33.1 36.4 39.5 36.6 4.6 0.0 0.0 8.8 1.3 5.1 30.2 0.7 0.6 0.7 5.3 3.8 52.8 35.8 2.7 20.2 0.0 25.3 0.6 1.4 86.1 12.4 16.0 118.2 8.7 6.8 7.8 367.1 3.8 4.9 2.8 10.2 9.2 78.9 55.3 38.9 17.9 5.0 8.9 0.0 11.5 3.2 4.1 6.4 2.1 16.3 34.5 47.4 92.5 2.8 9.2 9.8 2.1 3.0 1.7 3.0 1.2 80.9 1.4 69.9 2.2 15.5 6.4 0.8 0.0 12.6 7.4 6.5 17.2 1.3 1.8 6.8 3.5 19.4 3.8 8.3 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 253.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 18.8 22.3 20.7 19.4 21.4 31.2 19.6 20.7 23.2 23.7 18.5 23.6 18.3 23.3 17.5 17.0 22.6 15.3 25.1 20.5 22.4 17.6 22.0 20.6 25.5 21.7 21.2 20.7 28.2 22.3 27.7 26.2 25.1 20.8 22.1 15.3 28.8 21.9 18.6 30.4 22.6 23.4 20.6 18.9 29.0 22.1 63.4 22.2 31.2 20.4 23.6 25.8 21.8 20.2 21.7 23.5 21.9 31.0 50.7 34.2 31.1 37.4 27.5 37.7 68.1 75.9 33.3 15.3 48.6 30.5 40.7 63.8 25.7 39.7 28.4 51.7 33.8 35.2 26.8 26.8 37.2 26.3 38.9 17.6 27.1 20.9 37.6 26.7 35.7 32.2 44.3 60.6 34.5 36.3 38.5 49.8 34.6 15.6 15.7 20.7 39.0 36.7 28.1 22.0 28.2 34.2 25.6 30.8 23.4 40.2 22.1 39.8 29.7 30.0 40.7 30.3 16.3 31.1 39.3 21.8 253.0 16.0 40.1 45.6 4.2 5.4 3.5 4.9 7.1 4.1 5.5 4.3 5.2 5.1 3.8 4.7 3.9 3.3 5.6 5.5 4.2 6.1 4.6 20.7 21.4 20.7 23.2 20.5 22.4 21.7 21.2 20.7 20.8 18.9 22.2 21.7 11.3 9.6 9.2 5.9 12.0 3.6 3.9 4.0 8.6 14.2 6.3 5.5 10.4 8.6 11.5 7.3 33.3 18.0 15.4 5.3 0.0 4.5 20.2 7.7 15.4 9.6 8.4 6.5 15.1 8.5 8.0 8.8 11.7 8.9 3.8 24.9 7.9 10.1 7.5 11.8 13.9 8.4 4.1 7.5 2.3 11.3 7.8 9.5 3.6 14.0 11.5 8.8 7.2 10.6 14.2 8.5 3.3 6.8 12.4 4.3 4.7 4.0 11.2 11.9 6.6 8.5 13.5 16.8 10.6 5.8 4.7 20.8 11.5 22.0 6.9 3.6 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 33.2;skin 1: 67.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3" "Group enriched" "Detected in some" 4 "cerebellum: 3.9;pons and medulla: 1.0" "Low region specificity" "Detected in many" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.5 0.4 0.6 0.1 0.5 0.1 33.2 4.1 0.4 4.3 0.2 0.9 0.5 0.3 21.9 30.2 0.4 0.2 0.6 0.3 0.2 7.5 0.1 0.5 0.4 2.6 1.1 0.0 0.4 0.2 0.6 0.4 29.9 2.0 9.9 0.5 8.2 23.7 9.4 0.5 67.3 0.8 0.1 0.5 0.1 1.4 2.2 0.5 0.2 0.5 0.1 5.1 3.6 16.7 0.5 51.8 17.8 0.1 87.9 0.4 0.0 19.7 40.2 30.3 31.7 31.4 2.1 19.3 3.2 4.9 12.0 17.5 53.2 4.3 66.1 30.9 104.7 45.2 0.4 44.5 0.0 0.0 1.7 1.5 0.0 97.3 0.1 66.6 18.3 0.0 0.9 3.3 0.1 0.3 12.2 0.0 17.2 0.5 3.3 24.7 5.9 5.0 2.2 18.8 21.8 12.5 0.3 44.1 82.7 82.3 97.3 56.0 1.7 0.0 9.9 2.7 7.1 25.3 0.1 5.1 0.8 5.1 1.7 59.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 4.1 0.4 0.3 0.2 2.6 1.1 0.0 2.0 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.4 130.6 45.5 50.3 167.9 25.9 98.2 65.7 2.7 0.0 30.5 31.3 2.1 285.8 0.5 1.0 7.9 2.2 5.3 1.2 0.7 2.1 1.2 0.0 0.0 0.4 260.6 4.2 0.0 1.5 0.0 0.1 0.0 0.0 20.4 80.8 0.0 0.5 46.8 0.0 6.1 3.8 0.6 0.5 124.5 0.0 0.0 4.3 0.0 0.0 0.1 3.7 0.5 0.0 1.2 58.2 0.1 0.3 21.5 4.6 0.0 0.3 4.1 6.5 16.8 147.7 138.4 700.1 0.3 0.3 0.5 46.7 SLC22A7 "NLT, OAT2" ENSG00000137204 "Solute carrier family 22 member 7" Q9Y694 6 43295694-43305538 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 431.4" "Group enriched" "Detected in some" 17 "Hepatocytes: 254.5;Proximal tubular cells: 91.8" "Cancer enriched" "Detected in some" 37 "liver cancer: 81.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "Hep G2: 9.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA030220 Approved NA NA "HPA030220: AB_10603027" "unprognostic (9.17e-2)" "unprognostic (9.73e-4)" "unprognostic (2.13e-1)" "prognostic favorable (5.48e-6)" "unprognostic (1.45e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.1 47.8 431.4 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.7 0.8 0.4 0.1 0.4 0.0 0.2 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 254.5 0.0 0.0 0.7 0.0 0.0 4.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 91.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 YIPF3 "C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1" ENSG00000137207 "Yip1 domain family member 3" Q9GZM5 6 43511832-43516985 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 494.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014859, HPA063699" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA014859: AB_1845729, HPA063699: AB_2685095" "unprognostic (2.82e-2)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (4.71e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (3.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.70e-3)" "unprognostic (1.70e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.94e-2)" "unprognostic (3.55e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" 70.6 121.2 72.8 43.7 72.6 46.8 70.6 73.0 92.7 73.8 89.7 70.5 65.7 72.7 101.4 81.0 70.3 63.9 82.7 73.6 73.3 78.7 106.2 69.5 42.9 73.6 72.6 68.2 76.3 153.3 110.9 92.7 78.5 73.2 77.0 62.7 50.2 119.6 61.7 83.5 69.7 66.6 58.0 71.2 67.7 106.9 48.4 75.2 46.4 74.9 84.1 46.9 69.6 67.9 74.1 95.0 66.2 95.3 185.4 208.3 168.5 56.1 111.9 174.6 91.8 115.7 79.1 67.6 37.8 84.4 208.6 78.4 93.4 71.0 110.2 59.4 69.9 95.7 61.2 91.8 153.2 163.2 64.7 85.9 169.0 141.2 77.9 78.3 154.4 141.1 61.1 67.8 88.2 111.5 146.9 47.5 82.3 49.7 494.4 71.1 42.6 43.0 103.2 164.3 101.4 76.7 109.0 50.3 66.9 122.2 72.8 111.4 133.5 133.5 103.1 53.4 57.0 78.8 102.5 88.8 74.3 73.2 53.5 71.5 147.2 84.8 128.7 60.0 82.2 52.3 46.1 53.7 54.1 78.7 48.5 42.7 48.5 316.0 65.5 83.2 70.3 79.8 78.2 72.8 72.6 73.0 92.7 73.6 73.3 73.6 72.6 68.2 73.2 71.2 75.2 74.1 77.8 35.3 33.6 12.7 41.4 40.7 63.8 121.7 63.2 54.6 62.8 49.4 31.7 82.9 86.5 55.2 37.5 192.2 41.1 109.7 49.0 149.6 38.1 63.5 60.5 78.9 107.1 42.1 12.1 101.8 209.5 78.2 59.7 67.9 40.6 77.9 74.6 71.0 99.3 58.9 14.7 117.6 101.7 49.1 31.2 79.0 69.9 49.6 65.8 14.0 72.4 115.0 42.2 15.1 17.7 117.5 108.8 67.0 111.6 71.4 129.1 74.9 51.2 63.5 32.9 45.5 64.4 44.0 40.8 52.8 35.5 264.1 34.9 101.9 80.0 81.6 TMEM14B MGC1223 ENSG00000137210 "Transmembrane protein 14B" Q9NUH8 6 10747759-10852753 "Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (5.45e-3)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (5.45e-1)" "unprognostic (2.58e-3)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "prognostic favorable (7.41e-4)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (8.24e-2)" "unprognostic (4.77e-2)" "unprognostic (4.83e-2)" "unprognostic (1.92e-1)" "unprognostic (1.07e-1)" 79.1 101.9 60.2 45.4 62.6 187.9 75.5 64.1 81.8 52.2 74.9 60.9 54.2 46.9 78.7 47.8 72.6 49.1 134.1 60.9 64.5 82.6 91.7 45.6 71.5 62.3 60.8 60.2 50.6 64.8 77.9 40.6 41.9 62.0 66.0 59.4 152.9 86.9 44.5 147.9 46.4 59.6 43.0 63.0 42.5 64.9 27.8 61.8 79.3 129.3 142.7 58.0 52.7 41.8 65.1 376.2 155.9 72.9 106.7 80.0 102.8 106.4 77.9 136.6 163.8 193.2 153.8 171.8 130.8 187.1 93.1 375.9 81.8 65.5 135.1 253.4 89.3 89.6 107.9 123.1 235.2 120.0 163.2 102.1 83.6 76.7 174.6 174.9 92.3 91.6 120.1 267.2 54.1 135.0 134.7 144.4 182.0 110.1 198.6 118.9 120.1 97.1 304.9 198.7 91.7 117.9 88.0 95.7 188.6 251.3 139.0 132.3 145.0 91.7 120.0 150.0 82.3 268.6 128.4 289.4 175.7 98.5 92.4 190.1 178.1 112.1 161.2 86.1 109.8 121.5 121.7 120.7 100.1 136.3 114.7 130.3 111.5 64.4 117.0 122.3 168.6 141.0 154.9 60.2 62.6 64.1 81.8 60.9 64.5 62.3 60.8 60.2 62.0 63.0 61.8 65.1 103.2 80.1 77.2 21.5 95.4 82.0 92.1 169.9 90.5 85.5 157.9 206.8 141.4 144.4 113.8 88.3 60.5 177.1 89.7 94.1 365.9 183.3 18.9 190.4 73.2 83.5 80.5 399.9 19.9 220.9 183.0 97.0 68.3 101.9 82.4 90.2 70.6 156.3 210.0 107.7 21.2 143.2 130.2 121.0 132.6 53.5 96.3 110.1 120.9 9.4 265.8 239.0 52.5 17.1 18.1 261.3 102.5 75.2 102.5 145.8 142.0 309.5 247.6 196.1 26.3 95.6 92.8 46.5 129.9 103.9 100.7 105.9 99.4 133.3 164.3 109.0 TMEM63B "C6orf110, dJ421H19.2, DKFZp434P0531" ENSG00000137216 "Transmembrane protein 63B" Q5T3F8 6 44126914-44155519 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 87.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "OE19: 163.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029249, HPA029250, HPA029251" Uncertain Enhanced "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967" "unprognostic (8.83e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-3)" "unprognostic (3.61e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.97e-3)" "unprognostic (1.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (8.60e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.67e-2)" "unprognostic (6.12e-3)" "unprognostic (3.15e-1)" 12.5 19.8 17.1 9.6 18.5 18.0 12.7 18.4 24.0 15.2 13.9 22.8 17.2 11.5 12.2 34.9 10.8 13.0 24.2 24.3 20.4 17.1 39.5 38.6 5.8 19.1 17.4 20.1 12.2 12.7 20.3 15.7 13.7 20.3 17.6 19.6 31.9 21.0 8.7 52.1 41.7 18.7 10.0 14.8 9.9 25.6 31.3 19.4 8.7 16.4 21.4 8.7 18.9 23.4 20.7 41.7 23.1 21.1 34.6 32.3 18.6 34.6 17.0 22.8 18.7 17.7 16.1 15.7 7.2 25.5 25.3 30.1 37.8 25.6 62.6 12.3 20.6 19.5 20.8 17.2 49.1 22.2 4.6 19.2 24.8 55.5 26.2 16.7 37.8 18.9 15.3 67.7 11.2 22.0 42.7 4.6 10.3 11.4 163.7 11.2 5.8 14.0 13.2 52.2 44.5 24.3 18.8 15.2 35.5 35.8 26.0 40.1 11.6 21.8 23.8 27.0 17.9 20.7 14.0 11.1 8.8 35.9 6.6 30.7 0.2 0.4 0.2 0.2 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.2 0.4 0.2 17.1 18.5 18.4 24.0 24.3 20.4 19.1 17.4 20.1 20.3 14.8 19.4 20.7 7.2 16.0 19.7 17.6 3.3 13.6 14.9 41.3 21.1 18.4 11.2 9.3 3.8 10.0 25.1 11.0 16.7 14.1 4.2 75.1 1.9 17.0 72.9 10.6 8.9 6.9 18.6 28.4 26.3 15.2 16.6 11.0 45.9 25.1 0.0 11.0 11.7 43.4 26.4 16.8 28.4 32.4 30.5 11.7 11.4 87.6 11.8 9.1 7.2 15.0 8.5 9.4 5.2 21.6 12.1 32.5 45.7 9.1 6.4 21.9 32.7 10.8 15.7 27.6 6.6 10.4 12.0 2.1 14.7 19.4 18.3 20.0 5.5 7.1 24.3 29.4 FRS3 "FRS2B, FRS2beta, SNT-2" ENSG00000137218 "Fibroblast growth factor receptor substrate 3" O43559 6 41770176-41786542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 12.5;Spermatogonia: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030162, HPA030174" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA030162: AB_10599976, HPA030174: AB_10602093" "unprognostic (2.52e-2)" "unprognostic (1.31e-1)" "unprognostic (4.30e-2)" "unprognostic (8.91e-2)" "unprognostic (8.13e-2)" "unprognostic (1.67e-2)" "unprognostic (3.79e-2)" "unprognostic (8.47e-3)" "unprognostic (2.96e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.87e-4)" "unprognostic (4.23e-2)" "unprognostic (3.29e-3)" "unprognostic (2.96e-2)" "unprognostic (8.48e-2)" "unprognostic (5.10e-2)" "unprognostic (3.29e-3)" 5.7 6.1 10.9 2.9 13.3 2.8 5.9 9.1 21.7 7.3 1.8 7.4 3.3 8.2 2.0 3.4 8.3 3.1 7.1 12.7 11.3 6.4 5.5 5.1 4.1 12.8 10.3 12.5 7.4 6.2 3.2 7.3 3.1 15.1 7.0 2.0 4.5 5.0 5.2 9.2 2.8 5.5 2.9 5.8 6.8 6.1 17.6 10.8 3.0 9.8 5.0 2.2 7.9 5.7 15.0 2.4 2.0 3.4 4.7 2.6 2.8 7.0 2.5 3.6 3.0 3.0 2.8 1.4 4.1 2.8 2.2 3.9 1.6 2.2 2.7 2.5 4.3 2.2 2.5 4.6 4.5 3.3 2.1 3.6 2.8 3.2 2.9 2.6 3.9 3.1 9.9 2.9 3.3 2.7 3.9 6.2 4.6 1.7 5.3 2.1 5.8 3.0 3.0 2.6 4.6 4.8 7.3 1.8 2.5 5.6 2.5 3.2 4.2 2.7 5.2 5.5 3.4 2.6 5.9 5.3 7.3 1.4 3.5 1.6 0.0 0.3 0.4 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.0 10.9 13.3 9.1 21.7 12.7 11.3 12.8 10.3 12.5 15.1 5.8 10.8 15.0 4.0 0.0 3.7 4.9 1.7 1.0 1.3 1.0 2.8 5.6 2.1 1.9 3.1 7.2 1.2 0.0 0.0 1.9 1.1 0.3 0.0 1.6 0.9 1.9 2.8 3.2 1.8 0.4 7.8 1.4 1.0 3.0 0.5 2.4 0.0 2.2 1.4 1.7 1.9 5.0 8.2 1.5 0.0 2.9 3.7 1.0 2.5 1.9 3.6 4.7 0.7 2.9 0.0 7.5 5.4 1.3 1.6 4.5 0.4 0.9 1.7 1.0 1.3 4.3 0.0 2.8 2.9 12.5 12.4 0.8 0.6 0.5 1.4 1.7 1.6 1.6 TJAP1 "PILT, TJP4" ENSG00000137221 "Tight junction associated protein 1" Q5JTD0 6 43477523-43506556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 117.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030164, HPA030165, HPA030166" Supported Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858" "unprognostic (5.05e-3)" "unprognostic (2.82e-2)" "unprognostic (6.89e-3)" "unprognostic (1.03e-3)" "unprognostic (3.09e-2)" "unprognostic (4.50e-3)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.27e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.61e-3)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (5.15e-3)" "unprognostic (7.51e-3)" 23.0 32.3 24.8 17.4 33.8 18.7 24.6 26.1 33.1 30.4 22.0 26.9 20.5 31.4 10.2 16.9 29.0 13.5 22.8 24.2 26.9 22.0 26.1 21.9 20.8 31.8 31.9 20.9 37.5 33.5 13.3 24.7 15.1 33.6 31.6 9.3 11.4 24.2 14.7 44.5 19.0 26.1 15.2 25.2 32.5 26.2 20.5 30.8 17.3 30.6 16.9 15.0 28.9 23.7 48.7 40.6 15.7 27.1 40.7 21.5 20.1 30.0 25.1 26.8 26.2 28.4 23.8 17.2 22.4 18.6 23.3 25.0 35.0 22.9 30.0 16.8 38.7 35.2 28.5 30.8 26.3 25.8 29.2 39.6 23.0 39.7 32.6 28.6 20.7 17.4 28.6 24.9 41.2 23.5 22.5 28.7 48.3 23.7 69.0 23.9 34.2 17.8 24.0 16.3 22.1 17.8 24.7 21.4 13.0 33.5 16.7 23.2 56.7 15.3 34.9 26.9 29.3 37.9 30.0 26.9 40.0 15.3 33.1 30.2 13.6 7.1 5.7 7.1 8.2 9.2 6.3 5.8 6.2 5.4 6.7 6.5 7.2 4.0 5.5 7.5 5.7 3.5 7.1 24.8 33.8 26.1 33.1 24.2 26.9 31.8 31.9 20.9 33.6 25.2 30.8 48.7 10.9 12.8 10.3 12.1 10.3 7.5 14.7 9.3 13.6 11.1 9.9 13.0 7.7 10.0 6.3 12.9 29.2 21.3 7.3 7.2 3.9 10.0 1.4 7.3 10.6 10.5 11.4 7.8 11.6 8.4 18.6 10.6 8.6 9.8 14.7 21.9 8.2 8.3 9.8 8.4 9.4 8.5 14.2 7.7 8.7 2.2 10.5 9.1 5.4 14.0 8.3 10.0 6.2 19.6 117.1 9.5 7.2 12.8 10.2 14.9 7.9 6.2 5.9 15.2 6.6 9.5 10.0 14.1 14.8 4.9 3.7 18.7 9.8 10.6 7.0 9.0 CAPN11 ENSG00000137225 "Calpain 11" Q9UMQ6 6 44158811-44184401 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 30.6" "Cell type enhanced" "Detected in some" "Adipocytes: 14.0;Breast myoepithelial cells: 11.8;Early spermatids: 24.7;Late spermatids: 9.8;Spermatocytes: 50.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.2;TIME: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB018070, HPA030955" Enhanced NA NA "CAB018070: AB_2069481, HPA030955: AB_2673672" "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (1.64e-2)" "unprognostic (2.75e-1)" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (3.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (8.96e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (3.62e-6)" "unprognostic (2.38e-2)" "unprognostic (3.51e-1)" "unprognostic (2.27e-2)" "unprognostic (8.89e-2)" 1.5 0.4 0.1 0.3 0.2 0.5 2.3 0.4 0.5 0.6 0.1 0.2 0.0 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.1 0.2 0.4 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.5 0.2 0.3 0.1 0.1 0.4 0.0 0.1 0.8 0.4 0.3 0.1 0.1 0.2 30.6 0.2 2.2 0.3 0.2 0.3 0.5 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 5.8 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.4 0.5 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.4 14.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 11.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 24.7 0.0 0.0 3.9 0.0 2.7 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.1 1.1 0.0 1.3 0.0 0.3 0.1 0.0 0.3 0.3 9.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 50.0 0.9 0.1 0.0 0.0 0.1 0.1 0.1 0.1 TINAG ENSG00000137251 "Tubulointerstitial nephritis antigen" Q9UJW2 6 54307859-54390142 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "kidney: 111.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1" "Cancer enriched" "Detected in some" 4 "renal cancer: 15.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 33 "RPTEC TERT1: 91.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035427, HPA073753" Approved "Secreted to extracellular matrix" NA NA 40000 "HPA035427: AB_10601822, HPA073753: " "unprognostic (7.62e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (7.27e-2)" "unprognostic (5.99e-3)" "prognostic favorable (8.75e-5)" "unprognostic (7.10e-2)" 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 14.2 11.8 0.0 0.0 0.0 0.0 1.7 0.1 0.2 0.0 111.4 0.0 0.0 0.0 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 14.0 0.0 0.0 0.0 0.2 0.0 14.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 91.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.5 0.4 0.1 1.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.3 0.0 0.0 0.0 48.6 23.5 0.0 1.0 0.1 0.0 0.0 9.7 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 15.3 0.0 0.0 0.0 72.5 207.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 18.4 0.0 HCRTR2 OX2R ENSG00000137252 "Hypocretin receptor 2" O43614 6 55106460-55282617 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "brain: 3.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 11.7;Inhibitory neurons: 18.3;Peritubular cells: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "AF22: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054516 Enhanced NA NA "HPA054516: AB_2682513" "unprognostic (4.86e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-2)" "unprognostic (2.32e-1)" "unprognostic (7.45e-2)" "unprognostic (7.39e-2)" 0.0 0.0 1.1 0.0 0.9 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.4 0.6 0.0 0.0 0.0 2.1 2.5 0.5 0.3 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 1.2 1.0 1.5 1.4 2.1 2.5 0.5 3.6 0.4 2.1 2.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646191 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.7;pituitary gland: 4.1" "Group enriched" "Detected in some" 8 "Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enhanced" "Detected in single" "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA015607: AB_1852299, HPA076313: AB_2732308" "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.0 0.4 9.1 0.2 10.7 0.0 0.1 4.4 10.4 0.1 0.5 0.3 0.0 0.0 0.0 0.0 1.6 0.2 0.0 8.7 6.4 0.0 0.0 0.6 0.0 6.7 6.8 9.0 0.0 1.4 0.1 4.1 0.0 7.9 0.4 0.4 1.2 0.2 0.0 0.0 0.7 0.2 0.1 1.3 0.2 0.8 1.1 9.9 0.0 0.0 0.0 0.1 0.0 0.0 8.8 2.0 2.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.6 0.9 0.0 2.1 0.8 0.3 0.0 0.0 2.4 1.0 0.0 1.9 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.1 3.8 0.2 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.3 3.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 9.1 10.7 4.4 10.4 8.7 6.4 6.7 6.8 9.0 7.9 1.3 9.9 8.8 0.1 3.2 0.5 119.5 0.6 0.0 0.0 0.5 0.0 3.6 0.1 0.1 1.4 0.0 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 65.6 2.6 0.1 0.0 10.2 0.0 129.2 0.0 0.0 0.3 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 72.7 0.8 0.0 0.0 0.0 96.8 0.6 0.2 0.0 5.6 0.6 0.3 0.0 5.0 3.1 0.3 0.1 0.7 0.0 0.2 0.0 0.1 10.9 0.9 0.0 0.1 0.0 1.2 1.5 0.0 0.0 0.7 0.1 0.1 0.3 0.3 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391752-411443 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.5;cervix: 15.5;lymphoid tissue: 26.3" "Cell type enhanced" "Detected in some" "B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Region enriched" "Detected in single" 5 "hypothalamus: 1.7" "Group enriched" "Detected in many" 5 "memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8" "Cell line enhanced" "Detected in some" "HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 2.3 0.4 0.1 16.1 0.1 29.5 3.3 0.1 0.2 15.5 0.4 6.9 7.7 1.5 0.3 0.9 0.7 2.5 0.5 0.1 1.7 0.4 2.4 2.2 23.4 0.3 0.2 0.1 0.6 0.1 0.0 0.3 0.1 0.2 0.5 6.9 0.0 4.5 0.4 0.2 6.9 10.3 0.7 0.2 17.6 7.3 1.1 0.1 7.0 1.2 0.1 26.3 6.4 2.4 0.2 0.4 0.0 0.0 0.0 22.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 221.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.8 0.0 0.0 0.1 0.1 1.2 0.0 0.0 26.1 0.0 200.0 0.0 0.0 0.4 0.0 0.0 0.2 32.0 0.6 0.1 0.3 0.0 0.0 0.1 0.0 0.3 177.2 141.3 58.4 0.2 0.0 109.0 0.1 1.8 0.0 0.6 1.5 0.0 10.4 1.0 1.0 10.6 10.8 1.7 0.7 0.0 0.3 1.5 12.1 5.8 1.5 0.1 0.1 0.1 0.2 0.1 1.7 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.8 0.0 5.3 0.0 57.2 8.3 0.1 0.0 0.0 0.0 0.6 1.5 1.2 1.5 0.0 0.0 0.0 0.0 66.8 0.2 0.0 0.1 0.0 0.3 0.9 0.6 0.0 0.0 0.1 0.7 0.0 1.8 1.5 0.4 0.0 0.0 1.1 0.5 0.3 0.0 0.1 0.1 0.0 0.6 109.7 0.2 3.4 21.7 44.4 0.0 56.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 235.6 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 1.0 0.4 4.3 0.1 29.8 0.0 0.1 0.1 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457050 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.6" "Cell type enhanced" "Detected in many" "Early spermatids: 86.8;Late spermatids: 229.3;Oligodendrocytes: 285.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.0 3.5 19.4 4.6 27.2 9.7 8.5 23.1 21.3 8.0 1.4 18.5 20.9 4.1 12.3 23.9 11.1 4.9 3.1 15.1 25.7 7.7 18.3 8.4 4.4 28.3 28.6 12.3 4.1 15.6 27.3 8.8 8.6 29.2 18.8 15.0 4.8 14.7 2.4 9.0 17.1 22.6 2.8 24.5 6.3 26.8 11.6 25.7 7.3 5.7 7.8 6.0 4.4 15.7 49.6 4.3 10.1 20.1 22.6 7.2 7.8 26.6 0.7 0.3 1.2 0.5 22.5 0.7 1.0 2.5 4.8 18.2 6.1 4.2 10.8 0.4 3.5 13.1 10.4 3.9 18.9 1.0 0.7 0.6 2.0 21.3 19.4 1.0 4.3 0.7 5.4 9.6 5.3 0.7 5.3 1.0 2.4 7.1 23.2 3.9 2.2 1.3 18.1 0.1 26.9 2.4 0.3 5.7 7.8 7.0 20.9 31.8 0.2 5.6 12.0 4.0 15.9 2.6 12.7 0.2 0.4 21.2 0.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.2 19.4 27.2 23.1 21.3 15.1 25.7 28.3 28.6 12.3 29.2 24.5 25.7 49.6 22.6 6.4 17.5 46.7 1.0 11.6 5.0 18.7 4.6 8.0 9.5 8.1 2.8 10.0 18.0 5.5 8.4 16.1 0.5 43.3 0.0 2.9 86.8 11.6 2.5 8.2 4.2 11.0 59.9 8.0 1.3 1.9 39.8 4.1 0.0 13.1 6.4 12.7 12.9 0.0 67.4 49.7 12.2 13.0 3.0 229.3 1.8 4.8 3.6 77.8 6.4 8.6 0.0 45.8 285.5 6.1 20.5 0.7 0.4 13.9 34.3 4.2 42.0 3.5 0.0 4.5 2.6 2.5 1.2 10.3 12.6 9.2 1.3 0.1 25.3 4.5 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153497-3157544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 406.7" "Cell type enhanced" "Detected in many" "Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.2;monocytes: 1.6;T-cells: 3.2" "Cell line enhanced" "Detected in all" "AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favorable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (1.61e-4)" 56.4 17.9 202.2 19.5 257.9 68.1 48.2 131.3 289.9 25.0 14.4 63.4 24.4 51.2 28.3 91.3 23.7 21.6 29.1 234.1 239.2 31.2 67.5 16.6 11.1 266.0 215.3 260.4 15.6 39.7 2.2 56.7 24.1 301.1 17.7 8.2 50.3 52.7 15.7 22.5 135.8 35.2 42.1 115.5 7.7 41.4 9.6 241.2 6.5 10.1 11.9 9.7 23.8 51.6 406.7 55.9 45.3 241.1 53.6 30.6 34.0 14.5 119.8 44.7 80.6 115.7 247.6 18.4 27.4 72.9 115.5 80.2 26.0 86.6 26.8 28.0 134.1 57.7 9.4 11.4 77.0 31.6 1.5 8.4 35.1 31.1 85.1 5.3 28.9 37.3 10.6 33.7 8.8 74.2 25.1 14.9 2.8 207.2 16.0 58.3 12.4 22.6 18.9 28.0 27.4 57.6 52.9 30.5 8.5 179.7 365.5 19.1 2.0 76.0 53.9 56.7 117.3 65.8 3.2 4.6 18.8 19.7 7.0 280.1 0.0 1.1 0.0 2.2 1.6 2.4 3.2 2.1 3.1 0.5 0.6 1.0 2.0 0.3 0.4 1.3 0.2 3.2 1.2 202.2 257.9 131.3 289.9 234.1 239.2 266.0 215.3 260.4 301.1 115.5 241.2 406.7 125.3 16.0 13.1 43.1 31.6 311.4 63.3 87.0 132.6 105.6 32.0 134.6 20.4 42.9 62.7 12.9 16.7 6.0 53.4 87.0 217.2 54.0 60.9 46.7 29.6 40.6 73.1 322.3 59.9 182.4 50.4 96.2 185.0 57.9 34.9 10.1 12.5 55.6 50.8 516.5 73.0 103.9 73.2 6.3 164.4 32.9 20.8 36.7 129.9 24.4 72.7 261.0 0.0 18.1 23.0 103.4 181.8 15.4 15.8 34.9 126.3 40.4 50.3 86.2 6.6 95.6 87.9 32.4 14.9 140.6 368.5 6.2 58.9 6.4 60.0 54.7 LRRC1 "dJ523E19.1, FLJ10775, FLJ11834, LANO" ENSG00000137269 "Leucine rich repeat containing 1" Q9BTT6 6 53794497-53924125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 115.1;Late spermatids: 117.0;Oligodendrocytes: 138.8;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031603, HPA031604" Enhanced Supported Cytosol NA NA Cytosol "HPA031603: AB_10601753, HPA031604: AB_10601224" "unprognostic (2.90e-1)" "unprognostic (8.01e-2)" "unprognostic (9.59e-3)" "unprognostic (2.46e-2)" "unprognostic (7.04e-3)" "unprognostic (1.55e-2)" "unprognostic (2.19e-3)" "unprognostic (6.37e-2)" "unprognostic (7.02e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.97e-1)" "prognostic favorable (2.21e-7)" "unprognostic (1.74e-1)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-3)" 11.8 2.2 8.7 5.1 13.7 2.9 13.4 10.2 10.3 9.9 12.9 25.7 17.5 5.1 7.6 18.3 8.5 7.8 4.2 8.9 16.1 7.8 0.8 7.6 2.7 13.0 11.0 7.7 4.9 8.9 22.8 8.0 11.2 13.7 8.8 25.6 7.2 16.8 6.8 1.6 22.7 18.3 5.1 11.1 1.5 15.0 14.7 11.3 14.0 15.4 1.4 10.8 14.6 18.1 24.5 45.2 5.7 6.1 10.9 1.6 0.8 42.8 6.1 12.3 5.2 7.1 49.4 21.7 6.4 4.9 3.9 9.7 21.7 47.9 19.4 6.6 7.9 13.8 3.9 4.5 33.5 15.2 4.9 2.9 1.6 15.8 0.4 11.5 8.1 9.4 23.1 0.9 5.8 2.9 19.7 33.6 0.6 4.8 33.5 4.2 6.8 10.2 3.3 14.1 57.4 15.7 1.5 7.3 31.7 9.9 15.2 20.6 5.0 4.3 3.9 12.6 0.2 5.6 5.8 4.9 4.6 4.4 6.7 4.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.3 0.5 0.1 0.1 0.0 0.7 0.0 0.3 0.0 0.0 8.7 13.7 10.2 10.3 8.9 16.1 13.0 11.0 7.7 13.7 11.1 11.3 24.5 19.8 41.7 3.9 53.2 2.9 52.6 25.5 16.3 12.0 43.0 16.0 8.1 3.5 11.5 20.6 16.5 4.2 54.5 2.3 115.1 7.9 20.5 88.5 38.8 9.4 18.8 18.0 1.7 11.9 15.6 62.0 5.9 26.0 74.3 5.7 10.5 8.6 0.3 5.1 8.4 21.9 23.6 12.2 0.6 7.1 117.0 9.3 1.3 10.6 26.2 2.5 32.7 6.2 35.2 138.8 29.5 62.5 10.1 4.2 18.5 32.5 12.3 14.1 3.0 6.6 3.5 3.7 27.3 7.3 19.9 52.7 107.4 3.1 1.6 24.5 32.5 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing transcription factor 1" Q9NP62 6 53126961-53148841 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "placenta: 20.3" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 230.3;Syncytiotrophoblasts: 266.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "BEWO: 39.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA011343, HPA073469" Enhanced Approved Vesicles NA NA Vesicles "HPA011343: AB_2668489, HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.1 0.1 0.4 0.1 0.2 0.4 0.1 0.4 0.6 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.3 0.1 1.3 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.1 0.0 0.0 20.3 0.3 0.0 0.0 0.4 0.1 0.0 3.6 0.1 0.1 0.0 0.1 0.4 0.1 0.6 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 39.2 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.0 8.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.4 0.3 0.2 0.0 0.1 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.4 0.6 0.3 0.1 0.2 0.1 0.3 0.3 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.3 2.0 0.4 0.0 0.4 0.0 0.0 0.1 0.2 230.3 0.5 0.0 0.6 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 266.1 0.1 0.0 0.0 0.1 FOXF2 "FKHL6, FREAC2" ENSG00000137273 "Forkhead box F2" Q12947 6 1389576-1395603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.5" "Cell type enhanced" "Detected in some" "Endothelial cells: 5.2;Fibroblasts: 7.9;Microglial cells: 19.7;Smooth muscle cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 70.4;HEK 293: 24.3;U-2197: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.39e-2)" "unprognostic (3.32e-2)" "unprognostic (8.12e-2)" "unprognostic (1.11e-1)" "unprognostic (9.89e-3)" "unprognostic (2.53e-1)" "unprognostic (4.50e-2)" "unprognostic (8.76e-2)" "unprognostic (8.75e-7)" "unprognostic (1.03e-1)" "unprognostic (4.74e-2)" "unprognostic (2.08e-2)" "unprognostic (8.29e-2)" 1.6 0.4 8.0 1.8 5.9 0.0 2.4 5.3 10.2 0.9 5.6 35.5 6.1 0.2 0.8 9.7 0.5 1.5 0.6 5.7 4.9 0.2 0.1 17.9 0.4 10.1 5.8 5.1 0.1 1.0 0.6 7.7 9.2 7.9 10.9 9.4 0.1 1.3 0.6 1.0 1.2 18.9 3.6 4.7 0.0 17.9 0.9 6.9 0.0 3.7 3.5 1.8 11.2 2.1 6.8 1.6 3.4 1.0 0.8 3.2 4.9 0.1 15.6 70.4 6.3 2.9 0.3 0.0 0.0 3.3 4.6 6.8 11.9 12.2 0.6 2.8 0.0 24.3 0.0 5.7 0.0 6.1 0.0 0.4 0.8 5.0 0.0 5.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 6.9 0.2 0.0 3.7 0.0 5.2 1.3 0.0 0.2 0.0 5.8 11.0 28.7 2.8 0.3 0.0 0.0 0.0 4.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 5.9 5.3 10.2 5.7 4.9 10.1 5.8 5.1 7.9 4.7 6.9 6.8 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 5.2 0.0 0.0 1.1 0.0 1.5 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 2.5 0.1 1.8 19.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 5.5 0.2 1.5 0.3 0.1 0.1 0.1 0.0 0.0 0.0 BPHL "Bph-rp, MCNAA, VACVase" ENSG00000137274 "Biphenyl hydrolase like" Q86WA6 6 3118374-3153578 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 111.4;liver: 85.5" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 99.7;Proximal tubular cells: 336.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036752, HPA036753" Enhanced Approved Mitochondria NA NA 14000 Mitochondria "HPA036752: AB_10673662, HPA036753: AB_2675291" "unprognostic (2.93e-1)" "unprognostic (1.29e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-1)" "unprognostic (3.72e-3)" "unprognostic (1.84e-1)" "unprognostic (8.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.97e-4)" "unprognostic (4.59e-2)" "unprognostic (9.46e-3)" "prognostic favorable (5.16e-7)" "unprognostic (1.60e-2)" "unprognostic (1.51e-2)" "unprognostic (6.98e-2)" "unprognostic (5.20e-2)" 24.4 15.4 9.9 3.9 10.2 3.5 11.3 9.8 14.7 9.3 11.3 10.7 34.1 7.1 29.1 13.3 11.2 9.0 11.3 10.7 10.8 111.4 85.5 5.3 4.4 10.4 9.3 9.4 6.5 11.6 10.9 12.8 5.0 11.1 6.9 9.5 4.3 11.4 4.7 15.7 11.0 33.1 5.9 9.0 3.9 10.1 5.0 10.0 4.9 5.6 12.6 6.0 9.1 9.2 10.6 12.0 13.8 26.8 30.6 22.5 16.2 10.2 7.1 8.7 8.6 11.4 12.4 15.3 18.6 19.7 9.2 21.4 22.1 11.7 8.0 7.6 24.8 10.5 2.7 5.4 21.8 7.9 6.3 1.8 16.9 14.1 6.3 6.0 17.7 15.5 18.8 7.2 3.0 19.9 18.2 14.8 8.3 22.5 21.1 21.9 16.1 17.7 27.9 19.7 30.3 31.7 23.3 13.2 9.0 58.4 39.4 25.6 2.2 7.7 12.5 3.4 13.1 4.9 8.6 27.8 20.4 3.5 4.0 18.4 13.6 9.8 0.0 8.2 12.9 10.9 17.5 9.7 8.4 15.3 12.8 9.1 12.7 0.6 14.6 7.8 8.4 5.4 7.5 9.9 10.2 9.8 14.7 10.7 10.8 10.4 9.3 9.4 11.1 9.0 10.0 10.6 15.9 6.4 9.3 11.1 8.2 8.9 8.6 26.0 10.8 11.1 15.1 19.0 4.8 31.5 19.3 16.5 20.9 28.6 5.6 13.6 70.5 28.1 0.5 13.6 14.0 9.1 16.1 6.9 9.3 13.5 32.2 12.2 11.2 8.2 2.5 31.8 6.1 70.9 23.7 16.8 12.8 14.9 38.7 2.2 8.3 1.6 14.9 8.0 32.0 10.3 13.9 12.2 7.2 9.0 4.7 19.6 14.8 13.9 4.5 8.4 99.7 336.3 38.2 6.9 6.6 19.0 12.5 6.8 20.6 13.9 9.2 14.0 7.6 32.9 19.0 8.1 RIPK1 RIP ENSG00000137275 "Receptor interacting serine/threonine kinase 1" Q13546 6 3063824-3115187 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Inflammatory response, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010302, HPA015257" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB010302: AB_2178118, HPA015257: AB_1856294" "unprognostic (1.24e-1)" "unprognostic (6.83e-2)" "unprognostic (1.87e-1)" "unprognostic (7.75e-2)" "unprognostic (6.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (1.96e-1)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (5.00e-2)" "unprognostic (3.29e-1)" "unprognostic (9.65e-3)" "unprognostic (3.44e-1)" "unprognostic (9.01e-2)" "unprognostic (1.38e-2)" "prognostic favorable (6.71e-4)" 18.4 12.1 1.9 9.3 1.9 0.5 16.4 1.9 3.8 12.6 2.4 16.9 12.5 14.6 5.3 17.7 12.9 10.7 10.8 1.8 2.2 13.8 23.8 13.6 10.2 2.5 1.9 1.7 8.6 17.5 12.3 12.4 11.0 2.0 13.8 13.1 2.4 16.5 9.0 11.8 20.6 20.0 12.0 2.0 19.5 16.6 5.4 2.1 12.0 14.6 5.1 13.1 15.6 13.8 2.2 14.4 9.8 12.9 12.4 27.6 19.2 5.5 21.4 30.8 22.8 26.7 12.4 8.0 13.8 20.9 30.1 23.2 14.3 17.9 17.2 24.3 27.8 9.4 16.7 4.5 6.9 17.2 15.6 20.1 24.8 15.1 20.4 15.3 17.6 20.6 6.2 19.4 4.6 22.0 17.8 10.7 7.7 8.8 17.4 12.7 11.8 10.9 14.5 17.3 27.2 11.3 12.2 14.7 7.8 22.4 26.0 15.2 8.7 25.1 20.6 12.1 8.2 16.4 9.8 15.3 13.5 8.9 7.0 27.7 0.1 0.4 0.9 0.6 0.9 1.0 0.3 0.9 1.7 1.0 1.2 0.7 0.7 0.0 1.5 0.5 0.5 1.7 0.8 1.9 1.9 1.9 3.8 1.8 2.2 2.5 1.9 1.7 2.0 2.0 2.1 2.2 28.6 6.4 12.0 17.3 14.7 11.0 10.3 6.6 16.5 4.4 14.7 17.8 8.6 17.2 16.7 9.2 12.5 8.9 21.9 27.1 5.9 9.4 2.0 10.5 14.0 16.7 6.6 7.2 23.1 12.9 7.7 18.3 27.0 13.4 10.8 8.7 10.0 14.6 11.6 5.0 26.7 17.7 4.1 6.7 11.1 0.8 6.8 15.3 3.6 11.2 13.8 6.6 12.3 14.6 16.2 13.8 11.7 6.0 22.3 11.3 12.7 8.7 17.4 21.4 19.7 32.5 17.9 1.2 2.8 20.5 9.9 11.9 20.8 10.6 11.3 14.5 TUBB2B "bA506K6.1, DKFZp566F223, MGC8685" ENSG00000137285 "Tubulin beta 2B class IIb" Q9BVA1 6 3223324-3231730 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 416.0;choroid plexus: 127.0" "Group enriched" "Detected in many" 4 "Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1" "Cancer enriched" "Detected in many" 9 "glioma: 216.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Supported Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.66e-2)" "unprognostic (3.41e-1)" "unprognostic (5.92e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (6.81e-2)" "unprognostic (3.26e-2)" "unprognostic (9.03e-3)" "unprognostic (8.33e-2)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" "unprognostic (3.78e-3)" "unprognostic (3.34e-2)" "unprognostic (2.03e-2)" "unprognostic (6.24e-3)" "unprognostic (6.04e-2)" "unprognostic (3.58e-4)" "unprognostic (2.30e-3)" 4.0 7.3 262.7 8.2 276.2 1.0 5.0 322.1 391.1 9.5 127.0 14.0 2.4 4.2 45.8 2.4 3.3 3.8 3.6 242.8 336.4 10.6 1.0 1.4 8.2 346.8 298.4 221.5 1.1 5.7 0.0 35.4 4.4 333.6 3.8 2.7 65.8 10.9 4.6 6.3 3.4 6.2 7.4 305.1 0.7 4.5 1.0 309.1 2.3 0.9 1.6 5.7 2.6 5.7 416.0 0.0 8.2 541.9 164.2 0.6 0.2 0.9 5.1 7.4 20.8 45.0 415.3 2.0 0.9 5.6 5.7 0.0 1.3 212.8 0.7 12.0 1.6 98.3 0.2 0.0 33.2 1.1 0.1 6.1 3.1 0.0 2.3 0.0 7.6 1.4 0.5 6.8 1.2 7.6 0.3 1.5 0.4 268.0 1.0 17.6 0.6 26.3 277.7 2.9 0.8 797.7 390.2 0.3 1.7 4.3 245.9 3.2 0.0 0.0 1.9 89.9 6.3 2.2 51.6 0.1 0.0 0.8 0.1 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 262.7 276.2 322.1 391.1 242.8 336.4 346.8 298.4 221.5 333.6 305.1 309.1 416.0 3.6 0.0 0.0 109.4 1.9 8.7 2.3 1.8 4.6 63.5 3.9 31.9 40.1 5.7 0.3 7.3 16.7 0.7 1.0 0.9 414.8 15.4 5.8 2.7 3.3 7.6 66.7 0.0 2.4 3.5 1.2 18.7 7.1 3.9 0.0 0.5 0.7 0.6 3.0 430.7 19.4 1.0 24.4 0.0 12.4 7.1 0.3 1.0 92.5 9.4 3.6 847.3 0.0 37.2 21.6 12.0 0.1 0.0 8.4 3.9 0.2 2.0 0.0 43.1 0.0 350.1 19.1 1.3 6.2 3.1 2.7 0.8 0.6 0.0 0.6 1.1 UQCC2 "bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1" ENSG00000137288 "Ubiquinol-cytochrome c reductase complex assembly factor 2" Q9BRT2 6 33694293-33711727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 911.7;Late spermatids: 1207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039111 Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA039111: AB_2676352" "unprognostic (3.58e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.35e-3)" "unprognostic (2.43e-2)" "unprognostic (5.93e-2)" "unprognostic (2.33e-2)" "unprognostic (7.43e-2)" "unprognostic (5.77e-2)" "unprognostic (3.88e-1)" "unprognostic (1.07e-1)" 36.6 70.2 95.7 37.6 97.6 45.7 45.8 98.6 142.0 44.9 91.9 43.5 34.6 62.1 58.9 59.7 40.3 21.0 244.2 95.8 99.3 61.6 84.0 34.2 35.9 97.9 96.7 93.3 33.7 61.7 47.2 78.6 29.6 97.1 55.9 44.4 105.3 53.4 28.9 231.0 38.8 28.7 52.8 98.5 43.5 49.9 104.9 100.1 46.1 43.3 199.6 41.1 46.5 43.2 103.1 207.7 144.2 162.8 139.4 130.9 129.8 125.5 116.4 117.3 167.7 162.6 233.9 84.5 84.4 180.3 143.5 244.1 109.0 111.7 164.5 138.6 108.0 187.7 163.3 87.3 327.6 215.9 153.8 127.2 136.2 257.4 131.7 204.7 91.0 120.4 158.9 178.4 165.9 190.4 220.9 149.0 315.9 97.3 158.4 167.6 106.5 130.7 279.9 116.2 191.5 273.1 97.1 127.9 191.7 165.6 84.1 168.3 382.2 110.5 178.0 151.1 115.9 242.0 126.8 193.1 146.6 53.7 229.7 211.0 32.7 88.5 18.2 76.1 141.6 93.6 152.4 95.0 87.6 108.6 116.1 98.7 88.0 8.4 81.6 120.9 133.2 110.7 123.8 95.7 97.6 98.6 142.0 95.8 99.3 97.9 96.7 93.3 97.1 98.5 100.1 103.1 18.5 28.9 29.3 8.1 54.2 58.5 96.8 193.0 61.5 108.7 96.0 100.3 911.7 74.4 119.8 77.3 50.1 134.7 34.0 112.4 391.3 103.4 342.3 46.6 78.7 54.1 99.7 105.0 8.9 179.7 124.4 88.5 90.7 39.1 59.5 90.0 41.4 166.1 218.8 70.7 10.2 94.5 154.6 67.8 55.6 1207.0 78.6 64.8 83.6 3.7 63.6 79.1 46.4 9.0 10.0 95.6 64.2 83.8 88.3 122.1 44.6 257.2 87.1 123.8 0.0 32.9 269.4 155.9 96.0 103.3 76.3 95.4 43.5 159.3 102.3 118.5 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 277.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032200, HPA065612, HPA068442" Enhanced Supported Nucleoplasm,Nucleoli NA NA 72000 Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 26.7 9.0 21.0 80.3 19.9 185.6 27.6 15.7 27.5 51.2 3.5 60.4 119.8 23.0 16.8 277.3 41.3 39.5 32.5 22.9 20.7 55.3 20.2 46.9 140.4 25.1 16.9 21.0 4.7 32.1 15.2 15.5 83.1 22.3 28.0 57.8 32.5 70.2 12.7 120.6 134.1 104.5 9.8 17.9 69.2 73.9 80.8 21.9 157.5 31.7 35.4 156.0 101.1 110.5 24.4 1418.7 547.0 274.2 192.9 124.8 916.6 1193.8 556.0 628.8 421.5 233.4 361.3 960.0 658.9 273.1 229.1 264.0 294.7 326.2 991.8 332.3 146.0 228.2 202.6 177.1 488.2 263.7 732.1 227.3 396.1 109.4 765.1 395.8 1083.8 1290.0 369.3 832.0 32.9 596.0 143.0 650.0 898.8 1340.9 697.5 950.3 947.6 6.2 728.0 286.6 128.4 477.0 202.5 59.3 278.3 533.3 430.2 112.2 775.8 1132.1 218.5 691.2 321.3 528.0 260.5 444.5 867.4 461.2 301.7 1115.0 18.7 26.6 35.5 24.4 26.8 32.2 63.5 45.0 39.0 79.6 39.5 52.0 42.9 6.7 20.1 26.5 86.6 55.8 30.7 21.0 19.9 15.7 27.5 22.9 20.7 25.1 16.9 21.0 22.3 17.9 21.9 24.4 11.0 28.9 21.7 2.3 117.8 432.3 947.5 181.3 109.8 29.0 88.8 47.4 30.8 28.6 106.1 40.5 4.2 894.3 70.3 173.5 46.9 755.3 7.2 50.5 14.6 113.9 117.0 268.3 5.4 277.5 799.8 72.0 79.5 115.3 66.7 8.3 18.2 12.3 377.2 11.8 5.7 226.4 97.6 74.0 149.9 24.5 5.6 94.3 90.7 1.0 74.3 44.1 33.0 4.5 2.7 1838.5 249.1 2.6 198.2 1483.3 174.5 15.8 21.7 41.9 0.0 18.6 77.7 40.2 417.6 224.7 361.4 822.8 66.6 0.9 364.3 1681.0 TCF19 SC1 ENSG00000137310 "Transcription factor 19" Q9Y242 6 31158547-31167159 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 37.0;Glandular and luminal cells: 17.6;Plasma cells: 21.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 82.8;GAMG: 47.0;HEK 293: 43.3;JURKAT: 40.9;Karpas-707: 39.2;SCLC-21H: 48.5;U-138 MG: 49.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065994 Approved Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA065994: " "unprognostic (1.41e-2)" "unprognostic (4.92e-2)" "unprognostic (4.00e-2)" "unprognostic (5.16e-3)" "unprognostic (1.99e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (7.04e-2)" "unprognostic (1.35e-2)" "unprognostic (5.92e-2)" "unprognostic (1.74e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (3.54e-10)" "unprognostic (3.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.36e-2)" "unprognostic (1.21e-1)" 4.1 1.7 0.4 2.6 0.4 1.1 4.4 0.7 0.4 6.1 0.3 5.0 4.4 4.3 2.1 12.6 3.9 0.4 3.4 0.3 0.4 4.1 2.0 4.4 10.1 0.6 0.5 0.3 4.9 3.2 0.0 1.3 0.3 0.6 5.2 1.8 0.6 4.8 0.8 2.7 8.9 7.3 1.1 0.4 9.6 5.5 1.9 0.7 0.0 2.4 0.1 1.8 5.2 8.2 0.8 82.8 0.7 0.7 0.1 5.4 7.0 0.7 0.5 0.0 0.1 0.1 5.3 0.1 0.1 17.7 20.1 47.0 0.1 0.0 30.3 0.0 0.5 43.3 7.3 5.1 2.0 0.0 0.2 21.1 2.9 0.0 2.3 0.0 4.4 17.9 40.9 0.1 39.2 8.1 0.3 1.2 13.2 0.1 0.0 0.0 1.1 4.8 0.7 7.1 0.3 48.5 0.5 0.4 0.1 0.5 6.5 0.1 6.0 0.0 49.0 0.2 0.4 0.4 12.5 15.0 24.8 0.1 0.3 0.3 0.0 0.1 0.0 0.2 0.0 1.3 0.5 0.6 1.1 0.3 0.5 0.8 0.2 0.1 0.4 0.0 0.0 1.0 0.5 0.4 0.4 0.7 0.4 0.3 0.4 0.6 0.5 0.3 0.6 0.4 0.7 0.8 2.8 3.2 0.6 0.7 6.7 5.1 3.1 2.5 8.6 3.0 2.8 2.9 1.2 0.0 2.5 3.7 0.0 2.9 3.9 1.8 7.9 1.3 0.3 4.7 2.0 4.7 1.2 37.0 0.1 1.8 9.6 5.6 5.6 17.6 1.3 7.0 1.8 0.6 8.9 1.7 0.2 3.9 2.0 2.9 5.4 0.7 5.0 4.8 12.4 0.0 6.0 4.2 8.2 0.0 0.2 1.1 0.9 6.4 21.1 1.3 1.6 0.4 0.2 0.5 0.0 3.5 5.3 0.7 11.1 9.6 3.8 0.4 7.6 2.0 8.8 2.9 FLOT1 ENSG00000137312 "Flotillin 1" O75955 6 30727709-30742732 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 314.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 423.3;hTERT-RPE1: 242.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001393, CAB007766" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA 160000 "Golgi apparatus" "Vesicles, Plasma membrane" "CAB007766: AB_562116, HPA001393: AB_1078892" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (3.41e-3)" "unprognostic (2.68e-3)" "unprognostic (1.86e-1)" "unprognostic (2.65e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.81e-2)" "unprognostic (9.36e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (6.43e-3)" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (2.46e-2)" 137.2 241.5 43.8 28.1 49.2 42.0 130.9 44.0 61.4 108.8 51.5 131.6 29.0 109.8 8.5 82.5 96.6 23.3 208.8 48.4 50.2 146.6 128.3 138.0 22.3 46.5 44.6 43.4 84.8 89.2 41.7 103.3 35.3 53.1 110.5 17.9 6.3 99.9 46.2 191.5 49.9 87.8 33.3 40.3 130.7 97.7 65.5 47.1 25.1 112.6 83.8 17.2 135.7 97.7 49.1 54.3 18.3 46.4 62.0 49.1 71.0 1.3 59.7 67.5 82.8 79.3 19.4 30.0 13.0 29.0 101.3 423.3 41.8 35.0 20.1 28.6 36.1 1.3 41.1 17.5 19.1 119.2 12.2 67.0 75.4 30.6 40.9 71.3 242.7 65.9 37.9 21.7 52.7 77.9 22.9 38.0 14.5 15.1 29.4 15.7 20.2 48.4 38.0 30.3 13.0 16.4 17.2 33.7 28.7 164.6 30.4 43.8 10.1 44.0 199.5 37.6 20.6 120.6 18.6 19.7 28.8 26.2 42.6 122.7 179.3 76.9 132.0 35.0 38.9 24.1 28.0 21.3 30.4 58.9 23.0 23.7 27.4 314.3 79.9 26.3 59.2 3.9 58.3 43.8 49.2 44.0 61.4 48.4 50.2 46.5 44.6 43.4 53.1 40.3 47.1 49.1 175.4 89.8 77.0 26.1 38.1 28.7 111.5 44.9 80.2 14.7 72.1 73.4 90.6 62.9 59.2 84.6 6.2 82.2 57.7 103.2 123.3 77.6 60.2 73.9 50.1 141.6 68.8 41.7 41.3 85.9 70.7 67.6 55.5 75.2 143.3 41.4 154.9 59.7 130.6 20.2 40.2 66.6 57.0 61.3 84.9 144.1 61.8 89.4 71.2 28.1 99.2 64.7 68.0 27.2 22.7 65.7 112.0 38.0 60.4 69.5 89.0 172.1 80.7 18.1 52.6 58.1 65.9 80.2 26.7 63.7 26.9 61.6 51.2 29.1 83.2 99.4 IER3 "DIF-2, IEX-1, IEX-1L, PRG1" ENSG00000137331 "Immediate early response 3" P46695 6 30743199-30744548 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 260.0" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 2626.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 155.9;EFO-21: 55.6;HBEC3-KT: 189.9;RPTEC TERT1: 203.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043847 Approved NA NA "HPA043847: AB_2678699" "unprognostic (2.83e-3)" "unprognostic (9.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.78e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (5.57e-4)" "prognostic unfavorable (6.36e-5)" "unprognostic (1.38e-3)" "unprognostic (1.69e-1)" "unprognostic (9.28e-2)" "unprognostic (1.53e-3)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.10e-7)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.71e-2)" "unprognostic (8.77e-2)" 100.1 103.3 0.0 14.6 0.0 0.0 48.6 0.0 0.4 100.3 0.0 69.5 0.0 40.8 3.4 260.0 57.1 0.0 126.1 0.0 0.1 155.8 102.0 159.8 0.0 0.0 0.0 0.0 32.8 99.4 0.0 32.5 0.0 0.0 59.9 0.0 1.1 91.0 0.0 13.0 79.8 41.1 0.0 0.0 67.9 159.0 6.4 0.0 0.0 32.6 0.0 1.0 51.3 201.4 0.0 155.9 0.0 0.0 18.0 4.4 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 55.6 9.9 16.2 0.0 0.0 189.9 0.0 0.6 7.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 203.4 24.3 0.0 0.5 0.0 0.4 0.7 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.1 1.3 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.4 208.3 142.4 2.6 47.9 457.7 865.5 557.8 905.5 1.8 735.2 929.2 8.5 175.8 321.4 101.2 0.0 40.3 179.1 634.3 82.2 1141.6 1.4 889.8 539.8 400.7 147.9 3.6 2.9 710.7 58.1 824.8 431.2 2626.8 124.9 5.8 69.7 19.6 329.5 3.3 2.0 656.2 105.8 110.1 711.5 3.6 9.9 914.8 236.5 35.6 295.3 16.0 10.3 1.0 0.6 802.4 671.0 6.8 52.7 658.9 85.3 18.4 85.0 3.3 26.3 331.4 552.5 0.3 2.2 1251.9 329.2 83.0 92.2 35.5 434.9 644.5 MDC1 "Em:AB023051.5, KIAA0170, NFBD1" ENSG00000137337 "Mediator of DNA damage checkpoint 1" Q14676 6 30699807-30717447 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Spermatocytes: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 3.2" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006915 Enhanced Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites" No No "Nucleoplasm, Nuclear bodies" "Focal adhesion sites" "HPA006915: AB_1853669" "unprognostic (8.52e-2)" "unprognostic (4.32e-1)" "unprognostic (4.11e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-2)" "unprognostic (9.44e-2)" "unprognostic (2.74e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.99e-1)" "unprognostic (4.39e-3)" "unprognostic (3.23e-1)" 9.9 7.1 2.5 8.6 3.0 13.1 11.0 4.0 5.6 12.1 2.8 10.1 5.0 13.8 8.6 6.3 12.4 4.6 9.1 2.3 3.2 8.2 9.8 9.5 10.3 4.3 3.2 1.6 17.0 10.9 8.6 12.9 7.5 4.0 10.2 6.9 14.2 9.2 8.2 11.0 9.1 11.0 9.0 1.8 11.3 8.5 28.4 3.1 14.6 16.5 5.9 11.4 10.8 9.3 4.5 36.7 11.1 47.4 34.8 6.3 10.0 23.0 14.8 10.0 25.2 21.3 22.7 8.5 37.7 17.5 17.0 23.5 20.2 63.0 28.6 34.9 29.9 65.6 43.4 28.7 12.5 4.1 27.1 16.9 7.9 9.2 48.6 27.3 9.0 11.5 25.7 61.0 36.7 19.1 14.7 14.6 20.0 20.6 8.4 7.8 33.2 24.7 37.4 11.0 10.7 39.9 23.2 11.5 26.2 13.5 29.1 21.8 16.8 13.8 24.8 26.4 19.2 26.3 19.3 21.6 34.5 7.8 63.9 34.3 0.1 0.1 0.1 0.6 0.1 0.3 0.4 0.4 0.5 0.1 0.7 0.5 0.5 0.0 3.2 0.1 0.7 0.0 0.3 2.5 3.0 4.0 5.6 2.3 3.2 4.3 3.2 1.6 4.0 1.8 3.1 4.5 9.7 16.0 13.0 10.1 13.4 4.5 5.5 5.6 15.9 11.5 6.8 8.6 7.6 7.2 5.7 5.5 8.4 7.9 11.0 2.5 3.9 5.3 4.7 8.0 8.7 9.7 6.7 14.5 8.3 6.2 11.4 11.2 4.1 13.7 17.1 12.8 6.1 12.0 6.7 5.0 8.1 3.3 12.2 6.0 5.7 3.9 7.8 7.3 1.8 11.2 5.9 10.6 14.4 12.5 9.9 5.2 1.1 6.0 16.9 2.9 1.2 3.0 8.0 17.1 13.1 16.2 8.3 74.5 18.0 8.7 3.7 1.9 12.1 7.7 6.0 1.9 PGBD1 "dJ874C20.4, HUCEP-4, SCAND4" ENSG00000137338 "PiggyBac transposable element derived 1" Q96JS3 6 28281572-28302549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 33.4;Inhibitory neurons: 26.7;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.7;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007267 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007267: AB_1079601" "unprognostic (2.26e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-1)" "unprognostic (1.96e-3)" "unprognostic (1.28e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (5.38e-3)" "prognostic favorable (6.79e-4)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.97e-4)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (5.23e-2)" "unprognostic (2.68e-1)" 2.9 2.9 5.6 1.9 6.3 1.6 3.0 6.2 7.3 3.7 3.4 4.7 1.4 4.5 2.6 2.1 3.5 1.9 3.2 7.2 5.2 3.1 2.6 2.5 1.6 4.9 4.9 5.7 3.2 2.1 2.5 3.2 2.0 5.0 3.5 2.1 6.3 2.1 3.3 2.2 1.4 2.7 5.5 4.3 3.2 3.2 3.1 4.8 2.4 2.5 1.6 1.7 3.3 2.8 7.1 6.4 3.5 10.9 15.5 8.6 6.1 3.6 8.2 5.6 10.2 11.5 3.9 2.6 4.2 5.1 5.7 11.6 2.8 11.9 6.7 13.2 4.7 6.8 7.8 6.9 4.9 4.0 9.7 0.9 5.0 3.1 10.1 3.5 5.8 12.7 8.1 10.2 0.5 11.5 2.0 8.2 12.1 4.1 0.1 6.9 14.0 13.9 0.1 5.1 3.4 7.5 14.3 5.6 1.0 6.5 10.8 3.1 5.9 9.1 15.2 10.2 1.0 13.2 4.0 4.3 5.5 3.4 5.5 7.3 1.7 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.2 0.3 0.0 0.1 0.0 0.5 0.0 1.5 0.1 0.1 5.6 6.3 6.2 7.3 7.2 5.2 4.9 4.9 5.7 5.0 4.3 4.8 7.1 6.1 6.4 1.1 12.7 1.4 0.3 3.0 0.7 1.8 6.2 2.3 2.9 7.5 0.0 0.2 0.0 2.1 0.8 3.6 0.5 0.0 1.1 1.4 1.1 4.4 4.6 1.2 5.2 33.4 2.5 3.7 4.1 0.5 1.0 3.8 4.7 3.6 0.2 1.7 5.0 26.7 0.7 2.0 4.0 1.4 1.0 1.8 1.2 3.6 7.5 2.1 4.4 0.0 20.6 22.3 1.1 0.3 3.4 1.5 0.8 0.6 3.9 4.2 4.4 0.0 6.2 4.3 5.0 9.7 1.8 0.3 0.4 1.3 3.1 1.1 0.5 ATAT1 "C6orf134, Em:AB023049.7, FLJ13158, MEC17" ENSG00000137343 "Alpha tubulin acetyltransferase 1" Q5SQI0 6 30626842-30646823 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.6;Late spermatids: 42.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 8.0;AN3-CA: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046816, HPA050999" Approved Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Golgi apparatus, Cytosol" "HPA046816: AB_2679822, HPA050999: AB_2681303" "unprognostic (3.98e-1)" "unprognostic (3.18e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-2)" "unprognostic (8.86e-2)" "unprognostic (8.18e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.49e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-2)" "unprognostic (1.29e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.35e-4)" 5.2 6.1 1.6 0.6 2.4 0.6 7.7 1.5 3.3 11.8 0.8 8.2 0.5 9.7 3.6 7.7 9.8 0.7 5.4 2.1 2.1 8.6 7.6 5.9 0.6 2.3 1.6 1.7 13.5 6.0 0.2 21.5 0.4 2.6 13.7 0.6 2.5 7.8 0.3 4.9 6.3 7.9 0.7 1.5 5.6 7.5 13.6 2.0 0.7 9.4 0.0 0.7 9.3 8.5 5.6 1.4 0.7 8.0 5.3 0.9 0.7 0.6 0.3 0.0 0.2 0.4 2.3 1.4 0.1 1.1 1.1 2.2 1.5 2.5 0.9 0.0 1.0 4.2 0.1 0.1 2.6 0.4 0.5 1.1 1.4 0.5 0.3 0.0 1.0 0.5 3.8 1.5 0.0 1.3 1.5 1.0 0.3 0.4 2.2 0.0 1.0 0.1 0.4 1.3 2.4 0.3 3.2 0.6 0.6 0.4 0.0 2.9 0.4 1.0 3.0 1.3 0.0 0.5 0.9 2.5 0.8 1.6 3.4 2.1 0.5 0.4 0.3 0.1 0.3 0.1 0.5 0.2 0.1 0.4 0.2 0.4 0.4 0.3 0.1 0.2 0.5 0.1 0.1 1.6 2.4 1.5 3.3 2.1 2.1 2.3 1.6 1.7 2.6 1.5 2.0 5.6 6.2 0.0 1.5 14.7 6.4 5.6 14.0 16.9 14.2 9.0 9.4 11.4 1.9 5.7 8.6 14.7 10.4 11.9 4.1 7.6 7.9 11.9 87.6 9.0 7.7 7.9 18.0 3.0 7.8 4.5 6.3 6.9 8.2 8.0 1.3 16.0 3.3 2.9 6.1 1.7 11.4 8.9 14.2 1.6 3.1 42.4 4.1 3.1 0.0 5.6 9.1 12.5 6.2 16.6 13.1 9.3 10.8 8.6 4.1 11.6 9.7 5.4 10.8 10.7 6.6 8.0 7.8 12.4 11.8 8.0 5.4 8.9 4.7 6.1 11.1 15.3 TPMT ENSG00000137364 "Thiopurine S-methyltransferase" P51580 6 18128311-18155077 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 77.1;liver: 69.4;thyroid gland: 77.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 144.6;Proximal tubular cells: 307.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019851, HPA062364" Enhanced NA NA 39000 "HPA019851: AB_1858213, HPA062364: " "unprognostic (6.24e-2)" "unprognostic (3.16e-2)" "unprognostic (5.46e-3)" "prognostic unfavorable (8.45e-5)" "unprognostic (4.98e-2)" "unprognostic (2.25e-1)" "unprognostic (8.16e-2)" "unprognostic (4.36e-3)" "unprognostic (9.62e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.49e-2)" "unprognostic (3.40e-2)" "prognostic favorable (1.10e-4)" "unprognostic (7.56e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" 5.8 16.6 10.3 13.0 12.1 10.0 10.1 11.3 12.3 7.7 10.4 34.8 34.8 6.9 17.7 10.4 7.1 10.5 12.3 10.9 10.1 77.1 69.4 9.4 10.1 10.7 10.5 10.8 4.5 11.7 18.2 7.6 5.6 10.7 10.9 35.5 13.2 12.2 6.7 13.4 10.4 29.2 10.6 10.0 11.1 12.3 6.7 10.4 9.3 77.6 11.8 10.2 16.0 7.4 10.7 24.5 7.3 7.9 19.9 12.9 24.9 19.5 27.7 30.8 23.3 36.2 17.1 5.9 3.1 20.3 37.0 18.0 12.0 11.3 20.0 38.6 16.2 16.2 20.0 12.0 25.2 14.1 9.3 17.4 14.5 21.2 26.0 16.5 15.1 32.9 13.5 40.6 5.6 17.2 11.1 9.6 12.7 13.2 33.9 20.7 11.9 19.6 13.8 27.2 24.8 13.0 10.0 18.3 31.9 36.9 19.9 22.9 9.0 14.0 53.1 10.3 28.0 40.0 8.1 38.9 8.0 19.0 12.3 54.5 8.7 22.1 7.2 11.6 46.7 14.9 2.7 9.2 11.1 32.3 2.6 8.1 11.2 2.2 10.4 40.7 6.5 16.2 17.2 10.3 12.1 11.3 12.3 10.9 10.1 10.7 10.5 10.8 10.7 10.0 10.4 10.7 13.9 16.0 15.5 4.6 12.6 42.7 41.3 23.0 13.6 15.3 20.9 15.0 22.9 25.8 15.8 35.0 22.9 20.7 20.5 144.6 115.4 52.7 1.2 38.4 15.3 14.3 24.0 18.1 18.7 37.4 25.3 11.3 14.8 39.4 22.9 4.3 17.5 86.5 44.9 6.7 13.2 34.8 22.4 48.5 60.9 2.8 4.1 41.1 24.9 9.4 32.6 33.5 29.9 11.1 10.2 76.8 106.6 10.1 9.7 38.8 80.8 307.6 12.2 19.5 0.0 9.3 13.9 0.7 7.7 19.5 34.5 17.5 21.1 9.5 50.7 78.9 CLPS ENSG00000137392 Colipase P04118 6 35794982-35797344 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Digestion, Lipid degradation, Lipid metabolism" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1695 "pancreas: 264335.0" "Cell type enriched" "Detected in some" 17 "Exocrine glandular cells: 23175.0" "Cancer enriched" "Detected in many" 188 "pancreatic cancer: 1726.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA010512 Enhanced "Secreted to digestive system" NA NA 1600000 "HPA010512: AB_1846979" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.12e-3)" "unprognostic (2.47e-1)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" 27.2 6.1 0.5 5.8 1.5 9.1 17.9 0.1 0.7 7.8 0.2 5.7 40.6 6.1 5.7 10.0 3.9 0.0 46.8 1.1 0.0 5.4 17.8 4.1 10.6 0.5 0.3 0.6 155.9 264335.0 0.0 6.4 12.0 0.3 8.0 0.0 0.0 42.1 0.0 5.8 7.3 24.2 0.0 0.1 8.0 27.9 4.0 0.4 0.0 3.9 0.0 0.0 3.3 5.2 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.5 1.5 0.1 0.7 1.1 0.0 0.5 0.3 0.6 0.3 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.6 0.0 0.0 0.0 1.1 11.9 0.0 0.0 23175.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 130.8 0.0 0.0 0.0 0.0 1331.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468870 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 71.9" "Group enriched" "Detected in many" 9 "dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9" "Cell line enhanced" "Detected in many" "Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 9.5 2.0 8.6 15.7 7.0 24.2 29.4 7.7 9.0 9.6 10.0 3.8 1.8 5.8 4.7 8.5 11.9 6.3 6.8 6.3 8.4 9.9 15.7 19.6 11.4 11.8 11.0 5.3 1.6 3.3 2.9 1.7 15.2 8.8 13.2 2.8 5.1 17.0 7.3 57.5 20.7 3.3 6.3 8.2 13.2 5.8 2.3 10.1 5.1 41.3 14.3 13.0 9.5 7.2 13.6 4.6 1.0 0.4 0.0 0.3 2.0 9.8 5.3 5.7 11.0 11.8 0.1 0.4 192.8 50.7 2.3 0.6 16.3 0.1 16.0 15.5 0.9 1.4 0.2 0.2 4.2 0.2 0.2 0.2 2.7 59.1 4.3 13.2 4.9 55.6 4.3 0.1 0.0 2.7 2.0 1.5 0.0 1.6 0.6 1.1 0.7 1.7 11.8 33.2 10.6 1.9 0.2 1.2 23.9 18.5 1.5 28.2 0.5 56.1 8.6 1.9 0.8 1.2 0.0 0.1 160.6 1.0 0.4 0.7 0.4 20.7 12.9 0.5 38.9 1.6 4.6 0.8 0.6 13.3 3.6 1.6 1.0 36.7 0.6 71.9 18.4 0.5 7.1 8.6 7.0 7.7 9.0 6.3 8.4 11.8 11.0 5.3 8.8 8.2 10.1 13.6 28.8 44.8 15.0 34.9 21.7 634.4 48.8 86.0 14.8 0.9 35.7 26.3 12.8 17.2 48.3 38.6 2.1 14.1 9.8 2.2 19.6 8.6 2.1 49.0 5.8 34.6 1.2 3.8 2.3 8.9 3.7 7.8 10.7 58.5 3.8 0.1 47.2 21.9 15.0 0.0 99.0 1.8 14.2 109.4 296.9 1.8 1.2 171.7 60.5 92.8 54.1 17.9 1.0 3.5 2.5 5.2 3.6 3.0 3.4 112.3 0.9 20.6 36.7 1.2 0.0 9.0 7.8 2.2 3.2 30.0 1501.1 1.5 4.9 0.1 2.3 42.6 NRM NRM29 ENSG00000137404 Nurim Q8IXM6 6 30688047-30691420 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 60.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA072545, HPA073982" Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA072545: AB_2686532, HPA073982: AB_2686649" "unprognostic (2.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.71e-1)" "unprognostic (2.32e-2)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (1.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (3.52e-8)" "unprognostic (3.95e-2)" "unprognostic (1.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" 7.1 4.8 0.4 0.6 0.4 1.7 6.2 0.4 0.4 11.5 0.3 6.4 0.2 13.6 0.3 8.8 8.3 0.3 4.6 0.3 0.4 4.2 2.9 7.9 1.0 0.5 0.4 0.3 8.1 5.3 0.4 1.7 1.0 0.4 4.8 0.5 0.3 4.3 0.9 2.1 7.8 6.6 1.1 0.4 7.4 3.9 11.0 0.4 1.6 4.8 0.5 1.1 7.0 9.2 0.5 3.0 2.8 5.2 3.7 0.8 2.8 0.6 1.5 2.9 4.7 4.2 3.1 2.1 5.1 1.0 3.1 2.1 4.6 2.9 5.0 1.3 7.1 1.5 3.1 4.0 4.0 1.0 2.4 4.6 1.7 1.8 4.6 1.7 1.6 3.7 4.1 2.8 4.5 3.2 2.7 3.9 2.6 1.1 3.3 1.7 9.2 3.5 6.2 2.1 1.5 1.9 1.7 1.7 2.1 1.0 1.6 3.4 2.4 1.5 4.3 2.3 2.4 2.8 1.6 3.3 1.8 0.6 6.5 5.6 0.3 1.6 0.1 0.4 0.5 0.3 1.8 0.4 0.6 1.4 1.7 0.2 0.2 0.6 0.4 0.2 1.6 0.3 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.3 0.4 0.4 0.4 0.5 12.1 3.2 2.0 0.7 12.9 9.8 6.3 9.6 5.7 1.7 3.0 7.5 1.9 12.8 4.9 1.8 2.1 23.0 5.1 1.6 3.9 12.2 13.5 1.0 8.4 12.3 1.2 9.2 0.3 5.6 28.1 9.0 1.5 2.7 12.7 5.0 4.6 1.0 17.6 3.3 0.4 3.4 2.0 20.5 18.9 60.1 5.6 12.8 3.6 1.0 25.6 1.2 7.2 0.5 0.3 4.8 0.5 6.0 5.5 1.7 0.5 1.0 0.4 1.9 6.6 7.3 11.6 4.4 2.1 14.6 6.3 5.1 9.9 3.9 6.3 4.3 MTCH1 "CGI-64, PSAP, SLC25A49" ENSG00000137409 "Mitochondrial carrier 1" Q9NZJ7 6 36968141-36986298 "Predicted membrane proteins, Transporters" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 1002.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015971 Approved NA NA "HPA015971: AB_1854171" "unprognostic (3.17e-2)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.29e-1)" "unprognostic (2.88e-2)" "unprognostic (1.54e-1)" "unprognostic (7.49e-2)" "unprognostic (1.35e-3)" "prognostic favorable (1.16e-7)" "unprognostic (1.32e-2)" "unprognostic (3.11e-1)" "unprognostic (6.68e-2)" "unprognostic (4.70e-2)" 148.0 282.0 311.8 98.2 339.3 195.9 141.4 295.8 328.9 189.1 267.7 143.5 94.5 137.5 314.8 131.9 155.5 100.5 259.8 321.3 344.4 168.9 118.2 204.3 96.2 314.8 324.6 319.7 178.8 166.8 143.3 287.0 106.9 327.6 184.6 97.3 92.8 145.4 198.4 134.8 174.5 126.3 115.7 313.4 149.9 157.5 81.7 345.0 89.0 367.1 89.8 89.4 157.7 167.6 348.2 196.3 130.8 173.3 214.0 254.7 171.9 99.0 225.3 208.2 312.1 322.1 218.0 118.3 97.1 197.7 379.8 301.8 167.1 189.2 181.8 360.2 104.5 183.9 101.3 223.4 165.4 184.1 65.7 92.1 194.5 140.5 289.7 140.5 271.8 269.3 133.0 186.1 97.5 199.8 221.4 134.3 149.8 170.1 175.2 147.5 122.9 135.4 102.6 169.1 160.5 278.8 119.9 163.9 141.2 206.8 173.6 182.5 181.9 299.6 311.5 246.1 241.3 247.3 85.3 92.5 1002.9 112.1 179.4 250.1 11.0 34.7 45.4 14.5 34.9 13.5 18.8 27.5 29.2 31.1 31.2 26.2 15.4 37.8 18.4 44.7 17.3 22.4 17.3 311.8 339.3 295.8 328.9 321.3 344.4 314.8 324.6 319.7 327.6 313.4 345.0 348.2 133.7 48.1 99.1 47.3 79.1 113.7 177.1 138.6 71.7 0.0 152.7 125.2 162.5 117.2 101.2 69.9 0.0 183.5 91.8 149.9 168.3 213.0 8.2 99.0 139.4 112.3 149.3 67.6 54.1 170.0 224.0 163.4 94.3 177.3 29.2 193.6 85.6 50.9 189.2 0.0 52.8 133.0 105.8 97.2 150.6 16.3 138.2 109.5 136.9 44.0 173.2 0.0 55.6 28.1 106.4 181.7 162.3 132.4 57.6 255.0 144.3 129.4 68.0 0.0 52.6 108.8 133.5 18.5 46.4 86.2 123.5 248.3 85.8 118.5 145.1 208.5 VARS2 "DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL" ENSG00000137411 "Valyl-tRNA synthetase 2, mitochondrial" Q5ST30 6 30914205-30926459 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062449, HPA070267" Approved Approved Mitochondria NA NA Mitochondria "HPA062449: AB_2684766, HPA070267: AB_2686245" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "unprognostic (1.96e-3)" "unprognostic (2.50e-1)" "unprognostic (5.80e-2)" "unprognostic (3.05e-2)" "unprognostic (2.43e-2)" "unprognostic (1.66e-2)" "unprognostic (3.14e-1)" "unprognostic (8.98e-2)" "unprognostic (4.23e-2)" "unprognostic (2.60e-2)" "unprognostic (2.15e-3)" "unprognostic (1.04e-2)" "unprognostic (7.23e-2)" "unprognostic (1.19e-2)" "unprognostic (2.43e-2)" 10.1 14.6 1.5 2.1 1.3 1.9 9.8 1.6 2.7 11.8 0.6 10.2 1.2 10.5 1.5 22.7 10.2 0.2 10.3 1.5 1.3 12.5 19.1 10.6 3.2 2.2 2.5 1.5 15.4 14.1 2.3 17.2 1.0 4.5 10.3 2.2 1.4 11.0 1.1 21.0 10.2 12.9 0.7 1.1 13.5 11.7 11.9 1.6 4.2 15.2 0.2 2.3 10.6 13.3 2.6 13.8 9.6 5.5 23.1 4.9 4.4 0.7 2.2 1.9 2.5 1.6 12.6 8.9 11.9 7.5 3.0 9.4 0.0 21.3 0.0 2.4 4.6 15.7 13.2 10.2 0.9 6.7 2.3 0.3 6.2 8.1 5.9 1.3 0.9 1.3 19.5 0.1 10.5 5.4 0.0 4.6 0.0 1.7 0.0 1.2 9.1 0.0 10.3 18.3 0.0 8.5 0.2 0.2 6.6 5.4 5.0 16.3 7.4 2.2 14.2 1.4 1.0 0.1 10.0 17.1 18.8 0.0 0.6 8.7 0.0 0.0 0.0 0.3 0.1 0.4 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.2 0.1 1.5 1.3 1.6 2.7 1.5 1.3 2.2 2.5 1.5 4.5 1.1 1.6 2.6 3.0 6.4 12.5 14.7 8.0 4.0 4.9 4.7 4.0 6.6 6.4 3.7 11.6 8.6 5.5 9.2 0.0 8.7 4.1 10.1 1.9 6.7 1.5 7.7 5.2 3.9 13.1 3.4 8.3 7.1 9.6 4.8 11.7 8.6 12.7 12.9 7.5 22.5 9.2 8.4 9.1 8.4 2.0 6.9 3.5 1.6 4.1 5.1 1.8 3.7 7.9 2.8 4.1 8.0 7.2 8.9 4.7 4.1 12.3 2.3 12.4 12.5 8.9 6.0 0.0 2.9 3.7 10.4 8.0 9.0 4.1 3.4 4.8 6.9 10.9 3.8 TAF8 "FLJ32821, TAF(II)43, TBN" ENSG00000137413 "TATA-box binding protein associated factor 8" Q7Z7C8 6 42050513-42087461 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031730, HPA031731, HPA031734" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994" "unprognostic (7.41e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.46e-3)" "unprognostic (3.08e-1)" "unprognostic (2.23e-2)" "unprognostic (2.46e-1)" "unprognostic (3.53e-1)" "unprognostic (2.01e-3)" "unprognostic (6.74e-2)" "unprognostic (8.22e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (2.42e-2)" "unprognostic (2.26e-2)" 13.8 9.9 6.0 12.9 6.4 21.3 10.9 4.4 6.9 8.1 7.6 9.0 10.6 8.9 6.9 10.2 7.5 8.5 16.4 5.3 5.0 11.3 8.6 9.6 15.8 6.9 5.7 4.8 8.1 7.5 16.1 6.6 12.8 5.8 9.1 9.3 8.8 9.6 9.0 17.1 8.5 8.6 10.1 4.3 11.7 10.9 8.0 6.5 23.9 14.0 15.5 15.1 9.9 8.7 6.8 17.2 18.4 14.9 16.7 16.5 15.1 13.6 7.9 13.7 20.4 20.9 31.8 10.0 26.2 16.4 11.5 20.9 12.5 24.5 16.7 15.7 22.6 23.6 33.4 23.3 15.7 20.2 19.5 23.4 20.6 13.0 14.6 18.4 10.0 23.0 31.8 41.7 26.6 11.5 22.7 17.9 29.2 9.3 45.5 8.4 36.1 17.7 20.2 18.0 13.9 15.4 13.7 14.3 11.0 15.7 12.2 16.5 23.6 21.2 18.1 18.8 8.2 16.3 23.0 24.4 55.5 8.3 21.2 10.4 23.0 17.0 27.0 16.0 18.2 11.1 18.2 14.4 12.6 17.8 18.3 14.7 14.4 19.9 10.8 37.4 26.5 13.4 11.0 6.0 6.4 4.4 6.9 5.3 5.0 6.9 5.7 4.8 5.8 4.3 6.5 6.8 16.8 19.2 21.1 14.0 17.2 7.0 13.1 14.8 14.2 16.0 14.1 10.4 28.6 10.0 17.4 11.0 31.3 22.1 21.0 12.3 31.3 9.5 12.0 26.5 12.8 16.9 9.0 21.9 7.6 9.9 8.6 11.7 6.6 47.4 19.0 14.2 9.7 9.6 13.5 21.9 8.2 13.3 14.2 21.6 9.5 17.5 14.9 13.1 7.2 13.1 19.3 10.7 33.0 18.6 14.2 8.8 8.3 11.7 19.0 14.4 10.5 16.5 9.8 23.2 13.1 10.6 13.3 15.3 12.9 12.0 8.4 21.5 19.8 19.4 11.1 15.0 FAM8A1 AHCP ENSG00000137414 "Family with sequence similarity 8 member A1" Q9UBU6 6 17600302-17611715 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 759.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044698, HPA073675" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA044698: AB_2679051, HPA073675: AB_2732236" "unprognostic (4.06e-1)" "unprognostic (2.32e-1)" "unprognostic (9.11e-2)" "unprognostic (6.90e-2)" "unprognostic (1.99e-2)" "unprognostic (5.17e-3)" "unprognostic (6.13e-2)" "unprognostic (1.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.09e-3)" "unprognostic (4.44e-2)" "unprognostic (3.50e-1)" "unprognostic (1.56e-2)" "unprognostic (3.85e-2)" "unprognostic (3.71e-1)" "unprognostic (7.59e-2)" "unprognostic (2.98e-1)" 18.8 16.3 17.8 10.8 18.6 31.9 19.3 20.5 19.7 20.6 16.9 20.1 17.1 27.6 19.1 14.0 20.7 21.3 14.9 18.9 20.4 24.2 78.6 19.1 10.5 20.1 18.7 16.3 28.0 15.1 22.5 13.1 15.0 19.8 21.0 23.0 27.3 23.2 22.5 19.1 13.8 16.8 25.0 20.2 14.4 12.9 17.3 20.9 17.2 23.4 21.9 8.3 14.6 12.7 22.3 9.5 3.7 13.5 32.3 45.6 42.6 11.1 15.0 20.4 7.6 13.1 21.4 3.1 8.1 35.2 25.6 8.3 7.6 20.5 13.0 9.9 6.9 29.1 9.8 12.5 46.2 20.1 6.2 9.6 22.6 20.7 8.7 6.0 24.2 17.0 8.9 20.2 16.2 12.0 11.7 4.6 19.2 5.6 11.6 5.6 12.1 13.0 25.0 25.6 7.5 4.1 21.4 11.7 25.0 23.7 23.1 29.0 9.5 13.3 9.7 3.4 14.9 5.5 13.4 12.0 8.0 8.8 7.1 13.4 2.6 0.3 1.0 1.1 0.4 1.2 0.0 0.5 1.0 0.2 0.1 0.7 1.1 5.5 1.5 0.2 0.2 0.4 0.3 17.8 18.6 20.5 19.7 18.9 20.4 20.1 18.7 16.3 19.8 20.2 20.9 22.3 16.8 19.2 27.1 8.8 7.0 13.4 9.7 6.6 14.2 27.6 15.1 13.5 15.3 21.5 12.1 29.5 14.6 10.0 15.7 63.4 5.9 9.2 759.2 26.4 24.0 14.1 12.0 4.2 17.1 7.9 12.0 23.0 10.7 20.6 1.3 8.6 25.4 77.5 6.2 15.2 17.9 10.8 8.2 24.4 6.4 187.8 36.7 8.6 5.4 3.7 8.7 19.3 14.4 8.0 13.8 7.5 25.7 30.9 12.8 7.5 30.4 12.4 20.5 16.7 32.9 20.3 18.7 46.6 18.0 14.3 15.9 12.2 14.0 9.7 16.7 7.8 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 13.8" "Cell type enhanced" "Detected in many" "Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;U-266/84: 6.4" "Not detected" "Not detected" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 0.8 1.8 2.6 0.5 2.3 0.4 1.1 2.4 4.0 0.6 2.9 0.7 3.3 0.5 3.6 0.6 3.3 0.2 0.5 2.3 2.9 1.9 0.7 1.0 0.4 2.6 2.6 2.2 1.1 2.3 0.3 2.0 0.3 2.6 2.0 0.3 0.8 0.8 0.5 0.5 1.3 0.7 0.3 2.6 0.7 1.6 13.8 2.4 0.5 0.9 0.2 0.6 0.7 0.6 2.9 1.0 2.0 1.8 1.7 0.6 0.0 3.3 0.3 0.0 0.2 0.4 2.7 1.6 0.2 2.9 0.0 2.8 0.2 1.8 0.0 0.6 1.2 4.5 0.8 0.5 0.5 0.0 1.2 0.5 0.3 2.6 0.7 1.0 0.4 0.0 1.9 3.6 0.3 0.7 6.1 1.5 6.1 1.9 1.4 2.3 1.3 0.4 0.9 0.8 0.5 3.8 2.1 0.8 0.5 3.9 2.3 0.2 1.0 0.7 1.4 0.5 1.0 1.4 2.6 6.4 1.4 2.3 0.9 1.6 0.0 0.2 2.4 0.6 0.5 0.2 0.2 0.7 0.6 0.5 0.3 0.3 0.3 0.3 0.7 0.3 0.4 3.1 0.3 2.6 2.3 2.4 4.0 2.3 2.9 2.6 2.6 2.2 2.6 2.6 2.4 2.9 0.7 0.0 2.7 3.3 1.2 1.5 2.0 4.2 0.0 1.6 3.2 3.7 1.3 1.5 2.6 3.7 2.1 2.9 0.2 1.6 5.9 4.1 46.4 44.9 0.9 1.9 3.0 0.0 0.9 6.1 2.3 1.1 2.0 2.5 0.0 0.6 1.4 1.9 1.2 1.7 1.0 1.2 0.0 0.3 1.0 27.3 2.1 0.6 3.6 0.0 1.6 3.3 1.0 0.0 3.5 2.8 2.7 0.0 2.5 2.0 1.3 9.6 37.7 0.9 0.0 1.1 2.1 36.1 20.4 0.6 1.4 1.4 0.4 0.4 1.7 1.0 FGFBP1 "FGFBP, HBP17" ENSG00000137440 "Fibroblast growth factor binding protein 1" Q14512 4 15935577-15938740 "Cancer-related genes, Predicted secreted proteins" "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 425.2;vagina: 173.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1044.3;Basal respiratory cells: 596.2;Squamous epithelial cells: 528.5;Suprabasal keratinocytes: 786.2;Urothelial cells: 303.6" "Group enriched" "Detected in many" 5 "cervical cancer: 117.5;head and neck cancer: 246.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 556.3;HBEC3-KT: 968.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA004332 Enhanced "Secreted in other tissues" NA NA "HPA004332: AB_1078856" "unprognostic (2.87e-3)" "unprognostic (3.55e-1)" "unprognostic (5.03e-2)" "unprognostic (6.99e-2)" "unprognostic (1.86e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (5.03e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (3.31e-3)" 0.5 0.1 0.0 1.8 0.0 0.1 13.6 0.0 0.0 57.1 0.0 17.6 1.8 0.5 0.1 425.2 1.2 0.3 0.1 0.0 0.0 0.5 0.1 3.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 1.1 0.0 1.8 15.7 0.0 60.1 0.1 0.1 77.6 7.0 1.1 0.0 0.1 2.0 0.0 0.0 0.3 0.7 0.0 38.7 15.1 173.7 0.0 150.7 10.5 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 189.0 0.0 10.9 0.0 0.2 556.3 0.0 968.2 0.0 0.0 1.2 0.0 2.0 0.0 0.2 0.0 0.4 0.1 141.0 0.0 17.7 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 7.9 75.2 0.0 0.0 0.0 93.4 6.7 0.0 0.0 0.2 0.0 0.2 0.0 0.9 0.5 0.1 0.2 0.3 0.0 0.3 0.0 0.1 0.2 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 8.4 0.0 0.3 1044.3 182.5 596.2 217.4 0.0 11.8 3.2 0.1 0.0 223.2 0.0 0.0 0.2 0.2 49.6 0.0 49.7 0.0 52.8 3.3 6.3 0.0 0.0 0.0 7.5 2.4 6.2 0.0 65.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.1 42.7 0.0 60.6 0.0 0.0 0.9 74.7 0.0 0.6 0.0 1.0 0.0 0.0 139.1 50.8 0.0 0.0 90.8 0.7 0.0 56.8 0.0 0.0 0.0 10.4 0.0 0.0 528.5 786.2 2.3 2.1 0.0 26.1 303.6 FGFBP2 KSP37 ENSG00000137441 "Fibroblast growth factor binding protein 2" Q9BYJ0 4 15960245-15969309 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 55.0" "Group enriched" "Detected in many" 6 "dendritic cells: 486.6;NK-cells: 1627.2" "Group enriched" "Detected in many" 9 "glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "gdT-cell: 551.3;memory CD8 T-cell: 332.1" "Lineage enriched" "Detected in many" 8 "T-cells: 551.3" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.9;T-47d: 3.2;WM-115: 1.3" "Secreted to blood" NA NA 346000000 36000000 "unprognostic (3.51e-3)" "unprognostic (8.81e-3)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.55e-2)" "unprognostic (1.54e-1)" "unprognostic (6.14e-2)" "unprognostic (1.35e-2)" "unprognostic (9.89e-2)" "unprognostic (1.76e-1)" "unprognostic (2.55e-2)" "unprognostic (3.33e-1)" "unprognostic (3.51e-2)" "unprognostic (1.87e-1)" "unprognostic (1.59e-2)" "unprognostic (9.61e-2)" "unprognostic (1.49e-2)" 20.4 1.5 0.7 0.4 0.8 55.0 12.8 0.6 1.5 0.6 0.7 8.1 0.1 0.5 7.2 0.6 0.7 0.9 16.6 0.8 0.9 0.4 1.2 8.5 3.0 0.7 0.6 0.6 0.4 0.2 0.3 0.2 0.5 0.7 1.4 0.9 1.1 8.7 0.9 1.1 19.2 2.0 0.3 0.6 14.1 1.8 8.7 0.7 5.4 1.1 3.7 1.0 2.8 1.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.9 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 3.5 0.8 2.4 551.3 1.3 5.2 0.8 128.6 332.1 0.9 0.4 47.3 314.1 8.4 64.9 1.6 2.1 0.9 371.2 0.7 0.8 0.6 1.5 0.8 0.9 0.7 0.6 0.6 0.7 0.6 0.7 0.7 2.6 0.0 5.3 0.0 2.6 9.6 0.0 0.2 0.0 0.0 1.5 1.7 1.5 5.7 1.4 5.5 8.4 0.6 486.6 0.1 0.0 0.7 1.3 0.9 0.1 2.2 0.0 3.6 0.0 0.0 0.0 19.9 0.5 0.3 3.8 60.3 6.1 0.6 0.0 0.0 0.0 0.4 0.0 4.9 12.0 3.0 0.0 2.2 46.2 0.0 5.8 1.4 1627.2 0.0 0.1 0.2 0.0 0.4 17.5 0.0 0.0 1.3 1.3 0.4 0.0 1.8 2.5 0.7 0.1 0.1 7.7 1.0 167.2 0.2 0.1 0.0 CPEB2 ENSG00000137449 "Cytoplasmic polyadenylation element binding protein 2" Q7Z5Q1 4 15002481-15070153 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.2" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 127.6;Oligodendrocytes: 406.5;Suprabasal keratinocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072513 Approved Cytosol Yes No Cytosol "HPA072513: AB_2686529" "unprognostic (6.59e-2)" "unprognostic (4.21e-3)" "unprognostic (4.75e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-2)" "unprognostic (2.36e-2)" "unprognostic (5.67e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-1)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (8.62e-2)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" 9.1 6.0 15.0 5.2 22.2 26.8 12.4 19.7 28.0 7.2 6.8 9.6 8.4 7.5 8.3 13.4 6.0 9.6 7.4 15.2 20.0 12.1 17.7 8.5 5.7 22.6 18.3 13.5 6.3 4.5 16.4 4.2 6.5 24.2 8.5 9.8 16.2 8.1 10.8 5.8 23.2 8.8 8.7 21.8 5.9 10.8 38.2 19.1 4.5 4.9 6.3 6.5 8.1 13.3 47.2 2.9 18.1 1.9 0.7 13.1 26.2 3.6 10.8 6.7 5.8 4.6 0.3 4.2 1.9 2.1 10.1 11.8 3.5 3.9 2.6 3.6 4.8 1.5 0.5 16.3 3.5 6.1 1.0 2.6 12.3 12.5 15.6 14.7 8.7 6.1 0.3 0.4 13.2 26.9 1.5 0.2 4.7 1.7 5.9 2.8 0.3 1.8 0.8 57.3 2.6 1.7 11.1 3.1 2.4 10.6 8.7 1.5 12.2 11.7 24.0 2.1 15.3 6.1 9.0 1.3 1.0 19.3 10.6 9.5 0.0 0.2 0.6 0.1 0.1 0.5 0.0 0.2 0.1 0.2 0.1 0.3 0.1 1.1 0.5 0.1 0.1 0.1 0.1 15.0 22.2 19.7 28.0 15.2 20.0 22.6 18.3 13.5 24.2 21.8 19.1 47.2 24.9 32.1 14.2 55.8 8.1 85.8 12.2 6.8 58.1 8.6 31.2 17.8 22.3 12.8 9.3 31.3 27.1 1.4 10.7 26.4 1.9 4.6 64.5 38.4 9.9 14.7 10.2 3.8 58.2 4.9 1.8 13.4 15.3 50.7 10.8 1.8 13.2 23.8 11.2 15.2 127.6 13.1 4.1 14.1 31.0 20.3 6.2 20.3 53.4 39.4 6.6 8.5 3.1 89.5 406.5 7.0 16.9 8.2 17.5 11.8 18.7 14.8 5.1 19.3 0.0 20.7 16.5 16.6 4.6 77.0 129.4 1.4 11.0 3.6 8.1 17.0 FHDC1 "INF1, KIAA1727" ENSG00000137460 "FH2 domain containing 1" Q9C0D6 4 152936323-152979671 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;parathyroid gland: 17.7;thyroid gland: 15.8" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 85.9;Erythroid cells: 71.1;Syncytiotrophoblasts: 80.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 30.6;RT4: 10.5;SK-BR-3: 14.4;WM-115: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008527 Uncertain NA NA "HPA008527: AB_2104099" "unprognostic (5.42e-2)" "unprognostic (8.12e-2)" "unprognostic (2.42e-2)" "unprognostic (1.99e-3)" "unprognostic (1.16e-1)" "unprognostic (2.25e-1)" "unprognostic (2.95e-4)" "unprognostic (1.37e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-2)" "unprognostic (2.40e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.04e-2)" "unprognostic (1.90e-1)" "unprognostic (9.36e-2)" "unprognostic (1.30e-1)" 0.7 0.3 1.2 1.2 3.1 14.8 2.2 2.0 2.1 1.0 0.6 4.0 3.5 0.6 1.2 5.0 1.4 1.8 0.3 0.7 2.2 1.1 0.4 8.6 0.8 2.1 1.4 0.6 0.3 1.0 17.7 1.5 6.7 2.4 7.2 4.8 1.0 3.9 0.8 0.3 7.6 4.1 0.6 0.9 3.5 4.8 1.2 2.9 0.4 15.8 0.3 2.2 1.6 2.9 2.4 5.7 0.5 1.0 0.8 0.4 0.3 30.6 0.4 1.1 1.2 0.1 0.3 3.4 0.2 0.2 0.5 1.0 1.1 0.3 2.3 0.4 0.6 0.3 0.6 3.5 0.4 0.1 0.2 0.9 0.2 2.8 0.0 0.7 1.2 0.0 0.5 1.4 0.6 0.4 3.5 0.1 0.1 6.3 0.5 0.4 0.1 0.3 0.1 5.6 10.5 5.5 0.2 1.9 14.4 2.1 6.9 2.2 0.4 0.2 0.4 0.9 2.6 1.3 0.8 0.5 0.1 0.2 0.1 10.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.2 3.1 2.0 2.1 0.7 2.2 2.1 1.4 0.6 2.4 0.9 2.9 2.4 0.5 16.0 85.9 5.5 0.5 5.9 2.8 16.3 3.4 0.1 4.8 4.1 0.9 2.8 18.8 3.7 2.1 11.9 0.3 11.1 0.0 0.9 2.0 4.5 2.4 2.0 13.8 71.1 10.7 3.1 13.1 2.6 15.3 15.6 3.8 0.5 0.0 0.0 2.1 0.0 13.7 9.3 4.1 0.0 0.8 0.2 0.9 0.6 0.0 7.5 0.0 0.0 0.0 13.0 8.7 7.5 6.2 0.7 0.1 4.7 7.7 0.1 9.3 0.1 0.0 0.5 1.2 1.1 0.8 4.7 7.1 80.0 0.6 1.5 7.6 3.2 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153706260 "CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.6;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5" "Group enriched" "Detected in all" 49 "dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6" "Cell line enhanced" "Detected in some" "HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 27.0 12.0 4.7 52.1 5.8 70.6 12.7 5.4 7.6 7.9 8.9 4.3 3.9 3.4 11.9 5.4 8.2 16.4 5.0 4.5 10.7 5.1 11.4 40.3 8.9 9.3 6.6 4.1 2.5 8.9 3.4 4.1 11.5 8.1 4.8 3.4 1.5 17.4 12.5 1.7 3.5 5.0 11.8 8.0 36.1 5.3 1.9 6.8 3.7 3.4 3.7 15.5 23.8 4.1 8.3 7.1 0.1 0.3 0.0 1.0 2.9 0.0 0.0 0.5 0.5 0.8 3.3 0.4 0.0 0.8 0.0 0.0 6.4 0.6 0.4 0.3 0.1 0.1 0.2 0.0 0.8 0.1 11.6 0.9 12.5 12.7 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.0 11.4 0.7 0.0 2.7 0.3 0.0 0.0 13.3 16.3 0.0 0.3 0.7 0.1 3.3 0.4 0.0 62.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 11.3 1.7 48.4 199.6 1.8 0.3 178.9 0.5 0.4 1.1 0.3 121.3 1.2 1.3 0.2 457.8 5.3 121.5 1.1 0.2 76.2 4.7 5.8 5.4 7.6 4.5 10.7 9.3 6.6 4.1 8.1 8.0 6.8 8.3 1.7 6.4 77.3 0.7 1.1 1.1 1.2 18.4 1.2 0.0 9.7 2.2 1.3 2.8 19.5 3.7 0.0 0.2 0.6 0.2 0.0 5.0 0.3 1.6 0.5 2.6 0.0 3.6 0.1 3.8 0.2 1.9 2.6 4.9 3.8 0.5 1.4 1.8 17.4 0.0 0.5 0.3 0.0 117.2 35.7 1.3 0.6 101.8 1.8 33.7 68.4 0.4 1.0 1.0 0.1 3.1 0.0 0.4 1.4 3.4 1.5 1.0 7.5 0.3 13.1 0.6 5.1 0.2 1.0 1.9 1.1 0.1 2.3 0.5 0.5 2.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266165-139280225 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 230.2;retina: 117.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 151.3;Granulosa cells: 93.5;Horizontal cells: 208.6;Muller glia cells: 508.9;Theca cells: 474.8" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 20.4;fHDF/TERT166: 30.7;HHSteC: 23.6;HUVEC TERT2: 61.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015994, HPA070835" Enhanced Supported Mitochondria NA NA Mitochondria "HPA015994: AB_2630370, HPA070835: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 4.4 230.2 3.3 0.3 3.3 0.1 1.8 7.8 4.2 1.8 3.0 0.8 0.2 5.1 1.8 0.4 2.3 0.9 2.3 3.2 4.1 1.8 0.2 0.7 0.9 3.7 4.3 3.0 24.1 0.3 0.2 11.9 0.3 4.7 2.6 0.3 117.9 0.4 4.0 0.8 0.4 0.3 3.8 3.2 0.8 0.4 8.7 3.5 0.3 0.8 0.3 0.6 1.1 2.5 3.9 0.0 1.1 0.6 0.5 1.5 0.7 0.1 20.4 0.1 3.0 0.1 0.1 0.2 0.1 0.2 30.7 8.7 0.5 4.4 0.1 1.7 0.0 2.0 0.0 0.1 0.2 23.6 0.2 0.2 7.2 0.7 3.3 0.2 7.1 61.7 0.2 0.4 0.4 5.1 0.1 0.8 0.5 1.1 0.4 0.1 0.1 0.0 0.0 0.7 0.3 0.6 1.2 0.0 0.0 0.2 0.3 0.0 0.4 0.5 0.1 0.1 0.0 0.0 0.8 0.7 0.5 8.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.3 3.3 7.8 4.2 3.2 4.1 3.7 4.3 3.0 4.7 3.2 3.5 3.9 0.6 0.0 0.0 0.0 0.2 1.7 0.7 0.4 1.2 151.3 0.7 10.8 3.5 0.0 0.1 0.0 8.4 0.2 0.3 0.1 1.9 0.0 0.3 0.8 1.2 1.1 0.0 0.0 1.3 0.0 0.2 10.7 0.0 0.3 0.0 93.5 0.4 0.4 0.5 208.6 2.5 0.0 0.0 0.0 0.3 0.6 17.1 0.6 0.0 0.0 0.0 508.9 2.1 5.0 0.7 0.1 0.0 24.8 0.3 0.3 0.1 9.2 0.0 32.6 0.0 1.9 3.4 0.8 0.4 0.7 0.9 0.3 0.6 474.8 0.1 0.3 TTC29 NYD-SP14 ENSG00000137473 "Tetratricopeptide repeat domain 29" Q8NA56 4 146706617-146945882 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "fallopian tube: 20.2;testis: 72.5" "Cell type enhanced" "Detected in some" "Early spermatids: 697.9;Late spermatids: 445.9;Respiratory ciliated cells: 97.7;Spermatocytes: 157.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;hTERT-HME1: 1.4;U-266/70: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037006, HPA061473" Uncertain NA NA "HPA037006: AB_10670379, HPA061473: AB_2684534" "unprognostic (1.28e-3)" "unprognostic (1.52e-2)" "unprognostic (8.21e-2)" "unprognostic (1.70e-1)" "unprognostic (6.70e-2)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (1.32e-1)" "unprognostic (5.67e-4)" "unprognostic (9.81e-4)" "unprognostic (7.30e-2)" "unprognostic (6.88e-4)" 0.1 0.0 3.4 0.0 0.9 0.0 0.1 1.4 0.5 0.4 3.8 0.0 0.0 0.3 2.2 0.0 20.2 0.0 0.0 1.0 3.0 0.2 0.0 2.0 0.0 3.3 3.3 0.1 0.0 0.0 0.7 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 72.5 1.3 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 1.4 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 1.4 0.5 1.0 3.0 3.3 3.3 0.1 2.8 4.6 1.3 2.2 0.2 0.0 1.8 7.8 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 697.9 48.9 0.3 0.7 0.0 0.0 5.3 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 2.0 0.0 0.0 445.9 7.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 4.9 0.0 0.1 0.0 0.1 97.7 0.0 0.0 0.0 1.4 157.6 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYO7A "DFNA11, DFNB2, NSRD2, USH1B" ENSG00000137474 "Myosin VIIA" Q13402 11 77128246-77215241 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 42.3;choroid plexus: 41.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.6;intermediate monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 2.6" "Cell line enhanced" "Detected in some" "BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB034059 Uncertain NA NA "CAB034059: AB_2148626" "unprognostic (1.14e-3)" "unprognostic (2.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.61e-1)" "unprognostic (9.66e-2)" "unprognostic (4.02e-3)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (3.65e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (3.03e-2)" 5.1 42.3 6.3 3.1 2.8 1.0 3.1 2.7 2.9 1.7 41.7 2.7 2.2 1.5 1.2 1.0 2.7 2.8 2.4 3.9 6.7 4.2 23.5 2.3 2.9 6.1 8.5 1.5 5.3 5.4 0.5 19.3 16.1 5.8 2.5 1.2 27.7 1.5 0.8 1.5 0.8 2.8 2.2 4.7 15.9 2.2 24.7 4.8 1.4 2.0 0.7 1.1 2.0 1.6 8.2 0.0 1.3 0.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 9.0 2.0 0.0 2.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.3 5.7 0.2 0.4 0.0 0.1 0.0 0.0 0.5 0.0 3.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.3 0.0 19.5 13.8 0.0 0.3 2.9 0.9 0.1 10.5 0.1 2.2 1.3 1.3 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 2.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 6.3 2.8 2.7 2.9 3.9 6.7 6.1 8.5 1.5 5.8 4.7 4.8 8.2 1.7 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 14.2 0.5 0.5 4.4 4.3 0.0 0.0 47.9 42.3 0.3 0.2 0.0 0.6 1.9 0.1 0.5 2.2 1.2 0.0 0.7 1.7 10.5 1.4 5.6 0.3 0.0 0.8 16.4 16.1 30.1 0.0 0.8 0.7 0.0 17.8 0.9 6.4 3.1 7.3 0.0 6.5 0.8 17.0 0.0 3.0 0.1 0.7 0.2 0.4 0.1 0.1 1.7 2.7 0.1 31.4 0.0 5.2 0.3 0.4 0.6 0.1 0.3 16.1 1.4 3.2 0.6 0.2 FCHSD2 "KIAA0769, SH3MD3" ENSG00000137478 "FCH and double SH3 domains 2" O94868 11 72836745-73142318 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 164.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038545, HPA038546" Uncertain Approved "Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites" Yes No "Plasma membrane, Actin filaments" "Nuclear speckles, Focal adhesion sites" "HPA038545: AB_2676074, HPA038546: AB_10673013" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.62e-3)" "unprognostic (1.41e-2)" "unprognostic (2.62e-1)" "unprognostic (1.27e-2)" "unprognostic (2.56e-1)" "unprognostic (3.69e-2)" "unprognostic (6.16e-2)" "unprognostic (2.89e-3)" "unprognostic (2.02e-1)" "unprognostic (4.70e-1)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" 22.4 19.4 44.2 33.7 46.8 28.9 17.0 32.4 35.6 15.0 38.5 13.4 9.0 16.1 7.0 11.9 13.9 22.8 25.8 38.1 43.4 13.1 17.7 24.1 45.5 38.0 37.0 33.2 32.6 10.5 10.0 8.1 31.4 40.2 11.7 14.6 19.8 9.4 13.9 8.9 9.1 17.8 17.4 32.2 42.6 13.3 22.8 42.2 28.8 15.0 14.9 46.5 21.8 11.8 42.9 14.2 12.3 26.0 31.3 9.8 23.9 21.8 26.7 50.6 14.8 12.0 9.6 21.0 76.3 31.3 31.0 15.6 20.0 15.3 14.1 21.0 27.2 7.0 64.2 14.3 33.4 25.7 30.6 7.6 14.6 15.6 15.1 17.7 33.4 35.7 26.7 13.7 49.6 19.5 16.1 36.4 54.7 5.5 15.6 13.8 56.4 39.8 164.1 24.8 21.4 13.1 16.9 9.6 16.2 31.9 12.2 12.4 23.7 47.9 45.9 18.5 32.9 7.5 46.8 29.4 71.2 8.4 51.4 13.8 18.3 8.4 18.7 2.8 5.1 1.9 22.2 2.8 3.2 8.1 26.9 3.2 4.1 19.9 2.0 3.0 32.3 3.2 3.6 44.2 46.8 32.4 35.6 38.1 43.4 38.0 37.0 33.2 40.2 32.2 42.2 42.9 47.3 9.6 14.0 114.9 76.7 8.5 5.2 3.6 9.1 13.5 5.9 4.7 16.0 8.6 6.1 3.7 25.0 12.4 39.4 1.9 1.9 4.1 6.2 6.6 8.3 30.2 4.8 19.4 79.4 6.2 9.2 9.4 7.7 5.4 2.5 33.6 46.1 11.3 19.9 10.1 219.6 7.7 4.1 30.8 29.9 10.0 10.8 32.8 5.4 387.8 20.6 10.6 5.2 471.0 198.1 5.3 5.7 16.6 70.1 3.8 1.8 3.5 3.9 17.0 6.6 13.0 26.1 9.6 13.0 7.1 5.8 12.0 14.9 6.0 3.7 4.8 ARRB1 ARR1 ENSG00000137486 "Arrestin beta 1" P49407 11 75260122-75351705 "Predicted intracellular proteins, Transporters" "Protein transport, Transcription, Transcription regulation, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 136.8" "Group enriched" "Detected in many" 5 "dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8" "Cell line enhanced" "Detected in many" "HEL: 168.9;RH-30: 114.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003763, HPA049318, HPA070249" Approved Supported Nucleoplasm NA NA 1500000 Nucleoplasm "CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151" "unprognostic (3.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.88e-1)" "unprognostic (2.35e-1)" "unprognostic (3.27e-3)" "unprognostic (1.33e-2)" "unprognostic (1.15e-2)" "unprognostic (1.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (9.35e-2)" "unprognostic (2.34e-2)" "unprognostic (2.29e-1)" "unprognostic (7.10e-2)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" 31.0 7.1 50.2 22.1 49.0 15.9 24.3 28.7 47.9 9.8 3.3 26.4 22.1 10.3 6.2 19.2 16.1 13.0 17.8 54.7 41.1 12.1 10.2 53.4 15.4 48.5 54.7 49.1 16.4 24.7 3.8 4.1 25.3 41.6 16.4 22.7 5.3 12.8 9.7 11.6 17.0 27.4 22.0 19.2 40.5 34.1 4.3 47.8 10.0 8.9 11.0 10.4 16.7 11.1 38.3 5.1 23.6 24.2 12.0 20.2 17.6 48.8 5.0 17.2 6.2 4.3 34.5 23.9 2.0 58.9 4.5 4.7 1.1 9.5 0.1 2.4 0.2 5.5 168.9 3.3 20.6 5.5 5.1 63.9 8.9 1.2 10.3 0.0 7.4 70.4 6.1 83.5 0.2 12.2 14.1 3.1 58.4 17.8 76.9 7.1 18.8 114.4 6.8 26.8 20.4 12.5 13.5 8.7 61.7 15.0 49.3 44.8 27.6 61.0 4.7 5.9 19.3 0.6 0.1 0.1 0.1 3.5 78.0 5.8 33.7 65.7 45.9 11.6 106.5 4.3 0.4 5.5 6.6 42.5 0.2 5.0 6.6 49.5 14.8 136.8 0.9 5.7 41.1 50.2 49.0 28.7 47.9 54.7 41.1 48.5 54.7 49.1 41.6 19.2 47.8 38.3 24.2 28.9 14.8 52.2 1.9 1.9 2.0 1.9 2.8 3.1 9.0 14.7 4.6 8.6 5.8 3.7 6.2 41.7 10.7 38.5 1.9 5.0 2.6 0.8 4.3 19.4 5.4 10.3 35.6 8.4 4.1 9.1 17.3 0.9 23.5 2.3 25.7 2.1 39.6 0.0 48.9 11.1 8.2 55.2 17.9 21.4 15.8 31.2 3.6 55.3 42.1 0.2 29.9 8.0 23.9 9.2 19.1 16.6 1.0 3.6 29.9 0.2 4.7 1.1 13.1 4.5 7.7 0.2 0.8 1.0 3.0 33.7 5.9 9.4 20.0 2.8 SLCO2B1 "OATP-B, OATP2B1, SLC21A9" ENSG00000137491 "Solute carrier organic anion transporter family member 2B1" O94956 11 75100563-75206549 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 231.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020659 Uncertain NA NA "HPA020659: AB_1857219" "unprognostic (8.25e-2)" "unprognostic (5.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.57e-1)" "unprognostic (3.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (2.00e-3)" "unprognostic (1.99e-1)" "unprognostic (2.09e-1)" "unprognostic (9.75e-3)" "unprognostic (2.54e-2)" "unprognostic (4.57e-3)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" 40.3 31.8 32.8 34.3 34.7 2.9 12.2 31.9 52.3 18.3 22.2 31.2 42.5 9.6 3.7 19.9 13.3 28.6 15.7 26.9 75.4 21.2 231.5 61.2 60.6 58.6 39.7 10.6 9.5 22.3 8.0 5.1 44.2 55.0 6.2 23.8 1.5 8.5 9.7 5.6 4.3 51.7 26.5 35.8 46.8 15.1 6.1 80.1 16.8 10.2 8.0 28.7 26.5 6.3 58.6 0.0 0.7 2.8 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 90.3 0.0 0.1 0.1 0.0 21.2 0.2 0.0 0.0 0.0 1.1 0.0 15.0 1.0 20.4 0.0 1.1 25.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.3 8.7 0.0 0.1 0.0 0.1 0.1 111.1 0.0 0.0 2.4 9.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.8 0.0 0.0 1.9 0.0 0.1 0.3 0.0 1.5 1.8 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 34.7 31.9 52.3 26.9 75.4 58.6 39.7 10.6 55.0 35.8 80.1 58.6 4.7 0.0 8.9 1.3 0.7 1.9 0.0 0.0 1.8 3.4 0.9 1.4 2.8 11.5 1.8 0.0 0.0 0.9 0.1 14.7 1.9 0.0 2.8 0.0 0.1 28.8 0.0 2.7 0.5 0.2 2.3 3.6 0.5 0.0 22.9 6.1 3.6 204.5 122.2 0.0 0.5 6.6 0.0 155.8 8.9 1.7 10.8 92.4 0.0 232.3 2.0 0.2 0.0 1.5 0.6 0.1 14.6 10.5 1.4 0.0 46.7 8.2 0.7 0.7 0.0 3.0 1.1 0.4 0.2 4.5 0.4 2.5 0.7 0.4 13.3 0.1 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76381132 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 241.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008758, HPA077077" Approved Approved Cytosol NA NA Cytosol "HPA008758: AB_1855714, HPA077077: " "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 25.9 22.1 14.9 20.3 15.2 33.7 30.0 14.6 16.1 21.6 14.1 24.3 20.1 24.5 21.3 11.3 19.2 16.8 17.4 15.1 14.8 19.8 19.7 22.0 33.3 14.2 15.1 14.5 20.5 42.0 14.3 9.6 26.4 14.1 17.2 25.9 37.6 15.7 19.2 32.0 14.6 20.2 22.2 14.8 26.3 21.7 18.2 14.8 30.9 22.3 33.2 28.9 20.6 15.1 14.7 37.7 29.3 54.6 31.1 36.4 51.5 33.4 38.0 38.9 46.4 40.8 58.9 38.9 100.8 57.1 36.2 40.7 36.5 67.4 44.6 73.9 78.3 21.5 72.2 20.2 27.4 40.2 92.3 34.9 37.1 57.8 41.3 76.9 28.1 40.7 70.5 85.3 55.3 42.0 40.4 81.4 51.9 22.7 98.5 31.8 60.3 124.7 105.0 27.1 38.8 53.1 35.6 36.7 40.1 20.5 36.5 40.6 35.8 36.7 55.4 91.7 114.2 33.9 49.9 56.6 241.7 13.3 50.8 30.6 0.7 1.5 1.7 4.5 1.6 5.2 3.3 4.7 5.0 2.1 3.6 3.4 4.4 0.5 5.6 1.5 0.9 4.7 1.7 14.9 15.2 14.6 16.1 15.1 14.8 14.2 15.1 14.5 14.1 14.8 14.8 14.7 42.4 25.6 25.3 0.0 13.6 0.0 0.0 0.0 0.0 0.0 29.6 24.0 0.0 0.0 6.2 11.0 0.0 14.2 31.6 0.0 13.7 10.9 0.0 13.6 34.7 9.8 0.0 0.0 0.0 26.4 21.5 11.3 0.0 19.3 7.6 24.5 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 8.3 0.0 0.0 0.0 0.0 14.1 0.0 0.0 7.6 0.0 0.0 16.3 5.8 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 16.3 13.4 34.4 0.0 0.0 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193712-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.6" "Cell type enhanced" "Detected in all" "Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.3 13.4 11.3 5.2 10.5 9.0 6.1 6.7 13.1 7.0 15.9 5.5 5.2 6.1 19.9 4.9 16.0 7.7 4.6 12.3 13.8 11.2 4.7 6.6 3.8 11.4 10.6 8.9 8.8 6.0 12.4 13.2 3.9 9.2 7.3 4.2 18.0 6.1 7.5 2.7 5.5 4.9 5.3 10.1 4.5 6.3 37.6 10.4 2.9 11.9 2.2 4.1 7.4 5.5 11.4 5.6 9.7 4.7 9.5 14.3 15.0 4.1 11.4 8.8 6.7 4.1 5.9 6.8 2.2 14.1 10.3 13.4 11.9 5.0 7.8 5.5 3.2 3.7 4.0 14.5 4.0 10.0 11.6 9.0 8.9 8.8 17.0 8.9 12.3 7.0 4.0 12.0 2.0 9.8 7.9 1.7 12.2 3.9 8.8 6.1 2.7 6.5 2.8 21.8 6.6 3.7 4.9 14.9 9.2 2.9 6.1 13.9 6.2 10.2 10.2 7.1 37.1 5.4 2.9 7.1 4.5 7.9 6.7 4.3 5.7 2.6 3.2 2.9 3.0 1.9 5.0 2.5 2.9 3.5 3.8 1.2 2.0 2.0 4.4 8.0 1.4 1.1 1.7 11.3 10.5 6.7 13.1 12.3 13.8 11.4 10.6 8.9 9.2 10.1 10.4 11.4 7.6 9.6 16.0 7.5 8.5 11.2 21.5 6.5 4.0 3.9 11.9 9.8 7.8 8.6 8.0 7.3 39.6 3.1 7.1 5.2 9.8 7.7 170.5 53.1 21.9 8.5 3.0 2.1 33.3 6.7 3.3 13.0 7.7 15.4 13.9 7.8 9.3 4.8 5.0 1.7 27.3 3.1 12.2 7.2 9.9 63.2 8.7 8.8 7.2 7.5 7.3 7.4 2.1 4.5 2.9 5.7 4.9 10.5 4.7 10.6 5.8 14.8 61.6 22.4 13.1 16.6 9.0 55.5 17.3 4.7 15.3 5.5 9.1 14.5 3.9 11.5 IL18BP IL18BPa ENSG00000137496 "Interleukin 18 binding protein" O95998 11 71998613-72005715 "Disease related genes, Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.6" "Cell type enhanced" "Detected in many" "Adipocytes: 14.0;Exocrine glandular cells: 13.6;Kupffer cells: 14.2;Langerhans cells: 12.9;Macrophages: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025980, HPA041061" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 3070000 16000000 "Endoplasmic reticulum" "CAB025980: , HPA041061: AB_2677280" "unprognostic (2.66e-3)" "unprognostic (2.04e-3)" "unprognostic (9.14e-3)" "unprognostic (1.70e-2)" "unprognostic (5.58e-3)" "unprognostic (7.75e-2)" "unprognostic (1.41e-1)" "unprognostic (6.20e-2)" "unprognostic (1.19e-2)" "unprognostic (1.75e-3)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.93e-6)" "unprognostic (1.19e-1)" "unprognostic (4.14e-2)" "unprognostic (6.76e-2)" "unprognostic (1.93e-2)" 14.2 18.5 6.2 25.3 6.6 7.9 13.8 6.2 9.2 11.7 5.1 12.4 8.4 10.5 3.6 6.5 10.1 8.2 9.7 4.9 9.7 25.0 15.1 31.3 26.4 8.3 6.1 4.3 11.2 8.5 2.5 10.8 17.3 8.1 16.7 11.1 3.8 9.0 4.3 5.0 7.2 17.4 13.7 5.2 49.6 10.3 6.1 7.4 6.5 12.7 2.4 12.0 12.3 8.6 11.7 1.7 2.3 5.1 2.9 1.0 1.6 5.9 3.3 1.8 3.0 4.0 11.7 2.4 1.2 2.2 1.3 3.4 4.0 2.5 2.4 2.0 2.5 3.8 4.5 7.6 3.7 1.3 2.4 12.3 2.4 2.3 2.4 1.2 3.5 6.3 7.9 7.4 2.0 1.8 3.2 3.8 5.7 3.6 1.9 2.2 6.1 5.4 1.9 2.1 4.4 2.8 5.3 3.0 4.2 3.7 4.8 3.6 2.7 13.6 4.2 3.5 5.1 1.9 3.3 1.8 2.1 1.7 11.5 2.3 7.0 20.2 56.1 52.5 72.9 23.9 31.9 27.5 31.6 36.9 20.2 22.5 32.5 8.6 5.2 60.9 53.7 15.1 39.8 6.2 6.6 6.2 9.2 4.9 9.7 8.3 6.1 4.3 8.1 5.2 7.4 11.7 14.0 6.4 3.3 0.7 8.0 2.0 0.4 0.7 0.0 3.3 2.1 1.9 1.8 1.5 1.0 0.0 10.4 1.0 7.2 0.5 0.0 3.0 0.0 1.1 1.9 11.1 0.0 0.8 0.7 13.6 1.4 3.4 1.1 1.8 7.6 2.2 10.4 0.5 11.2 3.3 0.5 0.8 0.0 14.2 12.9 0.0 0.9 15.4 0.0 1.0 4.6 1.1 7.2 0.5 0.0 5.4 0.2 0.7 2.3 1.0 1.1 1.9 1.8 3.7 0.0 1.8 1.6 0.7 0.5 0.6 2.0 0.8 6.4 1.6 0.8 0.2 NUMA1 ENSG00000137497 "Nuclear mitotic apparatus protein 1" Q14980 11 72002864-72080693 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019841, HPA019859, HPA029912" Enhanced Supported Nucleoplasm,Cytosol NA Yes 62000 Nucleoplasm Cytosol "HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811" "unprognostic (1.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.06e-2)" "unprognostic (2.84e-1)" "unprognostic (1.14e-1)" "unprognostic (6.47e-2)" "unprognostic (5.75e-2)" "unprognostic (8.74e-3)" "unprognostic (5.91e-2)" "unprognostic (9.45e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "prognostic favorable (7.92e-4)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.49e-1)" "unprognostic (1.39e-1)" 55.7 60.4 24.3 51.5 40.6 70.2 67.7 33.2 34.5 76.0 30.5 68.5 60.1 112.2 43.7 68.5 83.4 63.3 48.0 18.9 26.7 50.3 30.0 66.0 58.4 33.9 29.7 16.5 113.3 69.4 99.4 42.4 61.3 39.2 112.4 55.0 46.6 78.8 86.4 83.2 94.5 62.4 87.4 24.1 57.3 59.6 42.8 30.7 80.0 74.5 55.3 53.6 75.8 66.5 79.3 64.4 80.0 97.2 66.4 85.1 88.2 48.8 85.0 97.2 86.4 74.6 83.9 115.5 86.7 72.0 104.0 61.6 134.2 89.7 85.8 78.0 89.9 43.1 105.8 130.4 64.1 69.1 81.1 74.0 94.0 55.7 84.1 84.3 133.0 74.0 76.7 63.4 101.1 59.4 124.2 105.6 45.2 61.2 122.3 57.6 127.9 170.0 67.6 64.2 98.6 117.3 166.6 134.9 123.5 123.6 42.3 166.4 47.1 103.0 90.6 69.9 130.1 56.9 64.8 69.7 120.0 61.1 38.0 53.0 3.7 4.1 1.9 6.4 2.3 4.7 3.4 4.0 5.0 3.5 5.8 4.9 3.6 2.8 5.0 4.4 8.2 5.2 6.0 24.3 40.6 33.2 34.5 18.9 26.7 33.9 29.7 16.5 39.2 24.1 30.7 79.3 52.4 41.7 41.3 42.7 36.6 25.9 30.1 25.3 74.0 60.7 62.3 63.4 5.7 34.3 32.2 53.3 73.0 25.5 42.6 56.3 17.6 27.9 31.9 55.5 48.5 44.9 47.4 43.3 27.5 32.1 13.4 41.9 57.6 92.8 31.0 84.7 37.9 23.6 28.7 52.2 34.0 68.3 32.6 32.1 24.9 17.8 69.0 36.3 19.6 33.7 26.8 51.8 53.5 27.6 58.9 30.9 31.2 50.8 40.8 29.6 57.0 26.9 35.4 59.8 39.5 64.3 36.9 14.8 21.4 51.9 28.1 45.0 44.8 44.2 52.2 26.0 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria NA NA Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 16.5 37.7 25.0 13.1 26.3 16.3 21.5 25.8 30.0 17.3 24.6 18.3 14.8 14.8 34.1 16.3 15.7 18.4 22.3 24.7 26.2 18.6 39.2 13.6 20.7 27.0 26.5 23.9 22.5 18.4 15.0 19.5 22.4 26.7 16.2 17.5 12.7 17.2 16.5 16.4 14.2 16.8 16.9 27.7 15.7 17.1 54.9 26.4 17.4 25.8 17.8 17.1 15.4 14.3 29.0 19.1 27.3 46.1 15.2 59.6 44.7 27.7 37.4 31.6 22.7 24.3 32.2 63.0 46.7 47.7 55.0 47.5 23.5 20.1 47.3 30.3 31.9 16.0 28.2 17.7 27.3 50.1 29.2 23.5 50.2 62.3 29.5 83.8 45.3 52.3 49.6 41.9 37.9 83.7 33.5 29.4 36.7 37.9 80.2 33.4 33.1 40.9 39.3 47.3 27.5 22.2 50.9 26.4 21.0 26.1 60.8 53.9 26.4 51.6 44.8 28.8 85.9 26.0 36.3 51.2 46.8 18.1 23.2 45.5 77.7 18.7 71.6 24.2 41.3 31.2 39.8 34.7 34.2 27.0 37.9 30.2 30.2 9.8 50.7 43.8 20.4 46.0 27.4 25.0 26.3 25.8 30.0 24.7 26.2 27.0 26.5 23.9 26.7 27.7 26.4 29.0 50.8 12.8 13.1 14.0 40.5 23.6 49.6 102.8 26.7 36.3 33.5 49.7 58.0 28.6 48.3 36.8 14.6 74.0 41.4 21.0 68.4 59.4 447.3 39.5 38.0 45.8 33.6 36.2 16.0 48.5 55.4 44.5 26.5 31.4 49.4 83.0 35.7 43.3 63.7 42.1 23.3 35.2 52.9 34.6 32.4 233.9 42.6 38.6 21.4 10.3 52.8 35.3 53.5 31.2 48.2 67.6 32.9 25.6 44.6 38.9 44.1 78.0 32.6 50.0 26.3 40.3 43.5 333.0 107.8 32.5 29.0 51.7 37.1 86.8 31.2 49.9 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 74.9;stomach 1: 128.9" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.0;MAIT T-cell: 23.7" "Lineage enriched" "Detected in many" 5 "T-cells: 23.7" "Cell line enhanced" "Detected in many" "MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 16.0 9.7 14.9 13.0 25.3 3.3 16.1 8.7 35.0 10.8 12.5 52.1 21.8 9.2 16.4 17.2 7.7 28.0 8.5 27.3 18.9 20.4 7.0 14.9 11.2 27.8 18.9 21.0 4.9 2.7 6.5 6.2 18.4 17.3 13.7 74.9 13.5 9.0 9.9 5.1 6.8 25.2 10.3 13.0 10.5 128.9 5.1 12.3 7.2 4.8 2.7 6.8 51.4 7.5 36.5 3.5 8.0 12.2 1.0 2.8 15.4 0.2 30.3 39.4 26.3 59.2 34.7 4.5 0.7 11.1 21.3 38.0 22.3 0.8 2.7 34.5 2.4 0.2 0.0 0.2 0.3 1.8 2.7 0.5 19.6 3.8 56.8 0.8 6.2 0.2 1.0 0.4 0.4 33.6 91.1 0.1 0.9 20.6 148.1 13.6 1.3 175.8 0.1 124.2 46.8 0.3 0.6 6.7 5.4 3.0 10.2 0.6 0.5 0.1 40.8 15.6 25.9 1.5 0.2 0.0 16.1 41.9 0.5 25.7 0.0 0.0 0.0 14.0 0.0 23.7 0.0 2.8 8.4 0.0 0.1 2.3 4.1 0.0 4.6 0.1 1.0 1.1 2.6 14.9 25.3 8.7 35.0 27.3 18.9 27.8 18.9 21.0 17.3 13.0 12.3 36.5 7.5 22.4 32.5 15.3 3.0 3.6 11.7 15.8 1.8 10.4 45.4 14.0 2.3 8.6 62.1 68.0 8.4 0.7 45.6 115.2 0.0 9.1 1.2 8.0 2.2 6.4 19.2 4.0 103.9 16.9 0.4 11.5 382.2 2.3 130.8 0.8 5.0 0.5 0.5 1.7 23.2 185.9 2.0 5.9 5.0 0.9 1.8 4.6 10.6 20.6 1.6 14.0 63.8 35.7 91.9 16.5 40.6 30.1 31.6 30.7 16.3 8.6 138.4 8.1 32.9 42.1 59.8 3.6 2.6 2.2 5.7 0.4 50.1 2.3 36.7 60.9 RAB30 ENSG00000137502 "RAB30, member RAS oncogene family" Q15771 11 82973133-83071923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.7" "Cell type enhanced" "Detected in many" "Astrocytes: 87.8;Oligodendrocytes: 243.1;Plasma cells: 260.9" "Cancer enhanced" "Detected in all" "breast cancer: 6.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 54.4;naive B-cell: 55.0" "Lineage enriched" "Detected in many" 5 "B-cells: 55.0" "Cell line enhanced" "Detected in many" "Daudi: 55.7;HDLM-2: 57.6;U-698: 164.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054514, HPA060565" Approved Enhanced Vesicles NA NA Vesicles "HPA054514: AB_2682512, HPA060565: AB_2684320" "unprognostic (3.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-1)" "unprognostic (5.18e-2)" "unprognostic (7.21e-2)" "unprognostic (8.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.71e-2)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-2)" "unprognostic (2.37e-1)" "unprognostic (2.42e-1)" "unprognostic (3.93e-2)" "unprognostic (1.85e-1)" 11.3 11.1 11.8 14.0 25.7 14.6 12.5 19.5 15.5 8.3 0.7 13.2 18.0 8.4 5.8 6.9 5.5 5.7 9.4 9.9 19.4 3.7 7.7 6.6 19.9 25.1 19.5 7.2 14.1 4.3 3.0 4.4 8.6 26.2 7.3 13.9 11.3 6.1 5.3 13.0 7.0 21.5 10.3 23.8 10.2 11.7 4.1 21.4 10.5 5.9 11.9 28.7 9.0 4.4 41.7 4.1 5.6 5.8 2.9 11.1 16.7 6.8 9.8 9.1 19.0 7.9 8.7 1.8 55.7 10.0 14.9 4.9 4.8 8.3 6.4 11.3 57.6 1.6 12.6 16.4 5.1 2.6 2.0 2.5 9.5 4.4 8.5 6.5 7.2 14.0 5.0 1.9 15.0 9.8 7.9 2.1 0.6 7.7 5.5 10.0 4.8 15.2 23.7 9.5 3.4 6.7 4.6 22.6 5.3 2.7 8.6 12.4 0.2 17.9 8.1 19.1 8.0 2.7 24.0 14.3 164.6 3.1 1.4 5.7 1.4 0.7 1.0 4.9 0.3 3.6 54.4 4.8 4.8 2.0 55.0 11.2 10.0 0.9 2.3 0.8 5.8 9.5 6.2 11.8 25.7 19.5 15.5 9.9 19.4 25.1 19.5 7.2 26.2 23.8 21.4 41.7 15.2 9.6 3.3 87.8 80.5 24.9 10.7 9.9 73.4 8.3 11.7 13.0 14.5 0.0 2.7 3.7 16.7 7.0 6.8 5.4 1.9 2.4 0.7 3.3 6.1 10.5 10.1 3.2 60.7 4.0 30.8 23.5 5.1 4.2 0.0 0.9 18.2 6.4 1.9 11.8 78.2 1.5 8.2 1.6 15.2 1.3 14.3 6.4 42.7 67.5 24.8 13.9 3.1 80.4 243.1 4.3 3.5 18.0 260.9 8.9 9.3 4.6 2.3 10.5 6.6 20.3 13.5 0.7 2.2 11.0 11.5 2.9 12.9 24.0 1.8 2.0 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85657990-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HeLa: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 14.5 12.5 11.9 13.0 13.1 9.8 16.9 20.6 14.8 15.4 13.1 12.6 14.2 21.5 12.3 10.2 15.3 10.4 7.8 12.3 14.2 8.9 10.9 15.6 18.8 12.7 12.9 11.9 21.9 14.9 11.9 8.8 13.3 14.9 13.0 13.8 28.1 16.5 10.3 10.0 16.8 16.5 10.4 12.7 17.4 12.8 6.1 12.6 13.7 16.4 6.8 15.5 12.2 15.0 15.5 5.6 12.4 18.4 7.6 8.4 8.8 13.7 9.8 6.0 8.4 11.0 15.6 22.5 16.4 9.1 5.8 22.1 19.6 12.7 6.2 14.1 9.3 11.9 14.9 53.1 7.2 5.7 14.1 8.0 7.8 12.2 8.5 11.8 11.5 5.3 10.8 11.7 18.6 10.1 7.9 12.0 27.5 6.8 16.3 8.7 19.2 15.7 10.1 9.2 10.7 14.5 12.4 12.6 19.3 4.2 11.6 20.8 20.8 6.3 17.4 10.7 24.3 11.0 6.4 7.6 16.8 4.1 10.4 10.9 0.3 0.1 0.1 0.4 0.1 0.7 0.2 0.3 0.3 0.2 0.2 0.4 0.4 0.2 0.4 0.3 0.2 0.6 0.1 11.9 13.1 20.6 14.8 12.3 14.2 12.7 12.9 11.9 14.9 12.7 12.6 15.5 30.3 19.2 21.5 58.1 41.9 41.3 21.6 12.4 31.3 97.5 35.1 20.6 13.9 17.2 17.9 22.0 91.8 16.9 53.1 30.0 9.8 13.2 34.5 27.6 31.1 25.1 39.4 30.1 57.6 8.6 14.9 34.7 46.9 34.0 22.2 64.3 23.2 29.5 9.9 90.9 60.7 23.8 10.2 19.2 27.3 16.6 30.7 15.6 33.8 25.3 24.8 47.9 46.4 56.8 114.5 9.2 22.8 33.4 39.1 29.5 29.8 8.0 22.5 113.5 13.1 34.6 30.9 27.4 11.4 27.7 41.3 14.4 43.0 51.9 25.7 26.5 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 78.0;Endothelial cells: 88.3;Extravillous trophoblasts: 164.2;Hepatic stellate cells: 95.3;Sertoli cells: 39.5;Smooth muscle cells: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 2.2" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Group enriched" "Detected in some" 6 "ASC diff: 115.0;ASC TERT1: 70.3;HSkMC: 44.0;HUVEC TERT2: 51.4;U-2197: 108.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 98000 Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 96.2 34.6 13.0 10.6 11.5 2.4 64.1 10.9 11.9 52.5 11.9 23.3 9.0 36.7 6.2 10.4 31.9 29.3 48.6 9.1 10.8 53.8 11.4 110.0 4.4 11.7 13.2 6.6 13.6 12.1 7.6 16.8 53.4 11.5 25.1 6.1 1.3 12.9 11.1 23.8 22.3 21.6 15.4 10.5 29.1 21.5 3.6 14.4 2.0 42.7 6.3 1.5 37.1 29.1 13.6 0.0 0.0 1.3 0.0 115.0 70.3 1.4 0.4 0.8 0.1 0.1 0.0 0.0 0.2 3.1 1.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 11.8 0.6 0.0 2.2 0.0 0.1 44.0 0.0 4.1 0.2 0.9 51.4 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 7.6 0.2 0.0 13.8 7.5 0.8 108.3 0.0 0.1 0.0 1.9 5.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 4.3 13.0 11.5 10.9 11.9 9.1 10.8 11.7 13.2 6.6 11.5 10.5 14.4 13.6 78.0 0.0 4.3 0.0 1.7 14.5 0.3 0.0 1.8 0.0 0.6 0.6 10.4 0.0 1.3 0.0 0.0 1.9 0.1 0.2 0.0 0.3 1.3 0.1 1.9 88.3 0.0 5.3 0.0 0.0 164.2 26.4 0.5 0.3 2.5 0.5 95.3 0.6 3.6 0.0 0.1 0.4 0.0 3.1 19.0 1.9 9.0 2.9 17.8 14.0 0.0 0.4 0.0 0.0 0.1 0.0 2.2 9.1 0.2 1.4 0.0 0.4 0.7 0.1 39.5 2.1 47.6 0.4 4.7 0.6 12.5 8.3 1.6 0.4 0.1 1.2 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82822936-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 348.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 463.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" NA NA 42000000 Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favorable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 75.4 88.1 83.4 58.3 81.3 38.0 70.7 87.9 110.0 92.7 93.8 49.8 28.9 63.5 82.2 62.6 57.5 64.8 64.4 79.0 103.5 146.0 153.1 58.6 92.9 87.2 83.0 71.3 53.9 38.3 79.0 34.8 154.0 83.6 53.0 47.1 22.1 86.3 56.0 16.0 54.6 32.1 81.5 89.8 54.4 32.2 42.2 88.9 34.0 64.3 28.7 85.7 101.1 58.0 89.5 34.9 41.8 49.6 121.0 463.5 146.7 67.1 67.5 131.9 70.9 97.0 103.5 70.7 55.9 100.7 117.9 72.6 53.2 53.7 45.2 72.0 43.9 38.3 37.7 56.5 76.7 86.2 31.0 124.7 122.0 39.3 72.7 68.6 166.5 224.0 26.3 39.1 69.8 72.7 19.5 4.9 171.7 33.9 90.3 31.1 27.1 97.0 65.1 118.0 71.2 24.0 51.9 101.9 60.2 41.5 80.6 66.6 49.6 65.0 78.8 77.4 71.1 33.5 64.2 113.6 46.3 32.9 41.7 44.5 53.5 76.9 50.9 13.7 79.0 16.1 31.7 14.0 15.9 140.2 34.2 12.0 17.4 89.0 34.7 64.8 27.9 14.8 49.6 83.4 81.3 87.9 110.0 79.0 103.5 87.2 83.0 71.3 83.6 89.8 88.9 89.5 86.9 19.2 12.9 58.8 45.5 31.4 41.5 53.4 25.0 11.7 26.2 25.1 26.6 37.1 25.2 62.5 2.1 65.1 29.0 9.8 29.4 32.9 44.9 17.4 37.7 180.4 19.7 13.7 42.2 12.0 120.1 73.6 23.9 29.9 12.7 18.2 348.7 65.4 80.7 16.8 38.5 19.1 14.2 152.9 118.9 47.6 44.1 88.0 71.2 33.7 79.5 53.5 28.8 34.7 10.5 8.2 10.2 46.3 62.2 23.3 3.9 83.8 9.1 5.3 65.7 25.5 25.6 60.8 6.3 54.3 34.9 52.9 22.3 27.7 20.9 39.2 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435968-78574874 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 7.3 12.0 11.3 6.9 12.9 6.2 11.2 13.1 13.5 9.5 18.5 11.4 10.4 9.2 11.3 8.1 10.0 7.1 11.4 11.1 11.8 19.1 23.7 7.7 9.7 12.5 12.9 11.1 11.5 10.7 11.5 7.6 8.0 12.6 10.9 11.0 13.5 10.8 7.4 23.7 7.2 9.8 7.4 12.3 7.5 10.0 7.6 12.4 11.8 11.6 19.7 9.8 8.8 8.2 13.0 16.7 22.8 23.5 15.4 16.1 13.5 19.5 13.5 13.1 20.6 16.9 39.4 17.4 40.9 34.1 8.7 19.8 21.5 39.9 26.3 28.3 27.0 21.3 28.9 17.3 33.7 13.3 31.3 10.1 9.4 16.8 18.1 32.0 18.3 17.9 33.7 44.5 11.0 23.1 19.4 32.7 50.3 25.6 67.3 27.3 33.6 38.2 55.5 27.2 23.0 27.8 17.5 20.1 25.4 35.5 25.1 24.1 12.3 10.9 27.7 32.8 32.0 23.1 18.1 33.1 91.1 5.4 27.7 19.2 9.5 9.3 4.4 11.1 10.4 13.8 17.6 12.8 12.5 16.6 15.0 18.5 16.7 2.0 20.3 12.8 12.7 10.5 10.3 11.3 12.9 13.1 13.5 11.1 11.8 12.5 12.9 11.1 12.6 12.3 12.4 13.0 5.8 19.2 26.4 27.7 14.5 13.5 14.2 12.0 12.5 5.2 9.4 6.5 8.8 5.7 10.3 5.5 2.1 20.0 4.4 4.0 29.4 9.5 13.1 10.1 7.4 6.6 12.0 9.2 34.7 7.3 23.6 9.0 10.2 9.0 8.2 14.0 2.5 19.8 12.4 0.0 45.1 8.3 22.4 6.3 11.6 5.4 7.8 6.3 17.8 45.0 2.9 6.3 4.1 42.7 47.7 7.5 9.9 4.9 14.6 17.5 7.0 28.9 10.2 9.0 6.6 7.5 8.8 8.6 19.5 12.0 13.8 15.3 7.8 9.0 14.6 10.7 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71929018-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favorable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 7.3 9.6 8.9 6.6 8.9 5.8 11.4 8.6 9.3 9.8 9.4 8.2 16.1 8.4 20.1 7.5 11.7 7.9 10.1 9.0 9.2 16.5 11.6 7.7 8.1 9.0 9.4 8.6 11.3 11.0 24.5 9.6 11.2 8.6 10.7 10.4 15.8 15.2 13.8 17.3 8.4 14.0 11.9 8.7 6.8 9.3 8.8 8.9 7.7 13.0 15.1 10.5 9.1 7.2 8.8 10.9 22.7 20.5 14.6 19.1 15.2 13.8 16.7 17.7 25.4 26.9 46.0 20.9 9.2 14.9 18.5 26.7 22.1 22.7 21.2 26.7 13.8 13.1 14.0 21.5 21.9 14.3 12.8 11.5 14.8 17.9 28.7 18.2 27.9 46.7 13.5 23.2 8.6 22.7 23.5 9.0 14.1 13.7 43.4 21.9 11.0 44.5 7.9 28.3 18.4 13.7 14.6 22.9 20.4 30.4 20.6 22.5 9.5 32.8 19.0 17.2 11.8 14.6 9.6 10.2 9.4 16.5 8.3 17.1 4.4 2.2 2.2 3.0 2.9 3.5 3.2 2.3 2.4 2.3 1.3 2.7 2.9 1.2 3.2 2.1 3.7 2.1 2.9 8.9 8.9 8.6 9.3 9.0 9.2 9.0 9.4 8.6 8.6 8.7 8.9 8.8 9.6 6.4 9.6 12.7 9.4 8.8 11.2 22.8 10.2 16.1 12.1 10.9 9.7 12.8 13.3 20.2 20.9 32.0 17.9 15.2 7.9 26.0 6.3 8.9 10.3 6.5 9.6 13.0 19.3 32.3 26.5 11.8 9.2 10.9 7.0 11.6 8.9 14.4 14.2 10.1 16.9 13.2 26.4 6.6 12.9 3.0 13.1 7.6 10.6 15.0 15.0 19.0 10.3 18.1 19.0 29.0 11.0 12.4 17.1 10.3 31.0 20.9 10.3 21.1 19.7 10.0 14.2 25.1 19.6 6.4 5.8 31.1 10.0 13.4 9.4 9.9 MRPL15 "HSPC145, L15mt, MRP-L15, MRP-L7, RPML7" ENSG00000137547 "Mitochondrial ribosomal protein L15" Q9P015 8 54135241-54148514 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 294.0;tongue: 281.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 248.4;Syncytiotrophoblasts: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044425 Enhanced Supported Mitochondria NA NA Mitochondria "HPA044425: AB_10969629" "unprognostic (5.67e-3)" "unprognostic (8.89e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (9.30e-2)" "unprognostic (1.90e-2)" "unprognostic (2.57e-2)" "unprognostic (3.10e-3)" "unprognostic (1.39e-1)" "unprognostic (3.39e-2)" "unprognostic (1.94e-3)" "unprognostic (1.57e-2)" "unprognostic (2.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (1.06e-1)" "unprognostic (1.06e-2)" 42.8 34.8 34.9 36.7 35.4 25.3 49.8 38.2 51.0 32.8 38.0 71.5 59.1 28.8 27.9 49.3 36.0 29.2 171.1 34.3 39.1 84.6 89.9 26.7 43.3 37.3 37.0 33.8 30.7 29.4 84.2 18.7 50.0 37.5 27.8 68.2 63.6 41.8 29.3 294.0 38.2 51.0 45.8 34.7 27.6 38.7 14.8 38.7 38.5 35.5 281.9 57.9 64.7 26.5 38.6 164.1 118.9 98.0 122.6 76.1 110.5 125.8 128.4 93.0 173.3 150.2 134.1 197.1 253.9 170.3 112.1 164.4 161.5 206.2 165.5 190.4 109.9 109.5 165.8 62.4 168.5 114.5 92.0 168.9 103.3 167.4 159.5 165.6 74.7 366.7 89.4 208.2 80.8 251.3 156.1 262.4 177.3 206.2 313.9 60.8 169.5 63.6 136.3 210.8 147.1 56.5 83.7 66.8 204.0 167.0 97.4 195.2 96.6 129.6 95.8 111.7 139.5 151.5 94.6 128.4 207.1 88.8 137.8 153.4 40.1 93.8 27.3 50.7 123.4 63.8 100.6 64.8 68.4 141.1 76.6 59.0 56.9 3.3 54.0 115.7 88.9 79.8 85.8 34.9 35.4 38.2 51.0 34.3 39.1 37.3 37.0 33.8 37.5 34.7 38.7 38.6 28.0 25.6 14.4 9.4 33.1 23.6 40.7 114.5 19.4 28.2 25.0 37.2 120.9 55.8 50.4 36.8 29.2 160.3 17.6 38.7 248.4 103.2 18.7 34.0 34.4 34.8 18.0 31.7 10.9 70.9 155.2 32.8 23.9 39.2 25.4 37.9 26.4 59.2 106.1 25.2 12.4 52.5 75.3 44.5 22.9 4.3 24.8 37.9 33.8 7.5 56.5 37.4 20.6 11.1 6.0 97.5 34.3 22.6 35.3 33.9 66.8 127.0 32.1 58.8 13.1 32.1 70.1 14.8 34.3 37.3 34.4 198.9 19.7 91.3 78.3 41.8 PI15 P25TI ENSG00000137558 "Peptidase inhibitor 15" O43692 8 74824534-74855029 "Predicted secreted proteins" "Developmental protein, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.9;prostate: 31.3;smooth muscle: 50.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 36.8;Breast glandular cells: 73.2;Breast myoepithelial cells: 13.6;Prostatic glandular cells: 19.3;Smooth muscle cells: 36.2;Urothelial cells: 15.7" "Group enriched" "Detected in many" 7 "breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 23.3;SH-SY5Y: 21.3;SK-MEL-30: 30.0;U-266/70: 7.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "spinal cord: 6.3" "HPA006593, HPA030057" Uncertain Approved Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA006593: AB_1078568, HPA030057: AB_10602143" "unprognostic (2.77e-1)" "unprognostic (1.57e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-2)" "unprognostic (3.22e-1)" "unprognostic (3.24e-1)" "unprognostic (2.94e-2)" "unprognostic (2.33e-3)" "unprognostic (1.87e-1)" "unprognostic (2.25e-1)" "unprognostic (3.65e-2)" "unprognostic (1.85e-2)" "unprognostic (8.63e-14)" "unprognostic (2.54e-3)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" 5.9 1.1 0.7 54.9 0.9 0.0 22.3 0.2 2.0 9.4 0.1 7.0 0.2 20.0 2.1 2.6 21.1 1.5 1.4 0.8 2.3 0.9 0.2 2.2 0.6 1.3 0.5 0.9 6.3 0.3 0.0 0.5 0.3 0.8 31.3 4.7 0.6 2.0 6.8 0.4 0.3 4.7 50.3 1.2 1.3 0.7 0.5 1.9 0.5 0.6 0.2 0.2 8.4 6.6 0.7 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 21.3 0.0 0.1 30.0 0.4 0.5 0.5 0.0 0.0 0.5 0.0 0.1 7.9 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.2 2.0 0.8 2.3 1.3 0.5 0.9 0.8 1.2 1.9 0.7 0.2 0.0 0.0 2.3 0.1 0.1 36.8 0.0 0.6 0.2 73.2 13.6 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.6 0.2 9.1 2.5 0.0 0.0 4.3 0.0 0.4 3.9 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.6 1.9 0.9 0.2 3.6 1.0 0.0 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.1 19.3 0.0 0.1 0.0 0.5 0.0 1.7 36.2 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 15.7 TTPA AVED ENSG00000137561 "Alpha tocopherol transfer protein" P49638 8 63048553-63086053 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 166.4" "Group enriched" "Detected in some" 4 "Astrocytes: 37.9;Hepatocytes: 72.0" "Cancer enriched" "Detected in some" 9 "liver cancer: 21.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;SK-BR-3: 6.0;T-47d: 2.1;U-2 OS: 2.9;U-2197: 3.7" "Low region specificity" "Detected in all" NA NA 10000 "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (7.82e-3)" "unprognostic (1.30e-7)" "unprognostic (1.78e-1)" "unprognostic (8.44e-2)" "unprognostic (1.25e-2)" "unprognostic (7.84e-2)" "unprognostic (4.04e-2)" "unprognostic (3.50e-1)" "unprognostic (5.40e-2)" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (1.49e-2)" "unprognostic (3.57e-2)" "unprognostic (5.46e-3)" "unprognostic (6.16e-3)" 1.6 0.2 2.7 0.4 2.4 0.2 0.6 3.0 2.3 0.1 0.7 3.1 0.3 0.0 0.0 0.1 0.1 0.3 0.0 2.4 2.3 2.4 166.4 0.7 0.2 2.8 2.9 1.8 0.0 1.2 3.6 0.1 1.7 2.4 0.1 4.3 0.9 0.1 0.1 0.2 0.2 0.3 0.2 2.1 0.0 0.3 0.3 2.7 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.8 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.0 0.0 0.0 2.0 0.0 1.5 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 6.0 0.6 0.0 2.1 0.2 0.1 0.0 2.9 3.7 0.6 0.2 0.0 0.0 1.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 2.4 3.0 2.3 2.4 2.3 2.8 2.9 1.8 2.4 2.1 2.7 2.6 0.0 3.2 1.1 37.9 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 7.2 1.3 0.0 0.0 11.2 0.0 2.1 1.9 1.1 0.0 0.0 0.1 0.2 2.4 0.0 1.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 1.8 72.0 0.6 0.0 2.7 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 12.9 0.0 10.6 0.1 0.1 1.2 0.0 0.0 0.1 0.0 5.5 0.0 0.2 0.0 0.7 0.1 0.0 1.0 0.0 0.1 9.9 0.1 0.0 4.9 0.1 GGH ENSG00000137563 "Gamma-glutamyl hydrolase" Q92820 8 63014881-63039407 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 126.9;liver: 190.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 510.3;Early spermatids: 471.0;Extravillous trophoblasts: 273.4;Proximal tubular cells: 340.8;Syncytiotrophoblasts: 754.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 30.6" "Lineage enriched" "Detected in all" 5 "dendritic cells: 30.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019296, HPA025226" Approved "Intracellular and membrane" NA NA 1200000000 "CAB019296: , HPA025226: AB_1849645" "unprognostic (9.29e-2)" "unprognostic (1.22e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.99e-7)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (1.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.11e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-2)" "unprognostic (9.62e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" 9.9 5.4 11.6 14.4 11.7 44.1 16.6 11.2 14.4 6.0 12.9 54.8 11.4 6.4 4.4 20.9 3.5 4.3 2.9 11.7 12.0 126.9 190.2 8.0 11.0 13.5 11.7 10.9 3.1 10.0 13.2 1.9 55.4 14.2 4.4 75.1 2.1 13.2 3.7 2.1 27.4 10.0 11.7 10.6 5.5 8.3 34.2 14.2 17.9 2.5 3.2 22.7 8.5 10.9 11.7 110.5 97.6 97.4 15.7 94.1 39.6 69.6 64.3 105.1 94.2 137.7 144.5 183.8 69.8 18.0 77.1 166.8 87.2 97.2 101.9 138.9 139.0 71.6 112.3 50.3 105.1 17.6 53.5 65.9 29.1 29.2 93.9 50.7 59.4 116.1 66.9 62.4 255.2 177.3 64.3 28.8 71.1 51.0 231.6 86.0 77.6 95.2 98.1 75.8 40.3 38.6 69.9 91.8 103.6 98.5 91.6 116.6 65.8 65.5 104.2 115.6 99.4 111.3 112.6 127.2 88.3 158.0 0.1 185.0 0.0 2.1 2.3 1.1 1.7 0.8 6.5 1.5 1.7 0.9 2.7 1.8 1.9 3.0 4.4 2.0 30.6 2.7 1.9 11.6 11.7 11.2 14.4 11.7 12.0 13.5 11.7 10.9 14.2 10.6 14.2 11.7 13.1 16.0 7.3 11.1 26.1 30.2 23.2 66.6 9.1 2.0 14.9 21.0 3.2 17.2 31.1 22.0 0.0 510.3 11.7 49.2 37.2 19.7 471.0 5.4 11.5 13.1 13.2 62.5 11.5 7.4 273.4 27.2 11.7 7.6 10.8 21.4 13.6 219.5 72.4 0.0 8.7 70.7 44.7 21.0 15.5 154.2 5.9 12.0 24.9 1.0 32.1 23.1 2.1 3.5 2.9 4.3 23.7 8.2 106.9 10.5 4.3 340.8 18.3 1.3 26.3 12.8 20.4 80.3 133.0 35.9 43.0 754.5 8.5 9.3 102.0 23.1 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667046-69834978 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.6;skeletal muscle: 7.7;tongue: 11.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory bulb: 6.7" "Region enriched" "Detected in some" 7 "olfactory bulb: 12.8" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.1 0.0 0.3 0.9 0.4 0.9 0.1 0.0 0.4 0.2 0.0 0.2 0.2 0.2 0.0 0.5 0.3 0.2 3.1 0.3 0.6 0.0 0.0 0.1 1.0 0.2 0.0 0.1 0.0 0.4 0.0 1.5 0.0 0.2 2.3 0.4 0.7 0.3 0.0 7.7 0.0 0.3 0.1 0.0 0.5 0.2 0.3 0.2 6.6 0.0 11.2 0.9 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 3.7 0.0 0.6 0.6 0.6 3.6 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 2.1 0.3 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.3 0.6 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.1 3.2 0.0 3.6 3.6 0.3 1.8 0.0 0.6 10.1 0.2 0.3 14.4 0.0 0.6 0.0 2.1 0.0 0.0 0.6 0.0 1.8 0.6 0.4 1.7 2.0 15.6 0.0 8.6 1.3 0.0 4.0 0.0 1.7 0.0 0.0 0.0 0.2 0.1 1.7 30.1 2.0 0.0 0.0 3.6 0.6 0.0 0.7 0.0 3.7 21.2 0.5 0.0 26.2 2.2 2.1 0.1 0.0 14.3 11.8 0.0 0.1 0.0 0.3 0.0 3.4 2.0 1.1 2.6 0.4 0.4 0.0 0.1 0.4 1.5 1.5 SULF1 "hSulf-1, KIAA1077, SULF-1" ENSG00000137573 "Sulfatase 1" Q8IWU6 8 69466624-69660915 "Predicted intracellular proteins" Apoptosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 168.7" "Cell type enhanced" "Detected in many" "Early spermatids: 214.2;Fibroblasts: 52.8;Inhibitory neurons: 63.0;Late spermatids: 101.4;Muller glia cells: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 315.4;BJ hTERT+: 420.2;fHDF/TERT166: 520.0;U-2197: 126.1;WM-115: 175.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054728 Supported "Intracellular and membrane" NA NA "HPA054728: AB_2682586" "unprognostic (2.89e-2)" "unprognostic (5.07e-2)" "unprognostic (3.87e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-2)" "unprognostic (7.62e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (3.58e-1)" "unprognostic (1.45e-1)" "unprognostic (3.69e-2)" "unprognostic (7.82e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (8.91e-3)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (2.69e-2)" 24.4 2.6 9.3 24.6 5.6 0.0 8.1 1.8 12.3 14.7 168.7 25.9 10.1 28.9 14.4 18.5 11.4 30.9 14.3 6.7 10.5 10.0 1.8 9.8 6.4 1.5 17.1 2.9 14.3 3.5 1.4 9.8 4.3 3.3 51.3 20.8 60.6 4.3 42.3 2.2 2.2 14.2 73.3 3.0 2.2 4.0 2.2 10.9 2.2 20.1 11.3 4.9 32.4 9.6 2.7 0.0 0.0 57.3 0.0 6.2 27.3 0.4 315.4 420.2 10.9 1.7 0.0 1.2 0.5 0.2 520.0 0.0 0.4 0.8 0.5 2.1 0.0 1.1 0.0 1.0 0.0 1.5 0.1 0.5 35.6 3.7 18.2 6.7 15.2 1.4 0.0 0.0 0.6 8.5 1.3 0.0 0.0 6.5 0.0 0.4 0.0 23.2 0.9 0.0 0.0 1.1 0.0 0.0 0.5 0.0 22.6 76.7 0.0 0.0 29.0 0.8 126.1 0.0 0.1 0.0 0.1 0.1 0.1 175.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 5.6 1.8 12.3 6.7 10.5 1.5 17.1 2.9 3.3 3.0 10.9 2.7 10.6 9.6 6.2 3.9 0.1 0.9 2.7 7.8 26.2 1.8 1.3 13.7 4.3 2.8 13.5 5.5 0.0 0.3 0.0 0.0 0.0 0.3 214.2 1.0 30.5 13.5 1.2 2.7 9.6 0.0 0.0 52.8 0.0 1.0 0.0 0.1 15.4 0.5 0.3 0.0 63.0 0.3 0.0 0.6 1.3 101.4 6.5 0.8 0.0 1.0 0.0 162.8 0.0 3.5 0.6 0.7 0.1 1.9 0.0 1.4 0.0 0.1 5.5 6.5 0.0 5.2 42.4 1.6 1.4 2.5 0.3 0.3 0.3 0.1 0.0 0.4 TGS1 "NCOA6IP, PIMT" ENSG00000137574 "Trimethylguanosine synthase 1" Q96RS0 8 55773446-55826445 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025024, HPA029824" Supported Supported Cytosol NA NA Cytosol "HPA025024: AB_1854330, HPA029824: AB_2673212" "unprognostic (4.13e-2)" "unprognostic (7.46e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.70e-2)" "unprognostic (1.60e-2)" "unprognostic (4.94e-2)" "unprognostic (9.32e-2)" "unprognostic (3.15e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (8.62e-2)" "unprognostic (7.23e-2)" "unprognostic (3.42e-1)" "unprognostic (2.85e-2)" 5.7 4.0 1.8 5.0 1.7 7.3 5.6 4.2 2.3 5.0 2.6 4.9 3.1 6.0 4.2 5.8 5.9 4.2 3.5 1.8 1.9 5.0 4.0 4.5 8.6 1.5 1.7 1.9 6.1 4.0 6.9 4.0 4.3 2.2 4.5 4.6 2.5 4.9 5.7 7.5 6.4 5.6 4.6 1.5 5.7 4.5 5.0 1.7 9.5 5.5 2.6 8.6 7.3 5.1 2.2 12.0 9.0 10.2 12.7 9.7 8.2 10.3 10.9 11.6 11.9 12.3 8.5 10.7 27.7 7.0 8.5 8.5 10.8 24.3 14.7 16.3 17.2 8.7 31.6 10.6 5.1 13.1 16.8 9.4 9.7 10.1 11.4 22.7 5.2 9.5 16.0 24.8 9.9 9.6 9.4 36.0 10.6 35.0 16.8 3.6 26.4 7.1 8.2 10.6 12.0 10.6 13.3 19.4 8.0 10.4 10.5 10.9 9.7 9.7 8.4 10.6 9.8 10.4 8.5 6.3 32.1 8.5 13.6 11.3 5.0 2.7 4.3 5.1 2.8 6.0 4.6 4.8 4.7 2.4 4.8 5.2 5.2 3.4 3.3 3.9 5.2 4.2 2.6 1.8 1.7 4.2 2.3 1.8 1.9 1.5 1.7 1.9 2.2 1.5 1.7 2.2 29.8 48.1 35.2 15.7 41.6 37.0 36.8 25.7 35.3 30.6 21.8 34.7 15.5 20.0 37.9 51.5 22.9 29.6 30.4 10.8 3.9 20.3 3.7 28.2 42.6 27.2 10.7 49.2 28.9 25.2 26.7 32.4 23.4 27.6 50.0 24.3 20.7 17.2 20.3 21.9 30.0 23.3 16.2 16.8 12.2 4.6 29.5 22.2 7.2 12.2 26.1 27.7 29.9 34.7 19.9 22.2 12.1 23.0 32.7 42.3 10.9 17.7 25.5 29.5 26.3 40.5 25.7 88.2 78.3 33.5 26.1 22.4 41.2 35.2 22.5 31.9 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582859 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 959.8;Melanocytes: 889.4" "Cancer enriched" "Detected in all" 4 "melanoma: 244.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1908.0" "Group enriched" "Detected in all" 5 "granulocytes: 1908.0;monocytes: 562.9" "Cell line enhanced" "Detected in many" "HHSteC: 787.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA 1300000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 225.9 127.6 100.6 162.2 116.5 247.9 168.5 109.4 131.2 162.2 126.2 120.8 83.9 110.8 84.3 89.6 96.6 196.5 119.7 107.5 122.1 117.5 175.5 225.9 122.2 120.8 109.0 94.4 89.9 81.5 134.0 46.1 266.5 120.2 71.4 136.0 27.0 126.0 79.0 66.4 78.8 93.6 152.5 114.8 204.7 131.2 41.5 114.5 131.1 121.8 114.7 93.6 251.2 92.6 121.7 123.5 185.9 194.2 101.4 711.7 607.1 86.1 122.9 439.6 175.3 228.9 74.8 250.7 0.4 194.8 166.4 321.2 49.7 106.0 142.4 215.7 22.6 91.3 184.3 156.0 60.6 787.9 47.7 287.1 417.9 188.1 176.5 525.2 273.0 428.0 125.2 92.3 104.6 403.4 32.4 104.1 55.9 122.2 478.6 52.3 49.6 59.4 24.3 282.1 127.0 84.9 153.5 133.8 56.1 630.0 213.8 51.0 127.9 382.3 168.8 72.5 200.8 81.5 31.4 45.6 74.8 428.9 0.5 155.1 777.4 562.9 528.1 61.2 349.6 78.0 69.4 82.0 67.3 251.8 61.0 103.9 80.2 1908.0 42.6 329.1 69.9 103.0 453.2 100.6 116.5 109.4 131.2 107.5 122.1 120.8 109.0 94.4 120.2 114.8 114.5 121.7 382.7 211.5 115.9 26.8 170.3 338.7 321.2 312.5 108.1 10.8 86.7 54.6 70.6 88.6 181.3 206.0 16.7 284.3 220.2 192.9 225.0 392.9 7.8 110.9 87.0 412.7 112.3 116.6 18.5 291.6 756.8 308.1 162.1 120.5 396.9 62.9 378.3 101.9 782.5 15.2 23.7 180.3 248.2 552.1 959.8 15.9 233.9 626.0 889.4 71.2 312.4 94.3 51.5 21.6 16.3 297.9 152.9 159.9 65.1 307.4 78.4 211.2 169.8 11.1 98.6 82.7 177.4 14.8 8.4 73.3 173.2 483.0 256.2 117.0 129.2 457.6 NEK1 "KIAA1901, NY-REN-55" ENSG00000137601 "NIMA related kinase 1" Q96PY6 4 169392809-169612627 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 126.3;Inhibitory neurons: 170.5;Oligodendrocytes: 196.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020873, HPA040413" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Cytosol "Nucleoplasm, Centriolar satellite" "HPA020873: AB_10671583, HPA040413: AB_10671169" "unprognostic (4.10e-2)" "unprognostic (2.97e-1)" "unprognostic (1.59e-2)" "unprognostic (1.97e-1)" "unprognostic (6.98e-2)" "unprognostic (3.10e-1)" "unprognostic (3.95e-1)" "unprognostic (3.29e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (4.06e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.42e-4)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.10e-2)" "unprognostic (3.46e-1)" 6.1 6.1 6.0 5.0 7.0 4.2 5.3 7.2 5.4 7.7 2.5 4.0 3.2 7.4 2.8 4.7 9.4 6.1 7.0 3.7 9.2 6.0 4.3 4.6 5.3 7.7 7.2 2.4 9.5 4.0 6.5 2.9 4.4 7.4 6.7 4.5 8.8 4.3 6.1 3.4 2.3 3.5 6.7 7.7 5.2 5.0 11.9 5.8 6.9 8.0 4.6 4.6 5.6 2.8 7.9 5.8 2.5 10.0 11.0 15.5 17.1 3.3 11.9 10.6 9.3 8.8 3.3 6.7 15.4 2.2 10.4 9.0 1.9 9.7 10.1 10.5 16.9 6.5 10.3 10.4 3.9 9.0 10.6 7.9 13.7 5.9 9.5 16.7 19.1 9.3 14.5 18.6 28.2 12.1 3.7 13.6 4.6 3.3 3.6 6.0 8.4 6.5 4.9 9.7 6.8 11.0 12.5 8.6 4.2 8.1 7.7 5.3 4.6 11.2 6.0 5.4 6.2 8.1 11.3 18.6 11.6 9.7 5.1 10.7 5.1 0.9 0.9 1.9 1.5 2.2 2.0 1.5 1.2 0.7 2.0 2.2 2.3 0.6 1.1 0.7 1.6 1.6 0.7 6.0 7.0 7.2 5.4 3.7 9.2 7.7 7.2 2.4 7.4 7.7 5.8 7.9 12.2 12.8 16.4 162.6 34.2 9.6 15.8 12.1 21.1 21.8 11.3 12.7 37.2 4.3 17.8 18.4 29.2 20.8 17.0 6.4 17.6 10.4 109.7 67.2 21.6 13.2 7.2 26.7 126.3 6.2 8.6 25.0 17.3 23.7 18.3 20.1 9.7 7.8 10.7 18.5 170.5 5.6 20.3 7.0 7.4 48.2 23.6 14.5 5.4 53.4 6.6 26.1 15.5 115.1 196.1 8.9 4.0 31.6 23.2 6.9 5.3 9.6 68.4 24.9 13.1 32.8 25.5 67.9 37.3 21.3 6.3 29.6 22.0 26.0 6.3 9.2 DDX60 FLJ20035 ENSG00000137628 "DExD/H-box helicase 60" Q8IY21 4 168216291-168318883 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 41.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA046952 Approved Supported "Intermediate filaments,Cytosol" No No Cytosol "Intermediate filaments" "HPA046952: AB_10963572" "unprognostic (4.05e-2)" "unprognostic (2.87e-1)" "unprognostic (7.22e-3)" "unprognostic (7.71e-2)" "unprognostic (2.30e-1)" "unprognostic (2.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.15e-2)" "unprognostic (3.06e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (2.48e-1)" "unprognostic (3.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.44e-1)" 8.0 6.0 2.6 9.9 3.0 5.7 7.2 2.0 2.4 7.5 3.0 17.6 13.4 7.8 4.8 3.5 7.1 9.8 5.7 1.9 3.6 6.8 9.5 11.5 9.8 3.9 2.3 1.5 11.1 4.1 6.4 4.0 11.6 2.8 6.1 15.9 3.3 21.4 5.9 2.4 6.6 12.4 6.1 2.6 17.5 41.2 3.4 2.8 15.6 6.3 3.6 6.9 6.9 5.6 6.8 8.3 1.1 4.2 1.4 2.9 10.4 5.3 2.3 14.9 27.4 26.1 0.0 20.2 0.0 1.4 3.1 12.6 6.6 0.5 4.1 8.7 6.1 0.3 12.9 7.3 0.0 9.9 3.8 3.3 7.2 1.7 6.7 1.2 7.1 10.1 4.8 0.0 2.0 3.4 0.3 6.2 2.5 0.4 0.4 2.1 5.1 1.5 0.0 5.3 4.6 0.8 0.7 5.4 1.3 18.8 0.3 1.0 5.1 8.9 2.1 1.5 0.9 2.0 1.6 0.3 0.0 6.6 6.1 6.1 1.6 1.2 1.2 4.2 2.5 4.8 1.4 3.2 4.1 1.1 1.4 3.3 3.7 0.6 3.7 3.0 0.0 3.0 1.8 2.6 3.0 2.0 2.4 1.9 3.6 3.9 2.3 1.5 2.8 2.6 2.8 6.8 32.4 35.3 6.5 14.0 12.2 4.2 4.8 6.2 5.7 0.8 3.9 3.2 8.6 11.5 11.5 12.9 0.0 7.6 13.4 57.6 5.9 8.2 3.3 11.8 10.5 22.8 3.0 8.4 0.7 6.8 10.4 11.6 90.2 10.2 27.3 16.2 14.3 4.0 6.2 0.0 1.3 22.4 2.0 4.1 2.8 2.2 8.1 13.5 3.6 25.3 9.3 7.4 17.5 27.6 1.3 12.0 14.9 9.4 3.1 4.1 11.0 4.2 15.3 2.9 6.6 10.0 9.0 1.1 1.0 2.2 2.7 2.9 17.2 18.4 6.0 3.7 NXPE4 "C11orf33, FAM55D, FLJ20127" ENSG00000137634 "Neurexophilin and PC-esterase domain family member 4" Q6UWF7 11 114570591-114595786 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 120.7;salivary gland: 77.9" "Group enriched" "Detected in some" 4 "Distal enterocytes: 95.5;Intestinal goblet cells: 88.1;Paneth cells: 41.8;Undifferentiated cells: 115.8" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 13.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042801 Approved "Secreted to digestive system" NA NA "HPA042801: AB_10793986" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-3)" "unprognostic (1.27e-1)" "unprognostic (3.51e-3)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (7.47e-3)" "unprognostic (4.36e-2)" "unprognostic (2.05e-1)" 0.1 0.0 0.1 7.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 115.3 0.6 0.2 6.9 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 5.3 120.7 0.0 77.9 0.2 0.0 0.0 0.8 5.3 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.5 0.0 0.0 0.5 0.0 0.0 0.0 17.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 41.8 0.0 0.1 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 115.8 0.2 SORL1 "C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1" ENSG00000137642 "Sortilin related receptor 1" Q92673 11 121452314-121633763 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Transport" Receptor "Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 125.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 125.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011500, HPA031321" Uncertain "Secreted to blood" NA NA 79000 "CAB011500: AB_443414, HPA031321: AB_2673826" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.08e-2)" "unprognostic (9.53e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-3)" "unprognostic (1.74e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.80e-7)" "unprognostic (2.48e-1)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.21e-2)" 7.1 6.2 29.2 24.6 33.7 47.9 14.0 51.4 32.7 44.8 3.6 17.5 11.7 5.5 9.0 5.5 40.5 7.4 2.4 33.0 35.8 19.2 58.7 10.5 21.2 38.0 47.6 13.6 9.1 8.1 10.5 16.9 2.3 44.8 20.9 17.0 20.4 22.0 25.7 1.7 3.3 18.2 4.6 60.3 22.0 10.4 5.2 34.2 17.1 13.6 4.0 23.2 15.9 6.6 64.2 1.3 8.1 7.3 1.1 0.0 0.0 7.4 0.4 2.4 0.3 0.0 11.9 142.8 68.7 8.5 1.8 10.5 47.4 9.1 7.0 0.1 0.0 2.6 0.0 10.3 16.8 0.1 29.6 0.1 0.0 7.6 0.0 25.8 4.0 0.0 8.7 0.0 0.7 0.0 9.7 7.1 15.3 8.8 93.5 10.8 7.7 0.4 1.6 15.8 102.1 5.1 1.5 15.2 21.5 0.0 16.0 21.0 9.5 0.3 0.1 4.9 1.0 0.0 0.0 0.0 139.8 0.1 38.6 0.4 44.3 15.9 59.1 22.1 6.9 29.3 1.9 24.6 20.0 6.6 5.1 23.1 20.8 125.7 20.9 9.4 16.4 19.3 21.2 29.2 33.7 51.4 32.7 33.0 35.8 38.0 47.6 13.6 44.8 60.3 34.2 64.2 1.6 6.4 23.3 160.9 20.7 4.5 42.3 23.3 18.2 68.8 44.5 22.0 12.3 18.6 36.8 79.1 387.8 0.4 130.1 132.1 0.0 10.3 1.2 21.6 2.9 10.3 6.1 8.8 247.4 0.7 0.7 5.8 14.3 24.7 12.0 20.6 34.6 114.5 39.1 50.5 80.1 54.6 40.7 62.4 16.9 5.0 77.9 67.0 3.6 404.7 97.5 28.0 146.2 74.9 86.0 6.4 81.1 57.9 28.6 36.1 168.6 1.0 15.6 31.2 0.0 19.5 10.3 2.9 18.8 20.8 2.4 0.4 60.2 32.7 42.2 33.4 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 109.6;intestine: 44.0;urinary bladder: 75.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 101.7;Club cells: 103.5;Distal enterocytes: 187.9;Squamous epithelial cells: 119.2;Urothelial cells: 258.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Immune cell enriched" "Detected in single" 7 "basophil: 2.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.1" "Group enriched" "Detected in some" 5 "CAPAN-2: 103.7;HaCaT: 39.2;OE19: 141.6;RPTEC TERT1: 70.6;RT4: 95.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain "Secreted in other tissues" NA NA "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.2 0.0 0.1 6.1 0.1 0.8 0.3 1.5 0.3 16.8 0.2 44.0 25.6 2.2 3.3 109.6 1.0 14.4 0.2 0.1 0.1 21.1 0.2 1.5 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.4 7.8 43.3 0.4 6.6 0.2 0.2 4.1 22.5 1.5 0.0 0.2 31.7 1.1 0.2 1.1 0.2 0.1 15.0 75.3 16.8 0.3 18.5 0.1 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.7 103.7 0.1 3.5 0.0 0.1 39.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 3.4 0.3 0.0 1.3 0.3 4.5 0.1 141.6 0.0 0.1 0.1 0.2 70.6 95.9 0.1 0.1 0.0 8.4 0.1 0.2 0.5 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.3 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.2 0.3 0.1 0.0 1.7 0.0 0.4 1.1 35.2 101.7 38.1 0.0 0.0 0.0 0.7 0.0 103.5 11.0 0.0 0.2 0.0 187.9 0.0 1.5 3.0 45.3 4.6 0.8 4.2 0.0 0.2 7.3 3.0 0.5 53.5 66.4 5.7 0.0 0.0 0.1 0.2 0.0 0.2 55.3 34.6 0.3 0.3 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 52.6 67.5 0.0 2.7 17.5 55.2 2.4 69.4 0.0 0.0 0.0 4.7 0.0 0.1 119.2 6.3 0.3 0.5 0.0 71.2 258.6 BUD13 "Cwc26, fSAP71, MGC13125" ENSG00000137656 "BUD13 homolog" Q9BRD0 11 116748170-116772987 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038340, HPA038341" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038340: AB_2675967, HPA038341: AB_10671528" "unprognostic (1.89e-1)" "unprognostic (1.73e-1)" "unprognostic (1.01e-2)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.07e-5)" "unprognostic (1.77e-1)" "unprognostic (8.39e-2)" "unprognostic (1.46e-1)" "unprognostic (4.23e-2)" "unprognostic (9.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.63e-1)" 10.6 7.6 7.6 12.3 8.8 12.8 13.6 10.5 9.4 11.9 8.4 11.5 11.1 15.5 10.6 11.5 13.8 8.2 8.0 7.4 8.4 9.2 9.8 12.3 16.5 8.6 8.2 7.1 16.2 11.3 10.6 8.1 11.1 8.9 10.3 13.5 10.7 10.2 10.7 12.4 11.3 12.9 12.9 7.6 12.8 11.4 21.8 8.6 25.8 12.1 14.1 18.9 11.1 11.3 10.5 22.4 12.0 33.3 20.1 10.4 12.5 16.6 21.6 23.9 24.3 23.5 28.6 33.0 47.1 26.8 17.9 25.4 30.7 27.2 16.8 26.6 27.8 11.1 55.1 8.8 21.8 12.7 46.9 31.6 11.3 19.2 20.6 20.8 15.6 24.0 46.1 36.0 22.8 20.2 17.7 57.5 41.0 20.0 31.6 19.0 42.9 28.6 36.3 17.0 25.5 19.7 26.2 25.3 18.3 10.0 21.0 25.1 30.6 13.7 27.7 17.5 14.3 29.0 9.3 12.4 39.1 9.0 42.6 25.3 15.8 7.6 20.2 10.0 7.8 10.8 10.4 8.6 7.9 8.2 7.4 9.5 8.1 9.1 7.5 8.7 7.2 8.1 5.7 7.6 8.8 10.5 9.4 7.4 8.4 8.6 8.2 7.1 8.9 7.6 8.6 10.5 11.7 9.6 5.6 6.2 14.3 7.6 10.8 7.1 11.4 6.8 6.6 6.0 4.9 2.8 6.5 9.2 12.5 9.2 9.5 11.7 7.9 8.5 13.5 10.4 8.7 8.5 9.6 17.7 7.2 8.1 10.5 7.8 7.1 9.3 11.4 9.6 7.1 8.0 8.2 3.3 6.8 6.9 2.0 12.0 6.7 5.3 9.0 7.8 7.2 3.7 9.4 7.3 26.8 9.0 11.2 6.4 8.5 10.9 16.6 6.4 15.4 5.8 10.9 7.3 6.6 8.5 7.7 51.2 21.8 11.0 4.8 9.9 13.1 7.9 11.3 7.0 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.4;placenta: 21.0" "Cell type enhanced" "Detected in many" "Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045098 Approved NA NA "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 3.6 0.5 2.3 0.7 1.5 0.2 3.3 0.7 1.2 3.4 4.9 2.3 1.2 4.9 1.7 5.8 5.4 2.3 0.5 1.5 1.8 1.4 0.1 13.4 1.1 1.7 3.1 1.0 1.2 0.7 0.9 0.2 21.0 1.1 2.2 1.6 0.3 0.9 5.5 0.4 1.9 1.3 4.0 1.8 2.2 1.6 0.6 1.7 0.2 9.5 1.0 0.8 1.8 2.0 1.1 0.0 4.9 0.2 0.0 8.8 2.1 0.0 3.2 4.9 0.7 0.1 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 2.3 1.5 0.7 1.2 1.5 1.8 1.7 3.1 1.0 1.1 1.8 1.7 1.1 3.4 0.0 2.6 2.0 0.0 2.3 1.9 0.0 0.0 1.4 0.4 2.9 0.7 0.0 10.5 3.7 0.0 1.3 0.0 0.1 0.0 0.0 1.0 3.0 4.0 1.6 0.0 0.0 19.3 0.2 0.0 3.1 0.0 8.0 0.0 0.1 0.0 0.0 0.3 0.0 47.2 0.0 0.0 0.0 5.3 0.5 6.2 1.8 1.8 12.2 0.1 0.0 0.0 2.0 0.3 0.0 5.1 0.7 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.3 20.2 0.1 0.7 0.1 3.4 0.4 0.1 2.1 0.0 1.5 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530750 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 514.6;salivary gland: 270.1;urinary bladder: 213.2" "Cell type enriched" "Detected in many" 8 "Ductal cells: 8176.2" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 35000 "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 2.4 0.1 0.0 2.0 0.0 0.3 170.3 0.0 0.3 13.4 0.0 1.6 0.6 98.3 28.2 21.5 92.0 514.6 0.2 0.0 0.1 138.6 3.5 31.9 1.9 0.1 0.0 0.0 0.7 85.9 0.0 0.3 0.8 0.0 54.5 1.1 0.0 270.1 35.2 0.1 32.2 0.7 4.9 0.0 0.2 7.4 0.6 0.3 3.4 0.4 0.0 29.5 213.2 1.7 0.1 0.2 145.9 0.0 0.4 0.0 0.0 0.2 0.0 2.1 0.1 0.1 1.9 815.9 0.0 189.8 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.6 1.0 0.1 0.2 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.5 11.8 0.0 0.0 0.0 0.0 350.1 1.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.1 0.0 0.7 3.0 0.0 1.6 0.1 0.6 0.4 1.0 5.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.7 86.6 43.3 0.0 1.5 1.0 382.2 135.4 1.2 0.0 124.2 93.7 0.7 100.1 401.2 1017.0 0.0 0.7 2.9 1.2 0.0 8176.2 6.1 62.1 3.3 8.8 0.0 0.0 0.0 209.4 0.3 3.4 0.0 124.6 2.5 0.0 0.0 0.0 98.0 0.0 0.0 0.0 38.7 0.6 0.3 10.3 11.8 12.6 0.0 0.0 65.2 0.0 0.0 0.0 0.0 850.9 0.0 0.0 0.1 603.3 0.0 33.9 72.6 0.0 0.0 0.0 31.4 0.1 0.2 17.0 2.4 0.8 3.6 0.0 2.3 840.8 MMP20 ENSG00000137674 "Matrix metallopeptidase 20" O60882 11 102576832-102625332 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Amelogenesis imperfecta" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "Early spermatids: 91.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (4.62e-3)" "unprognostic (2.61e-2)" "unprognostic (1.68e-3)" "unprognostic (1.75e-1)" "unprognostic (2.13e-1)" "unprognostic (3.06e-1)" "unprognostic (2.97e-2)" "unprognostic (6.75e-2)" "unprognostic (9.58e-5)" "unprognostic (6.10e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 MMP27 ENSG00000137675 "Matrix metallopeptidase 27" Q9H306 11 102691487-102705769 "Enzymes, Predicted intracellular proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 4.8;salivary gland: 1.9;skin 1: 2.4" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Fibroblasts: 4.2;Langerhans cells: 1.8;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069097 Approved "Intracellular and membrane" NA NA "HPA069097: AB_2686085" "unprognostic (3.99e-2)" "unprognostic (2.37e-4)" "unprognostic (1.25e-3)" "unprognostic (1.63e-1)" "unprognostic (4.60e-1)" 0.7 0.0 0.0 0.0 0.0 1.3 4.8 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.4 2.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 CFAP300 "C11orf70, FBB5, MGC13040" ENSG00000137691 "Cilia and flagella associated protein 300" Q9BRQ4 11 102047437-102084554 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.5;testis: 30.5" "Cell type enriched" "Detected in some" 4 "Endometrial ciliated cells: 142.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038585 Enhanced Approved Centrosome NA NA Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.8 3.5 5.0 0.4 2.5 0.0 2.6 2.9 2.1 5.5 9.2 1.1 0.8 4.3 10.8 1.8 29.5 3.3 1.1 2.1 7.2 1.7 0.1 3.0 0.9 5.2 4.6 1.4 4.2 0.8 2.7 4.1 3.4 4.8 4.0 0.8 1.4 0.8 6.7 0.2 1.2 0.8 2.9 5.7 0.1 1.9 30.5 3.3 0.6 3.7 0.0 0.5 3.1 1.9 4.0 0.1 8.5 8.5 0.0 7.5 17.9 0.2 3.4 8.6 4.6 6.5 0.6 11.1 0.0 2.0 6.7 2.3 2.1 2.1 1.0 3.3 0.0 1.3 0.0 1.3 0.0 5.3 0.0 0.0 7.8 10.5 11.9 8.0 8.9 0.1 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 12.6 2.4 9.4 0.0 11.0 0.1 0.0 0.0 9.6 0.0 1.3 1.1 3.5 11.2 2.8 0.1 0.0 0.0 3.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 2.5 2.9 2.1 2.1 7.2 5.2 4.6 1.4 4.8 5.7 3.3 4.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 0.0 29.5 0.0 7.1 0.1 0.0 1.9 4.0 0.0 142.5 9.8 0.2 0.0 0.0 0.0 0.0 0.5 3.4 0.0 2.1 0.0 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.2 6.0 0.0 0.0 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103050686-103092194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 14.6 14.7 11.7 4.2 12.6 4.7 13.3 16.6 17.6 11.1 7.9 10.9 1.4 11.2 3.9 21.5 10.4 1.8 21.6 12.8 12.3 11.1 13.8 11.1 5.1 12.2 12.6 11.1 9.1 14.3 3.1 13.1 3.3 12.1 11.4 2.2 7.5 12.3 3.0 31.6 11.2 9.5 2.8 13.0 12.4 13.4 18.7 12.6 4.6 9.2 7.8 4.1 12.0 12.2 13.1 18.2 14.5 18.8 16.3 11.6 13.2 10.0 17.9 6.8 9.0 12.7 51.2 24.8 8.0 32.8 13.3 29.0 21.3 24.3 24.0 16.1 9.7 22.4 21.6 16.2 22.3 18.7 33.7 12.4 7.6 23.8 17.7 22.8 18.3 18.1 32.6 26.3 0.1 10.5 21.6 24.4 46.5 24.5 33.6 32.9 9.5 15.1 22.4 15.4 33.9 12.8 11.0 10.0 21.8 21.4 25.1 20.4 22.4 4.0 12.4 14.8 16.6 17.6 7.8 12.5 33.0 7.9 31.4 13.0 12.8 6.6 6.5 8.7 8.5 10.2 11.3 10.8 9.5 9.5 9.3 9.3 10.3 2.5 15.1 7.1 11.1 11.8 9.3 11.7 12.6 16.6 17.6 12.8 12.3 12.2 12.6 11.1 12.1 13.0 12.6 13.1 24.9 16.0 11.0 26.8 30.2 79.5 63.2 101.6 38.1 11.7 34.4 36.2 30.7 15.7 42.8 9.2 8.4 57.2 29.3 8.2 49.0 59.5 5.0 26.5 38.2 27.2 14.4 52.1 50.7 55.6 88.6 35.6 21.9 25.3 15.8 37.3 16.1 25.3 44.7 6.7 39.6 17.9 67.1 29.8 32.4 8.4 14.3 22.7 30.2 15.9 26.5 18.9 15.5 25.6 27.5 63.1 12.2 19.5 52.8 92.6 8.6 39.2 28.0 14.1 26.3 31.5 74.6 121.6 119.8 59.0 83.7 43.8 30.9 59.8 23.2 73.0 YAP1 YAP65 ENSG00000137693 "Yes1 associated transcriptional regulator" P46937 11 102110447-102233424 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038884, HPA038885, CAB069915, HPA070359" Enhanced Supported "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154" "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 57.8 28.0 20.4 26.2 17.0 0.3 43.2 21.8 17.2 63.1 42.9 35.7 27.5 78.8 46.3 75.4 66.2 49.7 48.5 16.3 52.2 39.6 33.7 46.1 13.1 32.0 25.3 12.1 93.9 22.5 37.2 9.9 83.8 22.7 59.7 30.4 13.0 40.9 84.4 48.7 44.1 27.7 101.4 27.0 14.8 31.8 15.2 24.2 13.9 86.7 58.7 22.9 61.4 53.1 19.8 56.9 52.1 141.5 69.6 151.1 143.1 118.7 130.4 147.8 124.2 101.5 130.2 134.9 0.0 105.4 171.6 92.1 98.0 71.0 186.4 130.6 16.8 25.5 0.1 67.3 89.5 115.3 0.1 2.5 115.2 119.4 136.6 220.2 138.4 39.4 6.7 0.0 0.1 142.1 27.2 2.6 0.4 66.8 135.9 49.3 0.1 79.7 0.3 90.9 99.5 0.4 4.7 153.6 57.2 43.5 129.1 103.2 0.8 43.4 175.4 68.8 89.6 55.7 0.1 0.2 0.8 51.0 0.2 130.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 17.0 21.8 17.2 16.3 52.2 32.0 25.3 12.1 22.7 27.0 24.2 19.8 28.4 35.3 69.4 145.3 1.5 113.7 47.8 43.5 71.2 0.4 48.1 43.8 39.2 62.9 37.2 92.0 0.0 91.4 0.4 16.2 11.7 27.6 6.7 61.8 53.3 28.9 7.3 0.0 1.5 18.3 20.3 49.0 23.9 85.1 0.0 127.2 26.0 45.2 10.6 0.0 1.6 13.1 14.2 1.6 21.5 4.6 37.9 2.2 44.4 60.0 1.0 27.6 0.0 5.0 0.7 25.2 16.3 40.6 0.1 66.0 27.2 26.1 41.6 1.2 39.5 21.6 62.0 2.5 5.3 59.5 123.2 61.6 2.1 15.9 27.8 65.6 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111286-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 605.7;skin 1: 545.4;vagina: 271.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "spinal cord: 4.0" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 1.9 1.0 0.2 0.4 0.3 0.4 42.1 0.1 0.7 65.3 1.3 3.1 1.7 2.7 4.8 605.7 17.5 3.5 0.4 0.4 1.1 0.9 1.8 3.8 0.0 1.6 0.3 0.0 0.4 1.0 0.0 8.2 30.9 1.9 31.6 2.6 0.3 132.5 23.9 2.2 545.4 1.0 1.5 2.4 0.3 1.4 2.8 0.6 20.1 0.4 0.2 108.2 56.3 271.3 0.7 34.4 2.5 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.2 0.1 0.8 25.6 0.2 3.9 0.2 0.5 399.9 0.0 107.5 0.0 0.1 0.0 0.2 25.4 0.4 0.0 0.2 0.5 0.0 476.0 0.0 2.6 0.0 0.0 0.0 0.2 0.7 0.0 4.4 0.0 0.0 0.1 11.4 0.1 0.0 0.3 0.0 0.3 190.5 1.3 5.9 268.3 35.2 0.1 0.2 1.9 0.0 0.4 0.1 2.1 0.2 0.1 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.4 1.1 1.6 0.3 0.0 1.9 2.4 0.6 0.7 0.5 0.0 1.5 3.3 0.2 272.0 106.1 76.4 250.4 0.0 9.5 58.8 1.2 1.5 39.2 0.0 0.0 41.0 0.2 11.3 0.0 5.0 28.1 8.7 0.8 3.4 2.4 0.0 0.5 4.3 7.1 5.6 1.1 3.6 1.3 0.0 0.0 0.4 5.0 0.0 0.1 2.1 12.2 0.0 30.3 150.3 0.6 1.4 23.2 1.0 0.0 0.0 0.0 0.0 0.1 57.1 11.3 0.0 0.0 66.0 0.2 0.6 64.6 0.0 0.0 0.1 4.9 0.8 2.6 552.9 460.6 24.8 2.4 0.1 3.7 159.3 SLC37A4 "G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d" ENSG00000137700 "Solute carrier family 37 member 4" 11 119024114-119030906 "Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 171.6;Hepatocytes: 175.9;Proximal enterocytes: 277.2;Proximal tubular cells: 183.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 29.3;HEK 293: 28.0;Hep G2: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038939, HPA038940" Enhanced Approved Mitochondria NA NA Mitochondria "HPA038939: AB_2676279, HPA038940: AB_2676280" "unprognostic (4.77e-2)" "unprognostic (3.49e-1)" "unprognostic (2.08e-2)" "unprognostic (2.35e-2)" "unprognostic (4.70e-2)" "unprognostic (6.95e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (4.08e-2)" "unprognostic (8.27e-3)" "unprognostic (4.72e-2)" "unprognostic (3.89e-1)" "unprognostic (1.98e-1)" "unprognostic (4.04e-2)" "unprognostic (2.60e-1)" "unprognostic (4.34e-2)" "unprognostic (5.39e-2)" 4.5 8.1 4.9 2.5 5.0 2.5 5.1 4.7 6.9 4.3 4.8 7.8 36.5 3.5 21.0 4.7 5.5 1.7 4.8 5.0 5.0 48.4 141.0 4.6 1.6 5.1 4.9 4.9 5.3 40.5 3.4 6.3 2.6 5.0 9.5 6.6 4.7 7.1 5.6 30.3 4.8 27.5 1.3 5.0 7.2 12.1 7.2 5.0 1.1 5.4 3.9 1.0 4.6 4.7 5.1 1.2 12.2 5.6 6.2 7.5 3.2 4.9 0.7 9.7 2.6 6.9 29.3 2.8 3.8 7.2 3.9 5.4 0.7 2.3 14.9 4.4 4.1 28.0 10.3 3.4 37.1 2.8 6.0 2.0 0.5 4.2 1.5 7.1 10.7 8.7 0.6 4.7 11.2 4.5 25.9 0.3 13.3 0.1 3.6 13.6 8.4 0.0 21.1 5.5 12.9 7.3 6.4 0.0 2.6 5.4 5.8 5.4 4.2 0.0 0.0 4.9 1.3 5.4 1.7 2.9 1.3 1.2 15.6 2.0 0.0 0.9 1.3 1.4 1.6 1.2 0.7 1.0 1.7 0.3 0.5 1.0 1.1 0.0 0.9 0.7 0.1 1.0 0.6 4.9 5.0 4.7 6.9 5.0 5.0 5.1 4.9 4.9 5.0 5.0 5.0 5.1 7.9 3.2 7.8 7.5 5.8 1.8 8.3 10.1 5.7 7.5 13.0 10.7 4.5 171.6 8.2 16.5 0.0 30.1 3.2 23.8 31.3 29.5 14.0 11.5 6.6 9.2 24.7 28.6 4.5 25.3 21.4 5.5 13.7 11.2 0.0 72.3 19.2 175.9 28.8 16.8 4.2 26.3 14.2 11.1 2.4 3.3 9.6 7.9 3.6 7.5 10.0 93.4 2.1 3.5 2.9 19.7 27.5 10.5 5.7 12.5 277.2 183.0 12.6 11.3 0.0 4.4 5.6 11.2 25.8 5.9 2.7 15.2 5.4 6.7 50.3 8.4 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 26.7" "Group enriched" "Detected in some" 6 "Early spermatids: 61.3;Late spermatids: 80.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.3;Karpas-707: 4.5;U-266/70: 3.1;U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA057157: AB_2683354" "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.3 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 26.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.2 3.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 3.1 1.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.2 0.3 0.6 0.6 0.0 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 80.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 10.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 48.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.1 0.1 0.2 0.1 0.1 0.2 2.0 0.3 0.4 0.4 0.0 0.7 0.9 0.0 1.8 1.3 0.5 0.7 0.1 0.2 0.1 0.3 0.1 1.0 0.2 0.1 0.1 0.2 0.1 0.2 6.3 0.4 0.3 0.2 0.6 0.2 0.1 1.1 2.1 0.2 48.4 0.7 0.3 0.0 0.2 0.7 0.1 0.1 0.2 0.7 0.0 0.5 0.4 2.1 0.4 1.4 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.0 3.6 0.1 1.3 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 2.5 0.0 0.3 3.9 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.4 0.2 0.0 8.2 0.3 0.0 20.9 10.6 5.0 1.8 0.0 3.0 1.5 0.8 0.0 3.9 11.0 0.0 1.5 0.1 0.9 0.0 5.3 2.2 1.3 0.7 0.3 3.0 0.0 0.4 1.3 0.4 0.6 10.2 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.2 8.2 0.0 2.2 5.5 0.0 0.1 5.4 0.0 0.0 0.4 0.0 0.0 0.5 20.8 1.1 0.0 0.0 5.0 0.4 0.1 1.8 0.0 0.0 0.0 0.4 0.0 0.1 7.0 37.6 7.9 0.5 0.2 0.6 14.2 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296712 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 156.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 38000000 "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 40.6 156.5 40.0 17.6 56.5 12.1 16.5 53.0 42.4 32.4 36.0 12.1 6.9 29.0 13.0 27.6 19.9 27.4 41.4 37.1 46.3 50.6 69.1 49.3 11.5 55.1 51.2 29.2 53.3 53.1 33.5 7.7 35.6 55.9 25.6 11.2 19.3 20.9 26.2 82.9 12.0 7.5 35.3 51.0 26.8 15.2 34.0 47.2 14.4 46.1 60.3 14.7 27.4 10.2 82.4 69.6 35.3 137.3 54.8 78.8 87.4 79.3 85.8 47.6 54.3 59.2 99.7 115.4 0.1 127.4 104.7 84.9 61.5 77.3 80.4 80.5 41.9 44.2 51.5 107.7 74.1 73.6 19.0 33.2 89.7 45.6 68.0 120.1 89.3 149.8 11.1 73.5 29.5 127.0 120.0 11.0 15.6 44.0 4.0 58.4 31.2 96.8 30.1 68.1 33.5 37.2 40.5 148.5 65.9 52.7 102.5 85.0 29.9 92.6 89.5 66.8 43.9 67.4 9.5 17.3 65.9 34.2 11.3 210.9 29.5 14.8 22.0 11.6 12.5 15.5 11.5 10.2 8.8 12.8 8.3 6.8 5.8 2.0 17.6 9.9 10.3 22.0 8.4 40.0 56.5 53.0 42.4 37.1 46.3 55.1 51.2 29.2 55.9 51.0 47.2 82.4 248.8 484.0 98.8 53.5 30.0 56.1 51.8 124.6 56.9 85.9 47.4 45.7 159.3 70.1 77.9 75.4 43.8 122.1 21.6 17.7 109.5 128.1 15.5 109.1 117.2 289.2 22.2 104.8 27.1 423.4 189.8 88.4 19.9 135.3 67.2 132.0 319.2 260.1 85.1 101.0 57.6 7.3 61.1 103.2 59.9 43.6 275.2 71.6 72.9 42.2 135.4 77.0 36.0 68.3 229.4 134.3 22.1 266.7 36.1 65.9 0.1 236.9 52.2 94.8 124.9 74.0 143.8 73.9 257.4 52.8 40.5 227.3 29.2 229.9 11.8 45.9 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766389 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 172.1" "Cell type enhanced" "Detected in all" "Early spermatids: 306.1;Late spermatids: 160.7;Spermatocytes: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 173.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favorable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 59.0 10.6 10.9 14.2 17.1 16.3 21.7 18.3 12.4 13.1 15.7 14.9 14.0 8.8 8.1 12.8 8.1 13.5 6.4 10.9 14.7 14.7 172.1 8.9 12.2 14.0 13.6 9.3 13.4 33.5 13.1 10.8 9.3 14.2 7.8 14.9 8.6 9.7 6.1 9.7 9.6 15.3 7.9 11.4 6.3 22.5 54.5 13.3 16.0 10.7 9.0 14.2 12.3 7.4 20.7 38.4 25.1 35.6 24.2 34.9 18.7 35.8 37.2 25.9 27.0 24.6 86.0 39.3 48.3 27.1 24.1 25.6 35.4 53.4 30.5 34.3 33.7 16.6 47.2 14.5 37.8 17.3 55.7 36.1 21.5 18.1 30.6 22.2 19.1 33.8 49.7 58.3 62.3 30.1 12.4 60.8 22.6 43.8 41.4 27.3 45.9 23.6 58.6 40.2 41.9 11.6 31.4 33.1 30.2 6.1 38.3 35.0 20.6 36.7 31.3 37.8 15.6 23.9 6.6 17.4 173.8 11.1 63.9 40.7 6.1 10.1 10.4 13.0 11.7 12.7 10.0 12.9 12.1 14.9 12.5 11.2 12.0 2.6 15.3 11.4 6.4 15.0 12.2 10.9 17.1 18.3 12.4 10.9 14.7 14.0 13.6 9.3 14.2 11.4 13.3 20.7 21.2 19.2 10.5 63.3 11.0 14.3 11.0 12.0 18.2 5.4 14.1 8.5 3.2 15.7 13.4 12.9 8.4 13.5 11.0 23.8 13.7 18.7 306.1 29.6 13.4 20.2 15.6 32.4 23.8 22.9 20.3 12.3 15.3 46.1 8.2 34.3 9.3 89.4 9.5 1.7 14.5 11.5 22.4 5.8 9.2 160.7 6.5 7.5 8.8 17.8 8.9 9.9 7.2 26.2 49.1 23.6 9.0 7.5 9.0 10.9 16.2 17.6 16.8 11.0 13.1 14.5 14.4 135.9 20.8 12.0 14.6 17.6 11.0 9.7 13.9 15.0 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429948-110464884 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "adrenal gland: 316.3" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1139.6;Theca cells: 745.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favorable (3.58e-7)" "prognostic favorable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 9.1 316.3 7.5 6.9 7.8 12.2 8.5 8.0 8.7 7.5 8.5 13.0 22.2 6.3 8.3 9.3 5.9 9.2 16.5 7.2 8.3 29.9 44.6 10.9 8.0 7.9 8.1 7.1 5.5 13.6 9.3 6.2 17.8 7.9 8.3 10.8 5.4 8.7 26.5 20.8 6.1 18.5 6.1 8.1 6.8 13.6 7.6 8.9 12.1 20.5 18.7 7.5 10.6 5.6 9.3 10.2 7.0 10.6 11.6 10.1 17.8 23.5 9.2 11.2 8.0 13.5 24.1 16.7 23.8 26.4 11.9 14.2 11.8 12.4 13.9 10.8 22.9 15.8 12.0 12.0 14.8 17.7 12.7 18.8 31.3 11.4 7.3 17.1 13.8 16.5 16.2 12.2 34.4 17.3 11.3 18.2 28.3 9.5 19.3 13.1 26.4 10.1 22.1 17.4 18.1 14.4 7.4 17.5 19.7 12.5 12.3 11.7 8.7 9.8 8.0 9.8 9.8 9.9 7.7 6.4 71.7 6.0 25.5 10.5 1.8 4.5 2.8 3.8 3.3 4.1 9.7 5.2 5.4 5.2 7.5 6.2 4.4 0.5 3.4 4.6 4.0 7.4 2.6 7.5 7.8 8.0 8.7 7.2 8.3 7.9 8.1 7.1 7.9 8.1 8.9 9.3 53.2 19.2 38.1 15.0 68.6 68.3 104.3 45.4 42.7 33.0 40.3 37.0 57.1 102.9 28.3 80.9 8.4 174.3 65.7 109.5 244.6 71.4 53.4 49.6 35.6 36.7 47.9 28.8 22.6 144.8 169.4 48.1 61.2 42.0 45.7 36.3 45.0 192.7 113.3 42.1 25.8 56.2 34.6 58.4 68.3 11.0 46.9 77.3 69.4 15.0 57.3 42.3 50.4 22.1 19.6 78.5 76.5 45.5 102.7 114.2 183.9 338.7 18.6 17.3 26.3 50.6 43.6 48.0 67.0 75.3 97.5 1139.6 74.0 745.1 96.4 149.6 C11orf1 FLJ23499 ENSG00000137720 "Chromosome 11 open reading frame 1" Q9H5F2 11 111878935-111885975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 402.4;Late spermatids: 1147.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038410, HPA057519" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038410: AB_10672591, HPA057519: AB_2683454" "unprognostic (1.33e-2)" "unprognostic (1.61e-1)" "unprognostic (1.96e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (9.26e-2)" "unprognostic (3.23e-2)" "unprognostic (1.41e-2)" "unprognostic (2.86e-2)" "prognostic favorable (1.39e-4)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.97e-1)" "unprognostic (2.08e-1)" 21.7 37.3 25.5 10.5 27.5 18.2 49.7 25.5 36.4 20.7 24.0 26.5 20.5 17.4 64.7 24.2 28.8 19.7 31.2 25.4 27.4 71.0 55.4 16.5 15.2 25.6 25.5 24.7 28.2 48.4 40.2 28.6 9.5 25.8 27.6 26.6 22.5 33.3 27.1 16.4 33.2 21.6 15.0 25.0 11.7 30.8 61.7 26.1 20.5 41.5 21.3 17.9 22.9 18.5 26.3 25.1 31.9 40.3 44.6 45.6 34.3 42.0 13.5 34.2 10.9 13.8 54.5 45.6 91.9 63.5 23.2 31.4 28.9 16.5 50.2 17.0 40.6 23.4 30.9 6.9 42.0 28.6 45.7 20.9 63.8 76.9 39.0 74.4 48.4 13.5 96.2 45.3 66.8 36.9 25.0 62.2 70.8 46.3 86.8 48.0 31.5 42.0 127.6 69.4 46.0 36.3 34.1 8.7 31.5 31.3 38.4 63.1 31.8 11.7 40.2 28.8 17.6 19.1 38.8 61.2 136.7 20.3 53.1 24.9 6.5 7.4 9.0 13.0 14.6 24.9 26.0 22.0 17.0 11.1 17.7 34.5 26.5 1.7 16.7 10.1 32.8 17.6 10.2 25.5 27.5 25.5 36.4 25.4 27.4 25.6 25.5 24.7 25.8 25.0 26.1 26.3 14.3 25.6 19.8 3.6 22.6 23.7 67.5 60.6 71.2 8.6 56.5 79.6 57.6 28.6 43.4 35.0 6.2 28.9 17.3 15.1 201.5 21.8 402.4 30.5 17.3 15.3 26.4 26.3 3.5 27.2 22.5 16.5 22.4 22.6 29.2 23.3 11.0 43.4 23.0 15.2 4.7 39.8 28.5 7.9 11.4 1147.2 27.4 14.3 24.9 3.7 19.3 43.5 20.6 1.0 3.7 18.9 22.3 24.5 41.9 36.4 40.6 197.9 44.4 15.5 19.7 10.8 17.0 54.4 30.9 53.4 29.5 21.1 22.6 49.2 44.4 72.7 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "classical monocyte: 37.7" "Lineage enriched" "Detected in many" 6 "monocytes: 37.7" "Cell line enhanced" "Detected in some" "AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: AB_2677931" "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favorable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favorable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.60e-4)" 42.9 117.4 202.1 30.4 285.9 9.9 39.9 103.3 295.5 106.4 51.0 258.0 22.4 324.2 61.5 30.1 183.2 94.0 98.5 243.1 193.2 68.2 33.0 87.4 30.2 125.2 174.7 250.0 283.4 30.4 9.9 176.3 16.8 133.1 108.7 36.2 47.5 29.8 73.9 37.7 21.8 105.5 199.3 85.7 153.3 99.7 87.2 152.4 31.5 67.1 79.0 19.0 204.6 81.1 197.7 0.3 0.9 136.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.1 4.8 0.7 92.9 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.3 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.2 2.6 0.0 1.7 6.3 0.5 27.2 0.0 0.0 0.1 57.1 1.0 3.5 0.1 204.5 114.0 0.0 0.5 5.1 36.9 2.4 2.4 0.0 0.0 30.0 0.5 0.0 0.4 0.3 0.1 1.0 0.4 0.4 0.0 37.7 0.0 0.0 9.4 0.6 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.9 0.0 0.1 0.6 0.0 9.9 202.1 285.9 103.3 295.5 243.1 193.2 125.2 174.7 250.0 133.1 85.7 152.4 197.7 72.2 6.4 2.2 0.0 1.1 6.6 2.4 1.1 0.6 3.5 2.1 21.5 9.3 1.5 0.7 0.0 2.1 0.8 1.0 0.0 1.9 6.4 3.6 0.6 23.9 71.8 12.5 10.7 0.0 0.4 1.1 78.6 0.5 1.0 0.0 29.7 163.9 1.6 72.7 1.7 0.0 0.2 6.1 32.4 9.6 14.3 237.9 18.7 16.0 0.0 9.8 128.7 1.0 0.0 0.0 0.4 0.0 363.8 1.2 4.9 0.0 0.1 1.7 4.4 355.0 49.6 79.6 4.6 3.5 1.4 3.8 1.4 1.4 141.8 0.0 1.7 ARHGAP20 KIAA1391 ENSG00000137727 "Rho GTPase activating protein 20" Q9P2F6 11 110577042-110713189 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 78.0;Excitatory neurons: 97.9;Inhibitory neurons: 159.9;Leydig cells: 48.7;Oligodendrocyte precursor cells: 90.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 24.6;ASC TERT1: 8.2;HHSteC: 5.5;SiHa: 7.2;U-2197: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038458, HPA038459, HPA076303" Uncertain Approved Mitochondria NA NA Mitochondria "HPA038458: AB_10672517, HPA038459: AB_2676022, HPA076303: AB_2686792" "unprognostic (1.69e-2)" "unprognostic (3.97e-2)" "unprognostic (6.83e-2)" "unprognostic (1.34e-1)" "unprognostic (2.66e-1)" "unprognostic (8.47e-3)" "unprognostic (2.75e-1)" "unprognostic (2.90e-2)" "unprognostic (4.15e-2)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (9.52e-2)" "unprognostic (2.82e-5)" "unprognostic (1.84e-2)" "unprognostic (9.15e-2)" "unprognostic (6.21e-3)" "unprognostic (4.10e-2)" 8.9 2.3 2.4 1.3 4.5 0.0 4.5 2.1 3.7 4.5 0.4 1.9 0.8 4.4 3.6 2.2 3.1 2.2 0.4 3.4 4.4 0.3 1.7 4.2 1.2 1.0 0.8 3.1 1.2 0.2 0.8 0.9 1.7 1.0 4.0 2.8 1.1 1.3 8.9 0.9 0.9 1.5 3.4 1.2 1.3 1.8 8.3 2.5 0.4 4.8 1.3 0.8 3.3 2.3 2.9 0.0 0.0 0.0 0.0 24.6 8.2 0.0 1.1 3.3 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.3 0.0 5.5 0.0 0.0 3.0 0.0 0.0 0.0 0.1 2.4 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.3 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 0.0 0.1 0.0 2.1 0.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 4.5 2.1 3.7 3.4 4.4 1.0 0.8 3.1 1.0 1.2 2.5 2.9 1.7 0.0 2.3 5.2 1.7 0.8 4.9 1.1 10.2 9.9 0.5 6.0 0.9 1.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 13.1 1.7 78.0 4.3 0.0 0.0 97.9 0.4 0.1 15.1 0.0 1.2 1.3 1.1 9.7 2.0 0.2 3.3 159.9 0.2 0.0 0.8 1.6 4.6 48.7 2.1 3.6 22.5 0.0 0.7 0.0 90.0 3.2 0.7 0.0 36.5 1.2 1.9 0.0 0.0 0.0 1.4 0.0 2.3 4.6 11.8 11.7 1.6 0.4 0.7 0.5 3.6 0.0 0.8 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease variant, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 2798.3;pancreas: 617.8;salivary gland: 842.9" "Group enriched" "Detected in many" 5 "Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8" "Group enriched" "Detected in some" 25 "MOLT-4: 2255.4;RPTEC TERT1: 4711.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 5 "spinal cord: 27.7" "HPA064218, HPA068838" Supported Approved Mitochondria NA NA Mitochondria "HPA064218: AB_2685214, HPA068838: AB_2686047" "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favorable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 1.9 0.9 0.4 1.4 0.6 3.3 1.2 1.1 1.7 0.8 0.0 2.1 1.4 1.5 1.2 0.8 1.8 356.4 1.2 0.7 0.0 2798.3 24.0 4.4 9.0 0.2 0.0 0.2 2.4 617.8 0.2 1.6 0.8 0.6 1.7 0.8 1.1 842.9 0.7 0.3 1.0 1.6 2.2 0.0 3.2 2.8 0.6 0.0 75.5 1.0 0.6 4.5 1.9 0.9 0.8 0.0 118.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 3.5 0.0 0.2 0.4 0.2 0.0 0.3 0.2 0.0 0.1 0.2 83.6 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.9 140.3 0.0 0.0 0.2 0.3 2255.4 0.0 1.2 0.0 0.0 0.6 0.0 4.6 4711.9 0.0 1.9 0.0 0.0 2.9 0.2 0.2 0.8 0.3 0.8 0.0 1.3 0.5 0.0 1.0 0.3 0.2 0.1 0.2 0.0 0.0 1.2 0.0 1.0 0.0 1.0 0.2 1.8 14.8 0.2 0.3 5.1 4.3 0.0 9.6 0.0 3.8 1.7 2.1 0.4 0.6 1.1 1.7 0.7 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.8 1.0 0.0 0.6 0.0 33.6 1.1 0.1 0.8 0.6 0.2 0.1 0.5 1.2 1595.6 0.1 435.9 0.0 0.1 0.7 0.0 2952.4 892.8 21.8 1.6 4.1 2.2 15.1 2.7 0.0 10.0 0.1 3.5 0.5 41.3 0.0 0.6 4.2 3.9 3.6 0.0 0.0 0.3 16.2 4.5 4.1 25.9 9.3 24.8 0.0 0.0 8.8 0.5 1.0 0.0 0.0 23.2 0.0 7.5 0.4 0.2 0.0 3423.7 0.1 3.3 6.6 1.6 3.8 0.3 0.3 0.2 0.9 0.3 27.7 1.2 0.1 0.0 MMP13 CLG3 ENSG00000137745 "Matrix metallopeptidase 13" P45452 11 102942995-102955732 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "urinary bladder: 13.0" "Cell type enriched" "Detected in some" 12 "Basal respiratory cells: 426.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 70.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 17.9;PC-3: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB002742 Supported "Secreted to extracellular matrix" NA NA "CAB002742: " "unprognostic (8.98e-3)" "unprognostic (1.54e-1)" "unprognostic (4.75e-2)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-3)" "unprognostic (1.32e-1)" "unprognostic (6.35e-3)" "unprognostic (1.69e-1)" "unprognostic (7.55e-3)" "unprognostic (2.24e-1)" "unprognostic (1.73e-8)" "unprognostic (2.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.14e-2)" "unprognostic (4.33e-2)" 0.0 0.0 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 13.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 17.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 426.0 0.0 0.0 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.8 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 15.8 TMPRSS13 "MSPL, MSPS, TMPRSS11" ENSG00000137747 "Transmembrane serine protease 13" Q9BYE2 11 117900641-117929459 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.9;skin 1: 36.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 15.9;Extravillous trophoblasts: 21.2;Glandular and luminal cells: 10.9;Ionocytes: 16.2;Syncytiotrophoblasts: 19.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 13.8;BEWO: 29.9;MCF7: 27.0;SK-BR-3: 42.8;T-47d: 43.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.08e-3)" "unprognostic (5.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.06e-3)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (5.61e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-1)" "unprognostic (3.16e-6)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.08e-1)" "unprognostic (3.44e-1)" 0.2 0.4 0.2 0.7 0.2 0.6 7.2 0.0 0.7 6.7 0.0 0.4 0.3 0.6 0.6 15.9 0.3 0.4 0.1 0.9 0.0 0.5 0.2 3.9 1.2 0.2 0.0 0.3 0.1 2.5 0.0 0.3 3.0 0.2 1.4 0.4 0.0 11.1 0.1 0.2 36.8 0.8 0.2 0.0 1.5 0.2 0.4 0.1 0.9 6.6 0.0 4.9 0.5 9.3 0.2 13.8 0.1 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 10.2 0.1 0.7 0.1 0.0 0.0 1.3 0.0 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 27.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.0 0.4 0.1 0.0 42.8 0.6 1.7 43.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.2 0.2 0.2 0.0 0.7 0.9 0.0 0.2 0.0 0.3 0.2 0.0 0.1 0.2 0.1 0.0 4.6 0.0 0.2 1.7 4.6 1.7 1.2 0.0 7.4 4.6 1.4 7.2 5.3 0.0 0.0 15.9 0.2 0.3 0.0 8.3 0.3 2.4 1.3 0.2 0.0 0.0 0.2 1.2 21.2 0.3 0.5 10.9 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.5 16.2 1.2 1.9 0.8 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 5.7 3.9 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.2 5.2 8.0 19.4 0.4 0.5 0.8 9.0 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 127.0;lymphoid tissue: 91.8" "Cell type enhanced" "Detected in many" "Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2" "Region enhanced" "Detected in all" "olfactory bulb: 18.4" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 18.6 10.6 8.3 59.7 8.8 36.7 22.1 8.9 15.6 10.4 10.4 48.1 125.8 8.8 12.1 27.5 12.4 27.6 11.2 9.9 10.2 12.0 21.8 48.7 52.5 10.9 9.1 6.9 11.8 6.5 2.8 5.0 30.2 10.4 13.1 50.2 1.1 21.0 12.6 6.2 31.2 127.0 20.9 10.2 91.8 22.7 2.5 10.4 23.4 7.8 7.4 35.8 36.0 19.6 11.1 1.3 0.3 0.0 5.3 5.8 12.1 1.0 5.7 112.7 14.0 38.5 0.2 0.7 18.7 2.3 6.6 25.7 8.1 0.0 53.8 3.3 12.3 0.0 0.9 0.7 1.3 58.2 22.1 0.2 20.9 37.4 11.4 30.3 36.2 6.1 0.3 0.2 0.0 3.4 0.0 0.6 30.7 0.0 0.1 0.3 18.1 0.4 14.9 0.3 8.9 0.4 0.4 16.9 1.1 26.2 0.1 1.2 50.1 7.2 12.8 0.6 1.2 1.6 0.1 5.4 0.1 8.1 136.2 2.7 83.8 246.1 134.9 132.9 359.9 178.5 40.2 92.7 115.8 220.2 35.5 50.2 82.7 220.0 63.0 383.0 7.7 129.0 213.3 8.3 8.8 8.9 15.6 9.9 10.2 10.9 9.1 6.9 10.4 10.2 10.4 11.1 26.3 19.2 30.0 0.0 27.2 26.0 42.5 91.5 14.2 0.1 5.8 23.0 2.9 8.6 37.7 11.0 0.0 2.1 34.1 33.1 1.9 23.3 0.2 5.8 2.5 24.0 6.0 10.3 0.2 12.9 1.3 17.8 11.7 3.4 15.8 0.2 22.9 3.1 96.5 0.0 0.0 50.6 14.2 125.3 120.7 1.3 3.4 136.6 5.4 12.2 185.6 0.1 64.9 0.0 0.1 5.3 73.4 3.4 20.0 8.7 116.0 2.2 28.4 0.2 0.0 1.0 8.1 0.0 0.1 17.9 22.3 1.1 58.4 3.3 90.5 43.6 CASP5 ICE(rel)III ENSG00000137757 "Caspase 5" P51878 11 104994235-105023168 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.5;intestine: 16.9;lymphoid tissue: 14.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 31.4;Paneth cells: 18.7;Proximal enterocytes: 17.2;Undifferentiated cells: 7.3" "Group enriched" "Detected in some" 7 "colorectal cancer: 3.9;stomach cancer: 1.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "intermediate monocyte: 18.1;neutrophil: 13.0;non-classical monocyte: 41.2" "Group enriched" "Detected in many" 15 "granulocytes: 13.0;monocytes: 41.2" "Cell line enriched" "Detected in single" 6 "HHSteC: 3.7" NA NA "unprognostic (4.30e-2)" "unprognostic (8.86e-2)" "unprognostic (1.07e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.22e-2)" "unprognostic (9.90e-2)" "unprognostic (8.29e-3)" "unprognostic (1.47e-1)" "unprognostic (4.38e-3)" "unprognostic (7.39e-3)" "unprognostic (3.25e-1)" "unprognostic (1.82e-9)" "unprognostic (7.30e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (1.50e-1)" 0.7 0.1 0.5 14.8 0.5 0.2 0.1 0.5 4.5 0.2 1.2 15.8 10.0 0.1 0.2 0.1 0.2 0.4 0.1 1.1 0.9 0.1 0.2 1.6 0.9 0.8 0.5 0.3 0.1 0.0 0.0 0.1 0.9 1.5 0.1 13.0 0.0 0.1 0.1 0.0 0.0 16.9 1.8 0.7 2.7 0.1 0.3 1.2 0.1 0.1 0.4 0.3 2.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.1 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 18.1 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.1 13.0 0.0 41.2 0.5 0.0 1.4 0.5 0.5 0.5 4.5 1.1 0.9 0.8 0.5 0.3 1.5 0.7 1.2 1.7 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 2.3 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.3 0.0 4.7 0.4 0.7 0.0 4.8 0.0 1.9 2.4 0.0 0.0 0.0 0.1 0.1 18.7 0.0 0.0 0.0 17.2 0.0 0.8 0.0 0.0 0.2 0.1 0.5 0.7 0.0 0.0 0.0 0.3 0.0 7.3 0.1 ALKBH8 "MGC10235, TRM9, TRMT9A" ENSG00000137760 "AlkB homolog 8, tRNA methyltransferase" Q96BT7 11 107502727-107565742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038724, HPA038725, HPA061514" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547" "unprognostic (2.66e-2)" "unprognostic (3.82e-1)" "unprognostic (8.19e-2)" "unprognostic (3.76e-1)" "unprognostic (4.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (1.95e-1)" "unprognostic (4.45e-2)" "unprognostic (7.67e-2)" "unprognostic (1.89e-2)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.34e-3)" "unprognostic (1.01e-1)" 3.0 2.9 2.5 4.0 3.2 3.4 5.1 2.9 3.0 3.0 2.0 3.0 3.2 3.8 3.2 3.1 3.0 2.8 3.8 2.5 2.8 4.0 4.6 3.6 6.1 2.4 2.8 2.4 4.5 2.4 4.1 1.7 3.3 2.7 3.6 3.7 3.4 2.9 3.3 5.1 4.6 2.7 3.7 2.5 4.6 3.3 2.8 2.4 4.6 5.2 4.7 5.9 3.5 2.8 2.5 5.4 6.5 6.6 7.2 3.6 7.9 5.4 10.2 7.5 7.4 8.0 12.1 9.7 12.6 5.8 10.0 10.2 9.6 9.9 8.5 9.6 11.4 6.6 10.6 2.5 5.6 5.3 13.7 12.6 4.9 9.2 9.5 12.0 3.8 9.3 9.9 15.2 4.1 5.9 4.9 12.4 6.8 8.7 10.5 10.6 11.1 10.2 8.7 5.9 5.8 6.0 6.7 5.9 4.4 4.5 4.0 7.2 4.1 8.8 16.1 9.6 5.3 12.9 3.8 4.3 9.7 4.5 9.0 16.1 0.0 1.1 0.3 2.2 2.1 2.1 0.9 1.6 1.9 1.7 1.9 3.0 2.6 0.0 2.8 1.5 1.0 1.8 1.1 2.5 3.2 2.9 3.0 2.5 2.8 2.4 2.8 2.4 2.7 2.5 2.4 2.5 4.4 0.0 5.3 4.6 8.5 2.0 1.7 1.5 7.4 5.7 3.2 3.0 11.2 5.7 3.5 1.8 6.2 2.3 3.0 1.3 0.0 1.9 0.4 2.4 4.6 4.2 1.2 4.6 25.2 3.3 2.7 4.3 7.7 2.3 10.1 5.1 2.9 6.6 2.8 1.7 27.4 2.8 2.0 3.8 2.2 0.2 2.8 4.1 3.6 14.0 4.7 3.0 3.1 23.1 14.3 2.7 5.2 4.1 3.8 1.3 1.3 3.6 0.8 3.8 0.0 4.0 3.0 1.8 3.2 6.9 4.1 0.8 6.6 5.2 3.5 0.6 MAP2K5 "HsT17454, MAPKK5, MEK5, PRKMK5" ENSG00000137764 "Mitogen-activated protein kinase kinase 5" Q13163 15 67542703-67807117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Astrocytes: 119.5;Early spermatids: 138.1;Excitatory neurons: 201.4;Inhibitory neurons: 169.3;Late spermatids: 212.4;Microglial cells: 87.1;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022094, HPA027347, HPA027755" Supported Approved Nucleoli,Microtubules NA NA "Nucleoli, Microtubules" "CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883" "unprognostic (4.54e-2)" "unprognostic (1.87e-2)" "unprognostic (4.16e-2)" "unprognostic (9.06e-2)" "unprognostic (1.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" "unprognostic (3.73e-1)" "unprognostic (2.41e-2)" "unprognostic (2.83e-1)" "unprognostic (1.47e-2)" "unprognostic (5.41e-2)" "prognostic favorable (8.03e-5)" "unprognostic (1.68e-1)" "unprognostic (2.74e-1)" "unprognostic (3.99e-2)" "unprognostic (2.73e-2)" 13.1 14.9 9.1 6.3 9.7 10.4 12.5 11.2 13.8 13.2 4.8 14.7 9.3 11.6 6.2 8.7 12.2 8.8 13.4 11.2 9.5 9.9 10.1 9.8 8.6 9.7 6.2 9.3 17.3 13.3 19.0 10.2 11.2 9.7 9.5 8.9 11.3 10.6 10.7 23.4 14.3 10.2 9.0 5.8 9.1 11.7 13.9 6.6 17.3 10.7 17.9 7.6 11.9 11.2 12.0 9.0 23.4 13.8 16.3 20.0 34.9 10.9 8.8 17.8 16.3 17.7 9.4 15.8 14.8 18.2 14.8 17.7 13.3 23.8 14.3 13.4 21.6 23.7 20.2 17.0 10.3 25.1 12.3 12.1 23.9 18.3 11.8 26.6 35.7 21.7 33.6 18.0 24.1 13.6 11.6 20.1 14.7 19.4 10.4 11.3 19.7 16.0 24.9 9.8 16.3 8.6 13.4 9.9 14.5 36.5 23.6 18.2 23.7 18.2 16.7 10.9 11.7 12.1 33.7 43.4 17.5 22.4 27.6 12.3 10.9 5.8 5.6 5.6 4.4 8.3 4.8 5.3 6.7 8.1 4.3 7.3 7.0 1.4 9.4 5.4 3.0 6.2 4.4 9.1 9.7 11.2 13.8 11.2 9.5 9.7 6.2 9.3 9.7 5.8 6.6 12.0 7.9 6.4 5.8 119.5 10.0 6.9 8.1 3.7 8.6 12.6 8.6 6.1 8.1 5.7 3.2 5.5 10.4 13.4 10.2 13.2 7.9 9.3 138.1 4.4 5.0 7.6 9.5 9.4 201.4 8.5 10.7 9.7 7.7 3.9 2.5 12.3 12.5 8.7 10.0 5.0 169.3 9.2 4.1 10.1 6.1 212.4 12.5 7.9 10.6 87.1 7.2 17.9 11.3 146.3 146.5 7.5 12.5 11.7 5.6 5.3 12.2 9.7 4.0 8.2 0.0 7.9 6.3 11.9 13.0 9.9 8.2 9.9 10.4 11.6 10.4 4.6 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 53978201-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 106.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 73.1;Early spermatids: 184.4;Excitatory neurons: 130.3;Inhibitory neurons: 301.3;Late spermatids: 65.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Karpas-707: 73.7;U-266/70: 97.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 198.6" NA NA "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.1 0.2 12.1 0.1 13.0 0.1 0.1 106.6 26.7 0.1 1.0 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.2 21.2 26.4 0.6 0.0 0.1 0.3 28.5 38.6 12.1 0.8 0.0 0.0 1.1 0.0 37.2 0.0 0.1 19.2 0.1 0.0 3.5 0.1 0.1 0.0 6.3 0.1 0.1 8.8 14.1 0.0 0.6 0.0 0.3 0.0 0.0 22.3 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 97.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.1 13.0 106.6 26.7 21.2 26.4 28.5 38.6 12.1 37.2 6.3 14.1 22.3 0.1 0.0 0.0 8.5 0.1 0.4 0.4 0.0 0.0 73.1 0.1 0.3 0.8 1.5 0.0 3.7 6.2 1.0 1.3 0.0 0.0 0.0 184.4 0.0 0.0 0.4 0.0 0.0 130.3 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.7 0.0 0.1 0.0 301.3 0.0 0.0 0.0 0.6 65.9 2.1 0.3 0.0 3.7 0.0 3.2 0.0 4.5 3.2 0.0 0.0 0.4 0.0 0.3 0.0 0.4 0.0 33.8 0.0 2.2 0.7 1.2 1.2 0.0 0.1 0.3 0.1 0.5 0.0 0.5 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691281 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 212.0" "Cell type enhanced" "Detected in many" "Ductal cells: 118.1;Exocrine glandular cells: 176.2;Hofbauer cells: 134.3;monocytes: 154.5;Pancreatic endocrine cells: 156.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 304.0" "HPA017079, HPA041589" Enhanced Supported Mitochondria NA NA Mitochondria "HPA017079: AB_1857467, HPA041589: AB_2677565" "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 43.8 22.8 14.4 60.0 14.3 56.1 41.6 14.2 19.8 24.8 16.7 212.0 58.2 18.9 19.5 113.8 26.8 31.7 22.1 14.3 17.0 36.4 83.3 62.1 38.5 15.6 14.0 11.8 8.9 40.1 24.3 12.5 17.8 14.8 41.6 180.5 4.9 56.8 28.0 133.9 41.2 56.4 43.6 15.3 47.7 54.8 5.2 14.6 23.9 32.8 44.1 58.1 49.2 50.7 19.1 38.3 68.0 0.1 3.9 125.5 151.4 0.4 40.8 132.3 23.6 35.7 2.7 59.0 33.7 38.7 29.9 72.6 33.3 2.0 304.0 13.9 121.7 1.1 3.0 14.5 48.2 38.8 20.2 5.1 45.2 88.2 54.9 119.8 59.4 66.1 32.0 0.4 40.6 24.6 31.3 12.2 44.9 0.0 147.7 41.8 1.4 6.7 47.1 184.9 55.2 1.2 1.2 10.1 25.8 13.1 0.8 56.9 61.7 76.8 9.7 2.2 131.6 9.0 53.5 61.0 2.0 96.9 104.6 10.9 112.5 212.1 84.6 76.6 161.0 104.6 54.3 97.9 83.6 135.2 48.6 51.8 55.2 302.5 53.4 152.4 40.5 149.0 169.6 14.4 14.3 14.2 19.8 14.3 17.0 15.6 14.0 11.8 14.8 15.3 14.6 19.1 24.4 32.1 64.1 0.0 5.8 0.0 0.0 0.0 0.0 0.0 31.4 14.7 0.0 0.0 14.9 14.7 0.0 0.7 19.8 0.0 11.7 118.1 0.0 15.9 7.0 13.9 0.0 0.0 0.0 176.2 0.9 11.3 0.0 37.6 11.4 1.3 0.0 0.0 134.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.0 0.0 154.5 0.0 0.0 0.0 0.0 156.2 0.0 0.0 3.3 0.0 0.0 45.8 24.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.8 13.5 1.6 0.0 0.0 CTDSPL2 "FLJ10523, HSPC129" ENSG00000137770 "CTD small phosphatase like 2" Q05D32 15 44427622-44529038 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.5;Late spermatids: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040763, HPA062198" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040763: AB_10960989, HPA062198: AB_2684708" "unprognostic (6.64e-2)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (2.06e-1)" "unprognostic (7.39e-3)" "unprognostic (5.20e-2)" "unprognostic (7.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.37e-2)" "unprognostic (2.54e-2)" "unprognostic (3.68e-3)" "unprognostic (5.35e-2)" "unprognostic (8.36e-3)" "unprognostic (7.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.16e-1)" 9.1 7.5 3.5 13.1 3.9 20.6 14.3 13.3 5.2 14.1 3.8 10.9 10.0 17.6 7.0 12.6 11.2 12.1 9.6 3.6 4.0 10.8 10.4 10.5 19.6 3.4 3.3 2.8 19.3 11.6 11.2 4.0 15.9 5.6 10.3 11.4 15.2 9.2 10.3 5.4 8.1 12.8 14.1 2.8 13.4 9.8 21.1 3.2 25.5 15.2 9.5 19.2 12.4 6.3 6.4 28.6 14.2 57.7 29.4 9.1 19.9 31.9 29.1 25.4 37.3 46.8 29.3 26.4 30.1 27.7 20.3 20.6 39.2 33.4 19.6 42.6 30.9 16.1 37.4 34.8 17.6 12.3 65.7 33.5 15.7 14.0 25.6 33.4 15.8 28.4 37.9 44.2 34.0 26.7 12.1 78.2 23.1 31.2 30.4 20.3 86.7 80.5 28.0 19.4 38.9 26.7 38.5 36.0 28.5 16.2 21.2 38.7 57.7 24.9 46.0 49.5 44.3 49.4 19.3 79.2 93.9 22.2 50.4 36.0 7.4 10.8 9.2 10.3 11.3 9.4 10.6 9.8 9.3 13.8 10.5 10.4 11.8 7.7 15.7 8.9 8.8 14.9 9.4 3.5 3.9 13.3 5.2 3.6 4.0 3.4 3.3 2.8 5.6 2.8 3.2 6.4 34.4 19.2 35.7 26.4 25.4 24.6 14.7 14.5 27.9 23.7 24.5 21.0 23.1 11.5 31.3 12.9 10.4 18.9 40.9 16.9 17.6 12.5 165.5 18.3 35.4 27.2 9.0 16.2 41.8 14.6 18.4 30.2 11.7 29.6 36.0 26.7 20.3 13.6 14.0 30.3 41.2 13.9 20.3 22.2 20.9 166.9 20.2 22.1 16.0 49.6 23.8 19.2 39.1 50.3 65.7 17.7 10.4 13.2 24.0 18.0 17.2 14.5 19.5 31.1 26.3 30.4 34.2 23.7 31.4 19.6 21.9 14.6 31.4 21.9 15.3 16.8 SLTM "FLJ13213, Met" ENSG00000137776 "SAFB like transcription modulator" Q9NWH9 15 58879050-58933679 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040256, HPA040381" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA040256: AB_10674990, HPA040381: AB_2676953" "unprognostic (2.36e-1)" "unprognostic (6.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.81e-1)" "unprognostic (2.52e-3)" "unprognostic (9.65e-2)" "unprognostic (1.00e-1)" "unprognostic (2.48e-1)" "unprognostic (2.82e-3)" "unprognostic (3.44e-1)" "unprognostic (2.09e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (7.09e-2)" "unprognostic (3.69e-1)" "unprognostic (5.71e-2)" "unprognostic (3.24e-3)" 31.5 21.7 30.3 31.8 32.5 58.3 29.8 38.8 33.1 29.9 29.1 29.9 30.2 27.8 20.9 38.8 28.1 24.0 27.2 28.6 30.1 31.0 35.2 28.5 43.1 31.4 32.0 26.1 29.8 25.1 36.3 28.6 21.2 32.0 29.4 32.4 45.3 30.8 24.5 46.5 35.3 33.7 26.0 30.9 38.4 39.2 28.0 32.2 57.8 34.4 44.0 44.5 34.1 31.5 33.3 77.8 84.1 72.0 36.6 48.1 36.2 60.6 55.1 64.3 49.9 48.2 58.4 45.7 144.6 50.5 50.8 54.4 67.9 72.3 62.9 68.7 93.7 46.4 105.4 91.8 44.7 42.0 83.8 78.1 34.1 61.0 52.8 44.1 30.4 46.9 66.0 95.5 81.7 58.2 56.1 84.1 64.6 80.9 46.3 40.5 63.6 65.4 70.1 60.2 99.8 58.9 50.8 57.0 55.1 57.8 79.3 44.0 90.1 48.6 60.2 88.5 66.3 74.6 57.3 123.1 105.5 47.6 101.7 61.5 67.9 30.3 44.4 45.2 29.5 46.1 53.5 36.0 39.3 31.2 47.3 39.2 35.6 42.8 47.0 37.7 53.6 36.5 22.7 30.3 32.5 38.8 33.1 28.6 30.1 31.4 32.0 26.1 32.0 30.9 32.2 33.3 92.5 153.8 161.2 61.4 125.8 96.9 100.2 85.6 107.0 116.3 77.3 66.0 107.8 64.3 122.8 106.7 98.0 73.5 155.9 88.4 78.2 98.4 100.8 110.5 99.0 94.7 73.4 115.7 67.7 115.7 160.1 94.3 99.4 119.1 118.9 75.3 63.9 104.1 63.9 119.5 67.3 94.4 59.0 88.6 73.0 120.8 86.3 108.8 78.2 72.1 121.0 84.9 126.7 74.4 141.8 131.1 76.5 88.4 140.0 92.4 57.4 90.6 103.9 145.3 72.3 106.6 95.6 215.1 85.2 100.0 104.6 112.5 134.9 78.0 94.0 125.6 THBS1 "THBS, THBS-1, TSP, TSP-1, TSP1" ENSG00000137801 "Thrombospondin 1" P07996 15 39581079-39599466 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, Unfolded protein response" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "hypothalamus: 116.6" "Immune cell enhanced" "Detected in some" "eosinophil: 15.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 20.6" "CAB033678, HPA059756" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 16000000000 1400000000 "Plasma membrane" "CAB033678: AB_793044, HPA059756: AB_2684121" "unprognostic (1.72e-2)" "unprognostic (9.55e-3)" "unprognostic (7.49e-2)" "unprognostic (3.31e-1)" "unprognostic (4.34e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (6.40e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (8.47e-5)" "prognostic unfavorable (8.50e-4)" "unprognostic (1.00e-1)" "unprognostic (9.25e-3)" "unprognostic (1.48e-3)" 367.6 73.2 3.4 397.5 2.4 115.7 96.0 2.2 17.8 67.3 39.0 139.9 25.0 162.6 3.6 49.6 143.9 277.6 82.8 2.2 116.6 62.3 130.5 311.9 32.6 10.6 3.9 1.8 77.0 69.6 7.0 27.0 99.9 11.4 90.7 86.4 0.4 138.5 12.1 16.4 34.1 84.2 245.9 1.4 80.5 151.8 2.2 11.4 12.1 34.3 4.3 7.2 400.2 36.5 23.3 171.9 62.7 49.0 17.8 199.4 233.9 0.7 1025.7 861.6 283.6 185.5 185.0 135.7 1.0 348.4 2610.2 54.4 621.0 2.2 516.1 145.0 43.4 0.5 46.6 35.0 46.9 44.4 0.3 13.2 524.9 37.2 237.2 535.1 1123.6 2494.4 1.6 1.5 1.7 1863.4 14.7 0.8 3.6 8.9 17.7 20.3 0.7 125.7 1.3 430.6 472.6 0.6 0.4 300.7 16.4 18.5 60.8 178.6 3.3 3552.9 972.6 221.0 1141.1 1146.6 2.4 1.8 2.0 33.0 0.8 1064.4 0.3 8.7 15.7 0.7 0.8 2.7 0.0 0.4 0.5 0.5 0.1 0.1 0.1 1.5 7.8 0.1 0.4 0.0 10.5 3.4 2.4 2.2 17.8 2.2 116.6 10.6 3.9 1.8 11.4 1.4 11.4 23.3 19.0 25.6 19.6 0.7 4.9 95.7 131.2 37.6 181.6 0.1 66.8 69.8 48.7 18.6 19.9 69.9 6.2 1.9 8.2 144.5 0.0 52.1 0.2 64.9 127.7 79.2 3.6 0.0 0.9 127.5 2.5 279.5 15.8 38.2 162.7 228.3 44.6 7.4 6.3 0.0 1.3 46.4 48.8 105.9 97.9 0.3 1.8 598.0 39.2 13.1 5.9 0.1 3.1 0.0 0.1 183.9 55.1 0.4 5.9 79.2 8.5 48.3 11.9 1.5 6.6 59.0 283.8 0.2 0.3 51.8 51.0 2.1 19.5 10.8 67.8 42.1 MAPKBP1 "KIAA0596, NPHP20" ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 6.0 10.6 10.3 4.6 11.3 4.4 7.8 29.9 13.6 10.3 8.3 8.5 9.7 10.0 4.5 18.7 10.5 4.6 6.2 9.8 8.4 6.9 4.2 6.0 3.9 9.2 9.8 10.5 15.2 5.6 4.2 12.8 5.5 16.3 9.0 3.6 9.1 7.6 5.9 5.1 24.4 10.0 9.0 5.0 8.0 9.4 34.6 8.3 6.3 13.5 3.8 6.9 12.3 12.1 10.1 7.4 3.8 10.0 9.5 10.9 10.8 6.9 10.1 25.5 9.1 6.6 7.6 2.7 1.8 8.1 8.3 12.5 17.2 9.8 28.5 6.5 6.7 2.7 7.3 12.8 2.6 4.7 4.7 14.5 5.6 22.3 14.3 25.9 14.8 13.4 11.9 4.6 3.4 12.9 1.5 4.0 4.2 1.1 4.3 7.6 4.3 7.2 0.7 5.3 8.1 11.3 6.3 5.7 5.9 4.5 10.2 7.1 3.7 10.6 13.0 6.2 12.4 10.0 7.3 12.7 4.3 8.7 6.3 11.0 1.1 0.4 0.3 0.8 0.1 0.6 0.4 0.4 0.3 0.5 0.4 0.6 0.5 0.1 0.6 0.5 0.1 0.2 0.5 10.3 11.3 29.9 13.6 9.8 8.4 9.2 9.8 10.5 16.3 5.0 8.3 10.1 7.1 6.4 10.3 33.0 3.5 54.7 10.0 8.6 36.5 14.5 5.4 8.9 3.4 2.8 7.3 3.7 204.3 6.8 5.6 4.0 0.0 3.0 15.7 10.9 7.1 9.5 4.8 0.8 62.2 3.7 4.4 5.8 9.2 8.9 1.3 12.2 5.3 2.6 3.9 15.2 55.1 1.7 4.1 2.5 6.1 27.1 7.2 5.0 8.8 33.7 4.2 4.4 3.1 34.7 51.9 4.6 1.8 7.9 5.1 12.5 8.1 0.5 13.0 8.9 13.1 7.8 5.7 12.7 4.2 27.7 53.6 5.3 5.8 8.0 2.5 15.2 NUSAP1 "ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41320794-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 89.3;lymphoid tissue: 102.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 15 "basophil: 10.7;T-reg: 7.7" "Group enriched" "Detected in many" 15 "granulocytes: 10.7;T-cells: 7.7" "Low cell line specificity" "Detected in many" "HPA042904, HPA074847" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 1.7 14.2 0.3 7.9 0.2 89.3 1.5 0.3 0.4 2.2 0.3 5.7 7.0 1.1 0.1 17.9 1.1 1.0 1.1 0.3 0.3 2.6 5.1 3.8 28.9 0.3 0.4 0.2 4.5 1.4 0.0 0.7 6.5 0.3 1.1 8.1 0.1 3.6 0.6 5.4 9.4 7.4 2.7 0.2 7.9 4.6 11.0 0.3 102.4 0.9 0.1 31.7 1.9 6.5 1.0 146.0 38.3 165.1 64.6 3.5 5.9 37.0 107.4 74.6 138.9 130.6 58.4 67.0 63.5 42.5 44.4 99.1 107.6 104.2 46.2 132.4 98.5 62.3 149.6 102.0 50.7 0.2 67.3 57.2 0.9 1.3 69.1 37.3 21.7 72.0 104.2 70.1 237.5 105.7 30.7 147.5 82.2 59.8 139.8 55.0 136.5 156.5 67.5 42.4 29.3 85.7 55.2 129.8 88.5 25.7 46.0 106.2 76.1 33.7 89.9 104.8 101.5 206.2 81.3 145.8 200.5 42.1 163.6 171.2 10.7 0.1 0.5 0.1 0.0 0.0 0.3 0.5 0.5 0.3 0.6 0.0 0.3 0.2 0.4 0.0 0.3 7.7 0.5 0.3 0.2 0.3 0.4 0.3 0.3 0.3 0.4 0.2 0.3 0.2 0.3 1.0 1.9 0.0 1.5 1.3 14.2 38.5 10.3 21.2 31.9 0.9 9.9 13.7 1.1 17.2 5.0 0.0 0.0 72.2 13.4 14.4 3.9 2.3 33.2 10.7 11.6 7.3 3.0 266.7 1.4 0.5 121.2 14.6 25.5 21.8 7.0 93.3 10.8 3.9 36.7 0.0 1.5 15.5 24.4 13.8 22.7 14.6 0.3 17.5 3.6 1.9 6.1 1.9 4.1 1.0 1.3 1.5 0.4 1.9 57.2 5.3 2.6 5.4 1.1 1.0 0.0 2.8 12.1 99.6 59.9 69.5 24.9 19.3 22.9 38.8 30.0 10.3 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387218-41409403 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 85.3;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 16.1 33.7 22.1 9.6 22.7 4.3 12.6 23.6 29.8 9.7 24.3 12.1 12.7 10.5 15.7 13.9 9.9 7.7 34.6 22.6 23.4 29.3 39.0 9.4 11.6 23.1 23.0 22.3 9.8 11.9 18.4 11.6 8.1 23.1 10.2 10.5 12.6 12.3 13.3 64.0 9.8 11.0 10.9 23.2 12.0 14.3 21.2 22.7 11.0 10.6 61.5 13.2 12.9 10.0 25.0 15.9 13.3 16.4 13.3 30.0 28.3 14.9 26.1 25.1 23.6 21.3 22.5 8.1 16.7 38.2 24.9 17.5 25.0 20.1 15.9 19.3 32.9 23.9 22.4 25.0 13.8 27.1 24.7 17.0 30.0 18.5 20.8 18.0 19.9 19.0 31.9 38.2 17.2 30.6 17.5 19.9 28.6 12.6 27.5 17.9 15.0 17.4 40.6 41.9 27.8 17.5 13.8 13.2 31.8 12.6 16.9 25.1 50.2 15.4 18.0 10.1 30.5 24.2 15.8 34.7 28.0 24.0 43.5 19.3 35.0 12.8 16.2 7.8 15.0 9.1 13.8 9.6 9.5 11.8 11.8 10.6 8.6 9.4 13.4 13.3 18.2 16.8 8.5 22.1 22.7 23.6 29.8 22.6 23.4 23.1 23.0 22.3 23.1 23.2 22.7 25.0 7.7 12.8 10.1 6.5 14.6 4.7 15.8 43.8 9.6 15.7 12.3 11.9 58.7 15.7 27.3 22.0 12.5 36.3 19.8 8.5 64.6 30.5 59.5 14.2 14.2 11.1 6.7 13.5 8.8 31.3 34.6 12.5 12.2 13.1 7.0 16.3 8.6 28.2 28.8 6.7 9.1 8.5 30.5 12.8 7.0 15.0 16.4 16.2 10.6 3.7 23.4 20.7 16.5 4.0 10.3 20.9 3.7 16.1 15.0 11.8 23.3 85.3 30.6 19.2 26.3 15.3 17.3 84.7 21.6 11.3 7.7 50.3 12.3 32.6 11.9 16.3 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.8;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 13 "granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.0 1.5 0.3 5.7 0.2 21.8 1.5 0.2 0.3 1.0 1.2 4.1 3.9 2.0 0.1 5.4 0.9 1.3 0.6 0.3 0.3 3.1 0.5 1.5 8.0 0.3 0.3 0.2 0.8 0.5 0.4 0.1 6.4 0.3 0.9 5.0 0.2 1.1 1.2 0.1 3.8 3.8 4.2 0.3 2.2 2.0 10.7 0.3 16.0 0.3 0.2 9.9 1.8 2.1 0.7 100.7 81.5 64.2 59.0 3.7 7.3 36.3 105.3 57.0 154.8 120.6 50.2 72.4 56.8 31.4 53.1 78.6 110.5 121.6 39.5 158.7 52.9 60.2 55.3 78.8 30.7 2.1 55.6 48.3 3.3 4.2 71.8 60.5 19.4 52.0 46.9 36.0 70.2 95.4 44.1 31.2 28.2 71.6 35.5 33.2 37.0 133.8 31.2 39.3 49.7 32.5 25.3 120.4 51.9 44.9 74.5 50.6 25.3 34.5 90.0 120.8 62.0 157.6 26.3 74.3 48.4 31.5 72.2 78.0 0.0 1.2 4.6 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.2 0.3 0.3 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.7 0.4 0.0 0.5 0.0 2.3 1.9 3.7 4.2 0.0 0.2 1.8 2.8 0.8 5.7 4.7 7.3 2.1 24.2 1.4 3.3 3.9 1.8 13.3 13.1 3.6 2.2 1.8 42.3 1.8 0.0 32.4 5.8 3.6 8.7 2.5 22.4 3.9 0.3 8.1 0.0 1.0 3.1 0.0 2.8 3.4 4.8 0.9 3.2 0.0 1.0 8.1 0.2 0.0 0.0 0.2 0.4 0.4 1.9 6.8 1.6 0.8 0.9 3.6 0.1 6.6 0.4 8.2 70.8 20.9 11.3 1.0 2.5 4.2 3.6 8.6 3.3 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296532-68432163 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 25.0;endometrium 1: 53.6;smooth muscle: 25.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 13.8;Excitatory neurons: 13.4;Fibroblasts: 30.1;Microglial cells: 18.7;Peritubular cells: 13.5;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 119.5;hTERT-RPE1: 174.5;U-138 MG: 80.6;WM-115: 45.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 7.3;spinal cord: 2.1" HPA051813 Uncertain NA NA 260000 "HPA051813: AB_2681622" "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 5.0 3.4 0.2 1.1 1.4 0.2 3.2 0.6 0.9 25.0 0.7 1.9 0.8 53.6 13.6 1.5 12.1 2.4 10.2 0.4 0.2 5.4 0.7 1.7 0.5 0.3 0.1 0.2 4.6 0.8 0.4 1.8 1.5 0.6 5.2 1.3 0.4 1.2 7.4 2.2 2.3 1.6 25.3 0.0 3.2 1.6 0.9 0.1 0.2 2.1 2.5 0.1 3.9 8.3 0.7 0.0 0.2 0.4 0.9 3.7 0.1 0.1 7.9 15.1 1.6 0.5 0.1 0.2 0.1 0.6 119.5 2.1 0.2 0.0 0.0 0.4 0.0 0.2 0.5 6.8 0.0 10.8 0.2 7.0 1.5 0.0 3.1 0.3 174.5 0.0 0.1 0.2 0.3 20.9 0.1 0.1 0.4 0.7 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 5.5 0.1 0.1 18.5 0.1 0.5 5.0 80.6 0.7 2.1 0.1 0.2 0.0 0.1 13.5 0.2 45.4 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 1.4 0.6 0.9 0.4 0.2 0.3 0.1 0.2 0.6 0.0 0.1 0.7 2.9 0.0 0.0 0.3 0.3 0.8 0.5 0.0 0.6 3.9 1.0 7.0 13.8 0.0 0.0 1.8 0.0 0.0 0.3 0.1 1.9 0.3 0.3 0.2 0.8 1.1 0.0 0.0 13.4 0.0 0.1 30.1 1.5 0.3 0.0 0.2 2.2 0.5 0.3 0.0 0.7 0.0 0.0 0.6 1.2 0.5 6.8 0.6 0.0 18.7 0.0 0.3 0.0 0.0 0.5 0.2 0.0 13.5 0.2 0.3 0.1 0.3 0.0 1.6 19.7 2.7 5.4 0.0 0.2 0.2 0.4 0.1 0.6 0.2 0.0 0.3 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 5.4;lymphoid tissue: 7.5;testis: 17.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "white matter: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.3 0.1 0.1 1.9 0.0 5.4 0.3 0.1 0.2 0.2 0.2 1.3 1.6 0.3 0.2 1.0 0.1 0.3 0.1 0.1 0.2 0.5 0.7 0.4 3.7 0.1 0.2 0.0 0.0 0.0 0.3 0.0 1.3 0.1 0.1 1.4 0.2 0.2 0.0 0.0 0.8 1.7 0.7 0.0 0.6 0.9 17.1 0.2 7.5 0.3 0.1 3.4 0.5 0.2 1.1 19.1 9.3 18.0 13.8 0.5 2.6 8.6 20.5 8.1 16.0 13.1 11.6 7.2 11.9 6.1 9.3 12.0 21.9 17.6 9.7 16.3 21.4 5.0 35.5 15.5 3.9 0.0 26.2 17.8 0.5 0.4 10.8 6.4 2.1 13.8 20.9 22.9 19.2 18.3 6.1 23.5 6.1 9.4 11.3 9.5 21.2 25.8 5.9 2.6 15.6 15.9 7.7 17.7 10.6 2.1 5.9 11.1 9.0 13.1 18.7 16.3 21.9 11.7 7.5 27.9 22.3 7.6 18.5 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.2 1.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 1.8 1.8 0.0 8.5 2.6 0.0 1.9 0.2 0.0 3.5 3.5 1.9 0.0 0.0 0.0 0.6 11.3 4.2 0.0 2.9 0.0 22.8 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 11.5 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.7 1.9 1.7 0.0 0.0 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548828-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 8.0 5.8 6.2 5.8 6.3 36.9 7.6 6.6 9.5 4.6 5.1 5.8 4.9 6.1 5.6 6.4 4.7 4.6 5.8 6.8 6.4 5.4 5.4 7.0 8.2 6.8 6.2 6.1 5.4 6.7 4.5 4.2 6.4 6.8 4.2 6.0 5.5 5.1 3.8 7.2 6.2 5.5 6.8 6.6 5.5 4.9 5.0 6.3 9.0 5.2 5.9 7.9 7.1 4.8 7.9 23.6 12.0 21.5 13.7 10.9 12.3 20.3 22.9 13.9 21.8 17.1 24.5 11.8 13.8 11.1 13.4 18.6 34.6 23.7 15.2 21.5 19.4 13.3 20.0 19.7 19.0 15.6 34.2 14.5 10.6 11.1 16.2 17.7 9.2 22.0 19.2 36.2 17.5 21.3 14.1 21.4 28.5 16.8 31.9 15.3 27.9 26.4 15.0 12.6 16.4 17.8 14.8 23.2 20.6 13.2 15.6 18.7 22.4 17.1 28.7 21.4 39.0 43.8 18.7 61.1 40.0 18.5 38.0 21.6 4.0 4.3 3.9 4.4 5.3 4.5 6.0 4.4 3.7 3.9 5.1 3.3 4.5 1.9 2.9 7.5 4.5 5.2 2.8 6.2 6.3 6.6 9.5 6.8 6.4 6.8 6.2 6.1 6.8 6.6 6.3 7.9 17.5 12.8 14.4 5.5 19.4 13.6 20.9 10.9 18.2 7.8 8.6 8.0 4.2 14.3 11.6 3.7 16.7 14.5 17.7 7.1 3.9 14.2 35.2 10.9 12.3 14.6 17.3 31.1 11.6 16.5 27.6 12.9 12.2 10.4 24.6 9.0 7.9 9.7 21.7 16.8 9.3 10.6 8.2 18.5 23.6 7.3 11.1 19.0 1.8 9.4 19.6 9.7 10.3 11.6 10.4 18.8 11.2 11.3 20.1 20.2 8.7 13.3 15.8 16.3 19.7 16.5 12.4 34.0 9.6 23.2 15.3 13.4 21.1 14.0 10.8 17.1 RTF1 KIAA0252 ENSG00000137815 "RTF1 homolog, Paf1/RNA polymerase II complex component" Q92541 15 41408408-41483563 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006714, CAB079946, CAB079947" Supported Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "CAB079946: , CAB079947: , HPA006714: AB_1079855" "unprognostic (1.10e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.88e-1)" "unprognostic (8.87e-2)" "unprognostic (5.36e-2)" "unprognostic (4.21e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.19e-1)" "unprognostic (1.69e-2)" "unprognostic (8.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (9.50e-2)" 17.9 23.4 25.4 19.0 26.9 45.6 22.7 27.6 43.0 24.5 19.9 20.7 19.4 25.3 19.7 21.6 17.2 20.5 24.8 26.9 23.7 19.2 20.1 19.6 28.4 21.6 22.2 25.3 29.7 16.8 37.2 11.5 24.7 23.0 23.6 22.6 26.6 16.8 23.1 49.9 26.1 20.0 26.5 19.9 24.0 21.0 30.1 23.1 29.1 29.7 35.1 25.2 23.3 17.7 25.2 32.0 20.6 66.5 54.2 37.0 43.4 31.2 41.8 46.8 56.0 46.5 40.4 19.8 30.2 33.0 43.9 24.9 55.3 38.9 34.8 47.6 46.2 36.1 63.5 45.2 30.4 25.8 57.2 35.5 31.4 34.3 30.0 30.1 41.6 45.8 54.0 49.2 34.0 46.5 24.2 55.1 35.1 35.9 39.6 28.0 59.0 51.8 28.9 36.5 67.5 34.0 44.9 37.6 47.4 19.0 35.9 38.9 54.5 37.9 54.6 34.4 54.8 46.5 38.9 65.0 49.6 39.4 53.5 34.1 5.4 3.1 6.9 3.4 2.1 3.1 6.9 3.3 2.9 2.2 5.3 4.0 3.2 8.5 6.2 2.7 5.5 4.3 1.1 25.4 26.9 27.6 43.0 26.9 23.7 21.6 22.2 25.3 23.0 19.9 23.1 25.2 118.0 128.2 80.1 23.8 109.0 145.0 98.7 120.4 102.4 213.5 152.6 129.7 94.3 111.5 89.7 123.2 93.8 168.3 117.1 129.6 164.4 103.0 333.7 103.9 162.6 116.4 87.8 85.0 40.3 110.5 119.1 103.5 71.9 126.2 91.2 127.9 129.5 193.2 95.5 148.0 43.6 145.4 109.9 86.7 94.4 348.5 145.1 83.0 108.5 15.9 116.1 106.2 128.8 16.6 23.5 127.0 105.1 159.9 104.1 141.9 112.6 186.4 70.7 188.2 85.5 115.4 146.9 198.3 59.9 83.4 163.0 219.3 113.0 126.1 133.2 99.2 PARP6 "ARTD17, pART17" ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 178.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favorable (3.17e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavorable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 19.7 21.1 61.7 14.7 64.1 30.8 20.2 61.6 85.3 21.2 58.4 24.2 15.5 24.8 24.2 17.8 22.8 21.5 18.2 64.1 57.8 23.7 15.7 19.8 19.5 56.1 55.8 65.4 29.4 32.8 12.7 50.1 18.4 58.8 25.3 14.9 53.3 23.4 17.4 35.1 22.8 21.9 20.4 49.4 20.8 24.4 34.8 56.6 21.2 30.5 21.4 17.6 22.9 19.3 64.3 15.9 27.6 29.0 37.8 30.5 25.2 23.7 13.8 19.9 21.8 31.1 18.5 28.2 22.3 8.4 20.3 31.4 20.9 32.4 18.1 12.4 26.5 30.6 31.7 55.0 0.2 25.4 16.7 30.1 32.6 43.5 20.1 55.2 33.7 14.6 35.6 16.6 24.3 17.5 28.4 14.4 28.7 14.2 13.2 0.0 26.7 20.8 17.2 19.9 30.4 81.4 43.1 22.6 17.8 37.0 38.2 22.8 18.8 14.0 26.7 24.7 35.7 20.7 27.9 27.7 23.2 19.1 31.4 19.1 1.1 3.6 8.2 2.3 3.1 1.6 2.4 1.7 2.5 2.6 2.3 2.6 2.0 3.6 3.0 3.5 2.2 2.9 2.1 61.7 64.1 61.6 85.3 64.1 57.8 56.1 55.8 65.4 58.8 49.4 56.6 64.3 11.5 22.4 21.2 54.9 15.3 14.4 9.6 6.9 31.3 16.4 13.0 13.7 20.9 2.8 12.9 9.2 20.9 7.3 12.0 8.0 7.9 9.7 61.4 8.0 10.3 11.1 17.4 4.6 19.7 12.7 5.3 13.9 21.4 10.0 15.8 17.3 6.4 6.1 8.9 18.5 20.5 6.5 6.1 14.8 11.1 178.1 12.5 14.0 16.0 20.6 9.3 8.8 6.2 27.2 54.6 9.2 9.0 9.8 12.3 9.0 17.7 12.3 5.8 15.5 6.6 13.7 12.5 44.3 12.6 19.3 15.8 6.4 13.3 8.6 7.5 9.3 RPLP1 LP1 ENSG00000137818 "Ribosomal protein lateral stalk subunit P1" P05386 15 69452814-69456205 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 28402.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003368 Supported "Endoplasmic reticulum,Cytosol" NA NA 2000000 "Endoplasmic reticulum, Cytosol" "HPA003368: AB_1079845" "unprognostic (5.04e-3)" "unprognostic (2.26e-2)" "unprognostic (2.02e-2)" "unprognostic (4.29e-2)" "unprognostic (6.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (2.79e-1)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.30e-9)" "unprognostic (7.75e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "unprognostic (5.83e-2)" 1742.6 1678.3 719.6 901.6 709.0 2804.4 1911.6 681.4 1118.2 2323.2 794.3 1917.1 1211.1 1820.4 352.5 2795.8 1685.4 584.3 1859.2 668.3 715.7 1421.8 1579.0 1452.2 1596.5 728.1 718.6 654.0 3382.7 2020.4 266.9 931.8 570.2 749.7 2008.6 453.2 159.0 1719.7 420.9 4785.4 4424.6 1707.6 534.4 764.4 2008.1 2164.7 496.4 760.3 649.5 1150.3 768.1 1026.4 2117.8 2392.6 755.6 1890.5 1882.4 827.9 1919.4 1172.4 1394.2 1770.4 1615.7 960.9 892.0 711.8 1918.7 1861.9 2622.2 2346.4 869.5 811.2 2521.6 1296.6 1287.5 193.1 2639.9 3956.6 2208.5 2153.1 1914.5 2045.2 1976.4 1931.2 1782.1 2199.9 653.6 1219.6 1438.9 1092.7 2265.9 2127.7 2160.7 642.2 1757.0 2163.4 5781.3 3098.7 1172.2 1802.9 2192.5 2696.6 3893.7 876.0 2002.9 1319.3 2558.5 1620.5 1978.2 6979.8 742.8 1633.9 4449.5 1915.7 1273.2 2851.6 1535.0 2672.3 4382.2 7690.0 2245.6 1524.1 4968.6 1076.9 2903.3 5350.5 1819.3 3182.4 3677.4 5811.2 9096.0 6532.4 4349.4 6100.6 7551.7 6871.8 6057.1 733.9 5147.0 2138.6 6392.6 5921.8 13416.9 719.6 709.0 681.4 1118.2 668.3 715.7 728.1 718.6 654.0 749.7 764.4 760.3 755.6 3508.0 1891.0 3795.4 16.0 11229.3 24186.3 18565.6 9896.5 18630.1 626.6 14197.1 19613.8 1854.3 3877.6 5293.4 2265.9 350.3 9217.3 6668.2 2484.5 5141.7 5608.7 475.1 2702.4 5765.4 5131.7 2926.5 6423.8 19.7 7158.4 12076.7 5235.1 3541.4 4232.4 2605.7 4287.7 5261.2 6536.1 8166.9 373.5 22.5 7238.9 2396.6 8309.7 12226.0 1764.3 8447.2 6779.7 9051.8 28.1 11829.2 4015.4 6451.2 15.6 42.8 7495.3 5127.5 4732.9 10308.0 16198.4 5565.3 8039.9 2204.8 1167.3 2530.9 5356.8 5872.6 690.3 1864.1 18779.3 28402.5 9502.3 9179.6 6940.6 8549.1 17342.5 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298912-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Distal tubular cells: 46.9;Early spermatids: 38.2;granulocytes: 67.2;Late spermatids: 123.0;Proximal tubular cells: 42.3" "Cancer enhanced" "Detected in many" "renal cancer: 8.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 1.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 38.1;CAPAN-2: 46.4;fHDF/TERT166: 33.1;HMC-1: 79.8;U-87 MG: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076729 Approved Vesicles NA NA Vesicles "HPA076729: AB_2686813" "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 0.6 16.1 4.0 2.6 2.7 1.2 1.2 2.6 3.0 1.0 9.9 19.1 2.3 1.0 0.2 12.5 0.9 2.0 0.6 2.8 2.5 53.4 1.1 9.2 0.3 3.1 2.9 1.7 0.6 5.1 11.4 0.8 1.6 3.5 0.6 16.4 1.9 1.8 3.7 0.2 4.9 8.1 0.9 2.4 0.4 7.8 2.4 3.9 0.2 0.8 0.2 2.1 3.7 2.9 3.5 11.7 38.1 0.8 0.8 1.6 4.2 0.3 3.7 22.2 4.3 9.1 2.2 46.4 0.1 5.9 33.1 3.7 0.7 10.9 0.6 7.4 0.1 1.7 6.9 5.6 0.8 2.9 0.2 79.8 2.2 1.7 19.4 20.7 5.5 0.0 0.2 0.1 0.7 18.4 1.6 0.2 0.2 2.6 6.1 3.2 0.1 0.6 2.2 16.6 0.9 3.3 0.7 6.0 2.3 3.1 2.1 1.0 2.8 0.6 13.1 4.2 1.1 0.4 0.2 0.3 0.1 33.1 0.1 3.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.0 2.7 2.6 3.0 2.8 2.5 3.1 2.9 1.7 3.5 2.4 3.9 3.5 0.1 12.8 21.0 1.0 0.5 0.9 1.3 0.4 1.2 0.7 1.3 0.8 0.7 32.9 0.9 20.2 0.0 0.0 0.0 31.1 46.9 19.0 38.2 0.7 0.1 1.9 0.0 0.0 0.5 0.4 0.0 2.8 2.0 1.5 67.2 2.2 0.0 0.0 3.7 0.0 0.7 4.8 0.0 0.3 0.7 123.0 0.9 1.8 0.0 20.6 0.0 5.9 0.0 1.0 0.5 2.6 6.9 1.2 0.0 1.4 26.8 42.3 0.8 0.1 6.6 0.1 0.6 0.5 0.5 15.1 1.8 0.1 0.4 19.6 13.7 0.8 LRRC49 FLJ20156 ENSG00000137821 "Leucine rich repeat containing 49" Q8IUZ0 15 70853239-71053658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 56.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.0;Cardiomyocytes: 145.1;Early spermatids: 92.8;Excitatory neurons: 79.1;Inhibitory neurons: 88.4;Late spermatids: 105.3;Spermatocytes: 91.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 24.2;SH-SY5Y: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015596 Uncertain NA NA "HPA015596: AB_2669230" "unprognostic (9.74e-2)" "unprognostic (7.94e-2)" "unprognostic (3.25e-3)" "unprognostic (1.15e-2)" "unprognostic (6.10e-2)" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (1.72e-1)" "unprognostic (3.36e-2)" "unprognostic (9.43e-2)" "unprognostic (7.66e-4)" "unprognostic (3.02e-1)" "unprognostic (5.29e-2)" "unprognostic (7.60e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.09e-2)" 2.2 2.8 7.6 0.8 8.8 0.3 2.7 13.9 11.3 6.0 6.3 3.2 0.4 8.8 29.9 2.0 9.1 3.8 56.9 6.4 10.0 3.3 0.5 2.8 0.7 11.9 9.9 7.2 11.2 1.4 9.1 11.7 1.0 13.4 5.3 1.8 27.1 1.8 4.9 1.1 1.6 1.7 5.1 4.8 0.8 2.7 12.0 21.4 1.0 4.8 1.8 0.8 4.5 3.9 11.9 2.1 3.9 8.5 14.9 3.8 6.4 0.1 3.6 6.3 2.4 5.8 1.3 1.6 0.0 2.6 1.5 6.0 3.5 8.4 4.3 2.0 0.0 4.5 1.0 4.1 0.1 24.2 0.1 0.5 2.9 1.5 7.2 12.3 12.5 6.5 0.0 0.1 0.0 3.6 0.7 0.0 0.7 5.0 0.3 2.8 0.0 5.7 0.0 8.0 4.5 17.2 18.0 4.3 2.0 4.0 3.1 4.6 1.4 5.9 2.9 9.0 5.4 6.2 1.1 4.3 0.0 6.8 0.2 2.2 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.6 8.8 13.9 11.3 6.4 10.0 11.9 9.9 7.2 13.4 4.8 21.4 11.9 4.3 3.2 3.7 63.3 0.7 2.3 22.9 11.5 5.7 85.0 2.2 3.0 145.1 1.5 13.0 7.3 62.6 0.1 0.1 1.5 5.9 7.0 92.8 30.8 8.0 7.2 18.5 0.0 79.1 0.9 0.1 11.6 2.6 4.3 0.0 8.0 2.5 0.0 0.1 30.3 88.4 1.9 0.0 0.3 0.7 105.3 5.6 0.7 0.0 19.7 0.0 10.9 0.0 63.8 34.1 1.7 1.6 9.8 0.2 11.7 0.3 3.5 54.8 37.3 0.0 7.4 8.0 91.9 11.4 0.7 1.6 0.3 0.8 2.5 1.2 8.0 TUBGCP4 "76P, FLJ14797" ENSG00000137822 "Tubulin gamma complex associated protein 4" Q9UGJ1 15 43369221-43409771 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 55.5;Rod photoreceptor cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043212 Approved Supported Centrosome NA NA Centrosome "HPA043212: AB_10796690" "unprognostic (1.34e-2)" "unprognostic (3.57e-2)" "unprognostic (4.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (3.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.09e-2)" "unprognostic (2.91e-2)" "unprognostic (5.65e-1)" "unprognostic (1.73e-1)" "unprognostic (7.49e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-1)" 3.8 4.4 5.3 3.7 6.4 4.8 5.1 8.6 8.5 5.3 6.1 4.9 4.8 4.5 3.5 5.9 4.6 2.9 4.9 5.7 5.9 4.2 5.9 3.9 4.6 6.0 6.2 5.8 5.2 6.2 8.4 5.3 3.8 7.1 5.2 5.2 11.2 5.1 3.7 9.8 4.7 5.3 4.9 5.6 4.5 4.9 4.1 6.1 6.1 4.6 9.9 5.5 4.7 5.2 6.6 18.2 5.6 13.3 13.7 12.9 13.9 10.3 10.2 7.3 13.9 14.0 18.0 11.1 11.3 15.2 8.8 19.5 29.4 28.3 18.2 16.3 19.0 26.9 29.5 30.2 15.9 10.7 20.4 17.6 7.6 17.9 14.4 20.0 11.0 11.5 18.5 28.4 9.6 10.4 6.3 16.4 15.7 6.3 29.6 22.1 22.0 17.5 15.9 9.2 17.1 35.5 12.1 12.4 23.8 4.1 8.4 14.1 15.8 9.5 13.2 13.5 18.3 22.7 9.9 12.5 19.6 12.1 29.0 15.1 0.1 2.5 13.8 3.7 2.9 2.7 3.6 2.8 2.6 5.3 3.2 2.0 2.9 0.3 5.3 1.6 2.8 3.2 2.4 5.3 6.4 8.6 8.5 5.7 5.9 6.0 6.2 5.8 7.1 5.6 6.1 6.6 6.5 19.2 14.5 12.1 14.9 11.0 16.3 4.5 5.2 30.9 8.8 7.4 1.7 18.6 10.8 16.5 22.9 16.1 6.5 8.5 7.9 12.2 28.7 9.4 15.3 8.8 14.4 15.4 17.3 9.9 14.7 10.4 5.6 10.4 11.4 15.9 10.0 11.4 6.9 55.5 13.8 10.6 8.2 7.6 5.6 43.6 15.2 6.1 3.6 4.7 7.7 13.1 22.6 17.1 9.2 11.0 9.4 12.4 5.8 20.1 12.7 6.1 9.5 57.1 6.6 19.1 10.2 25.0 14.5 9.2 8.9 11.5 9.8 11.2 17.7 16.9 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Yes No 42000 Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favorable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 30.4 22.9 31.8 16.3 33.4 24.3 27.0 32.9 49.0 18.1 24.8 18.0 44.2 16.1 5.4 22.8 19.0 16.8 16.0 30.7 29.9 18.4 37.4 36.8 15.7 34.7 33.3 28.5 17.4 27.4 36.6 10.9 19.6 32.6 17.3 9.1 6.8 33.6 15.6 20.8 21.0 52.2 11.3 33.9 13.1 21.7 13.9 39.9 15.2 20.1 14.3 8.5 20.5 17.7 36.6 19.7 17.7 21.0 35.9 19.2 17.2 36.3 50.2 19.8 34.9 25.6 63.7 21.7 16.7 65.0 27.0 26.0 66.3 26.9 37.3 3.7 44.2 33.1 53.6 51.4 31.6 62.9 36.4 41.1 30.9 34.0 25.2 23.9 16.3 24.8 32.6 57.4 44.9 15.1 40.0 27.7 23.6 16.7 52.7 34.6 42.6 25.1 38.9 28.8 32.7 49.8 18.1 39.9 53.4 19.5 8.2 41.6 39.1 37.3 37.8 27.0 51.1 42.5 34.0 42.7 26.7 26.8 38.2 42.2 4.0 13.2 5.5 28.2 17.8 25.0 16.0 20.6 26.0 14.4 13.7 15.9 17.3 2.1 65.1 22.3 54.2 20.3 26.6 31.8 33.4 32.9 49.0 30.7 29.9 34.7 33.3 28.5 32.6 33.9 39.9 36.6 20.1 32.1 28.1 18.6 11.0 15.7 16.4 26.9 15.9 20.0 21.0 13.6 8.1 15.7 27.8 18.4 4.2 44.4 22.4 17.2 1.9 27.7 2.8 20.7 17.8 18.1 4.9 42.7 23.5 22.0 28.5 17.8 13.7 22.0 19.0 8.6 17.5 36.4 110.7 18.5 18.2 12.3 26.4 14.7 10.4 3.4 16.8 21.0 19.6 8.4 11.7 21.6 43.3 16.1 21.8 21.8 16.7 14.3 18.0 17.3 77.6 14.5 29.3 17.3 6.6 22.2 16.0 40.4 40.4 21.9 11.9 62.8 18.3 16.7 21.4 23.1 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.8;intestine: 18.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 11 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "Hep G2: 33.6;OE19: 18.2" "Low region specificity" "Detected in all" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.2 7.4 18.8 0.7 23.5 0.4 0.2 11.9 36.8 1.3 9.3 7.5 17.8 0.3 0.1 0.3 0.5 0.2 1.6 23.9 13.7 0.2 1.7 0.5 0.1 12.3 10.1 23.3 0.3 2.0 2.0 0.4 0.3 13.5 0.8 2.7 0.3 1.4 0.4 4.4 0.4 18.2 0.3 9.0 0.2 11.0 10.4 9.7 0.0 0.2 0.0 0.0 0.6 0.9 18.1 7.1 1.9 0.3 7.9 0.0 2.5 14.3 4.3 3.4 2.8 2.9 16.3 0.3 0.0 3.5 0.4 6.3 0.8 3.4 0.3 0.2 6.6 4.3 9.9 4.7 33.6 12.6 3.4 0.5 0.2 0.2 2.7 0.8 1.6 0.2 1.3 12.9 1.9 1.0 4.7 0.3 6.5 0.9 18.2 5.6 1.7 1.4 0.6 0.3 0.4 0.7 1.5 3.2 0.0 0.3 0.0 0.9 5.0 0.3 6.9 7.1 7.7 11.8 1.0 10.8 0.0 12.6 13.2 2.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.8 23.5 11.9 36.8 23.9 13.7 12.3 10.1 23.3 13.5 9.0 9.7 18.1 0.1 0.0 0.0 3.3 0.5 0.1 0.3 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.1 0.0 0.0 0.6 0.1 51.4 0.0 0.1 45.4 0.3 2.4 0.5 0.0 0.8 23.7 0.7 0.5 0.3 34.1 0.3 0.0 1.0 0.4 0.3 0.2 0.0 0.8 12.0 0.0 0.0 0.0 166.4 2.5 0.4 0.0 1.9 0.0 7.9 0.0 1.5 2.9 0.8 16.1 1.5 0.1 0.1 35.8 0.1 0.1 0.2 6.6 0.3 0.5 14.4 4.9 0.0 0.0 0.1 0.4 0.1 18.7 0.2 UACA "FLJ10128, KIAA1561" ENSG00000137831 "Uveal autoantigen with coiled-coil domains and ankyrin repeats" Q9BZF9 15 70654554-70763558 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 143.2" "Cell type enhanced" "Detected in many" "Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 244.5;BJ hTERT+: 148.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041412, HPA043503, HPA056006" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: " "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (7.01e-5)" "unprognostic (4.95e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (1.03e-4)" 38.0 18.0 12.4 7.9 13.7 1.0 33.2 12.1 13.2 24.7 26.4 14.7 22.4 22.3 21.7 29.1 21.8 32.5 28.2 10.1 11.4 31.1 17.4 31.0 8.1 14.2 13.8 7.6 31.4 12.8 12.6 11.6 28.9 15.4 21.8 15.6 12.0 25.5 18.6 143.2 18.9 22.4 16.2 13.1 30.3 16.0 16.2 13.5 4.7 35.9 107.0 6.7 13.3 25.6 16.1 42.7 34.8 15.2 20.2 29.9 127.9 0.1 244.5 148.4 62.7 53.8 58.5 61.5 29.2 65.6 61.4 18.4 48.1 34.4 19.4 78.3 0.1 15.3 16.4 27.9 12.3 38.8 0.4 6.0 60.8 10.7 37.1 28.1 103.3 67.7 6.9 4.1 0.1 78.7 14.0 0.1 2.6 12.7 19.3 18.0 0.0 109.6 0.2 30.3 14.4 4.0 7.6 46.5 7.1 48.9 30.3 13.4 4.9 130.5 3.6 24.8 20.6 39.1 2.3 8.8 0.2 31.4 4.4 27.4 0.1 0.9 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.8 1.2 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 12.4 13.7 12.1 13.2 10.1 11.4 14.2 13.8 7.6 15.4 13.1 13.5 16.1 293.0 6.4 6.4 31.6 5.4 11.3 14.6 13.7 10.2 6.3 22.2 33.3 175.1 18.6 19.2 49.7 4.2 1.0 2.1 66.5 3.9 49.0 21.0 75.3 46.3 177.4 9.1 3.0 0.9 48.7 1.9 81.6 33.6 53.0 15.2 34.9 47.5 18.8 9.6 25.2 0.7 33.1 6.1 24.3 8.6 15.2 125.2 15.8 30.2 184.6 9.5 49.4 2.1 6.0 62.0 78.8 35.7 141.1 0.8 21.8 45.3 5.0 61.9 4.2 52.6 53.5 96.2 46.4 35.2 16.4 13.1 1.0 2.9 62.7 24.2 10.9 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702236-66782849 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 28.2" "Cell type enhanced" "Detected in many" "Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.3 2.6 4.7 1.6 4.1 0.1 7.7 4.7 9.2 6.1 13.6 3.2 2.0 6.3 0.6 2.1 5.5 1.4 21.9 3.1 3.6 8.8 6.8 28.2 0.5 7.1 5.0 1.8 5.9 2.7 1.2 3.4 7.5 5.3 7.0 1.1 0.9 2.1 3.5 1.6 2.1 3.9 1.0 4.0 2.6 5.6 1.8 6.6 0.4 15.6 1.6 0.2 8.1 5.8 4.9 1.3 10.2 1.6 3.5 6.0 1.6 9.4 7.2 0.1 1.1 0.1 2.0 4.6 0.7 29.8 6.1 0.9 18.2 2.2 0.0 0.2 2.3 8.4 16.1 28.6 1.7 0.7 0.1 1.2 2.0 0.0 0.1 0.0 3.4 1.3 5.1 1.4 1.0 0.5 2.0 0.1 4.4 3.0 10.5 3.8 0.0 1.8 2.2 3.4 8.1 3.6 1.6 3.9 4.3 0.8 5.9 1.4 2.9 6.2 4.3 5.5 17.6 1.4 0.5 1.8 0.3 3.1 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 4.1 4.7 9.2 3.1 3.6 7.1 5.0 1.8 5.3 4.0 6.6 4.9 19.8 12.8 6.0 5.2 0.9 0.8 1.2 2.1 0.6 0.6 0.9 1.1 4.9 4.3 3.0 1.8 2.1 0.8 0.1 4.3 3.9 4.7 3.4 8.3 5.5 25.1 0.0 0.0 0.3 5.8 0.9 4.9 5.1 6.5 4.5 5.9 91.4 4.0 1.7 0.0 0.3 2.1 0.0 10.0 0.3 1.4 2.8 1.2 0.0 57.1 0.7 10.2 0.0 0.5 0.4 8.4 1.5 8.2 0.0 1.3 2.1 1.9 0.1 0.6 0.0 0.9 1.5 0.2 3.2 0.4 0.1 0.8 0.4 0.1 5.5 0.4 PLCB2 FLJ38135 ENSG00000137841 "Phospholipase C beta 2" Q00722 15 40278176-40307935 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.9;lymphoid tissue: 41.1" "Cell type enhanced" "Detected in many" "dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB009443, HPA041298, HPA068595, HPA069308" Enhanced Approved "Plasma membrane,Cytosol" NA NA 11000 "Plasma membrane, Cytosol" "CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: " "unprognostic (5.52e-2)" "unprognostic (4.96e-3)" "unprognostic (6.09e-3)" "unprognostic (1.88e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.00e-4)" "unprognostic (1.66e-1)" "unprognostic (3.08e-2)" "unprognostic (1.28e-1)" "unprognostic (2.34e-1)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (9.89e-2)" "unprognostic (2.06e-3)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" 5.9 4.0 3.2 29.5 4.1 52.9 2.6 3.5 4.3 3.4 4.0 5.2 6.2 2.7 1.4 3.0 4.5 9.8 3.1 3.4 8.4 1.9 6.4 16.9 28.9 7.8 4.9 2.0 1.6 1.3 1.3 2.1 7.1 6.2 2.6 8.1 0.5 5.4 4.1 1.2 1.9 10.5 7.3 5.4 41.1 5.5 1.3 6.0 20.7 2.2 1.7 22.4 7.4 1.8 8.1 0.4 0.0 0.6 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.1 19.1 1.5 17.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 78.6 0.0 0.0 0.0 16.9 93.4 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.7 4.3 0.0 0.0 4.7 9.2 0.9 0.0 0.2 13.7 2.0 0.1 0.1 0.0 0.3 0.3 0.0 0.0 0.2 5.1 0.0 28.1 10.1 0.0 9.1 0.0 0.0 0.0 0.0 3.7 0.0 53.2 0.0 1.7 2.6 5.3 1.8 2.7 1.2 0.4 0.9 0.9 2.7 0.5 0.9 1.0 4.2 1.2 2.7 1.0 1.9 1.5 3.2 4.1 3.5 4.3 3.4 8.4 7.8 4.9 2.0 6.2 5.4 6.0 8.1 0.9 6.4 16.8 0.3 9.6 0.9 0.1 0.1 0.6 0.1 1.9 2.5 3.3 1.5 3.2 1.8 0.0 0.5 22.6 0.2 0.0 0.1 2.2 0.2 0.5 1.7 0.0 8.0 1.8 0.0 0.5 1.9 0.0 0.2 26.6 0.1 1.1 0.4 30.3 0.0 0.8 1.7 0.0 46.6 15.5 0.6 0.3 41.7 3.6 39.4 20.9 0.0 26.8 0.5 0.2 0.4 0.3 0.0 5.7 0.0 0.0 0.9 4.4 0.2 0.0 0.4 0.7 0.5 2.3 0.3 0.6 0.4 20.8 0.3 2.0 0.0 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 61.0;U-266/84: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: AB_2678950, HPA062359: AB_2684747" "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favorable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 6.9 4.6 4.7 6.1 5.3 9.1 23.1 8.5 6.8 8.2 3.6 13.3 13.2 5.5 12.4 6.3 7.6 7.9 4.6 5.3 5.5 7.6 10.3 8.9 7.3 5.0 5.1 5.3 3.3 8.2 13.8 4.6 10.4 5.1 6.2 14.5 9.0 13.7 7.1 9.4 4.9 11.8 6.5 4.9 6.2 10.3 2.0 5.7 4.0 8.6 6.7 8.1 7.7 5.4 6.5 14.9 7.9 3.5 6.8 4.3 5.5 36.4 13.9 17.6 24.1 33.3 12.5 28.5 15.0 7.9 13.2 21.7 27.6 14.8 10.9 8.7 17.7 6.8 12.2 15.4 9.5 9.4 12.7 10.5 3.9 13.0 10.6 7.4 6.8 13.6 3.7 10.9 12.7 2.8 3.5 0.0 3.0 1.2 61.0 3.2 7.5 3.7 7.9 12.9 18.6 22.2 9.6 10.9 27.2 6.7 3.9 14.6 12.9 8.0 11.9 4.9 8.5 22.7 10.6 67.1 10.7 11.0 14.0 10.4 0.5 0.7 1.1 0.8 0.3 1.0 0.7 1.1 1.0 0.7 0.8 0.7 0.9 0.2 1.6 0.4 1.7 2.0 0.4 4.7 5.3 8.5 6.8 5.3 5.5 5.0 5.1 5.3 5.1 4.9 5.7 6.5 7.7 16.0 4.6 12.1 18.8 2.3 4.1 2.8 5.7 5.6 12.3 6.3 2.6 8.6 5.0 12.9 10.4 21.9 7.0 12.5 5.9 12.9 1.6 9.6 3.7 5.6 4.2 9.1 36.3 14.8 25.2 4.8 11.2 13.9 5.1 7.0 6.1 7.3 7.5 1.7 33.4 11.4 6.1 6.5 4.8 3.7 2.5 7.1 5.4 18.7 6.4 7.8 6.2 29.1 34.5 12.2 8.1 1.2 16.5 2.7 12.8 3.4 6.1 9.9 6.6 4.1 5.2 2.2 1.0 8.6 2.8 34.1 7.4 3.8 11.0 4.8 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40217428-40277487 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 25.8;skin 1: 27.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.2 8.3 12.8 0.4 16.0 0.9 2.1 8.2 17.9 2.8 0.0 1.3 1.5 0.9 1.0 25.8 4.3 1.1 8.4 17.1 5.6 4.5 0.3 2.6 0.9 3.8 3.2 17.2 0.6 8.1 8.1 12.2 7.6 5.7 4.5 1.1 0.8 6.2 3.9 4.5 27.9 1.5 0.3 0.9 0.9 3.9 17.8 3.1 0.5 7.5 1.3 1.9 3.5 9.5 8.9 3.9 0.0 0.2 0.0 0.0 0.0 6.0 0.0 0.2 0.7 0.7 26.5 2.9 0.1 3.6 0.0 1.3 32.2 4.5 6.9 0.3 0.2 1.0 0.0 3.0 0.2 0.0 0.1 0.3 0.0 19.4 0.3 4.5 0.2 0.0 5.5 1.8 0.3 0.0 4.5 0.0 0.5 0.5 3.9 2.9 0.2 0.2 2.9 1.5 8.4 7.3 2.0 2.6 10.9 0.3 1.7 1.7 10.3 0.0 0.3 0.6 0.0 0.3 0.1 0.3 0.1 0.7 0.6 0.2 1.2 0.1 1.2 2.3 0.1 0.8 0.6 0.1 1.9 0.3 0.1 0.1 0.4 0.5 0.9 0.1 0.1 0.0 0.6 12.8 16.0 8.2 17.9 17.1 5.6 3.8 3.2 17.2 5.7 0.9 3.1 8.9 0.0 0.0 4.2 0.7 0.3 9.8 9.6 4.8 8.6 3.5 2.8 2.9 0.0 4.3 5.4 5.5 0.0 52.7 2.1 0.3 13.7 4.4 8.6 3.3 0.4 0.3 4.9 0.0 8.9 4.3 3.0 0.7 0.5 5.1 0.0 0.7 0.0 0.0 4.1 0.0 7.3 1.1 2.0 0.6 0.9 5.8 1.8 0.3 1.8 1.0 0.0 1.3 16.5 0.5 0.3 2.5 1.0 1.9 0.1 5.2 0.2 0.2 3.9 0.2 0.0 0.3 0.4 1.9 3.3 13.9 19.0 9.0 1.0 0.8 2.0 11.3 ADAM10 "CD156C, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588809-58749791 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 377.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 296.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 690000 "Vesicles, Plasma membrane" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 15.1 8.8 12.6 19.2 18.0 18.8 15.4 21.5 15.6 16.2 10.1 22.4 16.0 16.5 7.8 15.6 14.1 19.1 12.2 11.8 13.1 18.1 16.2 21.1 22.4 16.8 18.1 8.5 14.2 8.9 7.9 8.3 29.2 16.8 25.4 17.4 10.9 9.4 12.3 6.1 17.1 17.6 13.5 17.1 29.3 20.4 8.6 15.6 43.1 28.9 7.2 16.5 28.2 10.5 25.4 48.4 88.5 27.6 31.2 34.8 49.8 70.0 39.0 116.0 28.6 39.1 39.9 62.6 22.7 118.0 35.2 49.2 95.9 16.8 43.5 37.0 30.1 19.3 38.7 35.1 42.1 40.8 25.0 103.8 44.4 30.0 19.9 29.2 41.1 55.6 45.0 24.5 57.9 50.4 15.4 89.5 32.0 40.2 15.4 14.6 36.4 91.6 57.1 66.6 121.4 29.9 20.3 44.0 52.8 73.1 60.0 30.4 55.0 41.4 37.1 41.2 296.6 39.6 30.7 70.7 23.5 54.1 50.8 67.3 30.9 36.2 19.2 12.8 41.1 19.2 8.3 12.7 11.6 23.6 9.6 12.7 10.8 51.5 17.7 48.6 10.2 18.2 25.8 12.6 18.0 21.5 15.6 11.8 13.1 16.8 18.1 8.5 16.8 17.1 15.6 25.4 60.1 83.3 50.8 83.2 37.9 26.6 30.7 33.3 33.0 22.7 61.6 30.9 40.0 30.0 46.7 80.9 27.1 35.6 69.4 79.0 1.9 56.0 21.2 39.5 56.4 72.5 36.1 20.8 106.1 31.8 57.8 36.1 53.0 74.0 30.3 31.5 71.4 36.2 63.8 45.4 96.2 43.6 36.7 90.1 28.9 19.4 18.0 77.9 46.2 147.1 69.0 30.6 44.3 75.9 377.6 48.9 48.1 17.0 51.0 89.1 45.1 23.7 41.2 33.4 13.1 34.4 42.8 20.3 17.8 39.5 22.3 26.5 51.3 34.1 39.5 83.9 DUOX1 "LNOX1, NOXEF1, THOX1" ENSG00000137857 "Dual oxidase 1" Q9NRD9 15 45129933-45165576 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 109.4;skin 1: 82.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.4" "Group enriched" "Detected in many" 5 "cerebellum: 11.3;pons: 5.1;white matter: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 9.6" HPA023544 Approved NA NA "HPA023544: AB_1847878" "unprognostic (2.85e-2)" "prognostic favorable (4.31e-6)" "unprognostic (2.49e-2)" "unprognostic (8.84e-3)" "unprognostic (1.44e-2)" "unprognostic (3.27e-2)" "unprognostic (1.23e-1)" "unprognostic (2.57e-2)" "unprognostic (5.87e-2)" "unprognostic (6.02e-3)" "unprognostic (5.13e-2)" "unprognostic (1.19e-1)" "unprognostic (8.91e-3)" "unprognostic (2.23e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (3.03e-1)" 1.1 14.2 0.9 1.0 1.1 0.2 4.6 11.3 1.4 44.8 0.0 0.9 0.6 3.1 50.5 109.4 14.1 3.4 2.2 1.2 0.2 0.5 0.4 70.7 0.4 0.5 0.6 0.7 1.8 0.5 5.2 1.3 1.5 5.1 13.9 0.3 0.7 18.8 13.2 0.4 82.4 0.8 0.4 0.1 0.3 64.8 1.6 0.2 1.1 70.9 0.0 14.9 11.2 42.3 3.4 8.3 0.1 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 64.4 0.0 6.1 0.0 0.8 0.4 0.0 0.9 0.1 0.0 0.0 0.3 0.0 30.5 0.0 1.9 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.2 0.1 0.0 0.0 36.3 0.8 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 1.1 11.3 1.4 1.2 0.2 0.5 0.6 0.7 5.1 0.1 0.2 3.4 0.9 83.3 168.6 4.2 4.5 11.1 14.3 22.8 11.4 21.3 4.7 2.8 2.4 8.6 32.5 3.7 8.4 5.3 7.6 2.5 0.0 3.8 0.7 67.1 9.4 3.8 21.7 2.7 5.1 5.4 0.6 5.1 17.9 88.5 8.2 7.9 7.9 1.5 1.2 6.7 3.9 4.0 16.2 3.1 43.5 0.3 3.4 3.3 16.0 1.0 3.2 3.5 33.0 9.5 10.6 4.7 4.0 3.8 0.1 9.5 6.8 0.5 64.9 4.4 0.0 8.5 4.7 11.5 7.5 36.4 18.0 3.7 4.5 0.4 5.6 30.0 SLC28A2 "CNT2, HCNT2, HsT17153, SPNT1" ENSG00000137860 "Solute carrier family 28 member 2" O43868 15 45252234-45277846 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 93.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9" "Cancer enhanced" "Detected in many" "stomach cancer: 3.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046068, HPA055623" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA046068: AB_2679523, HPA055623: AB_2682866" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (6.85e-2)" "unprognostic (6.31e-2)" "unprognostic (1.59e-2)" "unprognostic (1.61e-1)" "unprognostic (6.40e-4)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.44e-2)" "unprognostic (8.95e-2)" 0.1 0.3 0.5 0.7 0.5 0.1 0.0 0.3 0.6 2.6 0.0 9.6 68.6 0.5 0.4 0.1 0.1 9.9 0.3 0.4 0.1 3.6 0.8 0.1 0.3 1.2 0.4 0.2 0.3 0.3 0.0 0.0 0.6 1.1 0.1 35.0 0.7 0.2 0.0 0.3 0.3 93.0 0.0 0.1 0.2 23.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.6 0.4 0.1 1.2 0.4 0.2 1.1 0.1 0.2 0.7 0.5 0.0 8.1 1.6 0.9 0.1 0.4 0.4 0.0 2.9 0.3 0.0 0.7 8.6 4.5 0.0 2.1 12.3 0.3 19.6 0.0 0.1 0.7 1.0 0.4 1.0 13.9 2.7 1.8 0.0 2.7 1.0 4.6 1.2 8.8 0.7 0.7 0.3 0.9 1.7 1.5 14.5 0.0 0.3 0.4 0.4 0.0 1.3 0.0 0.0 0.2 1.0 2.1 2.0 2.0 0.0 35.7 0.7 0.4 0.2 43.4 1.2 4.6 6.6 0.0 0.3 0.2 2.4 2.1 0.0 0.3 4.7 1.3 0.2 48.9 0.2 STRA6 FLJ12541 ENSG00000137868 "Signaling receptor and transporter of retinol STRA6" Q9BX79 15 74179466-74212267 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 16.3;placenta: 7.6" "Cell type enhanced" "Detected in many" "Club cells: 17.6;Endometrial stromal cells: 43.1;Extravillous trophoblasts: 12.1;Fibroblasts: 16.1;Proximal tubular cells: 10.3;Syncytiotrophoblasts: 26.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 33.7;CAPAN-2: 94.5;SH-SY5Y: 59.2;WM-115: 142.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040839 Approved NA NA "HPA040839: AB_10794881" "unprognostic (1.20e-2)" "unprognostic (4.99e-2)" "unprognostic (3.71e-2)" "unprognostic (3.55e-3)" "unprognostic (1.37e-1)" "unprognostic (2.09e-2)" "unprognostic (4.38e-3)" "unprognostic (1.67e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (5.35e-2)" "unprognostic (3.89e-1)" "unprognostic (7.91e-13)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" 0.1 1.0 0.1 0.3 0.1 0.0 0.9 0.1 0.4 16.3 0.5 0.0 0.0 4.3 0.5 1.1 3.6 0.3 0.1 0.1 0.2 4.3 0.0 0.2 0.8 0.1 0.1 0.1 0.6 0.1 0.0 5.6 7.6 0.1 5.2 0.0 0.0 0.8 1.5 0.0 0.2 0.2 0.2 0.1 0.1 0.0 3.1 0.3 0.2 0.1 0.1 0.5 1.3 2.4 0.1 0.5 33.7 1.9 0.1 0.0 0.0 6.0 1.0 0.2 0.0 0.0 11.7 94.5 0.0 22.1 0.1 0.7 3.4 1.8 0.0 0.0 0.0 0.2 3.0 1.3 2.5 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 6.1 0.6 2.9 0.1 0.0 0.4 0.0 0.0 0.0 2.9 17.4 59.2 0.0 3.6 0.0 3.6 0.2 0.1 0.0 0.2 7.3 0.6 1.6 0.1 0.2 0.0 0.6 0.0 142.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.4 1.0 9.7 0.0 0.0 0.2 0.3 1.0 0.0 17.6 0.0 0.0 4.2 0.0 0.0 1.9 0.3 1.7 2.1 43.1 1.3 0.0 0.0 0.1 0.0 12.1 16.1 0.0 1.8 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 2.0 0.0 0.8 0.8 6.8 0.4 1.8 1.9 0.1 0.0 0.0 0.0 0.0 4.7 0.0 4.1 0.0 0.4 0.0 10.3 6.6 0.0 0.0 1.3 4.7 0.5 0.5 0.0 0.0 26.4 0.3 0.1 0.0 1.3 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338601 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "placenta: 125.5" "Cell type enriched" "Detected in some" 10 "Syncytiotrophoblasts: 2007.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 92.8;HDLM-2: 17.5;HSkMC: 31.4;SuSa: 16.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 5.3 9.1 3.8 0.5 0.6 0.2 2.1 0.1 2.1 0.6 0.0 0.2 0.7 0.3 0.0 0.1 0.3 0.5 1.0 0.2 3.0 0.1 0.1 0.7 0.0 1.0 2.3 0.2 3.2 1.3 0.2 0.0 125.5 0.4 0.6 0.1 0.6 0.9 2.8 0.6 1.5 0.2 1.4 0.5 0.6 0.2 6.5 3.2 0.2 2.5 0.3 0.0 3.5 0.5 2.5 0.1 0.0 0.0 0.0 1.7 92.8 6.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 17.5 0.0 0.6 0.2 8.1 0.6 0.0 0.1 31.4 0.0 0.3 4.0 0.3 0.0 0.0 0.0 0.8 0.4 0.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.4 0.2 16.3 0.0 0.5 0.1 0.3 0.1 0.2 0.0 3.0 1.6 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.1 2.1 0.2 3.0 1.0 2.3 0.2 0.4 0.5 3.2 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 7.9 1.5 0.0 0.0 0.0 191.3 0.0 0.0 14.0 0.0 0.3 0.0 0.0 0.9 0.0 5.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.9 12.3 0.3 0.0 0.0 2007.5 0.0 22.2 0.0 0.0 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630176-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 11.4 11.5 3.5 8.8 3.8 23.3 15.5 9.0 4.5 18.2 4.9 10.3 7.5 20.3 8.2 8.5 12.5 9.6 9.3 3.5 3.6 10.4 13.3 10.2 10.0 3.3 3.5 2.3 23.9 13.8 11.2 4.6 11.6 4.1 10.7 11.6 12.5 10.5 10.0 12.7 6.6 9.6 15.2 3.0 10.4 10.4 7.9 3.5 36.2 11.6 11.7 10.0 11.0 8.6 9.8 13.4 7.4 13.6 20.9 13.3 18.7 9.9 20.2 14.3 8.2 9.3 5.4 13.6 22.7 8.4 14.5 7.9 10.0 6.7 5.3 9.9 11.6 4.1 2.4 12.5 8.2 13.3 20.4 6.6 12.8 7.6 5.6 8.0 20.6 18.3 23.0 11.9 25.7 13.0 9.6 14.4 2.3 0.0 15.6 5.8 4.3 22.2 16.1 10.1 15.4 11.2 20.0 16.9 10.5 6.7 0.7 11.4 19.9 16.2 12.1 18.2 11.3 16.1 13.2 21.6 0.0 13.7 31.0 13.2 7.8 2.6 3.5 2.1 2.2 2.0 3.4 1.9 1.7 3.6 3.2 2.0 2.4 0.4 1.8 2.0 3.6 1.9 1.0 3.5 3.8 9.0 4.5 3.5 3.6 3.3 3.5 2.3 4.1 3.0 3.5 9.8 32.4 9.6 18.9 176.6 31.1 11.1 18.3 12.9 42.7 79.8 20.5 20.7 37.9 22.8 14.6 3.7 83.4 23.0 25.5 12.2 7.9 12.0 18.3 14.3 33.0 36.5 32.3 27.5 107.2 14.0 21.5 37.5 26.0 14.2 17.7 37.8 34.2 31.1 36.6 69.0 151.3 25.7 16.2 35.6 18.1 49.5 33.2 22.9 16.0 91.8 27.0 24.9 28.8 200.1 293.3 10.5 10.4 21.1 41.4 21.1 26.8 14.2 12.8 84.5 6.6 47.4 30.8 49.4 33.8 26.8 13.9 13.3 21.4 27.7 22.2 16.3 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774228 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.9;placenta: 43.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1" "Cancer enriched" "Detected in many" 4 "glioma: 8.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 4.7 1.5 11.5 4.0 24.6 0.4 5.1 11.4 20.6 4.9 0.0 10.7 22.0 1.7 2.5 1.7 5.0 4.0 9.5 12.5 16.5 15.2 3.1 8.9 2.1 22.8 30.3 12.1 26.9 16.3 10.7 5.5 43.5 21.0 4.6 12.8 16.0 4.5 8.5 21.0 3.0 38.9 3.3 9.3 2.5 3.0 2.6 21.3 2.7 5.8 6.0 0.6 3.1 10.1 28.3 0.0 0.0 2.5 0.0 1.5 1.2 0.2 0.6 14.9 0.4 0.0 0.3 0.1 2.2 0.0 4.0 0.0 7.6 3.4 1.1 0.1 1.1 1.7 0.0 5.0 0.0 4.0 0.0 0.2 1.1 8.3 0.0 0.5 0.0 1.0 5.7 0.1 3.4 0.4 0.8 2.8 0.7 4.6 0.0 0.0 1.6 0.1 2.4 1.1 1.1 13.3 12.1 0.1 1.0 4.3 14.2 0.5 0.0 0.0 6.9 0.3 0.2 0.0 10.0 0.0 2.3 1.8 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.5 24.6 11.4 20.6 12.5 16.5 22.8 30.3 12.1 21.0 9.3 21.3 28.3 13.9 51.3 1.5 72.8 0.2 2.0 4.0 1.4 1.2 6.2 0.5 10.7 10.0 4.3 2.1 11.0 114.7 19.7 0.1 40.6 5.9 1.0 0.2 0.5 2.3 10.1 17.4 0.0 120.7 0.2 1.8 10.8 0.0 0.3 3.8 71.0 5.0 0.9 2.6 79.1 319.5 5.4 0.0 0.0 1.9 1.2 23.3 1.0 8.8 15.9 0.0 9.3 0.0 43.2 140.1 0.3 8.5 13.5 0.0 1.2 53.5 0.2 0.1 2.3 0.0 9.3 13.9 0.8 6.3 0.3 1.1 4.7 0.2 3.4 15.1 1.6 BCL2L10 "BCL-B, Boo, Diva" ENSG00000137875 "BCL2 like 10" Q9HD36 15 52109263-52112775 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 9.6;skin 1: 6.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 13.7;Proximal enterocytes: 11.4;Proximal tubular cells: 9.8;Squamous epithelial cells: 7.9;Suprabasal keratinocytes: 8.7" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "NB-4: 34.1" "Not detected" "Not detected" HPA042222 Approved NA NA "HPA042222: AB_10794271" "unprognostic (5.33e-4)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (3.22e-4)" "unprognostic (1.19e-2)" "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "unprognostic (4.80e-3)" "unprognostic (8.86e-2)" "unprognostic (3.47e-2)" "unprognostic (9.52e-2)" "unprognostic (3.83e-1)" "unprognostic (2.18e-9)" "unprognostic (9.59e-2)" "unprognostic (1.86e-1)" "unprognostic (1.92e-1)" "unprognostic (3.20e-2)" 0.2 2.7 1.3 0.3 1.6 0.1 1.0 0.9 1.2 1.6 0.5 1.0 2.0 0.8 0.0 3.6 0.6 1.0 0.0 0.9 1.3 3.2 9.6 0.0 0.2 0.7 0.8 1.0 0.4 0.6 0.2 1.2 0.0 0.8 0.5 0.8 0.4 0.8 0.1 0.1 6.3 2.1 0.2 0.6 0.6 0.9 0.2 1.4 0.1 0.3 0.0 0.2 1.2 3.6 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 4.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.3 1.6 0.9 1.2 0.9 1.3 0.7 0.8 1.0 0.8 0.6 1.4 1.1 0.1 0.0 0.0 0.0 0.6 6.1 5.3 2.5 4.6 1.0 1.7 2.5 0.3 4.3 0.7 0.0 0.0 0.1 0.2 2.8 13.7 2.2 0.0 1.4 1.4 0.3 0.0 0.8 0.4 1.5 0.2 0.3 0.0 5.2 0.0 0.1 0.0 4.5 0.1 0.0 0.2 2.1 6.1 0.0 0.7 0.1 0.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.7 0.4 1.1 2.0 11.4 9.8 0.4 0.2 0.0 0.2 0.3 0.0 0.1 7.9 8.7 0.1 0.2 0.1 3.1 5.4 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197049 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 67.6 62.6 53.6 60.7 55.7 240.7 123.0 65.1 71.7 70.2 51.9 55.0 48.6 90.6 69.3 55.7 60.4 55.7 66.7 54.2 57.2 64.8 73.6 48.7 88.7 54.6 55.8 51.4 139.9 77.6 53.0 34.5 46.2 55.4 55.6 53.5 54.5 65.8 49.5 92.1 52.0 49.1 62.4 57.5 52.4 60.9 51.4 54.8 82.9 75.0 75.2 77.2 75.7 46.5 64.7 122.0 115.2 130.2 168.5 95.7 172.4 104.6 126.1 127.5 95.6 117.0 112.2 70.8 361.8 110.5 86.5 100.9 141.4 165.3 137.2 125.9 183.6 104.1 191.3 89.1 148.7 219.6 365.0 121.7 154.1 282.4 98.9 286.0 162.6 120.5 275.2 352.0 256.2 114.3 122.5 202.5 324.3 159.8 246.9 105.9 156.7 162.8 565.2 148.3 108.8 181.0 218.7 57.6 159.2 430.1 100.6 152.3 524.9 90.4 82.1 98.5 99.3 181.6 249.5 420.2 382.3 129.3 353.9 142.4 61.3 99.2 51.1 76.9 101.5 124.8 123.6 115.9 98.2 116.9 98.1 173.9 134.8 24.9 103.3 108.9 90.0 142.4 229.9 53.6 55.7 65.1 71.7 54.2 57.2 54.6 55.8 51.4 55.4 57.5 54.8 64.7 146.9 99.3 79.8 6.8 259.2 580.6 425.7 437.4 275.4 85.4 258.9 299.5 69.0 140.2 177.6 84.6 22.9 150.2 219.9 51.2 285.7 182.2 100.6 127.2 177.7 154.9 140.2 189.9 14.8 271.1 247.6 191.9 99.4 126.3 152.8 103.6 114.5 64.0 143.1 15.2 15.2 128.0 197.4 212.2 414.4 40.8 203.5 164.2 284.6 11.2 247.2 91.0 170.0 8.5 13.9 218.9 118.2 149.3 174.8 347.4 114.6 355.1 105.0 62.8 157.8 274.6 215.6 116.9 151.8 173.3 522.2 174.4 251.7 118.3 144.3 332.5 SPTBN5 "BSPECV, HUBSPECV, HUSPECV" ENSG00000137877 "Spectrin beta, non-erythrocytic 5" Q9NRC6 15 41848146-41894053 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 8.3;retina: 27.1" "Group enriched" "Detected in many" 22 "Cone photoreceptor cells: 210.6;Rod photoreceptor cells: 211.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 3.7;SCLC-21H: 5.1;TIME: 13.6;WM-115: 4.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "spinal cord: 3.6" HPA055283 Approved NA NA "HPA055283: " "unprognostic (5.46e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-2)" "unprognostic (5.84e-3)" "unprognostic (1.12e-1)" "unprognostic (6.84e-3)" "unprognostic (6.40e-3)" "unprognostic (2.25e-1)" "unprognostic (2.96e-2)" "unprognostic (6.92e-2)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.37e-2)" "unprognostic (1.11e-2)" 0.8 0.3 0.4 0.7 1.1 0.4 1.1 8.3 1.4 0.6 0.1 0.5 0.3 0.4 0.8 1.8 0.5 0.9 2.0 0.6 0.2 1.3 1.6 1.2 0.6 0.8 1.0 0.6 0.6 1.2 0.5 1.9 0.2 3.0 1.6 0.2 27.1 2.7 0.3 0.5 1.2 0.5 0.2 0.4 0.5 1.0 0.8 0.2 0.0 2.2 0.4 0.1 2.7 0.7 0.9 0.2 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.8 0.0 1.5 0.4 0.0 0.2 0.0 0.8 0.1 0.0 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.3 0.0 0.3 1.4 5.1 0.1 0.2 0.4 0.1 0.4 0.8 0.0 13.6 0.0 1.3 0.3 1.7 1.5 2.3 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 8.3 1.4 0.6 0.2 0.8 1.0 0.6 3.0 0.4 0.2 0.9 1.9 0.0 2.4 2.9 0.2 0.8 0.9 0.4 1.2 7.9 1.8 2.0 4.0 0.0 1.5 0.0 210.6 0.1 0.8 0.7 0.0 0.5 1.1 1.1 0.3 3.7 0.0 0.0 2.3 0.2 0.3 0.6 2.0 3.8 1.3 1.0 0.4 0.5 2.0 3.3 0.5 0.5 0.0 0.0 0.6 0.9 0.0 1.0 1.8 0.0 0.8 9.6 1.0 6.0 0.5 1.0 1.4 0.0 0.9 0.2 0.2 0.6 0.8 211.8 0.0 0.2 0.3 0.5 0.5 3.9 1.3 0.0 0.5 0.2 0.6 1.0 GCOM1 "FLJ30973, GRINL1A, MYZAP-POLR2M" ENSG00000137878 "GRINL1A complex locus 1" 15 57591908-57714745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 20.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 4.1;Granulosa cells: 5.7;Paneth cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.4;naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 49.0;RT4: 19.1;TIME: 20.4" "HPA039827, HPA068141" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039827: AB_10673364, HPA068141: AB_2685962" "unprognostic (1.10e-1)" "unprognostic (3.62e-4)" "unprognostic (1.10e-1)" "unprognostic (5.43e-3)" "unprognostic (1.31e-3)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (7.69e-4)" "unprognostic (1.22e-1)" "unprognostic (3.22e-3)" "unprognostic (3.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (7.44e-2)" "unprognostic (1.67e-1)" "unprognostic (5.78e-2)" 5.3 9.2 0.7 2.1 0.6 3.1 2.4 4.0 0.7 1.8 0.2 3.8 6.0 3.1 0.1 14.9 0.8 2.1 20.3 0.3 0.9 1.5 0.6 7.1 2.0 2.9 1.3 0.1 2.3 9.1 0.4 0.1 10.4 3.6 3.0 3.7 0.9 3.8 2.4 6.5 5.7 7.2 2.5 0.0 3.4 7.1 2.1 0.9 0.5 0.7 1.1 4.8 10.0 0.6 1.8 6.3 1.3 0.1 5.8 0.3 0.0 1.4 0.8 5.1 1.6 1.7 4.0 5.6 0.0 0.7 0.0 5.0 3.4 0.0 4.2 1.6 0.0 0.2 49.0 1.4 0.2 0.0 0.1 0.1 0.2 2.2 0.4 11.7 0.2 6.3 0.1 2.4 0.1 0.3 1.1 0.0 0.0 0.1 12.0 0.6 0.0 10.7 0.0 0.0 19.1 0.0 1.9 1.2 2.7 0.0 0.7 5.3 0.2 20.4 0.4 3.1 0.4 0.3 0.2 0.0 0.0 3.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.2 1.4 1.4 0.0 0.1 0.0 0.7 0.0 0.1 2.1 0.7 0.6 4.0 0.7 0.3 0.9 2.9 1.3 0.1 3.6 0.0 0.9 1.8 2.7 3.2 0.5 0.3 0.4 0.0 0.3 0.0 1.8 0.0 0.5 0.3 3.9 0.0 0.6 0.0 0.0 0.1 0.0 1.7 0.0 1.8 0.2 0.4 1.0 1.8 0.0 0.0 0.2 1.1 0.1 0.2 4.1 1.4 0.0 5.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.1 0.4 0.0 0.3 1.8 0.0 0.7 0.0 0.0 0.5 0.0 1.6 4.8 1.5 0.0 0.4 1.4 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.1 0.6 0.1 0.1 0.0 1.1 0.5 0.9 GCHFR "GFRP, HsT16933" ENSG00000137880 "GTP cyclohydrolase I feedback regulator" P30047 15 40764068-40767708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 352.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6" "Group enriched" "Detected in many" 5 "cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4" HPA046258 Enhanced Supported Nucleoplasm NA NA 170000 Nucleoplasm "HPA046258: AB_10967205" "unprognostic (2.50e-1)" "unprognostic (1.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.72e-2)" "unprognostic (9.89e-3)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "prognostic favorable (5.62e-4)" "unprognostic (4.63e-2)" "unprognostic (1.67e-1)" "unprognostic (3.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.03e-3)" "unprognostic (9.28e-3)" "unprognostic (2.91e-2)" "unprognostic (1.84e-1)" "unprognostic (2.55e-1)" 37.7 20.3 12.3 9.0 12.1 19.6 34.8 16.2 20.3 14.5 16.3 14.0 39.2 6.5 2.2 57.7 16.0 10.1 10.5 11.7 12.9 72.1 352.9 46.8 24.9 16.1 29.8 11.1 19.4 15.5 9.8 12.3 6.7 22.0 19.6 6.9 4.2 22.5 3.2 4.5 30.5 61.2 1.7 12.2 13.1 16.5 3.3 19.2 23.2 12.9 7.4 19.6 12.3 17.7 17.1 0.3 7.7 6.2 33.3 9.5 3.4 16.7 2.2 7.8 3.7 7.4 90.7 49.7 46.0 31.1 1.9 2.4 6.1 16.4 3.1 0.8 36.2 26.2 45.5 65.3 120.3 7.7 29.9 15.2 7.8 3.8 1.6 0.6 2.9 14.4 3.7 23.2 13.2 1.1 17.2 7.9 60.4 16.0 8.2 56.5 64.7 0.5 28.8 146.6 24.2 124.6 1.9 20.1 87.7 10.4 8.1 25.3 30.0 0.0 0.6 1.2 2.2 0.3 0.9 6.0 28.9 4.9 66.3 4.0 18.0 73.3 102.4 76.8 23.6 129.0 48.2 67.1 71.1 48.7 31.2 68.3 44.7 11.7 132.6 22.4 90.4 144.4 109.0 12.3 12.1 16.2 20.3 11.7 12.9 16.1 29.8 11.1 22.0 12.2 19.2 17.1 24.3 3.2 54.0 0.3 24.9 14.5 21.6 72.2 8.6 2.5 81.4 48.0 0.1 84.4 87.0 64.4 12.5 161.9 25.9 75.7 76.3 52.5 0.6 46.2 4.9 13.7 60.6 24.4 1.6 32.7 37.0 10.1 16.3 35.7 44.4 12.2 31.4 787.2 522.9 0.0 1.7 74.4 111.9 56.1 18.5 0.5 17.7 71.9 67.6 0.0 29.0 26.1 102.0 0.0 0.4 18.7 161.8 8.6 12.8 25.6 620.8 500.2 58.3 22.4 0.0 4.7 12.4 2.9 12.5 79.7 14.9 36.5 49.2 1.7 125.3 40.8 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3 adaptor protein, NSP family member" O75815 1 93561741-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 72.5;Basal prostatic cells: 149.0;Extravillous trophoblasts: 75.0;Urothelial cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.0;memory B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 159.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavorable (8.41e-4)" "prognostic unfavorable (5.42e-4)" "prognostic unfavorable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 31.3 10.7 16.4 6.7 18.4 1.0 18.7 19.2 15.4 10.0 18.3 15.4 13.6 5.8 3.7 8.2 9.6 7.6 12.3 13.7 19.9 16.1 12.0 14.3 13.9 20.4 17.1 11.7 11.5 4.2 4.0 4.6 17.1 17.6 9.0 16.7 1.5 22.1 9.6 24.6 15.4 13.0 8.1 17.5 4.8 16.4 6.3 21.1 4.3 10.5 21.3 13.1 13.8 9.9 17.1 56.0 23.4 43.5 3.4 18.4 14.4 37.1 56.9 98.3 45.9 28.1 4.0 40.9 9.0 18.9 88.1 59.4 34.0 1.3 73.5 39.7 4.0 1.3 0.0 16.2 10.3 33.1 0.4 0.2 17.3 79.5 47.5 159.7 44.1 51.1 1.1 1.6 0.3 125.7 8.6 1.0 0.2 13.6 24.5 79.7 3.7 62.7 1.3 120.4 70.1 1.5 3.6 27.4 29.1 36.1 16.8 32.9 2.2 60.8 67.3 17.5 29.2 76.0 4.5 2.1 1.2 10.1 0.2 25.2 2.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.3 1.6 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 16.4 18.4 19.2 15.4 13.7 19.9 20.4 17.1 11.7 17.6 17.5 21.1 17.1 26.9 3.2 7.2 72.5 10.2 9.8 149.0 11.3 2.8 0.9 7.9 13.5 7.1 11.5 11.7 14.7 0.0 27.5 2.5 30.8 27.4 11.3 11.3 13.3 2.6 17.9 14.9 0.4 5.2 6.3 75.0 6.3 15.8 16.6 3.8 33.7 5.7 10.3 11.9 21.9 11.2 20.7 8.2 5.3 12.7 12.8 10.2 8.3 19.6 64.6 9.4 4.0 0.0 3.0 2.1 28.0 22.0 1.2 8.9 36.3 25.8 23.7 18.1 0.4 72.3 23.8 19.9 4.2 3.7 4.8 10.2 18.9 3.7 8.3 10.3 106.1 TTLL7 FLJ23033 ENSG00000137941 "Tubulin tyrosine ligase like 7" Q6ZT98 1 83865024-83999150 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.6" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 1558.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 28.4;RH-30: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052249 Approved NA NA "HPA052249: AB_2681773" "unprognostic (9.68e-2)" "unprognostic (3.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.82e-2)" "unprognostic (6.56e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (1.95e-1)" "unprognostic (3.06e-1)" "unprognostic (3.63e-2)" "unprognostic (7.93e-4)" "unprognostic (4.34e-1)" "unprognostic (1.84e-3)" "unprognostic (3.32e-1)" "unprognostic (2.67e-2)" "unprognostic (3.77e-3)" "unprognostic (1.04e-3)" 4.2 1.5 14.8 1.3 30.9 0.0 1.4 13.0 27.9 2.3 0.0 3.3 1.7 4.5 1.4 3.2 5.9 4.1 2.6 15.1 18.3 0.8 1.1 3.1 0.1 20.7 21.6 11.2 1.3 4.4 1.4 7.8 0.0 27.2 5.5 2.2 8.3 2.7 2.7 3.5 0.7 1.8 7.5 10.1 0.4 3.7 5.0 18.3 0.1 1.6 1.7 0.2 5.4 2.5 56.6 3.4 0.2 2.5 4.5 2.1 5.0 0.0 7.1 2.8 2.5 4.7 0.0 0.5 0.0 2.1 6.6 10.2 0.1 5.0 2.5 3.8 28.4 3.6 4.1 5.5 0.1 1.1 0.2 0.5 1.5 0.2 3.9 0.1 7.4 2.8 0.1 0.0 10.3 10.3 0.0 0.0 0.0 2.0 0.0 3.5 0.0 22.1 0.0 0.4 1.8 13.9 8.9 3.8 2.2 2.3 4.6 3.1 0.2 0.4 3.8 1.5 0.6 7.7 3.5 6.6 0.2 5.2 0.0 5.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 30.9 13.0 27.9 15.1 18.3 20.7 21.6 11.2 27.2 10.1 18.3 56.6 3.9 67.3 7.5 12.4 3.9 3.2 18.8 2.1 0.6 138.6 6.9 4.8 16.8 17.2 7.7 7.3 73.0 0.7 0.9 1.8 1.9 18.2 211.6 36.3 6.8 6.1 27.6 0.0 230.3 7.6 0.2 14.2 10.2 1.7 25.3 2.7 3.9 2.4 0.5 95.9 216.6 5.3 4.1 0.3 7.7 38.6 10.8 2.6 17.8 16.9 0.6 19.1 2.1 113.6 1558.6 4.3 4.7 84.7 12.5 22.5 0.4 13.8 30.8 118.4 19.7 68.0 44.9 68.2 45.7 2.7 2.0 0.7 3.0 1.1 1.3 26.5 FNBP1L "C1orf39, FLJ20275, TOCA1" ENSG00000137942 "Formin binding protein 1 like" Q5T0N5 1 93448118-93554661 "Predicted intracellular proteins" "Autophagy, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065273 Approved Supported Cytosol NA NA Cytosol "HPA065273: AB_2685452" "unprognostic (1.83e-1)" "unprognostic (4.28e-2)" "unprognostic (2.57e-3)" "unprognostic (8.46e-2)" "unprognostic (7.68e-2)" "unprognostic (8.65e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (5.89e-2)" "unprognostic (1.74e-1)" "unprognostic (6.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic favorable (4.72e-7)" "unprognostic (3.59e-2)" "unprognostic (5.64e-2)" "unprognostic (2.74e-2)" "unprognostic (1.78e-1)" 28.5 7.8 14.0 5.4 22.9 2.1 33.3 14.1 13.9 18.2 12.9 17.4 20.8 16.9 18.8 9.0 13.5 14.6 18.3 12.4 15.6 36.4 13.4 17.0 3.1 15.1 15.2 12.1 14.1 17.5 21.0 10.5 17.3 16.4 15.8 17.6 12.5 43.4 11.6 17.5 12.5 20.3 12.4 14.8 2.8 23.9 15.2 14.1 6.6 32.1 21.6 4.0 15.0 13.4 13.5 29.7 16.2 83.4 46.8 17.6 12.4 92.8 14.6 9.9 10.8 15.0 19.9 9.2 0.1 29.4 14.3 29.0 14.9 20.3 16.7 15.4 18.5 15.2 15.8 23.5 29.9 8.8 2.8 0.3 23.0 27.2 10.2 14.8 28.2 52.1 18.1 6.2 0.1 25.8 13.8 11.6 1.2 63.7 50.5 16.4 24.4 63.7 7.8 47.5 44.6 32.6 47.0 45.4 88.0 25.8 97.3 33.5 4.0 52.1 25.2 31.7 0.6 10.2 9.1 7.5 0.2 2.5 0.4 17.5 7.3 0.1 0.7 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.0 1.5 0.2 0.1 14.0 22.9 14.1 13.9 12.4 15.6 15.1 15.2 12.1 16.4 14.8 14.1 13.5 130.0 109.0 42.1 48.0 4.3 26.5 61.5 27.5 18.2 13.3 62.9 59.1 42.6 40.0 60.9 62.5 4.2 37.6 2.2 35.4 56.7 77.9 12.1 61.1 30.0 49.8 67.0 36.6 41.0 48.4 35.7 20.5 50.0 91.7 16.4 19.6 25.0 21.0 11.8 69.0 110.8 33.0 14.2 4.7 22.7 19.7 8.1 10.6 39.2 80.6 7.1 18.8 0.0 55.3 4.2 55.8 34.5 3.8 1.0 56.0 43.6 50.8 53.8 10.0 26.3 5.9 49.9 23.4 37.2 22.0 25.7 17.1 4.1 10.2 38.4 75.6 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved "Nucleoli,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoli, Cytokinetic bridge" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favorable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favorable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 17.8 22.7 9.5 16.2 10.2 13.5 30.1 10.8 11.8 18.2 12.8 20.1 22.8 21.5 21.9 26.8 18.5 20.2 11.4 9.9 10.9 30.8 27.7 15.5 22.3 10.4 10.6 9.6 25.9 30.3 33.6 15.3 22.9 10.3 21.3 21.9 11.1 20.7 22.3 10.7 19.0 17.5 15.8 9.5 17.8 22.9 10.0 9.4 21.8 26.4 10.1 23.9 24.9 15.1 9.8 55.1 11.1 52.2 18.0 19.1 51.2 46.4 31.7 57.2 39.8 49.4 15.6 18.9 35.6 23.8 23.8 27.3 15.7 15.6 25.6 57.7 22.7 21.3 32.4 9.8 26.8 61.8 45.6 8.5 44.9 25.2 29.0 50.1 26.8 37.0 41.0 41.5 19.0 37.9 17.8 48.0 21.6 31.0 42.5 10.3 49.3 36.2 19.2 87.0 49.2 38.9 45.6 44.4 60.0 29.1 31.8 33.3 13.9 27.7 17.5 11.4 55.5 23.1 23.7 13.6 23.6 8.4 19.5 14.7 8.3 12.1 7.5 8.0 7.7 11.1 8.6 10.6 9.5 16.3 8.9 10.6 9.3 8.8 11.3 10.2 5.9 16.3 8.3 9.5 10.2 10.8 11.8 9.9 10.9 10.4 10.6 9.6 10.3 9.5 9.4 9.8 10.6 12.8 11.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 16.0 13.7 0.0 0.0 8.1 12.9 0.0 70.7 13.1 0.0 25.4 34.4 0.0 12.7 14.1 4.6 0.0 0.0 0.0 38.2 39.9 10.1 0.0 14.3 5.1 17.5 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 1.8 0.0 0.0 35.6 3.6 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 83.5 7.6 43.3 0.0 0.0 GTF2B TFIIB ENSG00000137947 "General transcription factor IIB" Q00403 1 88852633-88891944 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061626 Supported Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA061626: AB_2684570" "prognostic favorable (4.81e-4)" "unprognostic (5.21e-2)" "unprognostic (3.94e-3)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "unprognostic (2.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.37e-3)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (3.13e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.06e-3)" "unprognostic (3.74e-2)" 24.4 26.6 15.9 19.0 16.9 62.7 28.5 17.6 24.2 21.7 18.6 22.5 18.0 21.9 30.6 26.5 22.9 24.0 15.8 16.6 19.8 23.1 32.9 22.2 29.1 16.7 16.8 15.9 26.5 23.5 22.9 20.4 25.4 17.0 18.3 23.3 18.0 23.0 16.5 23.3 28.0 24.1 20.9 17.1 28.9 23.2 16.4 16.4 40.6 21.4 18.6 31.6 31.8 23.9 18.1 40.0 13.6 34.6 18.8 49.8 34.4 42.9 32.1 39.4 44.1 46.4 17.9 24.3 45.5 37.8 28.0 53.3 22.0 36.8 32.1 38.3 42.8 34.3 48.6 21.2 32.1 31.9 56.8 28.7 30.0 32.1 38.2 21.7 33.4 25.1 41.1 43.1 33.6 47.0 12.6 54.9 46.7 28.8 35.4 29.3 34.4 46.8 34.2 47.0 47.2 26.7 22.4 28.5 35.4 57.8 30.7 15.9 51.1 22.3 19.2 24.0 35.0 38.8 35.1 29.9 62.6 12.8 48.8 16.7 91.2 49.3 82.1 45.9 57.1 53.2 57.8 52.1 50.5 62.5 48.2 62.9 53.9 99.7 54.9 60.4 40.5 70.1 50.9 15.9 16.9 17.6 24.2 16.6 19.8 16.7 16.8 15.9 17.0 17.1 16.4 18.1 106.6 6.4 29.7 13.7 114.9 46.3 75.4 63.3 58.6 14.6 39.7 104.9 12.3 21.5 45.6 11.0 2.1 74.0 122.3 39.1 39.2 49.2 22.9 53.9 28.4 30.3 20.3 51.1 22.7 38.6 60.0 53.0 41.8 29.8 48.9 30.2 16.8 17.6 40.5 18.5 21.4 30.5 52.9 32.3 42.5 7.9 36.4 93.4 28.4 22.5 40.3 30.7 33.0 18.1 25.2 49.9 70.5 29.3 74.3 27.8 26.9 47.4 55.2 18.5 13.1 86.6 65.0 24.2 29.0 40.1 50.0 150.1 122.8 34.5 22.7 79.4 BRDT "BRD6, CT9" ENSG00000137948 "Bromodomain testis associated" Q58F21 1 91949343-92014426 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "testis: 132.6" "Group enriched" "Detected in some" 4 "Early spermatids: 1313.5;Spermatocytes: 561.9" "Cancer enriched" "Detected in some" 5 "testis cancer: 6.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 30 "BEWO: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB012237 Approved NA NA "CAB012237: AB_304756" "unprognostic (5.00e-2)" "unprognostic (2.86e-1)" "unprognostic (2.22e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (5.25e-2)" "unprognostic (2.53e-3)" "unprognostic (6.26e-2)" "unprognostic (1.97e-1)" "unprognostic (4.22e-13)" "unprognostic (2.70e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (2.00e-3)" 0.0 0.0 0.4 0.5 0.4 2.7 0.3 0.7 0.7 0.1 0.4 0.1 0.4 0.1 0.2 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.1 0.2 0.4 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.9 0.4 0.1 0.0 0.3 0.2 0.1 0.0 0.6 0.0 0.1 0.1 0.2 0.1 132.6 0.3 0.2 0.2 0.0 0.0 0.2 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.0 21.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.5 0.3 0.2 0.3 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.2 0.8 0.3 0.1 0.2 0.1 0.2 0.4 0.4 0.7 0.7 0.4 0.2 0.5 0.1 0.3 0.4 0.1 0.3 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.1 0.6 0.0 0.0 0.0 0.0 38.0 1.7 0.0 0.0 0.0 1313.5 0.0 0.0 1.8 0.0 0.0 1.2 0.0 22.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.9 0.0 0.0 0.0 0.0 228.7 7.8 0.8 0.0 0.0 0.0 0.0 1.0 1.0 0.3 0.0 0.0 6.8 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 2.3 561.9 19.9 0.0 0.0 19.4 1.1 0.1 0.0 0.1 RABGGTB ENSG00000137955 "Rab geranylgeranyltransferase subunit beta" P53611 1 75786197-75795086 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026585, HPA027167, HPA030793" Approved Supported Approved Vesicles NA NA Vesicles "HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: " "unprognostic (4.83e-2)" "unprognostic (3.04e-1)" "unprognostic (2.09e-2)" "unprognostic (2.45e-2)" "unprognostic (9.02e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (9.80e-5)" "unprognostic (9.62e-3)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (6.05e-2)" "unprognostic (1.56e-1)" "unprognostic (6.77e-2)" "unprognostic (3.89e-1)" 37.5 57.0 44.5 20.5 48.1 18.5 41.8 47.6 53.2 31.7 43.5 34.2 33.6 24.8 23.8 35.5 28.4 21.5 50.1 43.3 47.9 76.6 67.8 29.3 27.1 47.8 46.7 41.8 38.4 68.2 37.8 25.3 31.7 48.0 27.8 29.6 41.6 32.3 23.3 80.3 20.9 25.1 23.2 51.2 29.3 34.2 15.4 47.0 30.8 30.8 84.8 31.5 37.6 30.7 51.2 74.8 40.2 68.6 31.4 85.2 108.8 43.8 99.5 68.2 91.6 70.4 97.3 17.6 68.2 101.3 55.7 146.0 46.0 178.3 77.7 133.8 67.1 48.3 58.0 66.5 158.0 106.6 74.8 32.9 67.5 165.1 84.3 95.4 125.6 75.8 59.7 96.9 65.7 109.9 30.8 61.5 81.4 64.5 53.3 78.0 49.2 114.5 29.9 69.9 41.7 43.5 39.1 24.1 123.6 231.0 58.8 26.1 69.8 77.5 59.6 67.0 142.1 199.5 41.9 127.1 46.4 67.5 60.3 27.0 8.4 7.2 4.7 7.7 11.3 9.3 9.5 7.7 7.2 12.3 5.9 9.4 9.3 1.1 6.3 8.1 11.3 7.7 4.0 44.5 48.1 47.6 53.2 43.3 47.9 47.8 46.7 41.8 48.0 51.2 47.0 51.2 35.3 35.3 44.3 12.7 83.3 127.7 59.4 132.6 66.0 22.6 58.5 45.6 71.1 72.9 86.0 27.6 20.9 45.9 65.7 38.6 103.7 44.9 1.6 36.1 42.5 45.8 89.8 41.6 17.1 51.8 60.3 48.6 57.6 40.4 70.5 26.5 41.7 68.6 61.2 32.0 17.8 62.2 75.3 61.3 91.4 4.4 32.3 54.8 58.7 9.4 52.0 36.5 32.0 14.6 21.9 44.1 46.0 33.4 78.8 84.8 58.4 206.5 45.8 22.3 6.6 40.1 59.8 20.1 14.0 73.6 142.9 53.5 60.2 37.5 69.6 88.7 IFI44L "C1orf29, GS3686" ENSG00000137959 "Interferon induced protein 44 like" Q53G44 1 78619902-78646145 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 81.1" "Cell type enhanced" "Detected in many" "Adipocytes: 105.7;Endothelial cells: 78.2;Macrophages: 55.4;Microglial cells: 97.4;Peritubular cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 95.0;BJ hTERT+ SV40 Large T+ RasG12V: 108.8;GAMG: 74.4;HSkMC: 58.9;SK-MEL-30: 53.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA053247, HPA060372" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053247: AB_2682088, HPA060372: AB_2684267" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.99e-3)" "prognostic unfavorable (2.95e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.35e-1)" "unprognostic (4.52e-3)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (3.26e-2)" "unprognostic (3.33e-3)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (7.58e-2)" "unprognostic (1.10e-3)" "unprognostic (2.24e-1)" "unprognostic (9.03e-2)" 14.4 6.5 15.6 6.3 20.3 42.2 7.1 11.1 20.5 5.7 11.1 5.4 4.6 7.6 5.4 3.2 9.2 32.7 10.8 10.1 23.8 6.6 8.4 12.8 10.5 27.6 15.4 7.1 10.7 3.7 2.6 3.4 16.4 22.7 3.0 4.1 0.9 81.1 5.3 3.8 2.1 3.9 12.1 14.9 44.3 5.9 7.1 15.9 32.2 7.4 14.4 4.6 12.6 2.0 46.7 0.2 0.0 3.5 0.0 1.9 29.0 0.0 0.4 24.1 95.0 108.8 0.0 1.5 14.4 11.8 0.5 74.4 0.0 0.0 0.1 1.8 0.5 0.0 0.1 9.0 0.1 3.5 0.3 0.3 58.9 0.2 9.1 2.2 25.8 0.9 0.2 0.0 2.3 3.2 0.0 1.0 0.3 0.0 0.0 6.9 0.3 0.2 0.0 5.4 0.6 0.0 0.0 20.5 0.0 53.7 0.1 0.0 0.4 0.4 1.1 1.5 2.5 2.5 3.3 0.8 0.1 17.5 0.2 0.2 0.1 9.3 0.2 1.4 11.1 4.5 6.6 4.8 3.5 2.5 2.7 2.5 1.8 3.7 10.3 6.6 5.0 1.4 3.6 15.6 20.3 11.1 20.5 10.1 23.8 27.6 15.4 7.1 22.7 14.9 15.9 46.7 105.7 0.0 7.4 9.1 14.6 4.0 3.1 4.0 1.2 0.0 3.4 5.2 4.4 2.8 7.9 7.3 0.0 0.1 8.0 1.1 0.0 4.0 0.7 5.4 3.1 78.2 0.0 1.3 0.0 8.3 0.2 14.9 2.0 5.8 2.5 39.5 31.1 0.3 23.9 0.0 0.1 0.0 0.0 20.1 7.0 3.7 23.6 55.4 3.6 97.4 23.0 1.2 6.2 0.5 0.4 2.1 0.0 48.2 1.9 2.0 0.4 1.1 12.4 0.3 6.6 7.4 11.1 1.1 0.5 0.6 2.0 0.3 12.6 24.6 0.1 7.2 GIPC2 "FLJ20075, SEMCAP-2" ENSG00000137960 "GIPC PDZ domain containing family member 2" Q8TF65 1 77979542-78138444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.3;kidney: 41.8;lymphoid tissue: 28.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051212, HPA062684" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051212: , HPA062684: AB_2684833" "unprognostic (1.72e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.49e-4)" "unprognostic (1.09e-2)" "unprognostic (1.43e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.35e-1)" "unprognostic (7.63e-2)" "unprognostic (2.22e-1)" "unprognostic (5.91e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.11e-6)" "unprognostic (6.55e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-2)" "unprognostic (1.29e-1)" 3.9 24.0 0.5 1.7 0.4 0.3 3.1 0.4 0.9 1.8 1.0 15.8 38.3 2.1 0.9 2.1 3.1 5.6 1.5 0.4 0.5 41.8 18.5 2.7 0.8 0.4 0.4 0.4 2.4 18.3 2.3 0.9 3.5 0.4 1.7 15.0 0.1 4.2 0.9 1.1 4.7 38.3 2.8 0.4 28.1 6.0 1.0 0.4 0.4 1.0 1.7 0.8 2.0 1.9 0.4 0.0 0.0 0.0 0.1 2.4 6.1 0.0 1.0 0.0 0.5 1.1 5.1 3.3 1.5 0.1 0.5 0.0 6.0 0.0 0.0 3.2 0.2 0.0 0.8 0.0 23.0 1.2 0.0 0.0 1.0 0.1 3.5 0.1 0.0 23.5 0.0 0.0 0.1 2.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.9 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 33.6 0.0 1.3 2.0 2.0 12.9 2.4 0.9 4.0 0.4 5.2 1.5 3.2 27.1 2.5 9.2 2.1 6.7 0.0 43.7 33.2 11.8 2.5 13.3 0.9 21.6 3.0 0.4 14.7 33.0 3.1 2.9 8.6 7.2 0.0 5.9 22.9 43.3 13.2 0.0 15.2 34.4 0.0 0.8 1.9 1.2 1.2 2.1 0.0 14.0 1.0 0.0 0.0 4.5 8.9 16.5 39.3 0.0 0.0 0.8 122.1 267.7 11.7 0.5 0.0 1.3 1.3 0.6 2.5 7.9 21.7 1.6 1.3 32.4 63.8 6.0 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 12 "monocytes: 1.1" "Cell line enhanced" "Detected in many" "A-431: 118.8;hTERT-HME1: 100.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 30.2 3.7 7.9 2.8 5.2 0.1 30.6 20.7 8.1 8.6 7.8 7.7 2.1 7.5 5.4 4.5 10.3 6.6 17.2 4.6 5.6 21.4 17.0 27.4 4.9 6.8 6.9 4.0 10.3 7.4 6.6 6.3 17.6 11.4 11.3 3.2 15.0 12.2 7.1 11.7 13.2 6.5 5.6 6.0 21.9 10.5 5.9 7.8 3.0 23.0 12.8 2.8 8.1 9.3 7.6 118.8 4.8 7.0 0.1 26.7 57.5 24.5 38.6 62.9 31.0 45.1 13.7 5.4 0.0 85.2 76.5 36.3 24.8 0.2 27.4 63.9 0.1 4.1 0.4 6.6 7.6 2.7 0.0 0.0 11.7 5.4 23.7 100.9 36.4 88.0 0.1 0.0 0.0 32.1 4.7 2.2 0.1 9.0 0.6 82.1 1.4 5.6 0.0 82.7 10.8 0.1 1.5 24.1 20.5 2.0 26.5 5.6 0.4 84.2 20.0 26.2 29.7 32.3 0.1 0.1 0.2 3.7 0.0 0.9 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.9 5.2 20.7 8.1 4.6 5.6 6.8 6.9 4.0 11.4 6.0 7.8 7.6 440.8 51.3 18.4 26.4 2.9 23.5 239.2 31.7 4.6 16.0 87.3 46.1 26.0 31.5 39.6 130.6 18.8 29.5 2.0 0.9 54.8 83.5 94.1 36.9 11.4 298.6 0.0 3.2 11.3 17.2 102.6 63.6 20.9 106.2 3.8 13.8 177.1 56.1 3.0 92.5 24.1 1.0 6.1 13.6 17.9 24.4 24.5 6.2 26.6 208.9 2.5 94.2 0.0 2.0 3.5 55.7 0.1 21.8 0.1 593.9 0.1 78.1 12.5 81.2 190.7 58.2 127.8 80.3 116.5 1.7 17.2 14.1 4.1 11.1 1.6 146.9 IFI44 "MTAP44, p44, TLDC5" ENSG00000137965 "Interferon induced protein 44" Q8TCB0 1 78649796-78664078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 101.8" "Cell type enhanced" "Detected in many" "Adipocytes: 54.6;Endothelial cells: 54.5;Microglial cells: 53.4;Oligodendrocyte precursor cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 176.5;BJ hTERT+ SV40 Large T+ RasG12V: 216.2;GAMG: 177.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA027148, HPA043858" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027148: AB_1851411, HPA043858: AB_2678702" "unprognostic (1.20e-1)" "unprognostic (6.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.13e-3)" "unprognostic (1.63e-1)" "unprognostic (8.81e-2)" "unprognostic (5.52e-2)" "unprognostic (8.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.37e-8)" "unprognostic (1.71e-1)" "unprognostic (2.07e-3)" "unprognostic (8.89e-2)" "unprognostic (4.90e-2)" 18.4 16.9 22.0 25.5 22.6 101.8 16.7 19.5 33.3 12.9 20.7 9.7 20.1 15.5 35.2 10.9 12.2 45.8 17.9 19.3 24.3 21.4 21.1 31.1 20.2 25.4 20.0 18.1 14.1 8.9 3.8 14.3 21.6 23.8 9.7 9.4 1.3 72.2 11.5 5.9 10.4 14.6 18.6 22.0 65.6 21.2 7.6 21.4 31.3 16.7 11.0 11.7 21.2 9.7 28.4 7.7 0.3 1.3 0.3 5.3 35.9 0.2 5.0 65.5 176.5 216.2 0.0 22.0 10.3 49.9 4.7 177.9 4.1 0.0 2.9 28.6 22.5 0.0 26.8 20.6 0.0 7.3 0.0 0.0 22.7 0.3 76.8 1.0 13.8 33.5 6.7 0.0 35.1 42.5 0.2 22.7 1.9 0.0 0.1 14.4 17.4 53.6 1.2 5.2 5.0 0.6 1.4 1.8 0.5 82.9 0.0 0.0 1.1 41.6 32.3 13.4 3.6 33.9 3.0 3.8 0.3 50.1 30.4 9.2 0.4 15.4 0.1 6.9 15.4 13.8 2.4 10.0 6.6 7.1 1.7 4.2 5.6 4.5 7.8 8.4 2.0 5.1 6.0 22.0 22.6 19.5 33.3 19.3 24.3 25.4 20.0 18.1 23.8 22.0 21.4 28.4 54.6 28.9 16.2 10.7 4.7 3.6 10.2 16.3 5.7 0.0 4.6 5.2 5.4 2.8 21.0 9.2 0.0 0.2 9.9 1.1 0.0 13.1 0.6 6.7 4.4 54.5 6.7 4.6 0.0 12.3 0.3 15.8 11.7 7.0 18.3 25.1 43.5 3.6 29.5 0.0 2.1 1.7 6.1 34.2 7.6 1.1 13.4 38.1 5.4 53.4 27.8 0.6 5.2 51.8 0.5 11.8 0.1 17.3 3.2 5.1 3.8 2.7 20.7 0.3 19.7 12.3 12.4 0.3 0.5 4.4 4.5 0.0 22.4 24.8 2.5 14.0 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Group enriched" "Detected in many" 4 "Excitatory neurons: 274.5;Inhibitory neurons: 563.3;Oligodendrocyte precursor cells: 265.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 7.7;RPTEC TERT1: 7.4;SH-SY5Y: 11.5;SuSa: 11.7;TIME: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 0.2 0.7 1.8 0.5 2.2 0.3 5.6 0.1 3.3 0.7 0.1 2.1 1.2 0.7 0.4 6.6 3.6 1.0 2.6 2.5 3.2 1.9 1.0 0.6 0.5 2.6 1.8 2.0 1.1 1.8 3.8 3.2 3.8 3.1 0.8 2.8 2.6 1.4 0.2 1.6 10.8 1.4 0.2 1.2 0.8 1.5 4.5 2.8 2.6 0.7 1.6 2.1 1.6 2.0 2.7 0.2 0.2 4.6 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.7 0.6 1.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.4 2.7 2.7 0.0 0.0 1.9 0.0 4.7 3.2 0.6 0.0 0.0 2.3 7.4 5.2 1.1 11.5 0.0 4.8 0.0 11.7 0.2 0.0 14.7 0.4 1.3 0.0 1.5 2.1 2.1 3.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 2.2 0.1 3.3 2.5 3.2 2.6 1.8 2.0 3.1 1.2 2.8 2.7 0.1 0.0 1.1 12.4 0.4 1.9 1.0 0.4 0.0 4.0 2.9 1.7 0.8 0.0 1.0 0.0 0.0 9.1 0.0 2.0 0.0 0.1 86.9 1.0 0.1 0.6 2.4 0.0 274.5 0.9 3.9 0.4 0.0 0.3 0.0 20.1 7.5 0.0 1.1 0.0 563.3 1.0 0.0 0.0 0.2 35.2 0.9 0.1 0.0 6.5 0.0 0.0 0.0 265.4 10.1 0.2 0.2 0.0 0.1 1.1 0.0 0.1 2.5 0.8 0.0 0.6 0.2 0.4 0.4 0.9 6.7 3.8 0.1 0.5 1.2 3.6 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424171-86456553 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 118.6;skin 1: 89.4;vagina: 53.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 146.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 210.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 96000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.8 0.1 0.3 0.1 0.6 0.0 4.7 0.4 0.4 11.0 0.2 0.6 0.2 0.0 0.5 118.6 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.1 0.7 0.4 2.4 0.7 0.0 13.3 0.2 0.2 89.4 0.8 0.0 0.4 0.0 0.1 0.7 0.4 1.0 0.0 0.0 26.2 21.4 53.5 1.1 0.0 0.0 0.0 0.0 0.6 3.0 38.9 1.7 2.7 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 0.0 33.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 210.8 1.0 10.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.9 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.4 0.4 0.2 0.4 0.4 0.4 0.2 0.4 0.4 0.4 1.1 0.0 0.0 0.0 0.7 0.0 47.4 13.1 57.5 39.9 0.0 7.7 2.8 0.4 0.0 37.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.3 4.1 0.0 3.1 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 2.5 2.1 0.3 0.0 8.0 0.0 0.0 0.0 0.6 0.2 0.0 167.1 54.8 0.1 0.5 0.0 0.1 52.9 DNASE2B DLAD ENSG00000137976 "Deoxyribonuclease 2 beta" Q8WZ79 1 84398484-84415018 "Enzymes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "salivary gland: 171.8" "Cell type enhanced" "Detected in some" "Early spermatids: 1.9;Hofbauer cells: 5.8;Kupffer cells: 1.6;Late spermatids: 3.1;Macrophages: 4.2;Paneth cells: 1.7;Prostatic glandular cells: 2.0" "Group enriched" "Detected in some" 5 "melanoma: 2.8;prostate cancer: 9.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.24e-1)" "unprognostic (3.57e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-1)" "unprognostic (2.86e-1)" "unprognostic (1.62e-2)" "unprognostic (9.87e-2)" "unprognostic (7.90e-2)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (3.82e-5)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" 0.4 0.1 0.3 0.0 0.6 0.0 0.4 0.3 1.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.8 0.0 0.3 2.4 0.7 0.7 0.5 0.4 0.1 0.8 0.0 0.3 0.0 0.6 6.8 0.5 0.0 171.8 0.0 1.6 0.0 0.1 0.0 0.4 0.4 0.8 0.4 0.4 0.2 0.1 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 1.0 0.4 0.8 0.7 0.5 0.4 0.6 0.4 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 5.8 0.0 0.4 0.1 0.0 1.6 0.0 3.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.7 0.0 0.1 2.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 DBT "BCKAD-E2, BCKDH-E2, BCOADC-E2" ENSG00000137992 "Dihydrolipoamide branched chain transacylase E2" P11182 1 100186919-100249834 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026481, HPA026485, HPA026533" Enhanced Supported Mitochondria NA NA Mitochondria "HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" "unprognostic (3.67e-2)" "unprognostic (5.29e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "unprognostic (3.88e-2)" "unprognostic (1.65e-2)" "unprognostic (6.01e-2)" "unprognostic (1.21e-1)" "unprognostic (2.37e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.79e-12)" "unprognostic (1.63e-1)" "unprognostic (3.77e-1)" "unprognostic (9.67e-2)" "unprognostic (9.92e-2)" 11.2 13.8 4.3 5.9 5.3 4.7 11.9 4.2 4.8 11.4 3.6 9.3 8.1 8.3 6.1 13.0 11.2 6.4 26.1 4.1 4.7 30.6 43.7 7.5 7.6 4.9 4.9 3.6 11.2 15.5 19.5 2.3 10.1 4.6 16.0 10.3 6.0 12.9 11.3 13.5 7.5 7.2 8.1 4.3 6.2 17.5 4.7 4.8 9.9 17.4 19.4 9.0 9.5 4.0 7.1 18.5 8.2 9.5 17.4 23.9 17.6 20.6 13.1 12.3 13.9 15.6 17.7 7.4 17.1 18.3 9.3 8.1 18.7 20.3 17.7 16.8 18.2 11.5 12.1 16.3 9.5 18.0 16.1 6.1 18.2 18.1 10.6 17.9 11.4 12.4 17.9 20.9 19.2 11.1 4.9 14.4 4.1 18.6 14.8 18.4 14.1 30.3 14.2 15.3 15.9 15.8 8.7 27.5 25.4 23.7 16.7 20.9 11.9 10.8 12.1 7.6 15.9 11.0 12.7 14.1 9.1 13.8 10.7 5.3 2.1 1.2 0.8 2.2 1.5 2.4 1.9 2.0 1.9 1.2 2.1 1.8 1.9 1.1 2.0 1.4 1.3 1.5 1.1 4.3 5.3 4.2 4.8 4.1 4.7 4.9 4.9 3.6 4.6 4.3 4.8 7.1 9.6 22.4 36.4 29.0 9.6 6.8 6.5 9.8 13.6 22.2 11.9 8.5 65.9 18.6 11.3 12.9 39.6 19.8 10.9 11.4 50.9 10.0 0.8 18.5 20.5 11.7 9.1 8.2 24.0 8.5 11.6 11.3 15.8 15.4 2.5 19.6 15.4 53.2 8.7 15.2 25.2 12.0 14.2 8.8 5.0 1.7 15.2 7.3 3.6 3.7 10.3 14.5 12.3 22.1 26.1 6.4 6.0 21.1 7.1 9.4 9.9 32.1 18.0 22.4 6.6 15.0 12.9 2.8 6.1 18.7 7.2 8.2 9.7 17.3 15.1 5.5 RTCA "RPC, RTC1, RTCD1" ENSG00000137996 "RNA 3'-terminal phosphate cyclase" O00442 1 100266216-100292769 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027982, HPA027990, HPA028151, HPA028331" Uncertain Enhanced Nucleoplasm NA NA 38000 Nucleoplasm "HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: " "unprognostic (4.79e-2)" "unprognostic (1.17e-2)" "unprognostic (3.97e-2)" "unprognostic (3.82e-2)" "unprognostic (6.76e-2)" "unprognostic (4.12e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (9.55e-3)" "unprognostic (3.64e-2)" "unprognostic (1.12e-2)" "unprognostic (2.46e-1)" "unprognostic (8.09e-3)" "unprognostic (3.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (2.94e-2)" 21.9 21.0 14.5 20.6 16.3 32.2 17.3 16.0 17.5 13.2 17.1 22.4 34.9 13.0 26.8 24.0 12.8 16.9 28.7 16.3 16.2 34.8 22.6 15.9 26.5 16.3 15.6 15.9 11.1 24.3 23.9 14.4 23.4 17.3 21.8 23.5 22.5 18.8 14.7 39.6 15.9 31.9 15.6 16.0 21.9 24.1 12.7 15.7 19.4 18.2 35.7 23.6 18.7 15.8 17.7 56.8 28.6 27.8 37.4 34.5 55.4 75.7 65.7 32.0 41.9 35.9 47.0 27.7 57.6 48.4 42.0 51.4 28.0 34.3 31.1 50.2 57.8 28.5 38.0 32.8 59.9 52.9 70.2 57.3 45.5 48.0 54.9 72.5 41.3 52.9 41.1 66.6 84.7 64.1 18.6 36.4 54.3 42.7 40.0 54.8 25.7 49.6 25.5 51.7 45.5 22.2 27.6 42.3 60.5 93.3 43.3 13.2 88.5 45.7 39.2 27.5 62.0 80.1 48.7 51.9 46.3 82.5 60.0 23.7 11.8 10.9 9.4 11.8 14.4 15.5 10.6 11.1 14.2 9.6 9.0 10.2 11.6 5.3 13.5 26.1 9.3 24.7 9.3 14.5 16.3 16.0 17.5 16.3 16.2 16.3 15.6 15.9 17.3 16.0 15.7 17.7 20.5 6.4 16.2 15.0 27.1 13.6 13.7 23.2 17.6 24.2 19.8 14.0 52.8 11.5 20.4 18.4 12.5 56.7 30.9 30.5 25.4 42.1 19.3 23.0 17.2 20.7 19.2 25.0 20.7 34.5 85.9 18.8 18.8 24.0 13.3 19.8 21.0 17.4 80.9 21.9 22.2 26.2 20.3 48.8 14.5 9.0 19.3 29.5 16.0 21.5 46.2 25.5 25.7 21.1 33.5 57.3 31.9 12.8 36.0 16.1 79.4 73.9 21.0 29.7 6.6 14.3 20.2 43.0 23.2 21.7 14.6 46.4 32.1 25.7 33.0 20.2 IFT172 "BBS20, NPHP17, osm-1, SLB, wim" ENSG00000138002 "Intraflagellar transport 172" Q9UG01 2 27444377-27489805 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 439.9;Late spermatids: 703.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044893 Uncertain NA NA "HPA044893: AB_10795009" "unprognostic (1.05e-3)" "unprognostic (6.52e-2)" "unprognostic (7.04e-2)" "unprognostic (3.57e-3)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.05e-6)" "unprognostic (6.86e-3)" "unprognostic (1.45e-1)" "unprognostic (8.49e-2)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (4.32e-2)" "unprognostic (9.52e-2)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (5.47e-2)" 3.1 3.4 2.7 2.5 2.7 1.8 4.1 2.8 2.5 5.2 9.9 3.8 1.8 4.5 1.6 2.4 17.1 3.2 4.3 2.1 4.8 4.5 1.5 5.0 2.1 3.7 2.7 1.7 9.0 4.9 13.1 10.0 2.4 3.4 3.6 2.1 5.7 4.2 4.2 3.6 2.9 2.7 3.8 2.6 4.0 3.5 12.7 2.5 2.7 5.9 3.9 2.1 3.7 3.4 3.8 5.8 5.3 7.1 10.0 12.6 10.6 4.5 5.5 4.0 6.5 5.5 4.8 4.6 6.3 8.3 7.3 3.9 6.4 13.4 6.7 6.2 3.1 9.4 16.1 9.4 5.6 7.3 7.8 3.4 8.6 3.0 10.3 3.8 9.0 10.8 7.3 5.3 2.2 2.4 4.5 4.4 3.8 5.0 4.6 5.5 0.0 3.7 3.5 5.0 3.7 5.5 8.8 2.8 4.8 9.7 6.0 4.8 4.6 11.6 2.9 1.7 3.7 8.3 2.8 1.7 6.7 11.9 2.3 5.7 0.0 0.4 0.3 0.4 0.6 0.3 0.7 0.2 0.4 0.9 0.5 0.3 0.3 0.0 0.9 0.1 0.4 0.2 0.4 2.7 2.7 2.8 2.5 2.1 4.8 3.7 2.7 1.7 3.4 2.6 2.5 3.8 5.2 3.2 9.4 53.5 3.1 2.0 16.6 35.3 8.6 15.4 17.2 12.1 6.3 38.6 32.7 23.9 52.1 1.0 1.7 82.4 0.0 34.4 439.9 59.0 7.1 4.5 34.7 7.6 63.2 98.7 0.6 5.9 23.9 14.2 0.0 11.0 5.7 1.2 1.7 5.0 64.3 96.4 57.0 3.2 1.6 703.6 12.8 2.8 5.4 11.2 1.9 7.1 5.2 24.6 44.9 104.9 106.3 10.9 2.4 7.5 142.0 2.3 154.6 41.7 0.0 11.7 8.5 22.6 6.6 10.1 1.4 0.4 2.8 10.1 75.1 39.8 SELENOI "EPT1, KIAA1724, SELI, SEPI" ENSG00000138018 "Selenoprotein I" Q9C0D9 2 26308547-26395891 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 22.0;Endometrial ciliated cells: 16.3;Glandular and luminal cells: 15.3;Pancreatic endocrine cells: 13.6;Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064125 Approved NA NA "HPA064125: " "unprognostic (6.29e-2)" "unprognostic (7.46e-2)" "unprognostic (1.38e-3)" "unprognostic (3.05e-3)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "unprognostic (7.44e-3)" "unprognostic (5.00e-3)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.65e-2)" "unprognostic (9.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.95e-1)" "unprognostic (1.76e-1)" "unprognostic (9.87e-3)" "unprognostic (1.42e-2)" 3.6 6.5 7.1 5.6 9.3 12.2 8.2 12.0 11.1 4.7 5.1 8.7 12.4 4.1 5.5 11.1 3.5 4.0 3.9 10.0 9.0 8.0 23.4 4.5 5.7 7.9 8.8 9.4 3.6 9.0 17.3 4.6 4.8 9.2 6.3 8.8 9.4 6.3 4.2 7.1 18.4 18.5 3.7 8.1 4.4 7.2 4.4 9.2 6.4 7.2 6.6 6.1 7.5 7.2 14.6 42.7 25.7 20.9 21.0 12.8 10.2 32.0 20.3 9.2 10.0 10.2 54.5 26.6 49.5 24.2 9.5 21.4 34.1 32.4 17.9 14.4 13.7 15.4 31.3 17.5 32.3 12.2 41.9 9.7 8.1 15.6 22.3 21.9 6.1 9.4 17.6 35.9 16.6 13.5 18.4 25.1 20.7 26.8 21.6 17.4 22.6 49.2 25.0 19.3 32.4 45.7 19.4 17.3 36.2 16.4 17.3 17.4 12.4 15.1 17.1 22.0 22.7 31.7 22.6 60.8 65.8 17.5 25.4 15.6 0.0 0.7 0.0 0.9 1.0 0.9 2.5 0.9 1.2 0.7 1.0 1.2 2.0 0.2 0.9 0.9 1.3 1.8 0.4 7.1 9.3 12.0 11.1 10.0 9.0 7.9 8.8 9.4 9.2 8.1 9.2 14.6 9.1 12.8 8.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 12.2 7.1 0.0 0.0 3.1 22.0 0.0 6.1 11.7 0.0 0.0 10.4 0.0 16.3 12.8 3.7 0.0 0.0 0.0 10.4 6.2 2.9 0.0 15.3 1.3 8.6 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.6 0.0 0.0 3.9 0.0 0.0 5.6 2.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 16.6 4.7 11.5 0.0 0.0 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119128 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2;salivary gland: 25.5" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 40.1;SK-BR-3: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 700000 "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 4.3 2.3 20.3 1.0 20.3 1.9 6.4 16.7 28.2 3.1 2.5 2.6 4.0 11.7 1.4 3.6 12.5 3.9 3.0 27.2 17.4 3.7 15.0 1.1 0.5 12.5 12.5 22.2 14.0 2.1 0.2 3.3 0.3 16.5 4.2 3.8 3.7 25.5 0.9 6.5 2.2 5.7 5.4 7.7 0.6 11.5 3.9 14.9 0.2 1.8 6.9 0.4 3.8 1.5 16.2 7.6 6.3 0.3 8.1 18.3 6.8 0.7 9.1 0.0 0.8 0.4 1.7 6.2 0.1 2.4 18.2 2.2 0.4 1.4 2.1 0.5 0.7 3.7 0.1 10.4 16.4 16.9 5.3 0.6 4.7 18.1 2.6 2.1 11.6 0.7 1.3 0.2 0.4 1.2 24.0 4.0 6.8 2.1 40.1 16.8 0.3 0.0 0.6 0.1 0.3 17.8 26.6 17.7 78.7 9.4 0.2 25.3 13.3 0.0 0.0 6.9 0.0 0.7 2.3 0.8 0.7 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 20.3 16.7 28.2 27.2 17.4 12.5 12.5 22.2 16.5 7.7 14.9 16.2 0.1 0.0 0.0 2.6 0.4 0.6 0.2 0.0 1.8 9.2 9.2 12.6 1.4 0.0 0.0 0.0 4.2 0.0 0.1 0.2 0.0 0.1 1.1 0.3 3.0 0.4 0.0 5.5 16.6 1.5 0.2 3.8 4.6 0.1 0.0 0.4 3.6 5.0 0.4 0.0 15.9 6.8 0.0 0.6 0.7 3.1 4.4 0.2 0.0 1.9 0.0 0.5 0.0 12.5 0.8 2.1 0.0 8.6 1.1 1.8 3.4 4.4 0.0 2.2 0.0 1.7 0.7 3.2 16.2 2.2 0.4 0.1 0.1 3.2 0.9 0.1 HADHB MTPB ENSG00000138029 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta" P55084 2 26243170-26290465 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 958.4;tongue: 1106.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1167.5;Distal tubular cells: 520.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037539, HPA037540, HPA066099" Enhanced Supported Mitochondria No No 61000 Mitochondria "HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618" "unprognostic (5.15e-2)" "unprognostic (8.72e-2)" "unprognostic (8.21e-2)" "unprognostic (8.67e-2)" "unprognostic (7.70e-2)" "unprognostic (2.59e-2)" "unprognostic (7.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (2.03e-1)" "unprognostic (8.94e-2)" "prognostic favorable (1.37e-9)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (2.88e-1)" "unprognostic (9.68e-2)" 128.1 226.5 118.8 51.6 131.9 59.4 92.1 145.4 139.4 65.8 123.6 111.8 226.3 56.5 74.3 102.2 69.4 64.9 625.0 107.8 134.5 233.5 327.5 65.2 55.3 137.8 139.4 101.8 79.1 84.4 211.4 48.5 66.2 137.6 77.8 114.3 63.5 105.8 75.7 958.4 73.6 185.9 79.6 139.6 76.4 109.8 67.7 136.3 53.6 91.6 1106.8 63.0 90.1 64.6 153.1 108.2 83.2 56.6 102.2 342.1 190.1 57.9 89.0 134.6 89.0 86.8 100.5 101.7 53.9 60.8 145.3 100.1 82.8 95.2 124.8 109.2 121.1 83.1 123.6 44.9 194.2 145.9 100.6 90.0 183.7 201.6 92.7 149.0 151.0 168.2 81.0 105.2 83.9 189.5 78.0 57.1 190.7 39.8 160.2 89.0 61.7 188.3 103.2 183.3 148.9 27.2 93.7 151.7 169.8 239.5 68.5 105.4 177.9 118.0 83.5 86.9 79.3 65.1 62.6 101.1 94.7 95.5 158.4 84.4 95.7 168.1 66.4 45.2 150.3 57.6 65.5 61.3 56.6 154.2 49.7 55.8 51.3 72.7 88.2 123.3 51.8 94.7 135.6 118.8 131.9 145.4 139.4 107.8 134.5 137.8 139.4 101.8 137.6 139.6 136.3 153.1 106.5 48.1 36.5 63.0 48.3 62.1 136.5 183.3 49.5 29.3 49.5 52.3 1167.5 104.4 107.7 97.5 56.3 227.9 42.4 129.5 520.4 124.0 93.4 59.5 49.0 75.2 74.9 85.2 32.7 57.2 75.2 79.5 53.0 60.2 62.8 94.2 69.9 277.6 139.6 13.5 33.0 93.4 114.0 98.1 67.4 99.7 56.5 78.1 88.9 27.2 110.2 65.0 32.0 35.2 47.5 58.4 134.8 62.8 37.1 60.5 376.0 321.1 73.5 80.0 72.3 72.9 80.7 120.4 49.4 53.8 54.7 186.6 45.2 194.0 113.5 110.3 KHK ENSG00000138030 Ketohexokinase P50053 2 27086747-27100762 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "intestine: 122.2;kidney: 105.4;liver: 182.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7" "Group enriched" "Detected in all" 7 "liver cancer: 62.2;renal cancer: 32.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 32.8;Hep G2: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007040 Enhanced Approved Vesicles,Cytosol NA NA 620000 Cytosol Vesicles "HPA007040: AB_1079185" "unprognostic (8.44e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.62e-8)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "unprognostic (3.08e-2)" "unprognostic (3.13e-2)" "unprognostic (1.67e-2)" "unprognostic (2.50e-2)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (1.68e-2)" "unprognostic (2.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.44e-1)" "unprognostic (1.02e-2)" 2.2 4.6 3.8 3.1 4.0 1.7 2.0 6.9 5.9 2.5 1.1 4.2 113.4 3.8 0.7 2.4 4.3 1.3 1.4 4.6 4.0 105.4 182.0 1.6 1.9 5.0 3.8 4.3 3.7 9.5 2.6 1.4 0.6 5.3 1.6 1.2 1.5 4.4 1.4 3.9 2.4 122.2 1.9 3.4 2.0 2.9 3.2 3.8 0.7 1.1 2.0 1.2 1.8 2.4 4.6 25.0 18.5 2.8 11.0 2.0 0.5 2.5 1.7 1.1 2.3 1.4 9.0 5.3 3.7 5.8 0.1 2.6 10.7 9.4 3.1 0.8 8.8 17.2 32.8 5.2 48.0 1.1 4.6 3.7 0.1 1.3 2.7 0.2 1.2 2.1 5.1 5.9 6.1 0.2 16.0 5.4 3.6 4.0 22.3 7.2 18.9 1.4 20.9 2.7 3.0 10.2 15.8 3.6 6.2 6.9 1.0 2.7 2.0 1.9 0.7 3.6 1.6 6.5 7.5 14.4 6.3 3.0 10.7 1.8 0.0 5.4 0.3 4.1 3.1 5.5 3.8 6.6 6.0 4.9 3.6 4.7 5.8 0.5 4.9 1.4 6.1 4.7 4.9 3.8 4.0 6.9 5.9 4.6 4.0 5.0 3.8 4.3 5.3 3.4 3.8 4.6 6.5 3.2 3.7 1.6 6.8 3.6 2.6 0.8 6.8 3.6 4.7 5.8 1.8 20.0 1.0 40.5 2.1 4.1 1.3 7.4 129.1 3.2 1.2 0.1 0.6 5.5 6.0 15.6 3.4 3.0 3.6 2.4 3.6 0.3 4.5 2.9 9.7 428.5 8.3 6.7 2.7 89.6 4.1 11.9 2.0 6.2 1.8 10.8 8.8 0.0 1.9 9.8 4.1 2.5 2.3 2.1 95.7 1.5 8.0 0.7 1858.7 1019.7 0.0 5.4 0.0 5.0 5.0 1.1 5.8 4.6 6.8 9.4 6.8 0.8 82.6 2.2 ADCY3 AC3 ENSG00000138031 "Adenylate cyclase 3" O60266 2 24819169-24920237 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis, Olfaction, Sensory transduction" "Calmodulin-binding, Lyase" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 58.4;Sertoli cells: 111.7;Smooth muscle cells: 62.8;Theca cells: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010223 Approved NA NA "CAB010223: AB_630839" "unprognostic (3.05e-1)" "unprognostic (1.10e-1)" "unprognostic (4.91e-2)" "unprognostic (1.39e-3)" "unprognostic (5.01e-2)" "unprognostic (7.66e-2)" "unprognostic (1.28e-1)" "unprognostic (6.06e-2)" "unprognostic (8.43e-2)" "unprognostic (6.89e-2)" "unprognostic (8.22e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (1.32e-9)" "unprognostic (3.74e-2)" "unprognostic (5.56e-2)" "unprognostic (1.11e-1)" "unprognostic (8.55e-3)" 90.4 17.4 43.4 17.5 50.6 17.9 75.2 35.6 50.4 65.3 30.5 26.3 11.0 56.9 20.6 30.6 62.7 23.2 34.2 42.9 40.4 21.7 6.7 42.9 19.1 41.3 44.3 43.1 72.6 15.9 17.2 42.0 84.3 44.1 41.0 16.0 4.2 21.8 33.3 15.3 36.9 34.6 35.6 35.8 30.7 25.2 9.9 48.4 11.5 37.1 20.6 18.3 36.7 49.3 45.1 76.5 40.4 17.2 28.3 84.5 75.4 29.6 32.3 65.9 37.1 37.8 38.6 25.1 26.0 6.2 53.2 51.0 54.5 43.1 54.5 24.0 58.4 55.8 43.0 40.0 1.7 64.0 24.0 24.6 55.7 47.5 36.6 50.8 23.6 33.8 27.9 15.5 49.2 19.3 43.6 17.9 2.1 14.9 39.9 24.4 38.8 75.3 59.5 15.5 38.7 31.6 19.1 45.8 54.2 30.2 13.0 13.5 22.5 33.5 59.7 34.2 39.1 54.1 42.4 101.6 113.6 18.7 39.2 31.4 2.6 1.5 0.0 0.4 1.6 0.3 5.5 0.9 0.5 9.5 6.0 0.7 0.5 0.0 1.2 0.4 9.0 3.4 1.0 43.4 50.6 35.6 50.4 42.9 40.4 41.3 44.3 43.1 44.1 35.8 48.4 45.1 14.6 0.0 1.8 17.0 8.2 11.0 4.2 4.1 5.2 3.0 18.6 8.0 2.8 0.0 1.3 1.8 0.0 1.0 5.2 5.0 0.0 0.9 0.3 1.9 42.2 10.6 1.2 5.2 40.1 0.0 2.1 25.5 2.0 2.2 18.4 3.7 5.0 0.3 12.6 0.0 36.8 6.0 2.0 5.4 6.9 3.9 58.4 10.1 7.2 21.5 4.0 1.6 0.0 15.1 33.2 1.0 5.8 29.3 4.9 11.2 8.3 0.2 1.1 2.2 111.7 6.5 62.8 0.4 2.4 4.4 11.8 1.2 7.2 92.9 12.1 3.9 PPM1B "PP2CB, PP2CBETA, PPC2BETAX" ENSG00000138032 "Protein phosphatase, Mg2+/Mn2+ dependent 1B" O75688 2 44167969-44244384 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 218.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016745 Approved Approved Nucleoli,Cytosol NA NA 75000 "Nucleoli, Cytosol" "HPA016745: AB_1855622" "unprognostic (5.49e-2)" "unprognostic (2.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.96e-3)" "unprognostic (1.92e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-2)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (2.25e-1)" "unprognostic (6.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (1.75e-2)" 40.6 20.6 49.3 19.7 55.0 44.4 24.1 53.1 57.8 23.1 49.8 28.9 20.5 24.1 30.3 22.7 21.4 22.0 33.6 46.4 50.1 29.3 44.4 22.0 28.9 49.0 52.2 46.2 23.1 32.7 36.0 19.0 19.0 51.6 30.9 29.0 50.3 27.2 23.5 130.4 20.4 21.9 23.0 48.5 26.6 23.3 21.6 49.8 36.3 23.0 87.3 27.2 25.0 21.6 59.1 37.1 32.8 41.8 31.2 51.3 23.8 47.6 27.9 32.0 28.2 24.8 43.8 23.3 40.7 42.4 32.4 23.0 19.6 47.6 18.2 41.6 41.7 18.4 42.9 19.9 30.8 41.4 38.6 34.1 23.0 31.5 22.5 37.9 22.2 23.5 18.4 31.7 41.5 25.7 30.6 38.6 61.5 52.4 33.4 11.0 40.5 46.6 27.1 66.3 36.9 33.7 42.5 25.3 37.4 33.5 62.3 20.2 26.7 21.6 24.7 35.5 20.6 27.8 36.2 25.5 37.7 13.4 63.2 18.3 6.9 2.2 8.1 4.6 3.0 3.9 4.2 4.3 3.9 3.7 4.5 5.8 4.0 6.1 3.2 3.6 3.6 4.3 1.1 49.3 55.0 53.1 57.8 46.4 50.1 49.0 52.2 46.2 51.6 48.5 49.8 59.1 17.4 19.2 20.8 78.4 49.3 60.5 40.3 14.4 35.3 51.9 31.8 19.9 55.4 38.6 24.0 40.5 64.6 31.5 68.6 64.5 46.9 42.5 68.5 44.1 33.3 22.0 40.2 32.8 95.9 46.4 29.7 33.7 35.2 62.4 26.6 27.4 20.3 55.0 26.8 107.7 91.8 31.5 30.5 55.2 63.0 43.0 35.8 45.0 56.9 38.4 46.7 57.5 51.5 112.6 218.0 44.7 46.6 33.8 51.9 71.2 26.8 41.0 16.9 147.5 26.3 33.5 32.4 48.5 27.7 36.6 62.4 64.6 63.8 29.5 37.3 88.7 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634061-55693863 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease variant, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 6.7 5.9 6.3 4.0 8.4 7.5 5.8 7.5 8.1 5.2 7.2 5.5 3.3 6.5 4.5 4.6 5.8 3.1 5.9 5.7 6.5 5.4 5.2 5.0 4.4 8.4 7.1 6.0 4.9 7.9 4.9 5.0 2.9 8.9 4.5 5.3 5.5 5.1 3.2 11.5 6.0 5.3 4.3 5.8 6.2 5.8 3.2 7.9 3.4 5.2 5.9 3.4 5.6 4.6 9.7 9.0 4.3 6.5 2.9 4.7 7.8 8.4 12.2 7.7 19.8 13.1 13.5 4.2 17.9 5.4 5.8 6.2 7.1 8.3 10.1 9.5 6.3 16.3 10.2 5.9 7.0 11.8 25.0 6.4 8.6 6.9 8.4 7.0 4.7 6.4 7.3 11.5 4.2 8.0 4.4 15.4 17.9 15.5 9.3 8.1 15.2 10.9 16.6 8.6 5.2 15.2 9.6 4.4 14.3 17.0 5.6 3.8 11.4 6.4 4.6 3.9 4.2 13.5 18.9 1.3 3.8 9.2 21.1 8.3 3.3 3.4 4.0 4.2 2.8 2.4 3.1 1.7 4.1 1.3 5.6 3.4 3.9 3.4 2.2 2.7 4.1 1.4 2.9 6.3 8.4 7.5 8.1 5.7 6.5 8.4 7.1 6.0 8.9 5.8 7.9 9.7 25.1 48.1 57.0 23.8 21.6 24.2 23.1 17.5 29.0 41.3 12.6 11.2 25.6 15.7 46.8 20.2 58.4 19.9 14.2 7.7 9.8 18.6 25.6 27.9 28.9 24.4 10.2 17.4 48.4 16.0 23.3 25.3 14.8 14.3 58.7 21.8 11.7 14.7 15.4 30.3 48.1 12.8 26.4 12.2 17.7 4.8 17.4 26.7 16.0 17.8 16.5 23.9 13.4 34.2 97.7 15.8 11.4 18.4 23.1 26.0 7.6 19.8 38.5 58.6 26.3 31.7 22.3 43.4 20.7 25.7 20.2 12.3 24.7 58.2 18.6 17.6 DYNC2LI1 "CGI-60, D2LIC, DKFZP564A033, LIC3" ENSG00000138036 "Dynein cytoplasmic 2 light intermediate chain 1" Q8TCX1 2 43774039-43810010 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 197.5;Respiratory ciliated cells: 133.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 110.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062905 Approved Supported Cytosol NA NA Cytosol "HPA062905: AB_2684899" "unprognostic (3.46e-1)" "unprognostic (3.25e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-2)" "unprognostic (2.89e-2)" "unprognostic (4.05e-2)" "unprognostic (1.84e-3)" "unprognostic (9.85e-2)" "unprognostic (2.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.73e-5)" "unprognostic (1.06e-1)" "unprognostic (1.48e-2)" "unprognostic (4.32e-2)" "unprognostic (4.60e-2)" 16.1 23.4 22.7 7.5 22.7 6.9 32.9 18.4 23.9 28.6 33.8 15.5 19.2 36.0 47.0 11.1 53.9 20.9 15.7 21.5 23.0 50.7 13.5 23.6 10.2 22.7 21.0 21.7 40.1 16.3 42.6 31.5 13.8 20.0 21.0 18.1 44.4 16.4 20.2 10.3 15.9 16.4 20.0 20.3 11.1 17.3 45.3 21.2 10.9 34.6 8.6 9.8 15.1 14.0 22.2 21.2 12.0 20.5 13.1 32.5 64.5 17.6 11.5 24.8 13.3 12.4 4.0 14.4 12.0 24.8 15.2 17.0 13.8 9.9 16.5 15.4 15.4 21.1 9.4 5.5 15.3 31.3 18.7 14.8 38.3 23.4 26.5 12.1 40.6 18.5 14.1 29.0 5.6 18.7 10.8 9.2 20.6 9.4 27.3 12.0 12.2 19.0 3.8 110.1 18.0 14.0 25.1 13.0 7.1 15.5 19.4 19.7 16.9 13.1 11.6 10.5 14.4 9.8 21.0 12.3 3.0 25.8 4.7 12.6 14.8 2.3 2.1 1.7 3.9 1.8 3.7 2.2 2.4 3.1 2.1 2.7 2.3 0.8 2.6 3.1 1.8 1.4 1.4 22.7 22.7 18.4 23.9 21.5 23.0 22.7 21.0 21.7 20.0 20.3 21.2 22.2 11.9 19.2 16.8 58.1 6.4 9.7 18.2 42.9 7.4 21.7 19.3 22.4 13.9 21.5 31.3 53.3 29.2 19.7 2.3 10.2 90.1 21.7 197.5 71.7 42.2 8.1 12.7 5.5 96.8 22.0 9.1 27.8 15.3 24.2 17.7 26.2 14.6 7.3 12.4 16.8 64.9 20.3 50.8 4.5 5.3 39.4 33.2 5.9 23.2 22.5 3.3 29.3 4.1 33.7 43.4 14.5 32.1 33.8 4.7 9.6 52.4 84.1 133.8 36.9 19.7 14.8 14.8 102.1 15.9 9.1 9.1 9.3 4.9 30.1 17.5 12.8 LHCGR "HHG, LCGR, LGR2, LHR, ULG5" ENSG00000138039 "Luteinizing hormone/choriogonadotropin receptor" P22888 2 48686774-48755730 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;ovary: 2.2;testis: 2.2" "Cell type enriched" "Detected in some" 22 "Theca cells: 143.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB009814 Uncertain NA NA "CAB009814: AB_2135467" "unprognostic (8.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.22e-2)" 1.3 0.8 0.9 0.0 0.4 0.0 0.7 1.0 0.5 0.0 0.7 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.7 0.2 0.0 0.1 0.0 3.3 0.9 0.0 2.2 0.0 0.0 0.5 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.2 2.2 1.0 0.2 0.6 0.1 0.0 0.3 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 1.0 0.5 0.2 0.7 3.3 0.9 0.0 1.9 1.6 1.0 2.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 5.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 1.0 1.2 0.1 0.0 6.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 143.2 0.0 0.0 THUMPD2 "C2orf8, MGC2454" ENSG00000138050 "THUMP domain containing 2" Q9BTF0 2 39736060-39779267 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043042, HPA058025" Approved Uncertain Nucleoplasm Yes No Nucleoplasm "HPA043042: AB_10964424, HPA058025: " "unprognostic (6.30e-2)" "unprognostic (9.12e-3)" "unprognostic (2.48e-2)" "unprognostic (4.62e-3)" "unprognostic (2.16e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.22e-1)" "unprognostic (2.31e-2)" "unprognostic (1.30e-1)" "unprognostic (2.72e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-3)" 2.1 2.0 2.6 0.5 2.6 1.7 2.1 3.0 2.9 1.9 2.6 1.9 0.5 1.7 0.2 3.6 1.5 0.5 3.2 2.6 2.7 2.3 2.3 2.2 1.4 2.7 2.7 2.6 3.3 2.2 0.5 2.4 0.4 2.7 2.0 0.7 0.4 2.1 0.4 6.0 2.2 2.0 0.4 2.6 2.5 2.3 0.9 2.8 2.1 2.2 4.1 1.5 2.1 2.5 2.8 4.9 4.7 1.0 6.5 2.3 3.3 2.7 1.3 2.5 3.0 3.1 5.0 4.5 7.8 2.7 1.6 7.6 2.0 9.7 4.4 3.2 13.1 10.8 4.7 3.0 5.7 4.1 6.3 2.4 3.9 3.2 3.1 1.0 2.9 4.9 1.5 5.9 1.8 6.1 2.3 3.3 5.0 0.0 13.0 2.9 3.4 4.2 5.4 2.9 2.6 5.7 3.1 1.3 5.6 3.2 0.4 1.8 3.9 2.5 4.0 2.5 1.1 3.6 2.4 3.1 5.1 2.0 11.4 3.2 0.0 0.6 0.0 0.1 0.4 0.6 0.7 0.4 0.1 0.5 0.3 0.6 0.4 0.1 0.4 0.1 0.9 0.1 0.6 2.6 2.6 3.0 2.9 2.6 2.7 2.7 2.7 2.6 2.7 2.6 2.8 2.8 17.4 25.6 20.6 26.8 17.8 14.3 29.0 19.5 15.9 26.8 14.4 29.8 23.7 8.6 20.3 14.7 18.8 11.5 23.0 7.2 19.6 16.6 4.5 7.5 16.9 13.7 9.6 23.8 42.2 13.7 13.6 18.4 17.9 10.9 7.0 19.2 10.0 9.9 11.3 6.7 41.6 8.1 8.2 10.9 7.7 4.0 28.0 10.0 5.4 45.0 11.8 12.1 15.5 45.2 30.3 16.7 17.1 25.6 8.2 23.7 10.3 16.4 10.9 21.1 6.6 20.5 16.0 9.1 19.7 16.9 13.5 6.8 12.6 22.2 13.5 22.7 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease variant, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Peritubular cells: 170.8;Prostatic glandular cells: 747.6;Urothelial cells: 498.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "classical monocyte: 156.9" "Lineage enriched" "Detected in many" 24 "monocytes: 156.9" "Cell line enhanced" "Detected in many" "ASC diff: 128.7;ASC TERT1: 136.8;HSkMC: 551.3;hTERT-RPE1: 128.9;SiHa: 270.0;U-87 MG: 142.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 34.6" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 28.7 12.1 4.2 32.2 4.8 2.0 29.7 1.8 14.4 35.2 17.5 3.6 2.3 41.4 19.7 7.7 45.3 24.0 25.4 2.4 22.2 24.3 7.1 16.9 11.7 3.4 2.8 4.1 5.7 7.2 0.9 14.9 4.5 4.7 35.0 2.1 1.2 4.3 39.5 3.5 6.2 5.9 35.4 3.8 27.5 16.1 8.0 6.0 28.5 8.7 5.6 2.0 35.4 6.7 2.1 7.0 71.9 2.3 0.0 128.7 136.8 0.4 0.6 4.4 1.3 12.3 0.2 30.1 0.0 19.1 17.8 3.1 58.7 0.3 4.0 2.3 5.5 3.8 0.0 21.2 0.0 36.0 0.2 0.1 551.3 55.3 30.7 1.4 128.9 0.0 0.3 0.7 0.2 0.7 29.2 0.3 22.5 7.5 10.4 14.2 0.1 0.0 0.2 13.4 0.9 0.5 2.1 270.0 38.8 0.0 7.5 49.4 10.8 0.0 1.1 0.2 107.9 0.1 0.3 0.2 0.0 142.2 0.1 11.8 1.6 156.9 0.0 0.1 23.2 0.0 0.1 0.1 0.0 1.5 0.0 0.1 0.1 6.5 0.1 18.6 0.7 0.1 70.2 4.2 4.8 1.8 14.4 2.4 22.2 3.4 2.8 4.1 4.7 3.8 6.0 2.1 56.8 19.2 66.3 0.0 1.7 17.7 118.4 86.9 8.0 0.7 18.3 42.0 3.4 0.0 79.7 46.0 0.0 0.3 1.1 0.9 15.6 6.0 15.1 11.7 100.4 103.8 1.8 0.0 4.5 0.5 0.8 114.1 3.6 28.2 3.8 0.1 7.5 12.2 12.6 0.0 0.3 1.3 4.1 103.0 50.6 12.1 159.7 112.2 17.8 64.6 140.1 1.6 3.1 0.0 0.2 0.6 0.1 170.8 0.3 747.6 0.1 1.6 11.2 0.5 19.7 4.5 32.7 12.6 2.6 2.4 14.2 0.3 2.4 1.3 1.0 498.7 SULT6B1 ENSG00000138068 "Sulfotransferase family 6B member 1" Q6IMI4 2 37167820-37196598 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.6;testis: 2.4" "Group enriched" "Detected in some" 8 "Early spermatids: 3.5;Late spermatids: 1.8;Spermatocytes: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "WM-115: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.86e-1)" "unprognostic (8.98e-2)" 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 1.6 0.2 0.1 0.3 0.3 0.1 0.2 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB1A "RAB1, YPT1" ENSG00000138069 "RAB1A, member RAS oncogene family" P62820 2 65070696-65130331 "Plasma proteins, Predicted intracellular proteins" "Autophagy, ER-Golgi transport, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 911.4;Syncytiotrophoblasts: 703.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005331, HPA056141" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 3000000 "Endoplasmic reticulum, Cytosol" "CAB005331: AB_632290, HPA056141: AB_2683051" "unprognostic (4.78e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (1.55e-3)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (4.30e-3)" "unprognostic (2.79e-1)" "unprognostic (4.81e-2)" "unprognostic (2.77e-1)" "unprognostic (7.80e-2)" "unprognostic (1.83e-2)" "unprognostic (8.63e-2)" 137.6 144.1 93.0 91.4 95.6 234.5 120.1 94.0 106.1 114.2 110.7 129.3 134.8 110.6 181.5 156.3 104.4 101.0 124.8 95.5 103.4 195.9 196.5 143.2 71.0 95.2 96.6 92.3 95.2 135.0 114.0 118.1 149.5 97.3 97.5 128.0 90.2 133.0 94.7 101.1 99.4 128.7 118.5 96.2 89.3 137.1 86.9 96.7 59.5 130.8 81.1 91.9 120.4 121.5 101.3 211.3 150.7 186.2 110.5 445.5 261.2 287.5 299.9 212.3 134.8 142.8 270.1 137.5 85.8 167.9 311.2 221.4 130.6 173.7 277.6 214.1 96.3 100.6 108.3 119.2 403.8 281.9 115.4 93.7 232.0 279.6 176.9 158.5 213.3 271.2 67.7 157.2 96.6 271.1 190.6 67.3 138.6 148.6 329.1 134.6 68.3 177.3 137.3 266.1 236.0 133.9 118.5 139.2 230.6 282.4 218.7 143.3 106.9 253.4 172.5 214.6 183.2 171.8 147.6 95.3 205.6 230.2 173.9 170.4 96.8 84.6 78.7 41.9 86.3 46.7 42.6 45.4 45.8 76.0 29.3 43.2 45.1 102.1 56.4 80.9 63.1 59.0 54.3 93.0 95.6 94.0 106.1 95.5 103.4 95.2 96.6 92.3 97.3 96.2 96.7 101.3 84.8 83.3 89.1 51.2 64.6 297.2 322.0 384.6 74.0 48.5 117.1 71.8 120.7 87.2 218.6 125.0 6.2 309.5 70.3 182.0 328.7 216.5 350.3 102.8 110.9 133.0 133.4 45.0 50.7 219.5 366.9 171.6 105.0 162.8 50.7 67.1 102.4 183.7 375.3 58.9 53.4 200.4 262.4 122.9 221.6 911.4 145.7 153.3 197.5 83.4 110.5 144.7 41.2 50.3 71.7 234.0 148.2 212.9 107.1 323.2 168.4 441.7 162.4 45.6 72.3 103.8 210.9 193.8 106.7 90.7 293.8 703.8 70.5 76.5 168.4 477.9 ACTR2 ARP2 ENSG00000138071 "Actin related protein 2" P61160 2 65227788-65271253 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005083, HPA015050" Approved Approved Cytosol NA NA 35000000 Cytosol "CAB005083: AB_2221848, HPA015050: AB_1844556" "unprognostic (2.23e-1)" "unprognostic (1.15e-3)" "unprognostic (3.89e-2)" "unprognostic (2.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (3.88e-2)" "unprognostic (3.16e-2)" "unprognostic (7.06e-2)" "unprognostic (1.16e-2)" "unprognostic (8.59e-2)" "unprognostic (2.36e-3)" "unprognostic (3.18e-2)" "unprognostic (4.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.03e-2)" 114.0 71.4 48.2 218.1 55.5 161.9 77.8 48.5 59.3 82.1 51.0 143.8 105.8 70.7 65.1 112.0 54.1 91.7 65.5 56.4 55.8 86.4 109.8 116.9 248.4 50.3 49.3 48.8 44.3 62.2 62.4 25.2 110.5 49.9 72.4 140.5 70.9 65.4 64.7 61.0 70.0 119.2 105.4 58.7 173.5 108.3 46.6 49.2 183.9 73.8 65.5 258.4 129.8 46.4 62.1 267.3 221.2 205.5 224.5 218.8 296.1 213.2 367.3 284.1 280.0 193.6 249.3 214.2 590.6 181.8 406.9 174.3 196.8 179.8 258.3 459.4 337.2 150.8 652.1 147.6 235.9 248.0 619.8 731.6 256.5 201.6 312.2 297.7 228.6 356.6 202.0 282.1 209.2 480.0 198.2 325.4 330.6 173.2 245.7 157.5 347.9 266.0 248.6 328.7 341.7 105.2 171.6 239.0 273.5 262.0 186.9 167.6 417.4 467.9 306.5 184.8 202.8 408.9 158.0 155.2 824.1 264.4 598.7 353.9 325.4 182.4 220.6 104.3 241.4 111.8 97.1 91.1 98.6 213.1 80.4 70.3 99.2 258.2 104.1 273.3 79.3 113.9 344.5 48.2 55.5 48.5 59.3 56.4 55.8 50.3 49.3 48.8 49.9 58.7 49.2 62.1 187.1 86.6 112.7 32.3 202.4 74.7 88.0 93.0 70.0 81.8 75.8 57.1 76.3 51.5 93.2 97.5 66.7 81.8 257.9 280.5 50.9 100.5 37.5 114.5 131.4 131.0 110.8 89.8 152.6 129.0 138.6 96.0 105.0 163.2 191.1 77.8 113.6 102.9 277.7 104.3 106.0 166.5 85.5 450.1 311.8 92.5 65.3 352.0 88.9 97.4 378.9 87.9 207.0 38.7 68.9 164.4 195.3 74.4 119.7 114.9 131.1 89.0 127.7 82.4 124.9 63.3 122.8 31.4 41.8 102.5 90.6 124.4 203.2 74.2 172.8 181.7 PREB SEC12 ENSG00000138073 "Prolactin regulatory element binding" Q9HCU5 2 27130756-27134666 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 369.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013582, HPA014133" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013582: AB_1855694, HPA014133: AB_1855695" "unprognostic (2.32e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" "unprognostic (1.61e-1)" "unprognostic (2.01e-2)" "unprognostic (1.21e-2)" "unprognostic (4.96e-3)" "unprognostic (1.44e-1)" "unprognostic (9.89e-2)" "unprognostic (1.21e-3)" "unprognostic (1.24e-2)" "unprognostic (2.69e-1)" "unprognostic (2.33e-3)" "unprognostic (5.13e-2)" "unprognostic (4.14e-2)" "unprognostic (5.25e-2)" "unprognostic (1.28e-2)" 43.0 46.4 42.5 28.8 43.0 16.7 39.8 43.0 48.3 38.0 38.9 32.6 27.9 57.8 105.7 41.3 46.5 26.1 57.2 43.3 43.3 49.1 138.4 33.7 33.6 46.0 43.2 41.1 50.3 74.6 31.0 43.1 22.8 44.0 43.1 28.0 16.9 60.6 35.0 135.6 29.5 36.3 41.0 44.0 52.0 42.8 35.3 43.7 31.3 30.5 113.0 38.6 35.2 32.6 44.9 63.5 62.2 35.4 56.5 84.8 30.2 65.8 44.6 46.5 63.5 44.4 59.1 38.7 78.3 45.9 44.5 68.7 35.3 70.3 56.3 41.3 58.7 63.2 64.2 30.7 128.3 111.1 74.3 58.2 28.8 67.5 60.2 68.2 34.2 44.7 61.4 48.0 68.3 57.6 73.4 69.2 56.5 37.2 81.5 64.8 63.9 70.9 369.2 46.9 33.2 79.8 42.8 42.8 88.3 65.7 36.1 39.4 125.3 25.0 33.9 48.7 29.8 51.0 150.5 67.9 95.1 56.4 83.4 65.4 73.7 61.0 103.3 50.4 52.2 53.7 44.5 42.1 50.2 62.5 43.9 40.1 41.7 25.4 65.0 55.8 74.1 50.9 63.9 42.5 43.0 43.0 48.3 43.3 43.3 46.0 43.2 41.1 44.0 44.0 43.7 44.9 9.7 16.0 12.7 5.5 33.5 18.0 9.8 14.3 9.1 12.2 21.8 19.0 14.2 20.0 10.6 20.2 12.5 45.3 22.8 17.3 35.2 29.8 5.9 5.8 14.7 10.8 8.4 30.7 7.4 35.1 60.3 18.2 28.1 11.9 23.6 13.1 16.1 36.1 38.0 6.7 7.7 28.5 20.3 19.8 16.3 9.1 23.6 17.9 19.6 8.4 16.6 25.3 24.7 9.5 9.1 30.9 20.4 44.8 101.5 18.4 30.0 29.2 3.8 10.9 32.9 10.2 21.0 32.1 44.8 18.7 17.3 77.4 22.6 16.2 22.3 12.9 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 104.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 310.9;SK-BR-3: 337.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 42.8 8.7 26.3 14.4 21.8 18.3 31.8 21.3 28.4 9.3 38.2 13.1 21.1 14.5 68.0 10.9 11.6 7.6 7.2 20.9 21.3 7.6 104.8 8.0 14.0 21.7 21.8 18.1 10.3 11.7 9.9 8.1 39.5 22.4 9.4 12.8 6.4 12.6 11.2 17.1 9.5 15.4 9.8 21.3 9.2 10.2 23.6 28.3 11.7 8.1 8.9 26.7 11.5 8.9 23.7 78.9 79.6 49.9 66.1 45.4 16.5 310.9 28.1 19.1 41.8 28.7 118.8 27.0 54.2 41.3 15.4 44.7 42.8 108.3 32.4 29.1 42.2 63.5 96.6 34.9 184.4 53.8 125.1 47.8 57.1 27.1 51.4 39.7 11.1 38.2 43.3 143.6 21.1 27.0 161.0 42.7 60.4 144.8 90.1 29.0 70.7 58.7 78.2 24.0 74.5 42.0 61.7 30.3 337.1 40.1 48.6 74.9 26.0 17.5 45.3 62.5 27.9 76.1 35.7 88.6 84.7 24.5 86.1 65.2 0.1 5.9 1.8 7.4 6.6 8.9 5.8 7.0 7.0 8.7 5.3 7.1 8.6 0.3 6.3 8.9 8.9 7.6 5.8 26.3 21.8 21.3 28.4 20.9 21.3 21.7 21.8 18.1 22.4 21.3 28.3 23.7 2.5 0.0 4.4 7.8 13.4 8.0 8.6 3.8 7.4 5.3 41.9 31.9 6.8 8.6 3.1 7.3 4.2 119.1 12.5 6.7 1.9 9.8 15.1 3.9 7.4 6.2 5.4 12.6 7.2 8.2 111.7 6.0 5.6 6.9 0.0 18.1 7.1 67.7 21.8 11.8 9.0 9.2 4.1 9.1 6.0 32.0 7.2 6.6 0.0 29.0 47.9 2.5 6.2 6.6 5.0 7.0 4.3 13.9 10.0 14.1 11.7 3.9 2.9 3.1 13.1 5.5 5.2 35.1 21.5 7.6 6.3 227.9 8.6 9.4 15.2 7.8 ABCG5 STSL ENSG00000138075 "ATP binding cassette subfamily G member 5" Q9H222 2 43812472-43838865 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "intestine: 48.2;liver: 62.5" "Group enriched" "Detected in some" 6 "Hepatocytes: 60.3;Paneth cells: 23.9;Proximal enterocytes: 30.9" "Cancer enriched" "Detected in some" 23 "liver cancer: 11.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 54 "Hep G2: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.71e-1)" "unprognostic (5.47e-2)" "unprognostic (4.01e-1)" "unprognostic (6.92e-2)" "unprognostic (2.24e-1)" "unprognostic (9.97e-2)" "prognostic favorable (2.60e-5)" "unprognostic (4.59e-2)" "unprognostic (3.10e-1)" "unprognostic (1.38e-3)" "unprognostic (3.07e-4)" "unprognostic (1.86e-1)" "unprognostic (3.07e-1)" "unprognostic (5.52e-3)" "unprognostic (8.29e-2)" "unprognostic (5.31e-2)" "unprognostic (3.08e-2)" 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 48.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 62.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 5.7 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.1 0.6 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.7 60.3 0.0 0.0 3.2 2.5 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 1.8 0.0 23.9 0.0 0.0 0.0 30.9 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 PREPL KIAA0436 ENSG00000138078 "Prolyl endopeptidase like" Q4J6C6 2 44316281-44361862 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 243.1;Inhibitory neurons: 219.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063238 Approved NA NA "HPA063238: AB_2684967" "unprognostic (5.60e-3)" "unprognostic (9.81e-2)" "unprognostic (4.51e-2)" "unprognostic (4.65e-3)" "unprognostic (2.22e-1)" "unprognostic (8.53e-2)" "unprognostic (5.98e-3)" "unprognostic (4.38e-3)" "unprognostic (2.27e-1)" "unprognostic (2.72e-2)" "unprognostic (1.52e-2)" "unprognostic (4.67e-2)" "unprognostic (2.33e-2)" "unprognostic (3.79e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (1.75e-1)" 26.4 51.4 49.8 18.6 75.1 5.5 32.2 50.1 133.9 36.2 30.7 24.6 26.3 47.7 71.5 23.2 33.9 28.7 63.3 70.9 79.3 63.0 21.8 24.7 17.6 49.4 40.7 62.7 50.3 25.4 54.8 52.9 21.5 53.5 37.6 29.7 124.9 26.4 33.5 34.6 22.5 28.1 34.4 23.8 23.3 26.6 28.4 53.4 19.3 61.8 51.8 18.0 23.8 24.1 116.7 41.2 31.7 35.3 45.3 55.7 58.0 26.8 45.1 34.6 32.0 27.4 34.1 28.4 52.3 61.2 47.5 36.6 34.6 50.6 33.0 61.0 48.7 36.2 35.5 24.2 26.3 40.0 35.8 32.5 37.9 64.6 61.8 50.1 62.9 31.4 24.3 45.6 72.6 43.6 22.2 39.1 17.4 33.4 52.8 35.1 30.1 42.8 38.0 61.4 24.0 58.3 46.5 28.9 30.6 67.4 33.9 41.4 27.6 32.8 56.3 32.1 44.6 31.0 40.2 28.2 34.3 65.9 40.1 42.5 6.9 4.4 3.5 7.9 4.9 11.2 8.5 7.3 8.5 6.3 7.0 10.7 8.7 1.3 11.1 4.3 2.9 8.8 5.8 49.8 75.1 50.1 133.9 70.9 79.3 49.4 40.7 62.7 53.5 23.8 53.4 116.7 16.3 32.1 37.4 83.2 34.0 13.0 16.0 13.2 21.6 89.1 33.4 26.7 88.1 32.9 21.1 64.4 47.9 8.7 30.0 20.4 39.2 17.4 21.1 40.1 36.7 18.7 33.0 13.9 243.1 23.6 4.9 29.5 28.1 32.1 13.3 21.9 16.8 32.8 11.6 144.7 219.9 24.2 18.3 13.5 7.5 10.0 35.4 14.2 17.8 55.3 12.8 41.4 32.0 81.4 126.2 13.6 20.8 33.1 21.8 16.3 12.2 38.8 35.5 63.2 19.7 44.5 27.2 29.2 28.7 16.3 14.8 8.8 29.1 26.0 17.1 10.7 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 137.4;kidney: 655.2;pancreas: 219.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 106.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.4 0.3 0.6 1.1 1.6 0.6 0.4 6.7 2.8 0.7 0.0 22.6 114.9 1.4 1.9 0.2 0.6 51.9 0.4 1.3 1.1 655.2 36.9 0.4 0.4 0.7 1.3 1.4 0.5 219.4 0.0 0.5 0.1 2.6 1.0 22.9 3.5 0.3 0.3 1.0 0.6 137.4 0.5 0.0 0.5 0.9 1.7 0.8 0.0 0.4 0.1 0.1 0.3 0.3 2.9 0.0 1.0 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.1 4.9 0.0 0.1 4.3 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.4 0.2 0.0 0.0 0.4 0.1 1.2 0.5 0.1 0.1 0.2 106.1 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.1 0.3 0.2 0.4 0.3 0.3 0.7 0.3 0.4 0.5 0.6 0.3 0.1 1.0 0.6 0.7 0.4 0.4 0.1 0.3 0.2 0.1 0.6 1.6 6.7 2.8 1.3 1.1 0.7 1.3 1.4 2.6 0.0 0.8 2.9 0.2 3.2 1.5 0.3 6.1 0.0 0.3 0.0 0.0 12.1 0.2 0.0 0.4 74.4 0.0 42.3 10.4 0.1 0.8 18.2 62.6 37.0 12.4 62.2 14.4 0.6 0.0 0.0 9.1 13.8 0.0 0.9 1.1 128.9 0.0 0.1 0.4 4.6 0.1 21.9 9.0 8.4 0.0 0.0 0.0 8.5 1.2 3.2 0.0 1.0 1.6 1.0 1.0 3.0 3.7 4.8 18.6 0.4 1.5 1.1 258.9 363.0 0.0 11.2 0.0 2.6 1.2 0.8 0.4 0.7 0.1 0.1 2.8 0.2 15.7 1.2 EMILIN1 "DKFZp586M121, gp115" ENSG00000138080 "Elastin microfibril interfacer 1" Q9Y6C2 2 27078615-27086403 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 64.5;Fibroblasts: 111.3;Hepatic stellate cells: 45.0;Leydig cells: 85.1;Peritubular cells: 167.3;Sertoli cells: 72.3;Smooth muscle cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 98.2;BJ hTERT+: 65.0;HHSteC: 99.0;HSkMC: 109.6;SH-SY5Y: 129.4;U-138 MG: 63.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002822 Supported "Secreted to extracellular matrix" NA NA 4300000 "HPA002822: AB_1078738" "unprognostic (3.14e-1)" "unprognostic (2.44e-2)" "unprognostic (3.92e-2)" "unprognostic (3.42e-2)" "unprognostic (3.26e-2)" "unprognostic (1.46e-1)" "unprognostic (3.07e-1)" "unprognostic (2.89e-2)" "unprognostic (4.10e-3)" "unprognostic (3.07e-2)" "unprognostic (1.85e-1)" "unprognostic (7.97e-2)" "prognostic unfavorable (8.13e-9)" "unprognostic (8.96e-3)" "unprognostic (3.77e-2)" "unprognostic (1.20e-2)" "unprognostic (5.70e-3)" 50.1 56.2 5.9 47.4 5.5 1.9 44.0 5.7 7.1 122.4 5.5 167.1 25.1 208.0 7.4 23.5 130.3 35.7 60.4 4.8 10.5 55.5 42.8 101.6 11.8 11.3 6.3 3.8 173.8 21.4 1.4 27.1 16.4 7.7 97.2 8.0 0.3 17.7 52.5 10.3 17.4 72.6 50.8 7.9 119.1 88.3 17.0 10.8 2.5 30.0 2.7 2.2 144.1 70.8 7.9 0.9 0.7 5.9 0.9 35.8 49.0 1.1 98.2 65.0 20.7 29.7 0.5 0.8 0.6 0.9 56.6 0.1 0.9 0.2 0.2 3.8 3.1 1.3 1.8 0.5 43.9 99.0 1.5 27.0 109.6 0.1 14.2 0.0 0.2 0.2 1.3 1.0 0.9 4.3 1.1 0.9 28.8 3.2 0.5 0.7 15.6 1.3 1.2 0.0 0.4 1.6 129.4 0.3 0.5 1.1 0.4 0.4 2.5 11.9 63.6 2.0 7.6 0.4 1.7 1.8 1.1 0.7 1.3 17.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 5.9 5.5 5.7 7.1 4.8 10.5 11.3 6.3 3.8 7.7 7.9 10.8 7.9 5.2 0.0 0.5 6.5 0.4 3.3 0.2 0.0 0.0 0.6 0.8 7.1 2.9 1.5 0.0 0.0 0.0 1.6 0.6 0.2 0.0 0.4 0.6 1.9 64.5 6.3 0.0 4.0 0.2 0.4 1.5 111.3 0.5 1.3 4.5 0.2 45.0 1.0 6.4 0.0 0.3 0.3 0.0 2.5 5.8 10.0 85.1 4.1 10.6 8.4 0.5 3.6 0.0 0.5 0.3 0.8 0.1 167.3 0.8 0.2 0.5 1.0 0.0 1.1 72.3 35.3 52.4 0.6 0.4 0.4 3.1 2.9 1.3 10.7 0.1 0.1 FBXO11 "FBX11, UBR6" ENSG00000138081 "F-box protein 11" Q86XK2 2 47789316-47906498 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002690 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA002690: AB_1848448" "unprognostic (1.18e-1)" "unprognostic (8.65e-3)" "unprognostic (3.93e-2)" "unprognostic (2.05e-2)" "unprognostic (7.92e-2)" "unprognostic (1.42e-1)" "unprognostic (3.85e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-2)" "unprognostic (9.82e-2)" "unprognostic (5.77e-2)" "unprognostic (2.33e-2)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" 28.1 19.8 24.6 19.3 27.3 32.5 21.2 34.1 29.0 21.3 23.4 18.7 16.9 33.4 25.0 18.9 22.4 21.1 23.1 27.2 26.5 21.9 27.0 22.7 25.9 24.2 24.6 24.4 34.7 19.8 30.5 17.6 23.2 25.4 22.9 20.3 33.6 16.6 20.6 28.5 19.2 17.5 29.9 24.3 24.4 19.3 41.3 26.0 22.7 26.4 29.0 27.9 22.3 17.0 26.4 52.8 26.9 62.9 53.9 42.6 40.2 37.2 36.0 48.6 32.6 31.9 22.9 25.9 32.8 45.4 50.2 40.5 25.6 42.5 37.1 47.9 22.3 21.5 31.6 21.3 36.6 41.0 33.5 32.1 39.3 41.7 28.8 48.2 51.9 42.1 16.6 31.3 33.9 40.4 25.5 31.7 32.8 38.2 34.7 26.2 40.9 58.3 25.5 47.1 42.5 44.1 52.3 34.2 31.5 54.6 46.4 14.7 27.9 46.4 40.2 37.2 27.5 40.0 28.9 16.5 60.9 27.4 30.8 42.1 4.3 1.1 2.1 1.5 1.2 1.6 2.1 1.4 1.7 1.4 1.5 2.6 1.7 2.6 2.2 1.1 2.0 1.6 1.1 24.6 27.3 34.1 29.0 27.2 26.5 24.2 24.6 24.4 25.4 24.3 26.0 26.4 40.6 16.0 39.0 100.9 34.1 67.0 44.4 22.0 24.5 45.1 22.3 15.1 11.0 15.7 24.9 18.4 33.3 19.6 37.8 24.7 11.7 17.2 34.4 38.6 40.3 39.4 23.9 17.1 151.4 15.2 16.0 37.0 23.4 48.6 29.1 37.3 33.2 20.0 25.5 55.5 134.8 17.1 24.4 40.1 81.4 40.4 30.1 51.8 35.6 137.7 30.9 30.2 25.7 138.7 143.8 25.8 17.1 39.9 36.3 44.3 17.3 14.6 37.4 42.5 19.7 42.3 34.6 86.6 50.7 24.2 59.0 36.0 35.6 33.4 19.5 65.1 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941702-44946071 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 30.1;choroid plexus: 10.5;parathyroid gland: 9.2;pituitary gland: 28.0;retina: 25.6" "Group enriched" "Detected in some" 14 "Bipolar cells: 203.9;Horizontal cells: 185.1;Muller glia cells: 392.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 68.7;SCLC-21H: 63.1;SH-SY5Y: 25.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 38.7;hypothalamus: 19.5" HPA067988 Approved Nucleoplasm NA NA Nucleoplasm "HPA067988: AB_2685939" "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.0 0.0 10.4 0.0 17.9 0.0 0.1 0.8 13.1 0.7 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 30.1 0.1 0.0 0.0 0.1 6.8 4.8 3.2 0.0 0.6 9.2 28.0 0.0 7.9 0.0 0.0 25.6 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 1.8 7.1 0.0 0.0 0.1 0.0 0.0 0.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.6 0.0 11.7 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 68.7 0.0 1.4 0.0 0.0 0.0 0.0 0.4 2.7 0.4 0.0 0.3 0.0 0.4 0.0 0.0 0.0 63.1 25.2 0.1 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.4 0.4 0.5 0.2 0.3 0.1 10.4 17.9 0.8 13.1 1.9 30.1 6.8 4.8 3.2 7.9 0.2 7.1 1.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 203.9 1.1 1.3 0.7 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 11.2 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.1 0.1 0.2 0.0 0.0 0.3 2.7 0.0 0.1 0.0 0.0 0.0 392.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.2 18.3 0.0 0.5 0.4 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ATRAID "APR3, C2orf28, HSPC013, p18" ENSG00000138085 "All-trans retinoic acid induced differentiation factor" Q6UW56 2 27212027-27217178 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051353 Uncertain NA NA "HPA051353: AB_2681451" "unprognostic (4.58e-2)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-2)" "unprognostic (4.41e-2)" "unprognostic (1.59e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.73e-2)" "unprognostic (5.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.76e-1)" "unprognostic (1.92e-1)" 87.3 80.3 58.9 48.5 63.4 72.8 111.1 64.6 71.4 109.7 73.8 82.8 60.3 82.9 346.6 59.6 124.8 68.6 130.9 58.1 69.3 134.5 72.6 75.4 64.3 66.2 61.8 56.0 120.7 121.3 121.4 41.0 75.5 65.0 82.3 93.2 57.2 108.7 108.3 144.0 56.3 59.9 73.4 63.3 64.9 73.9 97.0 62.7 69.1 115.1 140.4 66.8 80.0 38.5 68.3 126.9 145.6 82.4 144.9 408.7 242.2 126.9 75.6 227.6 93.8 87.0 116.2 184.4 63.5 126.6 201.3 134.8 108.7 75.9 132.2 81.1 101.2 77.2 75.0 79.4 182.6 185.9 65.2 93.6 192.5 275.5 80.2 179.3 213.3 123.7 110.5 76.4 191.7 144.5 161.8 78.8 174.0 124.0 263.3 123.0 70.5 218.7 293.2 161.2 68.6 90.7 136.5 89.7 112.4 122.8 118.4 96.3 98.5 82.8 147.9 87.4 54.1 77.8 302.4 249.6 166.2 152.9 124.8 143.5 188.4 242.1 206.7 198.5 223.2 202.9 278.5 227.6 226.9 251.1 271.1 238.8 219.6 54.1 189.1 240.7 293.2 277.5 443.1 58.9 63.4 64.6 71.4 58.1 69.3 66.2 61.8 56.0 65.0 63.3 62.7 68.3 143.0 60.9 82.1 7.8 96.4 102.2 176.4 306.4 112.1 44.2 135.0 155.7 163.2 114.4 169.9 143.5 18.8 273.0 95.0 68.6 181.9 182.5 159.6 113.7 109.5 118.4 91.8 47.1 4.3 191.3 328.2 200.0 57.6 96.8 90.7 124.6 113.2 82.7 209.4 28.6 6.6 134.6 205.4 110.7 104.8 223.9 196.3 100.9 176.1 9.4 157.6 153.9 92.7 9.5 13.9 126.1 123.1 141.1 177.0 109.6 135.1 212.0 160.8 48.9 52.6 103.8 137.8 374.7 162.6 110.2 100.7 250.5 93.5 167.8 137.6 153.7 CENPO "CENP-O, MGC11266" ENSG00000138092 "Centromere protein O" Q9BU64 2 24793136-24822376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046189 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA046189: AB_2679579" "unprognostic (1.67e-2)" "unprognostic (2.42e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.79e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (1.73e-6)" "unprognostic (5.56e-2)" "unprognostic (4.02e-1)" "unprognostic (4.81e-2)" "unprognostic (5.93e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (5.71e-13)" "unprognostic (4.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" 5.1 4.0 3.4 3.5 3.2 9.3 4.7 2.8 4.1 4.0 2.1 3.3 3.2 3.1 0.8 4.5 3.1 1.6 2.7 3.5 3.3 2.9 2.6 3.6 4.9 3.6 3.3 3.1 4.5 2.0 1.6 3.6 3.3 3.2 3.2 3.8 1.4 2.6 1.1 3.0 3.9 3.9 2.2 3.0 4.3 2.7 8.4 3.4 11.5 3.4 2.0 5.9 2.5 3.7 3.0 31.1 36.4 40.7 21.7 4.8 7.3 22.7 36.8 21.7 51.0 38.7 46.2 15.5 21.4 4.2 22.8 29.8 16.3 40.6 14.0 34.1 28.1 21.1 34.3 23.9 31.0 2.4 28.7 24.4 3.6 2.5 51.5 11.4 9.3 24.0 25.4 40.3 23.8 31.8 21.8 39.2 20.6 29.3 21.0 22.8 31.0 53.4 11.5 12.9 18.6 27.0 29.3 22.1 16.9 7.9 18.5 16.3 11.8 15.4 46.9 42.8 15.9 41.6 14.5 20.1 42.8 14.5 27.5 36.4 0.0 0.3 0.0 1.0 0.2 0.4 0.4 0.4 0.5 0.4 0.3 0.3 0.7 0.1 0.7 0.3 1.1 0.7 0.3 3.4 3.2 2.8 4.1 3.5 3.3 3.6 3.3 3.1 3.2 3.0 3.4 3.0 0.7 3.2 2.2 4.2 1.5 1.1 0.7 1.3 2.2 0.9 1.9 1.4 6.5 0.0 1.2 3.7 0.0 3.9 1.9 3.0 1.9 1.5 3.9 1.5 2.2 2.0 0.0 11.2 5.3 1.3 11.5 2.4 6.6 1.5 1.3 6.5 1.8 0.9 4.9 1.7 4.9 1.6 0.0 1.6 1.1 9.6 0.3 1.1 1.8 3.7 1.2 1.6 1.0 2.0 2.5 1.1 0.5 1.2 8.6 0.5 1.8 1.7 0.7 0.7 0.0 1.1 3.3 11.7 9.5 3.3 1.4 2.9 1.4 2.8 2.7 0.9 LRPPRC "GP130, LRP130, LSFC" ENSG00000138095 "Leucine rich pentatricopeptide repeat containing" P42704 2 43886224-43995989 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033786, HPA036408, HPA036409" Enhanced Enhanced Mitochondria No No 210000 Mitochondria "CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-3)" "prognostic unfavorable (1.72e-5)" "unprognostic (1.68e-1)" "unprognostic (8.34e-3)" "prognostic unfavorable (2.31e-7)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.44e-3)" "unprognostic (7.68e-2)" "prognostic favorable (6.65e-6)" "unprognostic (9.07e-2)" "unprognostic (1.92e-1)" "unprognostic (1.12e-1)" "unprognostic (5.00e-2)" 32.5 33.5 31.6 24.0 34.3 50.0 42.0 42.5 36.4 23.7 47.4 51.1 33.7 32.8 28.7 28.7 27.9 18.3 47.4 32.9 35.0 64.0 48.7 19.7 31.4 35.8 34.2 31.2 34.4 30.6 49.1 19.4 27.4 38.3 28.0 49.3 40.8 28.0 25.5 101.9 30.4 30.5 27.8 31.8 24.5 27.4 33.5 35.2 29.6 31.4 94.4 32.0 27.2 22.7 37.7 127.8 101.9 62.3 80.0 58.1 79.9 108.0 82.7 59.4 88.0 67.3 164.4 65.7 181.7 78.4 50.8 58.8 105.2 118.8 86.3 116.8 110.2 75.2 164.2 76.5 217.9 85.5 239.9 71.4 77.3 73.8 81.6 130.4 49.2 71.2 53.6 246.5 71.5 75.8 68.5 126.8 273.7 104.0 123.8 71.8 139.7 140.7 147.6 95.3 115.3 111.0 107.3 93.6 120.6 154.5 79.2 90.1 140.6 62.6 63.2 86.4 66.9 89.2 72.5 87.4 156.2 60.0 144.1 55.6 10.5 16.5 2.9 13.3 16.2 25.5 22.5 18.0 17.9 23.5 24.5 24.8 21.9 1.2 20.3 18.9 9.6 16.3 20.2 31.6 34.3 42.5 36.4 32.9 35.0 35.8 34.2 31.2 38.3 31.8 35.2 37.7 29.2 22.4 34.1 56.8 46.2 46.3 27.2 34.6 46.1 66.4 37.6 30.4 97.2 32.9 35.4 46.0 31.3 37.1 22.5 33.1 21.5 25.6 5.3 31.2 48.2 30.4 27.5 58.4 91.6 17.7 23.6 32.4 40.2 40.1 29.2 51.0 22.1 55.1 25.2 65.6 96.5 49.2 20.3 38.8 25.9 6.3 25.1 28.9 21.4 38.4 36.8 24.5 23.7 55.3 94.9 20.0 33.0 23.7 34.4 31.9 36.6 62.3 25.8 57.0 13.1 45.8 32.6 27.2 33.3 53.9 44.3 33.2 32.2 63.7 76.0 31.9 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282429-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 156.8;skeletal muscle: 585.5;tongue: 178.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 17 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 17 "NK-cells: 3.6" "Group enriched" "Detected in some" 8 "HAP1: 7.3;NTERA-2: 15.6" "Region enhanced" "Detected in some" "amygdala: 3.1" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 0.3 9.4 1.6 0.0 1.1 0.0 0.3 0.9 3.8 0.6 0.2 0.3 4.3 0.8 24.7 5.0 0.8 0.2 156.8 2.1 0.4 1.6 0.1 0.2 0.2 0.7 0.5 1.4 0.5 0.5 0.0 0.1 0.0 1.4 3.4 0.0 0.0 9.6 0.1 585.5 0.5 2.1 0.0 0.4 0.9 0.1 22.5 0.3 0.1 0.5 178.8 0.0 0.1 0.5 1.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 7.3 0.0 0.0 0.0 0.2 0.0 1.4 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 15.6 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.6 1.1 0.9 3.8 2.1 0.4 0.7 0.5 1.4 1.4 0.4 0.3 1.8 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.4 81.7 10.0 0.1 3.7 0.0 0.0 0.3 2.3 0.0 35.5 1.5 0.1 0.0 0.8 0.0 2.7 11.3 42.5 0.0 2.2 0.0 0.2 4.5 0.0 0.4 0.0 0.1 0.0 0.8 1.8 0.0 0.0 0.0 4.7 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.3 46.5 1.9 0.7 0.0 0.2 2.4 3.1 0.2 0.0 0.0 17.9 16.8 6.8 2.4 0.0 0.0 0.0 0.3 0.2 6.4 0.3 DTNB ENSG00000138101 "Dystrobrevin beta" O60941 2 25377198-25673647 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 36.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.8;Inhibitory neurons: 214.1;Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 343.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA061357 Uncertain Approved Mitochondria NA NA Mitochondria "HPA061357: AB_2684489" "unprognostic (1.14e-1)" "unprognostic (1.39e-2)" "unprognostic (3.17e-2)" "unprognostic (7.40e-2)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.78e-2)" "unprognostic (3.67e-3)" "unprognostic (3.98e-2)" "unprognostic (9.45e-2)" "unprognostic (4.67e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-2)" "unprognostic (6.49e-2)" 2.1 2.1 9.0 1.6 8.2 2.9 9.8 4.5 13.2 4.3 0.0 1.5 1.2 2.8 10.2 4.5 4.6 3.4 2.0 13.7 5.4 4.2 3.4 4.3 2.5 5.7 2.8 7.1 4.4 7.7 9.9 5.8 1.9 5.9 8.5 1.0 5.0 36.3 5.2 2.7 4.5 1.6 1.3 0.3 2.7 5.6 6.8 3.4 4.1 11.2 1.6 1.9 3.5 4.0 7.2 10.7 9.1 6.6 7.5 4.0 5.2 0.2 3.2 4.2 4.0 5.3 3.5 2.6 5.5 1.3 2.5 5.0 3.7 4.6 13.1 2.2 8.2 11.1 4.5 2.9 10.0 2.9 5.4 4.1 3.6 10.9 4.2 7.2 4.9 5.5 10.5 0.4 8.0 3.0 10.9 8.5 4.6 7.3 2.9 5.4 7.0 11.5 9.7 4.9 9.7 8.9 13.7 10.3 16.2 12.9 3.6 8.7 3.3 2.3 1.6 7.3 2.4 5.7 14.6 6.8 10.0 4.6 9.5 5.7 0.4 1.6 5.7 4.1 0.9 4.4 4.4 5.0 3.7 0.5 5.8 5.0 3.3 3.2 4.1 0.4 0.9 5.2 2.0 9.0 8.2 4.5 13.2 13.7 5.4 5.7 2.8 7.1 5.9 0.3 3.4 7.2 3.9 9.6 12.8 53.2 12.6 8.0 26.6 16.4 44.3 9.4 20.3 18.9 2.3 7.2 9.3 14.7 6.2 3.7 4.2 0.9 11.7 4.0 3.1 7.2 4.2 4.7 3.0 4.4 176.8 11.6 1.5 3.2 15.8 12.1 1.3 4.6 5.0 5.6 33.6 21.9 214.1 2.8 14.2 7.8 1.7 6.9 1.5 4.9 12.4 83.4 3.2 18.5 7.2 137.7 343.3 9.5 1.4 2.6 8.7 17.9 0.3 9.3 2.2 9.9 6.6 1.9 3.2 12.6 27.9 15.7 2.0 2.1 10.8 2.3 1.3 17.7 ACTR1A "ARP1, Arp1A" ENSG00000138107 "Actin related protein 1A" P61163 10 102461881-102502712 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037193, HPA047443" Approved Approved Microtubules NA NA 560000 Microtubules "CAB037193: AB_258253, HPA047443: AB_2680049" "unprognostic (9.64e-3)" "unprognostic (1.92e-2)" "unprognostic (8.34e-2)" "unprognostic (4.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (7.77e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (4.13e-1)" 57.8 59.3 98.7 39.7 103.2 37.1 51.9 104.3 110.1 49.7 81.8 76.2 38.1 62.3 37.8 62.1 47.8 36.4 84.9 103.5 105.2 48.8 40.7 59.0 34.0 116.8 109.8 103.0 37.2 42.2 56.9 55.1 45.7 119.4 53.5 42.1 42.3 46.8 52.4 175.7 63.1 49.6 69.6 103.7 49.1 56.7 40.8 108.5 57.4 41.6 128.1 42.5 75.5 51.6 123.0 80.5 95.8 113.5 117.1 138.0 109.2 45.5 100.3 177.3 154.4 142.4 52.7 63.3 54.4 75.2 149.5 76.2 78.3 109.9 123.7 106.5 70.7 75.8 72.9 53.4 77.9 99.6 56.9 65.0 112.4 89.6 141.2 100.7 155.7 201.6 88.7 60.5 53.5 154.6 67.1 103.5 97.9 45.4 62.5 86.2 78.5 146.0 35.0 125.2 43.9 40.5 88.8 60.1 35.4 75.1 98.3 130.0 38.9 147.0 74.7 71.5 83.6 102.1 54.0 58.8 63.3 78.7 98.3 45.9 32.2 40.7 44.3 31.1 51.8 25.5 18.8 22.0 30.4 40.6 17.6 18.0 20.7 31.2 23.9 57.0 20.8 33.6 39.2 98.7 103.2 104.3 110.1 103.5 105.2 116.8 109.8 103.0 119.4 103.7 108.5 123.0 40.0 57.7 41.0 10.1 23.4 33.8 24.0 42.3 13.1 26.6 22.1 17.1 51.6 14.3 34.8 27.6 16.7 54.9 23.8 52.4 54.8 75.5 53.0 15.3 21.0 45.2 39.6 45.9 14.9 77.5 63.3 36.9 23.4 19.3 32.3 27.3 34.6 24.1 73.9 26.9 15.5 24.4 46.8 37.6 38.2 53.9 33.2 44.5 51.6 5.6 70.3 31.5 38.1 10.1 15.3 92.0 36.8 36.1 30.0 26.7 40.9 45.6 26.5 24.5 46.0 17.1 48.5 61.9 14.0 27.3 32.4 104.7 28.2 32.9 24.2 26.6 CYP2C9 "CYP2C10, P450IIC9" ENSG00000138109 "Cytochrome P450 family 2 subfamily C member 9" P11712 10 94938658-94990091 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 1734.1" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 1704.9" "Cancer enriched" "Detected in some" 41 "liver cancer: 118.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015066, CAB016123, HPA074424" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Plasma membrane" "CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: " "unprognostic (3.37e-1)" "unprognostic (5.68e-2)" "unprognostic (9.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "prognostic favorable (2.83e-6)" "unprognostic (2.37e-1)" "unprognostic (2.05e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-4)" "unprognostic (7.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.45e-2)" "unprognostic (1.24e-2)" 0.1 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.1 0.6 0.0 1.5 88.6 0.0 0.0 7.7 0.0 8.0 0.0 0.0 0.0 4.2 1734.1 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 2.3 46.6 0.1 0.0 0.5 18.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.6 0.2 1.8 0.0 0.0 0.0 1.5 0.0 7.6 0.0 0.8 0.7 1.1 0.0 16.0 0.0 0.7 0.0 0.2 44.4 7.4 0.0 0.0 26.7 1704.9 0.0 0.0 0.1 1.4 0.0 34.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.6 0.0 0.1 0.0 65.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.1 1.9 0.0 2.7 0.0 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 2.3 2.5 9.5 3.3 11.8 5.2 2.1 12.7 12.9 2.4 2.4 4.7 5.5 3.1 0.7 3.0 2.3 2.4 3.1 10.3 7.0 2.5 6.3 9.1 3.2 7.4 7.4 10.8 1.4 3.9 1.7 4.2 2.3 8.9 3.2 3.3 4.9 1.8 0.9 2.3 11.2 4.5 2.5 5.8 7.0 4.0 3.7 8.5 1.8 5.4 1.5 3.7 2.2 2.6 9.0 12.0 5.4 4.0 9.6 0.4 0.4 6.2 2.3 6.0 4.6 10.5 10.7 16.0 10.6 11.8 0.9 4.4 14.6 7.4 6.3 1.7 13.5 6.8 13.1 8.2 5.6 10.1 6.7 12.3 5.2 2.6 2.6 4.6 3.7 5.3 14.2 3.0 5.7 0.4 2.4 11.3 4.3 6.8 10.5 5.2 13.6 0.6 1.8 2.0 3.1 10.0 9.5 2.2 1.2 5.2 1.4 6.0 4.0 1.6 2.1 2.5 2.6 3.3 1.9 5.5 14.0 11.6 10.9 2.9 0.4 4.3 3.5 2.9 3.2 2.8 3.4 2.7 2.3 4.5 1.4 2.8 3.2 2.5 1.2 1.8 0.4 0.8 2.6 9.5 11.8 12.7 12.9 10.3 7.0 7.4 7.4 10.8 8.9 5.8 8.5 9.0 4.1 19.2 15.4 0.0 1.1 0.0 1.5 0.0 0.6 8.2 1.5 1.9 0.0 1.5 0.6 1.8 4.2 1.8 5.7 2.6 0.0 2.8 1.8 1.0 1.0 3.8 2.4 3.6 0.0 3.6 2.6 1.6 5.6 1.6 1.3 2.8 6.4 4.0 15.7 21.9 0.0 3.8 0.0 4.8 0.0 1.0 0.9 8.7 0.0 0.0 5.6 3.2 2.1 0.0 0.0 3.2 4.6 2.2 0.8 1.4 5.6 1.5 0.7 13.8 0.0 2.8 1.1 4.5 3.0 2.4 0.0 28.5 3.2 4.0 4.5 1.4 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 359 "liver: 2174.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 1834.2" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013547, HPA013970, HPA015066, HPA074424" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Plasma membrane" "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: " "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favorable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.2 1.8 1.6 0.0 1.9 0.2 0.3 1.3 2.0 0.2 1.4 0.3 0.2 0.1 0.3 0.1 1.1 4.7 0.2 1.8 2.1 1.4 2174.2 0.4 0.1 1.7 2.1 1.6 0.1 1.7 0.5 3.1 0.1 1.7 0.6 0.0 3.1 0.2 0.3 0.2 0.1 1.1 0.0 1.3 1.0 6.0 4.0 1.9 0.2 0.9 0.0 0.1 0.2 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 1.3 2.0 1.8 2.1 1.7 2.1 1.6 1.7 1.3 1.9 2.6 0.0 0.0 0.0 1.6 8.9 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.2 147.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 7.3 0.9 0.1 2.0 1.8 57.5 4.5 0.2 0.0 0.1 0.0 0.2 0.0 0.6 52.8 1834.2 0.0 5.0 3.7 0.1 0.0 70.9 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 1.2 0.5 1.2 0.0 0.0 0.1 1.0 0.8 0.9 1.7 0.0 0.0 0.3 2.1 0.6 0.0 0.0 0.0 3.3 0.0 0.2 0.2 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482334 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 20.4;non-classical monocyte: 26.6" "Group enriched" "Detected in many" 57 "dendritic cells: 8.1;monocytes: 26.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 452.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" NA NA 190000 Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 27.9 8.1 3.6 20.8 4.1 1.5 43.7 5.3 5.2 56.9 33.8 22.6 5.4 27.7 7.2 36.7 37.2 26.8 13.9 3.3 14.2 11.0 2.9 32.5 4.5 8.9 6.0 1.0 9.9 5.9 24.0 3.8 55.7 10.0 27.7 29.6 0.9 19.8 31.7 3.7 56.5 9.1 44.7 5.8 6.5 13.5 2.2 6.0 5.2 36.1 6.2 9.1 62.6 29.7 7.0 228.9 206.3 21.4 14.6 159.4 318.4 62.0 190.3 452.7 110.1 109.2 51.1 177.1 0.0 76.9 353.7 116.2 350.0 1.8 204.7 82.6 1.4 0.9 0.0 80.8 2.1 55.2 0.0 0.2 183.0 71.6 77.7 323.8 289.4 299.7 0.0 0.0 0.5 275.6 39.4 0.1 0.9 1.6 72.0 171.6 0.0 15.8 0.1 314.3 281.5 0.1 0.0 130.4 29.7 46.1 83.1 141.5 4.7 378.5 167.3 11.8 111.3 113.9 0.2 0.3 0.3 128.2 2.6 201.0 0.0 5.4 0.0 0.0 20.4 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.3 0.0 26.6 2.8 0.2 1.6 3.6 4.1 5.3 5.2 3.3 14.2 8.9 6.0 1.0 10.0 5.8 6.0 7.0 42.5 60.9 52.5 1.6 1.2 23.7 63.0 101.4 39.3 0.1 48.4 34.3 9.2 14.3 91.5 22.0 0.0 56.6 3.8 74.1 1.9 54.8 0.6 50.9 45.9 28.8 1.8 0.0 2.7 33.7 23.7 38.1 23.0 123.4 1.3 1.7 35.7 0.4 22.9 0.0 0.8 29.6 42.7 29.2 20.2 0.6 5.9 28.5 8.8 60.0 12.8 0.1 0.0 2.0 0.7 153.7 22.2 9.1 0.8 86.7 0.6 1.5 60.7 0.8 6.6 15.9 39.6 0.1 0.3 53.4 30.7 51.2 1.9 8.3 18.7 100.7 LOXL4 "FLJ21889, LOXC" ENSG00000138131 "Lysyl oxidase like 4" Q96JB6 10 98247690-98268194 "Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Basal respiratory cells: 141.0" "Cancer enhanced" "Detected in all" "melanoma: 44.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "BJ hTERT+: 249.7;CAPAN-2: 301.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033876, HPA037609" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "CAB033876: AB_2135101, HPA037609: AB_2675579" "unprognostic (9.91e-3)" "unprognostic (3.97e-2)" "unprognostic (1.81e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (7.71e-2)" "unprognostic (1.75e-2)" "unprognostic (8.38e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (2.51e-1)" "unprognostic (4.97e-2)" "unprognostic (5.25e-2)" "unprognostic (5.77e-3)" "unprognostic (1.28e-1)" "unprognostic (6.10e-2)" "unprognostic (7.40e-3)" 6.2 2.4 0.8 1.6 0.9 0.5 12.0 1.1 0.7 11.9 2.0 7.6 1.9 7.0 3.0 2.0 7.8 1.9 2.2 0.7 1.3 4.7 6.1 4.4 0.4 1.2 1.0 0.6 7.2 6.6 1.2 1.9 5.8 1.2 6.6 1.8 2.7 19.8 10.9 8.4 3.7 3.3 7.7 0.9 2.7 2.9 5.5 0.9 1.4 7.1 1.5 0.7 5.0 7.5 1.0 0.0 1.6 0.1 0.3 6.9 29.5 0.9 32.1 249.7 2.6 26.6 5.4 301.6 0.1 28.4 25.1 1.1 0.3 0.1 0.0 2.2 0.0 0.2 0.0 4.4 13.3 6.7 0.0 0.0 3.3 0.0 4.4 0.0 0.4 0.1 0.0 0.3 0.0 0.4 0.0 0.0 2.3 0.6 0.1 0.5 0.1 2.9 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 8.7 0.2 0.7 0.7 0.2 53.7 3.2 1.1 0.0 0.0 0.2 0.5 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.8 0.9 1.1 0.7 0.7 1.3 1.2 1.0 0.6 1.2 0.9 0.9 1.0 0.3 6.4 1.5 0.7 0.3 0.9 2.1 141.0 0.0 0.4 6.5 6.5 1.6 4.3 17.5 31.3 0.0 0.2 1.7 0.1 0.0 11.1 0.3 1.5 1.2 0.9 0.0 0.0 0.1 0.5 0.4 6.0 0.0 4.2 1.3 1.1 2.2 0.4 0.2 0.0 0.1 0.2 8.2 0.0 2.1 0.4 4.1 0.2 0.0 9.4 0.0 5.4 0.0 0.0 0.0 3.0 0.0 1.5 0.3 7.9 0.0 0.4 6.3 0.1 0.0 5.2 2.2 0.1 0.2 0.1 0.9 0.4 0.2 0.7 0.0 3.4 STAMBPL1 "ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373" ENSG00000138134 "STAM binding protein like 1" Q96FJ0 10 88879734-88975153 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 24.0" "Cell type enhanced" "Detected in many" "Early spermatids: 54.3;Excitatory neurons: 60.5;Microglial cells: 32.8;Spermatocytes: 40.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040202 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040202: AB_10805708" "unprognostic (2.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.56e-2)" "unprognostic (4.25e-2)" "unprognostic (6.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-2)" "unprognostic (4.67e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (4.41e-2)" "unprognostic (4.06e-2)" "unprognostic (1.50e-1)" "unprognostic (4.40e-3)" 3.9 24.0 4.0 10.4 6.6 5.3 2.6 3.1 7.9 2.7 0.0 8.8 6.5 4.2 0.9 4.5 2.3 4.2 8.1 5.7 2.7 1.8 1.8 3.6 16.4 1.7 1.3 4.6 12.8 2.3 3.5 5.6 1.2 3.2 1.7 9.8 4.5 1.4 1.1 0.7 3.7 7.4 3.0 3.0 7.3 5.1 18.2 0.6 7.2 1.2 1.5 12.3 6.4 2.5 7.2 14.8 16.5 1.0 0.6 14.4 27.7 0.0 31.5 28.9 19.0 16.3 0.3 25.6 18.6 2.3 15.6 12.3 6.4 4.1 4.5 17.9 16.3 10.8 4.6 10.4 0.9 10.3 20.2 5.7 10.6 1.4 31.6 9.6 18.4 0.6 20.9 0.0 7.3 50.0 3.0 34.2 21.5 6.6 13.3 14.1 3.4 13.0 3.8 6.5 4.7 9.6 11.9 3.7 1.1 37.5 3.6 2.3 4.1 4.9 17.0 12.4 20.7 19.9 17.7 19.7 17.2 18.2 19.4 16.9 9.5 1.0 8.1 10.7 1.1 14.1 17.7 15.5 13.7 1.7 14.9 16.6 10.0 1.4 23.6 0.5 27.9 28.3 8.0 4.0 6.6 3.1 7.9 5.7 2.7 1.7 1.3 4.6 3.2 3.0 0.6 7.2 2.3 0.0 4.5 10.7 16.7 9.6 5.3 1.4 1.2 3.6 2.3 1.4 8.6 0.0 0.2 5.5 0.0 0.1 18.8 7.6 0.0 1.3 54.3 1.9 6.5 1.8 9.1 3.4 60.5 1.8 0.1 7.7 3.1 1.4 5.1 7.4 1.8 2.4 3.7 6.7 26.2 9.3 4.1 1.3 9.6 20.7 7.2 3.1 0.0 32.8 1.0 9.3 12.3 26.2 1.9 1.9 2.8 1.5 14.2 1.9 7.9 0.8 5.0 0.4 0.0 20.4 6.4 40.2 2.5 5.9 11.4 0.1 17.6 14.9 14.2 2.9 CH25H ENSG00000138135 "Cholesterol 25-hydroxylase" O95992 10 89205629-89207317 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 88.9;lymphoid tissue: 35.6" "Cell type enhanced" "Detected in many" "Adipocytes: 125.9;Basal squamous epithelial cells: 224.3;Macrophages: 47.3;Microglial cells: 40.3;Smooth muscle cells: 59.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 88.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.8;ASC TERT1: 4.4;fHDF/TERT166: 32.8;HSkMC: 8.2" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "spinal cord: 6.3" NA NA "unprognostic (6.07e-3)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (5.11e-2)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "unprognostic (8.65e-3)" "unprognostic (7.74e-2)" "unprognostic (4.76e-2)" "unprognostic (2.62e-5)" "unprognostic (2.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.29e-2)" 12.2 5.1 7.5 7.0 4.8 3.1 7.4 6.6 7.9 3.5 4.8 3.5 3.3 1.3 12.8 14.8 6.1 14.7 4.3 4.1 88.9 2.1 3.6 17.4 4.1 20.6 6.3 4.3 2.1 1.6 1.1 9.1 4.2 11.0 4.1 5.6 0.4 2.2 1.3 1.8 2.6 5.7 5.5 8.2 2.0 5.9 0.1 8.9 35.6 2.8 1.0 3.7 18.7 2.1 22.5 0.0 0.0 0.0 0.0 8.8 4.4 0.0 0.1 3.1 0.8 0.9 0.0 0.0 0.0 1.1 32.8 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 8.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 4.2 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 4.8 6.6 7.9 4.1 88.9 20.6 6.3 4.3 11.0 8.2 8.9 22.5 125.9 3.2 3.4 0.3 1.8 6.9 4.4 11.7 224.3 0.0 6.4 1.0 0.6 0.0 10.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 1.5 0.9 23.6 0.0 0.0 2.9 0.0 0.2 33.4 2.0 3.1 1.3 0.0 2.5 0.0 10.2 1.7 0.5 0.0 2.0 12.9 8.2 0.0 0.3 47.3 7.2 40.3 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.7 4.4 1.0 0.0 0.0 4.5 0.5 6.6 3.6 59.3 0.0 0.0 30.8 6.7 0.1 11.6 0.5 0.0 6.2 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 26.7" "Cell type enriched" "Detected in single" 5 "Skeletal myocytes: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1" "Group enriched" "Detected in some" 24 "cerebellum: 1.6;pons and medulla: 3.0" "Group enriched" "Detected in some" 18 "cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.6 0.0 0.4 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 9.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 1.9 0.3 0.0 0.0 2.7 0.1 0.0 1.8 2.8 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATAD1 "FLJ14600, Msp1" ENSG00000138138 "ATPase family AAA domain containing 1" Q8NBU5 10 87751512-87841361 "Disease related genes, Human disease related genes, Predicted membrane proteins" Translocase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 16 "Early spermatids: 987.5;Late spermatids: 1846.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037569 Uncertain Approved "Nucleoli rim,Mitochondria" NA NA "Nucleoli rim" Mitochondria "HPA037569: AB_10672496" "unprognostic (9.92e-2)" "unprognostic (2.90e-1)" "unprognostic (4.05e-2)" "unprognostic (2.68e-1)" "unprognostic (3.24e-2)" "unprognostic (6.60e-3)" "unprognostic (3.38e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-1)" "unprognostic (8.45e-2)" "unprognostic (1.35e-3)" "unprognostic (1.67e-2)" "prognostic favorable (3.98e-6)" "unprognostic (2.35e-1)" "unprognostic (3.29e-1)" "unprognostic (3.45e-2)" "unprognostic (4.22e-2)" 15.7 17.5 11.0 9.1 11.2 5.0 16.5 12.2 12.7 15.8 11.4 17.3 11.0 16.9 13.9 16.3 13.9 10.6 34.3 11.1 12.2 16.8 18.1 14.7 11.9 11.4 12.3 10.1 16.0 12.9 28.7 13.5 15.3 12.0 18.9 14.7 28.2 15.0 16.3 37.5 15.0 12.6 13.8 10.8 10.1 13.7 26.6 11.5 13.9 17.6 32.0 12.2 15.6 16.1 12.2 18.8 18.2 20.8 18.2 27.4 29.5 14.4 19.7 33.4 19.6 20.6 14.6 53.8 17.6 15.4 17.3 9.8 31.3 18.9 14.4 21.2 18.6 26.4 15.3 24.0 18.8 30.5 41.7 8.0 23.0 45.4 20.7 42.1 37.2 12.7 14.1 15.9 20.7 22.7 11.2 23.1 22.9 16.4 13.9 10.0 15.8 13.2 19.2 28.9 13.4 14.2 31.5 20.3 12.3 32.0 21.0 29.1 18.0 19.3 16.2 13.9 11.2 24.5 25.4 39.4 22.5 20.8 23.7 11.5 8.4 2.8 4.9 6.3 4.9 10.3 7.2 7.3 8.3 5.4 5.7 9.1 8.6 1.7 8.6 6.9 4.6 7.6 5.7 11.0 11.2 12.2 12.7 11.1 12.2 11.4 12.3 10.1 12.0 10.8 11.5 12.2 31.0 54.5 28.0 46.4 41.4 26.8 42.9 46.2 44.3 50.4 29.8 20.8 81.3 27.1 44.9 22.0 35.5 37.7 35.2 33.8 23.5 37.0 987.5 22.3 38.3 21.7 22.8 24.6 69.0 28.0 33.2 35.6 32.6 28.7 29.2 23.1 20.0 28.9 27.3 70.7 73.1 22.9 50.8 18.0 20.1 1846.8 35.8 25.1 32.0 37.5 16.1 59.6 23.7 58.8 52.7 39.0 25.2 47.0 32.3 42.3 20.5 29.5 44.8 54.8 59.2 29.5 43.8 77.2 29.8 34.6 30.1 88.4 40.0 34.8 23.7 54.6 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271296-122338159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.4;testis: 7.9;urinary bladder: 20.4" "Group enriched" "Detected in some" 9 "Early spermatids: 123.2;Late spermatids: 69.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RT4: 33.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.1 0.0 1.5 0.0 1.8 0.0 0.5 1.7 2.1 0.3 1.2 0.4 0.0 0.1 0.3 0.1 0.4 0.2 0.0 1.6 1.7 0.3 4.0 0.3 0.0 1.8 1.9 1.4 0.0 0.1 0.0 0.4 0.1 2.1 0.8 0.0 0.0 0.4 0.0 0.3 8.4 0.1 0.1 1.7 0.0 0.1 7.9 1.7 0.0 0.4 0.0 0.1 20.4 0.5 2.6 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 33.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 1.8 1.7 2.1 1.6 1.7 1.8 1.9 1.4 2.1 1.7 1.7 2.6 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 123.2 0.6 0.0 0.2 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.4 69.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 9.8 1.1 3.8 0.4 0.0 0.1 0.2 1.0 3.1 0.0 0.0 0.4 0.2 10.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 2.9 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92574105-92655395 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.6;lymphoid tissue: 38.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 1.1 0.8 0.6 8.5 0.8 19.6 2.5 0.5 0.7 1.3 0.6 6.4 5.5 1.8 1.0 6.7 1.0 1.2 0.7 0.5 0.6 1.0 1.1 1.3 17.6 0.7 0.6 0.5 0.6 0.5 0.7 0.3 3.9 0.7 1.0 7.4 0.8 1.3 0.7 0.2 6.0 5.4 2.5 0.6 2.9 3.9 11.7 0.6 38.2 1.7 0.4 18.6 2.3 2.4 0.9 103.1 45.2 100.6 94.5 7.3 10.5 24.2 72.6 62.8 78.8 78.1 39.6 67.2 111.1 36.5 34.4 32.9 72.0 72.1 36.5 92.4 68.3 41.3 70.5 41.4 42.4 1.4 116.0 63.0 3.6 3.3 61.4 55.9 18.3 50.0 46.1 51.2 126.4 61.1 41.4 99.3 65.8 40.3 42.5 30.7 106.6 98.8 40.2 21.0 30.1 30.0 42.9 56.4 25.9 29.2 34.1 67.9 37.6 28.6 35.7 51.3 37.1 96.9 35.4 58.3 113.4 29.5 82.3 50.3 0.8 0.0 0.1 0.0 0.3 0.3 0.6 0.4 0.4 0.2 0.1 0.1 0.2 0.2 1.0 0.1 0.1 1.1 0.2 0.6 0.8 0.5 0.7 0.5 0.6 0.7 0.6 0.5 0.7 0.6 0.6 0.9 0.4 0.0 2.0 1.3 3.5 2.9 1.1 1.6 3.4 1.0 1.8 1.8 1.7 1.5 2.5 1.8 0.0 6.7 2.3 2.9 1.9 0.5 16.3 3.4 4.3 2.0 0.0 39.1 2.1 0.6 11.4 4.7 9.2 4.9 0.0 20.7 2.2 0.4 8.2 0.0 1.8 4.3 4.1 4.6 3.4 4.4 0.9 4.0 0.0 0.0 1.0 0.7 2.1 2.5 1.1 0.2 0.4 0.7 15.2 0.8 0.5 0.6 3.7 0.4 0.0 1.7 3.7 38.0 23.4 12.6 3.3 1.5 4.5 2.5 8.0 1.7 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832158-122846175 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1632 "pancreas: 2434.7" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 266.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.9;U-937: 1.2" "Not detected" "Not detected" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.4 0.2 0.4 0.2 0.4 0.8 0.4 0.4 0.5 0.6 0.4 0.5 0.5 0.4 0.4 0.5 0.5 0.0 0.4 0.5 0.4 0.8 0.2 0.5 0.2 0.5 0.4 0.4 1.0 2434.7 0.0 1.4 0.1 0.6 0.7 0.0 0.4 0.5 0.0 0.1 0.7 0.9 0.0 0.4 1.1 0.4 1.0 0.4 0.3 0.5 0.0 0.0 0.5 0.5 0.5 0.3 0.5 0.1 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.1 0.2 0.3 0.3 0.3 1.0 0.1 0.4 0.3 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.4 0.2 0.3 0.0 0.3 0.5 0.4 0.6 0.5 0.0 0.5 0.2 0.0 0.0 0.4 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.5 0.5 0.4 0.5 0.4 0.4 0.6 0.4 0.4 0.5 0.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 2.8 0.1 0.1 0.1 0.0 0.4 0.0 266.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.0 0.0 0.1 0.0 0.3 0.3 6.7 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.0 43.6 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.7 0.2 0.0 0.1 0.0 0.7 0.1 0.2 0.1 TACC2 "AZU-1, ECTACC" ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989163-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 221.9;skeletal muscle: 390.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 86.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 32000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 21.2 15.4 18.6 5.4 19.1 0.2 21.1 23.3 22.9 27.8 25.9 72.6 15.5 26.3 9.3 64.7 33.2 13.0 221.9 19.2 17.7 33.9 19.0 69.3 1.0 16.1 14.5 16.2 8.9 25.5 36.8 59.1 21.8 16.9 68.3 20.9 7.3 61.2 13.6 390.3 104.1 36.0 22.2 11.5 4.2 49.5 5.9 14.9 5.7 51.2 160.4 5.7 62.9 49.5 18.0 17.8 55.1 26.5 15.2 7.4 7.4 31.7 7.7 20.7 10.5 7.3 22.7 28.9 0.0 7.0 12.3 12.1 58.1 8.5 20.9 10.9 3.0 4.4 0.0 7.7 43.8 11.5 0.0 0.3 3.4 86.0 5.6 36.6 8.6 22.2 0.1 4.5 0.6 10.4 23.5 0.2 9.9 15.7 27.6 24.8 0.3 15.2 8.5 28.9 26.9 17.6 14.2 12.7 52.0 29.5 7.6 10.2 0.4 20.6 4.7 3.5 11.8 14.5 2.4 11.7 0.3 8.7 0.1 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 19.1 23.3 22.9 19.2 17.7 16.1 14.5 16.2 16.9 11.5 14.9 18.0 15.5 83.3 94.1 16.3 0.7 33.6 49.7 54.3 33.0 21.6 23.4 14.1 210.1 8.6 70.7 36.8 0.0 53.3 0.4 75.2 1.9 8.2 2.4 88.4 11.0 21.3 30.0 0.0 32.8 14.2 4.4 21.2 38.7 62.8 7.0 0.1 6.1 18.9 6.5 43.7 48.2 38.8 57.0 0.3 4.3 2.6 6.8 1.9 7.2 7.5 0.1 1.1 0.0 80.9 7.6 19.4 47.1 7.5 0.2 49.6 36.5 13.5 84.9 2.7 13.1 27.2 23.7 0.5 8.2 79.5 54.0 228.5 2.6 2.8 41.9 80.5 DUSP5 HVH3 ENSG00000138166 "Dual specificity phosphatase 5" Q16690 10 110497907-110511533 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 116.5;urinary bladder: 177.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 10.3;plasmacytoid DC: 14.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8" "Region enhanced" "Detected in all" "cerebellum: 60.7" "Region enriched" "Detected in many" 5 "cerebellum: 45.4" NA NA "unprognostic (1.25e-1)" "unprognostic (3.57e-1)" "unprognostic (5.19e-2)" "unprognostic (1.03e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (8.30e-6)" "unprognostic (1.70e-2)" "unprognostic (4.60e-2)" "unprognostic (2.91e-2)" "unprognostic (1.20e-2)" "unprognostic (4.20e-3)" "unprognostic (3.79e-1)" "unprognostic (3.78e-3)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" 27.1 37.9 8.3 27.0 7.7 38.9 26.9 21.8 17.7 22.0 11.9 21.2 12.3 19.9 2.0 116.5 12.8 51.9 31.0 14.6 11.5 26.2 25.9 23.4 12.9 7.0 9.3 7.2 7.7 8.1 6.8 20.1 48.7 9.6 17.8 26.6 9.9 23.6 12.7 2.7 16.8 19.7 21.3 7.5 28.6 26.7 20.3 9.9 15.0 19.0 3.8 32.8 177.5 38.2 7.6 22.0 14.6 3.0 7.3 11.1 46.5 10.6 50.9 114.6 26.8 32.2 9.4 28.9 2.6 9.4 12.4 56.9 7.0 2.8 26.7 43.2 62.8 1.8 12.1 2.6 5.8 41.8 3.2 15.1 17.9 35.9 85.7 408.0 11.8 17.1 1.2 2.1 161.2 81.4 5.9 0.9 9.2 9.6 2.1 22.2 0.2 6.3 38.8 92.0 42.3 1.6 4.0 3.3 8.0 17.4 25.6 4.5 3.8 26.5 9.0 6.2 21.7 24.7 227.8 44.7 6.2 34.9 16.4 6.4 0.5 0.2 0.0 3.5 2.2 1.3 0.2 1.8 1.0 0.9 0.0 0.1 1.0 0.2 0.0 10.3 14.5 0.1 0.6 8.3 7.7 21.8 17.7 14.6 11.5 7.0 9.3 7.2 9.6 7.5 9.9 7.6 150.7 3.2 7.8 0.3 71.2 66.0 409.1 91.4 30.7 9.0 72.7 77.0 33.5 11.5 78.3 35.0 6.2 44.0 97.7 63.5 5.9 29.1 1.5 50.6 32.2 90.8 48.9 0.4 4.4 4.8 11.2 42.7 39.3 196.6 3.8 5.5 158.5 4.1 10.7 0.0 2.2 12.8 22.4 16.6 298.4 3.3 1.5 91.5 158.3 1.0 46.9 2.3 4.1 1.0 0.0 49.1 93.2 0.7 412.2 127.0 44.4 0.6 27.3 12.6 0.0 25.8 37.3 1.2 19.8 61.8 101.9 137.4 122.0 3.3 9.2 1063.2 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 48.5 18.6 6.3 12.6 5.9 2.2 39.3 5.4 9.1 53.9 7.5 17.8 6.5 58.6 5.5 12.3 43.7 21.8 29.1 6.0 6.6 9.4 4.5 23.4 13.8 7.1 5.6 5.3 48.5 7.2 3.1 7.4 10.0 7.0 21.3 4.3 0.4 15.1 10.7 9.7 16.6 19.8 16.1 6.5 35.5 13.9 11.6 7.0 5.7 21.8 11.2 6.1 34.2 39.7 6.6 11.0 7.5 1.8 2.4 27.3 45.1 9.1 37.7 37.5 11.2 15.7 3.3 5.3 3.3 4.2 43.2 0.7 5.0 3.8 0.0 2.1 0.4 21.5 7.8 2.5 0.6 12.4 1.3 0.7 15.6 0.0 3.3 0.1 20.8 13.5 8.3 1.8 19.8 7.5 25.0 3.0 3.7 4.8 2.3 6.7 9.2 3.0 7.5 1.0 0.9 5.3 2.3 1.5 6.2 2.1 0.8 1.2 2.5 24.5 3.6 4.4 12.6 2.7 3.0 7.6 3.8 31.0 24.0 0.8 70.0 91.9 1.8 83.7 178.4 69.6 27.7 56.5 69.7 152.1 7.3 10.8 42.3 3.6 62.9 214.6 17.8 82.7 85.6 6.3 5.9 5.4 9.1 6.0 6.6 7.1 5.6 5.3 7.0 6.5 7.0 6.6 18.2 3.2 0.6 1.0 4.9 5.4 2.9 0.6 4.0 0.1 3.4 4.4 3.3 1.5 0.0 3.7 0.0 3.1 11.3 0.1 0.0 4.2 1.0 1.4 19.8 25.5 1.2 5.7 2.3 0.2 75.1 38.2 1.5 2.1 8.8 11.4 48.2 0.6 53.7 0.0 0.5 0.1 2.0 28.8 18.8 2.5 45.7 21.5 8.8 2.8 17.3 0.2 33.0 1.0 0.2 0.1 0.1 16.1 3.1 0.8 0.0 0.3 0.0 0.1 19.7 16.8 27.9 0.8 0.9 0.8 3.8 19.2 19.4 6.0 0.0 1.0 ARL3 ARFL3 ENSG00000138175 "ADP ribosylation factor like GTPase 3" P36405 10 102673731-102714397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 97.2" "Cell type enhanced" "Detected in all" "Muller glia cells: 289.1;Rod photoreceptor cells: 318.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036292, HPA063596" Approved Supported Nucleoplasm,Centrosome NA NA 44000 Centrosome Nucleoplasm "HPA036292: AB_10673618, HPA063596: AB_2685053" "unprognostic (1.36e-1)" "unprognostic (2.89e-3)" "unprognostic (4.19e-2)" "unprognostic (7.58e-2)" "unprognostic (2.98e-2)" "unprognostic (3.24e-2)" "unprognostic (2.45e-2)" "unprognostic (7.69e-2)" "unprognostic (4.00e-2)" "unprognostic (3.21e-1)" "unprognostic (3.99e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.71e-6)" "unprognostic (5.62e-2)" "unprognostic (3.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-1)" 7.4 9.0 18.6 4.3 20.6 1.7 8.2 20.1 25.3 12.0 17.3 9.3 4.3 11.6 10.7 4.6 15.4 5.3 13.2 19.4 18.6 15.5 5.3 8.4 3.7 18.2 18.2 19.2 17.0 6.5 19.9 21.2 4.9 19.5 8.8 4.7 97.2 6.3 9.1 5.7 7.1 6.2 8.7 17.4 4.5 8.9 11.1 19.2 5.7 11.5 5.9 4.7 9.9 8.4 20.8 14.7 25.0 33.6 24.7 15.2 22.7 5.9 11.4 17.3 13.6 14.7 8.7 7.4 6.1 10.8 18.5 16.4 10.7 12.7 15.3 16.9 16.1 13.4 9.9 16.9 8.3 16.4 4.6 9.5 11.5 12.6 18.8 11.0 36.1 15.8 12.0 4.5 6.0 23.0 15.1 9.5 7.3 13.0 9.2 9.8 7.9 24.8 5.4 18.1 7.7 11.8 25.7 8.7 1.8 14.1 18.5 45.1 4.6 9.1 9.2 12.9 18.9 16.0 4.2 8.9 11.3 24.4 13.6 8.1 2.0 7.2 2.6 3.7 6.1 9.4 4.5 6.5 5.5 7.1 3.9 3.9 4.7 13.4 4.4 5.4 5.2 4.9 5.4 18.6 20.6 20.1 25.3 19.4 18.6 18.2 18.2 19.2 19.5 17.4 19.2 20.8 46.0 54.5 39.3 47.7 16.7 32.1 70.4 144.3 29.0 167.6 48.2 57.5 135.5 31.5 85.8 62.5 116.7 45.5 12.1 9.4 234.8 70.7 46.5 250.5 85.2 41.6 74.8 9.4 30.8 43.6 37.8 61.7 19.4 84.6 33.0 94.1 43.9 25.5 64.7 97.6 37.6 31.6 73.2 16.4 33.6 25.8 60.6 26.8 76.5 13.1 67.3 289.1 13.4 31.7 23.4 31.1 13.5 104.2 18.6 54.2 23.1 225.8 268.3 318.6 26.3 50.8 122.0 145.6 43.4 11.9 31.7 32.3 20.8 58.6 25.4 50.5 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496612-93529092 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.6;testis: 21.9" "Cell type enhanced" "Detected in many" "Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "T-reg: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA023430 Approved Approved "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 1.3 0.6 0.1 7.7 0.0 5.0 1.4 0.0 0.2 1.7 0.0 7.0 6.7 1.4 0.1 7.4 0.4 1.5 0.2 0.0 0.4 0.3 0.6 1.3 14.9 0.1 0.1 0.0 0.2 0.2 0.2 0.3 3.5 0.1 0.3 8.9 0.0 1.2 0.3 0.1 4.5 6.3 5.3 0.1 2.5 4.6 21.9 0.3 27.6 0.5 0.2 15.6 3.1 2.3 0.8 208.5 81.5 53.0 67.7 5.8 12.0 29.6 112.4 78.2 103.5 106.4 87.2 108.6 55.4 48.2 72.8 69.6 115.4 64.8 54.8 123.4 167.2 33.7 21.0 49.2 29.9 0.6 36.3 46.3 2.8 3.8 110.6 133.5 30.7 97.1 89.9 19.3 101.8 118.5 48.3 96.3 54.8 20.9 64.2 58.8 41.3 86.9 30.3 47.1 25.5 21.7 30.7 86.3 26.3 64.9 40.1 68.9 36.4 61.4 65.3 90.6 90.5 186.7 45.1 66.1 66.8 51.0 134.8 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.3 0.8 0.2 0.0 1.3 0.0 2.7 3.6 0.9 1.9 0.0 0.0 1.8 2.0 0.4 2.8 0.2 0.0 0.0 7.7 0.9 3.3 0.0 0.6 29.4 1.7 2.0 1.5 0.0 2.5 0.5 0.2 17.1 2.3 8.2 3.6 0.0 19.8 2.2 0.3 12.9 0.0 0.3 4.5 4.1 7.0 5.1 8.2 0.3 5.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.4 14.8 1.1 0.4 0.0 0.2 0.0 0.0 0.5 4.5 77.3 17.3 16.1 1.3 1.5 4.3 1.6 7.9 1.7 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701590-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.3;lymphoid tissue: 9.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 1.3 0.7 0.3 4.5 0.8 10.3 2.6 2.4 0.4 1.5 0.1 3.2 3.6 2.3 0.4 3.3 1.2 1.3 0.9 0.3 0.4 1.3 1.3 1.5 8.0 0.4 0.4 0.3 2.7 0.7 1.1 0.2 2.4 0.9 1.3 4.1 1.1 1.0 0.9 0.4 2.5 3.4 2.2 0.4 3.4 2.5 7.0 0.5 9.9 1.8 0.7 7.5 1.6 0.7 0.6 84.8 17.0 24.3 21.7 4.7 8.0 20.2 33.8 30.9 34.8 36.3 22.6 38.1 32.5 10.4 17.3 13.0 41.8 27.3 18.9 46.4 39.5 18.6 33.1 30.5 19.5 1.4 57.1 26.3 3.4 2.8 33.7 33.9 12.2 22.8 17.0 32.2 36.5 31.3 14.6 33.6 10.8 25.0 13.8 16.1 23.1 47.8 14.3 10.7 11.2 7.7 13.9 24.4 11.0 12.2 17.3 28.5 16.3 17.9 22.2 22.1 29.1 55.3 10.1 29.5 43.2 21.1 49.4 16.8 13.1 2.4 4.2 5.5 4.1 6.8 13.0 7.4 6.1 1.3 16.0 8.6 8.0 0.2 3.0 4.5 5.2 9.5 2.2 0.3 0.8 2.4 0.4 0.3 0.4 0.4 0.4 0.3 0.9 0.4 0.5 0.6 11.5 3.2 13.5 2.3 36.4 17.7 6.2 20.8 6.8 14.3 8.3 8.5 8.7 1.5 10.7 0.0 10.4 21.4 32.3 8.8 3.9 6.9 13.1 10.6 13.2 11.0 1.2 89.2 8.1 4.7 38.1 13.2 14.8 12.9 44.4 37.2 9.3 4.4 20.7 13.5 9.5 8.6 16.2 21.0 17.9 10.5 8.1 17.1 5.4 23.4 11.3 7.5 24.7 9.0 9.1 4.1 5.7 8.6 51.4 3.7 8.9 3.2 6.6 9.8 6.6 16.9 17.1 165.4 96.7 26.1 14.1 5.2 34.2 12.9 25.5 5.2 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95877266 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 17.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 102.2" "Group enriched" "Detected in all" 4 "dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0" "Group enriched" "Detected in many" 7 "HDLM-2: 147.5;Karpas-707: 135.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002494, HPA014067, CAB079986" Enhanced Uncertain Microtubules NA NA 19000 Microtubules "CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favorable (7.89e-4)" "unprognostic (5.09e-2)" 11.9 8.4 5.5 24.9 5.4 27.8 10.9 4.5 6.5 17.6 5.7 12.3 9.4 28.2 19.5 19.4 14.1 27.9 8.6 4.9 5.2 6.6 5.5 16.2 20.4 6.6 5.7 4.3 5.6 2.8 3.4 4.0 11.5 7.3 11.3 12.9 6.9 6.1 18.3 4.1 6.3 11.8 50.1 5.3 21.7 7.4 4.6 6.5 6.8 20.2 8.8 25.8 30.9 11.1 6.1 1.4 2.7 5.4 7.1 0.1 0.1 5.0 4.5 1.2 0.0 0.0 4.0 1.6 8.2 3.1 0.0 5.3 2.2 0.0 0.0 0.0 147.5 5.2 7.2 4.0 4.3 0.0 12.5 4.1 0.1 0.0 0.6 0.0 2.4 18.2 2.0 5.3 135.4 0.1 4.4 4.7 5.8 5.9 3.6 2.8 15.3 2.4 4.4 1.7 2.2 5.1 6.2 3.6 3.7 3.9 3.6 5.5 5.9 3.9 3.9 2.8 3.8 5.3 21.6 7.2 0.6 4.3 13.9 2.7 0.7 41.0 102.2 0.6 27.2 1.1 13.7 1.6 1.1 31.9 11.4 0.6 0.6 49.4 1.5 6.7 2.1 13.1 15.5 5.5 5.4 4.5 6.5 4.9 5.2 6.6 5.7 4.3 7.3 5.3 6.5 6.1 19.6 0.0 1.1 74.1 40.9 8.9 0.3 0.0 0.6 1.4 0.8 1.5 10.1 0.0 0.7 1.8 2.1 0.6 3.7 0.3 1.9 0.0 10.3 0.6 3.6 60.6 0.0 4.4 2.8 2.0 1.9 15.7 6.1 0.6 3.8 0.3 31.4 0.8 26.6 0.0 5.2 0.1 0.0 110.4 161.3 7.3 0.6 62.1 16.0 217.4 112.2 0.4 0.0 20.6 5.0 0.2 1.2 3.0 80.1 0.5 0.1 0.3 0.8 0.8 6.6 1.0 22.7 10.1 4.4 0.8 11.2 15.7 26.9 15.1 1.0 0.5 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92826831-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 165.7" "Cell type enhanced" "Detected in all" "Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: AB_2683907" "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favorable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 8.4 14.5 6.0 8.2 7.7 13.0 8.0 8.3 8.4 6.6 9.7 9.6 8.1 6.1 5.7 4.2 5.9 10.2 6.3 7.8 5.7 6.5 10.2 10.8 9.5 3.9 4.2 6.3 3.9 10.1 6.3 6.1 37.7 5.2 8.7 10.3 165.7 5.7 4.3 32.1 5.0 9.6 7.7 3.3 9.1 7.0 10.0 5.2 8.6 28.6 19.9 8.3 10.2 3.5 7.1 19.8 24.3 25.7 16.8 1.3 1.6 9.1 9.0 24.9 8.1 9.7 9.1 16.5 22.5 19.0 4.3 6.6 12.3 20.8 5.7 10.1 20.1 20.9 35.1 8.3 11.7 9.6 36.4 30.6 2.2 3.0 7.2 4.8 14.6 113.8 14.6 29.2 14.5 4.0 10.7 15.3 23.2 3.5 40.2 7.0 22.5 11.2 11.6 17.4 13.2 8.5 11.9 9.2 9.2 11.8 6.4 18.2 18.8 22.4 0.6 8.2 7.5 14.7 10.8 12.4 18.1 2.8 41.6 9.3 6.2 4.9 15.2 3.0 3.9 3.0 6.7 3.4 2.8 5.1 6.6 2.7 3.2 30.6 2.8 3.9 11.1 3.3 2.4 6.0 7.7 8.3 8.4 7.8 5.7 3.9 4.2 6.3 5.2 3.3 5.2 7.1 28.3 16.0 16.7 33.6 27.6 3.3 10.7 8.6 3.4 40.2 9.8 6.5 12.0 20.0 15.0 16.5 39.6 22.9 24.1 14.3 5.9 28.3 5.4 8.8 3.0 53.1 25.6 39.2 181.7 15.4 7.8 7.8 13.7 16.5 10.8 24.3 77.1 14.2 21.4 23.5 100.3 16.6 14.2 18.2 12.5 12.6 4.4 18.9 5.4 146.1 22.8 27.1 19.6 157.3 84.7 14.1 10.3 14.7 13.8 14.1 10.8 8.4 10.0 177.8 13.1 13.6 9.0 25.0 25.5 4.9 4.8 20.5 18.4 29.8 11.9 15.8 PLCE1 "KIAA1516, NPHS3, PLCE" ENSG00000138193 "Phospholipase C epsilon 1" Q9P212 10 93993931-94332823 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015597, HPA015598" Enhanced Supported Cytosol NA NA Cytosol "HPA015597: AB_1855321, HPA015598: AB_1855322" "unprognostic (4.73e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.59e-3)" "unprognostic (3.01e-1)" "unprognostic (2.96e-1)" "unprognostic (1.73e-2)" "unprognostic (4.76e-3)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-3)" "unprognostic (3.56e-1)" "unprognostic (3.92e-2)" "unprognostic (3.54e-2)" "unprognostic (4.30e-2)" 3.4 2.6 4.4 2.8 4.1 0.2 2.7 3.3 5.6 7.2 6.8 9.9 4.1 9.1 5.3 1.7 4.4 2.5 9.6 3.8 4.9 8.2 0.7 7.3 0.7 4.2 4.6 3.4 3.9 14.9 0.8 4.4 2.9 3.9 3.8 7.6 7.4 2.3 5.5 4.1 1.0 5.2 4.3 3.2 6.2 8.3 2.0 4.9 0.5 9.8 6.3 0.6 5.6 5.7 4.2 4.0 6.7 1.8 1.1 0.7 3.2 1.9 2.8 0.6 0.3 0.4 5.3 1.3 0.8 1.3 2.3 1.3 2.6 2.2 0.4 0.6 0.4 2.3 0.5 4.0 0.5 0.0 0.9 0.3 1.8 0.0 1.1 0.0 6.8 0.0 0.4 0.5 0.3 4.2 0.3 0.8 0.9 0.7 7.9 5.0 0.1 3.9 0.2 0.2 10.3 0.9 1.5 3.3 3.6 0.7 4.1 3.5 0.6 0.6 3.0 5.9 2.0 4.4 0.6 0.3 0.4 3.5 1.1 2.2 0.1 0.1 0.0 0.3 0.2 0.2 0.5 0.3 0.2 0.1 0.7 0.5 0.4 0.1 0.2 0.2 0.2 0.1 0.1 4.4 4.1 3.3 5.6 3.8 4.9 4.2 4.6 3.4 3.9 3.2 4.9 4.2 8.2 70.5 5.4 69.5 7.0 8.2 9.7 6.8 2.2 12.2 3.6 3.6 34.7 4.3 12.3 0.0 0.0 3.7 2.9 79.6 1.9 1.1 20.7 26.7 18.4 9.7 1.8 0.0 3.1 6.4 2.5 15.3 29.6 10.6 0.0 7.2 4.2 1.6 0.7 6.7 83.9 9.7 4.1 2.4 5.2 5.3 12.2 1.3 7.2 5.6 1.2 82.7 4.1 123.1 2.4 4.2 54.8 23.3 0.9 7.5 11.0 2.5 10.6 18.7 6.6 30.8 37.7 3.7 8.0 1.7 7.4 1.9 4.3 3.7 41.1 10.5 RBP4 ENSG00000138207 "Retinol binding protein 4" P02753 10 93591687-93601744 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 12018.0" "Cell type enriched" "Detected in many" 12 "Hepatocytes: 12711.6" "Cancer enriched" "Detected in all" 27 "liver cancer: 3135.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 1117.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001641, CAB004555" Supported "Secreted to blood" NA NA 46100000000 210000000000 "CAB004555: AB_670938, HPA001641: AB_1079795" "unprognostic (9.42e-3)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.60e-2)" "unprognostic (6.69e-4)" "prognostic favorable (1.74e-8)" "unprognostic (2.39e-1)" "unprognostic (5.76e-2)" "unprognostic (3.26e-2)" "unprognostic (3.26e-1)" "unprognostic (3.44e-1)" "unprognostic (7.14e-3)" "unprognostic (9.88e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (8.60e-2)" 600.0 32.7 29.9 6.3 39.2 1.1 397.5 16.0 48.5 5.7 16.9 9.2 4.9 2.3 1.0 1.1 2.1 7.5 10.7 34.5 87.4 144.1 12018.0 24.7 0.6 24.4 23.1 36.7 4.1 83.0 0.1 523.9 12.5 23.9 8.7 6.8 3.0 13.8 4.7 6.3 14.6 19.3 0.8 17.8 5.6 12.0 4.7 42.9 1.5 8.0 5.3 0.1 19.2 8.9 26.4 0.0 14.7 0.0 0.0 2.9 0.0 0.1 0.3 0.1 2.5 0.4 264.9 0.5 1.5 2.7 0.3 0.2 0.8 0.0 0.0 0.3 0.2 0.2 2.2 1.1 1117.2 0.2 9.2 0.2 18.7 0.5 0.7 0.0 0.0 0.0 0.0 1.4 0.2 1.2 0.0 0.1 7.3 1.3 2.4 121.7 0.4 7.0 0.0 0.0 0.6 0.9 0.2 9.6 0.0 0.0 0.6 0.5 0.8 0.4 0.0 7.8 0.2 0.3 0.9 0.3 3.7 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 39.2 16.0 48.5 34.5 87.4 24.4 23.1 36.7 23.9 17.8 42.9 26.4 9.1 0.0 4.2 0.3 17.2 0.8 0.5 0.0 0.0 0.0 2.1 6.7 0.7 999.4 0.6 23.9 6.2 0.3 0.2 21.9 97.8 7.8 2.8 1.6 3.1 10.8 62.5 152.4 5.8 0.2 22.6 10.5 0.0 22.1 0.0 0.0 158.1 12711.6 17.8 0.0 7.2 40.7 0.0 210.4 3.0 2.4 3.1 7.8 1.8 1.0 0.0 0.8 0.0 1.0 1.1 29.2 28.0 5.7 0.3 2.1 0.8 785.3 0.7 0.5 0.0 7.3 3.8 3.1 13.9 0.0 0.9 1.4 12.3 0.0 1.7 1.4 DBR1 ENSG00000138231 "Debranching RNA lariats 1" Q9UK59 3 138160988-138174921 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035365 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035365: AB_10611956" "unprognostic (1.20e-1)" "unprognostic (3.72e-2)" "unprognostic (8.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.83e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.33e-1)" "unprognostic (5.24e-2)" "unprognostic (9.99e-2)" "unprognostic (2.60e-1)" "unprognostic (3.33e-2)" "prognostic favorable (1.36e-4)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (5.35e-2)" "unprognostic (4.79e-2)" 6.3 6.8 4.5 6.8 5.2 15.4 7.7 5.6 4.9 5.8 5.7 6.5 5.4 7.4 8.2 6.6 6.6 5.6 6.1 4.5 5.1 7.3 6.1 7.7 9.1 5.3 5.1 4.4 8.2 7.4 7.5 5.7 5.7 5.3 6.7 6.3 5.1 7.0 6.2 6.7 7.7 7.3 6.9 5.2 9.7 11.4 3.0 4.8 9.8 8.2 6.6 9.1 6.3 5.6 5.9 24.5 9.9 17.7 19.7 9.6 9.0 18.4 14.2 10.4 15.1 18.2 16.9 10.6 22.3 26.4 12.9 22.8 17.8 20.6 7.0 19.7 19.2 17.1 24.2 12.3 13.9 11.8 31.5 20.5 12.4 11.6 14.0 13.1 8.9 12.6 19.1 16.0 4.7 15.4 18.9 31.2 18.5 20.4 18.9 11.4 19.3 20.1 20.4 13.2 23.6 17.1 22.0 38.0 13.1 21.1 14.4 24.6 25.5 11.9 12.6 8.8 23.6 16.7 7.1 10.5 46.6 8.2 22.4 16.8 4.2 7.1 13.3 8.4 9.7 11.1 7.0 9.6 8.1 8.6 7.4 9.6 10.7 2.9 8.4 8.4 5.2 8.4 6.2 4.5 5.2 5.6 4.9 4.5 5.1 5.3 5.1 4.4 5.3 5.2 4.8 5.9 7.5 6.4 12.9 6.5 8.2 5.2 3.4 6.2 6.2 5.9 6.9 11.9 6.1 7.2 5.9 9.2 0.0 11.3 14.7 4.7 9.8 10.8 0.1 6.1 9.8 6.7 6.0 16.2 4.2 9.0 8.6 8.6 9.2 9.5 5.7 8.7 6.1 6.9 10.4 6.7 4.8 6.6 6.1 16.7 4.8 0.5 8.7 10.2 3.6 8.4 9.0 8.0 6.2 8.5 7.8 8.2 5.6 8.2 7.0 3.7 3.9 5.3 5.5 5.1 0.0 10.0 8.7 4.3 2.1 5.6 4.1 4.5 12.9 6.5 7.3 2.9 DNAJC13 "KIAA0678, RME8" ENSG00000138246 "DnaJ heat shock protein family (Hsp40) member C13" O75165 3 132417502-132539032 "Human disease related genes, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036923, HPA036924" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA036923: AB_10672480, HPA036924: AB_2675386" "unprognostic (3.35e-3)" "unprognostic (7.47e-2)" "unprognostic (9.16e-2)" "unprognostic (1.20e-2)" "unprognostic (9.71e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (3.68e-2)" "unprognostic (3.38e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (8.36e-4)" "unprognostic (1.92e-1)" "unprognostic (4.81e-3)" "unprognostic (2.15e-1)" "unprognostic (1.71e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" 11.3 9.5 6.3 12.5 6.7 15.7 11.6 6.4 6.6 13.0 9.3 13.7 11.0 13.9 11.8 10.8 10.0 10.0 13.0 6.2 8.8 16.1 9.9 11.4 11.1 8.1 7.2 5.6 11.8 6.9 12.7 6.0 15.6 7.3 10.9 14.4 10.8 9.1 12.2 12.6 9.8 10.4 16.9 6.9 12.3 9.8 7.9 7.3 12.1 15.8 14.3 10.7 12.5 10.4 8.1 31.0 18.0 22.2 10.9 54.3 46.7 13.7 32.3 62.5 31.4 33.8 20.4 18.2 15.7 20.5 46.3 41.1 24.1 22.1 24.3 43.5 18.3 6.4 20.6 17.1 13.6 27.6 21.1 18.3 34.2 16.4 28.5 35.1 22.7 44.6 26.0 11.4 25.6 43.7 24.1 16.8 9.1 12.7 26.7 15.8 15.9 16.5 13.0 27.7 32.4 7.9 11.9 31.6 16.7 36.1 19.0 24.7 17.8 40.9 34.7 17.8 33.3 13.9 14.8 15.7 21.5 36.8 13.6 25.2 2.0 2.6 0.4 0.8 2.2 0.7 1.0 0.9 0.7 2.8 0.4 0.6 0.8 0.5 0.7 4.0 1.4 0.4 0.8 6.3 6.7 6.4 6.6 6.2 8.8 8.1 7.2 5.6 7.3 6.9 7.3 8.1 16.8 12.8 21.9 45.7 14.4 6.6 7.3 7.3 6.8 10.8 8.9 7.2 47.2 8.6 11.3 12.9 33.3 7.9 13.2 21.5 1.9 9.0 1.7 10.3 31.3 17.1 14.4 12.8 48.7 9.1 7.7 20.2 16.8 18.7 12.0 18.9 13.2 8.5 20.5 67.3 48.7 12.5 0.0 34.2 9.2 3.6 15.2 26.5 28.4 60.0 25.1 13.3 6.2 46.8 64.7 11.7 12.5 21.4 13.9 10.5 17.0 18.7 13.1 11.5 6.6 22.3 19.7 5.3 13.7 15.4 7.5 5.1 10.8 22.5 13.4 11.0 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316820 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.2;skin 1: 33.0;vagina: 24.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 3.3 0.1 0.9 5.1 2.4 0.0 0.0 0.0 3.3 36.2 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 9.6 0.1 4.4 0.0 0.0 13.8 5.6 0.1 33.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 3.5 0.0 0.0 12.5 13.3 24.0 0.5 110.8 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.9 0.2 0.0 40.8 0.0 0.0 0.0 0.6 90.6 0.0 116.7 1.1 0.0 0.1 0.0 1.1 0.0 0.8 0.0 0.0 0.0 152.8 0.1 62.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 6.1 0.0 0.0 0.0 3.8 46.7 0.0 0.0 19.0 0.5 0.0 3.1 0.4 0.1 0.0 0.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.9 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.0 1.1 1.0 0.0 59.3 139.2 150.0 46.7 0.0 2.8 1.8 0.1 0.0 49.9 3.7 0.0 59.0 0.4 0.0 0.0 1.2 0.7 3.3 0.0 1.5 0.0 0.0 1.1 0.7 8.7 1.1 0.0 2.4 1.3 0.0 0.0 0.0 4.2 0.0 0.4 0.0 28.5 0.0 3.6 0.1 0.0 0.6 10.6 0.0 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 60.6 0.0 0.1 19.6 0.0 0.0 0.0 4.1 0.0 0.0 52.7 68.2 205.0 0.9 0.0 0.0 211.4 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 693.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Uncertain Nucleoplasm,Cytosol NA NA 290000 Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: AB_2685233" "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 73.6 72.7 61.2 59.2 64.4 86.0 76.2 58.3 68.4 70.5 60.7 64.9 39.7 58.1 81.2 69.8 57.5 52.3 114.4 64.8 65.8 117.5 127.0 61.0 61.3 59.9 62.3 64.1 67.7 56.4 242.6 56.1 57.7 61.6 69.8 75.1 32.5 70.7 71.3 201.8 60.2 45.3 69.0 62.3 53.9 52.1 26.6 64.5 55.9 83.8 140.8 84.8 76.0 57.9 68.4 143.4 101.4 38.8 95.3 148.9 145.2 84.3 93.2 244.7 119.9 100.6 149.2 164.8 56.6 92.2 177.2 78.8 116.9 73.2 110.9 118.1 140.8 54.5 80.4 46.5 133.9 130.6 115.7 35.4 90.8 105.7 149.2 265.1 104.7 108.0 60.8 106.2 156.4 154.4 114.5 66.1 74.4 43.5 85.1 693.9 53.9 110.1 103.4 209.3 86.5 30.9 42.8 105.1 239.4 90.3 54.3 149.7 61.0 100.8 48.5 87.9 148.1 122.5 100.5 153.2 79.5 114.4 147.4 38.4 188.6 98.1 129.8 57.5 74.9 78.9 96.5 88.8 72.2 101.3 75.1 80.0 71.4 98.0 97.2 77.5 43.2 127.8 137.2 61.2 64.4 58.3 68.4 64.8 65.8 59.9 62.3 64.1 61.6 62.3 64.5 68.4 85.0 67.3 61.8 24.8 68.4 86.2 137.9 189.8 40.9 33.0 56.7 40.9 131.9 62.9 120.6 93.8 14.6 210.6 61.2 76.2 193.7 167.2 9.7 82.9 43.8 82.4 191.8 119.3 44.8 150.9 112.0 85.3 51.5 60.4 108.3 69.0 56.4 122.7 119.9 10.1 50.7 82.8 193.3 83.0 87.3 6.5 137.0 91.4 85.4 15.0 301.5 66.4 36.0 26.7 46.2 133.1 47.5 174.5 73.0 125.3 57.9 262.8 161.1 26.3 26.3 82.1 92.9 24.0 42.3 72.5 92.5 177.3 78.4 46.9 76.9 146.1 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168119-73244504 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039189: AB_10805355, HPA039859: AB_2676712" "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 12.4 10.7 22.2 6.5 24.2 5.2 12.6 24.4 21.7 14.3 20.7 9.3 7.8 11.6 12.7 11.8 13.7 12.7 12.7 20.5 22.9 22.0 19.2 10.4 9.4 23.1 23.6 19.7 15.1 12.3 14.0 6.3 13.4 23.9 11.0 10.0 11.9 11.4 10.7 13.8 7.9 9.0 11.6 23.3 8.0 10.0 22.1 22.8 12.5 12.4 17.3 9.8 10.7 7.6 26.9 8.7 8.4 19.8 19.0 45.9 28.5 13.9 12.5 28.6 9.8 17.1 2.5 23.6 8.1 5.8 25.8 10.8 10.1 12.6 18.4 11.7 11.1 4.7 6.3 5.6 7.4 23.8 10.2 6.1 24.6 13.4 12.6 48.6 44.5 24.9 11.7 5.8 15.2 18.0 10.4 7.7 12.9 8.7 29.8 19.7 4.3 11.2 9.9 26.4 12.1 3.3 20.1 11.1 30.1 19.6 17.8 18.6 9.9 12.7 8.2 6.6 8.2 12.6 20.0 8.8 4.4 15.9 11.3 7.0 0.7 0.2 0.6 0.3 0.6 0.2 0.3 0.1 0.2 0.4 0.4 0.5 0.4 0.5 1.0 0.2 0.6 0.1 0.1 22.2 24.2 24.4 21.7 20.5 22.9 23.1 23.6 19.7 23.9 23.3 22.8 26.9 5.4 3.2 3.1 24.8 3.9 2.0 3.5 4.6 6.8 6.7 5.3 5.2 12.2 5.7 5.4 1.8 6.2 7.4 2.4 4.6 1.9 3.9 21.8 6.1 7.0 6.2 7.7 3.0 19.7 3.6 5.8 7.2 5.1 6.1 2.5 8.2 7.1 4.0 5.4 3.3 24.9 5.0 6.1 6.3 3.1 27.6 8.4 4.0 1.8 12.2 4.1 4.6 1.0 23.6 41.3 4.2 2.2 4.5 1.8 4.6 6.6 6.9 9.8 11.4 13.1 5.9 5.0 13.4 5.1 5.3 3.7 8.2 3.4 7.2 5.4 4.3 ASCC1 "ASC1p50, CGI-18, Em:AC022392.3, p50" ENSG00000138303 "Activating signal cointegrator 1 complex subunit 1" Q8N9N2 10 72096032-72217134 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038038, HPA057567" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038038: AB_10674544, HPA057567: " "unprognostic (1.96e-1)" "unprognostic (2.79e-2)" "unprognostic (5.36e-2)" "unprognostic (1.03e-2)" "unprognostic (2.92e-3)" "unprognostic (2.34e-2)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.22e-2)" "unprognostic (8.30e-3)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.66e-1)" "unprognostic (6.64e-2)" 17.5 25.1 19.4 14.0 23.0 7.4 16.6 22.5 24.7 15.6 19.3 13.4 9.1 17.2 16.6 14.4 15.4 13.8 23.7 17.2 20.5 15.4 21.7 13.6 18.7 22.8 20.7 15.2 18.0 22.9 14.3 12.0 13.1 22.9 12.0 10.0 15.8 12.9 14.6 30.0 16.1 14.7 12.5 21.6 17.2 14.5 18.6 20.6 22.5 13.5 17.5 17.0 15.9 13.7 30.8 29.3 40.3 25.8 58.1 34.0 37.9 21.1 18.0 33.5 26.5 30.7 31.4 105.3 37.0 35.6 26.3 17.9 38.4 21.1 30.6 26.5 27.2 20.1 24.1 29.1 36.4 32.7 25.2 24.1 33.3 68.9 26.7 45.0 38.1 36.4 40.4 34.8 51.8 35.0 25.7 34.2 36.1 15.7 18.8 8.8 20.1 21.1 27.4 49.8 21.0 27.1 16.9 26.1 65.7 49.4 23.9 21.7 18.5 32.0 15.2 27.1 11.6 19.4 28.4 40.4 45.5 24.6 55.9 10.8 20.4 19.0 35.0 16.5 20.3 17.0 31.4 19.4 17.7 21.0 32.5 27.2 25.8 12.5 26.6 15.4 28.9 29.2 19.0 19.4 23.0 22.5 24.7 17.2 20.5 22.8 20.7 15.2 22.9 21.6 20.6 30.8 16.7 9.6 5.8 25.5 20.5 6.2 14.0 22.8 9.6 12.9 9.0 6.3 23.6 10.0 13.4 12.9 14.6 17.7 18.6 4.7 23.5 20.4 27.5 12.1 13.8 13.9 3.6 11.1 33.1 20.0 19.5 16.5 6.6 12.1 12.7 12.6 10.4 22.0 18.2 25.2 42.9 5.2 16.2 24.1 8.7 14.2 20.5 12.7 19.6 27.2 21.4 19.9 16.5 35.7 52.8 14.7 8.4 20.7 14.5 8.0 9.5 11.4 9.8 14.3 13.1 10.8 15.9 27.8 28.2 10.9 7.0 15.2 17.9 18.9 6.5 9.2 PLA2G12B PLA2G13 ENSG00000138308 "Phospholipase A2 group XIIB" Q9BX93 10 72934762-72954806 "Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 33.3;kidney: 14.5;liver: 71.6" "Group enriched" "Detected in some" 4 "Hepatocytes: 52.2;Proximal enterocytes: 70.0" "Cancer enriched" "Detected in many" 8 "liver cancer: 35.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 9.1;Hep G2: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA057745, HPA059562" Approved "Secreted to blood" NA NA 2300000 "HPA057745: AB_2683514, HPA059562: AB_2684064" "unprognostic (1.11e-2)" "unprognostic (2.66e-2)" "unprognostic (2.02e-3)" "unprognostic (3.41e-1)" "unprognostic (1.68e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 2.1 27.2 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 14.5 71.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 1.2 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.1 0.3 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.1 1.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.8 52.2 0.0 0.0 0.3 2.4 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 6.3 0.0 0.0 0.0 70.0 13.4 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 6.3 0.0 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" Q70YC5 10 62374192-62480288 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;esophagus: 10.3" "Group enriched" "Detected in some" 6 "Excitatory neurons: 112.7;Oligodendrocyte precursor cells: 113.6;Oligodendrocytes: 195.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "gdT-cell: 2.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.7;naive CD8 T-cell: 2.7;NK-cell: 6.4;T-reg: 5.9" "Group enriched" "Detected in many" 62 "NK-cells: 6.4;T-cells: 5.9" "Cell line enhanced" "Detected in many" "HaCaT: 22.3;PC-3: 13.9;U-251 MG: 18.6;U-87 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052446 Supported Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.0 1.3 4.4 0.1 3.0 0.0 0.3 1.3 22.3 0.9 0.0 0.0 0.1 0.1 0.2 10.3 0.1 0.3 1.0 7.5 4.1 0.1 0.0 0.7 0.0 0.8 4.6 3.9 0.0 0.4 5.6 1.7 0.1 3.4 1.8 0.1 5.1 1.1 2.0 0.0 0.8 0.1 0.1 0.0 0.4 0.0 0.5 8.0 0.6 0.6 0.1 1.4 0.8 1.1 16.5 6.3 0.6 0.1 0.0 0.1 0.0 0.0 5.5 5.8 2.6 2.1 0.0 1.0 0.0 0.2 3.1 8.4 22.3 0.0 0.4 3.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.9 6.6 0.9 0.0 0.0 0.0 5.5 2.1 0.7 0.0 0.9 0.0 13.9 0.0 0.2 0.0 0.3 2.8 0.1 1.2 1.1 0.2 0.6 0.0 0.0 0.0 0.0 1.1 6.1 0.0 18.6 0.0 0.0 0.0 12.9 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.1 2.7 0.0 0.0 0.4 2.7 0.0 6.4 0.0 0.0 5.9 0.8 4.4 3.0 1.3 22.3 7.5 4.1 0.8 4.6 3.9 3.4 0.0 8.0 16.5 0.0 0.0 0.0 15.3 0.2 0.5 3.7 0.6 0.0 13.5 0.3 0.3 2.6 1.5 0.1 3.7 2.1 0.0 2.8 0.0 0.0 0.2 0.5 0.3 0.2 0.2 0.0 0.0 112.7 0.0 0.0 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.1 18.5 23.4 0.0 0.0 0.3 1.1 0.3 0.0 0.4 0.0 6.5 0.0 2.7 0.0 113.6 195.5 0.9 0.0 0.0 1.9 1.2 0.0 0.7 0.1 5.3 0.0 0.8 0.8 0.1 0.7 0.0 0.4 0.0 3.9 0.2 0.0 6.0 OIT3 "FLJ39116, LZP" ENSG00000138315 "Oncoprotein induced transcript 3" Q8WWZ8 10 72893584-72933036 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 111.7" "Cell type enriched" "Detected in some" 11 "Hepatic stellate cells: 372.3" "Cancer enriched" "Detected in many" 4 "liver cancer: 4.6" "Region enhanced" "Detected in single" "cerebellum: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 2.3;Hep G2: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 52000000 "unprognostic (2.42e-2)" "unprognostic (6.76e-2)" "unprognostic (7.98e-4)" "unprognostic (9.26e-2)" "unprognostic (9.47e-4)" "unprognostic (3.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.50e-3)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" "unprognostic (1.35e-1)" "unprognostic (2.44e-1)" "unprognostic (3.68e-3)" "unprognostic (1.19e-1)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 0.5 0.0 0.1 0.3 5.3 0.0 0.0 0.0 0.0 0.3 2.4 0.2 0.1 1.5 111.7 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 6.2 0.0 0.1 7.9 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.5 0.2 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 14.6 0.0 10.7 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 372.3 10.6 0.0 0.0 0.9 0.0 0.0 31.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672506-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.3;gallbladder: 6.8;placenta: 7.6" "Group enriched" "Detected in some" 5 "Oligodendrocytes: 44.8;Paneth cells: 14.6;Theca cells: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;K-562: 10.4;RH-30: 5.4;U-138 MG: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 0.8 0.2 2.0 3.2 4.9 0.6 0.3 1.5 6.3 0.8 0.5 1.8 2.3 0.7 0.4 1.0 0.5 6.8 0.7 2.3 5.1 0.3 0.3 1.7 1.1 5.7 4.0 1.4 0.2 0.2 0.0 0.1 7.6 10.3 0.6 1.8 0.0 0.8 0.1 0.1 1.3 3.2 2.2 1.0 0.4 1.4 0.5 5.2 0.4 0.2 0.3 0.7 2.6 0.4 7.5 0.0 0.0 0.1 0.3 0.2 4.0 0.0 1.0 3.2 0.3 1.7 0.0 9.1 0.0 0.7 1.7 0.4 0.7 0.0 0.0 0.1 3.6 0.0 0.3 0.0 0.2 0.0 0.0 2.4 0.3 0.1 0.8 0.2 1.0 0.0 0.0 10.4 0.0 1.3 0.0 0.0 0.9 0.3 0.1 0.0 0.0 5.4 0.2 0.0 0.0 3.4 0.5 0.0 0.1 0.3 0.1 0.0 0.0 0.0 8.9 0.1 0.7 0.5 0.8 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.9 1.5 6.3 2.3 5.1 5.7 4.0 1.4 10.3 1.0 5.2 7.5 0.1 0.0 0.0 0.3 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.3 0.0 2.1 0.3 0.0 0.1 2.1 0.0 0.2 4.5 0.1 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.0 44.8 0.1 14.6 0.0 0.1 0.0 0.7 0.0 1.4 0.0 0.0 1.8 1.1 0.0 0.0 0.2 0.1 0.4 0.0 17.9 0.5 0.1 RPS24 "eS24, S24" ENSG00000138326 "Ribosomal protein S24" P62847 10 78033760-78056813 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003364, HPA073508" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 90000 "Endoplasmic reticulum, Cytosol" "HPA003364: AB_1079847, HPA073508: " "prognostic favorable (1.50e-4)" "unprognostic (1.58e-1)" "unprognostic (4.95e-2)" "unprognostic (1.09e-1)" "unprognostic (6.95e-2)" "unprognostic (8.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.25e-1)" "unprognostic (9.48e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.10e-10)" "unprognostic (3.18e-2)" "unprognostic (1.38e-1)" "unprognostic (6.65e-2)" "unprognostic (8.22e-2)" 2348.8 2012.7 1584.1 1437.8 1589.6 4712.7 4806.0 1580.6 2779.1 2876.5 1620.9 2600.7 1772.4 2543.2 2835.8 2312.1 2495.8 1620.8 1618.9 1541.7 1670.3 1770.2 2227.5 1471.5 2691.3 1626.6 1586.3 1497.5 5897.1 2980.5 1450.6 1187.3 1769.2 1644.7 1975.9 2598.6 973.0 2534.2 1653.0 3047.8 3069.4 1707.8 1962.7 1644.8 1932.4 1666.8 782.1 1619.8 2823.8 2272.8 2576.3 2729.8 2677.7 2568.7 1741.2 3390.5 1308.2 3303.3 5221.9 4021.6 7048.4 2884.3 3654.6 5055.0 3773.7 3323.4 1878.5 2339.0 7039.0 1940.5 3205.9 1303.4 2612.8 3847.7 4674.9 3460.7 2403.0 4325.8 2868.1 822.8 1879.0 4533.9 6943.1 1575.6 6732.0 6867.2 2652.4 9675.7 7591.6 4592.2 2981.8 4007.0 1455.6 4191.8 1388.2 3770.5 11229.0 2318.2 5976.0 12085.6 2567.9 3934.7 3482.3 4773.4 1608.2 1658.6 3234.9 1805.2 6010.8 4716.9 3414.2 3356.5 7559.6 3894.3 1175.5 2712.7 1570.9 4896.7 1774.5 3875.7 5354.8 1459.5 9444.0 970.5 1058.0 2124.4 809.3 1585.0 2036.3 2627.9 2796.4 2178.6 2037.5 2932.4 2380.3 2861.9 2644.0 276.9 2801.9 1626.7 2569.0 1916.3 4390.5 1584.1 1589.6 1580.6 2779.1 1541.7 1670.3 1626.6 1586.3 1497.5 1644.7 1644.8 1619.8 1741.2 2643.8 743.6 1535.6 44.1 4070.7 4105.7 5007.7 2774.6 5333.8 344.3 4139.9 6421.4 617.1 2051.8 1719.2 801.9 108.4 3406.3 3424.5 1200.3 3279.1 2335.3 1414.9 1799.8 4602.7 2194.2 2090.5 3250.6 40.4 4508.1 6260.1 2099.8 2310.4 2451.6 1237.2 3541.5 2346.6 2252.0 3311.9 151.4 42.6 3944.5 880.9 4754.9 4734.0 5440.1 5670.8 3861.9 2031.3 49.6 5590.7 1395.6 3262.7 23.1 45.9 2886.9 3231.4 2588.2 3109.6 4622.7 2703.3 3770.5 768.5 465.7 1268.8 3609.7 2661.0 653.8 709.0 7289.7 4590.1 3541.8 3518.7 4105.6 4384.9 4943.2 TET1 "bA119F7.1, CXXC6, KIAA1676, LCX" ENSG00000138336 "Tet methylcytosine dioxygenase 1" Q8NFU7 10 68560337-68694487 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.8" "Cell type enhanced" "Detected in many" "Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7" "Cancer enriched" "Detected in some" 15 "testis cancer: 10.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019032, HPA057273" Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA019032: AB_1847363, HPA057273: AB_2683391" "unprognostic (1.60e-1)" "unprognostic (8.30e-2)" "unprognostic (9.85e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (8.15e-2)" "unprognostic (3.60e-3)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (7.90e-3)" "unprognostic (1.83e-1)" "unprognostic (1.71e-1)" "unprognostic (1.18e-3)" "unprognostic (2.88e-4)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (9.52e-3)" 0.4 0.2 0.5 0.2 1.0 0.3 0.4 4.8 0.8 0.6 0.6 0.3 0.1 0.9 0.6 0.2 0.5 0.3 0.4 0.3 0.6 0.3 0.2 0.2 0.3 1.1 1.2 0.0 0.8 0.2 0.7 0.3 1.2 1.6 0.6 0.3 1.6 1.0 0.3 0.9 0.3 0.2 0.5 0.8 0.3 0.4 0.2 1.1 2.0 0.5 0.3 0.3 0.2 0.4 2.1 0.7 0.8 8.0 9.0 0.8 0.7 17.7 0.4 1.0 0.7 1.2 5.5 0.3 0.0 0.3 0.8 0.1 0.0 20.4 0.0 0.8 0.3 3.3 2.1 0.0 4.9 1.2 1.9 1.0 1.0 0.1 0.5 0.1 1.6 0.1 3.5 12.0 1.4 0.7 0.6 3.3 1.4 11.9 0.0 1.1 3.2 2.5 0.2 0.4 0.8 2.2 3.5 0.4 0.5 1.6 7.9 1.0 1.5 0.3 0.7 1.6 0.0 0.6 0.5 0.6 3.2 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.4 0.3 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.5 1.0 4.8 0.8 0.3 0.6 1.1 1.2 0.0 1.6 0.8 1.1 2.1 6.3 3.2 6.2 54.5 2.5 1.1 1.8 0.4 5.2 2.5 7.0 9.5 7.2 1.5 2.6 0.0 10.4 21.0 3.0 0.2 0.0 2.7 0.8 3.6 34.2 4.8 13.8 2.5 15.6 0.4 79.9 15.4 1.5 2.9 0.0 13.6 5.7 2.5 3.9 35.3 20.6 0.3 4.1 0.0 0.3 1.7 25.7 0.8 1.8 12.2 0.4 16.1 5.2 44.7 45.3 0.6 0.0 20.7 7.3 1.4 0.0 0.9 0.8 12.5 6.6 21.9 10.7 0.5 1.5 0.8 1.1 27.9 2.6 43.7 0.6 0.4 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "NK-cell: 1.8" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria No Yes Mitochondria "HPA037487: AB_10672493, HPA057526: AB_2683456" "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.1 0.9 2.1 2.8 2.4 4.6 1.8 2.8 3.6 1.3 1.4 2.3 2.1 1.1 1.0 1.9 0.9 0.9 1.6 2.1 2.1 2.6 4.2 1.8 5.3 2.6 2.3 2.1 1.2 1.6 0.4 1.5 1.7 3.2 2.0 2.9 5.4 1.6 0.4 1.6 1.8 3.2 1.1 2.1 2.1 1.9 2.9 2.6 8.2 1.0 0.9 4.3 1.4 1.5 3.6 25.6 13.0 29.0 20.7 3.2 2.2 20.4 12.4 10.3 17.4 21.2 31.1 16.1 26.1 4.6 3.8 6.7 15.2 16.8 6.5 20.7 16.2 12.6 15.8 8.5 12.3 0.9 27.7 16.4 1.8 2.6 12.3 3.6 4.5 7.9 17.0 23.6 22.8 10.1 9.0 42.8 19.8 20.5 10.9 24.0 33.1 20.0 8.4 7.5 11.7 13.1 15.7 16.9 21.4 4.2 20.1 16.5 11.6 3.4 6.6 20.5 8.5 23.8 11.5 13.9 38.3 5.7 26.1 8.9 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 1.8 0.0 0.0 0.1 0.0 2.1 2.4 2.8 3.6 2.1 2.1 2.6 2.3 2.1 3.2 2.1 2.6 3.6 1.0 6.4 1.1 4.9 1.3 2.3 0.9 1.7 2.8 2.5 2.3 1.4 10.5 2.8 1.1 1.8 6.2 3.9 2.2 1.7 0.0 0.8 2.2 2.0 1.4 2.0 1.2 33.2 14.1 0.9 4.8 2.0 2.6 2.8 0.0 6.0 0.7 4.6 2.2 0.0 15.5 1.8 0.0 1.3 0.7 3.7 0.6 1.5 0.0 4.7 0.5 0.5 2.1 5.5 18.4 0.7 0.1 0.7 7.4 2.5 2.4 0.6 0.8 4.3 0.0 2.4 1.1 9.1 12.2 4.7 1.7 1.2 1.6 0.7 3.7 1.0 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 64.7;skeletal muscle: 286.3;tongue: 174.3" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 114.2" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: AB_2684539" "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 0.1 0.3 0.2 0.2 0.1 0.6 0.1 0.5 0.3 0.0 0.0 0.3 0.1 0.1 0.1 2.2 0.0 0.1 64.7 0.7 0.5 0.0 0.0 0.0 0.2 0.6 0.3 0.2 0.1 0.6 0.0 0.0 0.1 0.2 1.7 0.1 1.7 2.7 0.0 286.3 0.1 0.1 0.2 0.0 0.1 0.8 0.9 0.1 0.1 0.1 174.3 0.0 0.1 0.0 0.3 2.9 1.3 0.0 0.0 0.7 4.1 0.1 39.8 19.7 14.4 5.4 0.0 0.1 0.1 0.0 112.3 20.5 0.7 0.0 0.2 25.6 0.4 0.0 0.0 14.6 0.0 0.3 0.0 0.1 1.6 0.0 7.9 0.9 3.6 0.4 0.0 0.0 0.2 47.6 8.6 0.0 0.1 0.0 0.0 1.3 0.0 2.2 0.0 0.1 0.1 0.1 0.0 5.7 0.9 0.2 0.1 0.0 0.0 1.1 0.7 0.2 4.1 0.1 0.1 0.0 0.0 4.6 0.1 4.2 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.3 0.7 0.5 0.6 0.3 0.2 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.2 0.0 114.2 0.0 0.0 0.0 25.0 0.0 0.0 1.8 0.0 0.0 1.0 1.5 0.1 0.7 0.0 0.0 0.5 0.2 0.0 1.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.1 AOX1 "AO, AOH1" ENSG00000138356 "Aldehyde oxidase 1" Q06278 2 200586014-200677064 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 303.4;liver: 898.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 749.1" "Cancer enriched" "Detected in many" 9 "liver cancer: 122.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040199, HPA040215" Enhanced NA NA 3300000 "HPA040199: AB_10795273, HPA040215: AB_10795360" "unprognostic (4.39e-2)" "unprognostic (1.03e-3)" "unprognostic (1.96e-1)" "unprognostic (3.15e-2)" "unprognostic (1.17e-4)" "unprognostic (1.92e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (5.48e-2)" "unprognostic (2.00e-2)" "prognostic favorable (6.05e-5)" "unprognostic (1.33e-2)" "unprognostic (8.16e-3)" "unprognostic (3.38e-2)" "unprognostic (4.99e-3)" 74.9 303.4 0.2 3.2 2.3 0.5 50.6 0.1 1.4 15.9 3.8 11.9 0.8 10.9 12.4 8.3 48.6 9.9 9.6 0.6 0.5 104.2 898.3 19.7 4.8 2.7 0.7 0.3 48.4 85.7 1.3 2.9 1.7 4.9 22.5 4.5 0.5 15.5 28.5 13.0 19.6 12.8 7.2 0.1 4.1 14.4 19.6 3.0 2.0 17.8 11.1 1.5 38.9 17.8 2.8 0.6 0.2 0.0 0.0 377.3 191.5 0.2 6.6 12.2 5.4 9.7 0.0 0.1 0.1 0.5 8.4 2.3 0.2 0.1 18.6 22.0 0.2 0.6 0.0 4.6 20.7 25.4 0.9 0.0 78.2 4.6 26.1 81.2 5.4 0.2 0.2 0.2 0.1 18.3 0.5 0.0 0.1 8.0 0.1 5.2 0.0 0.5 0.1 0.2 0.2 0.4 0.3 4.8 0.0 0.3 0.4 0.1 0.2 31.9 13.8 11.2 0.2 2.5 0.2 0.1 2.6 10.7 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.1 1.4 0.6 0.5 2.7 0.7 0.3 4.9 0.1 3.0 2.8 1.0 3.2 1.1 0.7 3.6 1.8 0.5 1.2 1.2 0.1 0.2 0.3 0.9 17.2 0.1 3.7 0.0 0.1 0.0 0.1 11.7 0.7 0.8 0.4 3.0 2.6 3.0 37.5 0.9 26.2 0.2 22.9 0.0 8.2 0.0 0.1 15.4 749.1 0.4 0.0 2.5 0.1 2.0 19.8 3.6 4.4 74.0 1.7 3.6 1.0 0.0 0.6 0.0 5.0 6.9 11.5 0.0 82.0 0.0 7.5 0.1 162.2 0.1 0.1 0.0 5.3 3.0 0.8 1.3 0.1 1.6 0.0 2.0 2.3 0.1 0.4 ATIC "AICARFT, IMPCHASE, PURH" ENSG00000138363 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase" P31939 2 215311956-215349773 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Transferase" "Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013462, HPA021012" Supported Approved "Plasma membrane,Cytosol" NA NA 3900000 Cytosol "Plasma membrane" "CAB013462: , HPA021012: AB_1845169" "unprognostic (1.41e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (8.46e-2)" "unprognostic (2.90e-1)" "unprognostic (3.81e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (1.86e-2)" "unprognostic (5.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.31e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.00e-1)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-3)" 25.0 26.2 19.6 32.0 22.5 26.7 34.2 20.1 23.7 22.3 16.5 36.7 32.3 30.3 20.4 19.6 29.7 20.6 21.5 18.4 19.5 33.0 34.9 18.2 45.2 20.3 21.0 17.6 32.3 26.4 29.9 18.7 37.6 22.3 29.0 48.0 19.2 19.0 38.7 43.6 24.0 27.5 37.3 17.0 27.8 24.7 20.3 21.2 42.2 22.7 25.6 52.2 29.4 17.8 26.5 102.2 133.8 85.1 144.0 112.5 113.2 40.6 105.4 91.9 117.4 134.9 278.6 157.3 149.6 122.8 110.0 164.5 106.7 187.8 157.0 169.5 113.4 189.3 179.1 108.7 271.5 145.4 226.1 92.0 98.4 119.8 154.7 188.5 82.0 79.7 144.5 237.0 124.4 166.3 178.7 203.4 112.1 330.3 167.4 84.9 185.8 117.3 133.4 126.4 146.5 129.3 87.8 84.3 103.1 124.3 189.2 169.7 82.9 70.2 96.0 101.2 127.3 65.8 160.3 195.7 300.1 85.6 124.5 146.8 12.6 16.4 0.4 34.6 23.5 59.1 56.6 49.0 53.8 36.3 39.9 50.0 46.9 1.8 55.4 21.1 31.7 50.2 29.0 19.6 22.5 20.1 23.7 18.4 19.5 20.3 21.0 17.6 22.3 17.0 21.2 26.5 7.2 12.8 19.3 18.6 34.7 15.0 28.2 55.0 30.7 10.0 18.2 16.1 21.1 28.6 33.3 23.9 4.2 171.4 23.3 17.6 27.4 45.2 1.1 20.7 28.2 6.1 19.2 32.2 15.4 49.3 166.3 25.3 22.4 20.8 25.3 32.9 5.3 22.2 52.4 10.1 15.4 33.8 26.4 14.4 10.8 1.7 23.9 20.2 30.2 2.8 26.1 21.3 26.8 16.6 25.7 32.4 28.5 34.3 36.3 24.0 18.8 52.7 27.3 14.7 26.3 19.2 29.0 3.3 43.8 24.6 8.5 95.4 29.8 40.7 58.4 18.1 SMARCAL1 "HARP, HHARP" ENSG00000138375 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" Q9NZC9 2 216412414-216483053 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020337 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020337: AB_2670410" "unprognostic (4.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" "unprognostic (2.20e-2)" "unprognostic (3.39e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.35e-3)" "unprognostic (3.31e-2)" "unprognostic (2.33e-1)" "unprognostic (1.36e-1)" "unprognostic (7.46e-2)" "unprognostic (2.00e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" 9.1 9.9 7.4 9.0 9.5 9.2 8.9 7.5 9.8 10.6 7.4 7.9 6.9 10.8 7.5 9.9 11.1 9.6 8.3 7.4 9.7 7.3 6.7 8.0 13.2 10.0 8.1 7.9 16.4 8.3 10.9 9.3 9.2 9.5 8.2 7.5 5.6 8.1 8.9 10.6 10.7 8.0 10.2 7.2 9.8 8.1 10.4 9.8 15.2 10.3 10.7 12.0 8.8 9.1 13.9 16.7 16.3 22.2 12.7 21.5 25.1 21.3 22.0 22.7 23.0 26.1 26.7 20.3 15.0 21.8 27.6 28.8 12.3 19.1 24.4 30.5 45.7 18.9 42.8 12.0 19.9 22.0 11.5 23.9 16.7 25.7 24.9 24.4 24.0 27.6 23.5 42.6 15.8 26.3 12.3 22.2 26.8 16.1 14.7 8.9 24.6 14.6 9.3 18.2 11.4 18.4 11.9 12.0 9.1 18.7 38.2 12.4 18.1 21.3 28.3 13.0 13.7 13.9 18.0 18.6 13.3 28.8 15.6 20.2 25.9 9.5 14.1 12.2 10.5 11.6 9.6 11.5 14.3 14.9 9.2 9.6 11.8 1.7 21.0 18.1 18.0 14.7 8.5 7.4 9.5 7.5 9.8 7.4 9.7 10.0 8.1 7.9 9.5 7.2 9.8 13.9 6.3 6.4 6.1 20.2 8.2 0.9 3.3 4.6 8.6 5.1 4.3 3.4 5.0 7.2 3.7 0.0 0.0 10.4 6.7 3.4 5.9 7.4 14.5 10.4 7.2 7.0 3.6 11.4 20.6 3.8 12.2 8.0 5.6 5.8 17.7 11.0 4.2 3.2 9.7 8.4 30.8 3.7 2.0 8.9 3.1 13.7 6.2 6.2 1.8 12.2 10.1 4.7 10.3 24.6 35.9 4.0 13.3 8.6 7.0 1.3 4.7 5.8 4.4 4.8 13.1 6.0 6.8 7.7 4.4 5.3 1.3 7.3 6.5 7.5 5.3 2.0 BARD1 ENSG00000138376 "BRCA1 associated RING domain 1" Q99728 2 214725646-214809683 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034106, HPA035354, HPA044864" Enhanced Supported "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" No Yes "Nucleoplasm, Nuclear speckles" "Cytoplasmic bodies" "CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119" "unprognostic (4.85e-2)" "unprognostic (1.87e-2)" "unprognostic (1.74e-2)" "unprognostic (8.37e-3)" "unprognostic (2.57e-2)" "unprognostic (1.03e-2)" "unprognostic (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.16e-2)" "unprognostic (3.92e-3)" "unprognostic (2.80e-2)" "unprognostic (7.41e-2)" "unprognostic (1.94e-8)" "unprognostic (3.94e-2)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" 1.6 0.6 2.9 2.7 4.1 11.5 2.9 2.3 2.5 2.5 0.2 2.9 2.3 3.3 2.6 5.2 1.9 2.1 1.4 2.3 5.6 0.8 1.0 2.5 5.5 3.8 3.0 0.6 2.3 1.6 2.4 1.2 2.3 3.4 2.9 3.7 2.0 1.9 3.6 4.3 7.9 2.1 3.9 4.0 2.6 1.9 6.6 4.4 7.0 1.4 2.4 6.7 2.2 3.9 4.6 12.3 8.8 20.2 9.3 2.7 4.0 12.0 17.3 10.6 17.8 21.8 12.0 12.2 12.6 7.6 8.5 9.5 12.7 16.5 10.5 22.7 11.5 6.4 12.5 13.8 8.7 0.9 13.9 12.7 4.7 1.1 15.0 8.1 4.5 6.1 14.7 7.9 36.0 13.7 10.7 27.9 12.5 14.3 7.9 3.7 24.7 19.8 11.2 3.9 14.0 5.8 8.8 15.0 14.7 5.3 10.9 16.3 13.4 4.7 18.0 14.0 11.7 13.6 10.2 12.6 28.0 7.6 11.3 13.4 3.9 2.0 5.8 4.6 4.0 3.2 9.7 5.4 5.5 3.6 8.2 2.4 4.0 0.3 7.3 3.8 6.9 17.1 2.3 2.9 4.1 2.3 2.5 2.3 5.6 3.8 3.0 0.6 3.4 4.0 4.4 4.6 12.3 6.4 2.2 14.7 13.0 68.6 62.2 13.0 14.2 3.3 9.9 14.1 17.4 17.2 12.7 9.2 0.0 18.2 11.3 8.2 3.9 8.0 9.2 13.3 11.9 9.6 1.2 34.5 5.5 6.9 16.0 10.0 10.2 18.0 15.2 28.2 10.0 4.2 12.5 1.7 15.4 13.1 8.2 10.1 12.2 5.7 6.2 11.2 3.6 15.9 16.6 4.4 9.2 19.6 31.7 6.5 6.5 10.1 22.0 22.9 3.2 0.7 12.3 6.8 19.7 15.4 16.9 27.6 43.4 28.6 74.4 5.1 13.4 10.5 14.7 67.2 STAT4 ENSG00000138378 "Signal transducer and activator of transcription 4" Q14765 2 191029576-191151596 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.4" "Cell type enhanced" "Detected in many" "dendritic cells: 139.0;Early spermatids: 275.1;Excitatory neurons: 85.9;Late spermatids: 66.0;NK-cells: 108.1;Plasma cells: 83.8;T-cells: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 76.6;T-cells: 121.2" "Cell line enhanced" "Detected in some" "Karpas-707: 58.8;U-266/70: 32.9;U-266/84: 12.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA001860, CAB013108" Enhanced NA NA "CAB013108: , HPA001860: AB_1080104" "unprognostic (3.90e-5)" "unprognostic (1.30e-1)" "unprognostic (4.16e-2)" "unprognostic (6.45e-4)" "unprognostic (3.77e-2)" "unprognostic (4.79e-2)" "unprognostic (3.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.07e-8)" "unprognostic (2.65e-1)" "unprognostic (6.02e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 4.7 4.0 3.5 11.6 5.4 15.8 3.0 0.6 9.8 1.5 1.2 2.8 4.5 1.9 2.6 1.4 1.6 5.1 21.2 4.3 5.1 2.4 9.6 7.9 18.2 3.2 2.5 3.6 1.6 2.3 1.2 15.1 2.7 4.7 1.8 3.5 2.1 2.2 1.3 1.2 1.1 6.9 1.4 1.3 15.6 4.4 29.4 3.3 9.1 2.4 1.0 10.5 5.9 1.8 5.4 0.1 1.7 1.1 0.0 0.0 3.6 0.3 0.6 2.2 0.6 2.2 0.4 0.8 0.0 0.2 2.8 1.6 0.9 0.0 4.7 1.2 0.0 0.8 1.3 0.0 0.0 0.6 0.0 0.1 1.5 2.3 1.1 0.5 0.1 0.0 6.0 0.0 58.8 0.2 0.0 3.5 0.0 0.3 0.0 0.9 0.0 0.0 4.3 0.2 0.1 0.1 1.2 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.1 1.6 0.0 32.9 12.8 0.0 1.2 0.0 0.1 15.7 0.4 0.1 121.2 0.8 107.3 1.8 71.6 101.2 0.6 1.0 68.1 95.8 2.8 76.6 0.8 9.3 28.1 55.3 3.5 5.4 0.6 9.8 4.3 5.1 3.2 2.5 3.6 4.7 1.3 3.3 5.4 2.9 3.2 4.2 2.6 14.5 1.3 0.6 2.9 0.0 0.9 0.9 1.1 20.3 4.3 0.6 1.8 8.4 0.4 139.0 0.5 0.0 0.6 275.1 1.1 0.5 1.2 0.0 10.5 85.9 0.2 2.9 2.9 8.6 0.7 1.3 0.8 1.1 1.1 1.1 0.0 59.4 0.3 0.0 6.3 10.6 66.0 0.3 14.4 5.4 7.5 6.3 0.0 108.1 6.0 2.4 0.1 0.3 0.4 83.8 1.0 0.0 0.8 2.4 0.2 0.0 0.6 3.7 8.3 1.2 0.4 1.7 0.5 137.4 0.1 0.3 0.7 MSTN GDF8 ENSG00000138379 Myostatin O14793 2 190055700-190062729 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Growth factor, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 10.2;tongue: 15.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.7;Cone photoreceptor cells: 4.2;Early spermatids: 17.8;Late spermatids: 4.2;Muller glia cells: 19.1" "Cancer enriched" "Detected in some" 9 "glioma: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "LHCN-M2: 25.9;RH-30: 52.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB009963 Approved "Secreted in other tissues" NA NA 7600000 "CAB009963: AB_2148798" "unprognostic (8.45e-2)" "unprognostic (2.84e-2)" "unprognostic (3.52e-2)" "unprognostic (2.54e-1)" "prognostic favorable (2.86e-4)" "unprognostic (7.59e-3)" "unprognostic (2.95e-1)" "unprognostic (4.09e-2)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-3)" "unprognostic (7.72e-3)" "unprognostic (1.12e-4)" "unprognostic (1.06e-1)" "unprognostic (3.94e-1)" "unprognostic (6.53e-2)" "unprognostic (5.67e-4)" 0.4 0.9 0.7 0.0 0.7 0.0 0.3 0.8 0.9 1.1 0.2 0.5 0.2 0.8 0.5 1.1 0.3 0.1 0.3 0.8 0.7 0.5 0.1 0.2 0.0 0.7 0.6 0.7 0.4 0.2 0.0 0.6 0.0 0.7 0.4 0.4 3.2 0.4 0.1 10.2 0.5 0.2 0.3 0.5 0.2 0.2 0.3 0.6 0.0 0.4 15.4 0.0 0.2 0.5 0.7 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.8 0.9 0.8 0.7 0.7 0.6 0.7 0.7 0.5 0.6 0.7 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.1 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 17.8 0.1 0.1 0.1 0.0 0.0 1.4 0.2 0.0 1.4 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 19.1 0.0 0.5 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.7 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CARF "ALS2CR8, FLJ21579, NYD-SP24" ENSG00000138380 "Calcium responsive transcription factor" Q8N187 2 202912214-202988263 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 66.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034557, HPA043191" Approved Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Cytosol" "HPA034557: AB_10601663, HPA043191: AB_2732503" "unprognostic (4.63e-2)" "unprognostic (3.11e-1)" "unprognostic (1.30e-1)" "unprognostic (1.93e-2)" "unprognostic (6.09e-2)" "unprognostic (8.65e-3)" "unprognostic (1.12e-1)" "unprognostic (2.13e-3)" "unprognostic (4.39e-2)" "unprognostic (1.10e-1)" "unprognostic (7.58e-3)" "unprognostic (1.08e-1)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" 4.5 5.3 3.8 5.8 8.0 5.4 7.8 6.2 5.0 5.6 2.2 4.6 4.5 9.5 10.0 5.6 6.8 6.0 5.0 3.7 4.1 6.8 4.5 5.1 8.9 5.3 6.2 2.6 8.0 4.0 7.9 5.2 4.8 6.3 6.7 6.1 16.2 4.7 6.5 4.5 7.4 5.0 6.7 4.5 7.5 6.1 21.7 5.5 9.5 10.7 5.5 7.9 5.7 5.1 12.1 2.5 2.4 6.1 5.4 4.5 9.5 4.7 3.7 4.7 3.8 3.4 2.8 6.2 3.8 1.6 4.3 4.6 4.5 3.2 2.7 4.3 3.0 1.7 5.9 3.0 1.7 3.8 3.5 2.9 7.8 5.2 3.3 8.6 9.6 2.3 13.9 2.5 15.5 5.9 4.9 7.2 5.6 2.6 1.6 3.5 5.1 4.2 3.1 6.9 2.6 4.3 4.6 4.0 2.2 1.7 7.7 3.6 6.5 2.7 7.1 1.8 4.6 2.4 13.7 8.4 4.2 6.1 4.1 4.4 1.4 1.0 0.8 2.2 1.9 2.4 2.0 2.2 2.1 1.2 2.4 3.1 2.2 0.4 8.8 1.1 1.9 4.7 0.6 3.8 8.0 6.2 5.0 3.7 4.1 5.3 6.2 2.6 6.3 4.5 5.5 12.1 5.6 9.6 15.7 28.7 14.6 3.2 3.9 5.5 5.2 33.5 6.7 5.5 6.6 7.2 14.1 14.7 18.8 4.2 9.2 2.7 11.7 4.4 19.0 7.1 5.0 5.6 1.8 7.6 21.5 2.4 9.3 7.4 5.6 2.9 20.3 19.6 8.2 3.2 3.9 26.9 25.0 4.7 6.1 8.2 3.7 16.7 10.8 4.9 1.8 16.9 5.9 9.6 18.6 39.2 66.1 2.9 3.2 9.4 4.0 2.0 9.5 5.8 17.7 31.1 6.6 7.1 5.6 37.2 8.6 4.4 2.7 1.8 10.2 10.5 6.2 2.7 ASNSD1 "FLJ20752, NBLA00058, NS3TP1" ENSG00000138381 "Asparagine synthetase domain containing 1" Q9NWL6 2 189661385-189670831 "Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036132, HPA036133, HPA075042" Approved Approved Cytosol NA NA Cytosol "HPA036132: AB_2674960, HPA036133: AB_10696650, HPA075042: AB_2686731" "unprognostic (1.32e-1)" "unprognostic (1.70e-1)" "unprognostic (4.88e-2)" "unprognostic (2.15e-3)" "prognostic favorable (4.54e-4)" "unprognostic (8.42e-2)" "prognostic unfavorable (8.66e-4)" "unprognostic (5.68e-2)" "unprognostic (1.35e-2)" "unprognostic (1.41e-3)" "unprognostic (2.09e-1)" "unprognostic (6.32e-3)" "unprognostic (8.98e-3)" "unprognostic (8.11e-2)" "unprognostic (2.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" 27.3 26.4 24.9 19.3 26.3 37.2 33.8 33.6 33.8 28.2 23.7 18.8 22.7 28.9 19.7 21.5 24.2 19.9 32.5 25.0 27.5 30.8 40.8 22.1 27.3 26.1 26.0 23.5 37.9 27.4 33.5 19.3 34.0 26.1 21.7 18.5 40.6 25.4 21.0 60.2 17.6 17.8 28.3 26.7 23.2 20.5 17.7 25.9 28.2 26.5 71.1 25.3 27.6 17.3 29.1 33.1 22.0 53.5 42.5 58.9 50.4 47.2 66.4 57.1 65.7 67.5 72.5 22.6 65.3 39.0 61.9 36.4 26.5 60.2 49.2 76.6 65.4 72.5 57.5 48.5 69.2 61.4 59.9 33.2 59.9 37.2 66.3 58.9 46.5 63.3 46.9 58.6 49.6 69.6 43.2 68.8 68.9 81.0 55.3 102.4 41.3 43.4 62.4 39.0 40.2 59.5 31.2 41.7 35.0 59.1 66.7 52.3 55.9 57.0 56.6 44.5 48.1 73.4 73.7 86.5 93.4 44.1 33.9 52.7 82.8 26.1 107.6 38.8 22.7 48.6 37.2 42.3 43.3 26.7 37.2 49.4 45.3 48.9 49.1 25.2 21.4 57.6 37.3 24.9 26.3 33.6 33.8 25.0 27.5 26.1 26.0 23.5 26.1 26.7 25.9 29.1 31.3 54.5 34.9 10.1 41.1 30.0 24.4 31.2 25.0 22.4 29.7 25.9 43.7 28.6 35.6 16.5 12.5 67.2 36.1 24.1 82.2 35.7 7.0 24.8 34.9 31.1 36.0 41.7 17.2 45.3 43.3 41.8 16.8 22.8 19.0 24.6 29.6 51.9 34.1 15.2 18.9 25.2 26.4 28.0 23.7 5.6 40.7 24.5 17.8 7.5 34.7 40.5 50.4 14.6 17.6 36.5 12.0 33.8 37.9 23.0 18.7 56.7 29.4 27.0 46.0 48.7 47.9 30.3 43.8 29.4 28.4 119.9 42.7 30.9 27.7 19.3 METTL5 HSPC133 ENSG00000138382 "Methyltransferase like 5" Q9NRN9 2 169810081-169824931 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038223 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA038223: AB_10672509" "unprognostic (2.55e-2)" "unprognostic (8.41e-2)" "unprognostic (4.73e-1)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (6.64e-5)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.06e-8)" "unprognostic (8.53e-2)" "unprognostic (1.70e-1)" "unprognostic (1.95e-2)" "unprognostic (6.87e-3)" 47.8 39.9 43.4 28.0 44.6 34.3 50.7 43.1 57.5 30.6 39.7 47.3 29.7 29.6 63.5 36.9 29.4 25.4 66.2 43.2 48.5 38.8 47.3 24.4 35.7 43.8 45.9 42.8 25.9 54.6 37.0 30.5 31.0 44.2 32.8 42.6 30.8 47.5 32.4 93.8 33.0 33.3 36.9 44.6 26.7 43.3 24.5 46.6 31.1 38.0 74.2 38.7 42.7 31.8 47.0 97.1 52.5 74.6 83.1 66.9 99.6 122.6 80.1 74.8 95.4 76.1 164.2 111.2 122.8 95.0 66.0 126.8 98.5 103.0 167.9 133.3 95.3 73.8 185.8 40.6 181.8 90.9 235.9 87.6 73.6 220.2 121.2 147.7 99.4 90.0 165.8 176.0 99.9 123.1 93.8 113.7 190.5 101.4 125.5 98.5 113.7 70.0 190.6 167.0 87.5 90.5 67.6 51.5 80.2 146.0 84.2 75.7 104.6 62.2 103.4 84.5 65.4 104.3 97.0 158.8 206.3 86.3 113.7 95.3 45.5 26.0 21.1 39.9 32.5 61.5 65.0 54.8 53.9 32.0 56.3 56.5 52.3 7.7 45.3 31.8 49.5 57.8 34.8 43.4 44.6 43.1 57.5 43.2 48.5 43.8 45.9 42.8 44.2 44.6 46.6 47.0 67.1 12.8 28.8 6.8 49.1 38.6 88.9 105.2 47.8 24.8 64.0 111.4 83.1 50.1 65.4 44.1 16.7 96.1 43.2 36.1 111.6 115.6 3.9 61.0 34.8 48.6 60.6 70.9 10.8 146.2 117.4 43.8 24.5 43.1 46.3 35.1 46.4 49.5 77.2 23.5 11.0 66.7 59.0 36.9 33.3 8.7 50.4 35.9 55.2 9.4 53.7 51.6 53.5 7.1 13.2 149.7 48.8 60.2 48.1 92.5 72.2 115.8 61.3 23.0 52.6 47.2 66.5 49.2 97.4 56.2 40.9 39.1 47.6 48.4 69.3 89.2 SSB "La, La/SSB, LARP3" ENSG00000138385 "Small RNA binding exonuclease protection factor La" P05455 2 169791933-169812064 "Predicted intracellular proteins" RNA-binding "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004643, HPA017287" Supported Approved Nucleoplasm NA NA 93000 Nucleoplasm "CAB004643: AB_425691, HPA017287: AB_1852672" "unprognostic (5.58e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (9.05e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.99e-4)" "prognostic unfavorable (8.30e-8)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (9.81e-3)" "unprognostic (3.24e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (6.17e-6)" "unprognostic (9.92e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-3)" "unprognostic (2.38e-2)" 115.2 76.3 56.0 76.5 57.8 106.2 76.6 58.0 73.4 59.1 64.9 57.1 49.6 69.3 82.7 52.0 61.5 58.6 69.7 57.0 58.6 75.2 69.1 56.3 94.1 58.5 58.1 54.8 69.6 40.6 80.7 65.1 74.2 58.4 78.9 57.6 55.7 50.4 59.3 62.8 46.9 49.7 62.0 57.5 63.3 50.2 41.5 58.4 70.9 82.5 53.3 81.9 89.2 51.6 60.9 189.0 109.3 231.2 173.5 244.9 226.0 287.8 226.8 150.8 208.2 192.7 332.9 201.7 419.8 251.7 149.8 188.9 197.9 315.3 198.6 283.9 231.2 258.4 505.9 138.0 323.4 218.6 410.8 181.5 175.1 187.1 265.0 156.8 170.6 235.4 156.1 599.0 95.5 442.4 149.5 273.6 428.2 373.3 180.7 110.5 267.9 245.7 304.6 266.3 205.6 219.8 168.0 179.9 132.4 262.9 223.4 152.5 292.0 213.9 151.1 180.1 153.8 221.9 110.3 227.3 355.9 149.2 381.4 168.2 83.4 47.3 59.9 71.9 81.6 104.2 89.8 100.9 92.1 56.8 75.8 90.5 97.0 7.9 93.8 104.5 60.6 100.9 67.2 56.0 57.8 58.0 73.4 57.0 58.6 58.5 58.1 54.8 58.4 57.5 58.4 60.9 143.0 86.6 79.9 21.9 107.9 91.6 229.2 308.7 83.6 114.7 78.1 126.7 91.9 77.2 168.9 112.2 27.1 212.4 111.6 33.6 187.9 206.6 20.3 235.3 188.4 131.5 73.0 154.2 25.4 146.7 212.4 133.5 46.9 101.2 205.0 111.4 92.8 77.0 185.7 136.3 26.8 82.7 240.1 86.8 91.4 49.7 184.2 111.7 80.0 15.0 113.4 152.7 84.5 20.1 21.5 113.2 47.8 186.9 78.7 199.2 40.2 194.9 371.1 91.4 216.9 183.7 194.8 154.4 156.7 68.5 88.4 165.4 128.4 183.3 100.0 155.9 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 29.5 20.5 19.1 23.7 18.3 18.7 35.1 48.6 24.7 28.3 12.6 23.0 15.9 32.6 50.6 36.7 27.7 28.3 28.8 20.5 37.6 20.1 38.2 23.0 27.0 15.2 16.6 16.3 26.3 18.1 23.7 21.3 26.6 20.3 18.7 25.9 41.8 20.9 21.1 8.1 67.2 17.3 25.4 16.9 20.0 38.2 26.3 13.6 21.4 38.3 17.4 26.5 31.5 24.4 27.6 35.5 25.8 65.0 22.6 24.5 42.7 111.0 35.5 55.7 26.4 29.8 62.8 38.4 39.6 40.6 28.3 48.9 88.4 37.4 45.9 51.8 126.1 31.0 46.7 96.3 30.2 15.8 19.8 22.4 24.6 70.4 55.9 17.1 37.4 41.5 23.9 46.3 33.2 40.6 17.4 28.7 20.0 22.8 38.4 35.2 35.0 46.7 15.9 19.3 34.5 57.9 46.9 41.8 13.9 37.3 82.8 11.4 30.6 29.0 54.5 43.0 31.0 21.6 25.7 30.3 29.5 57.3 17.6 43.7 0.0 1.3 0.6 1.3 1.1 1.9 0.7 1.3 1.7 0.9 0.4 1.4 1.5 2.9 2.6 3.7 0.8 3.3 0.8 19.1 18.3 48.6 24.7 20.5 37.6 15.2 16.6 16.3 20.3 16.9 13.6 27.6 24.1 6.4 21.2 14.0 5.9 102.0 23.1 24.6 31.3 26.1 19.7 19.7 18.2 11.5 29.8 12.9 12.5 4.3 9.2 11.4 3.9 10.3 1.4 17.5 10.8 30.1 14.4 12.0 37.2 8.0 11.1 25.2 21.4 23.4 20.3 14.2 44.6 25.7 6.7 6.7 21.2 17.5 14.2 17.3 77.4 3.2 13.4 20.7 39.2 24.4 10.6 12.4 11.3 29.1 28.3 10.2 26.3 14.7 14.9 30.5 4.8 5.1 22.3 15.5 46.0 24.6 39.2 1.7 27.3 55.7 138.9 1.2 16.7 7.3 16.0 29.9 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 15.4;ovary: 6.1" "Group enriched" "Detected in some" 13 "Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 2.2" "Group enriched" "Detected in some" 28 "basophil: 1.8;eosinophil: 3.7" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 0.7 0.3 0.0 0.2 0.0 0.0 0.8 2.2 0.4 0.8 0.0 0.5 0.3 0.6 15.4 0.6 0.5 1.9 0.2 0.4 0.0 0.3 0.0 1.0 0.1 0.4 0.1 0.0 6.1 0.1 0.2 0.3 0.0 1.4 0.7 0.7 0.0 0.3 0.3 0.9 0.6 0.8 0.4 0.1 0.0 0.7 1.9 0.1 0.2 0.1 0.7 0.1 0.8 0.5 0.2 0.3 0.0 0.0 0.0 1.6 2.8 0.0 5.9 22.6 10.2 20.7 0.0 3.0 0.0 0.0 2.3 0.5 0.0 0.0 0.0 30.9 0.0 0.1 1.9 0.0 0.0 0.3 0.1 58.4 3.4 0.0 2.7 1.5 0.4 0.0 0.0 0.0 0.1 19.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.5 2.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.4 0.0 0.4 0.1 0.0 1.4 0.1 0.1 0.2 0.1 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 79.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 40.3 0.3 0.1 3.6 1.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.5 0.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 PPIG "CARS-Cyp, SCAF10, SRCyp" ENSG00000138398 "Peptidylprolyl isomerase G" Q13427 2 169584342-169641406 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021788, HPA057469" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA021788: AB_1847408, HPA057469: AB_2683445" "unprognostic (2.70e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (3.49e-2)" "unprognostic (1.55e-3)" "unprognostic (3.66e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-3)" "unprognostic (2.47e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.56e-4)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (3.41e-2)" "unprognostic (3.39e-2)" 26.2 23.4 25.4 28.7 25.6 54.7 27.8 31.0 59.1 26.3 25.0 26.3 26.9 29.1 31.8 27.7 23.8 22.2 25.9 23.9 25.3 29.5 47.5 24.9 37.2 26.8 25.6 21.1 26.7 21.4 32.9 26.0 28.3 27.5 28.1 26.2 29.5 26.7 23.1 27.8 24.5 30.0 21.9 24.6 32.6 27.7 20.2 26.1 36.5 30.1 26.5 35.7 26.5 26.7 27.6 56.4 25.5 70.8 35.9 35.4 42.5 63.7 58.9 42.3 45.0 45.9 66.3 58.9 94.8 52.5 44.1 55.5 50.5 56.6 48.4 65.6 68.0 45.7 129.9 36.7 88.3 34.4 136.8 58.9 36.6 54.0 58.5 64.6 40.6 50.4 53.5 142.7 76.2 49.5 43.5 101.0 81.9 100.8 45.3 25.1 90.7 71.7 90.5 53.9 81.2 60.5 41.2 63.4 47.2 68.9 52.9 44.2 78.7 52.7 53.9 43.7 38.4 52.6 41.1 65.3 126.8 38.5 68.1 54.1 31.9 22.5 36.7 22.8 25.1 26.7 32.9 30.9 29.2 18.2 38.4 33.4 27.6 40.4 21.1 31.4 30.0 26.8 17.0 25.4 25.6 31.0 59.1 23.9 25.3 26.8 25.6 21.1 27.5 24.6 26.1 27.6 159.7 221.2 175.1 53.5 188.8 151.4 191.4 185.9 101.3 204.6 120.8 156.1 148.4 107.2 169.5 93.8 54.2 170.0 160.1 91.6 80.3 103.1 11.0 104.6 142.3 141.1 104.8 163.5 82.4 103.3 177.0 142.4 66.8 126.3 179.1 115.8 121.7 181.2 151.7 220.4 81.8 135.8 116.0 130.3 126.5 15.6 142.0 129.6 110.3 46.9 152.4 137.6 133.9 53.8 69.7 93.9 118.0 146.7 130.1 161.8 121.1 113.8 132.2 109.1 164.3 150.2 193.9 276.4 183.8 108.3 172.8 205.5 166.7 147.1 149.9 167.7 FASTKD1 FLJ21901 ENSG00000138399 "FAST kinase domains 1" Q53R41 2 169528508-169573875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 91.8;Inhibitory neurons: 89.9;Oligodendrocyte precursor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043719 Approved NA NA "HPA043719: AB_2678635" "unprognostic (3.08e-3)" "unprognostic (1.63e-1)" "unprognostic (6.91e-3)" "unprognostic (8.03e-3)" "unprognostic (1.99e-2)" "unprognostic (3.84e-1)" "unprognostic (5.56e-3)" "unprognostic (1.15e-1)" "unprognostic (3.83e-3)" "unprognostic (2.46e-1)" "unprognostic (1.29e-3)" "unprognostic (2.17e-1)" "unprognostic (4.26e-3)" "unprognostic (2.23e-2)" "unprognostic (1.41e-1)" "unprognostic (7.58e-2)" "unprognostic (7.62e-3)" 6.0 7.8 8.2 10.1 9.7 7.1 7.8 16.0 13.4 4.2 18.4 17.7 18.0 6.4 10.6 11.9 5.3 5.4 27.4 9.5 9.5 10.9 10.1 6.5 10.3 11.0 9.6 8.7 2.5 8.8 15.6 8.2 8.4 12.4 5.7 22.3 18.0 9.9 6.4 15.5 7.3 17.0 9.1 7.7 9.0 9.8 10.6 8.9 10.1 10.8 26.7 12.5 9.2 6.5 12.1 10.9 12.2 15.6 18.1 10.4 14.6 27.0 18.2 10.5 14.4 17.5 19.4 17.5 33.6 16.8 11.4 25.0 29.4 43.9 19.8 23.2 30.7 23.6 48.6 18.8 22.7 7.9 45.7 14.7 10.0 17.3 21.9 12.5 12.0 20.9 28.7 36.0 18.6 18.9 7.8 35.9 37.5 30.9 30.6 14.9 28.2 17.1 40.8 21.2 18.4 34.3 11.2 16.4 30.9 26.8 26.9 5.7 42.7 14.1 16.8 16.8 16.7 18.7 16.5 34.3 24.8 14.3 39.5 11.6 20.6 4.7 2.2 3.3 5.5 4.7 4.9 4.4 3.7 6.3 4.3 4.7 4.0 0.5 7.1 2.6 6.2 3.1 2.5 8.2 9.7 16.0 13.4 9.5 9.5 11.0 9.6 8.7 12.4 7.7 8.9 12.1 5.2 16.0 8.7 46.0 12.7 5.4 6.4 9.8 13.1 16.5 5.7 4.3 30.4 10.0 9.2 3.7 25.0 10.1 10.6 18.3 1.9 6.1 13.4 6.9 8.8 6.6 15.0 21.7 91.8 4.8 10.2 4.7 13.3 7.2 18.3 10.2 5.7 8.0 13.1 11.8 89.9 12.1 10.2 10.0 4.2 5.1 0.9 11.3 1.8 36.5 10.6 3.7 5.2 64.8 46.3 5.8 13.1 2.6 52.9 5.6 16.7 7.4 5.4 19.4 0.0 7.3 3.9 27.2 6.5 19.4 4.4 8.1 9.6 9.0 17.2 7.7 MDH1B "FLJ25341, RP11-95H11" ENSG00000138400 "Malate dehydrogenase 1B" Q5I0G3 2 206737763-206765328 "Metabolic proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.7;testis: 24.7" "Cell type enhanced" "Detected in many" "Early spermatids: 186.0;Endometrial ciliated cells: 50.1;Late spermatids: 33.7;Respiratory ciliated cells: 100.5;Spermatocytes: 114.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.6;SCLC-21H: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073761 Approved NA NA "HPA073761: AB_2732241" "unprognostic (1.03e-2)" "unprognostic (9.44e-2)" "unprognostic (1.58e-1)" "unprognostic (9.84e-2)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (2.01e-1)" "unprognostic (3.66e-2)" "unprognostic (3.23e-3)" "unprognostic (3.08e-1)" "unprognostic (6.10e-3)" "unprognostic (1.15e-1)" "unprognostic (3.09e-2)" "unprognostic (7.84e-3)" "unprognostic (3.01e-1)" 0.4 1.5 3.1 0.2 2.2 0.1 1.2 2.5 2.4 1.3 13.1 0.9 0.0 1.7 1.7 0.5 22.7 0.9 1.3 2.2 5.2 3.2 0.3 2.1 0.3 3.8 3.6 1.4 1.0 0.9 4.2 9.3 0.0 3.5 0.9 0.5 8.6 1.0 1.4 0.4 0.4 0.3 0.8 3.5 0.2 0.7 24.7 2.4 0.5 4.9 0.5 0.2 0.5 0.4 2.8 0.3 1.2 0.9 2.5 0.1 1.1 0.3 0.0 0.4 0.5 0.3 0.1 0.8 0.5 0.5 0.1 1.1 0.6 0.0 0.7 0.5 0.0 0.0 0.2 0.2 0.8 0.5 0.4 1.2 0.7 0.2 0.0 0.1 0.5 0.7 1.1 0.0 0.7 0.3 1.5 0.8 0.3 1.6 0.1 1.4 1.6 0.9 0.0 3.6 0.2 3.5 0.7 1.1 0.5 0.3 0.5 1.1 0.0 0.0 0.6 0.6 0.1 0.3 0.3 1.6 0.2 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.2 2.5 2.4 2.2 5.2 3.8 3.6 1.4 3.5 3.5 2.4 2.8 0.2 6.4 1.5 6.8 0.0 0.8 1.4 3.9 1.8 3.0 2.1 2.4 1.3 2.8 6.4 0.0 0.0 0.1 0.0 0.0 13.7 1.3 186.0 50.1 1.2 0.6 1.2 0.0 8.9 0.0 0.1 1.3 1.5 1.6 0.0 1.1 0.0 0.0 0.1 3.3 6.3 0.0 10.2 0.0 0.2 33.7 1.8 0.5 1.8 1.9 0.0 9.6 0.0 1.0 1.3 0.1 0.0 3.0 0.0 0.4 0.0 6.0 100.5 10.2 0.0 0.5 1.7 114.9 5.1 0.5 0.3 0.0 0.2 1.6 0.1 0.9 HECW2 "KIAA1301, NEDL2" ENSG00000138411 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2" Q9P2P5 2 196189099-196593684 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 331.5;Hepatic stellate cells: 99.2;Inhibitory neurons: 375.4;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 460.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 4.7;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 8 "granulocytes: 4.7;monocytes: 3.7" "Cell line enhanced" "Detected in many" "HDLM-2: 30.1;hTEC/SVTERT24-B: 16.3;HUVEC TERT2: 20.9;SCLC-21H: 31.6;TIME: 26.3;U-138 MG: 21.7" "Low region specificity" "Detected in all" HPA034609 Enhanced NA NA "HPA034609: AB_10669993" "unprognostic (2.65e-2)" "unprognostic (3.89e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-3)" "unprognostic (2.55e-1)" "unprognostic (4.28e-2)" "unprognostic (7.63e-3)" "unprognostic (1.23e-1)" "unprognostic (2.61e-2)" "unprognostic (7.05e-2)" "unprognostic (4.16e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (5.18e-5)" "unprognostic (8.05e-3)" "unprognostic (5.20e-2)" "unprognostic (1.49e-1)" "unprognostic (4.48e-2)" 4.1 1.5 1.3 1.2 3.2 0.1 1.7 4.4 7.1 2.2 0.0 0.4 0.4 0.8 0.3 3.1 3.5 2.2 8.1 3.3 1.7 1.6 2.8 5.3 2.0 1.6 1.1 3.0 0.2 0.6 4.3 1.2 7.4 2.7 0.4 0.4 2.7 0.9 0.5 1.4 0.8 0.5 1.3 0.0 6.0 0.9 3.6 1.8 0.8 3.8 3.5 2.4 1.0 0.6 6.6 0.1 1.4 2.3 0.0 1.4 4.2 1.6 2.7 7.3 2.1 2.6 0.3 0.1 1.4 0.5 13.4 3.3 3.2 0.9 0.1 4.5 30.1 1.6 0.0 2.3 0.2 0.2 0.5 0.3 1.0 1.3 16.3 5.7 4.1 20.9 0.0 0.2 0.1 6.7 1.8 0.0 0.7 2.5 0.2 1.0 0.0 0.5 0.0 0.1 0.0 31.6 2.5 2.0 0.5 0.0 0.4 0.1 0.2 26.3 21.7 1.4 4.6 0.7 0.2 0.0 1.3 5.4 0.1 0.2 0.1 0.3 0.8 0.0 1.1 0.0 0.4 0.0 0.0 0.4 0.5 0.0 0.0 4.7 0.0 3.7 0.0 0.0 0.1 1.3 3.2 4.4 7.1 3.3 1.7 1.6 1.1 3.0 2.7 0.0 1.8 6.6 61.2 0.0 12.1 12.7 3.6 2.2 0.3 0.1 3.4 9.5 1.1 0.8 18.7 0.0 0.1 0.0 0.0 0.2 0.7 0.6 0.0 0.1 11.1 0.4 1.6 34.2 2.4 0.0 331.5 0.0 0.3 4.2 0.5 0.3 1.3 4.9 99.2 1.5 0.1 0.0 375.4 0.6 0.0 7.2 3.0 5.3 0.0 1.4 3.6 14.0 1.2 12.0 0.0 143.2 460.7 0.1 0.0 2.6 3.4 0.4 0.0 0.1 1.0 1.1 0.0 1.2 2.2 0.5 6.1 9.2 1.6 0.1 1.4 0.7 0.1 0.6 IDH1 ENSG00000138413 "Isocitrate dehydrogenase (NADP(+)) 1" O75874 2 208236229-208266074 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 540.8" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 768.1;RT4: 524.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033218, HPA035248, HPA057936, CAB062556" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 16000000 "Nuclear bodies, Cytosol" "CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (6.93e-5)" "unprognostic (3.32e-1)" "unprognostic (2.20e-3)" "unprognostic (8.03e-2)" "unprognostic (5.54e-2)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.45e-5)" "unprognostic (2.09e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.69e-2)" 152.2 232.7 24.3 37.9 24.9 10.8 63.7 25.1 31.2 68.5 41.4 126.1 181.0 23.1 166.3 93.0 36.9 70.1 25.5 24.9 30.8 123.2 540.8 50.3 33.6 27.0 25.6 23.1 85.1 40.2 42.3 16.8 83.2 26.1 216.5 132.5 35.3 59.8 79.8 26.0 22.6 118.4 44.2 27.2 40.5 114.6 57.5 28.4 22.0 45.9 28.3 30.1 154.5 40.3 30.1 66.5 109.6 152.5 63.3 275.1 191.4 86.7 26.3 122.3 44.2 107.3 176.1 159.1 13.1 168.8 84.4 181.6 101.4 112.4 130.7 43.0 8.8 41.7 56.7 87.3 768.1 367.3 37.0 54.7 169.5 278.0 102.7 74.2 69.8 126.1 37.2 58.1 44.5 68.9 42.8 26.3 66.2 284.5 479.7 43.9 25.2 54.8 37.8 206.3 524.0 25.9 45.2 100.5 99.7 351.7 161.2 37.9 111.0 81.1 45.2 44.1 65.3 29.6 20.8 34.5 16.9 148.2 226.7 37.0 12.4 70.1 11.0 9.1 32.3 10.6 10.6 8.2 10.9 50.9 10.1 6.7 7.8 13.8 17.2 15.5 18.8 15.1 29.9 24.3 24.9 25.1 31.2 24.9 30.8 27.0 25.6 23.1 26.1 27.2 28.4 30.1 13.9 12.8 49.5 39.2 20.2 12.4 18.8 60.5 52.3 19.5 61.8 31.5 21.8 45.8 69.1 29.5 25.0 320.2 23.7 106.8 21.5 31.1 13.8 31.0 23.4 22.0 58.4 30.3 16.6 86.5 178.8 29.6 76.0 108.8 14.0 257.5 39.7 328.2 175.3 11.8 16.2 98.4 57.0 130.2 23.8 11.2 24.5 71.7 26.6 19.7 47.8 25.4 18.6 66.4 20.0 44.8 55.5 29.3 13.7 53.2 181.2 108.5 21.9 56.6 13.1 7.8 23.6 8.0 26.2 82.4 14.9 95.6 19.8 127.1 129.3 46.7 OLA1 "GTPBP9, PTD004" ENSG00000138430 "Obg like ATPase 1" Q9NTK5 2 174072447-174248599 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035790, HPA041443" Approved Enhanced Cytosol NA NA 3300000 Cytosol "HPA035790: AB_10601977, HPA041443: AB_2677483" "unprognostic (3.30e-1)" "unprognostic (1.06e-1)" "unprognostic (2.23e-2)" "unprognostic (2.85e-3)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "prognostic unfavorable (9.73e-8)" "unprognostic (6.51e-3)" "unprognostic (7.66e-2)" "unprognostic (1.09e-2)" "unprognostic (3.50e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-3)" "unprognostic (4.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.62e-2)" "unprognostic (9.75e-2)" 42.6 44.7 39.7 38.5 46.3 54.2 57.9 46.0 49.2 34.6 35.6 48.5 50.5 35.1 39.2 58.6 38.3 35.5 57.9 45.8 47.6 56.9 43.3 23.7 48.3 40.8 40.1 42.5 31.4 56.8 44.5 27.6 42.4 42.7 41.5 53.2 42.9 36.6 33.9 106.6 52.4 46.1 37.3 41.1 24.8 35.5 49.2 43.7 58.8 60.2 93.9 53.7 48.8 31.3 50.1 181.4 84.1 134.9 225.5 70.1 152.2 243.0 142.1 142.8 194.2 147.1 200.9 104.4 246.5 138.9 114.5 143.9 139.9 165.3 164.6 227.3 113.7 142.5 231.3 76.4 209.9 135.3 264.3 90.2 134.8 200.6 206.3 217.4 177.4 174.5 88.0 256.8 82.3 170.3 116.6 241.4 272.9 159.1 193.9 273.0 180.4 217.8 170.7 245.1 192.0 218.3 124.7 96.8 141.6 206.2 142.2 101.2 220.6 127.5 127.1 161.4 128.5 210.8 76.2 207.3 190.5 124.6 180.0 115.4 18.1 24.9 7.4 16.2 24.2 23.4 17.9 18.6 20.8 37.1 16.4 21.5 21.2 2.1 26.1 20.0 22.5 25.3 22.7 39.7 46.3 46.0 49.2 45.8 47.6 40.8 40.1 42.5 42.7 41.1 43.7 50.1 43.2 35.3 33.0 57.5 49.0 62.7 73.5 92.4 76.8 47.3 86.0 83.8 68.3 47.1 57.0 31.3 35.5 153.7 47.7 44.6 103.7 145.1 267.8 37.1 55.2 47.8 70.7 92.5 132.6 105.3 112.8 53.0 60.1 43.1 41.2 73.3 29.3 25.8 97.3 33.7 129.8 79.6 65.1 59.6 54.4 99.5 40.4 55.9 32.0 65.6 83.1 60.3 52.5 101.6 101.8 112.8 51.8 51.1 56.3 84.2 78.4 141.7 36.1 35.9 26.3 69.7 92.3 104.8 35.9 113.7 64.1 105.9 55.9 94.6 107.6 79.3 CIR1 CIR ENSG00000138433 "Corepressor interacting with RBPJ, CIR1" Q86X95 2 174348022-174395712 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 187.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 187.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015784, HPA061442" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA015784: AB_1846782, HPA061442: AB_2732664" "unprognostic (3.17e-3)" "unprognostic (4.07e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (2.40e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.00e-2)" "unprognostic (4.39e-2)" "prognostic favorable (9.80e-4)" "unprognostic (1.27e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (1.04e-7)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (8.10e-3)" "prognostic favorable (2.04e-5)" 24.5 24.0 39.0 23.7 40.4 67.9 36.3 40.8 61.6 26.8 41.8 25.5 26.0 27.6 43.9 20.5 28.6 23.6 28.9 38.4 38.3 26.2 27.7 26.9 31.4 39.1 39.2 37.4 34.0 25.1 27.6 25.3 30.1 39.3 26.4 26.6 23.9 25.1 26.3 31.0 30.6 26.9 20.8 38.5 35.3 25.7 31.7 38.2 32.6 29.3 25.4 29.8 24.2 24.4 42.3 20.4 11.4 26.5 21.2 36.3 50.4 39.2 32.9 46.5 32.3 39.5 21.5 30.7 14.1 30.3 32.4 28.3 24.0 22.1 23.4 38.6 26.1 29.1 29.4 17.8 34.9 35.1 35.2 26.0 41.7 41.9 35.5 26.5 55.6 32.4 24.9 30.7 30.8 31.0 19.5 44.1 55.6 24.5 33.2 31.6 24.7 38.1 42.2 38.4 32.1 30.7 36.1 22.7 28.7 52.9 45.7 21.6 51.6 33.6 26.1 19.0 24.9 17.3 34.6 31.4 5.2 37.4 18.2 23.3 71.0 33.8 55.9 28.4 31.7 28.4 41.2 32.2 30.5 21.4 40.5 33.4 30.9 187.8 45.3 33.9 39.5 37.2 28.3 39.0 40.4 40.8 61.6 38.4 38.3 39.1 39.2 37.4 39.3 38.5 38.2 42.3 82.0 118.6 79.8 30.0 80.8 28.6 52.2 118.6 39.3 51.7 40.6 66.8 61.4 61.5 101.2 42.3 31.3 72.7 116.5 69.1 119.3 67.3 201.5 192.2 79.7 58.7 51.4 102.5 30.4 78.7 58.1 69.9 30.1 79.6 81.6 59.1 75.7 58.6 63.8 45.4 33.7 81.9 85.5 93.0 30.3 43.4 107.2 75.3 33.8 22.5 108.2 85.7 111.2 30.2 37.3 57.7 79.8 82.4 49.1 37.5 91.6 114.0 202.3 56.2 72.3 71.4 72.1 219.5 54.7 25.4 32.0 116.0 80.5 62.6 53.5 45.7 ITPRID2 "CS-1, KIAA1927, KRAP, SPAG13, SSFA2" ENSG00000138434 "ITPR interacting domain containing 2" P28290 2 181891730-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 177.3" "Cell type enhanced" "Detected in some" "Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: AB_2674271, HPA039989: AB_2676788" "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favorable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (5.79e-5)" 31.1 20.9 60.1 20.8 62.3 42.8 32.5 63.5 66.8 31.2 54.7 50.9 36.7 26.1 18.5 23.0 20.5 38.1 23.6 50.2 65.1 48.8 80.0 45.3 17.8 70.4 63.0 45.8 13.7 177.3 21.1 18.4 34.9 65.2 34.3 44.7 17.1 70.5 17.3 32.2 113.8 34.3 25.8 62.5 32.7 56.6 37.7 68.4 24.3 36.8 23.6 16.2 31.6 29.7 64.8 56.0 25.8 71.6 12.6 53.8 41.3 21.7 94.6 82.6 29.1 37.0 25.9 56.0 1.2 30.7 59.7 31.5 46.2 14.5 41.6 56.6 25.2 20.3 52.5 106.6 23.5 45.7 28.5 48.9 30.0 64.4 51.3 57.7 66.7 145.8 22.3 25.0 29.5 82.9 28.7 25.4 41.0 5.0 47.0 62.5 18.7 29.3 19.2 87.0 16.3 13.7 12.1 55.7 19.7 91.0 27.6 14.2 61.6 68.1 73.1 37.0 27.5 50.3 20.9 9.4 21.9 34.0 17.1 57.2 6.1 2.8 4.2 0.9 2.7 0.6 0.4 0.6 0.6 2.7 0.9 0.8 0.7 4.7 0.8 5.1 2.1 0.4 1.3 60.1 62.3 63.5 66.8 50.2 65.1 70.4 63.0 45.8 65.2 62.5 68.4 64.8 30.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 25.7 5.8 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 26.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 33.4 1.1 0.0 0.0 0.0 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 171.4" "Cell type enriched" "Detected in some" 48 "Skeletal myocytes: 193.5" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Group enriched" "Detected in some" 12 "cerebral cortex: 13.1;hippocampal formation: 5.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "LHCN-M2: 445.4;RH-30: 360.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071554 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA071554: AB_2686416" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 0.1 0.0 0.3 0.2 0.4 0.0 0.5 0.2 13.1 0.6 0.3 1.5 0.2 0.0 0.2 0.6 0.0 0.0 0.3 5.6 0.3 0.0 0.2 0.6 0.8 0.4 0.3 0.4 0.0 0.0 0.0 3.4 0.2 0.6 2.1 0.9 0.0 3.2 0.0 171.4 0.3 0.0 0.0 0.4 0.0 0.1 0.4 0.3 1.2 0.0 20.6 1.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 21.5 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.2 445.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 360.2 0.0 0.0 0.3 2.9 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.4 0.2 13.1 5.6 0.3 0.4 0.3 0.4 0.6 0.4 0.3 0.8 0.1 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 4.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.5 0.0 0.6 0.4 1.7 0.3 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 193.5 0.3 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.2 0.0 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202634969-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 45.8;Inhibitory neurons: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Yes No Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: AB_2672760" "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 2.8 7.6 4.8 4.6 6.0 2.9 3.3 7.7 6.2 2.8 1.5 4.9 4.3 2.9 2.9 5.5 3.8 3.0 1.8 5.2 5.9 4.9 1.9 2.9 7.3 3.7 4.4 4.9 5.1 4.6 7.4 3.6 7.0 4.9 5.1 4.7 2.6 3.3 3.0 1.5 5.0 3.8 2.1 3.6 5.5 4.2 5.9 6.2 9.7 2.8 1.8 7.5 3.8 3.2 5.0 2.0 2.4 10.5 7.2 3.5 1.9 10.2 0.6 0.9 0.6 1.1 3.1 4.2 8.2 6.5 1.2 1.6 1.9 9.0 4.6 1.7 0.2 7.2 6.9 4.3 11.6 2.8 5.9 3.0 2.6 6.3 1.3 1.9 4.7 2.8 10.8 10.1 1.6 0.6 3.9 16.1 12.1 10.7 5.8 4.5 12.5 2.1 9.8 5.5 5.2 17.7 15.4 8.0 5.3 3.9 8.7 2.2 8.1 1.7 1.2 2.4 1.9 1.1 5.9 3.6 10.8 2.4 4.5 1.3 0.4 3.9 1.5 1.3 8.2 3.4 8.1 3.0 2.7 4.5 7.7 8.2 5.7 2.2 4.4 9.1 1.5 1.2 3.1 4.8 6.0 7.7 6.2 5.2 5.9 3.7 4.4 4.9 4.9 3.6 6.2 5.0 9.7 3.2 7.5 13.1 21.5 17.2 2.9 3.0 12.0 4.9 8.1 4.3 4.9 12.8 2.6 18.4 4.2 8.4 8.8 11.7 0.0 10.2 2.2 8.6 6.5 4.9 25.8 3.0 45.8 6.4 6.3 6.1 7.1 10.1 5.7 15.3 8.2 2.2 2.8 6.7 49.7 11.8 2.0 27.4 13.9 1.4 13.1 17.1 3.6 23.4 17.1 1.7 3.1 29.1 29.4 5.8 9.7 23.7 5.2 6.7 4.9 5.9 3.0 2.7 6.6 2.0 4.1 5.0 16.3 29.2 19.9 2.7 10.1 11.1 13.8 6.0 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874261-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 2.7 3.6 1.9 2.7 2.2 3.6 3.6 2.2 3.2 2.6 1.3 3.0 4.2 3.2 3.2 3.2 3.1 2.3 4.1 2.4 2.9 5.3 4.3 1.7 3.3 2.4 2.3 2.3 3.3 2.2 3.5 1.9 2.7 2.8 2.2 4.0 2.6 1.9 2.3 4.8 3.6 2.9 3.5 1.6 2.1 2.3 3.5 2.7 3.3 3.3 6.1 3.7 4.1 2.3 3.4 5.3 5.8 6.4 12.5 12.3 10.4 11.4 7.6 6.6 10.1 9.8 14.8 7.5 10.2 7.2 6.6 8.5 6.6 18.2 13.3 16.0 4.6 11.1 17.0 9.0 17.7 8.0 22.1 9.9 9.5 9.4 12.0 23.6 6.4 10.8 10.2 26.7 5.9 11.3 6.5 14.8 13.3 14.9 7.3 14.3 11.1 9.7 16.1 11.2 6.5 11.4 9.8 6.5 8.2 9.8 11.0 4.7 14.1 8.3 8.3 6.9 7.4 8.4 8.0 12.8 16.3 8.7 15.3 8.8 1.3 1.6 0.6 1.4 1.7 2.0 1.9 1.3 1.4 2.1 1.9 1.7 1.7 0.6 1.3 1.7 2.4 1.6 1.1 1.9 2.2 2.2 3.2 2.4 2.9 2.4 2.3 2.3 2.8 1.6 2.7 3.4 10.1 9.6 16.9 12.1 13.6 20.5 21.4 24.4 13.1 10.2 8.4 9.1 27.9 7.2 19.1 5.5 2.1 25.3 7.9 7.8 15.6 18.0 14.3 14.7 25.3 12.6 5.4 22.1 19.2 10.6 34.9 16.5 9.7 13.3 15.2 15.8 8.2 15.0 18.0 15.2 20.3 10.6 24.4 7.2 6.0 8.9 17.1 9.2 1.8 12.2 13.7 6.4 5.2 10.6 9.9 14.2 6.6 15.4 9.3 17.3 13.9 38.1 15.7 8.3 13.1 20.1 41.9 43.0 32.3 18.2 17.3 21.5 10.7 21.0 19.2 17.0 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328280-203447728 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA070567: AB_2686281" "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 10.3 13.3 29.8 9.6 43.1 3.4 15.3 24.5 36.9 19.1 9.9 15.0 5.8 28.2 18.8 12.0 22.7 13.5 33.0 38.0 32.9 21.1 7.5 16.3 8.2 18.6 24.8 30.9 28.1 7.5 20.6 20.6 19.6 19.8 18.9 10.8 30.3 8.6 23.2 7.4 7.6 9.0 25.5 19.3 13.0 9.4 27.7 29.5 22.4 26.8 15.9 8.8 14.8 12.0 25.1 19.3 29.4 102.5 64.4 23.9 40.5 22.6 33.0 29.0 27.9 32.2 27.3 35.5 0.0 22.0 39.0 38.8 20.9 47.1 34.6 54.8 9.5 27.4 47.9 30.9 21.4 36.3 20.6 21.1 28.8 16.5 51.2 39.5 80.5 52.6 54.1 34.7 41.8 49.7 35.0 52.8 20.4 53.5 18.2 64.8 34.5 51.4 3.5 29.3 19.6 43.2 55.3 6.2 19.2 37.4 76.8 25.0 23.9 39.9 50.4 43.0 27.8 36.2 29.3 28.7 26.6 54.7 8.5 33.2 0.2 1.4 0.0 3.3 1.6 3.6 1.4 3.7 3.7 4.0 1.3 4.4 3.9 0.2 3.9 3.8 12.7 4.4 3.2 29.8 43.1 24.5 36.9 38.0 32.9 18.6 24.8 30.9 19.8 19.3 29.5 25.1 39.7 54.5 26.5 123.4 14.7 30.1 55.7 37.7 34.1 111.9 39.5 38.7 56.7 28.6 32.8 53.3 162.6 23.7 33.1 10.1 33.2 24.3 128.2 62.3 68.4 43.6 49.2 30.3 201.3 13.1 15.7 54.1 25.0 72.3 15.8 100.0 65.7 12.3 16.7 102.6 128.6 10.9 20.3 11.4 62.3 81.6 46.6 22.1 49.8 57.1 18.6 67.6 26.8 114.1 94.2 15.5 19.4 63.2 18.3 44.2 11.1 38.5 83.1 89.6 26.3 70.5 67.9 89.0 52.4 22.0 26.1 19.7 21.7 69.9 17.0 37.5 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590056-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 6.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "RT4: 369.7;SuSa: 297.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" NA NA 2000000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 40.2 39.0 21.9 36.8 31.8 6.4 28.0 39.3 25.3 40.1 40.5 20.3 16.1 37.1 10.6 24.7 26.5 47.7 80.7 18.7 48.9 52.5 18.2 26.0 15.9 42.5 34.6 15.9 65.3 25.9 83.3 12.0 47.8 43.6 30.1 21.8 81.1 32.4 28.3 16.4 41.7 16.5 57.2 50.4 21.6 34.5 14.9 32.1 18.2 63.2 30.8 21.7 43.5 16.1 58.7 49.1 57.5 37.4 119.9 134.1 90.0 141.7 93.8 75.5 32.5 32.5 50.7 164.0 0.4 179.7 106.3 113.4 60.2 19.3 88.5 46.7 9.7 17.2 11.7 69.1 69.6 52.8 8.3 7.0 65.8 41.3 72.7 61.1 194.1 78.7 5.9 11.6 23.9 87.4 19.4 5.0 6.8 28.3 29.1 28.5 0.1 76.2 6.8 83.5 369.7 7.7 23.0 108.6 33.2 40.1 297.0 26.2 22.4 240.5 199.4 61.9 41.4 80.3 5.9 10.4 5.5 80.3 3.3 100.6 6.2 0.6 0.9 0.4 1.1 0.3 0.1 0.2 0.4 0.4 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 21.9 31.8 39.3 25.3 18.7 48.9 42.5 34.6 15.9 43.6 50.4 32.1 58.7 39.8 28.9 22.9 134.8 4.9 128.4 64.0 127.7 42.7 118.4 50.4 23.4 145.5 80.1 35.3 77.3 77.2 55.1 9.4 32.4 1.9 78.7 0.6 61.7 61.1 47.2 7.3 2.1 36.3 101.8 26.9 65.4 57.6 100.2 49.5 21.2 27.8 18.2 27.6 15.2 35.9 19.9 14.2 44.3 56.7 3.1 19.3 29.3 46.2 75.9 17.4 70.9 2.1 184.5 156.1 165.9 23.8 25.9 9.2 103.4 11.2 32.4 27.0 60.2 32.9 29.0 63.3 1.7 2.4 27.7 103.7 39.7 10.9 18.1 15.5 77.7 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560590-189583758 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 326.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 60.1 336.2 9.0 53.1 10.7 46.2 98.6 10.0 10.4 157.7 11.6 125.9 291.9 96.3 62.1 30.8 216.0 150.0 53.1 7.1 14.7 80.6 253.6 124.0 174.1 14.7 15.0 6.2 320.0 53.7 92.6 19.1 252.2 12.5 39.9 132.1 29.7 59.2 53.6 64.8 10.8 128.9 69.9 14.1 371.3 97.7 33.5 13.0 63.2 68.6 60.9 59.6 53.6 22.0 12.0 0.0 7.4 0.6 0.0 509.0 3.3 25.4 0.2 6.6 1.9 3.1 123.1 0.4 0.2 1.0 0.2 1.4 0.4 2.4 0.3 1.6 0.3 1.7 430.0 1.7 45.8 1.9 1.5 110.5 35.9 0.2 1.2 0.0 11.7 13.0 16.4 44.6 1.1 6.3 0.0 18.2 28.8 1.5 92.7 1.7 0.2 5.0 2.5 5.3 18.1 1.0 5.4 0.8 35.4 0.0 39.5 207.6 6.2 0.3 0.8 11.7 0.5 0.1 1.1 0.2 0.3 0.1 0.2 0.1 129.8 101.5 172.1 2.2 23.7 3.2 0.2 54.4 4.9 115.6 0.7 80.2 17.8 326.2 4.6 2.6 18.8 5.3 105.8 9.0 10.7 10.0 10.4 7.1 14.7 14.7 15.0 6.2 12.5 14.1 13.0 12.0 44.2 125.0 40.3 3.6 12.0 9.2 51.3 10.5 19.9 4.8 83.8 30.0 48.0 138.7 31.6 33.1 4.2 489.8 5.7 328.9 49.0 54.7 10.5 39.6 38.2 39.8 18.6 253.7 0.3 71.8 20.3 81.9 76.5 129.5 9.5 12.8 245.9 259.7 86.4 6.7 6.8 60.8 6.1 1340.2 26.8 9.2 121.2 172.7 8.8 34.7 41.7 17.5 2.1 14.6 0.2 71.5 86.2 58.6 4.1 26.2 163.0 150.0 34.4 48.4 65.7 13.7 49.1 7.4 3.9 12.5 8.1 2463.5 11.9 84.8 48.9 27.7 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585579 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: AB_2683566" "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favorable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 15.7 19.5 21.2 13.6 26.2 5.8 14.9 25.0 27.2 15.6 20.8 15.8 16.9 15.7 16.1 14.5 14.7 15.5 9.8 21.2 24.2 20.4 21.1 14.8 15.8 26.2 24.8 20.8 18.0 9.6 17.3 9.2 18.5 26.3 16.1 16.3 21.9 11.5 14.0 6.1 9.3 18.5 16.1 24.7 14.4 14.7 19.0 24.0 12.8 26.3 10.3 15.4 12.7 8.4 32.9 20.4 18.4 31.2 18.8 39.3 37.4 18.0 33.2 23.7 27.5 31.5 13.6 22.8 18.1 27.4 28.8 31.3 25.3 22.4 15.6 34.6 14.2 11.1 23.2 15.9 11.4 33.6 20.7 21.5 31.8 30.9 24.3 14.9 34.8 25.1 13.8 13.5 22.1 38.7 7.2 16.2 13.1 20.8 24.0 19.2 14.4 11.4 19.7 34.2 14.9 18.3 24.1 21.3 10.4 38.0 20.9 14.2 13.9 28.3 40.3 21.8 8.6 15.7 15.7 24.4 32.2 29.9 17.2 30.8 14.8 16.4 21.0 10.9 25.9 10.3 14.7 10.2 8.6 19.7 13.6 13.6 11.2 14.6 7.3 27.4 9.4 11.2 10.8 21.2 26.2 25.0 27.2 21.2 24.2 26.2 24.8 20.8 26.3 24.7 24.0 32.9 9.9 3.2 10.1 13.1 12.5 6.4 8.3 9.9 11.4 12.8 8.5 6.5 5.5 7.2 12.6 14.7 0.0 36.1 12.5 16.4 9.8 7.8 156.8 9.2 9.1 12.9 7.7 9.2 15.0 7.7 25.6 14.0 10.7 10.0 14.0 9.0 19.6 13.1 17.9 37.0 15.2 11.8 20.3 23.2 9.2 23.5 17.1 13.0 26.6 5.6 14.0 20.3 9.2 23.1 36.6 8.1 13.1 17.3 14.3 8.5 25.8 14.8 10.4 16.9 26.3 9.6 10.6 14.9 15.7 8.9 6.7 29.8 10.7 14.6 10.0 6.5 SLC49A4 "DIRC2, FLJ14784, RCC4" ENSG00000138463 "Solute carrier family 49 member 4" Q96SL1 3 122795069-122881139 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 44.0;Extravillous trophoblasts: 61.2;Syncytiotrophoblasts: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072579 Supported Vesicles NA NA Vesicles "HPA072579: AB_2686536" "unprognostic (1.40e-1)" "unprognostic (8.53e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (9.74e-2)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.87e-1)" "prognostic favorable (8.81e-11)" "unprognostic (2.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (7.13e-2)" 4.4 5.1 4.8 2.7 4.9 6.0 3.1 4.8 5.3 3.0 5.8 4.1 1.9 2.7 3.8 5.6 3.1 3.8 6.4 5.5 5.4 4.6 3.5 5.3 2.0 4.9 5.4 4.5 2.2 6.6 12.8 2.5 7.7 4.8 5.0 4.5 5.7 3.7 3.6 16.0 6.7 2.7 2.7 4.5 2.8 3.2 2.6 5.0 1.9 5.3 14.1 2.5 4.1 2.7 5.6 7.4 6.1 5.9 3.3 7.5 6.1 19.6 3.1 6.7 4.9 5.0 14.4 8.0 1.0 3.9 3.5 10.9 10.5 4.3 5.6 4.7 1.6 3.2 1.2 3.3 6.2 5.5 0.7 0.7 5.0 15.0 3.5 5.9 7.6 5.6 2.0 0.7 1.3 6.3 3.3 0.9 0.8 5.3 2.5 9.8 2.0 13.3 1.5 7.0 8.4 6.1 4.6 9.1 4.1 8.4 3.7 4.8 1.6 8.0 7.6 2.8 4.6 2.6 1.3 1.2 0.4 3.8 1.3 4.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 4.8 4.9 4.8 5.3 5.5 5.4 4.9 5.4 4.5 4.8 4.5 5.0 5.6 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 44.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 61.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 226.6 0.4 0.0 0.0 0.0 SENP7 ENSG00000138468 "SUMO specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 44.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 44.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 13.3 9.8 10.1 13.9 12.7 24.9 17.0 21.0 11.9 15.8 10.8 11.1 7.4 27.1 14.9 7.9 16.2 14.3 9.6 9.4 12.3 11.5 8.8 12.9 23.3 13.0 13.1 7.7 26.5 12.9 17.0 10.3 19.6 13.3 12.8 10.9 26.3 9.0 11.6 11.3 21.0 12.5 14.8 11.3 17.0 14.2 9.2 11.3 20.6 17.7 11.3 17.8 11.9 11.5 20.6 9.2 6.1 29.4 16.4 5.6 8.2 5.3 5.2 3.8 8.5 10.4 4.0 8.3 7.0 7.9 5.1 7.8 9.1 9.4 4.8 17.0 13.0 2.7 12.7 5.1 5.5 4.5 7.4 12.2 6.4 8.5 4.3 9.6 7.6 12.2 13.4 10.5 17.6 8.1 6.1 13.7 8.6 6.0 4.8 6.3 15.2 8.0 6.4 10.1 5.2 11.3 8.8 4.8 4.8 6.5 15.0 8.0 9.8 10.2 11.8 7.1 3.9 5.2 12.2 7.8 16.4 4.1 9.7 9.8 44.1 5.9 5.9 5.8 5.4 7.3 6.4 7.8 5.8 4.8 9.0 10.3 7.1 17.3 9.3 6.3 4.1 6.9 6.1 10.1 12.7 21.0 11.9 9.4 12.3 13.0 13.1 7.7 13.3 11.3 11.3 20.6 44.5 16.0 24.9 78.4 33.0 9.1 8.4 7.4 21.1 48.3 14.4 12.2 21.6 2.8 18.4 16.5 20.9 5.8 30.8 5.4 5.9 8.1 4.1 33.1 48.5 28.4 13.1 18.7 62.4 5.2 2.7 23.4 21.4 34.1 37.2 28.6 32.9 10.3 8.2 52.2 109.6 6.5 12.2 20.5 9.5 4.0 18.3 19.1 10.6 80.6 13.6 16.7 35.0 157.3 134.4 6.9 4.1 19.5 23.5 4.8 7.0 8.5 27.5 33.8 46.0 29.7 23.3 22.8 19.9 13.4 9.9 2.5 41.0 21.1 5.9 6.1 GUCA1C GCAP3 ENSG00000138472 "Guanylate cyclase activator 1C" O95843 3 108907792-108953879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 299.3" "Cell type enriched" "Detected in some" 4 "Cone photoreceptor cells: 125.1" "Cancer enriched" "Detected in single" 7 "pancreatic cancer: 0.5" "Group enriched" "Detected in some" 5 "hippocampal formation: 1.1;midbrain: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 85 "RPTEC TERT1: 14.0" HPA041597 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA041597: AB_10795501" "unprognostic (7.56e-2)" "unprognostic (6.56e-2)" 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 1.1 0.5 0.6 0.0 0.0 0.0 0.1 4.1 0.3 0.4 41.9 0.0 0.4 0.0 0.1 0.0 0.0 299.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.4 1.3 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 1.1 0.5 0.1 4.1 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 14.5 0.0 0.0 0.0 125.1 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 1.0 0.0 9.7 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.6 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 17.5 0.0 0.0 CCDC54 "FLJ25362, NYD-SP17, SP17" ENSG00000138483 "Coiled-coil domain containing 54" Q8NEL0 3 107377439-107378635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 71 "testis: 118.4" "Group enriched" "Detected in some" 114 "Early spermatids: 1528.4;Late spermatids: 3824.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (9.56e-3)" "unprognostic (1.56e-1)" "unprognostic (2.16e-1)" "unprognostic (2.98e-1)" "unprognostic (5.27e-2)" "unprognostic (9.79e-2)" "unprognostic (7.38e-3)" "unprognostic (1.53e-2)" "unprognostic (7.32e-2)" "unprognostic (5.20e-2)" "unprognostic (1.87e-3)" "unprognostic (8.75e-4)" "unprognostic (5.58e-2)" "unprognostic (5.78e-2)" 0.0 0.1 0.2 0.0 0.5 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.9 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.2 0.2 0.3 0.2 0.0 0.3 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1528.4 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3824.3 9.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX17 ENSG00000138495 "Cytochrome c oxidase copper chaperone COX17" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria NA NA 220000 Mitochondria "HPA042226: AB_2677911, HPA048158: AB_2680292" "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 82.3 180.2 107.9 77.8 110.5 114.3 69.5 116.6 123.4 50.7 143.7 91.0 91.0 41.6 115.1 56.4 47.7 60.0 282.5 105.8 122.0 92.6 174.1 62.8 111.3 116.4 115.9 102.8 31.8 102.8 415.8 120.2 64.4 117.0 79.3 79.5 121.6 81.5 91.5 405.2 43.6 89.2 63.5 116.6 65.5 108.5 44.8 113.8 107.5 95.2 367.2 90.5 76.6 36.0 121.3 219.6 257.0 122.7 33.3 53.4 53.1 45.7 130.5 84.2 127.3 133.4 226.4 157.7 164.6 158.0 72.1 174.8 84.0 138.5 154.9 74.9 205.5 155.9 145.0 195.3 180.1 63.1 205.0 246.7 56.6 142.7 77.9 106.0 82.2 87.9 200.8 122.4 370.7 155.4 410.2 212.8 283.5 133.8 212.2 413.3 88.3 82.3 273.7 203.2 141.0 210.5 86.4 153.1 137.1 189.7 76.9 180.5 313.0 66.6 91.3 144.9 59.8 168.4 257.5 348.9 361.1 129.0 157.8 164.2 591.4 241.1 630.6 218.1 357.5 208.1 378.3 241.7 230.3 252.8 320.4 189.1 187.0 174.4 213.6 487.3 538.7 352.6 260.1 107.9 110.5 116.6 123.4 105.8 122.0 116.4 115.9 102.8 117.0 116.6 113.8 121.3 194.5 157.0 167.1 5.2 161.5 94.1 132.8 267.9 46.7 108.9 153.8 147.2 622.8 238.8 202.4 498.4 43.8 137.4 116.7 385.3 716.1 264.0 115.0 282.4 64.3 164.7 214.2 162.9 3.8 413.7 193.9 99.3 150.3 178.8 309.3 70.2 116.0 779.8 216.1 75.7 5.6 327.8 427.2 181.8 281.2 39.9 91.0 190.8 277.5 11.2 345.7 178.8 137.0 8.5 8.8 459.7 512.8 136.9 176.5 198.2 434.6 786.2 280.2 174.4 184.1 112.9 171.6 286.0 159.2 85.4 125.4 211.0 129.0 49.6 151.1 199.0 PARP9 "ARTD9, BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 113.4;SK-MEL-30: 93.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA066708: AB_2685707" "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 20.1 29.6 14.5 36.1 15.4 21.0 17.8 13.5 17.5 19.1 15.2 20.9 21.4 19.8 19.3 25.0 20.2 29.1 15.8 12.6 19.1 20.6 68.8 36.8 30.7 17.4 14.3 11.6 13.0 22.2 23.9 18.7 20.2 15.8 19.0 19.7 5.9 40.2 12.7 13.8 11.7 21.5 29.4 14.8 44.7 20.2 6.4 16.3 30.8 16.9 17.5 26.2 26.2 16.7 21.3 23.1 7.7 2.8 1.9 16.9 34.6 2.6 7.6 41.0 95.8 113.4 12.0 24.9 5.2 16.4 15.3 60.2 24.8 6.6 13.4 19.9 40.3 4.5 24.9 7.6 6.4 18.0 8.1 15.9 28.4 12.9 13.6 3.4 19.1 20.8 15.7 2.3 20.7 3.9 10.2 26.0 10.1 1.1 4.7 21.1 27.3 27.2 1.7 37.0 13.1 1.7 6.6 20.2 3.3 93.8 1.5 10.7 9.0 12.6 4.1 11.8 0.9 4.7 12.8 7.1 9.5 14.1 8.7 7.7 41.9 29.9 36.9 19.8 41.1 18.5 15.9 20.6 22.3 27.5 11.4 15.6 19.3 87.5 30.2 45.2 3.3 24.9 23.3 14.5 15.4 13.5 17.5 12.6 19.1 17.4 14.3 11.6 15.8 14.8 16.3 21.3 37.0 41.7 44.2 13.4 18.9 7.1 10.8 13.8 12.5 0.8 10.5 6.3 5.8 10.0 35.1 20.2 0.0 5.2 14.0 32.5 1.9 30.4 1.6 23.6 28.1 37.4 10.7 19.0 0.3 39.9 19.3 19.9 22.4 23.2 10.1 19.5 21.8 50.1 42.0 0.0 1.3 11.5 10.2 32.3 9.2 4.5 18.3 41.2 7.2 45.0 50.2 12.1 32.0 17.1 3.9 36.8 11.7 24.0 13.6 8.9 17.5 19.3 48.8 1.0 19.7 18.9 16.3 0.9 1.9 15.7 6.7 1.6 23.5 17.0 8.6 14.4 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.4;testis: 48.6" "Group enriched" "Detected in many" 5 "Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.9 1.4 6.1 1.6 2.7 4.6 3.1 10.8 2.9 3.4 10.7 1.9 2.4 3.6 1.3 2.7 21.4 3.3 2.5 2.1 4.6 8.6 1.9 3.4 1.4 6.7 5.7 1.4 4.1 2.4 0.6 3.6 1.6 5.1 2.3 2.1 4.7 2.0 1.7 1.1 1.4 2.2 1.4 8.3 1.5 2.2 48.6 2.9 5.6 3.0 1.2 1.2 1.3 2.5 4.3 32.1 7.4 3.8 11.3 3.1 6.7 0.7 7.6 4.4 8.8 18.6 10.5 15.0 17.8 9.4 3.2 12.8 12.3 4.7 4.4 17.9 0.0 1.9 22.9 8.8 1.8 1.1 7.9 2.4 2.7 0.2 17.9 2.6 3.7 1.6 6.8 5.2 0.0 7.6 4.2 0.3 9.8 1.2 16.4 4.3 15.0 22.6 0.2 8.7 6.1 29.5 8.9 12.7 3.8 13.6 0.9 9.1 12.1 0.7 12.0 13.6 11.6 18.8 3.6 11.9 0.3 13.4 18.3 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 2.7 10.8 2.9 2.1 4.6 6.7 5.7 1.4 5.1 8.3 2.9 4.3 0.7 0.0 4.7 1.0 0.8 3.3 8.8 9.3 1.8 10.5 4.7 8.3 6.0 4.3 28.3 35.0 25.0 1.8 0.2 3.7 11.7 10.9 504.6 256.5 7.8 2.0 1.2 3.0 4.9 1.9 3.9 14.0 5.1 7.2 0.0 11.0 6.8 0.4 7.0 15.2 3.7 4.5 10.2 1.0 5.5 60.8 12.8 2.0 0.0 0.0 0.8 12.4 0.0 1.5 2.8 1.2 0.1 8.6 0.5 3.0 0.3 12.3 232.5 32.6 0.0 21.6 6.5 249.6 25.0 7.1 1.4 0.5 1.0 6.4 6.0 3.5 USP8 "HumORF8, KIAA0055, SPG59, UBPY" ENSG00000138592 "Ubiquitin specific peptidase 8" P40818 15 50424380-50514421 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050215 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA050215: AB_2681054" "unprognostic (5.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "unprognostic (9.58e-2)" "unprognostic (2.35e-2)" "unprognostic (2.91e-1)" "unprognostic (1.42e-1)" "unprognostic (3.96e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.94e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.89e-2)" "unprognostic (1.13e-1)" "unprognostic (3.79e-1)" "unprognostic (1.58e-1)" 20.5 19.0 10.9 21.3 10.7 27.8 19.8 14.1 13.4 20.7 16.1 21.7 27.0 19.3 10.5 20.9 18.6 16.5 15.2 8.8 13.2 27.2 28.3 19.6 19.1 14.4 11.8 6.6 20.1 17.6 45.4 10.6 20.5 11.6 17.1 21.0 22.4 20.0 17.4 17.7 14.3 24.6 18.6 11.2 18.9 22.7 32.3 11.6 21.1 25.6 22.9 24.5 20.2 12.7 12.8 30.6 35.8 23.7 41.1 32.3 44.3 31.0 45.7 43.9 35.7 40.4 19.5 17.7 28.8 35.0 43.5 46.6 57.8 28.8 28.3 39.9 27.2 19.3 52.9 31.9 27.3 35.9 34.3 34.4 32.4 36.2 26.0 55.8 37.0 36.3 23.3 28.4 36.8 32.9 45.9 26.6 12.0 28.5 32.6 17.1 24.1 39.1 45.8 29.5 61.3 29.1 23.8 42.5 55.9 57.4 48.9 35.8 36.9 45.0 41.1 24.1 122.7 52.7 28.5 69.8 32.4 30.6 65.6 40.1 114.6 27.7 50.1 21.4 26.1 22.1 37.3 22.9 23.3 22.7 34.3 24.0 21.2 47.9 22.1 35.0 20.5 20.0 16.0 10.9 10.7 14.1 13.4 8.8 13.2 14.4 11.8 6.6 11.6 11.2 11.6 12.8 63.5 96.1 130.8 36.2 101.8 28.9 40.7 47.3 35.9 54.5 41.7 40.0 69.8 51.5 72.7 47.8 68.8 59.0 92.7 79.5 25.4 53.7 153.7 91.5 79.7 53.8 53.3 36.8 41.0 51.3 45.4 55.8 58.1 65.6 86.7 48.5 51.0 56.6 45.4 33.7 44.3 68.7 36.7 73.2 38.2 28.4 53.7 77.6 40.9 46.9 85.3 45.5 72.1 34.7 46.1 57.3 58.2 61.7 87.1 51.0 88.9 49.9 114.9 74.2 46.0 108.2 56.2 140.5 54.8 39.6 41.5 105.2 72.6 77.1 64.8 55.3 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046447 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 123.2" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 248.6;Oligodendrocytes: 429.8;Syncytiotrophoblasts: 711.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favorable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 19.0 16.2 40.1 12.0 72.0 22.8 18.8 60.8 60.3 18.8 10.0 12.8 9.7 18.6 22.1 17.2 18.6 14.7 15.6 41.8 47.6 25.2 18.9 37.6 13.8 65.4 63.6 29.4 19.7 15.1 76.9 9.3 30.2 66.3 21.0 11.7 32.7 45.4 17.7 12.2 11.1 11.5 15.0 71.6 15.3 19.3 14.0 53.6 15.0 24.1 18.4 13.5 13.0 11.9 123.2 9.5 10.4 20.7 18.0 28.6 21.9 12.9 31.3 25.8 25.1 31.6 11.2 8.2 6.6 15.1 24.0 26.5 8.0 26.2 8.2 30.0 40.7 7.0 18.4 14.1 8.4 15.5 10.0 20.0 17.5 9.7 22.1 12.3 27.0 25.3 16.2 11.4 16.0 29.9 4.2 11.8 9.6 7.5 5.9 9.0 11.1 23.2 25.4 32.8 19.5 3.7 14.7 21.5 36.5 29.5 34.7 11.2 11.4 31.7 23.3 11.3 23.6 15.1 13.5 25.0 11.5 17.9 14.8 30.8 10.8 5.3 16.3 8.9 5.1 8.2 12.8 7.9 6.2 3.8 14.4 10.7 8.6 9.9 8.7 6.9 8.8 6.3 4.5 40.1 72.0 60.8 60.3 41.8 47.6 65.4 63.6 29.4 66.3 71.6 53.6 123.2 41.6 115.4 248.6 60.7 47.8 14.8 15.1 24.3 18.2 34.7 26.0 21.7 43.1 18.6 55.2 33.1 27.1 105.2 33.3 27.3 15.6 28.1 15.0 94.8 49.2 39.4 9.6 15.8 105.9 18.6 37.8 37.8 34.1 153.2 33.5 32.3 29.6 25.2 26.5 57.2 74.0 14.9 28.5 20.8 18.3 11.1 33.5 29.8 46.2 53.4 30.9 39.7 37.0 82.4 429.8 37.8 15.7 36.5 48.8 31.3 20.9 37.9 86.4 27.2 6.6 47.0 35.2 22.2 31.1 18.8 13.5 711.3 35.6 21.1 11.7 41.5 TMOD3 UTMOD ENSG00000138594 "Tropomodulin 3" Q9NYL9 15 51829628-51947295 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 397.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001849 Approved Approved "Actin filaments,Cytosol" NA NA 1200000 Cytosol "Actin filaments" "HPA001849: AB_1080313" "unprognostic (6.31e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.39e-1)" "unprognostic (7.31e-3)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.19e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (7.06e-2)" "unprognostic (7.97e-2)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (5.58e-3)" 12.3 7.5 5.0 13.7 5.1 9.7 9.5 4.4 5.7 11.5 8.0 15.5 15.6 10.0 10.4 43.8 13.4 12.0 7.0 4.4 5.3 13.6 13.8 21.9 12.9 5.2 5.3 4.1 7.0 8.1 7.4 3.4 22.1 4.9 7.6 15.6 3.6 12.9 9.9 3.5 15.1 16.1 9.7 5.0 13.8 17.0 3.4 6.1 12.7 9.7 6.5 19.7 16.6 18.8 5.5 59.4 56.0 22.3 5.8 21.6 35.9 25.8 26.1 35.5 26.7 23.8 21.8 42.4 13.9 21.7 28.0 18.9 82.3 20.7 58.5 33.9 23.8 9.1 20.6 62.6 17.9 24.0 26.6 22.1 24.2 55.7 21.5 66.2 32.9 47.7 20.0 22.3 20.6 32.6 43.9 17.8 17.7 12.4 36.3 10.3 21.0 26.7 37.8 43.5 41.5 5.4 14.6 43.5 28.9 15.6 29.7 19.7 21.0 53.8 33.9 22.6 27.8 31.3 12.5 39.5 15.6 21.7 48.0 20.4 47.6 27.9 41.4 22.7 34.7 20.2 20.4 19.8 20.3 20.6 23.8 16.7 15.7 45.5 18.8 39.3 29.0 26.0 16.7 5.0 5.1 4.4 5.7 4.4 5.3 5.2 5.3 4.1 4.9 5.0 6.1 5.5 147.9 397.4 68.2 23.8 43.5 106.9 91.4 66.3 70.6 8.3 38.8 27.3 45.8 30.0 112.7 42.3 14.6 56.1 63.3 117.4 41.1 85.8 38.9 67.5 87.6 131.6 18.6 50.9 29.4 71.6 66.3 84.1 71.9 91.3 143.0 28.8 101.4 52.9 53.9 15.2 25.5 52.0 36.7 51.7 74.1 99.3 45.1 88.4 32.0 33.7 67.5 19.2 60.8 17.1 17.1 152.6 79.0 44.4 44.1 160.3 65.5 56.5 82.2 12.6 13.1 35.2 58.0 14.5 13.9 137.0 132.1 51.3 74.3 57.4 59.9 215.9 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765709 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles NA NA Vesicles "HPA036062: AB_10611670, HPA067304: AB_2685820" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 41.5 35.0 8.4 58.1 10.8 55.0 32.3 12.1 10.2 36.9 42.0 94.3 80.3 28.1 21.6 26.7 27.0 39.7 37.5 7.1 22.6 58.4 107.8 43.8 40.6 17.1 11.6 5.0 13.7 64.3 159.8 13.1 54.6 12.1 29.7 83.6 12.6 44.9 32.9 110.2 25.1 68.2 41.4 11.7 37.6 42.1 18.7 11.0 39.9 35.6 82.5 42.1 52.2 21.1 15.2 57.3 96.9 37.0 49.2 142.3 84.3 58.2 89.1 149.1 80.5 114.1 113.1 64.3 35.1 65.0 176.3 120.7 83.5 45.2 54.3 89.5 72.2 27.5 67.0 61.5 58.9 117.4 42.0 104.5 73.9 98.3 66.8 106.7 59.4 80.2 37.7 51.3 134.2 107.6 131.5 20.1 16.2 15.8 90.8 22.0 24.2 57.3 77.6 109.7 130.4 29.7 33.4 54.0 102.7 63.4 74.0 73.2 81.6 98.9 128.7 51.7 83.7 106.7 54.0 100.2 38.8 58.1 69.4 90.3 48.7 52.3 48.9 27.9 48.6 17.4 18.3 22.3 25.5 37.4 19.2 12.4 20.5 37.7 23.5 56.6 33.1 30.4 50.2 8.4 10.8 12.1 10.2 7.1 22.6 17.1 11.6 5.0 12.1 11.7 11.0 15.2 66.2 48.1 35.9 20.5 51.9 43.1 79.1 76.3 37.5 14.8 36.4 21.3 77.5 52.9 44.3 68.0 20.9 136.5 72.7 215.5 23.5 87.1 18.8 107.2 56.6 59.6 38.4 30.3 32.0 167.1 88.3 74.3 52.0 57.3 45.7 20.5 46.8 124.1 85.9 8.4 31.4 86.5 36.7 68.7 55.7 7.0 44.7 83.0 32.0 23.4 134.5 27.5 64.9 25.6 26.2 131.9 127.3 36.5 49.9 92.2 143.0 46.8 41.8 17.2 26.3 88.0 51.6 31.7 15.3 39.3 38.8 204.5 60.6 30.8 76.0 94.1 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 79.0;Microglial cells: 76.8;Oligodendrocytes: 154.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 1.9;monocytes: 2.3;T-cells: 2.0" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 119.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" NA NA 240000 Mitochondria "HPA040481: AB_2677004, HPA048216: AB_2680317" "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 9.2 12.3 6.3 5.6 8.4 0.9 9.0 36.3 6.9 8.3 7.8 12.9 14.3 6.5 6.9 10.1 5.5 7.5 5.7 5.9 7.3 13.4 17.0 8.5 3.6 6.0 9.3 6.6 12.8 4.7 8.8 6.4 13.5 11.7 5.8 14.3 13.3 11.0 5.9 4.1 10.4 11.6 7.1 6.4 4.5 9.2 3.9 8.1 5.0 4.2 4.9 5.2 6.7 4.6 8.3 9.6 8.5 5.6 9.7 18.6 17.6 2.0 17.6 23.2 13.3 25.2 7.1 23.6 5.8 8.5 14.4 16.8 14.0 12.1 11.4 27.1 2.2 13.4 9.7 15.0 7.2 17.9 4.2 19.0 12.1 7.8 16.6 18.6 9.7 119.4 4.3 3.9 6.0 25.4 5.9 2.6 7.4 2.7 9.7 5.9 5.8 22.6 7.3 12.3 10.1 17.9 3.7 18.0 11.0 38.1 3.8 7.9 5.8 41.8 12.7 15.7 14.3 15.8 2.5 3.7 1.3 12.9 7.0 18.8 0.0 2.1 0.0 0.3 1.6 0.5 0.2 0.8 0.4 1.8 0.2 0.5 0.7 0.0 0.2 2.3 1.9 2.0 0.9 6.3 8.4 36.3 6.9 5.9 7.3 6.0 9.3 6.6 11.7 6.4 8.1 8.3 16.9 0.0 15.4 4.9 6.2 4.8 10.1 8.3 26.2 10.3 18.8 19.4 8.1 7.2 8.8 11.0 10.4 22.7 12.1 21.3 5.9 13.0 3.9 4.0 5.4 22.6 20.4 9.4 79.0 13.8 12.7 14.0 28.1 4.9 2.5 11.8 16.4 27.2 16.4 8.4 41.5 27.1 10.2 13.3 4.4 5.1 6.2 10.7 8.8 76.8 13.7 13.1 4.1 35.7 154.9 16.9 28.2 17.7 7.1 5.3 32.4 18.3 18.2 16.6 13.1 6.6 9.4 29.8 25.9 27.9 6.5 33.0 5.9 17.1 26.4 13.3 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.6;Granulosa cells: 58.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 133.7" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 121.0;SH-SY5Y: 54.1" "Region enriched" "Detected in all" 5 "cerebellum: 240.6" "Region enriched" "Detected in all" 4 "cerebellum: 106.2" HPA057381 Approved Nucleoplasm NA NA Nucleoplasm "HPA057381: AB_2683423" "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 5.9 22.9 17.6 4.4 20.3 1.0 6.4 133.7 27.5 14.0 0.9 11.0 13.2 12.0 4.7 5.1 10.6 6.7 7.4 20.6 17.0 3.7 38.9 5.7 2.7 13.5 17.5 19.5 24.0 3.2 4.5 8.3 1.9 48.7 10.2 5.3 7.2 6.7 6.0 3.8 11.9 8.4 7.6 8.6 4.3 6.7 8.5 19.6 2.5 7.5 4.8 1.9 10.3 11.8 15.6 0.1 1.4 24.0 0.7 1.8 0.9 11.2 3.0 2.1 6.7 9.5 3.6 11.6 1.3 9.5 4.2 6.6 2.1 9.2 0.7 3.2 2.2 4.2 0.8 2.2 24.8 1.0 0.1 8.0 2.2 0.6 0.9 0.2 5.0 5.2 12.0 5.0 0.5 9.5 4.1 5.5 0.9 9.6 4.5 0.6 15.0 19.1 0.5 2.3 0.5 121.0 54.1 0.7 0.8 0.4 7.4 1.2 2.4 0.3 0.8 10.0 0.7 0.4 1.1 0.9 1.1 0.3 0.6 3.8 0.1 0.6 0.5 1.3 0.6 1.4 0.8 0.5 0.8 0.6 1.5 0.7 0.5 0.8 2.0 0.6 0.9 0.1 0.5 17.6 20.3 133.7 27.5 20.6 17.0 13.5 17.5 19.5 48.7 8.6 19.6 15.6 4.1 0.0 0.6 3.3 4.2 3.6 5.8 1.7 0.0 50.6 3.6 5.5 2.8 0.0 1.3 0.0 0.0 1.1 2.6 2.1 0.0 0.8 7.9 1.1 3.5 5.7 13.1 0.0 5.9 1.3 0.5 5.8 1.5 2.2 2.5 58.8 5.3 11.7 0.6 10.1 6.9 10.9 2.0 1.0 15.0 15.3 4.4 2.9 8.8 5.6 0.1 5.9 2.1 9.0 1.8 0.7 5.6 4.1 0.7 3.5 18.0 1.1 0.8 5.0 6.6 6.7 9.6 5.4 2.9 1.4 2.6 0.7 2.8 1.8 4.6 9.7 APH1B "APH-1B, DKFZp564D0372, PSFL" ENSG00000138613 "Aph-1 homolog B, gamma-secretase subunit" Q8WW43 15 63276018-63309126 "Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 123.8" "Group enriched" "Detected in many" 15 "Early spermatids: 1363.2;Late spermatids: 359.9;Spermatocytes: 838.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 107.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.92e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-1)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (3.57e-1)" "unprognostic (7.86e-2)" "unprognostic (1.78e-1)" "unprognostic (3.86e-1)" "unprognostic (4.56e-2)" "prognostic favorable (1.05e-4)" "unprognostic (8.44e-2)" "prognostic favorable (2.25e-4)" "unprognostic (4.29e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" 10.2 12.2 9.8 9.8 11.2 8.2 10.7 10.6 10.6 8.4 10.7 5.6 3.8 7.0 11.7 3.8 16.4 7.6 5.6 8.6 11.1 7.8 3.5 8.9 10.1 12.4 12.5 8.7 14.7 4.5 7.5 7.0 8.1 10.8 11.8 4.5 12.3 8.3 8.0 4.0 5.1 7.8 6.5 12.2 13.7 5.1 123.8 10.5 9.8 19.7 5.6 7.9 7.8 6.7 13.5 1.3 8.8 9.3 7.5 20.7 36.2 3.3 11.2 22.6 8.3 13.9 8.1 12.3 11.1 5.2 12.4 15.4 1.2 15.8 4.4 15.5 7.6 2.5 19.6 1.9 0.3 17.1 4.3 30.9 22.8 7.0 12.3 8.3 14.1 17.6 13.9 6.7 8.0 26.1 3.9 5.9 13.2 8.8 2.8 4.6 5.7 5.1 0.2 4.3 8.9 8.1 4.4 4.5 3.7 0.1 9.8 13.6 25.1 11.8 24.5 9.4 4.0 1.6 19.6 35.3 15.2 17.8 25.1 14.6 32.0 31.8 41.4 10.7 63.1 9.0 24.1 10.8 9.7 15.3 18.0 11.8 12.0 44.1 6.2 107.5 5.5 11.7 18.6 9.8 11.2 10.6 10.6 8.6 11.1 12.4 12.5 8.7 10.8 12.2 10.5 13.5 8.4 9.6 18.8 16.3 21.7 5.2 12.4 15.5 5.7 6.8 16.2 13.7 6.1 11.5 15.9 22.0 2.1 6.3 10.4 1.0 1.9 36.9 1363.2 25.6 12.7 12.0 20.4 5.0 18.1 6.2 38.7 18.1 4.6 4.5 22.8 12.5 17.9 1.7 55.7 1.7 22.9 4.1 22.4 52.0 17.7 359.9 24.5 41.8 10.6 16.9 29.6 21.4 6.2 27.2 28.9 11.1 0.8 16.6 16.3 8.9 0.7 6.8 38.6 14.8 13.1 12.6 15.5 838.0 20.0 2.3 3.4 6.0 14.5 16.4 2.8 9.0 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 12.3 16.0 14.2 14.3 16.1 18.1 22.5 14.9 16.7 21.1 17.8 22.0 14.2 18.3 27.6 16.2 24.4 19.8 13.5 13.7 15.5 21.5 21.3 15.7 22.9 14.6 14.9 13.1 18.6 17.9 23.1 16.4 19.4 15.6 19.3 23.8 13.2 16.3 20.0 10.0 18.2 17.3 19.0 15.1 19.0 18.3 19.0 15.5 25.6 23.4 13.8 24.5 23.8 13.7 17.9 26.4 46.7 46.1 36.8 25.2 31.4 29.5 28.4 36.5 46.4 42.5 42.2 61.2 42.9 38.9 35.6 38.5 52.0 99.4 47.6 40.5 37.8 60.2 37.5 32.2 46.4 50.0 38.7 46.2 30.6 46.9 35.1 53.7 34.1 50.8 64.8 52.2 24.3 33.4 41.7 44.3 41.2 33.8 66.2 25.6 37.5 38.8 49.0 36.7 48.6 33.1 26.3 34.2 34.5 49.5 39.2 32.3 44.0 25.2 31.8 33.2 28.8 45.6 23.9 48.4 58.1 32.1 70.0 38.1 25.7 11.0 6.2 19.8 12.7 22.3 19.3 20.3 22.6 19.8 14.8 21.1 19.2 1.2 23.8 9.5 17.9 30.8 16.6 14.2 16.1 14.9 16.7 13.7 15.5 14.6 14.9 13.1 15.6 15.1 15.5 17.9 12.2 22.4 10.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 13.0 11.0 0.0 0.0 5.6 12.9 0.0 40.5 7.7 0.0 21.5 18.2 0.0 12.8 11.8 6.8 0.0 0.0 0.0 15.4 30.5 6.7 0.0 12.6 7.6 22.5 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 9.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.5 0.0 0.0 15.1 10.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 49.8 4.8 24.0 0.0 0.0 CILP HsT18872 ENSG00000138615 "Cartilage intermediate layer protein" O75339 15 65194760-65211473 "Disease related genes, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5" "Cancer enhanced" "Detected in many" "breast cancer: 30.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003195 Uncertain "Secreted to extracellular matrix" NA NA 13000000 "HPA003195: AB_1078524" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (4.22e-2)" "unprognostic (7.18e-2)" "unprognostic (2.94e-1)" "unprognostic (2.28e-1)" "unprognostic (2.60e-1)" "unprognostic (1.14e-1)" "unprognostic (1.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.31e-13)" "unprognostic (5.10e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (4.68e-3)" 40.7 0.8 0.2 9.5 0.2 0.1 22.1 0.3 0.3 45.3 0.1 18.4 2.4 14.0 3.6 11.1 15.9 37.1 27.6 0.1 0.2 0.7 1.6 3.0 1.6 0.2 0.2 0.1 7.6 3.0 0.3 0.7 2.6 0.2 3.2 7.0 0.5 9.4 4.8 15.6 12.5 22.8 51.4 0.2 0.6 8.4 12.2 0.2 1.8 2.4 33.2 0.8 27.2 28.3 0.2 0.0 0.0 0.0 0.0 4.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 8.1 0.0 0.0 0.0 0.0 5.2 0.1 0.2 0.0 0.9 0.4 0.5 2.1 0.0 0.4 1.8 0.0 0.0 0.2 0.1 0.0 0.1 1.7 1.2 42.9 1.5 0.0 0.0 0.3 0.0 0.0 138.1 4.1 1.7 0.0 0.1 2.2 0.1 0.1 0.0 0.6 0.1 2.0 0.0 11.9 7.1 231.5 1.7 1.8 1.9 0.0 0.2 0.0 1.0 0.3 0.0 0.0 57.6 0.3 0.1 0.0 0.0 0.0 0.1 0.0 14.7 6.6 0.6 0.3 0.1 6.1 0.0 1.6 83.5 0.2 0.0 PARP16 "ARTD15, C15orf30, FLJ20509, FLJ25281, pART15" ENSG00000138617 "Poly(ADP-ribose) polymerase family member 16" Q8N5Y8 15 65234460-65300618 "Metabolic proteins, Predicted membrane proteins" "Unfolded protein response" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 33.0;Spermatogonia: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017081 Approved NA NA "HPA017081: AB_10963218" "unprognostic (1.17e-2)" "unprognostic (6.51e-3)" "unprognostic (2.82e-2)" "unprognostic (6.37e-2)" "unprognostic (7.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.05e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.78e-1)" "unprognostic (3.41e-3)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-1)" "unprognostic (9.61e-2)" 6.3 9.9 5.0 4.8 5.0 6.0 8.9 6.8 5.6 11.9 4.5 8.9 6.3 8.8 5.2 7.5 9.8 4.3 4.9 5.0 4.8 6.3 13.4 5.1 7.0 5.0 4.9 4.9 12.0 7.5 8.3 5.5 6.1 5.8 8.5 6.5 5.2 7.3 6.3 3.8 7.9 7.2 6.8 4.8 6.6 8.0 4.8 5.0 10.1 6.5 3.9 8.3 10.1 9.2 5.2 6.0 6.3 6.5 10.4 5.3 4.9 2.8 2.8 7.1 7.0 7.3 4.5 5.4 18.9 7.3 3.5 15.3 9.4 30.3 3.7 5.0 7.3 11.3 3.1 6.5 6.3 9.1 8.7 5.6 6.1 6.0 2.0 7.2 10.6 6.4 17.9 7.6 7.1 5.9 6.8 19.0 8.8 2.8 29.7 8.2 33.5 11.8 14.3 5.0 5.3 10.8 7.2 8.3 7.5 6.8 5.1 8.7 7.5 2.7 8.5 6.5 4.7 3.9 13.3 16.5 24.2 7.0 12.5 4.2 19.9 3.9 12.2 12.6 6.0 14.0 8.5 11.9 12.8 5.2 11.1 14.7 10.9 15.0 12.5 6.5 4.4 10.8 6.9 5.0 5.0 6.8 5.6 5.0 4.8 5.0 4.9 4.9 5.8 4.8 5.0 5.2 3.7 3.2 3.1 10.1 9.6 5.2 6.0 3.9 9.6 12.1 5.0 4.7 4.1 7.2 3.4 3.7 0.0 12.5 9.1 3.4 0.0 5.8 0.8 1.5 4.7 4.5 1.8 3.0 14.0 9.1 5.7 7.0 11.7 2.7 0.0 6.5 2.9 6.0 3.8 3.3 18.3 4.9 4.1 2.5 1.7 1.9 9.9 4.3 3.6 11.2 4.3 7.3 9.2 10.6 13.4 5.3 2.5 7.9 9.8 3.2 7.1 4.0 2.6 33.0 6.6 4.3 4.5 1.6 28.6 4.6 4.3 5.5 9.0 6.3 5.4 3.0 PPCDC "FLJ14585, MDS018" ENSG00000138621 "Phosphopantothenoylcysteine decarboxylase" Q96CD2 15 75023586-75117462 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 71.4;granulocytes: 153.5;monocytes: 71.6" "Cell line enhanced" "Detected in all" "Karpas-707: 133.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045667 Approved Approved Cytosol NA NA 25000 Cytosol "HPA045667: AB_2679412" "unprognostic (8.66e-2)" "unprognostic (1.07e-3)" "unprognostic (6.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.95e-2)" "unprognostic (6.53e-2)" "unprognostic (1.76e-2)" "unprognostic (8.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.53e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (1.60e-2)" "unprognostic (7.67e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-1)" "unprognostic (2.13e-3)" 11.2 19.3 6.9 10.9 8.1 19.9 11.0 7.7 8.3 9.3 7.8 11.6 9.8 8.3 9.9 19.2 10.9 8.5 8.4 6.1 7.3 14.2 13.2 10.9 16.5 8.5 8.2 5.6 9.1 16.6 21.5 9.4 9.3 8.3 13.1 9.5 7.7 14.0 7.6 12.0 9.0 10.0 5.5 7.4 18.9 11.4 9.7 7.4 12.2 11.3 5.9 12.4 11.4 10.1 9.6 15.6 28.8 11.8 9.2 7.0 6.4 10.1 15.5 7.0 20.3 15.9 16.9 41.2 17.7 26.8 7.8 12.5 15.9 19.2 25.6 10.4 62.6 23.4 31.1 18.8 18.3 19.9 18.3 38.7 8.6 16.7 21.0 32.3 8.2 16.6 25.8 21.3 133.2 14.8 30.0 10.9 28.1 18.9 32.9 13.4 18.2 23.0 38.3 15.3 22.2 28.3 8.3 22.9 31.3 34.6 13.4 38.7 23.4 9.4 20.6 14.4 10.5 27.6 40.5 29.3 30.1 12.7 45.9 23.7 47.2 23.1 153.5 11.6 65.6 19.4 15.7 10.6 13.0 17.6 8.6 11.7 14.5 139.7 18.5 71.6 71.4 12.7 15.8 6.9 8.1 7.7 8.3 6.1 7.3 8.5 8.2 5.6 8.3 7.4 7.4 9.6 10.2 16.0 5.2 2.9 10.5 3.8 6.1 8.5 8.6 2.8 9.6 8.8 4.2 4.3 9.7 9.2 0.0 17.5 16.0 19.7 25.4 17.3 1.0 8.2 4.3 10.7 4.2 11.6 1.4 15.3 13.6 7.4 14.8 8.3 12.0 9.9 10.4 5.3 20.0 8.4 1.7 10.9 12.2 15.7 6.7 2.5 4.4 15.5 14.2 2.8 20.0 4.7 8.2 2.5 4.6 18.0 38.1 5.3 33.9 6.5 10.5 19.0 12.2 10.7 6.6 6.3 8.7 6.9 15.7 10.8 4.0 10.9 9.7 11.3 11.7 13.6 HCN4 ENSG00000138622 "Hyperpolarization activated cyclic nucleotide gated potassium channel 4" Q9Y3Q4 15 73319859-73368958 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 8.7;heart muscle: 6.4;testis: 7.2" "Group enriched" "Detected in some" 5 "Early spermatids: 29.4;Late spermatids: 49.5" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073174 Approved NA NA "HPA073174: " "unprognostic (2.21e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-2)" "unprognostic (3.14e-2)" "unprognostic (5.30e-3)" "unprognostic (1.92e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-2)" "unprognostic (2.37e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (6.05e-5)" "unprognostic (5.56e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-2)" "unprognostic (7.95e-2)" 0.0 0.4 4.0 0.0 0.7 0.0 0.0 2.5 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.4 1.0 2.4 0.0 0.0 0.0 0.0 4.5 4.0 1.9 0.0 0.1 0.0 0.5 0.0 5.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.1 7.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.7 2.5 2.2 1.0 2.4 4.5 4.0 1.9 5.0 1.2 8.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 29.4 0.6 0.0 0.2 1.8 0.0 1.5 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.3 1.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 60.6;retina: 34.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 1.8;eosinophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 38000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.0 2.6 6.3 7.1 10.7 9.9 1.9 17.5 13.8 1.9 2.4 2.3 1.5 2.9 0.9 4.8 1.4 1.9 2.1 6.1 7.5 2.8 1.6 8.2 13.3 17.3 12.3 3.7 7.8 0.9 2.0 2.7 16.4 21.7 1.8 0.9 34.9 2.2 1.2 2.1 8.5 10.9 1.1 14.1 60.6 3.5 29.8 15.7 9.5 1.3 0.3 13.0 8.3 2.5 20.5 16.7 0.2 4.8 1.4 6.0 20.1 39.7 75.2 30.1 15.5 23.8 6.5 26.6 0.1 4.3 34.2 12.6 4.9 1.5 4.8 16.0 1.3 0.9 30.0 0.1 8.3 1.3 0.9 275.8 14.3 0.2 108.7 6.0 39.0 0.2 2.0 17.5 10.1 51.2 1.4 4.3 9.9 5.2 0.4 11.3 0.6 3.3 4.4 6.5 7.1 0.3 0.5 0.5 13.4 6.1 4.1 1.0 6.0 3.0 28.8 19.2 14.1 166.3 1.8 1.3 0.3 92.4 3.4 1.5 1.8 0.0 3.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 6.3 10.7 17.5 13.8 6.1 7.5 17.3 12.3 3.7 21.7 14.1 15.7 20.5 1.8 3.2 0.0 1.0 22.6 0.4 1.6 3.1 0.6 13.7 1.2 1.3 1.4 0.0 4.0 1.8 68.8 25.6 5.2 0.6 0.0 19.8 0.5 4.6 1.5 5.3 0.0 21.7 12.4 13.9 58.8 1.8 1.5 10.6 8.2 65.1 0.7 0.7 7.2 1.7 5.9 0.0 0.0 0.3 12.0 2.5 3.7 4.8 8.8 0.0 28.6 6.8 1.0 4.0 16.3 91.0 0.1 1.9 6.4 3.3 0.1 0.1 2.0 58.3 0.0 0.2 9.0 0.9 0.8 0.2 1.4 166.4 5.7 22.0 0.0 24.4 UBL7 "BMSC-UbP, MGC14421" ENSG00000138629 "Ubiquitin like 7" Q96S82 15 74445977-74461182 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 175.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040423, HPA041897" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040423: AB_10673442, HPA041897: AB_2677732" "unprognostic (4.21e-2)" "prognostic favorable (6.37e-5)" "unprognostic (2.93e-3)" "unprognostic (5.56e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "unprognostic (3.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (6.71e-2)" "unprognostic (5.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-3)" "unprognostic (8.94e-3)" "unprognostic (7.05e-2)" "unprognostic (2.75e-1)" "unprognostic (3.43e-2)" 33.3 38.7 25.1 13.7 27.6 16.0 33.2 24.9 35.3 33.3 22.6 43.1 15.2 37.2 15.6 38.1 30.6 10.7 60.6 27.4 25.2 38.3 32.3 30.0 21.5 26.6 26.3 26.2 31.3 45.1 25.2 30.5 15.7 27.9 36.7 16.6 13.2 34.5 16.4 115.5 53.1 37.2 18.5 24.3 48.6 43.9 56.3 24.6 27.6 37.4 38.2 29.8 39.0 33.3 27.5 18.7 20.3 31.6 42.3 32.4 42.1 21.8 29.8 36.0 37.6 46.6 24.7 26.4 27.2 31.1 35.9 48.6 29.4 88.4 40.4 36.5 36.0 55.6 35.8 32.2 45.3 31.7 22.4 29.1 32.9 35.5 32.1 43.0 32.3 32.0 60.8 30.9 39.3 39.3 26.2 28.1 35.3 75.7 31.2 24.6 29.4 25.0 60.5 32.6 21.2 31.1 61.8 28.8 26.8 40.1 44.1 28.6 36.7 18.8 34.6 20.4 17.4 37.5 39.8 82.1 30.5 22.7 40.3 30.6 32.9 51.6 59.7 35.1 58.5 33.7 50.5 35.3 37.1 70.6 55.3 33.9 40.6 65.3 55.5 55.5 151.5 65.6 52.1 25.1 27.6 24.9 35.3 27.4 25.2 26.6 26.3 26.2 27.9 24.3 24.6 27.5 17.3 32.1 18.2 3.9 35.4 15.8 24.1 35.6 26.7 5.8 24.9 23.9 29.9 18.6 20.0 14.7 8.4 71.1 36.8 25.5 58.7 37.3 75.3 12.7 13.0 20.7 23.4 45.8 5.7 34.7 66.9 20.7 22.4 13.5 19.0 21.5 22.5 16.3 41.9 5.0 3.8 26.9 20.3 38.3 31.4 175.8 24.5 31.4 21.4 5.6 82.6 18.2 23.7 4.0 4.5 29.5 27.6 21.1 51.6 19.5 48.9 44.6 16.1 9.0 19.7 13.5 50.5 59.2 31.1 29.8 25.1 68.4 23.0 19.6 28.0 25.2 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475150-86002668 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 100.7" "Group enriched" "Detected in many" 4 "Astrocytes: 1364.3;Microglial cells: 905.0" "Cancer enhanced" "Detected in all" "renal cancer: 9.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 15.9;memory B-cell: 47.3;naive B-cell: 36.8;plasmacytoid DC: 12.7" "Group enriched" "Detected in many" 5 "B-cells: 47.3;dendritic cells: 12.7;monocytes: 15.9" "Cell line enhanced" "Detected in many" "ASC diff: 109.0;ASC TERT1: 65.5;HHSteC: 63.6;HUVEC TERT2: 121.9;RPTEC TERT1: 67.2;TIME: 87.0;U-138 MG: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favorable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 14.8 2.3 5.4 7.5 4.8 18.9 9.2 6.0 7.4 5.5 5.0 6.2 7.4 9.5 4.7 6.2 4.1 11.0 27.6 4.7 7.5 100.7 9.6 15.9 10.6 13.3 10.2 2.7 5.5 30.3 8.2 5.4 22.6 16.9 5.4 6.2 8.5 10.6 7.3 10.3 6.7 10.4 14.2 11.0 16.6 26.3 3.4 8.1 7.6 28.1 7.8 15.7 9.2 5.6 14.4 3.0 6.2 4.4 0.1 109.0 65.5 4.8 21.5 28.5 5.2 8.4 0.1 0.0 2.8 7.4 48.8 6.4 0.0 0.2 9.0 11.0 0.0 1.2 3.6 0.6 0.2 63.6 0.4 0.0 48.4 0.9 10.3 4.7 23.9 121.9 0.0 6.6 0.4 46.1 0.0 0.1 0.0 0.3 1.5 11.3 0.6 22.4 11.8 67.2 0.0 2.3 2.3 2.5 3.5 7.8 4.7 0.4 0.2 87.0 59.9 1.2 4.4 0.3 0.3 0.0 3.9 10.1 2.2 19.9 0.0 15.9 0.0 0.0 3.0 0.0 47.3 0.0 0.0 3.8 36.8 0.0 0.0 5.5 0.0 2.3 12.7 0.0 3.1 5.4 4.8 6.0 7.4 4.7 7.5 13.3 10.2 2.7 16.9 11.0 8.1 14.4 14.0 57.7 28.8 1364.3 142.1 8.2 3.9 35.6 10.2 6.6 1.2 4.7 26.4 47.1 18.3 46.0 6.2 54.8 9.9 1.0 226.9 9.4 30.5 1.2 12.9 9.5 2.4 0.0 12.2 11.8 26.2 24.7 25.0 1.4 1.3 6.7 4.2 9.5 10.5 111.0 51.3 3.3 6.1 33.7 21.3 8.8 16.8 26.3 19.6 905.0 34.0 27.7 0.0 27.2 21.8 7.4 2.9 12.4 2.0 2.3 0.2 205.9 24.8 6.6 6.6 50.0 21.3 8.1 5.9 4.0 6.3 232.9 4.1 18.4 5.0 1.9 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" Nucleoli "HPA038108: AB_2675837, HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favorable (4.28e-4)" 49.6 12.9 9.4 10.0 9.2 12.8 32.2 14.4 11.3 17.8 12.6 18.4 51.0 12.7 7.6 7.7 23.7 16.5 9.8 10.5 9.0 22.1 39.4 11.9 6.3 9.5 8.8 8.1 28.0 38.9 49.6 8.5 35.4 10.3 10.7 14.9 16.1 23.6 10.6 9.8 20.6 29.2 13.4 8.7 5.4 16.5 14.1 8.9 5.6 33.1 22.1 4.9 17.0 10.5 9.6 4.5 6.7 9.8 12.8 55.5 22.7 16.0 10.2 12.4 4.0 3.6 5.6 10.3 0.1 4.0 7.4 6.3 2.7 14.5 7.4 8.9 0.6 10.0 7.5 8.9 0.7 16.3 6.3 1.0 21.9 5.9 10.1 3.6 17.5 6.9 2.5 19.7 0.7 8.7 0.2 0.7 2.8 12.1 0.8 6.9 10.2 16.6 4.0 7.4 21.8 24.6 6.5 2.5 7.9 9.9 9.6 5.5 0.2 2.5 11.2 6.2 5.5 5.9 3.4 2.1 0.1 16.6 0.6 5.9 0.0 4.1 0.0 1.0 2.0 0.7 0.0 2.7 0.3 3.5 0.0 2.9 0.7 0.9 0.4 0.6 1.2 1.5 1.6 9.4 9.2 14.4 11.3 10.5 9.0 9.5 8.8 8.1 10.3 8.7 8.9 9.6 42.6 12.8 34.9 95.3 4.3 10.1 22.3 20.4 28.5 16.3 29.7 20.6 25.9 38.6 39.3 11.0 35.5 72.9 12.9 50.4 29.4 10.7 3.4 82.0 33.6 14.1 4.9 31.3 178.0 16.9 35.3 42.1 33.1 98.2 1.3 70.2 12.8 143.0 20.7 0.0 46.5 54.1 26.4 29.6 11.9 5.1 45.1 21.7 19.6 104.9 16.9 22.6 5.2 157.8 17.4 20.7 73.4 33.4 10.3 13.6 37.5 50.4 74.6 11.3 0.0 24.7 31.9 5.3 10.2 14.4 7.7 279.5 9.7 41.2 22.3 19.5 HERC3 KIAA0032 ENSG00000138641 "HECT and RLD domain containing E3 ubiquitin protein ligase 3" Q15034 4 88592434-88708541 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 115.1" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 23.8;Cytotrophoblasts: 7.0;Extravillous trophoblasts: 17.3;Hofbauer cells: 9.3;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 48.2;hTERT-HME1: 68.6" HPA039170 Approved Supported Cytosol NA NA Cytosol "HPA039170: AB_10673414" "unprognostic (2.21e-2)" "unprognostic (1.65e-2)" "unprognostic (9.28e-3)" "unprognostic (3.24e-1)" "unprognostic (6.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.30e-2)" "unprognostic (1.85e-2)" "unprognostic (9.77e-2)" "unprognostic (6.51e-3)" "unprognostic (3.48e-3)" "unprognostic (2.58e-2)" "prognostic favorable (5.65e-7)" "unprognostic (1.83e-1)" "unprognostic (3.21e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-2)" 10.5 10.3 9.6 13.4 14.0 24.5 14.1 24.7 12.9 11.6 9.3 11.5 11.7 10.0 9.7 16.7 10.2 12.1 22.1 10.2 10.5 15.0 12.2 13.7 17.3 13.8 11.8 10.9 12.1 9.3 21.2 9.5 10.1 14.6 19.7 12.2 115.1 12.2 11.0 19.5 18.3 12.2 13.8 8.5 16.2 12.9 3.2 10.5 16.9 14.7 24.6 15.1 11.1 15.5 17.4 12.2 2.4 2.4 3.8 15.3 23.9 9.0 14.5 24.2 13.0 8.5 2.8 14.8 12.0 7.9 48.2 6.1 5.2 4.4 14.1 13.0 7.2 3.4 8.9 6.3 1.9 7.9 22.6 15.7 13.2 15.4 12.7 68.6 8.9 14.2 7.5 7.8 6.2 29.5 3.8 17.8 6.7 0.4 9.6 3.9 19.7 16.5 4.5 8.3 2.6 3.4 3.2 20.4 10.7 4.6 3.9 1.9 12.2 25.7 16.7 9.6 19.9 10.4 11.5 3.1 7.5 11.5 10.2 6.1 7.8 4.9 7.3 3.8 5.6 4.4 4.3 4.7 4.0 5.4 4.2 7.0 4.4 16.2 2.4 9.2 2.4 8.1 2.9 9.6 14.0 24.7 12.9 10.2 10.5 13.8 11.8 10.9 14.6 8.5 10.5 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 17.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443097 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 116.1;BJ hTERT+ SV40 Large T+ RasG12V: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favorable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 4.1 5.6 6.2 5.4 7.4 8.0 6.2 5.1 11.4 9.9 4.4 6.1 5.3 8.6 4.3 21.1 9.8 10.8 9.6 6.7 8.6 6.1 4.9 8.2 5.0 8.3 6.4 6.4 8.4 5.5 7.2 4.5 5.5 7.4 8.5 6.1 4.5 30.7 5.1 3.0 4.2 5.4 8.0 5.9 8.3 7.3 3.9 6.3 12.4 4.4 4.7 5.3 6.0 11.3 15.3 6.7 4.5 0.3 0.9 0.3 3.8 1.2 0.8 22.1 116.1 85.8 0.4 8.3 0.0 1.5 2.1 18.8 2.5 10.9 5.7 7.6 13.9 2.2 6.3 3.8 0.6 3.7 11.3 4.2 5.2 1.3 9.1 0.3 7.0 3.4 5.2 0.0 1.5 2.6 4.1 5.3 3.6 1.5 6.0 2.2 3.6 0.1 0.5 7.8 8.2 0.3 2.7 8.2 2.7 13.5 5.6 4.8 2.0 1.2 1.6 2.1 0.2 2.1 0.3 0.1 0.0 5.2 2.5 5.4 4.4 3.2 4.7 6.4 3.4 12.8 3.5 8.9 6.3 2.8 3.0 6.9 4.7 1.9 6.0 7.4 0.3 12.5 4.2 6.2 7.4 5.1 11.4 6.7 8.6 8.3 6.4 6.4 7.4 5.9 6.3 15.3 11.4 12.8 10.6 14.4 5.8 2.8 5.2 3.3 4.6 18.1 4.9 4.6 13.9 7.2 9.8 5.5 16.7 5.8 5.0 8.3 0.0 7.8 1.3 6.4 3.9 11.5 1.8 4.8 21.5 17.4 1.8 6.6 5.6 5.0 5.7 25.9 5.3 2.2 5.0 1.7 25.8 2.9 4.1 2.2 0.8 1.6 4.4 4.7 5.4 28.1 5.7 3.7 4.1 24.1 2.8 13.3 2.4 5.7 3.8 8.3 6.2 4.1 14.6 1.0 6.6 2.0 3.6 0.8 2.1 18.4 1.1 2.5 8.2 13.3 2.5 8.0 HERC5 CEB1 ENSG00000138646 "HECT and RLD domain containing E3 ubiquitin protein ligase 5" Q9UII4 4 88457119-88506163 "Predicted membrane proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.4" "Cell type enhanced" "Detected in many" "Early spermatids: 90.5;Spermatocytes: 272.1;Spermatogonia: 431.3" "Cancer enriched" "Detected in all" 5 "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 89.9;BJ hTERT+ SV40 Large T+ RasG12V: 123.5;SK-MEL-30: 58.1" "Low region specificity" "Detected in all" HPA043929 Supported NA NA "HPA043929: AB_10962492" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (4.46e-5)" "unprognostic (3.00e-1)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.35e-1)" "unprognostic (2.54e-2)" "unprognostic (2.56e-1)" "unprognostic (2.23e-2)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (1.61e-1)" 5.5 6.1 3.5 6.1 4.0 18.9 5.0 2.9 5.2 7.5 4.8 3.9 4.0 15.6 3.3 2.6 6.0 5.9 4.0 2.9 5.5 6.5 9.8 6.6 7.3 4.7 3.8 2.6 14.1 7.8 9.7 4.2 10.3 3.9 5.5 2.7 3.7 12.0 5.9 1.5 2.6 4.6 13.6 3.5 12.2 4.9 58.4 3.4 14.0 5.3 3.4 4.3 4.6 4.5 6.4 7.5 3.5 2.0 0.4 0.4 0.8 27.9 0.6 10.7 89.9 123.5 1.1 19.9 0.3 4.9 0.0 40.8 1.4 13.7 2.1 7.6 46.4 8.4 12.1 13.2 0.3 0.8 14.8 5.5 0.8 0.6 22.7 0.0 4.9 0.6 24.4 0.5 28.2 1.7 0.8 45.9 18.2 7.5 0.4 2.4 45.3 35.9 1.9 1.6 1.7 0.5 11.7 15.0 0.3 58.1 23.3 1.2 8.2 0.3 1.1 0.2 0.5 5.9 38.7 36.3 0.3 8.6 10.9 1.1 14.8 7.2 11.6 7.6 8.4 8.6 7.1 8.7 6.3 2.7 4.4 5.4 4.7 25.1 8.0 7.9 8.0 27.7 5.0 3.5 4.0 2.9 5.2 2.9 5.5 4.7 3.8 2.6 3.9 3.5 3.4 6.4 26.9 0.0 0.5 5.5 14.8 4.0 5.9 0.8 8.0 7.9 6.4 7.1 2.3 2.8 1.0 1.8 18.8 25.8 19.9 1.1 23.5 2.6 90.5 5.4 2.0 20.6 0.0 3.8 0.4 5.1 12.1 10.9 3.6 3.9 2.5 57.1 14.3 7.8 15.0 0.0 1.1 0.7 0.0 8.1 2.5 19.4 9.9 16.6 7.2 7.5 8.3 9.6 16.5 18.1 1.8 2.8 2.3 9.1 34.5 7.3 2.6 9.8 1.7 2.8 19.7 10.8 7.9 272.1 431.3 2.5 1.8 11.9 19.2 20.2 0.4 1.7 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149294-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.5;placenta: 26.1;seminal vesicle: 17.5" "Cell type enhanced" "Detected in many" "Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA 88000 "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 0.5 5.2 14.7 0.3 24.5 0.0 0.1 1.3 23.2 1.5 0.0 0.4 0.1 1.6 0.5 0.3 1.2 0.5 0.6 19.1 13.3 2.1 0.1 0.7 0.0 14.0 24.0 19.8 2.3 0.2 0.0 1.4 26.1 18.7 10.7 0.2 3.0 0.5 17.5 0.0 0.1 0.4 0.7 0.9 0.0 0.4 1.5 15.2 0.1 0.5 0.0 0.0 1.8 2.8 15.4 0.0 0.7 8.7 0.0 0.3 0.0 0.0 8.6 4.6 0.7 0.4 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.9 0.0 4.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 11.5 27.4 0.0 0.3 0.0 4.2 0.0 24.1 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.3 55.4 14.5 0.0 0.1 12.9 0.0 0.0 0.0 1.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 24.5 1.3 23.2 19.1 13.3 14.0 24.0 19.8 18.7 0.9 15.2 15.4 1.4 0.0 0.6 58.1 0.0 0.1 0.5 0.1 1.2 15.0 1.2 2.7 2.3 0.0 0.7 0.0 0.0 0.8 0.0 0.9 1.9 0.0 5.6 26.5 4.6 4.0 0.0 0.0 64.9 0.0 0.9 15.5 0.0 29.1 0.0 5.0 0.0 0.0 1.8 0.0 57.7 0.2 0.0 0.0 0.0 1.7 0.0 0.5 0.0 6.5 0.0 8.6 0.0 46.8 59.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 2.7 0.0 4.3 11.5 17.4 0.9 0.0 0.3 2.9 0.2 3.9 0.1 0.4 NDST4 ENSG00000138653 "N-deacetylase and N-sulfotransferase 4" Q9H3R1 4 114827763-115113876 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 9.2" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 29.3;Oligodendrocyte precursor cells: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;CACO-2: 3.7;RH-30: 14.5;T-47d: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011129 Uncertain NA NA "HPA011129: AB_1079460" "unprognostic (5.58e-2)" "unprognostic (5.90e-2)" "unprognostic (4.82e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (6.55e-2)" 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 1.9 0.0 0.0 0.0 0.0 6.8 4.0 0.2 1.5 0.0 0.0 0.0 0.0 9.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.7 0.3 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 2.0 0.6 1.9 6.8 4.0 0.2 9.2 0.4 1.4 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 29.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 15.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 ZGRF1 "C4orf21, FLJ11331" ENSG00000138658 "Zinc finger GRF-type containing 1" Q86YA3 4 112539333-112636995 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.0;Microglial cells: 17.8;Oligodendrocytes: 27.5;Spermatocytes: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030704, HPA030706" Uncertain Approved Cytosol NA Yes Cytosol "HPA030704: AB_2673577, HPA030706: AB_10601784" "unprognostic (8.48e-2)" "unprognostic (6.17e-2)" "unprognostic (9.51e-2)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-3)" "unprognostic (5.83e-3)" "unprognostic (1.45e-1)" "unprognostic (5.89e-4)" "unprognostic (4.74e-2)" "unprognostic (4.30e-2)" "unprognostic (3.72e-3)" "unprognostic (7.60e-10)" "unprognostic (3.45e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (2.02e-4)" 0.9 0.8 1.1 2.0 1.6 7.9 1.3 2.6 1.5 0.9 0.4 1.1 1.2 1.2 0.3 1.0 0.8 0.5 0.6 1.1 1.1 0.5 0.7 0.9 2.5 1.6 1.2 1.0 1.1 0.7 0.3 1.3 1.7 1.7 0.9 1.4 4.3 0.9 0.4 1.2 1.4 1.5 0.9 1.3 1.8 0.9 3.7 1.4 5.2 0.8 0.6 2.9 0.7 0.9 2.4 5.0 3.6 12.1 8.6 0.9 1.6 4.7 8.8 3.7 8.7 7.8 6.9 7.3 13.2 2.5 2.7 3.6 4.0 12.7 4.7 10.0 7.3 3.1 8.3 5.8 2.1 0.4 18.5 5.3 0.8 0.6 11.0 3.0 1.2 3.5 13.6 12.0 14.3 6.0 8.2 25.0 6.7 6.3 5.2 4.2 13.8 18.1 4.5 1.5 4.4 5.6 9.5 3.9 5.3 1.7 8.8 2.5 5.4 4.2 10.9 10.6 5.9 7.1 5.5 10.1 17.0 4.9 6.3 6.3 0.0 0.1 0.3 0.2 0.7 0.1 0.3 0.1 0.0 0.0 0.5 0.4 0.4 0.2 0.2 0.1 0.7 0.2 0.1 1.1 1.6 2.6 1.5 1.1 1.1 1.6 1.2 1.0 1.7 1.3 1.4 2.4 3.3 0.0 1.3 10.4 5.4 0.0 1.3 0.0 0.6 10.4 2.1 1.7 2.4 0.0 3.7 1.8 8.4 3.5 10.4 2.1 0.0 1.0 2.9 1.8 3.5 1.9 1.2 11.1 18.0 0.5 2.7 2.3 4.6 2.8 2.5 12.2 1.1 0.6 1.8 5.0 14.5 1.8 0.0 1.6 0.0 2.8 0.6 4.1 0.0 17.8 1.3 1.6 6.2 17.6 27.5 0.6 1.4 2.2 10.5 0.8 0.7 0.3 0.7 17.6 0.0 3.1 2.7 22.1 15.6 3.6 0.0 0.8 5.0 2.2 2.5 0.9 AP1AR "2C18, C4orf16, gamma-BAR, PRO0971" ENSG00000138660 "Adaptor related protein complex 1 associated regulatory protein" Q63HQ0 4 112231740-112273110 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035863, HPA058115" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA035863: AB_10672098, HPA058115: AB_2683610" "unprognostic (1.11e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.19e-1)" "unprognostic (9.16e-2)" "unprognostic (1.86e-2)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (2.45e-1)" "unprognostic (2.69e-2)" "unprognostic (6.15e-2)" "prognostic favorable (4.05e-7)" "unprognostic (2.50e-2)" "unprognostic (1.36e-1)" "unprognostic (2.10e-3)" "prognostic favorable (7.79e-4)" 8.8 15.9 7.8 12.7 8.8 3.7 17.1 10.9 10.1 8.5 7.1 18.2 22.4 11.4 8.3 13.4 6.6 12.9 8.0 10.0 9.7 22.3 20.7 9.2 12.2 7.8 8.5 7.4 11.7 8.4 41.3 4.8 12.1 8.2 9.0 16.4 7.6 12.2 10.1 7.4 14.3 24.0 9.9 8.0 13.3 13.1 14.6 8.7 11.0 10.9 7.6 12.2 13.1 9.9 9.3 20.7 10.1 24.5 23.8 20.7 15.2 22.3 18.9 45.9 13.6 16.2 10.0 39.0 46.0 15.3 12.7 16.2 9.2 24.4 14.5 23.2 53.1 13.3 15.5 13.6 32.8 31.9 38.0 23.9 16.9 32.3 11.9 33.7 11.1 21.2 24.2 16.7 38.5 13.5 19.6 34.7 23.5 18.2 47.0 10.8 30.0 26.2 23.5 26.4 14.5 24.5 32.1 12.7 45.2 34.5 12.2 14.9 12.8 19.0 18.1 23.1 27.4 15.2 34.5 68.0 56.2 19.0 14.4 16.3 6.7 7.4 2.6 4.0 10.0 5.6 6.8 6.3 6.4 9.5 5.9 8.5 8.9 1.1 9.0 8.4 4.4 7.5 5.2 7.8 8.8 10.9 10.1 10.0 9.7 7.8 8.5 7.4 8.2 8.0 8.7 9.3 21.3 9.6 19.5 9.4 12.9 21.0 8.9 7.0 22.2 8.9 34.2 22.7 20.5 17.2 14.9 16.5 2.1 5.5 14.5 38.4 11.7 9.8 91.7 21.3 17.2 17.7 31.7 6.3 24.8 10.1 3.8 15.2 18.3 29.5 6.3 8.2 9.3 27.3 15.7 10.1 20.6 16.0 6.1 20.1 16.5 59.9 4.7 17.4 23.2 15.0 12.0 12.3 1.0 13.6 16.3 12.7 24.0 10.1 6.8 13.1 24.9 28.6 16.0 8.0 0.0 16.0 20.4 9.6 12.2 28.2 31.3 3.1 12.5 15.2 20.8 14.7 COPS4 CSN4 ENSG00000138663 "COP9 signalosome subunit 4" Q9BT78 4 83034447-83075818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036894, HPA042828" Approved Supported "Nuclear speckles" NA NA 100000 "Nuclear speckles" "HPA036894: AB_10670929, HPA042828: AB_2678191" "unprognostic (1.82e-3)" "unprognostic (1.01e-2)" "prognostic favorable (4.14e-4)" "unprognostic (7.97e-3)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (1.73e-2)" "unprognostic (1.57e-1)" "unprognostic (8.96e-2)" "unprognostic (3.26e-1)" "unprognostic (3.10e-2)" "unprognostic (9.21e-2)" "prognostic favorable (5.21e-6)" "unprognostic (5.84e-2)" "unprognostic (3.07e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" 25.7 39.0 28.3 22.2 31.4 41.4 32.3 27.5 33.8 32.0 26.7 25.5 23.3 31.1 29.0 30.8 26.2 22.7 60.3 30.1 34.4 39.2 29.4 22.4 30.2 29.4 29.3 28.9 32.2 24.8 44.0 39.5 30.5 31.5 30.6 25.3 46.0 23.9 30.8 105.8 26.4 22.1 33.6 28.4 22.6 22.6 45.4 30.9 36.5 38.8 84.9 33.0 32.1 23.7 32.7 51.7 30.4 64.1 59.0 56.0 71.7 34.8 67.2 85.7 74.8 66.0 43.7 51.8 86.9 57.3 140.5 41.3 37.7 80.6 68.9 101.1 55.6 56.9 50.4 43.5 42.1 46.3 86.8 135.6 54.4 47.0 55.8 47.8 56.2 101.1 53.5 65.2 48.0 91.9 43.4 105.0 63.6 35.3 81.1 40.6 74.0 48.8 48.1 59.8 47.2 67.7 39.6 45.0 69.4 43.5 43.8 52.7 46.4 66.7 52.2 55.1 39.7 48.6 49.8 32.7 96.8 50.3 55.2 52.8 91.4 37.0 55.2 43.0 50.4 53.9 39.7 47.1 49.7 45.3 38.9 44.7 48.1 8.2 54.6 59.8 29.0 47.6 52.3 28.3 31.4 27.5 33.8 30.1 34.4 29.4 29.3 28.9 31.5 28.4 30.9 32.7 25.6 12.8 20.1 21.9 34.1 42.8 42.2 94.5 23.3 38.7 20.1 23.4 81.3 20.0 51.5 20.2 31.3 82.5 36.5 14.5 90.1 42.4 130.6 24.9 27.6 31.9 31.2 26.5 34.7 33.2 62.7 39.9 15.3 21.3 34.2 38.2 20.0 22.4 49.0 26.9 32.9 22.0 67.1 29.2 29.2 38.3 30.7 27.2 33.8 18.7 37.8 62.5 37.0 28.6 32.9 28.2 22.1 42.9 28.6 20.5 22.6 75.7 37.9 44.6 32.9 34.1 42.5 121.2 50.2 29.7 35.2 95.0 32.8 53.3 26.3 34.3 HNRNPD "AUF1, HNRPD" ENSG00000138668 "Heterogeneous nuclear ribonucleoprotein D" Q14103 4 82352498-82374503 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004911 Supported Enhanced Nucleoplasm NA NA 1100000 Nucleoplasm "HPA004911: AB_1078250" "unprognostic (9.60e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (1.77e-1)" "unprognostic (1.03e-3)" "unprognostic (1.75e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-2)" "unprognostic (5.93e-2)" "unprognostic (1.08e-1)" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" 148.7 115.6 68.3 209.1 69.4 381.0 157.1 92.7 89.8 161.2 73.5 155.1 171.3 178.3 138.3 156.7 153.3 99.5 117.8 68.8 70.1 113.4 141.7 130.2 292.6 68.3 66.3 62.1 182.1 147.9 135.1 117.9 169.2 73.5 139.8 166.0 189.8 148.3 126.6 171.3 148.8 178.7 141.4 60.5 186.2 166.1 98.6 68.5 338.2 123.8 104.3 313.2 161.3 147.0 76.9 661.7 257.5 1073.5 344.2 138.9 179.1 508.9 506.2 384.6 566.7 484.9 461.1 565.7 1332.6 357.1 343.3 301.9 318.2 863.8 376.6 883.9 250.1 450.8 957.4 345.2 630.7 282.1 1283.9 475.2 221.0 164.7 459.6 459.5 290.2 521.2 637.3 1076.0 446.6 487.7 254.3 1569.2 887.2 897.8 487.2 236.1 1149.2 1089.0 556.7 478.0 394.8 540.9 583.3 496.5 426.0 262.2 497.0 319.7 504.9 443.7 435.3 595.3 339.7 661.7 472.5 403.1 1516.3 334.6 651.6 508.9 26.1 11.3 12.4 13.3 12.5 15.1 20.3 16.2 17.0 13.5 13.9 17.5 14.6 13.6 14.1 14.1 23.6 19.7 7.2 68.3 69.4 92.7 89.8 68.8 70.1 68.3 66.3 62.1 73.5 60.5 68.5 76.9 152.4 102.5 143.5 63.6 128.0 261.3 227.8 139.0 111.0 128.4 124.6 121.9 202.6 125.8 149.0 112.2 62.6 299.7 163.4 71.6 70.5 204.3 35.3 136.2 218.9 162.3 146.6 182.6 65.3 210.6 355.2 134.7 98.4 204.5 92.3 191.5 114.9 114.4 156.6 107.7 72.9 158.9 85.5 125.6 172.7 21.8 124.8 134.5 90.7 63.7 169.3 187.8 130.7 84.9 105.8 157.4 56.7 102.3 151.0 208.3 91.3 80.9 115.7 118.8 111.7 185.5 154.5 106.7 133.7 147.0 229.7 272.0 133.6 149.1 169.3 228.8 PRKG2 "cGKII, PKG2, PRKGR2" ENSG00000138669 "Protein kinase cGMP-dependent 2" Q13237 4 81087370-81215117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.2;prostate: 9.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Excitatory neurons: 32.6;Inhibitory neurons: 66.1;Oligodendrocyte precursor cells: 106.6;Proximal enterocytes: 19.7;Smooth muscle cells: 29.8" "Group enriched" "Detected in some" 4 "melanoma: 4.1;prostate cancer: 2.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.0;ASC TERT1: 3.8;HEL: 21.2;hTCEpi: 4.0;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007386, CAB018739" Approved NA NA "CAB018739: AB_2284387, HPA007386: AB_1079678" "unprognostic (6.14e-2)" "unprognostic (2.77e-1)" "unprognostic (2.14e-1)" "unprognostic (5.01e-4)" "unprognostic (4.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.13e-1)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (1.48e-1)" "unprognostic (8.27e-2)" "unprognostic (2.33e-1)" "unprognostic (1.58e-1)" "unprognostic (4.00e-3)" "unprognostic (1.06e-1)" 0.6 0.2 2.2 0.2 1.6 0.5 1.6 0.6 1.9 1.0 0.2 2.4 9.7 0.4 0.3 2.8 0.4 0.2 4.3 1.6 1.5 0.5 0.0 3.4 0.2 3.1 2.6 1.6 0.0 1.4 0.0 2.2 0.0 4.1 9.7 2.9 0.3 0.3 3.4 0.0 1.1 13.2 0.5 1.3 0.0 1.0 0.9 4.5 1.0 0.9 0.0 0.4 0.5 0.6 3.8 0.1 0.3 0.1 0.0 5.0 3.8 0.0 0.3 0.0 0.0 0.0 0.4 2.4 0.0 0.2 0.9 0.0 0.1 0.3 1.5 0.0 0.4 0.0 21.2 0.6 0.1 0.0 0.0 0.0 0.5 4.0 0.0 0.0 1.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.1 0.9 0.6 0.4 0.0 0.0 0.1 0.0 0.9 6.3 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 1.6 0.6 1.9 1.6 1.5 3.1 2.6 1.6 4.1 1.3 4.5 3.8 0.3 35.3 2.6 1.0 0.3 0.0 0.9 0.1 1.2 0.0 0.3 0.1 4.9 0.0 2.0 0.0 0.0 0.0 0.1 5.5 0.0 0.2 10.3 0.3 0.6 0.1 0.0 8.0 32.6 0.0 0.1 2.5 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 66.1 1.7 0.0 0.0 0.0 2.2 0.0 0.1 0.0 12.2 0.1 0.0 0.0 106.6 1.1 0.9 9.2 0.0 0.5 0.8 19.7 0.2 0.8 0.0 0.0 0.1 29.8 0.0 1.3 0.8 0.1 0.0 0.4 0.0 0.7 0.3 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 118.7;granulocytes: 107.0;Langerhans cells: 282.6;Macrophages: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 11.9;memory B-cell: 9.7;naive B-cell: 12.4;non-classical monocyte: 20.6;plasmacytoid DC: 28.0" "Group enriched" "Detected in all" 5 "B-cells: 12.4;dendritic cells: 28.0;monocytes: 20.6" "Cell line enhanced" "Detected in some" "CACO-2: 13.4;Daudi: 16.1;Karpas-707: 11.1;NTERA-2: 7.9;OE19: 9.2;SCLC-21H: 7.3;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favorable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favorable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favorable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 13.9 6.4 10.5 11.1 19.0 32.8 8.4 12.1 17.0 8.9 17.9 6.6 13.8 3.5 12.4 11.4 8.1 12.2 4.3 8.2 18.2 7.2 42.1 19.9 10.8 31.9 16.8 8.0 2.5 2.8 5.5 7.6 13.1 37.3 4.3 7.2 12.6 10.0 2.1 2.9 24.5 14.0 6.0 11.5 11.3 14.9 2.5 17.4 14.3 3.4 2.3 9.9 6.1 5.4 44.1 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 13.4 0.3 16.1 0.0 0.0 0.1 0.3 1.1 0.1 0.0 0.1 2.5 1.4 1.0 0.6 0.5 0.3 0.7 0.2 0.6 0.0 0.5 0.1 0.0 2.8 0.2 11.1 0.0 0.6 5.5 0.5 7.9 9.2 3.6 1.6 0.1 6.4 0.5 0.2 7.3 0.1 0.0 2.3 0.1 7.3 1.1 0.0 0.0 0.0 0.5 0.5 0.1 0.1 0.0 5.1 1.2 0.2 0.2 0.8 3.0 0.4 1.9 11.9 2.1 9.7 1.6 1.6 2.7 12.4 2.8 2.7 1.1 3.8 20.6 28.0 0.5 1.2 10.5 19.0 12.1 17.0 8.2 18.2 31.9 16.8 8.0 37.3 11.5 17.4 44.1 9.6 28.9 15.9 1.3 118.7 58.9 7.9 4.4 23.9 11.7 22.7 13.2 9.1 15.7 11.1 14.7 37.5 33.2 71.2 13.2 13.7 3.1 0.5 44.5 4.8 10.8 26.8 0.0 3.6 4.0 2.4 9.1 30.1 38.0 107.0 0.6 102.1 45.9 39.5 3.3 2.8 12.8 16.2 64.2 282.6 1.5 0.9 141.4 62.2 10.3 2.9 1.0 2.1 26.7 25.5 3.0 9.6 1.9 33.5 10.2 9.2 12.9 34.0 4.9 0.0 5.9 17.7 0.8 3.2 10.4 56.7 11.2 56.3 0.5 8.1 11.5 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818509-82901166 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol NA NA 40000 "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.69e-4)" 99.6 104.1 54.6 79.1 57.8 120.4 112.6 66.1 68.7 146.7 96.1 108.1 125.3 120.8 163.5 93.5 91.7 123.2 111.7 57.8 63.0 134.9 176.2 97.0 88.9 62.4 62.1 55.5 154.2 194.3 117.3 109.2 144.4 63.9 114.4 128.5 88.7 135.2 112.3 97.6 108.7 111.9 132.6 54.2 77.2 111.1 78.5 57.4 94.7 169.5 86.4 102.9 114.1 94.9 68.2 146.2 65.2 183.6 130.4 318.9 394.5 133.3 264.8 295.4 146.0 179.2 113.2 182.3 188.3 113.7 532.2 84.6 68.1 183.3 176.2 200.4 193.4 72.7 115.3 110.5 302.1 316.4 124.4 140.7 380.5 217.7 223.5 254.3 251.2 240.5 83.8 178.4 181.1 264.2 128.6 164.9 99.6 126.1 154.0 58.3 121.2 100.1 140.3 237.2 83.0 118.6 131.2 105.7 180.7 174.9 184.8 142.1 137.8 248.2 190.7 98.9 169.0 168.8 135.1 62.4 256.7 190.6 147.8 224.2 84.3 66.9 51.2 65.1 74.0 80.5 60.0 57.6 64.3 73.3 50.0 56.9 54.6 19.2 89.9 83.1 61.1 52.7 71.8 54.6 57.8 66.1 68.7 57.8 63.0 62.4 62.1 55.5 63.9 54.2 57.4 68.2 62.6 105.8 85.3 50.9 58.1 60.5 60.5 64.1 56.9 52.3 54.5 43.7 85.5 51.5 109.8 47.8 54.2 57.3 61.0 62.8 27.4 65.8 30.6 90.1 164.6 65.0 38.3 41.2 61.0 71.2 85.3 125.2 100.9 119.7 75.2 241.0 65.0 94.0 45.9 42.1 60.0 99.4 50.8 51.2 55.3 19.3 139.1 63.8 51.6 67.5 60.4 36.5 38.1 74.9 72.6 67.5 46.3 126.0 152.2 76.3 121.0 65.9 100.5 66.9 52.6 86.5 98.9 30.3 34.6 62.2 74.2 81.5 55.4 78.9 54.9 101.1 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 11.5;gallbladder: 3.4" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Excitatory neurons: 9.4;Microglial cells: 1.9;Proximal tubular cells: 4.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 11.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 64.1;BJ hTERT+: 120.0;fHDF/TERT166: 88.0;HBF TERT88: 88.0;LHCN-M2: 81.1;U-138 MG: 109.5;U-251 MG: 55.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: AB_2678001" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.0 0.0 0.1 0.6 0.1 0.1 0.0 11.5 1.1 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.0 3.4 0.0 0.6 0.2 0.9 0.0 0.0 0.0 2.3 0.7 0.1 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.1 1.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.1 6.1 21.8 0.0 64.1 120.0 16.5 12.2 0.0 0.1 0.0 0.0 88.0 1.2 0.1 0.1 22.5 88.0 0.0 1.1 0.2 0.1 0.0 1.7 0.6 0.0 6.3 0.0 48.6 23.0 27.9 5.7 0.0 0.0 0.2 81.1 0.0 0.1 0.3 0.1 0.0 2.1 0.2 0.2 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.8 0.0 0.0 0.2 20.9 109.5 4.6 5.4 55.0 0.0 0.0 0.1 6.3 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 11.5 1.1 0.6 0.2 2.3 0.7 0.1 4.3 0.0 0.8 1.6 0.0 0.0 1.1 0.3 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.6 0.0 0.1 0.0 0.0 0.0 9.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.0 4.1 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 60.0;Early spermatids: 82.3;Macrophages: 60.5;Proximal enterocytes: 56.2;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 182.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 157.6;GAMG: 116.4;HMC-1: 57.4;U-87 MG: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029414 Approved NA NA "HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 14.2 1.0 1.6 5.7 1.4 12.0 6.6 3.8 2.7 4.3 7.5 13.8 40.3 3.7 1.2 8.4 3.6 8.7 25.6 1.1 2.7 89.2 18.3 4.2 2.1 4.8 2.5 0.8 16.3 1.2 23.4 5.0 1.5 5.5 1.7 11.2 1.2 3.5 3.6 37.9 2.6 35.9 3.6 2.2 4.7 15.4 7.5 2.7 1.7 20.0 12.6 2.2 6.1 6.4 5.2 30.6 29.6 0.0 0.4 1.5 3.7 0.6 2.4 4.3 0.6 0.6 2.2 157.6 0.0 3.2 5.9 116.4 6.8 14.3 2.8 0.5 2.1 6.7 0.0 9.2 29.7 4.2 8.9 57.4 2.0 0.2 1.1 3.5 11.5 15.0 8.5 25.1 23.7 0.6 3.1 2.3 2.2 0.7 45.6 12.5 0.3 6.7 11.6 29.8 2.0 0.7 0.0 5.8 6.1 17.3 1.6 1.2 1.6 0.7 6.9 12.3 6.9 28.9 1.1 2.2 0.0 66.4 17.6 52.2 182.5 33.2 4.0 0.6 27.8 6.0 0.1 3.5 2.0 81.4 0.1 2.5 1.2 91.1 1.6 23.6 0.3 2.3 10.4 1.6 1.4 3.8 2.7 1.1 2.7 4.8 2.5 0.8 5.5 2.2 2.7 5.2 4.8 6.4 6.8 0.0 1.3 0.0 60.0 0.0 8.0 0.8 10.2 4.1 0.0 4.3 5.0 11.0 0.0 0.4 0.8 18.6 15.6 4.8 82.3 1.0 1.1 5.4 1.2 6.1 0.0 6.8 1.3 5.5 34.7 2.4 7.6 0.8 7.5 13.2 14.8 5.0 0.0 9.9 0.0 11.3 0.0 21.7 1.2 60.5 0.0 0.0 28.7 0.1 1.0 0.0 0.0 10.4 6.7 0.7 1.2 32.4 56.2 67.4 1.5 0.3 6.6 5.8 1.7 10.6 1.9 5.2 0.0 1.0 7.3 4.9 3.6 28.9 IL21 "IL-21, Za11" ENSG00000138684 "Interleukin 21" Q9HBE4 4 122610108-122621066 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "lymphoid tissue: 6.0" "Group enriched" "Detected in some" 18 "Early spermatids: 13.7;Late spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 55700 "unprognostic (2.42e-1)" "unprognostic (2.12e-1)" "unprognostic (6.80e-2)" 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 FGF2 FGFB ENSG00000138685 "Fibroblast growth factor 2" P09038 4 122826708-122898236 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000125, HPA065502" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Secreted in other tissues" NA NA 92500 "Nucleoplasm, Nuclear bodies" "CAB000125: , HPA065502: " "unprognostic (1.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-1)" "unprognostic (6.98e-2)" "unprognostic (1.25e-1)" "unprognostic (2.82e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.37e-1)" "unprognostic (4.61e-3)" "unprognostic (2.36e-1)" "unprognostic (1.81e-1)" "unprognostic (4.45e-2)" "unprognostic (3.45e-3)" 24.5 2.6 15.7 5.4 14.6 0.1 9.6 13.3 14.9 8.6 15.0 10.5 1.8 14.3 4.5 4.7 8.1 7.2 4.4 13.0 20.4 3.8 2.0 8.4 1.8 19.1 18.3 10.5 12.7 1.5 4.7 3.2 6.4 15.7 7.7 4.0 3.4 3.6 8.8 1.4 1.7 3.7 12.7 16.6 1.2 6.3 1.9 16.4 1.7 2.5 4.9 1.8 14.9 6.2 14.6 4.7 14.1 7.8 30.5 18.8 31.1 0.0 243.8 148.4 104.3 60.2 0.2 0.4 0.0 20.5 278.2 81.8 0.7 8.1 0.5 104.3 12.3 3.3 0.0 28.7 0.2 55.3 1.4 0.1 16.8 1.7 103.6 147.6 52.0 11.8 0.0 6.9 8.4 27.4 0.1 0.1 0.2 21.6 0.1 5.4 0.0 3.9 0.1 33.0 0.0 4.4 4.0 48.4 0.1 2.0 44.7 0.1 0.5 10.6 85.7 12.2 32.0 20.0 8.6 10.3 0.0 24.7 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 14.6 13.3 14.9 13.0 20.4 19.1 18.3 10.5 15.7 16.6 16.4 14.6 33.7 6.4 0.0 111.0 0.3 1.7 1.6 0.8 2.8 4.6 4.5 8.9 4.7 0.0 1.3 7.3 0.0 2.7 0.4 0.0 3.9 8.2 10.9 1.5 40.6 11.5 1.8 0.4 1.8 1.0 0.1 77.1 0.0 1.6 0.0 5.7 17.2 1.3 0.5 0.0 6.6 0.0 0.0 0.0 2.4 3.8 9.9 1.7 5.4 15.9 0.6 9.3 0.0 42.3 5.8 11.0 0.0 8.2 1.6 16.0 0.0 0.6 0.0 2.0 0.0 15.2 14.2 4.7 1.1 0.3 1.3 4.8 0.5 0.1 0.0 2.0 BBS7 "BBS2L1, FLJ10715" ENSG00000138686 "Bardet-Biedl syndrome 7" Q8IWZ6 4 121824329-121870487 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 57.1" "Cell type enhanced" "Detected in all" "Excitatory neurons: 65.1;Inhibitory neurons: 58.6;Rod photoreceptor cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044592 Approved NA NA "HPA044592: AB_10795882" "unprognostic (6.36e-2)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (1.85e-1)" "unprognostic (1.10e-2)" "unprognostic (1.89e-1)" "unprognostic (3.15e-5)" "unprognostic (6.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.48e-1)" "unprognostic (1.49e-1)" "unprognostic (9.10e-3)" "unprognostic (2.67e-2)" "unprognostic (1.62e-1)" "unprognostic (4.22e-2)" "unprognostic (1.41e-1)" "unprognostic (4.33e-1)" 6.6 6.5 7.8 5.4 8.4 2.1 6.1 10.7 12.8 7.6 3.9 6.2 5.1 10.6 4.9 6.3 8.0 6.0 4.0 7.8 7.7 6.8 2.4 5.4 5.0 9.6 8.7 7.6 12.5 3.7 9.1 9.2 4.8 9.5 6.9 6.4 57.1 4.8 6.7 3.8 6.8 5.3 10.4 6.1 4.6 4.8 9.1 9.2 6.4 5.5 5.6 4.9 5.9 6.9 9.7 13.7 6.6 14.9 10.9 18.8 27.2 5.4 18.3 14.6 15.5 14.2 5.2 7.4 15.0 5.1 21.7 11.6 7.1 15.5 14.8 17.6 14.4 12.1 8.9 10.0 6.2 16.7 12.7 8.0 14.0 10.6 17.7 13.3 20.2 16.8 10.0 6.0 14.8 22.1 4.3 21.3 6.1 7.9 8.3 8.2 9.7 19.3 4.6 15.7 4.8 16.4 7.0 17.5 7.7 14.0 19.7 6.5 4.7 16.9 11.6 12.5 16.2 11.8 13.9 10.3 13.1 13.4 10.0 11.6 0.6 1.0 1.7 1.9 1.1 1.5 0.9 1.5 1.8 1.2 0.9 1.2 1.6 0.2 2.0 1.2 1.2 1.6 1.0 7.8 8.4 10.7 12.8 7.8 7.7 9.6 8.7 7.6 9.5 6.1 9.2 9.7 15.7 6.4 8.4 12.7 6.9 8.7 10.8 13.7 5.7 16.6 6.0 9.3 8.4 4.3 13.0 11.0 47.9 8.5 6.6 6.4 13.7 14.6 22.2 14.4 19.9 11.2 6.1 9.5 65.1 9.8 21.5 14.4 6.1 10.6 15.2 9.2 8.6 5.0 11.4 16.8 58.6 8.2 16.2 6.3 6.1 12.9 13.1 7.7 8.8 16.9 6.3 12.6 5.2 30.7 26.4 15.6 5.1 11.3 5.6 9.3 6.0 15.1 16.5 68.9 19.7 12.2 15.2 39.6 22.4 10.9 8.5 5.7 10.7 11.4 8.4 8.6 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152331-122362758 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 245.2;Inhibitory neurons: 246.5;Oligodendrocytes: 239.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 28.6 25.1 39.2 13.9 49.6 60.8 32.0 41.3 43.9 29.7 62.8 28.3 19.0 27.9 30.0 17.6 27.4 19.9 21.4 36.8 41.2 28.0 21.5 28.4 20.0 47.6 41.2 36.3 42.0 25.0 56.7 47.5 17.7 44.0 22.1 22.3 83.1 22.6 21.9 56.0 28.9 28.5 22.3 38.7 26.6 23.5 26.9 42.9 23.4 31.8 42.6 16.9 24.7 25.8 61.6 30.5 9.5 22.3 14.8 36.3 46.7 11.6 13.5 25.3 13.6 14.9 7.2 15.7 15.9 7.6 32.2 18.4 11.2 13.7 16.7 22.0 12.1 8.8 17.7 18.4 13.7 18.9 16.7 9.4 27.2 19.6 16.4 22.3 37.2 29.3 17.0 11.6 18.8 28.5 10.3 14.5 13.0 7.4 14.6 10.7 8.2 30.8 4.1 24.1 22.6 13.0 11.6 8.4 9.7 18.8 35.8 10.6 13.5 39.8 16.8 16.7 14.0 14.0 18.1 12.5 11.5 17.8 14.4 12.6 1.8 0.7 4.3 1.6 1.8 1.7 1.2 1.1 1.1 0.7 1.8 0.9 1.1 3.3 1.0 0.9 1.1 1.6 0.4 39.2 49.6 41.3 43.9 36.8 41.2 47.6 41.2 36.3 44.0 38.7 42.9 61.6 94.6 86.6 42.8 245.2 36.0 20.9 22.0 19.8 26.2 126.0 36.2 27.6 69.2 22.8 35.9 42.3 125.1 12.0 59.6 42.4 1.9 13.8 35.1 34.3 52.8 47.2 21.6 27.1 194.0 17.5 7.0 41.2 59.7 47.2 21.5 64.4 35.0 24.1 12.7 92.5 246.5 27.3 20.3 30.1 17.5 27.7 51.3 41.0 16.0 153.6 32.5 60.9 26.8 161.9 239.9 20.7 34.9 50.8 47.9 19.3 50.0 10.3 33.1 145.0 32.9 63.1 54.9 63.2 33.9 28.9 24.4 13.0 52.0 34.0 32.0 23.0 BMPR1B "ALK6, CDw293" ENSG00000138696 "Bone morphogenetic protein receptor type 1B" O00238 4 94757955-95158448 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Chondrogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;cervix: 24.9;prostate: 22.6" "Cell type enriched" "Detected in many" 7 "Astrocytes: 480.6" "Cancer enhanced" "Detected in many" "breast cancer: 32.4;prostate cancer: 24.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.40e-3)" "prognostic favorable (2.84e-4)" "unprognostic (1.57e-1)" "unprognostic (4.22e-2)" "unprognostic (1.92e-1)" "unprognostic (2.86e-2)" "unprognostic (2.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-2)" "unprognostic (3.93e-1)" "unprognostic (1.62e-3)" "unprognostic (7.89e-4)" "unprognostic (6.22e-2)" "unprognostic (3.81e-3)" "unprognostic (2.63e-2)" 0.6 4.6 16.6 0.3 14.0 0.1 1.0 15.1 15.1 24.9 2.8 0.8 0.1 4.4 2.4 0.2 12.6 2.7 0.7 13.4 22.0 7.8 0.8 1.7 0.0 20.2 17.5 10.2 6.2 1.1 0.1 1.9 0.7 16.8 22.6 0.2 8.2 1.0 14.3 3.0 0.8 0.1 0.6 14.8 0.9 2.4 3.7 15.1 6.5 0.5 1.1 0.0 0.2 0.5 12.9 0.0 22.0 5.6 0.0 2.3 4.8 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 1.0 0.0 1.3 3.6 8.4 0.1 0.0 4.9 0.0 1.4 0.0 0.6 0.5 0.1 2.7 9.0 2.8 6.2 0.4 0.1 0.0 0.0 0.0 7.1 11.1 0.6 0.1 2.1 0.1 3.2 0.2 3.4 0.1 4.3 0.1 0.2 18.8 0.3 3.2 3.2 0.8 1.7 0.0 0.0 4.0 3.8 0.2 4.3 0.0 0.0 0.0 1.5 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 16.6 14.0 15.1 15.1 13.4 22.0 20.2 17.5 10.2 16.8 14.8 15.1 12.9 0.0 6.4 0.0 480.6 0.0 2.7 1.3 13.1 1.2 0.4 3.8 1.0 3.4 2.8 33.4 60.7 0.0 0.0 0.0 0.0 1.9 3.0 1.4 28.5 1.4 1.1 18.4 0.0 51.0 0.4 0.3 1.5 0.0 20.8 0.0 38.6 2.9 0.0 0.1 0.0 2.5 0.0 8.2 0.0 1.2 1.4 3.1 0.4 28.4 22.5 0.0 38.5 0.0 10.1 2.8 0.7 0.0 3.8 0.0 28.5 0.0 0.2 15.7 1.6 0.0 1.7 2.9 1.2 10.6 0.4 2.3 0.0 0.5 4.4 0.0 1.6 RAP1GDS1 SmgGDS ENSG00000138698 "Rap1 GTPase-GDP dissociation stimulator 1" P52306 4 98261384-98443858 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.3" "Cell type enhanced" "Detected in many" "Early spermatids: 434.9;Inhibitory neurons: 176.3;Late spermatids: 245.3;Oligodendrocytes: 357.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019060 Approved Supported Cytosol NA NA 62000 Cytosol "HPA019060: AB_1856068" "unprognostic (8.12e-2)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (1.35e-2)" "unprognostic (1.57e-3)" "unprognostic (3.44e-1)" "unprognostic (6.31e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (4.60e-1)" "prognostic favorable (2.00e-4)" "unprognostic (7.11e-2)" "unprognostic (3.09e-1)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" 15.7 12.7 54.9 19.0 57.5 14.4 17.6 57.4 59.7 11.8 30.9 16.6 10.1 12.3 11.3 18.6 9.7 11.7 9.6 53.0 57.2 16.6 21.3 14.1 23.6 65.0 60.8 48.4 10.9 19.2 10.4 16.3 13.3 69.8 10.4 18.7 66.3 12.6 15.3 5.9 14.5 14.4 22.3 57.2 18.1 11.3 22.8 74.8 32.7 17.8 5.7 24.6 19.2 13.0 76.3 50.8 30.4 37.8 32.8 47.6 56.4 14.2 86.7 48.6 51.1 40.0 22.7 66.5 61.0 26.3 65.9 24.3 27.8 47.0 80.5 68.7 60.4 17.1 37.0 35.6 29.6 93.8 64.1 25.2 65.7 47.8 45.3 69.5 42.3 67.9 61.9 25.7 51.6 128.3 27.7 104.9 31.3 13.9 43.0 19.0 41.5 22.4 20.8 51.7 40.8 55.0 32.5 36.2 81.2 48.9 20.6 18.5 41.5 67.2 52.7 36.8 23.9 51.7 16.5 30.1 51.1 43.9 47.3 69.7 32.8 17.4 10.4 23.3 24.9 24.2 23.9 24.4 23.5 27.9 17.1 12.3 19.5 2.5 37.0 28.5 60.6 41.2 14.8 54.9 57.5 57.4 59.7 53.0 57.2 65.0 60.8 48.4 69.8 57.2 74.8 76.3 17.6 16.0 12.2 88.8 34.7 13.9 10.8 11.7 22.8 48.2 17.1 12.2 11.1 14.3 14.7 16.5 50.1 6.8 45.7 9.7 23.5 17.7 434.9 7.4 16.2 15.7 20.9 19.8 146.4 20.9 16.5 11.5 16.8 11.2 15.2 19.8 13.9 18.5 23.8 15.2 176.3 13.0 12.2 33.4 27.6 245.3 9.3 24.7 17.8 89.0 32.6 16.9 34.0 110.6 357.6 23.4 14.6 10.9 30.4 16.3 14.5 20.4 7.6 77.5 0.0 12.7 17.2 16.7 36.5 26.8 16.8 4.5 34.3 19.8 18.4 15.1 LARP1B "DKFZp434K245, DKFZp686E0316, FLJ10378, LARP2" ENSG00000138709 "La ribonucleoprotein 1B" Q659C4 4 128061286-128222931 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 393.1;Late spermatids: 449.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036280 Approved Approved Cytosol NA NA Cytosol "HPA036280: AB_10673126" "unprognostic (1.84e-1)" "unprognostic (7.55e-2)" "unprognostic (9.39e-3)" "unprognostic (4.87e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.79e-1)" "unprognostic (2.63e-1)" "unprognostic (6.39e-2)" "unprognostic (3.36e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-1)" "prognostic favorable (5.13e-5)" "unprognostic (8.46e-2)" "unprognostic (5.94e-2)" "unprognostic (2.08e-1)" "unprognostic (7.50e-2)" 10.5 8.3 7.0 8.1 7.7 14.5 11.6 10.2 11.5 11.6 4.2 14.9 14.7 9.0 24.3 11.2 9.7 9.2 10.4 7.9 7.2 14.3 51.2 10.0 6.4 6.1 5.7 7.1 10.4 35.9 16.4 13.0 10.5 6.4 11.1 16.4 11.1 14.0 11.8 18.4 10.7 15.6 8.4 3.9 6.2 15.5 56.3 7.0 6.6 13.7 13.5 9.4 13.4 10.0 10.4 21.5 7.4 13.2 16.7 13.7 15.5 26.8 18.0 19.9 16.7 10.7 16.9 16.5 26.1 24.6 17.8 12.7 8.3 32.7 19.9 19.9 24.7 20.9 20.9 13.0 41.5 29.7 40.3 8.2 8.1 28.7 13.4 49.0 16.0 19.8 19.4 37.1 42.4 9.6 25.1 35.2 23.1 15.2 33.0 11.9 19.4 20.3 29.8 19.1 16.4 39.1 15.5 15.6 35.7 16.8 17.5 10.5 17.4 16.1 10.7 11.8 17.5 18.1 55.9 22.7 30.1 13.8 30.7 11.5 0.2 2.1 1.3 1.7 1.6 3.1 1.6 1.9 2.2 2.5 1.4 1.5 1.7 0.5 2.6 1.7 4.6 1.7 0.8 7.0 7.7 10.2 11.5 7.9 7.2 6.1 5.7 7.1 6.4 3.9 7.0 10.4 18.4 35.3 35.6 46.0 19.9 27.8 25.7 11.7 10.8 37.0 34.9 18.7 30.2 40.0 32.5 20.2 52.1 31.4 15.2 52.2 13.7 22.1 393.1 41.9 32.3 17.3 34.0 25.0 139.1 29.9 23.2 23.4 29.6 62.6 20.8 12.5 15.0 154.6 11.9 23.5 115.6 115.2 18.3 15.7 16.3 449.5 36.4 15.5 17.8 19.7 16.7 17.5 20.6 55.8 51.8 31.3 36.2 19.9 54.5 46.4 37.4 63.2 29.0 71.5 19.7 20.7 23.1 138.3 21.9 25.3 34.7 51.4 14.3 8.4 55.1 30.6 MMRN1 "ECM, EMILIN4, GPIa*, MMRN" ENSG00000138722 "Multimerin 1" Q13201 4 89879532-89954629 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 158.0;Hepatic stellate cells: 146.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "NK-cell: 6.3;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 9 "dendritic cells: 2.2;NK-cells: 6.3" "Cell line enriched" "Detected in some" 13 "HUVEC TERT2: 1242.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA035769 Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 200000000 "Endoplasmic reticulum" "HPA035769: AB_10696511" "unprognostic (1.15e-1)" "unprognostic (1.81e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.11e-1)" "unprognostic (7.05e-3)" "unprognostic (1.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.88e-1)" "unprognostic (2.12e-1)" "unprognostic (9.71e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.77e-4)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.14e-1)" "unprognostic (1.36e-1)" "unprognostic (2.23e-2)" 22.9 3.8 1.4 11.0 0.9 1.8 27.6 0.8 2.0 28.7 2.5 9.9 5.4 15.1 2.8 14.6 23.3 21.3 3.0 0.7 3.2 1.1 8.7 16.3 14.1 1.5 1.4 0.4 4.9 3.4 0.5 0.7 40.4 1.1 3.8 15.0 0.5 2.7 4.6 1.1 7.4 13.6 17.0 1.2 0.6 5.2 12.9 1.2 3.7 23.3 6.6 7.6 19.8 9.9 1.2 0.0 0.0 94.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1242.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 6.3 0.0 2.2 0.2 1.2 1.4 0.9 0.8 2.0 0.7 3.2 1.5 1.4 0.4 1.1 1.2 1.2 1.2 15.4 0.0 12.0 0.3 2.3 4.2 0.1 0.0 0.0 0.0 0.7 0.1 2.2 0.0 0.6 0.0 0.0 0.0 3.9 0.0 1.9 0.0 17.7 0.3 0.7 158.0 0.0 25.9 0.2 0.0 0.0 1.9 0.0 0.4 2.5 0.1 146.3 2.4 0.6 0.0 0.1 0.0 0.0 5.7 5.9 7.7 0.3 9.1 1.8 21.5 0.7 0.8 2.1 0.0 0.4 0.0 0.0 0.0 5.0 0.4 0.0 0.0 1.5 0.4 0.0 0.3 0.9 15.4 0.0 0.8 4.5 0.0 1.6 0.0 0.0 0.1 PDE5A ENSG00000138735 "Phosphodiesterase 5A" O76074 4 119494397-119628804 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9" "Group enriched" "Detected in all" 4 "prostate cancer: 7.0;thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6" "Region enhanced" "Detected in all" "cerebellum: 18.2" "Low region specificity" "Detected in all" "HPA004729, HPA012873" Approved Approved Cytosol NA NA 850000 Cytosol "HPA004729: AB_1079588, HPA012873: AB_1855124" "unprognostic (6.95e-2)" "prognostic favorable (5.20e-4)" "unprognostic (1.28e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (7.36e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.16e-2)" "unprognostic (1.52e-2)" "unprognostic (8.98e-2)" "unprognostic (8.71e-3)" "prognostic unfavorable (1.17e-4)" 14.2 11.4 1.1 11.0 3.4 2.1 9.7 5.0 4.3 33.0 13.1 27.6 15.6 14.6 41.9 41.7 23.1 10.5 12.9 1.6 2.3 5.9 1.6 22.3 6.4 4.9 8.2 1.3 5.4 12.5 8.4 3.6 13.3 5.5 60.3 26.2 9.6 9.9 50.2 7.0 4.3 19.0 11.5 0.1 5.8 9.7 9.5 3.3 3.7 17.0 5.7 3.5 14.8 15.9 2.2 16.7 0.8 11.0 1.2 3.7 5.5 1.9 10.7 47.5 0.5 1.0 1.0 1.3 1.6 0.5 13.4 3.0 5.8 3.5 1.7 1.3 0.4 7.4 18.5 2.6 0.9 65.9 3.9 1.7 6.1 3.3 1.1 0.1 24.6 1.4 3.7 2.0 2.9 1.6 0.9 5.0 0.6 2.3 1.8 2.8 0.7 5.9 4.3 4.1 4.9 4.3 8.8 13.0 15.3 1.3 8.1 2.7 2.1 2.5 6.2 5.2 3.4 1.5 4.1 2.0 1.5 5.9 1.0 0.9 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.3 0.1 0.0 0.3 0.1 0.2 0.4 0.2 0.1 0.1 0.1 1.2 1.1 3.4 5.0 4.3 1.6 2.3 4.9 8.2 1.3 5.5 0.1 3.3 2.2 7.8 6.4 3.9 19.9 1.3 3.4 2.8 1.1 5.7 8.1 11.0 8.4 5.5 14.3 3.7 1.8 14.6 0.4 0.9 15.5 0.0 15.8 30.6 5.0 12.6 7.8 2.4 0.0 66.1 2.9 0.3 28.1 1.1 3.9 1.3 1.6 0.7 0.9 0.3 5.0 58.3 9.5 2.0 0.0 3.5 11.5 20.8 11.3 5.4 40.3 1.3 28.5 2.1 56.8 41.1 3.9 10.3 104.9 1.4 3.6 7.9 0.5 0.8 5.8 19.7 5.5 80.9 5.4 6.3 3.5 2.4 0.3 1.7 7.0 11.1 2.6 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "eosinophil: 7.5;neutrophil: 5.4" "Lineage enriched" "Detected in single" 32 "granulocytes: 7.5" "Cell line enhanced" "Detected in many" "U-266/84: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 2.7 4.0 2.4 1.6 2.0 3.5 3.0 3.5 2.0 5.2 3.8 2.8 1.3 6.0 2.8 2.2 4.6 2.4 3.1 1.6 3.4 1.7 0.4 4.3 0.9 3.9 3.7 1.1 10.4 4.8 8.6 3.9 3.6 3.8 4.1 2.9 4.8 1.9 4.4 1.6 1.5 1.8 4.5 4.8 2.4 2.1 3.7 2.5 1.4 5.8 3.0 0.8 2.9 3.3 4.6 2.2 3.4 7.8 0.1 4.5 9.3 9.2 4.7 9.9 4.7 4.2 4.4 1.2 0.4 1.2 6.2 4.5 0.1 0.0 1.0 6.0 0.0 1.4 2.9 3.1 0.3 4.9 10.0 0.1 6.6 2.9 3.3 4.1 4.3 3.4 1.2 0.0 14.2 5.7 0.4 1.5 0.1 5.7 0.8 2.7 0.0 9.3 6.1 1.6 0.0 1.4 6.2 0.0 0.1 0.9 4.0 6.4 4.1 1.4 0.2 2.7 4.8 4.6 13.0 19.7 0.1 3.6 0.1 3.6 0.1 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.0 2.4 2.0 3.5 2.0 1.6 3.4 3.9 3.7 1.1 3.8 4.8 2.5 4.6 7.1 12.8 5.6 51.2 0.5 1.7 2.7 2.4 9.1 9.1 1.1 2.4 8.2 2.8 3.8 1.8 8.4 1.0 0.2 1.5 1.9 2.3 75.6 1.4 9.4 6.3 3.6 0.0 25.0 2.5 2.6 9.6 2.6 1.4 2.5 15.5 3.6 0.0 0.8 0.0 31.9 3.6 4.1 0.3 0.7 31.0 8.7 0.6 1.8 23.4 0.2 7.6 0.0 52.8 8.0 1.5 0.8 9.4 0.7 2.6 0.1 0.2 1.8 7.5 6.6 10.1 6.6 8.2 3.5 4.6 1.7 0.5 1.2 14.9 3.0 0.7 TRPC3 ENSG00000138741 "Transient receptor potential cation channel subfamily C member 3" Q13507 4 121874481-121952060 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;pituitary gland: 7.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 18.1;Inhibitory neurons: 82.7;Oligodendrocyte precursor cells: 33.7;Rod photoreceptor cells: 32.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.3;Karpas-707: 2.6;U-2 OS: 1.5;U-251 MG: 1.5" "Region enhanced" "Detected in all" "cerebellum: 57.8" "Low region specificity" "Detected in many" NA NA "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.39e-1)" "unprognostic (3.12e-2)" "unprognostic (5.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.12e-3)" "unprognostic (9.80e-2)" "unprognostic (4.80e-3)" "unprognostic (2.38e-1)" "unprognostic (3.26e-1)" "unprognostic (1.06e-1)" "unprognostic (4.33e-3)" "unprognostic (2.67e-3)" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (8.42e-3)" 0.3 0.0 3.6 0.1 3.2 0.0 0.2 4.5 6.0 0.8 0.4 0.2 0.1 0.4 0.2 0.0 0.5 0.8 0.1 1.4 3.1 0.1 0.1 0.9 0.1 8.3 2.9 0.9 0.1 0.0 0.2 7.5 1.1 2.9 0.2 0.1 3.9 0.1 0.6 0.4 0.1 0.5 2.7 1.0 0.2 0.2 0.4 4.2 0.0 0.1 0.2 0.0 1.7 0.7 3.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 0.4 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.4 0.0 0.1 0.0 1.3 2.3 0.2 0.0 0.1 0.7 0.3 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 2.6 0.5 0.1 0.8 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 1.2 1.5 0.1 1.5 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.6 3.2 4.5 6.0 1.4 3.1 8.3 2.9 0.9 2.9 1.0 4.2 3.0 0.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 8.4 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.3 0.2 0.0 0.0 18.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 82.7 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.1 4.6 0.0 33.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 32.0 0.0 0.3 1.4 0.5 0.8 0.0 0.0 0.0 0.5 0.5 0.0 0.1 NAAA ASAHL ENSG00000138744 "N-acylethanolamine acid amidase" Q02083 4 75913660-75941013 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 142.2;Kupffer cells: 115.8;Langerhans cells: 109.9;Proximal enterocytes: 167.7" "Cancer enriched" "Detected in all" 4 "prostate cancer: 31.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 672.4;non-classical monocyte: 583.3" "Lineage enriched" "Detected in all" 5 "monocytes: 672.4" "Cell line enhanced" "Detected in many" "U-2197: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026135 Approved "Intracellular and membrane" NA NA "CAB026135: " "unprognostic (5.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.41e-2)" "prognostic favorable (1.93e-4)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-2)" "unprognostic (2.24e-1)" "unprognostic (2.87e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.63e-1)" "unprognostic (2.15e-2)" "unprognostic (2.54e-1)" "unprognostic (3.20e-2)" "unprognostic (3.42e-3)" "unprognostic (6.21e-2)" 19.2 14.7 9.8 30.3 10.8 18.6 37.8 11.6 10.9 23.2 13.9 62.3 31.2 13.0 9.2 28.7 16.5 15.9 20.1 10.1 13.4 41.0 68.9 23.2 48.8 11.1 11.2 9.6 8.3 7.7 11.8 7.8 19.5 12.5 71.5 70.5 33.0 31.7 11.5 8.7 23.0 61.2 15.5 10.8 64.3 18.7 3.5 12.6 16.5 16.1 13.1 28.1 20.2 18.6 14.3 11.9 26.6 1.1 0.7 62.4 62.8 1.1 17.5 11.6 11.8 4.0 9.3 41.1 1.0 8.9 43.5 0.4 23.1 34.8 13.4 7.1 17.0 1.3 8.4 19.4 22.6 14.3 31.4 29.6 16.0 10.0 10.3 3.5 18.4 19.1 18.7 9.6 35.9 10.6 43.5 20.2 20.5 13.5 53.4 10.5 13.5 0.4 55.6 12.4 6.7 15.9 2.3 18.1 56.2 5.4 1.8 63.3 54.1 28.8 0.7 1.5 78.6 0.8 8.8 3.8 5.9 14.8 44.5 7.4 48.6 270.1 110.3 62.0 672.4 67.5 58.8 78.4 61.8 143.2 40.4 65.2 54.5 90.3 35.5 583.3 53.2 114.6 233.7 9.8 10.8 11.6 10.9 10.1 13.4 11.1 11.2 9.6 12.5 10.8 12.6 14.3 10.6 0.0 7.3 7.2 31.2 11.3 18.8 5.7 4.0 11.5 31.3 14.2 4.4 25.8 10.9 5.5 18.8 24.6 19.5 142.2 13.7 5.7 0.5 12.1 18.1 14.6 48.0 10.8 17.7 8.4 19.2 28.2 3.1 11.9 15.2 3.5 18.5 37.2 39.7 11.8 27.4 45.4 8.2 115.8 109.9 0.0 10.5 80.3 17.8 7.5 77.8 7.7 16.5 5.0 4.8 4.1 46.7 7.5 16.8 55.4 167.7 12.4 27.7 86.9 0.0 31.8 16.7 1.1 0.9 15.9 18.9 13.3 34.8 9.1 24.4 14.0 NUP54 ENSG00000138750 "Nucleoporin 54" Q7Z3B4 4 76114659-76148444 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035929, HPA058122" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035929: AB_10671236, HPA058122: AB_2683613" "unprognostic (6.70e-2)" "unprognostic (3.51e-2)" "prognostic favorable (8.80e-4)" "unprognostic (3.02e-1)" "unprognostic (3.58e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.51e-3)" "unprognostic (3.05e-2)" "unprognostic (1.62e-1)" "unprognostic (2.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.10e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (3.65e-3)" 17.7 13.2 7.3 15.9 8.0 35.3 23.7 12.9 9.4 22.6 7.2 19.4 16.6 23.8 18.9 18.2 20.1 15.9 12.3 7.7 8.7 15.4 22.4 16.2 22.3 7.6 7.6 6.4 24.5 16.7 15.8 7.6 24.6 8.1 18.7 20.8 12.5 14.8 18.6 12.8 19.5 16.1 20.5 7.4 16.7 16.4 22.0 7.4 28.9 20.8 14.3 24.7 21.9 15.1 10.1 42.6 14.2 52.3 37.1 44.2 40.8 45.0 42.1 61.1 62.1 63.1 36.9 58.4 64.4 34.5 42.3 33.4 27.5 57.0 47.6 76.5 42.5 31.1 38.5 19.1 36.7 41.1 75.8 44.1 37.4 33.6 48.8 50.7 27.1 52.8 41.4 67.1 38.9 44.4 35.9 81.0 39.9 81.3 51.2 14.2 61.6 81.0 25.0 37.3 39.1 31.7 26.6 38.6 45.2 35.4 39.5 18.7 47.2 35.5 48.2 43.0 58.8 52.8 25.1 10.0 60.8 35.1 44.5 44.0 10.1 8.8 9.3 13.3 10.7 18.4 9.7 14.0 13.1 12.9 10.9 14.7 14.1 4.1 26.6 12.6 9.5 14.9 8.5 7.3 8.0 12.9 9.4 7.7 8.7 7.6 7.6 6.4 8.1 7.4 7.4 10.1 26.1 22.4 16.7 25.5 31.3 35.2 42.8 29.4 32.5 13.8 18.8 19.3 11.8 14.3 17.8 11.0 20.9 41.3 30.5 13.5 29.4 25.1 12.5 24.9 31.6 23.7 14.4 35.7 42.8 27.7 47.5 26.8 17.3 34.4 24.1 23.0 19.2 13.6 21.7 8.4 42.0 20.8 16.2 16.4 24.2 7.4 27.4 20.2 17.8 18.7 28.6 12.8 35.0 34.2 54.2 19.2 17.1 25.9 30.5 34.1 14.4 20.4 19.2 22.2 32.9 24.8 26.5 46.8 39.9 30.2 29.1 39.1 31.8 21.6 24.4 36.1 CXCL9 "CMK, crg-10, Humig, MIG, SCYB9" ENSG00000138755 "C-X-C motif chemokine ligand 9" Q07325 4 76001275-76007509 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 312.4" "Cell type enhanced" "Detected in some" "Hepatic stellate cells: 5.0;Hofbauer cells: 6.2;Kupffer cells: 10.3;Macrophages: 12.6;Spermatogonia: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "RPMI-8226: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 902000 "prognostic favorable (6.36e-4)" "unprognostic (6.86e-3)" "unprognostic (1.25e-2)" "prognostic favorable (2.07e-4)" "unprognostic (2.97e-1)" "unprognostic (3.78e-3)" "unprognostic (8.79e-2)" "unprognostic (4.93e-2)" "unprognostic (1.46e-2)" "prognostic favorable (8.06e-4)" "unprognostic (2.18e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.15e-6)" "unprognostic (4.76e-2)" "unprognostic (4.14e-2)" "unprognostic (1.57e-2)" "unprognostic (6.54e-2)" 5.6 2.0 0.1 65.7 0.2 0.2 17.6 0.1 0.6 3.0 0.3 10.3 3.0 4.8 0.7 5.3 2.8 8.6 5.9 0.1 0.2 8.8 19.2 32.0 312.4 1.8 0.2 0.0 3.8 1.4 1.5 1.0 1.7 1.5 3.7 25.5 0.0 19.1 0.7 1.5 2.9 6.1 3.3 0.3 31.5 17.6 6.0 0.7 33.1 7.2 2.5 30.8 11.2 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.1 0.2 1.8 0.2 0.0 1.5 0.3 0.7 0.7 3.4 0.0 1.7 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.7 0.0 0.0 1.8 0.0 0.0 0.2 0.4 0.0 0.2 1.3 0.1 1.1 2.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 5.0 1.8 6.2 0.0 0.0 0.0 0.0 10.3 3.6 1.3 0.6 12.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 3.5 1.7 8.0 0.0 0.3 0.1 0.5 0.0 0.1 0.4 BMP2K "BIKe, DKFZp434K0614" ENSG00000138756 "BMP2 inducible kinase" Q9NSY1 4 78776342-78916365 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 242.9;granulocytes: 129.2;Hofbauer cells: 140.4;Microglial cells: 351.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 50.1;HEL: 73.6;HMC-1: 80.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026436, HPA026451, HPA026501" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341" "unprognostic (7.96e-2)" "unprognostic (3.68e-1)" "prognostic favorable (1.74e-4)" "unprognostic (9.08e-2)" "unprognostic (1.97e-1)" "unprognostic (9.73e-3)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.39e-1)" "unprognostic (9.60e-2)" "unprognostic (9.90e-2)" "unprognostic (9.45e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.18e-2)" 6.1 4.2 8.1 13.7 8.8 12.0 7.5 8.1 8.1 6.5 4.8 9.6 5.6 4.4 5.5 7.5 6.0 7.4 8.0 7.7 20.2 4.9 6.8 7.8 16.7 12.3 9.8 4.8 3.2 3.5 4.3 0.6 9.3 12.6 3.3 12.1 6.6 3.5 3.6 2.2 10.0 7.0 6.6 12.5 12.3 4.8 10.3 9.6 11.0 7.8 4.5 16.4 7.2 1.4 14.4 11.4 3.2 6.0 7.5 12.0 11.1 4.8 10.8 14.4 10.3 13.7 6.4 6.4 13.2 5.6 50.1 9.9 2.9 6.7 8.5 19.4 3.5 2.3 73.6 5.0 3.5 13.2 15.9 80.6 15.9 11.0 16.4 15.6 7.3 14.4 10.0 19.8 36.5 12.1 2.4 9.5 7.4 2.9 8.8 2.1 13.5 10.3 3.7 13.3 5.2 8.4 5.2 14.2 7.8 10.4 7.9 2.7 10.0 14.7 10.6 4.2 18.4 11.9 7.7 3.2 4.8 9.9 21.4 7.7 0.1 0.5 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.4 0.6 0.1 0.0 0.9 0.1 0.8 0.3 0.0 0.1 8.1 8.8 8.1 8.1 7.7 20.2 12.3 9.8 4.8 12.6 12.5 9.6 14.4 10.7 28.9 16.2 242.9 31.5 25.0 4.3 5.4 10.2 10.9 27.4 15.2 6.5 2.8 7.7 7.3 4.2 5.0 6.1 24.6 0.0 7.5 15.9 18.6 12.7 17.6 6.7 105.4 53.2 8.8 14.2 13.7 6.6 25.0 129.2 32.1 22.1 19.7 140.4 10.1 59.0 48.2 6.1 65.9 68.2 11.1 8.1 65.4 28.4 351.3 34.6 37.0 1.0 49.3 59.1 14.6 43.0 6.8 7.6 6.3 19.9 18.0 12.3 8.4 6.6 22.3 11.7 26.1 11.2 17.1 31.4 3.4 7.6 5.4 24.0 3.2 G3BP2 KIAA0660 ENSG00000138757 "G3BP stress granule assembly factor 2" Q9UN86 4 75641849-75724589 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018304, HPA018425" Enhanced Enhanced Cytosol NA NA 47000 Cytosol "HPA018304: AB_1849350, HPA018425: AB_1849352" "unprognostic (2.42e-2)" "unprognostic (5.79e-2)" "unprognostic (8.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.98e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.04e-1)" "unprognostic (6.83e-2)" "unprognostic (3.79e-1)" "unprognostic (7.38e-2)" "unprognostic (7.88e-2)" "prognostic favorable (6.65e-5)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (1.27e-2)" "unprognostic (6.99e-2)" 37.9 41.9 27.1 51.3 39.0 69.9 50.8 27.1 49.6 47.6 15.7 62.3 52.9 45.5 32.4 49.9 55.6 50.2 48.2 32.8 43.3 68.1 65.9 46.5 60.7 27.6 32.6 33.1 32.2 42.6 56.4 28.4 38.7 32.5 78.5 58.6 47.2 37.3 49.7 116.1 25.7 63.1 55.4 24.8 48.4 47.9 61.1 39.5 67.1 75.3 120.5 61.7 66.4 26.0 57.9 96.8 96.6 160.5 131.1 134.8 136.6 54.1 141.6 144.6 96.2 101.5 128.5 137.1 197.1 125.5 120.1 87.0 68.8 170.1 176.0 136.6 111.4 66.2 185.7 95.7 141.7 119.8 188.4 146.2 109.9 144.4 114.6 122.8 129.1 172.1 114.9 140.9 139.2 150.7 63.0 218.4 63.1 154.1 140.3 36.3 159.8 199.2 96.3 112.3 125.8 124.1 141.1 105.7 151.0 201.9 165.7 75.1 90.9 178.5 95.3 76.5 107.7 81.7 136.2 133.9 195.2 135.5 122.9 122.7 83.1 36.2 62.4 50.0 47.8 76.4 35.1 48.1 55.8 41.1 28.2 46.9 51.5 30.8 59.6 64.1 18.5 44.1 64.1 27.1 39.0 27.1 49.6 32.8 43.3 27.6 32.6 33.1 32.5 24.8 39.5 57.9 72.8 54.5 100.7 26.1 126.3 89.0 81.7 53.2 114.4 61.4 71.8 55.2 79.1 20.0 81.0 53.3 50.1 36.4 133.0 92.2 41.1 59.0 213.8 84.7 57.8 69.8 135.4 43.9 70.6 68.9 49.3 56.7 65.2 80.0 105.7 76.7 51.0 77.7 45.7 70.7 74.9 107.9 50.8 75.9 131.3 228.8 26.4 86.1 60.5 30.9 85.3 29.3 53.5 36.7 59.1 94.8 66.6 39.9 117.7 84.5 88.3 104.1 85.8 69.1 19.7 57.2 91.9 63.2 74.8 79.8 77.7 41.3 186.2 99.5 75.6 88.3 SEPTIN11 "FLJ10849, SEPT11" ENSG00000138758 "Septin 11" Q9NVA2 4 76949751-77040384 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 90.1;Extravillous trophoblasts: 266.8;Fibroblasts: 40.1;Hofbauer cells: 52.0;Syncytiotrophoblasts: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 495.8;fHDF/TERT166: 604.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Approved Approved Cytosol NA NA 2800000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (1.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.39e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.58e-2)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "prognostic favorable (2.40e-4)" "unprognostic (5.70e-3)" "unprognostic (6.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" 85.6 13.1 38.6 27.8 49.9 8.0 39.6 26.5 56.1 40.8 1.7 50.6 22.0 34.2 18.1 22.7 17.6 45.8 31.1 47.3 18.0 52.9 34.2 40.8 24.3 8.6 11.6 33.1 20.2 22.5 17.5 11.4 84.8 16.1 21.2 40.8 22.5 11.7 26.3 26.2 13.2 35.6 40.9 0.4 25.8 25.4 7.9 20.3 12.9 21.3 18.5 23.0 39.6 21.7 55.1 87.6 34.9 328.1 293.8 192.8 152.9 94.6 495.8 382.7 110.6 154.5 64.3 62.9 2.0 100.9 604.4 51.9 36.6 109.8 73.8 171.2 114.0 36.7 171.2 44.6 47.1 168.0 93.0 69.7 195.5 34.4 160.2 59.8 87.7 169.0 34.3 72.0 46.6 331.2 50.4 122.8 3.3 111.1 71.4 18.1 142.6 372.8 10.1 62.6 94.0 112.1 83.6 96.2 54.4 77.9 209.9 49.5 37.3 184.4 368.7 109.4 182.8 93.1 28.5 24.3 1.1 140.5 10.0 76.4 12.2 2.4 32.5 8.1 2.2 5.0 3.6 9.2 11.2 7.8 6.7 3.5 9.4 0.6 38.4 7.4 20.8 5.8 6.6 38.6 49.9 26.5 56.1 47.3 18.0 8.6 11.6 33.1 16.1 0.4 20.3 55.1 33.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 90.1 24.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 266.8 40.1 0.0 0.0 0.0 0.0 0.0 0.0 52.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 60.5 5.6 0.0 0.0 0.0 FRAS1 "FLJ14927, FLJ22031, KIAA1500" ENSG00000138759 "Fraser extracellular matrix complex subunit 1" Q86XX4 4 78057323-78544269 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 12.1" "Group enriched" "Detected in many" 9 "Excitatory neurons: 204.9;Inhibitory neurons: 377.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 35.9;Hep G2: 21.9;RH-30: 20.1;SiHa: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051601 Approved "Intracellular and membrane" NA NA "HPA051601: AB_2681547" "unprognostic (1.33e-2)" "unprognostic (1.04e-2)" "unprognostic (9.37e-2)" "unprognostic (8.91e-2)" "unprognostic (2.97e-1)" "unprognostic (2.04e-1)" "unprognostic (1.45e-3)" "unprognostic (2.02e-2)" "unprognostic (1.07e-1)" "unprognostic (2.69e-2)" "unprognostic (2.09e-2)" "unprognostic (4.02e-2)" "prognostic favorable (4.69e-4)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.78e-3)" "unprognostic (6.09e-2)" 1.3 0.6 3.6 0.5 4.3 0.0 0.7 0.0 8.0 2.1 3.5 2.8 0.3 2.0 1.9 1.7 1.0 0.9 1.1 3.8 3.2 7.4 0.3 3.4 0.1 2.9 3.4 5.0 0.2 5.4 0.6 2.4 5.8 3.4 2.3 1.4 2.2 1.0 0.7 2.7 1.3 1.0 1.4 0.0 0.7 0.9 0.6 9.7 2.6 12.1 2.2 0.2 0.5 1.5 5.7 4.6 6.9 2.7 0.0 7.0 2.9 4.8 1.1 4.1 0.6 0.4 5.4 9.8 0.0 8.2 35.9 0.0 1.3 3.8 2.1 0.1 0.0 3.8 4.2 8.5 21.9 0.8 0.0 0.0 14.1 2.3 0.0 5.2 5.4 0.1 0.3 0.0 0.0 4.1 0.2 0.1 0.0 8.6 3.6 1.3 0.0 20.1 0.0 8.7 9.9 5.0 9.7 21.6 6.7 1.3 12.3 0.0 0.0 0.0 0.0 4.5 2.9 1.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.3 0.0 8.0 3.8 3.2 2.9 3.4 5.0 3.4 0.0 9.7 5.7 0.5 32.1 0.0 9.1 0.1 1.9 2.2 2.5 10.2 10.8 0.8 1.8 7.3 22.8 9.2 29.5 0.0 28.0 0.0 0.8 3.9 7.6 2.1 5.5 1.0 2.0 1.2 0.0 204.9 1.7 1.4 5.3 4.1 13.5 0.0 0.1 1.1 0.2 4.4 0.0 377.7 1.0 0.0 0.0 0.7 2.8 0.6 0.4 1.8 20.6 0.0 0.6 0.0 10.1 5.5 2.7 2.5 0.0 0.0 1.8 1.4 4.3 2.5 2.7 0.0 1.5 3.4 0.8 1.2 10.4 1.3 15.6 0.1 2.8 2.4 0.4 SCARB2 "CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII" ENSG00000138760 "Scavenger receptor class B member 2" Q14108 4 76158737-76234536 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 12.5;classical monocyte: 14.1;intermediate monocyte: 26.0;myeloid DC: 8.2;non-classical monocyte: 24.9;plasmacytoid DC: 28.9" "Group enriched" "Detected in all" 5 "dendritic cells: 28.9;granulocytes: 12.5;monocytes: 26.0" "Cell line enhanced" "Detected in many" "ASC diff: 499.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015415, HPA018014" Supported Approved Cytosol NA NA 9200 Cytosol "CAB015415: AB_831511, HPA018014: AB_1852881" "prognostic unfavorable (2.82e-5)" "unprognostic (2.73e-2)" "unprognostic (4.09e-2)" "unprognostic (4.96e-2)" "unprognostic (4.17e-3)" "unprognostic (1.12e-3)" "unprognostic (2.08e-1)" "unprognostic (5.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.25e-2)" "unprognostic (4.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (6.88e-2)" "unprognostic (5.06e-2)" "unprognostic (3.89e-2)" 61.2 24.2 31.9 28.0 55.7 7.3 57.3 55.4 41.3 61.3 22.0 62.2 39.6 44.5 58.9 34.2 45.8 60.6 62.2 28.1 51.6 47.2 90.7 77.8 20.4 60.4 49.2 21.4 59.5 59.4 64.1 11.2 80.9 57.9 72.9 64.7 53.7 81.2 55.9 90.5 26.2 49.5 58.3 58.1 47.4 61.2 19.6 50.3 21.5 66.5 82.1 20.8 65.9 25.3 92.5 39.8 38.4 48.9 97.1 499.7 242.0 35.8 131.5 250.2 114.0 178.2 72.5 112.3 0.0 85.1 262.3 109.6 28.3 28.3 78.9 96.0 138.8 30.1 3.2 32.9 25.3 129.9 19.0 12.1 186.9 72.3 117.3 54.5 268.9 200.6 10.0 15.6 188.6 159.2 58.2 1.6 4.0 9.7 120.3 23.6 23.3 82.7 42.0 64.4 43.6 101.3 110.2 104.7 61.3 115.5 49.3 34.6 17.1 131.3 125.9 48.5 104.7 47.5 167.6 98.8 0.2 158.1 22.2 170.9 12.5 14.1 3.1 2.8 26.0 2.6 3.8 1.9 1.5 8.2 3.0 2.6 4.3 1.9 1.1 24.9 28.9 3.0 6.1 31.9 55.7 55.4 41.3 28.1 51.6 60.4 49.2 21.4 57.9 58.1 50.3 92.5 89.0 176.3 52.4 47.3 20.1 24.0 90.5 64.8 34.1 109.6 69.7 36.4 53.0 87.2 52.1 99.3 60.5 35.3 43.6 109.0 7.9 119.9 7.1 50.3 74.0 69.9 102.4 28.6 57.4 72.9 47.5 108.3 40.8 88.8 3.8 84.8 79.6 108.7 143.4 60.6 55.4 77.1 44.7 165.7 27.5 5.6 45.4 76.2 67.6 38.4 43.5 87.2 6.2 106.1 201.1 78.0 68.3 66.5 82.2 133.5 103.2 27.6 54.4 81.7 92.1 91.0 68.1 18.2 16.5 34.8 33.8 59.4 16.3 56.5 55.3 93.4 CCNG2 ENSG00000138764 "Cyclin G2" Q16589 4 77157207-77433388 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 21.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 56.1" HPA034684 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034684: AB_10669894" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (1.46e-2)" "unprognostic (2.29e-1)" "unprognostic (5.73e-2)" "unprognostic (8.15e-2)" "unprognostic (8.40e-3)" "unprognostic (1.72e-2)" "unprognostic (1.20e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.57e-4)" "unprognostic (2.04e-1)" "prognostic favorable (2.47e-5)" "unprognostic (7.98e-2)" "unprognostic (2.20e-1)" "unprognostic (2.28e-1)" "unprognostic (1.05e-3)" 46.8 23.9 17.1 35.9 18.1 88.9 82.3 65.1 20.5 40.0 10.0 33.8 28.3 39.6 26.9 137.2 19.0 33.1 15.0 17.6 14.2 71.6 11.1 26.5 74.1 14.3 17.0 15.5 37.8 14.8 46.7 8.9 65.1 28.6 78.7 34.8 81.9 34.6 31.7 12.4 29.4 25.3 34.1 13.6 48.6 25.6 11.3 15.9 67.9 53.7 34.7 74.1 54.0 37.4 19.5 30.9 3.9 66.5 35.5 43.1 54.9 45.0 25.4 72.6 19.4 36.0 4.6 43.8 61.7 40.0 23.7 18.4 21.7 17.6 83.8 37.2 43.2 11.8 5.2 18.1 9.1 22.4 9.3 62.1 46.9 40.8 9.1 19.9 64.6 29.4 35.9 3.0 36.7 36.0 12.0 42.9 19.7 6.8 15.0 4.1 24.3 64.8 4.1 121.9 84.1 17.7 56.1 30.0 46.7 18.0 39.4 34.9 13.8 27.6 26.3 26.0 19.1 4.2 26.9 21.9 43.8 18.4 14.4 13.4 14.8 1.7 21.0 0.9 2.7 2.1 3.2 1.3 1.0 1.9 6.3 1.0 0.6 8.0 2.1 3.1 2.8 6.1 0.8 17.1 18.1 65.1 20.5 17.6 14.2 14.3 17.0 15.5 28.6 13.6 15.9 19.5 25.0 12.8 12.3 14.7 55.8 37.1 29.0 27.8 113.8 112.4 101.1 53.6 4.7 8.6 25.4 55.2 22.9 29.7 35.5 57.6 86.1 33.7 0.8 50.4 44.6 35.7 16.7 1.7 13.8 19.6 98.7 61.5 18.3 107.7 39.3 20.3 35.3 3.9 32.3 25.2 26.7 38.0 50.8 45.3 56.7 2.3 27.7 35.8 56.9 10.3 61.8 28.4 17.5 17.1 13.9 49.2 24.6 27.4 20.5 74.3 29.6 70.9 15.3 46.8 65.7 61.3 41.5 9.2 10.1 40.8 26.7 15.7 31.1 17.1 16.1 57.8 CNOT6L "Ccr4b, DKFZp434K098" ENSG00000138767 "CCR4-NOT transcription complex subunit 6 like" Q96LI5 4 77713387-77819615 "Enzymes, Predicted intracellular proteins" "mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 366.6;T-cells: 240.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042688 Uncertain Supported Cytosol NA NA Cytosol "HPA042688: AB_10794384" "unprognostic (3.91e-1)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.10e-2)" "unprognostic (2.56e-1)" "unprognostic (3.72e-2)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (5.06e-2)" "unprognostic (6.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.51e-2)" "unprognostic (7.95e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-3)" 11.1 9.6 8.1 22.6 8.2 29.8 13.6 14.8 9.6 12.5 7.6 13.0 13.2 11.2 9.9 16.7 11.7 14.1 6.2 6.6 10.0 13.3 19.7 11.7 36.4 7.7 8.1 5.6 13.7 20.0 18.0 6.1 22.7 8.2 11.8 15.6 13.1 12.7 12.3 7.2 13.8 13.7 14.7 8.5 23.8 14.8 11.3 10.9 50.0 14.6 8.7 38.8 15.8 8.5 9.3 17.0 9.6 12.5 9.1 14.7 13.6 13.1 13.1 17.8 11.9 15.9 3.5 18.3 26.5 15.4 18.9 8.6 10.9 17.5 18.7 14.9 28.4 10.0 25.4 9.8 10.3 9.1 24.0 22.9 8.1 22.7 12.1 24.3 10.9 38.2 21.2 22.7 38.0 13.9 9.0 52.3 14.0 6.2 13.4 3.2 12.4 38.4 21.5 12.5 13.5 16.0 7.2 23.3 20.1 7.9 15.4 6.8 13.7 35.6 10.9 11.5 19.9 7.3 48.1 21.0 35.1 12.3 11.9 8.6 21.4 4.4 10.6 9.4 7.0 9.9 5.5 7.2 7.7 4.4 7.2 6.7 8.2 6.9 8.2 10.3 6.4 6.4 4.1 8.1 8.2 14.8 9.6 6.6 10.0 7.7 8.1 5.6 8.2 8.5 10.9 9.3 93.0 22.4 21.0 34.3 101.1 57.9 13.3 15.9 59.2 39.5 30.5 20.8 16.7 31.5 24.0 36.8 39.6 31.1 366.6 16.9 60.7 8.2 4.7 30.1 24.6 54.0 26.3 31.5 74.8 12.4 8.6 25.1 26.5 46.2 38.0 22.1 45.3 32.6 17.1 32.0 70.7 29.8 14.2 41.0 50.1 3.7 18.6 50.0 24.9 105.9 39.2 19.3 128.8 68.9 60.7 11.0 16.1 12.8 178.5 33.9 28.4 26.3 17.0 43.5 32.9 26.6 29.2 49.4 39.9 44.7 66.1 24.4 240.0 37.9 24.1 26.7 USO1 "p115, TAP, VDP" ENSG00000138768 "USO1 vesicle transport factor" O60763 4 75724577-75814286 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010108, HPA038282, HPA038283" Supported Supported "Nucleoli fibrillar center,Golgi apparatus" NA NA 170000 "Golgi apparatus" "Nucleoli fibrillar center" "CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929" "unprognostic (9.45e-3)" "unprognostic (3.12e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-3)" "unprognostic (6.29e-2)" "unprognostic (2.11e-1)" "unprognostic (2.03e-1)" "unprognostic (3.24e-2)" "unprognostic (9.18e-2)" "unprognostic (7.95e-3)" "unprognostic (4.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-2)" 35.3 39.1 14.0 32.6 15.7 13.1 39.4 16.1 19.2 44.6 26.5 34.2 36.0 32.6 64.7 50.6 30.3 32.3 57.9 16.1 16.5 39.1 77.5 30.7 32.7 17.5 15.8 12.7 57.4 58.0 38.0 31.8 44.0 17.3 40.3 37.3 39.5 55.2 37.8 221.0 36.5 34.0 36.0 16.5 26.6 41.2 43.5 15.9 31.0 53.9 139.9 40.0 40.6 27.8 20.0 46.8 36.0 49.5 66.7 118.6 155.8 45.5 106.2 129.4 57.2 69.2 36.2 70.4 60.6 64.0 98.0 49.2 52.8 74.9 66.5 85.6 67.2 29.3 41.8 31.4 76.3 93.0 55.8 46.2 89.2 80.6 59.8 116.4 110.6 87.1 41.7 73.7 67.9 85.8 30.9 55.4 29.5 67.9 98.2 21.3 36.3 47.2 49.2 85.5 53.1 39.4 38.3 39.1 82.4 67.3 73.6 60.6 45.1 67.4 52.2 32.2 95.8 40.7 63.6 36.6 29.5 77.6 33.1 63.2 21.9 13.1 11.9 16.4 18.7 22.2 9.8 13.6 15.7 16.8 11.2 13.9 13.8 8.1 22.2 26.9 13.4 15.1 13.7 14.0 15.7 16.1 19.2 16.1 16.5 17.5 15.8 12.7 17.3 16.5 15.9 20.0 34.5 60.9 84.5 59.1 43.2 38.0 52.8 59.6 51.2 33.3 35.0 28.4 126.9 28.6 71.7 25.8 43.8 47.9 32.6 32.0 35.2 38.4 11.1 35.7 57.5 36.4 40.1 20.8 70.9 48.6 49.0 62.7 61.2 55.0 48.8 126.2 32.9 62.0 42.8 26.9 68.7 63.7 40.7 38.0 35.1 10.9 78.6 41.3 28.4 60.9 54.8 32.8 45.3 77.4 113.7 48.5 33.4 68.4 106.9 78.2 44.3 50.4 66.4 51.2 39.5 54.0 50.5 73.8 68.2 58.7 40.3 90.6 37.8 36.3 41.9 63.8 CDKL2 "KKIAMRE, P56" ENSG00000138769 "Cyclin dependent kinase like 2" Q92772 4 75576496-75630716 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.4;choroid plexus: 8.2;retina: 9.7;testis: 11.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 76.4;Early spermatids: 57.8;Excitatory neurons: 32.8;Inhibitory neurons: 40.9;Oligodendrocytes: 46.4;Spermatocytes: 101.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;HHSteC: 1.9;RPTEC TERT1: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040672 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA040672: AB_10794744" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (6.91e-2)" "unprognostic (3.80e-5)" "unprognostic (3.43e-2)" "unprognostic (2.71e-2)" "unprognostic (1.59e-1)" "unprognostic (8.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.88e-15)" "unprognostic (5.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-1)" "unprognostic (7.52e-2)" 0.0 1.0 7.2 0.3 7.9 0.0 0.3 5.3 8.0 0.6 8.2 0.7 0.1 0.6 0.9 0.8 1.6 0.4 0.3 7.0 7.3 6.0 0.0 4.8 0.4 7.0 6.7 7.0 1.6 0.5 2.5 1.5 0.0 7.7 0.6 0.9 9.7 0.3 0.6 0.0 0.2 0.1 0.4 5.5 0.1 0.6 11.7 6.8 0.0 3.2 0.0 0.6 0.2 0.3 9.4 2.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.8 1.0 0.9 0.1 0.5 0.0 0.3 0.0 1.0 0.2 0.0 0.2 0.9 0.1 1.5 0.0 0.1 0.0 1.9 0.0 0.0 0.6 1.0 0.1 0.3 0.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.2 0.1 1.1 0.9 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.2 7.9 5.3 8.0 7.0 7.3 7.0 6.7 7.0 7.7 5.5 6.8 9.4 0.2 25.6 76.4 5.9 0.4 0.1 0.5 0.6 0.6 17.7 0.7 3.0 0.9 1.5 4.7 9.2 4.2 0.1 0.3 3.0 7.9 1.9 57.8 11.6 1.4 0.2 1.8 0.0 32.8 0.2 0.6 1.2 1.1 2.5 1.3 1.0 0.4 0.0 0.1 10.1 40.9 2.3 0.0 0.0 0.4 20.7 1.8 0.5 1.8 3.7 0.0 11.6 0.0 5.5 46.4 0.1 1.0 1.2 0.3 0.2 0.0 29.5 18.6 20.2 0.0 0.4 1.1 101.7 4.1 0.8 0.3 0.3 2.7 0.2 2.7 0.2 SHROOM3 "APXL3, KIAA1481, SHRM, ShrmL" ENSG00000138771 "Shroom family member 3" Q8TF72 4 76435229-76783253 "Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 313.1;Distal enterocytes: 154.5;Endometrial ciliated cells: 182.9;Glandular and luminal cells: 350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 40.8;AF22: 38.2;BJ hTERT+: 36.9;EFO-21: 39.9;OE19: 40.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047784 Enhanced NA NA "HPA047784: AB_2680155" "unprognostic (1.96e-1)" "unprognostic (2.50e-1)" "unprognostic (1.57e-2)" "unprognostic (5.33e-2)" "unprognostic (1.61e-2)" "unprognostic (3.33e-2)" "unprognostic (7.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (2.90e-1)" "unprognostic (1.45e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.64e-13)" "unprognostic (2.87e-2)" "unprognostic (2.25e-1)" "unprognostic (9.06e-2)" "unprognostic (1.87e-2)" 1.0 2.0 1.6 6.2 1.9 0.1 15.5 12.0 2.8 5.9 14.4 20.2 15.3 3.1 14.0 17.7 15.9 17.9 3.9 0.8 6.0 7.1 6.3 8.6 0.4 5.2 3.1 1.0 0.6 6.5 13.0 3.4 4.4 5.8 9.1 17.4 9.8 25.9 6.3 0.1 2.8 14.8 9.8 5.8 6.2 22.1 0.7 1.5 0.9 3.5 0.1 2.4 4.9 2.3 3.0 40.8 7.9 38.2 25.2 0.0 0.6 1.4 12.4 36.9 0.8 1.6 6.8 26.3 0.6 39.9 34.6 3.0 20.4 5.1 17.8 0.7 0.1 6.7 0.0 7.5 0.0 0.2 0.0 0.0 0.3 4.3 1.3 6.7 9.7 0.7 0.3 0.0 9.7 0.8 3.6 0.7 0.1 16.0 40.5 4.7 3.5 6.3 6.3 6.0 0.9 15.0 19.9 5.2 28.2 2.1 23.2 6.8 0.2 0.0 6.5 5.5 0.2 5.4 12.0 13.3 0.1 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 12.0 2.8 0.8 6.0 5.2 3.1 1.0 5.8 5.8 1.5 3.0 0.6 89.8 53.4 313.1 1.0 0.9 5.8 14.0 2.8 35.8 69.9 46.1 11.0 81.5 40.0 35.0 75.0 0.4 0.6 154.5 0.0 33.6 7.1 182.9 27.1 2.1 86.9 2.7 54.5 36.4 0.7 4.7 103.0 350.1 0.0 11.9 0.7 42.2 0.2 1.7 19.1 104.0 30.5 1.6 0.3 3.2 0.3 1.8 3.6 29.0 1.6 7.2 0.0 6.0 2.1 73.8 92.3 0.0 0.3 35.8 102.7 6.8 65.7 31.1 0.0 0.3 7.4 3.4 2.4 3.5 0.3 0.1 1.7 0.3 70.5 11.9 ANXA3 ANX3 ENSG00000138772 "Annexin A3" P12429 4 78551747-78610451 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Phospholipase A2 inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 340.8" "Cell type enhanced" "Detected in many" "Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 320 "neutrophil: 207.7" "Lineage enriched" "Detected in single" 327 "granulocytes: 207.7" "Cell line enhanced" "Detected in many" "A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8" "Low region specificity" "Detected in all" "HPA013398, HPA013431" Enhanced Supported "Plasma membrane" NA NA 6400000 "Plasma membrane" "HPA013398: AB_1844861, HPA013431: AB_1844862" "unprognostic (2.66e-1)" "unprognostic (5.65e-3)" "unprognostic (4.92e-3)" "unprognostic (8.67e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-3)" "unprognostic (4.17e-2)" "unprognostic (1.87e-1)" "unprognostic (5.09e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (4.82e-2)" "prognostic favorable (8.48e-6)" "unprognostic (2.23e-1)" "unprognostic (2.02e-2)" "unprognostic (7.20e-2)" "unprognostic (3.30e-2)" 47.0 3.2 17.6 22.9 16.8 340.8 44.2 15.2 22.9 19.8 13.3 27.9 16.0 12.6 3.7 55.6 17.0 17.5 36.0 15.0 22.9 25.1 3.9 145.6 2.4 20.0 16.5 13.6 2.5 32.9 34.3 5.9 82.1 21.6 68.6 27.0 1.7 120.5 13.0 28.6 10.0 13.4 20.3 15.0 21.8 91.3 1.9 19.3 7.2 84.5 37.1 12.8 10.3 15.8 17.0 419.5 77.7 1.3 0.9 1.0 0.9 0.6 4.9 0.4 11.0 10.9 403.5 563.7 0.1 334.7 14.4 0.4 161.6 0.1 300.0 16.0 1.4 3.3 36.4 142.0 23.9 45.9 5.9 0.2 2.4 262.6 4.1 566.3 60.1 118.9 9.0 0.7 0.3 1.9 15.9 1.7 0.2 13.0 502.1 55.4 0.0 0.8 0.0 477.8 45.2 0.3 0.3 235.5 58.2 16.6 186.1 9.9 4.3 153.2 0.6 52.6 0.2 93.0 3.1 5.1 2.2 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 207.7 0.1 0.6 0.1 0.0 2.9 17.6 16.8 15.2 22.9 15.0 22.9 20.0 16.5 13.6 21.6 15.0 19.3 17.0 322.7 589.7 47.3 0.0 1.1 24.9 81.8 144.9 1.8 0.2 27.6 85.9 8.6 55.8 175.2 38.6 0.0 212.6 1.0 35.4 17.6 434.5 1.1 33.7 4.4 84.6 5.4 3.2 0.9 305.3 106.2 16.9 99.9 58.1 5.1 0.1 23.2 0.6 18.9 0.0 0.3 33.4 122.1 0.3 0.3 0.3 3.1 6.9 5.4 42.2 21.0 1.2 0.0 1.0 0.6 754.2 61.6 0.4 0.6 158.6 11.5 5.5 89.6 0.4 0.0 7.6 18.7 1.1 0.6 21.9 6.7 62.8 2.3 1.3 29.7 46.7 PPA2 FLJ20459 ENSG00000138777 "Inorganic pyrophosphatase 2" Q9H2U2 4 105369077-105474067 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030888, HPA031671, HPA031672" Supported Approved Mitochondria NA NA 150000 Mitochondria "HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988" "prognostic unfavorable (2.98e-4)" "unprognostic (5.64e-2)" "prognostic favorable (6.60e-4)" "unprognostic (9.26e-3)" "unprognostic (2.93e-2)" "unprognostic (5.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.44e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.27e-11)" "unprognostic (3.69e-1)" "unprognostic (1.94e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" 7.5 12.9 25.5 9.1 26.2 22.2 12.1 26.1 54.1 7.4 30.2 17.5 14.3 7.5 12.6 10.9 8.5 8.1 24.5 25.2 28.5 20.9 14.9 7.6 8.4 26.1 26.2 25.4 5.9 11.9 11.8 7.8 7.4 26.4 13.4 14.1 13.7 13.9 5.8 27.8 12.3 13.9 6.9 26.1 10.0 12.7 6.4 26.5 7.1 11.6 35.8 8.8 8.1 6.7 28.0 20.6 8.5 18.5 32.3 11.3 9.1 12.9 10.2 15.7 14.6 9.9 22.2 30.4 15.6 14.5 9.7 11.3 9.5 39.2 18.7 17.0 23.6 11.8 13.5 13.7 19.9 9.3 36.7 13.6 9.7 19.6 9.9 7.9 15.4 14.6 28.4 22.3 22.0 12.5 26.2 32.5 26.6 13.9 42.4 28.3 28.2 10.9 17.9 49.7 14.7 17.8 10.7 7.8 48.9 19.0 10.7 24.8 32.1 6.9 9.2 19.2 8.9 20.0 19.0 27.3 18.4 17.5 18.6 14.1 27.0 20.9 15.4 21.0 30.1 18.6 28.5 21.7 23.7 49.9 22.6 21.1 23.9 9.5 36.4 26.4 25.9 23.4 23.5 25.5 26.2 26.1 54.1 25.2 28.5 26.1 26.2 25.4 26.4 26.1 26.5 28.0 26.7 9.6 67.3 86.2 37.6 50.0 82.4 205.0 38.1 29.7 64.8 40.9 63.3 45.8 126.2 33.1 16.7 119.0 25.9 73.3 264.1 114.0 113.7 42.3 35.3 36.3 65.7 70.2 138.2 120.1 98.5 31.1 37.2 42.3 45.6 26.4 24.3 64.2 83.5 21.9 134.6 104.6 142.4 42.9 86.1 126.4 27.7 47.1 76.5 74.9 50.5 39.2 30.9 169.9 145.7 65.0 90.4 32.4 41.9 68.1 112.2 285.4 90.7 22.6 39.5 46.3 43.6 50.8 10.8 59.1 57.7 84.7 34.3 72.1 138.0 94.6 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105349-103198445 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 10.1;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011110, HPA042294" Enhanced Enhanced "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA011110: , HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 0.4 0.2 0.4 2.7 0.4 10.1 0.6 0.2 0.5 0.4 0.4 1.8 1.5 0.6 0.0 2.0 0.2 0.8 0.2 0.3 0.6 0.2 0.5 0.8 5.7 0.5 0.5 0.3 0.1 0.1 0.3 0.0 1.4 0.7 0.3 2.0 0.4 0.3 0.2 0.0 2.0 1.7 1.2 0.3 1.2 1.1 4.2 0.5 9.3 0.2 0.6 4.9 0.8 0.6 0.8 42.6 11.8 42.2 20.5 2.7 6.2 8.4 36.7 18.2 26.9 17.9 19.6 22.2 28.6 9.2 13.7 19.2 18.2 30.3 15.1 42.2 35.9 11.3 33.5 26.8 13.6 0.4 39.9 18.6 1.8 1.1 21.7 18.0 6.0 22.9 25.2 34.4 32.5 34.8 15.6 31.5 18.9 13.8 17.0 17.9 20.9 38.5 9.3 8.0 8.4 19.3 11.5 32.9 22.9 9.0 16.0 12.9 13.9 26.1 25.8 27.2 27.2 38.6 15.9 28.6 28.8 14.2 21.7 27.8 2.9 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.3 1.5 0.2 0.6 0.0 0.4 0.4 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.7 0.3 0.5 0.8 1.4 3.2 2.2 1.0 6.6 3.6 1.5 2.9 0.0 7.6 1.8 2.7 1.9 0.0 1.3 0.0 8.4 12.7 3.9 4.7 0.0 0.5 7.7 3.5 5.7 4.2 1.2 75.1 2.0 0.0 28.4 6.5 4.6 6.9 7.0 32.0 4.2 0.9 14.1 0.0 1.9 4.3 4.1 10.4 5.7 3.5 0.9 9.6 0.0 0.0 6.0 1.3 2.1 0.5 3.1 1.8 1.4 2.6 16.0 1.4 0.8 0.3 0.3 2.6 0.0 5.7 7.4 75.3 51.0 8.3 2.8 3.6 6.6 7.0 11.6 1.9 GSTCD FLJ13273 ENSG00000138780 "Glutathione S-transferase C-terminal domain containing" Q8NEC7 4 105708778-105847725 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046160, HPA061782" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA046160: AB_10961048, HPA061782: AB_2797265" "unprognostic (4.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.06e-3)" "unprognostic (4.44e-3)" "unprognostic (6.44e-2)" "unprognostic (6.43e-2)" "unprognostic (1.84e-3)" "unprognostic (4.30e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-2)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (8.59e-2)" "unprognostic (2.68e-1)" "unprognostic (1.32e-2)" "unprognostic (7.02e-2)" 2.7 2.4 1.8 3.9 2.2 5.3 5.6 3.7 2.1 3.7 4.9 3.8 2.6 3.6 2.8 5.0 4.4 3.6 2.3 1.6 2.0 4.4 2.5 2.7 4.6 1.9 2.2 1.6 3.0 3.2 3.5 2.3 3.7 2.1 3.9 4.1 7.4 2.2 3.6 2.1 3.4 3.0 4.1 1.6 2.8 3.3 10.9 1.7 4.7 5.4 2.7 5.2 2.4 2.2 3.2 11.2 10.0 22.2 19.5 5.8 7.4 16.6 15.5 7.9 18.6 16.6 9.2 21.0 13.2 7.7 6.5 10.8 8.9 25.8 16.0 26.3 19.9 7.2 10.7 9.5 12.6 2.5 20.7 7.4 4.0 8.0 17.2 13.1 7.0 11.6 13.2 22.0 11.7 16.0 9.1 21.9 7.7 12.2 16.4 11.5 14.9 13.1 7.4 20.4 8.0 18.0 8.1 11.9 17.2 6.6 19.5 15.3 8.3 8.8 13.8 14.4 8.6 12.2 4.4 10.1 7.4 8.6 10.4 19.4 0.7 0.8 0.4 0.9 1.1 1.0 1.0 0.8 0.3 1.0 1.1 0.9 1.5 5.5 1.4 1.4 1.3 0.1 0.7 1.8 2.2 3.7 2.1 1.6 2.0 1.9 2.2 1.6 2.1 1.6 1.7 3.2 5.8 6.4 3.9 32.7 5.2 2.5 3.6 2.4 2.2 22.3 10.4 4.8 3.3 8.6 1.9 9.2 27.1 6.1 2.6 5.6 3.9 5.8 120.2 7.7 8.1 4.6 4.2 12.8 32.0 5.0 8.1 5.0 6.6 9.9 2.5 9.3 3.6 8.0 7.7 21.9 32.2 4.4 2.0 5.1 3.1 52.4 8.4 4.2 5.4 9.4 4.2 7.3 3.1 53.8 35.4 6.8 1.3 4.5 7.1 3.8 1.7 5.0 2.4 21.4 0.0 5.4 4.9 11.2 7.5 6.4 4.3 3.3 2.9 6.3 6.1 2.0 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 15.3 11.1 13.3 11.0 13.8 30.7 20.4 15.4 18.1 14.2 12.5 14.9 18.2 14.8 17.9 13.6 13.3 12.8 19.1 13.1 15.7 18.8 22.8 16.5 14.2 12.7 14.0 13.0 11.7 12.7 17.4 10.4 12.0 13.4 18.3 15.8 17.4 14.6 13.5 26.7 14.1 15.6 17.3 12.6 12.7 15.2 14.1 14.4 20.0 20.1 26.2 17.1 15.7 11.3 14.2 24.4 12.8 28.5 29.8 27.5 32.6 20.8 28.2 29.1 34.7 35.9 18.1 26.9 34.9 15.4 31.9 26.9 13.8 31.7 40.7 42.8 36.9 19.0 26.3 19.6 25.7 44.3 46.7 23.0 31.0 51.7 34.5 51.4 22.5 32.3 29.1 39.8 26.7 37.8 25.6 55.3 28.9 12.4 35.3 19.5 28.0 31.0 26.8 32.5 16.3 30.7 24.6 19.8 32.6 31.0 22.4 26.4 27.2 21.3 22.7 23.3 24.8 30.5 40.8 40.9 52.2 25.3 31.5 46.0 64.0 23.7 38.5 25.7 26.6 28.9 33.0 29.4 29.4 27.7 32.1 30.6 28.3 17.9 42.9 28.3 42.6 34.8 21.9 13.3 13.8 15.4 18.1 13.1 15.7 12.7 14.0 13.0 13.4 12.6 14.4 14.2 19.0 12.8 11.8 14.0 15.1 11.0 11.8 25.8 15.4 10.5 12.1 11.7 18.7 11.5 12.9 3.7 10.4 16.1 13.6 8.3 43.0 25.2 35.8 8.1 11.2 16.8 6.0 15.6 13.8 20.3 18.6 10.8 8.6 8.7 24.7 9.9 11.7 9.3 17.8 10.1 15.7 5.2 30.5 9.0 9.5 28.4 12.2 9.8 7.2 9.4 15.5 14.0 21.6 27.2 19.1 20.5 6.8 8.2 18.9 14.2 16.5 17.1 6.2 9.3 0.0 12.9 20.1 13.4 16.2 14.1 10.4 18.3 13.0 14.9 10.2 11.0 ENPEP "CD249, gp160" ENSG00000138792 "Glutamyl aminopeptidase" Q07075 4 110365733-110565285 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 164.9;kidney: 90.9" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 41.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005128 Enhanced NA NA 55000000 "HPA005128: AB_1844795" "unprognostic (2.73e-3)" "unprognostic (2.84e-3)" "unprognostic (5.16e-3)" "unprognostic (3.48e-1)" "unprognostic (2.90e-1)" "unprognostic (8.74e-2)" "unprognostic (3.34e-2)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.47e-2)" "unprognostic (4.49e-3)" "unprognostic (3.43e-3)" "unprognostic (1.52e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-3)" 11.7 2.2 0.8 1.5 0.5 0.1 4.9 0.6 2.3 1.4 1.6 1.2 37.0 13.0 4.1 1.7 2.4 4.5 4.1 0.6 0.6 90.9 29.2 4.7 0.8 0.8 0.6 0.4 1.2 1.3 45.5 1.2 15.6 0.6 1.9 0.8 0.0 1.2 1.2 2.3 0.6 164.9 10.6 0.6 9.3 1.2 0.5 0.5 4.4 5.0 9.0 0.3 2.6 1.6 0.9 0.0 0.2 0.0 0.0 0.1 0.1 2.7 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.8 0.3 0.3 0.1 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.1 0.0 1.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.6 2.3 0.6 0.6 0.8 0.6 0.4 0.6 0.6 0.5 0.9 10.7 0.0 2.0 1.6 1.1 1.7 0.1 0.0 0.0 0.0 0.2 0.1 3.9 0.0 0.3 11.0 0.0 37.0 0.0 1.5 17.6 0.0 0.5 3.1 40.7 2.2 1.8 0.0 7.3 0.0 3.5 15.4 0.0 2.3 0.0 0.0 1.4 31.4 2.7 0.0 2.9 28.4 2.0 1.0 1.9 0.2 0.6 1.1 0.0 1.0 0.0 0.0 1.0 0.0 0.8 0.0 31.6 0.4 0.1 0.2 663.2 177.6 1.7 0.0 157.8 0.8 54.1 0.0 0.2 0.1 1.0 58.6 1.9 0.5 42.1 0.1 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 41.2" "Cell type enhanced" "Detected in many" "Granulosa cells: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favorable (9.93e-4)" 6.5 6.7 3.9 8.5 3.9 10.9 10.6 4.3 5.4 7.7 4.0 35.6 41.2 7.7 5.1 7.4 7.7 9.4 5.5 3.9 4.1 11.6 18.2 7.8 9.7 3.6 3.7 3.6 8.4 13.5 4.9 4.2 4.8 3.8 9.1 31.9 3.0 8.7 6.6 3.3 10.8 37.1 7.4 3.9 8.1 15.9 1.8 3.7 11.6 8.6 2.4 7.7 8.2 7.1 4.3 26.6 8.4 16.5 14.8 11.0 11.2 24.3 15.3 9.2 12.4 13.4 13.8 50.3 2.7 16.4 14.7 17.3 12.1 19.7 21.8 8.4 43.5 13.0 22.8 7.1 12.9 9.4 23.5 15.7 12.6 15.1 12.4 2.8 17.1 22.9 30.1 29.9 76.1 19.2 13.7 62.0 14.4 12.7 17.1 16.1 20.5 10.8 13.3 39.6 24.8 17.2 13.2 15.0 25.7 8.8 19.6 11.0 8.0 20.3 12.8 14.6 6.6 16.7 11.4 23.0 2.8 17.1 26.9 7.1 16.3 6.9 8.9 6.3 6.9 7.0 6.1 23.8 12.3 8.8 8.6 28.0 16.1 1.4 7.5 11.2 11.6 24.8 9.4 3.9 3.9 4.3 5.4 3.9 4.1 3.6 3.7 3.6 3.8 3.9 3.7 4.3 10.5 16.0 14.6 5.2 7.7 10.8 10.2 26.7 12.0 6.9 23.6 16.0 4.1 28.6 23.2 20.2 6.2 20.9 7.6 54.0 9.8 40.8 2.6 19.8 9.5 12.2 59.2 19.7 6.4 46.4 41.1 13.4 18.3 23.3 10.1 112.3 9.7 20.4 19.8 0.0 7.3 53.9 32.6 8.7 9.3 1.7 12.8 14.5 1.8 2.8 17.9 16.0 6.2 5.5 5.8 45.9 52.5 9.8 8.8 7.4 71.7 35.7 18.6 1.3 6.6 7.6 12.3 1.9 8.6 10.8 11.6 5.7 17.5 12.4 74.2 8.0 LEF1 "TCF10, TCF1ALPHA, TCF7L3" ENSG00000138795 "Lymphoid enhancer binding factor 1" Q9UJU2 4 108047545-108168956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "lymphoid tissue: 352.4" "Cell type enhanced" "Detected in many" "Melanocytes: 33.8;Microglial cells: 145.2;T-cells: 70.3" "Cancer enhanced" "Detected in all" "melanoma: 25.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 142.6" "Lineage enriched" "Detected in many" 4 "T-cells: 142.6" "Group enriched" "Detected in many" 5 "JURKAT: 579.6;MOLT-4: 569.0;REH: 454.8" "Region enhanced" "Detected in all" "thalamus: 22.6" "Low region specificity" "Detected in all" "HPA002087, CAB019405" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB019405: AB_823558, HPA002087: AB_1079245" "unprognostic (1.03e-3)" "unprognostic (7.36e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.37e-5)" "unprognostic (9.08e-2)" "unprognostic (5.24e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (1.77e-1)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.47e-6)" "unprognostic (1.12e-1)" "unprognostic (5.22e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-2)" 0.8 12.8 14.0 13.9 6.9 11.7 2.0 6.4 8.0 4.0 13.2 1.5 0.7 8.1 4.8 3.2 5.2 4.0 0.2 5.6 9.8 2.5 0.3 3.3 31.6 8.9 10.8 2.7 1.1 0.1 0.3 1.0 11.1 8.5 3.8 1.4 0.5 1.0 1.0 0.1 2.8 4.1 3.9 5.1 9.9 1.5 12.4 19.8 352.4 3.1 0.1 23.0 5.6 3.0 11.4 0.1 0.0 8.0 0.0 0.0 0.0 0.0 0.2 7.2 1.8 4.7 27.1 0.0 0.0 0.1 0.0 2.5 0.2 7.9 0.0 3.7 0.3 17.6 6.9 0.0 0.0 0.0 23.6 2.9 0.4 0.4 0.0 0.7 3.5 0.0 579.6 14.2 0.0 2.6 1.0 569.0 0.0 1.7 6.3 1.4 454.8 9.1 0.2 2.4 1.3 3.0 5.2 0.0 0.5 83.8 6.7 2.4 0.2 0.0 11.9 10.3 0.0 15.3 38.3 17.0 100.9 7.8 0.0 48.4 0.3 0.2 0.0 8.2 0.0 1.6 0.6 68.3 29.9 0.1 0.9 142.6 102.2 1.9 32.9 0.3 0.5 97.7 36.8 14.0 6.9 6.4 8.0 5.6 9.8 8.9 10.8 2.7 8.5 5.1 19.8 11.4 1.4 3.2 1.9 2.0 4.4 3.3 1.4 1.0 24.5 0.1 0.4 5.0 1.6 0.0 0.7 0.0 0.0 0.1 6.2 0.0 13.7 0.0 4.2 5.8 22.3 22.0 0.0 9.2 0.2 0.0 0.2 2.1 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.2 4.1 0.3 1.4 7.9 0.6 2.0 33.8 145.2 3.5 0.6 10.3 0.5 0.6 0.1 0.0 0.0 5.4 1.8 0.0 0.5 2.3 0.3 0.0 0.6 9.0 16.1 6.6 11.3 1.3 0.4 70.3 0.0 0.9 0.4 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035174 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Oxidoreductase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 282.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 272.4;Proximal enterocytes: 383.0;Proximal tubular cells: 318.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Enhanced Supported Mitochondria No Yes 1000000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 144.3 54.6 22.5 21.1 23.4 27.6 75.6 24.8 26.6 38.2 30.6 102.2 85.1 50.2 25.1 34.5 56.7 24.2 177.2 21.9 30.4 141.5 227.3 23.1 22.4 25.1 24.1 20.9 54.8 42.5 40.5 18.2 13.8 25.1 35.7 91.6 10.5 56.4 42.8 252.0 26.6 89.8 73.4 25.2 18.1 61.2 28.2 25.4 76.7 38.1 282.8 28.8 34.4 28.9 27.3 32.2 27.9 64.3 46.2 149.2 48.2 27.0 43.1 68.5 49.6 48.9 21.2 60.9 185.0 23.5 38.8 34.6 42.0 85.5 64.5 55.5 49.6 37.2 39.9 50.5 48.9 24.3 88.2 17.0 50.4 34.1 35.1 32.3 41.4 34.4 127.1 53.1 98.7 57.3 58.9 163.6 36.7 29.0 147.8 30.1 113.5 84.3 89.2 54.5 129.4 73.2 43.1 41.1 161.9 45.6 37.0 77.4 70.8 20.6 35.5 18.9 48.5 26.7 52.1 63.3 80.6 47.0 60.2 27.0 0.0 11.1 11.4 17.2 14.2 22.1 31.4 19.5 20.7 36.8 27.1 22.4 22.2 1.2 36.7 20.1 41.7 17.7 16.3 22.5 23.4 24.8 26.6 21.9 30.4 25.1 24.1 20.9 25.1 25.2 25.4 27.3 17.3 28.9 33.8 11.1 25.7 15.6 54.2 65.8 41.5 6.9 46.5 56.1 225.6 52.9 48.1 35.0 4.2 41.0 18.3 164.7 160.4 43.3 196.8 41.4 22.6 17.5 32.4 65.6 15.1 32.2 44.7 28.2 52.5 26.1 10.8 63.9 21.0 272.4 116.5 6.7 18.9 93.3 36.7 37.8 11.8 108.5 46.3 25.3 21.4 12.2 15.3 26.8 8.2 9.5 9.9 23.0 100.8 35.3 32.0 33.9 383.0 318.8 70.8 6.8 39.5 21.7 38.2 22.4 20.3 64.0 18.2 17.0 19.6 66.3 194.2 49.1 EGF ENSG00000138798 "Epidermal growth factor" P01133 4 109912883-110013766 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 111.2;pancreas: 90.3;skeletal muscle: 29.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 12.9;Breast myoepithelial cells: 8.1;Cardiomyocytes: 8.2;Distal tubular cells: 7.9;Excitatory neurons: 8.5;Inhibitory neurons: 11.2;Muller glia cells: 26.2;Skeletal myocytes: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;SK-BR-3: 11.6;U-251 MG: 3.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 209000 680000 "unprognostic (2.83e-2)" "unprognostic (1.02e-2)" "unprognostic (8.50e-3)" "unprognostic (1.88e-3)" "unprognostic (4.24e-2)" "unprognostic (1.64e-3)" "unprognostic (5.06e-4)" "unprognostic (8.30e-2)" "unprognostic (2.21e-3)" "unprognostic (4.25e-2)" "unprognostic (1.80e-2)" "unprognostic (2.95e-1)" "unprognostic (7.72e-3)" "unprognostic (4.64e-5)" "unprognostic (2.63e-1)" "unprognostic (9.80e-5)" "unprognostic (3.92e-3)" 0.0 0.0 1.2 0.1 1.0 0.2 14.8 0.4 0.8 0.0 0.2 0.8 0.0 0.4 2.5 0.7 0.3 1.0 2.9 1.0 2.6 111.2 0.0 0.5 0.0 1.4 1.0 0.9 0.0 90.3 0.2 0.4 0.0 1.5 1.4 1.1 13.7 15.8 0.4 29.9 0.7 0.2 0.5 1.0 0.1 0.0 0.2 0.9 0.0 3.0 17.6 0.0 0.4 0.1 1.9 0.2 0.2 1.9 0.0 0.0 0.1 0.0 0.4 1.1 0.5 0.4 0.1 0.0 0.0 6.4 0.6 1.6 0.0 0.3 0.0 0.4 0.0 0.3 0.1 0.6 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.1 0.6 0.1 0.0 0.0 2.3 0.0 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.0 11.6 0.4 1.2 2.8 0.0 0.0 0.9 1.3 0.0 3.6 0.0 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.2 1.0 0.4 0.8 1.0 2.6 1.4 1.0 0.9 1.5 1.0 0.9 1.9 0.1 0.0 0.0 3.3 0.0 1.0 0.2 0.1 0.0 1.0 12.9 8.1 8.2 0.0 0.5 0.0 0.0 0.0 0.2 2.0 7.9 0.2 5.6 0.2 0.1 0.6 0.0 0.0 8.5 5.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 11.2 0.1 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.3 26.2 0.0 1.5 0.3 1.0 0.4 0.0 0.0 1.1 0.1 1.2 1.0 1.2 0.0 8.2 0.2 0.5 0.4 0.0 1.4 0.0 0.1 0.1 1.6 0.3 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720234 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 444.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 321.8;eosinophil: 359.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 359.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 13000 "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA049781: AB_2680879" "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favorable (9.14e-4)" "prognostic favorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 26.6 14.3 42.4 31.1 48.6 26.3 50.4 50.8 47.4 50.1 33.1 20.6 16.2 47.6 43.4 36.6 48.9 26.6 16.0 47.2 47.4 32.0 10.4 44.8 33.2 56.3 47.1 41.5 29.5 49.8 27.1 15.9 17.3 54.9 41.5 25.0 22.5 66.5 26.2 6.2 50.1 16.0 33.9 58.2 17.6 63.4 17.1 48.8 35.8 20.5 10.0 52.1 32.0 23.9 73.1 33.6 29.7 49.1 62.1 59.1 74.0 39.6 42.4 77.2 39.4 53.1 45.7 46.7 51.3 26.0 76.1 30.4 40.7 46.8 81.6 50.5 124.2 35.5 60.4 62.6 103.0 32.3 93.0 99.8 61.7 41.2 45.7 37.1 95.2 88.7 63.9 13.6 97.0 111.6 50.7 77.3 28.2 52.6 35.3 33.1 62.4 78.0 15.0 59.6 45.6 55.5 81.4 42.9 63.3 51.9 61.9 37.9 14.1 52.9 49.3 51.0 33.6 35.4 76.9 57.2 48.7 60.1 69.3 79.2 321.8 49.9 359.8 15.6 56.2 18.8 44.8 21.2 18.0 51.4 26.4 13.2 14.9 55.5 27.6 60.8 9.8 39.9 36.7 42.4 48.6 50.8 47.4 47.2 47.4 56.3 47.1 41.5 54.9 58.2 48.8 73.1 19.7 96.1 20.2 41.4 25.4 32.0 36.3 73.2 33.6 19.9 48.4 41.5 7.4 50.1 92.3 57.0 10.4 20.6 7.0 10.5 17.6 36.8 6.2 124.2 84.6 25.1 23.4 15.3 112.2 44.7 48.7 35.2 62.2 444.3 42.5 25.0 20.3 10.2 55.1 30.3 64.7 17.5 32.6 46.5 27.8 6.7 18.0 53.5 60.5 29.0 37.4 35.0 10.3 100.0 150.3 33.6 9.1 25.6 86.4 29.1 6.9 28.8 110.0 13.3 26.3 45.2 29.1 19.6 14.7 62.9 40.9 8.9 22.2 19.2 14.8 29.4 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 88.1;Oligodendrocytes: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles NA NA 14000 "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 18.3 13.8 7.1 13.3 7.5 28.2 17.6 14.8 10.0 16.4 13.8 14.6 14.2 17.1 13.0 17.4 15.1 13.9 15.8 6.6 9.1 16.8 46.5 14.9 14.0 7.7 7.4 6.0 21.6 18.8 22.1 11.3 20.8 8.7 15.7 16.2 32.9 14.4 16.2 28.3 19.8 12.8 18.1 6.7 14.8 13.4 11.4 8.1 27.5 18.7 23.1 16.8 17.7 16.2 9.7 21.1 18.9 29.3 22.1 34.9 34.7 16.8 27.0 32.8 22.5 19.8 17.4 23.8 19.4 13.8 41.1 19.3 17.4 33.2 26.9 33.0 24.0 16.6 20.3 16.6 19.2 23.4 27.0 22.9 34.4 33.7 25.8 30.8 31.8 33.7 19.7 31.5 17.3 33.6 17.1 39.2 12.5 11.2 26.1 15.0 25.1 25.9 11.3 27.1 25.8 20.6 16.5 20.8 43.8 16.0 30.0 12.9 10.3 31.3 26.2 17.6 23.1 19.5 16.6 22.3 18.1 23.3 10.7 21.5 6.1 9.5 11.5 8.6 10.4 9.5 10.3 9.5 9.0 11.8 8.9 10.8 9.3 9.2 11.5 10.5 4.6 9.1 9.0 7.1 7.5 14.8 10.0 6.6 9.1 7.7 7.4 6.0 8.7 6.7 8.1 9.7 25.1 25.6 15.4 63.0 23.0 35.4 20.1 11.8 28.5 27.0 12.9 10.8 30.5 14.3 17.4 5.5 6.2 13.3 13.2 22.7 5.9 10.4 4.4 18.7 14.6 22.5 15.6 11.6 71.1 13.1 9.2 16.4 19.9 21.9 11.4 15.9 16.8 29.9 12.3 16.8 84.1 15.6 4.1 17.6 16.8 7.9 20.5 18.7 17.8 88.1 14.5 20.3 13.4 76.9 91.6 12.6 18.7 21.8 21.3 22.5 16.5 9.6 19.6 22.0 13.1 16.3 16.8 14.7 13.6 22.2 36.7 16.1 17.0 9.9 14.4 30.3 C4orf17 DKFZP434G072 ENSG00000138813 "Chromosome 4 open reading frame 17" Q53FE4 4 99511012-99542303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 203 "testis: 20.2" "Cell type enriched" "Detected in some" 11 "Early spermatids: 230.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060374, HPA060564" Uncertain NA NA "HPA060374: AB_2684268, HPA060564: AB_2684319" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 230.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 138.9" "Cell type enhanced" "Detected in all" "Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 94000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 24.9 17.7 48.9 15.8 138.9 17.3 20.7 84.1 120.0 17.2 10.9 19.6 11.7 11.9 13.2 14.6 13.9 13.4 9.2 115.2 63.3 11.3 17.1 20.1 14.8 37.8 31.5 74.9 18.0 9.5 9.0 9.1 13.2 47.1 66.6 16.2 27.9 22.4 38.8 51.6 23.1 13.0 15.6 31.4 14.7 22.6 10.7 37.1 12.9 13.3 29.2 18.5 20.9 16.2 79.5 48.3 33.8 9.3 18.0 50.4 37.9 15.8 51.9 47.8 19.8 21.6 18.3 59.0 22.4 20.9 47.6 25.6 23.5 33.3 69.6 34.9 56.0 15.1 35.4 45.8 25.2 36.8 59.0 17.8 39.6 35.6 45.3 51.4 39.1 38.8 14.5 14.4 61.1 33.5 58.0 12.2 44.2 15.4 55.7 20.7 22.1 83.2 26.5 20.0 38.3 71.5 26.2 43.1 35.4 24.6 12.5 32.3 33.4 42.1 48.7 54.8 44.7 34.7 28.5 31.5 40.1 26.6 31.5 13.1 82.5 31.0 73.5 35.7 33.1 41.6 74.1 33.2 34.8 28.2 62.8 15.5 31.0 123.7 65.1 45.1 51.9 25.3 21.1 48.9 138.9 84.1 120.0 115.2 63.3 37.8 31.5 74.9 47.1 31.4 37.1 79.5 143.3 76.9 58.6 284.1 96.8 168.8 36.2 29.5 34.7 89.8 93.8 51.8 25.0 38.6 21.9 31.3 39.6 39.6 81.4 60.0 33.2 21.3 3.2 39.3 56.2 100.8 127.4 32.0 933.8 31.6 84.0 75.6 59.1 42.8 35.4 22.1 53.2 39.7 38.3 18.5 403.0 44.2 14.2 61.8 135.3 8.4 65.0 58.2 92.5 281.1 64.3 21.2 56.7 348.3 139.1 53.3 115.4 60.9 63.8 127.6 23.9 51.9 25.3 82.9 13.1 66.9 67.5 12.7 26.5 27.9 172.0 27.5 69.1 76.2 55.9 39.5 SLC39A8 BIGM103 ENSG00000138821 "Solute carrier family 39 member 8" Q9C0K1 4 102251041-102431258 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 172.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038832, HPA038833" Approved NA NA "HPA038832: AB_2676226, HPA038833: AB_10670910" "prognostic favorable (6.69e-4)" "unprognostic (1.29e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (6.50e-2)" "unprognostic (9.59e-2)" "unprognostic (6.07e-2)" "unprognostic (2.74e-1)" "unprognostic (1.20e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-3)" "unprognostic (2.78e-2)" "prognostic favorable (6.34e-6)" "unprognostic (3.25e-1)" "unprognostic (6.54e-2)" "unprognostic (6.40e-2)" "unprognostic (7.13e-3)" 26.4 3.5 9.9 29.1 10.0 36.8 18.3 9.8 12.2 85.4 8.9 38.2 6.8 11.1 5.7 3.0 12.0 7.9 16.7 8.2 11.8 18.5 40.3 172.6 13.4 13.2 10.2 6.4 14.1 54.9 42.3 8.1 13.1 13.1 8.5 43.4 6.5 90.1 6.6 1.1 8.6 7.3 9.1 13.1 6.8 7.9 2.7 12.4 14.5 12.4 2.0 12.4 21.0 6.9 11.3 20.2 19.5 4.4 0.1 15.8 35.4 10.1 2.2 158.9 5.8 9.3 0.9 72.5 19.3 21.0 0.6 20.0 1.4 13.5 4.4 3.4 34.1 39.5 51.0 37.5 0.3 6.3 120.9 16.8 19.1 5.0 3.1 9.1 15.4 2.1 47.1 51.6 171.2 30.7 13.4 43.7 55.9 13.0 26.8 19.0 11.0 0.2 63.8 33.3 7.4 5.6 14.0 55.0 1.0 5.3 3.8 13.4 44.4 11.3 19.3 7.3 39.1 31.6 76.3 34.1 90.4 31.0 77.4 18.2 0.0 1.8 1.4 6.3 1.1 10.9 1.8 11.7 10.0 3.3 3.9 8.6 5.9 0.1 13.7 0.4 1.2 5.0 4.2 9.9 10.0 9.8 12.2 8.2 11.8 13.2 10.2 6.4 13.1 13.1 12.4 11.3 16.1 778.8 305.6 15.7 14.5 11.7 9.2 35.9 5.2 2.6 42.8 13.1 21.3 4.3 23.9 5.5 4.2 19.2 14.9 20.3 11.7 1.8 0.7 17.7 5.2 19.8 24.0 46.7 6.6 32.7 217.5 17.4 4.1 40.9 3.8 32.4 5.7 26.1 42.9 3.3 1.5 74.1 6.1 29.8 79.0 0.7 1.2 28.9 28.4 60.9 10.8 5.2 9.2 5.0 1.7 11.8 26.2 1.2 56.0 9.6 2.1 17.7 2.9 1.6 6.6 2.6 8.8 2.3 6.0 2.1 7.0 60.6 23.6 31.0 64.3 6.8 MTTP "ABL, MTP" ENSG00000138823 "Microsomal triglyceride transfer protein" P55157 4 99564081-99623997 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 277.4;liver: 268.7" "Group enriched" "Detected in many" 9 "Hepatocytes: 244.2;Proximal enterocytes: 605.4" "Cancer enriched" "Detected in many" 13 "liver cancer: 28.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 10.8;Hep G2: 12.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA051170, HPA054862" Uncertain Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 640000 "Endoplasmic reticulum, Cytosol" "HPA051170: , HPA054862: AB_2682628" "unprognostic (1.66e-2)" "unprognostic (1.14e-1)" "unprognostic (5.64e-2)" "unprognostic (5.33e-2)" "unprognostic (3.49e-3)" "unprognostic (7.38e-2)" "unprognostic (1.05e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (3.66e-2)" "unprognostic (1.00e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (2.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" 0.3 0.1 1.4 0.2 0.9 0.0 0.2 1.0 0.8 0.1 0.3 0.8 245.4 0.1 1.1 0.1 0.6 1.3 0.7 0.7 1.7 13.1 268.7 0.3 0.3 1.1 1.1 0.5 2.0 0.0 0.0 0.5 0.0 1.2 0.5 0.3 5.6 0.1 0.2 0.4 0.1 277.4 0.5 1.1 0.0 0.8 9.7 1.1 0.2 0.1 0.3 0.1 0.9 0.0 1.8 0.0 0.2 10.8 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.2 0.1 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.5 0.1 0.2 0.1 0.1 1.0 0.0 0.0 0.7 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 1.0 0.8 0.7 1.7 1.1 1.1 0.5 1.2 1.1 1.1 1.8 0.1 0.0 0.0 4.6 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.8 4.3 0.1 1.8 0.0 0.2 0.2 0.2 0.0 0.0 44.2 1.0 0.1 0.1 0.0 2.7 1.6 0.0 0.0 0.8 1.5 0.2 0.0 30.1 3.6 244.2 0.1 0.0 0.7 16.7 2.0 3.5 0.0 12.0 0.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.2 12.5 0.4 0.1 0.0 605.4 23.5 1.0 0.0 6.6 0.5 0.5 32.1 5.7 0.0 0.0 0.0 0.4 12.0 21.0 0.0 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "placenta: 82.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 298.1;Syncytiotrophoblasts: 163.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.2" "Lineage enriched" "Detected in single" 5 "monocytes: 2.2" "Cell line enhanced" "Detected in many" "HHSteC: 134.1;HSkMC: 94.3;hTERT-HME1: 215.2;HUVEC TERT2: 122.3" "Region enhanced" "Detected in single" "olfactory bulb: 2.0" "Low region specificity" "Detected in many" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 11000000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.1 5.1 0.6 0.8 0.6 3.2 0.2 0.1 0.2 2.2 2.5 0.8 0.3 1.7 0.1 0.1 0.4 0.3 3.2 0.2 0.5 0.1 0.1 0.2 0.5 1.1 1.7 0.2 0.5 0.2 0.0 0.8 82.6 0.7 0.8 1.2 0.9 0.3 0.4 0.2 0.2 0.4 1.3 0.5 0.4 0.8 7.5 0.7 0.2 0.5 0.4 0.9 0.5 0.7 0.9 0.0 16.4 58.2 0.0 9.4 16.6 11.8 62.8 0.0 56.0 41.8 0.2 0.0 0.0 0.1 85.5 0.0 9.2 37.6 9.8 52.7 0.1 13.8 0.0 27.3 0.2 134.1 8.4 0.0 94.3 5.3 24.1 215.2 17.9 122.3 0.0 0.0 0.0 35.8 0.1 0.0 3.4 24.5 0.0 18.2 19.2 18.1 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.6 48.0 0.0 18.7 0.0 22.1 41.9 66.8 0.3 0.0 0.0 0.0 6.9 0.0 23.8 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.2 0.6 0.6 0.1 0.2 0.2 0.5 1.1 1.7 0.2 0.7 0.5 0.7 0.9 0.1 0.0 0.5 1.6 0.2 0.0 0.1 1.2 0.6 0.0 0.3 0.3 12.7 0.0 1.4 0.0 0.0 298.1 0.0 0.0 0.0 0.3 3.8 10.0 3.9 1.0 0.0 0.0 1.1 0.0 24.3 8.8 0.0 4.7 0.0 0.1 0.0 0.0 34.0 0.0 50.5 0.0 0.0 10.7 0.4 7.2 1.2 2.7 1.8 1.9 6.2 3.8 0.0 17.6 1.5 0.1 0.0 2.2 0.0 2.0 0.0 0.2 1.6 0.1 6.6 0.1 3.5 10.7 3.5 0.1 0.4 163.5 0.1 8.4 0.1 0.1 MAPK8IP3 "JIP3, JSAP1, KIAA1066, syd" ENSG00000138834 "Mitogen-activated protein kinase 8 interacting protein 3" Q9UPT6 16 1706183-1770351 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 62.1;Horizontal cells: 87.5;Inhibitory neurons: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005580, HPA041785, HPA069311" Approved Approved Vesicles NA NA Vesicles "CAB005580: AB_627840, HPA041785: AB_2677671, HPA069311: AB_2686116" "unprognostic (1.49e-1)" "unprognostic (2.22e-1)" "unprognostic (8.28e-3)" "unprognostic (8.32e-2)" "unprognostic (3.90e-1)" "unprognostic (6.83e-3)" "unprognostic (3.66e-2)" "unprognostic (2.41e-2)" "unprognostic (1.55e-1)" "unprognostic (8.67e-2)" "unprognostic (1.57e-2)" "unprognostic (6.91e-3)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (2.45e-1)" "prognostic favorable (3.95e-4)" 24.8 32.5 23.4 13.6 31.6 26.6 26.3 10.9 59.9 36.9 0.0 27.1 13.6 26.1 4.0 20.4 31.9 8.0 39.1 36.1 14.4 34.4 31.0 32.0 16.4 37.8 16.7 34.7 47.2 39.6 7.0 79.2 8.6 33.2 43.9 3.9 11.4 29.0 7.5 22.3 36.3 39.7 4.5 5.4 50.2 26.1 32.3 14.4 11.9 38.6 4.3 6.6 35.5 30.7 39.3 6.5 12.2 12.7 11.4 6.1 10.3 9.9 10.7 4.0 5.2 4.6 17.3 21.0 7.5 6.6 6.7 3.7 12.1 3.1 7.0 1.7 11.9 14.1 10.0 33.6 13.4 8.4 6.5 16.9 20.7 9.2 7.6 3.7 22.9 6.9 14.1 8.6 14.1 5.5 16.6 10.2 28.5 8.5 3.2 6.9 44.1 6.3 12.9 6.4 8.4 26.4 21.0 12.8 11.8 5.3 5.8 6.4 9.1 21.9 21.8 12.2 9.4 8.6 31.4 5.8 9.7 5.7 6.7 11.1 0.0 0.2 0.5 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 23.4 31.6 10.9 59.9 36.1 14.4 37.8 16.7 34.7 33.2 5.4 14.4 39.3 9.1 3.2 7.8 46.7 30.5 9.8 4.3 10.0 13.1 40.8 7.9 7.5 6.6 10.0 10.5 3.7 37.5 5.6 10.4 16.8 1.9 4.9 24.9 13.2 13.0 7.8 10.2 8.6 62.1 3.8 5.7 7.5 34.7 21.9 1.3 23.4 6.4 9.7 7.2 87.5 65.2 11.1 10.2 10.3 12.5 23.4 7.8 13.5 7.2 31.9 8.7 11.9 9.2 32.6 52.8 7.7 9.5 9.1 17.6 4.7 10.3 1.2 15.9 19.2 6.6 7.3 8.2 19.8 5.1 10.8 9.7 5.6 11.8 5.9 11.7 6.0 RGS3 "C2PA, FLJ20370, PDZ-RGS3" ENSG00000138835 "Regulator of G protein signaling 3" P49796 9 113444731-113597743 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endothelial cells: 111.6;Horizontal cells: 158.2;Proximal tubular cells: 195.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 248.4;HDLM-2: 413.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044234 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044234: " "prognostic unfavorable (9.93e-4)" "unprognostic (4.04e-2)" "unprognostic (5.33e-3)" "unprognostic (6.71e-3)" "unprognostic (1.49e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (6.62e-4)" "unprognostic (6.79e-2)" "unprognostic (9.17e-2)" "unprognostic (2.24e-1)" "unprognostic (8.59e-3)" "unprognostic (3.04e-1)" "unprognostic (2.51e-3)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (2.90e-1)" 54.1 31.7 32.3 18.2 36.0 9.4 44.0 31.1 29.9 17.4 47.2 27.8 17.0 21.0 11.5 10.9 15.3 42.8 95.9 22.3 27.3 70.6 54.9 64.8 24.1 29.7 40.8 17.9 10.4 24.1 12.4 16.7 32.6 36.0 26.6 15.9 10.4 10.8 10.3 48.6 14.0 20.2 18.1 26.9 32.2 27.8 31.4 55.8 8.0 24.7 19.4 11.5 26.7 15.5 31.2 4.5 16.6 40.1 37.0 12.2 18.1 2.9 41.2 248.4 32.9 27.9 40.8 14.7 17.9 29.7 33.6 32.8 10.6 0.6 16.0 19.2 413.2 0.1 1.7 13.0 24.8 24.8 0.4 5.5 32.4 16.6 91.4 13.2 72.6 125.4 1.0 0.3 17.1 60.5 18.7 1.2 1.9 10.6 28.6 13.7 1.3 19.8 2.9 67.7 8.1 31.3 4.2 3.9 31.3 24.7 19.6 21.5 3.8 61.2 109.7 11.8 5.1 79.1 8.6 1.5 2.7 126.2 3.8 51.6 10.2 6.8 3.7 24.7 7.1 16.7 2.4 5.7 20.3 6.6 2.4 2.4 10.8 18.5 42.3 6.0 0.3 3.8 15.6 32.3 36.0 31.1 29.9 22.3 27.3 29.7 40.8 17.9 36.0 26.9 55.8 31.2 49.5 16.0 13.9 14.4 5.6 12.0 9.9 7.4 4.6 1.4 9.1 10.7 55.8 72.9 8.4 22.0 6.2 4.6 23.5 28.0 82.2 65.1 38.8 9.9 14.9 111.6 0.0 6.1 2.4 30.4 3.7 29.3 27.0 4.0 47.7 12.8 66.0 35.2 15.6 158.2 3.4 7.4 4.1 14.3 13.8 17.4 4.7 14.6 55.2 21.5 10.3 3.5 50.4 3.5 24.4 31.0 23.4 13.9 4.5 5.0 20.5 195.7 7.5 6.4 6.6 8.4 35.4 9.9 1.8 4.1 11.4 3.0 18.4 55.5 11.5 12.9 GUCD1 "C22orf13, LLN4, MGC1842" ENSG00000138867 "Guanylyl cyclase domain containing 1" Q96NT3 22 24540423-24555935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 161.3;Proximal enterocytes: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022786 Approved Nucleoplasm NA NA Nucleoplasm "HPA022786: AB_1845711" "unprognostic (1.58e-1)" "prognostic favorable (6.84e-4)" "unprognostic (2.83e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.89e-1)" "prognostic favorable (7.26e-4)" "unprognostic (1.28e-1)" "unprognostic (3.55e-2)" "unprognostic (1.76e-2)" "unprognostic (4.36e-2)" "unprognostic (8.63e-2)" "unprognostic (1.59e-1)" "unprognostic (3.01e-2)" 37.3 27.7 19.0 25.6 20.8 90.7 29.4 20.2 17.5 19.8 17.8 37.8 68.1 19.2 16.9 25.4 21.3 25.6 49.4 16.4 19.0 43.4 94.6 34.6 34.9 23.0 23.0 14.9 19.6 37.5 24.3 12.4 21.8 22.4 31.3 36.6 11.0 25.2 20.4 97.4 25.9 60.1 23.3 21.4 30.7 37.5 19.0 21.6 28.1 16.8 118.7 37.2 27.0 20.0 21.8 40.8 37.1 30.9 38.5 62.5 58.4 25.7 38.7 59.5 63.3 61.0 56.9 30.2 72.1 26.0 50.9 39.3 51.2 35.2 43.3 33.6 74.2 45.4 31.3 36.1 51.3 50.6 83.2 63.2 59.6 33.9 64.0 29.0 38.7 67.5 35.9 32.3 75.6 48.4 47.2 49.2 34.1 31.0 95.3 30.6 57.2 52.0 73.1 49.8 44.9 33.8 33.2 47.2 60.6 33.3 23.6 49.6 56.7 48.7 143.4 59.8 44.5 34.6 70.1 53.8 50.8 57.9 45.3 49.9 20.2 14.9 52.5 7.4 14.8 8.5 37.0 7.1 7.7 13.7 42.6 6.7 7.6 15.2 7.5 14.5 9.7 7.6 13.8 19.0 20.8 20.2 17.5 16.4 19.0 23.0 23.0 14.9 22.4 21.4 21.6 21.8 20.5 16.0 33.9 6.8 41.5 12.4 11.8 13.9 21.1 5.3 25.9 18.3 51.2 78.6 13.3 5.5 6.2 18.6 21.2 99.7 52.8 27.1 15.8 13.4 13.6 16.4 19.8 86.1 2.3 66.0 20.1 17.5 35.7 17.9 15.2 19.5 18.5 161.3 27.1 3.3 3.0 52.3 16.2 23.5 12.0 8.6 19.0 21.0 17.8 2.8 28.6 18.2 18.6 5.5 7.5 48.1 72.4 16.1 17.5 32.1 149.6 84.9 9.7 13.2 26.3 12.4 16.7 24.3 32.0 18.7 11.1 16.3 14.6 28.9 36.7 18.9 TTLL8 ENSG00000138892 "Tubulin tyrosine ligase like 8" A6PVC2 22 50015123-50056935 "Predicted intracellular proteins" Ligase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 4.2" "Group enriched" "Detected in some" 42 "Cardiomyocytes: 1.8;Early spermatids: 4.6;Late spermatids: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA016882 Uncertain NA NA "HPA016882: AB_10603223" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (8.18e-2)" "unprognostic (1.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF185 FLJ38628 ENSG00000138942 "Ring finger protein 185" Q96GF1 22 31160182-31207019 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.33e-1)" "unprognostic (3.65e-3)" "unprognostic (4.76e-3)" "unprognostic (2.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.97e-1)" "unprognostic (2.56e-1)" "unprognostic (2.61e-1)" "unprognostic (9.41e-2)" "prognostic favorable (4.82e-5)" "unprognostic (3.04e-1)" "unprognostic (1.63e-1)" "unprognostic (2.86e-1)" "unprognostic (1.10e-1)" 19.9 18.8 22.4 14.5 23.1 10.2 23.1 22.7 25.3 22.4 23.3 22.1 20.7 22.7 25.3 26.1 23.2 16.5 21.3 23.3 23.0 36.5 48.8 19.2 16.3 23.0 22.9 21.0 26.4 19.4 49.2 15.9 21.2 22.7 38.6 22.4 16.7 30.4 29.0 23.6 29.2 22.1 25.8 22.9 16.8 21.9 10.9 24.0 21.2 52.4 25.7 21.4 24.4 23.2 24.3 23.7 13.8 26.1 29.9 51.8 34.5 24.9 27.7 53.3 37.2 50.2 15.6 11.1 22.5 15.2 49.3 32.8 14.6 25.3 28.6 38.1 22.6 27.5 9.8 13.2 19.1 72.5 24.1 14.6 37.1 100.8 26.2 60.2 34.0 31.7 23.5 11.7 26.2 45.2 16.8 20.8 13.5 11.7 48.8 15.2 21.1 26.1 26.5 27.0 20.4 11.6 23.4 20.2 26.5 41.0 26.7 18.4 15.8 22.2 26.1 18.7 30.9 13.6 36.2 31.6 28.4 34.5 15.1 21.4 16.9 15.7 9.0 12.2 15.8 13.6 10.0 12.4 13.8 13.3 8.2 12.5 11.5 22.3 16.9 13.7 4.9 14.6 14.8 22.4 23.1 22.7 25.3 23.3 23.0 23.0 22.9 21.0 22.7 22.9 24.0 24.3 9.3 22.4 12.6 10.7 8.8 9.1 10.3 10.0 9.6 11.0 14.2 10.8 5.5 20.0 11.5 18.4 8.4 13.0 11.3 16.4 21.5 15.1 19.0 8.9 8.2 8.5 16.8 5.0 14.0 14.9 23.2 10.9 8.2 10.3 5.7 8.4 23.2 28.9 14.2 8.4 17.3 15.8 14.2 8.8 7.5 18.3 7.5 10.5 8.8 10.3 10.7 11.9 7.2 13.6 22.5 15.5 12.7 15.8 6.8 14.5 17.7 22.9 12.4 7.8 6.6 9.5 9.3 7.4 9.8 10.6 10.7 37.2 7.2 6.0 7.8 9.8 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243665-44312951 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;endometrium 1: 33.9;smooth muscle: 29.6" "Cell type enriched" "Detected in single" 6 "Endometrial stromal cells: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA051178: AB_2681374" "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 1.0 1.8 18.6 1.3 17.2 0.0 0.2 0.0 13.0 15.4 0.0 13.2 2.0 33.9 0.5 1.6 4.6 3.1 0.7 16.5 12.3 0.2 0.1 0.3 0.4 8.4 17.9 20.1 1.0 0.8 0.1 2.6 0.5 5.8 3.8 2.0 5.6 0.3 11.1 0.0 0.7 2.4 29.6 0.0 0.1 1.6 1.1 49.7 2.6 0.4 0.1 0.8 12.0 5.3 8.9 0.0 0.3 3.5 1.2 0.0 0.0 0.0 1.0 2.3 2.4 1.4 0.0 0.0 0.0 0.0 2.3 14.5 0.0 5.0 0.3 0.3 0.0 2.3 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 1.8 11.2 0.5 0.0 0.0 0.1 0.1 0.0 0.4 0.0 3.3 0.0 0.8 0.0 0.0 0.1 0.0 0.0 12.9 0.0 36.2 0.1 0.2 0.4 0.0 0.3 0.1 13.1 2.0 80.8 0.5 0.0 0.0 0.0 46.3 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 17.2 0.0 13.0 16.5 12.3 8.4 17.9 20.1 5.8 0.0 49.7 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 PARVG ENSG00000138964 "Parvin gamma" Q9HBI0 22 44172956-44219533 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 50.2;lymphoid tissue: 30.3" "Cell type enhanced" "Detected in many" "B-cells: 56.9;dendritic cells: 51.7;granulocytes: 60.1;Hofbauer cells: 66.7;Kupffer cells: 87.3;Langerhans cells: 53.4;Macrophages: 91.9;monocytes: 62.0;T-cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HL-60: 116.4;NB-4: 44.9;THP-1: 64.7;U-937: 53.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031833, HPA031834" Uncertain NA NA "HPA031833: AB_2674063, HPA031834: AB_10601242" "unprognostic (9.83e-3)" "unprognostic (2.30e-2)" "unprognostic (2.06e-1)" "prognostic favorable (4.44e-6)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (3.19e-2)" "unprognostic (7.02e-2)" "unprognostic (2.17e-1)" "unprognostic (3.87e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (3.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.09e-1)" "unprognostic (9.89e-2)" 3.2 2.9 5.5 27.0 4.7 50.2 1.8 5.0 9.6 2.6 5.6 3.2 3.6 2.4 0.7 2.5 2.2 6.3 1.2 5.4 8.1 1.8 3.1 10.5 30.3 7.4 4.9 2.8 0.8 1.5 0.5 1.3 3.0 6.6 2.1 3.5 0.2 2.6 1.1 1.2 1.7 12.8 2.9 6.8 29.2 4.4 1.7 7.3 18.5 1.9 0.4 27.0 4.8 1.5 9.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 116.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 16.8 44.9 0.1 0.0 0.0 9.2 0.2 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 64.7 0.0 0.0 11.5 0.2 0.0 0.3 0.0 0.3 0.0 53.9 1.9 12.5 62.0 71.3 13.9 57.6 13.9 21.4 8.0 15.2 49.2 20.4 8.9 10.3 72.2 13.1 65.9 33.3 12.1 44.6 5.5 4.7 5.0 9.6 5.4 8.1 7.4 4.9 2.8 6.6 6.8 7.3 9.6 1.3 6.4 14.0 1.0 56.9 2.4 0.1 0.0 0.6 0.2 0.7 1.5 1.1 0.0 3.1 0.0 0.0 0.6 51.7 0.1 0.0 0.0 4.2 3.7 0.4 2.9 0.0 10.1 3.9 0.2 0.7 2.3 3.6 2.5 60.1 0.0 3.9 1.3 66.7 0.0 2.9 0.0 0.0 87.3 53.4 2.7 0.0 91.9 5.4 10.3 62.0 0.0 26.8 0.0 1.4 0.0 0.0 0.0 15.9 0.0 0.0 0.5 1.5 0.2 0.0 0.5 0.4 1.1 0.8 0.4 1.8 1.0 48.3 0.0 0.1 0.1 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 459939-563509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 61.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.2 7.0 0.7 3.2 0.7 2.1 1.3 0.0 1.2 7.4 1.0 18.6 1.0 6.2 2.7 7.6 3.7 2.3 24.1 0.7 0.1 4.6 0.1 5.3 0.1 0.3 0.0 0.7 0.4 2.6 17.1 9.3 0.1 0.4 2.0 12.6 0.1 4.8 0.7 1.5 14.7 2.0 2.2 0.0 0.3 61.5 8.1 0.0 2.4 2.3 0.1 0.7 1.5 5.6 1.0 0.0 0.0 0.3 1.2 0.0 0.0 33.5 0.0 0.0 0.0 0.0 8.0 6.6 0.0 0.9 0.0 0.7 3.6 8.0 1.1 0.1 13.2 12.5 0.0 0.0 1.8 0.0 0.1 5.3 0.0 5.3 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.1 14.8 10.5 0.6 0.5 5.0 0.0 7.1 6.8 3.8 2.7 0.8 0.3 1.0 4.9 0.8 2.9 0.0 0.0 2.7 0.2 0.9 0.0 0.0 0.0 0.0 9.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.2 0.7 0.1 0.3 0.0 0.7 0.4 0.0 0.0 1.0 0.0 0.0 7.0 1.3 0.3 7.5 6.0 3.4 0.0 0.6 2.9 0.6 15.1 1.5 6.2 9.2 0.0 0.0 0.6 81.1 0.0 12.0 26.3 20.4 4.8 0.6 10.3 0.0 32.6 4.8 0.1 1.6 128.0 47.4 0.0 0.1 0.0 0.1 0.7 0.0 5.2 18.6 2.0 0.0 1.1 89.2 0.0 0.5 0.0 2.8 0.6 0.0 0.0 1.0 3.6 16.6 33.4 0.0 0.2 12.7 1.9 0.2 9.1 0.2 0.0 0.2 0.8 2.8 1.3 0.9 17.3 0.0 1.5 1.9 26.1 14.4 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973042-14981865 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 192 "retina: 919.2" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 831.9;Rod photoreceptor cells: 218.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.0" "Low region specificity" "Detected in single" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.0 0.4 0.5 0.0 0.6 4.0 0.0 0.4 1.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.1 0.0 0.6 4.7 0.6 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 919.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.4 1.0 0.5 1.7 0.6 4.7 0.6 0.6 0.4 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.1 0.0 0.0 0.0 831.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.5 0.0 21.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 23.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.6 81.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 ERP27 "C12orf46, FLJ32115, PDIA8" ENSG00000139055 "Endoplasmic reticulum protein 27" Q96DN0 12 14914039-14938537 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "pancreas: 1818.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 41.7;Collecting duct cells: 40.5;Distal tubular cells: 164.4;Endometrial ciliated cells: 40.7;Exocrine glandular cells: 39.7;Theca cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RT4: 102.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA039636, HPA052851" Enhanced "Intracellular and membrane" NA NA "HPA039636: AB_10795403, HPA052851: AB_2681972" "unprognostic (9.02e-3)" "unprognostic (2.53e-1)" "unprognostic (1.41e-1)" "unprognostic (4.69e-2)" "unprognostic (8.70e-2)" "unprognostic (3.92e-3)" "unprognostic (2.70e-1)" "unprognostic (1.48e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (2.34e-2)" "unprognostic (1.88e-1)" "unprognostic (7.89e-2)" "unprognostic (4.55e-2)" "unprognostic (8.98e-2)" "unprognostic (1.76e-3)" "unprognostic (3.45e-2)" 0.8 0.8 1.7 3.7 0.3 5.3 6.8 0.0 2.2 6.7 0.2 0.8 1.1 1.1 2.1 1.4 78.1 1.0 1.0 1.4 0.0 23.9 0.6 12.0 5.0 0.0 1.6 0.1 1.6 1818.4 1.4 1.0 2.5 1.9 2.0 1.3 0.7 5.7 2.8 0.3 1.8 2.5 0.8 0.2 4.3 3.8 0.4 0.2 2.5 8.4 0.4 3.9 18.2 0.9 0.6 3.4 0.0 0.0 0.5 0.3 0.0 0.7 0.2 0.0 0.0 0.0 1.1 19.5 1.6 2.0 0.0 0.0 4.0 0.0 0.2 0.0 0.1 0.0 4.5 0.1 19.3 0.0 1.5 2.2 0.1 0.0 0.0 0.0 0.1 0.5 4.9 0.0 0.9 0.0 7.0 3.2 5.9 0.0 0.2 0.0 1.8 0.0 0.4 0.6 102.3 0.1 0.0 0.0 15.8 0.0 1.8 0.7 4.8 2.4 0.3 0.1 0.0 0.0 0.1 0.1 3.1 0.0 1.4 0.0 3.0 3.4 4.1 4.8 3.8 6.3 1.5 4.3 3.4 2.5 1.5 5.4 5.8 1.5 1.3 4.6 0.2 5.9 2.6 1.7 0.3 0.0 2.2 1.4 0.0 0.0 1.6 0.1 1.9 0.2 0.2 0.6 0.5 41.7 20.8 0.0 1.6 0.4 2.7 0.2 0.0 0.2 8.7 2.2 0.2 0.0 17.9 40.5 0.0 5.9 2.4 0.2 164.4 25.0 0.0 40.7 1.1 0.8 1.8 0.0 0.0 39.7 14.1 1.1 0.0 8.7 1.3 0.2 0.4 0.0 1.5 0.0 0.0 0.0 0.0 1.9 1.2 0.0 1.8 1.1 0.0 3.7 2.5 3.1 4.1 0.0 0.0 18.9 3.5 0.0 1.3 1.8 0.0 8.6 18.0 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.4 0.8 3.9 104.3 0.3 14.3 ETV6 TEL ENSG00000139083 "ETS variant transcription factor 6" P41212 12 11649674-11895377 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 137.2;Microglial cells: 216.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 85.1;NB-4: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000264 Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA000264: AB_611466" "unprognostic (4.03e-3)" "unprognostic (3.08e-2)" "unprognostic (7.54e-3)" "unprognostic (2.60e-1)" "unprognostic (2.07e-1)" "unprognostic (1.35e-3)" "unprognostic (2.74e-2)" "unprognostic (4.02e-2)" "unprognostic (3.16e-1)" "unprognostic (9.46e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.66e-8)" "unprognostic (1.33e-2)" "unprognostic (5.99e-2)" "unprognostic (8.92e-2)" "prognostic favorable (1.54e-5)" 13.9 8.8 4.7 16.5 4.5 41.2 20.2 5.1 5.6 9.5 4.4 14.0 7.6 8.0 11.2 9.6 8.0 9.8 6.3 4.2 8.5 8.4 9.3 16.3 12.9 9.2 5.5 3.2 5.0 9.7 5.6 5.4 8.2 6.6 13.6 11.4 2.6 33.6 6.8 5.6 21.0 14.3 9.3 6.2 16.8 8.5 3.5 7.1 17.4 8.9 2.7 14.8 15.2 8.5 7.9 5.6 7.5 6.7 11.6 5.0 4.7 8.1 4.1 6.9 5.2 6.1 0.5 25.9 4.7 4.0 7.0 6.1 7.1 3.0 12.4 6.2 85.1 1.4 29.9 4.0 2.8 6.2 32.0 31.2 9.3 7.5 5.1 10.5 9.9 15.9 21.3 2.3 15.3 4.7 3.6 18.1 45.3 10.9 5.9 2.0 5.1 6.3 12.3 11.9 34.8 1.3 6.8 8.1 7.7 7.7 10.6 2.6 19.9 18.1 11.6 9.8 3.9 8.8 6.7 5.5 2.6 7.6 0.2 13.6 6.2 4.5 5.9 1.1 5.6 1.6 2.3 1.7 1.1 3.5 1.7 1.0 0.6 9.8 2.1 6.8 5.3 1.2 1.2 4.7 4.5 5.1 5.6 4.2 8.5 9.2 5.5 3.2 6.6 6.2 7.1 7.9 38.3 6.4 9.6 84.2 37.7 14.9 31.8 27.2 10.8 3.1 66.7 57.8 9.1 21.5 30.7 14.7 6.2 15.0 21.5 45.7 1.9 17.9 17.6 45.3 17.5 37.5 32.4 33.6 63.6 35.9 4.3 12.9 20.9 69.7 10.8 24.0 38.6 10.9 18.3 0.0 117.7 28.9 22.4 53.3 137.2 4.5 7.8 62.6 28.4 216.4 55.7 4.3 8.2 106.6 37.0 38.6 31.6 10.9 71.4 34.2 15.4 11.5 39.3 3.9 19.7 17.6 34.2 0.6 5.4 17.3 22.4 8.6 20.9 21.5 22.5 71.8 GABARAPL1 "APG8L, ATG8B, ATG8L, gec1" ENSG00000139112 "GABA type A receptor associated protein like 1" Q9H0R8 12 10212458-10223128 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 432.4;Syncytiotrophoblasts: 929.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 62.1" "Group enriched" "Detected in many" 5 "granulocytes: 62.1;NK-cells: 22.6;T-cells: 26.7" "Cell line enhanced" "Detected in many" "HHSteC: 255.7;SiHa: 231.5;SuSa: 557.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051386, HPA065883" Approved Approved Vesicles NA NA Vesicles "HPA051386: AB_2681463, HPA065883: AB_2685574" "unprognostic (9.58e-3)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (1.85e-3)" "prognostic favorable (2.36e-4)" "unprognostic (2.90e-1)" "unprognostic (6.38e-2)" "unprognostic (2.79e-2)" "unprognostic (9.25e-3)" "unprognostic (1.72e-1)" "prognostic favorable (8.19e-8)" "unprognostic (5.42e-2)" "unprognostic (2.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.77e-1)" 173.9 98.6 103.3 33.9 140.4 165.8 152.0 111.1 221.9 73.6 107.2 87.9 41.2 78.4 126.4 44.5 91.8 76.1 318.5 141.4 160.7 316.5 209.1 147.3 15.4 148.8 120.8 144.4 159.3 139.3 127.0 219.9 191.7 155.6 93.7 35.4 329.9 119.1 70.4 384.9 69.7 67.7 65.3 96.0 42.6 134.7 37.7 143.7 22.0 94.2 164.8 14.4 108.4 83.5 239.5 8.7 18.3 36.2 34.2 200.8 57.3 30.2 200.0 91.8 33.6 43.9 79.5 30.1 2.0 16.4 215.4 84.8 54.6 32.0 24.2 24.5 6.1 29.9 11.8 115.4 22.0 255.7 14.8 13.3 101.0 52.0 25.9 20.4 96.7 82.5 23.7 14.9 0.5 14.4 0.7 12.4 15.2 88.3 1.9 18.2 0.9 66.1 0.9 139.7 21.6 3.5 7.6 231.5 36.8 71.5 557.0 16.9 8.8 113.1 10.9 36.6 17.4 9.6 35.3 60.4 55.8 36.5 6.7 16.2 53.6 4.8 43.0 26.7 2.7 8.9 0.2 3.6 16.3 2.9 0.1 3.4 14.2 62.1 22.6 6.7 1.1 5.8 6.5 103.3 140.4 111.1 221.9 141.4 160.7 148.8 120.8 144.4 155.6 96.0 143.7 239.5 216.8 60.9 35.7 15.0 23.5 62.8 196.6 57.1 101.3 118.3 45.0 26.0 197.8 72.9 33.6 58.8 154.3 310.8 171.8 38.5 432.4 62.5 295.1 57.8 75.0 88.0 71.0 61.7 45.5 57.2 31.1 128.9 61.7 143.9 17.7 15.4 63.9 112.1 72.0 89.2 41.4 37.6 75.3 73.1 56.4 70.3 25.7 111.6 74.7 18.7 24.6 114.2 25.7 13.0 26.6 45.4 31.5 24.5 57.2 130.7 55.0 250.3 16.1 237.6 19.7 96.8 85.2 10.0 8.8 32.6 42.3 929.0 125.6 25.8 11.5 169.0 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.6;retina: 78.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 308.6;Cone photoreceptor cells: 308.6;Inhibitory neurons: 221.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 7.1;MAIT T-cell: 3.4;memory CD4 T-cell: 4.4;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.8;NK-cell: 3.0;T-reg: 2.2" "Group enriched" "Detected in many" 9 "NK-cells: 3.0;T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 187.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB022079: , HPA058432: AB_2683717" "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favorable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 4.9 12.2 38.2 3.9 44.1 0.9 6.3 44.3 55.7 11.1 10.9 12.1 9.1 9.3 5.5 21.1 34.0 6.2 18.5 39.7 53.5 26.7 20.6 6.0 3.0 64.2 49.6 35.1 4.5 13.3 16.7 16.2 5.8 65.2 11.3 13.2 78.2 24.1 3.2 15.4 12.5 10.4 8.8 43.2 6.6 12.7 12.6 49.8 2.2 8.9 9.6 5.3 6.0 11.5 72.6 18.5 23.2 31.8 13.7 6.0 3.0 25.4 4.5 2.2 5.9 4.1 42.2 22.4 0.0 14.1 1.9 9.4 16.0 18.5 11.2 5.4 36.1 14.7 0.2 40.6 38.6 4.6 31.0 0.1 2.0 24.4 7.4 35.3 13.4 7.7 7.8 35.4 36.9 4.8 11.1 4.0 0.0 42.8 0.0 20.0 0.1 0.0 21.1 22.3 30.1 43.0 187.6 17.7 27.7 10.8 32.1 32.2 3.9 5.6 3.4 13.7 1.1 13.1 16.7 6.1 0.0 8.1 4.4 2.9 0.0 0.0 0.0 7.1 0.0 3.4 0.5 4.4 7.3 0.0 0.0 1.0 4.8 0.1 3.0 0.0 0.0 2.2 1.0 38.2 44.1 44.3 55.7 39.7 53.5 64.2 49.6 35.1 65.2 43.2 49.8 72.6 4.1 38.5 17.5 205.7 5.3 18.5 25.1 25.9 4.6 308.6 10.9 11.0 121.9 22.8 53.9 12.9 308.6 15.3 36.2 30.0 9.8 27.8 108.4 78.1 30.2 5.5 24.0 2.5 189.9 41.3 100.8 17.2 36.2 27.7 13.4 92.7 12.8 44.2 3.8 138.0 221.0 28.7 22.4 2.5 2.2 79.9 3.1 2.4 14.2 23.4 7.8 112.3 25.7 124.1 160.3 37.2 20.0 2.6 30.7 37.5 20.7 53.3 193.9 186.1 0.0 26.1 17.4 57.2 24.0 30.5 30.7 59.1 33.5 17.7 29.3 21.7 CPNE8 ENSG00000139117 "Copine 8" Q86YQ8 12 38646822-38907430 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 115.5;Microglial cells: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 66.8;THP-1: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038600 Approved NA NA "HPA038600: AB_10674690" "unprognostic (1.57e-1)" "unprognostic (3.07e-1)" "unprognostic (3.38e-1)" "unprognostic (3.78e-3)" "unprognostic (8.93e-3)" "unprognostic (6.28e-3)" "unprognostic (6.74e-2)" "unprognostic (8.44e-2)" "unprognostic (5.40e-3)" "unprognostic (4.29e-1)" "unprognostic (1.28e-2)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.21e-1)" "unprognostic (5.13e-2)" "unprognostic (8.73e-3)" 11.4 8.4 8.1 5.5 8.7 4.6 9.6 4.2 11.6 7.9 10.9 8.2 3.4 5.2 3.5 5.4 5.1 9.1 9.0 10.3 11.9 11.3 15.6 10.2 5.4 6.1 6.8 7.7 5.8 3.2 2.5 3.3 12.1 6.0 3.8 10.3 6.1 3.2 9.0 2.9 6.2 4.6 9.2 7.6 10.7 3.7 5.9 8.1 3.1 7.8 5.3 3.2 10.2 5.3 6.8 3.1 18.7 1.3 18.5 17.0 14.3 8.6 1.6 0.1 0.0 0.0 9.4 18.2 0.0 26.3 12.7 6.8 1.0 10.8 5.6 0.0 0.0 11.3 9.9 26.3 2.2 11.3 0.0 7.8 6.7 14.2 4.2 14.9 12.9 14.3 0.0 6.0 0.0 0.0 0.0 0.0 0.1 13.8 11.5 19.0 0.0 0.0 4.3 66.8 0.5 0.0 0.5 26.0 4.7 14.1 18.8 2.3 38.8 13.6 0.0 12.7 21.6 0.1 6.5 19.3 0.2 17.2 17.8 11.0 2.7 12.0 0.0 1.6 9.4 0.3 0.2 2.1 1.8 7.7 0.6 0.9 1.5 0.7 4.5 6.3 2.5 2.1 2.5 8.1 8.7 4.2 11.6 10.3 11.9 6.1 6.8 7.7 6.0 7.6 8.1 6.8 68.8 12.8 8.2 66.3 1.6 31.1 5.9 40.8 19.9 2.1 0.6 6.5 20.3 15.7 23.3 12.9 0.0 29.2 6.9 35.8 15.6 7.6 68.9 2.7 9.4 55.9 11.5 7.4 115.5 4.9 27.2 27.1 0.0 3.0 3.8 18.5 36.0 16.5 25.7 0.0 36.3 9.1 6.1 34.1 42.4 14.5 9.6 19.4 46.2 77.8 19.8 36.4 2.1 25.6 2.9 3.6 51.3 8.2 3.3 7.4 0.0 20.9 17.0 2.7 0.0 24.5 16.9 2.7 2.1 6.1 11.2 7.8 4.3 8.6 8.9 3.5 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755897 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavorable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 5.8 6.1 4.0 6.6 4.1 7.9 6.7 4.6 4.7 6.0 3.9 5.9 4.9 5.8 5.1 7.2 5.3 4.5 6.1 4.3 3.8 4.8 6.0 4.3 8.2 4.0 3.5 4.2 6.1 5.9 6.5 3.8 7.8 4.5 4.6 6.5 4.6 8.2 4.5 7.4 5.3 5.2 5.4 3.5 6.1 5.9 4.7 3.5 8.0 4.7 8.6 8.4 7.5 5.1 4.6 19.8 23.3 13.3 15.8 14.3 16.6 42.0 14.8 15.0 17.9 17.4 58.8 24.6 35.4 23.6 15.0 25.8 24.9 26.7 38.9 20.0 15.5 41.8 23.6 16.4 33.0 20.6 25.3 13.2 15.6 24.4 16.9 30.5 23.0 28.5 18.4 33.7 15.9 19.1 16.1 18.9 30.4 73.5 13.0 28.2 21.0 28.4 21.1 22.9 27.8 20.5 10.0 22.7 19.5 14.7 51.5 36.5 22.7 19.5 16.9 17.7 27.8 25.3 9.4 10.7 37.0 15.7 18.6 14.3 10.2 6.1 3.7 8.4 8.0 8.8 7.3 8.8 8.7 8.5 9.6 9.0 10.5 1.0 11.9 9.6 8.2 8.4 5.1 4.0 4.1 4.6 4.7 4.3 3.8 4.0 3.5 4.2 4.5 3.5 3.5 4.6 14.5 6.4 4.4 25.5 16.1 10.1 20.1 27.0 14.2 16.8 11.4 8.4 7.7 1.5 15.1 11.0 20.9 34.7 15.9 5.4 7.9 19.9 6.5 19.7 17.7 10.2 7.2 21.2 22.2 16.5 36.9 12.5 6.6 24.6 7.0 18.9 6.8 5.6 20.1 15.2 31.2 7.3 16.2 9.3 6.0 4.6 10.5 10.4 5.4 18.7 16.0 12.3 16.5 26.7 44.1 14.2 7.6 8.6 9.3 13.9 7.9 11.5 9.0 19.9 13.1 10.5 19.1 6.3 12.8 12.9 8.4 17.9 13.9 24.3 12.8 12.6 FGD4 "CMT4H, frabin, FRABP, ZFYVE6" ENSG00000139132 "FYVE, RhoGEF and PH domain containing 4" Q96M96 12 32399558-32646050 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 232.5;Early spermatids: 196.3;Late spermatids: 250.1;Microglial cells: 203.3" "Cancer enhanced" "Detected in all" "testis cancer: 14.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;granulocytes: 8.4;monocytes: 5.7" "Cell line enhanced" "Detected in many" "ASC diff: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039235 Approved Approved "Actin filaments" No No "Actin filaments" "HPA039235: AB_10673420" "unprognostic (6.73e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "unprognostic (2.64e-2)" "unprognostic (2.37e-1)" "unprognostic (5.45e-2)" "unprognostic (8.61e-3)" "unprognostic (3.91e-2)" "unprognostic (5.48e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-3)" "unprognostic (2.79e-1)" "prognostic favorable (7.16e-5)" "unprognostic (9.50e-2)" "unprognostic (7.52e-2)" "unprognostic (1.17e-1)" "unprognostic (3.41e-3)" 12.7 4.3 7.5 5.7 10.1 12.2 8.1 11.7 6.9 6.1 13.6 9.5 8.9 2.3 2.9 7.4 5.0 10.4 5.4 7.4 9.4 10.9 17.9 8.1 1.8 11.6 9.1 2.8 24.8 9.5 14.9 3.1 10.4 12.1 4.7 10.2 23.8 6.7 4.1 10.8 7.2 8.3 3.5 10.5 5.2 29.2 12.2 10.0 1.7 6.4 10.9 2.7 4.1 5.9 13.8 5.4 2.6 6.6 2.0 24.1 14.8 8.1 4.5 22.5 1.2 0.4 8.1 8.3 0.8 2.5 0.3 2.8 5.1 5.3 7.5 0.7 0.7 2.6 4.7 2.7 2.5 4.3 0.9 0.0 8.8 10.3 6.0 12.9 3.3 11.6 1.1 0.5 5.4 15.6 1.9 0.0 1.7 17.4 5.3 0.2 0.4 6.9 16.2 8.0 5.3 7.2 8.5 4.7 4.4 6.6 11.8 7.0 0.3 13.1 0.1 1.5 18.8 0.7 1.9 4.6 2.9 0.0 2.8 5.2 3.6 3.8 8.4 0.2 5.7 0.2 0.6 0.3 0.2 3.6 1.4 0.2 0.3 5.5 0.7 5.1 0.4 0.2 1.3 7.5 10.1 11.7 6.9 7.4 9.4 11.6 9.1 2.8 12.1 10.5 10.0 13.8 84.3 48.1 31.4 232.5 5.6 8.4 11.3 12.1 8.6 23.8 10.7 7.5 19.2 54.3 18.3 22.0 118.9 1.3 0.5 57.8 13.7 16.8 196.3 36.0 8.1 24.8 19.2 4.4 40.5 20.7 16.8 19.9 78.5 65.7 2.5 34.1 9.3 37.7 11.8 70.7 55.1 31.2 26.4 71.7 22.3 250.1 4.7 92.9 14.2 203.3 39.9 79.3 1.0 25.1 95.1 33.5 29.3 1.5 16.4 16.4 54.8 15.0 15.3 114.5 52.6 16.5 41.3 10.4 7.4 25.0 12.6 1.4 3.1 25.6 30.5 20.2 ALG10 "ALG10A, DIE2, FLJ14751" ENSG00000139133 "ALG10 alpha-1,2-glucosyltransferase" Q5BKT4 12 34022468-34029694 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (3.16e-3)" "unprognostic (2.80e-2)" "unprognostic (9.23e-2)" "unprognostic (3.49e-2)" "unprognostic (5.88e-4)" "unprognostic (2.13e-1)" "unprognostic (1.73e-2)" "unprognostic (8.01e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "unprognostic (9.29e-2)" "unprognostic (8.99e-2)" "unprognostic (1.53e-1)" "unprognostic (2.43e-1)" "unprognostic (6.45e-2)" 2.3 2.7 1.0 2.7 1.8 4.1 2.8 1.7 1.0 1.9 0.8 2.3 1.6 2.2 2.7 2.2 3.4 1.8 1.0 0.7 1.2 1.9 2.9 1.8 3.7 1.6 1.4 0.5 2.4 1.5 2.3 0.6 2.4 1.5 2.7 1.9 3.3 1.5 1.9 0.9 2.0 1.8 2.1 1.7 2.9 2.0 2.6 1.3 3.6 2.9 1.3 2.9 1.3 0.9 2.1 5.3 5.8 4.0 7.0 4.6 4.3 14.0 5.1 4.7 5.4 9.8 8.8 12.6 10.3 7.3 2.6 8.2 7.8 7.9 6.8 7.9 13.0 7.2 9.2 6.7 3.9 1.8 11.4 8.1 4.0 3.6 11.3 9.3 2.6 3.7 8.1 13.9 13.6 5.5 6.8 8.4 6.3 15.1 3.2 7.7 6.5 14.8 8.3 3.2 7.8 3.8 3.0 9.4 3.8 5.6 11.7 8.6 3.2 7.5 7.4 10.7 11.3 6.5 7.4 14.7 17.3 5.0 4.8 6.2 0.0 1.0 1.7 0.6 0.4 0.9 0.8 0.9 0.4 0.6 0.8 1.1 1.3 0.1 0.8 0.5 0.7 1.2 0.5 1.0 1.8 1.7 1.0 0.7 1.2 1.6 1.4 0.5 1.5 1.7 1.3 2.1 3.0 6.4 0.5 1.3 5.1 1.5 3.0 4.3 2.8 4.6 2.0 1.7 0.8 2.8 5.1 5.5 4.2 6.8 3.5 1.4 1.9 2.4 1.0 3.1 2.8 2.3 1.2 7.0 1.5 3.8 5.5 2.7 3.1 2.2 1.3 3.6 0.7 2.9 3.3 1.7 1.8 1.7 2.0 2.8 1.9 0.3 1.5 2.2 0.0 1.9 3.3 3.4 1.0 2.5 1.8 3.3 0.6 1.2 4.0 0.8 1.2 1.3 3.9 4.2 0.0 2.5 2.0 12.4 5.8 4.3 2.7 3.1 3.2 2.6 1.9 1.8 PIK3C2G ENSG00000139144 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma" O75747 12 18242961-18648416 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Chemotaxis "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.8;stomach 1: 21.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 44.9;Breast glandular cells: 30.4;Breast myoepithelial cells: 37.6;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 140.6" "Cancer enhanced" "Detected in some" "stomach cancer: 2.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.2;HaCaT: 2.1;hTERT-HME1: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.29e-1)" "unprognostic (1.61e-1)" "unprognostic (6.21e-2)" "unprognostic (1.47e-2)" "unprognostic (9.46e-2)" "unprognostic (8.27e-2)" "unprognostic (2.85e-1)" "unprognostic (6.52e-2)" "unprognostic (1.81e-3)" "prognostic unfavorable (3.50e-4)" "unprognostic (6.05e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-1)" "unprognostic (1.98e-1)" "unprognostic (2.37e-2)" 0.0 0.6 0.5 0.0 0.1 0.1 9.8 0.4 0.4 0.1 0.1 0.1 0.5 0.1 16.8 2.4 1.2 6.3 0.0 0.2 1.0 4.6 12.1 0.3 0.1 0.1 0.1 0.2 0.0 1.4 4.8 0.0 0.0 0.1 0.9 0.2 0.1 3.7 9.5 0.0 9.7 3.4 0.0 0.4 0.1 21.9 0.4 0.3 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.4 0.2 1.0 0.1 0.1 0.2 0.1 0.4 0.3 0.3 1.1 0.0 0.0 1.3 0.7 17.5 8.5 0.3 44.9 0.0 30.4 37.6 0.3 27.1 0.8 40.5 0.0 1.2 0.4 0.2 1.9 2.0 9.0 4.5 1.5 1.2 0.0 2.7 2.9 0.0 4.8 0.4 140.6 10.1 0.0 0.0 0.7 27.4 0.2 0.0 1.8 2.3 0.0 0.8 1.1 1.8 0.0 0.5 1.8 7.5 0.0 0.0 0.0 1.5 1.4 0.8 5.1 0.0 1.3 0.8 18.4 1.3 0.1 0.0 0.0 0.1 0.5 2.4 3.0 27.3 21.5 0.8 1.0 0.0 3.0 1.6 SINHCAF "C12orf14, FAM60A, TERA" ENSG00000139146 "SIN3-HDAC complex associated factor" Q9NP50 12 31280584-31327058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 150.5;Extravillous trophoblasts: 118.8;Glandular and luminal cells: 149.3;monocytes: 154.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 600.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038167, HPA057585" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038167: AB_10675629, HPA057585: AB_2732615" "unprognostic (2.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (2.80e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.15e-1)" "prognostic favorable (7.89e-4)" "unprognostic (3.22e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" "unprognostic (9.75e-2)" 13.2 11.7 1.1 23.0 1.8 25.9 26.9 2.9 2.0 24.3 8.5 24.5 21.7 52.4 18.2 25.3 36.5 15.3 8.0 1.0 2.4 28.5 7.8 16.8 34.7 1.7 1.4 0.9 28.3 22.8 22.7 25.0 26.5 1.6 27.2 26.1 4.0 26.0 30.6 3.3 22.8 19.8 33.6 1.7 17.5 19.7 17.2 1.6 51.4 14.1 3.6 33.8 34.4 23.9 1.6 27.8 29.9 128.7 26.6 8.0 12.0 238.3 10.7 10.3 25.9 36.7 91.6 74.8 95.9 94.9 3.9 26.7 48.1 105.4 48.4 51.0 92.6 42.6 61.7 21.2 66.6 28.4 105.2 54.7 13.0 82.0 21.6 102.2 45.3 61.6 98.9 88.0 39.1 11.4 17.5 173.7 71.7 600.6 81.7 19.0 159.6 62.4 80.0 57.3 67.8 180.0 113.5 26.5 54.1 71.8 280.2 24.6 64.5 58.5 6.0 36.1 2.8 46.4 40.3 50.5 156.9 17.9 42.9 34.0 29.5 12.9 19.8 21.8 15.8 24.8 59.1 30.4 25.9 27.5 48.5 35.8 29.0 3.9 50.4 24.2 71.9 15.3 29.6 1.1 1.8 2.9 2.0 1.0 2.4 1.7 1.4 0.9 1.6 1.7 1.6 1.6 31.0 76.9 35.8 0.0 26.5 0.0 0.0 0.0 0.0 0.0 52.3 48.8 0.0 0.0 56.3 46.0 0.0 75.1 37.7 0.0 82.2 70.1 0.0 150.5 37.8 21.8 0.0 0.0 0.0 43.2 118.8 14.9 0.0 149.3 11.4 48.8 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 154.5 0.0 0.0 0.0 0.0 56.0 0.0 0.0 11.1 0.0 0.0 41.1 59.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 60.5 18.6 18.3 0.0 0.0 PLCZ1 "NYD-SP27, PLCzeta" ENSG00000139151 "Phospholipase C zeta 1" Q86YW0 12 18683169-18738100 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fertilization, Lipid degradation, Lipid metabolism" "Developmental protein, Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 42.6" "Group enriched" "Detected in some" 47 "Early spermatids: 647.0;Late spermatids: 316.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "amygdala: 3.1" "Not detected" "Not detected" NA NA "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.39e-2)" "unprognostic (1.25e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.1 0.7 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.1 0.0 0.2 0.0 0.4 42.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.5 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 647.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 316.3 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AEBP2 MGC17922 ENSG00000139154 "AE binding protein 2" Q6ZN18 12 19404045-19720801 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020893, HPA022282" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020893: AB_2670528, HPA022282: AB_2670931" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (9.15e-2)" "unprognostic (4.56e-2)" "unprognostic (5.19e-3)" "unprognostic (1.87e-1)" "unprognostic (3.45e-2)" "unprognostic (1.68e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" 19.2 27.4 13.2 20.2 14.9 20.7 23.7 14.7 19.4 26.1 13.9 18.9 16.4 34.3 20.4 35.5 28.3 22.0 17.9 21.4 10.1 28.1 20.5 20.9 27.9 8.2 7.5 12.8 35.4 17.6 30.2 9.0 44.4 6.6 25.1 20.8 28.0 19.5 30.9 13.8 29.7 16.8 31.3 1.6 23.3 16.2 20.9 10.4 29.4 31.1 20.0 32.5 25.2 18.4 17.6 32.4 42.4 42.6 20.1 31.1 38.6 95.2 29.9 34.1 43.5 45.7 48.0 54.5 51.0 24.3 41.4 27.6 38.0 93.7 34.6 69.1 149.4 30.6 46.7 60.8 30.0 36.4 60.1 30.8 36.2 36.3 35.6 52.8 52.0 35.6 34.8 25.2 1.4 41.2 38.5 63.0 71.7 82.6 26.6 18.9 50.3 82.3 35.9 32.2 68.2 10.0 23.4 60.6 25.7 29.8 91.3 32.8 35.0 40.5 40.7 30.9 12.8 44.9 14.0 24.9 106.0 30.3 25.1 29.2 4.3 2.5 2.5 4.2 2.7 4.4 2.2 4.4 3.6 2.0 2.8 3.7 5.8 2.7 6.0 2.2 2.6 4.5 1.2 13.2 14.9 14.7 19.4 21.4 10.1 8.2 7.5 12.8 6.6 1.6 10.4 17.6 23.9 25.6 14.3 31.6 20.5 75.2 25.1 15.5 53.5 29.8 22.0 13.3 22.1 12.8 24.2 12.9 43.8 60.3 24.3 9.5 17.6 12.3 1.3 31.1 31.5 22.2 22.7 11.6 57.2 12.2 24.8 28.3 14.3 28.8 27.8 17.7 14.3 12.9 15.4 52.2 59.4 11.2 4.1 17.0 47.9 2.3 24.5 17.8 28.4 30.0 17.7 21.5 14.4 42.3 51.6 11.5 10.3 29.0 18.3 24.5 9.0 18.3 26.1 16.1 19.7 46.7 40.1 16.2 26.3 51.0 76.0 83.0 28.1 34.2 10.7 28.2 SLCO1C1 "OATP-F, OATP1, OATP1C1, SLC21A14" ENSG00000139155 "Solute carrier organic anion transporter family member 1C1" Q9NYB5 12 20695332-20753386 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 43.5;choroid plexus: 26.6" "Cell type enriched" "Detected in some" 12 "Astrocytes: 292.2" "Cancer enriched" "Detected in single" 17 "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (4.64e-1)" "unprognostic (3.16e-2)" "unprognostic (1.76e-1)" "unprognostic (7.32e-2)" "unprognostic (8.89e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (2.70e-2)" "unprognostic (2.37e-4)" "unprognostic (1.56e-3)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.76e-2)" 1.6 0.1 15.3 0.1 17.4 0.0 0.4 14.1 23.3 0.0 26.6 0.2 0.1 0.0 0.2 0.1 0.0 0.7 0.4 17.3 43.5 0.1 0.0 0.1 0.2 13.2 14.8 15.5 0.0 0.1 0.2 8.2 0.0 14.2 0.1 0.2 2.8 0.1 0.0 0.0 0.2 0.3 0.1 12.5 0.0 0.1 1.5 16.4 0.1 0.7 0.5 0.2 0.2 0.0 15.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 17.4 14.1 23.3 17.3 43.5 13.2 14.8 15.5 14.2 12.5 16.4 15.6 2.4 0.0 0.0 292.2 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 9.5 0.0 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.8 0.1 0.0 0.0 0.0 13.4 1.8 0.0 0.0 23.4 0.1 4.8 0.0 3.5 0.5 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 5.3 0.5 0.2 0.0 0.0 0.0 0.0 1.2 0.4 0.0 ETFBKMT "C12orf72, DKFZp451L235, METTL20, MGC50559" ENSG00000139160 "Electron transfer flavoprotein subunit beta lysine methyltransferase" Q8IXQ9 12 31647160-31673114 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 7.3;Distal tubular cells: 7.9;Endometrial ciliated cells: 10.3;Proximal tubular cells: 18.1;Theca cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039024 Uncertain NA NA "HPA039024: AB_10670917" "unprognostic (1.05e-1)" "unprognostic (6.46e-2)" "unprognostic (1.16e-1)" "unprognostic (7.91e-3)" "unprognostic (1.93e-1)" "unprognostic (6.13e-2)" "unprognostic (3.49e-4)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.72e-2)" "unprognostic (7.82e-3)" "unprognostic (2.77e-1)" "unprognostic (6.12e-5)" "unprognostic (3.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.32e-2)" 2.4 3.8 1.9 1.6 2.6 2.4 3.0 3.1 2.9 3.8 0.9 2.4 2.9 2.8 5.4 2.5 4.4 2.7 3.7 2.0 1.9 6.2 9.8 2.1 1.6 1.8 1.9 2.0 4.9 3.8 4.8 2.6 2.1 2.1 2.6 2.5 6.2 2.3 2.7 7.7 2.5 2.1 3.0 1.4 2.5 2.7 3.7 2.2 1.0 3.7 7.9 1.4 2.1 1.6 3.1 1.8 1.1 1.6 2.3 6.8 4.7 1.4 1.7 1.7 1.9 2.1 2.1 3.2 0.8 1.6 1.2 1.7 0.4 1.0 1.2 2.0 1.3 1.2 1.3 1.6 0.6 2.4 0.8 1.8 4.4 2.1 2.3 2.1 1.8 3.0 2.5 1.5 2.9 2.4 1.7 0.8 0.8 1.8 1.5 1.9 1.2 2.0 2.2 2.7 0.6 1.0 1.0 1.6 1.2 2.6 4.1 5.1 1.6 2.3 1.9 1.7 5.0 1.4 5.3 3.2 1.4 1.6 1.5 1.5 7.8 1.7 2.1 0.9 1.0 0.8 2.0 1.1 1.5 1.2 2.3 1.8 1.6 4.5 1.6 1.2 2.5 1.3 0.9 1.9 2.6 3.1 2.9 2.0 1.9 1.8 1.9 2.0 2.1 1.4 2.2 3.1 5.9 6.4 3.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 7.3 6.3 0.0 0.0 0.6 3.7 0.0 3.0 2.5 0.0 7.9 2.9 0.0 10.3 5.2 2.1 0.0 0.0 0.0 2.6 2.6 2.1 0.0 5.3 2.5 5.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 0.0 18.1 3.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.7 1.6 7.6 0.0 0.0 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 299.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA010712: AB_2668349, HPA029407: AB_2673026" "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.75e-4)" 10.0 14.6 15.2 14.6 17.4 12.3 13.8 10.2 16.8 10.6 17.5 27.5 23.6 10.3 19.7 10.9 10.2 14.2 6.8 15.8 25.0 18.6 18.4 12.7 17.6 14.0 13.4 15.9 11.8 10.8 10.9 13.8 11.3 16.7 11.0 15.5 18.3 12.5 6.2 6.2 15.4 15.6 7.7 12.1 16.8 45.4 17.9 20.6 23.3 14.7 5.7 14.4 10.9 9.5 25.4 14.8 27.9 30.4 27.5 21.2 21.3 21.7 15.6 12.2 17.4 16.0 20.6 33.3 41.1 14.7 11.6 16.5 10.7 27.1 7.6 28.2 36.8 23.7 34.7 11.5 18.9 20.6 33.9 29.4 13.7 7.2 21.9 17.4 25.8 20.3 15.7 41.8 17.2 22.3 7.7 38.8 67.1 59.3 17.9 20.1 32.7 28.1 32.9 25.6 16.5 9.8 17.8 18.9 13.9 27.1 41.1 24.1 32.1 17.5 12.2 19.9 18.6 25.0 12.9 18.1 46.8 16.2 21.0 23.9 44.0 14.3 15.9 15.4 22.0 15.2 22.2 16.4 14.4 14.1 15.3 17.7 17.7 14.6 17.7 23.4 12.6 20.5 19.2 15.2 17.4 10.2 16.8 15.8 25.0 14.0 13.4 15.9 16.7 12.1 20.6 25.4 33.6 48.1 32.2 48.0 55.9 144.3 75.7 34.7 64.9 41.0 56.8 42.2 10.1 45.8 43.8 44.1 50.1 30.1 57.6 116.1 27.4 30.7 299.0 64.2 49.1 34.8 108.3 48.8 104.4 44.5 24.2 38.2 230.4 51.4 34.8 40.9 28.2 41.5 42.9 26.9 104.3 60.7 46.8 88.3 60.0 43.5 24.2 57.0 67.6 84.3 39.1 17.7 43.3 121.2 152.9 39.5 62.9 21.4 63.7 73.8 57.7 33.2 81.6 39.5 39.5 23.3 38.9 49.1 18.5 51.9 170.2 75.4 49.0 41.5 47.8 90.3 ZCRB1 "MADP-1, MADP1, RBM36, SNRNP31, ZCCHC19" ENSG00000139168 "Zinc finger CCHC-type and RNA binding motif containing 1" Q8TBF4 12 42312086-42326257 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 221.2" "Cell type enhanced" "Detected in all" "Early spermatids: 889.2;Spermatocytes: 527.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.75e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.60e-2)" "unprognostic (9.28e-2)" "unprognostic (7.92e-3)" "prognostic unfavorable (5.33e-7)" "unprognostic (4.31e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.33e-4)" "unprognostic (3.11e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (1.39e-2)" "unprognostic (4.33e-2)" "unprognostic (5.32e-3)" "unprognostic (9.44e-2)" 47.0 53.2 115.7 31.4 117.8 37.7 44.3 117.7 221.2 30.5 103.0 41.0 36.1 35.9 67.3 40.7 38.9 39.2 62.4 110.0 120.9 51.8 57.8 27.7 44.7 125.0 118.5 102.7 41.6 63.4 44.3 41.1 33.6 127.9 43.2 30.4 40.1 45.2 41.0 130.1 34.6 35.9 30.4 126.5 31.6 47.3 90.5 121.5 43.9 45.4 92.3 41.5 42.3 30.7 128.7 94.8 69.4 76.0 99.2 67.4 102.2 74.1 77.6 86.8 59.4 57.4 60.6 110.7 59.5 152.2 74.9 83.9 58.6 46.6 78.8 87.2 162.6 96.3 94.4 55.2 58.0 96.8 103.4 81.2 68.4 87.9 58.6 98.7 140.8 81.2 153.7 91.2 120.0 85.6 61.8 146.8 129.7 83.3 233.0 91.5 82.4 140.6 128.8 97.8 52.0 79.9 75.0 105.6 72.9 109.0 84.8 175.1 84.8 76.6 86.8 104.1 82.2 76.2 118.1 120.6 222.3 129.7 366.4 41.2 79.3 33.2 65.0 35.4 42.0 45.0 68.2 47.7 43.8 55.5 60.3 39.8 46.8 22.1 51.1 44.0 67.6 82.7 40.9 115.7 117.8 117.7 221.2 110.0 120.9 125.0 118.5 102.7 127.9 126.5 121.5 128.7 58.8 60.9 67.5 13.1 54.5 45.4 82.0 108.8 56.3 43.2 90.1 129.8 152.9 82.9 83.5 57.0 25.0 143.6 53.8 44.1 217.2 139.0 889.2 113.6 76.4 68.8 48.6 35.9 13.5 200.7 141.5 67.2 35.7 88.6 53.7 39.9 61.4 114.0 111.4 38.7 14.7 82.2 73.2 76.8 69.9 159.6 112.8 61.4 71.2 9.4 103.4 122.8 82.4 15.1 27.4 156.1 52.2 100.1 59.1 82.3 62.6 249.8 113.2 51.8 72.3 63.7 129.7 527.1 185.3 53.6 41.2 87.2 56.6 85.7 75.4 90.0 TMEM117 DKFZp434K2435 ENSG00000139173 "Transmembrane protein 117" Q9H0C3 12 43835967-44389762 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 65.6;Excitatory neurons: 220.2;Inhibitory neurons: 190.3;Microglial cells: 80.6;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046223 Uncertain NA NA "HPA046223: AB_10960636" "unprognostic (1.37e-2)" "unprognostic (2.99e-1)" "unprognostic (4.32e-1)" "unprognostic (2.39e-2)" "unprognostic (3.57e-2)" "unprognostic (7.08e-2)" "unprognostic (3.07e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (2.89e-1)" "unprognostic (6.26e-2)" "unprognostic (1.99e-3)" "unprognostic (1.74e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (9.20e-3)" "unprognostic (3.80e-1)" 1.8 2.0 1.0 1.2 1.5 0.1 2.8 1.5 2.2 3.8 7.4 3.4 6.1 4.0 2.6 5.8 2.3 3.5 4.2 1.4 1.5 2.2 2.1 1.1 1.4 2.5 1.7 1.1 2.5 3.7 4.1 1.7 3.0 3.0 3.5 3.6 2.3 2.1 5.2 3.3 4.0 4.2 4.0 1.3 0.8 2.1 2.4 1.4 0.9 2.3 3.3 2.3 4.1 3.8 2.8 1.2 0.4 4.0 6.7 4.5 9.6 0.1 12.6 6.2 2.3 2.7 10.0 4.3 4.5 0.9 9.0 0.6 6.4 2.6 2.8 1.7 1.9 7.4 1.2 2.5 4.0 1.3 1.8 4.7 5.0 9.9 1.3 0.7 9.2 0.4 0.5 2.2 1.9 4.4 1.1 0.0 1.1 0.8 0.0 2.4 3.0 4.5 1.8 4.5 2.7 0.6 6.1 4.8 1.5 10.2 1.6 0.3 4.7 1.5 3.4 1.1 1.8 3.3 3.4 3.9 2.6 1.7 2.0 1.2 0.0 0.0 0.0 1.2 0.0 1.7 1.0 0.3 1.2 0.0 0.9 0.5 0.6 0.0 0.4 0.0 0.1 0.2 0.4 1.0 1.5 1.5 2.2 1.4 1.5 2.5 1.7 1.1 3.0 1.3 1.4 2.8 3.2 0.0 1.3 65.6 8.4 6.5 4.8 3.4 9.6 3.9 2.4 2.8 5.4 2.8 2.5 7.3 4.2 15.0 2.8 6.9 3.9 2.8 25.8 3.9 5.5 2.1 0.0 1.7 220.2 3.0 2.7 3.8 18.3 6.0 2.5 6.0 4.2 2.7 5.6 5.0 190.3 4.2 12.2 3.8 2.5 9.5 6.2 2.1 12.4 80.6 0.1 3.4 3.1 123.1 152.4 2.5 19.2 6.4 11.2 2.1 13.8 1.3 2.7 5.2 0.0 2.2 3.8 1.4 5.5 17.7 12.1 11.5 5.1 2.3 5.0 4.9 PRICKLE1 "EPM1B, FLJ31937, RILP" ENSG00000139174 "Prickle planar cell polarity protein 1" Q96MT3 12 42456757-42590355 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory B-cell: 7.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 4 "B-cells: 11.5" "Cell line enriched" "Detected in many" 18 "HBEC3-KT: 1015.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001379, HPA050037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001379: AB_1855703, HPA050037: " "unprognostic (2.44e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.22e-1)" "unprognostic (2.34e-4)" "unprognostic (3.53e-1)" "unprognostic (1.69e-2)" "unprognostic (5.89e-2)" "unprognostic (5.29e-2)" "unprognostic (7.77e-2)" "unprognostic (1.21e-3)" "unprognostic (2.29e-4)" "unprognostic (1.12e-1)" "unprognostic (8.95e-3)" "unprognostic (5.33e-4)" 5.6 3.0 2.1 5.2 4.6 1.7 5.0 0.0 6.6 12.6 0.0 3.3 2.7 12.2 1.6 2.4 6.4 10.1 14.0 4.1 2.6 5.0 1.7 9.6 4.6 0.2 1.6 3.7 12.6 2.0 1.4 2.0 5.4 1.5 5.1 2.3 4.3 7.9 5.6 4.0 4.5 2.4 12.8 0.0 15.0 2.9 6.1 4.0 1.7 7.9 4.7 3.5 5.5 6.3 4.4 7.7 4.4 17.0 0.5 12.4 13.1 0.5 11.0 5.2 3.0 5.1 0.5 16.0 0.5 31.4 1.6 0.0 2.9 12.5 1015.4 3.5 0.6 6.4 17.5 0.9 0.4 1.7 0.3 0.2 19.3 7.5 12.7 1.7 1.8 39.7 0.3 1.8 3.1 2.9 0.3 0.1 0.5 56.1 0.1 18.0 0.2 0.7 0.1 21.1 0.7 4.4 3.0 0.3 0.7 0.7 13.7 0.3 35.1 2.9 0.9 13.4 14.0 14.2 0.9 0.6 6.1 0.2 10.7 0.6 2.6 1.8 0.4 0.2 1.0 0.7 7.6 0.2 0.2 1.0 11.5 0.4 0.2 2.4 0.5 0.6 1.6 0.2 0.9 2.1 4.6 0.0 6.6 4.1 2.6 0.2 1.6 3.7 1.5 0.0 4.0 4.4 6.9 16.0 8.2 8.8 13.2 2.7 5.3 7.3 4.0 13.5 4.0 2.2 5.7 14.3 2.6 1.8 2.1 0.6 0.2 0.0 0.0 3.8 72.8 5.2 43.0 8.1 0.0 0.4 307.7 2.6 0.2 19.2 3.6 8.6 1.3 59.1 14.6 0.1 0.6 8.4 122.2 0.0 2.0 0.9 2.3 25.4 9.9 1.2 7.2 64.6 1.1 2.7 0.0 114.6 5.3 3.9 0.1 24.8 3.1 1.0 0.0 3.3 0.3 4.5 0.0 3.8 7.9 5.1 4.8 1.9 1.4 0.7 1.1 18.6 0.0 0.8 C1RL "C1r-LP, C1RL1" ENSG00000139178 "Complement C1r subcomponent like" Q9NZP8 12 7089587-7109238 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.1" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 54.2;Hepatocytes: 140.0;Leydig cells: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.2;HSkMC: 43.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA011338, CAB026172" Supported "Secreted to blood" NA NA 5500000000 15000000000 "CAB026172: , HPA011338: AB_1847111" "prognostic favorable (7.92e-4)" "unprognostic (7.76e-2)" "unprognostic (3.91e-3)" "unprognostic (5.25e-3)" "unprognostic (2.92e-3)" "unprognostic (9.60e-2)" "unprognostic (2.75e-3)" "unprognostic (7.76e-2)" "unprognostic (1.22e-1)" "unprognostic (4.34e-1)" "unprognostic (9.58e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.75e-1)" "unprognostic (5.74e-2)" "unprognostic (2.52e-1)" "unprognostic (2.26e-3)" 37.2 73.1 3.2 12.3 3.2 8.3 36.8 2.6 3.2 35.5 7.4 27.3 7.6 30.5 6.4 17.7 41.2 11.8 15.2 2.3 8.9 20.2 143.1 33.4 9.6 7.3 4.2 1.8 49.8 37.0 8.1 17.6 5.1 4.0 29.5 8.8 1.5 33.9 7.0 11.1 17.9 26.5 13.9 3.3 32.6 27.7 6.1 4.6 6.9 21.9 6.1 7.8 38.4 27.7 3.7 3.0 7.7 0.7 7.9 22.4 38.2 5.4 4.9 22.7 5.0 14.8 4.9 13.4 1.3 4.1 4.1 5.0 6.4 2.1 8.1 1.9 12.0 0.4 4.8 8.5 11.4 18.7 1.0 21.9 43.1 15.7 3.0 9.3 23.3 5.3 2.8 3.6 3.1 3.1 0.1 0.7 0.9 1.4 0.6 0.2 2.7 0.0 1.0 13.1 13.2 0.6 1.7 16.7 2.0 2.8 1.3 1.9 4.1 5.0 4.3 7.7 4.9 0.9 2.3 1.0 0.2 8.1 3.4 2.0 3.8 0.7 4.0 0.6 1.1 0.3 1.2 0.6 0.5 0.8 0.5 0.4 0.4 5.4 0.3 1.3 0.4 0.4 0.4 3.2 3.2 2.6 3.2 2.3 8.9 7.3 4.2 1.8 4.0 3.3 4.6 3.7 11.0 16.0 38.6 7.5 8.4 3.8 15.4 16.4 25.6 0.5 15.6 14.5 2.6 30.0 24.6 5.5 2.1 0.2 7.3 8.3 1.9 36.3 0.1 7.9 22.6 14.6 4.2 7.8 10.2 54.2 0.4 29.0 27.5 10.4 3.8 13.8 25.0 140.0 3.6 0.0 1.3 7.7 10.2 10.0 4.9 3.0 55.6 10.2 3.6 14.0 13.3 4.0 21.6 2.0 0.4 25.8 9.7 20.3 8.0 10.2 9.3 8.2 15.9 1.1 0.0 11.8 10.1 0.6 0.9 8.5 3.1 0.1 9.7 13.6 9.5 8.7 NDUFA9 "CI-39k, COQ11, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 617.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042268, HPA073212" Supported Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 19.1 29.4 26.4 14.9 27.4 35.6 19.2 29.8 38.8 17.6 28.7 33.9 30.9 20.5 14.8 31.1 17.6 6.2 91.1 27.1 26.7 41.1 49.8 18.2 11.9 26.3 26.9 26.7 14.8 24.4 34.5 22.0 10.3 27.6 21.6 31.5 20.3 24.5 11.2 111.4 23.9 31.2 12.8 26.4 23.9 31.9 14.4 27.6 18.3 19.4 111.6 14.6 21.4 20.0 27.9 29.8 52.5 25.3 33.9 18.3 18.1 73.1 22.1 22.4 41.9 31.6 114.4 58.0 33.2 11.6 24.2 47.5 48.9 37.1 32.9 27.0 64.8 65.3 32.5 51.0 88.1 40.0 48.0 33.8 23.3 31.2 28.7 38.6 26.0 32.0 46.8 23.1 60.8 31.5 57.6 48.5 55.1 65.5 55.6 43.2 67.4 37.5 34.5 59.2 66.6 18.2 20.6 27.9 74.4 41.9 54.4 15.4 45.4 22.2 31.8 64.7 29.3 52.3 11.9 15.1 57.1 33.2 29.4 35.7 75.9 134.3 53.3 99.2 165.1 102.1 148.3 102.4 109.3 161.9 110.0 88.9 91.1 11.8 107.5 133.5 168.0 143.6 265.0 26.4 27.4 29.8 38.8 27.1 26.7 26.3 26.9 26.7 27.6 26.4 27.6 27.9 37.5 28.9 32.1 26.1 45.2 48.6 63.7 199.3 21.6 48.6 40.1 37.0 185.1 45.8 99.4 64.4 58.4 111.1 45.7 89.4 166.3 130.0 112.2 29.3 29.6 46.4 47.4 36.0 21.0 131.3 118.7 38.5 35.2 26.0 57.7 36.6 34.6 78.5 114.7 33.7 26.3 125.4 140.4 35.6 31.8 617.2 28.3 41.8 55.2 15.9 60.0 48.2 49.4 27.2 20.1 108.0 83.5 36.9 50.8 40.5 108.5 163.2 74.9 67.8 19.7 32.0 54.8 30.6 31.3 38.5 47.2 99.9 43.4 66.3 147.7 69.4 CLSTN3 "CDHR14, CSTN3, KIAA0726" ENSG00000139182 "Calsyntenin 3" Q9BQT9 12 7129698-7158945 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 161.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 79.4;Inhibitory neurons: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 6.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 1700000 "prognostic favorable (5.08e-4)" "unprognostic (2.84e-2)" "unprognostic (1.06e-3)" "unprognostic (1.33e-2)" "unprognostic (6.73e-3)" "unprognostic (6.35e-2)" "unprognostic (9.52e-2)" "unprognostic (2.58e-1)" "unprognostic (2.94e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.19e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (2.19e-2)" "unprognostic (6.14e-2)" "unprognostic (1.91e-1)" "prognostic favorable (8.07e-4)" 12.9 14.6 18.2 13.8 23.7 12.5 13.4 21.4 45.3 12.3 0.0 7.9 6.9 11.1 2.7 6.8 11.8 10.2 5.9 20.4 27.6 21.0 29.5 12.8 14.4 15.6 16.8 31.7 25.6 10.5 11.3 30.5 3.8 21.3 9.7 3.9 20.4 11.1 4.4 2.5 10.6 14.3 7.3 0.5 20.9 7.6 4.4 30.0 10.3 12.5 1.6 9.1 9.9 9.7 49.2 6.7 11.2 4.3 10.3 4.7 5.2 30.1 3.9 9.4 7.1 12.1 18.3 10.1 12.1 2.9 6.0 9.1 8.4 6.7 8.0 3.5 10.9 7.5 19.2 19.9 18.6 5.9 2.7 34.6 15.2 5.9 8.5 7.4 30.6 9.1 11.2 19.0 6.6 1.3 2.4 8.3 2.8 12.6 0.6 0.7 5.3 0.1 3.5 10.7 13.8 5.6 9.2 8.4 9.5 1.7 10.4 5.4 7.0 4.6 3.9 13.6 8.6 2.4 8.7 2.2 1.6 7.6 3.2 2.8 1.5 0.0 0.0 3.3 0.0 1.9 0.1 1.5 2.9 0.1 0.1 0.5 1.2 0.2 6.9 0.0 0.0 2.0 1.0 18.2 23.7 21.4 45.3 20.4 27.6 15.6 16.8 31.7 21.3 0.5 30.0 49.2 6.0 0.0 3.9 5.2 2.8 4.1 2.3 4.9 7.4 161.2 15.7 7.5 2.3 4.3 3.3 14.7 62.6 5.4 14.1 2.9 0.0 9.2 1.2 3.3 18.0 15.3 29.3 1.3 79.4 7.5 9.3 12.0 7.7 6.3 5.7 8.6 5.7 26.6 1.2 26.9 60.2 4.0 16.2 2.0 7.3 1.9 12.8 3.6 5.4 4.7 1.1 9.5 13.4 10.6 3.1 7.2 3.2 6.4 12.7 1.9 1.3 23.3 3.0 40.3 6.6 5.1 6.8 0.7 1.1 2.7 5.7 3.3 16.6 6.8 3.6 1.8 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.5" "Group enriched" "Detected in many" 4 "dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 390.9;MAIT T-cell: 461.3" "Lineage enriched" "Detected in all" 22 "T-cells: 461.3" "Cell line enhanced" "Detected in many" "HEL: 25.1;NTERA-2: 22.1;U-937: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051403, HPA076494" Approved Enhanced Vesicles NA NA Vesicles "HPA051403: , HPA076494: AB_2686800" "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 3.0 1.7 2.9 3.8 2.9 3.0 2.5 4.2 2.8 1.3 1.4 1.5 1.0 1.3 2.1 1.0 1.0 3.3 1.9 2.3 3.1 1.4 3.0 2.3 10.5 2.6 2.4 3.0 1.0 0.5 0.4 1.2 0.6 3.2 1.1 1.9 1.3 1.6 0.7 1.7 1.0 2.2 1.6 2.0 8.9 1.6 1.1 2.7 2.5 1.0 1.8 5.1 2.4 0.8 4.1 0.2 3.1 1.6 2.3 3.0 0.7 1.4 0.5 0.3 0.4 1.1 1.1 1.1 4.9 0.1 0.4 2.1 0.2 3.3 0.5 0.4 3.6 1.9 25.1 0.4 1.6 0.8 1.1 1.6 1.4 0.4 0.5 0.0 0.4 7.6 2.5 1.4 0.4 0.2 0.7 1.0 2.0 22.1 1.0 1.7 1.2 1.0 0.0 0.5 0.4 0.4 4.4 1.1 0.5 1.6 4.3 0.3 1.7 0.8 0.7 1.0 0.6 1.4 1.4 4.1 2.6 1.8 17.3 0.2 17.5 2.6 1.5 390.9 2.9 461.3 4.2 85.1 237.7 8.2 5.0 23.5 147.7 5.7 20.9 5.4 3.9 8.7 99.7 2.9 2.9 4.2 2.8 2.3 3.1 2.6 2.4 3.0 3.2 2.0 2.7 4.1 12.7 0.0 4.3 2.9 4.7 0.4 0.4 0.0 4.0 5.0 1.0 0.9 2.8 1.5 0.1 0.0 8.4 1.0 93.7 0.1 1.9 0.7 1.6 0.8 0.6 2.9 1.2 24.6 3.8 0.2 0.5 1.3 0.5 0.5 118.9 0.9 25.7 2.0 3.4 5.0 3.6 0.1 0.0 9.1 1.4 3.1 0.6 3.7 1.8 2.8 5.4 1.8 164.8 9.5 6.2 0.3 0.1 0.0 16.9 0.2 0.3 3.1 0.1 3.9 0.0 2.1 1.0 7.8 7.3 1.3 0.0 0.3 109.3 0.7 0.6 0.1 VAMP1 "SYB1, VAMP-1" ENSG00000139190 "Vesicle associated membrane protein 1" P23763 12 6462237-6470677 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 175.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 20.0;Excitatory neurons: 22.6;Inhibitory neurons: 25.0;Oligodendrocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 200.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002779, CAB016119, CAB079000" Approved Supported NA NA "CAB002779: , CAB016119: AB_628309, CAB079000: " "unprognostic (2.33e-1)" "unprognostic (6.72e-3)" "prognostic unfavorable (6.37e-5)" "unprognostic (8.09e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.22e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.04e-11)" "unprognostic (1.47e-2)" "unprognostic (5.99e-2)" "unprognostic (1.62e-1)" "unprognostic (3.65e-2)" 10.6 19.1 68.9 22.1 56.7 64.0 11.6 100.1 175.8 19.3 30.8 29.1 7.0 21.0 7.1 12.6 22.6 6.5 11.3 51.8 79.2 13.0 18.7 15.3 40.0 159.6 91.3 40.5 12.8 10.5 2.7 12.9 3.3 161.4 24.3 12.0 36.0 14.7 10.0 10.0 8.8 33.2 10.4 93.3 42.5 17.6 11.4 96.8 12.9 31.1 3.5 36.2 21.5 18.7 171.2 3.0 11.0 5.8 8.1 16.7 19.1 7.1 5.4 10.5 5.7 16.0 3.9 9.5 30.8 1.1 13.5 5.8 8.9 7.2 3.0 8.3 24.3 15.5 4.9 40.1 4.0 7.6 11.6 11.8 13.7 1.4 7.4 4.2 19.5 5.2 13.4 1.9 8.9 13.0 3.4 15.6 13.9 27.4 1.4 4.7 17.5 9.2 5.6 3.5 4.4 1.2 2.3 10.5 6.0 4.5 30.9 2.0 4.6 6.5 2.8 8.5 5.8 3.9 7.6 3.1 200.3 10.2 24.4 2.3 9.0 1.0 14.1 5.9 0.4 4.8 4.8 4.9 5.7 1.1 1.0 5.1 4.4 5.1 2.2 0.5 2.2 6.8 2.3 68.9 56.7 100.1 175.8 51.8 79.2 159.6 91.3 40.5 161.4 93.3 96.8 171.2 2.8 6.4 2.0 11.1 10.3 1.1 3.3 1.6 9.1 20.0 2.2 5.0 1.9 1.5 1.9 0.0 6.2 0.3 17.8 4.1 1.9 0.2 0.9 3.3 1.2 2.9 4.8 1.3 22.6 0.5 0.7 3.5 5.1 1.6 10.8 2.6 2.2 3.1 1.7 1.7 25.0 2.1 8.2 3.8 2.6 0.5 3.7 3.6 0.0 6.5 6.0 6.4 10.3 6.6 26.8 0.6 2.8 4.9 12.2 1.8 0.6 0.4 4.9 6.8 6.6 4.7 4.2 2.7 4.3 3.0 0.9 0.1 14.8 2.9 1.6 0.9 TAPBPL "FLJ10143, TAPBP-R, TAPBPR" ENSG00000139192 "TAP binding protein like" Q9BX59 12 6451690-6466517 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Plasma cells: 94.2;Proximal enterocytes: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 64.2;HDLM-2: 37.6;Karpas-707: 44.9;RPMI-8226: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039545 Uncertain NA NA "HPA039545: AB_10673360" "prognostic favorable (1.98e-4)" "unprognostic (3.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.30e-1)" "unprognostic (1.32e-1)" "unprognostic (4.61e-2)" "unprognostic (1.91e-1)" "unprognostic (7.64e-2)" "unprognostic (4.07e-2)" "unprognostic (3.18e-1)" "unprognostic (5.66e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.04e-5)" "unprognostic (3.53e-2)" "unprognostic (7.61e-2)" "unprognostic (6.28e-2)" "prognostic favorable (7.86e-4)" 11.2 11.8 3.0 12.2 3.7 12.6 12.1 3.7 5.2 12.1 5.6 21.5 33.1 11.8 5.9 10.0 17.6 21.7 12.7 2.8 5.6 14.6 19.8 17.6 17.5 4.7 3.5 1.9 10.5 9.4 13.5 10.9 8.2 3.8 11.9 11.3 0.9 34.6 20.2 9.4 8.7 28.3 7.3 3.8 16.9 24.0 2.1 3.2 16.3 22.2 3.7 7.2 14.0 10.2 4.4 6.5 4.7 0.1 2.8 9.5 13.7 13.2 4.3 11.5 5.4 7.9 5.4 64.2 5.6 2.4 5.6 3.1 7.6 0.0 1.1 1.0 37.6 0.0 5.8 3.6 6.0 12.0 5.3 15.0 19.9 3.7 9.9 1.5 3.5 7.6 3.7 0.0 44.9 1.4 13.9 10.5 2.7 0.8 0.4 1.1 10.9 3.4 36.4 4.3 18.0 0.6 0.1 15.8 9.3 1.2 0.1 0.4 11.5 7.2 5.8 2.3 1.6 7.7 7.4 2.0 3.2 10.8 5.3 6.5 126.0 102.3 72.9 89.9 124.9 56.7 40.7 45.7 57.5 76.7 38.5 28.9 52.5 74.6 104.5 102.6 60.6 33.7 124.6 3.0 3.7 3.7 5.2 2.8 5.6 4.7 3.5 1.9 3.8 3.8 3.2 4.4 21.4 19.2 13.1 7.8 26.7 8.3 18.6 47.1 14.2 4.0 14.2 11.3 6.1 27.1 35.1 35.0 10.4 19.2 28.4 49.8 0.0 27.7 0.3 7.0 7.7 15.1 9.0 8.2 1.1 53.8 18.7 24.3 18.3 10.9 13.3 5.1 14.3 11.9 31.8 0.0 1.4 32.6 26.4 16.9 17.7 0.4 15.5 22.5 16.0 2.8 21.3 7.6 34.0 4.0 3.1 34.3 63.2 8.6 94.2 16.1 82.3 12.6 16.0 1.9 6.6 8.8 9.6 0.5 0.2 8.8 8.0 13.8 26.3 3.4 33.7 22.5 CD27 "S152, TNFRSF7, Tp55" ENSG00000139193 "CD27 molecule" P26842 12 6444955-6451718 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 149.0" "Group enriched" "Detected in many" 11 "B-cells: 119.4;Melanocytes: 97.8;Plasma cells: 352.1;T-cells: 109.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in all" "T-reg: 640.4" "Group enriched" "Detected in all" 7 "B-cells: 293.4;T-cells: 640.4" "Group enriched" "Detected in some" 107 "Daudi: 238.2;U-698: 141.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002420, HPA038936" Enhanced NA NA 100000 "CAB002420: AB_563539, HPA038936: AB_2676278" "unprognostic (2.75e-3)" "prognostic favorable (3.77e-5)" "unprognostic (8.87e-3)" "prognostic favorable (2.90e-4)" "unprognostic (2.35e-1)" "prognostic favorable (6.65e-7)" "unprognostic (3.56e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.50e-4)" "unprognostic (1.31e-3)" "unprognostic (4.32e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.80e-1)" "unprognostic (3.15e-1)" "unprognostic (1.28e-1)" "unprognostic (7.35e-2)" 2.1 2.6 0.1 59.6 0.4 10.7 4.3 0.0 0.3 2.4 0.1 18.2 22.7 1.8 1.0 10.3 1.9 11.1 4.0 0.1 0.1 1.3 2.1 8.2 149.0 0.4 0.3 0.2 3.1 1.5 0.0 0.3 0.4 0.7 2.5 11.7 0.4 12.4 1.4 0.6 1.9 34.8 1.6 0.2 74.4 16.7 0.9 0.4 45.1 6.5 0.7 107.2 19.1 1.4 0.9 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 238.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.8 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.5 0.1 0.0 0.0 0.0 141.7 0.3 0.1 0.0 6.2 1.6 1.4 117.2 1.3 201.2 293.4 283.5 262.6 1.0 114.8 382.8 281.1 6.2 65.0 1.6 2.4 640.4 182.4 0.1 0.4 0.0 0.3 0.1 0.1 0.4 0.3 0.2 0.7 0.2 0.4 0.9 1.1 0.0 4.9 0.3 119.4 2.3 0.1 0.0 0.6 1.1 1.1 1.3 0.1 0.0 0.6 0.0 0.0 0.1 7.0 0.3 0.0 0.2 0.0 0.2 0.3 0.9 1.2 8.4 0.2 0.0 0.0 1.5 3.1 0.3 1.3 0.0 2.5 1.5 0.3 0.0 0.3 0.1 0.0 3.2 4.4 0.3 0.3 3.0 97.8 0.0 5.7 0.4 14.4 1.0 1.0 0.0 0.1 0.4 352.1 0.2 0.0 0.9 0.8 1.4 0.0 0.7 1.3 0.1 0.1 0.6 3.1 0.3 109.5 0.0 2.4 0.0 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7115736-7128889 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 435.6;liver: 326.8" "Cell type enriched" "Detected in many" 8 "Proximal tubular cells: 3197.2" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.0;Hep G2: 13.4;K-562: 26.3" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA038723: AB_2676175" "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favorable (3.68e-4)" 5.5 11.8 0.1 15.1 0.1 1.6 5.2 0.2 0.3 9.8 0.5 6.2 4.7 8.7 3.2 3.9 8.2 6.0 1.3 0.0 0.8 435.6 326.8 3.8 31.4 0.5 0.2 0.0 5.0 5.2 1.4 6.2 0.3 0.3 10.1 5.0 0.8 3.7 5.0 0.7 2.4 20.8 5.4 0.0 97.9 5.3 2.2 0.2 14.3 8.0 0.0 21.6 7.5 4.6 0.7 0.9 1.3 0.0 0.3 0.0 0.0 0.2 1.1 0.0 0.0 0.2 1.1 1.2 1.0 0.3 0.0 0.1 1.2 0.1 0.0 0.0 1.6 0.0 6.0 3.9 13.4 0.0 0.2 0.9 0.2 0.0 0.0 0.0 2.4 0.0 0.6 26.3 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.1 1.2 0.0 0.2 1.4 0.9 0.0 0.6 0.5 0.7 0.7 0.6 0.5 2.8 0.4 0.3 0.1 0.0 0.3 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.0 0.8 0.5 0.2 0.0 0.3 0.0 0.2 0.7 4.9 0.0 0.6 0.7 15.2 1.5 0.5 0.1 0.0 1.2 1.3 1.3 0.1 5.7 0.1 80.9 0.0 0.1 0.3 0.1 352.1 0.2 4.1 0.3 1.7 28.8 0.0 0.0 2.1 0.4 0.0 8.2 0.0 0.5 0.0 0.2 8.9 361.1 0.1 5.0 1.1 0.0 0.0 8.1 2.6 6.7 2.5 16.6 0.0 1.9 0.0 1.4 0.0 0.5 0.1 0.2 0.0 0.4 0.1 0.5 0.0 3197.2 0.9 1.7 0.0 0.1 4.3 0.7 0.4 0.2 2.3 0.0 7.3 2.4 0.1 0.3 PEX5 "PTS1R, PXR1" ENSG00000139197 "Peroxisomal biogenesis factor 5" P50542 12 7188685-7218574 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Early spermatids: 277.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 156.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039259, HPA039260" Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA039259: AB_10673419, HPA039260: AB_2676417" "unprognostic (7.44e-2)" "unprognostic (2.54e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-1)" "unprognostic (1.27e-1)" "unprognostic (4.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (5.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.63e-2)" "unprognostic (2.92e-1)" "unprognostic (5.70e-2)" "unprognostic (7.31e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (1.13e-1)" 33.0 28.0 42.8 13.3 41.3 8.9 34.5 37.9 42.7 25.0 31.8 23.8 12.2 26.2 11.0 19.0 23.4 13.7 20.5 38.6 64.6 24.6 38.1 22.2 18.8 40.1 40.9 36.0 29.4 30.6 19.1 44.4 10.1 40.4 19.8 12.0 13.7 22.3 13.8 74.7 25.9 20.5 15.3 42.3 16.2 22.4 51.3 42.4 39.7 20.2 28.7 20.9 21.9 21.4 39.9 14.7 24.7 13.0 34.2 29.1 19.9 24.3 14.0 16.6 16.2 17.2 36.9 21.8 156.1 8.3 16.2 23.6 18.2 22.1 19.5 16.8 20.8 18.2 13.8 19.0 25.7 15.4 21.3 13.6 22.2 35.2 11.1 34.5 22.0 14.2 75.0 28.2 5.3 14.7 20.0 49.7 18.5 38.6 28.0 13.1 23.7 28.1 21.4 13.0 21.4 10.9 22.6 20.9 45.4 20.1 26.2 10.2 12.5 12.7 18.2 29.9 15.8 17.2 9.5 11.6 53.4 18.0 22.8 12.2 0.0 1.6 2.1 2.9 1.4 3.6 1.9 2.0 2.9 2.6 1.4 2.6 2.6 1.2 2.8 4.1 4.6 0.9 2.2 42.8 41.3 37.9 42.7 38.6 64.6 40.1 40.9 36.0 40.4 42.3 42.4 39.9 8.6 12.8 20.1 11.4 5.6 14.5 7.2 5.2 8.0 7.8 9.2 8.5 13.7 14.3 5.6 7.3 8.4 11.3 5.1 9.9 9.8 10.1 277.8 7.0 13.6 10.3 7.2 4.6 31.5 14.9 6.4 7.8 4.1 5.2 3.8 7.2 5.7 17.6 4.7 13.5 22.1 7.2 4.1 5.4 5.0 43.7 14.3 5.2 5.4 1.0 4.6 12.7 5.2 16.1 13.3 10.2 14.2 13.9 2.9 14.1 9.9 19.3 9.8 7.0 19.7 12.0 10.2 32.2 16.6 7.4 15.3 7.7 5.8 9.6 10.4 5.7 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693791-6700815 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 91.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.1;Excitatory neurons: 24.4;Horizontal cells: 18.5;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 16.1;Peritubular cells: 13.9;Spermatogonia: 6.7" "Group enriched" "Detected in many" 4 "glioma: 14.7;testis cancer: 7.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.9;HAP1: 9.8;hTERT-RPE1: 16.2;NTERA-2: 20.8;SH-SY5Y: 19.4;U-2 OS: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 0.3 5.4 67.2 0.9 55.7 0.0 0.8 13.6 91.1 16.2 0.0 4.3 0.6 21.3 2.2 0.8 7.5 1.7 0.9 60.4 36.5 0.7 0.2 1.0 1.1 20.4 19.0 57.5 3.4 0.7 5.4 15.8 0.3 25.8 5.5 0.7 8.0 0.8 5.5 0.3 0.4 3.0 5.1 1.8 0.6 2.3 4.0 27.7 0.0 0.9 0.4 0.4 3.8 10.2 53.1 0.0 0.5 7.4 1.4 0.2 0.4 0.2 2.0 9.9 5.1 4.6 0.1 0.2 0.2 0.0 3.5 0.8 0.2 9.8 0.3 2.4 0.3 1.3 0.4 0.3 0.0 0.3 0.4 0.3 1.2 0.0 2.0 0.0 16.2 0.0 3.0 0.0 0.3 0.5 0.2 0.3 0.3 20.8 0.0 0.1 1.4 0.1 0.2 0.1 0.1 2.6 19.4 0.1 0.1 0.0 1.3 0.1 0.0 0.0 5.2 10.5 5.5 1.4 0.2 0.0 0.3 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 55.7 13.6 91.1 60.4 36.5 20.4 19.0 57.5 25.8 1.8 27.7 53.1 0.2 0.0 0.0 3.6 0.1 0.3 0.0 0.0 0.0 16.1 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.8 0.3 3.5 0.2 0.0 0.0 24.4 0.0 0.0 1.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 18.5 23.9 0.0 0.0 0.0 0.2 1.1 2.1 0.0 0.0 3.7 0.0 3.9 0.0 16.1 3.1 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 1.6 0.1 6.7 0.0 0.1 0.1 0.3 0.0 0.0 0.1 SLC38A4 "ATA3, NAT3, PAAT" ENSG00000139209 "Solute carrier family 38 member 4" Q969I6 12 46764761-46832408 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 60 "liver: 614.9" "Cell type enriched" "Detected in some" 25 "Hepatocytes: 289.5" "Cancer enriched" "Detected in many" 14 "liver cancer: 61.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 17.7;LHCN-M2: 43.2;RH-30: 14.6;RT4: 86.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.81e-2)" "unprognostic (7.46e-3)" "unprognostic (5.22e-3)" "unprognostic (1.75e-2)" "unprognostic (3.12e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.37e-4)" "unprognostic (3.06e-2)" "unprognostic (2.57e-3)" "unprognostic (1.75e-2)" "unprognostic (1.95e-1)" "unprognostic (6.06e-2)" "unprognostic (2.84e-2)" "unprognostic (1.89e-2)" "unprognostic (8.28e-2)" "unprognostic (6.31e-3)" "unprognostic (2.21e-2)" 0.8 1.1 0.3 0.4 0.2 0.0 1.2 0.1 0.4 0.5 0.5 5.1 0.4 2.2 0.2 1.7 0.9 0.3 0.3 0.2 0.6 4.5 614.9 0.4 0.2 0.3 0.3 0.1 0.2 6.7 0.2 0.1 2.2 0.4 1.3 1.3 0.2 0.8 0.5 10.2 2.6 0.5 5.5 0.2 1.2 0.2 0.3 0.6 1.4 0.3 2.7 0.8 2.0 0.2 0.4 0.0 0.0 0.1 0.0 17.7 2.2 3.4 2.3 5.6 2.0 1.8 1.1 4.3 0.0 3.5 7.8 0.0 1.0 0.0 0.6 1.7 0.0 0.0 0.1 0.0 0.2 0.7 0.5 0.0 4.2 0.1 0.1 1.4 0.1 0.0 0.0 0.2 0.0 43.2 0.0 0.1 0.0 1.3 0.0 0.0 0.0 14.6 0.0 0.0 86.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.2 0.5 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.6 0.3 0.3 0.1 0.4 0.2 0.6 0.4 0.1 0.0 0.0 2.6 0.5 0.8 0.0 2.2 3.4 0.0 0.1 0.0 1.5 11.5 0.2 1.8 0.0 2.5 0.0 1.9 0.0 0.0 0.2 0.4 0.2 1.2 0.0 5.3 0.6 0.0 0.7 1.2 0.0 0.2 0.0 1.6 3.9 289.5 0.5 0.0 2.2 0.4 2.0 6.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.2 1.2 0.0 0.0 0.7 0.3 0.4 0.2 0.0 0.0 0.3 0.2 0.0 0.1 2.8 0.6 0.8 0.4 2.7 1.3 0.1 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079959 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 62.6;Enteroendocrine cells: 60.4;Glandular and luminal cells: 72.8;Granulosa cells: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 192.0;fHDF/TERT166: 183.2;hTERT-RPE1: 312.2;LHCN-M2: 179.2;RT4: 251.9;U-2 OS: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 390000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 10.5 19.9 6.3 7.1 5.1 3.5 23.0 4.4 5.6 18.2 3.1 28.3 3.3 31.0 7.9 4.1 36.7 19.4 4.6 3.3 12.0 7.7 4.7 20.1 12.5 9.5 16.4 4.3 29.0 3.6 6.4 5.3 13.3 14.3 11.4 9.1 26.0 4.5 11.1 1.1 3.8 12.7 34.6 4.9 17.5 5.6 10.8 14.2 2.8 4.3 2.2 7.7 22.8 14.4 8.6 44.4 105.5 6.3 0.2 2.5 0.2 17.2 14.8 39.3 4.7 3.8 0.3 192.0 0.0 47.6 183.2 117.0 64.8 0.0 117.6 5.5 8.6 0.7 0.0 11.0 0.1 3.8 1.2 1.7 0.9 20.1 122.6 59.5 312.2 15.0 0.9 8.5 0.0 179.2 2.1 3.6 0.1 4.5 21.2 27.1 0.3 46.5 0.1 52.3 251.9 18.8 0.0 76.2 9.0 0.5 3.4 11.2 1.0 4.1 2.6 149.9 1.7 121.3 1.9 0.4 0.2 10.0 3.4 2.8 0.0 0.1 0.0 4.4 0.2 6.0 3.7 6.8 6.9 0.7 1.6 15.3 12.1 0.1 8.6 0.0 8.8 4.4 4.7 6.3 5.1 4.4 5.6 3.3 12.0 9.5 16.4 4.3 14.3 4.9 14.2 8.6 7.2 9.6 3.1 1.0 3.6 2.4 13.1 39.4 15.4 62.6 10.8 37.7 1.6 1.5 4.9 1.8 0.0 1.0 12.4 0.4 1.9 5.3 1.4 31.5 6.0 12.7 60.4 5.7 2.6 19.3 28.1 11.1 0.5 72.8 7.0 76.8 32.2 1.2 4.8 0.0 0.2 3.1 2.0 3.5 1.1 2.3 2.5 7.2 1.8 1.9 5.3 15.6 2.1 0.0 0.1 40.4 1.5 0.7 3.8 10.7 0.0 0.1 2.9 4.9 0.0 3.2 27.7 0.7 2.4 2.5 0.4 8.5 7.6 12.8 0.3 33.9 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 31.3 21.4 23.6 42.1 30.5 90.4 40.5 40.7 26.6 28.2 38.2 31.9 29.7 34.8 41.5 26.9 26.9 31.2 30.3 21.3 33.1 30.2 42.8 31.3 55.1 30.7 27.9 17.2 38.1 23.7 40.1 17.3 31.8 32.4 29.7 35.3 61.3 27.3 25.2 35.5 40.6 32.0 29.4 29.3 43.4 29.9 29.3 27.4 44.8 35.1 38.9 50.2 32.1 23.8 39.9 56.4 49.4 60.6 50.7 41.0 55.7 56.0 64.7 52.6 54.8 39.3 180.3 60.1 116.7 71.0 69.3 32.3 54.0 62.4 52.2 61.9 62.1 42.1 108.8 64.5 47.0 32.3 115.6 70.4 46.4 54.7 47.2 71.1 62.9 57.1 50.0 85.1 62.3 70.3 51.9 87.2 63.4 47.0 0.6 67.4 70.2 81.7 57.9 52.4 70.5 34.2 35.0 71.9 60.8 35.0 47.6 56.4 123.4 71.6 55.9 46.3 42.5 34.9 44.4 36.0 187.9 47.0 245.0 21.8 39.4 19.6 29.5 21.7 19.9 19.9 28.6 20.6 21.3 16.0 28.2 22.2 20.0 51.5 21.3 23.5 30.2 20.8 12.9 23.6 30.5 40.7 26.6 21.3 33.1 30.7 27.9 17.2 32.4 29.3 27.4 39.9 180.2 176.3 164.0 91.4 200.4 128.5 127.6 87.4 132.1 134.9 101.8 96.8 187.4 88.6 131.7 79.1 127.2 86.3 229.6 96.1 54.8 117.8 57.7 133.3 148.7 146.2 103.3 118.4 75.3 107.9 72.5 135.3 69.3 152.4 222.7 224.7 114.5 138.9 109.8 107.7 81.7 123.3 67.1 158.0 160.9 39.2 121.8 157.3 67.6 141.5 211.7 105.2 185.3 119.6 122.4 103.4 103.4 103.8 126.4 121.6 97.2 83.5 149.6 198.4 124.9 176.3 129.7 157.6 82.5 116.4 120.5 61.0 170.6 114.2 107.5 145.0 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972967-48004554 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 19.3;pituitary gland: 9.2;retina: 5.7;stomach 1: 12.6" "Cell type enhanced" "Detected in some" "Early spermatids: 15.4;Enteroendocrine cells: 43.9;Late spermatids: 9.7;Muller glia cells: 22.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 156.3;HAP1: 98.9;HEK 293: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB002214, HPA055753" Approved Approved Nucleoplasm "Secreted to extracellular matrix" No NA 1400000 Nucleoplasm "CAB002214: AB_563666, HPA055753: AB_2682908" "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.2 0.0 0.2 19.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.2 0.2 0.0 1.3 0.0 0.0 9.2 0.3 0.2 1.0 0.3 5.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.6 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.7 0.0 0.0 0.0 98.9 0.0 0.0 0.0 36.3 0.2 0.0 5.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 2.9 0.0 0.0 0.1 2.2 0.1 0.0 0.0 0.0 11.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.0 0.6 5.7 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 15.4 0.3 0.1 0.2 43.9 0.0 0.2 0.0 0.3 0.5 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.2 0.0 1.7 0.0 0.9 0.3 0.6 1.1 0.0 0.0 0.8 0.1 0.1 1.7 0.1 PPFIA2 ENSG00000139220 "PTPRF interacting protein alpha 2" O75334 12 81257975-81759553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 55.5;retina: 50.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 806.6;Inhibitory neurons: 641.1;Oligodendrocyte precursor cells: 609.7;Oligodendrocytes: 409.8;Rod photoreceptor cells: 195.9" "Group enriched" "Detected in some" 4 "glioma: 0.8;prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 29.8;hTERT-RPE1: 5.0;SCLC-21H: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.31e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-2)" "unprognostic (6.78e-5)" "unprognostic (4.69e-3)" "unprognostic (2.13e-1)" "unprognostic (6.67e-2)" "unprognostic (7.10e-2)" "unprognostic (8.92e-2)" "unprognostic (3.97e-2)" "unprognostic (3.76e-1)" "unprognostic (9.84e-2)" "unprognostic (3.27e-3)" "unprognostic (2.45e-2)" "unprognostic (4.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.06e-3)" 1.5 5.8 24.6 0.3 26.8 0.0 1.1 0.4 50.3 3.9 0.0 1.1 0.3 2.3 0.6 0.6 2.6 1.7 0.5 55.5 12.8 0.8 0.2 0.8 0.1 6.5 9.4 27.4 1.1 0.5 0.1 4.6 0.0 6.6 1.4 1.4 50.5 0.5 3.2 0.3 0.7 0.7 2.1 1.5 0.2 0.9 6.2 6.6 0.1 0.9 0.1 0.1 1.3 2.2 21.1 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 29.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.1 0.0 1.4 0.0 10.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.0 2.0 0.0 0.0 0.0 0.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 26.8 0.4 50.3 55.5 12.8 6.5 9.4 27.4 6.6 1.5 6.6 21.1 0.6 0.0 1.1 136.8 0.0 0.4 0.0 0.0 0.0 107.8 0.0 0.9 0.6 0.0 0.0 0.0 89.6 0.0 0.0 0.1 1.9 0.0 140.3 0.7 16.0 0.7 16.3 0.0 806.6 0.0 0.0 2.3 0.0 0.4 0.0 0.1 0.0 0.0 0.1 48.8 641.1 0.2 0.0 0.0 0.5 61.5 0.0 0.0 0.0 11.2 0.0 12.6 0.0 609.7 409.8 0.0 0.0 16.6 0.0 0.3 0.0 0.1 0.0 195.9 0.0 2.4 8.6 6.5 2.4 0.0 0.6 0.1 0.0 0.2 0.0 0.1 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472559-48473622 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Smooth muscle cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 LLPH "C12orf31, hLLP, MGC14817" ENSG00000139233 "LLP homolog, long-term synaptic facilitation factor" Q9BRT6 12 66116555-66130750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048920, HPA058786" Enhanced "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA048920: AB_2680556, HPA058786: AB_2683820" "unprognostic (3.60e-3)" "unprognostic (4.94e-2)" "unprognostic (4.07e-2)" "unprognostic (3.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.31e-2)" "prognostic unfavorable (6.44e-7)" "unprognostic (7.15e-2)" "unprognostic (1.30e-2)" "unprognostic (8.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.07e-2)" "unprognostic (3.87e-2)" "unprognostic (9.65e-3)" "unprognostic (2.49e-2)" "unprognostic (3.37e-1)" "unprognostic (2.94e-2)" 21.8 34.6 12.8 24.6 13.8 50.7 18.8 13.3 16.1 13.4 12.3 20.3 19.3 15.3 18.8 19.6 13.3 14.8 23.3 13.3 13.8 21.1 21.4 15.6 26.5 14.1 13.9 11.9 17.7 17.4 17.1 10.8 17.6 14.3 15.4 20.5 7.5 14.6 14.3 29.9 13.9 18.3 19.5 13.6 18.4 19.3 22.2 13.9 22.3 17.5 25.6 25.8 27.5 14.1 15.6 77.0 61.1 36.4 44.2 42.6 40.8 44.5 87.0 56.4 63.9 53.6 52.8 31.0 87.0 70.6 58.6 50.7 63.6 57.2 52.9 85.7 78.4 48.8 94.5 41.7 47.3 49.8 162.5 61.8 41.9 53.6 53.7 58.3 50.1 56.6 44.1 81.5 60.9 76.1 81.3 74.1 110.4 77.9 61.6 63.0 61.9 67.2 62.7 63.3 90.8 36.3 45.1 57.0 58.3 97.4 38.0 77.4 89.5 60.5 48.3 71.3 60.9 80.4 45.7 77.6 130.2 65.4 76.0 76.8 34.3 32.0 35.5 27.8 38.0 32.0 29.2 32.3 30.6 31.3 27.5 27.4 29.2 43.8 27.4 48.4 27.0 38.9 28.8 12.8 13.8 13.3 16.1 13.3 13.8 14.1 13.9 11.9 14.3 13.6 13.9 15.6 34.2 12.8 33.9 2.9 47.6 27.1 53.9 86.3 30.1 15.9 24.5 28.4 25.1 41.5 64.3 31.3 4.2 66.3 49.4 34.1 66.5 68.3 63.3 40.5 45.4 32.5 13.8 33.4 5.0 71.3 70.4 34.8 35.7 46.6 89.4 61.2 35.7 60.2 64.2 21.9 4.4 31.1 85.5 50.4 26.5 17.0 43.8 45.6 35.6 3.7 84.1 30.8 59.8 3.0 5.8 96.3 43.3 30.1 27.3 46.3 44.0 86.5 35.8 15.2 26.3 29.7 36.8 126.6 48.6 30.6 30.5 72.7 43.8 126.4 36.1 60.6 LRIG3 "FLJ90440, KIAA3016" ENSG00000139263 "Leucine rich repeats and immunoglobulin like domains 3" Q6UXM1 12 58872149-58920504 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 42.8;Basal squamous epithelial cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 49.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010773 Approved Approved Cytosol NA NA Cytosol "HPA010773: AB_1853275" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-2)" "unprognostic (3.88e-2)" "unprognostic (2.53e-1)" "unprognostic (3.46e-2)" "unprognostic (1.83e-2)" "unprognostic (1.34e-3)" "unprognostic (1.21e-1)" "unprognostic (1.92e-1)" "unprognostic (3.04e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-3)" "unprognostic (2.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.46e-2)" 16.4 2.6 4.1 6.8 4.0 0.1 19.0 3.0 3.2 17.9 10.4 18.8 14.3 12.6 10.6 22.5 14.5 17.9 4.7 3.5 3.3 10.4 10.4 10.5 4.4 4.2 4.1 2.1 22.6 19.1 9.2 7.1 11.6 3.1 10.6 25.8 1.8 33.2 10.5 4.1 35.4 13.5 15.5 4.8 8.8 18.0 3.3 3.2 12.3 58.7 7.9 9.7 18.8 18.7 7.7 3.9 3.6 13.6 1.0 24.2 28.0 3.1 9.2 26.4 8.7 9.3 10.9 5.0 3.7 18.3 10.3 10.5 17.9 5.1 23.3 6.3 28.1 17.8 0.9 6.3 5.4 4.7 1.6 0.4 27.9 49.8 9.3 19.8 16.9 24.1 4.2 0.2 4.5 5.8 1.8 4.5 0.1 14.4 4.6 5.5 0.0 11.5 9.2 6.7 19.8 13.8 0.0 8.1 5.0 8.6 19.0 9.3 0.2 10.4 11.8 8.1 7.1 12.2 1.9 0.0 0.0 2.5 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.0 3.0 3.2 3.5 3.3 4.2 4.1 2.1 3.1 4.8 3.2 7.7 17.1 16.0 24.6 17.9 0.1 22.4 8.2 42.8 44.9 3.8 6.3 10.3 3.7 34.3 23.0 1.8 0.0 0.8 0.5 24.5 0.0 11.8 0.3 8.2 37.0 16.2 11.5 0.0 1.8 18.1 0.5 19.6 23.4 4.6 0.0 0.1 12.1 7.3 2.6 3.3 6.0 11.4 16.2 0.3 8.2 1.8 27.1 0.4 3.6 9.4 0.0 3.4 0.0 3.5 22.4 7.4 15.6 29.0 1.8 4.4 8.7 4.9 14.1 0.2 6.6 10.6 11.3 0.5 2.0 25.3 22.4 0.3 1.0 15.0 31.5 4.7 MARCHF9 "FLJ36578, MARCH9, RNF179" ENSG00000139266 "Membrane associated ring-CH-type finger 9" Q86YJ5 12 57755103-57760411 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Adipocytes: 6.0;B-cells: 6.6;Cardiomyocytes: 12.3;dendritic cells: 12.0;Hofbauer cells: 7.3;Plasma cells: 8.3;T-cells: 3.4" "Cancer enriched" "Detected in all" 4 "glioma: 39.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 12 "RH-30: 515.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-2)" "unprognostic (6.78e-2)" "unprognostic (1.90e-3)" "prognostic favorable (3.07e-4)" "unprognostic (2.16e-1)" "unprognostic (6.85e-2)" "unprognostic (8.15e-3)" "prognostic favorable (1.54e-5)" "unprognostic (7.76e-2)" "prognostic favorable (1.59e-4)" "unprognostic (1.08e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.44e-1)" "unprognostic (2.86e-1)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" 8.8 17.7 15.7 7.9 16.2 5.2 10.1 18.2 17.3 10.4 14.7 13.3 7.7 9.1 8.5 12.7 8.5 6.4 16.3 16.1 16.2 28.1 8.7 19.1 14.0 15.3 15.8 16.4 8.9 17.5 18.1 35.2 7.8 15.6 16.6 6.6 41.0 14.4 8.5 13.1 17.0 20.2 4.7 14.6 29.3 14.9 5.2 15.2 19.6 25.6 9.1 13.9 9.9 10.1 14.9 15.3 7.5 11.6 12.7 1.2 0.4 15.0 2.3 16.0 8.8 8.5 9.7 12.0 37.3 12.1 0.4 15.2 13.6 19.1 16.3 5.7 22.4 21.1 4.8 5.9 5.0 10.7 4.6 7.5 1.8 16.8 2.5 8.9 26.0 3.8 36.9 6.9 37.1 2.3 14.5 24.3 5.8 7.6 10.8 16.1 19.9 515.3 40.6 17.5 13.4 26.1 17.1 1.1 1.2 10.4 5.6 26.4 9.1 0.3 11.4 9.1 6.5 7.5 41.8 20.4 22.6 12.5 1.1 11.7 2.0 0.4 0.1 3.2 0.6 5.0 4.6 5.1 4.4 1.4 5.8 5.0 3.7 0.2 2.6 0.2 9.8 3.3 1.1 15.7 16.2 18.2 17.3 16.1 16.2 15.3 15.8 16.4 15.6 14.6 15.2 14.9 6.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 1.9 12.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 3.4 0.0 0.0 0.0 INHBE "activin, MGC4638" ENSG00000139269 "Inhibin subunit beta E" P58166 12 57452323-57459280 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 94 "liver: 149.6" "Cell type enriched" "Detected in single" 43 "Hepatocytes: 35.0" "Cancer enriched" "Detected in some" 27 "liver cancer: 34.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016843, CAB034017" Enhanced Supported Vesicles "Secreted to blood" NA NA 3500000 Vesicles "CAB034017: AB_2233745, HPA016843: AB_1851796" "unprognostic (7.34e-2)" "unprognostic (6.73e-2)" "unprognostic (3.45e-1)" "unprognostic (4.69e-5)" "unprognostic (2.61e-1)" "unprognostic (2.50e-1)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.79e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.66e-8)" "unprognostic (4.09e-3)" "unprognostic (1.56e-1)" "unprognostic (3.57e-2)" "unprognostic (7.52e-3)" 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.3 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 149.6 0.1 0.1 0.9 0.3 0.1 0.0 0.9 0.1 1.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 1.5 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.0 1.4 0.5 0.0 0.2 0.1 0.2 0.2 0.4 0.3 0.5 0.0 0.5 0.3 2.9 7.8 0.2 9.2 0.4 0.1 4.0 1.9 0.7 0.2 0.4 1.8 0.0 1.2 18.3 0.2 0.1 0.3 11.9 50.8 2.3 2.4 4.9 5.3 1.2 11.4 0.4 0.0 1.8 5.0 79.1 0.0 0.0 0.2 0.2 0.5 0.1 0.3 0.2 36.9 8.8 0.0 0.1 19.5 0.9 0.0 0.0 7.6 0.3 0.6 8.7 0.3 0.2 4.0 0.1 0.6 263.5 9.2 3.8 1.5 0.4 0.3 0.9 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.1 0.2 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.1 0.9 0.3 0.1 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 GLIPR1 "GliPR, RTVP1" ENSG00000139278 "GLI pathogenesis related 1" P48060 12 75480753-75503863 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 216.3;Extravillous trophoblasts: 384.2;Hofbauer cells: 242.4;Kupffer cells: 273.9;Langerhans cells: 393.2;Macrophages: 259.6;monocytes: 220.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 189.3;U-138 MG: 363.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011014 Approved "Intracellular and membrane" NA NA 64000 "HPA011014: AB_1849714" "unprognostic (2.32e-3)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-2)" "unprognostic (2.19e-1)" "unprognostic (3.31e-1)" "unprognostic (2.32e-3)" "unprognostic (4.09e-1)" "unprognostic (7.58e-2)" "unprognostic (3.10e-1)" "unprognostic (7.23e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.69e-9)" "unprognostic (9.06e-3)" "unprognostic (5.08e-2)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" 17.3 17.1 2.0 47.4 2.4 18.4 11.6 1.7 7.8 13.8 6.7 10.6 6.6 32.9 6.0 8.0 18.1 33.8 7.1 2.3 5.6 4.7 12.6 22.3 33.0 4.0 3.1 1.4 13.9 3.7 2.3 3.9 26.0 4.0 9.3 12.7 1.8 9.8 17.3 3.2 3.4 14.2 40.3 5.1 36.7 10.9 4.8 3.6 20.0 5.4 7.3 32.5 35.3 6.8 6.2 7.2 7.0 5.9 0.6 22.0 46.2 0.9 93.0 97.5 76.8 55.7 3.8 2.7 23.9 19.1 101.7 67.6 1.2 0.2 38.6 124.7 38.0 1.6 1.2 8.4 6.1 25.1 8.4 1.3 43.0 14.1 189.3 41.4 123.1 62.0 1.7 1.7 29.0 144.7 0.1 4.0 20.2 0.6 0.2 2.8 1.0 4.5 0.8 8.1 1.6 0.2 0.2 38.5 0.3 0.2 12.5 0.9 6.7 102.6 363.8 35.4 39.2 144.1 5.1 0.8 2.1 144.4 9.9 5.6 25.3 352.7 40.9 115.0 232.6 77.2 73.9 80.5 90.7 240.2 90.2 24.3 50.4 462.1 20.4 265.6 202.1 91.2 265.0 2.0 2.4 1.7 7.8 2.3 5.6 4.0 3.1 1.4 4.0 5.1 3.6 6.2 6.5 12.8 16.0 2.0 121.6 13.6 189.2 23.0 4.0 2.9 15.5 19.9 0.9 5.7 10.0 3.7 4.2 4.8 216.3 0.3 0.0 102.8 14.3 11.3 119.4 7.0 3.5 11.8 13.3 83.9 384.2 46.1 2.0 16.4 10.1 0.8 10.4 4.4 242.4 6.7 14.6 0.4 4.1 273.9 393.2 5.9 14.3 259.6 16.0 28.1 220.9 1.4 123.6 2.5 1.5 90.9 2.5 53.8 66.8 106.5 0.1 1.5 10.6 3.2 13.1 8.1 50.2 7.9 1.0 4.6 9.8 16.8 161.9 26.7 0.6 42.8 TPH2 "FLJ37295, NTPH" ENSG00000139287 "Tryptophan hydroxylase 2" Q8IWU9 12 71938845-72186618 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 256 "brain: 117.3" "Group enriched" "Detected in some" 5 "Early spermatids: 8.0;Inhibitory neurons: 3.2;Late spermatids: 7.4;Spermatogonia: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "medulla oblongata: 45.3;midbrain: 117.3;pons: 53.5;thalamus: 31.8;white matter: 32.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 31 "midbrain: 106.7;pons and medulla: 34.9" "Group enriched" "Detected in some" 5 "midbrain: 49.9;pons: 49.6" CAB078198 Enhanced NA NA "CAB078198: AB_2665804" "unprognostic (1.19e-1)" "unprognostic (6.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.31e-1)" "unprognostic (5.91e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 45.3 117.3 0.1 0.0 0.2 0.0 0.4 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 31.8 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 5.9 0.8 0.4 45.3 117.3 0.1 53.5 0.1 31.8 32.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.2 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76031776 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 160.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1438.7;Basal squamous epithelial cells: 582.8;Urothelial cells: 760.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "monocytes: 1.1;T-cells: 1.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 296.3;RPTEC TERT1: 233.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 16.9 31.3 10.7 17.4 10.4 21.9 28.4 9.3 11.1 16.3 6.6 9.0 6.5 13.6 4.4 60.3 7.8 39.6 20.8 10.6 19.1 14.1 68.2 27.4 5.9 10.9 12.3 9.8 19.4 18.0 5.4 8.3 14.5 11.6 8.9 10.3 13.9 160.5 8.3 5.9 11.0 8.7 14.9 11.0 19.6 22.7 3.1 11.5 7.4 27.4 1.5 7.6 61.5 34.0 13.9 60.9 71.5 54.9 30.4 25.0 51.6 3.9 50.5 134.7 22.4 30.8 39.7 72.2 0.3 14.8 21.2 73.8 30.7 1.5 84.2 47.9 9.3 1.2 1.5 3.8 68.2 36.3 1.4 15.1 16.2 60.6 93.2 182.6 296.3 54.4 0.1 5.0 1.7 115.8 7.8 0.2 7.9 20.1 36.3 108.7 0.2 14.3 1.8 233.7 135.1 4.0 10.4 8.8 0.8 169.5 67.8 35.5 0.7 50.8 75.8 7.2 89.3 50.4 0.8 0.3 0.2 127.9 0.8 96.7 0.2 0.0 0.0 0.9 0.1 1.5 0.0 0.9 1.0 0.0 0.0 0.1 0.2 0.2 0.0 1.1 0.0 1.6 0.2 10.7 10.4 9.3 11.1 10.6 19.1 10.9 12.3 9.8 11.6 11.0 11.5 13.9 98.5 12.8 12.4 7.2 13.0 195.3 1438.7 249.6 582.8 5.2 136.2 140.3 34.8 11.5 44.4 31.3 2.1 4.7 42.9 11.6 84.1 74.8 2.2 11.5 111.2 162.5 117.7 0.0 7.8 43.1 11.5 203.2 55.0 20.4 79.5 7.1 21.4 127.8 94.7 1.7 14.6 41.0 384.5 14.0 123.4 2.1 9.3 110.8 286.4 8.4 24.0 97.8 0.0 142.2 2.7 208.4 27.7 15.4 19.0 116.1 0.2 39.3 12.4 5.2 269.5 59.8 276.3 0.7 3.2 66.3 75.6 7.4 132.8 20.7 18.0 760.3 TMEM19 FLJ10936 ENSG00000139291 "Transmembrane protein 19" Q96HH6 12 71686082-71705047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016830 Approved NA NA "HPA016830: AB_1858107" "unprognostic (8.22e-2)" "unprognostic (3.47e-2)" "unprognostic (6.76e-2)" "unprognostic (1.44e-1)" "unprognostic (4.45e-1)" "unprognostic (3.43e-2)" "unprognostic (7.60e-2)" "unprognostic (5.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-2)" "unprognostic (4.27e-2)" "unprognostic (1.49e-2)" "unprognostic (4.42e-1)" "unprognostic (5.32e-3)" "unprognostic (1.00e-1)" 11.5 11.0 8.2 17.0 9.5 8.2 20.8 10.1 8.9 13.4 11.4 27.5 34.7 8.2 9.9 31.3 12.3 11.1 15.8 8.3 10.8 38.7 24.9 16.4 18.8 10.4 9.4 7.8 4.3 16.4 15.3 7.0 9.5 10.3 7.5 20.5 13.9 12.6 13.1 25.4 21.9 30.3 15.0 10.4 18.3 14.8 7.2 8.9 20.3 13.7 22.1 31.2 19.6 16.7 12.3 35.9 45.5 30.8 18.2 47.7 22.0 18.6 28.4 33.8 32.7 28.5 22.2 32.3 66.2 38.0 54.4 27.2 45.9 27.1 30.6 43.8 48.5 32.4 38.4 29.4 25.1 13.1 40.9 37.1 20.0 33.7 41.8 13.6 26.1 35.6 58.4 23.0 37.9 49.9 17.4 39.7 11.9 17.3 22.3 30.1 29.8 45.4 37.8 30.0 82.1 33.7 26.8 49.6 25.5 12.9 23.5 38.2 12.1 35.1 45.8 22.2 20.1 25.9 73.9 101.4 47.7 19.4 11.7 50.0 26.0 27.1 10.4 33.2 34.3 25.7 102.3 26.1 28.2 47.6 118.6 25.2 30.3 2.3 28.8 31.3 134.5 29.8 33.7 8.2 9.5 10.1 8.9 8.3 10.8 10.4 9.4 7.8 10.3 10.4 8.9 12.3 12.8 22.4 16.3 9.8 44.7 19.1 18.8 32.7 14.8 12.9 11.7 5.8 22.4 12.8 20.1 25.8 12.5 13.6 37.9 21.9 11.7 15.8 16.4 7.4 6.0 14.9 19.9 9.9 7.2 21.6 25.1 11.8 6.6 7.5 15.8 7.4 16.4 31.1 25.9 15.2 9.2 14.5 34.6 32.1 33.7 75.3 7.5 24.2 23.2 5.6 21.4 11.0 22.6 9.5 12.2 22.1 20.2 13.5 54.8 6.9 51.2 46.1 30.6 8.8 6.6 7.5 9.0 4.4 8.4 43.8 46.5 4.8 12.4 7.7 27.4 16.6 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439798-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;fallopian tube: 17.0;placenta: 19.2;skeletal muscle: 22.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 26.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 37.1;SH-SY5Y: 104.5" "Region enriched" "Detected in many" 8 "olfactory bulb: 34.1" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 0.9 1.6 2.8 0.4 6.8 0.0 1.5 4.1 6.2 1.5 0.2 3.4 5.1 4.0 1.2 0.1 17.0 0.4 0.1 2.7 7.1 0.3 0.9 0.9 0.1 8.1 5.5 1.6 0.7 0.0 0.2 1.0 19.2 8.4 1.2 3.6 0.2 2.0 7.4 22.5 2.7 5.5 0.2 6.3 0.0 2.3 0.1 5.4 0.1 0.3 0.9 1.7 0.1 0.4 19.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 13.3 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.5 0.0 11.9 0.0 1.0 37.1 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 12.2 1.6 2.4 0.0 0.0 0.0 14.6 0.2 104.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 6.8 4.1 6.2 2.7 7.1 8.1 5.5 1.6 8.4 6.3 5.4 19.4 0.0 0.0 0.0 1.3 0.2 0.9 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 55.2 0.0 1.2 0.0 0.0 0.6 35.7 5.3 0.5 4.9 0.0 6.8 0.0 2.3 1.4 0.0 84.4 0.0 0.0 0.0 1.0 6.4 0.0 12.3 3.0 0.0 0.0 1.6 0.2 0.0 0.4 1.8 0.0 0.0 0.0 0.0 45.2 105.0 0.1 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 3.4 0.0 0.0 0.0 1.3 26.4 0.5 0.0 20.3 0.0 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase receptor type Q" 12 80402178-80680273 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 6.9;urinary bladder: 4.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol No NA Cytosol "HPA053245: AB_2682087" "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 2.3 0.0 1.4 0.1 2.1 0.0 0.4 0.0 0.8 0.5 0.0 0.1 0.0 0.0 1.9 0.1 1.6 0.2 0.6 0.2 0.4 6.9 0.0 2.3 0.9 1.0 0.7 0.4 0.3 0.3 0.1 0.2 0.1 0.5 0.6 0.0 0.8 0.1 0.1 0.2 0.1 0.0 0.0 1.0 0.0 0.1 2.7 0.2 0.2 2.9 0.0 0.3 4.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 4.9 0.0 3.9 0.8 1.2 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.5 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.4 0.0 0.0 1.9 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.1 0.0 0.8 0.2 0.4 1.0 0.7 0.4 0.5 1.0 0.2 0.3 0.0 16.0 1.1 2.0 0.0 0.0 1.9 0.3 0.0 0.1 0.0 0.0 3.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.5 1.3 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 DUSP6 "MKP-3, PYST1" ENSG00000139318 "Dual specificity phosphatase 6" Q16828 12 89347235-89352501 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 228.1" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 97.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 1636.7" "Group enriched" "Detected in all" 13 "granulocytes: 1636.7;monocytes: 842.3" "Cell line enhanced" "Detected in many" "AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017566, HPA053188, HPA064692" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017566: AB_647991, HPA053188: , HPA064692: " "unprognostic (7.35e-2)" "unprognostic (1.50e-2)" "unprognostic (5.77e-2)" "prognostic favorable (7.21e-4)" "unprognostic (2.35e-3)" "unprognostic (2.10e-3)" "unprognostic (3.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.63e-2)" "unprognostic (1.67e-2)" "unprognostic (3.15e-3)" "unprognostic (2.09e-1)" "unprognostic (5.91e-3)" "unprognostic (1.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-2)" "unprognostic (2.84e-1)" 114.9 25.0 12.0 64.3 12.6 180.3 51.3 9.6 26.4 39.7 24.8 47.7 25.0 26.4 14.4 35.1 36.9 76.2 30.6 19.1 11.7 59.5 144.6 89.0 42.6 11.5 11.9 11.0 14.4 18.0 34.8 18.0 74.7 12.4 18.9 56.6 6.9 228.1 23.1 8.6 15.8 52.5 43.6 11.5 71.6 28.9 7.0 13.5 48.1 78.1 40.5 27.4 77.1 13.9 13.4 6.4 6.2 127.0 427.6 108.1 89.9 0.2 47.5 58.3 9.5 6.8 38.7 6.8 0.0 11.2 20.5 17.9 51.4 0.5 118.4 13.0 0.5 0.8 20.0 1.4 61.4 75.7 86.3 210.9 18.4 40.4 81.5 75.5 94.9 214.4 2.6 0.0 20.4 29.3 3.1 2.9 325.8 78.7 149.5 102.7 216.6 15.5 8.3 129.3 129.7 2.4 88.7 1.1 0.6 253.0 43.3 6.4 46.8 59.0 30.6 0.8 5.8 22.8 3.7 18.5 0.5 126.5 60.0 200.3 1636.7 558.9 247.2 9.8 842.3 4.5 2.7 2.7 3.5 97.0 11.6 1.6 3.2 230.5 14.8 841.0 12.2 6.7 455.2 12.0 12.6 9.6 26.4 19.1 11.7 11.5 11.9 11.0 12.4 11.5 13.5 13.4 182.9 102.5 246.8 12.4 18.0 90.9 79.4 97.4 38.7 2.1 30.3 85.5 11.1 81.5 80.5 180.3 33.3 72.6 36.1 58.3 17.6 12.6 1.6 67.4 14.1 159.8 19.2 6.6 19.6 14.0 4.2 54.5 19.4 134.2 456.9 24.2 177.8 130.2 49.6 1.7 3.8 13.2 46.8 266.7 61.2 1.7 1.5 193.2 12.4 33.7 198.9 8.7 20.6 24.6 2.4 17.1 45.7 3.4 16.2 26.1 17.0 27.5 21.2 2.4 26.3 21.4 29.7 2.6 7.0 14.7 24.7 49.3 42.3 3.5 22.0 61.4 POC1B "FLJ14923, TUWD12, WDR51B" ENSG00000139323 "POC1 centriolar protein B" Q8TC44 12 89419718-89526047 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 73.2;Late spermatids: 96.3;Oligodendrocytes: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.06e-2)" "unprognostic (1.32e-1)" "unprognostic (1.28e-2)" "prognostic favorable (9.59e-5)" "unprognostic (4.86e-3)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" "unprognostic (6.18e-3)" "unprognostic (1.12e-1)" "unprognostic (3.68e-2)" "unprognostic (2.05e-2)" "prognostic favorable (3.45e-6)" "unprognostic (3.10e-2)" "unprognostic (1.94e-1)" "unprognostic (1.89e-1)" "unprognostic (8.69e-2)" 5.9 5.6 9.1 6.4 11.2 6.6 8.1 10.4 11.3 11.5 7.2 12.7 12.0 8.8 5.0 6.0 12.4 8.5 5.9 8.2 9.9 12.1 8.1 6.7 8.0 10.9 10.1 7.5 7.3 4.8 9.4 5.3 7.0 11.2 5.3 12.9 5.4 8.1 6.4 5.0 4.3 12.8 6.3 11.1 8.9 11.0 7.3 9.7 7.7 8.2 7.2 8.1 8.5 5.9 15.0 13.4 12.0 12.2 21.6 12.3 9.6 8.5 13.3 12.7 10.5 9.4 7.1 6.1 5.3 3.5 9.2 11.2 10.2 10.6 15.4 16.1 17.9 9.2 11.3 4.0 9.2 7.2 17.5 13.1 6.4 10.7 13.3 21.9 25.6 21.7 19.6 11.9 10.9 13.5 8.9 13.2 17.0 5.9 25.1 30.8 15.3 12.9 15.1 17.0 16.1 11.2 12.1 10.3 15.7 18.9 14.7 24.6 8.0 12.9 9.0 3.1 12.7 10.8 13.7 12.1 12.5 7.5 14.6 10.1 12.1 9.8 14.8 15.0 10.0 19.2 9.4 10.6 13.2 8.9 10.4 8.5 11.6 10.3 18.9 9.4 2.3 10.6 11.1 9.1 11.2 10.4 11.3 8.2 9.9 10.9 10.1 7.5 11.2 11.1 9.7 15.0 8.6 9.6 9.4 30.7 15.5 9.1 9.1 9.5 4.6 6.8 8.6 4.6 8.2 17.2 18.6 3.7 31.3 5.8 19.1 12.0 15.6 9.2 60.5 53.1 11.4 10.0 10.2 22.3 39.4 12.5 3.6 8.3 18.8 73.2 17.7 9.7 8.2 6.8 7.2 5.0 25.0 13.9 10.2 14.1 17.7 96.3 7.2 14.2 10.6 15.9 11.2 6.9 18.6 30.7 99.1 9.2 14.8 8.2 15.1 13.0 15.3 19.4 30.3 41.1 0.0 6.3 8.0 14.6 2.6 10.7 11.9 5.6 20.1 6.2 14.2 22.2 TMTC3 "FLJ90492, SMILE" ENSG00000139324 "Transmembrane O-mannosyltransferase targeting cadherins 3" Q6ZXV5 12 88142296-88199887 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transferase "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038550 Approved NA NA "HPA038550: AB_10672715" "unprognostic (1.05e-1)" "unprognostic (6.16e-2)" "unprognostic (1.50e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (5.28e-2)" "unprognostic (3.62e-3)" "unprognostic (1.71e-2)" "unprognostic (1.46e-1)" "unprognostic (4.44e-1)" "unprognostic (8.07e-3)" "unprognostic (2.56e-2)" "unprognostic (2.28e-1)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" 6.0 4.4 4.0 3.9 4.4 1.7 6.7 6.5 5.3 5.7 2.9 4.6 5.4 6.4 5.2 9.2 3.9 5.8 3.8 4.2 4.8 8.2 9.1 5.2 2.9 4.3 4.8 4.0 5.4 3.3 6.3 2.8 10.2 4.7 7.5 4.7 8.0 3.8 6.3 1.7 12.6 4.5 9.3 3.6 4.0 3.9 4.1 4.4 4.0 6.3 4.3 4.5 6.8 4.7 4.7 13.2 14.0 12.6 11.9 28.8 25.4 22.5 28.1 26.6 15.8 16.9 20.3 9.2 4.1 5.0 25.8 9.6 28.9 13.5 22.4 26.5 2.4 10.2 4.0 9.5 9.3 15.0 4.3 2.5 21.7 12.0 30.5 12.0 16.2 24.9 3.4 8.9 1.4 17.8 7.9 3.0 5.5 9.7 5.0 7.3 2.6 27.4 4.1 13.7 21.3 10.7 10.6 22.8 16.1 7.3 13.3 25.9 4.3 26.4 21.8 12.0 19.4 13.7 4.5 6.3 4.7 6.8 5.0 16.5 7.4 1.3 2.3 1.8 1.1 2.2 2.3 2.0 1.4 0.9 1.8 2.4 2.0 1.3 1.2 1.6 0.9 1.7 0.7 4.0 4.4 6.5 5.3 4.2 4.8 4.3 4.8 4.0 4.7 3.6 4.4 4.7 15.9 12.8 8.2 19.6 6.9 34.2 24.4 29.1 24.5 12.5 11.4 8.1 11.1 5.7 20.0 7.3 27.1 29.6 3.5 6.7 3.9 14.5 26.8 23.7 22.2 16.9 3.6 9.5 51.6 10.8 18.2 23.8 8.6 21.9 9.5 12.4 15.7 19.2 8.2 13.5 46.8 5.9 75.3 5.9 6.0 18.2 20.2 3.7 8.8 20.6 2.8 8.3 2.1 28.1 42.4 12.4 4.9 19.5 4.6 18.0 7.3 13.9 34.9 23.4 19.7 17.1 22.3 12.0 8.7 32.6 40.5 17.8 5.2 14.1 7.1 14.4 LUM "LDC, SLRR2D" ENSG00000139329 Lumican P51884 12 91102629-91111494 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 745.3;placenta: 540.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 4 "cerebral cortex: 7.3" "Immune cell enriched" "Detected in single" 122 "basophil: 12.1" "Lineage enriched" "Detected in single" 122 "granulocytes: 12.1" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 1991.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 9 "spinal cord: 149.2" "HPA001522, CAB025783" Supported "Secreted to extracellular matrix" NA NA 29000000000 "CAB025783: , HPA001522: AB_1079285" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "unprognostic (3.32e-1)" "unprognostic (2.75e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.19e-1)" "unprognostic (1.65e-2)" "unprognostic (2.20e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (5.25e-3)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (2.06e-2)" 163.0 134.7 0.6 68.7 0.7 0.3 154.7 0.7 7.3 201.5 7.7 85.8 56.6 303.8 89.1 76.4 59.7 745.3 185.4 0.7 1.6 85.8 34.9 213.3 41.7 0.9 0.7 0.5 93.8 73.5 26.5 5.4 540.4 0.9 116.2 134.3 5.7 14.4 68.1 9.7 16.7 91.3 357.5 0.7 4.9 47.6 17.6 1.1 13.5 31.1 73.6 81.0 490.6 39.6 1.4 0.0 0.3 6.9 0.0 237.4 115.9 0.7 400.8 1991.0 16.0 24.3 0.0 0.1 0.0 0.0 339.9 0.0 0.6 0.0 0.0 5.4 0.0 0.0 0.0 21.5 0.0 183.7 0.6 0.1 160.5 0.0 33.7 1.0 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.6 1.2 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.3 14.9 0.1 0.0 10.8 16.3 0.0 0.0 0.0 17.0 4.5 14.3 0.0 0.2 0.0 0.0 8.8 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 7.3 0.7 1.6 0.9 0.7 0.5 0.9 0.7 1.1 1.4 77.5 12.8 30.9 0.0 0.6 97.6 1.2 0.8 3.4 0.2 9.4 8.6 15.2 0.0 5.0 0.0 2.1 44.9 4.0 0.1 0.0 0.7 3.5 27.0 966.4 27.2 0.0 0.0 0.0 0.0 38.9 2136.1 8.6 15.2 18.3 0.0 55.0 0.3 63.6 0.0 0.2 0.3 0.0 0.3 143.5 8.7 401.7 9.5 117.4 16.9 1.0 86.9 0.0 0.0 0.0 2.1 0.0 44.8 6.3 4.9 0.4 0.3 0.8 3.0 0.0 39.1 165.5 0.2 0.9 5.9 100.2 84.0 14.5 27.4 0.0 4.1 KERA "CNA2, SLRR2B" ENSG00000139330 Keratocan O60938 12 91050491-91058024 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Fibroblasts: 2.0" "Cancer enhanced" "Detected in some" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "amygdala: 4.1;basal ganglia: 5.6;cerebral cortex: 6.2;hippocampal formation: 5.6" HPA039321 Uncertain "Secreted to extracellular matrix" NA NA "HPA039321: AB_10795248" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.47e-1)" "unprognostic (3.70e-1)" "unprognostic (4.76e-3)" "unprognostic (3.65e-1)" "unprognostic (6.08e-2)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (5.96e-2)" "unprognostic (4.93e-3)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 SNRPF Sm-F ENSG00000139343 "Small nuclear ribonucleoprotein polypeptide F" P62306 12 95858928-95903828 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 486.5" NA NA 47000 "unprognostic (6.86e-2)" "unprognostic (1.70e-3)" "unprognostic (3.08e-1)" "unprognostic (5.63e-2)" "unprognostic (3.12e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (2.74e-2)" "unprognostic (6.81e-2)" "unprognostic (2.22e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (8.06e-2)" "unprognostic (3.81e-2)" "unprognostic (1.80e-1)" "unprognostic (1.52e-2)" 20.8 21.6 20.5 27.6 20.7 48.2 22.2 22.5 28.7 19.1 20.0 26.5 21.8 21.4 15.9 38.5 18.0 8.0 22.4 20.2 21.6 23.2 32.5 19.7 28.4 20.5 20.9 20.0 22.9 17.3 16.5 24.7 16.2 20.9 17.5 18.8 18.6 18.4 12.0 24.3 21.8 21.5 14.8 20.9 23.2 20.0 18.8 21.2 36.8 17.6 18.4 25.1 20.3 23.3 20.7 146.0 116.9 129.9 88.7 35.2 34.7 107.2 72.7 50.7 95.9 67.7 169.1 46.9 160.3 68.2 48.8 83.8 97.7 116.9 103.4 78.5 107.3 184.7 154.7 116.1 171.7 43.9 243.4 68.3 35.7 50.1 87.3 83.9 64.2 67.3 176.7 138.7 31.5 52.2 155.3 212.2 486.5 178.1 109.9 258.0 166.4 103.4 118.3 71.9 150.7 129.0 76.2 107.6 102.5 74.2 87.6 105.6 187.4 58.8 52.2 90.0 68.6 144.3 46.2 87.0 232.1 26.0 125.9 66.7 8.4 42.6 20.0 51.4 43.4 69.8 80.2 72.0 63.2 97.8 75.1 77.3 70.7 4.1 65.9 35.8 92.9 68.2 60.7 20.5 20.7 22.5 28.7 20.2 21.6 20.5 20.9 20.0 20.9 20.9 21.2 20.7 129.3 51.3 103.2 5.5 150.7 265.2 231.1 272.4 139.5 53.7 188.1 286.3 58.4 124.4 146.5 136.1 31.3 350.9 132.8 142.8 272.0 217.4 76.2 166.0 189.1 151.0 172.8 165.7 6.1 285.9 457.3 128.1 95.3 186.8 106.5 172.1 128.2 338.6 241.1 32.0 6.8 282.2 140.4 128.7 197.9 36.8 134.2 126.9 120.9 3.7 197.1 119.9 146.2 7.1 7.0 236.7 152.5 119.6 98.1 280.1 119.7 272.1 98.2 60.6 92.1 210.5 213.9 200.9 276.0 217.6 265.2 207.8 158.2 152.9 346.3 253.1 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943331-95968720 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 61.2;skeletal muscle: 27.6" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 132.5" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 1400000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.8 11.8 8.0 6.5 9.9 6.2 0.4 5.6 10.1 0.3 7.3 1.5 5.2 3.0 0.4 2.7 0.7 1.8 1.7 8.3 6.1 5.9 61.2 2.4 4.4 15.5 9.1 5.2 1.4 3.4 0.7 0.5 2.0 9.6 2.8 0.2 1.8 2.1 0.2 27.6 5.9 5.1 0.6 3.2 6.0 4.8 13.2 9.2 0.6 0.9 0.9 0.4 0.3 0.2 16.2 46.6 9.5 0.8 5.8 0.0 0.0 10.0 1.5 0.5 0.7 1.4 3.9 5.8 4.0 4.2 0.0 2.6 8.2 0.3 0.0 0.3 16.0 1.7 4.2 7.9 9.4 0.0 5.9 47.7 0.0 0.4 0.8 0.1 0.2 0.3 3.9 2.7 61.2 0.0 6.8 3.7 10.8 4.4 1.8 2.2 7.8 0.3 5.3 0.0 4.3 4.9 6.9 40.5 46.1 5.2 0.2 4.6 8.4 0.0 5.8 19.1 8.0 5.4 49.1 62.8 6.3 3.8 12.2 6.9 0.2 0.6 1.7 0.5 0.6 0.4 0.6 0.2 0.6 0.5 0.3 0.3 0.4 0.4 2.3 1.8 0.2 0.1 0.5 8.0 9.9 5.6 10.1 8.3 6.1 15.5 9.1 5.2 9.6 3.2 9.2 16.2 1.1 0.0 0.5 0.3 2.0 0.4 0.2 0.0 0.0 0.1 1.1 1.0 0.6 1.5 0.6 3.7 0.0 0.9 1.7 0.0 3.9 0.2 0.9 0.1 0.0 0.8 1.8 8.0 0.7 1.1 0.1 0.1 0.0 0.0 0.0 0.2 8.6 132.5 4.4 1.7 0.3 0.1 0.0 5.7 1.3 0.1 0.3 1.8 3.6 0.0 0.7 1.8 2.1 4.0 2.0 0.2 0.0 0.0 0.7 0.0 0.4 31.0 0.0 0.0 0.0 0.8 0.0 1.5 1.9 0.0 0.3 0.3 1.4 0.3 0.4 0.1 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "NEDD1 gamma-tubulin ring complex targeting factor" Q8NHV4 12 96907224-96953780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 255.8;Late spermatids: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 133.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (1.94e-4)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 9.2 5.8 4.3 9.8 4.6 15.4 12.9 4.7 4.0 10.0 7.5 8.4 7.1 12.8 6.5 10.1 9.2 7.5 9.3 3.1 7.3 9.0 6.4 8.9 15.5 5.0 4.2 2.4 9.9 7.1 15.0 3.9 11.1 4.7 10.7 9.8 7.2 6.9 8.2 38.4 8.3 7.0 13.2 5.5 13.5 7.2 23.8 3.9 22.7 10.6 25.9 15.3 9.7 6.2 6.6 39.4 25.8 43.3 26.8 21.1 19.0 30.7 133.1 47.0 60.5 51.7 17.0 14.2 24.1 12.6 107.7 28.8 34.5 29.5 31.0 80.7 46.7 26.2 30.2 16.1 15.1 17.5 41.8 26.2 14.1 24.9 37.2 28.3 39.8 30.0 41.0 17.8 17.3 43.9 16.3 76.1 19.0 23.8 20.6 80.8 40.0 43.7 24.0 25.0 25.7 13.4 23.6 37.4 20.9 23.7 33.5 28.2 14.6 21.5 38.0 28.8 27.2 31.9 17.0 22.0 32.3 11.7 20.9 46.7 14.1 8.5 25.6 13.8 13.8 15.8 11.1 15.4 15.0 7.4 10.4 15.7 12.5 6.3 19.9 10.2 5.7 17.8 9.4 4.3 4.6 4.7 4.0 3.1 7.3 5.0 4.2 2.4 4.7 5.5 3.9 6.6 18.8 9.6 11.5 11.4 19.1 19.4 28.1 7.3 13.1 8.0 10.4 6.9 10.5 21.5 11.9 16.5 0.0 8.2 20.5 6.3 9.8 9.8 255.8 15.3 10.0 14.6 6.1 34.1 3.7 8.2 13.9 13.3 8.6 9.7 16.5 9.3 15.0 4.8 8.6 18.5 3.0 7.5 4.1 8.1 9.2 92.0 12.5 9.4 7.2 15.9 7.5 11.5 17.5 9.0 15.1 8.3 8.3 10.1 13.3 49.6 4.7 11.2 21.8 8.4 19.7 13.9 13.6 34.3 26.0 12.0 14.1 4.0 24.6 9.8 8.0 18.3 SYCP3 ENSG00000139351 "Synaptonemal complex protein 3" Q8IZU3 12 101728648-101739472 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 83.7" "Group enriched" "Detected in many" 8 "Spermatocytes: 825.7;Spermatogonia: 346.9" "Cancer enriched" "Detected in single" 16 "testis cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB032978, HPA039635, HPA043938" Enhanced NA NA "CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740" "unprognostic (2.86e-3)" "unprognostic (3.91e-1)" "unprognostic (3.18e-1)" "unprognostic (9.61e-3)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" "unprognostic (7.15e-3)" "unprognostic (7.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.93e-2)" "unprognostic (2.24e-1)" "unprognostic (4.07e-2)" "unprognostic (5.86e-4)" 0.0 0.1 0.3 0.3 0.5 0.2 0.0 0.5 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 83.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.6 0.4 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 0.4 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.4 0.0 2.0 9.1 4.5 0.0 0.7 0.4 1.2 2.2 0.9 0.6 1.3 1.5 0.3 1.8 0.0 0.4 3.1 0.6 0.0 0.1 24.1 0.3 1.3 0.9 1.2 0.4 10.1 0.4 0.2 0.7 0.0 0.7 3.8 0.3 0.7 0.2 0.6 0.0 10.7 0.7 0.0 1.0 0.3 31.2 9.0 1.7 0.0 0.0 0.4 0.3 1.0 9.5 1.8 0.3 1.9 1.9 2.0 0.9 1.0 0.3 0.8 1.7 65.7 2.0 0.4 825.7 346.9 0.7 0.3 0.1 2.0 0.2 1.3 0.5 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957674-102960513 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.2;choroid plexus: 13.9;liver: 11.2;pituitary gland: 30.3" "Group enriched" "Detected in some" 5 "Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "SCLC-21H: 53.7;SH-SY5Y: 29.0" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.0 1.1 18.6 0.0 17.8 0.0 0.0 19.3 23.2 0.5 13.9 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 18.3 18.2 0.0 11.2 0.5 0.5 20.1 18.1 16.3 0.4 0.2 0.0 30.3 0.0 18.1 0.3 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 1.2 0.1 18.8 5.5 0.1 0.0 0.0 0.0 0.3 19.9 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 29.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 17.8 19.3 23.2 18.3 18.2 20.1 18.1 16.3 18.1 19.5 18.8 19.9 0.1 0.0 0.0 17.0 0.3 0.0 0.3 0.0 0.0 4.3 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.0 36.4 0.0 1.7 0.0 0.0 0.2 4.6 0.1 0.0 0.0 0.0 1.8 0.1 5.0 4.1 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.4 0.0 42.7 0.3 0.2 0.0 0.4 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.4 GAS2L3 ENSG00000139354 "Growth arrest specific 2 like 3" Q86XJ1 12 100573683-100628288 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;monocytes: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 4 "spinal cord: 13.8" HPA048593 Approved NA Yes "HPA048593: AB_2680455" "unprognostic (1.03e-1)" "unprognostic (5.13e-2)" "unprognostic (5.10e-2)" "unprognostic (2.70e-2)" "unprognostic (2.32e-2)" "unprognostic (1.46e-1)" "unprognostic (1.04e-7)" "unprognostic (2.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (9.21e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.58e-7)" "unprognostic (1.34e-1)" "unprognostic (2.35e-1)" "unprognostic (3.60e-2)" "unprognostic (6.67e-2)" 1.8 0.8 0.1 1.6 1.1 5.7 0.9 0.0 1.3 1.2 0.8 3.3 2.7 0.7 0.4 1.6 0.3 4.8 1.5 0.4 0.5 1.3 1.0 2.5 1.3 0.5 0.4 0.3 1.1 0.5 0.2 0.2 3.6 0.7 0.3 3.9 0.4 0.5 1.1 0.8 3.5 2.8 1.7 0.5 1.4 1.4 4.0 1.0 0.9 0.6 1.2 1.2 1.6 0.5 1.4 35.4 14.0 18.6 14.8 5.7 7.3 6.2 16.2 15.3 21.3 23.8 10.4 9.5 0.6 4.8 12.8 20.8 11.8 12.0 5.9 31.0 10.0 9.1 0.0 12.2 7.0 1.9 0.0 8.0 2.9 0.6 12.8 36.1 10.1 20.2 0.0 2.2 0.0 17.7 10.4 0.0 0.2 5.9 6.5 16.7 2.4 32.5 0.8 9.2 9.6 8.4 8.1 17.0 11.7 22.2 6.5 21.3 1.9 13.6 13.6 14.3 12.2 17.8 7.4 9.3 0.0 5.3 5.6 39.3 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.1 0.1 1.1 0.0 1.3 0.4 0.5 0.5 0.4 0.3 0.7 0.5 1.0 1.4 3.6 0.0 0.0 1.0 0.2 3.4 0.4 0.5 2.8 0.2 2.0 2.2 2.0 11.5 0.2 0.0 0.0 9.9 0.4 9.8 0.0 2.7 4.5 3.6 5.5 5.6 3.6 6.9 2.5 0.7 4.5 2.2 11.2 7.4 1.3 7.2 2.5 1.4 13.9 0.0 5.9 14.2 0.0 8.0 11.1 0.5 0.6 14.7 7.2 4.7 1.5 2.2 0.0 2.5 0.3 0.3 8.2 0.7 0.3 0.6 2.6 3.4 1.0 0.1 0.0 4.8 2.7 16.0 2.3 4.7 3.7 33.9 1.0 6.8 8.3 0.6 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 13.1" "Group enriched" "Detected in some" 8 "Astrocytes: 165.5;Excitatory neurons: 431.6;Inhibitory neurons: 481.5;Oligodendrocyte precursor cells: 268.9" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.1;HSkMC: 6.6;NTERA-2: 7.7;RPMI-8226: 3.5;U-138 MG: 11.8;U-937: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035661, HPA035662" Uncertain NA NA "HPA035661: AB_10669774, HPA035662: AB_2674726" "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.1 0.1 4.0 0.1 8.5 0.0 0.1 0.0 13.1 0.6 0.0 0.7 0.1 0.5 0.7 0.4 0.2 0.2 0.7 8.5 4.4 0.0 0.0 0.0 0.1 1.3 2.3 8.5 0.1 0.1 0.0 1.0 0.1 2.3 0.4 0.2 1.1 2.2 0.3 1.2 1.7 0.3 0.1 0.0 0.0 0.3 0.5 0.9 0.0 1.9 0.3 0.2 0.3 0.6 6.6 0.0 0.0 3.1 0.0 2.2 2.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 11.8 0.0 0.0 0.0 0.0 0.2 0.0 1.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 8.5 0.0 13.1 8.5 4.4 1.3 2.3 8.5 2.3 0.0 0.9 6.6 0.0 0.0 0.0 165.5 0.0 1.1 0.9 0.5 1.2 5.4 0.5 0.4 3.0 0.0 0.5 0.0 6.2 0.0 0.1 0.2 0.0 0.0 27.1 0.5 11.8 0.4 0.0 0.0 431.6 0.0 0.0 0.8 0.0 1.0 0.0 1.4 0.0 0.0 0.2 1.7 481.5 0.5 0.0 0.0 0.5 41.0 0.3 0.2 1.8 13.1 0.0 0.4 0.0 268.9 18.9 0.0 0.0 4.5 0.0 0.7 0.1 0.1 0.3 0.5 0.0 1.4 0.2 1.2 4.6 1.3 3.3 0.0 0.2 28.4 0.0 0.4 SLC15A4 "PHT1, PTR4" ENSG00000139370 "Solute carrier family 15 member 4" Q8N697 12 128793194-128823958 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 125.8;Early spermatids: 92.3;Late spermatids: 110.1;Muller glia cells: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 31.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016713 Approved NA NA "HPA016713: AB_1856978" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (3.63e-2)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (6.78e-4)" "unprognostic (5.14e-3)" "unprognostic (6.39e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.56e-6)" "unprognostic (1.28e-1)" "unprognostic (2.06e-1)" "unprognostic (2.34e-2)" "unprognostic (2.57e-1)" 11.1 6.4 3.5 10.9 4.8 22.3 9.0 5.7 4.4 10.2 23.3 6.1 6.0 12.6 5.0 9.5 9.3 10.5 10.0 4.1 7.3 7.4 15.3 10.2 17.6 6.4 4.7 2.9 10.4 7.8 7.6 3.6 9.6 6.2 7.7 5.8 23.5 6.2 8.9 28.0 10.2 6.0 12.7 5.6 11.6 7.4 11.4 4.5 11.6 7.6 20.0 19.7 10.4 7.3 7.8 12.0 19.3 4.9 10.8 41.9 26.9 17.9 20.6 17.1 14.3 16.1 8.9 16.9 43.7 10.6 18.0 14.3 13.5 13.5 12.8 15.5 21.6 12.5 6.0 11.1 15.8 43.7 20.2 6.2 17.4 22.9 11.9 31.0 42.9 10.1 8.8 9.9 26.9 29.5 8.4 10.8 5.5 17.4 13.0 11.3 9.0 10.6 17.2 28.3 15.4 8.8 7.3 8.5 15.8 22.5 13.1 21.0 5.8 15.5 15.9 8.9 8.1 12.7 9.0 21.1 20.3 21.5 14.2 0.2 0.0 2.8 7.2 7.3 3.8 3.6 2.9 1.3 4.4 1.7 2.8 1.4 3.5 18.8 6.8 1.6 31.8 0.7 3.1 3.5 4.8 5.7 4.4 4.1 7.3 6.4 4.7 2.9 6.2 5.6 4.5 7.8 8.6 19.2 8.0 15.7 14.8 10.3 8.7 10.4 8.6 11.4 10.2 12.3 8.5 12.8 9.0 22.0 12.5 5.5 125.8 4.5 1.9 24.9 92.3 9.3 14.1 6.5 10.8 11.8 23.6 11.1 7.0 14.5 6.6 40.1 11.4 9.7 12.8 20.0 22.0 15.2 23.0 4.4 4.1 24.6 28.2 110.1 12.5 24.5 24.9 21.5 33.0 91.6 45.3 37.7 25.7 24.8 6.8 13.5 11.6 9.3 5.5 6.1 5.1 15.6 6.6 14.4 11.4 51.1 10.6 7.5 9.1 4.0 16.7 10.8 6.5 6.9 TDG ENSG00000139372 "Thymine DNA glycosylase" Q13569 12 103965822-103988874 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052263 Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA052263: AB_2681777" "unprognostic (3.15e-1)" "unprognostic (1.36e-1)" "unprognostic (9.89e-3)" "unprognostic (6.93e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (1.56e-2)" "prognostic unfavorable (6.90e-5)" "unprognostic (5.37e-2)" "unprognostic (1.82e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.90e-10)" "unprognostic (3.68e-1)" "unprognostic (2.90e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" 10.9 13.7 6.5 16.0 6.9 18.3 12.1 7.5 7.9 10.1 7.6 13.3 11.5 11.7 9.6 17.9 8.8 12.3 9.3 7.1 6.3 7.8 12.2 9.7 21.2 6.2 6.3 6.6 9.8 9.6 10.5 9.6 17.6 6.7 9.7 15.8 10.6 9.3 7.4 9.6 12.1 13.5 11.0 5.2 12.0 11.3 5.0 6.2 25.9 10.7 9.7 19.2 17.3 11.3 7.1 42.6 21.4 64.4 37.2 15.5 13.7 69.4 32.4 12.3 42.6 23.6 39.1 18.2 99.4 18.8 26.3 6.9 27.9 76.8 36.5 32.6 42.8 66.8 76.4 31.8 17.5 14.8 95.4 55.8 16.3 48.0 31.5 24.6 25.9 42.3 58.4 91.1 15.8 20.6 45.2 107.6 53.6 76.7 33.0 34.0 107.9 32.8 35.0 46.4 61.4 84.2 58.0 38.9 42.7 28.4 37.7 70.7 52.2 26.5 13.3 21.5 14.3 37.5 34.5 49.5 81.8 14.2 52.0 25.3 55.0 53.0 45.8 28.9 39.2 22.0 43.4 28.1 24.3 34.6 39.8 28.5 25.5 35.5 33.6 40.1 92.5 30.5 17.6 6.5 6.9 7.5 7.9 7.1 6.3 6.2 6.3 6.6 6.7 5.2 6.2 7.1 35.4 38.5 23.8 12.1 54.6 79.0 49.1 63.0 38.7 51.3 61.2 54.9 25.9 37.1 49.4 33.1 27.1 66.7 68.7 35.2 37.2 68.6 6.2 44.7 44.7 45.2 81.7 69.4 30.3 53.9 82.6 38.5 47.4 45.7 40.4 27.0 39.3 36.4 44.1 35.3 30.0 55.7 87.5 44.8 42.1 3.8 27.4 42.4 16.0 23.4 41.1 24.4 43.3 20.6 20.9 79.7 39.0 30.1 52.6 52.4 28.4 30.5 40.8 39.0 46.0 37.4 38.0 11.0 23.1 52.8 102.9 156.7 49.8 25.0 42.6 61.8 RITA1 "C12orf52, FLJ14827, RITA" ENSG00000139405 "RBPJ interacting and tubulin associated 1" Q96K30 12 113185526-113192368 "Predicted intracellular proteins" "Neurogenesis, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 49.0;Proximal enterocytes: 62.0;Proximal tubular cells: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039094, HPA039095, HPA061531" Supported Supported Nucleoplasm No No Nucleoplasm "HPA039094: AB_10671037, HPA039095: AB_2676345, HPA061531: AB_2684554" "unprognostic (7.10e-2)" "unprognostic (4.26e-2)" "unprognostic (2.78e-2)" "unprognostic (3.55e-2)" "unprognostic (2.56e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (3.47e-2)" "unprognostic (2.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (2.59e-3)" "unprognostic (1.44e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 6.8 25.7 16.6 7.2 17.5 7.2 7.7 16.5 20.4 8.5 13.7 9.6 13.2 8.1 6.5 14.4 14.2 6.0 13.1 17.8 15.8 15.9 29.9 7.0 11.2 15.1 15.7 16.7 10.7 10.7 9.6 12.7 4.8 15.5 10.1 6.0 4.5 13.9 8.4 32.0 10.8 14.3 4.6 12.7 9.6 8.9 7.5 16.7 9.7 10.5 27.5 8.3 8.6 8.1 15.4 27.0 34.3 8.7 23.0 11.5 8.8 15.6 17.2 35.3 24.9 19.8 40.7 13.0 50.8 26.0 14.6 21.4 20.0 20.0 22.3 14.4 31.3 28.4 17.4 16.6 26.6 18.7 23.4 14.0 13.6 20.2 24.6 13.8 34.5 20.7 24.7 34.0 9.2 14.9 38.6 26.1 63.1 29.2 22.9 41.8 23.2 9.3 43.2 20.3 37.8 28.9 16.6 21.7 45.2 38.2 10.6 38.2 35.5 13.7 15.7 22.3 18.2 24.7 31.6 28.6 56.0 23.4 19.4 22.5 43.7 14.6 9.9 15.3 6.6 15.3 11.0 13.5 13.9 16.5 11.8 13.2 14.6 0.3 20.7 8.6 22.5 16.1 13.5 16.6 17.5 16.5 20.4 17.8 15.8 15.1 15.7 16.7 15.5 12.7 16.7 15.4 8.1 0.0 11.3 2.9 11.1 6.4 7.1 14.0 7.4 7.4 14.7 14.7 6.6 12.8 9.1 14.7 4.2 19.3 9.8 17.0 49.0 19.2 10.8 16.7 7.3 9.3 11.4 8.8 6.5 16.4 16.9 7.0 8.2 7.3 0.0 8.7 8.6 37.5 14.2 15.2 6.7 12.5 8.2 7.8 2.4 29.6 9.9 6.3 5.4 2.8 5.9 11.0 19.6 2.0 3.7 15.2 12.9 8.2 14.7 10.1 62.0 51.9 17.1 6.0 6.6 7.7 7.5 4.5 7.8 13.8 6.5 10.1 9.0 17.2 12.7 7.5 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422380-113438276 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 105.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 78.2;Hepatocytes: 116.7;Hofbauer cells: 95.7;monocytes: 103.1;Proximal tubular cells: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 8.7;intermediate monocyte: 10.0;myeloid DC: 18.5;plasmacytoid DC: 17.8" "Group enriched" "Detected in many" 6 "dendritic cells: 18.5;monocytes: 10.0" "Cell line enhanced" "Detected in many" "HMC-1: 51.4;MCF7: 90.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol NA NA 48000 Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favorable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favorable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 4.6 33.3 13.4 7.1 12.1 3.3 4.9 15.0 15.3 4.7 9.3 12.3 17.0 4.9 9.9 2.5 8.0 7.8 12.9 10.8 15.4 29.7 105.5 5.8 3.4 17.9 14.2 9.6 4.7 18.8 12.5 15.6 4.4 14.4 8.6 8.6 2.4 4.8 6.6 3.0 1.2 12.3 5.2 14.6 5.9 9.2 10.7 14.5 1.5 24.1 1.3 1.8 6.3 1.4 22.2 8.5 33.3 4.7 14.1 0.9 1.9 3.2 4.8 1.2 5.2 4.4 14.1 8.7 0.4 24.2 8.1 14.4 8.6 2.2 11.4 1.7 20.5 8.4 22.1 8.5 6.3 27.5 2.8 51.4 4.4 16.0 12.8 18.8 5.9 8.0 0.0 17.3 6.6 6.5 90.2 0.1 10.2 4.6 9.6 14.6 0.0 7.0 16.5 13.6 10.6 1.5 0.5 20.6 23.6 18.4 4.2 28.6 24.8 7.2 6.2 11.9 26.9 4.2 1.4 1.4 0.3 26.3 8.4 7.8 0.2 8.7 0.0 0.0 10.0 0.0 2.2 0.0 0.0 18.5 0.1 0.0 0.0 0.4 1.8 1.3 17.8 0.3 2.5 13.4 12.1 15.0 15.3 10.8 15.4 17.9 14.2 9.6 14.4 14.6 14.5 22.2 1.2 0.0 5.1 2.0 3.1 0.9 2.2 7.0 0.0 0.5 15.3 10.2 18.2 27.1 6.3 29.5 2.1 16.3 4.9 43.7 78.2 36.1 0.5 14.8 7.7 4.0 31.8 10.1 1.3 20.1 3.0 4.5 12.8 10.1 43.8 15.3 6.4 116.7 95.7 3.3 0.6 36.4 4.1 18.1 8.4 1.5 2.8 36.9 3.6 1.9 103.1 33.5 0.0 1.5 2.0 16.2 63.2 5.7 0.0 6.1 63.2 115.7 3.8 2.6 0.0 0.2 7.3 0.2 0.4 1.1 0.6 7.3 1.9 29.5 31.0 5.9 MMAB "cblB, CFAP23" ENSG00000139428 "Metabolism of cobalamin associated B" Q96EY8 12 109553715-109573580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 104.4" "Cell type enhanced" "Detected in all" "Hepatocytes: 225.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039017 Supported Approved Mitochondria NA NA Mitochondria "HPA039017: AB_10673603" "unprognostic (1.16e-1)" "unprognostic (1.25e-2)" "unprognostic (1.90e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-1)" "unprognostic (4.22e-1)" "unprognostic (2.04e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-3)" "unprognostic (2.58e-1)" "prognostic favorable (1.55e-4)" "unprognostic (4.90e-2)" "unprognostic (1.51e-1)" "unprognostic (2.23e-1)" "unprognostic (9.65e-2)" 14.4 51.6 18.4 6.4 19.2 5.9 15.9 19.3 27.1 12.4 18.7 13.8 13.1 10.8 21.3 29.3 13.1 6.1 26.5 18.1 19.2 28.4 104.4 15.0 6.3 21.8 19.7 18.8 19.1 23.2 9.9 20.7 5.0 21.9 26.7 8.0 7.4 17.2 6.3 21.3 16.8 14.2 5.7 20.1 12.5 17.9 12.7 19.7 5.5 22.3 16.3 6.6 14.3 14.8 23.5 32.2 22.3 22.2 17.6 8.8 17.7 11.3 7.1 16.2 10.3 10.8 25.8 29.5 21.0 19.9 8.0 19.1 32.9 14.6 54.9 4.6 8.2 60.9 8.6 15.9 42.1 31.3 18.4 7.2 24.0 33.5 22.2 9.7 12.3 9.7 16.4 27.5 15.5 7.3 74.7 16.6 29.2 27.3 3.3 31.6 13.6 8.7 53.9 45.3 30.3 34.1 14.8 15.8 29.2 12.7 6.2 60.5 50.5 5.4 8.6 3.6 6.1 10.4 11.9 9.6 24.0 19.0 22.2 23.9 7.4 7.2 1.0 15.3 10.0 12.2 13.6 11.1 12.1 11.3 17.8 15.2 14.6 1.9 11.2 10.9 9.2 5.8 10.3 18.4 19.2 19.3 27.1 18.1 19.2 21.8 19.7 18.8 21.9 20.1 19.7 23.5 25.1 35.3 80.8 9.8 20.4 10.3 33.1 105.6 17.1 32.9 59.6 47.0 52.3 60.1 68.9 42.3 29.2 55.4 15.2 33.6 150.6 49.7 41.3 23.8 10.0 22.1 33.0 34.1 6.4 71.3 37.6 24.7 28.5 16.5 16.5 34.3 28.5 225.3 34.8 104.3 8.5 50.4 71.2 20.4 10.2 82.9 40.4 13.5 26.6 4.7 25.1 30.6 30.9 6.6 21.5 29.7 30.0 30.5 18.1 31.8 61.9 143.6 62.1 29.7 13.1 17.9 26.3 26.0 15.8 44.7 19.7 61.8 16.1 121.1 56.6 30.3 GLTP ENSG00000139433 "Glycolipid transfer protein" Q9NZD2 12 109850945-109880541 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 336.8;skin 1: 269.3" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 266.5;Suprabasal keratinocytes: 479.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056461, HPA065503" Approved Supported Cytosol NA NA 25000 Cytosol "HPA056461: AB_2683138, HPA065503: " "unprognostic (1.18e-1)" "prognostic favorable (2.01e-5)" "unprognostic (7.46e-2)" "unprognostic (6.22e-3)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (6.63e-2)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (2.47e-1)" "unprognostic (3.03e-1)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (2.20e-1)" "prognostic favorable (4.17e-6)" "unprognostic (3.28e-2)" 19.2 21.8 71.8 17.6 94.6 19.4 27.4 93.8 75.9 54.0 47.7 37.0 14.7 16.0 35.1 336.8 13.7 14.3 19.8 63.4 73.8 35.9 15.3 24.6 19.4 102.7 93.7 54.4 18.4 24.0 31.7 12.6 18.0 100.3 29.7 32.1 7.1 85.4 19.3 18.8 269.3 32.4 18.9 100.2 21.7 21.8 16.4 89.2 18.1 23.7 18.3 109.1 33.9 179.4 141.7 39.3 27.9 15.5 16.7 36.2 41.4 11.0 47.4 58.2 36.0 29.7 11.3 14.9 34.5 25.3 57.8 17.5 47.3 24.2 54.9 50.7 35.0 21.5 22.6 15.9 16.5 31.6 24.6 25.5 30.1 68.8 64.6 45.3 53.9 61.3 34.8 10.1 22.5 53.2 52.9 33.6 19.8 28.1 32.0 36.8 29.3 36.4 36.3 20.5 116.1 20.0 19.8 30.1 77.1 26.0 14.1 36.1 8.6 83.2 41.4 21.9 61.5 36.5 30.1 27.7 23.8 83.0 25.1 25.9 42.6 65.7 37.3 51.5 66.0 32.4 23.9 31.0 46.5 48.8 21.5 20.1 35.8 32.9 42.4 57.0 8.0 37.6 40.6 71.8 94.6 93.8 75.9 63.4 73.8 102.7 93.7 54.4 100.3 100.2 89.2 141.7 48.1 25.6 60.9 10.4 37.5 145.4 109.1 72.1 88.2 11.4 55.6 44.4 14.6 18.6 62.7 44.1 14.6 86.5 48.3 95.6 199.6 39.0 20.5 30.1 33.3 47.9 32.4 10.1 9.9 56.5 20.0 35.0 28.5 59.1 20.8 19.0 34.2 15.3 34.5 13.5 11.4 39.2 50.8 61.6 84.6 11.7 23.0 55.3 60.5 13.1 61.8 23.4 64.9 21.6 140.1 53.5 40.0 18.0 26.2 80.6 102.3 38.2 25.2 12.3 39.5 23.5 37.3 22.9 20.8 266.5 479.2 210.6 46.3 31.4 59.1 129.0 GIT2 "KIAA0148, PKL" ENSG00000139436 "GIT ArfGAP 2" Q14161 12 109929802-109996389 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004681 Approved Approved Microtubules NA NA Microtubules "CAB004681: AB_425820" "unprognostic (1.07e-1)" "unprognostic (2.61e-1)" "unprognostic (3.67e-3)" "unprognostic (3.44e-2)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "unprognostic (8.71e-2)" "unprognostic (2.41e-2)" 15.7 18.1 11.9 25.7 17.0 60.7 13.1 20.0 16.6 13.8 11.1 14.1 11.3 14.2 10.9 11.6 12.2 15.5 17.5 16.1 13.3 10.2 11.9 17.0 33.3 15.5 13.2 10.8 18.0 17.4 14.2 13.9 23.1 16.3 12.9 14.0 9.2 13.7 12.9 14.9 13.0 19.2 20.0 12.2 36.3 10.8 14.0 13.7 37.3 16.6 15.7 32.3 16.5 12.9 15.8 20.6 24.6 16.6 18.4 28.6 26.3 11.9 42.1 41.3 37.0 23.2 12.5 10.8 49.8 16.3 51.7 14.6 14.9 14.5 18.8 38.1 42.1 14.3 32.7 15.0 14.6 18.1 47.7 49.6 22.0 17.4 34.9 18.7 34.0 39.5 28.5 17.2 12.4 46.0 13.1 42.0 66.4 11.7 11.7 17.7 34.5 41.7 27.9 18.2 17.1 10.1 14.9 27.1 12.5 16.6 17.0 17.9 39.3 37.3 25.0 12.6 20.0 22.0 25.0 22.8 49.3 21.5 34.9 21.2 85.6 76.4 172.9 42.7 72.0 41.6 42.4 42.3 43.9 74.7 49.4 36.0 32.2 165.1 49.3 71.3 30.6 46.5 63.7 11.9 17.0 20.0 16.6 16.1 13.3 15.5 13.2 10.8 16.3 12.2 13.7 15.8 26.3 19.2 15.3 24.8 44.8 9.6 6.4 11.3 11.4 24.7 10.8 10.0 7.8 14.3 12.2 27.6 8.4 13.1 37.7 9.9 3.9 16.0 6.5 7.6 16.9 24.0 7.8 19.4 73.2 14.0 11.3 15.3 14.8 11.1 14.5 36.1 24.7 13.7 35.1 33.7 82.2 6.7 8.2 65.5 32.0 5.2 18.6 45.1 14.2 66.5 64.5 9.3 61.8 28.6 39.8 18.4 8.6 19.9 26.1 4.3 22.8 7.2 12.4 18.7 13.1 29.4 14.5 36.1 20.1 11.8 11.4 6.2 36.5 19.1 9.9 7.4 TCHP "MGC10854, TpMs" ENSG00000139437 "Trichoplein keratin filament binding" Q9BT92 12 109900264-109983841 "Predicted intracellular proteins" "Apoptosis, Cilium biogenesis/degradation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038638, HPA061543" Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA038638: AB_10670785, HPA061543: AB_2684556" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (2.58e-1)" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.59e-2)" "unprognostic (9.75e-2)" "unprognostic (1.15e-3)" "unprognostic (4.63e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.52e-4)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" 6.5 7.3 10.2 9.0 10.9 6.9 6.6 11.3 11.0 9.3 8.3 9.4 7.3 9.2 7.6 15.5 7.7 6.0 7.8 9.9 9.7 7.1 5.6 7.4 11.8 10.7 10.9 8.9 9.0 11.0 7.4 6.4 7.7 10.9 8.7 6.9 9.3 10.6 8.0 9.2 27.6 8.2 7.7 9.8 11.9 8.2 9.4 10.8 10.5 8.7 7.0 11.7 9.4 13.9 11.4 27.6 24.0 12.7 15.3 11.0 11.9 17.3 25.6 13.4 21.8 12.1 15.2 9.4 38.2 7.2 14.9 11.8 22.5 14.0 16.0 19.5 20.7 13.8 27.6 15.3 15.0 13.3 38.0 20.4 9.8 19.1 22.9 17.1 13.7 19.7 23.8 30.5 7.5 18.2 18.9 35.0 38.4 15.3 6.6 24.2 31.7 24.9 32.4 9.9 24.2 18.8 19.8 18.5 19.8 18.2 9.0 17.9 27.2 21.8 22.2 15.5 14.3 32.7 21.8 29.5 27.0 23.5 31.0 23.7 0.0 2.7 2.3 3.6 1.7 2.6 2.0 3.2 4.5 2.1 1.3 3.2 2.5 2.7 5.9 3.7 1.5 4.7 3.1 10.2 10.9 11.3 11.0 9.9 9.7 10.7 10.9 8.9 10.9 9.8 10.8 11.4 11.7 19.2 21.4 18.9 10.4 9.8 7.7 9.5 8.0 28.9 11.3 11.4 13.2 17.2 12.0 7.3 18.8 11.2 14.3 12.8 9.8 20.7 32.5 23.0 19.1 15.2 14.8 15.4 8.3 15.1 8.4 11.4 10.2 13.2 13.3 15.7 7.9 7.4 11.6 25.2 12.3 10.7 10.2 13.0 7.8 47.6 11.1 11.4 7.2 1.9 14.3 13.9 35.0 10.1 19.4 18.8 14.4 27.8 15.0 9.1 14.2 6.6 33.6 24.0 13.1 19.6 12.6 25.1 33.2 14.8 24.7 7.0 15.9 30.9 12.2 30.7 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109713825-109770495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA075616" Uncertain Approved "Golgi apparatus,Cell Junctions,Midbody ring" Yes NA "Golgi apparatus" "Cell Junctions, Midbody ring" "HPA040181: AB_10796448, HPA075616: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 0.5 19.1 30.6 0.7 41.0 0.6 1.2 33.7 27.2 0.6 5.1 1.8 4.8 0.4 0.8 2.4 0.4 0.8 8.3 17.8 26.2 7.8 4.1 2.2 0.4 37.9 42.1 14.2 13.5 4.0 0.7 22.6 0.1 47.7 1.8 1.0 22.3 3.4 0.5 4.3 3.0 2.2 0.4 31.1 6.3 7.3 23.5 38.5 0.4 0.7 0.6 0.6 0.9 1.8 64.8 2.0 3.1 1.6 3.7 1.0 0.0 1.1 0.6 0.3 1.6 0.2 28.1 0.5 0.3 2.2 0.8 1.7 1.2 1.9 0.1 0.6 16.8 4.0 3.5 0.9 6.5 0.2 2.8 3.6 0.2 0.2 0.3 0.0 0.4 0.1 2.0 1.2 0.6 0.3 11.5 0.7 3.6 3.0 3.3 5.3 2.3 8.0 1.2 3.5 1.5 19.2 116.4 2.5 3.7 8.2 0.5 4.5 3.0 0.2 0.5 3.2 1.3 2.4 2.9 4.0 2.4 0.3 2.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 41.0 33.7 27.2 17.8 26.2 37.9 42.1 14.2 47.7 31.1 38.5 64.8 2.1 0.0 0.0 2.3 3.6 2.2 0.9 0.1 3.4 23.4 7.4 6.1 8.1 1.5 0.8 1.8 33.3 0.3 10.4 1.2 7.9 1.7 29.1 1.2 0.5 1.3 7.7 0.0 1.3 0.8 0.2 1.5 1.5 1.8 0.0 0.7 0.7 1.3 0.3 77.4 6.7 5.8 0.0 0.0 2.1 13.4 1.2 1.9 7.2 0.0 0.1 11.2 0.0 9.5 78.5 1.1 0.2 0.4 1.3 1.7 0.9 0.7 0.6 50.3 0.0 2.6 1.5 1.1 5.7 3.3 1.8 0.8 3.7 6.0 1.6 0.4 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277978-109309284 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.5" "Cell type enhanced" "Detected in some" "Early spermatids: 1.9;Endometrial ciliated cells: 2.6;Ionocytes: 2.0;Respiratory ciliated cells: 1.2;Spermatocytes: 2.8;Spermatogonia: 3.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;SCLC-21H: 3.5;SH-SY5Y: 3.6;U-266/70: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.2 1.4 0.4 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.8 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 11.5 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.6 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 2.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUP58 "KIAA0410, NUP45, NUPL1" ENSG00000139496 "Nucleoporin 58" Q9BVL2 13 25301556-25349800 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 122.5;Late spermatids: 238.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039360 Approved NA NA "HPA039360: AB_2676463" "unprognostic (1.13e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (1.13e-2)" "unprognostic (1.94e-2)" "unprognostic (3.35e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.85e-2)" "unprognostic (3.79e-2)" "unprognostic (2.40e-1)" "unprognostic (6.14e-2)" "unprognostic (2.04e-2)" "unprognostic (7.19e-3)" "unprognostic (3.02e-3)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" "unprognostic (1.06e-1)" 12.6 14.3 12.5 17.3 13.3 35.0 16.3 15.2 15.4 13.1 12.0 12.4 11.9 15.1 12.1 13.8 13.3 14.0 14.2 13.6 14.1 15.6 16.1 19.7 21.6 13.4 12.8 12.5 18.6 12.4 10.8 21.1 20.8 12.3 15.5 14.8 27.5 10.8 11.3 20.6 14.4 11.6 14.7 11.7 12.3 13.3 48.0 13.3 27.2 19.7 24.5 19.0 18.9 13.0 16.1 38.5 22.6 53.8 40.6 17.9 25.4 40.9 55.8 41.6 57.9 47.3 37.8 40.5 65.0 26.4 31.6 49.7 41.8 61.6 45.6 92.4 60.5 30.0 90.8 20.8 26.7 33.0 66.5 103.9 17.4 61.8 47.8 106.4 28.6 36.3 55.5 49.4 27.6 66.4 15.2 86.1 47.0 32.4 61.4 19.5 59.1 70.5 29.8 32.1 29.4 63.5 32.0 36.0 27.2 44.6 43.3 18.4 60.6 29.6 37.4 37.2 36.3 66.5 33.9 29.9 87.4 27.6 38.9 65.2 1.4 6.3 1.8 2.4 5.3 3.2 2.4 3.1 2.9 3.8 1.9 3.5 3.1 8.9 2.3 6.3 1.9 4.3 3.4 12.5 13.3 15.2 15.4 13.6 14.1 13.4 12.8 12.5 12.3 11.7 13.3 16.1 25.9 41.7 105.2 0.0 53.6 0.0 24.1 0.0 52.3 34.6 27.4 20.7 0.0 20.0 13.6 25.8 54.2 27.2 30.2 8.5 11.7 13.4 122.5 30.6 51.4 23.9 9.7 41.2 0.0 10.9 39.8 27.4 26.0 47.7 24.0 32.9 19.2 27.1 23.0 25.2 0.0 13.7 0.0 40.5 0.0 238.7 19.3 56.6 0.0 0.0 31.7 22.7 19.6 0.0 0.0 19.3 6.8 24.8 41.6 39.7 11.7 37.0 5.8 49.5 19.7 35.8 22.3 86.7 78.8 33.8 0.0 39.5 38.1 21.6 14.0 28.7 MTMR6 ENSG00000139505 "Myotubularin related protein 6" Q9Y217 13 25246222-25287488 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.68e-2)" "unprognostic (1.50e-2)" "unprognostic (1.21e-2)" "unprognostic (2.31e-3)" "unprognostic (1.91e-1)" "unprognostic (9.19e-2)" "unprognostic (3.21e-1)" "unprognostic (1.45e-1)" "unprognostic (3.41e-2)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-1)" "unprognostic (1.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.18e-1)" "unprognostic (5.06e-2)" "unprognostic (1.30e-1)" 13.5 19.2 10.8 14.3 12.3 32.2 12.6 11.9 14.0 10.8 8.3 11.0 8.6 12.3 7.8 10.9 8.8 12.9 15.7 12.6 12.9 14.9 13.5 13.1 15.1 13.0 11.6 11.3 9.4 12.9 16.5 6.2 12.3 12.4 13.0 12.2 22.1 16.2 13.5 11.9 7.8 8.9 15.9 11.9 14.3 11.0 18.7 12.2 16.9 15.5 15.1 14.5 14.4 6.5 14.7 12.3 12.6 20.3 17.3 21.2 22.1 9.9 38.0 42.6 36.9 28.9 8.4 21.4 18.8 11.0 35.7 18.7 14.9 13.1 22.5 42.6 22.7 8.6 23.1 8.4 6.9 25.5 48.5 40.8 15.9 25.9 26.8 35.8 21.1 30.4 24.8 10.9 20.9 37.5 8.7 27.8 13.1 6.1 23.6 9.4 11.8 28.5 25.9 26.7 14.2 10.7 15.2 12.4 21.8 20.2 19.2 8.4 30.2 39.4 22.6 11.6 25.2 22.5 11.3 14.0 24.6 11.4 18.6 37.6 22.9 9.8 8.0 5.8 14.0 7.4 6.5 6.1 6.2 7.9 4.2 6.2 6.4 18.9 6.0 13.0 4.7 8.9 8.9 10.8 12.3 11.9 14.0 12.6 12.9 13.0 11.6 11.3 12.4 11.9 12.2 14.7 24.5 16.0 32.1 20.5 44.3 11.0 8.0 8.7 8.0 0.0 16.7 10.4 29.5 8.6 11.9 16.5 0.0 5.8 21.8 14.5 13.7 13.1 64.0 19.0 18.9 20.7 16.7 6.1 29.4 15.0 6.9 16.7 14.8 10.5 19.0 10.6 27.1 23.1 16.3 0.0 63.9 16.0 12.2 40.5 27.7 23.4 12.5 36.4 19.6 26.2 28.1 0.0 5.2 33.2 51.6 22.3 10.0 19.9 28.3 10.2 7.3 31.3 26.6 0.0 0.0 20.4 17.7 62.1 20.4 10.3 11.9 8.2 26.3 17.5 12.3 11.9 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 76.6;liver: 96.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 53.2;Hepatocytes: 51.3;Proximal enterocytes: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.0;T-47d: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favorable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 13.9 11.8 5.4 10.3 5.5 3.0 10.1 7.7 5.3 14.8 9.5 19.9 47.1 5.6 11.2 4.0 7.6 24.0 12.4 4.7 5.6 18.4 96.8 11.6 16.5 6.0 6.1 4.2 4.0 6.7 24.1 10.3 9.6 6.1 6.6 18.9 16.1 9.1 10.0 8.5 4.3 76.6 8.3 6.6 18.3 7.8 11.0 7.1 11.7 12.6 8.7 11.2 7.1 2.2 6.3 0.0 2.8 0.0 7.6 6.0 2.3 0.2 2.7 15.7 3.0 4.4 0.1 6.6 5.2 4.7 4.0 11.5 0.6 3.5 1.4 4.5 3.9 6.2 3.6 0.0 0.0 11.4 0.0 4.3 9.8 2.9 4.5 7.3 3.0 5.6 15.7 3.9 0.0 14.5 3.0 8.6 0.6 0.3 8.0 2.2 3.5 13.3 0.2 27.0 0.9 1.2 0.4 0.0 14.1 5.7 3.1 20.6 4.6 2.0 1.4 2.7 0.4 16.0 4.0 2.0 0.8 0.9 0.0 2.8 33.1 8.9 3.8 10.3 13.1 8.6 7.4 8.0 10.1 11.7 9.7 11.4 10.8 9.8 7.0 19.4 11.0 10.6 8.7 5.4 5.5 7.7 5.3 4.7 5.6 6.0 6.1 4.2 6.1 6.6 7.1 6.3 6.2 0.0 5.4 16.0 14.5 1.9 0.1 7.4 1.8 33.7 15.1 3.3 9.6 17.2 15.6 9.2 8.4 0.6 16.4 49.0 1.9 15.5 4.6 2.1 1.7 12.2 3.6 4.6 11.6 5.6 0.3 6.2 0.0 2.1 25.9 53.2 17.5 51.3 10.8 21.9 13.0 6.8 2.0 32.1 36.6 1.8 1.5 22.5 7.2 16.9 9.3 14.2 12.3 14.6 15.6 3.5 5.3 2.2 6.5 0.6 125.0 10.1 15.4 9.8 0.0 2.8 7.2 2.6 0.9 4.9 1.7 0.7 11.4 16.8 13.9 0.2 SLC7A1 "ATRC1, CAT-1, ERR, HCAT1, REC1L" ENSG00000139514 "Solute carrier family 7 member 1" P30825 13 29509414-29595688 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 235.6;Microglial cells: 162.1;Squamous epithelial cells: 175.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039721, HPA077838" Approved NA NA "HPA039721: AB_10672893, HPA077838: " "unprognostic (1.85e-1)" "unprognostic (1.04e-3)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (1.36e-3)" "unprognostic (2.02e-3)" "unprognostic (4.98e-2)" "unprognostic (1.23e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.20e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (7.37e-3)" 6.0 6.0 39.9 10.8 22.2 11.4 7.7 27.1 29.9 8.2 20.4 10.2 10.3 8.5 10.3 55.5 7.4 4.5 7.4 29.0 24.2 4.5 2.0 4.9 8.6 39.0 27.5 16.7 2.8 30.8 4.5 7.5 3.0 39.8 7.8 7.4 9.1 16.2 9.2 2.1 17.8 14.9 9.1 33.1 6.0 11.4 7.0 33.8 7.9 9.6 1.7 10.5 11.1 11.2 30.3 42.2 33.2 28.7 58.0 14.5 28.6 32.6 87.8 58.3 74.2 55.0 68.0 72.1 82.9 23.3 134.5 82.8 188.0 50.4 62.2 97.1 78.3 30.1 62.1 36.3 37.0 75.0 91.6 39.4 36.6 129.4 82.6 96.9 17.4 37.1 92.8 40.5 37.6 31.5 56.5 67.2 24.6 27.5 74.2 22.1 45.7 59.1 48.3 47.2 27.5 97.3 46.3 50.0 48.3 79.4 17.9 21.3 76.6 35.1 58.2 40.6 51.6 63.6 42.1 33.1 93.8 46.4 36.3 60.1 0.0 0.4 0.1 1.0 0.4 0.8 0.6 0.7 0.8 0.6 0.4 0.5 0.9 0.0 0.2 1.0 1.2 0.6 0.7 39.9 22.2 27.1 29.9 29.0 24.2 39.0 27.5 16.7 39.8 33.1 33.8 30.3 12.1 0.0 5.0 7.2 14.4 49.8 53.9 33.0 235.6 15.6 21.4 12.8 10.2 12.8 16.2 71.7 16.7 1.1 10.3 14.7 1.9 19.9 0.2 32.5 10.0 29.2 31.1 54.7 28.9 56.9 40.0 10.3 26.5 69.2 7.0 8.0 5.7 0.4 6.1 25.2 27.0 34.5 26.4 5.7 18.2 0.8 6.2 8.6 8.8 162.1 5.7 3.1 3.1 23.6 13.1 56.5 21.1 3.8 36.8 55.2 20.7 0.3 10.1 18.6 6.6 28.1 9.0 4.5 2.1 175.1 34.9 4.0 11.3 10.8 33.5 41.6 PDX1 "IDX-1, IPF1, MODY4, PDX-1, STF-1" ENSG00000139515 "Pancreatic and duodenal homeobox 1" P52945 13 27920000-27926313 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 42.2;pancreas: 13.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6" "Group enriched" "Detected in many" 4 "colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025873, HPA059146" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB025873: , HPA059146: AB_2683927" "unprognostic (2.79e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (6.84e-2)" "unprognostic (3.89e-2)" "unprognostic (6.75e-3)" "unprognostic (7.10e-3)" "unprognostic (3.83e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 42.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 4.0 2.3 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 15.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.3 0.0 0.0 0.0 0.0 13.8 0.0 0.0 9.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 LNX2 "MGC46315, PDZRN1" ENSG00000139517 "Ligand of numb-protein X 2" Q8N448 13 27545913-27620529 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040698 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA040698: AB_10673138" "unprognostic (4.97e-2)" "unprognostic (1.97e-2)" "unprognostic (3.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-2)" "unprognostic (1.12e-1)" "unprognostic (8.38e-2)" "unprognostic (1.16e-1)" "unprognostic (9.27e-3)" "unprognostic (4.21e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.09e-13)" "unprognostic (4.18e-3)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.84e-2)" 3.2 6.7 2.2 3.8 2.6 3.9 7.0 5.4 3.1 4.0 6.0 10.8 14.3 3.0 4.9 10.7 4.7 8.0 8.8 2.6 2.6 8.0 20.7 11.6 4.0 2.0 2.3 2.0 4.4 19.7 7.1 3.2 3.7 2.9 6.4 10.6 8.0 9.5 4.8 6.0 6.7 13.5 3.8 2.1 3.1 10.0 12.4 2.5 7.9 9.9 6.0 5.1 6.3 6.7 2.2 6.4 3.5 6.5 7.2 6.7 3.1 6.8 5.6 4.9 5.4 4.9 12.7 12.5 9.6 4.7 4.9 9.8 12.0 11.8 15.0 7.0 6.0 4.9 12.3 7.2 9.3 10.5 6.6 7.6 2.6 22.8 3.8 14.7 15.4 9.9 9.9 3.8 3.6 7.9 7.9 10.0 4.4 7.2 29.0 3.9 9.2 12.7 5.0 11.9 11.1 16.7 3.5 7.6 15.4 10.1 8.0 10.7 5.2 12.6 3.1 4.3 3.1 4.6 3.5 6.3 9.9 2.0 6.3 4.4 2.0 0.3 0.9 0.5 0.1 0.7 0.5 0.6 0.7 0.3 0.5 0.6 0.6 0.3 1.1 0.2 0.1 1.0 0.2 2.2 2.6 5.4 3.1 2.6 2.6 2.0 2.3 2.0 2.9 2.1 2.5 2.2 4.5 32.1 27.6 9.8 5.6 25.4 27.7 15.8 23.9 8.9 13.3 7.6 11.4 25.8 11.4 20.2 2.1 1.5 5.5 27.8 3.9 10.2 16.4 11.0 2.7 7.2 10.2 18.9 23.2 14.2 8.1 3.2 11.7 14.7 1.3 10.8 9.3 59.2 2.3 5.0 8.0 17.0 8.2 5.0 7.7 7.3 2.8 2.8 10.6 21.5 2.3 4.4 5.2 3.0 6.7 11.0 23.5 3.4 5.4 16.8 17.8 7.8 15.9 16.3 0.0 3.1 3.5 15.6 17.5 14.8 22.0 3.0 5.5 11.1 11.9 20.9 SUOX ENSG00000139531 "Sulfite oxidase" P51687 12 55997180-56006641 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 49.6;Proximal tubular cells: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 72.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038208, HPA038209" Approved NA NA 44000 "HPA038208: AB_2675892, HPA038209: AB_10672738" "unprognostic (1.72e-1)" "unprognostic (7.40e-2)" "unprognostic (2.04e-1)" "unprognostic (1.25e-2)" "unprognostic (1.86e-1)" "unprognostic (9.72e-3)" "unprognostic (1.71e-3)" "unprognostic (2.86e-3)" "unprognostic (3.27e-2)" "unprognostic (9.74e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.95e-2)" "prognostic favorable (4.77e-7)" "unprognostic (1.65e-1)" "unprognostic (1.89e-1)" "unprognostic (2.85e-2)" "prognostic favorable (8.32e-5)" 19.4 35.5 18.4 9.6 19.7 12.9 18.4 19.9 22.8 16.7 20.2 20.3 19.5 17.8 33.3 21.7 23.1 16.9 29.4 18.7 18.8 41.2 72.9 15.8 8.3 20.1 20.3 18.4 22.3 17.6 49.0 16.7 11.6 19.7 25.4 17.3 13.9 20.4 24.8 46.0 10.5 15.7 17.6 18.2 13.7 21.5 8.4 20.4 6.8 18.3 29.1 12.1 21.3 14.4 23.2 10.2 29.8 18.5 30.2 29.6 12.2 40.1 11.5 12.5 15.4 11.1 28.8 22.1 1.2 19.8 14.0 10.6 13.2 13.7 14.5 8.2 45.8 9.0 15.7 19.4 34.9 10.9 0.2 25.9 19.0 5.5 13.1 6.8 23.0 38.9 1.6 28.2 19.0 16.2 25.1 0.4 10.0 9.9 15.6 21.4 13.6 7.7 22.4 17.8 20.4 9.2 12.3 21.1 42.6 17.4 17.2 72.2 14.9 20.6 8.5 10.4 10.8 8.2 22.0 21.3 1.6 13.7 10.2 12.7 11.1 12.6 29.6 0.2 18.7 0.1 2.5 1.2 0.0 16.1 0.3 0.9 0.2 5.1 16.5 16.2 0.5 7.9 11.8 18.4 19.7 19.9 22.8 18.7 18.8 20.1 20.3 18.4 19.7 18.2 20.4 23.2 4.5 9.6 10.9 10.7 1.1 1.3 3.8 6.7 6.2 5.1 9.1 6.1 21.7 11.5 12.8 14.7 6.2 29.7 0.9 7.7 17.6 5.6 0.7 7.7 6.7 7.1 6.0 6.5 4.1 6.3 19.1 6.4 6.6 12.4 4.5 6.6 8.9 49.6 10.5 10.1 4.4 6.0 4.1 8.9 4.0 0.9 4.4 4.3 1.8 5.6 10.0 8.5 2.1 5.5 6.2 5.3 7.4 9.1 3.2 3.1 7.9 35.8 6.1 8.4 6.6 8.4 5.4 2.4 1.4 6.8 2.3 30.8 1.6 6.7 7.7 3.0 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 26.8;testis: 37.6" "Cell type enhanced" "Detected in many" "Early spermatids: 151.1;Endometrial ciliated cells: 92.7;Respiratory ciliated cells: 155.7;Spermatocytes: 85.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 8.7;MAIT T-cell: 9.1;memory CD4 T-cell: 7.5;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.6;naive CD8 T-cell: 6.2;T-reg: 4.8" "Lineage enriched" "Detected in single" 11 "T-cells: 9.1" "Cell line enhanced" "Detected in many" "HeLa: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" NA NA Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: AB_2683473" "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.3 0.4 2.4 0.7 2.4 1.4 0.5 0.5 2.6 1.0 2.9 0.3 0.3 1.1 2.9 0.3 26.8 1.2 0.3 3.7 1.2 1.8 0.3 2.9 1.0 2.3 1.4 2.9 0.8 0.8 1.4 2.2 0.1 1.3 0.4 0.0 7.2 0.3 0.4 0.4 1.5 0.5 0.2 0.9 1.2 0.5 37.6 1.0 0.2 2.6 0.0 0.3 0.2 0.3 0.9 0.6 2.5 1.1 2.2 0.0 0.0 1.1 0.6 0.0 0.3 1.0 3.1 1.4 0.9 0.8 0.0 0.3 0.7 0.0 0.0 0.4 1.4 1.1 1.4 4.4 1.1 0.1 1.1 1.2 0.0 0.0 0.6 0.0 1.7 0.0 0.7 0.6 0.3 0.0 1.5 0.3 1.5 2.5 0.9 0.6 0.8 0.5 1.0 2.0 1.6 0.6 1.0 0.7 0.9 0.8 1.7 2.3 1.0 1.0 0.8 0.8 0.9 0.5 1.1 1.2 0.8 0.9 0.9 0.2 0.0 0.0 0.0 8.7 0.0 9.1 0.2 7.5 7.3 0.0 0.5 4.6 6.2 0.1 0.8 0.0 0.0 4.8 2.9 2.4 2.4 0.5 2.6 3.7 1.2 2.3 1.4 2.9 1.3 0.9 1.0 0.9 0.9 0.0 1.1 2.0 0.6 0.9 0.2 6.2 0.0 1.2 0.4 0.5 0.5 0.0 13.8 0.0 12.5 0.1 6.5 0.0 7.9 1.0 151.1 92.7 3.0 0.6 0.0 2.7 7.2 0.6 0.1 0.8 0.5 4.2 0.0 0.5 0.0 0.5 0.0 0.0 4.0 0.0 12.2 0.0 0.8 22.7 1.5 0.3 1.8 1.0 0.2 2.2 33.0 2.0 0.8 0.3 0.0 2.2 1.0 0.2 0.0 3.4 155.7 11.5 0.0 0.5 3.6 85.9 4.8 0.0 0.1 0.1 7.3 0.5 0.0 0.1 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "intestine: 239.6;kidney: 111.0;liver: 172.5;pancreas: 309.3" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 798.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 30.6;liver cancer: 36.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 53 "CACO-2: 39.9;Hep G2: 58.5" "Region enhanced" "Detected in single" "basal ganglia: 1.1" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.3 0.1 0.2 5.6 0.2 0.1 0.3 0.4 0.3 0.3 0.1 74.4 239.6 0.4 0.0 0.1 0.3 6.5 0.1 0.1 0.1 111.0 172.5 0.2 0.4 0.2 0.1 0.0 0.4 309.3 0.0 0.2 0.1 0.2 0.3 46.3 6.4 0.1 0.3 0.1 0.3 220.8 2.6 0.0 0.3 1.4 0.2 0.1 0.0 0.3 0.3 0.0 0.2 0.2 0.3 0.0 0.3 0.1 0.2 0.2 0.3 0.5 0.0 0.0 0.1 0.0 39.9 0.4 0.1 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.6 0.1 0.2 0.2 58.5 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.8 0.0 0.9 0.1 0.2 0.2 0.3 0.5 0.1 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 1.4 0.6 0.1 0.0 0.0 0.9 0.1 0.3 0.2 15.7 0.0 3.7 116.7 0.0 0.0 171.9 19.6 0.3 0.6 0.0 0.1 0.2 25.3 2.7 0.2 20.6 0.0 0.1 0.0 0.0 0.0 0.0 2.2 138.9 0.1 0.0 0.2 112.7 0.0 1.6 1.2 1.4 0.0 1.3 0.0 0.0 0.6 0.6 0.0 0.0 0.1 7.4 192.8 0.0 0.0 0.1 798.4 169.9 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.8 0.0 168.7 0.0 TARBP2 Trbp ENSG00000139546 "TARBP2 subunit of RISC loading complex" Q15633 12 53500921-53506431 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051181, HPA061454, CAB069406" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526" "unprognostic (1.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (6.61e-3)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.04e-1)" "unprognostic (4.72e-3)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (8.06e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (4.31e-1)" 8.5 13.2 9.5 9.3 9.6 6.9 9.0 13.1 11.4 8.9 9.3 8.8 9.1 8.5 8.0 13.2 11.8 6.7 8.7 9.3 9.9 17.8 20.8 10.2 10.6 9.7 9.8 8.9 8.1 18.9 8.6 8.6 13.9 10.9 11.4 5.5 6.8 11.1 5.2 9.9 9.6 9.6 6.2 9.8 15.3 12.5 13.3 10.3 10.4 12.1 7.2 9.1 10.5 8.9 10.3 25.5 69.1 26.8 29.6 15.3 20.8 35.0 22.6 19.2 34.1 20.3 61.2 33.5 24.5 44.6 24.9 22.2 20.0 32.8 34.1 19.9 30.5 54.1 28.6 26.6 43.9 33.3 48.0 31.9 24.3 21.0 35.2 16.5 23.2 41.2 36.6 37.1 38.3 24.9 102.9 32.5 62.9 53.0 19.7 37.1 23.9 14.4 31.6 22.6 26.4 34.8 24.8 11.8 28.7 58.9 19.1 40.4 63.7 22.1 31.2 29.8 11.9 27.4 19.7 39.6 26.1 34.8 24.2 35.6 2.1 11.5 5.7 13.9 11.9 13.3 10.9 13.3 12.8 14.9 15.3 13.7 13.6 0.7 13.1 7.7 13.3 11.7 12.5 9.5 9.6 13.1 11.4 9.3 9.9 9.7 9.8 8.9 10.9 9.8 10.3 10.3 5.2 0.0 8.2 4.6 10.7 6.4 10.5 15.3 17.1 9.3 12.0 10.0 6.0 15.7 11.2 9.2 10.4 46.5 7.2 9.8 21.5 20.7 10.7 7.9 8.8 11.6 5.4 9.4 2.3 26.2 48.9 9.3 13.7 7.2 10.8 10.5 12.1 18.4 25.6 1.7 3.1 10.8 18.3 9.3 4.7 23.8 5.6 7.9 14.2 1.0 12.2 10.2 10.3 4.5 6.2 16.8 9.9 4.1 15.6 11.2 11.3 28.6 7.1 14.2 0.0 4.0 10.0 11.6 13.0 14.4 4.7 32.2 9.0 9.9 14.8 10.1 RDH16 "RODH-4, SDR9C8" ENSG00000139547 "Retinol dehydrogenase 16" O75452 12 56951431-56959374 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 152 "liver: 799.6" "Cell type enriched" "Detected in some" 27 "Hepatocytes: 365.1" "Cancer enriched" "Detected in many" 20 "liver cancer: 44.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.0;hTCEpi: 4.3;OE19: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038518 Enhanced NA NA "HPA038518: AB_10672713" "unprognostic (5.42e-3)" "unprognostic (4.20e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "prognostic favorable (2.16e-5)" "unprognostic (8.83e-3)" "unprognostic (1.04e-1)" "unprognostic (2.84e-1)" "unprognostic (6.85e-2)" "unprognostic (6.10e-1)" "unprognostic (7.99e-12)" "unprognostic (2.24e-1)" "unprognostic (1.29e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" 0.3 0.3 1.0 0.0 1.0 0.0 0.3 1.0 1.0 0.9 1.0 0.3 0.0 0.4 0.1 1.4 0.5 0.0 0.3 1.0 0.9 0.5 799.6 0.4 0.1 0.9 0.9 1.0 0.5 0.6 0.0 0.3 0.0 1.0 5.2 0.0 0.4 0.5 2.4 0.2 2.8 0.5 0.0 0.9 2.5 0.3 1.3 1.0 0.2 0.3 0.0 1.4 0.3 1.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 1.0 1.0 0.9 1.0 1.0 0.1 0.0 0.0 2.0 1.9 0.0 1.2 0.3 0.0 2.2 0.2 0.0 2.0 5.7 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 8.5 0.1 0.1 0.6 0.0 13.5 0.2 0.4 0.0 0.3 0.0 0.1 0.0 0.3 3.6 365.1 0.2 1.7 0.2 0.0 0.0 6.3 0.3 5.8 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 1.8 0.2 0.0 0.0 0.3 5.7 0.0 0.1 0.2 1.0 0.0 0.0 0.1 1.4 0.9 0.8 0.3 0.0 0.6 0.1 0.0 0.3 DHH "HHG-3, MGC35145" ENSG00000139549 "Desert hedgehog signaling molecule" O43323 12 49086656-49094801 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 16.8" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 17.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 1.8;EFO-21: 2.3;HUVEC TERT2: 1.5;K-562: 5.6;TIME: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "spinal cord: 8.2" "Secreted in male reproductive system" NA NA "unprognostic (7.56e-2)" "unprognostic (2.05e-3)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (2.36e-4)" "unprognostic (1.29e-1)" "unprognostic (7.22e-3)" "unprognostic (8.21e-2)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" 0.7 0.2 0.3 0.5 0.3 0.0 0.7 0.7 1.4 0.4 0.8 0.3 0.0 0.6 0.2 0.3 0.4 0.3 0.6 0.3 0.3 0.2 0.1 0.5 0.1 0.5 0.4 0.1 0.3 0.1 0.0 0.6 0.6 0.4 0.4 0.1 0.0 0.3 0.3 0.1 0.3 0.4 0.4 0.6 0.2 0.3 16.8 0.4 0.0 0.3 0.4 0.0 0.7 0.5 1.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 1.4 0.3 0.3 0.5 0.4 0.1 0.4 0.6 0.4 1.1 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 17.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 ACVRL1 "ACVRLK1, ALK1, HHT, HHT2, ORW2" ENSG00000139567 "Activin A receptor like type 1" P37023 12 51906908-51923361 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 97.1" "Cell type enhanced" "Detected in many" "Adipocytes: 107.3;Distal enterocytes: 182.7;Endothelial cells: 84.7;Fibroblasts: 56.0;Hepatic stellate cells: 60.3;Paneth cells: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 1.5;myeloid DC: 2.1" "Group enriched" "Detected in many" 19 "dendritic cells: 2.1;monocytes: 1.5" "Cell line enhanced" "Detected in some" "ASC diff: 61.4;ASC TERT1: 42.1;EFO-21: 61.0;HUVEC TERT2: 200.0;TIME: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007041 Approved "Intracellular and membrane" NA NA "HPA007041: AB_1078097" "unprognostic (2.50e-1)" "unprognostic (4.83e-1)" "unprognostic (3.79e-2)" "unprognostic (3.61e-2)" "unprognostic (4.98e-1)" "unprognostic (4.06e-3)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (5.80e-2)" "unprognostic (5.10e-2)" "unprognostic (4.60e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-3)" "unprognostic (1.39e-1)" "unprognostic (7.98e-3)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" 48.8 12.2 18.7 20.3 13.3 0.6 38.7 14.6 15.0 33.8 14.0 39.5 10.3 28.3 4.3 11.5 33.0 14.4 28.8 12.5 13.8 23.8 3.3 97.1 15.2 17.0 16.0 9.5 4.9 12.1 23.8 6.2 84.5 16.7 17.8 28.6 0.7 11.9 13.4 18.4 17.7 28.7 16.4 13.1 29.4 19.2 1.7 20.5 4.6 29.5 15.9 6.2 25.3 25.8 19.3 0.0 0.7 0.4 0.0 61.4 42.1 0.1 3.0 5.6 0.1 0.3 0.3 0.4 0.1 61.0 24.0 0.2 0.0 0.0 0.0 0.1 0.1 2.1 1.4 0.0 0.0 9.0 0.0 1.3 16.8 0.1 0.4 0.0 0.0 200.0 0.0 0.2 0.1 1.1 0.5 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.1 0.4 0.0 4.1 161.2 0.0 0.4 0.7 0.0 0.0 0.1 0.2 0.3 0.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.7 13.3 14.6 15.0 12.5 13.8 17.0 16.0 9.5 16.7 13.1 20.5 19.3 107.3 3.2 7.9 0.0 0.6 5.2 0.3 0.0 0.6 0.4 1.0 1.3 4.0 0.0 1.3 0.0 0.0 0.6 0.3 182.7 0.0 4.0 0.0 1.4 19.9 84.7 5.4 0.0 0.1 1.4 36.9 56.0 0.5 0.7 0.0 0.0 60.3 0.1 12.0 0.0 0.0 26.4 0.0 30.9 12.4 1.2 11.8 7.8 5.4 25.3 9.9 2.0 0.0 1.0 0.1 0.0 74.7 3.4 0.1 0.6 4.5 0.0 2.8 0.4 39.5 32.9 18.2 0.1 0.8 0.6 5.4 2.6 1.2 0.6 49.3 1.0 GPR84 EX33 ENSG00000139572 "G protein-coupled receptor 84" Q9NQS5 12 54362445-54364487 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.0;urinary bladder: 15.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 21.9;Langerhans cells: 17.7;Macrophages: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 23 "basophil: 9.0;classical monocyte: 9.9;myeloid DC: 14.8;neutrophil: 6.0" "Group enriched" "Detected in many" 62 "dendritic cells: 14.8;granulocytes: 9.0;monocytes: 9.9" "Group enriched" "Detected in some" 5 "HL-60: 13.0;NB-4: 40.0" HPA027603 Enhanced NA NA "HPA027603: AB_10612115" "unprognostic (5.40e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (3.92e-2)" "unprognostic (2.36e-2)" "unprognostic (4.54e-2)" "unprognostic (6.16e-3)" "unprognostic (7.43e-2)" "unprognostic (9.29e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.92e-1)" "unprognostic (1.36e-9)" "unprognostic (1.27e-1)" "unprognostic (4.42e-2)" "unprognostic (1.40e-1)" "unprognostic (9.44e-2)" 4.5 1.1 1.1 8.3 1.3 23.0 0.3 1.1 1.8 0.3 1.4 0.4 0.3 0.3 0.3 0.5 0.7 1.0 0.5 1.1 3.4 0.6 0.4 2.5 0.3 2.7 1.4 1.0 0.3 0.4 0.1 0.8 3.1 1.9 0.6 0.6 2.7 0.6 0.2 0.0 0.7 0.4 1.9 1.8 3.6 0.6 0.3 1.7 0.5 0.6 0.2 0.8 15.9 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.0 2.2 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.1 0.0 9.0 9.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 14.8 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 2.1 1.1 1.3 1.1 1.8 1.1 3.4 2.7 1.4 1.0 1.9 1.8 1.7 2.7 0.2 0.0 0.5 2.0 0.3 0.9 0.1 4.6 0.0 2.6 0.2 0.3 0.1 0.0 1.2 0.0 4.2 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 1.6 0.0 0.0 0.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 1.1 0.0 0.0 2.8 17.7 0.2 0.0 31.8 0.0 0.0 1.2 0.1 0.0 1.5 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.5 0.0 0.1 0.4 0.3 0.1 0.1 0.4 0.8 0.1 0.0 0.0 0.1 NPFF FMRFAL ENSG00000139574 "Neuropeptide FF-amide peptide precursor" O15130 12 53506690-53507638 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 84 "epididymis: 827.7" "Cell type enhanced" "Detected in some" "Astrocytes: 11.1;Excitatory neurons: 1.3;Inhibitory neurons: 1.2;Microglial cells: 1.9;Oligodendrocytes: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HHSteC: 13.3" "Region enriched" "Detected in some" 7 "pons and medulla: 11.4" "Region enriched" "Detected in all" 7 "cerebellum: 50.8" "Secreted in male reproductive system" NA NA 0.2 0.4 2.2 0.0 2.3 0.0 0.1 2.2 9.8 0.2 2.2 0.1 0.8 0.0 827.7 0.1 0.1 0.1 0.1 2.2 2.8 0.1 0.1 0.3 0.0 4.0 3.1 2.2 0.2 0.1 0.0 0.1 0.0 2.3 0.1 0.0 0.2 0.3 0.3 0.0 0.1 0.1 0.0 3.7 0.1 0.1 0.1 2.5 0.1 0.1 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.5 0.2 0.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 1.6 0.3 0.0 0.6 0.2 0.0 0.2 0.2 0.4 1.5 0.0 0.0 0.2 0.0 0.5 0.1 1.7 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 2.2 9.8 2.2 2.8 4.0 3.1 2.2 2.3 3.7 2.5 2.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 NABP2 "hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1" ENSG00000139579 "Nucleic acid binding protein 2" Q9BQ15 12 56222015-56229854 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 243.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044615, HPA057213" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044615: AB_10795884, HPA057213: AB_2683371" "unprognostic (1.45e-1)" "prognostic favorable (8.35e-6)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (7.44e-6)" "unprognostic (4.00e-1)" "unprognostic (1.11e-1)" "unprognostic (6.96e-3)" "unprognostic (6.52e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.28e-1)" "unprognostic (3.01e-2)" 20.1 39.7 32.2 18.0 33.5 19.0 20.9 33.5 39.8 21.3 28.7 25.7 23.2 23.8 19.1 21.8 21.4 15.1 22.9 31.9 33.5 25.9 23.3 15.5 20.3 33.7 33.6 31.0 24.7 34.9 21.9 25.1 8.5 33.3 20.7 19.6 25.0 17.5 18.2 59.8 20.4 23.2 16.4 32.2 18.2 23.6 24.6 34.1 17.6 19.8 32.5 19.7 25.7 18.6 34.0 74.8 75.9 70.3 78.4 30.8 33.1 13.8 43.5 36.6 63.0 37.9 45.8 65.7 56.3 85.8 41.1 44.6 57.8 66.5 56.1 48.0 107.1 64.1 94.7 49.2 36.0 32.4 67.9 89.0 28.6 44.5 75.4 60.3 53.5 41.9 69.0 50.1 94.9 46.2 67.4 94.1 78.6 51.8 45.0 74.3 83.2 65.2 84.9 31.3 30.4 89.1 65.6 69.0 86.3 62.5 11.2 98.9 60.8 29.8 43.8 41.3 92.0 81.2 64.2 104.5 36.1 81.0 63.9 82.9 33.0 15.6 14.9 26.5 22.7 29.6 26.4 21.9 23.9 21.4 21.2 13.4 22.4 3.0 42.7 25.9 21.6 34.3 16.6 32.2 33.5 33.5 39.8 31.9 33.5 33.7 33.6 31.0 33.3 32.2 34.1 34.0 17.2 16.0 18.9 5.2 17.5 18.6 18.5 25.0 21.1 15.3 22.5 27.1 9.6 31.5 12.0 23.9 2.1 28.4 13.6 27.3 49.0 36.7 88.4 11.3 17.1 20.7 18.0 30.3 6.7 70.8 40.0 20.6 13.7 13.4 17.7 17.6 22.9 22.5 31.2 15.2 6.6 27.5 16.2 17.7 20.3 243.5 23.6 16.0 32.0 1.9 27.6 35.8 33.0 2.5 6.4 38.4 22.7 34.3 30.9 13.3 41.6 43.1 11.6 14.8 19.7 23.2 22.9 20.2 25.0 22.1 17.0 15.2 20.1 23.0 37.9 15.1 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.8;JURKAT: 22.2;NB-4: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038971, HPA057219" Approved Approved Cytosol NA NA Cytosol "HPA038971: AB_10673408, HPA057219: " "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 23.7 12.0 33.7 15.0 35.0 50.0 27.1 34.2 40.4 23.8 33.8 18.2 15.7 19.7 16.2 11.3 26.5 12.7 12.0 35.5 35.4 14.1 86.3 30.5 26.9 31.1 31.6 34.5 45.6 20.5 8.6 37.4 13.6 31.8 21.9 14.7 8.0 12.5 11.7 13.9 25.7 21.3 13.1 29.4 30.4 13.9 4.4 35.9 32.3 17.2 9.8 18.0 16.7 20.7 34.3 0.9 0.3 1.3 0.5 5.0 4.0 0.4 0.6 2.2 1.2 2.0 3.8 5.1 10.3 1.4 1.1 3.7 0.1 3.7 0.3 1.6 15.5 2.3 23.8 1.4 11.4 7.8 9.0 1.4 2.8 0.8 1.0 1.0 9.0 0.8 22.2 0.0 18.3 1.0 0.8 18.6 61.4 1.9 0.0 0.5 17.5 0.6 8.8 4.9 1.8 3.4 4.2 3.7 0.1 1.7 2.4 0.5 16.8 0.4 0.5 0.3 0.3 0.1 10.4 6.6 0.5 0.6 3.4 0.7 59.0 49.3 13.9 18.0 47.2 15.9 28.6 17.5 22.4 43.7 33.0 23.9 20.8 12.5 32.1 34.4 56.0 27.9 36.7 33.7 35.0 34.2 40.4 35.5 35.4 31.1 31.6 34.5 31.8 29.4 35.9 34.3 46.1 44.8 27.6 53.2 51.4 30.1 29.6 8.7 23.9 10.6 26.6 22.6 4.3 17.2 16.5 5.5 0.0 22.3 74.8 5.5 9.8 15.0 22.5 23.0 5.7 36.1 37.9 25.5 71.7 8.5 1.1 26.2 6.1 4.8 8.8 16.0 21.0 67.2 22.5 0.0 60.4 9.2 24.4 46.6 102.7 22.7 27.4 54.6 30.2 40.3 110.2 7.2 47.4 72.9 43.4 4.4 12.5 22.2 38.4 24.5 25.8 9.8 8.1 2.2 78.9 48.9 40.4 1.4 2.8 15.2 35.4 10.4 44.0 2.5 12.9 16.5 CELA1 ELA1 ENSG00000139610 "Chymotrypsin like elastase 1" Q9UNI1 12 51328442-51346679 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 2.2;pancreas: 6.6" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 16.6;Extravillous trophoblasts: 2.9;Kupffer cells: 7.9;NK-cells: 3.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 12.4;naive CD4 T-cell: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 12.4;T-cells: 12.3" "Cell line enriched" "Detected in some" 4 "BEWO: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (3.54e-2)" "unprognostic (1.64e-1)" "unprognostic (4.73e-2)" "unprognostic (2.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (3.59e-2)" "unprognostic (3.83e-3)" "unprognostic (2.52e-1)" "unprognostic (1.46e-1)" 0.0 2.2 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 6.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.4 1.6 0.1 1.0 0.8 0.4 0.3 2.7 0.8 1.0 0.0 12.3 5.9 0.2 0.2 1.0 0.0 0.3 1.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 16.6 2.9 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 1.4 0.0 0.0 1.8 0.0 3.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.5 1.4 0.2 0.0 0.0 SMARCC2 "BAF170, CRACC2, Rsc8" ENSG00000139613 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2" Q8TAQ2 12 56162359-56189567 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004321, HPA021213, HPA061788" Supported Enhanced Nucleoplasm NA NA 11000 Nucleoplasm "CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608" "unprognostic (7.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.31e-2)" "unprognostic (4.93e-2)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.43e-2)" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.04e-1)" "unprognostic (2.46e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" 35.1 33.7 48.7 24.0 51.5 23.8 38.8 48.6 57.7 43.9 22.7 36.6 28.0 43.3 23.0 30.7 41.1 23.5 26.0 50.4 44.1 31.7 19.9 29.9 29.7 48.9 46.1 42.9 52.3 32.9 35.8 32.7 25.5 45.1 35.1 23.6 39.6 37.5 33.8 47.1 36.8 34.8 28.6 41.4 32.2 33.3 33.0 50.4 39.3 50.2 30.8 28.9 39.5 37.7 53.0 49.3 74.9 77.2 56.4 47.2 48.9 32.4 42.6 45.3 50.3 48.4 43.5 59.5 71.4 40.0 50.0 47.7 54.8 49.9 42.9 45.1 54.3 47.6 112.2 51.6 27.8 25.6 53.4 79.8 46.4 31.5 47.6 23.7 91.3 65.4 54.7 65.5 57.2 48.1 52.1 90.4 56.0 26.4 39.0 50.4 53.5 62.0 55.0 38.6 63.4 56.6 59.0 72.8 49.4 20.6 40.3 84.3 49.3 56.1 42.5 51.7 38.4 31.8 54.8 41.9 48.4 44.3 35.5 46.9 15.4 8.5 21.0 11.4 10.2 12.3 8.6 8.2 8.6 7.3 9.4 6.0 7.6 7.9 8.3 13.9 6.0 8.6 11.6 48.7 51.5 48.6 57.7 50.4 44.1 48.9 46.1 42.9 45.1 41.4 50.4 53.0 40.8 67.3 43.5 40.1 40.9 20.5 43.2 24.5 62.6 59.3 26.6 28.8 25.7 34.3 40.6 42.3 39.6 20.4 39.0 17.9 7.9 25.4 1.6 24.3 42.8 38.5 22.7 51.9 39.5 18.0 11.9 40.2 33.6 36.3 65.1 56.3 33.9 17.3 16.6 38.7 37.5 22.3 32.6 20.6 20.7 7.8 69.0 29.3 19.6 23.4 36.0 42.3 70.0 33.2 23.4 22.7 17.1 55.3 44.6 32.2 19.8 17.3 25.0 66.0 19.7 47.9 42.3 45.5 31.7 55.9 22.6 13.3 49.9 36.6 21.4 37.7 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2 DNA repair associated" P51587 13 32315086-32400268 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.9;lymphoid tissue: 3.1;testis: 2.7" "Cell type enhanced" "Detected in many" "Spermatocytes: 115.4;Spermatogonia: 85.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA026815 Uncertain Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 0.2 0.1 0.0 1.3 0.1 5.9 0.5 0.0 0.1 0.1 0.2 0.7 0.5 0.3 0.0 0.5 0.1 0.3 0.0 0.0 0.2 0.1 0.3 0.3 2.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.1 0.1 0.8 0.0 0.3 0.0 0.0 0.8 0.5 0.3 0.1 0.9 0.6 2.7 0.2 3.1 0.2 0.0 2.0 0.5 0.2 0.2 4.7 4.0 6.0 5.0 0.6 1.4 7.0 4.8 3.1 5.5 5.0 10.6 6.0 15.9 3.2 2.1 7.6 6.1 5.5 2.9 10.5 10.5 3.1 10.3 2.5 3.5 0.1 15.4 4.9 0.2 0.0 10.3 6.9 0.4 4.5 8.1 7.0 5.5 6.4 5.1 11.8 8.3 8.3 4.9 2.3 11.4 17.3 3.0 1.4 5.4 2.4 4.6 5.9 2.4 2.2 2.2 2.9 7.3 1.3 6.3 6.8 7.0 6.7 2.0 3.3 8.0 2.7 5.7 5.8 0.0 0.3 1.5 0.5 0.7 0.1 1.7 0.4 0.4 0.3 2.2 0.5 0.4 0.8 0.5 0.8 3.0 1.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 4.4 9.6 2.6 0.0 12.4 2.5 3.3 2.5 2.2 0.0 4.3 3.3 1.9 0.0 1.8 0.0 0.0 14.1 10.5 4.8 0.0 2.5 5.2 4.4 6.3 5.5 1.2 29.5 0.7 1.6 12.7 5.8 10.7 4.6 3.8 26.9 1.4 0.8 9.5 0.0 0.5 4.4 0.0 7.5 11.0 4.4 2.1 14.4 3.6 4.7 20.1 0.3 0.0 0.0 0.6 1.2 1.8 1.2 27.8 1.2 1.0 0.6 2.9 0.0 13.1 8.3 5.3 115.4 85.6 8.0 1.3 5.5 7.9 4.2 7.8 2.3 KANSL2 "C12orf41, FLJ20436, NSL2" ENSG00000139620 "KAT8 regulatory NSL complex subunit 2" Q9H9L4 12 48653211-48682238 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038497, HPA038498" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038497: AB_10674685, HPA038498: AB_2676046" "unprognostic (3.87e-3)" "unprognostic (6.18e-2)" "unprognostic (3.67e-1)" "unprognostic (8.89e-2)" "unprognostic (5.37e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (5.46e-2)" "unprognostic (1.35e-3)" "unprognostic (6.16e-2)" "unprognostic (6.75e-3)" "unprognostic (4.19e-3)" "unprognostic (8.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "prognostic favorable (4.32e-4)" 11.5 11.5 6.1 8.3 6.9 42.2 12.4 8.6 8.0 13.6 7.1 11.5 8.2 14.2 11.6 13.4 12.7 7.8 12.3 6.5 6.7 12.3 9.9 10.9 14.0 7.0 6.6 5.9 16.4 9.8 12.3 9.4 12.3 6.8 11.2 9.4 11.9 13.1 8.4 41.0 13.5 12.0 9.9 7.1 13.4 10.9 14.7 6.7 14.4 11.6 23.4 13.9 12.5 12.9 8.8 19.5 26.5 21.8 12.8 25.6 22.0 48.1 20.8 17.6 35.9 19.5 45.2 25.1 31.9 39.0 25.5 14.0 18.3 37.1 23.5 29.5 30.4 22.5 37.1 20.2 12.9 29.2 40.0 13.9 20.8 31.2 25.5 46.2 18.0 17.2 24.8 43.7 20.9 25.0 18.7 39.2 29.2 28.6 28.1 26.0 33.4 21.3 35.9 17.2 27.1 25.1 17.6 43.2 30.0 25.7 21.8 40.2 43.4 12.8 25.5 18.9 10.9 19.7 29.8 50.7 46.2 12.4 89.5 13.6 35.3 19.7 23.5 25.1 21.2 23.7 27.3 23.9 25.9 25.8 23.8 27.9 26.9 9.0 24.3 23.0 20.2 32.2 24.0 6.1 6.9 8.6 8.0 6.5 6.7 7.0 6.6 5.9 6.8 7.1 6.7 8.8 18.0 3.2 14.3 9.8 24.7 11.9 14.7 17.9 32.5 15.6 15.7 15.5 10.9 8.6 15.0 14.7 29.2 22.5 36.5 10.2 9.8 13.3 24.4 8.2 13.9 13.7 9.0 14.1 11.5 9.8 12.5 15.1 12.2 12.4 11.4 19.8 14.6 9.6 11.9 15.2 13.8 9.1 10.2 11.9 13.2 13.8 12.5 13.7 16.0 7.5 14.8 8.2 11.3 15.1 18.8 12.2 4.7 10.1 16.9 12.1 10.8 15.6 10.2 22.8 26.3 15.7 16.6 38.5 34.8 19.9 11.2 25.3 30.6 15.9 12.4 9.8 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129289-50167533 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006780, HPA026589" Approved Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA006780: , HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavorable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavorable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favorable (5.76e-5)" "unprognostic (3.26e-1)" 26.3 22.5 27.1 4.8 27.7 5.2 26.9 28.9 48.5 36.1 26.5 21.8 3.1 30.8 12.1 24.2 28.5 7.0 15.4 26.8 28.4 31.4 14.3 23.0 6.2 27.6 28.1 26.9 35.4 23.1 9.2 42.6 5.6 27.9 31.5 3.0 5.5 21.7 3.5 5.5 33.9 20.8 4.7 26.9 29.4 21.7 13.9 28.9 7.6 25.0 2.3 3.8 29.7 29.4 28.9 12.1 13.2 17.1 3.5 6.5 3.9 10.6 23.3 6.6 8.0 7.4 36.2 13.9 10.6 20.2 24.4 7.7 7.9 6.1 4.4 6.7 23.4 12.7 6.1 11.2 23.2 16.5 8.0 12.4 19.4 13.9 11.6 6.3 18.7 11.9 10.0 6.1 10.8 8.6 18.7 15.4 45.6 8.2 4.1 7.0 10.7 4.3 12.7 28.7 17.7 5.2 6.9 10.3 9.4 33.6 10.7 13.0 9.9 10.6 17.6 10.2 11.6 8.0 8.1 14.3 11.6 12.8 5.9 8.4 36.3 23.0 42.4 37.0 37.4 28.7 22.0 28.6 28.6 26.8 30.6 20.1 28.9 41.2 39.6 55.1 36.0 37.1 37.1 27.1 27.7 28.9 48.5 26.8 28.4 27.6 28.1 26.9 27.9 26.9 28.9 28.9 14.9 19.2 18.4 22.5 17.7 17.3 20.9 29.1 12.0 41.0 11.5 9.8 6.8 14.3 16.5 14.7 20.9 32.9 23.1 8.1 7.9 21.2 0.9 7.7 16.7 17.2 15.6 9.1 47.7 14.0 65.2 21.9 10.7 11.8 15.2 15.0 18.2 4.6 19.0 32.0 56.1 7.9 28.5 17.9 18.3 2.2 16.8 14.3 12.4 20.6 26.6 21.3 24.7 40.2 34.8 19.0 6.8 17.3 12.7 15.5 14.2 7.7 8.6 44.3 32.9 18.2 20.8 7.6 8.1 9.3 14.3 33.7 22.1 15.7 6.7 14.7 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 85.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 55.9;HHSteC: 53.7;HSkMC: 51.8;hTERT-RPE1: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039936: AB_10795239, HPA071996: AB_2686481" "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favorable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavorable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 12.2 7.6 15.3 5.5 16.4 3.2 10.4 27.6 19.6 21.8 6.1 11.2 3.2 23.1 4.8 4.1 18.6 14.1 7.8 16.7 11.9 8.5 1.7 11.3 4.4 13.0 12.9 15.5 21.7 3.6 7.4 22.9 6.5 17.5 9.7 3.8 13.8 4.9 11.0 2.7 5.6 8.9 14.5 9.5 9.0 7.4 9.1 12.3 6.1 8.7 6.3 2.7 14.1 12.3 14.9 0.5 15.1 8.6 14.2 55.9 28.9 1.2 10.1 18.9 10.8 11.0 0.3 1.8 3.5 5.4 10.8 8.7 0.1 4.3 6.8 4.3 4.9 5.4 3.5 8.3 0.0 53.7 0.1 3.6 51.8 5.2 14.6 7.8 69.1 16.9 7.8 0.1 15.7 10.0 6.7 3.8 0.9 3.2 0.0 5.5 5.4 6.3 1.0 5.4 0.1 9.3 12.4 5.6 6.8 14.9 1.8 4.6 10.3 12.9 10.2 10.8 4.5 2.5 6.1 8.0 0.0 16.8 6.9 10.4 0.0 0.5 0.0 0.4 0.4 0.8 0.1 0.5 0.6 0.2 0.0 0.2 0.3 1.0 0.2 0.1 0.0 0.1 0.1 15.3 16.4 27.6 19.6 16.7 11.9 13.0 12.9 15.5 17.5 9.5 12.3 14.9 11.4 6.4 14.6 21.5 8.1 0.8 2.4 0.5 4.6 28.9 5.6 5.2 0.8 7.2 6.4 1.8 37.5 1.9 12.2 4.8 9.8 6.7 1.5 11.5 27.6 10.4 3.5 1.3 21.1 1.8 2.2 11.0 2.0 15.8 12.7 7.0 15.0 7.8 4.1 30.3 19.1 2.8 2.0 10.3 2.2 1.8 8.1 8.6 0.0 8.4 8.5 19.9 5.2 10.6 11.0 4.4 2.1 8.2 6.7 5.3 7.1 14.8 5.5 85.0 6.6 23.5 10.2 2.5 2.1 2.5 1.0 2.2 11.6 12.5 4.1 3.9 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191323-53207282 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.2" "Cell type enhanced" "Detected in many" "B-cells: 45.1;dendritic cells: 62.3;NK-cells: 134.9;Plasma cells: 115.9;T-cells: 62.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 99 "Karpas-707: 4821.4;RPMI-8226: 3980.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042277 Approved "Plasma membrane,Cytosol" NA NA 130000 "Plasma membrane, Cytosol" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.7 1.4 1.7 20.2 1.8 15.6 1.9 1.7 2.2 2.8 2.0 9.8 11.9 1.6 2.9 6.4 2.9 4.0 0.8 1.5 1.9 4.7 5.3 6.7 29.5 2.2 1.8 1.3 0.7 1.2 0.7 1.3 0.5 1.9 1.7 9.6 1.0 4.1 2.3 0.7 12.0 17.5 2.4 2.1 30.2 8.3 0.6 2.4 8.7 3.1 0.6 26.7 6.3 2.9 1.9 0.1 0.0 0.0 0.3 0.1 0.7 1.4 0.5 0.0 0.0 0.5 0.0 2.1 44.5 0.8 0.0 0.0 9.4 0.0 0.3 0.0 16.5 0.0 1.5 0.0 0.0 0.0 1.0 18.5 1.0 1.8 0.2 0.1 0.6 0.0 2.2 0.4 4821.4 0.0 1.6 0.9 7.0 0.3 41.7 0.1 1.8 0.0 3980.8 0.0 1.2 1.9 0.6 0.1 1.8 0.5 0.0 0.8 10.4 0.0 0.3 0.6 0.9 0.0 8.9 17.9 3.8 3.8 2.6 1.6 80.7 5.6 97.7 52.0 1.4 38.2 28.1 51.8 63.0 44.5 29.8 44.5 44.4 1.5 23.7 0.4 11.9 71.8 17.3 1.7 1.8 1.7 2.2 1.5 1.9 2.2 1.8 1.3 1.9 2.1 2.4 1.9 1.0 3.2 5.5 1.3 45.1 2.2 0.3 1.7 3.4 0.1 1.3 1.0 0.5 2.8 1.3 7.3 4.2 0.1 62.3 0.6 7.9 0.3 0.0 1.2 0.4 0.9 0.0 2.1 0.0 0.5 0.1 1.3 2.6 2.4 29.2 0.1 0.4 2.2 13.3 0.0 0.1 0.5 0.0 3.7 10.3 0.3 0.0 17.3 7.2 1.9 13.3 7.0 134.9 0.0 0.5 0.9 1.7 0.0 115.9 0.2 0.0 7.6 0.2 0.8 0.0 1.0 8.2 0.2 1.4 3.3 3.7 0.1 62.5 0.1 1.2 1.4 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 63.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6" "Cancer enhanced" "Detected in many" "breast cancer: 31.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 29.1" "Group enriched" "Detected in all" 4 "granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 4800000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 1.7 3.1 2.6 8.1 10.5 9.7 18.3 6.4 10.5 32.4 0.6 6.8 21.4 1.3 24.9 2.4 6.6 2.4 0.4 3.6 7.1 2.0 1.2 5.8 7.3 11.2 11.1 2.0 0.9 8.3 1.4 1.1 9.7 13.8 0.9 7.0 0.1 31.3 3.2 0.4 5.6 21.8 1.6 5.0 8.3 63.1 0.6 9.6 6.9 2.5 0.1 6.0 3.7 1.8 17.8 39.0 4.1 0.7 0.1 0.0 0.6 59.8 63.0 107.0 25.4 17.0 104.1 19.0 0.5 5.8 34.4 0.0 35.9 1.5 27.3 17.1 8.3 4.1 24.6 0.7 0.8 1.0 13.6 82.2 2.3 25.2 23.1 23.0 0.2 65.7 14.2 5.4 1.0 0.1 73.7 43.2 10.1 5.3 97.6 66.6 0.2 0.1 10.3 21.3 2.2 0.5 23.5 0.4 110.5 0.1 12.2 59.3 5.9 75.7 0.2 12.9 0.2 0.3 2.1 0.5 3.6 7.2 29.5 0.2 7.1 5.8 29.1 3.8 5.2 1.6 1.2 2.2 3.1 4.5 3.3 3.4 2.9 1.1 15.5 9.7 4.1 1.7 3.2 2.6 10.5 6.4 10.5 3.6 7.1 11.2 11.1 2.0 13.8 5.0 9.6 17.8 0.8 3.2 2.4 0.3 11.8 2.9 3.8 5.8 5.7 0.4 38.9 18.4 1.3 1.5 15.6 1.8 0.0 14.1 11.3 12.4 3.9 2.6 2.0 3.5 0.3 4.1 0.0 15.3 1.0 10.9 49.2 1.6 130.5 5.8 164.5 3.8 1.4 0.3 14.4 0.0 0.5 17.4 2.0 16.3 10.3 1.5 0.0 15.1 1.8 1.0 7.2 0.2 9.2 0.0 57.6 24.3 33.9 0.4 5.5 7.6 39.6 2.0 12.4 0.0 0.0 1.5 1.5 0.4 1.6 2.6 9.2 4.8 14.9 1.8 11.8 5.8 CSAD "CSD, PCAP" ENSG00000139631 "Cysteine sulfinic acid decarboxylase" Q9Y600 12 53157663-53180925 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 16.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.3" "Cell line enhanced" "Detected in all" "ASC diff: 84.5;T-47d: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039487 Approved "Intracellular and membrane" NA NA "HPA039487: AB_10672776" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (1.57e-1)" "unprognostic (7.99e-2)" "prognostic favorable (6.33e-4)" "prognostic favorable (1.37e-4)" "unprognostic (2.46e-2)" "unprognostic (7.87e-3)" "unprognostic (1.01e-1)" "prognostic favorable (3.39e-4)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.93e-6)" "unprognostic (4.59e-2)" "unprognostic (3.47e-1)" "unprognostic (1.38e-1)" "prognostic favorable (6.81e-6)" 68.1 28.5 24.3 16.1 24.8 39.5 63.0 24.3 26.0 50.6 32.0 31.0 17.5 31.5 52.8 29.5 41.9 19.4 25.1 23.9 22.4 36.1 102.6 31.0 19.3 24.9 22.9 21.4 54.5 36.2 15.0 41.3 13.1 25.4 50.7 16.2 16.9 35.0 20.0 19.7 60.1 28.8 19.8 20.4 37.8 32.1 27.9 23.3 14.3 36.3 7.8 14.2 26.0 37.9 36.8 3.7 6.8 16.0 6.8 84.5 34.4 5.7 14.5 3.2 6.0 5.0 4.1 8.8 4.9 10.6 7.7 2.0 12.6 7.1 11.2 3.5 6.6 8.6 7.8 19.4 8.8 7.6 3.3 4.9 42.6 13.8 9.0 11.2 30.8 5.6 10.4 8.4 42.8 5.7 30.8 1.8 9.2 3.1 1.9 6.3 6.6 1.0 11.4 8.0 9.6 8.0 6.3 14.3 19.9 5.7 9.9 52.7 6.5 12.6 17.5 3.4 5.2 4.2 12.2 3.4 2.6 14.7 8.3 7.1 3.7 2.0 2.5 1.3 1.1 0.8 1.1 1.8 0.8 1.0 1.8 2.4 1.4 16.3 1.6 1.3 2.3 3.4 0.5 24.3 24.8 24.3 26.0 23.9 22.4 24.9 22.9 21.4 25.4 20.4 23.3 36.8 23.5 3.2 22.0 40.1 15.6 16.6 28.3 18.3 4.0 29.0 27.9 43.4 8.9 20.0 17.4 23.9 16.7 12.2 18.5 19.3 3.9 12.6 0.7 11.6 20.4 22.5 14.4 0.4 47.0 9.1 6.9 23.0 19.4 14.3 9.5 22.0 21.4 38.2 8.4 26.9 51.1 21.3 14.2 11.9 12.8 3.5 27.1 11.1 14.2 30.0 15.6 18.3 20.6 34.2 62.4 10.0 25.5 30.9 6.9 28.8 22.5 5.1 15.4 30.0 39.5 22.5 27.9 48.0 64.4 5.5 18.3 8.9 13.0 17.9 15.4 24.2 LMBR1L "FLJ10494, KIAA1174" ENSG00000139636 "Limb development membrane protein 1 like" Q6UX01 12 49097136-49110900 "Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Granulosa cells: 722.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-1)" "unprognostic (6.56e-3)" "unprognostic (1.17e-1)" "unprognostic (1.77e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.50e-4)" "unprognostic (2.72e-2)" "prognostic unfavorable (4.45e-7)" "unprognostic (2.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-3)" 5.6 9.5 14.0 4.0 14.6 4.4 4.4 15.7 18.3 6.1 13.8 7.7 6.5 7.7 6.7 8.9 7.3 5.2 9.3 14.1 14.4 7.8 6.2 5.5 7.3 15.1 14.1 14.0 8.7 5.9 5.0 8.5 11.1 14.6 6.6 4.5 6.0 5.7 7.0 6.1 5.3 8.9 7.0 13.8 7.6 5.9 25.9 14.0 11.1 3.9 6.1 6.6 8.8 6.3 15.0 7.5 10.5 13.3 13.7 9.3 13.4 14.5 7.0 11.1 9.3 8.5 10.7 5.9 3.2 5.5 14.4 5.9 3.6 9.8 5.0 5.7 12.3 15.6 7.5 6.1 9.8 17.9 5.3 11.7 15.3 6.8 13.3 7.9 25.4 29.5 13.0 19.7 4.9 8.9 3.3 9.3 14.8 6.2 20.1 7.6 6.5 5.5 3.7 6.9 15.1 7.4 6.5 5.9 5.8 13.4 11.7 5.0 7.0 28.6 6.0 3.7 4.0 2.7 8.9 5.9 4.6 8.8 4.8 3.5 24.1 19.7 51.7 12.9 16.4 11.0 17.3 13.2 14.7 14.1 18.8 18.1 15.4 9.6 6.0 21.1 10.1 22.0 17.4 14.0 14.6 15.7 18.3 14.1 14.4 15.1 14.1 14.0 14.6 13.8 14.0 15.0 26.5 6.4 20.0 16.6 26.9 15.4 13.0 13.1 23.9 37.0 14.2 10.9 7.5 7.2 9.9 9.2 20.9 14.8 29.9 15.0 3.9 16.1 104.8 6.1 11.1 27.6 47.1 11.6 14.9 10.2 39.3 21.1 9.7 9.0 17.7 722.7 17.9 8.6 16.7 32.0 14.8 12.5 16.2 13.2 41.5 156.3 13.7 23.4 21.4 14.0 27.6 9.3 27.8 8.5 13.0 17.5 15.5 6.8 36.3 14.0 51.2 3.4 6.8 31.1 13.1 17.6 24.1 14.7 12.5 15.0 14.8 22.3 33.0 18.2 13.2 18.3 MYG1 "C12orf10, Gamm1, MYG" ENSG00000139637 "MYG1 exonuclease" Q9HB07 12 53299695-53307177 "Disease related genes, Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 16.4;Cytotrophoblasts: 38.4;Extravillous trophoblasts: 60.7;Hofbauer cells: 70.1;Syncytiotrophoblasts: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038626, HPA038627" Approved Supported Supported Nucleoplasm "Intracellular and membrane" NA NA 20000 Nucleoplasm "HPA038626: AB_10674692, HPA038627: AB_2676123" "unprognostic (5.33e-2)" "unprognostic (4.41e-2)" "unprognostic (6.77e-2)" "unprognostic (2.44e-2)" "unprognostic (3.59e-1)" "unprognostic (7.56e-2)" "unprognostic (1.61e-3)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-1)" "unprognostic (2.81e-1)" "unprognostic (6.41e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.61e-1)" 32.3 36.1 37.0 18.1 37.1 21.0 32.0 41.7 67.3 34.8 36.9 29.8 18.8 33.1 21.4 25.1 36.1 20.9 29.3 36.3 40.3 36.8 28.2 21.0 22.7 41.1 41.7 35.7 41.0 45.8 31.6 29.3 15.5 42.8 25.5 15.1 17.5 26.3 21.0 48.4 30.5 21.3 20.0 38.2 20.6 33.5 105.7 40.2 22.9 30.9 26.5 20.0 34.7 27.7 45.4 42.3 78.0 33.8 53.5 35.1 52.4 3.9 27.3 43.6 62.0 44.1 74.5 44.9 40.6 63.2 38.3 35.1 46.6 46.8 60.8 32.8 34.0 78.9 41.7 60.4 91.5 81.0 43.8 27.1 49.7 40.1 57.4 58.1 61.7 53.8 46.8 2.4 81.0 41.5 164.8 58.9 71.0 55.0 42.7 73.9 54.9 31.9 93.6 53.7 41.0 66.7 63.9 30.9 60.3 68.3 19.3 94.8 42.0 37.3 60.3 55.8 43.7 43.9 73.3 81.8 43.8 75.7 37.2 47.6 24.2 55.0 26.1 35.8 44.4 52.6 49.9 46.3 35.5 63.5 41.5 47.8 44.3 14.6 42.4 32.9 39.8 69.5 50.1 37.0 37.1 41.7 67.3 36.3 40.3 41.1 41.7 35.7 42.8 38.2 40.2 45.4 13.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 38.4 6.8 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 60.7 9.7 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 25.9 1.5 0.0 0.0 0.0 ESYT1 "FAM62A, KIAA0747, MBC2" ENSG00000139641 "Extended synaptotagmin 1" Q9BSJ8 12 56118250-56144674 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016858, HPA076926" Approved Supported "Endoplasmic reticulum" NA NA 720000 "Endoplasmic reticulum" "HPA016858: AB_1848404, HPA076926: AB_2686819" "unprognostic (5.02e-2)" "unprognostic (3.62e-2)" "unprognostic (6.26e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (8.44e-2)" "unprognostic (5.41e-2)" "unprognostic (1.55e-1)" "unprognostic (1.39e-2)" "unprognostic (1.77e-1)" "unprognostic (6.85e-3)" "unprognostic (1.29e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.04e-2)" "unprognostic (8.43e-3)" "unprognostic (1.52e-2)" "unprognostic (3.98e-2)" 108.8 39.6 18.7 38.8 16.1 18.8 73.3 19.6 19.2 35.2 19.9 40.8 17.4 53.9 22.4 29.5 47.5 28.1 24.7 13.8 21.2 25.2 47.1 45.4 46.3 31.2 21.5 13.1 39.2 39.8 41.0 11.8 39.0 37.6 30.7 36.6 9.0 28.2 47.7 54.8 26.3 31.0 75.0 23.0 37.5 29.5 12.2 24.0 36.9 28.0 33.5 50.2 45.1 32.6 30.8 107.0 78.1 62.2 158.2 90.8 67.3 53.4 117.4 129.3 136.2 94.4 72.4 114.3 40.8 92.2 201.3 50.7 118.7 73.7 120.4 121.6 58.8 54.2 244.7 56.0 58.5 125.9 193.2 371.6 76.7 125.5 147.1 81.3 145.3 117.8 39.2 153.6 263.9 124.4 81.2 70.4 116.4 78.9 44.6 102.5 105.4 85.0 107.3 113.7 89.0 52.4 54.8 174.1 52.9 80.5 71.3 111.1 128.4 154.5 104.8 94.7 59.7 85.7 62.3 99.0 58.7 97.3 79.6 111.7 423.2 37.4 423.0 127.2 69.4 157.2 62.4 129.4 129.5 87.2 48.2 102.3 120.2 9.3 84.2 85.6 29.7 139.6 177.8 18.7 16.1 19.6 19.2 13.8 21.2 31.2 21.5 13.1 37.6 23.0 24.0 30.8 44.4 9.6 9.3 4.6 25.9 16.3 19.8 23.5 14.2 5.5 20.5 21.3 8.2 14.3 12.9 31.3 10.4 31.9 22.3 6.1 0.0 36.8 2.0 20.5 15.1 28.2 25.2 17.9 10.2 26.8 18.1 17.6 9.2 19.3 62.7 24.7 27.1 37.8 46.4 0.0 7.1 12.0 22.4 21.3 24.8 2.1 17.4 22.9 35.6 6.5 50.6 5.7 60.8 2.0 4.1 26.2 3.5 25.2 18.5 19.9 2.2 4.4 10.7 5.9 52.6 14.3 22.0 3.9 2.9 18.0 11.9 37.9 40.3 12.5 10.8 12.7 TMBIM6 "BAXI1, BI-1, TEGT" ENSG00000139644 "Transmembrane BAX inhibitor motif containing 6" P55061 12 49707725-49764934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1818.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 2394.6;Late spermatids: 2375.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017378 Approved NA NA "HPA017378: AB_2669604" "prognostic unfavorable (3.54e-4)" "unprognostic (6.25e-2)" "unprognostic (1.90e-2)" "unprognostic (6.52e-2)" "unprognostic (8.46e-3)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (1.22e-2)" "unprognostic (6.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.80e-1)" "prognostic favorable (1.00e-5)" "unprognostic (1.95e-1)" "unprognostic (9.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" 336.4 368.3 322.7 278.8 349.2 318.2 421.0 346.8 379.5 417.1 481.1 498.3 480.1 254.7 646.5 410.1 434.9 363.6 217.5 295.6 375.2 1155.1 1818.0 427.1 294.7 365.7 343.2 287.6 283.7 579.0 582.3 134.8 305.6 363.8 386.6 499.2 307.6 484.0 413.1 234.3 233.2 540.6 297.2 348.0 270.1 554.8 250.1 344.5 315.9 601.7 234.3 335.0 410.0 218.3 394.9 609.6 516.6 413.3 381.1 1169.3 645.1 513.6 450.2 854.0 572.0 519.7 837.6 1703.8 380.3 746.9 882.6 598.6 648.1 363.7 659.4 619.2 551.7 390.3 606.2 367.8 414.0 707.7 701.9 959.4 657.5 1511.3 640.9 925.8 809.3 481.6 461.0 556.2 1526.5 662.5 589.5 362.1 424.2 432.1 730.6 392.2 302.8 413.0 651.0 871.5 909.9 319.0 208.7 603.5 786.1 511.2 530.7 989.4 731.6 456.8 522.6 393.9 355.8 396.9 654.2 717.8 326.8 730.9 324.3 260.8 896.4 749.8 795.5 559.9 721.8 587.8 403.6 501.1 558.5 585.5 356.6 438.9 501.8 1242.0 463.8 769.5 587.0 544.8 1813.1 322.7 349.2 346.8 379.5 295.6 375.2 365.7 343.2 287.6 363.8 348.0 344.5 394.9 428.2 477.5 455.5 80.6 314.2 261.0 535.0 836.9 222.5 245.8 526.8 337.6 221.0 571.9 766.5 544.4 114.7 406.9 366.7 995.8 131.0 927.3 1504.8 340.5 240.0 321.9 294.9 232.7 43.9 816.9 913.0 336.0 325.7 501.9 257.7 194.5 358.7 2394.6 618.9 180.0 57.3 612.6 598.1 570.6 292.8 2375.1 288.6 458.2 247.3 58.1 540.3 467.7 285.3 94.5 115.5 846.7 651.3 287.3 589.8 550.0 1585.8 809.6 874.1 154.8 170.9 191.7 361.1 458.1 214.7 272.7 235.0 891.0 315.9 372.8 552.2 654.4 ANKRD52 "FLJ34236, PP6-ARS-C" ENSG00000139645 "Ankyrin repeat domain 52" Q8NB46 12 56237807-56258384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043815 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA043815: AB_10961762" "unprognostic (6.25e-3)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (9.84e-2)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (6.31e-2)" 8.4 21.7 12.2 9.9 10.4 9.7 8.8 8.7 12.3 11.7 3.3 12.0 8.4 12.5 5.8 10.5 11.1 6.1 11.5 9.0 10.5 11.7 7.9 9.5 9.3 15.0 14.6 9.9 13.0 13.0 20.0 13.3 7.1 17.2 11.3 8.2 9.7 11.0 8.0 25.2 11.2 12.9 11.1 8.0 11.0 10.6 7.5 15.7 8.8 11.3 17.2 9.7 12.1 9.9 15.6 24.7 58.5 25.9 47.4 20.7 16.2 18.2 48.1 20.9 42.1 18.9 39.0 13.4 26.1 29.9 47.3 14.8 31.5 29.0 21.0 24.2 25.3 29.1 46.9 38.6 15.0 14.3 37.3 26.2 16.7 23.2 39.0 19.7 30.9 24.8 21.1 19.6 13.8 40.1 34.2 30.0 12.3 10.9 16.1 27.4 23.4 17.8 10.4 27.7 30.0 19.6 17.8 52.2 33.1 18.9 19.9 26.5 14.3 34.4 43.4 38.1 24.7 30.4 12.7 18.0 12.4 45.0 12.2 29.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.2 10.4 8.7 12.3 9.0 10.5 15.0 14.6 9.9 17.2 8.0 15.7 15.6 4.1 6.4 5.3 9.1 7.8 11.2 3.6 8.4 10.2 5.0 9.1 6.9 6.7 4.3 4.3 12.9 27.1 5.8 7.9 12.6 0.0 10.4 0.5 5.8 9.7 5.7 9.6 5.5 12.8 9.5 7.4 5.4 8.2 9.0 1.3 8.6 6.8 6.5 7.0 8.4 12.5 6.6 20.3 7.1 7.5 1.1 6.2 4.8 10.6 7.5 4.6 3.4 7.2 7.5 8.4 15.7 7.0 4.9 8.7 5.7 9.2 6.4 4.2 6.0 0.0 5.6 7.6 6.4 8.8 10.0 10.9 3.7 6.0 5.5 8.9 4.4 KRT71 "K6IRS1, KRT6IRS, KRT6IRS1" ENSG00000139648 "Keratin 71" Q3SY84 12 52543909-52553145 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 62.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "CACO-2: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA049404 Enhanced NA NA 110000000 "HPA049404: AB_2680748" "unprognostic (9.12e-2)" "unprognostic (2.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.14e-1)" "unprognostic (1.69e-2)" 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ZNF740 Zfp740 ENSG00000139651 "Zinc finger protein 740" Q8NDX6 12 53180704-53195142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035691 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035691: AB_10669777" "unprognostic (2.31e-1)" "unprognostic (3.40e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" "unprognostic (2.86e-2)" "unprognostic (3.20e-2)" "unprognostic (4.19e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (4.88e-2)" "unprognostic (2.36e-3)" "unprognostic (7.92e-2)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.30e-2)" 5.3 5.7 6.5 6.2 7.1 3.2 6.1 7.8 6.6 6.2 6.4 6.1 4.9 6.7 6.5 6.5 6.9 3.2 3.7 6.2 6.5 5.6 5.8 5.1 8.9 7.3 7.0 6.1 7.7 6.7 7.9 4.4 4.2 6.9 6.2 5.2 5.7 6.3 6.5 4.9 6.0 8.5 5.3 6.8 10.2 5.6 3.1 7.0 11.8 6.9 6.0 9.3 5.4 5.0 7.1 5.7 7.5 13.0 8.4 12.9 9.5 4.8 5.8 10.9 9.2 8.0 6.4 8.8 13.0 8.5 6.7 4.5 9.0 9.5 6.9 9.3 9.9 10.1 14.5 10.5 5.7 9.4 13.3 8.7 12.1 13.5 7.3 11.0 15.2 7.6 13.4 9.7 26.1 4.8 6.5 10.6 7.2 6.4 5.3 8.8 10.6 10.0 21.5 5.2 7.8 10.0 11.1 9.9 8.2 9.8 6.1 11.9 13.6 6.8 4.8 6.6 5.5 4.3 12.4 5.7 7.0 7.4 7.4 6.1 1.1 0.2 0.4 0.4 0.1 0.3 0.5 0.4 0.6 0.2 0.5 0.5 0.5 0.0 1.3 0.1 0.4 0.6 0.2 6.5 7.1 7.8 6.6 6.2 6.5 7.3 7.0 6.1 6.9 6.8 7.0 7.1 5.2 3.2 9.3 4.6 7.7 6.1 2.3 2.8 5.2 8.5 5.1 4.7 6.3 5.7 2.8 1.8 6.2 3.3 7.1 5.0 1.9 4.2 1.3 6.8 8.8 5.7 8.4 1.7 6.0 4.6 2.0 5.1 2.0 5.1 7.6 8.1 6.1 5.3 3.3 5.0 6.1 5.5 2.0 6.6 3.1 1.5 6.2 4.4 1.8 5.6 5.9 5.7 10.3 10.1 6.7 4.9 6.4 6.0 8.5 4.5 5.1 4.5 5.5 7.5 19.7 6.7 7.0 2.5 3.3 5.6 4.5 2.5 6.6 7.0 6.2 3.5 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143150-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 23.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 53.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.5;OE19: 4.8" "Low region specificity" "Detected in single" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.2 0.2 0.8 0.1 0.9 0.0 0.0 0.2 1.9 0.0 0.5 0.8 0.8 0.0 2.9 0.3 0.2 0.3 1.0 0.6 0.6 0.8 0.4 0.2 0.0 0.4 0.5 0.7 0.1 0.6 0.0 0.2 0.4 0.6 0.2 0.0 0.3 0.6 0.1 0.9 0.3 1.9 0.5 0.2 0.2 0.5 23.6 0.3 5.0 0.3 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.4 0.0 0.0 0.0 0.4 0.0 2.5 0.5 0.0 0.5 0.1 0.7 0.4 0.0 0.4 1.2 0.0 1.0 0.7 0.0 0.7 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.3 4.8 0.4 0.4 0.0 0.0 0.0 0.1 1.1 0.5 1.3 0.5 0.9 0.9 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.0 0.0 0.2 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.9 0.2 1.9 0.6 0.6 0.4 0.5 0.7 0.6 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 WDFY2 ZFYVE22 ENSG00000139668 "WD repeat and FYVE domain containing 2" Q96P53 13 51584455-51767709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050094 Supported Vesicles NA NA Vesicles "HPA050094: " "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (9.58e-2)" "unprognostic (2.28e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (7.49e-4)" "unprognostic (1.47e-1)" "unprognostic (7.04e-2)" "unprognostic (6.36e-2)" "unprognostic (2.48e-1)" 6.2 11.2 9.0 4.5 11.4 15.1 7.7 8.9 8.2 7.0 4.7 3.5 1.9 5.1 5.5 9.6 6.6 3.0 3.8 8.6 9.5 4.3 6.5 5.4 4.7 11.1 9.8 7.0 8.1 17.6 15.1 5.3 5.4 11.7 5.1 2.3 6.0 5.6 4.9 1.6 17.9 4.3 3.7 10.1 7.5 6.6 6.6 9.8 4.4 5.9 3.0 5.1 4.3 8.6 15.5 1.4 2.6 11.3 4.6 5.4 11.2 3.6 11.0 7.0 5.6 4.4 1.7 1.5 4.5 1.0 7.6 3.6 5.0 6.3 19.7 10.6 3.7 3.5 9.6 3.8 13.6 4.3 6.5 4.4 9.1 9.3 12.5 14.2 9.1 2.5 4.8 2.7 2.3 9.3 3.1 4.5 14.8 13.4 3.2 3.7 5.9 4.5 3.0 7.2 3.8 3.1 7.5 3.3 4.9 5.0 9.3 2.3 15.5 9.4 10.6 2.0 5.2 7.8 1.5 2.6 3.2 12.1 6.6 13.3 6.1 7.8 4.0 2.2 8.6 3.1 3.8 2.4 1.9 13.0 4.2 2.1 2.7 5.2 4.0 9.5 11.9 3.5 3.5 9.0 11.4 8.9 8.2 8.6 9.5 11.1 9.8 7.0 11.7 10.1 9.8 15.5 16.3 16.0 21.9 118.2 36.9 23.3 20.0 10.2 45.5 35.2 25.7 24.0 7.1 8.6 17.5 29.5 127.2 28.5 41.2 7.0 27.4 19.8 46.3 19.3 23.6 13.0 13.8 17.1 47.1 23.5 33.7 20.7 14.8 20.2 29.7 35.3 27.1 18.1 28.1 37.0 47.1 9.2 8.2 63.8 30.8 19.9 39.4 41.3 12.4 96.5 45.9 26.4 16.5 106.6 301.8 15.0 4.5 21.8 17.1 12.2 9.2 6.4 14.9 52.5 26.3 45.1 27.1 32.3 16.5 46.4 27.1 14.0 27.3 41.7 10.0 16.2 HNRNPA1L2 LOC144983 ENSG00000139675 "Heterogeneous nuclear ribonucleoprotein A1 like 2" Q32P51 13 52642425-52643796 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 97.8;Extravillous trophoblasts: 72.0;Suprabasal keratinocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "prognostic favorable (2.58e-4)" "unprognostic (1.37e-1)" "unprognostic (8.39e-2)" "unprognostic (2.05e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (2.30e-1)" "unprognostic (1.66e-2)" "unprognostic (3.68e-2)" "unprognostic (5.48e-2)" "prognostic favorable (4.26e-4)" "unprognostic (3.27e-3)" "unprognostic (1.88e-2)" "unprognostic (2.89e-1)" "unprognostic (7.38e-2)" "unprognostic (9.49e-3)" "unprognostic (1.92e-2)" 4.8 5.0 11.4 6.5 11.2 19.0 6.6 13.5 12.4 6.4 11.6 4.3 3.9 7.8 7.9 4.1 6.2 3.4 5.5 10.9 11.3 5.6 4.1 5.6 9.7 11.5 11.3 10.8 11.0 5.4 4.3 6.5 4.6 12.0 6.6 5.4 11.2 4.8 5.9 5.7 6.2 5.2 5.4 10.5 8.6 3.7 3.8 11.7 12.6 6.9 3.8 8.3 5.2 5.3 11.4 8.6 6.5 14.6 17.5 6.5 7.3 7.3 10.6 9.4 6.3 5.0 9.0 9.2 15.8 3.7 6.1 5.2 13.3 11.0 12.2 10.5 16.2 8.5 16.2 17.4 14.0 11.6 27.9 4.3 9.3 10.3 6.8 15.6 13.5 13.3 14.8 9.0 7.5 6.9 10.3 20.3 30.9 12.3 3.6 7.7 16.9 10.4 9.6 10.0 14.7 7.3 13.5 5.0 6.9 11.5 9.4 7.0 18.3 10.1 7.9 9.2 7.5 11.3 8.5 10.0 19.4 4.1 13.8 8.3 2.2 1.9 7.2 6.3 1.7 7.0 7.0 5.7 6.4 3.2 9.5 7.1 5.4 0.2 8.9 1.3 9.1 5.7 8.1 11.4 11.2 13.5 12.4 10.9 11.3 11.5 11.3 10.8 12.0 10.5 11.7 11.4 2.7 3.2 3.6 13.7 13.7 97.8 5.9 39.8 0.0 3.4 1.9 2.5 12.0 27.1 12.0 0.0 2.1 44.9 15.3 4.6 0.0 5.8 15.2 0.6 1.9 15.7 28.9 4.0 12.4 6.9 72.0 10.6 1.1 0.8 10.2 1.4 20.3 2.4 21.4 1.7 13.8 22.9 14.2 20.4 58.7 7.9 40.4 4.5 33.8 13.1 18.3 3.9 30.9 22.1 16.9 5.4 18.8 23.7 1.0 3.0 14.1 2.2 5.5 2.8 6.6 4.9 12.2 15.9 22.2 1.5 87.9 48.7 16.0 0.8 34.0 2.4 LPAR6 "P2RY5, P2Y5" ENSG00000139679 "Lysophosphatidic acid receptor 6" P43657 13 48389567-48444704 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 266.1;Basal squamous epithelial cells: 327.2;Early spermatids: 334.0;Langerhans cells: 703.7;Late spermatids: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 21.6;HUVEC TERT2: 35.3;MOLT-4: 20.0" "Low region specificity" "Detected in all" HPA028934 Approved NA NA "HPA028934: AB_2672833" "unprognostic (1.19e-1)" "unprognostic (4.10e-1)" "unprognostic (8.82e-2)" "unprognostic (9.30e-3)" "unprognostic (2.31e-1)" "unprognostic (5.57e-2)" "unprognostic (7.40e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.07e-2)" "unprognostic (8.00e-2)" "unprognostic (2.63e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (6.54e-2)" "unprognostic (3.81e-2)" "unprognostic (2.09e-2)" "unprognostic (1.94e-2)" 40.9 26.7 13.5 27.1 13.9 6.2 43.4 14.8 27.4 35.1 17.8 22.3 15.2 29.0 39.8 82.5 22.4 35.8 24.9 13.2 18.6 26.2 23.4 34.9 46.0 17.0 14.9 11.8 15.0 8.8 9.8 16.0 78.4 17.0 61.2 27.9 5.9 60.2 32.5 9.1 34.2 21.9 27.3 18.3 40.5 21.8 8.2 16.5 36.7 24.6 21.0 41.4 41.1 75.8 18.9 0.1 2.1 21.6 0.1 7.0 8.6 0.2 4.5 12.7 0.9 2.5 0.0 6.4 0.0 0.1 4.9 0.0 12.7 0.6 7.2 0.4 0.0 4.3 0.2 0.2 15.9 4.6 0.1 0.1 11.5 12.4 0.5 7.0 0.0 35.3 7.0 0.0 0.3 4.2 0.0 20.0 6.3 8.6 0.4 5.9 16.9 0.0 0.2 5.9 13.1 0.0 0.1 0.0 0.1 4.5 13.2 2.2 0.1 9.1 2.4 0.0 0.2 1.1 0.0 0.0 0.0 0.7 1.1 7.8 1.3 71.9 0.3 24.6 112.0 13.6 1.2 70.0 29.4 26.0 0.5 49.3 15.6 5.9 6.9 103.6 1.1 83.9 58.2 13.5 13.9 14.8 27.4 13.2 18.6 17.0 14.9 11.8 17.0 18.3 16.5 18.9 266.1 3.2 9.7 4.9 5.8 120.6 196.3 155.7 327.2 1.7 30.5 30.5 5.8 17.2 76.2 5.5 0.0 0.8 22.2 4.9 0.0 10.4 334.0 10.1 20.7 140.1 21.4 8.8 1.8 4.1 0.8 23.6 16.8 12.8 7.6 5.8 136.0 2.9 82.9 0.0 1.8 4.9 42.7 74.0 703.7 321.7 22.7 111.9 49.8 177.1 76.4 11.3 18.6 5.0 2.0 6.7 4.1 15.8 6.3 107.1 3.0 25.5 49.4 1.5 13.1 5.4 13.3 2.5 1.7 182.7 142.9 0.8 52.3 14.0 9.6 143.5 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797420 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 569.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 12000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 115.3 88.3 88.9 73.6 91.4 96.0 148.2 93.3 111.7 142.2 94.8 126.9 107.7 130.9 161.5 94.5 122.9 97.3 152.9 88.7 116.1 196.2 279.5 93.1 94.3 92.9 92.3 86.7 180.6 67.9 110.8 82.2 82.6 94.3 113.5 136.3 123.1 93.6 141.7 151.2 84.0 94.1 167.6 98.5 64.5 83.7 54.7 90.7 157.2 156.4 180.6 111.2 105.9 97.0 105.4 138.4 77.9 229.8 160.4 264.5 441.9 62.5 190.8 280.9 264.7 204.6 131.6 162.8 156.5 56.9 233.3 194.0 137.1 256.8 227.2 333.0 180.4 270.4 200.3 70.7 208.6 220.5 400.1 82.2 304.6 207.0 167.9 229.4 316.2 253.2 260.3 200.3 40.7 433.5 135.1 352.7 260.0 59.8 175.2 148.8 277.1 133.6 106.2 378.4 55.4 115.0 130.1 85.0 72.6 160.3 157.6 137.1 223.0 169.2 94.4 113.0 187.5 181.8 27.6 63.5 135.7 205.3 223.2 131.2 35.0 129.4 55.7 48.5 113.6 80.9 104.1 97.6 76.3 142.8 83.4 114.1 90.5 15.0 109.3 106.1 170.7 90.6 100.3 88.9 91.4 93.3 111.7 88.7 116.1 92.9 92.3 86.7 94.3 98.5 90.7 105.4 139.0 54.5 56.8 37.5 77.2 134.1 227.4 300.5 148.0 51.5 114.1 123.2 99.2 167.3 111.7 154.5 41.7 160.4 51.2 59.1 360.0 168.0 135.5 102.2 120.6 112.5 108.8 99.5 22.7 103.2 141.0 162.9 51.0 80.7 96.4 71.1 132.1 154.7 227.5 21.9 19.3 114.6 175.0 140.2 148.0 34.8 267.8 108.2 165.4 25.3 144.3 199.5 36.0 23.6 36.2 85.4 92.3 211.4 35.9 99.1 137.1 569.1 94.2 77.3 151.2 196.0 484.2 61.6 46.3 120.6 129.3 74.4 78.2 151.2 199.8 143.6 RB1 "OSRC, PPP1R130, RB" ENSG00000139687 "RB transcriptional corepressor 1" P06400 13 48303744-48599436 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 187.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000095, CAB016687, HPA050082" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008" "unprognostic (4.24e-3)" "unprognostic (1.00e-1)" "unprognostic (3.62e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-2)" "unprognostic (3.86e-1)" "unprognostic (4.69e-2)" "unprognostic (7.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.92e-4)" "unprognostic (4.06e-2)" "unprognostic (9.40e-2)" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (9.99e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" 20.9 18.8 10.1 23.0 10.7 19.5 18.0 13.3 13.1 18.9 12.4 15.2 14.8 15.9 21.3 22.1 13.3 17.4 17.9 9.7 18.2 18.6 14.6 18.2 31.0 15.4 11.3 7.5 11.6 9.3 20.7 6.6 25.1 14.1 15.2 17.3 12.6 17.1 16.0 19.2 23.7 15.7 18.5 13.5 25.0 16.5 13.0 12.0 34.5 22.6 21.4 30.4 20.0 10.6 16.8 29.1 15.8 40.9 44.2 19.8 22.8 18.5 56.6 45.9 57.4 48.3 13.4 49.8 37.3 12.8 37.4 31.7 39.6 53.7 44.8 86.6 53.0 20.8 68.5 29.4 22.7 21.1 59.5 62.0 12.9 27.0 37.3 47.1 47.8 40.1 90.1 23.4 29.6 66.4 13.7 187.2 29.8 20.0 65.6 17.3 79.8 41.1 43.0 59.6 27.6 2.0 41.8 55.1 27.3 46.2 36.2 29.8 76.3 32.1 35.3 23.3 43.7 51.2 13.1 3.9 0.4 18.8 36.7 48.9 23.8 14.9 8.8 6.9 19.9 5.6 30.2 5.7 6.9 15.2 29.4 4.8 5.6 20.6 5.9 20.9 16.9 7.4 7.1 10.1 10.7 13.3 13.1 9.7 18.2 15.4 11.3 7.5 14.1 13.5 12.0 16.8 59.2 3.2 19.6 75.4 97.3 28.4 23.3 27.6 63.2 17.3 26.9 21.0 18.3 14.3 19.2 31.3 29.2 7.1 50.1 17.8 15.6 19.3 28.1 40.1 36.2 46.4 17.5 50.7 99.5 11.9 9.6 22.2 29.0 40.4 12.0 25.9 35.7 17.3 77.4 18.5 98.9 20.0 8.2 105.3 198.9 13.9 26.1 104.2 26.6 152.7 93.7 20.4 22.6 101.0 98.3 17.4 10.7 28.6 69.9 24.0 15.7 23.6 25.3 19.6 19.7 28.5 32.3 33.0 21.3 72.1 38.2 4.4 38.3 21.2 16.6 18.0 SBNO1 "FLJ10701, FLJ10833, MOP3, Sno" ENSG00000139697 "Strawberry notch homolog 1" A3KN83 12 123289109-123364847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.0" "Cell type enhanced" "Detected in all" "Spermatocytes: 265.4;Spermatogonia: 219.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042388 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA042388: AB_10795704" "unprognostic (1.61e-2)" "unprognostic (9.61e-2)" "unprognostic (5.12e-2)" "unprognostic (2.54e-3)" "unprognostic (3.50e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (1.48e-1)" "unprognostic (5.33e-2)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (6.61e-3)" "unprognostic (2.06e-1)" "unprognostic (3.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-2)" 5.6 5.7 5.8 6.9 7.6 17.0 6.6 11.8 9.3 5.3 5.4 6.1 5.4 6.8 6.4 7.3 5.6 4.2 5.2 7.7 5.9 6.5 6.3 4.8 9.0 6.2 6.0 6.2 7.2 5.1 6.9 5.2 5.7 6.7 6.8 6.7 10.3 5.1 6.4 11.7 8.4 6.0 6.2 6.2 7.2 5.4 38.0 5.7 9.7 10.1 7.8 8.8 5.7 5.5 8.1 14.0 24.3 11.7 21.6 16.6 11.9 22.8 11.7 11.6 10.0 8.2 19.1 8.3 31.0 13.6 14.4 11.0 16.8 22.3 13.9 16.8 19.8 9.2 27.1 15.6 18.0 10.2 33.8 22.9 10.0 13.1 14.5 15.3 13.8 10.9 16.4 35.2 8.6 18.7 14.7 20.2 25.0 18.0 13.5 13.2 20.7 15.4 15.9 10.8 31.3 18.3 9.5 19.5 16.4 13.6 13.1 24.4 17.8 14.7 15.1 16.7 16.7 11.9 9.9 19.5 34.2 10.3 21.9 17.2 5.0 4.5 4.5 7.2 5.0 7.5 6.0 6.6 5.8 4.0 5.0 6.9 6.9 5.9 4.6 8.0 4.4 5.2 4.5 5.8 7.6 11.8 9.3 7.7 5.9 6.2 6.0 6.2 6.7 6.2 5.7 8.1 29.8 28.9 25.7 42.1 59.3 63.3 48.1 40.4 37.0 92.6 38.0 30.4 39.6 25.8 38.3 36.8 79.2 65.8 54.3 22.1 23.5 36.5 62.5 53.1 56.0 34.7 40.2 47.9 58.3 27.2 49.6 36.5 23.9 44.0 29.2 47.3 32.2 26.7 26.2 63.9 47.6 25.1 52.9 35.3 46.4 35.2 25.4 41.2 33.8 31.9 56.5 49.7 54.6 27.2 46.2 38.1 21.2 60.5 33.0 55.5 29.8 27.5 36.4 59.9 26.3 51.5 58.1 265.4 219.3 40.7 61.4 106.0 53.3 42.1 38.9 44.3 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.9;testis: 4.5" "Cell type enriched" "Detected in many" 6 "Late spermatids: 2271.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "BEWO: 13.6;CACO-2: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.2 0.3 1.6 0.5 1.5 0.9 0.4 1.2 1.6 0.3 3.5 0.2 0.3 0.3 0.5 0.1 3.9 0.4 0.1 1.4 1.7 0.5 0.1 1.0 1.2 1.4 1.6 1.4 0.3 0.3 2.4 1.3 0.8 1.2 0.2 0.2 0.6 0.4 0.3 0.2 2.0 0.4 0.2 1.3 0.7 0.7 4.5 1.2 0.9 0.6 0.0 0.6 0.2 0.2 1.3 0.2 0.1 0.4 0.2 0.0 0.3 13.6 0.2 0.1 0.0 0.1 8.3 0.4 0.2 0.2 0.1 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.6 0.5 0.5 0.2 0.5 0.9 0.1 0.3 0.4 0.0 0.1 0.3 1.0 0.2 0.3 0.1 0.3 0.9 0.7 0.3 0.0 0.1 0.4 0.0 0.1 0.5 0.2 1.2 1.1 0.1 0.2 0.0 0.6 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.2 0.1 0.4 1.0 0.4 0.2 1.3 0.3 0.1 0.7 0.1 0.8 0.3 0.8 0.4 0.1 0.5 0.7 0.5 1.2 0.9 0.3 0.5 0.8 0.2 1.6 1.5 1.2 1.6 1.4 1.7 1.4 1.6 1.4 1.2 1.3 1.2 1.3 1.1 3.2 1.3 0.0 1.6 3.2 1.2 3.3 0.0 1.3 2.5 1.8 1.4 4.3 8.2 1.8 0.0 0.5 6.6 0.0 7.9 4.4 352.0 34.1 1.2 2.1 0.0 0.0 2.7 1.4 0.7 1.4 0.0 3.0 2.5 2.5 0.7 0.0 0.9 0.0 2.3 0.0 4.1 0.0 0.3 2271.5 9.3 1.7 0.0 0.0 1.8 5.4 5.2 0.0 0.1 2.2 0.0 9.4 3.5 0.7 0.1 1.1 51.7 2.2 0.0 1.5 1.4 8.7 6.7 0.0 4.0 7.3 6.7 3.4 0.2 1.1 SETD1B "KIAA1076, KMT2G, Set1B" ENSG00000139718 "SET domain containing 1B, histone lysine methyltransferase" Q9UPS6 12 121804009-121832656 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021667, HPA059412" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021667: AB_1856753, HPA059412: AB_2684006" "unprognostic (1.69e-1)" "unprognostic (2.38e-2)" "unprognostic (6.32e-2)" "unprognostic (3.51e-1)" "unprognostic (2.06e-1)" "unprognostic (2.75e-2)" "unprognostic (5.32e-2)" "unprognostic (1.35e-1)" "unprognostic (1.28e-2)" "unprognostic (5.65e-2)" "unprognostic (1.59e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 12.2 9.0 2.9 8.6 2.6 15.2 12.2 7.2 4.4 18.3 1.0 23.2 7.6 26.2 4.7 14.1 19.7 4.6 7.6 2.8 1.2 8.5 11.4 9.2 7.0 2.2 1.5 1.6 15.9 12.6 5.5 9.3 5.5 2.9 15.7 3.7 3.5 11.5 10.1 9.1 11.3 15.8 7.2 0.5 13.2 16.8 9.5 1.2 8.5 14.1 4.2 4.8 22.2 14.2 2.3 7.4 14.8 7.4 12.5 6.9 4.7 11.2 6.8 5.4 5.1 2.9 8.1 4.4 5.4 6.1 7.6 3.2 11.3 8.6 5.3 3.0 9.7 10.5 16.3 20.3 7.1 5.9 15.3 14.0 5.7 6.4 7.0 5.6 6.2 5.6 10.6 17.1 3.7 3.9 17.1 22.5 21.5 10.6 3.6 8.5 17.3 4.8 7.9 5.0 15.1 9.0 6.9 15.0 10.5 5.7 5.5 12.8 13.8 9.5 7.6 9.4 10.8 7.7 7.3 4.0 3.2 6.3 9.7 8.8 1.4 0.2 0.6 0.4 0.5 0.3 0.3 0.3 0.4 0.2 0.3 0.5 0.3 1.0 0.3 0.2 0.5 0.3 0.2 2.9 2.6 7.2 4.4 2.8 1.2 2.2 1.5 1.6 2.9 0.5 1.2 2.3 10.1 3.2 7.3 9.8 11.2 11.7 3.2 5.7 26.2 13.8 12.7 9.5 9.7 10.0 6.7 5.5 8.4 7.9 17.6 8.5 0.0 5.1 9.8 13.9 14.5 9.5 7.3 7.8 10.6 7.2 7.0 8.5 8.6 20.3 3.8 10.1 12.1 13.8 6.5 11.8 11.7 7.8 4.1 17.7 14.8 21.4 11.5 10.8 1.8 5.6 13.9 5.0 9.2 5.0 6.8 6.5 10.5 10.1 11.2 9.1 6.8 3.2 5.4 10.0 6.6 10.6 12.9 11.3 3.5 29.4 12.9 13.1 13.3 8.1 6.6 9.1 VPS33A ENSG00000139719 "VPS33A core subunit of CORVET and HOPS complexes" Q96AX1 12 122229564-122266494 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038701 Approved Nucleoplasm NA NA Nucleoplasm "HPA038701: AB_10673473" "unprognostic (3.98e-2)" "unprognostic (2.90e-2)" "unprognostic (4.07e-2)" "unprognostic (4.61e-3)" "unprognostic (2.00e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.11e-5)" "unprognostic (2.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.29e-4)" "unprognostic (4.63e-2)" "unprognostic (7.65e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.09e-2)" 5.0 6.9 7.4 6.0 7.8 7.0 6.1 8.7 9.4 4.4 7.2 6.9 5.8 5.2 7.6 5.1 6.0 4.1 4.8 7.7 8.1 4.5 6.0 5.3 8.2 7.6 7.7 7.8 6.0 5.5 6.1 9.3 8.6 8.4 5.0 5.5 10.6 4.6 5.0 9.0 7.1 6.0 6.5 7.0 7.0 5.6 8.2 7.8 9.7 4.3 6.1 6.8 5.4 4.2 9.2 13.2 17.1 17.3 6.9 13.3 10.2 20.0 11.9 12.9 20.4 12.7 28.2 6.4 14.6 9.8 8.0 14.2 11.1 31.6 12.6 17.5 19.9 16.9 15.1 11.5 24.8 17.0 20.6 15.6 11.4 10.4 14.5 11.5 16.8 13.5 16.0 34.3 7.3 13.3 14.7 10.1 21.2 25.2 10.8 18.5 17.2 16.0 17.5 8.7 13.6 12.6 19.0 25.0 7.4 22.7 17.8 31.6 13.8 8.8 9.2 14.5 17.4 11.0 23.1 54.2 23.4 14.5 13.1 12.8 29.6 11.5 19.0 11.3 12.6 10.3 12.0 12.7 12.2 12.1 8.9 9.0 10.5 9.4 13.6 15.2 7.6 18.6 10.9 7.4 7.8 8.7 9.4 7.7 8.1 7.6 7.7 7.8 8.4 7.0 7.8 9.2 5.7 9.6 3.9 6.8 14.0 3.2 4.0 8.1 3.4 18.1 5.4 4.8 7.3 5.7 6.8 7.3 10.4 21.7 11.3 10.1 3.9 15.0 23.0 5.9 6.5 6.6 18.0 12.2 13.8 12.6 21.4 7.0 8.2 5.2 14.5 10.2 9.7 10.2 21.2 3.3 13.9 7.7 6.1 11.5 5.3 13.1 8.1 13.4 3.6 10.3 20.7 12.1 15.5 8.5 15.3 15.0 8.8 11.3 12.6 2.5 8.5 11.3 12.6 17.7 19.7 5.4 6.2 38.8 31.4 7.0 3.0 21.6 13.4 10.0 8.2 2.9 VPS37B FLJ12750 ENSG00000139722 "VPS37B subunit of ESCRT-I" Q9H9H4 12 122865330-122896127 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038217, HPA038218" Enhanced NA NA "HPA038217: AB_10672740, HPA038218: AB_2675898" "unprognostic (1.63e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-1)" "unprognostic (1.38e-1)" "unprognostic (8.33e-2)" "unprognostic (2.58e-1)" "unprognostic (4.30e-2)" "unprognostic (3.25e-2)" "unprognostic (8.26e-3)" "unprognostic (2.51e-1)" "unprognostic (5.57e-2)" "unprognostic (3.01e-1)" "prognostic favorable (1.35e-6)" "unprognostic (2.58e-3)" "unprognostic (6.38e-2)" "unprognostic (4.02e-2)" "unprognostic (2.44e-2)" 18.0 28.5 22.5 15.9 17.9 47.0 18.8 15.2 26.3 12.7 19.9 27.7 17.9 11.9 5.3 63.9 15.0 18.3 19.8 23.9 32.0 23.5 11.1 28.4 14.6 17.7 15.9 18.7 15.5 27.4 10.9 23.7 10.8 17.2 19.7 17.6 9.4 36.5 9.2 10.4 23.2 23.8 7.2 16.1 34.8 37.6 25.6 16.1 10.9 28.6 6.9 16.9 17.2 19.4 19.8 55.2 19.2 52.0 21.0 8.7 15.6 49.6 26.6 24.7 20.5 17.6 21.4 42.1 1.4 19.3 16.8 33.7 35.6 29.1 39.0 15.6 15.1 28.3 106.2 13.3 15.2 19.8 13.9 82.7 18.9 34.3 28.2 24.8 38.5 30.5 65.3 40.6 34.5 27.1 10.4 33.0 40.5 29.3 57.1 52.4 25.3 32.2 17.0 31.8 51.3 31.4 35.4 23.6 25.7 58.8 21.9 45.5 23.2 28.2 20.7 28.3 24.3 48.1 116.5 116.8 0.6 26.3 20.4 123.6 12.1 4.5 10.4 14.2 6.6 10.2 10.3 4.7 8.3 1.7 12.7 4.2 6.0 27.6 8.3 9.0 0.2 4.5 4.7 22.5 17.9 15.2 26.3 23.9 32.0 17.7 15.9 18.7 17.2 16.1 16.1 19.8 57.3 54.5 34.3 18.9 159.3 43.2 98.7 66.6 46.1 32.0 30.8 18.8 2.6 25.8 75.0 31.3 68.8 19.9 198.7 123.1 17.6 53.6 40.5 88.1 24.8 37.6 44.3 30.5 26.2 42.7 34.1 16.0 141.2 168.2 90.9 14.1 30.0 13.4 17.6 10.1 16.7 49.5 63.1 19.0 66.3 52.5 8.1 46.7 39.2 19.7 9.5 20.8 62.8 12.1 27.2 71.0 83.6 7.9 168.3 104.4 43.8 5.8 56.6 20.7 6.6 14.1 29.1 14.1 12.5 49.2 44.6 43.6 119.0 30.6 61.3 158.0 RHOF "ARHF, FLJ20247, RIF" ENSG00000139725 "Ras homolog family member F, filopodia associated" Q9HBH0 12 121777754-121803403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045912, HPA076019" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045912: , HPA076019: AB_2732299" "unprognostic (1.26e-1)" "unprognostic (8.73e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-5)" "unprognostic (1.38e-3)" "unprognostic (2.37e-4)" "unprognostic (1.34e-1)" "unprognostic (5.51e-2)" "unprognostic (1.10e-4)" "unprognostic (1.10e-1)" "unprognostic (5.01e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-2)" "unprognostic (7.51e-4)" "unprognostic (1.14e-1)" 6.6 13.4 10.7 26.9 10.1 47.8 5.6 21.7 12.5 12.7 9.5 24.5 32.1 13.3 22.0 11.8 10.0 9.8 11.9 10.5 9.7 13.5 4.0 20.8 41.3 12.8 12.3 10.4 9.0 6.1 7.8 5.2 5.7 14.7 9.3 19.5 10.0 11.6 9.9 11.9 9.2 32.6 11.6 8.6 33.6 28.4 9.1 9.9 25.8 14.8 2.9 31.6 9.2 7.3 13.0 58.3 69.2 12.4 15.3 4.4 6.4 5.6 5.3 5.2 2.5 4.4 28.8 129.0 6.3 42.6 6.0 1.4 8.6 23.2 33.7 2.2 177.1 8.0 37.9 47.5 27.7 10.1 38.6 25.8 9.0 7.5 5.4 2.9 23.8 17.6 44.7 5.6 9.9 1.4 41.7 50.7 56.7 10.4 13.6 147.3 26.5 0.7 10.8 127.9 4.9 9.9 9.4 38.5 4.5 2.6 5.6 19.9 15.0 21.4 4.0 40.1 12.5 1.5 12.3 7.6 20.0 5.0 42.9 2.6 23.8 10.9 41.5 97.0 36.5 92.7 55.5 77.2 82.5 31.0 45.2 59.5 73.2 24.4 61.4 69.8 74.3 90.2 43.3 10.7 10.1 21.7 12.5 10.5 9.7 12.8 12.3 10.4 14.7 8.6 9.9 13.0 3.1 38.5 10.7 1.0 54.1 8.7 1.9 5.5 3.4 8.1 9.3 3.8 1.5 15.7 11.3 23.9 0.0 2.7 111.8 273.9 41.1 34.0 20.2 16.5 5.6 3.5 6.7 12.2 5.3 55.3 3.9 5.3 50.4 37.1 20.8 13.1 10.0 4.0 14.4 0.0 3.9 28.6 2.0 10.9 224.9 53.8 4.1 40.3 21.4 3.7 241.2 4.7 103.0 1.0 1.2 191.7 279.6 2.2 39.4 3.8 121.6 15.1 13.5 9.7 6.6 2.6 4.5 17.7 2.9 2.5 13.2 5.5 99.2 23.4 17.3 44.3 DENR "DRP, DRP1, SMAP-3" ENSG00000139726 "Density regulated re-initiation and release factor" O43583 12 122752824-122771064 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 227.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021783 Approved Approved Cytosol NA NA 200000 Cytosol "HPA021783: AB_2670820" "unprognostic (3.65e-2)" "unprognostic (7.00e-2)" "unprognostic (5.69e-2)" "unprognostic (7.33e-3)" "unprognostic (6.62e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (2.23e-3)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (3.75e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (8.57e-6)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (2.65e-1)" "unprognostic (1.35e-1)" 25.6 22.8 18.8 27.3 21.1 27.8 29.9 16.5 24.4 22.4 16.2 25.8 26.9 23.9 22.3 32.8 21.9 22.3 24.7 20.2 20.0 25.7 27.9 18.9 36.5 18.5 22.7 20.1 19.4 21.4 59.4 17.3 31.9 19.8 28.2 26.3 16.7 28.6 25.0 60.8 29.8 25.2 24.7 15.6 28.2 23.5 14.7 18.9 39.3 30.0 45.1 35.8 30.3 20.6 21.0 113.1 62.1 77.7 80.1 48.7 71.9 67.6 100.5 56.1 87.6 60.6 86.9 40.6 99.9 103.4 72.5 66.6 84.0 93.8 89.5 117.6 90.9 67.3 122.8 36.2 63.8 63.5 139.6 97.4 62.8 86.9 79.3 107.4 81.6 86.4 109.7 129.8 35.8 94.8 74.9 137.7 134.1 159.2 67.2 128.4 120.6 91.2 63.7 85.3 99.9 89.3 63.4 139.2 40.8 107.3 79.1 129.5 78.1 82.2 81.2 95.9 91.7 102.1 58.8 145.8 160.4 76.4 100.1 90.9 227.9 35.0 58.1 38.8 53.3 45.3 45.5 41.9 39.4 47.3 41.4 48.5 43.4 42.2 47.3 69.9 42.1 49.2 44.5 18.8 21.1 16.5 24.4 20.2 20.0 18.5 22.7 20.1 19.8 15.6 18.9 21.0 43.4 70.5 40.1 31.0 59.8 71.9 65.9 55.4 59.7 37.7 66.2 69.8 66.3 45.8 47.7 47.8 41.7 73.0 60.8 40.9 64.6 68.6 17.9 67.7 83.5 51.4 84.8 53.8 39.0 61.8 130.3 48.3 40.8 70.7 43.1 50.4 42.1 54.3 57.4 55.5 36.2 53.6 44.7 50.1 42.4 8.0 50.4 49.3 26.6 25.3 60.2 47.3 75.2 48.2 31.3 88.0 44.6 45.9 47.9 73.2 40.3 67.3 49.5 35.9 19.7 46.2 62.5 120.3 136.8 72.8 64.9 60.6 54.7 47.3 58.8 51.3 DIAPH3 "AN, AUNA1, DRF3, FLJ34705, NSDAN" ENSG00000139734 "Diaphanous related formin 3" Q9NSV4 13 59665583-60163928 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;testis: 19.1" "Cell type enriched" "Detected in many" 5 "Early spermatids: 414.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032151 Supported "Plasma membrane,Microtubules" NA Yes "Plasma membrane, Microtubules" "HPA032151: AB_2674181" "unprognostic (3.78e-2)" "unprognostic (1.28e-2)" "prognostic favorable (9.04e-4)" "prognostic unfavorable (4.18e-4)" "unprognostic (2.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.27e-4)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.74e-2)" "unprognostic (2.19e-1)" "unprognostic (5.22e-5)" "unprognostic (3.59e-3)" "unprognostic (5.31e-5)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "unprognostic (2.74e-3)" 0.4 0.1 0.1 1.7 0.2 7.1 0.8 0.3 0.3 0.3 0.2 1.9 1.9 0.6 0.0 2.2 0.1 0.4 0.1 0.1 0.2 0.8 0.2 1.2 2.4 0.2 0.2 0.1 0.1 0.2 0.1 0.0 3.5 0.4 0.1 2.1 0.0 0.5 0.0 0.0 1.3 1.7 2.6 0.1 0.5 1.6 19.1 0.3 5.5 0.1 0.0 2.4 0.6 0.7 0.5 47.7 15.6 15.8 9.1 2.7 7.1 26.9 65.0 28.7 64.2 55.6 41.7 31.4 15.9 5.2 33.4 16.7 31.7 26.0 25.5 96.9 18.0 17.9 22.7 37.6 9.5 4.1 31.2 17.4 2.8 0.6 39.2 26.3 16.3 29.2 14.0 17.8 21.9 61.8 6.9 28.0 10.2 14.7 22.5 8.9 18.8 38.9 12.9 19.9 9.6 8.3 14.3 33.2 22.8 9.5 33.8 16.7 16.8 29.3 40.5 25.9 13.7 54.5 14.7 17.1 24.4 10.9 15.2 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.1 0.3 0.5 0.6 54.5 3.4 39.8 1.9 3.7 0.8 2.1 2.8 0.0 3.9 1.5 1.0 2.8 1.8 0.0 0.0 21.1 1.1 3.8 5.9 1.3 414.4 2.5 3.5 2.1 0.0 26.7 5.6 4.0 30.7 5.8 9.7 9.3 0.0 78.8 1.8 0.4 6.1 0.0 3.3 2.6 2.0 1.0 1.2 56.0 0.6 1.5 0.0 5.6 0.1 3.5 2.1 19.1 1.8 1.5 0.2 0.0 18.9 0.4 1.1 5.4 0.2 0.0 0.0 0.0 7.9 39.2 17.8 11.6 1.1 7.3 2.2 2.8 5.6 1.5 SLAIN1 "C13orf32, FLJ30046" ENSG00000139737 "SLAIN motif family member 1" Q8ND83 13 77697687-77764242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 414.4" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 1081.8" "Cancer enhanced" "Detected in many" "glioma: 25.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 58.1;HL-60: 78.8;MOLT-4: 90.5;REH: 62.1;SCLC-21H: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.76e-5)" "unprognostic (1.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.25e-3)" "unprognostic (1.60e-1)" "unprognostic (3.78e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (6.20e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.80e-3)" "unprognostic (3.83e-3)" "unprognostic (2.16e-2)" "unprognostic (4.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (1.97e-2)" 2.6 10.4 210.4 5.5 301.9 17.8 7.1 227.0 215.6 5.6 53.0 4.2 3.1 7.5 12.9 4.3 18.4 4.0 6.7 163.3 213.3 9.0 8.2 10.9 11.5 272.3 287.1 122.5 7.9 11.8 20.8 8.3 3.9 288.9 7.5 3.0 60.1 10.7 6.1 3.3 2.8 4.0 5.3 254.8 8.8 12.3 34.3 245.9 27.5 11.5 5.0 11.3 5.3 2.3 414.4 0.3 3.5 41.1 0.9 0.0 0.0 7.1 0.2 0.0 0.1 0.0 4.0 8.6 32.8 2.1 0.1 0.1 0.2 39.3 0.0 0.0 41.4 58.1 28.0 7.6 0.7 1.1 78.8 2.0 0.0 0.1 0.0 0.0 4.6 1.6 45.0 0.8 41.9 0.0 1.1 90.5 7.8 15.7 28.4 12.9 62.1 3.6 0.1 19.3 3.3 58.6 29.7 0.0 11.4 7.9 13.5 0.0 35.1 0.5 0.5 1.7 0.4 11.2 41.3 20.2 38.9 4.5 9.1 2.5 0.0 0.0 0.0 0.8 0.1 1.2 0.3 1.0 0.9 0.1 0.2 1.1 1.8 0.0 0.3 0.1 0.9 2.3 0.5 210.4 301.9 227.0 215.6 163.3 213.3 272.3 287.1 122.5 288.9 254.8 245.9 414.4 0.7 12.8 10.8 27.7 5.5 0.8 3.0 0.0 2.8 7.9 5.4 2.8 4.7 8.6 1.9 3.7 16.7 1.8 8.8 0.1 1.9 2.1 79.0 14.8 2.3 3.4 9.0 3.0 72.7 2.6 0.2 1.5 7.1 23.0 0.0 5.2 3.6 5.7 0.3 3.3 91.9 0.8 0.0 1.2 0.8 18.0 1.5 1.7 7.2 30.0 0.8 95.5 6.2 209.1 1081.8 2.3 0.0 0.7 4.1 5.0 0.1 4.4 0.0 4.0 0.0 5.5 2.3 3.1 2.1 2.5 1.3 0.4 6.0 0.7 0.4 3.2 RBM26 "ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17" ENSG00000139746 "RNA binding motif protein 26" Q5T8P6 13 79311824-79406477 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 251.4;Oligodendrocytes: 253.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040252 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA040252: AB_10672895" "unprognostic (5.55e-2)" "unprognostic (4.55e-1)" "unprognostic (2.65e-1)" "unprognostic (3.09e-2)" "unprognostic (3.03e-1)" "unprognostic (2.57e-1)" "unprognostic (3.05e-3)" "unprognostic (2.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (5.87e-6)" "unprognostic (8.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic favorable (8.20e-4)" 20.9 26.3 20.5 28.7 24.6 37.5 25.9 35.6 29.6 24.9 17.0 21.0 18.8 28.5 28.3 21.0 24.4 17.6 18.4 22.9 19.8 16.3 21.3 21.7 40.7 19.2 19.6 20.8 33.1 28.1 19.4 30.4 24.4 22.2 21.3 22.1 41.2 23.9 18.8 26.2 32.7 28.8 20.4 15.9 34.0 25.2 30.3 19.9 30.1 25.6 19.5 34.5 21.0 21.7 25.6 55.3 29.1 70.1 35.9 30.7 32.2 38.1 37.0 30.9 37.5 38.7 39.1 45.9 82.1 29.5 27.3 24.7 51.4 53.0 36.3 54.2 49.6 56.3 63.4 68.0 35.8 23.9 119.9 48.6 21.9 29.6 38.6 53.3 34.4 39.8 50.5 49.0 26.8 41.9 18.7 73.3 63.3 43.6 49.3 16.9 72.9 57.5 43.8 34.9 31.4 53.2 35.6 31.8 38.2 23.4 42.4 34.4 99.0 38.0 31.8 31.7 25.9 38.0 38.5 36.0 100.0 51.6 66.0 38.6 3.8 1.4 2.8 2.9 2.0 3.0 3.7 2.8 2.7 0.8 5.5 4.2 3.7 2.0 2.3 1.5 2.6 3.3 1.0 20.5 24.6 35.6 29.6 22.9 19.8 19.2 19.6 20.8 22.2 15.9 19.9 25.6 50.2 57.7 83.5 148.9 80.9 34.7 35.1 25.0 47.8 63.7 36.5 31.0 42.1 35.8 35.6 25.8 73.0 34.3 72.4 34.8 9.8 25.4 49.2 29.0 59.9 43.3 49.1 41.9 251.4 26.0 31.5 41.6 32.1 36.6 55.8 75.9 60.0 40.3 32.9 57.2 170.8 39.2 32.6 53.7 23.0 27.3 65.0 41.6 16.0 137.7 58.0 37.9 56.7 217.6 253.0 27.0 31.5 47.4 65.8 51.1 28.4 19.6 37.7 72.0 52.6 71.3 43.1 102.3 78.1 47.3 35.5 23.0 54.8 57.7 37.5 33.7 SRRM4 "KIAA1853, nSR100" ENSG00000139767 "Serine/arginine repetitive matrix 4" A7MD48 12 118981541-119163051 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 18.9;retina: 29.4" "Group enriched" "Detected in some" 11 "Bipolar cells: 330.4;Cone photoreceptor cells: 429.5;Excitatory neurons: 182.0;Inhibitory neurons: 322.2;Rod photoreceptor cells: 372.4" "Cancer enriched" "Detected in single" 7 "glioma: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 4.4;SCLC-21H: 3.9;SH-SY5Y: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052783 Uncertain NA NA "HPA052783: AB_2681945" "unprognostic (2.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-1)" "unprognostic (1.61e-5)" "unprognostic (1.10e-2)" "unprognostic (1.75e-1)" "unprognostic (5.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (1.61e-1)" 0.0 1.1 4.3 0.0 10.6 0.1 0.0 17.1 18.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 7.7 4.2 0.1 0.0 0.1 0.0 0.0 0.9 8.3 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.0 29.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.9 0.0 0.1 0.1 0.0 0.0 0.0 6.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 10.6 17.1 18.9 7.7 4.2 0.0 0.9 8.3 5.6 0.0 0.9 6.9 0.0 6.4 0.0 3.6 0.0 0.0 0.1 0.0 0.0 330.4 0.0 0.0 9.9 0.0 0.6 0.0 429.5 0.8 0.0 0.0 0.0 0.0 5.6 10.6 0.9 1.5 0.0 0.0 182.0 0.0 0.3 0.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 28.6 322.2 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 9.4 0.0 12.1 0.0 5.5 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 372.4 6.6 0.2 1.0 0.2 1.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 METTL21C "C13orf39, LOC196541" ENSG00000139780 "Methyltransferase like 21C" Q5VZV1 13 102685744-102694504 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 34.9" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 3.1;Early spermatids: 2.4;Late spermatids: 4.8;Syncytiotrophoblasts: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.07e-1)" "unprognostic (1.63e-6)" "unprognostic (2.64e-1)" 0.0 0.0 0.5 0.0 0.8 0.0 0.0 1.7 1.3 0.0 0.2 0.0 0.0 0.4 34.9 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.4 0.5 0.5 0.1 0.1 0.0 0.0 1.5 0.8 1.1 0.0 0.1 0.0 2.2 5.2 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 1.7 1.3 0.5 0.5 0.4 0.5 0.5 0.8 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 MBNL2 "MBLL, MBLL39" ENSG00000139793 "Muscleblind like splicing regulator 2" Q5VZF2 13 97221434-97394120 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 325.5;Oligodendrocytes: 702.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062685 Supported Nucleoplasm NA NA Nucleoplasm "HPA062685: AB_2684834" "unprognostic (8.02e-2)" "unprognostic (7.78e-2)" "unprognostic (6.37e-2)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (3.54e-1)" "unprognostic (1.44e-3)" "unprognostic (1.08e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.00e-1)" "unprognostic (5.26e-3)" "unprognostic (1.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.73e-1)" "unprognostic (9.17e-2)" 65.0 65.2 43.3 20.9 58.4 8.5 35.5 56.6 58.4 39.0 29.1 25.8 21.2 35.3 16.2 38.5 21.9 45.2 37.2 42.0 48.4 37.2 95.7 29.9 21.0 52.6 56.0 35.9 59.8 46.7 26.0 24.0 53.0 55.8 32.1 24.7 50.6 41.8 38.8 41.9 19.1 19.2 41.9 58.3 20.0 30.7 14.5 52.1 24.5 36.9 88.7 24.4 35.3 24.7 87.9 34.7 12.1 13.5 13.7 68.9 36.1 1.3 77.8 38.4 34.8 35.3 14.8 49.8 11.7 31.4 106.3 39.5 48.6 6.1 34.1 44.6 31.2 5.9 14.2 26.4 34.7 101.7 1.6 12.4 37.9 56.7 28.6 54.7 39.5 67.4 15.5 18.1 6.0 17.6 9.2 8.2 4.9 0.4 4.2 20.2 3.8 27.9 9.8 46.2 41.1 17.3 28.7 45.0 44.6 76.2 30.3 18.9 2.0 21.1 5.2 16.1 9.7 16.2 16.0 4.3 3.1 33.1 4.0 93.2 15.0 5.4 8.0 8.1 7.1 10.3 7.6 7.3 7.4 5.7 6.2 6.3 8.6 0.8 4.9 5.4 4.7 8.3 6.2 43.3 58.4 56.6 58.4 42.0 48.4 52.6 56.0 35.9 55.8 58.3 52.1 87.9 153.8 83.3 45.1 148.9 52.3 70.2 27.4 15.7 129.1 23.7 50.7 49.9 69.8 50.1 40.1 29.5 47.9 25.3 31.6 22.6 19.6 26.6 3.1 59.1 113.8 66.6 48.6 24.8 325.5 42.7 78.0 75.7 83.6 50.0 17.7 40.5 45.3 78.8 14.4 47.1 108.3 29.0 8.2 32.1 30.6 9.1 70.5 31.2 56.9 144.3 19.5 84.8 18.6 144.3 702.4 54.0 14.5 44.8 169.1 22.3 16.3 40.1 54.5 112.6 46.0 29.9 80.8 1.1 1.0 54.2 48.6 25.0 40.8 28.2 17.9 30.3 RNF113B "RNF161, ZNF183L1" ENSG00000139797 "Ring finger protein 113B" Q8IZP6 13 98175785-98177269 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "testis: 47.4" "Cell type enhanced" "Detected in some" "Early spermatids: 40.8;Late spermatids: 18.9;Spermatocytes: 106.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.69e-1)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (1.75e-1)" "unprognostic (7.48e-2)" "unprognostic (1.92e-3)" 0.0 0.2 0.6 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 47.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.6 0.3 0.4 0.2 0.4 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 1.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 106.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.8;choroid plexus: 7.0;testis: 3.6" "Group enriched" "Detected in some" 7 "Astrocytes: 20.5;Microglial cells: 15.0;Spermatocytes: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 22.0;HEK 293: 12.7;NTERA-2: 15.1;SCLC-21H: 85.5" "Group enriched" "Detected in all" 5 "basal ganglia: 18.9;cerebellum: 18.4;thalamus: 5.3" "Region enriched" "Detected in all" 7 "cerebellum: 39.7" HPA074045 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.0 0.0 2.9 0.0 3.6 0.0 0.0 16.8 9.4 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.7 0.0 0.0 0.0 0.0 2.8 2.7 2.0 0.0 0.0 0.0 0.2 0.0 7.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 2.2 22.0 1.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.0 2.1 0.0 3.1 0.0 1.1 0.0 4.5 0.0 0.0 4.0 12.7 0.0 2.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.9 3.3 0.0 0.0 1.7 0.0 1.7 15.1 0.0 0.3 1.9 0.8 0.0 0.0 0.0 85.5 0.0 2.4 2.0 0.0 1.6 0.0 2.8 0.0 1.2 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.6 16.8 9.4 3.7 2.7 2.8 2.7 2.0 7.1 1.9 2.5 2.7 0.1 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.0 0.0 1.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD13 "bA153I24.2, BEM46L1, C13orf6, FLJ14906" ENSG00000139826 "Abhydrolase domain containing 13" Q7L211 13 108218392-108234243 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032143, HPA032144" Approved Approved Cytosol NA NA Cytosol "HPA032143: AB_2674178, HPA032144: AB_10602304" "unprognostic (2.69e-1)" "unprognostic (2.81e-1)" "unprognostic (1.36e-2)" "unprognostic (2.91e-2)" "unprognostic (8.36e-2)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.63e-1)" "unprognostic (8.75e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (6.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (1.14e-1)" "unprognostic (5.62e-2)" 7.0 5.4 4.0 7.0 4.6 16.4 7.4 6.5 5.7 6.3 6.7 6.6 7.1 6.3 10.2 5.6 4.3 6.4 4.3 4.6 4.0 6.1 10.5 7.0 8.3 4.1 4.2 4.0 5.2 4.7 5.7 3.8 8.5 4.4 6.3 7.4 6.5 4.6 5.6 4.2 4.0 7.5 6.8 4.1 7.9 6.8 3.9 4.3 9.4 7.6 6.4 7.1 7.5 4.4 4.6 9.8 4.0 10.5 5.9 8.0 9.5 5.1 9.5 9.5 8.2 9.7 6.2 9.1 8.2 9.7 7.4 8.1 8.8 7.9 11.0 13.0 11.1 6.9 10.1 5.7 6.1 8.0 21.1 12.0 9.8 10.3 6.4 8.3 7.7 9.8 11.2 5.5 4.5 8.5 4.1 10.3 8.8 5.0 14.5 4.7 8.7 7.5 4.8 11.5 8.7 7.9 9.9 5.0 8.3 10.6 9.3 7.7 19.3 10.2 5.8 6.0 6.8 6.5 8.8 7.4 9.0 13.7 13.0 10.7 7.7 8.2 16.0 5.9 7.6 8.8 6.8 8.0 7.2 7.2 6.0 7.6 6.3 9.0 9.5 7.2 5.3 8.4 8.6 4.0 4.6 6.5 5.7 4.6 4.0 4.1 4.2 4.0 4.4 4.1 4.3 4.6 17.6 22.4 16.6 8.1 24.5 44.4 21.4 33.3 15.9 12.8 16.8 10.8 7.2 27.1 22.2 11.0 0.0 20.9 23.7 14.7 9.8 19.1 24.8 12.3 13.4 18.2 30.5 16.2 21.4 21.0 15.4 19.9 19.9 14.4 14.0 9.5 19.6 29.5 19.5 18.5 17.4 11.6 44.7 21.5 40.1 18.2 15.5 24.6 26.6 15.0 25.8 12.6 19.6 16.1 15.2 20.8 14.3 17.3 10.2 20.7 16.4 11.5 18.4 12.2 19.7 15.1 18.2 22.9 12.3 21.1 51.1 21.3 28.4 12.5 12.1 26.3 RAB20 FLJ20429 ENSG00000139832 "RAB20, member RAS oncogene family" Q9NX57 13 110523066-110561722 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002882, HPA052111, HPA068647" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013" "unprognostic (5.59e-3)" "unprognostic (1.30e-1)" "unprognostic (3.48e-1)" "unprognostic (1.42e-3)" "unprognostic (1.30e-1)" "unprognostic (3.82e-2)" "unprognostic (1.14e-2)" "unprognostic (5.99e-2)" "unprognostic (9.43e-2)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (2.65e-1)" "prognostic favorable (8.57e-4)" "unprognostic (6.96e-2)" "unprognostic (4.32e-2)" "unprognostic (2.28e-2)" "prognostic favorable (4.48e-4)" 27.2 55.9 5.4 21.9 5.2 25.5 23.6 5.4 8.0 11.8 9.2 18.6 27.9 7.0 4.9 4.6 11.6 18.1 20.0 4.8 9.6 26.1 51.8 31.0 16.6 6.7 5.2 4.4 20.7 24.4 6.2 9.8 23.0 5.9 12.2 14.5 2.7 10.8 5.1 5.8 4.4 25.5 7.7 6.2 44.9 28.8 10.7 7.0 4.0 22.2 2.3 5.1 20.8 6.7 8.2 20.1 2.9 1.9 3.8 12.4 3.3 31.3 1.7 6.2 8.1 12.5 47.9 39.9 0.0 13.9 1.7 10.8 7.5 3.8 12.3 4.2 22.5 3.0 19.8 3.6 22.6 7.8 2.8 5.7 6.9 2.0 4.2 1.2 6.3 3.1 3.3 3.8 0.0 1.8 24.0 0.1 29.0 4.0 60.9 8.5 1.9 0.1 9.0 14.2 26.3 0.5 2.1 3.8 85.7 27.4 6.2 54.4 30.5 2.3 2.0 4.2 0.2 2.7 0.1 0.0 0.2 27.7 38.9 4.2 7.8 35.5 7.1 1.0 33.3 1.3 3.5 2.8 0.9 15.8 2.8 6.5 2.3 26.3 0.0 26.6 0.8 0.9 11.2 5.4 5.2 5.4 8.0 4.8 9.6 6.7 5.2 4.4 5.9 6.2 7.0 8.2 18.6 19.2 20.4 4.2 10.6 4.5 10.9 14.1 10.8 0.2 12.8 13.0 5.0 48.6 16.2 25.8 0.0 34.6 1.8 31.1 31.3 60.3 1.6 20.7 2.6 10.3 18.0 0.0 0.4 67.9 91.3 11.5 15.3 23.2 21.0 41.1 53.6 34.5 105.0 0.0 0.4 23.9 28.5 92.1 19.9 1.6 3.7 100.5 7.2 8.4 16.2 7.4 0.0 4.5 0.1 36.4 17.2 6.4 0.4 8.0 48.1 68.9 20.4 2.0 13.1 6.2 26.2 1.0 13.2 1.9 3.0 20.0 3.6 7.2 24.0 11.1 GRTP1 "FLJ22474, TBC1D6" ENSG00000139835 "Growth hormone regulated TBC protein 1" Q5TC63 13 113324163-113364148 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 84.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Proximal enterocytes: 70.2;Rod photoreceptor cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 60.4;T-47d: 54.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046201 Enhanced NA NA "HPA046201: AB_2679584" "unprognostic (5.31e-2)" "unprognostic (2.27e-3)" "unprognostic (1.94e-1)" "unprognostic (1.89e-1)" "unprognostic (4.42e-2)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (6.05e-2)" "unprognostic (1.30e-2)" "unprognostic (3.07e-3)" "prognostic favorable (1.50e-5)" "unprognostic (4.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.56e-2)" "unprognostic (4.50e-3)" 4.2 14.4 2.5 3.2 2.4 3.0 8.0 3.1 4.6 13.5 4.9 18.6 46.4 8.7 3.6 21.8 10.6 6.2 2.3 2.6 2.5 19.2 84.5 4.5 1.6 2.7 2.4 1.5 12.9 9.8 8.3 2.8 2.9 2.3 18.4 13.4 21.1 14.6 4.9 10.1 24.1 39.2 3.1 2.7 7.9 13.3 9.6 2.3 1.6 4.0 1.3 2.5 10.7 17.2 3.1 10.1 3.8 7.5 12.9 1.2 1.9 23.6 1.9 0.0 0.5 0.2 21.9 23.2 0.6 1.5 0.6 4.7 15.5 6.6 1.9 0.0 0.5 8.7 13.5 11.2 21.9 2.1 1.1 4.8 0.6 2.9 1.6 0.2 1.0 0.0 1.3 8.2 0.7 0.0 20.5 0.2 1.9 21.2 60.4 2.9 1.1 0.3 0.4 1.7 12.3 0.6 6.6 0.4 11.3 2.7 8.9 54.6 1.3 1.0 0.4 2.8 1.8 0.7 3.8 4.3 1.5 8.1 3.0 4.4 0.6 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.1 0.3 0.5 0.2 2.2 0.3 0.5 0.3 0.1 0.7 2.5 2.4 3.1 4.6 2.6 2.5 2.7 2.4 1.5 2.3 2.7 2.3 3.1 1.1 0.0 6.0 11.1 0.8 21.7 24.0 23.4 14.2 5.8 12.7 8.6 1.2 30.0 15.9 3.7 81.3 28.8 0.7 51.8 23.5 10.0 0.4 6.2 4.8 3.0 3.6 3.8 0.5 9.2 9.2 4.0 14.3 8.8 0.0 18.3 5.7 30.1 1.7 3.3 0.5 28.2 16.2 0.8 1.9 0.8 8.1 2.3 1.8 1.0 2.6 13.7 0.0 1.0 1.0 9.6 43.3 8.6 0.1 11.0 70.2 45.8 9.6 69.6 0.0 5.9 5.3 0.2 8.8 18.2 23.7 25.3 1.2 2.7 40.1 23.8 CUL4A ENSG00000139842 "Cullin 4A" Q13619 13 113208193-113267108 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 173.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058979 Approved Nucleoplasm NA NA 44000 Nucleoplasm "HPA058979: AB_2683868" "unprognostic (3.01e-1)" "unprognostic (5.93e-3)" "unprognostic (6.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (2.53e-2)" "unprognostic (6.41e-3)" "unprognostic (6.77e-2)" "unprognostic (1.45e-1)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "unprognostic (5.16e-3)" "unprognostic (3.57e-3)" "prognostic favorable (2.84e-4)" "unprognostic (2.95e-1)" "unprognostic (3.91e-2)" "unprognostic (3.48e-1)" 36.0 34.9 18.3 26.3 19.5 63.9 34.6 20.1 18.3 30.5 28.7 32.6 27.2 31.1 24.4 37.2 29.4 24.6 63.7 17.0 22.8 30.6 40.8 31.0 33.2 23.9 19.7 16.5 28.9 36.9 34.2 25.5 30.5 21.9 33.9 30.1 21.2 37.4 25.3 173.3 47.5 31.7 25.5 21.2 31.6 34.5 47.6 20.0 26.3 31.8 126.8 31.4 32.5 32.7 24.5 106.9 50.9 50.7 43.9 60.2 67.0 65.5 104.9 79.0 88.9 68.5 93.0 85.8 129.7 44.7 92.7 87.3 67.4 76.9 58.3 82.4 57.2 77.1 85.8 109.3 74.8 72.1 134.2 56.8 48.1 70.3 52.5 82.2 59.3 60.3 47.8 88.2 24.8 89.7 51.4 67.7 123.3 47.9 149.3 53.5 70.9 52.2 59.7 61.5 47.8 73.7 43.5 54.3 118.6 53.9 43.6 84.6 141.7 83.2 42.7 90.0 47.2 59.9 65.3 49.8 113.0 93.7 108.2 69.0 12.9 20.0 18.1 27.6 29.1 25.7 17.1 27.1 31.2 17.4 16.5 23.5 27.9 5.9 16.2 30.4 13.5 19.9 25.8 18.3 19.5 20.1 18.3 17.0 22.8 23.9 19.7 16.5 21.9 21.2 20.0 24.5 27.8 28.9 36.1 46.7 28.2 46.4 30.9 24.9 52.9 14.4 35.5 27.2 140.3 31.5 24.4 35.0 10.4 32.3 25.0 29.2 25.4 28.3 61.6 28.7 28.0 30.0 23.9 73.8 46.1 37.2 40.5 33.0 36.7 41.7 11.4 26.1 23.6 56.9 30.4 28.6 41.0 34.2 24.4 40.9 30.5 118.2 35.8 31.0 39.2 37.5 28.5 13.0 28.8 43.2 66.1 39.8 25.3 31.6 38.0 54.0 22.2 26.9 26.4 18.1 32.9 30.5 30.9 65.3 38.1 53.8 60.0 39.7 32.5 25.2 32.3 45.6 TTC6 "C14orf25, NCRNA00291" ENSG00000139865 "Tetratricopeptide repeat domain 6" Q86TZ1 14 37595847-38041442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 8.0;prostate: 17.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 13.8;Club cells: 11.1;Early spermatids: 39.1;Late spermatids: 18.1;Spermatocytes: 10.7" "Group enriched" "Detected in some" 7 "breast cancer: 2.2;prostate cancer: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;MCF7: 12.2;RT4: 8.4;T-47d: 22.8" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "midbrain: 9.7" HPA069293 Approved Centrosome NA NA Centrosome "HPA069293: AB_2686110" "unprognostic (7.92e-2)" "unprognostic (6.95e-2)" "unprognostic (9.22e-2)" "unprognostic (1.98e-1)" "unprognostic (7.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.68e-1)" "unprognostic (3.60e-4)" "unprognostic (6.75e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-4)" "unprognostic (5.60e-2)" "unprognostic (8.91e-8)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-1)" "unprognostic (6.07e-3)" 0.0 0.0 2.8 0.2 0.9 0.0 8.0 0.9 0.8 0.0 1.0 1.0 0.6 0.0 0.0 0.4 0.3 0.7 0.0 0.6 2.4 0.0 3.5 1.1 0.0 2.2 6.2 0.6 0.0 0.0 0.0 0.3 0.0 1.2 17.6 0.5 0.0 2.7 0.1 0.0 0.6 0.7 0.0 5.3 0.0 3.6 5.9 3.1 0.0 0.0 0.0 0.1 1.4 0.3 0.9 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.4 0.0 0.0 2.4 1.3 0.2 0.0 0.0 3.4 0.0 1.2 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 12.2 0.0 0.0 0.0 1.7 4.5 0.0 0.0 0.0 1.0 8.4 2.4 0.0 0.0 4.5 0.0 0.0 22.8 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.9 0.9 0.8 0.6 2.4 2.2 6.2 0.6 1.2 5.3 3.1 0.9 0.2 0.0 8.4 0.3 0.1 0.0 2.8 1.5 6.2 0.0 13.8 6.9 0.8 1.5 11.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 39.1 0.0 0.0 0.4 7.7 0.0 6.4 0.0 0.0 0.4 7.1 0.1 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.7 0.0 0.0 0.0 18.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.8 0.4 0.0 4.9 0.0 0.0 7.5 0.0 0.0 0.2 0.4 10.7 1.9 2.3 0.0 0.0 0.3 0.0 1.1 3.1 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207904-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;intestine: 13.9;stomach 1: 21.9" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 18.1;Gastric mucus-secreting cells: 16.8;Hepatic stellate cells: 27.1;Oligodendrocyte precursor cells: 24.1;Paneth cells: 10.7;Proximal enterocytes: 11.8" "Cancer enhanced" "Detected in many" "prostate cancer: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 118.9;BJ hTERT+: 32.5;BJ hTERT+ SV40 Large T+: 21.4;fHDF/TERT166: 70.7;HeLa: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Uncertain Vesicles NA NA Vesicles "HPA003207: , HPA031506: AB_2673913" "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favorable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 0.8 0.3 3.8 0.3 10.2 0.0 0.9 0.8 7.4 0.8 0.0 3.6 13.9 1.0 0.4 0.3 0.9 0.4 0.9 9.9 11.1 2.0 6.9 5.3 0.0 4.6 6.4 8.6 0.8 3.6 0.0 0.9 2.7 7.8 1.0 2.3 0.3 0.3 0.4 0.7 0.3 8.2 0.5 0.6 0.6 21.9 0.1 4.5 0.0 0.3 0.9 0.0 1.8 0.7 6.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 118.9 32.5 21.4 1.8 1.2 0.0 0.0 0.0 70.7 0.0 0.2 0.0 0.0 15.4 0.0 0.0 0.0 26.7 0.1 6.3 0.0 0.0 0.2 0.0 0.0 0.3 0.4 1.5 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.1 9.6 0.2 0.0 0.0 0.1 4.7 0.0 3.4 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 10.2 0.8 7.4 9.9 11.1 4.6 6.4 8.6 7.8 0.6 4.5 6.0 1.7 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.5 0.2 0.0 0.8 2.8 0.0 1.8 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 2.4 18.1 0.0 3.9 0.8 0.0 1.0 16.8 0.0 0.0 0.0 27.1 7.2 0.0 0.0 5.5 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 24.1 0.3 0.2 10.7 0.0 0.1 0.1 11.8 1.9 0.0 0.1 0.0 1.0 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.2 6.2 0.0 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 11.7;Astrocytes: 9.1;Bipolar cells: 8.2;Endothelial cells: 8.8;Enteroendocrine cells: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074551 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA074551: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 3.8 2.5 4.1 1.3 3.6 1.2 3.6 3.6 4.7 5.4 2.0 2.7 1.1 8.6 1.1 4.0 4.3 4.2 2.0 9.1 3.6 2.9 0.5 3.4 1.3 3.9 3.7 3.3 2.5 2.1 2.2 1.9 1.6 3.4 3.1 1.7 1.7 3.1 1.6 0.7 2.9 2.5 4.0 2.1 2.4 2.0 1.7 3.3 3.8 4.6 0.5 0.9 2.6 4.2 5.3 4.6 4.5 18.3 20.9 4.4 2.2 10.1 8.4 5.4 7.0 9.0 5.7 6.1 0.3 6.7 9.2 1.8 25.8 8.0 7.1 5.6 7.1 6.7 1.0 12.7 1.9 4.9 13.2 0.3 17.3 2.3 7.6 5.0 8.5 11.5 4.2 2.9 11.0 6.1 12.9 1.0 8.8 4.6 4.7 10.2 22.9 6.1 8.4 2.0 3.8 52.9 14.2 19.7 10.4 1.1 5.0 9.3 1.9 10.7 6.9 26.0 2.8 6.3 3.5 1.1 0.3 7.2 3.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 3.6 3.6 4.7 9.1 3.6 3.9 3.7 3.3 3.4 2.1 3.3 5.3 11.7 0.0 0.0 9.1 0.3 1.5 0.8 0.5 3.4 8.2 2.1 1.1 2.0 0.0 0.5 1.8 0.0 2.3 0.9 1.9 1.9 0.5 0.4 0.6 2.1 8.8 10.7 0.0 2.6 0.5 2.5 1.7 1.1 1.0 0.0 4.3 2.5 0.0 0.6 0.0 1.7 1.7 0.0 0.0 0.3 1.0 0.0 0.1 1.8 2.8 0.1 4.4 0.0 5.5 0.2 0.6 0.3 0.0 0.3 0.8 0.2 0.5 0.5 0.8 0.0 0.2 1.5 1.1 2.5 2.0 2.3 1.9 0.7 2.5 2.1 0.9 REM2 FLJ38964 ENSG00000139890 "RRAD and GEM like GTPase 2" Q8IYK8 14 22883222-22887678 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Early spermatids: 29.2;Endometrial ciliated cells: 10.9;Late spermatids: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 3.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 3.1" "Region enhanced" "Detected in all" "basal ganglia: 44.8" "Group enriched" "Detected in some" 5 "basal ganglia: 8.3;cerebellum: 4.6;hippocampal formation: 3.2;midbrain: 2.2" NA NA "unprognostic (4.56e-3)" "unprognostic (1.89e-2)" "unprognostic (1.47e-1)" "unprognostic (3.95e-1)" "unprognostic (1.49e-1)" "unprognostic (9.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (1.49e-5)" "unprognostic (9.40e-2)" "unprognostic (4.63e-5)" "unprognostic (3.56e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" 0.7 0.4 2.0 0.9 3.4 10.0 0.7 1.5 2.1 1.1 1.8 1.2 0.3 0.8 0.4 0.8 2.6 0.3 0.4 1.2 1.6 1.2 0.6 2.3 0.9 1.0 1.1 0.8 1.2 0.6 1.3 5.8 0.2 1.0 1.5 0.1 0.5 0.8 0.3 0.8 2.2 2.0 0.3 1.0 5.8 0.9 4.8 1.7 0.6 1.0 0.3 0.5 1.0 0.9 0.8 0.7 0.3 3.1 0.1 0.3 0.4 0.4 0.0 0.2 0.0 0.2 0.3 1.0 0.3 0.1 0.0 0.1 1.3 0.0 0.1 0.2 0.5 0.7 0.1 1.5 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 1.3 0.2 1.0 0.0 0.3 0.1 0.3 0.6 0.0 0.1 0.3 0.1 0.1 0.4 1.5 0.3 0.4 0.5 0.1 0.5 0.2 0.0 0.0 0.7 0.0 0.1 1.2 0.5 0.8 0.1 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.3 0.6 0.2 0.3 0.0 0.9 0.4 0.5 3.7 0.0 0.4 0.2 0.2 0.1 2.0 3.4 1.5 2.1 1.2 1.6 1.0 1.1 0.8 1.0 1.0 1.7 0.8 1.6 12.8 2.4 0.0 4.0 2.8 0.9 1.2 4.0 0.1 4.7 4.3 1.7 1.5 1.9 1.8 0.0 0.5 3.5 1.4 0.0 0.7 29.2 10.9 1.3 1.1 6.6 0.4 0.2 0.0 0.3 0.7 1.5 4.7 0.0 0.6 0.4 0.0 0.4 0.0 0.1 1.9 0.0 0.6 1.0 9.6 1.2 0.6 3.6 0.0 1.3 0.7 0.0 0.0 0.1 0.4 0.2 1.2 3.1 0.9 0.4 0.5 4.6 0.9 0.0 0.4 0.9 0.8 0.8 4.5 3.0 0.4 1.7 0.3 1.2 1.3 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426545-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.7" "Cell type enhanced" "Detected in some" "dendritic cells: 3.0;Theca cells: 5.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 8 "cerebellum: 86.7;pons: 31.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.4;HDLM-2: 17.2;HSkMC: 23.3;Karpas-707: 18.3;U-266/70: 12.8" "Region enriched" "Detected in many" 25 "cerebellum: 429.5" "Region enriched" "Detected in many" 42 "cerebellum: 446.5" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 6.8 17.2 2.7 8.4 2.9 0.6 4.7 86.7 5.9 4.3 2.1 3.9 2.2 2.7 7.5 2.9 4.0 5.7 3.3 2.4 3.3 4.4 6.0 4.9 13.8 3.7 7.1 2.5 10.2 2.0 2.9 4.3 3.7 31.6 4.6 2.1 0.5 4.3 3.2 1.8 3.5 5.4 2.2 3.3 13.9 3.3 5.1 3.6 3.9 4.5 0.6 9.2 4.9 4.6 4.4 1.5 1.3 0.7 2.5 6.2 13.4 0.4 5.5 11.1 2.1 2.7 0.7 2.6 2.4 1.2 3.4 2.4 0.3 0.8 2.9 1.4 17.2 0.6 0.0 5.2 1.1 3.3 0.4 0.9 23.3 1.3 2.7 2.1 8.8 1.9 1.0 0.7 18.3 2.8 0.8 0.0 0.7 0.1 1.5 1.5 0.0 0.0 1.8 1.2 0.5 0.9 0.5 0.5 0.1 0.8 0.3 0.8 0.6 8.7 7.7 1.5 3.2 0.3 12.8 3.2 2.7 0.4 1.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.9 86.7 5.9 2.4 3.3 3.7 7.1 2.5 31.6 3.3 3.6 4.4 1.4 0.0 0.0 0.0 2.6 0.4 0.6 1.5 0.0 0.0 0.8 1.0 0.5 0.0 0.4 0.0 0.0 0.9 3.0 0.8 0.0 1.1 0.0 0.3 2.0 0.8 0.0 0.4 0.3 1.1 0.6 2.6 0.0 0.5 0.0 0.9 0.0 0.2 0.9 0.0 0.1 0.5 0.0 0.3 0.4 0.3 2.5 0.7 0.0 1.0 2.6 1.2 0.0 0.0 0.0 0.8 0.0 1.5 0.1 0.5 0.9 0.8 1.4 0.2 0.0 0.7 1.4 0.0 0.2 0.2 0.6 0.8 0.2 5.7 0.6 0.6 TSSK4 "C14orf20, STK22E" ENSG00000139908 "Testis specific serine kinase 4" Q6SA08 14 24205696-24208362 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 38.4" "Cell type enriched" "Detected in some" 9 "Early spermatids: 253.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060660, HPA077103" Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA060660: AB_2684339, HPA077103: AB_2732332" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.52e-1)" "unprognostic (5.69e-2)" "unprognostic (2.36e-1)" "unprognostic (3.38e-5)" "unprognostic (1.06e-1)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (3.39e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-3)" "unprognostic (3.42e-1)" "unprognostic (4.30e-2)" "unprognostic (6.28e-2)" "unprognostic (8.98e-2)" "unprognostic (7.26e-2)" 0.9 1.1 0.8 2.0 0.6 3.5 1.0 0.9 0.4 1.3 0.0 1.3 1.6 1.1 0.3 1.3 1.2 1.7 0.7 0.7 0.1 0.8 0.6 1.0 2.7 0.5 0.3 0.1 1.1 1.5 0.0 0.9 0.4 0.6 0.9 0.0 3.1 1.5 0.0 1.3 4.2 1.7 0.0 0.2 1.8 1.2 38.4 0.4 0.0 1.5 0.0 0.0 1.1 1.1 0.7 0.6 2.3 2.2 0.8 0.0 0.0 2.4 0.9 0.0 0.0 0.0 1.3 2.2 1.8 0.5 0.1 0.4 2.1 0.0 0.1 0.0 0.9 1.7 2.0 3.4 1.7 0.0 1.0 2.1 0.0 0.0 0.0 0.3 1.9 0.0 2.1 0.8 1.2 0.0 2.2 2.1 1.1 0.4 0.5 1.8 1.8 0.8 1.5 0.0 3.0 1.2 1.2 1.7 1.4 0.4 0.9 1.0 1.0 0.9 1.6 1.0 2.1 0.7 2.3 3.0 2.6 0.5 1.6 0.5 0.0 0.2 0.4 0.4 0.2 0.1 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.5 0.1 0.3 0.1 0.1 0.8 0.6 0.9 0.4 0.7 0.1 0.5 0.3 0.1 0.6 0.2 0.4 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 253.7 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 26.5 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.3 0.1 0.8 0.0 0.0 0.2 0.1 6.8 0.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 NOVA1 NOVA-1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443090-26598033 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.3;ASC diff: 25.6;HAP1: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 18.1 5.5 45.5 2.4 39.9 0.1 29.2 84.8 56.7 11.6 20.5 8.9 1.4 8.6 4.9 2.9 6.7 4.9 2.9 38.6 58.9 6.1 0.9 1.4 3.4 50.6 50.6 38.6 5.0 1.2 2.5 19.4 0.1 56.0 5.6 5.2 13.6 2.7 16.1 4.4 4.2 3.7 9.6 45.2 0.9 3.4 8.9 63.9 1.2 3.4 8.8 4.5 5.9 8.4 46.0 0.0 11.6 53.3 0.0 25.6 14.6 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.7 0.7 7.1 0.1 23.7 0.2 0.0 0.0 1.8 0.0 0.1 0.3 8.5 0.0 2.1 16.8 0.0 3.6 2.9 17.8 10.3 8.7 0.0 0.1 8.4 0.0 9.8 0.1 13.5 0.0 10.9 1.3 14.8 0.2 6.8 9.1 15.5 9.4 0.0 0.0 0.0 4.2 1.1 0.0 0.0 6.5 7.7 5.2 1.4 0.0 0.0 0.0 8.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.5 39.9 84.8 56.7 38.6 58.9 50.6 50.6 38.6 56.0 45.2 63.9 46.0 24.8 0.0 1.5 141.0 0.2 5.2 5.9 0.0 4.6 222.9 51.5 29.6 1.1 5.7 0.0 14.7 4.2 0.1 1.4 6.6 9.8 0.4 20.1 0.6 15.0 9.4 65.9 0.0 414.9 0.4 0.0 188.8 0.5 0.2 0.0 18.2 38.6 0.5 0.2 136.3 203.5 7.1 0.0 0.6 10.5 16.5 150.4 2.1 3.6 93.7 0.0 32.3 0.0 1269.7 319.5 2.0 11.7 65.8 1.9 6.7 0.3 30.3 4.4 12.0 6.6 28.6 17.7 163.1 64.3 0.7 3.1 0.0 1.5 30.0 8.4 0.6 FITM1 FIT1 ENSG00000139914 "Fat storage inducing transmembrane protein 1" A5D6W6 14 24130659-24132849 "Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 144.1;skeletal muscle: 225.9" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 281.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.0;HMC-1: 1.2;RH-30: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA019842 Uncertain NA NA "HPA019842: AB_1853025" "unprognostic (1.81e-2)" "unprognostic (4.29e-7)" "unprognostic (2.77e-1)" "unprognostic (2.02e-3)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "prognostic favorable (1.00e-3)" "unprognostic (1.20e-4)" "unprognostic (4.57e-1)" "unprognostic (2.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.68e-2)" "unprognostic (2.47e-1)" "unprognostic (2.86e-2)" "unprognostic (5.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.12e-3)" 1.0 7.3 0.7 0.2 0.8 1.7 1.2 1.1 1.1 0.9 0.5 1.0 0.9 0.8 0.5 1.3 0.8 0.2 144.1 0.6 0.6 1.9 27.2 1.4 0.5 0.8 0.7 0.6 1.4 15.6 0.2 1.6 0.1 0.7 3.3 0.3 0.8 7.5 0.4 225.9 1.6 2.3 0.0 0.7 10.3 1.3 2.3 0.7 0.4 2.1 1.7 0.2 0.7 0.9 1.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.3 0.1 0.2 2.0 0.2 0.0 1.2 0.2 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.3 0.3 2.0 0.0 0.1 0.3 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 1.1 1.1 0.6 0.6 0.8 0.7 0.6 0.7 0.7 0.7 1.0 2.7 0.0 0.0 0.0 0.6 0.1 0.3 0.4 0.0 1.8 1.3 0.9 281.6 1.5 0.2 0.0 0.0 0.2 1.1 1.9 0.0 1.0 2.2 0.5 0.3 5.0 1.2 0.0 0.3 3.0 0.2 12.2 1.1 0.9 0.0 0.6 1.1 37.4 0.2 0.0 0.2 1.1 0.0 0.8 0.3 3.9 0.0 0.4 0.0 0.0 0.9 0.9 2.1 0.0 0.4 0.8 0.3 0.7 0.2 0.3 3.8 0.6 0.3 0.7 0.0 56.8 7.5 1.5 0.3 0.7 0.6 0.7 0.8 12.3 0.9 0.2 MDGA2 MAMDC1 ENSG00000139915 "MAM domain containing glycosylphosphatidylinositol anchor 2" Q7Z553 14 46839629-47675605 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 8.6;retina: 4.5;testis: 3.8" "Group enriched" "Detected in some" 7 "Excitatory neurons: 1559.3;Inhibitory neurons: 1208.8;Oligodendrocyte precursor cells: 1972.9" "Cancer enhanced" "Detected in single" "melanoma: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.1;T-47d: 2.5;U-138 MG: 5.6;U-2 OS: 4.0;U-87 MG: 2.1;WM-115: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003084 Uncertain NA NA "HPA003084: AB_1079302" "unprognostic (3.27e-1)" "unprognostic (5.38e-2)" "unprognostic (9.13e-2)" "unprognostic (8.92e-3)" "unprognostic (6.36e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.49e-3)" "unprognostic (3.62e-3)" "unprognostic (3.06e-2)" "unprognostic (5.89e-1)" 0.1 0.2 3.7 0.0 6.7 0.0 0.0 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 4.4 0.1 0.1 0.0 0.0 6.3 1.8 5.1 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 4.5 0.1 0.0 0.0 0.3 0.0 0.0 3.1 0.0 0.2 3.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 2.5 0.0 0.0 5.6 4.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.7 0.2 6.3 6.6 4.4 6.3 1.8 5.1 8.6 3.1 4.7 7.6 0.0 0.0 0.0 24.2 0.1 0.4 0.0 0.0 0.0 50.6 3.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.9 0.0 0.0 0.1 0.0 0.0 1559.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1208.8 0.0 0.0 0.0 0.0 7.1 0.3 0.0 5.4 52.5 0.0 0.3 0.0 1972.9 209.4 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.2 4.4 6.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257655 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 26000 "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 11.1 8.9 6.4 10.9 6.9 10.8 11.4 7.5 8.7 7.8 7.8 12.4 10.7 8.2 10.9 9.2 6.7 8.6 4.5 6.1 7.3 10.3 12.7 9.4 12.5 7.3 7.8 5.6 6.6 9.2 9.5 5.5 13.3 7.5 8.0 12.3 6.9 8.4 9.3 5.2 9.9 9.4 10.0 7.8 10.8 10.5 5.1 7.4 11.7 11.5 4.4 10.6 13.1 6.7 7.8 27.0 23.8 33.8 18.4 26.0 20.3 35.5 33.5 26.8 33.2 42.2 24.9 49.0 38.8 30.0 22.6 15.6 26.1 60.3 21.5 60.4 38.6 19.6 28.4 19.4 24.7 22.4 66.2 27.4 24.4 19.5 22.2 16.3 24.0 29.7 31.2 23.6 25.9 32.1 32.6 29.7 35.5 38.3 42.2 28.5 30.9 60.9 23.4 32.2 34.8 21.1 15.5 26.6 17.8 24.6 22.2 25.8 28.6 19.0 34.9 32.2 24.8 30.9 22.4 23.9 31.4 15.4 36.6 33.5 10.5 12.2 6.2 8.6 14.7 10.6 7.7 8.8 9.0 13.6 6.3 8.5 10.1 4.3 11.5 11.0 15.7 11.0 12.4 6.4 6.9 7.5 8.7 6.1 7.3 7.3 7.8 5.6 7.5 7.8 7.4 7.8 43.0 38.5 29.1 24.5 55.9 108.6 63.1 80.5 71.2 13.7 40.7 20.8 9.2 44.3 55.7 35.0 12.5 73.9 82.6 38.2 9.8 62.1 2.5 22.0 42.2 47.5 17.4 81.2 8.9 67.6 149.3 48.4 32.1 28.0 43.6 24.4 43.2 44.0 73.2 10.1 11.2 29.2 63.1 61.1 84.3 4.3 24.8 65.7 55.2 18.7 70.0 27.0 46.4 22.1 25.2 50.3 44.0 28.6 79.2 58.4 29.3 32.4 42.2 32.6 59.2 37.3 49.4 59.5 68.7 79.0 97.3 57.7 62.5 58.7 46.5 59.5 FRMD6 "C14orf31, EX1, MGC17921, willin" ENSG00000139926 "FERM domain containing 6" Q96NE9 14 51489100-51730727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 160.6;Early spermatids: 219.1;Late spermatids: 473.0;Suprabasal keratinocytes: 137.5;Urothelial cells: 130.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 351.1;fHDF/TERT166: 765.6;U-138 MG: 290.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001297 Uncertain Supported Approved Mitochondria NA NA Mitochondria "HPA001297: AB_1078913" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-1)" "unprognostic (2.64e-2)" "unprognostic (8.05e-2)" "unprognostic (8.19e-2)" "unprognostic (3.55e-3)" "unprognostic (1.28e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.28e-4)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-2)" 11.8 13.5 5.7 9.6 4.7 1.2 27.4 13.5 7.8 26.5 9.3 13.1 5.2 54.1 11.4 60.4 13.5 33.3 7.3 6.4 9.1 4.2 10.5 8.6 5.5 6.1 8.1 4.0 26.2 5.0 2.4 3.5 14.2 5.7 28.0 10.9 1.5 21.6 31.0 7.5 43.6 7.5 47.2 5.6 12.1 7.3 31.3 6.5 12.7 6.6 6.8 12.8 31.8 30.4 5.9 71.4 14.1 20.1 42.1 40.1 67.6 8.8 351.1 163.2 169.5 146.0 51.9 16.4 1.9 10.6 765.6 47.6 82.8 5.7 113.8 200.3 1.1 8.6 0.3 7.6 2.2 46.8 0.2 4.2 58.8 40.9 152.0 200.5 77.8 52.6 3.7 0.7 24.6 181.8 12.2 7.1 0.2 3.9 0.2 27.4 0.8 79.1 0.7 33.4 113.7 4.1 44.9 27.8 3.9 31.3 37.7 3.0 1.0 242.6 290.7 97.6 73.3 73.5 18.9 17.3 0.2 19.3 0.3 114.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.1 5.7 4.7 13.5 7.8 6.4 9.1 6.1 8.1 4.0 5.7 5.6 6.5 5.9 6.9 3.2 1.5 34.6 0.8 111.4 160.6 42.4 41.5 0.4 40.5 49.4 2.9 8.6 11.6 0.0 0.0 40.1 1.5 0.0 0.0 16.9 219.1 2.0 41.1 14.4 0.0 2.5 45.2 2.9 4.8 57.8 1.1 3.6 1.3 0.9 9.3 4.2 3.8 0.0 22.5 0.3 10.2 0.3 21.1 473.0 17.7 1.5 32.0 68.4 0.7 8.2 0.0 74.9 5.9 64.0 0.0 22.2 3.7 52.0 0.1 0.4 2.7 0.5 6.6 24.5 28.0 10.2 9.8 115.7 137.5 39.0 3.3 0.9 0.1 130.7 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301524 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 9.2 3.0 8.2 4.4 8.1 18.7 7.8 26.7 6.6 6.6 6.1 6.3 11.1 6.8 2.6 4.4 6.3 10.1 2.4 5.5 12.0 9.3 2.8 6.7 4.0 9.3 9.8 3.9 15.1 28.8 1.9 2.7 3.1 12.6 4.8 3.9 15.3 7.8 3.6 2.4 5.8 9.3 3.3 8.0 6.8 14.5 10.1 10.7 19.2 4.1 3.9 2.0 10.7 5.8 9.2 0.1 3.1 8.8 0.0 4.8 7.2 0.2 1.2 4.2 0.9 0.1 0.2 0.7 0.2 4.2 2.5 0.0 0.9 6.9 0.0 0.4 2.3 2.4 7.9 13.0 0.0 4.1 1.1 33.3 4.5 0.4 0.0 0.0 4.8 1.6 43.8 6.0 0.1 0.9 0.0 39.5 0.4 14.5 0.1 1.2 19.2 0.5 1.8 3.6 15.4 17.5 0.0 0.8 0.1 10.2 5.5 0.0 6.3 0.5 2.6 4.4 0.8 4.4 0.7 0.1 1.0 4.6 5.4 2.6 0.9 1.9 2.4 0.3 1.0 0.5 0.1 0.3 0.2 1.3 0.4 0.2 0.1 5.6 0.3 0.8 0.3 0.0 0.7 8.2 8.1 26.7 6.6 5.5 12.0 9.3 9.8 3.9 12.6 8.0 10.7 9.2 13.9 0.0 10.0 114.3 7.7 14.3 10.4 1.7 9.6 30.7 7.1 7.7 2.7 8.6 6.7 12.9 29.2 0.1 11.8 15.0 3.9 5.9 3.7 23.7 14.5 18.0 7.2 5.5 13.5 14.1 0.1 13.5 34.1 21.2 5.7 5.7 17.5 1.0 1.2 21.9 22.1 7.9 2.0 19.7 14.0 5.7 17.1 20.3 17.8 100.2 22.9 9.7 10.3 150.8 77.5 9.1 6.0 18.0 5.6 7.8 12.4 10.1 8.8 19.7 13.1 5.4 22.0 2.0 24.0 4.7 18.3 0.1 6.2 5.6 3.1 12.6 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870776 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 146.5;pituitary gland: 60.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4" "Group enriched" "Detected in many" 14 "dendritic cells: 5.4;monocytes: 3.1" "Group enriched" "Detected in some" 4 "HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 150000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 9.8 12.1 80.1 9.3 145.5 0.4 7.2 68.9 146.5 2.2 0.0 6.4 2.6 1.3 0.4 1.6 12.9 5.6 0.9 125.0 145.5 1.6 1.0 6.5 2.8 42.7 58.8 116.3 0.7 4.1 17.5 60.5 2.5 46.8 6.5 2.8 34.4 3.5 2.0 0.8 2.6 4.2 2.4 14.7 18.5 4.0 2.3 69.4 1.0 2.5 0.7 1.8 1.9 3.7 119.1 0.0 0.0 0.7 1.0 2.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.1 0.4 0.0 2.1 61.7 0.0 0.0 3.4 0.1 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.4 0.0 0.3 0.7 0.3 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 71.8 115.1 14.9 0.0 0.0 0.2 0.0 0.0 0.0 9.9 2.8 0.1 5.6 0.0 0.0 0.0 19.4 4.4 0.7 0.0 2.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.7 80.1 145.5 68.9 146.5 125.0 145.5 42.7 58.8 116.3 46.8 14.7 69.4 119.1 1.0 0.0 1.1 64.3 0.5 4.8 0.4 0.0 0.0 34.1 11.4 4.3 1.0 1.5 0.6 0.0 25.0 1.2 1.4 0.8 0.0 0.0 16.2 23.5 0.3 2.9 54.2 0.8 495.8 0.0 5.0 1.5 5.6 0.4 0.0 0.2 0.0 0.5 17.8 240.6 394.3 3.6 0.0 14.4 59.7 21.4 2.8 23.8 10.6 87.1 22.8 14.3 0.0 188.0 247.7 1.4 0.1 1.2 0.1 5.8 0.8 0.9 0.7 33.3 0.0 10.7 2.5 2.3 3.8 0.2 6.5 2.5 0.7 0.1 0.5 0.3 ARMH4 "C14orf37, UT2" ENSG00000139971 "Armadillo like helical domain containing 4" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.8;kidney: 8.4" "Cell type enhanced" "Detected in some" "Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 1800000 "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 1.2 2.5 2.9 0.6 4.4 0.7 0.9 9.4 4.2 1.8 0.0 0.7 0.5 3.1 1.8 0.8 2.1 1.8 3.1 3.1 2.3 8.4 0.8 0.7 0.4 10.9 5.2 3.4 4.3 1.0 3.6 1.3 0.4 13.8 1.6 1.0 1.2 0.7 1.4 0.2 1.0 0.7 2.3 1.1 0.5 1.4 2.2 2.0 0.2 1.5 1.9 0.3 1.2 0.9 4.6 0.0 0.0 9.7 6.1 4.7 1.7 0.0 1.9 1.5 0.3 0.3 0.5 0.1 0.0 0.6 10.8 1.2 0.0 2.9 0.0 0.4 0.1 1.0 0.0 0.0 0.5 0.2 0.0 4.8 1.8 0.0 0.2 0.2 2.7 0.5 0.8 0.1 0.3 1.2 0.3 0.0 0.0 4.5 0.0 2.0 1.4 0.3 2.5 3.9 0.3 1.1 0.0 0.1 0.0 0.3 2.7 0.2 0.2 0.1 1.3 3.5 0.5 2.6 0.3 0.2 0.0 3.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.4 9.4 4.2 3.1 2.3 10.9 5.2 3.4 13.8 1.1 2.0 4.6 15.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 12.9 0.0 0.2 0.7 0.0 0.0 2.1 0.0 10.2 7.7 2.3 0.0 0.0 0.0 1.3 0.4 3.0 0.0 2.4 0.0 26.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 0.3 44.5 0.0 0.0 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.0;testis: 3.8" "Group enriched" "Detected in some" 5 "Excitatory neurons: 281.4;Inhibitory neurons: 279.7;Oligodendrocyte precursor cells: 127.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.8;hTERT-HME1: 4.1;PC-3: 5.4;RPTEC TERT1: 6.2;RT4: 17.0;U-2 OS: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol NA NA Cytosol "HPA004199: AB_1080156, HPA076871: AB_2732324" "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.0 0.4 4.6 0.0 12.5 0.1 0.1 0.0 10.4 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.1 11.4 9.9 0.1 0.0 0.0 0.1 0.0 0.8 15.0 0.0 2.0 0.1 1.1 0.4 2.5 2.3 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.8 3.4 0.0 0.0 0.0 0.0 0.3 0.2 5.2 10.8 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.0 1.0 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 5.4 0.0 0.0 0.0 6.2 17.0 0.3 2.8 0.5 0.7 0.0 1.0 0.0 0.0 0.0 2.7 6.6 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 12.5 0.0 10.4 11.4 9.9 0.0 0.8 15.0 2.5 0.0 3.4 5.2 0.0 0.0 0.0 8.8 0.1 0.0 0.1 0.0 0.0 2.0 0.0 0.0 1.3 0.0 0.0 3.7 2.1 0.7 0.0 0.0 0.0 0.3 45.0 0.1 0.4 0.1 0.0 0.0 281.4 0.0 0.6 0.1 3.1 0.3 0.0 3.4 0.0 0.0 0.1 0.0 279.7 0.0 0.0 0.0 0.0 17.1 0.3 0.0 0.0 8.4 0.0 0.7 0.0 127.2 13.9 0.1 0.0 0.0 0.3 1.7 0.0 0.2 0.1 0.1 0.0 0.0 0.4 3.8 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" NA NA "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 7.2 9.2 6.9 4.8 7.3 2.9 7.4 7.0 10.2 6.6 9.3 4.8 3.1 5.2 13.4 3.4 5.6 10.0 3.2 7.3 7.4 12.1 6.4 8.6 7.9 6.6 6.7 6.4 5.9 3.5 21.4 7.2 9.7 7.2 5.1 6.6 7.5 5.9 3.9 2.1 2.9 3.5 5.4 6.5 6.6 3.8 5.1 7.9 5.0 6.4 3.0 4.9 7.1 5.0 8.2 16.2 21.5 6.8 12.3 68.7 25.3 4.9 11.6 34.5 10.7 10.2 5.4 41.0 4.0 19.2 10.6 22.5 13.5 6.8 11.9 9.8 6.0 3.2 6.7 8.6 14.2 22.7 3.7 12.1 19.9 4.9 10.5 12.2 43.2 14.3 6.8 9.3 8.4 37.5 9.2 6.6 8.4 4.0 9.5 14.3 1.6 20.1 11.9 30.7 8.5 3.3 3.0 9.9 7.0 19.1 9.3 10.4 5.8 15.6 16.4 7.1 20.0 6.5 1.6 4.9 1.6 34.0 3.0 13.1 0.0 6.6 0.1 1.7 7.1 2.2 2.2 3.1 2.4 3.6 2.0 2.7 3.4 0.2 0.8 4.5 4.4 4.5 2.8 6.9 7.3 7.0 10.2 7.3 7.4 6.6 6.7 6.4 7.2 6.5 7.9 8.2 6.8 22.4 6.7 31.6 6.0 5.2 11.4 14.6 8.0 19.7 7.2 7.5 4.3 7.2 10.0 5.5 22.9 5.6 4.9 2.6 1.9 5.3 178.2 13.0 11.0 7.2 4.2 3.4 98.8 2.8 9.4 11.2 5.1 6.2 6.3 7.3 4.2 4.6 100.3 5.0 77.4 3.1 6.1 24.8 10.0 124.4 10.8 26.2 5.4 20.6 6.4 11.7 2.1 54.3 30.8 7.4 1.9 6.0 5.8 6.6 3.3 23.1 40.4 24.9 0.0 12.3 9.1 16.6 11.5 6.4 2.8 6.7 7.8 5.0 2.8 6.9 NAA30 "C14orf35, FLJ35355, MAK3, Mak3p, NAT12" ENSG00000139977 "N-alpha-acetyltransferase 30, NatC catalytic subunit" Q147X3 14 57390544-57415906 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057824 Uncertain Supported Cytosol NA NA Cytosol "HPA057824: AB_2683539" "unprognostic (5.13e-2)" "unprognostic (7.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (6.31e-2)" "unprognostic (1.84e-2)" "unprognostic (5.44e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.25e-8)" "unprognostic (1.77e-1)" "unprognostic (1.67e-1)" "unprognostic (5.75e-3)" "unprognostic (1.63e-1)" 9.7 7.7 10.0 7.2 12.0 15.1 9.7 11.3 12.1 7.8 7.2 8.5 10.0 9.2 7.2 11.4 7.5 7.1 14.3 11.5 11.7 12.5 16.8 6.5 9.1 9.5 10.3 10.1 15.0 9.1 12.6 5.7 13.5 9.9 10.2 8.0 12.1 8.1 10.2 32.1 8.4 8.7 10.2 10.2 8.4 7.0 18.6 12.1 9.0 10.7 27.6 9.2 8.3 6.0 10.1 19.4 18.2 10.2 16.7 16.8 21.9 17.1 22.1 21.3 16.5 15.0 16.5 13.9 14.1 19.0 18.4 12.5 20.1 18.5 14.3 27.4 24.7 9.4 11.4 10.1 14.5 17.5 23.1 12.8 15.0 20.7 15.0 24.9 18.4 25.8 17.3 11.3 13.6 22.1 22.1 19.5 13.4 11.0 17.8 20.0 15.3 29.4 11.0 16.9 17.4 21.8 11.5 18.7 18.3 23.0 18.2 23.6 11.9 22.7 25.7 27.0 14.2 14.3 10.1 13.2 16.9 17.1 11.5 18.7 0.8 0.4 0.2 1.2 0.9 1.2 1.0 1.1 1.8 0.3 1.1 1.2 1.2 0.2 2.4 2.8 0.6 1.7 0.4 10.0 12.0 11.3 12.1 11.5 11.7 9.5 10.3 10.1 9.9 10.2 12.1 10.1 11.8 9.6 6.3 10.1 16.7 41.0 11.8 8.6 25.0 13.5 16.5 10.9 34.9 17.2 8.0 3.7 18.8 18.3 20.1 11.6 9.8 12.5 107.1 9.0 13.1 17.0 21.0 9.0 20.3 11.6 15.6 13.1 12.8 10.8 7.0 14.9 11.0 25.5 9.9 10.1 20.3 13.7 6.1 13.2 12.1 37.6 13.7 8.2 23.2 10.3 9.9 13.3 8.2 16.6 18.9 14.5 13.8 13.5 18.1 18.9 13.6 17.9 9.5 15.3 19.7 13.3 15.4 69.2 20.5 25.5 41.2 22.2 17.0 13.3 12.6 16.7 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70417107-70460427 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 8.7" "Group enriched" "Detected in some" 41 "Early spermatids: 69.5;Late spermatids: 131.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 1.3;U-251 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA059016 Uncertain NA NA "HPA059016: AB_2683882" "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.4 0.3 0.1 0.4 0.0 0.1 0.0 0.9 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 8.7 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.4 0.3 0.0 0.1 0.2 0.4 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.4 0.3 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.7 0.0 0.3 0.0 0.2 0.6 0.0 0.6 0.0 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.5 0.1 0.1 0.5 0.2 1.3 0.0 0.1 1.3 0.1 0.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.9 0.4 0.5 0.1 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 69.5 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 131.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.1 2.4 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 RDH12 "FLJ30273, LCA13, RP53, SDR7C2" ENSG00000139988 "Retinol dehydrogenase 12" Q96NR8 14 67701886-67734451 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Oxidoreductase "Disease variant, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "retina: 224.7;skin 1: 62.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 453.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (4.25e-3)" "unprognostic (4.50e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (2.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (2.13e-1)" "unprognostic (1.69e-2)" "unprognostic (2.72e-3)" "unprognostic (7.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.42e-2)" "unprognostic (6.47e-2)" "unprognostic (7.83e-2)" "unprognostic (3.58e-1)" "unprognostic (3.92e-1)" 0.1 4.1 1.2 0.1 1.2 0.1 2.2 1.0 1.4 5.3 0.4 0.0 0.3 0.0 8.8 22.3 0.5 17.8 0.0 0.9 1.2 13.7 3.8 0.1 0.0 1.2 2.3 0.9 0.0 3.2 0.0 0.9 0.1 1.3 0.5 0.0 224.7 1.8 0.1 0.1 62.3 0.1 0.0 0.6 0.0 12.5 0.1 4.4 0.4 1.2 0.0 1.6 0.0 23.8 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 1.0 1.4 0.9 1.2 1.2 2.3 0.9 1.3 0.6 4.4 1.3 0.0 0.0 0.0 0.7 0.0 4.7 0.3 0.0 0.6 39.8 0.1 0.1 0.0 20.0 0.3 1.8 146.0 0.0 0.0 0.1 0.0 0.7 0.2 1.8 1.1 2.2 0.0 0.0 1.2 1.7 0.0 0.4 14.3 1.7 0.0 0.0 0.0 5.7 0.2 20.2 0.9 0.0 0.0 0.6 0.9 0.0 0.3 0.2 1.8 1.0 0.0 53.0 0.0 1.5 0.2 1.5 2.6 0.0 0.0 0.3 0.1 12.5 0.2 453.2 0.0 0.0 0.2 0.0 0.1 4.7 38.6 0.0 0.1 0.1 0.1 0.3 DCAF5 "BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22" ENSG00000139990 "DDB1 and CUL4 associated factor 5" Q96JK2 14 69050881-69153150 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041575, HPA048098" Uncertain Approved Mitochondria NA NA Mitochondria "HPA041575: AB_2677558, HPA048098: AB_2680263" "unprognostic (8.12e-2)" "unprognostic (3.28e-2)" "unprognostic (4.26e-3)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.27e-2)" "unprognostic (3.13e-2)" "unprognostic (1.25e-1)" "unprognostic (2.43e-1)" "unprognostic (5.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.63e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.06e-1)" 28.9 22.7 15.7 23.7 15.3 30.5 27.4 15.7 16.6 29.4 16.1 30.0 21.8 28.5 22.5 31.1 29.1 24.7 31.6 15.7 16.2 24.6 31.7 31.3 27.9 16.4 14.3 14.2 28.7 22.1 36.7 29.0 25.6 14.4 30.1 21.4 21.0 27.4 25.4 75.0 30.2 26.1 33.0 13.1 27.9 26.4 61.0 15.1 39.8 30.4 52.2 25.8 29.4 28.5 14.7 48.3 15.0 34.7 32.5 37.7 32.9 22.7 22.2 32.1 24.9 31.2 19.4 29.9 26.4 19.9 34.7 18.8 23.0 24.7 33.2 23.2 36.0 13.7 28.4 15.8 14.0 28.6 10.9 33.2 37.3 34.0 22.3 31.1 43.0 37.7 31.1 22.4 21.6 25.1 28.6 34.7 19.0 15.6 22.6 23.7 22.8 32.9 10.6 33.1 37.0 24.7 27.8 29.7 30.7 19.4 29.7 37.5 22.0 34.4 42.2 39.4 19.6 13.2 28.4 9.9 23.9 28.1 13.0 13.0 21.1 4.3 16.4 31.0 4.0 26.3 8.2 16.7 23.0 5.7 8.6 15.7 19.7 5.4 32.3 3.0 6.0 8.2 13.1 15.7 15.3 15.7 16.6 15.7 16.2 16.4 14.3 14.2 14.4 13.1 15.1 14.7 28.8 44.8 57.8 71.8 24.9 26.3 19.1 21.4 38.1 18.5 23.3 19.0 58.8 32.9 39.4 14.7 27.1 19.4 43.6 20.9 1.9 25.1 149.9 28.7 30.6 32.1 23.4 25.6 88.8 24.9 19.3 27.2 32.1 31.9 37.2 28.0 26.0 33.2 19.6 18.5 85.6 22.0 22.4 19.7 23.7 89.3 31.1 24.3 10.6 74.9 21.8 22.3 52.5 76.9 61.6 29.2 16.0 34.3 35.8 19.9 20.9 14.0 41.2 24.9 46.0 29.1 26.6 75.2 19.8 37.9 19.9 15.3 38.0 31.2 21.3 23.5 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.3;Inhibitory neurons: 28.0;Intestinal goblet cells: 35.2" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 128.1;RH-30: 151.2;RT4: 116.1;SK-BR-3: 116.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.8 5.0 31.1 6.3 36.1 0.8 8.5 30.0 45.1 7.3 15.4 13.7 12.8 4.2 5.6 4.3 4.7 6.2 32.1 39.9 28.6 19.2 21.4 10.0 3.8 23.2 23.3 36.7 2.2 12.7 39.7 9.6 16.3 26.3 11.0 20.4 5.9 36.8 4.6 10.1 6.1 13.2 11.9 18.1 2.8 11.0 1.7 29.7 7.8 6.8 1.2 3.0 18.1 5.1 34.4 10.9 57.0 20.3 20.3 4.5 6.4 57.6 6.7 9.3 13.5 11.8 26.8 28.4 0.6 3.9 16.5 6.2 10.9 128.1 1.3 9.5 3.6 6.2 12.3 1.1 23.5 0.6 0.6 7.5 4.4 2.5 5.9 1.2 3.5 42.6 29.2 0.4 2.0 23.9 61.8 15.2 11.3 45.8 65.6 8.2 18.5 151.2 1.0 15.8 116.1 65.4 12.7 3.4 116.7 15.0 23.6 33.2 11.8 11.2 11.5 49.0 5.5 8.7 0.6 0.4 5.8 2.4 0.3 8.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.9 0.1 0.0 31.1 36.1 30.0 45.1 39.9 28.6 23.2 23.3 36.7 26.3 18.1 29.7 34.4 1.7 6.4 3.9 5.9 0.8 2.5 3.2 1.3 0.6 2.9 12.4 7.4 22.2 4.3 4.2 16.5 0.0 24.7 5.0 5.5 3.9 7.9 0.5 6.6 2.8 3.7 1.2 0.0 51.3 12.2 16.0 2.0 2.6 13.6 1.3 4.1 4.6 8.7 2.7 11.8 28.0 35.2 0.0 0.3 1.3 1.1 0.3 0.9 0.0 4.7 1.0 2.0 1.0 10.6 4.9 13.0 5.5 1.5 0.2 5.6 2.9 5.9 1.3 2.9 0.0 2.4 5.2 0.9 0.4 1.6 1.1 17.9 1.5 1.5 12.0 14.1 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 5.0 5.9 4.7 7.7 5.4 3.0 8.2 7.5 5.8 6.9 3.7 6.2 5.1 7.0 6.9 5.4 6.5 4.9 4.4 5.0 5.1 8.9 8.8 5.5 11.3 4.8 4.8 4.9 8.3 6.0 7.5 3.1 6.7 5.2 5.8 6.8 11.5 4.1 4.6 5.9 6.2 4.1 5.4 4.1 8.7 5.5 5.3 5.2 10.2 9.3 7.4 10.4 6.7 4.4 6.2 35.4 16.2 18.2 10.2 10.7 11.2 27.2 14.0 7.6 14.4 16.2 11.6 17.0 33.7 11.4 4.2 9.7 16.7 22.8 13.2 24.3 21.8 13.1 22.7 10.5 14.4 13.8 29.9 15.5 10.1 17.1 16.0 22.7 8.1 12.8 24.0 19.7 17.8 10.5 19.5 24.0 17.3 17.5 23.9 29.2 18.2 18.3 19.2 15.5 14.6 16.5 12.4 15.0 16.8 11.1 18.1 19.2 16.0 9.2 16.8 16.4 11.0 16.6 10.4 8.8 20.9 7.2 20.9 11.9 0.1 2.8 0.5 8.4 2.7 10.5 8.0 8.8 7.8 4.8 7.3 14.3 12.4 0.6 9.4 4.6 3.1 10.1 5.3 4.7 5.4 7.5 5.8 5.0 5.1 4.8 4.8 4.9 5.2 4.1 5.2 6.2 5.6 9.6 6.7 4.9 14.5 9.7 13.9 4.6 8.0 6.7 6.3 5.3 4.8 8.6 7.0 5.5 4.2 9.9 7.0 3.8 13.7 6.8 2.8 3.4 7.7 7.0 3.6 11.6 11.3 5.5 13.6 6.5 2.6 4.1 1.3 7.5 5.3 8.0 6.3 1.7 13.2 5.1 4.1 6.3 4.2 4.6 4.4 5.1 3.6 6.5 5.6 7.0 8.2 8.5 14.5 3.6 2.4 6.4 6.1 11.2 2.7 7.9 3.1 9.3 13.1 6.9 4.9 6.1 11.6 6.3 10.9 7.0 11.2 8.7 5.5 7.3 ESR2 "ER-beta, Erb, NR3A2" ENSG00000140009 "Estrogen receptor 2" Q92731 14 64084232-64338112 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 6.2" "Cell type enhanced" "Detected in many" "Early spermatids: 61.4;Granulosa cells: 26.6;Late spermatids: 93.7;Rod photoreceptor cells: 35.6;Spermatocytes: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 4.2;U-266/70: 9.8;U-698: 16.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 6.1" "HPA068406, CAB079300" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB079300: , HPA068406: " "unprognostic (7.63e-3)" "unprognostic (2.28e-3)" "unprognostic (8.27e-3)" "unprognostic (5.41e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (8.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.65e-1)" "unprognostic (3.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (5.89e-2)" 1.5 6.2 1.1 1.2 0.7 1.1 0.9 3.0 0.9 1.1 3.0 0.9 1.0 1.2 0.5 0.7 1.0 0.5 0.4 0.6 0.7 1.1 0.7 0.6 2.1 0.8 0.7 0.5 5.4 2.1 0.1 0.8 0.2 1.5 1.6 1.0 2.0 0.8 0.2 1.4 1.0 1.3 0.3 0.2 1.8 1.0 5.8 1.3 2.5 0.6 0.2 1.6 1.1 0.6 0.9 0.8 0.4 0.7 0.6 0.0 0.1 1.5 0.2 0.0 0.1 0.1 0.3 0.9 3.1 0.1 0.1 0.4 1.0 0.8 0.0 0.1 0.7 0.4 0.3 1.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 1.1 0.5 4.2 0.2 0.8 0.5 0.2 0.7 0.6 0.4 0.5 0.4 0.3 0.1 1.3 2.2 0.6 0.4 0.2 1.1 0.4 0.7 0.1 0.5 0.4 1.0 0.2 0.1 9.8 3.1 16.4 0.2 0.1 0.8 0.3 0.1 0.5 0.3 0.2 0.2 0.5 0.2 0.4 0.0 0.7 0.4 0.3 0.6 0.2 0.3 1.1 0.2 0.1 1.1 0.7 3.0 0.9 0.6 0.7 0.8 0.7 0.5 1.5 0.2 1.3 0.9 0.9 6.4 0.0 6.8 5.5 0.3 2.2 0.4 2.8 1.6 0.3 0.1 0.9 4.3 0.9 0.0 6.2 0.7 5.2 0.1 0.0 0.3 61.4 3.5 0.9 3.0 0.0 0.4 12.4 0.7 0.5 2.2 0.0 4.9 1.3 26.6 1.1 0.1 0.1 0.0 17.9 0.8 0.0 0.0 0.3 93.7 0.9 0.2 1.8 7.5 0.1 0.9 6.2 10.6 7.6 0.5 0.1 1.2 16.6 3.8 0.4 0.1 1.7 35.6 0.0 1.5 1.4 28.0 1.4 0.5 0.1 1.1 3.0 16.4 0.8 1.8 KCNH5 "eag2, H-EAG2, hEAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699464-63102037 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 10.9;retina: 4.5" "Group enriched" "Detected in some" 16 "Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 7.2;RT4: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.0 1.1 2.4 0.0 2.2 0.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.0 0.0 0.0 0.0 0.0 3.0 3.5 2.6 0.0 0.0 0.0 0.3 0.2 3.5 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 10.9 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 0.0 5.8 4.9 1.0 3.0 3.5 2.6 3.5 0.2 10.9 5.2 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 62.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 5.8 0.1 0.2 0.2 0.0 0.0 185.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 74.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.8 0.0 0.5 0.0 65.9 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.6 0.0 0.0 0.1 1.6 1.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.3" "Cell type enriched" "Detected in many" 4 "Astrocytes: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 4 "monocytes: 1.2" "Cell line enhanced" "Detected in many" "HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003086 Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 3.5 0.8 68.7 1.2 67.7 5.6 9.7 38.4 52.1 3.1 14.6 4.5 4.0 1.2 5.2 14.4 10.8 5.9 2.5 66.2 81.3 14.4 3.0 5.0 1.1 43.0 61.2 43.6 2.8 0.9 0.3 10.1 2.5 49.5 2.1 5.0 10.3 5.6 2.7 13.3 8.1 4.3 1.7 25.0 16.5 5.8 3.4 55.5 2.6 10.9 17.5 2.9 6.4 9.6 56.8 4.7 3.1 12.1 0.2 0.0 0.1 13.4 0.0 0.1 0.0 0.3 10.0 4.2 0.0 5.5 0.0 3.4 30.6 16.5 39.8 0.0 0.8 5.5 113.4 19.9 4.2 0.0 0.0 60.9 1.7 33.5 0.0 11.0 0.0 0.0 6.1 40.2 58.3 1.2 6.8 5.4 0.0 11.9 11.5 2.4 0.1 17.6 3.4 8.4 46.0 28.1 1.7 13.7 0.6 0.0 9.9 1.7 0.3 0.3 2.4 8.8 9.7 2.6 6.0 11.9 0.1 8.4 0.4 2.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.1 68.7 67.7 38.4 52.1 66.2 81.3 43.0 61.2 43.6 49.5 25.0 55.5 56.8 6.3 3.2 0.5 253.4 0.1 13.6 13.2 20.5 30.7 0.6 11.8 8.1 1.1 2.8 6.8 18.4 12.5 1.4 0.1 4.8 7.9 0.6 0.4 56.0 1.2 5.0 0.0 12.2 0.9 0.5 0.4 8.3 7.1 16.1 0.0 12.5 4.2 0.9 3.4 3.3 4.4 3.2 14.2 18.0 6.1 1.6 10.2 13.5 1.8 23.4 2.3 23.9 0.0 12.1 15.2 3.2 2.7 8.6 1.0 6.8 4.6 20.6 5.8 6.1 0.0 36.1 3.2 1.0 5.9 24.3 8.8 15.5 0.9 6.3 2.7 33.2 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.1" "Group enriched" "Detected in many" 5 "Early spermatids: 557.0;Late spermatids: 363.3;Oligodendrocytes: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA051209: AB_2681389" "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 5.0 4.2 8.2 3.2 8.3 6.2 9.2 8.4 10.7 5.3 9.5 5.4 5.1 3.9 6.5 4.8 11.1 3.4 2.6 7.5 7.4 7.7 6.0 3.2 3.8 8.1 8.1 7.4 4.9 4.9 8.2 3.3 6.5 7.9 5.2 5.5 6.3 4.8 5.0 2.0 3.3 3.9 3.9 8.1 3.6 4.6 37.1 7.8 4.4 7.9 2.5 4.8 4.7 3.0 8.8 8.4 12.7 11.0 13.5 6.5 7.1 30.5 12.1 10.9 16.1 11.2 15.2 29.1 13.1 22.4 8.1 11.4 17.9 9.3 24.2 23.1 14.9 6.1 9.4 11.0 24.6 1.5 12.1 22.0 4.9 5.9 10.5 11.9 9.2 13.6 13.8 10.0 12.5 19.3 43.4 9.0 16.3 4.7 34.3 22.7 10.3 17.1 9.6 15.2 23.0 4.5 7.7 15.3 27.9 14.5 22.4 22.7 8.6 11.5 8.7 11.9 9.3 12.0 7.6 23.2 23.0 12.7 5.7 16.1 14.9 1.1 3.0 0.4 2.5 0.2 2.2 0.7 0.8 1.8 2.4 1.1 1.1 2.7 2.9 5.0 1.6 1.0 0.6 8.2 8.3 8.4 10.7 7.5 7.4 8.1 8.1 7.4 7.9 8.1 7.8 8.8 5.8 0.0 1.1 30.3 6.2 5.1 7.0 14.2 2.2 8.6 8.8 7.9 4.2 11.5 9.7 18.4 2.1 15.7 3.0 3.3 9.8 12.1 557.0 37.7 6.3 7.4 0.0 9.5 16.8 16.9 28.9 6.3 1.5 10.5 5.1 8.0 6.4 6.3 11.7 3.3 19.1 6.1 10.2 4.0 6.6 363.3 5.6 5.7 3.6 18.7 8.0 6.8 2.1 40.2 139.9 6.5 9.7 7.5 6.4 2.6 3.6 20.4 47.7 13.2 0.0 5.3 6.0 62.8 14.7 5.4 3.3 7.7 2.5 10.2 12.2 5.9 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005135-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.7;lymphoid tissue: 9.7" "Cell type enhanced" "Detected in many" "dendritic cells: 256.1;granulocytes: 317.8;Kupffer cells: 112.5;monocytes: 90.9;NK-cells: 319.3;T-cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 5.7;HEL: 6.2;HL-60: 7.5;HMC-1: 9.0;RH-30: 11.5" "Not detected" "Not detected" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 2.0 1.1 0.5 9.2 0.8 12.7 0.9 0.6 0.8 1.1 0.7 1.2 1.6 0.7 0.4 0.9 0.7 2.8 0.6 0.4 1.7 0.8 2.7 4.4 8.9 1.5 0.9 0.3 0.3 0.4 0.4 0.4 1.8 1.5 0.8 1.5 0.1 0.7 0.5 0.2 0.3 2.5 2.3 1.3 9.7 1.6 0.6 1.2 4.3 0.4 0.5 6.7 3.5 0.5 1.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.2 7.5 9.0 0.3 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 39.0 19.8 43.6 33.8 28.4 62.4 9.3 16.9 26.2 13.0 8.1 8.6 19.4 15.2 49.1 32.1 5.9 9.0 24.5 0.5 0.8 0.6 0.8 0.4 1.7 1.5 0.9 0.3 1.5 1.3 1.2 1.8 2.9 3.2 21.6 0.3 77.8 4.2 0.5 0.0 0.0 0.2 1.9 3.2 0.4 7.2 1.3 0.0 0.0 0.2 256.1 0.5 0.0 0.0 9.1 0.2 0.4 2.1 0.0 6.6 0.0 0.0 0.3 2.3 6.6 0.5 317.8 0.0 3.9 1.4 62.8 0.0 0.0 0.6 0.0 112.5 73.1 1.4 0.6 88.6 3.6 4.7 90.9 0.0 319.3 0.0 0.1 0.0 0.0 0.0 25.6 0.2 0.1 0.3 0.7 0.2 0.0 0.9 2.0 0.1 0.1 0.7 5.3 0.4 192.8 0.9 0.4 0.2 PTGR2 "FLJ39091, ZADH1" ENSG00000140043 "Prostaglandin reductase 2" Q8N8N7 14 73851844-73886827 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 41.9" HPA001125 Approved Approved Vesicles NA NA 36000 Vesicles "HPA001125: AB_2666207" "unprognostic (3.82e-2)" "unprognostic (2.79e-2)" "unprognostic (6.05e-2)" "unprognostic (3.26e-1)" "unprognostic (2.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (2.80e-1)" "unprognostic (8.10e-3)" "unprognostic (6.99e-3)" "unprognostic (5.96e-1)" "prognostic favorable (4.55e-12)" "unprognostic (4.42e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" 6.9 12.3 10.6 2.8 11.4 0.9 9.2 11.4 12.2 4.9 11.3 7.2 12.3 4.6 17.4 5.0 12.1 5.2 27.3 9.9 12.1 19.1 19.2 5.6 3.1 11.6 11.6 9.1 7.5 5.3 10.7 7.7 2.4 11.9 9.2 5.8 10.8 6.8 5.5 33.1 7.0 9.0 2.6 11.4 3.4 6.2 6.3 11.3 3.0 12.7 32.4 2.6 4.2 4.2 14.1 8.9 11.9 9.6 4.7 7.6 16.3 7.6 3.0 4.1 3.6 5.6 6.8 21.2 0.9 6.8 3.0 8.4 8.8 8.7 6.5 6.6 6.7 4.1 6.2 5.5 3.0 3.8 2.3 2.2 7.7 15.1 5.5 4.4 7.8 1.8 6.1 8.3 1.8 8.2 12.7 6.2 5.9 10.7 11.9 11.6 7.6 3.7 1.5 19.7 8.6 12.7 11.0 7.7 8.1 9.8 9.1 41.9 3.7 2.7 5.3 10.0 3.9 6.6 10.2 4.7 2.8 8.3 5.5 7.2 6.7 1.1 0.9 0.6 0.4 0.6 1.0 1.1 0.5 1.3 1.0 1.8 1.5 0.8 1.3 1.2 1.5 1.1 1.0 10.6 11.4 11.4 12.2 9.9 12.1 11.6 11.6 9.1 11.9 11.4 11.3 14.1 4.5 19.2 13.0 10.7 2.9 6.8 12.8 16.7 6.2 8.9 8.4 5.5 43.2 8.6 12.9 18.4 14.6 6.3 2.0 8.6 25.4 11.7 2.4 21.5 5.8 5.2 4.8 4.2 8.0 8.7 2.5 6.1 5.1 7.3 3.8 9.3 3.3 14.3 7.4 33.7 10.3 10.0 10.2 5.5 3.1 2.0 7.2 4.3 8.8 5.6 4.0 22.3 6.2 7.1 20.4 8.7 11.1 6.8 2.9 7.2 24.8 18.4 31.6 20.8 6.6 9.9 6.1 42.1 18.8 3.5 6.7 4.0 2.9 17.3 11.7 7.7 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 70.7;Kupffer cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2" "Cell line enhanced" "Detected in many" "HHSteC: 167.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA059511: AB_2684046" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 53.2 20.2 28.1 29.5 22.8 79.4 40.5 23.2 25.5 28.8 20.8 29.4 22.7 22.9 3.8 25.6 28.7 28.0 37.4 26.2 22.9 18.1 20.6 47.6 13.2 25.9 22.1 17.4 21.8 23.3 8.2 17.4 17.6 25.6 22.0 11.4 16.6 24.4 15.2 22.1 29.3 30.4 21.1 24.9 67.3 23.6 4.8 26.8 4.8 25.3 16.8 10.7 25.5 31.9 27.8 15.5 13.5 2.5 26.8 81.5 60.2 90.5 47.5 51.0 30.4 38.1 33.0 13.5 12.4 23.5 90.7 5.6 59.5 16.7 16.2 13.1 16.7 1.9 17.0 26.0 11.9 167.1 24.1 1.3 106.5 95.2 12.4 30.6 11.9 1.5 13.8 2.2 23.0 27.7 76.4 1.4 39.8 9.1 30.4 8.7 8.2 0.3 34.0 14.8 8.6 2.1 10.4 48.9 69.4 55.1 29.7 66.4 52.1 6.2 38.1 57.5 2.4 7.0 18.7 6.0 28.8 11.5 90.0 19.1 0.1 4.5 4.4 0.0 8.1 0.0 11.8 0.2 0.0 2.4 5.1 0.0 0.0 7.7 0.1 13.2 2.1 0.2 1.4 28.1 22.8 23.2 25.5 26.2 22.9 25.9 22.1 17.4 25.6 24.9 26.8 27.8 70.7 12.8 33.5 26.8 9.9 16.4 6.0 5.8 19.9 21.8 26.2 18.2 17.7 12.8 8.1 9.2 10.4 1.4 1.2 20.0 0.0 2.4 0.3 21.6 18.4 21.2 5.4 0.8 18.9 6.6 5.6 49.5 10.2 23.9 2.5 10.1 10.4 8.5 9.7 8.4 20.8 14.9 4.1 87.7 25.7 1.5 18.0 47.3 12.4 14.0 13.8 38.6 2.1 18.1 3.0 8.5 8.2 16.6 9.8 2.6 17.7 3.0 7.4 31.1 6.6 47.2 19.5 0.1 0.9 19.7 8.9 0.3 2.2 5.3 8.7 11.5 AK7 "CFAP75, FAP75, FLJ32864" ENSG00000140057 "Adenylate kinase 7" Q96M32 14 96392128-96489427 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.5" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "basophil: 9.0" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003543 Enhanced NA NA "HPA003543: AB_1078117" "unprognostic (4.18e-3)" "unprognostic (1.14e-1)" "unprognostic (9.40e-3)" "prognostic favorable (3.18e-4)" "unprognostic (4.98e-5)" "unprognostic (8.41e-2)" "unprognostic (9.81e-3)" "unprognostic (1.29e-1)" "unprognostic (9.02e-2)" "unprognostic (3.65e-4)" "unprognostic (8.64e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.00e-2)" "unprognostic (1.23e-2)" "unprognostic (4.01e-2)" "unprognostic (2.25e-3)" 0.7 2.6 5.4 0.6 3.3 1.5 1.5 2.7 2.2 1.7 11.2 2.1 1.9 2.1 3.9 1.6 24.5 2.7 0.7 2.2 5.4 4.6 1.6 4.2 0.6 6.1 6.2 1.5 0.4 2.2 7.0 5.2 0.5 5.4 0.9 1.6 3.0 1.0 1.3 0.3 6.1 1.2 1.1 5.4 3.3 2.8 7.7 3.6 0.5 2.7 0.0 0.4 0.5 1.0 4.5 0.2 4.9 2.0 1.5 0.8 2.6 17.0 0.3 0.6 0.3 0.3 0.5 15.1 0.4 0.3 0.0 0.3 1.9 4.7 0.2 0.1 2.2 0.4 0.4 2.4 0.2 0.8 0.1 0.3 0.2 0.6 2.5 0.1 0.8 0.2 1.4 0.2 0.3 0.3 49.5 0.3 0.3 0.8 2.2 1.0 35.2 0.3 0.4 7.6 0.3 3.1 6.7 1.9 0.6 0.1 1.8 4.2 0.2 0.1 0.4 0.2 0.6 0.2 0.6 2.3 0.2 0.2 0.0 0.7 9.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.1 5.4 3.3 2.7 2.2 2.2 5.4 6.1 6.2 1.5 5.4 5.4 3.6 4.5 1.6 6.4 4.1 0.7 0.8 1.8 0.9 3.6 1.8 0.2 0.9 0.3 0.4 4.3 12.3 7.3 2.1 0.7 0.1 1.4 3.9 3.2 18.7 97.9 1.7 1.9 1.2 6.9 2.0 1.1 1.7 0.8 5.1 11.6 0.0 0.1 0.7 2.4 0.2 0.0 2.4 0.3 4.1 0.3 0.4 4.1 0.0 0.5 1.8 0.0 0.0 0.6 0.0 0.5 3.7 0.5 0.1 0.0 0.0 0.5 1.0 3.4 137.1 1.8 0.0 0.4 1.6 25.4 9.1 0.7 3.0 2.9 0.2 1.5 1.2 0.6 FAM181A C14orf152 ENSG00000140067 "Family with sequence similarity 181 member A" Q8N9Y4 14 93918894-93929608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 9.1;testis: 32.8" "Group enriched" "Detected in some" 4 "Early spermatids: 48.9;Spermatocytes: 35.4" "Group enriched" "Detected in some" 6 "endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "AF22: 4.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 31.9" HPA001603 Enhanced NA NA "HPA001603: AB_1078326" "unprognostic (8.19e-2)" "unprognostic (6.78e-2)" "unprognostic (1.28e-2)" "unprognostic (1.31e-1)" "unprognostic (2.05e-2)" "unprognostic (1.84e-2)" "unprognostic (6.27e-2)" "unprognostic (4.44e-2)" "unprognostic (5.37e-2)" 0.0 0.0 5.5 0.0 5.1 0.0 0.0 5.6 7.6 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.9 9.1 0.0 0.0 0.9 0.0 6.8 5.3 4.5 0.0 0.0 0.0 2.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 6.0 0.0 0.0 32.8 5.5 0.0 1.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 5.1 5.6 7.6 4.9 9.1 6.8 5.3 4.5 5.8 6.0 5.5 5.5 0.0 3.2 3.1 8.8 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.4 0.4 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.9 6.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.7 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.1 35.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501481 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;choroid plexus: 76.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 251.6;Cone photoreceptor cells: 200.1" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 11.1;intermediate monocyte: 14.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 5 "monocytes: 14.7" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063206 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA063206: " "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 0.5 0.2 7.4 1.4 10.4 3.6 0.1 19.4 6.7 0.2 76.6 0.2 0.2 0.1 0.1 0.2 0.2 0.6 0.2 7.8 5.0 0.0 0.1 0.8 1.2 19.8 13.3 4.0 0.2 0.1 0.0 1.4 0.3 20.0 0.2 0.2 12.5 0.1 0.3 0.8 0.1 0.3 0.4 13.1 2.7 0.1 1.1 12.1 0.4 0.1 1.0 0.4 0.3 0.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 0.0 0.0 14.7 0.2 0.0 0.0 0.0 3.0 0.1 0.0 0.0 1.5 0.1 11.6 0.5 0.0 2.7 7.4 10.4 19.4 6.7 7.8 5.0 19.8 13.3 4.0 20.0 13.1 12.1 13.3 0.8 0.0 1.9 47.0 0.4 0.0 0.1 0.0 0.0 251.6 0.3 0.1 1.8 0.0 0.0 0.0 200.1 0.0 0.1 0.0 0.0 0.0 4.0 0.5 0.1 0.9 0.0 0.8 19.9 0.0 0.1 0.5 0.0 0.8 0.0 0.0 1.1 0.0 4.0 0.0 28.5 0.0 0.0 22.2 1.8 5.6 0.3 16.6 0.0 2.8 44.3 4.1 1.0 10.1 1.3 0.1 0.0 0.4 0.1 0.2 0.0 0.2 0.7 10.6 0.0 9.9 0.2 0.1 1.6 0.0 0.0 0.3 0.3 0.0 0.0 0.1 FBLN5 "ARMD3, DANCE, EVEC, UP50" ENSG00000140092 "Fibulin 5" Q9UBX5 14 91869411-91947987 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 6.6" "Group enriched" "Detected in many" 19 "granulocytes: 6.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000848, HPA000868, CAB025843" Supported Uncertain "Plasma membrane" "Secreted to extracellular matrix" NA NA 12000000 "Plasma membrane" "CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619" "unprognostic (5.53e-3)" "unprognostic (1.14e-1)" "unprognostic (7.78e-2)" "unprognostic (9.29e-2)" "unprognostic (5.55e-3)" "unprognostic (4.73e-2)" "prognostic favorable (6.75e-4)" "unprognostic (5.21e-3)" "unprognostic (4.76e-2)" "unprognostic (1.25e-2)" "unprognostic (3.74e-2)" "unprognostic (1.90e-1)" "unprognostic (7.26e-2)" "unprognostic (1.56e-3)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (3.17e-3)" 150.4 74.1 10.4 17.9 12.4 7.6 111.4 7.6 21.1 120.0 33.3 69.0 19.3 179.9 40.4 27.0 144.3 131.4 147.1 8.7 11.3 109.4 29.6 166.2 25.7 17.1 9.7 8.4 108.2 46.7 17.0 14.6 67.6 13.9 49.4 20.8 0.6 56.3 71.6 30.6 61.1 53.2 89.5 13.5 131.9 69.4 35.8 10.6 22.0 80.2 36.3 15.8 118.5 94.1 7.5 0.0 1.6 0.2 0.0 457.1 234.6 22.5 202.0 202.5 5.8 4.5 4.7 0.0 0.0 4.2 394.6 0.6 0.1 9.8 1.0 1.0 0.0 2.3 0.4 4.7 0.0 74.2 0.0 0.1 216.6 0.4 3.9 14.1 2.8 10.4 0.1 0.0 0.1 25.3 0.4 0.5 0.5 0.5 0.0 0.5 0.4 30.2 0.2 1.2 0.1 0.2 0.1 12.3 0.7 2.6 7.0 2.9 0.3 1.9 3.2 6.6 3.8 0.1 0.1 0.0 0.2 0.4 0.0 0.0 6.6 0.1 2.2 0.8 0.2 0.5 0.0 0.3 0.1 0.0 0.1 1.1 1.8 2.5 0.0 0.2 0.0 0.1 0.4 10.4 12.4 7.6 21.1 8.7 11.3 17.1 9.7 8.4 13.9 13.5 10.6 7.5 31.4 83.3 13.1 0.0 2.1 9.2 2.4 7.1 1.8 0.0 11.2 9.3 5.2 0.0 11.5 5.5 0.0 2.5 2.5 0.1 5.9 4.7 5.9 13.3 67.4 15.2 0.0 0.4 2.6 4.7 2.5 209.4 2.0 12.0 2.5 1.8 34.2 0.4 7.8 0.0 3.6 0.1 18.3 2.5 18.4 27.5 626.6 5.8 21.4 15.9 1.6 0.0 8.2 5.0 2.3 2.2 0.0 794.8 0.7 1.3 0.0 32.5 21.4 0.0 6.6 28.0 14.5 3.0 2.8 1.3 8.7 3.7 15.5 3.5 0.4 1.2 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280460-94293268 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 104 "liver: 349.8" "Cell type enriched" "Detected in some" 17 "Hepatocytes: 259.1" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 21.2" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 3960000000 4700000000 Nucleoplasm Cytosol "HPA048739: AB_2797237" "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.4 0.4 0.5 0.6 0.9 3.3 0.7 3.3 1.5 0.5 0.4 0.7 0.7 0.7 0.5 0.4 0.3 0.5 0.6 0.5 0.6 0.5 349.8 0.4 0.8 1.8 0.9 0.0 0.9 0.5 0.2 0.2 0.5 1.4 0.4 0.7 3.1 0.4 0.4 0.5 1.7 0.7 0.6 0.3 0.7 0.7 0.6 0.9 1.3 0.7 0.4 0.4 0.2 0.1 2.1 0.6 0.2 1.8 0.7 0.7 0.6 0.4 0.5 0.5 0.9 0.8 2.7 0.6 2.1 0.3 0.4 0.2 0.4 2.2 0.5 1.3 0.8 1.4 2.0 0.8 21.2 0.4 1.6 1.1 0.6 0.5 0.3 0.7 1.1 1.0 1.1 0.5 1.3 1.0 0.3 1.4 0.8 0.8 0.2 0.6 0.9 1.2 0.9 0.5 0.7 0.9 0.8 0.4 0.4 0.2 1.0 0.9 0.9 0.6 0.7 0.4 0.7 0.6 1.1 0.5 0.9 0.9 1.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.3 1.5 0.5 0.6 1.8 0.9 0.0 1.4 0.3 0.9 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 2.8 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 6.6 8.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 3.3 259.1 0.0 0.0 0.0 0.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 3.5 7.8 6.9 1.3 5.7 1.6 5.8 3.4 5.9 6.9 9.1 5.2 1.7 7.7 11.6 7.9 15.0 3.5 2.9 5.8 6.4 13.0 7.0 5.8 1.5 4.9 5.7 5.9 7.1 14.5 9.4 21.8 1.8 3.8 9.7 2.6 3.2 8.2 6.2 1.8 7.6 3.1 3.3 4.7 3.2 6.0 24.1 5.2 1.4 18.4 1.2 1.2 6.0 5.4 4.3 5.1 8.9 2.7 8.3 2.6 3.8 4.1 4.0 3.7 4.7 2.1 0.8 8.7 0.5 8.3 4.0 2.5 10.9 1.0 6.0 3.0 4.2 3.2 0.3 8.9 0.4 9.2 2.3 2.2 2.3 13.6 5.1 10.1 8.0 2.7 4.2 3.1 1.4 2.8 17.5 0.9 6.6 3.4 5.0 8.5 3.2 1.5 2.9 10.4 2.9 17.1 8.9 5.7 2.5 5.0 1.7 18.0 3.1 3.0 5.9 2.7 12.0 3.1 1.6 1.1 0.5 7.6 0.7 4.2 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.1 0.1 6.9 5.7 3.4 5.9 5.8 6.4 4.9 5.7 5.9 3.8 4.7 5.2 4.3 1.0 16.0 3.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 7.4 7.4 0.0 0.0 2.5 16.5 0.0 1.8 0.4 0.0 3.9 7.9 0.0 29.9 8.1 0.9 0.0 0.0 0.0 1.3 0.8 1.3 0.0 8.8 2.5 3.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 6.5 19.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.4 6.5 0.0 0.0 WARS1 "IFI53, IFP53, WARS" ENSG00000140105 "Tryptophanyl-tRNA synthetase 1" P23381 14 100333790-100376805 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 327.1" "Cell type enhanced" "Detected in some" "Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 1345.3;non-classical monocyte: 1608.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 908.5;SK-MEL-30: 1012.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005573, HPA018944" Enhanced Enhanced Cytosol No No 49000000 Cytosol "HPA005573: AB_2667366, HPA018944: AB_2669986" "unprognostic (5.36e-2)" "unprognostic (5.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.54e-1)" "unprognostic (2.30e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.14e-2)" "unprognostic (4.26e-2)" "prognostic favorable (1.94e-4)" "unprognostic (4.84e-2)" "unprognostic (3.21e-1)" "unprognostic (3.53e-3)" "unprognostic (1.37e-1)" "unprognostic (9.45e-2)" "unprognostic (1.62e-1)" "unprognostic (5.92e-3)" 92.9 68.5 46.7 187.3 43.8 71.2 65.9 40.2 46.2 36.2 45.6 68.5 45.2 39.9 70.9 54.8 51.2 49.2 115.2 42.7 79.8 66.8 48.3 209.3 140.1 60.1 49.9 38.4 21.4 47.9 39.5 63.9 327.1 58.6 49.5 72.8 38.1 49.9 38.7 75.4 27.0 68.3 76.9 42.2 111.6 70.8 68.3 52.3 62.3 161.3 67.6 86.9 108.7 31.0 55.4 91.2 85.7 54.6 319.1 78.7 110.7 87.3 117.4 220.7 232.1 301.4 57.4 80.2 101.7 105.5 277.4 59.7 151.1 158.8 130.3 153.1 154.4 48.3 64.1 60.9 72.3 908.5 184.9 101.6 126.9 186.9 141.3 290.1 74.5 225.0 66.1 202.8 255.0 107.5 178.0 64.3 87.1 55.4 94.1 152.2 51.4 86.5 64.9 119.3 80.8 145.7 84.9 69.4 58.7 1012.4 70.5 153.6 234.7 153.1 25.7 58.9 269.2 61.3 446.4 277.1 191.9 295.0 144.2 205.5 96.5 471.7 610.4 41.5 1345.3 38.4 71.4 34.5 38.4 337.9 68.0 24.8 28.6 170.9 44.5 1608.2 54.7 44.8 672.7 46.7 43.8 40.2 46.2 42.7 79.8 60.1 49.9 38.4 58.6 42.2 52.3 55.4 66.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 16.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 11.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 16.6 0.5 0.0 0.0 0.0 SLC25A47 C14orf68 ENSG00000140107 "Solute carrier family 25 member 47" Q6Q0C1 14 100323339-100330421 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 366 "liver: 539.1" "Cell type enriched" "Detected in some" 40 "Hepatocytes: 270.2" "Cancer enriched" "Detected in single" 273 "liver cancer: 56.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" NA NA "unprognostic (2.54e-3)" "unprognostic (2.57e-3)" "unprognostic (5.12e-2)" "unprognostic (2.27e-2)" "unprognostic (6.07e-2)" "unprognostic (1.30e-2)" "unprognostic (4.25e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (1.96e-3)" "unprognostic (4.46e-1)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-2)" "unprognostic (1.94e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.4 539.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.9 270.2 0.0 0.0 0.0 0.6 0.0 6.7 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 3.5 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.1 WDR20 "DMR, FLJ33659, MGC33177" ENSG00000140153 "WD repeat domain 20" Q8TBZ3 14 102139503-102224847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 241.9;Late spermatids: 250.6;Oligodendrocytes: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.59e-2)" "unprognostic (1.00e-1)" "unprognostic (8.45e-2)" "unprognostic (7.70e-2)" "unprognostic (5.48e-2)" "unprognostic (5.14e-2)" "unprognostic (2.43e-2)" "unprognostic (3.96e-2)" "unprognostic (1.78e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (3.26e-2)" "prognostic favorable (3.26e-9)" "unprognostic (6.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.68e-2)" "unprognostic (1.41e-2)" 12.0 17.1 11.1 9.5 16.0 10.8 11.8 18.3 14.4 11.1 12.2 10.9 16.2 10.4 12.1 13.6 10.8 9.0 10.1 11.9 13.0 12.6 11.0 8.9 11.6 15.8 13.9 10.5 12.4 12.4 12.0 10.6 10.0 16.2 10.3 10.6 30.1 11.5 7.5 11.9 16.0 13.2 9.2 13.0 10.4 10.7 24.1 14.1 12.4 14.3 13.1 10.8 10.5 12.2 28.6 16.2 20.6 14.6 13.0 16.4 14.3 19.2 19.8 16.4 21.9 17.7 17.6 15.2 17.7 12.9 18.6 11.9 19.3 21.6 17.8 27.7 25.0 9.8 9.3 14.8 19.4 12.6 14.4 16.1 11.2 16.7 15.8 15.5 22.0 15.4 14.2 12.3 18.6 23.9 37.2 13.3 21.8 13.0 22.3 22.7 13.3 14.5 11.9 31.8 25.4 18.4 20.8 17.3 22.2 13.9 16.2 24.1 13.8 17.0 20.3 9.3 32.2 18.7 14.6 21.9 18.8 18.5 11.7 22.2 28.5 20.7 37.7 25.8 21.2 27.0 27.6 28.4 24.2 21.0 19.9 28.9 27.4 40.2 30.4 21.4 12.4 33.6 21.0 11.1 16.0 18.3 14.4 11.9 13.0 15.8 13.9 10.5 16.2 13.0 14.1 28.6 17.5 9.6 14.5 48.6 21.0 25.1 15.4 19.6 16.5 20.5 16.3 12.7 10.4 10.0 16.7 11.0 16.7 25.6 22.8 19.6 21.5 17.9 241.9 20.1 14.5 12.9 11.4 25.0 43.3 17.3 19.4 15.6 14.3 21.1 22.9 15.0 15.0 12.7 13.4 33.7 42.9 12.8 18.3 10.4 13.8 250.6 13.1 12.9 21.4 48.7 15.6 23.8 22.6 68.9 201.5 18.9 17.6 15.1 17.4 19.0 27.5 25.1 15.6 54.6 13.1 18.6 17.4 43.0 25.3 16.4 27.4 34.9 22.3 8.7 12.1 21.7 NIPA2 SLC57A2 ENSG00000140157 "NIPA magnesium transporter 2" Q8N8Q9 15 22838644-22869362 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA067160: AB_2685794, HPA071342: AB_2686391" "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 24.2 27.2 16.6 35.3 16.4 30.8 21.0 15.8 17.9 21.4 19.2 40.9 40.1 21.3 18.6 25.7 17.3 24.9 19.1 16.7 18.3 31.3 27.6 23.2 36.6 16.4 18.2 14.9 15.1 24.4 25.7 18.6 28.9 17.2 26.7 39.2 16.0 26.8 17.2 27.7 15.0 36.0 24.6 18.1 27.4 28.8 17.1 17.5 28.9 27.1 27.4 43.2 35.1 15.4 17.1 103.6 103.7 51.7 61.7 55.9 58.1 57.3 117.3 99.1 78.4 90.4 76.5 64.3 101.0 70.6 71.7 88.6 82.6 99.9 58.3 77.3 109.7 61.0 89.9 66.4 61.2 72.3 127.0 81.8 54.9 61.2 64.2 65.5 51.6 87.7 79.2 137.4 117.1 99.8 39.2 40.1 56.0 60.2 109.9 99.9 88.3 87.0 74.9 71.6 120.9 69.4 71.7 95.6 84.8 98.9 48.4 74.4 114.3 91.4 104.0 65.6 73.2 237.5 90.0 153.3 107.4 76.3 129.9 88.2 72.1 44.5 38.9 41.1 55.4 46.9 76.3 36.9 45.4 54.9 67.1 34.2 34.6 32.7 48.6 55.7 82.0 52.8 49.2 16.6 16.4 15.8 17.9 16.7 18.3 16.4 18.2 14.9 17.2 18.1 17.5 17.1 26.0 16.0 23.1 10.7 62.9 45.0 41.3 26.1 20.5 9.4 25.2 16.5 3.8 22.8 25.0 12.9 12.5 39.9 45.0 53.7 21.5 39.6 10.7 21.7 24.5 28.5 24.4 29.2 14.7 43.8 65.4 23.4 26.0 27.6 10.1 26.2 22.9 22.1 48.3 21.9 15.4 30.2 38.7 30.3 41.3 3.3 13.4 35.5 23.2 14.0 31.4 27.3 35.0 9.5 13.3 57.8 31.1 21.1 60.8 56.5 31.8 23.3 20.6 13.0 13.1 17.6 28.6 32.8 35.2 28.8 57.8 84.4 37.3 38.7 38.1 89.7 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229784-34338060 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 15.2;neutrophil: 23.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.4" "Cell line enhanced" "Detected in many" "HaCaT: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favorable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 6.4 4.1 6.6 11.6 7.8 27.1 5.5 7.3 8.2 8.1 3.7 5.5 7.4 5.3 7.1 19.0 4.6 5.3 6.3 6.9 7.5 16.0 3.9 9.2 10.2 9.1 7.8 6.6 4.2 3.5 3.1 5.7 4.3 9.5 3.5 6.1 31.4 6.4 3.9 10.7 7.7 9.2 4.9 7.2 13.0 6.8 26.1 8.0 15.7 9.0 11.0 11.7 8.3 17.7 9.4 4.4 5.2 3.1 4.7 10.0 11.4 2.4 5.9 15.1 4.9 7.1 3.1 7.2 3.1 5.9 7.2 4.3 44.0 7.9 5.3 5.8 1.2 5.1 24.6 14.0 7.0 6.4 14.5 24.6 6.9 9.1 14.1 29.1 10.9 14.9 6.8 5.4 6.8 6.7 1.6 1.6 11.0 2.4 3.8 5.7 7.1 5.5 3.3 5.5 11.2 7.2 5.0 7.1 0.2 1.5 7.1 2.8 4.8 9.4 5.9 4.2 21.0 1.4 6.4 6.8 1.9 6.6 10.5 2.2 15.2 1.4 2.6 0.6 1.8 0.4 1.4 0.9 0.9 0.9 2.4 1.6 1.4 23.4 0.7 0.8 1.0 3.2 1.0 6.6 7.8 7.3 8.2 6.9 7.5 9.1 7.8 6.6 9.5 7.2 8.0 9.4 16.4 22.4 21.0 30.0 32.0 1.1 4.5 1.5 7.4 15.3 5.2 4.3 8.7 5.7 4.2 5.5 85.5 3.2 11.5 8.6 0.0 5.6 15.6 9.8 7.4 17.7 6.7 35.9 47.7 4.7 1.6 7.0 17.9 22.4 5.1 8.4 16.1 7.5 13.2 8.4 52.0 7.0 2.0 37.1 3.8 8.3 8.1 25.6 0.0 50.6 34.5 8.7 15.5 40.7 58.4 13.1 9.7 8.6 29.9 6.5 18.3 16.4 4.2 56.6 19.7 7.0 4.0 39.9 21.2 14.8 0.9 1.1 18.0 4.1 7.4 43.6 DUOXA1 "FLJ32334, mol, NIP, NUMBIP" ENSG00000140254 "Dual oxidase maturation factor 1" Q1HG43 15 45117367-45129938 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 190.5;skin 1: 92.3;thyroid gland: 112.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041578 Approved NA NA "HPA041578: AB_10795691" "unprognostic (1.28e-1)" "unprognostic (1.32e-3)" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (2.71e-1)" "unprognostic (6.87e-3)" "unprognostic (1.03e-1)" "unprognostic (4.45e-2)" "unprognostic (6.69e-2)" "unprognostic (3.68e-2)" "unprognostic (5.82e-2)" "unprognostic (1.86e-1)" "unprognostic (2.17e-5)" "unprognostic (8.11e-2)" "unprognostic (1.12e-2)" "unprognostic (4.69e-2)" "unprognostic (5.36e-2)" 1.0 5.1 0.2 1.3 0.6 0.1 4.0 0.7 1.2 23.7 0.0 0.9 0.8 4.6 49.7 190.5 5.7 4.4 1.5 0.5 0.6 0.5 0.3 64.9 0.1 0.6 0.3 0.2 1.1 0.4 5.0 0.8 0.8 1.0 21.8 0.5 0.1 27.7 12.1 0.5 92.3 0.8 0.2 0.2 0.1 44.0 0.2 0.4 0.7 112.0 0.0 18.1 23.5 78.0 3.0 10.6 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 103.9 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 14.5 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.7 1.2 0.5 0.6 0.6 0.3 0.2 1.0 0.2 0.4 3.0 0.0 60.9 118.0 1.0 0.0 9.4 18.8 26.9 18.2 0.6 1.4 1.7 0.5 0.0 35.5 0.0 2.1 2.4 0.0 3.3 0.0 2.0 0.1 28.7 4.0 0.8 3.0 0.0 0.7 3.1 0.1 1.6 8.6 47.7 1.3 0.3 0.0 0.0 0.3 0.0 0.4 0.1 4.1 0.0 1.2 0.0 0.3 0.8 0.0 0.0 0.6 0.1 0.0 0.5 1.8 1.9 3.3 0.0 0.0 13.4 0.0 0.0 36.9 0.1 0.0 0.7 1.1 0.0 0.9 53.6 21.9 3.0 0.6 0.1 0.4 44.2 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824690 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favorable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 16.0 24.2 18.3 17.7 18.8 13.1 21.6 22.0 23.4 16.3 19.8 17.2 14.6 18.9 23.6 22.4 18.6 15.1 20.5 18.3 20.0 23.9 18.2 15.4 26.9 19.2 18.5 17.1 25.0 15.4 33.4 14.7 23.4 19.5 23.0 18.3 25.2 17.2 17.9 26.6 20.7 15.1 19.2 18.5 17.3 16.9 19.5 19.1 24.6 25.0 23.4 32.7 20.8 17.6 21.5 40.1 41.0 69.4 46.0 57.9 36.3 42.7 63.1 43.8 50.3 58.2 64.1 25.6 42.8 58.7 39.4 50.9 70.8 62.5 51.7 58.9 72.9 37.6 103.7 71.6 48.5 45.4 62.3 53.2 34.1 55.3 48.0 43.3 48.0 49.8 48.3 95.8 35.7 60.9 30.0 51.1 47.0 49.2 74.2 35.4 73.9 69.6 27.6 52.0 59.0 43.8 43.0 55.6 47.0 27.0 55.2 70.7 39.5 47.4 50.6 35.8 56.3 51.7 43.5 112.2 91.8 42.5 58.4 37.9 42.5 25.5 56.9 35.3 34.8 34.7 35.0 35.1 33.6 32.6 28.3 35.7 35.0 22.6 50.5 29.1 26.8 44.1 26.3 18.3 18.8 22.0 23.4 18.3 20.0 19.2 18.5 17.1 19.5 18.5 19.1 21.5 30.4 35.3 30.2 5.2 32.8 30.3 59.6 50.1 35.9 41.8 22.4 28.8 31.0 25.8 43.2 51.5 6.2 94.6 33.2 27.4 56.7 44.2 6.2 43.1 39.9 35.6 11.3 32.0 9.0 29.4 55.0 29.8 21.4 39.4 46.3 37.6 20.7 18.8 35.4 32.0 8.6 24.4 38.7 20.7 20.5 6.3 28.0 25.5 26.6 5.6 30.6 51.5 33.0 2.0 8.2 26.8 27.1 35.7 20.6 39.3 22.1 42.9 60.0 35.2 19.7 35.9 41.7 49.7 84.8 28.1 27.7 147.4 33.6 39.4 21.3 50.6 TCF12 "bHLHb20, HEB, HsT17266, HTF4, p64" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 26.3 21.7 27.7 23.6 43.8 21.4 29.8 36.6 30.6 76.3 19.8 26.9 28.7 48.3 24.5 26.9 46.7 37.4 22.0 30.0 34.9 28.7 25.2 29.2 26.2 38.1 39.3 21.6 43.7 19.9 44.3 11.6 33.7 37.3 32.3 30.6 29.7 23.5 28.6 20.6 21.5 28.6 44.4 37.4 25.2 25.8 27.6 36.3 134.2 29.3 26.8 28.3 31.5 22.6 56.4 25.4 50.8 204.5 70.6 90.0 79.0 36.1 52.2 89.6 45.1 58.9 34.0 20.3 35.5 42.3 78.3 33.4 30.4 84.3 37.3 56.7 47.5 29.8 71.7 52.7 40.4 62.4 46.1 36.1 69.4 66.2 42.9 112.2 60.1 81.0 163.0 81.7 46.8 61.8 9.5 109.4 25.0 57.5 26.4 20.9 143.2 234.9 33.9 61.5 53.1 43.6 121.2 58.7 21.0 52.0 65.3 33.6 93.9 63.2 75.5 57.5 32.2 78.2 24.6 49.7 59.4 40.8 86.3 90.9 27.4 13.8 11.3 17.4 17.9 14.3 13.4 14.0 16.5 20.0 14.7 16.2 14.8 1.5 16.8 26.3 8.4 23.0 14.1 27.7 43.8 36.6 30.6 30.0 34.9 38.1 39.3 21.6 37.3 37.4 36.3 56.4 35.5 54.5 19.6 212.9 37.7 26.6 20.6 14.2 44.9 13.8 24.0 20.4 19.3 14.3 21.2 16.5 35.5 10.4 20.6 17.0 13.7 16.0 23.7 25.9 148.0 38.2 9.0 34.9 117.7 11.8 15.5 42.3 52.0 33.3 23.4 26.9 25.7 18.2 27.5 13.5 319.8 16.8 10.2 38.1 30.0 19.9 25.7 33.0 14.2 440.3 17.4 29.0 18.6 618.3 1512.7 15.9 18.4 34.6 29.1 23.4 20.0 15.3 15.9 23.3 46.0 39.9 36.5 22.2 15.0 33.6 33.8 13.0 28.4 16.5 20.1 18.2 SORD ENSG00000140263 "Sorbitol dehydrogenase" Q00796 15 45023147-45077185 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 165.2;liver: 249.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2" "Group enriched" "Detected in all" 4 "liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "basophil: 86.3;eosinophil: 55.9" "Lineage enriched" "Detected in all" 12 "granulocytes: 86.3" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040260, HPA040621" Enhanced Approved Cytosol NA NA 2800000 Cytosol "HPA040260: AB_10794872, HPA040621: AB_10795384" "unprognostic (8.18e-2)" "unprognostic (7.58e-2)" "unprognostic (8.19e-2)" "unprognostic (1.51e-1)" "unprognostic (5.69e-3)" "unprognostic (3.90e-2)" "prognostic favorable (6.14e-5)" "unprognostic (3.33e-3)" "unprognostic (1.67e-1)" "unprognostic (4.95e-2)" "unprognostic (7.04e-3)" "unprognostic (1.40e-1)" "unprognostic (4.26e-2)" "unprognostic (1.23e-2)" "unprognostic (8.53e-2)" "unprognostic (2.31e-2)" "unprognostic (1.56e-1)" 1.9 15.9 4.9 3.1 3.7 2.9 54.3 8.3 8.5 165.2 1.7 5.4 7.6 4.3 6.9 10.3 6.8 8.3 5.7 5.0 3.4 50.8 249.0 3.2 2.6 4.5 3.7 2.9 2.4 5.7 4.5 3.2 2.5 4.3 88.6 7.8 4.9 5.4 27.3 2.2 16.7 7.3 3.5 3.9 2.4 9.3 12.3 3.8 3.8 90.2 2.8 3.5 9.2 7.0 6.1 12.3 12.2 4.7 20.8 4.4 5.3 5.9 1.8 3.5 12.2 7.0 12.2 5.8 2.7 8.0 5.4 4.1 17.6 19.9 19.1 9.2 29.9 12.3 13.5 12.1 50.3 0.2 18.0 25.5 6.7 18.0 6.6 9.5 5.4 12.5 15.1 11.7 10.6 14.9 8.1 18.4 38.3 39.0 29.4 13.8 0.9 16.6 6.4 16.8 12.1 25.1 12.2 2.1 57.3 5.9 5.2 16.4 22.5 4.7 3.5 38.0 1.6 5.8 8.7 4.5 4.4 14.2 18.6 10.6 86.3 1.7 55.9 1.6 1.5 1.7 5.4 1.3 1.6 1.7 6.9 1.6 1.4 3.8 1.1 2.1 2.4 2.5 2.0 4.9 3.7 8.3 8.5 5.0 3.4 4.5 3.7 2.9 4.3 3.9 3.8 6.1 3.9 0.0 3.1 5.5 11.9 7.8 26.5 14.8 17.6 10.8 24.7 17.5 3.2 25.8 28.1 33.1 0.0 1.3 2.3 15.0 29.4 68.2 31.7 40.2 17.4 4.9 84.8 37.5 4.8 138.7 5.1 7.5 31.1 43.7 8.8 11.5 15.7 649.4 16.0 3.3 5.4 32.5 22.4 24.2 6.4 24.1 3.7 12.2 16.0 1.0 13.3 9.0 2.1 7.1 8.9 89.0 18.1 6.0 7.9 218.8 8.0 270.2 42.5 4.7 0.0 8.9 8.9 7.4 2.8 35.1 20.3 1.0 6.5 15.3 39.4 131.2 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 660.4 1076.1 649.5 450.8 663.0 953.2 624.7 693.1 913.4 620.3 910.8 683.8 447.4 514.2 783.0 895.1 460.8 473.6 1114.1 637.9 674.8 1003.9 1339.6 706.8 692.2 686.6 664.7 605.2 478.2 801.7 495.2 573.7 488.3 668.0 801.2 637.8 73.4 830.9 315.7 642.2 598.3 598.1 512.0 694.3 751.4 790.7 403.4 691.4 454.8 712.4 730.0 634.0 600.5 639.5 715.7 497.5 770.8 573.8 792.9 1963.2 1431.3 438.9 844.8 1042.5 540.4 682.7 991.5 470.0 250.4 694.7 1429.2 698.7 641.1 454.6 623.8 271.1 699.6 526.2 610.9 1074.9 1936.8 934.7 581.8 1235.8 1349.9 810.5 425.8 452.1 836.1 783.5 680.7 630.2 1593.5 1067.4 1441.8 758.6 1337.2 501.5 1849.7 885.1 743.9 382.6 1147.2 1462.5 1695.7 450.6 481.1 458.9 1871.5 463.9 488.4 1574.7 2363.9 682.9 920.0 469.0 1409.4 669.3 593.3 886.2 1837.8 989.2 1032.8 980.4 4033.8 5391.9 5884.9 2716.6 5055.2 2481.3 3853.8 2938.5 2784.5 4649.4 3901.8 2713.3 2731.7 3154.6 2568.8 4495.9 6486.5 3793.5 12856.7 649.5 663.0 693.1 913.4 637.9 674.8 686.6 664.7 605.2 668.0 694.3 691.4 715.7 1269.2 506.4 789.0 0.0 1149.8 1151.3 1379.1 3393.0 861.6 53.9 2373.1 2483.2 2229.8 1338.2 2099.5 1736.1 54.2 2660.9 1475.6 2388.2 3897.3 1707.6 576.8 1243.6 1343.1 1283.3 1167.5 1310.8 0.5 2255.2 3410.2 1489.3 1403.7 1261.0 785.9 775.2 1532.4 2884.5 3545.2 47.1 0.5 2862.6 2278.6 2262.1 2298.5 319.2 1225.3 2102.8 1817.8 0.0 2626.4 544.5 1881.6 1.5 0.3 1804.7 2363.9 992.2 1546.7 2188.9 3013.2 5083.6 1950.6 148.4 604.8 680.1 1737.3 750.2 381.1 1725.5 1556.5 3275.8 1216.9 1446.6 2042.5 2819.5 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 6.4 5.6 8.1 8.7 9.6 5.7 6.9 8.3 7.2 6.9 7.6 7.5 8.9 8.9 5.3 7.2 6.4 6.1 5.5 6.5 7.1 5.7 7.0 6.9 10.8 9.9 9.7 5.2 7.5 11.5 7.8 5.6 8.1 9.0 6.8 7.6 13.7 8.5 6.6 9.8 5.8 9.9 6.5 8.7 9.1 8.9 17.4 8.4 10.8 7.3 8.6 10.5 6.7 6.1 10.3 11.7 12.5 28.9 17.9 10.0 10.5 15.6 9.0 13.9 15.6 16.2 19.7 8.1 11.4 14.7 11.1 12.6 33.7 21.5 11.0 13.9 29.6 11.8 25.1 20.5 15.5 11.1 17.3 21.2 9.3 19.0 10.6 14.9 11.0 8.0 17.3 23.7 13.5 12.7 7.4 16.7 14.2 14.5 17.1 9.6 25.7 16.1 14.0 9.1 13.9 20.6 22.2 13.9 22.5 10.4 14.5 15.8 26.6 9.1 18.3 14.4 14.0 16.4 25.8 38.4 21.6 10.7 16.9 14.1 0.4 0.3 3.1 0.4 0.4 0.3 0.8 0.4 0.3 0.4 0.5 0.2 0.6 0.7 1.0 0.3 0.3 0.8 0.3 8.1 9.6 8.3 7.2 6.5 7.1 9.9 9.7 5.2 9.0 8.7 8.4 10.3 3.5 6.4 7.9 6.8 5.8 3.6 2.6 3.7 4.6 10.8 4.8 4.8 7.8 4.3 7.8 7.3 27.1 5.1 7.1 11.0 0.0 5.4 81.7 5.0 8.2 4.9 6.1 1.3 6.4 7.1 4.4 5.8 9.7 7.8 0.0 6.5 3.9 7.2 5.8 13.5 5.2 8.1 4.1 10.6 3.7 20.7 6.8 4.8 5.4 9.4 6.7 5.5 10.3 10.1 10.2 8.7 5.0 6.0 3.3 3.9 7.7 2.6 5.2 18.0 0.0 4.9 3.8 12.0 6.7 4.4 3.1 3.8 4.2 2.8 7.0 2.4 DUOXA2 ENSG00000140274 "Dual oxidase maturation factor 2" Q1HG44 15 45114326-45118421 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Protein transport, Transport" "Congenital hypothyroidism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 64.5;urinary bladder: 42.3" "Cell type enhanced" "Detected in some" "Ductal cells: 856.3;Exocrine glandular cells: 178.0;Pancreatic endocrine cells: 696.7;Urothelial cells: 552.0" "Cancer enhanced" "Detected in many" "pancreatic cancer: 27.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA063548 Enhanced NA NA "HPA063548: AB_2685037" "unprognostic (1.87e-1)" "unprognostic (9.88e-2)" "unprognostic (7.37e-2)" "unprognostic (6.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-3)" "unprognostic (6.73e-2)" "unprognostic (2.03e-1)" "unprognostic (2.10e-1)" "unprognostic (3.15e-2)" "unprognostic (1.26e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-4)" "unprognostic (9.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.54e-2)" 0.1 0.3 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.6 0.4 0.0 0.0 5.6 0.0 64.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.0 0.1 0.0 1.5 0.0 0.0 0.0 2.1 0.2 0.0 0.0 16.0 0.0 0.0 0.0 11.5 0.0 0.6 42.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 1.1 0.0 2.2 0.0 28.1 46.4 0.0 0.0 0.0 0.0 0.9 12.8 32.7 0.0 0.0 0.0 0.0 85.2 0.0 856.3 0.0 0.3 0.1 1.0 0.0 0.0 0.0 178.0 0.0 0.5 57.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 4.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.1 696.7 61.8 0.0 0.0 14.2 0.9 0.1 106.7 0.0 0.0 0.0 7.1 0.3 0.2 0.0 0.0 0.0 0.6 0.2 23.8 552.0 DUOX2 "LNOX2, P138-TOX, P138(TOX), THOX2" ENSG00000140279 "Dual oxidase 2" Q9NRD8 15 45092650-45114172 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 292.9;thyroid gland: 76.3;urinary bladder: 93.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 159.3;Ductal cells: 225.2;Exocrine glandular cells: 125.5;Gastric mucus-secreting cells: 85.1;Pancreatic endocrine cells: 411.7;Urothelial cells: 110.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 60.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HaCaT: 6.3" "Region enhanced" "Detected in single" "basal ganglia: 1.2" "Not detected" "Not detected" NA NA "unprognostic (3.19e-1)" "unprognostic (7.51e-2)" "unprognostic (3.77e-2)" "unprognostic (5.99e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (7.93e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.49e-2)" "unprognostic (9.59e-3)" "unprognostic (7.11e-2)" "unprognostic (5.32e-5)" "unprognostic (1.71e-1)" "unprognostic (1.62e-2)" "unprognostic (4.12e-2)" "unprognostic (1.63e-2)" 0.5 1.4 0.1 21.7 0.1 0.0 0.6 0.1 0.3 1.6 0.0 11.7 1.5 0.2 3.2 21.7 0.5 292.9 0.6 0.1 0.1 0.6 0.8 2.5 0.1 0.2 0.6 0.1 0.5 1.2 0.2 0.1 0.0 0.1 12.0 5.5 0.0 4.6 1.9 0.0 4.7 8.3 2.7 0.1 0.0 42.7 1.4 0.1 0.0 76.3 0.0 4.3 93.7 21.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 6.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 0.1 48.1 36.9 0.0 3.0 1.9 5.2 11.7 1.8 0.4 0.6 0.6 1.9 54.3 31.5 0.0 0.0 0.1 0.0 159.3 0.0 225.2 0.6 1.0 0.5 5.6 1.2 0.0 0.1 125.5 0.0 5.1 85.1 3.5 32.8 0.1 0.4 0.1 0.1 0.0 0.1 10.1 4.1 0.0 0.4 0.3 0.3 3.9 0.0 0.0 5.2 0.2 0.0 0.0 0.1 411.7 45.5 0.0 0.8 4.5 2.9 0.0 43.4 0.3 0.0 0.2 2.7 0.9 1.0 3.6 1.8 0.0 4.6 0.1 34.7 110.4 LYSMD2 MGC35274 ENSG00000140280 "LysM domain containing 2" Q8IV50 15 51723011-51751585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 164.4;monocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040460 Approved Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA040460: AB_10794874" "unprognostic (7.71e-3)" "unprognostic (2.69e-1)" "unprognostic (3.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.11e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.60e-1)" "unprognostic (1.85e-1)" "unprognostic (3.98e-1)" "unprognostic (4.17e-3)" "unprognostic (6.86e-2)" "unprognostic (1.58e-2)" "unprognostic (5.03e-1)" "unprognostic (4.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" 10.3 19.8 33.5 22.4 36.4 15.2 8.8 33.3 42.3 10.3 25.6 11.2 15.9 10.8 11.2 8.8 11.0 11.5 7.0 35.4 38.9 10.6 21.3 14.6 29.3 35.8 36.7 36.0 8.6 13.0 10.8 23.0 9.6 37.7 9.5 9.8 7.7 7.3 13.9 18.5 5.1 13.7 11.8 34.4 21.5 12.2 11.1 37.3 18.0 8.2 13.2 26.0 12.9 8.9 42.3 14.6 10.6 1.7 13.2 4.4 8.4 0.1 16.8 9.2 20.0 25.8 1.3 13.0 56.9 2.4 9.0 23.1 21.0 11.0 11.1 14.0 55.1 5.4 15.9 8.9 0.2 9.3 38.2 6.9 8.4 22.0 8.2 8.6 9.0 12.1 20.5 0.7 0.0 6.5 21.0 14.8 47.6 4.6 0.6 14.5 23.1 0.2 20.6 19.9 11.5 45.3 11.5 16.2 0.4 29.8 2.5 11.7 28.5 7.8 19.8 11.1 20.9 23.7 0.0 0.0 0.2 10.1 77.4 15.1 0.3 39.5 76.6 29.8 48.8 42.3 47.0 29.1 36.3 33.4 49.7 35.6 29.4 112.5 34.9 62.0 54.4 19.4 40.4 33.5 36.4 33.3 42.3 35.4 38.9 35.8 36.7 36.0 37.7 34.4 37.3 42.3 45.7 3.2 4.8 18.3 70.8 19.4 31.2 8.0 20.5 16.7 17.5 23.4 3.3 22.8 6.4 14.7 0.0 1.2 89.1 4.1 25.4 16.7 164.4 2.6 2.8 32.3 79.8 17.2 25.4 18.3 0.8 15.6 15.3 0.9 12.7 4.3 27.8 14.6 38.0 32.0 28.7 16.2 8.2 46.4 24.7 71.2 16.1 49.0 7.2 23.4 97.4 7.0 45.3 15.1 7.3 10.8 17.1 15.8 5.1 38.5 32.6 29.0 9.9 4.1 26.3 14.1 24.0 5.0 8.3 31.7 16.2 0.8 51.3 12.4 21.2 24.6 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236385 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 159.1;liver: 290.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 30 "basophil: 63.5" "Lineage enriched" "Detected in many" 30 "granulocytes: 63.5" "Cell line enhanced" "Detected in many" "A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026089 Enhanced NA NA "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favorable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.40e-4)" 4.8 16.1 1.6 2.9 2.2 6.6 13.5 1.8 3.5 1.6 7.8 18.3 11.2 0.3 66.5 2.6 11.0 2.4 0.0 2.9 2.0 159.1 290.4 1.7 1.5 1.0 1.2 1.8 0.1 7.2 4.2 12.5 17.5 1.2 5.5 16.4 3.5 1.0 1.0 0.0 1.3 21.5 0.9 0.8 0.4 1.8 1.0 2.0 0.5 4.6 0.0 1.7 3.7 1.2 1.3 0.0 50.0 0.0 0.0 0.0 0.0 0.1 0.9 0.4 0.9 1.3 26.2 6.9 0.0 0.6 1.2 0.6 89.3 22.8 0.7 2.3 36.0 27.9 37.5 43.0 23.6 0.5 66.3 25.8 0.0 2.1 0.2 0.1 0.0 0.0 16.9 11.6 0.0 0.0 8.3 1.8 44.5 1.7 101.8 1.8 0.0 0.0 1.8 4.7 45.7 40.4 2.6 8.7 1.1 0.0 1.1 4.7 22.8 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 21.2 0.0 63.5 0.0 0.9 0.8 0.0 0.7 0.3 0.7 0.8 0.0 0.2 0.1 0.2 0.3 2.0 0.0 0.0 0.9 0.5 1.6 2.2 1.8 3.5 2.9 2.0 1.0 1.2 1.8 1.2 0.8 2.0 1.3 0.3 0.0 1.1 0.7 2.2 1.0 1.3 8.7 1.2 1.1 1.1 0.3 0.3 0.0 13.6 9.2 0.0 265.5 1.6 17.2 11.7 0.6 0.7 9.8 0.1 0.8 4.2 8.0 4.9 2.0 7.6 0.9 1.5 0.7 6.3 0.1 3.9 205.7 16.4 1.7 6.6 18.9 10.2 3.2 0.3 0.9 0.3 1.2 0.0 1.0 0.0 0.6 1.0 0.0 0.4 1.4 26.6 0.0 0.8 3.3 81.0 198.9 70.2 1.9 0.0 0.0 1.0 4.4 4.2 5.1 0.3 54.9 4.6 0.2 25.9 4.9 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423237-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 63.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Fibroblasts: 216.6;Leydig cells: 83.3;Proximal tubular cells: 53.4;Smooth muscle cells: 71.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 112.1;ASC TERT1: 66.1;BJ: 45.6;fHDF/TERT166: 50.3;HSkMC: 84.8;RH-30: 119.7;U-138 MG: 56.5" "Region enriched" "Detected in some" 6 "cerebellum: 8.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" NA NA "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 44.2 4.6 3.7 31.8 4.2 0.1 8.6 4.4 4.7 29.6 2.4 11.2 3.7 29.5 4.4 9.6 15.6 46.4 10.6 3.9 5.1 4.6 1.4 13.0 8.4 5.1 5.3 3.2 13.5 2.2 3.6 2.2 23.7 5.5 16.4 9.6 8.5 5.2 12.1 2.3 2.6 3.7 27.2 4.2 1.8 5.5 2.4 4.5 3.0 7.4 24.0 4.8 63.9 10.3 6.2 0.2 0.0 0.2 0.3 112.1 66.1 0.1 45.6 25.7 0.0 0.1 0.0 0.3 0.2 0.2 50.3 0.4 0.9 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 10.6 0.3 0.1 84.8 0.8 9.4 0.0 0.3 0.0 0.0 0.1 0.3 5.4 0.1 0.0 0.1 0.2 0.1 0.3 0.1 119.7 0.1 0.1 0.1 1.8 0.6 0.4 0.0 0.4 0.2 0.2 0.2 0.2 56.5 0.5 1.1 0.2 0.5 0.4 0.0 13.3 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.2 4.4 4.7 3.9 5.1 5.1 5.3 3.2 5.5 4.2 4.5 6.2 16.1 12.8 19.3 2.0 2.2 14.4 16.8 1.3 1.2 7.9 11.1 9.5 46.8 7.2 0.5 9.2 2.1 6.2 3.2 0.2 119.3 2.0 3.3 8.8 46.2 5.2 0.0 2.7 1.9 0.6 3.3 216.6 2.0 29.2 1.3 0.6 1.8 2.7 2.0 3.3 3.3 0.0 2.0 1.6 15.9 4.0 83.3 1.9 7.2 1.0 0.2 9.8 2.1 1.5 2.9 0.6 0.0 4.9 0.7 9.4 0.0 53.4 0.3 6.1 6.6 43.6 71.6 0.6 0.7 1.8 12.6 2.9 2.9 2.9 0.1 8.4 HDC ENSG00000140287 "Histidine decarboxylase" P19113 15 50241947-50265965 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 87.6;epididymis: 46.5" "Cell type enriched" "Detected in some" 12 "granulocytes: 596.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.9;testis cancer: 2.7" "Group enriched" "Detected in many" 5 "hypothalamus: 87.6;pons: 36.0" "Immune cell enriched" "Detected in single" 2140 "basophil: 686.2" "Lineage enriched" "Detected in single" 2140 "granulocytes: 686.2" "Group enriched" "Detected in some" 4 "HEL: 460.8;HMC-1: 1051.3" "Region enriched" "Detected in many" 5 "hypothalamus: 43.9" "Group enriched" "Detected in some" 10 "hypothalamus: 16.5;midbrain: 4.2" HPA038891 Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA038891: AB_10673231" "unprognostic (4.97e-2)" "unprognostic (7.42e-2)" "unprognostic (1.43e-4)" "unprognostic (1.08e-1)" "unprognostic (6.16e-2)" "unprognostic (3.93e-7)" "unprognostic (4.18e-5)" "unprognostic (8.79e-3)" "unprognostic (1.48e-1)" "unprognostic (8.46e-2)" "unprognostic (4.60e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-1)" "unprognostic (7.20e-2)" "unprognostic (9.78e-2)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" 2.0 0.4 0.2 3.5 3.6 4.7 1.4 0.0 0.2 2.3 0.6 3.8 4.1 2.6 46.5 4.9 0.8 11.3 0.7 0.2 87.6 0.4 0.5 7.0 0.9 0.0 8.1 0.0 0.1 1.2 0.5 0.4 0.4 36.0 1.8 3.6 0.8 1.3 1.0 0.3 2.0 4.6 2.5 0.0 0.5 13.0 1.3 12.9 0.9 0.1 0.8 1.0 3.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 460.8 0.2 0.0 0.0 1.2 1051.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 181.8 0.3 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.4 686.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.2 3.6 0.0 0.2 0.2 87.6 0.0 8.1 0.0 36.0 0.0 12.9 0.1 0.0 12.8 47.5 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 10.9 0.3 0.0 0.0 2.3 9.2 0.0 596.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.8 0.4 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.1 0.1 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 76.1;intestine: 144.2;salivary gland: 56.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5" "Group enriched" "Detected in many" 4 "colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.2 0.7 0.3 12.0 0.2 0.5 0.4 0.6 0.4 19.4 0.2 144.2 98.4 2.0 0.0 16.0 4.2 76.1 0.1 0.2 0.1 6.2 0.4 0.7 0.9 0.2 0.2 0.1 0.1 2.1 1.0 0.1 0.1 0.3 1.2 124.4 0.1 56.3 0.3 0.2 0.3 124.3 4.7 0.1 0.1 26.1 4.4 0.2 1.3 2.1 0.0 10.7 9.2 30.2 0.4 0.1 147.4 0.0 0.2 0.0 1.0 0.2 0.1 7.7 0.0 0.0 6.3 6.0 0.6 24.6 0.0 9.5 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.5 30.3 0.0 0.2 0.2 0.3 3.5 0.7 0.0 0.1 0.0 0.2 0.0 0.4 1.4 0.6 0.1 0.2 0.2 75.9 0.3 0.4 0.0 0.6 10.2 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.2 0.4 7.3 0.1 0.2 0.5 0.8 8.9 0.3 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.3 0.2 0.6 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.2 0.4 0.0 0.0 2.2 0.0 1.0 0.0 18.3 8.9 0.0 0.0 0.5 0.0 0.7 11.5 40.5 104.8 0.0 0.0 0.1 360.1 0.0 92.6 9.8 23.3 8.6 0.3 7.8 0.0 0.0 14.9 0.0 0.2 27.5 75.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 26.9 8.2 0.6 0.0 19.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.4 163.2 0.0 0.1 8.0 85.5 4.4 9.8 0.0 6.6 0.6 1.5 3.0 0.3 1.4 0.0 0.0 0.8 0.0 48.5 52.4 BNIP2 "BNIP-2, Nip2" ENSG00000140299 "BCL2 interacting protein 2" Q12982 15 59659146-59689534 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 132.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026843 Approved Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA026843: AB_1845403" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "prognostic favorable (8.42e-4)" "unprognostic (6.70e-2)" "unprognostic (4.81e-2)" "unprognostic (2.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.44e-2)" "unprognostic (1.26e-1)" "unprognostic (4.72e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.68e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" 50.1 22.6 13.8 41.4 15.8 132.8 31.0 15.3 13.7 29.0 12.1 20.4 16.5 37.2 19.4 30.7 20.7 28.0 48.1 12.3 20.0 19.5 46.9 41.8 49.0 17.8 16.0 9.8 31.5 14.0 17.6 10.4 43.0 16.8 26.8 23.4 27.6 20.7 29.7 32.9 20.8 20.5 41.8 17.3 46.9 18.2 23.0 15.9 43.8 19.1 49.3 48.5 41.6 21.4 18.6 39.4 35.9 45.9 37.8 70.8 57.9 40.2 60.3 85.0 54.3 61.9 29.0 18.2 67.9 39.5 87.9 74.4 72.7 48.9 70.1 73.4 49.3 31.1 83.0 52.6 30.8 77.6 107.3 91.7 68.6 71.9 49.4 85.0 51.2 91.1 78.9 48.3 70.8 88.5 22.6 50.5 44.6 41.2 7.7 25.8 55.3 57.5 87.7 56.9 87.3 36.9 50.2 39.5 52.7 104.4 66.4 43.7 112.9 72.2 58.3 71.0 38.0 60.2 52.6 112.7 90.0 46.5 98.1 60.5 50.6 46.6 72.2 29.6 46.9 35.1 31.9 31.1 31.8 43.1 28.9 31.8 32.1 81.5 34.8 40.1 34.5 36.3 43.8 13.8 15.8 15.3 13.7 12.3 20.0 17.8 16.0 9.8 16.8 17.3 15.9 18.6 116.7 73.7 44.0 20.2 87.9 86.7 98.8 56.0 70.6 32.5 35.3 29.6 81.9 28.6 43.0 14.7 47.9 64.0 82.6 31.3 37.2 31.5 9.0 41.8 44.5 105.6 15.5 57.7 15.4 26.8 76.8 68.0 46.9 65.8 96.4 31.0 87.8 49.6 91.7 50.5 17.5 24.3 32.6 115.6 106.7 6.1 43.5 125.6 51.6 25.3 120.8 55.3 64.9 20.6 28.2 36.9 22.1 57.2 63.1 75.1 20.0 16.6 45.4 50.2 78.9 56.2 68.1 28.8 32.2 64.4 92.5 193.9 73.5 42.3 19.4 136.8 GTF2A2 "HsT18745, TFIIA" ENSG00000140307 "General transcription factor IIA subunit 2" P52657 15 59638062-59657541 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 1134.9;Late spermatids: 732.8;Spermatocytes: 1264.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056239 Supported Nucleoplasm NA NA Nucleoplasm "HPA056239: AB_2683074" "unprognostic (2.18e-2)" "unprognostic (3.21e-1)" "unprognostic (9.37e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (3.06e-2)" "unprognostic (1.31e-2)" "unprognostic (7.35e-2)" "unprognostic (6.29e-2)" "unprognostic (3.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.58e-1)" "unprognostic (2.79e-1)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" 51.5 57.5 36.3 55.0 38.2 72.6 50.1 40.8 44.4 50.7 37.1 63.4 40.6 49.1 55.1 61.5 46.6 44.0 64.6 36.3 44.6 60.1 50.2 40.0 53.1 40.2 40.2 34.0 52.4 43.5 66.0 58.8 43.7 39.8 46.4 51.6 42.2 58.7 34.6 75.7 39.5 42.3 45.7 40.5 43.6 46.7 213.6 38.2 60.6 41.5 55.6 52.2 62.0 66.1 42.7 149.1 206.4 136.8 130.9 83.8 70.5 157.7 164.0 79.8 134.6 133.3 224.4 58.9 136.5 149.5 107.9 197.6 124.3 138.7 100.6 95.4 242.2 112.9 157.4 146.5 143.4 107.5 171.5 134.1 66.0 95.1 112.3 94.9 95.3 87.6 105.6 226.7 136.1 113.6 103.8 112.9 130.8 181.7 49.6 120.0 104.4 142.9 166.5 133.7 172.2 148.0 157.1 152.1 171.5 160.1 180.5 120.7 179.2 121.5 126.4 224.7 142.5 297.7 134.1 426.3 303.8 143.2 284.0 157.2 174.0 129.8 170.3 88.1 140.7 92.4 126.9 103.1 98.9 174.2 100.2 87.4 96.7 70.0 117.5 135.1 201.0 132.7 134.9 36.3 38.2 40.8 44.4 36.3 44.6 40.2 40.2 34.0 39.8 40.5 38.2 42.7 109.4 41.7 58.5 17.0 89.8 98.7 184.6 213.0 83.1 51.1 107.3 155.8 120.4 62.9 132.2 64.4 47.9 217.8 99.9 122.4 211.3 148.8 1134.9 129.9 85.8 96.6 82.1 121.4 22.4 148.8 199.7 103.7 51.5 92.4 82.2 87.9 74.6 78.4 148.3 50.5 27.5 100.8 195.3 100.1 107.7 732.8 125.9 101.9 80.0 16.9 158.9 173.8 107.1 24.1 35.4 181.6 104.6 137.3 109.6 210.7 83.5 149.2 129.7 62.2 65.7 102.9 133.7 1264.3 166.3 89.8 106.8 151.9 87.3 120.8 120.5 236.2 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035690-40039181 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 440000 Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 298.7 310.0 316.0 119.2 320.8 254.9 302.9 308.6 429.5 294.0 309.8 260.8 122.6 313.7 284.6 259.8 273.1 157.2 354.5 309.9 310.0 357.7 231.4 222.7 169.4 343.5 319.5 289.1 326.2 194.1 327.1 309.2 145.0 329.4 266.6 160.4 214.6 239.8 160.4 357.7 199.5 217.5 164.9 306.3 221.5 249.7 166.9 312.7 279.5 277.8 341.5 174.3 269.0 256.1 374.3 131.8 163.7 399.5 301.4 300.0 275.5 189.4 232.4 265.0 213.4 223.3 297.8 113.7 107.9 245.0 305.1 319.5 216.6 322.8 260.9 207.0 257.5 230.3 258.3 530.2 364.0 231.4 238.2 211.8 276.0 298.3 177.8 213.3 391.0 360.6 297.7 280.2 204.2 356.3 204.5 370.2 291.4 217.6 520.1 301.3 247.6 176.8 192.6 477.5 401.7 287.2 255.0 231.2 243.2 171.2 243.7 332.8 448.6 290.9 240.4 160.3 229.4 171.1 161.8 494.7 291.0 234.7 255.4 229.7 729.8 525.0 875.7 484.5 485.8 473.9 600.9 547.9 549.0 562.5 509.0 522.0 510.2 452.7 525.9 459.5 1148.0 755.1 1262.6 316.0 320.8 308.6 429.5 309.9 310.0 343.5 319.5 289.1 329.4 306.3 312.7 374.3 1378.8 461.6 415.0 83.2 577.0 667.1 861.7 1395.7 427.4 432.9 617.7 914.5 880.3 649.1 906.9 995.0 125.1 867.3 812.5 742.7 2551.3 1366.9 353.1 1215.7 729.8 957.7 554.0 619.4 39.4 1087.2 1100.4 699.1 324.7 1513.6 564.0 669.5 654.7 819.4 1022.1 348.3 56.1 676.9 1226.8 631.1 882.8 377.3 1039.8 645.8 789.8 36.5 1174.3 1262.8 619.0 39.2 76.0 1240.7 894.4 986.9 610.9 826.3 874.5 2276.2 935.5 477.3 624.5 651.9 749.3 779.9 643.1 631.5 710.3 758.8 644.1 831.9 673.2 975.0 BAHD1 KIAA0945 ENSG00000140320 "Bromo adjacent homology domain containing 1" Q8TBE0 15 40439721-40468236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041196 Supported Nucleoplasm NA NA Nucleoplasm "HPA041196: AB_10803999" "prognostic unfavorable (1.55e-4)" "unprognostic (4.08e-1)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.35e-2)" "unprognostic (1.04e-1)" "unprognostic (7.19e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "unprognostic (2.00e-2)" "unprognostic (3.49e-3)" "unprognostic (4.81e-2)" "prognostic favorable (1.29e-10)" "unprognostic (4.95e-2)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" 9.2 22.1 10.4 8.1 10.5 8.1 9.3 8.3 10.6 10.5 9.2 11.9 9.1 12.6 10.3 12.1 13.7 6.4 13.0 11.6 10.2 12.8 11.7 12.6 9.9 10.0 9.1 9.7 21.6 14.0 13.1 13.4 8.8 9.2 10.4 5.8 5.3 12.7 10.3 12.8 11.0 12.1 7.3 8.8 12.7 12.8 18.7 9.8 11.7 16.7 7.6 9.2 12.4 9.2 9.8 16.9 8.5 14.7 24.5 11.7 9.1 32.0 13.3 9.5 14.4 14.0 23.1 7.9 12.5 17.6 12.0 17.6 32.6 24.2 10.1 8.0 24.2 15.2 32.9 13.2 11.5 11.1 14.4 24.0 12.0 10.2 8.8 8.7 12.8 12.5 15.8 32.8 10.4 8.6 16.0 16.2 21.8 14.6 19.7 15.6 27.3 16.6 10.4 15.9 19.7 23.0 13.9 8.2 42.8 9.7 9.1 34.4 23.1 14.8 15.6 17.4 22.4 14.1 15.5 18.4 14.2 16.3 22.1 10.7 0.6 0.3 1.4 1.3 0.6 0.6 0.5 0.9 0.7 0.3 0.7 1.2 1.0 0.3 1.4 1.2 0.6 0.3 0.4 10.4 10.5 8.3 10.6 11.6 10.2 10.0 9.1 9.7 9.2 8.8 9.8 9.8 9.7 19.2 7.0 7.8 4.9 8.3 3.7 4.1 6.8 3.9 11.4 9.4 11.7 5.7 7.7 11.0 2.1 5.5 5.6 20.7 1.9 5.4 1.0 6.1 4.9 8.4 7.8 2.5 10.3 7.4 7.3 4.7 2.0 8.4 8.9 5.6 9.7 12.0 5.7 16.8 8.1 7.4 2.0 12.0 4.6 2.7 10.2 5.4 0.0 7.5 6.7 5.2 10.3 9.0 8.9 6.7 8.9 5.7 1.6 5.3 11.6 5.0 5.0 4.7 6.6 6.1 5.5 6.3 10.9 6.9 7.7 4.1 5.8 7.6 8.0 4.9 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358219-40378621 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 17.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.0;Distal enterocytes: 16.8;Horizontal cells: 18.5;Intestinal goblet cells: 18.2;Proximal enterocytes: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.2;HaCaT: 6.6;SCLC-21H: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.2 0.7 3.2 0.4 4.6 0.3 0.1 17.6 5.7 0.2 0.0 1.4 1.1 0.2 0.1 0.1 0.2 0.2 0.1 3.2 3.5 0.0 0.1 0.1 0.4 4.8 1.9 4.9 0.3 0.3 0.1 1.3 0.2 6.9 0.1 1.2 1.6 0.3 0.4 0.1 0.3 1.2 0.3 0.2 0.2 1.2 0.7 3.2 0.2 1.4 0.0 0.0 0.1 0.1 4.4 1.3 0.5 0.3 2.0 0.1 0.0 0.7 0.2 0.1 0.8 1.2 1.9 0.6 0.2 1.3 0.8 4.2 6.6 0.2 1.1 0.5 0.1 0.4 0.3 0.4 0.1 0.0 0.4 1.1 1.4 0.0 0.2 0.1 0.2 0.4 0.7 0.5 0.8 1.1 0.3 0.2 0.3 0.3 1.7 0.9 0.2 0.3 0.4 0.2 1.7 13.4 1.9 0.2 0.1 0.2 0.3 0.3 0.2 0.4 0.9 0.7 0.2 0.2 0.2 0.1 0.2 0.3 0.5 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 3.2 4.6 17.6 5.7 3.2 3.5 4.8 1.9 4.9 6.9 0.2 3.2 4.4 0.9 3.2 3.6 1.0 0.5 0.0 1.9 0.0 0.0 19.0 0.8 1.3 1.7 1.5 4.4 3.7 10.4 0.2 0.2 16.8 0.0 0.4 1.3 0.3 0.6 1.4 9.6 2.7 5.1 0.4 0.3 1.6 5.1 0.5 8.8 0.4 0.4 0.4 1.0 18.5 7.0 18.2 0.0 0.6 0.0 1.8 1.2 1.1 0.0 1.0 0.3 2.3 4.1 4.0 0.3 0.3 3.2 0.0 0.3 1.2 12.1 0.2 2.2 7.6 0.0 3.1 0.8 4.1 6.1 0.0 0.0 0.3 1.1 0.8 8.6 1.1 CDAN1 "CDA-I, CDAI" ENSG00000140326 "Codanin 1" Q8IWY9 15 42723544-42737128 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039404, HPA040787" Supported Enhanced "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039404: AB_10673530, HPA040787: AB_2677137" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.79e-3)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.95e-2)" "unprognostic (1.26e-1)" "unprognostic (4.35e-3)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (9.20e-3)" "unprognostic (2.04e-1)" 3.6 5.0 2.0 3.6 1.9 8.2 4.4 3.5 2.8 7.6 2.5 4.3 2.8 6.0 4.4 4.1 6.1 2.5 2.9 1.9 1.4 3.3 4.0 3.6 4.2 2.9 1.3 3.0 11.4 4.8 3.6 5.2 3.2 2.6 7.0 2.5 2.6 5.4 3.5 4.2 5.0 4.2 2.8 0.8 4.6 4.5 6.4 1.4 5.3 5.2 2.8 3.4 5.8 5.6 2.3 8.1 5.4 7.2 10.4 6.3 5.4 8.6 10.4 4.3 9.9 7.2 13.6 4.2 3.9 11.2 5.8 9.7 15.5 7.7 4.7 2.9 9.9 7.2 14.5 10.3 5.3 4.7 10.8 13.2 7.4 5.2 6.3 4.5 6.1 7.6 13.0 18.9 5.7 8.2 4.5 8.4 14.2 3.6 7.7 8.5 11.9 9.0 3.4 3.1 7.9 5.9 6.8 8.2 11.3 1.7 4.6 8.6 15.9 5.6 10.4 9.2 8.6 12.1 11.2 12.7 8.7 5.4 15.8 8.6 1.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2.0 1.9 3.5 2.8 1.9 1.4 2.9 1.3 3.0 2.6 0.8 1.4 2.3 2.0 0.0 3.7 4.6 2.4 1.9 2.0 1.5 1.8 3.3 3.2 1.8 2.2 2.8 1.5 7.3 4.2 3.0 2.6 1.9 0.0 1.5 0.4 2.0 2.8 2.3 4.8 1.7 7.6 1.8 1.6 2.9 3.6 2.0 1.3 9.0 3.9 3.6 2.1 1.7 6.3 1.6 4.1 2.5 0.9 1.2 4.4 1.6 0.0 4.7 1.5 4.5 2.1 5.5 3.8 1.6 0.5 4.9 2.5 2.3 2.2 1.3 1.9 4.7 19.7 3.4 2.4 5.4 2.1 2.8 1.3 2.2 2.5 4.6 2.6 1.7 TLE3 "ESG, ESG3, GRG3, HsT18976, KIAA1547" ENSG00000140332 "TLE family member 3, transcriptional corepressor" Q04726 15 70047790-70098176 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 65.7" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 49.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 49.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054116 Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA054116: AB_2682386" "unprognostic (5.57e-2)" "prognostic favorable (2.09e-5)" "unprognostic (5.18e-2)" "unprognostic (5.13e-2)" "unprognostic (1.15e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (5.53e-2)" "unprognostic (6.74e-2)" "unprognostic (3.11e-2)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (4.90e-2)" "unprognostic (2.43e-1)" "unprognostic (6.71e-2)" "unprognostic (6.29e-2)" "unprognostic (2.74e-1)" 15.3 6.4 10.1 18.4 10.5 65.7 15.4 10.5 11.0 16.2 2.9 18.9 17.5 10.9 3.0 31.3 10.2 5.9 8.2 10.5 13.9 13.8 13.5 20.5 17.9 14.1 11.4 6.1 14.1 15.0 5.9 10.4 12.7 12.6 23.4 6.5 5.0 19.2 10.2 8.4 29.1 22.0 7.0 13.4 23.2 15.8 22.3 12.3 13.6 13.6 2.9 19.1 9.9 19.6 15.0 7.8 24.2 13.3 23.6 12.1 9.9 80.3 1.5 4.1 3.1 2.5 34.0 22.8 22.0 32.8 2.1 4.8 14.3 32.3 11.5 1.6 30.9 45.9 36.9 50.8 6.6 11.5 11.4 51.1 20.5 6.3 9.1 8.2 19.7 15.5 47.9 26.1 96.0 4.5 20.9 41.2 28.3 14.2 7.4 24.9 36.8 13.6 24.7 7.1 41.7 19.5 28.7 66.2 29.7 28.7 14.5 33.6 24.9 11.7 9.5 18.7 29.6 16.4 84.6 57.2 35.3 13.3 37.3 25.1 2.6 4.5 2.5 1.9 4.8 1.8 9.9 2.6 2.5 2.9 4.9 2.5 3.3 49.1 2.8 5.2 8.7 1.6 1.7 10.1 10.5 10.5 11.0 10.5 13.9 14.1 11.4 6.1 12.6 13.4 12.3 15.0 27.5 12.8 27.7 16.0 49.2 115.1 47.8 19.5 59.2 19.9 45.5 28.4 8.1 4.3 18.9 62.5 31.3 25.3 38.2 55.2 7.9 11.6 45.5 17.2 5.0 27.6 28.8 15.2 6.1 5.6 64.4 25.0 17.9 32.1 53.2 25.5 23.9 21.5 37.3 0.0 5.0 30.3 10.2 41.5 78.2 76.9 14.0 51.5 35.6 13.1 35.8 32.6 1.0 9.5 0.4 11.0 31.7 18.4 47.2 39.9 41.0 13.2 8.1 4.4 0.0 39.8 24.7 5.8 28.0 67.7 132.8 82.4 37.6 0.7 43.9 31.5 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 770000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 51.3 35.1 54.8 88.1 65.0 138.2 72.3 67.4 60.1 54.5 39.9 81.8 71.4 59.6 51.2 66.4 75.7 60.3 129.1 53.7 72.5 75.8 77.0 71.6 157.5 62.8 61.2 47.6 58.3 54.2 61.9 27.8 102.4 66.9 76.1 89.8 106.9 54.5 67.4 62.9 36.4 77.6 57.5 71.1 86.3 79.7 20.9 59.5 204.9 74.3 65.0 142.3 77.1 44.0 77.0 196.4 234.7 303.2 263.2 104.2 90.9 200.5 101.0 134.3 193.5 161.8 195.3 358.0 629.8 184.5 114.5 114.2 279.9 709.5 206.6 230.8 286.6 241.2 478.6 192.7 247.8 64.5 380.8 247.4 72.9 143.1 106.3 210.2 126.6 285.9 300.0 354.5 239.1 168.2 136.1 386.1 311.6 270.1 192.5 118.2 531.7 280.7 375.3 170.5 304.5 399.8 247.8 153.7 170.8 282.7 301.1 227.2 491.4 129.0 199.0 313.5 139.3 275.2 143.8 433.9 733.8 132.2 632.1 186.7 12.9 26.4 44.9 16.8 30.6 14.2 18.7 13.8 17.8 30.0 17.9 16.5 14.9 27.2 28.8 27.5 26.8 17.2 16.0 54.8 65.0 67.4 60.1 53.7 72.5 62.8 61.2 47.6 66.9 71.1 59.5 77.0 100.2 109.0 118.0 20.2 98.1 64.7 67.7 147.0 91.0 92.2 57.3 70.6 80.0 60.1 105.4 69.9 35.5 258.2 119.7 57.1 107.6 112.5 6.7 61.2 67.7 91.8 78.5 144.2 16.8 96.1 172.4 57.5 69.3 70.1 92.4 63.6 78.1 81.8 194.1 65.6 17.4 92.1 114.0 150.1 112.6 6.3 34.8 111.6 78.2 37.5 158.9 103.7 84.5 15.6 55.4 79.8 57.0 29.7 92.6 59.7 99.3 148.0 113.7 87.2 26.3 49.9 75.1 8.8 18.2 86.4 34.9 232.5 99.5 82.5 94.7 52.0 COMMD4 FLJ20452 ENSG00000140365 "COMM domain containing 4" Q9H0A8 15 75336020-75343224 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039935, HPA066957" Uncertain Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA039935: , HPA066957: AB_2685754" "unprognostic (7.77e-2)" "unprognostic (3.07e-3)" "unprognostic (1.03e-1)" "unprognostic (6.57e-3)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (1.49e-1)" "unprognostic (2.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.78e-3)" "unprognostic (2.01e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-3)" "unprognostic (2.51e-1)" "unprognostic (2.27e-1)" "unprognostic (1.96e-1)" "unprognostic (5.07e-2)" 36.4 72.9 38.1 33.8 37.7 53.3 37.1 39.4 50.8 31.3 41.3 42.0 48.7 30.5 30.5 40.2 34.9 37.6 39.3 35.7 39.1 55.0 51.4 34.9 45.1 39.9 36.8 36.5 24.6 34.1 49.3 34.2 31.4 38.9 34.5 34.1 13.5 43.8 34.3 30.6 35.1 42.6 25.0 39.9 41.6 42.8 81.8 38.9 53.8 39.2 15.4 37.0 33.9 32.1 42.2 138.2 222.5 97.5 124.8 42.3 64.9 98.5 98.8 106.2 191.2 196.6 133.8 184.0 88.8 100.2 79.5 168.8 144.8 175.2 116.5 82.7 70.1 242.4 104.8 169.8 151.0 76.4 79.4 111.0 74.3 63.6 116.2 21.9 48.4 96.5 103.6 108.2 128.1 147.1 179.7 71.0 117.4 140.9 75.2 127.9 127.5 137.4 127.8 98.6 127.8 79.2 114.8 131.2 105.1 169.8 63.8 164.7 160.9 78.6 135.3 119.2 125.8 184.8 93.4 218.7 101.4 138.9 181.9 125.4 27.0 44.1 40.7 84.7 61.8 52.8 47.5 51.7 63.2 50.0 46.4 31.9 47.4 9.5 76.8 55.6 70.6 87.6 39.4 38.1 37.7 39.4 50.8 35.7 39.1 39.9 36.8 36.5 38.9 39.9 38.9 42.2 43.7 28.9 52.4 15.0 26.2 27.0 44.8 58.5 28.5 40.7 44.3 50.3 18.7 38.6 46.2 35.0 31.3 80.9 34.8 59.6 58.7 72.6 12.2 37.1 44.9 42.7 30.5 60.8 9.0 78.7 107.0 43.4 33.1 45.7 41.8 91.1 37.5 41.9 127.5 16.8 8.8 72.8 44.7 35.8 27.0 17.6 49.0 41.3 37.4 11.2 28.5 78.1 53.5 7.1 17.6 72.4 61.7 34.3 43.0 26.6 71.2 98.1 39.8 49.4 46.0 36.1 59.3 152.9 63.5 34.3 30.7 50.8 32.2 53.4 58.7 48.7 UBE2Q2 DKFZp762C143 ENSG00000140367 "Ubiquitin conjugating enzyme E2 Q2" Q8WVN8 15 75843307-75901078 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.28e-1)" "unprognostic (1.66e-2)" "unprognostic (2.45e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-3)" "unprognostic (1.32e-1)" "unprognostic (6.38e-2)" "prognostic favorable (5.73e-4)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (1.47e-3)" "unprognostic (1.01e-3)" "unprognostic (1.92e-1)" "unprognostic (1.69e-2)" "unprognostic (5.92e-2)" 24.5 26.9 22.4 16.8 21.5 40.6 24.6 22.9 29.1 25.7 19.3 30.3 9.4 25.1 18.9 22.8 17.6 22.5 29.8 21.0 24.1 22.7 7.2 19.4 18.8 24.7 25.0 19.9 23.0 19.6 17.6 16.2 29.3 25.2 30.7 20.0 39.4 25.6 21.1 23.1 16.6 15.8 30.8 26.3 21.9 19.7 21.2 23.4 21.1 32.1 17.1 17.9 27.3 17.2 28.0 23.0 35.5 30.0 22.6 42.8 56.7 47.2 50.4 57.2 32.8 37.1 18.7 30.7 22.7 36.2 73.5 27.8 18.1 58.5 33.5 39.9 24.1 23.7 28.5 20.1 24.5 48.1 28.9 15.7 40.7 37.4 23.1 33.4 46.3 46.2 40.5 11.3 33.2 70.1 18.0 24.7 27.6 22.4 3.5 25.3 29.5 47.2 9.4 51.8 36.8 27.4 21.6 42.4 39.6 55.6 42.3 25.6 40.3 60.7 40.2 36.1 27.3 17.8 36.3 68.1 17.6 15.9 44.9 25.2 31.3 6.3 21.3 9.0 7.3 11.2 8.1 11.8 9.7 5.7 7.8 9.4 7.9 0.9 14.6 10.0 2.1 8.4 6.4 22.4 21.5 22.9 29.1 21.0 24.1 24.7 25.0 19.9 25.2 26.3 23.4 28.0 54.3 3.2 6.5 17.6 29.0 50.3 27.7 12.9 33.6 30.3 39.3 26.0 32.1 18.6 17.4 23.9 135.5 55.0 42.6 9.4 23.5 23.8 95.7 18.3 47.4 40.7 18.6 19.1 15.2 16.9 126.2 38.2 12.2 28.9 20.3 27.8 36.4 4.7 23.0 6.7 22.6 30.0 26.4 25.9 51.8 36.7 24.2 34.0 37.4 17.8 30.6 20.2 68.0 30.7 29.5 22.5 10.7 29.0 43.3 58.4 1.3 39.6 9.3 160.8 26.3 28.9 42.9 64.8 64.4 34.4 46.5 110.0 36.1 28.3 17.7 38.7 PSTPIP1 "CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP" ENSG00000140368 "Proline-serine-threonine phosphatase interacting protein 1" O43586 15 76993359-77037475 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 57.1;lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" "dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA010116, HPA010600, HPA072744" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010116: , HPA010600: AB_1855870, HPA072744: " "unprognostic (4.42e-3)" "unprognostic (1.31e-3)" "unprognostic (3.56e-2)" "prognostic favorable (4.74e-5)" "unprognostic (3.79e-2)" "unprognostic (1.12e-3)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (1.16e-1)" "unprognostic (9.85e-2)" "unprognostic (2.96e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (7.36e-9)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.91e-1)" "unprognostic (5.42e-2)" 4.9 2.6 2.5 11.8 2.3 57.1 2.3 2.4 3.1 2.0 3.3 2.9 2.5 1.6 0.1 2.0 3.1 2.9 2.4 2.3 2.6 3.3 3.4 10.4 13.6 2.8 2.8 1.9 1.0 1.3 0.2 1.6 1.8 2.7 2.9 0.8 0.1 2.4 1.0 1.5 1.7 9.5 1.5 2.7 34.2 2.9 0.7 3.3 4.2 3.0 1.0 5.6 4.4 2.7 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 55.1 0.0 0.0 0.0 3.3 0.0 14.4 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 20.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 4.0 0.6 0.0 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.1 0.1 0.0 0.0 1.3 2.4 0.1 59.8 0.0 4.8 71.5 71.4 39.9 33.5 30.8 13.3 27.2 32.7 59.0 18.5 14.3 22.3 85.3 41.6 38.3 5.2 27.0 42.2 2.5 2.3 2.4 3.1 2.3 2.6 2.8 2.8 1.9 2.7 2.7 3.3 3.3 1.1 0.0 5.1 1.0 19.2 9.3 1.2 0.4 0.0 1.1 0.9 1.1 1.9 0.0 2.5 0.0 0.0 0.3 60.0 3.1 0.0 0.0 9.6 0.3 0.3 0.8 60.0 4.8 0.4 0.2 0.7 1.9 0.0 0.3 2.5 0.1 2.2 0.9 42.5 0.0 0.1 6.1 2.0 41.8 36.5 18.6 0.9 41.8 7.2 0.0 51.1 0.2 91.6 5.5 1.0 0.1 2.5 2.6 8.5 0.3 0.3 0.4 0.0 0.4 0.0 0.8 3.1 0.2 1.2 0.2 4.8 0.5 68.4 78.1 0.3 1.2 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein subunit alpha" P13804 15 76215353-76311472 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 393.0;tongue: 497.9" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 402.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria NA NA 680000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favorable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 93.9 113.4 32.3 55.5 34.3 63.6 71.1 33.8 55.0 39.0 37.4 132.6 136.9 27.2 30.8 85.9 30.4 45.1 245.2 31.9 35.7 181.7 393.0 39.4 61.4 33.7 34.2 31.5 25.9 82.3 71.6 14.0 71.5 34.1 42.5 124.7 34.6 49.7 38.6 303.7 40.4 117.2 66.3 33.8 39.1 68.3 28.7 35.0 55.0 39.1 497.9 66.4 74.7 33.4 35.3 122.4 196.7 128.2 134.8 141.7 149.1 201.0 144.4 166.2 183.0 162.8 175.3 221.3 203.5 141.3 144.3 138.5 304.6 502.7 200.2 211.9 245.8 98.0 222.2 131.4 205.2 114.7 214.5 158.7 112.7 185.9 93.1 153.5 100.0 187.8 64.7 214.1 205.2 190.3 191.2 44.9 178.2 99.9 225.3 58.4 192.8 158.6 272.8 202.1 386.9 133.3 67.2 218.2 492.2 205.0 294.4 254.1 223.4 111.4 178.2 119.5 157.0 177.4 99.0 221.0 255.9 127.8 281.1 128.5 50.0 120.3 82.7 65.4 110.3 61.7 77.3 60.6 67.6 159.4 67.3 48.8 60.1 30.2 122.9 96.1 63.4 95.8 141.9 32.3 34.3 33.8 55.0 31.9 35.7 33.7 34.2 31.5 34.1 33.8 35.0 35.3 65.7 57.7 41.6 45.1 54.3 53.4 110.8 151.5 44.9 13.1 47.2 46.4 352.9 65.8 84.5 36.8 22.9 277.4 61.1 250.9 209.4 106.5 11.7 29.5 45.1 51.8 65.4 117.8 26.0 84.1 180.8 66.8 90.2 37.0 38.6 53.1 48.9 348.8 132.3 53.8 31.5 141.6 89.5 79.0 84.5 7.9 59.4 103.0 56.9 28.1 129.0 26.7 85.5 37.2 46.9 92.1 176.2 58.3 87.8 92.4 231.1 402.9 50.2 20.4 46.0 44.0 113.7 66.4 40.5 79.5 57.1 300.2 55.5 123.4 187.3 162.0 BCL2A1 "ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1" ENSG00000140379 "BCL2 related protein A1" Q16548 15 79960892-79971196 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 623.2" "Group enriched" "Detected in many" 5 "B-cells: 177.4;granulocytes: 220.7;Hofbauer cells: 214.9;Langerhans cells: 508.2;Macrophages: 604.2;monocytes: 386.0" "Cancer enhanced" "Detected in all" "melanoma: 39.4" "Region enhanced" "Detected in all" "cerebral cortex: 36.5" "Group enriched" "Detected in all" 5 "eosinophil: 284.0;intermediate monocyte: 195.8;neutrophil: 534.0;non-classical monocyte: 378.9" "Group enriched" "Detected in all" 7 "granulocytes: 534.0;monocytes: 378.9" "Cell line enriched" "Detected in many" 5 "SK-MEL-30: 525.0" "Low region specificity" "Detected in single" NA NA "unprognostic (3.19e-3)" "unprognostic (2.61e-1)" "unprognostic (3.99e-2)" "unprognostic (3.54e-3)" "unprognostic (9.65e-3)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-2)" "unprognostic (4.01e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.61e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" 28.9 1.7 3.2 106.0 3.3 623.2 4.3 3.2 36.5 4.3 6.8 5.9 4.6 2.8 1.6 2.5 8.5 17.5 3.8 2.8 4.9 3.4 14.8 59.5 72.6 4.9 3.8 2.6 0.9 4.7 0.9 1.3 20.6 13.4 2.3 6.0 0.6 4.4 1.0 0.9 1.7 8.0 13.6 4.4 58.4 5.7 0.5 5.9 17.4 2.4 10.8 57.1 52.6 1.7 9.4 0.4 1.4 0.0 0.1 0.6 0.9 0.0 0.0 6.9 0.0 0.6 0.0 0.1 3.0 0.2 0.0 0.2 0.0 0.0 14.3 4.1 1.5 0.0 0.6 0.0 1.4 2.2 3.7 111.4 2.0 0.1 8.2 0.0 0.2 0.7 0.6 0.0 0.4 0.2 0.0 0.1 19.3 0.1 0.0 3.5 0.2 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.0 525.0 0.0 0.0 5.0 0.0 51.8 4.9 0.2 1.1 0.5 0.3 4.3 2.3 40.3 27.4 24.2 42.3 284.0 24.5 195.8 13.9 64.4 31.3 32.4 25.2 44.2 38.1 35.1 534.0 21.5 378.9 5.0 8.0 49.1 3.2 3.3 3.2 36.5 2.8 4.9 4.9 3.8 2.6 13.4 4.4 5.9 9.4 7.6 22.4 57.3 0.0 177.4 11.0 0.8 50.9 0.6 0.1 2.9 3.7 4.3 0.0 38.0 1.8 0.0 1.9 33.9 0.3 1.9 2.2 1.3 12.0 4.2 6.2 0.0 1.3 0.1 1.6 2.3 8.4 2.0 41.1 220.7 0.2 1.4 1.6 214.9 0.0 0.1 0.1 2.0 60.5 508.2 1.5 0.0 604.2 33.8 0.0 386.0 0.3 13.4 0.0 0.0 6.5 0.1 0.0 14.6 1.4 0.1 0.8 13.8 0.2 0.0 1.3 4.8 0.3 0.2 0.5 10.2 4.5 53.3 0.1 0.2 1.8 HMG20A "FLJ10739, HMGX1, HMGXB1" ENSG00000140382 "High mobility group 20A" Q9NP66 15 77420412-77485607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008126 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA008126: AB_1079072" "unprognostic (2.04e-1)" "unprognostic (6.87e-2)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (9.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" 12.3 18.3 13.9 16.0 14.3 10.3 14.4 15.3 17.7 15.4 8.7 15.6 12.6 20.5 13.7 13.5 13.3 15.6 25.3 14.5 14.4 14.1 25.1 15.8 25.4 12.8 13.7 13.5 22.4 13.2 18.3 9.8 22.0 12.3 11.7 17.2 26.2 13.7 14.0 27.4 13.5 14.4 15.8 11.5 36.1 13.7 21.5 14.3 31.9 15.1 26.6 22.3 14.5 10.9 16.7 17.8 29.8 53.8 38.4 22.4 28.4 21.6 23.2 34.6 27.2 29.5 18.6 26.7 30.2 26.4 27.0 21.0 23.8 76.6 29.3 27.6 27.1 38.4 62.3 26.6 24.5 33.4 46.1 35.7 31.9 20.9 24.2 26.8 36.3 54.9 38.9 47.8 24.6 25.1 14.1 36.8 32.1 39.0 15.8 14.2 48.0 52.1 34.2 31.1 30.7 21.1 45.3 37.5 22.6 70.6 51.2 22.3 48.3 33.8 32.3 28.4 15.2 28.4 33.2 75.7 59.9 24.1 66.3 38.4 9.2 20.8 16.9 29.1 21.2 34.4 31.3 22.9 27.3 27.8 27.3 30.8 27.3 3.4 49.2 26.1 21.1 23.7 24.9 13.9 14.3 15.3 17.7 14.5 14.4 12.8 13.7 13.5 12.3 11.5 14.3 16.7 14.6 12.8 11.5 39.2 18.1 8.8 5.3 10.0 13.6 20.6 13.0 12.3 47.2 14.3 10.7 11.0 25.0 13.7 12.9 12.2 5.9 9.9 25.9 10.4 21.1 16.8 18.0 15.4 60.1 8.0 9.5 17.2 13.7 10.0 12.7 16.5 22.9 32.4 16.6 38.7 56.9 15.6 6.1 28.6 11.9 79.5 12.8 13.0 14.2 29.0 22.1 14.3 19.6 64.3 71.1 9.0 10.8 13.9 13.3 6.0 8.4 10.6 4.9 20.6 19.7 13.4 13.2 28.2 17.0 11.3 7.4 13.8 16.4 25.5 13.8 5.5 SCAPER "Zfp291, ZNF291" ENSG00000140386 "S-phase cyclin A associated protein in the ER" Q9BY12 15 76347904-76905444 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 55.8" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046253, HPA048077" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA No "Nucleoplasm, Nuclear speckles" Cytosol "HPA046253: AB_2679600, HPA048077: " "unprognostic (3.67e-1)" "unprognostic (8.60e-2)" "unprognostic (6.08e-2)" "unprognostic (8.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (4.94e-2)" "unprognostic (3.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.02e-1)" "prognostic favorable (2.69e-9)" "unprognostic (2.14e-1)" "unprognostic (3.79e-1)" "unprognostic (1.86e-1)" "unprognostic (2.89e-3)" 5.6 7.9 11.6 4.1 12.6 7.4 7.0 19.0 12.4 6.2 6.7 5.1 6.6 7.5 7.8 9.0 6.5 5.4 13.9 10.1 11.2 9.1 7.5 6.4 4.8 11.4 11.6 8.5 12.2 8.4 14.6 8.2 6.6 12.4 7.1 4.5 55.8 8.0 6.2 13.7 6.9 6.3 6.3 9.3 5.9 6.1 21.1 11.1 8.6 12.3 12.1 6.0 5.1 6.5 17.4 6.3 5.8 7.8 4.5 3.9 7.0 6.5 8.3 5.9 3.8 5.4 6.1 5.0 6.3 7.2 2.8 10.0 6.7 18.5 3.5 5.7 14.7 9.1 3.3 6.8 3.0 4.9 9.0 7.6 5.9 6.0 4.5 7.3 8.2 5.2 12.6 4.8 17.5 6.6 2.6 8.8 2.7 2.3 5.5 3.3 7.9 12.4 2.2 3.5 6.3 18.4 8.9 11.2 3.9 9.0 9.4 5.8 7.3 6.3 8.7 8.1 4.1 7.4 10.5 23.7 8.9 5.1 11.1 5.9 40.8 6.3 17.4 11.4 3.5 13.1 16.3 11.5 10.3 3.6 17.0 18.8 12.1 10.7 17.1 4.2 9.3 9.7 4.2 11.6 12.6 19.0 12.4 10.1 11.2 11.4 11.6 8.5 12.4 9.3 11.1 17.4 28.5 99.3 61.5 190.7 33.2 20.6 28.9 10.6 18.8 91.5 13.9 15.5 191.3 12.8 27.4 12.9 252.3 33.8 26.6 17.1 1.9 14.6 59.1 10.6 13.8 23.5 16.2 1.7 151.5 6.0 11.8 22.1 17.3 18.4 22.1 41.9 21.8 9.3 14.3 77.4 201.8 9.0 6.1 13.6 11.3 24.9 20.5 14.4 10.6 135.9 12.8 51.3 34.0 203.1 251.5 6.5 11.4 19.2 28.6 15.9 72.6 7.8 12.3 710.6 19.7 39.1 23.5 143.9 68.9 15.1 18.8 52.0 30.5 26.7 13.4 19.7 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 705.9;Muller glia cells: 508.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2" "Group enriched" "Detected in all" 5 "B-cells: 488.1;dendritic cells: 313.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 336.8 145.3 267.7 88.1 257.3 33.5 144.5 265.6 295.0 139.4 279.5 367.5 345.2 132.1 436.5 79.1 252.0 187.9 109.8 252.9 294.8 213.2 88.1 203.9 88.8 263.8 268.0 240.7 149.4 141.4 285.7 191.2 112.6 262.8 97.1 389.9 422.3 153.4 189.0 433.2 78.9 352.1 129.4 273.3 85.6 223.2 85.6 276.0 72.3 202.1 377.7 107.8 171.7 68.0 288.1 130.6 347.6 282.8 179.3 484.7 295.8 93.3 203.7 220.2 245.1 265.7 213.5 264.7 126.9 294.8 211.6 234.0 289.0 271.2 139.5 182.9 143.4 410.4 91.0 252.5 204.4 234.5 118.4 64.3 280.9 165.5 135.8 120.1 372.6 304.8 83.1 98.0 109.2 243.3 49.5 105.7 112.1 200.5 414.7 152.4 130.8 351.0 135.3 408.0 73.0 255.0 282.1 139.8 116.9 393.7 269.3 125.0 220.8 292.1 225.7 88.4 138.0 290.7 237.4 346.6 67.1 200.1 173.5 131.9 8.8 51.3 10.4 32.6 69.6 34.1 481.0 16.5 23.9 99.2 488.1 42.6 39.3 4.8 60.3 77.1 313.2 4.6 95.2 267.7 257.3 265.6 295.0 252.9 294.8 263.8 268.0 240.7 262.8 273.3 276.0 288.1 76.1 112.2 213.4 69.5 83.8 34.7 77.5 114.6 36.5 247.7 43.6 32.3 98.2 108.7 169.0 68.0 183.5 89.9 41.3 705.9 25.4 250.2 28.5 86.1 63.4 57.6 91.3 19.4 47.8 354.0 35.6 90.8 85.1 41.7 23.4 88.6 53.6 29.5 65.4 127.9 54.3 290.4 97.6 58.0 27.5 57.9 64.3 38.2 72.9 29.0 35.1 508.9 36.0 116.6 32.7 245.1 410.7 51.6 81.2 220.1 364.3 65.5 201.7 185.1 26.3 44.8 189.0 108.0 64.6 34.2 34.2 75.9 19.4 149.5 205.2 381.4 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299703 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 28000 "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favorable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 38.6 53.2 52.3 29.9 37.8 62.0 60.5 49.9 103.9 41.2 37.8 39.9 36.5 35.2 116.7 40.5 47.0 28.8 41.4 92.7 41.4 61.4 51.3 34.9 37.7 44.8 40.0 35.8 34.9 41.7 56.1 50.3 35.8 44.9 46.4 43.9 49.8 39.8 37.8 45.7 52.5 30.7 41.8 45.6 30.1 33.8 49.5 47.9 49.0 57.3 38.5 46.4 41.8 32.7 85.4 39.3 92.4 74.3 77.4 74.1 61.6 56.1 60.9 68.6 76.6 73.6 87.9 67.9 80.7 72.6 69.8 119.2 78.2 165.8 71.5 58.3 53.9 123.8 66.2 79.9 84.6 62.6 99.2 63.3 52.8 50.5 30.8 24.0 52.7 82.7 80.0 113.1 78.8 92.5 116.6 82.3 81.6 54.3 98.5 76.2 74.7 59.7 89.1 81.3 112.3 103.7 56.2 88.0 90.9 323.7 76.9 56.0 124.2 58.2 53.7 66.0 38.2 103.6 69.3 113.7 113.0 80.5 153.3 112.6 39.0 91.2 33.6 59.6 100.0 65.0 66.4 59.7 62.1 134.2 53.5 62.2 68.6 7.7 72.4 86.0 71.6 72.7 89.1 52.3 37.8 49.9 103.9 92.7 41.4 44.8 40.0 35.8 44.9 45.6 47.9 85.4 38.7 35.3 44.7 20.5 26.7 49.1 61.5 105.0 31.9 57.2 44.8 47.2 25.8 28.6 57.5 38.6 47.9 106.1 29.2 23.2 125.2 62.5 32.2 41.5 38.6 42.2 23.4 37.6 34.6 55.6 78.1 51.0 20.4 29.1 47.5 49.1 40.0 47.0 66.1 43.7 36.8 38.0 93.6 37.0 47.2 12.4 50.1 37.0 58.7 12.2 61.1 81.9 42.2 17.1 33.1 41.0 28.5 50.8 36.4 51.6 35.4 132.7 70.1 50.7 6.6 37.8 90.2 122.4 60.2 38.3 58.7 92.4 31.7 59.4 52.4 57.7 NCOA2 "bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2" ENSG00000140396 "Nuclear receptor coactivator 2" Q15596 8 70109782-70403808 "Cancer-related genes, Disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 161.6;Excitatory neurons: 158.9;Inhibitory neurons: 314.8;Microglial cells: 233.3;Oligodendrocyte precursor cells: 249.8;Oligodendrocytes: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060243 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA060243: AB_2684229" "unprognostic (9.79e-3)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.91e-2)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (2.06e-1)" "unprognostic (7.00e-2)" "unprognostic (2.20e-2)" "unprognostic (2.63e-2)" "prognostic favorable (5.08e-4)" "unprognostic (2.52e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-1)" 7.9 9.0 9.6 10.0 10.4 23.5 13.6 9.7 10.8 10.1 2.9 10.7 11.7 10.2 29.9 15.5 11.0 8.9 15.1 13.9 11.6 14.5 24.0 10.1 11.6 8.2 8.1 7.0 16.3 7.4 15.4 7.3 12.2 9.2 13.0 10.7 26.4 11.4 12.3 8.4 10.6 12.2 9.0 4.5 12.5 11.0 14.8 8.9 15.4 12.2 16.1 12.6 10.1 10.0 7.6 13.7 16.9 18.2 10.3 16.2 16.5 18.6 7.8 7.8 5.9 5.5 8.6 15.6 16.3 3.1 14.3 9.7 8.0 22.5 10.7 6.5 38.7 17.9 28.5 8.5 13.8 8.5 5.8 7.2 14.5 11.7 7.9 11.3 9.2 4.0 11.7 9.2 24.0 6.9 13.7 14.5 5.8 9.6 15.7 7.9 14.1 7.6 10.3 9.3 22.5 13.8 10.2 13.4 7.1 11.0 12.7 16.7 10.5 5.3 8.4 10.6 10.8 4.2 31.5 17.3 15.4 8.6 7.6 12.5 3.1 1.6 2.2 2.2 2.3 1.5 1.3 1.3 1.9 1.5 2.1 1.5 1.6 5.7 1.4 5.2 0.6 2.0 1.2 9.6 10.4 9.7 10.8 13.9 11.6 8.2 8.1 7.0 9.2 4.5 8.9 7.6 20.9 12.8 25.1 161.6 27.3 16.2 8.6 10.8 17.6 25.8 29.5 17.5 34.1 28.6 25.8 25.8 52.1 22.1 26.9 30.8 11.7 9.3 6.4 23.6 26.4 17.7 25.2 28.8 158.9 12.4 12.5 21.6 21.4 38.0 22.2 23.2 22.1 65.9 17.4 74.0 314.8 17.4 10.2 46.8 17.8 7.6 19.9 28.1 21.4 233.3 23.1 14.3 19.6 249.8 186.0 12.8 14.8 22.2 49.9 15.5 22.7 17.6 19.0 33.4 26.3 22.5 20.2 13.3 16.5 18.8 21.5 31.7 36.6 10.9 17.0 15.8 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357115 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Granulosa cells: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8" "Group enriched" "Detected in many" 11 "B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2" "Cell line enhanced" "Detected in many" "Daudi: 11.5;HeLa: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 7.7 14.7 2.0 3.1 2.3 4.4 11.7 5.3 4.7 13.6 1.4 9.2 5.8 10.1 1.7 7.3 13.0 3.9 5.5 2.0 0.7 8.8 12.9 8.4 6.1 1.3 0.6 1.8 13.4 11.0 3.4 11.1 2.5 2.1 12.5 1.1 2.7 16.7 4.1 9.0 8.1 8.4 2.0 0.0 8.8 10.5 3.7 0.5 2.7 10.8 0.6 3.0 8.2 11.0 1.7 2.2 3.6 2.3 1.4 0.7 0.8 4.5 1.3 0.0 0.5 0.1 0.6 4.0 11.5 2.1 0.2 1.1 6.1 1.4 0.4 0.0 5.7 9.1 2.0 11.8 1.7 0.9 2.1 2.6 0.3 1.7 0.6 0.0 5.6 1.4 1.1 1.4 3.3 0.3 2.9 0.4 6.3 2.1 0.4 0.8 2.1 1.5 0.5 2.1 2.4 1.4 2.8 2.2 1.0 3.2 1.2 4.2 3.5 6.3 1.3 2.3 1.8 1.2 5.2 5.5 9.7 1.1 9.4 1.2 0.0 0.6 0.0 5.2 0.3 1.3 4.8 0.9 1.2 0.2 6.4 1.4 1.4 0.8 15.8 0.2 0.3 0.3 1.4 2.0 2.3 5.3 4.7 2.0 0.7 1.3 0.6 1.8 2.1 0.0 0.5 1.7 15.9 22.4 19.2 19.9 33.7 6.4 15.4 10.1 23.3 20.0 22.1 15.9 2.9 10.0 21.9 14.7 10.4 10.8 19.1 13.6 1.9 9.0 20.4 31.8 7.3 16.9 21.6 8.0 33.5 8.3 3.6 7.7 22.4 15.4 11.4 105.6 24.3 11.5 3.4 10.1 29.9 20.0 10.2 5.7 7.0 2.6 19.0 3.3 8.8 8.4 1.7 14.6 55.6 5.5 4.5 7.3 16.0 13.5 9.1 9.2 21.4 8.9 41.9 6.5 6.6 6.6 6.4 1.6 1.5 11.0 5.8 4.8 10.0 2.0 14.5 8.7 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368612 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 110000 Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 49.5 66.7 16.8 24.1 17.8 38.0 49.7 14.5 29.1 51.4 15.6 41.1 25.7 49.7 12.2 30.2 51.0 16.6 52.8 17.1 16.5 52.7 50.4 50.8 20.5 19.8 15.8 19.0 59.0 49.5 26.5 57.0 21.2 18.2 49.8 15.1 14.9 37.6 19.7 58.9 35.6 41.9 18.8 14.5 55.1 46.4 35.1 16.2 17.2 65.3 24.7 12.8 46.1 41.8 19.1 11.0 25.5 21.3 15.7 23.8 20.4 27.1 25.3 23.5 12.9 10.9 20.3 38.3 5.7 14.6 18.6 11.8 33.0 11.7 17.1 8.4 30.8 26.1 34.0 58.5 18.1 35.3 23.1 5.7 25.3 17.0 12.3 15.3 27.3 30.9 16.9 20.5 27.4 10.7 22.1 11.9 25.2 9.0 13.2 11.8 16.0 11.0 34.6 16.8 49.8 13.2 22.7 16.4 23.9 11.5 15.6 26.1 26.1 61.5 27.1 18.7 19.0 25.5 27.9 7.1 9.3 17.6 25.9 27.6 4.0 19.8 3.5 9.2 23.0 9.1 3.2 6.9 6.8 22.6 2.6 9.5 6.9 2.2 6.0 18.9 9.2 10.2 14.3 16.8 17.8 14.5 29.1 17.1 16.5 19.8 15.8 19.0 18.2 14.5 16.2 19.1 34.1 22.4 51.7 29.0 12.5 13.5 15.2 13.0 11.4 30.7 18.2 16.3 2.8 5.7 19.2 9.2 54.2 17.2 17.2 22.4 3.9 11.4 10.4 10.1 18.3 23.2 34.2 7.6 28.9 8.7 10.9 20.4 39.3 12.7 31.7 46.8 32.5 22.4 20.4 28.6 23.8 19.5 12.2 29.8 20.2 14.0 23.3 26.3 16.0 15.0 31.4 17.3 19.6 18.1 19.5 11.2 20.0 12.4 12.9 16.0 27.9 15.9 19.3 52.4 26.3 25.6 16.3 21.1 10.4 14.9 8.5 21.2 16.2 17.0 24.0 15.3 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 145.8" "Group enriched" "Detected in many" 5 "Early spermatids: 673.9;Late spermatids: 1608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: AB_2677674" "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 13.4 20.2 83.6 14.1 74.4 64.2 12.7 68.2 128.9 14.2 60.3 16.5 13.9 8.4 20.4 16.0 39.2 11.3 124.4 95.0 89.4 26.5 3.3 19.9 11.4 73.4 74.6 65.1 12.2 6.6 7.5 31.2 9.6 84.6 27.0 18.7 33.3 15.8 15.8 124.4 28.8 16.4 19.8 86.5 13.6 24.4 78.9 94.9 9.5 9.7 145.8 12.5 29.9 13.7 113.9 33.6 0.2 0.0 0.0 0.0 0.0 0.1 4.1 0.0 1.1 0.5 0.0 43.3 0.0 0.3 3.2 0.0 31.3 0.0 0.0 0.1 0.1 0.0 19.9 47.3 0.0 9.4 0.0 20.6 3.6 4.1 2.6 0.0 0.0 6.6 0.0 0.0 0.0 0.4 33.6 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.1 85.2 53.3 0.0 42.7 8.6 3.6 2.3 32.4 39.8 0.5 0.0 8.7 4.0 0.4 0.6 2.4 0.0 0.1 4.2 0.0 0.0 0.3 1.1 0.6 0.3 1.0 0.7 0.9 0.9 0.4 0.1 1.7 1.4 0.0 0.1 0.4 0.2 0.5 0.6 83.6 74.4 68.2 128.9 95.0 89.4 73.4 74.6 65.1 84.6 86.5 94.9 113.9 41.9 6.4 4.8 12.7 10.0 28.8 209.9 14.0 2.2 19.6 44.6 29.2 43.6 2.8 33.5 7.3 81.3 1.9 6.7 55.5 1.9 1.3 673.9 124.0 11.4 18.9 100.3 92.8 16.6 2.4 3.8 18.3 21.4 41.8 36.9 7.5 6.8 0.2 16.5 6.7 24.0 34.9 10.2 9.5 81.7 1608.0 10.2 51.7 51.6 6.5 3.5 10.3 6.2 15.1 19.0 5.1 55.3 11.3 3.7 115.8 15.8 7.2 138.9 22.6 6.6 17.4 20.2 33.8 27.7 16.9 46.7 6.8 37.1 6.9 42.1 190.1 TLNRD1 "MESDC1, MGC99595" ENSG00000140406 "Talin rod domain containing 1" Q9H1K6 15 81000923-81005788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 36.8;Exocrine glandular cells: 31.5;Extravillous trophoblasts: 31.5;Glandular and luminal cells: 27.7;Hofbauer cells: 35.2;Pancreatic endocrine cells: 44.1;Proximal tubular cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 47.0;SK-MEL-30: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071716 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA071716: AB_2732183" "unprognostic (1.32e-2)" "unprognostic (5.30e-2)" "unprognostic (9.29e-2)" "unprognostic (5.37e-3)" "unprognostic (9.10e-3)" "unprognostic (1.24e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (1.68e-2)" "unprognostic (6.82e-2)" "unprognostic (1.81e-1)" "unprognostic (3.24e-1)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.91e-1)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "unprognostic (3.82e-3)" 11.5 9.7 5.5 5.4 8.7 7.5 7.9 12.6 6.6 5.9 5.9 6.4 3.8 7.3 2.0 8.2 7.2 3.7 8.3 5.3 4.1 7.4 6.2 14.6 4.3 6.8 5.5 4.6 4.7 10.2 1.6 5.9 4.6 6.6 5.4 3.0 1.2 6.3 1.8 1.9 3.3 7.0 2.4 5.2 11.9 8.1 1.6 6.3 3.6 5.3 2.1 3.0 7.8 5.6 5.1 11.2 3.6 9.4 6.8 4.1 2.4 15.5 10.0 2.8 6.2 4.5 6.3 10.0 12.1 13.7 2.5 3.7 14.2 5.8 3.2 3.5 47.0 17.0 23.8 2.2 6.9 3.1 8.4 16.6 2.5 4.2 3.8 3.7 2.2 9.4 10.3 13.7 29.3 4.2 5.6 13.3 9.7 14.9 7.2 5.0 16.9 9.5 27.7 4.0 11.2 14.7 12.5 5.6 6.1 48.0 8.0 5.4 7.3 11.2 7.1 22.3 9.9 15.1 20.2 21.4 12.9 4.8 12.0 7.5 0.5 0.3 0.4 0.6 0.5 0.5 0.8 0.7 0.7 0.2 0.5 0.3 0.5 0.5 1.2 0.4 0.5 0.3 0.3 5.5 8.7 12.6 6.6 5.3 4.1 6.8 5.5 4.6 6.6 5.2 6.3 5.1 36.8 0.0 9.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 23.3 12.7 0.0 0.0 4.3 12.9 0.0 8.4 19.3 0.0 1.9 15.1 0.0 13.4 21.4 17.6 0.0 0.0 0.0 31.5 31.5 10.4 0.0 27.7 2.5 15.9 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 44.1 0.0 0.0 4.1 0.0 0.0 30.9 2.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 9.0 6.5 11.1 0.0 0.0 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 9637.8;skeletal muscle: 12799.1;tongue: 5229.5" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 13012.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 48.7" "Group enriched" "Detected in all" 4 "dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 3141.3;SuSa: 3810.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" NA NA 120000000 "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (7.30e-4)" 346.6 104.6 48.9 235.0 47.1 21.7 351.9 51.1 57.2 563.8 73.6 2128.0 292.3 1580.2 252.7 645.0 831.0 290.6 9637.8 51.0 42.8 210.7 95.5 249.2 48.5 41.7 42.5 45.7 323.0 386.7 37.8 71.1 208.2 43.4 816.7 528.0 84.6 260.3 1560.2 12799.1 146.6 686.6 1770.5 43.4 135.4 984.8 52.7 46.7 21.3 158.1 5229.5 29.7 1523.6 429.4 43.5 554.5 357.3 418.1 20.9 143.1 89.9 1335.5 1509.1 552.8 905.9 669.2 253.9 107.6 1.7 677.7 1517.1 602.7 295.9 361.8 243.4 597.0 14.5 50.9 81.2 376.3 124.5 403.3 3.8 17.9 125.7 138.0 742.1 198.2 3141.3 243.2 14.7 8.7 20.4 695.3 286.4 25.6 7.1 496.0 129.0 61.1 9.0 146.5 15.8 1308.7 298.8 101.1 71.7 180.9 284.4 65.1 3810.3 204.8 15.3 1095.8 1178.8 572.0 181.6 1094.8 5.9 4.3 7.8 335.9 22.4 842.1 48.7 9.9 4.8 4.0 19.2 3.1 5.5 3.6 4.3 14.1 5.6 4.0 3.6 10.7 1.9 14.3 2.4 6.3 15.6 48.9 47.1 51.1 57.2 51.0 42.8 41.7 42.5 45.7 43.4 43.4 46.7 43.5 542.3 57.7 86.3 19.9 12.1 71.9 202.0 344.1 18.2 49.0 450.1 953.1 13012.4 346.0 147.0 318.2 383.7 212.1 20.6 561.3 187.9 2502.6 6.5 147.2 614.4 294.3 267.7 137.0 44.2 1671.1 3094.8 557.1 279.3 211.2 52.0 85.3 175.6 138.1 201.5 52.2 53.2 964.7 183.1 42.5 72.1 27.3 205.0 114.3 81.8 111.5 47.5 47.4 28.8 36.2 6.0 2372.3 623.4 1130.3 8.8 244.3 724.7 361.1 104.2 447.5 1038.7 484.0 1685.9 27.4 82.2 29.4 50.4 103.0 29.0 130.7 385.3 198.2 IGF1R "CD221, IGFIR, IGFR, JTK13, MGC18216" ENSG00000140443 "Insulin like growth factor 1 receptor" P08069 15 98648539-98964530 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 239.4;Inhibitory neurons: 194.6;Microglial cells: 245.4;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 261.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 6 "granulocytes: 4.3;T-cells: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010268, HPA045563" Approved NA NA 46000 "CAB010268: AB_671792, HPA045563: AB_2679368" "unprognostic (1.30e-3)" "unprognostic (5.81e-3)" "unprognostic (1.53e-1)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (2.05e-2)" "unprognostic (1.29e-2)" "unprognostic (6.87e-2)" "unprognostic (2.64e-2)" "unprognostic (2.87e-2)" "unprognostic (8.56e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.75e-7)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" 6.9 11.3 10.5 3.7 11.2 11.1 12.4 10.7 10.9 9.6 29.9 10.4 2.5 11.1 11.2 7.6 13.1 4.6 9.3 9.1 7.7 11.7 0.9 9.6 2.7 12.4 13.1 7.0 15.9 15.5 2.1 8.9 12.2 12.4 14.9 4.6 16.1 10.1 9.6 7.1 10.9 6.5 6.1 10.0 5.8 9.7 8.4 11.4 6.2 13.0 11.7 3.5 10.0 10.1 11.5 6.1 34.0 22.6 0.2 11.9 8.3 16.3 8.0 14.5 2.5 2.2 15.6 17.5 1.6 22.1 13.8 14.7 31.6 10.9 25.0 1.9 0.1 11.1 27.5 32.3 31.2 10.4 11.1 2.5 12.1 14.9 4.5 18.6 9.3 8.4 2.8 1.4 5.4 9.9 48.1 5.4 9.8 23.0 11.8 1.3 7.7 19.3 6.7 7.4 37.8 8.1 35.9 56.0 3.3 30.1 50.2 16.7 3.8 24.5 1.5 26.5 6.5 12.0 1.9 9.8 5.9 4.6 10.0 5.9 1.9 0.3 0.9 0.4 0.2 0.2 0.1 0.3 0.1 0.1 0.4 1.4 0.4 4.3 0.5 0.3 0.1 0.0 0.3 10.5 11.2 10.7 10.9 9.1 7.7 12.4 13.1 7.0 12.4 10.0 11.4 11.5 30.8 28.9 13.4 157.7 3.5 32.8 28.8 31.1 35.3 51.5 58.3 33.4 30.8 5.7 30.2 22.0 91.8 33.7 8.0 10.7 1.9 16.6 27.6 79.7 39.6 26.1 35.0 7.8 239.4 11.2 20.3 25.2 11.2 91.3 0.0 106.5 52.5 1.5 6.5 75.7 194.6 21.1 20.3 6.6 8.3 53.4 18.0 8.3 21.4 245.4 8.5 45.6 14.4 237.7 261.0 29.1 12.9 13.5 4.3 70.9 5.3 21.8 55.4 36.1 0.0 20.4 27.6 4.0 17.2 17.9 32.0 27.5 6.4 20.9 24.5 51.5 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960703-97973833 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 93.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 105.7;Paneth cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.1;classical monocyte: 2.5;eosinophil: 1.5;intermediate monocyte: 1.7;myeloid DC: 1.1;neutrophil: 1.4" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.5;monocytes: 2.5" "Cell line enhanced" "Detected in many" "BJ: 103.2;HSkMC: 55.8;hTCEpi: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 12.7 12.3 22.3 16.7 25.9 11.6 20.0 29.2 28.0 14.8 18.4 38.4 15.9 14.8 15.7 10.1 14.6 17.3 11.8 29.7 52.4 25.2 30.5 20.0 7.6 78.4 27.1 19.6 7.4 35.0 6.4 9.0 18.5 65.7 11.0 23.2 4.6 8.2 16.6 14.9 35.8 22.8 18.3 60.0 8.1 27.1 14.8 25.8 5.8 17.4 9.7 5.1 15.1 10.9 93.6 5.8 0.2 0.8 15.0 6.6 47.7 0.0 103.2 45.8 13.5 6.0 6.2 3.6 0.0 14.2 4.8 1.2 6.0 3.7 36.0 21.6 0.0 9.6 10.1 1.9 4.1 2.6 7.0 15.2 55.8 86.9 15.4 17.9 18.8 0.7 2.9 14.4 0.0 4.9 19.2 1.2 5.8 3.0 17.4 2.1 0.1 0.9 0.2 26.3 12.7 5.0 8.8 15.7 5.7 29.5 3.1 2.1 10.6 0.1 4.0 2.9 21.2 5.0 0.0 0.0 0.2 8.7 1.2 10.6 1.1 2.5 1.5 0.0 1.7 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 1.4 0.0 0.2 0.2 0.0 0.4 22.3 25.9 29.2 28.0 29.7 52.4 78.4 27.1 19.6 65.7 60.0 25.8 93.6 5.7 3.2 10.4 19.9 4.0 25.4 3.1 11.0 23.9 1.6 14.4 8.3 12.9 8.6 9.4 22.0 6.2 0.3 1.4 105.7 7.9 2.7 4.5 21.5 17.6 5.9 38.3 4.4 8.1 8.2 0.2 12.3 15.8 18.0 23.5 1.4 6.4 17.1 21.5 0.0 6.0 29.5 10.2 23.9 10.5 10.9 5.0 19.7 24.9 3.7 13.4 0.7 3.1 38.7 3.4 12.0 82.4 8.2 0.2 12.2 30.2 3.1 15.6 3.5 0.0 7.8 12.5 2.0 12.6 11.8 31.1 0.7 1.3 17.5 31.3 12.2 PIF1 "C15orf20, FLJ22692" ENSG00000140451 "PIF1 5'-to-3' DNA helicase" Q9H611 15 64815632-64825668 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.9" "Cell type enhanced" "Detected in many" "Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3" "Cancer enhanced" "Detected in many" "testis cancer: 10.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB018701 Supported Supported Nucleoplasm NA Yes Nucleoplasm "CAB018701: AB_2164654" "unprognostic (1.99e-1)" "unprognostic (6.11e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.62e-1)" "unprognostic (8.33e-3)" "unprognostic (8.66e-4)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (6.68e-2)" "unprognostic (2.38e-2)" "unprognostic (3.27e-2)" "unprognostic (0.00e+0)" "unprognostic (2.96e-3)" "unprognostic (1.78e-1)" "unprognostic (9.61e-2)" "unprognostic (5.95e-2)" 0.6 1.0 0.9 2.6 0.9 3.8 0.4 0.8 1.3 0.8 0.8 2.2 1.9 0.8 0.1 3.1 0.7 0.8 0.9 0.9 1.2 0.6 0.6 1.0 4.6 1.4 1.0 0.8 0.4 0.2 0.2 0.5 0.9 1.1 1.7 1.1 0.1 0.7 0.7 0.3 1.0 2.6 1.2 1.0 4.9 1.8 2.5 1.2 3.6 0.5 0.2 3.3 1.5 1.4 1.0 7.7 8.7 21.1 8.6 3.7 4.3 7.8 7.4 3.9 7.3 5.6 14.0 12.6 9.3 3.0 3.6 6.8 20.9 21.8 6.2 2.7 14.8 8.0 10.8 28.5 10.2 1.9 4.3 8.4 2.5 0.0 3.2 2.6 1.8 7.5 13.6 7.2 18.0 7.0 6.7 4.7 17.9 17.2 9.7 6.0 9.7 7.0 13.0 4.1 4.3 8.7 5.6 5.7 6.3 3.3 9.2 7.0 4.7 5.2 4.4 22.6 7.0 14.0 14.3 14.3 9.0 4.2 18.8 6.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.9 0.9 0.8 1.3 0.9 1.2 1.4 1.0 0.8 1.1 1.0 1.2 1.0 1.2 0.0 1.1 3.6 6.5 1.9 0.8 0.6 0.0 0.5 0.6 0.6 1.9 0.0 0.1 0.0 0.0 5.1 7.5 3.2 0.0 0.0 21.3 0.4 4.4 2.3 0.0 17.7 2.6 0.0 6.5 5.6 3.6 0.7 0.0 15.1 5.3 0.5 5.8 0.0 1.0 2.4 0.0 5.1 2.0 2.3 1.5 4.5 0.0 1.9 0.1 0.8 15.5 3.5 0.1 0.2 0.1 2.2 9.7 1.1 0.2 0.1 0.1 1.2 6.6 4.2 3.5 0.8 2.0 1.6 1.0 1.1 7.5 18.3 6.2 1.3 USP3 ENSG00000140455 "Ubiquitin specific peptidase 3" Q9Y6I4 15 63504511-63594640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053275, HPA060513, HPA077975" Supported "Nucleoplasm,Midbody ring" "Intracellular and membrane" Yes No Nucleoplasm "Midbody ring" "HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365" "unprognostic (4.63e-3)" "unprognostic (2.71e-1)" "unprognostic (7.88e-2)" "unprognostic (3.33e-2)" "unprognostic (2.16e-2)" "unprognostic (6.03e-2)" "unprognostic (6.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.62e-2)" "unprognostic (2.36e-1)" "unprognostic (3.54e-2)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (8.61e-2)" "unprognostic (2.78e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.38e-4)" 12.0 8.3 5.2 5.4 6.7 21.6 11.3 32.0 4.6 11.3 13.7 13.5 6.5 13.0 4.7 11.0 11.0 5.5 5.8 4.4 5.4 10.2 8.2 13.3 6.6 6.1 6.8 1.8 16.3 19.0 3.1 6.3 2.7 12.5 10.5 5.6 6.3 12.5 6.1 10.1 14.5 14.0 4.5 4.5 17.8 15.8 5.3 7.2 7.5 9.1 3.6 6.5 12.5 12.0 6.8 10.4 21.0 12.1 8.1 5.5 7.6 8.2 6.7 9.6 7.1 5.8 6.6 13.1 8.7 15.3 9.3 3.6 12.0 11.6 11.1 5.6 12.2 5.8 10.4 8.6 9.8 6.8 6.4 11.4 11.3 7.8 7.7 10.6 8.9 12.4 17.3 9.5 9.0 3.3 5.2 11.0 8.8 16.2 13.7 5.3 22.2 8.4 11.3 4.5 23.8 9.6 9.5 3.3 13.0 6.7 7.8 5.5 9.5 13.4 7.2 16.9 3.3 10.3 9.3 24.4 18.2 7.4 13.8 7.5 120.0 84.7 12.7 24.8 66.0 28.4 34.1 34.3 26.0 59.8 34.8 34.0 25.2 169.1 19.8 65.4 13.1 28.1 45.2 5.2 6.7 32.0 4.6 4.4 5.4 6.1 6.8 1.8 12.5 4.5 7.2 6.8 23.6 38.5 69.2 76.7 63.4 52.6 34.3 24.8 23.3 31.4 27.9 20.3 9.2 25.8 41.4 16.5 12.5 19.8 48.4 37.6 41.1 41.0 21.6 37.8 32.8 26.0 43.8 15.8 11.2 37.2 57.3 28.3 39.8 74.6 27.1 64.5 11.4 24.0 24.8 13.5 40.0 35.4 30.5 78.4 109.6 77.4 15.8 74.5 42.7 75.9 101.8 25.9 41.2 80.4 40.6 39.8 35.6 18.4 69.7 40.6 33.2 28.3 33.3 17.9 13.1 25.3 34.5 14.8 40.3 33.9 59.0 34.1 64.6 40.1 40.6 37.6 CYP11A1 "CYP11A, P450SCC" ENSG00000140459 "Cytochrome P450 family 11 subfamily A member 1" P05108 15 74337759-74367646 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "adrenal gland: 1018.2" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 345.1;Peritubular cells: 173.8;Syncytiotrophoblasts: 1452.0;Theca cells: 637.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "basophil: 10.2" "Lineage enriched" "Detected in single" 48 "granulocytes: 10.2" "Group enriched" "Detected in some" 5 "BEWO: 55.2;HEL: 46.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 1.8;hippocampal formation: 1.1;hypothalamus: 1.3;midbrain: 4.5;pons: 1.1" HPA016436 Enhanced NA NA "HPA016436: AB_1847423" "unprognostic (8.89e-2)" "unprognostic (6.96e-2)" "unprognostic (4.95e-3)" "unprognostic (9.31e-2)" "unprognostic (9.42e-4)" "unprognostic (1.90e-1)" "unprognostic (1.55e-3)" "unprognostic (8.06e-2)" "unprognostic (3.04e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-2)" "unprognostic (5.45e-2)" "unprognostic (9.66e-4)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (3.04e-2)" "unprognostic (7.95e-2)" 1.9 1018.2 2.1 0.6 1.9 0.1 1.9 1.9 2.0 1.7 2.8 0.6 0.3 1.6 0.8 6.4 2.4 0.4 1.2 1.6 2.6 0.6 3.6 0.6 0.1 2.4 2.0 1.4 39.2 0.3 0.0 2.8 25.4 2.5 1.2 0.2 0.7 1.2 0.5 2.6 0.5 0.8 0.9 2.4 4.9 0.9 23.2 1.7 0.4 0.3 1.0 2.2 0.5 1.0 2.3 0.0 0.0 0.0 0.2 0.0 0.4 55.2 0.1 0.0 0.4 0.1 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.2 46.8 1.2 0.5 0.2 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 11.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.9 1.9 2.0 1.6 2.6 2.4 2.0 1.4 2.5 2.4 1.7 2.3 0.1 0.0 0.0 6.2 0.0 0.3 0.0 0.0 34.1 0.1 0.6 0.9 1.2 2.8 0.0 0.0 0.0 144.6 0.0 0.0 1.9 0.0 1.6 0.2 4.9 0.8 0.0 0.0 0.2 0.0 345.1 10.0 0.0 0.2 0.0 41.3 0.0 3.6 22.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 48.7 0.4 0.0 1.0 0.6 6.2 0.0 0.0 0.2 0.5 0.0 173.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 1.2 4.6 2.8 8.7 0.0 1452.0 0.0 637.4 0.0 0.0 BBS4 ENSG00000140463 "Bardet-Biedl syndrome 4" Q96RK4 15 72686179-72738475 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 120.9;Rod photoreceptor cells: 89.9;Spermatocytes: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 62.3" "Low region specificity" "Detected in all" HPA039418 Approved Approved Cytosol NA NA Cytosol "HPA039418: AB_10672962" "unprognostic (3.47e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" "prognostic favorable (2.57e-4)" "unprognostic (3.54e-1)" "unprognostic (2.91e-1)" "unprognostic (8.76e-2)" "unprognostic (5.47e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (3.22e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.05e-1)" 8.8 14.9 11.5 6.9 11.4 7.8 11.0 10.8 13.3 12.7 16.5 10.3 5.1 12.6 15.6 5.8 17.7 9.4 11.2 11.1 12.5 15.7 12.8 10.5 8.0 11.3 12.2 10.7 14.1 11.2 17.6 20.8 7.9 12.1 20.9 7.7 45.8 8.0 9.5 18.9 9.3 8.0 9.4 10.8 7.6 11.1 20.6 11.3 11.6 16.2 10.2 7.1 11.2 9.2 11.8 6.1 15.7 34.0 14.4 16.5 19.7 9.0 11.9 24.4 11.3 14.8 8.1 20.2 9.6 24.7 10.2 8.6 9.4 9.1 9.9 10.3 10.0 11.0 11.4 13.3 9.2 13.5 10.2 8.6 18.8 13.2 16.3 12.8 17.1 8.9 18.3 25.4 8.2 18.1 10.7 9.6 9.6 48.8 12.3 6.8 6.4 17.1 12.3 19.2 15.2 16.4 19.2 20.8 15.0 31.2 13.1 20.4 11.3 12.5 13.2 10.0 62.3 6.7 17.1 17.8 21.0 14.9 15.3 18.1 5.5 1.9 3.3 5.1 2.9 4.9 4.8 4.3 5.5 1.6 6.0 4.3 5.9 1.6 11.0 2.5 3.1 5.7 2.8 11.5 11.4 10.8 13.3 11.1 12.5 11.3 12.2 10.7 12.1 10.8 11.3 11.8 6.0 19.2 19.2 35.3 8.3 3.1 6.0 9.4 10.8 39.0 8.4 10.5 19.8 4.3 18.2 12.9 120.9 10.0 10.6 3.5 5.9 14.4 19.9 28.8 11.1 8.1 4.2 5.2 18.6 11.3 5.8 12.4 7.7 8.4 13.9 8.7 7.1 7.4 7.8 21.9 22.8 8.0 6.1 5.8 2.4 12.2 15.8 5.9 5.4 19.7 4.4 39.4 9.2 31.7 30.7 8.9 4.9 20.3 9.0 8.0 5.1 9.4 48.8 89.9 0.0 11.0 11.5 79.0 63.6 4.6 2.8 5.3 9.3 24.3 5.1 2.8 PML "MYL, RNF71, TRIM19" ENSG00000140464 "PML nuclear body scaffold" P29590 15 73994673-74047827 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Transferase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008312, CAB010194, CAB016304" Supported Enhanced "Nuclear bodies" NA NA "Nuclear bodies" "CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643" "prognostic favorable (3.24e-4)" "unprognostic (4.83e-2)" "unprognostic (5.76e-2)" "unprognostic (1.58e-3)" "unprognostic (7.53e-3)" "unprognostic (1.58e-1)" "unprognostic (2.35e-2)" "unprognostic (5.30e-3)" "unprognostic (4.54e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-2)" "prognostic unfavorable (6.27e-8)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.99e-2)" 77.3 29.7 13.8 25.8 13.5 38.5 77.7 11.0 16.5 53.5 12.5 41.2 18.6 47.5 7.6 38.6 45.0 21.8 37.0 12.8 14.8 35.4 25.6 75.8 25.9 16.0 12.7 9.8 37.8 20.5 8.3 27.0 23.9 14.6 41.9 8.6 3.9 44.6 17.4 22.6 46.6 39.3 19.7 12.1 49.0 35.6 11.4 15.3 17.1 48.5 7.9 15.3 43.1 44.8 15.8 37.2 13.8 11.8 11.4 30.2 43.2 40.6 18.5 31.6 55.9 63.3 14.6 64.2 16.4 63.7 31.6 53.3 66.6 16.3 37.1 7.6 58.0 25.1 35.8 21.3 16.3 36.9 33.9 31.1 83.7 24.8 37.5 19.2 39.3 38.3 26.1 30.6 28.3 32.7 17.3 28.3 52.6 12.8 7.7 25.0 21.6 13.4 30.8 60.3 59.5 10.1 11.1 29.7 16.3 44.8 10.3 12.8 28.7 66.1 56.6 15.5 28.5 38.1 29.4 20.0 8.0 38.9 42.2 18.2 7.4 14.7 23.4 13.0 20.2 9.8 12.4 10.4 14.1 14.5 10.2 8.2 8.5 12.0 14.5 22.6 9.2 14.3 10.1 13.8 13.5 11.0 16.5 12.8 14.8 16.0 12.7 9.8 14.6 12.1 15.3 15.8 127.8 16.0 12.2 8.8 24.9 22.9 14.3 30.4 37.5 8.1 13.5 12.8 10.0 5.7 16.7 5.5 2.1 9.4 18.8 13.1 7.9 25.8 3.4 16.0 16.7 48.0 14.3 29.3 4.7 19.1 15.0 20.7 58.1 26.0 12.0 11.5 32.2 11.3 30.8 8.4 4.8 14.3 14.2 20.1 18.5 4.0 27.7 19.6 7.2 7.5 24.6 8.5 20.6 4.5 6.0 62.8 15.5 24.0 21.6 26.2 22.8 10.4 18.3 5.4 39.5 7.7 20.4 1.1 4.0 27.1 19.6 4.9 20.4 16.8 12.1 26.0 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725536 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.6;urinary bladder: 64.1" "Cell type enhanced" "Detected in some" "Adipocytes: 21.9;Endothelial cells: 13.7;Glandular and luminal cells: 5.9;Hepatocytes: 9.9;Urothelial cells: 16.4" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;hTCEpi: 19.5;HUVEC TERT2: 19.1;SK-BR-3: 14.7;SuSa: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" CAB018654 Uncertain NA NA "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 15.9 0.6 0.2 0.0 0.2 0.0 14.8 0.1 0.4 2.0 0.0 1.9 0.6 2.4 0.6 1.9 1.2 0.7 6.4 0.2 0.4 1.4 66.6 12.3 0.0 0.3 0.3 0.2 0.5 0.6 0.0 0.5 0.3 0.2 0.7 0.1 0.3 1.8 0.6 4.2 11.8 19.9 0.0 0.1 0.1 1.9 0.3 0.2 0.2 2.0 0.2 0.1 64.1 2.3 0.3 0.3 2.1 0.2 0.0 0.5 0.1 11.7 0.0 0.1 0.7 0.3 36.9 1.6 0.3 9.6 0.0 8.8 11.4 0.7 7.3 0.3 0.0 1.0 0.5 2.6 5.5 0.2 0.3 11.5 0.0 19.5 0.3 1.4 0.4 19.1 0.3 2.3 0.3 0.1 0.7 0.1 0.4 0.2 12.1 2.9 1.2 0.0 0.4 0.0 2.4 0.6 0.3 1.7 14.7 3.8 35.6 0.4 0.2 1.0 1.6 0.5 5.2 0.0 0.7 0.2 0.5 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.4 0.3 0.3 0.2 0.2 0.1 0.2 0.3 21.9 0.0 0.0 0.0 0.1 0.5 2.4 0.0 0.0 0.0 0.4 0.5 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.4 1.1 13.7 0.0 0.0 0.1 0.2 0.0 0.2 0.0 5.9 0.0 0.0 0.0 9.9 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 16.4 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971437-100342005 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.8" "Group enriched" "Detected in many" 8 "Astrocytes: 116.9;Early spermatids: 108.4;Inhibitory neurons: 275.7;Late spermatids: 91.0;Oligodendrocyte precursor cells: 337.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 6.4;JURKAT: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "HPA062487: AB_2684780" "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 0.7 1.2 1.2 0.5 1.0 0.6 0.6 0.2 2.3 1.3 4.7 0.8 0.6 1.2 0.6 2.1 1.8 0.3 1.0 1.2 1.4 0.8 7.6 1.5 0.5 1.0 0.7 0.5 1.8 5.0 0.2 1.2 0.5 1.1 1.0 0.4 0.7 2.6 0.5 5.6 2.0 1.2 0.5 0.5 0.9 1.0 2.7 0.9 10.8 0.7 0.1 0.5 1.6 1.4 0.9 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.2 0.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.7 2.0 0.5 0.2 0.9 1.0 0.0 0.3 2.3 0.0 0.2 1.7 0.2 0.2 2.2 2.7 0.4 0.0 0.2 0.3 0.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.4 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.2 2.3 1.2 1.4 1.0 0.7 0.5 1.1 0.5 0.9 0.9 0.7 0.0 0.0 116.9 0.3 1.0 0.9 0.1 3.4 0.8 1.5 1.3 4.3 1.5 0.9 0.0 0.0 0.1 2.6 0.4 1.9 0.1 108.4 1.2 2.8 0.9 0.0 0.0 8.2 0.9 0.0 1.6 5.1 1.8 0.0 0.1 0.4 4.4 8.2 21.9 275.7 0.7 0.0 0.6 0.3 91.0 2.1 0.4 0.0 22.5 0.0 1.3 1.0 337.3 9.5 0.3 0.2 0.0 0.8 1.6 0.5 0.1 0.0 0.7 0.0 3.2 0.9 1.7 1.9 2.1 0.6 0.1 3.7 2.5 0.4 0.9 LINS1 "LINS, MRT27, WINS1" ENSG00000140471 "Lines homolog 1" Q8NG48 15 100559369-100603230 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038578, HPA038579" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038578: AB_2676095, HPA038579: AB_10697393" "unprognostic (9.87e-2)" "unprognostic (3.32e-3)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (7.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.48e-2)" "unprognostic (3.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-3)" "unprognostic (1.14e-2)" "unprognostic (2.93e-1)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.28e-2)" 4.3 4.1 2.2 8.4 2.1 5.7 7.7 3.1 3.3 7.2 2.3 5.9 4.2 6.7 9.4 7.0 5.5 4.5 3.2 2.3 1.4 6.1 5.6 6.3 11.6 1.7 1.3 2.0 6.5 5.4 6.2 3.6 6.5 2.0 6.1 7.0 6.7 5.1 4.7 4.4 7.0 4.5 6.2 0.8 8.5 6.4 7.6 1.7 9.2 8.5 5.1 10.1 5.8 4.9 2.9 4.4 6.6 8.2 8.2 5.9 8.0 7.5 6.8 7.6 7.6 8.1 6.2 8.4 11.6 3.9 6.2 5.7 18.5 7.8 8.6 7.9 4.0 11.1 10.4 10.7 4.9 4.9 8.9 6.3 7.7 7.4 5.9 9.4 7.6 9.0 6.4 17.3 9.1 4.7 5.7 5.3 7.6 9.6 16.7 8.1 7.8 13.1 10.8 6.6 11.8 4.2 5.5 6.3 6.1 10.2 10.4 10.3 6.7 6.5 9.5 8.5 6.8 8.9 9.7 13.4 10.5 6.1 11.4 7.7 12.4 7.9 11.7 16.3 7.5 23.9 12.7 25.7 18.1 8.4 11.9 35.0 25.1 10.4 15.0 6.7 6.8 17.6 10.5 2.2 2.1 3.1 3.3 2.3 1.4 1.7 1.3 2.0 2.0 0.8 1.7 2.9 7.7 19.2 5.9 0.0 16.6 0.0 9.7 0.0 11.4 16.1 11.3 8.3 0.0 5.7 2.5 12.9 18.8 8.8 20.4 4.9 5.9 5.9 10.8 6.6 11.4 5.7 4.9 11.6 0.0 5.1 5.5 7.2 15.3 6.3 1.3 10.3 7.1 7.6 15.3 16.8 0.0 5.8 0.0 6.0 0.0 1.7 12.2 6.9 0.0 0.0 7.9 9.3 26.8 0.0 0.0 5.4 3.2 7.2 12.5 9.0 10.5 4.7 7.3 16.0 13.1 8.5 5.8 20.7 12.9 9.9 0.0 12.4 29.8 18.9 4.8 7.5 ULK3 "DKFZP434C131, FLJ90566" ENSG00000140474 "Unc-51 like kinase 3" Q6PHR2 15 74836118-74843346 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 89.7;Horizontal cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040474 Approved NA NA "HPA040474: AB_2677003" "unprognostic (3.67e-2)" "unprognostic (8.90e-3)" "unprognostic (2.65e-3)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (2.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (1.47e-2)" "unprognostic (4.18e-2)" "prognostic favorable (7.47e-4)" "unprognostic (1.97e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-2)" "unprognostic (1.63e-1)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" 6.5 15.3 25.6 6.5 29.6 2.2 6.2 26.7 30.4 10.0 21.7 9.8 5.0 4.4 3.5 36.0 5.5 4.6 15.9 27.7 25.6 17.4 13.9 8.3 5.8 31.5 25.5 25.7 5.7 12.1 16.4 12.6 3.6 34.0 10.0 9.5 15.6 11.6 3.1 21.2 24.3 15.8 4.4 24.0 13.2 10.7 7.1 26.4 6.4 7.6 19.2 7.9 9.5 15.5 28.6 6.7 17.7 7.4 14.4 9.3 6.7 6.0 5.1 7.3 10.1 11.1 7.0 15.4 13.0 8.8 6.2 10.8 4.7 23.1 7.6 4.4 26.1 26.1 30.3 25.0 7.4 14.8 10.3 22.5 9.4 14.0 8.2 7.1 3.5 15.8 16.8 10.3 11.9 7.0 9.4 7.3 6.6 10.0 10.6 8.7 18.6 10.3 23.0 6.0 7.4 16.7 22.3 8.6 9.8 25.6 9.1 11.0 26.8 9.4 16.0 8.9 12.7 10.3 20.7 19.7 9.3 7.4 29.5 12.4 5.2 3.5 1.4 10.9 7.3 8.7 3.3 6.4 9.0 3.7 2.8 7.1 4.8 0.8 5.8 6.1 4.0 9.2 5.1 25.6 29.6 26.7 30.4 27.7 25.6 31.5 25.5 25.7 34.0 24.0 26.4 28.6 16.5 9.6 15.3 37.2 11.4 10.1 7.5 6.0 10.2 89.7 18.1 13.6 17.1 14.3 6.7 12.9 16.7 9.2 23.3 46.4 19.6 11.0 1.0 8.9 8.8 10.7 11.4 14.1 64.7 11.7 2.5 9.2 23.4 11.9 21.0 6.2 13.2 13.3 16.1 89.2 56.5 17.5 4.1 7.9 8.2 2.2 13.1 11.2 5.4 18.7 13.2 18.4 29.9 16.6 15.3 12.3 17.9 11.7 8.6 10.4 68.5 16.5 8.0 54.5 0.0 12.9 8.8 9.5 17.3 19.7 21.7 5.7 19.7 12.3 27.9 8.9 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 12.2" "Cell type enriched" "Detected in some" 4 "Early spermatids: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (7.95e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 12.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 PCSK6 "PACE4, SPC4" ENSG00000140479 "Proprotein convertase subtilisin/kexin type 6" P29122 15 101289784-101525202 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 149.1;liver: 161.3;lymphoid tissue: 82.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 231.6;Horizontal cells: 196.9;Oligodendrocytes: 561.9;Theca cells: 106.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 47.2;CACO-2: 35.7;HEK 293: 60.3;Hep G2: 53.8;OE19: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004774 Uncertain "Secreted to extracellular matrix" NA NA 480000 "HPA004774: AB_1079583" "prognostic favorable (9.99e-4)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (2.46e-2)" "unprognostic (9.83e-2)" "unprognostic (8.14e-2)" "unprognostic (2.20e-3)" "unprognostic (8.56e-2)" "unprognostic (2.16e-1)" "unprognostic (2.39e-2)" "unprognostic (3.85e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.06e-7)" "unprognostic (2.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 5.3 2.2 19.9 3.0 56.5 1.1 11.3 52.0 37.3 2.3 3.3 16.6 6.9 2.0 3.4 9.1 2.8 3.1 20.2 16.5 44.4 2.7 161.3 3.7 2.5 106.2 63.5 8.6 6.2 2.6 0.6 5.1 32.3 79.6 3.1 14.9 7.7 2.8 0.6 11.4 9.3 10.2 3.6 58.7 82.1 9.9 13.1 49.1 21.1 2.2 16.4 1.9 3.7 2.6 149.1 19.7 14.6 2.6 0.9 0.2 0.4 47.2 0.7 2.5 0.0 0.1 35.7 8.3 0.4 2.4 0.6 1.1 11.4 12.5 1.5 0.0 2.8 60.3 33.5 8.4 53.8 1.6 4.5 0.4 0.3 7.5 0.2 0.2 0.2 0.1 4.3 24.5 0.2 0.0 8.8 0.1 4.7 9.3 65.9 6.5 0.2 0.4 4.4 4.4 25.4 7.3 8.6 26.2 1.5 9.1 6.6 2.2 21.9 0.2 0.3 1.2 0.3 0.2 0.5 0.6 0.7 0.2 0.6 7.3 0.8 0.2 0.9 0.2 0.4 0.3 0.5 0.4 0.2 0.1 1.0 0.6 0.5 0.4 3.3 1.3 0.4 0.1 1.2 19.9 56.5 52.0 37.3 16.5 44.4 106.2 63.5 8.6 79.6 58.7 49.1 149.1 1.7 3.2 0.6 2.9 1.3 0.4 0.3 0.9 0.6 1.7 15.4 6.6 2.0 8.6 1.4 1.8 20.9 6.7 0.6 22.6 0.0 0.6 1.6 4.7 21.6 4.9 0.0 3.2 19.4 0.8 24.3 15.5 1.5 6.9 0.0 4.2 12.5 231.6 1.4 196.9 30.8 3.7 0.0 5.2 1.1 2.4 10.5 1.7 0.0 5.6 1.0 1.7 3.1 25.6 561.9 7.3 8.2 0.0 0.0 1.7 2.3 0.1 1.2 1.6 0.0 2.0 1.0 4.7 2.4 0.9 0.1 3.3 1.0 106.5 8.5 0.2 CCDC33 "CT61, FLJ32855" ENSG00000140481 "Coiled-coil domain containing 33" Q8N5R6 15 74202705-74336472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 23.8;testis: 20.3" "Group enriched" "Detected in some" 9 "Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.4;ovarian cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 7.4" NA NA "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.13e-3)" "unprognostic (6.37e-3)" "unprognostic (2.16e-1)" "unprognostic (3.16e-3)" "unprognostic (3.68e-2)" "unprognostic (9.87e-2)" "unprognostic (2.05e-2)" "unprognostic (4.46e-1)" "unprognostic (4.18e-2)" "unprognostic (6.12e-2)" "unprognostic (9.37e-2)" 0.0 0.2 1.8 0.0 0.7 0.0 0.0 0.7 0.4 1.2 0.4 0.0 0.0 0.3 0.1 0.0 23.8 0.0 0.0 0.3 0.8 0.0 0.0 2.7 0.0 1.7 1.9 0.0 0.1 0.0 0.0 0.4 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.1 20.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.4 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.7 0.7 0.4 0.3 0.8 1.7 1.9 0.0 1.5 2.8 0.6 0.7 0.2 0.0 1.5 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.3 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 54.2 70.1 1.5 0.2 0.0 0.0 0.6 0.0 0.0 0.5 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 54.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.6 0.0 0.4 0.0 0.0 0.0 0.4 56.7 0.0 0.0 0.0 1.1 0.6 0.2 0.0 0.0 1.8 0.1 0.2 0.0 0.1 CELF6 BRUNOL6 ENSG00000140488 "CUGBP Elav-like family member 6" Q96J87 15 72284727-72320157 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Astrocytes: 17.3;Excitatory neurons: 18.9;Inhibitory neurons: 21.9;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 3.6;U-937: 1.9" "HPA046985, HPA053526" Uncertain NA NA "HPA046985: AB_2679891, HPA053526: AB_2682178" "unprognostic (6.83e-3)" "unprognostic (7.06e-3)" "unprognostic (9.55e-2)" "unprognostic (2.77e-1)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-4)" "unprognostic (1.16e-1)" "unprognostic (1.14e-2)" "unprognostic (2.16e-1)" 5.1 5.8 17.3 1.0 17.7 2.7 4.9 7.9 15.1 9.2 4.8 7.0 1.1 6.5 7.5 1.6 10.9 1.9 4.1 13.5 24.3 12.4 3.8 5.3 1.8 13.0 16.3 17.1 14.4 3.7 0.7 24.0 1.7 19.4 7.2 1.6 22.3 2.9 4.1 1.5 2.3 5.4 2.0 7.8 6.2 3.4 12.4 18.9 1.9 14.7 0.4 1.3 5.4 4.9 16.5 0.0 0.0 0.1 0.0 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.1 1.1 0.5 1.4 0.0 0.0 0.3 0.0 0.5 0.0 1.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.7 0.6 1.0 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.0 3.6 1.1 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 17.7 7.9 15.1 13.5 24.3 13.0 16.3 17.1 19.4 7.8 18.9 16.5 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.4 0.0 0.0 0.0 5.5 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" NA NA 71000 "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 41.6 47.1 22.6 40.7 27.1 51.9 41.0 28.2 31.5 38.3 32.7 76.7 76.4 37.2 37.2 104.3 47.8 35.8 32.1 21.6 28.5 45.2 42.3 50.0 48.3 33.1 26.2 18.3 26.7 54.9 86.3 29.6 49.3 31.4 35.8 73.4 4.8 93.5 32.7 34.5 67.8 80.8 33.9 29.3 67.3 65.5 36.5 28.7 33.3 38.6 19.1 53.8 38.4 49.8 32.5 44.7 57.3 24.2 37.6 72.0 37.2 72.0 45.0 56.6 46.9 50.1 83.0 102.6 36.5 57.8 68.1 67.7 157.8 72.3 55.9 19.4 145.8 71.1 92.8 31.2 57.6 54.3 48.0 170.9 48.0 97.6 44.4 32.0 37.0 46.0 42.0 31.3 67.5 33.3 68.1 24.6 55.3 24.1 111.0 36.6 42.6 22.3 126.4 54.0 63.1 24.9 25.0 36.7 64.3 42.4 35.4 88.5 76.3 43.4 40.2 23.9 43.8 53.0 46.1 73.2 37.6 37.8 112.2 30.2 118.3 111.3 90.0 94.1 106.9 76.1 80.8 85.3 95.9 81.8 70.9 69.4 75.8 74.4 83.8 119.3 128.7 105.3 120.8 22.6 27.1 28.2 31.5 21.6 28.5 33.1 26.2 18.3 31.4 29.3 28.7 32.5 36.0 73.7 31.7 17.9 49.5 17.5 41.7 40.5 19.4 6.8 28.0 24.8 14.4 24.3 53.1 40.5 2.1 156.9 63.4 116.8 15.6 67.4 132.3 30.8 22.0 36.2 37.3 29.0 7.7 92.8 61.9 37.2 54.0 40.6 79.2 31.3 26.4 27.7 164.7 6.7 6.1 77.5 42.7 78.3 44.5 56.2 32.0 77.0 32.0 21.5 56.9 41.4 63.8 12.1 17.9 96.1 75.5 23.0 73.1 54.0 105.7 48.1 52.6 8.4 26.3 25.6 35.8 47.1 35.3 39.6 22.3 136.4 55.1 40.0 64.2 58.5 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748845-74756607 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 311 "liver: 517.6" "Cell type enriched" "Detected in some" 57 "Hepatocytes: 85.7" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-BR-3: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced NA NA "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.2 0.3 0.6 0.2 0.5 1.0 0.1 1.6 0.9 0.0 0.2 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.1 0.5 0.3 0.2 517.6 0.4 0.3 0.5 0.5 0.8 0.1 0.0 0.0 0.0 0.7 0.8 0.1 0.1 0.4 0.2 0.3 0.3 0.6 0.2 0.0 0.2 0.3 0.2 0.3 0.5 0.1 1.4 0.0 0.1 0.1 0.0 1.6 0.4 0.3 0.8 0.5 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.4 0.8 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.4 0.9 0.6 0.1 0.0 0.7 0.3 0.1 0.1 0.0 0.0 0.3 0.1 1.3 0.7 1.3 0.0 0.2 0.9 0.3 0.4 0.3 0.2 0.9 0.8 0.3 0.1 0.7 0.7 0.3 0.6 2.3 0.1 0.6 0.5 0.2 0.2 0.3 0.4 0.3 0.3 0.3 0.2 0.5 0.3 0.9 0.3 1.5 0.3 0.5 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.2 2.1 0.4 0.2 0.4 0.1 0.1 0.6 0.5 1.6 0.9 0.5 0.3 0.5 0.5 0.8 0.8 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 85.7 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 LMAN1L "ERGIC-53L, ERGL" ENSG00000140506 "Lectin, mannose binding 1 like" Q9HAT1 15 74812716-74825757 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 20.8;lymphoid tissue: 25.9;prostate: 61.4;salivary gland: 20.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Late spermatids: 2.6;Prostatic glandular cells: 10.9;Spermatocytes: 7.3;Spermatogonia: 2.4" "Cancer enriched" "Detected in single" 45 "prostate cancer: 2.2" "Region enhanced" "Detected in many" "cerebellum: 11.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 1.4" NA NA "unprognostic (4.51e-1)" "unprognostic (2.44e-1)" "unprognostic (4.26e-2)" "unprognostic (3.09e-1)" 0.0 1.8 0.1 0.2 0.6 0.0 0.0 11.4 0.7 0.1 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 20.8 0.2 0.2 0.0 0.0 0.0 0.3 2.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 8.3 61.4 0.1 4.2 20.9 0.0 0.1 0.1 0.3 0.0 2.2 25.9 4.7 1.3 0.2 0.1 0.0 0.0 0.1 0.1 0.1 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 11.4 0.7 0.2 0.2 2.1 0.7 0.0 8.3 2.2 0.2 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 0.0 1.3 0.0 0.0 0.4 7.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877294-88895597 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 966.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 50.9" "Lineage enriched" "Detected in all" 5 "T-cells: 50.9" "Cell line enhanced" "Detected in many" "HDLM-2: 34.7;U-2 OS: 31.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 10.4 1.9 1.9 11.6 1.7 3.1 8.6 1.6 3.0 5.0 3.3 3.1 0.6 4.3 0.1 6.1 6.3 2.8 4.4 1.8 2.1 3.0 0.9 9.7 11.8 2.0 1.8 1.5 2.7 1.4 0.5 2.2 1.4 2.0 5.8 0.4 4.2 6.1 0.7 3.6 5.7 4.7 2.7 2.1 5.8 3.5 1.0 2.3 2.9 4.7 0.6 3.3 6.9 5.6 2.0 2.0 7.0 1.3 15.4 4.4 4.2 4.7 4.4 1.0 1.6 2.0 4.4 6.4 0.0 11.9 5.4 2.5 1.7 14.7 1.9 0.0 34.7 12.9 4.9 0.3 0.0 0.6 0.0 0.1 1.6 0.8 3.0 0.2 0.2 7.1 0.6 0.1 9.3 0.8 0.2 0.1 0.0 11.2 0.0 0.2 0.0 0.6 11.5 2.9 0.1 0.1 4.2 0.9 0.7 6.1 1.9 0.0 0.6 1.3 10.8 31.2 8.1 0.7 1.1 0.1 0.1 3.8 0.0 9.3 1.4 1.1 0.0 1.2 0.8 5.4 0.2 18.3 7.4 2.2 1.5 18.3 8.6 0.3 10.1 0.2 0.8 50.9 5.9 1.9 1.7 1.6 3.0 1.8 2.1 2.0 1.8 1.5 2.0 2.1 2.3 2.0 16.0 0.0 3.4 1.3 4.0 32.0 10.8 13.5 4.6 2.5 47.1 42.4 9.3 1.5 10.4 1.8 10.4 5.8 3.2 0.5 0.0 5.3 0.0 6.3 3.7 29.4 0.0 0.0 1.3 2.0 966.2 8.5 1.5 12.1 1.3 2.5 3.3 0.1 19.3 0.0 0.1 0.9 6.1 0.3 22.0 0.2 0.9 3.0 17.8 2.8 9.7 3.8 3.1 0.5 0.1 9.9 0.1 0.7 0.5 10.4 0.0 0.2 2.7 103.8 13.1 7.2 24.5 0.3 2.1 6.3 24.2 20.4 9.4 0.2 0.5 7.8 RHCG "C15orf6, PDRC2, RHGK, SLC42A3" ENSG00000140519 "Rh family C glycoprotein" Q9UBD6 15 89471398-89496589 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 4054.6;vagina: 1743.1" "Cell type enriched" "Detected in many" 21 "Squamous epithelial cells: 1544.7" "Cancer enhanced" "Detected in many" "cervical cancer: 152.9;head and neck cancer: 154.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.8;hTCEpi: 2.0;RT4: 1.2" "Region enriched" "Detected in many" 5 "olfactory bulb: 8.4" "Low region specificity" "Detected in some" "HPA041874, HPA043317" Enhanced NA NA "HPA041874: AB_2677719, HPA043317: AB_2678424" "unprognostic (1.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.52e-1)" "unprognostic (3.86e-3)" "unprognostic (1.98e-2)" "unprognostic (9.39e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.07e-1)" "unprognostic (9.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.84e-2)" "unprognostic (2.55e-3)" "unprognostic (2.68e-1)" "unprognostic (2.80e-2)" "unprognostic (2.27e-1)" "unprognostic (9.45e-3)" 1.3 2.1 4.8 0.0 5.0 0.0 0.8 4.6 6.9 393.6 3.5 0.5 0.0 0.6 0.0 4054.6 0.7 0.7 1.2 4.9 5.0 115.0 3.5 0.3 0.0 4.9 4.6 4.6 0.8 3.2 0.0 4.3 0.1 4.6 3.4 0.0 2.6 598.3 0.8 1.0 14.7 0.9 0.3 4.8 0.6 3.5 1.3 4.5 0.8 0.5 0.0 465.6 3.8 1743.1 4.6 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.0 4.6 6.9 4.9 5.0 4.9 4.6 4.6 4.6 4.8 4.5 4.6 0.0 0.0 0.0 2.0 0.3 1.3 28.9 22.9 6.2 1.0 0.9 0.5 0.7 0.0 47.6 14.7 0.0 0.0 0.0 0.6 15.6 1.5 2.0 0.0 0.1 0.7 0.0 0.0 6.0 0.4 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 2.0 0.0 0.7 1.4 0.0 1.5 0.0 0.0 0.0 64.4 0.0 4.0 0.3 0.7 4.8 0.0 0.0 34.8 0.0 0.0 1.6 2.8 0.0 0.0 5.4 1.5 0.1 1544.7 17.8 0.0 0.3 0.0 0.2 70.5 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria NA NA Mitochondria "HPA056821: AB_2683247, HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 12.8 11.2 5.6 4.1 4.6 2.6 12.1 4.5 6.0 12.1 4.3 13.0 5.5 13.0 0.4 14.7 11.3 1.0 12.2 5.8 4.2 10.1 13.0 13.9 3.0 8.8 5.3 5.6 10.9 10.8 2.9 8.5 2.6 6.5 10.6 1.0 1.4 12.4 2.3 25.3 15.9 14.7 1.3 5.8 16.4 12.0 5.5 5.0 7.3 10.6 11.0 2.4 12.3 12.8 6.2 8.0 17.0 6.7 10.0 7.7 1.6 16.4 16.4 2.7 7.9 5.9 28.0 10.9 14.4 33.6 5.9 16.9 11.8 14.3 4.8 0.9 35.8 31.3 19.4 19.5 11.1 10.8 21.3 33.6 2.4 8.7 7.0 3.0 8.3 12.2 26.8 19.5 5.4 6.1 22.8 16.3 16.5 8.7 13.7 8.2 18.2 13.7 17.4 3.2 19.2 24.5 6.9 26.8 9.6 16.8 6.0 7.7 10.8 17.3 12.8 15.6 28.5 14.2 17.0 9.4 18.6 9.5 14.3 11.6 3.3 4.3 6.1 5.5 4.0 4.3 2.0 4.6 6.8 6.0 3.0 3.7 4.4 1.8 5.0 3.5 4.1 3.3 5.3 5.6 4.6 4.5 6.0 5.8 4.2 8.8 5.3 5.6 6.5 5.8 5.0 6.2 15.7 12.8 11.9 11.4 17.2 12.2 11.0 10.7 9.1 7.6 12.0 10.3 19.0 11.5 9.5 11.0 2.1 15.0 33.8 17.2 9.8 10.4 1.3 8.4 9.4 12.4 5.4 9.0 12.9 10.9 15.8 11.9 21.4 11.3 8.2 14.8 14.6 17.8 12.7 3.3 9.9 24.9 4.1 18.5 14.7 1.5 14.3 17.2 19.6 8.4 21.8 6.1 30.9 9.5 11.9 11.4 15.9 10.5 16.8 17.7 10.5 7.5 7.8 6.4 6.6 13.3 12.9 9.2 11.1 11.8 11.9 21.8 21.7 14.8 17.6 15.5 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221614 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 268.0" "Cell type enriched" "Detected in some" 34 "Muller glia cells: 3148.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 53 "SK-MEL-30: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.0 0.2 13.6 0.1 15.3 0.1 0.0 13.6 21.0 0.0 14.8 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 14.3 13.0 0.0 0.0 0.0 0.0 13.6 13.0 13.5 0.0 0.0 0.0 2.6 0.0 13.6 0.0 0.1 268.0 0.0 0.0 0.1 0.0 0.4 0.1 12.5 0.0 0.2 0.9 13.0 0.0 0.0 0.2 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.6 15.3 13.6 21.0 14.3 13.0 13.6 13.0 13.5 13.6 12.5 13.0 13.4 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.3 0.0 0.0 0.0 39.6 4.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 2.0 3148.2 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 20.0 0.0 0.0 0.0 0.0 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "FA complementation group I" Q9NVI1 15 89243945-89317261 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.7;lymphoid tissue: 44.6;testis: 32.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 23.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.2 2.1 1.7 13.1 1.5 31.7 6.1 3.8 2.7 3.3 0.2 10.6 6.1 4.7 1.1 8.2 3.4 3.0 1.7 1.9 1.1 1.7 2.9 3.4 24.1 1.3 1.2 1.5 3.9 3.0 3.1 0.6 11.4 2.5 3.6 12.5 5.4 2.9 2.0 0.8 8.1 7.4 6.9 1.0 6.0 6.8 32.9 1.5 44.6 2.0 0.8 26.8 5.5 3.7 1.9 108.2 122.4 127.8 86.1 10.8 16.0 78.5 101.4 58.3 123.6 150.5 96.8 95.4 198.8 53.4 33.8 79.3 143.9 196.8 69.0 116.2 127.8 123.5 197.2 176.7 45.8 1.7 146.0 96.3 8.6 6.8 87.1 44.4 17.6 51.7 120.2 139.2 142.3 83.5 61.5 150.9 49.6 101.1 70.3 44.5 130.6 187.1 84.6 28.5 196.8 93.9 80.8 105.2 73.3 46.7 85.7 81.2 64.8 35.4 103.2 103.8 94.9 155.8 93.3 209.5 151.9 38.5 125.7 104.7 23.4 2.3 3.0 4.7 3.0 2.8 3.5 4.7 6.5 2.2 3.6 3.3 5.6 3.1 5.1 4.3 4.1 11.8 3.1 1.7 1.5 3.8 2.7 1.9 1.1 1.3 1.2 1.5 2.5 1.0 1.5 1.9 2.6 3.2 1.5 3.6 3.8 4.2 2.6 4.0 0.6 2.4 2.9 2.7 3.9 0.0 3.3 1.8 0.0 17.0 3.9 4.2 0.0 2.0 7.9 5.0 3.7 3.0 1.2 48.6 7.0 2.9 18.3 3.9 5.6 4.5 2.5 14.9 6.8 0.8 8.1 1.7 5.8 5.9 0.0 3.0 3.8 7.9 3.4 4.8 1.8 1.9 3.3 11.6 1.0 9.0 6.9 2.5 1.2 1.5 13.9 2.0 1.3 1.0 6.3 1.9 6.6 3.6 4.0 69.5 60.2 9.2 2.4 12.4 8.1 2.5 9.1 2.8 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2, acylglycerol lipase" P08910 15 89087459-89202355 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 69.8;neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEL: 340.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 18.7 36.6 19.9 20.4 20.6 35.2 22.7 38.7 26.3 19.6 107.1 21.3 48.3 20.9 56.6 17.5 23.6 47.7 36.4 28.7 72.3 22.6 138.7 45.7 14.8 13.4 31.1 20.4 24.7 58.4 18.6 14.1 11.2 18.8 44.6 19.1 14.6 12.8 18.8 22.0 13.2 36.2 22.6 9.8 24.8 73.5 52.5 21.7 15.7 17.3 46.7 16.2 31.4 9.6 17.9 33.0 62.3 14.7 16.3 29.2 39.0 8.2 21.4 62.5 19.8 18.6 15.7 55.3 9.4 23.9 27.4 54.1 42.6 32.4 26.4 28.0 48.1 15.8 340.5 14.0 12.8 14.8 24.2 74.4 20.1 18.6 70.1 45.5 33.7 25.3 20.7 30.3 27.4 56.3 13.3 15.0 5.8 6.6 76.9 18.1 20.7 32.2 71.9 27.0 51.5 25.2 39.0 41.4 19.4 34.4 13.5 21.7 18.6 38.6 70.9 23.7 24.2 55.8 23.5 49.3 10.9 58.2 21.5 55.4 8.4 13.4 69.8 3.5 11.3 2.1 2.4 3.2 3.4 7.1 2.2 3.2 3.2 52.2 11.2 17.8 5.7 8.7 6.9 19.9 20.6 38.7 26.3 28.7 72.3 13.4 31.1 20.4 18.8 9.8 21.7 17.9 43.4 96.1 118.1 87.5 10.7 18.6 47.3 27.0 7.4 25.5 26.6 17.8 52.0 130.1 82.1 42.3 18.8 4.6 53.7 65.9 1.9 48.9 331.8 28.3 36.8 27.7 48.7 40.8 103.6 85.2 7.7 26.6 103.0 25.9 60.7 18.5 21.0 402.5 40.8 20.2 114.7 58.7 87.5 59.2 26.6 462.1 32.9 67.3 58.7 46.9 46.4 45.5 36.0 421.2 54.4 106.4 38.0 59.8 27.4 171.1 53.1 18.0 158.0 14.7 78.9 36.1 53.4 119.8 13.2 20.8 17.5 2.6 24.5 35.2 38.7 117.5 WDR93 "C1d-87, CFAP297, FAP297" ENSG00000140527 "WD repeat domain 93" Q6P2C0 15 89690811-89743638 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.0;testis: 11.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 49.1;Endometrial ciliated cells: 28.1;Late spermatids: 42.4;Respiratory ciliated cells: 47.7;Spermatocytes: 30.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA046196, HPA048112" Uncertain Uncertain "Actin filaments" NA NA "Actin filaments" "HPA046196: AB_2679582, HPA048112: AB_2680267" "unprognostic (2.56e-3)" "unprognostic (3.21e-3)" "unprognostic (7.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.90e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-2)" "unprognostic (2.08e-2)" "unprognostic (1.22e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.40e-2)" "unprognostic (4.73e-2)" "unprognostic (9.84e-2)" "unprognostic (4.44e-2)" 0.4 0.2 3.1 0.0 0.7 0.4 0.7 1.6 1.0 0.6 3.0 0.1 0.0 0.4 4.9 0.0 9.0 0.2 1.2 0.8 1.9 0.7 0.1 1.0 0.2 2.2 2.1 0.4 0.4 0.6 0.6 0.8 0.1 1.2 0.6 0.1 2.8 0.3 0.5 0.3 0.2 0.1 0.0 2.1 0.1 0.1 11.7 0.8 0.1 1.8 0.0 0.1 0.0 0.0 1.1 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.2 1.0 0.1 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 3.1 0.7 1.6 1.0 0.8 1.9 2.2 2.1 0.4 1.2 2.1 0.8 1.1 0.1 3.2 0.5 2.9 0.0 0.3 0.7 1.8 0.0 2.7 0.8 0.6 0.5 0.0 4.2 9.2 20.9 0.4 0.1 0.1 3.9 0.8 49.1 28.1 0.6 0.7 0.0 0.0 2.7 0.2 0.3 0.4 0.0 0.8 0.0 0.4 0.4 0.0 0.2 3.3 2.1 0.1 0.0 0.3 0.8 42.4 1.5 0.3 1.8 0.0 0.6 0.6 0.0 0.5 1.0 0.3 1.1 0.7 0.1 0.7 0.0 2.1 47.7 14.8 0.0 0.9 0.6 30.4 5.7 0.0 0.1 0.3 0.6 2.9 0.2 0.4 TICRR "C15orf42, FLJ41618, MGC45866, SLD3, Treslin" ENSG00000140534 "TOPBP1 interacting checkpoint and replication regulator" Q7Z2Z1 15 89575469-89631056 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.4;esophagus: 4.2;lymphoid tissue: 4.2" "Cell type enhanced" "Detected in some" "Erythroid cells: 6.5;Extravillous trophoblasts: 6.0;Granulosa cells: 5.1;Spermatocytes: 5.4;Spermatogonia: 5.3;Squamous epithelial cells: 8.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046746, HPA049454" Supported Nucleoplasm NA Yes Nucleoplasm "HPA046746: AB_2732533, HPA049454: AB_2680773" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (3.41e-1)" "unprognostic (1.10e-1)" "unprognostic (6.22e-5)" "unprognostic (7.73e-3)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.64e-1)" "unprognostic (1.31e-4)" "unprognostic (5.87e-2)" "unprognostic (0.00e+0)" "unprognostic (3.54e-2)" "unprognostic (7.38e-2)" "unprognostic (4.53e-2)" "unprognostic (3.59e-2)" 0.3 0.1 0.1 1.0 0.1 3.4 0.3 0.0 0.1 0.4 0.0 0.8 1.0 0.4 0.0 4.2 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.4 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.9 0.1 0.2 1.1 0.1 0.5 0.0 0.0 0.5 1.0 0.2 0.1 0.5 0.4 1.5 0.2 4.2 0.1 0.0 1.8 0.3 1.2 0.2 11.0 15.0 19.0 11.0 0.7 1.5 10.7 8.0 3.7 11.0 11.4 16.4 8.4 14.7 4.2 2.6 9.2 21.5 26.3 7.0 10.0 7.4 25.4 21.9 15.5 8.7 0.1 15.8 7.6 0.4 0.5 9.0 6.6 1.6 5.5 12.8 21.3 16.6 6.4 10.4 13.9 13.3 12.7 11.0 7.6 19.6 17.1 11.8 2.6 15.5 8.1 8.0 19.0 10.6 3.1 13.9 7.9 10.5 3.3 11.9 14.8 24.4 16.5 3.9 8.0 12.3 4.1 13.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.2 1.2 0.0 0.3 0.8 1.4 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.0 1.7 0.1 0.3 0.3 0.0 6.5 0.4 0.0 6.0 0.5 2.0 0.3 0.0 5.1 0.0 0.0 1.3 0.0 0.6 1.6 0.0 0.0 0.7 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.1 0.0 2.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.5 5.4 5.3 8.6 0.1 1.0 0.1 0.1 1.6 0.1 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2" "Cell type enhanced" "Detected in many" "Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6" "Group enriched" "Detected in some" 4 "glioma: 2.5;testis cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-138 MG: 100.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 19000000 "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 13.0 3.7 31.1 0.8 30.0 0.1 7.9 29.4 32.5 10.9 1.5 3.3 0.5 10.5 3.2 1.3 15.1 1.6 4.3 35.2 22.5 5.1 1.0 5.3 1.2 21.7 19.9 31.0 7.3 1.0 0.1 12.3 1.0 22.5 9.0 2.1 5.2 6.8 4.3 1.8 4.1 2.2 3.8 9.9 2.5 3.3 9.9 26.7 1.2 3.1 1.9 2.0 8.8 7.4 22.5 0.0 13.1 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 2.6 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 100.6 1.8 0.0 1.3 0.0 0.0 0.0 3.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 31.1 30.0 29.4 32.5 35.2 22.5 21.7 19.9 31.0 22.5 9.9 26.7 22.5 0.5 0.0 0.0 239.3 0.0 0.5 6.4 0.0 0.0 53.8 3.7 6.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 119.6 0.4 25.0 1.2 0.0 0.0 360.0 0.0 0.0 5.7 0.0 0.5 0.0 0.0 2.2 0.0 1.0 1.7 277.8 0.0 0.0 0.0 0.6 148.9 3.4 0.6 0.0 177.1 0.0 8.6 0.0 499.6 7.4 0.0 0.0 27.4 0.0 1.3 0.0 0.1 0.0 3.7 52.6 20.3 40.9 11.0 3.7 0.0 0.1 0.1 0.2 0.0 0.0 0.7 DET1 FLJ10103 ENSG00000140543 "DET1 partner of COP1 E3 ubiquitin ligase" Q7L5Y6 15 88494440-88546681 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 3.6 5.3 2.5 2.0 2.6 1.2 3.6 2.5 2.6 5.5 2.7 3.7 3.5 6.8 5.4 2.2 5.7 3.0 5.7 2.3 2.4 3.0 2.7 2.1 3.0 2.5 2.8 2.2 10.4 3.6 3.7 3.7 3.5 2.8 4.2 3.3 5.1 4.1 3.9 9.8 2.5 3.3 5.6 2.3 2.6 3.4 1.5 2.4 5.6 4.2 11.8 3.1 4.5 3.4 3.1 1.7 6.2 8.6 6.0 3.4 6.0 1.1 5.4 6.1 4.5 5.1 1.0 4.8 3.3 4.1 7.3 4.5 2.4 8.7 1.3 3.9 0.2 5.9 6.9 3.1 1.5 6.7 2.5 1.1 5.0 5.9 1.9 6.9 4.4 3.8 2.9 8.5 3.8 6.7 2.6 3.2 2.8 3.6 2.6 1.8 4.2 6.9 3.8 2.4 5.3 3.0 4.9 6.5 2.0 14.9 5.6 2.9 5.2 3.0 5.1 3.7 4.8 5.4 2.3 1.4 2.1 5.4 4.3 4.5 0.0 2.3 1.6 2.2 3.4 1.4 1.8 1.7 1.9 3.7 2.2 2.6 1.9 0.3 1.4 2.3 1.9 2.4 1.3 2.5 2.6 2.5 2.6 2.3 2.4 2.5 2.8 2.2 2.8 2.3 2.4 3.1 3.5 3.2 2.7 6.8 3.5 0.6 2.0 3.7 4.6 11.5 4.3 3.8 2.3 1.5 2.1 3.7 10.4 7.2 1.7 2.1 1.9 3.4 1.2 3.4 6.1 2.3 3.0 5.5 5.7 3.9 6.3 4.9 2.0 2.4 0.0 10.6 2.2 2.8 4.4 6.7 6.8 2.7 2.0 1.6 2.2 0.6 4.4 2.5 3.6 3.7 4.7 7.1 2.1 6.0 9.5 3.1 1.0 3.8 1.6 1.5 3.1 2.6 3.1 7.9 0.0 5.6 4.5 8.1 9.9 1.5 1.3 4.1 2.7 8.4 3.3 1.4 MFGE8 "BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10" ENSG00000140545 "Milk fat globule EGF and factor V/VIII domain containing" Q08431 15 88898683-88913381 "Cancer-related genes, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 407.0;Cone photoreceptor cells: 385.7;Rod photoreceptor cells: 978.7;Sertoli cells: 1084.7;Smooth muscle cells: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 14.9" "Group enriched" "Detected in many" 8 "granulocytes: 5.3;NK-cells: 7.7;T-cells: 14.9" "Cell line enhanced" "Detected in many" "ASC diff: 1784.6;ASC TERT1: 918.2;fHDF/TERT166: 660.4;HSkMC: 935.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002753, HPA002807" Enhanced Approved Cytosol "Secreted to blood" NA NA 2830000 Cytosol "CAB002753: , HPA002807: AB_1078072" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.63e-2)" "unprognostic (7.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.11e-3)" "unprognostic (6.27e-2)" "unprognostic (8.49e-2)" "unprognostic (3.99e-1)" "prognostic unfavorable (6.06e-9)" "prognostic unfavorable (3.08e-4)" "unprognostic (4.85e-2)" "unprognostic (7.36e-3)" "unprognostic (2.41e-3)" 233.4 96.1 38.6 45.6 41.5 3.7 228.6 48.6 62.3 258.8 50.8 112.8 21.4 448.4 77.6 68.2 365.0 121.2 490.3 34.3 38.9 69.0 15.7 138.4 47.8 47.7 40.0 35.0 230.5 36.8 19.0 49.7 80.2 47.1 130.5 29.6 69.3 97.9 197.6 266.5 110.2 107.8 164.0 45.0 41.0 125.9 38.6 42.3 19.0 91.3 125.2 37.2 165.0 225.2 50.9 19.7 85.4 78.7 98.7 1784.6 918.2 6.9 482.7 142.4 95.4 110.3 90.5 23.5 0.0 147.5 660.4 144.6 10.2 27.6 95.8 31.1 82.3 64.7 138.1 4.6 10.2 469.8 0.2 50.1 935.7 251.8 73.5 122.5 205.3 37.0 35.3 23.4 41.1 185.1 6.2 22.6 3.2 405.4 8.3 38.4 22.7 74.4 26.4 32.6 7.3 8.2 42.9 28.0 2.5 226.1 165.6 2.4 11.1 42.0 233.2 127.8 62.3 36.3 145.3 30.5 15.9 31.6 12.2 91.5 5.3 0.2 0.4 1.3 0.0 4.2 1.2 4.2 2.9 0.0 0.9 4.3 3.3 0.0 7.7 0.1 0.1 14.9 2.1 38.6 41.5 48.6 62.3 34.3 38.9 47.7 40.0 35.0 47.1 45.0 42.3 50.9 72.1 12.8 5.4 39.2 4.0 48.7 32.2 116.3 24.5 22.1 407.0 190.4 92.8 8.6 25.5 3.7 385.7 4.5 13.1 1.6 0.0 15.7 11.0 33.3 202.2 66.9 44.8 3.8 5.1 4.3 18.6 220.0 12.8 29.7 5.1 30.1 22.1 15.5 8.1 16.8 0.4 6.4 36.7 32.9 39.7 27.9 187.0 12.9 119.2 15.0 1.8 75.9 9.2 5.5 9.6 28.3 0.2 109.1 8.8 15.8 0.1 0.2 8.3 978.7 1084.7 51.8 476.0 3.3 9.0 21.7 35.9 5.3 12.5 25.8 2.0 10.2 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001324-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 44.6" "Cell type enhanced" "Detected in many" "Astrocytes: 38.8;Microglial cells: 149.9;Oligodendrocytes: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 5.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.4;granulocytes: 1.9;monocytes: 5.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 3.6 4.3 10.4 14.8 11.6 8.8 5.4 6.1 8.4 5.7 2.2 7.9 9.2 5.4 5.0 17.3 5.3 7.1 10.1 6.3 9.8 5.2 5.3 9.9 10.1 13.9 11.4 4.3 4.9 44.6 3.3 4.5 5.7 14.0 7.6 6.9 1.2 9.6 4.3 33.7 12.1 8.1 3.4 7.9 14.4 10.3 1.7 10.9 5.7 6.3 1.6 6.6 7.7 9.3 13.2 9.2 10.7 20.1 7.6 2.7 4.0 10.5 9.4 8.8 6.8 8.6 7.7 8.3 9.3 4.3 9.1 6.4 6.2 5.1 13.5 3.8 6.0 9.4 17.1 4.6 13.1 5.5 5.0 25.6 6.6 7.2 14.6 7.9 3.2 11.8 10.0 5.8 6.2 2.6 23.7 11.1 13.9 15.8 11.3 6.9 13.5 4.5 10.2 2.7 11.4 18.3 12.3 12.5 44.8 6.4 5.2 9.6 17.2 17.1 13.9 6.8 4.2 7.4 5.0 2.7 9.0 10.6 14.6 7.4 0.0 1.6 1.2 0.2 3.5 0.2 0.1 0.1 0.2 1.2 0.1 0.4 0.4 1.9 0.2 5.7 1.4 0.5 0.7 10.4 11.6 6.1 8.4 6.3 9.8 13.9 11.4 4.3 14.0 7.9 10.9 13.2 1.7 3.2 8.2 38.8 2.7 5.4 4.7 2.8 1.8 1.4 7.1 3.6 12.1 4.3 6.3 11.0 2.1 2.3 6.8 7.7 0.0 3.6 0.8 4.0 4.1 4.3 4.8 2.5 10.2 6.1 3.0 3.1 7.1 6.2 1.3 2.1 5.7 1.6 11.6 3.3 12.0 8.1 0.0 15.8 33.5 5.5 2.5 15.7 1.8 149.9 13.3 1.4 2.1 22.1 36.4 10.1 11.5 3.0 3.8 8.5 2.3 0.8 3.6 0.9 6.6 1.6 3.0 0.3 2.5 4.3 7.5 2.3 2.5 2.0 6.5 13.7 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" NA NA 17000 "Nuclear speckles" Cytosol "HPA039228: AB_2676402" "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favorable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 25.2 25.5 7.7 16.9 7.6 17.5 23.4 8.0 9.2 31.1 9.7 35.5 16.6 38.5 11.1 31.7 28.6 17.4 15.4 7.3 8.2 19.0 13.1 20.4 19.1 8.3 10.8 6.9 26.4 22.5 33.5 17.7 19.7 9.1 25.4 13.5 5.7 26.1 34.5 9.7 37.1 23.7 28.2 7.9 19.9 28.7 13.2 8.5 18.1 19.7 10.7 17.4 39.7 29.7 8.4 38.2 76.3 30.9 27.2 83.0 38.0 27.3 42.4 36.2 56.5 45.1 61.3 49.4 44.7 55.5 53.8 32.5 82.1 52.9 54.4 26.6 49.8 75.9 86.2 77.0 44.4 46.8 21.5 56.2 47.3 65.8 55.7 40.5 54.2 77.5 35.1 38.6 35.8 43.3 62.2 28.1 18.6 41.8 69.5 38.0 54.8 46.9 48.1 38.4 89.2 43.1 39.4 57.1 55.9 54.3 36.8 50.8 44.3 77.0 48.0 34.1 40.4 45.0 33.6 50.5 21.1 46.6 49.7 49.8 11.5 8.3 5.0 11.8 7.3 11.3 7.9 9.6 9.1 10.4 6.3 7.8 7.4 1.6 9.8 11.6 9.1 9.3 9.8 7.7 7.6 8.0 9.2 7.3 8.2 8.3 10.8 6.9 9.1 7.9 8.5 8.4 21.7 22.4 22.4 9.4 23.2 16.3 24.8 26.1 30.1 27.2 17.2 19.6 12.7 35.8 23.8 18.4 18.8 53.6 17.5 26.9 13.7 33.6 26.7 12.8 20.3 25.3 37.0 25.2 19.1 18.2 22.7 23.7 26.5 22.1 29.2 30.9 18.9 13.4 28.2 18.5 18.4 15.9 26.4 12.2 14.0 29.0 29.5 20.7 19.6 9.4 28.8 21.5 27.8 7.1 11.0 23.3 26.0 51.6 20.6 16.8 22.0 19.6 11.7 35.1 32.9 15.2 33.9 24.8 6.4 33.9 18.8 46.2 21.4 26.0 22.7 20.3 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393881-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;heart muscle: 3.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.0 0.3 0.7 0.0 0.8 0.0 0.4 0.6 1.8 0.8 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.2 3.9 1.4 1.5 0.0 0.0 0.0 0.0 7.2 2.5 0.4 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.2 1.8 0.0 0.5 0.3 0.0 0.0 4.8 0.0 0.2 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.0 4.1 0.0 0.0 0.0 11.7 8.9 0.0 0.0 0.6 5.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.6 1.8 1.4 1.5 7.2 2.5 0.4 8.3 0.1 1.2 4.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 72.8;NK-cells: 97.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 6.2" "Immune cell enhanced" "Detected in many" "neutrophil: 32.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 2.3 3.8 0.6 6.6 1.8 18.2 3.0 0.0 6.2 5.4 1.4 10.7 7.0 1.8 8.7 4.0 4.1 4.6 0.5 1.1 1.9 2.0 1.5 8.8 6.1 0.3 0.2 0.5 1.6 5.8 3.6 7.3 19.5 1.1 5.5 12.4 2.6 6.0 4.1 0.1 3.4 6.4 1.7 0.0 21.2 4.8 1.0 1.1 3.0 5.5 0.5 6.3 6.7 3.8 0.7 3.6 0.0 0.1 0.0 0.0 0.0 2.5 1.9 1.1 0.3 0.1 2.4 4.4 10.3 0.5 0.1 0.1 8.0 0.1 6.6 0.0 2.1 0.8 20.8 2.9 1.2 1.4 4.4 16.4 1.1 7.8 0.1 8.2 0.0 0.0 3.6 0.8 5.9 0.0 0.0 2.0 11.4 0.8 3.6 3.7 4.7 0.1 4.0 0.5 10.7 1.9 0.4 0.2 3.4 1.3 0.8 0.0 0.3 0.2 0.1 1.7 0.0 0.0 12.0 0.3 22.4 24.1 11.1 1.2 6.6 0.8 12.1 6.1 0.2 3.0 3.5 1.7 2.8 0.0 3.6 0.7 2.7 32.1 10.9 0.9 0.3 0.1 1.9 0.6 1.8 0.0 6.2 1.1 1.9 0.3 0.2 0.5 1.1 0.0 1.1 0.7 1.1 3.2 18.6 1.0 38.9 4.2 12.9 8.6 22.8 15.6 3.8 4.3 1.1 7.2 13.2 3.7 0.0 17.0 72.8 39.4 0.0 3.4 4.0 6.5 3.4 1.8 15.6 35.7 15.6 4.7 7.3 7.8 5.6 6.6 36.2 0.3 1.4 1.4 9.6 0.0 10.3 43.8 8.2 8.7 2.1 4.8 0.3 11.1 1.8 25.3 4.7 0.1 97.9 0.0 0.7 4.2 24.6 0.0 45.8 14.2 18.1 1.9 8.7 0.6 0.0 2.5 1.6 3.4 2.5 15.0 2.3 24.5 26.6 0.5 21.5 19.6 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868588-90883564 "Enzymes, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 308.1;salivary gland: 222.4" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 130000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 50.2 24.6 10.3 36.7 8.3 74.5 42.7 7.6 14.7 26.6 10.1 31.2 27.9 32.6 9.9 33.9 30.7 19.6 52.5 12.4 19.6 43.4 308.1 63.8 13.1 10.2 8.5 7.9 22.6 109.5 27.5 46.3 41.0 8.9 60.6 12.2 13.1 222.4 17.8 61.8 59.5 35.8 14.4 7.0 51.8 34.3 8.6 11.1 11.9 56.5 25.5 11.3 30.5 33.6 8.5 50.8 31.2 6.8 29.8 49.4 32.1 77.5 64.4 48.1 26.3 18.1 45.4 54.3 1.9 148.8 47.5 46.1 91.5 14.0 32.5 5.4 148.0 35.2 90.9 52.8 57.7 26.2 13.0 141.2 35.6 35.3 29.5 13.2 62.4 84.7 14.6 70.5 8.5 17.8 32.3 5.0 29.2 21.5 44.2 9.3 7.9 26.6 10.9 35.2 39.1 13.1 9.2 54.5 28.5 42.5 31.9 10.7 31.4 125.9 29.4 60.1 43.7 95.5 15.2 93.4 3.4 55.8 40.1 60.7 2.0 0.9 1.5 0.7 0.1 0.2 0.4 0.2 0.3 0.6 0.1 0.0 0.1 0.7 0.4 0.0 0.3 0.0 1.1 10.3 8.3 7.6 14.7 12.4 19.6 10.2 8.5 7.9 8.9 7.0 11.1 8.5 44.1 3.2 27.4 4.2 7.3 19.4 10.0 10.4 2.8 12.8 12.0 9.0 16.3 21.5 8.5 22.0 25.0 20.9 26.9 49.5 0.0 47.1 0.5 15.2 9.7 29.4 37.8 26.5 7.9 117.5 16.5 11.4 21.9 32.3 15.8 7.0 23.9 131.8 24.8 8.4 7.5 31.7 10.2 35.3 42.1 1.4 11.1 33.6 16.0 5.6 14.0 13.6 24.7 2.0 4.4 108.3 26.4 10.9 7.2 24.3 28.7 7.8 2.0 28.0 26.3 10.5 18.6 2.8 3.6 8.5 23.0 84.3 19.6 4.7 17.9 16.4 IQGAP1 "HUMORFA01, KIAA0051, p195, SAR1" ENSG00000140575 "IQ motif containing GTPase activating protein 1" P46940 15 90388242-90502239 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013302, HPA014055" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 1500000 "Plasma membrane, Cell Junctions" "CAB013302: AB_2533146, HPA014055: AB_1851856" "unprognostic (2.83e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (5.95e-2)" "unprognostic (4.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.87e-1)" "unprognostic (1.25e-3)" 57.8 31.4 14.5 70.0 25.0 70.3 52.1 17.8 18.7 62.5 27.5 67.8 32.5 72.9 21.5 76.3 45.5 55.5 23.1 13.8 25.3 36.0 19.0 74.8 59.4 27.2 22.8 9.5 39.9 30.4 50.1 12.2 80.5 24.1 36.5 67.6 7.2 72.8 38.3 15.1 65.4 38.2 82.0 19.2 58.2 53.1 13.1 21.3 66.0 64.9 25.6 64.0 64.1 31.7 61.4 148.9 81.5 39.8 46.6 99.3 128.4 229.6 139.7 127.0 124.7 132.4 93.6 150.5 82.7 66.2 231.5 111.4 259.2 80.6 153.5 149.5 106.4 56.6 55.5 145.8 34.3 120.2 102.9 113.6 76.2 139.5 147.2 206.5 152.7 172.8 53.0 49.0 112.8 192.3 76.5 55.4 30.8 51.6 235.8 45.6 67.5 106.5 72.1 126.9 233.8 49.5 37.3 195.1 96.9 100.7 162.8 85.1 86.5 224.2 141.1 73.4 120.4 145.6 43.3 67.0 82.4 128.3 98.5 77.5 30.6 27.5 20.0 21.8 25.2 19.3 12.6 13.5 18.9 23.3 12.5 7.9 14.0 89.9 27.6 31.0 13.8 16.1 16.9 14.5 25.0 17.8 18.7 13.8 25.3 27.2 22.8 9.5 24.1 19.2 21.3 61.4 180.9 266.0 286.3 36.2 129.2 103.0 124.9 87.7 72.8 4.6 115.1 88.4 18.0 54.3 167.2 77.3 16.7 89.7 215.3 204.5 7.9 95.9 8.8 133.8 127.9 135.7 60.7 46.7 39.7 98.7 159.4 116.5 91.7 242.0 209.3 130.2 95.3 11.6 149.0 1.7 24.4 121.1 63.1 407.5 175.1 13.2 47.8 261.6 71.2 60.9 272.2 13.5 200.8 9.5 316.0 128.1 112.1 48.2 137.3 98.6 72.7 19.6 134.2 30.2 78.9 108.8 131.0 18.9 32.6 99.3 113.4 95.6 176.8 56.0 152.0 151.5 CRTC3 FLJ21868 ENSG00000140577 "CREB regulated transcription coactivator 3" Q6UUV7 15 90529923-90645345 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 21.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043735, HPA063691" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043735: AB_10794286, HPA063691: AB_2685092" "unprognostic (7.60e-2)" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.51e-1)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (6.48e-2)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (2.23e-1)" "unprognostic (5.22e-3)" "unprognostic (4.67e-2)" "unprognostic (9.32e-2)" "unprognostic (9.51e-2)" "unprognostic (2.30e-1)" 24.6 15.6 17.1 14.4 24.0 10.8 21.9 19.1 18.3 25.4 10.7 23.0 7.3 26.3 11.0 12.6 24.0 14.9 19.3 15.9 16.9 11.6 13.3 23.4 15.9 21.6 23.0 14.2 37.1 10.8 13.9 9.9 17.2 23.4 19.0 9.5 13.7 17.5 17.2 20.1 18.1 16.7 21.1 18.1 13.4 15.3 17.0 20.9 15.1 22.5 17.6 15.8 28.6 18.5 31.4 9.6 15.1 9.7 16.7 21.6 15.7 46.0 11.7 16.0 17.6 15.9 12.4 9.3 0.2 8.3 23.8 14.9 15.2 15.1 9.8 13.2 16.3 18.8 23.7 83.9 6.1 24.8 6.5 38.8 17.2 16.3 14.5 19.3 13.2 12.5 10.2 12.8 5.5 13.6 11.5 2.6 9.7 3.7 2.7 7.2 8.3 16.3 0.5 6.6 20.3 18.5 16.5 34.7 11.6 19.3 10.8 11.2 12.2 16.4 19.7 14.9 19.0 14.0 7.3 10.2 7.2 8.0 12.6 9.8 21.4 2.6 1.5 3.5 0.8 3.8 2.9 4.3 3.7 1.6 5.0 6.1 3.9 0.5 3.3 0.3 2.1 4.4 3.4 17.1 24.0 19.1 18.3 15.9 16.9 21.6 23.0 14.2 23.4 18.1 20.9 31.4 17.9 6.4 9.2 44.1 35.6 23.6 27.8 8.0 13.1 24.9 15.7 12.7 17.0 14.3 7.8 12.9 27.1 14.8 30.0 8.6 1.9 14.9 29.3 6.6 18.5 20.4 15.6 17.1 70.1 10.7 43.3 23.2 14.8 12.7 23.5 34.8 24.7 16.2 15.3 57.2 72.4 9.1 6.1 18.2 18.8 24.3 26.8 21.7 17.8 39.4 20.6 17.7 58.7 75.4 160.8 11.1 10.9 43.6 21.3 26.2 6.4 11.0 2.8 59.7 46.0 30.5 45.8 10.2 17.8 11.4 24.0 17.8 36.0 13.7 11.3 38.2 EFL1 "EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1" ENSG00000140598 "Elongation factor like GTPase 1" Q7Z2Z2 15 82130233-82262734 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Elongation factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.2;Glandular and luminal cells: 9.5;Granulosa cells: 16.0;Pancreatic endocrine cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039654, HPA047110, HPA052345" Uncertain Approved Cytosol NA NA Cytosol "HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794" "unprognostic (2.53e-1)" "unprognostic (2.04e-1)" "unprognostic (9.92e-3)" "unprognostic (8.99e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" "unprognostic (2.64e-3)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (4.75e-3)" "unprognostic (3.56e-2)" "unprognostic (3.14e-1)" "prognostic favorable (1.50e-6)" "unprognostic (8.58e-2)" "unprognostic (2.96e-1)" "unprognostic (2.60e-1)" "unprognostic (7.05e-2)" 5.8 7.5 5.1 8.3 5.3 8.9 10.0 5.2 5.5 7.4 6.8 13.4 11.7 7.2 7.5 8.4 7.8 7.0 7.3 4.7 5.7 8.7 9.4 7.0 9.7 5.3 4.9 4.5 5.0 6.2 14.8 4.6 7.0 5.5 7.3 16.6 7.2 6.8 6.8 11.7 8.8 12.9 8.8 5.1 7.0 8.4 11.3 5.3 16.8 7.9 12.5 10.9 8.2 7.2 6.6 9.8 24.5 18.0 14.9 11.7 16.1 11.6 28.0 33.1 19.9 26.1 12.2 16.7 24.0 11.4 21.4 25.2 24.9 47.5 18.5 31.8 21.8 23.1 26.8 20.2 9.3 18.3 17.0 18.3 7.9 28.9 20.5 46.0 23.7 27.0 30.8 20.5 10.8 23.6 14.1 22.5 13.9 16.0 17.5 12.6 23.8 26.4 13.3 14.1 29.7 15.8 16.8 17.7 20.5 21.6 30.7 15.6 15.1 22.9 28.1 18.5 71.6 28.6 13.4 54.9 20.1 25.1 32.2 10.5 23.1 5.7 14.6 8.6 8.2 6.9 9.4 8.0 7.5 7.0 9.9 6.9 6.0 1.0 6.5 9.9 3.3 7.9 4.8 5.1 5.3 5.2 5.5 4.7 5.7 5.3 4.9 4.5 5.5 5.1 5.3 6.6 4.1 3.2 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.7 3.9 0.0 0.0 4.3 0.0 0.0 7.1 5.5 0.0 3.9 6.8 0.0 9.2 5.1 1.4 0.0 0.0 0.0 6.0 4.0 2.5 0.0 9.5 5.1 16.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.4 0.0 0.0 5.5 7.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 6.8 2.9 4.9 0.0 0.0 SH3GL3 "CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13" ENSG00000140600 "SH3 domain containing GRB2 like 3, endophilin A3" Q99963 15 83447228-83618743 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 86.8;choroid plexus: 28.7;testis: 26.7" "Group enriched" "Detected in many" 4 "Early spermatids: 557.6;Late spermatids: 1307.0;Oligodendrocytes: 1142.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 35.8;HEK 293: 16.8;K-562: 29.9;RH-30: 11.1;SuSa: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039381, HPA077877" Enhanced Approved Mitochondria NA NA Mitochondria "HPA039381: AB_10794635, HPA077877: AB_2686863" "unprognostic (1.10e-3)" "unprognostic (6.62e-2)" "unprognostic (4.25e-2)" "unprognostic (1.86e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-1)" "unprognostic (9.76e-2)" "unprognostic (2.26e-1)" "unprognostic (8.20e-3)" "unprognostic (2.72e-3)" "unprognostic (1.43e-6)" "unprognostic (4.42e-2)" "unprognostic (3.59e-2)" "unprognostic (2.93e-1)" "unprognostic (5.78e-4)" 0.0 0.1 52.5 0.0 61.9 0.2 0.1 46.4 65.8 0.3 28.7 0.1 0.0 0.5 0.6 1.7 2.2 0.0 0.1 53.3 53.0 0.9 0.0 2.5 0.1 53.7 56.9 46.2 0.0 0.0 0.0 0.8 0.5 61.3 0.5 0.0 5.0 0.8 0.5 0.0 0.3 0.0 0.0 51.0 0.0 0.0 26.7 53.2 9.2 0.0 0.0 0.7 0.5 0.5 86.8 0.1 0.0 3.0 2.8 0.0 0.0 2.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.4 0.0 0.6 0.0 35.8 2.0 0.0 0.0 16.8 6.2 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.0 0.0 0.0 0.0 8.1 29.9 0.0 0.1 0.8 2.4 0.0 4.4 0.0 1.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 15.2 0.0 0.0 0.4 0.0 2.9 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 61.9 46.4 65.8 53.3 53.0 53.7 56.9 46.2 61.3 51.0 53.2 86.8 0.1 9.6 1.7 5.9 0.0 0.9 1.4 0.5 18.2 5.4 0.1 0.4 0.6 0.0 0.3 3.7 0.0 0.9 0.0 0.0 0.0 0.6 557.6 0.1 0.1 0.9 0.0 0.0 192.6 0.0 1.7 2.6 0.0 0.1 0.0 0.2 0.4 0.0 0.4 77.4 225.2 0.0 0.0 0.0 0.0 1307.0 9.3 0.5 1.8 6.5 0.0 3.1 0.0 29.1 1142.7 0.3 0.0 4.1 0.0 0.9 0.0 0.1 3.8 1.1 0.0 0.0 0.8 29.0 8.5 9.0 0.1 0.7 0.0 17.6 0.0 0.7 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 142.3 139.5 65.3 84.2 68.4 173.7 137.6 69.4 81.1 148.4 78.4 111.8 83.6 112.1 204.3 82.3 104.5 98.4 99.3 63.6 74.6 138.4 153.5 108.9 113.5 74.0 67.2 60.1 170.1 140.6 115.5 85.1 116.1 73.0 82.8 126.1 37.3 96.8 88.3 155.6 70.6 87.1 97.1 73.5 87.0 96.2 62.1 68.1 94.1 179.1 148.7 99.0 138.6 94.8 75.2 201.7 320.7 286.7 425.4 368.5 462.8 225.4 310.1 356.5 241.9 291.2 347.1 443.0 99.0 198.8 370.3 277.2 408.3 409.1 243.4 255.5 267.1 239.4 279.4 358.8 324.9 311.7 213.4 281.2 315.8 305.0 169.1 285.1 366.0 337.9 116.7 295.8 244.3 315.1 363.1 89.2 345.8 282.1 266.2 135.4 101.6 368.4 302.9 472.6 424.4 131.2 300.8 257.3 239.5 598.5 407.0 248.5 416.6 254.3 240.0 181.0 209.8 361.9 224.4 509.6 150.0 226.4 331.7 180.6 83.5 161.1 89.7 95.1 173.7 95.0 101.0 114.8 104.7 165.8 90.0 95.1 98.0 111.6 134.3 184.8 160.9 168.8 200.8 65.3 68.4 69.4 81.1 63.6 74.6 74.0 67.2 60.1 73.0 73.5 68.1 75.2 261.1 89.8 99.1 25.8 131.8 107.1 179.4 356.6 90.5 30.0 163.7 202.6 68.2 228.8 188.0 128.8 22.9 309.1 171.9 111.1 238.7 258.8 46.3 118.5 268.0 217.2 157.4 101.7 21.2 247.3 655.3 206.0 120.8 184.1 218.4 191.0 197.7 165.5 363.3 20.2 22.8 218.7 168.9 386.7 337.2 100.6 299.5 337.3 158.3 24.4 396.7 110.5 204.9 26.7 38.3 183.4 136.3 166.3 197.9 185.7 142.7 350.9 99.3 38.2 170.9 173.5 225.5 233.5 169.6 135.2 119.9 305.8 153.4 237.6 210.7 242.2 SEPTIN12 "FLJ25410, SEPT12" ENSG00000140623 "Septin 12" Q8IYM1 16 4777606-4788398 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "testis: 99.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041128 Uncertain Microtubules NA NA Microtubules "HPA041128: AB_10796568" "unprognostic (2.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.56e-2)" "unprognostic (2.29e-2)" "unprognostic (2.71e-1)" "unprognostic (5.45e-2)" "unprognostic (7.40e-2)" "unprognostic (1.39e-1)" "unprognostic (3.80e-2)" "unprognostic (1.61e-1)" "unprognostic (1.49e-8)" "unprognostic (7.41e-2)" "unprognostic (9.87e-2)" "unprognostic (8.36e-3)" 0.0 0.0 0.2 0.0 0.4 0.1 0.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 99.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.1 0.6 0.6 0.1 0.4 0.2 0.1 0.5 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GLYR1 "BM045, HIBDL, N-PAC, NP60" ENSG00000140632 "Glyoxylate reductase 1 homolog" Q49A26 16 4803203-4847288 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017022, HPA048226, HPA050136" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028" "unprognostic (4.72e-1)" "unprognostic (1.65e-1)" "unprognostic (3.19e-2)" "unprognostic (8.20e-2)" "unprognostic (2.77e-1)" "unprognostic (1.97e-2)" "unprognostic (3.86e-2)" "unprognostic (3.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (1.41e-1)" "unprognostic (8.47e-3)" "prognostic favorable (8.74e-7)" "unprognostic (3.34e-1)" "unprognostic (4.38e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" 34.7 35.3 26.7 43.8 27.9 43.8 28.0 21.4 27.9 32.0 31.9 46.5 43.6 30.4 24.8 38.0 45.8 30.6 39.7 28.4 24.8 47.3 38.7 33.1 42.1 24.7 25.6 26.1 25.2 36.1 60.8 31.7 34.0 23.7 40.6 44.3 42.3 43.9 37.8 44.4 33.9 40.7 37.6 21.6 39.6 45.1 20.5 25.6 46.2 40.5 38.2 43.6 36.8 27.1 22.5 43.2 47.5 76.4 47.9 66.1 52.5 73.4 80.0 59.0 59.6 50.7 66.7 75.5 69.8 74.0 74.2 49.0 47.3 96.4 67.0 53.4 114.0 59.4 72.4 57.7 47.7 37.3 117.6 129.6 50.2 52.3 56.3 41.5 57.6 77.2 65.0 122.8 58.8 65.6 69.8 96.6 64.8 91.0 65.0 35.2 123.5 59.9 86.5 73.4 64.0 93.1 47.1 86.4 80.7 37.1 83.1 90.3 123.9 86.1 41.1 46.0 186.2 50.3 49.0 73.1 145.5 29.3 57.9 85.5 10.3 14.1 7.8 9.0 12.7 8.0 6.2 6.0 8.9 9.7 9.6 6.2 5.6 28.1 7.0 20.8 10.8 6.5 8.2 26.7 27.9 21.4 27.9 28.4 24.8 24.7 25.6 26.1 23.7 21.6 25.6 22.5 28.6 38.5 47.3 35.6 29.9 19.1 18.7 17.1 19.4 36.8 30.3 23.6 42.3 28.6 37.3 31.3 29.2 28.0 31.1 54.9 66.5 24.4 11.3 58.2 36.7 28.1 46.3 45.6 43.6 19.4 31.6 23.0 26.0 43.0 31.6 27.4 26.7 53.0 32.0 45.4 37.0 41.2 18.3 39.3 23.9 10.3 24.2 35.9 21.4 32.8 54.5 25.0 28.8 28.6 35.8 29.2 38.8 16.1 26.5 29.0 38.9 54.7 73.3 42.6 19.7 24.6 36.1 21.9 24.5 23.4 24.2 35.7 26.1 28.1 38.8 21.3 PMM2 "CDG1, CDG1a, CDGS, PMI, PMI1" ENSG00000140650 "Phosphomannomutase 2" O15305 16 8788823-8849325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 8 "basophil: 210.5" "Lineage enriched" "Detected in all" 13 "granulocytes: 210.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040852, HPA063649" Approved Approved Nucleoplasm,Cytosol NA NA 21000 Nucleoplasm Cytosol "HPA040852: AB_10794069, HPA063649: AB_2685074" "unprognostic (8.62e-3)" "unprognostic (8.00e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.58e-2)" "unprognostic (1.79e-1)" "unprognostic (1.98e-2)" "unprognostic (6.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (5.14e-3)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.97e-6)" "unprognostic (1.22e-1)" "unprognostic (2.50e-2)" "unprognostic (6.89e-2)" "unprognostic (5.02e-2)" 18.7 18.4 3.6 15.3 4.9 6.5 16.8 3.6 4.2 13.8 7.8 26.2 25.2 10.7 12.0 29.2 10.8 10.7 12.9 4.1 3.8 16.1 52.2 13.9 13.8 3.8 3.9 3.5 7.6 36.8 10.3 12.2 15.6 4.0 14.3 26.3 1.5 22.8 7.4 9.8 16.2 21.4 12.7 3.8 14.1 19.8 4.5 4.0 9.7 11.4 6.0 14.3 21.9 15.9 4.0 26.1 56.5 12.3 32.7 21.8 33.7 27.4 39.8 47.3 38.8 41.6 42.5 31.5 41.0 16.3 69.4 20.2 35.1 25.3 48.5 39.2 30.7 29.0 13.6 33.0 73.8 40.4 36.9 31.6 50.4 33.7 41.1 37.9 18.1 40.1 24.5 18.9 39.6 26.0 68.3 37.9 33.9 52.8 60.0 35.8 47.2 27.4 82.8 43.5 45.0 23.5 43.7 32.7 71.4 23.9 19.5 46.4 31.7 47.7 27.8 31.5 76.6 39.5 48.2 43.3 51.5 23.4 45.5 38.0 210.5 16.5 3.2 7.9 13.0 11.7 9.5 7.0 10.2 12.1 7.8 7.7 7.5 26.5 6.2 8.4 10.9 5.7 10.9 3.6 4.9 3.6 4.2 4.1 3.8 3.8 3.9 3.5 4.0 3.8 4.0 4.0 16.5 16.0 24.1 12.7 18.4 3.8 11.6 7.7 14.8 4.7 10.6 9.5 3.1 4.3 28.8 0.0 14.6 8.9 11.9 11.2 9.8 16.3 0.9 15.9 32.0 11.7 7.7 9.0 29.3 28.5 11.9 16.6 23.9 38.5 22.8 12.9 2.5 12.8 5.5 1.7 26.1 21.2 2.0 4.7 1.7 0.9 6.2 10.4 1.8 21.5 9.6 2.5 9.2 22.6 21.6 23.3 9.7 2.2 49.5 12.6 12.3 17.4 16.8 9.0 0.0 13.5 9.8 2.0 4.2 27.0 4.1 10.7 16.0 13.1 12.6 14.9 SLC5A2 SGLT2 ENSG00000140675 "Solute carrier family 5 member 2" P31639 16 31483002-31490860 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 53.3" "Cell type enhanced" "Detected in some" "Early spermatids: 59.7;Late spermatids: 145.7;Proximal tubular cells: 142.9;Spermatocytes: 31.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041603 Enhanced NA NA "HPA041603: AB_10960540" "unprognostic (1.61e-1)" "unprognostic (2.95e-1)" "unprognostic (2.84e-1)" "unprognostic (3.00e-2)" "unprognostic (8.04e-2)" "unprognostic (8.23e-3)" "unprognostic (1.49e-1)" "unprognostic (2.25e-3)" "unprognostic (2.57e-1)" "unprognostic (1.12e-2)" "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (1.42e-3)" "unprognostic (5.88e-2)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (3.22e-1)" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 53.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.3 0.3 0.1 0.1 0.1 0.0 0.5 0.0 0.1 0.1 0.3 0.0 3.7 0.3 0.2 0.3 0.1 0.2 0.0 0.5 0.2 0.4 0.5 1.5 0.1 9.2 0.0 0.2 0.1 0.1 7.9 0.6 59.7 0.6 0.5 0.2 0.0 0.0 0.1 0.5 0.1 0.4 1.5 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.5 2.0 0.0 0.5 145.7 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.0 0.1 1.5 0.0 0.1 4.7 142.9 1.7 0.2 0.0 0.1 0.2 31.7 1.1 0.0 0.3 0.1 1.4 0.1 0.6 0.0 ITGAX CD11C ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382999 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.6;lung: 58.6;lymphoid tissue: 68.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 87.5" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HMC-1: 106.1" "Not detected" "Not detected" "CAB004458, HPA004723, CAB072871" Enhanced NA NA 50000 "CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 13.0 2.4 7.0 43.1 6.9 48.6 4.3 8.4 29.1 2.2 9.0 3.0 2.3 2.8 0.8 2.0 6.0 10.9 3.3 5.0 11.5 2.9 6.3 58.6 23.4 10.8 9.8 2.6 1.0 2.9 1.4 3.0 4.7 19.7 3.2 4.3 0.6 4.5 1.6 1.3 2.1 5.5 4.7 13.7 68.0 4.9 0.6 14.4 4.0 2.8 3.2 12.5 9.3 2.1 15.8 0.1 0.6 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 9.0 0.0 0.3 0.1 0.0 0.3 0.1 18.6 0.1 0.1 0.3 0.4 0.0 1.1 106.1 0.1 0.1 1.7 0.2 0.7 1.0 0.0 0.1 0.4 0.0 0.0 0.1 8.8 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.1 0.0 3.3 0.8 0.0 1.6 0.0 0.1 0.1 0.0 0.2 4.9 1.8 0.3 12.8 29.1 27.1 4.8 50.3 0.4 2.1 0.1 0.7 34.7 1.0 0.1 0.7 87.5 41.4 61.0 0.6 0.1 11.5 7.0 6.9 8.4 29.1 5.0 11.5 10.8 9.8 2.6 19.7 13.7 14.4 15.8 0.8 12.8 51.1 0.0 9.8 2.8 0.3 0.0 0.0 0.1 0.6 1.3 1.5 0.0 10.5 0.0 0.0 0.4 33.6 0.0 0.0 0.3 0.0 0.4 0.5 4.8 0.0 3.4 0.2 0.0 0.6 4.4 0.0 0.5 74.0 0.0 1.1 0.1 45.1 0.0 0.3 0.0 0.0 51.5 77.3 0.0 0.0 141.7 1.8 56.2 35.3 0.1 68.0 0.5 0.3 0.2 0.0 0.0 5.5 0.2 0.0 0.3 1.5 0.1 0.0 0.6 1.0 0.0 0.2 0.0 1.1 0.4 16.5 0.1 0.0 0.1 TGFB1I1 "ARA55, Hic-5, TSC-5" ENSG00000140682 "Transforming growth factor beta 1 induced transcript 1" O43294 16 31471585-31477960 "Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 267.8" "Cell type enhanced" "Detected in many" "Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 9.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 100.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB020844 Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 800000 "Focal adhesion sites" Cytosol "CAB020844: " "unprognostic (5.80e-2)" "unprognostic (3.09e-2)" "unprognostic (5.34e-2)" "unprognostic (1.18e-1)" "unprognostic (6.64e-2)" "unprognostic (9.52e-2)" "unprognostic (1.89e-1)" "unprognostic (4.95e-2)" "unprognostic (4.19e-2)" "unprognostic (1.71e-2)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.06e-8)" "unprognostic (1.06e-2)" "unprognostic (6.57e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (7.73e-5)" 58.7 17.1 4.5 22.9 4.3 1.0 53.2 4.2 6.9 110.9 5.6 189.3 14.7 267.8 12.6 38.6 144.5 14.5 41.1 4.1 4.5 26.6 9.8 55.1 4.8 5.1 4.1 3.6 79.2 8.2 8.7 8.3 19.9 4.7 88.3 24.1 0.7 21.1 81.6 13.2 25.2 62.3 107.0 4.3 33.2 79.2 10.2 4.4 1.4 27.0 10.6 5.0 172.5 74.2 4.3 13.3 16.6 25.9 0.0 25.4 46.1 0.3 70.8 64.8 43.6 30.1 6.6 4.5 0.0 65.1 62.3 29.1 20.6 6.0 13.3 56.4 0.1 0.3 17.5 29.1 3.7 67.4 0.0 19.8 31.1 18.7 27.5 16.3 100.0 29.2 0.0 1.5 0.0 51.9 0.1 0.0 1.6 1.4 1.4 16.2 0.0 30.9 0.1 12.5 6.6 0.0 19.0 27.5 0.2 14.1 20.9 0.1 1.7 82.4 79.8 19.2 21.4 31.8 0.1 0.1 0.2 34.9 0.8 49.6 9.5 0.0 0.1 0.2 0.0 0.3 0.9 0.9 0.1 0.0 0.2 0.1 0.6 0.2 0.0 0.0 0.3 1.6 1.3 4.5 4.3 4.2 6.9 4.1 4.5 5.1 4.1 3.6 4.7 4.3 4.4 4.3 76.9 6.4 4.8 0.0 0.4 12.6 23.9 34.8 14.8 0.4 4.1 71.5 13.4 5.7 3.4 7.3 0.0 1.2 1.5 1.8 7.9 33.3 1.2 3.6 76.2 48.8 0.0 11.0 0.1 22.5 1.2 64.4 4.6 2.9 6.3 35.3 29.6 0.3 14.6 0.0 0.1 4.7 0.0 0.3 15.4 3.3 92.2 9.3 40.9 2.8 4.2 7.0 0.0 3.5 0.1 28.4 2.2 179.0 1.4 20.1 13.3 19.7 1.1 1.4 223.5 17.4 176.0 1.5 3.6 1.9 11.2 1.8 2.6 20.3 5.3 4.6 RUSF1 "C16orf58, FLJ13868" ENSG00000140688 "RUS family member 1" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 26.8 32.1 16.1 20.2 17.6 21.7 29.0 10.6 21.5 44.0 12.3 29.8 31.6 43.6 20.9 26.7 38.6 23.2 28.8 18.0 17.0 29.7 58.3 25.2 19.9 16.0 15.2 17.8 50.0 57.3 46.6 48.8 25.9 15.3 39.5 19.3 22.6 65.4 34.5 9.5 26.4 30.5 25.8 11.4 22.5 39.8 21.6 15.6 18.2 42.4 9.8 15.8 32.1 31.6 15.3 28.6 37.2 22.7 39.7 51.7 34.3 42.3 33.4 56.6 25.5 30.2 11.3 49.1 24.5 69.4 49.8 32.9 39.0 22.9 31.0 11.8 35.8 23.0 24.8 20.6 28.8 74.8 29.4 28.6 41.7 33.1 33.7 68.5 50.2 24.9 38.4 37.3 40.9 25.3 53.9 13.7 19.8 17.8 41.8 24.1 31.1 34.2 74.8 29.3 17.6 24.8 38.2 25.2 65.3 52.8 21.5 56.6 42.9 22.0 44.3 24.7 28.7 22.1 59.0 37.0 18.8 56.7 44.7 62.5 3.1 5.7 7.6 7.8 8.4 7.2 6.7 8.2 7.8 9.7 6.3 7.9 7.0 0.9 9.4 8.1 8.9 9.4 7.2 16.1 17.6 10.6 21.5 18.0 17.0 16.0 15.2 17.8 15.3 11.4 15.6 15.3 5.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 22.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 21.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.3 0.4 0.0 0.0 0.0 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: AB_2685098" "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 5.0 8.0 8.6 3.5 8.5 21.6 4.4 8.3 11.8 6.0 6.5 5.8 4.6 6.9 0.9 10.0 5.7 2.0 5.7 8.6 8.2 8.4 24.8 4.6 3.2 11.7 8.8 8.0 6.9 6.5 3.1 9.1 2.1 11.9 7.7 0.9 2.4 5.3 2.2 16.1 7.4 7.1 1.8 8.7 8.9 6.9 6.8 8.8 3.0 9.8 4.0 1.3 5.7 6.7 10.3 5.0 7.6 3.3 4.8 2.0 1.5 8.4 6.5 2.8 3.6 3.0 7.2 5.0 4.9 13.3 3.5 3.6 7.5 3.9 5.7 0.7 6.8 9.9 2.2 12.4 16.7 4.0 14.9 14.3 3.7 6.3 3.6 1.0 4.2 5.5 8.0 11.2 11.5 2.5 12.2 5.6 59.5 5.3 2.2 5.0 10.0 4.7 18.2 2.9 5.6 10.7 9.4 5.9 7.8 4.6 2.0 5.1 17.6 10.9 7.8 5.7 3.2 5.4 10.4 9.8 3.0 5.1 12.2 5.7 2.9 2.3 0.7 3.2 1.1 2.7 2.7 2.5 2.6 3.0 2.2 2.2 2.6 1.3 7.1 1.3 7.2 3.2 2.6 8.6 8.5 8.3 11.8 8.6 8.2 11.7 8.8 8.0 11.9 8.7 8.8 10.3 8.7 6.4 14.3 4.2 6.2 6.5 9.2 8.7 9.1 6.0 6.3 5.0 5.8 11.5 8.2 0.0 6.2 7.5 7.6 11.1 3.9 5.0 1.2 5.2 8.6 10.8 7.8 8.2 4.3 4.4 5.4 6.1 6.6 7.6 9.5 6.7 8.9 28.7 6.1 13.5 4.0 8.7 6.1 3.7 4.0 0.6 4.4 6.7 1.8 2.8 3.9 7.2 6.2 2.0 4.6 4.4 3.8 5.7 8.0 6.9 9.2 4.6 3.4 5.9 0.0 8.7 6.6 5.5 8.0 9.6 6.3 11.5 7.6 6.1 7.7 6.1 PARN DAN ENSG00000140694 "Poly(A)-specific ribonuclease" O95453 16 14435700-14632728 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006314, CAB011673, HPA012010" Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976" "unprognostic (2.54e-1)" "unprognostic (3.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.99e-3)" "unprognostic (5.07e-2)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.52e-1)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (3.10e-3)" "unprognostic (1.09e-2)" 15.5 20.4 11.1 14.0 12.2 9.3 16.1 11.9 11.7 17.0 11.9 18.0 11.9 19.3 24.9 15.7 16.1 13.6 14.7 10.7 12.7 12.7 16.5 14.3 21.4 12.5 12.2 10.0 16.6 16.7 21.3 16.4 15.8 12.5 16.3 17.0 7.1 15.4 17.2 16.9 17.9 16.3 18.1 11.5 15.8 16.3 18.2 12.7 21.8 20.8 9.8 23.6 19.4 16.2 13.8 28.0 39.9 17.6 22.9 32.9 33.2 20.3 24.4 32.4 29.8 28.3 21.9 28.7 56.2 63.1 32.3 25.3 30.4 46.7 32.3 41.0 42.9 29.4 28.8 24.2 53.2 35.5 46.0 36.2 32.5 38.5 32.0 43.1 25.5 22.5 32.6 28.5 29.9 32.5 44.9 36.7 33.1 26.0 28.2 16.7 56.2 36.1 57.1 23.1 17.1 18.7 16.9 53.4 29.6 36.3 28.6 31.6 28.0 21.2 31.5 15.8 16.4 26.9 32.5 31.0 63.5 34.6 30.8 35.8 8.9 8.0 15.8 8.6 13.2 7.7 16.0 10.4 12.4 13.6 9.4 14.2 14.4 6.2 15.0 15.6 8.3 19.1 7.1 11.1 12.2 11.9 11.7 10.7 12.7 12.5 12.2 10.0 12.5 11.5 12.7 13.8 18.0 32.1 39.1 37.9 26.2 7.1 7.8 9.7 21.6 13.0 13.4 14.0 22.3 7.2 11.8 11.0 8.4 29.2 24.7 13.6 11.7 14.2 14.1 15.2 20.5 15.2 14.9 20.4 48.0 12.9 23.2 19.5 21.9 21.7 2.5 19.2 11.7 15.6 14.8 8.4 48.2 14.3 6.1 14.2 5.8 6.3 21.1 18.2 10.6 54.4 35.8 10.3 52.5 38.2 72.4 15.2 10.6 17.7 23.0 7.1 12.2 10.8 19.2 10.8 19.7 13.1 15.0 70.5 70.5 20.0 8.2 22.4 21.5 20.1 13.4 4.8 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Supported Vesicles,Cytosol No No 540000 Cytosol Vesicles "CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117" "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 24.6 33.9 29.6 12.6 35.6 8.3 36.6 29.0 38.0 25.8 27.5 18.6 7.8 27.1 21.6 17.4 25.5 21.8 27.4 32.2 34.6 25.2 17.5 37.2 15.2 30.7 30.4 31.4 27.5 20.9 40.9 26.4 20.3 30.1 20.2 14.2 38.7 19.1 24.1 33.3 20.9 12.6 30.2 25.4 16.5 15.2 8.4 31.1 17.1 27.7 23.2 14.9 22.1 18.7 42.6 15.1 26.8 35.0 35.9 67.3 50.4 11.5 35.6 32.2 29.3 8.5 16.8 19.3 34.4 38.2 46.3 16.6 21.7 32.4 34.9 42.5 16.0 25.5 15.5 33.6 31.7 46.2 12.5 17.1 55.9 36.5 26.6 32.5 36.6 44.1 25.1 15.2 8.4 48.1 11.8 28.0 19.2 18.1 15.5 17.5 42.2 52.9 32.3 44.6 12.3 43.0 29.7 40.4 23.6 10.8 33.7 31.1 29.3 42.4 36.4 23.9 19.8 22.1 15.9 13.9 35.0 33.9 22.9 28.7 14.9 17.9 9.7 25.6 22.7 32.4 17.6 24.4 25.9 23.8 17.4 22.5 24.4 2.9 26.4 16.5 9.5 26.6 23.1 29.6 35.6 29.0 38.0 32.2 34.6 30.7 30.4 31.4 30.1 25.4 31.1 42.6 15.1 80.1 62.0 173.3 10.3 12.4 10.0 8.6 13.6 22.8 69.1 39.5 22.3 15.7 54.4 7.3 12.5 9.3 10.2 4.8 7.9 9.0 39.1 11.0 18.3 17.4 6.6 9.7 226.1 5.7 7.4 23.1 9.7 9.9 25.9 16.8 11.0 13.8 9.2 16.8 240.7 6.6 10.2 9.0 13.2 69.9 14.3 11.8 10.6 134.0 5.5 19.6 10.3 210.6 282.5 5.5 5.0 15.1 18.7 6.0 4.5 15.8 182.7 14.1 13.1 21.6 16.8 3.5 3.4 11.0 9.1 5.1 12.9 17.8 6.3 7.9 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21953288-21983660 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 729.0;tongue: 941.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 556.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria NA NA 180000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favorable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 160.2 118.8 67.0 104.0 72.0 128.9 109.5 74.5 90.8 91.5 102.2 262.2 295.2 99.1 73.3 158.8 110.7 100.4 564.5 70.7 71.4 242.2 247.1 76.1 121.0 74.1 71.0 68.2 115.5 90.5 259.3 40.1 97.3 73.9 96.5 265.3 143.6 134.9 105.2 729.0 86.1 235.5 122.3 62.0 81.6 154.6 56.3 77.8 132.5 108.8 941.5 150.5 155.0 60.3 78.4 173.9 193.1 116.5 66.4 154.3 186.8 169.1 163.8 160.6 177.5 174.5 347.9 177.7 338.9 144.3 170.4 129.8 324.6 222.3 212.7 193.7 151.4 178.4 185.9 166.1 494.3 164.6 249.1 501.2 232.3 229.4 130.3 186.2 169.4 248.1 224.1 217.9 159.1 177.2 230.6 288.6 175.0 124.6 261.1 148.8 310.9 263.6 390.0 285.8 214.6 154.4 114.9 237.2 318.6 190.3 151.6 354.4 264.1 179.3 103.3 98.1 104.0 148.0 126.3 87.2 302.7 188.7 239.8 126.4 80.1 128.7 71.4 80.0 147.8 103.3 96.0 98.3 89.3 153.9 77.9 106.8 97.6 45.9 101.8 148.1 67.6 134.8 157.3 67.0 72.0 74.5 90.8 70.7 71.4 74.1 71.0 68.2 73.9 62.0 77.8 78.4 105.5 64.1 52.5 81.9 81.1 90.6 190.8 444.0 74.6 109.1 91.7 79.6 556.2 84.4 194.9 71.7 87.6 238.3 82.6 233.4 455.9 124.5 88.0 72.0 55.7 91.3 113.8 92.4 65.0 109.6 157.6 89.0 144.3 65.8 92.6 99.6 84.3 122.3 195.5 69.0 74.0 224.4 238.0 145.1 100.6 89.9 68.3 104.6 131.6 27.2 162.1 108.0 91.6 60.3 50.7 97.2 214.0 97.0 72.9 114.4 378.0 306.9 110.2 152.6 78.9 94.1 109.5 68.9 56.7 132.0 88.4 278.3 91.3 170.2 358.7 204.3 CDR2 "CDR62, Yo" ENSG00000140743 "Cerebellar degeneration related protein 2" Q01850 16 22345936-22437165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 70.2;Spermatocytes: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.4;NK-cells: 2.5;T-cells: 6.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018151, HPA023870" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018151: AB_1846457, HPA023870: AB_1846459" "unprognostic (7.89e-2)" "unprognostic (1.55e-1)" "unprognostic (5.23e-2)" "unprognostic (3.09e-1)" "unprognostic (6.59e-2)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.06e-1)" "unprognostic (9.86e-2)" "unprognostic (3.04e-1)" "unprognostic (2.04e-2)" "unprognostic (3.34e-3)" "unprognostic (1.38e-2)" "unprognostic (5.78e-2)" "unprognostic (1.67e-3)" 17.8 12.1 9.7 19.2 16.1 24.1 14.7 14.9 11.2 19.0 29.4 20.4 28.9 18.0 10.4 12.2 16.1 22.4 12.0 10.6 10.2 25.2 23.0 21.8 25.6 9.4 8.8 9.3 15.0 14.0 13.3 22.0 15.2 9.9 20.9 19.5 74.6 15.9 23.3 5.9 10.6 22.3 27.4 6.2 18.8 17.6 62.6 10.5 28.4 49.4 5.7 19.4 29.5 14.1 9.2 38.9 26.8 22.8 24.2 55.2 47.4 23.9 36.4 57.0 36.7 48.4 35.3 25.9 33.3 19.3 62.4 22.2 36.5 49.2 20.8 43.0 26.2 25.1 25.3 29.4 111.0 63.4 27.6 49.6 35.6 18.8 36.2 40.3 46.3 46.2 42.6 25.1 53.3 35.4 28.0 27.8 20.0 32.4 32.3 22.0 40.1 29.4 49.5 45.7 24.8 17.5 12.5 24.8 51.9 36.4 25.7 15.4 13.7 31.9 36.2 22.9 34.5 32.9 27.6 49.7 46.9 23.8 27.1 31.7 8.4 0.8 1.2 1.6 0.7 3.6 0.9 5.3 3.4 0.9 0.6 4.1 3.5 0.7 2.5 0.9 1.1 6.5 1.7 9.7 16.1 14.9 11.2 10.6 10.2 9.4 8.8 9.3 9.9 6.2 10.5 9.2 18.2 3.2 5.1 3.6 8.7 34.0 17.3 4.3 15.4 8.9 27.4 9.1 3.5 10.0 7.0 9.2 14.6 1.7 12.7 22.0 1.9 8.7 36.7 6.9 10.0 13.9 6.6 17.2 8.0 7.1 10.8 19.6 19.4 12.0 0.0 9.6 10.0 9.5 9.4 8.4 10.5 16.1 6.1 5.0 11.5 8.8 6.8 7.4 10.6 2.8 4.0 10.1 4.1 3.5 2.2 13.8 12.2 10.9 24.9 19.4 22.4 12.4 4.9 70.2 6.6 9.7 15.8 50.9 16.1 8.7 24.3 1.4 25.8 2.7 7.8 14.8 IGSF6 DORA ENSG00000140749 "Immunoglobulin superfamily member 6" O95976 16 21639550-21652608 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Group enriched" "Detected in many" 13 "Hofbauer cells: 216.2;Kupffer cells: 246.9;Langerhans cells: 132.6;Macrophages: 327.1;monocytes: 179.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 1213.7" "Lineage enhanced" "Detected in all" "granulocytes: 1213.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041023, HPA041072" Uncertain NA NA "HPA041023: AB_10794434, HPA041072: AB_10794262" "unprognostic (7.94e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.18e-2)" "prognostic favorable (1.54e-5)" "unprognostic (3.27e-1)" "unprognostic (4.03e-2)" "unprognostic (2.31e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-2)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (8.12e-2)" "unprognostic (1.81e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-1)" "unprognostic (2.02e-1)" 2.3 2.3 0.4 13.5 0.7 1.7 1.2 0.7 1.0 1.0 0.7 5.2 1.7 0.4 0.2 0.6 1.1 0.3 0.6 0.6 0.5 0.8 5.6 7.5 3.9 0.9 0.8 0.3 0.4 0.9 0.7 0.5 3.3 0.8 0.9 1.5 0.2 2.0 1.6 0.2 0.5 2.7 0.5 0.5 30.0 1.4 0.2 0.5 2.2 0.6 0.9 1.2 2.3 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.5 303.9 46.2 0.7 357.2 0.8 3.8 0.5 0.9 233.9 0.5 0.9 1.2 1213.7 2.7 263.5 55.5 1.0 210.7 0.4 0.7 0.7 1.0 0.6 0.5 0.9 0.8 0.3 0.8 0.5 0.5 1.4 1.7 3.2 12.2 0.7 7.1 3.2 0.7 0.0 0.0 1.3 1.4 3.7 4.0 2.8 5.0 1.8 10.4 0.7 15.2 0.0 0.0 0.2 0.4 1.0 1.2 4.0 0.0 6.5 1.1 0.0 1.4 3.2 0.0 2.5 10.1 0.4 2.9 1.8 216.2 0.0 0.8 0.3 0.0 246.9 132.6 0.1 0.9 327.1 8.8 16.9 179.9 0.7 3.1 1.0 0.4 0.0 1.2 0.0 1.3 0.6 0.1 0.4 4.4 2.1 0.0 0.9 1.1 0.1 0.2 0.6 2.0 1.4 5.4 0.2 0.0 0.5 ARHGAP17 "FLJ10308, FLJ13219, NADRIN, RICH1, WBP15" ENSG00000140750 "Rho GTPase activating protein 17" Q68EM7 16 24919389-25015666 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041703, HPA075891" Approved Supported "Plasma membrane,Cytosol" NA NA 21000 "Plasma membrane, Cytosol" "HPA041703: AB_10794304, HPA075891: " "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (8.11e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.42e-2)" "unprognostic (3.49e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (3.02e-2)" "unprognostic (6.62e-2)" "unprognostic (8.81e-3)" "unprognostic (4.99e-2)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.76e-4)" 45.2 40.8 8.0 15.4 9.2 9.3 37.5 8.8 10.3 28.4 9.5 29.4 11.4 29.1 8.0 33.9 28.9 12.0 40.3 7.4 10.2 26.0 23.1 32.0 25.1 9.7 9.1 6.8 25.0 24.3 9.4 30.5 15.4 10.7 23.9 12.3 2.4 21.5 8.0 41.3 33.6 39.6 11.7 8.9 67.3 29.1 25.7 8.9 12.1 28.4 11.2 21.1 25.8 30.0 11.3 28.5 16.7 21.9 23.1 22.0 23.0 23.7 18.1 19.3 20.9 20.4 25.9 11.5 13.0 12.0 36.4 19.9 7.7 21.8 12.8 22.2 20.0 26.1 10.8 37.8 43.3 25.0 15.5 10.7 29.4 7.7 22.6 16.3 15.0 35.7 11.7 14.3 0.0 23.6 20.8 14.3 19.8 25.2 8.1 13.7 68.1 17.9 5.2 25.9 6.4 14.6 14.5 18.6 20.5 8.2 17.5 11.1 40.2 46.7 15.5 11.9 35.6 15.1 13.0 17.3 7.5 19.1 22.6 14.1 5.6 9.7 9.0 6.3 17.5 5.7 25.3 5.5 6.3 14.6 22.8 6.2 6.1 4.8 6.2 15.8 25.9 8.0 8.1 8.0 9.2 8.8 10.3 7.4 10.2 9.7 9.1 6.8 10.7 8.9 8.9 11.3 33.8 9.6 11.0 26.8 46.3 14.5 6.8 8.9 14.2 6.4 11.0 9.7 24.9 7.2 9.1 5.5 10.4 11.1 36.3 49.5 3.9 13.3 6.3 30.6 21.8 32.3 21.0 16.2 28.8 16.0 18.9 16.0 15.3 66.4 7.0 16.9 26.7 6.8 27.1 10.1 33.0 21.8 8.2 30.3 21.7 10.8 13.4 25.2 16.0 59.0 22.8 6.4 14.4 40.2 68.9 17.6 27.2 11.7 11.5 11.1 35.4 5.0 8.5 7.5 26.3 15.5 43.8 7.0 11.7 24.7 24.0 15.7 21.1 15.9 19.7 12.2 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46702282-46790407 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "heart muscle: 104.3;skeletal muscle: 46.9;tongue: 73.2" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.6;hippocampal formation: 5.1" "Region enriched" "Detected in single" 5 "hippocampal formation: 3.5" HPA073447 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073447: AB_2732225" "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 4.5 0.1 1.9 0.3 0.1 3.6 2.5 0.5 1.5 0.0 0.1 0.3 0.8 4.3 1.7 0.2 104.3 2.2 6.6 1.1 0.1 0.5 0.2 8.8 6.4 0.3 0.3 0.1 0.0 0.4 0.5 8.1 2.3 0.1 0.2 2.2 0.1 46.9 0.1 0.1 0.2 7.7 0.1 0.1 6.0 4.4 0.1 0.1 73.2 0.1 0.0 0.0 3.2 0.0 0.1 0.1 0.1 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 2.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.5 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.4 0.0 7.9 0.2 3.5 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 4.5 1.9 3.6 2.5 2.2 6.6 8.8 6.4 0.3 8.1 7.7 4.4 3.2 0.2 0.0 3.3 0.7 0.5 0.0 0.7 0.0 0.0 0.9 1.3 0.0 169.0 0.0 3.7 0.0 2.1 2.0 0.2 0.0 0.0 0.0 8.1 44.8 7.1 1.7 0.0 0.0 0.9 0.2 0.5 6.7 0.0 2.2 1.3 1.6 0.7 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 7.2 0.6 0.8 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.8 0.0 0.2 8.7 1.3 0.0 4.9 2.7 1.0 0.7 0.0 0.0 0.3 0.8 0.7 0.0 0.8 ABCC12 MRP9 ENSG00000140798 "ATP binding cassette subfamily C member 12" Q96J65 16 48081006-48156018 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 4.4;Excitatory neurons: 5.1;Late spermatids: 2.2;Spermatocytes: 6.0;Theca cells: 3.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA043100 Uncertain NA NA "HPA043100: AB_10794922" "unprognostic (1.53e-1)" "unprognostic (6.87e-2)" "unprognostic (2.37e-2)" "unprognostic (4.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-2)" "unprognostic (2.65e-1)" "unprognostic (7.53e-2)" "unprognostic (4.23e-1)" 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.4 0.3 0.2 0.2 0.3 0.3 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 NKD1 ENSG00000140807 "NKD inhibitor of WNT signaling pathway 1" Q969G9 16 50548396-50649249 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell type enhanced" "Detected in many" "Microglial cells: 45.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 27.4;Smooth muscle cells: 13.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 12.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;CACO-2: 13.6;Hep G2: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041352, HPA049413" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA041352: AB_2677428, HPA049413: AB_2680753" "unprognostic (1.58e-3)" "unprognostic (1.24e-2)" "unprognostic (1.94e-1)" "unprognostic (6.02e-3)" "unprognostic (5.59e-3)" "unprognostic (9.80e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (5.25e-3)" "unprognostic (2.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.87e-1)" "unprognostic (6.88e-4)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (3.30e-2)" "unprognostic (3.44e-2)" 1.6 0.7 8.0 0.7 7.1 0.1 1.0 7.1 3.7 2.4 2.2 3.6 1.1 6.0 4.2 3.2 4.8 2.8 0.5 3.7 4.7 1.6 0.6 6.9 0.4 8.2 12.3 2.0 2.9 1.2 0.2 0.4 2.0 7.8 3.6 1.4 0.7 0.5 2.8 0.3 1.9 2.0 5.7 7.4 1.5 2.1 1.1 15.2 0.7 0.3 0.2 0.5 2.3 1.2 7.3 0.0 0.1 6.3 0.5 2.4 0.0 0.2 0.0 0.0 0.0 0.0 13.6 0.3 0.0 0.2 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.7 0.7 0.0 36.5 0.0 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.1 1.4 0.5 0.6 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 7.1 7.1 3.7 3.7 4.7 8.2 12.3 2.0 7.8 7.4 15.2 7.3 0.3 0.0 0.0 4.2 0.2 1.5 1.2 0.2 0.0 2.1 0.3 0.8 0.8 0.0 0.5 0.0 6.2 2.5 0.7 0.2 0.0 0.4 7.4 0.5 2.0 0.9 1.8 0.4 0.4 0.4 0.4 3.8 1.5 0.7 0.0 3.7 0.4 1.7 0.4 0.0 1.0 0.5 0.0 0.0 3.0 2.2 1.8 0.8 8.8 45.9 0.2 6.7 0.0 57.3 27.4 0.3 0.0 3.4 0.5 0.9 0.2 0.1 0.1 0.8 13.1 0.4 13.4 1.1 7.1 0.6 1.1 2.3 2.4 0.0 0.5 1.4 DHX38 "DDX38, hPrp16, KIAA0224, PRP16, PRPF16" ENSG00000140829 "DEAH-box helicase 38" Q92620 16 72093613-72112912 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041347, HPA041604" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041347: AB_10796571, HPA041604: AB_2677577" "unprognostic (2.38e-1)" "unprognostic (1.89e-1)" "unprognostic (1.24e-2)" "unprognostic (3.25e-2)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (6.32e-3)" "unprognostic (8.50e-3)" "unprognostic (6.97e-2)" "unprognostic (1.45e-1)" "unprognostic (7.92e-2)" "unprognostic (1.28e-3)" "unprognostic (4.20e-3)" "unprognostic (2.68e-1)" "unprognostic (9.46e-2)" "unprognostic (2.40e-1)" "unprognostic (2.40e-2)" 25.0 18.9 20.5 23.0 21.7 40.1 24.0 20.3 24.9 24.9 22.8 24.8 19.8 25.7 10.8 24.4 24.0 15.1 24.6 19.5 20.4 19.7 24.2 24.1 28.1 21.5 21.1 18.3 30.9 20.4 23.1 19.4 18.8 21.5 21.1 16.2 13.3 21.3 14.5 40.2 27.6 27.6 17.8 20.8 30.7 22.7 21.5 20.7 24.5 23.0 21.6 23.2 23.9 23.0 22.8 38.5 55.0 39.4 21.9 33.4 25.8 51.1 33.6 32.6 49.1 37.8 66.4 37.5 50.5 29.2 50.9 27.0 48.6 46.3 45.8 38.0 25.3 50.0 38.7 48.9 92.5 30.8 46.9 66.7 35.6 41.2 66.1 47.4 25.9 42.9 35.7 58.9 22.9 30.6 112.8 43.9 53.1 49.7 23.9 30.9 55.8 27.1 49.9 24.0 35.6 35.6 38.9 43.8 20.3 24.5 22.5 36.8 38.4 49.4 46.6 40.8 34.8 37.3 56.2 47.6 96.7 43.9 32.1 37.5 7.1 6.2 7.1 11.3 8.3 9.8 8.1 6.8 8.2 6.2 6.0 7.4 7.9 6.4 8.8 5.1 5.5 8.6 5.5 20.5 21.7 20.3 24.9 19.5 20.4 21.5 21.1 18.3 21.5 20.8 20.7 22.8 22.5 25.6 34.3 13.7 24.4 12.2 11.0 9.5 20.5 30.7 12.0 13.6 8.6 20.0 22.0 14.7 16.7 15.0 33.3 28.5 0.0 14.5 9.0 19.3 23.0 22.3 30.5 16.8 6.7 20.6 14.3 17.1 28.1 23.6 43.0 24.0 15.0 13.6 14.9 30.3 6.1 24.8 6.1 15.2 13.9 11.0 28.9 20.3 8.8 5.6 16.9 17.9 19.6 8.0 11.1 23.7 17.1 25.2 22.4 12.7 21.1 8.6 19.0 35.3 19.7 25.6 19.1 25.5 17.8 18.5 12.8 20.4 28.2 20.6 23.4 12.6 TXNL4B "Dim2, DLP, FLJ20511" ENSG00000140830 "Thioredoxin like 4B" Q9NX01 16 72044289-72094431 "Predicted intracellular proteins" "Cell cycle, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 86.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065865 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065865: AB_2685571" "unprognostic (1.45e-1)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (3.78e-2)" "unprognostic (8.72e-2)" "unprognostic (4.75e-2)" "unprognostic (2.65e-1)" "unprognostic (8.91e-2)" "unprognostic (4.75e-2)" "unprognostic (1.04e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.62e-1)" "unprognostic (2.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" 7.9 7.3 9.5 9.6 11.5 14.4 9.7 10.6 12.3 8.2 9.6 7.4 10.2 7.7 7.7 9.2 10.2 8.8 7.7 9.2 10.5 8.0 16.3 6.7 11.4 10.3 11.3 9.3 21.1 9.2 7.6 8.5 7.5 10.4 7.4 8.3 6.8 8.8 7.5 9.0 8.0 8.6 6.4 10.0 7.5 8.0 15.8 10.2 11.8 8.1 8.4 9.8 7.4 7.0 15.5 14.3 20.8 11.2 15.9 8.2 9.7 25.0 18.1 14.7 31.0 23.3 21.4 12.7 20.6 12.8 9.4 14.5 19.3 20.1 10.9 24.0 10.3 18.9 19.0 16.8 32.7 17.4 22.8 15.9 10.1 7.3 27.5 26.1 12.0 13.5 22.6 46.5 12.2 14.8 26.7 27.6 20.5 20.9 9.0 19.1 28.3 14.2 28.3 11.5 10.6 25.9 22.2 17.0 8.0 24.6 8.6 18.7 14.5 12.9 14.9 21.6 12.5 17.2 23.9 41.8 86.0 16.7 15.4 15.2 25.4 8.8 12.3 7.6 9.8 11.9 9.7 7.9 6.7 7.8 7.1 10.8 10.8 12.6 4.9 14.0 8.5 9.9 9.1 9.5 11.5 10.6 12.3 9.2 10.5 10.3 11.3 9.3 10.4 10.0 10.2 15.5 7.1 3.2 8.3 7.5 13.1 8.5 7.7 5.4 9.6 3.7 9.8 10.4 2.0 7.2 5.5 5.5 2.1 13.5 8.9 7.4 5.9 10.7 1.6 10.5 9.7 10.1 9.0 10.8 3.3 10.1 17.5 7.9 7.7 12.5 9.5 16.0 10.8 13.3 12.0 10.1 3.3 9.5 0.0 9.2 4.6 4.5 11.8 9.3 7.2 2.8 10.8 4.5 8.2 7.5 5.8 7.6 3.3 9.1 7.9 7.7 11.6 16.2 7.2 5.1 0.0 8.2 6.7 8.2 8.8 9.6 8.2 19.4 9.7 10.2 9.1 7.2 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" No NA Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favorable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.2 0.3 0.7 3.1 0.6 0.6 6.3 1.8 0.9 4.1 5.4 23.9 31.4 1.8 7.4 4.3 4.3 4.9 0.3 1.2 0.6 13.0 5.3 2.5 0.5 0.5 0.4 0.5 0.5 17.3 12.6 1.0 5.7 0.6 6.0 18.9 2.1 11.7 2.5 0.8 3.0 33.4 0.6 0.2 0.5 2.8 0.9 0.5 1.0 3.9 0.0 1.7 3.9 2.5 0.9 21.7 0.7 0.5 0.9 0.0 0.1 30.9 0.0 0.0 0.0 0.0 23.6 22.5 0.2 2.3 0.0 0.1 21.4 1.9 10.3 0.1 0.0 12.1 0.0 0.4 6.2 0.0 0.1 0.2 0.9 12.5 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.0 40.8 0.2 0.3 3.5 13.4 0.2 0.0 0.1 8.8 0.3 18.8 3.7 0.2 0.4 18.5 0.0 2.4 26.3 0.3 0.0 0.0 0.4 0.4 0.2 0.2 0.3 0.1 0.2 0.2 0.2 1.8 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.2 1.2 0.4 0.1 0.3 0.2 0.1 0.7 0.6 1.8 0.9 1.2 0.6 0.5 0.4 0.5 0.6 0.2 0.5 0.9 0.3 9.6 8.4 0.3 0.8 7.9 28.7 9.6 22.8 7.0 25.4 10.7 0.6 40.0 17.9 9.2 0.0 36.5 1.5 150.1 1.9 29.8 4.4 14.2 1.5 1.0 61.5 0.0 0.6 33.7 2.5 1.5 6.1 19.4 0.0 3.8 0.4 9.1 3.1 0.0 0.6 68.2 14.2 1.0 1.0 3.3 0.3 1.2 0.0 0.0 0.8 1.0 0.0 0.0 0.6 26.3 102.9 0.7 0.0 38.4 199.3 27.6 17.4 19.6 0.0 4.1 1.6 9.6 5.0 19.6 3.7 4.8 1.4 0.0 61.3 44.3 CHST4 "HEC-GLCNAC-6-ST, LSST" ENSG00000140835 "Carbohydrate sulfotransferase 4" Q8NCG5 16 71525233-71538748 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "gallbladder: 70.0" "Cell type enriched" "Detected in some" 24 "Cholangiocytes: 165.8" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 10.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.6;HL-60: 2.7;NB-4: 5.0;NTERA-2: 7.5;SCLC-21H: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021955 Enhanced "Intracellular and membrane" NA NA "HPA021955: AB_1846723" "unprognostic (2.22e-3)" "unprognostic (1.41e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-2)" "unprognostic (4.76e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (9.24e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-6)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" 0.2 1.3 0.2 0.2 0.1 0.0 0.2 0.1 0.1 2.5 1.4 0.0 0.0 0.1 0.0 0.2 5.4 70.0 0.0 0.1 0.2 0.0 4.4 0.2 1.3 0.3 0.3 0.0 0.0 12.5 0.0 0.5 0.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.1 0.0 0.3 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 2.1 0.1 1.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.0 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.1 165.8 6.7 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.7 0.4 0.0 0.0 0.0 0.4 0.7 0.0 0.3 0.0 3.8 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZFHX3 "ATBF1, C16orf47, FLJ26184, ZNF927" ENSG00000140836 "Zinc finger homeobox 3" Q15911 16 72782885-73891871 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Myogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 35 "brain: 382.9" "Cell type enhanced" "Detected in all" "Microglial cells: 285.8;Smooth muscle cells: 177.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebral cortex: 382.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059353 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059353: AB_2683987" "prognostic unfavorable (1.55e-4)" "unprognostic (3.57e-2)" "unprognostic (1.68e-1)" "unprognostic (2.03e-2)" "unprognostic (2.81e-2)" "unprognostic (3.12e-1)" "unprognostic (4.24e-2)" "unprognostic (6.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "unprognostic (4.16e-2)" "prognostic favorable (1.37e-5)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.15e-2)" 6.1 4.4 5.9 1.9 4.3 0.9 3.6 1.4 382.9 5.3 5.3 5.0 1.5 4.7 4.0 2.0 3.6 4.3 3.3 63.5 9.2 3.0 3.1 4.4 1.2 70.5 8.1 0.0 2.8 4.0 9.7 4.0 6.2 31.4 6.9 2.6 4.5 4.0 6.5 9.9 2.7 2.6 4.1 10.6 3.2 3.6 1.8 10.4 1.3 7.5 10.8 0.7 6.8 3.5 55.3 5.0 9.2 14.7 12.3 5.3 6.7 15.1 3.9 4.3 2.5 2.8 10.6 2.9 2.3 5.5 7.5 3.4 3.5 9.4 4.7 3.4 9.3 2.3 0.4 13.1 15.1 4.9 1.6 3.5 2.5 2.8 7.3 6.5 2.3 4.7 1.0 1.1 0.6 6.3 10.9 0.5 3.1 2.4 2.7 1.5 7.0 4.0 0.8 4.0 8.8 10.9 3.9 6.9 2.1 4.8 6.7 3.0 0.7 10.3 6.0 7.0 6.5 4.9 4.7 1.7 1.6 2.9 1.4 4.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 5.9 4.3 1.4 382.9 63.5 9.2 70.5 8.1 0.0 31.4 10.6 10.4 55.3 13.6 70.5 26.7 109.7 8.6 17.0 55.6 13.1 37.0 122.0 24.5 20.6 23.7 47.1 34.8 47.8 22.9 47.4 5.2 11.0 5.9 23.0 2.6 94.6 33.1 40.3 26.9 7.4 22.0 23.4 19.4 68.8 25.5 154.6 21.0 20.7 44.6 37.5 67.0 23.5 8.7 23.2 22.4 84.2 142.6 2.8 10.5 72.9 21.4 285.8 40.8 13.9 3.1 83.9 18.5 20.7 22.4 19.9 2.2 77.5 6.9 7.4 29.3 34.1 124.9 153.7 177.3 3.7 16.8 29.5 17.2 62.1 7.7 12.4 31.0 43.8 CLEC18B MRCL2 ENSG00000140839 "C-type lectin domain family 18 member B" Q6UXF7 16 74408270-74421953 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 32.7;testis: 11.9" "Cell type enriched" "Detected in some" 14 "Proximal tubular cells: 26.8" "Cancer enhanced" "Detected in some" "glioma: 2.7;renal cancer: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;JURKAT: 1.6;K-562: 3.1;U-266/70: 1.1" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (5.69e-2)" "unprognostic (1.46e-1)" "unprognostic (5.30e-3)" "unprognostic (9.37e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (7.15e-2)" "unprognostic (7.51e-2)" "unprognostic (4.49e-3)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (9.91e-2)" "unprognostic (3.58e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-2)" "unprognostic (5.87e-2)" "unprognostic (5.43e-2)" "unprognostic (4.27e-2)" 0.1 1.9 3.8 0.4 3.9 0.1 0.2 4.7 4.8 0.4 2.5 0.2 0.4 0.1 0.6 2.7 0.3 0.3 0.2 3.8 6.0 32.7 0.6 0.2 0.1 4.1 3.6 3.2 0.2 0.6 0.0 0.8 0.1 3.9 0.5 0.1 2.3 0.7 0.0 0.2 0.2 0.3 0.1 3.8 0.6 0.3 11.9 3.5 0.3 0.6 0.0 0.0 0.1 1.7 5.5 0.0 0.6 1.1 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.2 0.4 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.2 0.0 1.6 3.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.3 0.1 0.0 0.6 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.3 1.1 0.7 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.9 4.7 4.8 3.8 6.0 4.1 3.6 3.2 3.9 3.8 3.5 5.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.9 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 1.6 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.5 0.1 0.0 0.0 0.0 0.4 26.8 0.0 1.4 0.0 0.0 0.2 0.5 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092583-57148369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.4" "Cell type enhanced" "Detected in many" "Adipocytes: 84.3;Hepatic stellate cells: 82.8;Oligodendrocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: AB_2677316" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 35.5 7.4 36.2 12.9 45.7 61.1 25.1 38.4 36.4 36.8 33.1 29.5 6.1 20.8 6.6 16.0 28.3 14.4 15.7 33.0 44.6 14.2 9.4 37.5 11.1 47.7 44.0 24.2 10.8 7.3 11.0 7.6 28.1 47.2 14.1 28.5 1.7 11.0 17.2 11.8 11.3 21.4 25.3 37.4 18.4 9.3 16.5 52.5 6.4 16.1 13.6 9.3 16.8 18.7 85.4 23.9 45.1 68.0 38.1 12.0 11.6 11.3 25.4 39.8 56.8 39.5 12.7 27.0 14.2 22.7 38.6 31.4 36.7 27.1 15.1 30.6 17.7 15.9 5.9 17.5 10.7 21.6 4.8 0.6 11.1 16.8 22.3 10.8 42.4 84.5 7.6 16.0 0.5 14.5 11.1 7.2 69.9 15.5 11.6 9.5 88.8 21.3 11.9 37.7 9.0 1.4 27.6 32.3 6.9 19.4 30.5 7.5 94.4 60.3 51.6 27.7 13.1 33.5 3.4 3.0 31.8 33.4 20.6 37.0 0.0 1.5 0.8 0.2 0.4 0.2 0.0 0.1 0.4 0.8 0.0 0.1 0.2 1.5 0.1 0.1 0.0 0.2 0.4 36.2 45.7 38.4 36.4 33.0 44.6 47.7 44.0 24.2 47.2 37.4 52.5 85.4 84.3 19.2 7.4 8.1 1.5 2.3 17.1 6.0 7.4 0.4 8.2 6.9 2.3 4.3 5.1 5.5 0.0 0.6 1.4 43.4 5.9 4.7 19.9 33.4 13.8 41.0 3.6 0.8 1.0 4.2 2.9 12.3 1.5 39.3 0.0 26.7 82.8 2.0 23.6 0.0 7.4 13.7 4.1 25.3 7.4 5.9 6.8 12.0 7.2 8.4 10.7 3.6 0.0 17.1 86.3 6.2 25.1 7.5 0.8 14.2 35.4 2.6 9.2 0.0 32.9 9.3 21.7 0.6 2.6 6.2 4.3 0.8 8.4 2.1 18.2 16.3 NLRC5 "CLR16.1, FLJ21709, NOD27" ENSG00000140853 "NLR family CARD domain containing 5" Q86WI3 16 56989485-57083531 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.9;lymphoid tissue: 33.1" "Cell type enhanced" "Detected in many" "dendritic cells: 35.8;Distal enterocytes: 43.2;Gastric mucus-secreting cells: 41.8;NK-cells: 39.1;T-cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 94.2;NB-4: 51.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA060405, HPA074724" Supported Centrosome,Cytosol NA NA Cytosol Centrosome "HPA060405: AB_2684277, HPA074724: " "unprognostic (9.66e-2)" "prognostic favorable (9.69e-4)" "unprognostic (1.64e-2)" "unprognostic (1.23e-2)" "unprognostic (3.12e-1)" "unprognostic (9.27e-3)" "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "unprognostic (2.24e-2)" "prognostic favorable (2.30e-4)" "unprognostic (2.69e-1)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (2.99e-2)" "unprognostic (3.91e-2)" "unprognostic (5.06e-2)" "unprognostic (2.75e-3)" 5.9 3.7 2.3 24.3 3.3 34.9 2.9 2.0 2.2 2.7 1.7 8.5 6.1 4.2 1.5 5.5 2.7 8.5 4.2 1.3 4.1 2.1 2.7 11.4 29.2 5.2 2.6 0.5 2.8 2.6 3.1 4.8 2.7 5.3 3.0 6.8 0.7 8.7 2.6 3.1 13.7 8.9 6.0 2.9 33.1 9.3 1.2 4.0 10.7 2.8 4.8 17.4 7.1 2.7 4.9 11.3 2.1 0.3 0.8 0.7 3.6 0.1 6.1 9.4 19.1 18.4 0.0 19.0 22.9 4.5 10.0 7.5 7.3 2.4 0.6 2.1 1.0 0.7 94.2 21.8 2.3 6.5 3.3 5.4 7.0 0.2 15.6 1.7 6.1 7.5 3.2 0.1 4.5 4.0 0.4 5.2 51.8 0.1 0.3 2.0 24.5 6.9 9.4 2.1 0.9 0.7 0.8 12.4 1.1 2.6 0.0 1.3 12.3 9.7 9.1 3.2 33.7 5.1 9.0 5.0 23.9 16.3 6.9 1.7 7.2 3.8 12.6 5.8 1.9 3.5 4.6 3.4 5.7 1.5 2.7 2.1 2.3 8.5 2.3 2.3 1.1 4.1 3.0 2.3 3.3 2.0 2.2 1.3 4.1 5.2 2.6 0.5 5.3 2.9 4.0 4.9 29.8 0.0 11.2 6.2 28.0 6.8 0.9 1.1 2.2 0.9 3.1 2.8 5.3 0.0 3.6 5.5 0.0 0.1 35.8 43.2 0.0 5.6 0.5 5.1 8.5 16.9 8.4 4.8 0.5 8.4 0.2 3.4 41.8 16.7 9.5 2.2 7.9 5.5 4.5 0.0 0.8 20.7 4.1 16.2 5.4 0.5 0.9 14.2 0.0 26.2 17.8 0.2 39.1 1.5 4.5 9.4 14.1 0.4 14.7 2.3 3.0 0.9 2.5 1.3 0.0 3.7 6.4 0.1 0.1 3.3 9.9 0.1 42.2 7.8 15.9 3.5 KATNB1 ENSG00000140854 "Katanin regulatory subunit B1" Q9BVA0 16 57735739-57757244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041165, HPA041839" Enhanced Supported "Plasma membrane,Microtubules,Cytosol" NA NA "Plasma membrane, Cytosol" Microtubules "HPA041165: AB_10795584, HPA041839: AB_10795598" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.54e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-1)" "prognostic favorable (8.44e-4)" "unprognostic (2.89e-2)" "unprognostic (1.03e-3)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (6.88e-2)" "unprognostic (1.54e-1)" 9.6 13.4 12.1 10.9 16.8 23.2 10.7 4.5 24.6 9.8 8.6 9.1 10.7 11.3 4.2 16.0 19.4 6.3 10.8 15.7 10.2 10.3 9.5 12.0 10.6 9.3 8.0 16.4 9.6 14.1 10.8 13.8 7.3 10.7 10.3 5.5 6.0 13.2 7.8 10.4 27.6 10.2 6.6 4.7 13.0 10.4 37.4 9.2 12.9 11.1 7.9 8.3 8.8 12.0 14.8 20.8 35.7 19.2 25.0 10.4 9.2 35.2 13.9 18.5 35.2 19.6 30.2 18.3 16.1 28.0 8.8 13.2 27.0 25.8 27.9 16.2 11.1 74.8 21.0 20.4 42.5 11.5 47.6 77.6 9.5 17.3 28.7 16.1 14.8 21.2 58.8 42.8 8.2 15.0 21.6 67.6 60.1 34.0 14.7 61.4 53.7 23.8 59.6 10.6 9.9 97.0 29.2 23.8 27.1 16.8 7.6 10.2 23.9 16.0 24.5 21.9 22.9 31.0 18.5 16.1 19.9 35.2 36.6 15.7 50.8 18.9 46.1 21.0 20.8 20.4 9.3 17.5 16.3 17.8 9.3 16.0 15.5 27.9 16.1 22.7 11.9 20.1 21.7 12.1 16.8 4.5 24.6 15.7 10.2 9.3 8.0 16.4 10.7 4.7 9.2 14.8 5.5 3.2 5.5 3.3 5.2 9.1 8.0 11.5 9.6 10.2 8.4 7.1 2.6 4.3 7.7 5.5 6.2 17.3 8.5 13.2 11.7 13.7 115.4 18.8 4.4 6.0 4.8 8.8 14.8 13.6 11.7 6.6 12.8 4.7 5.1 7.6 6.8 4.7 9.9 18.5 11.2 9.2 6.1 5.1 2.5 36.6 7.8 7.6 7.2 3.7 6.1 10.0 11.3 2.5 4.9 10.1 5.1 4.9 13.3 7.3 10.5 8.0 26.2 10.9 6.6 4.9 6.3 41.8 8.3 11.9 13.8 7.7 10.9 8.2 11.8 7.8 KIFC3 ENSG00000140859 "Kinesin family member C3" Q9BVG8 16 57758217-57863053 "Cancer-related genes, Predicted intracellular proteins" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 141.8;Early spermatids: 203.7;Late spermatids: 430.5;Rod photoreceptor cells: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "A549: 215.1;HMC-1: 204.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021240 Uncertain NA NA "HPA021240: AB_1852509" "unprognostic (1.53e-1)" "unprognostic (3.10e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (2.95e-3)" "unprognostic (2.29e-1)" "unprognostic (3.71e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (7.66e-3)" "unprognostic (1.59e-2)" "unprognostic (2.18e-2)" "unprognostic (3.42e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-2)" "unprognostic (1.40e-1)" "unprognostic (4.33e-2)" 29.1 29.2 26.5 26.1 18.1 14.6 24.0 26.8 36.9 22.8 10.6 16.7 30.9 22.4 30.3 26.4 15.0 21.3 50.4 22.9 18.6 97.5 86.3 45.8 13.6 26.6 19.7 9.9 19.2 77.3 26.3 31.1 25.8 35.7 26.5 13.6 83.0 22.3 22.5 13.8 80.7 37.7 13.1 9.5 21.3 24.7 65.4 25.9 4.1 68.6 6.6 9.6 30.5 24.6 48.1 41.5 215.1 15.2 32.8 4.9 10.4 26.8 51.1 65.1 76.4 36.3 58.2 62.6 4.4 64.5 32.8 79.3 43.2 1.8 47.1 25.6 2.1 10.2 34.6 72.9 75.8 28.8 5.0 204.7 14.2 16.6 40.3 40.5 39.1 18.4 11.9 61.7 7.4 28.6 28.2 7.4 60.9 10.3 16.2 45.6 4.6 23.1 33.0 48.9 21.3 5.3 10.7 86.8 60.7 55.8 10.5 18.2 26.0 39.9 98.4 69.3 45.3 71.5 5.9 3.7 4.3 49.9 3.3 94.7 0.1 0.2 0.2 1.5 0.0 0.1 0.7 0.6 1.5 0.1 0.5 0.3 0.4 0.5 0.1 0.7 0.1 0.0 0.6 26.5 18.1 26.8 36.9 22.9 18.6 26.6 19.7 9.9 35.7 9.5 25.9 48.1 40.0 48.1 33.3 28.4 0.5 12.6 12.3 8.1 5.7 5.7 5.0 7.4 8.4 38.6 15.3 66.2 141.8 31.8 9.2 0.1 50.9 50.6 203.7 18.5 4.8 25.3 0.0 4.8 15.8 63.6 6.4 11.8 2.0 15.6 3.8 0.9 25.4 16.6 25.7 1.7 14.8 2.1 2.0 6.6 10.2 430.5 12.2 24.7 28.4 16.9 1.1 10.6 15.5 27.2 28.9 67.1 1.2 22.6 0.8 13.8 34.7 51.4 14.9 165.5 19.7 10.3 16.5 7.7 9.9 1.0 8.2 19.4 5.8 10.5 0.9 7.9 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435034 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.3;placenta: 20.8" "Cell type enhanced" "Detected in some" "Adipocytes: 36.8;Granulosa cells: 15.0;Muller glia cells: 13.7;Oligodendrocytes: 16.9;Rod photoreceptor cells: 7.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 11.6;HUVEC TERT2: 8.0;SuSa: 10.6;TIME: 2.5;U-87 MG: 4.8" "Region enriched" "Detected in single" 5 "cerebellum: 3.3" "Low region specificity" "Detected in all" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" Yes NA "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 2.6 0.1 1.3 0.3 2.8 0.0 2.9 10.3 2.9 1.1 0.7 0.0 0.1 0.8 0.0 0.1 0.2 0.6 0.0 1.8 3.7 0.2 0.0 0.1 0.1 3.8 2.5 1.3 0.1 0.3 0.0 0.8 20.8 3.9 0.4 0.0 2.0 1.3 0.1 0.6 0.1 0.0 0.6 1.9 0.0 0.0 0.2 2.6 0.9 0.0 0.0 0.0 0.9 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.6 0.0 0.5 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.8 10.3 2.9 1.8 3.7 3.8 2.5 1.3 3.9 1.9 2.6 5.8 36.8 0.0 0.0 4.6 0.1 0.1 0.1 0.0 0.0 1.8 1.5 4.3 0.6 0.0 0.0 1.8 2.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.6 0.0 0.1 1.2 0.0 0.3 0.0 15.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 13.7 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 1.1 0.2 0.6 0.0 0.1 0.3 0.0 0.1 0.0 0.0 NUDT7 ENSG00000140876 "Nudix hydrolase 7" P0C024 16 77722492-77742260 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 58.7;Proximal tubular cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 49.7;U-698: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042042 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA042042: AB_10806232" "unprognostic (1.92e-1)" "unprognostic (1.17e-2)" "unprognostic (6.64e-2)" "unprognostic (5.95e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.84e-4)" "unprognostic (2.48e-1)" "unprognostic (4.05e-2)" "unprognostic (2.11e-1)" "unprognostic (2.46e-2)" "unprognostic (4.74e-2)" "unprognostic (4.52e-1)" "prognostic favorable (5.36e-11)" "unprognostic (1.19e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (3.42e-2)" 14.5 23.8 6.0 5.3 6.3 2.2 9.3 6.6 7.5 5.4 13.8 12.1 10.9 7.9 17.7 6.7 10.3 6.8 37.9 5.7 7.3 22.3 70.7 6.1 9.0 6.4 5.6 5.9 7.4 9.6 16.5 6.0 4.5 6.5 6.7 12.4 9.8 9.1 7.3 8.2 9.0 8.8 7.5 5.0 7.1 7.6 8.8 6.3 6.5 11.9 12.2 9.2 8.2 5.9 6.4 2.1 7.0 6.2 3.5 28.4 7.2 5.8 1.8 9.1 2.7 3.5 2.0 8.8 10.3 6.6 6.9 6.5 6.9 4.7 7.6 1.6 3.3 6.4 0.1 0.4 9.6 3.1 7.1 1.4 12.2 9.4 1.5 5.3 1.2 4.8 14.7 7.6 4.4 1.1 19.1 3.7 16.8 6.6 12.4 1.7 7.8 0.8 3.1 14.1 0.0 5.1 5.0 6.5 2.6 5.7 10.6 18.6 49.7 3.7 3.1 0.4 1.4 0.3 0.0 0.0 40.6 12.1 8.8 0.0 3.8 12.4 1.7 12.6 17.5 14.4 14.2 14.8 15.1 10.2 19.8 19.5 13.5 2.0 3.5 17.5 11.7 31.5 8.8 6.0 6.3 6.6 7.5 5.7 7.3 6.4 5.6 5.9 6.5 5.0 6.3 6.4 8.3 16.0 8.7 12.7 4.1 9.7 6.5 14.6 14.2 2.5 10.9 14.5 17.9 18.6 7.9 14.7 0.0 20.3 7.9 12.1 58.7 8.0 11.6 19.5 4.7 8.2 6.7 3.6 4.3 9.5 9.1 8.5 3.6 6.6 1.3 7.0 5.3 41.2 5.9 6.7 5.6 6.6 10.2 9.2 4.4 4.6 5.6 4.1 8.8 1.9 2.1 25.0 10.3 3.5 2.7 4.0 10.4 4.9 1.1 2.0 22.6 42.2 21.0 7.3 6.6 7.1 8.9 14.2 20.0 12.2 13.9 6.7 6.9 10.7 14.8 4.5 GCSH ENSG00000140905 "Glycine cleavage system protein H" P23434 16 81081945-81096395 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 553.4;Extravillous trophoblasts: 1476.4;Proximal tubular cells: 655.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041368, HPA057079" Supported Approved Vesicles "Intracellular and membrane" NA NA 50000 Vesicles "HPA041368: AB_10804001, HPA057079: " "unprognostic (4.09e-2)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (2.47e-3)" "unprognostic (2.55e-3)" "unprognostic (4.87e-2)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.96e-2)" "unprognostic (6.92e-2)" "unprognostic (2.80e-2)" "prognostic favorable (6.26e-6)" "unprognostic (1.12e-2)" "unprognostic (2.59e-1)" "unprognostic (6.31e-2)" "unprognostic (6.47e-2)" 25.9 20.2 78.6 7.0 84.2 6.4 24.4 82.5 108.7 18.4 69.4 14.8 7.3 17.7 69.5 15.6 20.0 11.8 30.2 74.7 79.7 78.9 119.9 10.9 6.7 80.2 85.1 71.0 18.6 19.9 31.3 14.4 26.2 83.5 18.9 13.1 15.7 15.7 16.9 59.8 9.8 9.6 11.9 81.3 6.3 17.7 7.5 84.1 10.5 97.3 64.2 9.3 18.4 15.3 87.6 63.6 28.3 82.4 37.0 40.4 30.9 175.5 35.9 26.4 43.3 20.6 37.0 57.2 17.2 32.3 15.9 31.9 33.3 64.5 36.5 71.6 4.7 86.7 21.8 34.9 114.6 45.7 70.3 24.1 32.0 47.8 26.8 53.7 13.0 22.3 45.1 86.3 3.4 42.9 67.7 45.9 138.8 113.0 49.6 57.5 72.7 44.1 25.5 98.4 56.4 43.7 45.3 53.3 32.9 70.8 63.9 48.3 33.2 19.8 27.6 49.3 44.0 37.8 14.7 31.8 102.1 18.2 41.3 22.6 3.6 1.3 1.3 2.8 2.1 4.6 3.5 2.6 4.0 3.9 2.5 4.4 5.9 1.7 7.0 1.7 10.8 2.2 2.4 78.6 84.2 82.5 108.7 74.7 79.7 80.2 85.1 71.0 83.5 81.3 84.1 87.6 31.1 3.2 5.9 16.3 24.8 29.1 94.6 73.6 52.3 43.7 97.9 115.6 12.9 44.3 31.4 80.9 37.5 553.4 13.8 15.3 295.4 70.0 32.4 34.8 128.3 31.9 26.4 71.1 12.6 42.5 1476.4 61.6 31.1 55.2 36.3 38.5 33.2 352.0 118.8 38.7 11.9 34.3 67.1 19.7 34.6 19.5 140.8 18.8 85.4 4.7 17.7 215.8 19.6 19.6 35.2 42.3 17.8 141.1 51.7 123.9 13.7 655.9 20.0 45.7 32.9 46.2 50.2 20.7 77.3 78.4 27.1 228.8 16.3 114.5 49.4 69.8 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 222.1;Granulosa cells: 140.8;Hofbauer cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 164.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013870, HPA072695" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA013870: AB_1847003, HPA072695: AB_2732210" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavorable (4.42e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 45.3 16.7 15.8 25.2 15.5 20.2 33.0 16.4 28.4 39.7 12.3 16.3 7.2 30.7 16.8 10.5 25.7 33.0 25.8 15.8 20.7 16.0 10.8 35.8 32.6 25.8 14.9 11.7 39.2 8.0 29.6 10.2 44.8 18.0 23.6 12.2 3.1 17.6 16.9 6.4 19.7 19.0 28.0 19.4 36.4 12.0 60.2 18.5 35.8 16.2 13.1 21.1 34.6 27.0 18.4 6.7 33.8 93.4 66.2 68.4 42.6 59.2 17.5 78.6 34.4 34.0 18.6 21.0 0.2 47.7 49.0 59.7 7.8 63.7 57.4 27.3 34.6 23.2 21.5 4.4 53.5 92.2 65.8 77.4 85.5 4.5 36.6 7.7 141.3 78.9 59.5 34.6 0.7 42.8 7.8 53.1 108.9 45.0 0.5 31.8 164.7 65.6 3.3 16.4 0.8 9.9 33.9 8.5 0.3 58.5 59.9 0.7 59.3 54.0 48.7 58.8 12.0 21.1 4.4 0.7 21.8 30.5 50.0 53.7 7.9 14.2 9.9 9.2 13.9 12.9 2.6 10.3 10.5 12.3 0.9 8.0 9.8 8.0 8.6 8.9 24.9 15.7 5.8 15.8 15.5 16.4 28.4 15.8 20.7 25.8 14.9 11.7 18.0 19.4 18.5 18.4 38.0 0.0 7.1 0.3 12.9 14.7 33.5 10.0 6.8 0.5 12.3 25.7 2.0 4.3 6.4 5.5 0.0 10.7 101.2 0.4 0.0 28.1 2.8 4.9 56.0 50.4 12.5 12.8 0.6 6.4 222.1 62.6 2.6 6.2 91.3 140.8 44.3 1.3 119.8 0.0 0.3 0.7 8.2 74.7 77.9 9.4 39.4 78.0 28.4 10.3 61.5 10.0 82.4 8.0 0.2 41.0 0.1 24.5 5.7 40.8 0.1 4.4 3.1 0.8 6.6 26.3 36.1 4.9 8.1 1.1 8.7 9.4 68.9 10.5 0.2 21.6 CMTM2 "CKLFSF2, FLJ25732, MGC39436" ENSG00000140932 "CKLF like MARVEL transmembrane domain containing 2" Q8TAZ6 16 66579448-66588275 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 429 "testis: 654.0" "Group enriched" "Detected in some" 73 "Early spermatids: 3619.3;Late spermatids: 3073.4;Spermatocytes: 1347.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 20 "REH: 32.1" "Low region specificity" "Detected in all" NA NA "unprognostic (2.81e-1)" "unprognostic (3.75e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (8.71e-2)" "unprognostic (3.31e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (1.91e-2)" "unprognostic (3.27e-2)" "unprognostic (1.02e-4)" "unprognostic (1.80e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (1.32e-1)" 0.2 0.1 0.5 0.4 0.2 1.1 0.5 0.7 0.9 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.5 0.1 0.4 0.3 0.5 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.4 0.7 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.0 1.5 0.2 654.0 0.0 1.1 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.5 0.1 0.1 1.5 0.5 0.1 0.0 0.0 32.1 0.2 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.7 0.9 0.5 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.1 0.3 12.8 21.9 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 5.0 0.0 0.0 0.1 1.5 0.2 0.0 0.3 3619.3 0.1 0.1 2.3 0.0 0.0 1.1 0.2 0.2 1.8 0.0 0.1 18.9 0.1 1.1 0.3 1.4 0.0 0.6 0.0 0.0 0.9 0.3 3073.4 36.4 5.5 0.0 0.0 7.7 0.0 1.0 0.0 0.6 0.8 0.0 30.5 0.0 0.0 0.0 0.4 0.7 0.6 19.7 0.7 0.1 1347.5 20.4 0.0 0.0 0.1 1.7 0.4 0.0 0.0 CDH11 "CAD11, OB" ENSG00000140937 "Cadherin 11" P55287 16 64943753-65126112 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 179.8;placenta: 123.2" "Cell type enhanced" "Detected in many" "Astrocytes: 93.0;Endometrial stromal cells: 125.0;Excitatory neurons: 122.2;Fibroblasts: 102.2;Microglial cells: 145.2;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 106.3;Theca cells: 160.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 246.5;BJ hTERT+: 139.3;fHDF/TERT166: 332.3;HSkMC: 217.4;PC-3: 291.2;U-2197: 194.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013072 Enhanced NA Yes 4800000 "CAB013072: AB_2533068" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (6.93e-2)" "unprognostic (6.00e-2)" "unprognostic (1.02e-1)" "unprognostic (6.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.09e-1)" "unprognostic (2.30e-2)" "unprognostic (3.74e-2)" "unprognostic (6.75e-2)" "prognostic unfavorable (2.48e-9)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (1.26e-1)" "unprognostic (5.07e-3)" 14.8 8.7 16.3 25.9 26.3 0.3 10.8 12.8 18.5 58.2 24.0 11.5 7.0 53.3 9.5 7.5 12.6 59.1 10.3 20.1 27.7 10.3 1.8 46.0 17.7 18.1 23.2 11.5 179.8 3.4 2.6 10.5 123.2 19.6 20.2 12.3 14.1 12.8 24.6 2.6 9.9 9.0 54.8 22.0 90.1 11.9 8.1 20.3 3.7 8.2 3.2 13.1 48.0 13.7 24.6 0.2 0.0 51.4 0.1 35.7 77.5 0.3 246.5 139.3 61.0 34.5 4.6 0.2 0.0 0.0 332.3 0.0 0.1 0.1 1.7 43.4 0.0 2.1 0.0 1.4 0.0 29.7 0.0 14.4 217.4 0.1 74.7 14.9 0.0 17.4 0.0 0.0 0.0 33.1 0.3 0.1 0.3 19.2 37.4 291.2 0.8 38.0 0.0 0.0 0.0 0.8 36.0 0.1 0.3 0.2 64.5 0.3 0.1 0.0 124.4 17.2 194.0 70.1 0.0 0.0 0.1 21.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 26.3 12.8 18.5 20.1 27.7 18.1 23.2 11.5 19.6 22.0 20.3 24.6 11.4 3.2 0.0 93.0 0.1 3.8 1.0 7.9 0.0 19.9 1.0 7.4 3.1 1.5 3.3 0.0 0.0 2.6 0.2 0.1 0.0 0.1 2.7 3.9 125.0 17.8 0.0 2.7 122.2 0.0 2.3 102.2 0.5 2.7 0.0 60.0 68.9 0.0 4.7 0.0 67.6 0.6 0.0 0.6 6.9 4.2 52.5 0.9 5.4 145.2 0.0 41.9 0.0 158.3 106.3 0.8 0.0 77.5 0.0 1.6 0.0 1.4 0.4 2.1 26.3 12.8 38.0 1.7 1.1 0.5 3.1 5.6 1.1 160.2 0.3 0.5 NOL3 "ARC, CARD2, MYP, NOP30" ENSG00000140939 "Nucleolar protein 3" O60936 16 67170154-67175735 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009208 Enhanced Supported Nucleoplasm,Cytosol NA NA 26000 "Nucleoplasm, Cytosol" "CAB009208: AB_634091" "unprognostic (2.83e-2)" "unprognostic (1.63e-2)" "unprognostic (3.34e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.43e-5)" "unprognostic (5.74e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (2.15e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.39e-2)" "unprognostic (3.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.48e-2)" 34.6 78.1 37.1 3.8 36.6 0.8 35.7 37.6 36.5 35.3 30.8 30.0 6.7 28.0 11.5 49.0 35.7 10.3 93.2 33.8 36.1 32.9 52.4 29.1 3.1 44.8 35.9 32.8 29.5 51.0 38.0 60.6 11.7 40.9 70.7 7.6 28.8 51.5 13.9 143.4 74.9 18.2 8.1 35.7 16.0 28.5 7.7 39.9 2.8 35.9 98.3 4.2 39.1 40.1 37.2 14.9 23.9 3.9 22.1 19.2 14.5 22.0 11.8 12.5 12.6 7.4 5.2 38.2 0.3 38.0 13.8 3.3 24.3 5.4 18.3 3.0 13.4 8.3 0.6 19.8 7.8 12.0 1.3 2.9 8.9 33.1 9.9 7.0 35.9 5.3 5.2 5.5 15.3 24.0 38.7 0.3 1.9 3.7 13.5 58.1 13.3 8.3 29.8 21.5 4.5 31.1 16.6 49.5 35.3 5.7 5.1 75.5 4.0 12.4 16.5 14.1 16.3 10.3 22.1 7.5 4.2 46.4 3.7 5.7 0.0 3.5 0.0 0.1 0.3 0.0 0.0 1.7 0.1 1.1 0.0 0.0 0.2 0.8 0.4 0.1 1.1 0.0 1.3 37.1 36.6 37.6 36.5 33.8 36.1 44.8 35.9 32.8 40.9 35.7 39.9 37.2 5.1 28.9 33.6 19.2 2.7 13.8 27.6 70.6 21.6 18.5 29.3 32.6 51.2 35.8 28.8 3.7 16.7 8.1 0.8 18.2 15.6 61.3 1.2 8.6 14.0 10.1 22.3 0.0 5.0 34.7 11.3 13.8 11.2 16.4 2.5 7.6 13.2 30.9 11.4 55.5 7.6 23.7 38.7 4.1 4.5 0.7 25.1 3.4 21.4 4.7 14.6 36.3 1.0 4.0 11.3 44.2 11.4 30.1 10.4 28.5 15.5 26.2 21.3 47.9 13.1 38.7 32.3 0.3 1.2 16.4 19.7 11.1 3.2 3.6 16.4 31.6 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383953-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favorable (2.77e-7)" "prognostic unfavorable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 91.1 83.7 114.4 37.8 117.5 247.8 73.6 126.3 136.4 46.4 112.7 44.7 25.8 53.0 45.1 45.5 48.7 57.5 103.6 110.5 133.9 57.9 50.7 51.3 52.9 134.5 136.4 104.4 43.6 37.4 74.8 51.5 76.3 137.9 44.0 47.5 127.0 49.6 49.8 196.8 62.2 37.2 67.2 126.8 44.7 42.7 52.2 129.8 55.4 64.1 178.2 51.8 57.9 42.4 141.3 56.9 33.7 63.8 59.2 188.5 145.3 41.9 111.4 130.1 88.0 59.9 56.0 42.4 37.7 82.0 155.7 97.5 50.8 95.2 72.3 125.3 49.9 81.0 39.4 40.2 94.4 313.4 28.3 40.0 194.9 234.8 137.0 326.0 131.1 101.1 57.2 107.4 79.0 150.4 61.5 48.4 64.0 66.1 27.7 81.2 76.2 42.2 37.6 119.0 28.4 53.0 60.3 174.8 29.4 230.8 85.2 48.0 34.0 134.1 94.7 59.7 86.4 65.3 99.4 131.5 137.7 133.9 68.3 69.6 312.5 86.8 198.1 78.6 81.6 80.5 72.5 75.8 81.1 69.2 58.2 58.4 62.0 214.3 104.7 85.3 75.1 108.2 109.2 114.4 117.5 126.3 136.4 110.5 133.9 134.5 136.4 104.4 137.9 126.8 129.8 141.3 523.1 89.8 90.5 15.7 185.3 221.0 203.1 176.2 301.7 70.4 183.9 227.3 180.7 72.9 117.2 77.3 52.1 130.6 242.7 309.1 262.2 310.9 222.1 283.6 235.9 191.7 132.2 364.2 29.2 134.8 140.2 177.7 96.4 530.5 131.1 49.3 80.7 70.1 206.4 87.5 41.4 137.3 238.0 150.9 268.5 269.7 90.7 262.2 188.5 19.7 207.0 194.3 143.2 14.6 26.9 322.8 407.6 89.1 202.0 209.3 217.4 236.9 133.5 124.0 59.2 129.5 168.2 361.2 206.7 221.8 213.5 631.5 221.6 85.7 122.4 294.5 MBTPS1 "KIAA0091, PCSK8, S1P, SKI-1" ENSG00000140943 "Membrane bound transcription factor peptidase, site 1" Q14703 16 84053761-84116942 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Protease, Serine protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 318.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056109 Supported NA NA "HPA056109: AB_2683040" "unprognostic (1.50e-1)" "unprognostic (9.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (2.50e-1)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.59e-1)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.62e-1)" "unprognostic (2.92e-1)" "unprognostic (6.63e-2)" "unprognostic (6.88e-2)" 46.2 34.0 9.6 26.4 15.3 24.8 43.2 16.3 13.5 41.5 16.1 39.1 26.2 41.2 25.8 28.5 46.0 32.5 45.0 11.8 13.3 37.0 27.8 35.9 27.7 6.1 7.3 11.6 49.8 36.7 58.9 39.1 37.5 9.0 37.6 34.0 109.6 42.7 40.7 19.0 28.1 26.6 41.5 4.0 30.4 30.9 19.8 12.6 33.8 54.4 36.0 30.1 35.5 21.5 9.4 49.4 61.3 53.8 75.2 124.2 100.1 42.2 81.2 124.4 70.2 52.6 43.7 71.0 47.0 82.0 117.3 55.8 52.9 50.2 56.3 77.9 42.6 55.9 34.4 55.8 61.3 59.9 84.2 72.7 103.6 79.9 64.8 55.5 100.3 92.4 62.2 45.6 40.3 43.1 85.0 46.6 46.4 50.3 27.7 43.2 59.6 28.7 34.1 56.1 40.2 41.0 51.2 156.9 42.9 62.1 58.3 134.3 76.4 99.0 72.3 52.5 43.7 38.7 50.5 102.6 90.5 52.6 50.6 45.2 8.0 16.3 15.0 16.3 13.8 16.8 11.3 14.0 15.4 12.8 9.6 16.9 15.3 4.5 17.0 11.6 7.1 9.6 18.3 9.6 15.3 16.3 13.5 11.8 13.3 6.1 7.3 11.6 9.0 4.0 12.6 9.4 54.3 48.1 50.7 27.1 33.5 13.8 24.2 25.9 19.9 68.4 62.2 56.1 50.5 44.3 41.9 25.8 166.8 24.4 41.0 28.9 11.7 24.1 0.9 70.4 67.8 39.8 34.9 19.4 50.4 27.5 21.4 48.4 23.0 92.7 29.1 103.1 36.0 33.8 16.7 84.1 53.5 26.6 28.5 21.0 10.8 5.5 53.4 23.3 19.6 36.5 22.5 44.4 29.9 57.8 39.0 30.2 24.8 50.4 59.3 30.1 20.3 17.5 56.4 318.6 26.3 60.9 42.2 12.6 24.2 23.4 15.8 21.6 34.3 75.5 33.8 28.6 CDH13 CDHH ENSG00000140945 "Cadherin 13" P55290 16 82626965-83800640 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 57.6;skeletal muscle: 69.3;tongue: 58.2" "Group enriched" "Detected in many" 4 "Excitatory neurons: 328.8;Inhibitory neurons: 867.0;Oligodendrocyte precursor cells: 335.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.3" "Group enriched" "Detected in many" 6 "granulocytes: 2.2;monocytes: 4.3" "Cell line enhanced" "Detected in many" "LHCN-M2: 222.2;U-138 MG: 279.2;U-87 MG: 244.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001380, CAB025863" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 240000000 "Plasma membrane" "CAB025863: , HPA001380: AB_1078371" "unprognostic (2.50e-2)" "unprognostic (2.75e-2)" "unprognostic (5.61e-2)" "unprognostic (4.06e-1)" "unprognostic (4.88e-2)" "unprognostic (3.30e-3)" "unprognostic (3.01e-1)" "unprognostic (5.76e-2)" "unprognostic (3.49e-2)" "unprognostic (3.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.73e-6)" "unprognostic (5.16e-3)" "unprognostic (2.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" 20.5 2.8 18.4 3.9 22.4 0.6 10.1 0.0 12.8 42.8 2.7 4.2 1.5 47.6 3.3 9.6 7.7 5.1 57.6 8.9 8.1 5.0 1.8 16.2 1.4 1.6 7.2 12.1 3.1 0.6 2.4 0.5 6.0 1.4 3.5 6.2 1.5 4.9 7.3 69.3 19.7 2.3 30.1 3.3 2.1 1.7 1.9 16.6 1.8 5.9 58.2 1.9 7.1 19.6 2.4 10.2 0.0 3.6 0.5 63.2 60.6 0.1 47.1 51.9 53.6 23.1 0.1 0.4 0.1 8.5 138.5 26.0 89.1 1.0 70.7 79.8 0.0 0.2 0.1 31.4 0.1 36.4 0.0 0.4 7.9 59.9 107.8 130.4 83.9 26.7 0.0 0.2 0.5 222.2 0.5 0.1 0.2 10.6 0.0 19.4 0.0 57.7 0.0 46.2 0.4 0.1 0.1 84.4 0.3 0.1 103.5 0.8 0.1 43.1 279.2 22.7 1.6 43.0 0.2 0.1 0.2 244.0 0.2 70.1 2.2 0.5 1.4 0.0 2.1 0.0 0.5 0.0 0.0 0.5 0.5 0.0 0.0 1.1 0.0 4.3 0.3 0.0 0.2 18.4 22.4 0.0 12.8 8.9 8.1 1.6 7.2 12.1 1.4 3.3 16.6 2.4 125.4 0.0 0.5 11.1 0.3 70.7 28.7 32.3 25.0 3.0 1.0 5.8 86.9 0.0 2.6 3.7 0.0 0.1 0.9 2.1 7.9 0.4 44.5 1.0 27.1 49.2 1.8 0.0 328.8 0.0 0.2 9.7 0.0 0.7 0.0 0.0 29.6 0.3 0.6 5.0 867.0 1.6 0.0 1.9 13.3 43.3 0.3 1.4 8.8 17.8 0.0 0.4 0.0 335.8 65.0 0.1 1.4 0.0 0.0 36.7 0.0 1.3 0.8 0.4 0.0 51.0 22.7 2.9 0.6 3.3 18.8 0.1 1.2 0.7 0.1 6.4 ZCCHC14 "BDG29, MGC14139" ENSG00000140948 "Zinc finger CCHC-type containing 14" Q8WYQ9 16 87406246-87493024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014122 Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA014122: " "unprognostic (2.04e-2)" "unprognostic (2.84e-1)" "unprognostic (4.62e-2)" "unprognostic (2.67e-1)" "unprognostic (3.99e-1)" "unprognostic (6.74e-2)" "unprognostic (7.44e-2)" "unprognostic (1.69e-1)" "unprognostic (1.46e-1)" "unprognostic (6.41e-2)" "unprognostic (1.20e-1)" "unprognostic (2.88e-2)" "prognostic favorable (1.47e-14)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (7.13e-2)" "unprognostic (2.83e-2)" 10.8 13.0 10.1 6.1 8.1 3.2 10.0 15.9 10.9 11.9 5.9 10.0 13.8 10.6 6.7 9.2 8.8 10.2 9.4 11.8 5.6 10.1 22.2 10.4 5.1 8.0 6.0 8.1 15.4 12.4 13.7 10.3 7.5 7.7 7.3 8.0 10.9 8.2 7.3 9.7 11.8 14.2 7.7 3.3 5.3 9.0 35.6 6.3 4.0 12.5 8.0 4.2 10.5 9.7 6.5 12.7 9.1 15.2 19.8 19.5 13.5 9.2 6.2 9.2 7.4 3.7 19.9 11.0 6.8 8.0 12.3 18.5 20.2 14.4 4.8 9.5 2.0 17.6 6.7 13.9 19.9 8.5 1.8 3.2 11.8 9.7 14.1 8.7 11.0 10.4 3.9 15.8 1.9 6.6 13.5 0.3 8.3 11.9 7.7 8.2 17.7 8.1 3.0 13.2 6.9 34.0 42.8 45.7 6.2 26.1 9.3 14.8 14.6 8.4 17.6 13.5 16.3 10.5 3.9 2.5 20.0 8.1 10.7 11.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.2 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.5 0.0 0.4 0.0 10.1 8.1 15.9 10.9 11.8 5.6 8.0 6.0 8.1 7.7 3.3 6.3 6.5 21.4 12.8 12.2 30.0 2.3 18.2 2.6 7.4 6.8 19.6 12.8 11.6 11.1 11.5 12.9 5.5 6.2 3.3 6.7 17.7 3.9 7.0 26.0 11.5 23.7 15.2 21.0 3.2 43.6 8.1 1.9 15.0 10.7 18.6 1.3 17.3 11.4 33.2 5.2 23.5 47.6 14.6 8.2 7.2 10.9 40.2 11.1 7.0 7.2 28.1 2.7 7.1 6.2 46.8 29.7 8.7 7.7 10.1 3.0 3.3 24.6 11.1 9.9 15.1 19.7 12.3 21.8 53.9 22.9 12.1 17.5 3.7 6.3 26.0 15.7 2.6 MEAK7 "KIAA1609, mEAK-7, TLDC1" ENSG00000140950 "MTOR associated protein, eak-7 homolog" Q6P9B6 16 84476355-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 3.0 2.2 3.7 3.6 3.2 1.3 4.8 1.9 3.4 4.1 2.9 4.8 4.1 4.7 5.6 12.9 3.8 4.4 2.3 4.2 2.6 3.6 3.4 4.1 4.6 4.1 2.7 2.7 5.2 2.6 6.4 2.0 10.9 4.4 4.8 5.0 6.5 3.8 3.8 3.0 7.3 5.5 4.2 0.5 3.4 4.1 2.2 2.3 4.5 4.9 2.1 6.5 7.3 6.6 4.3 29.1 20.0 17.1 9.2 7.8 13.3 8.1 21.1 18.8 21.2 6.1 11.5 34.2 4.0 11.1 40.8 15.5 31.5 4.9 56.1 27.7 2.2 4.2 3.2 9.7 10.0 9.6 2.5 9.6 9.5 23.9 19.8 25.8 17.1 9.0 11.1 5.3 4.7 14.3 6.8 2.2 2.5 5.2 15.1 7.0 9.0 4.3 1.3 18.7 15.9 5.6 4.0 19.1 13.5 9.4 17.9 19.1 3.9 22.0 14.6 6.7 7.8 8.8 3.7 6.7 10.6 8.8 1.3 5.1 16.9 2.9 4.0 3.3 2.4 3.1 2.8 5.6 4.6 2.5 2.3 6.1 3.8 2.3 2.8 3.2 0.6 8.0 2.5 3.7 3.2 1.9 3.4 4.2 2.6 4.1 2.7 2.7 4.4 0.5 2.3 4.3 5.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 40.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 10.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 47.1 0.2 0.0 0.0 0.0 ADAD2 "FLJ00337, TENRL" ENSG00000140955 "Adenosine deaminase domain containing 2" Q8NCV1 16 84191138-84197168 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 65.2" "Cell type enhanced" "Detected in some" "Early spermatids: 80.0;Late spermatids: 26.2;Spermatocytes: 111.8;Spermatogonia: 29.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SCLC-21H: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA079443 Enhanced NA NA "HPA079443: " "unprognostic (5.73e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-2)" "unprognostic (2.18e-2)" "unprognostic (6.72e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (3.01e-2)" "unprognostic (6.68e-2)" "unprognostic (1.69e-1)" "unprognostic (7.40e-2)" "unprognostic (3.18e-1)" "unprognostic (3.52e-1)" "unprognostic (2.47e-2)" 0.6 0.3 0.4 0.0 0.4 0.0 0.5 0.0 1.5 0.3 0.0 0.1 0.0 0.5 0.0 0.7 0.1 0.1 0.4 2.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.6 0.3 0.0 0.0 3.7 0.2 65.2 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 1.5 2.1 0.1 0.1 0.0 0.7 0.4 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.3 0.8 3.1 0.6 1.2 0.0 0.1 0.3 0.9 0.0 0.6 0.0 0.0 0.1 0.0 0.0 5.9 0.0 80.0 0.1 0.1 2.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.3 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 26.2 1.5 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 111.8 29.2 7.8 1.8 0.0 0.1 0.2 0.0 3.8 OSGIN1 "BDGI, OKL38" ENSG00000140961 "Oxidative stress induced growth inhibitor 1" Q9UJX0 16 83931311-83966332 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 148.6" "Cell type enhanced" "Detected in many" "Early spermatids: 56.2;Hepatocytes: 78.4;Late spermatids: 261.1;Proximal enterocytes: 99.0" "Cancer enriched" "Detected in all" 5 "liver cancer: 65.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 12.6" "Group enriched" "Detected in many" 8 "granulocytes: 4.2;monocytes: 12.6" "Cell line enhanced" "Detected in many" "A549: 66.8;Hep G2: 103.7;T-47d: 73.3;WM-115: 62.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA019239 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019239: AB_1854779" "unprognostic (8.36e-2)" "unprognostic (9.44e-2)" "unprognostic (4.28e-2)" "prognostic favorable (4.89e-5)" "unprognostic (3.31e-3)" "unprognostic (9.14e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" "unprognostic (2.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.20e-2)" "unprognostic (2.80e-2)" "unprognostic (2.45e-2)" "unprognostic (2.48e-2)" "unprognostic (8.28e-3)" "unprognostic (1.89e-1)" 8.0 26.7 9.2 4.9 7.3 0.8 7.2 7.0 7.5 3.4 3.8 7.1 31.6 3.4 1.2 12.4 4.5 8.4 9.0 5.1 6.1 13.9 148.6 9.4 1.3 10.7 8.1 4.4 4.3 8.6 3.0 3.7 1.6 14.4 5.6 2.5 2.0 5.2 2.2 22.6 3.0 18.8 1.6 8.6 10.6 14.0 15.3 8.6 0.8 13.3 9.7 1.2 13.0 5.7 16.0 4.7 66.8 0.8 2.9 4.1 5.9 5.0 7.7 7.5 7.0 2.5 16.9 24.0 0.1 18.0 6.7 31.5 12.6 3.2 4.9 2.6 1.1 0.8 1.2 15.5 103.7 15.0 2.3 25.7 3.6 3.9 18.1 4.1 3.9 7.2 4.8 6.5 6.5 9.1 31.9 0.9 0.9 0.6 16.5 15.8 2.3 6.7 3.3 4.8 5.9 0.4 1.5 16.0 5.1 32.6 1.7 73.3 2.7 23.1 10.6 16.0 15.7 5.3 2.7 1.2 0.2 35.6 3.6 62.8 0.1 2.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.2 0.0 12.6 0.0 0.0 1.0 9.2 7.3 7.0 7.5 5.1 6.1 10.7 8.1 4.4 14.4 8.6 8.6 16.0 2.2 16.0 3.9 0.0 0.6 1.5 8.1 15.7 5.2 0.8 7.9 4.3 9.0 8.6 18.5 1.8 0.0 1.4 0.5 41.8 5.9 11.3 56.2 6.1 1.0 5.4 4.2 0.0 0.1 6.6 0.4 5.4 26.0 5.3 1.3 2.7 6.1 78.4 10.5 0.0 0.1 12.9 12.2 9.4 3.0 261.1 4.1 7.3 7.2 0.0 3.0 8.6 0.0 0.0 0.2 13.2 23.5 12.0 1.3 11.8 99.0 11.7 5.0 0.6 13.1 4.7 5.1 2.3 1.3 6.0 1.7 1.4 0.6 4.6 10.5 5.9 IRF8 "ICSBP, ICSBP1, IRF-8" ENSG00000140968 "Interferon regulatory factor 8" Q02556 16 85899162-85922606 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 86.3;lymphoid tissue: 246.1" "Cell type enhanced" "Detected in many" "B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "plasmacytoid DC: 2477.4" "Lineage enriched" "Detected in all" 7 "dendritic cells: 2477.4" "Group enriched" "Detected in some" 4 "Daudi: 240.7;THP-1: 382.3;U-698: 928.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002267, HPA002531, CAB013480" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904" "unprognostic (2.09e-3)" "unprognostic (7.51e-2)" "unprognostic (5.16e-2)" "unprognostic (1.19e-1)" "unprognostic (7.54e-2)" "unprognostic (3.46e-3)" "unprognostic (3.19e-2)" "unprognostic (5.31e-3)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (5.31e-2)" "unprognostic (3.14e-3)" "unprognostic (3.97e-2)" "unprognostic (9.66e-3)" "unprognostic (4.04e-1)" "unprognostic (1.10e-2)" 26.2 7.7 4.3 82.2 5.9 86.3 9.4 7.1 7.2 5.6 9.3 27.4 47.5 8.1 3.1 6.8 6.5 19.9 3.9 6.1 7.8 6.1 37.2 27.6 246.1 8.7 7.3 2.9 2.5 3.4 1.7 1.7 10.2 9.2 7.8 33.8 0.8 7.2 9.0 2.0 5.0 56.7 13.6 11.6 138.5 23.1 4.9 9.3 62.0 4.2 1.8 226.7 22.0 1.6 9.1 0.9 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 26.0 0.0 240.7 1.5 0.0 0.0 0.1 1.4 0.0 0.2 0.2 2.7 0.1 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.5 0.0 0.0 0.6 21.3 0.2 20.6 0.0 7.5 1.1 27.2 0.0 0.0 0.1 0.1 1.0 0.0 0.2 1.4 0.0 382.3 0.6 0.0 10.9 0.2 0.9 0.3 0.3 928.2 0.0 128.4 0.0 9.1 137.1 3.4 3.3 134.3 4.5 347.0 1.8 2.1 291.2 361.3 3.5 2.8 8.4 111.5 97.3 2477.4 0.7 150.1 4.3 5.9 7.1 7.2 6.1 7.8 8.7 7.3 2.9 9.2 11.6 9.3 9.1 3.7 0.0 4.2 0.0 225.8 10.5 0.8 0.0 0.6 0.0 2.4 3.4 1.5 2.8 1.3 0.0 0.0 0.8 492.3 13.0 1.9 0.5 1.5 7.3 7.6 7.6 28.7 7.4 0.6 1.4 5.7 10.8 15.3 12.5 2.5 0.4 1.8 6.5 64.1 0.0 0.2 11.8 0.0 105.1 366.0 4.6 0.3 122.2 44.4 33.7 35.3 0.4 23.7 1.0 0.4 0.1 10.7 0.0 14.1 2.3 34.2 3.5 0.0 0.2 6.6 0.7 6.7 0.7 6.7 0.4 9.2 1.1 23.1 48.8 25.6 2.5 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668105-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 264.8;Rod photoreceptor cells: 284.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Mitochondria NA NA Mitochondria "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favorable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 31.6 49.0 28.0 20.5 27.8 28.3 35.2 27.2 36.7 38.2 31.1 41.9 29.4 33.0 7.9 38.0 38.5 13.0 49.4 28.6 27.2 46.9 45.3 34.7 26.2 28.7 27.9 27.5 34.8 34.5 20.6 51.9 14.9 28.6 50.7 8.1 36.7 36.2 17.5 33.8 37.7 45.5 9.3 26.2 57.6 41.8 37.0 28.1 20.5 46.1 15.7 11.7 37.8 35.9 28.3 25.0 52.4 25.6 39.7 13.1 13.7 44.7 41.7 19.2 33.9 26.2 70.3 37.1 29.5 28.8 16.6 11.8 47.3 17.7 39.6 8.7 41.9 77.2 32.5 65.5 52.2 24.7 29.9 44.2 21.3 29.5 25.0 14.2 17.9 24.5 35.9 62.6 22.1 17.3 108.2 33.1 32.5 67.3 21.5 33.5 72.6 30.5 59.1 20.6 48.8 57.7 70.1 39.2 50.6 22.8 11.0 49.6 46.4 38.9 25.4 41.7 23.5 30.8 56.0 40.0 38.6 17.9 28.3 39.6 5.5 19.5 21.8 22.9 23.0 13.9 11.6 18.3 18.4 19.4 12.1 13.7 11.7 16.8 12.0 18.4 20.3 23.0 17.6 28.0 27.8 27.2 36.7 28.6 27.2 28.7 27.9 27.5 28.6 26.2 28.1 28.3 30.1 32.1 27.5 53.2 37.1 33.8 26.8 80.0 25.6 98.6 29.6 25.8 25.7 30.0 38.3 29.5 264.8 63.2 46.7 63.3 21.5 40.2 6.3 16.5 21.7 26.6 43.0 17.1 46.5 35.8 52.1 26.5 51.0 21.9 51.4 40.6 20.0 34.7 35.8 85.8 36.2 52.2 61.1 30.3 29.8 7.5 27.1 26.0 28.4 20.6 45.2 40.1 46.4 17.1 27.3 43.8 46.8 25.6 23.7 25.0 47.3 24.3 27.9 284.9 52.6 19.9 31.5 44.5 51.4 19.3 31.7 67.0 42.1 45.5 54.2 23.3 RPL3L ENSG00000140986 "Ribosomal protein L3 like" Q92901 16 1943974-1957606 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 952.6;tongue: 426.4" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 134.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049136 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049136: AB_2680648" "unprognostic (2.53e-1)" "unprognostic (2.63e-2)" "unprognostic (9.27e-4)" "unprognostic (6.38e-4)" "unprognostic (4.36e-2)" "unprognostic (3.48e-3)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.46e-2)" "unprognostic (4.53e-3)" "unprognostic (3.32e-1)" "unprognostic (4.24e-1)" "unprognostic (8.32e-3)" "unprognostic (4.60e-2)" 0.3 0.4 0.7 0.2 0.8 1.8 1.5 1.7 1.0 0.0 0.9 0.2 0.6 0.3 0.4 8.5 0.1 0.5 100.5 0.7 0.3 0.4 0.3 0.2 0.4 0.2 0.1 0.4 0.3 11.6 0.0 0.1 0.2 1.0 4.2 0.0 1.3 7.0 0.1 952.6 0.7 0.5 0.0 0.0 0.4 0.2 6.5 0.2 0.1 0.4 426.4 0.1 0.2 0.1 1.2 1.1 1.2 0.3 1.1 0.0 0.0 0.7 0.5 0.0 0.0 0.0 4.0 2.1 0.6 0.7 0.0 1.0 1.1 0.1 0.1 0.0 0.5 0.6 0.4 0.9 1.4 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.7 0.0 0.7 0.4 2.8 0.0 0.6 0.8 1.0 0.6 1.2 2.5 0.4 0.3 0.9 0.1 0.4 1.6 0.5 0.5 1.4 0.6 0.7 0.7 0.6 0.6 0.6 1.4 0.8 0.4 1.2 0.6 0.5 0.8 0.2 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.4 0.2 0.3 0.1 0.4 0.3 0.3 1.2 0.2 0.3 0.4 0.1 0.1 0.7 0.8 1.7 1.0 0.7 0.3 0.2 0.1 0.4 1.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.2 0.0 0.0 0.1 0.6 134.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.1 1.3 0.0 5.3 0.1 0.0 0.2 2.9 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 23.7 2.2 0.7 2.4 0.0 0.4 0.0 0.2 0.1 0.1 0.5 ZSCAN32 "FLJ20417, ZNF434" ENSG00000140987 "Zinc finger and SCAN domain containing 32" Q9NX65 16 3382081-3401065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005758 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005758: AB_1080720" "unprognostic (5.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-2)" "unprognostic (6.04e-2)" "unprognostic (2.84e-2)" "unprognostic (2.38e-3)" "unprognostic (7.72e-2)" "unprognostic (9.40e-2)" "unprognostic (2.19e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-3)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (1.18e-3)" "unprognostic (9.71e-2)" 4.8 6.0 9.8 5.6 10.3 3.7 6.0 9.7 10.2 6.0 10.4 5.9 7.8 6.1 4.5 5.0 6.9 5.1 5.2 9.5 10.0 6.0 5.5 6.1 8.7 10.8 10.5 8.9 8.2 7.5 7.7 8.5 5.4 10.7 6.5 5.8 11.7 5.0 7.1 4.6 6.1 5.4 5.5 10.1 6.9 5.9 7.5 10.3 10.2 7.2 3.4 9.2 6.1 5.3 12.5 6.0 10.1 12.7 15.3 10.1 10.0 9.5 7.1 12.6 10.3 9.9 5.2 8.8 19.4 7.5 10.6 6.8 6.4 10.6 10.6 12.0 13.0 7.6 16.7 9.1 7.1 12.7 11.9 12.1 10.0 17.1 10.2 17.3 11.2 10.6 21.3 16.5 7.5 13.5 7.5 16.4 8.1 13.8 10.6 5.1 16.0 13.1 18.6 8.9 6.4 11.2 8.6 14.4 8.8 7.8 8.1 10.1 14.7 12.8 8.9 8.4 7.3 8.6 12.4 14.8 25.1 2.5 9.4 13.6 4.1 5.4 7.3 9.7 4.2 8.3 8.3 6.7 6.2 4.9 6.7 9.3 9.0 6.0 15.0 13.1 5.0 9.5 6.2 9.8 10.3 9.7 10.2 9.5 10.0 10.8 10.5 8.9 10.7 10.1 10.3 12.5 3.9 19.2 5.3 3.3 5.1 2.3 2.2 1.7 1.8 4.6 3.0 3.4 0.9 5.7 6.2 1.8 8.4 4.9 3.6 2.7 11.7 5.6 1.6 3.5 3.8 3.9 0.0 6.1 4.8 6.2 2.7 2.8 1.5 2.2 5.1 4.6 2.5 3.4 3.0 8.4 4.4 3.3 2.0 5.1 1.8 1.4 4.4 5.1 1.8 9.4 6.2 6.0 9.2 8.0 7.7 5.8 3.2 5.3 3.6 3.9 3.1 3.7 1.7 4.2 0.0 4.1 2.9 15.9 15.9 2.9 2.8 2.6 5.6 6.5 3.1 1.5 RPS2 "LLREP3, S2" ENSG00000140988 "Ribosomal protein S2" P15880 16 1962058-1964841 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055133 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 320000 "Endoplasmic reticulum, Cytosol" "HPA055133: AB_2682708" "unprognostic (2.98e-2)" "unprognostic (2.44e-1)" "unprognostic (8.43e-2)" "unprognostic (3.49e-2)" "unprognostic (4.15e-2)" "unprognostic (4.39e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (7.43e-2)" "unprognostic (3.17e-1)" "unprognostic (7.23e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-1)" "prognostic unfavorable (3.04e-7)" "unprognostic (1.61e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.47e-1)" 1656.2 1382.6 673.4 1087.3 696.6 2776.8 1818.5 666.0 951.5 1787.2 715.4 1418.1 966.1 1393.6 621.1 2579.3 1598.0 702.6 1240.1 656.0 796.0 1053.9 1434.9 1214.6 1929.9 742.9 662.8 619.4 3284.0 4594.9 391.4 980.1 839.5 717.3 1486.1 770.1 149.4 1489.9 642.8 2386.7 2695.3 1495.3 622.0 725.7 1864.6 1612.8 423.0 729.3 1585.0 1033.7 1572.6 1615.5 1765.7 1825.7 800.3 2258.0 3020.8 1716.3 5571.2 2433.0 5946.5 3093.8 1506.8 3381.7 3653.7 2581.3 5415.0 1451.8 4124.7 2329.8 2599.8 1226.5 2625.3 2553.6 4786.8 1372.0 2720.7 4959.5 1437.5 3382.8 4939.7 6019.8 3263.4 2174.4 8105.2 6715.4 3155.0 5057.6 3734.5 3606.2 3601.3 3014.4 2244.9 2591.9 9854.0 4110.2 5683.0 5591.7 2742.4 2706.1 4981.3 2846.5 4915.9 3411.9 1993.3 3154.5 2856.4 1465.0 4355.3 3538.6 1481.8 2933.7 5612.6 1757.9 1961.2 2605.3 499.3 3123.2 908.6 1554.7 5464.5 1056.9 2809.3 2532.6 74.1 438.2 239.9 562.4 545.5 932.7 1765.0 1096.6 864.3 805.8 1525.5 1366.1 1034.5 88.0 667.8 449.4 803.5 844.5 749.9 673.4 696.6 666.0 951.5 656.0 796.0 742.9 662.8 619.4 717.3 725.7 729.3 800.3 1261.2 519.2 1240.7 8.8 5674.4 11938.0 10835.5 3903.6 3510.9 362.3 12291.0 12660.6 252.4 2427.7 2182.1 910.4 187.7 8328.8 4158.8 1406.9 3212.6 4491.8 298.5 1154.3 4108.9 4082.2 2111.6 4032.5 13.2 11401.9 14898.5 2987.2 1703.4 1777.4 1021.9 4053.7 3477.4 2195.6 6029.4 277.6 15.7 4569.6 1627.6 5640.5 9869.6 489.7 4210.7 3709.4 5115.6 15.9 6772.9 965.3 3821.9 13.0 25.5 5585.7 2941.4 1575.6 3202.3 9790.4 2044.2 2439.2 906.1 477.8 1255.6 4193.6 3603.8 388.8 1997.9 5900.2 15069.3 8184.0 4718.2 6863.0 6345.9 11758.5 NDUFB10 PDSW ENSG00000140990 "NADH:ubiquinone oxidoreductase subunit B10" O96000 16 1959538-1961975 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 629.3;skeletal muscle: 1310.8;tongue: 1022.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1191.7;Late spermatids: 1040.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073189 Supported NA NA "HPA073189: AB_2686579" "unprognostic (3.56e-1)" "prognostic favorable (7.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (7.84e-2)" "unprognostic (1.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.43e-6)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (4.43e-1)" "unprognostic (8.76e-2)" 132.5 133.7 145.4 58.6 150.3 73.2 124.3 157.0 174.4 102.2 137.7 207.4 133.3 124.5 91.2 131.8 110.8 48.6 629.3 150.1 148.7 196.3 208.1 91.8 65.1 149.7 145.6 137.4 89.1 156.9 176.5 88.2 61.2 151.3 116.2 116.3 65.1 141.1 87.8 1310.8 122.9 146.1 72.3 143.8 107.4 187.9 104.8 147.8 69.7 103.7 1022.2 74.7 136.4 106.3 147.2 103.2 311.7 146.2 170.9 144.9 137.9 144.9 126.2 159.7 149.9 100.9 233.3 139.9 209.5 208.5 165.9 77.4 215.4 161.5 197.8 113.5 192.4 598.3 162.5 242.1 269.6 185.6 266.7 150.8 154.1 180.2 141.3 160.6 161.3 177.7 191.8 153.6 206.6 195.1 457.9 316.6 284.9 183.8 287.6 335.7 367.6 151.3 461.5 222.7 110.8 320.9 203.1 236.6 390.3 172.4 85.9 232.8 181.6 149.7 132.5 124.1 189.3 139.9 326.8 274.0 283.3 95.0 131.6 142.8 280.4 288.9 273.4 210.5 254.0 206.7 257.6 258.5 266.3 309.0 230.0 203.5 213.8 160.5 215.8 225.8 331.2 346.3 355.0 145.4 150.3 157.0 174.4 150.1 148.7 149.7 145.6 137.4 151.3 143.8 147.8 147.2 216.7 115.4 84.9 22.2 146.8 170.5 168.9 296.0 186.7 95.6 208.5 307.2 1191.7 261.7 165.1 218.8 18.8 355.8 135.2 589.3 982.2 299.7 341.7 163.5 132.6 174.2 203.8 173.0 10.9 414.9 333.2 181.2 167.7 142.0 111.1 145.8 163.5 417.6 321.7 79.1 13.4 478.8 229.9 200.9 195.2 1040.9 158.1 160.0 277.5 10.3 252.8 236.6 150.4 11.1 22.7 298.8 488.9 156.1 209.0 136.1 918.2 877.6 209.4 112.1 190.7 171.6 260.2 195.4 123.2 240.0 182.7 200.0 150.1 142.8 489.6 192.1 PDPK1 PDK1 ENSG00000140992 "3-phosphoinositide dependent protein kinase 1" O15530 16 2537979-2603188 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004272, HPA035199" Supported Supported Cytosol NA NA Cytosol "CAB004272: AB_626657, HPA035199: AB_2674514" "unprognostic (2.67e-2)" "unprognostic (1.63e-1)" "unprognostic (3.12e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (4.69e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (8.17e-2)" "unprognostic (3.70e-2)" "unprognostic (1.52e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.29e-14)" "unprognostic (2.04e-2)" "unprognostic (5.96e-2)" "unprognostic (1.95e-1)" "unprognostic (2.16e-1)" 11.7 13.6 14.7 12.5 21.4 16.2 11.2 10.3 20.2 10.7 1.1 15.9 17.5 11.9 13.3 13.4 14.8 9.6 15.2 19.1 9.5 17.2 12.5 13.7 15.2 10.4 6.5 15.9 14.1 19.6 27.3 11.3 12.2 12.9 13.1 15.1 15.7 18.0 12.3 19.1 14.3 19.7 12.4 3.4 14.0 13.7 14.8 9.3 17.0 15.9 19.4 14.3 11.2 10.5 12.2 13.1 16.5 20.1 13.5 20.3 16.9 21.5 21.7 13.6 18.7 15.6 16.6 15.2 21.4 14.5 20.7 15.9 20.2 24.3 15.3 17.6 39.6 17.1 11.4 23.0 27.7 17.7 19.2 29.0 15.4 27.5 20.1 13.3 17.9 17.3 19.1 22.2 17.0 22.1 27.7 19.2 13.3 12.8 24.3 15.1 39.0 20.2 19.5 18.0 11.5 31.7 16.3 27.9 31.3 11.5 12.8 29.0 23.5 21.6 20.2 20.2 20.0 18.8 22.6 23.4 33.3 9.7 13.1 17.9 5.4 7.1 8.4 4.1 8.3 3.9 4.2 3.8 5.0 5.8 3.4 4.3 4.0 12.5 5.2 8.9 8.0 1.9 4.7 14.7 21.4 10.3 20.2 19.1 9.5 10.4 6.5 15.9 12.9 3.4 9.3 12.2 17.6 16.0 19.1 45.1 32.9 26.6 20.8 25.7 26.7 60.2 30.0 22.0 33.8 40.0 23.0 11.0 54.2 47.0 35.2 41.1 13.7 23.1 14.4 35.6 23.8 19.1 21.6 28.0 46.7 23.6 27.9 23.2 23.0 45.3 7.6 18.1 22.5 46.1 26.0 74.0 41.7 29.9 10.2 55.7 51.1 30.4 31.7 37.1 21.4 31.9 43.3 42.3 25.7 37.7 44.2 31.6 24.0 44.4 27.1 30.3 50.2 44.8 41.1 44.9 46.0 30.5 30.0 46.8 36.8 38.5 34.1 104.7 25.7 24.2 31.4 27.1 TIGD7 Sancho ENSG00000140993 "Tigger transposable element derived 7" Q6NT04 16 3298808-3305729 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041357, HPA041474" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041357: AB_10794992, HPA041474: AB_10795696" "unprognostic (7.69e-2)" "unprognostic (3.04e-4)" "unprognostic (6.56e-3)" "unprognostic (1.18e-3)" "unprognostic (1.79e-1)" "unprognostic (4.04e-2)" "unprognostic (6.50e-3)" "unprognostic (2.44e-1)" "unprognostic (2.78e-2)" "unprognostic (9.81e-2)" "unprognostic (8.56e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-2)" "unprognostic (8.87e-2)" "unprognostic (4.04e-1)" "unprognostic (5.90e-3)" "unprognostic (3.12e-2)" 2.8 3.3 5.3 1.8 5.2 0.6 4.8 6.1 6.1 4.6 6.7 3.9 1.8 5.6 4.6 2.0 5.1 2.6 5.1 5.2 5.5 4.5 3.1 2.8 3.4 5.4 5.4 5.0 10.7 2.8 6.5 8.2 3.2 5.7 5.7 1.9 5.1 2.7 5.0 4.2 2.1 2.8 3.5 5.2 4.8 2.7 8.5 5.5 3.7 6.8 5.3 3.0 4.1 3.4 5.9 0.9 1.9 5.5 3.0 2.4 3.6 4.2 2.7 1.6 4.0 3.7 0.2 1.7 2.0 4.5 2.0 3.3 0.5 1.8 0.7 5.0 0.2 2.7 5.9 1.7 0.1 2.8 1.0 7.5 3.9 1.3 3.7 1.1 4.7 3.1 1.4 2.9 3.5 3.4 1.2 1.9 9.0 6.3 0.6 5.1 10.2 1.3 8.3 2.2 0.5 7.1 2.6 6.8 0.9 2.7 4.8 3.2 3.3 1.2 2.6 6.2 2.7 1.6 7.5 8.3 6.5 1.5 3.4 2.9 0.5 0.6 3.4 1.5 0.5 2.7 0.6 1.2 2.3 0.5 2.5 2.4 1.7 2.1 2.0 1.7 0.5 1.4 0.7 5.3 5.2 6.1 6.1 5.2 5.5 5.4 5.4 5.0 5.7 5.2 5.5 5.9 1.7 9.6 4.5 11.4 4.9 0.8 3.2 2.1 4.0 6.1 2.4 2.4 9.9 4.3 4.4 0.0 4.2 1.5 1.6 0.6 3.9 2.8 4.7 2.3 3.8 2.3 1.2 2.5 14.6 1.4 1.1 2.6 4.6 1.7 1.3 5.9 0.4 0.6 0.9 5.0 12.7 1.0 4.1 0.6 0.8 2.0 2.8 1.1 5.4 2.8 0.9 3.4 4.1 20.6 12.1 1.1 0.1 4.5 2.0 2.3 1.0 0.9 2.9 2.2 6.6 3.1 3.6 11.6 10.5 2.1 0.6 1.4 2.9 3.8 0.6 1.5 DEF8 FLJ20186 ENSG00000140995 "Differentially expressed in FDCP 8 homolog" Q6ZN54 16 89948697-89968060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041745, HPA049434" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041745: AB_2677650, HPA049434: " "unprognostic (4.99e-2)" "unprognostic (1.01e-1)" "unprognostic (9.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" "unprognostic (8.24e-2)" "unprognostic (1.91e-3)" "unprognostic (9.96e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.39e-2)" "prognostic favorable (1.95e-8)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.09e-1)" 37.3 40.6 54.6 38.3 57.6 45.8 36.5 56.6 66.7 41.0 36.3 44.2 20.1 46.2 19.6 45.8 42.5 25.7 48.6 55.5 53.1 45.6 35.5 41.2 73.2 69.3 60.0 59.4 47.8 51.6 32.5 51.0 17.2 67.5 42.9 13.6 27.1 38.0 27.8 41.1 47.3 33.9 27.9 49.4 45.9 46.3 14.2 61.6 9.9 41.9 25.0 52.4 45.0 36.8 60.6 54.4 107.7 47.0 65.1 46.9 47.4 56.6 82.9 68.1 117.9 53.8 114.9 64.0 66.8 61.2 54.6 47.1 34.6 55.4 94.1 51.4 16.0 164.6 29.5 62.3 167.4 49.6 21.3 44.9 56.0 77.3 84.1 46.3 48.3 87.1 58.2 97.6 21.8 70.7 198.3 41.4 64.2 60.8 24.6 110.2 86.9 35.8 55.3 62.0 50.0 72.1 74.2 131.5 48.3 44.6 24.3 45.4 67.1 89.9 68.9 73.3 36.0 88.3 40.5 31.3 85.1 72.5 54.2 82.1 8.2 39.3 80.7 26.6 33.1 24.0 49.3 21.8 19.6 26.2 61.1 14.5 14.1 52.6 13.1 18.9 69.1 29.6 27.5 54.6 57.6 56.6 66.7 55.5 53.1 69.3 60.0 59.4 67.5 49.4 61.6 60.6 27.7 0.0 14.8 31.0 32.6 44.7 22.1 33.0 15.4 24.1 20.1 22.2 33.9 21.5 20.4 14.7 27.1 29.3 30.7 20.0 29.4 42.6 6.5 12.0 25.5 27.8 21.6 9.1 19.2 92.3 48.2 31.5 11.7 15.6 10.1 20.3 20.7 23.9 63.5 30.3 19.3 17.9 42.7 33.5 62.7 23.3 21.1 30.1 46.2 14.0 56.1 17.8 21.6 15.6 22.6 112.4 20.4 33.4 65.1 46.6 16.9 47.7 16.4 26.3 19.7 20.4 40.7 6.2 11.2 19.9 54.7 32.4 17.5 33.3 15.8 30.1 TCF25 "KIAA1049, Nulp1" ENSG00000141002 "Transcription factor 25" Q9BQ70 16 89873570-89913627 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041699, HPA041786" Enhanced NA NA "HPA041699: AB_10960254, HPA041786: AB_10960526" "unprognostic (1.33e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "prognostic favorable (6.95e-4)" "unprognostic (6.67e-2)" "unprognostic (4.96e-2)" "unprognostic (2.72e-1)" "unprognostic (6.02e-2)" "unprognostic (2.50e-1)" "unprognostic (3.49e-1)" "unprognostic (1.05e-2)" "unprognostic (1.27e-1)" "unprognostic (7.64e-3)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (6.10e-3)" "unprognostic (1.08e-1)" 70.2 91.9 47.9 51.6 49.2 99.6 71.7 44.4 58.9 71.8 34.6 77.0 61.9 78.1 42.7 69.8 69.6 55.5 73.9 50.5 47.3 66.0 79.1 68.9 64.3 47.5 45.9 49.6 86.0 86.6 65.9 86.4 53.8 49.3 71.2 37.5 23.1 73.4 54.2 84.4 71.6 71.5 46.5 33.4 78.6 85.6 77.5 43.9 45.4 78.4 41.7 44.8 74.0 66.0 47.3 51.1 72.9 80.6 107.8 65.4 70.1 89.7 122.4 91.9 91.9 42.9 46.9 75.4 120.2 95.0 88.2 30.7 50.3 45.7 53.8 36.5 50.6 96.7 61.2 71.0 94.4 109.7 72.1 78.7 84.8 55.3 56.6 61.1 90.4 83.1 46.7 113.6 72.4 95.4 166.8 78.4 138.9 52.1 77.3 40.4 122.4 77.2 68.2 78.1 69.0 71.7 42.7 184.5 70.5 67.9 33.6 66.0 75.1 126.6 75.0 81.6 42.7 51.8 91.0 34.7 68.7 72.0 83.0 98.8 124.5 131.5 107.5 97.8 107.4 72.3 74.9 71.2 76.3 91.5 93.2 60.1 63.0 222.6 78.2 102.9 145.3 67.2 81.0 47.9 49.2 44.4 58.9 50.5 47.3 47.5 45.9 49.6 49.3 33.4 43.9 47.3 160.7 160.3 154.7 64.3 170.9 102.3 155.7 145.6 124.7 360.0 135.7 142.0 90.7 107.2 148.7 165.5 277.3 249.1 277.8 194.9 148.7 110.8 271.7 165.3 209.1 143.3 148.2 85.0 65.2 152.3 329.5 149.4 181.5 203.1 172.8 153.1 126.7 157.7 156.4 464.4 69.7 233.2 120.1 154.6 161.0 383.9 173.4 160.2 186.7 45.0 195.6 150.8 307.9 38.7 54.7 117.2 179.7 184.3 236.4 175.1 192.8 179.1 162.7 279.4 157.8 119.1 152.1 192.7 74.6 114.9 104.0 538.8 193.8 185.4 185.6 199.4 GALNS "GALNAC6S, GAS" ENSG00000141012 "Galactosamine (N-acetyl)-6-sulfatase" P34059 16 88813734-88856970 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Dwarfism, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 11.3;granulocytes: 31.3;monocytes: 17.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026404, HPA042433, HPA074225" Supported Approved Cytosol "Intracellular and membrane" NA NA 2000000 Cytosol "CAB026404: , HPA042433: AB_2732499, HPA074225: " "unprognostic (3.16e-1)" "unprognostic (9.98e-2)" "unprognostic (4.03e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (4.15e-3)" "unprognostic (1.32e-1)" "unprognostic (4.84e-3)" "unprognostic (2.00e-1)" "unprognostic (3.53e-2)" "unprognostic (4.12e-3)" "unprognostic (4.24e-2)" "unprognostic (5.54e-2)" "unprognostic (3.59e-2)" "unprognostic (6.84e-2)" 9.3 12.9 12.8 9.3 10.5 22.4 6.4 11.1 10.1 8.7 18.8 8.3 10.7 7.5 14.6 8.9 11.5 9.8 9.8 9.6 12.3 8.7 8.2 10.5 7.4 10.2 12.2 8.2 6.8 5.0 8.6 12.0 8.7 11.8 7.8 6.2 3.4 8.3 4.8 6.4 7.8 10.7 7.2 11.1 9.2 8.1 26.5 11.8 4.8 9.2 3.6 5.7 9.0 9.2 11.1 5.7 42.7 6.2 43.4 47.1 22.4 41.9 17.9 27.3 19.1 14.7 22.7 36.8 7.1 37.1 29.2 28.8 33.0 9.0 14.2 11.4 4.7 13.8 4.5 17.0 13.2 31.5 3.6 28.5 31.4 26.9 21.4 6.0 27.0 16.4 7.8 9.9 4.1 11.3 33.3 9.2 15.0 14.2 14.3 19.6 19.6 5.4 12.1 11.9 13.2 15.8 12.2 42.4 4.0 21.9 14.4 27.3 32.5 31.3 41.8 31.5 43.2 10.0 4.3 4.5 12.6 45.2 29.7 25.4 1.4 17.4 31.3 4.5 12.5 3.9 3.0 2.5 4.0 11.3 1.3 2.5 3.1 21.7 4.0 9.6 4.7 4.6 8.5 12.8 10.5 11.1 10.1 9.6 12.3 10.2 12.2 8.2 11.8 11.1 11.8 11.1 4.8 16.0 4.8 9.4 5.9 6.5 7.3 27.7 9.1 5.0 6.8 5.0 8.4 4.3 11.0 3.7 6.2 9.9 8.5 16.8 3.9 5.7 21.0 27.2 9.6 7.2 12.0 1.3 7.6 3.7 14.0 13.8 6.1 8.9 1.3 11.9 7.5 6.4 18.7 25.2 10.4 6.8 8.2 13.2 6.3 37.3 7.2 11.3 7.2 2.8 18.2 8.8 14.4 4.0 9.8 5.6 13.6 6.8 9.9 6.7 17.3 5.9 35.1 10.0 6.6 9.4 9.0 51.3 42.8 6.3 5.7 15.9 7.9 16.5 10.1 6.8 GAS8 "DRC4, GAS11" ENSG00000141013 "Growth arrest specific 8" O95995 16 90019629-90044975 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041311, HPA048238" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041311: AB_2677402, HPA048238: AB_2680324" "unprognostic (2.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.73e-1)" "unprognostic (3.91e-1)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.47e-1)" "prognostic favorable (7.67e-4)" "unprognostic (3.06e-2)" "prognostic favorable (1.09e-7)" "unprognostic (1.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.19e-2)" 5.2 10.4 9.0 2.8 9.1 1.4 6.4 9.5 13.8 7.9 11.0 6.8 2.6 6.6 10.2 8.4 19.1 6.2 15.5 8.9 9.1 13.8 5.5 7.2 2.9 9.8 9.6 8.7 9.0 10.6 16.4 14.2 2.2 10.2 7.3 3.0 5.1 11.5 8.6 15.2 4.4 3.9 4.4 9.5 3.4 8.3 16.9 10.2 2.5 12.6 10.0 2.1 6.3 5.8 9.6 17.9 14.5 1.8 8.5 7.8 6.2 14.3 3.6 8.8 13.9 4.1 14.1 13.0 1.0 9.1 7.1 8.4 17.8 5.9 9.9 3.3 0.0 10.7 3.7 9.0 16.2 8.7 2.2 2.8 7.9 6.0 10.4 4.7 6.3 8.3 5.8 14.3 2.1 6.1 41.9 2.5 9.9 11.6 11.3 7.4 0.7 15.7 1.0 17.4 8.5 14.6 10.7 18.4 9.7 21.0 1.6 19.6 8.4 6.2 8.6 10.3 4.7 8.3 3.4 5.4 0.0 21.3 2.7 15.1 1.7 1.2 1.4 0.7 2.0 0.7 0.4 1.0 1.4 1.7 0.8 0.8 0.7 1.5 0.0 1.3 1.9 1.6 0.8 9.0 9.1 9.5 13.8 8.9 9.1 9.8 9.6 8.7 10.2 9.5 10.2 9.6 5.9 22.4 11.3 20.5 3.1 1.1 4.7 7.0 5.7 11.9 14.1 10.8 7.9 25.8 13.4 22.0 20.9 3.0 0.7 5.9 13.7 17.1 198.3 45.5 7.1 5.8 6.0 3.0 27.5 10.9 3.6 5.5 12.2 10.0 2.5 16.1 7.1 4.8 4.1 26.9 24.6 6.3 8.2 0.8 1.4 277.8 14.0 2.3 5.4 1.9 1.3 12.4 0.0 13.0 6.0 10.0 4.6 7.5 1.1 5.8 5.3 30.9 82.3 28.0 6.6 6.7 9.5 28.7 11.9 7.2 2.6 1.6 1.6 25.2 5.3 5.8 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476994-17493221 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA056415: AB_2683120" "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favorable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favorable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 9.3 15.1 22.5 4.9 23.7 10.7 10.4 21.4 28.3 11.8 19.3 11.0 8.2 12.2 12.0 10.3 8.7 4.6 28.5 22.8 22.1 17.7 23.8 7.4 6.8 22.5 22.5 22.8 9.4 10.1 18.4 12.9 5.7 21.5 11.9 7.5 10.0 13.0 8.6 27.5 13.6 9.5 5.8 21.5 10.5 12.5 11.0 22.9 11.7 14.0 41.9 6.8 8.9 9.4 22.5 12.0 15.0 12.7 13.7 10.0 9.0 11.0 9.6 11.9 14.5 13.0 22.0 5.9 14.7 10.8 9.9 8.8 15.3 16.3 13.2 13.5 9.6 26.3 9.0 10.0 15.9 10.8 7.2 7.5 14.6 12.3 12.2 12.5 10.8 10.0 21.3 10.7 6.7 9.7 10.1 32.7 14.9 11.7 24.8 15.4 24.8 28.7 9.8 13.0 8.4 8.2 13.0 12.6 9.8 21.7 47.6 11.6 9.3 6.8 10.6 12.3 18.6 15.3 12.4 9.9 8.2 13.3 12.5 11.5 2.6 7.0 11.8 9.3 9.5 12.3 9.9 9.7 9.7 7.7 9.1 10.2 11.4 2.3 10.7 12.4 12.5 10.2 7.8 22.5 23.7 21.4 28.3 22.8 22.1 22.5 22.5 22.8 21.5 21.5 22.9 22.5 6.0 3.2 4.4 10.1 5.8 4.6 8.9 5.5 5.2 25.9 8.2 6.7 19.6 10.0 5.0 9.2 14.6 8.6 8.1 9.1 11.7 6.6 8.7 6.0 6.3 6.0 15.7 4.2 14.4 4.5 5.8 5.6 11.7 8.8 0.0 14.5 7.5 5.5 6.1 16.8 12.9 9.6 8.2 4.4 2.8 8.9 5.6 4.0 1.8 1.9 4.7 24.1 10.3 14.1 6.5 3.3 5.7 9.4 7.2 8.4 9.5 6.1 4.0 25.0 0.0 6.0 6.9 10.9 29.9 5.6 4.8 9.6 6.6 13.4 8.1 9.0 NCOR1 "hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1" ENSG00000141027 "Nuclear receptor corepressor 1" O75376 17 16029157-16218185 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043246, HPA050288, HPA051168, CAB072830" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370" "unprognostic (1.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.10e-1)" "unprognostic (7.38e-2)" "unprognostic (3.59e-2)" "unprognostic (2.55e-2)" "unprognostic (4.27e-2)" "unprognostic (4.87e-2)" "unprognostic (4.06e-2)" "unprognostic (7.07e-2)" "unprognostic (1.52e-2)" "prognostic favorable (7.92e-5)" "unprognostic (4.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" 22.3 18.4 38.0 28.4 40.8 43.2 29.3 60.3 85.4 27.5 41.9 44.4 47.5 30.9 20.5 30.9 25.4 26.6 23.6 40.3 35.6 34.0 46.6 27.1 30.1 35.0 37.6 35.8 33.8 34.5 42.6 17.2 28.5 40.8 27.9 41.0 41.7 22.6 31.7 42.4 31.9 38.5 29.9 29.2 29.6 43.1 32.7 35.9 52.4 35.2 40.3 34.9 29.1 18.4 43.8 68.0 110.6 77.7 65.1 62.4 47.1 38.6 48.9 54.8 52.4 47.1 59.8 30.3 70.9 33.6 85.9 39.3 50.4 96.4 59.2 77.3 95.6 71.1 70.7 96.3 71.1 60.8 45.3 80.7 48.5 60.6 81.2 94.4 45.2 73.9 98.0 63.0 28.8 52.3 44.3 79.3 29.1 38.6 118.6 29.9 78.1 78.5 33.5 54.9 76.0 26.5 43.8 80.7 34.7 37.7 197.5 33.5 50.3 65.5 53.7 32.6 39.9 68.3 19.7 25.0 40.4 51.0 52.4 47.0 408.4 104.8 240.4 126.9 86.0 106.7 188.4 144.0 141.0 76.3 191.4 139.8 139.0 205.2 139.9 112.3 130.3 144.7 98.8 38.0 40.8 60.3 85.4 40.3 35.6 35.0 37.6 35.8 40.8 29.2 35.9 43.8 90.9 80.1 113.2 116.2 130.0 67.8 106.2 91.3 86.0 150.3 76.8 60.8 91.5 82.9 86.9 53.3 158.4 102.1 121.7 198.1 35.2 95.5 69.7 75.7 109.5 88.4 87.9 132.1 127.0 96.5 101.7 77.1 149.4 103.7 87.3 88.9 67.5 126.4 76.1 129.5 122.2 118.8 81.4 81.9 76.7 43.6 101.5 96.7 37.4 107.7 172.8 83.1 197.8 123.1 151.4 111.7 148.3 121.5 88.5 95.6 194.4 46.7 63.8 167.1 92.1 106.0 106.2 98.7 90.2 78.0 68.2 87.6 142.1 89.5 153.0 122.9 COPS3 "CSN3, SGN3" ENSG00000141030 "COP9 signalosome subunit 3" Q9UNS2 17 17246616-17281273 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021997, HPA050557" Approved Supported Nucleoplasm,Cytosol NA NA 38000 Nucleoplasm Cytosol "HPA021997: AB_1847152, HPA050557: AB_2681176" "unprognostic (3.35e-2)" "unprognostic (3.98e-3)" "unprognostic (1.84e-2)" "unprognostic (6.29e-2)" "unprognostic (6.39e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.91e-3)" "unprognostic (2.11e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (1.56e-4)" "prognostic unfavorable (8.65e-5)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.40e-1)" "unprognostic (3.03e-3)" 29.5 29.3 30.1 29.8 31.2 111.0 28.6 31.8 40.2 26.1 27.3 31.6 25.0 26.5 24.0 41.9 24.2 17.3 48.9 32.0 32.2 23.4 29.3 23.2 37.6 32.3 32.0 29.8 23.7 44.7 36.7 40.2 29.2 32.3 25.2 30.1 25.7 30.4 26.0 158.0 33.4 25.1 29.3 31.7 26.9 32.8 77.0 30.6 51.7 24.2 101.6 41.2 30.0 29.2 35.7 141.8 128.8 96.0 86.3 46.2 63.8 58.2 102.6 62.6 150.6 119.3 209.7 50.9 196.9 82.5 83.4 67.5 100.8 138.9 104.2 175.3 76.0 182.1 137.6 90.8 87.0 76.4 120.3 146.1 58.0 77.1 104.3 102.1 43.1 90.0 108.2 114.3 70.4 97.0 137.8 217.4 142.9 90.9 156.3 80.4 163.9 178.9 102.5 61.0 55.2 79.7 63.9 94.0 44.9 83.8 286.9 64.6 76.1 63.2 89.7 101.0 164.7 184.5 54.9 74.5 106.0 81.8 113.2 93.4 37.4 43.0 44.0 35.4 51.3 40.7 35.4 40.0 41.3 60.8 39.1 40.4 37.9 55.6 46.0 52.4 30.8 47.7 56.9 30.1 31.2 31.8 40.2 32.0 32.2 32.3 32.0 29.8 32.3 31.7 30.6 35.7 32.0 32.1 19.1 11.1 52.7 54.2 43.3 69.0 33.0 23.2 31.1 27.8 50.5 34.3 38.6 14.7 14.6 95.1 52.2 17.1 33.2 52.8 136.1 27.4 30.1 33.3 37.6 117.0 13.6 51.2 84.5 37.5 21.4 33.5 40.0 26.7 22.9 23.1 67.0 25.2 16.3 37.3 44.7 36.4 52.3 79.2 39.7 43.6 35.6 11.2 60.0 41.3 53.5 13.6 16.0 33.4 18.6 38.0 65.6 43.0 27.4 36.6 25.5 38.0 19.7 52.5 49.9 262.3 109.8 50.1 47.6 104.4 51.3 43.9 43.3 36.5 GID4 "C17orf39, VID24" ENSG00000141034 "GID complex subunit 4 homolog" Q8IVV7 17 18039408-18068405 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.6" "Group enriched" "Detected in many" 12 "Early spermatids: 665.5;Late spermatids: 1287.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044348 Uncertain Approved Cytosol NA NA Cytosol "HPA044348: AB_10959602" "unprognostic (1.52e-1)" "unprognostic (4.19e-2)" "unprognostic (4.65e-1)" "unprognostic (4.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (8.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-1)" "unprognostic (3.64e-3)" "unprognostic (2.11e-1)" "unprognostic (8.68e-2)" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" 7.7 5.2 8.6 4.7 8.0 5.9 6.1 9.5 8.7 6.7 5.5 7.9 4.3 7.4 6.5 11.7 6.2 5.2 10.2 7.9 7.1 5.9 5.6 5.3 5.5 8.6 8.0 7.9 7.9 7.7 10.6 3.0 6.6 8.3 6.8 4.6 5.8 8.0 8.0 27.9 11.6 4.7 8.6 7.5 5.8 5.9 69.6 8.1 7.3 6.8 14.5 6.0 8.9 7.4 8.0 11.8 12.1 6.7 10.9 17.2 16.8 11.4 9.6 15.6 10.5 11.8 10.2 4.5 14.9 8.1 11.3 9.6 13.1 9.8 10.6 13.7 8.1 19.6 6.6 9.5 7.5 14.9 3.9 11.1 12.5 18.6 10.5 16.3 13.9 11.8 20.9 6.0 4.1 8.6 3.0 12.8 8.4 5.9 14.4 8.8 10.8 23.9 14.8 7.2 4.6 5.0 7.6 6.5 5.7 7.2 64.9 3.6 5.0 10.0 6.7 3.8 15.7 4.9 7.3 6.7 3.2 9.6 6.7 8.8 4.3 1.1 3.6 1.2 0.6 1.3 2.6 1.1 1.2 0.9 2.0 1.3 1.4 2.9 2.0 0.8 1.6 1.9 0.6 8.6 8.0 9.5 8.7 7.9 7.1 8.6 8.0 7.9 8.3 7.5 8.1 8.0 8.7 0.0 1.1 5.2 6.0 11.1 7.5 4.5 4.6 5.8 6.4 7.0 12.4 5.7 3.1 1.8 4.2 8.3 6.1 4.1 9.8 5.3 665.5 5.4 9.5 8.4 1.2 17.2 8.2 5.7 15.2 8.0 1.1 5.5 5.7 10.7 8.2 6.8 7.3 16.8 8.1 4.9 0.0 9.5 7.7 1287.8 12.8 7.4 7.2 11.2 9.7 5.4 10.3 9.5 9.8 9.1 1.6 15.8 5.0 16.3 6.9 11.4 3.5 3.9 13.1 8.6 9.0 78.1 26.3 7.2 18.2 15.5 5.9 7.0 4.4 8.0 ZNF287 "ZKSCAN13, ZSCAN45" ENSG00000141040 "Zinc finger protein 287" Q9HBT7 17 16546954-16569204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029290 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA029290: AB_10603465" "unprognostic (4.74e-2)" "unprognostic (1.77e-2)" "unprognostic (2.88e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.99e-2)" "unprognostic (4.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "prognostic favorable (5.28e-5)" "unprognostic (5.69e-3)" "unprognostic (5.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.87e-1)" 2.5 3.4 1.3 2.0 2.1 0.7 3.2 4.3 2.0 3.1 0.3 1.6 0.8 2.7 4.0 2.0 2.8 2.1 4.9 1.7 1.4 2.9 0.3 2.3 2.7 1.7 1.6 1.4 4.2 2.2 6.8 3.5 1.5 1.9 3.1 1.9 5.0 1.7 3.6 3.0 3.1 1.5 3.0 1.0 2.6 2.4 2.7 1.4 2.6 3.7 4.5 2.9 2.4 1.6 2.6 3.9 7.0 6.1 6.4 4.0 7.8 1.5 3.2 5.7 6.0 7.5 1.3 2.8 1.7 3.5 5.2 4.1 6.1 3.7 5.7 7.3 2.7 3.1 0.0 0.5 0.0 5.0 0.0 5.6 5.8 3.8 2.6 3.8 5.8 3.7 7.9 0.4 0.0 8.9 3.5 5.5 0.2 1.3 3.3 3.3 0.0 6.8 0.2 3.5 1.9 3.5 5.8 10.2 1.3 4.1 16.5 4.8 0.6 3.0 3.8 2.0 5.0 4.3 3.1 2.4 0.0 5.5 0.0 4.7 0.1 0.6 0.5 8.0 0.7 6.8 10.9 8.6 8.1 2.9 7.7 9.3 9.4 0.1 6.7 3.1 1.8 7.0 4.4 1.3 2.1 4.3 2.0 1.7 1.4 1.7 1.6 1.4 1.9 1.0 1.4 2.6 2.3 3.2 1.7 4.6 4.2 0.6 1.5 6.0 2.2 3.7 1.4 1.8 10.0 1.5 4.9 0.0 4.2 0.2 3.3 0.1 5.9 5.2 3.0 1.8 2.3 3.8 2.4 0.4 7.2 9.1 0.7 4.0 2.0 0.9 7.0 3.5 1.8 0.1 1.3 16.8 8.4 0.6 0.0 1.0 0.9 2.9 2.1 1.1 0.0 1.0 1.0 3.8 4.1 8.0 9.2 4.6 0.2 3.4 0.8 0.6 0.1 2.3 7.2 3.7 6.6 2.6 3.1 12.6 5.9 1.7 1.4 0.0 4.3 6.3 0.9 0.7 MYOCD MYCD ENSG00000141052 Myocardin Q8IZQ8 17 12665890-12768949 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 47.3;Endometrial stromal cells: 48.5;Peritubular cells: 100.8;Sertoli cells: 26.3;Smooth muscle cells: 32.9" "Cancer enhanced" "Detected in some" "stomach cancer: 2.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.5;BJ hTERT+: 6.4;HBF TERT88: 10.4;hTEC/SVTERT24-B: 11.7;REH: 8.4;SuSa: 12.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.1" "CAB046485, HPA071528, HPA072582" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB046485: AB_10600720, HPA071528: , HPA072582: " "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (1.90e-1)" "unprognostic (3.79e-2)" "unprognostic (5.33e-2)" "unprognostic (2.15e-4)" "unprognostic (2.71e-2)" "unprognostic (1.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (4.83e-2)" "unprognostic (1.01e-4)" "unprognostic (2.88e-2)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.91e-2)" 3.3 1.1 0.4 4.3 0.6 0.0 1.2 0.3 2.0 8.4 2.7 17.3 2.6 13.1 2.4 13.2 8.6 4.7 14.3 0.5 0.4 0.7 0.2 2.7 0.1 0.6 0.6 0.3 4.4 0.3 0.1 0.2 3.4 0.6 8.8 4.9 0.0 0.2 20.9 0.5 1.1 5.1 15.9 0.5 0.6 6.2 2.1 0.6 0.1 0.7 0.9 0.1 17.3 4.4 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 6.4 2.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.4 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 12.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 2.0 0.5 0.4 0.6 0.6 0.3 0.6 0.5 0.6 0.7 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 47.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 2.0 48.5 1.2 7.8 0.0 1.2 0.2 0.1 3.6 0.0 1.0 0.0 8.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.0 0.5 0.6 0.2 0.0 9.4 0.0 0.0 0.0 1.0 0.3 0.0 0.0 100.8 0.0 0.1 0.0 0.1 0.0 0.0 26.3 0.2 32.9 0.3 0.8 0.1 0.9 0.5 0.4 6.0 0.0 0.1 KSR1 "KSR, RSU2" ENSG00000141068 "Kinase suppressor of ras 1" Q8IVT5 17 27456470-27626438 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 102.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 73.0;Glandular and luminal cells: 50.3;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 53.3;Oligodendrocytes: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 393.5;HEL: 140.5;HMC-1: 93.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009623, HPA011215, HPA011878" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "CAB009623: AB_2265455, HPA011215: AB_1852649, HPA011878: " "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (2.60e-1)" "unprognostic (3.48e-3)" "unprognostic (2.90e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-5)" "unprognostic (8.36e-3)" "unprognostic (1.32e-1)" "unprognostic (3.15e-2)" "unprognostic (1.12e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (1.00e-1)" "unprognostic (7.55e-2)" "unprognostic (1.74e-2)" "unprognostic (9.61e-2)" 18.9 17.7 19.4 20.1 19.7 16.8 15.7 16.1 35.2 33.9 12.3 12.6 8.2 26.8 10.0 30.1 21.0 21.6 11.9 31.6 17.7 23.8 6.6 26.4 14.4 27.3 16.9 16.0 26.6 102.3 7.4 15.2 45.3 23.9 15.7 8.6 19.5 8.5 18.7 30.3 21.2 15.4 20.2 17.5 22.7 9.4 25.5 20.1 11.7 31.3 14.1 14.7 14.7 23.3 25.8 4.6 18.1 11.1 5.8 9.2 6.5 64.7 4.2 9.1 6.2 7.2 55.0 0.8 4.4 9.5 8.0 40.8 2.8 11.0 2.5 3.7 393.5 12.1 140.5 19.3 23.0 16.0 1.8 93.0 8.1 4.0 17.8 0.5 25.3 34.8 6.1 75.0 0.5 3.6 4.4 2.1 5.4 8.3 4.0 3.2 9.1 61.5 3.2 25.1 3.3 17.1 11.3 22.3 5.1 6.0 29.4 0.7 7.5 32.5 1.8 8.2 5.1 3.0 0.5 0.1 0.1 1.8 7.9 10.5 0.0 1.0 3.8 0.3 2.1 0.3 0.4 0.1 0.2 0.5 0.1 0.1 0.1 1.1 0.9 1.1 0.0 0.5 0.4 19.4 19.7 16.1 35.2 31.6 17.7 27.3 16.9 16.0 23.9 17.5 20.1 25.8 19.7 6.4 3.4 33.6 4.1 3.1 3.6 3.1 1.8 11.8 1.9 2.3 1.2 1.5 11.9 14.7 73.0 19.2 4.9 7.1 3.9 2.0 33.4 24.0 21.6 9.1 6.6 0.4 26.2 5.3 21.0 8.2 3.6 50.3 0.0 10.8 11.7 1.3 6.7 10.1 50.2 2.2 0.0 8.3 6.9 47.7 1.5 9.0 8.8 27.2 10.4 5.7 4.1 53.3 49.2 2.1 7.1 2.2 2.8 1.6 6.7 3.2 14.9 25.8 0.0 5.3 4.8 2.6 6.1 11.3 6.0 19.4 5.7 8.4 1.2 6.2 UTP4 "CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292" ENSG00000141076 "UTP4 small subunit processome component" Q969X6 16 69131291-69231130 "Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 100.0;Spermatogonia: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 398.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041139, HPA043542" Approved Supported "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA041139: AB_10961278, HPA043542: AB_2678542" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "unprognostic (6.16e-3)" "prognostic unfavorable (9.05e-5)" "prognostic unfavorable (8.18e-7)" "unprognostic (1.31e-1)" "unprognostic (4.76e-2)" "prognostic favorable (2.88e-5)" "unprognostic (2.12e-2)" "unprognostic (4.45e-2)" "unprognostic (2.32e-3)" "unprognostic (9.57e-3)" "unprognostic (2.12e-1)" "unprognostic (1.33e-1)" "unprognostic (3.20e-2)" 25.4 17.5 8.1 17.7 9.1 27.4 21.2 8.1 10.9 16.2 7.6 19.2 10.9 20.8 10.0 23.2 19.7 12.8 18.7 10.6 9.3 31.5 19.3 16.5 19.3 7.0 7.7 8.6 18.4 24.3 16.8 14.3 15.6 7.4 16.2 17.8 11.5 15.8 14.5 62.2 20.1 14.1 22.9 7.2 14.1 19.2 31.6 8.6 17.8 23.4 26.5 23.5 29.1 17.0 8.1 79.6 95.6 56.9 79.8 48.5 42.9 94.5 83.7 57.2 152.1 112.8 188.1 68.8 166.4 68.0 57.7 63.1 106.0 130.8 102.7 167.4 33.2 74.6 82.2 58.6 99.7 58.6 96.5 52.7 41.0 55.2 143.0 129.5 40.7 68.6 88.8 169.4 22.9 90.0 96.2 105.4 50.5 139.1 80.3 66.7 174.3 85.3 163.4 63.6 77.7 96.4 67.1 178.3 45.3 48.3 63.3 80.2 53.4 48.2 83.3 83.6 73.4 119.2 59.5 116.1 398.1 56.5 76.5 87.4 4.5 18.6 3.5 26.7 26.1 38.5 30.6 30.0 26.9 25.6 20.1 34.7 31.6 1.7 35.0 19.4 21.6 31.5 30.2 8.1 9.1 8.1 10.9 10.6 9.3 7.0 7.7 8.6 7.4 7.2 8.6 8.1 12.1 6.4 11.4 0.0 14.6 0.0 30.0 0.0 28.5 5.7 12.4 11.6 0.0 5.7 9.9 5.5 8.4 18.9 7.4 1.7 9.8 27.4 17.9 7.0 13.2 12.1 0.0 12.4 0.0 25.4 22.1 14.8 10.2 9.0 2.5 12.0 9.3 7.9 16.7 6.7 0.0 6.4 0.0 8.9 0.0 7.6 15.8 9.8 0.0 0.0 8.2 7.6 11.3 0.0 0.0 24.4 5.4 14.7 13.4 26.7 4.5 100.0 5.8 5.7 6.6 26.7 12.8 30.1 49.5 25.1 0.0 12.9 11.0 16.5 10.0 22.6 RANBP10 KIAA1464 ENSG00000141084 "RAN binding protein 10" Q6VN20 16 67723070-67806652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-1)" "unprognostic (1.35e-1)" "unprognostic (3.37e-1)" "unprognostic (2.46e-3)" "unprognostic (4.51e-2)" "unprognostic (8.00e-3)" "unprognostic (9.04e-2)" "unprognostic (2.27e-2)" "unprognostic (1.31e-1)" "unprognostic (4.06e-1)" "unprognostic (2.77e-3)" "unprognostic (7.46e-3)" "prognostic favorable (7.52e-4)" "unprognostic (2.80e-1)" "unprognostic (1.17e-1)" "unprognostic (1.17e-2)" "unprognostic (2.16e-1)" 9.5 23.2 8.4 8.0 8.1 44.5 10.2 12.3 9.8 16.3 8.0 10.7 7.3 13.0 6.9 14.2 14.5 7.9 10.2 8.2 7.5 12.1 31.5 10.5 9.7 7.9 7.6 7.9 15.4 13.2 12.0 11.8 9.1 9.3 12.2 8.2 8.2 9.9 8.2 25.3 14.9 10.7 10.0 6.3 16.7 9.5 10.7 7.6 10.3 10.7 13.4 10.1 9.8 14.1 8.2 9.8 13.4 13.1 13.0 15.6 8.7 20.2 8.9 15.3 16.7 16.5 14.0 8.5 16.4 12.5 9.5 6.4 14.7 13.4 11.9 13.6 8.9 10.5 6.9 10.9 12.2 12.1 14.1 37.5 9.2 13.5 15.0 16.4 12.7 15.3 21.5 18.8 5.0 8.7 14.2 13.3 14.6 10.4 10.8 7.2 22.8 8.3 13.6 9.2 11.6 8.8 9.8 42.6 8.0 15.8 8.4 16.5 13.3 13.4 9.4 9.4 11.6 9.6 11.2 14.8 26.3 8.5 14.8 15.1 0.0 0.6 0.9 0.6 0.7 1.0 0.4 0.6 0.6 0.9 0.5 0.5 0.8 0.3 0.6 0.6 0.7 1.0 0.5 8.4 8.1 12.3 9.8 8.2 7.5 7.9 7.6 7.9 9.3 6.3 7.6 8.2 9.2 12.8 8.9 16.0 7.8 4.5 3.2 5.4 4.6 5.4 8.8 6.7 7.7 5.7 4.7 1.8 16.7 5.6 6.2 7.4 3.9 6.5 4.1 21.6 10.8 8.0 4.9 67.1 29.4 4.9 4.2 5.0 6.6 9.1 0.0 9.6 7.5 22.2 5.8 10.1 24.3 6.3 2.0 7.5 2.3 5.1 4.4 5.4 0.0 13.1 6.7 3.6 9.2 15.1 14.4 6.2 6.3 3.8 6.1 5.4 5.4 3.4 16.7 9.2 0.0 6.2 5.9 4.8 5.0 6.4 5.5 8.5 5.6 8.8 6.5 3.7 CTRL ENSG00000141086 "Chymotrypsin like" P40313 16 67927640-67932365 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1153 "pancreas: 7545.2" "Group enriched" "Detected in some" 20 "Exocrine glandular cells: 224.2;Pancreatic endocrine cells: 58.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034504, HPA034505" Enhanced "Secreted to digestive system" NA NA "HPA034504: AB_2674196, HPA034505: AB_10602212" "unprognostic (3.03e-5)" "unprognostic (3.53e-3)" "unprognostic (3.46e-2)" "unprognostic (1.37e-1)" "unprognostic (9.66e-2)" "unprognostic (2.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (6.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.88e-1)" "unprognostic (3.20e-4)" "unprognostic (6.69e-2)" "unprognostic (2.79e-1)" "unprognostic (2.63e-1)" "unprognostic (1.29e-3)" 1.1 0.7 3.3 1.1 3.5 6.2 0.9 3.9 4.2 1.0 2.5 0.7 1.9 0.6 0.2 0.5 0.7 0.7 1.7 3.3 3.1 0.8 1.0 1.7 2.5 3.6 3.3 3.2 6.5 7545.2 0.0 1.7 0.8 4.0 1.2 0.5 0.3 1.1 0.2 0.6 1.0 1.7 0.4 3.1 3.5 1.0 0.6 3.4 1.9 0.7 0.7 1.0 0.7 0.7 3.8 0.4 2.1 0.6 0.2 0.1 0.0 0.9 0.3 0.4 0.7 1.0 1.9 1.0 0.5 0.3 0.4 0.6 0.7 4.1 0.7 2.0 0.8 4.6 0.5 0.9 1.9 0.2 0.3 1.4 0.7 0.1 2.5 0.7 0.3 0.0 1.0 1.0 1.1 0.3 0.7 0.4 2.2 4.1 1.1 1.9 2.0 0.3 3.1 0.0 0.8 1.9 1.1 0.7 0.7 0.4 0.4 0.9 2.5 0.9 0.1 1.4 0.2 1.0 3.8 1.7 2.2 0.1 0.7 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.0 3.3 3.5 3.9 4.2 3.3 3.1 3.6 3.3 3.2 4.0 3.1 3.4 3.8 0.6 0.0 0.0 1.6 0.2 0.5 0.0 0.0 2.2 0.0 0.2 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.3 0.8 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 1.3 224.2 0.0 0.5 1.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.4 2.0 1.2 0.3 0.0 0.0 0.5 0.0 1.0 2.1 0.0 0.0 0.5 1.6 58.5 1.4 0.0 0.2 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.3 0.0 0.6 6.9 0.5 0.1 DPEP3 ENSG00000141096 "Dipeptidase 3" Q9H4B8 16 67975663-67980549 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 47.4" "Group enriched" "Detected in some" 7 "Spermatocytes: 290.4;Spermatogonia: 289.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 16.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 6.7;NK-cell: 1.8" "Group enriched" "Detected in many" 8 "granulocytes: 6.7;NK-cells: 1.8" "Cell line enriched" "Detected in single" 10 "U-266/70: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031870, HPA058607" Enhanced NA NA 27000000 "HPA031870: AB_2674079, HPA058607: AB_2683775" "unprognostic (9.93e-2)" "unprognostic (2.81e-3)" "unprognostic (1.86e-1)" "unprognostic (9.52e-2)" "unprognostic (3.61e-2)" "unprognostic (1.37e-2)" "unprognostic (1.55e-1)" "unprognostic (6.52e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.49e-3)" "unprognostic (9.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-3)" "unprognostic (1.13e-1)" "unprognostic (3.98e-2)" "unprognostic (1.51e-1)" 0.4 0.1 0.2 0.2 0.3 1.7 0.0 0.2 0.4 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.3 0.4 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.3 2.0 0.3 47.4 0.3 0.1 0.0 0.6 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.5 0.5 0.2 6.7 1.8 0.1 0.0 0.0 0.2 0.2 0.3 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 20.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 41.3 4.4 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.4 0.0 0.0 0.1 0.7 0.0 26.3 0.0 0.0 290.4 289.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 GFOD2 "FLJ23802, MGC11335" ENSG00000141098 "Glucose-fructose oxidoreductase domain containing 2" Q3B7J2 16 67674531-67719339 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040939, HPA041112" Uncertain Supported Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA040939: AB_10796564, HPA041112: AB_10794541" "unprognostic (9.80e-2)" "unprognostic (2.20e-1)" "unprognostic (2.06e-2)" "unprognostic (3.16e-3)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (2.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.17e-1)" "prognostic favorable (8.66e-4)" "unprognostic (1.90e-1)" "unprognostic (1.76e-1)" "unprognostic (7.87e-2)" "unprognostic (9.64e-2)" 11.8 12.3 12.6 7.0 13.6 16.8 12.7 27.7 14.9 14.1 12.4 11.9 11.8 10.9 5.5 33.7 13.1 8.0 6.7 12.5 13.0 12.1 41.2 9.4 8.8 11.2 13.4 12.4 6.4 8.9 12.1 13.3 14.9 15.7 11.0 9.4 8.2 12.8 7.4 9.2 16.5 9.3 9.3 8.3 18.7 8.1 11.2 12.4 8.1 10.4 7.2 13.0 11.0 26.5 13.4 15.8 25.1 15.1 31.0 14.9 11.3 18.1 12.7 16.5 23.3 23.9 21.5 13.9 26.6 11.8 14.8 12.6 19.4 15.6 14.9 19.3 16.2 20.1 6.7 14.5 30.4 11.4 11.0 12.5 9.1 16.9 31.0 9.2 11.7 34.5 26.9 14.1 4.9 13.2 33.0 18.2 13.4 20.7 9.4 13.8 28.7 8.9 20.8 14.5 21.5 30.4 18.4 31.6 10.5 9.6 8.7 15.9 7.3 26.4 17.8 18.1 16.3 13.0 13.2 19.8 29.0 11.1 15.8 13.3 0.5 4.8 5.2 4.4 2.9 7.2 6.3 7.7 7.9 4.8 7.0 6.6 5.3 9.0 5.9 3.1 5.4 9.2 3.7 12.6 13.6 27.7 14.9 12.5 13.0 11.2 13.4 12.4 15.7 8.3 12.4 13.4 36.1 0.0 8.4 8.5 7.7 22.9 15.8 8.1 15.9 13.7 21.7 12.4 5.3 15.7 10.9 11.0 14.6 10.3 10.6 23.8 5.9 21.1 89.6 22.5 10.9 33.8 43.2 56.6 18.3 11.6 24.1 10.4 3.6 8.7 4.5 12.2 31.1 46.7 6.6 21.9 16.8 17.0 16.2 7.5 10.0 29.9 8.7 4.6 8.8 6.5 5.2 12.0 11.3 8.5 7.3 15.8 14.2 11.3 9.1 12.4 20.6 13.0 24.5 11.0 6.6 11.9 11.4 19.9 14.8 10.1 27.3 22.2 10.3 9.3 18.3 21.3 NOB1 "ART-4, MST158, NOB1P, PSMD8BP1" ENSG00000141101 "NIN1 (RPN12) binding protein 1 homolog" Q9ULX3 16 69741871-69754926 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041522, HPA049430, HPA067411" Approved Approved "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA041522: , HPA049430: AB_2680764, HPA067411: " "unprognostic (5.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.15e-1)" "unprognostic (8.61e-3)" "unprognostic (9.45e-2)" "prognostic unfavorable (4.21e-5)" "prognostic unfavorable (8.16e-4)" "unprognostic (3.26e-2)" "unprognostic (3.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.16e-1)" 32.8 52.2 13.8 23.4 17.0 31.4 32.4 13.9 17.5 29.4 16.8 24.7 31.8 28.6 14.1 42.1 43.8 24.5 18.6 13.1 13.2 23.0 24.7 20.8 37.3 14.4 13.3 12.2 55.0 90.9 17.8 15.4 20.7 14.8 25.1 19.3 7.1 31.3 19.4 36.9 41.9 23.4 20.3 13.2 27.5 37.4 12.9 14.2 26.8 31.1 20.3 30.4 31.8 32.0 14.2 58.7 125.9 29.0 82.7 63.2 98.6 57.5 46.1 63.6 84.0 75.9 143.5 93.5 129.9 69.9 51.2 44.2 84.9 80.3 102.6 49.4 33.0 93.6 50.8 57.5 186.6 111.3 95.0 40.9 125.5 85.8 96.9 122.6 78.0 71.7 77.0 117.2 39.2 42.5 152.8 119.6 187.9 89.2 64.9 73.8 130.5 30.1 164.6 62.5 56.5 75.0 37.1 144.8 50.1 73.8 25.5 54.4 84.0 55.3 56.8 51.8 52.6 76.0 63.9 52.7 230.1 57.0 85.3 64.2 0.3 37.9 5.7 41.5 32.5 58.1 47.0 50.3 38.5 51.3 53.9 53.3 49.0 1.9 65.7 26.5 26.8 68.2 46.7 13.8 17.0 13.9 17.5 13.1 13.2 14.4 13.3 12.2 14.8 13.2 14.2 14.2 31.3 3.2 18.8 4.6 36.2 60.0 75.1 84.7 87.6 10.2 52.3 69.7 5.7 24.3 47.2 20.2 0.0 71.9 22.5 14.2 41.1 47.9 10.7 22.0 42.5 39.9 10.2 37.6 6.9 85.9 82.6 35.8 23.4 26.5 16.5 68.5 32.5 14.8 36.2 5.0 6.7 36.9 36.7 30.7 24.1 7.1 36.7 19.6 21.4 2.8 35.7 11.6 35.0 6.0 5.7 46.9 25.1 42.5 24.8 72.0 35.3 37.4 17.1 5.4 26.3 47.2 30.5 18.1 33.4 64.0 59.7 47.5 30.7 77.4 63.2 67.8 PRPSAP2 PAP41 ENSG00000141127 "Phosphoribosyl pyrophosphate synthetase associated protein 2" O60256 17 18840085-18931287 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 274.7" "Low region specificity" "Detected in all" HPA021881 Approved Approved Nucleoplasm,Cytosol NA NA 84000 "Nucleoplasm, Cytosol" "HPA021881: AB_1855782" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.78e-2)" "unprognostic (1.18e-1)" "unprognostic (2.01e-2)" "unprognostic (1.90e-1)" "unprognostic (3.25e-2)" "unprognostic (9.82e-2)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.71e-4)" "unprognostic (4.57e-2)" "unprognostic (8.98e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-1)" "unprognostic (9.08e-2)" 10.5 18.0 22.4 21.6 25.9 23.8 16.3 39.9 25.5 14.8 19.1 20.8 26.5 21.4 18.0 16.8 21.2 21.6 19.2 25.2 25.2 30.2 21.6 18.5 51.7 27.1 24.7 21.6 26.0 16.1 21.2 22.2 14.0 27.0 16.6 24.7 46.7 14.7 14.6 10.4 20.9 20.9 17.5 26.3 19.7 23.3 32.0 26.1 30.8 26.8 10.9 57.8 15.0 14.5 39.1 40.6 44.2 63.1 46.1 26.8 16.2 64.4 30.4 23.7 38.8 35.7 56.2 19.3 104.3 30.7 26.4 38.4 49.2 75.0 38.4 42.2 47.4 60.1 32.8 37.0 46.8 37.5 21.0 29.1 19.5 24.7 49.2 36.6 39.2 36.5 57.0 49.4 17.0 34.5 45.5 45.4 23.9 45.8 80.3 29.0 63.0 103.4 46.4 24.4 25.7 37.7 47.7 45.4 18.5 48.5 274.7 49.7 31.0 24.8 15.8 31.5 53.8 38.7 26.9 34.8 43.5 33.3 30.0 33.1 23.2 23.2 28.5 25.9 23.5 29.4 43.7 32.9 27.2 31.9 40.4 46.0 34.5 9.5 36.9 26.1 21.4 36.3 30.0 22.4 25.9 39.9 25.5 25.2 25.2 27.1 24.7 21.6 27.0 26.3 26.1 39.1 16.6 16.0 31.7 21.5 31.7 15.8 19.7 26.9 16.5 38.5 14.2 18.2 10.2 25.8 18.6 11.0 29.2 12.4 22.6 12.3 27.4 23.4 54.3 14.6 13.0 18.3 26.5 23.5 17.6 22.1 37.9 14.8 16.3 13.1 46.3 18.4 18.9 17.6 24.5 16.8 21.5 17.6 16.2 14.0 11.0 67.9 14.0 19.5 12.4 14.0 24.6 26.3 19.6 27.2 37.8 21.1 14.8 13.5 48.0 20.3 21.5 32.2 25.3 34.4 19.7 13.7 14.3 69.8 54.0 19.5 20.9 14.0 23.8 24.7 21.3 15.6 UNC45B "CMYA4, UNC45" ENSG00000141161 "Unc-45 myosin chaperone B" Q8IWX7 17 35147817-35189345 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 59 "heart muscle: 101.3;skeletal muscle: 198.4;tongue: 153.3" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 201.8;Late spermatids: 59.4" "Group enriched" "Detected in some" 5 "head and neck cancer: 0.9;testis cancer: 1.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Lineage enriched" "Detected in single" 9 "T-cells: 1.1" "Group enriched" "Detected in some" 11 "BEWO: 1.7;HSkMC: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017861 Approved Cytosol NA NA Cytosol "HPA017861: AB_1847012" "unprognostic (7.17e-2)" "unprognostic (6.47e-3)" "unprognostic (9.36e-3)" "unprognostic (2.93e-1)" "unprognostic (1.49e-3)" "unprognostic (5.30e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-2)" "unprognostic (5.46e-2)" "unprognostic (2.40e-2)" "unprognostic (8.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.13e-6)" "unprognostic (6.77e-2)" "unprognostic (5.05e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.1 101.3 0.2 0.1 0.1 0.0 0.7 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 2.5 0.0 198.4 0.0 0.0 0.1 0.1 1.4 0.4 1.3 0.1 0.4 0.0 153.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.2 0.5 0.0 0.0 0.1 0.6 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 201.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 24.6 0.0 0.0 2.3 0.0 2.7 0.4 0.0 0.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 59.4 0.6 0.1 0.0 1.9 0.0 0.0 1.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 4.5 0.2 0.7 0.0 0.1 0.0 1.1 0.5 0.0 0.1 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55751051-55842830 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 98.8" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 68.5;Hepatocytes: 72.8;Syncytiotrophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 241.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 94.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA022979 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA022979: AB_2671018" "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 15.4 8.6 7.5 10.5 7.4 11.5 12.5 7.6 9.0 9.9 7.9 23.3 18.2 7.4 28.6 10.8 9.0 9.8 16.6 7.3 8.5 30.0 98.8 19.0 10.0 7.9 8.7 6.6 8.4 11.9 13.5 7.9 29.0 8.4 9.6 24.0 4.3 10.8 23.3 19.0 5.9 16.7 10.8 7.5 15.6 19.2 13.4 8.9 5.9 8.6 19.5 9.0 13.5 8.0 7.5 21.2 19.3 13.9 5.1 18.4 17.7 36.6 8.1 10.3 12.5 12.1 22.0 26.7 5.9 61.0 12.7 11.8 11.5 8.2 13.7 11.2 94.8 19.5 51.9 5.7 40.2 16.3 20.0 39.5 14.7 17.3 7.6 13.5 15.2 24.8 17.7 38.4 20.2 13.7 18.7 16.0 16.1 15.4 0.0 16.9 8.1 20.5 4.9 13.4 15.6 7.1 16.1 4.2 8.7 34.6 30.4 23.6 33.8 18.2 14.7 10.4 16.2 10.9 57.9 19.4 3.6 13.2 32.7 25.5 77.3 60.9 241.1 9.4 52.6 5.6 8.6 6.1 9.7 49.0 5.3 3.6 8.2 63.3 27.5 58.9 3.9 11.8 29.3 7.5 7.4 7.6 9.0 7.3 8.5 7.9 8.7 6.6 8.4 7.5 8.9 7.5 13.1 3.2 8.1 25.5 4.2 1.0 2.4 6.6 2.8 4.0 5.4 4.8 15.7 15.7 3.2 9.2 2.1 51.6 5.2 17.8 11.7 13.0 18.3 6.4 6.0 10.3 13.1 12.2 16.5 13.7 68.5 8.2 7.7 6.3 15.2 7.1 10.4 72.8 22.1 1.7 26.4 17.1 8.2 25.2 5.1 20.0 16.4 20.1 12.4 9.4 15.1 4.0 11.3 19.6 4.2 9.5 10.1 25.9 5.3 1.7 13.9 40.6 3.8 2.3 13.1 4.3 8.9 17.9 7.7 6.6 1.4 67.2 5.6 8.2 16.2 2.6 OR4D1 "OR4D3, TPCR16" ENSG00000141194 "Olfactory receptor family 4 subfamily D member 1" Q15615 17 58148449-58159555 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "dendritic cells: 2.4;T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.9 0.0 0.9 0.0 0.8 0.8 0.0 0.0 1.2 1.4 0.1 1.8 0.0 0.0 0.2 0.4 0.3 0.2 0.4 0.3 0.3 0.2 0.3 0.2 0.2 0.4 0.1 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 TOM1L1 SRCASM ENSG00000141198 "Target of myb1 like 1 membrane trafficking protein" O75674 17 54899387-54961956 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 103.7;Late spermatids: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022916 Uncertain NA NA "HPA022916: AB_1858181" "unprognostic (1.50e-1)" "unprognostic (7.70e-3)" "prognostic favorable (1.61e-4)" "unprognostic (9.59e-2)" "unprognostic (1.59e-3)" "unprognostic (6.26e-3)" "unprognostic (1.18e-2)" "unprognostic (1.32e-1)" "unprognostic (2.49e-3)" "unprognostic (2.00e-2)" "unprognostic (2.14e-1)" "unprognostic (3.87e-2)" "prognostic favorable (3.81e-6)" "unprognostic (7.47e-2)" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.62e-2)" 7.8 16.7 6.9 7.2 7.5 1.4 33.2 8.5 7.2 36.8 17.2 33.9 107.9 12.7 45.5 21.3 35.3 19.2 8.1 5.0 6.6 79.4 109.1 17.2 5.2 5.4 6.3 6.0 4.8 42.7 65.4 13.0 6.9 5.3 33.2 36.8 19.2 33.1 20.2 2.7 20.7 61.4 8.6 7.0 4.2 55.2 15.5 5.6 8.0 58.0 3.4 12.1 12.2 12.2 6.3 48.6 50.3 8.8 59.6 0.2 0.5 0.6 25.2 39.9 24.0 33.8 33.1 48.3 0.2 62.2 22.7 36.5 31.4 47.9 52.6 36.0 1.2 59.7 72.3 43.5 52.4 50.2 0.4 0.2 21.3 83.8 22.5 124.2 44.0 14.5 14.3 30.9 0.4 23.7 45.1 2.1 0.7 21.1 90.1 36.1 0.6 39.2 29.2 108.5 61.2 42.2 48.5 24.8 41.5 60.1 41.9 102.7 7.0 17.8 13.3 1.9 31.7 45.3 0.9 37.1 1.1 22.4 0.2 28.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 6.9 7.5 8.5 7.2 5.0 6.6 5.4 6.3 6.0 5.3 7.0 5.6 6.3 1.1 22.4 21.6 15.3 1.9 15.8 17.2 21.3 19.4 14.3 30.4 26.7 4.9 27.1 20.6 36.8 22.9 8.9 0.8 37.4 103.7 60.8 82.5 29.4 6.0 0.9 18.7 3.8 57.0 44.9 3.7 4.2 36.7 29.7 1.3 16.4 1.8 43.2 3.1 15.2 28.6 55.2 8.2 1.3 1.2 184.0 2.8 3.1 12.4 7.5 3.2 12.7 0.0 40.7 20.2 52.0 30.4 3.0 0.7 26.0 86.1 93.2 20.1 19.0 6.6 4.9 6.5 2.5 6.6 28.0 17.8 3.1 1.2 21.5 42.8 18.5 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822927-53825193 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 390 "testis: 76.0" "Group enriched" "Detected in some" 68 "Early spermatids: 744.0;Late spermatids: 623.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 744.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 623.2 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 10.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 170.0;Late spermatids: 100.8;Spermatocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.7 10.2 10.1 9.6 10.5 3.2 11.3 13.2 12.2 12.0 9.3 10.1 10.6 14.6 9.8 8.9 12.4 8.9 15.9 9.9 10.1 12.9 10.0 9.2 13.8 9.3 9.3 9.2 17.3 9.3 16.8 10.7 12.6 10.3 12.7 10.1 23.5 10.8 12.1 24.8 8.8 9.8 12.9 9.4 10.9 10.4 40.0 9.4 18.0 16.2 22.0 12.3 9.2 6.9 10.4 20.0 20.6 28.1 17.2 20.2 17.2 27.2 25.6 22.2 35.6 33.6 19.7 16.1 37.7 17.8 13.2 24.2 19.5 39.4 14.7 41.4 13.8 26.8 34.6 21.5 23.3 17.6 37.0 19.7 13.5 18.1 23.8 19.5 17.8 30.9 25.1 38.3 21.9 24.0 11.5 43.1 17.5 22.3 22.1 22.1 25.7 77.2 19.3 18.4 14.9 34.3 30.8 13.7 24.7 30.0 44.0 27.1 23.0 17.1 37.1 34.0 12.1 24.8 24.7 31.9 35.8 14.9 16.5 24.1 17.3 3.3 4.8 6.6 4.0 6.6 4.9 4.9 5.9 3.8 4.7 4.5 6.6 1.6 4.4 4.4 5.8 7.2 3.4 10.1 10.5 13.2 12.2 9.9 10.1 9.3 9.3 9.2 10.3 9.4 9.4 10.4 10.3 6.4 15.1 10.7 6.4 5.0 2.1 3.0 8.6 10.3 6.1 7.2 20.2 5.7 7.9 5.5 20.9 9.5 14.9 4.6 9.8 6.1 170.0 8.9 12.3 11.0 5.4 1.3 10.8 3.8 5.8 9.6 5.6 7.0 7.6 11.8 5.0 4.6 5.0 8.4 10.9 3.8 6.1 5.1 2.6 100.8 5.3 4.8 1.8 9.4 5.9 10.6 4.1 10.1 9.0 4.5 5.1 7.5 5.9 2.1 6.6 7.5 15.8 15.8 0.0 10.5 7.7 67.1 13.6 7.1 4.4 16.8 5.5 17.9 4.8 1.4 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 253.3" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "HPA047839: AB_2680175" "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.04e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 41.9 212.2 33.9 22.5 35.2 70.8 65.9 35.1 40.2 55.8 54.3 47.9 56.7 24.1 26.7 78.4 55.0 48.0 44.8 31.4 62.9 68.6 170.0 37.1 19.1 39.8 41.6 27.3 64.0 209.7 82.0 50.5 13.9 40.6 72.9 58.0 102.7 100.6 93.0 180.2 127.6 48.5 29.7 33.0 17.9 88.3 26.3 35.8 17.9 96.3 110.9 21.1 82.7 71.5 42.1 44.1 88.7 28.1 11.5 51.4 25.4 22.0 31.9 79.2 20.5 25.0 36.0 54.6 40.0 60.6 43.9 20.7 61.0 19.5 54.1 21.1 20.4 29.3 4.8 100.7 60.5 72.0 21.5 18.9 54.5 65.5 23.9 120.0 27.3 9.9 12.2 17.0 33.7 43.4 119.0 16.1 19.4 10.2 109.4 33.9 14.0 35.6 47.6 80.9 89.4 16.6 40.4 55.1 158.9 19.9 42.5 253.3 27.1 13.2 23.3 16.7 26.7 15.8 51.9 57.7 18.5 19.2 10.2 9.1 417.7 53.5 285.6 245.8 107.3 269.9 40.7 222.7 192.5 119.1 31.9 192.1 233.6 130.7 28.8 152.5 38.5 206.0 169.0 33.9 35.2 35.1 40.2 31.4 62.9 39.8 41.6 27.3 40.6 33.0 35.8 42.1 101.6 115.4 118.3 71.8 53.1 283.2 232.9 119.8 284.0 125.3 180.6 179.6 115.5 210.1 81.8 68.0 56.3 20.8 124.8 183.3 103.7 42.6 97.9 143.7 51.7 40.7 203.4 18.1 11.5 54.1 2.0 83.5 123.3 176.2 63.9 19.7 33.2 205.6 35.4 18.5 14.1 223.2 48.8 27.6 249.2 40.4 26.4 89.9 71.2 5.6 29.1 118.3 20.6 16.6 34.1 41.8 186.7 59.8 41.3 187.2 126.2 60.4 87.8 62.7 164.3 137.3 123.8 36.9 12.1 153.8 230.7 10.9 154.7 77.4 167.6 287.2 VPS53 "FLJ10979, HCCS1" ENSG00000141252 "VPS53 subunit of GARP complex" Q5VIR6 17 508503-721717 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 270.0;Late spermatids: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022988, HPA024446" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA022988: AB_1848679, HPA024446: AB_1848680" "unprognostic (8.62e-3)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.39e-2)" "unprognostic (9.08e-3)" "unprognostic (3.12e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.53e-2)" "unprognostic (1.82e-2)" "unprognostic (1.89e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.31e-1)" 4.2 4.8 6.2 3.0 6.3 20.7 4.6 20.1 10.5 4.6 2.7 4.6 3.8 4.4 3.5 9.1 4.1 3.6 4.3 7.8 4.9 4.1 4.5 5.1 4.9 5.4 4.2 8.0 5.4 4.5 6.4 6.0 4.7 7.6 4.7 5.9 8.2 4.8 5.0 7.1 7.2 4.1 6.1 1.1 4.6 5.1 14.8 4.4 5.0 7.6 5.1 5.3 4.1 4.8 9.8 12.9 26.5 7.6 8.3 12.4 9.5 5.5 6.4 9.4 15.8 15.4 12.6 5.8 7.8 5.9 19.9 10.0 10.9 16.5 13.9 23.1 6.7 11.4 5.0 17.2 8.1 6.1 6.6 9.2 11.1 7.8 14.7 9.8 6.4 11.7 9.7 9.1 9.1 14.9 8.9 4.3 5.1 6.2 5.6 6.9 10.5 3.9 5.2 8.0 10.4 7.6 6.1 12.4 4.3 5.4 7.5 6.5 3.5 7.9 6.8 5.4 12.5 7.0 4.3 3.3 4.8 11.5 5.2 8.6 8.1 1.9 4.4 2.4 2.3 1.8 2.1 2.2 1.7 1.1 3.0 2.3 1.9 6.1 1.9 5.6 3.0 1.9 0.9 6.2 6.3 20.1 10.5 7.8 4.9 5.4 4.2 8.0 7.6 1.1 4.4 9.8 16.0 12.8 25.9 54.5 19.3 25.5 16.5 11.6 19.9 53.3 19.6 9.3 17.4 14.3 21.5 40.5 70.9 10.5 19.9 24.9 1.9 16.7 270.0 23.9 22.2 18.7 24.6 5.0 109.3 18.3 7.9 18.5 26.5 28.1 24.1 18.2 15.7 17.7 21.4 63.9 103.6 27.4 4.1 20.6 19.4 203.9 18.6 21.0 10.6 39.4 27.5 18.3 37.0 48.2 62.5 25.3 15.5 23.0 20.6 18.7 21.0 10.6 24.3 52.2 6.6 31.1 20.7 46.0 35.3 24.6 38.8 8.9 26.8 17.2 22.0 19.6 SPATA22 NYD-SP20 ENSG00000141255 "Spermatogenesis associated 22" Q8NHS9 17 3440019-3513852 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "testis: 232.3" "Cell type enhanced" "Detected in some" "Early spermatids: 293.3;Late spermatids: 207.8;Spermatocytes: 1047.6" "Cancer enriched" "Detected in single" 10 "testis cancer: 3.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 7.7;TIME: 10.9" "Not detected" "Not detected" NA NA "unprognostic (4.09e-2)" "unprognostic (9.31e-2)" "unprognostic (2.54e-2)" "unprognostic (7.07e-2)" "unprognostic (9.05e-2)" "unprognostic (1.98e-2)" "unprognostic (6.79e-4)" "unprognostic (4.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.27e-1)" 1.1 0.6 0.7 0.2 1.3 0.1 1.1 0.7 1.1 0.5 0.0 0.2 0.2 0.4 0.2 0.3 0.5 0.1 0.4 0.7 0.7 0.4 0.2 0.3 0.3 1.4 1.2 0.6 0.2 0.2 2.8 0.2 3.6 1.1 0.3 0.0 0.2 0.2 0.1 0.6 0.1 0.3 0.2 0.6 0.6 0.2 232.3 2.2 0.2 0.2 0.3 0.0 0.3 0.2 4.3 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.1 0.2 0.0 0.1 0.7 1.3 0.7 1.1 0.7 0.7 1.4 1.2 0.6 1.1 0.6 2.2 4.3 0.3 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.6 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 293.3 0.1 0.2 0.7 0.0 0.0 4.5 0.0 17.3 0.7 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 1.2 0.1 0.0 0.6 0.3 207.8 14.3 0.9 0.0 0.0 0.0 0.0 0.0 1.5 45.8 0.0 0.0 8.6 0.0 0.0 0.0 0.2 0.0 0.0 13.1 0.9 0.4 1047.6 58.8 0.0 0.1 1.2 0.1 0.2 0.0 0.0 SGSM2 "KIAA0397, RUTBC1" ENSG00000141258 "Small G protein signaling modulator 2" O43147 17 2337498-2381058 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 7.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021641, HPA024553" Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA021641: AB_2188702, HPA024553: AB_1856512" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-2)" "unprognostic (4.88e-2)" "prognostic favorable (3.11e-4)" "unprognostic (1.49e-1)" "unprognostic (7.84e-2)" "unprognostic (7.63e-2)" "unprognostic (1.90e-1)" "prognostic favorable (9.00e-6)" "unprognostic (2.78e-2)" "unprognostic (8.27e-2)" "unprognostic (1.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-2)" 20.8 30.4 79.2 20.4 77.4 28.7 31.3 46.5 103.5 31.6 49.1 32.6 15.6 26.5 52.2 36.3 27.7 21.3 27.1 78.0 68.6 36.6 19.5 28.5 24.5 60.9 61.9 79.5 29.1 28.2 27.6 81.3 15.9 58.4 54.2 10.2 15.9 42.2 21.8 21.8 33.6 32.8 18.0 50.5 37.9 33.9 30.3 65.9 17.6 41.8 14.1 14.2 32.1 29.0 66.9 20.7 31.1 27.9 39.0 15.5 18.6 41.4 17.4 20.4 23.6 23.9 31.2 38.6 9.9 18.5 25.3 8.7 28.4 17.2 20.6 8.2 14.5 35.3 17.2 55.6 33.8 13.3 10.4 25.0 20.1 13.4 24.1 13.7 34.1 24.9 26.4 10.5 14.4 14.3 43.5 22.4 14.0 13.7 14.7 13.5 48.5 14.2 8.0 30.5 42.5 13.5 31.9 21.7 16.2 13.4 17.1 41.9 12.3 29.3 18.9 21.5 28.1 23.4 11.8 1.9 9.5 16.4 13.6 17.0 7.0 0.3 1.3 0.9 0.1 0.8 0.1 0.3 0.5 0.4 0.3 1.1 0.6 0.1 0.9 0.0 0.5 0.6 0.4 79.2 77.4 46.5 103.5 78.0 68.6 60.9 61.9 79.5 58.4 50.5 65.9 66.9 9.4 6.4 24.7 52.9 5.4 6.8 8.3 13.8 5.7 59.6 31.9 24.0 15.6 11.5 23.5 12.9 135.5 13.8 9.3 7.1 0.0 6.7 18.2 9.9 11.0 11.8 13.8 5.7 39.7 4.5 8.8 10.0 14.3 14.7 20.3 18.1 14.3 8.3 7.8 30.3 38.2 9.9 16.2 7.6 9.9 38.1 8.1 9.2 5.4 16.9 6.3 11.9 7.2 22.6 10.3 6.4 4.5 12.0 4.6 15.0 7.0 4.0 16.5 51.2 19.7 9.6 11.0 4.1 6.7 11.9 7.7 14.1 11.6 15.2 8.2 13.5 NPEPPS "MP100, PSA" ENSG00000141279 "Aminopeptidase puromycin sensitive" P55786 17 47522942-47624665 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021453, HPA045649" Uncertain Supported Cytosol No No 3000000 Cytosol "HPA021453: AB_2670709, HPA045649: AB_2679406" "unprognostic (1.63e-1)" "unprognostic (3.15e-2)" "prognostic favorable (3.39e-5)" "unprognostic (2.66e-2)" "unprognostic (1.53e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (3.85e-2)" "unprognostic (3.63e-2)" "unprognostic (1.93e-1)" "unprognostic (8.55e-2)" "unprognostic (1.52e-1)" "unprognostic (1.23e-2)" "unprognostic (1.07e-1)" 31.4 50.4 33.6 19.5 37.9 7.3 30.4 33.5 41.4 35.3 28.4 38.7 20.5 32.3 11.2 92.9 32.9 22.4 30.8 36.5 33.0 31.2 23.9 30.8 18.5 37.6 37.6 32.9 40.3 34.5 30.4 26.9 27.5 39.8 28.2 27.7 21.2 44.8 20.8 115.4 45.9 37.4 34.0 30.0 32.2 33.6 19.3 35.4 26.6 27.0 87.4 27.7 35.1 58.7 36.2 105.7 81.7 67.3 49.4 92.1 81.9 147.5 47.5 63.9 70.4 66.5 55.7 100.6 68.4 76.1 69.2 70.1 62.0 83.7 44.8 108.7 31.5 73.2 76.5 62.3 59.2 48.3 48.8 46.6 61.5 41.1 52.7 26.8 99.2 77.5 20.1 72.5 30.7 109.9 37.2 66.0 34.7 47.8 74.4 68.0 50.5 107.2 60.1 82.6 81.0 59.7 46.0 59.1 34.9 44.7 122.0 256.3 35.5 88.6 44.1 35.2 72.5 34.9 63.7 81.1 39.9 64.8 25.3 33.5 14.2 9.9 12.4 8.8 7.9 9.6 7.7 7.2 9.2 9.7 6.9 6.3 7.8 28.4 8.8 9.1 10.1 8.8 6.3 33.6 37.9 33.5 41.4 36.5 33.0 37.6 37.6 32.9 39.8 30.0 35.4 36.2 32.0 83.3 59.1 68.6 44.7 77.9 68.9 40.2 109.8 144.6 76.6 33.8 60.3 55.8 53.6 42.3 268.9 81.2 35.6 87.0 27.4 69.3 34.2 95.2 80.9 45.4 44.3 44.6 98.0 54.4 74.4 66.0 58.1 158.1 41.7 62.7 45.7 32.5 40.5 112.7 95.3 44.1 38.7 51.0 62.1 50.8 52.8 45.4 58.7 37.5 51.5 38.7 38.1 69.4 74.9 103.4 61.6 50.0 52.5 106.2 58.7 46.5 63.8 153.3 78.9 53.8 53.5 52.0 28.6 101.6 102.6 104.7 40.4 45.9 51.5 195.2 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133442-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" "dendritic cells: 107.1;granulocytes: 120.1;Late spermatids: 156.1;NK-cells: 213.1;T-cells: 147.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 29.3;HDLM-2: 16.0;HMC-1: 13.0;JURKAT: 22.2;Karpas-707: 15.7;RPMI-8226: 19.8;RPTEC TERT1: 22.6;U-266/70: 14.8;U-266/84: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favorable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favorable (3.14e-4)" 1.4 6.5 0.1 11.3 0.2 6.6 8.4 0.0 0.4 10.2 0.3 3.4 2.7 3.8 17.4 1.7 13.9 3.6 0.5 0.3 0.4 11.0 3.1 5.5 28.9 1.0 0.3 0.0 0.8 5.5 13.9 9.8 0.5 0.4 1.1 4.6 0.0 6.1 6.3 0.2 0.8 5.3 1.1 0.7 12.3 4.9 9.6 0.2 36.1 1.0 0.5 26.8 6.3 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 29.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 15.7 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 19.8 22.6 0.0 0.0 0.0 1.7 0.0 0.2 0.0 7.8 0.0 0.1 0.0 0.1 0.0 0.0 14.8 11.2 0.0 0.0 0.0 0.0 12.6 0.7 1.8 171.0 0.5 144.2 15.9 139.7 155.6 0.7 54.5 121.2 135.4 3.7 121.0 1.1 0.9 268.9 126.8 0.1 0.2 0.0 0.4 0.3 0.4 1.0 0.3 0.0 0.4 0.7 0.2 0.7 3.1 3.2 10.5 1.0 27.1 2.0 0.1 0.0 2.8 0.1 9.7 5.3 0.8 0.0 3.1 9.2 0.0 0.1 107.1 0.5 46.9 0.5 58.1 12.3 1.6 2.4 1.2 9.0 7.0 2.0 0.1 1.1 7.7 14.0 120.1 0.0 7.5 28.7 0.3 0.0 1.4 1.1 0.0 5.4 3.1 156.1 1.5 3.8 1.8 12.2 2.6 1.6 213.1 0.5 1.6 1.3 0.3 0.7 31.0 0.2 0.8 2.0 1.5 0.3 6.6 0.7 1.1 46.4 9.9 0.7 1.3 0.3 147.0 1.2 0.3 0.6 LRRC46 MGC16309 ENSG00000141294 "Leucine rich repeat containing 46" Q96FV0 17 47831634-47837719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "fallopian tube: 79.1;testis: 54.7" "Group enriched" "Detected in some" 6 "Early spermatids: 143.1;Endometrial ciliated cells: 166.7;Late spermatids: 61.5;Respiratory ciliated cells: 225.8;Spermatocytes: 125.7" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 11.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021882, HPA074893" Enhanced Approved Cytosol NA NA Cytosol "HPA021882: AB_1853320, HPA074893: AB_2732271" "unprognostic (1.06e-1)" "unprognostic (6.01e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.40e-1)" "unprognostic (2.81e-2)" "unprognostic (4.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.21e-3)" "unprognostic (3.63e-2)" "unprognostic (2.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-1)" 0.2 0.3 3.7 0.1 1.0 0.5 0.3 1.9 0.8 1.8 3.4 0.1 0.1 1.1 0.9 0.2 79.1 0.2 0.3 0.9 2.5 0.6 0.5 4.9 0.3 1.9 3.6 0.3 0.3 0.5 0.2 1.7 0.1 2.8 0.5 0.0 2.4 0.3 0.3 0.1 0.1 0.2 0.0 3.9 0.5 0.2 54.7 1.9 0.4 0.9 0.0 0.1 0.2 0.2 2.2 0.7 2.8 0.3 1.4 0.2 0.4 0.8 0.1 0.8 0.7 1.3 1.1 0.7 0.2 1.7 0.3 0.8 0.7 0.3 0.6 1.1 1.1 1.2 0.6 0.9 0.5 0.1 0.0 0.7 0.0 0.5 1.7 0.5 0.2 0.1 0.4 0.6 0.4 1.1 1.2 1.1 0.0 0.1 0.2 0.4 0.9 0.0 0.6 1.4 0.5 1.2 0.9 0.3 0.0 0.5 0.1 3.6 0.1 0.2 1.6 0.5 0.2 0.2 0.6 0.5 0.5 1.1 0.2 0.1 1.3 0.4 0.5 0.0 0.5 0.0 0.1 0.0 0.3 0.7 0.1 0.2 0.0 0.5 0.8 0.4 0.3 0.0 0.1 3.7 1.0 1.9 0.8 0.9 2.5 1.9 3.6 0.3 2.8 3.9 1.9 2.2 0.3 0.0 2.3 0.0 0.5 0.0 0.3 9.7 0.0 0.6 0.7 0.9 0.5 1.5 21.9 5.5 2.1 0.1 0.4 0.2 0.0 0.9 143.1 166.7 1.9 0.4 0.0 0.4 0.2 0.0 0.5 1.2 0.0 3.3 0.0 0.3 0.0 0.1 0.5 0.0 0.3 0.6 12.2 0.0 0.3 61.5 2.8 1.0 0.0 1.0 0.8 1.0 0.0 0.0 0.4 0.6 1.1 1.9 0.2 0.3 0.1 1.4 225.8 7.0 0.0 0.4 3.7 125.7 4.2 0.0 0.0 0.1 0.7 0.3 0.0 0.2 SCRN2 ENSG00000141295 "Secernin 2" Q96FV2 17 47837692-47841289 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 149.7;Proximal tubular cells: 332.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022934, HPA023434" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA 370000 Nucleoplasm "Golgi apparatus" "HPA022934: AB_1856638, HPA023434: AB_1856639" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (1.73e-1)" "prognostic favorable (3.86e-4)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (5.77e-2)" "unprognostic (1.28e-3)" "unprognostic (8.72e-2)" "unprognostic (3.43e-2)" "unprognostic (5.28e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "prognostic favorable (5.83e-4)" 81.9 23.1 17.3 11.2 17.5 13.6 49.3 17.5 22.5 28.1 19.6 22.8 44.2 24.7 11.6 19.4 26.8 12.1 32.2 17.0 20.0 67.5 37.5 17.5 13.0 18.4 17.9 16.3 25.6 26.6 25.6 31.8 13.0 17.8 28.8 10.5 6.5 34.1 19.9 38.5 22.2 37.0 10.3 18.7 34.3 21.6 10.7 17.5 12.1 40.2 25.3 10.2 22.3 23.5 18.7 28.0 43.8 12.1 11.0 33.7 25.7 36.6 13.7 27.6 20.6 21.0 32.5 33.2 15.3 27.5 7.1 11.0 14.7 3.9 24.6 6.9 37.6 29.7 15.5 33.8 29.2 12.0 7.9 12.7 25.7 18.1 12.8 9.8 31.5 23.5 35.6 5.4 18.2 28.9 25.4 24.6 12.8 6.0 12.1 17.5 32.7 9.0 62.4 16.9 12.9 8.9 37.6 8.0 17.3 17.8 8.3 37.9 14.5 10.7 18.2 20.8 5.6 6.6 70.2 9.8 7.7 52.1 13.2 4.2 24.5 19.9 43.4 24.6 21.1 24.1 24.8 20.4 24.2 25.7 25.3 31.7 17.8 5.4 29.3 10.8 30.1 23.0 16.5 17.3 17.5 17.5 22.5 17.0 20.0 18.4 17.9 16.3 17.8 18.7 17.5 18.7 21.9 38.5 29.9 15.0 18.7 15.7 31.5 41.8 20.5 12.0 24.5 25.7 19.3 15.7 35.9 16.5 10.4 43.1 12.4 33.2 74.3 27.7 3.9 16.9 10.0 24.6 22.3 7.2 12.4 61.0 9.3 25.7 17.3 12.4 16.5 22.1 24.3 26.7 22.7 20.2 10.5 33.6 48.8 11.1 13.7 2.8 33.2 12.8 42.7 7.5 13.9 28.8 26.8 11.1 6.0 33.3 36.5 16.6 30.9 14.1 149.7 332.7 40.9 16.8 6.6 19.1 16.0 5.2 16.7 21.9 11.5 33.8 21.6 23.9 40.7 27.0 SSH2 KIAA1725 ENSG00000141298 "Slingshot protein phosphatase 2" Q76I76 17 29625938-29930276 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 92.3" "Cell type enhanced" "Detected in all" "Excitatory neurons: 269.0;Inhibitory neurons: 255.2;Microglial cells: 254.8;Oligodendrocytes: 547.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 134.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017189, HPA057099" Uncertain NA NA "CAB017189: , HPA057099: AB_2683336" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.44e-1)" "unprognostic (1.53e-1)" "unprognostic (3.00e-3)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (6.80e-2)" "unprognostic (9.80e-3)" "unprognostic (7.52e-2)" "unprognostic (1.48e-2)" "unprognostic (8.28e-2)" "unprognostic (7.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.86e-1)" 15.7 9.6 11.2 22.7 13.5 63.4 10.8 12.0 14.1 7.1 4.1 12.1 8.4 7.4 9.0 12.8 8.3 9.0 17.2 12.2 19.4 15.1 13.8 21.6 29.3 16.8 13.1 8.7 4.0 14.7 6.2 7.2 10.5 17.6 6.3 11.0 8.2 10.8 4.5 92.3 13.9 20.8 8.0 11.5 28.6 15.6 28.5 14.7 29.2 14.0 35.9 25.0 9.1 8.8 23.1 25.8 19.0 12.6 10.8 36.1 24.7 8.8 12.3 12.9 19.6 19.2 12.9 9.0 22.1 18.8 14.1 12.6 31.0 14.8 17.1 22.4 7.1 28.1 14.9 21.2 17.4 16.6 16.7 30.7 30.4 12.3 20.6 13.4 9.7 47.3 36.2 9.9 16.8 13.7 7.3 74.9 15.5 9.4 9.3 11.5 37.9 31.9 37.0 35.7 20.3 20.6 32.3 18.0 18.6 36.6 16.3 12.6 19.4 25.6 12.6 26.3 23.5 16.1 26.9 20.0 53.8 16.4 13.1 12.3 47.2 15.2 134.8 10.4 20.2 8.5 21.3 11.6 11.1 12.7 22.4 11.5 8.7 91.6 4.6 36.7 7.7 16.4 6.5 11.2 13.5 12.0 14.1 12.2 19.4 16.8 13.1 8.7 17.6 11.5 14.7 23.1 19.6 9.6 38.5 81.6 137.0 39.6 12.3 20.6 27.9 12.4 22.2 19.2 28.2 12.8 23.2 16.5 27.1 20.4 68.7 54.3 25.4 14.9 108.4 27.9 10.1 26.9 35.4 27.8 269.0 35.5 26.4 22.2 33.1 32.5 12.6 6.0 19.6 26.9 22.3 20.2 255.2 34.8 14.2 120.2 31.3 174.4 12.2 75.9 35.6 254.8 83.6 9.2 82.4 184.0 547.9 40.3 38.6 8.2 49.4 12.9 64.5 63.1 18.4 22.9 6.6 34.4 17.0 80.9 16.7 37.6 36.2 18.2 65.8 14.2 21.6 30.2 RHBDL3 "RHBDL4, VRHO" ENSG00000141314 "Rhomboid like 3" P58872 17 32265832-32324659 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;retina: 26.3" "Cell type enhanced" "Detected in some" "Astrocytes: 41.8;Excitatory neurons: 46.8;Horizontal cells: 102.6;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 34.2" "Cancer enriched" "Detected in some" 4 "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.6;AF22: 4.7;AN3-CA: 3.8;GAMG: 5.5;HDLM-2: 6.0;NTERA-2: 6.5;U-2 OS: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA059607 Uncertain NA NA "HPA059607: AB_2684081" "unprognostic (7.70e-2)" "unprognostic (3.71e-2)" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.91e-1)" "unprognostic (2.83e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "unprognostic (2.18e-3)" "unprognostic (2.11e-1)" "unprognostic (1.23e-1)" "unprognostic (8.87e-2)" 0.4 5.1 8.1 0.4 10.0 0.1 0.4 13.4 21.3 2.1 3.3 0.7 0.2 1.6 0.7 0.5 2.3 0.2 7.6 13.1 9.1 0.6 0.0 0.3 0.1 13.9 19.7 8.8 2.2 0.5 0.8 2.9 0.2 15.2 1.7 0.5 26.3 0.3 3.1 0.1 0.3 0.4 0.7 10.9 0.1 0.7 2.0 10.7 0.2 0.3 0.1 0.2 2.3 1.8 13.9 0.0 4.6 4.7 3.8 0.7 0.0 0.1 0.2 0.5 1.4 1.7 0.0 0.0 0.0 0.2 0.5 5.5 0.0 1.2 0.0 0.3 6.0 1.5 0.8 3.1 0.2 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.2 0.0 0.3 0.5 0.0 0.3 0.1 0.1 0.0 6.5 0.0 0.0 0.8 0.0 0.0 0.0 2.6 0.1 1.3 0.6 0.1 0.1 1.5 0.3 0.0 0.0 0.0 4.4 0.2 2.2 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.0 13.4 21.3 13.1 9.1 13.9 19.7 8.8 15.2 10.9 10.7 13.9 0.6 0.0 0.0 41.8 0.0 0.4 0.5 0.0 0.0 12.1 0.8 0.6 7.4 0.0 0.0 0.0 6.2 1.5 0.1 0.0 0.0 0.1 3.2 0.3 0.2 0.7 0.0 0.0 46.8 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.4 0.0 0.4 102.6 15.2 0.4 0.0 0.3 0.3 2.4 0.9 0.1 0.0 4.7 0.0 7.4 0.0 75.9 4.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 34.2 0.0 0.1 0.5 0.1 1.2 0.0 0.1 0.5 0.1 0.0 0.0 0.6 SPACA3 "ALLP17, CT54, LYC3, LYZL3, SLLP1" ENSG00000141316 "Sperm acrosome associated 3" Q8IXA5 17 32970376-32997877 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 126.3" "Group enriched" "Detected in some" 75 "Early spermatids: 1298.4;Late spermatids: 933.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enriched" "Detected in some" 16 "U-266/70: 91.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA023633 Enhanced "Secreted in male reproductive system" NA NA "HPA023633: AB_1857407" "unprognostic (6.48e-2)" "unprognostic (2.83e-1)" "unprognostic (1.30e-1)" "unprognostic (7.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.31e-2)" "unprognostic (3.37e-1)" "unprognostic (5.91e-2)" "unprognostic (1.68e-1)" "unprognostic (5.70e-4)" "unprognostic (3.86e-2)" "unprognostic (1.79e-1)" "unprognostic (4.63e-1)" 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.6 0.4 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 21.1 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.2 126.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 91.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.4 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1298.4 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 1.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 933.6 13.1 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 4.9 0.4 0.0 3.8 0.0 0.7 0.0 6.6 0.0 0.0 14.7 6.9 0.0 0.0 0.0 0.0 0.1 0.9 0.0 ARSG KIAA1001 ENSG00000141337 "Arylsulfatase G" Q96EG1 17 68259182-68422731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 30.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2;NK-cells: 42.2;Rod photoreceptor cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023245, HPA023285" Enhanced "Intracellular and membrane" NA NA 4400000 "HPA023245: AB_1845056, HPA023285: AB_1845057" "unprognostic (3.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-1)" "unprognostic (1.61e-1)" "unprognostic (9.02e-2)" "unprognostic (3.67e-3)" "unprognostic (4.11e-1)" "unprognostic (1.14e-3)" "unprognostic (5.18e-2)" "unprognostic (5.47e-2)" "unprognostic (6.11e-7)" "unprognostic (4.24e-3)" "prognostic favorable (7.04e-4)" "unprognostic (1.87e-2)" "unprognostic (3.68e-2)" "unprognostic (3.18e-2)" "unprognostic (1.49e-1)" 2.4 4.7 1.3 2.9 1.9 3.4 5.5 6.4 1.8 3.5 7.0 2.0 1.1 3.8 30.5 4.4 6.7 2.2 5.0 0.9 2.4 3.0 2.5 2.4 4.0 2.2 3.0 0.9 6.3 2.3 1.2 5.3 2.6 3.4 2.0 1.1 7.8 3.3 5.6 3.7 4.5 1.9 2.1 0.4 5.0 2.6 2.1 1.8 2.5 7.6 3.1 3.7 2.0 2.0 1.7 1.4 1.7 1.3 2.1 7.0 4.3 5.7 1.9 5.7 2.7 1.3 0.7 3.2 3.3 4.8 2.5 1.1 0.2 2.2 0.7 1.0 4.8 2.0 1.8 1.8 5.4 5.7 5.1 3.6 1.6 1.3 0.7 2.8 7.2 3.1 5.0 1.0 9.5 1.2 6.2 5.9 4.1 2.0 0.6 1.6 0.2 1.0 8.8 4.1 0.9 7.0 0.6 2.3 5.5 12.1 2.7 13.5 6.1 3.3 4.2 0.4 1.6 0.7 10.5 5.8 5.0 3.3 6.4 1.6 7.1 8.5 6.5 6.3 6.1 4.4 4.0 4.2 6.0 7.7 2.2 4.2 6.0 12.8 4.3 5.2 1.2 4.7 5.4 1.3 1.9 6.4 1.8 0.9 2.4 2.2 3.0 0.9 3.4 0.4 1.8 1.7 4.9 3.2 2.7 11.8 7.7 4.0 5.0 4.7 0.0 23.8 9.2 3.8 2.7 8.6 4.8 12.9 54.2 8.1 11.2 3.6 9.8 3.2 0.4 8.7 9.2 8.6 1.8 5.3 18.8 4.7 23.8 24.3 2.6 11.7 3.8 6.4 17.5 3.0 9.2 26.9 26.0 5.2 0.0 6.9 10.7 1.3 13.4 8.4 23.2 12.2 16.0 9.4 42.2 7.1 2.7 2.3 10.9 23.0 11.1 10.0 2.4 12.8 4.3 59.6 6.6 8.7 5.5 1.4 3.6 6.0 3.8 16.8 13.6 9.3 2.3 8.8 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867289-68955392 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 231.5;Granulosa cells: 117.3;Leydig cells: 502.6;Microglial cells: 162.1;Oligodendrocytes: 406.6;Skeletal myocytes: 216.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 31.9;ASC TERT1: 69.6;HSkMC: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 39.5 30.8 14.0 2.8 25.8 0.0 21.5 20.3 21.0 8.0 10.0 15.9 6.3 12.0 15.7 7.7 23.9 17.1 39.0 13.0 49.6 9.6 34.0 18.4 1.1 27.5 20.1 9.2 52.0 5.7 3.9 11.2 9.1 26.9 9.6 17.0 9.3 14.9 8.7 12.4 6.1 11.9 6.6 22.1 12.5 14.4 19.7 19.2 4.6 17.1 26.9 3.0 16.5 14.7 58.9 0.0 0.0 3.9 0.0 31.9 69.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 12.0 0.0 0.0 53.5 0.0 0.8 0.0 0.4 6.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 25.8 20.3 21.0 13.0 49.6 27.5 20.1 9.2 26.9 22.1 19.2 58.9 22.6 51.3 1.1 0.7 0.0 6.0 1.8 0.0 2.8 5.0 0.7 1.0 18.8 0.0 4.3 0.0 2.1 0.2 0.3 0.0 0.0 0.0 4.8 0.4 14.0 6.8 0.0 0.0 0.5 0.0 0.1 231.5 3.1 0.3 1.3 117.3 5.7 48.1 1.1 5.0 0.6 0.0 0.0 1.9 9.4 19.4 502.6 2.6 1.8 162.1 0.0 100.3 0.0 0.5 406.6 0.0 0.0 70.3 1.9 0.4 0.0 0.1 0.0 3.3 39.5 216.6 44.5 5.1 1.7 2.5 4.7 0.3 2.1 60.9 0.0 0.4 G6PC3 UGRP ENSG00000141349 "Glucose-6-phosphatase catalytic subunit 3" Q9BUM1 17 44070735-44076344 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067052 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA067052: AB_2685771" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" "unprognostic (3.61e-1)" "prognostic favorable (1.11e-4)" "unprognostic (1.88e-3)" "unprognostic (3.16e-1)" "prognostic unfavorable (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (2.43e-1)" "unprognostic (1.15e-2)" "unprognostic (2.59e-2)" "unprognostic (1.85e-3)" "unprognostic (1.87e-3)" "unprognostic (4.53e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (4.49e-2)" 54.9 98.0 64.0 22.7 64.9 16.2 56.1 69.2 79.9 45.4 80.2 42.4 28.9 55.8 64.5 37.4 46.0 24.1 58.5 63.4 72.8 75.8 26.7 43.2 19.5 73.5 74.2 58.6 44.6 57.0 67.3 95.8 26.1 84.0 60.0 18.3 17.2 49.1 41.0 54.8 25.7 39.9 23.2 66.6 45.6 51.8 55.5 70.2 15.3 71.7 26.7 12.1 49.1 38.1 72.0 40.0 231.7 73.7 128.5 77.9 58.3 55.3 45.0 86.9 96.2 64.4 97.1 62.3 88.9 62.8 95.1 65.4 67.4 53.5 92.1 44.5 46.4 86.0 49.3 142.5 182.4 84.1 46.1 59.8 77.3 44.3 93.1 62.3 59.6 79.3 35.9 51.5 109.6 72.5 112.1 22.4 71.4 99.3 48.7 133.5 45.6 48.4 207.5 137.6 93.6 92.7 83.0 49.1 57.4 59.3 82.9 158.6 45.1 87.6 98.8 53.1 26.8 63.5 74.0 56.2 26.1 110.3 38.2 128.9 3.0 33.1 7.9 9.9 43.4 12.1 12.1 8.0 9.1 54.2 13.9 9.7 12.9 1.4 17.5 26.3 74.5 8.5 16.9 64.0 64.9 69.2 79.9 63.4 72.8 73.5 74.2 58.6 84.0 66.6 70.2 72.0 22.3 3.2 12.9 5.2 10.4 2.5 17.3 31.8 8.0 10.5 20.7 21.5 6.4 21.5 25.2 40.5 12.5 64.3 17.1 12.4 13.7 59.3 5.0 18.9 22.1 26.0 22.9 9.7 2.8 49.4 41.1 25.0 16.8 20.1 18.3 20.2 18.5 7.1 58.7 5.0 4.5 14.1 24.4 21.6 12.2 6.2 20.2 20.9 14.2 0.0 21.8 30.7 10.3 8.0 5.5 33.6 13.6 23.0 27.2 19.5 20.5 36.0 24.6 8.3 13.1 15.3 21.4 31.5 26.7 14.3 2.6 42.5 7.0 43.9 19.7 17.2 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" Yes No 14000000 "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924" "unprognostic (1.56e-1)" "prognostic unfavorable (7.35e-4)" "prognostic favorable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavorable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.02e-4)" 106.4 96.1 41.6 90.5 55.4 97.1 82.4 65.0 104.8 93.1 36.7 122.8 74.8 83.9 127.6 82.8 68.4 89.7 91.5 57.0 59.8 126.7 118.6 82.8 76.1 86.5 55.1 46.0 73.8 57.3 188.2 52.0 140.8 94.9 98.7 129.5 165.1 69.2 105.1 89.1 82.0 74.0 122.0 44.9 79.5 92.0 71.9 70.8 76.7 115.1 84.6 87.6 102.0 52.0 101.9 293.3 426.1 207.6 207.0 345.8 280.5 240.0 305.7 321.7 268.2 278.9 264.7 175.2 200.6 340.1 436.4 296.9 186.2 313.6 255.1 356.2 214.4 166.8 328.2 248.8 414.0 262.3 228.5 182.3 266.9 154.6 408.0 262.3 211.4 302.0 99.9 334.4 280.4 429.1 511.1 135.6 65.1 179.6 263.3 248.2 118.7 343.6 244.9 297.5 404.1 184.1 216.7 188.3 122.9 180.4 270.5 290.3 142.3 385.6 492.4 287.9 237.0 317.8 213.3 320.3 181.4 357.7 151.6 305.3 16.6 33.1 21.3 17.5 36.3 21.7 13.7 16.1 19.2 36.5 12.9 13.4 15.0 19.9 18.9 32.5 22.8 22.1 23.3 41.6 55.4 65.0 104.8 57.0 59.8 86.5 55.1 46.0 94.9 44.9 70.8 101.9 62.6 99.3 107.9 80.3 46.3 63.9 44.4 75.6 28.5 91.9 58.5 34.7 77.9 71.4 103.3 77.3 60.5 109.1 60.7 184.0 27.4 76.2 23.3 95.5 95.6 79.7 120.6 115.9 137.7 97.7 47.7 84.5 99.4 106.1 68.4 75.5 120.7 185.4 182.5 85.8 135.9 120.7 77.3 195.0 93.2 77.2 74.0 128.3 53.4 79.6 102.8 53.9 38.1 73.4 124.2 106.2 76.1 93.6 83.0 86.3 102.7 132.4 128.0 65.2 78.9 66.0 82.8 52.7 38.0 60.5 79.3 107.9 45.9 81.3 127.8 91.6 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431426 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 173 "testis: 136.3" "Group enriched" "Detected in some" 25 "Early spermatids: 1057.0;Late spermatids: 524.2;Spermatocytes: 287.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Group enriched" "Detected in many" 4 "dendritic cells: 2.5;granulocytes: 1.0" "Cell line enriched" "Detected in some" 4 "MCF7: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044415 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.3 0.1 0.3 0.0 0.2 0.6 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.1 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.5 0.1 136.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 2.5 0.0 0.0 0.3 0.2 0.3 0.7 0.2 0.4 0.6 0.2 0.1 0.4 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1057.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 524.2 9.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 287.9 24.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 BCAS3 FLJ20128 ENSG00000141376 "BCAS3 microtubule associated cell migration factor" Q9H6U6 17 60677453-61392838 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Astrocytes: 241.9;Excitatory neurons: 298.7;Inhibitory neurons: 299.2;Late spermatids: 282.3;Microglial cells: 244.5;Oligodendrocyte precursor cells: 285.0;Oligodendrocytes: 552.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 88.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052409, HPA057289" Approved Approved Nucleoli NA NA Nucleoli "HPA052409: AB_2681821, HPA057289: AB_2683399" "unprognostic (2.84e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.20e-1)" "unprognostic (3.52e-1)" "unprognostic (5.52e-1)" "unprognostic (3.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "prognostic favorable (1.23e-5)" "unprognostic (2.55e-1)" "prognostic favorable (1.73e-5)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" 8.8 11.7 9.5 4.6 12.8 6.4 9.0 13.4 15.2 9.0 10.4 8.8 4.8 9.4 12.2 9.5 14.1 7.7 9.0 12.1 13.9 11.2 12.5 11.2 6.1 14.1 12.7 10.7 7.4 9.4 14.6 7.0 10.1 14.6 11.2 6.2 18.2 9.4 9.3 17.4 13.7 6.9 9.1 9.5 7.4 9.7 14.4 11.1 10.7 8.9 9.9 6.8 11.0 9.6 23.3 5.7 14.5 7.8 28.1 17.2 14.2 9.8 6.6 9.9 7.3 9.3 10.0 13.8 2.5 9.7 12.2 7.6 4.9 4.5 6.1 9.5 6.1 19.4 5.6 7.3 9.5 9.4 2.7 5.6 14.5 6.3 6.2 11.1 14.2 8.3 8.8 5.1 12.9 6.5 88.7 10.0 2.2 7.3 29.1 18.2 11.4 11.2 12.4 6.0 24.4 11.6 10.2 12.1 3.3 10.3 20.9 13.5 5.1 8.1 9.5 7.7 4.2 2.8 29.1 23.6 11.7 11.2 2.3 7.6 27.2 10.1 16.5 15.0 9.3 12.3 11.4 10.2 11.2 8.8 11.2 10.7 9.1 34.5 15.6 10.9 6.8 18.0 9.0 9.5 12.8 13.4 15.2 12.1 13.9 14.1 12.7 10.7 14.6 9.5 11.1 23.3 10.1 6.4 12.5 241.9 8.6 5.1 9.9 4.7 12.5 22.6 4.4 4.1 11.4 7.2 9.3 16.5 10.4 6.8 9.3 4.1 9.8 4.7 44.2 20.4 26.1 8.6 7.2 13.2 298.7 3.5 5.5 7.8 5.6 9.1 15.9 11.1 11.7 10.8 4.3 3.3 299.2 4.9 6.1 10.0 2.5 282.3 7.5 5.3 1.8 244.5 8.2 33.3 5.2 285.0 552.6 3.6 5.2 21.1 11.1 2.9 6.0 25.2 35.6 14.2 13.1 7.1 21.2 16.3 6.6 6.8 5.5 7.5 11.4 6.7 3.8 6.0 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria NA NA Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 19.3 26.2 26.2 17.5 27.1 14.6 27.9 27.0 32.1 19.8 25.6 24.4 15.5 19.0 48.9 18.3 18.6 18.3 13.8 26.9 27.5 18.6 46.1 14.9 19.2 27.6 26.7 26.5 17.0 19.7 18.8 14.2 18.8 28.7 20.9 27.7 10.3 16.1 18.7 25.2 15.8 13.3 23.1 26.9 17.6 16.2 19.6 27.0 17.4 16.4 21.1 24.3 44.4 11.9 29.3 75.9 142.9 44.3 40.8 84.8 72.6 47.4 70.6 63.8 60.7 89.0 94.1 57.7 54.1 105.0 60.9 101.1 73.3 98.4 93.8 89.4 104.2 133.2 96.7 72.3 176.2 129.4 86.0 52.5 82.0 120.9 93.9 108.5 42.8 102.5 37.4 111.3 58.2 92.4 187.9 74.2 71.2 38.0 194.5 113.4 39.1 74.8 80.7 103.7 109.2 57.9 74.2 36.7 39.6 91.5 50.7 93.1 61.1 67.2 77.8 77.8 47.1 77.9 73.6 91.9 82.3 50.7 54.4 60.4 6.1 69.0 2.9 22.7 67.4 30.9 43.1 26.3 25.7 50.0 33.1 37.4 27.0 29.0 34.8 86.0 59.4 34.0 37.9 26.2 27.1 27.0 32.1 26.9 27.5 27.6 26.7 26.5 28.7 26.9 27.0 29.3 21.4 16.0 13.6 5.5 18.7 36.7 50.1 48.1 27.9 4.1 17.1 22.4 15.4 11.5 51.6 11.0 4.2 26.8 13.0 8.9 11.7 27.2 22.1 23.4 33.1 22.5 6.7 17.9 9.8 25.6 25.0 29.7 17.3 24.1 22.8 12.8 12.8 31.5 16.9 8.4 9.1 10.3 22.4 9.7 17.2 12.0 17.4 14.6 14.2 2.8 11.4 7.2 13.4 7.5 11.5 28.8 12.3 9.8 24.8 35.1 10.0 16.5 33.3 3.4 13.1 25.4 32.2 33.4 13.3 21.3 35.7 31.7 12.6 22.4 16.7 37.5 SS18 "SSXT, SYT" ENSG00000141380 "SS18 subunit of BAF chromatin remodeling complex" Q15532 18 26016253-26091217 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055741, HPA059539" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055741: AB_2682901, HPA059539: AB_2684055" "unprognostic (2.03e-2)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.95e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "unprognostic (4.59e-2)" "unprognostic (1.53e-2)" "unprognostic (1.63e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (2.47e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (1.40e-2)" "unprognostic (1.30e-1)" 29.6 46.6 21.5 28.0 24.7 23.2 33.6 24.3 22.6 32.1 25.9 27.1 18.1 32.5 39.8 34.8 33.5 30.1 29.6 21.6 32.8 33.6 42.3 27.0 36.2 25.4 23.7 19.5 48.1 24.0 52.4 30.7 37.2 24.6 35.3 23.6 24.9 29.9 31.5 11.7 40.3 28.0 32.1 23.6 28.8 27.0 26.2 23.1 33.9 45.8 17.7 38.9 38.7 31.5 29.9 52.4 37.2 90.8 43.9 69.0 65.1 45.8 62.9 57.6 55.1 53.6 24.5 43.1 90.6 49.1 75.0 49.0 67.1 50.1 62.0 67.5 58.4 23.3 45.4 56.2 39.8 55.6 69.8 66.5 81.4 71.3 68.6 74.3 53.7 43.7 26.6 34.2 45.0 76.3 53.1 28.5 39.9 17.3 51.6 35.7 33.0 70.2 44.2 57.6 60.7 38.1 57.7 96.0 43.8 27.0 64.6 45.5 40.9 51.4 114.1 22.6 26.8 63.9 80.9 58.3 64.0 53.9 47.8 62.2 27.1 13.5 19.4 16.4 19.7 19.2 17.7 15.6 17.1 15.2 15.0 16.2 18.6 5.7 24.6 20.2 8.5 18.2 16.3 21.5 24.7 24.3 22.6 21.6 32.8 25.4 23.7 19.5 24.6 23.6 23.1 29.9 28.8 28.9 23.7 43.8 45.9 8.9 27.8 13.9 40.9 28.8 29.4 26.4 16.0 22.8 18.1 23.9 16.7 70.0 34.0 25.2 21.5 30.3 52.7 44.8 31.5 27.9 24.7 26.1 50.7 26.0 48.8 30.4 22.4 32.3 36.8 60.2 22.1 34.5 27.6 87.5 42.7 25.7 6.1 25.5 10.9 51.4 33.2 22.6 5.4 65.6 19.7 51.1 22.6 90.5 118.0 34.8 15.7 41.0 42.0 24.8 19.1 24.9 30.5 29.8 39.5 23.4 31.3 29.3 20.3 37.2 13.2 85.1 34.0 30.7 16.9 24.7 TAF4B "TAF2C2, TAFII105" ENSG00000141384 "TATA-box binding protein associated factor 4b" Q92750 18 26226445-26391685 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 80.3;Plasma cells: 52.3;Suprabasal keratinocytes: 78.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 65.0;U-266/70: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028937 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA028937: AB_10603034" "unprognostic (2.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-3)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "unprognostic (5.01e-2)" "unprognostic (2.67e-1)" "unprognostic (3.29e-2)" "unprognostic (2.21e-1)" "unprognostic (4.66e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (7.38e-2)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.72e-4)" 1.5 2.0 0.3 2.8 0.5 2.9 2.8 0.3 1.9 1.2 0.0 1.6 0.4 1.4 0.3 1.0 1.3 0.7 0.4 0.3 0.3 1.5 0.1 1.0 3.1 0.9 0.5 0.5 3.1 1.2 0.6 0.2 1.7 1.2 0.8 1.4 0.3 1.1 0.8 1.3 1.5 0.8 1.2 0.0 2.5 1.8 4.7 0.6 1.8 1.7 0.7 3.2 1.6 0.6 1.5 4.3 0.7 0.3 1.1 1.6 2.6 2.1 1.3 1.5 0.7 1.3 1.1 2.3 65.0 5.0 0.3 2.5 4.8 3.7 4.0 3.4 15.5 9.9 7.5 1.9 1.0 2.3 20.5 4.4 4.3 1.5 0.5 11.6 0.6 1.4 8.1 10.2 7.9 0.3 4.2 10.7 4.1 3.5 2.5 5.1 0.0 8.1 17.3 1.0 0.3 6.1 2.8 3.9 5.7 2.7 1.6 2.0 3.6 0.9 2.7 1.6 3.7 4.8 26.2 18.0 21.8 1.3 12.8 2.4 0.0 0.3 0.0 0.1 0.5 1.0 2.3 0.7 1.0 1.0 2.0 2.0 1.6 0.0 0.6 0.2 0.3 0.1 0.6 0.3 0.5 0.3 1.9 0.3 0.3 0.9 0.5 0.5 1.2 0.0 0.6 1.5 7.2 6.4 7.2 6.2 34.0 80.3 9.5 1.7 49.5 1.5 15.0 17.9 2.8 0.0 2.5 0.0 0.0 18.6 4.1 5.8 17.6 1.2 0.7 28.9 9.7 9.0 0.0 21.7 44.8 2.0 4.3 15.5 36.7 45.0 1.3 5.4 1.1 0.0 2.4 5.0 28.3 7.0 2.0 1.6 17.9 1.6 3.4 5.9 23.2 4.7 2.6 0.2 1.0 7.5 11.7 2.2 2.5 4.1 52.3 13.9 0.8 4.0 1.0 1.2 0.0 17.6 12.1 25.4 24.8 40.8 78.8 9.7 14.5 14.5 6.2 6.7 AFG3L2 "SCA28, SPAX5" ENSG00000141385 "AFG3 like matrix AAA peptidase subunit 2" Q9Y4W6 18 12328944-12377227 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004479, HPA004480" Enhanced Supported Mitochondria NA NA Mitochondria "HPA004479: AB_1078109, HPA004480: AB_1078108" "unprognostic (1.11e-1)" "unprognostic (7.49e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.31e-1)" "unprognostic (5.06e-3)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (5.35e-2)" "unprognostic (1.54e-2)" "unprognostic (4.05e-2)" "unprognostic (3.00e-2)" "prognostic favorable (6.05e-14)" "unprognostic (5.90e-2)" "unprognostic (9.41e-2)" "unprognostic (5.74e-3)" "unprognostic (2.22e-1)" 26.4 26.2 16.2 22.1 17.8 32.7 29.5 18.8 19.7 24.3 28.0 61.4 80.6 22.3 17.7 41.9 24.0 18.4 88.9 17.0 19.5 63.3 51.4 22.0 23.9 17.7 17.4 17.2 24.3 41.5 76.6 18.7 23.7 19.7 24.8 54.6 20.5 31.1 24.6 146.8 29.9 59.2 25.7 16.0 18.7 39.4 18.7 18.6 24.5 39.5 157.1 31.2 31.2 19.7 21.6 56.5 56.6 39.7 44.8 45.2 48.6 52.7 61.9 61.1 86.6 63.1 88.1 34.1 161.3 66.3 56.6 76.8 55.6 101.4 71.3 70.3 38.1 43.5 48.5 59.3 83.5 61.1 185.0 69.8 54.3 76.3 82.1 107.7 47.8 64.0 57.0 111.3 92.8 43.6 89.0 66.7 58.5 55.3 277.4 41.9 74.0 125.1 135.2 74.9 123.6 73.7 51.3 97.0 103.8 90.0 50.5 47.8 84.5 49.0 102.4 88.6 98.7 81.7 64.7 80.7 104.1 56.2 71.4 48.0 3.8 16.5 12.4 11.6 17.6 13.9 14.0 13.8 17.9 21.8 10.3 17.2 20.2 1.1 28.4 16.2 11.5 9.5 13.4 16.2 17.8 18.8 19.7 17.0 19.5 17.7 17.4 17.2 19.7 16.0 18.6 21.6 24.3 41.7 49.2 23.2 36.6 22.2 45.3 21.5 42.7 50.2 36.5 36.2 74.9 50.1 28.1 35.0 50.1 58.5 29.1 85.2 72.4 39.5 5.5 37.8 52.3 27.7 39.1 61.0 21.1 37.4 37.9 31.2 53.5 46.1 14.5 41.3 21.8 85.6 37.0 30.3 26.8 82.6 18.3 32.6 14.4 5.5 32.9 34.2 23.2 12.2 27.6 26.9 40.2 14.1 17.7 47.8 43.1 30.1 38.8 43.1 88.7 100.0 22.1 58.3 26.3 53.6 26.9 50.9 65.0 75.8 31.3 92.8 28.4 60.8 94.9 38.2 PRELID3A "C18orf43, FLJ31484, HFL-EDDG1, SLMO1" ENSG00000141391 "PRELI domain containing 3A" Q96N28 18 12407896-12432238 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 25.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.0;Hofbauer cells: 5.7;Horizontal cells: 8.4;Rod photoreceptor cells: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.75e-1)" "unprognostic (1.02e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (5.89e-7)" "unprognostic (2.08e-2)" "unprognostic (3.56e-1)" "unprognostic (2.77e-2)" "unprognostic (2.10e-1)" "unprognostic (1.69e-2)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.11e-1)" "unprognostic (1.08e-11)" "unprognostic (2.63e-2)" "unprognostic (2.65e-1)" "unprognostic (1.44e-2)" "unprognostic (9.42e-2)" 6.2 4.1 10.9 2.7 11.6 7.2 5.0 11.7 14.2 7.4 15.9 5.1 1.7 7.4 5.0 3.2 8.3 4.4 3.0 10.8 16.2 3.0 1.1 4.1 3.6 14.4 11.9 12.0 7.5 7.1 2.8 9.4 3.3 15.0 5.3 3.1 10.3 2.4 11.8 1.7 4.1 4.1 5.7 9.7 4.0 3.6 2.9 11.0 2.5 4.7 3.2 2.5 4.9 4.9 25.1 8.5 4.8 5.9 9.9 5.6 9.3 4.5 10.3 4.1 5.9 3.3 5.4 3.6 14.2 3.0 9.4 8.5 4.0 12.1 7.8 3.6 7.5 9.8 6.2 9.4 9.5 8.5 3.1 3.6 8.8 7.3 8.3 36.6 11.8 5.7 0.5 15.8 7.2 3.2 7.5 0.4 16.9 6.7 0.8 5.3 0.3 14.3 11.5 2.8 1.6 27.8 12.3 9.7 5.7 13.4 3.3 6.9 4.7 4.4 20.6 13.0 13.9 14.4 3.2 2.4 23.3 5.6 4.6 6.6 4.0 0.6 2.3 0.4 0.2 0.5 0.8 0.4 0.4 0.4 0.7 0.5 0.6 1.7 0.7 0.4 0.6 0.2 0.2 10.9 11.6 11.7 14.2 10.8 16.2 14.4 11.9 12.0 15.0 9.7 11.0 25.1 1.6 3.2 0.0 0.0 0.4 0.0 1.0 0.0 0.6 14.0 2.7 2.9 0.0 0.0 0.6 1.8 2.1 0.1 0.0 0.0 0.0 0.9 0.0 0.3 2.9 1.5 0.0 0.4 0.0 0.8 0.6 1.9 1.5 0.3 0.0 4.2 0.4 0.0 5.7 8.4 0.0 1.2 0.0 0.6 0.0 0.1 1.8 1.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 4.1 1.2 2.8 0.1 0.1 0.0 5.1 0.0 1.4 3.0 0.1 1.1 0.3 0.0 0.1 0.3 2.6 0.7 0.5 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030877 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 362.2;skeletal muscle: 259.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 26.0;neutrophil: 31.3" "Group enriched" "Detected in many" 11 "dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4" "Cell line enhanced" "Detected in many" "BEWO: 258.2;OE19: 299.8;SiHa: 155.1" "Low region specificity" "Detected in all" HPA029561 Approved Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favorable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 17.1 11.2 2.3 12.4 2.7 31.8 14.9 1.5 4.4 20.7 4.4 50.5 22.6 16.3 1.7 132.2 16.4 20.1 20.1 2.2 4.4 128.8 47.8 23.4 5.8 2.1 1.9 1.8 7.8 362.2 5.3 11.2 22.2 2.0 13.8 31.0 0.8 31.3 6.0 259.2 142.1 29.5 15.7 1.8 19.2 54.2 2.9 1.9 5.0 17.6 90.6 7.4 61.5 51.2 1.9 29.3 41.7 11.3 20.4 14.1 10.5 258.2 7.2 18.4 2.9 4.2 35.4 21.7 6.1 17.4 10.1 24.1 19.8 13.2 6.9 0.8 33.5 22.5 0.0 56.0 30.6 8.3 47.5 2.3 23.9 36.3 10.0 5.2 8.5 3.9 30.7 7.4 0.0 10.7 31.8 19.4 27.1 40.5 299.8 42.7 36.0 29.6 28.6 122.1 15.6 15.0 0.3 155.1 35.8 16.2 14.5 33.3 58.5 0.0 5.6 11.5 73.7 7.3 24.5 66.3 17.9 24.0 31.7 9.6 9.4 11.4 26.0 0.7 8.7 0.3 1.5 0.7 0.2 9.0 0.3 0.3 0.5 31.3 0.1 5.8 6.7 1.1 3.1 2.3 2.7 1.5 4.4 2.2 4.4 2.1 1.9 1.8 2.0 1.8 1.9 1.9 9.2 19.2 32.7 17.6 7.8 105.5 22.7 32.1 159.4 0.7 16.8 20.2 11.6 72.9 16.1 22.0 0.0 52.5 5.8 72.9 440.3 83.4 2.8 5.7 20.2 6.9 17.5 15.3 4.7 110.6 272.2 16.1 65.2 30.4 2.5 13.4 10.0 66.8 42.5 0.0 1.8 90.2 65.1 37.7 17.0 7.1 4.7 34.2 14.2 5.6 25.5 22.3 2.1 0.5 0.5 56.1 50.1 3.8 8.6 42.9 36.9 498.6 12.3 1.0 105.2 16.0 27.6 0.8 10.1 202.1 141.4 106.3 6.1 14.0 84.4 52.8 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11689264-11885685 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transducer "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 96.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 76.9;Inhibitory neurons: 119.5;Oligodendrocyte precursor cells: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 26.4;HeLa: 27.4;U-2 OS: 13.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 14 "basal ganglia: 164.1" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: AB_2732564" "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.7 1.5 30.0 2.9 96.8 0.9 4.2 4.4 30.7 7.4 3.2 5.6 1.6 6.7 2.2 8.1 4.0 4.7 2.7 40.2 18.8 4.0 2.1 2.7 4.9 34.7 8.4 20.3 3.0 1.9 4.9 16.4 2.8 22.6 9.4 3.6 4.2 4.7 17.1 22.0 7.3 3.2 7.6 1.6 3.0 3.1 6.6 19.8 4.3 7.9 13.2 5.6 13.3 7.0 16.3 0.7 8.7 10.3 0.7 0.8 0.2 1.2 0.1 0.4 0.7 0.0 9.2 1.6 26.4 1.6 0.1 5.7 0.4 9.7 8.1 0.0 5.6 9.0 0.2 27.4 5.2 0.1 0.3 0.6 1.2 11.9 0.0 0.2 0.4 0.0 0.3 2.4 0.3 0.3 0.3 0.3 0.8 8.4 7.2 0.2 0.2 1.4 0.2 0.6 0.3 9.4 0.2 12.3 0.6 3.0 2.3 0.2 0.3 1.5 1.1 13.2 0.5 2.6 0.5 0.3 0.1 0.5 0.3 0.3 0.6 0.0 0.1 1.3 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.5 30.0 96.8 4.4 30.7 40.2 18.8 34.7 8.4 20.3 22.6 1.6 19.8 16.3 4.3 3.2 5.9 17.0 1.1 10.6 11.6 6.6 10.2 7.2 2.4 8.9 3.6 0.0 8.0 3.7 16.7 0.5 13.8 3.2 1.9 0.4 4.2 1.7 3.6 5.7 0.0 0.0 76.9 3.0 3.5 7.2 1.5 3.8 5.7 3.2 1.8 1.9 0.9 3.3 119.5 0.6 30.5 0.8 5.2 2.7 0.9 2.3 14.2 8.4 0.0 1.1 21.6 58.8 3.7 1.2 1.9 3.0 1.7 6.8 1.5 5.0 10.4 3.9 6.6 14.5 10.9 4.3 10.5 11.5 7.5 0.5 2.9 0.3 1.4 15.0 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108531-36129385 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast glandular cells: 307.0;Prostatic glandular cells: 197.9" "Group enriched" "Detected in all" 4 "breast cancer: 361.9;prostate cancer: 127.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 27.5 26.1 23.0 21.8 27.1 11.7 148.7 27.7 26.3 34.8 43.1 12.7 9.7 57.5 56.7 17.1 64.1 24.4 14.1 20.8 27.1 28.5 16.6 19.1 17.5 28.5 26.8 19.6 43.5 38.0 87.2 24.1 31.9 30.1 130.2 13.5 50.6 31.2 115.4 12.8 51.8 8.9 30.4 28.7 15.6 16.6 19.5 28.4 18.7 37.6 16.7 28.6 53.1 16.2 34.2 43.7 54.0 127.1 75.1 131.4 96.6 33.0 116.2 137.3 76.5 88.7 30.3 47.5 47.1 57.3 113.1 53.1 104.1 112.4 109.2 115.5 105.4 40.7 20.6 69.5 44.4 83.2 69.8 49.6 88.7 236.1 116.2 100.5 69.9 11.7 38.6 10.7 92.1 108.9 67.0 69.0 15.6 30.6 24.0 30.4 70.6 72.8 61.4 84.4 145.2 132.8 116.8 143.5 41.5 200.6 52.1 56.7 32.4 18.9 184.9 30.5 35.5 59.2 85.9 90.0 35.7 64.0 48.3 99.8 29.2 13.3 31.2 16.3 19.7 19.7 16.7 13.8 14.7 16.4 17.3 12.0 17.7 10.2 18.1 19.4 33.6 17.0 14.2 23.0 27.1 27.7 26.3 20.8 27.1 28.5 26.8 19.6 30.1 28.7 28.4 34.2 13.3 38.5 18.7 8.8 22.5 45.9 58.2 79.6 59.2 41.5 307.0 132.2 19.6 10.0 66.4 42.3 33.3 6.6 36.7 4.0 1.9 53.1 21.3 37.1 76.1 12.9 25.6 4.6 13.0 37.8 56.7 45.6 9.2 73.8 23.5 18.9 8.9 11.0 20.4 23.5 23.9 7.4 38.7 20.1 30.0 18.1 37.3 26.0 67.6 1.9 25.7 38.2 10.3 34.2 36.5 39.5 1.9 47.8 24.4 197.9 2.7 13.6 44.3 41.3 39.5 40.4 38.6 43.9 27.8 32.6 74.4 23.8 23.2 23.0 5.7 69.3 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 233.0;Late spermatids: 362.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 23.5 35.1 47.2 16.5 51.2 11.4 25.0 47.3 57.1 21.2 40.6 25.6 19.2 26.0 116.3 23.8 25.5 18.6 29.4 50.6 50.2 27.0 21.9 19.4 19.6 46.7 47.2 45.2 24.3 23.6 26.3 28.0 18.0 47.2 29.9 20.7 41.9 28.5 29.2 55.3 20.4 19.1 21.5 48.6 22.4 21.5 28.3 48.7 20.1 32.3 46.9 19.5 27.8 20.2 50.7 31.6 34.1 57.0 60.8 30.6 35.8 35.5 55.6 54.5 31.7 44.5 9.4 34.2 44.1 57.2 40.7 16.9 51.2 64.1 56.3 44.7 39.2 36.6 46.9 48.9 37.0 53.9 78.9 24.3 27.6 73.7 30.2 85.4 39.8 46.0 51.5 42.8 46.7 41.1 39.3 42.4 33.3 45.9 16.2 24.4 34.7 18.3 70.8 48.4 66.9 99.1 83.4 46.5 25.7 48.3 46.2 35.2 55.9 56.4 33.0 20.6 17.7 46.0 52.5 77.6 45.0 33.6 64.1 33.9 0.7 4.7 2.2 2.9 6.3 4.4 5.0 4.0 3.4 7.8 5.4 5.0 4.0 3.5 7.0 4.2 5.4 2.3 3.3 47.2 51.2 47.3 57.1 50.6 50.2 46.7 47.2 45.2 47.2 48.6 48.7 50.7 19.0 32.1 20.7 54.9 40.6 34.4 35.9 23.6 54.7 49.6 29.9 22.2 39.4 17.2 21.0 35.0 31.3 17.1 28.7 13.6 27.4 21.0 233.0 36.3 30.2 23.1 28.8 24.6 105.0 19.9 17.6 19.0 25.0 52.5 13.3 50.7 20.7 29.3 9.8 37.0 91.0 16.7 22.4 20.1 24.2 362.4 22.1 18.8 30.2 58.1 18.1 32.2 18.6 84.9 98.5 20.4 25.2 23.0 33.1 41.5 17.8 26.2 20.3 50.8 13.1 26.1 27.0 39.5 42.2 45.2 38.2 14.6 21.9 51.9 22.2 38.2 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972625-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 145.2;Late spermatids: 76.3;Spermatocytes: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "HPA065505: AB_2685498, HPA067322: AB_2685822" "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favorable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 15.8 18.4 16.3 12.9 17.3 72.5 20.7 20.3 19.8 12.9 16.0 14.9 16.3 15.5 18.6 14.8 15.0 12.4 18.5 16.8 17.4 15.2 17.0 12.3 21.9 16.5 16.9 16.8 17.2 23.4 18.1 13.0 14.8 17.1 14.5 13.2 19.4 19.4 13.1 34.3 15.8 15.3 13.1 17.0 18.2 20.0 36.1 17.3 22.1 14.2 26.6 19.0 16.5 12.4 18.0 24.9 17.2 35.3 27.0 25.4 36.2 25.9 34.3 34.9 42.3 44.7 15.8 17.8 22.4 33.7 27.4 26.9 26.2 28.2 28.8 45.7 33.4 30.4 22.5 21.2 35.5 35.3 65.4 26.3 37.9 46.7 38.2 39.3 36.8 37.0 30.6 39.7 34.0 29.4 29.5 42.4 48.0 30.4 11.6 18.9 28.0 30.7 43.0 29.2 29.5 25.5 36.0 25.4 18.8 58.3 32.7 28.2 31.2 24.3 43.3 19.1 15.8 31.0 43.2 41.4 46.0 21.4 37.3 22.1 97.5 28.8 34.2 24.5 30.7 24.2 34.7 25.9 23.2 27.1 30.9 19.8 25.9 28.0 28.8 30.0 26.6 41.5 19.8 16.3 17.3 20.3 19.8 16.8 17.4 16.5 16.9 16.8 17.1 17.0 17.3 18.0 9.6 19.2 6.1 3.9 13.7 11.9 8.9 17.4 18.2 9.6 13.1 16.5 12.7 10.0 12.1 1.8 6.2 19.0 23.0 10.4 11.7 20.2 145.2 13.7 14.7 10.8 7.2 12.4 5.5 28.8 32.0 12.4 8.6 14.4 14.0 12.9 10.0 9.6 21.3 8.4 6.0 12.9 16.2 20.1 10.3 76.3 22.4 14.4 12.4 5.6 24.4 13.1 20.6 4.5 5.1 20.0 14.0 17.0 13.5 11.7 17.8 20.1 5.1 12.1 0.0 14.1 11.3 124.0 35.9 12.8 12.4 13.1 13.6 17.3 15.9 9.3 GALNT1 GalNAc-T1 ENSG00000141429 "Polypeptide N-acetylgalactosaminyltransferase 1" Q10472 18 35581117-35711834 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 331.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012628 Uncertain "Intracellular and membrane" NA NA 2600000 "HPA012628: AB_1849439" "unprognostic (9.81e-2)" "unprognostic (1.01e-1)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" "unprognostic (2.08e-1)" "unprognostic (2.83e-2)" "unprognostic (1.96e-2)" "unprognostic (7.06e-2)" "unprognostic (2.03e-2)" "unprognostic (1.51e-2)" "unprognostic (3.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (4.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.07e-2)" "unprognostic (8.60e-2)" 29.2 20.8 13.5 27.7 13.6 26.3 37.6 14.1 14.4 26.7 16.4 43.3 43.3 19.6 19.8 58.1 16.1 29.2 24.0 12.7 16.7 17.5 46.3 23.5 33.7 14.8 15.0 12.2 17.1 24.8 12.3 13.6 52.4 15.0 25.7 41.5 17.2 47.2 18.1 29.3 52.9 49.7 22.9 15.4 25.6 27.4 17.1 14.6 18.7 30.3 37.6 41.1 71.1 27.2 15.1 32.5 34.9 40.5 37.6 78.5 74.0 53.4 33.2 35.4 30.3 27.4 21.0 61.9 38.3 34.9 36.0 28.7 24.4 20.2 63.8 48.1 45.0 18.5 48.7 62.8 48.8 39.2 106.6 62.1 50.7 59.7 47.6 52.1 90.1 331.4 30.8 14.8 49.3 118.9 26.1 31.6 40.5 41.6 33.5 16.4 38.9 53.0 18.5 124.8 148.9 21.8 42.9 59.4 43.0 36.2 77.1 32.9 82.8 116.3 55.7 22.5 37.0 37.1 70.1 35.7 72.5 39.1 72.1 29.5 7.2 3.4 7.6 3.2 4.5 3.6 4.1 2.2 2.9 4.0 2.4 2.0 3.0 4.3 4.6 6.6 4.4 2.5 1.4 13.5 13.6 14.1 14.4 12.7 16.7 14.8 15.0 12.2 15.0 15.4 14.6 15.1 85.6 80.1 44.1 35.9 33.4 29.8 28.4 28.8 22.2 31.3 77.2 43.8 43.3 48.6 39.9 16.5 12.5 31.0 44.8 109.1 7.9 42.6 1.4 77.6 44.7 41.7 38.9 30.9 57.5 39.9 92.7 49.8 26.0 73.0 20.3 51.7 35.7 71.3 77.9 85.8 56.3 59.0 16.2 58.8 37.1 2.9 19.0 56.7 19.6 57.1 41.3 105.9 28.8 54.3 56.8 58.5 51.4 18.0 36.7 54.4 76.8 22.0 33.5 28.5 13.1 55.2 28.7 6.5 12.2 26.3 82.1 33.2 33.7 50.3 85.3 52.8 ASXL3 KIAA1713 ENSG00000141431 "ASXL transcriptional regulator 3" Q9C0F0 18 33578219-33751195 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;ovary: 2.2" "Group enriched" "Detected in many" 6 "Early spermatids: 52.5;Excitatory neurons: 125.1;Inhibitory neurons: 101.1;Late spermatids: 31.6;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 62.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.4;RPMI-8226: 7.4;SCLC-21H: 2.8;SH-SY5Y: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039539, HPA040034" Uncertain NA NA "HPA039539: , HPA040034: " "unprognostic (2.05e-2)" "unprognostic (6.88e-2)" "unprognostic (2.91e-1)" "unprognostic (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (3.19e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (9.16e-2)" "unprognostic (5.35e-3)" "unprognostic (5.92e-2)" "unprognostic (2.47e-12)" "unprognostic (4.69e-2)" "unprognostic (2.32e-1)" "unprognostic (4.98e-3)" "unprognostic (1.67e-2)" 0.2 0.0 1.4 0.0 1.7 0.0 0.2 0.0 2.2 0.7 0.2 0.5 0.2 0.3 0.3 0.0 0.5 0.4 0.5 1.6 1.2 0.6 0.4 0.2 0.0 0.5 0.3 1.9 2.2 0.3 0.2 0.7 0.0 0.4 0.6 0.1 0.5 0.2 0.6 0.0 0.0 0.3 0.2 0.1 0.1 0.8 1.6 0.3 0.0 0.9 0.0 0.0 0.5 0.4 1.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 2.8 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 2.2 1.6 1.2 0.5 0.3 1.9 0.4 0.1 0.3 1.8 1.0 0.0 0.0 11.1 0.0 0.1 1.0 0.0 1.2 5.3 0.2 0.9 4.8 1.5 3.1 1.8 0.0 0.6 0.0 1.0 1.9 1.7 52.5 0.1 1.5 0.4 3.0 0.0 125.1 0.0 0.2 3.2 3.1 0.1 1.3 0.0 0.4 2.0 0.2 1.7 101.1 0.7 0.0 0.0 0.0 31.6 2.1 0.1 0.0 10.3 0.0 1.0 0.0 88.4 62.2 0.4 0.4 1.9 0.0 0.4 1.5 1.2 0.0 0.9 0.0 1.1 2.6 2.9 3.7 0.2 0.0 0.4 0.0 11.2 0.6 0.3 ADCYAP1 PACAP ENSG00000141433 "Adenylate cyclase activating polypeptide 1" P18509 18 904871-912172 "Predicted secreted proteins" Neurogenesis Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.6;lymphoid tissue: 11.0" "Group enriched" "Detected in some" 6 "Excitatory neurons: 13.4;granulocytes: 43.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065887 Supported Supported "Secreted in other tissues" NA NA "HPA065887: " "unprognostic (2.68e-1)" "unprognostic (1.83e-2)" "unprognostic (7.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.87e-4)" "unprognostic (9.58e-3)" "unprognostic (1.00e-1)" "unprognostic (2.34e-1)" "unprognostic (6.86e-2)" "unprognostic (4.16e-2)" "unprognostic (9.94e-2)" "prognostic favorable (2.91e-6)" "unprognostic (2.24e-3)" "unprognostic (9.22e-2)" "unprognostic (1.74e-1)" "unprognostic (5.74e-4)" 1.8 0.2 2.4 11.0 5.4 0.0 1.3 0.6 8.3 2.1 0.1 1.7 0.1 3.0 0.0 1.3 0.4 7.1 0.5 3.1 27.2 0.5 0.2 1.6 1.0 32.6 4.0 2.4 0.1 4.8 0.2 3.6 0.2 14.7 1.4 1.1 0.3 1.9 0.5 0.2 0.6 1.3 1.0 2.7 0.1 1.6 2.5 13.1 0.4 0.2 0.0 1.0 2.3 1.3 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.4 0.6 8.3 3.1 27.2 32.6 4.0 2.4 14.7 2.7 13.1 11.1 0.2 3.2 0.6 0.3 0.0 0.6 0.1 0.1 0.0 0.5 0.1 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.0 13.4 0.0 0.0 2.4 0.0 0.0 43.1 0.0 0.4 0.0 0.1 0.0 0.5 0.0 4.1 0.0 0.9 1.5 0.3 0.2 0.0 1.9 0.0 0.2 0.0 0.5 1.1 2.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.2 MEP1B ENSG00000141434 "Meprin A subunit beta" Q16820 18 32185069-32220404 "Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "intestine: 366.9" "Cell type enriched" "Detected in some" 42 "Proximal enterocytes: 231.8" "Cancer enriched" "Detected in some" 5 "pancreatic cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA029119 Enhanced "Secreted to digestive system" NA NA 310000 "HPA029119: AB_2672913" "unprognostic (1.33e-1)" "unprognostic (6.72e-2)" "unprognostic (2.79e-2)" "unprognostic (1.00e-1)" "unprognostic (3.50e-4)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (4.30e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (8.31e-4)" "unprognostic (4.74e-2)" "unprognostic (3.39e-1)" "unprognostic (2.71e-1)" "unprognostic (3.39e-2)" "unprognostic (3.75e-2)" 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 8.3 251.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 6.6 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.0 0.0 0.0 0.0 366.9 0.3 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.0 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.9 0.0 3.8 0.0 0.1 0.2 231.8 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 2.5 0.1 SLC25A52 MCART2 ENSG00000141437 "Solute carrier family 25 member 52" Q3SY17 18 31759584-31760880 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 9.0" "Group enriched" "Detected in some" 4 "Early spermatids: 55.3;Late spermatids: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046388, HPA058261" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046388: AB_2679649, HPA058261: AB_2683657" "unprognostic (8.97e-2)" "unprognostic (4.85e-2)" "unprognostic (2.93e-1)" "unprognostic (4.87e-1)" "unprognostic (2.50e-1)" "unprognostic (9.05e-2)" "unprognostic (2.97e-2)" "unprognostic (1.30e-4)" "unprognostic (7.15e-3)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.41e-1)" "unprognostic (3.34e-2)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 0.0 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.0 0.4 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAREM1 "C18orf11, FAM59A, FLJ21610, GAREM" ENSG00000141441 "GRB2 associated regulator of MAPK1 subtype 1" Q9H706 18 32124877-32470882 "Predicted intracellular proteins" Mitogen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 30.2" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 54.7;Urothelial cells: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 15.5;hTERT-HME1: 20.7;RT4: 19.6;SH-SY5Y: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040709, HPA042046" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040709: AB_2677090, HPA042046: AB_2677818" "unprognostic (9.52e-2)" "unprognostic (4.13e-3)" "unprognostic (2.67e-2)" "unprognostic (3.32e-3)" "unprognostic (3.62e-1)" "unprognostic (5.53e-3)" "unprognostic (1.87e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (1.45e-1)" "prognostic favorable (5.49e-6)" "unprognostic (2.36e-1)" "unprognostic (2.56e-3)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 4.6 6.0 5.6 1.8 6.7 7.3 4.5 7.9 7.6 3.6 0.6 4.9 4.4 2.3 2.1 8.3 2.7 2.9 5.2 9.8 12.2 11.3 6.7 3.3 0.6 10.2 6.9 4.1 2.8 30.2 0.6 3.3 2.8 8.3 3.0 3.8 6.3 8.0 2.9 5.9 11.1 4.2 2.2 8.9 2.0 8.6 3.4 7.2 0.4 2.0 2.8 1.7 7.3 7.4 12.2 1.2 1.8 1.8 0.4 4.9 4.0 4.5 0.5 0.0 0.0 0.0 0.4 2.7 3.4 2.6 0.1 2.0 4.0 2.7 5.0 0.0 1.0 1.9 0.0 3.8 1.3 3.0 0.3 0.3 4.4 15.5 0.2 20.7 0.2 0.2 2.0 0.2 0.9 2.2 2.8 1.0 0.2 2.0 9.9 1.0 1.2 7.4 5.6 8.0 19.6 6.3 18.0 4.1 6.5 0.1 2.3 0.9 3.4 0.2 1.3 1.3 0.0 0.6 2.3 0.4 0.9 2.3 0.0 1.5 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.6 0.3 0.5 1.0 1.1 0.0 1.9 0.0 0.0 5.6 6.7 7.9 7.6 9.8 12.2 10.2 6.9 4.1 8.3 8.9 7.2 12.2 11.9 9.6 42.6 0.0 0.2 0.0 37.6 0.0 3.4 34.2 6.9 5.1 0.0 11.5 8.6 25.8 4.2 20.4 0.0 10.7 1.9 11.8 14.8 19.8 8.7 2.0 3.6 0.0 0.0 13.3 2.6 14.3 27.0 41.7 3.8 0.9 0.4 8.8 1.7 42.1 0.0 8.4 0.0 4.0 0.0 3.4 1.8 1.9 0.0 0.0 0.6 34.9 0.0 0.0 0.0 9.3 5.7 5.3 0.5 54.7 19.8 23.4 4.4 7.4 0.0 29.8 6.5 3.9 7.5 13.7 0.0 33.5 0.9 1.7 7.6 114.2 ESCO1 "EFO1, ESO1, KIAA1911" ENSG00000141446 "Establishment of sister chromatid cohesion N-acetyltransferase 1" Q5FWF5 18 21529284-21600884 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042497 Approved NA NA "HPA042497: AB_10794278" "unprognostic (8.12e-2)" "unprognostic (2.90e-2)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-3)" "unprognostic (1.38e-2)" "unprognostic (1.25e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-3)" "unprognostic (1.72e-3)" "unprognostic (6.80e-3)" "unprognostic (9.29e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.48e-1)" "unprognostic (3.72e-2)" 5.8 5.4 6.8 6.1 7.4 16.5 10.5 11.1 8.4 8.1 6.3 6.7 6.3 6.9 10.2 7.6 5.7 5.2 5.6 6.6 7.3 6.7 10.0 5.3 10.2 7.4 7.5 5.9 7.4 7.3 10.2 9.1 8.8 7.8 7.3 5.9 7.9 8.0 6.6 10.3 7.9 7.1 4.9 7.1 8.4 6.9 20.4 7.2 11.2 7.3 5.3 10.0 6.9 7.2 7.7 9.3 4.3 9.3 4.7 8.3 8.8 9.6 5.6 10.7 7.9 11.1 8.8 6.3 16.3 12.5 7.1 8.7 13.3 11.6 7.9 10.9 17.1 7.8 12.7 6.1 14.9 13.5 21.3 12.3 7.4 16.6 6.1 15.9 10.4 10.9 11.9 17.7 16.4 10.9 10.7 15.9 22.4 19.3 17.7 9.9 10.2 11.9 18.3 15.7 13.9 14.4 10.3 10.5 13.2 24.3 14.6 9.7 14.4 6.1 10.1 10.2 7.4 7.0 38.8 24.0 18.8 10.0 12.2 10.1 4.9 0.5 3.9 3.3 1.1 2.8 2.2 2.7 3.1 1.1 1.9 2.6 3.3 3.2 2.2 0.9 0.8 3.1 1.0 6.8 7.4 11.1 8.4 6.6 7.3 7.4 7.5 5.9 7.8 7.1 7.2 7.7 29.1 12.8 29.5 29.0 35.5 10.7 21.0 24.4 17.1 43.1 22.6 17.4 36.2 10.0 24.2 11.0 20.9 26.0 47.0 15.8 19.6 26.2 14.4 28.6 23.9 18.5 11.4 13.7 48.8 13.4 16.2 20.1 27.5 36.7 29.2 24.4 16.8 7.6 13.7 30.3 55.2 19.4 24.4 9.5 12.4 9.2 21.1 21.3 16.0 31.9 24.1 17.0 46.4 35.7 50.1 18.8 23.6 22.6 31.6 23.5 19.9 15.7 19.7 35.5 26.3 23.1 20.4 119.1 93.6 15.7 12.5 37.6 38.4 37.4 14.1 27.3 OSBPL1A "ORP-1, ORP1, OSBPL1B" ENSG00000141447 "Oxysterol binding protein like 1A" Q9BXW6 18 24162045-24397880 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 214.3;Oligodendrocytes: 433.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 22 "basophil: 93.4" "Lineage enriched" "Detected in many" 22 "granulocytes: 93.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040959, HPA043401" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040959: AB_10964295, HPA043401: AB_10960208" "unprognostic (1.75e-2)" "unprognostic (3.35e-2)" "unprognostic (9.84e-3)" "unprognostic (4.92e-3)" "unprognostic (2.34e-1)" "unprognostic (3.06e-2)" "unprognostic (5.82e-2)" "unprognostic (2.06e-1)" "unprognostic (5.88e-2)" "unprognostic (2.62e-2)" "unprognostic (2.41e-1)" "unprognostic (8.53e-2)" "prognostic favorable (4.98e-13)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.18e-2)" "unprognostic (5.42e-3)" "unprognostic (1.56e-1)" 72.7 28.1 88.4 9.5 107.9 15.5 48.4 105.2 128.7 52.8 112.4 30.2 20.9 48.4 17.4 31.1 29.8 21.3 52.4 87.3 93.3 43.9 13.4 24.4 10.5 95.2 103.0 76.3 27.6 16.7 63.3 18.8 8.3 105.6 23.2 22.9 82.9 51.9 26.5 172.6 17.7 20.3 41.4 94.8 10.0 21.5 14.5 96.6 9.7 29.2 124.2 8.0 25.6 20.2 143.5 38.2 11.4 26.3 49.1 60.0 48.7 24.5 14.0 40.4 12.4 10.2 7.1 38.9 0.1 16.0 25.1 19.7 37.9 10.4 24.4 11.4 0.2 19.6 12.1 7.8 0.2 29.9 30.4 6.0 63.4 34.4 9.5 38.4 54.0 15.9 10.4 0.0 0.3 15.5 16.1 7.0 9.1 21.7 19.5 36.8 0.0 21.0 3.2 3.3 27.7 16.9 16.6 32.6 37.5 46.1 24.5 13.7 21.7 3.4 45.9 9.4 14.9 13.6 0.4 5.3 1.0 22.3 8.7 26.8 93.4 4.2 1.1 0.2 2.2 0.1 0.0 0.8 0.6 4.1 0.4 0.6 0.5 1.6 0.2 0.7 4.1 0.8 1.5 88.4 107.9 105.2 128.7 87.3 93.3 95.2 103.0 76.3 105.6 94.8 96.6 143.5 214.3 16.0 21.6 142.0 5.4 20.1 43.4 16.6 29.6 66.6 73.6 64.3 78.0 41.5 20.0 20.2 22.9 12.1 11.1 23.6 64.6 13.3 67.7 27.6 55.3 89.9 4.8 18.7 180.3 7.4 8.1 59.9 16.3 17.0 17.2 137.9 37.5 12.4 26.6 25.2 166.4 40.0 40.7 27.4 17.9 76.4 42.9 34.3 58.7 67.5 11.0 124.8 0.0 75.9 433.0 10.7 19.1 54.9 2.5 27.1 29.8 71.7 21.7 112.3 32.9 44.7 65.8 6.7 9.9 27.2 10.2 6.4 3.8 103.7 16.2 26.4 GATA6 ENSG00000141448 "GATA binding protein 6" Q92908 18 22169589-22202528 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 58.3;ovary: 73.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 23 "basophil: 4.0" "Lineage enriched" "Detected in single" 23 "granulocytes: 4.0" "Cell line enhanced" "Detected in many" "BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011581, HPA066629" Approved Supported Nucleoplasm Yes No Nucleoplasm "CAB011581: AB_732529, HPA066629: AB_2685695" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (4.36e-2)" "unprognostic (3.47e-1)" "unprognostic (2.61e-1)" "unprognostic (8.45e-3)" "prognostic unfavorable (1.92e-9)" "unprognostic (8.75e-3)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-2)" 12.2 58.3 0.0 2.5 0.1 0.0 3.8 0.0 0.8 4.5 3.3 11.5 23.0 19.9 1.2 0.8 29.1 11.2 43.2 0.1 0.1 3.0 12.7 14.9 1.9 0.1 0.1 0.0 73.6 22.9 0.3 0.6 6.6 0.1 5.5 11.1 0.1 0.8 0.7 0.8 1.3 20.9 9.6 0.2 15.1 50.1 6.3 0.1 0.4 5.4 0.6 0.2 23.2 3.2 0.0 10.1 1.4 0.0 0.0 2.1 1.0 54.8 0.3 0.4 0.8 1.0 69.7 3.8 0.0 3.2 1.2 3.4 10.8 0.4 4.5 1.4 0.0 13.6 0.0 4.3 6.1 14.3 0.6 0.6 0.4 8.9 12.1 9.1 25.5 9.5 0.0 0.5 0.0 0.0 1.5 0.0 0.2 0.1 37.6 9.8 0.0 1.1 0.2 0.4 2.8 0.9 0.1 10.7 6.1 3.0 2.7 1.7 0.0 0.7 1.4 1.6 11.4 1.7 0.0 0.0 0.0 6.2 0.3 9.9 4.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 7.3 44.8 30.2 0.0 0.0 0.9 4.0 4.6 1.8 0.0 3.4 2.7 97.6 30.0 6.1 0.0 0.0 0.9 0.9 50.0 0.0 28.4 44.7 6.3 6.3 11.5 26.0 2.7 0.1 19.6 11.2 24.4 100.9 16.6 5.1 52.9 28.5 11.1 1.6 0.0 0.1 45.8 2.0 0.6 0.9 8.8 3.4 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.2 36.8 27.7 10.1 0.2 4.1 43.3 0.0 3.9 0.0 32.9 0.4 8.6 1.4 1.4 0.9 0.9 1.9 1.3 11.4 47.2 2.9 GREB1L "C18orf6, FLJ13687, KIAA1772" ENSG00000141449 "GREB1 like retinoic acid receptor coactivator" Q9C091 18 21242242-21525417 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 9.2" "Cell type enhanced" "Detected in many" "Granulosa cells: 95.2;Inhibitory neurons: 39.2;Leydig cells: 46.0;Oligodendrocytes: 252.5" "Cancer enhanced" "Detected in some" "breast cancer: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 50.7;BEWO: 100.9;CACO-2: 45.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041647, HPA044218" Uncertain Approved Mitochondria NA NA Mitochondria "HPA041647: AB_2677597, HPA044218: AB_2678859" "unprognostic (1.88e-3)" "unprognostic (9.01e-4)" "unprognostic (2.92e-1)" "unprognostic (2.45e-1)" "unprognostic (5.03e-2)" "unprognostic (3.67e-3)" "unprognostic (3.65e-1)" "unprognostic (1.11e-2)" "unprognostic (1.07e-1)" "unprognostic (1.97e-1)" "unprognostic (4.32e-3)" "unprognostic (2.87e-2)" "unprognostic (3.30e-8)" "unprognostic (4.72e-3)" "unprognostic (1.89e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-1)" 2.6 1.4 5.4 0.1 4.0 0.2 3.3 3.6 2.5 0.9 0.0 0.4 0.1 2.7 2.8 0.2 4.5 0.1 4.7 2.1 5.9 0.3 1.8 0.2 0.1 3.8 4.0 1.3 3.8 0.1 0.3 1.3 2.1 5.1 1.6 0.1 3.1 0.5 2.9 9.2 1.2 0.5 0.8 1.0 0.0 0.6 6.2 5.2 0.0 3.8 6.8 0.0 0.1 0.7 4.2 0.0 0.9 50.7 0.0 11.4 0.0 100.9 2.4 2.4 4.3 3.8 45.7 3.7 0.1 5.1 7.6 0.1 9.7 19.4 2.4 7.5 0.7 9.3 0.0 13.4 0.4 0.3 0.0 0.0 0.0 0.7 0.1 9.3 0.5 0.0 1.4 0.0 0.3 10.5 3.5 0.2 0.2 4.9 0.4 6.0 0.2 0.0 2.0 4.8 8.7 3.2 0.0 0.1 1.6 0.2 13.2 2.7 0.2 20.9 0.5 2.9 4.9 0.0 0.1 0.7 0.0 2.2 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 4.0 3.6 2.5 2.1 5.9 3.8 4.0 1.3 5.1 1.0 5.2 4.2 0.4 0.0 0.5 0.7 0.4 0.1 0.1 1.0 0.0 32.3 3.1 1.1 13.4 0.0 1.1 3.7 2.1 3.2 1.8 0.1 0.0 0.2 8.3 2.2 3.4 0.5 0.0 0.0 23.1 0.4 13.2 6.2 0.0 7.0 0.0 95.2 0.0 3.1 0.5 0.0 39.2 0.2 0.0 0.0 1.1 17.9 46.0 0.3 1.8 2.8 0.1 0.8 2.1 8.0 252.5 2.8 0.0 35.7 0.0 0.6 0.3 0.0 2.3 1.6 6.6 2.8 2.3 4.3 5.6 0.0 0.9 1.5 0.3 10.5 1.5 0.2 RMC1 "C18orf8, HsT2591, MIC1, WDR98" ENSG00000141452 "Regulator of MON1-CCZ1" Q96DM3 18 23503470-23531822 "Cancer-related genes, Predicted intracellular proteins" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 14.5;Proximal tubular cells: 19.9;Syncytiotrophoblasts: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043589 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043589: AB_2678568" "unprognostic (6.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.51e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" "unprognostic (1.25e-1)" "unprognostic (3.04e-2)" "unprognostic (4.13e-2)" 12.3 9.9 5.0 11.3 5.9 27.6 11.3 5.5 7.3 10.3 7.8 10.9 16.8 11.3 9.4 11.8 10.6 10.4 8.9 5.9 6.5 13.1 19.3 14.5 21.5 5.4 4.8 5.0 9.6 11.8 11.5 16.7 8.6 5.7 9.4 11.0 25.6 12.3 10.7 13.5 12.1 17.3 10.6 5.5 15.8 14.8 17.3 5.4 15.9 9.9 7.5 19.2 14.9 10.5 6.4 13.9 13.9 10.3 18.1 23.0 16.6 13.5 21.5 22.8 28.2 33.6 12.9 8.1 20.8 17.5 18.7 40.9 26.6 27.1 12.0 24.8 21.6 15.4 10.2 8.7 13.1 30.1 27.7 36.0 14.9 18.6 35.2 19.8 16.2 16.9 17.7 16.7 21.9 18.8 18.1 23.8 13.0 5.6 19.7 21.4 18.3 15.4 20.4 14.7 13.0 13.8 17.9 28.1 13.7 18.2 14.2 10.5 17.6 16.2 23.6 6.0 9.8 18.6 34.1 27.4 23.6 24.5 18.7 18.4 50.5 16.4 37.7 23.8 31.0 24.5 32.5 20.7 23.3 20.0 29.5 14.0 17.2 15.2 32.9 44.5 44.5 30.5 18.7 5.0 5.9 5.5 7.3 5.9 6.5 5.4 4.8 5.0 5.7 5.5 5.4 6.4 9.1 9.6 13.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.6 5.8 0.0 0.0 3.7 7.3 0.0 10.7 13.4 0.0 5.9 11.6 0.0 11.4 5.9 2.9 0.0 0.0 0.0 12.1 7.6 3.4 0.0 14.5 3.8 8.7 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 8.8 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.9 0.0 0.0 19.9 1.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 19.2 6.3 8.3 0.0 0.0 PELP1 MNAR ENSG00000141456 "Proline, glutamate and leucine rich protein 1" Q8IZL8 17 4669774-4704337 "Predicted intracellular proteins" Transcription "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053966, HPA056028, HPA060760" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355" "unprognostic (8.81e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-3)" "unprognostic (2.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (2.72e-1)" "unprognostic (2.76e-1)" "unprognostic (4.31e-2)" "prognostic favorable (4.07e-5)" "unprognostic (2.20e-2)" "unprognostic (4.05e-2)" "unprognostic (1.31e-2)" "unprognostic (3.31e-1)" "unprognostic (8.32e-2)" "unprognostic (5.15e-2)" 14.0 18.0 35.6 13.5 33.7 11.0 15.0 30.4 34.2 19.5 21.2 17.5 11.9 21.7 6.2 19.7 19.9 8.9 21.5 34.2 31.6 14.9 17.9 13.3 16.4 35.2 33.9 31.5 22.1 17.6 15.7 23.7 11.5 34.7 20.7 7.6 8.7 15.5 12.3 47.2 18.7 17.6 10.9 32.2 20.7 17.6 33.1 33.7 12.6 17.4 18.3 12.1 19.7 17.2 33.7 41.8 89.8 34.8 55.3 26.5 19.5 77.9 29.6 20.5 40.1 42.7 88.1 30.0 100.0 44.4 23.4 28.5 62.6 65.1 46.3 22.6 52.1 93.2 44.6 45.1 72.0 34.2 36.4 57.5 23.9 28.2 49.5 41.3 20.7 30.2 52.9 54.7 42.6 22.4 57.2 68.9 42.7 57.3 40.2 29.7 71.7 30.8 49.3 28.2 31.2 34.8 46.5 50.8 36.9 39.4 33.1 44.6 24.3 30.7 30.9 43.5 47.3 57.9 22.7 42.5 41.6 34.9 37.1 40.6 0.2 0.7 2.0 0.9 1.0 0.9 0.8 0.9 0.7 0.8 1.3 0.9 1.3 0.2 1.3 1.2 1.1 0.6 0.7 35.6 33.7 30.4 34.2 34.2 31.6 35.2 33.9 31.5 34.7 32.2 33.7 33.7 10.4 22.4 30.1 11.1 18.5 14.8 14.8 15.7 21.1 24.0 13.5 12.4 22.6 8.6 20.9 9.2 16.7 30.9 15.3 11.8 1.9 15.9 64.7 16.6 17.3 13.7 12.6 14.1 10.6 14.6 28.3 16.6 16.8 17.6 30.9 21.1 5.0 10.6 16.9 35.3 13.0 18.6 12.2 6.0 20.4 27.0 9.3 10.4 10.6 5.6 65.1 10.7 5.2 5.0 11.5 11.4 11.7 19.2 23.6 19.3 8.3 4.7 22.3 17.8 6.6 16.8 14.8 31.3 67.5 20.0 16.3 21.2 17.4 16.6 21.9 13.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586506 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease variant, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 110.4" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 70.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 273.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 17.4 77.4 34.1 17.1 64.0 43.1 20.2 53.1 54.8 16.1 26.9 13.8 14.6 16.9 15.2 20.7 13.5 15.4 11.3 40.7 48.2 16.9 15.3 29.3 20.5 65.0 56.5 32.2 16.2 12.0 73.1 15.1 28.0 62.4 13.3 12.1 28.2 37.1 13.4 23.1 24.3 18.0 15.2 53.4 17.3 20.6 13.8 54.2 12.3 11.9 14.2 15.7 16.0 18.2 110.4 21.5 41.4 17.8 29.3 55.8 44.6 40.7 37.3 81.1 38.8 84.3 28.1 30.7 18.4 28.0 55.0 132.8 59.3 22.6 63.2 35.2 15.0 17.9 6.8 35.7 63.2 79.2 25.0 28.5 42.2 61.3 81.7 273.2 76.8 40.3 20.7 20.1 47.5 44.2 32.4 10.6 14.9 12.5 24.4 37.3 15.3 28.1 45.0 88.8 51.9 7.5 14.5 44.6 62.0 54.3 27.7 15.9 19.5 50.0 81.1 15.3 32.4 32.3 29.7 97.1 12.2 177.7 21.8 37.1 4.4 9.0 8.8 29.7 8.7 20.5 5.0 12.4 20.7 4.0 6.7 5.5 15.0 7.9 10.5 13.8 70.9 17.4 10.6 34.1 64.0 53.1 54.8 40.7 48.2 65.0 56.5 32.2 62.4 53.4 54.2 110.4 18.4 25.6 56.1 32.7 9.6 9.3 34.1 16.5 8.0 6.7 10.5 9.4 4.4 11.5 21.8 9.2 18.8 15.1 61.0 24.8 0.0 11.2 1.2 23.3 12.2 16.4 3.6 2.5 23.8 15.1 7.8 13.0 15.3 53.9 10.8 31.6 6.8 9.8 28.9 3.3 20.2 7.3 2.0 11.9 6.5 1.5 9.0 21.0 12.4 59.0 7.2 15.1 25.7 39.2 182.0 34.4 22.6 10.5 15.6 41.5 8.3 5.4 10.0 12.7 0.0 10.3 14.4 13.9 25.1 17.6 14.5 23.8 19.1 52.4 7.6 64.0 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 136.7;prostate: 79.0;urinary bladder: 91.8" "Group enriched" "Detected in many" 7 "Adipocytes: 136.6;Astrocytes: 228.5;Basal prostatic cells: 313.4;Erythroid cells: 102.5;Prostatic glandular cells: 192.6;Urothelial cells: 249.9" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "GAMG: 273.4;RT4: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059570: AB_2684066, HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.1 1.7 66.3 1.0 89.5 15.3 2.1 119.5 63.7 2.1 23.7 1.3 1.3 0.5 0.7 0.4 0.3 10.2 15.5 60.1 91.9 11.1 1.1 4.3 2.3 123.0 113.5 26.2 0.3 1.7 0.9 1.0 1.6 110.3 79.0 1.3 0.3 2.3 3.1 4.0 4.0 3.4 0.5 86.7 4.6 1.8 0.2 136.7 7.8 6.4 7.9 2.3 91.8 2.3 103.9 0.0 0.4 0.0 0.1 0.0 0.2 0.7 0.4 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 273.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 38.3 0.0 0.2 0.0 0.2 0.3 0.1 0.9 0.3 0.0 0.3 0.2 0.0 0.0 0.2 3.0 113.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.5 0.9 0.1 4.1 0.2 0.1 2.7 1.3 1.3 0.0 0.0 1.1 0.8 0.0 0.0 0.3 0.9 0.9 0.0 0.3 0.2 1.5 0.0 0.9 0.0 0.1 4.1 0.6 66.3 89.5 119.5 63.7 60.1 91.9 123.0 113.5 26.2 110.3 86.7 136.7 103.9 136.6 0.0 0.6 228.5 3.1 0.3 313.4 0.1 0.6 0.3 5.4 1.5 10.9 5.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.6 0.0 0.1 28.7 0.0 102.5 0.6 0.2 0.1 3.8 0.0 0.1 0.0 0.2 21.4 0.3 0.1 0.0 0.7 0.2 18.3 0.6 0.3 0.4 0.0 2.0 12.4 5.6 0.1 0.0 5.2 3.5 0.7 0.3 0.0 1.2 2.1 192.6 0.0 0.0 0.0 0.2 0.0 1.7 3.7 0.1 0.2 0.2 0.4 0.0 6.1 0.1 0.0 249.9 ARRB2 "ARR2, BARR2, DKFZp686L0365" ENSG00000141480 "Arrestin beta 2" P32121 17 4710596-4721499 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 266.0;lymphoid tissue: 169.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075177 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA075177: " "unprognostic (1.12e-1)" "prognostic favorable (2.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" "unprognostic (7.43e-2)" "unprognostic (3.37e-2)" "unprognostic (2.62e-3)" "unprognostic (3.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.58e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.32e-2)" "unprognostic (8.61e-2)" "unprognostic (4.92e-2)" "unprognostic (1.49e-1)" "unprognostic (1.88e-1)" 46.7 40.0 57.1 111.0 57.1 266.0 26.3 50.8 62.7 17.8 56.5 27.8 51.0 17.6 10.9 15.2 29.3 31.7 23.6 64.9 67.4 25.1 35.9 95.6 59.9 61.4 59.8 55.1 17.7 19.6 16.5 25.1 35.8 61.1 19.7 27.8 17.0 21.1 11.8 12.8 14.7 51.5 29.9 63.3 169.6 35.2 7.3 59.6 45.6 16.0 18.3 38.3 42.0 17.7 68.3 17.3 88.7 34.7 32.9 6.8 9.5 18.6 13.7 18.0 38.4 48.0 31.0 14.2 49.1 12.2 10.3 18.3 28.5 58.0 18.4 39.4 116.6 85.0 195.8 46.8 55.6 10.2 89.2 315.9 8.8 23.5 47.9 18.7 24.9 29.6 89.1 13.5 46.4 8.9 30.5 87.9 199.2 18.9 44.9 18.4 104.3 31.0 53.8 13.2 9.2 36.0 49.2 30.8 50.8 23.6 14.2 24.6 40.0 26.1 14.3 29.1 25.1 51.5 19.8 28.6 27.6 37.9 279.4 21.6 116.2 145.5 269.7 49.1 151.1 35.1 10.1 31.1 51.3 84.9 9.0 29.3 38.7 250.6 29.9 168.6 20.7 28.8 93.5 57.1 57.1 50.8 62.7 64.9 67.4 61.4 59.8 55.1 61.1 63.3 59.6 68.3 7.7 22.4 32.3 5.5 26.4 11.5 7.7 16.6 3.4 20.5 9.6 12.3 8.3 14.3 47.9 3.7 2.1 7.5 83.8 7.4 15.6 11.2 0.6 1.5 3.6 10.1 8.4 33.9 20.4 7.3 12.0 8.7 19.4 1.8 94.9 7.8 19.2 12.4 262.0 21.9 18.2 17.0 50.8 242.5 164.2 3.5 5.0 226.4 10.6 42.2 311.3 5.8 89.6 7.1 8.4 6.3 22.0 4.9 23.4 4.4 35.5 17.5 24.4 8.7 19.7 10.9 8.5 1.1 13.1 6.8 8.4 6.0 77.2 3.5 11.4 11.7 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684719-6713377 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 417.4" "Cell type enriched" "Detected in some" 15 "Hepatocytes: 381.0" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 79 "Hep G2: 58.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 2.8 4.8 0.0 6.2 0.0 0.3 4.9 8.0 0.3 2.8 0.0 0.0 0.3 0.0 1.1 2.1 0.0 0.0 5.4 6.5 0.7 417.4 0.0 0.2 6.8 5.5 4.7 0.6 0.3 0.0 0.8 0.0 6.8 0.0 0.0 1.7 38.3 0.0 0.0 0.0 0.0 0.0 4.4 3.4 0.0 2.3 6.8 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 58.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.2 4.9 8.0 5.4 6.5 6.8 5.5 4.7 6.8 4.4 6.8 4.2 0.4 0.0 0.0 24.8 4.8 0.5 0.6 0.6 1.2 0.6 0.1 0.1 0.9 7.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 1.9 0.0 24.0 0.3 0.5 0.1 0.4 0.0 0.1 0.0 0.9 16.8 381.0 0.0 0.0 0.2 0.0 0.0 23.2 1.1 0.4 0.6 0.3 0.0 1.9 0.0 7.0 0.0 1.5 0.1 16.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.6 0.0 0.5 0.5 2.4 2.8 1.2 0.4 0.1 1.0 7.8 0.0 0.3 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4739833-4746119 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 28.5" "Cell type enriched" "Detected in many" 6 "Early spermatids: 191.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 1.8 1.4 1.7 2.4 1.6 1.0 1.7 1.8 2.5 0.9 1.8 0.8 4.0 0.6 0.5 0.9 1.1 2.9 0.6 1.7 2.1 2.0 3.1 4.7 1.7 2.1 1.9 1.2 0.7 1.2 5.5 1.4 1.2 2.6 1.7 0.7 0.3 3.1 0.9 0.4 1.4 3.1 0.7 2.4 5.5 1.9 28.5 2.0 0.8 1.1 0.1 0.4 1.8 0.7 2.6 2.1 0.3 0.0 0.9 0.0 0.1 0.1 0.0 0.5 0.5 1.1 0.9 1.9 0.0 0.0 0.0 0.2 1.6 0.4 0.1 0.0 0.2 0.7 0.0 0.2 0.5 0.3 0.0 0.6 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.6 0.6 0.9 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.7 1.6 1.8 2.5 1.7 2.1 2.1 1.9 1.2 2.6 2.4 2.0 2.6 0.8 0.0 2.0 1.3 0.6 0.9 8.0 1.8 0.6 0.3 4.4 3.7 0.7 2.8 3.1 1.8 0.0 0.1 0.2 3.3 0.0 1.6 191.4 2.8 0.3 1.4 1.2 0.0 0.0 3.9 0.0 0.7 4.6 2.7 0.0 0.3 3.9 0.6 5.2 0.0 0.1 2.9 0.0 11.9 7.3 30.9 0.6 12.9 1.8 1.9 21.9 2.0 0.0 1.0 0.5 3.5 1.4 2.2 0.1 6.7 3.8 0.8 3.7 0.3 0.0 0.2 1.0 24.3 2.0 0.5 0.9 0.0 0.2 0.3 1.3 8.5 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 29.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257" "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favorable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 3.9 3.7 3.7 4.5 3.3 7.7 4.0 3.4 3.5 4.1 4.4 4.0 2.7 4.5 2.3 4.5 14.6 3.0 3.8 3.1 4.2 3.9 3.6 4.2 7.0 3.8 3.8 3.0 3.3 4.5 3.1 4.1 3.5 3.6 3.0 3.6 3.4 3.6 3.1 6.2 4.2 4.7 3.9 3.8 6.9 4.3 5.3 3.2 8.1 3.5 4.5 6.6 3.9 3.7 3.8 22.7 40.6 28.9 29.5 9.2 8.0 16.5 14.3 14.9 45.6 42.1 24.2 13.2 23.3 15.0 13.1 18.7 24.0 33.8 24.5 35.2 14.4 41.4 12.0 22.6 20.5 7.9 8.1 14.7 6.8 9.3 39.9 8.9 6.8 28.8 27.4 12.0 7.7 18.7 21.1 27.0 22.2 15.4 16.7 20.5 35.0 19.3 14.0 17.2 7.7 13.3 19.4 23.1 11.9 12.1 14.0 16.7 10.3 10.1 17.4 19.0 0.1 36.6 5.3 15.9 13.1 16.8 15.2 21.4 29.4 5.8 5.0 5.3 6.3 6.1 3.0 4.2 6.2 5.3 4.2 3.8 4.2 2.5 5.0 2.8 7.4 8.9 3.8 3.7 3.3 3.4 3.5 3.1 4.2 3.8 3.8 3.0 3.6 3.8 3.2 3.8 4.6 3.2 3.4 2.3 7.0 3.8 5.2 12.9 2.8 5.6 4.1 4.6 3.6 2.8 7.0 11.0 6.2 12.3 9.2 4.5 3.9 10.1 3.9 22.4 3.4 5.8 3.0 10.8 2.0 10.4 17.0 4.4 4.1 4.1 1.3 7.3 5.3 4.6 7.7 1.7 2.1 5.6 18.3 7.2 3.1 1.9 2.5 5.4 3.6 1.0 8.7 7.2 12.3 5.0 2.8 6.9 3.7 2.2 8.8 2.2 5.2 6.5 51.0 6.3 0.0 6.4 6.3 13.3 6.7 3.5 4.5 4.1 5.7 5.8 7.2 2.9 MINK1 "B55, MAP4K6, MINK, YSK2, ZC3" ENSG00000141503 "Misshapen like kinase 1" Q8N4C8 17 4833340-4898061 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056296 Approved NA NA 26000 "HPA056296: AB_2683090" "unprognostic (2.80e-1)" "unprognostic (3.83e-2)" "unprognostic (1.85e-1)" "unprognostic (6.62e-2)" "unprognostic (2.88e-1)" "unprognostic (3.26e-3)" "prognostic unfavorable (3.00e-4)" "unprognostic (4.64e-3)" "unprognostic (3.21e-1)" "unprognostic (2.78e-2)" "prognostic favorable (2.77e-4)" "prognostic unfavorable (9.27e-4)" "unprognostic (8.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.37e-1)" "unprognostic (2.47e-2)" "unprognostic (1.62e-1)" 22.0 21.6 30.5 25.1 28.6 22.9 24.9 11.3 32.0 27.1 0.0 34.5 43.4 19.3 5.7 72.6 21.5 18.8 15.5 43.9 11.4 23.1 17.7 35.9 24.1 17.3 13.8 22.4 37.2 29.6 23.4 25.9 23.4 15.0 25.8 28.4 18.3 32.7 12.4 12.6 77.5 42.0 14.7 10.8 27.8 29.3 14.3 23.5 16.9 22.0 10.0 19.0 22.0 47.0 17.5 46.9 83.6 20.2 31.2 29.7 21.8 56.0 37.4 34.2 27.6 24.7 32.3 31.3 34.5 41.5 38.2 30.0 91.8 15.5 64.2 20.2 49.0 41.2 23.9 62.8 25.3 18.8 9.1 45.2 22.4 44.1 27.1 25.2 24.9 30.8 10.8 25.6 27.4 22.9 27.8 14.8 20.2 15.6 30.4 28.4 17.9 16.9 20.4 42.2 53.9 20.9 16.6 40.1 30.7 23.9 24.2 27.7 12.2 45.0 29.6 13.7 52.8 35.6 16.8 14.6 7.3 26.7 19.2 20.5 0.0 0.7 2.9 1.0 0.6 1.2 1.1 1.1 0.8 0.5 0.7 0.7 0.3 0.6 0.1 0.3 0.3 1.3 1.2 30.5 28.6 11.3 32.0 43.9 11.4 17.3 13.8 22.4 15.0 10.8 23.5 17.5 18.1 0.0 2.0 51.9 12.7 41.0 14.7 22.0 37.5 7.2 17.3 18.8 1.4 22.8 9.9 5.5 39.6 18.9 10.2 47.3 5.9 9.5 3.6 10.6 8.6 15.4 18.7 13.0 25.5 10.5 13.3 8.5 51.0 12.7 8.2 21.1 16.1 9.8 18.3 13.5 24.7 30.3 16.2 12.3 16.7 6.8 16.1 13.9 16.0 37.5 29.5 6.9 9.2 13.0 48.1 14.8 46.7 14.7 9.7 19.9 29.3 13.0 12.8 16.9 13.1 6.9 7.6 5.8 13.8 40.9 60.5 19.6 15.9 28.3 27.4 20.1 SAT2 SSAT2 ENSG00000141504 "Spermidine/spermine N1-acetyltransferase family member 2" Q96F10 17 7626234-7627876 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 140.9" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 1060.0;Proximal tubular cells: 1313.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022136, HPA057096" Enhanced NA NA 11000 "HPA022136: AB_1856592, HPA057096: AB_2683334" "unprognostic (2.61e-2)" "unprognostic (1.27e-2)" "unprognostic (3.23e-2)" "prognostic favorable (8.76e-6)" "unprognostic (2.18e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-2)" "prognostic favorable (6.71e-4)" "unprognostic (4.14e-2)" "unprognostic (2.75e-1)" "prognostic favorable (6.05e-5)" "unprognostic (1.83e-1)" "unprognostic (6.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" 27.9 103.6 29.2 9.7 29.4 11.4 27.0 30.2 37.8 25.0 33.3 27.3 93.6 25.4 25.3 17.4 26.3 16.0 33.4 29.0 32.6 98.5 140.9 19.2 9.6 29.8 30.1 29.0 44.9 47.8 36.3 30.6 8.7 29.6 27.7 15.6 21.3 27.2 16.5 32.1 18.7 66.1 17.2 30.6 29.3 33.7 17.3 30.8 8.1 28.4 20.7 11.9 22.8 20.0 30.3 17.9 27.3 24.1 44.9 37.5 43.6 3.0 12.2 44.3 27.2 33.8 9.3 8.9 3.3 6.8 11.9 30.4 15.3 15.4 11.1 18.0 5.1 41.9 3.6 15.8 49.2 45.3 0.1 12.3 54.6 28.3 16.2 11.9 36.6 39.9 3.5 2.5 5.3 28.8 1.6 0.3 4.1 9.9 10.2 16.6 6.6 11.8 4.2 42.8 20.6 2.6 22.4 11.4 23.4 26.3 21.4 15.5 3.3 17.3 13.2 8.5 0.3 19.3 9.9 9.6 0.7 44.5 5.2 19.7 7.6 41.9 9.5 14.2 28.3 16.7 13.6 12.0 14.6 30.7 12.7 17.8 12.7 2.7 12.4 14.9 14.0 19.5 22.5 29.2 29.4 30.2 37.8 29.0 32.6 29.8 30.1 29.0 29.6 30.6 30.8 30.3 70.3 44.8 121.2 76.4 76.2 82.6 90.6 83.2 134.3 121.9 124.1 140.8 62.8 257.4 82.6 80.9 68.8 70.8 68.7 80.4 422.6 135.9 19.4 66.9 79.0 69.8 132.7 25.9 86.2 66.2 33.7 97.3 43.3 59.2 62.1 181.4 114.5 289.0 165.3 129.5 64.6 116.4 124.1 142.7 165.1 28.0 181.7 110.7 94.3 25.3 103.4 156.9 49.4 32.6 36.9 92.8 129.1 119.2 92.9 108.6 1060.0 1313.7 83.9 148.6 72.3 91.2 92.2 30.4 7.8 79.6 56.1 79.2 67.0 321.2 116.8 103.9 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins, Predicted secreted proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 41 "liver: 1101.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 1107.9" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2" "Group enriched" "Detected in many" 8 "dendritic cells: 41.2;monocytes: 115.2" "Cell line enriched" "Detected in some" 29 "Hep G2: 493.2" "Region enriched" "Detected in all" 9 "cerebellum: 44.1" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Secreted to blood" NA NA 10000 Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 2.1 1.5 6.6 3.7 7.0 2.5 1.9 14.5 10.2 1.6 6.0 1.2 2.3 1.3 0.6 1.7 1.8 2.9 1.0 7.5 6.9 1.2 1101.2 3.9 1.3 7.3 7.6 7.4 1.2 1.0 7.1 2.9 0.5 9.1 1.7 0.5 4.9 0.9 0.3 1.5 4.2 1.4 1.3 5.4 4.9 1.4 26.7 7.8 0.4 5.9 0.4 0.3 1.7 1.5 8.0 0.3 0.7 9.2 4.2 0.0 0.2 0.8 0.8 0.9 0.9 1.6 16.8 0.5 0.3 1.1 0.2 0.4 0.2 0.3 0.2 0.4 0.3 0.8 1.2 1.4 493.2 0.1 0.8 1.7 1.2 0.2 0.5 0.1 0.6 8.4 7.4 1.1 0.6 0.5 0.4 0.7 1.2 1.7 0.2 0.4 0.9 3.5 0.2 0.1 0.7 0.6 3.5 0.7 0.3 0.6 1.5 0.5 0.2 1.2 0.9 3.4 0.7 0.4 0.2 0.3 0.5 0.6 0.4 0.3 10.0 115.2 0.4 0.2 55.5 1.1 0.5 0.2 0.2 41.2 0.5 0.3 0.4 3.3 0.5 14.9 1.8 0.3 36.7 6.6 7.0 14.5 10.2 7.5 6.9 7.3 7.6 7.4 9.1 5.4 7.8 8.0 6.0 0.0 4.7 2.9 2.6 3.2 1.7 2.0 3.4 37.8 5.6 6.0 1.5 55.8 2.0 3.7 160.6 3.6 2.9 1.4 3.9 0.9 235.4 4.2 3.6 13.2 15.6 16.8 4.6 0.2 3.7 1.9 3.6 16.5 0.0 5.1 27.5 1107.9 39.9 15.2 4.8 2.3 2.0 97.4 11.9 115.8 2.5 52.6 0.0 1.9 77.2 3.6 0.0 2.0 0.6 0.3 1.3 1.2 0.0 0.9 0.2 6.8 1.6 42.3 0.0 0.8 1.9 6.5 9.7 9.9 4.8 12.4 1.4 1.6 1.3 2.4 PIK3R5 "p101, P101-PI3K" ENSG00000141506 "Phosphoinositide-3-kinase regulatory subunit 5" Q8WYR1 17 8878911-8965712 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 88.2" "Cell type enhanced" "Detected in some" "dendritic cells: 29.9;Kupffer cells: 35.7;Langerhans cells: 40.5;Macrophages: 36.8;Microglial cells: 79.6;NK-cells: 32.0;Plasma cells: 24.7;T-cells: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 39.2;HMC-1: 5.7;JURKAT: 13.7;U-937: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044505, HPA052247, HPA052412" Uncertain Supported "Centriolar satellite,Cytosol" No NA Cytosol "Centriolar satellite" "HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (9.89e-3)" "unprognostic (1.42e-1)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (7.95e-2)" "unprognostic (1.33e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" "unprognostic (6.89e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.24e-1)" 6.5 3.7 1.1 19.9 2.1 88.2 2.7 1.3 6.5 2.1 2.9 2.8 3.3 1.4 0.8 2.5 3.0 6.7 1.6 1.1 3.6 1.3 2.9 14.2 13.9 2.9 2.1 0.1 0.8 1.3 0.8 0.9 3.1 3.8 1.6 2.6 0.0 2.1 1.0 0.7 1.4 9.6 4.0 3.2 22.6 3.6 2.2 5.2 12.4 1.8 0.9 9.0 6.6 1.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.4 1.5 0.0 0.0 0.0 0.5 5.7 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.3 1.5 2.5 0.6 0.0 0.0 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 9.5 16.1 5.7 18.1 14.3 11.8 4.3 10.1 15.6 11.5 5.7 7.5 12.0 34.4 8.6 19.0 9.0 13.2 16.2 1.1 2.1 1.3 6.5 1.1 3.6 2.9 2.1 0.1 3.8 3.2 5.2 4.8 0.2 0.0 6.1 0.7 11.7 1.0 0.0 0.0 0.0 0.0 0.2 0.3 2.1 1.5 0.0 0.0 0.0 0.1 29.9 0.0 0.0 0.1 4.5 0.1 0.1 0.7 0.0 4.0 0.3 0.0 0.3 0.5 1.5 0.1 5.1 0.0 1.4 0.4 18.3 0.0 0.5 0.0 0.0 35.7 40.5 12.2 0.3 36.8 1.8 79.6 19.8 0.0 32.0 1.0 0.3 0.0 0.0 0.0 24.7 0.1 0.0 0.2 0.0 0.0 0.0 0.4 1.4 0.6 0.4 0.1 0.9 0.4 25.7 0.0 0.0 0.0 TP53 "LFS1, p53" ENSG00000141510 "Tumor protein p53" P04637 17 7661779-7687538 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965" Enhanced Supported Nucleoplasm,Mitochondria,Cytosol Yes No Nucleoplasm "Mitochondria, Cytosol" "CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: " "unprognostic (2.29e-2)" "unprognostic (8.83e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.95e-2)" "unprognostic (4.00e-2)" "unprognostic (2.79e-3)" "unprognostic (4.99e-2)" "unprognostic (2.75e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (1.86e-3)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.08e-1)" 18.4 13.9 10.5 27.3 12.2 19.7 22.7 10.5 16.7 20.0 10.4 29.2 19.1 24.7 12.9 29.0 31.6 13.3 10.7 9.2 12.8 10.8 16.6 15.3 34.9 19.3 12.9 7.1 27.5 18.4 9.5 7.4 23.7 11.7 17.9 27.8 4.2 19.1 15.5 12.4 37.7 20.6 24.8 13.5 31.4 22.8 10.5 11.4 47.6 17.5 6.2 45.8 21.0 20.1 17.3 81.5 145.3 81.1 57.3 37.3 43.9 82.8 28.4 66.1 78.5 100.2 4.2 40.6 190.5 126.9 58.7 77.6 174.9 119.7 80.4 72.8 42.7 76.5 77.6 76.8 70.9 111.5 1.6 37.0 55.7 93.0 38.9 106.5 45.6 79.4 24.7 3.8 6.9 41.5 145.1 130.0 96.3 80.2 10.4 2.4 252.2 56.1 66.2 59.4 87.3 46.0 80.5 94.1 62.6 24.3 39.4 109.2 7.4 100.7 91.6 30.2 1.0 48.3 47.6 37.9 82.5 23.6 9.7 80.1 1.2 21.2 3.4 13.0 21.7 15.9 21.5 13.3 14.6 30.3 19.1 13.7 15.4 2.4 17.5 19.3 27.3 17.3 14.7 10.5 12.2 10.5 16.7 9.2 12.8 19.3 12.9 7.1 11.7 13.5 11.4 17.3 21.1 9.6 12.8 16.3 26.0 28.7 14.5 24.6 24.5 2.6 36.1 30.4 2.5 18.6 15.4 20.2 0.0 36.9 24.7 16.9 9.8 24.8 12.8 11.5 29.0 24.5 30.7 21.7 2.1 18.1 39.6 17.0 11.2 19.5 1.3 31.7 22.1 18.0 24.2 0.0 3.2 43.0 18.3 27.8 20.1 3.8 23.0 19.3 12.4 7.5 31.9 4.9 25.7 9.0 8.0 15.8 16.4 17.0 7.8 15.7 10.3 10.1 8.8 2.6 13.1 25.9 20.6 0.5 4.9 28.7 32.8 22.4 16.5 27.4 54.1 11.5 CCDC40 "CFAP172, CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640" ENSG00000141519 "Coiled-coil domain containing 40" Q4G0X9 17 80036632-80100613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 25.7;fallopian tube: 15.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.5;Respiratory ciliated cells: 92.9;Rod photoreceptor cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;SH-SY5Y: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022974 Enhanced Approved Microtubules NA NA Microtubules "HPA022974: AB_1848791" "unprognostic (5.89e-3)" "unprognostic (2.30e-1)" "unprognostic (8.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.04e-5)" "unprognostic (7.38e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.86e-1)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" "unprognostic (4.26e-2)" 2.1 2.3 9.3 0.9 2.2 0.3 2.2 2.4 2.1 2.1 25.7 1.8 0.6 3.2 2.6 0.7 15.0 2.1 3.0 2.1 6.0 4.2 1.8 3.2 0.7 4.9 8.3 0.3 1.7 2.6 1.8 6.9 0.6 3.4 3.2 0.5 5.7 2.3 1.6 0.8 1.1 1.6 1.0 5.6 1.3 1.8 8.5 4.3 0.3 4.9 0.5 0.6 1.7 1.2 2.7 2.2 7.0 6.2 6.9 0.8 0.9 1.6 2.0 1.4 1.7 1.8 0.7 3.0 0.3 0.9 1.4 2.9 0.6 1.6 1.5 0.4 0.1 1.3 0.1 3.9 3.5 1.4 0.1 2.2 1.6 2.1 2.1 0.2 3.0 0.9 1.3 0.8 0.0 1.4 2.5 0.1 0.4 2.8 3.0 2.3 1.8 3.3 0.0 3.5 1.4 12.1 8.7 3.1 1.5 1.4 3.3 2.8 0.2 1.1 3.8 2.3 2.5 0.4 2.0 0.7 0.3 0.8 0.2 1.9 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 9.3 2.2 2.4 2.1 2.1 6.0 4.9 8.3 0.3 3.4 5.6 4.3 2.7 0.8 12.8 5.2 16.6 0.6 0.6 2.4 2.5 0.6 4.2 2.9 3.0 3.6 0.0 10.0 7.3 14.6 0.4 0.1 0.3 1.9 2.9 13.6 58.5 4.0 1.4 3.0 0.0 10.7 1.5 1.0 2.3 1.5 4.7 0.0 1.8 1.8 1.2 1.4 11.8 11.7 1.7 8.2 4.3 1.4 7.9 1.2 1.5 0.0 10.3 0.3 4.7 0.0 8.0 1.9 0.9 1.1 3.4 0.1 1.5 0.3 2.1 92.9 28.6 0.0 3.3 3.2 16.0 5.3 0.5 0.3 0.3 0.5 2.4 0.7 1.1 ARHGDIA "GDIA1, RHOGDI" ENSG00000141522 "Rho GDP dissociation inhibitor alpha" P52565 17 81867721-81871378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010005, HPA021407" Approved Supported Cytosol NA NA 21000000 Cytosol "CAB010005: AB_2227516, HPA021407: AB_1856267" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (5.00e-2)" "unprognostic (8.39e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (5.32e-2)" "unprognostic (4.67e-2)" "unprognostic (2.67e-2)" "unprognostic (6.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (3.29e-1)" "unprognostic (6.88e-3)" 260.7 197.8 96.6 156.1 101.3 221.3 229.6 72.2 174.8 201.6 47.6 203.1 179.3 223.9 24.0 267.3 192.8 64.9 176.1 102.6 109.2 237.4 222.5 268.4 117.9 117.7 106.8 96.3 176.3 196.9 70.2 188.8 102.8 119.8 207.8 53.4 14.7 181.4 79.4 133.0 198.5 227.5 73.1 85.4 245.9 195.9 92.7 109.5 84.2 174.8 33.1 67.4 205.1 213.9 110.0 472.6 455.1 146.6 233.1 131.8 162.9 167.2 396.0 251.3 292.1 216.0 229.0 173.7 249.4 164.9 299.8 254.9 252.3 160.3 302.6 120.7 192.3 422.2 266.3 267.7 303.0 270.6 418.3 367.4 211.1 137.0 213.5 180.5 147.7 450.1 204.1 221.5 334.8 235.8 285.4 611.3 432.9 173.0 159.8 405.3 274.2 185.4 200.6 193.7 289.5 193.0 568.8 208.5 522.2 386.9 105.3 247.5 335.7 499.7 575.1 494.2 539.3 681.4 292.8 164.9 256.5 497.7 249.9 399.8 39.5 47.9 87.5 64.3 72.5 60.8 35.8 53.6 62.5 47.9 27.4 34.5 42.1 30.2 45.2 101.9 55.3 55.4 60.4 96.6 101.3 72.2 174.8 102.6 109.2 117.7 106.8 96.3 119.8 85.4 109.5 110.0 146.0 38.5 59.1 14.0 152.2 127.2 201.5 173.0 63.2 18.3 78.8 65.4 2.9 62.9 86.7 79.1 10.4 130.1 164.6 289.7 135.0 234.2 8.3 66.4 97.5 134.6 134.6 34.9 13.9 265.0 263.4 98.2 120.8 124.1 118.6 76.4 112.1 82.7 243.2 52.2 10.4 173.7 101.7 167.1 157.8 19.5 86.6 167.4 193.9 15.0 243.9 82.6 187.4 9.5 17.5 424.5 286.3 74.1 171.3 183.5 300.7 157.5 46.0 11.9 118.3 70.6 121.4 38.9 44.1 88.5 116.1 221.9 169.3 78.6 156.2 222.2 TMC6 "EVER1, EVIN1, LAK-4P, TNRC6C-AS1" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78107397-78132407 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 111.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 108.7;SK-BR-3: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain NA NA "HPA051430: AB_2681483" "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.20e-4)" 24.6 6.9 17.6 45.8 41.3 73.3 25.4 39.5 25.0 10.9 7.0 16.7 21.9 7.6 1.0 25.6 14.2 9.8 27.9 15.1 30.0 16.9 9.2 40.6 70.3 54.8 46.8 8.4 3.8 14.8 3.1 5.6 8.9 51.9 20.4 6.7 0.6 29.6 7.9 3.5 17.0 51.1 3.5 39.7 111.4 14.8 2.6 41.5 26.5 13.0 1.8 32.6 14.7 18.6 79.0 17.9 14.0 7.5 6.0 0.0 0.0 15.2 0.0 0.0 0.2 0.2 25.2 19.2 19.7 23.7 0.0 6.3 31.0 1.0 5.9 0.0 2.0 11.3 41.3 4.2 31.0 1.9 38.3 67.0 1.1 16.2 0.0 1.3 0.2 14.7 9.2 108.7 73.3 0.0 36.1 18.9 65.4 5.9 32.9 4.9 8.4 0.6 58.9 11.4 65.1 1.9 4.9 5.7 121.0 33.2 9.7 68.7 57.6 5.2 0.0 8.7 0.1 0.3 57.6 27.3 13.2 0.0 60.4 1.0 17.7 11.6 23.2 56.2 38.3 49.0 28.5 41.7 46.2 18.6 21.7 36.5 39.6 15.3 35.8 63.5 5.7 38.0 33.5 17.6 41.3 39.5 25.0 15.1 30.0 54.8 46.8 8.4 51.9 39.7 41.5 79.0 43.8 41.7 29.6 8.1 69.5 11.1 21.0 22.3 7.4 3.2 17.4 6.5 14.7 10.0 41.5 16.5 0.0 1.2 79.8 25.0 0.0 41.2 0.3 5.1 1.6 19.7 9.1 28.4 0.2 23.1 26.4 4.6 10.2 8.0 40.5 0.7 23.6 2.2 67.0 1.7 0.2 14.0 40.7 66.2 29.9 1.2 9.6 44.7 14.2 20.6 62.0 7.5 85.5 1.5 50.8 40.5 53.7 1.2 62.6 31.5 20.3 2.0 20.3 1.8 13.1 4.6 13.5 0.5 2.2 8.4 10.2 3.7 83.7 2.5 30.3 37.4 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82217934-82261129 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 199.9" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1667.1;Syncytiotrophoblasts: 748.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 109.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" NA NA 260000 "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavorable (1.19e-7)" "prognostic unfavorable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 25.6 17.0 5.5 25.6 5.3 22.9 15.8 6.4 8.2 23.3 5.7 23.4 11.8 11.7 1.3 42.8 18.7 12.9 24.3 4.9 17.2 38.9 11.4 46.8 5.8 17.2 7.6 3.0 9.2 5.8 2.5 12.2 24.9 11.0 19.8 5.7 5.8 27.7 6.0 199.9 8.2 23.1 6.0 8.5 58.0 22.2 32.2 11.4 2.9 29.4 73.9 5.2 26.5 28.8 12.0 52.8 24.4 0.6 1.3 7.8 28.8 51.7 225.6 107.7 117.4 142.2 10.1 119.1 0.7 158.0 122.5 127.9 18.9 15.6 242.0 51.8 78.1 1.2 87.4 144.0 236.4 164.1 105.2 111.5 64.8 38.2 77.0 38.5 185.8 69.1 2.2 1.0 26.6 116.1 14.0 1.4 166.3 1.9 22.1 223.5 0.9 1.6 33.2 75.9 3.0 2.9 1.7 196.7 166.9 3.2 20.4 25.4 131.4 124.0 281.7 5.1 4.5 200.9 97.3 1.9 3.9 140.2 94.7 3.0 56.6 32.6 92.1 9.6 30.4 13.4 8.1 7.7 10.5 24.1 6.2 4.2 5.3 109.1 25.3 31.4 15.2 7.3 16.0 5.5 5.3 6.4 8.2 4.9 17.2 17.2 7.6 3.0 11.0 8.5 11.4 12.0 19.2 9.6 9.8 3.6 27.9 6.5 47.5 210.1 2.8 13.4 3.2 2.5 6.1 4.3 182.3 57.0 4.2 67.6 72.4 216.7 0.0 136.1 3.0 33.7 15.4 29.9 20.9 9.1 0.3 18.0 1667.1 17.2 45.3 65.1 75.0 15.9 16.8 1.1 271.0 127.9 0.3 28.3 148.5 99.9 84.6 3.8 3.1 168.6 14.2 9.4 184.9 20.3 40.2 0.0 1.0 305.5 190.2 3.8 35.7 16.5 62.4 5.6 91.1 11.6 0.0 1.6 50.5 1.9 9.5 1.6 6.7 748.8 38.5 0.8 33.4 119.6 CARD14 "BIMP2, CARMA2, PSORS2" ENSG00000141527 "Caspase recruitment domain family member 14" Q9BXL6 17 80169992-80209331 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Apoptosis "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.6;skin 1: 14.1;vagina: 7.3" "Cell type enhanced" "Detected in many" "Kupffer cells: 8.2;Microglial cells: 6.5;Oligodendrocytes: 11.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 5.2;SK-BR-3: 6.9;T-47d: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA023388 Supported Aggresome,Cytosol NA NA Cytosol Aggresome "HPA023388: AB_1846020" "unprognostic (9.79e-3)" "unprognostic (3.86e-2)" "unprognostic (4.26e-1)" "unprognostic (1.05e-5)" "unprognostic (2.65e-2)" "unprognostic (1.37e-2)" "unprognostic (2.92e-4)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (2.63e-1)" "unprognostic (3.01e-1)" "unprognostic (5.48e-2)" "unprognostic (1.62e-8)" "unprognostic (2.52e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-1)" 0.3 1.1 0.4 0.6 0.3 0.2 2.6 0.0 0.4 2.6 0.0 0.3 1.1 0.3 0.3 13.6 0.7 0.4 0.2 0.2 0.2 0.5 0.3 0.6 0.6 0.4 0.3 0.2 0.4 0.4 0.0 0.5 0.2 0.6 2.6 0.0 0.3 3.4 0.0 0.4 14.1 0.8 0.0 0.2 1.5 0.5 1.2 0.3 0.0 0.5 0.0 1.6 1.0 7.3 0.8 1.7 0.4 0.3 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.8 0.6 0.0 1.9 0.2 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.0 5.2 0.0 0.0 0.1 1.0 0.1 0.0 1.1 0.4 0.0 1.6 0.4 0.1 0.0 6.9 0.8 0.4 10.4 0.0 0.4 0.1 0.3 0.3 0.0 2.2 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.2 0.2 0.4 0.3 0.2 0.6 0.2 0.3 0.8 0.3 0.0 1.1 1.6 0.1 1.8 4.0 2.1 0.0 0.6 4.5 2.2 0.9 2.8 2.0 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.7 1.3 0.2 0.9 0.0 0.0 0.9 2.2 0.4 0.5 0.0 1.5 0.0 0.4 0.7 0.0 0.8 0.0 0.8 0.1 0.0 8.2 0.8 0.1 0.3 0.6 1.8 6.5 0.1 1.4 0.0 1.0 11.6 1.8 0.1 0.4 0.1 3.2 0.9 0.3 3.6 0.8 0.0 0.2 0.3 1.3 0.4 5.0 3.0 1.5 0.3 0.7 0.5 3.6 TTYH2 C17orf29 ENSG00000141540 "Tweety family member 2" Q9BSA4 17 74213571-74262020 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 215.0" "Cell type enhanced" "Detected in many" "Astrocytes: 46.0;Bipolar cells: 59.2;Langerhans cells: 52.1;Oligodendrocytes: 206.9" "Group enriched" "Detected in all" 6 "glioma: 16.7;melanoma: 20.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 13.3;intermediate monocyte: 22.3;myeloid DC: 14.6;non-classical monocyte: 28.6;plasmacytoid DC: 18.2" "Group enriched" "Detected in many" 5 "dendritic cells: 18.2;monocytes: 28.6" "Cell line enhanced" "Detected in many" "HSkMC: 22.2;SK-MEL-30: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (5.08e-1)" "unprognostic (1.58e-3)" "unprognostic (3.51e-4)" "unprognostic (1.59e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-2)" "unprognostic (5.90e-2)" "unprognostic (8.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.81e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (9.74e-5)" "unprognostic (8.98e-3)" "unprognostic (5.70e-3)" "unprognostic (2.50e-3)" "unprognostic (3.51e-3)" 5.4 4.8 74.7 7.4 127.3 3.4 4.5 98.6 98.2 7.0 36.6 6.5 2.6 5.0 3.5 3.2 6.4 5.2 16.5 79.6 96.4 2.0 1.6 5.6 7.8 125.1 116.1 59.4 17.3 8.4 4.0 7.1 10.3 122.6 4.6 2.5 20.0 7.0 4.0 14.9 5.3 4.9 3.9 96.5 11.8 4.0 15.4 106.7 5.1 10.2 9.5 5.8 5.4 4.7 215.0 0.2 1.9 9.0 8.7 1.1 1.3 0.2 0.5 0.1 0.5 0.1 5.9 0.1 5.3 1.3 0.2 1.0 14.5 8.9 0.3 0.3 12.5 5.0 5.7 0.3 0.5 6.2 0.6 3.8 22.2 4.6 0.1 1.6 0.6 0.3 3.8 1.0 2.6 0.2 1.0 2.7 0.4 1.7 8.7 15.7 8.8 16.1 10.1 0.2 0.7 3.1 11.0 0.0 5.5 81.3 4.6 2.9 1.2 0.2 0.0 4.4 0.1 0.3 0.5 0.3 0.1 0.3 1.7 4.9 1.0 13.3 1.2 2.4 22.3 0.3 0.3 4.6 3.8 14.6 0.3 0.7 1.7 1.2 0.1 28.6 18.2 4.5 7.0 74.7 127.3 98.6 98.2 79.6 96.4 125.1 116.1 59.4 122.6 96.5 106.7 215.0 8.0 0.0 4.1 46.0 1.3 2.3 0.6 0.2 1.2 59.2 1.5 2.4 1.9 2.8 0.1 0.0 6.2 0.3 7.9 0.0 0.0 0.2 27.7 0.4 0.7 6.9 1.8 0.0 1.0 0.2 0.4 4.1 0.5 0.9 21.6 0.5 1.8 0.5 5.0 3.3 0.9 0.2 0.0 12.3 52.1 11.5 9.6 13.7 23.2 15.0 16.5 18.4 0.0 10.6 206.9 0.1 0.1 2.6 1.3 0.8 0.0 0.2 0.3 10.8 19.7 3.2 2.7 2.4 1.5 0.4 2.6 0.3 2.3 4.3 0.0 0.4 RAB40B "RAR, SEC4L" ENSG00000141542 "RAB40B, member RAS oncogene family" Q12829 17 82654973-82698698 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 79.6" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 134.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 33.2;OE19: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (2.21e-2)" "unprognostic (7.50e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-1)" "unprognostic (6.03e-2)" "unprognostic (2.34e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.74e-1)" "unprognostic (3.28e-2)" "unprognostic (1.36e-1)" "unprognostic (3.14e-2)" "prognostic favorable (2.95e-6)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (9.83e-3)" 7.7 8.7 58.3 2.0 67.4 0.8 9.9 55.4 60.7 8.7 30.7 13.3 7.5 8.7 14.9 9.3 7.7 5.3 16.3 57.9 55.8 19.4 14.8 5.3 2.0 62.8 59.2 53.7 12.5 6.8 5.0 16.0 3.1 63.5 9.4 7.9 3.4 9.8 5.4 42.9 12.5 6.3 4.1 61.0 4.2 17.6 5.2 57.8 2.1 6.3 19.9 2.3 11.4 9.4 79.6 7.3 11.7 3.5 10.5 8.6 10.7 5.2 7.9 2.2 4.9 1.6 3.8 1.9 1.0 15.4 8.0 3.1 13.1 6.8 6.4 4.3 0.6 33.2 2.8 12.2 10.9 4.3 0.8 3.1 9.2 10.2 2.8 2.2 4.7 4.6 7.0 8.5 1.0 6.7 9.7 2.8 6.4 0.7 40.6 15.3 6.8 9.1 6.3 17.2 13.3 19.1 12.1 5.6 5.0 11.1 16.0 10.8 5.9 9.4 13.7 4.1 14.5 6.5 5.5 4.7 10.5 3.2 1.9 2.4 1.4 0.5 0.0 0.9 1.2 1.3 2.7 1.2 1.6 0.8 0.8 1.6 0.8 0.1 2.0 3.3 6.5 1.8 0.7 58.3 67.4 55.4 60.7 57.9 55.8 62.8 59.2 53.7 63.5 61.0 57.8 79.6 19.0 9.6 8.8 22.5 5.8 30.0 28.4 21.4 19.9 11.4 30.0 37.1 32.8 44.3 13.4 14.7 0.0 2.5 9.9 40.0 82.2 22.1 37.3 25.2 17.8 14.6 21.0 6.1 39.2 8.7 5.6 22.2 61.7 59.9 1.3 4.9 15.4 21.3 6.8 33.7 17.6 48.0 73.2 3.2 11.0 26.6 20.2 5.8 48.0 9.4 2.7 11.7 11.3 21.1 134.8 10.3 42.4 18.4 18.6 55.5 43.7 86.7 12.2 11.3 26.3 17.4 17.0 5.0 11.4 30.0 29.1 1.2 6.5 18.5 44.7 99.0 EIF4A3 "DDX48, EIF4AIII, Fal1, KIAA0111" ENSG00000141543 "Eukaryotic translation initiation factor 4A3" P38919 17 80134369-80147151 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021878 Supported Supported Nucleoplasm NA NA 280000 Nucleoplasm "HPA021878: AB_1848090" "unprognostic (7.24e-2)" "unprognostic (7.33e-3)" "prognostic favorable (3.57e-5)" "unprognostic (1.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.68e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.71e-1)" "unprognostic (5.06e-2)" "unprognostic (4.64e-2)" "unprognostic (2.64e-2)" "unprognostic (9.78e-3)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (1.38e-2)" "unprognostic (2.91e-3)" 53.0 82.2 19.6 49.6 21.5 187.4 44.6 21.8 27.4 45.6 22.8 43.7 39.0 47.0 39.1 82.5 55.2 40.5 35.1 22.2 27.0 45.5 42.9 44.4 67.5 20.4 20.8 19.5 67.1 37.3 59.0 41.4 53.3 20.3 39.1 48.0 32.6 42.8 32.9 37.6 64.9 39.2 43.0 22.5 48.0 41.7 43.2 20.3 78.9 37.3 35.3 75.3 84.2 55.5 25.0 237.2 208.9 140.5 103.8 105.5 63.2 114.4 119.3 91.0 177.7 141.4 223.7 110.3 221.4 67.9 112.9 126.4 152.2 194.9 136.2 195.0 71.5 192.3 142.5 159.3 244.3 103.1 253.8 133.4 98.7 68.7 149.5 119.4 71.8 147.2 128.7 189.8 140.2 105.3 178.9 224.8 132.8 145.0 223.8 190.0 168.5 282.7 172.2 85.8 196.5 186.1 100.1 170.9 334.2 151.9 130.1 219.3 166.7 100.5 108.7 138.6 159.9 200.3 104.4 86.2 403.2 88.0 158.7 113.3 126.1 167.0 137.4 101.1 174.6 131.2 142.4 128.2 119.4 200.0 119.8 116.9 115.2 98.7 132.9 143.4 326.0 158.2 232.6 19.6 21.5 21.8 27.4 22.2 27.0 20.4 20.8 19.5 20.3 22.5 20.3 25.0 117.9 41.7 48.0 6.8 135.1 283.1 273.4 212.9 107.0 23.3 77.0 109.2 61.5 38.6 107.8 29.5 16.7 140.1 165.7 75.4 64.6 85.6 33.2 132.9 109.2 70.5 60.3 24.4 4.1 115.2 225.1 144.3 149.4 248.2 92.6 42.6 32.2 27.0 108.5 6.7 4.3 83.2 89.5 63.4 255.0 12.1 67.1 199.6 103.2 10.3 67.9 48.6 23.7 5.5 7.6 86.6 83.1 49.7 118.6 96.0 47.9 65.0 61.4 32.5 85.5 109.7 207.8 99.4 123.2 77.6 299.1 261.9 138.4 98.0 77.7 252.5 CSNK1D "CKID, CKIdelta, HCKID" ENSG00000141551 "Casein kinase 1 delta" P48730 17 82239023-82273731 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 312.5;Late spermatids: 775.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015410 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "CAB015410: AB_831049" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.38e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.38e-6)" "unprognostic (8.05e-2)" "unprognostic (1.09e-1)" "unprognostic (5.00e-2)" "prognostic favorable (9.62e-5)" "unprognostic (2.23e-3)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.54e-1)" "unprognostic (2.52e-1)" "unprognostic (5.52e-3)" "unprognostic (4.74e-2)" 44.2 57.5 34.9 29.1 33.8 26.2 42.7 31.5 38.2 43.1 26.7 53.7 35.4 57.1 27.0 51.2 45.7 25.1 39.4 35.5 35.4 45.8 41.2 45.7 31.1 33.1 34.2 31.6 43.4 47.9 43.5 54.6 30.4 34.4 52.2 20.2 15.2 49.0 37.1 89.6 36.0 51.3 29.2 32.4 56.7 49.7 61.2 35.8 34.3 45.0 39.0 23.0 49.4 37.3 29.7 60.3 70.9 39.5 54.7 50.8 53.9 77.7 85.1 54.4 61.0 56.8 58.6 49.4 55.0 66.3 62.5 64.8 57.1 37.4 88.3 48.9 47.0 90.5 68.5 53.4 63.7 146.9 56.9 50.4 81.9 61.5 41.6 61.3 76.0 90.0 39.5 78.5 28.4 58.5 70.6 73.7 59.3 42.2 71.3 108.6 62.6 48.7 49.7 64.8 93.4 48.5 87.4 100.4 85.5 97.7 54.3 61.5 73.0 95.6 86.9 77.3 76.2 67.0 61.0 32.1 58.4 69.5 48.1 64.7 8.8 20.8 27.4 12.3 21.3 11.8 11.1 9.6 12.1 20.1 9.0 8.1 8.7 50.4 15.3 20.3 9.6 9.2 15.4 34.9 33.8 31.5 38.2 35.5 35.4 33.1 34.2 31.6 34.4 32.4 35.8 29.7 65.8 48.1 54.3 36.6 81.1 56.6 116.0 58.3 52.9 46.5 59.8 51.2 19.7 31.5 65.7 42.3 27.1 61.8 101.0 105.2 33.2 71.6 312.5 69.6 54.0 54.2 46.2 32.4 24.4 69.6 95.2 42.8 87.1 93.2 60.1 45.3 42.5 33.6 65.3 95.9 21.2 62.8 67.1 51.5 83.8 775.6 30.1 75.7 28.4 24.4 65.8 28.7 79.3 24.6 21.2 87.7 83.2 40.3 80.9 90.8 94.3 43.8 66.6 54.4 39.5 78.6 57.5 55.1 29.6 44.2 48.3 126.6 87.6 46.7 56.7 118.6 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1161.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 106.7 121.5 88.1 52.6 89.6 110.2 104.3 93.3 150.7 83.0 83.0 115.2 61.5 87.1 39.4 126.9 81.0 58.6 209.7 88.4 89.2 127.7 187.2 90.0 73.6 92.5 87.5 88.0 77.1 109.0 59.5 92.7 55.3 87.0 106.6 27.5 19.5 118.6 42.4 275.1 99.1 84.1 36.8 94.2 87.4 118.8 191.2 92.9 50.6 91.4 127.7 34.3 96.7 95.5 102.3 262.4 605.0 139.0 209.7 118.7 132.8 164.3 123.4 100.6 111.4 127.1 248.6 226.9 82.1 133.3 114.4 121.8 148.9 58.1 166.4 40.5 122.5 437.1 126.8 257.9 379.0 131.3 95.3 103.6 145.6 151.8 120.4 98.2 73.4 184.9 111.9 173.7 233.8 120.8 474.1 225.5 150.6 131.2 259.2 448.7 92.3 136.2 168.0 104.9 229.3 175.8 282.6 133.5 205.7 253.8 96.7 254.1 222.7 108.4 215.0 169.5 229.4 234.1 110.5 52.1 107.0 228.7 144.5 177.7 495.1 419.8 418.8 229.7 359.9 218.7 309.0 232.0 252.9 348.0 296.2 223.0 212.3 212.1 258.5 345.4 581.1 297.9 506.0 88.1 89.6 93.3 150.7 88.4 89.2 92.5 87.5 88.0 87.0 94.2 92.9 102.3 137.2 128.2 157.2 11.4 110.5 148.6 215.0 406.1 145.7 59.5 272.5 332.7 360.2 201.6 272.3 198.6 20.9 467.8 119.5 239.6 522.3 260.6 451.9 157.0 151.3 152.9 190.3 201.6 9.8 337.7 524.6 182.9 124.4 169.5 108.3 158.3 159.2 496.4 448.2 33.7 10.2 272.6 319.4 174.6 194.3 1161.0 181.7 170.1 261.5 13.1 251.4 227.7 176.1 7.1 17.0 324.3 274.0 164.7 226.8 334.2 290.7 548.0 199.8 78.9 105.2 115.9 245.0 435.8 252.5 257.4 186.7 508.7 117.3 156.0 271.4 307.0 TBCD ENSG00000141556 "Tubulin folding cofactor D" Q9BTW9 17 82752065-82945914 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, GTPase activation" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 204.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045200 Approved NA NA 6200 "HPA045200: AB_10969134" "unprognostic (4.15e-1)" "unprognostic (1.01e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.39e-5)" "unprognostic (3.41e-3)" "unprognostic (9.03e-3)" "unprognostic (5.35e-2)" "unprognostic (1.75e-3)" "unprognostic (6.40e-2)" "unprognostic (1.16e-1)" "unprognostic (4.96e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" 31.4 24.1 16.0 22.4 16.7 23.4 31.9 9.5 15.0 33.0 13.9 22.5 15.6 27.3 24.9 29.2 27.0 33.3 31.3 15.8 13.7 26.2 25.9 26.5 24.2 15.1 13.3 15.8 25.9 28.7 26.5 26.7 27.8 15.3 28.4 14.9 11.4 70.6 18.8 25.3 23.5 23.5 21.8 10.3 34.9 30.8 24.7 13.3 52.2 37.0 18.7 21.2 26.4 26.9 16.7 63.1 61.9 63.9 89.8 36.9 40.5 65.3 37.0 24.1 40.5 28.2 34.9 16.6 36.7 34.3 44.3 52.0 64.8 144.6 36.0 34.5 46.7 56.7 85.8 52.8 46.1 23.9 30.8 60.9 33.8 26.2 30.5 13.6 28.4 122.6 68.5 47.2 14.9 35.1 70.9 204.4 19.4 30.1 32.2 45.0 107.9 71.7 23.1 28.5 59.2 61.5 70.9 40.0 70.0 24.6 39.7 52.7 18.7 52.8 75.9 56.8 48.2 60.4 21.1 17.2 40.7 47.3 37.7 29.5 21.3 17.7 9.6 23.4 41.3 28.6 1.3 21.0 24.7 15.4 1.1 8.6 10.4 3.7 18.2 51.7 3.0 16.8 16.9 16.0 16.7 9.5 15.0 15.8 13.7 15.1 13.3 15.8 15.3 10.3 13.3 16.7 50.3 19.2 43.2 31.0 9.1 6.8 10.7 9.3 8.6 15.6 16.0 13.8 7.0 11.5 15.7 12.9 12.5 31.8 14.8 11.1 11.7 12.0 11.5 17.8 11.7 34.3 16.2 24.4 48.5 15.2 27.9 18.3 27.5 27.5 38.1 30.5 16.1 26.4 25.7 13.5 43.9 11.4 32.6 15.7 7.0 20.8 15.2 14.2 19.6 31.9 10.8 7.5 17.5 19.6 45.4 9.7 4.7 18.8 16.7 9.9 6.0 16.0 14.9 13.8 6.6 15.7 10.6 15.9 21.8 15.8 10.1 49.7 29.3 21.0 15.3 12.1 FN3KRP "FLJ12171, FN3KL" ENSG00000141560 "Fructosamine 3 kinase related protein" Q9HA64 17 82716706-82730328 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056172, HPA065831" Approved Approved Nucleoplasm NA NA 44000 Nucleoplasm "HPA056172: AB_2683055, HPA065831: AB_2685565" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (1.54e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.31e-1)" "unprognostic (1.25e-2)" "unprognostic (8.67e-2)" "unprognostic (1.26e-1)" "unprognostic (1.99e-1)" "unprognostic (8.84e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-2)" 23.4 22.3 40.6 13.4 42.9 19.0 19.9 42.7 40.8 23.4 34.7 23.0 15.4 23.3 19.6 20.5 20.6 16.7 16.3 41.2 40.9 24.1 29.5 16.4 18.7 42.1 41.2 39.6 32.4 19.5 18.5 17.4 21.9 43.0 21.0 18.2 18.0 22.4 23.5 11.5 23.2 19.6 22.3 43.2 21.1 20.8 13.8 41.1 16.8 16.9 10.7 23.0 19.9 20.9 47.9 31.4 122.3 33.6 44.5 15.9 30.3 27.2 56.9 31.8 54.5 44.3 64.9 21.8 25.6 37.0 46.6 50.5 35.3 30.1 43.5 48.7 17.2 54.3 42.6 66.2 77.5 28.3 30.7 23.2 27.8 50.9 51.7 28.1 33.4 39.8 35.9 42.5 15.8 70.7 59.8 58.8 45.2 15.2 68.7 53.5 44.0 83.4 40.3 38.9 58.7 27.6 58.1 93.7 42.7 47.3 57.4 69.8 43.6 34.8 103.3 35.9 74.2 85.3 32.1 37.8 64.8 48.1 38.2 49.0 32.0 21.9 30.6 29.6 24.7 29.5 23.9 28.8 28.8 18.2 24.8 32.5 24.3 3.4 32.1 13.8 36.0 29.7 26.0 40.6 42.9 42.7 40.8 41.2 40.9 42.1 41.2 39.6 43.0 43.2 41.1 47.9 14.3 12.8 11.1 5.5 13.9 15.0 26.0 26.0 15.4 18.1 13.3 15.6 6.9 25.8 15.3 11.0 8.4 100.3 20.0 12.2 23.5 20.6 2.0 10.7 13.0 14.8 7.8 31.2 7.6 11.1 45.3 18.1 13.3 22.3 13.3 18.6 10.8 12.1 33.8 3.3 6.7 15.4 22.4 11.2 11.3 4.2 28.3 12.8 23.2 6.5 20.9 36.1 17.5 5.0 11.8 17.8 15.9 31.6 27.6 15.5 11.1 28.2 10.0 18.5 13.1 13.6 20.9 18.3 36.2 18.0 15.3 62.5 17.2 22.3 15.6 24.0 NARF "DKFZp434G0420, FLJ10067, IOP2" ENSG00000141562 "Nuclear prelamin A recognition factor" Q9UHQ1 17 82458180-82490537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 292.6;Late spermatids: 474.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053006 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053006: AB_2682013" "unprognostic (1.84e-1)" "prognostic favorable (1.15e-4)" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (4.14e-1)" "unprognostic (6.52e-2)" "unprognostic (6.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (3.42e-3)" "unprognostic (3.80e-3)" "prognostic unfavorable (1.48e-10)" "unprognostic (3.57e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-2)" "unprognostic (1.83e-2)" 18.7 18.2 17.0 12.5 17.9 33.2 17.6 19.6 21.9 15.9 16.8 21.3 10.4 14.6 5.8 21.7 16.3 7.8 36.5 18.2 17.6 15.8 23.2 15.2 10.8 18.4 17.6 17.9 17.0 20.8 6.7 18.9 7.5 18.4 17.2 6.6 11.6 18.6 8.3 49.6 24.3 19.3 7.1 15.7 29.0 23.5 59.6 17.9 14.8 16.7 26.1 9.0 20.0 16.4 19.9 21.2 23.3 32.8 50.6 15.2 14.3 18.2 13.1 12.7 21.2 21.2 23.6 8.4 14.0 13.6 9.8 23.8 18.6 23.8 15.5 14.2 15.3 55.7 29.0 30.4 27.7 13.1 30.9 50.6 21.9 26.4 16.5 5.7 20.7 39.2 44.9 67.5 9.6 9.2 18.1 51.2 49.8 13.7 16.3 44.1 42.6 34.3 21.6 9.7 23.3 40.1 55.9 32.1 21.3 38.8 20.7 18.4 23.2 21.7 26.4 22.4 22.4 21.7 94.1 38.4 30.1 24.3 20.6 15.9 94.5 33.0 96.2 34.2 30.0 38.1 38.2 33.1 33.7 32.0 40.9 37.7 31.2 156.0 53.7 23.9 26.2 44.1 38.6 17.0 17.9 19.6 21.9 18.2 17.6 18.4 17.6 17.9 18.4 15.7 17.9 19.9 45.2 12.8 23.2 25.1 50.7 37.3 32.9 55.4 28.5 38.1 30.4 30.1 43.2 21.5 40.0 5.5 54.2 32.4 87.9 38.5 39.2 53.3 194.2 46.2 23.3 53.1 56.9 292.6 30.6 66.7 57.7 30.1 80.5 25.3 52.7 24.4 45.7 18.5 34.3 50.5 31.6 32.4 95.6 23.8 35.3 474.5 25.1 39.3 62.2 15.0 56.7 24.2 72.1 12.5 20.8 65.7 29.6 18.0 89.9 23.7 41.9 22.1 61.6 37.3 13.1 36.9 36.0 152.5 87.6 20.7 35.4 30.6 57.4 28.4 36.3 30.2 RPTOR "KIAA1303, KOG1, Mip1, raptor" ENSG00000141564 "Regulatory associated protein of MTOR complex 1" Q8N122 17 80544819-80966371 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013514, HPA064306" Approved Enhanced Vesicles,Lysosomes NA NA "Vesicles, Lysosomes" "CAB013514: AB_2533523, HPA064306: AB_2685240" "unprognostic (5.09e-3)" "unprognostic (1.01e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "unprognostic (9.75e-2)" "unprognostic (3.34e-3)" "unprognostic (1.17e-2)" "unprognostic (9.63e-2)" "unprognostic (8.80e-2)" "unprognostic (4.40e-3)" "unprognostic (8.46e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-2)" "unprognostic (1.77e-2)" 6.0 4.6 2.9 4.4 2.8 4.1 3.6 1.9 3.7 4.0 0.2 4.9 4.8 5.7 1.8 4.5 4.5 2.9 6.1 3.5 2.4 3.1 3.5 4.3 3.3 3.1 2.6 3.1 4.9 5.5 5.4 4.0 3.6 3.3 4.5 2.4 2.6 4.6 5.1 14.3 5.0 4.6 4.7 2.0 3.9 4.5 4.0 2.9 4.4 3.7 7.1 2.7 5.4 3.6 3.6 16.2 34.7 6.8 12.9 9.5 7.0 15.5 12.7 9.5 17.9 12.4 21.5 13.8 13.3 10.1 12.9 13.8 11.6 10.5 15.7 8.9 5.6 19.6 20.8 16.8 21.2 8.9 19.8 15.3 12.3 9.9 17.3 9.1 5.9 16.6 15.7 24.9 4.6 8.6 8.8 12.4 7.8 7.4 9.2 24.0 10.2 12.9 11.2 4.6 17.8 13.4 17.4 14.4 22.9 14.9 6.6 16.3 14.5 9.6 37.1 17.8 11.6 15.7 8.9 3.9 12.6 22.4 10.1 23.6 0.0 0.1 0.0 0.5 0.3 0.3 0.2 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.1 0.2 0.0 1.0 0.4 2.9 2.8 1.9 3.7 3.5 2.4 3.1 2.6 3.1 3.3 2.0 2.9 3.6 4.3 0.0 3.9 46.0 8.5 3.2 3.0 2.4 4.6 6.8 4.2 3.3 4.5 5.7 1.6 5.5 4.2 4.4 7.2 3.8 1.9 3.6 6.7 3.9 5.4 4.3 6.0 4.8 70.1 3.8 5.9 4.8 8.2 4.9 2.5 7.5 2.2 7.5 4.7 11.8 66.3 3.1 6.1 5.7 3.2 10.9 3.1 6.7 1.8 32.8 1.7 4.3 2.1 50.8 66.2 4.7 3.5 5.3 9.4 4.5 4.6 2.7 2.0 7.0 0.0 5.5 4.1 4.5 3.5 5.1 3.0 4.4 9.3 6.0 5.6 3.8 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 14.1 24.2 10.3 12.8 11.3 8.1 12.2 14.0 15.1 14.3 1.2 16.2 9.4 19.9 9.9 20.4 13.3 10.1 16.5 11.4 8.4 10.4 13.2 14.3 12.6 6.6 7.4 10.8 14.8 15.5 20.2 17.9 15.8 8.6 13.4 9.5 11.7 12.2 12.7 43.4 18.7 12.2 16.5 3.6 11.7 14.8 28.3 8.0 18.6 15.5 28.7 12.0 15.6 13.5 12.3 48.4 50.4 46.3 50.9 26.2 28.5 31.0 27.6 31.6 47.4 47.9 49.1 30.1 40.7 19.6 34.4 52.3 27.6 49.7 32.0 44.4 28.3 47.9 42.3 32.7 49.4 41.0 47.3 27.2 27.2 57.2 50.4 56.8 29.2 48.9 43.7 57.7 40.7 26.3 28.8 81.8 30.4 26.5 39.7 38.2 53.0 39.4 34.2 21.7 40.1 76.2 56.1 27.4 69.0 65.1 48.8 48.7 54.3 38.3 62.2 43.2 42.2 56.6 46.7 45.1 53.5 33.4 39.0 33.4 1.5 1.0 1.2 1.4 0.7 1.1 1.5 1.1 1.4 1.2 1.0 0.8 0.9 0.1 1.6 0.9 2.0 1.3 0.6 10.3 11.3 14.0 15.1 11.4 8.4 6.6 7.4 10.8 8.6 3.6 8.0 12.3 21.5 51.3 27.1 23.5 11.5 37.2 8.0 10.6 10.2 19.2 17.7 15.7 19.5 7.2 16.2 14.7 12.5 11.9 19.3 15.6 3.9 8.7 15.6 19.4 22.4 14.9 10.9 7.8 44.6 10.7 8.8 13.2 14.3 26.7 2.5 22.1 10.8 13.4 20.0 47.1 39.6 12.6 8.2 17.3 22.0 24.1 9.3 19.2 12.4 20.6 13.9 12.3 6.2 33.2 49.1 11.4 12.4 13.2 13.3 13.6 12.2 7.1 13.9 16.7 0.0 19.8 16.6 15.0 10.3 17.0 43.0 9.7 11.6 30.6 13.0 10.7 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75896951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359" "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 11.7 7.8 11.9 8.5 13.7 7.5 10.8 15.1 12.2 15.5 10.5 13.5 8.8 14.8 6.9 14.3 13.2 7.1 8.9 11.0 12.9 11.2 8.5 13.0 10.6 14.1 13.6 10.5 14.2 15.8 7.5 11.9 5.4 13.9 11.8 8.0 7.3 12.7 8.1 13.3 14.8 13.6 8.4 13.4 16.8 11.4 4.0 13.6 6.5 12.3 6.9 8.2 14.7 14.1 16.6 19.8 20.2 7.8 22.2 13.5 19.2 4.0 8.3 8.9 11.1 9.4 9.1 17.0 21.4 6.5 7.2 15.6 13.7 16.8 18.6 6.8 11.1 28.9 16.9 20.4 12.5 13.4 17.2 18.9 12.0 14.4 8.9 16.0 9.3 29.2 27.2 29.3 19.5 8.7 20.6 38.0 33.7 17.7 20.0 19.5 31.3 11.2 30.9 11.2 8.2 16.1 14.9 11.4 21.3 22.7 9.7 21.2 24.2 14.5 26.6 13.5 13.3 16.9 17.9 7.4 6.2 16.2 32.2 11.8 1.4 1.1 1.8 1.9 1.0 2.2 1.4 1.4 1.9 0.9 2.0 1.5 1.5 1.1 1.9 0.6 1.3 1.3 0.6 11.9 13.7 15.1 12.2 11.0 12.9 14.1 13.6 10.5 13.9 13.4 13.6 16.6 8.4 6.4 4.8 13.1 7.5 2.9 5.7 2.4 3.4 19.0 3.7 3.0 4.3 5.7 3.4 9.2 12.5 0.9 9.0 3.6 1.9 3.2 0.4 2.8 9.2 8.2 0.0 9.5 4.5 3.4 3.6 6.6 7.1 4.0 7.0 8.6 5.7 3.8 8.9 5.0 5.9 6.6 6.1 5.4 9.3 0.5 13.7 6.9 8.8 3.7 4.9 6.3 3.1 6.6 9.3 5.3 2.9 9.4 5.8 5.1 4.8 5.9 1.8 12.9 0.0 9.3 5.2 0.8 2.9 6.7 3.7 0.5 8.5 6.4 5.9 2.8 CBX8 "HPC3, PC3, RC1" ENSG00000141570 "Chromobox 8" Q9HC52 17 79792132-79801683 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031462 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031462: AB_10601252" "unprognostic (4.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" "unprognostic (8.81e-2)" "unprognostic (3.26e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.94e-6)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "prognostic favorable (3.84e-5)" "unprognostic (4.74e-1)" "prognostic unfavorable (5.39e-7)" "unprognostic (6.99e-3)" "unprognostic (7.18e-2)" "unprognostic (4.51e-1)" "unprognostic (5.99e-2)" 3.7 3.4 1.7 2.5 1.7 2.1 3.3 1.8 1.8 3.2 1.8 2.3 2.9 2.4 11.0 2.9 8.6 1.9 3.2 1.5 1.8 3.6 5.7 3.2 3.1 1.9 1.9 1.2 2.1 3.6 6.7 7.7 2.6 2.1 2.3 0.7 4.6 2.6 2.0 2.4 2.8 2.8 1.1 1.3 3.0 2.9 11.0 2.3 3.8 3.0 0.8 2.0 2.1 1.8 2.9 12.4 24.9 6.5 23.7 3.5 2.2 8.0 6.2 4.4 5.2 3.6 13.6 6.2 9.1 17.1 3.5 4.6 11.6 8.5 1.9 2.3 7.0 11.9 3.3 13.9 14.8 4.1 13.8 27.4 1.9 3.8 3.3 0.9 5.2 1.1 10.7 8.2 4.0 1.6 15.2 15.7 20.3 2.7 9.0 13.4 14.5 5.8 16.9 4.1 8.5 9.5 19.3 8.9 28.2 14.8 2.3 14.8 17.7 2.8 10.9 15.0 4.4 9.9 11.3 4.8 6.0 6.8 13.5 6.2 0.9 5.0 15.0 3.2 6.8 1.1 4.5 1.8 1.9 5.7 1.8 1.7 1.7 6.3 3.3 7.3 4.6 1.9 2.0 1.7 1.7 1.8 1.8 1.5 1.8 1.9 1.9 1.2 2.1 1.3 2.3 2.9 2.3 0.0 0.5 0.7 2.8 1.8 1.2 4.4 4.0 5.3 2.7 2.2 4.1 8.6 2.3 3.7 8.4 7.1 4.1 3.9 0.0 4.6 2.8 15.6 4.9 2.1 9.1 0.0 0.2 5.4 2.8 2.4 5.6 5.2 5.7 2.3 0.7 2.5 5.0 8.4 0.3 7.1 2.0 2.2 1.0 0.4 0.9 2.3 1.8 0.0 1.9 7.2 2.1 0.0 1.0 4.4 5.1 2.2 2.7 0.9 4.3 2.3 5.4 11.0 0.0 0.6 3.9 6.2 11.5 3.8 1.1 2.5 3.4 4.0 4.7 0.4 SECTM1 K12 ENSG00000141574 "Secreted and transmembrane 1" Q8WVN6 17 82321024-82334074 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 91.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 63.4;Kupffer cells: 52.7;Macrophages: 36.8;Paneth cells: 48.2;Proximal enterocytes: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 154.2" "Group enriched" "Detected in many" 13 "granulocytes: 154.2;monocytes: 58.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 83.3;BJ hTERT+: 86.7;BJ hTERT+ SV40 Large T+: 66.1;BJ hTERT+ SV40 Large T+ RasG12V: 64.4;PC-3: 70.2;SiHa: 122.5;SK-BR-3: 66.9;U-2197: 92.8" "Low region specificity" "Detected in some" HPA051214 Approved "Secreted to blood" NA NA 16000000 "HPA051214: AB_2732565" "unprognostic (2.42e-1)" "unprognostic (2.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.15e-2)" "unprognostic (4.55e-2)" "unprognostic (9.39e-2)" "unprognostic (3.17e-3)" "unprognostic (7.75e-3)" "unprognostic (2.10e-2)" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (4.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" 17.2 4.0 1.5 40.9 1.5 11.8 13.1 1.1 3.3 15.1 3.5 37.0 67.4 11.1 1.7 13.0 14.5 12.5 4.8 1.2 4.9 18.2 5.9 29.0 17.5 2.9 1.4 1.0 5.9 4.1 1.9 2.4 13.2 2.3 14.0 23.8 0.1 34.9 5.8 2.4 16.0 91.1 14.7 1.4 42.8 24.7 1.6 2.5 5.9 3.8 2.6 8.6 17.9 13.5 3.7 20.4 4.5 0.0 1.4 33.3 83.3 1.7 9.9 86.7 66.1 64.4 2.1 40.9 0.0 0.4 29.1 1.0 60.4 0.0 4.0 2.5 6.5 0.2 8.3 28.2 5.5 25.4 0.0 0.0 35.8 8.6 3.6 1.5 4.9 1.9 0.2 0.3 0.1 42.7 0.8 0.1 0.1 0.2 5.3 70.2 0.0 0.5 1.0 19.0 0.1 4.5 0.5 122.5 66.9 1.5 0.2 5.6 1.8 0.7 7.5 0.6 92.8 0.1 0.3 0.0 0.1 1.7 0.0 0.4 0.1 30.9 0.0 0.4 58.2 0.3 0.0 0.6 0.2 8.3 0.0 0.1 0.1 154.2 0.0 56.3 3.5 0.0 4.5 1.5 1.5 1.1 3.3 1.2 4.9 2.9 1.4 1.0 2.3 1.4 2.5 3.7 8.2 12.8 2.4 0.0 1.0 9.4 4.6 0.8 5.2 0.0 4.4 1.5 0.9 0.0 3.0 1.8 0.0 0.3 1.8 63.4 0.0 9.5 0.1 3.0 4.4 6.0 0.0 0.0 0.0 9.9 0.9 6.1 8.6 7.3 1.3 0.0 3.6 1.3 7.1 0.0 0.0 8.7 2.0 52.7 10.7 0.4 5.3 36.8 1.8 0.0 19.5 0.0 1.0 0.0 0.0 5.4 48.2 0.0 1.1 19.5 62.5 3.2 3.6 0.0 0.0 0.6 1.8 0.1 0.2 0.9 3.4 0.3 1.1 0.0 1.3 21.3 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142465-76240493 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 87.4;retina: 59.5;skeletal muscle: 74.6;testis: 31.7;tongue: 44.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 114.1;Cone photoreceptor cells: 189.7;Excitatory neurons: 64.6;Horizontal cells: 180.0;Inhibitory neurons: 92.7;Rod photoreceptor cells: 70.9" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;T-cells: 5.8" "Cell line enhanced" "Detected in many" "HDLM-2: 100.9;U-266/70: 50.6;U-266/84: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 13.7 3.3 40.2 3.8 39.6 2.2 5.0 34.3 87.4 1.1 11.0 9.0 9.6 1.5 3.4 1.0 1.8 1.3 5.4 57.7 32.8 5.7 2.5 1.5 5.2 57.6 43.5 37.7 1.2 3.4 14.7 6.3 1.7 62.1 1.9 7.0 59.5 1.9 1.5 74.6 1.0 10.4 1.8 33.3 3.5 3.9 31.7 52.4 2.8 3.4 44.1 2.7 3.0 1.0 58.7 0.2 7.1 29.3 10.7 8.8 4.4 13.4 0.3 8.9 1.9 1.3 3.3 3.1 0.0 4.2 0.5 6.9 0.2 26.0 0.1 1.6 100.9 8.9 0.0 2.9 4.7 1.7 1.4 10.9 2.4 0.1 3.7 0.1 1.5 0.2 4.7 16.0 0.3 3.6 8.0 4.4 0.8 4.8 5.5 21.1 0.0 0.3 0.1 3.4 3.2 5.1 24.0 5.3 0.1 11.5 6.5 0.7 5.1 0.2 1.9 2.3 14.4 9.6 50.6 45.5 0.1 0.8 0.1 15.1 2.2 0.2 0.3 1.6 0.1 3.4 0.2 3.4 2.7 0.1 0.4 5.8 3.9 1.2 0.7 0.2 0.3 1.3 1.0 40.2 39.6 34.3 87.4 57.7 32.8 57.6 43.5 37.7 62.1 33.3 52.4 58.7 2.8 3.2 3.3 33.3 1.5 2.0 0.8 0.2 0.6 114.1 0.8 0.9 9.0 11.5 1.3 1.8 189.7 0.6 5.0 5.3 0.0 1.9 27.8 0.6 3.7 4.4 2.4 5.5 64.6 1.1 0.4 3.1 0.0 1.5 0.0 0.9 0.7 4.3 0.4 180.0 92.7 7.4 0.0 0.8 6.0 29.1 11.5 1.1 1.8 3.7 1.4 35.9 8.2 62.8 35.0 0.1 3.4 13.9 2.1 0.9 19.3 9.1 0.7 70.9 0.0 2.9 1.3 22.7 25.0 0.0 2.3 0.3 15.5 1.3 18.2 1.5 CEP131 "AZ1, AZI1, KIAA1118" ENSG00000141577 "Centrosomal protein 131" Q9UPN4 17 81189593-81222999 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatogonia: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024019 Approved Supported "Microtubules,Cytokinetic bridge,Centriolar satellite" Yes No Microtubules "Cytokinetic bridge, Centriolar satellite" "HPA024019: AB_1845227" "unprognostic (1.56e-2)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (2.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (9.68e-5)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.33e-3)" "unprognostic (7.04e-2)" "unprognostic (8.82e-3)" "unprognostic (1.36e-2)" "unprognostic (8.48e-2)" "unprognostic (2.66e-1)" "unprognostic (7.32e-3)" 8.4 8.6 5.7 5.3 5.4 10.3 10.4 6.3 10.1 14.0 6.2 9.6 4.7 11.5 0.9 9.1 11.6 2.0 13.0 5.4 4.7 11.5 6.8 10.8 7.9 5.7 5.1 4.9 12.9 10.2 2.2 15.5 4.2 5.6 12.1 0.8 1.9 9.4 2.1 11.2 10.1 10.3 1.7 4.7 19.2 10.0 28.4 5.2 3.6 10.4 2.0 2.3 10.5 10.8 5.7 21.1 20.0 10.6 19.4 1.7 2.7 33.6 14.4 2.5 10.3 7.9 23.8 10.5 14.8 8.0 3.5 6.3 14.9 3.1 7.0 2.5 6.2 26.8 14.3 32.7 41.3 2.9 12.5 30.6 2.3 4.6 7.5 2.1 3.3 7.3 15.6 10.6 8.5 2.7 23.5 29.0 24.3 9.5 6.1 17.7 29.0 12.1 6.1 3.9 18.4 24.2 27.2 18.5 11.4 18.0 3.9 17.2 12.3 10.0 18.6 32.1 16.7 19.2 22.0 4.0 11.3 9.6 10.7 13.5 2.1 0.8 0.5 1.2 2.3 0.3 2.9 0.7 1.1 1.8 1.7 1.1 0.8 1.3 1.0 4.6 2.0 0.1 0.8 5.7 5.4 6.3 10.1 5.4 4.7 5.7 5.1 4.9 5.6 4.7 5.2 5.7 6.5 0.0 4.4 5.5 6.6 0.0 3.4 0.0 3.4 5.8 3.3 4.4 13.4 2.8 1.3 3.7 6.2 8.7 4.8 5.6 0.0 4.5 14.0 8.4 3.5 6.0 6.7 5.7 2.1 3.7 7.2 6.9 6.6 2.8 15.9 9.3 2.5 1.7 5.2 5.0 2.9 5.1 0.0 1.9 0.0 17.9 9.6 3.6 0.0 1.0 1.3 6.0 7.2 2.5 2.8 5.2 0.8 3.0 4.4 1.2 1.8 1.4 3.6 6.9 0.0 4.3 5.7 14.7 20.5 3.7 0.0 6.0 3.5 8.4 7.9 2.7 ZNF750 "FLJ13841, Zfp750" ENSG00000141579 "Zinc finger protein 750" Q32MQ0 17 82829434-82840022 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 96.9;skin 1: 139.3;vagina: 52.2" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 33.3;Squamous epithelial cells: 156.8;Suprabasal keratinocytes: 41.1;Syncytiotrophoblasts: 68.1;Urothelial cells: 51.3" "Cancer enhanced" "Detected in many" "cervical cancer: 20.5;head and neck cancer: 24.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.3;hTCEpi: 7.2;MCF7: 5.4;SK-BR-3: 14.0" "Not detected" "Not detected" "HPA021573, HPA023012" Enhanced NA NA "HPA021573: AB_1859438, HPA023012: AB_1859439" "unprognostic (3.46e-3)" "unprognostic (1.94e-2)" "unprognostic (7.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.45e-1)" "unprognostic (9.73e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-3)" "unprognostic (1.34e-1)" "unprognostic (4.33e-2)" "unprognostic (6.30e-3)" "unprognostic (1.23e-2)" "unprognostic (5.30e-3)" "unprognostic (3.04e-2)" "unprognostic (5.94e-2)" "unprognostic (2.04e-1)" "unprognostic (4.25e-2)" 0.5 0.1 1.2 0.0 1.1 0.1 5.2 0.5 1.0 12.2 0.0 0.1 0.1 0.2 4.1 96.9 0.6 0.2 0.4 0.7 0.6 0.4 0.1 2.0 0.0 1.2 0.4 0.4 0.1 0.2 2.2 2.9 3.9 1.2 3.3 0.0 0.0 33.9 2.7 12.1 139.3 0.1 0.0 0.4 0.1 0.2 0.4 1.1 5.1 3.6 0.0 14.8 5.0 52.2 2.4 0.1 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 1.2 1.0 0.0 14.0 0.0 1.7 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.5 1.0 0.7 0.6 1.2 0.4 0.4 1.2 0.4 1.1 2.4 0.6 0.0 8.2 0.0 0.0 5.2 14.3 19.6 9.1 0.0 7.4 5.0 0.4 0.0 21.2 0.0 0.0 23.1 0.0 0.0 0.0 0.0 2.4 27.1 3.3 0.9 0.0 0.0 0.4 0.0 1.9 0.3 0.0 33.3 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 10.2 0.0 0.3 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 7.6 0.0 0.1 14.2 0.0 0.0 0.1 1.5 0.0 0.2 156.8 41.1 68.1 0.2 0.0 0.0 51.3 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 462.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 39.1 44.9 48.0 22.6 52.4 59.2 38.0 49.8 50.5 35.8 38.6 33.3 31.1 38.2 30.4 59.8 44.0 37.1 37.4 45.5 47.2 37.4 32.7 33.2 23.5 51.4 49.3 43.4 50.6 46.5 46.5 37.1 25.7 49.3 37.8 26.1 31.2 47.0 28.8 24.6 45.6 34.6 27.8 52.9 28.8 40.3 50.5 50.4 24.0 32.4 27.0 26.1 40.2 40.5 57.9 100.5 65.1 56.0 54.6 53.8 44.4 63.0 71.1 77.7 106.4 93.5 78.7 53.8 27.9 44.8 64.2 76.9 52.4 52.8 58.5 101.4 18.6 93.7 55.4 40.5 67.8 64.1 42.8 42.8 50.9 61.7 62.1 57.3 52.1 88.2 38.0 41.6 27.8 63.0 66.8 31.3 37.6 72.3 86.8 78.2 36.6 92.0 28.1 65.0 99.3 68.3 100.9 66.9 74.7 90.7 67.6 86.9 39.2 63.6 120.0 94.4 81.5 135.8 66.5 29.7 40.5 76.8 42.9 87.0 34.2 27.5 33.9 16.4 27.6 16.6 13.4 12.5 13.7 22.2 12.8 10.9 10.5 21.9 13.9 22.8 10.9 11.3 19.3 48.0 52.4 49.8 50.5 45.5 47.2 51.4 49.3 43.4 49.3 52.9 50.4 57.9 62.1 32.1 47.3 17.0 51.5 59.9 48.6 71.5 48.3 39.7 76.3 54.0 21.2 60.1 84.4 42.3 12.5 54.4 49.6 85.6 88.0 128.8 152.7 145.2 72.5 56.1 47.4 14.5 16.9 137.7 77.3 44.9 43.3 177.1 73.5 32.7 47.2 71.5 45.8 45.4 20.0 68.0 67.1 62.0 42.5 462.7 57.2 72.8 56.9 15.9 57.8 66.2 44.3 13.0 24.6 157.6 55.4 48.2 24.8 72.8 58.3 71.5 91.1 34.9 32.9 44.6 53.2 94.5 171.6 53.8 72.5 108.1 46.7 37.0 68.3 101.0 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839440 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 131.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.8;SK-MEL-30: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 8.4 14.4 9.4 11.2 9.7 131.4 9.1 7.6 12.6 7.3 0.3 7.7 7.2 6.3 4.7 20.9 8.1 6.4 15.9 12.2 9.5 8.0 21.8 12.5 14.7 11.2 9.4 8.8 9.7 19.2 17.2 19.2 15.3 11.9 9.4 3.2 12.4 13.4 4.7 3.5 29.9 12.0 3.8 7.4 21.1 13.0 6.9 10.7 23.3 8.7 1.4 7.3 6.7 10.4 16.1 32.1 28.3 8.4 36.3 5.2 4.7 23.5 14.3 8.5 5.1 5.4 20.5 17.5 12.3 19.7 5.6 11.4 16.3 9.3 9.5 3.8 13.3 17.7 7.0 28.0 38.4 25.4 37.0 52.5 6.5 54.4 4.7 8.4 8.5 4.3 35.5 21.7 67.5 5.5 23.0 50.9 37.7 4.6 33.2 28.2 51.9 8.6 56.3 7.2 15.3 8.7 16.6 21.4 110.8 130.9 3.5 26.3 58.3 11.2 29.8 26.3 18.4 18.6 58.0 32.4 35.0 18.7 31.6 40.4 1.6 0.5 1.8 0.9 0.6 0.6 1.5 1.2 1.3 0.3 1.5 1.4 1.3 2.1 0.4 0.7 1.7 0.2 0.6 9.4 9.7 7.6 12.6 12.2 9.5 11.2 9.4 8.8 11.9 7.4 10.7 16.1 40.4 3.2 15.7 4.6 31.8 23.3 5.4 13.4 36.5 31.7 65.2 79.8 51.6 30.0 12.1 1.8 22.9 34.2 77.6 26.6 0.0 7.5 0.2 63.9 19.3 21.6 52.7 7.8 5.5 7.3 5.0 15.8 20.9 62.8 7.0 22.3 15.7 16.3 13.8 20.2 5.5 49.5 2.0 19.8 17.0 1.0 4.4 35.4 17.8 12.2 15.4 39.2 15.5 6.0 11.6 10.0 18.4 5.7 26.1 6.3 9.6 2.8 14.6 44.3 6.6 15.3 24.4 0.5 2.4 65.7 30.7 8.6 42.5 13.7 29.7 5.2 RNF165 "Ark2C, ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 44.0;Cone photoreceptor cells: 100.1;Excitatory neurons: 47.4;Horizontal cells: 80.8;Inhibitory neurons: 34.4;NK-cells: 41.2;Oligodendrocyte precursor cells: 35.7;Rod photoreceptor cells: 49.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 10.1;HaCaT: 7.3;HeLa: 7.5;RPMI-8226: 6.4;SCLC-21H: 13.9;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041615: AB_2677582, HPA047798: AB_2680158" "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 0.6 0.6 3.2 0.3 3.7 0.3 0.7 6.9 6.0 0.5 0.0 0.3 0.0 0.2 1.9 1.2 1.2 0.3 1.0 5.0 1.9 0.8 5.2 0.3 0.2 0.4 0.6 4.2 0.0 0.3 2.4 4.1 0.2 2.6 2.2 0.1 18.4 0.8 1.4 1.6 1.2 0.3 0.1 0.0 2.0 0.2 0.5 1.0 0.9 4.0 0.8 0.4 0.3 0.5 1.9 1.6 0.1 10.1 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 7.3 0.5 1.0 0.0 0.0 1.1 0.1 7.5 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 2.3 0.0 0.2 0.0 0.0 2.6 0.9 1.7 0.4 1.3 2.7 0.6 6.4 0.7 2.2 13.9 13.2 2.0 0.0 0.0 0.9 0.3 0.5 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 3.2 3.7 6.9 6.0 5.0 1.9 0.4 0.6 4.2 2.6 0.0 1.0 1.9 9.1 3.2 1.7 1.6 0.3 2.7 9.5 12.9 28.5 44.0 2.9 7.2 8.4 1.5 2.8 0.0 100.1 0.2 10.0 0.2 3.9 0.0 3.8 1.5 9.3 5.0 0.0 0.0 47.4 0.0 0.3 2.4 0.0 0.6 0.0 0.0 1.8 8.9 0.1 80.8 34.4 0.0 2.0 1.9 1.3 5.1 2.5 0.4 1.8 1.9 0.3 5.0 41.2 35.7 1.8 0.1 0.0 4.1 0.4 5.0 0.1 0.1 0.6 49.1 0.0 4.5 0.7 0.4 0.9 3.7 2.0 0.3 3.2 3.2 0.0 2.4 DYM "DMC, FLJ20071, SMC" ENSG00000141627 Dymeclin Q7RTS9 18 49036387-49461347 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 113.6;Early spermatids: 353.4;Excitatory neurons: 173.2;Inhibitory neurons: 204.1;Late spermatids: 176.1;Microglial cells: 149.9;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 299.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043551, HPA049187" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA043551: AB_2678547, HPA049187: AB_2680668" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (3.12e-3)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.85e-3)" "unprognostic (1.77e-1)" "unprognostic (1.72e-1)" "unprognostic (8.30e-3)" "unprognostic (2.53e-2)" "unprognostic (2.58e-2)" "prognostic favorable (2.76e-5)" "unprognostic (3.89e-1)" "unprognostic (1.69e-1)" "unprognostic (4.26e-3)" "prognostic unfavorable (5.26e-5)" 17.6 19.3 18.8 14.9 18.9 24.2 23.5 24.8 20.6 23.8 22.9 18.1 16.0 20.0 20.4 25.5 18.7 17.9 20.6 16.5 20.8 21.3 19.9 15.9 17.1 22.2 21.0 14.0 29.7 81.4 28.9 10.0 14.7 24.7 20.8 17.0 36.3 36.9 22.2 50.1 18.2 14.2 25.3 20.4 12.8 16.7 44.4 19.7 33.3 32.9 46.4 20.8 23.4 22.4 23.9 32.9 19.8 30.6 47.0 56.9 63.9 24.1 32.2 42.1 37.7 36.8 14.6 20.7 102.1 27.8 60.1 27.9 41.0 48.1 42.1 46.0 38.6 24.7 23.8 16.9 43.4 56.7 83.5 41.5 50.1 49.1 44.1 112.7 63.3 59.0 51.6 25.7 60.5 30.4 35.0 56.5 35.5 9.8 27.1 15.2 29.2 39.2 48.3 34.8 37.2 56.5 36.5 21.9 26.1 30.2 34.5 36.7 29.8 32.6 35.6 16.9 15.5 18.9 67.8 52.7 57.4 19.1 51.6 40.5 20.9 26.9 32.7 20.2 23.4 27.2 17.0 19.3 18.7 29.2 13.9 19.6 15.2 11.9 30.6 20.6 8.4 21.4 21.4 18.8 18.9 24.8 20.6 16.5 20.8 22.2 21.0 14.0 24.7 20.4 19.7 23.9 16.0 6.4 6.9 113.6 29.1 11.6 20.4 8.1 29.0 20.1 17.9 15.4 24.5 17.2 8.4 3.7 6.2 19.5 17.4 10.5 13.7 18.1 353.4 11.6 17.2 16.3 16.2 17.9 173.2 20.3 22.2 20.6 17.3 14.8 16.5 23.3 14.3 11.5 16.7 21.9 204.1 15.1 6.1 23.0 15.1 176.1 27.7 20.5 3.6 149.9 19.7 16.1 24.7 167.9 299.4 14.7 11.4 27.1 23.8 25.0 16.1 22.5 13.4 24.9 13.1 22.4 15.4 49.8 16.2 19.4 11.4 35.2 21.6 18.1 16.2 20.2 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560087-50731826 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 114.5;parathyroid gland: 51.4" "Cell type enhanced" "Detected in some" "Astrocytes: 202.7;Excitatory neurons: 105.2;Inhibitory neurons: 58.5;Late spermatids: 66.4;Muller glia cells: 62.6" "Cancer enriched" "Detected in many" 4 "glioma: 15.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;HeLa: 3.3;NTERA-2: 2.2;SCLC-21H: 11.6;SH-SY5Y: 2.8;SK-MEL-30: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes NA "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 0.9 27.0 56.9 0.2 76.7 0.0 0.8 58.3 41.6 1.2 25.8 4.9 0.6 0.8 3.2 2.3 1.5 1.9 21.3 41.0 114.5 3.3 4.5 2.4 0.0 63.0 60.9 32.3 2.9 1.4 51.4 17.9 2.6 58.2 5.1 0.8 22.8 0.9 9.9 1.5 1.2 1.6 1.9 45.2 0.1 2.1 2.4 67.8 7.4 6.3 1.5 0.0 4.6 1.3 47.5 0.0 0.0 1.0 0.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.1 1.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.6 2.8 0.0 0.8 1.9 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 76.7 58.3 41.6 41.0 114.5 63.0 60.9 32.3 58.2 45.2 67.8 47.5 0.4 9.6 0.0 202.7 0.0 0.0 0.4 0.0 0.0 11.4 0.9 1.1 22.9 1.5 0.0 0.0 0.0 4.6 0.0 0.0 5.9 0.9 30.1 0.0 0.0 0.3 0.0 0.0 105.2 0.0 0.3 1.0 0.0 0.0 0.0 0.7 0.0 1.0 0.4 5.0 58.5 0.0 0.0 0.0 0.0 66.4 0.9 0.1 0.0 7.5 0.0 62.6 0.0 18.6 1.9 0.4 0.0 1.5 0.0 0.7 0.0 0.2 0.0 1.0 0.0 1.0 0.7 0.8 0.6 0.0 0.0 1.8 0.0 0.4 0.0 0.1 ELAC1 D29 ENSG00000141642 "ElaC ribonuclease Z 1" Q9H777 18 50967991-50988121 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040867, HPA066483" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040867: AB_10697716, HPA066483: AB_2685675" "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "unprognostic (6.95e-3)" "unprognostic (1.75e-2)" "unprognostic (8.61e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (3.03e-3)" "unprognostic (5.87e-2)" "unprognostic (2.82e-3)" "unprognostic (3.67e-3)" "unprognostic (6.36e-2)" "prognostic favorable (8.43e-8)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" 5.2 7.3 4.5 5.5 4.2 2.4 6.2 3.6 6.1 5.1 4.3 6.3 5.1 4.5 13.0 4.4 6.5 4.1 3.3 4.0 4.4 8.1 10.0 5.1 6.8 4.5 3.9 3.7 5.5 8.8 11.9 5.8 5.7 3.9 6.3 7.0 5.1 6.6 6.1 3.1 4.6 6.6 4.3 3.2 7.0 6.3 7.2 4.3 7.3 10.3 2.9 7.0 4.8 3.4 4.9 9.1 6.1 16.0 13.6 17.5 7.4 6.8 9.8 12.7 9.0 6.3 2.3 7.9 7.0 6.5 9.1 7.2 8.8 5.0 10.3 6.1 15.4 1.3 8.6 2.3 1.6 10.4 22.1 5.8 9.3 8.1 4.8 11.0 7.2 9.5 10.0 8.9 16.9 16.0 4.1 7.8 6.4 8.0 7.6 3.1 8.6 5.6 13.0 10.4 3.8 9.4 10.7 8.2 1.4 15.5 6.6 7.5 16.6 8.4 11.6 6.0 3.4 6.7 15.8 14.4 9.3 10.7 7.3 14.9 5.0 9.6 10.0 15.4 11.5 17.1 18.6 14.7 14.9 15.4 16.8 14.0 18.1 0.9 20.8 11.4 13.0 12.8 10.0 4.5 4.2 3.6 6.1 4.0 4.4 4.5 3.9 3.7 3.9 3.2 4.3 4.9 5.9 6.4 6.5 7.2 7.6 2.4 5.6 14.5 4.6 7.3 8.7 10.4 8.6 12.8 8.0 3.7 2.1 23.3 4.0 8.5 19.6 14.6 21.4 8.8 6.3 7.9 10.3 5.5 4.1 13.5 13.3 8.1 3.1 4.8 8.2 11.4 10.0 15.2 15.4 5.0 5.3 8.2 14.2 8.9 2.8 22.8 5.0 6.3 5.4 2.8 10.2 15.8 23.7 7.5 8.4 10.4 9.1 7.2 5.6 8.1 15.9 25.5 11.8 8.2 0.0 8.5 6.4 29.1 12.9 5.6 3.4 18.9 6.8 11.1 10.5 4.9 MBD1 "CXXC3, PCM1" ENSG00000141644 "Methyl-CpG binding domain protein 1" Q9UIS9 18 50266882-50281774 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 97.4;Spermatocytes: 136.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009017, CAB036003, HPA068850" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121" "unprognostic (2.12e-2)" "unprognostic (5.05e-2)" "unprognostic (6.88e-2)" "unprognostic (5.01e-3)" "unprognostic (9.20e-2)" "unprognostic (6.85e-2)" "prognostic unfavorable (5.08e-6)" "unprognostic (5.91e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (1.70e-6)" "unprognostic (7.06e-3)" "unprognostic (7.70e-2)" "unprognostic (7.05e-2)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 28.2 40.1 23.3 26.4 24.5 44.5 29.3 24.1 28.4 32.6 18.5 34.3 25.0 32.4 20.7 39.6 31.9 19.8 34.6 26.1 21.7 32.3 36.0 30.1 30.4 23.1 21.7 25.5 35.1 34.8 32.7 43.1 24.8 24.5 33.3 17.8 24.2 30.8 23.8 51.4 43.1 34.0 20.6 19.4 41.3 33.9 88.8 22.5 29.9 35.7 28.8 24.4 35.6 32.5 25.2 30.9 28.6 31.5 35.9 33.2 26.9 33.9 36.2 41.4 49.2 37.7 21.6 23.9 48.5 25.8 35.3 28.8 54.4 36.3 63.4 28.4 54.7 23.2 30.6 43.8 23.1 63.9 74.8 62.1 31.5 100.4 56.2 127.2 31.1 40.9 47.4 39.3 73.8 38.3 28.5 63.3 38.9 29.8 16.1 22.7 57.8 23.3 53.2 24.4 13.8 41.5 39.5 27.0 25.5 33.2 25.4 32.4 67.4 44.7 53.0 24.1 17.3 37.2 135.8 62.2 51.6 34.3 56.8 49.0 16.0 11.2 22.7 15.3 9.7 14.6 11.6 13.5 12.9 11.2 11.4 13.8 11.4 14.5 14.3 7.8 10.2 13.8 12.6 23.3 24.5 24.1 28.4 26.1 21.7 23.1 21.7 25.5 24.5 19.4 22.5 25.2 17.7 9.6 24.6 19.6 20.1 22.7 13.9 18.2 23.3 15.1 16.5 14.5 28.1 14.3 20.5 16.5 18.8 31.1 25.0 24.5 13.7 15.7 85.1 17.1 16.1 17.6 13.1 9.7 20.4 13.8 24.2 16.5 28.1 17.3 8.8 17.7 13.9 18.1 18.7 15.2 17.3 19.5 24.4 15.8 11.1 97.4 15.5 17.5 16.0 9.4 15.7 17.4 14.4 12.1 16.4 21.1 24.5 19.2 34.6 14.4 21.3 9.7 16.9 20.3 13.1 14.8 18.9 136.0 32.5 21.6 29.3 51.4 20.0 28.1 18.6 17.0 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favorable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 16.5 11.9 10.0 11.0 11.4 10.7 17.3 22.9 10.6 18.7 11.5 14.0 12.0 20.8 9.9 15.9 16.5 12.9 14.2 12.7 10.4 16.3 19.2 13.2 12.8 9.2 9.4 9.2 24.2 21.6 20.0 11.4 19.1 13.4 22.0 14.5 18.5 14.1 18.1 25.2 14.8 12.2 19.1 9.1 14.0 15.3 14.3 11.7 17.9 21.6 25.1 14.6 13.6 13.2 14.9 16.4 22.5 59.4 16.6 23.9 36.6 31.4 27.7 32.2 39.4 49.6 13.0 3.8 25.9 7.8 25.6 19.6 24.9 33.6 13.2 40.7 19.3 14.8 20.6 20.5 15.9 23.7 34.8 13.1 16.6 21.9 19.1 27.8 37.0 28.7 14.0 21.9 25.8 23.5 9.0 18.8 10.0 31.2 9.1 14.3 23.3 30.6 26.9 18.2 7.4 34.4 20.3 27.0 5.0 18.8 24.8 13.3 19.4 20.0 34.5 13.3 8.8 19.7 30.6 28.6 26.2 21.2 12.8 22.6 0.3 0.6 0.6 1.0 0.4 1.1 0.7 1.0 0.8 1.2 0.9 1.2 1.5 1.0 1.0 0.4 1.0 1.4 0.5 10.0 11.4 22.9 10.6 12.7 10.4 9.2 9.4 9.2 13.4 9.1 11.7 14.9 32.5 22.4 29.1 55.2 21.0 25.6 20.9 15.1 18.8 17.1 27.3 20.4 38.8 24.3 19.3 22.0 20.9 20.7 24.0 22.7 11.7 16.9 10.6 30.4 36.6 26.2 39.6 12.4 37.0 12.5 20.6 30.3 28.5 35.2 4.5 132.4 28.5 44.1 15.1 15.2 39.0 32.1 16.2 28.5 20.9 16.2 33.2 21.1 28.4 49.6 16.9 20.4 17.5 41.2 72.5 20.1 21.0 30.5 24.8 36.3 26.7 22.6 22.4 20.0 26.3 32.2 34.2 17.2 18.8 20.9 27.3 12.6 20.1 22.1 24.5 29.7 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391288 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 30.7;salivary gland: 25.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "NK-cell: 5.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 5.3" "Cell line enriched" "Detected in many" 6 "HDLM-2: 125.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 110000 "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 1.6 1.1 0.6 5.8 1.5 0.4 4.1 0.1 1.8 1.4 0.5 17.2 30.7 1.0 0.3 2.9 0.9 7.7 0.6 1.6 1.1 0.3 0.6 1.0 1.2 0.4 1.3 1.2 0.4 1.7 0.9 6.9 3.3 0.5 1.3 17.7 0.2 25.6 2.7 0.3 2.7 18.7 1.7 0.7 0.8 5.6 0.9 1.4 1.0 1.2 0.1 1.9 1.7 1.6 2.0 3.2 2.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 1.6 0.4 0.6 0.0 3.5 0.4 1.4 2.2 8.3 0.9 0.2 125.9 5.4 0.0 1.3 1.7 0.0 0.5 1.3 0.2 0.4 0.8 3.1 4.2 3.1 0.3 0.0 0.0 0.0 1.1 0.0 0.1 5.9 7.0 19.3 0.4 0.0 0.6 1.5 1.5 20.4 0.7 0.6 3.0 0.1 0.8 1.3 0.4 2.0 0.0 0.1 0.1 0.0 1.2 0.0 0.1 0.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.3 0.0 0.3 0.6 0.0 0.6 1.5 0.1 1.8 1.6 1.1 0.4 1.3 1.2 0.5 0.7 1.4 2.0 0.4 0.0 2.2 0.0 0.4 1.3 3.8 1.1 0.6 0.6 4.5 3.3 1.3 8.6 2.3 0.0 0.0 0.1 3.3 35.6 0.0 8.3 0.3 3.2 0.5 5.3 10.8 0.0 4.0 7.5 0.6 0.7 11.7 6.2 0.0 2.0 7.1 0.3 15.5 3.3 0.2 24.0 0.0 17.0 2.4 0.4 0.6 7.7 1.8 8.4 19.7 0.0 3.1 0.5 0.4 14.7 42.3 0.0 0.5 2.8 25.5 0.0 3.8 0.2 0.0 0.5 0.4 0.8 1.9 1.7 2.3 0.1 0.7 0.0 42.2 4.4 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523025-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 143.8;Late spermatids: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 10.0 5.5 8.4 5.8 6.7 26.7 9.2 8.8 8.3 6.6 5.8 6.9 6.8 6.3 6.0 5.6 7.9 8.7 8.5 6.8 9.6 5.5 23.5 10.3 7.1 7.6 6.5 4.8 8.0 6.2 5.8 8.1 8.1 7.4 7.4 5.4 10.1 37.5 5.3 12.3 11.5 7.6 5.9 4.8 9.1 6.4 12.1 7.9 7.6 7.4 7.4 6.4 7.9 6.6 13.9 8.0 6.8 5.8 11.5 17.1 7.3 10.9 4.5 6.7 10.5 10.4 3.7 4.8 22.4 5.8 7.4 8.6 13.2 18.6 9.9 4.3 15.5 8.8 5.9 15.6 25.2 5.9 11.4 8.3 7.2 12.6 6.7 12.3 7.6 19.9 9.9 6.4 7.3 3.5 6.5 7.5 4.8 3.7 5.8 6.7 9.7 6.1 0.1 7.3 8.0 7.2 4.5 7.5 16.8 6.6 10.2 5.9 8.9 8.6 10.3 7.0 4.1 6.5 2.8 5.8 9.4 7.6 4.7 3.9 0.0 0.3 0.8 0.5 0.5 0.4 0.1 0.3 0.4 0.1 0.4 0.6 0.4 1.5 0.2 0.1 0.3 0.4 0.1 8.4 6.7 8.8 8.3 6.8 9.6 7.6 6.5 4.8 7.4 4.8 7.9 13.9 23.1 25.6 18.8 28.1 10.8 26.6 16.9 7.5 10.8 33.1 15.2 13.2 18.8 20.0 12.4 16.5 54.2 7.4 33.6 10.2 3.9 6.8 143.8 24.1 12.3 28.8 12.6 8.2 48.5 6.2 10.9 9.7 10.2 27.5 2.5 4.4 17.5 35.4 14.1 43.7 33.9 15.5 2.0 44.4 22.0 158.6 8.1 30.6 7.2 29.0 11.9 7.7 9.2 37.2 51.7 5.1 9.1 7.9 10.7 16.5 8.4 5.3 10.8 19.5 6.6 15.6 15.0 16.3 15.2 15.3 18.5 6.8 22.6 5.6 11.5 12.2 FBXO15 "FBX15, MGC39671" ENSG00000141665 "F-box protein 15" Q8NCQ5 18 74073353-74147843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.1;testis: 7.1" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Endometrial ciliated cells: 41.1;Oligodendrocytes: 19.3;Respiratory ciliated cells: 59.2;Spermatocytes: 41.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "GAMG: 1.6;JURKAT: 2.6;SCLC-21H: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 17.6" NA NA "unprognostic (1.69e-2)" "unprognostic (1.97e-1)" "unprognostic (6.34e-6)" "unprognostic (1.65e-2)" "unprognostic (4.20e-1)" "unprognostic (6.77e-2)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (3.38e-2)" "unprognostic (1.00e-2)" "unprognostic (9.62e-2)" "unprognostic (4.46e-5)" "unprognostic (4.64e-2)" "unprognostic (3.35e-2)" "unprognostic (1.62e-4)" "unprognostic (2.87e-1)" 0.1 0.7 2.8 0.0 1.4 0.1 0.3 2.0 1.1 0.5 1.1 0.1 0.1 0.1 2.2 0.1 4.1 0.2 0.1 1.1 2.4 1.1 0.4 0.4 0.1 2.6 2.2 0.9 0.3 0.4 0.6 1.4 0.0 2.3 0.2 0.0 3.5 0.3 0.7 0.1 0.2 0.1 0.0 2.5 0.3 0.2 7.1 2.5 0.2 0.6 0.0 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.7 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 2.6 0.0 0.2 0.1 0.1 0.1 0.1 0.5 0.3 0.8 0.3 0.0 0.0 0.3 0.0 2.7 0.8 0.0 0.0 1.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 1.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.2 1.6 0.9 0.0 0.0 0.1 0.2 0.0 0.4 2.8 1.4 2.0 1.1 1.1 2.4 2.6 2.2 0.9 2.3 2.5 2.5 2.7 0.3 6.4 1.1 12.4 1.0 0.3 0.8 3.9 0.0 8.1 1.5 1.8 0.6 0.0 5.9 1.8 0.0 0.5 0.1 0.1 3.9 0.9 36.0 41.1 0.5 0.3 0.0 0.4 6.4 0.2 0.7 0.2 0.0 1.2 0.0 2.2 0.7 0.4 3.1 5.0 8.8 0.2 0.0 0.6 0.3 17.8 1.2 0.4 0.0 2.8 0.0 7.8 0.0 9.0 19.3 0.1 0.1 1.5 0.0 0.2 0.0 5.8 59.2 10.3 0.0 0.8 2.1 41.5 11.7 0.0 0.0 0.4 0.4 0.3 0.2 0.6 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 36.2" "Cell type enriched" "Detected in some" 13 "Excitatory neurons: 508.3" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 54.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA 1400000 "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.2 0.2 5.1 0.3 19.4 0.0 0.1 0.0 36.2 0.3 0.0 1.8 1.5 0.0 0.0 0.0 0.1 0.0 0.0 5.4 12.9 0.7 0.4 0.0 0.0 7.9 5.1 15.6 0.1 0.0 0.0 0.2 0.0 12.0 0.9 1.5 5.2 0.0 5.2 0.0 0.5 2.5 0.8 0.0 0.0 0.1 0.2 16.8 0.0 0.0 0.0 0.7 0.1 0.0 15.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 54.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 19.4 0.0 36.2 5.4 12.9 7.9 5.1 15.6 12.0 0.0 16.8 15.8 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 37.8 0.0 508.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.0 10.3 0.0 0.5 0.0 9.5 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PMAIP1 "APR, NOXA" ENSG00000141682 "Phorbol-12-myristate-13-acetate-induced protein 1" Q13794 18 59899996-59904305 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 88.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 169.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 169.8" "Cell line enhanced" "Detected in many" "GAMG: 207.5;U-138 MG: 202.1" HPA051063 Uncertain Uncertain Vesicles NA NA Vesicles "HPA051063: AB_2681330" "unprognostic (1.35e-3)" "unprognostic (5.02e-2)" "unprognostic (5.57e-2)" "unprognostic (4.88e-2)" "unprognostic (6.65e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.41e-2)" "unprognostic (6.12e-2)" "unprognostic (8.47e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.53e-1)" "unprognostic (7.68e-2)" "unprognostic (8.74e-2)" "unprognostic (1.09e-1)" 1.6 0.7 3.0 8.0 2.4 88.8 4.0 2.4 3.8 6.5 2.8 2.5 3.7 5.4 0.2 13.8 3.0 8.0 0.8 2.6 2.4 1.2 2.1 3.9 14.8 2.7 2.5 1.9 0.8 1.2 14.9 16.9 13.5 2.6 3.7 3.4 2.0 3.7 1.3 1.6 16.8 4.0 1.9 2.4 4.6 2.5 3.1 3.2 12.2 2.2 1.5 14.3 17.5 7.9 3.1 26.6 17.4 5.2 1.6 8.8 69.0 19.8 125.4 84.1 71.5 70.7 1.7 32.5 104.6 17.0 23.5 207.5 38.4 21.0 11.8 70.4 33.7 154.5 19.4 26.0 4.6 87.6 67.1 28.2 28.7 30.8 93.8 48.5 26.1 24.0 46.7 26.7 17.5 24.1 2.6 53.8 20.1 151.7 2.7 32.7 54.1 28.8 39.1 41.9 24.2 39.7 32.7 6.1 3.2 71.5 56.1 5.3 54.6 90.6 202.1 54.0 10.3 141.4 2.8 0.3 92.1 16.8 37.6 48.5 169.8 16.7 103.6 10.9 26.2 9.6 33.8 5.0 6.8 12.1 25.0 4.1 5.9 53.5 6.3 32.1 10.2 25.2 15.1 3.0 2.4 2.4 3.8 2.6 2.4 2.7 2.5 1.9 2.6 2.4 3.2 3.1 29.2 32.1 25.7 0.7 175.3 803.1 316.2 236.4 415.4 0.2 111.8 82.0 4.7 12.8 129.6 3.7 2.1 120.3 125.3 141.1 0.0 54.7 0.8 463.6 48.8 48.5 133.4 5.5 0.0 67.0 14.7 32.9 168.2 529.8 31.8 11.8 7.9 0.5 89.5 0.0 0.0 146.8 181.0 37.2 363.3 1.1 0.9 140.6 74.7 7.5 142.4 0.3 34.0 0.0 0.2 100.1 123.6 1.2 63.1 265.7 94.7 0.5 101.5 0.7 0.0 10.8 32.0 0.3 19.8 474.5 691.2 315.2 117.0 19.8 122.2 569.2 P3H4 "LEPREL4, NO55, SC65" ENSG00000141696 "Prolyl 3-hydroxylase family member 4 (inactive)" Q92791 17 41801947-41812604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 3.9;MAIT T-cell: 5.0;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.9;NK-cell: 8.5" "Group enriched" "Detected in many" 10 "NK-cells: 8.5;T-cells: 5.0" "Cell line enriched" "Detected in many" 13 "OE19: 1032.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022520 Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Vesicles" "HPA022520: " "unprognostic (9.11e-2)" "unprognostic (3.72e-3)" "unprognostic (3.66e-2)" "unprognostic (3.72e-2)" "unprognostic (8.69e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-3)" "unprognostic (1.94e-1)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (4.48e-6)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (8.96e-2)" "unprognostic (1.96e-3)" 4.7 11.7 4.8 5.6 4.5 0.5 4.9 6.7 6.7 10.1 6.3 6.2 7.7 10.8 5.0 2.8 7.7 6.9 7.0 4.1 5.6 6.6 2.3 6.0 2.8 4.6 4.4 4.3 7.9 13.0 11.6 10.6 12.2 5.6 7.3 4.2 1.3 10.5 7.3 4.9 7.5 6.5 10.2 3.7 3.3 5.3 2.3 5.2 1.3 12.3 2.0 1.7 7.2 6.5 4.6 9.2 45.0 27.4 70.8 29.1 28.1 26.9 75.5 33.6 25.6 35.0 22.3 12.4 1.4 30.6 58.7 19.5 16.4 23.6 32.3 10.1 21.0 35.5 11.4 44.1 30.3 35.4 2.3 3.6 29.5 9.5 22.3 20.3 61.0 32.6 3.2 2.2 11.6 16.7 31.6 0.6 6.8 17.1 1032.2 25.2 25.3 30.1 31.4 16.5 2.7 13.2 29.0 13.3 81.2 28.9 18.1 46.8 7.4 34.3 24.5 35.7 46.2 34.1 10.7 2.6 0.2 37.7 11.1 38.5 0.0 0.2 0.0 3.9 0.0 5.0 0.6 2.5 2.7 0.2 0.6 3.0 3.9 0.0 8.5 0.0 0.0 0.7 1.5 4.8 4.5 6.7 6.7 4.1 5.6 4.6 4.4 4.3 5.6 3.7 5.2 4.6 7.3 0.0 7.8 12.1 1.5 0.0 5.4 0.0 6.2 3.6 11.6 10.8 10.7 11.5 1.8 5.5 8.4 10.8 3.6 7.2 7.9 21.6 0.5 2.7 25.3 11.0 2.4 7.0 6.4 6.5 27.3 26.6 16.8 7.7 1.3 17.7 11.0 1.9 2.8 26.9 4.4 13.0 0.0 1.2 0.0 0.8 21.1 1.0 0.0 4.7 1.2 9.6 13.4 6.0 1.5 7.1 9.5 20.7 2.8 9.6 26.8 5.9 0.7 2.7 19.7 13.1 16.7 2.7 10.0 1.9 0.0 5.3 3.2 19.1 9.8 2.0 NT5C3B "cN-IIIB, MGC20781, NT5C3L" ENSG00000141698 "5'-nucleotidase, cytosolic IIIB" Q969T7 17 41825057-41836260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030786, HPA057095" Approved NA NA "HPA030786: AB_10602716, HPA057095: AB_2683333" "unprognostic (3.90e-2)" "unprognostic (5.75e-2)" "unprognostic (8.87e-2)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (8.11e-5)" "unprognostic (3.40e-2)" "unprognostic (6.05e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.67e-4)" "unprognostic (3.07e-1)" "unprognostic (7.17e-3)" "unprognostic (2.36e-2)" "unprognostic (4.80e-3)" "unprognostic (7.14e-3)" "unprognostic (1.42e-2)" 7.7 7.7 11.7 1.5 11.5 1.2 7.7 14.0 13.4 7.3 10.2 10.5 1.9 7.0 3.4 6.4 7.1 3.2 6.7 12.1 11.6 8.2 8.8 6.5 2.8 10.1 10.9 11.8 7.4 11.6 2.9 10.0 3.0 11.3 9.1 1.1 3.6 7.8 4.2 6.1 4.8 6.5 4.9 9.5 5.8 9.0 9.6 10.9 1.0 13.1 5.6 1.9 8.9 6.9 12.1 8.1 39.5 7.8 12.7 8.6 6.0 3.2 9.5 8.5 12.9 14.3 34.0 2.1 9.3 5.6 6.3 8.6 8.3 8.2 9.9 4.6 5.9 19.7 4.1 21.8 17.8 10.1 0.1 4.7 5.3 5.4 17.4 6.5 4.7 7.5 13.8 3.6 2.4 8.6 18.0 8.2 5.1 5.0 7.9 4.2 6.2 13.2 7.8 3.7 10.0 6.0 3.5 13.4 13.8 4.9 6.7 6.7 6.3 7.1 5.3 5.4 9.3 9.5 2.7 5.6 4.2 4.2 0.1 8.1 1.1 2.3 0.3 1.8 0.5 2.5 1.8 2.4 1.8 2.4 2.5 1.9 2.1 1.3 0.7 0.4 1.3 0.4 2.0 11.7 11.5 14.0 13.4 12.1 11.6 10.1 10.9 11.8 11.3 9.5 10.9 12.1 24.8 9.6 17.2 15.0 16.9 18.1 58.7 47.3 33.6 33.8 45.1 61.1 13.6 22.8 16.6 29.5 18.8 39.0 8.7 5.1 101.8 51.6 99.8 10.9 26.8 29.1 39.4 2.5 14.2 41.6 56.2 35.2 14.3 12.1 11.4 40.1 26.7 24.0 13.4 116.1 15.5 13.2 32.6 13.2 18.5 121.6 32.3 11.7 35.6 6.5 5.8 42.4 6.2 13.0 7.2 39.1 9.8 30.5 15.5 78.7 1.4 65.1 12.7 36.5 39.5 31.1 49.3 131.8 30.0 19.8 17.2 31.2 13.8 23.7 15.2 44.6 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 29.8;Collecting duct cells: 31.3;Pancreatic endocrine cells: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 15.6 21.9 18.2 13.3 17.5 7.0 17.1 17.4 19.1 22.3 19.2 18.8 14.3 18.7 21.5 29.4 17.0 11.0 14.2 17.9 18.3 17.3 33.6 17.5 19.6 17.8 19.1 17.3 19.8 40.3 19.0 20.5 21.0 17.9 25.8 17.0 31.7 23.4 14.1 22.6 34.1 20.9 15.3 17.0 30.4 23.0 39.0 19.6 20.8 16.5 16.6 21.8 19.5 23.3 17.6 12.0 36.6 15.8 25.8 39.6 21.9 22.5 16.9 22.7 19.6 22.9 17.5 25.3 26.3 23.1 27.5 20.1 45.9 20.5 25.3 18.9 28.2 19.3 10.7 22.2 31.0 27.2 18.6 26.5 33.6 34.2 21.5 21.8 21.7 21.3 19.0 22.3 25.4 15.7 20.7 27.5 26.9 10.0 22.5 9.0 14.7 24.2 27.2 22.5 38.2 28.2 19.3 18.1 14.6 26.1 28.9 41.5 14.2 27.2 21.0 12.8 21.1 16.2 43.4 55.3 22.7 19.3 11.6 16.2 54.9 16.2 36.4 44.5 19.2 39.1 23.7 36.5 42.9 15.1 24.8 35.1 40.4 13.8 28.2 24.1 15.0 57.0 36.4 18.2 17.5 17.4 19.1 17.9 18.3 17.8 19.1 17.3 17.9 17.0 19.6 17.6 16.7 25.6 29.8 0.0 8.8 0.0 0.0 0.0 0.0 0.0 21.7 18.3 0.0 0.0 6.2 31.3 0.0 22.4 24.7 0.0 7.9 16.4 0.0 14.5 16.7 7.4 0.0 0.0 0.0 25.4 16.0 7.4 0.0 20.0 7.6 26.8 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 33.8 0.0 0.0 8.8 0.0 0.0 13.4 5.1 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 20.4 8.1 17.3 0.0 0.0 ERBB2 "CD340, HER-2, HER2, NEU, NGL" ENSG00000141736 "Erb-b2 receptor tyrosine kinase 2" P04626 17 39687914-39730426 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 5.0" "Lineage enriched" "Detected in many" 4 "T-cells: 5.0" "Group enriched" "Detected in many" 41 "OE19: 6565.0;SK-BR-3: 3115.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 980000 "Plasma membrane" Cytosol "CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500" "unprognostic (1.97e-1)" "unprognostic (6.60e-3)" "unprognostic (6.21e-2)" "prognostic unfavorable (8.99e-8)" "unprognostic (2.96e-2)" "unprognostic (1.40e-2)" "unprognostic (1.97e-2)" "unprognostic (9.04e-2)" "unprognostic (1.79e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.92e-1)" "prognostic favorable (2.41e-14)" "unprognostic (9.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-2)" "unprognostic (1.96e-1)" 12.0 5.4 14.7 12.2 16.5 1.6 56.5 14.4 13.2 36.6 20.4 68.9 64.1 25.4 26.9 103.2 64.7 31.3 50.5 12.0 37.3 71.8 31.4 36.5 4.8 20.8 16.9 11.1 24.1 37.9 82.4 17.4 27.3 14.9 56.0 48.9 8.2 69.3 50.9 20.9 91.8 67.9 25.2 18.0 7.0 50.1 11.8 12.6 7.5 57.0 15.1 28.2 40.4 53.4 14.7 38.7 45.7 50.4 31.7 59.3 41.2 67.7 27.2 44.9 58.6 48.9 34.4 102.7 2.9 54.6 62.7 31.5 117.6 2.8 61.2 26.9 5.2 38.6 1.8 36.0 56.3 35.3 0.9 1.0 41.0 56.6 36.2 21.9 56.2 24.4 1.9 6.2 2.4 43.3 59.4 7.1 3.0 90.7 6565.0 11.7 3.9 20.5 5.4 58.9 118.9 9.4 2.6 51.5 3115.9 16.9 62.2 88.1 2.2 2.9 30.2 37.7 37.7 17.6 5.3 3.3 3.6 3.0 0.9 98.5 1.1 0.2 0.4 5.0 0.1 0.3 0.6 0.2 1.4 0.2 0.6 0.5 1.4 1.2 0.4 0.1 0.1 0.2 1.7 14.7 16.5 14.4 13.2 12.0 37.3 20.8 16.9 11.1 14.9 18.0 12.6 14.7 3.9 41.7 40.1 12.7 2.2 14.0 19.0 37.1 17.6 4.6 62.7 34.9 20.7 32.9 43.8 136.1 12.5 12.0 5.1 111.0 7.9 30.9 0.3 48.7 13.9 6.1 15.6 1.3 0.9 25.5 84.8 15.7 53.5 61.3 0.0 20.3 11.7 10.7 4.0 6.7 1.0 47.5 42.7 2.2 3.1 1.0 18.3 1.7 10.6 1.0 1.2 24.1 26.8 2.0 1.0 32.5 54.8 23.0 1.1 34.9 121.7 19.5 42.0 5.8 0.0 13.1 12.7 6.8 5.7 43.5 18.9 22.7 2.8 4.4 75.4 31.3 GRB7 ENSG00000141738 "Growth factor receptor bound protein 7" Q14451 17 39737927-39747291 "Cancer-related genes, Predicted intracellular proteins" "Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 4.7;pons: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "OE19: 1706.0" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Low region specificity" "Detected in many" "CAB005226, HPA057084, CAB073538" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330" "unprognostic (8.46e-2)" "unprognostic (2.06e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.60e-7)" "unprognostic (7.06e-3)" "unprognostic (2.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.10e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (2.59e-2)" "prognostic favorable (8.23e-5)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (5.49e-3)" "unprognostic (4.01e-2)" 3.1 0.1 0.1 0.7 0.3 0.0 14.3 4.7 0.4 8.3 3.5 8.2 11.9 3.4 3.9 60.7 22.5 9.6 1.1 0.2 0.3 42.1 11.2 10.7 0.1 0.0 0.5 0.0 1.0 33.0 11.5 7.0 12.0 1.4 14.7 10.1 0.1 25.5 11.7 0.3 39.2 10.9 1.0 0.0 0.5 17.1 1.2 0.0 1.1 6.7 0.1 8.8 7.5 26.4 0.2 12.6 14.4 0.0 0.0 0.0 0.0 19.1 0.0 0.8 0.1 0.5 44.7 24.3 0.0 4.2 0.4 0.9 24.1 0.0 16.1 0.0 0.0 2.1 0.0 6.4 38.5 0.0 0.0 0.0 0.0 15.1 0.2 3.7 2.5 0.1 0.0 0.0 0.0 0.0 11.5 0.2 0.1 4.9 1706.0 3.4 0.1 0.0 18.6 18.5 14.0 9.5 0.1 18.4 370.7 0.1 17.3 14.0 0.0 0.0 0.0 1.1 0.2 0.0 0.2 0.1 1.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.7 0.4 0.2 0.3 0.0 0.5 0.0 1.4 0.0 0.0 0.2 0.5 22.4 15.1 0.0 0.9 38.2 77.1 20.0 104.7 0.2 48.2 30.5 2.5 17.2 18.2 22.0 0.0 35.7 0.7 25.6 9.8 35.6 0.0 30.2 5.3 2.6 14.4 0.0 0.3 19.4 27.4 3.1 27.0 41.8 1.3 0.5 0.4 5.1 2.8 0.0 0.0 19.7 40.7 0.0 2.3 0.0 2.8 1.3 5.4 0.0 1.6 0.4 0.0 0.0 0.0 26.7 26.0 1.2 0.3 79.0 28.3 13.8 20.9 0.1 0.0 0.9 2.1 0.4 0.3 124.7 41.9 98.6 1.4 0.0 21.1 79.7 MIEN1 "C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4" ENSG00000141741 "Migration and invasion enhancer 1" Q9BRT3 17 39728496-39730532 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 14 "OE19: 1667.9;SK-BR-3: 502.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056650, HPA061344" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA056650: , HPA061344: AB_2684484" "unprognostic (2.48e-1)" "unprognostic (3.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-2)" "unprognostic (3.04e-1)" "unprognostic (1.17e-1)" "unprognostic (4.47e-2)" "unprognostic (8.37e-2)" "unprognostic (6.72e-2)" "unprognostic (2.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.17e-1)" "unprognostic (2.99e-2)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "unprognostic (2.22e-3)" 28.4 36.2 27.7 17.6 29.2 27.2 31.8 30.4 45.1 29.2 27.4 38.4 26.6 29.2 14.7 47.7 27.4 12.2 47.3 27.2 29.1 55.8 54.2 29.9 20.4 29.4 28.9 25.5 18.6 41.0 21.8 39.9 13.6 28.9 46.7 12.9 4.8 46.6 14.0 47.6 34.5 37.8 9.6 27.7 36.5 48.9 41.7 29.6 14.1 37.3 5.3 13.8 31.3 32.3 31.3 38.8 59.7 13.4 34.5 16.3 12.0 16.2 40.7 21.4 24.2 23.6 12.9 27.2 28.1 55.5 15.1 39.0 47.1 15.6 13.8 8.2 58.2 65.8 26.5 29.8 36.5 28.2 33.9 39.2 10.8 23.3 11.7 12.0 18.8 15.6 52.9 38.2 48.9 14.7 22.5 70.1 38.2 12.5 1667.9 26.4 32.2 23.6 56.8 12.2 21.8 43.6 41.7 40.8 502.3 70.7 12.0 66.1 48.1 41.5 16.4 41.8 78.9 47.1 62.3 62.8 55.1 64.5 41.1 32.4 138.5 76.2 107.3 80.1 100.9 43.4 109.2 56.2 72.3 54.5 88.3 43.9 63.1 132.9 58.7 104.2 79.4 94.6 119.9 27.7 29.2 30.4 45.1 27.2 29.1 29.4 28.9 25.5 28.9 27.7 29.6 31.3 59.8 44.8 64.2 7.8 60.9 60.2 138.1 185.1 95.6 25.7 127.0 114.2 59.6 82.9 129.3 99.3 4.2 150.2 69.1 226.6 303.3 137.0 136.2 81.6 48.7 58.9 188.8 72.0 11.0 176.1 74.4 50.9 76.5 77.3 81.8 43.8 54.7 118.9 148.0 35.3 9.6 178.3 254.3 101.3 42.8 76.7 42.3 81.3 138.7 12.2 80.1 90.7 130.7 4.5 20.8 216.8 283.7 49.7 54.0 194.8 188.5 224.9 122.1 17.3 46.0 31.5 61.1 108.5 68.0 131.7 70.3 266.1 65.4 51.7 128.1 204.0 PNMT PENT ENSG00000141744 "Phenylethanolamine N-methyltransferase" P11086 17 39667981-39670475 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "adrenal gland: 159.8" "Cell type enhanced" "Detected in many" "Breast glandular cells: 20.1;Breast myoepithelial cells: 15.1;Cardiomyocytes: 13.4;Endometrial ciliated cells: 24.0;Erythroid cells: 16.6;Hepatic stellate cells: 27.5;Skeletal myocytes: 48.0" "Group enriched" "Detected in many" 5 "breast cancer: 7.7;cervical cancer: 27.0;urothelial cancer: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 5.3;K-562: 12.8;NB-4: 24.1;NTERA-2: 4.5;SCLC-21H: 6.4;SH-SY5Y: 5.8" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "CAB017029, HPA043412, HPA051005" Enhanced NA NA "CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306" "unprognostic (1.50e-1)" "unprognostic (3.74e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (3.95e-5)" "unprognostic (4.27e-2)" "unprognostic (3.02e-1)" "unprognostic (2.98e-2)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (1.33e-1)" "unprognostic (1.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-2)" "unprognostic (1.87e-2)" 4.5 159.8 15.1 0.2 23.1 2.1 8.5 17.5 13.8 5.9 6.1 4.0 0.5 4.4 1.4 3.0 9.1 0.3 18.3 8.7 14.9 2.4 0.5 9.0 0.3 25.7 20.2 9.6 3.0 1.8 7.5 30.9 3.3 20.0 8.6 0.0 0.1 3.2 21.5 21.3 3.0 7.3 0.2 9.2 2.2 7.0 4.5 19.8 0.1 1.8 17.7 0.0 6.6 5.9 10.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 5.3 0.2 0.4 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 24.1 4.5 0.5 0.1 0.1 0.0 0.3 0.0 0.0 6.4 5.8 0.1 2.3 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.1 23.1 17.5 13.8 8.7 14.9 25.7 20.2 9.6 20.0 9.2 19.8 10.6 3.1 0.0 0.0 1.0 0.5 0.5 0.7 0.0 0.0 0.3 20.1 15.1 13.4 1.5 0.0 5.5 0.0 0.1 1.1 0.1 1.9 0.0 0.7 24.0 2.6 5.0 3.0 16.6 0.5 0.0 0.9 1.1 0.0 9.0 0.0 0.7 27.5 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.5 2.1 0.2 0.0 1.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.0 0.5 0.0 48.0 0.8 1.0 2.3 0.0 0.4 0.0 11.0 0.0 0.3 1.8 ARL5C ARL12 ENSG00000141748 "ADP ribosylation factor like GTPase 5C" A6NH57 17 39156894-39167484 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "lymphoid tissue: 3.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 3.1;dendritic cells: 1.4;Microglial cells: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA069849 Uncertain NA NA "HPA069849: AB_2686213" "unprognostic (2.57e-1)" "unprognostic (2.34e-1)" "unprognostic (1.60e-7)" "unprognostic (7.60e-2)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 STAC2 24b2 ENSG00000141750 "SH3 and cysteine rich domain 2" Q6ZMT1 17 39210541-39225945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.3;breast: 56.7;retina: 122.0;skin 1: 44.3" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 496.8" "Cancer enhanced" "Detected in many" "breast cancer: 15.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 9.8;HeLa: 32.5;U-87 MG: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076925 Approved Cytosol NA NA Cytosol "HPA076925: " "unprognostic (1.70e-3)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (4.05e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.42e-1)" "unprognostic (8.66e-2)" "unprognostic (2.94e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.12e-2)" "unprognostic (5.16e-2)" "unprognostic (2.35e-3)" "unprognostic (2.05e-2)" "unprognostic (1.94e-1)" "unprognostic (3.54e-2)" "unprognostic (3.17e-1)" 1.7 0.5 7.6 0.2 21.4 0.0 56.7 9.6 57.3 6.7 2.7 0.8 0.1 5.2 10.8 0.5 4.8 0.0 1.6 17.4 20.3 14.0 0.0 0.8 0.0 30.9 17.3 13.0 2.5 0.2 0.1 1.6 0.2 31.2 5.2 0.1 122.0 15.3 23.7 0.3 44.3 0.6 0.8 4.8 0.1 0.4 0.3 8.1 0.0 0.1 0.6 0.0 0.5 2.6 33.1 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 9.8 0.0 3.9 0.0 0.0 0.0 0.5 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.3 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 21.4 9.6 57.3 17.4 20.3 30.9 17.3 13.0 31.2 4.8 8.1 33.1 0.6 3.2 5.8 2.0 0.7 0.4 1.0 0.2 0.0 13.3 52.7 45.3 2.7 0.0 2.5 3.7 10.4 0.1 1.8 0.1 5.9 0.0 0.2 0.3 3.9 1.7 0.0 0.0 19.0 0.0 0.2 1.9 0.0 0.3 0.0 0.2 0.0 0.0 0.1 18.5 16.6 0.0 16.2 0.6 1.5 0.0 2.8 0.8 42.7 3.7 0.0 496.8 2.1 1.0 1.0 0.0 0.0 0.0 0.1 0.5 0.0 0.3 1.5 17.5 0.0 0.2 1.4 0.2 1.0 0.0 1.7 0.3 1.2 0.1 0.1 0.2 IGFBP4 "BP-4, HT29-IGFBP, IBP4, IGFBP-4" ENSG00000141753 "Insulin like growth factor binding protein 4" P22692 17 40443450-40457725 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 672.7;Endometrial stromal cells: 542.2;Endothelial cells: 502.3;Fibroblasts: 585.4;Hepatic stellate cells: 566.5;Hepatocytes: 501.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 19.5;NK-cell: 37.0" "Group enriched" "Detected in many" 5 "NK-cells: 37.0;T-cells: 19.5" "Cell line enhanced" "Detected in many" "A549: 1334.8;ASC diff: 961.5;ASC TERT1: 933.8;BJ: 1066.4;BJ hTERT+: 1088.2;HSkMC: 2001.2;U-2197: 882.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066240 Supported "Secreted to blood" NA NA 227000000 410000000 "HPA066240: AB_2685643" "unprognostic (1.03e-3)" "unprognostic (1.61e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.54e-4)" "unprognostic (7.44e-3)" "unprognostic (1.00e-1)" "prognostic favorable (5.49e-4)" "unprognostic (4.55e-2)" "unprognostic (1.19e-2)" "unprognostic (2.28e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (2.36e-1)" "unprognostic (3.81e-2)" 743.4 250.2 25.9 310.5 25.9 2.4 761.1 24.3 46.8 928.3 69.6 511.9 83.6 802.5 143.1 248.8 798.0 394.9 474.9 24.5 43.8 463.2 1487.9 393.5 60.5 29.6 32.2 24.7 1281.1 165.7 44.9 205.3 233.7 29.5 474.1 134.8 13.2 266.6 281.6 108.2 231.6 292.0 650.7 27.1 297.9 372.7 68.2 33.7 39.2 505.6 98.3 44.6 556.8 581.1 34.3 0.2 1334.8 66.8 0.5 961.5 933.8 2.2 1066.4 1088.2 199.7 154.4 59.7 17.3 0.3 563.7 511.0 27.2 11.9 22.6 6.8 90.2 4.8 1.3 4.3 91.3 89.9 601.2 2.9 0.5 2001.2 4.6 267.7 37.7 23.8 350.6 0.1 21.7 0.2 290.5 41.2 0.8 252.5 37.2 58.9 178.2 67.2 1.3 2.1 8.4 42.1 18.3 53.0 482.3 2.0 17.0 63.5 486.6 24.7 534.7 276.0 14.4 882.1 1.1 0.9 0.6 1.7 163.8 9.9 72.4 0.0 0.0 0.0 2.7 0.0 19.5 0.8 5.0 6.7 0.0 5.2 0.3 0.6 0.0 37.0 0.0 0.2 0.0 1.4 25.9 25.9 24.3 46.8 24.5 43.8 29.6 32.2 24.7 29.5 27.1 33.7 34.3 672.7 9.6 37.4 1.3 17.6 56.3 97.1 36.7 79.1 3.2 118.9 163.2 16.9 90.1 16.2 7.3 0.0 6.1 10.6 93.3 17.6 4.1 6.7 69.8 542.2 502.3 8.4 37.9 3.8 2.4 7.2 585.4 13.7 59.1 2.5 230.9 566.5 501.2 273.6 1.7 3.4 74.7 4.1 42.8 94.0 16.5 246.4 21.3 72.9 18.7 3.4 3.8 1.0 1.0 0.3 39.1 72.1 118.5 7.4 63.8 71.6 204.7 18.5 1.1 190.7 13.8 299.9 1.9 8.2 26.8 47.7 7.5 20.3 25.9 109.0 73.6 FKBP10 "FKBP6, FKBP65, FLJ20683, FLJ22041, FLJ23833, hFKBP65" ENSG00000141756 "FKBP prolyl isomerase 10" Q96AY3 17 41812680-41823213 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 79.1;Fibroblasts: 100.0;Sertoli cells: 59.2;Smooth muscle cells: 65.3;Theca cells: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 551.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051171, HPA057021" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA 110000 Mitochondria "HPA051171: AB_2681371, HPA057021: AB_2683312" "unprognostic (8.30e-2)" "prognostic unfavorable (4.16e-4)" "unprognostic (9.05e-2)" "unprognostic (1.71e-2)" "unprognostic (4.77e-2)" "unprognostic (2.95e-2)" "unprognostic (1.14e-2)" "unprognostic (9.98e-2)" "unprognostic (2.21e-2)" "unprognostic (7.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.34e-2)" "unprognostic (5.77e-2)" "prognostic unfavorable (3.43e-5)" "prognostic unfavorable (4.99e-4)" 37.4 39.9 21.4 27.3 21.9 0.5 33.8 22.8 26.3 62.8 24.1 26.0 7.7 62.0 17.0 14.0 51.3 46.4 34.9 20.9 38.2 17.8 7.8 38.2 11.0 24.2 22.0 19.2 58.9 15.2 48.9 57.1 61.2 22.7 32.8 10.9 6.0 14.9 31.1 7.7 19.1 19.3 56.1 22.4 14.4 18.6 9.1 23.7 5.0 35.1 9.4 4.5 42.6 39.5 22.4 0.7 119.6 110.7 363.3 379.3 441.7 92.0 490.4 497.4 185.6 159.0 62.1 4.8 0.3 6.6 551.9 45.9 0.8 66.7 133.4 77.9 33.0 99.9 48.6 132.1 181.0 411.4 0.0 0.6 476.1 0.5 150.3 115.5 352.6 158.8 0.0 1.9 16.7 157.0 163.2 0.3 0.1 85.4 258.0 38.3 9.9 125.2 15.7 31.7 0.1 26.7 92.1 0.7 349.3 166.0 137.4 54.1 3.1 181.0 219.0 111.5 145.8 76.0 0.8 0.2 0.3 299.7 0.0 213.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 21.4 21.9 22.8 26.3 20.9 38.2 24.2 22.0 19.2 22.7 22.4 23.7 22.4 14.9 0.0 4.8 38.2 0.2 8.5 11.5 2.7 1.2 0.6 10.8 13.2 2.3 1.5 1.4 0.0 0.0 6.1 0.2 0.1 0.0 8.7 0.7 3.0 79.1 34.9 0.0 0.0 0.3 4.7 30.8 100.0 1.5 4.6 0.0 32.9 30.4 0.0 4.7 15.2 0.3 1.3 0.0 0.0 9.7 2.9 46.9 1.5 16.0 15.0 0.0 32.0 0.0 17.1 0.1 2.2 0.1 44.8 0.5 8.2 0.0 0.0 0.1 1.1 59.2 35.2 65.3 0.9 7.6 0.5 5.1 11.9 2.1 54.0 0.6 1.6 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970813-80033949 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 360.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: AB_2677410" "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 57.0 79.7 90.4 40.3 91.9 60.1 52.5 96.3 99.6 35.9 93.1 51.9 33.1 36.0 50.7 70.0 38.4 24.4 80.1 95.7 96.5 83.5 97.9 48.6 53.8 92.1 96.2 89.5 32.9 86.8 42.5 96.2 31.9 94.5 54.4 33.5 36.9 55.4 25.6 89.3 56.5 48.4 25.8 95.3 68.4 61.0 88.7 92.6 52.9 51.5 61.9 45.9 46.5 45.9 100.8 98.5 129.3 113.0 108.1 90.3 94.7 99.8 104.3 83.5 138.7 124.9 121.2 68.0 118.8 37.8 100.3 94.1 81.4 137.1 121.5 91.2 139.7 173.7 85.6 196.1 288.7 115.4 247.6 134.1 88.6 105.5 98.7 125.6 87.9 132.4 145.0 76.2 168.0 97.8 177.1 177.0 166.3 88.6 74.3 276.9 106.2 75.7 245.4 137.7 152.7 172.1 125.0 51.6 151.8 200.5 96.9 74.6 145.0 62.9 121.3 149.5 55.7 129.4 74.0 302.3 198.6 113.4 185.7 113.9 10.6 10.3 9.0 14.7 12.7 9.9 15.8 11.8 11.6 14.5 17.6 11.7 14.0 8.2 15.6 13.1 31.3 17.3 6.1 90.4 91.9 96.3 99.6 95.7 96.5 92.1 96.2 89.5 94.5 95.3 92.6 100.8 81.0 19.2 42.6 14.0 89.2 87.2 76.9 73.6 64.3 35.7 131.9 139.7 80.3 65.8 62.3 66.2 35.5 107.8 104.8 53.6 360.0 123.4 259.3 98.5 66.0 65.2 56.3 94.1 25.3 125.2 156.9 69.8 71.4 88.1 11.4 84.1 47.2 97.4 126.0 45.4 22.5 88.4 59.0 66.4 76.9 245.5 42.0 89.5 94.3 14.0 87.2 81.5 60.8 21.1 34.8 144.5 54.9 45.1 177.9 177.2 48.6 271.8 41.9 51.3 46.0 61.2 100.8 84.6 74.2 147.6 109.8 96.7 78.7 112.6 71.1 119.4 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 91.8" "Group enriched" "Detected in many" 8 "Bipolar cells: 101.4;Enteroendocrine cells: 214.1;Excitatory neurons: 318.3;Horizontal cells: 249.0;Inhibitory neurons: 372.1;Oligodendrocyte precursor cells: 271.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 91.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 45.1;U-87 MG: 23.9" "Low region specificity" "Detected in all" "HPA064258, HPA068138, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA064258: AB_2685229, HPA068138: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favorable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 1.0 2.3 15.0 0.3 15.1 0.1 0.9 91.8 25.7 0.6 0.0 0.6 1.2 0.8 1.1 0.2 3.3 0.2 0.6 15.2 7.7 0.5 0.2 0.2 0.4 7.0 18.4 14.1 0.9 2.6 0.1 4.3 0.0 38.6 0.4 0.4 7.2 0.2 0.1 0.5 0.2 1.7 0.2 6.7 0.6 2.8 2.3 11.0 0.1 0.7 0.1 0.2 0.3 0.7 14.3 0.0 0.1 0.1 6.0 0.2 0.2 0.0 2.2 2.5 0.3 0.0 0.0 0.0 0.2 0.0 0.2 5.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.1 0.2 1.4 0.1 0.3 0.6 0.0 0.1 0.0 0.1 45.1 0.0 0.0 0.0 0.4 0.1 0.0 1.9 0.1 0.1 0.9 0.2 0.1 0.0 0.0 0.0 23.9 0.1 0.6 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.0 15.0 15.1 91.8 25.7 15.2 7.7 7.0 18.4 14.1 38.6 6.7 11.0 14.3 7.7 6.4 3.2 31.3 9.6 0.6 3.4 0.0 0.0 101.4 3.1 7.4 2.8 0.0 1.3 1.8 16.7 0.0 2.9 0.6 0.0 0.5 27.1 1.2 6.3 6.5 214.1 0.4 318.3 0.4 0.2 4.7 10.7 2.6 1.3 5.2 1.8 1.2 0.5 249.0 372.1 5.0 4.1 1.9 1.4 28.0 1.2 2.1 0.0 28.1 1.2 3.0 4.1 271.9 11.5 1.5 0.1 0.4 0.5 0.8 0.2 2.0 3.7 7.0 0.0 5.1 17.6 4.3 7.1 0.4 0.1 0.3 2.0 2.5 1.0 0.9 MISP3 ENSG00000141854 "MISP family member 3" Q96FF7 19 14072536-14075062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 19.3;Breast myoepithelial cells: 20.8;Collecting duct cells: 14.7;Distal tubular cells: 35.2;Endometrial ciliated cells: 12.4;Exocrine glandular cells: 11.5;Proximal tubular cells: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.3;OE19: 11.3;RPMI-8226: 6.3;U-266/84: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042225 Uncertain NA NA "HPA042225: AB_10795396" "unprognostic (1.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.01e-2)" "unprognostic (3.66e-2)" "unprognostic (1.76e-3)" "unprognostic (9.77e-2)" "unprognostic (1.31e-2)" "unprognostic (8.81e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.52e-4)" "prognostic favorable (3.11e-5)" "unprognostic (2.97e-1)" "unprognostic (1.01e-1)" "unprognostic (9.78e-2)" 1.2 2.1 8.1 0.3 8.1 0.5 2.1 8.5 10.3 1.5 7.1 5.2 3.9 1.0 0.4 3.0 3.0 0.3 6.2 8.4 8.5 12.9 5.6 3.0 0.0 8.3 8.1 7.9 0.5 12.2 2.9 2.6 0.5 8.7 3.6 1.4 1.2 7.8 1.0 2.5 8.0 5.3 0.1 8.5 1.3 11.2 0.9 8.2 0.2 3.1 1.0 0.1 1.7 2.8 9.5 1.7 0.9 0.3 0.7 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 1.1 0.1 0.0 0.6 0.8 0.0 0.0 2.1 1.5 0.2 0.3 0.8 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.7 0.2 1.0 0.2 5.3 0.0 3.0 0.3 0.7 0.0 11.3 0.7 0.5 0.1 6.3 1.1 0.0 1.5 0.4 0.0 0.5 0.6 0.0 0.9 0.0 0.1 0.0 0.4 0.5 0.0 3.6 4.3 0.4 0.8 1.3 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 8.1 8.1 8.5 10.3 8.4 8.5 8.3 8.1 7.9 8.7 8.5 8.2 9.5 3.2 9.6 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 19.3 20.8 0.0 0.0 1.8 14.7 0.0 0.2 3.7 0.0 35.2 2.5 0.0 12.4 0.8 0.7 0.0 0.0 0.0 11.5 0.1 1.0 0.0 5.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.3 0.0 0.0 22.8 2.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 1.5 0.3 0.0 0.0 SAMD1 ENSG00000141858 "Sterile alpha motif domain containing 1" 19 14087851-14091036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041662, HPA049059" Uncertain Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA Cytosol Mitochondria "HPA041662: AB_2677605, HPA049059: AB_2680616" "unprognostic (2.93e-2)" "prognostic favorable (7.41e-4)" "unprognostic (8.43e-2)" "unprognostic (3.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (2.66e-1)" "unprognostic (9.92e-2)" "unprognostic (3.86e-3)" "unprognostic (9.26e-3)" "unprognostic (4.00e-1)" "prognostic unfavorable (7.98e-5)" "prognostic favorable (8.31e-4)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" "unprognostic (2.45e-1)" 22.5 18.3 51.9 18.4 50.8 22.5 21.3 49.2 50.9 27.9 35.1 32.5 20.2 30.3 8.8 37.3 24.9 8.3 35.2 48.2 47.7 22.3 24.4 24.7 21.6 56.6 51.0 44.3 27.7 25.0 8.0 15.0 10.9 54.0 21.9 14.4 7.1 20.4 14.1 51.3 37.1 29.6 11.8 52.4 38.5 28.9 26.5 52.5 44.9 20.8 22.8 17.8 29.7 30.7 50.7 73.2 54.8 47.3 67.3 28.7 29.7 71.8 39.3 9.4 39.5 31.7 41.5 35.3 125.1 51.2 25.6 18.9 57.9 51.5 29.5 19.5 84.3 42.8 55.5 73.7 76.0 25.9 33.1 33.1 20.7 47.5 27.4 9.2 37.6 23.5 79.6 67.9 33.8 22.9 110.2 69.0 129.2 96.7 53.0 47.9 92.1 41.9 91.8 33.5 35.2 86.5 86.1 34.8 46.6 26.6 25.0 29.6 70.0 26.1 68.7 62.1 69.5 50.7 62.0 58.1 105.2 41.0 89.0 28.4 0.2 1.3 2.5 0.8 0.5 1.0 2.1 0.9 1.0 1.2 1.4 1.2 0.9 0.2 3.7 0.5 0.9 1.1 0.8 51.9 50.8 49.2 50.9 48.2 47.7 56.6 51.0 44.3 54.0 52.4 52.5 50.7 42.0 3.2 6.7 0.7 10.9 11.5 4.6 14.4 18.8 31.4 25.2 31.4 11.9 21.5 5.5 11.0 6.2 3.9 22.4 48.6 1.9 11.2 0.3 24.4 21.6 19.4 24.7 43.6 0.3 11.1 9.3 14.3 9.7 24.5 8.2 15.2 13.6 13.8 15.5 52.2 0.4 24.0 6.1 25.7 16.1 2.2 19.3 19.6 10.6 0.0 11.3 19.4 2.1 1.0 0.9 13.0 18.9 18.8 13.3 6.6 23.6 6.6 10.6 8.5 13.1 7.5 18.8 0.8 20.4 29.2 17.2 1.8 14.1 8.2 30.5 4.8 BRD4 "CAP, HUNK1, HUNKI, MCAP" ENSG00000141867 "Bromodomain containing 4" O60885 19 15235519-15332545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015055, HPA061646, CAB068177, CAB068178" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575" "unprognostic (2.83e-3)" "unprognostic (2.39e-2)" "unprognostic (6.37e-3)" "unprognostic (3.38e-2)" "unprognostic (2.15e-1)" "unprognostic (9.53e-3)" "unprognostic (3.03e-3)" "unprognostic (6.13e-2)" "unprognostic (7.63e-2)" "unprognostic (2.72e-2)" "unprognostic (3.98e-2)" "unprognostic (5.26e-2)" "unprognostic (1.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.73e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" 24.5 24.6 14.5 23.5 12.9 24.5 24.0 6.5 34.3 26.8 3.3 24.1 14.2 26.2 8.4 27.9 23.7 13.1 28.2 14.4 7.6 22.3 32.9 27.9 20.9 13.5 6.4 9.8 30.5 27.0 13.5 21.1 29.6 9.3 25.0 8.6 12.2 23.1 13.8 63.2 33.7 25.7 13.3 3.5 28.9 22.6 24.9 7.4 17.1 24.3 19.3 16.0 25.4 26.9 21.9 46.7 49.1 31.0 58.6 26.4 20.1 32.5 32.5 29.3 28.3 29.6 47.1 71.4 58.5 48.4 36.5 27.6 47.1 30.8 32.4 24.0 51.3 21.4 58.0 41.1 43.7 42.2 53.2 59.7 29.4 34.6 35.2 68.7 18.1 26.1 41.5 91.7 62.7 18.3 55.5 53.6 41.6 58.5 23.4 54.2 63.8 32.5 37.5 22.3 48.8 35.3 31.1 44.7 34.5 40.5 24.4 33.7 38.3 45.0 72.5 32.6 63.3 53.0 43.9 39.0 25.7 39.7 47.0 58.5 3.4 2.2 2.2 2.1 2.8 1.6 3.6 1.8 1.8 1.4 4.3 1.8 1.7 6.5 3.1 2.8 2.6 1.5 1.6 14.5 12.9 6.5 34.3 14.4 7.6 13.5 6.4 9.8 9.3 3.5 7.4 21.9 85.9 64.1 52.7 26.8 97.9 117.6 118.4 33.9 80.8 67.0 71.8 54.7 79.5 58.6 33.9 25.8 83.4 219.8 91.6 93.9 25.4 53.6 130.3 83.1 102.6 84.7 113.9 117.0 46.3 67.1 72.4 75.9 56.1 128.2 36.7 95.2 64.6 84.9 60.5 79.1 44.2 71.5 16.2 83.4 101.0 249.3 77.3 87.7 44.4 48.7 72.8 37.0 63.8 28.6 39.3 65.3 62.6 79.7 77.4 137.3 50.7 35.2 30.2 84.2 72.3 103.1 92.0 52.6 48.8 84.7 143.2 254.3 77.4 65.9 71.8 147.0 SLC39A3 ZIP3 ENSG00000141873 "Solute carrier family 39 member 3" Q9BRY0 19 2732204-2740028 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 101.1" "Group enriched" "Detected in all" 4 "Early spermatids: 302.1;Late spermatids: 433.3;Spermatocytes: 185.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 409.6" "Low region specificity" "Detected in all" "HPA042139, HPA058526" Uncertain Approved Vesicles NA NA Vesicles "HPA042139: AB_10793875, HPA058526: AB_2683743" "unprognostic (1.81e-1)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "prognostic favorable (9.76e-5)" "unprognostic (2.26e-1)" "unprognostic (2.44e-2)" "unprognostic (9.88e-3)" "unprognostic (1.01e-1)" "unprognostic (6.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.37e-3)" "unprognostic (4.07e-2)" "unprognostic (1.75e-3)" "unprognostic (9.22e-3)" "unprognostic (6.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.80e-2)" 18.0 27.2 19.7 14.9 20.3 46.7 17.6 17.7 22.7 19.8 13.7 18.2 16.9 25.3 30.7 17.5 23.4 15.4 22.1 22.8 16.9 19.6 33.1 16.4 19.3 19.4 18.1 20.3 13.6 20.8 35.0 27.4 12.4 19.6 19.5 14.5 10.3 21.5 18.0 23.1 14.7 16.6 23.2 16.3 22.9 17.5 101.1 20.7 22.0 20.6 24.9 16.3 22.5 14.5 18.5 53.3 44.1 32.5 80.3 66.1 45.0 30.6 38.6 46.5 71.3 72.4 47.8 35.0 32.2 23.6 68.2 56.3 42.9 50.2 52.7 44.3 0.4 37.1 144.4 31.4 48.9 72.1 123.2 209.5 40.6 83.3 53.1 43.3 25.6 36.9 61.8 162.8 147.6 48.6 35.2 61.4 99.0 34.6 48.8 59.4 81.4 20.9 100.7 34.1 42.7 44.1 40.3 33.9 24.4 82.4 20.9 42.4 162.7 22.4 49.5 27.0 75.6 56.4 38.7 66.6 32.6 37.4 409.6 59.7 41.1 36.0 67.9 35.9 35.6 30.1 53.3 30.5 29.2 48.9 53.7 24.5 29.2 16.7 29.7 34.1 83.9 21.2 35.2 19.7 20.3 17.7 22.7 22.8 16.9 19.4 18.1 20.3 19.6 16.3 20.7 18.5 18.1 3.2 2.8 2.6 31.6 10.3 16.6 37.1 2.2 19.2 25.5 23.6 7.8 24.3 22.6 7.3 8.4 37.5 16.8 20.2 17.6 50.7 302.1 17.8 16.4 21.8 24.0 57.6 5.0 61.8 56.3 18.4 10.7 13.3 24.8 24.2 21.8 31.0 64.9 48.8 5.9 19.7 32.6 25.7 12.9 433.3 21.5 39.3 24.9 4.7 26.7 33.5 26.8 6.6 5.6 46.9 25.8 27.8 12.9 33.3 23.0 23.6 17.6 22.0 26.3 14.0 23.6 185.8 29.7 10.5 9.8 26.4 14.5 29.4 25.6 17.6 NFIC "CTF, CTF5, NF-I, NFI" ENSG00000141905 "Nuclear factor I C" P08651 19 3314403-3469217 "Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 296.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 394.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 168.4;U-2197: 164.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004300, CAB004674, HPA052625" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889" "unprognostic (2.59e-1)" "unprognostic (5.07e-3)" "unprognostic (2.11e-1)" "prognostic favorable (1.52e-6)" "unprognostic (8.38e-2)" "unprognostic (1.71e-3)" "unprognostic (1.14e-1)" "unprognostic (3.04e-1)" "unprognostic (9.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.81e-2)" "unprognostic (3.16e-2)" "unprognostic (2.03e-2)" "unprognostic (2.54e-1)" "unprognostic (9.65e-2)" "unprognostic (2.85e-2)" "unprognostic (1.80e-3)" 43.3 51.5 18.9 18.2 23.8 9.4 38.8 25.5 45.0 49.3 12.5 45.8 9.3 54.1 10.1 32.8 45.1 16.4 62.9 13.3 27.4 21.4 57.3 35.0 6.4 37.6 32.2 3.0 52.7 69.3 29.7 29.4 7.6 44.6 39.6 7.7 10.6 45.6 33.4 296.0 41.5 23.1 29.0 28.1 20.3 43.5 13.2 31.1 7.9 34.0 63.7 5.7 46.7 36.6 28.4 63.5 92.8 1.1 53.7 47.9 41.2 5.6 55.6 30.3 36.9 25.7 2.3 20.8 0.5 19.2 51.1 26.4 30.1 15.4 37.8 15.6 44.6 13.7 11.6 75.1 19.2 37.2 19.0 22.8 34.8 25.9 50.2 19.8 24.3 34.9 3.6 32.8 55.3 28.1 45.7 11.1 4.0 3.0 2.8 37.8 28.1 34.0 23.1 14.7 13.3 12.6 32.1 168.4 16.4 17.0 0.8 48.7 14.1 49.5 61.7 56.2 164.1 76.3 1.9 2.5 0.5 83.9 38.6 91.8 1.5 4.1 1.8 2.3 4.0 1.9 1.5 2.2 2.2 3.1 1.6 1.5 1.5 8.7 5.9 0.9 1.2 0.8 3.0 18.9 23.8 25.5 45.0 13.3 27.4 37.6 32.2 3.0 44.6 28.1 31.1 28.4 96.4 80.1 82.6 40.8 18.9 100.1 136.5 85.5 174.8 189.5 117.1 101.2 124.8 270.2 50.0 92.0 58.4 9.7 12.4 25.6 52.8 146.5 32.0 77.7 156.3 101.9 47.9 31.1 42.2 190.8 5.9 174.6 80.5 140.1 26.0 85.5 112.5 394.2 55.9 80.8 34.4 41.9 63.1 146.1 50.2 22.0 252.5 58.2 46.2 46.9 56.8 151.1 11.3 21.1 44.5 113.8 32.0 253.2 20.8 175.1 27.0 59.4 67.7 65.4 72.3 285.7 110.8 14.6 39.2 124.7 97.7 8.5 26.1 62.3 59.3 101.2 TPGS1 "C19orf20, GTRGEO22, PGs1" ENSG00000141933 "Tubulin polyglutamylase complex subunit 1" Q6ZTW0 19 507497-519654 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 5.3;granulocytes: 3.9;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HEK 293: 35.8;SH-SY5Y: 35.9;U-266/70: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.42e-1)" "unprognostic (2.51e-3)" "unprognostic (7.05e-2)" "prognostic favorable (2.24e-4)" "unprognostic (5.85e-2)" "unprognostic (1.37e-2)" "unprognostic (2.52e-1)" "unprognostic (1.63e-2)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "prognostic favorable (8.82e-4)" "unprognostic (8.71e-3)" "unprognostic (5.03e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (4.18e-1)" "unprognostic (3.84e-3)" 14.6 15.9 3.6 1.2 2.3 2.0 14.1 4.5 7.0 14.5 1.1 11.4 4.0 17.1 0.0 11.5 12.5 0.2 10.7 3.9 2.5 18.2 17.0 10.9 0.6 5.7 4.2 3.4 12.9 17.2 0.4 14.3 0.9 8.0 11.6 0.1 0.0 10.8 0.8 10.6 12.8 10.7 0.3 3.0 11.8 13.9 9.1 4.9 0.2 14.0 0.1 0.2 12.9 12.3 4.6 13.9 1.7 0.5 2.7 0.1 0.6 7.8 8.8 1.5 1.3 1.0 0.7 2.9 11.9 7.2 0.8 0.2 8.7 0.0 0.2 0.0 16.6 35.8 3.4 2.4 1.1 1.0 5.8 11.7 1.4 1.0 0.1 0.1 0.5 0.9 2.0 13.6 3.3 0.6 2.8 10.1 16.1 6.8 0.2 14.8 9.5 4.2 12.7 0.4 0.6 11.2 35.9 3.9 1.1 18.6 0.0 2.3 3.4 8.4 4.8 8.5 11.7 7.0 34.9 10.9 5.4 6.8 5.4 4.5 0.1 0.8 3.9 0.7 0.4 0.4 2.7 0.9 1.7 0.7 5.3 1.0 0.4 0.8 0.9 0.8 0.6 3.7 0.5 3.6 2.3 4.5 7.0 3.9 2.5 5.7 4.2 3.4 8.0 3.0 4.9 4.6 37.0 35.3 36.2 5.5 23.9 27.0 30.0 1.4 29.0 30.9 43.0 43.6 4.4 48.6 16.1 40.5 25.0 38.7 36.5 70.9 76.3 8.3 7.6 32.5 29.1 34.6 55.6 42.9 3.0 8.9 13.3 38.8 40.8 24.6 32.4 32.0 38.9 35.0 51.5 28.6 4.0 62.5 0.0 59.6 41.8 4.6 28.9 42.2 32.0 3.7 34.2 51.9 59.8 2.5 9.8 4.2 55.5 31.2 32.1 27.9 71.7 147.8 12.3 33.9 32.9 35.9 39.6 7.5 4.5 31.5 35.5 48.3 42.7 48.7 40.4 34.2 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291403 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.2;MAIT T-cell: 6.6" "Lineage enriched" "Detected in single" 41 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "A549: 144.1;CAPAN-2: 154.6;OE19: 255.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055540, HPA058428" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA055540: AB_2682839, HPA058428: " "prognostic unfavorable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 4.3 13.3 41.5 8.6 58.4 0.0 37.3 56.9 50.4 64.0 28.3 40.9 63.3 16.9 8.4 27.5 82.5 52.9 1.4 39.2 48.6 11.4 3.7 8.4 1.4 56.0 55.1 34.9 2.7 37.6 19.7 11.9 3.6 54.8 31.9 32.4 29.9 106.6 33.2 0.6 49.8 51.4 6.5 50.6 4.8 50.8 7.7 50.4 5.2 5.7 0.5 6.1 36.8 14.3 85.5 85.5 144.1 2.1 0.1 0.0 0.3 0.2 8.2 0.0 25.3 18.9 41.7 154.6 0.0 88.3 11.9 0.1 45.3 0.0 17.6 11.1 0.8 2.6 0.0 55.9 0.0 28.6 0.0 5.5 5.2 7.6 12.7 16.7 53.4 4.2 0.0 0.7 0.1 0.0 98.5 0.4 0.1 61.5 255.8 0.0 0.0 0.0 2.4 62.1 13.7 17.4 40.9 23.3 38.3 60.3 5.8 50.0 2.5 4.5 55.7 36.5 0.5 61.9 0.8 101.7 70.4 15.5 0.0 46.9 0.0 0.0 0.0 3.2 0.0 6.6 0.0 1.3 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 41.5 58.4 56.9 50.4 39.2 48.6 56.0 55.1 34.9 54.8 50.6 50.4 85.5 17.0 6.4 7.5 0.0 1.5 0.0 134.2 0.0 8.0 19.7 137.1 149.9 0.0 204.5 35.3 22.0 10.4 0.5 2.7 77.0 3.9 352.1 0.3 115.2 9.2 15.2 8.5 0.0 0.0 139.5 15.1 3.0 91.3 90.1 1.3 0.0 0.0 0.5 0.9 16.8 0.0 38.8 0.0 1.0 0.0 1.6 0.0 1.9 0.0 0.0 2.6 21.7 0.0 0.0 0.0 128.8 85.2 0.0 1.6 97.4 209.8 1.4 91.1 234.9 0.0 0.8 2.7 0.6 35.1 20.3 0.0 0.8 3.5 0.1 87.2 205.8 ZIM3 ZNF657 ENSG00000141946 "Zinc finger imprinted 3" Q96PE6 19 57134096-57145202 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034575 Uncertain NA NA "HPA034575: AB_10603463" "unprognostic (9.06e-2)" "unprognostic (1.46e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRDM15 "C21orf83, ZNF298" ENSG00000141956 "PR/SET domain 15" P57071 21 41798225-41879482 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 12.5;Plasma cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "Daudi: 31.1;U-266/70: 32.2;U-698: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024268, HPA029255, HPA029256" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971" "unprognostic (8.73e-2)" "unprognostic (1.32e-2)" "unprognostic (2.43e-2)" "unprognostic (6.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.85e-4)" "unprognostic (4.22e-4)" "unprognostic (6.50e-2)" "unprognostic (4.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.52e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-8)" "unprognostic (1.34e-1)" "unprognostic (2.70e-1)" "unprognostic (9.72e-2)" "unprognostic (4.86e-3)" 2.0 1.8 1.9 4.5 1.8 1.7 2.1 1.3 1.9 2.2 1.2 2.2 2.8 2.2 1.6 2.5 2.4 1.4 1.7 1.8 1.4 1.4 2.1 1.9 8.4 1.6 1.4 1.7 2.5 2.3 1.8 2.1 1.2 1.5 2.5 1.8 1.6 2.3 1.5 4.5 3.9 2.9 1.4 1.1 3.7 2.3 2.0 1.4 3.2 2.2 1.8 7.5 2.0 2.2 1.7 2.8 6.0 4.4 5.8 1.9 2.4 4.4 2.2 1.8 2.2 1.6 4.1 3.0 31.1 2.5 2.7 2.1 4.1 3.9 2.9 2.1 3.3 5.5 6.5 15.1 5.0 1.3 5.6 3.9 1.1 3.9 2.7 1.8 2.4 3.3 3.4 5.6 2.0 3.0 6.4 5.5 3.7 5.1 3.1 3.1 8.5 3.5 2.5 2.3 4.8 7.5 4.3 10.1 5.1 1.5 1.7 3.8 2.7 3.3 3.8 2.1 2.9 4.3 32.2 3.5 76.0 3.6 6.5 5.3 0.0 0.4 0.5 0.2 0.8 0.2 0.6 0.1 0.3 0.4 0.2 0.2 0.3 0.0 0.1 0.1 0.1 0.2 0.4 1.9 1.8 1.3 1.9 1.8 1.4 1.6 1.4 1.7 1.5 1.1 1.4 1.7 2.4 3.2 12.5 6.2 5.1 2.9 1.8 1.6 2.2 3.4 2.8 2.4 4.4 1.5 7.8 1.8 6.2 1.4 2.0 2.3 0.0 1.3 2.2 2.6 2.5 2.5 0.0 2.5 9.0 2.6 0.9 2.6 3.1 2.0 3.8 3.3 1.1 2.2 1.9 3.3 6.4 1.3 2.0 2.8 2.2 4.3 1.2 3.3 1.8 6.5 2.9 1.1 4.1 3.5 8.0 1.7 0.8 0.4 15.9 2.3 1.1 0.8 5.3 3.1 0.0 3.1 2.3 2.3 2.9 3.2 3.4 0.7 2.7 1.3 2.2 1.8 PFKL ENSG00000141959 "Phosphofructokinase, liver type" P17858 21 44300051-44327376 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 273.7;Proximal enterocytes: 331.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030047 Approved Uncertain Nucleoli,Mitochondria NA NA 1100000 "Nucleoli, Mitochondria" "HPA030047: AB_10602815" "unprognostic (6.21e-3)" "unprognostic (2.93e-1)" "unprognostic (4.46e-2)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "unprognostic (6.98e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (4.41e-4)" "unprognostic (5.69e-2)" "unprognostic (5.40e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-1)" "unprognostic (2.49e-1)" "unprognostic (8.06e-2)" "unprognostic (3.01e-2)" 61.8 36.4 31.6 42.0 31.5 45.6 57.8 38.6 41.1 58.3 29.7 64.4 100.8 48.3 13.0 80.4 43.3 41.3 40.7 29.2 31.6 95.0 61.1 51.5 42.4 46.8 41.0 27.2 43.0 40.3 21.3 39.1 42.0 41.0 48.0 25.2 24.0 59.0 38.5 18.9 67.6 93.0 18.8 42.8 60.0 65.1 45.1 38.1 26.2 48.1 18.0 23.3 58.0 58.7 53.7 127.9 54.8 38.4 111.2 58.0 43.2 167.6 93.9 60.2 53.3 51.9 74.5 27.5 74.9 108.8 62.5 50.3 67.6 30.3 84.4 12.3 62.9 67.7 152.5 47.2 123.4 45.1 116.1 93.1 57.0 51.0 54.5 27.0 80.6 79.2 53.9 95.9 83.7 36.9 161.3 50.8 89.9 60.2 114.0 60.2 122.1 35.7 206.6 23.9 139.0 67.0 49.7 137.3 114.9 60.7 15.4 90.9 101.6 116.7 80.4 50.9 53.0 37.1 159.7 45.6 31.1 132.9 89.7 65.4 17.7 71.5 17.2 37.8 119.0 31.2 41.0 48.9 34.4 83.4 54.5 28.3 22.9 14.0 26.1 126.8 52.4 78.5 84.2 31.6 31.5 38.6 41.1 29.2 31.6 46.8 41.0 27.2 41.0 42.8 38.1 53.7 56.2 22.4 27.9 53.2 45.3 35.7 40.3 95.2 37.0 74.6 41.3 36.6 14.4 27.1 51.6 92.0 66.7 119.6 38.7 273.7 99.7 85.5 2.3 40.7 29.6 49.0 46.3 45.6 15.7 51.4 174.8 44.6 126.4 83.1 41.9 61.2 40.7 70.0 108.6 30.3 9.3 131.4 57.0 64.7 44.5 8.2 39.1 60.0 69.4 29.0 129.4 67.6 33.0 10.1 41.7 52.7 174.2 55.7 39.2 54.9 331.6 142.4 33.7 53.6 26.3 21.3 47.8 1.8 12.2 42.3 36.1 160.8 31.8 31.2 178.6 54.2 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791734-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "skeletal muscle: 276.2;tongue: 122.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 4.3 3.7 7.9 4.0 7.7 7.5 4.4 8.2 7.7 3.2 6.4 3.8 3.8 3.1 3.6 8.5 3.4 2.7 18.0 8.2 6.4 3.8 4.4 4.2 4.7 7.9 7.7 7.8 3.5 8.5 9.7 0.9 4.3 8.1 4.9 3.3 3.0 6.0 3.3 276.2 8.6 3.3 4.0 7.3 4.4 3.9 2.4 7.5 4.8 3.6 122.3 4.6 4.1 1.0 8.3 9.2 6.2 5.7 12.4 6.2 3.6 8.3 5.4 4.4 8.5 6.0 9.7 4.1 10.4 5.4 6.7 4.6 9.3 10.1 8.9 5.5 12.4 11.6 10.1 4.9 7.4 9.4 17.0 12.4 5.3 13.6 6.6 9.4 4.0 6.2 13.9 15.1 19.3 5.9 9.3 14.3 6.2 17.7 5.7 15.0 13.1 7.4 11.0 7.7 11.6 18.5 13.1 7.1 13.2 10.4 4.3 10.2 14.5 8.7 7.7 5.6 12.1 14.4 22.3 20.0 8.8 7.9 12.1 11.1 4.7 2.8 2.8 2.5 3.2 2.1 1.9 2.0 2.3 2.6 2.5 1.7 2.0 2.4 2.6 3.0 2.6 1.5 1.8 7.9 7.7 8.2 7.7 8.2 6.4 7.9 7.7 7.8 8.1 7.3 7.5 8.3 7.9 25.6 32.8 1.6 16.6 20.1 14.9 7.7 12.5 16.8 20.8 16.4 6.5 18.6 15.5 1.8 16.7 21.2 16.1 16.7 13.7 10.3 5.3 8.7 11.6 12.3 13.1 28.6 2.7 11.8 13.8 9.2 6.1 19.1 22.8 7.5 15.4 18.7 12.3 11.8 3.2 15.5 4.1 15.4 8.7 3.5 9.0 13.1 3.6 2.8 17.2 12.1 32.0 2.5 2.3 12.4 9.4 8.2 9.9 15.5 10.9 10.1 11.3 19.8 6.6 27.1 9.3 12.7 6.2 18.3 29.5 27.1 14.3 16.8 18.0 17.7 VAV1 VAV ENSG00000141968 "Vav guanine nucleotide exchange factor 1" P15498 19 6772708-6857366 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.6;lymphoid tissue: 46.8" "Cell type enhanced" "Detected in many" "B-cells: 30.7;dendritic cells: 31.3;granulocytes: 34.9;Hofbauer cells: 50.6;Kupffer cells: 29.4;Macrophages: 33.9;Microglial cells: 30.9;T-cells: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 100.7;Karpas-707: 114.7;MOLT-4: 115.8;REH: 76.1;THP-1: 88.9;U-266/84: 89.5;U-937: 95.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001864, HPA005925" Enhanced Approved Cytosol NA NA Cytosol "HPA001864: AB_1858722, HPA005925: " "unprognostic (2.93e-1)" "unprognostic (1.96e-1)" "unprognostic (1.80e-1)" "unprognostic (1.01e-1)" "unprognostic (6.82e-2)" "unprognostic (1.13e-2)" "unprognostic (5.62e-1)" "unprognostic (1.97e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-2)" "unprognostic (3.56e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (9.55e-2)" "unprognostic (1.78e-1)" "unprognostic (6.57e-2)" "unprognostic (3.28e-1)" 6.7 3.8 3.1 36.6 3.7 54.6 2.8 3.8 4.7 2.6 6.2 6.5 5.9 1.8 1.4 3.7 2.4 6.3 1.9 3.5 6.7 2.1 5.1 11.6 46.8 6.3 4.2 2.6 1.1 1.3 4.2 1.6 8.7 5.2 2.9 7.2 0.2 6.2 2.3 1.0 1.7 14.2 5.3 5.8 45.2 5.6 1.8 5.0 46.1 2.1 2.1 39.5 13.1 1.7 6.7 1.6 2.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 12.7 51.0 16.5 0.0 0.0 0.2 0.0 0.0 0.0 22.0 1.8 61.8 0.0 0.0 0.0 60.7 100.7 0.0 0.0 0.0 0.0 0.0 0.0 63.9 2.3 114.7 0.0 9.6 115.8 36.6 0.0 0.0 0.0 76.1 0.0 41.0 2.2 0.0 0.0 0.0 0.0 18.3 0.1 0.0 8.0 88.9 0.2 0.0 1.6 0.1 0.1 69.9 89.5 57.9 0.1 95.3 0.0 1.6 18.3 20.0 22.0 30.3 15.7 14.3 16.1 19.3 16.6 13.6 17.2 15.6 40.6 19.2 39.8 14.4 14.5 18.2 3.1 3.7 3.8 4.7 3.5 6.7 6.3 4.2 2.6 5.2 5.8 5.0 6.7 0.5 3.2 3.0 0.0 30.7 1.3 0.8 3.7 0.0 0.5 0.4 0.4 1.1 0.0 6.9 0.0 0.0 0.8 31.3 1.5 0.0 4.2 5.4 5.3 0.3 1.5 1.2 9.9 1.9 0.4 0.7 1.2 1.1 1.1 34.9 0.0 1.8 0.3 50.6 0.0 1.5 1.0 8.2 29.4 19.6 2.2 0.0 33.9 1.8 30.9 18.8 0.0 22.6 0.5 1.2 9.9 6.1 0.0 21.6 0.3 0.0 0.2 11.9 0.0 0.0 0.3 1.2 1.7 1.4 0.3 0.9 1.4 26.5 0.3 2.4 0.6 MVB12A "FAM125A, FLJ32495" ENSG00000141971 "Multivesicular body subunit 12A" Q96EY5 19 17405722-17433724 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041885, HPA042231" Approved Supported Vesicles NA No Vesicles "HPA041885: AB_10964218, HPA042231: AB_10961043" "unprognostic (1.34e-2)" "prognostic favorable (3.26e-4)" "unprognostic (1.48e-1)" "unprognostic (2.35e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (5.96e-3)" "unprognostic (8.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.77e-1)" "unprognostic (9.93e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" 21.1 28.6 10.0 17.5 10.8 18.4 21.6 11.0 12.4 17.7 12.0 15.9 29.3 17.5 7.5 29.8 22.2 18.9 12.6 9.4 12.2 20.2 20.1 15.6 21.9 13.4 10.3 8.1 34.3 20.2 22.4 7.5 19.4 10.8 13.8 11.7 1.2 24.4 17.6 14.5 24.6 22.2 11.7 11.4 22.5 21.1 5.2 12.0 24.2 21.4 12.5 19.4 17.2 18.2 13.1 51.2 23.4 12.1 33.9 15.7 28.8 71.1 18.3 28.4 33.8 40.8 20.1 60.5 32.7 52.7 28.2 28.8 25.5 19.5 35.5 9.0 37.6 60.7 9.5 41.8 44.0 50.3 13.0 29.1 28.2 28.5 29.1 18.0 25.5 40.7 29.9 26.8 65.2 15.6 32.2 24.6 26.2 17.0 40.8 63.9 34.7 14.8 53.1 32.4 21.2 25.3 40.7 19.6 30.2 77.6 10.9 40.1 30.9 21.7 31.5 18.4 35.1 20.5 59.3 72.9 35.0 34.1 49.3 38.9 57.4 61.7 42.9 33.0 66.9 31.0 23.3 34.0 32.0 60.5 29.8 28.0 27.5 36.0 38.2 53.4 53.3 57.2 36.2 10.0 10.8 11.0 12.4 9.4 12.2 13.4 10.3 8.1 10.8 11.4 12.0 13.1 67.5 9.6 8.2 5.9 16.4 39.0 41.4 65.1 42.1 5.3 53.6 61.8 5.6 48.6 33.5 46.0 6.2 60.7 18.1 85.0 54.8 78.7 13.5 30.1 26.8 47.7 26.5 8.4 2.2 48.4 99.0 38.6 43.3 30.2 21.6 45.7 62.4 28.0 72.3 3.3 3.2 48.5 50.8 44.9 30.8 16.3 43.5 31.2 32.0 11.2 46.7 32.7 19.6 4.0 7.3 63.4 84.1 47.0 23.5 19.0 104.4 61.3 36.4 13.8 6.6 22.8 40.9 11.8 12.3 58.3 43.9 40.6 21.2 44.3 57.1 45.0 CIB3 KIP3 ENSG00000141977 "Calcium and integrin binding family member 3" Q96Q77 19 16161368-16173525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "bone marrow: 1.2" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 30.2;Late spermatids: 9.5" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;MCF7: 2.2;NB-4: 1.4;THP-1: 1.3;U-937: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043553, HPA043995" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043553: AB_10964566, HPA043995: " "unprognostic (8.43e-2)" "unprognostic (7.26e-5)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.25e-1)" "unprognostic (3.14e-1)" "unprognostic (2.93e-2)" "unprognostic (3.05e-1)" "unprognostic (5.68e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 1.4 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.3 30.2 0.0 0.1 0.0 0.0 0.2 0.1 1.8 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SH3GL1 "CNSA1, EEN, MGC111371, SH3D2B, SH3P8" ENSG00000141985 "SH3 domain containing GRB2 like 1, endophilin A2" Q99961 19 4360370-4400547 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021485 Approved Enhanced Cytosol NA NA 390000 Cytosol "HPA021485: AB_1856816" "unprognostic (1.32e-1)" "prognostic favorable (1.50e-4)" "unprognostic (6.85e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.84e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.36e-8)" "unprognostic (5.48e-3)" "unprognostic (2.45e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" 58.4 65.3 22.7 29.6 25.1 54.9 50.4 27.3 38.4 59.2 20.9 38.7 41.2 45.5 8.2 177.2 44.3 25.6 35.2 31.6 19.9 39.3 57.9 44.2 23.0 22.1 20.0 22.6 49.4 42.1 10.9 47.2 39.2 22.8 49.2 9.2 7.1 52.2 24.2 21.4 118.8 44.1 21.0 18.8 47.2 36.2 28.3 19.6 17.0 37.4 10.2 20.0 53.5 92.4 25.1 111.3 49.2 50.0 66.8 57.4 89.0 92.2 94.2 80.3 82.2 81.1 77.4 56.8 24.9 39.0 94.1 39.8 89.5 35.6 103.7 21.9 33.1 59.8 30.0 66.5 102.7 82.6 27.2 32.6 75.0 70.9 69.4 42.4 40.6 97.8 23.7 78.9 55.1 67.1 92.6 26.5 28.4 126.0 40.4 54.3 20.8 69.8 43.6 65.8 96.4 49.1 75.7 83.3 81.9 59.3 23.5 56.5 42.5 149.3 78.6 57.1 166.7 97.2 34.8 23.2 26.7 112.9 70.0 110.4 0.8 2.3 3.1 2.7 1.1 2.6 3.7 4.0 3.9 3.0 2.7 2.2 2.5 5.6 2.3 3.4 3.8 4.1 2.3 22.7 25.1 27.3 38.4 31.6 19.9 22.1 20.0 22.6 22.8 18.8 19.6 25.1 31.6 9.6 21.5 11.8 15.2 60.8 41.0 43.2 19.4 17.1 17.1 15.7 3.6 11.5 25.1 9.2 6.2 41.2 14.7 23.6 13.7 32.1 7.2 17.9 33.8 30.7 10.2 30.7 23.4 29.3 153.7 37.5 19.9 29.5 9.5 23.4 32.9 27.3 51.5 10.1 14.0 18.6 20.3 19.4 51.8 6.7 32.6 22.3 23.2 14.0 14.7 20.3 15.5 12.5 10.3 50.4 17.0 24.0 16.4 38.0 61.6 22.9 15.4 8.7 13.1 17.2 29.3 15.7 11.5 36.8 85.8 44.2 15.1 50.1 19.8 67.1 DUS3L "DUS3, FLJ13896" ENSG00000141994 "Dihydrouridine synthase 3 like" Q96G46 19 5784832-5791225 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041854, HPA041944, HPA062846" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879" "unprognostic (1.25e-2)" "unprognostic (7.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.64e-3)" "unprognostic (6.08e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.87e-1)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (7.35e-3)" "unprognostic (4.25e-3)" "unprognostic (7.73e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" 14.0 15.5 5.9 8.5 6.2 20.9 15.8 5.6 10.3 16.7 5.6 14.8 11.5 16.4 1.6 20.8 17.3 4.1 13.2 5.9 5.6 16.8 25.4 11.8 9.6 7.6 6.1 5.2 18.3 24.3 4.0 13.8 5.4 7.4 19.1 2.8 3.0 17.9 5.0 16.9 24.4 18.5 2.8 6.1 19.8 17.1 40.5 6.3 8.2 18.7 3.8 3.7 15.6 16.9 8.2 29.9 28.3 8.1 29.0 2.3 3.7 26.9 9.8 5.7 9.9 7.6 44.4 13.9 30.2 36.1 3.9 11.5 18.9 7.3 9.5 1.5 22.7 63.6 20.3 15.4 16.9 14.2 45.0 56.2 8.6 10.0 11.3 7.8 1.3 6.8 19.8 53.2 0.0 5.4 38.0 38.8 45.9 28.4 10.7 76.9 19.4 17.0 38.1 4.2 20.7 27.9 28.6 10.3 17.0 19.7 1.9 12.1 36.1 9.4 14.3 25.2 43.1 42.6 83.4 66.9 29.3 13.9 46.1 16.4 8.3 20.1 5.8 21.5 30.2 24.7 15.2 16.4 20.3 29.8 19.0 21.2 21.5 2.2 27.9 25.3 30.9 20.1 16.3 5.9 6.2 5.6 10.3 5.9 5.6 7.6 6.1 5.2 7.4 6.1 6.3 8.2 7.2 9.6 10.0 2.6 19.9 14.7 19.3 16.7 25.6 6.6 7.7 10.2 3.0 7.2 9.7 1.8 12.5 18.3 9.3 14.4 7.9 12.4 48.8 6.7 8.3 9.2 7.7 25.2 4.2 22.4 17.7 10.9 18.3 8.2 35.5 7.7 4.6 7.5 14.8 11.8 5.0 12.8 4.1 7.2 9.1 10.9 12.8 10.6 5.4 1.9 6.9 4.3 14.4 1.5 4.8 12.0 10.3 6.4 12.3 8.6 12.8 7.2 6.2 11.1 19.7 15.8 9.8 55.0 10.7 16.1 12.8 21.8 13.5 9.8 15.9 12.7 DPP9 ENSG00000142002 "Dipeptidyl peptidase 9" Q86TI2 19 4675224-4724673 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 203.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036059 Approved Supported Cytosol NA NA Cytosol "HPA036059: AB_10671240" "prognostic favorable (4.96e-4)" "unprognostic (4.16e-2)" "unprognostic (2.03e-1)" "prognostic favorable (6.21e-5)" "unprognostic (5.67e-2)" "unprognostic (8.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (8.85e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.38e-8)" "prognostic favorable (7.72e-5)" "unprognostic (1.55e-1)" "unprognostic (4.22e-1)" "unprognostic (1.80e-1)" 19.6 16.3 11.0 24.7 12.2 33.1 19.6 11.0 13.8 19.1 21.3 23.6 20.3 20.5 5.9 24.7 16.4 13.6 27.0 11.6 10.9 16.8 57.6 27.6 25.1 12.6 12.9 9.4 17.5 20.8 10.2 12.8 13.1 12.9 19.1 13.9 9.6 17.8 12.9 71.6 24.0 26.5 15.5 10.2 28.6 21.3 9.1 13.3 18.1 17.1 23.2 17.2 23.4 20.4 13.3 77.5 60.4 17.6 27.5 26.2 36.3 31.7 44.3 58.5 73.1 47.4 54.3 58.2 36.5 32.8 57.7 49.1 51.7 35.9 203.9 44.5 47.3 34.8 26.8 33.6 47.2 40.0 47.2 55.8 27.9 46.6 114.4 67.2 62.2 66.8 25.0 37.4 78.3 64.1 21.2 54.2 30.0 36.0 30.4 89.0 34.0 37.4 42.4 38.3 52.5 24.8 22.2 38.2 67.8 29.5 18.1 18.8 38.2 54.5 64.9 28.0 101.6 89.6 54.6 62.3 36.8 63.4 53.7 55.7 10.8 7.1 7.7 10.6 8.3 7.9 8.0 4.7 8.5 7.1 4.8 4.5 7.3 3.7 11.4 6.5 3.3 9.7 7.7 11.0 12.2 11.0 13.8 11.6 10.9 12.6 12.9 9.4 12.9 10.2 13.3 13.3 21.8 28.9 25.8 14.4 18.8 7.9 13.6 10.2 10.8 18.6 12.2 12.3 14.6 10.0 11.2 3.7 37.5 11.7 22.7 37.4 3.9 12.4 2.0 12.7 14.6 19.4 12.5 7.6 10.1 12.8 18.3 10.7 36.2 22.8 17.1 13.3 17.2 39.5 19.0 23.5 10.2 21.3 6.1 20.4 17.6 3.9 9.9 22.0 5.4 16.9 42.2 9.0 25.7 7.5 13.7 26.6 28.4 9.4 32.9 15.6 20.1 5.1 9.5 30.8 19.7 21.7 12.4 7.5 6.9 12.4 5.5 15.6 21.2 12.8 20.6 16.7 DMRTC2 ENSG00000142025 "DMRT like family C2" Q8IXT2 19 41844743-41852333 "Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 106 "testis: 41.2" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 162.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045016 Uncertain NA NA "HPA045016: AB_10960404" "unprognostic (6.80e-3)" "unprognostic (4.38e-2)" "unprognostic (5.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 41.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 162.6 38.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 CCDC97 "FLJ40267, MGC20255" ENSG00000142039 "Coiled-coil domain containing 97" Q96F63 19 41310172-41324873 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043320, HPA043572" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043320: AB_10964344, HPA043572: AB_10962488" "unprognostic (9.25e-3)" "unprognostic (7.26e-2)" "unprognostic (1.68e-1)" "unprognostic (5.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (8.40e-2)" "unprognostic (1.91e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (4.51e-2)" "unprognostic (2.16e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-1)" "unprognostic (7.92e-2)" "unprognostic (1.65e-2)" 14.6 13.0 17.7 18.0 18.4 23.2 14.5 16.5 17.5 20.2 13.2 13.5 14.3 17.4 23.6 20.4 22.1 12.4 15.8 15.4 16.5 12.1 11.9 14.4 24.0 22.7 18.5 12.6 24.2 17.9 16.0 13.8 10.6 19.7 16.4 11.4 10.8 18.1 14.7 30.9 20.4 16.7 14.4 16.1 20.1 15.9 32.4 19.1 22.1 16.4 20.7 22.3 14.9 17.3 20.9 25.2 54.1 28.2 32.9 36.2 28.7 20.3 16.6 13.4 25.7 21.9 32.4 23.6 23.9 17.4 13.9 17.3 16.7 38.8 33.1 19.5 44.1 37.6 21.9 25.5 21.5 27.5 36.6 45.3 28.1 41.7 30.0 25.0 21.1 18.0 25.8 28.5 44.4 24.9 18.3 33.6 8.9 13.2 30.5 19.3 37.5 22.4 17.5 23.7 47.3 25.1 22.2 37.0 40.3 16.5 18.6 27.5 27.6 21.6 22.1 22.0 11.5 27.8 45.3 42.2 22.7 21.0 26.7 30.0 9.4 7.2 8.5 12.0 7.6 13.4 9.1 8.1 8.7 5.8 10.0 8.7 7.8 11.9 10.4 12.6 6.3 7.2 8.1 17.7 18.4 16.5 17.5 15.4 16.5 22.7 18.5 12.6 19.7 16.1 19.1 20.9 7.3 12.8 6.7 5.2 22.3 4.6 11.4 11.3 6.2 11.8 11.2 8.8 6.7 7.2 8.9 9.2 12.5 11.1 23.9 13.5 7.9 13.1 3.7 9.3 8.6 8.4 11.5 7.8 4.1 26.1 4.5 10.0 15.3 9.8 16.5 11.2 9.7 6.5 15.3 10.1 4.7 12.1 18.3 10.0 7.9 8.4 12.8 12.3 1.8 3.7 16.1 7.1 25.7 1.0 6.6 20.5 5.9 11.3 18.6 10.0 16.7 9.3 12.2 8.5 0.0 13.1 8.5 22.5 12.9 10.8 5.8 18.3 20.1 7.2 10.7 13.3 TMEM91 "DSPC3, FLJ27310, IFITMD6" ENSG00000142046 "Transmembrane protein 91" Q6ZNR0 19 41350911-41384083 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 212.0;Late spermatids: 451.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 193.3" "Group enriched" "Detected in all" 8 "granulocytes: 193.3;monocytes: 51.9" "Cell line enhanced" "Detected in many" "HEL: 20.1;HSkMC: 20.5;TIME: 19.8" "Low region specificity" "Detected in all" HPA053240 Uncertain NA NA "HPA053240: AB_2682085" "unprognostic (3.02e-3)" "unprognostic (1.92e-2)" "unprognostic (5.13e-3)" "unprognostic (2.97e-2)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (4.70e-2)" "unprognostic (2.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.69e-3)" "prognostic favorable (3.54e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.06e-2)" 20.8 12.9 35.4 6.9 41.5 36.5 19.9 19.6 31.5 37.2 26.8 21.3 3.5 18.8 10.3 22.8 30.5 8.3 15.1 28.5 39.8 20.4 9.7 23.5 6.6 28.4 30.4 24.7 20.3 17.9 4.1 26.4 9.5 26.3 23.2 3.9 9.3 11.5 8.6 5.4 49.7 14.4 8.8 21.7 37.8 12.4 38.1 42.2 5.7 20.7 7.3 7.7 30.0 31.5 23.4 3.3 7.0 5.4 2.7 6.4 13.6 5.0 2.6 3.4 1.3 2.1 0.5 2.9 1.5 2.4 3.0 2.1 0.9 1.3 2.4 3.0 2.3 3.6 20.1 5.7 11.1 12.3 3.4 5.2 20.5 12.6 4.0 9.8 14.8 9.2 3.7 3.8 6.2 2.1 6.3 2.5 6.6 2.3 0.9 4.2 4.2 1.2 1.4 3.4 1.6 1.4 3.3 5.0 1.0 4.1 3.8 1.3 9.9 19.8 3.1 3.0 2.9 2.7 3.8 0.6 1.1 6.5 4.6 1.2 36.8 51.9 4.0 5.9 12.3 7.4 0.7 3.4 3.1 9.5 1.4 8.0 3.9 193.3 1.5 9.1 14.6 4.7 41.2 35.4 41.5 19.6 31.5 28.5 39.8 28.4 30.4 24.7 26.3 21.7 42.2 23.4 20.2 3.2 22.4 23.8 3.5 17.8 22.9 59.8 7.4 8.3 10.7 15.9 5.3 2.8 25.0 7.3 6.2 2.7 10.6 0.7 1.9 5.3 212.0 12.0 12.1 13.7 14.4 4.8 11.7 3.2 84.3 21.7 1.1 4.8 34.2 13.0 20.0 3.8 15.7 8.4 18.9 1.6 10.2 67.6 8.4 451.5 14.0 51.6 8.8 7.5 30.7 4.1 20.6 5.0 5.8 3.8 18.5 7.2 1.7 6.5 2.3 2.5 13.5 6.4 6.6 4.8 8.6 4.9 9.0 9.7 21.3 8.6 7.8 3.7 1.7 10.4 ZFP14 "KIAA1559, ZNF531" ENSG00000142065 "ZFP14 zinc finger protein" Q9HCL3 19 36334453-36379201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.2;Rod photoreceptor cells: 105.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030637 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA030637: AB_10602353" "unprognostic (1.89e-1)" "unprognostic (3.80e-2)" "unprognostic (9.61e-2)" "unprognostic (3.53e-1)" "unprognostic (2.20e-2)" "unprognostic (3.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-2)" "unprognostic (1.17e-1)" "unprognostic (3.18e-3)" "unprognostic (1.91e-1)" "unprognostic (5.51e-2)" "unprognostic (1.86e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.75e-5)" 1.7 2.6 4.4 2.5 5.2 1.1 4.1 6.3 4.9 2.9 6.2 2.1 2.8 3.3 5.2 1.6 3.1 1.9 1.7 3.9 4.3 3.2 2.0 2.0 3.8 4.5 4.7 3.6 4.2 1.9 4.8 3.9 2.1 5.2 3.1 2.0 9.1 2.3 3.1 1.5 3.2 2.6 2.2 3.8 3.7 2.5 1.1 4.6 4.0 4.5 1.5 3.5 2.4 2.4 8.7 1.5 2.5 5.1 4.7 4.3 2.1 1.2 0.7 2.2 1.4 2.2 1.7 1.2 4.2 1.8 1.0 1.1 0.5 2.1 0.3 1.5 1.6 1.6 3.7 2.5 1.4 1.4 3.0 3.8 0.9 0.9 0.6 0.1 2.6 1.9 4.8 1.1 0.0 2.2 1.0 4.8 1.2 3.8 2.2 1.1 3.8 2.9 1.2 1.5 2.9 2.8 4.2 2.6 0.8 1.5 2.6 1.6 2.4 1.3 1.4 3.2 1.5 0.7 1.1 1.9 2.1 0.2 0.4 2.5 5.6 2.8 4.1 4.1 3.4 4.4 8.1 4.7 5.6 2.8 6.0 6.5 6.6 1.7 4.5 2.9 4.2 4.8 1.3 4.4 5.2 6.3 4.9 3.9 4.3 4.5 4.7 3.6 5.2 3.8 4.6 8.7 12.0 0.0 5.3 17.9 25.5 3.2 6.7 4.5 8.0 63.2 8.5 6.1 6.5 20.0 5.9 12.9 52.1 8.2 18.5 8.2 7.9 8.9 2.8 6.5 7.9 11.2 13.2 10.3 32.9 4.5 2.4 9.3 7.7 4.6 13.3 22.1 12.5 4.3 8.6 47.1 39.5 8.3 6.1 8.5 4.6 0.8 15.5 8.8 3.6 17.8 15.6 16.9 44.3 41.2 56.2 4.9 13.0 19.5 4.9 7.0 13.9 12.4 11.3 105.3 32.9 10.4 9.1 7.9 8.3 3.0 2.6 2.5 17.3 15.2 7.7 7.2 SIRT3 SIR2L3 ENSG00000142082 "Sirtuin 3" Q9NTG7 11 215030-236931 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026809, CAB037142" Approved NA NA "CAB037142: AB_1079982, HPA026809: AB_10601160" "unprognostic (1.76e-2)" "unprognostic (2.69e-1)" "unprognostic (2.04e-1)" "prognostic favorable (8.51e-5)" "unprognostic (1.52e-3)" "unprognostic (2.65e-1)" "unprognostic (3.45e-2)" "unprognostic (5.52e-2)" "unprognostic (8.64e-2)" "unprognostic (1.31e-1)" "prognostic favorable (4.45e-4)" "unprognostic (2.06e-1)" "prognostic favorable (4.85e-9)" "unprognostic (1.04e-1)" "unprognostic (5.53e-2)" "unprognostic (3.45e-1)" "unprognostic (3.75e-2)" 10.6 14.0 28.4 10.5 26.5 11.9 18.8 19.9 28.1 13.8 23.5 12.7 13.4 12.7 40.5 10.0 14.5 7.7 21.4 25.1 21.8 16.6 26.0 10.4 13.9 20.3 21.3 24.7 18.4 18.2 11.3 28.2 5.8 20.9 16.9 14.3 27.0 12.7 12.5 27.6 20.3 14.7 9.8 20.6 14.8 13.6 25.4 20.2 6.9 15.8 20.1 15.1 11.6 11.2 24.0 9.7 11.1 16.7 17.7 19.1 24.1 8.0 13.6 11.0 10.1 7.9 11.5 22.8 5.9 6.2 8.5 9.8 18.6 8.2 7.4 9.8 11.2 12.7 7.4 15.7 12.6 8.4 9.7 17.3 17.8 14.1 10.2 10.9 17.3 6.7 11.1 15.3 11.0 4.6 10.8 4.0 15.0 7.5 8.5 13.2 10.8 13.2 9.8 10.2 6.6 9.3 7.5 11.5 16.7 6.4 10.8 11.9 2.2 9.3 11.4 5.4 3.2 4.1 19.4 17.3 8.4 12.4 7.7 5.9 0.1 3.1 3.1 3.6 2.5 3.8 5.3 3.3 4.1 2.8 4.3 6.0 4.9 3.1 8.1 6.6 4.8 4.0 2.7 28.4 26.5 19.9 28.1 25.1 21.8 20.3 21.3 24.7 20.9 20.6 20.2 24.0 6.0 3.2 6.5 17.0 10.4 5.0 7.0 13.1 12.5 7.4 16.0 15.5 23.4 14.3 7.4 5.5 8.4 12.6 7.2 7.2 33.2 7.5 22.0 7.4 5.8 6.7 6.0 14.3 19.2 5.8 10.3 8.6 11.7 4.6 10.2 8.4 7.5 18.3 8.8 10.1 18.3 8.1 10.2 5.5 3.3 21.0 9.0 6.4 10.6 8.4 3.5 13.5 5.2 9.0 11.6 5.1 9.3 9.1 14.6 5.5 14.3 18.9 9.0 9.5 0.0 7.3 6.5 25.5 9.6 9.9 4.1 6.8 8.4 14.2 11.2 4.0 IFITM3 "1-8U, DSPA2b" ENSG00000142089 "Interferon induced transmembrane protein 3" Q01628 11 319676-329475 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 2128.0;Endothelial cells: 2064.8;Hepatocytes: 2268.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 2907.6;non-classical monocyte: 3344.3" "Group enriched" "Detected in all" 6 "granulocytes: 2907.6;monocytes: 3344.3;NK-cells: 926.2" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 3222.7;BJ hTERT+ SV40 Large T+ RasG12V: 4076.3;HHSteC: 3609.8;HSkMC: 3476.2" HPA004337 Uncertain NA NA "HPA004337: AB_1851427" "unprognostic (4.17e-2)" "unprognostic (4.19e-1)" "unprognostic (1.67e-1)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (6.00e-2)" "unprognostic (3.36e-2)" "unprognostic (6.44e-2)" "unprognostic (8.90e-2)" "unprognostic (9.42e-2)" "unprognostic (7.45e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (5.78e-7)" "unprognostic (7.81e-2)" "unprognostic (3.34e-2)" "unprognostic (8.28e-2)" "unprognostic (1.19e-1)" 1566.0 752.0 555.7 602.8 589.3 239.5 1292.1 560.1 917.3 1532.5 718.2 984.6 237.3 1558.6 847.5 488.4 1950.6 708.7 1172.9 551.9 757.0 1304.7 2527.0 1587.1 274.9 671.0 585.9 497.1 1272.9 581.1 642.0 497.1 836.1 630.6 893.2 241.3 93.4 559.9 637.6 367.5 487.2 605.0 1131.7 575.1 1251.8 742.2 268.8 728.5 231.4 943.5 429.8 156.2 1214.0 1047.0 639.1 554.1 49.6 1930.0 508.9 952.4 1538.6 44.2 842.4 1638.0 3222.7 4076.3 65.4 1818.6 1.3 873.1 1276.4 826.0 872.0 1.1 619.9 176.8 19.2 57.1 8.1 578.4 570.2 3609.8 5.7 5.2 3476.2 136.1 257.3 561.7 418.1 610.5 5.2 3.1 5.0 290.3 1095.0 2.7 26.3 243.0 2.2 425.3 74.2 185.3 4.8 1741.5 50.1 1.5 3.5 1007.5 170.0 891.9 259.0 41.3 39.7 1130.9 192.1 131.9 180.6 34.8 2.5 3.4 10.3 89.6 7.6 315.3 520.4 740.1 563.7 115.7 2745.9 69.0 82.2 82.6 118.9 396.9 55.6 77.8 109.0 2907.6 926.2 3344.3 31.1 52.9 921.0 555.7 589.3 560.1 917.3 551.9 757.0 671.0 585.9 497.1 630.6 575.1 728.5 639.1 1971.3 532.0 709.5 32.0 35.5 317.2 684.3 856.2 1237.9 1.2 207.9 253.1 157.4 539.1 562.1 527.8 2.1 122.2 68.6 94.4 559.6 2128.0 27.3 164.2 1197.8 2064.8 54.1 92.0 0.0 1898.5 635.5 1572.4 103.5 207.0 242.7 223.5 2002.5 2268.4 539.7 0.0 0.1 228.2 132.2 491.4 463.2 102.3 1861.8 713.0 361.1 39.4 130.7 162.4 62.8 0.0 0.5 1135.8 198.3 1060.7 18.7 416.9 54.1 563.8 260.3 7.8 959.8 953.3 1483.2 26.9 12.5 222.4 209.1 125.7 96.6 303.3 263.4 270.6 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289126-296107 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 663.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 160.3;Alveolar cells type 2: 81.8;Breast glandular cells: 35.1;Club cells: 31.6;Collecting duct cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 132.8;U-266/70: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol NA Yes Cytosol "HPA039383: AB_10796225, HPA058829: AB_2683830" "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.12e-4)" 21.1 5.7 4.5 42.0 4.3 16.4 42.3 4.4 21.4 39.6 8.1 21.5 50.9 21.8 32.9 14.2 35.0 19.1 18.4 4.2 6.1 56.0 78.5 67.6 64.0 5.8 4.7 3.2 8.7 663.2 2.9 12.6 7.4 7.0 34.9 6.3 0.6 36.5 46.6 4.5 7.8 103.8 3.1 4.6 102.7 18.7 6.4 5.8 37.7 75.0 3.2 17.7 21.7 22.8 5.9 5.4 5.8 10.5 11.7 4.2 3.7 8.2 4.2 3.4 2.4 2.1 5.0 15.0 0.0 5.3 5.1 5.1 3.3 0.9 1.9 0.3 13.3 4.0 2.5 4.2 6.8 5.3 0.3 22.8 13.8 1.5 0.9 0.7 8.9 8.1 132.8 10.5 15.9 1.3 7.7 24.0 12.1 8.3 1.8 1.0 21.5 2.1 7.8 5.6 1.8 0.1 2.4 1.5 7.8 7.2 4.6 5.7 2.9 7.5 4.9 7.0 1.5 0.5 34.8 1.0 6.0 0.8 4.3 5.8 1.2 0.7 1.0 6.1 3.2 5.1 1.5 1.0 3.3 0.5 1.5 2.1 4.5 3.7 5.6 2.5 2.0 0.1 2.2 4.5 4.3 4.4 21.4 4.2 6.1 5.8 4.7 3.2 7.0 4.6 5.8 5.9 17.8 160.3 81.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 35.1 26.8 0.0 0.0 31.6 33.1 0.0 0.3 29.8 0.0 0.0 4.9 0.0 12.5 12.0 4.5 0.0 0.0 0.0 8.3 3.3 4.2 0.0 17.6 6.3 1.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 16.1 0.0 0.0 2.9 10.2 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 14.4 0.9 0.0 0.0 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873020-32044633 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 9.9" "Cell type enriched" "Detected in many" 5 "Inhibitory neurons: 109.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.2;BEWO: 16.3;RH-30: 18.1;SCLC-21H: 14.8;SiHa: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA027295: AB_2672203, HPA027372: AB_2672239" "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 0.7 1.0 1.1 1.3 1.5 0.2 1.2 0.6 5.2 0.3 0.1 3.7 1.4 4.1 1.9 0.4 1.9 0.6 0.3 5.3 5.7 2.9 0.5 1.0 0.4 0.5 0.2 1.0 0.6 9.9 0.1 1.2 4.7 1.4 0.9 3.8 3.1 0.6 2.2 0.3 3.0 2.7 2.4 0.3 0.1 1.3 1.0 0.9 0.7 0.6 0.2 0.6 1.5 0.7 1.8 0.0 3.9 13.2 0.1 0.0 0.0 16.3 1.3 0.0 0.2 0.0 5.3 0.1 0.0 0.5 6.2 0.2 0.0 7.7 0.0 0.1 0.1 3.9 0.0 3.7 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 1.1 0.2 1.1 10.2 0.1 0.1 0.1 18.1 0.1 1.3 0.0 14.8 9.8 13.2 1.0 0.5 9.3 5.5 1.4 0.0 0.1 9.3 0.1 0.0 0.1 0.0 1.8 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.6 5.2 5.3 5.7 0.5 0.2 1.0 1.4 0.3 0.9 1.8 0.2 6.4 9.1 7.5 0.0 5.1 2.6 0.2 0.6 8.1 0.5 2.8 3.5 14.3 3.0 7.3 2.1 9.2 0.0 4.6 0.0 5.3 0.2 1.2 1.3 0.8 4.9 0.0 19.0 3.3 13.9 7.9 0.5 3.4 0.0 4.3 0.4 1.0 2.7 3.3 109.6 5.1 0.0 0.0 4.2 0.1 0.3 0.4 3.6 1.0 0.1 8.1 0.0 10.1 1.5 1.6 4.4 0.0 0.0 2.1 1.8 1.9 0.8 1.2 0.0 6.3 2.2 0.7 1.1 0.7 5.8 6.2 0.5 0.0 10.6 0.9 COL6A1 ENSG00000142156 "Collagen type VI alpha 1 chain" P12109 21 45981769-46005050 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 46.8" "HPA019142, HPA029401" Enhanced Approved Cytosol "Secreted to extracellular matrix" NA NA 250000000 Cytosol "HPA019142: AB_1847093, HPA029401: AB_10601361" "unprognostic (3.45e-1)" "unprognostic (4.09e-2)" "unprognostic (8.71e-2)" "unprognostic (1.72e-1)" "unprognostic (5.79e-3)" "unprognostic (2.12e-1)" "unprognostic (6.27e-2)" "unprognostic (1.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.69e-2)" "unprognostic (6.06e-3)" "unprognostic (3.86e-1)" "prognostic unfavorable (1.07e-8)" "unprognostic (5.16e-2)" "unprognostic (7.39e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (4.54e-4)" 263.3 50.5 14.8 154.6 8.1 0.7 175.4 31.4 20.5 490.7 31.8 576.3 73.9 561.0 24.9 91.9 415.1 196.2 153.9 8.7 18.5 66.6 48.7 141.5 37.8 18.2 17.4 6.2 495.5 58.3 29.4 118.7 289.5 19.9 248.9 40.9 3.5 98.6 143.6 86.2 124.4 219.5 179.5 11.6 71.3 232.4 33.0 13.3 30.9 93.4 39.9 16.7 482.7 287.2 17.7 2.9 20.2 31.2 99.6 1157.2 2331.5 3.9 927.1 586.3 231.7 80.7 16.2 62.8 0.1 75.1 522.2 183.6 4.3 13.5 2.3 19.5 0.5 14.9 0.0 3.7 5.2 1025.3 0.3 2.2 1711.4 1.0 578.6 7.8 20.9 5.6 0.2 0.7 0.6 60.9 1.4 0.3 3.2 22.4 13.4 263.2 0.1 19.5 4.3 1.6 11.1 1.0 39.9 87.6 1.1 17.9 10.4 4.2 4.2 0.5 1297.6 86.7 362.7 358.1 0.6 0.4 0.4 464.1 6.9 116.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 8.1 31.4 20.5 8.7 18.5 18.2 17.4 6.2 19.9 11.6 13.3 17.7 74.6 0.0 5.8 26.1 2.5 122.2 11.0 1.5 18.2 18.9 9.2 35.9 42.7 5.7 4.4 9.2 0.0 11.6 2.3 0.6 3.9 23.2 4.6 20.9 578.3 50.6 1.8 0.0 27.1 3.3 18.6 816.1 6.1 16.1 1.3 48.7 101.0 13.4 22.4 15.2 8.2 0.3 0.0 3.3 134.7 18.6 353.0 7.8 147.7 40.3 2.0 18.7 0.0 30.7 2.4 6.1 2.6 251.3 3.5 6.3 2.1 10.3 1.0 4.3 184.1 152.3 324.4 2.6 6.2 5.5 89.9 20.8 13.7 246.5 1.4 3.8 IFNAR1 "IFNAR, IFRC" ENSG00000142166 "Interferon alpha and beta receptor subunit 1" P17181 21 33324429-33359864 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 198.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029226 Approved NA NA 170000 "HPA029226: AB_2672954" "unprognostic (2.42e-3)" "unprognostic (2.95e-1)" "unprognostic (3.01e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (3.02e-1)" "unprognostic (4.69e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.38e-1)" "unprognostic (9.38e-3)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (8.45e-2)" "unprognostic (3.06e-2)" 41.2 22.5 14.4 36.7 14.9 31.1 32.6 16.0 16.2 26.6 12.6 29.2 27.0 22.7 23.4 25.4 24.1 30.4 21.4 14.7 17.7 32.3 77.2 29.9 29.0 17.9 16.0 13.4 23.7 29.5 40.8 7.8 49.9 17.1 27.5 30.8 23.8 30.4 24.4 33.0 20.7 27.6 24.3 16.7 33.8 31.9 21.1 17.9 33.4 41.5 25.0 30.0 40.2 9.1 18.5 47.3 24.4 27.4 24.2 55.8 80.8 23.7 44.6 74.2 32.9 36.1 31.7 57.2 42.4 35.4 49.4 36.3 28.4 23.3 37.0 43.8 33.8 26.0 62.8 29.0 20.2 33.9 50.8 43.3 58.2 38.4 43.6 37.7 39.4 63.1 40.3 67.6 198.2 56.5 22.8 38.7 22.2 24.9 46.6 25.6 29.5 75.0 62.4 33.7 44.0 22.5 24.1 50.5 42.4 39.3 20.8 58.2 36.8 61.3 39.3 24.7 58.2 28.2 102.3 132.7 43.2 66.3 64.4 50.5 77.3 45.4 27.7 23.6 64.0 23.1 56.2 31.5 28.6 37.4 57.0 37.0 29.0 166.7 28.0 80.3 54.3 41.2 35.2 14.4 14.9 16.0 16.2 14.7 17.7 17.9 16.0 13.4 17.1 16.7 17.9 18.5 101.2 109.0 45.8 17.6 69.3 45.8 57.0 72.3 18.8 51.9 42.5 29.7 33.5 34.3 78.8 44.1 29.2 28.1 43.8 25.3 21.5 73.0 17.7 37.9 58.4 75.5 26.9 27.1 26.3 90.5 92.4 61.1 35.7 44.5 39.2 30.3 53.9 81.3 69.2 58.9 29.4 28.9 46.8 82.1 47.5 10.7 32.6 77.6 37.4 30.9 86.8 34.3 42.2 34.2 27.2 64.7 25.5 30.9 137.3 63.9 37.6 28.7 59.6 30.0 19.7 54.9 44.9 38.5 17.5 21.5 44.9 20.1 38.3 25.1 27.5 72.2 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659666-31668931 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1659.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 3357.9;Proximal tubular cells: 3285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 44900000 50000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 256.8 602.0 571.9 119.5 586.0 167.8 235.5 612.6 722.7 197.7 597.1 246.5 363.5 181.0 230.4 222.9 198.8 207.9 431.1 577.5 608.8 487.7 1659.1 155.2 171.0 631.0 607.8 571.4 304.6 118.1 212.4 238.5 157.1 643.8 205.7 182.2 250.7 161.8 206.1 431.5 151.4 268.9 137.8 608.8 148.6 212.1 133.1 598.2 167.2 199.0 359.1 152.9 234.1 222.5 665.2 526.8 451.4 309.2 312.8 407.3 282.1 257.8 430.2 258.0 291.3 217.4 593.6 326.0 628.2 441.2 405.8 517.7 186.1 453.3 320.6 239.9 463.3 540.0 1008.2 579.5 866.3 267.4 451.7 363.1 294.8 240.6 406.5 225.2 327.9 331.2 469.0 704.4 773.2 357.4 860.0 489.0 454.5 466.1 830.0 475.4 413.0 622.0 981.4 579.4 320.5 335.9 281.4 805.1 419.4 438.3 279.2 484.3 393.4 387.4 222.9 489.2 304.7 322.0 583.4 1374.2 741.8 455.7 654.3 301.9 204.2 159.7 194.0 313.4 234.0 365.3 427.1 509.2 402.4 212.8 310.1 521.8 412.1 37.8 241.4 465.4 240.6 746.0 474.5 571.9 586.0 612.6 722.7 577.5 608.8 631.0 607.8 571.4 643.8 608.8 598.2 665.2 319.8 294.9 175.1 38.2 248.1 491.4 672.7 479.2 319.8 226.6 264.1 352.9 721.0 527.6 294.7 391.8 47.9 703.4 250.2 703.5 1631.7 426.3 277.0 410.7 241.2 261.0 288.4 898.8 39.7 807.3 574.9 365.8 198.8 216.3 220.0 278.9 318.1 3357.9 363.3 282.7 45.5 402.7 366.2 220.0 318.5 952.2 521.9 224.2 419.8 29.0 313.1 598.5 239.0 28.6 68.7 322.8 600.9 528.1 178.2 567.0 1158.3 3285.9 638.3 216.5 440.4 313.6 404.5 211.7 506.3 379.9 349.8 725.9 423.1 470.3 593.6 497.7 COL6A2 ENSG00000142173 "Collagen type VI alpha 2 chain" P12110 21 46098112-46132848 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 49.6" "HPA007029, HPA030920, HPA038799" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 8200000 Cytosol "Plasma membrane" "HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214" "unprognostic (3.53e-1)" "unprognostic (3.76e-2)" "unprognostic (3.20e-2)" "unprognostic (4.87e-2)" "unprognostic (2.92e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-1)" "unprognostic (5.28e-3)" "unprognostic (2.11e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (8.72e-14)" "unprognostic (2.13e-2)" "unprognostic (7.61e-2)" "unprognostic (2.31e-2)" "unprognostic (2.22e-3)" 668.2 97.0 9.2 221.9 7.8 4.6 458.9 10.0 16.3 828.6 27.7 960.2 98.6 1010.0 36.8 180.2 681.1 286.3 429.9 9.1 23.8 92.2 98.4 397.6 56.1 10.6 14.8 4.2 729.7 79.2 24.2 113.1 338.1 10.6 574.8 60.7 0.9 157.4 277.1 124.4 355.7 405.6 278.0 10.7 176.5 445.4 77.6 9.6 35.9 202.9 67.8 25.8 926.4 601.0 11.2 9.4 12.5 34.8 31.2 1155.7 2116.9 10.0 1073.7 982.8 265.5 121.5 2.3 42.4 0.2 79.2 775.0 170.8 0.9 8.1 0.7 21.7 0.8 12.3 0.2 0.2 0.2 1129.2 0.5 4.8 1524.4 0.2 503.6 10.2 0.1 0.6 0.6 0.6 0.8 108.7 5.2 0.4 2.4 19.3 0.0 130.5 0.4 66.9 1.8 0.0 0.1 1.1 54.2 41.6 0.6 0.7 19.4 1.2 6.6 0.2 1128.1 131.5 421.5 270.3 0.7 0.4 0.9 578.1 0.5 164.8 0.0 0.0 0.0 4.5 0.0 3.1 0.0 0.4 2.4 0.0 0.0 0.4 1.2 0.0 0.3 0.0 0.0 0.1 0.5 9.2 7.8 10.0 16.3 9.1 23.8 10.6 14.8 4.2 10.6 10.7 9.6 11.2 127.3 3.2 0.6 2.0 3.1 164.4 4.3 0.6 9.1 0.7 12.7 33.5 8.7 4.3 0.6 7.3 0.0 17.6 41.2 0.4 0.0 15.1 4.0 13.2 453.2 101.4 0.0 2.7 0.1 0.4 25.1 1455.4 13.3 10.3 0.0 36.1 123.1 1.4 35.3 0.0 0.8 0.1 0.0 3.1 219.7 23.7 605.5 11.7 181.5 44.0 2.4 3.1 32.0 0.0 0.1 5.9 1.0 472.1 12.1 11.2 0.0 0.4 0.1 0.5 295.9 284.8 555.2 3.7 11.5 4.6 140.4 40.4 32.7 125.3 0.4 3.9 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427131 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 75.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 302.0;Basal respiratory cells: 123.5;Langerhans cells: 141.9;Suprabasal keratinocytes: 422.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "hypothalamus: 27.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.3;HeLa: 63.1;hTCEpi: 45.4;LHCN-M2: 45.5;U-266/84: 37.7" "Low region specificity" "Detected in all" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB023801: , HPA038211: AB_2675894, HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 23.4 8.4 1.0 6.3 0.6 10.6 19.7 0.5 4.4 17.6 1.8 6.3 0.4 4.4 0.0 18.7 18.8 15.2 14.0 0.7 27.4 5.0 21.0 12.8 4.4 1.4 1.7 0.3 27.1 11.9 5.9 12.6 12.6 1.3 9.3 0.7 8.5 12.2 13.5 13.1 75.6 5.4 5.3 0.2 7.3 12.3 3.0 1.3 11.1 6.3 1.3 4.6 17.0 14.5 1.1 1.2 3.4 4.3 0.1 0.3 1.6 1.7 2.0 0.7 3.5 2.7 5.1 0.1 5.4 1.5 0.4 19.8 23.6 3.5 35.3 2.0 0.3 1.1 1.6 63.1 2.0 4.8 1.7 0.2 2.1 45.4 0.9 10.7 20.7 0.7 0.1 0.2 0.2 45.5 0.3 0.9 3.9 1.9 0.0 3.4 0.1 0.8 5.7 4.0 13.3 0.1 0.0 24.2 4.0 0.8 0.7 2.3 0.6 8.1 0.9 4.2 0.4 0.1 9.5 37.7 1.0 10.0 4.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.5 4.4 0.7 27.4 1.4 1.7 0.3 1.3 0.2 1.3 1.1 23.7 28.9 77.3 0.0 18.4 302.0 0.8 123.5 26.7 0.3 8.6 6.3 11.7 7.2 68.4 12.9 0.0 0.8 13.4 16.4 0.0 3.2 0.0 23.2 4.8 18.4 27.6 0.0 0.0 2.1 1.3 11.1 15.3 29.1 19.6 2.3 4.2 7.7 1.7 0.0 0.0 16.5 85.5 3.8 141.9 0.1 0.0 10.1 96.0 0.0 1.6 1.3 0.0 0.0 0.0 7.3 24.3 0.0 36.3 0.5 23.8 0.2 50.7 0.2 0.0 2.4 27.4 0.1 0.4 35.1 422.7 2.5 16.4 0.8 20.3 1.2 DNMT3L MGC1090 ENSG00000142182 "DNA methyltransferase 3 like" Q9UJW3 21 44246339-44262216 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "liver: 1.9" "Group enriched" "Detected in some" 6 "Hepatocytes: 20.8;Proximal tubular cells: 29.1" "Cancer enriched" "Detected in some" 90 "testis cancer: 46.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BEWO: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055234, HPA066780" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055234: AB_2682750, HPA066780: AB_2685719" "unprognostic (1.05e-4)" "unprognostic (1.91e-1)" "unprognostic (2.73e-9)" "unprognostic (2.77e-1)" "unprognostic (5.28e-2)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 1.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 TRPM2 "EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7" ENSG00000142185 "Transient receptor potential cation channel subfamily M member 2" O94759 21 44350163-44443081 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sodium transport, Transport" "Calcium channel, Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.5;brain: 26.6;lymphoid tissue: 18.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.8;plasmacytoid DC: 15.5" "Group enriched" "Detected in many" 6 "dendritic cells: 15.5;monocytes: 7.8" "Cell line enhanced" "Detected in many" "HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035260 Enhanced NA NA "HPA035260: AB_2674540" "unprognostic (3.61e-2)" "unprognostic (2.18e-1)" "unprognostic (7.55e-2)" "prognostic favorable (9.28e-4)" "unprognostic (6.49e-2)" "unprognostic (4.54e-2)" "unprognostic (5.17e-2)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (2.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.40e-1)" "unprognostic (3.31e-2)" "unprognostic (8.88e-3)" "prognostic favorable (7.59e-4)" 4.5 4.2 9.7 6.8 13.1 28.5 3.1 9.3 26.6 2.1 8.2 3.9 3.7 1.6 0.7 1.6 2.1 4.7 1.4 12.1 10.2 2.2 2.3 5.1 8.0 17.0 12.8 11.9 1.0 1.9 1.1 4.8 6.1 19.1 2.7 2.3 0.9 2.3 0.8 0.9 2.3 7.0 2.6 10.8 18.5 2.5 2.7 12.7 3.3 1.8 0.4 4.1 3.6 1.6 19.5 20.8 7.5 0.0 0.1 0.0 0.0 20.9 0.0 0.0 0.6 0.4 0.0 0.0 0.5 24.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.9 0.0 0.0 41.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 6.7 58.6 0.0 41.3 23.5 2.3 7.2 8.0 0.0 0.0 14.4 0.1 0.0 23.5 0.1 0.0 27.7 71.3 0.0 1.2 20.9 0.1 0.7 0.3 31.8 0.1 0.0 67.7 0.0 0.0 7.8 0.0 1.0 2.7 0.5 0.3 0.3 0.4 2.6 1.9 0.3 0.4 0.4 0.5 2.5 15.5 1.3 2.0 9.7 13.1 9.3 26.6 12.1 10.2 17.0 12.8 11.9 19.1 10.8 12.7 19.5 2.0 0.0 0.5 1.3 2.0 0.4 0.0 0.0 0.6 1.4 2.8 3.0 1.7 0.0 0.0 0.0 0.0 1.8 9.9 0.8 0.0 0.1 2.1 0.7 0.2 2.7 0.0 0.0 52.7 0.2 8.8 0.5 1.1 1.2 1.3 0.3 0.4 0.4 18.3 0.0 45.1 1.0 0.0 11.0 5.5 2.0 0.6 16.7 0.0 27.2 5.5 0.5 6.2 4.0 1.7 1.2 0.1 0.0 1.4 0.0 0.0 0.3 0.0 1.0 6.6 0.5 0.4 1.0 0.1 0.1 0.3 1.4 4.2 0.0 0.7 0.0 SCYL1 "GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP" ENSG00000142186 "SCY1 like pseudokinase 1" Q96KG9 11 65525077-65538704 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015015 Uncertain Supported Cytosol NA NA Cytosol "HPA015015: AB_1856643" "unprognostic (5.56e-2)" "unprognostic (1.16e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-1)" "unprognostic (1.23e-2)" "unprognostic (7.87e-2)" "unprognostic (1.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.14e-1)" "unprognostic (7.23e-2)" "unprognostic (4.41e-1)" "unprognostic (4.29e-1)" "unprognostic (7.86e-3)" "unprognostic (6.49e-3)" "unprognostic (4.27e-1)" "unprognostic (8.29e-2)" "unprognostic (2.29e-3)" 42.9 69.9 29.8 26.7 30.5 33.1 41.5 26.3 54.4 46.3 28.3 43.9 28.3 49.9 32.8 40.3 44.4 26.5 55.0 32.4 26.8 45.8 83.9 42.8 31.0 29.1 29.3 31.0 52.8 62.1 35.8 45.0 34.9 30.0 47.7 17.4 12.5 48.9 34.0 105.3 44.2 40.0 27.7 24.3 46.7 50.4 51.0 31.6 23.6 49.2 52.1 22.0 48.2 39.8 32.5 55.0 45.9 36.6 50.9 65.4 56.6 50.0 66.6 89.4 77.7 60.4 66.9 32.2 39.2 65.7 86.9 66.2 49.1 38.7 50.1 27.0 46.6 49.7 46.4 50.8 78.3 92.8 30.8 64.0 79.1 48.6 66.9 49.4 54.2 51.6 39.7 49.2 53.8 49.0 118.9 41.4 70.4 35.3 36.9 63.4 41.4 28.5 72.5 48.1 48.4 33.7 35.7 41.2 89.6 74.5 22.4 88.8 38.4 51.4 61.3 41.0 100.7 40.1 73.8 55.8 41.4 71.0 25.3 43.7 2.9 21.1 28.4 20.7 20.0 16.6 14.0 19.6 20.9 23.5 14.3 15.2 15.0 41.9 18.2 13.6 17.0 14.4 19.8 29.8 30.5 26.3 54.4 32.4 26.8 29.1 29.3 31.0 30.0 24.3 31.6 32.5 22.7 19.2 16.7 11.4 25.7 21.9 29.8 30.9 25.0 25.4 29.9 20.1 5.8 21.5 26.0 20.2 12.5 64.6 18.5 47.4 37.2 37.5 25.7 17.3 22.7 23.7 30.5 22.3 14.6 43.4 70.0 34.1 38.2 25.4 25.4 34.0 22.1 35.0 38.1 16.8 12.8 39.9 28.5 19.2 24.3 25.2 45.7 24.5 30.2 11.2 34.3 26.6 21.6 6.6 10.5 36.4 31.4 45.5 53.4 44.8 50.8 37.2 15.3 22.0 13.1 24.4 33.8 39.5 21.8 27.5 23.2 138.6 23.2 44.3 36.2 38.5 TMEM50B C21orf4 ENSG00000142188 "Transmembrane protein 50B" P56557 21 33432485-33479974 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034199, HPA068995" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "CAB034199: AB_2205160, HPA068995: AB_2686066" "unprognostic (3.22e-1)" "unprognostic (5.93e-2)" "unprognostic (7.82e-2)" "unprognostic (6.14e-2)" "unprognostic (1.26e-1)" "prognostic favorable (3.00e-4)" "unprognostic (2.24e-2)" "prognostic favorable (3.33e-4)" "unprognostic (8.65e-2)" "unprognostic (3.36e-2)" "unprognostic (1.85e-2)" "unprognostic (3.54e-2)" "unprognostic (9.58e-3)" "unprognostic (3.41e-3)" "unprognostic (8.28e-2)" "unprognostic (3.47e-3)" "unprognostic (3.32e-3)" 23.6 27.1 18.2 15.6 15.4 9.4 26.6 16.3 20.5 25.5 23.1 20.7 22.6 22.3 55.6 20.1 27.7 29.8 24.9 15.1 18.1 36.3 15.7 24.4 15.6 17.2 21.6 14.1 33.9 12.4 35.4 15.1 17.1 17.9 31.1 20.1 28.5 15.9 49.3 20.1 14.2 21.4 22.3 16.2 16.2 23.4 16.2 26.5 13.9 90.1 22.3 15.3 30.0 15.8 16.6 25.7 5.7 10.4 15.5 55.7 40.4 5.4 20.5 27.4 16.8 10.8 6.3 22.9 14.2 21.6 20.3 21.2 10.6 14.2 14.4 12.2 17.3 11.9 28.5 4.0 13.9 25.4 20.7 17.6 20.3 14.0 13.0 10.2 28.4 20.7 15.4 20.1 28.9 21.8 15.9 15.6 21.9 4.6 45.5 5.3 7.9 19.6 25.0 30.4 17.8 8.9 12.1 23.7 29.2 24.5 6.1 34.0 26.7 18.0 11.2 9.1 15.5 8.3 29.4 49.7 18.9 10.5 31.4 19.9 14.7 18.3 43.6 18.1 19.6 18.5 13.4 22.0 20.8 24.8 17.0 24.8 22.7 3.6 19.6 23.3 26.5 35.4 21.2 18.2 15.4 16.3 20.5 15.1 18.1 17.2 21.6 14.1 17.9 16.2 26.5 16.6 69.7 28.9 59.4 29.7 44.5 74.1 94.0 55.2 48.9 53.0 61.5 46.0 46.7 55.8 49.3 82.8 108.4 33.9 50.5 46.7 27.4 37.9 58.1 52.6 42.6 60.7 21.6 43.1 23.9 31.0 46.4 62.0 39.8 38.4 29.8 36.1 94.2 55.4 37.9 43.7 46.2 53.1 61.1 33.6 74.1 39.2 71.4 35.4 83.6 33.7 29.7 72.7 50.4 26.2 44.8 28.0 38.2 119.6 57.8 128.9 68.3 56.5 83.6 86.1 98.6 45.0 52.2 190.4 114.0 37.8 93.6 41.3 55.2 22.9 46.5 126.7 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 870.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 38.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 26000000 "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favorable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 250.4 502.7 475.1 158.8 507.5 135.6 452.0 475.0 548.1 266.4 453.7 360.5 228.4 283.8 295.9 180.3 310.9 353.9 392.5 507.7 493.2 537.4 300.6 281.8 79.6 495.7 474.0 494.2 308.9 326.3 280.9 156.6 455.7 516.3 262.9 331.7 211.1 272.9 346.8 108.5 215.3 202.0 383.2 503.9 155.7 215.5 167.1 529.5 160.7 474.2 177.5 78.8 307.8 153.0 605.3 388.7 489.9 538.4 448.5 707.7 869.8 559.8 757.1 1029.2 386.6 449.3 286.4 941.0 0.9 848.3 614.8 505.1 255.6 326.4 921.6 324.4 14.7 253.1 0.8 275.6 204.1 688.0 372.0 19.6 790.4 990.7 456.8 823.0 1584.3 1750.7 158.6 0.8 39.0 614.5 433.1 6.5 4.0 416.2 644.9 418.6 241.2 505.2 325.3 1283.3 270.1 267.3 385.6 824.0 549.0 393.4 720.0 482.4 400.1 1837.1 850.8 350.2 310.4 371.6 232.3 3.1 4.8 690.4 1.6 836.3 1.1 7.5 0.0 0.2 2.2 0.3 0.8 2.2 0.7 5.6 2.2 2.3 0.6 1.5 0.5 1.6 38.1 0.6 3.3 475.1 507.5 475.0 548.1 507.7 493.2 495.7 474.0 494.2 516.3 503.9 529.5 605.3 330.2 109.0 39.6 70.5 47.6 181.6 215.6 449.0 306.7 45.2 280.3 199.6 143.2 296.0 214.0 502.1 29.2 472.6 180.7 395.2 56.7 398.7 46.1 78.8 162.2 416.0 162.6 29.2 481.6 180.4 141.2 309.5 164.7 110.7 8.2 100.3 539.7 125.7 76.3 84.1 525.5 303.1 256.3 61.6 79.9 61.8 242.6 69.9 161.9 189.3 89.9 329.9 4.1 423.2 870.8 205.4 223.1 296.8 24.0 187.5 95.2 165.8 164.7 24.5 118.3 336.5 198.5 38.3 86.9 85.9 106.1 552.1 27.0 111.4 283.5 133.6 DOP1B "C21orf5, DOPEY2, KIAA0933" ENSG00000142197 "DOP1 leucine zipper like protein B" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.2;dendritic cells: 3.8;Extravillous trophoblasts: 11.4;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 18.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072065 Enhanced Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA072065: AB_2686486" "prognostic unfavorable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 3.1 1.7 1.4 5.6 3.7 24.4 5.8 18.7 6.7 3.2 0.6 15.5 12.7 2.3 3.0 11.9 4.3 4.2 3.3 2.9 1.6 3.2 9.2 5.0 4.7 2.8 1.6 2.0 1.6 4.7 30.6 2.4 3.1 5.8 12.2 15.2 1.6 19.4 3.5 16.1 7.1 11.8 3.8 0.4 5.5 20.7 3.6 2.0 6.5 4.0 13.6 6.4 4.1 6.0 2.9 25.9 5.4 4.0 6.8 4.4 8.4 38.2 12.0 14.2 16.7 10.4 3.8 2.0 4.8 1.8 9.0 12.7 5.2 7.8 2.8 13.5 8.8 7.0 11.0 1.2 1.4 3.9 10.8 5.5 2.9 5.5 10.9 2.9 10.0 7.1 11.2 3.5 7.6 5.0 29.0 8.7 11.1 3.3 30.4 5.6 15.4 2.3 23.7 8.8 10.2 10.7 6.1 8.0 35.9 10.1 5.5 13.1 13.2 12.2 6.4 1.7 8.4 9.8 5.7 15.0 2.2 9.2 23.0 3.7 1.0 3.0 6.1 2.6 2.7 1.4 7.3 1.7 1.5 1.9 10.5 1.1 0.9 4.8 1.0 2.4 5.9 1.4 1.4 1.4 3.7 18.7 6.7 2.9 1.6 2.8 1.6 2.0 5.8 0.4 2.0 2.9 2.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.9 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 11.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.1 0.6 0.0 0.0 0.0 URB1 "C21orf108, KIAA0539, NPA1" ENSG00000142207 "URB1 ribosome biogenesis homolog" O60287 21 32311018-32393012 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018334 Supported Supported "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA018334: AB_1856088" "unprognostic (1.58e-1)" "unprognostic (2.28e-3)" "unprognostic (9.55e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-3)" "prognostic unfavorable (4.93e-4)" "unprognostic (3.04e-1)" "unprognostic (4.57e-1)" "unprognostic (4.65e-3)" "unprognostic (2.65e-2)" "unprognostic (2.02e-1)" "unprognostic (3.58e-2)" "unprognostic (1.43e-1)" "unprognostic (2.08e-1)" "unprognostic (5.95e-3)" "unprognostic (2.78e-2)" 4.9 7.6 5.5 4.0 4.3 3.2 4.9 4.0 4.6 6.5 12.0 4.2 2.3 11.3 4.2 6.9 8.1 2.5 5.8 5.8 4.9 3.3 5.2 3.8 4.1 6.4 4.7 4.6 7.6 6.0 5.7 4.5 3.4 6.8 9.9 2.8 2.1 7.3 8.1 8.9 7.1 3.4 5.6 4.4 3.5 4.3 6.7 5.0 3.9 4.2 4.4 3.9 8.8 6.7 5.9 12.7 16.0 7.0 14.6 14.1 11.2 11.3 12.9 6.4 9.6 7.4 22.3 7.1 12.7 7.0 12.7 10.5 7.8 19.9 30.5 9.9 9.9 12.1 43.6 14.7 11.8 10.2 24.5 9.3 18.2 10.4 21.9 23.6 7.1 10.4 14.6 39.7 12.1 14.2 12.8 15.9 8.7 23.4 15.1 14.7 18.7 16.4 15.3 6.5 12.0 15.8 14.1 15.1 12.5 14.0 5.2 11.0 9.3 12.1 23.6 14.1 9.8 14.6 17.0 17.7 20.0 10.7 22.0 12.2 0.9 0.3 0.0 0.4 0.3 0.8 0.6 0.5 0.5 0.3 0.5 0.6 0.6 0.3 0.8 0.1 0.3 0.5 0.3 5.5 4.3 4.0 4.6 5.8 4.9 6.4 4.7 4.6 6.8 4.4 5.0 5.9 8.1 3.2 10.5 14.7 8.5 9.7 14.5 11.3 25.6 7.2 9.6 8.6 9.4 2.8 17.2 1.8 4.2 5.9 5.9 2.4 0.0 4.8 9.4 35.0 38.0 7.6 7.8 8.0 27.6 6.0 3.9 8.7 7.7 22.1 0.0 45.4 4.6 8.5 4.0 15.2 29.0 4.7 6.1 2.7 3.1 6.0 5.6 3.4 5.4 15.0 3.0 3.9 3.1 26.2 27.5 4.5 4.3 7.5 4.2 20.9 0.8 2.4 18.6 5.6 6.6 18.1 8.8 12.8 15.4 16.2 11.4 4.2 5.5 13.2 7.1 14.6 AKT1 "AKT, PKB, PRKBA, RAC, RAC-alpha" ENSG00000142208 "AKT serine/threonine kinase 1" P31749 14 104769349-104795751 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 61.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 61.5" "Cell line enhanced" "Detected in all" "MCF7: 558.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002891, CAB003765" Supported Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "CAB003765: AB_562035, HPA002891: AB_1078123" "unprognostic (3.30e-2)" "unprognostic (4.27e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (9.17e-3)" "unprognostic (1.55e-3)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "prognostic favorable (4.83e-4)" "unprognostic (3.58e-2)" "unprognostic (1.90e-2)" "prognostic favorable (2.12e-4)" "unprognostic (7.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 72.1 103.6 41.5 58.3 43.1 51.7 61.7 40.7 53.6 52.2 46.7 75.9 51.3 60.0 23.4 71.3 54.2 50.5 106.9 41.5 40.7 51.1 98.1 69.8 52.3 47.2 41.9 39.1 44.0 95.1 53.4 36.2 55.8 46.7 67.8 39.9 25.3 68.2 73.7 58.7 45.4 53.7 64.0 42.4 64.3 78.4 24.0 44.0 52.9 52.8 65.4 40.6 73.2 48.8 41.6 77.3 150.5 124.6 186.9 95.2 97.7 136.9 142.3 171.5 204.6 163.6 96.8 92.8 91.2 105.5 196.6 102.8 99.4 89.5 131.9 90.1 214.3 36.2 70.6 90.4 103.2 104.6 117.5 178.0 140.0 109.1 102.9 68.1 98.2 154.4 87.5 62.1 102.2 134.1 558.3 145.3 146.8 32.6 153.5 107.2 137.5 111.9 60.5 94.8 189.5 141.2 117.2 117.3 152.2 88.9 56.8 195.7 170.2 123.5 133.2 63.2 192.3 145.1 105.4 52.6 80.7 113.7 96.7 162.0 6.4 9.9 61.5 10.0 10.3 7.2 5.5 8.7 11.4 7.0 7.2 4.6 10.1 22.6 11.0 12.4 10.0 9.0 6.3 41.5 43.1 40.7 53.6 41.5 40.7 47.2 41.9 39.1 46.7 42.4 44.0 41.6 45.8 16.0 27.4 16.6 13.7 12.4 20.0 17.3 15.9 26.3 58.0 39.9 16.1 32.9 17.7 22.0 12.5 19.4 54.2 40.9 13.7 23.6 1.9 17.9 28.1 27.5 30.0 11.3 8.2 35.2 31.8 24.0 26.0 24.8 2.5 40.4 23.2 42.9 23.2 42.1 13.0 37.3 22.4 23.3 21.4 3.3 28.6 28.0 10.6 6.5 23.1 51.2 24.7 8.0 9.6 53.3 22.1 30.9 10.3 38.8 23.5 17.9 14.2 26.6 26.3 24.9 29.1 1.8 5.3 16.2 13.9 23.4 23.3 34.0 33.7 33.4 IL19 "IL-10C, IL-19, MDA1, NG.1, ZMDA1" ENSG00000142224 "Interleukin 19" Q9UHD0 1 206770764-206842979 "Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "cervix: 20.1;salivary gland: 7.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 11.3;Breast glandular cells: 3.2;Club cells: 9.6;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 5.2;Ionocytes: 4.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "BJ hTERT+: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 172000 "unprognostic (6.21e-2)" "unprognostic (3.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.17e-2)" "unprognostic (2.48e-5)" "unprognostic (1.07e-1)" "unprognostic (8.72e-3)" "unprognostic (8.42e-2)" "unprognostic (2.04e-3)" "unprognostic (9.17e-2)" "unprognostic (7.20e-2)" "unprognostic (4.91e-2)" "unprognostic (2.78e-1)" 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 20.1 0.0 0.1 0.0 0.3 0.0 1.8 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.1 7.0 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.2 0.1 0.0 0.4 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 11.3 0.0 0.0 3.2 0.0 0.1 0.0 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.9 0.7 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 4.1 0.0 1.2 0.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 2037.4;Macrophages: 699.2;Melanocytes: 1117.1" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 1472.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 104.5 86.3 34.9 116.8 35.4 328.0 69.6 36.4 41.3 150.1 37.5 131.1 37.2 145.1 61.3 37.4 97.1 73.1 90.3 35.4 62.6 48.2 29.3 142.2 86.8 49.4 37.5 31.0 111.8 18.6 17.3 21.5 67.7 42.2 61.9 66.2 9.3 42.1 90.9 21.9 60.9 82.2 204.7 44.4 92.5 65.9 33.7 44.9 45.6 43.6 44.1 95.4 134.0 107.8 44.7 73.8 739.3 44.9 127.1 691.3 1081.5 1.2 490.7 898.0 627.6 560.7 73.5 265.0 6.9 107.5 1101.0 296.4 12.1 45.5 54.6 390.4 241.3 20.5 335.0 192.0 43.3 572.4 160.2 338.9 586.1 12.2 635.3 436.3 455.5 277.9 66.1 237.4 616.1 1019.5 10.1 25.1 1472.4 55.4 12.1 196.9 22.1 150.1 355.7 554.6 0.4 1.8 2.0 225.2 1.2 131.2 77.2 2.7 253.1 456.6 574.7 236.5 435.8 388.1 287.6 426.6 20.1 339.2 232.5 402.5 2401.3 980.4 1402.3 1324.0 1173.0 1117.1 570.1 1425.3 1327.0 688.7 467.9 818.8 948.4 1094.0 854.5 1148.4 516.9 1631.4 1971.4 34.9 35.4 36.4 41.3 35.4 62.6 49.4 37.5 31.0 42.2 44.4 44.9 44.7 66.5 0.0 4.5 5.5 338.0 278.0 75.4 161.0 48.3 2.3 14.7 22.9 5.4 21.5 21.8 33.1 0.0 14.9 375.9 1.5 5.9 72.0 6.5 18.9 255.1 118.6 6.0 94.8 0.2 11.2 26.0 371.3 23.0 15.1 257.0 8.5 128.2 7.2 589.0 0.0 0.3 4.1 42.7 458.8 2037.4 21.3 335.5 699.2 1117.1 6.5 444.5 64.6 565.4 0.0 0.7 114.3 28.2 217.0 334.9 285.5 1.7 9.3 14.6 5.0 105.2 193.0 278.7 16.2 6.7 10.6 189.9 20.2 441.4 29.1 4.9 44.4 SAE1 "AOS1, FLJ3091, Sua1" ENSG00000142230 "SUMO1 activating enzyme subunit 1" Q9UBE0 19 47113274-47210636 "Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041906, HPA043552" Supported Enhanced Nucleoplasm,Cytosol NA NA 37000 "Nucleoplasm, Cytosol" "HPA041906: AB_2677735, HPA043552: AB_2678548" "unprognostic (9.69e-3)" "unprognostic (1.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.49e-8)" "unprognostic (9.86e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.15e-5)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.27e-1)" 42.3 35.0 31.1 18.9 32.9 21.7 39.3 29.3 40.3 44.9 29.1 91.8 10.0 59.0 5.0 53.4 44.9 14.8 43.2 33.1 32.2 29.6 32.7 39.9 23.3 32.6 33.4 31.2 36.7 29.5 22.3 27.4 21.8 33.7 38.8 15.9 11.1 31.2 22.5 54.0 41.5 43.6 27.8 29.9 52.2 59.6 77.2 33.2 36.9 51.3 17.8 25.1 68.7 42.7 32.8 126.7 71.6 189.2 81.8 57.9 68.8 51.3 180.7 130.3 154.7 192.7 76.0 61.6 131.4 72.6 112.0 89.6 49.4 179.6 93.2 141.0 138.4 172.0 117.4 45.2 62.7 68.4 142.3 81.7 64.0 42.2 75.4 72.0 58.9 142.2 141.3 138.7 51.3 135.9 68.0 127.1 396.8 87.3 116.0 68.5 171.7 110.2 47.9 56.2 77.1 59.9 79.3 126.8 87.9 79.3 84.3 70.8 75.9 72.7 71.0 103.8 47.0 161.9 97.0 352.1 206.5 44.7 108.7 98.5 55.3 37.6 21.7 41.6 34.7 45.2 37.2 50.4 43.2 45.2 29.6 69.9 54.6 18.9 63.8 23.6 30.1 69.4 65.3 31.1 32.9 29.3 40.3 33.1 32.2 32.6 33.4 31.2 33.7 29.9 33.2 32.8 29.2 9.6 18.7 11.4 24.1 25.6 32.6 33.2 16.5 20.1 19.2 16.3 21.9 15.7 18.6 12.9 6.2 77.7 20.5 18.5 11.7 41.6 13.1 13.3 34.4 39.4 19.2 36.6 20.9 34.9 107.2 30.8 17.3 22.0 15.2 40.2 22.1 21.0 57.6 20.2 21.8 25.2 42.7 17.2 25.0 19.1 15.5 19.2 46.2 10.3 48.5 25.8 41.2 10.6 16.3 38.1 20.1 18.8 26.3 32.6 11.4 15.6 7.2 16.6 52.6 16.5 39.0 151.3 113.7 22.4 24.6 57.5 33.5 35.4 32.5 30.5 NTN5 ENSG00000142233 "Netrin 5" Q8WTR8 19 48661407-48673081 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 5.1" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Bipolar cells: 5.4;Early spermatids: 9.2;Horizontal cells: 8.4;Late spermatids: 11.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.2" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Region enriched" "Detected in single" 5 "cerebellum: 4.8" "Secreted in brain" NA NA "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "unprognostic (5.26e-6)" "unprognostic (4.48e-2)" "unprognostic (2.23e-1)" "unprognostic (4.33e-2)" "unprognostic (3.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.89e-3)" "unprognostic (9.40e-3)" "unprognostic (1.74e-3)" "unprognostic (4.60e-1)" "unprognostic (5.11e-2)" "unprognostic (1.60e-3)" "unprognostic (3.51e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-3)" 0.3 0.4 1.8 0.2 2.0 0.3 1.2 1.6 2.8 1.3 0.4 0.5 0.2 1.0 0.5 0.5 3.2 0.7 0.3 1.8 1.2 0.8 0.4 0.4 0.8 2.0 1.5 1.2 2.3 0.4 0.5 5.1 0.0 1.9 2.8 0.0 1.2 1.0 0.8 0.2 1.2 0.6 0.1 1.7 0.9 0.3 0.6 1.6 0.6 1.9 0.1 0.3 0.4 0.8 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.5 0.2 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.0 0.0 0.3 0.2 0.4 0.0 1.2 0.0 0.3 0.3 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 1.6 2.8 1.8 1.2 2.0 1.5 1.2 1.9 1.7 1.6 1.9 1.1 0.0 0.0 4.6 0.1 0.5 0.4 0.1 0.0 5.4 0.8 1.9 0.3 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.1 9.2 0.5 1.3 0.6 0.0 0.0 1.1 0.0 0.0 0.4 0.0 1.0 0.0 2.3 0.4 0.1 0.1 8.4 0.6 0.1 0.0 0.0 0.4 11.8 0.6 0.1 1.8 1.0 0.0 1.6 1.0 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 2.8 0.0 0.7 0.4 3.1 0.2 0.1 0.1 0.1 0.2 3.1 0.0 0.2 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513935 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 44.3" "Cell type enhanced" "Detected in many" "Club cells: 41.4;Excitatory neurons: 37.0;Inhibitory neurons: 38.8;Urothelial cells: 49.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 9.4;SK-BR-3: 16.4;U-266/70: 9.8;U-266/84: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Supported Uncertain "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: AB_2732330" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 0.0 1.7 21.3 0.7 22.4 0.5 0.7 3.5 44.3 0.6 0.0 0.2 3.8 0.1 1.1 0.6 0.3 0.4 0.3 30.7 6.7 1.2 0.0 1.3 1.1 10.8 1.8 25.6 0.1 0.8 3.7 5.8 0.6 11.2 1.5 0.0 2.8 2.6 1.1 0.0 0.8 1.9 0.0 0.0 0.6 1.2 0.2 6.6 0.4 0.8 0.0 0.8 0.2 0.0 20.3 6.0 4.4 0.5 0.5 0.0 0.0 5.1 0.1 0.4 0.0 0.2 3.7 5.2 1.6 1.5 0.0 1.4 3.0 0.8 1.9 0.0 0.7 2.8 0.2 2.5 0.9 0.0 0.0 9.4 0.1 1.1 0.3 0.0 2.0 0.0 5.0 1.6 3.6 0.0 7.9 1.1 4.1 1.2 3.4 1.5 4.8 0.0 2.1 1.7 1.2 1.5 2.9 0.2 16.4 0.9 1.2 5.6 0.2 0.1 0.0 1.5 0.1 0.0 9.8 9.3 1.9 0.3 4.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 21.3 22.4 3.5 44.3 30.7 6.7 10.8 1.8 25.6 11.2 0.0 6.6 20.3 0.3 3.2 1.7 11.8 2.1 0.5 13.1 17.0 2.8 15.9 20.5 6.2 2.7 2.8 41.4 7.3 0.0 4.9 0.6 0.4 25.4 21.5 0.1 8.4 0.6 0.5 0.0 0.0 37.0 0.4 2.8 0.9 6.6 8.1 0.0 0.6 1.4 0.4 1.3 18.5 38.8 1.2 8.2 0.6 0.9 0.2 0.6 0.4 3.6 1.9 0.2 6.9 0.0 26.2 9.6 17.2 0.1 0.0 14.5 18.8 3.0 0.6 25.9 2.2 0.0 0.4 3.3 4.0 3.3 7.1 1.8 6.8 1.3 2.9 1.5 49.5 GEMIN7 FLJ13956 ENSG00000142252 "Gem nuclear organelle associated protein 7" Q9H840 19 45079195-45091518 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052075 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052075: AB_2681718" "unprognostic (3.32e-1)" "unprognostic (1.48e-2)" "unprognostic (3.84e-1)" "unprognostic (3.17e-2)" "unprognostic (1.60e-1)" "unprognostic (7.00e-2)" "prognostic unfavorable (5.86e-5)" "unprognostic (7.78e-2)" "unprognostic (2.17e-1)" "unprognostic (2.95e-1)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.64e-11)" "unprognostic (7.01e-2)" "unprognostic (4.54e-1)" "unprognostic (1.83e-1)" "prognostic favorable (8.00e-4)" 14.8 17.1 16.5 15.4 16.0 23.6 15.9 17.3 19.2 13.8 18.3 17.5 21.3 12.6 9.3 29.8 12.8 10.6 18.5 16.8 16.1 19.1 32.6 15.7 27.0 16.7 17.3 16.6 9.6 16.8 10.2 22.0 12.8 17.9 18.5 14.3 8.0 19.2 7.2 35.4 23.6 24.1 10.9 17.2 37.4 24.2 6.0 18.2 11.9 12.6 16.6 19.6 18.7 19.4 17.0 48.3 62.6 36.0 44.4 27.0 27.8 27.8 36.2 26.3 54.1 60.0 38.3 30.1 47.8 24.3 31.3 30.0 29.5 52.6 43.0 32.6 38.4 68.6 52.8 29.2 50.4 37.6 42.7 30.3 41.9 34.8 30.3 21.8 27.7 53.4 28.5 56.3 48.7 21.5 71.2 41.2 44.2 33.9 73.2 32.3 48.6 16.6 62.4 41.4 34.9 35.6 24.9 28.3 60.3 32.8 28.9 40.9 44.9 29.1 20.0 38.0 13.1 48.4 50.3 80.6 77.7 32.1 42.7 32.8 32.8 33.5 37.1 70.5 28.2 67.6 67.3 51.1 65.3 47.4 57.8 39.4 51.1 18.3 74.6 20.5 54.1 48.4 46.4 16.5 16.0 17.3 19.2 16.8 16.1 16.7 17.3 16.6 17.9 17.2 18.2 17.0 7.5 19.2 12.1 5.2 23.0 18.1 12.4 27.3 8.0 5.8 14.9 14.5 9.9 21.5 18.4 3.7 0.0 37.9 19.3 12.7 21.5 36.7 1.5 5.9 9.7 13.2 13.2 15.3 7.5 33.7 57.2 13.0 27.0 7.5 3.8 7.9 16.4 19.9 34.7 1.7 8.1 19.8 22.4 18.8 15.4 3.1 14.3 14.2 12.4 8.4 63.3 8.0 48.4 10.1 4.1 44.5 19.7 6.4 42.1 15.9 27.8 26.0 5.1 4.6 6.6 7.3 11.9 4.9 8.3 20.0 23.7 25.9 12.4 13.8 25.0 12.1 CBLC "CBL-3, CBL-SL, RNF57" ENSG00000142273 "Cbl proto-oncogene C" Q9ULV8 19 44777869-44800652 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.6;intestine: 51.4;skin 1: 40.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 108.6;Pancreatic endocrine cells: 95.0;Paneth cells: 108.1;Proximal enterocytes: 154.6;Undifferentiated cells: 67.1;Urothelial cells: 76.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 43.6;BEWO: 28.9;CACO-2: 28.3;CAPAN-2: 56.9;HaCaT: 41.0;HBEC3-KT: 34.8;hTCEpi: 26.0;OE19: 37.3;RT4: 34.7;SK-BR-3: 31.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB008087, HPA035266" Approved Approved Nucleoplasm,Aggresome NA NA Nucleoplasm Aggresome "CAB008087: AB_2228531, HPA035266: AB_2674542" "unprognostic (1.58e-1)" "unprognostic (2.25e-1)" "unprognostic (8.21e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (3.91e-2)" "unprognostic (1.67e-1)" "unprognostic (2.13e-2)" "unprognostic (3.82e-1)" "unprognostic (7.39e-2)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.11e-6)" "unprognostic (3.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.90e-2)" "unprognostic (2.21e-3)" 0.2 0.1 0.0 3.1 0.0 0.0 5.1 0.0 0.1 5.2 0.0 21.1 51.4 0.9 0.1 39.6 2.5 4.4 0.0 0.0 0.8 6.5 21.3 1.3 0.0 0.0 0.0 0.0 0.1 20.8 1.6 0.5 0.4 0.0 11.9 11.8 0.1 13.5 2.4 0.1 40.6 38.9 0.6 0.0 0.0 17.8 0.7 0.0 0.3 1.7 0.0 4.1 8.4 18.5 0.0 43.6 0.0 0.0 0.1 0.0 0.0 28.9 0.0 0.0 0.0 0.0 28.3 56.9 0.0 0.0 0.0 0.0 41.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 37.3 0.0 0.0 0.0 0.0 0.0 34.7 0.4 0.1 0.0 31.1 0.0 0.2 22.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.1 15.0 44.0 30.8 16.5 0.0 9.3 7.4 0.2 4.3 27.7 7.3 0.0 5.8 0.2 108.6 1.9 53.8 0.1 7.0 1.3 0.9 17.4 0.0 0.4 48.9 2.3 0.5 59.7 15.5 0.0 0.0 0.0 11.1 0.3 0.0 0.9 40.0 18.3 0.0 1.4 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 1.0 0.3 95.0 108.1 0.0 0.1 34.4 154.6 17.2 9.8 0.0 0.0 0.0 1.3 0.0 2.6 29.9 25.7 2.5 0.7 0.0 67.1 76.9 WTIP ENSG00000142279 "WT1 interacting protein" A6NIX2 19 34481758-34512304 "Predicted intracellular proteins" "Cilium biogenesis/degradation, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 51.4;Granulosa cells: 40.0;Late spermatids: 48.4;Sertoli cells: 72.3;Smooth muscle cells: 66.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.85e-2)" "unprognostic (8.01e-2)" "unprognostic (4.54e-3)" "unprognostic (1.03e-3)" "unprognostic (1.21e-1)" "unprognostic (6.13e-2)" "unprognostic (7.70e-2)" "unprognostic (2.48e-2)" "unprognostic (3.16e-2)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (6.28e-2)" "unprognostic (5.70e-2)" "unprognostic (6.34e-2)" "unprognostic (1.39e-1)" "unprognostic (9.36e-2)" 22.8 5.0 9.0 4.8 8.5 1.1 17.0 9.3 12.1 21.1 11.5 10.0 2.5 21.3 7.4 6.9 18.7 11.9 19.1 7.9 8.0 13.2 2.1 17.6 3.7 8.1 7.6 8.3 27.7 9.2 10.4 4.9 9.0 8.0 13.8 3.1 1.9 6.3 16.2 7.2 7.3 7.4 13.6 6.3 6.2 10.1 8.1 7.7 2.2 13.3 23.2 3.4 14.6 13.8 7.3 0.8 17.3 20.7 17.8 28.9 20.2 17.9 25.6 22.2 33.3 17.5 43.4 2.6 1.3 23.1 52.6 15.8 0.8 19.2 9.9 13.1 1.7 2.8 1.3 4.1 16.0 43.4 0.9 1.4 15.1 23.2 10.9 2.3 21.7 13.3 0.7 0.8 2.2 26.5 6.0 2.0 0.5 10.2 0.7 0.4 1.4 14.6 0.7 18.6 4.9 1.3 1.5 16.7 0.3 6.9 17.5 12.9 1.3 16.7 44.4 35.9 0.8 15.6 1.1 1.9 1.0 0.7 0.4 20.6 0.6 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 9.0 8.5 9.3 12.1 7.9 8.0 8.1 7.6 8.3 8.0 6.3 7.7 7.3 16.6 12.8 8.7 1.0 0.3 3.8 9.1 3.7 9.1 11.4 5.4 13.8 8.3 4.3 6.2 9.2 0.0 6.5 0.5 0.2 0.0 4.7 51.4 6.8 15.6 16.9 0.0 0.0 3.1 0.9 5.0 11.5 0.0 8.2 1.3 40.0 17.5 0.7 0.7 3.3 3.8 0.0 2.0 0.8 0.8 48.4 18.3 1.0 3.6 4.7 0.0 4.8 0.0 6.0 0.9 2.3 0.1 21.1 0.0 15.5 0.2 1.9 3.6 1.8 72.3 14.3 66.5 0.7 5.3 0.6 1.7 1.8 0.9 3.2 0.3 5.4 ADAMTS10 ADAM-TS10 ENSG00000142303 "ADAM metallopeptidase with thrombospondin type 1 motif 10" Q9H324 19 8580240-8610735 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 18.3;Excitatory neurons: 21.4;Inhibitory neurons: 19.9;Microglial cells: 30.9;Skeletal myocytes: 15.9;Smooth muscle cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 7.2;hTERT-RPE1: 7.5;NB-4: 37.0;REH: 9.8" "Region enriched" "Detected in many" 5 "cerebellum: 8.8" "Low region specificity" "Detected in all" HPA040223 Uncertain "Secreted to extracellular matrix" NA NA "HPA040223: AB_10795376" "unprognostic (2.60e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (1.14e-1)" "unprognostic (8.16e-2)" "unprognostic (1.91e-4)" "unprognostic (4.98e-3)" "unprognostic (4.06e-2)" "unprognostic (2.24e-2)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (6.86e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-1)" "unprognostic (4.12e-2)" 13.3 8.2 5.5 2.3 5.9 1.8 9.6 3.8 12.0 13.1 5.3 6.4 0.8 12.8 0.7 4.1 10.3 1.9 7.2 6.3 5.4 6.8 6.4 8.3 3.3 5.7 5.1 5.5 8.4 7.9 0.8 4.1 1.7 6.1 8.5 0.5 0.5 4.1 1.5 2.8 7.8 6.3 1.5 4.5 5.5 3.9 2.4 5.8 1.4 6.2 0.8 1.3 5.7 8.8 5.3 0.0 4.6 2.5 0.0 0.4 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 2.2 1.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 7.2 0.0 0.3 0.0 0.1 1.8 0.0 0.0 0.0 7.5 0.1 0.3 0.1 0.0 0.0 0.0 0.3 37.0 1.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 1.2 0.1 0.4 2.0 3.1 4.4 2.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 5.9 3.8 12.0 6.3 5.4 5.7 5.1 5.5 6.1 4.5 5.8 5.3 5.6 0.0 0.0 18.3 0.3 1.7 0.6 0.1 0.0 1.5 1.2 1.5 1.3 5.7 0.1 0.0 0.0 0.1 6.9 0.0 0.0 8.8 5.1 0.4 7.4 5.8 0.0 1.3 21.4 0.5 0.0 6.4 1.1 0.4 0.0 1.8 6.8 2.0 0.9 0.0 19.9 0.3 0.0 2.7 6.0 2.4 7.5 3.3 0.0 30.9 0.6 0.8 11.3 9.5 1.2 0.9 0.0 6.0 1.3 0.2 0.0 0.1 0.0 0.2 6.6 15.9 15.0 0.1 0.4 0.1 0.9 0.4 3.2 0.6 0.1 0.3 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392794-1445440 "Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 64 "brain: 53.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.3;Cardiomyocytes: 1.2;Smooth muscle cells: 1.4" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 17 "midbrain: 53.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "midbrain: 80.6;thalamus: 29.0" "Region enriched" "Detected in some" 152 "midbrain: 302.6" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles NA NA Vesicles "CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 3.2 53.8 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 3.0 0.1 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 3.2 53.8 0.0 0.7 0.0 3.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 RNPEPL1 ENSG00000142327 "Arginyl aminopeptidase like 1" Q9HAU8 2 240565804-240581372 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036772, HPA036773" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA036772: AB_10670848, HPA036773: " "unprognostic (3.92e-2)" "unprognostic (7.28e-2)" "unprognostic (1.20e-2)" "unprognostic (2.39e-1)" "unprognostic (5.24e-3)" "prognostic favorable (7.43e-4)" "prognostic unfavorable (5.06e-4)" "unprognostic (3.72e-3)" "unprognostic (9.10e-2)" "unprognostic (1.66e-3)" "unprognostic (3.10e-1)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (5.31e-2)" "unprognostic (9.86e-2)" 39.1 31.7 25.2 14.2 26.1 21.9 32.2 25.7 39.0 15.6 24.4 39.0 20.4 16.9 5.6 52.8 17.1 12.2 58.5 24.3 26.0 42.5 51.0 36.2 24.0 28.1 26.5 23.7 12.1 64.8 10.9 9.1 10.7 26.3 35.0 9.6 0.8 29.1 13.2 64.2 35.3 40.1 9.5 27.2 56.8 48.8 10.0 27.0 16.1 19.4 17.2 12.2 34.4 23.4 26.8 13.7 22.4 4.9 13.2 17.6 18.1 16.6 8.6 21.1 9.5 11.6 6.3 39.3 3.9 4.3 21.8 13.3 14.6 5.5 16.1 0.9 23.9 7.7 9.0 7.3 37.2 44.1 5.9 15.5 21.6 25.5 4.9 9.6 15.1 32.8 15.2 6.8 25.7 6.5 19.3 7.5 22.4 6.5 26.5 9.0 15.5 7.4 33.3 39.3 18.5 4.6 9.8 5.8 19.7 39.9 5.6 13.9 26.8 22.7 10.2 10.4 14.4 10.0 24.1 3.9 4.8 20.9 16.6 15.7 9.2 11.2 30.5 14.8 9.9 12.7 8.2 11.3 13.4 8.2 8.7 6.4 9.5 20.0 10.7 10.1 9.5 14.7 7.9 25.2 26.1 25.7 39.0 24.3 26.0 28.1 26.5 23.7 26.3 27.2 27.0 26.8 27.9 22.4 25.7 10.4 27.8 7.8 15.0 8.4 2.8 6.4 18.8 9.1 35.6 24.3 12.9 12.9 0.0 7.1 80.4 138.9 17.6 24.6 3.1 12.1 11.0 22.7 26.4 22.3 9.5 49.6 6.8 12.3 104.5 27.4 34.2 31.8 30.0 42.2 43.8 3.3 8.6 58.7 8.2 74.3 21.0 5.9 8.7 47.1 23.2 9.4 52.0 15.9 79.3 5.5 10.3 65.0 70.0 13.5 20.5 20.2 77.1 35.6 7.2 6.9 13.1 14.8 16.4 1.3 8.2 13.0 9.2 5.1 47.9 17.4 60.5 23.0 CAPN10 ENSG00000142330 "Calpain 10" Q9HC96 2 240586734-240617705 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004170, HPA056098" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004170: AB_1078381, HPA056098: AB_2683037" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (9.29e-3)" "unprognostic (6.09e-2)" "unprognostic (5.44e-3)" "prognostic favorable (8.47e-5)" "prognostic unfavorable (4.78e-6)" "unprognostic (7.48e-3)" "unprognostic (7.94e-2)" "unprognostic (1.31e-2)" "prognostic favorable (7.94e-5)" "unprognostic (1.46e-1)" "unprognostic (1.11e-2)" "unprognostic (1.19e-1)" "unprognostic (6.88e-2)" "unprognostic (5.76e-2)" "unprognostic (5.58e-3)" 9.2 18.8 15.1 6.9 14.2 8.0 9.6 18.2 25.2 11.1 13.5 12.3 13.2 10.8 3.7 14.7 13.8 6.1 21.0 16.2 12.2 21.1 14.8 12.3 10.7 13.7 14.0 13.8 13.4 12.7 5.3 18.2 4.5 14.7 15.0 7.2 10.7 10.2 5.4 5.8 12.2 14.1 2.8 10.8 30.0 15.9 17.1 15.1 6.5 13.3 2.8 5.4 11.2 10.1 15.0 8.0 11.2 11.2 9.5 4.5 3.6 19.7 9.9 4.1 6.5 5.9 8.7 18.7 5.9 3.5 3.6 8.9 12.7 3.0 6.6 3.3 23.0 19.8 10.9 20.4 16.0 7.1 7.1 15.3 2.6 4.8 6.7 2.7 6.7 5.2 16.8 12.5 7.3 2.8 7.1 16.2 27.5 17.4 9.5 8.1 15.5 8.1 13.1 9.9 9.8 28.1 22.0 6.3 9.3 13.8 3.5 4.8 9.3 8.6 11.0 9.7 9.5 11.8 16.3 4.2 10.7 10.4 12.8 11.0 1.5 0.9 1.8 1.0 0.6 0.3 1.0 0.6 1.1 0.4 1.1 0.7 0.9 4.1 3.0 0.6 1.2 1.3 0.4 15.1 14.2 18.2 25.2 16.2 12.2 13.7 14.0 13.8 14.7 10.8 15.1 15.0 8.9 3.2 6.0 19.6 7.5 4.6 7.2 3.8 6.2 14.9 6.2 5.3 9.5 12.8 4.8 9.2 14.6 5.4 14.2 7.2 7.9 13.0 1.9 14.7 5.7 7.0 11.3 1.7 9.5 9.1 5.2 5.3 4.6 13.8 22.9 11.3 7.5 3.0 6.7 48.8 9.0 6.3 8.2 5.3 1.7 2.6 9.0 7.8 1.8 7.5 7.7 13.4 8.2 7.5 7.2 13.8 4.6 9.4 7.4 10.1 9.9 6.2 9.4 18.6 0.0 5.6 7.6 12.6 7.7 3.7 5.3 5.5 11.3 9.0 6.4 6.9 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520778-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 96.8;lung: 24.6;lymphoid tissue: 78.7" "Cell type enhanced" "Detected in many" "dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 263.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 46000 Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 9.7 4.5 4.7 39.2 5.3 96.8 3.6 5.7 7.2 2.7 7.8 5.0 7.5 2.0 0.7 3.4 6.5 10.6 4.0 4.4 9.5 3.7 7.9 24.6 20.9 8.8 5.8 3.5 1.2 2.4 1.2 2.3 7.1 7.3 3.8 3.4 0.2 3.7 1.8 1.5 2.8 12.3 6.4 7.3 78.7 6.6 1.4 7.3 5.5 3.0 4.2 8.6 10.3 2.8 10.3 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 6.1 0.4 0.0 0.4 0.0 0.0 0.0 52.4 0.2 38.1 0.0 0.0 0.1 52.3 87.9 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.5 23.8 0.1 0.3 0.1 210.2 0.0 0.1 0.3 1.0 0.0 5.6 0.1 0.0 0.1 0.3 0.0 0.1 0.3 0.1 0.8 154.3 12.3 0.1 0.2 0.2 0.1 0.1 1.9 0.3 0.3 84.3 0.0 64.5 107.6 105.7 56.6 78.7 44.5 5.9 22.3 39.7 62.8 2.8 1.6 17.0 263.2 32.3 98.8 8.1 34.0 101.3 4.7 5.3 5.7 7.2 4.4 9.5 8.8 5.8 3.5 7.3 7.3 7.3 10.3 1.9 3.2 12.3 2.0 26.5 3.3 2.4 0.8 1.2 0.7 3.1 4.3 2.6 5.7 2.9 1.8 2.1 5.0 110.2 2.0 1.9 1.7 6.0 0.6 2.9 4.1 1.2 14.3 2.3 0.9 8.2 2.7 3.6 1.2 31.6 2.2 10.8 6.7 75.8 6.7 1.5 2.1 0.0 235.4 49.3 6.8 2.5 122.7 7.2 64.6 195.5 1.5 616.9 1.5 3.4 1.3 3.2 1.2 30.0 1.8 3.0 2.9 0.2 0.8 0.0 3.4 2.2 6.0 3.4 3.6 5.4 5.1 100.1 3.9 2.7 1.9 ERVK3-1 HERV-K(HML6-1) ENSG00000142396 "Endogenous retrovirus group K3 member 1" 19 58305319-58315663 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (2.06e-3)" "unprognostic (2.32e-1)" "unprognostic (2.71e-1)" "unprognostic (7.16e-3)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "prognostic unfavorable (9.45e-4)" "unprognostic (7.88e-2)" "unprognostic (5.91e-3)" "unprognostic (3.43e-2)" "unprognostic (3.88e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-1)" "unprognostic (1.18e-3)" 28.4 33.0 41.1 20.7 41.6 34.7 36.3 43.3 46.6 25.0 39.0 27.6 26.9 25.2 38.7 26.0 24.4 19.0 31.8 44.3 43.8 34.8 41.5 29.5 32.2 43.2 43.6 40.3 26.4 27.2 39.4 36.0 19.9 44.6 34.2 17.9 26.4 24.4 23.9 32.8 27.3 27.5 17.6 42.8 35.2 30.8 18.3 43.1 32.8 29.2 24.6 31.0 27.4 23.8 45.4 72.0 139.8 56.8 53.1 33.5 22.4 43.6 47.7 36.7 36.1 34.9 83.8 38.3 49.5 42.0 34.5 51.4 29.2 64.7 43.4 34.3 80.2 258.5 79.3 59.0 73.8 50.6 110.1 51.0 23.4 43.4 58.7 65.6 33.9 25.1 58.2 120.1 59.9 46.4 57.2 99.2 41.6 68.2 85.8 97.1 59.8 60.1 71.8 36.4 103.8 86.4 73.8 57.7 56.4 79.3 54.4 44.1 74.3 31.3 98.2 54.4 30.6 100.3 74.4 224.5 129.4 53.1 64.7 83.0 85.9 39.4 74.0 67.5 43.3 64.2 58.9 60.7 63.7 40.0 57.9 62.3 72.8 34.7 57.8 57.1 67.7 78.3 69.4 41.1 41.6 43.3 46.6 44.3 43.8 43.2 43.6 40.3 44.6 42.8 43.1 45.4 21.2 16.0 22.3 0.0 33.2 0.0 6.0 0.0 45.5 20.6 15.0 12.2 6.5 8.6 8.1 5.5 6.2 18.6 24.1 15.5 13.7 25.4 1.0 7.8 10.9 15.2 18.0 16.2 0.0 25.5 8.5 16.4 25.0 10.7 37.3 8.8 8.9 5.6 12.3 16.8 0.0 14.4 0.0 6.3 0.0 1.9 7.8 15.2 0.0 0.0 14.7 11.7 21.6 0.0 0.0 30.0 25.6 14.3 39.6 8.1 23.3 11.9 4.4 12.2 6.6 8.5 14.4 19.3 28.7 29.4 0.0 15.3 31.0 11.5 13.5 5.5 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793741-53824394 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 4.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.4;granulocytes: 7.6;Kupffer cells: 11.2;Macrophages: 7.8;monocytes: 20.5" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8" "Group enriched" "Detected in many" 5 "granulocytes: 56.9;monocytes: 18.1" "Group enriched" "Detected in some" 4 "HMC-1: 4.6;THP-1: 4.1;U-87 MG: 4.3;U-937: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA042981 Approved NA NA "HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 0.9 0.0 0.0 2.2 0.1 6.0 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.3 0.3 0.2 0.0 0.1 0.0 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.8 0.0 4.3 0.1 0.1 0.3 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 3.8 0.0 56.9 18.1 23.2 0.0 5.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 29.8 0.0 3.0 0.1 0.0 5.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.3 6.4 7.4 0.0 0.5 0.4 1.0 0.1 0.0 0.7 0.2 0.1 0.5 0.0 3.7 0.0 0.0 0.2 1.4 0.2 0.0 0.0 0.2 0.1 0.1 1.9 0.0 0.0 0.7 0.0 0.2 1.5 0.0 0.3 7.6 0.2 0.7 0.0 2.4 0.0 0.8 0.0 0.0 11.2 1.6 0.2 0.3 7.8 1.8 0.0 20.5 0.2 2.1 0.0 0.5 0.1 0.0 0.0 0.3 0.8 0.0 0.1 2.2 0.7 0.0 0.7 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.7 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53962937-53990215 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 39 "brain: 36.2" "Group enriched" "Detected in many" 7 "Excitatory neurons: 61.9;Horizontal cells: 50.5;Inhibitory neurons: 66.0;Oligodendrocyte precursor cells: 29.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "basophil: 5.5" "Lineage enriched" "Detected in single" 26 "granulocytes: 5.5" "Group enriched" "Detected in some" 5 "AF22: 7.2;HMC-1: 23.7;hTERT-RPE1: 8.4;TIME: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041351 Enhanced NA NA "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.0 0.0 10.5 0.1 10.3 0.2 0.0 0.0 36.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 31.1 4.1 0.0 0.0 0.0 0.1 1.6 1.7 10.5 0.0 0.0 0.3 0.6 0.0 4.9 0.1 0.0 0.9 0.1 0.0 0.4 0.2 0.1 0.1 0.8 0.1 0.2 0.6 5.1 0.0 0.1 0.2 0.0 0.0 0.0 10.1 0.0 2.4 7.2 0.2 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.5 0.4 0.0 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 1.0 2.7 0.7 0.1 1.1 0.0 23.7 0.3 0.0 0.1 0.3 8.4 2.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 1.5 0.3 3.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.1 0.1 0.0 0.2 0.2 0.0 14.9 0.1 1.3 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.1 5.5 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 10.5 10.3 0.0 36.2 31.1 4.1 1.6 1.7 10.5 4.9 0.8 5.1 10.1 3.6 0.0 0.0 5.9 0.4 1.7 1.5 0.0 0.0 6.9 0.1 1.5 3.3 0.0 0.7 1.8 0.0 0.0 0.0 0.4 0.0 1.9 2.3 0.7 1.0 6.4 0.0 2.7 61.9 0.0 0.0 0.6 0.0 1.0 0.0 0.0 5.7 0.0 0.1 50.5 66.0 0.3 0.0 0.8 2.1 1.7 0.0 0.5 0.0 0.0 0.3 1.1 1.0 29.7 4.3 0.2 0.1 0.4 0.0 1.5 0.1 0.2 2.6 1.7 0.0 3.8 1.0 6.2 7.1 0.0 1.1 0.1 0.6 0.5 0.9 1.3 ZNF787 ENSG00000142409 "Zinc finger protein 787" Q6DD87 19 56087366-56121295 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 110.5;Endometrial ciliated cells: 87.6;Rod photoreceptor cells: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 102.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 17.1 24.6 12.9 10.3 12.9 27.2 16.7 12.2 15.5 17.7 10.3 22.9 15.9 20.1 4.0 21.0 22.5 3.0 23.7 11.2 10.5 17.7 44.2 18.1 7.3 14.2 12.2 10.4 16.2 34.4 6.0 16.0 4.4 12.6 21.4 4.7 7.7 19.1 7.8 42.6 18.0 20.1 4.0 11.4 28.0 23.4 16.2 14.2 5.6 16.7 9.8 4.4 21.0 16.7 13.5 29.2 28.1 9.0 18.9 2.5 5.6 23.3 14.7 5.7 9.8 11.1 16.7 17.6 20.7 1.0 6.2 8.8 22.7 5.7 11.9 4.4 27.5 102.6 32.9 14.6 25.6 14.1 31.8 27.8 7.4 11.6 8.2 14.2 6.1 7.4 11.6 39.9 22.5 5.8 18.2 19.8 40.0 28.4 26.7 52.3 24.6 13.1 26.7 10.2 19.1 34.2 33.3 15.6 30.2 29.4 5.0 18.6 44.5 16.0 36.8 26.6 15.7 41.2 47.4 37.4 20.3 21.4 21.0 17.6 0.6 0.8 1.1 0.4 0.6 0.6 1.0 0.3 0.3 0.8 1.4 0.5 0.2 1.8 0.5 0.6 2.2 0.5 0.3 12.9 12.9 12.2 15.5 11.2 10.5 14.2 12.2 10.4 12.6 11.4 14.2 13.5 29.5 12.8 2.7 5.5 11.2 6.1 11.5 5.0 7.4 52.1 19.2 16.9 12.0 11.5 5.5 11.0 110.5 3.3 20.0 29.7 1.9 6.6 2.0 87.6 17.2 16.2 9.1 4.0 5.1 16.7 4.6 10.1 8.6 48.2 5.7 23.2 11.7 33.4 8.9 35.3 4.2 19.8 8.2 11.0 7.8 3.4 5.0 16.4 1.8 6.5 8.9 44.5 7.2 4.5 6.1 13.1 19.5 4.5 7.1 11.3 12.8 5.8 4.0 71.3 6.6 16.0 13.0 3.8 12.1 4.8 7.2 1.9 9.2 55.8 20.6 12.4 TIMM29 "C19orf52, TIM29" ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928811-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 36.0;Ductal cells: 21.6;Extravillous trophoblasts: 31.4;Hofbauer cells: 22.4;Proximal tubular cells: 22.1;Syncytiotrophoblasts: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favorable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favorable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 8.4 11.8 3.7 5.5 3.5 10.2 8.5 2.8 6.2 10.1 2.3 10.7 8.1 11.1 1.1 15.0 9.1 3.2 11.7 3.9 2.9 11.1 12.3 8.2 6.0 4.9 3.5 4.2 8.0 9.9 3.4 10.7 4.6 3.2 10.2 2.0 1.1 10.2 3.9 23.7 13.7 9.8 2.1 3.1 10.8 11.1 13.1 3.6 5.3 7.6 5.9 2.8 10.6 11.5 3.8 21.3 8.0 6.2 10.4 5.3 5.1 16.7 14.3 7.6 10.7 9.9 14.7 7.0 18.0 24.7 7.0 5.8 20.1 3.3 8.9 1.8 21.3 25.0 20.7 8.4 10.0 8.4 15.8 15.5 4.5 8.6 7.5 3.2 4.3 6.5 15.7 23.1 15.4 4.1 19.0 17.4 29.1 21.8 6.6 34.0 23.4 8.7 22.3 4.7 8.6 15.6 15.8 16.9 9.1 18.3 2.3 13.1 16.7 10.7 17.1 10.0 21.6 23.1 49.7 52.8 19.8 10.6 19.3 14.8 3.7 8.7 9.8 5.3 9.3 8.9 17.9 10.6 11.7 5.8 15.0 10.1 8.3 1.7 11.3 7.4 11.0 12.8 3.8 3.7 3.5 2.8 6.2 3.9 2.9 4.9 3.5 4.2 3.2 3.1 3.6 3.8 6.9 3.2 5.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 9.6 8.4 0.0 0.0 1.3 16.5 0.0 36.0 13.8 0.0 19.6 21.6 0.0 9.6 10.9 4.9 0.0 0.0 0.0 10.5 31.4 5.2 0.0 9.2 1.3 10.5 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 2.4 0.0 0.0 22.1 0.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 35.7 5.5 14.7 0.0 0.0 FBN3 KIAA1776 ENSG00000142449 "Fibrillin 3" Q75N90 19 8065402-8149592 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.4;salivary gland: 4.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Cardiomyocytes: 2.4;Inhibitory neurons: 3.4;Oligodendrocyte precursor cells: 17.1" "Cancer enhanced" "Detected in many" "testis cancer: 8.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;CACO-2: 3.7;NTERA-2: 12.3;REH: 18.6;SuSa: 4.5" "Not detected" "Not detected" HPA049482 Uncertain "Secreted to extracellular matrix" NA NA 2400000 "HPA049482: AB_2680786" "unprognostic (9.66e-3)" "unprognostic (5.15e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (4.14e-2)" "unprognostic (5.14e-3)" "unprognostic (6.26e-2)" "unprognostic (4.10e-3)" "unprognostic (3.17e-2)" "unprognostic (8.94e-2)" "unprognostic (4.61e-2)" "unprognostic (1.53e-1)" "unprognostic (2.76e-2)" "unprognostic (1.34e-2)" "unprognostic (2.57e-1)" "unprognostic (1.17e-2)" "unprognostic (3.17e-1)" 0.1 0.0 0.4 0.0 0.3 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.5 2.4 0.1 1.4 0.0 0.5 0.5 0.2 0.1 0.0 0.0 0.8 0.0 0.6 0.9 0.1 0.0 4.0 0.0 0.4 0.2 0.1 0.1 0.5 0.0 0.1 0.5 0.4 0.5 1.9 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 12.3 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.4 0.2 0.5 0.5 0.5 0.2 0.6 0.5 0.4 0.7 0.0 6.4 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 17.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871553-10923075 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 19.9 17.2 21.0 19.8 23.1 22.9 17.8 15.1 34.4 29.4 14.4 26.9 17.5 32.0 7.9 37.0 23.6 14.8 25.3 23.9 20.0 17.2 20.2 16.5 20.0 19.1 18.7 21.0 22.1 22.5 11.6 14.9 20.6 19.9 20.4 14.4 6.5 20.4 17.7 111.6 22.6 21.0 21.5 15.7 18.7 20.5 45.7 19.5 11.0 13.5 73.0 15.5 26.5 28.3 22.1 62.5 46.8 64.9 88.3 52.5 71.1 63.2 42.8 75.6 63.9 61.0 73.4 21.8 85.2 52.4 77.4 32.1 58.0 65.4 66.2 40.1 98.4 52.7 26.5 29.1 89.9 44.8 39.3 33.9 49.0 42.4 43.8 52.4 35.9 82.1 67.9 65.8 79.2 38.2 116.7 70.0 34.3 81.4 40.7 74.8 97.5 32.8 100.7 38.9 29.7 47.0 45.1 30.7 36.2 43.6 31.7 38.4 35.3 48.7 75.4 43.2 72.3 54.0 75.0 64.1 77.2 51.1 63.8 35.3 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 21.0 23.1 15.1 34.4 23.9 20.0 19.1 18.7 21.0 19.9 15.7 19.5 22.1 12.9 9.6 12.2 7.2 11.6 7.8 5.9 4.1 12.0 36.4 14.0 13.7 1.1 14.3 6.5 9.2 52.1 18.5 6.4 42.3 7.9 13.4 32.7 20.1 30.8 12.7 27.6 30.7 12.9 19.7 33.1 13.8 13.7 25.4 1.3 17.8 12.8 27.8 26.7 45.4 10.6 24.9 4.1 20.0 10.9 23.5 28.3 14.8 5.4 5.6 23.9 8.7 4.1 10.6 5.8 24.8 27.2 19.2 11.7 14.1 22.6 9.2 7.4 21.1 6.6 19.6 13.0 23.8 17.5 25.7 7.0 12.0 6.5 6.6 25.7 11.8 EVI5L ENSG00000142459 "Ecotropic viral integration site 5 like" Q96CN4 19 7830233-7864976 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.5;Horizontal cells: 33.7;Late spermatids: 32.6;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "U-2197: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043099, HPA043563" Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA043099: AB_10796685, HPA043563: AB_2678556" "unprognostic (3.90e-2)" "unprognostic (4.69e-2)" "unprognostic (9.29e-3)" "unprognostic (2.18e-2)" "unprognostic (1.74e-1)" "unprognostic (1.34e-2)" "unprognostic (2.06e-3)" "unprognostic (1.90e-2)" "unprognostic (7.66e-2)" "unprognostic (3.00e-1)" "unprognostic (7.48e-3)" "unprognostic (1.97e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (1.37e-2)" "unprognostic (2.04e-2)" 6.8 10.4 27.0 5.1 25.9 3.1 6.7 19.1 34.7 9.2 0.8 11.2 4.9 11.3 4.7 10.7 8.4 5.1 15.0 27.8 23.8 11.5 6.4 7.3 4.3 31.6 26.2 23.0 7.3 6.3 8.9 16.5 8.0 34.7 12.2 4.1 11.2 7.6 9.2 20.7 13.6 7.0 8.8 18.2 8.2 9.4 36.4 25.6 6.4 8.6 15.0 4.4 11.2 9.1 38.9 13.5 2.7 10.5 15.4 18.8 15.7 29.5 19.7 20.5 13.8 14.7 1.1 5.0 3.4 23.1 26.9 7.3 9.1 3.8 13.4 12.7 19.6 12.7 2.6 6.3 2.2 23.7 3.1 6.7 14.7 15.9 6.8 31.9 11.4 16.9 17.5 3.1 17.8 14.4 13.8 10.8 6.8 3.9 10.0 28.4 13.0 8.7 10.0 8.3 11.3 4.3 10.3 18.3 8.1 5.8 7.0 6.8 9.9 16.7 9.4 4.4 53.6 7.4 25.7 6.2 4.6 15.9 7.5 8.3 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.1 0.1 1.1 0.1 0.2 0.0 27.0 25.9 19.1 34.7 27.8 23.8 31.6 26.2 23.0 34.7 18.2 25.6 38.9 3.6 0.0 5.1 13.1 1.6 3.8 2.2 2.4 2.2 30.5 3.6 3.3 4.0 2.8 1.8 9.2 18.8 3.7 1.6 7.4 0.0 2.4 14.8 2.2 4.3 3.8 5.4 1.3 16.3 2.6 16.9 3.1 6.1 4.2 0.0 5.7 3.6 2.0 3.8 33.7 19.7 4.2 6.1 2.5 1.1 32.6 4.1 2.8 3.6 9.4 1.1 7.1 1.0 50.3 69.8 3.0 3.5 4.5 2.0 2.5 1.7 4.1 1.8 18.8 6.6 2.0 4.0 18.3 7.3 3.6 4.1 3.4 2.2 8.2 3.4 5.1 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins, Transporters" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 176.3;liver: 206.3" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 176.3 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 11.7 206.3 0.0 0.2 0.0 0.0 0.0 0.0 1.4 8.2 0.0 0.6 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 159.4 0.0 0.0 0.1 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 53.7 2.6 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 96.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.7 0.0 60.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.8 0.0 1.8 0.0 0.1 0.0 40.5 5.9 0.9 2.0 0.0 0.0 0.1 115.2 5.3 0.1 8.9 4.6 0.0 57.6 0.0 4.5 0.0 4.6 275.4 0.1 0.0 0.1 143.9 0.0 4.8 0.3 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 285.4 0.0 0.1 0.0 618.4 72.8 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.0 47.8 0.0 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 128.4;kidney: 101.2;liver: 104.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 189.2;Hepatocytes: 43.3;Proximal tubular cells: 52.9;Skeletal myocytes: 67.8" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 12.2;plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 6 "dendritic cells: 6.6;granulocytes: 12.2" "Cell line enhanced" "Detected in many" "A549: 21.3;AN3-CA: 16.7;Hep G2: 41.5;U-266/70: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced NA NA 18000 "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 2.0 128.4 2.1 0.8 2.6 2.7 1.4 3.5 16.0 29.7 8.1 1.7 1.4 16.3 2.5 1.9 7.5 3.8 4.3 15.8 4.6 101.2 104.8 7.0 1.6 3.0 2.8 2.1 7.8 0.3 1.4 16.6 0.4 3.6 6.4 1.0 1.2 2.6 12.4 34.4 25.2 1.3 7.8 2.6 3.7 1.2 14.7 4.2 1.5 6.3 38.0 1.3 1.0 10.7 3.3 0.1 21.3 0.6 16.7 0.5 0.1 0.1 0.6 0.5 2.5 2.3 0.0 0.6 0.2 3.9 3.1 8.3 0.1 7.4 0.6 0.6 0.1 9.8 0.2 10.6 41.5 0.2 0.2 0.5 0.4 3.7 1.9 0.3 2.8 5.9 0.0 0.0 0.0 0.0 3.0 0.1 0.4 2.2 0.3 0.8 0.2 0.2 0.2 0.0 1.3 3.9 3.4 7.0 0.1 1.9 5.6 7.1 1.9 0.0 0.1 0.8 0.3 2.0 31.0 13.1 0.1 0.8 0.1 3.6 0.3 1.4 12.2 0.3 0.9 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.6 0.2 0.0 0.1 6.6 0.0 0.5 2.1 2.6 3.5 16.0 15.8 4.6 3.0 2.8 2.1 3.6 2.6 4.2 3.3 0.5 6.4 3.7 0.7 1.3 4.7 2.3 0.4 6.2 0.9 0.1 0.8 4.1 4.3 0.1 1.8 0.0 0.0 1.7 0.0 3.9 0.1 15.5 3.0 1.3 1.2 0.0 0.0 3.5 0.0 0.0 4.4 0.0 9.2 5.7 189.2 0.0 43.3 1.5 0.0 14.4 0.0 0.0 2.9 1.2 4.8 3.7 2.5 1.8 3.7 0.4 1.4 0.0 2.5 0.3 0.0 0.0 1.5 3.9 2.3 0.0 52.9 0.8 0.9 6.6 67.8 3.3 0.6 1.1 1.1 6.7 0.0 1.7 0.3 0.0 1.5 PSMB6 "DELTA, Y" ENSG00000142507 "Proteasome 20S subunit beta 6" P28072 17 4796144-4798502 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023312, HPA063656" Supported Supported Nucleoplasm,Cytosol NA NA 1400000 Nucleoplasm Cytosol "HPA023312: AB_1855828, HPA063656: AB_2685078" "unprognostic (2.71e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (3.32e-3)" "unprognostic (8.80e-2)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (5.27e-2)" "unprognostic (5.66e-2)" 93.1 108.7 134.3 82.9 136.7 128.0 108.1 141.2 142.3 93.4 138.8 105.6 77.6 102.7 152.2 141.7 100.1 68.9 187.7 135.0 139.6 136.1 186.1 86.9 90.8 139.9 137.0 133.6 64.2 100.2 174.8 83.1 120.8 141.1 85.6 119.4 63.1 100.9 115.2 361.5 115.5 77.6 136.5 141.0 91.2 104.6 77.2 139.2 148.8 89.5 342.5 141.7 111.7 90.0 143.6 279.8 478.2 251.6 216.4 209.9 188.1 289.7 144.1 300.1 431.3 336.0 358.7 220.5 215.0 277.9 348.1 246.5 273.8 388.0 404.4 418.0 281.9 409.7 128.0 315.3 422.7 242.0 133.5 194.4 178.3 305.1 377.4 355.7 241.5 426.5 335.8 199.4 316.6 336.1 331.8 237.4 221.8 214.1 356.2 328.2 261.9 178.7 284.6 326.6 185.3 146.9 179.9 206.6 158.9 148.6 261.4 194.5 147.2 205.1 210.8 158.9 286.4 355.2 130.8 191.8 132.9 301.3 242.1 259.3 410.6 603.3 343.2 347.5 589.9 355.9 668.6 373.1 384.0 624.9 640.8 319.8 329.3 210.5 424.4 549.4 585.5 556.2 817.2 134.3 136.7 141.2 142.3 135.0 139.6 139.9 137.0 133.6 141.1 141.0 139.2 143.6 156.3 134.6 113.3 8.5 118.3 229.2 184.1 410.8 112.1 65.5 124.6 153.4 454.8 141.5 253.9 134.3 16.7 587.3 142.8 178.0 358.1 321.6 245.2 110.9 108.1 164.7 148.4 183.7 7.6 349.9 418.2 171.5 105.5 116.0 105.2 156.1 99.6 235.4 346.3 32.0 7.2 173.0 311.3 111.7 272.1 52.9 109.6 159.8 236.5 4.7 298.9 183.4 109.2 9.0 16.9 351.3 163.4 123.0 244.7 191.7 188.6 564.6 193.3 81.3 111.7 119.8 486.8 175.1 84.7 178.6 277.2 664.5 125.9 172.6 177.7 217.3 GPR32 RVDR1 ENSG00000142511 "G protein-coupled receptor 32" O75388 19 50770464-50771732 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "parathyroid gland: 58.4" "Group enriched" "Detected in some" 12 "Extravillous trophoblasts: 6.3;Syncytiotrophoblasts: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "BEWO: 37.4" "Not detected" "Not detected" NA NA "unprognostic (4.77e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 SIGLEC10 "MGC126774, PRO940, SIGLEC-10, SLG2" ENSG00000142512 "Sialic acid binding Ig like lectin 10" Q96LC7 19 51410020-51417803 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in some" "B-cells: 33.0;granulocytes: 39.3;Kupffer cells: 93.9;Macrophages: 51.5" "Cancer enhanced" "Detected in all" "glioma: 11.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 765.3;intermediate monocyte: 252.0;non-classical monocyte: 539.2" "Group enriched" "Detected in many" 16 "granulocytes: 765.3;monocytes: 539.2" "Cell line enhanced" "Detected in some" "Daudi: 28.8;HDLM-2: 9.0;HEL: 14.9;HMC-1: 10.7;NB-4: 10.4;U-698: 21.3;U-937: 12.0" "Not detected" "Not detected" "CAB025807, HPA027093" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane, Actin filaments" "CAB025807: , HPA027093: AB_1856858" "unprognostic (7.18e-2)" "unprognostic (3.90e-3)" "unprognostic (1.11e-2)" "unprognostic (3.67e-2)" "unprognostic (3.95e-2)" "unprognostic (9.41e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (3.16e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.73e-1)" "unprognostic (1.69e-2)" "unprognostic (1.39e-1)" "unprognostic (9.05e-2)" 3.5 6.5 4.0 34.2 7.5 15.1 2.2 4.8 6.1 1.4 3.8 5.4 7.1 2.1 1.0 2.1 2.4 3.8 1.1 4.3 10.6 1.7 3.2 8.5 20.1 11.8 6.1 3.7 1.6 3.6 1.0 1.4 1.8 9.1 3.0 4.6 1.1 2.2 1.1 0.7 1.2 12.3 4.5 5.6 38.8 4.7 1.3 8.5 4.1 1.0 1.1 19.7 5.5 1.2 12.7 0.2 0.0 0.5 0.5 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 1.3 28.8 0.9 0.1 0.3 0.5 0.0 0.2 0.0 9.0 2.5 14.9 0.3 0.1 0.0 6.4 10.7 0.1 0.0 0.1 0.0 0.1 0.0 1.7 0.7 1.4 0.0 0.6 0.2 10.4 0.8 0.7 0.4 1.9 0.1 0.5 0.0 0.3 0.4 0.4 0.3 0.1 0.2 0.5 0.1 5.2 0.7 0.7 1.3 0.6 0.2 1.3 0.3 21.3 0.5 12.0 0.5 14.0 41.9 765.3 0.8 252.0 0.4 41.4 0.5 0.5 38.0 27.4 0.3 0.5 87.2 0.4 539.2 2.2 1.1 40.7 4.0 7.5 4.8 6.1 4.3 10.6 11.8 6.1 3.7 9.1 5.6 8.5 12.7 0.7 3.2 1.3 0.3 33.0 0.1 1.2 0.0 0.0 1.4 0.4 0.9 0.3 0.0 0.0 1.8 2.1 0.1 0.6 0.1 0.0 0.0 0.9 0.0 0.0 4.2 0.0 5.2 0.6 0.0 0.1 0.8 0.0 0.1 39.3 0.1 0.4 1.0 8.1 0.0 0.2 0.1 0.0 93.9 6.3 0.4 0.0 51.5 0.0 15.0 14.8 0.2 6.2 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.1 0.0 0.7 0.0 2.0 0.4 0.5 0.7 0.0 1.3 0.1 2.7 0.1 0.0 0.9 ACP4 ACPT ENSG00000142513 "Acid phosphatase 4" Q9BZG2 19 50790415-50795219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Hydrolase "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 1.2;testis: 3.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;U-266/84: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.41e-2)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (3.70e-3)" "unprognostic (7.62e-2)" "unprognostic (3.18e-2)" "unprognostic (3.89e-3)" "unprognostic (5.46e-2)" "unprognostic (2.47e-1)" "unprognostic (5.59e-2)" "unprognostic (3.96e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-3)" "unprognostic (2.36e-1)" "unprognostic (4.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.3 0.0 0.1 0.5 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.5 0.0 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.3 0.2 0.4 0.1 0.2 0.5 0.3 0.1 0.2 0.0 0.5 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.2 2.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.2 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KLK3 "APS, PSA" ENSG00000142515 "Kallikrein related peptidase 3" P07288 19 50854915-50860764 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 320 "prostate: 8083.1" "Cell type enriched" "Detected in some" 77 "Prostatic glandular cells: 3438.6" "Cancer enriched" "Detected in some" 3905 "prostate cancer: 4241.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 173 "BEWO: 31.7;NB-4: 27.8;RPMI-8226: 19.3;SH-SY5Y: 10.5;U-2197: 10.7" "CAB000070, HPA000764" Enhanced "Secreted in male reproductive system" NA NA 7000000 "CAB000070: , HPA000764: AB_1079700" "unprognostic (5.06e-3)" "unprognostic (5.60e-2)" "unprognostic (9.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.13e-3)" "unprognostic (1.94e-1)" "unprognostic (4.64e-1)" "unprognostic (3.15e-1)" 4.4 7.6 0.0 5.7 0.0 0.0 9.0 0.0 0.0 0.4 0.0 2.3 4.9 1.6 14.5 0.2 4.0 0.0 0.4 0.0 0.0 1.4 1.5 1.2 1.7 0.0 0.0 0.0 0.3 0.9 0.6 0.2 0.3 0.0 8083.1 1.2 0.0 4.5 25.2 0.3 0.4 3.8 0.0 0.0 0.2 1.0 7.0 0.0 0.0 0.8 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 19.3 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 12.4 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 1.8 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3438.6 0.1 0.1 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 4.2 0.2 0.4 44.6 ZNF473 "DKFZP434N043, HZFP100, KIAA1141" ENSG00000142528 "Zinc finger protein 473" Q8WTR7 19 50025714-50053414 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 42.8" "Cell type enhanced" "Detected in many" "Early spermatids: 88.9;Late spermatids: 23.3;Spermatocytes: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA004191, HPA073309" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004191: AB_2667168, HPA073309: AB_2686594" "unprognostic (7.47e-3)" "unprognostic (3.57e-2)" "unprognostic (2.47e-1)" "unprognostic (3.40e-1)" "unprognostic (4.27e-1)" "unprognostic (8.00e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.31e-3)" "unprognostic (6.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.70e-2)" "unprognostic (3.22e-3)" "unprognostic (8.49e-2)" "unprognostic (1.60e-1)" "unprognostic (3.93e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" 3.8 2.9 5.4 2.9 5.0 4.3 4.6 5.9 6.4 3.6 8.1 3.1 2.9 3.8 4.0 3.6 7.4 3.2 2.9 6.2 5.1 3.6 3.3 3.5 3.6 5.1 5.5 4.1 4.5 4.7 4.4 5.4 3.0 5.5 4.8 3.0 6.2 2.4 4.0 4.1 3.7 2.5 4.9 4.9 6.8 3.1 42.8 5.5 4.1 4.6 4.7 4.6 3.2 2.4 7.2 14.4 9.6 14.7 12.4 5.7 6.6 8.3 13.2 7.9 18.4 17.2 18.4 9.5 22.2 5.0 7.7 6.8 10.8 18.4 8.8 23.4 15.6 18.0 22.5 8.8 9.3 6.6 16.3 13.1 6.8 16.1 19.3 25.2 7.6 6.2 13.1 32.1 19.3 9.4 6.2 13.0 7.8 10.4 22.4 15.1 15.8 20.5 9.8 6.1 15.6 12.1 13.9 18.6 10.1 8.9 10.0 9.4 14.7 3.0 25.7 13.1 5.2 13.4 8.9 22.8 18.4 6.1 12.7 21.0 2.0 5.0 2.9 6.3 7.3 6.6 11.7 6.3 7.7 5.0 10.0 7.8 10.0 4.4 2.5 3.4 5.3 3.9 4.2 5.4 5.0 5.9 6.4 6.2 5.1 5.1 5.5 4.1 5.5 4.9 5.5 7.2 2.8 0.0 1.7 0.3 4.6 4.6 2.9 1.9 6.8 0.7 2.9 2.8 2.2 0.0 1.7 0.0 0.0 2.3 1.5 2.3 3.9 2.4 88.9 5.6 5.1 3.8 1.8 5.2 3.1 3.2 3.2 3.5 7.7 4.0 0.0 3.8 6.8 1.7 2.2 0.0 3.1 3.7 2.0 1.3 1.7 23.3 3.7 2.0 1.8 1.9 3.2 1.7 2.1 1.5 2.8 3.4 3.0 3.8 4.1 4.1 1.6 1.7 10.4 4.3 13.1 3.5 2.7 64.7 20.5 4.8 4.7 1.9 3.5 3.5 2.4 2.1 FAM71E1 ENSG00000142530 "Family with sequence similarity 71 member E1" Q6IPT2 19 50466785-50476848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 77.2" "Group enriched" "Detected in many" 50 "Early spermatids: 2052.1;Late spermatids: 3617.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048111 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA048111: " "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (8.19e-2)" "unprognostic (7.61e-2)" "unprognostic (1.99e-1)" "unprognostic (5.45e-3)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.35e-7)" "unprognostic (7.26e-2)" "unprognostic (1.45e-1)" "unprognostic (1.32e-1)" "unprognostic (2.37e-2)" 0.3 1.0 3.5 0.2 3.4 0.0 0.9 6.2 6.7 1.0 2.1 0.7 1.2 0.6 0.7 1.7 1.4 0.6 1.5 3.1 4.4 3.4 2.7 1.0 0.0 5.1 3.7 3.2 2.6 2.4 1.2 4.0 0.4 4.2 2.0 0.2 1.2 2.6 0.7 3.8 1.5 0.9 0.0 3.2 0.3 1.6 77.2 3.8 0.4 2.2 1.8 0.2 0.6 0.8 4.1 1.9 1.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.3 0.0 0.1 0.4 2.9 0.0 0.7 0.0 0.2 13.8 0.0 0.7 0.0 2.1 0.1 1.7 0.6 1.4 0.1 0.3 0.2 0.0 1.0 0.5 0.8 0.0 2.4 0.5 0.0 0.0 3.6 2.1 1.5 0.2 0.8 0.8 2.5 3.2 0.7 1.0 3.4 0.4 0.8 2.6 0.8 0.0 0.0 0.8 0.1 0.2 0.7 1.6 0.1 0.0 0.0 0.1 0.4 0.4 0.9 0.8 0.1 1.2 0.5 0.8 0.4 0.1 1.1 0.8 1.0 0.4 1.5 0.2 0.9 0.1 0.2 3.5 3.4 6.2 6.7 3.1 4.4 5.1 3.7 3.2 4.2 3.2 3.8 4.1 1.5 0.0 0.5 0.3 1.1 0.6 3.5 3.9 2.8 5.0 8.2 12.4 2.1 0.0 2.3 3.7 0.0 7.0 0.0 0.9 11.7 3.9 2052.1 3.8 1.9 2.0 3.0 0.4 1.7 5.4 3.6 2.2 4.6 2.0 0.0 7.4 2.2 2.4 2.0 5.0 2.5 5.3 2.0 0.0 0.4 3617.6 17.1 1.7 0.0 0.0 1.6 11.6 0.0 0.5 1.1 2.4 2.1 15.1 0.4 4.4 2.3 16.3 3.9 9.9 19.7 1.2 1.5 56.2 30.2 5.2 2.4 14.0 0.4 5.6 3.2 4.1 RPS11 S11 ENSG00000142534 "Ribosomal protein S11" P62280 19 49496365-49499708 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049719 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 39000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA049719: AB_2680860" "unprognostic (1.49e-3)" "unprognostic (3.71e-2)" "unprognostic (1.22e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-3)" "unprognostic (3.57e-1)" "unprognostic (1.04e-2)" "unprognostic (4.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-1)" "unprognostic (5.68e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (5.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (1.71e-3)" 2774.7 1983.2 2312.1 1944.5 2328.1 5178.5 4422.5 2264.9 2993.5 3817.0 2319.5 2728.3 1787.3 2708.1 2762.0 2426.4 3456.0 1662.2 1788.5 2214.4 2360.5 2054.1 2135.0 2014.2 4088.2 2327.1 2273.7 2166.3 6130.1 3773.2 1897.8 2136.1 1875.3 2345.1 2591.2 2738.4 1015.2 2776.5 1979.4 3230.9 3711.8 2374.8 2317.4 2397.7 2840.9 2494.2 741.4 2375.5 3826.6 1995.0 3410.0 4796.4 2714.8 2932.6 2385.8 2932.3 4522.4 3340.7 5169.4 4778.9 7228.3 2239.9 2418.7 4891.5 3444.6 3294.2 3167.0 2392.5 7154.4 1461.9 3373.2 1470.8 1926.2 4003.2 4879.0 3375.9 3065.7 6870.8 4318.3 2858.4 4634.4 4446.2 7694.0 3083.3 7191.2 7968.8 2279.2 5867.3 5774.3 5106.5 4307.3 4374.9 3709.1 3792.3 3324.7 3612.0 5845.5 3067.8 7346.6 4594.6 3450.4 4209.9 3875.7 5006.0 6932.7 3555.4 4741.2 1646.4 5505.8 3793.8 3223.4 1790.9 7907.9 2886.2 2667.3 2377.5 1302.4 3236.1 3646.3 6191.7 5179.5 1104.6 5297.2 2335.7 1161.8 2103.1 653.8 1900.0 1810.3 2537.9 4890.5 2741.7 2206.3 2979.8 4589.4 3192.9 2762.8 507.2 2120.9 1563.8 3733.9 2382.4 6125.5 2312.1 2328.1 2264.9 2993.5 2214.4 2360.5 2327.1 2273.7 2166.3 2345.1 2397.7 2375.5 2385.8 820.0 836.6 1502.6 30.0 2589.7 2685.3 2499.6 1615.7 971.5 289.1 1028.9 947.2 716.6 1155.3 1344.7 474.5 143.9 1915.2 1891.9 1130.4 1216.9 1295.8 900.1 1044.9 2292.8 1236.5 1501.5 1404.7 9.6 2816.1 3575.5 1178.0 550.0 1527.0 1341.6 1228.9 1633.8 1645.8 1898.6 94.2 12.1 2720.4 612.3 2780.4 3206.1 1773.6 3212.5 1749.5 1538.5 22.5 2825.6 1123.6 2614.9 10.1 22.3 2021.0 1960.1 1538.8 1006.3 2063.5 1353.7 1873.6 857.0 493.5 874.4 2214.3 2008.7 603.1 589.5 1334.2 3413.1 2356.3 1587.9 1273.7 2434.5 2570.3 PTH2 TIP39 ENSG00000142538 "Parathyroid hormone 2" Q96A98 19 49422419-49423441 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "brain: 4.8" "Cell type enhanced" "Detected in some" "Early spermatids: 2.4;Late spermatids: 3.1;Muller glia cells: 2.4;Spermatocytes: 2.0;Spermatogonia: 2.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 4.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "olfactory bulb: 2.9" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (3.41e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.7 0.3 0.0 0.1 4.8 0.1 0.6 0.0 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 AC020909.1 ENSG00000142539 "Novel protein" 19 50415799-50428409 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.1;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 16 "B-cells: 1.1;dendritic cells: 2.0" "Cell line enhanced" "Detected in some" "REH: 3.0;U-2 OS: 1.1;U-266/70: 1.5;U-698: 2.4" HPA018523 Uncertain NA NA "HPA018523: AB_1857443" 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.5 0.3 2.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL13A "L13A, TSTA1" ENSG00000142541 "Ribosomal protein L13a" P40429 19 49487510-49493057 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038751 Approved Approved Nucleoli,Cytosol NA NA 44000 "Nucleoli, Cytosol" "HPA038751: AB_10962004" "unprognostic (2.35e-3)" "unprognostic (2.15e-1)" "unprognostic (4.08e-2)" "unprognostic (2.02e-1)" "unprognostic (2.95e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (1.21e-1)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.81e-2)" "unprognostic (7.85e-2)" "unprognostic (3.22e-1)" "unprognostic (1.87e-1)" 2089.2 2267.1 1062.4 1536.1 1073.9 3186.8 2299.3 1036.5 1629.8 2722.0 1132.4 1997.5 1696.5 1758.2 748.6 2721.0 2156.8 1071.3 1509.5 1005.7 1086.8 1544.7 1655.5 1480.0 3020.7 1093.7 1037.7 985.9 4499.5 4180.2 965.0 1254.4 1079.4 1079.0 2060.2 966.8 590.9 2402.6 972.3 2968.7 3158.6 1982.7 787.1 1124.4 2286.0 2165.8 455.4 1090.9 2089.4 1608.1 1498.0 1797.9 2110.1 2389.7 1087.2 2693.9 3191.9 1553.5 4384.1 2927.6 4606.7 1812.7 2265.3 2944.1 1696.6 1823.7 2817.9 2001.2 6730.4 1792.9 1804.0 687.0 1724.4 1978.2 3463.6 974.1 1895.7 4496.8 3377.7 1945.3 3984.3 3562.3 5127.9 2581.9 5363.6 5688.6 1203.5 4051.7 3536.9 2763.2 2430.9 2982.0 2472.0 1975.0 2322.6 3629.2 5266.7 2905.4 2535.0 2987.2 3504.5 3396.6 2968.4 2319.3 4481.3 2545.5 3362.0 1184.7 5205.9 5408.7 1180.0 2303.0 5907.2 3249.6 2026.5 2165.3 1276.1 3061.9 2474.5 3628.5 3102.4 1267.1 3505.6 1898.9 1499.6 2615.2 669.3 3673.1 2167.5 5384.1 8504.2 6249.9 5035.0 3741.0 7985.6 7293.6 5930.8 400.5 4696.2 1914.5 4364.8 5054.0 13490.7 1062.4 1073.9 1036.5 1629.8 1005.7 1086.8 1093.7 1037.7 985.9 1079.0 1124.4 1090.9 1087.2 759.0 1618.6 1998.3 5.9 5793.5 11583.3 12255.7 8593.4 1801.8 534.6 8903.0 5580.5 544.1 4340.8 4712.7 1590.9 214.8 7997.8 3602.5 2445.5 5433.2 4560.9 304.1 1462.1 3740.3 3725.7 3984.3 2696.0 5.1 12776.9 10340.4 3277.8 916.9 2114.2 2546.8 1496.7 5087.0 4397.2 5887.8 220.4 6.0 7002.5 2705.8 7291.2 8449.9 709.7 9127.2 3169.3 5695.4 9.4 7891.8 1658.7 5864.1 8.0 12.4 7364.8 6114.5 4432.7 1348.9 11217.2 5888.9 7303.9 2192.4 723.4 2655.9 5724.7 2897.9 456.9 817.2 2602.1 14282.8 8401.6 4958.9 2454.2 8198.9 13221.0 CTU1 "ATPBD3, MGC17332, NCS6" ENSG00000142544 "Cytosolic thiouridylase subunit 1" Q7Z7A3 19 51097606-51108409 "Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 45.9;Theca cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 43.5;PC-3: 20.5;U-266/70: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053797 Uncertain NA NA "HPA053797: AB_2682266" "unprognostic (2.07e-1)" "unprognostic (7.62e-3)" "unprognostic (1.32e-1)" "unprognostic (2.73e-1)" "unprognostic (3.95e-1)" "unprognostic (6.95e-2)" "unprognostic (4.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (3.96e-2)" "unprognostic (6.85e-3)" "unprognostic (8.57e-3)" "unprognostic (1.32e-2)" "unprognostic (2.26e-1)" "unprognostic (2.84e-1)" "prognostic favorable (5.73e-5)" 2.3 3.3 3.9 0.9 3.6 0.3 2.2 3.6 4.2 3.9 2.6 3.1 1.3 4.5 0.5 4.5 4.3 0.4 3.1 3.7 3.5 3.6 4.1 2.3 0.9 4.7 3.5 3.5 6.3 4.2 1.1 2.9 0.9 4.2 3.9 0.4 0.5 2.4 0.6 2.9 3.3 2.7 0.7 3.7 3.8 3.0 2.8 4.0 1.0 3.5 0.6 0.7 4.0 3.4 4.8 5.4 5.0 0.8 2.5 2.4 1.6 2.4 4.1 0.7 1.4 1.6 1.9 1.6 5.6 5.0 1.0 1.2 8.4 4.2 1.2 0.9 6.5 43.5 2.1 4.5 1.5 1.7 4.1 4.3 1.2 3.1 1.1 2.7 2.1 1.2 1.9 9.5 2.4 1.2 1.6 5.3 8.6 4.5 6.4 20.5 6.7 3.1 7.2 1.4 1.2 4.5 5.2 2.5 3.8 6.4 1.0 1.5 3.7 2.8 1.4 5.8 2.1 5.9 18.9 13.1 4.6 1.8 5.0 1.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.9 3.6 3.6 4.2 3.7 3.5 4.7 3.5 3.5 4.2 3.7 4.0 4.8 11.3 0.0 0.0 2.0 5.2 19.5 45.9 0.4 9.1 2.6 11.4 13.5 3.0 7.2 0.3 12.9 8.4 6.6 10.1 7.4 33.2 1.2 3.8 8.1 12.3 8.0 3.5 13.2 2.5 0.8 8.7 10.7 5.1 8.1 0.0 20.3 10.4 5.9 5.3 6.7 2.8 7.8 0.0 5.9 7.6 2.3 9.3 8.0 3.6 1.9 3.3 4.0 6.2 1.0 3.5 0.6 3.4 6.0 4.4 32.3 2.6 27.5 0.2 3.9 6.6 8.7 9.7 2.1 1.9 10.8 31.0 6.2 8.7 36.5 7.2 32.5 NOSIP CGI-25 ENSG00000142546 "Nitric oxide synthase interacting protein" Q9Y314 19 49555468-49590262 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 364.8;Late spermatids: 844.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043464, HPA062132" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043464: AB_10794284, HPA062132: AB_2684693" "unprognostic (2.27e-1)" "unprognostic (4.69e-2)" "unprognostic (1.39e-1)" "unprognostic (4.17e-2)" "unprognostic (1.59e-2)" "unprognostic (9.46e-2)" "unprognostic (1.47e-2)" "unprognostic (9.42e-2)" "unprognostic (3.79e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (9.73e-2)" "unprognostic (3.97e-2)" "unprognostic (2.15e-1)" "unprognostic (9.76e-2)" "unprognostic (1.02e-1)" "unprognostic (2.95e-3)" 42.6 48.4 28.7 27.4 31.1 31.9 43.2 32.2 45.5 49.9 25.5 47.7 29.4 49.7 10.1 48.2 45.5 15.5 57.0 27.5 30.3 48.5 49.0 39.8 52.2 31.7 30.3 26.2 44.8 126.2 24.2 41.1 21.8 31.9 44.3 14.7 10.2 38.6 20.8 135.9 46.4 51.2 16.3 30.9 63.7 45.2 144.6 32.2 40.3 41.3 65.8 26.7 41.7 42.1 33.4 239.7 114.5 49.6 113.1 43.5 32.7 44.5 54.8 50.0 90.9 85.3 84.9 43.1 63.4 93.5 48.2 37.0 51.0 47.8 98.4 40.3 74.1 126.0 81.3 67.9 96.6 66.6 67.8 64.6 43.4 66.5 71.4 37.7 38.0 54.4 101.8 90.7 46.0 50.3 59.7 66.2 127.0 65.9 89.3 100.4 89.3 74.0 58.3 43.5 70.6 57.4 71.2 74.9 59.1 50.2 21.8 53.9 72.6 83.5 83.6 64.4 27.0 99.3 87.8 186.7 86.6 31.2 90.7 65.2 261.9 129.1 192.3 257.3 126.1 328.8 161.8 519.8 294.6 127.8 157.2 841.3 466.7 244.1 244.5 117.6 168.8 303.6 579.4 28.7 31.1 32.2 45.5 27.5 30.3 31.7 30.3 26.2 31.9 30.9 32.2 33.4 78.3 19.2 34.9 13.1 67.3 72.8 54.8 109.8 40.9 25.4 45.5 49.5 38.4 62.9 59.3 51.5 22.9 94.2 74.7 171.6 86.1 84.5 364.8 56.3 44.9 73.0 58.7 58.5 9.2 283.6 85.0 51.7 57.6 68.6 68.4 57.0 93.9 49.5 72.2 11.8 9.1 108.9 91.6 63.8 67.0 844.8 71.7 55.5 62.2 13.1 100.5 45.5 120.5 9.0 12.3 219.2 138.2 72.2 55.4 43.2 129.6 133.8 58.4 37.2 59.2 85.1 66.1 268.7 50.9 39.6 76.3 136.3 154.2 73.1 108.5 54.4 IGLON5 LOC402665 ENSG00000142549 "IgLON family member 5" A6NGN9 19 51311848-51330354 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.2;retina: 14.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7" "Group enriched" "Detected in many" 5 "glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041994 Approved "Secreted in brain" NA NA 15000 "HPA041994: AB_10794641" "unprognostic (2.09e-1)" "unprognostic (5.76e-2)" "unprognostic (1.80e-2)" "unprognostic (8.87e-3)" "unprognostic (2.33e-1)" "unprognostic (2.66e-1)" "unprognostic (3.47e-4)" "unprognostic (6.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.89e-3)" "unprognostic (1.59e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.62e-7)" "unprognostic (1.77e-2)" "unprognostic (9.28e-2)" "unprognostic (1.36e-2)" "unprognostic (1.86e-3)" 1.2 1.7 17.0 0.2 9.7 0.7 0.9 23.1 21.5 0.3 1.5 0.4 0.2 0.1 0.7 4.2 0.1 0.2 0.3 12.2 17.2 0.1 1.9 0.2 0.0 40.3 19.8 9.4 1.2 0.2 1.8 1.3 0.4 44.3 0.2 0.0 14.1 0.7 0.7 0.0 0.6 0.3 0.1 14.9 0.1 0.2 8.0 26.7 0.0 0.2 0.0 0.0 0.4 1.2 49.2 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.6 0.0 0.4 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 16.0 0.2 0.0 0.0 0.0 3.5 0.0 0.1 0.1 23.0 0.0 0.0 0.0 9.9 0.2 2.2 0.0 0.0 6.4 0.1 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.0 9.7 23.1 21.5 12.2 17.2 40.3 19.8 9.4 44.3 14.9 26.7 49.2 2.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.9 0.0 0.0 6.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.8 0.1 0.3 79.1 17.6 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 3.7 0.0 2.5 0.0 5.5 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.9 0.9 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49528003-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 9 "granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8" "Cell line enhanced" "Detected in many" "AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No 1600000 "Endoplasmic reticulum" Vesicles "HPA043134: AB_2678332, HPA050402: AB_2681114" "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 60.2 35.6 15.4 33.9 16.1 6.9 48.6 14.9 24.3 76.7 23.5 36.6 40.3 47.8 4.4 11.5 41.7 25.4 46.8 15.0 18.7 41.1 62.9 41.1 8.8 17.1 16.3 13.8 50.4 16.5 3.9 20.9 31.4 16.8 32.7 11.5 1.4 19.2 12.2 11.8 24.0 43.6 26.0 16.5 66.4 23.6 17.3 22.3 4.0 26.6 7.5 4.1 43.5 46.7 21.3 3.2 4.3 2.7 166.6 283.3 175.4 1.9 353.8 86.5 122.0 179.6 4.2 1.3 1.3 19.5 304.0 1.3 0.3 6.8 0.5 49.2 0.1 2.5 19.5 1.5 9.1 105.7 0.1 43.0 119.5 0.2 93.2 0.4 3.2 43.8 2.3 8.7 1.0 87.8 2.9 0.1 2.0 1.4 8.8 24.5 0.5 3.9 4.0 1.4 0.0 1.7 10.5 0.3 1.1 0.3 2.8 1.3 11.5 121.4 1.7 52.4 135.3 0.1 14.9 44.5 2.6 7.9 9.6 13.4 0.0 0.2 1.6 0.7 0.0 0.7 0.4 1.7 0.6 0.4 0.2 6.8 2.3 2.5 1.8 0.3 0.2 1.6 1.1 15.4 16.1 14.9 24.3 15.0 18.7 17.1 16.3 13.8 16.8 16.5 22.3 21.3 12.0 0.0 6.1 4.6 2.8 18.6 0.6 2.9 3.4 0.8 1.7 3.3 2.1 1.5 0.8 1.8 0.0 2.5 1.4 10.5 1.9 1.6 2.2 1.5 54.7 10.6 1.2 0.0 1.0 0.5 5.0 105.1 6.6 1.6 1.3 7.0 27.1 3.7 22.6 1.7 1.1 7.6 0.0 11.4 23.2 3.0 38.2 11.9 10.6 10.3 3.1 0.6 0.0 1.5 0.8 1.5 7.9 44.8 4.8 0.9 13.1 0.6 0.9 0.8 13.1 37.5 66.5 6.5 6.8 2.8 13.9 6.2 2.2 17.2 8.0 0.4 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 47.9;Late spermatids: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 4.1 3.6 4.6 3.3 5.1 6.4 5.7 8.6 5.3 4.3 2.9 2.8 2.5 5.3 3.9 3.4 4.2 3.3 4.1 4.2 4.8 3.8 2.4 3.6 4.3 5.1 5.2 4.4 7.6 1.8 5.1 3.4 7.0 5.6 8.9 3.0 8.8 3.0 4.8 4.0 4.3 2.9 5.0 4.3 4.5 3.3 7.0 5.4 6.0 8.1 5.1 4.5 3.9 2.1 6.8 4.8 3.5 8.8 11.5 6.2 6.9 1.1 6.4 4.5 5.8 7.0 4.4 2.7 12.1 3.4 5.5 5.4 2.0 13.3 8.5 8.6 3.2 18.8 18.2 6.6 9.0 5.1 3.8 8.8 5.4 4.6 5.9 8.2 5.8 6.9 10.5 9.9 2.6 7.9 1.9 16.0 7.6 10.2 0.7 6.3 10.5 17.0 10.0 6.0 12.0 11.6 7.1 3.8 4.7 3.9 10.8 6.3 9.6 7.1 5.7 7.9 3.2 7.6 5.2 8.7 18.3 5.5 5.2 7.6 2.3 2.4 1.6 3.2 3.2 3.9 3.0 2.9 3.1 3.0 2.8 4.1 2.6 1.7 5.7 2.8 1.7 3.2 1.8 4.6 5.1 8.6 5.3 4.2 4.8 5.1 5.2 4.4 5.6 4.3 5.4 6.8 5.2 0.0 2.2 3.6 4.8 3.2 5.3 2.4 4.6 6.8 4.2 4.2 5.8 4.3 4.9 5.5 4.2 6.1 6.5 1.7 0.0 2.9 47.9 2.8 6.1 5.8 5.4 7.4 6.6 0.9 7.1 3.7 5.6 3.7 7.0 5.0 8.2 1.6 2.3 16.8 6.7 2.4 2.0 4.1 2.3 34.9 4.1 3.2 1.8 4.7 2.2 5.1 10.3 6.0 9.2 1.4 0.7 7.2 5.4 4.6 1.8 2.0 0.9 5.6 0.0 7.1 5.7 2.2 5.0 4.4 2.7 14.4 4.1 2.7 2.2 5.1 SLC2A5 GLUT5 ENSG00000142583 "Solute carrier family 2 member 5" P22732 1 9035106-9088478 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 98.1;intestine: 110.1;skeletal muscle: 79.5;testis: 77.1" "Cell type enhanced" "Detected in many" "Early spermatids: 64.3;Paneth cells: 55.6;Plasma cells: 35.3;Proximal enterocytes: 189.4;Spermatocytes: 83.2" "Group enriched" "Detected in many" 6 "glioma: 11.0;renal cancer: 11.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 23.3" "Lineage enriched" "Detected in many" 5 "B-cells: 23.3" "Group enriched" "Detected in some" 5 "Daudi: 190.3;THP-1: 47.8;U-266/70: 154.0;U-698: 178.2;U-937: 68.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005449, HPA075145" Enhanced Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA005449: AB_1078985, HPA075145: " "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (8.00e-3)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.47e-2)" "unprognostic (5.35e-2)" "unprognostic (4.18e-1)" "unprognostic (6.85e-2)" "unprognostic (3.77e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.44e-5)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (8.19e-3)" "unprognostic (8.61e-2)" 7.1 3.4 8.7 5.4 10.6 98.1 5.2 10.6 10.8 2.3 10.0 4.9 110.1 1.3 10.6 4.0 2.6 1.1 2.2 9.5 25.4 38.8 0.6 1.2 20.6 23.2 11.4 7.3 2.8 0.6 1.6 2.9 5.0 18.3 15.3 3.7 2.7 2.5 5.1 79.5 7.0 86.0 4.5 12.7 5.6 0.9 77.1 14.6 1.7 0.9 66.5 18.4 3.0 4.3 19.0 0.3 0.1 0.0 0.2 0.2 1.2 0.5 0.2 0.7 0.0 0.6 1.3 0.0 190.3 0.2 0.4 0.1 0.4 1.7 0.1 0.4 25.1 0.2 0.2 3.4 0.0 0.3 3.0 1.6 2.7 2.6 0.6 0.0 2.9 0.0 0.1 0.3 2.0 0.0 0.0 0.1 10.0 0.2 0.0 0.2 4.9 0.0 5.9 0.2 2.0 0.6 0.3 0.3 0.5 0.7 0.1 0.3 47.8 0.2 3.0 0.9 0.5 0.2 154.0 0.2 178.2 0.2 68.2 0.2 4.8 2.5 0.2 0.2 0.5 0.2 4.3 0.2 0.2 0.9 23.3 0.2 0.2 1.4 0.3 0.1 0.2 0.1 1.2 8.7 10.6 10.6 10.8 9.5 25.4 23.2 11.4 7.3 18.3 12.7 14.6 19.0 0.3 0.0 0.0 2.0 5.2 2.0 2.0 0.2 10.2 0.0 0.1 0.4 1.9 0.0 0.0 1.8 0.0 0.1 0.0 1.4 7.9 0.3 64.3 0.1 0.3 4.9 1.2 0.0 1.0 0.0 1.1 0.8 0.0 0.4 1.3 0.1 0.4 0.1 4.3 0.0 1.2 7.6 0.0 0.8 1.2 19.3 2.8 2.7 0.0 31.9 0.6 0.6 0.0 2.5 0.9 0.6 55.6 0.4 35.3 2.1 189.4 24.2 0.0 0.1 6.6 2.1 0.4 83.2 8.2 2.7 0.6 0.5 0.3 0.3 8.0 0.2 RERE "ARG, ARP, ATN1L, ATN2, DNB1, KIAA0458" ENSG00000142599 "Arginine-glutamic acid dipeptide repeats" Q9P2R6 1 8352397-8848921 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 373.9;Oligodendrocyte precursor cells: 392.0;Oligodendrocytes: 605.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 22.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024093 Uncertain NA NA "HPA024093: AB_1856177" "unprognostic (4.73e-2)" "unprognostic (4.31e-1)" "unprognostic (8.40e-2)" "unprognostic (2.61e-2)" "unprognostic (2.34e-1)" "unprognostic (2.50e-2)" "unprognostic (1.20e-3)" "unprognostic (1.04e-1)" "unprognostic (2.16e-2)" "unprognostic (5.94e-2)" "unprognostic (7.69e-2)" "unprognostic (2.25e-1)" "unprognostic (3.42e-3)" "unprognostic (2.51e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (7.46e-3)" 50.0 45.5 24.3 24.5 21.0 24.6 54.2 22.6 33.4 62.0 2.3 55.7 31.8 90.8 20.6 30.5 54.7 22.9 61.5 21.9 12.3 50.6 23.9 37.8 28.8 16.5 9.6 16.2 42.9 35.8 36.9 34.4 25.9 12.9 59.2 21.5 36.4 40.2 33.8 156.1 33.7 40.6 41.5 4.6 43.0 41.1 41.6 11.4 15.8 50.5 57.3 19.6 56.4 41.1 20.8 24.9 20.7 47.6 36.7 40.0 27.9 26.2 19.9 23.2 16.0 23.3 33.3 21.9 36.5 19.4 24.1 12.3 18.9 16.3 13.0 21.6 28.6 26.5 20.8 18.6 38.4 22.2 13.3 5.0 31.9 17.8 34.8 23.7 33.3 34.0 11.4 24.5 11.6 23.9 17.4 5.1 9.9 36.4 13.7 20.0 25.8 13.8 53.1 19.1 30.2 53.9 36.5 15.7 42.5 33.8 28.3 17.4 5.6 27.0 24.3 20.8 23.4 15.8 18.9 12.0 49.1 16.2 31.7 21.9 1.6 2.3 0.7 2.9 5.9 5.1 3.6 4.0 2.1 2.3 8.0 2.3 1.4 4.5 2.6 22.7 4.9 13.0 1.2 24.3 21.0 22.6 33.4 21.9 12.3 16.5 9.6 16.2 12.9 4.6 11.4 20.8 85.8 38.5 40.2 230.2 67.8 23.2 65.4 22.5 39.3 163.4 94.6 59.4 84.3 64.3 33.5 66.2 189.7 44.8 45.7 82.1 35.2 34.3 33.8 71.7 69.1 56.9 62.1 18.3 311.7 25.3 26.3 44.5 40.8 87.5 36.2 73.6 72.1 23.8 27.3 154.8 373.9 57.2 12.2 34.3 27.0 21.6 49.0 32.5 16.0 310.1 26.6 38.1 22.6 392.0 605.5 33.7 43.2 95.2 31.0 72.4 55.1 39.3 38.6 118.5 72.3 53.4 58.6 46.6 60.5 33.7 18.8 38.0 30.6 35.7 54.7 91.2 MMEL1 "MMEL2, NEPII, NL1, NL2, SEP" ENSG00000142606 "Membrane metalloendopeptidase like 1" Q495T6 1 2590639-2633016 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.8" "Cell type enhanced" "Detected in many" "Early spermatids: 131.2;Late spermatids: 36.1;Paneth cells: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007876, HPA008205, CAB020786" Uncertain "Intracellular and membrane" NA NA "CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011" "unprognostic (5.80e-2)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (4.27e-2)" "unprognostic (1.33e-1)" "unprognostic (2.71e-2)" "unprognostic (1.45e-1)" "unprognostic (7.96e-2)" "unprognostic (1.36e-2)" "unprognostic (2.37e-1)" "unprognostic (4.54e-3)" "unprognostic (2.44e-2)" "unprognostic (4.79e-2)" "unprognostic (3.18e-1)" "unprognostic (2.82e-1)" "unprognostic (2.18e-3)" "unprognostic (7.01e-4)" 2.1 1.4 0.7 0.0 0.6 0.0 3.0 0.5 0.9 2.4 0.3 2.5 2.6 0.7 0.9 4.8 2.9 0.0 0.4 0.4 0.8 2.3 0.5 2.8 0.0 0.8 0.9 0.4 0.4 2.0 0.6 0.7 0.0 0.9 6.6 0.3 0.1 1.6 0.3 0.2 0.6 4.3 0.0 0.9 2.5 8.3 24.8 0.9 0.0 1.1 0.0 0.0 3.1 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 14.2 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.0 4.7 0.3 2.6 0.2 0.4 1.0 0.4 0.7 0.0 2.7 1.3 0.6 1.8 3.6 0.1 4.2 1.7 0.7 0.6 0.5 0.9 0.4 0.8 0.8 0.9 0.4 0.9 0.9 0.9 0.8 5.9 0.0 0.0 0.3 0.4 0.0 5.2 5.2 1.2 0.0 10.3 8.9 1.1 20.0 10.2 18.4 0.0 0.0 0.3 12.1 0.0 9.4 131.2 7.1 0.5 2.3 1.2 2.5 0.1 3.4 0.0 1.3 8.6 7.3 0.0 0.0 1.4 0.2 1.2 0.0 0.2 16.5 2.0 1.0 0.2 36.1 1.8 2.4 0.0 0.0 0.9 0.5 0.0 0.5 0.0 4.0 54.9 1.2 0.2 6.7 20.8 0.1 8.8 0.2 0.0 0.0 0.6 0.6 1.1 0.6 0.0 0.0 0.8 0.4 9.7 12.6 CFAP74 "C1orf222, FLJ45476, KIAA1751" ENSG00000142609 "Cilia and flagella associated protein 74" Q9C0B2 1 1921951-2003837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.2;testis: 5.3" "Cell type enhanced" "Detected in many" "Early spermatids: 11.5;Endometrial ciliated cells: 36.0;Excitatory neurons: 11.6;Late spermatids: 20.3;Respiratory ciliated cells: 18.2;Spermatocytes: 16.4;Spermatogonia: 10.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028521, HPA029274, HPA030240" Enhanced NA NA "HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455" "unprognostic (5.41e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (9.12e-3)" "unprognostic (3.95e-2)" "unprognostic (2.21e-1)" "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.47e-1)" "unprognostic (1.26e-6)" "unprognostic (1.28e-1)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" 0.2 1.3 1.5 0.4 0.6 0.9 0.2 2.4 1.3 0.2 2.4 0.2 0.3 0.5 0.2 0.9 7.2 0.8 0.2 1.0 0.4 0.1 0.6 1.5 0.7 1.3 1.4 0.1 0.2 0.0 0.1 0.5 0.3 1.8 0.2 0.2 0.8 0.4 0.4 0.8 3.3 0.2 0.1 0.5 0.3 0.2 5.3 0.9 0.1 1.1 0.0 0.1 0.3 0.0 2.2 0.7 0.0 0.9 0.7 0.0 0.9 1.0 0.1 0.0 0.0 0.4 1.7 0.1 1.0 1.4 0.3 0.7 0.2 0.0 0.3 0.2 0.9 1.4 2.1 2.6 1.1 0.3 1.6 0.6 0.7 1.0 0.0 0.0 0.4 0.0 0.7 3.0 0.5 0.5 0.3 0.8 0.3 0.9 0.1 1.2 0.8 0.3 0.5 0.0 1.4 1.5 0.5 0.3 0.1 0.0 0.3 0.3 0.4 1.7 0.9 0.9 0.4 1.1 1.0 0.4 1.1 0.1 1.6 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 1.5 0.6 2.4 1.3 1.0 0.4 1.3 1.4 0.1 1.8 0.5 0.9 2.2 0.2 0.0 1.8 0.7 0.1 0.0 1.0 0.0 0.0 1.5 0.2 0.4 1.9 0.0 4.3 0.0 8.4 1.1 0.2 0.0 0.0 0.0 11.5 36.0 0.4 0.6 0.0 0.0 11.6 0.0 3.3 0.9 0.0 0.7 0.0 0.3 3.6 1.0 0.1 0.0 5.9 0.0 0.0 1.0 0.0 20.3 1.2 0.6 0.0 9.4 0.0 0.3 1.0 1.0 1.0 0.0 0.0 0.0 0.0 1.1 1.6 0.2 18.2 2.4 0.0 1.5 1.1 16.4 10.1 0.0 0.0 0.8 0.7 0.8 0.1 0.5 PRDM16 "KIAA1675, KMT8F, MEL1, MGC166915, PFM13" ENSG00000142611 "PR/SET domain 16" Q9HAZ2 1 3069168-3438621 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 13.4;stomach 1: 9.4" "Cell type enriched" "Detected in many" 4 "Astrocytes: 173.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 16 "NK-cell: 2.4" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5" "Region enriched" "Detected in many" 5 "basal ganglia: 15.7" "Low region specificity" "Detected in many" "HPA050343, HPA060467" Supported Nucleoplasm NA NA Nucleoplasm "HPA050343: AB_2681099, HPA060467: AB_2684287" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (5.31e-4)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (3.95e-2)" "unprognostic (9.15e-3)" "unprognostic (5.68e-4)" "unprognostic (2.58e-1)" "unprognostic (2.07e-2)" "unprognostic (5.21e-2)" "unprognostic (1.71e-1)" "unprognostic (7.80e-6)" "unprognostic (2.14e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (4.06e-2)" 1.3 0.2 3.2 0.5 4.5 0.0 1.1 0.0 4.0 1.3 13.4 1.0 7.5 1.0 2.1 0.3 1.4 1.1 3.3 2.8 1.1 3.8 0.2 2.5 0.5 1.5 1.0 0.4 1.5 5.8 0.9 0.6 0.1 2.8 0.8 0.2 0.0 0.4 2.2 0.5 0.4 2.7 0.2 0.0 2.2 9.4 0.7 3.8 0.1 8.1 0.6 0.3 0.9 1.1 2.5 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.0 0.2 0.0 0.2 0.0 1.3 0.0 0.0 0.1 1.8 0.0 0.0 0.3 2.0 0.0 0.7 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 3.2 4.5 0.0 4.0 2.8 1.1 1.5 1.0 0.4 2.8 0.0 3.8 2.5 4.5 35.3 10.5 173.7 0.1 0.6 0.3 2.1 0.6 0.1 0.2 0.3 5.2 22.8 6.3 7.3 0.0 0.0 0.1 0.2 5.9 10.0 0.3 0.2 0.0 2.1 5.4 0.8 1.2 4.9 4.2 0.6 30.5 0.4 0.0 0.3 0.0 0.0 0.0 1.7 1.0 0.9 0.0 0.0 0.4 0.2 1.5 0.1 0.0 14.0 0.0 1.4 0.0 6.6 1.8 7.1 0.8 1.9 0.1 0.8 0.5 0.2 1.9 0.3 0.0 3.3 9.0 0.3 1.8 0.2 0.0 0.0 0.4 0.0 1.5 0.2 CELA2A ELA2A ENSG00000142615 "Chymotrypsin like elastase 2A" P08217 1 15456728-15472091 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2323 "pancreas: 164113.1" "Cell type enriched" "Detected in some" 34 "Exocrine glandular cells: 7828.2" "Cancer enriched" "Detected in single" 3818 "pancreatic cancer: 463.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.2" "Secreted to digestive system" NA NA 2700000 "unprognostic (9.78e-2)" "unprognostic (3.33e-2)" "unprognostic (5.60e-2)" "unprognostic (5.27e-2)" "unprognostic (3.63e-3)" "unprognostic (2.35e-1)" "unprognostic (4.14e-1)" "unprognostic (1.96e-2)" "unprognostic (1.38e-1)" "unprognostic (2.48e-1)" "unprognostic (3.94e-9)" "unprognostic (4.10e-2)" "unprognostic (3.42e-1)" "unprognostic (3.55e-2)" 7.1 5.6 0.2 2.6 0.0 1.1 4.5 0.2 0.1 2.3 0.0 1.6 18.7 2.1 0.0 2.3 1.1 0.0 27.1 0.0 0.0 1.6 5.8 1.2 4.3 0.0 0.0 0.0 70.6 164113.1 0.0 1.3 10.3 0.0 2.8 0.0 0.0 28.2 0.0 1.6 1.8 8.8 0.0 0.0 2.3 15.5 2.0 0.0 0.0 1.1 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.8 0.1 0.3 0.3 0.3 0.0 0.0 1.1 7828.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 20.7 0.0 0.0 0.0 0.1 227.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 17.2;urinary bladder: 25.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9" "Cancer enriched" "Detected in many" 4 "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 14.0;RT4: 17.4;T-47d: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 17.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.9 3.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 25.8 3.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 14.0 0.0 1.4 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 17.4 0.0 0.0 0.0 2.5 0.1 0.1 12.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 7.9 FHAD1 KIAA1937 ENSG00000142621 "Forkhead associated phosphopeptide binding domain 1" B1AJZ9 1 15247272-15400283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 11.5;fallopian tube: 15.3;testis: 13.5" "Group enriched" "Detected in many" 7 "Early spermatids: 234.4;Endometrial ciliated cells: 179.0;Late spermatids: 244.9;Respiratory ciliated cells: 265.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 29.5;HMC-1: 80.4;K-562: 18.5;U-87 MG: 42.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054284 Enhanced NA NA "HPA054284: AB_2682436" "unprognostic (3.18e-2)" "unprognostic (1.12e-3)" "unprognostic (2.36e-3)" "unprognostic (2.15e-2)" "unprognostic (5.55e-2)" "unprognostic (8.32e-2)" "unprognostic (2.46e-1)" "unprognostic (2.06e-2)" "unprognostic (1.04e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.40e-1)" "unprognostic (1.17e-3)" "unprognostic (2.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.83e-1)" "unprognostic (1.04e-3)" 0.4 0.2 4.3 0.7 1.2 0.0 1.0 1.8 1.7 2.1 11.5 0.3 0.9 0.5 1.8 0.1 15.3 0.5 0.1 1.2 4.3 0.4 0.3 3.5 0.2 2.8 4.2 0.0 0.3 0.7 0.9 0.6 0.4 4.2 0.3 0.3 0.1 0.5 0.6 0.0 0.2 1.0 0.3 3.5 0.1 2.2 13.5 2.8 0.1 1.2 0.0 0.2 0.8 0.2 1.5 2.1 0.5 1.7 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.2 1.1 5.6 0.8 0.3 0.2 0.5 0.2 0.0 0.3 29.5 0.2 0.1 0.0 0.0 0.5 2.5 80.4 0.8 0.0 0.3 0.0 0.1 0.0 0.0 18.5 0.0 0.0 0.3 0.3 0.3 0.1 0.3 0.9 0.0 0.5 0.0 0.1 0.1 0.7 0.6 0.0 0.1 0.5 0.1 0.1 0.5 0.0 7.1 0.2 8.3 0.1 0.0 10.0 0.0 42.9 0.1 0.3 0.0 0.4 0.0 0.9 0.2 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.1 4.3 1.2 1.8 1.7 1.2 4.3 2.8 4.2 0.0 4.2 3.5 2.8 1.5 0.4 0.0 2.2 2.6 0.1 0.1 0.8 4.4 0.0 0.4 0.3 0.6 1.9 4.3 29.0 0.0 0.0 0.0 0.3 0.4 0.0 2.0 234.4 179.0 2.1 1.5 1.8 0.0 4.7 1.4 0.0 2.4 7.7 13.5 0.0 0.5 0.0 0.0 2.6 3.3 2.4 1.2 6.1 1.3 1.7 244.9 2.1 2.6 0.0 1.9 0.1 0.2 0.0 1.0 1.3 0.8 1.1 0.0 0.0 0.4 0.7 0.6 265.6 0.0 13.1 0.2 2.6 14.9 9.5 0.0 0.0 0.1 0.3 0.3 0.6 1.7 PADI1 "HPAD10, PAD1, PDI, PDI1" ENSG00000142623 "Peptidyl arginine deiminase 1" Q9ULC6 1 17205128-17246007 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "esophagus: 110.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.8;Extravillous trophoblasts: 14.0;Squamous epithelial cells: 5.6;Urothelial cells: 22.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 13.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.2;EFO-21: 2.1;HaCaT: 1.5;RPTEC TERT1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA062294 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA062294: AB_2684741" "unprognostic (9.30e-2)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.40e-1)" "unprognostic (5.22e-2)" "unprognostic (7.27e-2)" "unprognostic (3.84e-1)" "unprognostic (3.37e-2)" "unprognostic (1.41e-1)" "unprognostic (7.75e-2)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "prognostic unfavorable (8.34e-11)" "unprognostic (2.00e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 110.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.1 0.2 0.0 0.0 11.6 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.4 1.4 18.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 4.2 0.0 2.1 0.1 0.1 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.6 0.9 0.0 0.0 14.8 0.0 3.9 0.0 0.0 0.2 0.0 0.6 0.0 0.6 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 14.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.8 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.2 0.1 5.6 0.0 0.7 0.0 0.1 0.6 22.5 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156069 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 149.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 202.3;Glandular and luminal cells: 182.9;Squamous epithelial cells: 156.3;Suprabasal keratinocytes: 248.3;Urothelial cells: 200.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 94 "plasmacytoid DC: 9.4" "Lineage enriched" "Detected in single" 94 "dendritic cells: 9.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 201.1;PC-3: 229.0;U-251 MG: 242.1;WM-115: 258.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" NA Yes 12000 "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 17.8 9.6 3.5 4.8 2.8 0.3 14.7 2.7 3.8 23.6 9.9 11.3 10.1 12.2 1.3 149.0 13.6 28.5 15.0 2.8 4.5 15.2 19.1 18.1 7.7 3.5 3.4 1.8 5.9 23.4 3.7 7.5 14.1 3.3 11.3 5.9 6.5 68.3 4.3 4.6 37.1 12.9 3.8 3.1 7.7 15.8 1.8 4.2 3.2 15.3 5.1 11.2 56.6 59.3 3.6 76.9 151.7 41.4 20.1 2.9 3.5 24.3 45.2 63.4 79.9 50.6 63.9 201.1 0.1 189.8 25.9 98.8 30.6 9.9 104.4 27.6 0.4 7.0 0.0 46.7 41.1 51.3 0.1 0.2 4.8 38.1 43.7 95.6 125.0 86.4 0.0 0.3 0.1 51.6 24.3 0.0 0.0 20.0 57.2 229.0 0.1 37.6 0.2 85.1 39.0 0.1 6.4 87.8 21.2 6.1 21.3 3.0 0.9 108.1 28.5 76.7 2.0 242.1 0.0 0.5 0.6 22.0 0.1 258.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 3.5 2.8 2.7 3.8 2.8 4.5 3.5 3.4 1.8 3.3 3.1 4.2 3.6 17.1 54.5 38.4 2.0 1.2 202.3 114.3 110.9 66.0 2.7 39.5 43.9 6.5 44.3 113.4 9.2 4.2 9.7 8.9 96.8 0.0 33.8 5.8 104.5 19.2 26.3 3.0 0.0 0.1 14.2 1.2 5.8 68.3 182.9 5.7 0.4 29.3 23.3 1.9 0.0 0.2 42.0 34.6 1.6 17.0 0.2 3.4 3.7 26.6 4.7 1.1 7.1 0.0 0.0 0.0 104.6 111.7 0.0 0.0 60.8 22.4 1.8 89.8 2.5 32.9 11.6 21.2 0.2 0.8 156.3 248.3 7.5 2.6 0.4 42.9 200.4 ARHGEF19 "FLJ33962, WGEF" ENSG00000142632 "Rho guanine nucleotide exchange factor 19" Q8IW93 1 16197854-16212652 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 17.6;HaCaT: 14.4;T-47d: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068108 Approved "Nuclear bodies" No No "Nuclear bodies" "HPA068108: AB_2685956" "unprognostic (2.19e-2)" "unprognostic (1.85e-3)" "unprognostic (1.33e-1)" "unprognostic (3.52e-2)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (9.45e-2)" "prognostic favorable (6.53e-4)" "unprognostic (4.01e-2)" "unprognostic (2.43e-2)" "unprognostic (2.07e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (8.88e-5)" "unprognostic (3.72e-2)" "unprognostic (2.84e-1)" "unprognostic (1.26e-1)" "unprognostic (1.80e-1)" 2.8 10.2 0.7 2.8 0.7 0.9 5.0 0.6 1.3 7.6 0.7 2.5 2.3 6.0 1.1 16.0 6.4 2.1 1.9 0.6 0.9 2.6 1.5 3.2 1.6 0.8 0.7 0.5 6.9 7.9 2.2 1.8 3.1 0.8 8.4 0.9 0.2 17.4 4.5 0.8 22.7 3.0 1.5 0.6 2.8 6.2 1.5 0.7 1.9 12.1 0.4 2.3 6.1 11.5 0.9 17.6 4.6 2.4 4.9 0.3 1.4 0.9 4.3 4.1 2.4 3.3 6.9 2.7 0.0 3.4 3.9 1.8 14.4 1.0 1.6 0.6 2.9 0.4 1.4 11.7 0.5 5.7 0.8 5.6 4.4 0.9 6.3 1.8 0.5 0.7 5.5 3.2 3.8 1.0 3.7 2.0 2.0 0.7 2.5 4.9 6.8 2.2 4.1 0.9 1.3 1.7 2.9 3.3 2.0 0.8 0.2 25.7 2.9 1.8 0.0 7.6 3.9 0.0 4.1 6.7 1.0 0.0 4.3 6.6 0.0 0.5 0.4 0.9 0.2 0.9 0.7 0.8 0.7 0.6 0.5 0.8 0.4 0.0 0.8 0.0 0.6 0.5 0.5 0.7 0.7 0.6 1.3 0.6 0.9 0.8 0.7 0.5 0.8 0.6 0.7 0.9 6.1 6.4 6.0 1.3 3.9 4.7 9.3 8.8 14.2 0.5 8.6 8.0 0.5 2.8 8.8 0.0 0.0 1.7 6.5 3.8 0.0 5.7 0.2 7.0 4.5 4.6 0.0 4.2 0.0 5.7 4.9 4.5 3.6 7.8 9.5 2.1 7.5 1.0 2.6 0.0 0.1 5.2 8.2 4.4 1.4 0.0 7.8 1.9 3.6 2.8 2.4 5.3 7.2 1.0 0.0 4.7 5.2 3.4 3.1 2.3 2.5 1.6 4.0 0.3 0.0 4.7 3.9 1.8 6.8 10.7 7.7 1.2 5.4 3.0 4.7 6.4 EFHD2 MGC4342 ENSG00000142634 "EF-hand domain family member D2" Q96C19 1 15409888-15430339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 372.4;NK-cells: 416.1;Pancreatic endocrine cells: 481.2;Urothelial cells: 431.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 133.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 370.3" "Low region specificity" "Detected in all" HPA048961 Enhanced Approved Cytosol No No 220000 Cytosol "HPA048961: AB_2680572" "unprognostic (1.37e-3)" "unprognostic (3.69e-1)" "unprognostic (7.83e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (9.11e-2)" "unprognostic (9.61e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.31e-9)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "prognostic favorable (2.70e-4)" "prognostic favorable (3.60e-5)" 35.9 79.5 36.8 78.4 53.9 175.8 27.8 29.0 77.5 32.3 18.8 62.4 84.1 34.0 5.9 59.2 29.6 33.2 23.0 73.9 31.8 21.9 33.6 60.5 46.6 91.0 47.7 45.2 27.1 76.3 10.8 28.8 21.6 101.4 45.0 29.9 2.7 27.5 19.2 6.4 33.1 97.2 17.5 24.5 141.1 92.9 96.0 29.9 25.4 42.0 4.9 29.7 63.2 40.9 65.6 370.3 91.8 8.8 23.8 14.1 30.0 46.8 46.0 43.4 42.7 40.5 35.5 98.8 79.6 141.6 32.1 54.8 88.1 24.5 80.9 27.0 99.8 47.8 19.1 21.6 57.4 22.5 98.1 160.1 23.9 27.2 87.0 21.9 19.9 55.5 35.5 46.4 37.6 26.6 36.8 50.8 188.6 11.6 50.1 112.9 67.2 82.1 63.4 25.3 76.2 20.1 15.6 40.5 34.3 76.8 6.9 15.1 104.8 105.4 62.5 66.9 196.7 74.8 25.4 63.8 34.9 87.4 193.2 86.8 16.3 33.8 52.5 44.0 34.4 12.7 3.9 9.8 20.9 29.5 4.2 4.6 18.0 133.2 28.5 30.0 10.3 7.6 17.0 36.8 53.9 29.0 77.5 73.9 31.8 91.0 47.7 45.2 101.4 24.5 29.9 65.6 54.2 3.2 12.2 5.9 44.1 66.2 123.7 25.2 26.7 1.8 21.3 23.0 7.2 32.9 24.4 22.0 10.4 23.7 372.4 280.0 19.6 69.6 93.6 55.4 28.8 52.6 61.7 28.0 33.9 259.4 222.8 31.1 157.0 69.4 44.5 49.4 23.6 20.9 219.3 0.0 21.9 160.8 24.4 217.1 188.2 221.2 9.9 246.9 23.2 13.1 171.3 4.9 416.1 0.5 3.7 481.2 190.5 6.8 62.9 112.2 305.8 28.1 25.7 5.0 46.0 26.7 28.5 5.4 5.7 48.9 68.5 53.4 120.1 178.3 117.8 431.4 PEX14 ENSG00000142655 "Peroxisomal biogenesis factor 14" O75381 1 10472288-10630758 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 67.3;Syncytiotrophoblasts: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046104, HPA049231" Supported Supported "Nucleoli fibrillar center,Peroxisomes" NA NA Peroxisomes "Nucleoli fibrillar center" "HPA046104: AB_2679539, HPA049231: AB_2680683" "unprognostic (7.23e-3)" "unprognostic (7.93e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-2)" "unprognostic (3.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (5.32e-2)" "unprognostic (2.32e-1)" "unprognostic (5.85e-2)" "unprognostic (1.31e-1)" "unprognostic (3.05e-3)" "unprognostic (9.67e-3)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (3.75e-2)" 15.6 14.0 12.2 9.5 13.5 7.8 16.4 10.0 22.0 15.4 8.2 15.6 15.3 17.3 6.5 21.1 13.8 9.4 18.4 13.5 12.9 15.8 33.2 14.5 10.6 12.4 11.6 13.0 15.0 11.3 11.9 14.2 11.9 13.5 26.6 8.3 28.4 16.9 24.0 22.8 18.6 16.3 8.6 9.5 12.7 13.9 14.1 11.8 9.8 14.2 11.4 8.7 49.2 17.7 14.1 22.5 21.1 17.2 19.2 12.3 11.6 11.2 25.2 20.8 27.4 26.1 22.4 40.1 16.4 24.9 19.4 16.3 26.3 17.9 24.6 12.9 23.1 30.3 20.4 22.6 31.2 18.8 23.0 27.3 14.2 19.2 20.7 19.0 16.3 17.9 21.2 32.2 16.3 12.4 18.7 21.9 30.4 17.7 17.2 24.6 23.5 14.5 23.3 21.7 14.8 20.5 23.5 24.4 20.2 23.9 13.2 18.4 16.2 17.7 19.9 21.5 19.6 22.0 23.3 20.4 32.3 21.8 31.2 21.7 1.4 2.2 4.6 4.5 1.6 2.8 2.2 2.3 3.4 2.7 2.0 2.9 2.8 0.3 2.6 1.5 2.8 3.0 2.4 12.2 13.5 10.0 22.0 13.5 12.9 12.4 11.6 13.0 13.5 9.5 11.8 14.1 5.9 9.6 2.0 32.0 9.2 7.1 13.9 29.2 4.0 15.1 8.3 6.9 8.4 4.3 12.3 9.2 27.1 49.7 11.3 14.1 7.9 17.2 5.9 10.6 4.9 7.8 9.0 4.6 42.0 14.7 18.7 8.1 4.1 7.4 6.3 7.8 8.2 51.1 22.7 18.5 48.4 9.7 14.2 9.0 3.1 3.1 8.1 8.0 12.4 28.1 19.9 21.2 10.3 29.7 29.9 18.2 12.3 5.7 14.7 10.8 29.7 18.5 23.5 67.3 6.6 4.5 11.0 7.1 12.8 7.1 8.1 64.7 9.8 8.3 12.0 13.5 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420511 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 404.0;esophagus: 577.0" "Cell type enhanced" "Detected in all" "monocytes: 214.9;Squamous epithelial cells: 496.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6" "Group enriched" "Detected in all" 5 "granulocytes: 1074.7;monocytes: 321.0" "Cell line enhanced" "Detected in all" "A549: 1445.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" No No 41000000 "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 115.6 51.4 49.0 60.4 48.7 404.0 89.8 53.9 49.7 49.8 52.1 53.4 92.4 23.3 42.3 577.0 30.3 95.0 33.5 48.3 57.6 53.1 82.0 89.3 38.4 57.2 53.1 43.4 36.0 32.3 53.1 44.1 47.8 53.4 30.7 46.8 49.5 134.7 23.1 35.0 48.4 71.3 35.3 48.8 111.3 61.9 68.8 56.9 54.0 72.5 28.5 74.4 62.3 127.9 62.1 191.5 1445.2 319.3 340.6 445.4 274.0 71.8 124.8 185.9 144.4 195.3 219.2 190.4 163.5 151.0 109.2 202.4 148.0 225.6 192.1 96.4 127.5 199.9 227.8 264.3 452.1 136.3 390.9 249.7 196.5 92.2 229.4 55.5 186.9 344.0 223.0 305.3 145.7 183.5 202.5 321.4 179.4 194.7 221.0 109.1 252.7 298.1 312.2 199.6 105.5 178.0 154.1 99.1 153.5 137.5 196.7 173.3 308.5 369.3 81.1 149.6 98.3 134.5 111.6 256.0 323.5 175.1 393.9 73.6 1060.2 321.0 1074.7 23.2 137.7 26.5 33.1 21.4 20.8 144.6 23.3 21.1 22.3 332.6 19.7 105.6 98.7 23.1 225.0 49.0 48.7 53.9 49.7 48.3 57.6 57.2 53.1 43.4 53.4 48.8 56.9 62.1 7.4 19.2 35.0 11.8 24.9 13.0 30.8 78.0 70.6 7.8 30.4 18.5 11.0 50.1 73.2 20.2 18.8 134.6 29.8 24.3 52.8 52.1 10.9 17.8 18.6 22.6 23.4 55.7 8.6 40.3 40.7 37.5 41.8 24.5 25.9 53.9 16.1 66.2 134.6 1.7 12.6 30.2 59.0 163.8 30.9 13.4 17.1 150.9 17.8 4.7 214.9 16.5 10.3 13.6 9.0 38.7 26.7 10.5 41.9 43.5 66.6 55.1 46.2 20.2 19.7 23.4 21.5 41.5 38.4 496.0 16.6 81.3 19.4 27.3 51.7 76.1 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 177.1;skeletal muscle: 324.2;tongue: 258.1" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 198.3" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 4.6;Hep G2: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" Yes No 830000 Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 0.4 0.2 0.0 0.2 0.1 0.0 0.7 0.2 0.3 0.2 0.4 0.5 1.1 0.3 0.0 6.1 0.9 0.4 177.1 0.1 0.1 31.7 0.2 0.3 0.1 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 4.6 0.7 1.2 7.1 0.0 324.2 2.0 5.2 0.2 0.0 0.0 0.2 9.0 0.1 1.7 0.3 258.1 0.1 0.1 0.4 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.3 0.0 1.9 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 18.1 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.1 1.0 0.2 0.5 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.6 0.2 0.1 0.6 0.0 0.1 0.6 198.3 0.0 0.0 3.7 0.0 0.0 0.1 3.6 1.9 0.1 16.2 0.4 0.0 1.6 1.2 0.0 0.4 0.4 0.0 6.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.7 10.3 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.5 2.4 0.0 0.0 0.2 13.0 33.2 0.0 2.5 6.6 10.0 1.3 0.0 0.2 0.0 0.6 0.0 0.3 2.3 2.2 0.3 SH3BGRL3 ENSG00000142669 "SH3 domain binding glutamate rich protein like 3" Q9H299 1 26280086-26281522 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030848, HPA076219" Enhanced Approved "Nuclear bodies" NA NA 41000000 "Nuclear bodies" "HPA030848: AB_10602398, HPA076219: AB_2686787" "unprognostic (4.97e-2)" "unprognostic (9.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.73e-3)" "unprognostic (4.95e-2)" "unprognostic (8.68e-2)" "unprognostic (4.29e-3)" "unprognostic (3.16e-1)" "unprognostic (3.62e-2)" "unprognostic (4.32e-1)" "unprognostic (1.98e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.17e-10)" "unprognostic (1.66e-1)" "unprognostic (1.59e-1)" "unprognostic (6.35e-2)" "unprognostic (4.43e-2)" 223.9 102.9 287.9 426.8 293.0 535.0 143.1 297.0 383.1 136.7 276.1 420.3 163.4 86.5 714.4 371.6 102.3 179.0 117.3 291.7 311.8 116.7 122.6 292.1 407.7 304.4 306.0 279.5 67.3 158.8 86.2 83.8 156.6 307.0 83.2 442.2 32.5 140.8 113.3 48.1 308.4 166.1 204.4 302.3 315.8 225.2 26.5 320.9 309.5 83.6 81.7 440.6 428.6 177.8 357.1 501.1 274.9 187.5 265.7 769.3 2090.9 23.2 895.6 1315.0 959.2 611.0 220.3 460.4 120.8 297.9 1963.3 268.2 182.6 108.9 1030.2 642.6 192.0 109.3 976.3 212.1 213.3 604.8 280.1 1447.9 836.8 652.4 912.9 742.0 1115.0 1200.3 244.7 112.2 430.6 1767.3 337.8 182.1 478.2 221.6 434.8 2003.4 341.1 229.0 170.5 762.6 216.7 119.7 189.8 331.2 338.1 374.1 199.3 65.7 431.9 1451.5 1071.0 370.8 1492.9 402.3 135.7 241.6 104.0 2253.9 792.3 532.5 4277.3 7085.6 6427.9 4340.1 6247.2 3228.5 2422.2 3706.5 4249.4 5891.3 2181.2 1591.2 3072.9 7753.8 2344.8 6190.5 3152.1 5092.0 13045.6 287.9 293.0 297.0 383.1 291.7 311.8 304.4 306.0 279.5 307.0 302.3 320.9 357.1 445.2 96.1 168.0 9.8 603.5 984.1 995.1 708.3 373.9 17.1 216.7 227.1 7.8 193.0 290.5 367.8 4.2 133.1 1060.9 1614.6 313.1 1108.5 15.8 178.9 410.9 502.9 339.8 220.0 12.9 1031.5 436.1 493.8 388.4 344.0 1017.6 67.2 346.6 121.7 2516.1 16.8 8.2 1430.3 205.4 1796.4 2368.4 52.8 139.1 2209.6 779.1 16.9 1116.8 76.9 1251.3 4.0 20.2 2492.4 1309.6 162.1 397.9 1754.9 391.7 498.6 202.8 16.4 151.2 71.9 336.4 9.1 23.5 788.1 1058.7 227.1 1380.4 99.2 507.5 2342.3 CNKSR1 "CNK, CNK1, KSR" ENSG00000142675 "Connector enhancer of kinase suppressor of Ras 1" Q969H4 1 26177484-26189884 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 57.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 18.6;BEWO: 16.0;CAPAN-2: 29.1;HaCaT: 20.3;hTCEpi: 17.2;OE19: 15.9;SK-BR-3: 20.8;T-47d: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA030847 Uncertain Approved Cytosol NA NA Cytosol "HPA030847: AB_10601100" "unprognostic (2.73e-3)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.15e-1)" "unprognostic (1.61e-2)" "unprognostic (5.26e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-1)" "unprognostic (2.49e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-2)" "unprognostic (3.27e-2)" "unprognostic (2.91e-1)" "prognostic favorable (5.91e-4)" 0.6 0.1 3.1 2.6 3.5 0.3 6.1 4.7 4.7 5.4 1.7 9.2 12.0 2.5 8.2 18.9 8.3 3.6 1.2 3.3 2.9 5.9 1.6 7.3 1.5 3.6 3.3 3.1 3.3 13.5 11.8 9.7 4.8 3.7 10.4 7.5 0.9 15.7 6.6 57.7 16.8 11.5 0.8 2.8 2.4 10.5 2.4 3.2 1.1 16.8 14.4 2.9 5.5 9.0 4.4 18.6 0.0 0.3 0.2 0.3 0.0 16.0 0.3 0.0 0.2 0.0 2.9 29.1 2.0 9.1 0.0 0.2 20.3 0.5 13.0 0.4 0.0 0.9 0.4 7.4 9.2 0.1 0.2 0.3 0.0 17.2 0.0 5.0 0.0 0.0 0.6 2.2 0.1 0.0 8.4 0.2 1.5 7.7 15.9 1.7 0.2 0.2 0.0 1.9 10.7 3.5 0.9 0.1 20.8 0.3 6.9 16.7 0.0 0.0 0.0 2.4 1.0 0.2 5.8 1.1 0.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 3.1 3.5 4.7 4.7 3.3 2.9 3.6 3.3 3.1 3.7 2.8 3.2 4.4 1.6 16.0 7.2 3.6 3.1 14.7 16.9 36.6 17.6 2.8 22.9 20.2 1.1 17.2 21.2 35.0 2.1 34.2 0.5 26.7 1.9 12.3 1.1 15.9 2.8 1.9 18.6 0.0 3.3 12.4 13.7 1.3 34.7 25.9 0.0 1.8 0.7 0.2 2.8 0.0 3.7 20.0 28.5 0.0 1.2 0.8 1.2 0.8 1.8 0.0 1.4 0.7 0.0 0.5 5.1 25.0 29.9 0.7 14.3 15.7 28.4 0.5 33.1 2.9 0.0 3.6 3.3 2.4 4.2 20.2 11.4 32.4 1.1 0.1 20.0 26.6 RPL11 "L11, uL5" ENSG00000142676 "Ribosomal protein L11" P62913 1 23691742-23696835 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA002734 Approved NA NA 420000 "HPA002734: AB_1079838" "prognostic favorable (2.55e-4)" "unprognostic (3.98e-2)" "unprognostic (7.77e-2)" "unprognostic (3.30e-2)" "unprognostic (1.21e-1)" "unprognostic (6.70e-2)" "unprognostic (4.51e-3)" "unprognostic (4.94e-2)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (5.93e-6)" "unprognostic (8.65e-2)" "unprognostic (2.42e-3)" "unprognostic (5.41e-2)" "unprognostic (1.90e-1)" 2212.3 1360.2 762.8 349.5 776.6 813.7 2394.8 759.5 1083.0 2393.7 760.4 1684.0 320.7 1564.6 1117.3 2060.0 2001.5 267.4 1392.9 731.9 789.5 1551.3 1459.8 1475.4 707.5 795.7 759.8 706.9 3912.2 3234.8 642.9 1153.6 511.7 793.9 1804.1 995.4 390.1 1777.6 651.5 1538.6 2649.9 1729.5 695.7 797.2 1964.9 2333.0 463.8 789.1 1230.3 1426.5 888.2 1857.3 1731.6 2108.2 813.0 662.3 1068.4 1257.9 639.1 2123.4 2978.6 437.2 431.4 1845.0 1641.4 1217.1 1937.6 719.7 1370.3 470.9 1511.4 665.7 543.3 1611.2 2187.0 1824.5 492.7 2157.9 633.6 3936.3 2610.9 1589.8 1086.5 499.1 2928.6 3156.8 1394.3 2498.9 2009.5 1767.1 2371.5 747.4 713.2 1768.6 2068.0 650.7 1737.1 313.0 2165.7 1216.9 800.7 608.8 1319.0 1877.2 1173.3 491.0 601.2 337.3 697.8 1360.9 1083.0 514.3 1352.0 524.4 391.2 546.3 672.8 554.2 658.6 643.2 968.8 499.0 1529.0 458.4 1028.5 1455.4 431.6 1270.6 1217.3 2184.9 3261.3 2593.8 1881.3 1736.4 2812.9 3379.5 2575.7 211.5 1567.3 990.9 1725.9 2092.7 5471.7 762.8 776.6 759.5 1083.0 731.9 789.5 795.7 759.8 706.9 793.9 797.2 789.1 813.0 3418.4 1179.5 2275.5 43.8 6392.9 6628.5 7570.4 5085.6 5306.4 352.5 7418.2 12717.3 617.0 3247.0 2566.9 1125.5 154.3 4728.5 4068.6 1693.1 4807.1 2915.5 1052.2 1501.4 3771.6 3056.2 2161.7 2833.3 27.2 6657.0 7929.6 2968.4 2193.7 2008.2 2101.5 4064.4 3524.6 3426.2 3894.7 206.9 29.6 3865.1 1462.8 4584.6 6984.2 2224.6 4602.4 3661.8 3758.4 46.9 5264.1 1582.9 3300.8 24.1 64.1 4149.5 3575.9 2083.0 3334.0 6327.0 4545.4 5429.1 1260.7 664.2 1413.4 3920.1 3380.5 604.1 699.6 6295.1 7993.4 4651.9 5029.1 4961.7 4420.7 7534.5 IL22RA1 "CRF2-9, IL22R" ENSG00000142677 "Interleukin 22 receptor subunit alpha 1" Q8N6P7 1 24119771-24143140 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 201.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 34.8;Exocrine glandular cells: 12.0;Pancreatic endocrine cells: 11.3;Paneth cells: 33.4;Proximal enterocytes: 44.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 11.3;Hep G2: 8.1;OE19: 18.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.68e-3)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-3)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (7.63e-2)" "unprognostic (1.72e-3)" "unprognostic (2.28e-1)" "unprognostic (4.78e-3)" "unprognostic (1.05e-2)" "unprognostic (2.57e-1)" "unprognostic (2.63e-1)" "unprognostic (1.64e-2)" 0.5 0.4 0.0 1.2 0.1 0.0 2.0 0.4 0.3 1.9 0.1 11.5 20.2 0.2 0.1 17.9 1.5 2.6 0.3 0.5 0.1 2.0 7.0 0.8 0.0 0.1 0.1 0.0 0.3 201.0 0.0 2.1 0.1 0.2 0.7 10.1 0.2 3.0 0.4 0.4 38.2 28.5 0.4 0.1 0.0 3.6 0.4 0.0 0.0 2.3 0.0 2.4 0.3 7.1 0.1 2.9 2.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 1.3 1.5 11.3 4.8 0.0 0.9 0.3 4.7 5.0 0.6 3.0 0.4 3.7 0.0 0.0 1.4 8.1 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.1 0.1 18.7 1.0 0.0 0.0 0.1 0.0 0.6 0.1 0.1 1.4 0.0 1.6 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 4.2 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.7 2.8 0.0 0.1 0.3 0.3 1.5 0.2 0.0 0.0 0.0 0.0 34.8 0.0 1.1 0.3 0.5 0.1 0.0 0.0 0.0 0.2 12.0 0.0 0.3 3.6 0.5 0.0 0.5 0.0 5.8 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.4 0.0 0.0 0.1 11.3 33.4 0.0 0.0 0.2 44.0 1.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.3 1.1 0.0 0.0 0.0 7.0 0.2 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169908-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054363: AB_2682462, HPA059387: AB_2684001" "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 29.2 32.1 19.8 12.8 20.2 20.5 31.0 20.9 25.7 17.2 19.8 23.3 13.2 22.9 6.6 32.7 23.2 6.2 33.9 19.6 20.5 39.9 64.4 22.0 10.2 21.2 20.7 19.3 32.4 62.0 16.6 25.9 9.4 21.9 31.6 6.3 2.6 24.5 7.6 102.1 30.1 21.3 7.0 20.2 28.4 39.3 16.5 21.2 4.7 28.2 22.1 8.4 25.8 20.9 22.2 76.0 41.3 13.1 48.4 13.3 17.3 72.2 32.8 16.5 37.3 36.3 62.8 44.4 87.2 58.9 21.0 29.7 48.3 47.2 43.5 13.5 53.1 150.6 59.6 33.6 98.3 56.6 82.5 50.0 31.4 41.8 41.8 43.7 15.5 32.3 20.6 91.4 32.7 23.1 58.1 34.1 154.7 53.0 72.7 143.0 42.0 23.6 89.8 27.7 32.8 35.7 39.4 39.8 98.4 132.1 10.7 41.0 46.3 33.6 35.7 42.0 75.8 62.4 64.1 71.3 97.2 42.2 171.1 46.9 0.5 41.3 0.6 35.6 69.1 33.0 64.2 48.7 34.9 57.5 63.3 36.1 34.6 1.9 44.6 70.9 70.4 58.4 39.3 19.8 20.2 20.9 25.7 19.6 20.5 21.2 20.7 19.3 21.9 20.2 21.2 22.2 38.9 12.8 57.9 2.6 56.8 171.3 180.9 67.7 128.1 18.0 116.1 142.0 6.0 88.6 50.6 60.7 2.1 114.5 29.8 86.1 103.7 102.2 6.7 70.7 62.6 45.1 109.8 26.5 2.5 147.0 158.5 49.7 75.4 83.4 50.9 62.2 40.7 201.5 79.4 3.3 3.2 156.7 36.7 59.9 52.3 14.3 32.3 37.3 49.8 0.0 47.2 20.9 21.6 2.0 2.1 130.8 61.6 23.3 94.9 197.2 71.7 218.0 27.8 16.7 13.1 65.1 57.7 39.0 52.2 111.6 168.4 222.6 28.8 68.0 128.4 185.3 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713877-35718894 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.8" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: AB_2673834" "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavorable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 10.6 10.7 37.8 6.2 43.7 4.6 7.7 29.9 51.8 10.5 21.5 13.5 3.5 13.4 11.4 5.6 9.2 7.7 11.5 48.0 43.4 4.4 5.3 10.0 7.3 36.3 34.5 44.4 8.3 4.4 7.1 9.4 4.7 41.1 8.7 5.3 29.1 5.3 10.0 15.7 7.7 7.9 16.1 32.4 8.9 7.2 9.9 37.0 4.8 6.1 14.9 7.0 10.8 7.9 45.9 7.7 17.6 8.6 12.5 43.5 31.7 6.3 21.1 25.9 31.9 30.3 10.7 16.3 8.3 15.2 32.5 26.0 7.1 24.1 14.6 27.5 31.4 10.3 57.8 27.6 2.9 16.5 28.1 36.6 32.9 18.2 22.8 7.4 23.6 21.2 6.3 23.4 25.6 34.9 12.9 10.5 24.8 13.6 8.4 14.9 7.0 11.5 8.2 11.0 9.0 12.7 12.4 20.3 4.1 44.1 5.3 8.2 12.6 24.8 25.6 19.5 19.0 22.2 7.6 20.3 6.0 25.6 27.6 40.9 0.0 2.7 0.1 4.3 2.8 1.3 2.0 3.3 5.3 2.5 1.5 0.8 3.1 0.0 0.6 2.1 0.5 1.2 2.9 37.8 43.7 29.9 51.8 48.0 43.4 36.3 34.5 44.4 41.1 32.4 37.0 45.9 4.9 0.0 2.2 5.9 2.3 6.0 3.5 2.9 0.6 19.6 3.6 2.5 7.1 0.0 1.5 1.8 14.6 2.5 7.1 0.1 0.0 6.0 14.8 1.0 3.7 6.1 1.8 7.8 17.6 2.7 1.5 7.3 1.1 1.6 4.5 5.2 6.4 2.3 7.9 23.5 15.0 0.3 2.0 4.8 6.1 8.5 8.4 5.0 16.0 9.4 6.9 21.0 10.3 7.1 8.7 2.0 0.1 20.7 2.7 1.7 0.1 0.8 0.3 31.8 0.0 6.8 7.8 11.2 5.2 0.2 4.5 1.1 6.2 4.7 0.7 1.5 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433492-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 47.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" NA NA 1100000 "Golgi apparatus" Nucleoli "HPA072692: AB_2686549" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 14.4 26.8 27.0 13.2 26.1 16.0 28.1 22.3 27.3 25.8 25.9 25.9 26.5 14.6 26.4 18.5 35.4 21.4 44.9 26.2 26.5 38.6 34.5 31.1 17.8 25.1 27.7 25.9 15.0 42.5 45.9 27.1 30.9 24.0 35.2 30.3 34.4 33.8 18.6 38.1 20.2 25.0 14.5 22.5 20.3 34.7 17.3 30.0 17.9 41.8 40.4 16.9 15.9 15.2 24.1 13.5 19.6 39.8 31.5 52.7 36.9 37.8 17.9 37.8 25.5 37.5 21.2 52.9 15.0 48.0 19.6 38.1 26.1 29.7 28.8 28.9 23.8 21.7 20.3 23.4 23.6 41.3 16.9 26.8 52.3 36.2 29.5 38.0 84.3 42.2 18.1 27.2 21.0 35.2 13.6 10.1 14.3 45.3 37.4 11.7 11.3 33.8 18.7 41.8 32.4 8.7 24.6 25.8 30.6 53.3 86.9 32.3 23.1 43.6 17.4 18.7 14.9 28.0 31.1 26.7 9.8 44.3 21.8 17.7 8.8 19.4 9.4 5.0 6.1 4.8 3.4 4.1 4.7 5.6 4.1 5.5 4.0 47.2 9.8 4.0 3.7 4.0 8.7 27.0 26.1 22.3 27.3 26.2 26.5 25.1 27.7 25.9 24.0 22.5 30.0 24.1 24.2 73.7 74.1 85.2 18.3 7.9 14.4 16.5 15.4 74.8 33.9 26.0 55.0 47.1 42.4 35.0 108.4 33.3 16.6 35.4 3.9 19.2 9.6 21.0 17.7 24.6 21.6 14.7 93.2 32.5 22.5 19.4 28.5 30.8 21.5 42.7 28.9 47.4 19.1 63.9 95.2 59.5 16.2 31.4 7.6 7.5 17.4 19.2 14.2 62.8 31.4 30.5 29.9 115.1 99.3 30.3 27.6 17.3 17.2 26.0 36.8 17.5 45.4 61.9 6.6 24.5 15.7 22.5 21.2 17.8 9.2 31.2 21.9 30.1 31.2 14.8 EVA1B "C1orf78, FAM176B, FLJ10647" ENSG00000142694 "Eva-1 homolog B" Q9NVM1 1 36322031-36324154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 143.9;Extravillous trophoblasts: 250.3;Syncytiotrophoblasts: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.3;BJ: 29.0;BJ hTERT+: 22.4;HSkMC: 20.4;NB-4: 41.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041928, HPA043537" Approved Approved Cytosol NA NA Cytosol "HPA041928: AB_2677752, HPA043537: AB_2678538" "prognostic favorable (4.58e-4)" "unprognostic (5.66e-3)" "unprognostic (1.04e-3)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.45e-1)" "unprognostic (8.33e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.87e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" 26.7 19.5 5.0 3.5 4.2 2.1 36.1 4.4 6.4 41.5 7.0 17.8 2.5 34.3 0.7 12.3 22.1 1.3 18.4 3.6 6.6 37.5 8.5 26.3 2.0 5.5 5.0 2.6 30.4 7.9 1.9 9.5 9.1 4.7 29.2 0.4 0.0 28.9 2.9 5.8 23.9 15.9 1.6 5.4 37.9 14.3 7.6 6.3 0.5 34.1 1.0 0.5 22.2 30.3 5.6 0.7 2.7 1.6 3.0 7.9 23.3 6.8 29.0 22.4 5.4 6.3 0.2 2.1 0.0 8.5 9.2 1.0 0.2 0.2 1.1 1.1 3.3 6.0 3.6 0.6 1.3 17.4 0.1 0.6 20.4 0.0 6.9 0.3 0.9 8.7 0.1 1.4 1.0 3.6 0.2 0.1 41.7 1.7 0.0 10.4 1.5 0.3 7.1 4.6 0.0 0.1 3.9 2.8 1.1 13.3 1.1 0.0 2.7 12.7 7.9 0.0 10.5 2.7 0.3 0.0 0.1 2.9 1.8 7.1 4.0 0.9 0.0 0.2 0.3 0.6 0.0 0.3 0.5 0.5 0.0 0.0 0.0 1.7 1.6 0.1 0.0 1.2 0.1 5.0 4.2 4.4 6.4 3.6 6.6 5.5 5.0 2.6 4.7 5.4 6.3 5.6 82.8 0.0 0.0 2.3 6.2 16.2 19.3 7.3 0.0 0.0 143.9 90.6 2.2 1.5 5.1 7.3 0.0 54.7 8.4 0.3 1.9 20.2 7.1 9.4 88.4 53.9 0.0 0.8 0.0 15.2 250.3 56.6 0.0 15.2 4.5 15.7 84.9 0.9 48.7 0.0 0.0 0.1 6.1 41.3 28.8 24.8 50.7 30.4 12.4 5.6 10.2 14.1 4.1 0.0 0.1 28.9 1.1 48.5 7.9 56.6 0.4 7.7 5.6 0.9 26.3 7.8 98.4 8.4 3.3 0.7 12.4 161.3 9.7 58.2 0.5 30.3 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 19.8" "Group enriched" "Detected in some" 28 "Early spermatids: 65.2;Late spermatids: 27.9;Spermatocytes: 34.6" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 17.0;U-87 MG: 48.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 1.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.5 0.3 0.6 0.5 0.5 0.3 0.5 0.7 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 65.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 34.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423443 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.7;esophagus: 1.5;pituitary gland: 2.0;testis: 1.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.9;Basal squamous epithelial cells: 17.6;Early spermatids: 10.8;Squamous epithelial cells: 5.9" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HBEC3-KT: 3.3;RH-30: 11.7;SH-SY5Y: 2.4;SiHa: 2.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: AB_2684911" "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 1.4 0.0 0.9 3.3 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.4 2.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.6 0.3 1.2 0.5 1.0 0.1 0.6 0.3 0.8 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 17.6 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 10.8 0.1 0.1 0.1 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.2 1.3 1.0 5.9 0.0 0.0 0.0 0.0 0.1 0.0 PLK4 "Sak, STK18" ENSG00000142731 "Polo like kinase 4" O00444 4 127880893-127899224 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 22.8;lymphoid tissue: 14.5;testis: 22.8" "Cell type enhanced" "Detected in many" "Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017327, HPA035026, HPA043198" Approved Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504" "unprognostic (2.44e-1)" "unprognostic (4.24e-2)" "prognostic favorable (7.46e-5)" "unprognostic (2.18e-1)" "unprognostic (3.79e-1)" "unprognostic (9.20e-2)" "unprognostic (1.06e-5)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.44e-3)" "unprognostic (5.66e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.27e-1)" "unprognostic (2.22e-11)" "unprognostic (2.29e-2)" "unprognostic (3.58e-1)" "unprognostic (4.75e-2)" "unprognostic (7.93e-2)" 1.0 1.1 0.5 5.0 0.6 22.8 2.0 0.3 0.8 0.8 0.2 3.6 2.8 1.5 0.6 3.3 1.3 1.1 0.5 0.6 0.6 0.6 0.8 0.9 7.5 0.5 0.6 0.4 1.0 0.4 0.6 0.2 3.6 0.5 0.9 4.3 2.1 0.9 0.9 0.1 2.4 2.9 1.9 0.4 1.6 2.0 22.8 0.6 14.5 0.9 0.7 7.4 1.4 1.4 0.6 26.1 12.1 44.3 22.9 1.5 4.2 20.1 24.9 17.6 32.4 33.3 17.0 26.1 34.9 9.0 13.9 26.3 16.7 31.6 19.9 49.6 27.4 13.1 31.6 20.0 16.0 0.5 45.2 35.9 1.4 2.0 29.7 13.6 5.9 25.3 26.3 37.5 45.2 27.6 18.2 69.9 20.1 20.7 26.3 13.6 36.0 30.9 12.1 10.8 16.4 24.4 20.0 15.8 14.2 7.6 18.7 11.5 19.3 11.0 25.3 24.4 17.4 31.4 23.1 27.4 49.0 13.0 33.7 28.7 0.0 0.1 0.4 0.4 0.2 0.3 0.1 0.5 0.5 0.2 0.2 0.1 0.6 0.0 0.4 0.1 0.1 1.2 0.2 0.5 0.6 0.3 0.8 0.6 0.6 0.5 0.6 0.4 0.5 0.4 0.6 0.6 1.6 0.0 0.6 0.0 1.6 1.7 0.9 1.7 1.2 1.8 1.0 0.9 0.9 0.0 0.6 1.8 0.0 6.0 1.9 2.0 0.0 0.6 65.9 4.7 1.0 1.0 2.4 19.6 0.8 0.4 12.9 1.6 4.1 2.0 1.3 7.5 0.4 0.5 3.7 0.0 0.8 3.3 6.1 1.3 0.6 87.5 2.8 1.5 0.0 1.0 1.2 1.1 1.0 1.0 1.2 0.1 0.5 0.4 8.7 0.7 0.5 0.6 3.7 0.8 0.0 0.4 3.6 53.5 13.4 6.8 0.9 3.8 2.1 0.8 4.5 1.7 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27354067-27366961 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: AB_2681380" "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.13e-4)" "prognostic favorable (7.26e-4)" "prognostic unfavorable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 42.7 17.9 16.2 5.6 15.8 0.6 42.9 16.5 20.9 46.4 16.5 23.3 1.8 31.1 4.1 70.5 39.1 4.7 51.4 15.6 19.3 37.5 10.5 54.7 4.7 17.2 16.4 15.1 15.8 15.3 5.3 18.1 5.1 17.1 41.7 4.5 1.4 30.5 7.4 15.3 64.8 17.9 12.2 16.3 22.5 23.8 8.3 17.4 2.9 30.5 11.4 8.0 40.1 53.9 16.2 7.2 7.2 6.9 4.4 9.9 12.5 1.4 9.0 5.3 7.2 4.4 2.0 9.4 0.1 8.4 16.4 3.2 10.1 2.0 6.4 3.6 6.5 7.1 0.3 16.0 4.7 2.7 0.5 0.4 10.2 17.6 7.8 2.3 8.8 4.0 0.7 2.0 2.7 10.2 25.1 0.2 9.0 2.2 8.7 8.1 2.3 3.2 1.7 12.9 9.1 2.0 3.0 8.5 7.1 6.3 3.1 4.4 5.0 11.6 13.2 7.2 16.6 5.2 3.5 4.1 0.0 12.1 5.8 4.3 0.9 0.6 3.3 2.8 2.0 3.7 1.5 2.5 3.1 1.3 2.0 1.8 1.6 1.2 0.7 4.5 0.0 3.0 1.2 16.2 15.8 16.5 20.9 15.6 19.3 17.2 16.4 15.1 17.1 16.3 17.4 16.2 45.8 19.2 17.8 6.2 3.9 12.5 11.9 8.8 17.1 1.1 8.1 8.9 12.2 5.7 10.3 3.7 0.0 1.2 4.3 8.4 3.9 2.8 0.4 2.3 6.0 27.7 0.0 0.8 1.5 4.4 2.5 10.3 8.6 5.2 2.5 1.2 28.9 0.9 2.8 5.0 1.7 6.1 4.1 8.5 7.1 1.2 16.1 6.4 5.4 5.6 9.3 5.4 8.2 0.0 0.2 12.8 1.9 15.1 3.1 9.5 1.1 1.7 6.2 0.8 6.6 10.8 11.1 13.5 7.7 14.7 14.8 0.1 8.2 0.3 8.8 14.9 FCN3 "FCNH, HAKA1" ENSG00000142748 "Ficolin 3" O75636 1 27369110-27374824 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 280.5;lung: 730.9" "Cell type enriched" "Detected in some" 16 "Hepatic stellate cells: 2828.6" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB025945 Approved "Secreted to blood" NA NA 22800000000 14000000000 "CAB025945: " "unprognostic (1.59e-1)" "unprognostic (5.25e-2)" "unprognostic (1.55e-2)" "unprognostic (8.27e-2)" "unprognostic (1.45e-3)" "unprognostic (1.27e-2)" "unprognostic (1.87e-3)" "unprognostic (1.21e-1)" "unprognostic (6.28e-4)" "unprognostic (7.07e-2)" "unprognostic (2.86e-2)" "unprognostic (3.23e-2)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.97e-2)" "unprognostic (1.61e-2)" 44.5 36.2 1.1 5.8 1.0 0.0 41.1 1.1 1.6 1.8 8.5 3.3 0.8 3.9 0.1 2.9 3.1 1.6 45.0 1.3 2.5 53.5 280.5 730.9 4.3 1.2 1.1 0.9 2.4 12.6 2.7 6.7 22.8 1.2 5.3 0.5 0.0 2.6 0.5 9.0 1.7 6.8 1.8 1.2 11.4 8.5 2.4 1.2 0.4 20.6 7.6 0.3 3.0 1.9 1.2 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 1.1 1.6 1.3 2.5 1.2 1.1 0.9 1.2 1.2 1.2 1.2 94.1 0.0 9.3 0.0 16.6 0.8 0.6 0.5 0.6 0.0 0.8 2.8 2.4 52.9 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.5 0.4 0.2 155.1 0.0 136.4 0.1 0.0 0.0 3.8 0.5 0.2 3.8 0.0 2828.6 31.8 0.3 0.0 0.1 0.0 2.0 168.6 0.3 2.7 3.4 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.0 0.1 5.1 0.0 0.0 1.0 2.7 0.5 0.5 1.0 1.1 0.0 4.9 0.5 0.0 0.3 GPN2 "ATPBD1B, FLJ10349" ENSG00000142751 "GPN-loop GTPase 2" Q9H9Y4 1 26876132-26890283 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028059 Uncertain NA NA "HPA028059: AB_10612113" "unprognostic (2.14e-1)" "unprognostic (4.44e-2)" "unprognostic (5.44e-2)" "unprognostic (1.19e-2)" "unprognostic (1.71e-2)" "unprognostic (9.09e-3)" "prognostic unfavorable (3.56e-8)" "unprognostic (1.17e-1)" "unprognostic (9.68e-3)" "unprognostic (1.75e-2)" "unprognostic (2.75e-3)" "unprognostic (1.18e-2)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (1.63e-2)" 14.8 22.4 10.6 12.0 10.9 21.8 14.6 12.3 12.2 13.6 9.6 16.1 15.6 14.5 16.2 21.3 12.1 12.1 16.9 10.6 11.3 15.2 19.8 13.2 15.9 11.6 10.5 11.1 12.6 15.0 17.5 13.9 13.3 10.8 16.7 17.3 12.0 14.1 12.4 23.4 18.8 15.6 15.5 9.9 17.4 15.5 13.1 10.8 15.4 12.8 13.4 20.1 16.9 15.0 11.9 35.6 16.7 20.2 19.4 21.2 20.3 15.7 26.1 35.0 40.3 41.9 27.4 38.4 17.0 33.7 37.5 32.0 34.3 43.7 60.9 51.9 20.1 28.7 29.6 30.7 29.8 36.3 39.6 30.8 25.4 23.3 65.3 46.1 23.1 40.1 20.7 30.1 19.3 34.9 29.6 19.8 35.0 36.8 38.2 35.2 26.6 29.9 28.6 30.3 19.8 27.2 18.5 34.9 23.0 43.0 21.5 27.5 16.1 24.3 29.8 31.0 25.6 27.3 39.6 21.9 25.6 23.1 36.1 26.9 7.5 29.1 31.3 23.6 33.5 26.5 30.0 22.9 22.7 27.2 31.0 17.2 16.6 9.2 21.4 35.0 28.0 29.8 16.5 10.6 10.9 12.3 12.2 10.6 11.3 11.6 10.5 11.1 10.8 9.9 10.8 11.9 9.4 16.0 11.8 1.6 12.6 18.7 15.7 20.1 9.1 9.6 9.3 6.5 4.1 24.3 16.4 16.5 8.4 35.4 9.8 26.5 13.7 22.1 13.8 12.1 10.0 12.2 18.5 11.1 3.8 19.1 26.3 12.6 14.8 14.6 17.7 13.2 12.1 14.6 22.3 13.5 3.3 17.2 4.1 13.9 9.5 6.1 9.6 11.6 8.8 2.8 23.2 7.5 5.2 3.5 4.0 19.0 20.4 11.7 9.1 20.4 25.9 17.2 8.5 9.6 6.6 10.9 11.1 19.8 12.6 11.7 22.4 43.2 11.4 12.2 17.8 27.4 SYTL1 "exophilin-7, FLJ14996, JFC1, SLP1" ENSG00000142765 "Synaptotagmin like 1" Q8IYJ3 1 27342020-27353937 "Plasma proteins, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 104.8;pancreas: 107.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA037825 Enhanced NA NA "HPA037825: AB_10671635" "unprognostic (4.23e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-1)" "prognostic favorable (6.83e-7)" "unprognostic (7.81e-3)" "unprognostic (5.81e-2)" "unprognostic (1.05e-1)" "unprognostic (7.18e-3)" "unprognostic (4.41e-1)" "unprognostic (1.14e-2)" "unprognostic (2.07e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (1.45e-1)" "unprognostic (3.02e-1)" "unprognostic (1.72e-2)" "unprognostic (5.88e-3)" 1.6 0.7 4.3 19.3 0.6 47.1 7.8 8.3 1.4 14.5 5.1 6.8 7.9 1.4 1.2 104.8 15.6 8.7 0.8 1.6 1.0 2.8 2.1 13.2 33.1 1.1 0.8 1.2 0.6 107.2 4.3 15.8 3.0 3.9 64.1 3.4 0.0 48.0 12.8 0.5 80.8 17.8 0.4 0.5 42.3 42.1 0.9 1.1 21.6 9.9 0.5 20.2 21.8 51.3 0.6 11.3 0.2 0.0 0.4 0.0 0.0 47.8 0.0 0.0 0.0 0.0 1.2 55.8 8.5 10.9 0.0 0.3 34.7 0.0 21.0 0.0 0.0 2.1 1.0 0.9 15.3 0.8 21.9 0.0 0.0 37.8 0.0 7.8 0.2 0.0 28.2 0.7 9.5 0.0 15.5 12.9 81.8 0.5 19.1 5.7 14.9 0.1 40.2 8.6 9.6 15.9 0.9 0.0 15.9 0.6 0.5 40.4 23.3 0.2 0.1 5.1 0.0 0.0 44.3 11.7 8.0 1.6 27.7 0.0 47.0 18.9 176.5 65.0 49.1 58.4 42.8 51.5 53.2 51.0 32.3 30.6 37.3 34.1 49.0 100.8 3.0 63.4 40.0 4.3 0.6 8.3 1.4 1.6 1.0 1.1 0.8 1.2 3.9 0.5 1.1 0.6 1.9 22.4 13.6 0.0 68.6 41.2 78.2 84.4 158.8 0.6 33.6 49.8 3.9 8.6 69.2 0.0 0.0 37.4 92.3 4.8 7.9 3.7 0.8 67.8 2.4 2.3 11.4 15.8 0.3 25.5 10.1 3.1 100.9 18.3 1.3 0.2 2.2 1.1 3.2 0.0 0.3 47.6 32.6 6.7 12.7 0.7 0.3 15.7 10.6 0.0 18.8 2.0 208.1 0.0 0.1 12.1 3.7 0.7 52.3 46.8 3.1 6.4 62.8 0.8 0.0 1.3 5.6 30.3 23.1 179.1 55.3 14.1 74.9 0.2 9.4 95.3 WDTC1 "ADP, DCAF9, KIAA1037" ENSG00000142784 "WD and tetratricopeptide repeats 1" Q8N5D0 1 27234632-27308636 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028177, HPA028180, HPA028182" Uncertain Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204" "unprognostic (3.18e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.69e-2)" "unprognostic (8.28e-2)" "unprognostic (3.31e-2)" "unprognostic (2.00e-3)" "unprognostic (1.25e-2)" "unprognostic (9.44e-2)" "unprognostic (2.44e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "prognostic favorable (8.84e-8)" "unprognostic (1.28e-1)" "unprognostic (9.33e-2)" "unprognostic (3.01e-2)" "unprognostic (2.51e-2)" 16.3 24.6 24.2 10.6 20.9 14.9 17.7 19.0 24.3 18.7 11.3 22.1 13.0 19.9 7.1 18.1 20.1 10.6 34.2 20.6 18.4 19.9 18.8 17.1 14.5 24.2 19.8 17.8 19.2 22.3 48.0 17.1 10.7 24.4 19.5 9.6 33.7 20.2 15.3 63.5 24.6 18.2 12.1 17.4 17.9 23.3 37.9 21.8 20.0 18.6 54.9 12.8 20.0 18.6 19.8 19.8 8.6 13.5 1.3 18.9 15.8 5.6 12.0 20.1 12.7 15.5 2.9 19.3 17.0 14.0 24.0 9.3 10.1 13.0 18.4 11.0 23.2 22.0 17.7 8.9 7.9 17.0 9.0 22.4 15.1 29.6 15.8 14.4 22.9 17.4 5.4 18.2 17.2 13.6 11.1 14.6 21.6 6.3 13.0 18.1 7.3 10.1 18.7 15.2 4.2 19.7 16.9 15.7 6.6 14.4 10.1 9.8 15.5 15.2 10.3 6.2 14.5 5.9 24.7 14.2 8.1 20.8 17.3 12.5 0.1 0.2 2.7 1.4 0.3 0.5 0.6 0.3 0.6 0.7 0.4 0.2 0.6 2.1 0.4 0.2 0.5 0.4 0.5 24.2 20.9 19.0 24.3 20.6 18.4 24.2 19.8 17.8 24.4 17.4 21.8 19.8 10.8 9.6 10.7 19.6 13.8 12.9 10.3 8.4 16.5 31.4 18.5 14.5 15.6 14.3 7.6 31.3 54.2 14.2 14.3 17.3 9.8 15.1 29.8 15.3 8.2 10.1 16.7 32.8 22.4 14.1 4.8 10.6 16.3 13.2 1.3 15.4 18.5 16.6 13.0 21.9 21.2 16.9 6.1 21.0 11.3 66.2 17.1 15.8 10.6 19.7 18.9 15.8 28.8 16.6 22.2 16.0 10.1 16.6 12.3 17.2 26.6 19.1 18.4 70.0 6.6 17.1 10.3 30.9 6.6 13.0 17.3 16.4 13.3 14.1 15.0 16.8 CELA3A "ELA3, ELA3A" ENSG00000142789 "Chymotrypsin like elastase 3A" P09093 1 22001657-22012542 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2214 "pancreas: 264842.4" "Cell type enriched" "Detected in some" 56 "Exocrine glandular cells: 34710.4" "Cancer enriched" "Detected in some" 2497 "pancreatic cancer: 1481.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "MOLT-4: 24.9" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (1.27e-1)" "unprognostic (2.71e-1)" "unprognostic (1.79e-1)" "unprognostic (6.32e-2)" "unprognostic (2.67e-1)" 18.4 4.5 0.0 3.0 0.0 2.8 11.7 0.0 0.0 7.4 0.0 4.2 21.5 4.2 0.0 7.4 3.1 0.1 45.0 0.0 0.0 4.1 13.6 3.1 6.1 0.0 0.0 0.0 119.6 264842.4 0.0 6.9 15.0 0.0 8.9 0.0 0.0 44.4 0.0 3.9 4.5 12.3 0.0 0.0 6.3 48.0 3.2 0.0 0.3 3.1 0.0 0.0 2.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 25.5 40.7 0.1 0.0 0.6 0.0 0.0 0.1 34710.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 197.1 0.3 2.4 0.0 0.0 94.0 0.0 0.0 0.0 0.0 619.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF3 AE2 ENSG00000142794 "NBPF member 3" Q9H094 1 21440128-21485005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 9.9" "Cell type enhanced" "Detected in many" "Early spermatids: 33.8;Excitatory neurons: 17.6;Inhibitory neurons: 18.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.0;HHSteC: 12.0" "HPA042595, HPA043692, HPA044023, HPA046971, HPA058050" Approved NA NA "HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.49e-2)" "unprognostic (1.19e-2)" "unprognostic (5.09e-3)" "unprognostic (2.57e-2)" "unprognostic (3.11e-1)" "unprognostic (2.01e-1)" "unprognostic (2.82e-2)" "unprognostic (2.10e-1)" "unprognostic (2.22e-3)" "unprognostic (1.09e-1)" "unprognostic (3.11e-3)" "unprognostic (1.63e-1)" "unprognostic (5.31e-5)" "unprognostic (8.35e-2)" "unprognostic (1.23e-2)" "unprognostic (2.69e-2)" "unprognostic (1.66e-2)" 1.4 2.0 1.3 0.7 1.3 0.7 1.8 1.3 2.1 1.5 1.2 1.5 0.1 0.9 1.3 1.2 1.4 0.1 1.1 1.2 1.4 1.9 1.7 0.9 0.9 1.4 1.2 1.3 1.5 1.4 1.4 2.2 1.6 1.3 1.5 0.9 1.5 1.5 0.9 0.7 1.7 1.6 1.0 1.2 1.5 2.0 9.9 1.5 1.1 1.7 0.0 1.4 1.5 1.2 1.2 1.6 1.6 0.0 4.3 2.9 1.1 4.9 3.7 12.0 3.3 2.9 2.9 4.3 3.0 1.2 6.9 0.8 0.2 2.2 2.6 0.3 1.7 3.0 2.3 0.2 0.9 12.0 1.1 1.3 0.8 0.8 3.1 0.1 1.2 0.4 0.0 0.2 0.6 0.4 5.3 0.0 2.6 0.7 2.1 3.3 0.0 0.0 2.4 0.3 1.5 3.4 3.7 5.2 1.0 3.5 1.0 1.3 1.7 3.5 1.1 2.2 4.6 1.1 0.0 1.8 4.7 0.3 2.2 1.4 0.0 0.2 1.0 1.7 0.3 2.4 0.4 0.7 1.4 0.1 0.2 1.2 1.6 0.1 0.7 0.0 0.0 0.8 0.9 1.3 1.3 1.3 2.1 1.2 1.4 1.4 1.2 1.3 1.3 1.2 1.5 1.2 1.6 0.0 3.7 14.0 1.9 1.3 2.8 1.2 2.8 1.8 3.8 2.8 2.9 1.5 1.3 1.8 6.2 3.7 2.7 0.8 0.0 1.2 33.8 1.9 1.5 2.3 0.0 2.1 17.6 2.5 1.1 3.4 4.1 3.2 2.5 1.8 3.6 1.1 0.9 0.0 18.4 2.8 4.1 1.6 6.7 4.3 2.8 3.0 0.0 6.5 1.9 1.0 0.0 29.1 17.2 2.4 0.2 1.9 0.9 1.6 1.4 2.2 5.9 2.0 0.0 2.8 2.3 15.7 8.0 2.2 3.0 2.5 3.4 4.0 1.1 2.2 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822244-21937310 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1400000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 130.2 55.1 4.1 36.4 4.0 1.7 97.0 3.4 21.5 61.1 39.2 118.4 18.5 153.2 6.7 44.5 85.8 53.9 143.5 3.1 3.0 37.7 10.7 49.4 14.3 5.2 4.1 0.8 31.6 31.9 13.2 11.9 30.6 4.8 60.8 8.6 0.3 45.3 57.1 65.7 38.6 55.4 97.0 3.7 37.7 76.8 9.0 6.4 6.8 69.7 41.1 3.5 111.1 60.2 5.6 44.0 40.7 13.8 45.9 131.0 99.4 51.5 70.2 17.8 21.1 18.7 50.5 86.7 3.3 293.0 112.9 0.8 26.9 3.1 31.9 5.4 0.6 4.3 15.7 46.0 35.7 27.0 0.0 4.1 61.6 9.4 19.9 6.0 28.1 620.8 0.3 21.4 5.7 32.4 11.8 0.0 20.0 11.7 19.6 17.9 6.3 87.8 6.1 35.1 6.5 1.3 4.1 51.4 20.0 28.7 14.0 8.1 7.2 504.3 41.1 51.8 29.7 2.3 0.5 7.3 2.6 9.7 0.1 54.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.1 4.0 3.4 21.5 3.1 3.0 5.2 4.1 0.8 4.8 3.7 6.4 5.6 366.8 70.5 28.6 3.6 3.9 26.4 13.5 81.1 21.1 0.6 6.2 21.5 5.8 38.6 30.3 92.0 0.0 11.0 3.4 52.9 0.0 76.1 1.4 24.2 47.7 322.9 2.4 22.9 0.8 25.0 89.0 141.3 62.2 39.8 23.4 776.0 600.4 6.6 6.8 3.3 0.8 12.6 16.2 22.1 19.2 5.8 75.2 4.6 60.5 15.9 1.8 1.6 0.0 2.5 4.3 87.5 29.9 69.2 4.6 19.3 19.2 0.9 28.7 0.6 32.9 82.5 69.8 0.3 4.8 10.0 17.8 9.3 5.0 83.3 20.1 11.8 ITGB3BP "CENPR, HSU37139, NRIF3, TAP20" ENSG00000142856 "Integrin subunit beta 3 binding protein" Q13352 1 63440770-63593721 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028463 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028463: AB_10601435" "unprognostic (4.98e-2)" "unprognostic (5.88e-3)" "unprognostic (6.28e-3)" "unprognostic (3.96e-2)" "unprognostic (4.58e-1)" "prognostic favorable (4.32e-4)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.68e-2)" "unprognostic (7.89e-3)" "unprognostic (2.15e-2)" "unprognostic (1.35e-1)" "unprognostic (4.97e-3)" "prognostic unfavorable (8.45e-6)" "unprognostic (1.34e-2)" "unprognostic (5.24e-2)" "unprognostic (7.34e-3)" "unprognostic (6.14e-2)" 6.8 11.6 2.3 7.9 2.2 12.0 15.2 2.4 4.6 7.6 3.4 10.8 8.1 8.9 16.0 9.0 9.3 10.9 4.5 2.2 2.7 12.7 6.5 7.3 18.1 2.5 2.3 2.1 14.2 10.2 18.4 5.4 10.2 2.4 8.8 10.2 2.8 7.9 6.3 2.5 9.1 6.1 5.6 2.4 9.0 8.1 20.8 2.2 20.4 13.6 4.4 16.6 10.2 8.3 2.6 63.6 32.9 35.9 28.6 8.6 25.2 32.3 30.3 18.7 51.6 63.4 18.2 29.0 57.4 22.6 7.3 26.2 44.3 28.2 30.8 63.7 43.4 74.2 43.9 41.3 35.1 9.2 60.4 27.6 6.5 22.4 29.9 23.5 24.3 26.6 34.5 51.5 74.6 7.3 27.8 66.4 57.0 45.5 24.1 38.2 42.5 61.4 84.7 34.8 19.4 46.1 28.8 34.7 20.0 50.4 53.0 19.9 20.0 16.1 17.9 26.1 36.6 46.2 37.1 64.1 54.4 30.0 75.4 27.7 14.2 4.0 1.4 6.5 3.2 11.3 15.9 10.2 10.6 5.1 15.4 11.3 10.2 1.1 15.6 3.9 8.8 12.2 6.7 2.3 2.2 2.4 4.6 2.2 2.7 2.5 2.3 2.1 2.4 2.4 2.2 2.6 22.0 9.6 13.9 24.2 40.9 33.9 56.3 49.8 34.7 10.7 35.9 43.7 11.5 28.6 38.2 25.8 10.4 45.9 19.3 10.1 29.4 42.2 100.8 45.2 22.1 21.6 17.4 40.0 23.6 34.3 56.3 28.6 20.4 21.1 23.5 40.7 23.9 9.7 30.0 6.7 23.6 18.1 42.7 21.0 26.1 121.4 21.5 18.9 21.4 15.0 23.7 21.2 30.9 18.6 31.0 24.8 4.1 25.9 30.7 13.7 6.0 39.1 54.3 15.8 32.9 18.2 21.9 200.5 54.4 30.8 32.7 19.2 26.6 13.6 31.9 35.8 SERBP1 "CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1" ENSG00000142864 "SERPINE1 mRNA binding protein 1" Q8NC51 1 67407810-67430415 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020559, CAB026297" Supported Enhanced Cytosol NA NA 810000 Cytosol "CAB026297: AB_425924, HPA020559: AB_1856701" "unprognostic (1.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.45e-2)" "unprognostic (6.80e-3)" "unprognostic (2.71e-3)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.98e-2)" "unprognostic (1.32e-3)" "unprognostic (5.97e-2)" "unprognostic (8.25e-3)" "unprognostic (3.04e-1)" "unprognostic (1.33e-2)" "unprognostic (1.40e-2)" "unprognostic (4.76e-1)" "unprognostic (6.64e-2)" "unprognostic (1.34e-3)" 114.8 80.3 47.5 111.1 49.8 131.6 107.8 48.4 48.9 88.5 47.9 92.1 100.5 90.7 66.3 189.7 82.2 67.0 94.3 44.5 57.8 82.5 132.5 77.2 124.8 53.3 49.2 37.3 87.5 122.2 132.6 48.4 93.6 53.4 78.0 85.3 48.0 120.0 66.8 340.0 148.6 93.5 82.9 54.0 82.1 94.9 83.6 56.8 126.8 91.9 160.4 119.1 102.3 119.4 55.1 444.4 272.4 274.9 280.4 236.9 214.0 420.9 452.9 163.8 294.7 241.6 524.8 195.4 828.9 341.1 236.0 294.6 337.4 435.2 411.2 309.5 375.7 535.8 764.1 488.7 460.7 207.0 614.9 290.8 221.3 272.1 384.6 356.0 205.9 319.7 276.0 867.4 293.0 236.2 314.9 494.9 412.9 978.1 298.1 355.2 566.3 600.4 429.8 231.0 349.8 468.8 330.8 351.0 385.6 442.4 231.1 212.0 386.4 345.9 283.4 351.5 421.2 618.3 273.6 369.2 747.9 233.0 603.3 326.9 37.8 84.1 53.7 100.4 92.5 125.4 101.3 99.0 100.9 107.5 102.1 114.6 105.6 27.1 147.4 90.1 98.2 131.5 119.2 47.5 49.8 48.4 48.9 44.5 57.8 53.3 49.2 37.3 53.4 54.0 56.8 55.1 251.3 250.0 225.5 17.6 262.6 686.4 437.3 363.8 536.7 146.7 262.1 251.8 144.8 214.4 311.4 117.7 91.8 271.5 343.7 200.0 242.6 324.4 555.9 368.1 411.9 314.9 230.1 398.8 24.1 361.5 531.0 231.0 169.7 400.5 219.2 215.6 179.2 331.5 297.9 143.0 24.6 338.7 183.1 247.7 281.2 240.9 221.2 214.2 192.1 27.2 298.4 153.6 325.4 26.7 33.2 349.3 192.0 278.7 277.4 540.5 168.4 323.0 206.3 139.7 138.1 301.6 516.0 569.8 281.6 597.9 719.7 229.3 271.4 318.8 405.0 470.2 BCL10 "c-E10, CARMEN, CIPER, CLAP, mE10" ENSG00000142867 "BCL10 immune signaling adaptor" O95999 1 85265776-85276632 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 194.1;Paneth cells: 210.2;Urothelial cells: 297.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 97.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001944, HPA017925" Approved NA NA "CAB001944: , HPA017925: AB_1845312" "unprognostic (3.78e-3)" "unprognostic (2.53e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.61e-1)" "unprognostic (3.47e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (7.06e-2)" "unprognostic (2.36e-1)" "unprognostic (9.46e-2)" "unprognostic (1.27e-2)" "unprognostic (1.73e-1)" "unprognostic (4.92e-3)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (1.07e-1)" 10.2 7.5 4.7 14.0 4.8 24.6 10.7 5.6 7.1 14.9 7.1 27.0 14.9 8.2 7.9 18.3 9.1 19.1 5.5 5.2 6.1 8.8 9.9 9.3 13.8 5.1 4.9 4.1 7.3 9.0 6.2 2.6 9.4 4.9 7.8 23.7 2.8 8.5 5.1 6.8 9.0 16.7 11.9 5.1 11.7 15.1 6.5 5.6 9.5 9.0 5.7 16.5 23.3 11.4 5.6 38.5 7.6 11.6 11.8 13.7 23.7 16.9 26.8 27.6 20.9 27.8 8.1 14.5 14.5 19.1 22.5 39.3 19.6 12.8 32.4 28.7 14.8 8.2 16.9 6.5 11.9 24.0 16.7 15.4 18.6 31.7 31.4 25.6 24.5 97.9 10.0 11.7 14.1 33.2 6.8 16.4 13.5 19.0 22.1 25.0 12.2 21.8 9.8 71.2 29.2 6.3 8.5 8.2 28.6 23.2 14.8 9.6 10.2 47.3 19.0 13.2 24.1 27.5 11.7 6.5 16.6 9.9 13.1 14.7 78.4 34.1 48.2 20.8 41.8 23.5 46.7 27.0 24.4 33.7 41.4 24.7 23.5 85.0 24.6 33.1 26.3 31.1 22.9 4.7 4.8 5.6 7.1 5.2 6.1 5.1 4.9 4.1 4.9 5.1 5.6 5.6 40.6 22.4 18.1 3.3 49.6 194.1 167.2 75.4 48.3 5.7 29.2 19.8 4.6 17.2 54.9 23.9 0.0 16.0 24.1 174.3 17.6 71.5 85.1 97.7 36.1 48.2 49.0 9.1 8.8 44.7 28.4 24.9 57.1 152.2 39.3 17.9 28.2 19.8 21.2 10.1 6.1 79.7 38.7 31.8 68.8 13.4 11.1 41.7 16.0 2.8 21.7 11.1 11.3 9.5 6.1 74.1 210.2 11.3 25.0 80.0 45.2 25.4 32.9 6.3 0.0 19.9 21.8 9.7 12.9 76.7 171.3 23.7 31.3 21.5 77.2 297.4 CCN1 "CYR61, GIG1, IGFBP10" ENSG00000142871 "Cellular communication network factor 1" O00622 1 85580761-85584589 "Predicted secreted proteins" "Cell adhesion, Chemotaxis" "Growth factor binding, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 256.5;Cardiomyocytes: 107.6;Cytotrophoblasts: 258.1;Extravillous trophoblasts: 529.9;Fibroblasts: 296.2;Syncytiotrophoblasts: 131.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 26.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 431.8;BJ hTERT+ SV40 Large T+: 422.0;EFO-21: 410.9;SiHa: 551.2;TIME: 541.3;U-251 MG: 642.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029853 Uncertain "Secreted to extracellular matrix" NA NA "HPA029853: AB_10611822" "unprognostic (6.09e-2)" "unprognostic (3.25e-2)" "unprognostic (9.97e-2)" "unprognostic (8.90e-2)" "unprognostic (1.80e-2)" "unprognostic (3.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.56e-2)" "unprognostic (2.59e-1)" "unprognostic (9.95e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.04e-3)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (3.74e-3)" 534.2 100.5 3.1 28.5 3.0 0.2 316.1 1.2 26.0 257.9 10.6 182.2 5.1 275.9 0.1 49.1 476.5 65.4 287.6 3.9 11.2 210.6 202.2 411.4 3.9 5.2 2.3 0.0 124.1 71.3 14.9 56.5 30.1 2.9 158.6 1.7 1.2 95.0 2.9 98.6 175.8 102.9 142.8 1.2 132.4 203.4 20.2 4.2 11.2 270.3 17.5 0.0 266.7 152.1 4.0 159.3 5.2 0.7 1.0 47.4 90.6 77.4 431.8 216.6 422.0 264.6 24.1 4.3 0.0 410.9 185.5 82.8 36.3 15.9 33.4 164.4 0.7 6.9 0.3 6.8 0.7 245.2 3.7 0.2 39.9 6.9 121.2 50.1 13.4 366.0 0.1 1.6 0.0 150.3 0.8 0.3 0.7 24.9 1.8 42.2 0.4 94.9 0.7 166.0 2.5 0.4 4.0 551.2 17.7 62.1 4.9 16.5 0.8 541.3 272.3 213.3 82.2 642.6 0.3 0.7 1.8 1.9 0.2 73.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.0 1.2 26.0 3.9 11.2 5.2 2.3 0.0 2.9 1.2 4.2 4.0 256.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.6 0.0 0.0 0.0 0.0 258.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 529.9 296.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.1 0.0 0.0 0.0 0.0 131.3 0.0 0.0 0.0 0.0 PRKACB PKACb ENSG00000142875 "Protein kinase cAMP-activated catalytic subunit beta" P22694 1 84078062-84238498 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 120.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010363, HPA029754, HPA071185" Approved Approved "Cytokinetic bridge,Cytosol" Yes NA 130000 Cytosol "Cytokinetic bridge" "CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356" "unprognostic (9.38e-2)" "unprognostic (1.18e-1)" "unprognostic (6.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "prognostic favorable (1.89e-6)" "unprognostic (1.22e-1)" "unprognostic (3.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.48e-1)" 16.7 48.1 75.4 26.3 115.9 16.2 17.8 83.2 111.6 19.9 12.6 56.5 10.9 19.4 39.1 18.0 10.1 26.4 24.0 102.9 112.2 24.0 21.0 15.9 42.1 74.8 83.0 93.2 17.9 28.0 23.7 24.9 11.6 76.9 30.9 52.2 72.2 84.4 27.6 5.0 4.1 12.8 29.0 65.7 36.3 34.5 8.2 98.5 64.1 25.4 13.6 37.1 27.9 7.8 120.0 8.6 16.9 26.4 31.8 29.9 26.1 12.3 41.7 31.4 20.8 19.4 0.4 7.5 45.1 28.0 32.8 38.0 5.8 12.6 13.6 22.0 44.1 6.8 99.3 21.3 3.2 29.4 39.8 2.2 15.6 6.0 20.2 11.2 30.2 97.2 16.7 3.2 25.2 34.3 1.6 51.8 21.0 26.1 0.1 11.8 39.6 41.2 27.3 50.5 30.2 8.6 33.4 23.0 8.8 25.6 19.7 8.1 8.2 86.8 28.7 22.4 29.4 31.9 18.6 24.2 45.3 13.7 41.5 36.5 56.3 7.5 16.4 59.3 10.2 47.7 35.2 43.4 52.9 19.4 28.4 65.0 69.5 3.8 73.1 16.2 11.1 44.2 66.8 75.4 115.9 83.2 111.6 102.9 112.2 74.8 83.0 93.2 76.9 65.7 98.5 120.0 9.5 0.0 1.5 118.8 56.6 5.1 7.2 3.5 11.4 44.9 11.5 9.1 44.4 21.5 5.2 14.7 35.5 1.9 103.0 115.5 33.2 6.2 2.9 11.4 27.0 13.4 21.7 52.3 334.4 11.9 1.2 17.0 16.3 14.0 58.9 15.2 28.5 17.0 27.1 47.1 348.8 58.1 4.1 62.3 24.4 3.6 14.9 51.6 16.0 95.5 14.6 35.6 96.8 302.6 499.0 20.6 42.2 21.8 53.9 10.0 4.5 25.6 6.3 34.4 13.1 14.1 20.3 13.9 8.0 8.1 2.8 0.7 87.6 11.4 51.1 9.1 PIGK "GPI8, hGPI8" ENSG00000142892 "Phosphatidylinositol glycan anchor biosynthesis class K" Q92643 1 77088989-77219430 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Hydrolase, Protease, Thiol protease" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056383, HPA057040" Uncertain "Intracellular and membrane" NA NA "HPA056383: AB_2683109, HPA057040: AB_2683319" "unprognostic (2.43e-2)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (2.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.07e-1)" "unprognostic (5.19e-1)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (1.76e-2)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (8.12e-3)" 9.9 12.5 6.6 6.4 8.0 8.9 12.5 7.1 9.3 9.8 7.1 8.6 7.0 9.6 9.8 6.6 9.4 10.0 14.2 7.1 8.0 17.8 13.3 9.3 8.9 7.3 7.5 6.6 9.7 9.6 16.4 6.6 6.4 7.4 11.3 9.4 9.9 9.6 8.9 7.0 4.9 7.4 10.8 7.1 9.8 8.9 6.0 7.0 8.6 16.5 9.9 7.6 9.4 4.3 10.6 12.3 14.2 11.5 14.7 64.1 48.1 18.6 24.4 33.1 25.0 35.6 11.8 12.2 10.7 24.4 43.1 29.7 10.8 14.8 20.8 45.2 22.1 15.1 14.6 13.8 11.1 14.4 32.5 12.4 29.2 11.1 26.7 22.9 29.9 37.4 13.2 18.0 35.6 39.0 8.3 10.3 13.2 10.4 13.7 23.4 12.0 33.7 13.3 31.9 8.9 9.7 9.1 23.2 20.8 27.1 18.9 10.0 18.5 21.5 40.1 15.6 21.9 25.0 16.1 23.7 10.7 29.8 40.5 16.2 7.2 3.0 5.8 5.8 3.4 6.0 3.7 6.0 5.0 5.7 3.2 7.5 6.8 1.5 7.4 3.5 3.9 9.8 4.7 6.6 8.0 7.1 9.3 7.1 8.0 7.3 7.5 6.6 7.4 7.1 7.0 10.6 17.7 9.6 9.1 16.3 14.4 9.6 15.2 23.7 5.2 14.2 21.0 14.2 23.0 18.6 18.3 40.5 2.1 16.0 14.1 9.7 3.9 20.8 2.1 15.6 15.5 18.1 10.8 16.4 51.4 21.1 35.7 29.3 6.6 14.1 17.7 14.7 20.3 29.3 20.3 8.4 40.2 12.4 24.4 14.5 13.9 3.7 19.6 11.9 19.6 26.2 9.2 17.6 18.6 40.7 78.2 11.9 8.5 27.4 41.7 10.1 9.3 23.3 25.3 12.4 52.6 16.3 24.1 75.8 30.2 9.4 11.9 15.2 15.5 12.7 12.7 11.5 TINAGL1 "ARG1, LCN7, LIECG3, P3ECSL, TINAGRP" ENSG00000142910 "Tubulointerstitial nephritis antigen like 1" Q9GZM7 1 31576485-31587686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1235.1;Sertoli cells: 427.3;Syncytiotrophoblasts: 1946.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 87.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Cell line enhanced" "Detected in many" "BEWO: 322.7;CAPAN-2: 178.9;EFO-21: 403.6;HaCaT: 181.4;HBEC3-KT: 211.9;HUVEC TERT2: 173.4;TIME: 376.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048695 Approved "Secreted to extracellular matrix" NA NA 370000 "HPA048695: AB_2680497" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.80e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-3)" "unprognostic (8.29e-3)" "unprognostic (6.02e-3)" "unprognostic (4.18e-1)" "unprognostic (6.96e-2)" "unprognostic (7.02e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.65e-6)" "unprognostic (7.42e-2)" "unprognostic (6.64e-2)" "prognostic favorable (9.64e-4)" "unprognostic (3.43e-2)" 173.6 41.1 18.7 18.7 16.4 1.0 151.8 16.5 20.0 84.4 19.6 80.7 27.0 102.6 10.8 31.3 83.2 24.1 168.1 13.8 16.4 178.9 22.9 86.5 8.6 18.3 17.0 12.2 39.1 31.3 13.3 25.5 185.1 17.4 71.8 16.7 1.1 64.4 41.0 47.0 33.3 52.0 36.9 14.7 120.6 66.9 6.2 19.1 3.8 116.1 30.9 5.3 89.1 70.8 17.1 96.6 0.2 0.0 0.5 0.8 0.2 322.7 14.9 1.9 0.7 0.4 44.5 178.9 0.2 403.6 13.4 7.0 181.4 0.2 211.9 0.1 0.7 0.1 0.1 7.3 11.5 4.5 0.1 0.5 0.2 37.9 0.0 7.6 0.1 173.4 0.1 2.4 0.4 0.0 0.0 0.7 0.6 0.9 52.6 6.1 0.4 0.1 0.4 57.0 72.6 0.4 0.5 38.0 125.6 4.2 18.8 7.5 0.3 376.6 0.3 91.6 0.7 2.8 0.4 0.5 1.6 0.2 0.2 3.3 2.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.0 18.7 16.4 16.5 20.0 13.8 16.4 18.3 17.0 12.2 17.4 14.7 19.1 17.1 345.4 9.6 5.8 0.7 2.7 11.0 121.5 244.1 8.0 0.0 32.0 73.0 46.7 37.1 28.6 132.4 0.0 1235.1 2.6 158.9 1.9 378.7 1.4 8.4 3.2 161.4 11.4 13.5 0.1 92.2 223.5 35.0 50.0 14.4 14.7 49.7 306.6 4.4 89.3 0.0 1.1 35.5 14.2 8.8 10.3 0.7 7.5 4.2 23.2 13.1 2.0 0.2 0.0 0.5 0.0 344.6 115.3 4.1 0.2 131.4 45.2 80.9 9.1 0.4 427.3 9.5 357.4 0.3 0.8 4.9 6.5 1946.1 3.8 2.7 59.7 219.4 AZIN2 "ADC, KIAA1945, ODC-p, ODC1L, ODCp" ENSG00000142920 "Antizyme inhibitor 2" Q96A70 1 33081104-33123492 "Metabolic proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.4" "Group enriched" "Detected in many" 6 "Early spermatids: 233.2;Late spermatids: 855.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 6.4;plasmacytoid DC: 18.9" "Group enriched" "Detected in many" 8 "dendritic cells: 18.9;granulocytes: 6.4" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.0;SK-MEL-30: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028527 Approved Cytosol NA NA Cytosol "HPA028527: AB_10602077" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.16e-3)" "unprognostic (7.50e-2)" "unprognostic (8.28e-2)" "unprognostic (4.56e-2)" "unprognostic (1.15e-4)" "unprognostic (9.19e-3)" "unprognostic (3.89e-2)" "unprognostic (1.54e-2)" "unprognostic (1.06e-3)" "unprognostic (2.16e-1)" "unprognostic (3.18e-1)" "unprognostic (6.91e-2)" "unprognostic (2.91e-1)" "unprognostic (9.45e-2)" "unprognostic (2.41e-1)" 1.4 3.9 6.1 0.8 7.2 0.1 2.1 7.3 9.5 3.6 4.4 2.8 0.4 2.4 1.1 1.0 4.4 1.9 3.5 6.6 6.3 2.7 0.7 1.4 1.0 7.7 7.3 6.5 6.3 1.6 3.3 3.5 0.5 8.2 2.2 1.1 3.0 2.2 1.7 1.1 1.3 1.3 1.4 8.8 1.1 1.0 32.4 6.4 1.1 2.6 2.0 1.2 1.5 2.2 12.8 0.5 0.0 1.8 0.3 0.9 3.0 0.2 0.6 1.8 1.3 1.1 0.0 1.5 0.0 0.8 0.5 1.0 0.2 0.9 0.2 0.7 0.0 0.0 0.4 0.0 0.0 3.6 0.0 1.6 3.5 2.0 1.5 1.3 11.0 0.3 0.3 0.0 0.1 1.4 0.0 0.2 0.4 0.8 0.3 0.0 0.2 2.1 0.1 2.1 0.2 0.2 1.3 0.5 0.0 14.0 1.2 0.0 0.3 0.1 0.0 0.8 1.1 0.2 0.8 0.0 0.0 3.2 0.0 0.6 6.4 0.0 0.0 1.4 0.0 1.3 0.1 1.6 1.4 0.0 0.0 1.6 1.6 0.1 0.0 0.0 18.9 0.0 0.8 6.1 7.2 7.3 9.5 6.6 6.3 7.7 7.3 6.5 8.2 8.8 6.4 12.8 2.6 0.0 3.0 24.2 2.3 0.0 2.9 0.0 2.8 6.5 3.8 5.2 1.0 0.0 0.6 1.8 18.8 0.5 11.4 10.8 0.0 1.7 233.2 1.7 1.5 2.6 1.2 0.0 45.4 1.4 0.4 4.8 7.7 0.3 0.0 2.0 1.8 0.1 1.2 6.7 27.3 1.4 0.0 0.6 0.0 855.9 6.2 2.8 0.0 44.0 1.7 12.2 0.0 23.6 86.0 1.5 5.2 7.5 1.0 1.5 0.8 3.1 2.2 7.9 6.6 2.9 2.7 22.2 5.8 0.5 0.0 0.3 3.3 2.1 3.3 1.0 RPS8 S8 ENSG00000142937 "Ribosomal protein S8" P62241 1 44775251-44778779 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029266 Enhanced "Endoplasmic reticulum,Cytosol" NA NA 290000 "Endoplasmic reticulum, Cytosol" "HPA029266: AB_10601611" "unprognostic (9.70e-3)" "unprognostic (2.26e-1)" "unprognostic (3.02e-1)" "unprognostic (9.75e-2)" "unprognostic (1.62e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.02e-1)" "unprognostic (6.17e-2)" "unprognostic (7.30e-2)" "unprognostic (9.31e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (9.05e-9)" "unprognostic (1.94e-1)" "unprognostic (8.55e-2)" "unprognostic (8.83e-2)" "unprognostic (5.57e-2)" 1784.2 1842.8 942.6 1274.9 958.9 3514.9 2406.7 936.1 1229.3 2408.5 985.9 1497.8 1205.9 1658.1 1386.2 2263.4 1944.9 1001.0 1058.5 899.8 985.8 1160.3 1090.1 1089.3 2620.9 986.6 949.0 887.7 5465.4 2669.8 807.1 1022.9 1247.6 984.5 1605.0 1253.1 333.6 1810.0 912.4 1690.8 2777.3 1415.4 1157.2 1037.8 1590.6 1387.8 334.6 990.9 1906.1 1104.8 1244.3 2249.3 1677.3 2091.4 1026.1 2441.2 1215.3 1875.4 2510.4 3244.1 5078.7 3072.1 1749.9 2806.5 2463.5 1966.2 2104.1 2601.9 4624.8 1869.5 2168.8 1554.5 1629.2 2474.1 3090.7 1814.6 1684.7 4320.2 1721.5 1606.0 2864.5 4578.2 3450.8 1612.1 4061.4 5060.2 1638.3 4357.4 3481.0 3002.5 2729.6 2630.2 3148.3 2334.1 1961.4 3810.0 3659.2 4103.8 2046.8 2070.8 3020.4 2294.4 5221.6 2795.6 2097.6 2026.9 2298.2 946.6 5242.8 7264.1 1814.9 1835.0 6739.3 2030.0 1204.7 2069.4 1857.6 3031.1 2418.8 2600.5 3553.2 1458.2 4134.2 1478.9 201.9 847.4 259.3 827.7 813.6 1414.6 2308.1 1504.1 1152.2 1266.5 1942.3 1855.5 1597.6 78.9 1020.7 652.7 1553.9 1384.4 3322.6 942.6 958.9 936.1 1229.3 899.8 985.8 986.6 949.0 887.7 984.5 1037.8 990.9 1026.1 2553.4 1416.6 2077.3 17.9 8208.6 7906.9 9285.2 4955.0 10969.2 235.7 6782.7 6808.8 749.2 2836.7 2980.6 1092.5 91.8 5226.0 3583.3 1280.8 4149.8 2597.7 491.8 2480.8 7101.2 3339.7 2141.2 5081.3 22.7 6066.6 7604.6 3510.7 3144.2 2929.1 1842.5 4531.7 3832.6 2417.2 3576.9 60.6 24.8 4271.4 1249.2 4339.4 5493.4 663.3 6143.9 3744.2 2947.3 23.4 4350.2 1090.6 2637.5 19.6 24.2 3967.8 3960.4 2751.4 6055.5 7588.1 2355.6 4494.0 1621.0 281.4 1505.4 4004.0 4560.2 415.9 479.9 14643.0 11209.1 5363.5 4833.7 4645.1 5165.6 8250.4 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 33.3;lymphoid tissue: 37.8;testis: 77.1" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1860.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "white matter: 2.1" "Not detected" "Not detected" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 0.8 0.8 1.1 7.1 0.6 33.3 1.6 1.9 0.6 1.2 0.8 6.3 5.5 1.8 0.7 7.3 0.9 1.3 1.3 0.5 0.7 0.6 0.7 1.3 16.6 0.9 1.0 0.3 0.7 0.5 1.3 0.4 5.5 1.3 0.8 7.7 0.8 1.3 0.7 0.9 6.1 5.1 3.2 0.9 3.7 3.5 77.1 0.8 37.8 1.1 0.7 19.4 2.1 2.7 1.8 119.7 45.8 99.6 79.8 5.3 11.6 66.6 86.9 62.1 175.0 151.3 77.6 84.2 136.2 41.3 43.2 121.7 55.2 102.8 59.6 158.2 89.1 44.4 162.1 83.3 65.5 0.6 121.5 71.8 2.7 5.8 125.0 60.3 16.5 57.6 95.4 130.4 113.1 112.4 46.5 127.5 72.9 97.1 58.4 56.5 101.1 149.3 86.4 29.6 42.8 68.3 48.5 116.1 81.6 71.5 71.9 47.2 90.7 34.7 62.9 124.2 69.0 155.6 59.4 65.0 195.3 40.3 115.4 123.9 0.0 0.0 0.0 0.9 0.0 0.0 0.6 1.7 1.2 0.1 0.1 0.3 0.2 0.0 2.0 0.1 0.8 2.9 0.5 1.1 0.6 1.9 0.6 0.5 0.7 0.9 1.0 0.3 1.3 0.9 0.8 1.8 0.1 0.0 0.5 1.6 1.3 1.8 0.5 2.4 0.0 1.0 0.9 0.9 1.6 0.0 1.7 1.8 2.1 12.2 1.9 2.9 1.9 0.3 461.1 1.2 1.4 1.6 0.0 34.5 0.8 0.4 23.4 3.2 3.1 2.1 0.0 13.0 2.9 0.2 9.2 0.0 1.0 3.5 0.0 1.9 1.5 1860.6 9.3 3.4 0.0 1.0 4.3 0.4 0.0 0.5 0.2 0.1 0.2 6.8 7.8 0.8 0.3 0.2 0.3 0.2 6.6 0.8 3.4 60.6 36.8 4.6 0.4 3.7 2.7 0.8 7.4 0.7 PTPRF LAR ENSG00000142949 "Protein tyrosine phosphatase receptor type F" P10586 1 43525187-43623666 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 314.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012710 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA 160000000 "Golgi apparatus" "HPA012710: AB_1855933" "unprognostic (8.20e-2)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (9.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.59e-1)" "unprognostic (1.51e-1)" "unprognostic (4.97e-2)" "unprognostic (4.68e-2)" "unprognostic (7.07e-2)" "unprognostic (1.99e-2)" "prognostic favorable (7.03e-4)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.58e-1)" 92.5 12.0 44.9 14.1 46.4 1.8 58.0 21.7 41.2 31.0 3.6 80.2 71.2 28.2 72.5 102.5 71.2 30.7 5.0 41.3 35.8 27.8 108.1 35.8 4.7 31.6 39.1 42.0 22.2 57.3 31.3 23.7 56.2 31.6 67.9 51.9 24.9 102.6 43.5 2.7 108.8 79.2 35.3 26.7 4.1 50.2 9.5 39.1 29.8 24.0 3.4 26.4 40.3 51.6 35.1 165.6 76.5 49.0 58.0 11.2 0.6 274.3 92.1 36.1 73.9 62.6 82.0 214.9 0.4 25.6 40.2 59.2 124.7 57.5 200.7 89.1 2.0 72.1 1.0 48.7 75.3 33.8 1.2 1.3 11.3 113.2 106.4 174.9 92.6 111.5 7.7 25.4 7.1 27.5 94.0 1.2 1.3 75.9 89.8 21.0 57.2 86.9 3.7 28.3 241.5 73.3 28.0 90.8 314.0 11.8 128.8 91.5 17.3 88.2 1.6 116.5 7.5 126.1 3.1 2.7 0.4 7.4 3.9 233.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 46.4 21.7 41.2 41.3 35.8 31.6 39.1 42.0 31.6 26.7 39.1 35.1 2.3 157.0 101.1 39.2 2.3 62.8 51.3 67.4 52.9 33.5 146.3 102.9 7.6 130.1 74.9 86.5 43.8 64.3 1.4 259.9 0.0 147.4 4.9 80.6 17.2 7.7 100.9 8.0 40.6 120.8 290.1 19.8 93.8 70.6 5.1 72.8 10.4 159.6 14.1 185.1 16.1 171.7 50.8 4.9 5.8 8.5 6.8 3.4 12.4 7.5 2.9 27.2 2.1 16.6 68.1 165.0 124.7 7.2 1.8 68.0 208.1 13.9 128.3 31.0 0.0 15.8 18.5 9.0 37.5 107.5 91.4 66.2 3.9 9.6 142.5 78.7 BEST4 VMD2L2 ENSG00000142959 "Bestrophin 4" Q8NFU0 1 44783585-44788170 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 13.4;fallopian tube: 8.3;intestine: 21.3" "Cell type enriched" "Detected in some" 25 "Paneth cells: 1290.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;U-698: 1.8" "Low region specificity" "Detected in many" HPA058564 Uncertain NA NA "HPA058564: AB_2683759" "unprognostic (5.76e-2)" "unprognostic (1.22e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-2)" "unprognostic (6.51e-3)" "unprognostic (1.09e-1)" "unprognostic (8.39e-2)" "unprognostic (1.45e-3)" "unprognostic (1.04e-1)" "unprognostic (8.97e-2)" "unprognostic (5.72e-2)" "unprognostic (1.29e-1)" "unprognostic (2.69e-5)" "unprognostic (1.43e-1)" "unprognostic (3.72e-1)" "unprognostic (1.28e-1)" "unprognostic (4.13e-3)" 0.2 1.9 2.5 0.7 1.1 0.7 0.5 2.3 1.3 1.0 13.4 21.3 9.2 0.7 3.0 0.2 8.3 0.2 0.2 0.9 1.5 0.5 0.6 1.9 0.6 1.5 2.1 1.0 0.5 0.3 0.3 2.7 0.2 2.3 0.4 16.2 1.1 0.3 0.5 0.5 2.2 8.1 0.5 1.7 0.5 0.4 0.7 1.4 0.5 0.6 0.1 0.4 0.3 0.3 1.4 0.0 0.2 0.3 0.4 0.1 0.1 1.1 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.5 0.1 0.3 0.5 0.1 0.0 0.1 0.3 0.2 0.0 0.8 2.5 0.1 0.0 0.3 0.2 0.3 0.1 0.2 0.6 0.3 0.4 0.1 0.2 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.8 0.3 0.1 0.1 0.1 0.2 0.4 0.0 0.5 0.1 0.1 0.1 0.2 0.4 0.1 1.8 0.4 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.8 0.6 0.7 0.0 0.5 0.2 0.5 0.1 0.3 0.0 0.3 0.6 0.1 2.5 1.1 2.3 1.3 0.9 1.5 1.5 2.1 1.0 2.3 1.7 1.4 1.4 0.2 0.0 0.0 0.0 0.8 0.3 0.8 3.4 0.0 0.8 0.4 1.0 0.5 0.0 4.2 5.5 0.0 0.3 0.4 31.2 1.9 0.7 0.0 26.7 0.5 0.2 2.4 0.0 1.9 0.8 0.2 0.6 0.5 1.2 0.0 0.3 0.4 0.0 0.3 0.0 4.3 3.2 0.0 0.0 0.9 0.2 0.9 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.6 1290.4 0.4 0.4 0.7 6.1 1.0 50.1 0.2 0.0 1.2 0.8 0.7 1.6 0.0 0.6 0.3 1.4 0.4 9.1 0.5 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favorable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 18.0 11.4 11.5 9.5 12.3 5.8 14.3 15.9 11.9 13.3 10.9 14.9 10.4 10.0 10.9 17.6 13.3 11.2 16.5 10.4 15.3 12.5 10.3 17.1 10.2 13.2 12.2 9.4 15.7 38.5 11.3 14.2 14.0 13.3 16.7 10.5 1.8 14.3 13.3 24.8 7.8 13.8 11.2 11.7 19.5 14.7 5.7 12.3 9.3 13.2 49.9 10.6 21.0 14.9 12.2 10.6 4.5 2.0 6.1 19.7 15.2 0.9 5.8 14.7 10.3 10.0 1.6 7.3 0.9 6.2 9.9 14.9 14.7 2.2 7.5 5.4 15.7 0.3 24.6 6.1 1.5 10.2 2.1 8.9 12.5 11.3 9.8 2.7 13.7 6.8 2.5 3.8 6.0 4.3 4.4 1.0 3.3 0.7 6.5 12.7 2.8 6.7 4.6 5.7 18.7 0.8 2.5 9.0 6.3 7.4 2.4 3.8 8.2 5.1 5.1 3.6 8.7 5.2 5.6 1.3 0.7 7.7 3.6 4.3 3.0 11.5 22.9 15.8 12.7 27.6 9.3 15.4 15.9 7.9 11.2 13.4 13.6 8.1 22.9 8.4 9.8 11.1 16.8 11.5 12.3 15.9 11.9 10.4 15.3 13.2 12.2 9.4 13.3 11.7 12.3 12.2 12.0 6.4 6.9 3.6 4.9 11.1 10.2 5.6 12.5 2.9 6.3 4.8 4.9 5.7 4.6 7.3 0.0 1.9 5.1 7.0 5.9 3.2 7.7 2.0 4.3 7.7 8.4 7.8 0.5 6.3 0.9 9.1 3.1 2.3 5.7 7.7 8.2 3.3 13.1 5.0 0.8 8.9 2.0 8.4 14.9 0.9 6.2 23.9 3.6 5.6 5.9 1.8 4.1 3.5 1.3 3.9 2.7 6.8 5.4 14.5 6.8 4.0 5.4 0.8 6.6 13.7 8.1 0.2 0.4 8.0 6.5 1.4 8.1 6.9 5.7 18.5 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 244.3" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 1227.5;Club cells: 405.1;Respiratory ciliated cells: 763.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enriched" "Detected in single" 13 "hypothalamus: 8.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RT4: 286.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles NA NA Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favorable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 78.3 4.9 0.3 0.0 0.2 0.0 62.5 0.2 0.6 10.5 1.1 14.1 1.3 9.6 1.7 44.3 48.4 0.5 24.9 0.2 8.6 2.4 0.1 244.3 0.5 0.4 0.2 0.1 1.8 3.5 0.7 9.4 1.2 0.3 22.9 0.7 0.0 16.8 16.0 24.2 39.5 15.4 0.1 0.2 0.4 11.6 0.5 0.3 3.2 22.5 24.9 15.3 82.4 30.8 0.2 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 286.7 0.1 0.0 0.0 11.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.6 0.2 8.6 0.4 0.2 0.1 0.3 0.2 0.3 0.2 60.8 1227.5 89.3 0.0 0.0 0.5 139.6 111.5 36.5 0.0 2.0 1.5 6.4 1.5 405.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.7 93.8 12.5 23.5 0.0 0.0 0.1 0.0 0.2 47.9 1.1 8.5 6.3 0.0 1.4 0.0 0.6 0.0 0.1 0.0 48.8 0.0 0.3 0.9 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 6.9 0.0 1.1 763.9 0.0 0.0 3.0 23.3 0.1 0.1 71.4 4.1 0.8 1.8 0.0 0.0 163.0 TMEM61 ENSG00000143001 "Transmembrane protein 61" Q8N0U2 1 54980628-54992288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 18.5;parathyroid gland: 13.8;pituitary gland: 48.0;salivary gland: 19.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 49.0;Enteroendocrine cells: 48.4;Intestinal goblet cells: 64.4;Ionocytes: 248.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 20.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA030614 Uncertain NA NA "HPA030614: AB_10603216" "unprognostic (7.62e-2)" "unprognostic (1.67e-3)" "prognostic favorable (1.07e-4)" "unprognostic (1.00e-1)" "unprognostic (6.63e-4)" "unprognostic (6.15e-2)" "unprognostic (2.67e-3)" "unprognostic (1.49e-1)" "unprognostic (3.05e-1)" "unprognostic (4.46e-2)" "unprognostic (1.91e-2)" "unprognostic (7.24e-2)" "prognostic favorable (1.78e-7)" "unprognostic (8.47e-2)" "unprognostic (2.20e-2)" "unprognostic (4.01e-2)" "unprognostic (4.62e-3)" 0.3 6.1 0.7 0.3 0.8 0.0 3.1 3.3 0.9 0.7 1.1 3.5 1.9 0.1 0.1 3.3 2.0 0.3 0.0 0.6 1.6 18.5 0.1 1.0 0.0 2.6 1.3 0.4 0.1 3.6 13.8 48.0 0.1 3.3 2.9 1.8 0.2 19.7 4.9 0.2 3.1 4.3 1.0 0.7 0.3 3.6 0.4 1.0 0.3 0.5 0.1 0.0 2.1 1.1 1.7 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 20.5 2.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 3.3 0.9 0.6 1.6 2.6 1.3 0.4 3.3 0.7 1.0 1.7 0.1 0.0 3.1 0.0 0.4 0.9 6.7 8.2 1.8 2.6 10.5 11.6 0.0 0.0 5.7 7.3 2.1 0.1 0.0 4.7 49.0 4.7 0.1 5.5 1.1 0.2 48.4 0.0 0.4 3.4 0.2 0.3 0.0 11.4 0.0 0.1 0.0 0.0 0.1 0.0 0.3 64.4 248.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.5 0.1 3.7 7.4 0.7 0.0 3.5 1.3 0.2 10.5 0.9 0.0 1.2 0.8 0.3 1.6 5.3 2.4 0.3 0.1 0.1 2.7 4.1 DMRTB1 ENSG00000143006 "DMRT like family B with proline rich C-terminal 1" Q96MA1 1 53459399-53467488 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 63.1" "Cell type enhanced" "Detected in some" "Early spermatids: 54.3;Late spermatids: 120.2;Spermatocytes: 222.5;Spermatogonia: 138.5" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA036490, HPA058553" Enhanced NA NA "HPA036490: AB_10671844, HPA058553: AB_2683753" "unprognostic (2.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.2 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 222.5 138.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMO4 ENSG00000143013 "LIM domain only 4" P61968 1 87328880-87348923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial stromal cells: 508.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AN3-CA: 586.8;T-47d: 373.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022345, HPA045877, HPA061638" Approved Supported "Nucleoplasm,Midbody ring" Yes No Nucleoplasm "Midbody ring" "CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572" "unprognostic (5.39e-2)" "unprognostic (4.62e-3)" "unprognostic (2.67e-2)" "unprognostic (4.33e-3)" "unprognostic (1.37e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.97e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.46e-2)" "unprognostic (6.82e-2)" "unprognostic (1.14e-2)" "unprognostic (2.86e-2)" "unprognostic (2.87e-2)" "prognostic favorable (1.42e-4)" "unprognostic (1.70e-1)" 46.7 16.4 107.3 28.9 133.2 22.1 35.0 96.3 158.8 48.4 88.5 37.4 26.9 43.6 39.7 51.3 32.7 45.9 38.5 128.1 106.1 28.5 33.6 38.6 29.8 101.1 97.7 126.0 40.0 25.7 23.1 31.8 64.4 102.1 56.9 31.9 34.8 88.2 81.7 48.0 40.1 43.4 30.6 97.2 39.1 91.5 28.3 97.0 23.7 34.0 25.7 88.5 39.2 54.5 120.2 55.1 42.3 32.3 586.8 96.6 113.9 81.8 48.4 38.3 44.9 49.8 104.3 34.0 127.5 60.3 57.2 72.4 44.7 13.1 33.8 44.5 68.6 32.4 116.5 87.2 32.3 92.9 63.6 151.2 60.2 76.4 70.0 39.8 80.9 30.8 48.7 26.8 109.8 24.5 22.3 1.8 41.3 118.1 58.6 39.3 72.8 45.0 28.5 56.1 206.7 26.5 1.7 195.3 28.7 149.6 61.1 373.3 171.8 20.1 208.9 39.0 50.6 161.7 99.7 70.6 28.8 26.1 13.8 30.7 30.5 9.1 19.5 7.8 11.6 9.0 10.1 6.9 8.0 6.9 6.9 1.8 4.4 15.0 22.4 11.5 10.3 2.1 5.1 107.3 133.2 96.3 158.8 128.1 106.1 101.1 97.7 126.0 102.1 97.2 97.0 120.2 103.5 44.8 24.1 50.9 88.6 98.4 49.3 105.6 245.3 226.2 170.0 191.5 72.4 153.0 78.1 36.8 73.0 322.8 116.5 50.0 62.6 74.2 2.1 106.5 508.1 65.6 31.1 48.1 204.4 127.6 363.3 149.0 159.6 131.5 307.4 19.5 78.1 85.7 74.0 111.0 37.5 80.6 14.2 138.4 73.2 7.5 95.1 76.1 65.8 22.5 74.6 82.7 83.4 52.8 25.8 107.2 29.9 235.5 174.6 49.3 90.3 56.8 31.0 35.9 32.9 80.6 175.5 4.4 97.9 200.3 92.9 256.0 77.9 61.7 64.9 37.5 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466546-109482134 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 20 "skeletal muscle: 366.9;tongue: 176.9" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Cardiomyocytes: 10.6;Collecting duct cells: 3.7;Hepatocytes: 4.8;Late spermatids: 11.1;Proximal tubular cells: 5.1;Skeletal myocytes: 4.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 31.6;ASC TERT1: 13.2;BJ: 14.1;BJ hTERT+: 44.1;fHDF/TERT166: 23.1;HAP1: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 2.6 11.8 1.4 0.6 1.3 0.0 1.5 1.2 2.3 3.6 3.4 4.6 0.5 6.7 4.5 4.6 1.4 0.9 13.6 1.5 2.6 9.7 9.6 1.3 0.5 1.3 1.3 1.2 3.0 5.1 5.8 1.1 3.2 1.2 3.2 1.0 0.4 4.2 6.0 366.9 0.7 1.6 6.1 0.9 1.1 3.2 9.4 1.4 0.1 8.1 176.9 0.3 4.2 2.4 1.2 0.0 0.1 0.1 1.8 31.6 13.2 0.0 14.1 44.1 4.3 1.6 0.0 0.1 0.0 0.0 23.1 0.5 0.0 11.8 0.0 0.9 0.0 5.1 0.0 0.4 0.2 0.6 0.0 1.1 1.2 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.1 0.0 1.4 3.3 2.3 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 1.2 2.3 1.5 2.6 1.3 1.3 1.2 1.2 0.9 1.4 1.2 0.2 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 10.6 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.2 2.8 0.0 0.1 0.4 0.0 0.0 0.3 1.3 0.0 1.0 0.0 0.0 0.0 0.9 0.0 4.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 1.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 5.1 0.0 0.0 0.0 4.8 2.6 0.4 1.4 0.0 0.0 0.1 0.2 0.4 0.0 0.0 BARHL2 ENSG00000143032 "BarH like homeobox 2" Q9NY43 1 90711539-90717302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 27.2" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 23.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "cerebellum: 27.2;pons: 8.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.0;HEK 293: 3.7;HMC-1: 1.0" "Region enriched" "Detected in many" 5 "cerebellum: 12.9" "Region enriched" "Detected in some" 20 "cerebellum: 24.6" NA NA "unprognostic (1.83e-1)" "unprognostic (1.73e-1)" "unprognostic (6.80e-2)" "unprognostic (3.10e-1)" "unprognostic (1.60e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 27.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.7 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 27.2 0.6 0.0 1.3 0.5 2.7 0.0 8.6 0.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 4.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTF2 "M96, PCL2, TDRD19A" ENSG00000143033 "Metal response element binding transcription factor 2" Q9Y483 1 93079235-93139079 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 117.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069047, HPA069066" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA069047: AB_2686073, HPA069066: AB_2686078" "unprognostic (1.84e-2)" "unprognostic (1.45e-1)" "unprognostic (5.56e-2)" "unprognostic (7.88e-3)" "unprognostic (7.12e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.90e-7)" "unprognostic (1.26e-2)" "unprognostic (9.22e-3)" "unprognostic (3.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.05e-4)" "prognostic unfavorable (2.47e-7)" "unprognostic (7.19e-3)" "unprognostic (2.48e-1)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" 5.5 6.5 6.4 10.5 7.1 23.7 9.4 10.8 8.0 7.4 5.8 7.6 7.6 8.2 7.4 5.7 6.8 6.3 4.4 6.5 6.4 6.2 6.8 7.3 20.2 6.0 6.4 6.2 10.2 5.5 5.5 5.8 12.4 6.9 5.6 7.7 8.8 5.2 4.1 7.3 7.6 7.9 6.0 6.0 11.6 6.9 17.0 6.6 29.5 7.2 6.0 19.0 6.7 6.6 7.2 20.8 9.8 33.7 22.8 5.7 5.5 38.8 12.8 10.3 21.9 27.3 17.3 11.0 66.9 23.3 8.2 19.2 10.4 31.1 13.4 32.5 25.8 22.7 45.7 15.7 22.4 8.5 61.4 19.4 7.0 7.2 21.2 12.4 10.1 21.3 50.9 53.2 20.0 13.9 9.2 88.1 49.5 57.4 8.9 13.0 70.4 40.8 17.9 20.5 22.1 20.8 24.8 21.1 25.1 26.5 34.8 15.2 42.1 12.1 14.7 21.4 14.1 19.8 15.3 19.2 117.7 2.8 35.4 9.8 9.1 7.3 11.8 7.9 8.1 9.3 7.2 8.3 10.3 9.4 8.6 9.8 8.9 5.4 10.6 5.1 8.7 10.1 4.9 6.4 7.1 10.8 8.0 6.5 6.4 6.0 6.4 6.2 6.9 6.0 6.6 7.2 36.4 28.9 29.7 52.2 53.8 46.5 28.5 37.0 26.2 0.0 33.2 25.0 13.6 18.6 32.6 38.6 0.0 68.3 64.5 26.2 7.9 33.8 5.0 24.7 29.2 40.2 32.2 51.6 70.3 19.3 67.4 23.9 23.4 36.0 60.1 56.4 43.5 15.0 34.1 0.0 58.0 31.1 40.7 27.4 54.0 7.4 32.6 34.5 17.8 54.4 50.4 0.0 90.6 68.9 68.1 30.9 28.5 23.7 39.6 41.2 39.2 15.5 21.0 0.0 39.5 24.2 39.4 125.5 89.3 24.1 43.2 60.7 54.0 45.8 33.7 48.1 SLC44A3 "CTL3, MGC45474" ENSG00000143036 "Solute carrier family 44 member 3" Q8N4M1 1 94820342-94895246 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "OE19: 35.9;RPTEC TERT1: 101.4;RT4: 69.5" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in all" HPA047433 Enhanced NA NA "HPA047433: AB_2680046" "unprognostic (8.06e-2)" "unprognostic (7.65e-2)" "unprognostic (4.63e-3)" "unprognostic (3.57e-2)" "unprognostic (1.53e-2)" "unprognostic (2.37e-1)" "unprognostic (1.14e-1)" "unprognostic (4.03e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-1)" "unprognostic (5.78e-2)" "unprognostic (2.44e-2)" "prognostic favorable (7.63e-5)" "unprognostic (9.09e-2)" "unprognostic (8.28e-2)" "unprognostic (5.95e-2)" "unprognostic (3.31e-3)" 2.2 8.9 14.6 6.3 13.8 0.1 8.1 16.9 17.1 8.8 12.7 31.8 26.4 7.2 6.6 9.5 8.1 11.0 3.6 13.7 15.8 29.6 6.4 10.4 0.8 20.0 14.6 12.8 1.8 27.2 5.2 15.1 3.4 14.8 10.9 35.8 4.3 23.7 7.8 0.2 6.0 28.2 2.8 15.7 0.9 29.6 2.5 15.0 4.9 5.2 0.6 2.2 22.3 6.5 17.0 23.4 3.2 0.8 0.0 2.5 3.2 15.9 0.4 3.4 0.8 3.7 21.4 5.8 0.0 15.4 0.4 6.9 7.7 3.5 5.5 1.4 0.0 4.1 0.0 1.2 1.7 1.1 0.0 0.0 9.9 5.1 1.6 0.0 6.3 0.4 0.0 0.0 0.0 1.4 3.4 0.0 0.3 1.0 35.9 0.8 1.8 0.7 1.3 101.4 69.5 10.4 17.0 1.0 10.8 7.8 7.3 6.2 0.7 0.0 0.5 3.5 1.5 0.2 0.0 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 13.8 16.9 17.1 13.7 15.8 20.0 14.6 12.8 14.8 15.7 15.0 17.0 0.4 25.6 6.7 26.1 0.6 3.1 27.8 14.6 4.0 0.7 15.6 8.3 5.7 37.1 22.7 12.9 0.0 15.9 0.1 18.2 15.6 33.4 32.5 12.8 3.2 1.3 16.3 0.0 1.4 27.8 0.8 3.8 16.3 22.5 1.3 5.3 0.7 2.1 1.3 0.0 4.6 32.2 20.3 0.3 0.4 5.3 5.0 0.8 5.4 2.8 1.0 17.0 0.0 5.5 2.0 38.3 36.5 10.9 0.0 12.9 22.8 38.6 11.4 0.2 0.0 9.6 3.4 0.1 0.2 10.2 3.8 6.7 0.8 4.1 42.8 30.3 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 256.5;WM-115: 239.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.5 1.8 1.6 1.3 2.2 0.3 8.6 2.4 4.0 3.8 1.2 6.6 7.8 2.9 5.7 23.3 2.0 3.2 9.2 1.0 3.0 11.5 0.5 8.5 0.5 1.8 3.0 1.4 0.4 2.6 2.1 2.4 11.2 2.4 5.7 5.8 7.6 9.1 5.8 1.7 18.3 8.8 2.9 2.3 0.4 8.7 4.2 4.8 11.0 8.3 1.5 5.4 5.1 11.0 3.3 22.3 36.9 28.2 7.2 6.4 13.4 75.5 0.1 1.0 2.9 1.0 21.5 12.4 0.0 11.4 0.3 15.8 60.7 12.6 30.4 1.3 256.5 9.3 12.1 13.7 0.6 0.0 1.2 22.2 1.7 23.1 0.2 5.2 5.3 0.2 4.1 3.7 0.2 0.6 78.0 0.9 0.8 17.8 13.4 0.9 9.1 34.6 0.1 21.6 27.5 16.4 50.0 8.9 84.7 55.1 53.9 28.7 1.5 0.1 4.9 16.4 0.2 23.0 0.3 1.3 0.1 2.2 0.7 239.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 2.4 4.0 1.0 3.0 1.8 3.0 1.4 2.4 2.3 4.8 3.3 3.5 16.0 36.0 1.0 0.0 19.6 8.6 23.2 23.9 29.3 17.1 10.8 16.1 7.2 9.1 14.7 0.0 13.7 0.1 29.3 3.9 14.0 2.1 8.3 2.1 3.3 3.0 0.0 11.8 1.9 27.3 7.8 16.8 14.4 1.3 7.3 1.8 0.6 2.1 6.7 18.8 5.0 2.0 1.3 11.1 2.2 1.2 0.5 8.8 0.0 3.1 11.3 0.0 1.5 0.4 16.4 7.3 0.0 0.0 10.2 15.4 11.4 11.3 0.8 0.0 26.4 2.8 0.5 3.8 30.6 27.7 13.3 0.4 3.5 9.3 11.4 ZNF697 MGC45731 ENSG00000143067 "Zinc finger protein 697" Q5TEC3 1 119619377-119648266 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.0;Syncytiotrophoblasts: 19.8" "Cancer enhanced" "Detected in all" "melanoma: 14.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 42.8;WM-115: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049933 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049933: AB_2680958" "unprognostic (2.57e-1)" "unprognostic (7.02e-3)" "unprognostic (4.32e-2)" "unprognostic (2.45e-2)" "unprognostic (3.38e-1)" "unprognostic (9.79e-3)" "unprognostic (1.20e-3)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (1.45e-1)" "unprognostic (5.09e-2)" "unprognostic (1.14e-1)" "prognostic favorable (6.20e-5)" "unprognostic (1.19e-2)" "unprognostic (6.48e-2)" "unprognostic (3.53e-2)" "unprognostic (3.36e-1)" 4.1 2.9 1.3 1.4 3.3 1.0 3.4 0.0 3.8 1.5 0.0 1.3 1.7 2.2 2.4 0.8 1.4 1.5 4.3 1.6 1.3 7.6 3.2 4.4 0.6 0.9 0.0 3.1 2.0 2.9 5.0 2.8 6.9 0.7 4.3 1.4 0.9 5.4 1.0 2.1 1.4 1.5 1.2 0.0 1.5 1.9 3.1 0.3 0.5 3.2 2.0 0.4 2.0 1.0 0.6 2.0 1.0 4.9 1.6 6.4 7.0 6.6 8.8 12.2 5.1 4.6 3.1 0.4 0.0 2.9 4.9 4.0 2.2 3.8 8.7 11.9 0.0 3.8 3.3 2.0 5.9 12.2 2.2 2.2 11.9 2.4 11.4 24.2 5.6 10.1 2.8 3.0 0.4 2.3 1.5 0.0 1.6 26.1 1.8 2.9 0.0 11.8 0.2 2.4 4.5 1.1 6.8 2.0 2.1 42.8 15.4 1.0 3.1 23.4 8.4 10.7 6.0 15.4 1.2 2.0 0.0 11.9 2.3 42.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 3.3 0.0 3.8 1.6 1.3 0.9 0.0 3.1 0.7 0.0 0.3 0.6 2.2 0.0 0.5 1.3 0.1 2.2 1.5 2.5 0.6 0.8 1.7 0.6 8.8 1.5 1.9 1.8 0.0 7.9 0.0 0.7 3.9 1.8 1.6 1.1 2.6 3.5 2.4 0.0 17.0 0.9 2.3 4.3 1.5 1.8 0.0 5.5 3.3 4.2 2.6 0.0 6.9 2.1 4.1 3.7 12.0 3.6 4.7 3.1 5.4 4.7 2.7 1.1 0.0 8.0 0.6 2.1 3.3 6.4 0.0 3.7 1.8 6.4 0.4 0.9 6.6 0.5 5.4 1.3 1.5 0.4 1.8 19.8 0.1 5.3 1.8 0.9 CTTNBP2NL DKFZp547A023 ENSG00000143079 "CTTNBP2 N-terminal like" Q9P2B4 1 112396214-112463456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Langerhans cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 68.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007301 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA007301: AB_1847693" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "prognostic favorable (1.14e-4)" "unprognostic (4.21e-3)" "unprognostic (4.54e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (1.05e-1)" "prognostic favorable (8.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.63e-1)" "unprognostic (9.99e-2)" "unprognostic (5.12e-2)" 13.3 4.9 6.1 10.3 5.4 0.5 11.4 5.0 6.2 11.9 5.6 15.6 7.6 15.4 4.7 19.7 8.4 16.7 6.3 4.9 7.4 9.2 5.6 13.1 6.3 7.9 6.1 3.5 9.5 4.6 7.5 3.5 20.3 7.7 9.0 14.9 8.2 7.1 9.3 3.0 14.5 10.6 13.6 6.7 10.7 8.7 5.9 6.3 4.4 8.4 6.9 8.3 15.7 11.9 8.9 21.8 7.9 25.7 12.2 17.0 22.3 8.6 33.6 31.4 21.4 21.1 6.1 10.7 3.4 13.2 25.4 10.5 17.4 16.9 23.2 24.9 7.1 8.1 4.6 13.1 4.9 19.7 1.6 7.8 26.4 14.0 26.5 23.0 24.5 52.7 5.7 4.2 3.0 29.9 6.4 3.0 0.6 16.6 6.1 12.3 5.3 24.0 0.0 32.6 15.9 12.6 13.2 26.0 5.3 13.3 24.5 4.3 1.8 68.5 21.3 24.9 22.0 15.8 0.4 3.1 0.1 22.1 2.0 57.0 0.0 2.6 0.0 0.0 2.1 0.0 0.1 0.0 0.0 8.6 0.3 0.0 0.0 0.1 0.0 0.4 3.7 2.0 0.4 6.1 5.4 5.0 6.2 4.9 7.4 7.9 6.1 3.5 7.7 6.7 6.3 8.9 100.4 57.7 22.4 17.6 4.4 38.7 30.2 32.0 24.5 10.2 12.3 9.5 9.7 7.2 41.4 22.0 6.2 17.6 4.6 64.0 3.9 39.1 3.3 29.1 30.7 71.6 8.3 3.6 44.1 21.6 12.8 24.2 14.8 58.5 19.0 17.8 41.7 1.6 13.5 5.0 31.2 27.4 30.5 29.7 131.7 4.0 10.5 40.8 16.0 81.5 30.5 11.0 0.0 30.2 25.1 47.7 52.7 11.3 0.7 25.4 21.7 22.6 17.5 7.9 19.7 20.1 29.2 16.8 16.7 25.0 60.7 25.4 2.7 9.1 24.4 69.3 STRIP1 "FAM40A, FAR11A, FLJ14743, KIAA1761" ENSG00000143093 "Striatin interacting protein 1" Q5VSL9 1 110031577-110074641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060302, HPA060498" Approved Supported Cytosol NA NA Cytosol "HPA060302: AB_2684247, HPA060498: AB_2684293" "unprognostic (2.75e-2)" "unprognostic (3.91e-1)" "unprognostic (2.81e-2)" "unprognostic (1.63e-1)" "unprognostic (5.09e-1)" "unprognostic (2.90e-2)" "unprognostic (1.01e-2)" "unprognostic (9.08e-2)" "unprognostic (2.83e-1)" "unprognostic (6.29e-2)" "unprognostic (1.41e-3)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (1.82e-1)" "unprognostic (6.23e-2)" "unprognostic (2.23e-2)" 14.1 15.0 12.4 11.8 13.8 22.8 14.0 9.8 14.5 18.5 8.7 15.8 13.2 19.3 15.7 15.3 15.7 10.9 12.8 13.7 13.0 11.3 9.9 12.8 15.7 11.7 12.7 13.1 21.7 12.7 21.4 15.8 16.7 13.3 13.0 13.5 12.0 14.3 14.0 14.3 17.3 19.8 18.2 9.5 22.8 13.6 19.6 14.0 16.4 13.7 13.9 15.5 15.5 15.1 13.0 19.7 12.8 34.3 23.4 29.3 19.3 24.7 30.3 26.3 30.9 26.8 13.5 11.2 16.0 16.2 27.0 19.6 18.3 18.4 21.5 21.7 34.2 22.3 26.7 23.1 17.7 16.2 24.3 25.6 20.7 25.3 26.2 28.6 22.7 25.0 21.6 24.1 19.9 30.3 23.3 28.0 25.5 27.9 14.8 17.2 27.0 44.1 14.3 21.4 28.5 44.1 25.4 25.9 32.4 19.5 19.7 16.2 21.9 25.9 23.2 22.1 27.2 20.5 20.3 12.0 16.3 26.5 25.9 34.2 13.9 10.5 14.8 14.9 11.4 13.0 10.7 12.5 15.7 12.2 10.2 14.4 13.0 9.6 16.1 15.5 5.6 12.6 12.8 12.4 13.8 9.8 14.5 13.7 13.0 11.7 12.7 13.1 13.3 9.5 14.0 13.0 9.0 3.2 7.8 17.3 16.4 13.8 10.0 7.2 9.6 12.6 8.3 5.7 8.5 4.3 8.2 9.2 18.8 16.1 11.9 15.5 1.9 10.7 47.3 9.1 9.6 13.2 15.0 13.0 15.6 7.2 10.4 10.6 11.7 15.1 7.0 16.2 14.6 9.8 12.9 6.7 17.7 13.0 8.2 11.1 11.6 58.0 9.9 8.9 3.6 7.5 14.3 7.1 17.5 15.1 12.6 12.5 10.2 10.1 11.9 11.5 23.1 3.9 3.0 18.9 6.6 11.4 12.5 11.3 10.2 10.9 12.8 25.9 15.2 13.0 11.5 14.1 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMA5 ZETA ENSG00000143106 "Proteasome 20S subunit alpha 5" P28066 1 109399042-109426448 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028392, HPA028398, HPA028441" Approved Supported Cytosol NA NA 20000000 Cytosol "HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003" "unprognostic (3.82e-2)" "unprognostic (3.09e-3)" "prognostic favorable (1.45e-5)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (5.95e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-3)" "unprognostic (4.20e-3)" "unprognostic (3.05e-1)" "unprognostic (1.07e-3)" "unprognostic (3.99e-2)" "unprognostic (2.34e-1)" "unprognostic (8.81e-3)" "unprognostic (1.05e-1)" 3.5 4.7 5.2 4.3 6.4 3.9 6.8 4.3 7.8 5.8 2.9 7.5 7.6 5.5 8.7 6.9 9.1 5.5 7.8 7.2 5.7 11.0 20.4 6.0 12.8 4.8 5.0 5.4 5.2 3.2 5.9 1.4 6.9 5.8 5.5 8.6 4.8 5.0 6.2 6.1 6.2 6.7 6.5 3.9 4.8 5.3 3.5 5.0 6.4 10.3 5.1 9.4 6.1 0.9 6.9 10.1 11.7 6.2 5.7 17.6 16.9 12.6 4.9 29.8 23.2 17.9 15.0 5.5 28.1 7.8 21.2 4.2 5.7 13.8 13.7 16.1 10.7 13.1 13.4 7.7 12.4 14.0 15.2 5.3 8.5 12.3 12.7 14.3 6.2 15.0 8.2 17.1 6.5 12.4 18.6 54.4 10.3 5.7 7.0 16.5 4.4 16.9 7.4 19.0 11.5 7.3 5.2 10.5 16.2 8.9 5.0 5.9 14.1 11.7 4.6 4.6 7.9 10.3 3.6 11.6 19.7 20.0 26.0 7.4 11.0 4.3 3.1 7.7 6.3 8.4 5.7 9.0 8.3 5.9 4.7 9.7 9.7 1.4 7.2 6.1 4.2 11.4 7.0 5.2 6.4 4.3 7.8 7.2 5.7 4.8 5.0 5.4 5.8 3.9 5.0 6.9 68.9 41.7 56.8 9.4 77.4 63.6 73.5 231.0 38.1 32.6 59.5 75.7 89.5 75.8 120.9 42.3 6.2 227.0 114.5 82.1 140.8 164.9 82.0 157.6 74.1 71.6 56.3 85.0 21.7 183.0 181.4 60.4 74.9 81.9 82.4 77.7 51.4 117.4 166.9 13.5 18.4 144.1 168.9 57.8 73.6 23.4 67.7 86.3 58.7 15.0 184.8 50.2 114.4 13.0 20.2 191.6 103.5 62.1 113.1 122.2 138.0 205.6 172.4 31.7 46.0 56.1 182.6 120.3 89.1 70.4 65.9 241.2 106.1 121.4 135.3 104.2 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712908-108742749 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 1.1" "Cell type enhanced" "Detected in some" "Astrocytes: 2.6;Early spermatids: 4.6;Late spermatids: 1.5;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" NA NA "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: AB_2682441" "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.8 0.9 1.0 0.6 0.2 0.6 0.7 0.3 0.6 0.2 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 4.6 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.8 0.0 3.5 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 116.0;lymphoid tissue: 135.6" "Cell type enhanced" "Detected in many" "granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA026988 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 45.6 23.8 21.0 71.5 22.6 116.0 22.5 22.2 29.3 12.5 25.0 15.9 7.4 11.6 6.3 9.9 22.7 31.4 15.1 21.2 25.7 12.6 42.3 86.4 71.0 25.4 22.6 20.2 9.5 9.5 4.8 9.2 15.3 24.4 11.8 18.1 9.6 11.3 6.6 10.2 7.7 21.4 37.9 22.7 135.6 12.6 7.6 25.8 28.0 10.1 7.5 56.4 25.3 10.9 24.6 0.3 0.1 0.5 1.1 0.4 0.6 0.6 0.9 0.1 0.3 0.3 0.2 0.4 0.5 0.5 0.2 0.1 0.2 0.8 0.5 0.6 141.3 0.4 0.4 0.5 0.0 0.4 70.4 11.1 0.0 2.6 0.8 0.9 1.0 2.0 0.7 0.5 0.4 0.5 0.5 0.6 40.3 0.2 0.7 0.8 0.1 0.7 0.1 0.3 0.1 0.5 0.2 0.5 0.6 0.8 0.6 0.3 55.2 0.0 0.8 1.0 0.7 0.6 0.6 0.1 0.6 0.3 117.9 1.2 1114.1 1026.8 1294.8 166.6 1529.2 47.6 231.0 206.5 97.3 1021.6 296.4 318.0 193.6 143.3 536.7 1173.4 302.8 66.7 1189.5 21.0 22.6 22.2 29.3 21.2 25.7 25.4 22.6 20.2 24.4 22.7 25.8 24.6 4.4 22.4 43.9 8.1 84.1 7.9 0.7 0.4 0.6 4.0 2.2 5.2 3.8 10.0 4.5 7.3 2.1 1.0 103.4 0.6 0.0 0.2 36.7 0.8 0.9 8.1 1.8 23.5 9.2 0.2 2.0 3.2 0.5 1.0 182.3 0.9 15.7 8.9 195.3 0.0 13.0 0.0 0.0 797.4 226.7 90.7 2.8 413.5 12.4 12.2 278.6 0.2 355.3 6.0 7.7 0.2 0.0 0.7 4.2 0.8 0.9 1.0 0.9 4.2 32.9 2.4 2.9 2.4 2.0 0.2 6.5 1.6 59.8 0.3 0.7 0.3 CD53 "MOX44, TSPAN25" ENSG00000143119 "CD53 molecule" P19397 1 110871188-110899922 "CD markers, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 452.0" "Cell type enhanced" "Detected in many" "B-cells: 310.0;dendritic cells: 375.0;Hofbauer cells: 365.7;Kupffer cells: 324.3;Macrophages: 294.8;NK-cells: 383.1;T-cells: 297.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 473.5;HDLM-2: 214.8;HMC-1: 298.4;Karpas-707: 188.1;U-266/70: 251.2;U-698: 149.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047216 Enhanced NA NA "HPA047216: AB_2679986" "unprognostic (2.93e-2)" "unprognostic (1.25e-2)" "unprognostic (7.45e-3)" "unprognostic (1.02e-3)" "unprognostic (8.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.96e-1)" "unprognostic (6.07e-2)" "unprognostic (2.83e-2)" "unprognostic (2.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.58e-2)" "unprognostic (4.95e-2)" "unprognostic (1.33e-1)" "unprognostic (7.72e-2)" 64.0 31.1 11.0 286.9 13.5 127.7 27.3 14.0 16.7 21.0 17.3 41.9 38.2 17.5 10.6 20.2 23.0 59.0 12.3 10.4 24.6 13.4 47.2 116.0 401.2 20.1 14.2 9.1 9.3 12.0 6.6 6.3 59.0 19.1 12.9 55.3 2.1 19.5 12.9 4.5 6.7 104.2 56.3 23.7 271.5 44.7 5.7 16.1 146.2 11.4 10.7 452.0 85.9 9.1 22.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 473.5 0.2 0.0 0.2 0.5 0.0 0.0 0.0 214.8 0.0 26.4 0.1 0.0 0.0 60.4 298.4 0.0 0.0 0.0 0.0 0.0 0.0 139.2 11.2 188.1 0.0 0.0 103.1 71.1 0.4 0.0 0.0 98.0 0.7 104.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.5 0.0 88.4 17.2 0.2 0.4 0.1 0.5 251.2 123.2 149.2 1.5 68.7 3.4 1483.0 779.5 479.0 732.4 808.6 658.1 794.0 527.8 649.2 631.9 745.1 377.9 552.5 1144.2 526.6 882.9 517.5 740.3 1621.0 11.0 13.5 14.0 16.7 10.4 24.6 20.1 14.2 9.1 19.1 23.7 16.1 22.8 4.2 16.0 24.4 0.7 310.0 7.0 0.6 0.0 0.6 0.0 2.3 5.1 1.0 5.7 8.6 1.8 0.0 2.1 375.0 0.2 0.0 0.5 0.4 0.4 0.5 13.0 0.0 42.9 5.8 0.2 5.4 6.7 7.1 0.6 162.2 0.0 16.4 6.7 365.7 0.0 1.4 0.3 0.0 324.3 161.5 1.9 2.1 294.8 39.2 69.3 156.3 0.1 383.1 1.0 0.6 0.3 0.1 0.4 134.0 0.3 0.0 1.6 4.4 0.6 6.6 1.9 1.8 0.1 0.6 1.1 5.5 4.1 297.0 0.0 0.2 0.3 PROK1 "EGVEGF, PK1, PRK1" ENSG00000143125 "Prokineticin 1" P58294 1 110451149-110457358 "Predicted secreted proteins" Angiogenesis "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ovary: 198.7;placenta: 50.6;testis: 59.6" "Group enriched" "Detected in some" 8 "Leydig cells: 173.1;Peritubular cells: 668.0" "Cancer enhanced" "Detected in many" "testis cancer: 4.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "ASC diff: 22.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.4" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (2.66e-1)" "unprognostic (2.71e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" "unprognostic (3.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.24e-2)" "unprognostic (3.74e-2)" "unprognostic (7.39e-3)" "unprognostic (1.90e-1)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" 3.2 9.8 0.5 0.4 0.7 0.0 5.2 0.4 0.8 11.1 0.3 0.2 0.1 0.3 0.1 1.2 3.5 0.4 2.1 1.2 0.5 0.1 0.2 0.3 0.0 5.0 1.0 0.4 198.7 0.3 0.0 0.7 50.6 1.2 12.9 0.0 0.1 0.5 10.0 1.3 2.2 0.2 0.0 1.8 1.5 0.4 59.6 0.8 0.1 0.2 0.0 0.0 4.6 25.3 1.5 0.0 0.0 0.0 0.1 22.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.4 0.8 1.2 0.5 5.0 1.0 0.4 1.2 1.8 0.8 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.6 16.4 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.3 0.0 1.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 23.4 173.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 668.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.7 1.1 0.0 0.0 1.0 0.1 52.3 0.0 0.1 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109249539-109275751 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3;skin 1: 24.9" "Cell type enhanced" "Detected in many" "Horizontal cells: 97.6;Oligodendrocytes: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 47.9;HaCaT: 48.4;MCF7: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA 1300000 Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 0.8 1.5 10.5 0.5 14.2 0.3 4.2 0.0 41.7 5.2 0.0 2.2 0.8 2.2 3.2 14.1 16.3 1.1 4.5 48.3 0.8 4.1 0.6 1.1 0.7 5.5 2.3 11.8 0.6 3.9 6.1 3.0 0.9 7.4 3.0 0.7 5.8 5.7 8.0 9.0 24.9 1.1 1.6 0.9 0.4 2.0 9.4 1.3 1.2 9.2 4.0 2.5 1.9 9.5 21.9 14.0 12.8 47.9 8.9 0.1 0.0 13.0 1.6 1.1 2.9 0.8 2.0 0.4 2.5 10.9 1.0 2.2 48.4 12.5 7.8 1.5 0.3 5.3 1.1 11.8 2.8 1.0 0.8 6.2 0.2 18.5 1.2 0.8 10.8 0.5 7.7 8.5 0.6 0.0 56.6 1.4 0.7 15.7 1.6 2.5 12.8 4.4 0.7 10.3 4.7 19.5 9.2 7.6 16.2 10.1 11.3 15.3 3.1 0.0 0.0 8.5 0.8 12.4 3.2 1.0 0.7 2.6 1.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 14.2 0.0 41.7 48.3 0.8 5.5 2.3 11.8 7.4 0.9 1.3 21.9 0.9 9.6 5.0 15.0 0.2 15.7 5.1 19.7 9.6 13.2 16.4 16.3 13.5 2.8 11.3 18.4 4.2 2.2 1.9 1.3 1.9 2.6 5.1 12.8 1.4 1.5 1.8 0.0 34.0 0.4 1.3 1.2 2.6 17.7 1.3 5.5 0.4 7.1 1.1 97.6 27.7 0.9 2.0 0.8 3.4 9.3 3.4 0.9 10.6 5.6 1.0 29.9 3.1 24.6 48.1 1.5 0.5 19.2 0.4 4.3 0.2 3.1 8.4 5.2 6.6 5.0 4.9 1.6 6.8 31.0 22.9 0.5 1.5 0.0 2.0 6.9 ITGA10 ENSG00000143127 "Integrin subunit alpha 10" O75578 1 145891208-145910111 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Endothelial cells: 22.7;Hepatic stellate cells: 55.3;Horizontal cells: 20.2;Late spermatids: 44.8;Microglial cells: 19.7" "Cancer enriched" "Detected in many" 4 "melanoma: 6.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 50.7;HSkMC: 46.3;hTERT-HME1: 41.0;LHCN-M2: 72.6;TIME: 125.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.18e-4)" "unprognostic (4.53e-1)" "unprognostic (4.44e-3)" "unprognostic (2.32e-2)" "unprognostic (3.60e-2)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-1)" "unprognostic (4.37e-1)" "unprognostic (5.72e-3)" "unprognostic (6.48e-2)" "unprognostic (5.79e-2)" "unprognostic (2.58e-6)" "unprognostic (2.77e-3)" "unprognostic (1.54e-1)" "unprognostic (2.05e-5)" "unprognostic (2.57e-2)" 3.0 2.0 4.5 0.8 4.5 0.2 8.4 4.4 5.9 5.9 10.2 3.7 1.4 4.0 2.1 2.1 4.5 1.4 6.1 4.2 4.3 2.6 1.8 16.6 0.9 4.2 4.5 3.7 3.7 1.6 0.7 5.8 1.9 4.4 5.0 0.7 3.8 5.3 0.8 13.7 2.5 5.7 1.9 4.3 2.0 4.6 2.8 4.6 0.6 5.7 2.8 0.9 6.7 3.6 4.6 0.0 1.4 0.2 0.3 1.3 50.7 0.0 0.6 14.2 0.2 0.6 0.0 0.7 0.3 0.8 0.3 0.1 0.3 0.4 1.3 0.5 0.6 0.1 0.2 0.0 0.5 9.2 0.2 0.7 46.3 2.7 1.9 41.0 19.4 23.5 1.5 0.1 0.2 72.6 0.3 0.1 0.5 0.2 1.1 1.1 0.3 0.1 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.6 0.5 0.8 0.3 125.7 22.2 0.3 0.3 0.3 0.2 0.8 0.1 2.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.5 4.4 5.9 4.2 4.3 4.2 4.5 3.7 4.4 4.3 4.6 4.6 7.3 0.0 3.7 0.7 1.8 2.3 6.3 0.6 0.6 10.5 10.2 16.5 4.3 0.0 2.8 7.3 8.4 0.8 2.7 0.4 0.0 0.1 36.0 1.1 1.3 22.7 0.0 0.0 3.9 0.2 0.5 4.2 2.0 1.4 0.0 0.2 55.3 0.8 0.6 20.2 4.0 0.2 0.0 0.6 2.2 44.8 0.9 1.2 0.0 19.7 0.6 0.6 2.1 2.5 0.8 0.0 0.1 0.7 0.1 3.6 0.2 0.0 0.4 7.3 0.0 4.8 3.9 5.8 1.9 2.0 2.7 0.8 1.8 0.4 0.7 1.3 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 41.9;smooth muscle: 27.8" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 158.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Uncertain Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 3.5 1.1 3.5 5.4 2.7 0.2 2.7 3.2 3.7 6.3 1.6 6.3 1.5 41.9 3.6 9.9 10.8 5.7 2.7 3.7 2.1 1.3 0.4 4.2 1.0 3.6 8.9 2.2 7.3 11.8 5.5 1.7 2.2 3.2 9.6 3.2 2.1 1.8 11.9 1.0 2.1 3.3 27.8 2.6 2.0 3.0 1.7 4.2 2.0 1.7 2.0 1.3 4.6 5.4 2.7 11.7 7.1 28.0 18.1 6.6 11.7 0.0 11.1 11.9 9.2 9.7 44.9 1.8 0.0 6.0 16.6 17.2 33.9 6.9 10.7 5.3 4.4 8.8 4.2 5.8 0.1 2.8 1.2 2.8 4.2 6.9 7.9 12.7 21.3 18.7 3.6 3.9 0.1 14.2 1.0 1.3 0.2 11.5 19.4 11.0 3.4 12.1 0.0 4.9 3.1 5.7 24.6 12.0 0.4 32.2 10.6 6.3 1.4 25.4 18.9 9.7 25.6 12.7 0.0 0.0 0.0 5.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 2.7 3.2 3.7 3.7 2.1 3.6 8.9 2.2 3.2 2.6 4.2 2.7 5.8 3.2 1.1 13.7 0.1 2.2 5.7 2.5 5.2 2.2 2.2 4.2 3.6 0.0 1.4 0.0 0.0 0.5 0.0 2.8 0.0 4.1 0.4 1.3 19.4 9.1 0.0 0.0 10.8 8.0 0.4 12.3 1.1 1.8 0.0 15.3 8.9 0.1 0.8 158.2 10.9 1.5 0.0 2.5 6.3 0.9 7.5 2.0 1.8 3.7 1.1 3.2 0.0 9.5 0.4 2.6 2.4 17.0 0.0 10.9 0.0 0.1 1.1 2.1 19.7 8.8 15.1 0.3 3.3 2.7 1.4 0.4 1.0 0.7 2.5 2.7 ALDH9A1 "ALDH4, ALDH7, ALDH9, E3" ENSG00000143149 "Aldehyde dehydrogenase 9 family member A1" P49189 1 165662216-165698863 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 311.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA006077, HPA010873" Approved Approved Cytosol "Intracellular and membrane" NA NA 2000000 Cytosol "HPA006077: , HPA010873: AB_1078126" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (4.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-2)" "unprognostic (4.87e-2)" "unprognostic (2.30e-1)" "unprognostic (1.83e-1)" "prognostic favorable (4.56e-4)" "unprognostic (5.51e-2)" "unprognostic (9.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-1)" "unprognostic (2.15e-1)" 120.3 106.4 48.0 30.1 48.5 25.0 77.6 48.6 60.7 51.9 57.8 46.1 55.3 39.0 94.3 106.5 50.7 32.3 48.7 46.0 65.7 143.7 208.2 38.8 40.6 48.6 49.8 43.7 54.0 44.3 82.5 40.2 38.3 48.9 65.9 51.1 46.8 105.0 46.1 94.5 55.1 49.0 42.4 48.2 38.2 39.9 63.9 48.5 39.4 124.1 56.9 60.6 39.7 44.2 53.9 55.7 53.5 48.7 44.1 152.1 132.8 40.7 71.9 101.5 70.8 61.0 33.4 40.7 0.1 67.1 64.8 34.9 42.8 40.0 70.3 83.0 25.9 50.6 35.3 34.7 36.5 78.2 56.0 36.1 86.0 34.8 75.2 62.5 97.8 62.2 45.9 56.9 48.4 111.7 33.4 37.6 57.6 71.3 145.1 64.7 31.7 62.0 74.3 92.5 52.0 57.7 39.8 51.4 57.1 67.4 65.6 108.8 84.0 61.9 42.5 41.5 52.4 37.1 44.7 62.5 54.8 47.9 52.6 41.7 61.8 35.2 50.9 45.5 37.7 48.8 49.9 43.8 49.6 34.5 46.8 43.8 50.4 51.3 43.0 45.3 21.6 69.8 45.6 48.0 48.5 48.6 60.7 46.0 65.7 48.6 49.8 43.7 48.9 48.2 48.5 53.9 56.2 16.0 47.6 12.7 43.3 32.6 43.3 43.8 68.3 25.0 83.0 54.6 46.5 55.8 36.8 51.5 22.9 48.5 39.3 43.9 97.8 42.9 45.4 27.7 39.1 49.4 55.8 28.2 5.6 37.0 76.4 60.6 36.2 20.4 38.0 60.9 59.3 158.8 61.9 13.5 8.3 56.9 32.6 59.1 24.9 39.8 95.4 43.8 56.9 6.5 34.6 311.5 39.1 12.1 12.2 32.2 33.1 115.5 34.8 39.6 80.3 204.4 59.4 28.9 26.3 32.5 40.1 85.6 49.9 123.8 51.9 38.2 43.7 148.4 63.6 28.3 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 895.9;kidney: 1350.1" "Cell type enhanced" "Detected in all" "Collecting duct cells: 1723.3;Proximal tubular cells: 1070.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 919.7;RPTEC TERT1: 513.0;SH-SY5Y: 382.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced NA NA 2100000 "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favorable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 11.0 148.3 238.4 48.4 264.2 4.4 80.1 393.7 480.4 37.8 348.2 248.3 339.7 109.8 64.9 161.3 49.3 180.3 158.8 397.3 357.9 1350.1 181.6 93.4 8.6 554.2 399.8 271.1 58.7 180.0 738.7 80.4 44.4 590.0 49.1 203.0 100.1 316.9 73.3 345.7 61.6 286.7 97.5 302.1 53.1 405.8 46.8 450.8 19.4 333.2 340.8 84.7 102.1 52.5 895.9 89.7 215.8 73.3 56.3 15.9 3.3 23.8 45.3 33.1 41.7 43.3 276.8 183.5 0.1 158.3 35.1 50.8 102.4 38.1 83.2 45.1 1.1 16.6 5.7 152.6 138.9 26.6 4.0 7.5 9.1 21.1 31.8 42.5 79.7 40.5 6.6 1.3 1.4 52.6 38.0 7.9 16.0 28.1 919.7 47.4 1.3 89.3 15.6 513.0 118.6 54.3 382.5 263.1 271.3 12.5 85.4 55.7 9.8 92.0 35.2 90.4 60.9 159.3 4.8 6.8 2.0 42.0 13.9 47.9 13.2 1.0 0.2 2.7 3.2 1.5 1.5 3.3 1.3 9.3 0.2 1.0 1.1 0.3 6.2 1.1 0.4 10.1 1.4 238.4 264.2 393.7 480.4 397.3 357.9 554.2 399.8 271.1 590.0 302.1 450.8 895.9 14.4 240.4 251.5 79.0 18.4 52.5 156.5 490.4 153.1 86.9 274.2 166.5 147.3 664.8 425.7 1723.3 14.6 4.8 21.0 817.1 923.4 629.9 3.8 199.6 11.6 18.6 160.9 6.9 344.7 591.9 9.0 78.7 353.7 190.6 23.4 89.0 45.7 273.3 385.3 580.5 602.3 296.7 370.2 99.5 676.1 9.0 89.8 101.5 247.3 81.5 27.1 23.4 1.0 94.5 514.7 377.9 666.4 149.0 16.9 84.4 646.8 1070.2 332.5 64.9 6.6 93.6 32.5 10.6 66.9 142.8 31.7 9.9 48.2 111.8 436.0 322.8 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178962-168202109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: AB_2682435" "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 16.4 15.0 15.7 19.7 18.1 34.1 21.2 16.8 21.0 17.9 15.0 22.4 19.2 23.4 16.9 20.2 14.5 17.0 23.9 17.9 17.6 17.9 22.7 15.0 22.4 15.4 15.5 17.6 17.6 16.1 27.6 13.7 17.7 17.1 18.5 22.2 14.9 12.1 17.4 24.6 16.4 18.7 22.9 15.8 16.4 15.5 18.4 16.3 30.4 17.6 23.2 20.1 18.9 13.7 19.0 69.4 31.0 45.9 41.6 36.7 53.1 27.5 50.5 53.0 54.6 48.4 48.3 50.1 49.0 68.2 48.7 40.1 81.8 34.5 49.3 52.6 47.2 36.4 47.3 29.2 22.9 64.5 94.7 62.0 43.2 62.8 47.4 62.7 36.0 58.1 75.4 69.0 66.3 47.7 25.4 84.9 49.0 37.0 96.7 54.2 41.1 47.0 66.4 49.7 33.9 29.6 66.1 39.3 54.6 102.2 51.6 59.9 96.3 53.4 45.6 52.4 43.6 69.7 72.2 80.5 108.1 29.8 61.4 53.4 71.6 26.7 36.8 22.0 32.1 22.1 27.3 25.7 23.8 31.6 27.6 22.8 22.4 34.5 29.6 33.9 23.4 36.0 28.2 15.7 18.1 16.8 21.0 17.9 17.6 15.4 15.5 17.6 17.1 15.8 16.3 19.0 52.1 25.6 20.4 9.4 39.7 48.2 42.1 70.4 50.1 27.3 31.3 36.2 46.3 22.8 40.7 22.0 16.7 44.2 49.0 37.1 29.4 68.5 53.4 36.0 50.1 43.4 24.0 32.6 41.6 88.9 62.8 47.3 24.5 30.8 40.0 35.2 36.0 33.5 65.1 52.2 37.9 33.9 44.7 26.6 41.1 15.4 37.6 42.6 30.2 19.7 61.0 43.9 51.5 22.1 21.3 69.7 27.7 38.0 37.1 43.3 35.9 77.2 36.1 20.8 26.3 35.4 51.1 151.5 51.6 56.0 41.8 29.0 48.0 84.5 38.5 37.5 NME7 "CFAP67, FLJ37194, NM23-H7" ENSG00000143156 "NME/NM23 family member 7" Q9Y5B8 1 169132531-169367948 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 274.9;Inhibitory neurons: 307.2;Oligodendrocytes: 277.7;Respiratory ciliated cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028334, HPA038014, HPA054289" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028334: , HPA038014: AB_10673037, HPA054289: AB_2682437" "unprognostic (1.28e-1)" "unprognostic (8.52e-2)" "unprognostic (6.21e-2)" "unprognostic (6.30e-2)" "unprognostic (1.11e-1)" "unprognostic (7.44e-3)" "prognostic unfavorable (3.24e-5)" "unprognostic (1.42e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (2.00e-1)" "unprognostic (6.63e-2)" "unprognostic (2.67e-2)" "unprognostic (1.12e-1)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" 6.6 10.7 10.3 5.6 10.2 3.5 11.2 9.0 12.2 13.1 11.5 7.9 3.9 13.0 13.4 7.5 27.9 10.0 6.2 10.7 10.9 12.6 7.9 7.7 5.6 10.5 10.0 9.5 13.7 7.3 18.5 14.3 4.9 9.9 8.0 5.7 20.9 4.4 11.6 4.2 4.1 4.6 15.1 9.8 4.4 5.9 16.1 9.7 11.2 13.7 4.9 6.4 8.8 6.2 9.9 24.3 23.6 26.4 20.9 25.1 26.1 9.4 16.6 24.2 28.5 35.8 13.8 33.7 7.1 29.4 14.5 38.8 16.2 15.6 35.3 46.1 25.5 12.3 12.5 21.3 14.1 18.5 23.8 8.3 18.8 20.1 29.5 38.3 39.2 40.8 21.1 12.6 9.5 28.8 7.1 22.7 16.8 26.5 27.4 25.2 16.1 29.4 15.3 46.0 7.3 27.5 40.6 23.0 7.6 18.4 28.3 24.4 16.4 25.4 17.4 59.5 16.5 40.2 11.7 21.3 14.8 19.8 8.2 17.8 1.6 3.9 2.1 9.6 6.3 11.6 9.9 12.0 9.9 6.3 9.3 10.1 11.7 1.1 11.4 9.8 5.1 14.9 5.3 10.3 10.2 9.0 12.2 10.7 10.9 10.5 10.0 9.5 9.9 9.8 9.7 9.9 12.3 6.4 10.9 97.6 9.0 14.4 34.5 61.9 15.4 18.9 13.7 14.7 5.1 20.0 29.3 27.6 25.0 7.6 9.2 2.1 23.5 26.6 43.2 75.7 20.4 12.8 17.5 13.7 274.9 8.9 7.4 21.1 12.8 22.2 21.5 21.8 13.9 11.2 14.6 28.6 307.2 4.1 36.7 4.1 11.9 13.8 18.0 6.5 8.8 64.6 3.3 23.8 10.3 106.1 277.7 16.9 6.0 20.7 7.2 8.6 4.9 40.9 142.9 64.9 19.7 21.2 24.7 67.7 21.9 9.2 10.2 2.7 18.7 26.4 6.0 16.5 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856359 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630, HPA075919" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: " "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 11.4 9.2 38.4 13.6 40.6 11.1 14.3 35.7 37.4 15.0 28.5 12.4 9.6 15.8 11.0 14.8 12.0 11.3 10.4 34.0 34.5 14.0 11.2 19.7 13.6 38.3 40.1 31.8 17.4 13.8 19.6 8.3 14.3 40.3 10.6 13.9 26.7 11.7 13.2 6.9 19.0 11.4 15.4 39.0 14.4 14.1 6.4 37.2 12.4 11.8 9.6 17.0 17.7 11.6 47.0 33.4 27.4 29.5 36.5 30.5 25.2 17.1 22.6 22.7 28.1 21.2 21.0 27.4 37.3 33.1 23.3 23.8 32.6 37.1 29.7 25.6 46.3 25.4 14.9 25.2 15.0 26.0 52.8 39.7 19.2 46.1 31.7 44.9 24.8 25.4 33.9 51.0 24.3 27.0 15.7 33.0 13.2 48.5 38.5 32.2 37.2 16.5 32.9 29.4 79.4 38.4 46.5 32.1 43.6 41.7 43.5 41.7 48.3 24.1 29.7 29.7 23.9 41.2 34.2 47.7 47.8 16.7 25.9 28.7 2.2 6.0 5.1 4.7 7.5 5.1 6.7 4.6 5.1 7.8 3.9 4.2 4.6 0.8 7.5 9.0 3.7 4.3 4.9 38.4 40.6 35.7 37.4 34.0 34.5 38.3 40.1 31.8 40.3 39.0 37.2 47.0 11.7 54.5 19.5 12.4 20.2 21.9 26.2 13.0 18.8 30.7 17.8 12.8 10.1 11.5 19.4 12.9 10.4 10.8 15.3 9.8 1.9 16.9 2.8 9.8 19.9 16.0 9.0 5.9 14.7 16.3 12.3 15.4 13.3 15.2 24.1 23.4 15.0 13.4 16.0 48.8 15.7 11.9 4.1 20.1 17.5 1.6 10.8 18.7 8.8 8.4 21.6 16.5 10.3 23.1 27.8 15.0 11.9 18.0 11.6 31.9 9.2 7.3 11.1 29.5 13.1 19.8 17.1 1.0 3.3 25.4 24.0 9.0 13.7 7.8 15.6 28.0 MPC2 "BRP44, DKFZP564B167, SLC54A2" ENSG00000143158 "Mitochondrial pyruvate carrier 2" O95563 1 167916675-167937072 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 268.8" "Cell type enhanced" "Detected in all" "Early spermatids: 2288.1;Late spermatids: 5134.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056091 Uncertain NA NA "HPA056091: AB_2683035" "unprognostic (3.25e-1)" "unprognostic (6.82e-2)" "unprognostic (8.79e-3)" "unprognostic (4.15e-2)" "unprognostic (3.47e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-3)" "unprognostic (1.44e-3)" "unprognostic (1.08e-2)" "unprognostic (9.13e-2)" "unprognostic (2.39e-1)" "unprognostic (6.95e-2)" "unprognostic (5.43e-2)" "unprognostic (1.67e-1)" 52.1 90.6 35.1 15.9 38.4 63.9 51.2 35.5 39.4 32.7 34.4 68.2 48.2 30.9 15.9 39.1 34.8 19.8 147.3 36.6 38.1 143.9 268.8 35.4 14.1 33.1 35.3 36.2 35.6 52.8 35.9 74.1 13.9 33.1 90.1 34.0 28.6 55.7 16.1 163.4 40.4 66.3 14.9 32.7 29.2 141.5 242.3 36.1 20.2 32.6 66.9 15.1 43.4 35.7 37.2 40.7 43.2 14.6 32.3 31.5 26.2 4.1 70.2 26.9 23.7 27.2 92.3 19.6 75.0 49.4 29.1 21.4 31.4 17.0 28.1 20.3 98.3 34.5 33.2 34.1 60.7 22.4 38.1 21.9 19.6 23.6 41.8 21.8 20.0 20.3 52.5 39.6 34.9 38.7 18.1 52.4 31.4 26.2 73.7 45.2 27.8 31.3 54.7 155.0 30.5 25.8 28.4 41.6 39.1 34.3 29.2 73.9 38.9 30.4 27.8 24.8 45.3 29.9 61.2 65.9 74.5 73.5 28.6 14.6 95.0 33.1 92.5 44.1 30.5 45.7 50.2 51.6 45.8 58.7 41.3 48.6 46.7 61.4 55.6 38.5 40.2 81.3 84.2 35.1 38.4 35.5 39.4 36.6 38.1 33.1 35.3 36.2 33.1 32.7 36.1 37.2 81.6 35.3 43.7 14.4 75.0 126.1 157.7 213.8 52.9 54.5 167.2 166.9 428.0 513.3 119.2 130.6 22.9 468.6 78.2 267.5 1025.2 206.1 2288.1 153.3 38.5 75.0 331.5 388.3 23.5 145.5 55.3 119.3 112.1 98.3 88.2 332.1 55.3 679.5 159.6 45.4 19.9 326.4 146.5 77.1 113.3 5134.8 106.2 93.9 120.9 15.9 272.9 123.8 76.2 13.0 16.8 100.5 237.2 112.8 84.7 245.6 516.2 974.3 175.3 69.7 65.7 90.3 147.1 788.0 170.5 75.3 114.4 343.1 94.9 705.0 415.5 173.9 CREG1 CREG ENSG00000143162 "Cellular repressor of E1A stimulated genes 1" O75629 1 167529117-167553805 "Predicted secreted proteins" "Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 545.7;Kupffer cells: 559.7;monocytes: 322.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 55.4;classical monocyte: 128.4;eosinophil: 75.7;intermediate monocyte: 75.7;myeloid DC: 89.9;neutrophil: 43.7;non-classical monocyte: 72.3" "Group enriched" "Detected in all" 6 "dendritic cells: 89.9;granulocytes: 75.7;monocytes: 128.4" "Cell line enhanced" "Detected in all" "RPMI-8226: 1237.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056390 Approved Vesicles,Microtubules "Secreted to blood" NA NA 520000 Microtubules Vesicles "HPA056390: AB_2683113" "unprognostic (3.25e-1)" "unprognostic (2.00e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-3)" "unprognostic (4.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.55e-1)" "unprognostic (5.02e-2)" "unprognostic (2.07e-3)" "unprognostic (8.54e-2)" "unprognostic (8.65e-2)" "unprognostic (1.21e-1)" "unprognostic (8.24e-3)" "unprognostic (2.99e-1)" "unprognostic (4.63e-2)" "unprognostic (3.78e-3)" "unprognostic (3.16e-1)" 131.7 128.7 37.9 79.7 40.8 127.0 110.8 39.8 48.0 77.5 53.2 77.8 60.8 62.4 110.6 92.5 71.5 129.4 81.5 37.1 60.0 133.3 297.6 100.0 99.7 46.9 39.6 35.6 85.0 71.3 76.0 65.3 111.7 43.3 63.5 83.5 80.7 105.3 75.4 72.0 107.1 63.6 78.6 45.0 138.0 62.0 50.5 45.7 35.8 126.9 78.9 64.0 117.4 63.8 60.1 93.5 41.5 21.1 43.5 325.8 89.8 53.0 39.2 17.8 30.7 39.8 67.8 104.4 101.7 112.2 43.6 57.2 143.3 24.3 84.9 20.9 140.3 82.3 41.5 31.1 37.9 111.5 93.6 295.2 94.5 250.5 35.6 38.7 42.7 10.3 35.9 218.5 405.0 42.6 39.2 19.6 95.9 22.8 214.0 63.9 32.5 58.8 1237.2 54.7 64.9 14.0 25.7 98.1 132.8 112.8 70.1 175.5 252.7 19.1 8.0 39.6 126.2 25.9 79.4 168.4 67.7 131.6 96.0 16.3 55.4 128.4 75.7 5.1 75.7 8.0 4.3 7.5 6.5 89.9 2.1 16.6 8.8 43.7 11.0 72.3 6.2 3.9 57.6 37.9 40.8 39.8 48.0 37.1 60.0 46.9 39.6 35.6 43.3 45.0 45.7 60.1 44.7 35.3 90.1 5.9 15.3 44.1 49.1 23.1 56.9 17.9 61.7 63.8 55.7 65.8 32.2 55.2 89.6 91.5 18.3 15.6 23.5 36.0 27.6 33.9 19.3 34.2 29.3 124.8 24.7 39.7 41.7 78.4 21.9 64.1 29.9 62.0 48.2 90.3 545.7 15.2 22.1 44.5 14.2 559.7 57.6 27.4 43.5 213.8 24.9 26.2 322.8 30.5 6.2 10.1 14.6 21.0 31.5 28.6 27.8 34.0 46.3 60.6 18.5 31.5 13.1 43.2 40.8 65.5 42.0 86.3 51.1 126.7 17.3 38.9 50.4 44.0 DCAF6 "IQWD1, PC326" ENSG00000143164 "DDB1 and CUL4 associated factor 6" Q58WW2 1 167935783-168075843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 647.4;tongue: 475.0" "Cell type enhanced" "Detected in all" "Early spermatids: 438.6;Excitatory neurons: 243.8;Late spermatids: 700.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054305 Supported "Nucleoplasm,Focal adhesion sites" NA NA "Nucleoplasm, Focal adhesion sites" "HPA054305: AB_2682444" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.19e-1)" "unprognostic (5.42e-2)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.74e-1)" "unprognostic (3.20e-2)" "unprognostic (9.21e-2)" "unprognostic (7.06e-2)" "unprognostic (6.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 29.4 46.3 13.1 16.3 18.1 24.8 29.6 10.2 22.2 33.2 21.0 31.7 21.9 25.0 19.7 30.0 25.8 27.7 131.1 18.7 10.5 28.8 95.9 25.7 17.9 7.0 9.7 15.9 25.5 21.1 34.8 20.1 27.5 8.9 35.7 29.5 21.5 29.1 25.5 647.4 22.0 21.6 34.1 5.8 18.7 28.4 83.4 11.4 24.6 23.7 475.0 21.6 28.3 20.3 14.8 64.8 30.0 16.4 27.0 52.7 74.3 57.4 64.9 95.3 44.5 65.7 50.4 53.1 52.8 36.9 83.3 21.4 47.4 25.8 47.9 62.4 30.2 27.6 56.5 42.8 36.4 42.4 25.7 26.1 53.2 47.4 42.3 35.0 67.4 49.1 16.9 64.8 42.9 66.3 14.8 28.9 23.3 10.6 36.0 33.1 21.9 34.0 41.7 110.6 30.9 24.2 19.2 51.8 47.0 36.6 33.9 80.8 31.3 70.3 44.6 27.5 44.0 27.3 45.4 39.3 41.3 59.9 21.6 18.6 5.4 5.5 10.4 4.9 7.5 5.2 4.8 3.9 4.3 6.0 3.3 3.5 4.6 5.7 3.7 12.0 3.6 4.8 4.0 13.1 18.1 10.2 22.2 18.7 10.5 7.0 9.7 15.9 8.9 5.8 11.4 14.8 22.9 57.7 43.3 81.3 22.5 57.9 30.5 32.1 33.0 14.7 26.7 19.3 216.3 48.6 43.4 25.8 22.9 75.7 19.7 28.1 17.6 33.0 438.6 39.3 24.1 25.3 21.1 111.9 243.8 19.3 32.4 42.7 39.3 35.5 19.6 73.0 23.6 95.4 19.6 5.0 90.0 27.9 26.4 44.0 38.3 700.1 57.5 23.6 37.4 70.3 113.0 15.9 18.6 108.6 71.0 21.2 26.7 48.5 31.1 35.6 35.7 34.9 52.3 18.4 32.9 29.1 30.6 108.3 64.1 34.6 39.8 81.3 22.2 81.5 33.0 29.0 GPA33 A33 ENSG00000143167 "Glycoprotein A33" Q99795 1 167052836-167166479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 217.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 775.5;Intestinal goblet cells: 211.6;Paneth cells: 420.3;Proximal enterocytes: 266.1;Undifferentiated cells: 147.2" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 84.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 24.2;T-reg: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 24.2" "Cell line enriched" "Detected in some" 8 "OE19: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018858, CAB025943" Enhanced NA NA "CAB025943: , HPA018858: AB_1849909" "unprognostic (2.41e-2)" "unprognostic (1.71e-3)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (8.39e-4)" "unprognostic (1.55e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-2)" "unprognostic (9.63e-2)" "unprognostic (2.10e-2)" "unprognostic (9.44e-2)" "unprognostic (6.75e-2)" "unprognostic (5.22e-3)" "unprognostic (3.13e-1)" "unprognostic (9.68e-3)" "unprognostic (2.96e-3)" 0.4 0.0 0.0 18.7 0.0 0.7 0.2 0.0 0.2 0.0 0.3 217.9 151.4 0.3 0.0 0.1 0.0 0.2 0.7 0.1 0.0 0.1 0.0 7.2 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 198.0 0.0 0.0 0.5 0.3 0.0 138.0 7.3 0.0 0.9 1.6 0.2 0.1 2.3 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.3 1.8 14.4 0.0 0.0 0.8 0.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 3.8 1.6 0.2 10.9 5.7 2.7 2.2 24.2 3.5 0.2 0.2 2.6 0.0 19.5 6.8 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.3 775.5 0.0 0.0 3.9 0.0 0.0 0.1 26.1 0.8 0.4 0.0 0.0 0.0 0.5 0.0 4.5 0.0 0.0 0.0 0.5 0.0 0.3 211.6 0.0 1.9 1.3 2.3 0.3 1.8 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.1 420.3 0.0 0.0 0.0 266.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.1 0.0 3.1 0.0 147.2 0.2 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400922-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;pituitary gland: 30.1;retina: 24.5;skeletal muscle: 50.2" "Group enriched" "Detected in some" 4 "Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 39.4" "Region enriched" "Detected in many" 5 "basal ganglia: 100.2" "Low region specificity" "Detected in many" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: AB_2732406" "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favorable (9.40e-5)" "unprognostic (5.03e-2)" 1.7 3.2 12.9 0.4 14.1 0.0 1.0 10.0 14.4 3.0 9.4 3.2 0.7 1.1 0.7 1.0 2.8 0.6 5.3 10.9 16.3 0.2 0.3 2.8 0.3 20.4 11.2 10.7 1.0 2.1 0.1 30.1 0.7 21.1 1.1 2.0 24.5 1.2 1.4 50.2 2.3 1.6 1.2 11.2 0.4 1.4 1.0 21.6 0.1 0.7 7.7 0.0 1.6 2.1 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 39.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 14.1 10.0 14.4 10.9 16.3 20.4 11.2 10.7 21.1 11.2 21.6 13.7 0.9 0.0 0.0 13.4 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.0 0.0 4.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.3 2.8 5.0 0.0 28.4 0.0 0.0 16.8 0.0 1.0 1.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.5 13.1 35.9 3.4 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 TBX19 "dj747L4.1, TPIT" ENSG00000143178 "T-box transcription factor 19" O60806 1 168280877-168314426 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "pituitary gland: 50.6" "Cell type enhanced" "Detected in many" "Langerhans cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 5.5;HDLM-2: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005800, HPA072686" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA005800: AB_1080219, HPA072686: AB_2732209" "unprognostic (2.47e-1)" "unprognostic (1.20e-2)" "unprognostic (8.76e-4)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (8.36e-2)" "unprognostic (7.14e-7)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (5.58e-2)" "unprognostic (9.78e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (8.57e-2)" "unprognostic (6.63e-2)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" 1.6 0.8 1.0 0.8 1.1 0.7 1.8 0.9 1.3 2.8 1.2 2.1 0.8 5.1 0.8 1.7 2.8 1.2 0.9 1.0 1.7 1.7 1.1 2.4 1.8 1.5 1.1 0.7 3.7 1.1 0.5 50.6 0.6 1.1 2.3 1.0 0.4 1.8 1.0 0.8 2.3 1.6 2.2 1.1 2.3 1.1 1.1 1.4 1.6 1.3 0.8 1.1 1.5 2.1 1.3 1.0 0.0 0.8 3.1 1.4 0.6 1.0 1.6 0.9 0.5 0.8 1.4 1.0 0.8 1.7 0.6 0.8 5.5 0.4 0.4 0.8 5.1 0.7 0.1 1.1 0.4 1.5 1.6 2.0 1.2 1.4 0.2 0.8 1.3 0.7 0.3 1.1 1.3 0.7 0.2 0.8 1.3 0.2 3.3 0.5 1.3 0.4 0.3 1.2 0.4 1.1 1.6 0.9 0.7 1.0 1.3 0.2 1.3 1.2 0.5 1.3 1.1 1.7 1.0 0.8 0.6 0.1 0.4 1.6 0.2 0.7 0.4 1.1 0.5 0.5 0.4 0.8 0.7 0.7 0.5 0.5 0.5 1.0 0.9 1.0 2.4 0.8 0.6 1.0 1.1 0.9 1.3 1.0 1.7 1.5 1.1 0.7 1.1 1.1 1.4 1.3 1.4 0.0 0.5 2.3 1.4 2.7 1.3 1.2 2.2 0.0 3.1 3.0 0.4 0.0 0.6 0.0 0.0 0.1 6.1 2.6 0.0 0.6 0.6 3.2 1.8 2.5 1.2 0.8 0.7 0.4 0.4 2.5 0.0 5.6 4.5 1.8 0.4 0.7 1.3 0.0 0.5 0.9 2.0 2.8 8.9 0.7 3.4 4.2 0.0 6.5 3.9 0.4 6.2 0.5 3.1 1.9 0.6 2.6 1.1 4.3 0.7 0.6 1.2 0.0 0.0 0.7 0.9 1.0 1.1 1.9 3.3 0.1 1.6 0.9 0.9 2.7 UCK2 UMPK ENSG00000143179 "Uridine-cytidine kinase 2" Q9BZX2 1 165827614-165911618 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 110.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057128 Approved Nucleoplasm NA NA Nucleoplasm "HPA057128: AB_2683346" "unprognostic (5.37e-2)" "unprognostic (1.75e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" "unprognostic (4.54e-2)" "unprognostic (6.83e-3)" "prognostic unfavorable (9.22e-8)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (6.70e-4)" "unprognostic (3.04e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.12e-13)" "unprognostic (2.49e-3)" "unprognostic (1.14e-1)" "unprognostic (2.01e-3)" "unprognostic (1.83e-1)" 12.2 6.1 6.2 9.2 6.2 11.9 15.5 9.1 8.0 7.0 2.9 14.6 14.0 8.0 15.3 17.6 7.6 5.0 8.6 7.5 6.9 5.0 10.7 10.0 8.6 7.9 7.6 6.2 5.5 16.1 4.9 7.5 28.2 9.2 6.9 14.2 3.8 13.2 8.4 17.1 13.6 13.3 8.5 6.1 5.9 11.3 6.0 6.9 17.9 5.3 10.9 10.7 14.3 10.0 9.3 66.1 67.7 36.6 34.4 20.2 32.9 49.3 63.4 59.7 86.7 92.2 70.6 75.3 32.3 43.5 57.6 35.2 46.3 88.6 106.2 72.3 51.3 40.8 40.2 52.3 81.8 56.2 72.1 29.2 35.0 52.1 176.6 111.7 21.5 60.8 73.6 95.3 43.0 78.1 54.1 63.6 49.4 103.4 104.7 54.5 27.8 37.6 112.5 43.5 37.6 51.5 58.3 47.2 104.4 48.8 83.3 62.5 65.9 32.9 41.4 52.1 50.3 71.9 49.8 84.9 116.0 36.7 50.1 33.3 0.8 5.9 0.1 1.5 3.7 3.6 3.3 1.6 2.5 15.1 4.4 0.1 1.4 0.1 3.8 4.2 13.9 2.2 1.9 6.2 6.2 9.1 8.0 7.5 6.9 7.9 7.6 6.2 9.2 6.1 6.9 9.3 10.2 0.0 1.1 10.7 6.6 22.9 29.6 18.3 19.9 4.2 22.4 26.2 5.7 8.6 8.8 9.2 0.0 4.4 12.9 41.5 7.9 14.7 110.4 8.7 12.1 22.3 6.7 10.7 32.8 22.2 60.1 12.4 17.3 11.4 0.0 15.4 5.0 5.8 13.0 0.0 33.1 16.1 14.2 4.1 10.2 56.2 6.5 7.9 10.6 30.0 13.5 4.5 9.2 19.6 23.3 54.8 16.1 3.4 25.8 33.0 31.4 6.7 4.5 4.6 0.0 23.0 15.3 5.6 12.0 26.9 29.7 26.4 4.1 5.4 20.4 22.3 TMCO1 "HP10122, TMCC4" ENSG00000143183 "Transmembrane and coiled-coil domains 1" Q9UM00 1 165724293-165827755 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease variant, Glaucoma, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054768, HPA078775" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA054768: AB_2682597, HPA078775: " "unprognostic (1.22e-2)" "unprognostic (3.28e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (5.17e-7)" "prognostic unfavorable (3.21e-4)" "unprognostic (5.92e-2)" "unprognostic (4.16e-2)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.85e-1)" "unprognostic (1.94e-1)" "unprognostic (2.14e-2)" "unprognostic (9.80e-2)" 68.2 93.4 46.6 52.0 51.0 48.9 92.0 54.0 64.0 74.6 68.8 128.2 116.7 56.4 112.4 59.1 66.5 80.9 56.9 46.1 61.6 111.3 163.8 55.5 62.9 54.4 52.5 44.2 60.0 74.2 144.8 34.0 57.9 54.6 80.3 130.0 74.9 78.4 70.6 49.2 39.6 109.8 61.9 55.6 46.9 81.4 76.0 50.4 90.2 104.7 48.5 71.4 98.6 29.3 59.8 158.4 172.1 132.2 77.9 243.9 120.7 126.9 259.4 191.7 156.0 162.1 249.9 229.2 99.1 267.4 195.9 67.1 214.7 171.8 140.3 175.1 252.0 164.2 121.1 180.3 158.7 195.1 216.6 154.1 159.0 173.9 179.5 142.6 148.4 117.1 122.6 329.7 186.0 227.3 123.1 172.1 160.6 169.4 527.6 197.3 125.0 143.4 256.1 204.7 198.4 133.5 235.4 201.3 209.2 170.9 195.0 277.1 275.7 121.5 138.9 116.5 123.8 248.3 357.4 521.1 346.5 111.4 139.7 187.4 213.3 172.2 172.9 159.7 169.4 170.4 151.8 168.7 173.1 135.5 132.6 134.3 156.5 132.1 156.6 201.7 243.8 207.1 290.3 46.6 51.0 54.0 64.0 46.1 61.6 54.4 52.5 44.2 54.6 55.6 50.4 59.8 124.0 96.1 70.7 23.8 95.6 84.8 89.8 264.5 75.1 79.1 142.9 135.9 62.6 224.4 181.1 213.3 68.8 136.1 138.9 371.5 43.0 202.3 82.2 131.4 147.9 92.7 88.6 75.5 20.7 191.7 148.4 113.1 64.2 154.7 76.5 71.9 106.7 326.0 140.9 75.7 24.9 137.0 227.9 106.4 76.0 151.6 123.6 92.7 99.6 16.9 78.9 236.7 152.4 25.6 23.3 227.0 215.7 129.4 153.5 73.6 290.0 151.5 175.2 75.9 124.9 67.7 101.7 232.1 87.7 89.4 92.9 111.4 109.2 117.6 143.6 94.5 XCL1 "ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1" ENSG00000143184 "X-C motif chemokine ligand 1" P47992 1 168576605-168582069 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.6" "Group enriched" "Detected in many" 4 "dendritic cells: 185.3;T-cells: 213.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 14 "NK-cell: 88.5" "Lineage enriched" "Detected in many" 14 "NK-cells: 88.5" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;Hep G2: 4.1;SCLC-21H: 3.3;SuSa: 6.1;U-266/70: 5.0;U-266/84: 1.9" "Not detected" "Not detected" HPA057725 Approved "Secreted to blood" NA NA "HPA057725: AB_2683511" "unprognostic (5.38e-3)" "unprognostic (5.72e-2)" "unprognostic (8.23e-3)" "unprognostic (4.19e-3)" "unprognostic (1.43e-1)" "unprognostic (6.10e-2)" "unprognostic (2.96e-1)" "unprognostic (4.27e-2)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (4.61e-1)" "unprognostic (8.85e-2)" "unprognostic (5.34e-10)" "unprognostic (1.96e-1)" "unprognostic (1.32e-1)" "unprognostic (5.47e-2)" "unprognostic (2.15e-2)" 0.4 0.1 0.1 1.0 0.1 3.5 1.0 0.1 0.2 1.0 0.1 0.7 1.0 2.3 0.8 0.2 0.6 1.1 0.5 0.1 0.2 0.2 2.7 1.8 2.4 0.1 0.2 0.1 0.2 0.5 0.0 0.1 2.2 0.3 0.4 1.0 0.0 1.5 0.3 0.1 0.1 1.5 0.3 0.1 4.6 1.2 0.2 0.5 4.1 0.3 0.0 1.7 0.9 0.4 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.3 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.0 1.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.2 0.0 0.2 0.0 1.0 5.9 0.0 0.0 0.3 4.0 0.3 88.5 0.0 0.0 0.0 1.7 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.5 0.1 2.3 3.2 5.5 0.0 1.5 4.0 0.5 0.0 2.2 0.0 1.3 1.5 2.0 1.5 0.0 0.0 0.0 1.4 185.3 0.7 0.0 0.0 1.3 2.0 1.9 1.9 0.0 8.4 0.0 0.2 1.2 1.9 8.2 2.9 2.5 0.0 1.4 0.9 0.4 0.0 0.1 0.8 0.0 1.9 10.6 0.0 0.0 3.1 39.2 0.0 0.1 0.0 42.2 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.1 0.0 0.0 0.0 0.3 1.7 0.2 0.2 1.8 4.3 0.8 213.4 0.0 0.4 0.1 XCL2 "SCM-1b, SCYC2" ENSG00000143185 "X-C motif chemokine ligand 2" Q9UBD3 1 168540768-168543997 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.3;lymphoid tissue: 13.5" "Group enriched" "Detected in many" 10 "dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 8 "NK-cell: 423.5" "Lineage enriched" "Detected in many" 8 "NK-cells: 423.5" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;RT4: 1.1;SuSa: 1.1" HPA057725 Approved "Secreted to blood" NA NA "HPA057725: AB_2683511" "unprognostic (9.88e-3)" "unprognostic (7.89e-3)" "unprognostic (4.77e-2)" "unprognostic (9.32e-3)" "unprognostic (8.21e-2)" "unprognostic (6.79e-4)" "unprognostic (9.33e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.58e-3)" "unprognostic (6.26e-2)" "unprognostic (2.02e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (8.36e-9)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "unprognostic (3.02e-2)" "unprognostic (1.06e-1)" 0.8 0.8 0.3 3.2 0.3 14.3 0.9 0.3 0.5 1.0 0.5 1.9 3.3 3.6 0.9 0.6 1.8 1.9 0.8 0.3 0.4 0.4 5.7 3.3 5.6 0.5 0.4 0.3 0.4 0.6 0.3 0.2 1.4 0.4 0.6 1.5 0.0 1.9 1.0 0.3 0.1 2.0 1.4 0.4 13.5 2.9 0.3 0.5 3.9 0.6 0.5 3.7 2.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.4 47.2 0.2 2.7 0.3 3.6 50.1 0.3 0.1 2.1 37.1 1.9 423.5 0.3 0.1 0.0 17.1 0.3 0.3 0.3 0.5 0.3 0.4 0.5 0.4 0.3 0.4 0.4 0.5 0.4 2.9 0.0 1.1 0.0 3.3 2.4 0.0 0.0 1.8 0.0 1.6 1.4 0.8 0.0 0.0 0.0 0.0 0.1 513.6 0.3 0.0 0.1 0.0 2.4 2.0 1.0 0.0 19.2 0.0 0.0 0.0 1.1 8.2 2.2 1.3 0.0 1.4 0.6 0.4 0.0 0.0 0.7 0.0 5.0 4.0 0.0 0.0 3.7 33.8 0.0 0.8 0.0 277.1 0.0 0.0 0.0 1.1 0.0 13.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.9 1.1 0.0 240.6 0.0 0.1 0.1 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220876-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 270.6;Excitatory neurons: 187.6;Inhibitory neurons: 184.0;Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" No No "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 3.4 2.5 5.1 2.2 5.1 3.9 3.4 7.4 5.3 3.6 3.4 3.4 1.3 4.1 2.6 2.7 3.4 1.4 2.6 5.0 4.8 2.5 2.4 3.6 3.0 4.4 4.7 4.4 4.1 2.4 3.5 3.6 2.5 5.3 3.2 2.2 13.1 3.0 2.0 4.1 3.4 3.6 1.4 4.0 4.3 2.6 4.3 4.7 3.8 3.3 2.6 3.4 3.5 3.2 4.7 7.4 4.0 14.8 4.5 1.7 1.7 6.1 0.9 1.6 1.7 1.7 8.1 4.2 8.3 3.8 1.5 1.7 5.6 8.8 2.7 2.6 3.3 3.5 5.9 3.9 7.1 1.1 6.5 3.8 1.2 1.6 2.0 3.6 2.1 2.3 5.7 6.4 4.3 2.3 3.7 6.0 4.3 17.4 4.0 2.3 8.7 5.4 3.7 3.1 4.0 9.0 6.9 5.6 4.1 3.7 7.4 4.6 7.9 3.8 3.4 5.3 2.0 3.5 4.4 2.1 18.3 1.6 3.9 4.4 4.6 0.3 0.3 0.2 0.3 0.3 2.0 0.2 0.0 0.4 0.7 0.3 0.2 0.4 0.2 0.3 0.9 0.2 0.4 5.1 5.1 7.4 5.3 5.0 4.8 4.4 4.7 4.4 5.3 4.0 4.7 4.7 19.9 12.8 17.2 270.6 25.2 13.4 11.3 9.7 9.6 58.7 12.5 11.8 15.8 14.3 11.6 20.2 102.2 17.8 20.2 12.3 5.9 10.5 26.2 17.7 18.7 19.8 24.1 14.5 187.6 11.6 18.5 17.5 10.2 18.9 19.7 18.7 15.0 13.3 13.3 47.1 184.0 14.3 8.2 52.5 12.4 44.1 25.7 19.9 7.2 114.3 21.7 43.8 14.4 186.0 202.1 16.5 8.0 20.7 33.5 16.1 5.3 8.3 11.5 101.7 26.3 28.4 16.4 17.6 35.7 12.7 11.1 51.7 14.1 11.0 14.5 21.0 MAEL "CT128, FLJ14904, SPATA35" ENSG00000143194 "Maelstrom spermatogenic transposon silencer" Q96JY0 1 166975582-167022214 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 160.6" "Group enriched" "Detected in some" 4 "Early spermatids: 1324.3;Late spermatids: 406.1;Spermatocytes: 573.7" "Cancer enhanced" "Detected in many" "testis cancer: 3.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NTERA-2: 3.4" "Region enriched" "Detected in single" 5 "thalamus: 1.1" "Low region specificity" "Detected in all" HPA078602 Approved NA NA "HPA078602: AB_2732386" "unprognostic (1.36e-1)" "unprognostic (7.01e-2)" "unprognostic (5.81e-2)" "unprognostic (3.15e-1)" "unprognostic (9.78e-2)" "unprognostic (3.08e-1)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (1.42e-1)" "unprognostic (9.00e-3)" "unprognostic (3.04e-1)" "unprognostic (8.88e-2)" "unprognostic (5.49e-2)" "unprognostic (1.26e-1)" "unprognostic (3.32e-1)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" 0.1 0.2 1.7 0.0 2.0 0.0 0.1 1.3 2.2 0.1 1.0 0.9 0.0 0.0 1.4 0.2 0.1 0.3 5.7 2.1 1.9 1.6 0.3 0.2 0.1 1.5 1.6 1.8 0.1 0.2 0.0 0.8 6.6 1.6 0.7 0.0 4.4 0.3 1.0 0.3 0.0 0.1 0.4 1.3 0.0 0.1 160.6 1.6 0.1 0.1 0.3 0.1 0.4 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 2.0 1.3 2.2 2.1 1.9 1.5 1.6 1.8 1.6 1.3 1.6 1.8 0.2 0.0 0.0 8.8 0.1 0.1 0.5 0.0 0.0 1.4 0.1 0.1 4.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 1324.3 0.0 0.0 1.3 0.0 0.0 11.5 0.2 0.4 4.8 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 3.9 0.0 0.0 0.0 0.3 406.1 10.8 0.8 0.0 1.0 0.0 45.3 0.0 8.0 3.3 0.0 0.0 10.1 0.0 0.2 0.0 5.6 0.0 1.5 0.0 3.4 0.4 573.7 156.3 0.0 0.0 0.3 0.2 0.2 0.0 0.2 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975540 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 9.0;kidney: 2.8;retina: 10.7;testis: 8.9" "Cell type enhanced" "Detected in some" "Astrocytes: 22.9;Excitatory neurons: 45.0;Muller glia cells: 89.1;Oligodendrocyte precursor cells: 96.0" "Cancer enriched" "Detected in some" 5 "glioma: 4.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;JURKAT: 5.7;MOLT-4: 4.3;U-2 OS: 9.6;U-251 MG: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.1 0.3 5.6 0.2 6.8 0.5 0.0 0.0 6.4 0.1 0.0 1.3 0.1 0.1 0.4 0.1 0.2 0.3 1.2 8.9 5.1 2.8 0.4 0.4 0.2 0.1 4.8 7.4 0.1 0.1 0.0 1.4 0.1 2.0 0.8 0.3 10.7 0.1 1.1 0.1 0.0 0.2 0.7 0.0 0.1 0.1 8.9 9.0 1.1 0.1 0.2 0.2 0.3 0.1 5.5 0.0 0.0 7.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.8 1.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.2 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 0.0 4.3 0.0 2.7 0.1 0.0 0.0 0.2 0.5 0.5 0.1 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 9.6 0.0 5.4 1.8 0.0 0.4 1.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 6.8 0.0 6.4 8.9 5.1 0.1 4.8 7.4 2.0 0.0 9.0 5.5 0.0 0.0 0.0 22.9 0.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 4.3 0.0 0.6 0.0 6.2 0.0 2.0 0.2 0.0 0.1 12.7 0.0 0.1 0.2 1.2 0.0 45.0 0.2 0.3 0.6 0.0 0.1 0.0 1.7 0.4 1.6 0.1 1.7 17.6 0.0 0.0 0.0 0.0 18.8 0.6 0.2 0.0 5.6 0.6 89.1 0.0 96.0 16.5 0.1 0.2 0.0 0.9 0.0 0.0 4.9 0.0 8.8 0.0 8.8 0.5 4.8 2.0 0.0 0.0 0.3 0.5 0.1 0.3 0.0 DPT ENSG00000143196 Dermatopontin Q07507 1 168695468-168729206 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Fibroblasts: 457.5;Leydig cells: 231.8;Peritubular cells: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 143.3;fHDF/TERT166: 59.9" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "midbrain: 1.0" HPA065548 Approved Vesicles "Secreted to extracellular matrix" NA NA 610000 Vesicles "HPA065548: AB_2685511" "unprognostic (1.49e-1)" "unprognostic (7.62e-2)" "unprognostic (5.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.64e-2)" "unprognostic (3.78e-3)" "unprognostic (4.09e-2)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" "unprognostic (1.03e-2)" "unprognostic (8.88e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.12e-3)" "unprognostic (2.89e-2)" "unprognostic (1.09e-1)" "unprognostic (8.98e-3)" 337.6 40.0 0.5 28.9 0.7 0.0 253.4 0.6 1.0 156.1 0.7 312.8 19.0 63.8 61.4 86.8 130.3 78.8 187.5 0.6 0.5 11.6 29.3 49.0 59.1 0.6 0.6 0.6 30.6 85.5 4.9 2.1 37.8 0.7 55.7 58.8 0.0 72.6 53.2 37.4 39.4 95.1 139.8 0.6 1.0 109.5 15.5 0.6 48.5 75.6 211.1 70.7 104.2 168.4 0.8 0.0 0.0 0.0 0.0 143.3 0.6 0.2 0.1 6.7 7.2 7.4 0.0 0.0 0.0 0.0 59.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 4.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.6 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.6 1.0 0.6 0.5 0.6 0.6 0.6 0.7 0.6 0.6 0.8 18.7 3.2 1.7 0.3 0.3 31.9 0.1 0.0 1.8 0.0 2.2 2.3 7.4 0.0 0.6 0.0 0.0 0.6 0.4 0.1 0.0 0.1 1.2 0.3 10.7 6.9 0.0 0.0 4.8 0.2 0.8 457.5 3.1 0.2 0.0 0.0 8.9 0.0 0.6 0.0 3.4 0.0 0.0 0.0 45.6 4.4 231.8 4.0 39.2 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 123.8 0.5 0.5 0.0 0.1 0.0 0.0 0.0 24.4 18.5 0.5 0.3 3.1 32.0 0.4 5.0 2.2 0.0 0.6 MGST3 GST-III ENSG00000143198 "Microsomal glutathione S-transferase 3" O14880 1 165631213-165661796 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 2092.0;Syncytiotrophoblasts: 2371.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 793.9;OE19: 781.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053311, HPA077929" Enhanced Approved Nucleoplasm NA NA 27000 Nucleoplasm "HPA053311: AB_2682108, HPA077929: " "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.65e-2)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (7.78e-2)" "unprognostic (3.09e-1)" "unprognostic (2.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.90e-1)" "unprognostic (3.96e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.60e-2)" "unprognostic (8.88e-2)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" 262.6 164.9 220.4 58.2 226.1 127.2 198.1 244.8 275.4 96.6 211.1 221.6 361.9 92.7 525.1 98.4 113.3 115.4 777.5 228.8 253.7 256.6 168.1 118.5 49.3 238.6 228.5 228.7 119.1 90.9 140.3 86.8 174.6 247.4 114.4 219.9 90.6 165.4 115.9 573.4 84.8 304.1 119.9 228.1 54.8 164.5 64.7 228.2 52.4 144.1 583.9 48.1 108.2 90.7 250.5 178.2 128.0 150.0 106.1 533.4 312.1 653.1 158.1 244.2 119.1 205.2 126.8 219.1 10.9 117.1 198.6 117.8 204.7 36.2 155.2 118.5 793.9 94.5 27.1 84.7 60.4 144.9 45.0 58.9 284.2 107.5 178.0 62.3 239.4 202.0 54.2 72.3 65.6 233.6 37.0 48.9 97.4 292.3 781.6 165.8 44.8 63.0 22.2 599.8 159.4 104.1 134.2 148.7 181.1 313.2 308.4 139.1 215.9 174.7 135.8 82.6 92.9 110.8 49.7 37.0 5.8 239.8 109.7 92.3 44.8 172.9 81.2 107.2 150.2 107.9 79.3 130.5 117.3 138.0 78.2 81.4 89.1 32.3 62.3 195.0 58.2 125.5 185.0 220.4 226.1 244.8 275.4 228.8 253.7 238.6 228.5 228.7 247.4 228.1 228.2 250.5 915.1 102.5 164.8 48.3 87.6 228.3 251.8 603.8 111.0 144.6 177.0 267.6 670.1 301.7 292.6 557.3 266.9 2092.0 96.5 500.3 1001.8 380.2 18.2 325.6 132.6 268.0 152.8 785.4 75.8 425.9 1327.2 300.3 193.7 257.7 91.8 519.5 257.7 295.0 837.4 131.2 86.4 302.9 374.3 130.0 243.1 46.1 388.0 234.9 519.4 43.1 296.6 257.9 87.6 45.8 90.6 401.8 613.9 399.8 92.9 173.9 1004.1 1227.6 459.9 162.5 506.2 197.5 652.1 23.1 40.4 157.1 232.6 2371.4 123.1 288.6 440.7 237.6 ADCY10 "HCA2, RP1-313L4.2, SAC, SACI, Sacy" ENSG00000143199 "Adenylate cyclase 10" Q96PN6 1 167809386-167914215 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "liver: 6.1;testis: 17.8" "Group enriched" "Detected in some" 7 "Early spermatids: 87.5;Late spermatids: 85.4" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015243, HPA017749" Approved NA NA "HPA015243: AB_1856540, HPA017749: AB_1856541" "unprognostic (1.20e-1)" "unprognostic (2.53e-1)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.56e-1)" "unprognostic (1.63e-1)" "unprognostic (3.65e-1)" "unprognostic (4.43e-2)" "unprognostic (7.83e-5)" "unprognostic (5.86e-7)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "unprognostic (7.83e-2)" "unprognostic (2.59e-1)" 0.1 0.2 1.3 0.0 1.2 0.0 1.0 2.5 2.4 0.1 0.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.2 1.5 0.8 0.4 6.1 0.2 0.0 0.6 1.0 1.3 0.1 0.4 0.0 0.1 0.1 1.6 0.4 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.3 17.8 1.6 0.1 0.1 0.0 0.0 0.1 0.1 1.7 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.2 2.5 2.4 1.5 0.8 0.6 1.0 1.3 1.6 0.7 1.6 1.7 0.1 0.0 0.0 2.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 87.5 0.3 0.2 0.1 0.0 0.0 9.9 0.0 0.7 0.3 0.0 0.1 0.0 0.9 0.7 7.6 0.1 0.0 7.6 0.0 0.0 0.0 0.4 85.4 0.6 0.1 0.0 1.0 0.0 0.0 0.0 3.5 3.6 0.0 0.0 0.4 0.0 0.2 1.1 0.2 0.0 0.0 0.0 0.2 0.4 11.3 0.6 0.1 0.4 1.8 0.0 0.8 0.2 0.2 COP1 "CFAP78, FAP78, FLJ10416, RFWD2, RNF200" ENSG00000143207 "COP1 E3 ubiquitin ligase" Q8NHY2 1 175944831-176207286 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 28.1;Extravillous trophoblasts: 33.5;Syncytiotrophoblasts: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.99e-1)" "unprognostic (3.76e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.96e-4)" "unprognostic (2.95e-2)" "unprognostic (4.33e-1)" "unprognostic (2.01e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" "unprognostic (3.52e-2)" "unprognostic (9.24e-2)" "unprognostic (1.67e-1)" "unprognostic (1.33e-2)" "unprognostic (6.68e-2)" "unprognostic (7.01e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-1)" 13.2 9.6 6.6 12.1 7.9 17.0 12.8 12.2 9.7 12.2 9.0 18.3 13.9 11.9 9.9 14.4 9.5 9.6 9.5 9.0 7.0 12.5 16.7 12.6 15.8 5.2 5.9 6.8 8.7 13.3 10.6 8.1 11.2 6.4 10.2 16.9 8.6 13.2 8.6 13.7 17.5 14.0 11.1 7.1 16.9 13.8 15.7 6.3 15.0 10.7 7.4 16.9 14.8 12.0 9.1 35.3 17.5 22.1 13.8 23.0 22.6 56.1 21.7 22.0 17.7 18.6 30.0 28.1 59.4 25.8 20.9 18.9 32.3 16.9 27.0 17.7 23.7 17.0 22.6 19.4 28.0 18.9 49.2 33.0 16.8 28.9 17.6 19.8 17.9 26.6 21.7 43.9 24.9 24.8 42.5 27.0 28.2 47.4 55.8 2.0 26.1 20.4 40.2 26.8 93.7 22.6 41.6 27.8 44.9 35.9 37.4 32.1 69.1 40.4 19.4 16.1 28.3 23.4 35.3 62.7 49.8 19.1 26.7 26.9 8.5 3.0 12.0 1.9 3.7 1.4 1.7 2.0 1.4 2.1 1.5 2.7 2.0 14.1 0.6 3.4 1.1 1.7 1.0 6.6 7.9 12.2 9.7 9.0 7.0 5.2 5.9 6.8 6.4 7.1 6.3 9.1 15.8 22.4 14.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 15.4 10.9 0.0 0.0 3.1 9.2 0.0 28.1 12.2 0.0 21.5 14.8 0.0 17.9 14.6 7.2 0.0 0.0 0.0 22.7 33.5 7.4 0.0 20.1 7.6 18.1 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 21.8 0.0 0.0 3.1 0.0 0.0 22.1 4.4 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 31.3 6.7 13.8 0.0 0.0 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070998-161089558 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 99.7;salivary gland: 33.8;skin 1: 112.6;vagina: 57.8" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 384.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 170000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.3 0.1 0.1 0.5 0.1 0.7 13.8 0.3 0.2 13.5 0.0 1.5 0.7 1.3 7.0 99.7 2.9 3.8 0.1 0.1 0.1 3.1 0.1 3.5 0.1 0.1 0.1 0.1 0.0 4.5 0.4 0.6 12.3 0.2 9.5 1.7 0.1 33.8 4.4 0.6 112.6 0.6 0.1 0.1 0.0 8.9 0.6 0.2 0.8 0.2 0.0 14.6 17.0 57.8 0.4 10.9 0.4 0.0 0.1 0.0 0.1 56.5 0.1 0.1 0.1 0.2 0.0 14.6 0.0 0.2 0.0 0.1 37.0 0.0 1.2 0.2 0.0 0.5 0.0 0.8 11.1 0.0 0.1 0.7 0.0 14.6 3.0 3.6 0.1 0.0 0.0 0.0 0.1 0.1 24.0 0.1 0.1 0.1 24.6 0.0 0.0 0.0 0.1 0.0 17.5 0.0 0.2 0.2 47.8 0.0 6.4 31.1 0.0 0.0 0.1 2.4 0.5 0.2 0.2 0.1 0.1 0.1 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.4 0.2 6.4 9.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.6 17.8 0.0 0.0 8.1 16.5 0.0 39.4 0.4 0.0 0.0 41.7 0.0 28.1 2.9 0.6 0.0 0.0 0.0 30.0 67.1 1.2 0.0 43.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 67.1 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 384.2 0.4 0.1 0.0 0.0 UFC1 HSPC155 ENSG00000143222 "Ubiquitin-fold modifier conjugating enzyme 1" Q9Y3C8 1 161152776-161158856 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 703.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027481, HPA028722" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 62000 "Nuclear speckles" Cytosol "HPA027481: AB_10599850, HPA028722: AB_10601674" "unprognostic (2.16e-1)" "unprognostic (6.17e-2)" "unprognostic (1.83e-1)" "unprognostic (8.25e-3)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-3)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (3.40e-2)" "unprognostic (5.04e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.62e-6)" "unprognostic (3.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.13e-1)" "unprognostic (6.22e-2)" 81.5 113.2 134.2 76.8 137.2 135.6 135.3 137.7 168.8 101.2 138.8 115.6 113.7 92.6 172.1 101.1 211.1 104.1 112.9 132.6 151.5 130.7 116.4 88.5 108.5 135.1 135.3 129.4 142.0 166.1 149.2 103.2 93.7 140.2 107.4 143.3 85.9 127.1 113.3 101.8 111.4 103.9 109.3 139.9 79.8 117.3 56.8 136.2 111.4 109.9 109.3 129.7 127.1 77.5 140.5 140.7 119.8 107.8 129.9 137.5 226.7 223.5 124.7 154.0 122.7 111.8 165.0 268.6 183.2 232.8 180.7 77.3 65.7 89.1 127.2 96.1 154.4 238.6 109.4 163.0 200.9 139.8 233.4 271.9 190.4 202.6 152.5 104.6 207.4 227.9 189.4 183.0 123.8 159.8 161.3 126.1 234.9 198.9 387.9 128.5 152.6 80.8 258.6 248.4 158.2 112.9 196.2 108.1 324.2 163.8 176.8 148.2 482.1 165.6 90.5 92.2 90.7 196.1 233.3 322.2 177.5 140.7 164.8 119.7 137.3 156.7 104.5 174.7 164.1 212.8 209.3 185.0 188.2 192.4 164.1 161.9 175.4 28.4 208.3 121.6 206.4 274.4 268.1 134.2 137.2 137.7 168.8 132.6 151.5 135.1 135.3 129.4 140.2 139.9 136.2 140.5 107.0 70.5 85.3 18.3 151.9 99.8 173.3 244.6 106.4 57.4 174.2 177.5 117.6 147.3 171.6 104.8 41.7 253.8 170.8 150.8 440.3 224.2 131.0 421.2 96.6 123.3 204.5 124.7 8.7 380.8 386.9 99.2 111.6 113.2 119.7 143.1 116.7 106.2 244.7 47.1 7.7 240.0 205.4 150.7 138.5 392.3 105.0 132.0 131.6 9.4 229.3 161.8 195.7 11.1 13.3 265.5 189.1 91.0 182.6 148.0 243.5 380.9 703.0 72.0 65.7 86.3 106.7 96.6 42.4 125.2 120.9 431.9 155.1 124.4 193.7 218.6 PPOX "PPO, VP" ENSG00000143224 "Protoporphyrinogen oxidase" P50336 1 161166056-161178013 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 65.9;Respiratory ciliated cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030123 Uncertain Approved Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "HPA030123: AB_10603987" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (9.88e-2)" "unprognostic (2.13e-2)" "unprognostic (3.24e-1)" "unprognostic (1.64e-2)" "unprognostic (9.58e-3)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.18e-3)" "unprognostic (7.12e-3)" "prognostic unfavorable (9.89e-4)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "unprognostic (1.80e-2)" 9.2 17.2 26.8 3.5 26.5 25.4 10.4 27.2 38.6 13.4 26.2 11.0 3.9 11.0 8.4 9.0 22.2 4.7 11.3 26.2 26.7 15.6 11.6 8.7 5.7 27.0 26.5 26.2 13.9 10.9 7.3 13.8 6.5 26.9 13.5 3.9 12.7 8.8 7.8 7.6 10.7 8.6 6.6 27.3 13.7 11.0 7.0 26.0 5.1 12.0 5.6 5.2 11.7 9.7 27.2 10.0 8.0 12.7 8.5 10.4 9.3 3.5 5.9 5.7 7.5 10.3 10.4 9.3 7.4 14.3 5.3 4.1 6.3 9.8 8.8 7.1 4.6 20.3 9.0 18.9 23.9 8.6 3.0 4.6 7.6 11.0 6.3 9.4 9.4 14.7 7.0 22.8 11.2 5.6 9.2 12.0 8.6 8.2 11.2 18.8 13.6 8.2 16.7 15.1 4.2 9.8 14.7 6.6 10.3 12.0 14.6 19.9 9.5 5.7 6.5 7.1 6.5 7.5 19.4 15.3 10.5 6.8 6.0 4.9 6.3 7.2 5.3 10.4 7.6 7.2 9.0 7.8 7.6 10.4 8.2 6.8 6.9 2.9 12.0 5.2 6.6 16.1 7.8 26.8 26.5 27.2 38.6 26.2 26.7 27.0 26.5 26.2 26.9 27.3 26.0 27.2 10.9 3.2 13.7 10.4 9.8 12.0 8.3 16.6 9.1 18.0 12.1 14.1 10.1 4.3 15.6 7.3 22.9 21.4 10.6 3.6 21.5 9.5 9.8 39.1 5.9 8.3 6.0 65.9 5.9 5.6 9.4 9.1 5.1 4.6 6.3 12.3 8.9 6.1 9.3 15.2 7.5 7.3 26.4 4.7 8.4 12.1 10.2 8.0 1.8 5.6 8.1 10.4 8.2 9.0 8.9 6.3 3.8 6.8 16.9 3.2 6.6 17.2 84.4 20.9 6.6 9.6 15.6 12.8 9.3 7.2 14.9 10.4 10.6 11.1 7.5 6.2 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.6;placenta: 108.2" "Cell type enhanced" "Detected in many" "Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 2322.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 2322.4" "Cell line enhanced" "Detected in some" "HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA 46000000 "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074" "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 68.7 25.0 6.9 102.6 9.5 49.0 13.4 8.4 17.5 18.2 17.3 16.1 8.2 7.4 4.3 11.8 14.8 37.2 9.8 7.4 20.5 10.6 12.4 78.2 16.3 15.0 10.5 5.1 7.3 12.8 8.6 7.7 108.2 12.8 6.2 21.3 2.3 10.0 9.7 2.6 3.4 10.9 41.3 14.2 62.3 10.2 4.5 12.9 9.9 6.4 10.3 7.8 68.9 5.2 16.8 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 2.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 29.4 0.3 0.0 0.7 8.6 56.2 0.5 0.0 0.0 0.0 0.7 0.1 0.0 17.9 0.5 0.0 0.0 0.4 15.8 0.0 0.0 1.1 0.2 1.2 8.1 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 61.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.4 26.7 6.6 2.4 358.3 421.8 0.7 268.4 1.0 3.2 0.5 0.4 89.9 1.7 0.4 0.7 2322.4 0.4 232.7 3.8 0.9 170.3 6.9 9.5 8.4 17.5 7.4 20.5 15.0 10.5 5.1 12.8 14.2 12.9 16.8 2.3 22.4 49.1 0.0 8.6 8.7 0.9 0.3 1.2 0.4 1.1 3.8 1.8 2.8 12.1 0.0 0.0 1.0 3.4 0.1 9.8 0.2 38.2 0.1 0.8 15.6 0.0 3.0 0.1 0.6 1.6 8.9 1.1 0.1 30.4 0.1 3.9 2.1 178.2 0.0 0.1 0.0 0.0 159.1 336.6 66.5 1.5 305.0 17.8 12.2 97.3 0.5 7.2 1.0 0.6 0.5 0.0 0.0 4.6 0.3 0.0 9.6 3.7 0.2 6.6 1.5 6.0 0.4 0.6 0.8 7.7 1.6 4.8 0.2 0.1 0.4 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2 component of NDC80 kinetochore complex" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 28.6;lymphoid tissue: 26.2;testis: 54.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 0.8 0.7 0.7 6.9 0.8 28.6 1.2 0.6 0.9 0.7 0.5 4.3 4.4 1.1 0.3 5.9 0.4 1.0 0.3 0.7 0.9 0.3 0.7 0.9 18.4 0.9 1.1 0.6 0.4 0.2 0.6 0.2 4.7 1.1 0.4 5.3 1.5 1.0 0.3 0.1 4.2 4.4 2.3 0.8 3.6 2.6 54.0 0.8 26.2 0.5 0.2 16.8 1.9 1.8 1.5 90.8 30.8 80.5 33.9 2.5 8.1 43.6 55.9 39.3 88.9 77.3 23.7 77.7 77.4 45.5 22.6 37.0 51.6 49.6 21.0 111.5 81.4 35.6 30.3 34.8 34.4 0.3 53.0 60.2 1.0 2.0 45.0 31.6 16.8 41.1 74.5 58.1 103.9 85.0 17.6 97.3 70.6 43.9 66.1 47.0 65.0 70.3 68.4 25.3 12.4 59.9 68.9 29.9 32.2 30.6 49.7 49.3 109.5 29.4 65.9 73.8 50.1 115.1 73.9 111.5 148.9 22.0 42.9 74.7 1.4 0.1 1.3 1.2 0.0 0.5 0.6 1.8 1.2 0.2 0.7 1.2 1.0 0.4 1.8 0.1 0.3 4.3 0.4 0.7 0.8 0.6 0.9 0.7 0.9 0.9 1.1 0.6 1.1 0.8 0.8 1.5 0.5 0.0 0.5 1.3 5.3 5.9 1.9 4.2 1.2 1.2 1.3 2.7 0.9 0.0 3.3 0.0 0.0 21.7 3.6 2.6 0.0 0.8 17.7 2.5 2.5 1.8 0.0 60.8 1.1 0.2 29.7 3.4 5.6 3.0 4.5 18.3 3.3 0.4 14.0 0.0 1.4 3.3 0.0 5.2 3.6 21.4 2.5 3.1 0.0 1.0 0.9 2.0 6.2 0.5 3.6 0.2 0.1 2.2 17.8 0.8 0.9 0.2 0.7 2.3 6.6 0.9 4.2 208.2 40.3 10.6 2.4 4.0 5.0 1.7 9.0 3.8 RGS5 ENSG00000143248 "Regulator of G protein signaling 5" O15539 1 163111121-163321791 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Sertoli cells: 5114.5;Smooth muscle cells: 1592.3" "Cancer enhanced" "Detected in all" "renal cancer: 226.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 1303.0;OE19: 692.4;SH-SY5Y: 4234.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001821 Supported Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA001821: AB_1079806" "unprognostic (3.75e-1)" "unprognostic (3.93e-3)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.65e-2)" "unprognostic (7.38e-2)" "unprognostic (3.54e-3)" "unprognostic (2.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.81e-3)" "unprognostic (7.05e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-1)" 139.4 315.3 85.0 29.9 97.8 0.1 58.9 88.2 113.9 161.9 82.0 77.7 65.1 74.4 63.6 72.5 66.0 144.0 240.4 71.2 92.1 89.0 34.4 56.0 34.1 102.3 93.1 60.9 19.7 30.8 84.0 45.8 20.1 133.4 75.7 43.3 15.4 28.0 191.8 117.6 18.1 76.5 280.6 70.7 16.8 94.3 40.9 90.4 21.4 166.1 238.9 39.7 137.4 61.0 94.6 0.4 0.0 62.9 8.0 1.3 3.0 2.6 1.1 4.4 2.0 1.3 5.3 1.6 0.5 9.2 1.1 0.7 0.4 0.8 0.8 3.3 3.0 1.0 1.3 0.9 0.1 2.6 0.8 0.7 2.0 1.9 2.1 2.6 14.3 1303.0 0.3 0.2 1.2 4.7 0.0 0.9 2.2 38.7 692.4 1.4 0.4 0.1 3.6 0.7 0.0 5.2 4234.9 0.9 0.0 1.5 185.8 0.0 1.3 5.3 1.0 2.3 0.9 2.0 1.5 1.2 0.4 1.4 0.2 2.9 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.5 0.2 0.1 0.2 0.4 0.4 0.1 0.2 0.1 0.0 0.2 0.1 85.0 97.8 88.2 113.9 71.2 92.1 102.3 93.1 60.9 133.4 70.7 90.4 94.6 458.3 3.2 5.6 61.4 1.7 17.1 6.0 1.0 0.6 1.8 9.8 12.1 0.0 0.0 7.3 1.8 4.2 1.5 2.4 0.3 1.9 1.0 32.7 3.4 11.6 353.7 0.0 0.0 24.4 1.1 0.8 43.0 223.3 8.1 1.3 0.9 0.0 0.0 1.2 0.0 60.5 0.2 0.0 0.0 26.3 17.0 6.8 11.9 23.2 80.6 0.6 2.6 0.0 25.1 69.7 3.9 0.2 2.6 0.4 12.7 0.2 2.5 5.9 5.8 5114.5 44.9 1592.3 5.7 1.7 5.2 12.6 1.2 5.8 5.5 0.2 7.0 SDHC "CYB560, cybL, PGL3" ENSG00000143252 "Succinate dehydrogenase complex subunit C" Q99643 1 161314381-161363206 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 776.7;Proximal tubular cells: 916.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-2)" "unprognostic (6.88e-2)" "unprognostic (6.38e-3)" "unprognostic (1.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.02e-2)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" "unprognostic (7.38e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "prognostic favorable (2.20e-4)" "unprognostic (9.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.19e-3)" "unprognostic (3.77e-1)" 130.1 144.9 76.3 64.7 80.7 61.0 101.4 88.1 85.8 79.4 89.4 120.1 129.0 71.6 76.6 110.6 99.4 63.9 155.6 70.8 84.8 288.4 322.1 66.1 75.3 84.2 81.4 69.1 69.8 63.1 175.1 52.8 73.7 80.0 78.0 133.5 85.1 75.5 85.5 280.0 69.2 102.3 102.3 88.4 63.3 90.8 53.1 85.3 94.0 90.3 290.9 106.0 89.3 61.9 89.4 161.1 129.7 157.5 147.7 248.3 213.3 196.3 150.9 190.3 180.3 137.3 185.4 208.7 53.7 190.6 214.8 121.6 178.5 244.3 214.2 193.2 185.6 205.6 110.2 106.6 196.7 126.9 193.8 109.1 211.5 181.7 174.3 119.4 167.9 177.5 164.0 178.9 43.8 266.3 167.0 152.4 112.5 145.4 376.3 123.7 131.6 151.0 217.1 330.3 167.8 118.3 180.7 211.0 385.1 225.4 207.9 342.1 259.3 133.5 103.7 125.1 127.9 147.3 173.3 287.8 269.4 140.3 139.2 193.6 88.6 111.0 65.7 76.6 99.6 79.6 68.6 66.2 75.4 136.1 65.7 71.2 71.0 52.0 66.9 87.5 100.6 78.3 130.0 76.3 80.7 88.1 85.8 70.8 84.8 84.2 81.4 69.1 80.0 88.4 85.3 89.4 50.9 44.8 59.4 14.7 70.1 61.8 151.2 342.6 59.7 74.9 81.4 58.3 94.0 131.5 163.5 150.8 64.6 248.0 65.5 95.9 776.7 218.4 18.6 87.1 63.8 80.7 66.8 81.4 19.3 145.2 248.5 79.8 79.5 62.6 58.3 66.6 83.2 249.1 237.3 72.3 27.4 103.4 215.7 100.6 74.4 34.7 102.9 94.6 129.9 9.4 176.1 107.8 107.1 17.6 24.5 142.7 89.5 109.1 71.9 100.2 139.1 916.5 177.9 69.3 52.6 74.5 94.4 115.3 114.4 111.2 76.4 307.6 72.0 215.7 154.2 155.0 PFDN2 ENSG00000143256 "Prefoldin subunit 2" Q9UHV9 1 161100556-161118055 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 641.9;Suprabasal keratinocytes: 642.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028700, HPA058304" Approved Enhanced Cytosol NA NA 85000 Cytosol "HPA028700: AB_10603983, HPA058304: AB_2683673" "unprognostic (2.56e-1)" "unprognostic (2.76e-2)" "unprognostic (1.01e-2)" "unprognostic (2.62e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.10e-4)" "unprognostic (9.59e-3)" "unprognostic (1.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.50e-2)" "unprognostic (8.46e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (4.39e-8)" "unprognostic (1.01e-1)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (3.66e-2)" 87.1 80.9 173.1 55.9 180.3 111.5 72.3 179.7 196.9 59.0 159.4 59.9 44.3 59.7 67.8 74.5 58.2 40.1 94.9 171.6 180.9 81.8 104.0 71.6 64.5 184.6 182.2 170.5 60.6 50.2 53.9 101.3 57.4 187.4 54.7 42.3 54.1 51.4 46.0 184.8 51.3 47.2 46.7 181.9 54.9 53.2 59.1 181.4 67.7 48.9 115.6 61.8 83.4 60.4 188.8 305.9 205.3 154.0 201.1 141.3 134.1 167.2 218.4 205.1 190.9 150.6 274.2 228.4 204.6 252.4 148.1 185.6 220.0 241.6 279.1 235.2 224.6 236.3 226.1 322.4 394.9 405.9 314.5 217.1 149.0 362.8 305.6 877.0 144.1 222.4 208.9 343.6 142.6 177.8 316.4 237.2 372.6 300.1 359.7 495.8 200.4 154.9 249.8 212.1 186.7 202.5 334.1 168.3 224.3 367.6 200.5 184.9 394.3 188.9 195.4 283.8 245.1 472.2 211.6 226.3 403.5 236.7 214.2 273.1 112.6 104.8 115.5 58.5 107.5 66.9 116.6 72.5 72.1 129.2 120.0 74.7 72.1 54.1 66.1 135.1 201.5 98.8 73.5 173.1 180.3 179.7 196.9 171.6 180.9 184.6 182.2 170.5 187.4 181.9 181.4 188.8 178.2 32.1 39.7 13.1 94.6 641.9 320.5 407.2 124.7 76.3 105.5 140.2 125.2 62.9 163.9 115.8 16.7 183.1 114.3 83.6 342.4 168.0 36.1 152.7 140.4 162.3 101.3 93.0 21.5 150.6 242.9 157.2 55.5 176.1 99.5 116.8 97.5 143.5 175.0 21.9 21.8 97.3 248.2 64.2 399.6 26.9 126.5 120.0 184.9 7.5 123.8 94.8 80.3 11.6 62.4 230.3 78.9 110.2 79.1 426.2 86.2 281.2 135.0 77.6 78.9 135.7 298.2 142.7 269.8 153.3 642.6 179.6 113.8 137.3 95.9 355.6 NR1I3 "CAR, CAR1, MB67" ENSG00000143257 "Nuclear receptor subfamily 1 group I member 3" Q14994 1 161229666-161238244 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 171.3" "Group enriched" "Detected in some" 4 "Hepatocytes: 134.8;Proximal tubular cells: 47.1" "Cancer enriched" "Detected in single" 67 "liver cancer: 17.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA051365 Approved Nucleoplasm NA NA Nucleoplasm "HPA051365: AB_2616454" "unprognostic (2.59e-3)" "unprognostic (1.06e-2)" "unprognostic (9.33e-2)" "unprognostic (6.92e-4)" "unprognostic (2.55e-1)" "unprognostic (1.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.85e-1)" "unprognostic (6.23e-2)" "unprognostic (5.63e-3)" "unprognostic (2.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.44e-2)" "unprognostic (5.48e-3)" "unprognostic (2.62e-2)" 0.1 0.1 0.2 0.0 2.0 0.6 0.0 0.4 0.8 0.0 0.0 0.1 2.4 0.1 0.0 0.2 0.1 0.0 0.4 0.1 0.0 10.1 171.3 0.2 0.2 1.0 0.1 0.1 0.1 0.2 0.0 1.7 0.0 0.5 0.1 0.0 1.0 0.0 0.0 1.5 1.2 3.6 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.1 0.4 0.4 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 3.8 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.2 0.0 0.3 0.1 0.2 0.7 0.7 0.5 0.4 0.3 0.2 0.0 0.7 0.8 0.6 0.1 1.2 0.1 0.5 0.8 0.5 0.8 0.2 0.3 0.6 0.1 0.6 1.0 0.5 0.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.4 0.8 0.1 0.0 1.0 0.1 0.1 0.5 0.0 0.2 0.6 0.8 22.4 11.7 0.0 1.3 0.6 1.2 0.1 0.0 0.7 0.2 0.1 0.5 5.7 5.0 3.7 0.0 0.1 0.2 0.2 3.9 0.1 1.7 0.1 0.2 2.3 0.0 8.0 0.4 0.0 0.2 1.9 0.0 0.1 13.3 0.1 3.9 134.8 0.3 0.0 0.6 0.0 0.0 4.1 1.1 3.1 0.3 1.8 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.1 0.0 0.4 0.8 0.5 5.0 47.1 4.4 1.6 0.0 2.4 0.5 0.2 0.2 0.0 0.0 0.0 1.6 0.1 0.3 0.9 USP21 "USP16, USP23" ENSG00000143258 "Ubiquitin specific peptidase 21" Q9UK80 1 161159450-161165723 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028397 Uncertain Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028397: AB_10603227" "unprognostic (9.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.22e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (5.35e-2)" "unprognostic (6.73e-2)" "unprognostic (2.76e-2)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (9.50e-6)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.35e-5)" 12.2 15.4 19.2 12.0 19.4 15.2 14.5 17.8 23.0 19.5 17.0 16.5 13.7 18.4 12.1 16.6 28.2 12.2 12.5 19.0 16.9 14.6 10.9 13.2 16.2 19.0 18.7 17.9 23.4 16.5 17.2 15.8 13.3 20.1 17.8 11.1 13.0 16.6 20.5 21.1 21.0 16.0 12.8 16.9 17.9 16.5 14.3 19.3 18.5 18.6 17.9 14.1 17.7 17.0 21.4 12.5 20.6 26.9 26.2 21.1 17.5 16.5 9.1 14.6 24.2 18.9 19.4 23.3 16.0 14.6 11.2 15.1 20.7 17.6 17.5 13.2 30.8 30.0 19.3 34.1 15.3 15.2 17.4 13.4 14.8 23.0 16.6 23.9 27.1 17.3 35.0 28.4 21.6 15.6 22.6 30.7 26.9 25.2 24.3 26.1 28.8 9.0 26.5 14.4 14.9 24.2 31.5 17.2 17.2 13.9 20.1 37.3 27.5 10.1 16.9 14.8 11.9 15.3 42.9 36.5 23.9 15.3 14.7 15.5 15.2 10.0 17.1 12.6 6.4 14.6 11.0 11.5 13.2 10.8 11.3 13.1 12.3 8.4 13.3 7.6 10.8 12.3 11.0 19.2 19.4 17.8 23.0 19.0 16.9 19.0 18.7 17.9 20.1 16.9 19.3 21.4 4.5 0.0 3.7 5.2 6.5 1.5 1.8 2.4 16.5 5.0 4.9 4.1 3.9 8.6 2.9 1.8 6.2 4.9 3.6 3.6 1.9 2.0 1.0 6.3 5.7 4.4 5.4 10.7 2.4 2.3 2.3 5.1 9.2 3.7 2.5 4.5 5.3 2.1 2.2 0.0 2.7 4.0 4.1 4.8 0.8 1.0 5.0 2.1 1.8 1.9 1.2 3.3 5.2 2.0 4.6 2.0 2.4 4.1 7.8 2.7 3.5 2.5 9.5 5.2 6.6 2.0 5.2 5.3 3.2 10.7 1.4 3.1 5.6 3.1 4.1 1.5 F13B FXIIIB ENSG00000143278 "Coagulation factor XIII B chain" P05160 1 197038741-197067260 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 211 "liver: 201.8" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 54.9" "Cancer enriched" "Detected in single" 816 "liver cancer: 46.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003827, HPA052139" Supported "Secreted to blood" NA NA 4700000000 "HPA003827: AB_1078794, HPA052139: AB_2681744" "unprognostic (1.46e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 201.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 54.9 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PRCC RCCP1 ENSG00000143294 "Proline rich mitotic checkpoint control factor" Q92733 1 156750610-156800815 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017151, HPA019463, HPA019481" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673" "unprognostic (6.12e-2)" "unprognostic (2.68e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (5.55e-4)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (3.03e-1)" "unprognostic (9.16e-2)" "unprognostic (3.27e-3)" "unprognostic (1.14e-1)" "unprognostic (6.80e-2)" "prognostic unfavorable (8.99e-15)" "unprognostic (1.72e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.02e-2)" 31.6 32.0 45.0 30.0 46.0 42.3 31.7 46.0 50.7 32.6 42.8 34.4 27.2 34.7 23.3 40.0 29.9 23.2 34.1 46.4 44.0 31.4 34.5 29.9 36.6 44.9 44.5 46.3 31.1 29.2 35.0 28.3 29.2 45.7 33.8 22.8 26.8 30.6 24.3 63.9 43.0 31.2 27.6 42.6 37.7 32.1 27.3 44.7 37.8 31.3 34.7 30.9 32.9 32.4 48.2 79.1 67.3 51.6 59.5 42.5 33.8 89.8 53.8 52.8 59.3 50.8 106.2 65.0 80.6 90.4 43.1 34.1 80.3 74.7 57.0 45.3 101.6 97.4 59.1 47.4 68.4 52.5 81.9 66.6 48.1 64.7 51.5 46.6 45.7 55.2 52.5 99.7 72.1 41.8 140.2 94.1 94.6 124.9 108.9 82.0 81.6 45.7 108.7 62.5 74.0 91.6 163.4 57.0 140.6 92.4 84.4 102.7 129.8 51.1 59.3 61.9 66.0 89.6 184.6 298.5 124.1 58.7 52.2 56.1 46.9 28.6 57.4 27.5 29.9 26.5 24.0 24.7 30.0 32.5 27.6 24.0 25.2 27.7 30.2 37.1 38.9 27.1 26.0 45.0 46.0 46.0 50.7 46.4 44.0 44.9 44.5 46.3 45.7 42.6 44.7 48.2 22.2 9.6 16.4 12.7 32.0 52.4 38.2 52.1 46.1 19.8 31.1 24.4 13.0 18.6 29.4 20.2 22.9 63.1 36.0 27.2 21.5 39.4 13.5 21.4 21.9 30.2 34.3 16.6 15.9 32.2 63.4 28.7 24.5 23.2 17.1 28.9 25.4 16.0 44.0 28.6 14.4 26.9 40.7 22.6 27.4 10.4 30.4 28.4 21.4 9.4 44.9 16.9 30.9 18.1 25.4 35.5 34.2 28.6 48.8 43.8 29.8 29.9 21.5 19.8 32.9 32.2 29.2 43.3 46.2 39.6 51.3 101.1 30.3 32.4 29.4 39.2 FCRL5 "BXMAS1, CD307e, FCRH5, IRTA2" ENSG00000143297 "Fc receptor like 5" Q96RD9 1 157513377-157552515 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 36.6" "Group enriched" "Detected in some" 5 "B-cells: 102.6;Early spermatids: 63.6;Plasma cells: 190.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "memory B-cell: 13.0;naive B-cell: 14.2" "Lineage enriched" "Detected in single" 17 "B-cells: 14.2" "Group enriched" "Detected in some" 5 "U-266/70: 3.4;U-698: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 169000000 65000000 "unprognostic (1.30e-3)" "unprognostic (3.51e-2)" "unprognostic (7.59e-3)" "unprognostic (1.57e-2)" "unprognostic (9.41e-3)" "unprognostic (4.32e-5)" "unprognostic (2.61e-2)" "unprognostic (6.93e-2)" "unprognostic (7.40e-2)" "unprognostic (7.66e-3)" "unprognostic (4.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.51e-10)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.99e-2)" "unprognostic (2.78e-1)" 0.4 0.4 0.0 13.9 0.0 2.3 2.4 0.0 0.1 0.7 0.0 5.5 5.9 0.1 0.3 0.8 0.4 1.2 0.3 0.0 0.1 0.4 0.4 1.1 24.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 4.4 0.0 3.9 0.3 0.0 0.0 5.1 0.1 0.1 15.2 4.5 0.6 0.0 4.2 0.7 0.0 36.6 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.3 102.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.1 2.9 0.1 0.0 0.0 63.6 0.0 0.0 0.1 0.0 1.3 0.1 0.0 0.2 0.3 1.1 0.0 1.3 0.0 0.4 1.8 0.3 0.0 0.1 0.0 0.0 0.3 0.3 10.1 0.3 0.2 23.2 0.0 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.0 190.5 0.2 0.0 0.1 0.0 0.0 6.6 0.0 0.3 1.2 0.1 0.1 0.0 0.7 5.7 0.0 0.6 0.0 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047426: AB_2680041" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 16.9 21.5 16.0 14.2 18.2 12.0 22.1 17.8 18.2 22.5 19.0 20.8 27.6 22.2 26.3 22.0 28.5 17.9 15.0 14.5 16.7 17.8 28.6 17.8 19.7 19.7 17.7 13.7 26.7 27.9 25.6 20.7 14.9 18.4 25.2 17.6 18.0 27.4 23.1 30.5 29.4 24.2 14.9 18.1 20.5 24.0 24.6 16.8 14.4 29.6 23.0 17.2 22.6 21.1 21.9 14.6 28.3 20.6 20.3 54.2 24.7 31.3 10.8 32.8 18.3 13.7 15.3 65.7 24.8 31.6 17.1 25.7 60.7 28.9 25.4 7.3 49.5 24.3 15.0 27.5 11.6 34.1 22.4 39.2 38.4 47.5 18.3 34.3 21.5 15.5 21.8 36.3 54.1 9.9 35.3 11.6 26.0 23.9 63.2 8.7 18.7 13.6 58.1 21.8 15.6 26.7 38.2 19.2 38.7 24.0 31.2 51.5 47.2 15.0 11.3 13.8 17.7 14.7 62.7 67.7 31.8 12.7 24.9 13.9 4.1 1.8 2.7 3.5 1.3 3.6 1.7 3.3 2.5 3.2 2.3 2.7 3.0 4.0 4.0 2.3 1.2 5.1 1.7 16.0 18.2 17.8 18.2 14.5 16.7 19.7 17.7 13.7 18.4 18.1 16.8 21.9 9.5 6.4 15.1 11.4 15.8 10.1 21.5 13.5 22.2 11.2 20.0 19.9 7.1 31.5 13.9 3.7 12.5 24.9 8.9 16.4 9.8 12.7 60.2 12.3 6.4 9.7 9.6 14.3 4.6 13.1 17.2 11.2 18.3 10.9 5.1 8.7 12.5 19.5 10.9 8.4 6.3 16.9 14.2 11.1 4.9 14.7 11.1 9.6 8.8 4.7 10.1 20.5 5.2 5.5 15.9 9.3 12.8 9.4 14.8 21.4 36.5 12.8 13.9 13.6 13.1 9.6 9.6 20.6 23.2 18.9 11.5 32.4 8.1 8.2 16.2 18.0 MRPL24 MRP-L18 ENSG00000143314 "Mitochondrial ribosomal protein L24" Q96A35 1 156737303-156741590 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 213.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030295, HPA054323" Approved "Intracellular and membrane" NA NA "HPA030295: AB_10600932, HPA054323: AB_2732583" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (2.26e-2)" "unprognostic (1.47e-2)" "unprognostic (2.83e-1)" "unprognostic (3.69e-2)" "unprognostic (1.71e-2)" "unprognostic (3.11e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (3.05e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.47e-1)" "unprognostic (8.75e-2)" "unprognostic (3.74e-1)" "unprognostic (1.94e-1)" 78.8 94.6 76.5 43.4 80.4 24.2 70.5 81.4 81.9 51.5 73.0 65.1 41.1 58.8 95.4 55.8 73.4 34.1 94.7 76.2 78.0 78.6 131.7 37.5 46.4 79.7 77.5 74.0 66.2 101.0 86.8 41.4 41.9 80.4 49.5 68.5 27.2 71.8 66.3 151.0 51.1 42.2 77.3 77.5 43.5 62.5 37.7 78.7 43.2 52.9 144.2 57.5 67.7 48.4 83.7 146.0 238.2 50.2 62.0 157.0 167.6 98.7 115.6 72.2 153.6 86.5 96.5 149.7 112.1 189.3 153.2 74.9 141.3 121.8 238.9 153.3 136.6 152.7 104.9 164.9 94.7 176.8 115.9 70.8 156.5 205.0 232.3 243.4 92.9 136.4 136.5 105.4 129.2 155.1 259.9 130.6 115.2 93.0 495.3 289.8 83.7 134.7 229.1 192.3 105.2 64.0 129.4 70.3 391.6 192.5 95.4 233.9 130.6 104.1 141.8 108.9 141.1 200.3 144.1 131.5 116.1 133.8 135.5 143.8 38.3 62.3 11.2 63.1 77.4 95.8 87.2 82.3 77.5 81.5 86.9 81.4 86.0 3.3 97.1 75.0 68.4 72.0 93.5 76.5 80.4 81.4 81.9 76.2 78.0 79.7 77.5 74.0 80.4 77.5 78.7 83.7 26.3 32.1 31.6 3.9 33.7 30.5 67.0 65.4 39.3 13.8 46.8 51.3 157.0 80.1 49.1 42.3 4.2 92.4 27.5 28.0 154.6 53.5 26.7 31.5 45.0 40.9 36.0 22.9 5.7 76.6 87.9 51.0 36.7 37.0 60.3 30.9 35.7 133.6 79.7 15.2 6.3 45.7 36.7 27.3 29.4 13.4 55.9 29.1 74.7 1.9 47.9 22.2 36.0 4.5 10.0 40.2 35.3 53.0 43.4 53.7 44.9 213.2 41.7 13.7 32.9 53.0 62.0 46.8 48.5 66.1 36.7 40.8 28.7 59.7 69.5 62.1 PIGM GPI-MT-I ENSG00000143315 "Phosphatidylinositol glycan anchor biosynthesis class M" Q9H3S5 1 160024953-160031990 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047418 Uncertain NA NA "HPA047418: AB_2680039" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (9.89e-2)" "unprognostic (2.88e-2)" "unprognostic (2.69e-3)" "unprognostic (1.52e-1)" "unprognostic (3.85e-2)" "prognostic favorable (3.27e-4)" "unprognostic (2.63e-2)" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (8.55e-2)" "unprognostic (1.69e-1)" "unprognostic (2.06e-2)" "unprognostic (1.50e-1)" 3.3 4.2 3.3 4.1 4.8 1.8 5.3 5.2 4.0 4.1 3.5 3.9 4.5 3.6 6.1 3.4 4.0 3.3 2.6 3.5 4.3 4.0 5.2 3.7 4.3 5.5 4.6 3.1 4.0 7.9 6.7 3.6 3.4 5.3 6.1 4.3 8.2 6.4 4.1 1.4 5.5 4.9 3.2 5.5 4.2 4.6 3.5 4.5 4.9 6.2 1.7 4.0 3.0 2.6 9.2 5.8 5.2 6.1 9.1 8.0 6.5 2.0 8.6 5.4 5.6 5.1 2.8 10.3 4.1 6.9 5.6 4.8 11.5 6.9 6.9 7.0 8.7 7.2 9.3 6.8 4.2 4.9 12.1 7.0 6.0 4.5 6.6 5.0 4.8 4.7 8.9 5.1 7.5 6.5 9.8 7.9 6.4 6.5 10.9 7.4 2.3 6.4 18.0 6.1 7.9 8.7 13.5 9.4 11.0 6.9 5.8 20.7 14.4 6.7 7.3 6.4 11.1 5.3 13.5 16.0 0.2 6.7 6.1 8.3 8.9 12.4 5.3 6.7 10.4 6.9 5.1 6.7 5.3 7.7 4.8 8.4 6.7 2.2 8.9 13.8 9.1 7.8 7.3 3.3 4.8 5.2 4.0 3.5 4.3 5.5 4.6 3.1 5.3 5.5 4.5 9.2 10.0 12.8 19.8 7.5 7.7 4.2 4.7 6.4 17.1 16.1 14.1 9.0 5.3 17.2 13.2 16.5 10.4 7.6 5.0 7.3 1.9 13.3 6.7 5.5 12.5 10.0 12.6 14.1 5.7 18.5 3.2 11.9 7.1 8.1 5.1 9.6 15.4 22.2 7.3 16.8 5.5 12.8 2.0 14.5 5.0 3.9 8.4 9.2 8.8 4.7 12.3 27.9 9.2 12.5 23.1 12.0 5.3 9.1 11.2 8.1 10.1 6.6 10.2 13.6 19.7 10.7 8.6 29.3 8.1 17.0 4.5 1.8 7.3 11.0 12.1 3.7 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190575-160201886 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 64 "skeletal muscle: 4485.2;tongue: 1909.5" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6" "Cancer enhanced" "Detected in many" "glioma: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007845, CAB015170, HPA026823" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA 270000 "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favorable (8.93e-5)" 0.8 0.4 5.4 0.8 7.0 1.5 1.4 5.9 10.1 0.4 4.2 2.3 0.5 1.7 0.3 43.5 1.9 1.2 45.4 7.5 4.7 0.3 0.4 0.7 3.0 4.5 4.8 6.2 0.4 0.3 0.2 1.0 6.2 4.8 16.3 0.6 50.1 16.9 5.0 4485.2 0.9 2.0 7.4 4.0 1.3 0.8 5.8 4.6 0.5 0.6 1909.5 1.0 5.8 0.9 7.0 0.0 0.0 0.5 0.0 0.2 0.0 19.3 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 38.5 0.4 0.1 0.0 0.0 0.1 0.6 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.7 0.4 0.1 0.0 0.2 0.3 0.2 0.0 67.4 0.0 0.1 0.3 0.2 0.0 3.5 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.7 0.8 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.4 7.0 5.9 10.1 7.5 4.7 4.5 4.8 6.2 4.8 4.0 4.6 7.0 0.1 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 1.9 0.7 0.9 17.6 0.0 0.0 0.0 2.1 3.0 0.1 0.0 0.0 0.1 3.0 0.1 0.1 0.2 0.0 0.0 2.0 0.0 4.9 0.3 0.0 0.1 3.8 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.3 0.6 0.6 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 25.2 0.0 20.6 0.6 1.2 1.9 0.0 0.0 4.5 0.1 0.1 0.0 0.3 ISG20L2 FLJ12671 ENSG00000143319 "Interferon stimulated exonuclease gene 20 like 2" Q9H9L3 1 156721891-156728766 "Predicted intracellular proteins" "Ribosome biogenesis" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 96.4" "Group enriched" "Detected in all" 30 "Early spermatids: 816.3;Late spermatids: 2897.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028005, HPA054285" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028005: AB_2126319, HPA054285: " "unprognostic (1.67e-2)" "unprognostic (7.87e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (3.52e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (6.05e-2)" "unprognostic (2.40e-1)" "unprognostic (8.17e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (5.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.82e-3)" "unprognostic (2.32e-1)" 10.7 10.6 6.2 11.5 6.2 16.9 10.8 7.8 8.2 10.8 5.1 12.2 9.3 13.0 7.6 18.7 11.6 9.1 9.7 6.8 6.2 10.4 13.6 10.1 15.0 6.0 6.1 6.3 13.9 11.8 9.4 9.2 12.0 6.4 11.4 12.5 6.7 11.4 8.1 9.8 14.5 12.1 12.6 5.7 13.4 12.3 96.4 6.2 12.4 9.8 6.7 17.1 15.4 12.5 6.3 29.8 22.6 19.1 20.5 19.4 14.2 29.5 20.4 17.9 26.3 18.2 30.2 21.3 56.7 24.3 15.3 11.9 39.2 47.0 32.2 19.9 28.4 30.6 30.9 16.4 17.8 18.9 73.7 32.3 14.3 32.4 24.6 24.7 17.1 24.2 23.9 49.5 25.4 17.0 40.4 31.8 21.3 62.9 60.3 38.0 37.5 22.3 35.9 19.6 23.8 40.4 48.5 24.8 69.8 21.3 27.8 44.5 45.8 16.2 15.2 22.4 18.8 41.9 33.9 56.3 70.3 13.8 37.1 20.2 28.2 8.7 17.2 8.5 11.0 9.8 7.2 6.5 8.7 8.2 8.6 6.6 7.7 15.1 12.1 12.4 5.5 6.7 6.1 6.2 6.2 7.8 8.2 6.8 6.2 6.0 6.1 6.3 6.4 5.7 6.2 6.3 16.4 28.9 43.4 4.9 43.6 52.9 40.4 18.9 46.7 22.4 30.5 23.6 10.1 18.6 29.1 7.3 25.0 34.9 57.7 32.0 17.6 21.2 816.3 21.7 22.8 24.9 31.8 29.8 13.5 17.3 37.5 24.2 26.0 38.5 27.8 22.7 21.4 18.6 21.3 23.5 9.8 32.3 10.2 28.4 38.0 2897.0 29.2 33.2 23.2 2.8 21.6 19.8 36.0 6.0 6.3 23.6 16.7 25.9 38.4 38.0 33.8 13.9 19.5 20.5 26.3 30.2 24.5 48.0 27.3 41.7 60.7 37.5 51.5 23.4 31.5 45.8 CRABP2 CRABP-II ENSG00000143320 "Cellular retinoic acid binding protein 2" P29373 1 156699606-156705816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "esophagus: 1199.3;vagina: 609.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 485.4;Breast glandular cells: 224.2;Club cells: 266.7;Squamous epithelial cells: 714.0;Urothelial cells: 506.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1592.5;MCF7: 625.9;T-47d: 1201.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 36.0" HPA004135 Supported Supported Nucleoplasm,Cytosol NA NA 76000 Cytosol Nucleoplasm "HPA004135: AB_1846516" "unprognostic (1.17e-2)" "unprognostic (9.30e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (1.75e-2)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" "unprognostic (6.45e-2)" "unprognostic (7.79e-2)" "unprognostic (7.23e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.19e-13)" "unprognostic (3.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" 22.1 8.1 9.2 4.9 10.4 5.7 105.5 11.0 19.6 157.3 26.9 10.3 0.9 77.0 4.7 1199.3 83.8 18.4 4.9 11.1 12.1 12.0 2.3 6.4 3.9 8.3 16.4 9.8 6.3 3.5 55.6 43.8 40.8 8.1 35.1 4.8 4.5 94.3 57.7 5.0 171.5 3.9 57.4 7.7 8.0 5.7 5.3 10.3 15.7 14.6 1.9 76.9 81.9 609.9 10.4 103.4 5.4 115.3 1.6 147.1 218.0 0.4 215.4 1592.5 17.3 21.3 184.9 369.8 1.6 103.1 234.0 2.2 131.2 28.1 0.8 5.1 2.9 8.1 0.1 13.5 1.6 29.0 0.3 2.5 69.3 10.6 25.4 0.5 13.8 0.7 2.0 1.0 2.2 1.9 625.9 1.7 1.9 136.5 12.3 57.3 1.7 0.8 3.4 2.3 4.0 280.7 20.2 3.0 366.2 1.5 214.9 1201.3 0.7 0.2 4.2 63.1 35.5 13.4 9.8 23.8 1.3 28.6 1.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.2 10.4 11.0 19.6 11.1 12.1 8.3 16.4 9.8 8.1 7.7 10.3 10.4 7.0 0.0 2.6 1.3 1.8 65.0 131.2 485.4 104.2 1.8 224.2 96.8 0.7 1.5 266.7 16.5 2.1 53.9 4.9 0.9 0.0 12.6 2.2 18.0 51.9 10.3 0.0 0.0 3.1 5.2 6.2 168.4 1.1 29.3 0.0 0.5 6.4 0.2 10.0 0.0 1.8 0.9 40.7 0.0 55.4 1.0 19.9 3.9 62.2 0.0 0.0 1.0 0.0 1.5 0.3 18.1 0.2 37.6 0.2 194.9 0.1 0.3 28.2 0.6 0.0 4.3 40.0 2.0 6.1 714.0 190.7 18.1 7.6 4.8 1.7 506.4 HDGF HMG1L2 ENSG00000143321 "Heparin binding growth factor" P51858 1 156742109-156766925 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "DNA-binding, Growth factor, Heparin-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026035, HPA048728, HPA053422" Enhanced Enhanced Nucleoplasm "Secreted to blood" NA NA 790000 Nucleoplasm "CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146" "unprognostic (2.80e-1)" "unprognostic (9.63e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (9.06e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.43e-8)" "unprognostic (9.80e-3)" "unprognostic (2.34e-2)" "prognostic favorable (9.84e-4)" "unprognostic (2.45e-3)" "unprognostic (3.67e-2)" "unprognostic (1.40e-3)" "unprognostic (8.66e-3)" "unprognostic (2.14e-1)" "unprognostic (2.06e-1)" "unprognostic (3.86e-2)" 90.4 90.4 100.8 73.5 103.1 307.9 91.3 105.2 114.4 86.6 102.2 108.7 131.4 78.3 70.6 187.8 113.8 63.0 112.3 98.5 110.3 136.3 224.1 114.5 65.1 114.1 104.1 93.8 87.5 94.0 93.6 68.3 72.4 105.9 82.4 119.3 69.5 97.4 57.3 236.8 155.6 129.5 71.1 107.9 77.9 99.9 42.9 105.0 158.7 91.4 133.7 115.9 107.7 103.5 111.7 491.5 249.1 258.2 125.6 150.0 203.0 296.8 158.4 406.3 366.8 234.4 279.4 500.9 335.5 310.6 325.0 158.6 338.8 408.9 365.0 356.0 276.1 299.9 278.1 339.4 241.2 202.0 411.9 227.4 152.4 335.7 292.8 560.4 278.6 272.4 249.6 387.0 260.4 293.7 369.3 345.5 459.2 472.1 755.4 347.7 384.8 156.9 435.1 401.0 162.6 396.9 432.0 380.4 480.3 199.3 319.8 387.6 621.9 242.4 181.1 286.5 230.3 408.9 364.0 486.0 555.6 238.9 318.4 235.2 6.2 9.9 9.2 6.6 8.8 4.9 5.6 5.6 5.9 11.6 6.6 5.0 4.7 5.6 5.2 10.0 11.9 8.2 6.8 100.8 103.1 105.2 114.4 98.5 110.3 114.1 104.1 93.8 105.9 107.9 105.0 111.7 51.9 70.5 99.2 12.1 35.3 147.3 185.1 90.5 76.2 66.7 89.9 66.0 91.0 98.7 75.3 71.7 27.1 44.1 72.4 121.4 80.3 112.2 48.4 144.0 79.2 66.1 124.6 217.8 12.0 132.0 107.3 66.7 62.7 91.8 30.4 67.4 35.0 164.5 52.7 53.8 12.4 104.3 48.8 45.6 89.1 47.0 40.7 71.0 39.2 14.0 57.3 71.4 25.7 5.5 16.1 165.7 59.5 45.9 59.0 281.3 138.2 118.1 126.8 34.9 19.7 70.9 57.8 27.7 28.3 108.6 159.4 54.9 50.5 83.2 114.9 228.6 ABL2 "ABLL, ARG" ENSG00000143322 "ABL proto-oncogene 2, non-receptor tyrosine kinase" P42684 1 179099330-179229684 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 166.8;Langerhans cells: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "hTERT-HME1: 73.5;TIME: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001866, CAB017106, HPA072754" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212" "unprognostic (3.05e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.07e-1)" "unprognostic (4.71e-2)" "unprognostic (9.45e-2)" "unprognostic (8.23e-3)" "unprognostic (1.91e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-1)" "unprognostic (6.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (1.78e-7)" "unprognostic (4.76e-2)" "unprognostic (4.14e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (8.40e-4)" 9.4 3.2 4.8 5.0 6.4 2.7 5.8 6.1 5.4 5.4 3.3 4.0 2.8 3.7 2.7 2.5 3.2 11.9 3.5 7.1 4.7 3.1 2.8 6.6 2.7 3.8 4.2 4.6 3.6 5.8 4.2 3.8 4.2 4.4 3.5 3.3 9.3 3.5 2.7 3.1 4.0 3.3 4.6 3.0 2.7 3.7 4.4 5.0 4.1 3.8 4.3 2.5 6.5 4.1 4.8 24.2 13.1 8.7 5.8 7.3 16.8 5.3 26.3 21.6 31.9 23.1 9.9 7.2 13.7 18.9 19.2 21.7 11.0 12.6 9.1 44.6 8.5 11.4 6.7 12.4 4.9 13.3 7.5 2.1 15.6 11.6 45.3 73.5 13.9 36.2 7.0 16.1 3.8 42.6 6.5 5.9 4.0 8.3 5.0 4.3 8.6 14.4 6.5 10.8 4.0 5.2 11.9 22.0 7.0 53.8 13.2 6.2 6.4 70.7 33.3 24.5 15.7 42.8 7.0 9.3 14.1 15.6 4.0 32.4 1.4 0.3 0.0 0.5 0.1 0.2 0.5 0.3 0.3 0.2 0.7 0.4 0.5 0.6 0.5 0.1 0.5 0.2 0.1 4.8 6.4 6.1 5.4 7.1 4.7 3.8 4.2 4.6 4.4 3.0 5.0 4.8 33.5 22.4 24.0 44.1 14.4 46.9 43.6 16.3 12.5 40.0 18.7 9.5 8.9 22.8 10.8 11.0 166.8 9.3 7.7 15.5 11.7 14.3 15.6 12.3 23.4 67.2 27.0 9.9 81.6 13.9 8.2 67.6 10.2 21.5 17.1 19.5 31.1 15.3 22.9 25.2 62.0 11.0 10.2 34.9 188.1 32.2 15.2 67.7 69.4 45.0 13.9 11.3 8.2 72.4 57.1 45.5 16.0 13.5 10.3 42.6 9.9 9.4 11.0 35.7 6.6 32.3 30.5 17.8 30.5 11.5 38.4 10.4 12.4 11.6 14.9 25.3 XPR1 "SLC53A1, SYG1, X3" ENSG00000143324 "Xenotropic and polytropic retrovirus receptor 1" Q9UBH6 1 180632022-180890279 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Host cell receptor for virus entry, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 100.9;Excitatory neurons: 118.2;Inhibitory neurons: 102.5;Microglial cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016557 Supported NA NA "HPA016557: AB_2669382" "unprognostic (2.65e-1)" "unprognostic (2.68e-2)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (1.30e-3)" "prognostic unfavorable (3.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.59e-1)" "unprognostic (3.78e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.82e-2)" "unprognostic (7.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.59e-1)" "unprognostic (8.44e-2)" 7.7 9.1 7.9 7.4 7.8 6.3 6.7 4.8 7.8 19.5 11.8 9.3 11.1 11.0 7.4 7.2 15.4 8.5 30.6 5.0 12.5 20.4 6.3 10.2 5.9 5.4 8.7 4.6 7.4 12.7 20.4 6.2 14.2 6.8 6.5 10.0 10.2 6.1 10.2 5.4 4.2 11.1 9.8 5.4 7.1 4.7 16.9 9.7 8.6 13.7 8.4 6.8 12.5 4.5 7.3 16.1 22.6 54.4 19.1 17.9 24.1 51.5 18.2 24.1 12.1 12.9 32.6 23.2 15.2 42.3 21.1 19.2 42.7 22.0 32.3 17.8 21.4 14.1 19.7 15.0 23.3 20.9 16.6 20.7 20.2 31.3 17.2 35.5 19.7 26.7 20.2 61.3 24.7 28.8 14.7 15.9 7.6 51.4 20.3 4.9 16.6 19.5 20.2 30.8 32.8 34.6 145.7 25.0 22.0 16.0 37.0 19.5 18.8 22.3 15.9 15.3 22.9 23.1 27.3 27.5 29.9 11.5 16.3 26.4 0.9 4.5 2.1 3.1 8.4 2.7 1.6 2.8 2.8 3.8 2.0 2.6 2.7 4.3 2.8 13.4 1.1 3.2 3.2 7.9 7.8 4.8 7.8 5.0 12.5 5.4 8.7 4.6 6.8 5.4 9.7 7.3 22.4 9.6 14.4 100.9 11.2 25.6 19.7 22.6 55.8 16.3 11.0 9.1 47.3 15.7 15.0 5.5 27.1 13.7 5.3 20.2 3.9 22.3 19.4 27.1 13.3 21.3 12.0 18.3 118.2 44.6 6.6 10.7 8.2 48.2 7.6 11.6 15.0 11.9 9.8 13.5 102.5 7.0 20.3 21.4 17.7 9.7 4.7 14.8 10.6 102.1 9.7 8.1 12.3 79.9 47.5 23.5 12.4 14.3 13.4 13.5 25.6 24.3 23.0 10.5 6.6 8.9 10.5 15.5 17.5 22.3 17.0 7.7 13.4 10.0 10.4 14.1 RGS16 "A28-RGS14, RGS-r" ENSG00000143333 "Regulator of G protein signaling 16" O15492 1 182598623-182604389 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.6;thyroid gland: 104.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 535.4;Muller glia cells: 265.9;Smooth muscle cells: 581.5;Theca cells: 253.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "thalamus: 111.6" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 109.3;NB-4: 60.7;SCLC-21H: 109.6;U-266/70: 124.0;U-698: 162.8" "Region enriched" "Detected in all" 5 "thalamus: 79.9" "Group enriched" "Detected in many" 7 "midbrain: 76.5;pons: 68.5;thalamus: 124.2" "HPA053250, HPA055824" Uncertain Approved Cytosol NA NA Cytosol "HPA053250: AB_2682090, HPA055824: AB_2682934" "unprognostic (4.03e-2)" "unprognostic (6.08e-2)" "unprognostic (4.87e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (3.55e-2)" "unprognostic (2.01e-2)" "unprognostic (2.10e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.93e-2)" "unprognostic (3.65e-2)" "unprognostic (9.07e-3)" "unprognostic (5.39e-2)" 23.2 10.5 21.7 11.8 10.1 4.8 7.9 10.2 11.1 2.7 15.5 10.5 2.8 3.3 4.8 6.3 12.2 16.6 8.2 7.2 37.7 15.4 13.2 26.9 18.0 17.1 68.4 7.2 4.0 7.9 5.8 50.8 12.2 12.6 4.8 5.4 60.9 6.4 6.4 6.0 5.3 6.9 12.1 19.0 14.4 8.9 1.0 111.6 8.7 104.5 9.0 6.7 38.6 2.9 24.0 0.8 0.1 6.4 0.0 1.0 0.2 48.6 0.2 1.7 0.0 0.1 0.1 0.3 109.3 0.5 0.0 0.0 0.5 11.9 1.0 0.1 12.5 8.8 11.5 1.2 0.0 1.8 18.4 9.5 2.5 17.8 0.0 0.7 0.0 0.0 3.9 0.5 18.6 0.0 12.3 0.6 60.7 34.2 1.0 3.5 0.2 35.1 26.2 0.1 5.1 109.6 11.5 0.2 9.1 0.2 6.4 3.6 14.6 0.1 0.3 2.4 3.1 5.5 124.0 6.1 162.8 0.6 11.8 5.8 2.6 0.3 0.6 0.3 0.4 0.6 4.7 4.3 0.5 0.5 2.2 1.9 0.6 1.2 2.6 0.9 9.7 2.9 1.1 21.7 10.1 10.2 11.1 7.2 37.7 17.1 68.4 7.2 12.6 19.0 111.6 24.0 80.8 134.6 185.5 6.2 48.3 82.3 10.0 3.8 37.5 535.4 25.8 94.5 25.7 0.0 18.7 9.2 18.8 8.5 28.7 11.2 0.0 1.6 0.4 21.4 41.5 181.8 50.5 20.4 0.1 2.4 201.9 103.7 17.3 30.5 71.8 0.5 18.9 2.6 19.1 32.0 8.3 12.1 16.2 2.8 116.7 0.0 0.3 18.4 81.8 0.0 11.9 265.9 0.0 0.0 0.7 2.9 4.7 0.4 64.3 12.4 1.1 0.8 2.6 46.9 65.7 47.3 581.5 0.2 2.1 37.0 63.1 34.5 33.5 253.5 6.4 9.7 TOR1AIP1 "FLJ13142, LAP1, LAP1B, LAP1C" ENSG00000143337 "Torsin 1A interacting protein 1" Q5JTV8 1 179882042-179920077 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 275.9;Late spermatids: 190.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047151, HPA050546, HPA070991" Enhanced Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: " "unprognostic (1.41e-1)" "unprognostic (3.95e-3)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (9.00e-2)" "unprognostic (6.33e-2)" "unprognostic (7.04e-2)" "unprognostic (8.62e-2)" "unprognostic (1.93e-1)" "unprognostic (9.10e-2)" "unprognostic (4.40e-2)" "unprognostic (4.41e-2)" "unprognostic (2.87e-1)" "unprognostic (7.75e-2)" "unprognostic (4.02e-2)" 40.1 35.1 21.3 27.5 24.6 85.3 34.2 24.1 25.2 42.9 29.6 37.6 16.1 40.9 36.2 41.0 31.8 34.6 38.9 19.5 30.0 36.9 38.7 35.8 34.5 25.5 23.3 17.1 55.0 28.2 37.2 20.3 28.7 24.8 44.2 23.0 25.3 31.8 43.6 54.6 20.3 23.8 41.3 22.0 35.3 31.6 27.2 22.6 27.8 47.2 75.4 27.8 40.8 26.7 26.0 37.1 36.4 24.9 32.3 109.7 73.6 47.7 48.2 57.7 44.5 45.6 28.5 68.5 9.7 52.1 50.2 31.8 63.5 23.6 39.6 52.8 62.9 23.2 26.4 31.5 28.5 50.4 90.8 78.4 57.8 29.8 55.3 51.3 50.1 40.9 39.5 39.2 47.6 47.9 33.1 37.4 28.5 35.5 47.9 13.9 22.8 38.9 25.5 43.7 71.3 20.9 29.2 60.7 57.9 83.6 36.6 44.3 91.9 41.9 60.7 26.5 42.0 58.8 53.4 75.3 19.5 23.6 49.3 95.1 177.7 86.0 205.3 76.4 94.8 89.6 54.9 68.9 76.8 90.8 66.7 71.0 73.1 132.8 74.6 127.5 65.1 81.9 115.5 21.3 24.6 24.1 25.2 19.5 30.0 25.5 23.3 17.1 24.8 22.0 22.6 26.0 42.4 32.1 36.1 21.2 33.9 43.3 64.4 21.3 48.3 11.8 27.5 17.8 30.2 18.6 24.2 20.2 16.7 16.2 44.1 13.1 13.7 20.5 275.9 25.9 30.9 33.6 20.3 25.2 13.6 25.2 26.0 51.7 23.4 48.4 36.1 19.8 36.8 27.4 27.6 6.7 16.9 10.6 20.3 48.5 26.1 190.0 47.5 40.4 14.2 21.5 36.6 40.5 35.0 15.6 26.9 29.0 12.5 58.6 32.8 48.4 11.1 19.2 29.2 13.6 26.3 72.5 38.0 14.0 20.4 38.1 37.5 18.2 47.5 23.6 8.3 54.0 FAM163A "C1orf76, MGC16664, NDSP" ENSG00000143340 "Family with sequence similarity 163 member A" Q96GL9 1 179743163-179816198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;lymphoid tissue: 15.4;pituitary gland: 29.8;testis: 12.7" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 51.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 112.0" "Low region specificity" "Detected in many" NA NA "unprognostic (8.74e-3)" "unprognostic (3.42e-2)" "unprognostic (1.32e-2)" "unprognostic (3.24e-1)" "unprognostic (2.62e-1)" "unprognostic (1.66e-1)" "unprognostic (5.67e-6)" "unprognostic (5.56e-2)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (3.81e-3)" "unprognostic (9.14e-2)" "unprognostic (7.75e-5)" "unprognostic (1.67e-2)" "unprognostic (2.83e-1)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" 0.1 5.8 1.7 1.3 3.4 0.0 0.0 0.1 5.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.3 1.1 0.4 1.1 1.9 0.0 0.1 0.0 0.6 13.9 4.7 2.8 0.3 0.3 0.0 29.8 0.3 18.3 0.2 0.5 0.7 0.0 0.1 0.1 0.1 1.0 0.4 0.5 0.2 0.9 12.7 10.2 15.4 0.8 0.2 0.7 0.0 0.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 112.0 0.1 0.0 0.5 0.1 0.0 1.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.4 0.1 5.0 1.1 1.9 13.9 4.7 2.8 18.3 0.5 10.2 15.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.3 0.0 0.1 0.0 0.0 7.8 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 51.9 0.6 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 HMCN1 "ARMD1, FBLN6, FIBL-6, FIBL6" ENSG00000143341 "Hemicentin 1" Q96RW7 1 185734391-186190949 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Cell division, Sensory transduction, Vision" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 20.5" "Cell type enhanced" "Detected in many" "Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0" "Cancer enriched" "Detected in many" 6 "melanoma: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 9.9" "HPA008220, HPA051677" Uncertain Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 9200000 "Golgi apparatus, Cytosol" "HPA008220: , HPA051677: AB_2681572" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (8.00e-2)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (4.36e-2)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.59e-7)" "unprognostic (1.22e-2)" "unprognostic (5.17e-3)" "unprognostic (3.52e-1)" "unprognostic (2.00e-3)" 7.9 1.4 1.3 0.6 1.0 0.0 8.5 0.8 2.9 3.3 3.8 6.9 0.9 1.9 2.5 5.4 1.8 6.5 7.6 0.7 1.1 2.2 7.9 20.5 0.4 1.4 1.8 0.5 3.9 0.9 0.9 3.3 4.8 1.3 7.5 2.8 0.6 7.8 1.4 4.9 4.1 3.2 4.3 1.1 8.4 1.7 2.6 1.6 0.9 3.2 7.0 2.4 1.8 3.9 1.2 0.2 0.1 1.6 0.0 4.7 4.7 0.0 0.5 0.9 0.3 0.5 0.0 0.1 1.9 0.2 22.3 1.6 5.0 0.1 0.2 0.1 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 4.7 0.0 5.6 0.4 20.1 2.8 0.0 0.2 0.0 0.0 76.5 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 50.2 4.5 0.1 0.0 0.0 13.7 1.3 0.0 5.1 0.2 0.0 0.3 2.7 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 1.0 0.8 2.9 0.7 1.1 1.4 1.8 0.5 1.3 1.1 1.6 1.2 33.8 3.2 7.0 0.3 0.0 3.2 0.2 4.9 2.2 1.7 1.2 1.8 2.8 0.0 0.8 0.0 0.0 0.1 0.2 0.3 0.0 0.0 8.3 0.6 1.5 21.4 0.0 0.0 1.1 0.0 0.8 22.2 0.0 0.9 0.0 5.2 7.9 1.9 0.1 26.9 3.8 0.0 0.0 0.3 2.8 2.7 3.7 0.4 5.4 45.0 0.0 0.1 0.0 3.0 1.5 0.0 0.0 2.2 1.2 0.1 0.0 0.2 1.0 0.0 0.0 2.5 7.7 0.5 0.1 0.4 1.7 0.0 0.4 0.1 0.0 0.2 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928532 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 133.5;Excitatory neurons: 176.1;Inhibitory neurons: 141.8;Kupffer cells: 109.1;Oligodendrocytes: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;HSkMC: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.49e-5)" "prognostic favorable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 25.0 17.0 23.2 20.0 25.4 1.6 17.3 17.5 27.3 18.8 20.8 11.2 8.8 18.2 6.4 10.7 15.4 22.7 17.2 26.5 22.6 28.9 16.4 21.1 23.1 24.4 21.5 23.0 19.4 6.8 8.9 9.6 16.3 18.9 13.3 12.9 15.8 7.8 11.7 2.7 8.5 10.7 22.4 17.9 45.8 7.0 14.8 21.5 8.8 9.2 7.8 10.2 18.9 9.0 28.5 0.3 1.5 26.3 4.0 35.0 16.1 26.7 12.4 20.6 5.5 6.8 12.2 0.7 0.3 11.3 8.8 4.3 0.6 1.8 3.1 5.4 0.4 1.9 0.2 2.6 12.6 9.3 0.4 1.5 54.9 0.7 14.0 3.3 26.2 20.8 2.7 0.0 19.6 11.8 0.1 2.9 0.2 9.6 0.9 0.7 23.7 1.7 24.3 1.5 7.5 3.3 7.9 3.9 4.2 2.1 8.5 0.2 0.3 15.3 7.9 3.1 24.7 6.8 2.0 0.5 0.1 8.3 0.3 22.2 0.0 0.8 0.0 0.0 2.1 0.1 0.0 0.3 0.0 0.9 0.0 0.4 0.2 0.0 0.0 0.8 0.0 0.2 0.5 23.2 25.4 17.5 27.3 26.5 22.6 24.4 21.5 23.0 18.9 17.9 21.5 28.5 9.4 9.6 12.3 133.5 1.6 8.2 2.2 2.5 5.2 5.1 6.7 4.6 8.7 5.7 9.0 5.5 0.0 5.1 0.6 2.6 5.9 4.0 13.8 7.9 23.2 19.7 0.0 0.4 176.1 0.9 2.6 22.0 3.6 24.1 3.8 11.0 41.4 2.6 43.3 8.4 141.8 0.8 4.1 109.1 50.4 17.6 13.1 43.7 5.4 76.8 1.7 23.0 0.0 38.7 184.3 1.0 0.1 20.7 0.1 3.5 2.8 30.1 14.2 2.0 26.3 1.2 9.7 4.0 2.5 5.8 4.7 5.2 2.2 13.1 0.6 2.9 LYPLAL1 Q96AV0 ENSG00000143353 "Lysophospholipase like 1" Q5VWZ2 1 219173869-219212865 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 209.4;Proximal tubular cells: 349.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045806 Approved Supported Cytosol NA NA 8600 Cytosol "HPA045806: AB_10966647" "unprognostic (1.27e-2)" "unprognostic (1.29e-1)" "unprognostic (3.98e-2)" "unprognostic (8.64e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (2.01e-1)" "unprognostic (3.73e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.68e-1)" "unprognostic (5.87e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-2)" 9.4 18.0 8.9 3.9 8.8 1.1 10.1 9.1 11.4 8.6 8.4 5.7 8.7 7.4 3.6 7.9 5.4 8.7 36.9 8.5 10.4 42.7 27.5 7.1 8.7 9.6 9.0 8.2 9.9 7.6 11.9 5.9 8.3 9.0 13.4 6.0 6.5 8.6 6.6 7.5 9.6 7.6 7.9 9.3 4.5 6.2 6.6 8.5 5.8 16.4 12.2 7.7 6.0 4.0 10.0 9.1 9.4 4.1 0.0 8.1 16.3 10.3 5.3 5.9 4.8 5.6 4.3 12.9 10.0 13.9 4.5 4.7 4.9 8.6 12.1 7.3 13.7 9.3 5.8 4.9 9.8 32.9 12.6 4.3 19.5 11.1 4.8 12.1 11.3 14.5 9.5 16.8 10.2 11.4 6.1 6.1 10.3 7.8 8.6 15.4 3.3 10.5 17.5 19.9 7.1 10.1 5.6 6.3 16.9 17.7 13.5 16.2 15.6 7.8 4.0 2.0 8.2 6.2 8.7 5.3 6.8 13.5 10.1 9.0 0.9 2.0 1.5 0.8 1.8 1.9 3.3 1.3 1.0 1.8 2.0 2.3 1.8 2.2 1.4 1.8 1.5 1.6 1.3 8.9 8.8 9.1 11.4 8.5 10.4 9.6 9.0 8.2 9.0 9.3 8.5 10.0 23.6 25.6 35.5 93.0 37.1 22.2 18.7 75.5 29.0 28.5 23.9 25.4 105.9 31.5 42.0 51.5 8.4 89.5 12.8 10.8 209.4 49.3 40.9 7.7 17.4 16.3 18.6 10.3 50.2 53.2 35.4 29.7 11.7 23.6 17.1 18.5 22.9 39.8 64.8 18.5 51.7 18.0 44.7 26.8 21.2 7.8 27.1 49.3 42.7 79.6 27.1 108.7 20.6 82.9 123.4 37.5 16.9 30.9 15.0 13.0 33.4 349.2 38.2 28.9 13.1 24.8 23.3 36.0 24.8 24.9 29.3 62.5 14.2 26.5 15.8 12.3 LHX9 ENSG00000143355 "LIM homeobox 9" Q9NQ69 1 197911902-197935478 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;ovary: 9.3" "Group enriched" "Detected in some" 6 "Leydig cells: 157.5;Peritubular cells: 50.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 17.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "fHDF/TERT166: 272.7" "Group enriched" "Detected in many" 4 "hippocampal formation: 6.3;midbrain: 17.3;thalamus: 12.2" "Group enriched" "Detected in many" 5 "midbrain: 16.8;pons: 6.7;thalamus: 14.5" HPA009695 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009695: AB_1079251" "unprognostic (8.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.38e-4)" "unprognostic (1.43e-1)" "unprognostic (5.68e-3)" "unprognostic (3.55e-1)" "unprognostic (1.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.63e-2)" "unprognostic (3.26e-2)" "unprognostic (5.15e-2)" "unprognostic (2.62e-3)" "unprognostic (6.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" 0.0 0.0 2.5 0.0 0.4 0.0 0.0 1.1 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 3.5 0.0 0.4 1.4 0.0 1.8 17.7 0.2 9.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 10.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 27.4 4.3 7.2 0.6 0.0 0.0 0.0 0.1 272.7 0.1 0.0 6.7 0.0 2.3 0.0 0.5 0.0 7.6 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.6 0.1 8.1 7.7 3.1 0.0 0.0 0.0 0.0 6.7 0.0 2.4 1.3 11.7 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 1.1 0.6 0.6 3.5 1.8 17.7 0.2 2.3 0.6 10.3 1.6 0.0 3.2 15.4 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.9 0.1 1.1 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 157.5 0.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.5 2.5 0.9 0.0 0.0 0.1 0.1 0.1 0.2 0.1 PRUNE1 "DRES-17, H-PRUNE, HTCD37, PRUNE" ENSG00000143363 "Prune exopolyphosphatase 1" Q86TP1 1 151008420-151035713 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 169.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028411 Uncertain Supported Cytosol NA NA 41000 Cytosol "HPA028411: AB_10603229" "unprognostic (6.24e-2)" "unprognostic (2.24e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (6.91e-2)" "unprognostic (2.02e-1)" "unprognostic (2.12e-3)" "unprognostic (7.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.92e-2)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" 9.7 9.5 13.0 7.8 12.9 4.5 15.0 17.0 15.2 15.1 13.0 13.8 12.6 14.9 15.7 12.5 16.1 9.2 33.7 13.0 14.9 19.0 14.4 10.9 10.9 13.0 13.0 12.1 17.3 10.8 21.1 12.7 7.2 12.7 12.3 14.7 10.9 13.3 14.5 29.6 11.4 12.1 14.2 13.0 11.3 11.3 18.5 13.1 16.4 32.8 21.5 12.7 13.8 12.0 14.3 11.0 11.6 20.2 19.3 24.3 6.6 10.9 5.1 11.2 18.7 16.4 14.1 13.0 22.2 21.7 6.9 5.5 15.5 19.9 13.4 14.6 24.5 22.6 26.6 11.8 20.4 13.5 17.5 13.0 8.4 24.7 10.2 9.5 15.4 9.2 29.4 21.1 18.3 8.9 26.2 27.2 14.1 18.7 39.7 15.0 24.2 12.8 21.5 13.4 14.9 28.7 23.5 17.5 23.5 16.1 28.3 32.6 25.7 6.3 6.6 7.8 7.5 8.1 44.1 40.0 169.1 6.5 13.0 16.9 19.1 8.1 17.8 16.4 7.8 19.8 14.4 18.1 18.6 11.9 15.4 21.7 17.5 18.6 18.8 12.2 6.4 18.5 22.3 13.0 12.9 17.0 15.2 13.0 14.9 13.0 13.0 12.1 12.7 13.0 13.1 14.3 4.5 6.4 13.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 9.8 8.9 0.0 0.0 3.1 11.0 0.0 4.1 3.2 0.0 0.0 6.0 0.0 4.3 7.8 2.1 0.0 0.0 0.0 5.7 4.8 2.5 0.0 6.4 0.0 8.9 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.0 0.0 0.0 8.9 2.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 5.1 2.8 4.8 0.0 0.0 RORC "NR1F3, RORG, RZRG, TOR" ENSG00000143365 "RAR related orphan receptor C" P51449 1 151806071-151831845 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.9;skeletal muscle: 129.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Hepatocytes: 47.8;Proximal enterocytes: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 50.3" "Lineage enriched" "Detected in many" 44 "T-cells: 50.3" "Cell line enhanced" "Detected in some" "HDLM-2: 23.8;Karpas-707: 11.5;MOLT-4: 6.3;RPMI-8226: 6.0;SK-BR-3: 5.7;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065620 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA065620: AB_2685521" "unprognostic (6.51e-2)" "unprognostic (7.78e-2)" "prognostic favorable (1.83e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-4)" "unprognostic (6.29e-5)" "unprognostic (1.13e-3)" "unprognostic (8.94e-2)" "unprognostic (1.67e-1)" "unprognostic (7.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.94e-5)" "unprognostic (2.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.80e-2)" 1.9 4.9 1.0 1.8 0.2 0.4 7.6 4.0 0.3 6.6 4.2 9.4 11.7 1.9 4.6 5.5 21.4 3.7 8.0 0.2 3.5 18.6 86.9 12.8 0.9 0.7 0.9 0.0 0.3 59.7 33.8 18.5 0.0 2.4 15.9 9.3 0.0 41.3 11.1 129.0 23.3 14.0 0.3 1.0 1.3 20.0 10.8 0.4 53.2 26.7 59.3 2.4 3.0 3.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.1 0.0 0.0 0.0 23.8 0.0 0.0 2.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 11.5 0.0 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.1 0.0 0.0 0.2 0.1 5.7 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 50.3 0.0 8.0 7.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 5.8 1.2 1.0 0.2 4.0 0.3 0.2 3.5 0.7 0.9 0.0 2.4 1.0 0.4 0.4 0.1 6.4 6.0 0.3 0.8 2.0 4.4 3.1 3.4 0.0 18.4 9.8 5.9 21.5 5.3 16.5 0.0 0.0 1.8 12.0 35.2 8.3 0.4 15.3 2.6 0.7 9.6 5.3 0.1 7.0 0.0 0.3 17.3 18.9 0.0 0.3 1.8 47.8 0.1 0.0 0.0 20.0 16.2 2.7 0.3 0.9 0.6 0.6 3.6 0.0 0.2 0.0 0.0 0.0 0.0 3.2 16.0 0.4 0.3 5.0 32.9 17.1 10.5 0.0 0.0 4.2 0.5 0.2 0.0 5.0 3.0 0.0 6.8 0.1 15.3 3.5 TUFT1 ENSG00000143367 "Tuftelin 1" Q9NNX1 1 151540305-151583583 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 106.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 69.2;Glandular and luminal cells: 76.8;Suprabasal keratinocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 5.2" "Group enriched" "Detected in many" 5 "granulocytes: 5.2;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 41.7" "HPA028112, HPA054301" Approved Approved Approved Vesicles "Secreted - unknown location" NA Yes Vesicles "HPA028112: AB_10603224, HPA054301: AB_2682442" "unprognostic (6.16e-2)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.83e-4)" "unprognostic (4.49e-3)" "unprognostic (1.12e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-2)" "unprognostic (8.29e-3)" "unprognostic (9.06e-2)" "unprognostic (6.70e-3)" "unprognostic (7.88e-2)" "unprognostic (2.58e-3)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-3)" "unprognostic (4.53e-2)" 5.1 6.9 4.5 2.9 4.5 6.8 10.2 5.2 5.3 14.2 3.5 11.3 7.5 5.3 6.4 48.5 5.2 5.9 4.6 3.9 5.4 14.0 7.1 8.5 1.0 4.2 4.1 4.3 7.4 17.4 11.5 7.2 13.4 4.7 9.7 13.1 2.2 18.4 9.3 2.6 106.9 10.9 6.2 3.8 1.5 12.9 5.4 5.5 2.2 5.7 2.7 6.2 12.5 27.1 4.9 40.7 13.7 10.0 11.5 2.3 1.9 63.1 10.7 9.5 41.3 39.6 43.6 31.5 3.5 64.6 12.5 19.5 46.4 17.6 16.2 30.1 27.0 8.7 2.2 23.0 6.7 32.2 0.8 4.7 6.5 18.9 32.5 71.6 24.5 3.4 5.0 3.6 26.8 12.8 16.8 2.0 0.5 11.7 29.6 11.4 0.1 28.1 14.2 34.7 61.8 19.5 8.0 68.2 45.8 8.0 29.4 36.5 2.1 8.6 7.4 51.7 46.2 71.7 6.6 13.7 0.5 6.3 0.9 4.7 5.2 0.6 0.7 0.3 0.1 0.7 0.6 1.0 0.5 0.9 0.2 0.8 0.3 2.5 0.1 0.3 0.1 3.5 0.5 4.5 4.5 5.2 5.3 3.9 5.4 4.2 4.1 4.3 4.7 3.8 5.5 4.9 2.1 25.6 2.0 1.6 3.8 69.2 35.2 14.7 35.9 2.5 28.8 20.2 9.8 8.6 19.0 14.7 0.0 28.1 6.6 59.5 13.7 18.2 2.7 43.2 8.9 2.7 32.2 2.7 4.4 15.2 13.9 7.0 46.9 76.8 4.5 9.0 1.1 10.5 4.0 0.0 9.3 39.1 20.3 0.0 12.7 3.2 2.5 6.5 8.8 1.0 2.0 2.1 0.0 8.5 1.8 47.4 34.6 5.3 7.7 21.7 15.4 11.2 15.9 0.5 6.6 4.1 5.5 0.6 3.5 39.6 66.5 56.8 5.8 10.9 35.7 35.6 SF3B4 "Hsh49, SAP49, SF3b49" ENSG00000143368 "Splicing factor 3b subunit 4" Q15427 1 149923317-149927803 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028578, HPA064660" Approved Approved "Nuclear speckles" NA NA 36000 "Nuclear speckles" "HPA028578: AB_10601601, HPA064660: AB_2685314" "unprognostic (2.43e-1)" "unprognostic (6.58e-2)" "unprognostic (2.49e-2)" "unprognostic (9.26e-3)" "unprognostic (2.74e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (6.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.74e-7)" "unprognostic (9.63e-2)" "unprognostic (6.54e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" 35.9 37.1 24.5 42.6 25.3 75.0 31.9 27.1 36.1 36.3 25.6 47.5 40.0 48.9 37.9 45.5 52.3 34.1 29.2 25.6 28.5 28.9 27.3 37.2 48.8 28.0 25.0 23.8 47.9 34.9 53.9 26.2 40.4 25.4 32.6 44.6 21.0 40.5 48.3 22.7 62.9 40.4 47.1 25.2 39.8 32.7 46.7 25.6 58.6 39.5 27.1 58.1 50.8 33.7 28.6 153.0 144.1 119.4 110.9 75.5 58.4 172.0 119.0 118.2 188.0 143.0 152.0 125.6 144.2 87.1 139.7 103.0 154.3 150.9 158.2 161.8 95.3 110.7 130.0 77.3 112.8 121.7 156.6 163.5 74.7 122.6 184.0 84.5 59.0 94.6 126.7 116.6 119.6 172.9 456.6 203.9 148.9 199.4 175.9 146.1 157.9 106.4 157.6 137.4 128.2 79.6 147.6 109.8 151.1 92.5 141.4 229.9 205.1 78.3 154.9 170.0 122.9 222.8 169.0 259.4 161.2 124.2 133.8 147.5 70.5 81.1 130.5 84.0 109.8 87.4 80.2 79.6 90.4 71.3 73.1 74.3 71.9 111.2 104.7 120.0 84.6 100.1 67.5 24.5 25.3 27.1 36.1 25.6 28.5 28.0 25.0 23.8 25.4 25.2 25.6 28.6 30.4 16.0 13.4 4.2 39.9 54.2 47.5 83.2 65.4 20.0 34.3 41.4 3.9 21.5 41.2 23.9 4.2 80.8 54.2 42.2 60.7 64.3 80.3 38.9 30.4 30.6 26.0 34.3 4.1 51.6 77.5 31.8 27.0 44.5 39.3 32.9 16.8 14.7 53.0 8.4 4.8 40.0 59.0 24.7 42.5 13.3 45.1 34.9 24.9 3.7 61.8 27.5 44.3 4.5 7.0 62.3 35.9 29.3 38.6 32.2 28.5 43.0 49.8 15.9 46.0 30.8 64.6 64.0 51.5 47.0 51.3 94.7 44.9 27.9 36.7 43.8 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 488.3;esophagus: 1381.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027241, HPA076029" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 8700000000 Cytosol Nucleoplasm "HPA027241: AB_1847976, HPA076029: " "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.20e-5)" 38.5 15.5 7.8 11.9 8.5 0.8 27.3 7.1 14.1 157.7 6.5 17.3 9.5 51.6 488.3 1381.4 20.3 77.2 58.8 7.7 8.6 15.7 61.7 26.5 1.2 16.4 9.0 7.1 9.0 4.1 3.5 12.8 44.9 15.3 15.6 18.2 0.9 225.7 14.1 7.1 70.6 12.5 32.9 8.4 11.6 12.5 2.7 8.9 1.3 11.2 7.8 136.2 24.6 363.1 12.4 35.4 3.5 12.6 0.2 73.9 402.1 11.4 126.9 293.1 76.2 99.5 1.9 19.1 0.6 1.3 279.6 8.8 71.5 0.2 15.0 79.3 0.6 0.7 5.7 4.1 0.7 20.4 0.3 125.5 35.7 0.9 195.6 7.2 112.8 21.3 0.7 27.7 0.8 215.2 0.1 0.4 4.2 1.4 147.8 4.1 2.0 92.7 0.5 2.8 0.1 0.8 0.4 28.8 0.9 106.4 5.8 0.3 34.0 5.8 159.3 23.9 18.3 27.9 0.5 1.1 1.5 84.6 11.7 22.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.8 8.5 7.1 14.1 7.7 8.6 16.4 9.0 7.1 15.3 8.4 8.9 12.4 9.1 0.0 1.1 2.9 0.6 14.7 1.9 6.9 0.0 0.7 0.5 0.6 1.8 7.2 7.9 3.7 0.0 2.2 0.6 1.0 0.0 6.2 0.3 3.1 113.3 15.7 0.0 0.0 12.1 4.3 40.9 118.6 7.7 2.5 10.2 1.0 42.5 1.0 17.0 1.7 10.9 1.4 18.3 2.2 22.8 0.3 9.9 10.8 74.7 2.8 0.1 0.5 0.0 1.0 4.4 70.2 1.1 22.2 0.4 1.5 0.1 0.1 0.4 1.2 13.1 4.1 32.3 0.7 0.6 28.1 19.0 10.9 2.1 5.0 0.5 6.9 ZNF687 KIAA1441 ENSG00000143373 "Zinc finger protein 687" Q8N1G0 1 151281618-151292176 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.5" "Group enriched" "Detected in many" 8 "granulocytes: 13.5;monocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021193, HPA023948" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021193: AB_1859415, HPA023948: AB_2671380" "unprognostic (2.23e-1)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (9.64e-3)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.39e-1)" "unprognostic (9.91e-2)" "unprognostic (8.69e-3)" "unprognostic (2.10e-1)" "unprognostic (5.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.41e-1)" "unprognostic (8.54e-2)" "unprognostic (7.99e-2)" 7.4 11.0 7.7 8.3 8.4 31.5 8.8 10.8 10.3 9.5 5.6 10.4 8.7 10.6 5.6 11.1 9.8 7.1 8.0 7.5 7.3 10.3 9.8 8.7 10.2 9.7 8.8 6.8 11.8 16.1 14.2 13.1 7.2 10.3 11.4 5.8 9.5 12.1 8.7 11.0 11.8 11.4 6.2 8.2 14.6 10.9 14.6 8.8 9.4 10.9 6.9 7.6 10.5 8.8 8.9 14.8 21.5 20.4 12.6 11.3 9.5 26.3 7.6 12.9 13.8 13.1 18.1 19.6 12.6 18.7 12.3 14.7 22.3 18.1 15.2 6.1 17.3 18.3 11.9 18.8 20.1 12.1 14.3 16.7 14.7 15.3 11.6 12.1 12.3 9.4 13.4 19.5 22.6 7.8 44.8 19.2 16.8 27.6 19.8 16.5 16.9 16.1 22.8 11.6 22.1 18.5 27.7 20.8 24.6 19.7 19.2 32.2 30.1 9.2 11.0 12.1 13.9 11.6 26.2 24.1 31.3 14.0 9.4 14.2 0.5 1.8 13.5 0.5 2.3 0.5 1.0 0.5 0.4 0.9 1.1 0.7 0.8 8.8 0.4 4.5 0.8 0.4 1.2 7.7 8.4 10.8 10.3 7.5 7.3 9.7 8.8 6.8 10.3 8.2 8.8 8.9 4.3 3.2 4.6 3.6 5.8 4.7 2.8 4.9 5.7 6.7 6.0 5.5 1.4 10.0 3.5 1.8 10.4 6.7 3.8 9.3 3.9 5.5 3.1 4.3 3.7 4.4 2.4 3.0 1.6 6.0 5.3 4.2 7.7 5.3 0.0 8.5 2.9 4.5 5.3 8.4 1.9 5.6 8.2 5.2 4.1 2.8 6.2 5.8 0.0 2.8 6.0 5.2 5.2 3.0 1.7 7.3 3.5 7.2 5.8 4.7 10.2 4.1 3.4 10.8 13.1 4.4 3.9 6.9 6.8 4.3 3.4 9.4 4.3 6.5 7.3 5.1 TARS2 "FLJ12528, TARSL1" ENSG00000143374 "Threonyl-tRNA synthetase 2, mitochondrial" Q9BW92 1 150487364-150507609 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028626 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028626: AB_10601719" "unprognostic (2.48e-1)" "unprognostic (7.75e-2)" "unprognostic (6.68e-2)" "unprognostic (3.75e-3)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "unprognostic (4.93e-2)" "unprognostic (2.14e-1)" "unprognostic (9.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (9.23e-2)" "unprognostic (9.29e-3)" "unprognostic (4.19e-2)" "unprognostic (1.14e-2)" "unprognostic (5.55e-2)" 9.9 16.7 10.6 10.7 10.5 10.0 10.4 10.3 12.6 9.1 9.5 10.4 9.0 9.0 13.2 13.5 11.8 7.8 20.5 10.3 10.5 14.4 25.5 8.7 14.8 11.5 10.7 10.4 11.9 8.5 17.8 9.4 8.9 11.5 8.8 11.4 14.8 9.8 9.4 32.2 11.6 9.7 10.1 9.3 12.6 12.1 11.1 10.9 12.8 11.3 31.4 15.5 9.7 9.5 12.0 33.5 27.4 18.1 27.4 19.9 18.2 34.1 15.9 17.2 30.7 30.8 22.4 30.3 48.0 34.2 12.0 21.1 33.8 44.2 36.8 23.5 29.2 38.4 22.7 25.2 22.7 19.7 31.4 33.4 16.2 30.2 23.4 31.6 19.9 20.1 26.4 40.3 32.6 21.8 40.4 27.0 26.0 22.3 46.0 40.2 27.5 23.0 59.8 20.9 15.7 25.5 29.8 24.1 52.5 38.7 25.4 42.3 48.9 11.9 17.8 18.8 14.9 27.2 31.2 39.6 36.2 26.6 36.3 17.6 30.5 15.4 30.5 21.0 27.0 21.3 28.7 20.5 21.2 25.0 25.3 19.6 20.7 2.4 33.2 29.3 16.7 31.4 18.3 10.6 10.5 10.3 12.6 10.3 10.5 11.5 10.7 10.4 11.5 9.3 10.9 12.0 6.3 3.2 12.8 6.2 13.2 3.3 5.6 10.4 5.2 15.3 6.2 4.6 22.3 11.5 11.9 7.3 20.9 24.5 8.8 8.2 11.7 11.5 1.6 9.6 12.8 7.4 4.2 11.1 9.3 9.8 14.3 8.4 13.3 11.7 22.2 11.0 6.8 22.6 13.2 15.2 9.1 12.6 6.1 7.7 5.2 2.5 8.4 8.8 3.6 2.8 12.5 7.6 9.2 6.0 9.9 11.9 3.5 7.2 9.9 4.5 8.5 8.8 9.4 16.8 6.6 10.3 8.3 18.2 12.3 7.4 4.0 14.1 10.6 15.8 12.6 4.8 CGN KIAA1319 ENSG00000143375 Cingulin Q9P2M7 1 151510510-151538692 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 118.6;Distal enterocytes: 173.2;Paneth cells: 108.7;Proximal enterocytes: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 91.4;CAPAN-2: 59.1;OE19: 58.6;RT4: 44.0" "Low region specificity" "Detected in many" "CAB017193, HPA027586, HPA027587, HPA027657" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527" "unprognostic (1.57e-1)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (8.74e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (8.38e-2)" "unprognostic (4.61e-1)" "unprognostic (2.11e-2)" "unprognostic (2.96e-3)" "unprognostic (7.10e-2)" "prognostic favorable (5.84e-10)" "unprognostic (2.66e-1)" "unprognostic (3.00e-1)" "unprognostic (8.28e-2)" "unprognostic (2.10e-2)" 2.7 1.1 2.4 6.0 2.9 0.4 9.1 7.5 2.9 4.9 5.1 37.5 53.2 1.4 1.5 8.7 13.3 13.7 0.4 1.9 2.9 12.3 32.4 27.5 0.4 4.7 3.3 1.4 2.0 24.4 32.4 3.8 1.6 5.3 10.2 25.3 3.7 21.3 7.1 0.2 17.5 56.8 1.5 1.4 0.4 30.7 6.7 3.1 0.8 4.9 0.1 2.3 8.4 6.3 6.8 28.9 3.2 2.7 4.6 0.0 0.0 35.4 0.1 0.1 0.8 0.9 91.4 59.1 1.3 9.4 0.0 4.9 27.0 8.6 5.0 0.6 17.3 6.0 2.4 1.3 1.8 0.0 0.4 3.6 0.0 1.0 1.3 0.7 0.0 0.3 7.8 1.2 8.1 0.0 26.8 5.0 0.6 22.9 58.6 2.5 5.4 2.8 4.3 17.9 44.0 8.9 4.4 1.8 27.1 1.0 10.3 33.5 0.3 0.5 0.3 8.3 0.5 1.2 7.7 8.4 5.2 0.3 3.3 2.4 0.2 0.1 0.0 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.0 2.4 2.9 7.5 2.9 1.9 2.9 4.7 3.3 1.4 5.3 1.4 3.1 6.8 0.1 118.6 33.3 2.3 0.2 0.3 3.3 5.9 0.6 4.3 14.9 9.1 0.7 24.3 22.4 3.7 0.0 3.5 0.5 173.2 0.0 21.5 0.3 13.8 2.1 0.6 10.3 2.7 0.8 25.4 0.3 2.3 54.6 27.3 0.0 0.5 0.0 29.6 0.3 0.0 10.4 32.7 8.2 0.0 0.4 1.2 0.6 0.5 3.6 0.0 2.1 13.5 0.0 3.5 11.7 49.5 108.7 0.7 0.5 11.9 88.7 3.0 46.8 1.5 0.0 0.1 1.0 1.5 6.9 4.2 1.8 0.4 0.6 1.8 27.2 18.3 SNX27 "KIAA0488, MGC20471, MY014" ENSG00000143376 "Sorting nexin 27" Q96L92 1 151612006-151699091 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 21.4;classical monocyte: 35.8;intermediate monocyte: 30.8;myeloid DC: 16.3;neutrophil: 40.4;non-classical monocyte: 35.4" "Group enriched" "Detected in all" 5 "dendritic cells: 16.3;granulocytes: 40.4;monocytes: 35.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028551 Approved Vesicles NA NA Vesicles "HPA028551: " "unprognostic (3.35e-1)" "unprognostic (4.76e-1)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (2.79e-2)" "unprognostic (3.42e-1)" "unprognostic (2.41e-2)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (5.92e-2)" "unprognostic (1.63e-1)" "unprognostic (5.45e-2)" "unprognostic (2.81e-1)" "unprognostic (4.15e-1)" "unprognostic (7.30e-2)" "unprognostic (1.04e-1)" 7.6 8.7 18.8 7.8 23.2 8.8 7.3 20.1 21.3 8.7 9.6 12.0 5.4 9.2 9.2 7.6 8.7 6.7 8.6 18.0 23.3 14.6 8.6 8.9 6.9 21.7 21.8 16.9 9.8 7.0 11.9 10.3 10.8 22.2 9.6 7.5 16.0 7.3 11.7 17.8 9.7 8.4 10.1 21.2 11.3 8.6 7.9 21.4 7.3 7.5 21.5 6.6 12.5 8.3 21.9 9.7 14.2 14.7 18.6 22.9 16.8 32.7 5.1 10.5 8.9 9.5 11.6 12.5 9.1 10.9 8.3 9.5 11.7 19.1 10.4 11.0 13.1 6.9 14.7 8.4 13.1 15.1 17.8 9.6 13.4 7.7 10.2 11.6 9.0 10.1 14.3 9.0 54.8 11.8 17.3 10.6 12.2 26.1 19.0 9.0 10.8 14.3 11.8 13.9 14.3 14.7 12.6 13.8 25.4 10.1 15.8 16.3 14.9 13.4 12.5 8.2 13.1 10.9 11.4 12.2 17.8 14.8 11.2 14.2 21.4 35.8 5.4 4.6 30.8 6.6 3.2 5.8 4.2 16.3 4.4 5.5 4.6 40.4 3.5 35.4 4.2 5.1 17.3 18.8 23.2 20.1 21.3 18.0 23.3 21.7 21.8 16.9 22.2 21.2 21.4 21.9 18.4 12.8 27.1 24.8 17.9 21.2 15.5 14.6 13.1 45.8 21.6 13.7 29.9 20.0 17.3 29.5 27.1 56.0 20.4 13.8 25.4 25.7 32.6 18.5 28.0 19.7 18.7 10.8 58.3 20.9 22.4 25.4 14.3 22.7 3.8 20.8 25.7 19.4 43.3 40.4 77.6 12.8 20.3 85.4 21.3 10.4 30.4 51.9 30.2 40.3 71.4 24.6 11.3 45.2 60.0 26.9 10.5 39.9 16.4 16.2 19.6 57.7 13.7 26.6 32.9 27.6 27.0 53.3 28.8 17.0 24.7 104.8 19.4 33.8 15.3 17.9 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated histone lysine methyltransferase 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 341.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: AB_2683731" "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 12.3 11.3 6.8 15.4 8.0 18.3 16.8 12.1 9.0 14.4 8.5 12.9 12.6 18.3 13.2 11.9 15.4 11.6 8.2 6.7 7.5 11.8 11.6 13.5 19.7 7.7 7.6 6.1 19.6 13.4 15.9 8.7 17.9 8.6 11.6 15.6 14.4 12.4 12.3 16.5 14.2 13.8 16.6 6.0 20.1 13.5 25.3 7.9 21.8 15.7 11.8 20.5 13.2 12.9 10.2 22.9 26.3 37.1 24.6 17.5 23.2 61.7 18.6 21.2 26.2 22.2 17.9 31.1 44.9 24.9 20.7 10.4 28.1 35.0 20.0 20.7 21.8 43.3 25.5 27.3 20.8 24.7 45.3 23.2 30.5 22.0 21.8 34.8 26.6 31.2 28.3 43.4 35.6 18.9 44.1 31.6 26.4 51.1 32.1 20.6 36.3 24.3 33.4 20.1 25.9 27.1 49.1 28.4 32.9 22.5 44.5 35.7 60.4 21.2 15.3 15.7 17.0 26.3 36.6 42.3 341.6 15.7 15.7 15.1 6.9 8.3 5.7 5.8 11.6 6.1 6.1 5.3 6.6 9.7 8.3 5.7 5.9 4.8 6.3 8.5 6.5 3.5 4.3 6.8 8.0 12.1 9.0 6.7 7.5 7.7 7.6 6.1 8.6 6.0 7.9 10.2 8.5 6.4 14.0 15.3 15.3 5.5 9.3 6.6 10.2 11.0 9.8 10.7 5.5 10.0 7.8 7.3 18.8 13.9 8.8 6.6 3.9 7.6 26.1 10.8 13.3 8.3 3.6 9.2 19.6 5.7 8.5 9.1 10.2 10.7 7.6 17.9 11.4 8.1 9.9 6.7 19.4 9.7 12.2 17.2 5.1 31.0 10.2 13.9 1.8 23.4 14.4 6.2 14.4 15.6 23.5 8.1 9.5 9.8 8.9 8.2 7.6 6.4 11.0 10.4 6.6 10.2 10.3 24.4 15.9 10.9 5.1 10.0 10.2 14.6 10.7 7.8 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Human disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 146.7;Endometrial stromal cells: 36.9;Extravillous trophoblasts: 46.4;Fibroblasts: 34.5;Hofbauer cells: 34.0;Syncytiotrophoblasts: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 92.0;BEWO: 200.3;HSkMC: 43.8;K-562: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 110000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 28.7 5.1 1.0 15.0 0.9 4.3 24.9 0.6 9.4 22.5 6.7 17.1 3.7 20.1 1.6 33.5 29.5 7.8 21.4 0.5 4.0 3.6 17.5 26.3 1.8 4.1 2.1 0.1 17.2 3.0 0.5 3.1 63.4 3.2 9.1 3.8 0.6 11.9 3.4 38.1 11.5 13.8 11.5 0.9 5.5 17.4 2.4 2.5 0.8 6.1 48.3 1.2 33.0 23.5 2.2 22.0 0.6 0.3 3.9 19.1 92.0 200.3 20.8 18.0 12.1 7.0 1.8 8.5 0.2 4.3 14.4 0.2 11.0 0.8 3.2 4.9 1.7 0.4 6.2 2.6 8.9 15.3 0.3 3.0 43.8 0.9 3.0 6.8 10.3 0.1 0.0 67.7 0.7 2.2 0.5 0.0 1.1 3.5 0.6 0.7 0.0 0.0 0.1 2.1 0.8 0.1 0.6 6.7 15.9 0.1 10.0 4.5 11.5 3.8 0.7 5.5 8.6 0.3 1.9 0.6 4.5 0.8 4.0 0.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.3 1.0 0.9 0.6 9.4 0.5 4.0 4.1 2.1 0.1 3.2 0.9 2.5 2.2 2.8 0.0 1.5 1.0 0.5 2.4 2.3 0.2 0.6 1.7 1.3 1.8 2.2 10.0 0.6 0.0 0.0 146.7 1.0 0.2 0.0 1.7 0.6 2.6 36.9 5.3 0.0 0.0 0.3 0.6 46.4 34.5 0.0 5.4 2.5 0.9 1.8 10.6 34.0 0.0 0.1 0.2 0.0 24.0 12.5 0.7 30.1 20.0 3.6 0.0 23.1 1.4 1.0 0.0 0.0 12.3 0.1 3.4 3.2 2.2 0.0 0.2 0.9 2.2 0.0 14.3 3.8 0.1 1.6 5.5 2.8 99.5 1.7 0.5 0.3 2.5 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1 apoptosis regulator, BCL2 family member" Q07820 1 150560895-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 691.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 106.3" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 4726.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Enhanced Enhanced Mitochondria Yes No Mitochondria "CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 280.7 150.6 77.5 267.3 71.6 691.2 176.8 76.5 83.7 144.6 87.0 136.2 100.3 99.3 42.2 201.1 192.4 281.2 130.8 66.5 147.6 119.4 408.0 239.2 162.6 86.1 75.8 58.8 106.2 163.0 89.9 83.4 148.1 75.8 97.2 121.3 90.9 125.7 56.9 155.0 175.7 134.7 172.9 79.0 173.0 168.4 41.6 88.8 130.1 134.6 161.5 158.4 305.5 125.6 85.3 140.2 74.8 131.9 73.3 262.9 262.2 175.8 164.8 174.5 173.0 139.4 91.9 112.3 184.9 102.2 120.2 80.3 187.7 101.7 203.3 166.7 154.8 68.3 76.4 109.9 106.2 204.7 130.6 151.3 147.3 221.3 170.6 330.0 159.5 192.7 49.4 168.1 225.3 234.2 160.3 64.6 80.7 242.0 122.9 131.9 94.7 111.1 85.9 195.2 103.7 95.9 134.2 125.6 135.9 232.4 191.2 100.4 195.2 251.6 109.2 119.4 55.5 212.8 310.2 409.5 4726.7 189.5 95.1 141.9 23.3 19.8 51.8 15.0 17.4 17.4 12.6 19.0 16.6 16.6 14.0 22.8 17.6 106.3 10.6 16.2 9.4 30.1 11.2 77.5 71.6 76.5 83.7 66.5 147.6 86.1 75.8 58.8 75.8 79.0 88.8 85.3 366.0 198.7 295.5 12.4 339.2 489.2 394.7 142.6 434.2 38.7 339.3 229.9 84.8 228.8 148.8 33.1 60.5 108.6 398.5 491.8 41.1 196.4 209.2 187.5 310.8 241.9 259.6 61.8 6.5 174.7 203.4 278.4 228.3 365.7 343.8 209.0 229.2 218.8 262.7 11.8 5.5 309.0 107.8 453.6 930.9 347.0 72.7 614.2 273.9 30.0 250.6 101.2 94.7 10.1 6.8 183.4 345.1 60.9 831.8 293.4 233.1 68.9 110.3 78.0 78.9 350.3 217.4 47.4 35.4 372.2 572.0 270.4 499.8 126.0 205.7 401.1 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150794880-150809577 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 358.1;endometrium 1: 336.8" "Cell type enhanced" "Detected in many" "Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebral cortex: 20.6" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.8" "Lineage enriched" "Detected in single" 4 "monocytes: 1.8" "Group enriched" "Detected in many" 9 "ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA050346: AB_2681101" "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavorable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 165.4 12.6 3.3 33.4 3.3 3.1 230.1 3.4 20.6 358.1 15.6 61.9 13.9 336.8 45.3 46.4 74.6 301.8 25.8 3.2 3.3 12.8 9.1 36.7 42.4 3.2 3.5 3.3 79.1 10.7 6.1 14.7 19.0 3.1 34.4 62.4 6.9 53.7 38.4 15.9 193.7 64.3 142.9 3.2 20.4 42.0 15.2 3.2 12.4 35.0 46.8 49.1 212.5 177.7 3.4 0.7 0.3 1.4 0.8 2284.0 813.2 1.0 55.2 1949.1 3.3 8.3 0.3 0.3 0.4 0.6 129.8 0.0 0.6 0.3 0.4 1.2 0.4 0.4 1.4 0.5 0.0 11.0 0.2 1.3 156.5 1.7 50.5 0.7 137.6 4.2 0.6 0.4 1.4 1.5 1.4 0.0 3.0 10.2 1.0 0.0 0.2 0.1 0.1 3.2 0.1 0.6 2.9 0.4 0.0 29.3 3.9 1.0 1.5 1.0 0.7 0.5 0.6 0.6 2.3 1.7 3.6 184.1 0.0 9.9 0.0 1.8 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.4 0.6 3.3 3.3 3.4 20.6 3.2 3.3 3.2 3.5 3.3 3.1 3.2 3.2 3.4 17.9 3.2 4.6 2.6 1.1 68.8 0.5 1.6 2.2 12.1 3.7 9.5 2.0 1.5 3.9 3.7 4.2 1.3 2.8 1.5 0.0 1.0 0.9 2.5 59.0 10.2 1.2 0.8 5.0 0.2 2.5 372.4 11.2 3.8 0.0 77.5 14.6 0.5 21.4 3.3 7.7 1.6 8.2 4.6 123.6 4.4 119.0 8.7 97.8 7.5 4.9 2.7 3.1 7.1 2.5 1.4 1.4 149.7 0.8 1.0 1.4 0.1 2.2 7.7 13.1 4.5 33.9 1.4 1.0 2.6 59.1 1.0 5.4 80.9 1.0 0.7 RFX5 ENSG00000143390 "Regulatory factor X5" P48382 1 151340640-151347326 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018519, HPA079241" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA018519: AB_1856209, HPA079241: " "unprognostic (1.17e-3)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" "unprognostic (3.21e-2)" "unprognostic (2.68e-2)" "unprognostic (2.49e-2)" "unprognostic (3.73e-2)" "unprognostic (2.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.96e-1)" "unprognostic (8.29e-2)" "unprognostic (4.42e-2)" "unprognostic (5.66e-3)" "unprognostic (2.00e-3)" "unprognostic (3.43e-2)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" 18.5 25.8 13.5 43.7 13.1 24.2 15.0 18.3 14.0 18.4 11.7 22.1 31.9 22.2 13.2 18.5 18.6 23.6 18.4 12.3 17.1 18.5 13.2 28.1 68.3 16.8 17.2 10.8 10.2 9.6 22.3 18.2 12.5 18.8 20.6 28.4 14.7 16.2 25.4 17.2 13.2 26.4 32.1 14.8 51.2 19.8 15.7 14.8 51.0 23.9 24.0 72.4 26.7 11.5 15.0 37.7 41.8 57.6 32.8 27.6 24.0 12.6 17.8 30.0 43.6 57.7 13.7 50.9 145.2 63.9 21.5 42.6 59.5 24.9 34.4 31.9 177.4 39.7 54.8 89.4 23.0 17.7 48.9 59.4 25.2 18.8 28.8 13.2 35.7 39.9 92.0 26.8 88.3 33.8 34.2 78.7 36.2 41.9 30.5 21.2 97.1 32.3 80.1 42.0 49.1 20.4 60.0 35.7 55.0 52.8 69.2 51.6 114.3 39.9 23.8 25.1 11.8 33.7 110.9 118.2 168.6 37.8 26.4 31.3 5.6 22.6 11.5 17.4 28.2 15.3 47.9 13.9 17.4 47.4 53.3 10.9 12.2 3.1 31.4 30.8 25.1 28.5 21.5 13.5 13.1 18.3 14.0 12.3 17.1 16.8 17.2 10.8 18.8 14.8 14.8 15.0 8.4 9.6 7.5 4.9 32.0 6.6 12.5 11.4 14.2 7.6 9.4 6.5 5.1 8.6 12.1 7.3 0.0 8.8 16.9 3.8 9.8 15.7 8.4 7.5 6.3 9.9 4.2 16.6 3.2 9.2 3.4 6.1 5.6 12.8 24.1 9.4 10.8 7.3 12.4 1.7 7.0 5.1 10.2 18.5 15.7 17.9 5.0 13.3 5.4 8.4 40.8 7.2 21.6 3.0 2.4 8.6 2.7 9.8 9.5 14.1 11.2 10.7 7.4 2.7 6.6 5.3 5.7 15.5 7.5 14.2 6.1 3.4 13.7 15.7 7.3 14.6 PI4KB "PI4K-BETA, pi4K92, PIK4CB" ENSG00000143393 "Phosphatidylinositol 4-kinase beta" Q9UBF8 1 151291797-151327715 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006280, HPA006281, CAB022071" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.42e-3)" "unprognostic (5.23e-3)" "unprognostic (7.32e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.25e-5)" "unprognostic (8.51e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.53e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (7.08e-2)" 45.7 45.3 56.7 33.4 60.7 78.7 48.1 62.2 63.5 60.8 51.5 48.1 36.1 59.3 55.3 48.4 59.1 40.5 45.8 57.8 57.0 50.7 40.8 47.6 47.2 60.0 60.3 56.2 60.7 46.5 56.4 57.0 39.9 61.3 58.1 44.5 46.8 46.2 43.0 69.1 61.0 47.4 62.7 53.7 60.3 48.4 46.4 58.6 46.1 68.4 59.1 47.9 49.4 51.7 67.8 49.2 40.1 34.2 53.9 92.8 68.1 28.9 50.9 88.3 65.3 53.8 51.7 43.4 46.1 57.1 78.5 41.1 44.9 57.3 52.5 50.1 63.0 50.9 33.0 48.8 26.6 64.8 38.5 60.9 71.7 62.4 72.3 51.3 56.3 63.7 46.3 57.5 67.9 56.0 91.2 41.0 30.9 27.6 69.5 60.3 36.2 28.8 54.4 45.2 61.2 41.3 35.4 35.5 71.1 46.7 53.9 60.1 71.9 50.3 46.5 36.3 37.3 55.1 71.6 50.4 89.8 52.9 39.7 82.3 41.3 22.7 36.0 17.8 24.7 19.9 20.4 18.5 23.6 24.3 16.7 15.1 14.3 21.0 19.3 26.3 13.9 20.0 23.9 56.7 60.7 62.2 63.5 57.8 57.0 60.0 60.3 56.2 61.3 53.7 58.6 67.8 16.8 16.0 24.3 19.2 26.4 22.3 18.2 17.7 28.5 33.5 24.3 24.6 7.0 21.5 17.7 12.9 20.9 30.1 16.0 28.7 19.6 20.9 12.2 21.5 19.9 19.3 18.5 26.9 17.8 24.9 20.5 25.9 23.0 24.6 19.0 30.0 15.4 12.4 29.2 35.3 19.0 16.4 10.2 20.1 20.5 15.5 23.3 21.3 14.2 15.9 29.3 23.1 21.6 18.1 25.8 23.5 17.3 24.8 24.4 17.7 25.7 15.2 17.1 28.4 13.1 24.2 23.2 28.9 25.1 24.8 31.1 48.7 23.8 44.7 20.2 28.1 PIP5K1A ENSG00000143398 "Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha" Q99755 1 151197949-151249536 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029366 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029366: AB_10602116" "unprognostic (1.05e-1)" "unprognostic (2.36e-2)" "unprognostic (8.64e-2)" "unprognostic (7.94e-3)" "unprognostic (1.17e-1)" "unprognostic (3.28e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-1)" "unprognostic (8.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.16e-7)" "unprognostic (1.44e-1)" "unprognostic (8.14e-2)" "unprognostic (2.93e-1)" "unprognostic (1.59e-1)" 17.7 19.3 16.2 16.2 17.9 9.7 19.7 18.1 19.4 19.0 20.4 16.2 16.4 19.0 21.2 20.5 19.1 19.9 19.1 16.9 18.2 17.8 18.8 22.0 18.8 16.0 15.7 17.2 18.8 13.7 23.1 21.6 26.1 15.5 16.8 15.2 30.4 17.0 14.2 29.5 20.9 17.0 20.5 14.9 19.1 16.7 35.5 16.2 24.9 18.6 25.6 20.2 20.7 17.6 18.9 49.3 37.4 57.7 67.6 37.5 38.8 56.7 63.5 89.3 116.6 103.7 68.7 46.8 43.9 66.8 67.9 52.7 42.0 75.7 42.6 101.2 68.8 54.0 36.0 48.4 33.9 70.1 64.9 43.8 51.1 40.3 72.7 90.7 52.1 48.8 69.4 35.6 36.7 60.4 69.9 63.6 32.4 86.0 38.2 58.3 60.5 50.7 34.1 61.2 27.1 38.6 49.4 87.1 66.6 57.4 96.4 69.2 59.4 47.4 46.6 64.7 42.6 77.0 50.5 93.6 99.3 44.7 18.6 56.6 0.1 3.9 5.7 3.7 4.7 2.8 6.6 3.3 4.1 6.4 3.0 3.7 2.9 8.9 3.9 3.8 6.7 3.1 4.7 16.2 17.9 18.1 19.4 16.9 18.2 16.0 15.7 17.2 15.5 14.9 16.2 18.9 11.6 32.1 12.2 43.8 21.3 66.2 23.2 17.0 39.9 34.1 31.3 22.0 18.4 17.2 15.3 31.3 98.0 25.9 18.3 12.7 9.8 13.5 4.9 64.0 26.2 15.6 6.0 12.4 59.6 8.7 29.3 19.8 19.4 71.0 12.0 19.9 14.3 14.3 12.8 26.9 51.2 9.7 18.3 10.7 29.5 4.8 13.4 14.9 12.4 44.0 12.2 12.5 9.2 54.8 64.0 19.4 8.9 10.9 16.8 20.9 21.0 10.1 18.4 43.0 13.1 17.4 20.9 52.1 24.6 38.4 50.0 63.5 15.9 18.4 10.7 39.4 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 222.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 280000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavorable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 20.2 30.7 40.7 39.2 43.6 76.4 18.2 58.6 45.4 20.7 35.2 20.1 22.7 26.5 34.7 18.8 21.3 20.3 35.4 37.0 42.8 31.1 29.2 23.2 71.6 46.8 44.3 34.3 23.5 8.9 33.3 16.6 21.8 44.7 16.4 18.4 99.5 13.0 24.7 50.2 21.8 25.9 21.1 43.2 33.4 17.5 10.4 46.4 89.0 30.8 26.2 62.7 22.0 16.4 40.6 224.0 141.7 289.7 144.0 22.3 32.7 109.8 117.7 66.6 111.8 106.0 105.6 154.0 405.1 101.8 68.3 66.3 76.6 164.9 73.6 158.4 466.1 101.3 280.7 175.6 153.2 21.1 572.0 136.6 26.8 11.9 104.1 95.4 54.8 84.6 193.3 274.8 231.2 103.6 232.3 231.5 148.3 292.5 72.9 64.8 245.4 161.2 214.1 80.2 88.8 94.5 161.2 245.4 39.6 70.7 127.5 105.3 287.7 87.4 56.7 158.4 59.1 239.1 297.6 325.6 388.7 64.5 403.6 105.5 56.6 20.8 35.9 35.0 15.6 53.2 54.5 46.4 38.5 17.4 39.5 32.6 40.7 14.7 31.5 20.3 12.2 56.2 36.5 40.7 43.6 58.6 45.4 37.0 42.8 46.8 44.3 34.3 44.7 43.2 46.4 40.6 48.7 12.8 84.0 16.3 88.9 97.3 37.6 36.8 40.5 117.5 33.8 37.7 99.9 24.3 32.8 73.5 33.3 58.4 98.2 12.1 86.1 36.4 1.4 52.5 64.0 52.3 14.4 222.5 7.9 26.5 133.1 57.6 20.9 41.9 63.3 28.4 39.7 59.0 52.3 63.9 9.9 19.9 28.5 48.0 108.9 1.9 30.4 54.3 67.6 6.5 57.0 134.3 60.8 3.0 6.6 27.0 14.2 33.4 116.3 21.6 20.4 58.6 59.6 135.1 26.3 56.8 75.1 12.4 22.7 55.2 98.5 40.6 108.9 27.9 37.8 25.8 MINDY1 "FAM63A, FLJ11280, MINDY-1" ENSG00000143409 "MINDY lysine 48 deubiquitinase 1" Q8N5J2 1 150996086-151008375 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 98.4" "Cell line enhanced" "Detected in many" "T-47d: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028351, HPA028358, HPA061086" Approved Enhanced Nucleoplasm NA NA 220000 Nucleoplasm "HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425" "unprognostic (5.73e-2)" "unprognostic (2.86e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-1)" "unprognostic (3.39e-2)" "unprognostic (6.90e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.22e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.43e-8)" "unprognostic (2.30e-1)" "unprognostic (7.95e-2)" "unprognostic (2.50e-2)" "unprognostic (6.06e-2)" 13.2 13.1 26.3 8.3 42.7 7.3 15.2 39.1 25.3 18.9 24.9 18.4 16.9 18.3 7.1 37.4 17.5 14.2 33.4 18.1 27.0 30.2 19.1 13.0 6.5 50.5 41.4 12.3 21.9 48.0 30.3 15.2 6.8 46.4 14.4 17.4 13.4 29.9 13.8 16.8 20.8 14.9 15.7 38.3 15.3 26.2 23.8 37.5 3.6 47.7 18.1 8.8 15.1 20.2 73.3 11.3 7.3 7.7 10.8 13.4 11.1 6.4 3.6 9.1 5.0 7.9 15.6 26.3 0.7 8.4 4.7 1.5 5.5 6.1 6.8 2.2 8.6 9.2 11.0 13.8 13.5 3.0 3.3 4.3 9.1 5.9 9.0 2.5 16.8 12.9 3.8 7.0 27.5 5.3 17.4 0.6 7.4 3.5 3.5 2.5 8.3 1.4 34.8 23.4 22.1 13.1 9.7 6.9 12.4 7.4 3.6 49.5 11.1 12.0 4.3 5.5 2.2 3.1 10.1 9.9 37.5 10.2 7.2 20.4 98.4 9.3 56.2 0.4 4.1 0.3 0.8 3.5 1.0 11.5 1.5 5.8 2.0 85.4 4.7 2.8 1.7 4.8 9.9 26.3 42.7 39.1 25.3 18.1 27.0 50.5 41.4 12.3 46.4 38.3 37.5 73.3 4.5 9.6 5.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.8 5.8 0.0 0.0 3.7 3.7 0.0 3.8 1.4 0.0 39.2 11.6 0.0 3.4 3.7 3.7 0.0 0.0 0.0 7.0 0.8 2.9 0.0 4.5 3.8 6.4 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 12.0 2.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.6 0.8 5.0 0.0 0.0 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982249-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 61.5;Collecting duct cells: 12.9;Ductal cells: 21.2;Hepatocytes: 17.4;Proximal tubular cells: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;granulocytes: 1.0;monocytes: 1.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.6;Hep G2: 42.3;MCF7: 59.2;OE19: 47.8;T-47d: 139.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favorable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 2.6 3.7 2.6 2.6 6.0 2.4 7.0 5.5 2.3 1.9 2.4 2.1 4.7 6.5 6.0 26.4 4.7 9.3 6.1 1.2 3.0 22.2 30.1 3.1 2.3 7.1 6.3 0.5 4.7 36.1 19.4 1.2 1.0 6.6 2.4 0.3 7.2 7.6 21.4 3.9 32.6 4.3 2.9 5.3 2.9 4.2 3.8 4.6 0.5 25.2 0.2 23.4 6.4 6.0 11.8 11.7 2.8 4.2 4.4 0.0 0.0 11.4 1.0 0.8 0.1 0.0 33.9 40.6 0.4 2.5 0.0 1.3 6.8 0.0 0.8 0.1 3.9 4.4 6.1 4.7 42.3 0.0 2.4 2.6 0.0 0.3 0.1 0.2 9.5 0.0 1.8 3.0 13.2 0.1 59.2 0.5 3.2 1.1 47.8 0.8 2.8 0.6 15.0 0.1 17.0 6.4 3.6 2.6 28.8 1.7 2.3 139.9 3.7 4.7 0.9 1.3 0.7 0.8 4.0 13.0 18.8 6.2 4.2 3.3 0.0 1.2 0.7 0.0 0.7 0.3 0.2 0.1 0.2 1.6 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.0 0.4 2.6 6.0 5.5 2.3 1.2 3.0 7.1 6.3 0.5 6.6 5.3 4.6 11.8 0.1 0.0 1.1 0.3 0.2 0.1 0.4 0.8 0.0 0.0 4.5 2.5 0.4 61.5 4.5 12.9 0.0 2.0 0.1 0.0 3.9 21.2 1.5 1.3 0.8 0.1 0.0 0.0 0.2 7.5 0.3 0.6 0.0 1.6 1.3 0.0 0.0 17.4 2.2 0.0 0.2 0.0 0.0 0.6 0.4 0.9 1.5 1.4 1.8 0.0 0.2 0.0 0.0 1.0 0.5 2.9 0.1 1.2 0.0 0.3 0.3 44.6 2.5 0.0 0.0 0.1 0.3 4.9 0.2 0.3 0.0 1.5 0.2 0.0 0.3 5.4 SELENBP1 "hSBP, hSP56, LPSB" ENSG00000143416 "Selenium binding protein 1" Q13228 1 151364304-151372707 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein transport, Transport" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 476.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enhanced" "Detected in single" "dendritic cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005741, CAB008366, HPA011731" Enhanced Supported Nucleoli NA NA 59000000 Nucleoli "CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663" "unprognostic (1.51e-1)" "unprognostic (7.01e-2)" "unprognostic (8.52e-3)" "unprognostic (6.25e-3)" "unprognostic (6.28e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.08e-2)" "unprognostic (1.21e-2)" "unprognostic (3.78e-3)" "unprognostic (2.86e-1)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-2)" "unprognostic (6.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.86e-2)" "unprognostic (6.86e-3)" 129.4 18.8 45.4 25.1 45.1 96.6 77.1 41.9 55.2 57.5 42.3 455.6 75.4 31.6 43.8 32.1 133.9 52.7 57.7 42.6 53.6 77.9 263.8 182.6 11.0 45.0 43.6 39.1 49.9 29.2 12.0 15.1 20.6 42.8 44.6 476.1 3.9 62.1 49.2 73.5 24.4 95.0 49.9 40.8 51.5 127.5 6.1 45.5 7.1 116.1 139.3 6.8 58.8 29.5 40.9 0.0 17.2 31.9 1.8 144.9 59.1 8.4 5.9 2.6 3.1 6.5 18.1 5.4 0.0 30.7 10.7 0.0 0.4 0.0 0.4 2.8 0.1 14.8 120.5 53.1 28.9 30.5 0.2 0.0 75.9 1.0 5.3 0.1 0.4 19.0 0.0 12.4 0.0 8.0 13.2 0.0 0.0 26.6 92.8 32.2 0.1 1.7 0.7 7.1 0.0 0.4 0.7 0.5 274.4 0.0 25.1 49.4 1.8 1.8 0.0 1.1 16.8 0.1 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 45.4 45.1 41.9 55.2 42.6 53.6 45.0 43.6 39.1 42.8 40.8 45.5 40.9 36.6 294.9 525.6 38.2 4.0 10.8 27.7 56.4 30.7 0.3 73.0 59.9 135.7 75.8 123.9 5.5 0.0 2.4 1.9 1056.9 115.4 17.1 0.7 30.9 14.9 27.5 155.0 590.9 0.1 9.1 2.1 85.2 163.6 14.1 27.3 10.9 26.0 501.5 15.3 0.0 0.1 137.2 79.3 39.6 12.4 4.2 66.5 3.9 33.8 13.1 0.2 37.4 0.0 0.0 2.0 6.5 451.4 80.9 0.8 25.6 251.0 148.3 101.5 1.4 52.6 15.6 102.3 0.1 0.3 22.7 9.9 4.0 5.7 30.5 452.4 71.0 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975003 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 738.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027262, HPA078737" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717, HPA078737: " "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 92.6 309.7 139.3 53.6 177.3 80.8 101.1 182.1 161.5 94.6 154.0 81.2 95.4 80.7 90.4 46.6 94.9 98.0 72.3 137.1 182.2 263.9 738.3 136.2 56.8 209.3 182.5 126.6 105.3 130.4 160.7 85.4 114.8 196.3 83.9 89.5 38.5 62.0 83.4 37.8 45.4 103.6 100.0 190.3 65.6 129.1 50.2 171.8 68.1 162.8 57.8 70.5 91.8 71.3 237.4 154.3 175.8 138.1 277.9 395.1 237.1 100.8 153.1 217.9 278.1 189.1 188.4 248.5 137.7 244.3 242.4 174.6 165.5 195.5 160.7 247.6 194.0 157.7 193.4 107.5 219.3 277.6 216.4 218.5 214.0 197.9 254.3 315.6 341.4 174.3 189.8 210.4 281.0 363.4 255.6 134.2 135.7 200.9 499.4 299.6 160.0 95.4 208.4 311.5 127.2 121.7 185.8 169.6 278.7 183.8 172.1 335.6 296.5 145.4 196.4 93.6 180.1 267.9 189.5 229.0 841.7 222.4 91.0 200.7 212.1 80.2 136.0 76.9 43.7 93.6 34.6 70.3 78.8 69.5 31.9 60.6 60.1 86.5 63.4 32.8 70.1 86.7 88.5 139.3 177.3 182.1 161.5 137.1 182.2 209.3 182.5 126.6 196.3 190.3 171.8 237.4 46.3 67.3 67.9 8.8 23.1 24.1 38.2 37.0 18.2 7.5 52.8 27.6 2.8 120.1 23.2 53.3 4.2 77.8 40.2 60.7 13.7 104.6 7.5 24.9 39.9 47.9 24.6 24.8 5.5 92.8 42.4 44.2 16.3 29.7 36.8 33.0 38.9 200.5 55.9 3.3 5.9 29.3 30.5 45.2 35.2 7.9 56.2 54.5 37.4 5.6 39.4 26.5 26.8 7.5 51.3 103.7 32.4 40.3 29.2 52.4 98.8 81.7 21.2 9.9 39.5 37.2 33.8 13.8 6.8 13.9 15.6 54.2 34.3 39.0 29.1 34.2 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 11 "U-698: 8664.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol NA NA 700000 "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: AB_2681425" "unprognostic (6.27e-2)" "prognostic favorable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 141.8 107.6 163.6 116.2 170.4 221.7 156.5 146.6 187.9 123.5 143.3 137.2 134.8 118.8 184.9 290.3 101.4 95.7 121.3 170.2 161.0 119.9 150.1 125.0 129.5 148.4 150.8 158.2 103.3 109.4 174.5 92.8 104.6 162.8 98.6 125.1 122.9 123.9 95.5 303.9 225.3 133.8 106.7 147.1 100.5 125.2 45.6 155.3 159.2 135.6 214.2 147.9 148.4 167.0 168.8 287.1 170.8 236.9 206.9 149.7 126.8 220.7 141.0 148.4 199.9 171.7 207.3 216.6 288.9 196.8 122.1 125.1 238.3 198.5 325.4 160.1 415.1 277.4 434.3 239.6 158.2 108.3 372.1 462.6 100.5 202.0 214.1 293.6 118.8 206.2 224.8 321.7 551.8 140.9 775.5 302.3 272.6 431.2 386.2 211.1 298.6 199.9 328.0 299.2 306.0 303.8 193.3 201.6 385.6 222.1 200.8 533.9 442.9 208.2 143.9 261.9 171.8 340.3 309.4 441.4 8664.2 197.1 357.6 191.8 67.3 54.4 94.3 55.6 62.9 52.2 64.3 46.3 57.5 70.7 55.3 37.7 56.0 53.0 68.8 64.3 58.3 58.2 75.1 163.6 170.4 146.6 187.9 170.2 161.0 148.4 150.8 158.2 162.8 147.1 155.3 168.8 103.1 41.7 166.1 20.9 132.9 190.3 225.1 303.9 124.7 59.7 152.7 117.1 102.6 98.7 172.9 82.8 45.9 286.5 148.9 170.7 254.3 160.3 9.7 109.1 68.5 114.2 130.8 178.2 44.7 152.4 184.2 85.9 71.9 93.7 224.3 51.1 80.3 86.9 203.3 67.3 29.3 169.1 211.6 101.1 171.4 17.7 86.0 123.3 103.2 19.7 409.7 83.6 184.4 21.6 19.3 91.5 146.8 104.2 135.6 128.0 187.2 186.0 128.8 50.0 72.3 85.5 94.4 27.6 25.0 269.7 286.8 382.8 140.4 87.9 163.9 253.7 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 326.0;tongue: 97.7" "Cell type enhanced" "Detected in many" "Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 8.1 2.8 5.7 1.8 6.5 1.3 7.9 19.5 9.3 11.6 0.8 6.6 13.8 10.6 1.4 5.5 10.8 3.8 32.6 7.7 5.1 11.9 12.5 5.2 1.7 4.3 5.4 6.4 14.9 3.6 2.1 13.5 1.9 10.4 8.3 1.8 5.3 8.5 2.3 326.0 9.0 10.9 6.3 0.9 3.0 5.5 32.5 6.8 2.2 4.7 97.7 0.9 8.4 8.9 5.7 0.9 1.0 14.1 5.4 5.8 1.9 1.3 1.0 0.5 0.9 1.3 0.3 0.6 0.7 4.0 3.3 2.0 1.4 1.3 0.5 0.8 1.3 4.2 7.7 0.7 1.2 0.8 0.1 2.7 3.3 1.7 1.2 0.6 2.8 24.8 4.1 0.7 0.7 2.3 0.5 1.3 1.0 6.3 0.2 1.7 9.0 3.1 0.3 0.5 0.4 7.1 9.3 1.3 0.6 1.2 3.5 1.6 1.3 11.8 2.3 3.3 3.5 0.6 5.9 1.2 6.1 0.6 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 6.5 19.5 9.3 7.7 5.1 4.3 5.4 6.4 10.4 0.9 6.8 5.7 12.9 0.0 2.8 3.9 1.0 1.7 0.8 0.3 0.6 5.7 1.9 3.0 19.1 1.5 0.8 0.0 20.9 0.2 0.6 0.1 0.0 0.3 0.6 0.4 2.8 10.2 0.0 0.8 6.7 0.4 0.6 4.4 0.5 0.4 0.0 9.9 6.8 5.3 0.4 6.7 13.7 0.3 0.0 2.5 0.7 3.1 5.6 0.5 1.8 4.7 0.4 1.9 1.0 5.5 1.5 0.4 0.0 2.6 1.9 0.5 3.3 2.9 0.3 7.5 0.0 12.0 2.9 3.3 1.2 0.5 1.0 0.1 0.8 0.5 0.8 0.5 MRPL9 ENSG00000143436 "Mitochondrial ribosomal protein L9" Q9BYD2 1 151759647-151763496 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008579 Approved Supported Mitochondria NA NA Mitochondria "HPA008579: AB_1079412" "unprognostic (2.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.34e-1)" "unprognostic (7.43e-3)" "unprognostic (7.66e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.04e-7)" "unprognostic (1.47e-1)" "unprognostic (5.22e-2)" "unprognostic (9.51e-3)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (6.30e-2)" 32.4 27.8 26.8 28.8 27.9 41.5 33.8 29.7 29.6 28.9 26.3 33.8 27.2 33.2 31.2 32.4 29.1 21.4 31.3 26.8 29.3 33.1 30.1 25.6 40.2 28.7 27.4 25.5 32.9 30.7 49.4 22.7 29.3 29.3 31.1 28.3 18.2 40.8 28.9 72.0 35.2 29.6 29.1 28.3 32.5 31.0 24.7 28.5 46.9 31.0 55.8 39.1 32.5 28.6 30.6 120.3 98.6 63.8 74.6 44.9 50.5 103.9 66.4 62.7 102.3 80.5 151.9 113.3 79.5 126.7 67.8 65.7 106.3 111.8 84.8 81.6 107.3 107.2 64.0 81.7 99.5 71.4 177.1 56.7 56.3 77.7 89.7 113.6 68.3 100.2 119.7 133.3 104.4 80.5 284.6 112.9 134.8 134.6 139.4 141.1 93.6 74.0 155.7 63.0 96.5 103.2 108.2 79.5 113.1 98.7 88.6 169.4 210.1 69.4 79.2 79.5 66.6 149.5 113.2 168.1 252.5 96.2 116.8 91.7 58.1 42.7 29.5 82.0 54.4 94.7 96.2 94.4 96.3 98.7 89.0 89.1 84.8 5.2 85.4 49.0 83.0 122.0 73.5 26.8 27.9 29.7 29.6 26.8 29.3 28.7 27.4 25.5 29.3 28.3 28.5 30.6 31.5 28.9 21.8 8.1 41.0 31.4 48.0 52.9 30.7 19.9 46.2 51.3 4.3 28.6 38.1 33.1 6.2 98.4 43.4 17.2 64.6 69.6 100.0 21.9 27.6 43.8 28.7 39.5 7.5 64.4 124.4 29.2 19.4 22.1 41.1 44.8 43.9 28.4 65.6 18.5 7.7 31.6 42.7 32.4 38.2 36.0 39.1 26.6 35.6 3.7 64.0 32.1 54.6 7.1 7.8 67.1 24.6 47.0 26.9 44.6 29.5 86.8 33.4 19.8 72.3 37.6 35.5 56.3 36.4 33.0 31.7 74.6 43.9 42.5 46.8 40.2 ARNT "bHLHe2, HIF-1beta" ENSG00000143437 "Aryl hydrocarbon receptor nuclear translocator" P27540 1 150809713-150876708 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "U-698: 397.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001759, CAB004318" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB004318: AB_626698, HPA001759: AB_1078213" "unprognostic (1.81e-1)" "unprognostic (8.14e-2)" "unprognostic (6.87e-2)" "unprognostic (5.76e-2)" "unprognostic (1.86e-1)" "unprognostic (4.10e-2)" "unprognostic (9.43e-2)" "unprognostic (5.27e-3)" "unprognostic (5.05e-1)" "unprognostic (3.42e-2)" "unprognostic (1.22e-1)" "unprognostic (9.52e-2)" "unprognostic (1.85e-3)" "unprognostic (2.68e-1)" "unprognostic (4.67e-1)" "unprognostic (6.45e-2)" "unprognostic (6.92e-2)" 24.5 20.6 10.1 18.3 10.0 17.3 22.8 16.0 12.3 31.0 17.8 18.7 15.1 27.7 15.0 19.3 25.2 20.7 20.2 9.5 12.4 18.0 43.3 24.9 17.6 11.2 10.8 8.9 38.1 28.9 19.8 12.6 31.5 11.5 16.4 21.4 39.5 15.6 17.8 32.6 23.4 17.2 29.3 8.4 19.7 19.2 17.5 10.7 20.6 19.8 28.4 22.6 21.5 24.2 11.9 17.1 17.2 25.6 19.5 53.4 50.9 34.2 19.0 36.9 25.2 22.7 15.1 17.0 18.3 16.5 34.0 12.4 19.1 24.2 21.3 21.9 29.3 13.8 21.4 28.7 17.6 31.0 26.4 24.7 39.9 20.0 30.7 26.9 30.6 31.3 24.4 27.9 34.9 26.3 33.8 21.1 15.0 21.2 30.9 13.0 26.1 30.8 25.5 20.6 17.4 17.6 25.1 36.6 25.3 15.2 34.4 32.6 59.4 22.6 20.9 18.8 16.8 16.8 39.8 30.8 397.5 25.5 0.9 14.4 46.6 23.6 21.2 12.1 21.6 11.1 8.7 10.0 11.7 18.7 8.7 9.5 9.8 11.9 12.0 23.4 7.8 11.1 16.2 10.1 10.0 16.0 12.3 9.5 12.4 11.2 10.8 8.9 11.5 8.4 10.7 11.9 14.8 12.8 10.3 28.1 14.9 14.1 9.9 11.0 8.0 23.6 10.2 6.9 12.8 24.3 11.6 11.0 54.2 24.5 12.6 13.3 3.9 11.2 5.0 10.3 23.3 14.8 20.4 16.6 41.6 9.7 37.1 25.4 8.6 20.6 3.8 17.1 30.0 47.7 20.3 6.7 47.5 16.5 8.2 39.1 20.1 4.3 32.3 20.0 10.6 39.4 27.9 7.9 13.4 41.7 50.9 9.6 8.1 32.7 13.0 8.8 10.1 13.1 9.7 38.3 13.1 17.0 19.4 18.4 16.7 11.0 15.3 29.6 12.7 20.7 9.0 10.0 POGZ "KIAA0461, ZNF280E, ZNF635" ENSG00000143442 "Pogo transposable element derived with ZNF domain" Q7Z3K3 1 151402724-151459494 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division" DNA-binding "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 347.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006800, HPA008781" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006800: AB_1855516, HPA008781: AB_1855517" "unprognostic (2.87e-1)" "unprognostic (7.16e-2)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.87e-2)" "unprognostic (1.11e-2)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "unprognostic (7.99e-3)" "unprognostic (2.99e-1)" "unprognostic (1.00e-2)" "unprognostic (9.69e-2)" "prognostic unfavorable (3.92e-5)" "unprognostic (2.32e-1)" "unprognostic (2.92e-2)" "unprognostic (3.29e-1)" "prognostic favorable (4.40e-4)" 26.8 32.7 31.9 15.7 43.1 40.5 29.3 50.4 43.3 42.6 22.6 38.2 15.3 36.9 56.7 22.7 45.9 23.9 26.1 27.0 28.4 35.2 29.4 26.7 21.3 38.4 33.2 29.8 67.1 29.4 34.7 62.1 16.2 39.9 40.7 21.6 55.8 27.5 25.3 26.4 37.0 29.3 28.5 23.2 32.7 30.0 33.9 32.7 27.6 47.3 20.3 21.9 36.1 32.8 78.7 22.1 28.0 68.4 38.8 29.8 28.7 23.3 18.9 17.3 21.1 21.9 31.3 22.2 45.4 31.5 23.6 16.7 18.6 40.9 20.0 27.5 38.4 22.4 27.8 41.1 18.4 21.8 38.5 26.9 25.7 16.0 23.4 27.8 39.3 34.2 33.4 26.3 42.2 21.5 55.7 42.7 24.4 48.4 22.8 16.5 41.2 33.1 22.8 22.9 34.8 36.6 37.8 31.5 26.3 31.2 56.0 34.3 49.9 28.3 25.2 29.8 21.0 27.2 30.6 27.6 86.1 18.0 20.3 21.7 3.3 1.0 2.5 1.8 0.9 1.5 2.1 1.7 2.4 1.0 2.0 1.8 1.8 2.1 1.3 1.2 1.8 1.4 0.8 31.9 43.1 50.4 43.3 27.0 28.4 38.4 33.2 29.8 39.9 23.2 32.7 78.7 42.7 60.9 41.6 167.8 60.6 45.2 26.8 25.2 54.1 83.7 48.4 34.9 18.8 37.1 30.0 64.4 83.4 17.1 34.4 31.8 3.9 22.3 17.0 31.5 40.9 45.0 58.2 29.3 147.8 14.7 11.3 40.2 34.7 43.6 27.8 87.6 47.2 44.4 21.3 79.1 142.4 32.4 20.3 30.0 49.2 12.2 53.7 32.8 51.6 112.4 30.7 37.8 26.8 155.8 347.4 23.7 26.3 73.7 58.9 31.4 29.3 13.7 29.7 60.1 65.7 55.8 41.3 32.3 49.9 40.3 34.1 11.5 39.9 44.0 36.4 28.8 C1orf56 "FLJ20519, MENT" ENSG00000143443 "Chromosome 1 open reading frame 56" Q9BUN1 1 151047751-151051986 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 77.1" "Cell type enhanced" "Detected in all" "dendritic cells: 213.9;Early spermatids: 440.4;Langerhans cells: 245.2;Spermatocytes: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037429, HPA037430" Enhanced "Secreted to blood" NA NA 87000000 "HPA037429: AB_10671755, HPA037430: AB_2675473" "unprognostic (7.60e-2)" "unprognostic (8.26e-2)" "unprognostic (1.09e-2)" "unprognostic (3.83e-1)" "unprognostic (4.31e-2)" "unprognostic (2.83e-2)" "unprognostic (1.11e-2)" "unprognostic (3.81e-3)" "unprognostic (1.59e-2)" "unprognostic (2.70e-3)" "unprognostic (3.28e-3)" "unprognostic (5.29e-2)" "unprognostic (3.61e-2)" "unprognostic (3.61e-2)" "unprognostic (6.16e-2)" "unprognostic (2.26e-1)" "unprognostic (4.79e-2)" 4.1 10.3 2.2 1.5 2.7 0.6 4.4 3.3 2.6 5.7 2.9 4.4 2.1 5.3 3.3 5.4 5.8 2.6 7.4 2.1 3.5 5.7 8.4 2.9 1.6 2.9 2.5 1.5 5.9 7.6 3.4 10.0 1.2 2.5 6.4 0.7 2.0 5.6 3.1 6.6 4.1 3.5 1.2 3.0 4.3 5.5 77.1 2.3 0.4 8.3 2.3 0.4 5.2 5.0 3.2 4.1 8.0 2.7 1.2 4.4 4.2 2.4 2.2 3.2 1.4 1.1 3.5 5.6 0.9 3.5 2.4 3.0 5.3 1.5 0.3 0.8 5.2 1.7 1.0 5.9 4.3 3.0 1.1 0.9 3.1 1.7 2.1 0.8 2.7 2.1 1.7 2.2 2.1 1.3 15.9 1.5 2.8 4.5 3.2 4.4 1.3 2.7 2.9 1.2 2.3 3.6 7.0 7.0 3.7 5.5 5.0 7.3 3.0 2.2 1.9 3.3 5.1 2.0 4.7 4.0 12.2 3.5 0.6 2.4 223.6 22.7 50.4 90.8 54.5 70.3 46.7 78.6 80.8 19.7 51.7 64.8 90.8 69.8 59.0 48.2 28.1 48.9 4.1 2.2 2.7 3.3 2.6 2.1 3.5 2.9 2.5 1.5 2.5 3.0 2.3 3.2 57.6 6.4 10.1 19.2 56.8 64.6 38.1 20.8 4.6 20.2 80.3 46.2 7.1 40.0 17.1 42.3 20.9 53.8 213.9 15.6 39.2 21.2 440.4 12.3 20.4 34.4 14.8 12.4 27.6 14.5 35.9 34.5 4.1 12.5 38.8 10.7 66.8 38.3 30.9 18.5 25.6 14.4 16.2 95.5 245.2 80.7 28.6 50.4 88.9 24.4 78.0 20.0 119.4 26.7 37.2 32.4 19.5 25.6 50.9 35.7 8.8 36.5 10.8 26.6 26.3 41.4 35.3 308.8 13.7 3.9 83.3 89.5 90.7 11.5 15.0 46.2 OAZ3 ENSG00000143450 "Ornithine decarboxylase antizyme 3" Q9UMX2 1 151762899-151771334 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "testis: 246.6" "Cell type enriched" "Detected in many" 5 "Late spermatids: 12007.9" "Cancer enhanced" "Detected in many" "prostate cancer: 3.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA030136, HPA045808" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030136: AB_2673331, HPA045808: " "unprognostic (2.12e-1)" "unprognostic (3.86e-1)" "unprognostic (1.53e-1)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.01e-2)" "unprognostic (1.48e-3)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (2.89e-1)" "unprognostic (8.05e-6)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (2.50e-2)" "unprognostic (8.36e-2)" 1.5 1.6 2.4 1.6 2.4 0.6 2.4 4.3 2.7 0.6 1.5 1.3 0.7 0.5 2.7 1.7 0.9 0.8 1.0 2.6 2.4 1.6 2.8 1.5 1.5 2.9 2.5 2.3 0.3 2.1 4.3 2.7 0.6 2.9 15.4 1.7 2.7 8.2 1.3 3.0 1.2 1.2 0.5 1.9 1.3 1.4 246.6 2.4 0.6 3.3 0.9 0.6 1.1 1.0 2.4 0.9 1.8 1.0 2.5 0.8 2.4 2.3 1.9 0.4 1.7 0.7 1.0 2.3 0.8 1.5 0.6 1.2 0.9 1.0 1.7 0.5 5.8 5.3 0.8 3.2 1.5 1.0 0.4 0.9 3.8 1.0 1.9 2.3 1.1 2.6 2.3 1.2 2.8 1.9 7.7 0.7 1.3 2.5 3.6 1.9 0.4 0.8 1.3 0.3 2.3 1.2 2.8 0.8 3.7 3.6 2.3 8.2 2.1 2.3 1.0 0.5 1.9 1.0 4.0 7.5 2.0 1.3 1.2 2.7 0.6 0.8 0.1 0.3 0.4 0.3 0.3 0.3 0.6 1.0 0.2 0.3 0.6 0.4 0.7 1.5 0.3 0.7 0.4 2.4 2.4 4.3 2.7 2.6 2.4 2.9 2.5 2.3 2.9 1.9 2.4 2.4 2.3 0.0 1.7 0.3 0.3 0.8 2.6 1.8 1.8 0.5 16.0 6.2 1.4 0.0 2.2 0.0 2.1 1.7 0.9 4.2 1.9 2.4 2386.5 3.4 0.6 5.3 3.6 0.4 0.4 3.1 3.0 1.0 1.5 1.5 1.3 0.5 1.8 3.1 4.8 0.0 0.3 7.4 2.0 4.2 1.6 12007.9 46.0 5.1 1.8 0.0 1.8 1.7 0.0 0.0 0.3 3.3 4.9 42.5 1.6 20.4 5.7 7.4 3.2 1.6 0.0 0.4 0.8 67.6 31.8 1.2 0.6 1.5 0.6 1.4 2.7 3.2 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720895 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 118.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 727.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.5 0.1 0.5 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.4 0.1 0.4 0.0 0.0 6.8 0.2 0.1 0.2 0.9 0.1 118.8 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.1 0.0 0.1 4.9 0.0 0.0 0.1 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.1 6.5 0.0 11.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.2 5.4 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 3.4 0.0 0.3 0.0 0.1 88.3 0.5 0.1 0.5 0.0 0.0 2.7 0.0 2.1 0.4 0.0 0.1 0.0 0.1 0.4 0.0 0.8 0.0 2.0 0.0 0.0 1.3 0.9 35.1 5.3 0.8 0.0 1.0 1.5 0.0 0.0 1.0 0.1 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.5 0.0 32.9 0.0 0.4 727.7 163.5 0.0 9.2 2.2 0.0 0.3 0.2 0.1 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646230-150697154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 313.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072016 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA072016: " "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 10.8 14.5 9.9 11.9 9.8 6.1 21.0 9.9 10.3 21.9 13.6 31.4 18.1 14.8 33.6 30.5 25.5 14.2 10.4 8.9 11.2 18.8 9.7 13.8 12.7 9.7 10.7 8.3 21.6 23.0 19.1 11.0 13.1 11.2 15.9 36.8 12.9 23.5 17.8 14.9 19.0 20.3 15.4 9.8 11.1 22.9 14.5 10.7 15.9 25.9 13.6 18.7 21.7 13.6 12.0 25.2 23.0 12.2 7.6 31.8 22.5 21.8 22.6 33.0 23.7 32.9 10.3 45.1 29.3 31.5 14.7 16.1 21.6 20.8 18.5 28.6 21.1 21.5 33.8 13.2 15.2 26.7 27.8 28.2 16.1 31.8 24.2 54.4 26.1 37.5 21.1 27.6 19.6 14.1 25.4 24.2 13.1 25.7 46.1 21.6 16.8 14.5 36.5 30.6 17.5 19.3 18.8 11.6 33.2 18.0 31.4 25.6 32.5 29.3 7.3 13.3 10.2 18.5 23.8 22.9 313.5 22.3 28.3 10.9 7.5 1.6 2.8 9.5 1.6 13.0 10.5 9.9 9.7 8.7 9.8 12.7 9.4 1.4 18.0 3.6 12.6 11.6 5.4 9.9 9.8 9.9 10.3 8.9 11.2 9.7 10.7 8.3 11.2 9.8 10.7 12.0 11.7 9.6 10.3 12.1 9.8 12.9 11.3 16.7 9.6 9.0 26.3 14.4 10.4 24.3 22.6 12.9 6.2 22.1 9.7 50.0 25.4 21.6 22.2 27.5 10.3 14.1 21.0 10.9 12.7 36.6 17.9 12.9 17.9 15.6 11.4 48.6 16.1 10.9 12.4 0.0 13.6 46.6 14.2 9.1 7.4 12.7 16.4 7.5 16.0 24.4 13.1 14.9 6.2 11.6 13.5 21.2 34.6 19.9 15.0 27.7 31.6 26.9 51.2 13.3 0.0 10.0 9.5 14.6 4.3 15.7 17.8 30.8 10.4 22.0 36.0 39.6 GABPB2 MGC29891 ENSG00000143458 "GA binding protein transcription factor subunit beta 2" Q8TAK5 1 151070578-151125542 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028471, HPA058483" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028471: AB_10602319, HPA058483: AB_2683730" "unprognostic (1.21e-1)" "unprognostic (7.03e-3)" "unprognostic (2.76e-2)" "unprognostic (9.95e-2)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" "unprognostic (4.65e-2)" "unprognostic (7.71e-2)" "unprognostic (1.98e-2)" "unprognostic (8.02e-2)" "unprognostic (1.75e-2)" "unprognostic (1.61e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.90e-3)" 5.2 5.0 4.9 4.3 6.7 7.0 4.5 7.1 5.3 5.7 4.2 5.1 3.5 5.2 3.8 4.9 5.8 3.6 5.6 4.4 5.9 4.4 3.8 4.5 5.5 5.8 5.6 3.4 9.4 4.2 5.1 5.9 3.3 5.3 5.4 4.8 5.3 4.3 3.7 5.2 7.2 4.7 3.9 4.7 5.5 5.0 11.8 5.0 9.9 5.5 3.8 5.2 5.7 5.5 8.2 9.2 3.2 2.2 2.7 7.6 11.2 2.9 8.4 5.2 4.7 3.3 0.9 6.7 9.6 3.0 8.0 2.5 7.8 4.8 4.3 6.9 3.6 1.8 2.6 5.3 0.1 5.1 10.6 5.2 6.1 4.9 6.5 9.7 3.7 1.7 10.0 6.6 6.5 5.7 13.1 14.6 1.9 1.0 5.3 3.4 4.3 3.6 4.5 4.0 2.5 3.8 1.6 10.7 3.7 3.1 2.1 9.3 11.2 5.3 1.2 4.0 8.5 6.8 3.5 1.8 33.9 3.8 7.9 5.7 1.5 0.9 0.5 1.4 1.1 0.8 1.0 1.5 1.2 0.8 1.3 1.3 1.4 1.4 0.8 1.8 1.6 0.6 1.0 4.9 6.7 7.1 5.3 4.4 5.9 5.8 5.6 3.4 5.3 4.7 5.0 8.2 9.4 9.6 16.8 21.2 10.0 11.5 9.3 9.6 10.2 26.3 8.9 10.3 22.4 17.2 14.8 12.9 25.0 5.8 18.0 12.3 9.8 5.7 36.3 13.5 15.4 11.0 9.6 14.9 18.4 5.8 4.6 16.2 9.7 9.7 7.0 11.7 15.7 7.1 8.2 33.7 25.3 15.6 4.1 13.4 9.7 17.1 22.4 11.3 8.8 15.9 14.3 10.9 33.0 11.6 39.3 5.3 8.5 21.4 8.1 6.9 10.7 4.6 20.8 36.5 6.6 38.5 15.4 75.6 55.7 9.6 10.1 4.5 16.3 15.6 16.8 7.0 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209900923-210171389 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 7.0;retina: 1.9;testis: 3.2;thyroid gland: 5.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 208.7;Inhibitory neurons: 213.9;Oligodendrocyte precursor cells: 152.8;Oligodendrocytes: 197.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Region enhanced" "Detected in some" "cerebellum: 7.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.7;GAMG: 6.7;hTERT-HME1: 4.7;SCLC-21H: 6.5;U-138 MG: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles NA NA Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.0 0.7 0.3 0.0 0.8 0.0 0.0 7.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.5 0.7 0.2 0.0 0.2 0.0 0.6 0.0 1.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.4 0.0 5.1 0.0 0.0 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 9.7 2.2 1.2 0.0 0.0 0.0 0.0 0.1 6.7 3.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 4.7 1.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.0 1.9 6.5 2.0 0.0 0.0 3.6 0.8 0.0 0.0 1.6 6.4 3.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 7.0 1.2 0.5 0.5 0.5 0.7 0.2 1.9 0.2 0.4 1.8 0.0 0.0 0.0 30.3 0.0 0.0 0.1 0.0 0.0 30.1 0.2 0.0 2.2 0.0 0.0 0.0 27.1 0.0 0.0 0.0 3.9 0.3 17.0 11.6 2.9 0.2 0.0 0.0 208.7 0.6 0.0 0.2 0.0 29.3 0.0 0.9 0.0 0.0 0.0 52.2 213.9 0.0 0.0 0.0 0.0 5.0 0.6 0.2 0.0 3.7 0.0 1.6 0.0 152.8 197.6 0.3 0.0 0.0 0.0 0.7 0.0 0.4 0.0 29.4 0.0 0.9 0.2 6.0 16.8 0.0 0.0 0.0 0.1 0.7 0.0 0.2 KCNH1 "eag, eag1, h-eag, hEAG, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134165 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 16.8;choroid plexus: 4.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 533.5;Inhibitory neurons: 261.0;Oligodendrocytes: 116.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 6.2;RH-30: 10.1;RPTEC TERT1: 6.0;SH-SY5Y: 12.9;SK-MEL-30: 12.9;T-47d: 9.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 34.0;cerebellum: 19.1;cerebral cortex: 23.9;hippocampal formation: 17.9;olfactory bulb: 8.9" "HPA014551, HPA019445, HPA076421" Enhanced Supported Vesicles NA NA Vesicles "HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: " "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.2 0.9 8.5 0.4 10.9 0.0 0.2 11.3 16.8 0.6 4.8 0.4 0.3 0.4 0.2 0.1 0.6 0.2 0.0 11.8 7.9 0.1 0.1 0.0 0.0 6.9 6.3 11.4 0.1 0.2 0.0 0.7 0.3 8.2 0.5 0.3 0.3 0.1 0.1 0.2 0.1 0.8 0.2 6.0 0.0 0.5 1.5 7.1 0.2 0.1 0.6 0.0 0.2 0.4 12.4 0.0 2.1 0.4 0.1 0.0 0.1 0.1 1.0 0.2 2.1 2.4 0.0 0.0 0.0 0.0 1.4 2.4 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 10.1 0.0 6.0 0.0 0.4 12.9 2.4 0.2 12.9 1.7 9.2 0.0 0.0 1.6 0.2 2.0 1.2 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 10.9 11.3 16.8 11.8 7.9 6.9 6.3 11.4 8.2 6.0 7.1 12.4 0.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.2 2.8 0.1 0.0 0.0 533.5 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 261.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 7.5 0.0 0.0 0.0 19.1 116.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 14.7;intestine: 4.8;lymphoid tissue: 14.3;placenta: 3.9;testis: 13.9" "Cell type enhanced" "Detected in many" "Early spermatids: 25.3;Erythroid cells: 36.2;Extravillous trophoblasts: 16.2;Spermatocytes: 53.2;Spermatogonia: 20.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028016, HPA032023, HPA032031" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 0.6 0.2 0.0 4.1 0.0 14.7 1.9 0.0 0.1 0.6 0.0 3.4 2.3 1.1 0.1 2.0 0.4 0.4 0.1 0.0 0.1 0.1 1.2 1.5 5.6 0.0 0.1 0.0 0.1 0.1 0.5 0.2 3.9 0.1 0.4 4.8 0.0 0.4 0.1 0.1 2.1 3.0 1.9 0.0 2.6 1.3 13.9 0.1 14.3 0.5 0.0 6.4 1.2 0.7 0.3 34.1 28.1 48.0 23.6 2.9 5.8 23.3 41.3 25.5 38.1 56.1 17.6 29.0 25.2 15.4 16.1 25.0 25.8 62.5 34.9 54.7 31.4 30.9 40.7 33.6 21.5 0.1 54.1 25.3 2.5 1.2 62.2 32.4 6.8 17.7 44.7 49.1 51.1 44.4 13.5 75.3 24.3 56.6 25.2 32.9 57.2 84.0 49.2 11.6 22.9 29.6 46.0 39.2 37.5 17.6 47.7 32.0 24.1 9.7 38.2 28.6 40.5 47.8 18.4 30.5 57.7 19.1 35.5 37.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 1.2 0.0 0.0 0.0 2.3 2.3 0.4 1.7 0.0 0.0 1.3 1.3 7.0 1.5 0.9 0.0 0.0 12.8 1.4 1.5 0.0 0.4 25.3 0.4 1.3 5.2 0.0 36.2 0.2 0.0 16.2 2.4 3.1 1.0 0.0 11.4 0.7 0.4 4.7 0.0 0.3 3.3 0.0 0.3 0.8 12.4 1.2 2.2 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.4 0.0 12.8 0.2 0.6 0.0 0.1 0.0 0.0 0.2 2.7 53.2 20.8 5.6 1.7 1.5 2.6 1.6 5.2 0.7 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 48.4" "Cell type enhanced" "Detected in many" "Early spermatids: 235.3;Late spermatids: 48.1;Spermatocytes: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075041 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA075041: AB_2686730" "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.0 2.4 4.4 4.2 3.7 8.9 5.7 1.8 3.7 5.6 5.1 2.0 1.0 5.3 3.2 2.8 5.7 13.6 7.0 5.1 9.9 3.3 4.1 5.5 1.7 3.5 4.2 3.0 5.0 3.9 3.0 6.6 1.2 3.6 2.9 1.5 6.5 4.3 3.0 0.8 1.5 1.7 8.2 2.8 1.3 3.1 48.4 4.1 6.0 8.4 1.9 1.8 7.5 2.8 3.5 5.0 6.7 1.6 9.8 16.7 15.9 0.4 15.4 36.7 15.0 19.6 0.4 2.7 7.6 2.2 20.1 25.8 1.5 8.6 14.1 15.8 0.1 4.8 10.5 8.9 1.7 26.9 7.5 6.8 10.9 8.9 25.6 73.6 15.1 11.8 11.6 20.1 1.4 23.2 2.0 16.9 4.4 13.2 0.5 10.8 41.1 4.9 0.1 4.8 0.4 9.3 6.9 13.6 0.6 20.3 2.0 2.0 1.9 8.1 31.1 11.2 14.8 13.2 5.6 2.2 9.1 17.7 8.3 2.9 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 2.7 0.0 0.0 4.4 3.7 1.8 3.7 5.1 9.9 3.5 4.2 3.0 3.6 2.8 4.1 3.5 13.9 3.2 8.2 4.2 1.0 6.5 10.7 9.6 3.4 0.2 4.7 3.3 10.8 1.5 4.2 1.8 10.4 0.0 1.5 0.3 0.0 5.1 235.3 12.6 8.0 8.5 2.4 23.6 3.6 2.2 0.1 12.7 1.1 5.9 0.0 3.4 3.9 1.1 1.0 0.0 1.5 0.4 2.0 1.0 4.6 48.1 4.1 2.9 8.8 1.0 1.0 3.4 0.0 2.5 0.3 1.2 1.2 1.9 2.1 3.8 0.2 1.7 10.5 8.2 6.6 10.2 10.4 108.7 6.4 1.3 3.7 0.4 2.4 3.0 0.6 5.3 EIF2D LGTN ENSG00000143486 "Eukaryotic translation initiation factor 2D" P41214 1 206571292-206612465 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028220 Approved Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA028220: AB_10602022" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (4.09e-3)" "unprognostic (2.39e-1)" "unprognostic (2.20e-3)" "unprognostic (6.60e-2)" "unprognostic (1.45e-1)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (3.54e-1)" "unprognostic (1.97e-1)" "unprognostic (8.32e-2)" "unprognostic (2.13e-2)" 32.2 32.7 17.9 19.0 20.3 33.3 43.7 19.3 21.2 37.3 22.9 33.7 22.0 35.8 32.1 32.7 43.1 24.1 25.0 17.5 19.2 31.3 31.6 24.6 33.0 20.4 19.8 16.9 60.8 41.7 44.0 23.7 27.7 20.3 30.3 32.9 9.9 47.5 30.4 54.6 34.3 24.5 38.5 19.6 23.6 36.0 18.4 19.9 37.3 35.9 52.2 38.9 31.9 32.1 22.3 63.4 38.3 30.6 26.7 88.2 115.1 37.2 34.9 71.7 61.8 60.4 31.3 53.6 106.7 26.5 71.5 19.7 43.6 50.3 78.8 54.4 35.2 66.2 37.5 44.4 59.5 97.2 68.6 36.9 105.9 103.2 49.1 96.9 78.4 79.4 77.0 88.8 48.5 54.5 49.6 61.8 31.7 25.1 46.9 57.9 49.4 65.5 118.4 63.0 23.2 28.6 26.3 30.7 80.9 76.4 45.5 62.0 52.9 56.1 33.9 34.0 15.9 47.2 44.1 26.3 74.4 45.7 45.7 25.9 15.1 17.6 2.8 19.2 16.7 25.9 32.7 26.4 23.6 28.9 26.9 33.7 24.7 0.4 30.0 25.1 15.3 26.3 17.7 17.9 20.3 19.3 21.2 17.5 19.2 20.4 19.8 16.9 20.3 19.6 19.9 22.3 18.1 16.0 17.5 15.0 24.1 14.4 37.6 24.3 23.3 10.6 24.6 22.9 10.1 20.0 19.1 11.0 4.2 40.7 15.2 9.4 25.4 19.9 41.3 18.8 17.5 20.9 4.9 26.9 11.4 20.0 26.6 21.6 17.3 12.6 17.7 24.8 23.6 11.4 22.1 3.3 10.7 14.8 24.4 17.2 11.7 16.1 28.9 12.7 17.8 6.5 23.3 12.0 14.4 14.1 17.6 14.4 15.0 27.4 22.9 23.7 15.2 28.8 17.1 14.3 19.7 23.3 23.3 26.4 10.4 31.5 23.2 25.6 20.6 32.7 27.6 30.5 INTS7 "C1orf73, DKFZP434B168, INT7" ENSG00000143493 "Integrator complex subunit 7" Q9NVH2 1 211940399-212035557 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 35.6;Oligodendrocytes: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072611 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA072611: AB_2732204" "unprognostic (1.25e-1)" "unprognostic (2.92e-1)" "unprognostic (1.81e-1)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (5.74e-2)" "unprognostic (1.65e-2)" "unprognostic (4.66e-3)" "unprognostic (2.80e-3)" "unprognostic (1.37e-2)" "unprognostic (9.80e-2)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (2.48e-1)" "unprognostic (4.17e-2)" "unprognostic (2.11e-1)" "unprognostic (7.44e-2)" 5.5 5.1 5.4 6.3 7.2 8.0 6.8 5.9 8.6 5.1 5.9 6.3 5.8 4.7 6.7 8.3 4.5 4.6 4.3 5.6 6.3 4.4 11.2 5.2 9.2 6.2 6.1 5.7 4.3 4.8 2.7 5.7 5.9 6.8 5.6 7.7 7.9 4.2 3.1 5.4 7.6 5.4 7.1 5.9 6.0 5.4 21.6 6.2 13.7 6.7 8.6 10.2 6.4 5.5 9.2 31.1 27.2 21.4 17.1 15.3 16.7 25.7 24.9 15.8 29.2 36.8 25.8 26.4 36.0 13.1 18.1 22.7 27.9 32.2 20.0 24.2 34.8 27.5 31.3 27.9 19.0 16.6 56.3 27.9 14.9 24.1 46.8 35.4 13.8 17.7 19.5 46.8 31.2 24.3 18.1 45.6 16.1 39.2 21.3 26.8 27.9 39.7 53.0 16.9 23.2 36.1 28.2 32.4 34.7 20.6 24.7 28.9 26.7 12.6 23.7 25.5 22.0 37.5 13.5 24.3 42.8 21.0 22.8 27.2 12.6 7.3 6.1 8.7 7.5 7.3 9.4 8.7 10.4 10.9 10.9 5.2 6.4 0.8 22.2 10.0 7.6 15.0 7.6 5.4 7.2 5.9 8.6 5.6 6.3 6.2 6.1 5.7 6.8 5.9 6.2 9.2 2.4 0.0 12.0 9.1 7.3 9.9 8.2 4.6 10.8 8.5 5.9 3.7 4.9 5.7 4.6 3.7 4.2 10.5 6.9 6.7 1.9 5.1 35.0 5.1 4.9 4.6 1.2 11.6 20.4 7.0 7.9 5.7 6.6 4.5 4.5 8.1 4.6 10.8 5.5 5.0 24.5 5.6 6.1 4.7 5.1 35.6 5.0 3.8 1.8 19.7 6.2 4.2 10.3 34.7 46.6 5.5 1.9 6.8 9.1 4.2 4.4 3.3 6.2 5.6 0.0 5.4 4.5 31.5 18.8 9.9 11.9 6.8 6.7 17.7 8.3 3.9 VASH2 FLJ12505 ENSG00000143494 "Vasohibin 2" Q86V25 1 212950520-212992037 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 8.0" "Group enriched" "Detected in many" 6 "Early spermatids: 92.8;Late spermatids: 80.8" "Cancer enhanced" "Detected in many" "testis cancer: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 24.2;AN3-CA: 29.6;NTERA-2: 46.2;RH-30: 135.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045820 Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA045820: " "unprognostic (2.22e-1)" "unprognostic (1.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.57e-2)" "unprognostic (1.25e-2)" "unprognostic (4.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.50e-2)" "unprognostic (2.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.84e-5)" "unprognostic (1.95e-3)" "unprognostic (2.74e-1)" "unprognostic (6.85e-2)" "unprognostic (6.81e-4)" 1.7 0.1 1.1 3.4 0.8 0.9 2.0 0.3 1.3 1.5 0.0 0.5 0.7 1.9 0.4 4.1 0.7 2.6 0.9 0.9 0.6 0.4 0.2 1.1 2.3 1.6 1.1 0.9 0.6 0.2 0.9 2.6 0.8 1.8 2.8 0.6 0.5 0.9 0.8 0.5 0.5 0.9 1.9 0.3 1.2 0.8 8.0 1.8 4.3 0.3 0.8 2.1 1.5 0.5 1.6 0.3 1.7 24.2 29.6 0.2 0.1 4.0 0.1 0.0 1.0 1.3 0.1 0.6 0.1 0.4 0.1 0.6 0.1 9.9 0.0 1.2 20.3 3.7 2.0 1.4 1.5 0.1 0.2 0.4 3.8 0.0 1.3 0.0 0.6 0.3 11.4 0.1 5.9 2.0 0.5 13.1 1.5 46.2 0.0 3.6 7.6 135.5 1.3 0.2 1.9 5.6 8.6 3.1 0.2 0.3 12.4 4.5 0.9 0.0 1.0 2.7 0.6 1.3 3.4 6.2 0.9 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.8 0.3 1.3 0.9 0.6 1.6 1.1 0.9 1.8 0.3 1.8 1.6 0.9 0.0 1.1 0.0 0.6 1.5 0.8 0.2 5.7 3.0 4.1 6.0 1.2 0.0 0.0 0.0 2.1 0.1 12.6 0.2 0.0 0.7 92.8 0.9 1.4 1.1 1.2 0.8 5.4 0.2 0.3 10.9 2.0 1.0 0.0 11.2 0.0 0.1 0.2 1.7 4.3 0.2 2.0 0.3 3.2 80.8 0.3 1.5 0.0 0.0 0.7 0.4 0.0 0.5 0.6 0.1 0.0 0.7 1.0 1.5 0.0 0.4 0.9 2.0 0.0 8.4 4.0 3.2 1.1 0.4 1.6 0.0 0.5 0.1 0.3 0.4 TAF1A "SL1, TAFI48" ENSG00000143498 "TATA-box binding protein associated factor, RNA polymerase I subunit A" Q15573 1 222557902-222589933 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054334 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054334: AB_2682453" "unprognostic (3.01e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (7.98e-2)" "unprognostic (9.59e-3)" "unprognostic (1.22e-1)" "unprognostic (8.98e-3)" "unprognostic (3.88e-3)" "unprognostic (3.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.93e-1)" "unprognostic (3.86e-3)" "unprognostic (2.25e-1)" "unprognostic (2.41e-4)" "unprognostic (8.43e-2)" "unprognostic (1.76e-1)" "unprognostic (2.35e-3)" "unprognostic (9.06e-2)" 2.5 3.5 2.2 4.8 2.1 2.8 3.2 2.4 2.3 2.9 1.8 2.1 2.5 4.1 3.0 2.6 2.8 2.7 1.6 1.6 2.8 2.1 1.8 2.8 6.6 2.4 2.0 1.8 6.9 1.9 1.9 2.5 4.5 2.2 3.2 2.6 4.0 2.0 2.7 1.2 2.1 2.4 2.6 2.2 4.4 3.4 6.4 2.4 4.4 5.1 1.3 5.6 5.4 2.6 3.1 13.8 7.3 19.5 6.8 6.6 5.8 17.2 9.1 7.0 10.8 13.2 7.8 14.8 12.6 17.4 3.2 8.6 13.7 13.1 5.6 15.2 8.3 9.9 7.5 6.3 7.5 7.4 18.2 3.3 3.0 6.0 12.1 15.4 5.1 4.5 8.7 23.4 5.6 14.9 5.0 21.6 13.0 39.5 15.8 21.0 13.2 39.1 12.2 4.5 7.3 11.1 23.1 14.0 8.1 10.1 9.9 4.6 9.1 6.1 10.9 10.9 19.4 23.2 6.8 6.6 16.5 9.7 11.7 14.7 1.8 1.5 2.1 3.2 2.5 4.7 5.2 2.8 2.9 1.5 7.4 3.3 4.1 0.3 3.0 2.5 5.3 2.5 1.7 2.2 2.1 2.4 2.3 1.6 2.8 2.4 2.0 1.8 2.2 2.2 2.4 3.1 3.1 0.0 1.1 6.5 8.6 8.5 6.4 3.9 6.8 10.2 3.1 3.6 1.5 2.8 1.9 3.7 6.2 7.2 4.6 2.4 1.9 2.9 2.5 3.0 6.1 2.7 1.2 3.8 5.2 0.7 6.7 6.0 4.1 3.0 1.3 7.7 1.1 2.0 4.4 6.7 7.1 3.0 0.0 3.8 1.0 1.3 5.6 4.7 0.0 3.7 2.7 3.8 2.1 8.0 8.0 1.3 1.8 2.2 4.4 8.0 0.9 1.3 2.6 8.5 6.6 4.5 4.3 11.5 12.1 4.9 2.8 5.9 4.7 4.2 3.2 8.8 SMYD2 "HSKM-B, KMT3C, ZMYND14" ENSG00000143499 "SET and MYND domain containing 2" Q9NRG4 1 214281102-214337131 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 198.0;skeletal muscle: 93.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 148.0;Cytotrophoblasts: 168.7;Early spermatids: 134.5;Extravillous trophoblasts: 110.5;Late spermatids: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029023 Uncertain Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA029023: AB_10601605" "unprognostic (8.53e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (5.98e-2)" "unprognostic (1.00e-2)" "unprognostic (8.55e-2)" "unprognostic (2.53e-2)" "unprognostic (2.24e-2)" "unprognostic (1.72e-2)" "unprognostic (1.90e-3)" "unprognostic (1.65e-1)" "unprognostic (9.44e-2)" "unprognostic (2.77e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (8.10e-2)" "unprognostic (6.37e-2)" 14.5 15.1 15.4 9.1 15.5 9.0 18.9 16.6 32.4 12.3 18.6 13.1 13.9 9.6 7.6 18.3 27.8 9.4 198.0 16.5 19.0 20.6 26.5 18.2 13.6 17.3 18.2 14.5 12.1 19.3 7.0 17.2 27.6 17.2 12.2 14.5 14.4 13.8 8.2 93.3 10.7 12.7 10.1 17.6 15.2 19.4 24.5 16.0 22.8 20.5 4.2 14.3 11.9 10.2 18.6 64.4 14.5 22.7 16.8 21.7 37.7 102.4 36.6 28.8 41.8 46.6 68.3 52.0 34.6 36.7 39.8 19.7 28.9 21.3 63.5 36.8 28.3 29.8 10.1 30.0 46.7 19.9 47.6 7.4 42.9 31.2 30.5 21.6 27.2 32.1 29.5 35.0 7.5 36.4 33.5 32.6 26.1 21.3 32.4 26.3 20.6 59.9 27.8 33.9 45.2 23.7 55.3 28.9 95.0 73.3 47.8 75.5 30.1 38.6 32.9 49.6 18.0 55.2 33.2 13.0 39.2 43.1 35.1 37.8 15.8 10.0 14.4 15.0 5.7 17.8 15.4 22.5 19.9 9.5 7.5 19.3 18.0 0.9 29.2 1.9 6.4 26.7 13.0 15.4 15.5 16.6 32.4 16.5 19.0 17.3 18.2 14.5 17.2 17.6 16.0 18.6 10.5 19.2 9.7 7.5 13.7 20.6 16.5 40.0 25.0 8.7 16.8 19.9 148.0 24.3 17.7 3.7 0.0 168.7 12.2 10.0 31.3 34.3 134.5 48.7 9.9 15.6 4.2 8.6 60.7 20.0 110.5 11.1 11.7 17.4 3.8 27.9 17.2 20.3 38.4 15.2 26.9 13.4 14.2 21.5 10.6 120.4 11.8 11.4 16.0 22.5 11.7 28.1 9.2 7.1 10.3 26.1 11.7 3.8 16.4 16.1 21.9 34.6 69.6 8.0 13.1 6.8 16.7 13.9 39.6 28.9 18.0 85.9 16.8 30.0 19.3 10.9 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364233 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.2;esophagus: 51.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.7;Inhibitory neurons: 89.7;Oligodendrocyte precursor cells: 101.6;Squamous epithelial cells: 68.3;Theca cells: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 6.8;naive CD4 T-cell: 10.2" "Lineage enriched" "Detected in single" 40 "T-cells: 10.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.7;RPTEC TERT1: 11.1;SCLC-21H: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.4 6.0 28.9 0.8 21.8 0.4 8.8 5.8 65.2 5.1 0.0 1.0 1.0 0.3 25.3 51.5 3.5 0.8 15.0 62.1 18.1 13.8 3.8 2.9 1.6 8.8 10.9 20.8 45.6 10.8 15.0 26.2 0.5 12.5 6.0 0.2 12.3 17.1 4.4 3.5 6.2 0.6 0.4 2.5 0.4 11.1 6.6 18.7 3.4 1.0 2.3 15.1 3.6 25.5 16.2 5.9 0.5 0.2 0.0 0.0 0.0 0.1 0.8 0.4 1.0 0.5 5.8 1.8 0.0 1.8 0.2 0.0 9.7 0.2 1.5 0.9 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.0 6.6 0.5 0.0 0.5 3.9 3.8 0.0 0.2 3.0 1.3 0.0 0.2 0.1 11.1 2.8 36.3 0.4 0.0 3.2 0.0 0.8 2.1 0.2 0.0 1.7 6.2 0.0 2.9 0.7 0.1 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.3 0.1 5.5 0.0 6.8 1.7 0.0 0.0 10.2 1.9 0.0 0.2 0.0 0.0 0.9 1.4 28.9 21.8 5.8 65.2 62.1 18.1 8.8 10.9 20.8 12.5 2.5 18.7 16.2 0.2 0.0 4.8 6.2 0.0 0.6 8.6 8.4 10.2 17.9 9.7 5.0 9.5 5.7 14.8 16.5 10.4 0.1 0.3 0.1 31.3 0.6 3.1 4.0 0.4 0.6 1.2 0.0 83.7 6.9 0.0 3.8 2.6 6.1 0.0 9.1 0.4 1.8 2.8 21.9 89.7 0.1 2.0 0.6 0.3 3.4 20.5 0.3 5.4 8.4 0.0 1.6 0.0 101.6 2.5 2.6 0.0 12.4 0.1 4.6 0.0 0.3 5.4 6.2 0.0 1.4 2.8 1.3 10.7 68.3 1.7 0.0 1.7 65.5 0.3 25.7 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742089 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.2" "Cell type enhanced" "Detected in many" "granulocytes: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 19.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 102.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 3.5 2.5 3.4 5.3 6.0 25.2 6.1 7.0 5.3 4.5 5.4 6.5 1.4 3.6 1.2 6.1 6.4 6.7 2.6 3.6 5.5 1.4 33.2 6.3 9.2 6.0 5.6 2.3 1.6 17.1 1.2 1.2 3.9 6.8 2.8 4.1 15.0 6.4 0.9 23.1 5.2 4.0 9.0 3.9 6.1 2.5 3.1 6.7 5.7 4.5 3.7 7.7 6.1 2.7 12.7 15.2 6.4 0.5 0.4 45.4 22.6 0.5 10.1 25.9 16.2 12.5 0.3 4.2 11.6 3.3 26.1 11.9 102.3 2.2 9.8 14.0 30.5 1.2 20.4 3.0 1.8 10.6 9.1 13.3 31.9 7.0 17.6 17.8 7.5 0.6 3.0 2.1 4.0 16.0 0.3 1.8 7.2 1.5 3.2 0.7 1.1 28.5 0.9 5.7 9.1 37.4 3.0 1.3 1.2 43.6 5.6 2.1 5.5 3.6 8.1 2.2 12.6 12.4 6.8 5.1 6.2 12.8 4.1 8.9 8.2 5.5 0.3 4.5 4.6 3.9 0.8 2.9 3.1 7.0 0.9 1.0 1.7 0.5 19.7 1.9 0.2 16.9 2.2 3.4 6.0 7.0 5.3 3.6 5.5 6.0 5.6 2.3 6.8 3.9 6.7 12.7 4.9 0.0 1.7 2.6 21.7 50.9 13.5 13.6 25.6 6.0 42.4 18.7 4.7 14.3 19.2 3.7 20.9 2.8 39.0 3.1 0.0 35.9 61.1 57.9 6.6 6.7 43.9 2.5 0.3 9.1 3.7 7.9 4.6 53.7 133.5 0.2 1.8 53.6 22.3 1.7 30.9 17.7 69.2 9.7 46.9 7.1 24.8 26.0 23.2 2.8 14.1 14.3 17.5 17.1 50.5 26.2 0.8 12.8 9.9 11.0 0.4 1.1 18.5 34.2 0.0 33.7 5.3 9.7 3.2 16.7 41.3 3.4 47.0 28.7 3.6 16.5 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548104 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.9;thyroid gland: 2.0" "Group enriched" "Detected in some" 9 "Early spermatids: 16.7;Late spermatids: 25.5;Spermatocytes: 13.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 18.7;Hep G2: 5.7;RH-30: 21.3;SuSa: 7.8;U-87 MG: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.1 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 18.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.3 0.0 21.3 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 7.8 0.0 0.0 0.0 1.0 0.3 0.0 0.2 0.0 0.1 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 25.5 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 13.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TP53BP2 "53BP2, ASPP2, PPP1R13A" ENSG00000143514 "Tumor protein p53 binding protein 2" Q13625 1 223779893-223845954 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021603, HPA050429" Supported Enhanced "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA021603: AB_1844384, HPA050429: AB_2681124" "unprognostic (1.29e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-1)" "unprognostic (1.38e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (7.37e-2)" "unprognostic (2.67e-1)" "unprognostic (7.99e-2)" "unprognostic (5.08e-2)" "unprognostic (1.24e-1)" "unprognostic (2.81e-2)" "unprognostic (1.83e-1)" 11.4 8.6 33.1 12.3 34.9 50.2 9.6 33.3 39.8 10.7 32.7 9.7 8.6 12.7 10.1 17.0 10.2 18.5 12.3 31.3 38.3 9.7 15.0 18.6 12.9 34.2 32.8 29.4 14.0 12.1 16.0 7.2 9.0 31.1 9.0 10.0 38.3 12.5 8.2 13.1 12.4 10.1 11.2 31.0 9.4 12.5 11.3 33.9 15.9 20.8 11.3 13.2 16.8 11.8 34.2 32.8 16.2 42.9 27.3 15.0 14.5 27.3 20.6 29.3 29.4 25.1 33.6 19.2 0.0 17.5 17.3 21.3 21.9 33.9 12.3 39.3 62.9 33.2 43.1 15.2 11.5 30.3 36.0 28.9 17.5 13.3 27.2 27.7 22.1 17.7 23.6 55.7 31.7 24.8 9.5 27.5 22.2 37.0 19.7 15.6 36.0 44.7 3.7 26.5 20.4 36.9 47.6 22.8 27.9 29.9 27.9 15.8 48.6 20.7 30.0 21.1 32.7 39.2 15.4 17.3 26.4 18.1 23.9 35.0 4.8 1.2 0.8 0.9 1.3 1.2 0.9 1.1 1.8 1.3 0.8 1.1 0.8 1.4 3.3 1.0 0.8 0.8 1.0 33.1 34.9 33.3 39.8 31.3 38.3 34.2 32.8 29.4 31.1 31.0 33.9 34.2 18.2 48.1 22.7 76.4 23.7 17.2 41.6 7.2 21.1 8.1 12.6 8.0 20.3 18.6 28.3 7.3 52.1 10.3 24.2 13.0 1.9 20.4 1.1 45.0 42.2 19.1 14.9 54.3 1.7 10.7 5.9 22.6 21.9 152.0 48.8 14.1 8.6 10.7 9.8 0.0 5.3 8.7 14.2 14.1 44.4 2.4 10.5 41.7 8.8 23.4 9.6 10.0 7.2 27.2 29.0 21.4 7.3 8.6 27.4 30.9 6.7 5.5 15.6 45.5 0.0 41.2 26.3 12.3 20.1 21.1 11.6 4.8 38.8 31.4 10.2 40.6 ATP8B2 "ATPID, KIAA1137" ENSG00000143515 "ATPase phospholipid transporting 8B2" P98198 1 154325525-154351304 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 26.8;Excitatory neurons: 28.5;Inhibitory neurons: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 2.8;T-cells: 3.7" "Cell line enhanced" "Detected in many" "ASC diff: 120.9;fHDF/TERT166: 112.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046680, HPA061103" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046680: AB_2679749, HPA061103: " "unprognostic (1.68e-1)" "unprognostic (3.68e-1)" "unprognostic (8.40e-2)" "unprognostic (5.16e-2)" "unprognostic (4.52e-1)" "unprognostic (8.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.93e-3)" "unprognostic (2.57e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.60e-4)" "unprognostic (2.82e-1)" "unprognostic (1.89e-3)" "unprognostic (7.77e-3)" "unprognostic (6.58e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (5.29e-5)" 16.4 9.6 8.8 22.9 8.3 5.5 14.1 17.8 11.5 28.3 19.6 15.8 12.6 39.6 17.9 11.1 31.1 18.4 12.3 11.3 9.3 6.3 3.4 18.1 25.6 8.7 8.8 8.9 35.7 6.0 10.6 19.5 15.5 11.5 19.0 9.2 2.2 7.3 21.4 3.5 7.8 17.7 40.0 5.6 19.7 14.6 16.5 9.2 18.6 15.2 7.5 19.8 19.9 18.0 9.3 2.1 15.6 20.0 20.5 120.9 80.4 0.3 41.8 77.4 26.1 30.5 0.3 0.6 1.9 21.4 112.4 17.7 9.2 23.0 5.5 19.3 46.6 16.8 19.7 20.4 18.9 37.2 0.1 14.8 53.4 1.3 40.6 38.7 35.6 40.0 25.1 37.6 47.8 22.7 21.8 36.2 2.5 43.7 0.4 17.4 39.9 12.7 71.5 5.3 0.4 17.4 22.7 11.3 2.8 30.3 28.3 14.9 15.3 34.7 40.2 19.2 51.4 13.5 58.0 75.7 11.1 14.1 2.2 24.7 2.8 0.0 1.7 1.1 0.0 0.7 0.3 1.7 1.9 0.0 0.2 1.4 1.2 0.0 0.5 0.0 0.3 3.7 0.5 8.8 8.3 17.8 11.5 11.3 9.3 8.7 8.8 8.9 11.5 5.6 9.2 9.3 6.4 3.2 4.5 26.8 7.7 2.5 1.4 0.9 0.0 4.5 1.9 2.3 6.2 0.0 1.9 0.0 2.1 0.1 16.0 0.1 0.0 1.6 0.6 6.5 20.5 9.0 0.0 0.4 28.5 0.2 0.5 12.8 0.5 2.4 7.6 10.8 13.6 0.8 0.4 8.4 31.7 0.2 0.0 1.0 4.2 1.4 11.5 1.3 7.2 4.7 0.9 3.4 7.2 4.0 4.2 0.9 0.0 14.7 13.9 5.6 0.0 0.2 4.4 0.5 0.0 9.5 11.2 2.6 4.3 0.6 1.6 0.3 17.2 6.7 0.1 0.8 FLG2 IFPS ENSG00000143520 "Filaggrin family member 2" Q5D862 1 152348735-152360006 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 487.8" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 24.2" "Cancer enriched" "Detected in some" 8 "melanoma: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028699 Approved NA NA 21000000 "HPA028699: AB_10601905" "unprognostic (2.58e-1)" "unprognostic (2.33e-1)" "unprognostic (3.08e-1)" "unprognostic (6.85e-2)" "unprognostic (6.59e-3)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (2.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" 0.2 0.0 0.1 0.0 0.0 0.1 32.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 487.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.5 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 1.1 0.0 1.0 0.2 0.1 0.2 0.0 24.2 0.0 0.0 0.1 0.0 0.3 CRNN "C1orf10, SEP53" ENSG00000143536 Cornulin Q9UBG3 1 152409243-152414263 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 5389.2;vagina: 1705.5" "Cell type enriched" "Detected in some" 24 "Squamous epithelial cells: 79.9" "Group enriched" "Detected in many" 18 "cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024343, CAB026182" Enhanced NA NA 100000 "CAB026182: , HPA024343: AB_1847162" "unprognostic (1.96e-2)" "unprognostic (1.74e-6)" "unprognostic (4.20e-2)" "unprognostic (3.43e-1)" "unprognostic (6.43e-3)" 1.0 0.9 0.1 0.0 0.1 0.0 0.7 0.0 0.2 413.5 0.0 0.6 0.0 0.8 0.0 5389.2 0.7 1.1 1.8 0.1 0.1 0.6 1.5 0.4 0.0 0.1 0.1 0.0 1.2 3.0 0.0 3.5 0.0 0.1 0.8 0.0 0.0 914.1 0.0 1.4 7.5 1.2 0.1 0.1 0.9 5.0 0.8 0.1 0.0 0.6 0.0 252.0 1.2 1705.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 79.9 0.0 0.0 0.0 0.0 0.0 0.0 ADAM15 MDC15 ENSG00000143537 "ADAM metallopeptidase domain 15" Q13444 1 155050566-155062775 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 164.5;Extravillous trophoblasts: 172.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 26.5;myeloid DC: 64.0" "Group enriched" "Detected in all" 5 "dendritic cells: 64.0;monocytes: 39.1" "Cell line enhanced" "Detected in many" "PC-3: 329.5;RPMI-8226: 361.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011633, HPA072878" Uncertain Uncertain Vesicles NA NA 640000 Vesicles "HPA011633: AB_1844574, HPA072878: " "unprognostic (6.35e-3)" "unprognostic (1.51e-1)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (5.83e-5)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.64e-9)" "unprognostic (3.35e-2)" "unprognostic (6.20e-2)" "unprognostic (2.04e-2)" "unprognostic (7.40e-2)" 69.0 18.6 10.4 21.6 12.7 34.4 65.3 14.2 14.0 37.0 8.9 34.3 16.5 42.9 7.6 79.8 41.9 21.8 50.2 7.9 13.6 23.1 15.3 50.4 10.1 19.2 13.1 6.5 25.7 25.7 30.2 14.2 39.4 16.8 40.3 24.0 3.4 45.7 16.8 22.9 108.0 31.6 38.9 16.6 29.1 44.6 4.9 15.2 7.4 31.9 32.7 13.7 39.2 57.8 16.2 112.0 35.0 7.0 153.2 54.9 45.6 66.3 48.2 60.9 60.1 40.5 25.9 63.3 30.9 210.7 63.5 26.7 135.9 34.5 147.9 15.8 14.3 44.9 7.6 63.1 25.3 95.5 63.4 7.9 48.7 153.8 60.5 86.6 82.6 274.7 9.3 11.9 124.8 45.2 64.7 0.5 47.1 21.6 193.4 329.5 10.0 20.5 361.8 43.7 29.7 20.8 44.7 105.2 131.2 41.8 10.7 194.8 38.9 205.1 58.6 24.6 58.9 54.1 13.9 11.7 13.7 42.7 47.6 65.4 0.0 39.1 0.8 9.5 26.5 6.5 2.0 4.7 5.6 64.0 2.1 2.0 2.5 1.4 1.6 6.2 5.3 8.9 22.8 10.4 12.7 14.2 14.0 7.9 13.6 19.2 13.1 6.5 16.8 16.6 15.2 16.2 164.5 3.2 6.7 8.8 6.6 48.9 30.4 81.6 47.8 9.7 34.6 20.7 11.5 35.8 38.3 9.2 29.2 13.0 8.1 100.4 0.0 33.4 1.7 13.3 9.2 120.8 12.7 4.6 8.1 25.5 172.4 19.8 85.6 15.4 1.3 8.5 62.2 19.9 31.7 6.7 9.8 80.7 18.3 65.0 43.6 1.3 17.4 27.2 14.2 15.9 28.8 8.8 13.4 9.0 16.8 42.1 50.9 18.0 8.0 55.2 47.4 2.6 22.9 17.0 13.1 15.7 14.5 0.8 6.4 91.2 57.1 17.8 8.6 2.7 76.9 40.0 JTB "hJT, PAR" ENSG00000143543 "Jumping translocation breakpoint" O76095 1 153974269-153977674 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006514 Approved Uncertain Vesicles NA NA Vesicles "HPA006514: AB_1079164" "unprognostic (1.33e-1)" "unprognostic (1.77e-1)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.40e-1)" "unprognostic (5.66e-3)" "unprognostic (8.62e-3)" "unprognostic (5.60e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.00e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (1.36e-1)" "unprognostic (4.25e-1)" "unprognostic (5.48e-2)" "unprognostic (2.58e-3)" 100.4 120.8 119.2 61.0 120.8 128.1 103.9 119.5 155.1 100.2 139.8 110.9 90.3 90.5 97.2 111.7 92.6 54.2 119.1 117.6 121.7 120.6 208.8 111.2 81.1 122.6 119.5 115.1 99.2 234.1 94.7 187.4 68.6 118.3 132.1 87.5 50.2 163.4 68.6 167.9 97.3 116.3 50.6 120.7 138.0 166.2 47.0 121.9 78.5 121.5 83.4 80.8 97.1 90.2 120.4 206.3 139.4 57.9 108.0 189.0 116.2 163.5 144.6 142.3 95.9 96.0 135.3 166.7 193.7 198.7 171.8 59.1 181.0 151.0 113.2 78.1 180.5 296.0 112.5 158.4 139.0 198.1 221.4 165.7 110.4 210.4 101.1 119.1 131.0 115.4 223.7 169.3 139.2 68.4 359.6 161.5 280.5 125.8 402.1 239.1 163.9 79.3 393.1 123.7 110.9 158.4 158.8 115.3 332.7 208.4 107.4 209.1 316.4 89.6 46.5 80.4 144.4 189.0 201.8 244.7 211.3 114.5 209.6 103.7 98.7 119.5 173.2 74.7 86.4 90.9 143.5 104.0 118.7 88.9 139.9 107.0 85.6 104.9 85.3 96.5 147.4 98.5 97.7 119.2 120.8 119.5 155.1 117.6 121.7 122.6 119.5 115.1 118.3 120.7 121.9 120.4 127.7 80.1 101.1 15.7 184.3 156.8 177.4 227.5 104.7 56.6 253.4 207.3 96.5 213.1 171.4 99.3 22.9 308.8 237.3 273.4 258.2 251.9 7.1 145.0 95.3 120.4 212.0 178.8 26.3 411.8 405.0 155.6 149.9 125.9 82.5 113.2 125.7 341.3 289.1 57.2 24.0 423.4 213.6 235.8 185.8 20.1 151.6 176.3 170.7 19.7 207.9 140.4 257.5 19.6 29.1 274.1 302.2 123.4 344.8 346.0 368.2 274.1 138.2 60.2 105.2 105.3 114.0 58.9 71.5 173.4 190.2 289.5 173.6 136.6 315.2 304.0 RAB13 ENSG00000143545 "RAB13, member RAS oncogene family" P51153 1 153981617-153986358 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 7.0;myeloid DC: 10.5;plasmacytoid DC: 12.9" "Group enriched" "Detected in many" 11 "dendritic cells: 12.9;monocytes: 7.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 846.1" HPA003996 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003996: AB_1079728" "unprognostic (4.39e-3)" "unprognostic (1.20e-1)" "unprognostic (2.51e-2)" "unprognostic (4.11e-2)" "unprognostic (4.28e-3)" "unprognostic (3.20e-2)" "unprognostic (1.18e-3)" "unprognostic (2.80e-1)" "unprognostic (3.53e-2)" "unprognostic (2.11e-2)" "unprognostic (2.10e-1)" "unprognostic (5.93e-2)" "unprognostic (1.06e-3)" "unprognostic (2.45e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (1.28e-2)" 141.0 133.9 77.9 91.8 79.0 105.2 125.2 79.8 113.3 114.8 88.2 110.9 54.6 93.0 112.2 102.8 96.8 84.0 89.7 76.7 95.7 147.8 112.0 117.8 42.8 92.6 82.7 72.8 112.0 116.0 98.7 35.6 64.8 87.4 124.6 74.3 10.6 97.1 74.2 46.2 91.0 79.7 68.1 85.2 98.3 124.3 62.2 88.4 19.4 113.8 49.9 48.1 124.2 108.6 86.3 133.4 162.5 143.7 152.8 478.2 846.1 43.2 157.9 381.1 142.6 144.6 165.4 111.9 0.1 230.7 194.4 72.7 88.4 86.9 146.7 198.0 78.6 62.3 110.1 100.5 94.3 199.5 0.4 70.9 620.1 125.3 246.6 109.1 401.0 253.4 0.0 20.6 0.5 246.6 280.0 0.5 55.4 231.8 183.9 151.2 28.9 186.1 0.1 327.0 140.5 7.2 112.6 208.7 179.8 337.0 215.4 294.2 87.0 469.6 256.0 149.5 161.1 174.7 0.4 0.1 0.9 399.6 17.4 399.7 0.0 7.0 0.1 0.0 1.0 0.1 0.7 0.1 0.0 10.5 0.6 0.1 0.4 0.8 0.0 0.1 12.9 0.0 1.9 77.9 79.0 79.8 113.3 76.7 95.7 92.6 82.7 72.8 87.4 85.2 88.4 86.3 230.1 41.7 83.4 1.0 9.0 92.0 181.3 196.3 110.4 1.2 126.9 149.2 75.2 120.1 105.3 108.5 2.1 116.3 2.8 81.5 135.0 234.4 119.9 91.9 163.2 239.8 89.1 116.4 0.0 149.2 181.2 100.8 76.5 111.4 40.6 111.9 192.4 136.2 249.1 0.0 0.0 184.2 83.4 111.1 104.5 232.1 106.2 116.0 99.6 7.5 247.4 71.5 2.1 0.0 0.1 158.1 110.6 124.1 10.6 197.0 135.7 206.5 72.2 3.8 151.2 46.9 151.4 103.6 18.4 124.8 98.2 92.9 8.9 141.6 146.1 195.9 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391073 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 35720.4;esophagus: 24762.8;lymphoid tissue: 9029.8;vagina: 11258.1" "Group enriched" "Detected in many" 7 "Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 9 "classical monocyte: 26833.7;neutrophil: 52973.6" "Group enriched" "Detected in all" 9 "granulocytes: 52973.6;monocytes: 26833.7" "Group enriched" "Detected in some" 24 "hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" NA NA 10900000 370000000 "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 587.7 54.7 41.9 1256.9 48.1 35720.4 70.6 44.3 88.7 2715.0 61.7 51.0 15.6 23.3 5.5 24762.8 238.3 99.9 119.3 41.4 53.2 100.4 178.2 1071.0 29.7 48.3 46.9 41.2 26.0 52.5 9.7 42.1 207.5 47.8 43.5 14.9 5.6 4019.8 5.1 48.9 262.4 48.1 434.4 44.3 3265.5 94.6 16.3 45.0 284.0 49.2 176.3 9029.8 567.1 11258.1 53.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 1.3 0.0 0.3 12.4 0.0 18.7 0.0 0.1 0.0 3.5 0.0 0.0 0.0 5.6 0.1 0.0 241.8 0.0 7.5 0.0 0.0 0.0 9.6 1.2 0.0 0.9 0.4 1.5 0.3 0.0 0.0 0.4 5.8 1.0 0.0 0.0 0.4 0.5 3.6 719.0 0.0 0.0 4.7 400.6 10.6 0.0 0.2 0.9 0.1 0.2 1.3 2.7 0.3 13.9 0.0 848.0 26833.7 3023.7 33.4 1999.2 49.2 57.2 21.8 18.2 4686.1 23.5 21.6 23.3 52973.6 27.1 493.1 188.1 37.1 24979.9 41.9 48.1 44.3 88.7 41.4 53.2 48.3 46.9 41.2 47.8 44.3 45.0 53.2 1.1 224.4 489.8 0.0 77.2 19.6 3.5 4126.5 50.7 0.0 13.2 3.9 10.0 70.1 817.0 14.7 0.0 5.8 67.1 0.3 0.0 1.0 210.7 0.5 0.6 33.1 0.0 143.5 0.0 0.9 8.5 61.3 1.1 0.5 227.1 0.1 76.1 54.6 417.5 0.0 0.0 0.2 207.5 6348.0 5.1 172.4 4.1 3758.3 0.0 0.0 6932.6 0.0 289.4 0.0 0.0 1.4 0.0 1.5 26.1 0.9 0.0 25.0 162.8 0.0 0.0 7.7 32.3 2.1 1.0 8480.1 113.2 6.7 91.4 0.0 0.0 31.3 TPM3 "NEM1, TRK" ENSG00000143549 "Tropomyosin 3" P06753 1 154155304-154194648 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease variant, Nemaline myopathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 13 "skeletal muscle: 8990.1;tongue: 6160.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" NA NA 170000000 "Actin filaments" Cytosol "HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.64e-1)" "unprognostic (2.11e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.39e-1)" "unprognostic (2.69e-3)" "prognostic unfavorable (6.73e-6)" "prognostic unfavorable (4.01e-4)" "unprognostic (2.80e-1)" "prognostic favorable (2.39e-5)" "prognostic unfavorable (3.65e-4)" "unprognostic (3.31e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.98e-2)" "unprognostic (1.00e-2)" 142.0 104.2 96.5 235.3 106.7 595.4 98.1 84.9 117.1 95.7 79.6 200.9 164.9 70.2 74.1 290.0 101.5 137.3 208.7 104.0 100.5 82.3 115.4 180.3 289.6 98.7 103.0 99.2 45.8 268.2 92.5 19.8 142.2 100.5 123.4 203.4 60.8 102.4 56.5 8990.1 103.8 169.2 112.6 94.3 210.7 154.2 65.4 98.8 204.9 89.6 6160.7 289.6 184.9 29.9 101.6 529.4 332.8 306.1 225.4 262.1 341.1 317.9 439.0 419.1 597.9 437.7 596.1 513.9 414.6 366.9 500.2 206.4 472.1 320.0 468.7 485.8 315.7 171.9 537.6 234.1 311.7 200.9 728.2 627.5 260.0 246.2 515.8 355.1 224.9 929.4 269.0 411.8 429.7 710.0 342.2 582.0 683.1 714.2 775.9 515.9 510.0 233.2 574.9 405.6 387.4 234.4 409.4 360.0 443.7 419.2 303.9 645.0 788.9 758.8 558.8 353.9 497.3 711.1 332.4 623.0 516.2 490.7 514.7 860.0 932.1 743.2 1729.3 547.2 945.6 480.1 395.2 464.0 504.4 792.6 324.5 347.2 442.6 824.3 386.4 1104.4 392.9 551.5 2029.4 96.5 106.7 84.9 117.1 104.0 100.5 98.7 103.0 99.2 100.5 94.3 98.8 101.6 346.0 621.8 343.2 17.6 318.6 149.5 227.6 169.5 127.5 84.2 135.4 88.4 85.0 125.8 275.6 97.5 31.3 127.3 475.7 494.5 105.7 292.1 72.3 353.7 191.1 395.7 141.0 189.8 65.7 347.0 331.0 170.4 245.6 474.2 531.3 119.5 200.3 110.6 559.1 304.5 50.5 291.2 93.6 355.6 504.7 182.3 46.6 648.3 152.9 31.9 704.0 54.5 466.5 12.5 30.6 530.4 363.9 29.7 218.2 204.8 220.1 179.8 230.8 62.8 19.7 155.1 128.5 38.6 67.6 223.6 143.3 101.9 422.6 119.2 302.1 324.6 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell type enhanced" "Detected in some" "Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "MCF7: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" No No "Nuclear bodies" "HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.1 0.0 0.6 0.0 1.0 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 1.3 0.1 0.0 0.1 0.0 0.8 0.7 0.3 0.1 0.1 0.0 0.3 0.0 1.1 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.0 26.8 1.1 0.0 0.2 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.6 1.0 2.4 1.1 0.7 1.3 0.8 0.7 0.3 1.1 0.6 1.1 2.5 0.6 0.0 0.0 6.2 0.5 0.3 0.1 0.1 0.0 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 20.3 0.7 0.6 0.9 0.0 0.4 7.0 0.2 0.1 0.5 0.0 1.5 0.0 0.1 0.0 0.0 0.2 0.0 8.4 0.1 0.0 0.0 0.6 8.5 0.9 0.8 0.0 2.8 0.0 0.0 0.0 4.5 19.2 0.0 0.0 1.2 1.7 0.1 0.0 0.1 0.1 0.0 6.6 1.8 0.3 28.2 5.1 0.3 0.6 0.0 0.4 0.1 0.1 0.3 SNAPIN "BLOC1S7, BORCS3, SNAPAP" ENSG00000143553 "SNAP associated protein" O95295 1 153658703-153661852 "Predicted intracellular proteins, Transporters" "Exocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046974 Approved Approved "Nucleoli,Golgi apparatus" NA NA 20000 "Golgi apparatus" Nucleoli "HPA046974: AB_10962506" "unprognostic (3.65e-1)" "unprognostic (1.67e-1)" "unprognostic (1.47e-1)" "unprognostic (5.66e-2)" "unprognostic (1.75e-1)" "unprognostic (2.06e-1)" "unprognostic (1.64e-3)" "unprognostic (1.54e-1)" "unprognostic (4.86e-2)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.31e-1)" "unprognostic (4.73e-1)" "unprognostic (1.31e-3)" "unprognostic (4.89e-2)" 33.4 51.2 39.5 18.7 39.6 13.2 30.6 42.3 43.4 24.0 36.5 31.5 12.9 31.0 34.4 35.4 27.8 21.8 56.4 37.4 42.3 32.7 32.4 21.2 27.6 41.4 39.9 36.6 24.3 17.6 41.5 16.5 19.2 40.7 24.7 20.4 25.3 22.3 29.7 92.4 27.6 23.4 30.7 41.9 31.2 26.5 19.4 41.0 30.9 25.7 77.6 32.2 31.4 23.7 44.0 50.8 60.6 51.5 31.0 63.2 42.7 32.4 41.7 46.1 57.8 43.9 43.9 39.3 35.8 82.6 42.9 29.0 65.6 42.5 54.4 40.9 49.3 57.4 39.6 41.3 21.1 65.4 39.3 24.4 50.5 41.1 43.6 49.0 61.0 54.8 41.7 34.7 27.8 59.5 82.7 46.0 23.9 27.5 78.6 64.7 42.9 44.1 96.8 65.0 47.6 38.9 67.8 48.0 55.0 57.8 50.3 84.0 43.5 48.4 27.2 40.5 54.4 40.0 65.6 77.4 56.0 51.4 24.9 36.1 106.2 146.9 139.7 86.8 154.1 100.6 130.1 88.2 88.9 153.5 119.6 96.9 87.9 30.4 118.1 126.8 115.6 136.3 146.6 39.5 39.6 42.3 43.4 37.4 42.3 41.4 39.9 36.6 40.7 41.9 41.0 44.0 41.7 19.2 16.6 7.2 31.6 20.6 35.1 88.7 35.9 14.2 39.1 44.4 39.8 40.0 45.3 29.5 8.4 64.4 35.9 18.0 74.3 71.4 9.6 31.5 24.2 34.9 13.8 33.6 5.9 65.2 49.5 31.2 16.3 25.6 30.4 31.9 40.7 35.1 90.2 21.9 6.5 20.0 40.7 48.3 21.8 26.6 30.7 34.7 26.6 4.7 76.5 84.8 59.8 8.0 14.4 53.5 25.5 49.7 23.8 34.7 26.6 76.7 40.9 21.7 46.0 25.3 39.7 29.3 42.6 45.5 23.4 73.7 26.9 44.2 24.6 36.2 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 7.4;granulocytes: 12.6;monocytes: 11.1" "Cell line enhanced" "Detected in many" "ASC diff: 53.3;MCF7: 30.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: AB_2685857" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favorable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 19.0 5.0 3.8 3.3 3.9 2.5 17.8 3.3 5.7 7.3 4.6 8.0 2.5 6.3 38.0 6.2 9.9 5.8 7.7 3.8 3.8 11.2 20.6 19.1 4.7 4.0 4.1 4.1 9.3 8.1 9.3 10.0 6.5 3.7 7.2 5.0 0.6 5.2 8.0 3.1 12.4 7.8 5.8 3.2 8.6 19.4 12.3 3.8 2.3 9.4 3.7 2.8 7.5 9.6 3.9 2.6 0.5 3.1 1.5 53.3 10.8 0.8 0.5 3.9 1.2 1.0 1.8 1.8 1.1 1.6 2.4 0.6 9.3 3.0 1.5 0.7 0.4 1.4 1.5 2.8 1.9 6.7 1.4 5.8 5.5 6.6 0.3 1.4 1.1 7.0 0.3 0.8 1.4 0.3 30.8 0.3 8.1 3.4 12.2 1.4 8.6 0.6 0.9 1.5 0.9 2.7 1.7 0.6 9.6 3.0 4.1 3.9 5.5 0.0 1.5 2.8 3.3 0.1 2.4 2.4 0.3 2.5 5.7 1.2 9.5 10.7 12.6 2.1 8.8 1.3 0.6 0.6 2.1 7.4 0.7 0.2 0.6 0.9 2.5 11.1 1.0 0.2 3.4 3.8 3.9 3.3 5.7 3.8 3.8 4.0 4.1 4.1 3.7 3.2 3.8 3.9 47.3 19.2 51.8 6.5 5.5 11.7 12.6 9.0 8.0 0.9 4.4 11.3 4.6 34.3 10.1 3.7 0.0 27.2 20.7 4.2 0.0 4.3 0.6 5.1 12.1 42.4 4.2 0.4 2.6 7.3 13.0 20.3 16.8 7.9 25.4 1.8 106.1 30.6 33.2 1.7 2.6 23.7 6.1 31.7 39.8 3.2 19.0 21.3 23.2 1.9 44.6 2.0 35.0 0.5 1.6 3.1 42.3 14.3 7.9 3.4 2.5 3.6 6.6 1.0 6.6 3.4 15.7 1.7 2.9 5.5 7.7 8.8 13.0 5.2 10.7 7.0 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460651 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "esophagus: 1074.2;lymphoid tissue: 1250.1;skin 1: 349.3;vagina: 1028.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 59.3;Club cells: 70.4;Ionocytes: 18.3;Suprabasal keratinocytes: 89.6;Syncytiotrophoblasts: 26.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 1201.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 7.2;SK-BR-3: 16.9" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 14000000 Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 0.7 0.2 1.1 0.0 1.1 0.8 15.7 1.7 1.8 83.8 1.0 0.3 0.0 1.2 27.9 1074.2 0.3 0.2 0.4 1.1 1.1 0.1 0.5 0.4 0.2 1.2 1.1 1.1 0.5 0.4 0.0 0.2 0.2 1.3 0.5 0.0 0.0 55.9 0.2 0.4 349.3 0.3 1.4 1.1 0.3 0.4 0.3 1.1 12.5 0.2 0.0 1250.1 1.3 1028.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.2 0.0 2.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.7 16.9 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.7 1.8 1.1 1.1 1.2 1.1 1.1 1.3 1.1 1.1 1.4 0.0 0.0 0.0 0.0 0.0 11.7 0.2 59.3 0.0 0.0 1.1 0.0 0.0 0.0 70.4 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.3 0.0 1.9 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.3 0.0 0.0 0.0 4.7 0.2 0.2 3.8 89.6 26.4 0.1 8.4 0.6 0.4 UBAP2L "KIAA0144, NICE-4" ENSG00000143569 "Ubiquitin associated protein 2 like" Q14157 1 154220179-154271510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 147.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035068 Approved Approved "Nuclear speckles,Cytosol" NA NA 67000 "Nuclear speckles, Cytosol" "HPA035068: AB_10696366" "unprognostic (3.14e-2)" "unprognostic (1.50e-1)" "unprognostic (8.82e-2)" "unprognostic (2.93e-3)" "unprognostic (3.98e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.65e-5)" "unprognostic (1.97e-2)" "unprognostic (5.10e-3)" "unprognostic (9.01e-2)" "unprognostic (1.67e-1)" "unprognostic (6.96e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (7.40e-3)" "unprognostic (9.14e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-1)" 53.2 49.7 30.3 61.4 30.9 63.4 50.4 29.0 40.7 52.1 30.0 47.7 34.6 60.4 49.0 55.5 55.1 45.2 63.3 31.9 26.0 40.0 36.9 55.0 61.2 27.5 24.9 28.1 61.0 38.2 60.9 49.8 71.2 29.0 46.1 41.2 46.4 48.3 47.6 83.8 60.7 40.9 55.7 19.6 54.0 46.3 65.1 26.3 60.0 54.1 49.5 66.5 54.4 51.3 34.1 189.3 184.8 167.4 136.5 121.0 138.0 148.1 212.1 154.9 187.6 131.6 197.9 143.6 235.3 213.2 178.9 94.6 160.8 224.3 158.4 167.7 208.1 199.7 255.7 184.6 162.7 113.7 269.6 144.0 130.5 68.3 173.8 114.8 117.9 153.1 92.0 235.0 111.5 152.6 212.6 207.8 101.1 320.4 140.1 170.9 148.9 135.5 207.8 120.7 220.5 173.1 209.3 245.1 227.2 91.4 186.8 226.6 180.6 245.9 117.0 123.8 145.1 205.7 239.1 278.4 313.2 125.7 144.8 179.0 15.1 28.2 20.4 23.1 35.9 25.4 20.9 21.8 21.2 34.9 26.4 24.6 27.7 24.5 36.4 41.3 16.3 21.5 29.6 30.3 30.9 29.0 40.7 31.9 26.0 27.5 24.9 28.1 29.0 19.6 26.3 34.1 29.2 25.6 38.5 22.9 31.7 18.4 18.7 21.5 22.2 18.4 21.5 21.5 39.0 17.2 32.3 18.4 8.4 51.3 32.7 16.7 17.6 28.4 80.6 34.3 43.8 26.8 23.4 34.9 26.7 27.1 39.5 29.0 21.9 35.7 24.7 32.3 23.2 19.1 36.1 15.2 25.3 21.7 26.4 22.6 30.2 147.1 21.5 32.4 19.6 26.2 24.5 13.7 24.7 29.1 29.1 30.9 10.4 22.6 20.6 25.1 12.5 15.9 29.7 20.4 13.1 31.1 51.6 42.2 48.8 31.7 20.5 77.8 23.5 35.6 22.0 21.9 SLC39A1 "ZIP1, ZIRTL" ENSG00000143570 "Solute carrier family 39 member 1" Q9NY26 1 153959099-153968184 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 342.4;Ductal cells: 219.3;Extravillous trophoblasts: 297.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.27e-2)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.13e-1)" "unprognostic (2.63e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (5.26e-5)" "prognostic unfavorable (4.12e-7)" "unprognostic (2.36e-2)" "unprognostic (2.62e-2)" "unprognostic (4.41e-1)" "unprognostic (4.83e-3)" "unprognostic (1.93e-1)" "unprognostic (5.10e-3)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (5.51e-2)" "unprognostic (6.68e-2)" 67.0 73.8 38.9 49.1 41.7 10.7 63.0 42.2 42.0 54.9 45.0 53.2 36.5 60.4 34.1 50.5 54.3 55.7 62.4 37.2 46.4 73.9 77.3 88.1 35.5 51.9 43.6 35.0 55.2 49.4 66.0 30.7 95.7 43.4 57.3 38.5 10.3 52.4 46.8 45.7 63.2 48.8 50.3 44.7 56.5 59.5 20.8 45.3 26.3 57.1 39.1 36.5 61.0 48.7 44.4 122.5 138.3 111.5 93.7 103.4 105.2 244.2 76.8 188.7 128.1 140.2 203.6 303.0 47.2 240.0 108.5 106.8 266.8 114.8 118.9 72.6 146.5 92.5 64.3 138.9 92.9 118.3 49.4 71.1 128.6 108.9 101.1 99.8 119.2 92.7 54.2 62.6 53.5 104.5 251.5 51.0 64.1 158.6 253.4 107.2 56.3 96.3 57.2 202.7 88.1 49.3 116.0 143.6 363.4 136.4 142.9 195.7 104.8 81.6 114.7 105.6 84.3 113.6 64.8 87.1 61.8 82.0 38.8 157.0 16.6 68.1 20.3 33.9 78.9 21.1 34.8 25.1 25.6 56.0 39.8 27.2 24.7 67.3 30.6 95.5 51.3 26.9 58.1 38.9 41.7 42.2 42.0 37.2 46.4 51.9 43.6 35.0 43.4 44.7 45.3 44.4 71.0 9.6 3.3 7.5 21.9 56.5 97.7 105.8 59.2 7.7 56.7 50.2 13.5 61.5 39.0 53.3 2.1 342.4 35.6 33.9 13.7 219.3 1.0 21.4 38.9 70.1 19.2 17.4 1.8 113.8 297.2 60.6 17.3 35.7 36.8 22.2 49.6 25.6 116.5 18.5 3.1 28.4 40.7 63.6 43.4 3.4 48.4 57.8 48.0 8.4 78.6 36.5 28.8 6.0 6.6 127.8 33.9 62.1 19.8 127.4 49.8 39.6 19.2 6.9 46.0 41.3 55.2 31.3 35.7 26.1 53.4 153.1 21.3 42.5 32.3 74.0 HAX1 "HAX-1, HCLSBP1, HS1BP1" ENSG00000143575 "HCLS1 associated protein X-1" O00165 1 154272589-154275875 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055141, HPA075289" Approved Supported Mitochondria NA NA Mitochondria "HPA055141: AB_2682714, HPA075289: AB_2686742" "unprognostic (1.32e-1)" "unprognostic (2.68e-1)" "unprognostic (9.50e-2)" "unprognostic (6.93e-2)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (2.20e-1)" "unprognostic (9.09e-3)" "unprognostic (3.09e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.96e-1)" 59.1 63.5 99.0 44.0 102.4 37.2 75.1 103.5 125.1 60.6 97.8 56.3 48.5 46.6 100.9 54.2 62.2 40.7 157.1 98.1 104.6 76.8 104.9 45.6 58.7 102.9 97.8 96.5 73.6 86.2 85.6 89.3 40.8 100.8 56.0 63.9 54.6 86.6 64.4 259.1 49.1 43.6 64.6 102.5 47.5 66.9 70.1 101.6 68.0 69.8 244.8 77.9 59.0 49.3 101.5 115.3 100.7 84.2 178.0 100.3 111.8 132.1 109.8 178.7 227.0 207.5 126.6 125.7 170.9 150.7 188.0 105.9 100.0 190.7 151.3 172.3 171.0 140.8 81.8 76.5 104.4 221.5 172.5 167.0 104.4 274.2 172.8 206.3 82.2 129.7 246.1 166.1 244.8 145.6 260.9 169.9 136.1 88.7 277.4 213.2 121.3 59.7 326.7 115.4 60.8 123.2 121.7 96.4 228.2 326.7 137.5 190.0 454.8 64.5 92.7 122.7 97.7 148.8 284.8 315.9 315.3 139.0 158.4 153.4 266.5 97.6 215.4 113.7 121.9 129.3 136.1 139.2 128.3 118.6 142.2 166.5 132.6 61.1 116.7 150.1 122.8 183.3 163.9 99.0 102.4 103.5 125.1 98.1 104.6 102.9 97.8 96.5 100.8 102.5 101.6 101.5 69.9 28.9 37.6 7.2 125.2 74.6 112.2 118.8 60.9 57.0 92.8 123.1 106.9 62.9 71.6 46.0 47.9 84.8 76.1 54.1 181.9 93.3 147.6 41.3 36.6 65.6 57.6 66.0 12.0 106.4 132.1 62.2 36.7 34.0 99.6 80.6 61.4 90.3 98.7 40.4 12.9 67.1 91.6 63.9 79.3 104.6 61.2 66.8 87.2 9.4 128.5 91.1 91.6 7.5 17.1 84.6 63.6 62.1 192.9 92.5 128.7 141.8 59.3 97.5 59.2 58.2 76.0 223.8 112.0 71.0 76.4 88.8 97.7 74.3 71.7 101.7 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974361 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 107.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 6.3 8.6 4.2 4.5 3.6 7.6 48.7 4.2 4.7 30.8 4.1 11.6 11.5 13.1 13.1 8.3 19.4 6.8 4.8 3.4 3.6 7.5 14.1 5.8 6.0 3.7 3.8 2.7 17.6 13.3 6.8 6.2 6.4 3.7 107.2 15.3 5.0 44.2 7.7 5.7 10.2 9.1 5.8 4.0 7.6 29.6 5.3 3.4 12.1 11.4 5.4 7.5 6.8 7.0 4.6 7.5 10.6 9.8 10.9 6.9 10.0 24.7 6.2 7.2 8.3 7.3 5.1 31.0 13.9 31.7 2.6 6.1 12.0 14.5 9.7 4.5 11.4 5.9 10.3 11.7 8.9 5.6 4.9 8.5 10.9 9.2 7.9 17.9 7.5 7.4 16.5 8.1 16.9 3.8 81.8 9.3 3.8 6.7 82.7 12.7 20.9 10.3 26.1 9.0 5.3 18.5 20.1 6.6 174.6 16.8 12.8 139.9 14.9 4.5 2.5 7.3 5.2 4.9 31.4 17.3 10.6 5.3 8.5 8.2 1.5 2.9 2.2 3.4 1.2 4.5 4.5 1.9 2.4 5.0 4.8 1.8 3.5 0.1 9.4 1.7 5.7 1.8 2.5 4.2 3.6 4.2 4.7 3.4 3.6 3.7 3.8 2.7 3.7 4.0 3.4 4.6 7.2 6.4 13.1 3.6 6.2 2.9 13.1 10.1 6.8 5.3 49.9 40.1 2.0 7.2 20.3 1.8 2.1 12.9 5.6 3.6 9.8 14.0 0.4 10.6 5.2 6.9 9.0 8.6 0.4 13.3 17.0 4.8 10.7 13.5 5.7 8.7 4.2 14.2 5.4 0.0 0.4 56.9 6.1 7.5 2.0 0.6 7.2 5.1 5.4 0.0 2.8 6.6 8.2 1.5 2.2 7.9 4.3 2.2 5.3 49.3 4.0 4.1 16.6 8.8 19.7 3.1 5.0 7.4 10.6 6.3 3.0 4.2 4.5 7.6 10.9 7.0 EFNA3 "Ehk1-L, EPLG3, LERK3" ENSG00000143590 "Ephrin A3" P52797 1 155078837-155087538 "Predicted membrane proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.2;skin 1: 99.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 63.2;Basal squamous epithelial cells: 44.3;Extravillous trophoblasts: 30.0;Squamous epithelial cells: 32.6;Suprabasal keratinocytes: 108.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 46.3;SCLC-21H: 26.8;T-47d: 25.3" "Low region specificity" "Detected in all" CAB010494 Uncertain NA NA "CAB010494: AB_2097783" "unprognostic (3.75e-2)" "unprognostic (1.53e-2)" "unprognostic (1.56e-2)" "unprognostic (1.51e-2)" "unprognostic (3.88e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.86e-2)" "unprognostic (3.56e-1)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.66e-10)" "unprognostic (2.83e-3)" "unprognostic (6.38e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-3)" 1.1 2.1 13.1 0.7 15.8 0.2 5.2 8.0 23.8 7.0 5.7 3.5 1.0 1.3 3.8 31.2 0.8 0.6 1.0 18.4 13.5 1.1 3.4 0.7 0.6 14.0 11.8 15.5 1.6 1.1 5.6 14.6 0.8 15.2 2.3 3.6 3.2 5.5 0.5 0.8 99.2 1.5 0.7 9.2 1.3 1.1 3.6 12.0 1.1 1.0 0.6 2.5 0.9 28.2 17.6 6.1 1.5 2.6 16.6 2.9 1.5 1.9 0.3 0.5 0.7 1.0 1.0 2.6 4.7 2.7 0.6 1.5 10.0 18.4 3.7 0.6 2.8 4.0 0.6 0.6 1.3 0.3 0.7 3.3 0.8 4.5 0.3 1.1 7.7 1.4 3.0 3.0 2.9 0.6 8.3 0.9 2.5 1.8 46.3 4.8 6.0 1.5 15.6 2.0 0.2 26.8 8.2 1.0 17.7 0.5 2.3 25.3 0.9 0.5 1.8 5.1 0.8 0.5 5.6 2.6 1.1 3.1 2.4 0.2 0.0 0.6 0.8 0.8 0.8 0.8 1.0 0.6 0.4 1.4 1.2 0.9 0.5 0.0 2.7 0.3 1.1 1.6 0.4 13.1 15.8 8.0 23.8 18.4 13.5 14.0 11.8 15.5 15.2 9.2 12.0 17.6 3.8 0.0 0.6 2.0 2.1 63.2 3.8 13.6 44.3 1.5 16.9 12.2 0.2 0.0 4.4 0.0 0.0 1.1 3.5 8.6 1.9 3.9 0.6 1.6 0.7 4.2 1.2 0.0 6.5 2.9 30.0 1.5 0.0 1.6 0.0 1.6 1.1 1.1 2.1 3.3 7.9 9.1 2.0 1.2 6.8 1.1 1.2 1.3 8.8 1.0 0.8 9.6 3.1 0.0 1.3 3.2 7.4 0.4 0.4 9.9 6.1 1.3 1.1 1.3 0.0 1.1 8.8 6.5 9.3 32.6 108.8 2.9 2.2 10.1 7.4 3.8 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 69.1" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Erythroid cells: 1.3;granulocytes: 5.7;Hepatic stellate cells: 1.4;Macrophages: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 18.0;HMC-1: 7.1;K-562: 21.0;SH-SY5Y: 4.8" "Not detected" "Not detected" "HPA062621, HPA065947" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA062621: , HPA065947: AB_2685584" "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 69.1 0.0 0.1 0.1 4.6 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.1 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.1 5.7 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.1 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870281 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.0" "Group enriched" "Detected in many" 4 "Astrocytes: 168.8;Skeletal myocytes: 121.5" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.7;memory B-cell: 2.6" "Group enriched" "Detected in many" 11 "B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4" "Cell line enhanced" "Detected in some" "Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 0.6 1.1 25.7 3.9 21.0 0.3 0.7 16.1 11.0 2.2 0.0 5.6 3.0 5.0 0.6 1.7 5.8 1.5 2.1 17.9 15.7 1.7 0.2 1.6 3.6 17.5 27.0 10.2 0.8 0.3 1.1 1.2 0.0 18.3 1.6 2.4 0.3 1.3 1.2 6.1 0.3 2.2 6.1 10.8 3.6 2.4 0.5 22.2 1.0 1.9 5.3 5.6 3.1 1.6 11.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 39.3 3.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 26.1 0.5 0.0 0.3 0.0 0.1 0.8 0.1 0.0 65.5 0.6 0.1 0.2 0.0 0.8 0.0 2.5 0.0 16.2 18.7 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 62.3 8.8 21.4 0.6 0.0 6.2 4.7 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 25.7 21.0 16.1 11.0 17.9 15.7 17.5 27.0 10.2 18.3 10.8 22.2 11.2 8.7 12.8 2.7 168.8 3.9 1.3 0.6 0.7 0.6 0.5 0.1 0.0 3.4 0.0 2.1 0.0 2.1 0.1 0.0 0.0 3.9 0.2 3.4 26.6 0.6 25.9 4.2 0.0 18.2 0.2 0.0 16.3 0.0 5.8 0.0 2.0 13.9 0.3 0.4 0.0 13.6 0.0 4.1 0.0 3.0 7.7 0.3 0.9 0.0 11.2 0.0 2.2 0.0 12.1 5.0 0.0 2.2 0.0 30.9 0.5 0.0 0.3 18.3 0.4 0.0 121.5 1.3 0.7 0.2 0.8 1.7 0.0 0.5 22.5 0.0 0.7 C1orf43 "DKFZp586G1722, NICE-3" ENSG00000143612 "Chromosome 1 open reading frame 43" Q9BWL3 1 154206696-154220637 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010725 Approved Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA010725: AB_1078341" "unprognostic (3.90e-2)" "unprognostic (1.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.87e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.72e-1)" "unprognostic (2.78e-1)" "unprognostic (2.64e-2)" "unprognostic (3.51e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" 127.9 133.0 153.4 73.2 164.0 78.0 120.9 162.8 170.0 91.2 150.9 110.3 119.5 81.4 116.3 108.5 101.4 87.5 181.4 146.3 162.3 189.4 223.8 107.2 82.7 158.5 158.6 145.8 77.7 151.0 150.9 86.3 68.2 156.3 95.7 122.3 136.9 99.9 91.0 482.1 106.4 107.0 91.4 162.2 82.3 118.1 62.6 158.2 92.8 109.6 371.5 99.8 115.0 86.4 174.2 183.5 188.4 156.5 185.1 231.1 230.7 96.2 180.2 309.4 205.0 188.4 127.7 249.8 237.9 268.1 162.9 177.5 182.4 218.5 163.3 147.2 191.1 232.1 184.9 182.6 168.1 357.9 235.4 209.6 187.1 376.6 219.8 449.7 278.6 239.9 262.6 199.1 220.1 268.4 287.5 177.4 212.1 302.3 414.8 282.3 159.8 145.8 435.9 256.0 180.6 254.8 333.5 161.1 420.8 624.9 180.8 416.6 513.5 164.4 157.9 133.6 193.3 229.7 403.5 424.1 227.6 263.4 234.4 430.9 189.9 204.8 134.3 85.9 185.4 102.4 100.3 98.7 93.3 211.5 90.0 102.8 86.8 114.9 83.3 174.6 156.2 154.3 242.7 153.4 164.0 162.8 170.0 146.3 162.3 158.5 158.6 145.8 156.3 162.2 158.2 174.2 107.2 115.4 100.8 27.1 92.1 94.2 128.4 155.3 81.4 112.6 132.9 114.4 135.8 128.7 115.4 71.7 29.2 87.2 86.8 106.1 252.4 171.5 247.1 69.6 62.1 105.4 122.0 110.0 27.3 202.0 125.1 80.2 77.5 58.1 62.1 79.5 100.6 146.9 178.9 58.9 30.8 133.9 116.0 162.5 116.1 171.8 65.0 131.5 124.5 16.9 155.4 107.0 64.9 26.2 50.5 162.8 131.6 74.9 104.1 186.1 218.3 262.1 85.7 89.5 72.3 75.8 86.6 70.7 59.2 113.9 100.6 126.1 76.7 117.4 133.6 167.5 GATAD2B P66beta ENSG00000143614 "GATA zinc finger domain containing 2B" Q8WXI9 1 153789030-153923360 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 4.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017015 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA017015: AB_1854905" "unprognostic (1.90e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.43e-2)" "unprognostic (2.59e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-2)" "unprognostic (4.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (5.17e-2)" 9.4 7.2 0.0 6.2 2.2 10.1 10.0 9.2 3.7 10.7 0.0 9.6 4.3 11.2 1.8 8.0 9.2 3.2 9.1 1.5 0.4 6.8 8.2 13.0 7.9 2.8 0.4 0.0 11.8 7.6 5.7 7.7 5.9 1.8 8.4 3.6 3.6 7.9 5.4 16.7 13.3 9.4 7.1 0.0 10.7 7.8 10.4 1.7 11.0 8.7 8.3 7.5 9.6 9.9 9.3 7.9 14.7 12.8 14.2 2.7 8.2 7.7 4.8 11.5 15.0 17.5 7.2 12.0 15.5 11.2 10.9 7.9 15.6 18.1 9.4 12.2 14.2 12.5 15.2 16.2 2.9 8.6 9.2 20.7 6.5 6.5 16.7 32.9 7.1 14.4 21.2 11.5 20.6 3.0 14.5 33.3 2.6 5.6 6.3 7.1 33.5 6.5 17.1 2.9 10.9 14.8 15.6 18.0 21.8 8.7 9.4 20.1 7.7 13.0 14.6 12.8 8.1 10.2 27.9 20.5 23.4 8.2 6.0 12.8 4.9 0.5 0.5 0.6 0.3 0.6 0.4 0.3 0.8 0.2 0.6 0.2 0.3 3.5 0.9 0.2 1.6 0.6 0.3 0.0 2.2 9.2 3.7 1.5 0.4 2.8 0.4 0.0 1.8 0.0 1.7 9.3 32.1 9.6 14.4 53.8 30.0 43.8 13.4 12.8 47.8 45.9 20.9 19.9 16.6 21.5 12.3 25.8 39.6 10.3 31.9 15.1 7.9 13.9 15.8 16.8 26.6 28.2 23.8 21.7 104.6 14.3 7.1 20.7 17.3 21.3 24.7 19.3 22.5 21.8 13.5 35.3 77.5 15.8 16.2 31.4 42.8 7.6 27.1 23.7 14.2 80.6 36.3 17.8 23.7 86.5 117.9 17.1 20.7 35.0 25.6 22.3 9.9 10.4 15.2 35.9 6.6 28.2 27.1 30.4 21.4 26.0 47.5 9.9 31.2 21.4 15.9 21.1 ILF2 NF45 ENSG00000143621 "Interleukin enhancer binding factor 2" Q12905 1 153661788-153671028 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007484 Supported Supported Nucleoplasm No No 3400000 Nucleoplasm "HPA007484: AB_1079137" "unprognostic (1.97e-3)" "unprognostic (8.68e-2)" "unprognostic (3.44e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-3)" "unprognostic (9.70e-2)" "prognostic unfavorable (5.71e-8)" "unprognostic (2.64e-1)" "unprognostic (4.66e-2)" "unprognostic (3.22e-3)" "unprognostic (1.94e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.61e-1)" "unprognostic (4.17e-2)" "unprognostic (2.65e-1)" "unprognostic (2.09e-1)" 77.2 84.9 43.5 82.3 45.3 159.5 101.7 46.9 51.5 76.1 51.2 81.2 57.9 76.2 86.4 99.9 78.2 61.6 69.2 44.3 54.9 98.5 69.5 76.8 98.5 46.2 46.6 43.5 76.0 80.3 102.5 75.9 86.9 47.4 64.1 92.2 43.8 85.0 61.8 115.5 88.3 63.9 79.9 47.2 78.7 77.6 102.1 45.5 191.4 89.5 86.7 133.4 106.9 70.1 51.8 323.3 244.7 420.1 297.8 173.1 162.4 336.2 233.5 263.6 411.9 294.5 362.1 254.3 441.5 349.5 233.6 198.8 239.3 508.8 248.3 394.6 242.0 328.9 330.5 182.2 310.0 158.6 521.0 234.7 149.6 139.7 314.4 339.1 171.7 389.3 256.0 423.5 203.4 347.2 424.3 702.8 215.4 607.5 468.5 366.2 502.1 367.2 418.3 194.8 304.0 379.5 350.2 272.3 336.1 272.3 392.0 367.2 442.7 239.5 210.7 266.4 191.6 391.8 348.6 522.6 882.9 177.2 314.1 327.2 168.7 158.1 118.1 147.4 156.0 188.0 198.7 169.8 160.3 219.2 165.0 190.7 164.8 14.8 218.5 129.7 212.2 212.6 357.3 43.5 45.3 46.9 51.5 44.3 54.9 46.2 46.6 43.5 47.4 47.2 45.5 51.8 101.4 57.7 68.5 6.8 102.1 197.9 220.9 238.0 129.7 38.0 113.5 112.1 62.2 70.1 130.4 38.6 27.1 215.3 99.0 54.2 131.0 209.9 73.9 81.6 84.4 114.0 106.8 113.0 9.4 156.4 259.3 110.8 50.4 103.0 94.4 107.0 49.2 31.5 124.8 28.6 10.5 87.2 164.8 54.9 117.4 33.1 60.0 74.0 112.1 9.4 112.9 82.8 61.8 10.6 17.1 145.4 63.5 65.8 125.4 139.9 45.5 201.6 80.7 36.3 65.7 102.4 124.2 360.3 159.9 119.1 158.8 260.4 101.4 144.9 110.9 181.0 RIT1 "MGC125864, MGC125865, RIBB, RIT, ROC1" ENSG00000143622 "Ras like without CAAX 1" Q92963 1 155897808-155911404 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.4" "Cell type enhanced" "Detected in all" "Langerhans cells: 107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053249 Approved NA NA "HPA053249: AB_2682089" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (7.27e-2)" "unprognostic (3.66e-2)" "unprognostic (1.35e-2)" "unprognostic (3.11e-2)" "prognostic unfavorable (8.64e-6)" "unprognostic (3.80e-2)" "unprognostic (4.99e-2)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (2.19e-2)" "unprognostic (9.22e-3)" "unprognostic (4.82e-2)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.33e-3)" 20.0 14.0 11.9 23.1 12.5 81.4 13.4 12.8 13.1 14.6 13.2 13.5 12.9 15.0 15.5 37.6 10.9 18.7 15.9 10.9 16.1 25.3 12.3 22.9 18.4 14.3 12.9 9.4 12.9 13.9 16.6 11.1 23.2 13.6 13.9 14.5 16.2 14.5 18.2 10.9 12.9 12.6 21.4 13.2 21.9 19.9 12.3 13.9 21.7 13.5 16.7 23.8 23.8 22.1 15.1 21.0 22.9 42.3 21.7 21.5 26.6 12.0 37.2 37.4 35.2 35.4 24.1 40.0 9.6 50.0 43.9 25.3 24.7 32.0 18.5 29.4 12.9 16.4 21.0 24.4 15.6 55.7 22.5 37.9 37.1 22.5 40.9 27.4 47.7 48.7 19.7 21.0 26.3 54.3 27.3 30.7 14.9 23.0 36.2 13.9 24.0 33.3 19.6 29.9 44.2 19.7 30.7 27.1 51.1 34.8 76.9 37.3 29.4 62.5 31.7 22.3 27.3 30.7 31.1 30.9 38.8 33.9 22.8 43.0 22.8 41.0 46.9 19.5 25.5 15.6 16.9 16.8 18.5 31.1 17.1 20.2 18.1 106.3 28.8 29.3 12.5 23.8 30.0 11.9 12.5 12.8 13.1 10.9 16.1 14.3 12.9 9.4 13.6 13.2 13.9 15.1 45.8 48.1 23.9 12.4 22.4 28.9 36.5 43.7 21.6 8.1 17.4 12.3 14.2 8.6 40.4 18.4 10.4 14.5 41.8 14.1 21.5 39.4 10.4 20.4 25.7 50.5 12.6 16.4 5.1 23.4 16.8 20.8 13.3 32.5 14.0 15.2 24.7 7.0 50.7 6.7 5.3 11.5 42.7 45.6 107.9 10.3 7.2 62.6 33.8 11.2 79.2 25.9 16.5 8.5 8.1 28.3 15.4 15.8 13.4 48.8 15.4 70.6 21.9 11.9 26.3 18.2 26.1 12.7 23.2 26.0 30.7 33.5 32.7 20.7 10.0 79.2 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728050-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 14.3 18.9 2.0 10.9 2.5 3.0 14.8 1.0 3.2 16.8 1.5 14.5 4.3 18.4 13.5 12.2 20.9 9.8 12.9 2.5 2.3 16.0 11.9 15.0 8.6 3.0 1.1 2.8 23.5 13.1 8.3 18.0 9.7 1.7 12.0 6.6 3.7 12.2 11.4 15.0 11.7 13.0 9.5 0.0 13.3 16.8 12.9 2.9 6.8 15.4 8.4 7.8 13.7 14.5 2.3 26.2 15.8 14.0 19.2 21.3 17.4 19.1 18.2 8.7 21.7 17.4 8.5 24.5 21.3 37.8 24.2 11.8 27.0 28.0 18.7 10.2 24.6 23.0 15.4 37.7 3.8 13.8 18.8 20.5 12.3 7.5 9.5 11.7 17.5 14.4 13.8 19.2 14.6 9.0 8.5 18.6 10.0 23.6 25.5 26.8 24.5 6.4 13.1 8.1 24.7 11.8 15.5 18.9 39.7 11.4 18.4 13.3 25.3 6.1 22.7 6.7 18.1 18.1 17.1 13.7 19.5 24.9 8.9 11.3 0.0 0.8 0.9 0.9 0.5 0.8 0.3 0.3 0.5 1.2 0.3 0.2 0.5 0.8 0.7 2.9 0.3 0.5 0.2 2.0 2.5 1.0 3.2 2.5 2.3 3.0 1.1 2.8 1.7 0.0 2.9 2.3 29.1 22.4 22.8 59.7 11.9 10.5 9.5 10.4 15.9 23.7 20.2 22.4 4.6 10.0 11.7 31.3 20.9 13.9 11.6 9.2 0.0 11.9 13.1 39.3 29.4 21.5 12.1 10.9 30.8 8.4 13.4 16.3 23.9 38.8 5.7 32.9 26.7 13.9 12.2 21.9 26.1 16.5 8.2 9.1 22.0 7.6 9.6 14.6 7.2 30.0 17.6 15.4 14.4 27.2 29.7 9.9 14.9 12.0 11.6 10.6 9.8 13.3 25.9 22.4 26.3 11.2 16.5 10.2 12.2 13.9 10.2 10.3 10.0 20.2 14.0 12.2 PKLR ENSG00000143627 "Pyruvate kinase L/R" P30613 1 155289293-155301438 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 19.7;kidney: 25.4;liver: 93.3" "Cell type enhanced" "Detected in some" "Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9" "Cancer enriched" "Detected in some" 9 "liver cancer: 56.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "K-562: 107.8" "Region enhanced" "Detected in single" "basal ganglia: 1.6" "Not detected" "Not detected" "HPA006653, CAB034376, CAB034378" Enhanced Approved Cytosol No NA 5200000 Cytosol "CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632" "unprognostic (9.16e-2)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (2.62e-1)" "unprognostic (7.86e-4)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (8.79e-2)" "unprognostic (1.89e-1)" "unprognostic (4.07e-1)" "unprognostic (4.53e-2)" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (6.21e-3)" 0.0 0.0 0.1 0.0 0.1 19.7 0.0 0.7 0.2 0.0 0.0 0.4 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.4 93.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.8 7.3 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 11.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.2 0.0 0.4 0.2 0.2 0.0 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.4 1.5 0.0 1.8 0.0 0.0 0.0 0.6 0.0 0.0 9.3 0.2 0.3 0.1 0.0 22.1 1.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.7 16.3 0.2 0.0 1.2 0.9 0.0 0.0 0.0 23.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 14.8 48.9 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 HCN3 KIAA1535 ENSG00000143630 "Hyperpolarization activated cyclic nucleotide gated potassium channel 3" Q9P1Z3 1 155277463-155289848 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.8" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 9.3" "Cancer enhanced" "Detected in all" "liver cancer: 10.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026584 Approved NA NA "HPA026584: AB_1850534" "unprognostic (1.04e-1)" "unprognostic (6.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.34e-1)" "unprognostic (3.17e-1)" "unprognostic (1.48e-3)" "unprognostic (1.63e-1)" "unprognostic (5.97e-2)" "unprognostic (4.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.36e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.55e-2)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" "prognostic favorable (6.93e-4)" 1.5 3.1 0.5 0.5 0.3 0.1 1.7 2.4 0.8 4.3 0.0 3.9 2.6 2.6 0.0 4.6 1.5 0.0 1.1 0.1 1.2 6.0 14.8 1.4 0.3 1.1 0.7 0.5 3.7 2.6 0.1 7.3 0.2 1.7 2.9 0.5 0.2 3.4 0.2 0.7 5.7 5.1 0.0 0.1 1.5 2.3 1.2 1.3 0.0 2.9 0.0 0.1 2.5 4.2 2.6 2.0 0.7 2.4 0.7 0.6 0.0 1.3 1.6 0.7 0.0 0.3 0.0 2.7 1.8 1.2 0.0 1.2 5.1 0.3 0.0 0.0 2.5 3.1 0.7 2.6 0.5 0.0 0.8 1.3 0.0 0.0 0.0 0.1 0.7 0.2 2.7 4.3 3.1 0.4 0.0 1.4 0.7 1.9 0.3 2.3 3.0 2.0 2.7 0.0 0.3 4.3 5.2 1.3 1.7 0.0 0.0 1.4 0.3 0.2 1.3 1.3 4.0 1.5 1.6 0.7 1.1 0.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.4 0.8 0.1 1.2 1.1 0.7 0.5 1.7 0.1 1.3 2.6 1.1 0.0 0.6 2.3 0.2 1.3 0.9 1.3 1.8 3.1 2.0 1.8 1.8 1.5 1.4 1.8 4.2 0.4 0.2 5.8 0.0 1.1 0.6 0.5 0.9 0.6 4.2 0.4 5.0 0.4 0.4 1.1 2.0 1.4 1.3 1.3 2.5 2.1 0.8 0.0 9.3 2.0 4.1 0.3 1.0 0.8 0.9 0.8 0.0 2.8 0.6 1.4 0.0 4.5 1.5 1.3 2.6 1.2 0.7 0.8 6.1 1.2 0.2 1.9 0.0 0.6 0.6 3.6 3.6 2.2 2.7 0.0 0.6 1.5 4.0 0.9 FLG ENSG00000143631 Filaggrin P20930 1 152302165-152325239 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "skin 1: 461.9" "Cell type enriched" "Detected in some" 13 "Suprabasal keratinocytes: 44.0" "Cancer enriched" "Detected in some" 7 "melanoma: 11.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 10.1;NTERA-2: 3.1;TIME: 2.1;U-2 OS: 2.4;U-2197: 2.6;WM-115: 2.0" "Not detected" "Not detected" "CAB002210, HPA027505, HPA030188, HPA030189" Enhanced Enhanced "Cytoplasmic bodies" NA NA 3800000 "Cytoplasmic bodies" "CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999" "unprognostic (3.37e-2)" "unprognostic (3.76e-1)" "unprognostic (8.83e-2)" "unprognostic (2.96e-3)" "unprognostic (9.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.03e-2)" "unprognostic (1.12e-1)" "unprognostic (9.98e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-1)" "unprognostic (2.35e-2)" "unprognostic (1.45e-1)" "unprognostic (4.28e-2)" "unprognostic (4.15e-2)" "unprognostic (7.41e-3)" 0.3 0.4 1.1 0.1 0.5 0.1 15.9 0.4 0.6 3.2 0.0 0.2 0.0 0.5 0.0 12.1 0.4 0.1 0.3 0.4 0.9 0.3 0.2 0.2 0.0 1.6 0.9 0.3 0.9 0.4 0.0 0.2 0.0 1.2 0.2 0.0 0.2 2.7 0.0 1.8 461.9 0.1 0.0 0.7 0.1 0.2 0.3 0.8 0.5 0.3 0.0 0.5 0.1 4.9 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 10.1 0.0 0.0 0.0 1.1 0.0 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 2.1 0.8 2.4 2.6 1.9 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.4 0.6 0.4 0.9 1.6 0.9 0.3 1.2 0.7 0.8 2.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.0 0.0 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.0 44.0 0.0 0.1 0.1 0.0 0.0 ACTA1 "ACTA, NEM3" ENSG00000143632 "Actin alpha 1, skeletal muscle" P68133 1 229431245-229434098 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 134678.2" "Group enriched" "Detected in some" 36 "Cardiomyocytes: 1901.9;Skeletal myocytes: 1541.2" "Group enriched" "Detected in many" 18 "head and neck cancer: 133.1;prostate cancer: 34.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 22 "BEWO: 469.2" "Low region specificity" "Detected in all" "CAB000045, HPA041264, HPA041271" Enhanced NA NA 2800000000 "CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (3.07e-4)" "unprognostic (5.75e-3)" "unprognostic (3.84e-3)" "unprognostic (1.86e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.64e-3)" "unprognostic (2.50e-1)" "unprognostic (1.56e-3)" "unprognostic (9.40e-4)" "unprognostic (2.61e-1)" "unprognostic (1.58e-2)" "unprognostic (1.01e-1)" 11.6 3.8 1.2 1.6 1.1 0.3 20.0 1.8 2.8 1.0 0.8 6.9 0.3 3.1 0.0 609.8 0.6 1.6 5048.3 1.2 2.6 2.5 7.4 7.7 2.2 0.8 1.1 1.1 4.7 7.4 0.0 4.7 1.2 1.0 166.3 0.0 0.1 595.8 0.7 134678.2 25.6 5.3 67.0 0.6 3.1 5.1 2.5 1.1 3.1 14.6 21052.7 0.9 3.1 5.4 1.0 0.2 0.2 0.1 0.4 0.0 0.1 469.2 0.0 0.0 0.3 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.4 0.2 0.5 21.5 0.0 0.5 0.7 20.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.5 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.2 4.3 0.1 0.0 0.3 0.4 0.6 0.3 0.2 0.5 0.5 0.6 1.0 0.3 0.3 0.6 0.3 18.3 16.5 34.2 11.5 25.4 8.4 6.7 9.4 11.2 23.6 6.4 7.2 11.5 18.8 8.2 24.1 7.5 15.7 45.4 1.2 1.1 1.8 2.8 1.2 2.6 0.8 1.1 1.1 1.0 0.6 1.1 1.0 0.2 0.0 0.0 0.3 0.1 0.5 0.4 0.8 0.0 0.8 0.3 2.2 1901.9 0.0 0.1 0.0 4.2 1.7 0.0 0.0 0.0 1.9 0.4 0.1 0.4 38.1 0.0 0.0 0.6 0.0 3.3 43.6 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 2.1 0.3 0.0 9.7 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1541.2 46.6 1.1 0.2 0.7 0.4 0.3 8.2 0.1 0.1 0.2 C1orf131 DKFZp547B1713 ENSG00000143633 "Chromosome 1 open reading frame 131" Q8NDD1 1 231223763-231241187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028452, HPA029920" Enhanced NA NA "HPA028452: AB_10610979, HPA029920: AB_10600423" "unprognostic (5.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (7.40e-2)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.66e-2)" "unprognostic (3.76e-3)" "unprognostic (1.39e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (2.64e-9)" "unprognostic (8.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.05e-1)" "prognostic favorable (9.84e-4)" 8.6 10.0 6.8 11.5 7.2 12.0 8.8 8.7 9.1 7.0 7.0 13.4 21.6 7.4 7.7 10.5 9.3 8.5 8.3 6.8 7.2 6.8 13.9 6.7 16.0 7.4 7.2 6.5 8.9 8.8 7.5 6.5 11.9 7.5 8.4 15.0 4.6 10.9 5.8 12.6 8.7 18.4 8.7 7.2 11.0 13.7 6.0 7.2 14.4 7.9 9.8 15.2 9.7 8.0 8.9 23.4 22.6 16.6 24.1 17.9 17.7 54.9 16.9 12.2 22.0 14.7 35.7 21.2 50.7 30.4 13.3 10.6 33.9 32.7 13.8 20.4 27.2 51.0 22.7 14.3 38.7 18.7 40.5 30.3 14.8 21.1 16.6 19.9 9.7 18.3 26.7 47.1 16.5 16.7 24.9 44.8 37.7 34.2 65.9 18.0 41.1 22.3 54.1 20.9 16.9 19.1 29.1 28.2 18.6 21.8 8.0 32.2 51.8 12.1 14.4 18.7 24.7 29.8 26.4 44.5 41.9 14.4 31.6 32.6 30.4 25.4 37.2 16.9 26.1 20.3 33.5 22.3 23.2 24.7 30.0 22.4 21.5 14.8 33.1 27.3 27.8 31.2 16.4 6.8 7.2 8.7 9.1 6.8 7.2 7.4 7.2 6.5 7.5 7.2 7.2 8.9 27.8 22.4 19.1 6.8 30.7 9.6 12.3 41.9 24.5 23.4 22.0 24.6 15.0 38.6 24.1 25.8 12.5 68.8 28.7 26.2 39.2 32.8 2.9 26.2 41.1 23.7 21.1 28.0 9.5 36.0 60.9 21.4 31.6 23.0 17.1 25.7 18.5 54.7 29.9 23.5 13.2 41.9 28.5 23.3 6.9 3.1 29.8 20.1 12.4 9.4 29.4 20.9 41.2 6.6 13.0 29.8 35.8 22.6 22.5 16.8 52.6 18.5 17.9 16.3 13.1 18.0 18.1 22.4 34.1 31.0 11.5 38.9 25.9 35.2 46.7 13.6 GALNT2 GalNAc-T2 ENSG00000143641 "Polypeptide N-acetylgalactosaminyltransferase 2" Q10471 1 230057990-230282122 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 133.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 429.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011222 Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 13000000 "Golgi apparatus" "HPA011222: AB_1849446" "unprognostic (1.26e-1)" "prognostic unfavorable (1.22e-6)" "unprognostic (1.15e-2)" "unprognostic (1.35e-2)" "unprognostic (8.70e-3)" "unprognostic (7.77e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.48e-8)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (1.70e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.79e-13)" "unprognostic (3.79e-3)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" 33.2 50.0 16.3 35.1 17.7 14.0 22.0 14.8 16.8 23.2 19.4 27.6 19.6 27.3 7.0 21.2 22.6 21.4 25.4 14.7 28.9 18.5 101.0 27.4 14.1 22.4 17.8 13.9 39.5 68.7 10.0 13.7 27.8 16.6 21.5 12.5 20.0 22.3 14.5 68.0 14.8 23.8 25.3 14.1 17.5 33.4 19.8 20.6 43.2 19.1 27.6 11.3 33.7 19.6 21.1 79.5 103.7 59.9 71.4 112.4 95.3 122.8 146.3 90.0 58.4 55.6 45.2 146.5 20.0 106.2 77.7 135.9 150.7 39.9 123.0 48.6 200.1 52.0 60.7 217.2 50.9 60.9 23.4 114.8 136.9 59.8 78.0 30.9 127.3 69.2 110.1 77.0 29.6 65.6 21.8 122.3 23.9 82.1 52.8 97.7 134.3 85.5 61.7 57.4 92.9 18.9 70.1 148.4 7.9 91.0 31.7 46.5 43.5 165.3 56.7 107.9 129.5 118.0 97.9 60.3 44.4 146.1 46.3 429.7 1.5 10.7 3.6 4.4 9.3 3.2 3.4 2.6 4.5 7.8 5.8 2.5 5.0 3.2 2.8 10.2 13.2 3.3 7.7 16.3 17.7 14.8 16.8 14.7 28.9 22.4 17.8 13.9 16.6 14.1 20.6 21.1 18.6 16.0 21.3 71.5 32.1 15.3 20.0 52.8 20.5 30.8 13.8 10.7 13.6 18.6 30.1 23.9 33.3 7.3 21.7 24.1 5.9 49.7 47.2 18.7 15.4 17.9 16.8 27.6 67.3 133.0 123.4 36.1 21.4 24.5 13.3 20.5 19.6 98.8 24.9 28.6 82.0 18.9 4.1 42.4 9.7 24.6 35.8 28.9 24.9 106.8 44.0 10.9 18.6 72.9 44.6 88.5 21.6 29.3 109.0 23.5 17.9 19.2 23.5 73.5 13.1 33.1 25.4 3.4 14.0 16.6 8.0 16.6 21.2 32.8 17.6 29.9 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 42.7;Excitatory neurons: 70.9;Inhibitory neurons: 76.7;Microglial cells: 56.2;Oligodendrocyte precursor cells: 41.7;Oligodendrocytes: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018022: AB_2211524, HPA051558: AB_2681534" "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favorable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favorable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 7.5 5.1 7.6 11.8 10.0 11.7 7.1 8.3 8.3 6.8 5.3 10.6 8.1 6.0 6.5 6.1 6.6 6.2 5.9 7.7 8.9 5.3 7.9 10.0 19.8 8.0 7.7 8.4 5.7 10.6 6.9 9.3 7.6 8.1 6.4 16.1 11.9 6.7 5.2 11.5 9.9 12.3 6.2 7.7 20.4 12.4 2.9 8.5 10.3 6.8 6.2 14.9 6.6 6.7 9.8 12.4 12.4 12.0 23.5 11.0 7.1 24.5 17.7 13.9 9.8 11.0 18.4 13.2 22.7 15.9 10.8 9.7 19.4 8.0 6.6 6.5 25.6 23.3 6.8 13.7 12.5 11.6 14.1 6.0 6.3 11.4 9.2 8.5 9.8 17.5 9.7 7.3 12.9 9.1 6.5 7.5 13.5 13.5 41.1 15.2 12.0 17.2 31.9 10.2 8.5 16.5 14.2 13.5 13.8 24.2 5.2 14.8 18.1 9.0 11.5 1.6 15.7 31.9 15.8 27.9 6.8 11.3 8.8 19.2 5.7 5.5 4.9 6.6 4.1 4.5 2.8 4.5 5.3 7.7 2.2 3.5 4.4 1.9 7.9 5.3 4.9 3.9 4.2 7.6 10.0 8.3 8.3 7.7 8.9 8.0 7.7 8.4 8.1 7.7 8.5 9.8 7.2 6.4 7.4 42.7 18.9 3.3 1.0 1.8 1.2 6.1 3.4 2.4 3.0 1.5 4.0 1.8 6.2 4.3 21.8 6.6 1.9 5.6 1.7 1.7 2.4 5.4 6.1 11.6 70.9 8.6 5.1 5.2 14.3 3.0 9.5 4.6 1.8 5.0 5.0 11.8 76.7 11.3 8.2 7.8 6.6 2.3 2.8 8.9 1.8 56.2 7.2 4.5 17.5 41.7 70.6 4.1 8.7 6.8 13.6 1.9 2.6 1.2 1.3 10.8 6.6 5.5 4.9 3.1 3.5 3.8 2.7 1.6 16.9 2.1 9.4 1.6 SCCPDH "CGI-49, NET11" ENSG00000143653 "Saccharopine dehydrogenase (putative)" Q8NBX0 1 246724409-246768137 "Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 1380.7;Spermatocytes: 822.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 20 "basophil: 872.9" "Lineage enriched" "Detected in all" 26 "granulocytes: 872.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050775, HPA076030" Enhanced Approved Vesicles NA NA Vesicles "HPA050775: AB_2681231, HPA076030: " "unprognostic (4.25e-1)" "unprognostic (3.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (2.83e-2)" "unprognostic (6.43e-2)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (5.51e-2)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (2.70e-2)" "unprognostic (9.63e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" 26.9 54.2 38.8 14.5 46.8 36.0 23.8 53.3 43.6 22.8 41.1 27.0 34.7 26.4 17.8 9.4 31.9 21.8 33.1 38.0 46.3 50.3 159.5 21.2 13.6 64.8 48.4 36.5 22.6 19.0 36.8 24.4 24.0 62.7 39.7 27.0 32.0 15.5 26.2 61.2 24.3 34.9 24.2 66.5 11.6 28.3 160.9 49.8 20.3 33.8 55.2 10.7 82.3 12.1 94.6 55.3 53.2 37.7 22.8 44.5 55.7 0.5 42.3 58.8 70.1 58.3 32.7 150.6 29.3 53.8 49.0 38.9 17.7 32.4 12.6 71.6 40.8 11.9 49.6 46.9 65.9 41.6 97.1 40.7 37.6 5.9 47.4 4.8 65.7 76.4 60.0 62.9 0.1 70.9 13.5 101.6 122.6 56.5 29.6 41.7 83.8 48.5 0.3 216.6 128.2 42.7 48.0 57.3 2.5 39.0 20.2 42.1 99.6 49.8 32.1 28.5 78.7 110.5 138.0 51.1 17.4 54.7 130.2 43.3 872.9 24.3 44.1 18.1 22.2 22.4 11.2 5.4 15.7 10.7 9.4 7.1 22.0 6.4 34.1 15.4 18.2 4.0 17.1 38.8 46.8 53.3 43.6 38.0 46.3 64.8 48.4 36.5 62.7 66.5 49.8 94.6 25.0 6.4 11.5 25.8 8.0 30.1 40.6 54.6 1.8 31.2 42.4 17.5 38.0 55.8 40.5 152.6 18.8 41.4 14.6 42.4 31.3 67.2 1380.7 72.7 39.4 23.6 44.9 54.7 23.7 69.0 17.4 35.7 32.6 111.9 57.2 49.2 22.5 187.8 89.4 6.7 20.5 27.4 52.9 45.7 13.7 245.6 47.5 29.7 48.0 10.3 20.3 67.4 18.6 27.2 37.3 75.2 27.8 47.4 8.3 49.2 138.4 69.7 79.4 39.2 19.7 36.7 39.4 822.3 76.2 5.6 68.5 84.6 17.0 42.8 55.0 201.9 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.6;retina: 28.1" "Cell type enhanced" "Detected in all" "monocytes: 277.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in many" 5 "granulocytes: 12.2;monocytes: 6.1" "Cell line enhanced" "Detected in many" "HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 5.1 2.7 2.0 8.5 2.6 31.6 6.5 9.8 3.2 7.1 8.7 4.5 3.0 4.4 2.7 4.3 3.9 5.1 2.2 1.6 2.6 3.6 5.5 5.6 7.6 2.0 2.8 1.1 4.6 2.2 6.3 1.8 4.7 2.6 3.4 4.3 28.1 4.4 3.3 1.7 9.8 3.4 4.4 2.4 10.9 7.8 6.1 2.9 25.9 6.5 3.8 6.5 5.8 5.2 3.0 8.6 1.9 0.9 2.0 12.7 14.4 1.3 3.1 12.5 3.3 3.1 0.0 2.3 1.1 1.2 6.8 7.7 4.1 1.2 1.6 2.9 30.8 2.7 2.8 1.9 0.6 2.3 4.2 3.7 4.8 7.8 4.0 10.0 4.8 2.8 1.3 0.2 1.7 2.6 0.4 5.3 8.7 0.2 1.6 0.9 0.4 1.2 0.0 9.2 9.2 5.4 1.1 3.4 0.2 27.1 1.0 1.2 99.5 5.8 2.4 1.1 2.8 2.8 2.1 0.1 0.2 4.1 38.0 7.0 0.4 2.9 5.7 0.6 3.4 0.8 1.0 0.2 0.7 1.7 1.4 0.2 0.4 12.2 1.7 6.1 0.2 0.2 0.7 2.0 2.6 9.8 3.2 1.6 2.6 2.0 2.8 1.1 2.6 2.4 2.9 3.0 66.3 19.2 41.1 71.2 70.9 71.0 89.8 14.6 18.8 67.4 17.6 15.6 11.6 15.7 28.4 11.0 93.8 6.7 77.3 25.0 11.7 6.6 24.6 22.6 23.8 51.2 9.6 21.0 151.5 12.3 5.0 27.0 41.3 22.4 112.5 9.4 26.0 15.4 31.9 52.2 155.9 14.3 28.5 65.6 81.3 17.7 28.0 111.4 120.9 159.3 277.4 25.6 88.6 112.1 81.6 39.6 24.2 21.8 37.3 56.0 12.7 10.9 26.7 162.5 13.1 31.2 22.7 93.3 28.0 18.7 65.1 8.8 71.3 13.6 7.6 98.5 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327724-233385148 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 20.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 10.0;Collecting duct cells: 14.7;Ductal cells: 11.9;Exocrine glandular cells: 9.8;Glandular and luminal cells: 11.7;Proximal tubular cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.5" "Cell line enhanced" "Detected in many" "HEK 293: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.5 3.9 1.3 1.3 1.9 2.1 2.5 5.5 2.6 1.0 0.8 6.4 11.8 1.2 3.3 2.5 4.6 1.7 0.4 1.6 1.3 11.5 5.4 4.5 0.9 1.6 0.9 1.8 0.7 20.5 4.4 2.1 0.3 2.2 1.3 7.0 1.0 3.8 2.7 0.0 3.3 10.2 0.6 0.2 0.5 12.5 9.5 1.6 0.5 2.4 0.0 1.3 1.2 1.8 2.1 11.6 19.4 0.4 0.0 0.0 0.0 9.6 0.3 0.0 0.4 0.8 10.8 9.8 1.1 7.7 0.2 3.6 6.0 14.4 5.9 1.2 21.6 27.4 0.1 11.4 0.0 0.7 19.0 4.3 0.2 7.8 0.3 10.9 2.2 0.7 8.7 0.2 3.7 0.0 2.6 6.1 6.8 13.6 13.4 8.4 0.0 0.0 20.7 13.1 4.8 13.9 3.7 6.6 0.3 0.0 1.5 5.6 6.0 0.0 0.0 1.8 0.1 11.5 3.4 4.6 0.0 1.8 5.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.3 1.9 5.5 2.6 1.6 1.3 1.6 0.9 1.8 2.2 0.2 1.6 2.1 0.9 35.3 10.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 6.5 0.0 0.0 0.6 14.7 0.0 0.0 0.4 0.0 3.9 11.9 0.0 5.7 1.0 0.3 0.0 0.0 0.0 9.8 0.0 0.5 0.0 11.7 0.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.7 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 53.1;brain: 63.7;testis: 90.5" "Group enriched" "Detected in many" 10 "Early spermatids: 1490.6;Late spermatids: 4804.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 120.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Supported Centrosome,Cytosol NA No 21000 Centrosome Cytosol "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 7.9 5.1 6.8 8.6 19.4 53.1 5.9 24.6 15.3 5.8 0.0 4.5 3.2 7.3 3.6 4.9 5.2 8.2 7.6 8.6 17.5 2.7 6.4 8.6 6.5 27.0 18.1 7.0 9.0 2.1 2.2 4.4 8.3 27.0 4.1 3.1 11.0 3.8 4.1 10.3 3.6 4.4 6.3 31.4 6.8 3.4 90.5 21.2 10.9 12.5 5.9 6.3 6.6 4.5 63.7 17.9 21.7 28.6 23.2 17.8 30.3 9.4 58.3 19.3 23.3 18.6 13.6 14.4 17.0 33.8 33.8 8.5 8.2 23.1 17.6 23.7 36.8 24.9 18.5 21.5 5.8 12.1 28.7 26.4 25.8 4.8 81.3 36.0 51.2 54.3 8.4 43.3 12.4 21.6 4.0 14.8 13.1 47.2 2.7 53.6 31.7 33.6 5.3 5.2 3.1 47.7 79.1 28.0 1.5 19.4 19.0 6.1 26.8 109.7 50.7 21.8 33.9 51.4 16.9 22.4 29.9 31.3 22.3 120.1 4.3 8.7 8.1 1.8 10.6 2.8 3.4 3.7 1.6 9.2 9.4 4.6 2.7 12.8 3.3 11.9 5.9 3.1 2.5 6.8 19.4 24.6 15.3 8.6 17.5 27.0 18.1 7.0 27.0 31.4 21.2 63.7 33.4 19.2 19.8 90.4 46.4 15.2 4.8 11.2 26.2 40.2 8.7 12.1 22.2 8.6 9.6 12.9 6.2 3.8 10.9 0.7 0.0 19.5 1490.6 25.3 40.1 43.4 10.8 16.4 115.9 6.9 7.5 37.3 5.6 12.8 23.4 31.3 22.5 7.3 35.9 45.4 124.6 2.4 4.1 38.9 85.0 4804.7 44.1 70.9 23.2 141.5 36.9 11.9 4.1 147.2 299.7 27.4 1.2 35.3 22.3 2.5 1.0 2.8 24.0 19.3 26.3 41.2 34.4 73.5 29.4 16.9 11.5 1.9 13.6 29.1 1.6 3.1 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1061.1;Late spermatids: 2128.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol NA NA 2000000 Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 39.8 104.9 48.5 45.9 52.4 92.7 65.4 48.1 53.1 43.8 63.9 62.0 64.6 47.0 69.9 43.7 58.4 45.8 57.8 52.6 52.3 78.8 107.3 47.2 66.8 49.1 48.8 49.5 59.8 94.9 74.5 59.7 62.2 48.7 52.5 65.3 73.3 71.7 44.6 77.3 41.7 61.2 41.8 48.7 45.1 67.6 46.5 50.4 66.8 64.3 75.6 62.4 48.0 36.7 54.2 78.3 112.5 177.4 97.4 76.1 77.1 142.2 92.6 97.7 91.9 80.8 151.7 78.5 48.8 70.7 85.1 114.6 76.5 169.4 97.0 82.3 118.7 157.9 142.3 99.0 348.5 105.7 162.5 80.4 78.7 90.5 81.9 102.3 95.5 105.8 176.9 145.1 95.1 110.9 103.1 178.5 161.3 214.1 204.7 111.7 118.2 176.1 114.5 144.2 110.5 191.6 191.3 56.0 137.6 196.3 115.0 82.1 89.8 88.9 101.3 65.2 84.0 142.6 123.8 261.2 150.4 120.0 138.9 123.7 65.4 61.6 57.2 88.8 75.2 118.1 106.6 100.4 103.2 57.3 97.2 118.1 115.2 10.9 121.5 80.2 65.3 117.6 115.0 48.5 52.4 48.1 53.1 52.6 52.3 49.1 48.8 49.5 48.7 48.7 50.4 54.2 62.5 44.8 96.7 9.1 102.6 79.2 105.3 173.4 51.8 53.1 118.8 130.0 84.9 131.5 119.6 68.0 8.4 207.1 101.3 81.9 270.1 226.7 1061.1 113.1 56.2 70.6 82.5 291.5 20.4 169.0 279.7 74.2 54.6 85.5 70.3 95.9 56.0 115.8 141.1 28.6 21.0 125.1 126.1 72.0 66.3 2128.2 94.4 74.6 81.8 16.9 117.8 92.2 152.4 19.6 26.0 174.4 109.2 92.2 106.4 187.0 174.2 306.6 128.1 56.9 92.1 42.5 87.0 122.6 137.4 87.4 91.2 187.7 86.0 124.4 143.9 148.3 SNAP47 "C1orf142, SNAP-47, SVAP1" ENSG00000143740 "Synaptosome associated protein 47" Q5SQN1 1 227728200-227781826 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028167 Supported Approved Cytosol NA NA Cytosol "HPA028167: AB_10603032" "unprognostic (3.31e-2)" "unprognostic (1.31e-1)" "unprognostic (1.93e-2)" "unprognostic (7.31e-2)" "unprognostic (4.88e-2)" "unprognostic (2.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-2)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (6.14e-2)" "unprognostic (4.81e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-1)" 13.4 44.2 18.7 10.1 22.0 10.2 17.1 18.8 24.0 22.2 12.4 17.9 10.2 29.1 15.5 14.1 26.1 12.5 38.9 22.6 19.0 19.5 27.2 11.9 18.2 14.8 16.0 22.5 47.6 16.6 23.7 27.6 20.2 17.0 17.4 9.0 13.1 18.4 12.2 36.6 16.7 15.4 18.7 14.5 14.7 17.2 38.9 17.2 17.2 17.2 23.6 14.2 20.0 14.8 20.8 33.5 44.2 27.2 27.7 30.3 25.1 35.0 21.2 33.7 35.5 26.5 29.4 29.8 23.8 37.9 33.2 27.3 36.2 33.6 37.9 27.6 48.1 63.4 19.8 28.0 18.9 21.6 30.8 17.8 28.0 32.2 43.3 24.7 28.3 29.4 28.7 37.6 23.7 32.1 22.0 31.5 29.0 44.3 42.5 65.1 32.8 32.3 37.7 20.4 28.1 50.5 32.1 33.6 44.0 33.5 26.4 55.1 27.8 21.3 30.9 38.4 30.7 52.5 30.2 23.2 28.9 28.0 23.0 40.8 19.1 21.0 34.0 29.4 21.2 28.3 22.6 33.1 34.2 23.3 21.3 27.1 25.4 7.4 30.5 27.7 24.0 46.4 25.4 18.7 22.0 18.8 24.0 22.6 19.0 14.8 16.0 22.5 17.0 14.5 17.2 20.8 10.1 6.4 13.1 9.4 16.1 13.4 15.9 16.2 16.5 30.8 16.5 14.7 13.0 22.8 13.2 14.7 27.1 24.3 18.7 8.7 35.2 19.9 49.4 7.2 14.3 11.7 16.2 13.5 12.0 18.2 28.4 15.1 10.7 6.9 5.7 21.0 11.0 13.8 16.3 42.1 9.6 8.6 22.4 8.8 6.2 95.9 25.7 7.6 12.4 8.4 22.3 30.5 45.3 6.6 6.1 17.0 3.3 20.7 22.7 16.5 12.4 15.8 8.9 33.5 13.1 12.0 14.0 41.9 26.4 8.5 15.3 27.5 19.4 23.3 10.5 10.1 SRP9 ENSG00000143742 "Signal recognition particle 9" P49458 1 225777813-225790468 "Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 22000 "unprognostic (1.45e-2)" "unprognostic (2.28e-1)" "unprognostic (5.84e-2)" "unprognostic (9.00e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-2)" "unprognostic (3.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.78e-2)" "unprognostic (1.57e-3)" "unprognostic (1.30e-1)" "unprognostic (1.83e-1)" "unprognostic (5.06e-2)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" 154.4 256.7 219.5 141.3 218.8 184.2 231.0 229.5 281.8 164.1 220.5 209.3 167.0 153.2 217.2 149.8 164.5 162.7 199.8 209.3 254.6 269.0 353.4 137.8 195.7 224.4 225.9 202.1 156.9 136.7 219.8 113.9 117.3 226.1 191.3 204.5 166.5 157.5 140.8 257.7 130.1 165.5 150.2 233.5 136.3 150.1 114.4 224.3 272.9 194.7 267.7 199.2 168.5 93.9 242.4 453.4 259.9 712.4 371.3 288.7 352.2 274.8 310.0 335.2 336.3 390.3 291.0 323.9 450.0 410.8 376.9 319.4 284.5 450.8 375.1 489.7 375.6 613.9 363.8 347.7 398.5 245.5 667.8 302.7 260.9 341.2 308.3 382.0 360.3 534.8 450.5 657.0 299.2 562.2 199.7 629.2 484.1 227.9 816.3 436.9 496.5 664.4 523.7 540.7 424.8 624.2 532.6 356.7 407.9 461.6 363.4 471.1 619.7 342.4 299.8 263.1 404.4 589.9 174.0 537.1 420.0 347.5 450.9 597.1 343.8 316.8 376.9 270.1 350.2 343.7 340.9 333.0 312.7 354.4 296.4 395.5 340.2 177.3 371.2 305.2 256.8 457.0 635.4 219.5 218.8 229.5 281.8 209.3 254.6 224.4 225.9 202.1 226.1 233.5 224.3 242.4 217.7 105.8 96.0 30.7 162.9 262.8 185.6 410.5 126.3 67.5 234.4 181.0 157.6 205.9 224.8 174.7 31.3 221.7 145.4 151.0 598.7 256.4 39.1 228.8 121.3 174.3 239.9 223.2 21.3 186.2 259.0 171.4 135.1 158.9 84.3 204.3 127.5 201.2 207.5 63.9 29.3 244.8 518.8 129.4 213.9 34.9 187.4 128.0 316.6 15.9 177.2 556.2 201.8 25.6 40.4 179.2 172.0 212.5 154.7 249.8 152.7 537.3 236.7 101.1 131.5 114.1 208.0 302.6 123.1 190.2 290.2 199.1 167.8 322.8 248.0 264.2 NVL NVL2 ENSG00000143748 "Nuclear VCP like" O15381 1 224227334-224330189 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028207, HPA028219, HPA028224, HPA028654" Supported Enhanced Nucleoli NA NA Nucleoli "HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714" "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (5.77e-5)" "prognostic favorable (2.95e-4)" "unprognostic (4.43e-2)" "unprognostic (7.14e-2)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (4.10e-11)" "unprognostic (1.67e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" 6.9 7.8 5.6 8.8 5.9 9.8 10.8 7.8 7.6 9.2 6.1 9.2 6.4 9.1 7.8 7.2 8.9 5.7 5.8 5.4 5.5 6.8 6.1 8.1 12.7 5.4 5.9 5.0 10.7 8.9 9.6 10.3 13.1 6.2 9.1 10.7 12.9 7.5 7.9 6.6 15.9 8.2 8.1 4.6 10.5 7.2 6.7 5.6 13.1 10.2 5.2 12.2 8.9 9.0 7.6 28.8 15.8 31.2 25.2 11.5 16.6 31.6 22.0 16.5 30.6 27.0 23.4 23.4 39.6 22.5 14.7 11.7 26.1 37.3 22.2 31.5 30.5 47.0 16.4 25.5 11.3 20.3 39.1 28.8 13.5 16.9 26.8 28.5 14.3 19.2 23.0 48.9 23.8 19.1 21.3 30.6 18.3 47.5 20.0 26.1 34.2 37.3 24.8 17.8 19.2 27.5 22.9 34.2 53.1 31.9 25.6 24.3 32.1 19.8 23.2 14.9 27.1 42.9 15.6 33.3 39.3 15.1 30.2 24.8 13.9 7.8 8.4 11.5 11.8 11.7 13.5 11.8 9.1 8.7 9.0 9.9 10.0 0.8 11.9 16.4 9.0 9.3 7.8 5.6 5.9 7.8 7.6 5.4 5.5 5.4 5.9 5.0 6.2 4.6 5.6 7.6 10.2 22.4 23.1 21.2 14.3 5.2 4.6 7.8 4.0 14.5 7.9 8.3 10.5 7.2 12.2 1.8 10.4 21.5 12.6 26.9 13.7 9.5 10.1 10.0 11.6 9.3 4.2 7.2 32.1 8.4 14.0 9.3 5.6 7.3 16.4 13.4 4.6 4.5 10.7 10.1 31.0 12.6 10.2 6.5 5.7 3.1 9.6 8.1 5.4 26.2 8.7 9.7 15.5 24.6 43.0 7.0 23.4 10.9 12.3 3.7 7.0 8.1 16.7 20.4 0.0 8.5 10.1 17.5 11.3 7.3 4.5 18.3 12.9 11.4 14.7 3.7 SDE2 "C1orf55, FLJ35382" ENSG00000143751 "SDE2 telomere maintenance homolog" Q6IQ49 1 225982702-225999343 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028467, HPA031255, HPA031256" Approved Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Golgi apparatus, Plasma membrane, Cytosol" "HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568" "unprognostic (9.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (9.59e-2)" "unprognostic (2.68e-1)" "unprognostic (3.63e-2)" "unprognostic (1.84e-2)" "unprognostic (3.34e-2)" "unprognostic (9.01e-2)" "unprognostic (1.41e-3)" "unprognostic (3.90e-2)" "unprognostic (3.51e-1)" "unprognostic (3.98e-2)" "unprognostic (3.84e-2)" 15.9 8.6 5.9 11.4 7.3 33.2 11.9 6.9 6.7 9.0 5.8 8.4 9.0 11.9 7.9 9.7 7.5 10.6 7.7 5.4 7.4 9.3 14.7 9.3 12.5 7.2 7.3 4.9 10.3 9.7 11.2 4.4 11.9 7.0 9.9 9.1 5.1 6.7 7.3 12.8 10.8 9.1 9.9 7.4 10.5 7.8 8.4 6.7 23.1 12.6 9.7 10.7 11.8 7.8 9.0 13.1 9.3 14.9 15.9 10.2 11.3 18.5 13.7 12.9 18.4 14.0 13.7 14.7 19.2 20.9 11.6 7.2 16.5 18.9 11.9 22.2 14.7 15.3 21.1 7.9 12.7 18.6 21.0 24.6 12.5 16.9 19.6 24.6 10.3 12.8 22.6 39.3 22.6 13.7 3.8 29.5 16.6 20.8 20.2 9.8 24.4 19.1 24.9 11.1 9.2 13.3 22.0 15.6 16.9 26.3 11.9 16.6 25.4 12.7 15.6 11.0 20.3 30.4 13.4 10.3 23.4 16.1 12.9 31.5 21.8 6.3 5.9 8.0 6.4 10.8 8.0 8.1 7.8 7.1 7.0 8.1 7.7 18.5 13.5 7.9 8.1 6.7 6.9 5.9 7.3 6.9 6.7 5.4 7.4 7.2 7.3 4.9 7.0 7.4 6.7 9.0 36.0 28.9 22.6 4.2 39.9 43.6 17.2 11.2 29.0 6.2 19.8 13.6 9.4 2.8 20.1 9.2 0.0 9.6 29.3 14.3 15.6 6.5 72.8 24.8 15.1 24.8 17.4 56.2 4.7 7.1 10.2 17.8 13.3 35.9 35.5 9.7 12.8 20.6 11.1 15.2 5.0 10.8 16.2 16.4 28.8 20.4 9.9 27.0 19.6 1.9 7.4 12.6 10.3 4.5 8.6 9.7 9.4 6.4 26.6 14.2 9.5 12.7 12.7 8.9 6.6 28.8 23.9 23.9 14.4 26.5 59.1 14.2 23.2 21.0 9.9 18.2 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skin 1: 539.9" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 246.0;Cytotrophoblasts: 281.8;Suprabasal keratinocytes: 320.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria NA NA Mitochondria "HPA076422: AB_2686799" "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (2.53e-4)" 60.8 31.3 34.1 45.3 36.3 70.2 62.5 38.3 36.3 43.3 43.1 40.2 47.4 44.9 29.7 49.1 34.7 40.9 42.4 34.9 41.7 38.5 36.0 49.5 48.4 40.2 38.1 33.7 27.4 22.7 31.8 35.1 129.8 39.4 83.9 27.5 21.0 39.0 59.2 21.1 539.9 33.7 71.5 41.1 39.0 38.9 22.9 38.1 34.5 52.8 23.6 51.3 48.9 73.4 47.3 72.8 50.7 65.2 49.5 275.7 181.1 51.2 201.1 223.8 137.5 164.2 47.1 55.2 58.0 252.4 181.0 82.4 76.3 76.5 67.9 153.0 84.2 141.5 41.7 51.1 29.2 167.9 84.2 86.1 177.4 153.6 125.5 69.9 143.0 140.4 31.4 62.8 61.8 181.2 27.5 43.2 46.9 83.3 40.0 76.1 38.8 92.4 37.5 181.1 19.8 42.3 69.8 106.6 169.4 110.4 118.8 57.1 123.4 125.7 133.4 41.4 153.1 197.5 44.5 55.3 52.8 141.9 41.7 154.2 104.6 61.4 120.3 30.9 67.8 59.8 58.2 52.7 43.3 104.4 74.3 40.7 37.0 67.7 43.9 48.7 34.9 59.0 52.8 34.1 36.3 38.3 36.3 34.9 41.7 40.2 38.1 33.7 39.4 41.1 38.1 47.3 71.7 83.3 29.3 13.4 69.9 246.0 44.0 33.6 89.4 31.2 40.7 38.4 20.8 10.0 19.8 11.0 14.6 281.8 40.5 4.0 13.7 34.9 27.9 54.0 90.2 66.7 14.9 18.7 17.4 43.3 48.3 77.7 21.4 146.1 106.5 21.3 55.6 20.8 93.0 18.5 20.4 6.2 34.6 57.8 90.5 13.6 63.0 72.8 69.4 20.6 57.1 26.0 10.3 25.6 32.1 29.5 5.9 79.4 50.1 44.2 20.1 29.7 20.1 18.4 105.2 42.7 89.1 84.3 44.0 50.4 320.4 198.9 58.9 43.7 6.6 13.7 FBXO28 "CENP-30, Fbx28, FLJ10766, KIAA0483" ENSG00000143756 "F-box protein 28" Q9NVF7 1 224114111-224162047 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003289 Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA003289: AB_2666879" "unprognostic (4.91e-2)" "unprognostic (5.57e-2)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.12e-1)" "unprognostic (8.25e-2)" "unprognostic (2.03e-1)" "unprognostic (7.09e-2)" "unprognostic (5.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-2)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (2.61e-1)" 11.0 7.6 7.6 8.4 8.2 9.0 12.4 9.8 10.4 11.0 7.9 10.4 8.6 10.1 8.0 12.5 8.2 9.5 8.2 8.2 9.8 13.7 17.5 9.0 10.6 9.1 8.4 7.8 11.4 7.7 13.8 4.4 9.1 9.5 10.1 10.7 8.4 8.0 8.6 12.6 21.3 7.8 9.9 8.6 9.0 8.6 7.9 8.8 11.0 9.9 14.3 10.7 11.6 9.1 10.8 24.6 10.6 16.2 17.4 16.6 19.0 26.7 24.3 19.7 16.0 15.2 14.9 18.7 11.8 24.4 22.3 10.3 20.9 24.2 23.4 27.4 17.0 27.0 15.0 12.8 10.7 20.7 28.3 18.8 18.6 27.7 23.2 41.9 18.8 27.1 15.0 24.8 16.4 29.1 8.1 14.9 14.4 38.6 32.3 22.8 15.7 23.1 22.3 30.2 16.1 26.2 28.1 25.1 38.0 27.4 16.9 20.2 28.2 31.2 19.8 15.0 25.0 46.1 17.8 22.3 18.0 24.5 13.7 39.3 7.4 6.5 11.8 5.8 6.0 7.2 8.9 5.9 6.8 7.8 9.0 5.9 6.6 4.2 8.6 6.9 3.5 8.8 4.6 7.6 8.2 9.8 10.4 8.2 9.8 9.1 8.4 7.8 9.5 8.6 8.8 10.8 15.0 6.4 10.6 22.5 16.8 34.3 25.5 11.3 9.6 20.5 14.7 11.7 11.4 7.2 13.5 11.0 22.9 14.2 12.3 17.2 9.8 13.2 30.3 15.9 13.0 16.4 18.5 17.4 48.8 11.5 13.1 12.7 7.1 22.9 14.0 12.6 14.3 23.4 13.9 18.5 43.8 12.7 14.2 17.7 16.3 14.8 13.1 16.8 28.4 34.7 16.4 12.6 7.2 45.8 43.7 17.7 12.2 13.2 15.4 21.5 12.0 22.8 11.5 18.6 13.1 14.9 12.7 24.7 26.8 17.2 39.1 23.0 18.9 10.9 14.6 30.7 ARF1 ENSG00000143761 "ADP ribosylation factor 1" P84077 1 228082660-228099212 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007742 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB007742: AB_562043" "unprognostic (9.54e-2)" "unprognostic (1.35e-2)" "unprognostic (2.30e-2)" "unprognostic (2.50e-3)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.73e-1)" "unprognostic (8.95e-3)" "unprognostic (6.74e-2)" "unprognostic (2.96e-2)" "unprognostic (5.85e-2)" "unprognostic (2.69e-2)" "unprognostic (1.56e-1)" "unprognostic (8.57e-2)" "unprognostic (1.94e-1)" 257.7 284.8 201.4 178.3 213.0 430.7 244.0 178.4 263.9 249.1 205.8 248.1 244.8 268.8 194.8 307.1 249.7 190.8 343.1 228.3 208.7 257.8 327.4 300.8 186.5 189.6 195.3 213.3 239.3 330.4 299.4 301.5 279.2 193.7 246.0 179.0 97.6 358.3 205.8 333.6 236.3 242.8 177.7 185.4 253.4 267.8 195.4 200.8 186.1 242.3 208.3 156.0 230.9 235.1 210.1 476.6 321.6 257.4 257.9 289.9 362.6 425.7 409.5 433.0 444.3 386.8 383.6 442.7 239.9 428.8 438.3 204.6 298.8 316.4 399.4 219.4 355.3 506.8 234.3 209.8 386.6 559.5 342.1 333.8 350.4 476.7 408.6 427.0 374.1 443.3 267.0 456.0 533.3 431.4 341.8 350.0 495.9 331.7 656.7 643.0 279.0 228.1 750.6 315.1 242.1 362.6 320.0 265.9 790.0 466.8 87.8 543.9 681.0 406.0 324.6 256.5 479.4 626.8 498.5 301.0 331.1 445.9 285.0 670.6 1003.7 556.5 625.5 387.3 527.8 472.4 276.7 328.0 359.8 423.6 261.3 253.2 280.8 863.6 345.5 528.2 571.4 417.9 1082.4 201.4 213.0 178.4 263.9 228.3 208.7 189.6 195.3 213.3 193.7 185.4 200.8 210.1 276.9 173.1 185.2 25.8 205.1 262.6 281.7 248.0 104.2 114.3 209.1 172.0 139.8 125.8 208.1 115.8 45.9 373.7 267.8 487.8 230.9 422.7 236.3 164.6 218.7 247.2 230.1 173.8 42.3 404.5 565.8 227.3 142.8 240.8 198.3 128.8 152.4 124.8 409.4 158.2 41.1 436.9 213.6 198.8 256.2 429.9 229.2 300.1 300.6 35.6 356.0 162.2 214.2 30.7 40.7 400.2 407.2 227.2 282.8 344.6 370.1 173.3 180.7 80.2 230.1 149.6 416.0 321.1 155.7 158.3 286.0 676.7 224.9 174.6 335.2 370.0 LEFTY2 "EBAF, LEFTA, LEFTYA, TGFB4" ENSG00000143768 "Left-right determination factor 2" O00292 1 225936598-225941383 "Disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 44.3;endometrium 1: 171.6" "Cell type enhanced" "Detected in some" "Early spermatids: 17.4;Endometrial stromal cells: 30.8;Granulosa cells: 43.6;Late spermatids: 34.6;Leydig cells: 18.0;Peritubular cells: 12.0" "Cancer enriched" "Detected in many" 8 "testis cancer: 41.7" "Region enriched" "Detected in single" 12 "hypothalamus: 9.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 10.6;NTERA-2: 44.4;RPMI-8226: 50.9;SuSa: 25.5" "CAB025801, HPA047883, HPA056210" Approved "Secreted in other tissues" NA NA "CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067" "unprognostic (3.78e-2)" "unprognostic (4.10e-3)" "unprognostic (5.79e-3)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-1)" "unprognostic (4.87e-2)" "unprognostic (9.75e-4)" "unprognostic (2.91e-1)" "unprognostic (3.84e-1)" "unprognostic (7.98e-2)" "unprognostic (9.14e-3)" "unprognostic (1.15e-1)" "unprognostic (4.69e-2)" "unprognostic (1.90e-4)" "unprognostic (1.64e-3)" 1.8 1.4 0.2 1.2 0.3 0.0 0.7 0.2 0.4 44.3 13.1 1.1 0.3 171.6 12.2 0.1 3.6 0.4 2.6 0.7 9.0 0.4 0.0 2.5 0.2 0.2 0.4 0.2 38.1 0.3 0.0 16.2 3.5 0.2 1.5 0.2 0.9 0.1 12.5 0.7 0.2 0.4 37.3 0.2 0.7 0.3 4.5 0.7 0.2 0.1 0.8 0.0 0.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 44.4 0.0 0.0 0.0 0.0 50.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 2.6 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.7 9.0 0.2 0.4 0.2 0.2 0.2 0.7 0.4 0.6 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.4 17.4 2.2 30.8 0.6 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.7 0.0 43.6 0.4 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.2 34.6 18.0 0.3 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 12.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.3 1.7 6.7 0.4 0.0 0.0 0.0 0.2 0.7 0.0 0.1 CNIH4 HSPC163 ENSG00000143771 "Cornichon family AMPA receptor auxiliary protein 4" Q9P003 1 224356858-224379459 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 320.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044268 Approved NA NA "HPA044268: AB_10965330" "unprognostic (2.01e-1)" "unprognostic (1.34e-3)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.40e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (4.47e-3)" "unprognostic (1.02e-1)" "unprognostic (1.62e-1)" "unprognostic (5.96e-3)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.51e-1)" "prognostic unfavorable (4.27e-6)" "unprognostic (3.15e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-3)" "unprognostic (1.63e-2)" 21.2 19.6 15.3 12.3 16.1 27.2 19.9 15.7 17.5 15.5 17.8 19.8 16.7 18.6 12.2 23.7 16.1 12.2 17.4 15.3 16.8 19.5 18.4 21.6 9.4 16.3 15.9 15.2 15.7 11.9 19.0 10.6 18.7 16.7 13.3 15.7 14.9 14.5 15.7 25.3 19.5 18.0 19.4 15.9 15.2 16.6 10.1 15.8 9.8 12.4 19.3 11.4 21.0 18.4 16.4 81.1 110.4 51.6 46.3 91.6 59.5 42.5 54.4 50.7 55.8 51.1 110.7 93.7 24.0 86.5 54.9 60.5 94.6 95.4 59.9 58.6 29.8 101.1 20.6 70.7 59.0 79.6 40.9 38.9 61.7 80.8 69.7 91.0 55.9 74.8 42.3 49.3 31.1 66.8 62.8 17.6 37.0 68.2 106.3 63.0 19.1 94.8 26.4 92.4 89.9 13.1 43.9 82.4 90.1 69.3 64.6 69.4 96.2 71.9 51.5 44.6 64.2 112.6 13.4 18.7 23.9 63.5 55.3 56.1 54.5 60.0 72.7 36.7 106.6 35.4 25.8 47.8 42.2 52.3 23.9 38.1 41.8 48.4 31.6 153.7 17.5 36.0 58.1 15.3 16.1 15.7 17.5 15.3 16.8 16.3 15.9 15.2 16.7 15.9 15.8 16.4 68.4 125.0 84.9 9.8 27.3 66.5 137.0 320.0 42.7 20.4 49.5 74.0 117.8 61.5 160.2 53.3 29.2 145.9 29.7 138.7 29.4 140.3 16.2 61.3 62.6 76.2 15.6 56.2 15.4 125.2 180.6 90.9 27.5 60.8 32.3 54.0 58.5 70.1 107.6 20.2 14.2 38.5 120.1 124.4 60.0 10.9 65.9 86.5 58.7 12.2 72.9 52.9 45.3 13.6 16.9 132.9 116.7 65.1 28.1 148.7 136.2 101.5 127.7 34.3 85.5 45.5 196.5 145.6 63.4 73.0 86.9 161.2 50.4 45.7 72.7 149.0 ITPKB "IP3-3KB, IP3KB" ENSG00000143772 "Inositol-trisphosphate 3-kinase B" P27987 1 226631690-226739323 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 204.7;choroid plexus: 109.7" "Cell type enhanced" "Detected in many" "Adipocytes: 70.5;Astrocytes: 225.3;Microglial cells: 58.1;Oligodendrocytes: 110.6" "Cancer enhanced" "Detected in all" "melanoma: 44.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030273, HPA072923" Enhanced Approved Nucleoplasm NA NA 39000 Nucleoplasm "HPA030273: AB_10601127, HPA072923: AB_2686558" "unprognostic (4.54e-2)" "unprognostic (3.85e-2)" "unprognostic (8.41e-3)" "unprognostic (9.37e-3)" "unprognostic (1.53e-1)" "prognostic favorable (1.72e-5)" "unprognostic (1.24e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.29e-1)" "unprognostic (9.57e-2)" "unprognostic (1.41e-2)" "unprognostic (1.75e-2)" "unprognostic (3.23e-3)" "unprognostic (2.90e-2)" "unprognostic (7.46e-2)" "unprognostic (6.54e-3)" "unprognostic (7.87e-2)" 29.9 4.5 136.7 15.8 179.1 19.2 19.8 153.0 104.3 28.1 109.7 34.4 6.7 49.2 17.1 14.1 27.2 10.1 11.8 106.3 136.5 13.6 3.2 22.7 29.2 204.7 179.1 83.6 9.6 5.8 7.1 6.8 16.0 164.5 14.7 6.7 0.6 30.4 23.0 12.6 18.9 25.1 32.0 151.2 23.7 21.4 3.7 190.3 33.5 8.3 12.4 20.5 38.9 15.7 136.0 4.7 5.0 7.9 9.1 6.1 3.9 2.1 1.2 5.5 2.5 5.7 0.7 5.8 21.6 7.4 1.2 0.5 6.8 10.1 4.1 1.2 3.0 6.9 9.6 5.5 0.0 2.3 8.8 16.4 4.4 5.9 2.8 2.5 6.9 17.2 10.8 0.1 2.9 0.3 4.5 16.7 12.1 17.3 3.5 8.0 6.4 14.2 4.8 18.2 7.5 4.6 6.0 3.8 2.8 47.2 7.7 11.7 10.1 12.0 3.2 2.4 2.9 7.6 0.2 8.0 25.8 0.8 8.0 12.1 0.9 0.9 5.4 2.6 1.3 2.3 1.2 3.2 2.7 0.6 1.8 4.7 3.5 3.4 2.1 2.5 0.5 1.9 2.0 136.7 179.1 153.0 104.3 106.3 136.5 204.7 179.1 83.6 164.5 151.2 190.3 136.0 70.5 0.0 7.4 225.3 16.0 12.2 4.8 3.1 7.4 0.3 7.0 5.3 8.5 1.5 4.5 7.3 0.0 0.6 28.9 1.2 3.9 2.2 2.8 4.7 6.8 42.2 4.2 5.2 2.4 2.4 2.3 8.9 3.6 4.5 10.1 21.8 27.8 1.0 19.8 0.0 6.9 2.8 2.0 16.0 38.0 22.9 7.2 14.4 19.6 58.1 10.2 1.2 28.8 10.6 110.6 2.7 3.7 9.4 11.8 5.1 2.0 0.6 2.6 0.1 0.0 5.9 16.3 0.9 4.7 5.3 10.1 0.4 35.2 3.7 3.1 2.7 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587, HPA068324" Approved Uncertain Nucleoplasm,Cytosol NA NA 240000 Nucleoplasm Cytosol "HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: " "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 228.3 200.5 250.0 94.8 236.3 254.0 215.1 215.6 468.8 170.3 230.5 183.6 114.8 170.6 49.0 336.5 163.2 117.4 232.3 263.3 223.7 229.9 320.7 224.8 125.5 223.9 222.7 243.1 148.2 210.6 72.6 167.0 79.5 225.2 162.7 31.8 111.7 192.6 72.3 150.3 284.9 156.3 54.1 231.1 180.9 203.7 108.2 232.9 97.9 152.6 62.4 39.5 190.2 204.1 248.0 356.1 122.4 53.0 164.5 155.6 186.6 264.3 230.8 116.5 130.8 102.8 70.6 239.1 133.4 266.5 151.4 110.0 230.3 45.7 252.0 14.0 203.7 357.1 79.3 292.9 156.3 282.8 90.5 133.0 260.0 150.6 91.9 73.3 94.2 179.2 279.9 219.5 205.1 109.5 295.2 411.4 194.3 166.8 172.6 522.9 155.3 99.9 354.9 125.2 164.1 173.7 311.3 148.7 250.2 309.7 13.5 185.2 191.7 318.5 237.7 157.4 353.4 387.5 186.8 221.9 151.6 300.3 146.2 246.0 379.0 323.8 663.9 420.6 363.0 406.5 265.0 346.8 454.1 279.7 230.8 256.5 323.4 420.1 339.5 390.9 567.3 394.6 571.4 250.0 236.3 215.6 468.8 263.3 223.7 223.9 222.7 243.1 225.2 231.1 232.9 248.0 503.7 60.9 87.2 35.3 199.9 660.0 271.5 643.5 215.7 195.5 425.9 448.7 130.8 195.9 312.2 237.3 717.2 241.6 351.2 655.8 694.6 510.9 134.0 212.5 272.0 451.4 269.6 866.9 50.2 685.5 417.9 276.9 189.1 304.2 182.6 162.5 365.5 353.4 407.5 109.4 33.5 426.5 384.5 291.7 557.0 609.3 233.6 265.6 519.4 22.5 355.5 411.0 398.6 16.1 58.6 975.0 718.8 243.8 365.6 571.5 857.7 801.1 231.6 570.9 249.8 158.2 378.6 89.8 100.3 448.6 719.7 262.4 326.7 226.3 331.5 612.2 CDC42BPA "FLJ23347, KIAA0451, MRCK, MRCKA, PK428" ENSG00000143776 "CDC42 binding protein kinase alpha" Q5VT25 1 226989865-227318474 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 320.3;Excitatory neurons: 447.6;Inhibitory neurons: 479.0;Oligodendrocyte precursor cells: 444.3;Oligodendrocytes: 671.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB070414, HPA071252" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB070414: AB_11156796, HPA071252: AB_2686374" "unprognostic (3.67e-3)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" "unprognostic (3.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.89e-2)" "unprognostic (2.27e-1)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (4.88e-2)" "unprognostic (2.87e-2)" "unprognostic (7.73e-3)" "unprognostic (1.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.79e-2)" "unprognostic (1.21e-2)" 15.8 12.7 27.5 5.5 32.5 3.6 12.3 34.2 32.1 16.0 14.0 18.7 14.9 15.1 7.8 10.2 12.7 13.8 15.0 26.1 24.3 17.5 14.9 12.4 2.0 28.1 27.9 23.4 14.2 13.2 19.8 14.7 12.8 27.9 15.9 10.4 23.9 7.7 15.1 11.5 6.4 13.0 14.6 21.4 6.6 22.6 24.6 28.8 2.3 8.1 13.7 1.8 23.2 11.4 36.8 22.6 21.1 21.9 10.4 21.5 26.4 7.7 25.4 35.7 17.2 17.9 17.1 50.1 0.1 26.6 42.4 13.0 10.3 16.3 14.2 20.9 0.1 13.2 17.4 25.5 6.7 24.3 14.1 7.5 18.6 17.9 27.8 27.8 21.3 58.0 13.6 45.1 0.1 28.2 6.2 0.4 2.5 18.0 29.3 20.0 0.0 37.0 0.1 27.7 43.1 15.7 22.9 43.0 17.8 24.8 13.4 23.1 0.8 59.0 31.3 16.2 36.1 33.9 0.1 0.1 0.1 41.4 0.0 42.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.5 32.5 34.2 32.1 26.1 24.3 28.1 27.9 23.4 27.9 21.4 28.8 36.8 82.6 41.7 35.7 320.3 0.8 11.7 26.0 15.9 12.0 97.7 14.0 12.8 59.9 30.0 38.9 44.1 118.9 5.9 1.8 49.3 13.7 26.0 128.0 18.7 45.1 68.4 26.4 45.6 447.6 41.1 7.3 44.4 92.8 25.7 7.0 21.5 47.8 28.9 3.7 223.8 479.0 30.5 22.4 4.4 9.9 132.3 44.1 6.4 16.0 180.8 5.9 33.4 0.0 444.3 671.8 65.1 74.0 85.4 1.8 30.1 50.7 41.3 24.8 66.9 78.9 64.0 68.4 45.6 57.7 8.0 8.0 1.4 1.3 23.4 34.4 43.1 CNIH3 "CNIH-3, FLJ38993" ENSG00000143786 "Cornichon family AMPA receptor auxiliary protein 3" Q8TBE1 1 224434660-224740554 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 13.4;pancreas: 8.0" "Cell type enhanced" "Detected in many" "Astrocytes: 65.3;Distal tubular cells: 31.3;Excitatory neurons: 61.1;Inhibitory neurons: 47.5;Late spermatids: 38.0;Oligodendrocyte precursor cells: 68.3" "Group enriched" "Detected in many" 4 "glioma: 6.0;melanoma: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.7;hTEC/SVTERT24-B: 47.0;hTERT-RPE1: 26.4;NTERA-2: 17.3;U-266/70: 25.1;U-87 MG: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (5.18e-2)" "unprognostic (2.88e-1)" "unprognostic (7.18e-2)" "unprognostic (4.96e-2)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (4.63e-2)" "unprognostic (3.15e-1)" "unprognostic (2.30e-1)" "unprognostic (5.23e-5)" "unprognostic (1.03e-1)" "unprognostic (3.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.63e-1)" 0.7 0.3 6.0 0.2 7.8 0.0 0.9 2.3 11.4 0.9 2.3 0.4 0.3 0.7 0.4 0.2 0.9 0.6 0.2 12.0 13.4 0.8 0.3 0.4 0.4 6.4 6.9 7.3 1.9 8.0 0.1 1.0 0.1 4.0 0.5 0.2 1.2 0.6 0.5 0.4 0.4 0.2 0.4 3.3 0.2 1.0 2.2 4.6 0.2 0.5 0.4 0.4 0.8 0.9 6.7 0.5 0.3 0.6 0.6 0.5 0.9 0.2 3.5 18.7 0.5 1.0 0.1 4.3 0.1 1.8 8.2 1.4 0.0 0.0 0.0 3.1 0.1 1.0 0.0 0.0 0.0 0.3 1.7 1.4 0.6 0.0 47.0 0.5 26.4 0.0 0.2 0.0 0.1 2.8 0.1 0.1 6.0 17.3 0.2 2.2 0.1 0.9 0.0 3.0 1.7 0.6 0.4 0.0 0.0 12.1 1.8 0.1 0.4 0.1 0.1 4.2 0.1 0.5 25.1 1.1 0.0 55.3 0.2 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.0 7.8 2.3 11.4 12.0 13.4 6.4 6.9 7.3 4.0 3.3 4.6 6.7 2.7 0.0 2.0 65.3 1.8 2.8 2.1 3.6 2.8 2.8 5.3 7.7 2.4 1.5 2.9 1.8 0.0 2.3 1.0 1.4 31.3 0.9 16.0 3.0 3.3 2.9 1.2 4.0 61.1 3.0 0.6 3.9 0.5 1.9 2.5 6.9 3.3 2.6 6.2 0.0 47.5 2.7 0.0 0.6 2.5 38.0 2.8 1.9 0.0 19.7 1.1 15.1 2.1 68.3 25.3 0.6 0.8 1.2 0.8 1.9 0.4 17.3 28.8 0.7 0.0 5.0 2.5 2.3 8.6 3.2 2.3 5.1 2.5 5.3 1.5 2.7 C1orf35 "MGC4174, MMTAG2" ENSG00000143793 "Chromosome 1 open reading frame 35" Q9BU76 1 228100726-228105411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046175 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA046175: AB_10959459" "unprognostic (1.12e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.71e-4)" "unprognostic (6.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.64e-2)" "unprognostic (5.44e-3)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "prognostic favorable (7.38e-4)" "unprognostic (6.12e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.70e-1)" "unprognostic (8.58e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" 10.4 12.6 18.6 6.3 18.5 14.4 11.8 17.7 24.6 15.2 16.5 12.5 7.9 13.5 5.6 19.0 13.2 4.1 8.5 18.7 17.3 11.2 11.7 8.7 9.1 19.0 17.9 17.5 16.3 13.0 7.4 10.0 7.1 19.1 14.3 3.9 2.7 12.6 8.6 9.7 19.7 10.6 5.0 17.3 10.9 12.4 7.6 18.6 9.3 12.2 3.5 7.3 14.6 14.9 19.2 22.2 24.3 17.0 10.9 8.2 8.3 40.0 16.8 7.4 14.6 10.9 24.1 22.2 22.7 35.6 6.6 10.3 25.4 16.0 16.6 5.3 24.6 76.7 13.9 20.1 23.1 13.3 32.0 16.7 7.6 19.5 14.3 13.1 9.2 16.1 26.1 35.2 13.3 10.7 27.8 42.0 44.4 34.4 28.5 55.6 32.1 24.2 36.4 13.6 18.2 28.1 27.2 16.0 29.4 23.3 4.5 31.0 29.2 15.1 11.8 18.1 32.7 37.2 23.9 12.7 21.6 14.2 18.3 19.2 14.9 29.0 43.3 28.2 35.9 35.2 37.2 31.1 30.7 37.6 29.9 36.1 30.2 4.7 35.9 34.9 49.3 34.7 17.5 18.6 18.5 17.7 24.6 18.7 17.3 19.0 17.9 17.5 19.1 17.3 18.6 19.2 37.7 22.4 22.4 10.4 29.8 66.8 35.5 58.5 47.3 51.4 41.1 50.9 18.1 28.6 31.0 38.6 18.8 76.2 49.8 61.6 45.0 38.0 4.4 28.2 31.7 33.9 26.3 57.4 12.9 39.5 59.3 34.3 25.0 43.7 24.7 36.9 32.2 24.4 40.4 47.1 10.1 58.8 54.9 24.2 72.7 5.5 51.3 29.8 32.0 2.8 32.4 42.5 30.9 9.5 14.3 37.5 43.5 46.6 28.1 37.4 47.8 38.3 25.1 54.5 65.7 31.6 44.7 44.0 50.0 54.1 80.6 28.3 47.2 28.0 56.6 25.8 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003709 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 171.1;Erythroid cells: 162.6;Excitatory neurons: 134.6;Horizontal cells: 141.3;Oligodendrocyte precursor cells: 177.4;Oligodendrocytes: 230.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.7;eosinophil: 1.7;neutrophil: 4.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 41.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles NA NA Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.32e-4)" 2.0 2.1 17.9 2.4 23.1 27.2 9.0 21.4 18.6 6.1 24.2 7.7 2.4 4.6 2.7 16.0 2.9 3.6 4.7 18.9 21.3 7.1 0.8 6.7 1.9 22.4 21.6 16.0 5.8 1.4 29.5 5.5 3.2 22.2 14.6 8.6 15.8 5.7 2.4 1.1 11.7 3.7 3.9 22.1 2.4 6.1 2.2 22.1 2.4 4.6 1.1 4.8 3.9 8.5 30.6 14.0 4.2 12.7 5.4 5.6 12.5 7.3 6.5 2.4 8.5 5.6 1.1 21.9 3.9 7.5 15.9 6.8 10.5 11.4 13.5 12.6 12.3 19.0 16.7 5.9 0.0 6.9 0.0 5.0 9.1 7.8 8.1 5.6 18.5 4.5 5.5 14.4 3.0 7.5 3.6 4.9 0.3 5.0 6.4 15.8 7.4 20.0 0.1 12.6 2.0 7.6 23.0 6.9 41.1 6.6 6.2 7.7 4.8 2.5 14.7 7.7 11.6 19.0 1.1 0.4 4.3 23.3 2.4 5.1 4.7 0.4 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 4.0 0.0 0.1 0.1 0.0 0.2 17.9 23.1 21.4 18.6 18.9 21.3 22.4 21.6 16.0 22.2 22.1 22.1 30.6 7.7 19.2 12.7 171.1 1.7 3.3 4.6 33.1 0.6 20.6 18.1 12.1 12.2 7.2 54.7 40.5 8.4 3.9 1.1 28.2 5.9 5.6 9.7 3.2 19.4 13.4 37.6 162.6 134.6 1.5 1.4 12.7 21.4 2.9 8.2 14.7 4.6 0.2 1.8 141.3 107.8 59.3 32.6 1.9 17.7 12.7 5.3 5.0 14.2 33.7 29.0 98.7 0.0 177.4 230.5 88.1 42.9 7.5 0.3 19.5 1.6 10.4 45.7 8.8 6.6 10.5 15.2 12.1 24.8 24.4 5.1 1.9 2.0 1.9 12.7 66.4 PARP1 "ADPRT, ARTD1, PARP, PPOL" ENSG00000143799 "Poly(ADP-ribose) polymerase 1" P09874 1 226360210-226408154 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "DNA-binding, Glycosyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727" Supported Supported Enhanced Nucleoplasm,Nucleoli NA NA 150000 Nucleoplasm Nucleoli "CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240" "unprognostic (2.02e-1)" "unprognostic (9.40e-2)" "unprognostic (7.44e-3)" "unprognostic (1.32e-1)" "unprognostic (4.29e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (3.40e-4)" "unprognostic (2.20e-1)" "unprognostic (3.62e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.38e-2)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (2.64e-1)" 32.3 26.6 34.2 64.4 40.1 29.7 29.8 46.0 34.1 26.5 21.3 37.9 29.5 30.5 20.0 31.6 29.2 20.6 49.3 31.8 35.0 22.6 37.4 27.6 126.5 48.4 40.7 26.6 27.8 51.2 95.5 38.3 58.7 46.1 41.1 37.6 45.3 29.1 46.8 95.4 21.1 37.1 46.0 45.1 58.2 29.8 40.9 41.4 65.2 28.7 70.9 152.0 39.1 24.8 58.2 182.4 108.9 295.4 209.3 75.9 61.3 137.1 101.3 119.1 178.2 144.9 175.4 98.1 559.3 147.2 80.9 77.9 135.1 411.6 132.4 144.4 204.1 396.6 216.2 135.9 114.5 44.6 372.2 93.3 61.7 50.5 144.2 101.3 49.3 140.5 132.2 346.9 291.8 94.1 99.6 114.7 110.0 476.2 290.5 165.1 334.2 484.5 533.4 76.4 144.5 264.0 229.2 165.2 190.3 100.1 205.3 159.6 225.8 99.3 93.3 140.9 120.6 235.1 110.9 151.8 472.6 78.2 125.7 214.3 11.1 11.7 12.3 31.2 20.5 45.3 72.2 37.3 36.7 28.2 69.9 28.2 32.5 2.2 22.0 42.3 16.2 49.3 25.7 34.2 40.1 46.0 34.1 31.8 35.0 48.4 40.7 26.6 46.1 45.1 41.4 58.2 33.4 54.5 73.6 13.7 169.1 72.3 83.9 56.4 51.2 96.1 58.8 43.3 115.0 44.3 69.8 57.0 141.8 469.2 53.8 27.7 72.4 88.9 34.1 53.3 66.5 62.0 75.0 100.5 16.5 107.0 111.7 49.8 37.8 55.2 122.1 116.2 34.2 69.4 139.6 90.9 17.5 50.0 57.0 47.8 35.7 20.5 40.0 48.3 62.2 16.9 76.9 80.1 95.8 10.1 31.9 48.5 24.2 35.0 186.9 82.8 25.6 48.5 56.4 118.1 46.0 58.7 48.0 88.8 199.6 77.2 48.2 137.6 85.0 103.5 61.9 41.7 PSEN2 "AD3L, AD4, PS2, STM2" ENSG00000143801 "Presenilin 2" P49810 1 226870184-226927726 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ionocytes: 36.7;Syncytiotrophoblasts: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.94e-1)" "unprognostic (3.86e-2)" "unprognostic (6.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.72e-2)" "unprognostic (1.31e-1)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (8.25e-3)" "unprognostic (8.53e-3)" "unprognostic (8.45e-2)" "unprognostic (1.17e-1)" "unprognostic (8.36e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" 11.2 19.9 9.7 7.6 9.7 1.6 10.7 12.4 10.6 9.4 9.9 13.7 10.6 16.0 9.1 10.4 13.5 8.4 13.2 9.4 10.8 13.5 12.7 11.6 8.1 10.1 10.0 9.7 12.9 45.9 18.3 17.2 9.0 10.6 15.0 8.1 7.5 13.2 13.8 26.8 9.4 13.9 10.5 8.0 15.8 11.6 13.6 11.1 3.3 9.5 16.9 5.1 13.6 9.7 9.7 14.1 24.5 7.2 21.9 10.0 3.5 10.2 12.4 26.5 16.9 12.9 13.8 21.5 1.0 17.0 16.8 10.5 7.9 12.1 11.9 6.7 13.6 20.7 8.7 10.5 12.0 15.4 7.5 15.7 9.1 13.9 18.9 10.4 11.2 6.9 0.7 18.1 6.4 10.0 14.7 0.4 8.2 20.5 22.0 16.0 0.4 22.6 26.4 15.9 13.4 11.3 18.3 9.7 30.6 51.6 18.4 26.5 13.1 8.5 11.2 8.9 9.9 15.2 25.6 45.0 0.9 21.5 2.5 15.7 37.4 8.7 18.4 4.5 9.7 5.1 7.4 1.5 4.6 11.4 3.1 0.7 2.0 1.6 20.0 30.2 0.8 2.4 5.2 9.7 9.7 12.4 10.6 9.4 10.8 10.1 10.0 9.7 10.6 8.0 11.1 9.7 11.0 16.0 10.8 2.6 3.9 1.7 4.5 4.0 1.8 6.2 6.6 4.1 12.9 15.7 4.7 5.5 0.0 15.9 1.3 5.9 1.9 13.0 2.5 4.5 3.0 10.0 6.0 6.1 4.2 18.0 4.1 5.9 7.7 5.2 14.5 10.1 19.2 8.4 17.2 16.8 4.5 5.1 36.7 7.2 6.5 1.3 7.2 8.2 33.8 5.6 18.9 21.2 2.1 2.5 1.5 15.2 7.8 13.2 9.9 5.3 13.8 7.2 4.9 5.8 6.6 9.4 10.6 1.5 6.1 3.8 1.8 45.8 2.9 6.6 4.3 4.6 PYCR2 P5CR2 ENSG00000143811 "Pyrroline-5-carboxylate reductase 2" Q96C36 1 225919877-225924340 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA056873 Approved Approved Mitochondria NA NA Mitochondria "HPA056873: AB_2683263" "unprognostic (1.11e-1)" "unprognostic (8.08e-2)" "prognostic unfavorable (5.02e-5)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-3)" "unprognostic (1.56e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (9.07e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.69e-2)" "unprognostic (2.61e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" 36.9 72.3 50.3 36.1 57.3 47.7 36.1 65.8 54.7 43.4 46.5 37.0 22.5 48.9 26.6 32.6 45.1 22.6 59.2 47.2 62.1 39.9 40.7 38.6 47.6 66.3 55.8 44.3 48.3 47.6 42.4 57.5 28.7 61.4 39.9 18.5 34.3 40.0 41.3 67.3 28.3 34.7 25.9 64.3 49.9 39.2 34.6 55.6 44.3 30.2 49.6 34.2 50.8 33.6 69.0 72.6 59.6 35.0 59.1 38.8 40.0 73.2 74.8 46.3 49.7 44.1 77.2 58.3 126.1 156.6 55.0 39.1 81.6 50.5 58.6 28.3 154.6 107.5 120.6 60.2 81.5 59.8 107.9 189.1 38.8 72.3 56.1 64.1 44.1 47.8 103.7 178.4 81.6 50.9 60.5 135.8 120.9 196.0 112.8 80.4 120.2 79.0 263.6 65.2 58.3 44.0 56.7 62.4 48.7 161.0 27.9 62.3 202.0 40.3 38.4 46.5 82.9 104.4 129.9 156.2 127.4 60.7 80.6 109.3 38.4 19.6 39.6 45.5 29.2 47.8 34.4 43.8 42.4 31.3 41.9 74.9 62.4 13.3 67.9 26.3 59.2 44.0 45.1 50.3 57.3 65.8 54.7 47.2 62.1 66.3 55.8 44.3 61.4 64.3 55.6 69.0 28.0 19.2 22.8 11.4 31.6 14.8 64.6 53.4 8.0 15.6 24.3 21.2 47.6 20.0 24.8 35.0 14.6 90.6 39.1 12.9 49.0 50.0 8.2 92.8 25.6 26.7 26.5 58.7 4.6 34.0 46.3 23.7 10.2 31.8 38.7 74.9 21.0 16.6 40.0 13.5 5.8 17.8 57.0 20.4 19.8 8.8 38.2 31.5 33.8 8.4 46.4 46.9 46.4 5.5 29.3 29.1 15.8 37.6 23.1 42.1 18.3 35.8 55.4 42.7 26.3 19.8 24.4 40.1 46.2 9.4 12.8 41.7 34.9 44.9 16.1 40.4 LBR "DHCR14B, TDRD18" ENSG00000143815 "Lamin B receptor" Q14739 1 225401502-225428925 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "DNA-binding, Oxidoreductase, Receptor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 248.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062236 Enhanced Supported "Nuclear membrane" NA Yes "Nuclear membrane" "HPA062236: AB_2684721" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (2.14e-3)" "unprognostic (1.32e-2)" "unprognostic (7.96e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.60e-2)" "unprognostic (1.11e-2)" "unprognostic (3.43e-2)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (6.42e-2)" "unprognostic (2.08e-1)" "unprognostic (5.45e-1)" "unprognostic (8.32e-2)" "unprognostic (2.78e-1)" 28.9 9.1 9.9 53.7 10.5 96.5 17.3 10.5 12.0 26.4 10.7 52.6 41.1 47.5 44.7 29.9 32.1 21.9 9.6 9.7 12.1 19.5 47.7 19.4 82.3 13.2 11.0 8.4 19.5 17.0 5.7 6.5 27.9 12.1 24.0 46.6 5.3 11.2 37.0 9.8 13.9 40.3 41.7 11.9 41.9 28.5 20.7 10.7 106.5 11.9 12.9 71.2 32.5 23.2 14.2 122.2 42.0 154.9 69.3 64.8 39.7 77.3 31.2 39.2 65.0 69.0 87.2 207.2 248.4 66.6 32.8 38.6 88.8 114.2 32.9 98.5 142.2 107.1 61.4 40.4 81.5 39.9 274.7 105.5 34.3 21.3 58.9 52.0 33.1 82.9 117.4 189.6 164.6 44.4 16.3 254.9 156.6 140.6 121.8 14.2 164.9 141.4 234.0 75.6 52.7 40.6 53.4 52.7 39.6 26.6 68.2 53.3 181.0 50.5 17.6 91.7 49.3 115.9 56.6 83.0 274.5 24.3 120.5 61.2 83.6 44.3 67.3 43.6 31.6 50.9 39.0 43.5 48.8 38.4 39.5 42.4 52.9 211.4 41.3 25.2 21.5 61.9 69.8 9.9 10.5 10.5 12.0 9.7 12.1 13.2 11.0 8.4 12.1 11.9 10.7 14.2 98.1 28.9 36.4 13.4 86.4 27.0 33.4 17.3 21.6 4.5 11.9 11.0 8.5 48.6 34.4 31.3 6.2 40.5 98.3 33.4 5.9 23.6 1.2 31.5 31.0 53.1 27.0 248.9 10.5 19.8 23.9 29.0 29.0 53.9 10.1 24.0 48.5 73.6 44.4 11.8 14.3 43.0 12.2 88.5 18.1 3.4 33.8 71.7 26.6 19.7 56.0 11.6 82.4 37.2 34.1 20.6 24.6 32.4 74.0 32.9 19.3 26.0 26.0 10.4 39.5 13.9 46.6 21.0 26.7 68.4 35.5 11.1 81.3 13.2 73.8 36.7 WNT9A WNT14 ENSG00000143816 "Wnt family member 9A" O14904 1 227918656-227947932 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.5" "Cell type enhanced" "Detected in many" "Fibroblasts: 5.1;Ionocytes: 6.1;Respiratory ciliated cells: 12.5;Urothelial cells: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;PC-3: 10.8;RH-30: 16.4;SCLC-21H: 14.9;SiHa: 14.7;U-2197: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (2.27e-2)" "unprognostic (3.24e-1)" "unprognostic (3.77e-3)" "unprognostic (4.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.48e-1)" "unprognostic (1.38e-2)" "unprognostic (1.70e-2)" "unprognostic (3.72e-2)" "unprognostic (8.71e-2)" "unprognostic (5.04e-2)" "unprognostic (9.93e-2)" 2.4 1.4 1.0 1.1 0.7 0.1 3.0 0.6 0.6 3.8 6.3 13.5 1.3 5.3 0.4 5.9 5.6 2.1 10.2 0.8 0.6 0.9 0.2 4.0 0.3 1.1 0.9 0.8 9.8 2.8 1.2 2.8 2.1 1.4 2.5 1.1 0.0 2.5 1.0 26.5 1.1 6.1 4.3 0.8 1.1 5.9 1.5 0.5 1.1 2.0 2.8 0.3 5.0 3.5 1.3 1.0 3.3 0.4 0.1 0.4 0.7 8.1 1.1 0.9 0.1 0.0 0.0 8.8 0.0 4.7 1.5 3.3 16.2 0.4 0.8 0.0 1.6 0.6 0.0 6.0 0.2 0.4 0.0 0.5 0.1 4.0 0.1 0.1 0.3 1.0 0.0 0.0 0.1 1.8 2.2 0.0 0.0 1.0 0.0 10.8 0.2 16.4 1.7 4.6 1.1 14.9 0.0 14.7 6.6 0.0 5.2 8.4 1.8 0.6 2.1 1.3 10.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.6 0.6 0.8 0.6 1.1 0.9 0.8 1.4 0.8 0.5 1.3 0.3 3.2 0.6 0.3 0.0 0.9 1.3 3.6 0.0 0.0 3.1 1.3 1.4 0.0 4.3 1.8 0.0 0.3 0.2 0.8 0.0 0.7 0.1 2.1 2.1 0.4 3.0 0.0 0.7 1.3 0.2 5.1 1.5 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.9 6.1 0.0 0.4 0.1 4.4 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.9 1.1 0.0 4.5 0.1 1.8 0.1 0.1 12.5 0.0 0.0 1.3 1.1 0.0 1.8 3.9 0.3 0.0 0.2 0.1 0.1 5.3 EPHX1 EPHX ENSG00000143819 "Epoxide hydrolase 1" P07099 1 225810124-225845563 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Aromatic hydrocarbons catabolism, Detoxification" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 1188.3;liver: 1718.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 349.9;Hepatocytes: 757.6;Theca cells: 1042.6" "Cancer enriched" "Detected in all" 6 "liver cancer: 1047.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "ASC diff: 1161.8;SiHa: 413.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020593, HPA048847" Enhanced NA NA 160000 "HPA020593: AB_10601373, HPA048847: AB_2680538" "unprognostic (2.85e-2)" "unprognostic (2.52e-2)" "unprognostic (2.00e-2)" "unprognostic (2.53e-3)" "unprognostic (2.50e-1)" "unprognostic (6.60e-2)" "unprognostic (3.92e-2)" "prognostic favorable (7.02e-5)" "unprognostic (1.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.32e-4)" "unprognostic (8.10e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "unprognostic (1.88e-2)" 248.0 1188.3 211.0 23.8 220.7 22.9 165.1 217.0 251.2 189.9 297.3 77.8 103.2 109.0 98.5 160.9 155.1 97.4 92.6 199.0 274.0 111.7 1718.8 148.1 39.4 213.0 203.1 171.9 331.8 540.7 148.8 106.6 33.2 210.3 114.1 53.0 30.9 144.8 129.3 143.7 68.0 53.2 110.6 180.7 56.2 100.8 75.0 223.4 26.1 172.5 96.5 33.7 136.6 141.6 247.2 32.1 202.3 12.3 108.5 1161.8 120.2 24.3 29.7 49.2 28.1 35.1 38.8 293.6 1.3 128.7 147.3 30.6 38.1 32.7 16.8 12.1 7.8 46.5 21.8 83.5 282.7 129.8 12.9 15.1 109.2 40.0 74.6 6.3 116.5 22.1 13.4 14.5 27.3 50.4 30.3 13.5 31.0 61.6 178.1 79.4 27.8 15.2 92.9 91.1 132.5 98.3 13.0 413.0 192.1 51.3 32.1 131.7 43.5 46.8 41.9 35.4 54.5 59.0 9.1 38.9 4.1 63.5 14.2 59.5 0.0 2.6 0.1 0.2 0.7 0.4 0.1 0.3 0.2 0.6 0.2 0.5 0.3 0.2 0.7 0.3 0.9 0.3 0.8 211.0 220.7 217.0 251.2 199.0 274.0 213.0 203.1 171.9 210.3 180.7 223.4 247.2 196.9 0.0 14.0 41.1 5.7 19.6 121.8 244.2 74.0 8.8 29.7 27.4 1.2 102.9 255.5 51.5 29.2 46.6 3.4 34.5 17.6 95.3 10.2 142.9 32.2 82.7 10.8 7.0 3.1 73.0 7.6 175.6 30.5 93.4 5.7 349.9 88.2 757.6 149.1 1.7 5.0 17.5 103.7 30.9 28.7 28.4 311.3 25.8 42.7 23.4 9.6 99.2 0.0 7.1 19.4 45.5 27.2 159.1 9.5 40.4 63.4 128.9 174.3 10.1 223.5 29.3 146.9 4.4 5.1 129.0 17.6 22.8 4.7 1042.6 31.5 108.5 REN ENSG00000143839 Renin P00797 1 204154819-204190324 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 156.5" "Cell type enhanced" "Detected in some" "Early spermatids: 6.8;Late spermatids: 28.4;Paneth cells: 5.6;Smooth muscle cells: 10.7;Urothelial cells: 7.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 39.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;BJ: 2.0;HMC-1: 2.6;SK-BR-3: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA005131 Approved "Secreted to blood" NA NA 692000 10000 "HPA005131: AB_1079174" "unprognostic (4.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.62e-1)" "unprognostic (8.58e-2)" "unprognostic (2.89e-1)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.37e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (6.49e-2)" 0.4 1.4 0.3 0.2 0.7 0.0 0.1 0.0 0.2 4.4 2.6 0.4 0.3 9.6 0.3 0.2 2.3 0.1 0.9 0.2 0.0 156.5 0.7 0.7 0.0 0.3 0.3 0.1 16.4 0.0 0.0 0.6 15.3 0.4 0.4 0.2 0.1 0.8 0.8 0.0 0.1 0.1 1.5 0.0 0.1 0.0 0.9 0.2 0.5 0.0 0.0 0.5 5.3 0.3 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.2 0.0 0.3 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.8 0.7 0.0 0.7 0.1 0.0 0.2 0.0 0.3 1.8 0.0 0.3 0.0 0.0 0.0 1.2 6.8 0.2 0.5 0.4 0.0 0.0 0.3 1.1 0.2 2.8 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 28.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 5.6 0.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 10.7 0.3 0.2 0.0 0.0 1.1 0.1 1.3 0.0 7.0 SOX13 "ICA12, MGC117216, Sox-13" ENSG00000143842 "SRY-box transcription factor 13" Q9UN79 1 204073115-204127743 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Sertoli cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.9;SK-BR-3: 138.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051790, HPA054843" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051790: AB_2681610, HPA054843: AB_2682622" "unprognostic (4.88e-3)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (4.74e-2)" "unprognostic (2.65e-1)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.75e-1)" "unprognostic (2.95e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (1.04e-1)" "unprognostic (8.20e-2)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 33.8 15.5 16.0 5.0 15.8 0.5 29.5 15.6 14.3 36.2 12.3 26.6 14.1 41.3 8.9 16.0 40.1 9.6 15.2 11.2 12.7 27.9 22.8 37.2 4.8 20.6 21.4 8.9 19.3 17.4 24.4 8.7 26.1 18.0 35.7 8.1 2.0 21.9 17.9 21.3 15.5 21.6 18.1 18.0 14.3 14.8 7.2 16.9 1.9 17.3 14.0 3.9 29.9 33.4 19.4 24.8 15.6 32.7 2.2 30.6 9.2 65.9 9.4 5.5 14.7 9.0 13.1 18.0 0.2 30.4 6.0 3.8 39.0 12.6 12.2 6.9 11.5 6.4 0.0 11.2 14.6 6.9 0.2 14.0 9.5 6.1 9.2 8.0 7.0 21.7 0.5 0.2 0.1 3.0 30.1 0.3 0.2 43.6 39.5 18.6 0.2 11.1 15.3 11.0 55.9 5.1 2.7 9.5 138.2 42.4 29.0 61.7 3.0 12.4 3.2 8.6 14.2 6.6 0.1 0.1 0.0 5.2 0.5 8.8 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.4 0.5 0.0 0.0 0.0 0.3 0.1 1.6 0.0 0.0 0.0 0.1 16.0 15.8 15.6 14.3 11.2 12.7 20.6 21.4 8.9 18.0 18.0 16.9 19.4 20.5 6.4 7.7 26.8 0.2 2.2 8.7 3.5 2.8 0.9 8.7 7.6 28.3 5.7 4.9 9.2 0.0 5.2 3.9 16.3 1.9 3.6 9.2 13.3 13.0 17.4 7.7 0.0 0.5 1.5 5.6 8.4 5.1 22.3 17.1 0.2 8.9 6.0 1.4 0.0 7.6 5.3 8.2 0.9 2.1 27.7 20.8 1.2 1.8 21.5 0.0 4.9 4.1 50.8 16.8 3.7 7.6 19.5 0.5 7.8 16.0 4.5 4.1 1.0 39.5 9.7 22.3 0.3 0.5 6.6 1.6 1.9 2.3 2.9 5.5 7.7 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152044 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 109.1;liver: 237.4;testis: 126.0" "Group enriched" "Detected in many" 4 "Early spermatids: 417.0;Late spermatids: 1337.3" "Cancer enhanced" "Detected in all" "liver cancer: 32.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 53.8;MCF7: 55.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 22.6" HPA057167 Enhanced NA NA "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 12.4 6.1 12.1 2.1 11.4 2.8 17.5 7.6 12.1 16.4 24.3 5.0 1.9 10.9 30.2 24.1 13.2 5.3 5.5 9.8 11.5 109.1 237.4 3.3 2.1 10.2 11.6 10.1 36.4 9.6 18.7 25.8 4.3 10.5 13.8 2.1 5.8 28.0 16.3 2.0 19.3 3.8 6.5 7.2 7.2 4.9 126.0 11.8 3.7 10.7 4.2 9.4 10.1 26.2 7.6 11.3 3.8 11.0 20.9 4.0 1.3 10.9 11.4 25.2 15.6 6.8 19.2 5.4 0.4 18.4 2.8 18.2 9.9 19.7 15.9 10.7 0.4 17.3 0.2 2.5 30.6 16.2 0.5 0.7 5.4 53.8 3.2 0.7 8.0 11.1 11.9 1.6 0.4 2.0 55.1 3.2 0.3 23.0 0.4 8.4 0.8 13.0 0.4 13.4 4.3 2.9 15.4 7.2 33.6 5.4 35.1 32.5 0.7 0.7 4.4 23.8 1.0 8.4 0.5 0.2 0.5 0.3 0.6 6.3 0.0 0.1 0.0 2.2 0.0 2.1 0.0 0.5 1.3 0.0 0.1 1.3 1.6 0.1 0.8 0.0 0.0 0.3 0.6 12.1 11.4 7.6 12.1 9.8 11.5 10.2 11.6 10.1 10.5 7.2 11.8 7.6 1.3 0.0 0.0 1.3 1.0 4.1 13.8 8.2 1.8 4.2 12.3 11.6 1.1 4.3 2.5 3.7 4.2 6.1 1.6 0.1 39.2 9.5 417.0 4.5 1.9 2.1 1.2 13.5 1.2 6.3 9.2 6.4 1.1 3.2 8.9 47.4 6.8 196.9 0.8 0.0 2.9 0.1 2.0 6.5 1.1 1337.3 29.2 1.6 10.6 0.0 0.0 3.8 1.0 2.5 0.2 4.5 0.0 42.2 0.0 14.9 0.3 147.2 3.1 0.8 0.0 4.1 4.4 11.0 7.4 16.1 2.4 9.4 2.9 34.1 0.2 13.5 PPFIA4 ENSG00000143847 "PTPRF interacting protein alpha 4" O75335 1 203026498-203078740 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.6;heart muscle: 22.2;skeletal muscle: 19.0" "Group enriched" "Detected in some" 4 "Astrocytes: 12.7;Cardiomyocytes: 35.3;Excitatory neurons: 36.9;Inhibitory neurons: 31.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 55.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 8.0;hTERT-RPE1: 13.1;RH-30: 13.6;U-266/70: 8.5;U-87 MG: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053419, HPA054132" Enhanced NA NA "HPA053419: AB_2682143, HPA054132: AB_2682393" "unprognostic (2.83e-1)" "unprognostic (2.34e-3)" "unprognostic (3.38e-5)" "unprognostic (3.19e-1)" "unprognostic (6.58e-2)" "unprognostic (5.36e-2)" "unprognostic (7.49e-8)" "unprognostic (4.65e-1)" "unprognostic (6.01e-4)" "unprognostic (1.29e-1)" "unprognostic (7.70e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.73e-8)" "unprognostic (6.82e-3)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (4.28e-2)" 0.4 0.6 11.7 0.4 5.6 1.0 0.6 55.6 39.9 3.0 0.0 1.2 0.5 2.4 2.4 1.1 1.0 1.7 22.2 9.6 2.4 5.2 0.3 0.8 0.2 5.1 2.2 9.0 0.9 0.1 0.4 1.6 2.9 22.4 1.0 0.2 7.2 1.4 0.6 19.0 2.1 0.8 1.3 0.0 1.6 0.8 3.2 3.4 0.4 0.6 12.1 0.2 0.6 2.0 7.8 8.0 0.0 0.1 1.9 0.0 0.3 0.3 0.4 0.9 0.7 3.2 0.4 0.3 0.4 1.6 1.8 0.2 0.9 0.6 1.5 1.5 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.0 2.5 0.1 0.4 0.0 13.1 0.0 1.6 0.1 0.3 6.5 1.1 0.6 1.0 0.9 0.0 0.3 1.4 13.6 2.3 0.0 0.0 2.6 3.3 0.8 0.2 1.1 1.2 0.2 0.6 0.0 4.8 2.8 0.1 0.1 8.5 0.2 0.1 12.4 0.7 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.7 5.6 55.6 39.9 9.6 2.4 5.1 2.2 9.0 22.4 0.0 3.4 7.8 0.1 0.0 0.0 12.7 0.1 0.0 0.1 3.7 0.6 5.1 0.5 0.3 35.3 0.0 0.9 0.0 6.2 0.1 0.1 0.0 0.0 0.9 2.7 0.4 0.3 0.6 0.0 0.0 36.9 0.0 0.4 1.7 0.0 0.7 0.0 1.8 0.7 0.0 0.3 6.7 31.9 0.1 0.0 0.0 0.0 3.6 0.3 0.7 0.0 4.7 1.9 1.5 1.0 5.5 1.9 0.4 0.1 1.9 0.0 0.1 0.0 0.1 1.0 1.5 0.0 1.1 0.8 0.6 1.4 0.3 0.0 0.3 0.1 0.1 0.0 0.0 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218853-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 111.0;Distal enterocytes: 66.6;Excitatory neurons: 102.6;Inhibitory neurons: 62.5;Oligodendrocyte precursor cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 60.3;BEWO: 94.6;CAPAN-2: 79.2;OE19: 80.9;RT4: 66.4;SK-BR-3: 58.4;T-47d: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028152, HPA028157, HPA054311" Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cell Junctions" Vesicles "HPA028152: AB_10601048, HPA028157: , HPA054311: AB_2682446" "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favorable (3.57e-4)" 3.8 6.6 23.8 6.1 19.8 0.4 13.9 23.0 35.3 4.2 8.1 32.5 25.8 4.8 13.0 17.4 9.4 13.4 17.1 20.9 19.1 27.7 27.8 3.2 0.6 24.8 24.3 16.6 4.7 10.3 5.7 31.3 8.8 26.6 13.9 29.6 11.5 9.0 14.1 6.0 4.0 29.8 3.8 18.9 3.2 40.1 5.5 37.4 1.0 4.0 2.4 2.4 12.8 7.6 25.1 60.3 36.8 23.7 0.1 0.3 0.6 94.6 2.1 6.6 0.2 0.3 17.8 79.2 0.3 17.3 1.4 0.3 6.7 0.3 6.5 0.3 0.2 3.8 0.2 15.2 25.7 3.5 0.0 0.1 1.0 19.6 0.0 5.0 7.2 10.4 0.8 0.1 0.2 23.9 26.7 0.1 0.1 7.4 80.9 44.6 0.0 0.2 0.1 23.0 66.4 4.8 48.4 26.6 58.4 0.4 4.9 55.3 0.3 0.7 0.0 1.0 0.3 0.5 0.2 0.0 0.1 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 19.8 23.0 35.3 20.9 19.1 24.8 24.3 16.6 26.6 18.9 37.4 25.1 0.2 0.0 10.9 111.0 0.3 0.1 4.2 1.9 0.6 41.6 15.7 8.1 16.6 37.1 4.5 9.2 20.9 6.6 0.5 66.6 3.9 8.4 10.4 4.0 1.3 1.2 16.8 2.7 102.6 5.1 2.4 9.0 40.8 6.2 0.0 0.3 5.0 21.4 0.8 18.5 62.5 32.7 4.1 0.6 0.7 4.0 5.3 0.7 0.0 15.0 0.1 1.2 0.0 85.5 41.8 13.3 33.2 3.8 0.1 6.9 15.2 11.7 7.2 7.1 0.0 26.4 1.1 0.6 0.2 1.4 0.6 21.6 0.6 0.1 34.5 13.7 PTPN7 "HEPTP, LC-PTP" ENSG00000143851 "Protein tyrosine phosphatase non-receptor type 7" P35236 1 202147013-202161588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 40.0;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in many" "B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 8.2" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0" "Cell line enhanced" "Detected in some" "HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0" "Region enriched" "Detected in single" 9 "basal ganglia: 6.1" "Region enriched" "Detected in many" 8 "basal ganglia: 13.3" "CAB009530, HPA019118" Approved Supported "Microtubules,Mitotic spindle,Cytosol" Yes NA Cytosol "Microtubules, Mitotic spindle" "CAB009530: AB_2173845, HPA019118: AB_1855755" "unprognostic (4.19e-3)" "unprognostic (1.08e-3)" "unprognostic (3.09e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.91e-2)" "prognostic favorable (1.84e-4)" "unprognostic (3.01e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.42e-8)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" 1.3 4.3 0.8 10.3 8.2 40.0 0.7 1.1 1.3 0.8 0.5 2.2 4.5 1.1 0.1 1.5 0.7 3.3 0.5 0.4 1.8 1.3 1.1 2.6 21.0 3.3 1.0 0.2 0.3 0.4 0.1 0.3 0.6 2.3 0.8 2.8 0.0 1.3 0.6 0.1 1.2 5.6 1.5 1.8 9.9 2.4 8.4 1.7 31.4 0.9 0.5 20.9 3.3 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.6 0.0 54.1 0.0 0.0 0.0 118.6 150.8 0.0 0.0 0.0 0.0 0.0 0.1 40.0 2.3 5.0 0.0 0.0 16.3 51.4 0.0 0.0 0.0 2.4 0.0 39.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 53.7 0.3 0.0 0.5 0.0 0.1 22.8 6.3 33.7 0.1 84.0 0.1 17.9 1.5 24.9 13.7 1.5 12.5 2.6 9.2 14.0 2.9 3.2 6.7 8.2 9.9 14.9 0.6 3.8 12.8 4.5 0.8 8.2 1.1 1.3 0.4 1.8 3.3 1.0 0.2 2.3 1.8 1.7 1.7 3.2 3.2 5.1 3.3 46.8 2.3 1.3 0.1 0.0 2.7 1.5 1.8 0.7 1.5 0.7 0.0 0.0 0.5 112.7 0.5 0.0 0.5 0.6 0.9 0.8 5.6 0.0 35.5 0.7 0.0 0.2 2.2 1.5 0.7 140.7 6.7 3.6 0.4 15.4 0.0 0.7 0.1 0.0 11.2 31.2 2.4 5.3 21.3 8.8 1.0 10.4 3.8 99.9 1.0 4.6 0.1 0.1 2.2 63.9 0.6 0.2 0.7 0.1 3.7 0.0 0.9 1.1 0.8 0.7 0.5 2.4 0.8 127.2 54.6 0.5 0.6 SYT2 ENSG00000143858 "Synaptotagmin 2" Q8N9I0 1 202590596-202710454 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" Differentiation "Congenital myasthenic syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 64.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 23.2;Inhibitory neurons: 22.7;Oligodendrocytes: 7.4" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.5;NTERA-2: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063655 Enhanced Supported NA NA "HPA063655: AB_2685077" "unprognostic (1.32e-2)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.00e-1)" "unprognostic (2.35e-3)" "unprognostic (8.81e-3)" "unprognostic (1.17e-1)" "unprognostic (1.53e-2)" "unprognostic (6.33e-2)" "unprognostic (1.56e-2)" "unprognostic (6.23e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (5.17e-3)" 0.2 1.3 11.6 0.2 9.2 0.0 0.1 42.6 64.8 0.2 0.1 0.2 0.2 0.4 0.8 0.0 0.2 0.2 0.3 4.3 15.2 0.0 0.0 0.1 0.1 52.0 26.6 0.0 0.6 0.0 0.0 0.0 0.0 62.5 0.1 0.1 5.2 0.2 0.0 0.2 0.1 0.2 0.0 12.3 0.2 0.1 0.5 20.0 0.0 0.0 0.0 0.0 0.2 0.1 52.9 0.0 0.1 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.6 9.2 42.6 64.8 4.3 15.2 52.0 26.6 0.0 62.5 12.3 20.0 52.9 0.2 0.0 0.0 2.6 0.1 0.5 1.6 1.1 0.0 3.6 0.2 0.1 2.9 0.0 0.5 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.6 1.7 0.3 0.0 0.0 23.2 0.0 0.1 0.3 0.0 2.0 0.0 0.9 0.0 0.0 0.0 3.3 22.7 0.1 0.0 0.0 0.0 0.5 3.4 0.2 0.0 1.0 0.1 1.2 0.0 1.0 7.4 0.0 0.0 1.9 0.0 0.4 0.0 0.1 0.7 5.1 0.0 0.3 0.6 0.3 0.9 0.0 0.6 0.1 0.1 0.1 0.4 2.2 ARL8A "ARL10B, FLJ45195, Gie2" ENSG00000143862 "ADP ribosylation factor like GTPase 8A" Q96BM9 1 202133404-202144743 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038759, HPA040515, HPA045924" Approved NA NA "HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500" "unprognostic (1.20e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (3.08e-5)" "unprognostic (5.15e-3)" "unprognostic (5.10e-2)" "unprognostic (2.50e-3)" "unprognostic (1.17e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (4.30e-1)" "unprognostic (2.26e-2)" "unprognostic (1.57e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.75e-1)" "unprognostic (5.39e-2)" "unprognostic (1.66e-2)" 40.4 40.4 56.6 25.3 75.3 70.6 37.8 76.2 79.5 36.6 33.8 31.6 21.8 35.3 17.0 32.7 34.6 21.6 41.3 63.5 68.3 34.6 45.5 46.5 21.4 81.4 77.3 57.7 35.6 28.6 26.4 31.9 31.3 80.1 30.0 11.0 18.9 31.1 19.8 46.7 37.5 26.6 21.9 74.6 38.7 32.2 19.6 73.1 18.2 32.6 26.2 13.4 31.6 34.1 99.1 24.2 25.6 26.2 31.9 23.1 19.9 11.3 28.1 36.6 31.3 24.1 9.2 18.7 23.3 18.1 29.2 29.2 34.0 17.6 19.4 10.0 45.7 24.7 14.1 13.2 9.6 45.8 28.6 63.8 21.8 50.4 27.4 23.6 32.9 32.2 23.3 13.6 34.7 22.3 26.4 20.0 39.3 37.4 8.3 8.9 19.2 22.9 20.5 29.5 20.4 24.2 62.8 22.9 73.8 46.2 32.7 34.2 31.6 38.7 25.1 22.8 43.4 24.1 54.0 54.6 19.3 20.4 15.1 21.4 3.5 2.1 7.3 1.5 2.1 1.1 1.1 1.3 1.2 1.5 1.5 0.7 0.9 5.2 0.7 2.0 2.7 1.5 0.9 56.6 75.3 76.2 79.5 63.5 68.3 81.4 77.3 57.7 80.1 74.6 73.1 99.1 45.4 19.2 10.2 17.0 16.6 41.3 24.0 12.1 7.4 36.0 39.0 33.5 2.5 22.8 13.2 11.0 14.6 33.3 37.1 11.3 5.9 38.9 0.4 20.7 28.2 26.0 20.5 7.0 17.8 29.3 14.7 25.7 14.3 26.8 19.0 26.0 20.7 39.8 57.2 53.8 18.6 14.7 14.2 57.8 51.0 2.1 33.5 45.7 32.0 6.5 35.4 47.1 18.6 13.0 82.8 50.3 21.1 27.4 14.5 31.8 16.6 27.1 10.7 23.1 26.3 22.8 28.6 1.3 5.2 13.4 51.7 76.1 21.4 16.5 10.1 37.2 OSR1 ODD ENSG00000143867 "Odd-skipped related transcription factor 1" Q8TAX0 2 19351485-19358623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 82.0" "Cell type enhanced" "Detected in some" "Fibroblasts: 35.8;Leydig cells: 133.6;Peritubular cells: 45.9;Smooth muscle cells: 21.4" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.9" "Region enhanced" "Detected in some" "hypothalamus: 8.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 11 "U-2197: 101.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015525 Uncertain NA NA "HPA015525: AB_1854822" "unprognostic (1.71e-3)" "unprognostic (1.23e-1)" "unprognostic (6.85e-4)" "unprognostic (1.42e-1)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (8.47e-4)" "unprognostic (2.79e-1)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "unprognostic (3.56e-2)" "unprognostic (1.03e-1)" "unprognostic (2.21e-3)" "unprognostic (1.89e-1)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (1.62e-1)" 24.6 2.4 0.6 3.5 0.7 0.0 22.6 0.3 1.7 13.2 2.2 18.4 1.4 10.4 0.3 3.6 8.2 6.0 10.1 1.5 8.4 1.5 0.5 17.1 0.5 0.5 0.2 0.8 6.1 2.8 0.2 2.7 3.4 0.2 14.1 2.0 0.0 31.7 3.7 3.0 10.2 11.2 11.4 0.2 0.1 9.8 5.4 2.7 0.7 10.3 3.6 0.1 82.0 12.4 0.5 0.0 2.4 0.1 4.7 3.2 9.2 0.0 6.0 2.8 5.6 2.8 0.0 0.1 0.0 0.0 8.5 2.7 0.0 3.0 1.4 1.4 0.0 0.2 0.0 0.1 3.5 4.0 0.0 0.2 4.6 0.0 5.2 6.9 4.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.1 0.0 3.6 5.0 0.0 0.2 0.0 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.3 0.4 101.8 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.3 1.7 1.5 8.4 0.5 0.2 0.8 0.2 0.2 2.7 0.5 1.2 0.0 0.5 0.0 0.0 4.7 1.0 1.7 0.6 0.0 1.0 6.1 7.2 0.0 1.1 3.7 0.0 0.5 0.1 0.1 0.0 1.3 0.7 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.4 35.8 0.0 0.1 1.3 1.2 0.0 0.0 0.9 0.0 0.0 0.3 4.1 0.0 4.9 3.8 133.6 0.3 3.6 2.8 0.0 0.0 0.0 0.0 0.1 0.4 0.1 45.9 0.0 0.4 0.0 2.9 0.3 0.0 0.0 1.3 21.4 0.4 0.1 0.3 4.1 0.4 0.7 0.8 0.2 1.1 GDF7 BMP12 ENSG00000143869 "Growth differentiation factor 7" Q7Z4P5 2 20667144-20679243 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 9.3;seminal vesicle: 22.6" "Group enriched" "Detected in some" 12 "Endometrial stromal cells: 137.0;Granulosa cells: 83.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebral cortex: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.7;Hep G2: 4.4;RT4: 8.3;SH-SY5Y: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA069106 Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA069106: " "unprognostic (1.35e-1)" "unprognostic (9.93e-3)" "unprognostic (5.10e-1)" "unprognostic (2.44e-3)" "unprognostic (1.35e-1)" "unprognostic (2.06e-3)" "unprognostic (8.63e-3)" "unprognostic (6.31e-3)" "unprognostic (8.00e-3)" "unprognostic (3.85e-1)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.28e-3)" "unprognostic (8.02e-3)" "unprognostic (2.05e-1)" "unprognostic (3.44e-2)" "unprognostic (1.89e-3)" 0.4 0.4 0.1 1.0 0.5 0.2 0.1 0.0 2.6 9.3 0.3 0.5 0.2 7.3 3.4 0.9 0.7 0.6 0.8 0.4 0.2 3.7 5.0 0.4 2.4 0.2 0.1 0.3 0.3 0.6 0.1 0.3 0.8 0.2 3.9 0.2 0.1 0.1 22.6 0.0 1.3 1.6 1.1 0.0 1.4 0.7 0.2 0.3 0.2 0.2 0.6 1.8 1.1 6.6 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 1.2 8.3 0.0 3.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 2.6 0.4 0.2 0.2 0.1 0.3 0.2 0.0 0.3 0.5 0.1 6.4 0.0 0.0 2.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 8.8 2.8 3.1 5.5 0.0 0.0 0.1 0.1 1.9 0.1 0.1 3.5 137.0 1.8 0.0 2.7 0.2 0.0 0.1 1.3 0.0 2.9 0.0 83.7 0.0 8.2 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 4.1 0.7 0.0 0.0 0.3 7.1 0.5 1.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 PDIA6 "ERp5, P5, TXNDC7" ENSG00000143870 "Protein disulfide isomerase family A member 6" Q15084 2 10783391-10837977 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1202.1;Plasma cells: 883.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034347, HPA034652, HPA034653" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 15000000 "Endoplasmic reticulum, Cytosol" "CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982" "unprognostic (8.16e-2)" "prognostic unfavorable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.20e-4)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" "unprognostic (5.25e-3)" "unprognostic (6.03e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (6.59e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-2)" "unprognostic (3.69e-3)" 119.4 113.3 55.6 157.2 62.5 142.0 126.2 58.7 64.0 180.3 70.9 157.5 123.5 132.9 422.2 99.1 134.7 97.5 114.4 55.7 69.2 131.5 262.6 104.7 119.1 62.6 58.2 52.7 100.7 254.3 150.9 74.6 172.7 60.3 128.6 173.3 48.4 185.6 136.8 59.8 64.8 122.5 156.9 64.7 108.3 156.8 55.6 63.4 87.4 366.6 59.9 155.0 132.1 76.3 67.2 287.0 304.6 425.7 672.6 535.6 459.4 753.4 677.8 625.9 348.3 465.1 435.1 548.5 460.9 464.7 668.9 674.1 228.0 324.1 568.3 371.1 363.2 253.4 374.2 228.4 713.2 577.5 387.9 268.9 334.2 428.4 338.1 603.3 642.1 798.0 171.8 328.0 963.6 348.7 338.8 150.5 400.8 356.6 923.4 236.4 355.7 433.0 846.4 498.3 339.9 272.0 543.2 267.6 387.0 396.2 547.8 136.8 648.5 395.0 324.4 409.8 296.3 399.1 900.0 596.6 297.1 438.5 479.6 464.8 276.1 200.0 95.5 198.4 210.9 219.0 197.6 154.2 187.6 215.0 161.0 74.3 125.1 35.0 241.6 161.4 268.9 174.4 319.2 55.6 62.5 58.7 64.0 55.7 69.2 62.6 58.2 52.7 60.3 64.7 63.4 67.2 217.1 57.7 124.2 17.6 193.9 103.0 294.2 552.8 61.5 69.1 121.1 91.7 35.9 148.7 264.6 196.8 29.2 456.3 164.6 125.8 43.0 338.6 8.2 146.5 382.9 176.2 157.7 89.2 47.4 240.6 1202.1 228.2 138.1 255.0 131.3 210.6 211.3 355.6 413.1 42.1 30.5 276.3 170.9 155.7 149.8 16.2 121.2 145.9 199.3 15.0 132.1 106.5 142.2 32.6 25.3 175.4 131.2 135.1 883.2 385.4 99.9 149.6 145.8 60.1 85.5 96.9 225.3 98.5 117.9 95.4 102.6 554.1 125.7 254.3 248.3 265.3 RHOB "ARH6, ARHB, MST081, RHOH6" ENSG00000143878 "Ras homolog family member B" P62745 2 20447074-20449440 "Cancer-related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Protein transport, Transport" "Developmental protein" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 1272.8;Basal squamous epithelial cells: 1327.7;Hepatocytes: 1360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 5.6;eosinophil: 18.0;intermediate monocyte: 11.4;neutrophil: 21.5;non-classical monocyte: 13.3" "Group enriched" "Detected in many" 13 "granulocytes: 21.5;monocytes: 13.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 297.9;RPTEC TERT1: 462.9;SK-BR-3: 561.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.66e-3)" "unprognostic (5.57e-3)" "unprognostic (8.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.85e-1)" "unprognostic (9.16e-3)" "unprognostic (5.41e-3)" "unprognostic (4.91e-2)" "unprognostic (1.04e-2)" "unprognostic (3.22e-2)" "unprognostic (3.29e-1)" "unprognostic (2.13e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.71e-2)" "unprognostic (2.56e-1)" "unprognostic (3.01e-2)" "unprognostic (2.49e-2)" 563.3 543.9 223.3 95.5 313.5 72.6 463.9 311.4 229.9 488.6 132.7 509.8 40.8 373.9 67.6 167.9 604.3 167.9 307.8 181.7 283.9 173.5 647.6 390.0 44.1 366.7 320.1 163.9 441.0 112.4 34.7 136.2 171.7 315.5 345.9 81.8 27.8 137.1 221.7 369.6 371.9 205.1 263.1 348.8 116.6 442.1 53.3 293.8 52.9 172.6 154.8 13.2 494.1 356.6 404.9 29.0 42.5 79.9 19.4 202.3 48.1 112.7 133.5 48.2 58.0 19.6 27.2 32.9 0.1 13.8 68.2 113.8 16.4 1.3 27.4 20.5 33.5 86.8 1.5 118.4 224.4 52.7 0.4 86.0 88.7 93.3 34.6 45.5 55.8 297.9 0.2 8.6 51.1 35.6 78.0 1.4 10.9 35.4 45.3 17.7 7.5 35.8 52.4 462.9 66.6 64.7 39.7 27.9 561.2 81.7 224.2 98.6 7.3 178.8 25.8 61.2 10.8 51.7 96.4 15.3 0.5 6.6 0.4 24.3 5.6 2.5 18.0 0.6 11.4 0.1 0.2 0.0 0.4 1.3 0.2 0.0 0.1 21.5 0.9 13.3 0.1 0.1 1.1 223.3 313.5 311.4 229.9 181.7 283.9 366.7 320.1 163.9 315.5 348.8 293.8 404.9 1272.8 48.1 101.9 238.3 118.7 73.9 281.4 53.0 1327.7 20.4 465.1 460.4 118.6 700.6 70.6 77.3 2.1 114.2 66.8 655.2 64.6 296.4 6.0 346.3 283.8 409.6 561.2 33.7 17.3 119.9 134.5 621.3 670.7 364.6 24.7 390.9 376.6 1360.8 190.1 33.7 18.2 496.4 73.2 418.1 136.4 20.9 270.6 473.4 96.0 43.1 31.6 344.8 5.2 32.6 91.9 200.8 318.8 197.5 191.6 212.1 203.1 289.0 89.1 19.3 927.0 542.5 800.5 6.5 22.5 701.2 90.5 270.1 62.5 244.6 340.7 85.2 ATP6V1C2 "ATP6C2, VMA5" ENSG00000143882 "ATPase H+ transporting V1 subunit C2" Q8NEY4 2 10721100-10785110 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 81.0;salivary gland: 104.1;skin 1: 88.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 147.2;Distal tubular cells: 45.0;Enteroendocrine cells: 41.5;Glandular and luminal cells: 73.4;Ionocytes: 93.6;Syncytiotrophoblasts: 169.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "BEWO: 78.4;SK-BR-3: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034734, HPA067305" Approved Uncertain Mitochondria NA NA Mitochondria "HPA034734: AB_2674305, HPA067305: AB_2732763" "unprognostic (2.29e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (6.55e-3)" "unprognostic (2.69e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-3)" "unprognostic (8.53e-2)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" "unprognostic (6.77e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.12e-11)" "unprognostic (6.17e-2)" "unprognostic (3.30e-1)" "unprognostic (2.37e-1)" "unprognostic (8.27e-2)" 2.9 4.1 1.1 1.7 2.1 4.3 5.8 0.7 1.5 58.0 0.9 2.1 0.9 4.7 81.0 18.4 2.9 0.9 2.8 1.7 0.9 42.6 6.0 2.8 2.1 0.7 0.8 1.1 2.9 3.8 1.2 23.7 37.0 0.7 5.1 2.5 1.6 104.1 6.9 1.1 88.3 2.7 0.2 0.7 4.0 2.4 2.1 0.9 0.5 3.9 0.0 5.0 2.0 19.2 1.6 0.6 0.9 2.4 2.7 0.0 0.0 78.4 1.1 0.0 0.0 0.0 1.5 1.9 1.9 1.3 0.0 1.2 1.2 1.3 0.1 0.1 1.1 2.6 0.9 1.4 2.7 0.0 1.8 1.0 0.0 0.3 0.0 0.0 1.8 0.0 0.6 0.9 3.6 0.0 2.1 0.7 2.9 1.8 1.1 0.8 1.6 1.4 5.5 0.0 1.7 1.9 2.3 0.7 27.2 0.8 10.0 2.4 4.0 0.4 0.9 1.8 1.1 1.1 6.2 2.5 1.1 1.1 1.5 0.8 0.0 0.1 0.1 0.3 0.3 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 1.1 2.1 0.7 1.5 1.7 0.9 0.7 0.8 1.1 0.7 0.7 0.9 1.6 13.6 0.0 2.6 0.3 1.0 0.4 3.7 2.8 1.2 0.0 1.4 1.8 0.9 0.0 6.6 7.3 0.0 147.2 0.8 0.3 45.0 0.1 0.7 31.3 13.4 1.4 41.5 0.0 2.4 0.2 33.0 2.7 1.1 73.4 2.5 0.3 0.0 0.2 13.8 0.0 1.2 0.2 93.6 0.8 0.8 0.4 0.6 0.9 0.0 2.8 0.0 0.0 0.0 0.5 1.3 0.2 0.1 0.0 4.0 1.1 0.0 1.1 4.4 0.0 0.0 0.7 1.2 0.2 1.2 0.6 2.4 169.1 1.0 0.3 0.8 0.4 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561969-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 155.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 15.5 16.5 13.1 12.6 21.6 52.2 14.8 20.2 18.1 16.0 13.3 15.3 15.6 18.3 14.1 10.3 16.8 14.2 11.3 27.1 25.2 11.2 10.9 16.6 12.6 7.8 9.4 19.8 17.1 16.0 16.9 9.2 13.2 11.0 14.0 11.9 26.9 12.9 15.2 14.0 11.2 12.8 12.9 8.8 12.1 15.9 22.8 9.9 31.2 17.9 12.0 9.7 15.3 12.9 18.8 36.7 16.9 48.2 28.4 22.9 21.6 30.1 33.8 27.5 28.8 24.1 19.0 20.7 0.5 29.5 30.4 30.9 23.0 30.7 25.4 29.6 54.6 26.8 26.7 32.3 48.6 21.6 49.9 26.4 16.9 19.6 24.0 26.5 28.5 30.6 23.9 45.9 79.7 34.3 17.2 54.9 27.2 48.4 35.2 30.6 10.6 33.9 18.1 25.0 47.2 32.9 36.9 29.8 25.8 26.0 26.7 21.8 21.6 32.0 21.5 32.1 23.8 28.1 43.4 46.9 0.3 18.5 12.2 26.8 10.6 6.3 9.7 10.3 3.2 17.9 0.4 24.2 18.9 12.0 1.9 7.2 4.6 4.2 6.8 1.2 0.2 38.5 5.8 13.1 21.6 20.2 18.1 27.1 25.2 7.8 9.4 19.8 11.0 8.8 9.9 18.8 17.0 19.2 23.4 26.8 5.5 28.7 35.2 16.5 33.0 13.3 18.0 15.2 18.8 8.6 18.8 27.6 8.4 26.2 6.4 13.9 19.6 22.4 155.6 18.1 18.8 20.1 14.4 22.5 68.6 24.3 28.9 26.0 32.1 11.6 9.5 26.3 22.5 7.4 24.4 6.7 40.1 15.4 6.1 15.0 90.2 48.7 27.7 23.1 39.2 37.5 24.5 22.3 2.1 48.7 28.4 21.2 14.2 52.3 23.0 23.6 16.6 18.6 14.5 11.7 39.5 22.6 28.4 91.1 28.8 19.4 21.3 22.2 48.0 22.3 18.8 21.4 GALM ENSG00000143891 "Galactose mutarotase" Q96C23 2 38666081-38741237 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 87.2;kidney: 121.3" "Cell type enhanced" "Detected in many" "Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 68.3" "Group enriched" "Detected in all" 5 "granulocytes: 39.1;T-cells: 68.3" "Cell line enhanced" "Detected in many" "Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035472, HPA035473, HPA064835" Enhanced Approved Nucleoplasm NA NA 620000 Nucleoplasm "HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723" "unprognostic (5.02e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (9.20e-2)" "unprognostic (1.88e-2)" "unprognostic (9.99e-3)" "unprognostic (1.63e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (6.65e-2)" "unprognostic (6.45e-2)" "prognostic favorable (9.06e-5)" "unprognostic (1.70e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "prognostic favorable (1.32e-4)" 9.1 87.2 5.1 12.3 5.0 3.8 10.5 5.6 6.1 9.3 7.7 35.0 72.0 8.2 23.2 5.9 36.1 16.7 13.1 4.8 7.3 121.3 73.1 14.4 16.2 5.3 5.9 4.5 15.7 15.1 21.5 3.0 7.8 5.0 10.3 33.6 4.4 8.8 21.0 13.3 3.8 53.3 10.5 5.9 6.7 15.0 4.4 6.3 11.1 15.2 12.4 10.3 10.9 6.5 6.1 0.2 27.1 8.1 0.0 27.3 15.4 14.9 3.2 10.3 7.5 12.2 32.4 14.4 10.9 18.9 15.3 14.5 4.3 11.7 0.7 14.5 49.5 19.3 5.9 7.1 62.7 10.0 2.4 0.4 11.1 0.4 17.5 0.0 10.5 8.2 0.0 17.2 71.1 13.9 0.9 23.4 41.0 12.4 59.2 8.6 15.2 0.6 21.3 9.3 45.1 1.5 11.2 0.1 18.9 14.7 10.2 9.0 5.4 3.4 2.5 0.5 18.6 1.0 76.4 54.3 0.3 17.9 7.0 0.3 39.1 4.8 4.2 21.5 3.3 31.8 6.8 33.1 31.2 10.3 4.7 11.7 10.2 11.3 5.5 0.7 0.8 68.3 11.9 5.1 5.0 5.6 6.1 4.8 7.3 5.3 5.9 4.5 5.0 5.9 6.3 6.1 9.7 28.9 11.0 13.4 10.0 6.6 6.7 3.4 10.8 3.6 7.8 4.2 23.4 24.3 6.5 69.9 0.0 23.6 19.0 83.2 25.4 12.1 1.4 28.5 11.6 10.0 13.2 8.2 2.3 15.1 31.4 16.1 17.9 10.1 7.0 16.8 14.6 48.1 94.8 3.3 1.4 40.5 4.1 18.6 43.6 1.3 20.2 34.7 17.8 4.7 9.9 38.2 18.6 0.5 1.3 6.8 64.5 97.8 14.7 5.7 161.1 222.1 14.8 6.8 6.6 16.6 10.4 1.0 2.3 3.2 6.0 6.3 44.0 43.3 80.4 5.7 CAMKMT "C2orf34, CLNMT" ENSG00000143919 "Calmodulin-lysine N-methyltransferase" Q7Z624 2 44361947-44772592 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 155.1;Excitatory neurons: 88.7;Inhibitory neurons: 93.7;Microglial cells: 114.3;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067912 Supported Nucleoplasm NA NA Nucleoplasm "HPA067912: AB_2685922" "unprognostic (2.28e-1)" "unprognostic (6.15e-2)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "prognostic favorable (9.10e-4)" "unprognostic (1.03e-1)" "unprognostic (9.58e-3)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (7.42e-2)" "unprognostic (8.76e-2)" "unprognostic (1.37e-1)" "unprognostic (3.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (8.57e-2)" 4.2 5.4 14.4 3.9 19.6 10.3 5.3 18.0 21.3 5.9 16.3 7.1 5.3 4.2 6.6 6.1 4.9 5.8 5.0 14.0 19.2 6.9 4.9 3.9 5.5 15.7 15.0 13.9 3.9 9.9 9.9 5.7 3.3 17.0 3.6 6.9 8.6 4.8 3.9 7.8 5.9 5.8 3.9 14.2 3.8 5.8 13.3 16.1 6.3 7.3 3.3 5.4 4.5 4.7 19.2 10.2 6.2 7.4 6.8 8.0 8.1 15.0 7.4 6.0 4.3 5.5 11.9 9.0 9.6 8.6 5.6 5.3 8.3 10.6 13.2 7.6 35.2 13.3 14.2 12.1 22.4 3.1 9.4 9.5 2.6 8.0 5.9 10.9 6.1 6.4 9.9 10.4 17.1 7.1 10.9 17.6 19.1 13.9 24.6 6.1 10.3 8.3 19.4 20.8 11.6 14.0 13.4 7.6 24.1 9.2 7.0 8.8 7.7 7.6 5.5 6.4 6.1 5.9 13.3 11.5 18.2 6.1 16.5 3.9 13.1 8.2 6.2 11.1 6.9 11.5 20.9 11.2 9.7 9.7 14.7 16.9 13.4 5.2 8.7 8.4 10.1 18.3 6.9 14.4 19.6 18.0 21.3 14.0 19.2 15.7 15.0 13.9 17.0 14.2 16.1 19.2 5.4 6.4 3.1 155.1 11.0 5.2 7.9 10.9 9.1 5.3 6.6 5.2 2.2 10.0 5.5 9.2 0.0 3.3 6.9 4.5 23.5 13.3 74.3 8.2 7.2 4.0 0.0 13.3 88.7 15.6 4.5 6.2 11.7 10.0 5.7 2.0 3.3 6.3 5.8 1.7 93.7 5.5 20.3 1.9 4.9 39.0 8.1 4.3 10.6 114.3 6.4 20.3 13.4 121.2 211.7 8.6 8.3 5.7 13.3 5.8 7.2 14.5 7.4 3.0 0.0 3.6 5.0 35.5 5.8 10.7 7.4 2.6 9.2 7.9 8.1 6.0 ABCG8 GBD4 ENSG00000143921 "ATP binding cassette subfamily G member 8" Q9H221 2 43831942-43882988 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "intestine: 31.7;liver: 63.9" "Group enriched" "Detected in some" 4 "Hepatocytes: 32.0;Proximal enterocytes: 13.8" "Cancer enriched" "Detected in some" 30 "liver cancer: 21.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "Hep G2: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019556 Uncertain Approved Vesicles NA NA Vesicles "HPA019556: AB_1844444" "unprognostic (1.99e-1)" "unprognostic (4.49e-1)" "unprognostic (3.22e-1)" "unprognostic (1.37e-1)" "unprognostic (3.09e-2)" "unprognostic (2.43e-1)" "unprognostic (1.99e-3)" "unprognostic (1.27e-1)" "unprognostic (6.28e-1)" "unprognostic (6.14e-3)" "unprognostic (4.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.68e-1)" "unprognostic (7.86e-3)" "unprognostic (5.03e-1)" "unprognostic (1.50e-1)" 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.2 1.2 0.0 0.0 0.2 30.1 0.1 0.0 0.0 0.2 0.9 0.0 0.2 0.3 0.2 63.9 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 31.7 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 1.2 0.2 0.3 0.3 0.1 0.5 0.5 0.0 0.5 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 2.8 0.6 1.8 0.0 0.0 0.1 0.0 1.9 0.1 0.0 0.2 0.7 0.6 0.0 2.7 3.6 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.4 32.0 0.0 0.0 2.8 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 5.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.0 EML4 "C2orf2, ELP120, ROPP120" ENSG00000143924 "EMAP like 4" Q9HC35 2 42169353-42332548 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 186.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036687, HPA036688, HPA065337" Enhanced Supported Microtubules,Cytosol NA NA 25000 Microtubules Cytosol "HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.79e-2)" "unprognostic (9.19e-2)" "unprognostic (8.61e-3)" "unprognostic (1.61e-2)" "unprognostic (2.96e-3)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 11.3 13.8 1.5 32.7 2.3 41.5 14.2 1.0 2.1 11.8 4.0 23.8 39.2 11.2 4.7 11.2 10.0 20.1 4.7 1.4 4.3 19.6 38.5 24.5 28.5 1.8 1.6 0.7 9.0 24.5 13.9 4.3 35.9 1.9 9.8 23.9 10.4 21.1 8.0 2.4 18.4 36.8 14.3 2.4 28.5 21.0 20.6 2.9 15.0 21.7 3.9 30.3 27.6 5.7 2.2 45.1 76.7 43.7 34.9 15.6 25.4 47.7 27.3 21.4 29.7 28.5 80.8 55.1 41.1 18.5 26.9 45.6 22.7 38.0 26.3 51.3 80.8 31.8 37.7 23.5 186.3 19.7 28.8 37.1 27.9 9.8 39.4 26.5 14.4 20.9 14.0 37.9 40.3 32.5 26.4 27.3 7.7 44.8 57.8 21.9 27.8 69.2 24.3 24.2 64.3 42.9 86.3 26.9 27.7 20.8 39.6 14.4 11.4 24.6 30.1 39.9 24.3 24.9 44.9 33.3 34.6 26.3 27.0 21.6 5.6 4.7 9.9 9.0 13.7 19.0 13.9 15.0 14.8 4.1 9.1 12.8 9.6 12.3 11.9 14.6 5.3 22.3 7.6 1.5 2.3 1.0 2.1 1.4 4.3 1.8 1.6 0.7 1.9 2.4 2.9 2.2 47.0 60.9 107.3 37.9 137.6 67.3 74.3 60.5 75.1 35.1 53.5 45.7 7.0 51.5 60.9 40.5 47.9 143.0 120.8 57.0 17.6 34.0 33.1 33.4 50.1 50.8 102.3 20.8 54.2 75.4 47.5 55.3 76.0 86.6 48.1 80.7 43.9 61.9 65.6 16.8 60.0 69.3 34.6 40.3 56.6 31.0 23.9 74.8 16.0 119.9 38.4 35.1 47.4 62.8 32.9 38.1 58.9 23.0 139.5 65.4 51.3 41.3 28.6 47.3 6.6 25.0 47.6 46.5 39.4 73.4 79.7 118.9 223.8 42.0 85.0 96.4 CALM2 "CAMII, PHKD" ENSG00000143933 "Calmodulin 2" P0DP24 2 47160083-47176921 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007790, HPA044999" Approved NA Yes "CAB007790: AB_562257, HPA044999: AB_2679177" "prognostic unfavorable (5.05e-4)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.84e-4)" "unprognostic (9.21e-2)" "unprognostic (2.04e-3)" "prognostic unfavorable (8.35e-5)" "unprognostic (1.63e-2)" "unprognostic (4.67e-3)" "unprognostic (1.79e-2)" "unprognostic (1.97e-2)" "unprognostic (1.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.18e-2)" "unprognostic (2.29e-2)" "prognostic favorable (1.94e-5)" "unprognostic (1.24e-1)" 513.9 658.3 1350.5 337.4 1393.9 242.4 693.0 1372.5 1669.6 423.7 1177.8 690.4 554.8 511.9 555.9 370.2 531.1 394.2 447.1 1393.2 1368.2 440.9 497.2 510.1 431.4 1384.6 1387.2 1330.9 419.6 215.1 335.1 444.7 472.8 1367.7 453.0 712.7 579.9 495.1 566.8 265.1 302.1 626.3 640.3 1361.5 648.5 393.9 512.8 1396.9 576.2 447.3 260.4 471.1 463.4 343.1 1566.2 2459.6 905.8 1062.2 459.7 579.4 679.5 655.8 2177.2 1504.3 1437.1 1240.1 958.1 923.2 956.1 979.5 1753.2 1030.4 624.7 878.3 855.6 1907.0 729.3 438.6 821.6 526.6 1409.6 779.5 996.3 686.2 381.2 825.0 1265.3 1347.0 1230.4 977.3 312.8 812.1 854.7 3485.7 635.9 1270.2 984.3 801.3 2961.6 488.6 314.3 1142.9 1021.9 1631.0 441.0 756.8 2016.6 726.5 756.0 1120.1 1144.3 573.7 556.7 1084.8 1060.8 1135.8 627.0 1703.6 648.8 529.1 1038.2 718.8 711.3 1357.7 944.7 447.6 776.8 139.7 844.1 177.2 285.6 203.4 213.2 354.0 182.1 173.7 201.6 417.9 277.1 761.4 445.6 227.4 496.5 1350.5 1393.9 1372.5 1669.6 1393.2 1368.2 1384.6 1387.2 1330.9 1367.7 1361.5 1396.9 1566.2 597.4 1387.8 613.5 195.2 570.7 1780.5 1101.0 2616.3 524.8 654.3 844.4 572.9 639.6 581.9 1751.8 759.6 98.0 931.4 649.8 906.5 2304.8 1977.0 312.7 889.1 363.8 652.0 597.1 697.1 317.5 683.4 627.9 943.6 354.8 452.5 665.4 484.5 280.6 536.6 1267.1 341.6 179.0 1020.1 3352.8 867.1 1858.2 287.0 1055.3 911.0 1771.6 143.4 1167.2 2063.1 350.1 129.7 339.8 2584.9 1114.4 863.6 309.7 1016.8 1231.6 1020.2 3245.3 334.2 907.2 671.6 1882.0 2193.5 714.3 503.0 1663.1 255.3 669.1 615.4 771.1 1062.2 CHAC2 GCG1 ENSG00000143942 "ChaC glutathione specific gamma-glutamylcyclotransferase 2" Q8WUX2 2 53767804-53775196 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 44.0;Plasma cells: 27.0;Spermatocytes: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049235 Approved Approved Cytosol NA NA Cytosol "HPA049235: AB_2680686" "unprognostic (2.22e-1)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (3.91e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (3.80e-7)" "unprognostic (5.52e-2)" "unprognostic (1.74e-2)" "unprognostic (1.30e-2)" "unprognostic (1.36e-2)" "unprognostic (3.09e-2)" "unprognostic (4.28e-6)" "unprognostic (1.52e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" 5.1 4.4 1.9 4.8 2.0 7.0 2.1 2.7 2.4 1.0 1.2 4.4 7.4 1.1 2.6 4.6 0.7 1.3 2.0 1.9 2.0 2.9 4.5 1.4 6.7 2.0 2.0 1.7 0.6 2.0 1.3 1.6 1.1 2.2 1.7 3.7 3.8 1.7 1.5 4.9 1.3 4.5 2.2 1.7 4.3 4.6 5.4 2.1 5.0 1.0 4.8 6.6 3.3 2.2 1.9 39.9 13.0 13.5 12.1 6.7 3.3 2.9 17.9 3.6 12.5 14.8 9.1 10.0 33.5 25.3 7.8 18.8 14.0 31.1 21.3 21.7 71.3 27.1 26.6 16.3 15.0 10.2 31.8 11.6 4.2 6.2 23.2 17.5 3.3 24.8 23.0 27.8 19.2 16.6 13.0 38.0 26.5 17.5 17.1 23.1 28.6 28.9 34.2 17.3 10.6 16.8 4.7 20.7 15.3 8.7 8.1 9.3 12.5 11.0 7.3 26.1 28.2 29.3 18.9 26.1 28.8 9.9 39.5 10.2 1.3 0.3 0.8 3.5 0.7 3.7 4.3 3.8 3.9 0.8 4.4 4.3 4.1 1.0 1.1 0.5 1.8 3.9 1.9 1.9 2.0 2.7 2.4 1.9 2.0 2.0 2.0 1.7 2.2 1.7 2.1 1.9 2.3 0.0 1.1 2.0 11.7 3.4 3.7 7.4 0.6 1.6 2.2 2.0 3.0 7.2 4.1 1.8 0.0 1.9 5.1 3.4 11.7 5.4 13.1 2.2 1.0 3.0 0.0 44.0 4.8 8.0 0.9 1.6 10.2 2.2 1.3 1.5 3.3 7.6 7.8 1.7 4.3 4.6 2.0 1.9 3.0 3.5 2.8 1.7 3.6 1.0 5.8 5.7 8.2 5.0 2.1 7.9 1.4 4.1 27.0 4.1 3.7 9.8 1.9 6.8 0.0 2.4 3.1 47.0 6.6 5.5 3.4 0.4 5.3 5.1 10.6 4.0 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA Yes 230000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 1403.2 1218.4 1158.7 1087.6 1182.5 2588.3 2536.8 1140.5 1899.0 2084.4 1155.5 1432.8 831.0 1463.0 1114.8 1712.1 1741.6 577.3 938.1 1122.1 1164.3 1142.4 1171.8 1106.7 1971.7 1172.7 1155.8 1108.3 3175.0 2060.6 736.4 1065.7 880.2 1167.6 1442.4 1055.1 637.5 1399.4 926.6 1098.5 1706.2 1339.8 821.7 1220.0 1733.1 1490.4 409.1 1196.4 1534.4 1211.6 800.8 1789.2 1519.1 1709.1 1200.3 2384.4 1092.2 1412.2 1842.3 1892.6 3200.3 2412.6 1824.5 1779.4 1692.3 1069.1 2073.7 1987.4 3081.3 2833.2 1698.5 1115.0 1784.3 2061.7 2465.1 1981.0 2899.1 2419.0 2693.9 1088.0 2758.1 2705.9 3674.4 1605.2 3166.1 4213.4 1280.5 3401.6 3015.5 2415.9 1959.5 2469.0 2228.9 1937.3 1509.9 2307.6 4328.7 2831.1 2690.2 1710.6 2086.4 3051.2 3173.8 1994.3 1817.4 1546.0 1319.2 1064.4 4071.8 3843.7 2065.9 1811.0 3411.1 2108.9 1351.7 2395.8 1318.7 3006.7 2322.2 1881.5 1867.9 1923.5 3226.7 1392.6 1301.5 1656.9 637.7 2924.2 1530.8 4268.2 4727.8 4504.3 3592.2 2219.0 4232.8 5675.0 4744.3 351.6 3178.7 1388.8 3292.5 3058.2 8225.2 1158.7 1182.5 1140.5 1899.0 1122.1 1164.3 1172.7 1155.8 1108.3 1167.6 1220.0 1196.4 1200.3 3051.9 1272.4 2321.3 39.8 7158.8 8321.0 8963.0 6850.9 5010.5 446.4 8189.8 10987.6 438.8 3029.7 3486.3 1397.8 214.8 5340.9 5465.1 1499.3 4055.8 3640.9 1050.2 1695.4 3081.0 3385.0 2057.4 3362.1 45.8 7348.0 6754.1 3043.5 1762.0 1917.3 3014.6 3565.0 3729.5 3181.0 3498.7 218.7 47.8 3995.4 2199.2 5051.0 6045.7 1576.9 5081.5 3382.7 3639.2 59.0 6346.8 2229.4 5579.8 29.1 61.0 5045.3 3396.0 2881.2 3458.4 8189.2 3670.3 5961.1 1726.4 760.9 1643.5 5220.3 4020.2 1047.7 863.4 5750.5 8931.2 5390.3 6365.7 3721.9 4717.6 7980.9 WDPCP "BBS15, C2orf86, CPLANE5, fritz, hFrtz" ENSG00000143951 "WD repeat containing planar cell polarity effector" O95876 2 63119559-63827843 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 18.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 169.9;Alveolar cells type 2: 128.0;Astrocytes: 124.7;Excitatory neurons: 261.4;Inhibitory neurons: 240.9;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 296.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044144 Uncertain Approved "Cell Junctions" Yes No "Cell Junctions" "HPA044144: AB_10969458" "unprognostic (3.36e-1)" "unprognostic (3.22e-2)" "unprognostic (1.95e-1)" "unprognostic (7.07e-2)" "unprognostic (2.95e-1)" "unprognostic (6.88e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-3)" "unprognostic (7.22e-2)" "unprognostic (6.48e-2)" "unprognostic (1.93e-1)" "unprognostic (4.87e-2)" "unprognostic (2.34e-3)" "unprognostic (6.02e-2)" "unprognostic (1.97e-1)" "unprognostic (2.25e-3)" "unprognostic (2.00e-1)" 4.7 3.6 9.6 2.5 12.0 8.3 3.3 17.8 16.0 2.5 5.2 1.6 1.8 3.9 4.0 2.0 4.2 2.8 4.9 9.2 8.9 3.6 2.4 2.5 3.3 8.7 7.9 11.7 4.6 1.5 2.9 1.9 2.6 10.4 2.6 1.9 12.3 2.2 2.1 5.3 3.4 1.7 3.0 2.2 3.3 3.3 5.1 6.0 3.7 3.5 3.0 2.7 1.8 1.1 18.9 5.2 4.6 3.3 4.0 3.7 4.6 3.0 4.3 2.2 2.8 2.3 3.3 2.6 5.8 3.5 2.9 3.3 3.4 2.3 2.8 3.3 5.7 3.8 6.1 3.5 2.8 2.5 5.0 4.1 2.3 1.9 2.9 1.9 3.7 2.9 6.7 2.3 5.7 2.9 5.3 5.8 5.1 3.9 2.7 1.7 6.2 4.3 5.0 1.9 2.5 5.2 5.2 3.7 4.4 5.3 4.7 3.8 3.9 4.7 4.6 7.2 4.0 3.6 5.3 3.6 10.3 5.2 5.3 5.3 6.6 2.8 1.5 1.9 1.5 3.7 1.8 1.7 2.6 2.3 3.1 2.3 3.6 1.9 3.8 1.3 2.7 1.5 1.1 9.6 12.0 17.8 16.0 9.2 8.9 8.7 7.9 11.7 10.4 2.2 6.0 18.9 6.0 169.9 128.0 124.7 8.0 4.1 3.2 4.3 2.8 16.1 4.4 3.2 10.1 7.2 59.6 1.8 22.9 2.5 5.5 0.8 1.9 2.6 46.7 17.9 6.2 14.4 0.0 7.8 261.4 2.2 2.6 13.5 6.6 3.7 65.0 7.4 5.0 1.8 4.0 11.8 240.9 1.3 4.1 3.0 4.4 17.5 4.4 8.4 5.4 103.0 3.8 7.5 6.2 136.2 296.3 1.8 1.6 3.8 5.1 1.5 0.5 4.5 98.8 27.4 0.0 8.6 5.7 16.1 9.5 2.3 3.4 1.9 9.4 4.0 1.1 1.7 VPS54 "HCC8, PPP1R164" ENSG00000143952 "VPS54 subunit of GARP complex" Q9P1Q0 2 63892146-64019428 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055894, HPA067981, HPA070582" Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282" "unprognostic (1.35e-1)" "unprognostic (3.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.46e-1)" "unprognostic (3.37e-1)" "unprognostic (9.47e-3)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.16e-1)" "unprognostic (4.62e-2)" "unprognostic (1.82e-1)" "prognostic favorable (2.03e-4)" "unprognostic (3.20e-1)" "unprognostic (8.38e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (1.57e-1)" "unprognostic (4.91e-2)" 11.8 11.6 8.7 10.7 10.3 15.1 14.6 14.4 9.5 13.6 11.1 11.7 13.1 14.6 12.4 10.9 12.5 10.5 8.5 8.6 9.1 16.1 14.5 13.2 11.2 9.5 9.6 8.0 14.7 17.1 28.5 13.1 13.6 10.4 17.6 13.5 17.5 37.1 12.9 9.4 11.0 12.3 12.9 9.2 13.0 14.5 13.5 9.3 13.3 17.9 10.0 11.3 11.0 9.8 11.8 23.3 11.9 22.5 17.4 15.7 17.1 16.6 14.3 21.4 15.0 14.9 22.0 14.9 15.8 10.5 20.1 22.3 10.7 22.1 12.9 27.1 23.0 15.9 14.7 10.0 38.9 15.0 10.3 6.2 16.3 19.8 10.5 22.7 18.0 23.0 11.3 16.6 13.4 19.4 10.1 10.9 11.5 13.8 22.9 9.1 10.8 21.8 9.0 17.1 13.1 13.1 19.6 12.8 16.3 17.8 17.3 11.9 20.6 16.8 19.3 15.3 11.8 23.9 30.8 8.7 20.4 14.3 20.5 16.4 1.0 0.7 0.3 0.5 0.6 0.5 0.6 0.4 0.5 0.4 0.7 0.6 0.5 0.6 0.7 0.5 0.6 0.9 0.2 8.7 10.3 14.4 9.5 8.6 9.1 9.5 9.6 8.0 10.4 9.2 9.3 11.8 16.6 16.0 22.3 62.7 5.2 11.1 8.7 6.4 3.4 20.9 11.8 9.8 14.3 15.7 14.2 1.8 12.5 6.5 6.4 11.1 1.9 6.8 53.9 9.3 16.6 13.4 13.2 2.1 71.6 13.2 6.8 11.8 15.8 11.0 2.5 15.2 10.8 15.4 8.1 23.5 81.8 17.4 2.0 9.8 9.3 37.4 18.6 12.2 5.4 76.8 9.6 9.4 3.1 105.6 108.9 11.3 12.8 12.4 7.7 17.3 11.6 9.9 10.6 16.2 19.7 13.4 12.8 14.9 8.3 9.4 10.4 5.5 7.5 15.9 12.9 13.8 REG3G "LPPM429, PAP1B, UNQ429" ENSG00000143954 "Regenerating family member 3 gamma" Q6UW15 2 79025686-79028505 "Predicted secreted proteins" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pancreas: 3546.5" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 184.9;Pancreatic endocrine cells: 53.5;Proximal enterocytes: 39.4" "Cancer enriched" "Detected in many" 13 "pancreatic cancer: 71.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047894, HPA048334, HPA060705" Uncertain Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (8.82e-2)" "unprognostic (7.20e-3)" "unprognostic (5.64e-2)" 0.8 46.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 2.4 0.1 167.2 0.3 0.3 0.0 0.2 0.0 0.0 5.9 0.4 0.1 0.0 0.0 0.0 0.0 0.2 3546.5 0.0 0.3 1.1 0.0 0.1 0.0 0.0 0.3 1.3 0.2 0.1 37.3 1.5 0.0 0.2 0.4 57.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.1 0.0 0.0 0.0 184.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 6.2 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 53.5 0.0 0.7 0.0 0.4 39.4 2.2 0.0 0.0 0.0 0.0 0.2 1.3 1.2 0.0 0.0 0.0 0.0 0.9 5.4 0.0 ASXL2 "ASXH2, FLJ10898, KIAA1685" ENSG00000143970 "ASXL transcriptional regulator 2" Q76L83 2 25733753-25878487 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034646, HPA058040" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034646: AB_2674261, HPA058040: AB_2683586" "unprognostic (4.78e-2)" "unprognostic (3.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.88e-2)" "unprognostic (2.98e-2)" "unprognostic (2.80e-1)" "unprognostic (2.68e-3)" "unprognostic (3.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.33e-3)" "unprognostic (1.82e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-1)" "unprognostic (3.75e-2)" 6.9 6.2 3.6 9.6 5.1 8.4 7.3 4.2 3.9 8.3 3.7 9.2 6.4 7.2 5.0 7.8 7.3 6.8 7.2 3.5 9.4 8.8 6.2 7.0 11.1 7.6 4.1 0.0 6.6 7.7 14.2 3.5 7.1 6.2 6.4 9.0 8.9 6.6 6.4 8.1 7.7 7.2 8.3 3.1 9.9 7.9 17.9 4.0 14.0 10.6 7.4 10.6 7.6 4.2 5.9 25.1 23.1 11.0 7.8 9.8 13.7 12.9 16.0 19.0 12.4 10.5 19.4 12.6 14.8 9.7 13.9 13.8 14.1 21.1 14.9 16.9 22.5 10.2 32.9 20.1 16.6 8.3 42.2 25.1 6.8 15.2 17.9 15.3 10.4 15.2 8.8 29.0 12.2 12.5 9.2 15.5 9.2 14.4 13.2 9.4 15.4 48.2 11.4 10.7 30.1 11.3 12.5 22.2 13.9 13.5 10.4 8.9 12.3 31.4 16.6 22.0 15.9 22.4 26.8 39.8 41.0 15.5 27.4 13.2 1.7 2.7 4.2 2.7 1.4 2.3 2.2 1.9 1.9 1.5 2.0 2.2 2.5 6.0 1.2 3.3 2.3 2.2 0.8 3.6 5.1 4.2 3.9 3.5 9.4 7.6 4.1 0.0 6.2 3.1 4.0 5.9 16.1 25.6 24.1 54.2 25.9 32.4 8.9 15.9 29.0 22.3 19.1 10.8 27.0 14.3 19.1 9.2 25.0 10.2 22.5 20.1 15.6 15.7 48.9 25.8 20.4 22.0 10.3 33.6 62.5 14.4 9.4 17.3 24.5 19.8 23.5 12.6 28.5 12.6 18.2 25.2 47.6 16.8 18.3 25.7 23.6 26.9 19.6 25.2 23.2 68.4 34.4 12.4 12.3 46.3 72.8 18.4 14.2 13.2 29.8 13.4 12.4 14.3 41.3 24.9 39.5 20.6 16.8 34.4 26.6 29.7 41.1 14.6 45.0 17.2 19.7 19.3 ETAA1 ETAA16 ENSG00000143971 "ETAA1 activator of ATR kinase" Q9NY74 2 67397322-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 4.7 11.2 2.8 4.3 3.1 3.9 7.2 4.1 3.3 6.4 3.9 4.8 3.7 7.0 6.3 5.9 6.7 4.4 3.6 2.5 2.8 6.1 5.3 5.4 6.6 3.3 3.0 2.3 7.4 8.3 6.1 3.3 4.2 3.0 5.0 4.5 5.8 6.2 3.9 3.5 6.2 5.5 5.1 2.7 5.5 5.3 4.6 2.8 6.4 6.4 3.1 5.0 5.1 6.6 3.5 7.9 5.9 10.2 9.0 7.6 10.4 8.0 8.2 10.8 8.7 8.3 4.8 9.3 14.8 4.4 6.8 12.1 9.5 8.9 10.0 12.3 8.6 6.8 8.1 14.7 7.1 7.2 8.3 7.4 8.3 13.8 6.4 9.7 13.7 13.8 11.8 6.8 6.1 12.0 3.5 12.3 9.0 10.3 12.7 6.3 8.6 16.0 6.8 10.5 5.1 8.5 16.7 8.4 7.6 8.0 9.9 6.6 4.0 9.6 11.6 8.9 5.6 9.8 6.8 6.5 11.6 10.9 8.6 9.0 1.3 1.1 0.9 2.2 1.8 2.4 3.5 2.0 1.3 1.4 3.6 2.7 2.4 0.1 2.0 2.6 2.0 3.2 1.3 2.8 3.1 4.1 3.3 2.5 2.8 3.3 3.0 2.3 3.0 2.7 2.8 3.5 7.7 22.4 21.0 10.4 7.6 2.4 7.9 8.3 6.8 5.1 8.8 8.4 10.1 15.7 9.1 12.9 0.0 6.6 9.1 3.5 11.7 17.8 0.6 15.0 15.0 7.8 10.7 13.7 6.3 18.4 6.3 10.9 6.6 11.1 6.3 15.4 10.4 8.9 4.8 5.0 6.6 7.1 2.0 5.1 1.5 1.9 12.2 4.8 1.8 2.8 9.4 6.5 15.5 15.1 13.6 20.4 4.7 13.2 7.0 8.0 5.9 15.0 16.6 4.6 0.0 8.9 7.3 12.7 8.2 7.9 2.6 2.1 7.2 14.1 7.0 6.1 SNRPG Sm-G ENSG00000143977 "Small nuclear ribonucleoprotein polypeptide G" P62308 2 70281362-70293740 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064152, HPA067814" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA064152: AB_2685199, HPA067814: AB_2685903" "unprognostic (6.42e-2)" "unprognostic (7.89e-2)" "unprognostic (6.10e-2)" "unprognostic (5.42e-2)" "unprognostic (1.29e-1)" "unprognostic (1.11e-3)" "unprognostic (1.75e-3)" "unprognostic (2.28e-2)" "unprognostic (3.60e-3)" "unprognostic (6.19e-2)" "unprognostic (1.00e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.37e-2)" "unprognostic (1.33e-1)" "unprognostic (8.96e-2)" "unprognostic (1.41e-2)" 61.4 92.7 59.2 86.7 60.7 119.0 86.0 62.0 86.4 50.8 64.5 88.7 62.7 55.7 103.9 96.2 46.0 40.9 87.2 58.5 68.4 89.2 96.3 60.3 101.5 62.4 61.3 58.7 49.7 53.5 70.1 60.9 84.5 62.7 54.1 81.1 93.6 59.7 46.4 89.0 41.8 63.7 52.1 62.2 77.2 61.6 60.5 61.1 141.2 61.7 84.6 97.7 92.3 56.8 66.8 398.0 414.3 412.2 240.0 146.5 157.1 369.0 255.4 230.5 332.8 307.2 718.7 258.1 355.1 180.6 202.2 404.9 253.9 415.1 355.7 356.7 333.2 404.5 474.0 256.6 875.4 194.0 602.3 313.6 140.2 198.1 312.8 308.8 135.0 341.5 301.1 645.3 254.8 266.9 479.0 541.5 961.8 430.4 489.9 340.2 350.4 507.9 419.0 483.9 367.1 238.1 204.4 235.9 201.1 295.8 250.7 202.1 470.1 232.9 235.3 440.2 246.3 520.4 188.1 228.3 731.8 211.1 510.0 260.9 163.1 168.5 181.1 144.2 219.2 147.4 209.1 193.4 168.8 202.5 166.0 157.8 188.9 88.1 135.8 222.4 273.0 230.1 264.8 59.2 60.7 62.0 86.4 58.5 68.4 62.4 61.3 58.7 62.7 62.2 61.1 66.8 191.7 201.9 198.9 7.2 237.0 299.1 340.3 625.6 143.4 88.8 192.3 239.1 145.7 178.7 314.8 202.3 33.3 655.3 175.7 249.1 534.1 389.6 51.0 253.2 184.7 209.1 186.6 319.4 7.4 391.5 818.7 173.3 119.3 188.4 213.3 140.7 175.3 391.8 390.8 65.6 8.7 301.5 370.2 186.6 270.8 45.4 175.8 194.0 224.1 5.6 329.1 446.1 208.1 4.5 13.8 434.1 271.6 159.1 251.9 366.1 226.5 676.1 401.8 91.4 184.1 181.3 244.4 340.7 367.4 236.6 318.2 521.5 220.2 125.9 324.1 375.1 ABHD1 "FLJ36128, LABH1" ENSG00000143994 "Abhydrolase domain containing 1" Q96SE0 2 27123789-27130812 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.8" "Group enriched" "Detected in many" 9 "Early spermatids: 295.1;Late spermatids: 1030.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.5;T-47d: 3.3;U-266/70: 3.0;U-266/84: 2.8" "Low region specificity" "Detected in all" HPA044390 Uncertain NA NA "HPA044390: AB_10959380" "unprognostic (1.20e-3)" "unprognostic (6.07e-3)" "unprognostic (7.71e-4)" "unprognostic (1.63e-2)" "unprognostic (6.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-3)" "unprognostic (2.75e-1)" "unprognostic (1.76e-1)" "unprognostic (9.09e-4)" "unprognostic (9.76e-2)" "unprognostic (1.70e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-2)" "unprognostic (3.09e-2)" "unprognostic (7.97e-2)" 1.2 0.6 0.9 0.1 0.8 0.0 0.5 1.5 1.1 0.1 0.3 0.0 0.0 0.3 0.4 0.2 0.2 0.2 0.5 0.8 0.7 0.3 3.3 0.1 0.2 1.0 0.7 0.7 0.4 0.1 0.4 0.2 0.0 1.0 0.7 0.0 0.4 1.5 0.2 1.9 0.0 0.1 0.3 1.0 0.1 0.2 21.8 1.0 0.0 0.4 1.7 0.1 0.0 0.0 0.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 1.5 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 3.0 2.8 0.0 0.1 0.1 0.1 0.0 0.2 0.8 0.6 0.0 0.2 0.5 0.3 0.3 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.9 0.8 1.5 1.1 0.8 0.7 1.0 0.7 0.7 1.0 1.0 1.0 0.7 0.8 0.0 0.0 4.9 1.0 0.0 3.3 0.0 2.8 5.1 1.9 2.8 3.1 1.5 0.0 0.0 8.4 0.2 0.9 0.2 0.0 0.3 295.1 0.4 0.6 1.9 0.0 3.2 0.6 0.2 0.0 1.3 0.0 0.5 1.3 1.6 2.5 3.9 0.1 0.0 0.8 0.2 0.0 0.3 0.3 1030.5 6.5 1.2 0.0 1.9 0.5 8.1 3.1 2.0 2.2 0.0 0.0 5.7 0.5 3.6 0.2 3.0 0.7 4.9 0.0 2.4 1.2 70.5 3.9 0.3 0.3 0.0 1.8 0.3 0.2 2.2 MEIS1 ENSG00000143995 "Meis homeobox 1" O00470 2 66433452-66573869 "Disease related genes, Predicted intracellular proteins, Transcription factors" Transcription "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 1.6;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011521, HPA056000, HPA058641" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784" "unprognostic (6.84e-2)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "prognostic favorable (2.70e-5)" "unprognostic (2.45e-2)" "unprognostic (7.78e-3)" "unprognostic (2.36e-2)" "unprognostic (5.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-2)" 12.5 52.4 7.5 12.1 10.3 2.5 13.2 32.1 8.5 81.6 4.1 53.3 5.7 84.7 23.2 23.2 83.4 15.8 12.9 4.6 9.2 9.5 3.9 34.4 2.3 15.2 12.4 5.0 43.9 45.4 7.0 1.6 15.4 16.0 34.1 12.4 43.4 39.4 35.7 5.7 9.9 19.9 50.4 9.8 18.5 32.0 2.9 9.7 4.7 5.8 3.4 6.9 39.5 56.4 19.4 0.3 1.6 12.4 2.7 16.3 10.9 1.6 17.0 43.5 14.4 15.2 1.5 12.3 0.0 4.2 13.5 0.8 2.0 7.7 7.5 14.1 0.0 6.9 20.3 29.3 3.1 31.3 0.0 5.8 9.6 8.8 6.0 2.4 11.5 6.7 3.3 1.8 0.0 0.6 0.7 1.8 0.4 0.3 1.6 1.8 0.0 3.3 3.6 1.2 4.0 3.8 26.2 3.0 1.0 1.3 9.4 1.3 2.5 2.1 3.1 4.8 2.3 4.8 3.4 1.1 0.1 2.3 18.2 0.8 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.5 1.6 0.0 1.3 0.1 2.1 7.5 10.3 32.1 8.5 4.6 9.2 15.2 12.4 5.0 16.0 9.8 9.7 19.4 0.6 0.0 0.5 55.5 0.2 3.2 11.9 10.1 15.4 19.8 2.5 1.4 18.7 1.5 8.3 0.0 110.5 5.7 0.4 2.1 0.0 21.6 10.3 36.8 117.2 4.4 1.2 5.9 6.5 17.5 1.6 19.4 7.1 27.9 0.0 0.2 16.1 1.8 2.2 82.4 5.8 0.7 10.2 1.4 1.9 14.1 34.5 10.3 3.6 15.9 0.5 21.4 1.0 54.3 227.5 20.1 67.3 28.2 0.0 2.4 0.6 3.2 6.8 121.0 19.7 6.7 12.5 2.7 2.0 17.9 2.3 1.9 2.0 6.3 1.2 18.8 TRIM43B ENSG00000144010 "Tripartite motif containing 43B" A6NCK2 2 95477164-95484731 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042223, HPA042772" Uncertain NA NA "HPA042223: AB_10962361, HPA042772: AB_10964436" "unprognostic (3.93e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM43 TRIM43A ENSG00000144015 "Tripartite motif containing 43" Q96BQ3 2 95592001-95599778 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 1.4;Spermatogonia: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042223, HPA042772" Uncertain NA NA "HPA042223: AB_10962361, HPA042772: AB_10964436" "unprognostic (7.17e-3)" "unprognostic (1.42e-1)" "unprognostic (9.27e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CIAO1 "CIA1, WDR39" ENSG00000144021 "Cytosolic iron-sulfur assembly component 1" O76071 2 96266159-96274173 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017882 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017882: AB_1846738" "unprognostic (2.34e-1)" "unprognostic (4.68e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.55e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (9.86e-2)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.26e-2)" "unprognostic (2.15e-2)" 17.9 32.6 28.1 17.2 29.0 12.2 19.6 31.1 30.6 19.1 26.6 16.9 20.2 15.0 18.2 20.2 19.9 15.3 30.7 29.2 28.2 31.3 33.0 17.8 22.5 29.2 28.8 28.4 18.8 18.0 36.5 13.5 18.9 29.1 17.1 17.8 17.5 23.8 19.7 28.0 19.5 17.8 16.7 29.8 21.5 16.9 17.2 29.5 22.4 20.7 28.2 21.5 18.8 14.0 31.1 31.8 27.2 28.8 32.3 49.8 40.9 32.0 27.1 31.9 37.5 39.8 44.1 23.0 44.6 46.6 29.8 42.0 28.0 40.8 29.7 33.4 25.0 58.0 28.9 19.4 47.4 28.8 37.8 32.2 35.1 34.5 28.5 43.2 35.9 39.9 33.8 36.9 29.8 35.9 38.1 42.2 40.8 51.3 44.5 58.0 38.3 33.2 47.3 42.6 31.6 36.0 42.2 19.9 48.0 53.1 40.1 24.8 41.4 30.4 26.2 35.4 36.7 29.3 43.5 49.6 30.1 38.4 37.9 31.4 30.9 27.7 34.2 27.8 23.8 31.9 20.9 25.8 29.8 29.1 24.9 24.3 28.5 23.6 30.0 33.8 18.8 23.5 33.0 28.1 29.0 31.1 30.6 29.2 28.2 29.2 28.8 28.4 29.1 29.8 29.5 31.1 33.3 28.9 31.4 26.8 32.4 29.1 28.7 39.0 35.9 24.3 23.2 28.4 27.0 15.7 31.6 14.7 14.6 59.3 42.5 21.8 39.2 40.0 25.0 21.2 30.7 30.1 15.7 32.4 44.5 33.6 60.1 32.6 28.1 21.2 37.2 33.3 19.2 27.4 45.2 26.9 36.6 21.1 44.7 23.4 29.6 25.8 20.2 30.6 19.6 20.6 40.6 19.0 42.2 25.1 25.2 35.5 13.0 16.6 44.8 51.7 43.6 72.7 36.2 24.0 32.9 27.3 34.4 42.5 42.3 43.5 34.5 49.8 38.6 54.5 23.6 43.0 ZNF514 FLJ14457 ENSG00000144026 "Zinc finger protein 514" Q96K75 2 95145000-95165413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028974 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028974: AB_10603845" "unprognostic (8.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (4.68e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" "unprognostic (5.17e-2)" "unprognostic (1.80e-3)" "unprognostic (4.33e-2)" "unprognostic (1.91e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-2)" 9.3 9.3 13.8 6.0 14.1 2.5 13.3 14.6 15.5 17.4 12.2 12.3 10.3 15.8 27.0 7.9 14.6 6.0 9.4 14.5 12.5 12.4 6.7 9.1 8.8 15.5 13.1 13.6 23.4 10.3 12.8 17.4 8.2 15.2 15.0 10.0 30.2 11.8 11.4 14.5 15.1 9.9 10.6 11.5 10.2 10.9 11.3 14.4 10.2 18.1 13.4 8.2 11.5 13.1 16.5 16.7 5.5 16.0 11.5 11.1 15.0 12.2 6.6 7.2 11.0 11.2 9.3 6.5 2.8 3.3 7.1 16.8 10.7 8.6 6.3 12.2 5.5 11.1 3.2 8.8 7.6 4.6 1.9 8.3 8.9 18.9 6.9 4.7 16.4 5.1 9.5 9.3 3.4 8.9 8.2 5.0 10.3 5.3 5.4 6.0 8.5 5.8 6.1 7.1 6.6 14.8 11.2 7.1 3.5 7.6 21.6 6.3 6.4 5.9 7.9 9.9 2.7 5.6 8.5 6.9 4.9 8.2 3.7 5.2 12.7 4.3 8.4 3.9 2.3 4.7 6.8 5.1 3.7 4.2 7.0 8.5 7.0 1.4 6.1 2.6 3.5 6.2 4.2 13.8 14.1 14.6 15.5 14.5 12.5 15.5 13.1 13.6 15.2 11.5 14.4 16.5 8.0 9.6 7.9 20.2 4.6 5.6 9.9 8.0 2.2 13.9 9.4 11.9 14.0 12.8 6.7 0.0 18.8 6.3 4.9 6.3 27.4 6.6 44.1 7.1 7.9 8.0 9.6 7.0 22.8 5.2 3.5 7.2 4.6 5.3 1.3 27.9 7.1 9.4 8.3 15.2 22.3 10.6 10.2 5.1 2.2 43.2 10.5 5.4 7.2 13.1 5.9 12.9 8.2 15.1 34.3 4.9 5.1 7.5 3.1 10.0 10.3 18.2 10.3 31.5 6.6 7.9 8.0 20.6 12.5 3.8 6.3 3.7 4.7 8.2 8.7 10.7 SNRNP200 "ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD" ENSG00000144028 "Small nuclear ribonucleoprotein U5 subunit 200" O75643 2 96274338-96321271 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029321 Approved Supported Nucleoplasm NA NA 78000 Nucleoplasm "HPA029321: AB_10604096" "unprognostic (2.63e-2)" "unprognostic (1.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (2.48e-3)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (6.46e-2)" "unprognostic (2.61e-2)" "unprognostic (1.82e-1)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" 26.7 22.0 10.7 38.4 10.8 59.4 39.0 16.5 10.5 32.2 22.3 29.9 29.7 41.4 20.4 29.8 40.1 26.0 27.1 9.8 16.1 29.1 29.6 29.6 43.6 12.7 9.6 8.7 53.7 34.6 52.8 19.9 39.6 11.6 31.8 34.9 68.2 35.4 33.3 47.9 31.1 30.5 38.8 12.0 36.8 30.9 40.7 9.4 74.2 37.7 39.0 52.7 30.3 21.8 14.0 97.8 107.7 144.1 106.1 63.1 57.1 131.5 67.3 80.6 119.5 112.9 197.3 69.3 169.3 101.3 83.3 178.9 74.9 264.4 88.8 130.8 94.3 139.4 221.6 169.8 106.7 40.9 171.2 92.4 58.1 53.7 133.2 112.0 61.3 97.3 98.3 198.2 112.3 68.3 82.3 158.8 49.4 182.8 77.9 102.4 185.0 139.3 107.4 43.8 145.4 159.8 150.5 107.7 88.7 65.4 165.0 86.4 100.5 86.2 98.3 117.2 101.3 96.2 101.0 134.0 207.6 66.2 109.0 106.2 16.7 4.7 6.0 7.9 5.0 8.9 5.7 6.0 9.5 5.6 6.1 5.2 7.1 4.7 7.3 6.1 5.8 6.8 5.5 10.7 10.8 16.5 10.5 9.8 16.1 12.7 9.6 8.7 11.6 12.0 9.4 14.0 47.3 44.8 53.9 21.9 57.4 29.6 27.2 35.5 38.1 79.3 40.2 42.4 35.2 54.3 46.2 51.5 104.3 43.2 64.2 43.4 5.9 42.6 29.3 42.4 48.7 44.8 46.7 54.1 21.2 46.7 36.1 37.9 52.0 48.8 25.3 79.0 40.4 49.4 35.1 87.5 21.1 40.6 34.6 31.9 33.2 18.2 57.5 35.2 17.8 16.9 45.2 79.1 73.2 17.1 16.7 46.1 30.7 55.3 68.3 34.8 47.3 17.9 50.7 135.2 65.7 54.7 45.5 77.6 56.0 38.7 33.0 44.6 71.6 53.3 49.4 30.3 MRPS5 "MRP-S5, S5mt" ENSG00000144029 "Mitochondrial ribosomal protein S5" P82675 2 95085369-95149434 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055765 Approved Supported Mitochondria No No Mitochondria "HPA055765: AB_2682911" "unprognostic (1.18e-1)" "unprognostic (7.79e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (7.98e-7)" "unprognostic (7.51e-3)" "unprognostic (6.30e-3)" "prognostic unfavorable (7.73e-5)" "unprognostic (8.59e-2)" "unprognostic (1.87e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-1)" "prognostic favorable (6.36e-4)" "unprognostic (1.25e-1)" 24.4 33.9 5.8 3.8 5.9 7.6 22.5 7.0 7.2 23.9 6.2 31.6 7.0 24.3 4.8 34.8 24.5 3.6 46.0 5.9 5.8 34.5 54.0 24.5 5.5 5.9 5.8 5.6 25.1 24.3 6.8 20.0 3.8 6.1 18.7 7.0 5.0 24.9 3.0 71.8 19.4 27.0 5.1 5.4 25.2 30.4 19.6 5.9 6.3 24.0 13.8 5.5 23.9 25.0 6.4 18.8 14.8 8.1 7.8 8.6 10.6 15.3 9.5 4.2 7.1 7.6 28.7 12.9 18.4 7.5 8.4 17.1 11.3 14.0 11.8 13.8 13.0 11.2 11.6 12.3 22.8 11.6 16.5 7.3 10.5 9.3 12.0 12.5 9.0 12.3 10.4 18.0 7.8 10.4 15.1 18.6 17.8 9.0 16.5 13.5 10.5 8.0 21.3 17.4 18.5 12.4 7.8 8.2 17.2 17.6 12.8 7.4 16.0 9.5 10.6 12.9 15.1 15.5 7.6 8.9 14.0 8.8 16.3 9.6 2.5 5.4 3.8 3.6 7.2 4.4 4.5 4.8 4.2 4.8 3.3 4.2 4.4 2.2 3.6 7.4 3.3 5.9 4.2 5.8 5.9 7.0 7.2 5.9 5.8 5.9 5.8 5.6 6.1 5.4 5.9 6.4 46.3 80.1 84.6 33.3 52.3 34.8 59.1 112.5 56.9 52.8 42.1 40.5 130.2 58.6 74.4 66.2 50.1 81.8 51.2 68.3 185.9 74.8 68.3 48.5 69.9 48.1 59.4 79.3 31.8 55.4 83.8 53.9 51.0 43.0 40.4 90.7 50.3 129.8 74.1 47.1 29.3 65.0 109.9 51.8 41.2 48.9 51.3 55.3 44.4 7.5 61.5 29.7 44.3 30.7 40.3 50.2 44.2 53.4 69.7 68.1 87.3 131.8 72.3 69.0 39.5 52.2 59.5 80.9 99.1 78.7 32.0 39.4 57.4 60.7 104.5 48.2 ANKRD53 "FLJ12056, FLJ36160" ENSG00000144031 "Ankyrin repeat domain 53" Q8N9V6 2 70978380-70985499 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.7" "Group enriched" "Detected in many" 21 "Early spermatids: 158.6;Late spermatids: 481.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 7.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;HHSteC: 1.6;HSkMC: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA049574 Approved NA NA "HPA049574: AB_2680819" "unprognostic (6.11e-3)" "unprognostic (6.51e-2)" "unprognostic (1.70e-3)" "unprognostic (2.68e-1)" "unprognostic (2.01e-2)" "unprognostic (6.31e-3)" "unprognostic (2.20e-1)" "unprognostic (6.35e-2)" "unprognostic (3.53e-1)" "unprognostic (1.27e-1)" "unprognostic (6.39e-3)" "unprognostic (1.83e-1)" "unprognostic (1.13e-2)" "unprognostic (1.68e-3)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" 6.1 1.8 0.8 0.6 0.3 0.3 6.2 1.4 0.7 1.7 0.0 1.7 0.7 1.8 0.4 0.7 3.0 0.7 0.9 0.3 0.2 0.8 0.6 1.3 0.3 0.8 0.5 0.1 4.2 8.3 0.3 3.2 0.3 0.6 2.0 0.3 6.2 4.6 0.6 0.4 0.8 1.7 0.6 0.4 0.8 2.0 27.7 0.3 0.1 3.1 0.3 0.3 1.6 1.6 0.6 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.1 0.4 0.4 0.4 0.2 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 1.6 0.0 0.4 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.8 0.3 1.4 0.7 0.3 0.2 0.8 0.5 0.1 0.6 0.4 0.3 0.6 1.1 0.0 0.0 0.3 1.1 0.1 1.4 0.5 4.6 1.3 0.3 1.3 0.4 1.5 0.1 0.0 2.1 0.1 1.0 0.0 0.0 1.2 158.6 4.3 0.5 0.7 0.0 0.4 0.4 0.4 1.0 1.9 1.1 2.2 0.0 0.4 1.1 0.2 0.0 1.7 1.2 0.0 0.0 0.0 0.4 481.3 3.4 0.4 0.0 0.0 0.0 4.1 0.0 1.5 0.3 0.5 0.0 3.0 11.7 0.7 0.1 1.5 0.6 15.1 6.6 2.8 1.5 1.5 1.7 0.6 0.0 0.3 0.4 0.1 0.1 0.1 TPRKB "CGI-121, CGI121" ENSG00000144034 "TP53RK binding protein" Q9Y3C4 2 73729104-73737400 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 259.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035712 Approved Supported Cytosol NA NA Cytosol "HPA035712: AB_10669674" "unprognostic (1.11e-1)" "unprognostic (2.41e-2)" "unprognostic (6.59e-2)" "unprognostic (2.31e-2)" "unprognostic (2.74e-1)" "unprognostic (2.67e-2)" "unprognostic (1.21e-3)" "unprognostic (4.96e-2)" "unprognostic (3.16e-3)" "unprognostic (3.01e-3)" "unprognostic (5.10e-3)" "unprognostic (6.06e-2)" "unprognostic (2.68e-3)" "unprognostic (5.66e-2)" "unprognostic (8.45e-3)" "unprognostic (1.82e-1)" "unprognostic (5.03e-2)" 22.2 23.3 13.7 22.5 14.3 70.8 43.1 16.6 17.3 32.9 14.6 36.9 39.0 30.5 36.2 31.3 55.3 20.4 30.2 14.0 14.6 35.8 39.6 17.5 37.3 15.0 14.3 13.5 36.4 26.9 18.6 12.8 22.8 15.1 25.3 34.2 16.3 31.3 19.2 68.8 25.9 35.8 29.4 14.8 22.5 25.1 52.2 14.1 37.4 21.5 51.4 34.0 26.5 25.4 15.1 106.1 73.3 73.4 85.5 27.2 37.6 62.2 73.5 40.0 72.2 54.2 110.8 66.0 67.0 54.0 38.2 130.7 62.6 60.6 77.6 116.0 53.4 79.2 135.7 49.8 90.6 26.6 198.3 72.8 27.2 43.6 76.4 76.3 37.4 76.9 114.7 119.8 105.1 75.5 56.4 142.5 130.6 94.9 130.5 93.9 83.6 211.6 93.8 67.2 89.8 69.1 83.1 53.1 79.5 105.6 59.8 58.7 78.6 48.5 62.4 104.7 113.6 182.6 69.1 127.6 176.9 55.9 131.2 78.4 32.5 18.2 29.1 16.5 28.5 26.4 23.9 23.6 22.3 22.1 20.9 27.0 25.5 13.1 24.6 21.5 30.1 25.4 15.8 13.7 14.3 16.6 17.3 14.0 14.6 15.0 14.3 13.5 15.1 14.8 14.1 15.1 56.3 32.1 39.8 7.2 43.1 53.2 66.8 123.0 38.7 15.0 51.8 94.9 63.5 50.1 70.6 22.0 4.2 81.3 39.7 64.0 88.0 95.4 138.9 50.2 42.7 81.9 33.6 62.1 8.6 184.9 107.9 45.1 17.9 43.4 48.7 51.3 148.2 44.3 86.7 8.4 8.7 71.2 71.2 55.6 60.0 28.9 59.0 52.1 33.8 2.8 65.0 36.6 64.9 10.1 8.3 110.7 76.9 52.3 35.6 47.8 103.4 154.9 54.4 21.8 52.6 61.7 46.2 259.3 87.8 44.8 53.0 45.6 42.8 53.9 85.4 58.2 NAT8 "ATase2, GLA, Hcml1, TSC501" ENSG00000144035 "N-acetyltransferase 8 (putative)" Q9UHE5 2 73640723-73642422 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 739.2" "Cell type enriched" "Detected in some" 13 "Proximal tubular cells: 2565.5" "Cancer enriched" "Detected in some" 5 "renal cancer: 242.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "Hep G2: 10.7" "Low region specificity" "Detected in all" "HPA067855, HPA074519" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA067855: AB_2732774, HPA074519: AB_2686699" "unprognostic (4.51e-2)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (4.95e-3)" "unprognostic (2.46e-1)" "unprognostic (1.90e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (8.60e-2)" "unprognostic (1.37e-3)" "unprognostic (2.07e-2)" "unprognostic (4.11e-3)" "unprognostic (2.13e-2)" "unprognostic (8.36e-5)" 0.1 0.3 1.3 0.1 0.7 0.1 0.2 0.2 0.9 0.2 0.0 1.1 4.7 0.1 0.0 0.0 1.2 0.6 0.0 1.1 0.6 739.2 83.3 0.2 0.0 0.6 0.2 1.0 1.3 0.2 0.0 0.6 0.0 0.5 0.2 0.1 1.8 0.1 0.1 0.0 0.0 7.3 0.1 0.0 1.1 0.6 0.5 0.7 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.2 0.9 1.1 0.6 0.6 0.2 1.0 0.5 0.0 0.7 1.1 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 36.8 0.0 0.0 0.0 0.3 187.9 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 22.9 51.1 0.0 0.0 0.0 1.1 0.0 1.0 0.4 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 61.3 2565.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.6 0.1 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.2" "Cell type enhanced" "Detected in many" "Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 11.4 13.5 22.5 4.3 32.3 1.2 8.7 19.6 25.6 11.0 6.1 7.8 7.3 10.2 6.1 15.2 7.8 6.6 51.2 21.7 22.5 7.3 3.8 7.3 3.1 26.2 26.0 18.5 15.1 5.0 13.4 6.1 13.1 25.7 8.0 5.8 14.2 7.7 9.0 11.2 25.8 9.2 10.1 18.8 5.3 6.9 6.9 22.8 4.4 10.3 11.6 6.5 9.8 13.1 39.5 21.7 16.3 14.7 17.8 41.2 16.9 25.3 15.6 21.9 13.2 8.6 22.3 3.3 5.6 9.5 26.2 19.6 35.4 12.4 25.7 18.9 4.2 10.1 16.7 11.0 12.8 22.2 2.4 5.5 14.6 36.6 14.9 23.1 20.6 21.8 8.7 1.8 0.0 17.6 7.5 6.4 2.9 15.3 14.9 9.0 3.4 26.4 2.3 12.7 50.1 7.3 6.3 26.7 8.2 10.9 16.1 5.7 2.3 24.3 15.2 12.8 13.1 9.6 5.5 5.9 0.0 17.7 1.2 12.4 1.3 0.5 0.0 0.7 0.4 0.5 0.7 0.5 0.4 0.4 0.7 0.6 0.9 0.0 0.5 0.6 0.1 0.8 0.4 22.5 32.3 19.6 25.6 21.7 22.5 26.2 26.0 18.5 25.7 18.8 22.8 39.5 17.8 0.0 4.1 210.3 4.1 26.1 10.2 9.8 14.8 17.4 5.2 5.2 87.1 12.8 5.1 9.2 25.0 15.1 5.0 10.2 5.9 9.3 62.9 5.6 14.5 14.1 3.0 2.1 351.1 11.5 13.2 12.4 30.5 9.2 8.2 11.6 11.4 5.6 4.6 16.8 393.6 6.0 4.1 12.0 7.1 8.2 8.4 5.0 5.4 286.7 2.0 9.9 1.0 288.5 863.3 11.0 8.6 7.5 3.7 8.1 28.2 5.5 8.4 11.1 0.0 13.5 14.7 12.0 4.9 13.1 37.4 24.6 4.7 5.5 4.5 10.7 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.1" "Cell type enhanced" "Detected in many" "Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4" "Cancer enhanced" "Detected in all" "glioma: 13.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: AB_2683261" "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 3.2 11.8 44.2 4.7 36.9 13.8 2.5 36.0 64.1 2.9 17.4 5.9 7.0 3.2 16.8 3.1 4.2 4.0 3.4 42.8 37.7 11.5 29.6 3.6 3.9 44.5 42.3 35.4 2.6 2.4 2.1 3.6 3.7 44.2 4.2 5.7 6.3 2.2 4.5 7.8 4.6 6.6 4.0 35.0 5.6 4.7 2.4 48.0 4.9 3.7 4.7 3.0 3.9 2.3 34.3 4.2 9.1 13.7 11.5 3.0 5.0 5.4 8.4 5.4 13.3 6.9 13.7 10.7 2.3 8.8 8.9 9.2 3.7 10.8 11.1 6.0 10.2 6.7 10.7 11.0 18.7 4.4 5.9 11.1 5.8 3.5 9.0 1.1 4.9 7.4 3.2 9.5 2.9 4.3 8.7 1.5 9.5 17.1 8.1 6.6 10.6 12.2 3.1 8.1 10.5 9.0 2.7 8.6 4.3 3.5 7.7 2.2 5.3 6.8 4.1 13.5 6.1 10.2 4.0 4.1 3.1 15.0 10.3 5.3 4.7 6.0 3.5 0.6 2.6 0.9 1.6 0.3 0.7 2.7 2.4 0.4 0.5 4.6 4.3 3.2 1.9 0.7 1.7 44.2 36.9 36.0 64.1 42.8 37.7 44.5 42.3 35.4 44.2 35.0 48.0 34.3 7.1 0.0 4.4 405.2 4.8 4.7 4.3 7.6 4.6 26.8 6.9 5.5 5.8 7.2 4.8 36.8 33.3 12.4 6.8 18.4 3.9 5.1 96.4 5.1 13.1 7.6 13.8 13.7 84.4 9.1 2.4 8.9 9.2 11.2 0.0 42.8 9.3 61.3 12.4 20.2 57.4 8.6 2.0 8.7 9.6 168.4 10.5 9.6 8.8 43.1 19.7 65.8 10.3 40.2 29.9 8.0 6.5 11.3 7.1 3.6 17.5 22.2 3.2 42.3 13.1 12.2 8.8 11.2 15.7 7.3 9.2 4.2 6.3 15.9 8.8 2.3 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985942-70994873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 39.9 39.1 30.2 21.7 32.7 20.1 30.0 32.3 30.8 32.5 35.8 28.6 25.2 25.6 45.9 27.7 35.6 22.9 34.6 28.4 35.5 41.5 39.1 30.6 22.2 38.7 33.5 26.1 39.9 47.9 66.6 29.4 25.2 32.5 31.9 33.0 44.2 36.3 34.6 56.9 21.1 25.8 34.3 31.8 23.7 30.2 37.2 32.0 25.9 46.5 54.8 27.3 26.5 21.8 33.4 61.9 57.1 39.4 50.3 116.4 58.9 44.7 69.8 65.6 79.1 49.6 67.5 49.8 50.2 25.9 122.5 74.7 45.6 75.3 82.7 113.8 38.4 62.8 60.1 28.7 71.8 68.3 70.7 48.7 53.7 54.3 76.2 51.6 43.4 81.5 51.3 75.7 32.4 93.6 48.2 61.2 39.3 26.2 98.7 66.4 43.1 120.7 43.1 57.7 53.1 64.0 33.8 72.3 70.9 46.0 26.2 46.3 41.3 66.1 96.8 83.6 52.4 93.8 25.3 23.9 58.4 84.4 91.7 83.2 8.7 3.8 7.7 3.4 3.9 2.9 1.8 3.7 4.6 2.9 2.7 4.1 3.3 2.8 2.6 3.9 3.1 3.3 2.1 30.2 32.7 32.3 30.8 28.4 35.5 38.7 33.5 26.1 32.5 31.8 32.0 33.4 14.7 3.2 14.7 9.4 11.3 8.3 10.7 8.2 5.7 14.7 20.6 14.9 22.9 20.0 8.4 23.9 37.5 16.4 9.0 21.8 7.9 24.9 15.7 10.8 11.9 15.5 8.4 17.4 8.0 23.8 17.4 16.3 12.2 13.3 2.5 17.1 16.4 35.2 19.5 8.4 7.5 18.2 8.2 18.3 6.4 28.5 15.8 11.9 19.6 6.5 13.0 28.1 14.4 15.1 12.6 21.1 14.9 18.4 7.4 12.9 24.4 18.3 5.5 72.9 0.0 16.7 15.0 45.3 11.2 12.8 7.5 17.9 8.7 14.4 18.9 7.7 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526281 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 16.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 17.3;Gastric mucus-secreting cells: 13.7;Intestinal goblet cells: 17.3;Paneth cells: 13.9;Proximal enterocytes: 44.2;Undifferentiated cells: 12.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.8;Hep G2: 18.4;hTCEpi: 6.1;OE19: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039158, HPA046763" Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA039158: AB_10960125, HPA046763: " "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.0 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.2 0.4 0.0 6.4 16.5 0.0 0.0 1.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 5.6 0.0 0.4 0.0 0.0 1.1 14.0 0.5 0.0 0.1 3.2 0.0 0.1 0.0 0.0 0.0 1.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.6 0.1 5.8 0.1 0.0 0.0 0.5 0.2 18.4 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 15.5 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 2.4 0.0 0.9 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.5 0.5 0.1 4.5 4.6 0.4 0.1 0.0 0.3 1.5 3.5 0.0 2.1 1.6 0.0 17.3 0.0 0.0 0.0 0.2 0.1 0.0 2.4 0.0 0.6 0.0 0.8 0.6 13.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 17.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 13.9 0.0 0.4 0.0 44.2 0.0 5.0 0.9 0.0 0.1 0.1 0.6 0.3 3.1 0.0 1.1 0.1 0.0 12.5 0.2 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" Yes Yes "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: AB_2670577" "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavorable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 15.6 13.4 7.2 17.3 8.3 35.5 20.6 13.9 11.2 22.6 8.2 16.1 17.5 21.4 19.5 30.7 39.3 16.0 14.4 8.2 7.1 20.3 18.1 14.4 25.5 7.1 6.4 7.7 23.7 11.1 14.8 14.1 20.7 8.7 16.6 17.5 8.4 16.2 14.6 14.4 27.8 15.4 19.8 5.3 19.2 16.4 16.9 7.0 25.0 16.7 17.9 26.3 25.5 22.6 8.8 39.4 16.7 17.6 18.6 31.2 38.7 31.2 28.2 36.7 35.8 36.4 24.2 29.1 50.6 17.7 30.6 32.1 26.7 22.0 56.8 34.3 35.2 22.9 31.2 12.0 37.3 32.7 35.5 28.0 31.6 67.3 32.1 44.1 31.1 40.4 24.2 33.6 28.6 40.2 21.3 34.3 37.6 28.4 36.7 22.7 13.6 47.3 46.0 29.3 32.1 25.9 14.1 26.1 30.6 35.7 21.0 16.4 18.6 23.1 25.4 31.4 29.5 33.7 30.7 26.2 68.1 23.5 35.5 25.3 72.5 42.2 99.5 56.3 39.3 73.5 68.3 65.8 67.4 47.3 65.9 69.4 65.5 65.2 69.8 40.6 35.7 88.6 71.7 7.2 8.3 13.9 11.2 8.2 7.1 7.1 6.4 7.7 8.7 5.3 7.0 8.8 26.5 9.6 12.0 7.5 39.5 83.2 55.1 93.0 39.3 11.0 12.9 15.1 8.6 27.1 45.7 12.9 4.2 32.8 34.8 15.5 50.9 29.6 9.1 18.0 15.7 34.6 12.0 21.0 14.9 27.3 42.0 26.5 16.3 13.6 40.7 20.5 52.1 15.3 30.7 5.0 12.7 18.0 36.7 20.2 27.1 7.0 28.9 17.0 23.2 10.3 34.8 9.8 41.2 13.0 13.8 28.2 17.8 25.6 31.8 30.0 22.8 50.4 38.2 16.6 6.6 18.2 23.1 23.8 34.6 42.8 83.0 38.6 39.8 20.7 18.8 60.9 ST6GAL2 "KIAA1877, SIAT2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.4;thyroid gland: 29.0" "Group enriched" "Detected in some" 4 "Astrocytes: 58.8;Excitatory neurons: 78.7;Granulosa cells: 111.5;Inhibitory neurons: 44.8;Oligodendrocyte precursor cells: 94.0" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;hTERT-RPE1: 6.4;NTERA-2: 4.4;PC-3: 5.9;RPMI-8226: 9.6;SCLC-21H: 6.1;U-138 MG: 7.5;U-266/70: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 0.5 0.1 6.8 0.2 7.6 1.0 0.7 0.0 11.4 1.7 0.0 0.9 0.2 2.6 0.3 1.8 0.7 5.2 0.5 11.1 0.4 0.4 2.6 0.6 0.4 0.0 0.4 8.0 0.6 0.1 0.1 0.1 1.6 5.4 0.8 2.3 1.9 0.8 0.8 0.1 0.7 0.4 2.0 0.0 0.1 0.6 5.3 3.5 0.1 29.0 0.0 0.3 0.6 1.0 3.8 0.0 5.3 2.8 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.3 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 6.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.4 0.0 5.9 0.0 0.0 9.6 0.2 0.0 6.1 3.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.5 0.1 0.2 0.0 9.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 6.8 7.6 0.0 11.4 11.1 0.4 0.0 0.4 8.0 5.4 0.0 3.5 3.8 0.0 0.0 0.0 58.8 0.0 0.9 0.2 0.0 18.8 6.6 0.2 3.4 1.4 0.0 0.6 1.8 0.0 0.0 0.0 4.7 0.0 0.1 0.4 0.8 12.2 0.3 1.2 6.3 78.7 0.0 0.0 1.7 0.0 0.5 0.0 111.5 2.2 0.0 0.2 0.0 44.8 3.3 0.0 0.0 0.0 1.2 0.3 0.1 0.0 2.8 0.0 0.9 0.0 94.0 1.9 0.0 1.0 0.7 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.2 2.9 0.1 1.1 4.3 0.0 0.3 0.1 0.1 3.2 0.0 NPHP1 "JBTS4, NPH1, SLSN1" ENSG00000144061 "Nephrocystin 1" O15259 2 110122311-110205066 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.6" "Cell type enhanced" "Detected in many" "Early spermatids: 148.5;Endometrial ciliated cells: 136.3;Respiratory ciliated cells: 167.4;Spermatocytes: 146.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046093, HPA074071" Approved NA NA "HPA046093: AB_2679535, HPA074071: " "unprognostic (2.10e-2)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (5.58e-2)" "unprognostic (4.63e-2)" "unprognostic (1.56e-3)" "unprognostic (4.66e-2)" "unprognostic (1.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.66e-2)" "unprognostic (1.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-3)" "unprognostic (3.35e-2)" "unprognostic (1.82e-1)" "unprognostic (8.64e-2)" 3.0 3.8 5.7 1.1 5.2 0.1 4.0 4.8 8.7 4.4 10.1 4.1 1.0 5.5 9.1 1.3 17.3 3.3 4.4 5.1 6.2 7.5 0.8 4.3 0.9 5.7 5.9 5.0 4.6 3.2 17.1 11.8 1.3 5.3 4.4 1.7 10.9 2.5 4.7 36.6 1.7 1.9 4.7 5.1 1.9 3.6 25.2 5.2 1.1 7.5 10.9 0.6 4.1 2.7 5.1 9.8 3.1 5.9 4.3 3.3 7.9 1.3 2.4 7.9 8.5 8.4 3.1 7.1 0.5 6.0 5.8 7.8 4.7 2.8 7.5 10.0 1.7 3.9 0.2 1.9 2.1 4.5 1.4 0.0 5.2 4.4 12.7 3.6 12.0 4.7 1.9 0.1 0.8 4.9 2.0 1.0 2.1 2.8 0.2 4.9 0.2 6.5 0.3 14.5 0.8 3.0 3.1 3.2 4.2 9.2 2.8 5.1 1.0 3.2 4.9 4.2 5.0 7.7 2.4 2.9 0.7 13.9 0.2 3.3 0.3 0.0 0.0 0.3 0.1 0.5 0.8 0.2 0.1 0.3 1.5 0.5 0.3 0.2 1.1 0.0 0.0 0.0 0.1 5.7 5.2 4.8 8.7 5.1 6.2 5.7 5.9 5.0 5.3 5.1 5.2 5.1 8.3 6.4 8.9 31.6 1.6 5.2 8.7 18.1 2.8 11.8 5.3 6.6 14.3 8.6 23.3 9.2 47.9 1.9 0.3 0.8 19.6 15.6 148.5 136.3 15.8 7.0 0.0 0.0 29.1 4.9 0.5 8.1 0.0 17.0 0.0 13.4 9.3 2.7 1.4 21.9 15.0 0.9 18.3 0.8 3.1 65.2 7.5 1.4 7.2 4.7 0.0 12.3 0.0 12.1 11.5 6.4 1.3 9.8 0.1 3.1 0.2 35.9 167.4 69.1 13.1 14.3 10.3 146.3 24.9 1.0 4.0 0.3 1.3 9.6 1.7 5.8 MALL BENE ENSG00000144063 "Mal, T cell differentiation protein like" Q13021 2 110083870-110116022 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 371.4;intestine: 237.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 857.8;Ductal cells: 299.2;Pancreatic endocrine cells: 354.9;Paneth cells: 374.4;Proximal enterocytes: 742.2;Urothelial cells: 426.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 8.4;neutrophil: 2.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.4" "Cell line enhanced" "Detected in many" "A-431: 267.4;A549: 269.9;CAPAN-2: 347.7;fHDF/TERT166: 380.9;HaCaT: 276.4;PC-3: 158.3" "Not detected" "Not detected" HPA051410 Uncertain NA NA "HPA051410: AB_2681474" "unprognostic (5.17e-1)" "unprognostic (4.15e-2)" "unprognostic (2.92e-1)" "unprognostic (3.53e-1)" "unprognostic (1.92e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (4.46e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (2.37e-1)" "unprognostic (7.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.84e-1)" "unprognostic (2.80e-1)" "unprognostic (6.50e-3)" 17.0 2.9 4.1 17.3 3.6 2.4 13.5 3.5 6.9 30.5 8.0 115.2 237.5 6.3 5.8 371.4 8.5 20.5 15.2 3.5 4.2 7.0 3.1 80.6 6.2 4.0 4.1 3.2 2.1 4.4 98.5 2.7 9.4 4.4 19.1 96.0 0.4 41.1 4.3 6.4 41.6 220.6 14.5 4.7 5.0 9.3 9.8 6.1 3.2 28.9 10.9 55.4 99.6 149.3 4.8 267.4 269.9 0.2 0.9 0.1 0.1 0.8 48.5 2.1 0.2 0.2 44.3 347.7 0.6 127.6 380.9 0.1 276.4 0.0 12.6 0.1 0.7 0.2 1.8 7.3 0.1 1.9 0.1 0.6 4.8 13.9 1.2 0.0 0.0 111.9 0.0 0.1 0.4 0.0 10.0 0.0 1.0 0.2 117.8 158.3 0.1 0.1 1.2 30.4 15.3 0.7 0.2 0.2 9.3 0.7 0.4 0.3 1.4 130.9 0.4 0.9 0.7 0.8 0.3 0.4 31.7 0.4 0.4 0.2 8.4 0.4 0.6 0.2 0.2 0.2 0.5 0.5 0.4 0.2 0.5 0.3 0.5 2.5 1.2 0.1 0.4 0.3 0.3 4.1 3.6 3.5 6.9 3.5 4.2 4.0 4.1 3.2 4.4 4.7 6.1 4.8 45.1 41.7 185.9 0.3 2.0 16.4 107.2 38.6 3.4 0.0 10.9 6.1 3.2 2.8 64.6 1.8 0.0 0.3 0.4 857.8 0.0 299.2 26.3 3.2 1.8 50.6 17.5 0.0 0.8 66.1 0.1 8.2 2.6 7.6 7.0 0.4 33.9 0.5 8.2 0.0 0.1 51.2 30.5 0.9 3.8 9.7 2.5 2.9 14.2 2.8 1.0 0.1 0.0 0.0 0.0 354.9 374.4 1.2 0.0 187.4 742.2 14.6 19.4 0.1 0.0 1.1 5.6 27.2 1.3 57.9 13.2 0.5 2.4 0.6 97.4 426.0 THNSL2 "FLJ10916, SOFAT, TSH2" ENSG00000144115 "Threonine synthase like 2" Q86YJ6 2 88170295-88186636 "Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 58.7;Proximal tubular cells: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;MCF7: 12.2;SK-MEL-30: 12.6;SuSa: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035395 Approved "Secreted - unknown location" NA NA "HPA035395: AB_10601600" "unprognostic (1.51e-2)" "unprognostic (1.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (4.53e-2)" "unprognostic (8.73e-2)" "unprognostic (6.64e-2)" "unprognostic (7.26e-2)" "unprognostic (1.93e-1)" "unprognostic (3.47e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "unprognostic (2.01e-3)" "unprognostic (6.98e-2)" "unprognostic (8.81e-2)" "unprognostic (1.40e-1)" "unprognostic (1.24e-2)" 14.0 22.8 14.0 2.4 14.7 0.9 16.6 14.2 15.8 13.3 13.6 15.3 5.6 11.3 22.8 6.6 19.3 7.7 17.3 12.4 18.3 28.3 50.4 7.2 2.0 16.3 14.5 12.3 15.0 14.3 32.5 29.3 8.7 14.7 22.5 3.7 7.4 13.0 13.6 50.5 9.4 12.7 6.4 14.7 7.6 13.6 13.1 14.7 1.1 22.1 36.1 1.8 12.6 9.9 16.0 0.3 0.0 0.0 0.0 2.7 0.9 1.5 4.6 5.0 6.4 8.3 6.6 7.7 0.0 2.2 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.1 0.0 0.0 0.0 31.6 0.0 0.6 5.1 10.3 1.9 0.0 0.5 0.0 0.0 0.0 0.0 4.7 12.2 0.0 0.1 6.2 7.1 0.6 0.0 0.0 0.0 5.2 0.5 0.3 0.0 5.4 0.4 12.6 15.0 8.8 2.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.3 0.3 0.4 0.2 0.4 0.1 0.2 0.4 0.7 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 14.0 14.7 14.2 15.8 12.4 18.3 16.3 14.5 12.3 14.7 14.7 14.7 16.0 2.8 3.2 9.3 13.1 3.1 6.6 8.6 8.3 9.6 12.8 23.2 20.2 17.3 20.0 2.9 14.7 0.0 42.5 0.4 9.2 58.7 14.8 1.3 14.5 8.9 3.6 2.4 6.1 2.8 3.0 15.7 13.8 6.6 8.4 0.0 8.1 7.9 43.6 4.6 13.5 3.0 6.8 4.1 10.7 4.6 4.2 9.0 2.8 14.2 5.6 11.3 43.5 3.1 4.0 16.7 5.4 8.9 9.8 1.7 6.3 13.4 87.2 5.2 7.3 0.0 8.9 6.4 3.7 11.4 3.7 5.1 23.9 1.7 13.8 6.2 5.6 RALB ENSG00000144118 "RAS like proto-oncogene B" P11234 2 120240064-120294710 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Cell division" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 338.2" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 378.4" "Group enriched" "Detected in all" 4 "granulocytes: 378.4;monocytes: 176.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026010, HPA065232" Enhanced NA NA 440000 "CAB026010: , HPA065232: AB_2685440" "unprognostic (5.16e-2)" "unprognostic (9.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.38e-2)" "unprognostic (3.89e-2)" "unprognostic (5.92e-3)" "unprognostic (1.77e-2)" "unprognostic (4.15e-2)" "unprognostic (4.91e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (2.29e-2)" "unprognostic (8.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" 54.3 36.3 31.7 57.7 31.1 60.6 40.3 33.6 39.0 44.7 35.1 59.8 50.9 37.9 16.0 74.0 46.1 45.2 51.5 32.4 36.8 57.1 34.5 51.1 36.1 31.1 34.1 27.6 28.9 25.8 338.2 16.7 63.6 31.1 51.5 52.3 26.1 36.5 32.0 30.4 25.9 45.2 46.9 31.6 54.6 39.7 30.2 35.8 27.7 31.1 44.3 35.3 51.5 49.5 32.8 179.8 47.7 46.8 29.5 71.2 115.5 66.7 121.4 105.8 93.3 70.5 99.4 118.0 7.1 63.9 131.6 88.2 64.1 22.5 93.1 85.7 293.3 25.8 84.4 36.3 71.3 46.0 45.1 144.9 60.3 99.0 97.2 74.0 77.1 272.9 6.3 66.5 28.1 108.2 91.9 5.9 100.0 31.7 71.6 101.9 1.2 59.3 38.1 97.5 45.6 13.3 32.1 50.4 137.9 85.1 39.3 43.3 66.3 168.4 91.1 69.8 93.9 48.8 16.2 9.1 12.8 72.7 57.5 95.6 101.8 80.9 230.5 19.0 117.7 18.5 45.0 18.0 19.0 65.4 59.6 11.9 13.7 378.4 25.5 176.1 6.9 24.6 59.5 31.7 31.1 33.6 39.0 32.4 36.8 31.1 34.1 27.6 31.1 31.6 35.8 32.8 69.3 9.6 27.0 6.5 23.8 19.4 30.1 22.4 7.4 4.1 23.2 7.9 55.8 18.6 21.9 11.0 12.5 6.0 11.8 95.3 66.5 84.9 18.8 28.4 22.8 77.8 18.6 8.4 12.9 55.0 128.5 32.7 17.9 26.7 106.1 90.6 78.5 9.8 53.6 13.5 9.7 19.1 18.3 54.3 59.4 23.0 19.9 66.7 35.6 16.9 62.6 26.3 21.6 10.1 5.4 138.1 62.1 31.2 6.7 28.5 44.6 104.4 46.3 7.5 19.7 18.3 33.4 13.1 16.2 16.4 18.9 36.7 19.5 12.9 31.3 32.2 C1QL2 "C1QTNF10, CTRP10" ENSG00000144119 "Complement C1q like 2" Q7Z5L3 2 119156243-119158751 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 25.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 28.3;Cone photoreceptor cells: 8.4;Oligodendrocyte precursor cells: 37.2" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.6" "Region enhanced" "Detected in many" "hippocampal formation: 22.7" "Low region specificity" "Detected in many" HPA057934 Uncertain "Secreted in brain" NA NA "HPA057934: AB_2683558" "unprognostic (6.95e-2)" "unprognostic (9.74e-2)" "unprognostic (4.48e-3)" "unprognostic (1.08e-1)" "unprognostic (9.91e-4)" "unprognostic (2.60e-5)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 16.3 0.0 7.8 0.0 0.2 2.1 17.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 10.6 0.0 0.0 0.0 0.1 5.9 5.1 7.1 0.1 0.0 0.0 0.5 0.0 6.1 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.0 0.0 0.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 7.8 2.1 17.2 25.1 10.6 5.9 5.1 7.1 6.1 2.7 12.9 6.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 28.3 1.3 0.8 0.5 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 37.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 TMEM177 MGC10993 ENSG00000144120 "Transmembrane protein 177" Q53S58 2 119679167-119686507 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 66.5;Proximal tubular cells: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036689, HPA053816" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA036689: AB_2675253, HPA053816: AB_2682272" "unprognostic (1.24e-1)" "unprognostic (2.65e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (9.81e-3)" "unprognostic (2.05e-3)" "unprognostic (3.17e-2)" "unprognostic (8.05e-2)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-1)" "unprognostic (4.90e-1)" "unprognostic (6.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" 3.0 8.0 6.8 4.9 7.3 1.0 6.9 7.5 8.0 5.3 2.8 11.0 16.2 6.7 9.0 5.8 10.7 3.9 7.5 7.0 4.8 12.0 26.0 3.4 5.1 5.0 6.1 6.9 8.0 5.6 8.2 12.6 3.2 5.7 6.0 9.2 7.3 6.9 5.9 12.4 6.8 13.8 5.2 3.8 4.1 6.3 7.8 7.0 4.8 5.7 7.1 5.2 5.2 4.9 6.9 22.9 19.9 17.2 16.7 4.6 4.5 8.9 8.4 10.4 24.3 18.3 50.4 12.6 37.9 20.1 7.4 19.9 13.7 27.9 28.7 14.0 18.0 51.4 19.5 11.8 56.7 10.1 12.5 13.9 12.4 20.1 19.2 12.5 9.3 15.7 22.3 30.7 4.9 13.3 19.0 21.8 24.3 44.0 16.7 29.2 19.6 16.8 22.4 24.4 11.8 33.8 19.3 10.9 23.2 26.9 15.9 17.7 21.1 12.8 12.0 28.7 9.2 16.7 4.9 3.8 23.3 4.5 15.2 22.0 0.0 2.6 2.6 8.2 2.1 8.5 6.6 6.9 8.4 4.9 8.7 16.2 10.3 0.8 7.2 1.4 5.8 7.9 5.5 6.8 7.3 7.5 8.0 7.0 4.8 5.0 6.1 6.9 5.7 3.8 7.0 6.9 2.6 3.2 0.0 3.3 3.6 2.9 12.1 13.9 1.8 13.3 8.2 9.7 13.0 11.5 10.7 5.5 14.6 11.9 2.1 8.9 66.5 16.0 2.2 4.0 6.8 5.0 2.4 3.4 4.1 14.3 9.7 5.4 5.6 2.8 0.0 10.1 1.4 30.5 6.3 11.8 4.1 7.2 8.2 1.2 1.1 2.1 7.5 1.5 14.2 0.0 4.7 9.4 5.2 5.5 2.0 12.3 6.5 12.4 3.4 9.2 22.8 47.2 5.4 21.8 0.0 2.6 6.1 6.5 6.6 5.1 2.0 2.1 4.1 21.5 14.1 4.5 NT5DC4 ENSG00000144130 "5'-nucleotidase domain containing 4" Q86YG4 2 112721486-112742879 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.2" "Group enriched" "Detected in some" 11 "Early spermatids: 20.0;Late spermatids: 6.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "K-562: 16.1" "Not detected" "Not detected" HPA046856 Uncertain NA NA "HPA046856: AB_2679841" "unprognostic (2.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-2)" "unprognostic (1.34e-2)" "unprognostic (2.20e-4)" "unprognostic (2.26e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-1)" "unprognostic (1.19e-1)" "unprognostic (5.38e-4)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-4)" "unprognostic (9.02e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-4)" 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 1.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.6 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 1.2 0.0 0.0 0.1 2.2 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 20.0 0.3 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.9" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.6" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.5 1.2 3.4 1.3 3.0 0.9 2.8 2.3 3.4 3.7 4.1 2.8 1.4 4.5 3.7 1.6 19.9 1.6 2.1 3.1 3.2 2.0 1.9 2.7 1.0 2.8 3.1 2.3 5.0 1.5 1.4 3.0 0.8 3.1 2.7 1.0 6.7 2.1 2.0 1.3 2.4 1.8 2.2 3.4 1.7 1.9 5.4 2.4 3.0 3.5 1.4 2.0 2.7 2.8 2.7 2.1 3.7 5.0 4.0 4.1 5.8 3.7 2.0 1.6 2.9 2.0 3.3 1.4 3.1 8.5 0.7 2.0 2.3 2.5 0.3 1.9 4.1 4.7 1.6 0.1 0.4 3.3 0.6 1.1 2.1 4.3 0.5 1.2 4.2 2.1 4.6 1.5 0.8 1.7 1.8 10.6 0.7 2.8 1.9 1.3 2.0 1.9 1.3 2.1 0.5 2.0 7.0 1.9 2.2 1.9 1.5 0.4 3.0 0.5 0.4 0.6 0.7 1.4 2.9 3.4 0.8 5.8 2.3 1.0 0.0 4.3 2.4 6.2 7.1 6.9 8.9 9.0 6.5 7.1 8.2 7.5 5.7 0.5 12.8 7.1 9.1 4.9 5.4 3.4 3.0 2.3 3.4 3.1 3.2 2.8 3.1 2.3 3.1 3.4 2.4 2.7 4.2 9.6 8.1 13.4 6.4 4.5 5.6 8.1 5.2 7.6 6.4 8.0 9.5 2.8 12.1 7.3 10.4 3.4 6.3 4.9 13.7 7.6 16.3 36.9 5.6 3.4 7.2 3.0 30.2 3.1 2.9 6.8 5.6 2.8 11.4 9.9 5.3 4.4 3.6 16.8 20.5 4.3 4.1 3.2 3.5 14.5 8.1 3.1 7.2 3.7 5.7 7.3 9.2 7.1 19.4 3.6 3.2 7.2 0.8 2.9 7.2 6.8 123.2 16.8 0.0 5.9 8.1 22.3 9.6 3.6 4.8 2.5 6.0 4.4 4.1 3.6 SLC20A1 "Glvr-1, GLVR1, PiT-1" ENSG00000144136 "Solute carrier family 20 member 1" Q8WUM9 2 112645939-112663825 "Metabolic proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Phosphate transport, Symport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 353.3;Paneth cells: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 522.4;U-87 MG: 507.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019279, HPA035834" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB019279: , HPA035834: AB_2674809" "unprognostic (1.81e-1)" "unprognostic (2.18e-1)" "unprognostic (5.38e-2)" "unprognostic (4.03e-3)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.50e-2)" "unprognostic (3.38e-2)" "unprognostic (2.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.43e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.44e-5)" "unprognostic (6.85e-2)" "unprognostic (1.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-3)" 26.2 11.8 17.0 33.4 22.9 75.3 15.7 28.4 26.8 11.0 26.1 54.1 14.5 13.8 8.5 15.1 14.7 26.6 19.1 20.6 20.1 22.2 49.4 29.5 37.4 25.4 22.1 19.6 9.3 31.0 10.5 16.0 29.9 25.7 13.5 22.1 52.8 12.9 9.4 19.9 12.6 28.6 15.2 20.2 29.7 20.4 15.8 23.3 27.4 16.0 7.6 27.8 41.2 13.4 24.3 69.0 55.5 71.1 57.8 52.9 128.8 54.4 181.6 215.3 79.1 102.2 85.0 164.9 124.0 97.5 67.7 305.0 70.5 78.8 138.0 114.8 68.5 80.4 105.5 57.1 81.3 78.2 61.2 178.9 66.0 53.8 279.1 193.9 522.4 102.2 52.9 199.5 126.3 346.7 26.8 83.9 235.9 119.3 31.8 147.6 77.8 63.5 34.9 114.5 312.8 64.4 60.8 91.7 54.9 127.9 31.4 56.0 42.9 223.6 143.5 94.7 50.8 142.4 52.1 143.7 102.2 507.2 57.9 178.3 13.4 33.5 30.1 52.8 59.8 59.4 8.3 22.2 38.4 25.4 5.0 17.5 27.6 14.7 50.2 37.2 41.8 14.6 33.9 17.0 22.9 28.4 26.8 20.6 20.1 25.4 22.1 19.6 25.7 20.2 23.3 24.3 61.7 12.8 25.9 42.4 40.3 112.8 59.1 38.7 104.7 60.0 41.9 31.6 49.6 32.9 35.3 9.2 210.6 44.7 119.1 353.3 13.7 18.1 1.5 86.0 34.3 48.2 35.7 53.2 47.3 14.0 13.5 61.5 96.4 167.8 25.3 20.6 41.0 58.1 28.2 20.2 27.2 85.8 32.6 58.5 86.2 3.3 3.7 80.5 26.6 19.7 42.8 31.8 66.9 18.6 26.1 26.9 261.6 4.9 59.8 34.0 156.3 5.2 59.6 84.6 0.0 36.9 25.9 8.5 18.7 119.5 61.8 74.3 70.4 19.0 96.5 90.3 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188218 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 14.4;Fibroblasts: 16.6;Inhibitory neurons: 30.7;Melanocytes: 17.8;Skeletal myocytes: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 26 "memory CD4 T-cell: 34.4;naive CD4 T-cell: 29.5;T-reg: 36.5" "Lineage enriched" "Detected in many" 35 "T-cells: 36.5" "Cell line enhanced" "Detected in many" "AF22: 24.5;BJ hTERT+: 17.7;hTERT-RPE1: 12.8;SCLC-21H: 15.8;SH-SY5Y: 12.6;U-2197: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" NA NA 310000 "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 6.2 4.1 1.8 4.3 0.6 0.7 7.9 4.0 6.0 9.1 0.3 1.6 1.1 4.8 2.8 2.0 7.1 3.4 2.1 2.1 3.3 1.3 5.3 2.8 9.9 7.9 4.2 0.9 1.4 2.4 7.0 12.3 3.2 10.0 3.4 1.3 2.5 2.5 3.1 1.4 5.4 2.9 2.2 1.9 5.7 3.0 0.5 3.7 8.6 10.8 2.6 6.0 2.6 7.5 12.1 0.0 0.1 24.5 0.0 2.6 1.9 0.1 5.5 17.7 5.9 9.2 0.0 0.2 0.0 0.1 8.3 1.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.9 1.1 1.2 0.0 0.0 1.9 0.1 9.9 0.0 12.8 1.4 0.3 0.0 0.0 2.1 0.0 0.7 0.1 0.6 0.0 0.5 0.0 0.0 6.6 0.3 0.0 15.8 12.6 0.1 0.1 0.7 0.1 0.7 0.2 5.2 0.8 0.7 25.4 0.8 0.0 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.4 0.0 1.3 0.0 34.4 0.4 0.0 0.0 29.5 1.0 0.0 0.0 0.0 1.0 36.5 6.2 1.8 0.6 4.0 6.0 2.1 3.3 7.9 4.2 0.9 10.0 1.9 3.7 12.1 1.4 3.2 0.5 0.3 0.7 4.5 1.0 0.3 0.0 3.8 1.0 2.4 1.1 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.0 0.3 1.7 1.2 5.9 2.6 0.0 0.0 14.4 0.2 10.1 16.6 0.0 1.2 1.3 0.7 0.4 2.2 0.5 3.3 30.7 0.0 0.0 0.0 4.0 3.6 0.3 0.4 17.8 1.9 0.0 2.3 0.0 6.6 0.9 0.6 0.0 5.3 0.1 0.4 0.1 0.5 0.3 7.6 6.6 19.3 7.8 0.1 0.4 0.1 3.8 1.5 7.7 0.2 0.0 0.3 ZC3H8 "Fliz1, ZC3HDC8" ENSG00000144161 "Zinc finger CCCH-type containing 8" Q8N5P1 2 112211529-112255136 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034803, HPA034804" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA034803: AB_2674338, HPA034804: AB_10670284" "unprognostic (2.45e-1)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.29e-3)" "unprognostic (8.76e-2)" "unprognostic (1.20e-2)" "unprognostic (5.04e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.74e-2)" "unprognostic (3.49e-2)" "unprognostic (8.02e-3)" "unprognostic (4.88e-3)" 3.6 3.9 5.1 5.8 5.2 6.2 8.1 6.9 6.3 5.0 3.6 4.7 5.3 4.6 4.5 8.7 5.1 2.6 8.6 5.4 5.1 5.3 5.9 3.0 8.6 5.0 4.6 5.0 6.0 9.1 11.3 6.7 3.7 5.7 5.7 6.1 6.0 7.2 3.9 11.1 7.6 4.6 4.4 4.1 6.1 4.5 9.0 4.8 9.1 7.3 11.1 8.7 4.9 6.2 5.5 22.1 10.5 13.2 13.7 7.4 8.0 20.6 6.8 5.8 9.5 7.9 25.3 8.3 45.6 12.4 4.8 13.3 13.1 19.4 13.7 12.5 16.2 9.0 30.3 11.8 12.9 11.7 28.6 13.4 10.0 27.0 18.4 28.4 7.0 7.2 27.3 39.2 12.2 7.5 14.6 31.0 25.7 12.2 23.1 29.2 21.2 22.5 18.8 8.7 9.7 19.8 15.4 12.9 13.7 29.9 11.5 10.9 15.1 9.6 12.3 15.9 8.8 17.4 21.9 27.9 44.4 8.8 23.4 4.9 2.7 2.5 0.8 4.0 2.0 8.4 5.9 4.2 4.3 2.5 6.1 7.1 5.9 1.4 7.2 2.6 4.1 4.7 2.4 5.1 5.2 6.9 6.3 5.4 5.1 5.0 4.6 5.0 5.7 4.1 4.8 5.5 15.5 9.6 15.2 17.0 35.6 12.6 18.2 16.6 30.7 50.2 28.7 28.6 35.4 12.8 22.8 7.3 41.7 18.1 38.7 13.4 27.4 15.2 30.9 25.5 28.0 15.4 14.9 19.8 35.8 18.6 16.8 16.4 12.2 15.1 35.4 20.2 13.6 11.3 11.4 38.7 46.2 27.4 22.4 15.7 7.8 40.6 22.1 13.7 1.8 12.2 18.1 16.1 43.3 41.2 27.8 19.5 11.3 20.3 14.3 21.2 12.7 24.3 17.4 53.5 13.1 20.9 16.2 60.9 39.0 34.3 17.8 14.2 31.6 24.4 24.0 12.5 LIPT1 "MGC12290, MGC13378" ENSG00000144182 "Lipoyltransferase 1" Q9Y234 2 99154955-99163157 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 41.0;Spermatocytes: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034802 Approved NA NA "HPA034802: AB_10669851" "unprognostic (1.13e-2)" "unprognostic (7.21e-3)" "unprognostic (1.75e-1)" "unprognostic (1.32e-2)" "unprognostic (7.46e-2)" "unprognostic (6.48e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.70e-4)" "unprognostic (1.49e-2)" "unprognostic (4.11e-2)" "unprognostic (1.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.32e-3)" "unprognostic (1.72e-1)" "unprognostic (4.92e-2)" "unprognostic (3.16e-1)" "prognostic favorable (9.60e-8)" 7.0 7.8 6.8 6.9 7.7 12.5 11.0 7.5 8.4 7.2 6.4 6.8 8.5 8.2 14.2 5.1 8.2 6.6 7.9 7.3 7.2 9.0 8.2 5.7 10.8 7.5 7.6 6.5 11.9 7.3 6.3 6.7 4.9 7.4 9.2 7.3 7.6 9.0 6.0 9.2 7.1 8.4 5.7 7.3 12.0 7.0 13.6 7.1 5.4 11.4 9.0 7.4 6.3 5.7 10.6 6.2 4.0 5.4 9.2 9.3 11.0 13.0 4.0 4.7 3.1 3.4 9.8 10.3 9.9 8.4 2.4 8.4 5.4 6.6 5.0 6.1 10.6 12.0 10.3 5.1 8.7 9.9 7.0 5.1 6.5 8.0 5.6 12.7 6.3 8.8 11.4 10.0 5.8 5.4 5.0 6.9 13.4 13.8 6.0 9.9 11.7 5.8 10.4 10.1 9.2 5.2 5.0 5.6 6.2 14.8 9.8 6.6 14.2 6.4 4.6 6.4 4.1 3.8 9.1 12.9 10.7 4.8 11.4 6.7 15.4 10.3 16.1 16.8 9.6 20.9 14.2 18.9 18.5 5.6 12.4 23.6 19.9 2.7 18.4 9.5 5.6 12.3 11.6 6.8 7.7 7.5 8.4 7.3 7.2 7.5 7.6 6.5 7.4 7.3 7.1 10.6 9.3 3.2 6.7 6.5 7.5 3.6 10.8 14.5 6.2 5.2 3.9 7.9 6.6 2.8 8.5 12.9 2.1 7.6 9.7 3.3 13.7 5.1 41.0 3.6 6.5 7.8 6.1 3.2 5.3 3.4 4.3 7.2 3.1 3.4 5.1 8.3 12.8 2.2 7.2 11.8 5.5 6.1 6.1 7.9 2.2 25.4 9.6 4.6 1.8 1.9 8.5 12.1 18.6 9.5 14.3 3.4 6.9 7.5 2.7 5.6 15.9 11.8 9.0 10.6 6.6 13.1 5.8 40.6 12.8 3.0 4.3 5.3 8.9 5.0 6.2 6.2 CNGA3 "ACHM2, CCNC1, CCNCa, CNCG3, CNG3" ENSG00000144191 "Cyclic nucleotide gated channel subunit alpha 3" Q16281 2 98346188-98398601 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;pituitary gland: 10.2;retina: 5.9" "Cell type enriched" "Detected in some" 14 "Cone photoreceptor cells: 43.8" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "U-87 MG: 6.8" "Group enriched" "Detected in some" 6 "basal ganglia: 1.8;hypothalamus: 1.9" "Not detected" "Not detected" "HPA049378, CAB079025" Approved Approved NA NA "CAB079025: , HPA049378: AB_2732551" "unprognostic (2.34e-2)" "unprognostic (1.83e-2)" "unprognostic (4.96e-2)" "unprognostic (4.81e-2)" "unprognostic (1.13e-1)" "unprognostic (2.18e-1)" "unprognostic (4.17e-4)" "unprognostic (4.65e-2)" "unprognostic (1.86e-3)" "unprognostic (2.88e-1)" "unprognostic (3.85e-3)" "unprognostic (8.98e-2)" "unprognostic (5.90e-2)" "unprognostic (3.71e-2)" 0.1 0.0 1.0 0.5 0.8 0.0 0.2 0.7 0.7 0.0 2.3 3.1 1.0 0.0 0.0 1.5 0.4 0.0 0.0 0.7 4.4 0.0 0.0 0.1 0.0 3.6 1.6 0.2 0.0 0.3 0.0 10.2 0.0 3.4 0.0 1.2 5.9 0.2 0.2 0.0 0.0 1.4 0.8 5.7 0.0 0.9 0.5 1.0 0.0 0.0 0.0 0.0 0.6 0.1 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.7 0.7 0.7 4.4 3.6 1.6 0.2 3.4 5.7 1.0 4.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.1 0.0 0.0 3.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAHD2B DKFZp434N062 ENSG00000144199 "Fumarylacetoacetate hydrolase domain containing 2B" Q6P2I3 2 97083583-97094882 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 235.0;Late spermatids: 212.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 8.8;NK-cells: 16.2;T-cells: 15.5" "Low cell line specificity" "Detected in many" "HPA042145, HPA044987" Approved NA NA "HPA042145: AB_2677873, HPA044987: AB_2679170" "unprognostic (6.55e-3)" "unprognostic (5.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (9.03e-3)" "unprognostic (4.13e-3)" "unprognostic (8.84e-3)" "unprognostic (1.59e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-3)" "unprognostic (1.94e-1)" "unprognostic (7.67e-2)" "unprognostic (1.48e-1)" "unprognostic (5.03e-2)" "unprognostic (6.26e-3)" "unprognostic (2.04e-1)" 10.3 7.1 24.3 3.3 27.7 3.5 12.9 29.6 25.8 16.2 20.8 11.9 2.5 17.8 38.4 7.4 17.4 4.3 27.6 23.6 28.1 10.7 4.0 8.0 5.8 27.8 27.2 22.6 23.8 14.5 11.2 10.4 1.7 27.6 11.0 5.5 6.9 10.9 6.8 30.6 13.4 8.3 11.3 28.2 6.8 24.9 47.1 28.4 4.3 3.9 46.4 7.7 14.4 12.3 33.1 5.0 6.0 8.2 16.8 8.0 9.5 13.0 4.3 5.0 7.3 6.7 5.6 7.7 9.6 3.7 1.7 13.7 5.2 12.0 9.6 4.1 12.5 22.1 10.5 7.6 4.5 25.6 11.9 6.5 12.8 10.0 0.9 15.5 3.4 7.8 37.0 18.3 22.9 0.5 0.0 14.5 35.5 8.1 2.2 16.7 14.0 2.3 34.5 8.1 8.3 1.8 7.1 14.7 3.8 21.5 15.3 16.1 9.4 1.3 0.8 13.7 1.0 4.2 15.1 21.1 25.4 1.2 30.5 10.1 0.0 0.2 0.2 11.3 0.3 15.5 8.8 11.0 11.1 1.8 4.2 7.5 9.7 0.2 16.2 0.1 2.9 15.0 4.8 24.3 27.7 29.6 25.8 23.6 28.1 27.8 27.2 22.6 27.6 28.2 28.4 33.1 8.2 6.4 11.1 11.1 6.1 6.5 11.5 5.9 9.6 6.3 17.9 21.0 42.3 4.3 8.0 5.5 2.1 2.1 5.8 1.1 27.4 7.3 235.0 2.3 6.5 7.8 1.8 5.5 10.4 4.3 1.0 13.5 30.1 1.2 5.7 18.5 8.2 2.3 3.5 5.0 12.1 3.3 6.1 1.6 2.6 212.6 17.1 2.2 30.2 2.8 1.6 21.7 9.2 2.5 8.0 6.9 1.2 17.0 17.3 7.7 0.2 3.8 4.6 5.8 0.0 9.7 10.5 24.5 7.3 7.3 7.1 1.0 8.2 11.1 4.4 8.3 LYG1 SALW1939 ENSG00000144214 "Lysozyme g1" Q8N1E2 2 99284238-99304742 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 161.4" "Cancer enriched" "Detected in many" 15 "renal cancer: 31.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.53e-2)" "unprognostic (3.13e-2)" "unprognostic (1.53e-2)" "unprognostic (3.73e-1)" "unprognostic (9.74e-2)" "unprognostic (3.76e-4)" "unprognostic (6.94e-4)" "unprognostic (2.58e-2)" "unprognostic (4.72e-2)" "unprognostic (9.74e-3)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.58e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-3)" 1.6 1.6 3.4 1.2 3.6 0.9 2.1 6.3 4.4 3.5 2.2 2.2 1.3 2.3 1.8 1.3 2.3 0.8 1.8 3.3 3.0 23.6 5.9 1.9 1.7 3.5 3.3 3.3 2.4 1.7 0.2 2.0 0.7 4.0 3.3 1.1 2.6 1.7 0.7 2.2 1.6 2.8 0.9 2.9 4.8 1.7 5.6 3.4 2.5 2.6 0.4 1.3 2.5 2.3 4.4 0.3 2.3 1.7 2.8 3.9 2.2 1.9 0.9 1.0 0.9 1.5 0.4 2.0 0.5 1.5 0.4 0.2 1.0 2.3 0.3 1.1 1.6 1.4 1.3 2.0 0.7 0.7 0.4 3.1 1.8 2.4 1.4 0.6 2.0 0.5 3.0 0.7 1.5 1.0 0.5 1.2 4.0 0.4 1.2 2.1 2.9 1.0 0.8 3.9 0.9 1.0 0.6 0.3 0.7 0.6 2.0 0.3 0.4 1.3 1.2 1.4 2.0 1.0 1.7 1.0 0.3 0.3 2.4 0.5 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.1 3.4 3.6 6.3 4.4 3.3 3.0 3.5 3.3 3.3 4.0 2.9 3.4 4.4 0.6 0.0 0.0 3.6 1.5 0.0 0.2 0.6 0.0 1.0 0.8 0.8 0.5 1.5 1.5 1.8 2.1 0.3 0.5 0.5 21.5 0.7 10.8 0.2 0.3 0.5 0.0 0.0 4.6 0.2 0.2 0.4 0.0 0.2 4.5 0.8 1.1 0.5 0.3 0.0 4.2 0.3 0.0 0.3 0.3 4.8 0.3 1.4 0.0 2.8 0.8 0.2 0.0 2.0 5.6 0.6 0.1 0.4 0.0 0.6 0.2 161.4 0.2 0.6 0.0 0.1 0.5 2.4 1.1 0.0 0.0 0.5 0.6 0.3 0.4 0.2 AFF3 "LAF4, MLLT2-like" ENSG00000144218 "AF4/FMR2 family member 3" P51826 2 99545419-100192428 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6" "Group enriched" "Detected in many" 5 "breast cancer: 11.4;prostate cancer: 7.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9" "Group enriched" "Detected in many" 17 "B-cells: 44.2;dendritic cells: 23.9" "Cell line enhanced" "Detected in many" "Daudi: 51.1;U-698: 56.5" "Low region specificity" "Detected in all" "HPA044512, HPA053379" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044512: AB_10795984, HPA053379: AB_2682133" "unprognostic (1.05e-2)" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.88e-3)" "unprognostic (1.02e-1)" "unprognostic (4.98e-5)" "unprognostic (1.11e-3)" "unprognostic (3.04e-2)" "unprognostic (8.75e-2)" "unprognostic (3.07e-1)" "unprognostic (1.95e-3)" "unprognostic (7.57e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (6.40e-3)" "unprognostic (6.79e-2)" "unprognostic (3.69e-2)" "unprognostic (7.87e-3)" 3.4 1.6 2.0 6.2 4.2 11.3 11.7 18.0 13.9 3.3 0.0 4.4 1.1 7.8 0.8 3.5 4.5 2.2 4.3 10.5 5.2 1.4 1.7 6.6 14.3 2.8 0.9 2.8 6.4 0.4 0.1 4.4 6.2 6.2 16.3 2.2 4.3 1.9 2.5 0.7 0.8 6.0 6.0 0.0 7.4 4.6 5.5 0.7 7.8 1.2 0.7 12.3 6.8 2.3 10.3 0.2 0.0 18.0 6.4 0.0 0.6 0.0 2.8 0.7 5.6 1.9 0.0 0.0 51.1 0.1 3.8 12.4 0.2 0.5 0.0 4.0 14.3 6.3 0.0 0.0 0.0 0.4 0.2 12.4 0.8 0.0 12.8 0.2 13.8 0.0 2.2 0.3 0.1 0.0 0.1 4.3 0.3 1.8 0.0 3.2 7.5 0.0 0.3 0.0 0.0 17.4 6.5 0.0 0.3 11.0 1.5 17.9 16.5 6.7 19.1 3.4 0.5 2.9 0.8 0.1 56.5 15.9 1.5 2.0 0.6 0.5 0.1 0.0 0.5 0.3 31.0 0.2 0.0 5.1 44.2 1.9 0.0 0.0 1.0 0.4 23.9 0.0 0.8 2.0 4.2 18.0 13.9 10.5 5.2 2.8 0.9 2.8 6.2 0.0 0.7 10.3 1.2 6.4 40.9 41.8 154.9 1.8 0.4 0.0 1.8 21.8 78.9 37.7 11.1 0.0 3.7 0.0 12.5 0.4 32.8 0.1 0.0 0.0 33.9 0.9 19.8 6.0 22.9 3.4 491.3 0.0 0.2 13.5 1.1 1.1 0.0 31.6 0.7 1.2 1.8 47.1 300.7 0.5 0.0 9.2 18.2 38.5 10.8 16.5 14.2 66.5 5.2 6.8 0.0 211.6 46.7 0.0 0.1 21.1 0.8 14.3 0.1 1.9 0.0 1.7 0.0 1.1 8.5 10.5 9.8 0.0 1.3 0.1 6.1 5.7 0.6 0.3 UBXN4 "KIAA0242, UBXD2, UBXDC1" ENSG00000144224 "UBX domain protein 4" Q92575 2 135741734-135785056 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 863.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036325 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA036325: AB_10669788" "unprognostic (1.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (1.47e-1)" "unprognostic (1.54e-1)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (2.91e-1)" "unprognostic (5.40e-2)" "unprognostic (2.94e-2)" "unprognostic (2.63e-2)" "unprognostic (1.93e-1)" "unprognostic (1.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (5.14e-3)" 52.4 56.1 32.1 58.9 36.5 66.0 58.0 35.9 38.3 62.8 42.6 57.7 70.5 56.5 71.7 44.8 49.4 57.7 44.8 30.1 38.2 64.7 94.5 47.6 60.0 39.1 36.1 27.9 53.1 74.0 84.2 19.7 63.6 38.6 65.2 60.8 86.4 72.4 48.2 55.6 56.4 68.5 44.2 35.5 56.2 65.2 58.2 32.8 77.3 76.8 53.1 60.3 61.1 25.3 47.3 136.2 34.6 85.1 66.2 106.9 107.0 95.5 106.6 106.3 87.0 77.4 65.3 91.8 84.0 149.4 105.1 46.6 98.3 50.7 68.4 103.5 115.5 62.8 80.5 60.7 98.6 99.4 85.2 70.7 81.6 66.6 86.7 85.8 118.2 110.5 66.2 74.4 116.1 95.3 64.1 109.9 61.3 64.3 70.6 70.9 87.9 100.5 146.5 112.2 97.7 77.4 50.2 97.2 64.1 64.4 77.1 68.0 78.2 101.8 78.4 40.1 82.5 58.4 108.7 72.2 76.2 99.0 59.3 75.5 62.9 35.8 59.1 46.5 42.3 42.6 45.9 42.5 42.5 35.8 42.6 41.4 41.0 73.7 48.4 52.2 56.6 52.3 35.9 32.1 36.5 35.9 38.3 30.1 38.2 39.1 36.1 27.9 38.6 35.5 32.8 47.3 178.1 208.3 171.4 56.2 177.4 175.1 283.0 318.5 160.5 172.3 164.1 153.3 150.8 134.4 264.1 126.9 223.1 238.2 140.8 168.9 90.1 254.6 863.9 209.3 223.1 151.7 186.6 129.8 85.2 195.8 214.0 197.4 129.5 240.6 176.9 151.5 113.2 225.7 138.8 97.6 78.4 246.9 183.1 88.6 125.2 325.1 172.7 139.9 92.5 60.9 158.8 162.2 122.6 71.9 105.3 190.7 166.7 143.7 300.3 344.1 183.0 156.8 286.7 349.8 105.2 159.3 173.9 446.1 248.4 176.1 183.6 379.4 171.6 271.6 186.0 303.7 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138669157-138780390 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.5;kidney: 4.1;ovary: 8.1" "Cell type enriched" "Detected in some" 6 "Inhibitory neurons: 156.1" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;SiHa: 3.0;SuSa: 2.1;U-2 OS: 4.7;U-251 MG: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" NA Yes "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.0 0.0 1.6 0.1 2.0 0.0 0.1 1.3 3.2 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.2 1.1 4.1 0.0 0.0 0.0 10.1 2.9 1.3 8.1 0.0 0.0 0.1 0.1 13.5 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.6 3.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.0 1.3 3.2 1.2 1.1 10.1 2.9 1.3 13.5 2.0 3.6 8.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPOPL BTBD33 ENSG00000144228 "Speckle type BTB/POZ protein like" Q6IQ16 2 138501770-138573547 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034687 Uncertain Approved Vesicles NA NA Vesicles "HPA034687: AB_10670573" "unprognostic (1.39e-3)" "unprognostic (1.24e-1)" "unprognostic (2.48e-2)" "unprognostic (3.02e-2)" "unprognostic (3.37e-1)" "unprognostic (3.12e-2)" "unprognostic (4.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (2.75e-2)" "unprognostic (8.90e-2)" "prognostic favorable (3.63e-4)" "unprognostic (2.25e-2)" "unprognostic (1.15e-1)" "unprognostic (9.09e-2)" "unprognostic (1.91e-3)" 7.9 6.0 7.6 9.8 8.5 14.4 12.8 7.3 7.7 6.6 6.0 8.4 8.0 8.5 3.6 6.3 6.6 7.3 5.5 6.6 7.6 8.9 9.5 7.7 11.4 8.5 8.2 5.5 10.4 5.6 7.4 4.4 6.8 8.8 9.5 9.0 9.9 11.6 8.2 4.7 8.5 8.5 7.5 8.8 11.3 9.3 3.7 7.7 4.9 8.6 8.1 9.8 8.1 6.4 10.0 13.3 4.0 7.2 7.0 5.8 9.7 13.8 9.6 7.2 5.9 7.0 14.8 10.6 14.2 9.0 8.3 5.3 5.1 9.5 8.4 12.4 11.1 7.7 9.0 9.2 23.2 6.0 10.0 12.1 6.4 12.3 11.7 10.8 12.0 9.6 3.3 3.0 19.2 10.1 12.9 1.0 9.4 6.5 9.3 6.9 5.0 12.6 8.1 9.3 18.7 8.4 10.3 14.7 13.8 7.3 8.5 7.6 10.9 9.6 9.5 8.1 12.0 14.7 27.6 21.6 10.3 15.9 9.2 8.8 0.4 1.6 2.8 0.3 1.5 0.3 1.1 0.2 0.3 2.2 1.1 0.1 0.2 5.7 0.4 1.3 0.9 0.4 0.6 7.6 8.5 7.3 7.7 6.6 7.6 8.5 8.2 5.5 8.8 8.8 7.7 10.0 16.9 12.8 13.6 25.8 25.9 55.6 11.4 7.9 13.6 9.9 38.8 13.8 13.2 15.7 20.6 3.7 4.2 6.4 15.0 20.3 7.9 10.1 1.7 11.9 10.3 12.4 19.2 5.0 55.3 13.3 7.3 12.3 17.3 11.8 8.8 12.5 8.9 13.8 8.9 18.5 67.2 19.8 18.3 31.5 37.7 2.8 17.1 33.2 12.4 48.7 27.5 9.2 9.2 63.8 54.1 21.1 12.6 15.8 11.8 19.5 11.0 16.4 16.1 16.6 6.6 18.8 18.5 10.0 18.8 10.3 44.8 6.2 10.8 4.9 12.0 21.3 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677718 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.1;retina: 19.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 25.0;Horizontal cells: 90.9;Inhibitory neurons: 153.4;Rod photoreceptor cells: 32.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Daudi: 11.0;SCLC-21H: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051416: AB_2681477, HPA056745: AB_2683224" "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 1.9 0.0 1.1 0.0 1.0 0.0 0.7 0.6 1.8 0.2 0.3 0.1 0.0 0.2 4.2 0.3 0.9 0.2 0.5 1.3 2.0 0.9 0.1 0.1 0.0 7.0 2.7 0.5 0.0 0.0 0.3 0.7 0.2 9.1 0.7 0.0 19.9 0.4 0.2 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.3 1.5 0.8 0.7 0.1 0.0 0.2 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.0 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.6 1.8 1.3 2.0 7.0 2.7 0.5 9.1 0.6 1.5 4.5 1.1 0.0 0.0 2.6 0.0 0.1 0.7 0.0 13.6 1.6 0.1 0.9 0.8 0.0 0.0 0.0 25.0 0.0 0.0 0.0 1.9 0.0 3.7 0.5 0.2 0.8 0.0 0.0 9.5 0.0 0.0 0.2 0.0 1.4 0.0 1.7 1.8 0.0 0.0 90.9 153.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 8.4 0.0 1.8 0.0 1.5 7.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 32.2 6.6 0.3 3.3 0.5 0.5 1.4 0.0 0.0 0.0 0.4 0.0 0.1 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 58 "Oligodendrocyte precursor cells: 58.3" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "HeLa: 3.1;REH: 4.4;TIME: 4.3;U-2 OS: 1.7;U-2197: 2.0;U-251 MG: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles NA NA Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 8.5 1.2 9.6 3.4 6.9 0.1 7.9 5.8 9.8 3.4 5.0 17.3 1.5 14.9 1.4 2.4 5.4 2.1 16.6 7.1 6.2 3.0 2.6 9.3 1.1 10.0 8.5 5.2 1.8 2.2 0.0 0.7 1.2 10.6 5.5 0.1 0.1 2.0 0.0 7.6 3.4 6.0 0.0 7.6 7.6 5.9 0.9 8.1 0.1 3.8 0.2 0.0 8.9 5.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.3 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.1 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 4.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 1.2 0.1 0.0 4.3 0.0 1.7 2.0 2.6 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 6.9 5.8 9.8 7.1 6.2 10.0 8.5 5.2 10.6 7.6 8.1 7.8 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 58.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 POLR2D RPB4 ENSG00000144231 "RNA polymerase II subunit D" O15514 2 127843553-127858155 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 75.0" "Cell type enhanced" "Detected in all" "Late spermatids: 170.2;Spermatocytes: 86.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034694, HPA046092" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA034694: AB_2674284, HPA046092: AB_10963049" "unprognostic (3.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.59e-1)" "unprognostic (2.54e-2)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.91e-4)" "unprognostic (2.51e-1)" "unprognostic (7.95e-3)" "unprognostic (2.64e-3)" "unprognostic (1.97e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.66e-2)" "unprognostic (6.57e-2)" "unprognostic (1.17e-1)" "unprognostic (2.38e-1)" 12.4 10.5 7.4 14.6 9.3 32.7 12.0 9.6 8.5 9.5 7.0 12.1 9.8 10.4 8.1 12.5 10.7 8.5 9.1 7.8 9.2 8.9 19.4 10.3 19.8 8.0 8.9 6.4 15.2 14.9 10.5 8.3 16.0 8.1 9.6 14.8 8.2 8.5 9.3 29.6 11.3 9.3 15.1 8.6 12.9 9.4 75.0 8.1 28.5 9.2 27.3 27.1 15.4 8.5 10.9 63.4 40.6 73.9 51.9 26.8 29.2 59.0 59.1 27.9 69.6 61.9 92.0 50.9 97.7 49.6 40.0 39.8 32.7 107.0 51.2 107.3 57.7 58.3 96.6 37.9 85.4 31.4 104.9 51.6 20.8 37.8 93.3 53.2 19.3 46.1 70.4 137.1 84.8 40.4 50.1 105.0 47.5 103.6 65.9 46.4 99.3 77.8 88.0 23.1 42.6 45.7 60.9 39.9 48.9 50.7 54.7 54.6 71.4 47.0 60.1 84.4 34.4 69.0 99.4 173.4 173.0 52.4 51.2 60.5 9.9 22.8 17.3 26.3 31.7 25.0 22.8 21.0 23.2 29.9 20.2 27.6 23.7 7.3 25.8 35.0 19.5 20.6 21.3 7.4 9.3 9.6 8.5 7.8 9.2 8.0 8.9 6.4 8.1 8.6 8.1 10.9 10.9 3.2 11.7 2.6 22.0 10.8 22.0 7.6 15.9 15.1 9.8 6.2 10.4 11.5 10.1 12.9 8.4 33.0 23.4 7.6 11.7 20.3 70.8 13.2 16.1 12.5 8.4 31.1 4.7 17.5 31.0 15.2 9.7 10.4 18.4 23.1 11.4 17.0 21.7 33.7 5.2 11.9 8.2 11.1 14.1 170.2 17.7 13.3 8.8 2.8 23.4 13.2 16.5 2.5 7.5 18.4 8.4 18.4 46.6 26.2 10.2 11.1 6.8 13.7 13.1 18.5 15.5 86.1 48.9 19.3 10.1 26.7 17.1 31.5 14.0 18.9 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000590: AB_2666037, HPA057234: AB_2683376" "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 12.0 10.1 3.0 3.4 3.0 2.4 11.0 3.0 3.8 12.2 2.5 9.8 4.5 12.2 2.5 10.1 11.6 5.0 8.8 3.0 3.3 8.1 12.8 9.0 3.7 3.4 3.1 2.9 10.9 10.6 8.5 7.3 7.4 3.2 9.8 4.6 2.3 8.9 5.7 8.4 11.5 9.5 7.4 2.8 10.2 9.6 12.8 3.3 5.5 9.0 8.0 5.1 9.5 11.5 3.1 8.0 5.6 16.4 12.3 15.7 12.0 11.1 10.0 14.4 13.6 14.6 15.0 7.4 6.5 6.6 18.2 6.0 7.7 17.2 10.5 17.9 13.1 9.8 5.7 5.4 11.2 18.3 9.7 9.6 15.6 21.9 18.8 18.4 12.6 19.1 9.5 8.3 5.4 14.6 4.7 10.3 2.7 11.3 9.7 14.1 11.0 15.7 4.7 10.1 3.7 11.0 11.9 12.9 16.2 27.0 14.1 7.0 8.6 13.4 16.6 9.0 5.4 8.5 5.6 11.1 7.6 7.7 7.7 12.5 0.5 1.2 3.8 1.5 1.3 2.0 1.4 1.6 1.5 1.7 1.6 1.4 1.1 1.8 1.6 1.6 1.8 1.4 1.3 3.0 3.0 3.0 3.8 3.0 3.3 3.4 3.1 2.9 3.2 2.8 3.3 3.1 9.8 19.2 8.1 5.9 7.2 18.0 8.6 4.8 9.6 5.3 14.5 9.7 12.0 10.0 9.2 3.7 6.2 5.9 7.1 8.6 0.0 6.2 11.4 11.8 27.0 10.4 5.4 5.0 10.4 5.8 7.7 11.1 10.2 12.6 7.0 10.2 8.2 16.2 4.6 1.7 9.2 9.4 2.0 7.5 6.6 15.1 6.8 5.8 5.4 8.4 4.4 4.2 3.1 7.5 10.8 9.2 6.7 8.2 12.2 14.8 5.5 4.6 14.7 6.0 0.0 15.4 11.8 6.6 9.8 13.2 15.8 7.7 7.0 6.4 9.3 13.9 GALNT13 "GalNAc-T13, KIAA1918" ENSG00000144278 "Polypeptide N-acetylgalactosaminyltransferase 13" Q8IUC8 2 153871922-154453979 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 30.7;retina: 10.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 214.6;Inhibitory neurons: 333.1;Oligodendrocyte precursor cells: 986.7;Oligodendrocytes: 398.2" "Cancer enriched" "Detected in some" 5 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 43.8;U-251 MG: 12.0;WM-115: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060775 Approved NA NA "HPA060775: AB_2684358" "unprognostic (1.97e-1)" "unprognostic (3.43e-3)" "unprognostic (2.47e-2)" "unprognostic (1.00e-3)" "unprognostic (4.21e-3)" "unprognostic (7.73e-3)" "unprognostic (6.50e-2)" "unprognostic (8.17e-2)" "unprognostic (3.57e-1)" "unprognostic (9.15e-2)" "unprognostic (3.83e-2)" "unprognostic (3.09e-2)" "unprognostic (5.17e-2)" "unprognostic (2.05e-5)" "unprognostic (8.61e-3)" "unprognostic (1.52e-1)" "unprognostic (2.05e-1)" 2.0 5.0 8.9 0.2 9.6 0.1 1.2 30.7 7.7 1.7 1.4 0.3 0.2 1.8 1.3 0.1 0.4 0.5 0.1 8.1 18.4 0.1 0.0 2.1 0.0 9.6 12.4 6.0 0.5 0.4 0.0 1.7 0.4 13.0 2.1 0.3 10.0 4.2 1.4 1.0 0.5 0.3 1.1 9.3 0.0 0.4 0.6 11.2 0.0 0.0 0.0 0.0 0.7 0.2 11.8 0.0 5.2 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 5.5 0.0 0.0 0.1 2.8 0.0 5.0 1.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.6 0.0 0.1 0.1 0.5 1.0 0.0 0.0 0.2 7.3 0.2 6.9 0.0 0.3 1.0 0.0 0.0 7.5 43.8 0.1 0.1 0.0 0.7 0.0 0.1 0.0 0.1 1.9 0.1 12.0 0.6 0.1 0.0 7.2 0.0 33.5 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.9 9.6 30.7 7.7 8.1 18.4 9.6 12.4 6.0 13.0 9.3 11.2 11.8 0.2 25.6 1.1 13.1 0.0 0.1 0.0 0.0 0.0 14.4 0.2 0.3 1.0 0.0 1.3 0.0 52.1 0.1 0.0 0.1 0.0 0.0 1.9 0.4 21.5 0.7 3.5 0.0 214.6 0.2 0.0 2.8 0.0 0.3 0.0 0.1 0.0 0.0 0.1 72.3 333.1 1.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 2.8 0.0 0.9 0.0 986.7 398.2 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.6 0.0 0.2 0.5 0.8 0.6 0.0 0.1 0.0 0.2 4.2 0.9 0.0 PKP4 p0071 ENSG00000144283 "Plakophilin 4" Q99569 2 158456952-158682879 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 278.0;choroid plexus: 115.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 261.0;Inhibitory neurons: 260.9;Oligodendrocyte precursor cells: 235.3;Oligodendrocytes: 864.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037334, HPA066647, HPA070648" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291" "unprognostic (2.76e-1)" "unprognostic (5.26e-2)" "unprognostic (1.48e-2)" "prognostic favorable (5.80e-4)" "unprognostic (2.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (9.53e-2)" "unprognostic (1.82e-2)" "unprognostic (9.69e-2)" "prognostic favorable (3.29e-7)" "unprognostic (2.23e-1)" "unprognostic (9.80e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-3)" 13.0 6.6 231.3 6.8 234.1 8.4 26.5 208.5 189.6 32.1 115.4 12.7 12.5 14.1 14.4 17.9 19.7 15.4 22.3 155.1 175.8 57.5 16.9 12.7 6.0 259.7 237.7 132.1 13.5 15.2 18.2 9.6 6.2 242.0 13.0 13.5 18.7 34.3 21.1 8.2 16.3 11.4 14.4 264.5 6.1 13.9 10.4 225.9 16.3 30.7 9.9 10.2 16.6 12.5 278.0 36.9 21.8 26.7 30.4 12.1 13.4 25.7 29.1 15.9 44.5 38.4 72.4 32.5 23.4 21.5 35.4 16.0 29.0 35.2 29.8 74.1 35.4 19.2 21.2 23.5 56.3 20.9 34.4 4.6 5.7 28.1 30.0 46.3 26.7 23.0 28.9 30.1 33.3 34.7 42.6 15.2 14.3 28.8 51.4 15.9 20.6 40.2 19.3 64.6 26.6 46.2 8.2 20.3 30.4 24.5 24.9 34.7 31.3 10.6 25.9 29.2 19.3 38.2 19.8 18.0 17.0 14.8 19.2 25.4 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.5 0.2 0.1 0.0 0.4 0.1 0.4 0.0 2.0 0.2 0.7 0.2 231.3 234.1 208.5 189.6 155.1 175.8 259.7 237.7 132.1 242.0 264.5 225.9 278.0 59.8 41.7 18.9 28.7 3.1 27.0 21.3 23.5 34.1 44.5 44.3 35.9 49.7 38.6 28.7 47.8 29.2 0.2 3.5 17.7 23.5 21.3 14.6 21.0 12.2 71.1 9.0 24.6 261.0 18.1 0.3 15.3 26.0 38.5 10.1 11.8 23.2 28.6 3.1 5.0 260.9 16.6 16.2 7.6 10.0 9.2 10.8 6.2 7.2 163.9 4.5 8.6 2.1 235.3 864.7 17.4 16.7 17.0 5.2 44.6 12.4 33.1 29.0 19.2 13.1 11.4 13.9 15.4 6.3 30.4 30.4 0.3 5.0 15.5 19.4 26.8 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 24.4" "Group enriched" "Detected in some" 11 "Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 6.1;Hep G2: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: AB_2686888" "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 0.0 0.0 4.3 0.0 4.0 0.0 0.0 2.9 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.6 6.3 0.0 0.0 1.4 0.0 13.1 6.4 3.4 0.0 0.0 0.0 2.0 0.0 19.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.9 0.0 0.0 6.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.0 2.9 24.4 4.6 6.3 13.1 6.4 3.4 19.4 1.7 12.5 13.5 0.0 6.4 33.9 27.4 0.0 0.0 0.0 0.0 0.0 47.4 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 0.0 0.3 1.8 0.0 409.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 494.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 18.7 0.0 2.8 0.0 692.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SLC4A10 "NBCn2, NCBE" ENSG00000144290 "Solute carrier family 4 member 10" Q6U841 2 161424332-161985282 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.1;choroid plexus: 99.5;retina: 34.6" "Group enriched" "Detected in some" 4 "Excitatory neurons: 604.4;Inhibitory neurons: 560.9" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 8 "MAIT T-cell: 63.3" "Lineage enriched" "Detected in single" 65 "T-cells: 63.3" "Cell line enriched" "Detected in single" 11 "Karpas-707: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034755, HPA076725" Enhanced NA NA "HPA034755: AB_10670296, HPA076725: " "unprognostic (4.64e-4)" "unprognostic (3.88e-1)" "unprognostic (2.88e-2)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "unprognostic (7.89e-3)" "unprognostic (5.99e-4)" "unprognostic (1.12e-1)" "unprognostic (2.27e-1)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" "unprognostic (5.65e-2)" "unprognostic (9.23e-3)" "unprognostic (1.87e-1)" "unprognostic (2.10e-3)" "unprognostic (2.26e-1)" 0.0 2.0 4.7 0.7 13.6 0.2 0.2 0.9 23.1 0.1 99.5 1.8 0.3 0.0 1.3 0.0 0.6 0.4 0.0 12.5 10.9 0.0 0.2 0.0 0.1 0.0 0.7 12.1 0.0 1.5 0.0 1.3 0.0 2.9 0.2 1.3 34.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.2 0.4 0.6 0.0 0.0 0.0 0.4 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.5 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.5 0.0 63.3 0.0 1.2 7.8 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.5 4.7 13.6 0.9 23.1 12.5 10.9 0.0 0.7 12.1 2.9 0.0 0.6 6.8 0.1 0.0 0.0 21.2 0.1 0.0 0.0 0.0 0.0 116.3 0.0 0.0 0.6 0.0 0.0 0.0 8.4 0.0 2.6 1.1 0.0 0.0 18.3 0.0 0.0 0.3 0.0 0.0 604.4 0.0 0.0 0.0 0.5 0.0 2.5 0.0 1.8 0.6 0.0 0.0 560.9 2.8 0.0 0.6 0.0 10.5 0.0 0.1 0.0 16.9 0.5 2.8 1.0 129.2 16.5 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 9.4 0.0 0.3 0.0 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol NA NA 27000 "Vesicles, Cytosol" "HPA034689: AB_2674282, HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 16.5 16.6 12.6 10.0 15.1 5.2 13.7 15.0 15.9 9.6 7.9 13.0 18.7 12.0 11.5 16.4 10.5 11.3 26.2 11.8 14.1 20.3 22.2 12.3 11.5 16.3 14.6 10.4 13.3 14.8 28.0 14.1 13.2 14.4 15.3 13.4 23.0 11.1 12.7 40.9 13.9 14.5 14.2 14.9 11.9 12.5 10.7 14.6 12.6 20.5 36.2 12.2 10.5 8.3 19.4 15.9 9.7 25.8 22.8 18.8 21.1 13.7 24.1 19.0 18.2 22.0 9.6 11.4 3.0 15.6 24.2 14.0 15.5 19.3 21.1 23.9 34.8 17.8 29.7 21.1 7.5 27.8 22.8 15.0 23.5 25.4 34.4 24.5 20.4 21.8 16.7 20.2 11.1 25.0 18.0 18.9 22.2 12.0 35.4 41.0 9.3 25.7 17.5 21.2 16.5 16.0 44.5 16.6 16.2 30.7 26.4 21.8 21.7 15.7 20.9 10.9 25.6 21.0 29.4 32.8 0.5 22.9 11.2 21.8 7.2 5.2 2.2 4.8 3.3 3.4 8.6 5.1 4.6 5.1 11.0 7.8 6.3 20.0 6.9 4.3 8.0 5.6 2.6 12.6 15.1 15.0 15.9 11.8 14.1 16.3 14.6 10.4 14.4 14.9 14.6 19.4 7.8 9.6 15.6 18.6 7.0 3.6 12.1 23.7 12.5 12.8 7.9 6.3 22.8 4.3 12.5 9.2 10.4 10.7 3.8 8.4 13.7 9.1 5.1 9.4 8.3 6.0 6.0 11.6 21.0 9.8 6.3 6.9 11.2 5.4 8.8 9.5 8.6 8.7 9.3 18.5 26.3 7.3 20.3 5.8 2.2 4.0 4.7 6.2 3.6 6.5 6.1 22.6 7.2 27.6 25.7 12.2 4.0 6.8 10.3 5.4 9.9 12.5 13.6 15.0 0.0 8.2 7.1 18.9 7.1 20.4 4.8 6.8 5.8 13.0 6.4 9.7 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923882-176002839 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 159.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" NA NA 15000 "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 13.7 9.0 7.8 7.7 10.7 30.4 9.9 10.6 9.7 12.1 5.1 12.1 7.7 8.6 6.3 13.2 6.4 7.8 12.4 7.8 13.9 8.3 14.5 6.8 7.3 11.8 9.5 7.2 10.8 5.6 15.7 6.0 6.1 13.9 10.2 10.2 24.3 6.5 8.3 34.5 12.2 7.5 9.7 12.5 6.0 7.9 24.7 10.1 14.1 8.9 27.0 7.9 7.7 9.3 19.7 24.5 12.3 28.3 40.1 58.5 36.1 14.3 70.8 33.7 32.2 45.1 17.0 28.2 24.4 39.4 31.5 42.3 26.5 26.9 18.9 44.6 37.5 27.4 27.6 14.8 15.2 13.8 47.2 32.9 29.9 17.5 31.4 15.4 26.4 6.0 19.3 28.9 31.5 44.9 16.0 31.4 18.8 9.2 24.9 23.4 31.3 28.6 18.0 13.6 22.2 32.6 32.9 31.3 17.5 24.1 26.6 26.2 15.4 9.2 159.0 23.6 53.9 33.7 18.5 36.6 20.3 49.4 15.2 30.4 3.7 4.2 7.9 4.9 4.8 5.8 4.3 4.2 5.4 3.9 3.3 4.2 6.7 3.4 6.5 4.5 4.4 7.8 3.4 7.8 10.7 10.6 9.7 7.8 13.9 11.8 9.5 7.2 13.9 12.5 10.1 19.7 10.8 19.2 13.6 0.0 4.4 0.0 0.0 0.0 0.0 0.0 19.3 15.0 0.0 0.0 6.2 16.5 0.0 5.7 14.5 0.0 5.9 14.0 0.0 10.1 24.6 3.5 0.0 0.0 0.0 9.6 17.3 12.8 0.0 12.7 11.4 10.6 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 0.0 0.0 9.1 8.7 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 8.3 7.2 12.0 0.0 0.0 ZNF385B "FLJ25270, ZNF533" ENSG00000144331 "Zinc finger protein 385B" Q569K4 2 179441982-179861612 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 89.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 124.2;Bipolar cells: 220.1;Excitatory neurons: 566.5;Inhibitory neurons: 393.1;Rod photoreceptor cells: 133.7" "Cancer enhanced" "Detected in many" "prostate cancer: 6.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 17.6;HAP1: 31.9;U-698: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046086 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA046086: AB_2679532" "prognostic favorable (4.86e-8)" "unprognostic (8.05e-3)" "unprognostic (1.14e-1)" "unprognostic (3.91e-2)" "unprognostic (3.49e-1)" "unprognostic (1.51e-2)" "unprognostic (3.49e-3)" "unprognostic (1.14e-1)" "unprognostic (8.99e-3)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "unprognostic (2.69e-1)" "prognostic favorable (1.04e-9)" "unprognostic (7.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-3)" 1.6 5.3 2.7 0.3 18.9 0.4 7.0 26.4 17.2 1.6 0.0 2.3 0.3 1.5 3.8 1.1 1.1 0.7 20.5 6.9 4.1 8.6 19.3 18.5 1.6 9.5 6.2 4.0 15.4 0.3 0.0 1.0 2.2 12.4 12.7 0.7 89.5 1.2 0.5 17.2 1.3 0.8 0.4 0.0 0.5 14.3 10.4 7.9 0.5 1.2 11.0 0.6 1.5 2.2 12.5 0.0 0.0 7.3 0.3 0.1 0.3 0.1 0.0 0.0 0.4 0.8 0.0 0.0 17.6 0.1 0.0 5.9 0.0 31.9 0.0 0.4 0.0 4.3 0.2 0.7 1.2 0.0 0.0 0.0 3.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.3 0.1 0.1 1.3 0.0 2.0 0.0 1.3 1.3 1.8 0.0 0.7 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.3 2.3 0.3 1.5 0.0 0.0 91.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 18.9 26.4 17.2 6.9 4.1 9.5 6.2 4.0 12.4 0.0 7.9 12.5 1.0 28.9 124.2 12.1 0.0 3.4 0.7 0.0 0.0 220.1 5.1 2.2 32.4 5.7 1.3 0.0 54.2 0.0 0.0 0.3 82.2 0.0 58.4 1.0 0.1 0.5 1.8 0.0 566.5 0.0 0.0 6.4 3.1 1.7 1.3 19.6 1.4 14.3 0.3 1.7 393.1 0.0 0.0 0.0 0.3 29.2 0.6 0.5 1.8 89.0 0.0 6.4 0.0 20.1 10.7 0.1 0.0 0.4 0.1 4.9 0.0 24.5 1.5 133.7 0.0 5.2 1.6 6.2 1.8 0.1 0.9 0.1 0.3 3.3 0.1 0.9 TMEFF2 "CT120.2, HPP1, TENB2, TPEF, TR" ENSG00000144339 "Transmembrane protein with EGF like and two follistatin like domains 2" Q9UIK5 2 191949043-192194933 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.7;prostate: 36.9;seminal vesicle: 13.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 416.1;Inhibitory neurons: 382.0;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 1337.5" "Cancer enriched" "Detected in some" 21 "prostate cancer: 57.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 36.9;LHCN-M2: 107.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015587 Approved "Secreted in male reproductive system" NA NA "HPA015587: AB_1858069" "unprognostic (2.12e-3)" "unprognostic (5.37e-1)" "unprognostic (3.10e-1)" "unprognostic (5.89e-7)" "unprognostic (4.96e-2)" "unprognostic (1.27e-1)" "unprognostic (8.82e-2)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (5.55e-2)" "unprognostic (2.09e-2)" "unprognostic (3.79e-2)" "unprognostic (4.17e-3)" "unprognostic (1.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.20e-1)" 0.2 2.3 30.8 0.1 25.9 0.0 0.3 15.6 28.3 0.1 6.4 0.9 0.6 0.0 8.2 1.2 0.1 1.7 1.1 28.7 24.7 0.0 0.0 0.1 0.0 24.3 22.7 26.8 0.2 0.0 0.0 0.3 0.0 26.1 36.9 1.5 3.4 0.1 13.4 0.3 0.2 0.6 0.1 17.4 0.0 0.9 0.7 26.7 0.0 0.2 0.6 0.1 0.8 0.5 33.7 0.0 0.9 36.9 0.0 5.6 5.8 0.1 0.1 0.7 1.8 2.2 0.0 0.0 0.0 0.0 10.3 4.5 0.0 2.3 0.0 7.1 0.0 0.1 0.1 0.3 0.0 0.7 0.0 0.0 15.6 0.0 2.0 10.8 9.0 0.1 0.0 0.0 0.0 107.1 0.0 0.0 0.1 2.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.2 2.8 0.0 0.0 0.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 25.9 15.6 28.3 28.7 24.7 24.3 22.7 26.8 26.1 17.4 26.7 33.7 0.1 0.0 0.0 11.8 0.0 0.1 0.1 0.0 0.0 16.6 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 416.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.6 382.0 0.5 0.0 0.0 0.7 2.3 26.4 0.0 0.0 11.2 0.0 0.6 0.0 210.6 1337.5 0.0 0.0 8.6 0.0 5.7 0.1 0.0 0.0 1.6 6.6 24.6 0.6 1.2 2.6 0.3 0.3 0.0 0.4 0.0 0.0 0.1 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.7;lymphoid tissue: 50.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 45.7;Intestinal goblet cells: 40.7;Leydig cells: 53.7;Undifferentiated cells: 124.2" "Cancer enhanced" "Detected in all" "colorectal cancer: 43.3" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 279.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol No Yes "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.8 0.3 0.9 13.2 0.7 23.2 2.4 0.7 0.7 12.7 5.4 25.7 31.0 14.0 3.3 10.2 3.8 1.5 0.6 0.7 1.3 0.4 0.3 1.6 37.8 0.8 0.9 0.4 1.1 1.7 0.3 0.1 7.4 0.8 3.1 29.8 0.4 2.5 1.2 3.2 11.8 32.7 3.5 0.8 2.4 14.4 6.0 1.0 50.5 0.5 0.8 41.6 2.9 6.8 1.1 44.2 33.3 76.4 83.3 3.6 14.0 79.9 26.0 9.2 60.3 67.2 51.6 54.4 122.1 32.2 15.8 23.5 45.0 122.4 46.6 87.0 59.2 67.4 27.6 24.6 66.0 3.8 181.2 25.1 11.4 3.9 32.8 27.3 7.8 28.0 158.1 67.4 27.2 17.7 35.4 279.7 181.7 90.4 103.4 22.7 194.4 58.2 77.3 29.5 38.2 22.3 39.2 40.8 13.4 22.0 67.9 0.3 70.5 13.0 39.3 16.8 12.9 48.5 7.4 17.1 173.0 24.4 99.8 34.0 0.0 0.5 0.0 1.1 0.0 0.4 1.9 3.0 5.9 3.5 0.3 0.2 1.0 0.2 3.2 0.0 0.5 7.9 2.3 0.9 0.7 0.7 0.7 0.7 1.3 0.8 0.9 0.4 0.8 0.8 1.0 1.1 1.0 0.0 0.6 0.7 3.0 20.3 14.9 3.3 14.8 0.0 2.6 6.5 1.1 0.0 0.3 0.0 0.0 45.7 1.6 17.1 0.0 0.2 0.9 3.2 33.0 3.4 12.2 33.6 0.1 0.2 29.9 4.1 22.4 6.8 0.0 18.5 0.0 0.2 10.4 0.0 10.5 40.7 4.1 1.0 4.4 2.2 53.7 2.3 3.6 0.0 1.2 0.7 0.0 0.5 0.1 1.0 11.1 34.6 3.8 5.3 11.9 0.0 0.1 0.0 0.0 1.1 7.2 13.8 28.9 21.8 15.9 10.1 9.1 2.7 124.2 3.8 DLX1 ENSG00000144355 "Distal-less homeobox 1" P56177 2 172084740-172089677 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 9.0" "Cell type enriched" "Detected in some" 23 "Inhibitory neurons: 30.4" "Cancer enhanced" "Detected in many" "prostate cancer: 11.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1" "Group enriched" "Detected in many" 5 "basal ganglia: 28.6;olfactory bulb: 82.6" "Region enriched" "Detected in many" 4 "olfactory bulb: 48.8" "HPA007175, HPA045884" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA007175: , HPA045884: AB_10960361" "unprognostic (2.14e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (7.92e-3)" "unprognostic (8.86e-2)" "unprognostic (2.80e-2)" "unprognostic (2.03e-1)" "unprognostic (5.74e-2)" "unprognostic (2.04e-1)" "unprognostic (7.40e-9)" "unprognostic (2.22e-1)" "unprognostic (9.19e-2)" "unprognostic (1.25e-1)" "unprognostic (5.91e-3)" 0.0 1.3 5.3 0.2 5.1 0.0 0.1 0.0 4.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 9.0 0.0 0.0 0.0 0.0 0.3 0.2 3.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.2 0.0 0.1 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 4.4 0.0 1.0 0.2 0.3 0.1 0.2 2.7 2.4 0.6 0.6 134.5 2.0 4.5 0.3 3.2 6.5 7.7 4.1 1.0 0.2 0.0 7.8 7.2 7.5 9.4 7.4 1.2 5.2 0.3 33.3 21.1 14.4 5.7 0.1 7.9 15.9 0.0 2.2 1.9 3.2 5.4 0.0 6.7 12.4 0.0 6.3 8.1 0.1 1.9 0.1 0.0 22.9 0.4 15.8 0.0 0.9 4.5 11.3 0.0 6.1 0.8 17.5 0.4 5.2 9.5 7.1 36.9 0.2 16.4 16.4 0.2 0.0 0.1 15.2 21.4 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.3 5.1 0.0 4.4 3.2 9.0 0.3 0.2 3.0 1.1 0.0 4.4 2.7 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3" Q6ZT12 2 169827454-170084131 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.9;tongue: 87.8" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 14.3 12.5 2.1 7.8 5.1 7.5 9.3 5.3 7.6 11.0 1.8 8.8 8.1 10.2 6.9 12.9 8.5 9.4 29.7 7.7 3.8 15.4 21.2 8.9 7.2 2.2 3.3 4.7 10.3 12.0 21.7 2.1 8.8 2.7 13.2 8.6 21.3 11.6 10.4 71.9 9.3 7.6 11.2 1.3 8.8 9.4 9.8 2.8 9.6 18.1 87.8 7.4 11.1 2.3 6.5 14.8 12.4 12.9 17.1 25.0 19.7 10.8 26.1 15.0 14.7 11.8 19.1 9.1 16.7 22.2 20.5 12.0 19.0 15.5 13.2 18.2 17.4 13.4 61.1 12.6 20.3 12.4 20.4 18.9 11.9 12.1 19.3 12.9 11.7 14.8 8.3 32.4 17.6 25.6 14.0 13.3 10.0 10.1 14.9 10.2 12.6 21.1 17.8 10.5 20.5 25.1 13.7 18.4 16.7 10.6 10.2 10.9 11.4 18.9 22.1 9.0 17.5 16.7 14.2 11.9 15.1 18.2 11.8 12.5 0.0 0.6 0.5 0.9 0.6 1.3 0.6 0.5 0.8 0.9 0.3 0.9 1.2 0.6 0.8 0.5 0.7 1.0 0.4 2.1 5.1 5.3 7.6 7.7 3.8 2.2 3.3 4.7 2.7 1.3 2.8 6.5 19.0 44.8 26.9 162.6 16.3 25.9 12.4 14.8 20.5 46.3 15.8 8.9 109.7 17.2 20.0 12.9 81.3 19.7 22.9 17.1 3.9 8.7 7.6 16.8 21.9 26.4 16.7 24.4 305.1 11.0 8.4 22.2 23.4 22.0 16.5 22.7 30.4 39.0 10.2 63.9 302.0 11.3 22.4 20.9 18.7 10.2 25.7 18.7 16.0 110.5 18.7 61.7 14.4 232.2 288.0 10.7 15.0 19.2 21.3 20.9 15.3 10.0 13.4 51.5 26.3 29.0 21.8 12.4 8.6 22.9 29.0 23.0 18.1 17.3 13.2 17.2 PHOSPHO2 MGC22679 ENSG00000144362 "Phosphatase, orphan 2" Q8TCD6 2 169694454-169701708 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 158.7;Spermatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034726, HPA034727" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA034726: AB_10602191, HPA034727: AB_2674302" "unprognostic (1.98e-1)" "unprognostic (1.22e-1)" "unprognostic (7.56e-2)" "unprognostic (1.39e-3)" "unprognostic (1.30e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (3.82e-6)" "unprognostic (4.31e-2)" "unprognostic (2.11e-2)" "unprognostic (5.19e-2)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "prognostic favorable (9.53e-4)" "unprognostic (4.10e-1)" "unprognostic (2.60e-1)" "unprognostic (6.12e-2)" "unprognostic (7.53e-2)" 5.1 2.9 2.0 2.4 1.7 2.9 10.7 3.9 1.7 4.8 2.8 5.9 6.5 5.3 4.3 3.2 6.0 4.0 2.4 1.6 2.2 5.6 3.7 3.3 3.0 1.2 1.4 1.2 6.1 5.2 7.3 4.7 3.0 1.6 13.1 5.9 7.3 8.6 4.8 3.5 3.5 6.4 3.1 1.4 2.6 4.8 13.8 1.8 3.0 9.9 1.6 3.0 3.8 2.8 1.7 6.6 1.8 4.6 6.2 8.5 2.7 17.8 2.8 1.9 4.3 4.7 6.3 4.9 6.4 6.1 2.1 8.9 5.0 6.2 3.4 3.5 9.5 7.0 6.4 6.1 11.0 5.6 5.3 5.6 4.9 6.3 4.9 6.5 3.6 3.9 8.9 10.8 6.4 2.7 6.0 3.7 6.8 6.0 4.2 2.3 3.6 2.8 5.1 6.8 19.6 19.1 6.5 5.8 3.1 6.8 5.5 8.4 3.2 2.3 4.7 4.3 4.2 3.1 6.2 6.0 5.7 5.5 3.2 5.1 0.1 0.7 1.0 3.3 0.9 4.6 6.5 3.6 3.2 0.9 8.8 4.7 4.6 1.3 9.8 0.9 4.2 4.4 1.4 2.0 1.7 3.9 1.7 1.6 2.2 1.2 1.4 1.2 1.6 1.4 1.8 1.7 6.1 3.2 3.6 0.0 6.8 2.5 10.3 5.4 2.8 8.7 15.2 11.0 4.1 5.7 4.7 3.7 6.2 8.8 2.5 7.0 9.8 7.6 158.7 10.6 5.0 4.3 15.0 6.9 0.0 11.1 9.3 6.9 15.3 3.3 0.0 5.7 2.5 3.7 2.8 6.7 0.0 6.6 12.2 0.6 1.6 35.9 4.7 2.0 3.6 0.0 1.0 6.4 1.0 0.0 0.0 6.4 6.8 4.9 3.8 6.5 12.7 12.2 13.4 10.2 0.0 6.7 9.3 68.9 13.9 4.5 4.3 5.5 5.7 8.8 7.5 5.5 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP PTB domain containing engulfment adaptor 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 83.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 136.5;Inhibitory neurons: 115.5;Muller glia cells: 129.4;Syncytiotrophoblasts: 204.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.9;SH-SY5Y: 83.4;WM-115: 228.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020587 Enhanced Approved Vesicles NA NA Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favorable (4.25e-6)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 9.5 24.7 2.0 5.9 7.8 0.2 13.2 0.1 6.7 27.9 28.5 11.3 13.6 35.6 83.7 19.4 18.3 17.7 4.9 3.9 6.0 21.5 0.8 13.4 1.7 20.5 5.0 3.7 32.1 22.4 26.3 3.4 19.9 24.9 27.9 7.9 17.9 16.2 28.3 9.7 6.2 16.0 21.9 0.1 5.9 22.8 28.3 6.2 1.8 7.9 16.9 3.3 12.0 14.4 17.0 12.5 26.9 106.9 23.8 17.1 15.5 18.6 16.5 27.0 25.1 19.9 18.9 62.6 0.0 13.2 13.2 28.2 8.3 20.0 1.5 18.9 0.0 13.9 27.0 20.5 0.2 15.1 0.0 0.2 10.1 4.2 13.0 14.2 42.9 12.7 0.0 22.5 0.5 19.3 1.8 0.0 0.4 27.4 18.1 46.0 0.1 25.1 14.0 60.0 4.7 0.5 83.4 0.0 14.6 40.2 47.9 4.7 0.1 5.9 7.8 3.8 26.3 9.6 0.0 0.1 0.0 4.6 0.0 228.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.0 7.8 0.1 6.7 3.9 6.0 20.5 5.0 3.7 24.9 0.1 6.2 17.0 22.8 16.0 13.4 43.4 1.6 15.7 23.9 3.6 10.2 1.5 10.6 12.2 1.6 45.8 28.2 23.9 0.0 41.1 0.6 3.7 45.0 33.0 5.0 23.9 35.4 32.1 136.5 0.0 82.7 38.2 5.9 55.3 39.8 52.1 0.0 2.2 10.0 1.5 3.2 1.7 115.5 4.6 14.2 1.0 10.5 7.9 20.5 2.0 35.6 53.4 1.1 129.4 0.0 3.0 3.1 51.3 9.8 61.3 1.4 79.8 30.8 43.2 43.5 3.7 6.6 42.2 27.9 79.6 23.9 38.9 27.6 204.4 2.7 27.0 4.7 34.5 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186694060-186765959 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.3" "Group enriched" "Detected in many" 5 "Astrocytes: 258.6;Bipolar cells: 141.4;Excitatory neurons: 126.5;Inhibitory neurons: 114.2;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 78.5" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 43.7;U-138 MG: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.03e-4)" 2.9 14.5 40.7 1.5 54.6 0.5 3.4 13.6 55.3 6.7 0.8 1.7 1.0 7.6 2.1 1.9 2.7 4.9 1.4 54.2 35.0 1.2 0.4 1.4 1.2 24.6 25.6 54.1 10.3 1.0 7.6 10.8 3.3 20.4 2.7 2.0 24.3 23.2 2.3 0.7 3.7 1.4 4.4 19.6 1.5 2.0 0.9 25.9 2.8 2.3 3.7 1.1 2.2 2.2 44.8 4.2 4.9 7.2 22.6 20.9 15.7 0.1 4.5 8.0 5.5 7.8 13.6 21.9 0.0 1.6 12.9 9.3 0.5 9.9 4.3 7.8 0.0 5.7 5.1 2.1 0.0 1.6 1.5 1.7 20.2 1.8 4.2 3.4 7.1 12.1 3.9 0.0 43.7 10.5 2.9 3.0 0.0 9.6 0.0 4.9 0.0 13.9 1.0 8.5 15.8 22.4 12.2 2.3 1.4 6.1 4.2 1.7 1.0 7.1 29.7 3.9 0.5 2.9 11.5 12.0 0.0 9.2 0.0 4.2 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.2 0.2 0.0 0.0 40.7 54.6 13.6 55.3 54.2 35.0 24.6 25.6 54.1 20.4 19.6 25.9 44.8 9.1 0.0 0.0 258.6 0.1 8.9 2.8 1.2 4.0 141.4 10.7 5.7 0.8 5.7 5.7 0.0 14.6 11.4 0.5 0.0 0.0 1.0 1.3 1.5 13.0 14.4 4.8 1.3 126.5 0.4 0.8 14.1 2.6 4.7 0.0 0.8 6.8 0.1 2.0 23.5 114.2 0.0 4.1 0.3 2.8 4.0 7.8 1.0 3.6 18.7 0.7 16.2 0.0 102.1 78.5 0.7 0.0 13.9 0.2 1.4 0.0 0.2 2.6 17.0 0.0 8.6 4.5 0.4 1.5 0.6 5.3 8.2 0.9 2.6 0.0 1.1 HSPD1 "GroEL, HSP60, SPG13" ENSG00000144381 "Heat shock protein family D (Hsp60) member 1" P10809 2 197486584-197516737 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, Isomerase" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 797.0" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 1737.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001523, CAB002775, HPA050025, CAB072816" Supported Enhanced Mitochondria NA NA 18000000 Mitochondria "CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995" "unprognostic (2.79e-2)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.59e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (2.25e-4)" "unprognostic (3.51e-2)" "unprognostic (9.91e-2)" "unprognostic (8.63e-3)" "unprognostic (3.47e-2)" "unprognostic (7.83e-3)" "unprognostic (5.64e-3)" "unprognostic (1.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (4.10e-2)" 145.5 797.0 201.6 129.4 193.6 111.5 170.5 209.2 314.1 95.7 221.7 171.6 159.5 91.5 90.1 125.5 133.8 69.7 139.6 200.0 205.3 378.4 466.4 137.8 150.5 208.8 200.3 176.9 169.0 220.8 160.5 116.9 149.8 214.5 105.4 197.0 72.4 94.7 94.5 164.1 75.6 150.0 105.4 218.5 95.3 156.7 58.2 204.4 100.2 139.9 178.3 174.1 146.0 93.1 243.6 559.7 650.1 541.3 496.9 373.6 389.2 786.5 573.2 304.7 686.1 495.6 2219.1 326.2 1724.4 730.0 304.1 834.2 538.4 2232.9 633.2 943.0 417.0 888.2 1209.8 984.8 2562.8 353.2 1331.4 349.1 445.5 717.1 599.5 1053.2 471.4 542.6 919.1 1535.3 606.8 501.7 690.4 853.6 1304.2 1086.4 735.2 1424.9 1000.1 679.7 1235.5 709.5 539.7 716.5 400.8 582.0 608.5 771.0 1116.3 425.0 789.4 242.2 405.8 570.4 532.8 910.0 331.1 861.4 1399.5 485.7 795.3 456.7 12.1 52.3 11.4 36.4 81.8 71.7 63.8 59.6 54.3 84.6 54.0 81.0 70.3 11.0 62.6 72.1 49.4 51.8 70.6 201.6 193.6 209.2 314.1 200.0 205.3 208.8 200.3 176.9 214.5 218.5 204.4 243.6 216.4 166.7 172.5 38.8 220.4 246.6 1737.2 247.5 264.0 75.8 216.0 263.1 239.2 195.9 287.9 79.1 256.5 825.7 197.7 213.7 375.6 235.0 6.2 322.2 304.5 233.9 274.6 241.6 31.9 145.9 419.8 356.0 215.6 445.2 299.5 407.1 63.1 312.5 328.0 95.9 47.2 302.2 166.8 88.6 479.3 12.8 130.5 381.9 163.7 30.0 138.5 125.7 68.0 20.6 35.6 171.4 163.2 113.6 322.9 705.9 160.1 797.1 328.6 117.1 85.5 199.0 471.7 88.5 106.0 262.4 207.1 1001.2 467.2 1017.4 512.1 861.5 CCDC150 FLJ39660 ENSG00000144395 "Coiled-coil domain containing 150" Q8NCX0 2 196639554-196763490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.6;testis: 4.9" "Cell type enhanced" "Detected in many" "Early spermatids: 54.5;Granulosa cells: 16.5;Late spermatids: 20.9;Oligodendrocytes: 16.4;Spermatocytes: 32.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048104 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048104: AB_2680264" "unprognostic (1.92e-1)" "unprognostic (3.75e-1)" "unprognostic (2.95e-1)" "unprognostic (2.58e-4)" "unprognostic (9.88e-2)" "unprognostic (1.42e-3)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (5.91e-4)" "unprognostic (2.01e-2)" "unprognostic (3.16e-2)" "unprognostic (9.17e-3)" "unprognostic (5.66e-4)" "unprognostic (7.29e-2)" "unprognostic (1.99e-2)" "unprognostic (4.35e-2)" "unprognostic (2.69e-5)" 0.0 0.0 0.2 0.2 0.3 0.6 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 2.6 1.2 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 4.9 0.2 1.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.3 4.4 2.8 0.1 0.3 1.9 1.0 0.5 0.7 1.9 1.5 0.9 0.6 0.5 0.7 0.6 1.3 1.7 0.8 1.9 4.2 2.4 1.4 2.4 2.5 0.0 0.9 0.6 0.0 0.1 1.0 0.5 0.2 0.5 1.5 2.0 1.8 0.5 0.5 0.8 1.3 2.6 0.3 1.0 1.8 0.6 0.6 0.3 0.4 4.6 0.9 0.7 0.4 0.2 2.2 0.7 0.5 0.9 1.5 1.4 1.4 0.9 0.8 0.8 1.4 0.5 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.3 1.5 3.2 1.7 2.3 1.0 1.5 2.2 0.2 0.0 3.6 0.6 1.3 1.5 1.5 0.1 0.0 2.1 2.2 0.7 1.4 1.9 0.3 54.5 2.1 1.7 2.6 0.0 2.1 1.1 0.4 2.0 2.3 1.5 3.8 3.8 16.5 1.4 3.8 1.3 1.7 3.0 1.4 0.0 1.3 2.5 20.9 1.5 1.3 7.2 0.0 0.5 1.1 2.1 2.0 16.4 0.4 1.2 1.9 2.4 1.3 0.7 12.5 2.5 1.3 0.0 4.0 2.3 32.2 14.8 2.0 1.0 0.7 1.2 2.8 1.7 1.3 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Paneth cells: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 11.2 9.1 21.5 10.9 21.5 22.9 7.9 24.4 22.9 8.8 18.3 9.5 8.2 9.8 8.0 6.8 8.0 7.1 13.7 19.3 18.8 11.0 23.9 9.1 16.7 21.2 20.7 17.6 11.2 8.9 10.0 10.0 12.6 25.9 8.5 8.9 16.1 8.7 6.6 22.1 9.3 8.9 7.7 17.7 16.3 12.2 7.6 21.0 17.8 12.5 8.9 15.2 8.6 6.9 28.8 18.4 16.8 27.4 20.8 11.9 12.4 53.0 10.1 12.3 15.9 16.0 32.3 28.6 26.2 21.5 7.7 27.8 10.4 39.6 13.2 13.1 15.3 27.1 30.9 26.7 53.6 21.0 40.7 30.0 11.1 17.2 7.9 13.2 19.5 18.1 43.3 45.0 15.1 10.6 29.7 41.2 69.4 45.5 24.9 11.8 30.1 11.4 38.2 23.0 15.3 32.3 26.5 21.8 7.4 21.6 37.8 10.3 59.4 9.3 13.8 30.6 12.9 17.8 22.3 29.8 54.1 22.6 31.5 20.9 32.8 28.6 54.8 9.5 29.0 16.0 54.2 14.4 13.7 24.1 44.8 26.8 17.4 10.4 16.9 45.6 30.0 12.7 16.6 21.5 21.5 24.4 22.9 19.3 18.8 21.2 20.7 17.6 25.9 17.7 21.0 28.8 30.8 16.0 25.3 16.0 55.0 15.9 38.1 25.7 5.7 22.0 16.6 16.4 23.8 21.5 23.1 11.0 8.4 35.5 24.3 17.1 29.4 27.9 31.4 12.5 10.1 24.6 5.4 42.5 20.6 25.1 31.3 16.9 18.3 8.5 46.3 17.7 20.7 12.3 29.9 18.5 17.6 16.3 69.2 22.2 93.7 45.6 9.9 32.8 44.4 44.0 29.7 17.4 16.5 20.6 25.9 23.8 114.4 7.5 16.6 48.1 8.9 23.4 23.3 20.3 13.1 9.6 16.0 24.8 19.1 9.3 12.6 10.5 23.0 15.6 18.6 19.6 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771832-209999300 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.6;pituitary gland: 13.7;retina: 19.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5" "Cancer enhanced" "Detected in some" "glioma: 0.8;prostate cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" NA NA "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.0 3.9 3.8 0.0 10.3 0.0 0.0 15.9 21.6 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.4 1.2 0.0 6.5 7.4 0.1 0.0 0.1 0.0 7.2 3.6 7.6 0.5 1.0 0.2 13.7 0.0 6.8 0.9 0.1 19.1 0.1 0.2 0.0 0.1 0.1 0.2 0.9 0.2 0.4 3.5 4.3 0.1 0.3 0.0 0.0 0.2 0.0 12.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 10.3 15.9 21.6 6.5 7.4 7.2 3.6 7.6 6.8 0.9 4.3 12.2 0.2 0.0 1.1 49.0 0.0 0.8 0.3 1.9 0.0 117.7 0.2 0.1 2.1 0.0 0.7 0.0 66.7 0.0 0.0 0.0 0.0 0.0 31.9 1.1 1.7 0.5 0.0 0.0 432.0 0.0 0.0 1.1 0.0 0.1 1.3 0.6 0.0 0.0 0.1 52.2 354.7 0.0 0.0 0.0 0.0 10.5 0.9 0.3 0.0 10.3 0.0 26.6 0.0 290.5 12.8 0.1 0.0 1.9 0.0 1.2 0.0 0.2 0.8 75.6 0.0 0.2 0.1 7.5 3.8 0.0 0.1 0.0 0.0 15.1 0.0 0.3 PTH2R PTHR2 ENSG00000144407 "Parathyroid hormone 2 receptor" P49190 2 208359714-208854503 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 16.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 12.5;Distal tubular cells: 7.9;Excitatory neurons: 15.9;Proximal tubular cells: 16.1;Rod photoreceptor cells: 26.5" "Cancer enhanced" "Detected in many" "renal cancer: 6.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "EFO-21: 10.7;HEL: 16.0;HL-60: 4.0;SH-SY5Y: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA010655 Approved NA NA "HPA010655: AB_2668333" "unprognostic (4.76e-3)" "unprognostic (1.39e-3)" "unprognostic (1.64e-1)" "unprognostic (5.78e-2)" "unprognostic (3.77e-1)" "unprognostic (8.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (3.45e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-1)" "unprognostic (1.09e-3)" "unprognostic (2.54e-3)" "unprognostic (6.87e-2)" "unprognostic (1.30e-2)" "unprognostic (1.37e-2)" 1.2 0.3 2.5 0.1 1.4 4.2 1.0 0.2 2.9 0.0 0.4 0.0 0.0 0.7 2.1 0.0 0.0 0.0 0.0 2.8 1.7 0.2 0.6 0.1 0.1 0.8 1.0 1.8 0.0 0.6 0.0 0.3 1.2 1.0 0.5 0.0 16.7 3.6 0.5 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.5 3.4 0.0 0.0 0.0 0.1 0.0 0.0 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.5 1.4 0.2 2.9 2.8 1.7 0.8 1.0 1.8 1.0 0.4 3.4 1.9 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.1 0.0 1.1 1.8 3.2 0.2 0.0 0.1 5.5 12.5 0.5 0.9 0.0 7.9 0.1 0.6 0.2 0.5 0.1 1.8 4.2 15.9 0.0 0.1 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.0 0.1 2.5 2.1 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 26.5 0.0 0.0 0.4 0.6 0.4 0.0 0.0 0.1 0.1 0.3 0.0 0.0 CPO ENSG00000144410 "Carboxypeptidase O" Q8IVL8 2 206939518-206969474 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 112.7" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 349.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 30 "basophil: 12.0" "Lineage enriched" "Detected in single" 84 "granulocytes: 12.0" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (9.39e-2)" "unprognostic (2.64e-1)" "unprognostic (2.95e-2)" "unprognostic (5.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.16e-1)" "unprognostic (9.06e-2)" "unprognostic (4.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.75e-3)" "unprognostic (1.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.52e-1)" "unprognostic (6.56e-2)" "unprognostic (4.03e-2)" "unprognostic (4.89e-2)" 0.5 1.0 2.4 0.1 2.5 0.0 0.8 1.4 3.1 0.5 1.2 0.9 0.5 0.3 7.6 0.2 0.7 0.4 0.4 2.3 2.2 1.3 0.7 0.3 0.1 2.1 2.2 2.3 0.4 0.5 1.0 1.2 0.2 2.4 0.9 0.4 0.6 0.9 0.8 0.7 0.5 112.7 0.7 1.9 0.2 0.5 0.8 2.5 0.1 1.0 0.5 0.1 0.5 0.3 3.4 0.0 0.0 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 12.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.5 1.4 3.1 2.3 2.2 2.1 2.2 2.3 2.4 1.9 2.5 3.4 0.1 0.0 0.0 9.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.2 0.0 0.0 0.0 43.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 35.9 6.3 0.0 0.0 0.0 0.7 0.3 0.0 0.0 6.5 0.0 0.0 0.0 2.0 14.6 0.0 3.8 0.0 0.0 0.0 349.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 NBEAL1 "ALS2CR16, ALS2CR17, MGC164581" ENSG00000144426 "Neurobeachin like 1" Q6ZS30 2 203014879-203226378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 1030.4;Langerhans cells: 1016.1;Suprabasal keratinocytes: 1304.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049189, HPA049447" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049189: AB_2680669, HPA049447: AB_2680771" "unprognostic (3.66e-2)" "unprognostic (5.26e-2)" "unprognostic (2.86e-2)" "unprognostic (1.11e-1)" "unprognostic (4.52e-4)" "unprognostic (1.16e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-3)" "unprognostic (2.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (7.98e-3)" "unprognostic (7.59e-2)" 3.0 2.1 1.8 1.7 3.2 1.1 3.3 4.3 1.9 2.7 7.8 7.0 4.7 2.6 2.2 2.1 3.5 3.1 2.7 1.3 4.3 6.5 5.8 4.5 1.1 2.8 2.3 1.1 3.7 2.9 2.9 0.9 2.8 3.0 2.2 6.7 4.0 1.7 1.8 1.5 2.2 5.6 2.7 1.9 1.7 7.2 3.6 2.6 1.4 4.6 3.9 1.3 2.9 1.7 3.8 4.2 3.9 1.6 1.4 9.7 7.5 2.3 4.0 2.9 2.1 3.2 4.4 2.1 0.9 3.2 6.8 4.1 3.4 3.2 4.7 4.8 1.9 1.4 1.6 6.0 2.5 2.3 1.5 1.8 2.9 3.0 3.4 4.2 5.0 3.3 1.7 2.9 1.4 4.8 2.9 0.6 0.8 0.8 1.8 3.6 0.7 2.6 1.0 5.8 7.8 1.0 0.8 3.4 2.5 2.5 3.9 2.9 1.5 5.7 5.5 4.6 2.6 1.8 2.4 1.9 1.2 3.3 0.6 1.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.0 1.8 3.2 4.3 1.9 1.3 4.3 2.8 2.3 1.1 3.0 1.9 2.6 3.8 53.0 38.5 72.2 103.5 145.5 1030.4 399.8 231.1 117.8 18.4 81.2 89.2 21.4 223.1 94.4 38.6 27.1 205.9 58.8 173.8 84.1 57.4 30.9 57.8 73.5 155.1 293.5 49.0 88.0 99.2 276.5 154.4 103.9 69.3 107.2 43.3 287.0 203.7 154.5 82.4 79.7 515.3 91.6 531.4 1016.1 49.5 274.3 78.0 629.7 81.5 186.0 19.5 171.9 105.1 130.9 78.5 335.8 129.4 52.4 304.8 343.9 103.1 59.2 26.9 118.3 388.6 265.6 45.1 41.2 118.4 1304.2 229.3 182.3 31.4 528.3 305.2 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021421-210171409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "parathyroid gland: 200.3" "Cell type enhanced" "Detected in many" "Astrocytes: 113.6;Inhibitory neurons: 117.9;Microglial cells: 103.0;Oligodendrocyte precursor cells: 190.5;Oligodendrocytes: 158.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol NA NA Cytosol "HPA043102: AB_2678316, HPA046790: AB_2679808" "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 10.1 8.4 11.9 6.2 13.9 5.6 10.4 14.6 12.8 14.5 10.3 8.4 6.5 18.9 17.5 7.0 13.4 15.8 9.8 10.4 21.6 22.9 9.5 12.0 6.7 11.3 12.2 7.6 28.8 15.3 200.3 10.0 8.4 11.9 17.1 6.9 12.7 10.1 17.2 12.2 13.4 6.8 13.4 11.5 6.3 12.6 25.5 11.6 26.9 19.9 18.6 5.2 13.7 11.4 18.1 2.7 1.4 14.5 6.1 11.7 8.7 4.0 4.1 5.4 2.7 7.4 2.7 10.9 7.9 5.5 2.8 6.5 3.8 3.4 1.5 4.3 3.4 2.7 6.3 6.1 4.6 7.3 7.4 4.3 5.5 6.5 2.7 1.9 11.5 6.1 7.2 4.5 7.1 4.1 2.7 8.5 19.7 8.4 4.8 1.9 6.1 3.9 6.1 16.0 4.0 9.0 8.5 3.7 2.3 2.9 14.4 2.5 16.1 4.9 5.3 4.3 1.9 3.1 4.9 2.2 7.7 7.0 3.5 7.1 0.2 0.3 0.5 0.2 0.4 0.2 0.1 0.2 0.2 0.4 0.3 0.3 0.3 0.4 0.6 0.1 0.3 0.1 0.1 11.9 13.9 14.6 12.8 10.4 21.6 11.3 12.2 7.6 11.9 11.5 11.6 18.1 12.8 28.9 20.1 113.6 4.6 7.4 6.7 3.9 11.4 8.6 5.4 6.7 9.2 20.0 6.6 31.3 14.6 1.7 1.5 2.3 3.9 13.2 30.3 22.3 17.0 8.8 6.0 4.6 79.0 5.5 0.9 14.2 9.2 14.7 10.8 23.6 6.4 7.4 2.7 5.0 117.9 3.2 8.2 2.8 6.7 22.2 14.6 8.5 7.2 103.0 5.5 9.6 4.1 190.5 158.9 6.7 4.7 30.1 3.0 7.0 2.0 15.8 36.0 8.7 13.1 31.1 15.6 44.9 7.8 5.5 11.1 1.9 2.7 6.6 2.8 4.1 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 243.1;Inhibitory neurons: 273.7;Respiratory ciliated cells: 330.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 70.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037542 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.90e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 16.4 17.0 40.3 6.4 41.5 2.5 21.0 40.5 42.2 21.2 41.0 15.7 18.9 18.4 31.9 26.4 46.9 22.2 22.4 38.0 45.7 30.7 19.0 10.9 11.6 43.1 42.8 34.0 26.0 15.7 24.6 30.0 9.9 41.7 22.3 17.3 21.7 15.8 20.7 10.4 25.1 11.0 12.2 46.1 8.1 26.3 46.8 40.9 13.1 26.6 10.9 14.0 19.0 19.5 44.9 26.8 9.9 29.4 0.0 19.3 35.0 0.2 14.3 17.1 18.3 19.3 20.8 28.8 11.1 16.7 16.0 29.3 18.5 13.4 17.4 38.6 0.0 10.5 5.8 28.0 24.6 21.9 6.3 0.1 30.1 23.5 16.3 9.5 25.0 7.6 11.6 18.8 12.3 18.4 0.0 21.4 0.1 16.3 0.0 8.7 22.6 30.9 0.5 29.4 25.8 21.4 25.1 16.3 15.1 21.3 24.2 70.3 2.7 7.8 17.2 9.2 9.3 15.1 20.0 9.7 0.4 28.6 0.0 8.0 2.0 0.3 0.9 8.1 1.3 11.7 9.3 9.1 10.4 3.1 8.5 12.0 10.4 0.5 15.4 0.9 5.1 9.4 3.4 40.3 41.5 40.5 42.2 38.0 45.7 43.1 42.8 34.0 41.7 46.1 40.9 44.9 17.7 16.0 19.5 89.5 10.7 42.3 46.6 82.8 22.8 47.6 38.0 45.6 67.5 74.4 73.6 40.5 95.9 50.6 7.5 17.1 76.3 44.0 243.1 207.0 31.3 18.5 38.2 9.0 205.9 24.9 20.8 30.8 32.1 30.3 10.1 34.0 12.8 16.9 11.7 40.4 273.7 37.8 101.7 4.6 9.6 86.2 41.3 5.9 23.2 42.2 29.2 82.7 8.2 92.0 74.9 27.3 18.8 44.8 9.4 25.4 9.4 94.9 330.0 69.0 13.1 30.8 36.1 167.9 31.0 64.6 56.4 23.5 12.9 55.3 39.8 53.8 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138626 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 5.8;skin 1: 20.9" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "cerebral cortex: 1.0;hippocampal formation: 1.1" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: AB_2732373" "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 5.8 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.3 0.2 0.2 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 2.8 0.3 3.9 0.1 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 38.7 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.5 0.1 2.7 0.0 18.3 0.0 0.2 9.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 12.9 0.9 6.0 0.0 0.2 1.0 0.5 0.5 0.0 5.1 0.0 0.0 1.1 0.0 3.0 0.0 0.1 2.2 2.6 0.3 0.1 0.0 0.0 1.4 0.0 2.7 0.1 1.5 3.7 0.0 0.5 0.0 0.0 0.4 1.7 2.9 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.6 1.9 0.0 0.7 0.0 1.0 0.0 0.1 3.1 0.2 0.0 0.0 0.2 0.7 0.4 2.2 38.6 3.4 0.0 0.1 0.9 2.7 SUMF1 "FGE, UNQ3037" ENSG00000144455 "Sulfatase modifying factor 1" Q8NBK3 3 3700814-4467273 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 116.4;hTERT-RPE1: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038025 Uncertain "Intracellular and membrane" NA NA 2800000 "HPA038025: AB_10675624" "unprognostic (5.02e-2)" "unprognostic (2.30e-1)" "unprognostic (1.08e-1)" "unprognostic (8.99e-3)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (8.34e-3)" "unprognostic (3.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.65e-2)" "unprognostic (2.28e-1)" "prognostic favorable (4.79e-7)" "unprognostic (5.12e-2)" "unprognostic (2.58e-1)" "unprognostic (1.45e-1)" "unprognostic (7.86e-2)" 20.9 19.7 10.3 13.2 11.8 10.3 29.4 11.1 12.3 21.5 15.3 24.1 13.4 16.0 27.0 28.9 25.8 19.9 11.2 9.7 14.1 39.7 27.7 23.2 12.7 12.1 11.7 9.1 17.6 19.0 47.2 14.6 19.0 11.4 22.3 29.9 3.4 23.0 17.9 4.3 20.2 14.2 20.7 11.9 17.0 24.0 5.2 12.6 10.7 28.6 7.7 13.5 20.1 18.6 12.9 25.0 20.6 11.4 6.3 116.4 61.3 21.9 34.4 53.9 16.2 18.2 9.6 78.9 3.7 20.3 63.0 24.3 13.3 5.0 39.0 25.2 12.0 10.1 5.4 18.9 26.2 30.0 6.1 14.4 56.6 43.2 18.2 5.3 117.9 44.8 8.9 9.1 8.4 45.8 40.2 3.4 9.1 12.0 22.8 23.4 6.3 17.0 16.0 86.6 28.0 2.2 12.6 24.6 56.8 20.4 19.5 75.7 15.6 41.4 32.5 4.2 25.3 21.0 10.4 22.8 1.7 63.2 13.5 24.7 66.1 100.5 35.6 38.9 81.8 35.2 26.6 31.2 32.9 86.6 30.7 39.4 32.0 36.2 42.0 78.2 45.9 16.9 90.2 10.3 11.8 11.1 12.3 9.7 14.1 12.1 11.7 9.1 11.4 11.9 12.6 12.9 12.8 19.2 20.1 36.9 13.8 12.7 18.8 32.9 21.1 5.6 29.5 23.2 5.5 18.6 16.7 38.6 6.2 29.8 9.7 16.5 11.7 39.3 26.1 14.2 14.1 13.7 8.4 11.1 53.2 19.1 23.3 25.8 21.4 21.9 17.1 10.4 17.5 18.7 28.2 3.3 57.0 19.7 4.1 37.1 12.0 10.7 16.4 24.3 19.6 62.8 43.9 6.8 11.3 56.8 85.5 14.0 16.4 17.3 11.5 13.7 10.5 23.8 19.4 6.2 6.6 21.2 16.5 4.8 5.1 25.9 11.8 24.4 11.6 11.1 25.6 18.3 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.2" "Group enriched" "Detected in some" 8 "Excitatory neurons: 136.8;Inhibitory neurons: 238.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SiHa: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045531, HPA056945" Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045531: AB_10960749, HPA056945: " "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.0 0.0 0.9 0.0 1.6 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 1.5 0.0 0.0 0.2 0.0 0.6 2.0 0.9 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.6 0.9 3.2 1.7 1.5 0.6 2.0 0.9 0.8 0.9 1.4 0.7 0.1 0.0 2.3 4.9 0.1 1.3 1.7 0.0 0.0 21.8 0.2 0.0 0.5 0.0 0.6 0.0 2.1 0.2 0.2 0.1 0.0 0.3 0.6 0.2 0.1 0.4 0.0 0.0 136.8 1.2 0.3 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 238.3 0.0 0.0 0.8 1.8 0.8 0.0 0.6 0.0 1.0 0.2 0.5 0.0 1.5 2.5 1.2 0.0 0.0 0.1 1.1 0.0 0.1 0.0 1.5 0.0 3.6 0.5 0.2 0.1 0.0 1.0 0.1 0.5 0.0 0.0 0.8 RHBDD1 DKFZp547E052 ENSG00000144468 "Rhomboid domain containing 1" Q8TEB9 2 226835581-226999215 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Differentiation, Spermatogenesis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 66.9;Microglial cells: 57.1;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 109.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 73.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013972, HPA057125" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013972: AB_2178629, HPA057125: AB_2683343" "unprognostic (1.42e-1)" "unprognostic (5.37e-2)" "unprognostic (3.26e-1)" "unprognostic (5.23e-2)" "unprognostic (2.57e-1)" "unprognostic (2.91e-1)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-1)" "unprognostic (9.40e-2)" "unprognostic (4.74e-3)" "unprognostic (4.97e-2)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.09e-1)" "unprognostic (9.77e-2)" "unprognostic (3.04e-2)" 10.4 9.0 12.6 13.7 18.5 12.0 11.6 11.9 12.5 11.7 2.4 11.6 10.4 13.7 12.6 11.6 13.0 11.0 10.4 7.7 17.5 12.1 15.2 10.0 16.3 14.5 13.8 3.9 13.8 14.0 16.7 4.4 10.0 16.1 13.2 11.3 7.5 9.7 13.5 9.0 8.9 11.9 14.4 17.2 14.4 11.5 17.5 14.3 37.8 15.8 8.7 17.0 11.6 7.0 22.6 10.7 9.3 9.9 15.1 28.6 28.8 0.0 24.1 20.9 12.6 14.6 8.3 18.7 10.1 19.8 25.2 18.0 11.9 0.1 26.8 23.9 25.1 9.9 15.3 5.9 6.7 31.5 15.2 8.0 25.6 38.2 23.8 51.4 14.3 9.8 26.7 41.7 25.6 13.4 18.9 27.8 8.5 0.0 12.2 10.3 12.0 0.1 14.9 10.3 13.3 9.7 7.3 13.6 5.1 18.8 17.6 14.1 18.9 13.1 5.6 12.2 22.0 7.5 28.8 14.9 73.9 17.8 19.6 16.2 10.4 13.7 12.8 7.3 20.0 11.8 22.1 11.0 8.9 17.2 24.5 12.6 10.6 3.3 11.8 13.8 21.1 16.2 10.8 12.6 18.5 11.9 12.5 7.7 17.5 14.5 13.8 3.9 16.1 17.2 14.3 22.6 6.6 12.8 6.4 66.9 28.4 5.2 8.5 7.2 8.0 8.0 7.6 4.2 16.6 4.3 8.1 11.0 16.7 7.6 9.3 6.6 3.9 7.0 16.7 8.3 8.6 6.8 1.8 15.2 28.4 9.3 4.1 9.3 8.2 7.8 8.2 22.7 3.3 14.0 5.2 11.8 41.5 6.1 6.1 8.2 4.4 24.4 5.6 7.6 12.4 57.1 6.2 6.3 9.2 55.8 109.0 8.3 1.9 6.8 48.8 13.2 6.8 3.4 7.1 6.3 0.0 5.6 6.6 15.2 9.5 7.3 5.5 5.6 8.6 25.7 5.7 8.9 ACKR3 "CMKOR1, CXCR7, GPR159, RDC1" ENSG00000144476 "Atypical chemokine receptor 3" P25106 2 236567787-236582354 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 39.6;Endothelial cells: 59.8;Fibroblasts: 171.2;Smooth muscle cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "NK-cells: 4.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "HeLa: 103.7;MCF7: 80.0;RT4: 312.3;SiHa: 97.0;U-2197: 328.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032003, HPA049718" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA032003: AB_2674107, HPA049718: AB_2680859" "unprognostic (1.65e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.50e-1)" "unprognostic (1.92e-3)" "unprognostic (2.10e-1)" "unprognostic (1.23e-1)" "unprognostic (7.34e-3)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (9.70e-3)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.76e-6)" "prognostic unfavorable (2.01e-4)" "unprognostic (9.71e-2)" "unprognostic (8.57e-3)" "prognostic unfavorable (2.93e-4)" 106.7 5.3 13.8 14.5 12.7 3.5 71.0 13.9 15.7 24.2 17.3 37.2 12.0 17.4 10.6 25.2 34.0 31.1 57.5 13.1 22.0 7.8 28.6 26.5 10.5 21.9 13.2 10.6 16.1 38.2 5.0 24.6 124.3 13.2 20.3 25.0 1.7 21.6 17.0 35.7 37.1 34.4 24.5 14.1 56.4 28.1 14.8 13.2 6.5 58.6 38.2 5.6 108.1 38.5 12.9 0.0 0.1 6.3 0.0 10.5 0.2 44.9 2.6 1.4 2.3 4.6 0.5 0.1 0.0 5.1 0.2 16.9 68.0 0.2 24.0 0.4 0.1 0.0 0.1 103.7 0.2 0.1 0.2 0.1 3.2 61.0 0.3 0.0 15.4 11.2 0.3 1.2 0.1 0.0 80.0 0.2 0.2 11.0 0.0 0.7 0.1 7.6 0.8 0.0 312.3 0.4 0.1 97.0 0.5 0.0 23.9 0.0 0.3 0.0 0.8 23.3 328.5 0.1 1.4 0.0 0.1 1.2 6.6 0.5 0.0 0.1 0.0 2.5 0.2 3.8 0.3 1.3 3.2 0.1 0.6 1.1 1.5 0.0 4.7 0.4 0.0 2.0 0.5 13.8 12.7 13.9 15.7 13.1 22.0 21.9 13.2 10.6 13.2 14.1 13.2 12.9 33.2 9.6 4.8 20.5 1.1 22.0 0.2 39.6 1.2 1.7 0.2 1.0 9.1 0.0 24.8 0.0 0.0 0.1 0.7 1.0 0.0 0.2 0.9 13.5 24.2 59.8 0.0 0.0 0.7 10.4 0.8 171.2 1.1 24.8 6.3 6.3 33.5 2.5 0.8 0.0 2.3 0.1 6.1 4.1 10.1 0.4 1.5 6.9 1.8 12.2 0.8 0.1 1.0 1.0 0.1 1.3 5.3 1.2 0.5 0.5 3.3 0.9 5.8 0.1 0.0 35.7 37.1 0.2 0.3 1.1 15.9 0.3 1.5 1.1 0.2 2.6 TRPM8 ENSG00000144481 "Transient receptor potential cation channel subfamily M member 8" Q7Z2W7 2 233917373-234019522 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 57 "liver: 31.7;prostate: 80.9" "Group enriched" "Detected in some" 5 "Hepatocytes: 45.2;Prostatic glandular cells: 16.3" "Cancer enriched" "Detected in some" 27 "prostate cancer: 72.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.4;Karpas-707: 5.5;RPTEC TERT1: 8.1;SK-MEL-30: 8.9;WM-115: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.41e-3)" "unprognostic (7.91e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-3)" "unprognostic (1.05e-1)" "unprognostic (4.60e-3)" "prognostic favorable (7.15e-4)" "unprognostic (3.28e-2)" "unprognostic (3.71e-1)" "unprognostic (9.88e-3)" "unprognostic (7.10e-3)" "unprognostic (4.69e-2)" "unprognostic (3.36e-5)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.53e-2)" 0.0 0.2 0.6 0.2 0.3 0.1 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 31.7 0.0 0.1 0.2 0.9 0.2 0.0 0.0 0.1 0.5 0.0 0.3 80.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.6 8.1 0.0 0.5 0.3 0.0 0.1 8.9 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.0 1.2 2.0 0.0 0.7 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.2 0.2 0.9 0.2 0.3 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.4 5.5 0.1 0.0 0.7 0.2 0.0 1.1 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 2.3 1.2 0.6 0.5 0.0 2.7 0.3 1.7 0.0 0.3 0.0 4.4 0.0 0.1 0.7 45.2 0.3 0.0 0.9 0.0 0.0 0.6 0.8 3.9 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 16.3 0.0 0.0 0.0 0.2 0.0 0.4 0.2 1.3 0.6 0.0 0.1 0.0 0.5 0.0 0.0 4.1 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;pituitary gland: 63.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 86.0;Enteroendocrine cells: 109.9;Erythroid cells: 120.0;Intestinal goblet cells: 176.0;Ionocytes: 93.6" "Cancer enhanced" "Detected in all" "glioma: 62.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "eosinophil: 5.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.1" "Cell line enhanced" "Detected in many" "NB-4: 196.8;SCLC-21H: 123.5;SK-MEL-30: 192.4;THP-1: 85.1;U-937: 100.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073997 Approved "Nuclear bodies,Cytosol" NA No "Nuclear bodies" Cytosol "HPA073997: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.79e-4)" "prognostic favorable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 3.3 10.3 46.7 2.8 49.8 12.6 2.6 56.8 58.0 11.9 32.7 20.0 18.5 17.0 0.5 3.0 14.1 1.6 4.5 43.4 42.9 5.0 8.4 5.5 3.1 50.8 44.6 36.4 2.6 23.7 4.1 63.1 1.1 47.0 4.0 9.1 1.0 5.1 1.0 26.0 2.6 19.9 2.7 55.9 9.2 11.2 25.7 44.3 3.6 5.1 1.6 2.3 4.7 2.9 59.0 4.9 5.6 23.5 26.9 1.6 0.8 15.1 1.7 1.8 2.3 3.5 4.8 3.0 0.3 3.9 0.4 9.8 3.1 24.1 1.8 0.7 11.5 30.4 5.9 4.5 50.7 3.8 42.7 33.0 2.3 14.6 3.4 4.7 1.3 1.5 25.1 53.4 0.5 1.5 12.3 6.3 196.8 38.5 4.8 4.3 28.1 62.5 11.7 3.1 2.3 123.5 54.6 7.7 10.7 192.4 2.8 9.4 85.1 1.9 2.3 4.9 13.2 14.7 11.6 2.1 8.9 8.2 100.2 4.2 0.1 0.1 5.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.1 46.7 49.8 56.8 58.0 43.4 42.9 50.8 44.6 36.4 47.0 55.9 44.3 59.0 3.3 0.0 1.1 63.0 5.7 3.3 6.4 3.0 1.8 9.2 8.8 5.2 6.5 1.5 4.7 3.7 22.9 2.2 30.5 37.1 7.9 9.2 32.2 86.0 7.8 3.8 109.9 120.0 9.6 31.8 3.9 3.5 13.7 6.7 0.0 39.0 2.2 5.2 5.5 3.3 10.3 176.0 93.6 4.8 5.8 9.3 1.5 7.4 35.6 8.4 8.3 6.2 23.7 17.6 19.6 14.9 22.2 1.5 7.1 5.2 13.1 4.9 9.5 4.9 0.0 26.9 12.5 35.3 36.5 2.9 2.0 0.3 9.4 30.0 41.8 2.2 ESPNL FLJ42568 ENSG00000144488 "Espin like" Q6ZVH7 2 238100340-238133287 "Predicted intracellular proteins" Hearing Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;intestine: 3.5" "Cell type enhanced" "Detected in some" "B-cells: 1.8;Cardiomyocytes: 2.5;Granulosa cells: 2.0;Muller glia cells: 1.4;Proximal tubular cells: 3.4;Skeletal myocytes: 1.6;Theca cells: 2.2" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 7 "cerebellum: 4.7;pons: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;Daudi: 2.6;fHDF/TERT166: 2.3;HHSteC: 2.6;THP-1: 1.8;U-87 MG: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA055103 Uncertain NA NA "HPA055103: AB_2682694" "unprognostic (8.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.34e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-2)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (3.20e-1)" "unprognostic (1.79e-1)" "unprognostic (2.18e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (3.94e-6)" "unprognostic (3.49e-2)" "unprognostic (8.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.67e-2)" 0.4 0.3 0.3 0.1 0.2 0.0 0.4 4.7 0.3 0.7 0.6 0.7 0.4 1.0 0.0 0.2 1.5 0.1 0.5 0.4 0.4 0.2 1.6 0.2 0.5 0.3 0.2 0.2 2.2 0.3 0.0 2.1 0.1 2.1 0.6 0.0 0.0 0.0 0.8 0.2 0.1 3.5 0.4 0.3 1.1 0.2 0.4 0.2 0.3 1.0 0.0 0.2 0.6 0.4 0.4 0.0 0.0 0.0 1.8 0.3 0.6 0.3 1.0 0.4 0.8 0.8 0.0 0.0 2.6 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.9 2.6 0.0 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.8 0.8 0.0 1.0 0.0 0.0 1.1 0.1 0.0 0.0 0.8 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.7 0.3 0.4 0.4 0.3 0.2 0.2 2.1 0.3 0.2 0.4 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.6 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 2.0 0.0 0.5 0.1 0.0 0.1 0.4 0.0 0.6 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.6 0.3 0.0 0.6 0.0 0.0 0.0 0.4 2.2 0.0 0.0 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.5" "Cell type enhanced" "Detected in many" "Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.8 4.4 14.2 5.7 6.1 12.6 6.3 4.6 6.3 7.3 4.2 6.1 6.6 5.5 8.8 5.8 24.8 4.8 3.3 3.9 4.1 5.1 6.2 7.0 9.1 6.7 8.7 3.0 7.4 8.7 6.2 4.5 4.0 8.6 6.6 5.5 3.9 5.1 5.3 3.5 8.2 7.2 3.0 8.9 8.2 9.7 68.5 6.3 7.2 6.5 2.1 6.7 5.7 6.4 8.6 7.0 15.2 3.2 6.0 2.9 4.1 13.4 3.3 5.0 2.7 3.6 4.9 14.2 7.0 0.6 3.7 4.1 7.6 6.2 7.8 3.2 12.9 5.2 13.9 8.6 13.0 2.4 7.8 12.8 6.6 18.7 2.5 17.7 8.2 2.8 11.0 13.2 8.8 4.6 6.7 7.2 12.8 2.7 12.1 9.0 20.1 9.8 11.1 4.1 15.0 7.5 5.6 2.7 7.2 10.0 3.9 6.2 11.9 3.6 10.0 3.3 4.0 5.9 20.0 5.5 7.0 5.7 11.8 7.9 0.0 2.1 4.5 4.6 1.8 2.7 2.8 2.8 2.9 2.7 4.1 4.1 3.0 0.9 1.3 2.3 1.8 0.9 2.4 14.2 6.1 4.6 6.3 3.9 4.1 6.7 8.7 3.0 8.6 8.9 6.3 8.6 3.0 0.0 8.1 23.8 7.2 0.9 1.8 5.3 13.1 3.5 4.3 3.7 2.2 1.5 10.1 3.7 4.2 3.0 8.1 4.8 1.9 2.7 187.5 40.8 3.6 3.5 4.2 6.5 17.0 4.3 1.7 2.8 16.8 4.5 5.7 4.8 2.9 6.4 2.7 3.3 25.4 4.5 6.1 7.6 2.0 213.1 4.1 6.7 0.0 38.4 5.5 2.6 7.2 21.1 42.9 3.2 2.2 3.0 3.4 2.8 5.7 2.9 62.6 4.0 0.0 2.2 3.5 28.8 8.9 5.0 2.3 2.9 8.6 2.9 4.7 2.0 COPS7B CSN7B ENSG00000144524 "COP9 signalosome subunit 7B" Q9H9Q2 2 231781671-231809254 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034675, HPA034676" Uncertain Supported Nucleoplasm NA NA 44000 Nucleoplasm "HPA034675: AB_10696360, HPA034676: AB_2674274" "unprognostic (3.21e-1)" "unprognostic (1.59e-1)" "unprognostic (6.25e-3)" "unprognostic (3.59e-3)" "unprognostic (3.50e-1)" "unprognostic (4.77e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.19e-1)" "unprognostic (4.81e-2)" "unprognostic (1.89e-1)" "unprognostic (5.77e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (2.37e-2)" "unprognostic (1.39e-1)" "unprognostic (6.64e-2)" "unprognostic (1.55e-3)" 10.4 15.7 16.6 11.4 17.6 11.8 11.4 16.5 26.5 16.8 14.6 14.0 7.0 14.4 10.6 12.8 15.2 8.1 10.9 17.1 16.5 11.6 14.8 11.7 18.0 16.6 17.7 16.0 13.9 11.6 20.0 15.6 15.1 17.5 15.0 15.3 9.5 14.2 15.1 13.7 17.1 13.5 16.8 16.0 17.6 16.1 20.7 16.7 23.1 14.0 12.9 22.5 14.0 13.9 18.5 24.8 20.9 31.7 33.5 22.1 27.8 33.9 19.8 18.6 31.5 37.3 35.9 26.6 23.4 21.2 24.3 38.1 19.5 45.6 36.1 46.8 40.3 42.3 46.2 17.9 51.4 23.8 49.1 25.0 19.4 36.2 35.2 25.8 28.6 36.4 58.2 51.7 18.6 30.2 31.8 49.7 40.0 48.5 24.8 22.0 54.6 38.8 25.6 24.2 21.1 34.2 28.5 18.6 15.8 35.4 44.9 20.1 39.6 23.6 22.9 22.1 26.8 27.7 29.9 26.9 65.0 22.0 34.2 23.4 12.6 8.4 4.6 12.3 9.9 12.1 13.3 9.6 11.4 12.5 13.3 13.1 9.4 1.8 15.8 13.7 9.8 10.5 11.5 16.6 17.6 16.5 26.5 17.1 16.5 16.6 17.7 16.0 17.5 16.0 16.7 18.5 10.6 16.0 11.3 28.1 17.1 12.4 12.2 24.0 18.2 13.8 16.7 16.5 6.7 10.0 15.2 16.5 10.4 24.2 19.7 8.6 13.7 14.1 54.6 10.7 10.1 11.1 23.3 7.6 14.8 9.3 20.5 12.3 9.7 9.0 5.7 18.1 14.6 7.9 15.1 13.5 14.3 15.7 18.3 12.7 9.7 14.9 18.0 10.1 12.4 14.0 18.6 9.5 35.0 18.1 17.8 13.7 9.5 20.3 13.5 12.5 10.4 9.9 11.4 18.3 13.1 8.3 13.5 43.3 61.4 16.5 8.1 17.8 16.5 21.1 14.3 12.1 DIS3L2 "FAM6A, FLJ36974, MGC42174" ENSG00000144535 "DIS3 like 3'-5' exoribonuclease 2" Q8IYB7 2 231961245-232344350 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 93.4;Oligodendrocytes: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035796, HPA035797" Approved NA NA "HPA035796: AB_2674786, HPA035797: AB_10669978" "unprognostic (1.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.05e-2)" "unprognostic (2.40e-2)" "unprognostic (8.17e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (2.21e-1)" "unprognostic (6.45e-2)" "unprognostic (3.26e-2)" "unprognostic (1.64e-1)" "unprognostic (1.63e-1)" "unprognostic (5.93e-2)" "unprognostic (2.16e-1)" "unprognostic (3.55e-3)" "unprognostic (3.02e-1)" "unprognostic (1.97e-1)" 8.9 10.3 10.8 7.8 11.4 10.6 10.8 13.7 13.1 13.1 11.9 10.1 7.1 11.4 9.3 16.4 12.8 7.7 9.9 10.7 10.3 11.2 10.8 9.7 10.6 11.5 10.7 9.3 14.7 11.4 12.4 12.2 9.3 12.5 13.2 8.6 15.4 10.5 9.0 9.2 15.2 9.4 9.0 8.8 11.4 10.7 14.2 10.5 14.8 15.2 7.3 9.7 11.4 12.4 15.4 12.6 13.1 19.8 11.8 11.1 11.4 18.8 11.5 11.6 12.8 11.8 10.9 17.1 10.5 9.5 12.3 17.0 15.3 11.7 15.2 13.3 16.9 12.9 16.2 15.7 22.4 10.3 14.7 15.7 9.0 16.7 11.1 11.7 13.3 16.6 17.0 17.6 7.2 11.1 16.9 20.4 27.8 13.6 12.0 6.9 17.1 24.4 9.6 16.0 21.4 15.9 23.2 10.1 20.6 14.3 13.3 11.3 18.3 16.3 16.5 17.0 14.5 12.9 19.3 10.0 11.8 12.5 10.6 15.8 0.1 3.7 3.0 4.8 4.3 5.1 4.8 4.3 4.4 3.8 9.2 4.5 5.1 0.4 4.0 3.4 5.7 5.1 2.3 10.8 11.4 13.7 13.1 10.7 10.3 11.5 10.7 9.3 12.5 8.8 10.5 15.4 12.9 3.2 9.1 64.6 19.5 9.9 17.8 11.4 19.9 33.7 7.9 7.4 9.3 11.5 17.4 12.9 66.7 14.2 9.0 13.0 3.9 15.1 82.3 23.7 15.7 12.1 8.4 12.0 82.6 10.6 14.2 10.1 12.2 13.7 1.3 22.8 10.0 7.4 8.6 40.4 93.4 10.9 12.2 12.8 8.7 30.7 10.5 9.7 5.4 42.2 10.6 15.4 20.6 57.8 150.8 15.0 10.2 10.5 11.1 10.0 11.0 10.9 19.0 56.0 19.7 22.2 11.6 20.6 13.0 15.0 9.7 9.9 17.0 15.5 13.8 15.6 CPNE9 KIAA4217 ENSG00000144550 "Copine family member 9" Q8IYJ1 3 9703826-9729908 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 66.4" "Cell type enhanced" "Detected in some" "Early spermatids: 12.9;Excitatory neurons: 28.2;Inhibitory neurons: 8.0;Late spermatids: 61.3" "Cancer enriched" "Detected in single" 4 "testis cancer: 1.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 1.0" "Cell line enhanced" "Detected in some" "Daudi: 2.3;U-937: 2.0" "Low region specificity" "Detected in all" HPA060813 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA060813: " "unprognostic (2.96e-1)" "unprognostic (4.75e-2)" "unprognostic (1.34e-1)" "unprognostic (5.04e-3)" "unprognostic (1.10e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (1.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-4)" "unprognostic (2.67e-2)" "unprognostic (5.44e-4)" "unprognostic (1.47e-2)" "unprognostic (8.59e-2)" "unprognostic (3.45e-1)" "unprognostic (7.48e-2)" 0.1 2.1 13.2 0.2 9.6 1.2 0.1 14.0 25.2 0.1 2.9 0.3 0.3 0.1 0.0 0.1 0.1 0.1 0.1 8.6 19.3 0.1 0.0 0.3 0.2 59.4 23.7 7.8 0.1 0.1 0.1 5.3 0.1 66.4 0.1 0.1 1.1 0.1 0.2 0.0 1.7 0.3 0.2 6.3 0.2 0.3 1.3 51.8 0.1 0.1 0.0 0.1 0.1 0.1 54.0 0.0 0.3 0.1 0.0 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.2 0.3 0.3 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.5 0.0 0.0 0.2 0.4 0.7 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.4 0.3 2.0 0.1 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 13.2 9.6 14.0 25.2 8.6 19.3 59.4 23.7 7.8 66.4 6.3 51.8 54.0 0.1 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.6 0.8 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.9 0.1 0.1 0.1 0.0 0.0 28.2 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 1.9 0.0 8.0 0.0 0.0 0.8 0.3 61.3 0.0 0.8 0.0 3.7 0.0 0.7 0.0 2.0 2.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.9 0.7 0.2 0.4 0.0 0.1 0.0 0.1 0.0 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "FA complementation group D2" Q9BXW9 3 10026414-10101932 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 120.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 1.2 0.7 3.3 7.8 2.0 17.9 3.5 1.6 5.5 1.5 1.7 4.1 3.3 2.1 0.7 2.5 2.6 2.0 0.5 3.4 1.8 0.9 1.1 1.9 12.3 3.3 2.1 1.2 3.6 0.8 0.8 0.5 4.8 3.2 2.0 6.4 3.2 4.9 1.0 4.8 4.6 4.0 2.0 2.9 6.4 3.6 11.9 3.1 9.9 1.9 0.4 13.1 2.3 1.3 5.5 24.1 25.4 46.5 13.2 2.4 3.5 120.7 22.0 9.8 31.3 25.4 18.8 23.0 46.7 9.8 7.0 25.1 20.2 48.8 16.7 31.0 22.6 33.0 63.6 39.6 17.9 0.4 48.1 37.9 1.2 2.6 34.1 18.4 4.2 18.4 39.3 39.6 51.6 23.1 27.2 40.6 17.9 56.1 18.1 17.6 43.4 37.7 32.5 10.3 26.7 13.0 25.3 26.4 20.1 8.3 33.5 31.0 29.4 10.6 24.6 28.4 15.1 31.5 21.7 46.4 77.2 14.1 47.7 43.2 2.7 0.6 1.9 0.6 0.5 0.6 2.4 0.9 0.5 0.4 3.2 1.1 0.9 1.5 1.0 1.4 1.8 1.5 0.5 3.3 2.0 1.6 5.5 3.4 1.8 3.3 2.1 1.2 3.2 2.9 3.1 5.5 0.7 0.0 0.5 0.7 12.5 4.6 3.5 2.9 2.8 3.1 4.5 2.7 2.0 1.5 1.9 1.8 10.4 12.7 5.6 3.1 0.0 1.9 5.9 2.6 1.5 2.1 1.2 25.2 3.0 3.5 15.2 2.6 2.0 3.4 1.3 11.8 3.3 1.5 5.7 0.0 2.6 3.2 6.1 3.8 7.0 8.0 2.1 3.7 3.6 1.9 4.9 0.6 1.0 1.5 2.4 1.8 3.6 1.5 8.1 2.2 0.5 0.7 2.0 5.6 19.7 2.6 2.1 62.5 30.2 4.1 2.7 7.0 5.2 1.6 7.6 3.1 TAMM41 "C3orf31, DKFZp434E0519, MGC16471" ENSG00000144559 "TAM41 mitochondrial translocator assembly and maintenance homolog" Q96BW9 3 11790442-11846919 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036834, HPA044861" Uncertain Approved Cytosol NA NA Cytosol "HPA036834: AB_10672270, HPA044861: AB_2679116" "unprognostic (2.40e-2)" "unprognostic (4.41e-2)" "prognostic favorable (1.23e-4)" "unprognostic (4.45e-2)" "unprognostic (1.44e-2)" "unprognostic (5.60e-2)" "unprognostic (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.33e-3)" "unprognostic (3.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-1)" "unprognostic (7.34e-2)" "unprognostic (3.59e-3)" 7.8 7.5 5.7 5.7 6.0 4.4 8.1 6.3 8.6 8.1 2.7 6.4 4.9 7.3 9.8 9.0 7.0 4.2 7.9 5.5 4.9 6.3 5.5 5.0 7.1 4.7 3.8 5.2 11.1 5.7 5.8 5.6 4.2 5.0 5.2 5.0 6.4 6.8 4.5 9.3 10.0 6.2 6.3 2.8 6.5 6.1 5.7 4.2 6.6 6.1 5.2 7.8 8.4 8.3 6.4 6.2 11.3 13.5 9.4 14.3 18.0 24.9 9.3 6.6 13.9 13.8 13.6 9.9 23.4 13.3 9.8 6.2 7.4 22.9 13.9 17.9 8.8 21.6 14.0 10.6 15.9 16.7 25.8 7.1 10.3 20.3 13.1 14.6 9.1 21.8 18.3 20.8 7.0 18.0 17.8 14.6 19.2 10.9 9.6 23.8 14.4 7.7 20.7 21.6 14.8 6.2 5.4 8.1 10.3 16.6 15.1 13.5 11.6 5.7 7.2 8.3 21.8 13.5 5.4 14.2 12.1 8.8 21.8 6.7 1.9 4.5 7.1 5.7 3.2 7.6 7.5 9.1 5.8 7.8 7.1 8.4 8.8 0.2 6.9 6.7 5.8 7.7 4.8 5.7 6.0 6.3 8.6 5.5 4.9 4.7 3.8 5.2 5.0 2.8 4.2 6.4 9.4 6.4 7.0 24.5 11.4 4.2 8.1 15.7 5.7 11.5 5.5 8.3 8.9 0.0 8.7 3.7 12.5 12.2 8.6 3.3 9.8 10.1 2.2 5.4 9.2 7.6 3.0 9.4 34.5 9.3 11.0 7.2 6.6 4.4 2.5 10.5 5.7 5.8 9.2 10.1 34.7 8.1 12.2 6.4 6.4 1.5 7.8 6.8 3.6 14.0 5.9 11.0 10.3 34.7 32.0 7.9 3.4 6.4 7.1 6.7 4.2 10.3 11.8 14.7 0.0 8.6 8.7 7.4 12.4 6.6 4.1 7.0 9.5 10.8 7.3 5.9 VGLL4 KIAA0121 ENSG00000144560 "Vestigial like family member 4" Q14135 3 11556069-11771350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038225, HPA038614" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA No "Nucleoli fibrillar center" Nucleoplasm "HPA038225: AB_10674549, HPA038614: AB_2676115" "unprognostic (1.21e-2)" "unprognostic (4.68e-3)" "unprognostic (3.29e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.24e-2)" "unprognostic (2.73e-1)" "unprognostic (1.66e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (1.86e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (9.42e-2)" "unprognostic (1.26e-1)" 35.9 44.5 28.5 17.0 28.7 14.8 37.5 21.1 31.7 53.4 60.5 30.2 25.6 51.1 21.5 37.3 46.1 36.2 28.1 32.2 30.7 34.7 16.0 33.3 20.1 30.9 25.5 25.5 78.7 25.4 37.5 25.5 25.3 28.9 31.8 18.1 20.0 44.2 23.1 19.0 39.6 25.9 31.4 22.8 21.2 27.2 24.7 33.7 29.8 46.2 12.7 22.1 35.5 46.5 35.7 26.6 17.1 38.8 9.9 55.0 28.5 97.4 16.7 33.0 12.8 14.0 15.2 26.0 33.0 36.1 26.1 25.1 18.1 20.4 29.9 9.2 20.8 32.5 27.1 15.7 22.6 43.2 27.9 23.0 36.0 61.8 16.1 25.4 72.6 51.8 33.1 10.4 5.1 20.1 23.1 27.3 31.0 25.0 37.1 24.7 43.5 25.9 44.3 33.3 39.0 20.6 50.0 16.8 21.7 43.1 29.8 21.3 26.0 27.1 33.1 18.5 22.3 39.0 9.9 28.9 72.7 37.4 44.9 64.0 20.2 3.9 0.8 10.2 2.3 7.0 5.9 6.0 9.0 5.1 3.8 6.9 8.5 2.5 5.6 9.2 4.2 3.3 6.1 28.5 28.7 21.1 31.7 32.2 30.7 30.9 25.5 25.5 28.9 22.8 33.7 35.7 76.8 32.1 20.8 92.4 21.3 64.5 61.8 101.8 82.6 43.1 63.1 68.6 4.1 61.5 53.3 44.1 148.0 74.0 22.6 23.8 62.6 73.3 15.6 63.8 44.4 78.4 34.6 29.9 108.9 35.8 80.6 59.5 35.2 67.5 14.5 66.5 69.3 17.2 33.1 74.0 75.5 34.1 105.8 20.2 43.6 16.1 73.3 21.1 44.4 50.6 23.1 95.3 32.0 111.6 60.8 54.5 35.3 90.7 14.7 101.7 36.2 27.1 61.7 55.3 32.9 58.9 59.0 8.7 28.3 78.2 76.1 44.7 26.8 66.0 41.3 77.7 RAB5A RAB5 ENSG00000144566 "RAB5A, member RAS oncogene family" P20339 3 19947097-19985175 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Endocytosis, Phagocytosis, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004567, HPA049354" Approved Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004567: AB_628191, HPA049354: AB_2680725" "unprognostic (2.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.58e-2)" "unprognostic (4.72e-1)" "unprognostic (3.85e-1)" "unprognostic (5.58e-2)" "unprognostic (1.40e-2)" "unprognostic (6.75e-2)" "unprognostic (7.12e-2)" "unprognostic (5.97e-2)" "unprognostic (1.83e-3)" "unprognostic (4.68e-2)" "unprognostic (2.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" 36.1 27.5 43.6 27.3 43.9 41.7 33.6 45.9 49.9 30.8 40.4 30.0 29.8 22.9 42.8 42.7 21.3 32.5 36.6 42.4 51.7 33.9 43.2 29.7 24.5 46.8 46.3 40.8 20.1 27.4 54.2 20.6 49.6 46.7 31.0 30.8 35.8 36.1 29.0 29.3 36.3 28.5 28.3 48.1 24.4 32.9 18.2 45.2 29.2 41.5 30.5 29.4 35.7 29.9 50.5 29.8 26.8 38.5 26.4 65.8 57.8 38.9 51.3 59.7 47.8 55.0 31.9 45.7 21.8 30.3 56.7 27.6 18.4 29.0 38.2 55.7 37.9 24.1 31.9 24.9 31.1 82.2 45.0 38.1 53.6 71.0 56.1 81.9 59.9 61.6 28.5 37.1 34.1 57.9 46.2 34.8 31.9 48.4 40.8 42.6 25.8 27.2 32.2 98.9 38.8 12.0 39.6 36.9 45.3 60.3 57.0 35.4 35.8 61.6 34.5 30.1 44.4 44.2 42.0 73.5 28.6 55.0 40.4 57.1 28.7 18.0 31.3 7.9 19.6 10.6 7.9 9.3 9.6 18.1 5.8 8.5 8.1 36.0 20.3 26.3 11.8 10.9 11.5 43.6 43.9 45.9 49.9 42.4 51.7 46.8 46.3 40.8 46.7 48.1 45.2 50.5 114.8 60.9 45.1 33.0 43.6 170.0 129.5 48.8 62.0 34.0 57.0 35.9 57.0 27.1 52.6 42.3 31.3 74.7 44.2 68.7 103.7 52.2 21.2 45.9 44.4 72.4 62.0 55.3 33.7 45.3 67.2 65.2 66.3 72.0 85.0 39.1 41.7 39.3 54.2 15.2 31.4 59.4 65.1 44.4 158.8 15.9 36.7 60.9 83.6 28.1 43.1 86.1 41.2 65.9 44.1 65.2 55.9 35.3 50.7 109.7 49.4 62.3 48.1 36.8 52.6 86.5 72.4 24.6 27.1 65.0 188.0 164.3 60.6 37.1 41.5 151.0 RETREG2 "C2orf17, FAM134A, MAG-2, MGC3035" ENSG00000144567 "Reticulophagy regulator family member 2" Q8NC44 2 219176225-219185475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 42.1;Collecting duct cells: 46.0;Ductal cells: 43.8;Exocrine glandular cells: 48.3;Pancreatic endocrine cells: 40.4;Proximal tubular cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011170, HPA011844, HPA075910" Approved Approved Cytosol NA NA Cytosol "HPA011170: AB_1845713, HPA011844: AB_2668544, HPA075910: " "unprognostic (2.63e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.95e-4)" "unprognostic (1.03e-1)" "unprognostic (2.88e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (1.49e-4)" "unprognostic (8.74e-2)" "unprognostic (9.61e-2)" "unprognostic (1.34e-2)" "unprognostic (4.37e-2)" "unprognostic (2.36e-1)" "unprognostic (4.29e-3)" "unprognostic (4.45e-2)" "unprognostic (4.47e-2)" "unprognostic (1.53e-2)" "unprognostic (3.70e-2)" 33.4 48.0 78.5 26.7 77.9 47.8 34.4 76.8 90.8 40.9 70.0 37.2 31.9 35.4 46.3 38.8 38.8 32.3 23.6 77.7 80.1 52.3 57.7 30.0 34.6 80.8 81.1 78.2 52.3 52.9 77.3 44.0 28.5 81.0 37.2 38.9 51.1 40.2 30.0 25.1 44.9 37.0 34.2 80.8 38.5 43.2 104.8 82.5 34.6 45.0 28.0 34.9 38.0 36.2 81.1 34.6 36.2 30.5 46.5 113.2 47.7 32.5 41.4 71.3 49.4 42.7 36.3 58.1 28.1 40.4 78.5 101.4 43.3 37.1 37.1 54.1 39.5 31.0 37.5 51.2 61.1 64.7 41.1 49.6 52.0 95.5 55.5 53.3 84.7 45.2 29.9 26.3 62.8 69.3 50.9 24.8 44.4 22.6 44.0 41.5 31.4 33.8 22.7 41.1 40.3 43.6 44.9 26.7 50.8 98.4 47.4 42.4 44.9 36.0 55.0 29.4 78.6 31.5 63.4 39.3 31.5 57.5 40.3 31.0 12.5 6.3 6.3 9.3 8.3 8.3 8.3 7.4 9.5 4.3 5.7 6.6 8.8 23.5 5.2 8.1 6.6 9.6 3.6 78.5 77.9 76.8 90.8 77.7 80.1 80.8 81.1 78.2 81.0 80.8 82.5 81.1 22.4 16.0 13.7 0.0 7.9 0.0 0.0 0.0 0.0 0.0 42.1 32.0 0.0 0.0 6.2 46.0 0.0 31.1 21.1 0.0 21.5 43.8 0.0 21.4 19.3 8.6 0.0 0.0 0.0 48.3 37.2 11.9 0.0 30.5 5.1 29.2 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.4 0.0 0.0 0.0 0.0 40.4 0.0 0.0 5.7 0.0 0.0 42.3 2.2 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 30.1 8.2 24.2 0.0 0.0 CTDSP1 "NLIIF, SCP1" ENSG00000144579 "CTD small phosphatase 1" Q9GZU7 2 218398256-218405941 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 184.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062654 Supported Nucleoplasm NA NA Nucleoplasm "HPA062654: AB_2684819" "unprognostic (1.97e-2)" "unprognostic (4.02e-2)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (3.90e-2)" "unprognostic (8.69e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (3.70e-1)" "unprognostic (1.79e-1)" "unprognostic (2.58e-1)" "unprognostic (6.67e-2)" "unprognostic (2.62e-1)" "unprognostic (7.01e-2)" "unprognostic (1.57e-1)" 81.7 55.9 40.6 43.4 44.5 53.6 77.1 41.5 42.5 81.4 42.8 72.8 57.2 80.8 32.2 72.3 75.0 47.1 72.5 36.9 41.0 83.9 119.6 75.1 49.6 54.9 46.4 32.1 83.0 79.7 57.3 28.7 78.4 47.0 105.5 45.1 8.8 65.9 57.7 60.6 72.0 76.5 48.8 43.2 93.4 89.1 17.0 43.6 48.5 79.6 54.2 45.8 83.3 71.0 42.8 29.8 37.8 21.8 71.9 58.1 53.8 80.0 38.9 56.2 37.2 32.0 49.7 72.7 18.0 33.0 69.8 25.3 59.1 32.4 47.2 19.0 63.8 25.5 68.3 48.6 67.0 69.4 42.9 89.3 61.5 56.7 28.3 31.7 58.3 55.5 27.5 56.5 62.6 39.9 84.0 37.5 122.1 15.5 47.6 37.8 51.4 30.8 39.2 47.7 36.6 14.5 36.4 34.4 72.9 38.6 27.4 40.8 101.1 48.5 58.7 35.0 45.4 17.4 40.1 28.1 42.6 52.3 39.7 33.2 54.2 30.4 74.1 24.3 24.7 15.5 7.8 14.7 15.8 15.9 7.2 9.3 12.4 56.4 17.3 26.3 5.4 13.8 21.2 40.6 44.5 41.5 42.5 36.9 41.0 54.9 46.4 32.1 47.0 43.2 43.6 42.8 65.0 44.8 40.0 15.0 43.0 27.3 29.1 24.7 37.5 14.6 34.8 34.5 35.1 58.6 23.7 31.3 2.1 42.7 70.5 95.0 33.2 36.6 1.9 15.1 35.1 43.4 21.7 52.6 0.7 42.7 43.3 44.7 45.3 27.7 18.3 23.0 67.5 57.3 39.3 6.7 1.0 53.5 12.2 83.2 28.1 4.6 59.4 59.9 33.8 14.0 56.9 55.6 184.4 13.0 12.9 38.5 43.1 44.0 35.7 39.8 85.1 51.1 10.0 28.0 26.3 36.0 44.8 1.7 8.7 37.8 20.3 54.3 55.1 29.4 41.5 30.2 CNOT9 "CAF40, CT129, RCD1, RCD1+, RQCD1" ENSG00000144580 "CCR4-NOT transcription complex subunit 9" Q92600 2 218568580-218597080 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046622 Approved Approved "Cytoplasmic bodies" "Intracellular and membrane" NA NA "Cytoplasmic bodies" "HPA046622: AB_10962694" "unprognostic (7.70e-2)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.58e-2)" "unprognostic (1.34e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (8.41e-9)" "unprognostic (8.08e-3)" "unprognostic (1.91e-3)" "unprognostic (1.53e-2)" "unprognostic (7.02e-2)" "unprognostic (6.89e-2)" "prognostic unfavorable (4.69e-9)" "unprognostic (1.87e-2)" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 17.2 22.1 18.8 26.2 20.3 40.5 16.8 21.6 20.3 17.2 19.3 17.9 18.2 17.8 19.6 21.5 18.9 16.2 19.3 19.2 22.0 13.9 21.2 18.4 31.5 19.2 19.9 18.8 18.9 16.0 21.2 25.4 18.2 19.5 18.5 22.9 26.3 15.3 15.2 22.6 20.1 17.5 20.4 19.6 22.8 17.3 27.3 19.5 34.0 15.5 17.3 36.5 22.0 17.8 22.7 49.9 38.2 62.2 82.2 35.2 33.8 79.8 55.5 57.4 69.6 67.4 68.2 40.4 55.4 33.7 64.3 60.9 57.2 88.1 61.6 81.4 79.8 55.6 110.6 72.1 81.1 48.9 120.2 61.7 31.0 48.5 73.1 74.2 32.7 53.1 74.0 67.1 121.1 56.3 40.0 117.2 72.8 94.5 38.4 60.4 97.8 88.7 57.1 37.1 71.5 79.2 64.8 54.5 47.5 52.2 59.1 38.1 66.5 43.2 75.5 55.8 55.3 69.0 57.6 62.6 128.3 53.7 73.1 55.0 36.9 25.6 29.1 41.5 31.7 36.4 29.9 34.0 35.4 30.4 26.6 31.8 35.0 10.5 35.5 34.0 35.1 30.8 37.9 18.8 20.3 21.6 20.3 19.2 22.0 19.2 19.9 18.8 19.5 19.6 19.5 22.7 22.1 22.4 20.7 0.0 10.0 0.0 0.0 0.0 0.0 0.0 20.4 15.1 0.0 0.0 9.9 12.9 0.0 28.4 27.1 0.0 27.4 21.2 0.0 32.2 21.2 10.3 0.0 0.0 0.0 20.7 40.7 10.9 0.0 22.4 16.4 18.9 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 20.7 0.0 0.0 0.0 0.0 25.6 0.0 0.0 7.0 0.0 0.0 16.1 10.2 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 28.3 11.0 16.9 0.0 0.0 MARCHF4 "KIAA1399, MARCH-IV, MARCH4, RNF174" ENSG00000144583 "Membrane associated ring-CH-type finger 4" Q9P2E8 2 216257865-216372483 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 5.0;pituitary gland: 6.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 69.0;fHDF/TERT166: 43.8;TIME: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014348 Approved NA NA "HPA014348: AB_1853578" "unprognostic (4.84e-2)" "unprognostic (1.02e-4)" "unprognostic (1.63e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (6.49e-2)" "unprognostic (5.55e-3)" "unprognostic (1.07e-1)" "unprognostic (6.81e-5)" "unprognostic (4.82e-2)" "unprognostic (2.06e-1)" "unprognostic (1.23e-1)" "unprognostic (1.09e-3)" 0.0 0.7 2.9 0.0 4.3 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.6 0.0 0.0 3.0 2.3 0.0 0.0 0.0 0.0 0.9 1.7 5.0 0.0 0.4 0.0 6.2 0.6 1.3 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 12.5 2.5 0.0 0.0 0.2 1.6 0.0 69.0 23.2 14.5 5.1 0.1 1.0 0.0 10.5 43.8 24.2 0.1 0.0 26.7 14.1 0.0 0.0 5.1 0.0 0.0 3.4 0.0 0.0 0.1 0.0 13.3 19.6 9.3 19.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.4 1.9 0.1 0.0 0.0 2.2 0.0 0.0 32.7 22.7 23.9 0.1 18.6 0.0 0.0 0.0 5.2 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.3 0.0 3.8 3.0 2.3 0.9 1.7 5.0 1.3 0.8 0.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STK11IP "KIAA1898, LIP1, LKB1IP, STK11IP1" ENSG00000144589 "Serine/threonine kinase 11 interacting protein" Q8N1F8 2 219597857-219616451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 15.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036837, HPA036838, HPA053192" Approved Enhanced Vesicles NA NA Vesicles "HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075" "unprognostic (3.37e-1)" "unprognostic (1.33e-1)" "unprognostic (3.51e-1)" "unprognostic (1.97e-1)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (1.22e-3)" "unprognostic (8.36e-2)" "unprognostic (9.36e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.63e-4)" "unprognostic (9.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-3)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" 7.4 10.0 12.4 9.6 11.7 19.7 7.1 10.4 13.3 9.1 11.4 9.4 9.3 9.3 15.1 9.7 10.5 9.6 7.8 11.9 10.0 9.5 6.0 9.3 14.1 11.3 10.9 11.6 24.7 9.6 7.5 21.7 8.3 11.9 10.0 7.9 12.4 8.2 6.6 5.9 18.5 10.0 8.4 9.9 15.2 8.6 31.4 10.7 19.6 11.2 4.3 11.2 9.1 8.4 12.3 10.1 15.4 16.1 11.0 5.6 9.9 16.5 8.7 7.6 13.9 11.7 14.3 16.7 5.8 8.7 8.4 12.6 24.4 7.7 18.7 10.3 8.7 11.7 15.1 17.2 11.6 7.4 15.9 38.2 9.6 16.5 11.7 5.9 14.2 8.6 9.7 11.4 8.5 7.9 19.7 9.3 19.6 16.2 4.8 8.4 17.5 5.9 4.5 13.8 15.8 10.6 16.8 5.7 13.8 12.0 12.9 8.8 15.3 6.5 15.0 12.6 14.5 8.6 9.4 4.5 10.8 11.4 8.7 9.5 1.5 4.3 5.3 2.6 5.8 2.1 1.7 1.2 2.1 7.7 1.2 1.0 1.0 1.4 3.7 6.5 15.1 2.1 2.6 12.4 11.7 10.4 13.3 11.9 10.0 11.3 10.9 11.6 11.9 9.9 10.7 12.3 3.5 6.4 6.7 12.4 3.9 2.3 2.1 6.3 1.2 7.8 5.1 5.5 3.6 1.5 7.8 7.3 18.8 10.0 10.3 14.6 1.9 5.0 14.0 11.9 4.0 4.6 13.1 6.9 10.7 6.5 5.6 5.3 17.3 5.8 12.7 29.7 4.2 3.3 8.4 11.8 8.0 8.8 6.1 8.6 5.7 30.9 25.4 8.9 3.6 8.4 7.0 4.9 4.1 8.5 7.4 4.2 3.3 14.7 2.8 1.7 5.4 2.7 19.9 12.6 13.1 3.2 4.9 18.5 13.8 3.5 2.7 16.1 4.5 5.4 8.8 2.8 GMPPA ENSG00000144591 "GDP-mannose pyrophosphorylase A" Q96IJ6 2 219498884-219506989 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035512, HPA035513" Approved Approved Nucleoplasm NA NA 51000 Nucleoplasm "HPA035512: AB_2674660, HPA035513: AB_10671934" "unprognostic (3.43e-1)" "unprognostic (3.95e-2)" "unprognostic (7.75e-3)" "unprognostic (1.40e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.57e-1)" "unprognostic (2.39e-1)" "unprognostic (2.25e-1)" "unprognostic (1.17e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.90e-10)" "prognostic favorable (5.24e-4)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (2.28e-1)" 20.9 26.0 18.4 24.1 19.0 19.2 21.8 19.0 22.7 32.4 20.8 30.0 29.0 26.6 69.3 25.7 24.9 19.9 26.7 19.0 19.5 25.9 69.0 21.1 20.9 19.8 18.8 18.4 20.3 60.8 24.9 48.8 21.4 19.1 37.6 32.6 8.0 40.5 23.7 23.0 17.8 30.2 26.4 18.7 35.5 32.8 9.7 19.6 13.4 28.9 12.7 24.0 25.4 23.3 19.1 43.4 36.0 21.2 37.8 79.5 70.6 56.4 73.8 98.6 85.2 105.2 66.8 40.5 23.4 51.1 107.7 54.3 40.1 39.7 63.9 73.3 45.3 35.0 45.5 35.7 119.3 72.0 24.1 51.7 54.3 50.7 79.9 89.9 43.9 52.8 29.7 82.3 66.3 66.8 55.5 23.8 45.3 21.7 52.8 38.5 18.6 22.9 42.4 48.6 30.1 27.4 24.0 31.0 46.3 52.1 44.4 31.5 38.8 30.9 49.2 33.6 89.4 40.9 45.4 19.4 28.9 100.4 26.7 55.8 76.0 52.6 37.3 30.1 56.0 35.0 32.1 23.4 31.9 43.5 24.1 17.3 15.7 11.8 36.4 59.3 43.9 34.8 35.2 18.4 19.0 19.0 22.7 19.0 19.5 19.8 18.8 18.4 19.1 18.7 19.6 19.1 12.5 16.0 14.4 5.5 18.8 5.6 12.8 25.2 6.2 6.1 20.9 13.5 13.2 10.0 20.1 16.5 6.2 37.6 16.6 37.7 35.2 24.3 1.3 8.5 15.8 9.5 10.8 19.1 3.1 30.0 79.8 19.2 38.7 14.4 19.0 13.3 11.0 36.3 33.7 1.7 3.6 61.6 10.2 17.6 10.0 3.4 18.3 16.5 12.4 1.9 15.9 11.1 12.3 1.0 4.9 19.0 37.6 13.5 50.3 15.1 45.9 36.8 11.6 4.7 13.1 7.9 27.1 4.4 6.5 9.9 8.5 47.2 13.5 10.7 29.1 15.1 GRIP2 KIAA1719 ENSG00000144596 "Glutamate receptor interacting protein 2" Q9C0E4 3 14489107-14556075 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 13.4;skeletal muscle: 36.1;tongue: 12.6" "Cell type enriched" "Detected in many" 4 "Inhibitory neurons: 89.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035673 Approved Cytosol NA NA Cytosol "HPA035673: AB_10669776" "unprognostic (1.48e-1)" "unprognostic (6.26e-3)" "unprognostic (2.43e-2)" "unprognostic (3.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.14e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-2)" "unprognostic (9.14e-2)" "unprognostic (2.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (5.82e-1)" "unprognostic (4.01e-1)" 1.0 1.1 3.1 0.7 2.8 0.0 1.0 0.0 6.7 0.9 0.0 0.8 0.4 1.1 0.4 2.2 0.8 1.2 13.4 0.3 3.0 2.2 0.3 0.4 0.4 3.0 3.8 0.9 3.4 0.5 0.3 1.0 3.9 1.3 0.9 1.0 0.3 0.9 0.4 36.1 2.0 1.0 1.0 0.5 1.6 4.6 0.7 7.4 0.3 0.8 12.6 0.7 1.1 1.2 2.1 0.1 0.9 0.0 0.0 0.3 0.2 0.0 0.3 3.1 0.3 1.9 1.2 0.0 0.0 0.7 0.2 0.5 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 1.5 6.1 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.3 0.0 1.0 1.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.0 6.7 0.3 3.0 3.0 3.8 0.9 1.3 0.5 7.4 2.1 2.3 0.0 0.5 2.3 0.1 0.0 0.1 0.0 1.2 14.9 0.1 1.3 8.5 0.0 0.6 0.0 14.6 0.0 0.7 0.1 0.0 0.0 3.0 2.1 1.4 0.8 4.2 0.0 3.0 0.2 0.0 2.0 2.0 4.9 0.0 0.0 1.1 0.0 0.1 0.0 89.0 0.1 0.0 0.0 0.0 5.2 4.1 0.7 0.0 2.8 0.0 0.5 0.0 0.5 0.9 0.0 0.0 2.2 0.3 0.1 0.0 0.2 0.0 21.9 19.7 4.3 14.7 0.1 0.8 0.2 0.0 0.1 0.3 1.1 0.0 0.0 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427598-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Group enriched" "Detected in all" 6 "Early spermatids: 268.7;Late spermatids: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA No "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 13.0 9.0 9.2 10.5 9.6 57.7 9.2 7.8 10.2 7.3 8.2 9.1 10.7 7.9 7.6 9.9 7.1 10.5 5.2 10.9 10.9 11.3 19.2 8.4 10.8 10.1 10.2 9.1 5.6 9.9 11.9 8.6 10.3 11.6 10.1 10.0 7.8 7.0 6.8 5.4 10.6 10.1 8.4 8.4 9.9 11.5 7.4 11.4 10.7 10.6 5.9 11.1 11.6 5.8 10.7 10.3 16.6 17.1 17.6 9.8 8.3 137.4 14.7 10.5 16.7 16.3 22.7 11.4 28.7 9.3 10.9 10.9 8.6 22.5 13.2 19.2 23.6 16.2 24.8 14.5 20.8 22.1 23.6 19.2 11.0 22.8 24.3 16.2 12.8 16.8 23.1 26.9 20.6 14.1 21.2 23.6 13.2 30.7 19.3 16.9 21.3 14.2 16.0 14.5 17.8 17.6 30.6 18.2 16.7 17.6 21.9 25.2 18.5 16.6 17.5 12.8 15.6 21.8 27.1 58.3 29.7 17.0 27.7 21.1 8.0 7.1 4.6 11.1 5.4 14.3 4.9 9.1 8.7 4.2 3.6 5.4 8.7 6.5 8.1 6.9 9.8 10.9 4.4 9.2 9.6 7.8 10.2 10.9 10.9 10.1 10.2 9.1 11.6 8.4 11.4 10.7 11.5 9.6 17.3 6.8 14.2 46.9 9.1 6.0 14.2 8.1 15.8 7.7 4.8 15.7 9.0 12.9 6.2 8.0 29.1 15.5 9.8 8.6 268.7 10.8 16.0 11.8 34.3 7.8 16.4 8.2 14.6 13.9 16.3 14.1 10.2 9.9 12.1 30.4 15.8 21.9 14.0 12.5 12.2 30.7 31.6 389.5 11.5 37.6 23.2 3.7 19.4 5.5 22.6 5.5 10.7 15.6 10.3 12.0 12.2 16.1 16.0 29.7 8.6 6.4 26.3 13.6 11.0 21.5 11.6 17.7 54.3 35.8 22.0 4.3 12.8 19.9 CNTN4 BIG-2 ENSG00000144619 "Contactin 4" Q8IWV2 3 2098813-3057959 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.8" "Cell type enhanced" "Detected in many" "Early spermatids: 411.7;Excitatory neurons: 960.7;Inhibitory neurons: 1048.5;Oligodendrocyte precursor cells: 248.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 8.3;CACO-2: 9.0;HEK 293: 5.5;SH-SY5Y: 16.5;WM-115: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 170000000 "unprognostic (1.64e-1)" "unprognostic (7.17e-3)" "unprognostic (9.85e-2)" "unprognostic (5.75e-2)" "unprognostic (9.94e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (2.60e-2)" "unprognostic (7.38e-3)" "unprognostic (2.41e-2)" "prognostic favorable (1.00e-4)" "unprognostic (1.22e-2)" "unprognostic (2.88e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" 3.4 0.5 2.0 1.2 6.0 0.0 2.5 12.7 12.3 8.8 0.0 4.7 1.8 8.4 1.9 3.1 4.2 5.1 2.5 1.7 5.4 4.2 2.9 2.4 1.1 0.4 8.5 6.1 1.0 1.6 22.8 1.9 8.0 4.2 4.3 3.3 20.0 0.9 5.7 0.7 0.7 4.1 4.5 1.1 1.0 3.7 13.6 8.7 2.2 10.4 4.1 2.6 3.6 1.7 3.7 0.0 0.0 1.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 16.5 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 6.0 12.7 12.3 1.7 5.4 0.4 8.5 6.1 4.2 1.1 8.7 3.7 0.4 9.6 3.6 26.8 0.1 0.8 1.3 0.0 1.8 96.5 2.0 1.8 1.4 7.2 5.6 0.0 0.0 0.1 0.0 1.8 0.0 4.4 411.7 0.3 9.1 1.9 7.8 0.0 960.7 0.0 0.1 18.1 0.0 0.3 0.0 6.9 0.7 0.4 0.3 101.0 1048.5 2.0 0.0 0.3 0.7 156.3 5.0 0.4 1.8 31.9 0.0 27.5 0.0 248.3 14.7 0.0 1.6 5.3 0.4 0.4 3.7 3.7 0.0 5.9 6.6 0.5 8.3 4.5 4.9 0.9 0.0 0.3 0.1 0.1 3.5 0.2 DYNC1LI1 DNCLI1 ENSG00000144635 "Dynein cytoplasmic 1 light intermediate chain 1" Q9Y6G9 3 32525974-32570858 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 192.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035013 Approved Supported Centrosome,Cytosol NA NA 23000 "Centrosome, Cytosol" "HPA035013: AB_10600807" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.78e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (5.38e-2)" "prognostic unfavorable (9.19e-9)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (7.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (2.21e-2)" "unprognostic (2.14e-2)" "unprognostic (5.51e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-2)" 18.0 11.4 16.3 18.0 18.3 37.7 21.5 25.0 23.4 14.4 13.9 14.6 13.7 18.8 12.5 15.8 16.5 16.2 49.0 17.5 19.9 21.3 18.9 19.4 20.6 19.1 18.7 16.2 16.8 18.0 21.6 13.7 13.1 21.3 20.8 15.9 40.1 11.9 13.9 46.9 35.0 15.1 22.6 15.6 19.7 14.4 41.1 18.8 23.0 14.6 35.6 20.8 20.1 14.2 22.2 40.1 42.2 64.5 40.7 36.2 42.4 177.7 60.4 82.8 106.4 86.9 45.2 33.7 49.7 39.9 61.5 50.6 20.1 65.4 47.3 100.8 47.7 45.5 66.2 28.9 40.7 44.4 75.6 36.9 34.5 37.1 75.3 58.4 38.8 69.8 55.9 75.8 44.6 57.9 32.0 58.2 33.7 66.8 38.1 56.1 50.7 34.4 51.8 44.2 36.0 27.6 41.1 42.4 52.1 47.0 51.2 43.7 43.9 52.3 58.2 48.9 51.2 61.6 32.0 87.1 80.7 32.7 64.5 46.6 33.1 29.5 26.6 10.3 35.4 11.0 13.0 11.1 11.7 33.0 13.4 7.8 10.3 62.7 16.4 59.0 18.0 13.7 28.9 16.3 18.3 25.0 23.4 17.5 19.9 19.1 18.7 16.2 21.3 15.6 18.8 22.2 48.6 25.6 28.3 20.5 49.4 43.0 30.9 40.7 40.5 48.0 30.9 28.8 95.7 11.5 40.2 14.7 18.8 34.9 53.8 14.2 46.9 50.5 102.6 65.8 54.9 39.3 30.9 48.8 43.6 46.5 36.6 37.6 25.0 66.8 17.1 29.2 23.6 28.8 39.4 65.6 55.0 23.0 26.4 35.9 54.2 39.9 26.1 50.7 28.4 28.1 80.0 37.2 34.0 25.6 33.5 56.1 20.0 28.6 28.7 23.4 18.9 61.9 44.3 81.9 46.0 36.7 44.9 192.0 169.5 23.7 50.2 11.1 40.8 39.9 16.8 15.0 RBMS3 ENSG00000144642 "RNA binding motif single stranded interacting protein 3" Q6XE24 3 28574791-30010391 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 331.1;Inhibitory neurons: 655.9;Microglial cells: 1013.7;Oligodendrocyte precursor cells: 229.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 5.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 9 "dendritic cells: 3.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.7;WM-115: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034719 Uncertain Approved Vesicles NA NA Vesicles "HPA034719: AB_10670172" "unprognostic (8.39e-2)" "unprognostic (2.54e-2)" "unprognostic (1.02e-1)" "unprognostic (7.08e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.90e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.25e-3)" "unprognostic (3.81e-2)" "unprognostic (8.48e-2)" "unprognostic (3.24e-4)" 15.8 8.7 6.8 2.1 6.2 0.1 12.3 9.6 6.4 9.5 16.1 6.5 1.4 6.2 6.7 3.1 9.9 6.8 10.9 2.1 19.2 5.1 3.7 12.7 2.7 11.3 7.0 1.4 11.7 2.0 5.0 3.3 10.5 9.2 6.5 2.7 0.4 4.7 8.8 6.5 3.5 4.1 4.5 5.6 6.6 4.3 2.2 10.4 5.5 15.5 10.9 1.7 8.2 7.4 10.7 2.2 0.2 10.2 0.1 19.6 12.5 0.0 5.7 3.6 5.9 6.8 0.0 0.4 0.0 6.1 20.7 1.8 0.2 0.5 3.8 10.9 0.0 1.1 5.9 8.7 0.0 19.9 0.1 0.0 11.8 2.6 10.5 12.3 8.4 7.9 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.3 0.0 0.4 0.4 7.5 0.0 2.2 0.0 0.0 19.4 13.7 0.0 0.7 4.6 0.0 0.0 17.1 11.1 11.6 13.5 11.7 0.0 0.0 0.8 1.5 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.9 0.3 0.0 6.8 6.2 9.6 6.4 2.1 19.2 11.3 7.0 1.4 9.2 5.6 10.4 10.7 100.9 118.6 18.8 331.1 0.6 8.3 25.5 23.0 2.2 0.4 2.7 19.8 16.2 31.5 21.3 9.2 0.0 16.4 5.9 0.0 0.0 5.3 35.1 2.8 7.0 54.4 0.0 0.0 20.7 1.2 3.0 96.8 2.0 4.6 5.1 19.8 129.9 1.9 2.8 0.0 655.9 0.0 6.1 30.3 14.1 18.8 159.7 2.7 7.2 1013.7 0.6 0.0 0.0 229.2 8.9 0.4 0.0 110.6 0.1 24.3 0.0 2.9 10.5 0.0 111.7 154.6 73.5 1.2 1.5 2.4 7.2 9.6 2.9 22.4 0.0 4.7 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 26.1;tongue: 11.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.7;TIME: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.3 0.4 2.1 0.4 2.3 1.2 0.4 2.7 2.7 0.1 0.2 0.2 0.2 0.3 0.6 0.6 0.3 0.3 0.6 2.1 0.8 0.7 0.4 0.3 0.4 1.3 0.7 2.2 0.6 0.4 0.2 0.2 0.4 1.7 0.6 0.2 1.7 0.4 0.1 26.1 0.9 0.2 0.3 0.1 0.6 0.3 0.5 0.9 0.1 0.9 11.4 0.3 0.2 0.0 2.9 0.4 0.0 0.2 0.4 0.3 0.1 0.5 0.2 0.1 0.0 0.0 0.5 0.5 0.4 0.2 0.0 0.2 0.3 4.7 0.1 0.1 0.6 0.1 0.5 0.8 0.2 0.0 0.3 1.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 0.5 1.7 0.2 0.3 0.2 0.5 0.5 0.1 0.1 0.7 0.9 0.4 0.2 0.6 0.5 0.3 0.2 0.3 1.3 0.3 0.4 0.3 2.4 0.6 0.5 0.8 0.2 0.6 0.3 0.3 0.2 0.2 0.6 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 2.1 2.3 2.7 2.7 2.1 0.8 1.3 0.7 2.2 1.7 0.1 0.9 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 1.3 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 1.8 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657912-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 440.2;Late spermatids: 1206.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 93.3;RPTEC TERT1: 118.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.85e-4)" 7.4 2.7 2.2 7.9 3.3 1.2 6.0 0.3 3.6 10.3 6.0 6.6 3.8 8.5 6.7 13.1 5.9 11.5 2.9 5.2 2.4 13.4 2.2 5.9 13.0 1.6 5.2 3.1 3.1 1.6 1.6 6.8 22.5 2.5 11.9 7.9 5.6 6.9 21.1 1.6 4.5 6.8 11.2 0.3 9.6 6.1 25.2 1.6 2.8 3.6 2.3 18.0 20.5 5.9 2.9 19.3 10.6 2.0 39.3 4.2 7.4 63.1 5.2 6.1 4.9 6.8 27.0 14.3 45.6 48.8 1.1 17.0 11.5 8.9 45.1 6.0 0.3 8.2 0.1 26.4 18.3 2.7 0.1 0.2 7.7 39.7 7.8 93.3 18.2 23.4 0.2 0.1 0.2 22.7 16.0 0.2 0.1 24.9 64.9 26.5 0.5 0.8 0.9 118.3 7.8 3.0 0.5 8.9 17.0 5.4 36.9 11.1 0.2 15.2 6.1 61.7 0.5 26.2 4.1 3.0 42.6 8.6 0.1 39.3 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 2.2 3.3 0.3 3.6 5.2 2.4 1.6 5.2 3.1 2.5 0.3 1.6 2.9 20.5 9.6 3.9 2.9 50.6 10.8 7.5 10.1 4.6 7.3 13.8 6.6 2.3 4.3 7.3 7.3 0.0 15.3 2.4 7.9 9.8 1.8 440.2 11.0 26.5 21.1 15.0 5.7 70.5 4.9 25.9 10.4 6.1 26.4 0.0 1.3 18.2 0.6 2.5 0.0 129.9 4.6 6.1 0.9 6.3 1206.2 11.1 2.2 8.8 17.8 1.7 45.7 1.0 12.1 2.3 16.2 9.0 4.1 21.0 18.3 6.1 24.8 6.9 2.3 19.7 4.8 15.6 7.0 4.1 14.4 12.4 30.2 3.5 1.0 8.8 16.3 POMGNT2 "AGO61, C3orf39, FLJ14566, GTDC2" ENSG00000144647 "Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)" Q8NAT1 3 43079232-43106079 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034870, HPA040989" Uncertain "Intracellular and membrane" NA NA "HPA034870: AB_10602701, HPA040989: AB_2677238" "unprognostic (2.37e-3)" "unprognostic (8.22e-2)" "prognostic favorable (8.13e-5)" "unprognostic (2.57e-2)" "unprognostic (4.17e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.26e-5)" "unprognostic (8.71e-2)" "unprognostic (1.73e-2)" "unprognostic (7.43e-2)" "unprognostic (1.95e-2)" "unprognostic (4.01e-1)" "prognostic favorable (4.00e-7)" "unprognostic (4.98e-2)" "unprognostic (1.55e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" 10.5 13.6 21.4 4.3 19.8 20.9 9.9 21.7 23.3 18.3 17.0 12.1 3.6 51.1 11.4 7.6 31.2 9.0 19.2 21.8 19.5 11.5 9.3 10.3 3.1 19.6 20.0 20.2 30.6 15.5 17.9 19.3 5.5 23.7 15.4 2.9 9.0 14.0 14.7 31.7 11.5 7.2 19.9 16.6 6.1 14.0 14.9 26.4 5.5 11.9 18.8 2.3 15.4 13.7 17.6 20.0 14.9 8.5 26.0 32.0 8.2 13.5 5.6 10.0 19.5 22.7 18.2 13.7 0.0 20.6 10.2 23.6 0.4 14.0 16.3 8.5 0.1 39.2 14.0 11.1 17.4 12.1 9.9 15.9 9.5 11.9 13.2 7.7 7.7 7.6 29.7 11.6 0.1 7.6 11.8 18.1 2.6 18.7 12.4 27.7 7.0 6.0 12.3 11.6 14.4 13.4 12.2 11.8 9.4 10.9 5.7 17.8 8.6 3.6 15.7 21.9 23.3 23.3 14.5 23.2 0.1 20.2 19.6 17.0 0.0 0.5 0.5 3.0 0.4 2.7 1.9 1.9 1.9 0.6 0.9 2.3 1.9 0.0 1.0 0.4 0.6 1.7 1.0 21.4 19.8 21.7 23.3 21.8 19.5 19.6 20.0 20.2 23.7 16.6 26.4 17.6 4.1 3.2 2.0 11.8 2.6 8.0 2.8 3.8 6.8 15.3 8.2 7.5 17.0 10.0 3.4 14.7 8.4 3.4 3.2 2.4 5.9 9.9 10.4 6.9 6.6 3.9 6.0 28.4 13.2 10.7 5.3 14.3 4.6 2.5 0.0 12.6 5.0 6.6 6.2 10.1 14.1 1.9 4.1 4.2 4.8 24.5 19.9 3.7 5.4 3.7 1.1 10.1 5.2 15.6 7.4 5.5 2.0 29.3 3.1 4.4 1.4 5.2 9.2 5.2 13.1 8.5 8.3 10.0 19.0 6.0 11.6 1.8 3.6 3.2 2.7 2.2 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 9.5;placenta: 16.1" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 33.0;Extravillous trophoblasts: 106.2;Syncytiotrophoblasts: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 3.9;NK-cell: 1.1" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;NK-cells: 1.1" "Cell line enhanced" "Detected in some" "BEWO: 51.2;HEL: 17.1;SK-BR-3: 28.0;U-937: 10.7" "Group enriched" "Detected in many" 5 "amygdala: 2.2;basal ganglia: 7.9;cerebral cortex: 4.9;hippocampal formation: 2.4" "Low region specificity" "Detected in all" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 5.3 1.0 1.5 1.0 1.2 0.7 2.9 1.3 1.4 1.3 1.0 1.9 0.9 0.9 2.8 1.6 2.3 1.3 0.9 1.0 0.6 1.2 9.5 1.6 1.1 1.3 0.9 0.9 0.4 0.9 0.4 0.5 16.1 1.4 0.6 2.1 0.7 2.2 0.4 0.6 1.9 1.1 1.1 0.7 0.7 1.1 0.8 1.1 0.4 3.0 0.9 2.2 1.8 2.3 1.4 0.1 0.0 0.2 0.4 2.4 0.2 51.2 0.1 0.0 0.0 0.0 0.5 0.1 1.2 0.1 0.1 0.2 0.4 0.0 0.2 0.1 0.1 0.2 17.1 0.4 3.1 0.1 0.2 1.9 0.5 0.5 0.0 0.1 0.0 0.1 0.5 2.2 0.4 0.3 0.3 0.0 0.2 0.1 0.7 0.2 0.1 0.0 0.1 0.7 7.5 0.3 0.1 1.3 28.0 0.1 2.9 2.8 0.3 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 10.7 0.1 0.4 0.1 3.9 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.1 0.4 1.1 0.3 0.1 0.0 0.1 1.5 1.2 1.3 1.4 1.0 0.6 1.3 0.9 0.9 1.4 0.7 1.1 1.4 1.0 0.0 0.0 9.8 0.1 0.1 0.1 0.3 0.0 0.7 1.2 0.3 0.8 1.5 3.3 0.0 2.1 33.0 0.3 3.0 1.9 0.1 3.0 3.7 0.8 3.3 1.8 0.0 2.0 0.0 106.2 2.1 0.0 5.9 2.5 2.5 4.6 7.0 5.3 1.7 1.2 0.6 0.0 0.6 0.4 1.8 0.3 0.4 0.0 5.6 0.1 2.6 0.0 1.0 4.5 0.8 0.5 1.2 0.1 0.4 1.6 0.5 3.4 1.0 0.0 0.4 0.3 4.8 5.4 0.0 0.0 73.6 0.5 0.5 1.1 0.6 GASK1A "C3orf41, DKFZP434B172, FAM198A" ENSG00000144649 "Golgi associated kinase 1A" Q9UFP1 3 42979267-43060211 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7" "Cancer enhanced" "Detected in many" "glioma: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047726 Approved Supported Vesicles "Secreted - unknown location" NA NA 600000 Vesicles "HPA047726: AB_10960554" "unprognostic (2.16e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.93e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (2.69e-1)" "unprognostic (6.21e-2)" "unprognostic (2.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.57e-4)" "unprognostic (4.45e-2)" "unprognostic (2.09e-2)" "unprognostic (3.49e-2)" "unprognostic (3.81e-1)" 5.6 2.2 4.9 2.5 5.7 0.0 4.2 6.6 4.8 9.1 4.5 3.0 0.7 9.9 2.2 1.8 11.4 5.4 1.1 4.0 5.6 1.0 13.2 3.1 0.8 7.6 6.4 2.9 6.8 2.0 0.1 3.1 2.0 7.3 2.6 1.0 4.0 2.6 2.2 1.4 1.7 2.1 6.0 5.7 0.9 3.5 2.9 8.7 0.6 2.2 0.8 0.3 3.2 4.0 5.2 0.0 0.0 0.0 3.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.1 0.9 0.0 1.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.6 0.4 1.2 0.8 0.0 0.4 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.0 0.0 0.0 3.4 0.0 0.5 0.1 0.3 0.0 2.6 0.0 0.1 6.7 0.9 0.0 0.4 0.6 1.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 5.7 6.6 4.8 4.0 5.6 7.6 6.4 2.9 7.3 5.7 8.7 5.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 194.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 17.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 77.8 56.4 13.7 34.3 12.8 194.9 52.2 15.4 21.8 35.0 15.1 32.3 12.1 30.4 6.5 62.3 80.5 68.1 45.4 11.9 47.5 26.3 67.9 81.6 15.1 20.7 14.5 11.6 41.8 39.8 23.7 43.6 25.2 14.8 33.0 15.5 5.8 21.4 18.7 37.2 51.0 26.6 64.6 16.8 20.5 48.4 14.8 16.2 35.2 34.1 19.1 8.8 52.1 28.0 14.5 4.4 9.7 2.5 4.8 4.7 4.9 7.8 15.9 22.1 13.0 10.6 13.7 4.0 14.4 3.3 12.1 9.3 4.9 3.0 21.0 6.4 21.6 4.0 16.4 8.0 10.5 5.8 4.1 15.7 2.3 11.3 20.4 3.2 11.6 17.8 3.9 12.7 24.9 10.7 13.9 0.8 6.7 11.4 7.4 8.1 6.8 10.4 23.7 10.3 15.9 7.0 1.1 8.7 64.2 5.5 14.5 7.2 7.5 9.0 6.6 28.2 5.6 11.9 6.3 5.8 6.6 14.4 5.2 8.4 0.1 3.0 3.8 1.7 5.9 2.1 3.6 1.6 2.0 3.3 3.7 2.0 1.3 17.1 2.6 11.0 4.2 2.7 2.3 13.7 12.8 15.4 21.8 11.9 47.5 20.7 14.5 11.6 14.8 16.8 16.2 14.5 200.8 48.1 66.3 6.8 75.0 103.2 88.1 40.2 153.1 1.4 121.1 95.8 15.8 37.1 31.2 11.0 0.0 19.7 86.3 77.3 9.8 37.6 54.4 119.6 65.2 92.8 59.3 13.2 3.5 38.5 43.0 98.1 75.4 199.4 96.5 4.2 73.9 40.7 38.7 0.0 1.5 54.7 22.4 36.7 165.2 46.8 1.5 94.5 69.4 4.7 14.8 7.6 7.2 1.5 1.3 49.2 60.9 4.1 74.3 49.4 54.1 6.0 21.0 1.7 13.1 154.4 103.9 0.6 4.7 85.7 79.6 90.7 132.4 8.9 38.0 38.9 SLC25A38 FLJ20551 ENSG00000144659 "Solute carrier family 25 member 38" Q96DW6 3 39383370-39397351 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041027 Approved NA NA "HPA041027: AB_10794403" "unprognostic (3.82e-2)" "unprognostic (3.27e-2)" "unprognostic (1.96e-1)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (3.94e-2)" "unprognostic (1.94e-1)" "unprognostic (1.26e-2)" "unprognostic (5.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.06e-1)" "prognostic favorable (7.29e-4)" 18.9 35.7 23.4 19.0 24.1 70.6 21.2 26.7 27.0 22.5 31.8 28.4 25.5 27.5 27.8 14.7 27.5 19.6 20.9 23.3 26.2 28.9 58.5 21.2 36.5 24.7 23.8 23.1 44.5 46.0 39.0 30.9 15.5 25.6 29.5 37.2 23.2 22.7 24.2 48.6 16.4 25.4 20.4 23.5 27.4 34.0 18.9 25.4 33.9 52.5 36.0 35.7 28.1 19.3 26.6 24.3 38.3 24.3 41.2 56.4 46.4 30.8 33.6 46.1 48.3 43.7 26.3 5.6 67.8 19.6 31.6 40.7 18.4 55.2 40.1 36.0 43.6 45.0 52.0 33.5 40.2 75.6 37.7 33.9 58.8 46.1 46.2 93.2 44.6 31.5 52.8 47.7 40.6 36.4 35.2 44.7 67.0 66.2 35.9 44.3 16.2 26.4 47.7 37.5 45.4 24.3 31.1 11.9 65.9 34.0 44.5 33.5 35.0 26.9 38.3 26.4 56.2 48.9 54.7 93.1 41.9 29.3 48.3 24.7 30.7 9.6 18.1 38.8 5.7 44.7 50.8 39.1 43.3 14.9 37.8 41.7 40.5 1.0 57.0 8.4 18.5 55.3 29.2 23.4 24.1 26.7 27.0 23.3 26.2 24.7 23.8 23.1 25.6 23.5 25.4 26.6 10.4 22.4 27.4 8.5 35.6 11.5 13.0 12.5 28.5 13.2 26.1 22.6 16.8 22.8 9.6 27.6 6.2 35.2 33.1 21.9 21.5 15.7 6.5 26.6 16.3 11.1 12.6 73.7 8.9 16.9 32.6 13.7 16.8 38.5 22.2 24.0 9.7 27.0 15.2 5.0 10.1 25.6 12.2 7.0 13.7 12.9 15.5 9.8 12.4 1.9 11.2 18.9 29.9 7.1 6.2 13.4 22.2 13.5 23.3 17.7 23.1 31.3 12.3 12.6 6.6 15.2 14.9 11.0 7.8 19.4 10.2 19.4 36.6 32.8 26.7 8.4 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823507 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 23.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 500000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.9 15.6 1.5 4.6 1.6 8.6 5.9 0.0 6.2 22.0 5.1 7.4 6.3 10.7 4.0 15.6 5.4 9.5 20.3 6.9 4.7 4.0 14.9 9.0 4.1 0.6 1.6 1.7 5.0 1.8 2.6 1.7 9.9 1.2 12.6 6.9 0.7 4.2 10.9 2.8 3.0 9.1 15.9 0.2 22.8 7.6 7.0 2.4 1.8 20.9 9.9 2.4 6.6 4.5 1.5 0.2 0.0 4.3 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 10.1 0.0 3.2 1.4 0.0 0.1 0.2 3.8 0.0 0.0 0.1 0.6 8.1 0.1 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.4 0.3 0.0 0.2 0.5 11.8 0.1 0.5 0.7 16.9 0.0 3.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 0.0 6.2 6.9 4.7 0.6 1.6 1.7 1.2 0.2 2.4 1.5 20.8 0.0 14.7 16.0 0.1 2.5 1.1 0.1 1.2 1.2 1.1 2.9 12.9 2.8 3.1 1.8 0.0 0.2 0.0 0.0 0.0 0.1 1.5 1.4 4.9 21.6 0.0 3.0 82.0 0.0 0.5 7.5 0.0 0.9 6.3 36.2 54.3 1.3 2.8 0.0 61.0 0.1 0.0 31.9 2.2 4.2 41.3 5.7 3.6 53.4 0.1 0.6 0.0 93.5 6.2 0.0 0.0 74.9 0.4 0.2 0.0 0.1 0.0 0.0 0.0 3.2 3.3 0.6 0.9 0.0 1.7 0.3 1.8 25.9 0.4 0.3 SLC22A14 "OCTL2, ORCTL4" ENSG00000144671 "Solute carrier family 22 member 14" Q9Y267 3 38282294-38318575 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 11.7" "Group enriched" "Detected in some" 7 "Early spermatids: 70.1;Late spermatids: 101.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.26e-2)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.17e-1)" "unprognostic (6.25e-2)" "unprognostic (4.78e-2)" "unprognostic (2.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.07e-1)" "unprognostic (4.97e-2)" "unprognostic (4.81e-2)" "unprognostic (1.69e-1)" "unprognostic (3.57e-4)" "unprognostic (2.19e-1)" "unprognostic (4.02e-2)" "unprognostic (1.69e-1)" "unprognostic (2.35e-1)" 0.1 0.0 0.7 0.0 0.8 0.3 0.1 0.8 2.3 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.7 0.1 0.6 0.2 0.1 0.1 0.6 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 11.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.8 2.3 0.7 0.1 0.6 0.0 0.7 0.9 0.0 0.0 1.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.1 0.0 1.0 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 70.1 0.5 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 1.7 8.3 0.0 0.0 0.0 0.0 101.8 0.9 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.2 1.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 GOLGA4 "GCP2, GOLG, golgin-240, p230" ENSG00000144674 "Golgin A4" Q13439 3 37243177-37366751 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 683.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035102, HPA040675" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035102: AB_10601472, HPA040675: " "unprognostic (9.46e-2)" "unprognostic (1.55e-1)" "unprognostic (1.18e-2)" "unprognostic (5.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.54e-1)" "unprognostic (5.61e-2)" "unprognostic (1.38e-1)" "unprognostic (5.79e-3)" "unprognostic (3.90e-2)" "unprognostic (5.62e-2)" "unprognostic (8.55e-2)" "prognostic favorable (3.62e-6)" "unprognostic (7.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.92e-2)" "unprognostic (1.33e-1)" 39.0 36.6 19.5 19.7 27.4 21.4 29.1 28.6 23.0 27.9 52.6 28.2 39.1 20.1 23.7 37.6 21.3 19.4 58.7 19.0 32.5 34.8 61.3 25.9 17.2 28.6 26.1 15.1 23.6 48.4 33.7 40.9 36.4 27.6 29.9 28.4 57.3 38.8 20.9 119.8 48.5 37.2 19.7 24.8 24.3 38.5 44.7 26.3 17.8 47.6 103.2 19.7 25.2 29.1 31.5 62.6 42.3 21.4 27.1 55.2 47.2 54.4 78.3 65.2 30.2 36.3 36.5 33.9 21.4 19.9 67.1 34.7 35.9 34.4 55.5 62.3 27.4 25.2 28.9 37.9 58.5 55.2 30.9 20.3 25.4 51.8 47.7 92.1 48.8 44.4 15.8 35.9 32.6 49.1 26.8 23.7 13.4 23.4 31.7 39.9 5.4 64.8 22.8 37.4 64.4 13.7 18.1 48.6 51.8 61.4 40.8 76.3 22.4 54.0 30.7 35.6 60.0 56.7 39.8 30.1 18.3 54.4 26.6 36.8 30.7 6.6 15.5 16.2 7.6 14.0 9.9 10.3 11.9 5.5 11.6 10.7 8.1 8.9 15.7 15.2 11.8 7.6 4.3 19.5 27.4 28.6 23.0 19.0 32.5 28.6 26.1 15.1 27.6 24.8 26.3 31.5 85.4 237.2 312.9 142.0 98.2 158.3 134.0 70.2 128.1 171.9 97.0 84.1 683.5 84.4 147.4 46.0 358.6 112.7 126.4 154.3 29.4 117.5 240.7 131.6 141.8 102.2 89.6 127.1 154.5 120.2 117.8 128.0 140.2 242.7 62.0 112.9 63.1 147.5 92.0 188.4 168.6 166.2 65.1 73.1 73.9 46.7 119.9 80.3 69.4 107.7 91.9 145.8 132.8 133.7 223.2 136.4 109.1 113.6 150.2 169.7 181.2 64.5 82.4 361.0 85.5 161.8 95.7 435.6 227.2 98.5 175.7 249.6 97.2 125.7 139.3 189.2 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861880-37984469 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 132.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA048325: AB_2680359" "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favorable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 21.3 9.3 19.3 6.3 20.7 10.1 28.3 23.9 23.3 20.4 16.9 31.5 14.5 20.4 14.1 24.0 18.1 29.5 29.6 18.6 19.4 40.1 21.6 27.5 4.2 20.2 18.1 18.4 19.8 16.0 12.1 10.7 32.0 18.5 26.7 30.5 3.2 27.4 31.6 21.4 53.4 17.7 23.4 17.5 17.4 31.9 10.7 18.1 7.2 14.1 20.1 5.6 26.6 19.3 18.3 44.5 18.9 7.6 24.0 29.2 41.0 57.2 30.0 37.0 20.1 23.5 27.4 35.3 0.2 17.9 36.9 8.4 36.3 19.2 56.1 16.0 0.1 15.1 27.2 18.8 63.1 26.4 0.0 6.4 21.5 132.3 21.2 25.5 22.4 28.2 12.0 8.9 0.0 33.7 13.7 11.1 0.1 31.5 17.7 2.7 12.3 14.9 0.2 63.3 28.7 6.3 19.9 16.5 28.7 33.5 30.5 28.1 7.3 23.2 14.4 20.4 27.3 19.1 0.6 0.2 0.2 15.8 14.8 27.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.1 19.3 20.7 23.9 23.3 18.6 19.4 20.2 18.1 18.4 18.5 17.5 18.1 18.3 26.8 67.3 27.6 170.4 1.2 30.1 17.0 17.7 27.9 10.1 25.7 59.4 42.2 65.8 25.7 23.9 0.0 34.7 1.0 35.6 23.5 14.2 21.5 7.6 17.6 22.4 45.2 7.8 189.3 4.7 9.9 32.4 10.2 27.2 1.3 15.7 22.9 18.1 7.2 10.1 126.3 18.5 2.0 13.3 6.5 51.3 71.7 11.3 8.8 22.5 1.4 9.5 1.0 87.4 48.8 14.2 17.9 98.2 0.4 15.5 9.1 19.7 12.4 1.7 26.3 55.4 40.4 10.0 16.9 17.7 28.7 9.4 2.0 65.8 42.0 14.4 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380503-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 14.0" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5" "Group enriched" "Detected in many" 5 "granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1" "Low region specificity" "Detected in many" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 2.0 5.1 1.5 0.6 1.9 0.4 1.9 3.5 3.0 7.1 4.2 2.2 0.1 1.4 0.3 2.1 3.3 2.7 0.5 0.7 4.3 2.5 0.9 11.2 0.4 2.1 3.0 1.0 2.5 0.1 10.1 1.2 0.3 4.7 14.0 0.7 5.8 1.3 4.5 1.6 1.0 0.4 3.5 1.5 0.6 0.9 1.9 2.1 0.8 0.5 5.4 0.2 3.7 2.3 2.3 7.7 3.3 1.6 0.0 6.5 2.1 0.1 19.9 0.4 4.0 4.6 0.0 0.0 0.0 7.8 46.8 13.0 34.1 2.4 8.2 4.1 0.0 7.2 1.1 10.0 0.2 0.0 20.3 0.4 2.4 0.2 0.1 0.7 27.6 0.0 1.8 0.0 0.4 0.5 0.0 4.1 0.2 13.8 0.0 3.0 0.0 0.0 0.0 10.8 0.0 6.2 49.1 7.9 5.2 0.1 13.6 0.0 2.0 8.5 0.5 19.1 0.6 30.3 0.0 0.0 0.0 48.1 7.9 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.5 0.0 1.5 1.9 3.5 3.0 0.7 4.3 2.1 3.0 1.0 4.7 1.5 2.1 2.3 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.7 2.3 0.8 0.9 0.0 1.3 0.0 0.0 0.0 0.1 0.0 5.9 0.2 5.2 0.9 0.5 0.4 0.0 2.1 0.6 0.0 0.1 1.5 0.0 2.1 6.3 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.2 5.3 0.0 4.8 0.0 0.0 0.0 21.6 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 5.0 1.8 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain ArfGEF 1" Q6DN90 3 12897043-13283281 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 183.0;Cone photoreceptor cells: 193.9;Excitatory neurons: 191.3;Horizontal cells: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 66.5;U-266/84: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported "Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim, Vesicles" "HPA038143: AB_10697241, HPA038144: AB_2675860" "prognostic unfavorable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favorable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 27.1 39.0 31.9 19.5 49.2 55.4 19.9 13.8 86.0 19.3 1.8 17.7 7.1 19.7 7.5 9.2 19.7 11.1 32.2 42.9 18.5 16.7 31.2 28.6 24.8 47.4 26.0 42.5 21.3 19.5 31.1 18.7 19.1 51.7 22.6 7.1 56.8 15.4 13.8 34.7 12.6 22.5 12.4 3.6 46.9 17.8 10.9 17.6 14.1 16.3 27.3 16.5 19.8 15.4 55.4 10.2 13.3 11.4 12.5 9.6 12.8 66.5 10.8 9.1 7.2 5.5 9.1 8.1 21.2 12.0 20.1 7.9 5.8 9.0 5.7 5.3 14.1 19.0 12.6 8.0 38.0 10.3 0.2 5.1 13.0 10.6 14.7 8.3 9.6 6.7 8.6 36.0 20.6 5.1 31.6 8.2 13.1 12.3 7.6 26.4 11.3 3.9 29.6 4.4 12.8 9.5 18.2 7.4 27.5 6.5 10.4 11.6 8.6 17.5 7.5 19.2 6.4 1.5 43.6 64.7 8.1 14.2 6.0 6.1 4.5 2.7 3.9 2.5 2.9 1.9 5.0 1.7 1.9 1.4 4.3 1.7 2.0 8.3 1.3 2.8 4.9 1.3 2.1 31.9 49.2 13.8 86.0 42.9 18.5 47.4 26.0 42.5 51.7 3.6 17.6 55.4 29.1 3.2 17.9 59.7 45.6 11.5 7.9 7.8 12.0 110.1 16.1 15.9 183.0 21.5 10.7 3.7 193.9 9.9 48.5 3.4 7.9 6.8 2.9 7.3 13.2 29.8 10.2 46.3 191.3 12.9 42.2 22.8 8.2 5.0 15.2 21.6 24.7 42.7 22.0 235.6 128.4 13.3 4.1 60.4 42.4 4.8 16.8 34.2 7.2 78.7 36.3 16.6 45.3 67.3 78.8 7.8 3.8 22.6 23.3 19.0 3.0 5.8 29.1 123.1 26.3 24.9 30.6 2.2 1.7 3.5 7.7 21.8 24.8 45.2 8.5 13.2 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 136.1" "Cell type enriched" "Detected in many" 4 "Early spermatids: 120.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 19.4;REH: 12.4;U-266/84: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA005777: AB_2667431" "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 3.0 3.3 7.5 0.5 7.8 1.0 1.9 6.2 7.7 4.4 7.1 4.9 0.9 6.4 2.2 2.4 6.2 1.8 24.5 7.7 9.1 2.4 1.6 2.4 0.8 7.8 7.4 8.4 5.0 2.4 5.5 8.4 0.8 8.2 3.6 0.7 2.2 3.3 3.0 136.1 1.2 2.3 3.4 6.3 2.2 3.3 15.9 7.8 0.8 3.2 36.5 0.6 4.4 2.8 7.7 0.8 1.6 5.6 0.2 0.2 0.1 0.3 1.4 0.6 3.4 4.1 0.9 0.3 1.0 1.9 0.9 0.9 0.2 6.4 0.1 2.6 1.8 19.4 1.5 2.9 1.4 5.2 0.2 0.1 1.2 0.3 3.1 0.1 3.3 0.7 7.2 5.3 1.0 1.0 3.3 2.6 0.8 3.8 0.4 2.0 12.4 1.2 1.0 0.2 1.5 3.9 4.6 0.1 0.9 1.2 1.1 1.6 6.3 0.4 1.0 0.9 1.0 1.4 1.3 9.9 8.4 0.6 1.2 2.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 7.5 7.8 6.2 7.7 7.7 9.1 7.8 7.4 8.4 8.2 6.3 7.8 7.7 0.9 3.2 1.1 5.9 0.2 0.4 0.8 0.6 1.8 16.0 0.4 0.5 4.8 1.5 0.7 1.8 10.4 0.2 0.2 0.1 0.0 0.9 120.6 0.4 1.4 1.8 0.0 0.4 19.3 0.0 0.2 2.6 0.5 0.3 0.0 5.6 3.3 2.0 4.2 13.5 25.3 0.0 0.0 0.0 0.8 23.2 4.7 0.4 0.0 4.7 0.0 2.9 1.0 12.1 7.2 0.0 0.0 10.1 0.2 0.5 0.0 0.7 0.3 3.1 0.0 4.1 4.0 1.4 5.3 0.4 0.1 0.1 1.0 9.2 0.0 0.4 RPL32 L32 ENSG00000144713 "Ribosomal protein L32" P62910 3 12834485-12841582 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047501, HPA051994" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 45000 "Endoplasmic reticulum, Cytosol" "HPA047501: AB_2680070, HPA051994: AB_2681686" "unprognostic (6.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.55e-1)" "unprognostic (4.58e-3)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (1.68e-2)" "unprognostic (2.20e-1)" "unprognostic (6.93e-2)" "unprognostic (1.94e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (8.36e-2)" "unprognostic (1.44e-2)" 1899.1 1203.8 1140.1 994.6 1176.1 2997.3 2543.8 1111.9 1639.1 2115.3 1116.3 1460.0 896.9 1472.4 2037.7 1814.3 1874.0 936.3 1271.6 1103.1 1175.3 1256.7 1306.4 1196.3 2365.9 1159.7 1124.0 1089.6 3730.3 2788.6 781.8 994.0 982.4 1183.2 1550.5 1576.0 528.4 1574.6 787.7 2442.8 2570.4 1391.9 1332.7 1221.1 1524.1 1432.3 572.3 1172.7 1757.0 1143.6 1557.8 3009.6 1580.2 1882.8 1215.1 1494.9 1746.7 1497.4 1918.8 2298.7 4080.5 4927.7 1200.0 2217.5 2476.7 1684.5 2327.2 1482.5 2572.0 1066.1 1735.3 812.9 909.5 1718.2 2495.2 2023.2 1198.1 2874.3 1501.4 2099.3 2562.1 3427.6 2450.0 1456.5 3696.3 5338.3 1895.4 3629.5 2438.7 2198.5 1863.5 1879.0 2323.9 2054.2 4479.6 2773.8 4208.3 2534.9 2129.5 3285.7 2180.2 1344.1 3390.6 2540.9 2434.9 945.7 1887.9 807.8 2141.2 2740.7 1329.5 3137.0 4624.7 1280.6 1066.6 1359.4 1419.3 2254.0 1557.7 2671.2 4640.8 1357.9 3466.6 1629.6 1259.1 2347.0 621.3 2399.6 1800.7 4325.6 5980.2 4749.7 3485.2 3077.9 5413.0 6661.3 5216.7 320.4 2897.7 1489.1 3049.5 3940.9 9478.6 1140.1 1176.1 1111.9 1639.1 1103.1 1175.3 1159.7 1124.0 1089.6 1183.2 1221.1 1172.7 1215.1 3508.6 1070.5 1834.7 48.6 7663.9 9224.7 7932.7 5817.1 6926.2 342.4 9401.1 14609.2 488.6 3061.2 2689.8 1460.3 166.8 4947.7 4337.7 1512.3 4560.6 3028.0 1986.6 1422.0 4295.9 4075.7 2307.8 4056.3 39.3 6515.0 7623.3 3321.2 2414.9 1972.5 2387.6 3801.4 4734.3 3694.7 4285.0 180.0 41.2 5268.2 1723.2 5797.3 8513.9 7985.2 6662.4 3978.7 4845.2 43.1 6310.8 1703.6 4092.7 18.1 47.3 4383.7 3899.5 2998.1 3398.6 7138.0 3381.8 6786.8 1088.2 684.5 1965.6 5442.0 4616.2 1064.1 1260.6 8612.8 10963.5 4878.3 6299.1 5026.8 5534.7 8006.9 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase receptor type G" P23470 3 61561569-62297609 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 356.8;Excitatory neurons: 416.1;Inhibitory neurons: 684.3;Microglial cells: 771.0;Oligodendrocyte precursor cells: 920.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 81.7;HSkMC: 61.1" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" NA NA 520000000 "Plasma membrane" "HPA000546: , HPA064237: AB_2685221" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 18.2 13.3 8.4 4.7 8.8 0.0 12.9 6.0 12.6 12.0 25.4 7.5 3.7 10.7 8.4 4.2 9.1 8.4 9.4 13.4 7.7 14.5 5.8 12.9 1.8 9.2 7.7 7.1 12.1 3.9 26.8 5.2 10.0 7.4 7.8 6.1 8.7 5.2 8.4 7.5 4.1 6.0 13.1 10.2 7.0 5.8 7.8 9.1 2.2 13.3 10.5 1.7 7.1 6.8 6.0 0.0 5.3 27.3 0.0 81.7 41.6 13.5 17.6 28.5 18.2 24.4 13.2 0.5 0.6 10.1 20.7 14.5 0.2 13.4 13.6 28.3 1.5 7.7 1.4 0.1 15.0 27.5 7.5 0.1 61.1 5.3 25.9 30.9 5.8 19.7 2.0 0.0 17.3 16.3 7.6 0.0 0.1 17.0 0.1 0.0 11.9 8.6 0.6 18.2 8.2 2.1 4.5 4.3 0.1 6.9 11.2 0.2 0.3 46.0 25.4 24.1 41.0 14.7 5.5 6.8 0.0 19.2 3.2 31.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.4 8.8 6.0 12.6 13.4 7.7 9.2 7.7 7.1 7.4 10.2 9.1 6.0 45.3 12.8 32.4 356.8 2.2 9.2 6.4 5.0 13.1 98.5 9.6 6.3 12.5 8.6 5.8 22.0 6.2 10.5 0.9 12.1 5.9 9.6 3.6 14.4 31.9 55.5 24.6 0.0 416.1 1.8 0.8 47.7 4.1 30.5 0.0 64.6 90.3 32.7 19.7 154.8 684.3 8.9 22.4 2.9 8.8 4.3 66.5 1.1 17.8 771.0 0.6 40.8 2.1 920.3 11.8 5.3 5.6 56.8 4.2 10.9 13.9 18.2 2.8 5.7 72.3 81.1 60.6 2.0 8.6 2.1 4.8 12.6 2.3 20.0 12.1 2.7 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 23.2" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA039577: AB_2676580, HPA043550: AB_2678546" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 1.7 0.8 4.8 0.9 5.7 0.0 7.5 5.5 4.4 6.1 23.2 4.2 0.4 13.7 10.7 2.5 6.5 3.4 2.0 5.4 7.5 5.8 0.2 0.6 0.3 8.9 5.9 3.6 7.5 0.9 9.5 2.3 0.3 5.3 5.2 1.8 0.3 6.1 8.5 0.6 2.0 1.0 12.1 6.4 2.5 1.2 9.8 4.6 0.3 0.5 2.6 0.5 2.8 3.3 7.0 4.0 0.8 25.0 67.9 0.1 0.6 4.0 0.4 0.2 0.3 0.8 0.5 1.9 0.0 0.2 1.4 5.3 0.2 4.8 1.0 0.8 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.1 1.0 2.6 0.0 0.5 16.6 1.1 0.6 0.0 0.1 1.4 0.5 0.0 0.1 39.2 2.2 1.9 0.0 9.1 0.0 5.2 1.0 0.6 102.0 1.0 1.5 2.9 8.1 0.9 0.0 0.7 1.3 1.6 1.2 4.2 0.0 0.0 0.1 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 5.7 5.5 4.4 5.4 7.5 8.9 5.9 3.6 5.3 6.4 4.6 7.0 1.4 0.0 2.3 11.4 0.0 0.9 2.0 3.1 0.0 0.1 1.5 14.0 1.6 1.5 2.4 0.0 0.0 0.3 0.1 0.1 0.0 3.1 17.9 0.5 5.5 4.0 0.0 0.0 0.6 0.2 0.1 10.1 0.0 1.0 0.0 2.0 1.1 0.1 0.1 0.0 0.9 0.3 2.0 0.0 1.2 23.7 11.5 0.6 0.0 15.0 0.0 0.6 0.0 7.5 2.1 0.7 0.7 25.9 0.0 2.9 0.0 5.0 1.8 0.0 0.0 4.8 1.3 10.6 7.5 1.1 0.9 0.1 0.3 6.5 0.3 0.7 SHQ1 "FLJ10539, Shq1p" ENSG00000144736 "SHQ1, H/ACA ribonucleoprotein assembly factor" Q6PI26 3 72749277-72861914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 113.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042792 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA042792: AB_10959736" "unprognostic (1.10e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.83e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.05e-1)" "unprognostic (4.54e-3)" "unprognostic (9.21e-3)" "unprognostic (3.19e-2)" "unprognostic (8.89e-2)" "unprognostic (6.78e-3)" "unprognostic (3.76e-1)" "unprognostic (5.28e-2)" "unprognostic (7.30e-3)" "unprognostic (3.59e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" 5.7 7.1 8.1 8.1 10.0 9.2 8.2 7.8 7.7 6.7 6.4 8.9 6.7 7.2 11.5 6.4 10.8 5.6 10.2 5.8 7.3 7.5 8.0 6.2 9.0 7.8 7.6 4.4 7.7 7.1 8.6 4.6 5.3 8.2 5.7 8.8 5.5 5.8 6.1 9.2 7.6 6.2 8.1 6.7 7.1 6.5 10.1 7.9 15.5 8.2 8.6 10.1 8.4 5.1 11.3 13.5 18.1 12.0 20.3 15.7 19.2 12.1 21.8 15.8 22.4 24.6 14.5 10.7 22.4 10.2 15.2 18.2 10.9 24.9 20.5 27.5 20.1 19.6 23.3 14.1 17.3 15.9 39.7 18.8 19.2 15.4 33.1 13.6 10.4 21.2 35.8 19.0 13.5 18.5 20.2 113.4 14.1 33.9 41.5 22.7 27.1 18.8 17.3 19.7 17.6 7.6 30.4 20.3 14.3 10.6 16.0 14.7 14.9 15.1 18.0 17.5 30.1 19.5 24.9 53.8 32.7 16.1 32.0 18.3 0.9 11.9 4.3 14.2 13.5 19.1 13.7 15.8 15.4 12.3 13.3 17.7 15.4 0.5 24.2 12.3 17.6 14.4 14.5 8.1 10.0 7.8 7.7 5.8 7.3 7.8 7.6 4.4 8.2 6.7 7.9 11.3 5.9 12.8 6.9 8.8 8.3 13.3 4.3 6.9 5.7 7.5 7.2 5.3 9.5 4.3 6.5 5.5 0.0 6.1 9.9 4.3 7.9 8.6 6.9 11.5 9.6 9.1 4.2 10.3 12.1 6.1 7.9 7.1 5.6 8.0 15.2 6.6 11.4 7.6 6.9 3.3 13.5 6.8 4.1 6.6 6.2 1.9 5.9 5.7 5.4 20.6 4.1 3.2 2.1 16.1 33.9 6.5 4.3 5.7 6.1 5.1 4.7 5.7 16.2 5.4 0.0 8.0 5.9 9.1 19.5 10.8 10.2 5.7 7.6 14.8 9.3 3.9 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria NA NA Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favorable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 15.4 16.1 10.8 5.7 11.0 13.0 15.1 9.6 11.7 12.2 8.1 16.5 7.9 13.4 9.5 16.0 12.8 7.9 26.8 10.8 10.6 18.5 26.1 11.7 10.8 10.3 10.6 10.1 16.7 15.6 15.0 10.3 7.7 11.1 13.6 9.6 8.6 16.2 9.0 42.7 21.4 13.4 7.8 11.4 13.6 17.5 14.4 11.0 8.6 15.9 21.2 9.7 17.6 14.3 12.3 10.7 10.4 6.5 12.4 13.9 13.1 13.9 9.0 15.7 10.7 10.2 13.5 13.9 12.3 5.5 15.1 14.3 7.6 7.3 15.8 11.7 11.5 16.8 16.3 8.1 19.2 14.7 22.5 13.4 17.7 29.6 8.4 21.3 11.2 8.9 21.5 9.2 12.8 12.9 12.5 9.9 28.3 20.8 23.2 6.8 10.0 11.7 19.4 10.1 8.3 5.4 14.6 12.4 11.8 21.4 10.9 9.8 19.7 10.4 12.7 11.0 15.9 16.6 21.1 30.6 15.1 17.4 21.1 14.7 1.8 9.9 6.1 15.4 10.8 14.5 19.3 16.9 16.4 18.3 16.2 20.5 17.5 0.9 18.1 6.7 17.5 17.7 13.4 10.8 11.0 9.6 11.7 10.8 10.6 10.3 10.6 10.1 11.1 11.4 11.0 12.3 11.6 32.1 22.2 22.9 29.5 35.8 38.6 45.7 28.5 17.7 36.1 34.0 106.9 30.0 25.0 18.4 12.5 36.8 27.3 14.1 35.2 28.8 33.3 17.2 13.6 20.5 18.6 9.2 55.5 45.1 44.6 26.1 17.3 19.1 19.6 21.1 13.2 39.1 30.3 11.8 51.4 29.2 28.5 22.3 26.5 28.6 16.1 15.8 37.4 31.9 21.4 26.5 32.0 32.2 63.9 27.6 20.8 21.8 18.7 49.1 30.8 57.7 16.2 24.5 19.7 31.7 22.1 29.4 32.9 28.2 36.8 32.7 39.6 22.3 33.3 37.8 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 378.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA 35000 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473" "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 34.6 32.6 91.3 39.8 193.8 39.5 43.9 127.9 101.4 32.4 30.9 34.8 29.1 36.2 41.4 34.2 27.7 29.9 67.3 84.6 150.4 34.2 31.4 32.5 50.0 195.7 149.3 36.1 30.2 19.4 45.9 23.1 42.0 208.1 36.9 36.2 62.5 45.3 32.5 41.9 45.4 30.5 40.2 146.0 39.2 26.6 23.9 166.9 45.2 27.3 35.0 50.2 39.8 26.8 378.8 76.6 31.4 75.8 47.1 69.0 90.9 56.1 65.9 74.4 70.4 70.2 39.2 52.2 55.2 18.6 72.5 71.3 42.1 59.1 76.5 80.2 105.0 38.5 77.0 57.7 39.6 53.8 77.1 62.4 72.0 49.8 67.9 54.9 86.7 92.3 45.2 31.9 45.6 94.0 26.8 49.5 49.7 67.5 95.4 26.9 39.6 55.9 53.0 113.2 94.6 32.8 46.2 70.3 51.0 58.4 80.9 34.3 73.3 71.4 53.0 46.9 70.6 93.3 53.2 91.8 67.3 54.5 84.3 69.7 87.9 45.7 71.0 24.3 54.0 28.1 33.6 32.2 30.3 40.1 29.7 29.6 30.5 40.9 39.8 57.1 20.1 40.8 53.0 91.3 193.8 127.9 101.4 84.6 150.4 195.7 149.3 36.1 208.1 146.0 166.9 378.8 21.9 35.3 31.4 35.9 35.5 33.8 29.2 66.2 31.9 22.9 21.6 17.9 68.5 14.3 44.5 35.0 39.6 74.5 19.8 15.8 19.6 37.1 15.2 25.1 21.2 26.9 18.6 30.7 44.6 23.6 57.2 28.3 22.4 25.6 42.4 26.0 22.9 17.2 34.1 33.7 62.8 16.3 97.6 37.1 49.6 10.3 40.4 39.6 30.2 44.0 60.6 29.1 24.7 53.3 76.7 31.5 11.7 38.0 28.3 23.7 16.7 36.9 47.3 48.9 26.3 22.2 31.0 34.2 32.1 34.9 42.8 56.8 34.0 24.3 17.5 32.5 ARL6IP5 "DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b" ENSG00000144746 "ADP ribosylation factor like GTPase 6 interacting protein 5" O75915 3 69084937-69106092 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015540, CAB019321" Supported Approved "Endoplasmic reticulum" NA NA 1100000 "Endoplasmic reticulum" "CAB019321: , HPA015540: AB_1852061" "unprognostic (8.01e-2)" "unprognostic (1.71e-1)" "unprognostic (8.09e-2)" "unprognostic (1.51e-3)" "unprognostic (2.65e-1)" "unprognostic (3.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (3.06e-1)" "unprognostic (3.72e-3)" "unprognostic (1.31e-2)" "unprognostic (7.23e-2)" "unprognostic (2.05e-3)" "unprognostic (3.60e-1)" "unprognostic (4.44e-2)" "unprognostic (3.42e-2)" "unprognostic (1.31e-2)" 159.1 131.9 109.6 110.8 112.5 68.4 141.1 116.8 142.1 124.0 105.0 88.1 59.7 73.5 105.3 79.0 91.3 103.0 218.3 107.3 122.1 89.3 80.9 126.6 139.5 118.8 120.4 102.5 74.9 55.8 84.1 47.9 89.5 122.2 130.7 86.0 136.2 161.0 91.4 185.0 48.9 66.7 101.3 125.6 101.2 73.2 35.2 118.6 93.1 71.8 188.5 131.1 112.8 61.5 130.9 86.9 59.0 71.1 52.8 361.4 335.2 89.7 87.9 196.5 66.7 77.4 30.1 205.9 17.0 28.9 151.1 124.8 67.0 59.2 100.8 57.0 339.5 55.2 59.6 91.1 45.8 92.9 51.4 280.5 243.6 177.5 61.5 77.3 235.0 206.0 55.7 26.6 156.7 163.6 50.3 56.0 67.0 18.5 200.2 55.1 48.6 65.0 159.1 330.5 143.1 17.8 47.0 87.0 93.5 119.5 69.7 61.7 80.2 203.7 44.1 34.8 112.5 96.1 139.4 208.5 31.7 146.0 126.0 72.8 697.4 388.2 650.2 332.4 357.6 257.1 397.7 462.4 427.6 275.7 336.1 391.2 409.5 162.0 298.4 315.1 176.0 530.4 933.9 109.6 112.5 116.8 142.1 107.3 122.1 118.8 120.4 102.5 122.2 125.6 118.6 130.9 101.1 176.3 132.0 34.6 183.6 72.8 70.6 275.5 108.7 201.9 214.9 174.5 422.0 95.8 185.0 93.8 187.7 305.8 212.7 146.7 25.4 281.4 20.8 144.9 79.5 121.4 42.0 89.8 45.9 214.4 379.2 254.8 64.2 233.4 336.6 75.7 150.3 72.5 292.0 122.8 70.7 57.1 270.6 260.0 402.1 18.9 207.2 275.4 272.1 35.6 476.6 235.7 272.9 49.8 97.0 244.2 95.7 261.8 93.4 93.6 91.7 77.8 155.0 272.4 190.7 190.3 125.4 7.3 4.3 207.8 73.9 178.4 292.2 133.6 77.8 94.0 TMF1 "ARA160, TMF" ENSG00000144747 "TATA element modulatory factor 1" P82094 3 69019827-69052339 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 508.1;Late spermatids: 544.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008729 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA008729: AB_1080310" "unprognostic (2.71e-1)" "unprognostic (2.11e-2)" "unprognostic (8.02e-3)" "unprognostic (7.19e-2)" "unprognostic (2.74e-1)" "unprognostic (6.75e-3)" "unprognostic (6.73e-3)" "unprognostic (1.79e-1)" "unprognostic (4.62e-2)" "unprognostic (2.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.83e-2)" "unprognostic (1.50e-1)" "unprognostic (1.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.51e-2)" "unprognostic (1.01e-1)" 10.4 10.7 5.0 14.1 5.5 26.4 14.2 6.8 6.0 13.4 11.4 12.6 13.1 15.0 14.2 11.6 13.1 14.2 9.3 4.9 6.8 12.7 11.1 12.1 16.1 5.8 5.6 4.1 12.7 13.7 15.7 10.0 16.6 5.7 14.6 14.3 12.6 17.6 10.4 9.9 9.8 14.9 11.7 5.8 13.0 14.2 19.5 5.6 9.7 21.1 8.4 14.9 13.7 8.0 6.7 19.5 8.3 7.8 7.9 20.7 26.4 17.5 24.6 23.6 16.1 19.2 11.9 14.1 7.4 3.9 25.1 11.3 10.5 10.2 10.8 26.4 14.3 7.6 14.4 11.0 14.1 18.5 16.3 19.7 15.6 17.0 21.4 19.3 17.1 17.5 6.0 8.8 11.8 21.2 11.1 9.5 14.1 6.8 12.3 4.4 7.8 9.9 10.4 21.0 15.4 5.4 8.3 20.2 14.2 15.4 10.4 10.7 19.4 23.1 15.8 6.7 27.9 14.8 13.2 13.6 7.2 24.1 16.6 13.1 4.8 2.4 5.1 3.1 2.0 2.1 2.6 2.8 2.7 2.1 3.1 2.9 2.6 5.3 2.7 3.4 2.4 3.1 1.6 5.0 5.5 6.8 6.0 4.9 6.8 5.8 5.6 4.1 5.7 5.8 5.6 6.7 49.2 64.1 78.9 21.9 84.7 37.5 37.6 41.7 39.3 43.4 46.2 35.8 36.9 38.6 86.4 42.3 37.5 39.6 108.4 48.8 15.6 52.4 508.1 150.4 92.8 43.1 55.6 45.0 32.2 56.2 58.7 70.0 54.6 86.2 74.7 51.7 29.3 19.7 28.4 35.3 38.4 61.6 38.7 31.8 54.4 544.8 51.0 55.1 35.6 32.8 66.7 41.5 59.8 36.2 40.9 50.6 40.8 62.1 129.3 64.8 49.4 25.1 200.5 52.1 32.9 62.8 56.8 116.2 39.3 30.6 39.5 80.6 94.5 54.5 38.5 85.7 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 145.6" "Cell type enriched" "Detected in many" 5 "Astrocytes: 331.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in many" "Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol NA NA 78000 Cytosol "HPA011846: AB_2668545" "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.50e-4)" 31.3 1.8 29.5 17.2 24.3 4.0 27.5 15.6 21.1 30.1 2.2 29.6 17.0 22.1 3.0 13.6 27.0 21.0 37.4 21.0 24.2 3.7 11.3 17.7 8.0 24.2 36.7 11.0 17.3 145.6 5.3 6.6 4.7 21.7 25.0 14.8 5.0 19.4 7.3 37.6 11.8 13.5 30.8 13.2 4.0 36.9 12.6 40.6 3.5 16.4 33.2 9.7 6.0 5.2 18.8 1.4 1.3 27.6 0.5 7.6 4.8 2.8 4.9 26.6 4.6 14.0 23.6 0.3 79.7 13.1 2.2 6.1 0.0 5.5 10.0 10.1 0.0 16.8 0.0 4.1 2.0 1.8 0.7 16.7 6.0 5.4 55.2 9.0 18.8 24.3 0.3 0.3 0.0 1.0 3.6 0.0 0.1 22.8 2.3 0.0 14.1 8.7 3.7 5.1 0.0 3.9 1.0 4.6 4.1 0.2 4.6 25.6 6.7 8.2 13.9 6.3 27.9 12.9 6.2 3.2 59.5 24.3 0.0 5.0 0.0 0.0 0.3 0.1 0.0 0.6 0.1 0.4 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.1 0.1 29.5 24.3 15.6 21.1 21.0 24.2 24.2 36.7 11.0 21.7 13.2 40.6 18.8 12.5 38.5 50.2 331.1 4.3 11.3 7.8 8.0 14.2 2.1 51.9 35.8 32.0 11.5 25.0 0.0 8.4 0.2 5.8 9.6 1.9 5.6 1.6 29.1 9.7 9.2 26.5 0.0 10.6 17.1 0.1 17.1 19.9 58.8 1.3 14.9 6.4 20.7 2.0 8.4 15.6 26.2 12.2 1.9 7.7 2.1 11.5 2.4 10.6 57.1 1.7 39.8 0.0 37.7 58.3 6.0 10.2 17.3 8.7 15.6 5.7 1.2 33.7 6.8 0.0 65.5 19.9 1.6 20.0 8.9 11.5 0.1 15.2 2.1 22.8 5.0 LRTM1 HT017 ENSG00000144771 "Leucine rich repeats and transmembrane domains 1" Q9HBL6 3 54918231-54967088 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 79.6;skeletal muscle: 26.1" "Cell type enriched" "Detected in some" 12 "Bipolar cells: 389.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (9.56e-2)" "unprognostic (2.16e-1)" "unprognostic (1.87e-3)" 0.1 0.0 1.4 0.0 3.0 0.1 0.5 0.5 3.5 0.2 2.7 0.4 0.0 0.0 0.3 4.0 0.1 0.0 0.1 2.2 3.3 0.0 0.3 0.2 0.1 1.0 5.8 2.4 0.0 0.1 0.1 0.0 0.6 1.7 1.1 0.1 79.6 1.0 0.5 26.1 0.0 0.2 0.0 0.1 6.7 0.1 0.5 1.1 0.1 0.3 2.5 0.1 0.1 0.0 3.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.4 0.1 0.2 0.0 1.1 0.3 0.2 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 1.4 3.0 0.5 3.5 2.2 3.3 1.0 5.8 2.4 1.7 0.1 1.1 3.0 0.2 0.0 0.0 5.9 0.0 0.4 0.6 0.1 0.0 389.8 0.0 0.0 0.5 0.0 0.0 1.8 16.7 9.3 0.0 0.1 0.0 0.0 3.0 0.1 0.2 1.0 0.0 0.0 27.1 0.4 1.3 1.2 0.0 0.3 0.0 0.2 0.0 0.0 0.7 1.7 10.9 0.0 0.0 0.0 0.6 0.7 5.9 0.1 0.0 1.9 0.1 17.2 0.0 4.0 0.5 2.0 0.0 4.5 0.0 0.6 0.0 0.0 0.0 30.8 0.0 3.2 1.6 3.1 3.7 0.0 0.4 22.2 0.1 0.5 0.0 0.4 AC073896.1 ENSG00000144785 "Novel protein" 12 56285916-56316059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.0;salivary gland: 19.5" "Cell type enhanced" "Detected in single" "Club cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038466, HPA068007" Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA038466: AB_10672646, HPA068007: " "unprognostic (3.07e-2)" "unprognostic (9.89e-3)" "unprognostic (8.23e-2)" "unprognostic (3.45e-2)" "unprognostic (8.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.13e-1)" "unprognostic (1.38e-1)" "unprognostic (3.74e-3)" "unprognostic (2.83e-1)" "unprognostic (1.04e-1)" "unprognostic (9.26e-4)" "unprognostic (2.22e-1)" "unprognostic (3.01e-1)" "unprognostic (1.93e-1)" 7.1 5.7 1.5 3.5 1.4 5.1 3.9 1.3 5.4 1.7 2.2 9.0 9.9 1.2 0.3 3.1 3.4 6.0 1.4 1.5 1.4 3.1 4.8 1.9 2.2 1.5 1.2 1.3 3.7 19.0 3.8 0.3 4.4 1.6 2.6 0.3 0.7 19.5 6.7 1.5 1.0 5.6 0.9 1.3 4.3 7.1 2.0 4.7 3.3 3.3 1.5 0.9 2.7 0.3 2.0 22.0 38.1 5.4 23.4 17.4 12.6 37.7 42.5 42.1 33.2 23.4 43.2 22.7 15.8 61.9 17.7 18.8 49.0 9.9 15.3 3.8 30.6 18.4 0.8 22.8 42.6 37.6 15.5 45.4 24.5 23.3 18.3 1.1 19.8 29.0 43.8 19.2 18.5 5.1 36.9 11.0 24.7 37.5 19.1 97.7 50.3 21.2 29.2 0.3 3.4 30.6 29.1 26.1 25.8 26.9 0.6 20.9 84.8 20.6 30.1 15.6 18.8 37.4 29.4 62.0 17.1 41.4 27.0 41.3 31.5 41.3 19.4 40.8 36.4 41.6 65.1 35.5 43.2 50.3 51.9 40.9 38.7 6.9 41.7 22.1 59.5 39.6 70.1 1.5 1.4 1.3 5.4 1.5 1.4 1.5 1.2 1.3 1.6 1.3 4.7 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 LIMD1 ENSG00000144791 "LIM domains containing 1" Q9UGP4 3 45555394-45686341 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064220, HPA071736" Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA 8100 "Nucleoplasm, Focal adhesion sites" "HPA064220: AB_2685216, HPA071736: " "unprognostic (2.77e-1)" "unprognostic (3.22e-2)" "unprognostic (5.43e-2)" "unprognostic (7.78e-2)" "unprognostic (6.53e-2)" "unprognostic (2.07e-2)" "unprognostic (9.44e-2)" "unprognostic (1.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (2.11e-3)" "prognostic favorable (6.73e-5)" "unprognostic (8.02e-2)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (6.61e-3)" 7.1 3.8 4.3 7.9 4.2 6.1 5.5 3.2 4.6 5.2 9.0 7.4 7.2 6.6 4.7 5.6 6.1 7.3 9.7 2.9 6.5 3.7 11.2 17.3 10.7 7.5 4.9 2.4 4.2 10.3 9.0 2.9 6.4 8.8 6.2 7.5 2.8 9.9 4.8 17.5 6.6 7.9 5.6 4.7 10.9 8.3 2.5 5.2 8.1 12.3 8.7 8.7 6.0 4.9 9.0 13.3 24.7 8.8 11.9 7.6 14.7 17.7 12.4 17.0 12.7 11.0 11.7 6.8 1.7 8.1 11.4 26.1 8.8 18.8 10.0 10.5 28.1 11.7 14.7 20.5 9.7 7.7 13.3 18.2 6.2 8.3 19.1 10.0 9.2 11.3 14.7 12.4 40.0 12.6 8.7 16.2 8.3 14.2 10.4 23.7 7.9 10.3 20.2 6.8 23.3 4.1 8.0 10.5 18.8 12.4 9.0 11.4 11.8 20.7 14.3 12.9 14.5 13.4 38.1 52.7 6.5 30.9 11.7 16.0 3.8 0.9 1.1 1.0 2.0 0.6 2.4 0.8 0.8 0.9 4.0 0.8 0.8 1.0 0.7 4.0 5.8 0.8 0.8 4.3 4.2 3.2 4.6 2.9 6.5 7.5 4.9 2.4 8.8 4.7 5.2 9.0 5.0 38.5 27.4 17.6 17.8 2.9 5.7 4.3 4.0 1.6 5.2 3.8 16.5 21.5 12.4 7.3 2.1 6.4 23.9 8.0 1.9 7.2 1.2 7.9 10.2 5.9 6.7 10.3 1.4 5.3 12.8 9.0 9.7 10.7 3.8 11.1 9.7 22.9 17.1 6.7 3.6 15.9 10.2 17.0 10.1 0.9 11.8 13.5 5.4 18.7 11.1 4.8 12.3 74.4 22.5 6.2 6.9 3.4 9.7 9.1 5.9 2.9 11.9 1.5 6.6 8.2 15.2 1.0 3.5 4.1 2.3 5.3 7.9 2.5 9.6 5.4 ZNF660 FLJ36870 ENSG00000144792 "Zinc finger protein 660" Q6AZW8 3 44578223-44599694 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.9;Muller glia cells: 28.1;Rod photoreceptor cells: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;HEL: 3.4;NTERA-2: 5.2;RH-30: 3.4;SuSa: 2.8" "Low region specificity" "Detected in all" HPA029705 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA029705: AB_10602592" "unprognostic (5.43e-2)" "unprognostic (3.58e-2)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-1)" "unprognostic (3.73e-2)" "unprognostic (2.46e-2)" "unprognostic (1.36e-2)" "unprognostic (2.91e-3)" "unprognostic (8.56e-2)" "unprognostic (2.79e-3)" "unprognostic (4.87e-3)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" 1.1 0.8 0.9 0.4 0.6 0.8 0.9 2.3 0.7 2.1 0.1 1.2 0.1 2.2 0.7 0.3 1.8 0.7 0.9 0.6 0.7 0.7 0.3 0.9 0.9 1.0 0.8 0.4 3.5 0.8 0.7 2.5 0.7 1.2 1.6 0.3 4.6 0.6 0.9 0.4 0.3 0.9 0.9 0.6 1.1 0.8 1.7 0.9 0.9 1.6 0.4 0.6 1.3 1.2 0.7 0.0 0.0 3.4 0.8 0.0 0.0 0.5 0.4 0.8 0.5 0.5 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 0.0 0.6 0.0 0.0 3.4 0.3 0.5 0.8 0.0 0.0 1.3 0.0 1.2 0.0 0.1 0.8 0.0 0.0 0.1 1.8 0.0 0.0 2.0 5.2 0.0 0.0 0.0 3.4 0.0 0.1 0.1 0.8 2.2 0.0 0.0 0.0 2.8 0.0 1.3 0.2 0.9 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.9 0.6 2.3 0.7 0.6 0.7 1.0 0.8 0.4 1.2 0.6 0.9 0.7 3.2 0.0 6.0 11.8 1.4 0.1 1.1 0.5 0.0 27.9 1.0 1.0 2.2 4.3 3.2 0.0 6.2 0.0 2.3 0.2 0.0 1.2 10.3 1.9 7.8 4.0 4.2 3.0 7.6 0.5 0.0 4.4 0.5 1.1 6.3 12.4 3.6 0.2 2.0 11.8 11.5 0.3 0.0 1.0 0.5 2.0 5.0 1.3 0.0 11.2 2.9 28.1 6.2 15.6 13.7 0.5 0.0 3.4 0.3 0.8 0.0 0.2 1.0 25.6 0.0 7.9 5.1 7.7 3.9 0.1 0.0 0.0 0.7 7.0 0.4 0.3 NFKBIZ "FLJ34463, INAP, MAIL" ENSG00000144802 "NFKB inhibitor zeta" Q9BYH8 3 101827991-101861022 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 409.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "hypothalamus: 46.0" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 33.9" "Group enriched" "Detected in many" 5 "granulocytes: 24.7;monocytes: 33.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.1;RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010547, HPA075363" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA010547: AB_1854442, HPA075363: AB_2686745" "unprognostic (2.20e-2)" "unprognostic (1.11e-2)" "unprognostic (6.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-2)" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (5.96e-2)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" "prognostic unfavorable (4.30e-8)" "unprognostic (2.69e-1)" "unprognostic (8.90e-2)" "unprognostic (3.30e-1)" "unprognostic (8.52e-3)" 49.3 12.1 4.6 44.8 4.8 409.8 32.0 4.8 7.4 13.5 17.8 23.8 53.0 36.6 3.7 27.1 65.3 51.8 19.0 4.8 46.0 25.2 52.9 48.6 27.4 7.3 3.9 2.1 19.3 27.2 3.7 12.6 22.5 5.2 26.8 30.9 8.0 81.5 7.5 4.7 44.7 23.4 55.1 5.8 27.1 30.8 3.7 5.9 19.0 24.9 10.3 22.9 72.0 18.5 10.3 6.5 5.2 3.5 4.4 9.7 16.7 5.3 26.2 72.1 11.3 10.7 6.3 7.8 12.2 32.4 7.2 34.8 20.5 2.5 11.4 29.2 35.9 2.3 11.7 10.2 3.4 14.7 0.8 0.7 11.6 17.3 30.5 13.7 27.8 8.4 0.3 2.0 24.6 16.2 8.1 0.2 6.9 6.0 2.3 15.3 1.5 15.7 1.5 71.0 42.7 1.5 1.9 4.4 5.3 29.6 7.4 6.3 4.8 10.6 18.1 18.0 6.9 8.6 20.4 7.8 8.1 32.9 2.2 2.5 11.7 5.9 1.7 1.4 13.1 1.7 2.9 2.1 1.6 3.8 4.6 6.0 4.2 24.7 0.8 33.9 6.0 1.3 2.3 4.6 4.8 4.8 7.4 4.8 46.0 7.3 3.9 2.1 5.2 5.8 5.9 10.3 199.5 86.6 266.6 10.7 91.3 281.7 61.2 123.0 103.0 9.0 108.7 105.8 20.6 84.4 143.0 66.2 2.1 19.3 98.6 157.8 0.0 213.0 4.6 116.1 221.4 135.3 73.6 21.0 23.7 132.1 41.0 214.2 277.8 291.9 381.8 17.9 82.1 65.2 56.5 10.1 20.2 69.7 59.0 150.6 291.5 1.3 20.2 318.4 71.2 16.9 79.0 25.7 12.3 17.1 79.3 127.6 115.8 0.7 128.5 88.8 91.2 5.6 117.3 8.9 19.7 218.4 131.1 0.6 2.6 136.4 251.7 25.6 134.0 19.2 111.7 70.5 COL8A1 "C3orf7, MGC9568" ENSG00000144810 "Collagen type VIII alpha 1 chain" P27658 3 99638475-99799226 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 34.1" "Region enhanced" "Detected in many" "hypothalamus: 26.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053107 Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA053107: AB_2682046" "unprognostic (3.13e-2)" "unprognostic (2.92e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-3)" "unprognostic (2.49e-1)" "unprognostic (2.31e-2)" "unprognostic (4.83e-2)" "unprognostic (2.62e-2)" "unprognostic (4.79e-2)" "unprognostic (3.58e-2)" "unprognostic (3.71e-1)" "prognostic unfavorable (9.39e-8)" "unprognostic (2.98e-3)" "unprognostic (1.72e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-3)" 19.2 7.1 5.5 5.9 2.5 0.0 5.7 2.0 13.1 3.2 18.8 9.5 1.0 5.2 2.7 11.2 9.1 10.9 37.6 1.2 26.3 5.8 0.9 33.1 0.9 3.4 3.3 0.7 9.3 1.2 18.0 11.4 4.2 2.8 12.8 7.0 0.5 7.1 12.1 2.3 2.6 3.7 31.8 3.1 1.0 5.3 0.5 2.6 0.4 27.7 7.9 0.5 25.2 5.4 3.0 0.1 0.4 3.0 0.3 142.2 236.4 0.2 68.5 45.7 69.6 138.6 0.0 0.3 0.1 5.9 1098.3 1.9 0.1 0.4 88.2 157.8 0.1 0.2 0.1 7.9 0.0 26.8 0.0 0.1 142.8 3.2 52.6 82.9 431.9 129.4 0.0 0.1 0.2 313.0 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 144.3 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.1 0.2 471.5 31.0 24.1 1.6 34.2 0.1 0.0 0.1 58.4 0.0 241.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 2.5 2.0 13.1 1.2 26.3 3.4 3.3 0.7 2.8 3.1 2.6 3.0 4.4 246.8 22.1 0.0 0.4 0.8 0.5 2.8 14.8 0.4 1.8 5.2 4.9 4.3 3.9 9.2 0.0 0.1 0.9 0.0 0.0 0.1 1.3 0.2 2.6 14.1 0.0 0.0 1.9 0.0 0.3 53.3 2.0 0.3 5.1 0.2 102.8 0.8 0.1 0.0 0.7 0.0 0.0 1.9 2.3 1.0 2.1 0.8 1.8 4.7 0.2 0.7 2.1 9.0 0.6 0.1 0.0 9.4 0.5 0.2 0.0 1.6 1.0 0.6 0.0 1.9 51.6 0.3 0.3 1.0 0.6 0.4 0.9 0.1 0.0 0.5 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101828231 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.9;tongue: 51.0" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 177.7;Plasma cells: 59.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 92.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 12000 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 7.9 6.5 14.5 11.8 21.9 12.6 6.1 18.2 16.7 7.7 1.7 4.9 3.5 8.1 3.4 6.2 7.5 6.6 18.6 12.6 19.7 3.4 3.5 9.5 16.9 20.5 21.3 9.1 7.1 2.6 20.8 6.9 6.7 26.8 8.4 4.6 11.4 3.5 9.8 73.9 2.0 5.0 10.6 18.9 12.6 5.0 7.5 19.1 13.3 6.0 51.0 14.3 7.3 4.5 34.5 19.8 29.9 25.1 9.2 26.6 26.9 5.7 21.7 27.2 25.4 36.6 7.0 2.0 29.3 62.6 24.4 30.4 4.1 28.3 23.2 31.2 36.7 8.9 22.7 19.0 19.3 35.0 19.4 19.9 15.6 3.9 21.1 7.8 33.1 27.8 27.3 4.7 92.0 42.5 10.6 26.2 4.6 14.6 1.0 18.6 11.5 30.7 12.7 18.8 5.1 19.6 23.4 9.3 2.2 16.7 14.9 4.3 27.2 24.5 28.0 33.7 3.3 23.0 43.0 47.5 34.0 23.9 83.7 5.4 8.0 16.5 20.1 14.6 13.0 10.0 10.8 16.0 15.2 14.2 6.4 21.6 17.6 8.6 8.9 12.7 8.8 20.8 14.1 14.5 21.9 18.2 16.7 12.6 19.7 20.5 21.3 9.1 26.8 18.9 19.1 34.5 24.1 25.6 5.1 11.4 19.2 3.7 2.2 2.3 6.2 26.1 9.8 9.0 49.4 4.3 2.3 0.0 8.4 0.7 12.8 1.0 0.0 2.6 1.4 2.9 11.8 17.2 7.2 0.0 34.1 2.6 1.6 10.0 1.5 1.9 13.3 46.0 40.4 1.8 6.8 48.8 35.2 0.6 4.1 19.1 10.0 1.8 9.3 11.0 7.2 9.4 26.3 22.7 23.7 44.2 177.7 2.9 0.1 7.5 59.6 1.0 0.8 0.8 3.1 17.1 19.7 14.9 8.3 11.8 15.1 3.8 3.0 0.7 16.2 20.0 0.9 1.1 ADGRG7 "FLJ14454, GPR128" ENSG00000144820 "Adhesion G protein-coupled receptor G7" Q96K78 3 100609601-100695479 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 43.3;liver: 24.9" "Group enriched" "Detected in some" 4 "Hepatocytes: 23.9;Paneth cells: 14.0;Proximal enterocytes: 39.4" "Cancer enhanced" "Detected in some" "stomach cancer: 3.4" "Region enhanced" "Detected in some" "white matter: 7.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056451 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056451: " "unprognostic (1.65e-1)" "unprognostic (1.10e-1)" "unprognostic (2.79e-1)" "unprognostic (8.46e-3)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-3)" "unprognostic (2.84e-5)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.77e-2)" 0.1 0.1 0.0 0.9 0.8 2.2 0.1 0.3 1.2 0.4 0.0 5.3 43.3 0.3 0.0 0.2 0.6 0.7 0.1 0.1 0.1 0.1 24.9 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 1.3 0.2 3.0 0.2 0.1 0.0 0.1 0.1 39.7 1.5 0.0 0.1 0.2 0.1 1.9 0.0 0.1 0.0 0.0 0.7 0.2 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 1.2 0.1 0.1 0.1 0.0 0.0 1.3 0.0 1.9 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.2 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.0 0.0 0.0 0.0 39.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 MYH15 KIAA1000 ENSG00000144821 "Myosin heavy chain 15" Q9Y2K3 3 108380368-108529322 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;retina: 2.9;tongue: 1.8" "Cell type enhanced" "Detected in some" "Astrocytes: 14.0;Excitatory neurons: 8.8;Inhibitory neurons: 6.3;Muller glia cells: 8.0;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 10.6;Rod photoreceptor cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.4;Karpas-707: 2.3;PC-3: 5.1;SH-SY5Y: 1.8;U-87 MG: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034871, HPA057915" Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA034871: AB_10669996, HPA057915: " "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.62e-1)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (7.84e-3)" "unprognostic (7.32e-2)" "unprognostic (1.89e-2)" "unprognostic (5.67e-2)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (8.41e-2)" "unprognostic (3.57e-2)" 0.1 0.2 1.5 0.1 1.8 0.1 0.0 1.5 1.4 0.1 0.6 0.4 0.4 0.0 0.3 0.0 0.1 0.2 0.4 1.6 1.5 0.0 0.0 0.3 0.1 1.8 1.5 1.2 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.3 2.9 0.1 0.0 0.2 0.4 0.6 0.0 1.6 0.2 0.2 0.6 1.6 0.1 0.1 1.8 0.0 0.0 0.0 1.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.2 0.0 0.4 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.5 1.2 0.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 1.8 1.5 1.4 1.6 1.5 1.8 1.5 1.2 1.5 1.6 1.6 1.6 0.0 0.0 0.5 14.0 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.0 2.3 0.0 0.0 0.0 2.1 0.0 0.1 0.4 0.0 0.2 3.0 1.0 0.1 0.1 0.0 0.0 8.8 0.2 0.0 0.6 0.0 0.1 0.0 0.5 0.0 0.0 0.1 1.7 6.3 1.1 0.0 0.0 0.3 0.9 0.0 0.1 1.8 1.0 0.0 8.0 0.0 5.0 10.6 0.5 0.0 0.0 1.6 0.4 0.1 0.1 0.0 5.1 0.0 0.1 0.6 1.1 0.6 0.0 0.1 0.0 0.1 0.5 1.2 0.1 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 249.9;Basal prostatic cells: 189.9;Suprabasal keratinocytes: 114.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "hypothalamus: 16.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 103.8;HaCaT: 105.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 25.8 7.2 3.1 15.8 1.7 1.5 11.4 0.9 4.2 10.6 9.8 21.0 6.0 20.6 7.5 11.2 13.5 15.5 43.1 1.1 16.0 31.8 35.9 17.8 5.2 1.4 2.0 1.0 9.0 10.0 1.8 5.7 41.1 1.7 16.5 8.6 0.5 10.7 25.9 4.9 6.7 7.8 24.5 1.6 16.6 11.8 2.9 3.5 5.0 6.3 8.7 3.2 26.8 10.6 2.2 103.8 11.2 62.2 0.1 19.8 32.3 25.5 58.3 28.5 37.8 44.5 32.1 7.5 0.0 59.6 22.6 38.2 105.2 0.9 37.5 68.6 1.6 1.5 0.0 26.1 10.6 21.3 0.2 0.3 38.1 21.9 26.1 48.1 42.5 61.8 1.0 0.1 0.4 11.5 0.2 4.2 0.1 25.3 1.0 19.3 9.0 80.1 0.0 22.2 24.5 1.6 4.7 57.6 1.1 5.9 34.1 2.1 0.3 54.4 10.2 85.2 27.4 14.3 5.4 0.2 0.2 10.4 0.1 19.9 0.1 0.0 0.0 2.6 0.0 1.8 0.2 1.8 2.9 0.0 0.4 0.0 1.1 0.2 1.0 0.0 0.5 0.4 0.8 3.1 1.7 0.9 4.2 1.1 16.0 1.4 2.0 1.0 1.7 1.6 3.5 2.2 30.9 80.1 7.5 2.6 1.6 249.9 189.9 33.3 33.0 0.2 11.6 9.8 95.8 25.8 16.8 33.1 2.1 27.0 13.0 0.6 23.5 62.6 12.9 3.7 15.3 44.8 10.8 2.7 51.7 20.5 51.5 40.3 14.3 26.2 7.0 1.2 35.3 35.2 3.5 0.0 9.5 3.4 8.2 2.5 20.6 5.3 14.3 2.9 23.2 39.4 1.0 0.1 23.7 4.5 1.8 45.4 0.5 22.6 2.8 60.1 0.0 30.9 6.8 0.3 13.1 21.0 95.9 0.5 3.3 17.7 114.7 66.8 6.7 2.7 1.9 84.0 ABHD10 FLJ11342 ENSG00000144827 "Abhydrolase domain containing 10, depalmitoylase" Q9NUJ1 3 111979010-111993368 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036991, HPA036992, HPA066081" Supported Approved Mitochondria "Intracellular and membrane" No No 71000 Mitochondria "HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610" "unprognostic (1.65e-1)" "prognostic favorable (7.57e-4)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (1.14e-1)" "unprognostic (8.50e-2)" "unprognostic (1.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-2)" "prognostic favorable (4.72e-9)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (4.18e-3)" "unprognostic (2.76e-2)" 11.1 22.1 25.6 10.7 27.5 11.0 15.2 26.9 29.5 11.4 24.4 14.3 11.8 11.2 51.2 8.3 15.0 10.2 25.3 25.9 26.5 49.9 34.7 10.2 18.1 25.9 25.6 25.3 19.9 13.9 16.9 28.1 10.9 25.9 20.6 14.9 27.2 25.8 13.8 14.3 10.1 10.4 10.1 25.9 14.8 15.0 16.5 27.3 22.0 31.4 19.8 16.3 9.6 8.4 27.6 40.2 34.1 36.4 12.0 20.5 27.5 19.8 41.4 21.5 33.0 31.7 35.3 22.4 36.0 22.6 17.2 22.7 21.6 16.3 23.0 44.9 12.1 20.6 29.7 15.4 30.7 16.3 60.3 30.4 16.9 16.7 17.0 42.4 22.7 35.9 42.1 13.9 14.9 36.7 13.7 56.9 27.9 23.7 43.8 53.2 50.9 23.4 16.7 34.6 17.1 24.6 17.9 33.2 23.7 39.8 14.3 26.8 21.8 20.6 19.7 25.3 14.4 21.7 23.6 9.0 61.4 20.1 32.4 21.5 29.4 16.5 25.2 9.8 21.6 16.8 26.2 12.2 11.3 28.1 21.6 15.4 13.9 2.5 11.4 17.3 17.8 13.2 16.1 25.6 27.5 26.9 29.5 25.9 26.5 25.9 25.6 25.3 25.9 25.9 27.3 27.6 9.1 0.0 7.2 11.1 19.7 7.0 10.2 12.1 14.2 21.8 12.7 10.9 26.1 7.2 12.4 11.0 8.4 19.2 16.1 7.0 35.2 5.2 1.0 11.1 10.3 8.8 12.1 24.2 16.0 7.8 14.9 12.3 12.8 6.8 9.5 9.5 10.0 26.2 14.1 42.1 16.2 13.4 6.1 19.5 7.0 3.0 10.5 11.0 10.6 15.0 10.7 20.4 12.3 14.6 15.6 5.4 4.0 7.5 25.0 5.1 7.0 42.5 19.5 16.2 0.0 7.9 8.9 29.7 37.0 13.6 8.2 5.5 14.6 19.2 12.1 4.5 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998739-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 445.9;choroid plexus: 194.2;pituitary gland: 101.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7" "Cancer enriched" "Detected in many" 4 "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced NA NA 9000000 "HPA062620: AB_2684810" "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 0.3 33.8 278.0 1.5 333.5 0.0 0.1 271.3 445.9 0.0 194.2 8.5 0.6 0.0 0.0 0.2 0.0 0.2 0.6 324.2 335.5 4.5 0.3 0.5 0.2 318.5 270.1 350.6 0.3 5.7 0.0 101.7 0.0 319.5 0.5 2.3 75.0 0.2 0.2 0.3 0.4 2.4 1.1 228.6 0.1 3.3 0.3 308.8 1.4 0.4 0.0 0.2 0.2 1.2 436.8 0.0 0.0 104.1 0.2 0.0 0.0 0.1 2.6 1.9 0.1 0.1 0.4 0.2 0.0 3.8 0.0 0.1 0.7 0.1 7.2 1.4 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.8 0.4 0.0 0.1 0.0 4.0 0.0 9.0 15.1 2.8 0.0 41.6 0.0 55.5 94.5 0.0 0.1 0.0 2.1 0.1 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 278.0 333.5 271.3 445.9 324.2 335.5 318.5 270.1 350.6 319.5 228.6 308.8 436.8 0.1 0.0 0.0 16.6 0.0 0.8 1.2 1.0 0.0 104.3 0.2 0.3 0.7 0.0 1.8 5.5 8.4 0.0 0.1 0.0 0.0 0.1 2.6 0.2 0.0 1.1 5.3 0.0 78.1 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 297.8 49.3 0.0 30.5 0.0 0.0 0.9 0.0 0.4 0.0 15.0 0.0 16.3 0.0 32.2 18.8 2.3 0.0 0.0 0.0 1.1 0.0 31.9 12.8 50.7 0.0 0.4 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.9 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597875-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 139.6;parathyroid gland: 66.3;seminal vesicle: 67.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 14.7;Endothelial cells: 14.3;Hepatocytes: 26.0;Langerhans cells: 15.6;Peritubular cells: 14.3" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA 420000 "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 4.9 0.7 12.1 3.5 10.3 0.3 3.5 10.4 16.5 4.7 23.7 2.8 1.1 4.8 139.6 1.5 5.7 2.8 4.3 11.2 10.7 7.8 39.9 21.4 15.7 12.0 11.0 9.2 1.1 3.8 66.3 1.7 9.9 11.9 9.1 2.5 1.1 3.6 67.8 16.4 0.7 3.6 8.9 12.2 1.0 4.5 3.8 14.1 1.6 6.9 3.1 8.7 4.0 1.9 15.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.3 0.5 0.1 0.0 0.2 0.0 0.0 25.0 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.1 10.3 10.4 16.5 11.2 10.7 12.0 11.0 9.2 11.9 12.2 14.1 15.3 6.5 0.0 1.7 0.0 0.0 0.6 0.5 0.4 0.6 0.0 0.1 0.1 2.8 2.8 1.0 14.7 0.0 0.2 0.1 0.0 1.9 4.7 6.6 0.1 0.1 14.3 1.8 0.0 0.2 2.2 0.0 1.6 0.0 0.9 1.3 0.7 7.9 26.0 1.6 0.0 0.1 0.1 0.0 1.0 15.6 3.2 0.3 5.4 1.8 4.7 4.2 0.0 0.0 0.0 0.0 1.3 0.6 14.3 0.0 0.5 0.0 5.1 7.5 0.1 0.0 0.9 5.9 0.0 0.2 0.0 0.6 1.9 0.1 0.0 0.1 0.2 RABL3 MGC23920 ENSG00000144840 "RAB, member of RAS oncogene family like 3" Q5HYI8 3 120684938-120742993 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035150, HPA035151, HPA069861" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA035150: AB_2674493, HPA035151: AB_10601154, HPA069861: " "unprognostic (1.69e-2)" "unprognostic (5.10e-2)" "unprognostic (8.32e-2)" "unprognostic (3.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.22e-2)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (2.94e-1)" "unprognostic (2.11e-3)" "unprognostic (2.78e-1)" "prognostic favorable (2.79e-5)" "unprognostic (2.33e-1)" "unprognostic (6.15e-2)" "unprognostic (8.44e-3)" "unprognostic (3.65e-1)" 10.9 16.2 2.2 5.6 2.5 5.4 8.9 2.5 4.1 6.6 2.4 8.2 5.5 7.0 2.8 8.0 6.0 5.7 6.8 1.9 4.2 9.9 9.8 5.6 6.0 2.8 2.6 1.1 9.2 6.4 11.9 6.3 7.0 2.6 6.9 8.6 5.8 7.0 6.6 13.9 6.3 6.1 6.3 2.4 5.6 7.2 4.2 2.2 6.4 12.4 12.0 7.4 7.4 8.0 3.5 20.6 17.8 12.6 3.9 11.7 17.0 11.4 18.8 13.8 10.0 8.3 12.6 6.5 17.3 8.5 15.4 17.6 7.1 14.0 9.2 18.3 14.8 5.9 16.0 12.9 15.7 8.1 31.2 9.1 8.4 11.2 8.9 10.7 11.6 15.1 9.4 14.2 9.7 12.8 20.8 18.2 3.0 6.4 19.9 8.6 7.7 17.4 6.6 9.6 10.0 5.8 4.5 9.2 5.5 5.4 4.8 10.5 9.8 22.1 6.5 7.5 4.8 17.1 5.4 7.9 13.6 16.7 25.4 8.4 3.7 3.6 2.6 4.6 5.6 3.6 3.2 4.5 5.1 6.5 2.6 3.8 4.4 3.7 5.6 3.1 3.4 5.3 3.4 2.2 2.5 2.5 4.1 1.9 4.2 2.8 2.6 1.1 2.6 2.4 2.2 3.5 17.6 9.6 11.7 14.7 11.6 6.4 17.2 17.3 11.4 39.8 13.7 10.0 14.3 12.8 16.7 9.2 116.7 13.3 7.7 13.1 7.9 15.2 25.5 22.3 11.9 12.8 5.4 10.7 11.7 16.2 18.0 13.8 9.7 14.2 8.2 10.4 8.2 18.1 14.7 8.4 10.2 12.7 16.2 10.6 7.2 9.8 5.9 12.0 10.6 2.8 11.4 19.2 9.2 7.5 17.1 14.6 15.8 6.0 11.3 12.2 9.6 26.4 15.7 20.0 0.0 16.5 10.4 26.9 8.5 10.5 11.1 22.0 10.0 16.6 12.1 15.4 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB001701: , HPA036961: AB_2675405" "prognostic favorable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 10.7 6.2 3.3 7.3 3.3 3.4 8.0 3.3 4.2 7.0 8.6 4.8 2.3 6.1 5.0 4.0 4.2 7.0 7.2 2.8 4.8 4.2 3.1 13.6 11.1 4.6 3.3 2.3 1.9 6.8 8.0 2.0 11.4 4.2 6.2 4.1 6.7 5.1 9.4 11.9 2.3 5.5 9.2 3.9 12.0 4.0 2.4 4.1 5.9 5.8 10.0 13.1 6.6 3.4 4.7 2.4 3.0 0.7 0.0 2.4 2.7 0.0 2.1 0.4 1.8 2.3 0.9 2.0 0.6 0.9 3.2 0.1 0.2 2.0 0.0 1.7 23.9 0.2 17.1 0.4 0.0 3.9 0.1 18.5 4.0 0.1 0.9 0.1 0.8 7.3 0.0 1.6 25.3 11.0 0.7 0.0 4.1 6.9 0.2 5.8 0.0 8.2 1.1 1.0 0.9 0.5 0.1 0.0 0.1 6.4 1.0 4.4 10.6 6.0 0.0 1.1 4.6 0.4 24.5 5.8 0.1 3.0 0.0 4.6 13.9 18.7 19.1 0.8 17.2 0.8 11.0 1.9 1.7 11.2 6.8 0.2 0.7 0.6 5.3 13.9 9.8 14.3 7.5 3.3 3.3 3.3 4.2 2.8 4.8 4.6 3.3 2.3 4.2 3.9 4.1 4.7 12.6 9.6 8.6 0.3 5.0 0.8 0.7 0.4 0.0 0.5 1.5 1.9 4.7 2.8 2.7 3.7 4.2 5.8 5.0 0.3 1.9 3.6 0.7 0.2 0.9 9.9 0.0 2.7 0.1 3.2 3.8 2.1 2.6 0.5 10.8 2.5 7.1 1.6 9.4 0.0 0.2 0.2 2.0 12.2 11.1 0.5 0.3 14.8 1.8 4.7 10.2 0.8 4.1 0.0 0.6 2.1 0.5 3.0 3.9 0.7 0.0 1.3 2.1 4.3 0.0 3.6 3.9 0.4 0.6 0.1 0.9 11.8 1.2 0.7 0.2 0.2 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 45.9;ovary: 16.3;retina: 51.0;testis: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 0.2 7.9 19.2 0.4 33.3 0.0 0.2 26.4 24.6 0.7 1.3 2.9 0.2 0.5 1.1 1.2 0.6 0.8 1.6 18.5 26.4 8.3 0.1 0.1 0.1 28.2 27.7 19.6 16.3 3.7 1.3 1.7 0.1 27.1 0.7 0.8 51.0 0.6 0.9 3.9 1.5 0.9 0.5 26.0 0.1 1.6 36.0 24.7 0.3 3.4 5.0 0.2 0.6 0.9 45.9 0.0 8.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 2.7 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.7 0.6 0.0 0.1 35.1 2.1 0.7 0.1 0.0 0.0 1.4 0.0 0.1 11.9 15.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 33.3 26.4 24.6 18.5 26.4 28.2 27.7 19.6 27.1 26.0 24.7 45.9 0.1 0.0 0.0 133.9 0.6 0.4 0.1 0.3 2.8 9.1 0.3 0.1 1.3 0.0 0.5 0.0 75.0 0.2 0.1 0.0 0.0 0.9 257.9 4.2 0.8 0.3 0.0 0.0 77.8 0.7 0.0 2.0 0.0 7.2 0.0 26.8 0.0 0.0 0.0 16.8 139.1 0.0 6.1 0.0 0.4 334.0 3.7 0.4 3.6 4.7 0.0 22.3 0.0 43.2 283.2 0.2 0.0 1.9 0.2 0.1 0.0 5.9 0.4 25.7 0.0 0.8 0.9 22.4 6.0 0.7 0.0 0.1 0.2 6.8 0.0 0.4 ATG3 "APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96" ENSG00000144848 "Autophagy related 3" Q9NT62 3 112532510-112562046 "Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 657.9;Spermatocytes: 341.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037260, HPA040471" Enhanced Supported "Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" "CAB037260: AB_1078236, HPA040471: AB_2677000" "unprognostic (2.77e-2)" "prognostic favorable (6.82e-4)" "unprognostic (4.90e-3)" "unprognostic (1.30e-1)" "unprognostic (2.63e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.35e-6)" "unprognostic (6.79e-2)" "unprognostic (6.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.52e-3)" "unprognostic (4.66e-2)" "unprognostic (6.02e-2)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" 33.4 39.0 44.4 49.5 52.1 94.9 35.0 53.6 50.1 28.6 42.8 38.6 38.6 24.9 25.0 35.1 23.4 24.9 33.6 42.8 49.4 42.0 43.7 31.4 48.8 52.4 51.6 40.1 25.8 42.2 45.2 30.9 33.9 51.5 23.4 40.7 29.4 29.7 28.5 29.7 29.9 36.9 30.1 53.5 48.6 38.1 86.1 48.8 51.7 42.6 33.9 46.7 39.1 26.6 59.0 105.0 55.9 51.5 52.6 66.6 54.5 57.5 89.8 65.3 86.9 78.9 78.9 60.6 130.3 66.6 78.0 106.6 74.1 84.9 78.0 120.9 22.8 40.9 82.0 52.3 51.0 102.9 145.2 67.0 50.6 58.3 85.5 130.2 56.8 82.2 81.2 71.6 108.8 92.9 91.4 86.4 68.2 56.3 135.8 109.7 74.9 45.9 110.5 72.6 56.1 88.1 34.7 74.7 70.5 109.5 48.4 79.8 107.5 66.7 92.3 75.8 39.4 80.1 70.2 72.0 201.3 84.4 133.2 69.4 64.4 167.7 121.9 39.4 258.8 49.4 61.8 48.0 49.2 169.4 59.2 46.2 46.3 174.2 50.5 327.9 36.3 75.6 138.2 44.4 52.1 53.6 50.1 42.8 49.4 52.4 51.6 40.1 51.5 53.5 48.8 59.0 45.6 48.1 39.0 10.1 53.3 74.1 42.4 74.3 37.5 22.5 32.0 50.2 86.2 37.1 51.3 25.8 12.5 73.1 45.3 47.0 117.4 73.7 657.9 37.9 40.8 54.1 31.2 90.0 11.7 86.1 85.0 42.6 36.7 45.2 39.9 42.0 40.0 40.0 121.3 18.5 11.4 53.3 75.3 106.3 131.1 146.5 42.6 134.8 69.4 11.2 185.8 42.1 54.6 13.0 33.7 70.9 49.2 43.2 70.4 39.1 76.0 87.5 37.3 22.2 59.2 45.5 77.6 341.0 119.7 57.4 70.6 122.3 55.0 68.6 69.8 54.2 NR1I2 "BXR, ONR1, PAR2, PXR, SXR" ENSG00000144852 "Nuclear receptor subfamily 1 group I member 2" O75469 3 119780484-119818487 "FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 31.5;liver: 47.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0" "Group enriched" "Detected in some" 24 "colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 15 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 15 "NK-cells: 2.8" "Cell line enriched" "Detected in some" 5 "Hep G2: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029309, HPA055121, HPA073926" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643" "unprognostic (6.76e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (1.24e-4)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" "unprognostic (4.03e-3)" "unprognostic (3.97e-2)" "unprognostic (5.78e-2)" "unprognostic (5.05e-2)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.51e-6)" "unprognostic (4.86e-1)" "unprognostic (6.95e-2)" "unprognostic (3.13e-1)" "unprognostic (6.12e-3)" 0.1 0.1 0.2 1.0 0.1 0.6 0.1 0.0 0.1 0.0 0.1 12.4 28.4 0.0 0.1 0.0 0.1 5.2 0.0 0.1 0.3 0.0 47.8 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.2 0.0 0.0 31.5 0.6 0.1 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 1.5 0.0 1.8 0.0 0.0 0.1 26.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.1 3.1 0.0 0.0 1.7 0.0 32.2 0.2 0.0 0.4 6.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 13.8 0.0 0.1 0.2 51.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.5 9.0 0.0 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 7900000 "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 28.9 5.9 16.3 10.5 13.0 0.2 30.1 16.1 12.5 25.8 29.1 36.7 4.9 47.0 10.2 25.1 63.8 19.5 11.3 17.4 28.3 7.7 1.0 6.6 3.6 51.8 23.7 7.1 35.5 16.2 2.8 21.0 2.2 22.5 34.0 4.7 3.2 24.0 21.5 6.4 35.2 18.5 32.9 31.8 4.6 19.2 5.1 29.7 5.7 24.8 9.1 3.2 32.7 26.0 23.4 0.0 7.6 27.6 79.2 113.6 6.0 0.9 12.8 41.9 3.2 2.7 0.0 0.0 0.1 7.8 21.8 1.7 0.0 5.6 2.7 1.1 0.0 3.4 0.0 2.3 0.0 0.6 0.3 0.2 19.7 1.8 1.7 0.2 25.7 0.0 0.0 0.1 0.0 0.6 2.1 0.2 1.4 7.0 0.0 6.9 0.2 12.3 0.0 0.7 0.1 8.2 11.7 0.1 0.5 0.3 8.1 3.4 0.4 0.0 4.5 7.3 0.1 4.2 0.0 0.0 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 13.0 16.1 12.5 17.4 28.3 51.8 23.7 7.1 22.5 31.8 29.7 23.4 9.6 0.0 0.5 71.8 0.0 21.2 3.1 3.6 112.1 0.6 3.7 17.3 1.1 1.5 0.7 5.5 0.0 4.8 0.2 0.0 0.0 0.1 1.4 12.6 10.5 5.6 1.8 0.0 8.8 0.0 4.3 55.4 0.5 11.7 0.0 5.7 3.3 0.1 0.8 0.0 2.5 0.0 0.0 0.3 5.5 3.3 84.8 1.0 10.6 6.5 0.0 12.2 0.0 24.1 0.7 0.3 0.0 47.8 0.6 3.3 0.0 0.0 0.3 0.5 0.0 18.0 13.5 1.5 3.2 11.5 11.1 1.9 0.8 1.1 0.0 0.9 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor subunit beta" Q9Y5M8 3 133784023-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" NA NA 12000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 20.6 27.0 22.6 18.6 24.2 14.2 25.0 24.4 24.9 26.8 26.8 23.3 19.2 14.6 48.3 30.1 18.1 13.4 16.8 22.9 26.0 26.8 53.4 15.0 15.4 25.8 26.4 22.3 14.0 83.9 27.8 25.6 16.1 25.8 18.3 26.3 6.9 50.3 23.9 19.2 14.7 15.6 21.1 24.9 15.7 24.6 27.1 24.5 10.8 26.4 16.7 29.1 24.0 13.9 30.3 44.8 37.5 22.6 72.7 91.8 62.3 45.6 97.4 49.4 50.2 44.3 73.7 34.6 90.4 131.5 72.4 51.2 64.8 69.8 50.9 47.7 57.8 59.6 80.6 34.9 65.2 110.8 124.5 56.7 57.3 83.3 46.2 135.9 28.1 43.5 43.6 68.1 96.9 55.5 65.6 40.9 55.5 43.8 120.3 63.8 49.1 43.5 190.8 61.9 32.1 74.7 32.7 77.3 66.6 28.3 17.0 76.9 55.1 46.0 51.9 29.0 82.8 54.0 118.8 131.5 131.4 45.3 82.9 56.9 13.1 30.5 3.9 54.3 41.1 73.0 38.9 45.4 47.9 36.3 36.7 43.3 51.9 2.2 41.5 27.5 53.8 29.1 50.3 22.6 24.2 24.4 24.9 22.9 26.0 25.8 26.4 22.3 25.8 24.9 24.5 30.3 16.8 16.0 20.6 15.3 43.4 37.7 32.0 38.2 11.4 6.5 36.4 22.0 26.6 37.1 32.8 36.8 12.5 65.4 29.1 14.2 11.7 46.0 68.9 18.7 51.2 26.3 32.2 21.7 16.0 67.4 71.2 40.6 28.5 30.1 32.4 19.8 18.9 88.4 49.4 6.7 15.7 58.8 36.7 19.7 23.1 35.9 32.0 20.6 35.6 8.4 16.4 17.2 20.6 17.6 92.6 36.0 17.7 27.8 146.0 52.3 20.0 33.0 24.3 9.4 13.1 38.2 30.2 60.1 40.6 52.1 31.5 51.7 26.1 52.9 43.9 28.5 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397775 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5;skeletal muscle: 23.4" "Cell type enhanced" "Detected in many" "Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 55000 "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 1.4 11.4 7.0 1.5 10.5 0.2 1.6 3.9 10.8 2.1 3.1 1.3 0.4 2.4 0.6 9.7 1.7 0.8 5.7 9.3 3.9 0.4 0.1 11.1 1.8 0.0 4.5 6.2 0.3 0.4 3.0 2.2 2.4 2.6 1.0 1.4 35.5 1.3 2.0 23.4 1.4 1.6 5.6 0.0 1.3 1.3 14.0 10.3 1.3 3.1 7.1 2.3 8.4 0.8 3.9 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 0.2 0.0 0.7 1.0 1.8 8.5 0.0 0.0 0.0 0.0 24.2 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 13.8 0.7 0.1 0.3 3.8 0.0 0.0 0.0 4.8 0.1 1.1 0.0 21.0 92.6 0.0 0.1 0.3 5.5 0.2 0.0 0.0 0.1 0.1 0.0 3.4 1.3 0.0 0.7 1.8 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 10.5 3.9 10.8 9.3 3.9 0.0 4.5 6.2 2.6 0.0 10.3 3.9 0.6 3.2 4.6 209.9 0.0 2.4 0.5 0.2 0.0 10.4 1.3 2.8 1.7 1.5 5.0 0.0 102.2 1.8 0.0 0.0 0.0 0.0 80.6 1.0 0.6 1.3 0.0 0.0 357.3 0.4 8.6 4.6 4.1 0.2 1.3 5.5 0.4 0.0 0.3 1.7 475.3 0.0 0.0 0.0 0.8 38.2 0.9 0.1 0.0 33.7 0.0 5.7 0.0 480.0 22.2 0.3 0.0 0.7 1.2 0.2 0.0 0.0 0.0 57.6 0.0 6.8 3.3 17.2 11.2 0.0 1.6 1.1 1.0 4.9 0.0 0.4 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 97.4;placenta: 142.8" "Cell type enhanced" "Detected in some" "Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Group enriched" "Detected in some" 6 "hypothalamus: 6.1;medulla oblongata: 2.2;midbrain: 7.3;pons: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2" "Low region specificity" "Detected in all" HPA003596 Enhanced Uncertain Vesicles NA NA Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 52.7 38.5 0.3 1.8 0.7 0.0 40.2 0.3 0.4 3.4 0.4 15.3 0.9 3.5 2.8 2.8 9.9 6.3 7.7 0.4 6.1 18.6 97.4 10.5 0.7 2.2 7.3 0.2 3.9 3.5 2.9 3.9 142.8 2.6 5.4 4.4 0.9 4.8 4.2 11.7 12.9 4.3 4.6 0.2 9.1 6.5 2.2 0.5 3.0 14.3 13.9 0.2 14.7 6.2 0.3 0.0 1.0 0.8 0.0 176.8 24.4 0.0 0.2 3.9 34.8 20.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 53.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 32.2 0.0 3.4 1.8 1.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.4 0.4 6.1 2.2 7.3 0.2 2.6 0.2 0.5 0.3 20.5 0.0 0.6 0.0 0.0 3.4 0.2 0.0 0.0 0.0 1.3 0.9 6.3 2.8 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.1 0.8 0.0 0.3 3.8 23.5 0.0 0.1 7.6 0.3 53.1 0.5 0.0 0.0 0.0 17.5 30.9 0.7 0.0 0.0 0.2 0.0 0.3 3.5 1.7 145.1 0.5 1.8 2.8 0.0 5.7 0.0 0.0 0.1 0.5 0.0 7.5 0.4 1.1 0.0 0.1 0.0 0.1 144.7 7.6 71.2 0.0 1.8 0.3 1.7 0.3 0.5 0.3 0.0 0.1 MED12L "KIAA1635, TNRC11L, TRALP, TRALPUSH" ENSG00000144893 "Mediator complex subunit 12L" Q86YW9 3 151085697-151437072 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.5;choroid plexus: 20.4" "Group enriched" "Detected in many" 4 "Astrocytes: 383.3;Excitatory neurons: 302.4;Inhibitory neurons: 120.7;Oligodendrocyte precursor cells: 225.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.3;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.5;HEL: 20.9;JURKAT: 13.0;MOLT-4: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036807 Enhanced Approved Nucleoli NA NA Nucleoli "HPA036807: AB_10670242" "unprognostic (1.01e-2)" "unprognostic (5.82e-2)" "unprognostic (5.12e-2)" "unprognostic (8.14e-4)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (1.23e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (1.38e-3)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (4.36e-3)" "unprognostic (3.84e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" 0.7 1.5 1.5 0.4 3.0 4.4 0.2 0.6 6.5 0.8 20.4 0.2 1.0 0.4 1.9 0.1 0.3 0.5 0.2 2.5 1.1 0.1 0.0 0.2 1.0 1.0 1.3 2.7 0.2 0.1 0.2 1.7 1.2 1.6 0.6 0.0 3.0 0.3 0.3 0.3 0.1 0.4 0.3 0.0 0.4 0.2 4.6 2.0 0.5 0.4 0.0 1.0 0.3 0.4 1.3 0.9 0.4 2.9 0.2 0.1 0.1 18.5 0.0 0.3 0.7 0.8 1.0 0.3 0.0 0.2 0.1 2.1 0.1 3.8 0.3 0.8 0.0 1.8 20.9 0.1 0.1 0.0 0.7 7.1 0.0 0.1 0.1 0.1 0.1 0.0 13.0 0.0 3.1 0.0 3.1 9.9 0.0 3.4 0.1 0.7 0.1 1.1 0.5 0.3 3.0 4.9 0.7 0.4 0.2 0.0 5.2 1.0 0.1 0.0 0.0 2.2 0.0 1.5 5.9 0.0 7.3 0.2 1.8 1.1 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 1.5 3.0 0.6 6.5 2.5 1.1 1.0 1.3 2.7 1.6 0.0 2.0 1.3 0.1 0.0 0.0 383.3 1.0 1.1 1.1 0.3 2.8 11.1 0.5 0.4 1.2 0.0 1.3 1.8 4.2 18.6 0.4 0.2 0.0 0.1 13.2 1.1 0.4 0.4 0.0 13.0 302.4 0.6 1.5 0.9 0.0 0.3 0.0 0.2 0.4 0.2 1.9 33.7 120.7 0.0 0.0 1.6 1.1 7.3 0.9 1.7 0.0 52.5 1.3 26.2 0.0 225.7 9.6 0.2 0.0 0.4 1.3 1.1 0.0 0.5 0.9 1.9 0.0 0.3 0.5 8.2 4.3 0.4 0.1 27.0 0.2 1.1 0.0 0.4 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150586016 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Uncertain Mitochondria,Cytosol No No 16000 Mitochondria Cytosol "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 57.5 54.5 15.6 48.2 19.1 87.6 104.4 27.9 25.7 64.4 23.7 58.4 66.1 70.3 47.4 65.3 63.2 56.2 73.0 16.4 18.7 72.8 75.8 48.1 69.0 17.5 18.0 14.6 95.8 108.1 63.3 33.0 52.8 18.7 53.2 71.5 52.8 77.8 47.5 88.0 74.6 55.8 68.9 18.2 47.8 60.3 24.5 16.3 69.3 92.9 77.4 84.0 68.2 43.7 21.3 158.0 69.4 76.6 79.9 100.8 234.3 105.0 97.3 158.0 134.1 143.0 202.5 168.9 212.0 142.4 134.3 160.1 125.1 149.9 152.9 193.5 81.3 91.6 129.4 76.1 130.9 101.1 155.0 113.0 151.4 153.6 97.2 221.9 200.7 180.3 112.3 109.8 116.5 105.5 121.3 109.6 70.6 108.4 161.3 98.7 97.5 101.1 238.8 119.9 116.9 93.7 102.1 62.6 88.0 144.5 91.6 130.9 127.3 99.9 76.3 69.3 109.2 186.6 194.9 119.6 195.0 96.4 130.5 39.5 23.6 47.2 10.4 27.9 49.5 46.1 36.2 40.6 35.7 54.2 34.7 51.5 41.6 3.7 46.1 56.9 26.5 37.0 44.4 15.6 19.1 27.9 25.7 16.4 18.7 17.5 18.0 14.6 18.7 18.2 16.3 21.3 77.7 35.3 67.1 14.4 91.4 140.1 157.3 109.8 109.3 30.6 86.0 76.5 102.4 58.6 69.2 35.0 27.1 84.1 85.7 43.1 137.0 76.1 21.5 39.6 64.3 67.5 56.8 80.3 30.4 108.3 113.6 63.8 64.7 51.4 75.5 45.0 60.0 30.6 62.4 23.5 33.1 81.7 54.9 96.4 82.8 6.6 61.5 72.7 69.4 19.7 97.4 37.2 73.2 32.6 34.7 64.0 57.7 56.4 112.1 79.6 77.0 138.4 41.7 31.2 78.9 95.4 77.9 40.4 41.9 102.3 122.9 120.3 95.0 55.1 99.0 130.4 ALDH1L1 "10-fTHF, FDH, FTHFD" ENSG00000144908 "Aldehyde dehydrogenase 1 family member L1" O75891 3 126103562-126197994 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 372.7" "Group enriched" "Detected in many" 4 "Hepatocytes: 633.3;Proximal tubular cells: 197.4" "Cancer enriched" "Detected in many" 4 "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036900, HPA050139" Enhanced Supported Supported Cytosol No No 3000000 Cytosol "HPA036900: AB_10672273, HPA050139: AB_2681031" "unprognostic (5.93e-2)" "unprognostic (1.22e-1)" "unprognostic (9.12e-2)" "unprognostic (2.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (4.73e-2)" "unprognostic (3.05e-3)" "unprognostic (8.40e-2)" "prognostic favorable (2.42e-8)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (7.03e-3)" "unprognostic (7.93e-2)" 77.1 37.5 50.2 2.0 52.4 0.4 29.1 52.7 64.1 15.8 33.7 9.7 0.2 7.3 2.5 6.7 16.2 2.3 18.5 44.3 49.0 117.7 372.7 3.1 0.3 52.6 48.8 42.1 45.7 44.7 15.3 4.5 0.0 50.2 14.7 5.4 8.8 89.4 7.0 91.5 3.2 5.6 2.1 41.5 0.4 9.5 15.1 48.1 3.7 2.6 60.5 4.6 28.6 6.5 42.1 1.3 0.0 0.0 0.0 36.5 0.0 0.4 0.3 1.5 0.4 0.6 0.0 3.2 2.6 10.2 0.0 2.1 0.4 0.6 1.5 0.7 0.0 0.2 0.1 0.3 78.1 10.6 10.6 0.2 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 82.0 1.6 0.0 0.0 0.2 0.3 1.1 0.0 0.1 0.2 45.0 0.7 219.1 0.4 0.3 1.3 10.6 0.0 0.6 0.1 0.0 0.3 1.4 6.2 0.0 0.1 44.8 14.8 0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 52.4 52.7 64.1 44.3 49.0 52.6 48.8 42.1 50.2 41.5 48.1 42.1 0.8 0.0 6.0 92.7 4.6 0.1 53.5 9.1 1.8 0.2 14.4 2.2 16.1 38.6 44.0 12.9 0.0 0.0 0.1 7.2 72.4 2.9 22.3 57.2 5.2 4.6 1.2 34.7 0.6 5.6 0.2 9.1 0.0 3.6 27.8 12.4 17.2 633.3 0.1 0.0 3.0 17.6 2.0 24.5 1.9 35.0 26.4 9.3 3.6 3.7 0.0 40.0 0.0 11.1 0.2 2.2 0.4 22.6 0.0 12.2 0.8 197.4 32.2 1.4 6.6 10.5 5.3 1.6 4.3 1.7 0.0 0.1 2.8 0.9 5.6 61.7 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595497 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.8;tongue: 80.8" "Cell type enhanced" "Detected in many" "Kupffer cells: 74.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 10.1 5.5 11.9 11.0 12.8 7.1 6.1 9.4 10.6 6.3 5.2 8.3 6.8 7.6 5.6 8.5 5.7 6.5 6.7 9.6 13.8 8.6 29.2 14.1 13.2 11.2 12.9 7.7 5.6 3.8 13.4 4.0 11.0 12.1 5.6 8.2 6.1 4.3 7.8 57.8 7.6 6.3 8.9 10.1 15.5 5.2 10.4 11.7 12.5 7.4 80.8 12.3 8.5 4.9 12.2 21.2 10.9 20.4 11.7 22.4 12.0 27.5 15.6 11.9 18.7 21.3 21.3 7.2 34.2 19.2 12.5 15.5 15.5 22.7 13.3 24.7 9.6 10.2 15.6 12.5 14.0 12.6 11.9 20.8 9.7 15.8 15.6 13.6 7.5 13.8 16.2 16.5 15.0 17.1 12.2 24.4 5.8 28.8 15.1 10.0 21.1 11.8 40.4 15.5 12.6 4.6 12.4 18.9 10.6 16.3 13.9 11.2 6.1 14.8 15.2 13.9 22.4 12.2 9.8 11.1 41.5 10.7 4.1 14.9 16.5 12.3 3.1 2.1 12.1 1.8 4.3 1.3 2.2 14.9 3.3 1.4 1.6 18.2 2.5 10.1 6.2 2.9 4.5 11.9 12.8 9.4 10.6 9.6 13.8 11.2 12.9 7.7 12.1 10.1 11.7 12.2 14.4 9.6 14.4 33.3 16.0 9.9 7.3 3.9 10.8 18.7 12.1 11.6 9.4 7.2 9.9 9.2 12.5 12.4 22.8 29.1 5.9 8.5 1.3 34.5 13.7 9.7 4.2 9.4 14.8 6.9 10.3 9.4 6.6 24.3 3.8 10.6 10.8 37.6 26.6 8.4 18.6 6.0 0.0 74.0 27.5 4.0 6.5 40.3 12.4 38.4 48.6 12.2 13.4 15.1 18.1 11.4 21.3 7.2 10.5 7.8 10.7 9.7 8.9 33.8 6.6 18.0 10.5 13.0 18.6 9.2 15.8 23.1 11.1 5.3 9.5 10.4 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724034-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Astrocytes: 93.7;Excitatory neurons: 144.6;Granulosa cells: 91.8;Inhibitory neurons: 184.4;Microglial cells: 49.6;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 164.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles NA NA Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 5.0 4.7 7.0 1.9 8.5 0.3 4.8 11.5 8.1 8.9 6.2 5.9 1.2 11.2 5.3 3.6 8.7 5.4 10.2 8.5 7.5 3.3 0.8 3.4 1.9 7.7 7.4 7.5 14.4 1.5 6.5 10.4 3.5 8.3 7.1 2.5 23.0 2.9 7.8 1.2 3.6 3.9 10.7 6.5 2.9 3.3 4.9 6.4 1.5 5.2 3.7 1.0 6.3 7.0 8.5 4.2 5.7 10.8 1.2 9.7 23.9 4.8 6.8 10.5 8.4 12.2 1.7 1.1 0.0 2.1 7.0 14.2 0.3 3.0 3.2 12.2 1.0 4.1 6.8 2.6 2.9 4.0 0.4 0.0 11.4 3.2 7.9 9.4 14.2 4.9 0.0 0.2 0.0 12.1 2.6 0.4 0.5 6.0 0.1 3.1 0.0 5.0 0.0 5.9 0.1 6.7 4.8 8.1 0.0 1.5 9.9 3.3 0.1 4.3 10.1 1.6 14.0 9.1 3.9 1.8 2.1 7.7 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.0 8.5 11.5 8.1 8.5 7.5 7.7 7.4 7.5 8.3 6.5 6.4 8.5 6.2 3.2 0.5 93.7 2.9 2.9 1.6 1.2 7.4 17.9 0.9 1.8 12.0 1.5 0.6 5.5 16.7 0.2 0.3 0.0 0.0 0.3 3.6 0.5 10.8 4.6 1.8 0.4 144.6 0.2 0.2 13.2 0.0 0.9 0.0 91.8 3.6 0.0 0.1 13.5 184.4 0.0 0.0 0.0 1.6 2.9 8.4 0.5 1.8 49.6 0.1 7.7 0.0 154.8 164.8 0.1 0.0 10.9 1.5 0.9 0.0 0.7 3.0 16.0 0.0 10.4 12.0 9.8 2.8 0.7 1.1 0.3 2.2 1.7 0.0 0.3 NCEH1 "AADACL1, KIAA1363, NCEH" ENSG00000144959 "Neutral cholesterol ester hydrolase 1" Q6PIU2 3 172630249-172711218 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.2;Pancreatic endocrine cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 287.7;LHCN-M2: 133.1;U-251 MG: 132.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026888, HPA043873" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" No No "Endoplasmic reticulum" "HPA026888: AB_10601557, HPA043873: " "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (5.74e-2)" "unprognostic (1.27e-1)" "unprognostic (6.88e-3)" "unprognostic (5.41e-2)" "unprognostic (3.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (5.29e-2)" "unprognostic (2.96e-2)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (2.81e-2)" "unprognostic (2.28e-1)" 3.8 16.4 7.4 8.8 14.3 8.4 5.6 4.8 29.6 4.3 0.5 11.7 4.2 4.6 3.3 4.0 3.4 6.9 11.8 16.4 12.5 21.7 5.0 20.1 14.4 11.4 7.4 14.9 1.5 4.8 8.0 3.2 6.8 13.4 6.7 12.1 19.8 10.4 4.5 6.2 1.3 4.8 3.4 4.2 11.3 12.9 1.6 11.7 4.9 4.5 7.5 11.3 8.6 2.1 23.6 98.1 55.3 1.9 3.0 3.3 3.4 7.8 71.8 47.5 46.5 27.2 14.0 287.7 8.1 105.4 43.4 44.4 19.2 2.0 35.1 107.0 27.1 4.5 5.6 8.5 10.8 3.9 14.8 19.9 1.7 3.5 32.3 47.5 43.6 31.5 4.4 1.4 6.9 133.1 8.0 2.5 5.1 2.6 27.4 43.5 2.3 5.2 10.0 83.0 12.6 1.6 0.8 43.6 45.2 9.6 3.1 15.4 6.8 86.9 71.3 10.7 34.1 132.0 8.2 16.4 6.8 53.3 14.1 55.4 6.8 17.9 0.7 2.6 11.6 1.7 3.3 1.6 1.9 12.8 2.2 1.6 2.0 0.6 3.4 7.8 0.7 1.7 6.4 7.4 14.3 4.8 29.6 16.4 12.5 11.4 7.4 14.9 13.4 4.2 11.7 23.6 6.6 48.1 17.9 35.9 6.6 6.8 18.3 5.2 1.8 14.8 11.5 3.7 31.6 22.8 20.1 16.5 22.9 9.0 4.7 43.0 3.9 64.1 7.5 41.2 6.4 8.5 7.8 50.5 83.2 31.0 5.2 6.6 25.0 64.1 5.1 5.5 6.8 2.4 49.7 5.0 68.2 11.5 4.1 42.8 15.2 4.1 0.9 32.8 5.4 22.5 12.2 5.4 3.1 15.6 5.4 72.9 13.0 2.6 2.9 30.6 7.3 24.6 27.4 20.5 6.6 8.6 7.0 0.0 1.1 4.3 3.4 10.5 4.6 9.3 7.8 27.3 SPATA16 NYD-SP12 ENSG00000144962 "Spermatogenesis associated 16" Q9BXB7 3 172889357-173141235 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 601 "testis: 60.0" "Group enriched" "Detected in some" 49 "Early spermatids: 288.6;Late spermatids: 129.3;Spermatocytes: 192.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037884 Enhanced NA NA "HPA037884: AB_2675717" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 288.6 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 129.3 4.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 192.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM86B2 ENSG00000145002 "Family with sequence similarity 86 member B2" P0C5J1 8 12425614-12436343 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.2;Early spermatids: 1.6;Granulosa cells: 2.7;Late spermatids: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTERT-HME1: 5.3;RPMI-8226: 12.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (3.75e-2)" "unprognostic (1.87e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (3.26e-2)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.48e-1)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (6.04e-4)" "unprognostic (9.37e-2)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.13e-2)" 0.3 0.4 0.1 0.1 0.2 0.0 0.4 0.1 0.3 0.4 0.1 0.3 0.1 0.5 0.0 0.9 1.4 0.1 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.2 0.3 0.1 0.6 0.6 0.4 1.0 0.0 0.2 0.4 0.1 0.1 0.4 0.4 0.1 0.3 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.9 0.0 0.0 0.4 0.4 0.2 0.2 0.6 0.1 0.0 0.2 1.1 1.3 0.2 0.6 0.4 1.0 0.4 1.1 0.7 0.0 1.2 0.3 0.2 0.9 1.5 0.0 0.0 0.0 0.2 0.9 0.0 1.0 0.0 0.0 0.3 1.3 1.3 5.3 0.0 0.0 0.0 1.1 0.2 0.0 0.3 0.0 0.3 1.0 1.9 0.4 0.1 0.1 12.5 0.0 0.9 1.6 0.0 0.4 1.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.2 0.1 0.3 0.2 0.2 0.2 0.3 0.1 0.2 0.0 0.2 0.2 0.1 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 2.7 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 LPP ENSG00000145012 "LIM domain containing preferred translocation partner in lipoma" Q93052 3 188153284-188890671 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 566.5;Late spermatids: 1737.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 18.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 97.0;EFO-21: 115.2;U-698: 200.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011133, HPA017342" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 2700000 "Focal adhesion sites, Cytosol" "HPA011133: AB_1853247, HPA017342: AB_1853249" "unprognostic (1.50e-1)" "unprognostic (4.97e-3)" "unprognostic (1.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.86e-1)" "unprognostic (4.05e-1)" "unprognostic (2.43e-3)" "unprognostic (7.97e-2)" "unprognostic (2.17e-1)" "unprognostic (5.56e-2)" "unprognostic (3.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.57e-3)" "unprognostic (2.25e-2)" "unprognostic (6.86e-2)" "unprognostic (2.82e-3)" "unprognostic (1.48e-1)" 24.2 10.9 6.1 28.7 6.5 10.0 19.0 7.9 10.2 27.5 34.2 56.1 13.9 62.4 11.9 49.8 32.5 21.5 16.8 4.9 21.7 11.6 12.2 19.3 17.3 15.8 5.7 0.8 14.8 8.9 10.0 2.9 11.6 11.1 39.3 32.0 2.4 12.1 53.6 12.5 11.2 23.2 82.0 6.8 10.9 33.0 18.7 12.0 8.0 8.8 9.2 21.5 57.5 22.3 13.3 25.6 23.3 16.7 11.3 35.3 36.0 17.9 16.0 20.9 11.8 7.8 42.2 12.1 97.0 115.2 37.3 14.7 10.7 5.2 11.0 29.5 10.7 5.7 4.6 18.4 11.1 15.0 2.0 5.5 25.7 15.3 26.4 22.5 16.9 20.1 5.2 0.2 2.0 21.0 8.1 5.1 2.1 6.6 16.3 7.6 6.2 12.3 0.5 13.1 26.8 1.1 0.3 35.3 11.4 19.2 27.3 9.0 8.8 43.7 27.1 20.8 19.6 41.1 0.2 4.0 200.0 13.6 4.3 24.9 0.8 4.9 2.2 5.1 4.5 3.3 3.3 4.5 3.8 2.6 5.6 2.4 2.9 18.9 4.8 4.6 5.3 1.8 1.9 6.1 6.5 7.9 10.2 4.9 21.7 15.8 5.7 0.8 11.1 6.8 12.0 13.3 104.7 89.8 69.8 357.5 48.5 78.0 84.9 65.0 70.0 9.5 141.8 111.5 143.0 100.1 86.2 69.9 14.6 44.7 65.7 207.1 29.4 139.7 566.5 49.3 134.4 91.8 77.5 12.0 132.8 90.9 24.1 124.9 97.9 93.6 18.3 136.6 126.4 94.8 42.5 5.0 191.2 91.7 44.7 65.1 121.0 1737.1 225.3 75.8 80.0 308.2 55.8 24.8 54.6 395.6 214.9 120.2 158.1 476.9 24.6 172.5 127.5 80.2 60.9 7.1 335.2 159.2 368.2 9.8 8.0 64.2 68.2 18.6 55.3 46.8 151.3 149.3 TMEM44 DKFZp686O18124 ENSG00000145014 "Transmembrane protein 44" Q2T9K0 3 194587673-194633689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 31.2;Hepatic stellate cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 3.7;NK-cell: 8.1" "Group enriched" "Detected in many" 10 "granulocytes: 3.7;NK-cells: 8.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043718 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA043718: AB_10794662" "unprognostic (8.94e-2)" "unprognostic (1.01e-1)" "unprognostic (8.31e-3)" "unprognostic (4.53e-2)" "unprognostic (2.78e-3)" "unprognostic (9.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (6.55e-13)" "unprognostic (1.23e-2)" "unprognostic (3.36e-1)" "unprognostic (1.65e-3)" "unprognostic (5.66e-2)" 9.9 2.9 9.4 2.4 10.4 5.3 9.0 7.1 12.4 6.8 6.8 7.9 2.7 5.7 13.8 5.7 5.4 4.6 8.1 9.5 9.0 6.0 3.4 11.4 3.0 9.1 8.4 8.6 5.0 3.6 0.9 2.6 7.5 9.3 5.2 7.3 0.6 7.7 2.3 3.2 3.5 6.8 3.3 7.7 9.3 5.0 2.2 9.3 2.0 5.7 2.3 1.6 5.4 5.9 8.7 11.1 9.1 13.4 14.2 4.8 16.2 11.8 8.2 15.3 6.8 10.8 5.0 21.8 2.0 38.9 10.0 20.3 12.6 4.5 6.4 4.6 18.1 6.3 12.4 10.6 3.8 8.7 3.9 18.9 10.0 6.8 15.4 6.8 32.8 28.2 12.1 3.4 0.5 22.9 10.1 5.9 9.9 6.9 11.1 14.8 11.5 8.4 0.3 7.2 6.3 3.7 7.7 6.1 1.9 12.6 5.6 9.0 8.5 33.7 20.8 7.6 6.4 11.2 1.5 1.2 4.0 31.4 15.0 10.4 3.7 0.2 0.2 0.4 0.1 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.2 0.4 8.1 0.3 0.4 0.0 0.0 9.4 10.4 7.1 12.4 9.5 9.0 9.1 8.4 8.6 9.3 7.7 9.3 8.7 22.0 0.0 2.3 3.3 2.1 0.5 3.3 4.9 1.8 0.9 2.8 2.3 1.7 1.5 6.0 5.5 2.1 9.5 1.7 31.2 0.0 5.7 0.6 2.3 3.7 23.8 6.0 4.0 12.7 4.9 4.0 6.0 22.4 2.0 17.7 10.6 53.2 0.6 3.5 0.0 5.4 25.2 6.1 1.3 3.4 0.3 3.1 1.5 1.8 12.2 0.1 0.5 2.1 2.5 1.5 14.9 21.0 1.9 1.3 6.0 3.9 0.4 7.5 0.6 6.6 1.8 3.6 0.5 6.5 2.4 0.6 8.8 1.9 6.0 21.0 6.3 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "Rubicon autophagy regulator" Q92622 3 197668867-197749727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.0" "Cell type enhanced" "Detected in many" "monocytes: 67.5;Plasma cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA050908: , HPA054497: AB_2682507" "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 8.1 7.6 15.4 11.7 16.4 8.6 7.3 9.1 15.2 9.3 3.7 9.7 7.3 8.9 4.1 12.1 8.6 7.3 10.4 16.5 46.0 7.7 5.6 11.9 15.4 19.5 17.0 13.2 10.8 9.2 6.9 15.9 5.9 14.8 7.5 5.7 11.0 7.4 7.3 9.0 8.9 13.2 7.8 14.3 19.3 8.2 14.7 20.3 8.8 7.1 8.2 16.2 9.0 8.5 16.0 30.9 7.4 8.2 16.2 14.4 8.3 8.6 13.8 9.2 17.0 14.2 12.7 8.4 33.6 26.7 15.8 16.1 17.0 15.0 8.0 13.6 9.3 13.9 21.6 13.4 4.9 8.4 12.0 18.0 7.0 9.6 14.8 17.6 7.9 10.7 14.4 12.3 87.7 11.5 24.4 15.7 7.5 7.1 8.8 23.2 14.9 8.6 22.6 9.6 13.9 34.3 7.9 10.2 19.8 10.8 5.5 29.2 8.1 13.7 9.9 9.9 27.8 18.9 36.5 34.2 27.0 13.6 22.4 8.7 0.8 2.6 17.5 3.7 3.9 2.4 7.7 3.1 4.7 1.6 8.5 2.2 3.2 2.9 1.8 4.8 16.6 4.4 1.7 15.4 16.4 9.1 15.2 16.5 46.0 19.5 17.0 13.2 14.8 14.3 20.3 16.0 8.5 6.4 11.2 0.0 33.9 0.0 6.0 0.0 8.0 21.0 7.3 7.0 0.0 7.2 4.3 12.9 18.8 1.8 28.9 3.8 1.9 5.8 21.7 4.8 6.2 6.7 0.0 5.7 0.0 6.4 3.7 4.8 7.1 9.8 2.5 6.1 9.3 3.5 9.2 21.9 0.0 3.7 0.0 16.3 0.0 16.4 5.0 18.7 0.0 0.0 67.5 15.0 14.4 0.0 0.0 8.5 1.5 6.4 48.3 8.9 5.8 2.7 0.7 14.3 6.6 9.7 6.8 34.1 21.3 5.6 0.0 6.4 15.9 4.9 2.8 12.3 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416778-49422685 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 49.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0" HPA005566 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.6 12.9 8.5 1.2 9.0 8.9 5.7 9.6 11.8 11.3 11.1 12.3 13.9 6.8 8.3 3.5 10.2 5.8 21.8 8.1 9.8 23.4 49.5 5.5 2.1 8.7 8.7 8.0 12.6 19.7 14.3 12.0 2.3 8.8 11.4 11.9 6.6 10.7 8.6 3.1 4.5 12.2 3.7 8.6 6.3 11.2 3.0 8.5 3.8 5.8 4.3 1.5 8.1 6.5 8.6 0.1 0.7 1.4 0.4 0.6 0.0 17.1 0.0 0.4 0.1 0.3 0.5 0.6 0.0 0.2 0.4 0.0 0.3 0.1 0.7 0.1 0.3 0.0 0.0 0.5 47.5 1.8 0.0 0.0 0.6 1.8 0.0 0.7 1.3 0.6 0.2 0.0 0.0 0.2 0.4 0.1 0.1 8.0 0.0 0.2 0.0 0.5 1.0 0.8 0.4 0.0 14.9 0.2 0.0 1.1 9.0 0.1 0.3 0.6 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 3.2 0.0 1.7 0.0 0.5 0.0 0.0 4.2 0.2 1.2 0.9 0.1 7.9 0.5 0.3 0.0 1.3 8.5 9.0 9.6 11.8 8.1 9.8 8.7 8.7 8.0 8.8 8.6 8.5 8.6 1.2 3.2 9.2 11.4 3.6 2.8 12.1 3.1 3.4 17.4 1.2 1.3 21.8 14.3 6.3 0.0 20.9 25.6 1.4 13.8 0.0 0.8 2.5 0.7 1.6 3.2 12.7 8.8 8.7 0.7 8.8 4.5 15.8 1.0 7.6 2.0 3.9 42.4 5.0 8.4 8.5 18.4 2.0 3.8 2.9 1.6 10.5 2.6 5.4 7.5 1.8 26.0 7.2 6.0 6.6 0.6 18.9 6.4 1.1 6.7 33.3 1.1 6.6 19.3 6.6 5.2 3.1 1.9 0.3 2.2 2.7 10.3 3.8 1.0 31.6 10.9 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol NA NA Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favorable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 21.9 48.4 47.1 13.2 48.7 12.4 21.7 47.8 53.4 23.4 43.6 23.8 19.1 23.3 61.1 15.7 26.4 16.7 21.6 46.2 47.0 51.2 42.2 23.7 15.9 49.3 49.0 44.9 27.3 24.3 40.2 49.2 14.6 49.4 34.8 29.0 14.1 22.0 25.3 19.7 13.9 23.3 22.0 46.4 26.2 23.5 15.8 49.0 20.3 45.7 13.9 16.1 25.7 16.0 49.2 12.8 15.5 9.8 14.8 42.5 18.5 12.9 26.0 19.2 25.8 21.6 9.1 13.6 15.2 18.6 61.5 29.6 14.4 19.3 26.2 21.0 22.9 13.4 25.4 19.6 11.9 25.8 10.9 31.9 40.2 26.8 28.7 22.9 24.7 27.0 12.0 9.4 33.8 63.8 11.7 13.4 9.8 8.0 24.1 35.5 8.1 10.6 36.0 44.5 16.7 26.3 8.7 30.9 33.8 28.6 19.7 28.8 10.2 24.5 19.3 11.9 40.4 9.8 18.4 26.1 10.4 45.4 19.3 27.2 20.4 17.8 23.2 19.1 34.2 11.1 12.0 12.0 14.7 10.1 13.7 14.9 15.5 20.1 23.0 47.5 15.6 17.8 22.4 47.1 48.7 47.8 53.4 46.2 47.0 49.3 49.0 44.9 49.4 46.4 49.0 49.2 15.5 25.6 15.6 8.8 19.3 2.7 10.0 10.3 14.2 10.2 19.9 18.0 14.1 20.0 12.9 27.6 12.5 25.9 20.5 34.0 46.9 15.3 8.0 15.5 15.0 14.7 17.5 9.0 12.3 11.6 11.5 17.6 53.5 17.0 5.7 7.1 11.4 31.8 24.8 10.1 11.0 19.1 20.3 18.6 6.0 14.3 15.5 19.2 14.2 11.2 15.5 26.3 26.8 11.1 16.8 15.1 28.6 16.1 13.2 13.4 34.9 50.3 22.8 11.3 6.6 13.7 16.6 8.2 6.1 10.4 4.5 20.0 21.6 22.1 16.6 7.9 NICN1 MGC12936 ENSG00000145029 "Nicolin 1" Q9BSH3 3 49422333-49429326 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 24.3;Late spermatids: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058014 Supported Nucleoplasm NA NA Nucleoplasm "HPA058014: AB_2683579" "unprognostic (4.10e-2)" "unprognostic (1.08e-2)" "unprognostic (7.31e-2)" "unprognostic (1.33e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.50e-3)" "unprognostic (1.04e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.46e-1)" "prognostic favorable (8.81e-7)" "unprognostic (3.11e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-2)" "unprognostic (2.96e-2)" 7.9 11.3 20.2 4.6 23.0 2.6 7.9 17.8 24.2 9.8 16.2 10.3 4.3 10.6 8.2 5.9 10.2 5.5 11.4 22.2 20.9 12.3 10.6 8.4 7.0 19.6 19.2 22.4 11.2 7.6 10.0 11.7 4.5 21.4 11.6 4.0 9.1 9.2 6.8 12.6 6.4 8.0 6.6 18.5 10.0 9.8 11.9 20.1 10.6 13.7 10.0 6.5 9.1 8.2 22.5 3.7 10.9 11.8 9.6 5.1 6.1 3.8 4.6 4.0 3.8 5.2 2.6 10.9 10.8 4.0 9.1 8.0 3.1 6.4 5.6 4.3 18.2 4.2 10.6 12.2 13.0 9.5 4.2 6.6 13.0 7.2 8.7 3.1 19.8 5.8 22.6 6.5 0.2 4.2 3.5 6.7 6.3 3.5 4.1 3.4 5.9 3.8 13.5 7.0 2.1 1.9 4.6 3.8 3.1 8.0 22.1 5.9 2.1 12.2 3.1 3.2 3.0 1.7 13.7 4.1 3.7 9.3 11.6 5.1 5.3 3.7 3.1 4.1 3.1 2.7 5.0 2.4 5.0 3.3 2.1 3.1 3.7 0.8 4.1 5.2 4.2 6.2 3.8 20.2 23.0 17.8 24.2 22.2 20.9 19.6 19.2 22.4 21.4 18.5 20.1 22.5 0.0 0.0 1.1 4.9 3.7 4.1 5.6 7.6 1.8 6.8 0.0 0.0 14.3 5.7 3.3 0.0 10.4 6.2 4.0 2.3 0.0 0.0 24.3 0.0 0.0 2.9 12.1 6.5 4.4 0.0 2.2 3.3 8.6 0.0 1.3 0.0 3.9 5.5 5.8 3.3 4.9 4.2 0.0 5.2 3.0 52.7 9.6 1.7 3.6 1.9 1.0 6.2 9.2 3.0 2.9 0.0 1.6 6.0 3.5 2.2 5.4 0.0 3.0 6.8 6.6 4.7 2.8 11.0 2.3 3.3 3.3 3.3 3.8 0.1 3.4 4.6 UCN2 "SRP, UCN-II, UCNI, URP" ENSG00000145040 "Urocortin 2" Q96RP3 3 48561718-48563781 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 13.2;vagina: 4.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 2.9;Basal respiratory cells: 1.4" "Cancer enriched" "Detected in many" 5 "melanoma: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 18.8;hTCEpi: 27.3;hTEC/SVTERT24-B: 21.5;SiHa: 19.1;U-251 MG: 20.7;WM-115: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA066841 Uncertain Approved Vesicles "Secreted to blood" NA NA 98600 Vesicles "HPA066841: AB_2685735" "unprognostic (7.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (1.96e-2)" "unprognostic (2.39e-2)" "unprognostic (4.26e-2)" "unprognostic (1.92e-3)" "unprognostic (2.02e-3)" "unprognostic (1.62e-1)" "unprognostic (2.93e-3)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (3.34e-14)" "unprognostic (4.39e-2)" "unprognostic (2.75e-1)" "unprognostic (1.36e-1)" "unprognostic (2.88e-2)" 0.0 0.0 0.3 0.3 0.2 0.1 0.4 0.3 0.4 1.8 0.1 0.2 0.1 1.2 0.7 3.4 0.2 0.4 0.2 0.3 0.3 1.4 0.0 0.2 0.0 0.3 0.2 0.1 0.2 0.0 0.0 0.3 0.2 0.4 3.1 0.0 0.0 1.6 0.4 0.3 13.2 0.2 0.2 0.3 0.7 0.2 1.4 0.3 0.0 0.0 0.0 0.1 0.5 4.5 0.3 0.0 3.1 0.5 0.1 1.8 1.1 2.6 9.7 12.1 5.9 4.4 0.0 0.0 0.0 0.4 2.3 7.0 1.9 0.0 11.6 3.2 9.2 0.2 0.2 18.8 1.5 2.0 0.0 0.5 1.3 27.3 21.5 4.3 4.1 0.0 0.2 0.0 0.2 0.9 0.0 0.0 1.8 0.8 0.0 0.2 0.2 0.3 0.0 1.8 0.0 0.0 0.0 19.1 0.0 14.5 1.7 0.3 0.4 0.0 2.6 1.8 0.3 20.7 0.1 0.3 0.0 8.8 0.1 55.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.4 0.3 0.3 0.3 0.2 0.1 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 2.9 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DCAF1 "KIAA0800, MGC102804, VPRBP" ENSG00000145041 "DDB1 and CUL4 associated factor 1" Q9Y4B6 3 51395867-51500002 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.8" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 17.9;Granulosa cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036142, HPA052445, HPA053203" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (3.71e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (9.75e-2)" "unprognostic (2.58e-2)" "unprognostic (1.24e-1)" "unprognostic (8.75e-2)" "unprognostic (2.15e-1)" "unprognostic (2.89e-2)" "unprognostic (2.21e-2)" "prognostic favorable (7.45e-5)" "unprognostic (5.49e-2)" "unprognostic (5.00e-1)" "unprognostic (6.81e-2)" "unprognostic (1.64e-1)" 11.0 11.4 8.1 11.8 8.8 16.0 11.3 11.3 9.5 9.5 9.7 10.7 8.0 10.4 9.5 10.7 9.0 7.4 8.8 7.9 8.8 11.1 11.6 10.1 15.0 8.8 8.4 7.4 10.4 10.5 19.0 8.7 10.3 8.9 9.8 11.0 19.9 11.4 9.7 28.1 13.6 11.5 9.3 8.3 11.4 10.4 53.8 8.6 18.8 14.7 16.3 16.0 11.3 10.1 9.1 19.9 23.9 22.8 20.7 20.1 15.9 21.6 21.8 16.2 23.1 22.5 26.4 18.8 48.1 11.7 17.2 35.3 17.1 43.3 19.5 29.6 33.7 21.5 41.2 32.4 22.8 14.7 54.4 28.7 10.6 22.2 29.8 21.6 15.0 18.2 26.1 24.5 30.3 18.3 20.3 41.8 22.0 24.0 23.5 26.0 17.5 24.4 32.0 18.0 30.5 11.8 21.0 24.1 22.0 13.2 16.7 15.0 22.8 22.9 18.8 25.1 31.4 33.9 20.5 29.7 48.2 21.9 36.6 15.7 2.5 3.0 2.4 6.5 3.3 7.4 5.1 5.6 5.6 4.8 4.9 6.0 5.1 0.7 5.8 5.0 3.8 6.7 4.9 8.1 8.8 11.3 9.5 7.9 8.8 8.8 8.4 7.4 8.9 8.3 8.6 9.1 11.1 3.2 10.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.3 9.4 0.0 0.0 6.8 3.7 0.0 7.6 9.7 0.0 1.9 7.0 0.0 11.2 10.3 5.6 0.0 0.0 0.0 6.7 5.7 3.0 0.0 17.9 6.3 13.1 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.8 0.0 0.0 6.1 5.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 10.5 5.0 7.4 0.0 0.0 MANF "ARMET, ARP" ENSG00000145050 "Mesencephalic astrocyte derived neurotrophic factor" P55145 3 51385291-51389397 "Plasma proteins, Predicted secreted proteins" "Stress response, Unfolded protein response" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 426.1;Syncytiotrophoblasts: 459.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 109.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011175 Approved Supported "Endoplasmic reticulum" "Secreted to blood" NA NA 7500000 "Endoplasmic reticulum" "HPA011175: AB_1845039" "unprognostic (2.90e-2)" "unprognostic (5.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "prognostic unfavorable (9.58e-6)" "prognostic unfavorable (7.48e-4)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.12e-3)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.21e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" "unprognostic (5.10e-2)" 33.3 37.0 36.0 71.5 34.4 35.6 42.2 37.4 50.9 59.9 43.9 55.9 42.9 48.6 170.8 53.6 43.1 32.4 47.0 34.2 41.6 41.8 110.1 44.6 51.0 39.3 36.5 31.5 28.9 81.8 39.1 56.9 60.4 39.6 51.7 59.4 17.9 51.5 51.0 12.5 36.6 39.8 47.7 37.5 56.5 60.0 43.6 38.7 48.1 118.9 20.9 76.7 68.5 35.8 42.5 128.6 61.2 164.7 207.7 107.8 139.4 173.8 200.2 160.6 194.0 184.5 99.6 292.6 271.6 162.6 121.9 449.8 77.7 201.4 200.0 187.3 128.9 92.2 220.2 93.5 230.3 349.8 108.2 137.1 60.6 168.5 201.3 271.7 189.9 252.7 112.3 48.3 299.5 181.6 75.5 184.8 215.6 144.6 298.0 237.6 76.4 105.3 288.7 162.8 86.9 64.4 201.6 165.3 104.2 130.3 175.8 83.7 141.2 129.3 117.4 112.1 140.4 222.6 247.9 105.0 186.5 195.4 217.5 221.2 73.2 15.3 9.4 28.8 13.0 35.5 17.4 20.2 27.5 16.0 12.1 14.9 16.0 8.5 26.0 8.3 109.8 13.4 16.9 36.0 34.4 37.4 50.9 34.2 41.6 39.3 36.5 31.5 39.6 37.5 38.7 42.5 55.9 32.1 21.5 5.2 134.1 163.1 223.7 232.5 31.3 15.1 50.5 40.5 69.3 61.5 104.0 55.2 6.2 188.1 142.8 75.7 43.0 172.6 99.0 73.3 101.9 88.3 116.6 26.1 5.8 124.6 387.0 101.2 71.9 99.4 62.9 77.9 79.6 156.1 179.5 11.8 8.5 235.9 118.0 36.1 170.6 123.3 60.0 63.0 181.5 7.5 79.1 39.6 117.4 5.0 9.5 167.8 90.5 51.6 426.1 245.0 47.7 78.9 71.1 19.1 65.7 59.7 194.2 176.8 91.1 42.8 160.5 459.0 94.8 40.6 120.9 202.0 STXBP5L "KIAA1006, LLGL4" ENSG00000145087 "Syntaxin binding protein 5 like" Q9Y2K9 3 120908072-121424761 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 69.5" "Group enriched" "Detected in some" 10 "Excitatory neurons: 1544.2;Inhibitory neurons: 529.4;Oligodendrocyte precursor cells: 390.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 69.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.4;HeLa: 4.7;MOLT-4: 6.6;NTERA-2: 3.5;RH-30: 3.3;SCLC-21H: 8.8;SH-SY5Y: 3.9;U-937: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.42e-1)" "unprognostic (9.47e-2)" "unprognostic (6.30e-2)" "unprognostic (2.85e-3)" "unprognostic (1.75e-1)" "unprognostic (2.89e-2)" "unprognostic (7.01e-2)" "unprognostic (1.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-3)" "unprognostic (2.52e-1)" "unprognostic (6.52e-3)" "unprognostic (5.13e-2)" "unprognostic (3.58e-1)" "unprognostic (1.86e-3)" "unprognostic (8.61e-3)" 0.0 1.8 2.3 0.0 7.1 0.0 0.0 69.5 25.5 0.4 0.0 0.7 0.3 0.9 0.0 0.3 0.1 0.0 0.0 18.8 5.6 0.0 0.0 0.0 0.0 6.1 3.4 7.4 9.5 0.2 0.0 2.9 0.0 20.6 2.1 0.2 4.4 0.1 3.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 2.1 0.3 0.0 7.6 0.0 0.0 0.9 0.3 15.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 4.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 6.6 0.0 3.5 0.0 0.7 0.0 3.3 0.0 0.0 0.6 8.8 3.9 0.0 0.0 0.1 0.0 0.9 2.5 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 1.7 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.1 69.5 25.5 18.8 5.6 6.1 3.4 7.4 20.6 0.0 0.3 15.6 0.0 0.0 0.0 51.2 0.0 0.1 0.9 0.0 0.0 32.8 0.0 0.0 0.5 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.3 0.1 12.1 0.0 1544.2 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 10.1 529.4 0.6 0.0 0.0 0.0 12.8 2.8 0.0 0.0 24.4 0.0 0.8 0.0 390.6 27.9 0.1 0.1 0.4 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.7 0.3 11.2 7.2 0.0 0.0 0.0 0.0 3.6 0.0 0.2 EAF2 "BM040, TRAITS, U19" ENSG00000145088 "ELL associated factor 2" Q96CJ1 3 121835183-121886526 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 72.4;lymphoid tissue: 54.1" "Cell type enhanced" "Detected in many" "B-cells: 73.7;Plasma cells: 144.1;Proximal tubular cells: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "memory B-cell: 104.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 73.5;HL-60: 114.9;THP-1: 59.9;U-698: 93.5;U-937: 64.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA008411 Enhanced NA NA "HPA008411: AB_1847950" "unprognostic (3.43e-1)" "prognostic favorable (2.25e-9)" "unprognostic (1.48e-1)" "prognostic favorable (2.66e-4)" "unprognostic (1.00e-1)" "unprognostic (3.18e-2)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "unprognostic (2.08e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (9.04e-2)" "unprognostic (8.34e-2)" 4.3 2.6 3.0 19.7 2.6 72.4 10.1 2.8 3.1 5.6 3.2 10.4 8.9 2.0 4.9 2.8 1.4 5.0 1.7 3.3 3.0 30.5 3.6 4.3 54.1 2.6 2.8 2.3 1.0 4.2 3.1 3.3 3.0 3.2 21.1 11.8 1.7 7.6 8.4 0.8 1.0 7.7 3.6 2.3 17.1 8.3 4.7 3.2 7.8 1.7 1.3 43.7 7.9 1.4 3.4 3.5 3.0 2.0 2.5 0.7 2.1 6.0 1.3 0.8 2.4 4.4 5.8 2.0 73.5 1.5 0.3 7.7 5.7 5.0 3.0 6.0 35.8 2.9 42.4 3.0 11.1 1.0 114.9 44.7 1.0 6.9 2.8 2.6 0.0 2.3 10.0 5.0 14.2 1.1 1.0 16.3 15.1 2.9 13.8 2.5 17.1 6.4 11.2 2.4 4.3 2.5 0.6 2.1 2.0 5.7 5.5 1.8 59.9 0.7 1.5 2.4 1.4 3.4 25.4 12.2 93.5 2.8 64.0 4.7 11.9 18.8 42.8 1.4 41.2 2.8 104.4 2.2 1.5 22.5 97.4 2.9 1.6 3.5 1.8 54.7 30.5 2.7 13.1 3.0 2.6 2.8 3.1 3.3 3.0 2.6 2.8 2.3 3.2 2.3 3.2 3.4 4.5 3.2 4.2 48.0 73.7 2.4 6.9 25.0 6.2 1.3 5.9 6.6 4.3 0.0 16.5 1.8 4.2 15.5 15.3 2.9 17.6 4.4 36.4 4.3 2.0 2.5 1.2 10.3 17.3 17.6 2.2 4.9 7.7 7.7 10.1 2.5 3.9 1.6 16.5 0.0 28.6 5.7 16.2 32.4 15.7 4.6 5.0 29.8 16.0 8.4 29.5 9.4 6.2 12.1 7.7 4.2 4.7 3.0 144.1 11.1 2.4 128.0 9.1 5.3 0.0 4.5 4.6 37.6 18.1 2.3 2.4 7.7 11.1 2.2 3.5 5.9 ILDR1 "DFNB42, MGC50831" ENSG00000145103 "Immunoglobulin like domain containing receptor 1" Q86SU0 3 121987323-122022247 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 15.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Club cells: 14.7;Collecting duct cells: 20.2;Cytotrophoblasts: 16.6;Distal enterocytes: 17.5;Glandular and luminal cells: 13.5;Respiratory ciliated cells: 13.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 4 "B-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;HDLM-2: 8.2;MCF7: 5.1;RT4: 7.5;T-47d: 5.3;U-266/70: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA018207 Approved "Intracellular and membrane" NA NA "HPA018207: AB_1851742" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (9.24e-2)" "unprognostic (4.46e-3)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-2)" "unprognostic (2.80e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (7.78e-2)" "unprognostic (2.37e-1)" "prognostic favorable (5.79e-9)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (3.25e-3)" "unprognostic (2.21e-2)" 0.0 0.7 0.2 1.3 0.2 0.3 3.0 0.1 0.3 11.8 0.1 8.3 3.3 1.0 12.9 3.8 5.2 3.3 0.0 0.1 0.1 6.6 0.2 2.9 1.1 0.1 0.1 0.1 0.0 6.8 15.8 2.4 1.8 0.2 7.0 7.3 0.2 8.1 10.7 0.1 1.2 2.4 0.3 0.0 0.6 0.8 0.6 0.1 0.8 7.4 0.0 2.2 2.2 1.1 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 6.3 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.0 0.1 0.0 1.2 0.0 0.0 0.0 2.4 2.8 7.5 0.2 0.0 0.0 0.7 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 1.4 1.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 12.8 7.4 0.3 1.3 0.0 0.8 7.5 0.0 0.0 4.2 2.4 0.7 4.3 14.7 20.2 0.0 16.6 0.1 17.5 1.9 7.5 0.2 6.3 1.6 0.1 3.5 0.0 0.5 3.7 0.5 0.1 1.1 13.5 0.0 0.2 0.0 0.1 1.2 0.0 0.5 7.9 8.2 0.6 0.0 0.0 0.0 0.3 1.8 1.9 0.0 0.0 0.0 0.0 0.2 2.6 8.9 0.0 2.1 2.2 2.5 2.1 13.7 0.0 0.0 0.0 0.6 0.0 0.1 5.9 0.6 5.1 0.1 0.0 7.8 3.5 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.7" "Cell type enriched" "Detected in some" 8 "Hofbauer cells: 74.6" "Group enriched" "Detected in some" 4 "cervical cancer: 1.4;head and neck cancer: 3.4;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 0.9" "Region enhanced" "Detected in single" "thalamus: 1.8" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.9;naive CD8 T-cell: 4.9" "Lineage enriched" "Detected in single" 16 "T-cells: 14.8" "Cell line enriched" "Detected in many" 12 "GAMG: 427.6" NA NA "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 3.9 0.3 0.0 0.5 0.2 0.7 2.9 0.2 0.9 0.8 0.0 0.3 0.2 0.3 0.0 3.4 0.3 0.1 0.1 0.2 0.3 0.2 0.5 3.6 0.5 0.2 0.2 0.1 0.7 0.3 0.0 0.1 0.8 0.3 0.5 0.2 0.5 1.5 0.0 1.6 1.8 0.2 0.1 0.1 0.6 0.5 4.7 1.8 0.2 0.7 0.5 0.8 0.3 1.7 0.8 15.6 7.2 0.2 0.4 0.9 4.6 0.3 0.0 4.4 1.6 2.9 0.0 8.2 0.2 2.6 0.0 427.6 2.2 0.0 1.7 1.1 0.6 0.0 0.3 2.1 0.0 1.0 0.5 0.4 0.5 1.4 18.8 31.3 0.0 0.0 0.9 9.8 0.9 4.8 1.2 0.1 0.8 0.0 0.2 36.2 0.2 3.2 0.9 0.0 0.4 0.3 0.0 2.5 0.1 0.7 0.4 0.6 0.2 1.4 18.6 15.6 2.9 9.1 0.5 5.6 0.3 20.2 0.7 0.3 0.9 0.3 0.4 14.8 0.4 0.1 0.1 1.3 3.9 0.1 0.3 0.7 4.9 0.6 0.7 0.1 0.6 0.4 1.6 0.0 0.2 0.2 0.9 0.2 0.3 0.2 0.2 0.1 0.3 0.1 1.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 9.3 4.9 4.9 0.0 0.4 0.9 0.1 0.0 0.0 MUC4 ENSG00000145113 "Mucin 4, cell surface associated" Q99102 3 195746765-195811973 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 19.3;intestine: 18.2;prostate: 15.0;vagina: 15.1" "Cell type enhanced" "Detected in many" "Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4" "Cancer enhanced" "Detected in many" "cervical cancer: 16.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 3.4" "HPA005895, CAB013536" Approved "Secreted in other tissues" NA NA "CAB013536: , HPA005895: AB_1079427" "unprognostic (4.16e-3)" "unprognostic (1.00e-2)" "unprognostic (6.79e-2)" "unprognostic (1.11e-2)" "unprognostic (3.03e-2)" "unprognostic (5.16e-2)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (3.19e-1)" "unprognostic (4.22e-3)" "unprognostic (6.68e-3)" "unprognostic (5.30e-2)" "unprognostic (2.43e-3)" "unprognostic (3.19e-1)" "unprognostic (6.78e-2)" "unprognostic (3.46e-3)" "unprognostic (9.97e-3)" 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.1 2.9 0.0 18.2 0.0 0.0 0.0 19.3 2.1 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.8 0.0 7.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.2 1.2 15.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 6.4 15.6 0.3 2.1 0.0 18.5 82.1 0.6 0.0 25.7 2.9 2.5 0.0 193.7 0.0 0.0 0.1 0.3 185.1 0.0 1.6 3.5 6.2 0.2 0.7 16.4 0.0 0.9 5.2 4.3 0.6 163.1 5.1 2.5 0.1 0.0 0.0 0.1 0.0 1.0 193.3 40.7 0.0 0.0 0.7 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.2 37.5 64.3 0.4 0.8 12.4 1.1 0.2 336.1 0.0 0.0 0.5 11.1 2.1 1.9 0.4 0.0 0.1 1.2 2.3 174.5 319.4 SLIT2 "SLIL3, Slit-2" ENSG00000145147 "Slit guidance ligand 2" O94813 4 20251905-20620561 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Excitatory neurons: 256.7;Inhibitory neurons: 544.9;Oligodendrocytes: 157.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 98.0;BJ hTERT+: 200.8;BJ hTERT+ SV40 Large T+: 97.8;fHDF/TERT166: 117.8;HBF TERT88: 112.0;HEK 293: 88.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB007590, HPA019511, HPA023088" Uncertain "Secreted in other tissues" NA NA 77000 "CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227" "unprognostic (1.44e-1)" "unprognostic (4.54e-2)" "unprognostic (3.26e-2)" "unprognostic (6.13e-2)" "unprognostic (9.01e-3)" "unprognostic (6.49e-2)" "unprognostic (1.71e-1)" "unprognostic (4.78e-2)" "unprognostic (1.73e-1)" "unprognostic (6.16e-3)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "prognostic favorable (6.51e-4)" "unprognostic (4.93e-3)" "unprognostic (6.80e-3)" "unprognostic (1.74e-1)" "unprognostic (7.16e-4)" 6.8 25.1 3.5 3.3 7.4 0.0 9.5 1.1 15.2 24.2 10.1 9.4 2.4 16.6 10.0 5.9 13.2 9.5 6.3 7.2 21.1 12.5 2.0 35.2 1.8 8.1 5.3 6.0 4.4 2.8 1.5 8.9 25.4 5.4 12.7 5.4 13.3 6.1 15.8 2.9 3.8 4.8 25.2 0.4 14.3 9.1 1.3 13.0 2.4 9.3 5.1 1.2 13.2 14.1 5.1 0.1 0.0 54.6 0.0 37.8 34.8 1.7 98.0 200.8 97.8 36.9 0.4 0.1 0.0 3.4 117.8 0.2 1.2 15.7 7.9 112.0 0.2 88.3 0.0 0.4 0.0 7.2 0.9 0.0 8.5 0.0 63.6 18.6 2.1 35.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 1.7 0.0 6.3 61.2 0.5 0.0 1.0 0.1 3.5 0.8 0.0 0.2 0.4 1.9 0.2 0.2 2.0 34.9 5.0 35.0 54.2 0.0 0.1 0.0 0.9 0.0 19.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 7.4 1.1 15.2 7.2 21.1 8.1 5.3 6.0 5.4 0.4 13.0 5.1 1.6 0.0 9.0 10.1 0.0 8.0 2.0 0.1 0.6 47.6 1.0 0.6 5.2 1.5 1.3 0.0 0.0 1.1 0.0 0.6 1.9 1.7 0.6 6.4 1.9 2.0 1.2 0.0 256.7 0.5 1.2 58.8 0.0 7.1 2.5 1.3 4.2 0.2 1.9 0.0 544.9 0.0 0.0 1.0 9.7 1.7 26.4 0.7 8.8 31.9 0.0 1.3 0.0 43.7 157.9 0.2 0.0 26.7 0.1 3.7 0.0 11.5 7.4 2.1 6.6 3.2 6.4 0.2 1.7 1.2 6.7 2.1 1.1 20.3 0.1 1.9 EIF2B5 "EIF-2B, EIF2Bepsilon" ENSG00000145191 "Eukaryotic translation initiation factor 2B subunit epsilon" Q13144 3 184135038-184146127 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015412, HPA064370, HPA069303" Approved Enhanced Cytosol NA NA Cytosol "CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (9.05e-3)" "unprognostic (3.33e-2)" "unprognostic (1.15e-2)" "unprognostic (9.33e-2)" "prognostic unfavorable (3.38e-8)" "unprognostic (8.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.21e-2)" "unprognostic (3.80e-1)" "unprognostic (1.32e-2)" "unprognostic (9.97e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" 15.8 19.0 11.3 8.3 10.8 5.3 17.7 11.7 12.6 16.3 12.8 18.9 9.5 15.5 5.7 24.9 15.0 6.6 20.4 10.9 12.3 15.6 20.2 15.9 9.8 11.9 10.7 9.7 15.1 19.1 22.2 18.1 11.9 11.3 18.2 14.0 2.3 24.0 11.3 54.3 24.4 19.6 11.7 11.6 20.5 21.2 10.1 11.2 18.3 16.9 33.9 19.2 18.9 19.7 11.0 60.7 25.4 24.3 25.4 32.4 23.4 28.0 29.1 36.2 51.7 42.4 41.5 24.5 48.6 37.8 32.5 65.0 34.7 56.6 39.1 47.7 39.7 55.4 75.6 28.4 42.4 24.8 61.8 32.9 19.6 32.1 28.7 24.1 19.5 37.3 49.7 46.7 29.2 35.2 49.5 49.5 34.3 39.9 76.1 49.3 45.1 37.6 61.3 43.1 38.6 35.2 34.2 27.9 91.9 41.5 20.3 83.6 60.8 33.6 22.9 35.4 28.5 62.7 24.3 61.2 69.6 33.0 58.8 35.2 9.5 10.0 14.7 8.7 9.1 11.5 15.4 12.2 13.3 11.8 16.9 18.1 11.5 1.3 14.3 9.8 5.1 11.6 7.6 11.3 10.8 11.7 12.6 10.9 12.3 11.9 10.7 9.7 11.3 11.6 11.2 11.0 19.8 25.6 22.7 8.8 31.6 30.8 36.6 18.2 29.6 18.5 33.1 30.1 25.8 17.2 28.4 36.8 8.4 39.3 25.4 32.0 52.8 27.5 3.7 20.5 17.7 24.0 45.9 27.6 14.6 36.0 28.8 17.8 35.2 23.3 16.5 21.3 13.6 27.1 24.9 35.3 18.6 28.0 24.4 18.5 22.6 2.7 18.3 18.2 19.6 12.2 30.8 14.5 22.6 18.1 15.3 26.3 17.9 14.7 19.0 34.6 27.2 30.0 21.9 16.7 13.1 17.5 22.8 17.7 17.0 31.2 29.0 38.6 26.5 34.2 34.7 44.9 AHSG "A2HS, FETUA, HSGA" ENSG00000145192 "Alpha 2-HS glycoprotein" P02765 3 186613060-186621318 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Mineral balance" "Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4297 "liver: 5864.7" "Cell type enriched" "Detected in some" 38 "Hepatocytes: 1242.5" "Cancer enriched" "Detected in some" 284 "liver cancer: 1231.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 78 "Hep G2: 2287.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001524, HPA001525, CAB026209" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 864000000000 110000000000 "Golgi apparatus" "CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849" "unprognostic (6.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (3.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (7.47e-3)" "unprognostic (3.05e-1)" "unprognostic (5.27e-2)" "unprognostic (8.64e-2)" "unprognostic (3.99e-7)" "unprognostic (5.21e-2)" "unprognostic (5.21e-2)" "unprognostic (1.04e-1)" 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 1.3 5864.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.9 1.0 2287.3 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 3.5 0.0 0.0 1.1 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.2 4.3 0.2 0.1 0.9 0.0 32.0 0.6 0.6 2.4 0.1 0.0 0.1 0.0 0.0 28.2 1242.5 1.3 0.0 0.1 0.0 0.0 32.4 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 2.0 0.0 0.0 0.1 ECE2 "KIAA0604, MGC2408" ENSG00000145194 "Endothelin converting enzyme 2" P0DPD6 3 184276011-184293031 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 46.7;pancreas: 25.4;pituitary gland: 20.0" "Cell type enhanced" "Detected in many" "Early spermatids: 79.5;Extravillous trophoblasts: 51.1;Inhibitory neurons: 63.8;Late spermatids: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "REH: 10.3" NA NA "unprognostic (2.70e-2)" "unprognostic (1.44e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (8.41e-5)" "unprognostic (1.37e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.47e-2)" "unprognostic (3.69e-1)" "unprognostic (2.65e-3)" "unprognostic (1.70e-2)" "unprognostic (5.95e-2)" "unprognostic (1.63e-9)" "unprognostic (3.66e-2)" "unprognostic (6.16e-2)" "unprognostic (2.19e-1)" "unprognostic (1.25e-2)" 0.0 9.4 23.1 0.2 21.7 0.0 0.0 20.3 23.8 0.0 6.6 1.0 0.0 0.0 0.5 0.0 0.1 0.0 1.0 14.2 46.7 0.0 0.0 0.0 0.0 26.3 30.1 15.7 0.0 25.4 4.3 20.0 0.0 27.3 0.6 0.2 5.6 0.3 0.3 0.0 0.0 0.3 0.2 17.5 0.0 0.7 0.2 43.7 0.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 21.7 20.3 23.8 14.2 46.7 26.3 30.1 15.7 27.3 17.5 43.7 18.2 0.0 0.0 0.0 5.2 3.8 38.2 18.2 15.5 20.5 5.5 0.0 0.0 2.2 10.0 7.2 0.0 2.1 21.6 2.7 6.7 0.0 0.0 79.5 0.0 0.0 3.3 12.2 6.3 5.1 0.0 51.1 3.5 9.2 0.0 0.0 0.0 3.3 35.3 17.2 26.9 63.8 12.8 16.2 4.4 5.7 119.8 3.1 4.1 8.8 1.0 4.6 2.4 5.2 30.2 1.1 0.0 5.9 2.2 12.5 35.1 13.5 0.0 2.2 2.3 6.6 2.6 5.1 43.4 9.7 16.9 39.1 21.5 2.3 0.0 13.8 16.2 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 41.1;brain: 17.0" "Group enriched" "Detected in some" 7 "Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9;pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.9" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.0 41.1 8.7 0.0 2.2 0.1 0.0 0.8 17.0 0.4 0.0 0.3 1.9 0.2 0.1 0.0 1.3 0.0 0.0 7.4 1.8 0.1 0.0 0.1 0.0 8.0 0.9 2.9 0.4 5.7 1.4 8.4 0.0 5.9 0.5 0.3 0.2 0.6 2.5 0.0 0.0 1.2 0.0 0.1 0.0 2.9 1.0 3.6 0.0 0.3 0.0 0.0 0.1 0.1 7.2 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.9 0.3 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.3 0.0 0.0 31.7 2.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.1 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.2 0.8 17.0 7.4 1.8 8.0 0.9 2.9 5.9 0.1 3.6 7.2 0.4 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 7.6 0.1 0.1 112.4 0.0 39.2 0.2 0.0 0.0 6.1 0.8 0.0 0.2 1.1 0.0 0.2 3.3 29.2 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 1.7 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 DGKQ "DAGK, DAGK4, DAGK7" ENSG00000145214 "Diacylglycerol kinase theta" P52824 4 958887-986895 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.5;Intestinal goblet cells: 21.6;Paneth cells: 33.1;Proximal enterocytes: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026797, CAB033835" Uncertain NA NA "CAB033835: AB_2091307, HPA026797: AB_10600902" "unprognostic (7.39e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "unprognostic (5.08e-2)" "unprognostic (3.37e-1)" "unprognostic (6.39e-2)" "unprognostic (2.90e-2)" "unprognostic (1.06e-1)" "unprognostic (6.45e-2)" "unprognostic (1.06e-2)" "unprognostic (9.77e-2)" "unprognostic (3.08e-3)" "unprognostic (4.38e-2)" "unprognostic (2.65e-2)" "unprognostic (1.65e-3)" 6.5 8.3 9.9 9.3 10.1 9.8 6.8 14.7 15.4 8.5 2.6 14.4 22.4 7.9 2.6 10.9 7.7 5.2 5.7 13.4 8.9 8.3 8.2 9.6 11.1 13.4 8.2 11.6 6.5 9.9 3.7 10.5 3.3 10.0 9.3 6.6 1.0 9.5 4.0 3.7 12.8 23.8 2.7 5.0 15.6 8.5 9.1 10.3 7.6 8.8 1.4 4.4 8.5 9.8 8.4 5.7 9.1 3.9 13.2 4.7 3.8 14.5 10.7 6.0 6.0 5.9 6.5 11.1 7.6 8.8 6.8 12.2 6.5 2.2 7.5 1.4 6.0 6.9 11.8 10.3 11.6 8.0 5.1 15.2 7.2 12.5 4.9 2.3 5.1 7.3 15.6 9.1 0.9 4.7 8.6 10.7 29.6 6.9 15.9 15.3 17.0 1.1 0.9 6.5 7.9 2.4 6.6 3.7 4.1 11.3 3.0 9.9 12.3 10.8 10.3 4.8 11.7 7.2 20.2 9.4 6.0 8.9 10.9 9.5 2.9 0.5 1.3 2.0 0.5 0.9 0.5 0.7 1.7 0.4 0.4 0.7 1.3 0.3 2.4 0.4 0.8 0.5 0.8 9.9 10.1 14.7 15.4 13.4 8.9 13.4 8.2 11.6 10.0 5.0 10.3 8.4 4.3 3.2 3.1 8.5 3.6 2.8 1.3 2.9 1.2 3.6 3.5 3.9 3.0 4.3 2.9 3.7 4.2 0.5 15.1 33.5 0.0 3.0 0.6 2.6 3.3 3.3 7.7 5.7 12.4 4.9 2.1 2.9 3.1 4.1 0.0 6.2 2.5 5.8 2.5 3.3 11.8 21.6 0.0 4.1 2.3 1.3 4.1 4.6 3.6 5.6 4.5 3.0 10.3 3.0 3.2 5.7 33.1 2.6 4.6 3.1 29.1 0.9 4.4 1.0 0.0 2.6 2.8 3.2 4.3 2.9 3.8 0.7 6.7 3.6 14.5 3.8 FIP1L1 "DKFZp586K0717, FIP1" ENSG00000145216 "Factor interacting with PAPOLA and CPSF1" Q6UN15 4 53377641-53460862 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "mRNA processing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037475, HPA058202" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037475: AB_10696933, HPA058202: AB_2683636" "unprognostic (3.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.60e-3)" "unprognostic (1.40e-1)" "unprognostic (7.18e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.87e-1)" "unprognostic (9.00e-3)" "unprognostic (1.14e-2)" "unprognostic (5.48e-2)" "unprognostic (1.42e-1)" "unprognostic (4.07e-1)" "unprognostic (1.10e-1)" "unprognostic (8.66e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-1)" 18.3 15.8 6.0 15.0 6.1 32.0 17.1 11.7 8.8 18.4 1.9 14.2 11.8 18.0 12.8 16.0 16.1 11.0 12.9 5.3 6.3 13.0 13.8 14.4 20.4 5.1 5.6 2.9 22.2 9.8 16.5 9.8 21.3 6.1 12.4 15.2 17.1 14.8 11.5 26.0 17.8 14.6 16.0 5.0 15.0 14.6 31.7 5.7 29.6 14.8 11.8 23.5 17.7 16.3 8.8 43.7 29.5 51.8 32.6 36.4 31.9 63.5 52.8 64.0 45.1 35.0 43.2 37.8 79.5 42.6 47.2 44.4 26.7 55.6 37.9 55.8 27.0 31.0 60.0 25.5 40.7 51.2 95.4 53.6 31.2 35.6 51.6 49.8 42.0 32.3 47.7 71.3 34.3 34.1 33.3 88.5 44.4 35.9 53.7 28.8 79.2 22.0 36.9 33.9 34.7 40.8 41.5 37.6 40.3 65.1 47.0 25.2 33.6 33.9 44.2 39.7 39.9 67.2 43.3 27.8 100.8 38.4 59.2 84.3 45.2 23.3 51.4 32.5 25.0 38.8 34.8 33.0 32.9 31.9 32.3 36.6 32.3 28.3 50.7 37.0 46.5 45.9 33.1 6.0 6.1 11.7 8.8 5.3 6.3 5.1 5.6 2.9 6.1 5.0 5.7 8.8 36.1 25.6 25.4 47.0 50.4 38.7 46.6 41.5 30.1 41.2 24.0 25.4 14.4 21.5 34.1 27.6 18.8 58.7 54.0 26.9 37.2 45.8 10.3 37.6 51.1 33.4 36.6 29.2 78.8 34.9 52.2 41.9 29.6 41.6 49.4 40.0 28.5 21.2 33.2 77.4 78.7 27.0 32.6 19.8 24.6 15.2 66.8 32.2 32.0 60.9 41.3 48.6 29.9 137.7 91.4 36.9 33.3 53.4 40.3 36.5 25.2 23.3 44.8 30.3 39.5 38.9 46.9 118.5 87.6 31.8 34.1 86.3 49.8 56.8 29.4 38.5 SLC26A1 "EDM4, SAT-1" ENSG00000145217 "Solute carrier family 26 member 1" Q9H2B4 4 979073-993440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 16.9" "Cell type enhanced" "Detected in some" "Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "basophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA041654 Uncertain Approved Microtubules NA NA Microtubules "HPA041654: AB_10796350" "unprognostic (1.96e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-1)" "unprognostic (4.91e-2)" "unprognostic (1.74e-1)" "unprognostic (2.67e-4)" "unprognostic (5.13e-2)" "unprognostic (5.82e-2)" "unprognostic (2.16e-1)" "unprognostic (3.88e-2)" "unprognostic (1.53e-3)" "unprognostic (2.92e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.65e-3)" 1.7 7.1 2.4 1.5 2.2 1.4 2.7 4.2 3.3 2.4 0.0 1.9 5.2 2.1 0.2 1.6 2.1 1.2 1.1 2.8 1.4 5.8 16.9 2.0 1.5 3.6 1.6 2.1 2.5 3.4 0.1 3.3 0.3 3.5 3.1 0.1 0.6 3.3 0.1 1.4 2.6 4.6 0.0 0.8 2.4 3.1 1.2 1.5 0.1 3.2 0.3 0.1 1.8 1.9 2.5 1.3 2.1 0.0 1.6 0.1 0.4 4.1 1.7 0.1 0.0 0.0 4.6 2.7 0.7 2.4 0.0 1.6 1.3 0.1 0.0 0.0 2.7 0.8 3.0 3.3 13.8 0.1 2.1 8.7 0.5 0.2 0.1 0.0 1.0 0.3 2.6 3.3 0.0 0.3 2.8 1.4 3.5 0.8 1.6 7.2 6.9 0.0 0.3 0.7 4.5 0.2 1.2 0.4 0.2 1.2 0.3 9.1 1.3 2.0 4.4 0.9 4.8 1.3 6.5 3.2 1.0 1.4 4.1 2.1 5.4 0.3 0.2 0.2 0.1 0.3 0.2 0.5 0.4 0.1 0.0 0.3 0.7 0.0 0.6 0.1 0.1 0.8 0.3 2.4 2.2 4.2 3.3 2.8 1.4 3.6 1.6 2.1 3.5 0.8 1.5 2.5 0.3 0.0 1.1 6.2 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.8 1.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 1.9 0.1 0.0 0.7 0.3 0.3 0.0 0.0 4.4 0.4 3.6 0.3 0.5 0.8 1.3 0.8 1.4 10.4 0.7 0.0 4.4 0.8 0.0 0.3 0.0 0.0 0.9 0.4 1.8 1.0 0.3 0.3 0.0 5.5 1.7 0.4 1.3 0.4 0.1 0.2 6.4 9.7 0.0 0.3 0.0 0.4 0.3 0.1 0.1 0.2 0.1 0.8 0.5 0.6 0.7 0.1 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290154 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 103.0" "Cell type enhanced" "Detected in all" "Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 13.5 8.5 8.0 20.0 8.4 20.5 11.3 8.1 13.1 9.8 7.2 10.3 8.9 9.2 5.7 16.1 10.4 8.2 15.7 7.9 8.3 5.7 10.5 11.9 24.5 8.7 8.5 7.2 12.5 9.7 5.3 8.5 11.2 8.9 7.9 10.2 11.2 7.4 6.8 21.4 9.3 9.4 9.1 8.0 18.9 8.0 103.0 8.3 13.0 6.8 11.8 18.0 19.0 10.9 9.3 59.9 30.8 26.7 39.3 22.9 26.0 46.1 53.2 18.1 53.7 37.1 97.1 75.6 158.9 37.5 23.0 86.2 37.0 100.6 55.4 69.8 28.6 74.8 159.2 29.5 109.0 38.7 184.4 41.4 20.5 34.4 61.8 103.9 13.9 47.2 89.1 217.9 51.2 37.8 60.5 63.4 236.6 134.0 62.1 99.2 96.2 48.6 76.4 24.4 40.7 63.4 27.4 29.0 31.0 55.8 34.0 32.3 54.4 44.7 53.3 42.7 70.2 169.1 36.2 59.1 250.4 36.5 154.7 44.2 37.3 26.4 24.4 73.5 26.8 85.5 21.7 48.2 80.3 19.5 15.0 22.1 47.9 7.6 30.3 39.2 14.3 25.4 30.2 8.0 8.4 8.1 13.1 7.9 8.3 8.7 8.5 7.2 8.9 8.0 8.3 9.3 29.1 16.0 23.5 6.8 26.9 120.1 59.2 19.9 27.9 10.1 15.7 32.9 20.9 14.3 25.6 1.8 8.4 47.7 128.9 11.5 9.8 24.9 223.1 17.7 29.4 32.3 10.7 46.3 3.6 19.8 55.6 31.9 9.7 12.7 21.5 31.5 14.3 11.2 35.8 15.2 4.2 16.1 4.1 30.4 34.0 113.4 34.2 44.7 21.4 2.8 35.2 14.1 197.8 6.0 9.3 30.0 11.4 26.7 36.1 117.5 3.0 7.4 19.2 30.2 39.5 34.4 27.9 718.6 36.6 36.0 115.8 20.2 135.3 46.8 28.9 64.1 CENPC "CENP-C, CENPC1, hcp-4, MIF2" ENSG00000145241 "Centromere protein C" Q03188 4 67468762-67545503 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049740, HPA058252" Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "HPA049740: , HPA058252: AB_2683654" "unprognostic (4.35e-1)" "unprognostic (6.41e-3)" "unprognostic (4.31e-3)" "unprognostic (7.85e-2)" "unprognostic (6.31e-2)" "unprognostic (3.85e-3)" "unprognostic (6.40e-2)" "prognostic favorable (9.67e-4)" "unprognostic (3.22e-2)" "unprognostic (7.13e-2)" "unprognostic (8.35e-2)" "unprognostic (4.32e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-3)" 1.3 1.6 2.1 1.0 3.3 3.6 3.3 5.8 2.7 2.7 0.4 1.9 1.1 3.1 2.4 1.5 2.9 1.1 1.5 2.1 2.1 2.1 1.5 1.5 1.9 1.7 2.1 2.2 5.7 3.8 1.5 2.5 1.3 2.5 2.9 1.2 2.7 2.0 1.7 1.2 2.4 1.8 1.6 1.2 2.0 2.1 1.7 1.8 2.0 3.1 1.1 1.5 2.0 2.3 3.0 0.4 0.5 1.6 0.9 1.9 1.1 0.9 0.6 0.5 0.7 0.5 0.7 1.3 2.7 0.8 0.8 0.2 0.8 2.2 0.9 1.2 0.8 0.4 2.1 0.9 0.9 0.6 3.9 0.8 1.4 0.3 0.5 1.3 1.2 0.4 1.8 3.0 1.6 1.1 0.7 5.3 3.5 1.8 0.8 0.3 2.4 4.0 0.9 1.0 0.8 2.8 1.3 1.2 2.5 0.7 1.6 0.7 1.3 0.4 1.0 0.5 0.7 0.5 1.3 0.5 2.7 1.1 2.2 0.6 0.5 0.2 0.5 0.7 0.4 0.3 0.8 0.8 0.9 0.2 1.1 1.2 0.9 0.2 0.5 0.2 0.4 0.4 0.2 2.1 3.3 5.8 2.7 2.1 2.1 1.7 2.1 2.2 2.5 1.2 1.8 3.0 53.1 32.1 35.5 38.8 68.4 15.2 25.3 17.7 35.9 53.7 26.0 32.3 24.3 18.6 31.6 16.5 14.6 20.2 75.0 17.7 11.7 13.5 4.1 21.0 39.0 33.7 13.1 31.7 58.5 16.7 12.9 41.3 35.7 25.1 26.6 39.8 23.2 14.1 12.8 52.2 57.0 18.4 18.3 16.7 7.9 5.5 34.8 26.7 16.0 31.9 27.4 31.6 60.8 46.3 74.6 14.6 13.0 25.6 89.1 15.3 24.2 20.4 27.2 29.0 19.7 54.1 34.2 47.2 44.4 34.7 9.2 18.3 69.8 43.3 16.4 23.9 EPHA5 "CEK7, EHK1, Hek7, TYRO4" ENSG00000145242 "EPH receptor A5" P54756 4 65319563-65670495 "Enzymes, Metabolic proteins, Predicted membrane proteins" Neurogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 22.9" "Group enriched" "Detected in some" 10 "Excitatory neurons: 202.5;Inhibitory neurons: 162.8;Oligodendrocyte precursor cells: 96.0" "Cancer enhanced" "Detected in some" "glioma: 0.8;prostate cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 10.0;PC-3: 9.4;TIME: 12.6;U-138 MG: 25.5;U-2197: 15.7;U-251 MG: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 33000 "unprognostic (1.02e-2)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (4.89e-4)" "unprognostic (7.43e-4)" "unprognostic (1.60e-1)" "unprognostic (6.68e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (9.25e-2)" "unprognostic (5.88e-3)" "unprognostic (2.55e-2)" "unprognostic (5.97e-4)" "unprognostic (3.81e-3)" 0.0 0.8 2.1 0.1 5.9 0.0 0.0 0.0 22.9 2.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.8 15.9 3.3 0.0 0.0 0.1 0.0 3.1 3.1 5.8 2.3 0.0 0.0 0.7 0.9 4.1 1.5 0.1 1.5 0.3 1.4 0.0 0.2 0.0 0.2 0.9 0.3 0.3 0.7 1.7 0.0 0.9 0.0 0.0 0.1 0.5 8.4 0.0 0.7 0.8 0.0 0.8 0.4 0.0 0.4 1.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 4.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.0 0.3 0.0 0.0 1.5 2.6 0.0 0.0 0.0 0.1 0.0 9.4 0.0 2.9 0.5 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 12.6 25.5 3.1 15.7 20.6 0.0 0.0 0.0 2.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 5.9 0.0 22.9 15.9 3.3 3.1 3.1 5.8 4.1 0.9 1.7 8.4 0.0 0.0 0.0 8.5 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 2.2 0.1 0.0 0.0 202.5 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.7 162.8 0.0 0.0 0.0 0.0 15.2 0.9 0.0 3.6 5.6 0.0 5.7 0.0 96.0 4.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.7 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593999-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "heart muscle: 57.5" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 69.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 44.0" "Region enhanced" "Detected in some" "basal ganglia: 2.6" "Low region specificity" "Detected in some" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.2 0.1 0.1 0.0 1.0 0.1 0.2 2.1 0.6 0.3 0.1 4.5 0.6 0.9 1.5 4.6 57.5 0.1 0.8 0.7 0.1 1.9 0.0 0.7 0.6 0.1 0.5 0.2 1.2 1.9 0.4 0.2 2.4 0.0 0.3 0.4 6.1 0.1 7.5 0.3 0.7 0.1 1.1 0.5 2.5 0.4 0.1 0.1 0.1 0.1 1.2 4.0 0.2 0.0 0.0 0.1 0.3 10.3 44.0 0.0 2.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 2.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.4 0.0 0.3 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.8 0.7 0.6 0.1 0.2 0.1 0.4 0.2 0.3 0.0 7.5 1.0 0.0 3.8 0.3 0.0 0.0 1.0 8.3 0.3 69.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 1.3 1.0 0.0 0.0 6.5 0.0 0.0 9.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.6 5.5 2.0 4.7 0.1 5.4 1.0 0.0 0.7 0.0 2.0 3.9 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.0 0.3 0.0 0.3 2.3 4.6 4.4 0.1 2.7 0.0 0.6 0.1 0.0 0.3 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485275-47593486 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 12 "basophil: 84.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 84.3" "Cell line enhanced" "Detected in many" "HAP1: 41.6" "Low region specificity" "Detected in all" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 4.9 6.1 2.6 5.0 3.0 1.3 4.3 2.1 3.2 7.0 15.8 3.6 4.0 7.5 7.3 10.3 4.7 7.4 4.2 1.8 5.2 10.2 2.5 6.1 6.3 3.3 3.4 1.8 8.1 4.5 10.5 3.1 15.0 3.0 4.7 3.8 4.2 3.4 6.4 1.0 10.0 4.5 9.8 2.5 10.1 5.2 2.0 3.9 4.6 9.2 2.8 8.0 7.4 6.6 2.9 2.6 1.8 4.0 2.8 11.1 12.0 0.7 17.9 21.5 8.4 15.1 9.4 15.4 8.1 6.5 29.1 14.3 4.6 41.6 15.0 12.9 3.2 3.2 6.5 2.8 0.5 9.8 2.1 3.9 10.3 11.2 16.4 10.9 27.5 14.4 4.0 0.1 4.3 23.2 1.0 4.4 1.2 1.4 0.0 2.2 4.9 9.0 0.1 15.0 3.1 2.6 4.9 8.4 2.1 5.2 8.7 3.8 2.1 21.9 20.7 4.1 1.9 7.8 1.9 1.5 0.0 10.2 11.9 6.8 84.3 3.1 0.4 1.1 5.0 1.9 2.7 0.5 0.8 4.0 6.7 0.1 0.9 1.5 2.3 6.9 2.4 0.8 1.6 2.6 3.0 2.1 3.2 1.8 5.2 3.3 3.4 1.8 3.0 2.5 3.9 2.9 22.9 9.6 7.5 39.2 27.8 19.2 9.2 21.9 23.9 12.2 6.7 8.4 4.9 4.3 8.5 16.5 31.3 48.5 17.1 1.6 1.9 5.5 4.4 4.8 29.5 16.1 9.6 4.0 25.7 4.6 11.0 22.4 14.3 7.0 2.5 21.3 18.2 6.6 13.0 13.5 42.8 4.6 18.3 21.7 7.9 1.5 62.1 17.7 7.2 47.8 15.7 21.9 15.5 52.3 24.1 2.7 3.4 25.2 23.0 5.7 1.9 9.2 6.2 9.2 26.3 12.8 23.6 0.6 2.8 35.4 27.0 176.8 15.5 51.7 4.1 8.1 OCIAD2 MGC45416 ENSG00000145247 "OCIA domain containing 2" Q56VL3 4 48885019-48906937 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.9" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 325.2;U-251 MG: 399.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040979, HPA041090" Enhanced Enhanced Mitochondria No No Mitochondria "HPA040979: AB_10795497, HPA041090: AB_10796236" "unprognostic (4.29e-1)" "unprognostic (2.69e-1)" "unprognostic (3.76e-2)" "prognostic favorable (7.37e-4)" "unprognostic (3.49e-2)" "unprognostic (1.66e-2)" "unprognostic (9.05e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-1)" "prognostic favorable (6.56e-4)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.38e-1)" "prognostic favorable (2.67e-5)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (8.24e-3)" "prognostic favorable (2.34e-4)" 9.2 20.6 14.2 22.4 13.0 16.4 23.6 10.3 15.5 20.0 14.2 55.2 123.4 20.9 47.3 26.0 22.6 32.7 11.4 17.1 15.1 156.9 130.6 19.2 34.8 13.1 13.2 12.7 8.8 27.2 44.8 33.9 8.7 12.0 24.0 50.4 27.1 40.5 29.5 4.4 20.0 89.1 15.2 11.6 12.8 85.8 6.4 13.1 54.1 37.7 3.9 40.7 28.3 12.1 12.7 208.9 108.5 1.6 0.0 0.0 0.0 2.7 53.3 23.9 28.4 26.9 0.0 249.4 35.7 230.1 30.5 248.0 65.5 29.7 325.2 29.1 83.8 22.6 0.1 78.6 0.1 25.6 101.7 0.3 14.7 150.8 0.1 61.1 81.4 115.5 140.2 0.1 17.6 30.3 78.3 172.2 70.2 102.5 234.2 145.2 38.5 0.1 59.4 288.7 135.0 230.3 69.5 75.4 25.5 5.4 0.8 26.2 25.2 195.6 0.2 215.1 1.2 399.5 49.5 59.6 113.3 163.0 0.3 0.4 208.4 3.5 69.1 101.6 1.5 136.9 168.0 191.0 147.3 18.1 156.7 247.2 165.0 11.2 156.0 1.3 122.4 338.7 137.7 14.2 13.0 10.3 15.5 17.1 15.1 13.1 13.2 12.7 12.0 11.6 13.1 12.7 135.9 28.9 70.6 2.0 102.5 109.0 146.6 401.4 81.4 17.6 152.7 190.6 39.2 194.5 224.2 176.6 29.2 46.2 66.3 359.7 217.2 510.5 1.4 197.5 22.9 103.3 306.4 38.9 10.1 570.2 11.4 14.9 157.5 190.8 36.8 75.3 31.1 193.9 44.3 1.7 11.6 301.3 341.8 6.4 27.0 2.5 5.0 21.7 65.8 5.6 15.9 49.9 82.4 2.5 1.8 1277.4 311.6 21.4 53.5 180.1 702.0 1384.9 171.4 77.6 0.0 3.7 41.8 2.6 3.2 105.2 131.4 15.3 129.8 52.1 188.6 239.2 SLC10A4 MGC29802 ENSG00000145248 "Solute carrier family 10 member 4" Q96EP9 4 48483343-48489526 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 27.6" "Cell type enriched" "Detected in some" 4 "Inhibitory neurons: 16.2" "Group enriched" "Detected in many" 4 "endometrial cancer: 1.8;glioma: 5.9" "Region enhanced" "Detected in many" "midbrain: 27.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1" "Group enriched" "Detected in many" 4 "basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4" "Group enriched" "Detected in many" 5 "basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7" HPA028835 Uncertain Supported NA NA "HPA028835: AB_10603025" "unprognostic (4.06e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (5.41e-2)" "unprognostic (3.67e-1)" "unprognostic (1.86e-1)" "unprognostic (4.08e-3)" "unprognostic (9.98e-3)" "unprognostic (1.46e-1)" "unprognostic (3.50e-1)" "unprognostic (5.14e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (8.73e-2)" 0.1 2.7 0.6 0.2 1.7 1.1 0.1 0.0 3.6 0.6 0.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 7.2 0.1 0.1 0.2 0.0 6.4 27.6 0.3 0.1 0.1 0.0 6.8 0.0 15.5 0.2 0.1 0.1 1.4 0.0 0.1 0.1 0.4 0.1 1.1 0.1 0.5 0.4 8.9 0.0 0.4 0.0 0.0 0.1 0.6 5.4 0.0 3.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 1.0 0.0 9.2 0.0 0.1 0.0 2.8 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.9 32.1 0.4 0.0 0.1 0.3 0.0 4.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 3.6 0.1 7.2 6.4 27.6 0.3 15.5 1.1 8.9 5.4 0.4 0.0 3.2 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.1 1.7 0.1 0.2 0.4 0.0 3.0 0.6 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 16.2 0.0 0.0 0.0 0.4 2.4 0.3 0.0 0.0 1.0 0.1 0.0 0.0 4.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.7 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 SLC10A6 SOAT ENSG00000145283 "Solute carrier family 10 member 6" Q3KNW5 4 86823468-86849384 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.1;skin 1: 13.2" "Group enriched" "Detected in some" 5 "Early spermatids: 59.5;Late spermatids: 191.7" "Group enriched" "Detected in many" 5 "cervical cancer: 3.5;head and neck cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.5;BJ hTERT+: 1.2;HaCaT: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA016662 Enhanced NA NA "HPA016662: AB_1669899" "unprognostic (2.79e-2)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (8.31e-3)" "unprognostic (5.88e-2)" "unprognostic (8.87e-3)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.84e-4)" "unprognostic (1.54e-1)" "unprognostic (2.06e-1)" "unprognostic (9.22e-2)" "unprognostic (5.89e-4)" 5.2 0.3 0.1 0.7 0.2 0.0 2.8 0.1 0.3 1.7 0.1 0.4 0.1 0.5 0.3 9.1 0.6 1.0 0.6 0.1 0.9 0.1 0.1 0.3 0.1 0.2 0.3 0.0 0.1 0.8 0.6 0.2 0.1 0.2 0.4 0.3 0.0 1.5 0.2 0.7 13.2 0.2 1.0 0.1 0.2 0.3 4.3 0.7 0.3 1.0 1.1 1.2 1.0 4.7 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.9 0.2 0.3 0.0 0.2 0.1 0.7 0.7 9.3 0.0 0.0 6.2 0.0 13.8 0.0 0.8 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.5 1.7 1.0 2.6 0.0 0.0 2.5 0.0 0.1 0.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.2 191.7 1.5 0.1 0.0 2.8 0.0 0.0 0.0 3.5 4.8 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 1.2 1.2 0.6 6.0 24.9 0.0 0.0 0.0 0.0 0.2 SCD5 "ACOD4, FADS4, FLJ21032, HSCD5, SCD4" ENSG00000145284 "Stearoyl-CoA desaturase 5" Q86SK9 4 82629539-82798796 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 158.2;brain: 350.7" "Cell type enhanced" "Detected in many" "Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6" "Group enriched" "Detected in all" 6 "glioma: 152.4;thyroid cancer: 38.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 69.2;RPTEC TERT1: 90.1" "Low region specificity" "Detected in all" HPA042380 Uncertain NA NA "HPA042380: AB_10794797" "unprognostic (3.23e-2)" "unprognostic (3.84e-2)" "unprognostic (2.86e-1)" "unprognostic (6.98e-2)" "unprognostic (1.58e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (3.82e-2)" "unprognostic (6.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "prognostic favorable (2.32e-5)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.88e-3)" "unprognostic (2.92e-2)" 5.4 158.2 242.0 3.7 278.4 2.9 5.7 310.9 262.5 10.7 101.9 9.9 4.5 12.6 98.5 5.9 18.9 9.4 6.0 227.7 282.0 33.4 2.5 15.1 3.1 350.7 275.3 215.7 94.6 41.2 18.9 31.6 7.6 298.1 12.8 4.1 70.8 18.2 24.5 1.3 8.3 6.0 12.1 317.6 4.5 10.7 33.6 268.2 10.7 35.8 4.3 4.5 7.8 8.7 331.4 11.2 7.1 36.0 18.6 19.7 12.5 0.6 69.2 33.9 29.7 22.8 0.5 1.7 22.5 23.5 14.5 8.0 19.9 10.6 7.6 37.0 4.4 4.7 1.0 8.1 0.7 2.9 10.0 6.9 10.0 30.6 5.9 5.2 30.5 48.4 25.8 1.3 2.2 15.6 4.4 42.6 2.1 2.6 0.2 5.0 35.6 21.5 17.9 90.1 11.2 20.1 11.5 11.4 0.5 6.8 3.5 1.3 5.0 59.5 31.5 18.1 11.9 18.9 6.0 2.5 2.2 15.3 10.5 9.0 1.9 0.6 0.1 3.9 0.2 2.5 0.2 0.8 2.3 0.3 0.4 0.7 2.6 0.7 1.1 0.4 0.7 0.2 1.2 242.0 278.4 310.9 262.5 227.7 282.0 350.7 275.3 215.7 298.1 317.6 268.2 331.4 1.4 44.8 3.9 248.4 0.8 10.7 16.5 16.3 5.7 101.4 6.8 4.8 2.9 27.1 25.7 27.6 25.0 1.9 3.9 0.4 13.7 79.7 115.0 13.5 9.3 7.7 7.7 0.0 84.3 46.9 0.2 16.8 2.6 14.8 0.0 10.5 10.4 0.2 1.1 101.0 107.0 0.3 10.2 1.3 3.3 100.3 55.0 1.8 3.6 23.4 1.9 145.3 4.1 892.7 513.6 8.9 0.0 58.3 0.7 11.3 0.2 20.4 13.0 14.6 6.6 3.6 11.5 2.9 3.7 2.7 7.2 0.1 3.2 137.4 2.0 9.3 PLAC8 "C15, onzin" ENSG00000145287 "Placenta associated 8" Q9NZF1 4 83090048-83137075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 369.2;esophagus: 92.8;intestine: 238.2;lymphoid tissue: 156.4;stomach 1: 118.6" "Cell type enhanced" "Detected in many" "dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6" "Cancer enhanced" "Detected in many" "stomach cancer: 17.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 2310.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040465, HPA077912" Enhanced Approved Cytosol NA NA Cytosol "HPA040465: AB_10794875, HPA077912: AB_2686870" "unprognostic (6.82e-5)" "prognostic favorable (3.03e-4)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.05e-1)" "unprognostic (4.86e-2)" "unprognostic (1.14e-1)" "unprognostic (1.94e-3)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (7.44e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-7)" "unprognostic (3.89e-2)" "unprognostic (2.85e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" 9.3 2.0 2.5 82.1 4.5 369.2 3.8 2.7 4.2 33.1 1.5 238.2 79.6 2.7 1.2 92.8 18.9 6.6 2.2 1.9 2.6 2.6 35.7 41.5 94.5 5.1 2.9 2.1 1.1 1.6 0.5 2.0 34.0 6.0 3.7 164.8 1.1 6.7 2.3 2.1 1.0 89.3 18.7 1.5 156.4 118.6 0.8 7.3 40.8 2.6 0.8 138.6 11.1 5.9 10.3 183.2 1.3 0.5 1.1 0.0 0.2 28.6 4.6 1.1 11.1 13.7 3.5 510.7 30.7 1.5 52.3 17.0 18.7 3.2 1.4 41.6 0.2 0.6 0.8 33.4 15.2 1.8 329.1 1.7 0.9 3.6 1.8 2.4 0.3 0.8 16.0 0.4 2.6 29.5 0.8 62.6 160.1 1.0 14.4 0.9 8.0 10.6 238.2 0.9 5.4 25.8 0.5 1.2 29.1 0.6 9.0 1.6 187.8 1.3 1.1 31.7 0.9 0.9 1.8 0.4 81.7 2.3 149.7 0.2 49.2 139.2 95.9 392.1 635.8 299.4 523.8 185.1 229.2 129.5 481.1 225.9 263.4 29.7 1053.3 358.9 2310.7 13.8 577.1 2.5 4.5 2.7 4.2 1.9 2.6 5.1 2.9 2.1 6.0 1.5 7.3 10.3 4.3 195.5 39.2 0.3 247.4 0.4 1.7 77.3 0.0 0.3 0.9 1.4 0.5 2.8 119.1 0.0 0.0 18.5 1118.2 1514.4 0.0 0.3 0.5 45.6 1.1 95.0 86.8 58.4 0.1 3.6 572.2 3.1 119.8 2.9 26.6 0.6 141.0 8.4 21.7 1.7 0.1 231.2 67.1 384.5 7.4 0.6 0.0 213.3 7.2 1.0 157.3 1.2 1103.0 0.0 0.2 99.0 865.7 0.0 35.7 1.1 374.4 1.4 549.6 0.3 6.6 0.7 8.0 0.2 0.8 10.1 0.1 14.2 150.6 0.1 104.2 9.0 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430590-82461177 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA 240000 Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavorable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 17.2 24.4 74.8 21.4 81.5 26.9 26.4 81.9 92.8 20.9 65.0 21.3 20.5 16.9 36.2 23.7 16.7 14.8 18.9 74.2 79.3 33.8 22.3 18.5 29.2 83.1 81.0 71.8 20.0 23.7 34.4 20.7 29.3 82.6 26.9 24.2 42.4 19.3 18.2 18.3 21.9 18.6 18.1 85.4 22.4 22.5 10.7 79.0 31.1 28.9 18.8 31.9 22.1 18.0 93.0 56.6 36.6 64.3 40.4 38.3 37.6 69.7 63.7 42.6 57.2 50.6 67.3 61.3 110.8 64.8 49.0 62.6 29.8 86.1 81.3 103.3 67.2 39.2 67.1 33.7 91.0 62.0 113.3 56.0 36.5 84.9 59.7 70.6 41.4 58.8 69.2 88.3 60.1 76.1 73.2 125.8 67.6 59.2 141.8 28.8 88.1 98.2 61.0 94.7 55.5 90.5 55.2 36.2 109.7 86.3 57.3 49.4 54.5 43.3 70.9 52.8 71.2 85.7 67.5 62.4 138.5 45.9 69.5 97.5 5.8 13.9 7.2 21.8 17.1 27.1 20.2 25.9 25.0 20.5 16.9 29.4 24.2 1.2 24.7 14.9 22.4 30.4 20.6 74.8 81.5 81.9 92.8 74.2 79.3 83.1 81.0 71.8 82.6 85.4 79.0 93.0 24.6 16.0 10.5 9.4 31.8 68.6 40.8 47.3 30.7 36.6 22.9 19.8 13.5 18.6 27.5 12.9 16.7 86.7 24.7 10.7 88.0 48.1 7.7 15.2 14.2 25.6 29.3 24.6 18.5 25.7 61.3 22.4 15.3 19.5 38.1 15.3 17.9 10.8 57.7 28.6 21.4 24.8 61.1 23.2 27.9 5.1 26.4 23.1 39.2 6.5 35.6 62.8 29.9 15.1 37.9 41.1 11.1 24.0 28.0 52.6 17.7 56.2 18.8 37.7 13.1 16.4 23.8 9.0 24.9 37.8 64.1 46.7 34.3 27.5 26.7 39.9 CABS1 "C4orf35, CLPH, FLJ32897, NYD-SP26" ENSG00000145309 "Calcium binding protein, spermatid associated 1" Q96KC9 4 70334981-70337116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 107.2" "Group enriched" "Detected in some" 144 "Early spermatids: 1299.5;Late spermatids: 4446.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044016, HPA055352" Enhanced NA NA "HPA044016: AB_10964494, HPA055352: AB_2682790" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1299.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4446.4 19.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GC "DBP, hDBP, VDBP" ENSG00000145321 "GC vitamin D binding protein" P02774 4 71741696-71804041 "Metabolic proteins, Plasma proteins, Predicted secreted proteins" Transport Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 8327.9" "Group enriched" "Detected in some" 27 "Cholangiocytes: 1552.8;Hepatocytes: 3017.1" "Cancer enriched" "Detected in many" 18 "liver cancer: 1016.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 2.0;RH-30: 3.0;SiHa: 1.8;U-698: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001526, CAB008596, HPA019855" Supported "Secreted to blood" NA NA 143000000000 73000000000 "CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545" "prognostic favorable (8.08e-4)" "unprognostic (1.06e-3)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.55e-1)" "unprognostic (2.15e-1)" 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 60.8 0.0 0.6 0.1 0.0 500.0 0.1 0.0 0.0 46.6 8327.9 0.0 0.2 0.0 0.1 0.0 0.0 44.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.1 0.0 0.0 1.8 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.4 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 7.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1552.8 0.0 0.0 0.0 0.0 0.0 0.0 5.9 39.5 0.5 0.1 0.0 2.0 0.0 37.5 0.1 16.2 0.2 0.0 0.0 0.0 0.0 0.0 58.5 3017.1 0.1 0.0 0.1 0.7 0.0 83.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564039 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 99.5;Spermatogonia: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 4.3 3.7 2.2 3.2 2.7 2.2 4.5 2.8 2.9 1.9 1.7 3.6 4.4 2.8 3.9 3.7 5.9 3.4 2.1 1.8 2.3 5.0 9.9 2.5 4.5 3.1 2.8 1.6 3.4 5.9 3.8 2.3 3.8 3.0 4.2 3.6 2.9 3.9 2.2 4.0 3.7 4.5 2.7 2.8 3.6 4.5 10.0 2.4 4.4 6.1 2.7 4.4 2.9 2.0 4.4 8.2 5.4 10.1 5.7 6.0 8.4 7.8 9.6 3.7 5.8 4.1 4.9 9.4 10.9 3.7 5.6 5.9 4.4 10.9 5.1 8.6 13.7 5.4 8.0 4.4 7.6 5.5 19.6 7.8 5.4 14.4 5.7 14.0 3.0 6.4 10.0 17.5 9.4 4.5 9.4 16.4 3.5 6.5 13.8 5.0 9.5 10.2 7.2 8.5 6.8 6.3 5.8 5.3 28.3 9.9 8.5 9.3 7.8 4.9 6.9 7.2 5.5 11.1 7.0 12.4 10.0 4.9 10.9 4.7 2.7 3.9 2.1 1.8 3.8 1.7 3.5 3.3 3.3 5.2 5.8 3.5 3.2 4.9 3.3 3.4 3.0 3.9 1.9 2.2 2.7 2.8 2.9 1.8 2.3 3.1 2.8 1.6 3.0 2.8 2.4 4.4 7.2 3.2 10.3 8.8 8.7 8.2 5.6 8.4 10.2 4.3 12.1 8.6 6.4 11.5 6.6 11.0 4.2 16.8 6.1 10.6 43.0 13.8 46.8 33.5 12.1 7.2 7.2 2.1 5.3 19.3 16.4 6.9 8.6 21.6 8.2 11.0 8.2 32.6 8.5 5.0 4.6 11.1 12.2 8.1 4.1 17.0 6.5 5.0 5.4 1.9 8.4 8.7 5.2 3.5 19.7 14.1 11.0 7.5 10.4 4.8 19.0 31.9 20.6 5.9 13.1 5.7 8.1 99.5 55.0 10.2 9.5 17.5 5.5 8.1 10.6 6.6 KLHL8 KIAA1378 ENSG00000145332 "Kelch like family member 8" Q9P2G9 4 87160103-87240314 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 61.0" "Cell type enriched" "Detected in all" 4 "Muller glia cells: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013856, HPA017762" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013856: AB_1852594, HPA017762: AB_2669660" "unprognostic (2.93e-2)" "unprognostic (4.91e-3)" "unprognostic (3.44e-2)" "unprognostic (4.66e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (2.12e-1)" "unprognostic (4.46e-3)" "unprognostic (3.27e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "prognostic favorable (1.53e-5)" "unprognostic (4.24e-3)" "unprognostic (3.05e-1)" "unprognostic (3.57e-3)" "unprognostic (1.57e-3)" 6.8 7.4 4.8 6.2 4.9 3.2 9.5 7.4 4.9 8.8 2.3 8.0 7.8 6.9 61.0 4.8 5.4 5.0 4.6 4.4 5.7 12.1 11.3 5.2 5.9 4.5 5.7 3.7 6.0 5.3 8.6 3.6 4.3 4.1 5.6 8.9 27.4 7.2 7.5 13.8 4.1 7.7 6.7 5.2 6.4 4.2 4.3 5.5 8.6 19.0 9.8 4.9 6.1 4.2 4.9 9.9 8.5 15.1 6.8 13.5 9.8 8.1 12.4 6.6 8.1 9.5 13.8 7.3 14.3 9.8 9.2 6.6 4.1 16.2 12.2 17.4 13.7 10.1 17.4 6.0 8.1 11.5 28.9 10.5 12.4 8.6 12.4 12.4 7.9 9.7 10.6 22.8 12.7 8.5 10.9 34.8 14.4 3.8 22.1 3.4 12.9 12.9 8.7 13.7 10.1 31.6 11.0 8.1 19.6 9.2 5.6 6.8 21.0 9.2 10.2 12.6 10.9 10.4 18.7 13.1 25.1 7.7 13.5 11.4 2.0 12.2 7.6 2.9 9.2 4.6 3.2 2.2 2.4 10.4 3.5 4.0 4.0 8.6 8.4 9.8 2.6 0.9 5.0 4.8 4.9 7.4 4.9 4.4 5.7 4.5 5.7 3.7 4.1 5.2 5.5 4.9 9.5 3.2 22.9 29.4 14.3 13.8 10.8 10.1 13.6 22.8 11.1 7.7 15.4 5.7 11.6 44.1 41.7 4.1 12.1 21.4 11.7 5.2 4.0 8.3 21.4 12.8 9.0 12.4 44.6 4.5 6.9 10.4 3.1 9.8 7.6 16.8 8.6 20.0 9.7 23.5 41.5 10.8 4.1 38.8 12.0 3.5 9.6 23.3 10.6 24.4 22.1 216.0 11.3 47.3 35.7 4.9 12.2 8.2 6.4 13.8 14.5 19.2 10.1 47.0 13.1 20.1 9.2 32.5 22.5 12.9 14.8 23.8 9.9 4.4 15.2 11.4 SNCA "NACP, PARK1, PARK4, PD1" ENSG00000145335 "Synuclein alpha" P37840 4 89700345-89838315 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 275.9;brain: 137.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4" "Cancer enriched" "Detected in many" 8 "melanoma: 37.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 102.9" "Group enriched" "Detected in all" 4 "dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9" "Cell line enhanced" "Detected in many" "HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005459, CAB010877" Enhanced "Intracellular and membrane" NA NA 28000000 "CAB010877: AB_261518, HPA005459: AB_2667324" "unprognostic (4.80e-2)" "unprognostic (1.52e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-3)" "unprognostic (2.65e-2)" "unprognostic (1.54e-2)" "unprognostic (1.78e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-2)" "unprognostic (3.85e-3)" "unprognostic (1.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.57e-1)" "unprognostic (2.51e-3)" "unprognostic (1.68e-1)" "unprognostic (3.93e-4)" "unprognostic (7.48e-3)" 12.1 10.0 96.5 10.1 137.1 275.9 7.9 69.9 134.4 22.8 42.7 20.7 3.3 34.6 3.4 8.6 11.3 5.4 21.1 128.1 85.2 12.3 3.0 16.7 2.3 115.4 114.2 116.7 29.5 2.2 1.1 28.9 28.6 114.7 17.5 7.0 20.4 16.1 9.8 1.3 16.5 8.6 33.6 56.7 15.3 6.4 3.2 90.9 5.4 10.3 8.6 4.8 9.4 23.4 128.1 0.5 1.0 40.1 0.0 0.7 0.0 0.6 0.4 44.5 1.6 3.0 0.0 0.0 0.2 12.0 0.0 0.0 9.3 53.6 97.7 1.5 0.0 22.6 221.5 115.4 0.5 84.2 0.0 1.4 2.1 38.2 0.0 109.5 117.3 269.8 2.2 2.0 0.6 0.2 0.0 2.1 0.3 10.6 0.2 4.8 0.0 15.8 0.0 0.3 137.3 23.2 15.6 0.2 0.3 271.6 29.0 0.0 0.4 311.4 1.3 8.0 0.1 0.8 0.2 0.2 0.1 8.8 0.2 87.4 51.5 66.9 0.1 0.3 27.7 0.1 4.2 1.9 0.3 84.6 1.7 1.0 0.5 11.1 17.3 8.2 102.9 0.0 63.7 96.5 137.1 69.9 134.4 128.1 85.2 115.4 114.2 116.7 114.7 56.7 90.9 128.1 1.8 0.0 0.6 40.1 2.6 76.6 16.3 173.4 101.3 10.4 0.9 14.4 13.4 0.0 21.5 11.0 0.0 10.1 10.1 0.1 1.9 0.0 0.6 0.3 1.1 19.4 1.8 1225.0 251.5 0.2 1.9 32.7 0.0 0.3 0.0 23.9 7.5 0.8 62.3 10.1 53.8 0.0 44.7 17.2 64.2 1.5 2.1 100.7 352.2 76.8 24.4 19.4 4.1 95.5 195.4 0.2 0.0 0.0 0.5 11.3 0.0 2.0 6.6 7.4 13.1 0.5 5.3 19.6 16.9 4.5 22.6 3.4 3.8 43.6 0.0 3.4 PYURF PreY ENSG00000145337 "PIGY upstream reading frame" Q96I23 4 88520998-88523776 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036455 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA036455: AB_10673388" "unprognostic (8.25e-2)" "unprognostic (9.14e-2)" "unprognostic (6.61e-2)" "unprognostic (2.03e-1)" "unprognostic (5.03e-2)" "unprognostic (7.23e-2)" "unprognostic (1.10e-2)" "unprognostic (8.84e-3)" "unprognostic (3.64e-1)" "unprognostic (1.48e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-2)" "unprognostic (9.04e-3)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" 70.9 72.8 37.1 23.3 38.6 44.9 71.0 40.6 43.8 68.0 35.7 66.1 31.0 75.5 46.0 64.6 66.1 22.7 56.7 36.0 39.4 66.3 82.4 56.9 28.0 40.0 37.7 34.7 65.8 59.5 42.2 66.8 28.7 38.7 62.4 31.5 23.1 55.8 34.3 67.5 65.6 54.4 36.5 41.1 54.8 57.3 42.6 39.1 27.6 54.9 42.7 29.6 62.2 63.0 41.7 60.1 19.8 39.1 46.4 76.7 78.3 26.2 43.2 60.6 53.1 44.6 15.5 46.3 0.2 47.3 61.7 36.4 25.2 35.6 54.4 66.6 73.4 61.8 66.2 24.8 59.9 58.0 110.7 40.9 54.4 80.8 34.5 69.5 50.4 88.5 20.4 75.9 64.9 77.8 45.5 68.5 67.6 32.7 70.5 37.5 68.0 36.3 69.8 44.4 33.4 46.7 45.7 54.9 49.4 119.9 38.4 23.0 54.8 60.6 56.1 51.9 55.3 40.6 45.6 40.1 7.5 49.3 55.7 63.1 82.4 92.1 79.0 90.4 94.9 102.2 98.9 103.2 98.3 111.0 80.5 105.4 101.6 18.1 108.9 95.3 68.3 116.8 186.1 37.1 38.6 40.6 43.8 36.0 39.4 40.0 37.7 34.7 38.7 41.1 39.1 41.7 136.2 51.3 71.3 0.0 92.0 230.4 176.0 167.2 158.8 28.7 207.2 205.2 5.8 84.4 98.8 86.5 10.4 232.3 106.8 65.5 287.6 118.0 44.0 69.7 103.9 127.0 114.6 98.2 0.0 129.5 120.6 119.6 53.5 51.2 105.8 97.7 114.2 147.3 139.4 26.9 0.0 99.4 101.7 115.9 124.7 98.3 125.9 100.0 348.6 0.0 129.2 113.3 176.1 0.0 0.0 103.4 102.7 120.0 84.6 208.7 128.0 236.9 79.1 33.0 59.2 107.3 109.2 108.1 62.3 189.9 289.0 163.9 119.6 136.5 132.8 142.3 TBCK "HSPC302, MGC16169" ENSG00000145348 "TBC1 domain containing kinase" Q8TEA7 4 106041599-106316683 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 134.8;Excitatory neurons: 196.6;Inhibitory neurons: 221.1;Microglial cells: 128.4;Oligodendrocyte precursor cells: 147.2;Oligodendrocytes: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 44.0;BJ hTERT+ SV40 Large T+ RasG12V: 81.7;HBF TERT88: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039951, HPA051611" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA039951: AB_10795300, HPA051611: AB_2681550" "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (8.47e-2)" "unprognostic (1.12e-1)" "unprognostic (8.06e-2)" "unprognostic (1.13e-3)" "unprognostic (1.55e-1)" "unprognostic (3.81e-1)" "unprognostic (8.68e-2)" "unprognostic (1.85e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.20e-4)" "unprognostic (8.17e-3)" "unprognostic (1.69e-1)" "unprognostic (1.12e-1)" "unprognostic (2.29e-1)" 7.4 5.3 5.5 3.1 5.3 1.4 3.4 11.0 5.9 4.6 8.7 3.3 2.3 4.3 6.1 4.2 5.4 5.7 2.8 5.5 6.4 6.4 4.4 4.2 3.0 4.5 5.1 5.2 6.5 5.8 4.8 4.0 5.5 6.6 4.7 3.1 7.6 3.6 6.1 1.6 4.1 3.3 4.8 3.3 3.6 3.6 6.2 5.9 4.8 5.6 4.3 2.6 5.2 3.0 10.2 1.4 5.9 9.0 2.7 36.7 19.1 1.1 8.1 8.9 44.0 81.7 10.9 6.4 2.3 13.0 28.0 7.0 5.4 5.7 8.1 59.3 5.1 1.8 14.1 4.5 10.3 9.7 2.7 6.3 20.9 5.9 4.1 7.1 14.5 11.1 6.0 7.2 3.8 10.2 7.7 5.2 3.7 2.0 14.4 2.0 4.1 3.7 6.8 11.1 9.0 4.4 4.1 8.2 4.0 5.6 7.6 4.8 8.5 8.3 7.7 4.3 2.4 4.4 2.5 6.1 6.8 10.1 5.6 5.0 14.1 5.1 5.1 4.7 5.7 5.6 4.8 4.9 6.4 4.8 7.9 5.6 5.2 0.4 5.2 3.8 4.4 5.5 4.0 5.5 5.3 11.0 5.9 5.5 6.4 4.5 5.1 5.2 6.6 3.3 5.9 10.2 7.7 19.2 25.2 134.8 13.9 2.3 6.4 9.0 17.1 20.7 8.2 6.9 8.2 5.7 15.5 14.7 20.9 11.5 9.0 3.5 3.9 4.3 45.7 10.2 15.9 8.9 5.4 9.2 196.6 0.9 6.6 12.5 15.3 21.1 11.4 21.5 8.6 4.6 6.8 11.8 221.1 5.7 10.2 6.2 1.6 28.2 11.1 7.7 5.4 128.4 4.6 8.1 10.3 147.2 188.8 2.2 8.0 12.8 10.4 4.3 4.8 8.0 11.9 15.3 0.0 10.6 9.6 14.5 8.2 14.2 2.4 7.4 10.6 13.9 5.5 4.5 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 160.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 272.6" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 28.4 25.9 55.1 26.9 47.8 5.8 21.2 48.1 50.2 18.4 7.8 36.8 29.1 23.7 9.9 29.9 19.0 30.9 160.7 55.7 39.9 19.5 37.6 23.1 35.5 16.0 38.4 47.4 25.7 15.4 56.9 9.2 20.0 18.0 32.5 39.4 79.9 13.5 42.1 106.0 15.3 34.4 25.1 17.4 18.6 37.5 19.9 47.1 16.4 24.0 60.6 31.7 27.6 19.8 36.8 4.8 62.5 67.5 22.8 144.0 272.6 24.0 145.4 96.3 56.0 48.0 42.3 17.6 91.2 20.7 102.3 70.7 2.1 42.6 22.8 56.6 35.1 10.8 0.0 22.0 49.2 73.0 0.1 0.2 176.3 30.5 43.5 107.1 88.5 50.6 11.3 3.6 39.4 106.8 17.1 9.3 3.6 9.8 60.3 22.8 17.9 79.0 0.4 57.3 42.7 18.2 18.3 20.0 29.3 19.5 55.9 0.6 23.7 30.7 146.9 34.8 63.6 29.1 30.4 16.5 76.7 75.7 5.5 70.8 0.0 12.7 0.0 6.7 7.0 12.7 11.2 6.6 7.5 15.7 22.6 7.4 6.5 0.9 9.7 2.5 0.1 13.2 7.7 55.1 47.8 48.1 50.2 55.7 39.9 16.0 38.4 47.4 18.0 17.4 47.1 36.8 43.7 41.7 37.6 128.3 55.1 18.4 16.6 8.3 22.8 83.3 14.0 17.1 272.9 62.9 24.7 29.5 87.6 0.5 19.0 70.9 5.9 8.4 3.2 18.2 35.2 27.2 103.8 3.6 182.9 20.1 0.4 50.1 71.9 47.0 10.1 13.0 24.3 57.2 18.6 72.3 200.0 88.1 14.2 17.3 22.3 6.2 20.2 31.5 5.4 187.4 16.0 35.9 28.8 203.1 128.0 11.6 57.3 19.9 20.4 36.2 52.4 23.1 21.7 74.0 6.6 32.8 44.4 3.1 3.4 37.1 31.8 1.1 27.8 12.3 48.6 27.5 CISD2 "ERIS, Miner1, NAF-1, WFS2, ZCD2" ENSG00000145354 "CDGSH iron sulfur domain 2" Q8N5K1 4 102868974-102892807 "Disease related genes, Human disease related genes, Predicted membrane proteins" Autophagy "Deafness, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.4" "Cell type enhanced" "Detected in all" "Erythroid cells: 256.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015914 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA015914: AB_1846794" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (6.54e-3)" "unprognostic (8.02e-2)" "unprognostic (2.78e-2)" "unprognostic (3.56e-2)" "unprognostic (1.17e-3)" "unprognostic (3.48e-3)" "unprognostic (9.12e-3)" "unprognostic (2.04e-1)" "unprognostic (2.54e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" 9.8 19.2 2.8 5.5 3.1 6.1 9.1 4.2 3.3 9.3 4.2 10.4 1.7 9.6 5.4 12.6 8.9 4.3 10.6 2.8 3.3 17.9 46.4 10.8 5.5 3.2 3.0 2.5 8.9 20.2 5.4 12.9 3.1 3.3 9.6 3.9 6.1 12.1 1.9 7.4 9.4 11.0 3.0 3.1 14.9 11.5 6.6 3.1 4.0 13.7 1.7 3.5 9.9 10.2 4.3 16.8 5.5 5.8 7.2 14.2 15.2 3.7 12.6 4.6 5.4 8.2 6.5 27.7 12.1 10.9 12.2 12.9 8.1 28.2 10.1 24.8 10.7 4.2 10.5 3.6 6.7 10.1 18.7 16.1 5.9 15.1 23.0 17.8 5.2 9.8 6.7 22.7 21.3 14.7 4.6 16.5 5.4 11.2 5.7 4.0 6.7 5.9 22.2 13.6 5.3 13.4 7.8 7.5 12.8 12.8 6.6 8.5 4.0 4.4 15.8 17.8 21.3 7.8 16.3 23.5 24.2 11.2 5.7 12.6 4.6 2.8 5.8 2.6 2.7 2.7 2.5 2.6 2.7 2.7 2.1 1.7 2.2 2.0 4.4 3.1 3.5 3.5 2.3 2.8 3.1 4.2 3.3 2.8 3.3 3.2 3.0 2.5 3.3 3.1 3.1 4.3 24.2 25.6 26.1 10.1 65.3 85.7 45.3 131.0 60.3 33.5 61.2 51.3 27.8 58.6 70.4 77.3 20.9 74.2 52.7 52.9 72.4 101.8 12.2 39.9 41.8 35.8 43.0 256.8 17.5 77.2 131.0 39.6 39.8 48.3 57.8 24.2 26.0 159.9 110.9 30.3 22.1 94.2 146.5 93.5 128.9 6.9 23.9 66.4 69.4 12.2 78.4 36.9 45.3 17.6 25.9 74.3 88.5 33.8 194.3 63.7 82.7 203.9 63.1 33.1 32.9 22.1 41.6 41.7 36.7 56.4 90.1 56.8 54.0 33.4 68.6 53.9 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 326.6;tongue: 107.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 22.0;Distal tubular cells: 21.5;Extravillous trophoblasts: 18.5;Granulosa cells: 23.5;Sertoli cells: 19.7" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.3;BJ: 29.6;fHDF/TERT166: 16.2;HSkMC: 14.7;hTERT-RPE1: 32.8;RPTEC TERT1: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 2.8 1.0 6.7 0.6 17.9 0.4 2.2 8.2 11.1 23.1 7.0 1.7 0.3 1.5 1.8 7.7 2.2 0.6 2.3 9.9 8.1 13.0 0.4 0.8 0.5 11.1 8.5 6.5 7.8 0.4 0.6 2.0 3.7 11.7 11.3 0.9 1.2 17.5 7.0 326.6 0.9 0.7 1.6 8.9 1.2 0.5 3.1 8.3 1.2 1.1 107.9 0.4 1.2 2.6 8.5 0.0 2.2 8.5 0.0 3.7 19.3 1.2 29.6 2.5 0.5 0.1 0.1 0.9 0.0 0.7 16.2 0.7 0.0 6.2 0.5 0.5 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 14.7 0.1 0.3 1.5 32.8 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 9.7 0.0 0.0 0.6 0.0 0.0 20.5 0.1 0.1 0.1 0.6 1.2 4.0 2.0 0.0 0.1 0.1 0.0 0.0 0.0 2.3 3.9 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 6.7 17.9 8.2 11.1 9.9 8.1 11.1 8.5 6.5 11.7 8.9 8.3 8.5 3.8 0.0 0.0 6.2 0.0 2.7 0.2 4.2 1.8 0.1 1.0 0.9 7.3 0.0 1.3 22.0 0.0 1.9 0.4 0.2 21.5 0.1 0.8 0.5 0.3 3.6 0.0 0.0 0.0 0.0 18.5 5.1 1.5 0.9 0.0 23.5 0.0 0.0 12.0 0.0 0.5 0.3 0.0 0.0 3.0 0.4 0.9 0.3 7.2 0.0 0.0 8.6 0.0 0.5 0.0 0.5 0.0 2.2 0.2 1.1 0.0 2.2 0.1 0.2 19.7 7.3 11.9 4.7 0.8 0.9 1.4 4.0 0.6 8.3 0.4 0.3 ANK2 "CFAP87, FAP87, LQT4" ENSG00000145362 "Ankyrin 2" Q01484 4 112818032-113384221 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 166.7;retina: 192.8;skeletal muscle: 173.3;tongue: 151.8" "Group enriched" "Detected in many" 4 "Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893" "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 31.3 13.7 83.9 11.3 112.0 0.1 18.5 65.8 166.7 31.9 0.0 22.7 8.6 16.0 5.9 13.0 9.7 22.6 120.7 97.9 87.2 111.1 2.4 7.3 9.3 131.2 75.0 91.8 27.5 3.2 1.2 19.5 2.1 125.2 7.9 11.5 192.8 6.8 13.5 173.3 8.0 12.8 25.1 46.1 28.6 8.4 9.5 91.2 4.5 9.7 151.8 7.3 9.5 12.4 141.9 0.1 2.9 18.7 5.2 29.2 32.2 0.1 1.5 3.4 0.9 2.6 4.2 0.0 6.9 2.1 5.9 4.1 0.1 11.0 0.6 1.0 2.3 7.3 4.0 0.0 2.9 1.7 1.9 1.2 15.2 3.0 1.2 6.0 3.9 0.0 0.4 0.0 9.3 5.8 0.3 0.2 0.1 9.4 0.1 2.0 0.7 49.6 0.0 0.2 0.0 13.6 24.1 0.2 0.7 8.1 11.7 0.1 1.1 0.0 4.7 2.2 0.4 3.0 6.8 1.8 0.9 20.1 0.6 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.9 112.0 65.8 166.7 97.9 87.2 131.2 75.0 91.8 125.2 46.1 91.2 141.9 6.9 0.0 3.9 1101.2 1.1 10.5 0.0 0.0 1.8 376.6 0.2 0.6 188.5 0.0 1.3 20.2 479.6 0.1 0.0 0.0 15.6 0.0 111.2 36.4 6.0 6.4 66.0 0.0 1282.0 1.6 0.1 79.0 2.0 7.2 1.3 81.8 0.0 0.4 1.0 1431.8 1060.7 0.4 8.2 0.0 19.7 49.8 36.4 2.9 17.8 90.9 0.6 44.5 0.0 497.1 1351.0 0.1 5.0 30.1 0.9 0.4 0.1 127.9 0.8 484.4 6.6 24.3 26.5 2.3 1.5 0.8 9.5 0.0 1.9 2.6 0.3 0.2 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274537-112285904 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 86.6;Syncytiotrophoblasts: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 137.4;U-698: 123.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.2 6.4 2.0 20.1 1.9 40.9 13.8 4.3 2.7 7.7 4.4 7.1 6.8 5.6 2.2 15.7 6.8 7.5 10.8 2.2 3.4 5.2 11.3 10.3 32.5 2.2 2.2 1.5 9.4 41.7 11.6 2.1 14.3 2.5 6.7 7.0 2.9 35.1 3.7 3.9 9.3 8.9 5.4 2.3 11.8 10.4 2.1 2.4 15.6 21.3 6.5 34.9 11.7 7.8 2.2 21.9 5.5 7.9 13.4 9.5 7.7 15.9 17.0 32.0 10.6 18.1 2.8 19.1 66.3 13.5 6.8 15.5 6.3 10.9 13.0 22.1 54.1 6.4 6.6 12.4 6.2 6.4 21.2 8.8 10.4 7.0 11.4 12.3 18.0 17.0 18.1 6.8 137.4 14.3 11.0 37.3 11.5 1.6 13.4 7.0 63.7 19.9 44.7 23.6 14.7 18.1 18.6 13.7 28.2 6.6 3.4 12.2 29.9 12.7 16.7 19.8 14.2 13.6 85.3 84.8 123.8 15.7 13.8 12.6 6.8 7.2 4.0 11.1 5.2 18.1 38.2 20.4 19.4 13.2 40.4 9.0 11.6 21.4 17.4 6.8 12.3 33.9 11.3 2.0 1.9 4.3 2.7 2.2 3.4 2.2 2.2 1.5 2.5 2.3 2.4 2.2 35.7 19.2 27.4 0.0 44.8 21.3 15.7 27.8 43.9 1.4 31.6 30.9 15.4 12.8 15.7 12.9 0.0 47.9 23.4 4.4 19.6 16.5 0.1 10.0 9.6 31.8 9.0 7.6 1.4 24.4 20.9 22.3 14.8 21.0 3.8 5.4 6.4 10.7 17.8 0.0 0.6 8.4 28.5 13.0 29.7 1.4 9.0 13.1 33.8 2.8 7.1 12.5 11.3 0.5 0.1 11.4 8.0 10.9 86.6 29.2 11.0 9.5 8.8 0.6 6.6 27.2 10.5 2.5 3.8 39.2 26.0 79.4 35.9 5.7 7.0 15.1 SPATA5 "AFG2, SPAF" ENSG00000145375 "Spermatogenesis associated 5" Q8NB90 4 122923070-123319433 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Chaperone, Developmental protein, Hydrolase" "Deafness, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036450, HPA036451" Approved Approved Cytosol NA NA Cytosol "HPA036450: AB_2675131, HPA036451: AB_10670107" "unprognostic (4.28e-1)" "unprognostic (7.54e-2)" "unprognostic (7.37e-3)" "unprognostic (1.26e-1)" "unprognostic (5.16e-1)" "unprognostic (1.18e-1)" "unprognostic (7.65e-4)" "unprognostic (1.95e-3)" "unprognostic (9.00e-2)" "unprognostic (2.78e-1)" "unprognostic (4.43e-3)" "unprognostic (4.62e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (5.68e-1)" "unprognostic (2.63e-2)" "unprognostic (1.79e-1)" 1.2 0.8 0.7 0.9 1.1 1.4 1.7 2.2 0.9 1.3 1.2 1.0 0.6 1.3 0.8 1.0 1.0 0.8 0.9 0.6 0.9 1.1 1.1 0.9 1.2 1.0 1.1 0.5 1.2 0.8 1.5 0.7 1.4 1.3 1.1 1.2 2.3 1.0 1.1 1.3 1.2 0.7 1.3 1.0 1.3 2.3 3.6 1.0 2.0 1.5 1.2 1.2 1.0 1.1 1.3 2.3 3.2 2.9 7.1 2.4 1.7 1.9 4.0 1.6 3.3 3.3 1.5 3.2 3.7 2.4 2.4 2.4 2.0 5.0 2.2 5.6 6.2 0.9 3.8 5.7 2.5 1.1 5.2 4.0 1.2 1.1 3.8 3.3 1.7 3.4 2.4 7.7 6.2 4.6 2.4 10.1 3.2 2.1 3.6 1.3 3.3 7.2 2.4 1.9 1.9 4.8 3.1 3.2 2.3 1.7 4.2 2.2 2.0 2.6 6.9 5.2 4.6 4.2 3.9 5.0 3.3 3.3 4.4 6.2 0.5 0.2 0.2 0.6 0.6 0.4 0.5 0.5 0.5 0.1 0.5 0.5 0.5 0.3 0.5 0.2 0.7 0.3 0.2 0.7 1.1 2.2 0.9 0.6 0.9 1.0 1.1 0.5 1.3 1.0 1.0 1.3 10.7 16.0 5.0 34.6 9.1 5.1 5.6 2.6 6.2 6.2 4.2 3.2 4.3 11.5 7.4 1.8 14.6 5.1 6.7 2.9 0.0 3.1 207.9 4.5 9.6 8.5 2.4 11.2 48.8 3.6 4.3 5.1 14.3 5.2 5.1 8.6 4.2 3.2 3.5 3.3 59.0 2.6 0.0 4.1 5.3 25.0 7.2 5.3 0.0 104.0 1.8 4.0 4.1 79.9 91.4 4.2 2.1 4.5 10.6 3.9 1.5 3.1 6.4 11.3 0.0 12.5 6.6 14.7 10.6 5.0 5.4 2.2 9.9 4.7 4.1 3.0 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322138 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 173 "intestine: 554.6" "Cell type enriched" "Detected in some" 10 "Proximal enterocytes: 5965.8" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basophil: 1.6;neutrophil: 4.2" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.2" "Cell line enhanced" "Detected in some" "NB-4: 1.2;RPMI-8226: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 61000 "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.2 0.1 0.1 3.2 0.1 0.9 0.0 0.7 0.3 0.0 0.4 28.5 293.6 0.3 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.3 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 35.6 0.3 0.0 0.0 0.1 0.4 554.6 1.9 0.0 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.3 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 1.6 0.4 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.2 4.2 0.4 0.1 0.3 0.3 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 1.8 0.0 0.0 0.0 242.0 0.0 0.0 0.0 1.4 0.1 0.1 1.2 0.0 0.0 0.2 0.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 570.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 383.1 0.0 0.0 0.0 5965.8 17.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 222.5 0.0 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823883 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.9;lymphoid tissue: 47.3;retina: 32.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 3.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 3.4;white matter: 7.6" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 1.5 1.3 3.4 11.5 2.7 38.9 2.5 3.7 3.9 3.6 2.8 9.9 10.2 2.5 0.6 8.5 2.2 1.8 1.3 2.7 2.7 1.4 1.6 1.8 25.2 2.8 2.9 2.4 3.8 0.8 0.6 2.7 10.5 3.9 2.0 11.6 32.0 1.8 0.8 0.7 6.7 10.0 4.0 3.1 4.6 4.5 6.2 3.3 47.3 1.2 0.5 24.5 2.9 3.9 4.0 177.1 45.3 120.5 51.8 6.4 16.3 98.8 119.7 52.8 156.7 115.6 99.4 106.5 161.2 31.7 63.8 55.0 58.0 154.2 71.1 128.0 77.8 70.8 129.7 56.0 96.9 1.5 197.0 88.0 4.2 5.3 65.1 38.7 24.7 95.4 84.3 187.9 156.9 126.1 63.8 251.8 113.1 95.5 109.9 49.8 114.1 233.5 78.2 44.8 34.6 51.0 53.8 63.1 76.0 32.4 89.8 63.7 81.9 56.5 72.7 109.3 77.4 115.9 98.0 112.3 181.9 41.5 197.6 82.4 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.9 0.6 0.4 0.0 0.0 0.2 0.1 0.8 0.1 0.0 3.1 0.9 3.4 2.7 3.7 3.9 2.7 2.7 2.8 2.9 2.4 3.9 3.1 3.3 4.0 0.8 0.0 1.1 1.6 5.7 2.8 1.5 5.5 1.8 2.9 1.9 1.8 0.8 0.0 1.6 0.0 12.5 47.9 1.9 4.9 0.0 0.7 9.6 0.6 2.7 3.3 1.2 102.1 3.3 0.2 92.8 6.3 9.2 2.1 0.0 18.1 4.2 0.9 25.3 0.0 4.1 7.7 8.2 6.9 3.6 2.1 0.9 3.6 1.8 2.8 0.2 1.2 0.0 4.5 5.2 0.5 3.1 1.2 35.5 3.3 1.8 0.2 2.5 14.2 0.0 0.9 6.0 10.3 17.7 24.0 1.3 8.5 6.3 1.4 19.9 2.1 METTL14 KIAA1627 ENSG00000145388 "Methyltransferase like 14" Q9HCE5 4 118685392-118715433 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038002 Supported Supported Nucleoplasm Yes No Nucleoplasm "HPA038002: AB_10672401" "unprognostic (4.48e-1)" "unprognostic (5.13e-2)" "unprognostic (5.98e-3)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.83e-1)" "unprognostic (3.75e-2)" "unprognostic (4.40e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-2)" "unprognostic (3.64e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (1.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-3)" "unprognostic (7.76e-3)" 8.3 8.8 5.2 8.7 6.2 19.7 11.6 6.8 6.3 8.7 5.6 8.8 8.9 11.8 10.8 9.0 8.8 7.8 8.4 4.8 6.4 10.3 15.0 9.2 11.7 5.6 5.4 4.2 12.8 7.8 11.0 8.3 9.0 6.2 9.8 8.3 11.8 7.7 8.0 8.5 11.0 9.3 9.3 5.1 10.9 7.9 15.2 5.7 12.6 10.7 7.8 11.1 8.6 7.9 7.5 19.6 8.9 19.0 17.8 11.7 14.7 13.8 17.1 13.0 12.6 14.4 12.9 22.8 22.0 9.8 12.0 12.6 9.4 16.2 14.1 16.1 17.5 9.8 18.5 11.4 14.4 13.3 30.2 21.2 13.1 15.8 14.6 9.6 16.5 11.5 17.4 20.1 18.2 17.5 13.2 29.7 24.7 16.2 16.7 7.7 16.8 23.7 11.2 13.8 12.7 15.4 17.3 12.0 22.0 17.2 17.2 10.0 28.5 15.8 18.1 16.6 16.3 13.7 15.2 17.0 24.9 12.9 16.5 15.1 37.7 12.8 29.0 17.0 19.6 19.3 24.3 17.8 17.7 15.3 25.3 21.0 19.0 10.3 21.8 23.7 12.1 20.8 13.7 5.2 6.2 6.8 6.3 4.8 6.4 5.6 5.4 4.2 6.2 5.1 5.7 7.5 18.6 25.6 25.9 14.7 20.6 10.8 18.3 10.6 16.5 16.8 13.4 12.6 15.7 17.2 20.8 23.9 22.9 18.7 28.3 13.7 11.7 11.9 96.9 14.5 21.7 17.3 12.1 8.4 18.7 15.6 10.2 16.8 9.2 18.0 22.1 18.3 16.4 32.1 12.1 8.4 17.0 15.2 6.1 17.9 7.6 16.7 18.6 13.3 7.2 14.0 14.0 13.4 25.7 14.1 26.9 14.8 13.0 13.9 8.2 17.1 15.4 20.6 15.2 25.4 13.1 15.3 15.5 42.2 28.1 12.4 11.9 15.3 20.6 17.0 12.8 16.0 USP53 KIAA1350 ENSG00000145390 "Ubiquitin specific peptidase 53" Q70EK8 4 119212587-119295517 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 586.8;Microglial cells: 269.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 327.9;SK-MEL-30: 102.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035844, HPA035845" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035844: AB_10669532, HPA035845: AB_2674817" "unprognostic (9.33e-2)" "unprognostic (1.49e-2)" "prognostic favorable (3.15e-6)" "unprognostic (4.37e-3)" "unprognostic (4.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.54e-6)" "prognostic favorable (3.58e-8)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" 38.2 14.6 6.1 5.8 6.0 0.9 25.5 7.0 7.3 18.7 12.5 16.4 5.7 13.2 13.3 17.2 30.9 10.3 24.2 5.3 9.0 20.1 7.4 29.7 12.5 9.4 7.7 3.3 9.5 24.9 8.2 10.3 10.6 8.8 9.3 16.2 3.4 12.8 11.6 33.8 10.9 9.7 10.3 7.1 7.2 15.2 7.9 8.4 5.5 10.6 52.1 8.0 12.8 12.1 6.3 11.4 6.8 2.4 0.0 60.5 60.4 13.6 70.6 327.9 6.2 8.1 7.4 10.4 46.1 2.5 21.1 12.1 5.5 5.5 5.3 16.1 6.1 4.5 3.1 5.2 2.6 47.2 3.9 0.7 20.3 15.0 21.9 31.0 11.7 29.8 3.0 7.3 1.7 8.4 2.5 2.9 5.2 6.7 7.0 3.8 0.9 11.4 9.2 16.4 7.2 3.8 3.0 3.9 27.5 102.4 13.3 7.0 2.7 32.3 2.0 7.0 26.3 6.4 3.3 5.2 7.8 31.4 1.7 7.9 1.3 0.0 0.0 0.4 0.0 0.5 0.7 1.0 0.8 0.1 0.7 1.9 1.0 0.2 0.9 0.0 0.3 0.9 0.3 6.1 6.0 7.0 7.3 5.3 9.0 9.4 7.7 3.3 8.8 7.1 8.4 6.3 27.6 35.3 44.5 80.6 18.5 61.8 73.6 21.2 48.3 17.8 74.1 46.6 99.0 32.9 33.9 119.5 29.2 48.4 15.1 207.8 45.0 33.4 5.6 167.2 45.9 35.7 34.6 4.8 32.4 62.7 17.3 86.0 41.8 586.8 70.8 19.8 23.9 30.5 9.3 25.2 32.5 80.4 52.9 21.3 76.4 7.3 19.0 36.5 14.2 269.8 45.6 25.0 12.3 11.6 11.9 110.6 214.5 10.9 18.6 138.6 46.0 20.1 27.3 31.5 6.6 91.8 32.9 18.0 4.0 62.6 42.3 49.8 26.8 14.8 62.6 124.8 SETD7 "KIAA1717, KMT7, SET7, SET7/9, Set9" ENSG00000145391 "SET domain containing 7, histone lysine methyltransferase" Q8WTS6 4 139495941-139606699 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058111 Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA058111: AB_2683607" "prognostic unfavorable (8.28e-4)" "unprognostic (7.07e-2)" "unprognostic (4.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.92e-1)" "unprognostic (4.82e-2)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.71e-2)" "unprognostic (9.10e-2)" "unprognostic (6.44e-2)" "unprognostic (7.75e-2)" "unprognostic (1.37e-1)" "unprognostic (6.16e-3)" "unprognostic (1.17e-1)" "unprognostic (6.92e-2)" "unprognostic (6.56e-3)" 45.1 18.7 17.1 15.3 21.1 9.8 27.6 19.2 19.2 40.8 21.0 19.6 7.3 33.3 12.7 28.3 19.0 27.0 41.4 16.8 18.7 10.2 50.5 19.4 11.8 24.7 21.0 10.9 19.8 22.1 35.0 8.9 19.3 24.1 35.4 15.4 11.6 16.3 20.8 107.6 22.9 12.2 35.1 27.7 17.1 20.3 14.5 23.9 10.2 14.2 74.3 16.1 23.6 18.4 30.8 28.4 37.2 13.0 7.8 77.1 65.9 29.6 65.7 67.3 32.4 27.1 22.7 37.2 68.0 25.5 110.5 22.4 13.9 44.3 51.3 52.4 32.8 33.0 8.9 45.5 0.8 38.4 31.9 12.9 57.7 58.6 52.1 54.6 41.2 41.7 27.8 5.5 96.1 42.3 46.8 21.0 4.6 6.4 40.8 23.9 19.7 48.4 37.3 31.5 25.3 55.3 18.5 44.7 63.5 15.3 12.6 25.3 28.0 68.8 57.1 40.7 68.6 55.2 89.6 86.8 42.2 65.9 31.1 28.0 0.5 3.9 0.2 0.3 2.0 2.7 1.0 1.1 1.1 4.4 1.2 0.4 0.2 0.9 0.2 3.2 2.1 3.7 1.2 17.1 21.1 19.2 19.2 16.8 18.7 24.7 21.0 10.9 24.1 27.7 23.9 30.8 28.7 6.4 18.8 17.3 8.9 17.2 14.5 14.1 12.5 5.4 24.0 14.7 43.1 20.0 15.0 9.2 12.5 26.2 4.2 4.1 0.0 22.7 1.3 3.5 35.9 29.4 1.2 3.6 21.1 21.2 16.7 39.8 16.8 7.5 2.5 2.9 37.1 70.6 20.4 8.4 42.4 13.6 18.3 31.0 20.9 4.3 23.0 19.5 10.6 19.7 19.0 15.0 0.0 36.2 29.2 22.4 4.1 28.2 13.2 38.4 1.3 4.5 14.0 12.9 19.7 35.2 23.3 3.7 2.7 17.9 22.0 46.1 9.8 9.5 11.7 20.4 NAF1 ENSG00000145414 "Nuclear assembly factor 1 ribonucleoprotein" Q96HR8 4 163110073-163166890 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036241, HPA036242, HPA066090" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614" "unprognostic (6.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-2)" "unprognostic (2.58e-1)" "unprognostic (8.99e-2)" "unprognostic (2.00e-2)" "unprognostic (1.18e-2)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.64e-3)" "unprognostic (1.45e-1)" "unprognostic (8.73e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.17e-2)" "unprognostic (3.05e-1)" 9.6 8.2 4.1 7.6 5.7 7.7 8.4 3.6 6.8 8.8 7.4 7.3 4.8 10.5 6.1 7.1 12.4 7.0 6.5 5.9 5.9 6.9 7.2 7.0 8.7 3.1 2.5 4.0 11.0 7.8 10.8 4.9 6.7 1.4 8.5 8.2 13.6 7.7 8.6 19.5 8.4 4.9 8.8 3.4 7.3 6.0 13.5 1.7 7.1 10.3 10.4 8.0 9.5 4.9 5.2 15.2 12.7 16.0 16.4 9.2 14.5 18.8 17.6 11.7 15.1 15.0 14.4 17.8 39.4 5.0 10.9 12.2 12.5 32.7 18.9 19.7 17.5 20.2 41.7 11.4 12.3 16.1 27.2 14.3 13.7 16.5 18.5 14.9 15.6 13.6 12.5 47.7 20.3 20.4 15.0 31.8 15.5 20.9 11.5 12.5 26.1 11.8 20.7 15.0 6.9 17.3 13.1 11.6 20.9 13.0 13.9 11.3 11.8 14.4 18.0 15.6 14.1 20.2 12.7 19.1 30.2 17.1 15.6 18.2 0.0 0.5 0.0 0.7 0.5 0.2 0.6 0.7 1.0 0.8 0.7 1.0 0.7 0.0 0.4 0.5 0.8 0.2 0.5 4.1 5.7 3.6 6.8 5.9 5.9 3.1 2.5 4.0 1.4 3.4 1.7 5.2 15.2 6.4 16.7 24.8 25.9 32.4 23.6 10.5 19.4 10.9 10.7 12.8 4.0 11.5 8.0 9.2 18.8 14.3 19.0 4.2 3.9 9.8 48.0 35.7 13.3 9.2 19.2 11.1 44.8 6.8 15.6 25.1 9.2 22.1 10.8 10.2 12.1 5.0 11.7 8.4 30.9 8.2 4.1 17.9 13.3 19.1 6.8 32.8 8.8 19.7 6.0 10.3 4.1 31.7 29.8 7.8 4.0 5.3 16.4 14.4 2.8 8.9 30.3 14.7 32.9 29.8 24.7 23.6 16.2 14.8 41.1 21.3 24.9 13.0 8.0 13.1 MARCHF1 "FLJ20668, MARCH-I, MARCH1, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;retina: 27.8" "Group enriched" "Detected in some" 4 "B-cells: 21.4;Hofbauer cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 94 "classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 7.1;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014600, HPA048024" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA Vesicles "Endoplasmic reticulum, Golgi apparatus" "HPA014600: AB_1853573, HPA048024: " "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 6.5 3.5 6.8 21.7 8.0 4.0 2.7 4.1 9.3 3.0 3.2 3.5 4.0 2.5 0.7 3.0 2.8 5.3 1.7 7.1 10.6 1.6 4.2 8.1 31.9 8.4 6.9 6.7 2.7 2.9 0.8 2.5 10.0 7.3 2.3 4.6 27.8 3.2 1.2 1.0 4.5 7.0 6.2 6.4 26.0 3.9 1.7 11.9 5.6 2.1 1.0 25.7 7.8 3.0 15.3 0.6 0.5 2.1 1.2 0.0 0.0 1.3 0.9 0.0 0.0 0.0 1.2 2.4 7.1 2.5 0.0 0.2 1.0 0.0 0.0 0.0 0.8 0.7 5.0 3.0 0.5 0.0 3.1 1.6 0.0 0.0 0.0 0.1 2.8 0.0 1.3 1.9 3.6 2.4 0.7 1.8 1.9 2.6 0.2 0.9 2.0 0.3 0.5 0.1 1.1 1.0 0.9 0.6 1.0 0.4 1.4 2.9 0.5 2.3 0.8 1.4 0.5 1.7 7.0 2.5 1.9 0.9 1.5 1.1 0.0 41.8 25.5 0.1 41.0 0.0 42.3 0.1 0.0 44.2 35.8 0.0 0.0 0.3 0.3 45.4 16.5 0.0 18.4 6.8 8.0 4.1 9.3 7.1 10.6 8.4 6.9 6.7 7.3 6.4 11.9 15.3 0.1 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 SFRP2 "FRP-2, SARP1, SDF-5" ENSG00000145423 "Secreted frizzled related protein 2" Q96HF1 4 153780591-153789083 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 321.6;urinary bladder: 309.6" "Cell type enriched" "Detected in many" 4 "Fibroblasts: 806.1" "Cancer enhanced" "Detected in all" "pancreatic cancer: 370.9" "Region enhanced" "Detected in all" "hypothalamus: 44.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002652 Approved "Intermediate filaments" "Secreted in other tissues" NA NA "Intermediate filaments" "HPA002652: AB_2732394" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (7.21e-3)" "unprognostic (1.80e-2)" "unprognostic (2.73e-1)" "unprognostic (8.80e-3)" "unprognostic (5.71e-3)" "unprognostic (2.62e-2)" "unprognostic (2.79e-1)" "unprognostic (7.47e-3)" "unprognostic (1.44e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (9.29e-3)" "unprognostic (4.72e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.39e-4)" 189.8 16.2 5.3 85.4 3.9 0.3 156.5 3.5 11.4 21.8 21.9 72.9 18.5 12.1 22.4 214.7 62.7 321.6 4.3 12.2 44.9 4.4 0.3 63.1 11.9 4.5 6.4 2.1 8.4 45.5 7.0 73.1 0.4 6.7 57.0 44.7 2.3 84.1 71.2 6.5 78.7 57.8 90.4 3.9 0.7 34.7 1.5 3.2 9.6 93.1 39.1 3.7 309.6 63.5 10.4 0.0 0.0 229.1 0.2 85.2 15.1 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 140.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 318.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.1 0.1 0.0 8.1 0.2 0.0 0.0 0.4 0.1 0.0 12.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.9 3.5 11.4 12.2 44.9 4.5 6.4 2.1 6.7 3.9 3.2 10.4 15.5 3.2 0.6 9.4 0.5 115.5 0.8 0.0 5.7 0.0 3.7 7.9 0.3 0.0 1.9 0.0 0.0 0.1 2.0 0.0 0.0 0.2 0.0 0.1 0.1 11.8 0.0 0.0 0.7 0.0 0.2 806.1 38.7 0.3 1.3 0.0 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.0 175.0 0.5 4.1 5.0 119.2 0.0 0.6 0.0 0.0 0.5 0.1 0.1 0.0 7.2 4.1 0.7 0.0 0.1 2.9 0.0 0.0 6.7 59.4 0.0 0.1 6.9 106.0 0.1 8.6 0.0 0.0 0.9 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099624-151104642 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No 300000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 2169.2 1372.5 1062.3 1370.3 1086.0 4357.7 4649.6 1069.2 1685.9 3073.8 1106.6 1898.6 1326.4 1983.4 2323.5 2268.7 2327.8 1197.3 1401.0 1029.5 1090.9 1663.5 1382.3 1483.8 3368.9 1083.3 1072.8 1015.2 4918.6 3544.2 1117.1 1336.1 1384.1 1084.4 1999.7 1795.1 869.4 2126.0 1335.5 1984.1 2760.2 1864.0 1349.2 1143.0 2055.0 1914.4 591.4 1109.2 3019.0 1983.1 1512.4 2787.5 1986.7 2507.8 1112.7 2090.9 1501.8 2780.1 2751.6 3524.5 6867.8 2849.1 2150.7 3334.5 3006.4 1848.2 2933.6 2944.4 9381.3 1048.4 2383.2 1050.5 1339.3 2877.1 3624.3 2840.5 2075.6 2762.0 2023.6 1589.8 3421.2 4067.8 4855.0 1999.1 5125.5 7353.9 1849.5 4874.5 4195.4 3639.4 3417.8 3320.0 4722.3 3632.8 3124.8 5289.7 5604.8 2624.1 3296.7 1147.0 3798.0 2719.3 3175.4 3505.2 2487.1 2668.0 2635.2 971.4 3495.1 5019.9 1954.5 2341.0 5780.5 2212.2 1451.6 1915.8 1618.1 2424.7 3626.8 6367.6 5820.6 1863.4 3508.9 1758.5 1918.8 3362.4 977.5 3828.9 2626.4 6462.8 7155.1 6390.5 5052.0 5393.2 6165.0 8750.8 7174.2 495.2 5199.2 2256.0 6377.8 5103.3 18540.3 1062.3 1086.0 1069.2 1685.9 1029.5 1090.9 1083.3 1072.8 1015.2 1084.4 1143.0 1109.2 1112.7 2387.5 971.2 1605.1 15.0 5574.2 6158.3 8280.0 5535.6 4255.3 412.4 6080.4 8681.6 381.3 2194.8 2530.5 825.8 120.9 4538.4 4799.4 1188.9 4284.8 2316.3 1754.6 1570.1 3613.3 2564.2 2154.3 3366.6 17.8 3732.2 7502.1 2388.6 1599.9 1895.7 1468.6 3424.3 2653.9 1441.0 3403.7 163.2 18.6 4137.0 1454.6 4309.4 5658.7 4012.5 4428.4 3332.7 3260.3 20.6 5502.6 1760.6 4551.0 23.6 22.4 2788.3 3029.1 2592.3 2412.5 6111.5 2682.0 5073.3 1084.8 593.9 1768.4 4410.8 3918.5 834.4 820.8 5042.0 6756.0 4591.7 4520.4 4186.2 5049.9 7641.8 RNF175 FLJ34190 ENSG00000145428 "Ring finger protein 175" Q8N4F7 4 153710160-153760024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;choroid plexus: 13.4" "Group enriched" "Detected in some" 5 "Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5" HPA035837 Uncertain NA NA "HPA035837: AB_10601609" "unprognostic (3.23e-2)" "unprognostic (4.12e-2)" "unprognostic (3.34e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-4)" "unprognostic (1.17e-1)" "unprognostic (2.96e-3)" "unprognostic (6.30e-3)" "unprognostic (1.42e-1)" "unprognostic (3.63e-4)" "unprognostic (7.25e-3)" "unprognostic (3.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" 1.5 2.5 19.2 2.9 21.7 6.1 0.8 17.5 25.4 3.0 13.4 0.5 0.1 0.2 0.9 0.6 0.5 1.0 2.4 20.1 22.8 0.2 0.4 1.4 1.2 19.9 17.9 21.0 0.1 0.3 0.0 4.0 0.1 19.8 2.5 0.1 3.5 1.5 3.5 0.1 0.7 0.5 0.1 16.6 2.5 0.3 1.6 20.4 0.1 0.2 0.5 0.6 0.5 1.5 24.0 0.2 0.0 8.8 0.0 0.0 0.6 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.0 0.0 0.0 6.7 0.0 0.3 0.0 0.1 0.0 7.6 0.0 0.0 0.2 0.1 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.0 2.4 0.0 2.1 0.0 0.6 0.6 19.2 21.7 17.5 25.4 20.1 22.8 19.9 17.9 21.0 19.8 16.6 20.4 24.0 0.1 0.0 0.5 6.8 0.0 0.4 0.1 0.6 0.6 0.7 0.1 0.6 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.8 0.0 0.1 0.2 0.0 0.4 91.4 0.0 0.0 2.9 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.0 95.7 0.0 0.0 5.9 2.9 14.6 0.0 1.5 1.8 2.8 0.7 0.8 0.0 38.7 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 1.6 0.0 0.0 0.3 1.5 1.3 0.0 0.3 0.0 0.6 0.0 0.0 0.2 PDGFC "fallotein, SCDGF" ENSG00000145431 "Platelet derived growth factor C" Q9NRA1 4 156760454-156971799 "Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.5" "Cell type enhanced" "Detected in many" "Astrocytes: 98.6;Granulosa cells: 124.1;Microglial cells: 85.3;Oligodendrocyte precursor cells: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 60.0;hTERT-RPE1: 56.8;U-138 MG: 41.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009134 Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" NA NA 37000 "Plasma membrane, Cytosol" "HPA009134: AB_10601981" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (5.79e-2)" "unprognostic (3.67e-2)" "unprognostic (3.97e-1)" "unprognostic (3.41e-2)" "unprognostic (8.78e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.35e-5)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.17e-4)" 4.8 4.0 0.8 1.3 1.0 0.6 7.6 0.4 1.0 9.3 0.9 2.3 2.0 10.0 2.1 3.3 6.8 4.9 2.6 0.9 0.8 5.6 5.2 3.1 1.1 0.8 0.6 0.8 7.7 4.3 20.5 0.4 4.5 0.6 8.8 2.0 0.8 8.4 7.1 1.3 1.6 2.8 9.5 1.0 1.3 2.9 0.9 0.8 2.1 6.6 1.2 1.0 3.2 1.2 0.8 2.5 3.7 38.6 25.4 7.0 13.4 1.0 21.5 21.5 12.0 16.1 2.2 9.4 0.0 3.8 60.0 9.2 2.6 10.8 13.4 16.5 0.0 5.0 25.5 3.2 2.4 18.3 3.9 0.3 14.2 6.6 30.6 21.7 56.8 6.0 0.1 0.1 0.1 30.2 0.1 0.0 0.0 0.4 0.0 1.7 0.0 8.1 0.0 22.5 0.9 0.0 0.0 0.0 0.2 0.4 6.0 3.1 1.3 28.3 41.7 0.4 10.9 17.3 0.0 0.0 0.0 16.1 0.0 1.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 1.0 0.4 1.0 0.9 0.8 0.8 0.6 0.8 0.6 1.0 0.8 0.8 2.4 6.4 14.2 98.6 0.7 49.6 22.7 12.4 25.0 2.0 14.7 13.6 16.8 58.6 7.8 12.9 0.0 0.6 3.4 0.5 0.0 15.4 30.5 6.9 15.0 7.3 0.0 5.5 64.4 7.1 0.3 18.6 8.2 11.4 1.3 124.1 10.0 15.9 13.0 0.0 32.1 2.1 4.1 34.4 21.6 23.8 5.3 32.1 10.6 85.3 14.2 6.3 0.0 233.2 3.0 18.0 0.5 23.0 1.4 8.7 2.4 18.6 3.5 0.5 6.6 34.8 18.2 0.7 2.9 3.4 13.5 0.5 0.9 13.8 2.1 4.8 CBR4 "FLJ14431, SDR45C1" ENSG00000145439 "Carbonyl reductase 4" Q8N4T8 4 168863770-169010275 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037499 Supported NA NA 51000 "HPA037499: AB_10672386" "unprognostic (1.60e-1)" "unprognostic (8.25e-2)" "unprognostic (1.37e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (2.39e-2)" "unprognostic (2.41e-3)" "unprognostic (4.06e-2)" "unprognostic (1.29e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "prognostic favorable (3.64e-14)" "unprognostic (1.97e-2)" "unprognostic (2.00e-1)" "unprognostic (1.81e-2)" "unprognostic (7.38e-3)" 9.2 14.3 12.6 8.0 14.4 6.8 14.2 14.4 14.5 9.5 12.7 12.2 12.9 10.0 20.3 8.4 9.4 8.2 18.0 12.2 13.1 27.5 50.0 7.4 11.1 14.0 13.5 11.6 11.1 10.0 11.8 10.0 8.2 14.7 11.8 14.1 17.7 13.3 11.3 17.5 15.8 11.9 8.9 12.8 9.5 10.9 7.6 13.8 9.8 15.7 16.1 11.6 8.4 8.4 17.1 9.0 6.6 20.2 12.8 17.2 20.3 4.1 6.3 8.6 7.5 6.9 7.9 9.3 18.3 3.4 4.9 7.0 9.4 18.8 20.1 8.2 7.0 9.3 32.3 16.9 10.7 10.3 12.9 10.9 13.4 17.1 5.4 9.1 17.8 22.4 15.3 17.8 14.4 12.0 4.6 13.5 21.0 7.3 6.2 10.0 11.6 7.1 8.0 26.5 9.4 17.9 13.4 7.7 10.9 16.7 16.7 11.7 8.2 13.4 7.8 4.2 8.8 6.4 14.2 10.2 8.8 13.6 15.6 4.9 7.9 4.0 6.4 6.6 3.6 3.9 5.7 4.5 6.4 3.5 7.5 4.9 6.4 3.0 5.8 5.3 4.8 4.0 2.1 12.6 14.4 14.4 14.5 12.2 13.1 14.0 13.5 11.6 14.7 12.8 13.8 17.1 16.1 0.0 9.4 86.2 24.2 23.1 32.2 27.7 10.8 37.3 20.7 12.1 30.0 28.6 19.9 49.7 39.6 40.6 19.8 24.2 50.9 66.5 16.1 22.5 17.5 20.5 29.3 34.9 68.0 42.9 27.5 17.8 16.8 15.8 2.5 36.0 24.7 81.6 24.9 62.2 82.3 26.5 34.6 26.6 8.9 34.6 44.4 16.8 35.6 61.8 26.1 28.3 46.4 150.3 135.8 37.6 39.8 31.2 8.7 24.6 31.7 93.4 19.8 51.3 59.2 18.5 16.3 56.6 41.6 15.3 20.2 20.2 15.9 38.3 27.4 29.6 GLRA3 ENSG00000145451 "Glycine receptor alpha 3" O75311 4 174636920-174829247 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.7;breast: 2.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8" "Cancer enhanced" "Detected in single" "breast cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.75e-3)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (1.36e-1)" "unprognostic (9.02e-2)" "unprognostic (3.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.12e-2)" "unprognostic (4.26e-2)" "unprognostic (1.64e-5)" "unprognostic (4.61e-4)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" 0.0 0.8 3.0 0.0 4.0 0.0 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 4.0 0.0 0.0 0.0 0.2 1.0 3.2 2.8 0.0 0.4 0.0 0.6 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.5 6.7 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 4.0 0.0 2.8 2.5 4.0 1.0 3.2 2.8 0.6 0.5 6.7 1.2 0.0 0.0 0.6 1.3 1.6 0.0 1.3 0.0 0.0 5.0 25.3 0.3 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.1 0.4 0.0 0.0 52.4 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.0 2.8 0.0 0.2 0.0 1.0 1.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.6 0.0 1.0 0.3 0.7 1.6 0.1 0.1 0.0 0.3 0.0 0.0 0.4 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191567-186213463 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 114.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 103.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 15.2;SK-MEL-30: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 7.5 16.6 4.7 5.3 6.5 2.2 5.7 5.4 5.1 8.6 15.3 9.7 16.6 5.6 2.6 5.1 6.2 14.9 9.3 4.5 6.0 34.2 114.4 10.9 5.7 5.9 5.7 3.4 5.8 15.7 33.7 3.7 3.6 6.1 8.3 12.0 14.3 7.1 7.6 4.5 1.2 16.9 7.1 4.7 11.3 6.3 3.3 5.3 6.6 17.5 5.1 5.0 6.5 2.3 6.5 3.4 1.8 0.8 0.0 15.2 6.3 0.2 4.4 9.9 1.7 1.9 0.0 13.0 1.1 0.5 3.5 5.9 1.6 1.9 1.7 0.3 6.0 2.2 4.7 0.8 0.5 5.6 2.6 1.9 5.8 0.8 1.9 1.0 5.9 0.1 6.4 1.4 14.3 6.8 2.9 3.6 1.3 1.5 1.6 0.0 3.1 0.7 1.0 7.4 6.1 4.0 4.9 1.1 0.0 27.5 0.3 2.6 4.6 4.1 3.6 0.7 3.5 1.6 0.1 0.0 0.5 10.9 11.0 4.7 0.0 0.6 0.0 1.8 1.9 1.0 0.4 1.4 1.8 0.7 1.0 1.3 1.3 0.0 0.8 3.1 1.3 1.1 0.9 4.7 6.5 5.4 5.1 4.5 6.0 5.9 5.7 3.4 6.1 4.7 5.3 6.5 9.0 6.4 11.5 31.3 13.8 2.5 4.5 5.1 9.6 33.6 9.3 7.2 18.8 42.9 8.7 14.7 31.3 2.0 9.6 14.7 9.8 24.2 2.7 6.7 5.1 7.7 16.9 16.4 15.4 22.4 2.1 14.2 12.8 7.6 7.0 6.5 8.9 103.7 13.5 5.0 23.4 16.5 2.0 14.8 6.0 2.1 5.0 11.3 3.6 6.5 3.5 52.2 4.1 15.6 11.0 9.6 9.0 6.4 12.3 3.8 47.2 28.5 11.9 27.4 0.0 10.1 10.6 8.9 6.3 6.8 3.1 1.0 17.2 6.7 10.5 5.7 ROPN1L "ASP, FLJ25776, RSPH11" ENSG00000145491 "Rhophilin associated tail protein 1 like" Q96C74 5 10441524-10472029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 325.5" "Group enriched" "Detected in many" 5 "Early spermatids: 3125.2;Late spermatids: 3173.9;Spermatocytes: 987.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 9.6;ovarian cancer: 3.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "basophil: 45.1;eosinophil: 55.0;neutrophil: 105.3" "Lineage enriched" "Detected in many" 18 "granulocytes: 105.3" "Cell line enriched" "Detected in some" 5 "NB-4: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039193, HPA041830" Enhanced NA NA "HPA039193: AB_10673415, HPA041830: AB_2677695" "unprognostic (2.39e-4)" "unprognostic (1.21e-1)" "unprognostic (3.78e-3)" "unprognostic (6.84e-3)" "unprognostic (3.59e-2)" "unprognostic (2.82e-1)" "unprognostic (5.88e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (3.13e-1)" "unprognostic (1.32e-3)" "unprognostic (7.54e-3)" "unprognostic (1.58e-2)" "unprognostic (1.73e-2)" "unprognostic (3.22e-2)" 0.7 0.2 3.8 0.3 1.4 4.4 0.8 2.4 1.2 1.2 5.3 0.2 0.0 0.8 0.0 0.1 27.7 0.3 0.6 1.6 3.6 0.7 0.3 5.4 0.4 4.4 4.1 0.3 0.2 1.1 0.0 1.2 0.2 4.7 0.6 0.0 1.0 0.1 0.1 0.2 0.3 0.3 0.0 5.5 4.5 0.3 325.5 1.6 0.2 0.8 0.3 0.0 0.2 0.2 2.2 0.1 0.4 0.0 0.0 0.4 0.0 0.5 0.0 0.6 0.5 0.5 0.1 0.1 0.0 1.5 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.7 0.0 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.1 0.0 0.1 0.0 13.4 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.9 1.5 0.1 0.1 0.4 0.0 1.5 1.6 0.3 45.1 0.8 55.0 4.0 0.3 2.7 0.0 3.5 4.7 0.1 0.0 2.3 2.7 105.3 0.4 1.4 0.0 5.8 2.1 3.8 1.4 2.4 1.2 1.6 3.6 4.4 4.1 0.3 4.7 5.5 1.6 2.2 2.0 3.2 2.0 1.6 0.1 0.3 0.0 38.0 0.0 0.2 0.4 0.4 0.4 0.0 45.3 0.0 0.0 0.0 2.2 0.0 0.0 1.0 3125.2 311.3 2.0 4.0 0.0 0.0 5.4 0.0 0.1 0.9 0.0 3.4 1.3 0.0 7.5 0.2 0.1 3.3 4.0 0.0 38.7 0.6 0.3 3173.9 36.1 2.2 0.0 0.0 0.2 0.2 0.0 1.0 0.3 0.1 0.0 18.4 0.1 0.3 0.0 1.3 482.3 3.3 13.1 0.4 14.1 987.8 35.8 0.0 0.1 0.1 0.8 2.9 0.0 0.1 NDUFS6 CI-13kA ENSG00000145494 "NADH:ubiquinone oxidoreductase subunit S6" O75380 5 1801407-1816048 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 621.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 972.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1796.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064221 Supported NA NA "HPA064221: AB_2685217" "unprognostic (2.34e-1)" "unprognostic (1.43e-3)" "unprognostic (4.04e-1)" "unprognostic (9.74e-2)" "unprognostic (5.91e-2)" "unprognostic (6.27e-2)" "unprognostic (1.13e-2)" "unprognostic (5.67e-2)" "unprognostic (3.22e-1)" "unprognostic (9.99e-3)" "unprognostic (1.68e-3)" "unprognostic (8.57e-2)" "unprognostic (2.14e-2)" "unprognostic (1.16e-3)" "unprognostic (2.46e-1)" "unprognostic (9.08e-2)" "unprognostic (1.02e-1)" 111.7 84.9 101.9 84.7 104.6 117.5 51.6 108.1 148.1 45.2 106.8 124.3 147.7 48.8 52.3 80.6 50.7 39.3 267.9 101.2 106.5 96.8 117.4 52.3 75.8 107.6 104.7 95.1 42.7 108.6 123.6 41.2 57.7 107.7 71.4 68.8 49.7 111.9 57.8 621.3 70.3 116.4 52.0 101.5 71.8 107.4 57.0 108.2 71.1 51.5 307.1 62.1 58.6 42.3 110.0 241.2 487.3 206.4 310.5 81.7 74.9 483.3 180.6 108.8 161.7 139.8 556.8 291.0 344.0 531.4 117.6 261.5 247.6 174.3 221.5 91.9 404.3 576.4 250.4 1796.7 476.9 155.0 320.8 230.0 106.8 157.4 136.0 103.7 85.0 158.6 226.8 344.6 314.2 181.6 607.0 433.4 679.5 218.8 355.9 678.9 345.0 211.5 477.9 162.9 388.6 237.1 213.7 638.5 507.5 275.2 110.3 341.1 403.3 206.2 221.6 386.0 201.5 355.1 283.2 512.4 443.0 250.5 511.4 243.6 239.5 283.7 233.5 207.5 342.7 207.9 246.2 213.6 209.2 349.1 197.9 177.9 196.9 124.8 218.9 307.5 347.1 261.1 261.5 101.9 104.6 108.1 148.1 101.2 106.5 107.6 104.7 95.1 107.7 101.5 108.2 110.0 166.4 67.3 107.6 12.7 129.7 125.5 153.6 328.8 82.6 95.5 164.5 206.0 698.3 198.8 164.8 207.8 47.9 358.0 142.9 574.7 972.4 270.1 246.9 165.2 132.4 155.6 267.1 162.0 10.6 341.5 246.0 146.8 170.2 133.5 104.7 163.1 153.8 526.3 413.9 65.6 11.3 468.0 236.0 224.6 167.8 308.1 154.7 162.9 218.7 12.2 239.8 208.5 178.2 9.5 20.1 296.2 447.5 157.2 178.7 186.2 615.8 868.5 158.8 166.9 164.3 147.0 188.1 288.0 159.1 227.7 167.5 245.2 124.7 200.4 480.7 219.2 MARCHF6 "MARCH-VI, MARCH6, RNF176, TEB4" ENSG00000145495 "Membrane associated ring-CH-type finger 6" O60337 5 10353695-10440388 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 38.5;Cardiomyocytes: 102.5;Cytotrophoblasts: 54.4;dendritic cells: 25.8;Extravillous trophoblasts: 30.0;Hofbauer cells: 36.4;Syncytiotrophoblasts: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040841, HPA063246" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA040841: AB_2677162, HPA063246: AB_2684970" "unprognostic (3.31e-2)" "unprognostic (2.04e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-3)" "unprognostic (4.00e-1)" "unprognostic (2.26e-1)" "unprognostic (3.06e-2)" "unprognostic (9.52e-3)" "unprognostic (1.53e-1)" "unprognostic (1.05e-3)" "unprognostic (3.94e-2)" "unprognostic (5.58e-2)" "unprognostic (5.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "unprognostic (8.50e-3)" 22.0 25.7 18.1 20.4 25.6 77.2 26.1 30.2 22.0 20.3 5.8 27.2 33.1 22.9 25.7 21.1 25.1 24.7 31.1 21.2 27.7 34.4 32.7 25.3 24.9 16.7 22.2 15.9 36.3 39.6 62.9 20.9 23.0 18.7 22.9 20.0 36.9 25.8 24.0 48.8 25.0 30.5 19.1 16.8 28.4 30.5 30.1 25.5 32.6 29.6 52.2 23.4 24.0 18.8 34.5 37.4 55.1 90.1 69.9 50.6 40.4 73.7 57.7 53.7 48.9 61.8 52.8 97.0 39.4 85.4 54.4 67.2 52.3 48.2 37.7 65.4 82.9 43.0 50.7 179.7 36.2 35.6 61.4 54.6 47.4 40.6 49.0 53.1 50.0 45.8 41.4 62.1 85.1 45.0 42.4 33.1 47.2 32.8 29.9 38.5 50.9 37.6 57.0 38.0 72.4 38.7 56.0 107.2 57.9 38.4 41.3 48.2 32.5 44.8 58.4 56.8 29.1 43.7 59.3 94.1 55.7 43.1 40.7 42.8 15.6 7.4 12.6 11.2 8.4 12.8 11.7 10.8 11.0 6.3 9.6 12.5 12.4 12.1 9.1 11.1 5.0 10.4 9.1 18.1 25.6 30.2 22.0 21.2 27.7 16.7 22.2 15.9 18.7 16.8 25.5 34.5 38.5 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.5 0.0 0.0 0.0 0.0 54.4 25.8 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 30.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 81.3 5.8 0.0 0.0 0.0 NKD2 Naked2 ENSG00000145506 "NKD inhibitor of WNT signaling pathway 2" Q969F2 5 1008802-1038943 "Predicted intracellular proteins" "Exocytosis, Transport, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 42.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 6.8;Fibroblasts: 11.6;Langerhans cells: 7.1;Melanocytes: 7.2;Microglial cells: 7.5;Muller glia cells: 7.1;Spermatogonia: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 24.4;HEK 293: 14.4;MOLT-4: 7.3;NB-4: 13.4;REH: 8.8;RPMI-8226: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049463 Uncertain NA NA "HPA049463: AB_2680777" "unprognostic (6.23e-3)" "unprognostic (2.82e-1)" "unprognostic (4.38e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (6.24e-3)" "unprognostic (5.87e-3)" "unprognostic (4.43e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (3.35e-2)" "unprognostic (6.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-1)" 2.6 5.1 0.5 0.2 1.0 0.0 3.8 0.0 2.5 1.4 0.0 3.5 0.1 1.1 0.0 8.6 3.1 0.1 5.4 2.4 0.0 5.7 3.2 42.5 0.0 0.7 0.0 0.3 1.3 4.2 0.1 2.0 0.4 1.0 6.2 0.0 0.1 4.9 0.0 0.3 9.0 3.5 0.0 0.0 15.4 2.4 8.1 0.0 0.9 2.3 0.0 0.1 3.8 2.5 0.7 0.0 0.2 0.5 0.2 0.0 0.0 24.4 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 1.2 7.3 13.4 0.2 1.9 0.0 8.8 0.0 22.1 0.0 1.7 0.2 0.0 0.2 0.0 1.2 0.1 0.0 2.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 2.5 2.4 0.0 0.7 0.0 0.3 1.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 6.1 2.8 0.5 4.6 0.2 0.8 1.9 3.3 2.8 0.1 0.0 2.1 0.1 0.2 0.0 0.0 2.9 0.6 2.1 6.8 2.0 0.0 0.0 1.5 0.0 0.1 11.6 0.0 0.5 0.0 0.0 0.7 0.0 0.3 1.7 1.4 0.0 0.0 0.0 7.1 1.3 0.3 0.5 7.2 7.5 0.0 7.1 0.0 0.0 0.2 0.1 0.0 0.4 0.1 2.7 0.0 2.0 0.0 0.1 0.0 0.1 1.9 1.0 11.3 0.5 5.7 0.0 1.3 0.0 0.0 1.2 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19471296-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 36.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 923.8;Inhibitory neurons: 694.3;Oligodendrocyte precursor cells: 248.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Region enhanced" "Detected in many" "cerebellum: 36.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.4;GAMG: 7.6;hTERT-RPE1: 4.2;U-2 OS: 6.8;U-2197: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" NA Yes "HPA014416: AB_2668996" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.0 4.7 1.7 0.0 7.1 0.0 0.0 36.7 12.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 9.7 0.1 0.0 0.0 0.0 0.1 3.1 6.9 0.0 0.3 0.9 4.0 0.0 8.4 0.1 0.0 2.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.2 0.0 0.3 0.0 0.6 2.9 2.5 0.1 1.6 0.1 0.5 0.0 0.0 0.0 4.4 0.0 7.6 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 1.7 4.2 0.0 0.0 0.1 0.5 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 6.8 6.2 0.0 1.7 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.1 36.7 12.8 5.6 9.7 0.1 3.1 6.9 8.4 0.0 2.8 5.9 0.0 0.0 0.0 22.9 0.0 0.0 1.3 0.0 0.0 6.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.0 0.0 0.0 923.8 0.0 5.3 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 694.3 0.0 0.0 0.0 0.0 19.2 0.3 0.1 0.0 17.8 0.0 0.2 0.0 248.3 15.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 0.1 6.4 3.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.0;ovary: 10.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 7.3;Excitatory neurons: 44.7;Fibroblasts: 13.7;Granulosa cells: 22.2;Theca cells: 15.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 15.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 3.9;SuSa: 3.5;U-2197: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" Yes No "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 5.5 0.2 1.4 0.5 2.2 0.5 0.7 15.0 2.7 1.4 0.0 0.7 0.6 1.3 1.7 1.5 0.7 6.5 0.2 3.8 0.6 3.5 0.4 0.7 0.2 0.8 0.9 2.5 10.5 4.6 0.1 0.0 0.2 5.3 0.1 0.3 1.2 0.2 0.5 0.2 0.4 0.5 1.1 0.0 0.2 0.2 0.4 0.0 0.2 0.3 0.2 0.1 1.1 0.6 2.0 1.7 1.7 1.7 0.1 0.1 0.3 0.2 0.0 0.0 0.4 0.5 0.0 1.4 0.1 2.1 0.0 3.0 0.1 0.0 0.0 0.4 0.1 0.9 0.3 2.8 0.0 0.0 0.2 0.0 0.0 0.0 3.9 0.1 0.5 0.0 0.3 0.6 0.4 0.7 0.0 0.4 0.2 1.1 0.0 1.6 0.4 2.2 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.1 3.5 0.1 0.1 0.1 2.1 3.0 5.8 1.4 0.9 0.3 0.1 3.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 2.2 15.0 2.7 3.8 0.6 0.8 0.9 2.5 5.3 0.0 0.0 2.0 0.7 0.0 0.6 2.6 0.0 0.0 0.0 0.0 0.6 2.0 0.7 0.4 0.5 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 5.0 0.1 0.0 0.0 44.7 0.0 0.0 13.7 0.5 0.5 0.0 22.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 6.9 1.6 0.1 0.0 0.0 0.0 0.0 0.1 15.9 0.0 0.0 SRD5A1 ENSG00000145545 "Steroid 5 alpha-reductase 1" P18405 5 6633427-6674386 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 67.2;Hepatocytes: 103.4;Ionocytes: 52.9;Squamous epithelial cells: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051402 Approved NA NA "HPA051402: AB_2681470" "unprognostic (1.40e-2)" "unprognostic (1.33e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.73e-6)" "unprognostic (9.38e-3)" "unprognostic (8.90e-2)" "unprognostic (3.78e-2)" "unprognostic (5.90e-2)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.56e-3)" "unprognostic (3.01e-1)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.47e-2)" 1.5 2.0 4.0 1.9 5.6 2.2 11.1 7.5 9.0 2.6 0.1 2.4 4.1 1.7 3.0 11.1 1.7 1.7 1.0 5.9 3.0 4.7 29.3 1.9 2.3 6.3 4.5 4.6 2.5 2.3 1.4 1.1 1.0 6.6 1.5 2.3 3.8 2.7 1.1 1.3 13.7 4.1 1.6 2.2 1.4 2.5 1.5 6.2 1.6 1.3 0.8 4.1 1.1 6.6 8.5 5.2 6.1 8.0 6.7 7.6 7.3 3.5 5.7 4.5 5.7 3.5 6.0 5.3 7.1 8.1 8.7 9.1 9.8 6.6 4.0 6.0 4.3 2.6 2.2 15.3 3.7 3.4 3.3 1.8 5.4 11.3 4.1 3.2 4.2 2.9 2.7 3.7 6.2 7.5 7.1 1.4 3.6 4.5 4.1 4.7 5.1 5.8 2.0 7.6 5.4 14.0 6.4 18.2 7.6 5.8 6.1 2.6 0.9 5.8 8.6 3.4 14.2 7.6 2.3 3.6 2.6 7.2 3.6 8.0 3.5 1.3 0.5 0.3 1.0 0.2 0.5 0.3 0.5 1.6 0.6 0.2 0.3 0.7 0.5 1.1 0.7 0.4 0.5 4.0 5.6 7.5 9.0 5.9 3.0 6.3 4.5 4.6 6.6 2.2 6.2 8.5 3.7 3.2 2.7 7.8 11.9 18.5 6.7 19.0 67.2 5.0 14.5 9.1 2.6 11.5 12.8 5.5 4.2 0.9 5.0 8.3 7.9 9.8 8.1 2.6 4.3 3.2 2.4 4.4 15.5 4.7 7.4 4.7 16.3 3.2 1.3 6.0 4.6 103.4 13.0 6.7 14.9 7.2 52.9 19.4 11.6 2.6 3.4 11.6 7.2 6.5 50.7 5.1 10.3 9.0 7.6 6.7 10.4 7.9 7.2 9.4 24.9 23.4 10.4 3.8 0.0 3.7 6.1 3.4 4.4 139.2 30.4 0.8 5.9 5.2 12.0 10.2 MYO10 KIAA0799 ENSG00000145555 "Myosin X" Q9HD67 5 16661907-16936288 "Plasma proteins, Predicted intracellular proteins" Transport "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 189.5;Muller glia cells: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "non-classical monocyte: 2.5" "Lineage enriched" "Detected in single" 5 "monocytes: 2.5" "Cell line enhanced" "Detected in many" "HeLa: 182.1;SK-MEL-30: 205.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015224, HPA024223" Enhanced Supported "Nucleoli rim,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli rim" "CAB015224: , HPA024223: AB_1854248" "unprognostic (1.13e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (7.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.43e-2)" "unprognostic (2.96e-2)" "unprognostic (4.40e-2)" "unprognostic (8.34e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-2)" "unprognostic (8.42e-2)" "unprognostic (1.85e-1)" "prognostic favorable (2.75e-4)" "unprognostic (8.93e-2)" "unprognostic (9.86e-2)" "unprognostic (4.56e-2)" "unprognostic (1.84e-1)" 13.9 3.0 40.9 6.3 51.4 3.2 8.0 25.4 41.5 6.7 48.4 19.5 23.0 6.3 3.5 9.4 4.3 8.5 4.5 39.9 23.3 14.8 7.7 19.1 1.3 58.6 29.9 28.7 15.9 32.5 10.8 9.6 31.7 33.0 5.9 19.3 15.2 11.1 5.1 8.3 15.5 19.7 4.9 25.9 14.0 32.3 15.8 27.8 5.0 37.8 4.4 2.0 11.2 7.8 42.8 68.2 108.3 31.3 14.9 24.7 17.0 35.1 117.2 89.2 35.5 27.4 63.1 10.2 1.5 78.9 52.9 42.3 33.4 139.1 73.7 57.1 0.2 16.7 0.1 182.1 13.7 81.5 0.4 1.5 30.9 26.8 78.5 92.1 57.4 110.5 0.2 0.2 4.8 28.7 10.5 0.2 0.4 80.5 56.6 37.2 26.1 10.3 66.9 22.0 49.6 5.2 2.8 27.0 11.4 205.0 53.2 8.1 9.1 137.8 77.6 23.6 0.7 61.1 0.7 0.5 0.5 38.3 11.2 76.2 0.5 0.2 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 0.3 0.1 2.5 0.1 0.1 0.1 40.9 51.4 25.4 41.5 39.9 23.3 58.6 29.9 28.7 33.0 25.9 27.8 42.8 53.5 35.3 34.6 158.7 1.4 40.9 31.0 23.0 29.6 11.0 18.6 11.6 3.8 55.8 26.3 31.3 18.8 20.4 0.3 46.4 17.6 110.8 30.2 118.5 20.8 61.3 74.0 0.0 3.9 40.6 63.4 13.7 68.3 116.0 27.8 189.5 77.1 1.7 5.6 82.4 5.4 53.2 20.3 7.1 4.8 9.5 12.8 5.7 67.6 87.1 3.8 233.8 0.0 103.5 23.5 114.7 50.3 19.2 0.4 42.6 28.3 4.2 18.8 9.2 65.7 8.2 31.5 3.8 12.2 30.7 31.8 147.8 2.4 4.1 66.9 38.6 OTULINL "FAM105A, FLJ11127, NET20" ENSG00000145569 "OTU deubiquitinase with linear linkage specificity like" Q9NUU6 5 14581792-14616180 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 3.2 2.7 1.2 6.8 1.2 30.6 4.2 1.4 1.6 3.7 4.4 12.4 6.7 1.5 1.4 1.7 1.4 2.8 0.9 1.2 1.6 3.7 1.5 13.3 5.4 1.7 1.5 0.9 2.0 7.7 1.2 2.6 4.3 2.0 8.4 13.4 0.5 1.4 10.1 0.4 1.8 9.5 2.5 2.7 7.9 3.3 2.5 1.7 3.4 2.8 0.8 3.6 5.2 3.2 3.1 0.0 0.8 1.6 0.0 0.3 0.0 6.9 2.0 1.8 0.5 1.0 2.8 1.7 0.1 1.1 0.9 2.8 0.1 3.7 1.6 0.7 1.1 4.9 4.6 17.7 0.4 1.7 0.1 55.6 0.1 0.3 0.2 0.0 0.0 0.1 2.9 0.0 7.1 0.2 1.4 0.0 1.7 2.5 16.1 11.9 0.5 0.7 2.0 0.0 13.9 6.0 7.0 0.9 0.6 0.0 1.7 0.6 16.9 0.0 0.9 4.4 0.4 1.6 0.0 0.0 0.1 1.0 27.2 0.4 0.2 33.4 0.3 5.5 16.2 7.3 0.1 6.7 7.2 33.8 0.1 9.0 9.1 8.6 19.2 12.7 25.0 12.8 24.6 1.2 1.2 1.4 1.6 1.2 1.6 1.7 1.5 0.9 2.0 2.7 1.7 3.1 10.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 7.4 7.9 0.0 0.0 0.0 29.5 0.0 0.9 36.7 0.0 1.9 0.4 0.0 0.9 16.6 1.1 0.0 0.0 0.0 6.2 2.2 1.4 0.0 1.2 0.0 0.5 0.0 0.0 100.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 12.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 8.8 0.2 0.0 0.0 RPL37 L37 ENSG00000145592 "Ribosomal protein L37" P61927 5 40825262-40835222 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (1.85e-1)" "unprognostic (8.27e-2)" "unprognostic (2.31e-1)" "unprognostic (1.35e-2)" "unprognostic (1.83e-1)" "unprognostic (6.40e-3)" "unprognostic (1.23e-1)" "unprognostic (8.03e-2)" "unprognostic (8.28e-2)" "unprognostic (4.98e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.67e-6)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-2)" "prognostic favorable (6.34e-4)" 382.3 262.6 569.9 227.9 576.5 426.8 762.1 561.9 731.8 404.5 549.7 287.3 197.9 283.1 248.4 421.6 330.3 106.3 241.5 553.3 575.5 254.2 259.7 257.9 350.5 577.8 571.2 546.4 750.5 519.5 447.9 156.0 154.1 580.8 299.8 212.6 86.6 344.8 239.7 456.0 509.9 295.7 182.8 595.4 326.7 318.7 87.7 584.4 1000.5 236.3 725.5 428.1 510.2 397.8 591.3 466.0 406.1 708.3 252.1 1196.8 1384.0 576.3 494.4 863.9 535.6 408.8 646.4 168.4 736.7 403.6 815.3 867.9 265.1 762.8 1308.5 409.9 723.8 452.3 374.1 1725.3 735.8 1727.4 705.7 256.8 1985.8 1317.7 700.9 1556.1 1540.8 786.7 1042.4 438.2 354.0 670.9 804.0 705.4 1038.0 224.4 1270.3 484.0 349.1 513.1 662.3 1237.0 738.5 210.0 471.4 444.4 301.1 819.8 643.2 224.0 1162.7 347.6 84.6 377.7 151.7 491.4 515.8 656.6 685.4 97.8 862.4 103.6 297.5 538.1 160.3 605.2 441.6 837.9 1134.0 957.1 798.1 712.0 1030.1 1095.7 996.6 163.0 665.7 336.8 836.6 822.7 1321.1 569.9 576.5 561.9 731.8 553.3 575.5 577.8 571.2 546.4 580.8 595.4 584.4 591.3 1962.6 871.8 1524.8 12.1 5388.8 3406.6 2616.8 2323.5 4842.1 211.1 3831.5 3625.5 353.1 2496.4 1525.7 779.8 89.6 2929.1 3934.0 1319.4 1749.1 2316.5 993.5 1834.1 4790.7 2050.4 1781.0 2838.1 14.2 4513.1 5692.1 1920.9 1979.1 2757.6 1615.5 3312.0 3311.1 3384.2 2623.5 109.4 12.3 4086.9 671.4 4029.1 3567.5 2745.7 5349.6 2905.7 1741.4 6.5 4827.0 1422.5 3843.5 8.0 12.1 4083.5 3173.9 2232.7 2862.9 2506.5 3003.3 3173.5 636.0 264.4 1347.7 3410.6 2525.0 548.3 596.5 5819.8 4018.6 2947.6 3926.1 1888.7 4331.5 2522.4 SKP2 "FBL1, FBXL1, p45" ENSG00000145604 "S-phase kinase associated protein 2" Q13309 5 36151989-36196849 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 38.2" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 134.4;Extravillous trophoblasts: 227.3;Syncytiotrophoblasts: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 274.7;RH-30: 286.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013491, CAB013533, HPA051196, HPA054633" Approved Supported Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550" "unprognostic (2.32e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" "unprognostic (5.74e-2)" "unprognostic (9.56e-2)" "unprognostic (1.52e-2)" "unprognostic (1.21e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.72e-7)" "prognostic favorable (8.57e-4)" "unprognostic (5.06e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (4.77e-15)" "unprognostic (2.50e-2)" "unprognostic (3.73e-1)" "unprognostic (1.63e-1)" "unprognostic (2.19e-1)" 4.9 4.0 3.9 5.9 4.2 11.5 4.9 5.1 4.7 5.3 4.4 6.2 6.4 4.8 4.4 8.4 5.1 2.9 2.5 4.1 3.6 2.4 9.8 4.2 7.9 4.1 3.9 3.9 5.2 3.8 2.5 4.0 38.2 4.2 4.0 6.2 4.6 4.0 3.7 2.2 5.7 6.5 4.1 4.4 6.0 4.1 2.7 3.9 12.4 3.1 1.7 8.3 4.7 5.6 5.8 25.4 14.8 35.6 54.3 15.5 20.1 274.7 31.2 25.7 89.5 48.7 83.3 22.8 43.3 10.6 20.0 13.3 28.3 53.3 46.7 71.0 19.2 46.7 23.9 51.4 47.1 6.1 44.8 11.4 18.1 12.2 16.9 8.5 7.7 24.2 40.2 37.9 9.1 31.9 16.4 58.9 26.8 51.5 23.8 24.2 53.7 286.7 28.3 7.2 28.1 45.5 46.8 94.3 27.4 14.1 32.2 22.7 33.3 8.0 31.4 36.1 13.5 24.5 12.4 13.1 50.8 15.2 61.3 21.9 9.2 6.6 13.4 4.2 6.1 6.9 5.2 4.7 4.5 14.0 6.0 6.4 4.6 1.1 6.2 3.2 3.5 4.8 4.7 3.9 4.2 5.1 4.7 4.1 3.6 4.1 3.9 3.9 4.2 4.4 3.9 5.8 4.4 22.4 8.9 11.8 8.7 3.7 2.4 7.1 12.0 8.2 3.6 4.2 1.3 1.5 1.7 1.8 10.4 134.4 7.4 2.4 1.9 2.4 0.7 5.2 6.5 6.5 3.0 14.1 22.4 2.9 227.3 11.6 7.1 2.4 2.5 20.9 1.8 11.9 35.0 0.0 13.1 6.0 4.1 9.3 3.1 0.3 4.1 5.3 1.8 12.2 7.6 2.5 9.2 11.6 29.5 2.6 3.4 6.4 10.9 1.0 3.2 1.4 6.2 6.8 0.0 11.5 4.1 1.4 6.4 19.8 4.0 83.9 5.6 11.8 9.6 1.2 OSMR "OSMRB, OSMRbeta" ENSG00000145623 "Oncostatin M receptor" Q99650 5 38845858-38945596 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 74.9;Pancreatic endocrine cells: 72.4;Prostatic glandular cells: 73.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 154.3;GAMG: 162.7;HSkMC: 192.7;U-2197: 158.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017278 Approved Approved Nucleoli "Intracellular and membrane" NA NA 51000000 Nucleoli "HPA017278: AB_1854818" "unprognostic (6.34e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.58e-1)" "unprognostic (2.11e-1)" "unprognostic (2.18e-3)" "unprognostic (1.13e-1)" "unprognostic (8.00e-3)" "unprognostic (5.70e-2)" "unprognostic (1.79e-3)" "unprognostic (1.72e-3)" "unprognostic (1.60e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.96e-6)" "unprognostic (1.88e-2)" "unprognostic (1.49e-2)" "unprognostic (4.43e-1)" "unprognostic (1.75e-2)" 51.4 30.0 8.0 25.6 7.5 0.1 37.6 7.6 8.5 22.9 10.7 20.8 5.6 23.1 7.7 17.2 28.0 29.0 23.8 6.4 26.2 26.6 19.3 46.6 16.1 13.6 9.8 5.0 24.8 16.6 6.6 10.4 35.6 11.8 24.8 10.6 4.4 27.6 13.6 11.9 20.6 15.2 39.4 9.3 18.1 18.6 5.7 12.0 14.0 24.1 8.6 15.2 41.3 22.5 9.5 32.6 41.2 6.9 17.7 72.6 154.3 23.4 51.7 81.7 49.8 66.4 0.1 85.9 0.0 23.9 55.3 162.7 43.9 8.9 63.6 79.8 0.1 5.1 2.2 31.2 31.6 82.4 0.0 0.6 192.7 37.3 111.9 94.9 92.3 7.7 0.0 0.0 0.2 31.8 8.8 0.1 0.1 1.1 6.8 13.3 0.0 2.3 0.0 99.8 9.5 0.1 0.3 116.8 0.2 0.2 9.5 35.4 0.3 12.2 120.6 45.1 158.1 28.0 0.0 0.1 0.1 96.8 0.1 26.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 7.5 7.6 8.5 6.4 26.2 13.6 9.8 5.0 11.8 9.3 12.0 9.5 41.5 44.8 56.8 13.4 0.6 30.3 74.9 55.0 27.3 0.2 21.7 10.8 5.0 15.7 51.4 12.9 0.0 6.9 0.2 0.2 0.0 48.7 0.6 6.6 38.9 47.0 0.0 0.4 2.0 48.6 6.8 37.2 6.6 9.2 1.3 2.6 55.0 16.6 1.6 0.0 1.8 0.0 8.2 6.1 7.6 1.4 41.7 1.1 7.2 46.9 1.6 0.7 0.0 13.6 3.6 72.4 0.0 7.5 0.6 73.8 0.0 5.9 19.3 0.6 19.7 32.4 33.6 0.3 1.6 10.5 24.0 17.1 1.7 4.7 0.0 57.7 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951006-36001028 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 51.5;liver: 58.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 49.7;Early spermatids: 125.9;Hepatocytes: 72.1;Late spermatids: 24.5;Proximal tubular cells: 87.0" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 28.2" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 51.5 58.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.7 0.1 0.2 3.0 0.1 6.8 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 49.7 0.0 0.0 0.0 0.0 3.9 0.0 125.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 72.1 0.1 0.0 0.3 0.7 0.0 2.6 0.0 24.5 0.9 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.5 0.4 0.0 0.0 3.8 87.0 0.0 0.2 6.6 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.5 0.0 1.8 0.1 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460139 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 380.7;Extravillous trophoblasts: 257.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "NK-cell: 9.1" "Lineage enriched" "Detected in many" 4 "NK-cells: 9.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1060.6;T-47d: 396.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 22.1 8.4 27.1 7.5 35.7 9.4 41.0 8.7 33.9 35.9 16.7 11.7 9.3 29.3 9.4 35.8 21.1 32.4 55.2 42.8 21.7 14.5 31.4 32.5 7.3 12.7 14.5 29.2 19.4 23.6 5.9 6.4 48.0 13.9 17.8 14.7 2.1 43.3 10.6 7.5 45.0 13.0 26.8 8.6 84.3 10.5 38.5 12.1 7.3 18.1 13.7 7.7 30.0 32.4 21.6 131.1 115.6 38.3 3.1 19.9 31.9 15.1 27.1 44.8 86.3 49.8 8.6 112.1 0.0 176.3 95.2 208.3 159.8 1.7 61.5 75.6 0.3 3.5 0.0 50.8 9.7 106.1 0.6 3.6 18.7 82.0 33.3 90.9 1060.6 175.4 0.0 0.1 4.4 169.8 47.5 0.3 0.2 7.6 12.4 18.5 6.3 106.5 0.0 221.6 25.4 2.3 5.1 82.4 16.0 76.0 66.1 396.9 2.0 231.9 24.3 63.8 11.0 217.8 0.1 0.3 0.3 18.8 0.3 110.7 2.2 0.5 1.9 0.1 1.2 0.0 0.8 0.5 0.0 2.2 0.6 0.9 0.4 1.5 9.1 0.5 1.5 0.4 0.4 27.1 35.7 8.7 33.9 42.8 21.7 12.7 14.5 29.2 13.9 8.6 12.1 21.6 144.6 19.2 15.8 5.9 23.4 141.7 194.1 116.1 380.7 3.8 108.5 203.7 128.9 30.0 134.9 18.4 4.2 66.5 22.7 66.3 9.8 109.8 10.9 132.7 67.8 178.7 84.3 2.7 44.3 77.9 257.3 107.8 136.6 165.4 9.5 4.1 89.3 7.7 14.9 0.0 22.8 39.9 124.1 8.1 19.3 5.0 12.8 39.5 24.9 15.9 3.2 3.3 0.0 3.5 4.9 103.2 44.6 10.9 8.2 76.1 38.5 5.5 31.6 2.9 0.0 74.0 106.6 65.1 10.4 184.9 103.4 129.8 21.2 7.4 45.6 63.1 SHISAL2B FAM159B ENSG00000145642 "Shisa like 2B" A6NKW6 5 64690442-64718190 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 2.0;pancreas: 5.0;stomach 1: 2.9" "Group enriched" "Detected in some" 13 "Breast glandular cells: 1.8;Pancreatic endocrine cells: 1.0" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 3.9" "Region enhanced" "Detected in some" "hypothalamus: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 9.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA011778 Enhanced NA NA "HPA011778: AB_1848382" "unprognostic (5.83e-2)" "unprognostic (9.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-2)" "unprognostic (3.25e-1)" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.97e-1)" "unprognostic (4.84e-2)" "unprognostic (5.36e-5)" "unprognostic (1.44e-1)" "unprognostic (1.98e-1)" "unprognostic (5.60e-1)" "unprognostic (6.99e-2)" 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 9.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 2.0 1.2 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GZMA "CTLA3, HFSP" ENSG00000145649 "Granzyme A" P12544 5 55102646-55110252 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 68.7" "Group enriched" "Detected in many" 24 "dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 15 "gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8" "Group enriched" "Detected in all" 42 "NK-cells: 718.8;T-cells: 941.4" "Cell line enhanced" "Detected in some" "HL-60: 4.0;JURKAT: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054134, HPA076751" Enhanced "Secreted to blood" NA NA "HPA054134: AB_2682395, HPA076751: " "prognostic favorable (7.27e-4)" "unprognostic (7.29e-3)" "unprognostic (1.50e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.96e-3)" "unprognostic (1.85e-3)" "unprognostic (8.30e-3)" "unprognostic (1.15e-2)" "unprognostic (5.15e-3)" "unprognostic (3.03e-2)" "unprognostic (1.77e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.26e-6)" "unprognostic (5.91e-2)" "unprognostic (5.57e-1)" "unprognostic (5.73e-3)" "unprognostic (3.33e-3)" 5.7 6.0 0.9 16.8 1.3 35.6 7.3 0.9 2.5 7.7 1.4 14.8 29.5 14.9 8.9 4.9 4.7 14.1 4.1 0.9 1.0 3.2 15.3 22.1 68.7 1.5 1.1 0.8 4.6 1.0 1.3 1.0 3.1 1.2 3.1 17.9 0.0 7.2 3.0 1.7 1.6 27.8 7.3 1.2 51.5 11.8 2.0 1.3 12.5 2.9 1.3 19.3 13.6 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.5 3.8 941.4 2.3 926.2 3.4 250.0 922.7 3.1 1.3 48.5 494.1 19.9 718.8 4.0 3.2 33.1 712.7 0.9 1.3 0.9 2.5 0.9 1.0 1.5 1.1 0.8 1.2 1.2 1.3 1.5 5.1 3.2 18.1 0.0 12.3 0.4 0.1 0.0 2.8 0.0 2.7 2.4 1.6 5.7 3.1 0.0 0.0 0.4 739.3 1.4 0.0 1.6 0.0 1.7 2.7 2.8 0.0 36.2 0.0 0.0 0.2 7.8 20.4 2.1 7.6 0.0 17.9 2.8 0.3 0.0 0.1 1.5 0.0 25.8 2.6 0.0 0.0 12.3 3.6 0.0 12.6 0.0 1543.8 0.0 0.1 0.0 3.9 0.0 40.8 0.1 2.8 3.3 2.9 0.0 0.0 2.6 2.6 0.0 0.1 1.1 1.4 0.7 709.4 0.0 1.8 0.0 PIK3R1 "GRB1, p85, p85-ALPHA" ENSG00000145675 "Phosphoinositide-3-kinase regulatory subunit 1" P27986 5 68215756-68301821 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Protein transport, Stress response, Transport" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 410.2;Endometrial stromal cells: 479.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 265.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001216, CAB004268" Approved Approved Cytosol NA NA Cytosol "CAB004268: AB_628126, HPA001216: AB_1079612" "unprognostic (5.74e-2)" "unprognostic (6.58e-2)" "unprognostic (2.01e-1)" "unprognostic (1.31e-2)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "prognostic favorable (8.09e-4)" "unprognostic (3.78e-3)" "unprognostic (1.78e-1)" "unprognostic (2.71e-1)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (4.59e-3)" "unprognostic (5.66e-3)" "unprognostic (1.27e-1)" "unprognostic (5.92e-2)" "unprognostic (1.54e-1)" 61.2 27.5 19.1 28.0 32.9 127.5 93.0 15.8 42.6 51.7 1.6 31.5 17.4 66.4 45.4 43.6 69.6 35.3 72.9 31.2 17.9 36.3 101.6 27.0 28.8 13.1 26.6 15.3 53.8 13.5 40.5 7.4 32.7 19.7 26.9 22.4 60.5 65.0 32.2 64.1 28.1 24.8 75.4 15.7 38.4 18.4 8.7 24.4 47.0 20.8 34.2 23.9 27.2 31.9 39.3 4.3 8.2 23.8 71.4 265.5 76.9 10.4 23.2 10.6 8.8 9.4 20.4 7.4 21.8 38.5 32.0 4.3 10.2 6.7 46.9 11.0 90.6 8.9 26.1 6.5 17.0 89.2 27.0 20.1 81.9 104.2 16.1 83.6 4.1 11.7 25.0 4.1 16.1 8.1 11.3 65.7 10.5 6.9 14.7 4.3 61.1 11.3 17.0 11.5 47.9 4.7 21.3 4.0 6.3 15.0 13.7 34.3 19.0 14.0 10.3 10.4 17.3 14.8 18.0 29.2 25.2 11.1 32.9 7.8 22.0 1.7 8.8 11.5 2.4 16.6 1.7 14.9 11.1 3.0 3.9 18.6 14.1 2.2 11.7 6.5 1.2 12.3 5.5 19.1 32.9 15.8 42.6 31.2 17.9 13.1 26.6 15.3 19.7 15.7 24.4 39.3 47.7 51.3 24.8 112.3 47.7 14.4 23.5 30.8 175.2 46.0 61.4 168.4 263.0 38.6 19.3 5.5 25.0 13.4 410.2 28.4 72.4 15.8 12.6 38.7 479.9 39.0 9.6 43.5 232.8 9.5 18.5 151.0 43.8 93.2 68.9 110.4 31.1 198.3 30.7 48.8 82.7 32.6 28.5 69.2 24.7 11.9 172.1 68.8 33.8 117.1 37.6 194.1 137.0 281.5 199.9 12.3 19.8 122.2 173.2 8.4 24.3 39.1 8.7 89.4 19.7 127.2 76.5 1.7 4.5 37.2 10.2 10.0 309.9 45.4 36.5 8.1 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83720855 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 75.6" "Cell type enhanced" "Detected in some" "Fibroblasts: 146.7;Granulosa cells: 43.2;Inhibitory neurons: 35.6;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "PC-3: 152.4;SuSa: 70.1;TIME: 91.8;U-2 OS: 139.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavorable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 0.4 0.8 0.7 0.0 0.1 1.1 0.9 0.1 0.2 9.1 7.3 0.6 0.3 2.1 0.0 0.8 4.0 0.6 2.5 0.1 0.0 0.5 0.0 0.9 0.7 0.5 0.5 0.5 0.2 0.0 75.6 0.7 0.9 11.2 0.1 0.5 0.0 0.0 0.2 10.9 0.5 0.3 0.2 4.8 0.0 0.1 0.0 0.2 0.0 0.1 2.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.0 3.4 0.0 152.4 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 70.1 0.1 0.0 91.8 0.0 139.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.1 0.9 0.6 2.5 0.9 0.7 0.5 0.7 0.3 0.1 0.7 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.2 0.0 0.2 0.0 0.0 0.0 0.1 0.5 6.9 0.0 0.0 0.5 0.0 10.6 146.7 0.0 0.1 0.0 43.2 0.0 0.0 10.6 0.0 35.6 2.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 23.7 0.1 3.8 0.4 0.0 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.9;Microglial cells: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.9;plasmacytoid DC: 6.3" "Group enriched" "Detected in many" 9 "dendritic cells: 6.3;granulocytes: 7.9;monocytes: 3.9" "Cell line enhanced" "Detected in many" "GAMG: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042402, HPA076743" Uncertain Approved "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear bodies, Vesicles" "HPA042402: AB_10794276, HPA076743: " "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 18.3 19.0 10.2 19.7 11.1 18.6 20.8 12.0 13.5 14.2 14.9 17.9 24.0 18.1 19.1 6.3 9.2 22.8 9.6 9.8 16.4 2.6 6.4 19.9 15.4 13.6 12.6 7.8 18.7 11.5 10.5 5.8 14.9 14.6 11.5 17.7 5.6 19.5 24.9 2.7 5.5 21.4 22.2 16.0 4.3 15.0 9.2 16.1 14.9 9.2 4.2 14.5 36.6 10.4 16.7 9.8 36.1 10.6 14.1 63.0 18.0 32.7 11.0 28.0 18.7 32.5 12.8 28.4 24.4 4.8 21.7 116.4 16.6 10.2 11.8 30.6 0.2 9.1 24.3 7.2 21.6 46.5 0.1 0.2 20.7 46.6 57.3 88.4 29.6 44.8 0.9 0.2 17.8 42.9 5.2 0.1 1.4 11.8 7.9 10.3 4.7 15.0 6.8 7.1 42.6 2.0 14.4 17.9 6.6 62.5 22.3 3.9 3.0 29.8 21.7 11.8 60.1 33.2 0.7 0.1 34.1 57.5 0.2 39.7 7.9 3.9 4.0 0.0 1.4 0.1 0.6 0.0 0.0 0.9 0.6 0.0 0.0 0.7 0.0 0.5 6.3 0.1 1.3 10.2 11.1 12.0 13.5 9.8 16.4 13.6 12.6 7.8 14.6 16.0 16.1 16.7 13.5 3.2 3.4 20.2 5.7 8.7 7.3 5.2 0.6 6.6 18.2 15.6 3.7 1.5 7.6 7.3 0.0 4.0 20.3 34.8 0.0 9.1 1.5 7.5 26.3 21.4 2.4 10.7 15.8 12.9 2.6 38.1 10.7 14.6 0.0 121.9 35.3 1.4 60.1 3.3 7.9 16.3 6.1 40.4 14.7 1.7 19.3 36.3 10.6 209.9 5.5 5.4 0.0 55.3 4.6 17.0 16.1 33.4 3.3 10.4 29.8 0.7 3.9 2.2 6.6 19.1 13.1 0.7 1.7 1.4 4.8 7.3 1.3 22.1 10.0 12.4 SSBP2 HSPC116 ENSG00000145687 "Single stranded DNA binding protein 2" P81877 5 81413021-81751797 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 281.7;Excitatory neurons: 263.4;Inhibitory neurons: 350.0;Microglial cells: 339.2;Oligodendrocytes: 340.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 136.8;MOLT-4: 132.4;REH: 196.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020834, HPA068605, HPA071780" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020834: , HPA068605: AB_2732116, HPA071780: " "unprognostic (4.62e-2)" "unprognostic (1.96e-3)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.78e-3)" "unprognostic (2.36e-3)" "unprognostic (6.01e-2)" "unprognostic (1.01e-2)" "unprognostic (3.04e-3)" "unprognostic (6.56e-2)" "unprognostic (9.81e-2)" "unprognostic (4.39e-3)" 26.8 12.8 28.2 13.1 29.0 14.2 26.7 38.5 26.3 31.4 25.5 24.2 5.7 29.4 30.5 24.6 30.2 16.4 32.1 24.1 36.4 12.1 3.4 16.4 19.9 26.5 31.8 25.6 37.4 11.3 47.6 28.2 13.9 28.0 19.3 13.0 53.7 21.0 21.5 23.8 26.7 15.6 30.0 25.2 12.6 17.9 8.0 30.1 97.3 17.8 22.4 24.5 25.9 26.3 27.2 3.8 6.8 85.1 48.8 48.0 72.6 5.2 18.1 16.4 16.5 16.9 0.3 7.1 60.8 1.2 21.3 8.2 0.4 23.6 9.7 15.9 26.1 10.1 12.8 14.6 0.3 27.1 6.4 32.5 74.8 82.1 2.8 15.9 35.6 7.1 136.8 8.4 29.2 17.9 8.7 132.4 10.7 11.7 0.1 3.8 196.2 19.3 47.2 8.8 3.3 44.2 39.7 19.1 21.1 6.6 34.3 31.1 18.1 4.9 6.5 10.4 12.3 4.9 30.4 25.1 101.6 21.8 11.3 4.4 60.4 19.0 61.1 5.0 17.5 8.0 23.9 16.2 9.3 18.3 33.6 31.3 11.1 27.9 61.3 29.6 5.9 7.8 18.7 28.2 29.0 38.5 26.3 24.1 36.4 26.5 31.8 25.6 28.0 25.2 30.1 27.2 43.7 9.6 18.6 281.7 39.0 34.9 40.3 44.3 122.9 75.0 25.1 38.1 45.3 12.8 34.4 29.5 27.1 7.7 12.5 4.1 17.6 14.0 5.9 25.2 27.3 21.4 15.0 29.7 263.4 10.0 3.7 48.6 10.2 22.0 25.3 5.4 23.9 2.3 20.5 42.1 350.0 5.4 61.1 17.0 21.7 4.2 37.9 29.9 35.6 339.2 15.6 122.4 5.2 185.0 340.2 6.1 13.6 48.5 14.9 14.9 2.5 4.5 34.1 49.3 52.6 48.9 59.4 10.0 29.8 60.3 36.2 7.4 23.9 9.9 4.4 27.3 BHMT BHMT1 ENSG00000145692 "Betaine--homocysteine S-methyltransferase" Q93088 5 79111809-79132288 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 83 "kidney: 786.1;liver: 1151.3" "Group enriched" "Detected in some" 10 "Hepatocytes: 604.2;Proximal tubular cells: 996.1" "Group enriched" "Detected in some" 4 "liver cancer: 90.6;renal cancer: 50.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.6;NTERA-2: 1.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA038285, HPA058310" Enhanced Supported Cytosol No NA 10000000 Cytosol "HPA038285: AB_10675791, HPA058310: AB_2683675" "unprognostic (2.61e-2)" "unprognostic (4.12e-1)" "unprognostic (4.45e-1)" "unprognostic (4.14e-3)" "unprognostic (5.62e-2)" "unprognostic (4.14e-1)" "prognostic favorable (7.32e-4)" "unprognostic (5.33e-2)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (9.66e-4)" "unprognostic (6.42e-2)" "unprognostic (8.26e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.30e-3)" 0.6 0.3 0.3 0.0 0.7 0.0 0.5 0.1 0.6 0.2 0.2 0.6 1.2 0.2 1.8 0.1 0.2 0.2 0.1 0.5 0.3 786.1 1151.3 0.1 0.0 0.3 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 3.2 0.3 0.3 0.5 0.4 0.0 0.0 11.7 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.6 0.5 0.3 0.3 0.2 0.3 0.3 0.2 0.3 0.4 0.1 0.0 0.0 1.0 5.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 4.3 0.0 16.5 0.0 0.0 0.0 0.0 78.2 0.0 0.5 0.1 0.8 0.8 0.0 13.5 0.9 0.0 0.1 0.1 8.2 0.2 0.0 0.1 8.9 604.2 0.0 0.0 0.2 0.4 0.0 12.2 0.0 0.5 0.9 3.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 2.6 0.0 0.0 0.0 996.1 0.0 0.4 0.0 0.2 0.1 0.2 1.0 0.0 0.0 0.1 4.2 0.5 0.1 0.3 ANKRD31 FLJ40191 ENSG00000145700 "Ankyrin repeat domain 31" Q8N7Z5 5 75068275-75236911 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 5.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 148.9;Spermatogonia: 37.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA038028, HPA057566" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome NA NA "Nucleoplasm, Centrosome" "Nucleoli, Vesicles" "HPA038028: AB_10672615, HPA057566: AB_2683470" "unprognostic (1.37e-1)" "unprognostic (4.28e-2)" "unprognostic (5.25e-2)" "unprognostic (5.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.72e-2)" "unprognostic (4.81e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-2)" "unprognostic (1.69e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 5.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.1 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.5 5.2 0.4 0.4 0.4 0.5 0.6 3.3 0.8 1.1 1.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.3 3.6 2.8 0.8 0.1 0.0 0.8 5.8 0.2 0.6 0.4 4.1 0.4 12.0 0.5 0.4 0.0 0.1 1.7 5.4 0.0 0.0 0.0 0.0 4.7 1.5 0.1 0.0 1.0 0.1 1.3 0.0 3.0 5.6 0.1 0.1 0.4 1.3 0.0 0.1 0.3 1.2 2.2 13.1 0.6 0.4 148.9 37.7 0.4 0.1 0.3 1.1 0.7 0.1 0.2 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403285-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 114.0" "Cell type enhanced" "Detected in many" "Early spermatids: 1011.9;Late spermatids: 351.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 21.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0" "Region enhanced" "Detected in many" "hippocampal formation: 30.5" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" NA NA 3700000 "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460" "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favorable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favorable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 8.0 12.3 2.5 11.8 0.7 25.2 27.4 0.9 2.6 19.8 3.5 25.9 57.0 3.3 9.5 2.9 3.5 18.8 2.9 0.4 1.5 35.6 114.0 10.0 14.5 1.9 1.5 0.0 8.9 26.0 44.7 1.1 30.9 1.7 15.3 23.3 24.1 34.9 15.6 0.3 2.5 31.7 4.4 2.3 13.3 39.5 51.6 1.8 7.3 28.8 1.3 8.3 6.6 1.5 2.0 0.0 9.6 31.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 74.2 0.1 0.7 2.7 0.0 2.7 0.2 12.1 0.0 0.1 8.6 12.0 27.6 6.8 61.7 0.2 15.7 211.8 0.0 0.0 0.0 0.0 0.0 1.2 14.9 24.6 21.4 0.0 0.0 13.5 42.4 14.8 25.4 0.3 4.9 0.1 81.6 0.0 0.1 0.6 3.2 17.3 0.9 0.1 31.4 0.0 9.3 0.4 0.0 0.5 0.0 0.3 19.8 0.0 18.7 0.1 57.0 3.0 21.3 3.1 1.9 4.5 2.5 3.7 0.5 4.7 3.9 2.9 0.2 1.8 3.3 6.0 4.3 3.4 7.7 6.2 1.4 2.5 0.7 0.9 2.6 0.4 1.5 1.9 1.5 0.0 1.7 2.3 1.8 2.0 9.1 12.8 12.2 0.7 27.3 4.7 21.5 2.4 0.0 6.7 68.9 34.5 3.5 107.2 9.1 35.0 108.4 14.2 230.3 96.2 7.9 44.5 1011.9 43.8 3.3 7.7 9.1 76.3 2.3 66.7 1.2 22.0 99.4 37.5 94.9 8.7 18.5 235.7 65.9 1.7 19.0 52.9 61.1 132.6 63.3 351.0 7.5 141.3 16.0 47.8 63.4 14.0 114.4 0.5 1.1 18.7 37.5 5.3 148.3 21.5 87.1 65.2 16.1 121.8 0.0 3.9 3.5 25.5 11.4 1.2 3.8 7.3 112.1 82.7 43.7 6.5 CRHBP "CRF-BP, CRFBP" ENSG00000145708 "Corticotropin releasing hormone binding protein" P24387 5 76953045-76981158 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 167.9" "Group enriched" "Detected in some" 6 "Granulosa cells: 480.8;Hepatic stellate cells: 1319.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 4.4;BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HBF TERT88: 7.7;hTEC/SVTERT24-B: 2.6;RPMI-8226: 2.5;U-698: 7.6;U-87 MG: 4.3;WM-115: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036234, HPA046120" Approved Supported "Secreted to blood" NA NA 69000000 "HPA036234: , HPA046120: AB_10959760" "unprognostic (1.41e-1)" "unprognostic (2.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.36e-3)" "unprognostic (4.44e-5)" "unprognostic (2.16e-1)" "unprognostic (7.08e-2)" "unprognostic (4.98e-4)" "unprognostic (1.09e-1)" "unprognostic (6.63e-5)" "unprognostic (2.76e-2)" "unprognostic (4.64e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-2)" 22.4 13.8 8.0 0.7 5.6 3.2 6.3 3.0 7.5 3.7 2.1 0.4 0.6 2.6 0.9 0.2 1.8 0.9 7.4 5.6 15.9 36.9 167.9 0.5 0.9 7.1 7.2 4.6 1.3 0.1 0.6 0.1 10.3 11.7 1.2 0.4 0.1 1.1 4.2 0.9 0.4 0.7 1.5 3.4 37.6 0.3 0.8 20.9 0.5 4.1 1.3 0.6 0.9 0.8 7.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 4.4 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 7.6 4.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.0 5.6 3.0 7.5 5.6 15.9 7.1 7.2 4.6 11.7 3.4 20.9 7.0 134.9 0.0 0.0 1.3 8.8 0.4 0.0 0.0 0.0 0.0 0.4 1.1 0.7 17.2 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 45.9 0.0 39.4 0.8 0.2 0.2 0.3 0.0 0.0 0.0 480.8 1319.7 9.9 1.8 0.0 32.4 0.0 0.0 75.0 2.1 1.0 0.3 3.8 0.0 4.7 0.3 0.0 0.0 0.5 11.1 0.0 0.0 0.0 0.9 0.0 0.0 3.6 0.0 0.0 0.0 0.1 2.3 0.5 1.9 0.1 0.0 0.0 1.7 0.0 0.0 0.1 RASA1 "CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA" ENSG00000145715 "RAS p21 protein activator 1" P20936 5 87267883-87391931 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 97.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 196.7;Excitatory neurons: 192.1;Inhibitory neurons: 234.7;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 220.1;Syncytiotrophoblasts: 487.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007789, HPA036393, HPA064556" Enhanced NA NA 12000 "CAB007789: AB_598183, HPA036393: AB_2675097, HPA064556: AB_2685285" "unprognostic (1.57e-1)" "unprognostic (7.63e-2)" "unprognostic (1.88e-3)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.38e-2)" "unprognostic (6.88e-2)" "unprognostic (8.38e-3)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (4.12e-3)" "unprognostic (1.03e-1)" "unprognostic (3.98e-2)" "unprognostic (1.59e-2)" "unprognostic (5.39e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-3)" 15.7 14.8 12.1 15.2 16.0 14.1 18.8 23.5 15.7 17.6 11.3 14.9 12.5 21.3 20.4 16.8 15.7 16.4 13.0 15.9 12.8 15.3 12.5 15.1 19.8 11.8 11.4 13.2 26.0 13.4 25.0 11.6 97.6 12.8 14.2 17.6 34.9 15.6 15.4 9.6 18.8 13.9 15.6 11.1 19.2 13.8 26.9 12.8 25.5 24.6 15.8 18.3 17.2 12.7 16.8 31.7 16.1 31.0 20.6 26.5 37.3 23.5 47.5 32.0 30.3 49.2 13.0 82.9 20.7 11.1 54.9 33.8 15.4 14.0 40.7 95.0 19.9 11.1 15.6 15.3 13.7 25.3 12.7 18.6 21.0 27.1 84.1 48.5 51.5 42.5 11.8 8.8 44.4 109.3 20.5 14.7 21.8 16.6 6.9 29.5 17.5 66.4 30.0 29.0 27.7 18.2 20.1 18.4 24.4 29.6 29.4 21.7 20.4 61.3 38.3 17.6 21.1 60.0 16.0 15.6 20.5 55.1 25.3 27.3 2.1 0.6 0.9 0.9 1.2 1.6 0.7 1.2 1.0 0.5 1.1 1.0 0.9 0.8 3.9 1.2 0.6 1.8 0.5 12.1 16.0 23.5 15.7 15.9 12.8 11.8 11.4 13.2 12.8 11.1 12.8 16.8 18.6 12.8 15.8 86.5 13.9 14.9 6.7 12.5 16.5 35.7 18.5 11.4 6.4 7.2 15.2 16.5 29.2 196.7 11.5 12.5 5.9 10.4 7.7 15.7 18.3 20.2 16.2 12.8 192.1 7.8 53.7 16.2 18.3 16.5 8.8 22.1 18.2 11.7 47.8 32.0 234.7 12.9 12.2 27.1 9.5 4.8 14.0 21.2 14.2 128.4 13.6 12.6 7.2 165.4 220.1 23.4 14.8 13.5 15.9 11.9 10.7 11.2 19.1 18.6 0.0 21.6 15.0 33.9 20.0 17.7 17.5 487.5 17.7 16.4 13.8 11.2 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 34.3;retina: 43.0" "Cell type enriched" "Detected in some" 13 "Muller glia cells: 289.4" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 6 "B-cells: 2.2" "Group enriched" "Detected in some" 13 "RPTEC TERT1: 53.5;SuSa: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: AB_2683715" "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 0.0 0.3 22.6 0.2 19.4 0.3 0.0 26.2 17.6 0.0 6.8 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 25.3 34.3 3.1 0.0 0.0 0.5 29.8 26.9 13.1 0.0 0.0 0.0 1.5 0.4 23.1 1.6 0.3 43.0 0.0 5.8 0.0 0.1 0.2 0.2 28.4 0.1 0.4 0.1 24.3 0.0 4.7 0.0 0.0 0.0 0.0 28.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.1 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 22.6 19.4 26.2 17.6 25.3 34.3 29.8 26.9 13.1 23.1 28.4 24.3 28.1 0.0 0.0 0.0 21.2 1.3 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.7 0.0 0.1 12.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 3.3 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 289.4 0.0 0.5 1.4 0.0 0.0 0.0 0.1 0.1 0.0 2.3 0.0 9.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: AB_2684491" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 2.2 4.1 2.2 2.9 2.4 0.6 4.4 3.4 3.6 3.4 1.9 2.5 2.5 3.2 3.6 2.3 3.2 1.8 6.8 2.2 2.6 4.3 4.3 2.3 3.7 2.6 2.6 1.8 5.4 2.9 5.3 1.1 2.4 2.9 3.6 3.2 7.3 3.1 3.6 7.9 2.4 2.5 2.9 2.6 3.0 3.3 4.7 2.5 4.3 4.1 6.9 3.5 2.8 1.7 3.6 4.0 4.7 5.8 4.0 2.8 7.1 4.4 5.6 3.8 4.0 3.6 2.6 5.3 2.5 5.0 2.2 3.5 4.7 5.4 7.9 5.3 3.3 4.4 3.5 4.2 3.1 5.5 3.5 2.3 2.6 8.7 3.6 7.3 4.8 3.0 4.1 3.3 3.6 6.4 2.9 4.6 2.3 4.6 3.3 7.0 4.0 6.4 6.0 5.3 3.4 5.1 3.2 4.3 2.8 5.6 4.1 8.7 5.9 2.4 4.0 2.5 4.4 4.2 4.4 3.5 3.6 5.3 5.6 3.5 0.4 1.4 2.8 1.7 1.8 2.0 2.6 2.4 2.6 1.7 2.6 2.8 3.0 2.1 2.3 4.0 1.7 4.4 1.4 2.2 2.4 3.4 3.6 2.2 2.6 2.6 2.6 1.8 2.9 2.6 2.5 3.6 5.4 9.6 5.3 11.4 6.1 0.9 4.7 12.5 4.0 9.4 3.5 4.4 18.7 2.8 6.5 5.5 0.0 7.7 3.6 2.9 23.5 8.0 1.6 4.3 6.5 3.9 4.2 1.7 9.1 4.3 4.9 4.7 4.1 3.1 16.5 6.1 3.3 4.5 5.5 0.0 12.2 4.0 10.2 3.5 2.0 0.7 5.0 4.8 0.0 4.7 4.8 9.3 5.2 23.1 23.7 4.0 4.7 6.8 2.6 3.6 4.5 8.8 7.6 13.4 6.6 4.0 6.5 23.8 12.2 2.7 2.0 8.2 6.1 5.7 3.6 3.0 PPIP5K2 "CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2" ENSG00000145725 "Diphosphoinositol pentakisphosphate kinase 2" O43314 5 103120149-103212799 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hearing "Kinase, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 160.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037895, HPA038442" Approved Approved Vesicles NA NA Vesicles "HPA037895: AB_2675724, HPA038442: AB_10673173" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (1.93e-1)" "unprognostic (8.83e-2)" "unprognostic (1.60e-3)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.60e-2)" "unprognostic (8.59e-3)" "unprognostic (1.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.32e-2)" "unprognostic (1.29e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (8.80e-2)" 15.9 19.2 5.9 22.2 8.5 52.1 25.3 19.4 14.1 22.4 7.8 28.3 18.5 20.8 21.4 17.3 14.6 20.6 19.7 7.0 8.6 20.4 29.4 16.4 25.7 14.8 11.5 4.1 26.3 27.0 23.2 18.3 16.9 15.8 16.4 25.7 19.4 17.2 15.5 4.2 17.4 16.7 18.5 5.5 24.1 22.7 15.2 7.1 28.2 23.5 7.8 24.7 18.0 14.0 11.0 27.4 25.3 50.8 65.2 40.8 53.4 47.8 63.5 39.3 34.2 47.6 20.9 48.3 67.6 56.2 60.9 52.7 16.5 43.9 33.2 57.5 53.7 23.5 84.7 44.3 33.4 29.0 72.1 70.4 34.5 23.4 52.0 46.1 31.2 40.0 42.5 84.9 57.0 53.1 21.3 60.9 44.6 55.4 12.7 64.4 58.6 46.7 89.3 36.8 31.5 29.6 40.1 43.5 39.9 40.7 34.0 33.5 48.9 42.7 55.8 25.7 56.0 45.1 38.1 87.3 91.3 31.5 116.0 51.2 41.7 21.5 39.6 13.0 22.9 15.8 19.5 12.6 14.2 25.6 16.1 16.1 17.0 19.7 17.8 32.4 15.5 12.3 11.1 5.9 8.5 19.4 14.1 7.0 8.6 14.8 11.5 4.1 15.8 5.5 7.1 11.0 35.8 48.1 23.1 49.3 39.3 13.6 12.8 13.7 31.9 38.5 26.1 26.4 48.9 18.6 29.6 16.5 45.9 12.7 35.7 29.7 5.9 11.6 5.6 25.4 44.7 28.7 16.3 70.7 88.4 17.0 19.2 33.0 33.6 30.6 43.6 49.2 14.6 20.6 30.6 16.8 160.3 24.2 16.2 39.5 22.4 6.7 29.5 43.3 12.4 49.6 47.5 14.5 27.8 62.8 67.0 16.9 19.1 23.7 56.6 12.1 13.3 22.6 25.1 25.2 6.6 30.3 28.1 39.7 21.6 31.6 15.8 26.0 31.6 38.7 30.1 12.6 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1468.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA 98000000 "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: AB_2677919" "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 111.6 204.4 80.7 34.9 82.8 10.2 100.0 55.6 86.3 600.1 99.1 104.4 53.1 142.3 684.1 70.0 88.4 98.1 1468.4 79.4 152.4 117.1 20.3 89.1 27.9 85.2 105.5 63.7 137.6 105.3 259.8 138.0 60.5 146.5 92.4 81.2 37.9 207.2 238.8 156.6 61.1 52.5 159.3 56.4 52.9 132.7 22.6 102.8 18.1 95.9 160.9 30.7 104.3 117.1 134.7 111.3 16.3 195.9 87.2 529.9 314.8 78.0 307.6 457.0 89.1 268.9 53.5 143.2 0.1 65.0 714.5 125.7 36.8 11.0 135.3 244.0 13.5 44.7 22.9 60.0 17.7 80.3 7.4 23.9 173.4 57.3 65.6 49.2 562.6 186.8 8.9 0.9 15.0 255.6 22.9 0.1 3.2 35.3 19.7 59.3 8.5 108.9 62.4 346.1 13.0 92.3 63.9 131.2 8.3 83.3 114.0 34.0 7.3 144.9 280.8 72.4 133.3 93.4 33.1 8.6 0.4 322.3 30.8 247.6 4.2 8.0 0.2 20.7 1.5 14.9 0.8 12.3 15.6 3.1 0.4 4.1 6.8 16.6 26.3 3.4 1.6 19.9 10.8 80.7 82.8 55.6 86.3 79.4 152.4 85.2 105.5 63.7 146.5 56.4 102.8 134.7 45.7 54.5 39.3 47.0 3.9 28.2 12.0 26.1 12.0 19.1 27.5 12.1 1406.5 0.0 30.4 60.7 2.1 1.6 12.6 13.7 7.9 12.6 8.8 47.6 48.6 63.5 321.4 3.4 229.2 21.5 40.6 220.4 26.0 83.0 9.5 68.3 74.6 3.5 5.9 8.4 487.7 13.8 18.3 10.3 48.3 8.1 60.3 9.3 37.4 192.0 9.5 11.6 22.6 154.8 9.3 30.6 6.3 58.6 12.1 26.4 4.8 43.8 19.2 3.8 19.7 36.4 44.9 2.6 5.6 8.0 23.7 6.7 16.6 19.3 6.3 18.2 BDP1 "HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR" ENSG00000145734 "B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB" A6H8Y1 5 71455651-71567820 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064166, HPA077984" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064166: , HPA077984: " "unprognostic (4.96e-2)" "unprognostic (2.19e-1)" "unprognostic (6.65e-2)" "unprognostic (3.01e-1)" "unprognostic (3.47e-2)" "unprognostic (1.44e-2)" "unprognostic (7.72e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (8.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-1)" "unprognostic (7.83e-2)" "unprognostic (2.50e-2)" "unprognostic (5.86e-2)" 2.5 2.7 0.2 1.3 0.3 0.9 3.4 0.6 1.9 1.8 0.1 0.9 0.0 1.2 0.0 0.8 1.3 2.0 0.7 0.3 0.1 2.7 1.6 1.4 1.2 0.8 0.2 0.2 1.8 4.0 0.4 0.3 1.4 2.2 1.5 2.4 5.8 0.8 1.9 2.2 2.0 0.8 2.1 0.3 0.7 1.0 0.9 0.2 2.4 2.8 3.5 1.6 0.9 0.6 0.9 1.3 2.1 10.1 3.1 1.6 5.0 7.7 0.2 0.1 2.4 0.0 0.7 1.0 0.5 9.4 4.0 11.0 0.0 3.2 0.2 11.0 0.0 0.0 1.6 7.0 3.1 4.2 4.4 0.4 0.0 0.1 0.9 5.9 5.4 7.9 0.0 12.7 0.7 5.0 3.9 0.0 1.2 0.0 1.0 7.7 10.5 1.3 7.9 4.4 6.6 1.2 7.3 0.2 2.1 6.4 7.2 0.0 0.0 16.1 5.6 0.9 3.6 0.5 3.4 8.5 0.1 0.0 3.8 8.6 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.3 0.6 1.9 0.3 0.1 0.8 0.2 0.2 2.2 0.3 0.2 0.9 69.5 60.9 96.2 52.5 79.7 44.5 63.7 26.9 55.8 78.2 57.9 55.8 110.7 38.6 57.3 35.0 102.2 37.9 101.1 38.7 1.9 48.1 37.8 88.7 109.5 71.7 58.6 59.7 116.7 36.3 50.2 57.0 57.1 127.3 58.2 66.0 28.9 32.0 31.7 94.2 96.4 39.3 24.4 27.7 36.9 21.1 58.7 53.3 28.4 57.1 62.3 41.7 76.2 57.3 86.8 52.2 26.0 54.5 72.3 57.9 18.5 10.9 39.9 125.1 52.6 104.3 74.0 85.8 60.4 60.0 43.3 48.2 86.3 69.0 50.0 64.5 GTF2H2 "BTF2, BTF2P44, p44, T-BTF2P44, TFIIH" ENSG00000145736 "General transcription factor IIH subunit 2" Q13888 5 71032670-71067689 "Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 18.5;RPTEC TERT1: 19.1" HPA047001 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA047001: AB_2679899" "unprognostic (7.40e-3)" "unprognostic (4.71e-1)" "unprognostic (6.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.62e-1)" "unprognostic (3.07e-1)" "unprognostic (1.29e-2)" "unprognostic (4.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.22e-3)" "unprognostic (3.74e-1)" "unprognostic (3.06e-1)" "unprognostic (3.67e-2)" "unprognostic (3.93e-2)" "unprognostic (2.43e-1)" "unprognostic (1.87e-3)" "unprognostic (1.62e-1)" 2.9 2.9 1.1 1.1 1.2 1.1 2.9 1.4 1.8 3.6 0.7 3.9 0.2 3.9 2.0 2.6 3.4 1.2 2.5 0.9 1.0 3.6 3.4 2.8 4.8 1.7 1.1 0.8 3.5 4.4 1.1 2.6 0.9 1.6 2.3 1.1 1.7 2.8 0.6 3.5 1.9 2.9 5.1 1.0 2.8 2.9 3.7 1.2 1.4 3.5 0.0 0.3 2.7 3.1 2.1 4.8 0.0 4.2 0.0 11.0 12.8 13.9 0.5 0.2 0.3 0.7 12.0 0.4 18.5 8.4 10.2 6.1 3.1 0.6 0.1 0.3 15.0 14.0 8.7 0.2 0.9 12.3 0.4 0.0 0.0 2.7 0.4 0.0 2.4 0.0 0.1 0.2 3.3 0.0 7.3 5.6 6.0 0.1 0.1 0.0 6.6 2.6 11.1 19.1 0.0 0.4 4.6 12.1 1.4 11.5 0.3 7.7 8.0 4.2 5.3 1.1 0.7 8.7 0.2 0.8 4.7 0.1 0.8 10.1 0.2 0.5 0.2 0.6 0.3 0.2 0.5 0.7 0.5 0.3 0.8 0.7 0.5 2.1 0.3 0.3 0.3 0.0 0.3 1.1 1.2 1.4 1.8 0.9 1.0 1.7 1.1 0.8 1.6 1.0 1.2 2.1 6.9 16.0 27.0 6.8 17.6 16.6 23.5 17.5 7.4 23.3 14.9 8.1 16.7 28.6 18.7 12.9 39.6 37.3 9.6 8.4 46.9 19.1 5.4 17.0 17.7 12.6 12.0 15.2 10.0 20.5 17.5 14.6 7.1 17.7 6.3 25.5 14.6 12.5 15.0 25.2 10.2 5.9 14.2 15.0 9.9 7.0 24.2 11.0 14.2 4.7 7.9 10.6 9.2 9.0 11.0 16.7 7.5 13.2 14.6 23.7 8.9 22.5 22.7 39.7 26.3 14.1 12.5 60.3 55.9 6.9 12.5 9.6 15.3 15.5 9.1 18.7 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093949-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 26.0 25.9 12.4 21.2 13.0 19.8 30.6 14.2 15.7 30.0 18.9 27.1 25.0 25.8 38.6 19.5 24.5 24.2 23.0 12.3 14.2 29.4 29.2 21.3 24.9 13.2 13.1 11.9 22.5 33.2 36.2 24.2 27.7 13.2 29.6 24.9 18.7 31.0 24.2 16.5 27.3 23.8 23.0 12.4 22.1 26.6 16.6 13.2 21.0 37.8 16.7 23.9 23.8 19.9 14.7 37.4 29.9 26.3 46.2 69.1 53.2 82.5 58.8 53.6 36.4 55.1 26.0 45.7 50.2 70.6 41.4 63.7 38.8 38.6 46.1 61.5 60.2 43.5 55.7 35.0 43.2 55.0 34.8 58.3 35.7 57.1 38.3 46.5 50.1 36.6 34.2 34.9 57.0 46.1 46.9 46.4 71.6 29.4 25.3 33.3 35.5 33.2 89.9 53.6 34.5 46.0 36.8 47.4 45.0 84.5 36.0 43.7 76.2 33.3 23.2 29.5 58.7 58.2 49.5 67.5 37.9 46.6 62.3 58.9 11.9 5.1 8.5 4.1 5.3 4.4 6.9 6.4 6.2 6.3 4.3 5.9 4.8 4.1 4.0 5.5 9.6 4.9 2.8 12.4 13.0 14.2 15.7 12.3 14.2 13.2 13.1 11.9 13.2 12.4 13.2 14.7 17.3 19.2 21.5 14.7 26.9 18.7 27.9 27.5 19.9 15.3 28.5 20.6 29.2 18.6 23.2 25.8 22.9 42.0 35.3 19.9 29.4 22.0 6.9 28.8 35.8 19.3 13.2 29.9 29.6 27.1 80.4 24.8 34.7 23.7 41.3 15.4 21.8 19.8 22.3 8.4 30.6 27.9 32.6 17.2 18.4 9.9 24.2 16.8 14.2 19.7 21.2 14.9 15.5 22.1 23.3 19.0 16.7 22.2 51.8 34.7 16.9 21.3 27.7 24.7 26.3 17.5 21.4 11.0 14.9 26.6 21.5 51.6 23.4 20.9 23.2 28.6 BTF3 "BTF3a, BTF3b, NACB" ENSG00000145741 "Basic transcription factor 3" P20290 5 73498408-73505635 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013007, HPA056420" Approved Supported Cytosol NA Yes 180000 Cytosol "CAB013007: , HPA056420: AB_2683125" "unprognostic (3.48e-3)" "unprognostic (2.11e-1)" "unprognostic (2.87e-3)" "unprognostic (1.86e-1)" "unprognostic (6.25e-2)" "unprognostic (1.41e-1)" "unprognostic (1.90e-3)" "unprognostic (1.78e-2)" "unprognostic (8.20e-3)" "unprognostic (5.18e-2)" "unprognostic (8.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (1.06e-1)" "unprognostic (2.87e-1)" "unprognostic (1.26e-2)" "unprognostic (2.16e-1)" 625.5 443.8 246.4 377.1 256.3 868.5 770.7 256.2 310.3 626.5 257.4 551.8 465.1 551.5 425.7 741.7 589.4 379.9 479.3 237.3 275.1 440.2 526.8 420.0 649.7 262.8 251.9 228.9 1191.4 614.7 405.2 290.4 433.1 264.9 444.9 545.3 185.5 513.4 394.5 887.2 784.7 450.4 463.1 266.8 396.9 539.2 183.3 255.5 635.1 444.0 605.4 765.1 630.1 631.8 278.4 1148.3 747.2 798.7 1145.9 779.6 1301.4 1246.4 781.1 1084.9 1327.8 1267.4 972.1 1267.3 1719.2 1203.2 816.0 963.9 787.9 1176.6 2011.7 1517.2 716.2 1502.5 976.3 652.7 1280.2 1132.7 934.0 754.5 1139.7 1597.0 857.6 1572.3 1512.0 1227.4 975.3 924.1 1087.8 1134.7 1037.8 1410.0 1735.0 1017.4 423.0 742.0 1061.5 944.4 2147.0 1414.6 1126.0 930.6 1239.4 767.0 861.7 1650.4 744.4 1108.4 1884.6 894.7 569.6 780.5 690.2 2142.1 1020.7 1114.3 1607.2 757.0 1405.3 862.8 261.1 883.1 221.9 535.6 684.0 907.0 957.3 906.7 754.3 1140.2 788.4 986.3 892.7 116.0 878.6 556.1 637.6 1146.0 2128.9 246.4 256.3 256.2 310.3 237.3 275.1 262.8 251.9 228.9 264.9 266.8 255.5 278.4 753.2 246.8 324.7 17.0 889.7 1962.5 2039.6 2425.9 1664.7 138.9 1675.6 2355.4 357.8 566.2 908.0 323.7 43.8 1370.6 740.7 648.3 909.8 971.1 718.0 502.1 809.7 864.3 592.8 968.4 25.2 1219.7 2062.4 753.8 465.3 646.9 417.7 935.1 742.8 439.4 1066.3 85.8 29.3 1169.4 787.3 968.7 1357.2 464.2 1248.3 803.3 791.5 29.0 1487.9 376.5 726.1 20.6 49.6 1221.7 998.2 846.3 540.1 1626.5 1308.9 1229.5 432.9 137.6 644.2 1023.8 1051.0 333.7 238.2 1582.0 1953.2 1712.1 868.7 1029.7 1337.1 2269.9 FBXL17 "DKFZP434C1715, Fbl17, Fbx13, FBXO13" ENSG00000145743 "F-box and leucine rich repeat protein 17" Q9UF56 5 107859035-108382098 "Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Astrocytes: 270.0;Excitatory neurons: 568.2;Inhibitory neurons: 578.0;Microglial cells: 205.2;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036410, HPA036411" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA036410: AB_2675109, HPA036411: AB_10669603" "unprognostic (8.15e-2)" "unprognostic (3.77e-2)" "unprognostic (2.18e-2)" "unprognostic (1.21e-1)" "unprognostic (4.58e-2)" "unprognostic (2.72e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-1)" "unprognostic (6.67e-2)" "unprognostic (3.08e-2)" "unprognostic (5.98e-2)" "unprognostic (6.30e-2)" "prognostic favorable (4.60e-8)" "unprognostic (1.86e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.35e-2)" 15.5 13.9 13.6 7.9 14.7 6.0 10.5 9.3 15.6 10.8 5.6 10.2 10.7 10.0 9.0 12.2 9.1 9.2 27.2 13.7 13.8 17.1 14.4 9.0 8.6 11.8 14.1 13.7 9.3 10.1 26.2 5.7 6.0 11.6 11.9 10.5 25.8 9.8 13.9 56.3 8.8 11.0 11.8 11.0 10.7 10.2 8.7 13.3 10.2 24.8 42.1 10.8 8.6 4.5 12.1 8.7 8.5 9.6 17.7 15.8 16.4 6.4 10.4 23.3 8.4 11.3 1.7 17.9 9.7 16.0 16.9 13.0 3.8 7.7 11.9 13.0 9.8 6.9 9.2 9.0 4.2 8.2 6.2 10.1 11.8 17.4 7.8 5.7 16.3 10.1 3.9 1.3 12.2 18.5 6.5 5.4 7.9 1.3 6.7 7.9 7.6 12.8 12.7 11.7 11.9 8.2 14.0 13.6 11.9 13.4 6.6 9.4 14.6 11.0 18.9 5.9 5.9 13.6 9.5 14.3 7.0 16.7 9.4 12.6 0.1 0.1 0.8 0.4 0.2 0.4 0.2 0.4 0.4 0.2 0.3 0.4 0.3 0.3 0.2 0.1 0.4 0.2 0.1 13.6 14.7 9.3 15.6 13.7 13.8 11.8 14.1 13.7 11.6 11.0 13.3 12.1 13.2 19.2 14.5 270.0 13.9 16.8 7.4 7.5 6.8 37.2 18.6 10.2 38.3 17.2 8.3 29.5 56.3 4.8 12.8 22.8 17.6 7.3 5.6 8.5 9.7 12.3 29.9 5.7 568.2 13.1 6.5 12.1 12.2 10.7 16.5 12.2 21.0 21.4 8.4 30.3 578.0 21.7 2.0 21.0 14.1 5.4 14.0 9.9 16.0 205.2 13.1 20.8 12.3 302.6 256.1 13.3 16.0 16.6 10.7 8.6 14.4 15.0 6.1 50.4 0.0 16.6 9.8 9.5 3.9 10.6 24.6 4.5 12.6 13.8 16.6 8.8 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 26.9" "Group enriched" "Detected in some" 18 "Early spermatids: 580.3;Late spermatids: 498.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.0;THP-1: 1.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA010848, HPA076967" Approved Approved Mitochondria NA NA Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 1.1 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.4 0.3 0.0 0.0 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.1 0.2 0.0 26.9 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.3 0.1 0.2 1.0 0.0 0.5 0.0 0.2 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.1 0.3 0.1 0.2 0.6 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.4 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.9 0.3 0.0 0.0 0.1 580.3 0.3 0.5 0.2 0.0 0.0 1.9 0.0 29.2 0.4 0.0 0.2 0.0 0.9 0.0 0.1 1.3 1.7 2.6 0.1 0.0 0.3 0.0 498.7 3.7 0.2 0.0 3.7 0.1 0.5 2.1 14.1 1.7 0.0 0.4 3.4 0.1 0.3 0.1 0.0 0.2 0.4 0.0 1.7 0.3 7.7 3.2 0.0 0.1 4.2 0.1 0.6 0.2 0.2 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078026 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.6;urinary bladder: 12.1" "Group enriched" "Detected in many" 4 "Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1" "Not detected" "Not detected" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 38400 "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 1.7 0.7 0.2 1.3 0.3 0.0 1.6 0.3 0.5 1.2 0.3 1.1 0.7 0.8 0.3 3.8 0.6 8.9 4.4 0.2 0.6 0.5 11.6 1.9 0.4 0.4 0.3 0.2 0.3 0.3 0.4 0.4 0.1 0.3 6.2 0.9 0.0 1.2 4.0 1.4 0.7 1.0 0.6 0.4 0.4 1.3 4.9 0.9 0.2 2.7 1.4 0.5 12.1 1.9 0.4 0.0 0.0 0.0 1.8 2.3 15.0 0.0 0.0 2.3 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.5 0.5 0.8 0.0 2.4 2.8 0.1 0.0 17.1 0.5 0.0 0.3 10.3 18.9 12.5 38.6 0.0 6.6 0.3 0.0 3.2 0.0 2.5 0.0 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.1 0.0 0.0 14.1 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.2 0.6 0.4 0.3 0.2 0.3 0.4 0.9 0.4 6.2 0.0 3.1 0.3 0.1 55.8 26.6 108.1 338.6 0.0 6.5 8.0 7.4 0.0 35.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 38.5 0.1 0.9 10.5 0.0 0.0 0.0 0.0 0.1 10.0 0.0 0.1 0.0 0.9 7.9 9.4 0.2 0.0 0.0 0.0 24.4 1.2 5.0 26.3 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 24.7 0.2 1.6 3.5 0.0 0.0 6.9 3.8 0.4 0.9 38.0 25.1 0.0 0.8 1.9 0.1 3.1 TNFAIP8 "GG2-1, MDC-3.13, SCC-S2" ENSG00000145779 "TNF alpha induced protein 8" O95379 5 119268692-119399688 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 118.7" "Cell type enhanced" "Detected in many" "granulocytes: 211.8;Langerhans cells: 323.4;Syncytiotrophoblasts: 292.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 155.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054434, HPA057089" Uncertain Enhanced Nucleoplasm No Yes 470000 Nucleoplasm "HPA054434: AB_2682487, HPA057089: AB_2683331" "prognostic favorable (2.45e-4)" "unprognostic (6.06e-2)" "unprognostic (9.81e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.86e-3)" "unprognostic (4.92e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-2)" "unprognostic (5.81e-3)" "unprognostic (4.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.88e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-2)" 73.0 5.1 4.2 62.9 5.0 66.0 19.5 8.5 6.9 14.7 31.4 18.0 16.2 13.4 17.2 25.5 10.6 16.8 8.6 4.0 4.5 12.5 10.2 19.2 118.7 5.6 3.7 3.4 3.5 17.0 14.9 1.6 52.9 4.3 19.1 19.2 2.4 11.3 14.5 3.3 31.9 31.6 15.6 2.4 61.6 28.8 17.7 5.1 100.9 25.6 5.7 116.8 44.0 17.9 6.5 27.7 19.0 10.0 16.1 20.5 17.2 91.2 15.0 40.4 11.1 23.0 10.2 31.6 51.0 4.7 16.7 17.6 38.4 8.3 45.4 15.7 56.6 17.9 81.4 41.1 17.6 9.9 99.6 86.4 19.1 42.0 33.7 15.9 21.2 15.4 99.9 32.0 155.2 15.5 10.7 84.5 128.9 15.0 16.0 8.9 25.6 44.1 75.8 44.5 54.8 5.1 7.8 56.6 10.9 5.5 32.1 9.4 111.4 8.1 20.2 7.8 14.1 17.9 76.0 90.0 103.3 23.3 104.8 11.9 491.9 96.1 305.0 111.0 105.1 217.3 267.2 221.9 164.7 133.6 243.5 260.8 169.7 54.6 111.4 86.7 63.8 188.4 213.0 4.2 5.0 8.5 6.9 4.0 4.5 5.6 3.7 3.4 4.3 2.4 5.1 6.5 8.9 9.6 18.7 1.6 174.9 160.5 80.9 81.9 123.5 0.2 14.4 10.8 10.3 12.8 38.3 18.4 0.0 142.6 83.6 2.7 17.6 55.4 4.4 11.8 7.8 23.2 1.2 34.5 0.8 101.0 158.8 30.1 17.9 9.5 211.8 0.7 6.4 1.9 48.9 0.0 2.3 9.9 20.3 59.4 323.4 1.4 2.1 126.0 37.4 24.4 196.6 4.3 111.2 1.0 6.8 125.7 2.7 1.9 45.6 63.9 0.9 19.8 47.2 0.4 46.0 4.0 32.9 1.1 18.0 93.1 119.2 292.7 139.0 35.2 4.3 103.6 FEM1C "EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785" ENSG00000145780 "Fem-1 homolog C" Q96JP0 5 115520908-115544775 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059919, HPA060977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059919: AB_2684161, HPA060977: AB_2684402" "unprognostic (1.14e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.83e-4)" "unprognostic (1.28e-1)" "unprognostic (3.31e-1)" "unprognostic (7.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (4.67e-2)" "unprognostic (5.52e-3)" "unprognostic (1.99e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" 13.0 5.6 7.6 8.0 9.3 63.7 10.7 13.6 12.0 12.6 3.8 13.4 11.2 9.8 6.2 14.8 6.2 12.4 15.0 6.5 8.9 7.5 15.8 11.2 7.0 7.7 9.0 5.7 7.6 11.1 5.6 4.2 6.3 7.9 9.8 12.3 17.3 5.9 7.0 20.8 9.7 12.2 10.4 6.8 8.5 10.7 13.7 9.6 6.7 8.3 21.5 6.6 9.9 7.7 10.4 11.8 7.0 9.8 15.3 17.3 24.1 7.9 18.3 14.5 13.5 15.6 7.7 10.2 12.0 12.2 13.5 15.5 9.0 8.0 15.2 19.7 18.6 7.6 6.3 9.7 5.9 11.5 4.2 8.2 15.9 12.6 16.8 15.1 12.5 13.4 9.8 4.0 15.3 20.5 5.1 11.0 7.1 6.9 7.5 8.7 9.3 17.9 13.1 14.9 22.1 8.0 6.5 11.8 8.1 20.1 7.8 10.5 8.4 23.7 23.0 12.0 21.3 16.4 12.0 9.4 9.4 13.4 11.6 9.5 2.5 4.7 5.0 2.7 6.9 3.9 2.3 2.8 2.0 4.6 1.3 3.1 2.6 4.8 2.2 8.8 1.2 3.4 2.8 7.6 9.3 13.6 12.0 6.5 8.9 7.7 9.0 5.7 7.9 6.8 9.6 10.4 35.4 22.4 13.6 28.4 15.3 26.5 15.8 7.8 18.8 17.2 17.6 13.0 31.5 20.0 14.8 11.0 20.9 4.4 15.8 64.7 5.9 11.6 48.1 31.1 33.0 18.8 16.7 12.2 13.3 8.4 8.6 27.5 23.0 36.9 13.3 29.6 17.9 47.0 7.6 5.0 7.2 27.5 8.2 15.8 52.9 80.7 8.7 22.5 30.2 5.6 9.7 23.1 5.2 15.1 18.2 17.1 53.2 6.8 19.4 18.9 31.7 12.3 18.3 28.2 0.0 24.0 22.8 16.5 6.3 25.4 24.7 5.1 16.7 8.0 21.5 40.2 COMMD10 PTD002 ENSG00000145781 "COMM domain containing 10" Q9Y6G5 5 116085016-116412762 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 184.6;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 236.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045441, HPA054156" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA045441: AB_10961905, HPA054156: " "unprognostic (1.14e-1)" "unprognostic (2.15e-2)" "unprognostic (5.38e-2)" "unprognostic (5.72e-2)" "unprognostic (1.79e-1)" "unprognostic (5.72e-3)" "unprognostic (2.12e-2)" "unprognostic (1.51e-1)" "unprognostic (3.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.07e-1)" "unprognostic (3.14e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.99e-4)" "unprognostic (9.47e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.59e-1)" 19.5 24.3 14.0 14.4 14.1 15.1 23.3 14.3 16.1 19.3 15.5 17.1 13.1 16.8 32.5 15.7 13.0 17.4 31.6 13.2 16.6 35.8 24.8 14.0 22.3 14.4 14.7 12.5 14.0 24.3 25.6 14.4 19.8 14.9 20.8 20.2 17.3 31.0 17.2 14.5 9.2 13.9 19.8 15.1 18.7 16.4 8.2 14.4 16.4 27.7 17.6 20.4 18.2 13.7 16.4 34.7 36.7 37.5 20.0 27.3 37.1 40.2 26.5 30.0 37.5 31.0 29.2 43.7 17.9 29.0 37.9 75.0 18.6 20.8 42.6 56.9 49.3 14.6 22.1 10.7 22.9 30.8 17.5 37.1 23.7 28.7 22.4 29.2 31.1 37.9 25.2 13.6 12.1 50.2 24.2 32.9 41.9 32.7 26.8 16.9 30.9 40.1 51.2 54.7 21.8 20.2 26.0 31.3 30.5 39.7 28.1 34.6 64.1 20.9 31.5 38.5 15.3 46.0 11.9 16.3 45.8 32.1 63.2 36.5 13.6 24.6 18.3 9.9 29.7 13.7 16.2 12.9 12.8 32.7 11.3 12.5 13.0 4.7 22.7 31.0 24.9 15.3 18.9 14.0 14.1 14.3 16.1 13.2 16.6 14.4 14.7 12.5 14.9 15.1 14.4 16.4 25.7 9.6 20.0 97.3 36.7 22.2 30.4 54.0 17.6 15.7 28.1 18.3 48.9 11.5 29.5 23.9 6.2 44.9 16.9 11.5 92.0 26.2 1.9 15.8 22.2 24.0 10.7 18.5 84.8 15.1 53.4 25.0 27.0 22.8 46.3 22.5 26.4 15.1 48.7 16.8 90.5 25.1 46.8 28.7 38.4 3.7 21.1 33.1 32.0 184.6 27.1 30.2 15.5 142.7 236.7 17.1 17.2 20.3 30.6 33.1 17.3 101.3 10.4 20.9 0.0 13.4 22.4 8.7 15.6 20.5 25.1 49.5 28.4 36.3 25.5 32.0 ATG12 "APG12, APG12L" ENSG00000145782 "Autophagy related 12" O94817 5 115828200-115841837 "Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013272, HPA068989" Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB013272: AB_2533272, HPA068989: " "unprognostic (2.48e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.72e-2)" "unprognostic (2.87e-2)" "unprognostic (5.51e-2)" "unprognostic (9.36e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.54e-7)" "unprognostic (1.27e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (5.11e-2)" 15.6 10.6 14.1 10.8 14.2 11.4 10.3 14.5 16.3 12.1 12.5 9.7 11.7 10.9 12.0 11.4 9.9 11.7 9.8 14.7 15.0 7.2 18.5 10.4 13.7 14.9 14.4 13.3 12.1 9.6 7.4 8.8 13.8 15.3 10.9 11.3 9.7 8.0 11.0 11.2 9.1 12.0 12.8 14.8 11.3 8.9 9.5 14.7 14.1 8.7 12.7 11.7 11.9 8.8 16.6 20.7 10.9 26.3 24.1 42.9 57.4 20.0 34.9 38.3 22.6 36.5 15.8 16.5 17.8 14.5 32.1 35.3 11.3 20.5 29.4 36.4 93.2 20.2 11.5 13.0 14.8 33.7 12.8 22.0 43.0 31.5 25.1 29.6 26.3 27.6 19.0 16.8 24.4 43.5 13.5 27.2 20.2 17.9 15.7 23.6 19.8 25.4 25.7 15.7 13.7 25.8 27.6 37.3 14.7 36.6 20.0 20.3 19.2 28.3 41.3 18.9 38.2 36.0 18.7 31.5 28.9 37.7 27.2 39.6 15.4 11.5 19.3 11.8 13.6 16.5 12.3 14.3 11.7 10.3 12.2 14.6 14.1 20.9 14.4 17.4 13.8 12.3 11.0 14.1 14.2 14.5 16.3 14.7 15.0 14.9 14.4 13.3 15.3 14.8 14.7 16.6 52.5 44.8 41.0 17.0 82.8 85.8 65.4 81.6 44.3 42.3 46.8 36.1 45.2 38.6 56.9 25.8 77.2 61.8 92.3 50.3 37.2 60.6 28.7 49.0 60.7 55.1 41.8 23.8 28.5 81.6 134.1 75.2 36.2 55.8 96.9 48.8 47.5 57.9 68.2 30.3 26.5 54.5 59.0 72.1 69.8 14.9 64.0 53.7 53.4 19.7 76.8 34.1 99.9 26.7 35.5 105.5 45.8 53.8 50.1 68.4 56.3 44.3 49.7 59.2 26.3 39.5 50.5 50.0 45.1 40.0 84.7 88.7 78.8 45.1 46.0 78.1 MEGF10 "KIAA1780, SR-F3" ENSG00000145794 "Multiple EGF like domains 10" Q96KG7 5 127290796-127465737 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis, Phagocytosis" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 52.2" "Cell type enhanced" "Detected in some" "Astrocytes: 218.4;Oligodendrocyte precursor cells: 97.5;Oligodendrocytes: 381.7;Skeletal myocytes: 62.9" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 31.6;RH-30: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 73000000 "unprognostic (7.02e-2)" "unprognostic (4.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-3)" "unprognostic (8.91e-3)" "unprognostic (1.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-4)" "unprognostic (5.28e-3)" "unprognostic (2.59e-1)" "unprognostic (9.36e-4)" "unprognostic (1.17e-1)" 0.2 1.7 16.1 0.1 31.9 0.0 0.7 28.7 18.3 0.3 0.4 0.6 0.1 0.7 0.4 0.1 0.1 0.0 0.2 13.9 21.5 0.0 0.4 0.0 0.0 27.8 26.4 10.5 0.1 0.0 0.0 1.7 0.1 26.0 0.7 0.2 8.1 1.9 1.1 3.0 0.3 0.2 0.3 25.3 0.1 0.1 0.4 24.2 0.7 0.1 4.8 0.2 0.0 0.1 52.2 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 6.8 0.0 0.2 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.4 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.7 0.0 0.1 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 31.9 28.7 18.3 13.9 21.5 27.8 26.4 10.5 26.0 25.3 24.2 52.2 0.0 0.0 0.0 218.4 0.0 0.0 0.1 0.0 0.0 2.0 0.7 1.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 6.5 1.3 0.2 0.0 0.0 4.5 0.0 0.0 0.4 0.0 15.4 0.0 0.7 0.0 0.2 0.0 8.4 3.5 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 29.0 0.0 38.9 1.0 97.5 381.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 2.0 0.0 62.9 0.2 0.4 0.7 0.0 0.1 0.0 0.1 5.1 0.0 0.1 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" 5 129460281-129738683 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 10.2;endometrium 1: 9.9;smooth muscle: 6.0" "Group enriched" "Detected in some" 4 "Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7;testis cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 15.9;SH-SY5Y: 34.8" "Region enriched" "Detected in single" 5 "olfactory bulb: 2.6" "Low region specificity" "Detected in many" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.0 0.7 0.6 0.0 2.1 0.0 0.0 0.0 1.7 10.2 0.1 0.2 0.1 9.9 0.0 0.2 0.2 0.0 0.2 0.8 0.4 0.3 0.0 0.0 0.0 0.8 0.5 1.2 0.4 0.0 0.1 0.0 3.8 1.3 0.1 0.3 0.5 0.3 0.0 0.5 0.0 0.1 6.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 15.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 34.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 1.7 0.8 0.4 0.8 0.5 1.2 1.3 0.0 0.3 1.1 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.4 0.0 0.0 1.8 0.0 15.6 0.0 0.3 0.0 0.0 1.5 0.5 8.9 0.2 0.0 0.0 82.6 0.2 0.7 1.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 79.7 0.1 0.0 0.0 0.3 0.7 0.0 0.1 0.0 1.0 0.0 1.1 0.0 12.5 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.4 0.1 0.1 0.0 5.2 0.1 0.1 0.3 0.0 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158162-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 236.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: AB_2677953, HPA073622: AB_2686618" "prognostic unfavorable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.12e-5)" "prognostic unfavorable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 22.4 20.6 9.0 17.8 10.2 21.2 24.3 10.0 11.1 24.9 15.6 26.0 30.8 20.4 21.4 28.8 20.5 21.6 18.2 9.8 12.3 25.6 31.9 20.4 19.1 10.0 9.8 8.8 20.7 32.3 25.9 17.1 30.4 11.4 18.4 26.3 20.8 26.4 19.4 9.4 17.9 27.6 28.8 10.7 15.7 22.9 21.1 10.8 16.2 22.8 14.6 24.1 24.2 14.5 12.6 43.2 28.2 36.0 28.6 84.4 90.5 32.9 143.6 96.9 63.2 101.5 45.3 44.0 23.5 67.3 156.9 72.5 38.7 34.7 70.5 84.8 32.9 30.2 17.4 44.9 46.7 68.0 39.3 27.7 69.1 64.3 56.8 46.3 108.9 61.0 25.6 18.8 38.5 86.4 22.5 19.4 22.2 23.3 27.5 30.7 20.3 53.4 39.3 39.4 37.7 24.4 30.0 49.7 26.4 66.5 36.2 54.9 25.5 236.7 74.0 35.8 72.5 57.2 34.7 61.8 29.9 70.7 36.9 55.2 48.9 34.5 48.7 47.2 47.4 53.1 37.9 47.1 52.4 41.2 36.4 49.0 46.3 26.0 41.0 44.7 45.0 62.8 40.6 9.0 10.2 10.0 11.1 9.8 12.3 10.0 9.8 8.8 11.4 10.7 10.8 12.6 43.5 38.5 27.4 8.5 35.6 29.4 24.5 49.4 26.2 40.6 33.4 29.6 21.8 31.5 35.9 20.2 33.3 56.7 40.5 33.0 31.3 43.7 14.9 31.4 49.8 44.1 14.8 20.0 19.7 68.3 77.1 51.9 33.6 31.2 36.8 34.1 30.4 34.7 36.5 33.7 16.9 50.1 22.4 34.0 24.4 7.3 35.4 28.7 30.2 6.5 38.3 54.9 27.8 13.6 16.2 60.5 35.5 33.8 70.0 23.4 56.0 36.1 50.6 53.8 39.5 31.8 45.4 83.9 56.0 33.4 26.0 67.5 42.0 41.1 27.4 24.5 ARHGAP26 "GRAF, KIAA0621, OPHN1L, OPHN1L1" ENSG00000145819 "Rho GTPase activating protein 26" Q9UNA1 5 142770377-143229011 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 237.3;Excitatory neurons: 611.6;Inhibitory neurons: 261.5;Late spermatids: 153.3;Microglial cells: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "neutrophil: 24.7;NK-cell: 9.8" "Group enriched" "Detected in many" 4 "granulocytes: 24.7;NK-cells: 9.8" "Cell line enhanced" "Detected in many" "Karpas-707: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035106, HPA035107" Enhanced Approved Cytosol NA NA Cytosol "HPA035106: AB_2674465, HPA035107: AB_10669855" "prognostic favorable (2.05e-4)" "prognostic favorable (1.36e-4)" "prognostic favorable (6.95e-4)" "prognostic favorable (5.93e-6)" "unprognostic (1.19e-1)" "unprognostic (1.93e-2)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.22e-1)" "unprognostic (9.43e-3)" "unprognostic (7.19e-3)" "unprognostic (8.65e-2)" "unprognostic (3.21e-3)" "unprognostic (5.67e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-2)" "prognostic favorable (2.88e-6)" 11.1 4.5 11.2 17.9 7.4 36.7 11.4 21.0 17.0 12.0 2.7 13.0 12.1 7.8 9.1 6.4 15.7 14.3 14.9 10.7 34.9 6.6 6.8 19.2 6.4 1.7 3.8 4.4 3.1 5.0 3.9 12.3 21.1 6.3 7.5 12.8 17.4 12.9 4.3 12.7 7.1 11.4 9.7 2.0 16.8 15.4 15.5 7.3 13.9 8.4 10.6 12.3 12.3 5.9 10.2 16.4 29.1 8.0 7.6 12.3 12.7 12.4 2.2 2.4 7.6 12.1 44.9 33.0 2.0 16.1 4.9 21.5 7.5 4.1 15.3 8.7 33.8 4.6 0.1 5.3 26.9 7.8 22.6 2.9 4.7 23.0 12.8 31.0 5.6 10.2 9.9 0.6 85.4 2.4 2.3 12.9 9.2 4.3 23.2 7.7 5.2 12.5 36.5 20.4 25.6 3.4 4.7 3.8 4.4 7.1 6.5 2.4 6.2 21.0 4.1 5.8 0.4 8.1 4.0 14.0 0.4 10.7 21.3 5.6 4.0 3.9 2.3 3.8 2.5 1.7 0.5 0.8 2.4 3.0 0.4 0.3 1.1 24.7 9.8 1.6 0.7 0.3 1.8 11.2 7.4 21.0 17.0 10.7 34.9 1.7 3.8 4.4 6.3 2.0 7.3 10.2 39.4 16.0 22.5 237.3 5.8 6.9 13.8 13.2 5.7 15.9 20.7 17.0 37.6 21.5 14.1 0.0 8.4 1.3 41.6 38.7 0.0 17.9 77.2 17.9 4.0 32.5 3.6 11.8 611.6 21.1 0.6 13.6 39.8 55.6 26.6 6.4 40.0 6.5 26.4 75.7 261.5 26.4 0.0 48.0 44.9 153.3 6.5 51.6 10.6 326.0 47.3 7.5 40.2 30.7 29.8 21.1 27.8 14.3 14.5 29.3 27.9 5.8 16.1 52.6 46.0 27.6 17.7 2.6 8.7 7.5 5.5 1.9 29.3 50.5 26.8 36.2 CXCL14 "BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14" ENSG00000145824 "C-X-C motif chemokine ligand 14" O95715 5 135570679-135579279 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 786.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 3435.4;Basal squamous epithelial cells: 3284.9;Breast myoepithelial cells: 1544.3;Fibroblasts: 2220.8;Glandular and luminal cells: 1201.1;Proximal tubular cells: 3662.8;Suprabasal keratinocytes: 2115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "HAP1: 61.6;hTCEpi: 79.9;RPTEC TERT1: 222.2;SuSa: 115.2;U-2 OS: 84.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB029996 Uncertain "Secreted to blood" NA NA 800000 "CAB029996: AB_2086070" "unprognostic (1.82e-3)" "prognostic favorable (1.71e-4)" "prognostic favorable (4.52e-4)" "unprognostic (2.75e-2)" "unprognostic (2.71e-3)" "unprognostic (2.94e-2)" "unprognostic (1.33e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" "unprognostic (5.34e-2)" "unprognostic (1.26e-1)" "unprognostic (9.89e-2)" "unprognostic (2.09e-1)" "unprognostic (3.48e-1)" "unprognostic (1.85e-1)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" 262.3 5.2 78.3 76.9 78.3 0.6 231.5 68.8 103.5 167.7 72.6 153.8 215.9 7.0 67.2 93.6 33.2 20.0 11.0 81.9 96.2 348.8 59.0 7.5 91.4 70.4 82.7 82.1 5.5 11.7 1.9 122.9 172.2 72.1 10.2 183.0 17.7 295.9 17.7 81.8 786.5 249.1 6.3 64.5 88.2 108.2 3.8 82.4 26.9 55.6 36.8 129.6 77.3 97.1 75.5 0.0 0.0 2.7 0.0 0.2 0.2 0.7 2.9 0.8 0.2 0.0 0.0 9.1 0.0 2.7 0.1 3.8 0.2 61.6 1.6 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 79.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 4.0 0.0 0.0 0.2 0.0 1.1 222.2 0.0 1.1 0.7 0.2 0.2 0.0 115.2 0.1 0.0 0.0 0.1 84.9 0.4 0.1 0.3 0.0 0.0 1.4 0.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 78.3 78.3 68.8 103.5 81.9 96.2 70.4 82.7 82.1 72.1 64.5 82.4 75.5 123.8 0.0 1.1 32.7 13.1 3435.4 14.4 276.9 3284.9 245.7 47.5 1544.3 4.1 0.0 5.1 283.3 0.0 35.9 6.1 0.0 563.4 0.0 0.8 45.0 140.8 45.9 0.0 0.0 1.0 0.0 25.4 2220.8 0.5 1201.1 0.0 0.0 43.5 0.2 63.6 6.7 150.8 0.0 240.1 0.9 887.9 1.3 20.8 35.3 439.4 8.4 0.0 6.7 0.0 4.5 4.2 0.1 0.0 0.4 13.3 10.6 0.0 3662.8 2.1 19.0 0.0 889.8 99.2 0.4 5.2 69.3 2115.0 77.2 43.4 0.3 0.1 9.3 LECT2 "chm-II, chm2" ENSG00000145826 "Leukocyte cell derived chemotaxin 2" O14960 5 135922279-135954983 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "liver: 481.9" "Group enriched" "Detected in some" 15 "Early spermatids: 147.7;Hepatocytes: 100.7;Late spermatids: 55.8" "Cancer enriched" "Detected in single" 216 "liver cancer: 35.1" "Region enhanced" "Detected in some" "cerebellum: 5.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA043883, HPA058246" Enhanced Supported Vesicles,Cytosol "Secreted to blood" NA NA 26500000 5300000 Cytosol Vesicles "HPA043883: AB_2678714, HPA058246: " "prognostic favorable (4.16e-5)" "unprognostic (2.57e-2)" "unprognostic (3.52e-1)" 0.2 0.5 0.3 0.4 0.8 2.4 0.4 5.9 2.3 0.1 0.0 0.2 0.5 0.3 0.9 0.4 0.1 0.4 0.1 0.9 0.1 0.6 481.9 0.3 0.9 0.2 0.3 0.4 0.3 0.1 0.2 0.0 0.2 2.3 0.4 0.2 3.1 0.7 0.2 2.1 1.4 0.9 0.1 0.0 1.0 0.4 8.9 0.2 0.2 0.4 0.0 0.2 0.2 0.0 1.2 0.3 0.4 0.5 0.7 0.2 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.8 0.6 0.3 0.3 0.5 0.0 0.2 0.0 0.3 1.0 0.7 0.7 1.3 0.3 1.0 0.1 0.2 0.1 0.3 0.3 0.6 0.1 0.8 0.2 0.3 0.6 0.0 0.4 0.4 0.5 0.3 0.6 0.5 0.5 0.2 0.2 0.9 0.3 0.6 0.0 0.2 0.0 0.9 0.1 0.5 0.8 0.3 0.4 0.4 0.1 1.1 0.5 0.3 0.3 0.9 0.8 0.6 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.8 5.9 2.3 0.9 0.1 0.2 0.3 0.4 2.3 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.7 0.0 0.1 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 100.7 0.0 0.0 0.1 0.0 0.0 2.9 0.0 55.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 28.7;skeletal muscle: 8.9" "Cell type enhanced" "Detected in some" "Astrocytes: 31.0;Distal tubular cells: 9.8;Proximal enterocytes: 11.1;Proximal tubular cells: 45.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.7;HEK 293: 2.0;HEL: 1.7;RPMI-8226: 1.9;SCLC-21H: 1.9;U-2 OS: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" NA NA "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 0.5 0.1 12.8 0.3 15.8 0.2 1.1 11.0 17.8 0.2 5.4 0.9 0.7 0.2 0.1 0.4 0.1 0.2 0.2 13.6 16.3 7.6 0.5 0.0 0.3 15.6 21.6 10.2 0.1 2.1 0.0 0.1 0.4 21.7 0.4 0.9 0.5 1.7 0.0 8.9 1.8 2.5 0.1 15.2 0.2 0.1 0.4 16.2 0.0 0.2 2.3 0.1 0.1 0.2 28.7 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 2.7 0.0 0.0 0.3 2.0 1.7 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 1.9 0.1 0.2 1.9 0.2 0.3 0.2 0.4 0.7 1.0 0.2 0.1 0.1 2.3 0.1 0.1 0.8 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 12.8 15.8 11.0 17.8 13.6 16.3 15.6 21.6 10.2 21.7 15.2 16.2 28.7 0.1 0.0 0.0 31.0 0.0 2.4 0.1 0.0 0.0 0.2 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.0 9.8 0.0 0.0 2.0 1.2 0.1 0.0 0.0 0.6 0.0 0.2 0.7 0.0 7.1 0.0 0.0 0.0 1.3 0.1 0.0 3.1 2.8 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.0 5.0 4.2 0.1 5.0 0.0 0.0 0.3 11.1 45.8 0.0 0.2 0.0 0.5 0.1 0.5 4.3 0.0 0.9 0.1 0.1 0.0 1.6 0.1 DDX46 "FLJ25329, KIAA0801, Prp5, PRPF5" ENSG00000145833 "DEAD-box helicase 46" Q7L014 5 134758771-134855133 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036554, HPA057501" Supported Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA 13000 "Nuclear speckles" "Nucleoli fibrillar center" "HPA036554: AB_10673621, HPA057501: AB_2683449" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "prognostic favorable (9.01e-6)" "unprognostic (7.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.71e-2)" "unprognostic (2.04e-3)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (5.05e-2)" "unprognostic (9.21e-2)" "unprognostic (6.02e-2)" "unprognostic (9.70e-3)" "unprognostic (4.36e-2)" "unprognostic (4.35e-2)" "unprognostic (1.64e-2)" "unprognostic (4.50e-2)" 16.7 14.7 8.8 24.1 9.5 23.3 17.9 17.0 11.1 15.8 11.6 17.5 17.1 20.0 12.4 17.6 15.1 13.5 13.0 8.1 7.8 18.9 17.8 16.0 25.8 10.6 9.1 6.5 18.7 21.0 18.5 11.1 15.8 12.7 15.6 20.9 18.2 16.9 12.2 35.5 19.6 18.8 17.8 6.5 20.8 20.2 16.5 10.9 32.4 18.9 23.1 26.8 18.4 15.7 11.5 87.1 78.0 54.4 71.1 20.8 23.2 75.0 56.8 43.7 58.8 65.6 119.2 61.7 108.9 47.7 38.3 62.3 52.5 80.9 54.2 68.7 73.8 73.3 131.0 84.7 48.5 18.0 120.5 67.8 21.0 28.9 62.1 34.8 24.9 47.3 85.9 113.6 45.3 44.1 41.5 104.2 46.9 75.2 50.1 34.8 89.7 142.0 54.8 32.0 73.9 64.2 61.3 79.4 37.2 42.7 63.0 58.3 68.0 59.0 61.8 43.2 47.9 114.0 35.6 103.2 140.2 42.8 112.0 40.0 55.6 31.9 48.2 30.7 29.2 28.0 38.1 30.4 31.3 25.3 43.4 30.9 31.5 55.9 32.3 27.5 38.5 29.7 17.8 8.8 9.5 17.0 11.1 8.1 7.8 10.6 9.1 6.5 12.7 6.5 10.9 11.5 102.4 76.9 131.5 35.9 123.6 113.8 121.5 102.7 68.9 131.5 80.6 79.4 69.3 64.3 94.9 103.0 83.4 133.7 142.3 91.3 56.7 100.5 53.4 111.4 155.8 104.7 92.2 90.6 38.7 107.9 160.4 85.1 69.3 115.9 101.2 122.3 76.8 113.1 94.4 121.1 41.2 112.4 63.1 119.3 113.2 26.7 111.9 103.4 56.9 21.5 178.5 79.9 194.7 28.1 57.6 130.7 62.6 113.2 134.7 139.5 79.2 84.1 74.5 176.0 98.6 114.9 115.2 246.3 275.7 81.0 137.0 157.2 131.8 114.5 112.7 144.1 IL9 "HP40, IL-9, P40" ENSG00000145839 "Interleukin 9" P15248 5 135892246-135895841 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 279 "HDLM-2: 43.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 11000 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.3 0.3 0.0 0.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TIMD4 TIM4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919292-156963226 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 55.7;testis: 145.1" "Group enriched" "Detected in some" 23 "Early spermatids: 1336.2;Late spermatids: 1946.7" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.6;naive CD8 T-cell: 1.6;T-reg: 4.0" "Lineage enriched" "Detected in single" 18 "T-cells: 4.0" "Group enriched" "Detected in some" 18 "U-266/70: 96.7;U-266/84: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015625, CAB026027" Approved Approved "Plasma membrane" NA NA 32000000 "Plasma membrane" "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favorable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 15.0 0.4 0.3 7.0 0.3 16.2 0.4 0.2 1.1 0.1 1.6 1.1 0.4 0.0 1.3 0.1 0.1 1.3 0.6 0.4 0.3 3.3 16.5 1.6 55.7 0.4 0.3 0.3 0.0 0.2 0.1 0.0 5.0 0.5 0.4 0.8 0.0 0.2 0.0 0.1 0.3 1.8 1.0 0.3 8.1 0.2 145.1 0.4 22.6 1.1 0.0 17.5 4.9 0.1 0.4 0.1 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 96.7 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.3 2.4 0.0 0.0 1.6 1.6 0.0 0.0 0.0 0.0 4.0 0.7 0.3 0.3 0.2 1.1 0.4 0.3 0.4 0.3 0.3 0.5 0.3 0.4 0.4 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.4 5.9 0.1 1336.2 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.7 0.1 0.5 0.0 0.0 0.0 0.7 0.3 46.4 0.0 0.3 0.0 0.0 69.4 1.9 1946.7 14.9 1.9 0.0 2.8 0.0 0.0 1.0 0.0 0.3 0.0 0.0 10.9 6.5 0.0 0.0 0.8 0.0 0.0 13.1 0.0 0.1 16.6 8.1 0.0 0.0 0.3 1.7 0.1 0.1 0.0 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 27.6 39.7 11.8 39.8 14.3 20.6 28.5 15.5 14.3 24.9 17.4 26.6 12.3 21.2 31.2 53.5 17.1 48.7 19.0 14.0 22.1 19.7 15.4 74.2 39.0 11.1 12.9 14.2 29.2 12.5 48.0 19.5 52.8 12.3 26.1 29.6 34.1 25.8 33.0 9.1 21.4 16.7 27.7 13.9 29.4 26.9 12.2 16.0 26.8 34.1 13.8 48.8 68.8 24.6 13.7 65.5 63.5 95.2 115.1 98.5 43.6 18.6 51.3 88.9 46.3 74.6 22.2 52.9 22.4 89.7 45.3 87.9 83.1 75.9 67.3 80.9 92.7 27.2 47.2 68.5 18.4 42.1 31.4 43.2 27.0 118.8 43.2 63.0 64.7 46.2 53.6 47.7 83.6 44.1 1.9 36.1 9.8 41.3 20.5 32.0 47.3 41.6 44.8 61.4 22.3 34.5 63.9 51.8 54.7 86.5 64.7 38.5 28.4 49.7 51.6 47.0 41.9 92.1 18.4 27.6 20.6 60.3 38.4 113.1 3.5 2.5 16.0 3.0 2.6 3.5 11.4 4.4 3.6 1.9 5.1 5.8 4.0 9.5 2.3 2.3 2.7 6.3 1.3 11.8 14.3 15.5 14.3 14.0 22.1 11.1 12.9 14.2 12.3 13.9 16.0 13.7 34.1 112.2 244.1 25.1 62.9 122.7 102.0 90.0 73.4 106.7 97.2 77.3 12.7 65.8 114.0 36.8 58.4 2.8 55.1 98.4 19.6 75.0 28.9 27.5 37.1 75.7 54.1 67.5 89.2 114.4 24.3 45.7 52.0 36.7 69.1 30.2 127.8 19.5 45.5 114.4 74.2 41.8 32.6 115.0 240.8 39.5 46.3 69.4 65.8 52.5 153.9 56.1 47.4 40.2 38.9 108.6 53.7 51.9 38.1 123.8 16.9 10.6 65.6 53.4 46.0 25.4 46.5 19.2 34.8 81.9 99.4 10.9 69.3 19.0 72.0 163.1 C1QTNF2 CTRP2 ENSG00000145861 "C1q and TNF related 2" Q9BXJ5 5 160347754-160370641 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Fibroblasts: 23.7;Leydig cells: 23.3;Peritubular cells: 29.7;Skeletal myocytes: 16.9;Smooth muscle cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 5 "basophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "RH-30: 34.4;U-138 MG: 15.1;U-2 OS: 8.3;WM-115: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061290 Uncertain Approved "Golgi apparatus,Centrosome" "Secreted to blood" NA NA "Golgi apparatus, Centrosome" "HPA061290: AB_2684468" "unprognostic (2.28e-2)" "unprognostic (5.61e-2)" "unprognostic (4.09e-2)" "unprognostic (4.53e-2)" "unprognostic (8.92e-3)" "unprognostic (6.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.94e-1)" "unprognostic (5.91e-2)" "unprognostic (8.33e-2)" "unprognostic (3.23e-2)" "unprognostic (8.32e-2)" "unprognostic (2.11e-5)" "unprognostic (5.40e-5)" "unprognostic (1.14e-1)" "unprognostic (6.75e-2)" "unprognostic (1.10e-2)" 2.4 0.7 0.9 0.7 0.9 0.1 1.9 1.0 1.3 3.8 0.3 2.5 1.2 3.3 1.1 1.4 2.3 1.8 3.4 0.9 0.8 0.6 0.4 2.5 0.3 0.2 1.3 0.8 1.3 0.3 0.2 0.5 0.8 0.7 1.9 1.1 0.2 1.4 1.0 2.0 1.4 2.3 1.9 0.2 0.6 2.0 1.8 1.7 0.1 2.1 2.1 0.3 2.1 2.6 0.7 0.3 0.0 0.5 0.1 0.0 0.0 0.0 3.9 5.3 0.9 3.3 0.1 0.9 0.0 0.1 1.4 0.6 0.2 0.1 0.4 0.2 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 34.4 0.0 0.0 0.2 0.0 0.8 1.0 0.1 0.2 0.1 0.4 0.1 0.2 15.1 8.3 1.5 4.4 0.1 0.0 0.0 0.5 0.0 6.8 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.9 0.9 1.0 1.3 0.9 0.8 0.2 1.3 0.8 0.7 0.2 1.7 0.7 2.0 0.0 0.0 0.0 0.0 6.5 0.2 0.2 0.6 0.8 0.3 0.4 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.9 0.1 0.0 0.1 1.0 4.2 0.0 0.0 0.6 0.2 0.3 23.7 0.5 0.2 0.0 0.2 1.1 0.0 1.1 0.0 6.2 0.1 0.0 0.0 6.2 0.4 23.3 0.5 5.4 1.0 0.6 0.1 0.0 1.0 0.3 0.1 0.1 29.7 0.0 0.1 0.0 0.0 0.0 0.8 0.0 16.9 22.8 0.1 0.5 0.6 3.8 0.8 0.3 2.1 0.1 0.3 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor subunit alpha6" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "brain: 68.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 12 "cerebellum: 68.4;pons: 21.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 40 "cerebellum: 1073.8" "Region enriched" "Detected in some" 37 "cerebellum: 262.3" CAB022462 Approved NA NA "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.1 0.1 0.0 0.3 0.0 0.0 68.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 68.4 2.2 0.1 0.4 0.3 3.7 0.0 21.5 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRB2 ENSG00000145864 "Gamma-aminobutyric acid type A receptor subunit beta2" P47870 5 161288429-161549044 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 69.7" "Group enriched" "Detected in many" 20 "Excitatory neurons: 570.3;Inhibitory neurons: 780.2" "Cancer enriched" "Detected in some" 20 "thyroid cancer: 10.2" "Group enriched" "Detected in many" 4 "cerebellum: 67.3;cerebral cortex: 69.7;hypothalamus: 20.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001964, HPA067632" Enhanced NA NA "CAB001964: , HPA067632: AB_2685874" "unprognostic (5.46e-2)" "unprognostic (1.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.26e-6)" "unprognostic (2.33e-2)" "unprognostic (6.65e-2)" "unprognostic (3.58e-2)" "unprognostic (1.82e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (1.33e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.04e-2)" 0.5 2.3 3.2 0.0 5.6 0.0 0.1 67.3 69.7 0.5 0.0 0.6 1.2 0.1 3.5 0.0 0.4 0.0 0.1 12.7 20.0 1.8 0.0 0.9 0.0 0.0 3.2 10.6 0.1 0.1 0.1 0.5 0.2 12.2 0.1 1.1 6.6 0.5 0.6 0.1 0.1 0.6 0.1 0.0 2.4 0.5 0.6 10.0 0.1 0.5 0.4 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.6 67.3 69.7 12.7 20.0 0.0 3.2 10.6 12.2 0.0 10.0 9.1 0.0 0.0 0.0 21.5 0.0 0.3 0.0 0.1 0.0 19.8 0.1 0.0 1.9 0.0 0.0 0.0 27.1 0.0 0.0 1.0 5.9 0.0 1.6 0.0 0.3 0.3 1.2 0.0 570.3 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 780.2 1.8 4.1 0.0 0.4 1.4 0.0 1.3 0.0 20.6 0.0 2.3 0.0 33.7 17.9 0.0 0.5 0.4 0.0 0.1 0.0 3.2 0.0 10.6 0.0 0.3 3.5 3.1 1.8 0.1 0.4 0.0 0.0 1.9 4.2 0.1 FBXO38 "Fbx38, FLJ13962, MOKA, SP329" ENSG00000145868 "F-box protein 38" Q6PIJ6 5 148383935-148442836 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034821, HPA041444" Approved Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" Yes No "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA034821: AB_10669897, HPA041444: AB_2677484" "unprognostic (7.72e-2)" "unprognostic (5.75e-3)" "unprognostic (1.95e-2)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-2)" "unprognostic (7.06e-2)" "unprognostic (5.43e-3)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (2.03e-1)" "unprognostic (6.29e-2)" "unprognostic (2.21e-3)" "unprognostic (1.31e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (4.70e-3)" 11.8 11.6 8.3 13.0 9.3 9.9 14.0 9.2 9.9 14.2 9.6 12.1 9.7 12.6 11.2 10.6 10.1 11.6 17.6 8.2 8.9 13.0 18.2 14.6 14.7 9.0 8.8 7.7 12.4 9.6 18.6 10.3 13.9 9.1 14.8 13.1 11.1 11.6 12.1 18.9 11.8 11.7 12.4 8.8 14.5 12.6 12.5 8.9 20.4 12.3 17.0 15.7 13.9 11.3 11.0 12.6 13.2 20.1 14.7 22.1 24.6 10.4 16.1 30.7 22.4 30.5 19.6 15.1 18.2 15.5 26.2 23.6 17.2 21.2 20.3 26.8 20.1 13.6 10.8 19.0 13.3 21.9 29.6 17.0 24.0 17.1 21.6 21.1 24.0 30.7 16.6 12.2 19.1 22.3 5.1 18.8 13.8 9.4 13.9 19.8 16.6 29.3 18.4 21.7 14.5 17.9 17.3 21.4 14.2 21.2 17.1 15.0 21.2 20.2 20.4 7.3 10.8 18.2 23.3 25.1 15.3 20.3 16.6 15.8 15.1 6.1 9.1 5.0 8.0 5.5 4.9 4.7 5.0 7.5 3.8 4.8 6.2 11.2 7.7 15.2 3.7 7.4 4.9 8.3 9.3 9.2 9.9 8.2 8.9 9.0 8.8 7.7 9.1 8.8 8.9 11.0 10.6 16.0 45.7 25.1 13.8 3.3 5.5 7.4 7.4 10.3 8.5 6.7 18.7 11.5 10.6 11.0 10.4 7.5 13.4 11.3 5.9 8.8 11.2 8.9 9.9 10.8 9.6 7.2 40.2 6.7 6.8 11.8 14.8 10.4 15.8 9.6 11.4 16.9 12.6 13.5 37.4 10.1 6.1 24.9 6.4 2.9 9.0 17.8 3.6 38.4 12.3 5.9 12.3 33.2 44.4 9.9 8.9 18.4 11.0 8.6 9.3 9.3 16.4 9.0 0.0 6.9 7.8 20.6 8.6 9.2 3.8 12.3 12.1 11.2 9.0 8.7 SPINK7 "ECG2, ECRG2" ENSG00000145879 "Serine peptidase inhibitor Kazal type 7" P58062 5 148312419-148315922 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 625.4;vagina: 619.0" "Cell type enriched" "Detected in some" 7 "Squamous epithelial cells: 49.2" "Group enriched" "Detected in many" 6 "cervical cancer: 4.5;head and neck cancer: 15.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036294 Enhanced "Secreted in other tissues" NA NA 230000 "HPA036294: AB_10671243" "unprognostic (2.82e-1)" "unprognostic (8.99e-3)" "unprognostic (8.52e-3)" "unprognostic (1.81e-1)" "unprognostic (1.12e-2)" "unprognostic (3.37e-2)" "unprognostic (9.10e-2)" "unprognostic (1.49e-1)" "unprognostic (6.86e-2)" "unprognostic (7.24e-2)" "unprognostic (4.22e-2)" 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.2 122.6 0.1 0.0 0.0 0.1 0.1 625.4 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.5 0.0 0.7 0.0 0.2 0.1 0.0 0.0 141.2 0.0 0.2 7.4 0.1 0.1 0.1 0.1 4.2 0.1 0.1 4.8 0.1 0.1 117.0 0.6 619.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 4.5 PCYOX1L MGC3265 ENSG00000145882 "Prenylcysteine oxidase 1 like" Q8NBM8 5 149358037-149369653 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 17.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 50.2;RPMI-8226: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037463, HPA038402" Approved Approved Nucleoplasm,Mitochondria "Secreted to blood" NA NA "Nucleoplasm, Mitochondria" "HPA037463: AB_10673632, HPA038402: AB_2675997" "unprognostic (1.34e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (7.83e-2)" "unprognostic (5.73e-2)" "unprognostic (4.18e-3)" "unprognostic (7.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.25e-1)" "unprognostic (3.05e-3)" "unprognostic (8.77e-2)" "unprognostic (4.90e-2)" "unprognostic (2.86e-1)" "unprognostic (2.49e-1)" "unprognostic (2.26e-3)" "unprognostic (3.28e-1)" 3.1 4.7 1.4 5.4 1.9 3.9 3.3 1.8 4.1 4.5 0.0 3.2 1.9 4.9 0.7 3.6 5.4 4.7 3.4 2.2 2.6 2.0 0.5 3.4 6.7 2.6 2.1 1.9 5.8 3.1 17.6 5.0 4.2 3.3 4.0 0.7 7.6 2.9 4.5 0.8 5.2 4.8 5.3 0.6 4.0 3.7 6.5 2.1 4.6 2.7 1.8 3.3 3.8 3.9 3.9 4.3 2.7 9.2 20.3 7.8 7.9 4.9 9.0 4.0 7.8 13.2 0.8 7.6 17.9 27.1 6.7 36.1 7.7 8.8 20.3 0.7 8.4 8.2 8.4 0.0 0.7 17.3 7.3 9.1 14.9 3.0 10.7 12.6 9.4 17.3 16.6 4.9 50.2 0.4 17.9 8.1 11.2 4.7 15.8 16.3 10.7 6.7 50.8 4.9 2.0 13.3 13.6 17.9 11.9 14.6 10.0 20.0 12.4 8.2 6.8 5.5 14.7 4.2 20.1 29.2 10.6 11.2 38.3 14.6 3.0 7.1 4.0 2.8 9.6 3.7 1.6 5.3 2.1 13.2 1.0 6.3 4.4 1.2 4.8 9.6 0.9 7.3 4.7 1.4 1.9 1.8 4.1 2.2 2.6 2.6 2.1 1.9 3.3 0.6 2.1 3.9 4.5 9.6 1.7 2.9 2.3 1.0 1.0 3.2 2.8 5.2 2.4 1.8 5.3 4.3 3.6 1.8 0.0 6.0 1.9 0.6 0.0 3.0 3.3 3.2 2.4 4.6 0.0 2.5 10.5 2.3 6.6 5.0 2.0 2.3 2.5 9.6 2.5 0.4 7.6 11.8 12.4 1.8 6.1 8.2 1.4 1.5 3.4 6.9 1.8 4.7 7.0 7.8 1.0 5.5 4.9 2.1 1.7 2.6 1.3 0.8 2.6 0.6 2.8 14.2 0.0 2.5 2.7 1.2 3.5 1.9 1.6 1.2 5.6 9.7 2.3 0.9 GLRA1 STHE ENSG00000145888 "Glycine receptor alpha 1" P23415 5 151822513-151924851 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 35.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.4;Excitatory neurons: 1.7;Horizontal cells: 1.7;Inhibitory neurons: 5.0;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "hypothalamus: 9.4;midbrain: 15.1;pons and medulla: 26.3" "Low region specificity" "Detected in many" CAB079042 Supported NA NA "CAB079042: " "unprognostic (3.17e-1)" "unprognostic (2.47e-1)" "unprognostic (3.85e-7)" "unprognostic (8.24e-2)" "unprognostic (9.45e-3)" 0.0 0.3 9.7 0.0 3.3 0.0 0.0 11.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.6 0.0 0.0 0.0 0.0 35.4 9.3 0.2 0.0 0.2 0.0 0.0 0.0 30.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 3.3 11.8 7.0 0.3 5.6 35.4 9.3 0.2 30.4 21.0 11.5 11.7 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 5.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 1.0 0.1 0.2 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.5 TNIP1 "ABIN-1, KIAA0113, NAF1, VAN" ENSG00000145901 "TNFAIP3 interacting protein 1" Q15025 5 151029945-151093577 "Human disease related genes, Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 265.5;Proximal enterocytes: 257.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 406.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037893, HPA037894, HPA071950" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: AB_2686476" "prognostic favorable (5.69e-4)" "unprognostic (1.08e-1)" "unprognostic (1.10e-1)" "prognostic favorable (6.86e-5)" "unprognostic (7.45e-3)" "unprognostic (2.94e-1)" "unprognostic (5.35e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (2.25e-2)" "unprognostic (1.96e-1)" "unprognostic (7.68e-3)" "unprognostic (1.47e-1)" "unprognostic (4.69e-2)" "unprognostic (2.29e-1)" "unprognostic (9.84e-2)" 121.0 50.1 36.2 80.3 31.8 129.1 91.4 34.1 38.5 52.9 33.2 66.9 73.8 37.9 22.6 90.0 38.2 54.8 82.4 30.9 35.1 83.8 108.8 92.5 69.9 40.4 35.9 27.2 42.1 72.2 43.1 27.4 28.9 37.7 48.3 52.9 17.5 53.5 39.5 213.2 59.3 91.6 32.9 36.2 102.1 64.1 14.7 36.9 43.8 46.3 131.8 84.0 85.2 69.9 40.4 117.7 81.3 15.4 55.7 58.4 58.6 39.4 54.7 174.5 48.6 91.1 78.4 155.5 95.8 182.3 74.2 285.3 68.3 25.2 406.4 59.4 167.8 34.6 37.8 44.4 51.1 111.4 43.6 168.3 84.3 74.5 80.3 166.2 134.1 69.1 37.2 24.6 94.2 122.7 43.7 48.2 60.0 13.9 41.1 43.4 39.0 118.4 131.4 152.3 85.0 21.7 49.9 42.4 131.5 57.2 41.6 67.5 54.5 107.8 162.7 53.0 28.7 79.2 184.6 102.2 43.4 177.0 63.7 39.6 18.2 12.1 36.0 11.9 11.1 14.0 12.7 13.9 12.0 9.2 16.8 7.1 7.9 41.3 12.4 10.8 12.8 21.2 10.4 36.2 31.8 34.1 38.5 30.9 35.1 40.4 35.9 27.2 37.7 36.2 36.9 40.4 31.1 57.7 45.4 4.9 73.1 29.7 50.4 119.9 27.3 14.3 33.3 24.9 48.8 54.3 72.2 27.6 4.2 18.3 53.7 233.7 72.4 218.0 3.3 39.8 18.0 75.1 37.3 52.4 6.5 139.1 31.3 38.9 92.8 64.8 48.2 105.2 42.1 62.7 39.0 18.5 6.4 69.0 46.8 49.6 113.1 6.9 27.1 64.9 26.6 8.4 238.3 20.3 68.0 5.5 9.4 265.5 173.9 23.7 63.6 179.1 257.5 56.4 49.1 15.0 32.9 69.2 45.7 2.2 13.9 30.2 28.6 48.2 60.7 12.2 77.1 158.6 G3BP1 "G3BP, HDH-VIII" ENSG00000145907 "G3BP stress granule assembly factor 1" Q13283 5 151771045-151812911 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity, Transport" "DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004052, CAB037068" Supported Supported Cytosol NA NA 280000 Cytosol "CAB037068: AB_1840864, HPA004052: AB_1849348" "unprognostic (1.31e-1)" "unprognostic (3.94e-2)" "unprognostic (1.19e-3)" "unprognostic (1.28e-2)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "unprognostic (1.03e-3)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (2.06e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (1.97e-1)" "unprognostic (1.33e-1)" "unprognostic (2.11e-2)" "unprognostic (3.88e-2)" 52.8 47.2 32.9 60.7 37.1 27.7 54.6 43.4 45.0 42.3 45.2 48.2 35.1 42.9 33.4 55.3 51.5 39.1 51.4 30.7 47.4 57.6 69.6 36.5 78.9 36.7 37.2 27.1 63.0 30.6 41.8 16.6 58.6 36.8 41.7 51.1 18.4 32.1 37.7 113.3 43.7 34.2 48.2 37.5 47.1 40.7 66.1 38.3 66.6 43.0 93.0 86.4 66.9 32.2 44.3 204.9 267.0 177.0 96.3 253.2 119.2 232.4 204.1 190.6 290.6 348.6 413.7 310.3 384.7 307.0 188.0 231.6 210.9 319.7 395.6 333.7 122.5 173.8 232.9 201.1 334.8 128.8 281.6 163.9 123.4 186.7 243.7 232.2 98.7 209.7 140.9 191.3 173.3 254.5 179.7 273.9 142.4 231.4 146.0 209.6 254.3 235.1 187.2 163.1 290.5 195.2 132.0 200.8 307.0 319.3 169.2 246.3 174.7 238.2 202.0 239.7 187.3 364.0 104.9 171.3 305.0 132.2 229.6 337.8 132.2 102.3 84.7 189.2 135.4 255.3 168.8 215.6 186.7 141.0 160.0 201.8 193.2 37.8 203.7 134.1 134.7 249.2 287.2 32.9 37.1 43.4 45.0 30.7 47.4 36.7 37.2 27.1 36.8 37.5 38.3 44.3 88.9 19.2 41.4 32.7 112.0 239.5 101.3 82.4 148.0 37.1 74.8 60.7 62.3 44.3 66.2 64.4 16.7 94.0 91.7 47.3 78.2 69.6 49.6 80.6 104.4 112.1 50.2 96.1 25.7 53.0 94.6 98.0 70.3 87.2 73.6 73.8 76.8 169.4 78.2 57.2 30.6 59.4 50.8 81.2 195.0 30.1 65.0 73.3 87.2 37.5 83.7 54.3 45.3 29.7 45.3 59.2 42.9 57.2 89.3 160.0 33.5 80.0 74.2 36.6 39.5 111.6 90.7 58.0 89.3 155.6 256.4 67.3 99.6 72.2 78.5 98.0 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 36.1" "Low region specificity" "Detected in all" "HPA028975, HPA051777" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" NA NA Nucleoplasm "Nucleoli, Nucleoli rim, Nuclear bodies" "HPA028975: AB_2672851, HPA051777: AB_2681606" "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavorable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 3.5 1.0 2.6 2.6 3.5 2.7 4.5 4.1 2.8 6.1 2.6 3.3 2.7 7.5 2.3 5.1 4.5 3.4 2.8 2.6 3.3 4.6 1.2 2.4 3.0 3.2 3.5 2.4 10.3 5.6 0.8 2.5 1.5 3.5 5.4 2.7 9.1 2.8 2.3 0.9 4.5 3.9 4.0 3.0 3.9 4.7 6.5 3.3 2.8 7.0 1.5 2.9 4.5 4.9 3.8 2.1 4.7 28.2 0.0 2.4 5.8 0.0 7.1 5.6 6.1 8.7 2.4 3.5 0.0 6.1 5.9 18.3 4.2 0.0 16.2 9.5 0.0 9.3 0.0 36.1 3.9 5.0 0.2 0.1 8.9 5.0 12.7 14.7 8.6 10.4 0.1 0.0 15.1 6.1 0.0 0.0 1.5 27.2 0.0 0.0 0.0 4.1 8.5 4.4 5.3 15.9 26.2 16.7 14.3 9.8 17.1 9.4 0.0 4.6 8.1 3.4 5.9 12.9 0.5 0.2 0.0 0.8 0.1 17.1 0.0 0.1 0.3 0.1 0.4 0.0 0.2 0.2 0.0 0.3 1.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 2.6 3.5 4.1 2.8 2.6 3.3 3.2 3.5 2.4 3.5 3.0 3.3 3.8 2.0 0.0 0.5 0.3 1.8 1.5 3.1 2.3 7.4 4.0 2.3 1.7 0.6 1.5 2.7 7.3 0.0 0.7 1.9 0.3 1.9 2.5 3.2 1.8 5.3 2.3 3.0 4.0 0.8 1.6 2.2 3.8 13.3 1.9 0.0 11.5 1.8 0.2 0.5 0.0 1.9 1.4 2.0 1.0 1.2 0.9 2.5 0.8 0.0 5.6 1.5 3.3 3.1 5.5 6.7 1.8 0.1 1.2 0.3 2.0 0.6 1.8 0.8 4.3 6.6 4.1 2.8 7.2 3.7 5.9 2.3 0.8 1.2 2.7 1.8 3.0 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113532-178126081 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 35.7;Extravillous trophoblasts: 130.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 1.7;naive B-cell: 1.6;naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 16 "B-cells: 1.7;dendritic cells: 2.1;T-cells: 1.2" "Cell line enhanced" "Detected in many" "BEWO: 14.9;MCF7: 21.2;RH-30: 20.3;SK-BR-3: 72.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favorable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 1.9 0.8 1.8 1.0 0.8 2.9 2.5 2.4 3.5 1.6 0.4 1.3 0.5 0.8 0.3 15.8 1.0 0.7 1.4 0.8 1.8 2.4 0.1 3.9 1.8 2.1 1.8 0.8 0.5 0.7 4.2 2.2 8.4 2.6 1.0 0.4 4.7 6.8 0.8 4.4 7.3 1.8 0.5 0.0 1.8 2.2 0.9 4.0 0.9 1.4 3.0 2.9 1.4 4.0 2.6 0.1 0.1 2.3 1.7 0.2 0.0 14.9 0.0 0.0 0.0 0.0 3.3 1.1 1.4 2.0 0.0 0.1 4.7 0.4 0.1 0.0 2.5 0.8 4.1 1.8 0.1 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.0 12.0 1.3 2.6 0.9 0.0 21.2 0.2 0.3 11.2 3.6 0.1 11.6 20.3 5.4 1.2 2.4 1.7 0.8 0.6 72.2 4.9 2.8 2.8 0.1 2.4 0.0 1.7 0.0 0.0 3.2 2.3 13.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 1.7 0.1 0.1 0.0 1.6 0.4 1.2 0.0 0.1 0.0 2.1 0.0 0.2 1.8 0.8 2.4 3.5 0.8 1.8 2.1 1.8 0.8 2.6 0.0 4.0 2.6 7.8 3.2 0.6 0.0 12.7 9.4 13.1 6.7 4.0 35.7 7.3 3.6 1.7 2.8 3.4 1.8 12.5 3.0 10.4 9.4 13.7 3.4 0.4 1.9 1.1 15.7 4.2 0.0 2.9 0.8 130.4 1.6 6.6 5.8 4.5 0.5 0.4 0.2 2.3 1.7 4.9 3.7 6.1 0.0 1.7 0.8 0.6 1.0 12.4 3.7 1.1 2.0 0.0 0.5 0.2 7.3 8.7 1.9 6.1 10.3 0.1 0.8 0.3 9.2 0.0 2.5 0.7 0.2 8.1 14.1 6.8 23.1 3.0 0.7 3.5 12.1 NHP2 "FLJ20479, NOLA2" ENSG00000145912 "NHP2 ribonucleoprotein" Q9NX24 5 178149463-178153894 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 1398.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044171, HPA050400" Enhanced NA NA "HPA044171: AB_2678844, HPA050400: AB_2681113" "unprognostic (1.19e-1)" "unprognostic (1.59e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (4.05e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (5.24e-4)" "unprognostic (8.87e-2)" "unprognostic (9.12e-2)" "unprognostic (1.78e-2)" "unprognostic (4.20e-2)" "unprognostic (6.72e-2)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (4.04e-2)" "unprognostic (8.63e-2)" 95.6 106.9 92.4 76.9 97.4 112.6 102.9 96.3 130.1 97.6 77.8 87.9 57.4 100.6 41.1 186.9 89.8 41.9 105.1 96.2 94.0 101.4 108.3 71.0 97.6 93.7 92.6 91.4 108.5 115.6 53.1 79.6 51.5 93.1 90.7 45.6 31.3 90.8 51.6 134.2 130.1 68.9 50.0 94.6 77.7 90.4 64.8 95.6 65.4 78.9 58.6 68.9 105.8 111.9 99.7 288.3 474.1 148.2 417.3 99.9 133.1 499.8 216.1 119.0 260.4 222.5 290.8 252.4 413.6 396.3 133.4 233.8 185.3 225.7 514.8 131.8 778.2 789.2 216.4 343.0 319.3 168.1 371.8 229.6 162.3 240.5 199.6 176.9 96.7 243.6 294.0 226.5 273.5 143.6 1398.1 529.0 280.1 215.9 271.9 739.0 362.6 190.9 641.5 192.3 195.5 375.2 407.7 167.9 470.0 426.5 89.7 227.1 274.6 222.4 253.3 274.0 207.6 513.3 316.8 679.2 494.1 250.1 519.9 284.6 58.3 218.3 32.8 188.4 254.5 265.5 335.5 232.7 218.7 310.1 347.2 238.9 245.3 16.8 260.1 188.2 507.4 245.0 363.7 92.4 97.4 96.3 130.1 96.2 94.0 93.7 92.6 91.4 93.1 94.6 95.6 99.7 94.4 60.9 67.3 9.4 123.7 193.2 226.4 222.9 155.4 46.8 228.2 309.9 11.6 131.5 139.5 126.9 18.8 233.7 85.4 88.0 358.1 230.6 59.2 75.2 165.5 116.6 126.6 100.7 9.2 302.4 359.6 113.8 76.5 83.2 79.3 133.0 84.3 172.3 172.6 30.3 9.1 151.8 97.6 78.4 131.8 114.0 134.8 81.3 145.9 5.6 117.2 78.3 93.7 9.0 14.0 231.0 71.2 97.4 128.7 389.5 54.5 320.7 73.1 36.7 59.2 100.0 139.4 107.5 129.2 343.9 242.9 166.9 87.0 183.3 207.7 289.4 RMND5B "FLJ22318, GID2, GID2B" ENSG00000145916 "Required for meiotic nuclear division 5 homolog B" Q96G75 5 178130996-178150568 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 186.6;Late spermatids: 415.4;Spermatocytes: 133.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 130.3;MCF7: 185.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047778 Uncertain NA NA "HPA047778: AB_2680153" "unprognostic (2.08e-1)" "unprognostic (6.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.35e-2)" "unprognostic (4.38e-2)" "unprognostic (9.81e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "prognostic favorable (7.66e-4)" "unprognostic (1.60e-1)" "prognostic favorable (7.22e-8)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (6.43e-2)" "unprognostic (5.78e-2)" 19.1 23.5 19.3 11.3 20.1 13.4 19.0 19.4 20.5 21.2 19.1 22.4 13.3 22.9 12.3 70.3 19.4 9.7 26.5 19.8 19.1 22.5 27.4 17.5 18.2 22.6 20.0 19.2 17.3 25.7 23.7 20.9 16.5 19.4 19.1 11.5 10.6 24.5 16.0 45.9 29.5 17.5 16.0 19.8 19.4 23.4 82.3 20.6 24.0 20.6 32.6 23.2 22.2 28.5 21.1 21.3 37.5 21.4 53.5 27.4 2.8 71.3 16.9 18.2 25.1 29.2 42.1 30.2 44.6 32.9 11.9 27.6 27.6 21.5 36.7 8.8 130.3 28.7 46.8 39.1 22.8 29.0 21.9 16.3 5.9 27.1 17.3 27.3 14.0 25.5 14.7 40.1 28.8 8.1 185.2 15.5 12.5 29.5 25.9 20.4 19.7 15.8 31.6 21.1 32.4 22.5 32.2 22.8 73.0 40.3 17.3 56.9 29.5 17.7 13.9 21.9 12.8 21.3 42.4 43.4 37.0 18.2 21.2 19.6 21.8 16.5 42.5 6.5 20.1 2.8 18.3 13.0 7.3 8.8 24.9 20.4 11.3 11.4 4.2 27.2 13.7 22.4 12.4 19.3 20.1 19.4 20.5 19.8 19.1 22.6 20.0 19.2 19.4 19.8 20.6 21.1 13.5 12.8 6.9 7.8 20.5 9.6 20.6 15.3 14.2 48.6 19.3 16.1 22.2 27.1 12.2 31.3 52.1 31.7 8.0 17.6 23.5 21.0 186.6 7.8 10.2 13.3 9.0 28.0 15.4 19.1 29.8 16.7 23.0 10.5 5.1 16.4 15.0 14.0 21.7 48.8 16.6 15.0 28.5 15.0 9.6 415.4 28.9 10.5 7.2 10.3 22.7 30.9 14.4 8.5 14.1 19.1 13.3 25.2 14.8 20.6 26.1 21.6 7.3 61.4 13.1 17.5 16.3 133.0 35.7 28.9 13.4 44.5 10.9 18.5 17.9 20.0 BOD1 FAM44B ENSG00000145919 "Biorientation of chromosomes in cell division 1" Q96IK1 5 173607145-173616659 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036293 Uncertain NA NA "HPA036293: AB_10673127" "unprognostic (2.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.04e-3)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.02e-4)" "prognostic unfavorable (2.49e-6)" "unprognostic (1.21e-1)" "unprognostic (7.66e-3)" "unprognostic (8.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.29e-2)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-1)" 41.2 42.1 34.9 19.4 37.0 7.7 44.4 34.8 43.0 42.6 36.2 35.1 22.8 38.2 38.2 25.5 35.7 23.0 44.2 34.7 36.6 32.8 29.8 29.4 22.3 36.0 35.9 33.7 54.3 49.3 35.0 34.8 34.8 35.9 35.0 24.8 45.9 27.7 29.7 112.7 38.0 24.3 28.1 35.4 26.2 34.7 40.6 37.0 19.0 50.4 78.7 17.8 40.2 35.6 40.5 57.9 60.8 113.5 117.8 98.1 74.8 88.1 50.7 102.1 82.1 132.3 116.0 61.7 39.3 123.4 77.0 201.5 45.8 91.1 124.6 108.6 34.7 72.2 11.5 51.0 106.5 115.8 25.7 15.6 73.9 101.7 54.3 208.6 60.5 69.2 24.6 24.3 25.7 70.2 120.4 38.7 31.1 94.7 64.4 107.0 35.4 58.5 34.5 34.1 55.9 142.2 59.0 38.7 42.8 163.6 95.5 125.7 29.6 53.0 92.1 56.7 73.1 78.5 29.7 34.9 47.6 49.0 37.8 71.5 0.0 2.0 5.6 2.7 2.4 2.1 2.3 2.0 2.4 2.8 2.4 3.8 2.9 0.4 3.5 1.1 3.5 2.3 1.1 34.9 37.0 34.8 43.0 34.7 36.6 36.0 35.9 33.7 35.9 35.4 37.0 40.5 56.6 32.1 20.3 7.5 24.2 72.8 50.2 15.0 27.9 41.0 47.7 46.0 41.8 28.6 22.0 9.2 12.5 67.1 20.8 10.2 60.7 38.3 116.0 24.6 52.6 47.1 23.4 7.2 7.0 26.9 83.5 58.5 23.9 28.5 8.8 93.9 28.2 16.6 27.8 53.8 7.9 26.2 20.3 12.0 33.1 141.1 73.0 16.8 33.8 4.7 23.9 61.9 25.7 8.5 10.1 21.9 13.4 59.8 17.4 84.1 19.1 50.4 14.8 39.7 13.1 50.7 46.2 89.7 69.5 30.9 83.5 59.4 19.0 165.5 37.5 47.9 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884021 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 310.8;epididymis: 129.7;pituitary gland: 66.2" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9" "Cancer enhanced" "Detected in many" "liver cancer: 9.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 0.7 28.6 240.0 1.0 109.5 0.0 0.1 84.1 288.6 0.0 0.0 2.7 2.1 0.0 129.7 0.1 0.0 0.0 0.2 310.8 48.4 0.1 0.2 1.3 0.0 54.2 119.2 149.1 0.2 9.1 0.1 66.2 0.0 84.9 0.2 1.4 19.5 0.1 0.0 0.2 0.1 1.6 0.3 0.0 0.0 5.0 3.0 23.5 0.1 0.2 0.0 0.0 0.1 0.5 157.4 0.0 496.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 323.4 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.3 2.1 15.2 0.1 0.0 0.0 0.6 0.0 0.2 201.3 16.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 240.0 109.5 84.1 288.6 310.8 48.4 54.2 119.2 149.1 84.9 0.0 23.5 157.4 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.2 36.6 0.0 44.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.9 35.9 1.0 0.0 0.0 0.0 32.9 0.9 0.0 0.0 4.7 0.0 1.1 0.0 5.5 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TENM2 "KIAA1127, ODZ2, Ten-M2, TEN2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins, Transporters" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 9.1;heart muscle: 26.1" "Group enriched" "Detected in many" 5 "Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli No No 11000 Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019" "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavorable (7.52e-4)" 0.1 0.5 1.3 0.0 4.7 0.0 1.9 0.0 9.1 0.8 0.0 0.2 0.4 0.0 0.5 2.0 0.1 0.4 26.1 5.2 3.7 0.8 1.3 0.2 0.0 0.8 0.9 4.0 0.7 0.1 0.0 0.7 0.0 2.0 2.2 0.1 4.2 0.5 1.1 0.0 2.9 0.2 0.0 0.0 0.0 0.1 1.4 2.5 2.3 0.4 0.5 1.0 0.1 2.0 1.5 0.1 0.0 13.4 0.0 0.0 0.4 0.0 1.9 0.0 0.7 1.8 0.0 0.0 0.0 0.0 66.1 1.7 0.0 0.0 43.0 0.8 43.3 0.0 0.0 0.2 0.0 2.0 0.0 0.0 3.0 7.4 0.3 5.3 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 9.8 0.2 0.0 0.0 6.6 0.0 0.1 0.0 0.1 2.4 3.8 0.1 0.0 74.6 64.0 0.1 50.0 0.0 0.0 0.0 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.7 0.0 9.1 5.2 3.7 0.8 0.9 4.0 2.0 0.0 2.5 1.5 0.5 0.0 0.0 512.9 0.0 14.8 1.1 20.3 33.6 15.5 0.3 13.0 144.0 0.0 1.4 0.0 18.8 0.0 0.0 1.0 0.0 3.4 23.5 0.1 0.3 1.7 0.0 0.0 706.2 0.2 0.0 2.2 0.0 0.2 1.3 1.6 0.4 5.1 0.1 121.1 965.9 0.7 0.0 0.0 1.2 18.2 4.4 0.2 1.8 36.5 0.0 2.3 0.0 21.6 12.8 0.0 0.0 61.7 0.0 1.4 0.3 0.0 0.6 1.8 0.0 0.4 1.5 1.2 1.1 1.4 1.7 0.0 0.1 0.0 0.4 0.1 KCNMB1 hslo-beta ENSG00000145936 "Potassium calcium-activated channel subfamily M regulatory beta subunit 1" Q16558 5 170374671-170389634 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 59.7;intestine: 53.6;seminal vesicle: 51.1;smooth muscle: 53.6" "Cell type enriched" "Detected in many" 6 "Peritubular cells: 354.3" "Cancer enhanced" "Detected in many" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 5.9" "Cell line enhanced" "Detected in some" "REH: 8.8;SK-BR-3: 2.1;U-937: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.06e-2)" "unprognostic (2.70e-4)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (8.88e-2)" "unprognostic (1.61e-2)" "unprognostic (3.46e-1)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (5.37e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.08e-1)" "unprognostic (2.49e-1)" "unprognostic (4.31e-2)" "unprognostic (1.04e-2)" 5.8 1.8 2.6 10.6 2.5 1.7 7.0 2.4 3.5 14.8 1.7 53.6 4.3 59.7 6.2 16.8 20.8 7.3 4.2 1.9 1.8 1.2 0.7 4.0 1.7 5.3 3.2 1.5 4.1 0.7 0.3 0.5 1.1 6.2 24.7 9.0 1.1 6.9 51.1 1.1 2.6 14.4 53.6 3.6 2.3 21.6 2.8 4.0 1.0 1.4 1.1 1.4 32.8 11.2 5.6 0.1 0.1 1.5 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.1 1.0 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.1 1.2 0.6 0.2 0.0 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.1 0.4 0.3 0.7 0.1 0.7 0.0 0.8 0.3 0.0 0.1 8.8 0.0 0.2 0.0 0.2 0.4 0.2 0.1 2.1 0.0 0.7 0.1 1.0 0.5 0.2 0.3 0.3 0.0 0.4 0.2 0.1 0.1 3.8 0.1 1.3 3.3 0.3 0.1 5.9 0.1 0.2 0.2 0.1 5.7 0.3 0.1 0.1 0.9 0.4 5.1 2.0 0.2 1.0 2.6 2.5 2.4 3.5 1.9 1.8 5.3 3.2 1.5 6.2 3.6 4.0 5.6 1.3 0.0 6.3 0.3 1.2 2.0 1.2 0.4 0.0 1.6 2.5 55.1 3.7 4.3 4.5 1.8 6.2 0.5 1.7 0.1 0.0 0.1 0.6 0.6 14.4 3.6 0.0 1.3 0.1 0.4 0.6 9.8 0.0 0.6 19.7 0.4 1.8 0.4 7.4 1.7 0.3 0.2 0.0 18.9 10.9 4.5 38.5 15.6 3.6 4.7 27.8 0.6 2.1 0.0 0.1 0.0 0.0 354.3 0.3 1.3 0.0 0.1 4.5 2.3 46.0 2.2 43.6 0.7 1.2 0.1 1.7 0.5 1.7 1.4 0.0 0.7 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849373-3851320 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 88.3;MCF7: 27.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064111, HPA067817" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Midbody" Yes NA Nucleoplasm "Cytokinetic bridge, Midbody" "HPA064111: AB_2685191, HPA067817: AB_2685904" "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favorable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 6.3 9.2 11.4 3.8 13.8 1.8 7.0 12.1 15.2 8.0 8.0 8.3 6.7 9.7 3.9 6.7 8.9 3.7 15.6 12.5 12.2 9.9 13.0 5.4 5.1 11.6 11.4 11.1 9.4 9.3 4.2 10.4 1.8 11.3 6.5 1.4 5.5 10.3 5.8 32.4 6.9 6.5 2.8 10.6 7.2 8.2 14.1 11.7 4.0 9.9 8.9 3.5 9.7 6.3 12.8 6.6 8.7 0.1 0.0 4.9 4.7 0.4 7.6 3.7 5.1 6.5 0.0 11.7 7.0 8.0 5.5 2.0 4.9 0.0 3.0 3.8 88.3 4.6 0.0 21.1 0.0 5.2 0.0 0.1 5.2 6.0 4.0 1.1 1.6 5.1 0.0 0.0 0.0 4.6 27.5 0.0 9.8 1.9 4.0 4.1 0.0 0.0 0.0 2.5 0.0 11.8 10.3 12.4 7.7 0.4 0.0 8.4 7.8 7.2 0.0 0.9 10.1 0.0 0.0 19.7 0.0 2.7 0.6 14.1 5.7 7.9 4.4 11.3 10.8 26.7 25.0 21.8 14.6 10.5 20.8 17.7 11.2 3.3 33.8 17.7 17.3 36.0 9.0 11.4 13.8 12.1 15.2 12.5 12.2 11.6 11.4 11.1 11.3 10.6 11.7 12.8 11.4 16.0 7.0 2.6 8.3 6.4 5.7 10.2 15.4 18.1 8.7 13.5 19.8 17.2 8.3 12.9 4.2 4.2 9.3 2.3 33.2 13.5 31.5 6.8 5.0 6.7 1.2 6.7 2.5 11.1 6.9 8.0 7.1 3.3 3.8 7.5 11.0 21.6 10.1 15.2 2.6 3.5 8.2 6.8 4.7 28.8 8.4 5.6 12.4 1.0 8.7 20.9 4.1 1.0 4.6 8.5 5.1 10.9 6.9 3.3 7.4 36.9 6.8 16.0 0.0 13.0 8.4 38.3 43.9 12.5 6.7 1.0 6.1 7.8 3.8 2.1 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750922 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 30.4;tongue: 72.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HEL: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.9 0.5 0.6 0.4 0.6 0.8 1.0 0.6 0.9 0.6 0.6 0.4 0.3 0.6 0.7 1.3 0.5 0.4 1.4 0.7 0.6 3.0 0.5 1.3 0.4 0.5 0.6 0.7 0.4 0.9 0.9 1.3 0.6 0.6 0.8 0.3 0.8 2.5 0.6 30.4 1.4 0.6 0.3 0.4 0.6 0.6 0.4 0.5 0.3 0.8 72.7 0.7 0.6 0.8 0.6 0.1 0.1 0.3 0.6 0.5 0.6 0.3 0.4 0.8 0.2 0.2 0.3 0.6 0.6 0.9 0.4 0.1 1.0 0.1 0.2 0.3 0.1 0.3 7.2 0.4 0.0 0.2 0.2 0.3 0.8 0.3 0.0 0.6 0.3 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.8 0.1 0.2 0.0 0.5 0.0 0.0 0.4 0.1 0.5 0.3 0.1 0.1 0.3 0.5 0.2 0.5 0.4 0.2 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.9 0.7 0.6 0.5 0.6 0.7 0.6 0.4 0.5 0.6 0.5 3.2 1.1 1.6 0.5 0.1 0.1 0.5 0.6 1.0 0.6 0.3 1.9 1.5 1.0 0.0 0.0 0.3 0.1 0.2 0.0 0.3 0.4 0.1 0.7 0.6 1.2 0.0 7.8 0.2 0.0 0.5 0.0 0.2 0.0 0.6 1.1 0.2 0.3 1.7 7.2 0.0 0.0 0.8 1.2 0.2 0.3 0.4 0.0 4.7 1.1 0.3 0.0 8.0 2.9 0.0 0.0 1.5 0.0 0.2 0.1 4.5 0.3 0.3 0.0 0.8 0.3 0.0 0.3 0.3 0.9 0.3 0.2 0.4 0.3 0.2 FAM217A "C6orf146, MGC43581" ENSG00000145975 "Family with sequence similarity 217 member A" Q8IXS0 6 4049434-4087344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 15.0" "Group enriched" "Detected in some" 15 "Early spermatids: 246.0;Late spermatids: 418.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA035455 Uncertain NA NA "HPA035455: AB_10669905" "unprognostic (5.93e-2)" "unprognostic (3.70e-2)" "unprognostic (1.24e-1)" "unprognostic (8.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.53e-2)" "unprognostic (2.99e-2)" "unprognostic (1.08e-2)" "unprognostic (2.09e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (4.54e-1)" "unprognostic (6.55e-2)" "unprognostic (2.86e-1)" "unprognostic (1.85e-1)" "unprognostic (1.53e-2)" "unprognostic (5.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 246.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 418.8 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 20.9 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D7 "dJ257A7.3, FLJ32666" ENSG00000145979 "TBC1 domain family member 7" Q9P0N9 6 13266542-13328583 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "melanoma: 13.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 320.4;U-266/84: 174.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034748 Approved NA NA "HPA034748: AB_10671232" "unprognostic (9.53e-2)" "unprognostic (8.39e-2)" "unprognostic (3.18e-1)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.95e-3)" "unprognostic (5.54e-2)" "unprognostic (9.30e-2)" "prognostic favorable (4.98e-5)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.57e-1)" "unprognostic (3.46e-2)" "unprognostic (3.48e-1)" "unprognostic (2.78e-2)" 9.2 12.1 14.6 9.8 16.4 26.7 11.6 14.3 26.3 10.0 12.1 15.3 14.6 8.5 20.1 17.3 6.7 10.4 31.9 15.7 14.6 21.6 17.7 11.1 14.0 14.3 13.6 15.6 7.7 10.3 12.5 10.8 14.6 14.9 12.6 16.6 11.6 12.3 7.1 16.4 13.8 10.9 10.2 12.5 12.4 9.9 14.1 14.1 17.1 8.1 14.6 15.7 10.1 11.5 17.2 26.2 25.5 36.0 36.8 27.5 15.7 24.9 11.5 13.3 24.0 26.8 51.8 23.0 18.1 75.0 19.3 55.8 20.8 24.5 29.0 21.9 28.4 29.1 50.3 16.5 45.8 63.6 32.7 73.6 21.4 40.6 29.7 19.3 24.0 40.5 57.2 57.3 23.7 30.8 42.8 42.2 78.5 24.4 32.4 24.6 61.7 15.7 77.7 54.1 35.1 69.4 30.8 28.4 55.4 320.4 71.3 53.6 19.1 29.4 24.6 30.8 13.6 16.2 55.8 174.2 86.2 23.1 34.1 51.1 28.2 21.6 27.0 11.6 20.0 7.6 15.4 9.9 10.5 43.3 14.5 9.1 11.1 42.2 21.4 13.7 42.2 14.6 10.4 14.6 16.4 14.3 26.3 15.7 14.6 14.3 13.6 15.6 14.9 12.5 14.1 17.2 11.0 12.8 13.9 3.9 16.2 7.5 9.9 37.2 11.4 6.5 15.7 20.6 30.6 15.7 28.8 16.5 4.2 41.0 15.0 12.9 33.2 16.4 8.1 15.2 12.7 12.4 9.0 57.4 8.4 14.3 23.3 9.9 15.8 15.7 9.5 14.4 12.1 15.2 24.2 10.1 9.5 18.3 50.8 12.9 23.0 5.8 4.4 31.3 10.6 4.7 13.9 8.9 13.4 6.6 7.3 22.2 18.3 5.3 21.9 11.6 13.1 56.1 16.4 8.0 13.1 5.6 20.2 14.7 34.3 21.7 8.9 46.9 11.3 14.4 16.4 13.4 FARS2 "dJ236A3.1, FARS1, mtPheRS" ENSG00000145982 "Phenylalanyl-tRNA synthetase 2, mitochondrial" O95363 6 5261044-5829192 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 110.4;Early spermatids: 77.4;Excitatory neurons: 217.0;Inhibitory neurons: 122.6;Late spermatids: 78.8;Microglial cells: 106.8;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018148, HPA028836" Approved NA NA "HPA018148: AB_1848426, HPA028836: AB_10601377" "unprognostic (2.73e-1)" "unprognostic (4.08e-3)" "prognostic favorable (5.14e-4)" "unprognostic (2.68e-1)" "unprognostic (1.94e-2)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (4.31e-3)" "unprognostic (7.18e-2)" "unprognostic (1.02e-2)" "unprognostic (8.91e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.24e-6)" "unprognostic (2.81e-2)" "unprognostic (2.83e-1)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" 9.2 12.1 7.9 9.7 9.3 11.8 11.2 5.5 9.6 8.4 19.9 10.7 7.4 9.3 7.4 9.9 15.1 6.8 14.9 7.6 8.0 14.3 14.6 9.7 12.5 5.5 6.5 8.4 7.8 10.4 13.3 9.9 8.9 5.8 7.3 11.4 6.9 8.5 8.7 19.9 11.2 7.9 9.9 6.0 9.9 10.0 11.8 8.5 12.6 14.5 18.1 11.1 8.8 9.0 8.2 14.2 13.4 14.1 14.7 17.1 20.5 11.6 15.1 17.9 19.4 19.2 18.0 10.7 19.7 23.1 14.9 18.9 13.9 18.2 23.9 20.2 59.5 12.2 7.9 11.0 16.1 8.9 18.9 11.4 16.5 24.0 21.9 15.8 11.4 23.6 21.8 23.7 4.5 14.6 14.5 20.6 21.2 8.7 21.7 12.9 20.0 17.6 38.9 18.7 16.4 23.9 11.8 14.1 11.0 17.6 18.4 22.1 20.6 13.7 20.7 9.4 12.3 19.8 9.3 34.2 10.9 11.6 11.1 26.6 0.1 14.7 5.2 23.1 16.7 20.3 20.0 20.5 21.2 26.0 17.5 22.3 22.1 1.1 24.6 11.9 15.5 28.0 17.6 7.9 9.3 5.5 9.6 7.6 8.0 5.5 6.5 8.4 5.8 6.0 8.5 8.2 10.4 9.6 13.7 110.4 15.7 14.8 18.5 17.7 10.2 8.8 8.9 12.1 18.4 12.8 8.5 9.2 2.1 19.5 10.5 6.9 27.4 14.6 77.4 10.2 7.6 10.9 10.7 13.9 217.0 12.9 20.9 10.5 13.3 7.2 22.2 14.3 11.4 12.0 15.8 0.0 122.6 9.4 14.2 12.5 11.6 78.8 6.2 17.4 5.4 106.8 9.4 14.2 8.2 186.5 122.4 7.8 8.6 7.2 16.1 6.6 7.4 30.7 19.3 11.1 0.0 10.1 10.8 19.2 9.4 13.3 13.2 10.7 16.2 24.2 11.9 13.2 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell type enhanced" "Detected in many" "Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 15.5;NK-cell: 13.1" "Group enriched" "Detected in many" 5 "granulocytes: 15.5;NK-cells: 13.1" "Cell line enhanced" "Detected in many" "HEL: 30.5;HMC-1: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 10.6 2.0 11.9 2.8 22.1 12.8 9.7 11.9 27.3 4.0 1.9 5.7 1.8 3.7 0.8 8.7 4.4 4.4 16.7 24.9 7.5 1.8 7.3 9.8 4.4 5.8 4.2 19.1 1.5 1.5 1.7 3.6 4.0 9.2 4.0 2.9 2.1 3.6 1.4 12.1 5.3 6.6 5.0 0.6 8.9 8.0 0.6 3.8 3.0 2.7 9.8 4.2 6.2 5.8 18.0 12.5 1.3 1.0 2.1 1.7 1.8 1.3 1.0 0.5 0.7 0.4 0.4 0.9 16.8 16.6 1.2 1.0 10.9 3.4 5.4 0.7 1.2 6.0 30.5 7.2 6.6 2.4 9.0 46.3 0.9 4.1 1.6 4.5 2.6 9.5 4.5 0.9 1.5 1.3 4.1 2.0 5.2 1.8 4.3 3.3 6.9 2.1 8.8 0.6 2.4 5.5 1.0 4.0 0.7 4.0 2.1 0.9 0.9 12.2 1.6 3.2 3.5 5.6 13.4 8.3 19.8 1.4 5.3 0.4 0.2 0.4 15.5 1.5 0.9 0.2 2.7 0.2 0.7 0.2 1.9 0.1 0.5 0.3 13.1 0.9 0.1 0.1 1.0 11.9 22.1 11.9 27.3 24.9 7.5 5.8 4.2 19.1 9.2 0.6 3.8 18.0 100.9 0.0 1.8 33.0 14.3 20.3 4.9 14.5 19.9 43.8 7.4 3.7 108.2 10.0 14.4 0.0 0.0 1.5 46.1 18.2 0.0 5.3 0.1 3.8 1.0 49.0 8.4 31.2 133.2 3.1 34.7 9.1 2.0 8.0 4.5 0.2 51.4 19.5 2.5 1.7 106.2 11.2 8.2 15.7 31.3 0.3 2.5 21.4 12.4 42.2 4.7 2.1 142.2 58.8 56.6 30.5 31.7 1.2 14.5 3.1 10.6 0.3 13.6 2.7 13.1 19.9 17.5 0.0 3.3 34.6 22.4 0.7 23.4 1.0 4.4 4.7 CDKAL1 FLJ20342 ENSG00000145996 "CDK5 regulatory subunit associated protein 1 like 1" Q5VV42 6 20534457-21232404 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" Transferase "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 133.2;Excitatory neurons: 159.5;Inhibitory neurons: 134.1;Microglial cells: 198.6;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 255.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SCLC-21H: 188.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.64e-2)" "unprognostic (7.23e-3)" "unprognostic (8.40e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.05e-1)" "unprognostic (1.51e-2)" "unprognostic (3.47e-2)" "unprognostic (4.25e-3)" "unprognostic (6.72e-3)" "unprognostic (1.61e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "unprognostic (5.79e-3)" "unprognostic (3.11e-2)" "unprognostic (1.75e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" 5.4 4.1 4.0 5.9 5.7 9.6 7.0 7.3 4.6 6.6 6.0 5.2 4.6 8.2 5.8 5.0 6.8 6.3 4.7 3.6 5.3 5.7 5.5 5.6 8.3 6.1 5.0 3.7 8.6 5.7 6.5 4.0 6.7 6.2 5.5 6.6 5.4 6.0 4.9 14.1 7.5 5.2 6.4 5.6 7.3 5.9 6.7 5.1 9.7 9.5 9.6 8.7 5.7 5.1 9.2 8.7 5.3 12.1 15.6 6.7 9.0 12.8 9.0 8.2 13.0 17.1 9.8 7.7 20.7 22.0 7.7 14.1 8.6 16.5 9.1 17.3 37.3 9.1 17.7 9.1 13.3 8.7 17.6 11.7 8.2 9.4 12.5 11.5 8.0 12.0 12.6 23.3 8.2 9.7 7.3 22.4 21.0 8.5 8.9 5.8 13.1 16.1 19.5 16.6 9.9 188.5 11.1 10.0 16.0 13.2 10.2 11.7 8.8 11.7 15.2 10.4 6.1 16.8 12.9 36.8 17.7 5.5 9.9 26.0 1.5 3.3 3.1 6.4 5.3 5.3 7.0 6.3 6.5 4.4 6.4 7.7 7.1 1.5 10.3 11.2 4.6 7.4 3.5 4.0 5.7 7.3 4.6 3.6 5.3 6.1 5.0 3.7 6.2 5.6 5.1 9.2 13.9 6.4 4.6 133.2 19.5 10.5 10.9 5.2 9.1 8.7 8.7 6.0 9.0 4.3 8.1 7.3 6.2 9.4 12.2 4.6 11.7 8.3 15.4 16.9 13.6 12.2 33.4 6.7 159.5 7.8 10.0 9.4 13.3 18.5 13.3 12.5 8.2 6.4 7.1 11.8 134.1 8.5 14.2 6.1 7.6 6.3 8.7 9.5 3.6 198.6 13.2 6.0 10.3 198.5 255.4 8.8 5.8 4.5 20.8 4.1 5.4 10.7 4.7 10.8 6.6 14.2 9.7 13.3 11.8 9.5 10.5 9.0 17.4 5.0 7.1 6.3 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795808-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 104.2" "Cell type enriched" "Detected in some" 4 "Astrocytes: 229.9" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.1;U-2 OS: 1.1;U-698: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054625 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054625: " "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 0.1 0.3 70.4 0.3 81.6 0.2 0.5 92.6 63.9 0.8 20.8 0.1 0.1 0.2 1.6 0.0 0.4 0.2 0.2 58.0 72.1 0.1 0.1 0.1 0.0 89.7 94.7 50.0 0.1 0.4 0.0 1.0 0.0 94.2 0.2 0.1 4.1 1.7 0.4 0.3 0.1 0.1 0.1 63.6 0.2 0.1 1.1 104.2 1.0 0.1 0.0 0.1 0.1 0.2 67.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.3 1.1 0.0 0.0 0.2 0.0 1.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 81.6 92.6 63.9 58.0 72.1 89.7 94.7 50.0 94.2 63.6 104.2 67.9 0.0 0.0 0.0 229.9 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.5 0.0 2.6 0.0 52.8 24.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRTM2 KIAA0416 ENSG00000146006 "Leucine rich repeat transmembrane neuronal 2" O43300 5 138868921-138875368 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 13.2;retina: 4.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.0;Excitatory neurons: 23.7;Glandular and luminal cells: 9.7;Inhibitory neurons: 24.3;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 16.3" "Cancer enriched" "Detected in single" 11 "glioma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 15.8;SCLC-21H: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.77e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (2.85e-1)" "unprognostic (3.58e-1)" "unprognostic (8.72e-2)" "unprognostic (4.31e-2)" "unprognostic (4.48e-1)" "unprognostic (4.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.13e-2)" "unprognostic (3.13e-2)" "unprognostic (2.86e-2)" "unprognostic (8.11e-2)" "unprognostic (1.08e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" 0.9 1.7 5.0 0.1 9.3 0.1 0.4 2.1 13.2 0.2 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.3 0.1 8.3 5.4 0.1 0.2 0.1 0.2 2.7 4.5 8.6 0.2 0.4 0.0 0.4 2.0 3.2 0.1 0.2 4.3 0.1 0.0 0.2 0.1 0.3 0.3 0.4 0.6 0.1 0.0 8.4 0.3 0.2 0.0 0.0 0.1 0.1 11.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 15.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 9.3 2.1 13.2 8.3 5.4 2.7 4.5 8.6 3.2 0.4 8.4 11.3 7.6 6.4 1.5 2.9 0.4 0.0 0.2 0.2 0.6 11.0 0.3 0.9 0.8 0.0 0.7 0.0 4.2 0.0 0.4 0.1 0.0 0.0 0.0 4.9 1.6 2.9 0.0 0.0 23.7 0.0 0.0 0.5 0.0 9.7 1.3 0.4 2.5 0.2 0.1 6.7 24.3 0.0 0.0 0.3 0.4 0.0 0.0 0.4 1.8 1.9 0.0 2.1 0.0 28.1 16.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 3.6 0.0 1.7 1.1 0.0 0.0 0.7 0.4 0.3 0.3 1.2 0.0 0.0 ZMAT2 "FLJ31121, hSNU23, Snu23" ENSG00000146007 "Zinc finger matrin-type 2" Q96NC0 5 140698680-140706686 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036518 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036518: AB_10671960" "unprognostic (4.00e-1)" "unprognostic (2.43e-3)" "prognostic favorable (7.96e-4)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "unprognostic (1.60e-3)" "unprognostic (1.25e-3)" "unprognostic (2.16e-1)" "unprognostic (2.35e-1)" "unprognostic (3.38e-3)" "unprognostic (6.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.60e-3)" "unprognostic (2.54e-1)" "unprognostic (2.72e-2)" "unprognostic (2.91e-3)" "unprognostic (2.84e-2)" 51.9 53.6 68.9 42.0 76.1 73.7 59.8 65.2 86.2 46.8 66.8 52.6 35.5 50.1 53.5 67.6 51.9 34.3 39.9 73.4 70.0 61.2 58.3 42.1 55.7 68.8 67.5 71.2 49.5 39.1 78.7 45.3 47.7 72.2 42.5 57.2 47.3 49.8 47.2 82.5 58.9 46.0 48.6 66.4 55.8 49.3 29.2 69.3 69.9 44.5 80.2 70.0 50.6 51.7 73.3 78.2 128.0 81.5 138.5 128.8 85.8 109.5 79.2 84.9 107.0 114.9 195.5 127.7 87.0 126.2 136.7 121.6 72.9 116.7 158.0 136.4 96.2 99.9 70.6 151.0 138.3 82.1 168.5 89.0 100.0 119.1 111.2 128.0 106.6 90.9 138.1 81.0 93.5 100.6 117.2 135.1 115.4 61.4 54.7 79.5 93.0 96.4 96.9 92.5 110.3 96.8 73.0 112.5 109.8 124.5 115.5 151.6 144.6 77.4 92.5 50.8 48.3 123.4 60.0 130.9 97.5 100.7 114.5 73.7 63.7 37.2 59.9 30.7 29.9 38.7 29.6 33.3 32.3 27.0 27.6 30.6 33.6 96.9 29.3 31.9 28.8 34.8 30.2 68.9 76.1 65.2 86.2 73.4 70.0 68.8 67.5 71.2 72.2 66.4 69.3 73.3 44.1 51.3 81.3 9.1 63.8 56.7 76.9 70.8 50.1 30.5 52.4 56.8 87.1 72.9 73.6 69.9 6.2 132.5 66.8 81.0 117.4 80.9 10.8 80.8 69.5 60.0 68.8 170.9 12.8 67.4 126.3 54.5 43.8 70.5 82.8 47.3 51.0 92.7 82.6 16.8 9.7 55.7 44.7 95.8 61.1 11.2 56.5 68.9 58.7 10.3 135.4 82.4 95.8 5.5 9.2 70.9 86.9 57.9 55.3 71.6 68.6 168.0 96.8 22.4 52.6 56.4 58.2 60.1 73.5 68.0 63.2 207.6 71.9 38.0 59.2 87.5 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252380-138274621 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.9" "Region enhanced" "Detected in single" "cerebellum: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 32.0" "Not detected" "Not detected" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" NA NA 150000 "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 1.8 1.7 0.0 2.1 0.1 0.0 1.6 2.5 0.3 6.6 0.0 9.6 2.7 0.5 2.6 2.3 1.3 1.9 3.8 0.1 0.2 0.5 0.5 2.1 0.1 0.1 0.2 0.1 1.3 3.7 0.0 2.1 0.0 0.9 4.2 3.8 0.0 3.3 5.9 0.2 2.7 3.3 2.0 0.1 0.0 6.3 4.2 0.1 0.5 0.8 0.4 0.1 5.1 7.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.1 0.0 0.0 2.0 1.2 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 32.0 0.5 0.0 0.3 0.2 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.3 0.1 0.2 0.1 0.2 0.1 0.9 0.1 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 1.8 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 8.7 0.0 0.0 0.0 53.1 0.0 0.2 0.2 0.2 0.5 0.0 0.0 26.7 0.3 0.0 0.0 0.1 0.0 0.1 0.2 6.1 0.0 0.2 20.9 0.0 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 3.8 8.4 0.1 0.0 0.3 0.0 0.1 0.0 0.1 KLHL3 KIAA1129 ENSG00000146021 "Kelch like family member 3" Q9UH77 5 137617500-137736089 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell type enhanced" "Detected in many" "Early spermatids: 44.1;Excitatory neurons: 91.9;Inhibitory neurons: 56.1;Late spermatids: 60.7;Muller glia cells: 46.2;Oligodendrocytes: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 5.8;RT4: 6.1;TIME: 13.5;U-266/70: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051291 Approved NA NA "HPA051291: AB_2681423" "unprognostic (4.31e-2)" "unprognostic (5.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-1)" "unprognostic (6.39e-3)" "unprognostic (3.28e-1)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.71e-1)" "unprognostic (5.20e-3)" "unprognostic (1.50e-4)" 3.9 7.2 8.5 2.4 11.5 1.0 4.0 27.4 9.8 4.9 4.0 2.7 1.8 3.3 1.8 2.6 3.8 4.0 14.9 10.0 7.5 8.4 2.6 3.0 3.9 8.2 8.4 8.9 5.8 2.5 0.4 8.6 2.3 13.7 3.2 1.6 7.8 2.1 1.5 1.9 2.1 2.9 2.4 5.9 4.2 3.5 6.5 8.4 4.0 9.3 1.6 2.9 3.4 4.7 13.1 0.3 0.3 1.4 0.0 0.8 1.1 0.9 0.3 0.4 0.1 0.2 0.5 5.3 1.3 2.8 0.0 0.0 0.1 0.3 2.5 0.2 1.4 0.6 0.6 1.1 0.0 0.3 0.0 1.0 1.0 0.2 0.6 0.0 2.2 5.8 3.7 0.2 1.1 0.2 0.0 3.0 0.8 2.4 0.0 0.8 2.4 0.0 0.0 0.9 6.1 1.6 0.9 0.3 0.0 0.5 3.8 0.0 0.5 13.5 0.4 0.3 0.0 0.4 7.9 4.7 0.0 5.0 0.1 0.6 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.9 0.5 0.0 0.7 0.0 0.4 0.4 0.2 8.5 11.5 27.4 9.8 10.0 7.5 8.2 8.4 8.9 13.7 5.9 8.4 13.1 13.3 0.0 2.2 20.2 1.9 1.1 1.7 1.4 1.2 15.6 1.8 1.5 36.4 1.5 1.4 7.3 22.9 0.6 5.6 0.5 1.9 0.8 44.1 7.1 1.8 14.1 15.6 2.7 91.9 0.9 0.1 3.9 9.2 7.1 1.3 6.6 24.7 3.7 0.6 5.0 56.1 1.0 0.0 1.3 1.2 60.7 2.5 0.7 1.8 7.5 1.0 46.2 5.2 30.7 66.4 1.3 0.3 1.9 1.0 0.8 0.5 0.3 2.3 6.6 0.0 3.7 3.9 9.2 8.5 1.8 0.9 0.1 3.2 6.8 1.9 1.2 DCDC2 "DCDC2A, DFNB66, KIAA1154, NPHP19, RU2" ENSG00000146038 "Doublecortin domain containing 2" Q9UHG0 6 24171755-24358059 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Neurogenesis" "Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.0;pancreas: 26.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031582, HPA031583, HPA031584" Enhanced Supported "Microtubules,Mitotic spindle,Centriolar satellite,Cytosol" Yes NA Cytosol "Microtubules, Mitotic spindle, Centriolar satellite" "HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-2)" "unprognostic (1.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (5.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.99e-2)" 0.0 1.3 2.5 0.0 1.3 0.1 4.5 0.9 1.1 1.7 12.8 0.7 0.7 4.4 5.3 0.0 7.7 3.9 0.0 0.8 2.3 22.0 2.2 3.5 0.0 1.9 2.1 0.7 0.2 26.4 8.3 1.2 0.6 1.5 1.2 0.7 1.4 0.4 2.3 0.3 0.1 0.1 0.1 2.5 0.1 1.8 3.7 1.1 0.1 8.3 0.2 0.0 0.4 0.0 1.7 0.0 8.8 0.5 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 71.8 0.2 0.0 48.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 8.2 0.0 0.0 82.3 0.0 0.0 0.0 0.0 0.0 9.7 0.0 1.4 0.0 0.2 0.1 0.0 0.3 10.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 254.5 0.3 5.2 0.5 0.0 1.3 0.0 0.2 12.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.5 1.3 0.9 1.1 0.8 2.3 1.9 2.1 0.7 1.5 2.5 1.1 1.7 0.2 19.2 14.4 3.9 1.4 0.1 0.6 0.3 0.0 0.0 20.3 11.7 0.3 62.9 6.1 79.1 0.0 0.4 0.0 1.2 56.7 135.9 40.1 160.3 5.3 0.4 3.6 0.0 11.3 8.4 0.0 1.3 3.6 102.4 0.0 4.1 0.0 1.0 0.5 0.0 8.3 2.9 0.0 0.0 0.0 14.6 0.3 1.0 0.0 1.0 2.0 2.3 0.0 1.0 0.5 27.9 4.1 0.4 0.0 1.3 0.0 54.3 37.1 0.1 0.0 0.0 2.4 32.3 2.6 0.0 0.1 0.1 1.1 5.6 2.7 0.9 SLC17A4 KIAA2138 ENSG00000146039 "Solute carrier family 17 member 4" Q9Y2C5 6 25754699-25781199 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "gallbladder: 16.4;intestine: 32.1;liver: 47.7;pancreas: 22.9" "Group enriched" "Detected in some" 5 "Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2" "Group enriched" "Detected in some" 6 "liver cancer: 11.0;renal cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 1.5" HPA055564 Approved NA NA "HPA055564: AB_2682852" "unprognostic (6.52e-2)" "unprognostic (5.64e-3)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (1.19e-3)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 20.8 28.9 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 3.6 47.7 0.0 0.0 0.0 0.2 0.0 0.0 22.9 0.0 0.0 0.1 0.2 0.0 26.9 0.0 0.0 0.0 0.0 0.0 32.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 94.4 0.0 0.0 0.0 0.0 0.0 133.5 0.0 8.3 0.8 0.0 0.0 0.0 13.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 41.8 0.1 0.0 0.0 11.7 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.1 0.0 0.0 0.0 51.2 1.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 11.5 0.0 H2BC1 "bA317E16.3, H2BFU, HIST1H2BA, STBP, TSH2B" ENSG00000146047 "H2B clustered histone 1" Q96A08 6 25726777-25727345 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 6.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011603, HPA042205, HPA043013" Enhanced NA NA "CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269" "unprognostic (3.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KAAG1 "RU2, RU2AS" ENSG00000146049 "Kidney associated antigen 1" Q9UBP8 6 24356903-24358285 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 4.6;pancreas: 1.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 3.7;Glandular and luminal cells: 2.7;Proximal tubular cells: 1.1;Spermatocytes: 2.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 5.2;EFO-21: 4.1;Hep G2: 5.3" HPA036021 Approved NA NA "HPA036021: AB_10601918" "unprognostic (7.57e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.65e-1)" "unprognostic (3.32e-2)" "unprognostic (3.58e-2)" "unprognostic (3.05e-1)" "unprognostic (3.05e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (2.23e-2)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 4.6 0.9 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 3.7 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 2.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 195.2;tongue: 51.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 17.8;Cardiomyocytes: 40.1;Squamous epithelial cells: 39.6;Suprabasal keratinocytes: 28.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HDLM-2: 35.0;PC-3: 18.8;TIME: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.8 1.6 1.4 0.4 1.1 0.4 2.1 10.3 2.8 3.5 0.5 1.6 0.3 1.3 3.1 27.3 2.3 0.2 7.8 1.0 1.9 2.5 0.6 2.7 0.4 3.1 3.7 0.8 1.5 4.9 2.7 5.6 0.3 4.1 2.8 0.5 1.6 7.4 0.6 195.2 28.0 1.3 0.6 1.3 1.4 2.2 1.3 2.0 0.4 6.3 51.5 2.1 2.2 9.5 2.5 9.0 4.4 0.1 0.5 0.7 0.8 0.2 1.9 0.0 0.7 1.8 0.4 12.0 0.6 6.1 2.6 3.7 16.4 4.8 13.8 0.2 35.0 1.8 0.9 12.2 0.2 2.2 0.0 2.0 0.1 10.5 0.4 6.7 2.7 3.9 1.6 0.5 2.0 0.4 1.3 0.5 0.3 0.0 14.5 18.8 0.4 6.0 1.4 4.9 0.0 0.4 1.1 4.2 0.2 6.5 0.2 1.0 0.4 16.0 0.2 3.4 0.6 6.3 2.8 0.4 1.0 0.5 0.7 1.5 0.0 1.7 0.0 0.4 0.7 0.7 0.1 0.4 0.4 0.3 0.2 0.7 0.5 0.0 0.1 0.5 0.2 0.9 0.3 1.4 1.1 10.3 2.8 1.0 1.9 3.1 3.7 0.8 4.1 1.3 2.0 2.5 7.3 0.0 1.1 0.0 1.0 17.8 4.3 11.1 12.0 6.2 0.8 1.5 40.1 0.0 6.3 3.7 0.0 0.1 0.8 5.9 5.9 0.7 0.9 0.2 0.3 4.6 0.0 0.0 1.3 2.4 0.7 4.8 11.2 0.7 0.0 0.1 5.7 0.4 1.1 0.0 3.9 3.3 2.0 6.0 2.8 0.0 0.9 2.9 1.8 0.0 5.7 0.6 1.0 2.0 0.1 5.0 6.5 1.5 0.1 2.5 0.0 1.5 2.9 2.9 13.1 17.3 5.8 1.5 0.4 39.6 28.4 0.0 1.4 0.1 3.4 5.3 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235808 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 77.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 7.9 9.7 62.1 7.5 58.4 8.1 5.8 53.3 51.4 6.8 36.4 6.3 8.5 7.6 5.8 10.2 6.5 3.3 8.5 47.3 49.6 9.6 12.3 6.3 5.0 62.4 61.6 42.2 6.1 10.0 11.8 11.0 4.1 64.3 6.8 2.8 7.1 7.7 5.6 26.3 9.7 7.3 3.6 60.8 8.3 8.9 13.3 57.7 10.2 11.8 12.8 5.3 6.8 6.7 60.2 9.3 24.0 8.7 14.6 10.1 10.0 20.6 13.3 7.2 9.6 9.0 20.4 13.8 16.0 21.4 9.1 18.0 17.3 9.1 31.9 5.2 77.8 29.2 17.8 24.9 11.7 9.7 13.3 11.8 8.8 16.1 12.0 4.2 9.3 5.6 23.8 22.7 18.8 5.3 33.8 20.0 14.7 8.3 7.0 11.3 18.7 13.2 20.9 5.5 14.7 13.5 12.7 12.3 14.3 18.7 3.8 28.7 14.8 11.7 13.1 8.9 8.0 10.3 41.2 28.1 21.9 13.7 15.3 11.3 0.2 0.3 0.6 0.6 0.3 0.9 0.5 0.6 1.1 0.4 0.6 0.6 0.8 1.0 0.6 0.7 0.7 0.9 0.4 62.1 58.4 53.3 51.4 47.3 49.6 62.4 61.6 42.2 64.3 60.8 57.7 60.2 9.1 3.2 12.4 11.4 10.1 8.0 9.5 7.5 8.0 19.1 10.5 8.9 13.2 12.8 10.0 11.0 18.8 14.6 13.6 12.3 11.7 8.5 8.0 15.8 12.9 10.4 12.7 5.9 5.2 12.1 10.0 7.5 16.8 12.4 2.5 12.3 10.4 21.0 8.8 28.6 5.3 13.1 12.2 15.1 7.3 4.0 5.3 10.1 8.8 5.6 11.8 15.0 14.4 1.5 5.8 9.9 12.3 11.7 11.1 9.5 16.0 8.0 24.1 30.4 0.0 24.4 10.7 33.2 23.7 12.3 11.2 13.0 13.6 10.2 12.6 8.3 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388751-176389761 "Metabolic proteins, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA042715: AB_2678127" "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 130.4 177.0 134.8 87.8 135.1 134.2 114.5 139.2 176.4 101.6 153.7 196.3 120.0 112.7 51.7 131.0 105.9 81.2 276.1 131.1 143.4 183.3 164.6 96.5 134.0 135.0 132.8 123.8 119.7 109.6 206.7 126.1 55.0 133.1 129.0 97.2 45.9 164.6 93.6 426.6 134.2 137.7 68.7 137.6 130.4 149.8 66.6 140.9 111.7 114.9 300.5 93.4 153.6 106.1 138.3 104.9 166.6 99.0 172.6 98.5 186.4 262.2 66.6 109.7 164.7 206.4 176.0 202.2 183.3 149.9 107.1 214.2 127.3 146.2 260.6 65.9 424.0 234.0 92.6 161.7 244.7 137.4 149.7 230.1 238.2 213.2 93.7 113.3 126.3 141.7 146.5 104.0 341.5 124.0 315.9 165.3 178.1 124.8 195.5 181.7 157.1 75.6 324.7 265.5 158.7 107.9 141.5 71.4 295.2 310.5 100.7 173.3 233.7 96.8 118.5 124.7 110.2 142.5 165.2 216.6 158.4 150.5 254.1 77.5 284.2 743.6 219.8 391.2 975.8 389.5 618.1 540.1 452.6 930.0 496.0 488.1 464.2 124.6 308.0 1024.9 616.8 621.8 971.3 134.8 135.1 139.2 176.4 131.1 143.4 135.0 132.8 123.8 133.1 137.6 140.9 138.3 100.4 73.7 78.6 0.0 212.5 232.2 332.8 358.0 272.0 60.5 225.5 288.5 145.3 174.5 191.0 182.1 12.5 223.0 184.2 415.6 534.1 204.5 83.9 140.0 120.6 110.9 266.6 90.8 0.0 237.3 185.4 129.1 142.2 124.2 130.0 157.0 120.3 217.0 378.7 65.6 0.0 450.7 219.7 458.8 345.2 56.8 140.1 292.1 257.9 0.0 449.7 138.1 230.7 0.0 0.0 110.0 493.0 85.0 184.2 292.6 313.8 542.8 142.3 47.7 118.3 145.9 138.8 96.7 79.4 301.8 225.0 280.2 223.7 182.1 385.3 532.4 FAM193B "FLJ10404, IRIZIO, KIAA1931" ENSG00000146067 "Family with sequence similarity 193 member B" Q96PV7 5 177519789-177554563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035847, HPA035848" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035847: , HPA035848: AB_10601320" "unprognostic (6.58e-3)" "unprognostic (1.07e-1)" "unprognostic (8.95e-3)" "unprognostic (2.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-3)" "unprognostic (4.07e-2)" "unprognostic (1.48e-2)" "unprognostic (1.91e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-3)" "unprognostic (2.78e-2)" "prognostic unfavorable (3.71e-8)" "unprognostic (1.08e-1)" "unprognostic (1.35e-1)" "unprognostic (3.15e-1)" "prognostic favorable (1.30e-5)" 36.8 25.9 23.9 24.7 20.8 58.5 41.2 23.6 26.1 51.3 15.3 37.3 22.2 38.8 14.2 35.1 41.4 17.4 25.3 25.5 20.9 41.6 51.4 45.7 32.0 17.3 17.9 21.7 51.8 52.5 11.3 38.2 21.7 17.4 51.0 15.9 20.8 37.5 17.5 22.3 53.3 49.9 14.9 13.5 70.9 37.0 32.1 23.4 31.2 41.8 8.0 22.5 34.9 43.9 20.5 10.4 13.5 29.3 25.7 14.3 13.5 63.2 9.0 9.8 14.9 14.1 36.6 19.4 19.4 13.8 9.0 18.9 17.7 13.6 19.2 11.1 43.5 13.9 13.7 22.9 17.8 8.3 13.6 27.5 13.6 21.1 12.5 13.8 26.6 15.3 30.4 13.4 18.7 10.9 34.5 24.9 39.4 20.4 9.0 10.6 40.4 6.4 16.7 14.2 29.1 27.2 17.2 10.6 30.0 9.8 22.2 29.5 18.4 19.1 16.4 13.5 10.8 11.2 20.1 9.2 16.1 13.1 21.8 13.9 0.0 0.4 0.1 0.5 0.0 0.3 0.1 0.2 0.4 0.2 0.2 0.1 0.1 0.6 0.5 0.2 0.3 0.1 0.2 23.9 20.8 23.6 26.1 25.5 20.9 17.3 17.9 21.7 17.4 13.5 23.4 20.5 16.9 19.2 26.7 45.1 8.5 8.7 5.8 7.2 11.4 11.5 12.1 18.3 14.6 20.0 11.2 11.0 18.8 5.0 11.9 14.3 0.0 6.1 6.1 8.3 10.2 12.5 8.4 6.1 41.0 8.9 8.3 11.7 22.4 10.8 5.1 14.1 12.1 13.8 5.0 11.8 39.3 15.6 6.1 10.0 8.2 8.4 9.9 10.6 8.8 21.5 8.3 7.3 9.2 39.2 38.0 6.0 8.4 5.3 6.9 7.7 9.8 2.8 10.7 12.5 6.6 12.4 11.1 15.4 13.2 11.8 12.9 4.5 10.4 8.6 11.7 6.7 PLA2G7 "LDL-PLA2, PAFAH" ENSG00000146070 "Phospholipase A2 group VII" Q13093 6 46704201-46735693 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Asthma, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.4;placenta: 23.5" "Group enriched" "Detected in many" 5 "Hofbauer cells: 372.2;Macrophages: 140.9" "Cancer enhanced" "Detected in all" "prostate cancer: 37.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 43.4" "Group enriched" "Detected in many" 49 "dendritic cells: 14.1;monocytes: 43.4" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;PC-3: 3.4;RT4: 1.6;U-2 OS: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 7380000 290000000 "unprognostic (3.63e-3)" "unprognostic (2.82e-3)" "unprognostic (8.69e-2)" "unprognostic (3.00e-1)" "unprognostic (1.47e-1)" "unprognostic (6.26e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.33e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "unprognostic (9.20e-2)" "unprognostic (1.93e-1)" "unprognostic (7.08e-2)" 4.3 3.1 2.6 23.1 4.4 2.8 2.7 3.1 5.7 2.5 0.8 7.6 4.2 4.8 1.1 0.6 1.9 6.0 0.6 3.0 4.0 0.3 7.0 7.3 27.1 4.3 2.7 2.4 1.1 0.8 21.2 2.1 23.5 4.6 13.2 10.4 0.6 1.4 2.6 0.4 3.6 3.4 2.8 5.8 27.4 3.0 0.9 7.4 5.0 20.4 0.0 10.1 11.2 0.3 4.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.9 0.7 0.0 0.0 0.0 0.1 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 3.4 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.4 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.6 0.3 43.4 0.3 0.1 9.2 0.3 0.3 0.0 0.0 14.1 0.0 0.0 0.1 0.5 0.0 0.5 0.3 0.0 11.9 2.6 4.4 3.1 5.7 3.0 4.0 4.3 2.7 2.4 4.6 5.8 7.4 4.8 0.5 0.0 1.3 0.3 3.6 0.8 4.4 0.0 0.0 0.2 0.3 4.3 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.6 0.1 1.6 50.3 0.6 3.5 0.0 7.1 0.0 5.1 1.8 0.0 1.5 0.0 0.0 0.0 0.0 372.2 1.7 4.8 0.3 0.0 24.6 4.9 0.1 0.0 140.9 10.6 11.2 29.3 0.3 0.0 6.0 0.3 0.3 0.0 0.0 0.1 6.9 0.0 0.1 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.1 0.1 3.1 0.8 8.9 0.2 3.8 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Host-virus interaction, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 110.4;urinary bladder: 149.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 35 "plasmacytoid DC: 69.2" "Lineage enriched" "Detected in single" 303 "dendritic cells: 69.2" "Cell line enhanced" "Detected in many" "OE19: 208.0;RT4: 523.8;SuSa: 213.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" NA NA 2300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favorable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 56.2 6.7 28.8 17.8 30.0 13.5 13.5 49.0 38.6 17.6 4.2 38.5 12.4 17.2 2.5 41.7 16.5 36.0 8.0 25.5 28.1 50.0 9.0 17.1 17.4 71.2 47.2 19.6 6.5 20.2 59.3 6.5 33.5 55.3 13.8 35.2 4.1 25.8 4.1 6.1 3.9 19.3 15.9 64.3 15.0 61.4 8.2 49.4 27.1 4.1 14.2 33.1 149.5 17.3 110.4 156.6 50.0 47.7 15.3 127.4 37.5 53.9 17.9 34.9 5.5 2.1 86.7 107.7 11.6 70.3 13.1 101.8 92.2 7.2 66.1 3.1 0.2 15.1 0.1 6.4 88.2 74.6 2.5 0.6 67.1 77.2 3.3 58.1 4.2 25.8 10.1 3.8 0.1 1.9 30.8 13.9 1.4 37.5 208.0 50.8 29.1 14.7 17.1 90.8 523.8 34.1 7.5 15.6 14.4 12.9 213.0 11.1 11.0 5.2 14.1 12.9 0.5 16.5 0.1 0.2 16.1 23.1 11.1 40.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.1 0.1 0.1 69.2 0.0 0.6 28.8 30.0 49.0 38.6 25.5 28.1 71.2 47.2 19.6 55.3 64.3 49.4 110.4 5.5 0.0 9.8 1.6 3.1 23.7 179.9 140.5 64.9 1.1 8.0 10.8 10.2 35.8 59.9 1.8 0.0 31.0 77.3 100.7 15.6 86.8 55.0 12.0 17.3 8.6 12.0 3.0 46.6 29.6 21.4 32.9 80.5 13.8 19.7 2.1 1.1 0.3 22.4 0.0 29.6 42.9 107.8 53.6 12.5 40.3 2.8 22.6 12.4 13.1 0.6 5.4 0.0 53.3 44.7 89.1 54.5 1.2 2.0 180.8 14.7 51.3 54.7 1.4 78.9 21.5 24.2 1.0 3.7 40.4 9.9 178.7 2.8 13.1 19.9 387.3 RNF44 KIAA1100 ENSG00000146083 "Ring finger protein 44" Q7L0R7 5 176526712-176538025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 105.1;Late spermatids: 398.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038981: AB_10674846" "unprognostic (1.85e-1)" "unprognostic (3.07e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.57e-7)" "unprognostic (1.50e-1)" "unprognostic (2.56e-2)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" "unprognostic (4.54e-2)" "unprognostic (5.36e-2)" "unprognostic (5.78e-2)" "unprognostic (1.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-3)" "unprognostic (1.62e-1)" "unprognostic (5.12e-3)" "unprognostic (1.15e-2)" 16.2 17.9 15.4 29.2 13.2 43.0 18.3 7.9 19.4 18.0 5.7 22.8 20.3 16.5 5.5 26.1 19.3 9.2 16.0 14.2 13.3 21.9 14.8 22.2 38.0 12.2 12.1 13.1 25.1 19.7 10.3 15.9 13.2 11.5 19.7 12.7 8.5 23.4 9.4 11.9 29.8 34.9 7.9 8.0 55.1 20.5 20.3 14.1 31.2 25.3 7.6 24.4 18.1 21.3 10.8 9.3 20.9 32.7 30.6 6.4 5.3 87.6 5.3 4.6 3.5 4.5 31.9 20.2 17.7 32.0 3.0 16.0 24.8 14.8 31.8 4.0 69.0 26.1 18.9 20.1 29.8 8.1 22.1 25.0 10.3 25.1 3.9 11.7 11.4 9.8 33.8 21.4 25.9 4.8 32.1 51.6 49.3 43.4 12.1 25.5 21.0 8.6 25.8 12.0 21.4 40.1 48.8 8.0 21.7 31.2 21.5 24.0 43.9 16.0 8.8 13.1 7.1 10.0 32.6 26.3 24.1 4.3 44.7 11.7 0.0 1.5 2.9 3.0 1.8 2.2 1.9 2.3 2.5 1.0 2.3 2.2 2.7 5.3 2.1 1.6 1.1 3.1 1.8 15.4 13.2 7.9 19.4 14.2 13.3 12.2 12.1 13.1 11.5 8.0 14.1 10.8 18.3 12.8 28.6 22.9 39.0 40.3 10.5 24.4 43.3 17.1 30.7 25.4 13.3 20.0 18.2 12.9 10.4 10.5 46.6 41.7 7.9 12.3 105.1 15.3 13.7 19.9 40.7 10.1 20.5 16.2 11.7 11.1 21.4 20.2 15.8 13.7 15.7 10.5 15.3 28.6 24.7 40.7 18.3 56.5 19.6 398.5 19.9 26.8 5.4 21.5 38.4 9.2 40.2 13.0 12.2 21.2 24.3 12.4 17.0 22.2 27.1 10.8 13.9 8.5 6.6 14.1 13.0 3.6 12.0 35.0 49.6 12.0 40.3 12.9 35.7 15.3 MMUT "MCM, MUT" ENSG00000146085 "Methylmalonyl-CoA mutase" P22033 6 49430360-49463253 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 200.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035971, HPA035972" Enhanced Approved Mitochondria,Cytosol NA NA 150000 Cytosol Mitochondria "HPA035971: AB_10696648, HPA035972: AB_2674895" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.17e-2)" "unprognostic (3.72e-2)" "unprognostic (3.18e-3)" "unprognostic (1.20e-1)" "unprognostic (1.16e-2)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (1.89e-2)" "unprognostic (6.57e-2)" "unprognostic (9.89e-2)" "prognostic favorable (8.71e-13)" "unprognostic (5.38e-2)" "unprognostic (3.78e-1)" "unprognostic (6.01e-3)" "unprognostic (1.91e-1)" 19.9 23.5 12.9 11.6 14.1 8.7 18.6 14.6 16.3 14.1 18.5 22.8 27.4 15.4 15.8 18.0 14.1 14.3 31.3 12.5 13.9 51.1 200.6 12.6 11.9 13.6 15.0 12.4 24.4 24.8 31.3 11.8 13.3 14.3 21.0 21.8 17.4 18.9 15.9 23.8 15.1 20.3 15.0 13.3 9.5 20.3 14.7 13.6 12.4 19.3 36.4 11.3 13.2 12.0 16.9 23.9 8.3 24.6 28.8 47.8 45.1 13.6 20.9 27.3 21.6 31.7 9.7 12.1 21.9 16.3 22.4 32.6 13.3 27.6 14.8 30.2 18.9 20.0 11.7 17.5 25.4 34.8 15.1 10.8 27.4 21.6 22.0 25.4 19.3 21.1 23.4 21.6 25.6 25.7 15.0 17.9 14.9 10.5 25.0 6.0 15.8 30.8 30.7 24.9 22.6 22.7 15.8 23.0 16.3 35.7 25.6 14.2 23.9 15.4 20.0 14.6 27.4 28.7 10.0 12.2 18.8 28.1 17.6 17.9 16.0 6.5 11.4 6.4 8.8 8.2 7.6 7.7 8.1 7.8 6.9 9.6 7.2 3.8 12.5 14.7 5.5 10.9 5.8 12.9 14.1 14.6 16.3 12.5 13.9 13.6 15.0 12.4 14.3 13.3 13.6 16.9 6.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.0 26.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 13.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 33.4 0.6 0.0 0.0 0.0 RASGEF1C FLJ35841 ENSG00000146090 "RasGEF domain family member 1C" Q8N431 5 180100795-180209211 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 20.6;testis: 5.8" "Cell type enriched" "Detected in some" 9 "Microglial cells: 188.3" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;HEK 293: 1.7;MCF7: 2.2;SCLC-21H: 7.6;U-2 OS: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028242 Uncertain Approved Mitochondria NA NA Mitochondria "HPA028242: AB_10602294" "unprognostic (2.21e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (4.75e-4)" "unprognostic (4.65e-2)" "unprognostic (4.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.02e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.65e-4)" "unprognostic (5.89e-2)" "unprognostic (8.25e-3)" "unprognostic (3.70e-1)" "unprognostic (1.77e-2)" 0.2 0.2 3.7 0.2 12.9 0.0 0.4 20.6 8.6 1.0 0.0 2.4 0.1 0.0 0.1 0.3 0.5 0.3 0.8 6.7 2.5 0.1 0.0 0.0 0.0 6.8 4.1 6.9 0.1 0.1 0.0 0.1 0.1 7.5 0.9 0.2 0.3 1.1 0.9 0.0 0.5 0.8 0.1 4.5 0.0 0.7 5.8 2.9 0.0 1.2 0.0 0.0 0.7 1.1 7.3 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 12.9 20.6 8.6 6.7 2.5 6.8 4.1 6.9 7.5 4.5 2.9 7.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 1.8 1.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.5 0.0 0.0 20.2 0.0 0.6 0.1 0.0 0.5 0.0 1.5 0.0 0.0 0.1 0.0 12.5 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 188.3 0.0 0.2 0.0 15.1 19.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.7 1.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 DOK3 FLJ22570 ENSG00000146094 "Docking protein 3" Q7L591 5 177501904-177511274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 94.5;lymphoid tissue: 119.4" "Group enriched" "Detected in many" 5 "B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 133.6" "Group enriched" "Detected in many" 6 "B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6" "Cell line enhanced" "Detected in many" "Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0" "Low region specificity" "Detected in many" HPA077312 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" Yes NA 240000 "Plasma membrane" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA077312: AB_2732339" "unprognostic (2.21e-2)" "unprognostic (1.14e-2)" "unprognostic (2.05e-2)" "unprognostic (5.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.34e-3)" "unprognostic (4.17e-2)" "unprognostic (2.20e-1)" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.82e-11)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 9.0 6.1 7.1 30.5 8.4 94.5 4.4 7.5 10.0 3.0 7.2 7.1 6.5 3.5 1.7 5.6 7.9 4.4 3.7 6.8 7.7 4.9 6.5 27.3 31.7 11.3 7.7 6.2 2.1 4.5 0.8 3.4 7.1 11.6 5.6 3.5 2.1 6.7 2.0 3.7 2.5 29.2 4.6 7.2 119.4 5.9 9.0 9.5 4.3 4.4 4.1 32.6 7.1 4.0 12.3 5.2 7.8 5.4 6.3 3.2 0.4 13.0 4.4 1.1 14.0 12.9 11.0 2.2 124.0 3.2 4.0 6.8 8.9 12.2 7.6 6.9 26.1 14.6 21.3 21.4 2.5 1.0 46.1 87.5 1.6 4.5 16.2 1.6 1.5 1.9 11.4 14.8 50.2 5.1 12.9 2.7 52.5 12.2 1.5 12.9 148.6 9.3 1.2 4.4 5.2 7.4 4.9 2.0 2.1 6.2 4.8 11.7 63.4 2.7 12.3 11.3 6.5 5.4 11.1 15.0 122.1 2.7 88.0 2.2 16.8 62.4 57.0 0.3 61.3 0.6 37.2 0.1 0.3 14.5 19.6 0.1 0.1 133.6 0.5 77.6 1.2 0.0 28.7 7.1 8.4 7.5 10.0 6.8 7.7 11.3 7.7 6.2 11.6 7.2 9.5 12.3 1.4 0.0 5.6 1.6 31.6 0.3 0.1 0.4 1.8 0.8 1.0 0.9 0.4 0.0 0.2 0.0 0.0 0.5 0.3 0.2 0.0 0.2 0.0 0.4 0.4 1.9 0.0 6.3 4.1 0.2 0.7 1.2 0.5 0.8 18.3 0.2 7.1 0.8 55.7 0.0 3.5 0.3 0.0 51.1 2.3 0.4 0.6 38.3 1.8 3.7 45.4 0.3 2.1 0.5 0.5 0.0 0.7 1.2 38.3 0.2 0.2 0.1 0.1 0.6 0.0 1.8 0.4 3.0 1.9 0.7 0.3 1.0 2.2 0.3 0.8 0.1 ABT1 Esf2 ENSG00000146109 "Activator of basal transcription 1" Q9ULW3 6 26596953-26600739 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077039 Approved Vesicles NA NA Vesicles "HPA077039: AB_2732328" "unprognostic (1.32e-1)" "unprognostic (3.94e-2)" "unprognostic (3.05e-1)" "unprognostic (1.15e-3)" "unprognostic (1.77e-1)" "unprognostic (7.74e-2)" "unprognostic (2.55e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.30e-3)" "unprognostic (2.93e-2)" "unprognostic (7.25e-3)" "unprognostic (7.20e-2)" "unprognostic (9.57e-2)" "unprognostic (1.49e-1)" "prognostic favorable (3.80e-4)" 9.2 8.0 6.5 9.6 6.6 23.4 9.4 7.7 7.7 8.9 6.4 9.8 10.1 10.9 6.4 14.0 9.2 6.0 7.6 6.4 6.4 7.0 13.1 7.9 15.9 6.4 6.3 6.4 9.2 9.5 8.4 7.4 10.8 6.6 8.3 6.8 4.7 9.1 6.8 9.7 13.7 11.7 5.8 6.4 14.9 10.0 8.0 6.6 13.1 7.3 7.1 10.6 9.3 9.8 6.6 23.3 11.9 16.3 28.4 8.9 9.3 23.9 13.4 13.6 20.0 19.5 21.6 10.0 33.8 30.0 11.1 15.9 14.5 19.0 19.5 11.7 18.9 38.7 22.2 11.2 40.6 14.3 30.6 21.7 12.4 17.9 15.9 9.4 9.3 17.5 26.2 39.3 22.1 11.2 23.6 35.6 39.1 16.8 14.9 15.9 21.4 13.2 35.8 12.5 18.7 21.4 17.2 8.3 21.6 32.9 8.6 20.8 24.6 15.1 15.2 11.2 12.2 27.3 25.8 40.9 30.9 7.2 37.6 23.8 76.1 41.6 53.8 66.1 40.2 63.3 66.5 63.8 66.2 39.7 70.2 67.4 60.8 37.2 57.5 41.7 37.1 76.3 88.1 6.5 6.6 7.7 7.7 6.4 6.4 6.4 6.3 6.4 6.6 6.4 6.6 6.6 22.4 16.0 15.5 3.3 41.8 59.9 35.8 65.2 34.1 16.2 23.1 22.2 7.1 21.5 31.8 11.0 2.1 96.0 50.8 16.1 41.1 39.4 39.7 12.1 14.0 31.6 34.0 26.9 4.4 38.7 97.5 21.1 16.8 17.3 29.1 17.7 25.4 21.2 42.2 15.2 4.3 25.3 50.8 21.2 22.6 81.8 27.7 22.2 16.0 2.8 32.3 22.0 78.2 3.5 4.5 35.9 19.5 23.7 29.4 31.6 27.9 24.4 21.8 17.2 19.7 15.1 23.4 29.6 41.2 28.3 59.8 109.5 44.3 24.5 29.5 33.6 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 208.4;Kupffer cells: 164.4;Langerhans cells: 179.3;monocytes: 212.8;NK-cells: 332.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 215.8;neutrophil: 169.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 215.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 11000 "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 34.7 16.8 11.7 42.9 8.8 56.5 26.1 9.3 16.4 29.6 10.1 31.2 8.9 37.1 3.5 18.2 28.9 25.8 21.9 9.6 16.5 13.1 16.9 51.9 76.1 18.0 10.1 5.7 27.0 10.1 2.7 7.0 21.6 12.4 19.9 7.8 2.6 15.5 11.6 10.9 20.9 34.0 17.5 14.4 81.1 19.6 6.0 13.3 54.0 17.7 9.1 38.6 36.4 24.6 32.2 63.2 9.4 34.4 37.3 28.0 80.4 1.7 48.4 63.6 43.3 29.9 6.6 11.2 64.7 25.0 77.3 73.7 35.8 21.6 44.7 29.6 74.8 2.2 79.3 20.7 6.6 59.1 28.6 116.3 44.0 44.0 97.9 89.8 64.5 60.0 53.3 27.2 58.2 57.8 6.9 40.8 43.5 3.2 1.6 13.8 162.8 28.8 33.9 18.0 3.4 3.8 19.2 30.1 10.9 65.9 18.8 9.4 26.8 90.8 139.4 29.2 29.4 103.3 11.6 57.3 77.3 40.7 131.9 155.9 43.0 16.4 215.8 43.4 21.8 31.8 20.9 23.1 42.5 9.5 22.0 16.7 32.5 169.6 37.8 25.2 14.9 39.7 22.6 11.7 8.8 9.3 16.4 9.6 16.5 18.0 10.1 5.7 12.4 14.4 13.3 32.2 39.1 3.2 15.7 1.6 89.7 109.0 29.6 15.7 79.6 2.3 14.2 14.6 3.1 8.6 4.6 9.2 0.0 3.1 116.5 0.8 0.0 25.1 24.2 4.4 24.4 67.8 1.8 35.4 0.8 8.2 20.4 34.1 7.1 6.7 53.2 5.9 32.9 8.2 208.4 3.3 1.3 0.8 8.2 164.4 179.3 19.9 27.7 123.3 39.2 19.7 212.8 1.0 332.7 11.1 0.1 20.8 0.0 23.3 52.9 23.8 0.4 2.5 4.4 3.1 26.3 28.6 53.5 1.2 1.3 38.3 59.7 4.0 141.6 6.8 0.7 22.5 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 270.8;choroid plexus: 82.7" "Group enriched" "Detected in many" 5 "Astrocytes: 275.6;Oligodendrocytes: 449.8;Sertoli cells: 151.2" "Group enriched" "Detected in all" 5 "glioma: 15.0;melanoma: 21.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 54.9;JURKAT: 30.4;LHCN-M2: 55.8;SK-MEL-30: 68.7;WM-115: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA051300: AB_2681430, HPA054630: AB_2682549" "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 30.5 22.7 201.0 9.1 227.9 1.9 23.5 195.5 160.2 15.3 82.7 17.4 9.9 14.1 10.5 36.9 18.7 7.4 10.0 158.7 173.2 9.2 4.9 12.5 3.6 270.8 209.2 112.4 10.0 7.6 4.1 5.1 12.3 248.4 11.1 8.8 1.6 7.6 21.9 38.6 7.8 21.1 18.4 212.9 40.5 19.0 12.4 208.3 2.5 13.2 38.5 2.4 10.0 11.4 249.5 0.1 0.0 5.8 0.1 12.2 0.3 0.2 9.8 13.1 2.2 1.2 0.9 0.0 0.1 0.5 14.7 4.5 0.1 0.0 0.0 0.8 0.0 2.4 0.0 0.0 0.1 8.8 0.0 0.1 54.9 0.0 0.3 0.0 15.6 0.0 30.4 0.0 0.1 55.8 0.2 1.5 0.1 1.6 3.1 0.1 0.0 10.0 8.1 0.0 0.0 2.0 2.3 0.0 0.7 68.7 11.7 0.0 0.1 0.6 20.8 6.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 201.0 227.9 195.5 160.2 158.7 173.2 270.8 209.2 112.4 248.4 212.9 208.3 249.5 11.2 9.6 12.2 275.6 0.1 1.8 0.9 0.0 0.0 1.3 1.5 1.5 2.5 1.5 3.8 0.0 0.0 0.5 0.1 0.0 0.0 0.5 3.8 1.2 10.4 9.0 0.0 2.7 1.4 3.3 0.5 11.8 0.5 2.3 0.0 1.9 2.5 1.2 0.2 0.0 5.8 0.0 0.0 31.5 2.4 6.4 23.6 6.2 8.8 21.5 0.0 5.8 1.0 8.5 449.8 0.3 0.0 22.2 0.0 0.8 0.0 0.1 1.5 1.6 151.2 12.7 48.8 1.0 1.9 0.4 1.1 0.3 0.7 55.9 0.0 1.2 PRIM2 PRIM2A ENSG00000146143 "DNA primase subunit 2" P49643 6 57314805-57646850 "Plasma proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 30.9" "Cell type enhanced" "Detected in many" "Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046566 Supported Nucleoplasm NA NA Nucleoplasm "HPA046566: AB_2679701" "unprognostic (1.24e-1)" "unprognostic (1.55e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (3.08e-1)" "unprognostic (6.24e-2)" "prognostic unfavorable (3.44e-5)" "unprognostic (2.31e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.00e-5)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.89e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" 4.0 3.3 4.1 6.7 4.2 15.1 7.0 6.2 4.6 5.6 7.3 7.0 6.0 7.2 6.9 4.3 6.3 4.3 3.3 4.0 5.5 3.9 5.0 4.9 10.7 4.4 5.6 3.5 7.2 4.1 3.9 1.9 7.6 4.6 30.9 8.4 4.0 4.3 5.7 2.3 5.9 5.3 8.0 3.2 5.5 4.9 6.5 5.1 15.4 4.5 2.4 11.9 5.9 4.2 7.2 44.8 17.7 34.1 37.6 16.8 29.5 27.3 53.1 48.8 57.0 74.7 26.6 21.1 39.4 27.7 66.6 39.6 27.9 30.2 29.2 71.6 35.1 24.2 47.6 22.7 43.0 7.3 43.5 27.4 12.1 12.0 61.0 20.3 14.2 26.9 44.1 46.2 38.9 48.3 28.2 49.8 37.6 22.0 37.1 17.2 34.7 46.9 31.2 21.0 20.7 24.5 19.2 31.5 15.9 21.3 38.9 33.3 47.4 17.9 54.7 55.5 106.2 44.2 14.4 29.3 47.2 26.6 50.5 30.4 0.7 1.9 1.8 4.1 3.7 4.3 3.5 3.5 5.4 3.0 4.0 2.8 5.7 1.4 5.2 4.2 5.1 4.7 2.1 4.1 4.2 6.2 4.6 4.0 5.5 4.4 5.6 3.5 4.6 3.2 5.1 7.2 5.9 0.0 2.7 30.0 11.2 4.0 6.7 4.1 11.4 5.6 6.2 4.2 1.1 2.8 4.6 3.7 12.5 17.0 15.1 4.3 3.9 5.1 10.3 4.9 7.1 5.0 1.2 26.5 38.0 5.2 22.0 6.9 4.1 6.0 12.0 13.7 4.2 3.5 9.3 6.7 32.6 6.5 10.2 6.6 6.4 3.7 6.5 7.0 0.0 70.3 7.3 4.8 17.5 56.8 54.5 4.9 5.3 6.8 12.7 7.1 4.4 1.8 4.1 5.6 19.7 4.9 6.8 10.1 11.2 8.7 3.0 5.7 13.6 8.0 8.6 5.3 MLIP "C6orf142, CIP, MGC18257" ENSG00000146147 "Muscular LMNA interacting protein" Q5VWP3 6 53929982-54266280 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "heart muscle: 166.4;liver: 132.4;skeletal muscle: 248.7;tongue: 150.8" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 224.9;Excitatory neurons: 244.1" "Group enriched" "Detected in some" 4 "glioma: 0.8;head and neck cancer: 0.5;liver cancer: 1.9;melanoma: 1.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 19.6;SK-MEL-30: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029252, HPA046654" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029252: AB_2732446, HPA046654: " "unprognostic (7.95e-3)" "unprognostic (4.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-4)" "unprognostic (2.38e-2)" "unprognostic (1.26e-2)" "unprognostic (5.60e-2)" "unprognostic (2.74e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.91e-5)" "unprognostic (7.49e-2)" "unprognostic (2.65e-2)" "unprognostic (5.27e-2)" "unprognostic (3.29e-3)" 3.8 4.3 2.2 0.1 5.3 0.0 3.5 0.0 15.8 1.5 0.0 0.9 0.3 0.3 0.9 12.7 0.7 1.6 166.4 7.6 1.6 0.9 132.4 0.4 0.2 0.0 0.0 3.3 0.2 0.8 0.3 0.5 0.1 1.5 1.6 0.7 0.9 7.0 0.3 248.7 17.5 2.6 0.5 0.0 0.1 0.3 1.0 0.0 0.3 6.9 150.8 5.2 1.3 2.6 2.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.4 2.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 2.4 0.0 0.0 0.0 19.6 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.2 0.0 0.1 0.6 1.4 0.0 0.0 0.5 19.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 5.3 0.0 15.8 7.6 1.6 0.0 0.0 3.3 1.5 0.0 0.0 2.0 0.5 0.0 0.0 4.9 0.0 0.4 0.1 0.5 0.6 0.1 0.2 0.0 224.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 15.7 0.5 0.5 2.6 0.0 2.7 244.1 0.0 0.0 4.9 0.0 0.4 0.0 0.1 0.7 20.0 0.0 13.5 4.6 3.7 0.0 0.8 0.6 12.9 0.3 0.2 7.2 16.9 0.0 0.0 0.0 5.0 4.2 0.0 0.0 0.0 0.0 0.1 1.0 1.9 0.6 0.1 0.0 17.8 1.9 1.5 0.4 4.1 2.0 0.0 0.1 0.1 0.1 0.1 HMGCLL1 "bA418P12.1, DKFZP434G1411" ENSG00000146151 "3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1" Q8TB92 6 55434373-55579197 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.9" "Cell type enhanced" "Detected in some" "Astrocytes: 49.9;Excitatory neurons: 80.7;Inhibitory neurons: 76.2;Oligodendrocytes: 23.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.74e-3)" "unprognostic (1.54e-2)" "unprognostic (4.08e-3)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (9.54e-3)" "unprognostic (8.97e-3)" "unprognostic (2.12e-2)" "unprognostic (9.27e-3)" "unprognostic (4.11e-2)" "unprognostic (1.18e-4)" "unprognostic (3.13e-3)" "unprognostic (7.57e-2)" "unprognostic (2.55e-1)" "unprognostic (1.52e-1)" 1.2 3.7 6.1 0.2 7.3 0.0 1.5 7.1 5.5 0.8 0.0 0.7 0.2 0.2 0.0 1.0 0.4 0.6 1.8 6.1 10.4 0.9 0.7 2.6 0.3 6.9 7.6 5.9 0.4 1.6 0.1 4.7 6.2 6.7 3.1 0.8 4.6 0.8 1.0 1.1 0.1 1.0 0.5 9.6 0.0 1.0 2.7 8.2 0.6 0.4 2.8 0.2 0.9 0.7 11.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 7.3 7.1 5.5 6.1 10.4 6.9 7.6 5.9 6.7 9.6 8.2 11.9 0.6 0.0 1.3 49.9 0.0 0.0 0.0 0.0 1.2 15.1 3.7 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.5 0.0 0.0 80.7 0.0 0.0 5.8 0.0 0.0 0.0 3.5 3.9 0.0 0.1 0.0 76.2 0.0 0.0 0.3 0.0 1.3 0.3 0.1 0.0 15.0 0.0 1.5 0.0 5.5 23.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.9 5.6 1.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319983 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 2.0;liver: 3.8;placenta: 1.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0" "Cancer enriched" "Detected in some" 4 "lung cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 2.0 3.8 0.2 0.0 0.3 0.1 0.1 0.0 0.3 0.0 0.0 1.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.4 0.2 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 2.2 0.0 1.1 1.9 0.1 1.2 2.0 0.0 0.1 0.0 0.0 3.5 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.3 0.0 3.7 0.7 0.0 0.3 0.0 4.4 0.3 0.1 0.0 1.9 0.0 0.0 0.0 1.5 5.9 0.0 0.3 0.0 0.1 0.2 0.1 5.6 3.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 0.1 0.1 0.8 0.2 FGD2 ZFYVE4 ENSG00000146192 "FYVE, RhoGEF and PH domain containing 2" Q7Z6J4 6 37005646-37029069 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" "B-cells: 53.7;dendritic cells: 29.7;Kupffer cells: 118.2;Langerhans cells: 49.3;Macrophages: 52.0;Microglial cells: 43.1;monocytes: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 16 "classical monocyte: 22.3;intermediate monocyte: 64.8;memory B-cell: 23.2;myeloid DC: 35.0;naive B-cell: 18.6;non-classical monocyte: 70.5;plasmacytoid DC: 27.4" "Group enriched" "Detected in many" 18 "B-cells: 23.2;dendritic cells: 35.0;monocytes: 70.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;Daudi: 11.5;HDLM-2: 11.3;U-698: 9.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029145, HPA049692" Approved NA NA "HPA029145: AB_10601321, HPA049692: AB_2680852" "unprognostic (3.54e-2)" "unprognostic (1.40e-4)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.67e-4)" "unprognostic (7.97e-2)" "unprognostic (1.58e-2)" "unprognostic (2.47e-2)" "unprognostic (2.78e-1)" "unprognostic (3.39e-2)" "unprognostic (2.82e-1)" "unprognostic (1.15e-2)" "unprognostic (3.91e-1)" "unprognostic (1.02e-2)" "unprognostic (3.88e-1)" "unprognostic (7.10e-2)" 6.1 3.4 0.8 15.0 1.4 6.0 2.6 1.1 1.2 1.5 2.3 3.3 3.8 1.3 1.5 2.4 2.8 4.1 1.6 0.8 2.1 1.4 2.5 8.0 22.7 2.0 1.5 0.5 1.0 1.3 0.3 1.1 2.7 1.7 1.5 2.7 0.1 2.3 1.8 0.6 2.0 11.2 4.8 1.7 40.0 3.8 0.6 1.9 5.5 2.7 0.9 9.9 4.5 1.6 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.1 22.3 2.3 0.1 64.8 0.1 23.2 0.0 0.0 35.0 18.6 0.0 0.0 0.3 0.4 70.5 27.4 0.1 7.5 0.8 1.4 1.1 1.2 0.8 2.1 2.0 1.5 0.5 1.7 1.7 1.9 3.0 0.3 6.4 7.4 0.0 53.7 2.0 3.0 1.0 0.6 0.3 0.7 0.6 3.2 2.8 0.5 0.0 0.0 0.3 29.7 0.3 0.0 2.8 11.9 0.5 0.2 1.2 0.0 1.3 0.1 0.9 0.4 1.0 1.5 1.2 7.6 0.0 2.5 0.6 17.7 0.0 0.2 0.1 4.1 118.2 49.3 2.1 1.5 52.0 1.8 43.1 51.8 0.4 2.1 0.5 0.2 1.0 3.9 0.0 14.2 1.6 0.1 0.2 3.2 0.2 0.0 2.3 0.5 0.0 0.1 3.3 2.3 0.4 3.0 0.1 0.4 5.6 SCUBE3 "CEGF3, FLJ34743" ENSG00000146197 "Signal peptide, CUB domain and EGF like domain containing 3" Q8IX30 6 35213956-35253079 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "thyroid gland: 29.2" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 10.8;Horizontal cells: 10.1;Rod photoreceptor cells: 7.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.0;ASC diff: 76.7;ASC TERT1: 102.2;HSkMC: 48.1;hTEC/SVTERT24-B: 30.1;U-138 MG: 29.1;WM-115: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040606 Uncertain Approved "Plasma membrane" "Secreted to blood" NA NA 1890000 490000 "Plasma membrane" "HPA040606: AB_10795383" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (2.22e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (2.00e-2)" "unprognostic (7.41e-2)" "unprognostic (1.57e-1)" "unprognostic (2.64e-2)" "unprognostic (4.83e-8)" "unprognostic (1.54e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.06e-3)" 1.1 2.4 0.9 0.9 1.0 0.1 0.4 1.8 0.9 0.5 2.8 3.0 0.1 0.6 0.9 0.7 0.8 0.5 2.0 0.6 0.5 2.8 0.1 0.7 0.1 0.8 0.7 0.4 0.5 0.1 0.1 1.7 0.7 0.8 2.2 0.9 1.4 0.2 4.6 0.3 0.6 0.8 0.9 0.2 0.2 1.4 1.1 0.7 0.1 29.2 0.0 0.2 5.1 0.9 0.9 0.0 0.1 26.0 0.2 76.7 102.2 0.3 6.7 3.3 0.1 0.1 0.5 0.1 0.0 0.9 15.5 0.0 0.0 5.3 0.0 0.4 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 48.1 0.0 30.1 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 1.2 0.0 0.4 0.1 0.0 0.0 0.1 2.9 0.5 0.0 0.1 0.7 1.9 10.2 0.7 0.1 1.5 29.1 1.3 0.0 0.2 0.1 0.0 0.0 4.6 0.0 25.2 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.9 1.0 1.8 0.9 0.6 0.5 0.8 0.7 0.4 0.8 0.2 0.7 0.9 0.2 0.0 0.6 0.7 0.5 0.0 0.2 0.4 0.0 2.6 0.3 0.0 3.5 0.0 2.0 1.8 2.1 1.2 0.5 0.0 0.0 0.0 2.1 1.2 0.4 0.6 10.8 0.0 2.2 0.0 2.1 1.3 0.0 0.4 1.3 0.5 0.0 0.1 0.3 10.1 3.2 0.1 0.0 0.6 0.4 3.3 0.9 0.2 1.8 0.0 0.1 3.0 0.0 4.0 3.5 0.1 0.0 3.8 0.4 0.1 0.0 0.1 0.9 7.1 0.0 0.6 3.2 0.5 2.1 0.0 0.0 0.7 0.2 0.1 0.0 0.2 ANO7 "IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G" ENSG00000146205 "Anoctamin 7" Q6IWH7 2 241188509-241225377 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 14.8;prostate: 70.2;stomach 1: 28.3" "Group enriched" "Detected in many" 5 "Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 53.4" "Cancer enriched" "Detected in many" 19 "prostate cancer: 32.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.2;Hep G2: 2.3;OE19: 2.5" "Low region specificity" "Detected in many" HPA078464 Enhanced NA NA "HPA078464: " "unprognostic (1.93e-2)" "unprognostic (3.45e-3)" "unprognostic (1.09e-3)" "unprognostic (5.13e-2)" "unprognostic (1.35e-2)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (8.45e-2)" "unprognostic (2.90e-2)" "unprognostic (4.94e-2)" "unprognostic (4.82e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (2.14e-1)" "unprognostic (2.53e-2)" 0.3 0.3 0.2 1.0 0.6 3.6 0.2 0.3 1.0 0.3 0.0 10.4 10.8 0.5 0.0 0.2 0.3 0.0 0.2 0.1 0.4 0.2 0.1 0.1 0.0 1.2 0.2 0.2 0.5 0.4 0.0 0.2 0.1 0.6 70.2 10.2 0.0 4.9 0.2 0.0 0.2 14.8 0.1 0.2 0.3 28.3 0.2 0.5 0.0 0.2 0.0 0.0 0.2 0.2 1.6 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 2.5 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.6 0.3 1.0 0.1 0.4 1.2 0.2 0.2 0.6 0.2 0.5 1.6 1.2 0.0 0.0 1.6 0.7 0.3 0.8 0.8 1.2 0.2 1.9 2.7 1.6 0.0 0.2 0.0 0.0 0.6 0.1 2.6 0.0 2.7 0.1 0.8 0.7 2.1 3.0 0.0 4.8 4.2 5.6 2.0 80.0 1.9 0.0 12.4 2.9 3.9 1.5 0.0 2.7 53.4 0.0 1.3 0.0 0.0 3.4 0.7 1.8 7.5 0.0 1.4 0.0 1.0 6.9 6.4 1.9 2.2 0.5 11.9 3.6 2.8 0.0 0.6 0.0 0.8 1.0 0.1 1.7 0.1 0.0 0.7 0.3 2.6 2.4 0.8 CRIP3 "bA480N24.2, TLP, TLP-A" ENSG00000146215 "Cysteine rich protein 3" Q6Q6R5 6 43299710-43308826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.6;testis: 25.9" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6" "Cancer enhanced" "Detected in some" "liver cancer: 3.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 16 "myeloid DC: 44.6" "Lineage enriched" "Detected in many" 16 "dendritic cells: 44.6" "Cell line enhanced" "Detected in some" "HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036198 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036198: AB_10670791" "unprognostic (8.35e-3)" "unprognostic (4.14e-3)" "unprognostic (6.37e-2)" "unprognostic (5.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (2.30e-2)" "unprognostic (4.34e-2)" "unprognostic (1.46e-2)" "unprognostic (8.49e-4)" "unprognostic (1.86e-2)" "unprognostic (7.30e-3)" "unprognostic (5.02e-2)" "unprognostic (4.89e-2)" "unprognostic (4.46e-2)" "unprognostic (2.80e-4)" 0.8 0.6 11.5 1.7 11.6 2.6 0.9 12.7 14.6 2.3 9.6 1.0 2.0 1.3 1.6 0.7 2.0 0.6 24.6 11.5 11.3 5.3 10.5 0.6 5.5 10.8 10.8 11.6 2.1 1.7 2.1 2.4 0.2 11.2 5.8 0.4 2.5 0.8 8.1 0.4 1.8 3.5 0.6 10.5 8.0 0.8 25.9 11.1 1.6 2.1 0.0 5.9 1.1 1.4 11.9 0.0 0.8 0.2 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.1 0.6 2.8 0.1 0.0 0.0 3.3 0.0 3.5 6.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.6 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 2.7 0.9 0.0 1.7 0.0 2.3 0.0 0.0 44.6 2.6 0.0 0.0 0.8 0.3 2.3 0.4 0.0 1.8 11.5 11.6 12.7 14.6 11.5 11.3 10.8 10.8 11.6 11.2 10.5 11.1 11.9 0.2 0.0 0.0 9.4 2.8 0.6 0.3 0.0 0.0 0.9 0.1 0.8 3.2 5.7 0.1 0.0 0.0 0.0 0.1 0.3 9.8 1.1 3.9 1.1 0.2 0.2 0.0 0.8 4.7 0.2 0.0 0.2 0.0 0.1 0.0 12.5 0.0 2.9 0.2 0.0 3.5 0.1 0.0 0.9 3.4 7.9 1.2 0.7 0.0 1.0 1.4 0.5 1.0 6.6 3.4 0.3 0.1 0.0 0.1 0.1 0.7 4.5 0.3 0.8 0.0 0.3 0.4 5.3 1.6 0.0 0.0 0.0 0.3 1.0 0.4 0.1 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243481-43288258 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 20.6;pituitary gland: 9.3" "Cell type enhanced" "Detected in some" "Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4" "Group enriched" "Detected in some" 4 "glioma: 3.0;liver cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 20.3;SH-SY5Y: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031735: AB_2674019, HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 0.0 1.3 11.7 0.2 10.0 0.0 0.0 2.9 20.6 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.2 0.1 12.1 2.5 0.4 1.9 0.0 0.1 5.5 2.5 11.6 0.0 0.2 0.3 9.3 0.0 7.6 0.1 0.1 3.0 0.0 0.1 0.0 0.0 2.8 0.0 0.4 0.1 0.1 0.9 6.3 0.0 0.0 0.0 0.2 0.0 0.0 11.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 20.3 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.0 2.9 20.6 12.1 2.5 5.5 2.5 11.6 7.6 0.4 6.3 11.0 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 12.1 0.2 0.0 0.1 0.0 0.0 0.0 2.2 0.4 2.5 0.1 5.0 13.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 2.8 0.0 1.4 0.0 12.1 12.4 0.0 1.1 0.0 0.0 0.0 3.8 3.5 0.0 0.5 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278734-44297698 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 14.6;testis: 30.2" "Group enriched" "Detected in some" 10 "Early spermatids: 161.8;Late spermatids: 359.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;U-266/84: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031739 Uncertain Vesicles NA NA Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 3.1 0.0 1.4 0.9 0.2 6.4 1.5 0.6 1.0 0.2 0.0 0.4 0.2 0.1 14.6 0.1 0.0 1.4 1.0 0.1 0.1 1.4 0.0 2.6 2.4 0.9 0.5 0.1 0.0 0.5 1.9 2.8 0.2 0.1 1.0 0.2 0.1 0.1 0.5 0.2 0.1 3.3 0.2 0.1 30.2 1.4 0.1 0.1 0.2 0.0 0.1 0.2 1.2 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.7 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.4 6.4 1.5 1.4 1.0 2.6 2.4 0.9 2.8 3.3 1.4 1.2 0.1 0.0 0.0 1.0 0.0 0.1 0.1 0.7 0.0 1.1 0.1 0.1 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 161.8 7.3 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 359.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 16.0 0.2 0.0 0.4 0.3 23.9 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879616-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: AB_2681138" "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 37.5 39.9 26.3 32.0 29.2 22.8 40.6 28.5 33.7 28.4 22.4 30.7 25.6 30.2 34.3 35.7 34.5 21.6 31.1 28.9 27.5 38.1 48.8 25.4 34.6 25.1 25.8 29.0 33.9 32.5 45.8 29.3 31.9 26.2 34.0 34.4 20.2 28.2 28.0 45.9 34.2 23.6 33.6 24.9 27.3 28.9 16.3 27.3 37.5 36.2 44.8 43.2 35.9 27.2 28.3 155.6 48.4 84.2 135.5 77.5 99.5 57.1 121.3 87.8 115.0 94.6 120.4 57.6 231.4 107.0 102.6 93.4 72.5 193.4 147.6 189.4 121.9 144.6 123.7 64.5 109.9 85.2 192.5 91.6 102.5 110.6 151.0 144.7 77.5 114.7 100.2 243.1 77.6 106.2 113.3 110.5 124.2 85.1 472.2 70.3 124.9 94.3 147.1 89.7 96.6 160.1 97.8 103.7 78.2 131.3 66.1 105.0 183.1 110.1 110.5 91.9 88.4 211.3 96.7 163.8 343.2 61.7 178.7 117.7 7.3 13.1 12.4 16.0 15.8 20.3 14.9 15.7 17.0 12.5 17.4 16.5 16.0 2.8 19.7 14.9 14.5 14.3 13.6 26.3 29.2 28.5 33.7 28.9 27.5 25.1 25.8 29.0 26.2 24.9 27.3 28.3 56.2 76.9 103.0 12.7 69.3 57.1 89.3 70.6 67.7 62.6 49.2 61.8 42.2 61.5 71.2 42.3 33.3 88.2 77.7 23.9 86.1 92.2 12.6 68.4 96.6 71.6 94.4 73.0 25.9 66.9 84.1 67.5 42.8 44.9 51.2 120.6 51.8 65.0 53.0 72.3 23.3 44.4 54.9 45.0 34.4 12.5 79.2 44.5 30.2 8.4 75.8 78.6 64.9 12.5 15.6 81.3 30.8 71.5 56.1 83.8 25.1 79.8 71.3 69.7 52.6 89.9 64.0 54.9 75.6 65.8 60.2 80.0 65.6 117.8 52.5 58.9 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.3" "Cell type enhanced" "Detected in many" "Langerhans cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favorable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favorable (8.07e-4)" 5.8 5.9 10.8 19.3 10.7 31.8 5.9 12.4 17.8 3.9 11.1 7.3 7.5 3.8 4.8 6.0 3.3 8.4 5.3 11.8 11.8 14.5 10.6 13.7 20.1 11.4 11.3 10.3 2.7 8.4 5.4 4.5 5.6 10.9 8.4 5.9 3.7 7.4 3.3 3.6 9.5 12.2 3.6 12.3 35.3 7.1 10.8 11.5 10.0 5.3 4.0 25.3 16.5 5.0 11.9 28.4 7.9 9.5 15.1 3.7 2.8 5.3 4.9 23.8 14.9 15.4 15.0 12.9 15.7 17.0 5.1 39.7 6.2 10.3 15.4 16.6 26.1 6.0 7.9 3.0 17.0 11.4 26.1 23.0 7.1 6.7 13.8 8.8 12.5 10.7 7.2 7.7 39.2 3.9 14.4 5.2 52.7 5.0 44.1 4.0 9.9 8.5 14.0 34.7 30.3 6.1 7.8 3.4 12.5 20.9 8.0 8.6 29.9 18.1 8.4 9.8 5.3 15.4 25.0 11.4 28.7 7.4 28.4 16.1 8.8 7.5 4.0 1.6 9.4 3.2 8.6 2.2 1.5 6.6 6.5 1.0 1.6 3.0 0.8 11.1 8.1 3.1 1.7 10.8 10.7 12.4 17.8 11.8 11.8 11.4 11.3 10.3 10.9 12.3 11.5 11.9 7.5 0.0 9.7 1.0 26.0 38.2 28.7 11.6 14.8 3.4 15.3 9.9 5.4 22.8 9.2 3.7 2.1 5.2 12.5 12.2 17.6 49.5 17.3 10.0 6.2 15.9 14.9 1.7 1.1 21.0 8.0 17.3 10.7 12.8 32.5 2.5 6.1 2.0 57.2 3.3 2.0 11.9 6.1 22.6 151.2 34.1 1.8 48.6 48.0 3.7 55.2 3.3 1.0 0.5 0.9 58.9 33.3 2.6 18.7 32.6 14.3 14.4 6.1 4.1 6.6 11.8 11.0 25.9 12.3 11.6 39.2 5.3 13.8 7.0 8.5 34.7 CYP39A1 ENSG00000146233 "Cytochrome P450 family 39 subfamily A member 1" Q9NYL5 6 46549580-46652830 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 100.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 62.9;Late spermatids: 20.1" "Cancer enhanced" "Detected in many" "prostate cancer: 11.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 6.5;hTCEpi: 13.6;OE19: 6.1;SiHa: 8.4;U-698: 10.4" "Region enhanced" "Detected in all" "olfactory bulb: 22.9" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-1)" "unprognostic (1.62e-2)" "unprognostic (8.46e-3)" "unprognostic (5.89e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (4.99e-2)" "unprognostic (7.33e-2)" "unprognostic (6.11e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.54e-1)" "unprognostic (5.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" 1.9 2.5 2.3 1.0 2.5 0.0 5.5 3.6 2.4 3.7 4.6 2.7 0.8 3.6 21.2 3.3 4.2 6.3 4.0 2.4 4.1 5.8 100.1 3.3 0.5 2.3 2.4 1.6 11.6 5.7 15.5 3.0 0.4 2.4 14.9 3.6 4.2 23.7 2.6 0.6 16.0 1.7 2.4 2.7 0.7 2.9 4.2 2.5 0.4 6.2 1.2 1.4 2.7 3.0 2.9 0.2 0.4 0.3 1.8 0.3 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.5 6.5 4.4 0.0 0.9 1.7 0.8 1.4 0.0 0.0 2.8 0.0 1.7 1.8 4.0 0.0 0.0 0.5 13.6 0.0 1.6 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 1.5 0.5 1.1 0.1 2.9 4.0 0.7 0.0 8.4 0.0 0.2 0.4 1.5 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.0 10.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.5 3.6 2.4 2.4 4.1 2.3 2.4 1.6 2.4 2.7 2.5 2.9 3.3 16.0 1.5 3.9 0.2 4.0 8.8 2.7 2.8 1.4 4.6 6.5 5.8 10.0 4.3 3.7 2.1 0.0 0.0 1.1 5.9 2.9 12.7 4.4 1.0 3.5 0.0 5.3 3.2 0.4 0.9 4.5 1.5 3.1 0.0 2.7 1.1 62.9 0.2 0.0 2.0 4.0 10.2 2.5 0.9 20.1 6.2 0.3 3.6 8.4 0.0 8.6 0.0 1.0 7.2 0.5 2.7 9.4 0.0 7.9 0.3 5.3 7.2 1.5 0.0 1.9 2.3 0.7 0.8 2.6 15.3 0.0 0.2 6.3 2.5 8.1 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82367420 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm NA NA 310000 Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 15.6 2.5 2.6 3.4 17.3 0.5 17.4 1.9 5.8 21.8 1.6 7.3 3.6 15.9 2.6 26.5 15.0 7.0 7.8 0.7 4.4 9.7 1.5 7.6 1.9 8.0 10.0 0.7 6.0 8.4 4.3 14.3 6.3 10.7 15.4 3.1 0.2 20.3 7.1 3.0 15.9 8.0 6.7 3.8 10.0 9.1 3.6 5.0 4.3 15.8 1.9 3.1 35.4 20.4 8.8 17.1 27.6 8.7 21.2 35.2 40.4 17.6 84.9 94.6 16.7 22.0 3.9 26.9 0.0 9.6 39.5 51.9 37.3 10.3 44.6 13.9 0.0 14.5 11.9 13.1 0.8 29.1 0.9 9.2 25.8 115.2 98.5 34.1 12.9 4.5 0.7 2.3 0.2 3.9 37.8 0.0 0.0 12.5 8.8 22.3 0.0 19.4 0.2 24.4 25.8 4.4 16.9 20.9 28.3 0.0 16.2 49.4 3.5 10.8 15.1 15.8 33.5 19.2 0.1 0.0 0.0 71.3 1.3 17.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 17.3 1.9 5.8 0.7 4.4 8.0 10.0 0.7 10.7 3.8 5.0 8.8 16.4 12.8 6.5 2.3 0.2 67.9 78.2 120.3 68.3 1.1 44.6 24.0 2.1 21.5 62.4 55.2 0.0 42.7 0.4 9.0 0.0 35.8 8.6 29.2 38.7 25.4 1.2 0.0 21.3 45.4 82.5 48.0 14.8 68.0 0.0 3.8 11.0 0.2 3.6 1.7 0.9 20.2 75.3 0.6 11.5 6.5 12.8 2.3 17.8 7.5 0.1 2.1 0.0 2.0 3.2 38.2 17.8 6.0 0.0 51.9 1.9 0.7 29.9 0.3 32.9 55.6 47.0 13.7 11.8 25.2 31.3 65.9 3.5 9.7 10.8 78.8 IRAK1BP1 "AIP70, SIMPL" ENSG00000146243 "Interleukin 1 receptor associated kinase 1 binding protein 1" Q5VVH5 6 78867551-78946440 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 65.4;Excitatory neurons: 73.1;Inhibitory neurons: 57.2;Late spermatids: 52.0;Oligodendrocyte precursor cells: 56.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035742, HPA035743" Uncertain Approved Vesicles NA NA Vesicles "HPA035742: AB_10670119, HPA035743: AB_2674764" "unprognostic (2.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (5.82e-2)" "unprognostic (2.12e-1)" "unprognostic (2.38e-3)" "unprognostic (3.93e-2)" "unprognostic (6.55e-2)" "unprognostic (2.34e-2)" "unprognostic (1.32e-2)" "unprognostic (9.88e-2)" "unprognostic (2.81e-2)" "unprognostic (4.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.39e-2)" "unprognostic (2.58e-1)" 1.5 1.8 0.8 1.0 1.4 5.3 2.4 6.0 3.4 1.8 1.8 1.5 1.2 2.8 4.4 1.2 3.3 1.4 1.5 1.6 0.7 2.9 0.9 2.2 1.8 0.7 0.5 1.4 3.1 3.2 3.6 3.4 1.1 2.1 1.8 1.4 5.7 2.7 2.4 1.2 2.3 1.4 2.1 0.1 2.0 3.5 3.9 0.7 3.0 3.3 1.1 1.1 1.5 1.5 1.8 1.1 2.0 3.7 3.5 1.6 3.5 2.1 0.8 2.1 0.8 1.4 1.8 0.9 1.6 0.9 1.9 2.0 2.3 7.1 3.4 1.4 3.7 2.8 1.3 2.4 0.9 2.1 7.6 1.3 2.9 3.3 1.5 1.8 2.7 2.7 4.9 4.0 2.1 1.3 0.6 2.2 3.8 1.8 0.5 2.0 0.4 2.2 1.2 3.6 1.9 5.1 6.0 1.1 1.2 0.9 2.4 2.8 5.1 1.9 1.8 1.3 0.6 2.4 2.5 3.3 2.2 0.6 0.3 2.3 0.9 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.1 0.2 0.4 0.4 0.4 0.2 0.1 0.4 0.4 0.1 0.8 1.4 6.0 3.4 1.6 0.7 0.7 0.5 1.4 2.1 0.1 0.7 1.8 6.1 19.2 7.8 39.2 3.3 2.5 5.3 3.9 10.8 10.3 5.2 8.5 13.6 8.6 9.3 3.7 33.3 3.6 3.5 1.0 9.8 5.5 65.4 20.5 11.5 5.5 6.6 7.8 73.1 6.0 0.8 5.8 5.1 3.6 0.0 11.6 5.0 2.4 1.6 5.0 57.2 2.7 0.0 1.3 0.9 52.0 10.5 1.6 0.0 22.5 0.8 12.9 2.1 56.3 33.6 3.3 1.0 8.2 3.1 1.2 0.6 11.8 21.5 17.9 13.1 8.2 8.1 42.3 15.2 6.3 2.6 0.8 2.5 11.1 3.2 2.8 PHIP "BRWD2, DCAF14, FLJ20705, ndrp, WDR11" ENSG00000146247 "Pleckstrin homology domain interacting protein" Q8WWQ0 6 78934419-79078254 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019140, HPA019838" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA019140: AB_2670073, HPA019838: AB_2670287" "unprognostic (1.58e-1)" "unprognostic (1.60e-1)" "unprognostic (9.43e-2)" "unprognostic (8.47e-3)" "unprognostic (1.05e-1)" "unprognostic (2.01e-3)" "unprognostic (3.50e-3)" "unprognostic (5.03e-2)" "unprognostic (4.03e-2)" "unprognostic (6.40e-3)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.55e-2)" 8.0 5.8 8.1 8.5 10.4 29.7 12.1 19.4 9.2 10.7 7.2 7.7 5.9 11.2 8.5 6.3 9.9 6.4 6.3 7.3 9.3 6.1 4.8 8.9 11.1 9.4 9.9 7.0 11.8 8.5 8.5 9.5 8.0 11.1 8.7 7.7 20.7 8.6 7.1 9.8 9.0 8.0 7.2 8.6 9.9 8.1 6.4 9.2 13.2 7.8 8.5 9.2 8.5 9.3 14.8 13.6 10.8 25.2 24.6 9.6 13.7 14.6 14.3 11.3 12.0 15.1 13.4 8.2 22.3 11.1 9.0 10.1 12.2 19.1 9.1 20.1 32.2 13.9 25.0 20.7 10.0 4.4 28.2 15.4 8.4 7.9 14.4 14.3 10.1 12.9 14.0 25.5 20.8 11.7 9.1 11.0 21.0 15.9 7.0 11.8 18.9 32.3 9.7 12.9 18.0 24.7 15.8 19.0 14.4 9.2 16.0 11.2 37.6 15.2 13.9 9.8 6.8 23.8 14.2 14.9 12.3 5.9 17.9 21.2 10.0 4.2 7.7 4.4 3.0 4.7 6.1 5.3 5.0 2.9 6.6 5.8 4.6 14.4 4.6 5.7 5.3 4.8 2.1 8.1 10.4 19.4 9.2 7.3 9.3 9.4 9.9 7.0 11.1 8.6 9.2 14.8 64.4 70.5 109.9 181.8 92.5 63.2 88.9 56.7 48.9 183.4 53.7 52.2 58.6 54.3 95.9 55.2 152.2 85.4 95.3 52.1 1.9 71.6 33.8 94.6 75.1 74.5 72.7 80.4 168.9 47.2 91.0 77.3 59.7 58.4 115.2 76.6 71.0 21.3 51.0 181.7 196.4 58.2 71.2 83.8 75.6 17.2 101.2 83.3 49.8 154.6 134.7 84.4 83.4 154.3 346.1 58.1 49.1 87.6 124.8 81.5 46.7 19.0 148.4 174.1 52.6 97.9 87.4 127.3 53.6 50.1 56.4 102.1 92.9 50.5 62.1 104.5 PRSS35 "C6orf158, dJ223E3.1, MGC46520" ENSG00000146250 "Serine protease 35" Q8N3Z0 6 83512534-83525704 "Enzymes, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 50.9" "Cell type enriched" "Detected in some" 36 "Muller glia cells: 410.9" "Group enriched" "Detected in some" 4 "glioma: 2.8;testis cancer: 4.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in single" 195 "T-cells: 19.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7" "HPA038787, HPA038788" Uncertain "Secreted in female reproductive system" NA NA "HPA038787: AB_10675951, HPA038788: AB_2676208" "unprognostic (6.17e-2)" "unprognostic (8.75e-2)" "unprognostic (1.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.70e-4)" "unprognostic (6.08e-2)" "unprognostic (1.18e-3)" "unprognostic (2.33e-2)" "unprognostic (7.01e-2)" "unprognostic (9.07e-2)" "unprognostic (3.88e-6)" "unprognostic (7.15e-3)" "unprognostic (5.81e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-4)" 1.3 2.4 3.0 0.1 3.8 0.0 0.3 1.7 6.8 2.9 1.7 0.1 0.3 1.4 1.1 0.3 1.4 4.2 2.7 3.3 2.6 3.2 0.4 1.3 0.7 2.2 2.0 3.6 10.3 0.3 0.3 1.1 3.7 2.8 1.2 0.3 50.9 0.3 0.4 0.1 0.2 0.1 1.5 1.8 0.7 0.3 3.1 2.0 0.1 0.4 0.1 0.1 1.3 0.5 2.9 0.0 0.5 1.9 0.0 0.1 0.0 0.0 0.3 10.4 1.0 2.0 86.3 0.0 0.0 0.1 0.4 0.0 0.0 12.8 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.6 0.4 8.2 0.0 0.0 0.0 24.6 0.0 0.0 1.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 19.5 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 3.8 1.7 6.8 3.3 2.6 2.2 2.0 3.6 2.8 1.8 2.0 2.9 0.3 3.2 0.5 8.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 1.5 0.0 0.0 1.8 0.0 0.3 0.0 0.1 9.8 0.1 0.1 0.0 0.3 0.8 1.8 0.0 0.2 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.3 0.4 6.7 0.2 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 1.0 0.0 410.9 0.0 1.0 0.1 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 11.4 6.6 0.1 3.7 0.1 0.5 0.0 0.0 0.1 0.7 5.1 0.0 0.0 MMS22L "C6orf167, dJ39B17.2" ENSG00000146263 "MMS22 like, DNA repair protein" Q6ZRQ5 6 97142161-97283217 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA067042 Supported Nucleoplasm NA Yes Nucleoplasm "HPA067042: AB_2685768" "unprognostic (3.61e-2)" "unprognostic (2.80e-1)" "unprognostic (2.26e-2)" "unprognostic (1.97e-3)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.00e-5)" "unprognostic (9.63e-2)" "unprognostic (5.81e-3)" "unprognostic (8.21e-3)" "unprognostic (9.39e-2)" "unprognostic (6.58e-2)" "unprognostic (1.34e-6)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" 1.1 1.1 0.7 2.0 1.7 7.1 2.3 1.3 1.3 1.6 0.8 1.6 1.3 1.5 0.5 1.7 1.4 1.0 0.7 0.6 1.0 0.8 0.9 1.1 3.5 2.2 1.4 0.5 1.4 1.3 1.4 0.5 2.0 1.8 1.3 2.3 2.4 1.0 0.8 0.6 2.9 1.6 1.5 1.4 1.4 1.1 6.9 1.4 5.3 1.1 0.5 3.4 1.3 1.2 2.4 7.5 8.2 13.5 14.8 2.2 4.0 10.6 15.0 6.9 13.8 20.1 11.4 8.6 16.4 9.0 5.7 16.0 13.4 17.1 8.3 27.4 14.1 12.7 16.7 11.3 7.2 1.3 25.8 11.3 2.2 4.3 19.5 9.0 2.8 6.0 15.2 23.1 25.6 13.1 8.9 9.5 10.4 5.2 12.1 6.1 15.8 12.8 5.8 5.9 9.7 7.7 6.6 9.8 4.9 4.0 7.6 7.6 15.7 4.5 14.0 13.3 11.8 20.8 3.2 10.3 18.3 8.0 16.0 15.7 0.5 0.4 0.9 0.6 0.7 1.0 0.5 0.9 1.0 1.1 0.7 0.8 1.1 0.4 0.6 1.6 1.2 0.9 0.4 0.7 1.7 1.3 1.3 0.6 1.0 2.2 1.4 0.5 1.8 1.4 1.4 2.4 5.9 3.2 8.6 16.6 9.7 9.2 5.8 4.0 4.0 11.6 6.1 6.2 4.2 5.7 6.9 3.7 41.7 12.5 14.6 3.3 1.9 2.9 67.8 4.4 6.1 6.5 1.2 26.3 11.3 4.1 11.2 6.1 7.7 2.8 7.6 24.0 10.8 3.1 6.4 3.3 7.7 8.4 8.2 7.5 6.0 17.2 9.9 6.8 7.2 36.5 6.4 6.1 6.2 22.6 52.3 3.0 2.0 5.7 13.1 2.9 5.4 0.8 6.1 31.9 6.6 7.9 5.1 56.9 45.8 7.1 8.2 3.6 9.6 5.2 10.3 3.0 FAXC "C6orf168, dJ273F20, MGC2817" ENSG00000146267 "Failed axon connections homolog, metaxin like GST domain containing" Q5TGI0 6 99271168-99350062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Excitatory neurons: 57.1;Inhibitory neurons: 60.1;Oligodendrocyte precursor cells: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 26.0;HAP1: 23.8;SCLC-21H: 34.2;SH-SY5Y: 23.7;SK-MEL-30: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039106 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA039106: AB_10697546" "unprognostic (8.03e-2)" "unprognostic (4.91e-2)" "unprognostic (5.04e-3)" "unprognostic (6.44e-2)" "unprognostic (3.80e-1)" "unprognostic (5.00e-3)" "unprognostic (7.56e-2)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (2.47e-3)" "unprognostic (6.70e-4)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.86e-2)" "unprognostic (3.49e-3)" 0.5 2.2 8.0 1.5 12.9 0.1 3.3 9.9 19.0 2.4 1.9 15.9 1.6 6.5 11.0 6.2 3.7 2.5 0.8 12.8 11.0 1.6 0.0 1.7 0.1 7.2 7.0 10.5 2.2 2.5 6.6 16.0 0.8 8.6 8.3 2.9 10.5 7.5 10.7 0.5 0.9 3.4 7.9 3.5 0.4 7.1 2.1 9.9 2.3 1.7 0.6 0.1 14.4 2.9 12.8 4.0 3.2 10.3 14.3 0.0 0.0 3.8 5.0 3.2 8.1 7.0 1.9 1.3 0.0 0.6 1.0 26.0 0.1 23.8 4.7 7.0 0.0 11.8 0.1 1.9 0.7 0.6 0.0 0.0 0.5 7.5 0.2 3.8 5.9 0.0 2.0 0.5 0.0 2.7 7.0 0.0 0.0 12.2 0.0 4.8 0.0 1.0 0.0 4.3 0.3 34.2 23.7 4.5 3.2 22.6 4.2 10.0 0.0 1.0 2.5 4.7 0.0 15.5 0.0 0.0 0.0 0.1 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 12.9 9.9 19.0 12.8 11.0 7.2 7.0 10.5 8.6 3.5 9.9 12.8 0.2 25.6 15.2 5.5 0.5 0.4 4.2 4.2 5.7 14.4 5.3 9.0 1.1 0.0 8.1 1.8 10.4 1.2 0.4 0.2 9.8 2.3 2.6 0.6 1.0 1.7 0.0 0.0 57.1 0.7 0.2 1.4 0.0 0.4 3.8 0.4 1.4 0.1 0.2 3.3 60.1 0.2 4.1 0.6 1.1 5.0 0.0 1.2 1.8 2.8 0.1 3.6 2.1 43.7 4.4 1.0 0.1 1.9 0.1 4.8 0.0 1.0 2.1 13.6 0.0 0.2 1.3 1.3 8.9 1.2 0.3 0.3 1.2 0.2 0.4 1.2 GABRR1 ENSG00000146276 "Gamma-aminobutyric acid type A receptor subunit rho1" P24046 6 89177504-89231278 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 25 "retina: 24.8" "Cell type enriched" "Detected in some" 12 "Bipolar cells: 63.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 1.2;OE19: 2.6;SuSa: 1.6" "Region enhanced" "Detected in single" "midbrain: 1.3" NA NA "unprognostic (5.75e-2)" "unprognostic (3.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.90e-2)" "unprognostic (5.78e-2)" "unprognostic (4.90e-2)" "unprognostic (8.32e-3)" "unprognostic (2.52e-3)" "unprognostic (1.74e-1)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (1.62e-5)" "unprognostic (1.18e-1)" "unprognostic (9.90e-2)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 24.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 63.1 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 4.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 1.9 0.0 0.6 0.0 3.5 3.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.2 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 1848.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 212.8;hTCEpi: 234.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: AB_2685684" "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavorable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 192.8 173.3 64.6 147.2 69.5 371.5 136.6 86.9 68.0 94.6 63.0 128.3 70.8 101.5 81.1 92.2 206.2 140.5 127.8 62.7 104.3 101.2 320.8 161.0 135.2 90.0 67.5 58.4 224.4 90.0 87.5 79.1 123.6 83.6 95.8 78.2 130.9 92.6 85.1 464.4 145.0 95.1 131.5 82.1 140.8 105.5 50.5 65.8 167.4 106.5 164.8 112.1 142.8 99.3 82.9 12.1 12.0 25.3 42.4 96.7 166.6 16.9 16.0 110.6 29.5 69.0 10.2 34.5 25.9 71.2 19.4 116.3 40.5 13.3 23.9 45.6 31.8 36.3 4.7 69.8 31.9 212.8 25.0 57.9 117.6 234.4 19.6 90.1 107.9 49.4 30.3 4.1 81.0 33.3 11.5 6.8 124.7 7.0 13.9 23.1 29.1 30.0 21.5 70.2 21.1 15.7 42.2 40.3 56.3 44.0 73.6 27.9 119.4 44.8 23.1 13.2 16.2 5.9 118.3 64.0 9.0 46.3 20.6 14.9 32.8 17.3 103.8 18.3 19.0 19.0 20.7 22.1 19.7 11.3 23.0 24.9 25.9 100.9 19.2 17.9 18.7 19.0 10.5 64.6 69.5 86.9 68.0 62.7 104.3 90.0 67.5 58.4 83.6 82.1 65.8 82.9 405.7 141.1 149.8 36.2 747.6 968.9 776.8 98.9 1286.2 130.6 412.5 381.5 188.6 230.2 65.2 90.1 50.1 235.8 662.8 158.1 234.8 203.5 103.4 528.4 655.3 356.1 248.0 284.1 10.0 238.2 78.6 720.1 225.8 955.1 164.6 153.2 238.5 207.6 229.4 72.3 15.5 200.7 34.6 452.6 1848.0 41.5 481.9 898.3 439.4 39.4 763.5 403.3 440.8 20.1 41.5 143.0 184.6 377.3 530.6 738.5 211.1 319.2 61.5 134.8 420.7 731.3 725.6 51.9 64.6 840.2 1250.8 274.5 735.8 214.3 136.9 472.8 PM20D2 "ACY1L2, bA63L7.3" ENSG00000146281 "Peptidase M20 domain containing 2" Q8IYS1 6 89146055-89165565 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 88.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030325, HPA030326, HPA030327" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129" "unprognostic (3.60e-2)" "unprognostic (1.40e-1)" "unprognostic (6.36e-2)" "unprognostic (3.18e-3)" "unprognostic (3.22e-2)" "unprognostic (2.73e-1)" "unprognostic (1.13e-3)" "unprognostic (8.60e-2)" "unprognostic (1.04e-1)" "unprognostic (5.86e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (9.99e-2)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" 5.3 6.1 5.2 8.7 4.9 9.3 9.4 7.8 5.2 9.1 9.4 11.7 8.9 11.9 8.3 9.0 13.0 6.6 7.9 4.9 5.9 9.3 4.8 5.0 11.3 4.8 4.8 4.6 22.5 10.8 9.3 8.3 4.9 5.9 25.6 10.2 14.2 7.9 8.6 29.4 12.8 9.0 10.5 3.8 6.2 8.6 3.0 5.4 13.8 12.6 16.4 10.9 11.0 8.1 4.6 30.7 13.4 11.8 18.3 3.8 2.3 0.8 15.1 15.0 22.1 28.2 15.7 14.6 88.3 18.0 3.3 18.8 11.5 24.3 12.1 49.9 27.8 30.8 18.0 8.0 14.9 4.2 52.4 13.9 3.8 8.8 8.4 17.7 18.0 5.4 26.2 7.0 46.3 6.9 4.7 33.3 41.3 4.8 26.4 13.2 54.5 58.5 65.1 24.8 5.7 33.1 23.0 9.1 14.5 15.1 15.3 0.1 45.5 8.8 0.4 13.3 4.6 32.0 24.5 38.3 19.0 6.1 44.3 2.1 0.8 0.3 1.2 0.7 0.2 1.2 1.5 0.9 1.3 0.6 1.0 1.4 1.2 1.0 1.9 0.2 0.9 0.1 0.6 5.2 4.9 7.8 5.2 4.9 5.9 4.8 4.8 4.6 5.9 3.8 5.4 4.6 7.3 9.6 10.3 21.5 14.3 30.2 23.8 7.4 17.1 28.5 21.6 16.5 23.4 27.1 11.5 16.5 31.3 2.8 7.1 6.8 5.9 11.9 5.5 15.1 13.6 8.8 10.8 18.3 29.5 10.4 2.4 12.0 15.3 20.6 6.3 17.3 8.9 9.2 3.4 8.4 38.9 21.4 6.1 6.7 17.9 9.0 24.5 6.8 17.8 26.2 14.6 11.1 4.1 32.2 27.3 18.1 7.9 19.2 15.5 44.4 5.2 15.6 12.2 24.3 6.6 26.9 20.3 5.3 6.6 24.4 31.7 1.2 10.5 5.3 28.4 17.4 RARS2 "DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL" ENSG00000146282 "Arginyl-tRNA synthetase 2, mitochondrial" Q5T160 6 87513938-87589987 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039987, HPA042645" Uncertain Approved Mitochondria NA NA Mitochondria "HPA039987: AB_2676786, HPA042645: AB_2678097" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (6.98e-2)" "unprognostic (9.27e-2)" "unprognostic (5.41e-2)" "unprognostic (6.61e-2)" "unprognostic (4.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.08e-3)" "unprognostic (8.28e-2)" "unprognostic (2.20e-1)" "unprognostic (7.56e-3)" "unprognostic (1.62e-1)" "unprognostic (1.89e-2)" "unprognostic (5.73e-2)" "unprognostic (7.16e-3)" 23.0 39.9 11.0 15.9 12.2 19.5 21.5 15.2 11.7 21.3 18.6 21.0 18.0 22.0 18.7 17.9 19.8 19.2 22.9 11.0 12.6 19.1 28.2 18.5 16.9 11.8 11.9 10.8 18.7 24.2 21.6 17.7 22.4 12.4 19.0 22.9 26.2 20.9 13.7 22.7 18.7 22.7 21.7 11.2 18.7 19.4 25.6 12.4 18.6 20.7 19.5 19.1 20.8 18.3 16.1 19.8 19.1 45.1 49.8 44.6 47.5 31.9 46.6 54.2 30.8 38.6 36.6 21.6 25.0 26.9 47.4 32.0 26.7 37.9 25.8 43.2 18.0 36.0 25.7 24.4 58.7 56.1 30.7 21.3 48.9 24.6 26.4 33.1 44.5 41.0 25.7 59.6 24.4 46.8 35.2 10.0 32.8 29.2 42.3 20.0 19.9 45.9 22.2 38.5 40.1 40.8 54.7 24.8 12.1 33.1 38.2 22.5 45.8 28.1 21.2 16.8 22.8 38.4 25.6 45.1 21.1 32.2 31.8 36.6 18.8 17.8 22.7 16.1 18.6 19.0 15.1 20.4 15.1 15.6 16.2 19.9 16.9 11.9 18.6 20.7 17.9 27.9 15.4 11.0 12.2 15.2 11.7 11.0 12.6 11.8 11.9 10.8 12.4 11.2 12.4 16.1 34.4 19.2 15.6 30.0 21.2 17.3 35.4 51.3 12.5 13.9 17.3 16.8 19.9 10.0 37.8 11.0 20.9 31.0 18.1 14.6 45.0 32.9 95.3 23.5 29.3 22.8 9.0 7.4 46.8 46.9 45.5 28.3 12.8 20.3 18.3 27.9 23.6 15.5 20.5 6.7 59.0 23.5 44.7 13.5 14.1 50.6 25.4 15.0 19.6 38.4 22.6 13.6 19.6 56.3 63.9 37.6 21.2 24.0 20.7 30.8 57.2 32.9 24.2 20.3 26.3 18.9 30.0 61.8 33.7 14.1 18.0 39.5 20.6 51.4 27.0 33.9 SCML4 dJ47M23.1 ENSG00000146285 "Scm polycomb group protein like 4" Q8N228 6 107702154-107824317 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 10.2;lymphoid tissue: 12.2" "Cell type enhanced" "Detected in many" "dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2" "Group enriched" "Detected in many" 6 "NK-cells: 53.2;T-cells: 74.8" "Cell line enriched" "Detected in some" 5 "HDLM-2: 65.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA063326, HPA065958" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA063326: AB_2684986, HPA065958: AB_2685587" "unprognostic (4.00e-5)" "unprognostic (2.10e-3)" "unprognostic (4.71e-2)" "unprognostic (4.24e-3)" "unprognostic (1.38e-3)" "unprognostic (4.75e-4)" "unprognostic (3.84e-3)" "unprognostic (6.65e-3)" "unprognostic (4.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.13e-4)" "unprognostic (3.68e-1)" "unprognostic (3.77e-4)" "unprognostic (8.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.52e-3)" "unprognostic (5.09e-3)" 0.4 0.8 0.9 7.2 0.7 3.3 1.0 1.3 0.9 0.5 0.3 2.3 10.2 0.5 4.7 0.9 0.7 1.4 0.6 0.8 0.6 0.6 1.7 1.7 12.2 0.8 0.6 0.5 0.6 0.7 0.2 1.9 0.3 0.7 0.6 2.0 0.9 1.0 0.5 0.4 0.9 8.3 0.5 0.2 7.5 2.9 2.2 1.0 9.4 0.8 0.2 9.9 1.1 0.7 0.8 0.1 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.0 0.0 0.0 1.4 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.1 65.1 0.0 0.1 0.4 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.7 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.1 0.3 0.1 0.1 13.8 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.3 0.2 0.7 0.1 0.1 0.1 4.2 0.3 3.5 48.2 0.1 47.7 10.1 74.8 65.7 0.2 5.8 69.1 59.5 6.6 53.2 0.4 1.2 5.8 26.6 0.9 0.7 1.3 0.9 0.8 0.6 0.8 0.6 0.5 0.7 0.2 1.0 0.8 0.5 0.0 0.0 0.7 18.0 1.5 0.0 0.0 0.6 0.6 0.4 0.4 1.1 0.0 0.0 0.0 0.0 1.3 31.7 0.4 0.0 1.2 72.1 0.0 0.1 0.7 0.0 1.3 2.7 0.0 0.2 1.0 4.6 0.1 1.3 0.0 1.1 1.8 0.2 1.7 2.5 1.4 0.0 0.8 1.4 168.4 0.9 1.2 3.6 1.9 2.0 0.0 35.0 0.5 0.1 0.1 2.6 0.7 11.6 0.0 5.5 0.4 0.7 0.0 0.0 0.3 0.6 1.1 0.5 0.3 0.1 0.1 73.3 0.0 4.7 0.1 TBC1D32 "bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235" ENSG00000146350 "TBC1 domain family member 32" Q96NH3 6 121079494-121334745 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 7.5" "Cell type enhanced" "Detected in many" "Astrocytes: 68.2;Excitatory neurons: 124.1;Inhibitory neurons: 87.4;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 102.6;Rod photoreceptor cells: 110.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013413 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013413: AB_10602702" "unprognostic (3.31e-2)" "unprognostic (1.28e-1)" "unprognostic (9.12e-3)" "unprognostic (4.82e-2)" "unprognostic (2.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.60e-4)" "unprognostic (7.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (8.14e-2)" "unprognostic (2.01e-2)" "unprognostic (3.73e-2)" "unprognostic (1.57e-2)" "unprognostic (7.62e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 1.2 2.4 1.4 0.9 1.7 0.8 1.7 0.8 1.6 1.8 1.0 1.1 1.8 1.7 0.8 1.0 1.6 1.9 0.7 0.9 1.5 1.4 0.4 0.9 1.0 1.5 1.3 0.7 1.8 1.3 2.3 1.6 2.9 1.4 1.6 0.8 7.5 0.8 0.9 0.2 1.2 1.5 0.8 0.6 1.0 1.3 3.7 1.1 1.6 2.4 0.5 1.1 1.0 1.0 2.7 1.7 2.0 3.4 4.4 2.8 4.5 1.8 1.9 2.9 3.2 4.6 0.1 1.3 3.4 3.2 2.0 4.7 1.5 1.6 1.6 4.0 22.7 2.2 3.9 0.7 0.7 1.2 2.1 1.5 1.7 1.2 2.8 2.1 3.8 0.7 3.9 2.2 0.0 2.5 1.0 2.3 1.3 1.9 1.1 0.7 2.1 1.6 0.3 1.6 0.8 6.5 3.5 2.2 1.4 1.0 1.8 2.1 1.6 0.4 2.1 2.1 0.6 2.2 1.6 0.0 1.3 3.0 1.1 3.3 6.1 0.9 1.3 1.8 0.5 1.3 2.5 1.4 1.3 0.7 4.5 2.6 2.0 0.8 2.6 0.9 8.2 1.6 0.3 1.4 1.7 0.8 1.6 0.9 1.5 1.5 1.3 0.7 1.4 0.6 1.1 2.7 3.9 3.2 8.4 68.2 6.4 6.1 3.7 3.1 9.6 26.2 6.1 5.0 3.1 4.3 10.1 7.3 43.8 4.4 8.7 3.4 0.0 2.4 9.8 8.8 9.5 3.5 5.4 1.7 124.1 2.2 1.7 6.2 10.2 4.7 3.8 26.7 2.9 1.1 1.4 13.5 87.4 6.0 4.1 1.6 2.9 3.5 2.5 2.8 1.8 36.5 1.5 6.7 3.1 105.6 102.6 1.0 3.9 1.9 1.8 2.3 8.0 1.5 20.3 110.4 0.0 6.6 5.3 21.5 7.9 3.4 5.1 2.3 4.9 4.8 4.8 2.3 CLVS2 "bA160A10.4, C6orf212, C6orf213, RLBP1L2" ENSG00000146352 "Clavesin 2" Q5SYC1 6 122996235-123072925 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.4" "Group enriched" "Detected in some" 4 "Excitatory neurons: 137.8;Inhibitory neurons: 171.5;Muller glia cells: 60.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Region enriched" "Detected in many" 4 "cerebellum: 41.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 12.2;SCLC-21H: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043764 Uncertain NA NA "HPA043764: AB_10960281" "unprognostic (1.35e-1)" "unprognostic (3.28e-2)" "unprognostic (4.68e-2)" "unprognostic (3.60e-1)" "unprognostic (2.38e-1)" "unprognostic (7.04e-2)" "unprognostic (1.43e-2)" "unprognostic (5.72e-3)" "unprognostic (9.60e-2)" "unprognostic (8.71e-2)" 0.0 0.9 3.1 0.0 5.4 0.0 0.0 41.4 8.8 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.8 7.0 0.0 0.0 0.0 0.0 5.8 1.6 3.1 0.0 0.0 0.0 2.0 0.0 9.2 3.0 0.1 8.2 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.3 0.0 0.1 0.2 9.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.4 41.4 8.8 4.8 7.0 5.8 1.6 3.1 9.2 0.0 1.9 9.6 0.4 0.0 0.0 22.2 0.0 0.0 17.9 0.0 0.0 5.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.0 0.3 0.0 0.0 137.8 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.5 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 2.8 0.0 60.8 0.0 27.2 4.0 0.0 0.0 0.4 0.0 4.6 0.0 0.0 0.0 4.8 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 GPR6 ENSG00000146360 "G protein-coupled receptor 6" P46095 6 109978256-109980718 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "basal ganglia: 21.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 91.1" "Region enriched" "Detected in many" 4 "basal ganglia: 29.7" NA NA "unprognostic (1.14e-2)" "unprognostic (1.59e-2)" "unprognostic (7.10e-3)" 0.0 0.0 2.5 0.0 21.4 0.0 0.0 0.1 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.4 0.0 0.0 0.0 0.0 4.3 0.3 3.6 0.0 0.0 0.0 3.5 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 21.4 0.1 5.1 2.8 3.4 4.3 0.3 3.6 4.3 0.2 4.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF217 "C6orf172, dJ84N20.1, IBRDC1, MGC26996" ENSG00000146373 "Ring finger protein 217" Q8TC41 6 124962545-125092633 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.0" "Cell type enhanced" "Detected in many" "Early spermatids: 127.8;Oligodendrocytes: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029598 Uncertain NA NA "HPA029598: AB_10602297" "unprognostic (2.96e-2)" "unprognostic (2.34e-3)" "unprognostic (8.07e-2)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (7.22e-3)" "unprognostic (4.94e-2)" "unprognostic (6.69e-2)" "unprognostic (2.47e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (4.60e-5)" "unprognostic (8.29e-4)" "unprognostic (2.16e-1)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.92e-4)" 8.1 3.0 3.2 2.0 2.4 11.1 6.1 3.0 2.1 5.6 4.3 5.5 1.3 4.4 2.0 5.0 7.4 4.2 5.1 2.8 7.9 1.8 5.7 6.4 0.7 2.7 2.4 0.9 8.7 2.9 43.0 2.9 3.9 2.2 3.6 1.3 3.7 4.7 3.6 7.6 7.9 2.5 4.2 0.9 1.8 3.5 7.0 2.0 1.5 5.9 5.9 0.4 5.4 5.7 5.2 4.9 5.0 1.7 0.6 6.1 2.4 9.7 6.6 8.9 4.4 5.8 0.0 4.6 0.0 9.0 6.3 10.1 7.0 1.0 5.9 6.2 0.0 5.5 2.7 7.6 1.5 5.7 0.0 0.2 6.5 5.4 3.3 9.7 5.2 5.0 0.0 14.0 0.0 7.8 0.0 0.0 0.0 1.5 0.0 1.3 0.1 6.8 0.0 4.5 2.2 0.8 0.0 2.9 0.7 2.5 4.8 4.8 0.8 8.1 3.6 11.5 0.0 14.3 0.0 0.0 0.0 2.7 0.0 4.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.4 3.0 2.1 2.8 7.9 2.7 2.4 0.9 2.2 0.9 2.0 5.2 25.0 22.4 21.0 49.0 0.6 48.2 15.8 17.5 18.2 6.3 10.0 10.7 14.4 4.3 12.1 5.5 16.7 24.2 0.9 1.3 0.0 8.1 127.8 11.4 21.5 19.0 3.0 6.5 56.3 9.6 29.7 23.1 4.6 22.8 1.3 9.0 15.7 26.9 9.8 21.9 65.0 2.4 12.2 14.6 20.9 62.1 25.7 11.3 19.6 51.5 9.8 4.2 1.0 37.7 102.1 11.8 2.0 21.1 0.4 21.6 6.9 2.3 9.6 5.7 6.6 44.9 12.3 1.7 2.9 17.5 47.0 17.9 1.8 5.3 4.3 16.3 RSPO3 "FLJ14440, THSD2" ENSG00000146374 "R-spondin 3" Q9BXY4 6 127118671-127199481 "Cancer-related genes, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 51.8" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 18.5;Endothelial cells: 42.4;Fibroblasts: 73.0;Hepatic stellate cells: 26.4;Inhibitory neurons: 17.8;Leydig cells: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 21.9;BJ hTERT+: 3.6;hTERT-RPE1: 6.3;U-138 MG: 4.6;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "hippocampal formation: 21.2" HPA029957 Uncertain "Secreted to blood" NA NA "HPA029957: AB_10602087" "unprognostic (4.77e-2)" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (2.27e-2)" "unprognostic (1.10e-1)" "unprognostic (2.99e-1)" "unprognostic (9.71e-2)" "unprognostic (1.49e-2)" "unprognostic (3.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-1)" "unprognostic (1.07e-3)" "unprognostic (7.94e-2)" "unprognostic (2.76e-1)" "unprognostic (1.64e-2)" "unprognostic (7.89e-3)" 17.2 15.3 2.1 16.3 2.5 0.0 12.5 3.1 4.9 11.3 0.0 7.4 2.2 51.8 28.6 5.4 25.5 11.2 0.6 7.4 1.0 4.0 6.6 5.1 3.7 1.2 1.7 1.5 3.6 1.6 0.1 3.1 35.7 0.9 6.4 6.7 0.1 5.4 20.2 40.2 2.2 10.4 48.5 0.0 1.8 13.4 1.1 1.5 2.4 3.6 5.1 1.4 8.7 7.2 1.3 0.0 21.9 0.0 0.0 1.0 0.0 0.0 0.0 3.6 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 6.3 2.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 4.6 1.8 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.5 3.1 4.9 7.4 1.0 1.2 1.7 1.5 0.9 0.0 1.5 1.3 3.6 0.0 0.0 0.7 0.1 0.9 0.1 0.0 0.6 1.5 0.2 0.9 0.5 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.4 12.3 0.3 18.5 42.4 0.0 0.0 5.9 0.0 1.1 73.0 5.1 0.3 0.0 0.0 26.4 0.4 1.6 0.0 17.8 0.0 0.0 1.0 0.8 2.2 27.4 0.4 1.8 1.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 6.6 2.1 3.5 0.1 0.4 0.4 0.1 1.6 0.1 0.1 0.0 0.2 ARHGAP18 "bA307O14.2, MacGAP" ENSG00000146376 "Rho GTPase activating protein 18" Q8N392 6 129576132-129710177 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 253.6;Respiratory ciliated cells: 265.3;Syncytiotrophoblasts: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 395.8;LHCN-M2: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031595 Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA 1900000 Cytosol "Nuclear speckles, Plasma membrane" "HPA031595: AB_10959905" "unprognostic (6.39e-2)" "unprognostic (1.60e-1)" "unprognostic (5.45e-2)" "unprognostic (5.49e-2)" "unprognostic (3.05e-1)" "unprognostic (3.17e-1)" "unprognostic (9.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.98e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (4.08e-1)" "unprognostic (2.29e-3)" "unprognostic (2.22e-1)" "unprognostic (3.05e-2)" "unprognostic (5.52e-2)" "unprognostic (1.08e-1)" 20.7 37.6 3.5 13.1 2.9 4.3 13.5 3.1 3.1 15.0 13.6 14.9 25.1 6.8 20.4 6.0 28.5 15.5 6.0 3.0 7.6 28.6 6.4 29.0 9.5 4.4 5.3 1.9 6.1 33.5 14.3 6.8 20.9 4.0 10.0 15.1 2.6 14.7 8.5 10.7 3.9 27.6 10.7 4.1 9.0 28.2 8.4 5.5 6.2 23.2 13.1 8.0 12.7 4.1 3.5 8.6 18.8 1.9 2.6 17.8 25.0 15.1 64.0 48.8 27.7 18.5 10.0 14.1 7.1 30.6 43.2 8.8 11.0 13.4 20.9 51.3 7.0 5.7 46.7 13.8 57.3 25.4 6.9 395.8 15.9 3.2 50.4 44.7 57.8 79.8 0.0 25.3 17.4 113.1 2.3 0.1 6.8 2.0 16.0 4.5 0.3 8.5 13.7 84.6 4.8 0.0 0.1 5.3 8.8 32.3 9.3 9.7 8.1 61.6 28.8 4.1 2.3 51.8 7.8 6.0 4.8 9.7 12.7 40.9 12.0 5.1 13.5 4.9 5.8 3.1 2.9 2.5 5.5 4.8 1.7 0.4 2.6 3.9 2.5 3.2 11.8 2.8 6.0 3.5 2.9 3.1 3.1 3.0 7.6 4.4 5.3 1.9 4.0 4.1 5.5 3.5 139.5 57.7 33.3 1.6 13.0 13.0 17.7 15.7 10.8 0.7 53.4 14.7 4.1 17.2 39.5 38.6 2.1 92.7 31.0 19.0 150.6 48.2 20.7 176.1 5.8 89.2 13.1 10.9 16.8 120.5 24.9 45.3 63.2 35.7 253.6 34.7 11.0 5.0 110.4 0.0 23.1 22.1 63.1 48.4 112.4 21.2 3.7 163.9 7.2 43.1 23.9 16.4 28.8 12.5 2.2 102.4 25.0 1.2 26.4 18.5 69.8 31.7 265.3 0.9 26.3 38.9 32.5 10.6 1.1 11.2 12.9 212.3 35.9 69.1 31.3 19.1 TAAR2 GPR58 ENSG00000146378 "Trace amine associated receptor 2" Q9P1P5 6 132617022-132624275 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "Astrocytes: 1.0;Early spermatids: 2.4;Late spermatids: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR6 "TA4, TRAR4" ENSG00000146383 "Trace amine associated receptor 6" Q96RI8 6 132570322-132571359 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR8 "GPR102, TA5, TAR5, TRAR5" ENSG00000146385 "Trace amine associated receptor 8" Q969N4 6 132552693-132553721 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028745-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 440.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 501.5;NB-4: 530.8;U-937: 515.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol NA NA 9200000 Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.65e-6)" 17.5 9.7 17.9 74.4 17.3 88.5 45.4 14.9 21.0 20.8 16.6 95.9 74.7 22.2 137.2 42.3 12.5 36.3 12.5 19.7 16.7 50.5 61.2 31.5 124.2 15.9 15.8 16.8 4.1 16.2 49.5 14.5 29.4 16.6 16.5 87.4 5.5 41.1 12.3 3.0 39.1 75.0 23.7 16.0 74.6 34.7 32.6 16.7 140.9 42.8 7.6 88.6 80.3 17.2 17.2 76.8 40.7 100.7 94.8 39.7 62.2 110.6 59.7 42.9 44.5 91.2 91.2 87.4 0.4 105.8 59.8 189.5 112.9 90.4 130.0 51.9 204.4 167.4 297.8 20.7 31.6 57.6 501.5 130.5 55.9 108.2 59.9 49.1 79.4 237.5 204.9 38.4 100.4 129.5 162.7 314.2 530.8 120.9 119.1 78.5 199.8 62.3 23.8 121.7 225.0 225.4 24.8 40.5 112.3 194.5 141.9 45.1 369.8 175.7 28.2 24.0 58.9 107.7 54.1 169.2 20.9 35.7 515.5 84.2 232.3 178.0 114.2 161.1 334.3 252.2 93.8 259.3 208.2 193.9 96.9 250.9 235.9 48.8 152.1 514.5 215.9 260.2 347.8 17.9 17.3 14.9 21.0 19.7 16.7 15.9 15.8 16.8 16.6 16.0 16.7 17.2 54.2 19.2 22.2 2.0 87.1 139.6 71.4 195.2 108.1 0.3 86.6 67.8 3.8 27.1 126.2 44.1 0.0 77.1 151.3 304.5 60.7 145.3 4.8 85.8 20.1 55.0 43.1 75.7 12.8 145.0 207.7 23.5 55.5 129.0 79.4 59.9 53.6 254.3 353.1 0.0 9.1 116.8 162.8 286.1 133.9 13.7 4.7 187.6 87.2 5.6 167.9 49.8 189.5 1.0 1.0 167.4 250.6 12.8 121.0 47.9 247.5 440.3 74.1 1.3 32.9 7.2 37.3 3.6 7.7 116.6 90.1 48.6 198.5 17.7 123.6 133.8 TAAR1 "TA1, TAR1, TRAR1" ENSG00000146399 "Trace amine associated receptor 1" Q96RJ0 6 132644898-132646051 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "stomach 1: 6.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055614 Approved NA NA "HPA055614: AB_2682862" "unprognostic (2.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC18B1 "C6orf192, dJ55C23.6" ENSG00000146409 "Solute carrier family 18 member B1" Q6NT16 6 132769370-132813339 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 93.4;Hofbauer cells: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029747 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA029747: AB_10600797" "unprognostic (1.84e-2)" "unprognostic (3.94e-1)" "unprognostic (4.22e-2)" "unprognostic (2.85e-1)" "unprognostic (2.41e-2)" "prognostic favorable (3.55e-4)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.53e-1)" "unprognostic (2.39e-1)" "unprognostic (4.09e-1)" "unprognostic (6.97e-3)" "unprognostic (1.13e-1)" "prognostic favorable (9.24e-4)" "unprognostic (7.20e-3)" "unprognostic (1.08e-1)" "unprognostic (2.08e-2)" "unprognostic (7.88e-2)" 9.6 9.0 22.7 6.4 22.4 4.6 9.8 24.8 27.2 9.5 23.9 9.8 14.7 6.4 5.8 13.7 9.9 12.0 3.9 23.0 23.1 12.6 7.6 5.7 7.7 23.5 23.6 20.0 7.0 10.0 13.0 8.4 15.9 26.0 5.4 10.2 2.6 13.3 4.6 3.3 9.5 10.5 6.0 23.7 8.4 16.3 2.1 25.8 8.0 10.3 3.5 8.2 11.2 7.2 24.2 6.8 6.5 10.0 0.0 1.5 3.2 5.7 2.5 7.2 4.4 13.4 14.9 13.8 0.2 9.2 1.5 7.9 17.3 13.4 15.4 3.3 10.3 27.6 3.6 11.3 16.8 7.5 3.0 0.3 9.3 13.7 7.2 14.5 7.3 13.6 20.7 40.4 2.5 3.8 9.4 10.5 0.3 14.1 15.8 8.7 15.7 11.7 11.8 36.6 11.4 21.2 0.0 12.9 25.2 20.1 6.0 8.9 0.1 6.0 1.9 5.3 2.1 5.7 8.5 0.5 0.4 11.5 0.1 1.7 0.0 14.4 0.8 4.3 3.2 8.1 6.6 6.5 6.0 19.9 9.7 9.5 6.6 0.8 3.4 0.3 15.5 11.9 8.1 22.7 22.4 24.8 27.2 23.0 23.1 23.5 23.6 20.0 26.0 23.7 25.8 24.2 10.4 0.0 6.5 93.4 15.2 10.1 10.3 30.4 22.8 5.5 13.0 7.4 3.1 40.0 20.6 27.6 2.1 53.1 8.2 5.4 9.8 32.0 0.2 12.6 4.8 7.8 16.3 49.1 32.2 15.1 19.3 7.8 20.4 5.8 0.0 5.8 18.2 15.6 65.6 0.0 25.3 11.9 32.6 21.5 9.0 0.5 6.8 26.7 14.2 27.2 11.4 9.3 5.2 51.3 4.4 14.6 6.0 4.5 6.6 8.8 7.2 6.4 27.9 3.5 0.0 8.6 4.8 0.3 0.5 25.5 10.9 28.5 7.3 21.7 15.3 13.2 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5;lymphoid tissue: 6.4;testis: 7.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 23.6;Spermatocytes: 27.6;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA029792, HPA029794" Approved Uncertain Vesicles NA Yes Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavorable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 0.7 0.6 0.5 3.6 0.4 16.5 1.0 0.5 0.6 0.4 0.3 2.9 2.8 0.5 0.3 2.6 0.3 0.3 0.3 0.5 0.7 0.5 0.4 1.2 6.4 0.5 0.6 0.4 0.3 0.4 0.0 0.4 1.8 0.5 0.4 3.8 0.5 0.8 0.2 1.2 2.0 2.3 1.1 0.6 2.3 1.2 7.1 0.5 6.2 0.3 0.1 5.3 0.8 0.9 0.5 15.2 11.5 9.7 18.2 1.6 2.8 17.4 19.6 13.6 22.8 31.7 20.7 12.2 39.2 11.7 7.9 30.1 23.1 22.3 14.4 33.8 22.1 17.1 31.0 7.8 18.9 1.0 57.4 28.1 2.3 3.1 25.5 16.1 2.7 12.4 33.8 33.9 29.6 17.2 20.2 32.5 47.8 9.8 20.2 14.1 29.3 15.5 19.7 9.9 11.6 7.7 7.6 12.4 21.5 11.3 11.9 9.1 39.1 6.8 11.3 11.8 40.2 30.4 11.2 28.3 26.1 6.5 38.5 17.6 0.0 0.2 0.0 0.3 0.9 0.1 0.4 0.4 0.7 0.9 0.3 0.0 0.4 0.0 0.0 0.7 0.7 0.7 0.3 0.5 0.4 0.5 0.6 0.5 0.7 0.5 0.6 0.4 0.5 0.6 0.5 0.5 2.0 0.0 1.1 0.0 2.2 1.0 0.6 3.1 0.0 0.0 3.4 3.6 0.4 0.0 2.3 0.0 0.0 8.4 1.3 2.2 0.0 1.1 7.9 2.4 1.3 1.7 0.0 9.9 0.5 2.5 23.6 1.5 2.6 2.5 1.3 3.5 0.7 0.5 6.6 0.0 0.4 2.1 4.1 3.8 2.1 5.9 0.3 2.5 0.0 1.0 2.3 0.0 1.0 0.5 0.0 1.3 0.4 0.0 7.4 1.2 1.3 1.4 2.5 0.0 0.0 5.3 1.8 27.6 13.0 5.3 0.3 3.0 3.1 0.8 4.6 0.9 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133987581-134052624 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 72.2" "Cell type enhanced" "Detected in many" "Astrocytes: 24.8;Oligodendrocytes: 14.5;Syncytiotrophoblasts: 36.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.6;hTERT-RPE1: 14.8;SuSa: 21.7;U-2 OS: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: AB_2673948" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.4 1.1 3.6 0.3 4.9 0.0 1.2 7.7 4.7 2.2 72.2 1.4 7.3 8.3 2.1 6.2 2.8 2.7 10.8 5.8 3.5 5.9 6.8 3.1 0.1 2.6 3.7 3.5 1.2 1.1 2.3 1.5 1.6 3.2 22.6 1.0 2.4 5.1 9.4 3.8 2.5 9.9 3.1 1.5 0.1 14.4 0.4 3.5 1.0 0.2 4.1 1.2 3.5 1.2 3.4 2.5 0.9 2.3 0.0 1.4 0.7 0.1 1.5 5.4 0.7 2.9 0.0 7.6 0.3 1.2 0.1 5.7 5.9 0.0 0.5 1.0 0.0 5.3 0.0 0.8 0.1 0.2 0.0 0.0 1.0 0.5 0.6 0.1 14.8 0.4 0.4 0.5 0.8 0.1 0.8 0.1 0.1 2.0 0.0 0.5 0.0 1.0 2.2 1.6 0.8 0.2 0.7 0.1 2.1 0.0 21.7 0.1 0.0 0.1 0.2 7.6 0.2 0.9 3.2 2.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 4.9 7.7 4.7 5.8 3.5 2.6 3.7 3.5 3.2 1.5 3.5 3.4 0.2 0.0 7.7 24.8 0.1 2.0 1.0 3.3 8.6 0.4 0.5 2.2 6.3 0.0 2.2 0.0 0.0 2.0 0.1 1.2 3.9 1.5 0.1 3.4 0.4 2.3 4.2 0.0 8.0 0.2 0.6 2.2 2.6 1.6 0.0 0.4 0.0 1.1 0.3 0.0 3.2 0.2 6.1 0.0 0.3 0.0 0.0 0.1 0.0 4.7 0.1 9.8 0.0 4.5 14.5 1.1 2.4 1.5 1.6 10.5 0.5 0.5 10.4 0.5 0.0 2.1 1.3 0.0 0.0 8.6 1.8 36.7 0.2 3.5 0.4 1.3 SHPRH "bA545I5.2, FLJ90837, KIAA2023" ENSG00000146414 "SNF2 histone linker PHD RING helicase" Q149N8 6 145864245-145964423 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Helicase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034854, HPA044852" Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA034854: AB_10964488, HPA044852: " "unprognostic (3.10e-2)" "unprognostic (4.46e-2)" "unprognostic (5.61e-3)" "unprognostic (1.53e-2)" "unprognostic (7.40e-3)" "unprognostic (2.20e-2)" "unprognostic (2.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (5.03e-1)" "unprognostic (7.90e-2)" "unprognostic (6.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" "unprognostic (3.01e-1)" 5.0 4.2 3.3 4.7 4.2 4.2 7.2 19.1 5.1 5.5 3.3 4.3 4.3 7.7 6.1 4.3 5.2 4.7 3.6 3.3 2.8 5.6 4.6 4.2 6.9 3.7 4.6 2.7 12.3 3.9 6.7 2.0 4.6 7.1 5.5 5.0 16.4 5.8 5.2 4.3 9.8 4.5 5.7 3.0 6.5 5.4 7.7 3.5 7.3 8.5 5.2 5.8 4.4 3.3 5.9 4.2 3.2 15.3 9.1 7.0 7.3 7.2 4.9 3.9 5.9 7.6 7.0 2.9 14.5 5.9 3.7 4.6 7.0 9.5 6.9 7.7 6.5 10.9 14.6 7.6 6.1 5.2 31.2 8.6 5.2 7.8 5.6 8.0 5.8 6.4 10.0 20.3 7.9 5.1 3.7 19.8 11.6 10.3 6.9 5.4 14.1 23.6 5.0 8.0 4.1 12.6 8.8 8.7 7.9 5.4 10.5 4.2 14.6 7.2 3.7 7.0 7.4 5.8 6.4 9.4 17.1 3.9 13.0 6.0 0.7 0.9 1.9 1.7 0.9 1.5 1.5 1.4 1.1 1.1 2.5 1.5 1.3 0.0 1.5 1.0 2.0 1.4 0.5 3.3 4.2 19.1 5.1 3.3 2.8 3.7 4.6 2.7 7.1 3.0 3.5 5.9 31.4 28.9 23.4 106.7 31.0 21.2 17.9 14.5 19.4 117.2 21.5 20.3 17.2 20.0 20.7 22.0 210.6 16.1 34.6 9.1 7.9 18.6 20.4 20.9 52.8 26.0 19.2 15.3 131.0 12.9 7.0 25.9 23.9 18.1 13.3 145.7 15.7 20.5 12.0 94.2 140.3 14.7 6.1 21.4 9.8 8.0 50.7 19.8 14.2 93.7 30.6 40.7 36.0 143.7 164.6 15.9 8.8 34.3 23.5 18.8 17.2 7.5 14.9 158.5 72.3 47.1 39.1 83.2 65.0 16.5 19.7 6.6 26.4 61.5 18.0 12.5 AIG1 "AIG-1, dJ95L4.1, FLJ10485" ENSG00000146416 "Androgen induced 1" Q9NVV5 6 143060496-143341058 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 237.8" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 245.4;Proximal tubular cells: 261.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060766 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA060766: AB_2684356" "unprognostic (2.70e-2)" "prognostic unfavorable (3.26e-6)" "unprognostic (4.27e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.25e-7)" "unprognostic (1.91e-2)" "unprognostic (8.75e-3)" "unprognostic (2.17e-1)" "unprognostic (5.53e-2)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.11e-2)" "unprognostic (2.75e-1)" 42.4 30.1 44.1 10.5 45.0 31.9 30.3 43.7 46.5 15.2 47.4 21.1 47.0 14.5 33.3 34.4 34.7 24.7 46.7 44.1 46.3 102.9 237.8 20.1 10.8 45.2 45.0 42.9 35.0 31.3 31.3 36.9 12.0 47.8 22.9 19.0 34.2 19.9 24.3 24.0 16.7 46.3 15.4 44.1 20.2 21.0 15.8 49.5 6.9 43.3 32.8 14.9 29.6 26.3 53.3 32.6 25.2 20.6 56.9 29.7 22.3 7.6 28.3 57.1 26.8 61.9 37.5 81.5 20.0 40.5 66.1 41.7 42.0 26.5 79.2 64.2 67.2 63.0 5.6 35.6 157.3 40.8 46.0 2.7 32.9 76.7 35.7 129.6 88.2 10.9 30.8 4.0 67.6 59.3 45.6 14.2 9.8 40.8 37.4 27.6 20.2 61.6 36.6 100.6 77.6 75.5 42.4 35.5 33.2 17.2 36.0 31.7 96.0 3.0 25.2 27.8 22.7 33.4 99.6 95.1 2.1 59.7 9.5 26.9 12.0 6.2 9.6 6.6 29.3 15.1 9.6 12.4 10.6 33.0 5.6 13.1 10.0 11.3 11.8 35.4 2.9 9.7 9.2 44.1 45.0 43.7 46.5 44.1 46.3 45.2 45.0 42.9 47.8 44.1 49.5 53.3 40.8 16.0 27.7 114.9 22.0 25.0 51.8 82.5 27.9 68.3 69.9 65.4 73.7 72.9 66.9 51.5 25.0 79.6 8.6 12.6 52.8 60.3 22.4 99.8 25.9 32.8 39.5 29.3 204.3 31.5 10.5 42.2 26.0 83.1 36.8 90.9 36.8 229.6 32.7 53.8 245.4 33.3 59.0 40.1 42.3 7.0 32.0 37.2 55.2 100.2 18.2 74.3 8.2 105.1 172.9 25.8 65.2 38.4 47.7 35.3 232.9 261.5 69.1 36.9 32.9 41.7 50.8 5.6 17.3 53.1 45.7 108.1 18.5 61.5 42.4 53.2 DYNLT1 TCTEL1 ENSG00000146425 "Dynein light chain Tctex-type 1" P63172 6 158636474-158644743 "Predicted intracellular proteins" "Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 946.1;Ionocytes: 830.0;Respiratory ciliated cells: 1335.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046559 Approved Nucleoplasm NA Yes Nucleoplasm "HPA046559: AB_2679698" "unprognostic (1.80e-3)" "unprognostic (3.09e-1)" "unprognostic (3.69e-2)" "unprognostic (2.22e-3)" "unprognostic (5.31e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.62e-2)" "unprognostic (1.83e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.58e-2)" "unprognostic (2.72e-3)" "unprognostic (2.61e-1)" "unprognostic (1.74e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" 73.8 115.4 65.0 71.8 65.7 41.1 115.8 70.0 88.3 110.7 80.8 128.1 110.3 101.3 145.4 156.5 166.8 85.4 132.4 63.7 81.1 171.8 101.4 97.5 63.3 72.6 68.5 61.6 80.2 53.3 116.1 73.0 81.8 71.2 102.6 130.8 34.6 100.3 116.2 126.3 51.7 124.2 165.9 71.0 81.3 91.4 130.5 66.6 54.8 120.8 95.8 85.4 129.0 99.6 74.8 188.4 130.6 211.8 208.2 214.3 216.7 87.3 190.6 152.7 229.9 270.2 155.8 165.5 45.1 77.5 398.0 172.7 169.1 134.4 205.6 277.5 64.3 187.2 71.2 115.8 182.7 225.4 33.4 48.1 187.9 217.5 190.0 188.8 198.7 295.1 62.2 139.0 52.4 342.4 166.7 14.9 86.6 116.0 336.5 106.0 29.7 113.9 41.3 323.7 126.9 421.7 211.1 268.1 216.7 83.0 178.8 147.7 73.6 258.9 113.6 143.9 123.2 174.8 31.6 42.2 75.7 161.6 136.9 125.9 158.9 383.6 39.2 106.0 374.8 119.5 76.4 112.7 122.1 192.6 51.7 93.8 96.8 681.1 92.4 290.9 93.4 146.0 254.2 65.0 65.7 70.0 88.3 63.7 81.1 72.6 68.5 61.6 71.2 71.0 66.6 74.8 91.4 96.1 96.1 7.5 56.7 54.0 253.2 946.1 62.0 16.9 186.0 206.5 150.7 160.2 610.7 211.5 12.5 227.8 84.5 227.3 416.7 422.0 137.3 710.6 152.7 107.3 172.6 43.7 16.4 274.4 197.9 124.8 86.2 271.7 60.8 137.7 116.4 93.6 155.1 23.5 19.4 238.6 830.0 108.7 67.9 68.4 107.8 126.1 113.8 13.1 201.3 114.1 143.2 16.1 19.3 451.4 317.4 127.9 51.8 291.4 379.8 661.2 1335.9 42.0 138.1 55.2 241.5 452.0 177.7 172.3 61.1 215.1 106.8 187.5 168.6 443.0 TIAM2 STEF ENSG00000146426 "TIAM Rac1 associated GEF 2" Q8IVF5 6 154832697-155257723 "Metabolic proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.6;testis: 13.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Early spermatids: 141.5;Excitatory neurons: 74.2;Late spermatids: 347.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 6.4;non-classical monocyte: 9.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 65.7;HDLM-2: 27.8;RH-30: 43.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 36.9" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.4 1.2 3.0 0.9 7.8 0.4 1.2 6.7 10.6 1.1 0.0 1.0 8.3 0.8 0.6 0.6 0.8 2.2 2.2 6.0 4.3 0.3 0.3 0.5 1.2 1.1 2.0 6.0 0.3 1.3 0.1 1.4 0.5 3.4 2.0 0.8 3.3 1.4 2.8 2.5 0.5 7.9 1.1 0.5 0.7 3.0 13.4 1.9 0.6 5.6 1.8 2.0 2.0 0.7 6.9 8.3 1.5 65.7 6.1 2.9 7.9 0.4 3.2 2.2 3.3 5.5 0.7 4.8 1.1 3.1 6.3 0.9 0.5 2.4 0.0 2.3 27.8 3.3 0.0 1.1 1.9 1.8 0.2 1.7 5.4 0.2 1.1 0.2 2.5 4.7 0.5 0.2 0.1 7.5 0.5 0.7 0.7 4.1 0.1 1.3 8.4 43.3 0.3 0.2 0.2 1.1 14.5 0.1 0.3 0.2 11.9 0.3 0.6 1.5 0.2 15.5 0.4 1.5 0.2 3.6 0.2 0.0 0.3 3.9 0.0 0.0 2.1 0.0 2.0 0.0 2.0 0.1 0.1 0.3 0.7 0.0 0.0 6.4 0.4 9.5 0.0 1.2 0.1 3.0 7.8 6.7 10.6 6.0 4.3 1.1 2.0 6.0 3.4 0.5 1.9 6.9 2.9 3.2 2.6 8.8 9.6 3.1 22.5 2.8 1.8 14.3 3.3 5.3 8.3 7.2 2.1 1.8 81.3 1.8 4.3 2.2 0.0 5.3 141.5 8.3 4.9 2.7 0.0 3.6 74.2 3.1 2.6 4.4 6.1 12.1 19.7 6.8 11.0 1.5 1.9 23.5 31.4 3.9 6.1 2.2 2.2 347.4 9.9 5.2 12.4 4.7 9.8 7.6 4.1 28.6 5.1 5.9 5.8 7.9 13.3 9.6 23.9 1.0 3.3 23.9 0.0 7.0 4.3 6.7 7.3 2.1 2.6 0.4 5.0 5.3 3.9 11.6 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 14.7 12.5 16.0 12.3 17.9 9.1 18.9 10.7 17.2 27.6 10.7 22.9 24.8 15.3 9.1 13.2 12.8 16.7 10.1 18.0 18.3 7.9 15.0 13.4 9.5 14.6 16.2 18.3 10.4 34.6 13.5 11.9 15.1 14.1 20.2 25.0 10.6 52.8 21.1 10.3 16.2 28.8 17.6 12.9 14.4 36.0 21.5 21.2 6.4 21.5 8.8 8.3 20.8 13.5 16.3 22.1 12.6 17.5 27.0 45.1 41.1 33.4 49.1 28.6 25.1 28.4 21.5 26.5 9.3 24.7 41.0 53.5 32.0 26.1 32.4 39.6 13.7 18.7 17.3 18.9 45.6 36.8 21.9 15.8 34.3 31.2 27.9 37.6 37.6 40.7 13.1 33.4 11.3 41.4 13.3 9.7 27.1 13.6 43.8 15.9 9.3 20.1 10.6 23.9 17.1 51.3 35.3 36.0 33.3 24.2 23.9 12.7 30.4 39.1 25.7 17.4 43.1 43.0 6.6 4.9 10.0 31.0 26.8 25.1 5.7 1.1 3.0 2.2 1.1 1.7 0.4 1.2 1.8 0.8 0.4 1.1 1.5 0.7 2.0 1.9 1.0 1.3 0.8 16.0 17.9 10.7 17.2 18.0 18.3 14.6 16.2 18.3 14.1 12.9 21.2 16.3 26.7 12.8 33.1 19.9 9.4 20.4 15.6 20.5 17.6 15.6 30.0 18.8 14.2 27.1 23.1 16.5 18.8 8.8 46.0 47.2 3.9 23.3 4.2 16.8 27.7 27.5 44.3 21.5 61.1 32.7 12.5 16.6 49.5 40.5 11.4 36.8 21.0 22.5 10.2 20.2 66.3 35.9 18.3 15.3 16.4 6.7 13.1 14.7 14.2 28.1 13.3 6.0 51.5 43.2 61.7 35.3 25.7 17.7 26.6 37.5 39.4 4.6 25.8 14.6 6.6 12.7 17.8 13.1 22.7 23.6 21.0 5.2 27.0 24.2 30.5 37.1 PNLDC1 "dJ195P10.2, FLJ40240" ENSG00000146453 "PARN like, ribonuclease domain containing 1" Q8NA58 6 159800249-159820704 "Enzymes, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.4;testis: 8.1" "Cell type enhanced" "Detected in some" "Early spermatids: 19.9;Late spermatids: 13.6;Spermatocytes: 14.3;Spermatogonia: 13.3" "Cancer enhanced" "Detected in many" "testis cancer: 4.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052026 Uncertain NA NA "HPA052026: AB_2681699" "unprognostic (1.58e-1)" "unprognostic (3.88e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-3)" "unprognostic (8.47e-3)" "unprognostic (3.55e-2)" "unprognostic (2.04e-1)" "unprognostic (4.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.37e-2)" "unprognostic (4.19e-1)" "unprognostic (9.98e-2)" "unprognostic (2.69e-9)" "unprognostic (1.14e-2)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-1)" 0.2 0.2 2.0 0.1 3.0 0.1 0.5 2.3 9.4 0.1 1.9 0.2 0.0 0.1 0.0 0.2 1.9 0.0 0.2 3.4 1.8 0.2 0.5 0.2 0.4 1.8 1.7 1.6 0.4 1.7 0.0 0.3 0.0 2.8 0.3 0.0 0.1 0.1 0.0 0.1 0.7 0.1 0.0 2.0 0.4 0.2 8.1 2.1 0.2 0.2 0.0 0.2 0.2 0.2 2.7 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 3.0 2.3 9.4 3.4 1.8 1.8 1.7 1.6 2.8 2.0 2.1 2.7 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.3 0.0 0.0 0.3 0.5 0.3 4.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 3.8 19.9 2.1 0.1 0.1 0.0 0.0 1.5 0.9 0.0 0.2 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.8 13.6 0.3 0.1 0.0 3.7 0.0 0.0 0.0 0.5 1.3 1.3 0.0 0.0 0.0 0.1 0.0 0.9 2.7 0.0 0.0 0.5 0.2 14.3 13.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 WTAP "KIAA0105, MGC3925, Mum2" ENSG00000146457 "WT1 associated protein" Q15007 6 159725585-159756319 "Predicted intracellular proteins" "Cell cycle, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 560.1;Suprabasal keratinocytes: 455.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010550 Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA010550: AB_1858866" "unprognostic (9.57e-2)" "unprognostic (1.58e-2)" "unprognostic (5.10e-2)" "unprognostic (2.32e-1)" "unprognostic (7.19e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (7.72e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (3.01e-5)" "unprognostic (7.92e-2)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (1.32e-2)" 82.1 64.2 35.5 62.8 36.0 247.3 75.6 40.4 41.6 68.6 42.2 54.8 35.2 65.3 65.6 65.5 64.7 52.7 53.7 35.1 49.7 53.9 51.2 69.2 78.1 38.7 39.7 33.9 71.1 63.8 53.7 50.2 62.3 40.2 65.7 55.8 35.9 62.6 45.0 181.2 69.9 62.1 51.9 37.4 67.5 59.0 35.2 39.7 90.5 57.9 68.0 81.4 103.6 65.7 41.5 55.5 51.1 115.8 100.2 136.5 147.7 67.1 86.2 299.4 108.7 145.4 95.7 49.0 126.8 50.8 92.6 238.4 70.4 112.2 94.3 138.1 70.0 71.9 135.0 46.7 144.2 108.4 116.1 75.4 172.0 94.7 120.0 155.0 82.6 81.6 130.7 149.1 114.2 116.0 53.5 170.5 165.0 91.9 88.6 44.2 107.4 74.3 94.4 114.0 62.6 104.5 74.5 158.2 83.5 45.7 77.5 41.3 152.6 72.6 70.0 81.4 100.1 125.0 83.9 109.6 206.5 67.8 120.9 76.8 46.6 24.5 31.0 28.1 31.7 31.7 33.1 33.9 34.3 29.1 27.5 29.9 31.4 42.9 32.1 38.3 24.3 40.2 20.2 35.5 36.0 40.4 41.6 35.1 49.7 38.7 39.7 33.9 40.2 37.4 39.7 41.5 131.1 35.3 57.3 31.3 138.1 419.0 198.0 52.9 113.8 30.0 144.2 123.6 58.1 74.4 39.9 60.7 35.5 107.3 138.5 61.2 86.1 128.1 47.1 86.4 125.5 118.8 61.6 59.3 41.5 81.4 126.7 226.9 97.9 171.9 40.0 56.7 58.2 90.5 75.4 37.0 36.6 65.7 24.4 99.7 560.1 50.7 65.3 168.6 243.7 33.7 113.7 49.7 88.6 44.7 57.0 75.8 59.7 50.8 111.5 307.5 49.6 106.5 35.3 36.2 72.3 222.2 124.5 93.8 73.9 113.0 455.3 149.3 138.6 54.7 74.0 150.9 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268709-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 127.9;Inhibitory neurons: 136.5;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 12.2 11.5 14.5 12.6 14.6 13.7 17.4 24.9 15.7 17.4 12.6 11.9 9.0 16.4 15.6 12.8 14.9 13.7 11.3 12.0 14.6 13.4 12.9 12.2 14.5 13.6 14.5 10.5 21.9 14.0 18.2 9.4 17.4 14.8 15.1 11.6 24.8 12.3 13.8 15.0 10.9 9.3 13.8 14.7 14.9 13.8 34.5 14.7 21.0 18.5 15.4 17.2 14.7 10.0 16.9 28.1 22.6 67.7 35.0 19.2 41.4 24.9 32.7 49.1 39.1 50.7 24.6 27.6 52.0 19.6 41.3 19.1 17.8 47.3 24.4 56.2 29.5 27.8 63.5 25.0 21.4 35.5 54.7 28.1 31.3 21.1 38.3 35.9 32.4 44.0 28.5 70.0 14.1 47.9 17.4 47.4 32.0 56.3 15.0 19.9 52.4 43.4 26.1 28.7 37.2 39.1 37.5 39.1 29.4 45.7 42.3 23.2 41.4 53.7 36.4 37.8 16.3 35.9 15.3 29.9 40.0 26.2 41.4 35.7 1.8 3.6 2.7 3.1 5.1 2.9 3.2 2.8 2.7 3.5 2.4 2.7 2.6 0.7 6.6 7.1 7.0 2.4 1.9 14.5 14.6 24.9 15.7 12.0 14.6 13.6 14.5 10.5 14.8 14.7 14.7 16.9 33.6 12.8 21.9 94.3 17.4 11.5 16.6 14.4 17.1 30.7 31.8 29.1 32.0 25.8 20.8 27.6 31.3 14.7 20.6 6.6 5.9 22.7 59.8 25.0 45.1 22.8 22.3 22.5 127.9 23.7 12.5 27.0 21.9 33.7 14.5 49.1 18.5 16.1 13.1 23.5 136.5 14.7 14.2 23.1 12.5 91.9 26.4 21.4 5.4 109.6 27.5 22.5 26.8 174.4 132.6 19.9 8.1 23.0 13.9 22.7 5.5 11.8 21.6 33.0 19.7 33.4 29.0 34.4 13.3 13.8 11.4 14.1 13.9 45.5 14.0 22.7 VIP ENSG00000146469 "Vasoactive intestinal peptide" P01282 6 152750797-152759765 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 72.9;lymphoid tissue: 156.9" "Group enriched" "Detected in some" 5 "Inhibitory neurons: 80.6;Melanocytes: 28.4" "Group enriched" "Detected in some" 6 "colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.7;TIME: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017324, CAB018649, HPA072701, CAB079780" Supported Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 122000 "Endoplasmic reticulum" "CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550" "unprognostic (9.58e-2)" "unprognostic (2.29e-2)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (3.33e-2)" "unprognostic (2.48e-2)" "unprognostic (7.21e-2)" "unprognostic (2.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (3.62e-1)" "unprognostic (2.92e-3)" "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.30e-1)" "unprognostic (5.90e-2)" 2.0 12.3 6.5 156.9 8.8 0.1 1.9 5.7 11.0 1.5 5.6 72.9 16.7 1.2 0.4 4.3 1.5 3.7 3.1 7.8 25.3 2.0 1.1 3.4 0.4 7.7 17.9 7.3 0.8 8.3 0.3 0.8 0.6 7.3 2.7 62.0 1.0 0.5 0.5 1.4 0.3 46.1 42.0 5.6 9.8 22.4 1.0 10.9 0.1 2.4 1.7 0.1 1.6 9.4 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.8 5.7 11.0 7.8 25.3 7.7 17.9 7.3 7.3 5.6 10.9 6.8 2.5 0.0 0.0 3.3 0.2 0.4 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 80.6 0.0 0.0 0.3 0.0 6.5 0.0 0.0 28.4 4.7 0.0 0.0 0.0 2.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 410000 "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 17.3 16.1 10.2 15.4 10.6 5.5 25.3 11.2 12.1 16.2 10.3 16.7 19.1 16.1 16.3 12.1 12.7 11.4 16.9 10.1 11.2 41.9 37.9 19.7 21.2 10.8 10.6 9.4 12.0 6.9 11.7 5.4 22.3 10.6 12.4 17.8 16.6 7.6 11.2 19.2 8.9 14.7 15.0 11.0 12.9 14.2 14.2 11.0 15.7 27.9 22.8 18.6 17.4 8.2 11.3 24.6 18.4 37.9 34.2 30.3 47.4 60.9 44.8 39.1 36.9 48.4 47.8 19.7 36.2 29.5 31.8 33.7 24.2 112.7 33.5 61.7 40.6 34.9 26.0 21.7 55.9 37.8 50.1 31.7 38.2 23.3 49.3 29.2 30.6 52.8 27.0 38.5 44.3 46.4 101.8 31.7 47.4 64.4 23.7 15.3 41.0 32.7 28.6 112.6 31.2 15.6 10.2 37.5 34.9 23.8 67.4 98.9 38.6 44.6 17.9 25.0 66.8 36.3 21.1 28.5 43.7 31.7 60.7 21.6 53.8 26.9 52.0 13.5 34.5 18.1 17.5 17.4 14.5 22.9 14.7 15.9 14.8 22.1 21.0 33.4 8.5 25.1 21.1 10.2 10.6 11.2 12.1 10.1 11.2 10.8 10.6 9.4 10.6 11.0 11.0 11.3 16.3 25.6 40.4 6.5 13.2 0.0 8.4 0.0 11.4 10.0 33.5 16.3 18.6 14.3 6.2 23.9 8.4 31.7 12.6 10.6 45.0 19.5 1.4 19.4 29.3 10.6 4.9 6.5 11.4 17.8 39.0 14.2 12.2 23.3 3.8 7.7 15.4 48.7 35.4 8.4 9.8 8.9 0.0 34.0 0.0 3.1 19.3 23.6 0.0 5.6 36.0 17.3 18.6 6.6 8.9 19.5 7.2 14.7 15.2 5.4 18.6 79.3 10.9 20.9 0.0 6.7 14.3 25.2 14.8 11.1 0.0 36.0 14.0 15.5 10.7 9.6 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348378-160452577 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 67.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8" "Cancer enhanced" "Detected in many" "prostate cancer: 19.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029750 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavorable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavorable (7.26e-4)" 11.8 15.3 2.8 3.9 2.8 0.0 6.6 3.5 2.4 13.9 2.2 7.3 1.7 18.6 27.8 7.8 18.9 11.1 1.5 2.1 3.5 6.3 35.2 16.6 16.3 6.2 3.7 1.7 21.3 0.7 0.2 1.3 44.7 4.6 43.8 2.4 0.2 52.2 53.1 67.9 10.4 5.7 26.6 3.2 0.6 6.1 2.7 4.1 0.5 2.0 8.5 5.0 6.2 15.9 3.3 0.0 27.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.5 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 0.0 0.0 38.1 23.7 1.2 0.0 0.0 0.8 6.9 3.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 12.0 7.7 0.0 0.0 0.0 13.8 0.0 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.8 3.5 2.4 2.1 3.5 6.2 3.7 1.7 4.6 3.2 4.1 3.3 0.6 16.0 78.9 6.2 0.1 4.7 0.3 2.1 2.8 0.2 0.2 0.3 2.9 5.7 6.4 0.0 0.0 0.3 0.1 0.2 5.9 8.2 0.6 0.2 10.2 1.0 0.0 0.0 0.5 3.0 0.3 10.0 12.8 0.3 2.5 0.8 0.0 68.8 0.7 0.0 25.1 1.6 2.0 1.0 2.4 1.6 33.8 0.3 3.6 7.5 0.0 0.0 0.0 19.6 0.2 57.3 0.1 24.5 0.1 6.1 2.1 2.9 0.8 0.1 0.0 29.8 12.3 0.3 0.2 3.7 6.7 0.4 1.2 0.0 2.8 0.8 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.3;salivary gland: 3.3;thyroid gland: 3.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.8;Excitatory neurons: 11.8;Granulosa cells: 5.4;Inhibitory neurons: 11.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 5.0;K-562: 13.0;NTERA-2: 4.8;SCLC-21H: 7.0" "Low region specificity" "Detected in many" "HPA026619, HPA036044, HPA036045" Uncertain Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA026619: AB_2671920, HPA036044: AB_2674916, HPA036045: " "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.0 0.3 0.5 0.1 0.7 2.3 1.6 0.0 0.5 0.1 0.0 0.3 0.1 0.4 4.3 0.1 1.1 0.4 2.0 0.3 0.3 0.2 0.1 0.2 0.1 0.3 0.5 0.1 0.0 0.0 0.3 0.4 0.1 0.4 1.1 0.1 0.0 3.3 1.6 0.0 0.4 0.1 0.1 0.1 0.1 0.7 0.3 0.3 0.1 3.2 0.0 0.0 0.4 0.0 0.4 0.0 0.8 0.0 1.2 0.0 0.2 2.4 0.0 1.5 0.5 0.7 0.3 2.4 0.1 0.0 0.0 0.9 0.7 1.7 1.6 1.1 2.7 2.4 3.4 5.0 0.0 0.0 1.9 1.5 0.1 0.2 0.0 1.1 2.4 1.0 1.3 13.0 0.0 0.0 1.6 0.0 0.0 4.8 0.0 0.8 0.0 0.0 1.1 0.4 1.2 7.0 1.5 0.0 1.4 0.0 1.7 0.0 0.8 0.1 0.0 0.9 0.0 1.5 2.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.7 0.0 0.5 0.3 0.3 0.3 0.5 0.1 0.4 0.1 0.3 0.4 0.1 0.0 1.5 0.3 0.0 0.3 2.1 0.9 2.8 0.0 1.6 1.0 8.8 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.0 0.1 1.2 0.7 0.2 0.2 0.0 3.0 11.8 0.0 0.5 1.1 0.0 1.8 0.0 5.4 0.0 0.0 0.1 0.0 11.6 0.1 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 1.2 0.0 0.0 2.9 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.4 0.4 0.7 0.1 0.1 0.7 0.4 0.5 1.8 GNA12 gep ENSG00000146535 "G protein subunit alpha 12" Q03113 7 2728105-2844308 "Human disease related genes, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 68.3;Syncytiotrophoblasts: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010046 Approved Supported Cytosol NA NA Cytosol "CAB010046: AB_2263416" "unprognostic (1.21e-1)" "unprognostic (1.19e-2)" "unprognostic (9.28e-2)" "unprognostic (1.54e-1)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.20e-6)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "unprognostic (4.45e-3)" "unprognostic (7.90e-2)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.22e-2)" "unprognostic (2.52e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.27e-4)" 18.0 15.0 42.4 11.3 41.4 11.1 12.3 39.2 33.3 12.5 18.8 13.8 5.1 17.1 4.7 7.7 13.0 9.5 16.9 35.3 37.8 8.6 9.4 12.9 12.9 50.4 42.2 30.2 18.3 12.0 8.1 12.4 24.6 41.4 9.6 6.1 3.0 8.1 11.5 6.8 4.8 11.4 13.7 45.4 10.7 11.7 10.2 45.3 5.7 6.7 7.3 10.2 16.7 9.3 43.2 35.5 19.1 19.4 29.2 30.4 24.1 53.5 29.1 33.7 30.9 35.3 18.4 24.5 7.5 19.4 34.6 64.7 15.6 13.5 30.1 20.9 89.9 13.5 15.3 9.9 19.6 35.4 2.5 13.1 23.5 16.1 36.3 24.4 31.8 33.3 10.6 17.3 23.0 28.1 16.8 4.1 14.1 27.3 9.1 32.9 26.8 22.4 15.2 11.4 23.8 15.4 22.3 16.4 24.4 12.2 27.6 13.6 20.9 39.5 33.6 39.9 33.2 48.6 16.1 20.3 6.8 36.1 22.5 33.7 1.4 0.5 0.1 0.2 1.3 0.3 1.0 0.5 0.3 0.4 1.7 0.5 0.0 0.1 0.0 0.3 1.8 0.7 0.4 42.4 41.4 39.2 33.3 35.3 37.8 50.4 42.2 30.2 41.4 45.4 45.3 43.2 21.8 6.4 11.7 41.8 22.0 7.0 3.8 5.4 0.6 6.0 14.5 10.4 16.3 10.0 6.1 1.8 12.5 63.7 16.6 8.0 3.9 7.9 13.3 9.3 21.8 16.7 7.8 9.5 31.9 10.2 17.0 19.6 10.2 10.8 0.0 13.9 19.2 13.5 25.4 8.4 36.0 5.5 6.1 21.6 63.5 13.6 17.1 25.8 21.4 22.5 21.7 16.1 7.2 68.3 29.9 13.2 4.0 18.8 7.3 8.4 4.7 7.1 5.8 10.7 0.0 16.8 17.3 8.6 9.4 1.2 3.7 173.2 6.2 23.7 5.3 3.2 C7orf50 "MGC11257, YCR016W" ENSG00000146540 "Chromosome 7 open reading frame 50" Q9BRJ6 7 996986-1138260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 295.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052281 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA052281: AB_2681784" "unprognostic (1.64e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (1.79e-2)" "unprognostic (1.28e-3)" "unprognostic (2.57e-3)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "prognostic favorable (6.20e-6)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (3.37e-2)" "unprognostic (8.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 39.9 40.9 63.2 17.7 56.3 13.5 43.6 51.2 104.1 51.8 46.3 60.3 15.5 56.3 12.7 47.1 56.7 13.0 88.7 59.5 53.3 79.6 59.7 45.9 16.9 59.5 54.0 56.2 70.4 109.4 19.9 141.1 16.8 55.3 66.5 8.9 8.8 41.5 32.6 70.6 32.9 35.3 15.3 53.9 39.8 60.9 38.9 59.1 11.2 75.4 22.7 11.0 64.7 41.8 54.2 167.9 104.8 34.5 105.2 18.2 25.8 72.2 73.3 35.6 63.8 54.0 74.3 69.9 49.9 47.1 47.4 80.9 104.1 41.6 88.6 12.6 47.7 84.0 45.8 75.1 102.6 73.7 58.7 30.2 37.0 69.3 59.6 54.4 28.0 44.1 41.5 82.7 46.5 29.0 241.6 27.3 156.3 84.2 74.8 153.7 79.4 12.8 83.0 30.2 45.6 78.7 112.8 60.2 70.6 103.9 22.7 169.7 106.6 51.6 36.9 162.9 110.9 97.5 39.3 57.2 45.8 74.1 96.0 119.0 18.1 129.4 400.1 97.1 136.4 69.4 123.7 79.1 82.6 208.0 165.6 59.9 69.8 15.1 44.8 134.1 60.5 104.9 116.7 63.2 56.3 51.2 104.1 59.5 53.3 59.5 54.0 56.2 55.3 53.9 59.1 54.2 42.9 35.3 57.2 16.0 115.8 23.2 43.4 81.6 12.5 74.0 89.2 80.9 72.2 44.3 55.9 66.2 18.8 73.5 42.2 40.5 295.4 89.2 8.5 55.9 30.9 44.3 90.8 21.2 34.1 85.5 78.6 51.6 27.0 37.5 55.8 88.1 37.5 37.7 163.1 57.2 30.8 64.6 73.2 67.5 71.0 7.5 37.0 68.8 71.2 15.9 108.9 140.2 66.9 20.6 17.5 64.2 27.0 44.4 52.4 52.4 9.9 152.0 54.4 73.3 26.3 30.8 73.0 20.4 42.8 34.2 24.4 46.5 60.4 48.0 62.2 39.0 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301252-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 12.7" "Cell type enhanced" "Detected in many" "Early spermatids: 96.1;Excitatory neurons: 222.4;Inhibitory neurons: 551.0;Late spermatids: 190.0;Microglial cells: 201.4;Oligodendrocyte precursor cells: 112.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 8.5;BEWO: 10.5;RPTEC TERT1: 8.7;RT4: 11.2;SuSa: 10.3;U-2 OS: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol NA NA 9500000 Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 3.6 0.5 3.1 4.0 0.9 0.8 2.1 0.2 1.6 9.5 3.9 3.5 1.0 3.2 2.6 1.6 2.6 1.4 1.1 3.5 3.7 1.6 0.1 4.0 1.5 1.4 1.2 0.3 2.2 12.7 0.8 2.2 1.7 1.6 1.7 1.3 1.5 0.8 4.2 0.9 1.3 2.5 2.8 1.3 5.4 2.0 3.5 0.9 2.5 0.5 1.6 1.9 5.2 2.2 0.4 2.2 1.8 8.5 0.0 0.0 0.0 10.5 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.4 0.0 3.4 0.2 0.9 0.0 0.2 0.0 5.0 0.0 0.4 0.3 4.1 0.0 0.0 1.7 0.0 0.4 0.5 0.0 0.7 0.1 0.0 0.0 4.2 2.2 0.0 0.0 2.9 0.1 0.0 6.3 5.9 0.0 8.7 11.2 5.3 7.7 0.0 0.0 0.0 10.3 0.0 2.8 0.2 0.0 13.2 0.0 3.8 0.0 0.0 0.0 0.0 1.8 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.1 0.9 0.2 1.6 3.5 3.7 1.4 1.2 0.3 1.6 1.3 0.9 0.4 1.2 0.0 3.0 31.3 0.1 1.3 0.5 2.3 0.6 22.3 0.6 1.8 20.2 1.5 5.5 5.5 0.0 3.6 1.3 0.0 0.0 1.5 96.1 16.9 57.1 1.9 4.9 0.0 222.4 5.4 0.7 11.6 0.5 9.9 0.0 23.4 1.1 0.0 0.5 1.7 551.0 0.5 0.0 0.3 2.1 190.0 1.8 0.7 5.4 201.4 0.0 0.2 0.0 112.1 14.3 2.2 0.0 5.7 0.0 0.7 0.0 1.5 6.7 1.2 6.6 1.7 7.8 9.8 5.5 0.3 0.4 1.9 0.7 1.4 0.1 0.4 CCZ1B "C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819" ENSG00000146574 "CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated" P86790 7 6794134-6826770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (8.06e-3)" "unprognostic (1.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (4.94e-2)" "unprognostic (1.45e-2)" "unprognostic (1.88e-3)" "unprognostic (2.74e-1)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (2.86e-1)" "unprognostic (2.96e-3)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" "unprognostic (1.24e-1)" 29.2 40.6 21.1 25.3 21.1 37.4 29.1 21.9 26.4 18.7 23.1 31.6 27.7 28.7 40.7 42.9 25.8 28.6 28.9 20.8 22.3 29.1 24.3 23.7 38.3 21.2 22.8 19.4 18.4 21.3 73.7 9.2 26.9 21.7 21.0 27.4 32.7 33.2 19.2 36.2 30.4 22.2 22.7 22.4 25.7 31.1 23.7 21.3 39.2 24.8 54.0 35.8 39.8 9.4 22.8 120.6 31.6 66.8 138.5 49.7 51.5 67.2 64.1 69.4 58.1 61.4 32.4 65.7 52.2 57.0 72.0 132.5 68.7 87.9 60.5 62.4 31.1 51.8 33.6 40.7 72.0 54.3 165.4 104.1 37.9 37.6 51.1 30.2 40.0 57.9 108.6 63.5 49.2 62.6 124.7 84.2 81.5 171.2 78.2 66.7 67.3 123.1 59.4 41.8 66.4 87.1 161.5 62.4 117.6 78.8 65.9 94.0 185.0 71.1 27.7 93.7 78.2 116.5 52.9 104.8 45.6 53.9 176.4 120.9 21.8 5.5 10.2 5.3 8.0 6.3 6.1 6.7 7.8 8.3 5.1 4.5 5.8 4.6 10.6 15.5 6.3 15.7 3.4 21.1 21.1 21.9 26.4 20.8 22.3 21.2 22.8 19.4 21.7 22.4 21.3 22.8 9.5 6.4 12.7 11.1 17.4 8.4 7.8 8.6 8.0 10.4 10.9 10.0 7.3 2.8 10.7 3.7 14.6 8.0 12.9 18.7 15.6 20.1 3.7 16.0 11.1 8.9 18.6 9.0 19.6 28.1 11.7 9.2 9.2 10.3 2.5 6.6 15.7 7.1 9.8 16.8 19.0 17.5 6.1 11.1 22.8 2.2 7.2 11.2 14.2 8.4 24.7 11.5 17.5 14.6 23.6 24.8 11.9 10.5 7.6 9.6 7.1 12.4 23.7 11.4 19.7 8.1 9.0 12.0 8.9 11.0 12.5 7.9 11.1 5.7 15.3 11.9 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590021-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 17.9 19.1 15.3 12.3 16.6 21.5 19.0 14.7 18.6 22.7 13.6 19.7 12.7 23.5 6.6 16.7 22.4 9.4 15.9 15.1 15.2 17.0 21.7 17.3 17.5 17.6 16.1 14.6 20.1 21.9 10.1 17.2 7.3 16.5 23.1 7.1 3.8 16.7 9.9 22.1 21.3 18.7 11.2 15.1 27.5 20.1 17.4 16.4 18.7 19.1 10.3 11.0 21.1 17.3 19.2 21.5 17.6 12.0 28.5 19.3 10.7 15.8 12.6 10.9 17.8 10.9 16.5 8.7 25.2 16.0 9.4 33.7 23.3 16.2 11.5 8.1 9.9 23.3 9.4 11.5 17.6 22.5 22.7 29.0 12.4 17.0 10.7 11.2 9.4 19.6 26.7 25.1 18.6 10.7 36.1 19.9 46.9 24.0 10.6 23.2 40.1 9.5 21.5 11.6 18.5 15.7 29.2 12.2 39.9 17.3 12.5 18.3 33.8 14.2 14.7 48.2 16.3 27.9 22.5 23.8 23.8 9.9 24.9 44.3 0.5 1.5 2.2 2.0 1.5 2.6 1.7 2.4 2.6 1.1 1.6 2.4 2.0 1.4 1.6 1.6 2.9 2.7 0.9 15.3 16.6 14.7 18.6 15.1 15.2 17.6 16.1 14.6 16.5 15.1 16.4 19.2 12.9 9.6 8.6 11.1 13.7 15.2 8.8 4.6 13.1 7.1 14.2 14.5 6.0 12.8 6.1 1.8 6.2 11.6 23.6 11.8 0.0 8.9 8.2 9.9 12.6 12.8 12.6 4.2 9.5 10.2 10.6 11.2 10.7 8.9 1.3 16.0 12.5 7.4 13.4 5.0 8.3 12.5 8.2 11.3 10.2 3.5 8.1 12.9 7.2 7.5 8.4 6.7 18.6 9.5 13.2 10.2 9.8 8.6 10.9 10.9 8.5 8.0 5.3 6.5 6.6 12.0 14.5 11.9 13.5 11.7 12.8 9.7 17.5 14.0 11.6 7.6 RBAK ZNF769 ENSG00000146587 "RB associated KRAB zinc finger" Q9NYW8 7 5045821-5069487 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071231 Supported Nucleoplasm NA NA Nucleoplasm "HPA071231: AB_2686370" "unprognostic (2.82e-2)" "unprognostic (1.98e-2)" "unprognostic (7.40e-2)" "unprognostic (1.85e-2)" "unprognostic (5.04e-1)" "unprognostic (4.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (5.91e-2)" "unprognostic (6.84e-2)" "unprognostic (5.10e-2)" "unprognostic (1.28e-1)" "unprognostic (2.50e-1)" "unprognostic (3.66e-2)" "unprognostic (6.12e-3)" "unprognostic (5.75e-2)" 4.4 3.8 4.5 4.4 4.3 3.8 5.9 7.1 5.8 4.7 4.1 4.4 4.5 5.2 4.7 5.9 4.4 3.8 4.1 4.1 4.8 4.5 6.6 4.0 6.5 4.9 5.0 3.7 4.8 5.5 7.0 3.9 4.6 5.0 4.8 4.9 8.4 4.7 4.8 4.2 6.0 5.1 4.5 4.3 5.2 5.0 2.9 4.7 5.7 5.6 6.1 6.8 4.2 4.7 5.1 8.9 6.7 9.2 17.0 6.6 6.1 7.5 5.5 4.3 5.3 6.3 8.3 5.4 10.5 4.5 6.4 10.0 10.8 10.4 8.5 8.2 2.3 7.4 7.7 9.2 6.9 7.0 12.9 8.9 5.9 9.9 5.3 11.8 7.7 5.3 6.1 16.2 3.7 6.7 15.7 3.2 11.9 14.5 3.0 7.0 5.3 14.9 7.7 6.1 11.3 9.4 15.4 7.7 12.6 11.5 11.7 7.7 15.3 4.5 6.3 10.0 7.3 9.1 11.4 9.7 9.2 6.3 9.5 8.2 0.0 0.2 0.4 0.5 0.4 0.7 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.0 0.5 0.1 0.4 0.3 0.1 4.5 4.3 7.1 5.8 4.1 4.8 4.9 5.0 3.7 5.0 4.3 4.7 5.1 7.4 0.0 8.2 0.0 6.5 4.2 3.4 4.7 5.2 8.2 6.1 3.9 13.4 7.2 7.3 0.0 10.4 2.8 7.9 5.1 1.9 5.9 1.1 7.5 10.1 6.1 4.9 11.6 0.0 5.8 2.2 6.7 8.6 6.9 5.7 11.7 7.9 5.3 3.7 21.9 0.0 5.6 2.0 8.2 4.0 1.4 8.1 5.2 3.6 0.0 5.7 6.0 5.2 0.0 0.0 6.0 3.8 8.6 6.7 5.9 5.6 3.7 8.8 8.2 0.0 8.8 7.0 5.0 3.2 7.5 7.0 1.9 6.4 9.1 6.1 4.2 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell type enhanced" "Detected in many" "Adipocytes: 165.7;Basal prostatic cells: 192.2;monocytes: 163.9;Oligodendrocyte precursor cells: 229.7;Oligodendrocytes: 734.9" "Cancer enhanced" "Detected in many" "renal cancer: 5.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 198.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 198.8" "Cell line enhanced" "Detected in many" "HL-60: 62.5;Karpas-707: 25.0;U-2 OS: 25.7;U-2197: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Nucleoplasm "Vesicles, Plasma membrane" "HPA050020: AB_2680993, HPA061622: AB_2684569" "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 10.6 1.3 3.8 7.9 15.4 6.2 5.0 3.5 15.3 1.7 0.0 2.8 0.9 8.5 2.8 3.5 2.3 11.5 5.3 6.5 8.0 2.8 1.8 6.2 0.9 20.7 12.4 3.0 0.7 3.2 0.2 1.1 3.7 27.9 1.2 1.7 1.3 3.5 1.0 3.2 2.5 2.2 4.7 2.3 7.4 1.5 0.7 15.0 0.7 1.8 4.0 0.8 4.5 2.3 30.2 0.1 0.6 7.3 0.4 0.4 10.3 0.3 0.7 1.6 4.4 6.6 4.2 2.7 18.9 1.3 1.8 4.5 0.7 0.2 6.4 13.8 0.0 5.0 20.4 4.2 0.4 0.4 62.5 0.7 1.3 1.2 18.9 20.1 0.9 3.0 0.1 2.4 25.0 1.5 0.1 0.1 0.0 9.1 0.1 7.4 0.5 6.8 0.5 9.0 2.0 0.7 5.2 0.3 0.4 2.2 10.0 0.2 1.5 0.8 8.6 25.7 28.7 8.5 1.5 4.5 0.2 9.4 0.3 14.8 0.1 29.9 0.0 0.0 9.7 0.0 1.9 0.0 0.0 18.2 0.1 0.0 0.0 198.8 0.0 3.9 0.3 0.0 7.0 3.8 15.4 3.5 15.3 6.5 8.0 20.7 12.4 3.0 27.9 2.3 15.0 30.2 165.7 6.4 7.2 10.7 3.2 21.9 192.2 8.2 13.1 1.3 10.7 8.9 16.8 17.2 6.3 12.9 0.0 4.0 0.8 0.0 1.9 74.2 0.4 41.0 56.3 31.3 0.0 0.4 17.0 27.4 13.4 108.0 3.1 69.7 14.0 0.6 14.3 0.5 8.3 5.0 22.2 0.0 6.1 47.4 118.2 1.6 5.9 75.8 30.2 22.5 163.9 14.3 4.1 229.7 734.9 22.5 0.0 0.4 3.2 44.9 0.0 25.6 4.7 0.9 19.7 143.5 31.8 12.6 7.3 12.0 13.2 24.8 3.1 2.6 0.0 35.1 FERD3L "bHLHa31, N-TWIST, NATO3" ENSG00000146618 "Fer3 like bHLH transcription factor" Q96RJ6 7 19144782-19145421 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "brain: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebral cortex: 1.7;medulla oblongata: 1.8;midbrain: 5.3;pons: 2.3;white matter: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 109 "SCLC-21H: 10.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 16 "midbrain: 20.2" HPA043494 Uncertain NA NA "HPA043494: AB_10964193" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 1.8 5.3 0.3 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.7 0.5 0.2 1.8 5.3 0.3 2.3 0.5 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019017-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 68.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 287.9;Skeletal myocytes: 251.2;Syncytiotrophoblasts: 376.8" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 13 "A-431: 5282.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 4740000 88000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.04e-5)" 28.2 11.5 11.8 4.0 14.5 0.0 20.2 17.6 9.8 20.6 8.9 12.4 5.7 11.5 10.4 23.7 14.1 9.0 6.9 6.2 10.1 11.7 35.6 15.0 2.5 11.8 15.3 3.4 15.2 16.0 3.5 2.9 68.5 14.4 16.4 10.8 10.3 22.3 15.1 11.0 51.4 9.6 9.4 6.0 5.1 11.2 4.3 19.1 12.9 20.7 20.8 8.3 14.9 24.3 7.3 5282.1 61.9 16.5 22.4 102.7 63.5 16.7 47.9 68.7 30.8 23.8 11.5 54.2 2.7 11.4 43.8 130.7 197.1 0.4 230.2 37.1 2.2 3.6 0.1 27.3 3.4 27.0 0.0 0.2 31.2 205.4 74.1 409.9 45.5 4.0 0.0 0.0 0.5 68.0 3.0 0.1 0.1 5.1 21.2 30.4 0.1 9.1 0.2 38.1 52.6 0.8 20.0 42.7 50.6 9.3 16.8 4.9 12.0 15.6 27.1 7.2 215.7 45.8 0.1 4.8 3.1 37.9 1.6 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 14.5 17.6 9.8 6.2 10.1 11.8 15.3 3.4 14.4 6.0 19.1 7.3 16.4 96.1 49.9 147.6 1.2 85.8 77.1 101.5 116.1 3.5 12.1 30.4 11.1 47.1 50.6 22.0 6.2 287.9 0.0 45.9 0.0 32.9 4.9 25.9 57.2 12.5 4.2 8.0 1.2 24.3 37.1 91.6 22.4 39.8 0.0 50.6 6.8 79.5 28.3 0.0 107.5 21.6 48.8 7.7 11.6 5.8 128.3 1.9 17.8 40.3 1.6 90.0 0.0 63.3 1.4 54.8 19.9 133.5 0.0 75.4 14.1 13.4 21.7 3.8 78.9 251.2 34.7 2.4 2.5 73.3 89.9 376.8 2.2 41.9 24.9 55.8 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 53.8;lymphoid tissue: 27.8;testis: 38.1" "Cell type enhanced" "Detected in many" "Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NK-cell: 2.8;T-reg: 2.0" "Group enriched" "Detected in many" 5 "NK-cells: 2.8;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.4" "Low region specificity" "Detected in many" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.4 1.2 1.3 10.6 1.2 53.8 2.0 0.8 1.7 1.2 0.8 6.9 5.8 1.3 0.3 9.4 0.9 0.9 0.8 1.3 0.9 0.9 1.3 1.9 17.2 1.4 1.2 1.2 0.6 0.7 0.4 0.5 6.6 1.6 0.8 7.7 0.5 1.5 0.5 0.6 4.3 5.9 3.2 0.7 6.6 3.2 38.1 1.5 27.8 0.6 0.5 16.3 2.2 2.8 1.7 131.7 74.9 67.2 57.3 4.5 7.3 57.8 92.7 37.4 103.6 81.5 77.7 75.4 121.3 52.3 29.4 120.8 87.9 110.3 49.5 98.6 122.0 52.2 107.7 54.4 64.1 0.4 116.8 81.8 2.5 4.5 96.3 44.0 10.8 32.6 138.4 126.6 206.6 63.5 109.2 164.7 116.9 107.8 63.0 92.4 140.4 76.8 111.9 21.2 49.6 89.1 68.4 59.3 80.7 62.8 41.6 104.7 54.7 19.9 92.7 97.2 99.5 101.7 106.9 187.8 195.4 37.2 69.5 97.4 0.0 0.1 0.2 0.4 0.0 0.0 0.3 0.5 0.3 0.4 0.5 0.0 0.3 0.0 2.8 0.3 0.3 2.0 0.7 1.3 1.2 0.8 1.7 1.3 0.9 1.4 1.2 1.2 1.6 0.7 1.5 1.7 0.9 0.0 0.5 0.0 4.6 3.8 1.2 1.3 0.6 0.6 2.3 4.4 1.0 0.0 0.8 0.0 2.1 19.7 2.2 4.6 1.9 0.8 56.5 1.1 1.5 2.3 0.0 21.8 1.1 0.8 38.3 3.5 3.1 1.5 3.8 14.5 1.1 0.0 11.7 1.7 0.6 4.7 2.0 2.8 1.5 116.9 2.8 1.7 0.0 1.0 2.1 0.9 2.1 0.0 0.6 0.6 0.1 1.5 16.2 1.1 1.1 0.6 0.4 0.2 0.0 0.5 2.7 50.4 31.1 7.1 1.0 3.7 4.2 1.9 9.4 1.6 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 1880.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 457.7;Basal respiratory cells: 777.7;Extravillous trophoblasts: 2064.1;Fibroblasts: 463.4;Urothelial cells: 809.9" "Cancer enhanced" "Detected in all" "renal cancer: 377.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 54.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8578.6;U-2197: 3469.4;U-87 MG: 1774.2" "Low region specificity" "Detected in all" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3250000000 3600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 338.0 16.3 17.1 28.7 17.9 1.2 280.6 13.9 24.0 280.4 36.5 88.5 68.5 552.5 43.5 28.4 132.0 45.0 214.0 17.9 40.9 66.5 727.3 37.8 68.9 23.0 20.5 15.1 235.1 14.6 28.3 98.8 1880.0 22.2 88.2 58.9 12.0 46.5 81.8 58.4 178.0 78.6 199.9 14.0 192.7 82.5 10.9 16.8 18.4 41.2 73.9 68.0 373.2 166.8 18.5 199.6 59.5 113.1 1.0 83.9 34.7 0.9 850.6 153.8 71.9 38.8 0.2 157.4 0.2 263.2 8578.6 35.6 466.5 1.5 3.4 29.2 0.6 0.1 0.3 20.8 0.2 21.9 0.4 1.6 285.7 12.8 15.1 53.8 112.3 0.7 0.0 0.1 3.2 26.8 1.2 1.3 1.4 7.8 1.8 10.9 0.8 0.4 81.4 53.2 423.6 13.6 32.7 293.9 11.4 15.3 250.6 1.5 0.7 0.5 815.4 1.7 3469.4 49.3 11.6 0.7 1.1 1774.2 0.3 282.1 0.0 0.0 0.0 10.1 0.0 8.0 0.0 10.9 10.7 0.0 0.0 4.9 8.1 0.1 0.0 0.0 54.5 0.8 4.5 17.1 17.9 13.9 24.0 17.9 40.9 23.0 20.5 15.1 22.2 14.0 16.8 18.5 260.4 3.2 3.9 0.7 1.9 457.7 148.9 777.7 8.0 2.8 12.6 30.4 12.6 8.6 409.7 228.1 0.0 94.1 10.0 0.7 11.7 145.6 1.3 32.3 220.1 168.0 273.7 5.3 2.5 2.0 2064.1 463.4 1.5 31.3 1.3 12.2 182.0 2.6 80.9 0.0 5.6 8.4 57.0 7.2 21.9 3.5 288.3 3.5 16.0 1.9 7.2 0.6 0.0 0.5 0.2 19.0 2.5 6.8 1.0 212.1 0.8 1.0 136.0 0.5 0.0 12.6 124.6 0.8 1.4 9.3 244.6 154.2 9.3 3.6 2.0 809.9 PURB PURBETA ENSG00000146676 "Purine rich element binding protein B" Q96QR8 7 44876299-44885530 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048766 Supported Nucleoplasm NA NA 150000 Nucleoplasm "HPA048766: " "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (9.49e-2)" "unprognostic (4.96e-2)" "unprognostic (2.18e-1)" "unprognostic (8.44e-3)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (1.88e-3)" "unprognostic (2.01e-1)" "unprognostic (4.12e-1)" "unprognostic (5.66e-2)" "unprognostic (4.29e-2)" "unprognostic (7.96e-2)" "unprognostic (1.41e-1)" "unprognostic (3.22e-2)" 10.7 7.9 9.1 10.8 10.5 13.6 11.8 18.5 12.0 10.5 8.4 11.2 7.6 10.8 7.6 11.5 9.4 7.9 7.8 10.1 9.3 9.3 8.6 10.5 10.3 7.6 9.7 9.5 10.0 8.5 11.0 7.5 13.2 10.3 10.3 7.5 25.2 9.0 9.1 12.3 14.2 9.0 9.8 8.9 9.8 9.0 6.0 8.6 13.5 11.6 9.2 10.4 9.8 9.4 12.0 16.4 9.0 15.9 30.0 14.5 22.9 10.6 22.1 17.3 16.3 15.7 13.6 12.4 24.4 18.9 25.7 38.6 29.6 15.0 19.6 32.1 20.0 12.2 12.2 23.2 7.7 14.5 19.4 18.7 18.9 24.6 31.2 22.7 17.3 17.5 19.8 21.8 22.2 34.6 22.7 16.2 24.2 24.7 11.0 15.7 13.2 48.0 16.0 13.5 27.7 15.7 22.2 22.1 45.5 14.0 19.0 30.5 21.9 29.7 28.4 31.2 18.6 37.7 38.8 36.6 7.7 21.2 22.3 38.5 0.4 0.2 0.3 0.3 0.1 0.3 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.1 9.1 10.5 18.5 12.0 10.1 9.3 7.6 9.7 9.5 10.3 8.9 8.6 12.0 50.1 38.5 40.9 17.0 20.1 69.8 39.5 21.5 35.9 65.3 40.1 29.6 19.8 27.1 28.1 18.4 33.3 19.0 38.9 19.1 9.8 19.6 21.3 45.4 59.1 41.7 20.4 9.2 24.0 22.5 12.0 26.9 23.9 53.7 36.8 33.0 36.0 14.6 16.4 53.8 23.9 18.1 30.5 25.7 108.3 16.9 20.8 53.8 17.8 20.6 21.9 40.2 21.6 18.6 42.4 28.9 12.3 19.9 16.0 46.0 13.5 12.0 28.3 57.0 46.0 61.0 44.6 25.6 11.8 43.4 86.1 18.9 23.8 21.6 23.3 44.1 IGFBP1 "AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12" ENSG00000146678 "Insulin like growth factor binding protein 1" P08833 7 45888360-45893660 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 1208.7" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 994.8" "Cancer enriched" "Detected in many" 29 "liver cancer: 385.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004445, HPA046972, HPA050640" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 28100000 25000000 "Golgi apparatus" "CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197" "unprognostic (8.66e-3)" "unprognostic (1.45e-1)" "unprognostic (9.41e-2)" "unprognostic (7.80e-2)" "unprognostic (7.04e-2)" "unprognostic (2.93e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.89e-2)" "unprognostic (2.09e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.90e-11)" "prognostic unfavorable (6.64e-4)" "unprognostic (7.20e-2)" "unprognostic (7.98e-2)" "unprognostic (3.43e-1)" 1.2 0.1 0.3 0.0 0.2 0.0 2.4 0.3 0.3 0.2 0.1 0.0 0.3 80.3 0.1 0.0 4.1 0.3 0.3 0.2 0.3 1.6 1208.7 0.1 0.1 0.8 0.4 0.2 46.6 0.5 0.0 0.5 206.2 1.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.5 0.1 0.1 0.4 1.1 0.3 0.0 0.0 0.0 0.2 0.7 0.2 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.3 1.4 0.1 1.6 0.3 0.0 0.0 0.7 0.0 0.0 0.3 0.5 54.7 0.3 1.1 0.1 0.1 0.7 11.3 0.1 0.6 0.3 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.3 0.0 2.2 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 84.9 0.0 0.0 0.0 0.2 145.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.3 0.2 0.3 0.8 0.4 0.2 1.0 0.3 0.4 0.7 0.4 0.0 0.5 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 5.7 1.0 35.8 0.7 0.0 0.0 0.9 0.0 0.0 0.0 11.0 0.1 4.7 94.3 0.9 3.5 10.7 0.1 0.0 1.6 1.8 0.0 15.9 0.0 2.1 6.8 994.8 1.7 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.1 0.5 0.0 0.0 3.4 0.8 0.0 0.0 0.0 SSC4D "S4D-SRCRB, SRCRB-S4D, SRCRB4D" ENSG00000146700 "Scavenger receptor cysteine rich family member with 4 domains" Q8WTU2 7 76389334-76409697 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.6;parathyroid gland: 7.1;pituitary gland: 2.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 11.0;Distal tubular cells: 3.9;Hepatocytes: 3.7;Spermatogonia: 3.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "EFO-21: 6.7;Hep G2: 9.6;SuSa: 10.7;U-2 OS: 25.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA062611 Uncertain "Secreted - unknown location" NA NA 980000 "HPA062611: AB_2684807" "unprognostic (3.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.83e-6)" "prognostic unfavorable (7.08e-4)" "unprognostic (3.52e-2)" "unprognostic (3.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.49e-2)" "unprognostic (8.49e-3)" "unprognostic (3.18e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.59e-1)" "unprognostic (3.90e-1)" "unprognostic (2.56e-2)" "unprognostic (1.73e-2)" 0.5 0.3 0.2 0.0 0.3 0.0 0.3 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 2.6 0.4 0.1 0.0 0.3 0.1 0.2 0.7 2.2 7.1 2.6 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 1.1 0.1 0.0 0.5 0.0 0.0 1.0 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.1 1.0 0.5 0.0 0.0 10.7 0.2 0.0 0.0 0.0 25.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.1 0.3 0.1 0.2 0.4 0.0 0.2 0.3 0.1 0.0 0.5 1.6 0.1 0.0 0.5 0.0 0.6 0.4 1.4 1.4 2.1 0.0 0.0 11.0 0.0 0.3 0.0 0.2 3.9 1.9 0.1 0.5 0.1 0.3 0.0 0.0 1.6 1.7 1.4 0.4 0.0 0.4 0.0 0.7 1.1 3.7 2.8 1.7 1.4 0.1 0.0 0.6 0.0 0.4 0.9 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.4 0.1 0.4 0.0 0.4 0.4 1.3 0.0 0.2 0.0 0.8 0.6 0.6 3.5 1.0 0.0 0.3 0.1 0.6 0.2 0.4 MDH2 ENSG00000146701 "Malate dehydrogenase 2" P40926 7 76048051-76067508 "Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 703.7;tongue: 607.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019714, HPA019716, HPA019848, HPA026720" Enhanced Enhanced Mitochondria No No 14000000 Mitochondria "HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685" "unprognostic (3.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-3)" "unprognostic (8.94e-2)" "unprognostic (6.45e-2)" "unprognostic (3.77e-2)" "unprognostic (3.60e-1)" "unprognostic (2.02e-2)" "unprognostic (1.40e-1)" "unprognostic (9.70e-2)" "prognostic favorable (1.49e-5)" "unprognostic (8.57e-2)" "unprognostic (9.64e-2)" "unprognostic (5.68e-2)" "unprognostic (2.66e-1)" 74.5 164.7 60.5 51.9 73.1 72.5 74.6 61.1 81.9 62.5 73.0 109.3 113.7 69.8 35.0 146.1 67.4 38.4 316.8 69.5 67.9 122.1 217.3 61.2 62.9 64.1 61.8 67.3 64.7 119.2 91.3 71.3 45.6 65.2 67.9 81.1 40.6 99.7 57.4 703.7 117.6 95.2 60.5 54.8 76.2 104.1 60.7 64.0 61.0 62.8 607.2 66.7 86.3 83.1 74.5 176.5 278.4 99.2 250.7 110.3 121.2 172.0 113.9 145.8 159.4 143.2 246.2 204.7 261.3 51.1 151.1 172.6 174.4 256.3 170.0 112.7 192.1 368.3 144.6 138.7 229.9 135.2 229.3 144.6 153.7 149.7 155.2 229.3 124.9 150.9 160.5 466.3 149.4 149.7 389.6 206.4 402.1 222.8 306.6 344.3 164.3 121.7 379.9 149.9 225.5 247.4 226.9 114.6 567.5 247.0 124.9 323.4 260.0 117.7 160.0 151.6 175.5 232.7 166.5 148.1 290.8 138.6 289.1 249.1 95.4 129.9 63.3 102.4 148.8 107.1 122.2 113.7 111.2 176.0 110.2 109.0 102.6 34.0 107.4 164.2 157.2 156.6 175.8 60.5 73.1 61.1 81.9 69.5 67.9 64.1 61.8 67.3 65.2 54.8 64.0 74.5 98.8 51.3 65.9 7.8 110.2 135.9 190.8 437.9 118.4 68.0 151.8 165.5 486.2 135.8 217.3 115.8 18.8 328.1 104.9 242.3 448.0 269.8 263.7 108.0 97.9 96.8 169.7 97.2 13.0 333.1 334.0 112.6 111.1 104.8 54.5 150.9 88.5 246.6 248.1 72.3 15.0 280.6 288.9 132.6 113.5 161.5 99.4 117.6 181.5 9.4 171.4 85.7 126.7 8.0 12.8 255.0 252.1 99.3 149.8 197.3 433.3 466.3 139.0 67.3 85.5 114.7 150.9 157.8 65.3 256.6 166.1 294.8 105.4 233.4 372.7 234.7 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 45.3;Late spermatids: 60.8;Spermatocytes: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA049817, HPA071198" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA049817: AB_2680896, HPA071198: " "unprognostic (2.23e-1)" "prognostic favorable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favorable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 13.8 10.7 5.9 3.6 5.8 6.9 13.4 7.8 9.8 14.6 4.5 13.4 2.4 16.3 4.6 10.8 12.4 2.2 13.7 6.0 4.9 11.3 5.6 10.5 3.4 6.2 5.7 5.3 16.7 13.0 2.6 10.2 1.9 6.1 14.6 3.5 6.3 9.4 4.4 20.0 12.2 9.5 6.3 3.8 9.1 12.7 29.8 5.4 4.8 11.4 0.9 3.7 14.0 12.4 6.3 2.8 11.1 17.7 22.7 11.4 4.4 2.6 3.9 6.2 2.7 3.7 6.5 5.0 1.7 1.0 3.6 6.2 1.5 4.1 1.9 2.7 7.0 6.4 7.6 6.2 4.0 2.6 3.4 4.8 3.8 7.3 9.8 3.2 1.4 1.7 2.8 4.2 12.8 12.8 3.5 6.2 14.2 7.9 4.1 5.6 2.4 12.9 2.9 2.1 4.2 9.1 16.7 3.6 16.2 6.1 18.6 6.1 4.5 7.0 8.9 1.2 22.2 9.5 3.2 3.0 12.3 1.7 13.7 12.7 0.6 1.2 2.3 0.8 0.5 1.2 0.8 1.4 1.4 1.2 1.6 1.7 0.9 1.3 1.0 0.6 1.2 1.4 0.4 5.9 5.8 7.8 9.8 6.0 4.9 6.2 5.7 5.3 6.1 3.8 5.4 6.3 5.5 3.2 4.1 4.2 8.1 7.0 7.3 11.5 21.1 5.0 8.0 8.4 6.7 2.8 3.5 5.5 12.5 6.9 7.7 8.1 0.0 1.4 45.3 5.8 5.7 4.3 13.1 9.4 8.2 2.2 3.2 8.1 25.5 7.0 5.7 4.7 2.5 1.7 3.2 3.3 8.6 4.8 2.0 4.9 3.3 60.8 6.2 6.5 10.6 2.8 0.8 5.0 2.1 6.6 8.1 1.8 9.3 7.9 15.2 4.7 4.3 5.9 4.1 5.3 13.1 2.9 5.6 33.0 8.0 18.3 7.0 10.4 9.1 2.0 6.3 11.1 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "heart muscle: 269.0;skeletal muscle: 651.6;tongue: 791.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 226.9;Endometrial ciliated cells: 107.5;Proximal tubular cells: 106.8" "Cancer enhanced" "Detected in all" "glioma: 73.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 301.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria NA NA Mitochondria "HPA063084: AB_2684938" "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 61.8 71.0 48.7 25.6 51.1 39.5 59.6 50.4 57.4 45.8 51.6 49.4 31.7 41.5 36.9 49.5 50.8 27.7 269.0 47.1 52.5 64.4 14.6 37.2 26.7 49.0 51.1 45.4 35.0 49.7 71.0 27.3 31.2 49.3 53.8 54.3 27.9 79.9 56.4 651.6 21.8 32.7 47.0 50.9 26.3 46.9 20.7 51.9 40.4 87.3 791.2 28.9 41.2 26.2 51.7 301.3 52.3 67.5 112.6 38.7 65.8 33.1 24.7 58.2 69.7 53.5 36.5 64.9 43.8 40.5 46.6 67.5 39.1 51.4 52.2 68.7 27.9 75.4 31.1 27.6 46.9 54.6 68.0 30.2 60.3 78.4 23.8 64.5 79.1 74.6 62.2 56.2 41.9 54.8 13.4 68.1 70.4 66.7 66.5 52.3 68.0 31.3 90.8 94.6 46.7 71.7 80.8 56.2 67.0 78.3 53.0 129.9 72.3 43.9 31.7 47.4 11.3 52.0 34.1 30.9 81.2 35.1 41.9 95.7 48.2 86.6 39.1 22.6 86.4 27.2 37.7 28.8 23.8 91.7 37.0 34.2 25.2 15.3 41.9 69.1 38.1 37.9 72.4 48.7 51.1 50.4 57.4 47.1 52.5 49.0 51.1 45.4 49.3 50.9 51.9 51.7 45.4 51.3 57.7 0.0 10.3 0.0 0.0 0.0 0.0 0.0 80.4 63.8 0.0 0.0 43.3 62.5 0.0 76.0 20.1 0.0 226.9 74.8 0.0 107.5 56.1 22.1 0.0 0.0 0.0 57.2 56.4 23.4 0.0 57.6 16.4 64.7 0.0 0.0 88.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 39.8 0.0 0.0 0.0 0.0 46.2 0.0 0.0 5.2 0.0 0.0 106.8 88.2 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 51.4 12.3 74.0 0.0 0.0 CCT6A "CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20" ENSG00000146731 "Chaperonin containing TCP1 subunit 6A" P40227 7 56051685-56063989 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 1612.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Supported Approved Cytosol NA NA 3600000 Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "prognostic unfavorable (4.04e-4)" "unprognostic (5.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (9.00e-10)" "unprognostic (1.19e-2)" "unprognostic (3.17e-1)" "unprognostic (1.67e-2)" "unprognostic (3.24e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.35e-1)" "unprognostic (1.20e-1)" "unprognostic (1.78e-1)" "unprognostic (9.44e-3)" 59.0 59.2 53.8 67.2 53.6 67.6 60.3 55.1 64.5 43.0 58.4 53.1 53.6 52.4 38.5 68.6 51.3 40.2 57.2 54.0 57.9 73.2 53.7 41.5 70.1 55.8 54.2 49.5 42.5 61.3 70.0 39.4 56.9 56.8 45.3 60.7 46.9 45.9 49.8 125.4 58.5 52.2 61.9 58.5 46.5 52.6 49.9 56.5 61.9 50.1 86.3 81.8 72.7 48.0 64.0 1612.6 357.8 211.6 322.5 145.7 181.6 243.2 293.0 165.4 284.4 227.7 407.0 196.7 487.8 222.9 192.1 511.6 333.2 438.2 339.2 390.0 276.8 328.1 306.1 337.0 363.8 157.3 444.1 240.5 157.1 191.1 287.8 284.4 224.8 283.7 221.2 682.0 121.2 325.5 199.2 346.4 392.7 449.3 356.6 466.8 315.1 213.9 284.8 321.6 302.3 280.3 282.0 259.2 440.7 272.6 321.8 324.6 341.6 238.6 194.1 372.4 651.4 617.1 146.7 321.5 596.7 194.4 389.0 658.4 21.0 69.9 34.0 57.8 87.7 77.3 65.9 59.7 63.3 96.5 50.4 59.8 64.8 8.4 77.7 103.0 54.0 68.3 81.2 53.8 53.6 55.1 64.5 54.0 57.9 55.8 54.2 49.5 56.8 58.5 56.5 64.0 94.6 89.8 106.4 13.1 83.3 108.8 201.4 175.3 91.6 60.2 77.4 83.2 114.0 65.8 187.7 47.8 27.1 199.6 93.4 56.6 88.0 263.1 22.5 209.6 121.0 129.4 102.1 163.4 19.3 274.2 264.8 97.0 88.2 133.8 131.7 123.4 71.0 66.7 148.2 38.7 23.7 94.2 124.1 83.5 79.2 19.5 70.5 104.0 58.7 19.7 206.9 80.7 80.3 18.1 22.7 245.6 66.7 90.7 106.4 184.8 65.2 146.4 190.3 60.8 59.2 99.1 136.3 115.0 219.8 160.9 109.7 199.9 91.8 189.7 138.6 145.9 PSPH PSP ENSG00000146733 "Phosphoserine phosphatase" P78330 7 56011051-56051604 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7" "Cancer enhanced" "Detected in all" "glioma: 41.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020376, HPA029515" Approved Approved Cytosol NA NA Cytosol "HPA020376: AB_1855867, HPA029515: AB_10601492" "prognostic unfavorable (2.30e-4)" "unprognostic (7.80e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (2.75e-5)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "unprognostic (4.45e-2)" "prognostic favorable (3.77e-4)" "unprognostic (3.78e-2)" "unprognostic (5.74e-2)" "unprognostic (2.64e-1)" "unprognostic (3.01e-2)" "unprognostic (1.90e-3)" "unprognostic (9.05e-3)" 4.8 9.5 11.6 3.7 12.5 3.7 3.9 12.3 11.0 4.5 12.7 4.8 4.2 4.9 5.3 8.8 16.3 5.9 8.2 11.2 11.3 10.1 6.9 3.5 5.1 12.3 11.8 10.6 8.2 6.8 6.7 9.5 3.7 12.8 6.5 4.4 4.4 4.5 6.5 4.6 4.1 4.1 5.1 12.7 4.0 6.2 7.2 13.2 5.9 7.1 6.1 5.9 5.3 5.8 16.3 130.1 37.6 23.1 93.0 18.9 25.3 16.7 32.5 18.5 18.7 32.7 34.7 23.5 62.9 21.0 29.4 44.5 26.9 52.6 26.9 19.0 48.1 27.9 17.9 11.1 62.2 44.4 18.6 26.8 31.8 50.2 27.7 32.6 25.1 17.7 61.2 44.4 42.4 26.4 17.3 27.7 48.3 38.0 47.5 52.1 35.9 14.4 39.8 17.2 6.8 43.6 49.8 23.5 14.9 68.9 20.9 44.8 41.4 14.5 15.1 24.8 45.5 30.3 26.9 53.0 72.8 21.9 39.9 49.7 2.5 6.2 5.9 3.1 4.4 2.3 5.4 3.0 3.8 9.6 6.1 4.5 4.1 2.9 4.7 7.1 9.3 4.0 4.8 11.6 12.5 12.3 11.0 11.2 11.3 12.3 11.8 10.6 12.8 12.7 13.2 16.3 2.1 3.2 1.5 11.4 5.2 6.8 16.9 20.5 8.6 5.2 8.3 5.8 13.1 11.5 11.4 5.5 2.1 12.8 4.5 2.4 107.6 8.6 149.8 62.9 5.4 4.2 4.8 7.2 9.3 8.0 7.5 9.9 3.1 9.4 1.3 16.5 5.0 9.8 9.5 1.7 9.8 5.0 4.1 4.4 5.8 211.5 8.4 4.3 7.2 0.0 5.7 46.8 2.1 7.1 13.8 7.1 3.5 6.0 10.1 6.5 3.1 91.7 28.3 3.1 13.1 5.1 20.0 30.1 22.5 7.6 8.5 4.7 3.9 16.1 7.3 7.7 TRIM50 "FLJ32804, TRIM50A" ENSG00000146755 "Tripartite motif containing 50" Q86XT4 7 73312536-73328082 "Enzymes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 29.3;parathyroid gland: 33.6;stomach 1: 49.1" "Cell type enhanced" "Detected in some" "Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2" "Group enriched" "Detected in some" 8 "liver cancer: 2.9;renal cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "Hep G2: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA019862, HPA047843" Uncertain Approved Cytosol NA NA Cytosol "HPA019862: AB_1858305, HPA047843: AB_2680176" "unprognostic (1.93e-1)" "unprognostic (3.93e-1)" "unprognostic (1.07e-2)" "unprognostic (5.96e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-3)" "unprognostic (2.63e-2)" "unprognostic (2.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.36e-7)" "unprognostic (3.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.25e-1)" 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.2 1.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 6.6 0.3 0.1 0.0 0.0 0.0 0.0 0.2 29.3 33.6 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 0.0 0.4 49.1 8.7 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 17.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.2 4.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 ZNF92 "HPF12, TF12" ENSG00000146757 "Zinc finger protein 92" Q03936 7 65373799-65401136 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "unprognostic (8.53e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (5.48e-3)" "unprognostic (1.30e-2)" "unprognostic (3.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.40e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-3)" 2.7 4.5 3.3 5.5 4.0 16.6 10.5 6.2 4.9 5.1 2.1 4.2 4.1 3.5 4.5 5.6 3.4 4.0 3.0 3.4 3.6 3.5 3.2 3.2 11.0 4.2 4.5 3.0 5.6 3.7 5.0 2.0 3.8 4.3 3.6 4.5 3.1 2.7 3.3 2.8 3.2 4.6 2.4 4.2 6.8 5.1 5.3 4.0 10.3 6.0 4.2 9.7 3.8 2.4 5.4 7.6 5.0 21.7 21.6 5.4 6.6 10.4 6.1 4.6 6.6 9.6 9.3 10.9 29.3 11.6 3.4 10.0 7.3 17.2 4.2 10.7 11.1 11.4 13.1 2.7 9.3 2.0 16.2 12.1 5.6 3.6 6.1 4.7 8.9 8.3 15.4 17.3 11.7 9.7 2.2 23.7 17.6 29.3 7.9 6.9 21.3 12.8 9.9 7.3 15.1 18.5 14.0 9.4 14.6 7.0 20.7 10.3 21.5 6.1 7.7 6.9 4.6 8.8 7.4 6.9 41.8 5.1 12.6 6.9 4.7 1.3 3.5 2.1 1.8 4.4 8.5 3.2 3.2 1.9 7.1 3.8 4.1 1.1 7.7 2.5 1.9 5.0 1.7 3.3 4.0 6.2 4.9 3.4 3.6 4.2 4.5 3.0 4.3 4.2 4.0 5.4 13.9 9.6 1.1 3.9 44.9 5.6 7.2 3.1 8.6 8.2 15.9 11.6 5.2 5.7 6.2 5.5 0.0 6.5 35.4 4.6 11.7 7.9 1.3 5.8 11.2 9.3 7.2 13.5 7.7 4.7 5.4 9.6 6.6 11.9 11.4 17.0 9.3 2.2 4.5 5.0 11.1 8.2 6.1 6.3 3.8 2.2 7.2 11.7 5.4 3.7 10.8 11.8 14.4 12.1 12.3 6.4 7.4 6.4 17.6 6.7 2.4 5.0 2.1 5.0 0.0 11.1 10.2 25.1 24.8 5.1 3.8 4.9 23.2 16.4 6.2 7.1 ATXN7L1 "ATXN7L4, KIAA1218, MGC33190" ENSG00000146776 "Ataxin 7 like 1" Q9ULK2 7 105604772-105876599 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 60.7;Early spermatids: 93.4;Excitatory neurons: 107.3;Inhibitory neurons: 96.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021448 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021448: AB_1845213" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (4.36e-2)" "unprognostic (1.01e-2)" "unprognostic (2.84e-1)" "unprognostic (8.20e-3)" "unprognostic (3.69e-1)" "unprognostic (2.51e-2)" "unprognostic (8.71e-2)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-2)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 4.8 4.3 2.2 4.5 3.1 4.4 4.5 4.6 4.5 6.7 0.5 4.8 4.2 4.7 4.5 4.1 5.9 4.3 2.6 3.0 1.1 7.3 6.4 4.0 6.5 2.0 1.0 2.1 6.6 3.3 4.9 3.3 5.7 2.3 4.8 5.9 2.1 5.9 3.9 2.3 5.9 5.0 4.2 0.0 5.8 4.8 10.3 1.3 10.2 5.0 3.1 5.9 4.5 5.3 2.6 3.2 4.3 9.0 4.2 5.5 6.5 2.8 5.7 5.6 5.0 4.6 4.2 6.1 1.3 4.3 6.1 4.4 3.0 5.1 5.9 3.7 18.0 3.3 4.3 3.2 4.1 3.3 7.1 13.9 4.5 4.7 3.3 3.3 3.7 4.6 3.0 5.2 2.8 4.2 7.7 3.9 4.3 16.7 9.0 4.3 3.8 3.0 1.0 3.8 3.2 5.6 3.7 4.0 8.0 7.9 8.9 4.1 7.2 11.5 7.8 3.5 6.5 2.2 0.6 0.0 0.1 4.8 10.9 8.0 2.3 3.8 4.2 2.4 4.4 1.8 3.5 6.5 5.6 2.9 3.5 6.9 3.9 1.3 4.4 2.8 1.9 14.3 3.3 2.2 3.1 4.6 4.5 3.0 1.1 2.0 1.0 2.1 2.3 0.0 1.3 2.6 8.3 0.0 3.9 60.7 8.0 5.1 5.4 4.9 6.2 7.8 5.2 3.9 2.4 4.3 3.6 5.5 2.1 6.3 16.8 11.3 5.9 3.9 93.4 13.1 6.4 5.2 5.4 9.4 107.3 2.6 3.6 5.9 11.2 7.9 5.1 7.9 6.4 17.0 7.5 8.4 96.3 8.5 2.0 11.6 6.1 56.6 6.5 9.3 8.8 55.3 10.8 2.0 19.6 46.8 51.3 4.2 11.0 4.5 7.4 4.6 43.7 42.6 14.9 1.0 6.6 7.5 6.4 20.9 2.5 7.0 4.0 5.3 13.3 7.7 9.4 3.7 TMEM168 DKFZp564C012,FLJ13576 ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762377-112790423 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favorable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 13.0 10.7 5.6 12.6 7.4 6.7 15.8 7.2 7.2 11.7 8.9 22.6 13.9 13.3 18.1 14.2 10.8 12.3 14.0 5.6 6.5 12.9 8.4 12.2 11.4 8.0 6.9 5.1 12.2 6.8 28.8 8.3 14.5 7.4 16.5 24.8 20.4 20.8 13.5 9.5 26.9 14.9 15.5 7.5 12.4 12.7 10.3 6.6 13.6 17.9 9.5 11.3 11.0 13.0 9.8 16.0 13.2 12.2 10.9 20.4 41.5 17.2 17.3 16.2 6.4 5.6 17.0 16.4 16.9 11.4 17.2 14.6 16.8 12.5 15.1 16.5 26.8 12.9 14.7 16.8 9.7 13.7 16.4 17.9 20.3 38.6 7.3 10.9 6.0 18.9 13.6 19.9 15.0 23.3 25.2 14.2 10.3 9.9 16.7 10.2 9.5 6.1 24.9 16.0 29.9 9.2 18.2 23.3 30.6 14.0 14.9 17.5 14.4 27.0 30.5 15.5 14.5 22.6 25.4 23.1 18.9 19.7 14.7 40.0 21.2 14.9 11.6 12.1 12.6 14.4 10.9 12.9 11.8 16.0 13.2 18.6 13.0 8.4 13.5 13.2 11.1 13.0 9.5 5.6 7.4 7.2 7.2 5.6 6.5 8.0 6.9 5.1 7.4 7.5 6.6 9.8 17.4 12.8 22.3 43.1 18.6 31.1 19.1 12.0 27.3 31.5 16.4 14.4 18.1 10.0 18.9 33.1 27.1 35.5 14.3 16.9 0.0 5.9 2.9 9.2 22.1 17.3 20.5 14.1 29.9 9.1 8.9 17.6 18.3 11.8 12.0 19.2 18.5 12.6 8.9 16.8 32.6 34.8 16.2 13.5 9.3 1.9 18.3 10.9 24.9 41.2 10.8 16.3 15.5 70.9 71.5 6.1 17.0 14.7 10.2 21.6 15.5 6.0 7.1 29.6 6.6 19.4 16.7 18.1 13.3 24.8 26.0 14.2 13.8 21.1 30.5 14.5 ASB15 FLJ43370 ENSG00000146809 "Ankyrin repeat and SOCS box containing 15" Q8WXK1 7 123567010-123639481 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 27.6;skeletal muscle: 120.5;tongue: 84.8" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 54.2;Early spermatids: 35.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.19e-1)" "unprognostic (7.45e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-1)" "unprognostic (6.09e-6)" "unprognostic (7.31e-2)" "unprognostic (6.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.6 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.6 0.0 120.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 84.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.4 0.0 1.7 0.3 0.3 54.2 0.0 0.2 0.0 0.0 0.2 0.2 0.3 1.9 0.2 35.0 0.8 0.4 0.4 0.0 0.0 0.4 0.4 1.4 0.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 5.6 0.6 0.0 3.6 0.0 0.0 0.3 0.0 0.5 0.1 0.7 0.0 0.0 0.0 0.7 0.1 10.4 0.1 0.1 0.0 6.9 0.8 1.2 0.4 0.0 0.1 1.1 0.2 0.3 0.2 0.3 MAP11 "C7orf43, FLJ10925, TRAPPC14" ENSG00000146826 "Microtubule associated protein 11" Q8WVR3 7 100154420-100158723 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 7.0;Extravillous trophoblasts: 7.2;Hofbauer cells: 7.7;Syncytiotrophoblasts: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019359, HPA029463, HPA029464" Approved Enhanced "Vesicles,Plasma membrane,Centriolar satellite" NA NA Vesicles "Plasma membrane, Centriolar satellite" "HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205" "unprognostic (1.57e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-3)" "unprognostic (2.59e-1)" "unprognostic (5.23e-2)" "unprognostic (1.06e-1)" "unprognostic (9.36e-3)" "unprognostic (5.68e-3)" "unprognostic (6.97e-3)" "unprognostic (1.25e-1)" "prognostic favorable (6.19e-5)" "unprognostic (2.42e-2)" "unprognostic (1.85e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-1)" "unprognostic (3.26e-1)" "unprognostic (6.54e-3)" 7.1 13.4 8.7 16.8 8.8 12.0 8.5 8.5 9.8 9.4 6.0 14.8 14.4 11.9 6.4 16.1 9.6 7.2 7.0 9.7 10.7 15.9 17.3 10.7 20.9 10.2 10.5 8.6 6.8 13.9 17.8 18.0 7.3 10.8 13.0 11.6 5.0 15.4 8.5 5.6 25.2 22.6 5.8 6.1 32.5 17.9 30.5 11.5 14.0 15.6 3.8 12.5 9.5 10.9 10.6 7.6 9.7 11.1 18.8 6.8 3.7 12.5 13.9 10.8 9.4 6.8 7.6 8.8 9.6 12.4 10.5 14.6 14.4 5.3 11.0 3.6 18.1 10.6 7.3 13.5 6.7 8.1 9.0 32.1 7.5 7.4 9.1 7.0 6.8 8.3 9.7 15.9 16.9 12.4 23.6 20.7 19.3 12.4 14.0 13.9 12.3 5.1 10.7 8.2 8.6 14.0 14.8 12.5 35.7 7.6 7.3 7.2 10.7 11.5 18.6 15.7 24.7 10.9 24.8 25.4 9.7 10.5 12.3 20.2 0.6 0.3 1.4 0.6 0.6 0.5 0.2 0.8 0.6 0.2 0.6 0.4 0.7 1.9 0.2 0.6 0.2 0.0 0.2 8.7 8.8 8.5 9.8 9.7 10.7 10.2 10.5 8.6 10.8 6.1 11.5 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 SLC12A9 CIP1 ENSG00000146828 "Solute carrier family 12 member 9" Q9BXP2 7 100826820-100867010 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 61.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067536 Approved NA NA "HPA067536: AB_2732768" "unprognostic (6.53e-2)" "unprognostic (3.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.11e-3)" "unprognostic (3.47e-2)" "unprognostic (2.37e-2)" "unprognostic (8.38e-3)" "prognostic favorable (5.97e-4)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.00e-4)" "unprognostic (2.47e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.52e-2)" "unprognostic (6.00e-2)" "unprognostic (6.74e-3)" "unprognostic (6.38e-2)" 7.0 8.2 6.2 8.7 9.1 7.7 6.4 9.4 10.9 8.0 5.3 8.4 7.9 8.2 1.2 7.4 6.8 9.6 4.3 6.1 8.5 7.4 6.8 8.3 7.3 11.2 9.5 6.1 6.8 10.6 6.4 3.6 14.1 9.5 8.1 5.7 0.7 7.5 6.5 2.6 7.9 8.4 6.7 9.1 14.2 7.0 2.7 7.9 6.0 5.9 3.2 3.8 9.3 6.2 11.9 16.1 12.4 4.2 33.9 12.4 7.3 42.2 7.9 15.1 11.7 16.6 17.7 26.7 11.5 25.1 15.0 18.8 17.3 7.3 17.6 3.1 12.3 12.1 4.4 13.8 12.6 15.1 5.4 18.0 18.0 9.9 9.3 9.4 9.5 23.2 9.1 10.5 6.1 16.8 49.8 5.7 25.5 8.3 33.3 24.6 13.3 4.2 17.9 11.6 14.3 7.0 15.8 8.7 61.7 16.7 7.0 7.7 19.1 14.5 14.4 14.3 23.8 14.4 3.2 13.7 4.0 10.2 18.0 17.4 0.0 1.5 0.0 0.2 1.8 0.3 0.6 0.1 0.1 2.4 0.6 0.2 0.1 1.4 0.2 1.9 1.2 0.3 0.9 6.2 9.1 9.4 10.9 6.1 8.5 11.2 9.5 6.1 9.5 9.1 7.9 11.9 10.6 3.2 16.1 3.9 12.3 11.0 12.0 6.9 10.8 6.6 12.6 11.0 2.1 11.5 10.1 18.4 2.1 90.0 21.7 14.1 0.0 12.7 0.9 5.6 9.1 13.6 11.4 1.7 2.0 13.4 28.2 10.2 18.3 9.5 1.3 14.7 15.7 6.9 31.2 6.7 2.6 13.6 10.2 23.9 18.3 0.7 9.0 27.2 8.8 3.7 24.6 18.7 8.2 6.0 5.8 14.9 23.7 6.4 9.7 8.3 14.7 10.9 4.8 6.7 13.1 9.4 7.3 1.7 7.8 12.9 11.4 50.2 13.4 17.2 19.6 9.6 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 100.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules NA NA Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.42e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 23.2 26.1 18.6 15.8 20.1 30.7 27.1 25.4 24.3 33.1 18.8 25.3 15.9 35.2 11.1 19.2 30.5 10.5 21.5 18.1 15.6 23.2 23.3 22.8 19.1 19.4 17.6 17.4 43.8 36.4 13.6 42.3 11.5 20.0 28.7 8.1 8.9 29.8 13.8 26.7 33.4 30.9 11.3 14.7 39.4 25.3 32.5 18.0 17.3 33.1 16.8 11.4 23.7 23.8 21.3 16.5 16.8 26.1 38.2 12.3 9.6 46.6 15.3 12.4 9.4 10.8 9.8 27.6 22.9 19.2 11.1 19.0 19.4 12.9 15.3 5.8 24.4 26.4 15.9 48.5 14.3 12.2 18.1 26.1 15.1 12.2 12.0 17.0 15.3 9.5 26.4 44.8 21.9 8.7 37.5 32.1 100.1 32.0 6.5 20.1 51.2 13.9 23.1 6.9 14.8 23.3 36.7 19.8 31.2 18.2 17.6 14.2 30.2 14.7 26.8 32.9 44.7 14.2 17.8 8.4 12.3 15.6 35.9 16.2 2.2 1.3 1.2 2.4 1.2 1.8 1.3 1.6 1.5 0.5 1.9 1.4 1.5 4.5 1.3 1.3 2.0 0.9 0.5 18.6 20.1 25.4 24.3 18.1 15.6 19.4 17.6 17.4 20.0 14.7 18.0 21.3 26.5 3.2 7.8 19.9 18.1 31.7 11.0 5.8 8.0 25.5 25.5 20.6 8.3 32.9 5.8 18.4 18.8 12.0 31.2 19.5 15.6 11.5 1.0 12.2 24.3 17.5 18.6 9.9 18.1 9.4 10.7 17.8 18.8 17.5 5.7 26.5 22.5 19.0 11.4 52.2 17.7 22.8 6.1 25.5 19.8 3.8 24.5 15.6 17.8 29.0 12.5 15.3 20.6 14.6 22.6 11.8 18.0 18.0 10.5 16.7 20.4 9.9 5.0 28.0 32.9 33.2 19.6 16.4 36.0 6.8 22.4 16.3 20.5 12.9 16.1 10.2 TRIM4 RNF87 ENSG00000146833 "Tripartite motif containing 4" Q9C037 7 99876958-99919531 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019356, HPA029461" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA019356: AB_1856376, HPA029461: AB_10600834" "unprognostic (1.88e-1)" "unprognostic (2.97e-2)" "unprognostic (3.37e-1)" "unprognostic (3.46e-2)" "unprognostic (1.80e-2)" "unprognostic (7.06e-2)" "unprognostic (1.22e-1)" "unprognostic (5.42e-2)" "unprognostic (3.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.48e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.36e-6)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (7.46e-2)" "unprognostic (5.65e-2)" 18.0 21.7 11.6 17.2 12.3 9.3 27.1 15.7 12.8 18.8 15.0 17.5 17.6 24.0 20.0 15.4 23.2 15.3 9.6 10.7 12.7 20.8 23.1 18.7 22.6 11.5 11.8 9.8 41.6 24.0 25.7 16.4 20.1 12.2 23.2 19.4 21.7 19.1 20.4 7.6 21.9 18.8 20.1 11.0 21.7 20.3 16.2 11.8 21.1 24.7 11.9 24.0 17.4 17.5 13.4 20.8 26.2 14.4 12.0 37.0 34.6 6.3 34.6 41.3 28.0 32.4 13.1 20.1 30.3 0.1 28.8 24.2 24.3 19.0 21.2 28.4 31.2 1.4 25.3 13.1 20.8 52.4 35.9 29.4 36.9 44.3 21.6 54.7 37.8 24.6 14.9 37.1 45.3 23.9 26.4 26.8 32.2 10.9 31.0 21.0 15.0 20.6 34.6 31.6 26.4 16.8 11.9 26.4 39.4 42.3 20.7 18.2 20.2 30.6 30.7 27.6 59.5 33.6 37.7 44.4 24.0 20.1 39.7 41.7 38.2 28.4 23.6 28.5 28.6 32.8 26.2 29.4 32.6 24.9 25.3 40.7 30.4 11.7 22.3 26.1 18.5 32.8 28.0 11.6 12.3 15.7 12.8 10.7 12.7 11.5 11.8 9.8 12.2 11.0 11.8 13.4 17.8 25.6 20.1 19.2 32.3 25.1 24.8 17.7 25.0 21.6 21.8 18.0 6.1 18.6 14.2 22.0 18.8 16.4 28.1 10.1 9.8 15.9 7.4 12.5 25.4 18.8 9.0 16.8 18.3 12.8 6.7 20.1 19.4 11.4 27.3 19.0 22.5 20.4 14.3 6.7 20.7 10.4 16.2 21.4 14.8 13.1 31.1 21.2 23.2 12.2 27.0 35.9 32.0 23.1 22.5 14.9 10.4 27.4 20.1 26.6 17.8 19.0 16.5 22.1 0.0 21.8 20.4 22.4 9.4 18.0 23.0 16.3 29.8 52.5 13.5 23.6 MEPCE "BCDIN3, FLJ20257" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434118 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" NA Yes Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: AB_2681544" "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favorable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 26.3 41.4 28.2 19.5 28.5 28.5 24.4 31.6 31.8 24.7 24.3 25.3 18.7 29.1 28.0 27.8 27.3 19.6 22.8 27.8 29.4 32.2 37.2 22.1 29.2 29.2 28.2 25.9 36.3 22.7 35.3 23.7 21.1 28.9 26.7 13.1 10.0 25.1 20.9 38.8 34.8 27.4 18.1 27.7 57.0 24.8 80.5 28.3 28.3 36.8 31.8 24.4 28.5 22.1 29.2 42.6 53.6 38.9 41.9 36.8 36.7 29.1 46.4 66.5 48.7 37.4 43.8 60.1 87.1 75.5 29.1 38.5 38.4 43.0 34.9 32.0 39.4 49.4 45.1 41.5 33.3 30.9 58.0 53.0 38.2 40.9 55.7 70.0 26.5 41.1 27.4 90.6 62.2 47.2 155.6 66.3 129.8 72.1 35.0 58.9 53.0 31.5 79.1 32.7 25.6 58.5 50.6 72.5 139.1 49.1 19.3 35.6 52.1 36.2 81.5 63.5 55.9 62.0 41.0 42.4 96.3 45.8 71.1 72.9 2.6 2.6 3.7 3.8 2.3 4.6 6.2 4.4 4.2 3.3 6.6 6.2 5.5 6.4 5.9 1.9 6.3 4.5 7.5 28.2 28.5 31.6 31.8 27.8 29.4 29.2 28.2 25.9 28.9 27.7 28.3 29.2 34.2 9.6 18.9 5.5 33.8 30.2 17.3 7.1 19.9 9.9 30.2 21.6 25.6 20.0 7.8 22.0 8.4 15.8 34.3 32.2 15.6 10.3 29.6 18.3 13.1 21.7 10.7 9.9 2.8 12.0 8.5 17.3 54.6 18.8 18.3 14.5 28.9 22.1 12.7 11.8 2.6 26.1 8.2 26.7 16.9 66.5 17.4 32.9 8.8 7.5 18.1 19.4 15.5 2.5 2.7 10.4 23.6 15.4 14.9 15.6 39.9 14.4 10.4 9.5 6.6 35.0 17.9 44.8 15.1 22.3 25.1 21.2 25.0 19.5 20.3 9.9 ZAN ENSG00000146839 Zonadhesin Q9Y493 7 100733595-100797797 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Early spermatids: 15.0;Late spermatids: 16.2" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (3.69e-1)" "unprognostic (4.60e-2)" "unprognostic (5.83e-6)" "unprognostic (9.44e-2)" "unprognostic (4.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (5.70e-2)" "unprognostic (4.10e-9)" "unprognostic (5.70e-2)" "unprognostic (2.58e-1)" "unprognostic (8.43e-2)" "unprognostic (3.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.1 0.1 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164713-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" NA NA "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 9.0 15.5 5.0 8.5 6.9 9.7 10.7 8.5 6.6 7.5 11.8 11.1 8.9 10.9 9.5 5.6 9.7 6.5 6.3 4.8 7.3 8.7 10.4 9.3 12.0 7.7 6.5 3.6 10.3 8.6 15.2 4.5 9.6 6.6 8.4 11.3 13.4 7.9 8.4 5.2 7.3 10.8 9.1 5.4 10.6 7.6 15.1 6.3 14.3 16.3 7.7 12.2 7.7 4.3 10.2 23.4 21.8 29.3 36.7 16.8 17.2 21.4 20.8 20.9 18.3 24.7 23.0 39.2 34.6 15.1 13.3 34.5 34.2 34.7 24.2 33.0 42.7 20.0 17.9 34.0 16.5 29.6 38.2 17.2 18.9 24.6 37.0 36.8 11.4 14.5 35.1 58.9 38.2 23.2 30.2 73.2 23.6 44.1 20.9 19.4 38.9 33.1 57.4 19.1 29.3 26.2 40.0 47.5 75.8 31.3 22.7 23.7 25.6 11.4 33.0 13.1 35.4 50.6 51.7 81.6 70.4 54.7 43.4 53.0 16.1 12.2 13.8 22.0 18.3 23.0 18.3 22.3 20.2 12.0 17.3 25.6 22.3 1.8 19.5 16.8 14.9 24.6 15.1 5.0 6.9 8.5 6.6 4.8 7.3 7.7 6.5 3.6 6.6 5.4 6.3 10.2 12.3 3.2 12.3 11.4 15.3 4.7 4.0 8.2 6.8 13.6 8.8 5.2 8.6 10.0 9.8 9.2 4.2 8.9 15.2 7.2 1.9 6.4 33.5 9.6 8.0 9.5 13.8 25.9 10.4 9.1 9.3 7.5 7.7 10.4 10.1 10.0 9.7 9.4 7.9 5.0 13.0 11.9 8.2 13.1 4.4 8.5 6.5 7.8 7.2 15.0 7.7 18.1 8.2 10.6 20.9 7.6 11.6 5.3 11.0 5.3 13.4 4.9 9.8 14.6 0.0 9.0 5.9 16.6 16.0 6.4 5.4 6.6 13.1 12.1 9.5 3.7 AGBL3 "CCP3, MGC32955" ENSG00000146856 "ATP/GTP binding protein like 3" Q8NEM8 7 134986508-135147963 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 8.0" "Cell type enhanced" "Detected in many" "Early spermatids: 70.5;Excitatory neurons: 40.7;Inhibitory neurons: 34.2;Oligodendrocytes: 37.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 5.5" "Low region specificity" "Detected in all" "HPA020397, HPA024150" Uncertain Approved Cytosol NA No Cytosol "HPA020397: AB_2242453, HPA024150: AB_1844639" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (4.72e-2)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-3)" "unprognostic (3.32e-3)" "unprognostic (4.18e-2)" "unprognostic (7.15e-4)" "unprognostic (5.00e-3)" "unprognostic (6.10e-4)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.18e-2)" "unprognostic (2.14e-1)" "unprognostic (8.13e-2)" "unprognostic (1.11e-3)" 1.0 1.0 1.9 2.4 1.9 2.2 2.4 2.4 2.7 0.8 1.6 1.2 0.8 2.9 8.0 0.1 1.8 0.7 0.8 1.4 1.9 1.7 0.6 1.8 2.4 1.8 1.6 1.5 3.5 2.3 0.4 0.3 0.9 1.9 1.9 1.5 1.3 2.6 2.1 2.5 2.5 2.0 1.6 1.9 3.8 2.5 5.1 1.6 0.9 2.8 0.8 0.9 0.3 0.2 2.2 1.7 0.9 2.2 0.5 0.6 0.8 1.3 0.4 0.0 0.3 0.5 3.0 1.9 2.7 0.8 0.0 0.9 1.8 0.8 0.3 0.0 2.2 5.5 2.3 4.0 3.0 0.0 1.0 0.0 0.1 0.0 1.3 0.0 0.0 0.9 3.0 1.7 1.5 0.3 1.5 0.6 0.9 1.9 0.2 0.2 1.6 0.1 0.8 1.5 0.3 1.3 1.4 0.3 0.0 0.2 0.0 1.2 2.3 0.0 0.2 0.5 0.3 1.0 3.3 1.1 1.3 1.1 2.8 2.7 0.0 0.1 0.1 0.8 0.0 0.7 0.8 0.4 0.9 0.2 0.7 0.7 1.7 0.2 0.9 0.0 0.6 0.6 0.6 1.9 1.9 2.4 2.7 1.4 1.9 1.8 1.6 1.5 1.9 1.9 1.6 2.2 6.7 3.2 0.6 18.3 3.5 1.3 0.9 1.2 2.8 5.1 2.2 2.2 2.1 4.3 2.0 9.2 2.1 0.3 0.9 0.6 7.9 4.6 70.5 6.6 1.8 4.8 3.0 3.0 40.7 2.9 0.4 2.8 4.6 2.6 1.3 3.2 5.0 1.9 0.5 3.3 34.2 0.4 0.0 1.3 0.7 11.8 3.4 0.8 5.4 22.5 6.9 2.8 1.0 16.6 37.3 1.7 0.1 2.2 6.1 1.3 0.4 7.6 6.4 3.3 0.0 2.0 4.1 21.4 6.3 1.2 0.3 0.1 2.0 2.4 0.5 1.0 STRA8 ENSG00000146857 "Stimulated by retinoic acid 8" Q7Z7C7 7 135231979-135258492 "Predicted intracellular proteins" "Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "choroid plexus: 5.3" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 10.8" "Cancer enhanced" "Detected in many" "renal cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;THP-1: 2.4;U-266/84: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA078044 Approved Cytosol NA NA Cytosol "HPA078044: " "unprognostic (2.84e-1)" "unprognostic (4.86e-2)" "unprognostic (3.89e-2)" "unprognostic (9.67e-4)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (1.26e-3)" "unprognostic (1.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.45e-1)" "unprognostic (2.69e-1)" 0.1 0.0 0.6 0.0 0.4 0.0 0.0 0.2 0.4 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.3 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.1 0.1 0.0 0.0 0.0 0.2 1.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.4 0.9 0.2 0.4 0.4 0.2 0.6 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 10.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 ZC3HAV1L "C7orf39, MGC14289" ENSG00000146858 "Zinc finger CCCH-type containing, antiviral 1 like" Q96H79 7 139025706-139036042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 5.6;Gastric mucus-secreting cells: 4.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "basophil: 10.2" "Lineage enriched" "Detected in single" 11 "granulocytes: 10.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020386, HPA050741" Uncertain Enhanced Cytosol NA NA Cytosol "HPA020386: AB_2257412, HPA050741: AB_2681224" "unprognostic (1.12e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (3.07e-2)" "unprognostic (1.50e-1)" "unprognostic (6.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (8.51e-2)" "unprognostic (3.34e-3)" "unprognostic (2.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.00e-2)" "unprognostic (1.49e-3)" "unprognostic (5.04e-2)" "unprognostic (2.88e-1)" "unprognostic (1.84e-2)" "unprognostic (3.08e-3)" 3.2 3.8 2.4 2.6 2.5 1.3 3.4 0.1 2.2 3.3 8.4 2.3 3.3 6.8 2.2 4.3 4.9 3.2 2.6 3.4 2.9 2.9 0.9 2.5 2.5 1.4 1.1 1.8 9.3 1.8 2.3 1.6 9.6 1.2 4.0 3.3 0.5 2.6 4.3 1.8 8.8 2.7 5.3 0.9 4.7 2.8 2.0 3.1 2.9 8.4 1.6 3.1 2.7 2.8 1.0 14.9 11.9 8.6 28.8 7.1 10.8 0.4 7.2 3.2 5.3 7.3 19.9 8.4 0.4 10.1 7.8 0.0 10.5 12.1 3.0 16.0 8.8 0.1 19.0 12.6 6.8 5.7 0.1 6.6 8.3 4.6 7.9 3.7 0.3 9.1 9.3 8.3 0.5 10.9 0.1 20.4 11.4 1.5 2.0 7.4 21.1 29.2 0.2 4.9 7.9 5.8 26.1 17.7 2.5 10.6 1.7 10.9 7.7 12.7 9.5 8.5 3.2 0.1 0.5 0.1 0.3 5.3 0.1 9.0 10.2 0.1 0.9 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.9 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.2 2.4 2.5 0.1 2.2 3.4 2.9 1.4 1.1 1.8 1.2 0.9 3.1 1.0 2.4 0.0 0.0 1.6 0.1 0.4 0.9 0.2 2.8 0.3 0.8 1.7 0.5 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.2 0.0 1.4 4.4 1.6 0.0 3.8 5.6 0.0 1.6 2.0 4.6 0.8 4.5 3.0 1.1 0.0 0.9 0.0 2.3 0.0 0.0 0.3 0.3 0.0 1.8 0.5 0.0 9.4 0.0 0.6 0.0 5.5 0.2 0.2 0.0 1.5 1.5 0.6 0.0 0.3 0.1 0.0 0.0 0.9 2.3 0.0 0.6 2.9 1.0 0.7 0.2 3.8 0.2 0.5 TMEM140 FLJ11000 ENSG00000146859 "Transmembrane protein 140" Q9NV12 7 135148072-135166215 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 41.0;Plasma cells: 56.0;Syncytiotrophoblasts: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 358.4;eosinophil: 109.1;neutrophil: 429.1" "Lineage enriched" "Detected in all" 8 "granulocytes: 429.1" "Cell line enhanced" "Detected in many" "ASC diff: 77.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.52e-2)" "unprognostic (2.34e-2)" "unprognostic (3.26e-1)" "unprognostic (3.11e-1)" "unprognostic (1.79e-1)" "unprognostic (3.37e-2)" "unprognostic (9.72e-2)" "unprognostic (7.65e-3)" "unprognostic (3.41e-1)" "unprognostic (7.59e-2)" "unprognostic (5.20e-2)" "unprognostic (7.19e-2)" "unprognostic (2.35e-2)" "unprognostic (3.17e-2)" "unprognostic (1.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 33.8 19.4 17.0 19.7 20.2 11.0 28.6 20.3 18.0 15.6 13.4 16.3 18.0 15.3 7.6 9.3 11.8 19.4 23.0 11.8 17.5 27.1 53.8 31.0 20.3 29.3 19.9 9.5 15.0 15.0 2.5 5.3 21.8 24.0 12.1 8.5 3.0 17.7 10.4 88.4 8.8 17.4 10.6 19.6 28.1 12.7 4.8 19.5 6.5 11.0 21.1 9.2 16.6 14.9 34.3 11.5 27.5 9.8 19.4 77.3 15.2 8.8 8.8 13.2 6.6 16.7 10.7 11.5 15.3 11.2 3.6 45.5 11.2 0.0 0.2 1.1 30.1 12.6 9.2 11.7 10.9 16.2 21.4 14.1 4.0 0.6 2.6 0.0 16.4 10.5 11.3 20.6 50.2 2.1 10.2 20.7 9.8 19.8 16.9 15.6 14.5 14.1 33.0 4.0 17.6 10.8 17.2 8.4 12.4 21.7 6.7 5.1 19.2 10.8 8.0 5.6 17.9 10.9 55.5 44.8 22.1 24.4 25.1 19.8 358.4 28.1 109.1 45.0 23.6 33.2 34.7 36.9 43.9 12.0 46.2 41.0 44.6 429.1 39.2 32.7 1.9 50.6 63.6 17.0 20.2 20.3 18.0 11.8 17.5 29.3 19.9 9.5 24.0 19.6 19.5 34.3 27.8 3.2 0.6 1.0 17.9 1.8 0.6 0.8 0.0 1.1 0.9 1.1 5.3 11.5 1.8 9.2 0.0 7.5 7.2 17.2 3.9 24.9 11.6 2.6 3.9 26.4 5.3 7.0 1.2 3.8 2.1 11.6 5.6 7.2 5.1 2.3 41.0 27.2 17.6 3.3 1.1 3.9 0.0 10.5 3.2 2.8 10.5 15.6 26.6 15.0 10.1 0.2 12.3 2.5 16.6 4.5 15.0 5.3 56.0 1.4 24.8 17.9 2.1 0.6 0.0 5.2 6.0 0.4 0.2 0.8 2.3 48.4 18.4 3.3 1.0 1.5 TLK2 "MGC44450, PKU-ALPHA" ENSG00000146872 "Tousled like kinase 2" Q86UE8 17 62458658-62615481 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" "unprognostic (7.06e-2)" "unprognostic (1.48e-2)" "unprognostic (9.53e-3)" "unprognostic (6.57e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (4.53e-2)" "unprognostic (5.28e-2)" "unprognostic (2.32e-1)" "unprognostic (2.82e-2)" "unprognostic (4.78e-2)" "unprognostic (5.32e-2)" "unprognostic (9.79e-2)" "unprognostic (4.32e-2)" "unprognostic (4.88e-1)" "unprognostic (7.30e-2)" 20.1 17.0 7.2 21.2 13.4 36.4 11.9 18.7 12.8 12.5 7.2 21.9 20.7 23.1 8.7 23.8 13.3 21.1 22.8 7.5 9.8 15.3 12.6 16.3 25.7 17.0 12.9 2.5 21.8 18.1 16.2 9.9 17.6 14.9 16.2 15.0 43.8 16.7 11.5 32.7 23.9 20.7 16.2 10.1 21.6 18.7 52.5 10.5 23.5 30.3 22.0 17.3 19.3 11.0 24.4 40.9 36.9 62.2 66.4 20.3 26.0 36.6 44.1 34.4 51.7 46.6 39.0 35.7 79.0 22.0 29.2 45.1 27.2 45.1 19.0 48.9 42.3 36.1 54.2 33.6 39.2 36.2 57.9 33.1 22.7 25.4 34.7 41.7 31.2 25.9 44.9 54.4 36.0 28.3 89.2 82.7 22.0 39.8 24.4 30.9 55.9 81.8 25.7 24.9 40.7 66.9 90.6 37.6 25.5 57.1 52.0 43.2 51.8 34.9 71.2 66.9 32.5 50.6 40.1 54.5 72.3 29.4 29.1 38.2 2.5 1.4 4.9 1.2 1.2 1.3 2.2 2.1 1.5 1.3 2.2 1.7 2.3 2.8 3.9 1.3 1.9 2.8 0.9 7.2 13.4 18.7 12.8 7.5 9.8 17.0 12.9 2.5 14.9 10.1 10.5 24.4 27.5 32.1 26.7 33.6 22.1 22.7 14.4 9.6 9.1 62.2 17.3 14.0 27.3 11.5 11.6 14.7 83.4 11.5 29.5 19.9 11.7 10.3 107.7 28.7 34.4 22.3 18.0 23.6 37.7 10.0 12.0 19.0 10.7 36.4 20.8 27.7 13.6 10.3 12.5 28.6 37.2 16.0 14.2 18.2 19.7 173.0 21.1 22.0 17.8 37.5 15.1 22.4 15.5 45.8 67.1 15.7 21.8 17.7 24.5 21.2 14.8 7.3 27.2 84.5 6.6 30.0 21.9 81.7 38.0 18.7 21.9 15.2 21.4 30.8 15.8 21.3 EPHA1 "EPH, EPHT, EPHT1" ENSG00000146904 "EPH receptor A1" P21709 7 143390289-143408856 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 57.7;parathyroid gland: 208.1" "Cell type enhanced" "Detected in many" "Early spermatids: 23.3;Gastric mucus-secreting cells: 13.3;Proximal enterocytes: 13.2;Squamous epithelial cells: 28.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.9;naive CD4 T-cell: 3.8;naive CD8 T-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "CACO-2: 17.9;HaCaT: 16.6;HBEC3-KT: 13.5;MCF7: 15.0;NTERA-2: 54.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" CAB026144 Uncertain NA NA 32000000 "CAB026144: " "unprognostic (1.54e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-1)" "unprognostic (4.58e-3)" "unprognostic (5.82e-3)" "unprognostic (2.45e-2)" "unprognostic (9.56e-2)" "unprognostic (1.81e-2)" "unprognostic (5.09e-1)" "unprognostic (7.59e-3)" "unprognostic (6.54e-2)" "unprognostic (3.24e-3)" "prognostic favorable (1.14e-6)" "unprognostic (3.73e-2)" "unprognostic (3.28e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" 0.1 0.0 0.0 1.3 0.0 0.3 2.2 0.4 0.1 5.9 0.9 2.1 8.5 0.3 1.2 57.7 3.4 1.5 0.0 0.0 0.0 3.8 15.7 2.3 2.0 0.0 0.1 0.0 0.0 5.7 208.1 2.5 0.6 0.1 4.1 1.6 0.0 11.1 1.2 0.0 19.6 6.3 0.1 0.0 0.9 4.2 2.0 0.0 3.5 5.4 0.0 3.6 1.9 26.1 0.1 8.7 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 17.9 7.1 0.0 0.1 0.0 0.0 16.6 0.0 13.5 0.0 0.0 0.0 1.8 0.0 1.7 0.0 0.8 0.1 0.0 4.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 15.0 0.0 1.9 54.4 8.8 0.0 0.0 0.0 0.0 1.1 6.7 0.3 0.0 0.0 8.2 0.0 3.2 3.8 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.2 0.0 3.8 2.9 0.1 0.1 0.0 0.4 0.1 1.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 2.2 0.3 0.1 2.0 6.3 6.5 6.8 0.0 3.3 5.0 1.0 2.8 9.9 7.3 0.0 2.0 0.2 4.2 0.0 4.4 23.3 4.0 1.0 0.2 1.2 0.0 0.6 4.3 2.6 0.5 13.3 6.6 0.0 0.0 0.4 8.8 0.4 0.0 0.3 4.7 2.0 0.3 0.3 9.9 0.6 0.3 0.0 1.0 0.0 0.3 0.0 0.5 0.2 6.3 8.8 0.0 0.6 2.0 13.2 1.5 2.1 0.2 0.0 0.4 0.4 0.5 1.9 28.7 3.7 1.0 4.4 0.0 7.6 5.5 NOM1 "C7orf3, PPP1R113, SGD1" ENSG00000146909 "Nucleolar protein with MIF4G domain 1" Q5C9Z4 7 156949712-156973176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019866, HPA051624" Approved Enhanced Nucleoli NA NA Nucleoli "HPA019866: AB_2670300, HPA051624: AB_2681556" "unprognostic (1.24e-1)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (3.30e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-2)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-1)" "unprognostic (6.30e-3)" "unprognostic (1.49e-1)" 5.0 4.5 2.8 4.7 2.9 6.8 4.5 2.9 3.6 4.4 2.6 4.8 3.4 4.9 3.3 5.2 4.7 2.7 3.5 2.8 2.4 3.4 5.1 3.9 5.7 3.4 2.6 2.2 5.3 6.0 4.3 3.2 4.1 3.6 3.8 3.7 3.2 4.2 3.1 7.6 6.1 4.4 4.6 2.0 4.7 4.4 4.1 2.8 4.3 3.8 4.4 5.1 4.9 4.7 3.4 13.5 11.4 8.2 12.3 8.1 8.4 11.3 13.2 6.5 10.5 8.5 12.4 11.1 23.4 12.9 10.8 10.7 10.7 14.9 15.9 12.8 10.7 12.9 19.6 9.9 11.5 6.5 34.7 11.6 6.0 7.7 9.4 12.1 6.1 8.9 12.9 30.3 12.2 9.6 17.7 22.1 28.9 19.9 11.9 12.2 15.7 12.4 18.1 6.8 15.8 10.0 12.3 12.0 9.4 9.2 9.2 4.6 18.5 14.5 11.2 3.7 21.1 17.2 15.7 12.1 21.1 14.4 24.4 10.8 0.8 0.8 0.4 0.6 0.5 0.3 1.3 0.7 0.8 0.8 1.8 0.9 0.5 0.2 0.7 0.7 0.8 0.3 0.3 2.8 2.9 2.9 3.6 2.8 2.4 3.4 2.6 2.2 3.6 2.0 2.8 3.4 15.3 9.6 18.3 7.2 16.1 39.4 46.9 10.5 12.0 16.8 9.5 7.9 11.7 8.6 15.5 5.5 20.9 16.2 19.3 20.0 3.9 19.2 9.6 17.9 20.7 16.0 7.8 19.1 9.6 13.6 20.5 16.9 13.3 18.6 21.5 21.2 6.8 13.6 14.3 11.8 10.8 16.2 6.1 10.4 26.0 4.4 17.4 13.3 24.9 13.1 18.3 7.5 21.6 7.1 10.2 15.9 14.1 13.2 15.3 36.3 8.7 6.3 15.3 29.8 0.0 28.9 18.0 33.5 37.6 20.0 42.5 7.3 21.0 26.6 21.8 37.3 CNPY1 ENSG00000146910 "Canopy FGF signaling regulator 1" Q3B7I2 7 155474206-155555450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 22.9" "Group enriched" "Detected in some" 6 "Astrocytes: 2.6;Oligodendrocytes: 2.0;Spermatocytes: 2.3;Spermatogonia: 6.3" "Cancer enriched" "Detected in single" 10 "glioma: 1.6" "Group enriched" "Detected in many" 5 "cerebellum: 22.9;pons: 7.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "AF22: 30.7" "Region enriched" "Detected in some" 29 "cerebellum: 192.3" "Region enriched" "Detected in some" 10 "cerebellum: 58.6" HPA047400 Uncertain NA NA "HPA047400: AB_10960413" "unprognostic (4.28e-3)" "unprognostic (2.12e-1)" "unprognostic (4.18e-2)" "unprognostic (8.27e-12)" "unprognostic (1.44e-1)" "unprognostic (2.16e-1)" 0.1 0.1 0.4 0.1 0.8 0.4 0.0 22.9 1.1 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.5 0.4 0.0 0.0 0.1 0.2 0.7 2.9 0.5 0.1 3.6 0.0 0.1 0.0 7.5 0.0 0.1 1.1 0.2 0.0 0.0 0.5 0.3 0.0 0.4 0.0 0.1 1.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 30.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 2.7 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.9 0.0 0.0 0.2 0.1 0.0 0.1 0.8 0.2 0.1 0.6 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 22.9 1.1 0.5 0.4 0.7 2.9 0.5 7.5 0.4 1.2 1.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NCAPG2 "CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB" ENSG00000146918 "Non-SMC condensin II complex subunit G2" Q86XI2 7 158631169-158704804 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.6;lymphoid tissue: 28.1" "Cell type enhanced" "Detected in many" "Spermatocytes: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026631, HPA049637" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA026631: AB_1845983, HPA049637: " "unprognostic (2.73e-2)" "unprognostic (1.77e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.91e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (5.33e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.79e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.19e-2)" "prognostic unfavorable (4.06e-5)" "unprognostic (2.58e-3)" "unprognostic (1.28e-1)" "unprognostic (8.21e-2)" "unprognostic (7.37e-2)" 3.8 2.5 2.1 8.9 2.3 24.6 5.5 2.7 2.1 4.0 1.5 7.0 4.5 4.3 2.2 7.0 3.0 3.0 2.9 2.3 2.1 2.6 4.2 3.1 12.5 2.3 2.0 1.9 3.1 2.2 4.7 3.5 5.9 2.2 2.8 7.7 2.8 3.5 2.8 3.5 6.8 5.9 4.9 1.9 4.6 5.6 15.0 2.0 28.1 3.3 4.1 14.0 4.1 4.0 2.5 103.9 53.7 64.1 41.8 9.5 15.4 25.3 74.3 47.4 89.0 99.0 48.5 52.0 64.0 45.0 30.3 95.1 51.7 53.7 33.8 117.2 68.4 40.4 57.2 64.8 38.8 4.2 72.2 62.3 6.8 3.7 73.1 21.0 16.2 50.4 72.9 71.9 91.6 82.8 111.4 119.2 48.8 63.7 58.8 43.3 69.7 67.8 60.6 22.6 45.9 69.6 54.5 91.6 35.0 20.2 40.4 31.4 46.5 25.9 60.6 45.9 166.2 120.6 61.3 48.2 77.2 64.6 89.6 118.5 5.9 0.9 1.1 5.2 1.2 7.5 1.6 5.2 3.6 2.3 1.0 1.6 1.8 0.7 5.2 5.1 1.1 7.2 2.2 2.1 2.3 2.7 2.1 2.3 2.1 2.3 2.0 1.9 2.2 1.9 2.0 2.5 3.6 6.4 1.5 3.9 4.1 4.0 2.1 2.8 1.8 3.9 3.7 3.3 4.8 2.8 4.6 1.8 0.0 6.7 5.1 3.4 0.0 2.3 15.1 4.0 4.6 4.3 0.0 19.6 10.7 3.3 10.4 4.5 4.1 5.9 1.3 12.6 2.9 2.6 7.3 8.4 7.2 2.9 2.0 3.8 5.2 7.2 2.8 4.4 1.8 3.7 2.7 2.1 2.1 10.1 10.7 2.3 0.4 4.1 11.0 1.1 0.3 1.3 6.0 2.8 6.6 4.3 5.7 48.2 18.5 6.1 2.0 2.6 4.9 5.0 5.7 3.0 ASB10 GLC1F ENSG00000146926 "Ankyrin repeat and SOCS box containing 10" Q8WXI3 7 151175698-151187832 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 78.6" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079685 Enhanced NA NA "HPA079685: " "unprognostic (6.72e-3)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLGN4X "HLNX, KIAA1260, NLGN, NLGN4" ENSG00000146938 "Neuroligin 4 X-linked" Q8N0W4 X 5840637-6228867 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5;lymphoid tissue: 14.4" "Cell type enhanced" "Detected in many" "Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7" "Group enriched" "Detected in many" 4 "endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7" HPA001651 Approved NA NA "HPA001651: AB_1079470" "unprognostic (2.21e-1)" "unprognostic (4.01e-2)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.36e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (9.49e-2)" "unprognostic (1.48e-2)" "unprognostic (9.32e-2)" "unprognostic (5.10e-3)" "unprognostic (7.16e-4)" "unprognostic (6.70e-2)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" 3.4 1.3 8.2 1.9 11.2 0.0 2.2 11.1 13.5 5.1 0.0 2.8 1.3 2.3 0.4 0.7 2.1 2.6 3.1 15.9 19.5 0.3 1.3 1.1 0.8 7.7 5.8 10.9 11.7 0.4 5.2 1.7 3.7 6.0 1.1 1.9 9.3 0.8 1.9 0.3 0.6 2.6 3.7 1.5 2.2 1.1 2.6 8.5 14.4 0.7 0.2 0.5 2.2 1.4 5.5 0.0 0.0 55.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 7.4 0.0 44.1 0.0 0.1 0.0 0.0 0.1 4.1 11.5 2.7 3.5 0.0 0.1 0.0 42.7 5.7 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 11.2 11.1 13.5 15.9 19.5 7.7 5.8 10.9 6.0 1.5 8.5 5.5 12.1 0.0 0.5 113.9 0.3 0.3 0.1 0.2 0.0 15.0 5.2 3.4 2.8 0.0 0.1 0.0 25.0 3.7 0.1 0.0 0.0 0.0 0.1 19.7 69.5 2.5 0.0 0.0 162.2 0.0 2.4 9.6 0.0 33.2 0.0 2.2 1.8 0.0 0.6 0.0 236.8 0.0 0.0 0.3 0.5 0.7 18.0 0.3 14.2 4.7 0.0 12.5 0.0 702.7 68.3 0.0 0.0 29.7 0.1 0.0 0.0 0.1 0.7 3.3 13.1 18.4 5.0 2.0 5.5 0.2 0.6 3.6 0.5 8.8 0.0 0.3 SHROOM2 APXL ENSG00000146950 "Shroom family member 2" Q13796 X 9786429-9949443 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 21.0" "Cell type enhanced" "Detected in many" "Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051646 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" No No "Plasma membrane, Cell Junctions" Cytosol "HPA051646: AB_2681562" "unprognostic (8.65e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-2)" "unprognostic (4.06e-2)" "unprognostic (6.99e-3)" "unprognostic (8.05e-2)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.51e-1)" "unprognostic (6.54e-2)" "unprognostic (2.82e-2)" "unprognostic (9.73e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (1.93e-1)" "unprognostic (7.67e-3)" 0.7 1.8 4.0 0.4 5.7 0.0 1.0 3.3 9.2 2.1 4.0 1.5 0.7 1.5 2.8 5.0 1.6 3.2 0.6 5.3 3.8 3.7 4.1 4.1 0.3 4.5 3.6 4.3 6.9 3.7 2.4 4.4 7.6 5.8 5.3 1.3 21.0 3.2 2.6 0.1 4.1 0.5 0.8 4.4 0.7 1.5 3.5 4.0 3.7 1.4 0.1 1.4 2.4 3.2 4.9 6.2 0.7 11.0 1.5 0.6 1.7 6.2 0.6 2.0 2.4 3.8 7.5 0.1 0.0 2.0 1.6 0.4 4.8 5.7 15.9 2.8 0.0 4.3 0.0 0.0 1.2 3.5 0.0 7.4 0.3 10.9 18.0 0.7 3.9 13.7 0.0 0.0 0.0 3.9 6.5 0.0 0.1 9.7 0.0 0.0 0.0 12.1 0.0 10.2 19.2 1.6 0.9 0.5 0.1 18.2 18.6 6.5 0.4 6.4 17.3 2.2 0.1 0.6 0.0 0.0 0.0 11.4 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 5.7 3.3 9.2 5.3 3.8 4.5 3.6 4.3 5.8 4.4 4.0 4.9 1.1 0.0 1.5 26.4 0.0 1.9 3.3 2.8 10.8 9.5 3.4 1.7 4.1 4.3 3.1 3.7 47.9 8.9 0.0 2.0 3.9 3.0 0.5 4.8 2.5 7.2 1.2 2.7 9.5 0.0 1.3 1.5 3.1 5.9 0.0 5.4 10.0 5.7 0.7 1.7 9.5 0.3 4.1 0.8 0.0 1.0 3.7 0.2 0.0 24.4 0.0 2.4 0.0 9.5 4.6 1.6 0.1 83.1 0.0 5.4 0.1 1.0 2.8 18.0 0.0 0.6 1.8 0.1 1.1 10.8 2.0 2.1 0.5 5.5 0.9 5.3 RAB19 RAB19B ENSG00000146955 "RAB19, member RAS oncogene family" A4D1S5 7 140404058-140427974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9" "Cell type enhanced" "Detected in single" "Enteroendocrine cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;HDLM-2: 5.4;MCF7: 3.3;RT4: 4.8;SK-BR-3: 4.6;T-47d: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA051077 Uncertain NA NA "HPA051077: AB_2681336" "unprognostic (3.40e-1)" "unprognostic (2.07e-2)" "unprognostic (2.26e-1)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-2)" "unprognostic (1.65e-1)" "unprognostic (2.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.91e-2)" "unprognostic (2.53e-1)" "prognostic favorable (2.36e-8)" "unprognostic (1.73e-3)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (6.09e-3)" 0.1 0.2 1.0 1.1 0.6 3.9 0.5 1.4 1.1 0.2 0.5 2.3 2.2 0.3 0.9 0.2 0.7 0.7 0.2 0.6 0.4 1.6 0.3 0.7 1.1 0.7 0.4 0.9 0.1 1.7 3.1 0.9 0.3 1.1 0.6 2.8 0.3 0.6 0.2 0.6 0.6 2.0 0.2 0.2 0.5 1.5 0.2 0.4 1.0 2.2 0.0 0.8 0.8 0.0 1.5 0.7 0.2 0.1 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 3.8 0.2 0.4 0.0 0.1 0.8 0.0 0.6 0.0 5.4 0.3 0.1 0.6 0.2 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.4 0.0 3.3 0.5 0.3 0.1 0.4 0.3 0.1 0.1 0.1 1.8 4.8 0.8 0.1 0.1 4.6 0.0 0.3 4.8 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.8 0.3 0.4 0.9 0.2 1.6 0.5 1.0 1.5 0.1 0.6 1.1 1.3 1.3 0.9 0.2 0.4 2.1 0.3 1.0 0.6 1.4 1.1 0.6 0.4 0.7 0.4 0.9 1.1 0.2 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 LUC7L2 "CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2" ENSG00000146963 "LUC7 like 2, pre-mRNA splicing factor" Q9Y383 7 139340359-139423457 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051631 Approved Approved Nucleoplasm NA NA 28000 Nucleoplasm "HPA051631: AB_2681558" "unprognostic (1.07e-3)" "unprognostic (2.71e-2)" "unprognostic (8.26e-3)" "unprognostic (2.91e-1)" "unprognostic (2.84e-1)" "unprognostic (1.00e-2)" "unprognostic (4.54e-3)" "unprognostic (2.05e-2)" "unprognostic (1.12e-2)" "unprognostic (1.48e-3)" "unprognostic (3.54e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.23e-2)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (4.28e-3)" 38.4 32.5 49.9 30.2 49.5 80.1 47.0 51.5 58.3 51.1 43.7 39.5 26.2 40.8 40.0 44.7 47.1 33.3 39.6 49.1 47.8 40.4 49.4 34.5 49.9 49.5 49.5 44.3 51.2 46.4 40.6 26.4 36.9 51.4 46.8 35.6 44.0 38.4 37.4 62.8 49.2 37.6 35.8 44.8 40.3 40.9 36.1 48.9 63.3 61.3 41.7 54.1 42.2 45.6 59.4 65.7 37.4 79.3 73.6 53.0 43.6 58.0 74.4 71.6 71.5 74.6 41.4 61.2 108.5 43.4 60.7 44.6 46.3 96.5 75.7 100.7 51.1 94.7 92.5 56.1 41.9 44.8 150.2 75.4 38.6 93.6 67.3 81.9 49.5 58.5 56.1 119.5 57.1 78.6 62.5 180.4 140.9 65.2 87.6 53.1 107.7 77.7 98.7 81.9 72.7 68.2 65.2 82.0 82.5 75.5 59.3 55.8 59.1 56.0 54.7 31.8 61.1 68.3 86.5 88.0 230.1 60.5 143.8 74.3 10.7 9.4 17.9 17.7 14.3 19.8 16.0 17.3 18.6 12.8 14.9 21.3 18.3 8.7 16.3 17.1 13.2 19.0 12.3 49.9 49.5 51.5 58.3 49.1 47.8 49.5 49.5 44.3 51.4 44.8 48.9 59.4 53.5 54.5 56.8 0.0 63.0 0.0 74.8 0.0 72.8 54.0 54.4 45.1 0.0 35.8 39.6 38.6 52.1 77.0 48.5 16.5 54.8 45.1 18.7 31.4 43.1 46.8 21.9 102.9 0.0 38.5 74.3 48.2 57.1 32.8 60.5 37.7 42.1 58.5 43.9 43.7 0.0 29.0 0.0 42.5 0.0 8.5 53.1 41.9 0.0 0.0 46.4 46.7 43.3 0.0 0.1 34.9 18.7 67.7 68.6 62.0 34.6 40.8 37.2 49.2 59.2 54.9 45.6 74.1 68.7 51.5 0.1 82.4 63.7 43.0 28.0 56.2 DENND2A "FAM31D, KIAA1277" ENSG00000146966 "DENN domain containing 2A" Q9ULE3 7 140518420-140673993 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 114.9;Horizontal cells: 89.2;Oligodendrocyte precursor cells: 72.4;Paneth cells: 69.5" "Cancer enriched" "Detected in all" 6 "glioma: 28.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 57.7;BJ hTERT+: 60.8;PC-3: 29.1;RPTEC TERT1: 72.7;U-2197: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.02e-2)" "unprognostic (1.14e-1)" "prognostic favorable (9.35e-4)" "unprognostic (1.78e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.95e-2)" "unprognostic (1.43e-1)" "unprognostic (3.10e-2)" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-3)" "unprognostic (2.09e-2)" "prognostic unfavorable (3.05e-6)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (3.54e-2)" "unprognostic (2.38e-3)" 12.3 3.9 30.3 2.5 31.0 0.6 11.1 24.7 24.5 23.4 40.4 10.8 3.9 26.4 5.1 9.7 30.9 11.2 14.2 25.3 34.8 6.8 3.1 17.8 2.3 44.1 36.8 20.6 21.9 2.2 5.0 26.5 15.6 34.4 11.5 5.7 11.6 2.7 5.5 7.1 3.6 9.0 16.1 33.1 12.3 6.7 2.1 31.3 0.8 3.7 7.9 1.8 12.2 11.5 27.6 0.2 0.9 57.7 0.5 6.2 1.1 12.4 2.2 60.8 9.5 15.3 0.0 0.1 0.1 0.4 0.6 10.2 0.2 11.0 0.8 17.8 0.0 1.0 0.0 0.2 0.0 1.6 0.2 0.1 2.8 0.6 13.9 2.1 24.9 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.3 12.3 0.1 29.1 2.1 3.7 0.2 72.7 0.1 4.6 14.5 0.0 0.0 0.0 16.7 0.1 0.6 0.0 10.9 2.2 32.1 5.9 0.3 0.0 0.1 0.9 0.1 3.9 1.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.1 1.2 0.3 0.1 0.2 0.1 0.0 30.3 31.0 24.7 24.5 25.3 34.8 44.1 36.8 20.6 34.4 33.1 31.3 27.6 13.8 0.0 3.0 34.9 0.5 1.3 1.9 0.1 0.6 7.4 1.9 1.0 4.3 0.0 1.3 0.0 8.4 1.0 0.3 114.9 7.9 0.0 1.4 0.4 8.3 4.6 9.6 0.0 10.0 0.0 4.9 14.8 1.1 0.3 11.4 22.4 9.7 0.7 2.4 89.2 23.2 37.1 0.0 0.3 2.1 1.0 18.6 0.6 1.8 32.8 0.1 16.2 0.0 72.4 42.3 0.1 69.5 10.5 0.0 2.2 3.8 0.1 1.0 10.5 13.1 11.8 11.3 0.1 0.9 0.2 0.4 0.4 1.1 0.2 42.7 1.2 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15675012 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "kidney: 490.8" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 885.4" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" "HPA048543: AB_2680436" "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favorable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.5 0.8 0.6 0.0 0.6 0.3 2.0 0.7 0.8 1.0 13.6 0.6 1.4 1.6 3.1 0.6 2.4 3.8 1.1 0.7 0.5 490.8 62.0 1.8 0.4 0.7 0.8 0.5 3.2 5.4 10.6 0.6 0.5 0.7 1.5 0.3 1.2 0.8 1.3 0.1 1.2 0.4 0.4 0.5 0.2 11.0 1.1 0.6 0.8 4.1 0.1 0.3 0.8 0.4 1.0 2.3 1.8 1.1 0.3 0.7 1.0 0.7 0.0 0.0 0.1 0.1 0.1 0.5 0.1 1.6 0.2 0.2 8.5 0.7 2.3 0.0 0.3 0.7 0.2 0.0 0.8 1.0 0.0 0.0 0.2 2.0 0.3 5.2 0.6 0.0 2.1 0.5 0.4 0.2 2.8 0.1 0.3 2.9 0.8 2.6 0.2 0.3 0.9 8.5 0.1 1.1 1.0 0.6 0.1 1.8 5.1 0.6 0.2 0.0 0.2 0.4 0.3 0.0 0.4 0.2 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.1 0.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.6 0.7 0.8 0.7 0.5 0.7 0.8 0.5 0.7 0.5 0.6 1.0 0.1 0.0 4.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 3.0 3.2 0.0 0.0 1.8 27.6 0.0 2.1 0.0 0.0 54.8 25.1 0.0 2.8 0.6 0.1 0.0 0.0 0.0 0.6 0.5 0.3 0.0 3.3 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 885.4 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 3.7 0.5 0.0 0.0 SH3KBP1 CIN85 ENSG00000147010 "SH3 domain containing kinase binding protein 1" Q96B97 X 19533977-19887600 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 207.8;monocytes: 289.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003351, HPA003355, CAB021892" Enhanced Supported Cytosol NA NA Cytosol "CAB021892: , HPA003351: AB_1079956, HPA003355: AB_1079954" "unprognostic (1.17e-2)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (4.65e-3)" "unprognostic (1.62e-1)" "unprognostic (2.88e-2)" "unprognostic (6.47e-2)" "unprognostic (9.91e-2)" "unprognostic (9.75e-2)" "unprognostic (1.76e-3)" "unprognostic (5.96e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (4.00e-1)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (4.92e-2)" 45.5 11.1 18.2 46.0 17.8 69.2 26.8 14.7 20.5 18.3 42.5 37.4 13.8 10.8 11.4 8.6 12.1 21.4 20.1 17.3 18.1 13.6 15.7 26.3 68.7 20.9 20.8 15.5 8.8 6.9 14.5 12.0 32.8 21.2 6.7 35.6 5.2 10.5 7.5 13.2 23.5 18.5 14.9 22.9 37.4 19.1 5.8 30.6 55.6 20.7 32.7 69.2 17.8 11.3 26.4 52.5 54.3 8.4 19.4 41.6 80.0 44.2 46.4 67.4 23.3 37.2 37.2 105.6 97.4 47.6 67.5 67.0 5.9 19.8 18.4 37.3 32.3 13.4 21.2 13.6 30.1 27.2 134.0 160.2 47.4 18.0 48.5 141.9 64.6 35.4 67.6 8.0 114.2 59.7 23.5 80.4 135.4 14.8 63.1 71.2 49.1 82.0 9.1 27.1 10.6 6.0 6.2 43.2 5.6 65.3 53.8 5.4 155.2 113.6 40.6 34.9 52.2 51.9 165.6 119.0 86.0 86.5 109.4 183.5 49.2 104.7 171.1 180.2 77.7 140.4 55.4 174.2 187.8 132.6 50.3 143.3 142.5 210.0 76.5 96.9 148.4 224.1 195.9 18.2 17.8 14.7 20.5 17.3 18.1 20.9 20.8 15.5 21.2 22.9 30.6 26.4 40.3 16.0 54.4 5.5 75.6 12.0 3.5 7.5 5.2 5.1 5.4 6.2 78.1 11.5 25.0 9.2 16.7 26.2 174.3 207.8 1.9 8.3 0.7 6.3 28.5 26.5 50.8 23.3 72.3 18.9 39.3 56.9 23.4 8.3 96.6 5.9 27.8 17.6 55.8 8.4 126.3 34.4 10.2 87.4 102.1 1.9 52.8 113.0 33.8 108.7 289.2 0.1 175.1 87.0 145.9 48.0 153.3 38.4 63.5 3.5 26.4 40.3 20.1 2.8 59.2 12.1 72.2 24.3 22.7 1.9 10.9 22.6 138.7 26.7 59.4 7.7 TMEM47 "BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9" ENSG00000147027 "Transmembrane protein 47" Q9BQJ4 X 34627075-34657285 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 110.7;Astrocytes: 85.5;Leydig cells: 74.3;Muller glia cells: 148.0;Peritubular cells: 92.9;Sertoli cells: 92.1;Skeletal myocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 112.6;fHDF/TERT166: 348.1;RPTEC TERT1: 83.6;U-2197: 74.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046658 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA046658: AB_2679742" "unprognostic (1.50e-1)" "unprognostic (1.44e-1)" "unprognostic (5.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "unprognostic (3.82e-2)" "unprognostic (6.74e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.67e-2)" "unprognostic (4.23e-2)" "unprognostic (1.36e-1)" "prognostic favorable (4.05e-6)" "unprognostic (2.69e-2)" "unprognostic (7.19e-2)" "unprognostic (2.76e-1)" "unprognostic (9.94e-2)" 40.3 21.0 37.6 8.6 36.3 0.0 19.0 31.5 39.8 47.1 40.2 20.7 8.6 46.2 33.7 34.9 35.4 28.9 36.5 32.2 58.2 27.9 25.1 22.1 6.3 37.5 37.5 27.1 21.9 11.4 5.7 6.6 1.2 33.8 33.2 15.0 18.0 29.9 46.1 24.0 5.7 11.6 51.4 42.2 7.6 13.9 5.0 35.3 3.2 20.4 31.4 4.2 36.5 20.3 35.2 0.0 1.7 50.7 21.4 43.8 33.1 0.0 112.6 0.3 21.8 18.7 0.1 0.0 0.0 9.2 348.1 0.0 0.1 14.5 4.0 32.0 0.0 9.9 0.0 13.2 0.0 25.3 0.0 0.0 30.0 0.1 8.9 9.7 38.9 24.8 0.0 0.0 0.0 41.6 0.9 0.0 0.0 6.0 0.6 0.3 0.0 25.3 0.0 83.6 33.0 0.5 0.0 0.1 1.3 0.0 5.4 0.2 0.0 0.9 44.0 4.4 74.4 4.8 0.0 0.0 0.0 18.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.6 36.3 31.5 39.8 32.2 58.2 37.5 37.5 27.1 33.8 42.2 35.3 35.2 110.7 19.2 0.6 85.5 0.1 8.2 15.9 0.9 1.8 8.3 10.8 12.7 27.7 10.0 1.5 16.5 6.2 0.0 0.6 0.0 7.9 0.8 0.4 7.6 4.6 29.8 0.0 0.0 4.3 5.3 0.2 48.3 1.1 6.2 2.5 0.7 46.4 17.5 0.1 30.3 25.6 0.0 0.0 0.8 11.7 3.8 74.3 1.2 65.8 13.1 0.0 148.0 0.0 5.0 2.2 3.0 0.0 92.9 0.1 14.3 0.0 13.4 2.0 7.3 92.1 84.7 67.1 0.3 2.1 1.9 5.3 0.1 0.7 0.8 0.0 12.1 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 9.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 8.8;Inhibitory neurons: 20.4;Squamous epithelial cells: 10.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 9.8" "Immune cell enriched" "Detected in single" 5 "basophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "HEL: 11.8;HMC-1: 3.6;K-562: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria NA NA Mitochondria "HPA005470: AB_2134886, HPA076575: AB_2732315" "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 0.1 0.2 0.4 0.1 0.4 0.2 0.1 2.7 1.1 0.3 0.0 1.0 0.1 0.2 0.0 1.5 0.1 0.1 0.1 0.6 9.8 0.1 0.0 0.3 0.1 1.1 1.1 0.5 0.0 0.0 0.0 0.5 0.0 1.1 0.1 0.5 0.6 0.4 0.2 0.2 0.7 0.2 0.1 0.7 0.1 0.6 0.2 2.0 0.1 0.1 0.1 0.2 0.3 1.1 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 1.5 0.2 0.0 0.0 0.2 11.8 1.1 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.6 0.0 0.1 0.2 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 1.1 0.5 0.0 0.0 1.8 0.0 0.3 3.8 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.3 0.3 0.4 0.4 2.7 1.1 0.6 9.8 1.1 1.1 0.5 1.1 0.7 2.0 0.6 1.3 3.2 4.1 2.9 0.1 8.8 1.2 1.8 6.8 0.8 0.6 0.4 0.9 0.0 1.2 0.0 0.0 0.0 3.0 6.6 0.0 0.0 0.1 0.3 0.6 1.1 1.8 0.8 3.1 0.2 0.2 0.4 4.1 0.7 1.3 0.1 0.0 0.2 0.1 3.3 20.4 0.4 2.0 0.3 0.5 0.0 0.3 0.2 0.0 1.0 0.2 0.5 4.1 1.0 2.0 2.1 1.4 1.5 0.2 0.7 1.6 0.2 0.0 1.4 0.0 1.8 0.9 0.7 3.1 10.1 4.4 0.1 1.4 0.2 1.0 2.5 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006553-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;stomach 1: 12.2" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 37.2;Inhibitory neurons: 92.0;Intestinal goblet cells: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;MCF7: 5.8;OE19: 8.4;SK-MEL-30: 14.8;SuSa: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.0 8.3 7.1 0.3 7.5 0.0 2.6 0.2 5.4 5.6 0.1 2.9 2.3 2.2 0.8 3.2 0.4 0.6 1.1 6.2 8.9 0.9 4.5 0.7 0.0 3.8 11.8 3.1 0.1 5.9 0.0 0.6 7.4 4.4 0.9 3.3 0.5 2.3 0.4 0.0 0.1 2.4 3.4 2.0 0.0 12.2 0.7 10.9 0.0 0.1 0.0 0.0 1.0 0.8 2.5 0.0 1.2 0.2 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 6.2 1.4 0.0 0.0 0.5 2.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.2 0.2 5.8 0.0 0.0 2.5 8.4 0.0 0.0 2.0 0.0 0.0 0.4 3.2 0.0 0.3 1.2 14.8 19.5 0.0 0.0 0.0 0.1 4.7 0.0 3.3 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.1 7.5 0.2 5.4 6.2 8.9 3.8 11.8 3.1 4.4 2.0 10.9 2.5 0.0 0.0 2.0 1.6 0.0 0.0 0.2 0.8 0.0 0.0 4.0 1.5 0.3 0.0 8.7 0.0 0.0 3.3 0.0 4.6 0.0 0.0 0.0 0.7 3.6 0.1 3.0 0.0 1.4 0.9 3.6 0.6 37.2 4.0 0.0 1.0 0.4 1.3 0.3 0.0 92.0 20.8 6.1 0.0 0.0 0.0 0.6 0.2 0.0 1.0 0.2 0.0 0.0 0.0 1.1 4.9 3.0 2.6 0.3 0.6 0.6 0.1 3.3 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 8.9 0.1 0.0 0.7 1.0 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923554 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 135.8;Oligodendrocyte precursor cells: 447.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 47.1" "Lineage enriched" "Detected in many" 10 "granulocytes: 47.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 10.2 11.2 14.8 12.0 12.7 7.4 15.9 12.8 10.9 11.7 11.5 25.5 32.4 11.2 9.5 13.9 10.6 18.7 6.9 13.4 16.4 16.6 13.5 12.4 12.6 12.3 17.0 10.6 13.6 13.0 11.9 6.4 16.4 13.0 10.7 27.5 20.0 13.3 8.4 5.1 9.4 32.1 12.1 14.8 12.5 20.0 3.6 20.1 15.6 10.7 6.1 10.5 15.4 8.9 15.6 27.4 32.5 31.4 19.1 21.6 18.6 10.9 23.2 18.7 13.2 12.3 72.3 42.6 0.4 12.0 29.3 23.8 52.3 35.2 23.2 22.8 25.4 20.9 0.6 27.7 26.2 22.1 4.4 3.6 19.8 63.2 25.1 30.1 27.5 11.6 15.3 2.2 21.3 30.2 30.9 8.4 2.2 29.7 37.6 22.6 12.7 79.8 13.2 31.2 54.8 29.7 15.6 43.7 17.7 13.9 52.7 19.0 0.8 14.2 24.4 25.8 22.1 13.3 7.6 5.2 9.5 24.4 3.1 16.9 47.1 1.5 8.7 0.8 1.1 0.8 0.7 0.9 1.3 0.4 0.9 1.2 1.1 1.7 4.3 0.7 0.5 4.5 0.6 14.8 12.7 12.8 10.9 13.4 16.4 12.3 17.0 10.6 13.0 14.8 20.1 15.6 13.0 12.8 20.4 101.9 8.8 32.6 42.7 11.1 8.0 42.2 23.7 16.5 7.8 8.6 14.6 7.3 22.9 2.0 12.1 25.8 50.9 13.7 0.9 9.6 24.1 16.0 13.8 0.8 96.6 14.5 0.7 18.8 18.8 11.9 0.0 17.4 8.9 15.0 21.3 50.5 135.8 28.7 14.2 2.8 21.5 1.0 9.9 10.7 10.6 60.0 2.5 9.3 0.0 447.8 59.7 22.1 24.1 9.4 7.0 16.4 35.2 20.9 15.7 25.7 19.7 38.2 20.6 2.9 2.1 13.9 32.5 1.6 26.5 47.7 41.8 33.2 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873188-45112779 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 116.2;Oligodendrocyte precursor cells: 118.1;Oligodendrocytes: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 9.0 8.1 7.2 4.6 8.0 19.6 10.7 7.6 10.7 14.9 7.3 8.7 6.2 14.1 5.1 11.2 14.1 3.4 6.6 7.3 7.6 6.0 10.5 10.9 8.0 7.8 8.3 6.7 17.4 10.9 6.4 8.6 3.9 7.8 7.8 4.1 3.9 10.6 3.1 10.5 18.1 13.1 4.1 7.7 14.2 12.6 12.3 7.6 13.0 9.4 6.1 5.4 9.9 15.3 10.5 7.3 5.8 7.0 9.3 5.0 6.8 15.7 4.9 4.2 4.0 4.1 10.4 5.2 4.6 3.2 3.5 10.1 13.9 6.5 5.4 3.9 7.6 10.8 2.4 4.5 5.2 3.7 2.6 13.2 2.6 6.4 8.2 6.6 5.1 4.2 5.3 6.4 10.1 2.4 6.0 6.9 13.6 6.8 4.2 7.4 6.4 7.1 1.4 3.8 9.2 6.2 4.4 18.2 6.8 10.7 14.1 8.5 0.0 3.0 5.4 5.2 5.2 3.6 5.5 8.8 5.6 4.0 3.3 3.3 7.3 1.7 1.5 1.9 3.5 2.1 1.9 2.5 2.8 3.1 1.2 2.5 2.4 2.8 2.8 3.0 1.7 2.2 2.0 7.2 8.0 7.6 10.7 7.3 7.6 7.8 8.3 6.7 7.8 7.7 7.6 10.5 23.2 6.4 10.6 92.1 26.0 26.1 14.3 9.4 38.1 7.7 16.8 12.1 12.8 12.8 10.9 7.3 14.6 4.5 26.1 24.6 0.0 8.4 1.5 26.4 25.5 13.1 13.1 16.8 88.3 7.5 7.9 14.2 23.0 39.7 2.5 27.3 6.4 17.6 7.0 25.2 74.0 14.0 6.1 9.1 13.8 2.0 6.5 19.9 10.6 116.2 12.6 6.8 6.2 118.1 264.6 9.1 17.4 7.2 31.4 14.2 22.6 3.7 8.9 9.7 6.6 20.9 17.0 14.1 12.5 29.3 26.3 10.9 27.4 10.6 13.1 17.1 SPIN2A "DXF34, SPIN2, TDRD25" ENSG00000147059 "Spindlin family member 2A" Q99865 X 57134530-57137625 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.8;Cardiomyocytes: 5.0;Cone photoreceptor cells: 4.2;dendritic cells: 3.2;Rod photoreceptor cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.1;HSkMC: 3.1" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA069835: AB_2686211" "unprognostic (3.18e-1)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (1.10e-4)" "unprognostic (1.02e-1)" "unprognostic (2.61e-3)" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (1.12e-1)" "unprognostic (4.35e-2)" "unprognostic (8.01e-2)" "unprognostic (1.48e-1)" "unprognostic (7.95e-5)" "unprognostic (3.63e-2)" "unprognostic (8.61e-2)" "unprognostic (2.75e-1)" "unprognostic (5.07e-3)" 1.2 0.9 1.0 0.9 1.0 0.2 1.1 1.3 1.5 1.6 0.0 1.2 0.8 1.0 0.3 0.8 1.0 0.7 0.8 0.8 0.8 1.1 0.9 0.9 1.3 1.0 1.1 0.6 1.3 1.0 0.4 1.6 0.5 1.4 1.4 0.7 0.6 0.9 0.6 0.4 1.2 1.1 0.8 0.2 1.5 1.0 0.5 0.9 0.5 1.5 0.6 0.8 1.2 1.6 1.2 0.4 0.8 2.2 0.4 0.3 0.4 0.6 0.8 0.3 0.1 0.3 0.4 0.7 0.2 0.3 1.4 0.2 0.5 0.5 0.4 0.1 0.3 0.3 0.3 3.1 0.4 0.7 0.3 0.4 3.1 0.3 0.1 0.1 1.0 0.2 0.3 0.3 1.0 0.4 0.5 0.2 1.0 0.8 0.0 0.3 0.4 0.5 0.3 0.3 0.4 1.4 0.4 0.4 0.2 0.1 0.7 0.4 0.4 0.3 1.1 0.5 0.5 0.2 1.0 0.1 0.1 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 1.0 1.3 1.5 0.8 0.8 1.0 1.1 0.6 1.4 0.2 0.9 1.2 0.8 0.0 0.5 0.0 0.4 0.3 0.5 0.6 0.0 5.8 0.3 0.1 5.0 0.0 0.2 0.0 4.2 0.2 3.2 0.8 1.9 0.4 0.0 0.8 1.8 1.3 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.9 1.3 1.5 1.4 0.0 0.2 1.7 0.1 0.3 0.0 0.0 0.3 0.0 2.8 0.2 0.0 0.0 0.5 0.3 2.1 0.0 0.1 0.2 0.2 0.0 0.3 0.4 0.0 0.1 0.1 4.5 0.0 0.7 1.1 0.0 0.0 0.0 0.4 0.0 0.8 2.0 0.2 0.4 MSN ENSG00000147065 Moesin P26038 X 65588377-65741931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 337.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338" Enhanced Enhanced "Plasma membrane" NA NA 130000000 "Plasma membrane" "CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054" "unprognostic (1.03e-1)" "unprognostic (7.89e-2)" "unprognostic (7.64e-2)" "unprognostic (5.38e-2)" "unprognostic (4.08e-3)" "unprognostic (3.51e-2)" "unprognostic (1.11e-2)" "unprognostic (1.44e-2)" "unprognostic (3.35e-2)" "unprognostic (1.70e-2)" "unprognostic (9.04e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (5.68e-3)" "unprognostic (7.75e-2)" "unprognostic (7.21e-2)" "unprognostic (6.81e-2)" 215.2 83.9 63.6 262.1 67.3 272.2 145.8 78.4 76.7 114.8 87.3 100.2 44.3 157.1 45.4 88.7 111.0 124.2 128.7 59.9 121.4 136.2 92.6 284.0 209.2 101.7 73.3 47.9 92.8 41.4 39.5 48.6 151.9 93.1 73.1 79.2 24.3 76.7 127.8 56.6 95.3 97.4 253.8 91.0 201.8 79.1 22.1 85.2 178.6 153.8 76.4 244.2 156.3 98.8 96.6 298.3 223.2 214.0 177.9 250.6 328.9 1.9 733.9 472.2 397.3 305.5 0.6 50.9 247.7 638.8 654.4 210.3 199.4 228.5 523.4 514.1 461.7 63.0 687.5 355.0 0.6 236.0 845.3 1063.8 248.1 110.7 733.1 641.5 384.2 892.3 338.5 339.5 747.1 638.4 0.6 503.0 631.0 266.1 0.3 418.9 259.8 384.0 189.0 426.5 0.2 1.7 0.8 590.6 4.4 231.5 239.7 2.7 453.8 1426.9 449.5 285.3 613.2 494.6 268.6 438.4 262.5 328.9 1053.3 513.0 219.9 312.4 194.0 214.8 359.3 160.4 91.9 116.9 170.6 225.3 76.9 78.3 121.9 334.3 177.5 460.3 31.9 97.0 673.8 63.6 67.3 78.4 76.7 59.9 121.4 101.7 73.3 47.9 93.1 91.0 85.2 96.6 243.4 179.5 163.0 19.9 140.8 205.5 62.2 56.5 38.7 0.7 27.9 30.9 27.5 11.5 45.4 68.0 4.2 6.0 227.3 7.5 29.4 177.3 1.4 35.7 64.9 256.2 0.0 71.9 2.2 170.0 16.0 85.7 16.3 62.9 164.6 22.6 100.3 51.2 167.2 5.0 3.8 3.2 2.0 255.3 206.2 5.3 73.7 251.9 69.4 67.5 291.9 43.6 337.8 7.1 14.7 327.7 3.3 109.4 105.7 102.2 0.0 113.6 25.6 2.4 72.3 85.0 131.0 1.9 3.6 24.3 149.5 4.2 206.9 24.4 2.2 54.0 AKAP4 "AKAP82, CT99, Fsc1, hAKAP82, HI, p82" ENSG00000147081 "A-kinase anchoring protein 4" Q5JQC9 X 50190777-50201007 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1022 "testis: 197.2" "Group enriched" "Detected in some" 137 "Early spermatids: 778.9;Late spermatids: 2587.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005949, HPA020046" Enhanced NA NA "HPA005949: AB_1078120, HPA020046: AB_1844693" "unprognostic (2.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 778.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2587.5 11.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 12.2 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CCNB3 ENSG00000147082 "Cyclin B3" Q8WWL7 X 50202713-50351914 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.5;epididymis: 4.8;testis: 6.0" "Cell type enhanced" "Detected in some" "Oligodendrocytes: 9.1;Sertoli cells: 13.1;Spermatocytes: 48.2;Spermatogonia: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;GAMG: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA000496 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000496: AB_1078605" "unprognostic (1.57e-1)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-3)" "unprognostic (8.11e-2)" "unprognostic (1.86e-1)" "unprognostic (1.82e-2)" "unprognostic (1.34e-2)" "unprognostic (1.48e-3)" "unprognostic (6.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (4.51e-2)" "unprognostic (2.63e-2)" 0.2 0.3 0.5 0.0 0.9 0.0 0.2 0.9 0.9 0.0 0.4 0.1 0.0 0.0 4.8 0.1 0.2 0.1 0.1 0.5 0.8 0.2 0.4 0.3 0.1 1.1 1.0 0.4 0.1 0.4 0.1 0.7 0.0 1.1 0.1 0.1 0.5 0.1 0.2 0.5 0.3 0.1 0.0 0.9 0.3 0.4 6.0 0.9 0.2 0.3 0.0 0.1 0.1 0.1 1.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 1.7 0.5 0.3 0.1 2.3 0.1 0.2 0.1 0.1 0.4 0.5 0.3 0.0 0.0 0.4 0.4 0.3 0.2 0.0 0.1 0.3 0.0 0.1 1.2 0.0 1.3 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.3 0.1 1.1 0.1 0.1 0.7 1.2 0.3 0.2 0.3 0.2 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.9 0.9 0.5 0.8 1.1 1.0 0.4 1.1 0.9 0.9 1.5 0.0 0.0 0.0 1.6 0.4 0.0 0.1 0.1 0.0 0.6 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.6 1.2 0.2 0.2 0.0 0.0 0.5 0.2 0.0 0.1 2.0 0.2 0.0 0.1 0.4 0.9 0.1 0.0 0.4 0.1 2.0 1.0 0.3 1.3 0.3 0.6 0.0 1.9 0.0 0.2 5.2 0.0 9.1 0.1 0.1 0.0 0.4 0.1 0.0 0.3 2.0 0.4 13.1 0.3 0.1 48.2 12.4 0.4 0.1 0.0 0.3 1.7 0.1 0.0 HDAC8 "HDACL1, KDAC8, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573101 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease variant, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 120.8;Excitatory neurons: 186.8;Inhibitory neurons: 191.3;Microglial cells: 134.9;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 141.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA048560 Supported NA NA "HPA048560: AB_2680442" "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.1 21.3 16.0 9.9 17.0 17.7 10.4 24.0 19.9 10.3 13.8 9.6 8.6 9.6 23.0 10.3 8.8 9.8 12.0 16.7 15.0 15.3 16.4 9.1 11.0 15.4 14.3 16.3 11.3 11.1 11.6 13.5 9.5 16.4 11.3 11.9 16.7 11.5 8.2 10.8 11.6 8.2 10.7 9.8 8.5 10.3 4.2 15.8 8.6 13.1 10.5 11.0 9.8 9.6 21.4 21.0 27.2 20.5 29.9 26.9 24.4 13.5 14.0 21.3 15.9 19.1 20.8 23.3 15.2 38.6 17.2 27.5 14.5 37.0 23.1 21.7 25.9 25.5 21.5 32.7 22.4 14.2 29.9 30.4 22.3 15.4 20.2 15.1 27.6 27.1 20.3 22.4 38.4 24.4 24.8 15.9 53.8 25.9 31.2 38.1 19.7 24.0 26.7 32.8 21.0 16.5 33.0 26.7 19.7 26.9 25.9 12.0 26.9 21.8 15.0 21.3 19.4 13.5 13.5 28.1 18.1 18.5 34.7 20.3 13.8 16.5 28.1 10.5 13.8 8.7 11.9 11.2 9.6 17.2 12.2 8.4 7.5 1.7 10.9 14.5 6.0 15.6 9.8 16.0 17.0 24.0 19.9 16.7 15.0 15.4 14.3 16.3 16.4 9.8 15.8 21.4 13.0 3.2 25.7 120.8 14.5 6.1 12.7 15.3 17.1 15.4 9.5 9.7 11.3 12.8 15.7 7.3 43.8 16.4 8.0 7.2 9.8 13.9 0.9 8.8 11.3 12.5 9.1 17.1 186.8 12.4 13.2 14.0 10.7 8.4 12.0 19.2 12.5 10.3 15.8 23.5 191.3 9.3 16.2 8.2 9.0 1.2 11.8 13.3 7.2 134.9 10.9 10.3 8.2 146.8 141.1 11.2 4.7 10.5 19.9 10.6 9.3 22.6 17.4 17.3 26.3 10.1 16.0 4.7 0.8 12.6 6.3 13.5 11.8 15.1 9.7 12.6 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421493-74533917 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 41.0" "Cell type enhanced" "Detected in many" "Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 83.9;GAMG: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA072719: AB_2686552" "prognostic unfavorable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (3.16e-4)" 13.9 24.9 4.7 4.8 5.9 0.0 5.5 1.9 5.7 8.0 1.1 5.5 3.3 10.4 1.7 2.9 9.4 6.1 7.4 7.5 17.4 7.9 41.0 7.5 0.9 5.9 4.0 3.9 12.9 5.5 11.8 9.9 9.3 2.1 6.2 1.8 1.1 5.1 5.9 2.7 2.4 3.1 6.9 2.8 1.2 4.7 0.9 5.4 5.7 12.7 3.7 1.8 6.6 6.3 2.9 8.4 10.4 7.2 43.1 20.8 11.1 0.0 83.9 29.7 38.2 20.6 0.1 0.9 0.0 1.3 37.5 70.8 1.7 1.1 40.2 22.1 6.1 3.6 0.0 0.0 0.0 1.5 0.0 0.0 16.5 9.5 19.3 23.3 14.6 0.1 0.1 0.0 0.0 9.1 0.0 0.5 2.7 27.2 0.0 7.8 17.4 19.9 0.0 18.0 0.1 1.9 12.0 9.6 50.2 0.3 2.5 0.6 1.1 0.0 32.5 8.8 35.7 41.9 0.0 0.0 0.0 34.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 5.9 1.9 5.7 7.5 17.4 5.9 4.0 3.9 2.1 2.8 5.4 2.9 5.6 0.0 0.6 22.2 0.2 0.8 4.3 2.4 0.6 5.7 4.3 3.4 4.5 8.6 2.9 3.7 0.0 5.7 0.1 0.0 3.9 4.3 0.1 0.3 9.8 6.1 8.4 0.0 14.5 2.4 4.9 11.8 0.5 0.5 2.5 1.7 3.6 63.7 1.0 3.3 21.6 0.3 0.0 1.3 0.8 1.2 15.2 0.1 3.6 15.9 0.6 6.2 0.0 23.1 7.1 4.6 0.0 20.7 0.1 5.1 0.4 4.7 2.4 1.5 13.1 9.7 5.6 0.1 0.1 0.9 1.3 2.1 0.4 1.4 0.2 4.9 DIPK2B "CXorf36, DIA1R, FLJ14103" ENSG00000147113 "Divergent protein kinase domain 2B" Q9H7Y0 X 45148373-45200901 "Disease related genes, Predicted secreted proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Adipocytes: 96.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 57 "HUVEC TERT2: 81.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002806 Uncertain "Secreted - unknown location" NA NA 940000 "HPA002806: AB_1078595" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (8.51e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "unprognostic (4.07e-3)" "unprognostic (7.30e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (3.39e-1)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (1.75e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (8.47e-2)" "unprognostic (3.11e-2)" 38.8 5.4 14.4 6.1 13.9 0.8 37.3 10.9 14.0 19.7 7.4 8.2 2.6 20.6 7.0 6.5 18.2 8.8 18.9 10.8 11.0 6.7 1.4 14.2 5.7 13.9 13.6 8.8 6.9 3.5 4.7 3.4 40.9 13.6 11.4 3.8 1.4 6.9 7.2 16.7 7.1 7.8 20.9 11.6 3.1 6.3 1.5 14.6 2.8 18.6 16.8 3.4 14.4 14.0 14.9 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 81.7 0.1 0.0 0.5 0.0 0.1 0.0 0.3 0.1 1.4 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.4 13.9 10.9 14.0 10.8 11.0 13.9 13.6 8.8 13.6 11.6 14.6 14.9 96.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ZNF157 HZF22 ENSG00000147117 "Zinc finger protein 157" P51786 X 47370578-47414498 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.6;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 2.5;Spermatogonia: 1.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;U-266/84: 2.3" "Not detected" "Not detected" HPA003319 Uncertain NA NA "HPA003319: AB_1080677" "unprognostic (1.85e-1)" "unprognostic (3.99e-1)" "unprognostic (7.24e-4)" "unprognostic (1.17e-2)" "unprognostic (1.02e-2)" "unprognostic (7.38e-4)" "unprognostic (2.99e-1)" "unprognostic (2.32e-1)" "unprognostic (4.59e-4)" "unprognostic (5.36e-2)" "unprognostic (6.51e-2)" "unprognostic (1.80e-2)" "unprognostic (3.51e-2)" "unprognostic (7.15e-2)" "unprognostic (4.92e-2)" 0.1 0.2 0.5 0.1 0.5 0.2 0.1 2.8 0.6 0.3 0.0 0.1 0.0 0.3 1.4 0.1 1.2 0.1 0.0 0.4 0.5 0.3 0.0 0.1 0.5 0.3 0.6 0.4 0.4 0.0 0.7 0.9 0.0 1.1 0.2 0.1 1.1 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.3 0.5 0.5 0.5 0.1 0.3 0.1 0.1 0.6 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.1 0.3 0.0 0.8 0.4 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 1.2 0.1 0.0 0.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.0 0.1 0.1 0.8 0.5 0.1 0.0 0.3 0.4 0.0 0.0 0.6 2.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.5 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.5 2.8 0.6 0.4 0.5 0.3 0.6 0.4 1.1 0.2 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 2.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.6 1.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059574: AB_2684068" "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favorable (1.55e-7)" 4.3 4.2 4.5 4.0 4.7 5.1 4.5 6.3 5.9 6.1 4.7 4.7 2.9 4.7 4.6 3.0 5.5 3.2 3.4 4.3 4.6 5.4 5.4 4.5 6.6 4.9 4.8 4.0 6.3 6.5 4.4 7.8 3.4 5.0 5.7 3.5 6.8 4.2 3.6 3.0 3.7 5.7 2.9 4.3 8.5 4.7 2.8 4.8 7.7 8.9 3.6 6.3 4.7 4.4 5.5 3.6 4.8 5.8 5.6 3.2 3.6 2.2 4.5 5.3 6.4 7.7 3.7 4.7 9.2 3.2 2.9 6.1 4.3 9.7 2.6 7.7 6.6 5.6 4.6 6.3 4.7 4.0 8.6 7.2 3.2 5.5 5.5 6.5 7.7 3.9 8.9 4.0 6.7 6.0 2.7 6.7 15.2 9.2 2.4 5.4 5.7 11.0 10.2 5.6 2.4 5.4 7.3 7.3 2.3 4.3 12.6 5.9 7.5 3.9 5.1 5.5 7.6 3.8 8.7 7.6 7.1 3.5 7.2 3.4 1.8 1.9 4.2 3.3 1.9 3.8 4.4 3.0 3.1 2.4 2.9 4.6 3.9 4.2 3.0 5.5 1.8 3.2 2.5 4.5 4.7 6.3 5.9 4.3 4.6 4.9 4.8 4.0 5.0 4.3 4.8 5.5 3.5 12.8 7.0 6.2 5.8 0.3 1.0 1.3 3.4 6.7 2.3 2.0 4.4 5.7 2.4 1.8 2.1 2.1 4.7 0.6 0.0 2.8 0.2 3.6 4.1 3.5 7.7 7.8 6.6 1.8 1.4 2.5 1.1 2.5 0.0 10.3 4.2 2.5 1.7 1.7 7.4 4.1 2.0 3.7 0.7 0.4 2.5 4.0 3.6 4.7 4.9 3.8 6.2 5.0 8.0 2.7 3.0 1.9 6.0 1.1 0.9 2.1 4.4 2.9 0.0 4.0 4.5 2.8 3.2 1.7 1.1 0.8 3.8 6.5 2.5 1.1 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573765-46598496 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 35.6" "Cell type enhanced" "Detected in many" "Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 18.5" "Group enriched" "Detected in many" 10 "granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5" "Cell line enhanced" "Detected in many" "EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favorable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 11.5 3.5 5.1 1.7 5.7 2.6 7.6 6.2 7.1 10.2 3.5 3.7 0.8 5.9 0.4 2.5 5.0 1.9 17.4 5.0 8.3 4.0 7.6 3.6 1.8 5.6 7.0 4.5 35.6 2.0 1.2 4.2 2.1 6.4 4.1 0.8 1.0 3.5 1.4 4.4 6.3 4.0 1.4 4.1 10.3 3.4 2.1 7.1 1.4 5.8 4.0 0.7 4.5 7.7 4.5 5.5 4.7 3.9 3.5 10.8 7.5 0.2 7.6 5.4 2.0 2.6 1.2 2.1 0.0 22.8 3.1 1.3 4.1 3.8 1.3 1.7 3.2 8.1 1.1 0.3 4.1 16.6 1.9 0.1 2.5 1.1 3.8 3.1 3.4 6.2 2.5 0.0 4.7 1.5 2.6 0.7 2.4 20.5 0.4 17.0 3.6 3.2 10.3 5.5 0.2 8.8 3.4 1.1 0.2 0.9 9.6 1.3 0.4 1.4 6.1 0.6 3.3 3.5 11.0 2.4 1.7 6.8 0.1 0.4 2.4 2.2 0.7 1.5 7.1 1.4 1.2 5.8 2.8 1.2 0.6 1.2 1.1 10.9 0.6 10.2 0.8 18.5 1.9 5.1 5.7 6.2 7.1 5.0 8.3 5.6 7.0 4.5 6.4 4.1 7.1 4.5 33.8 0.0 3.1 22.9 2.5 12.4 2.0 4.8 1.2 0.8 2.2 3.7 7.4 10.0 2.6 1.8 0.0 5.3 11.5 1.7 1.9 2.8 0.0 3.6 20.8 16.3 0.0 0.0 0.9 2.5 4.3 23.6 0.0 1.6 0.0 19.7 15.7 4.5 11.5 3.3 4.1 2.9 0.0 14.2 45.4 0.3 19.0 14.1 14.2 4.7 55.5 5.2 4.1 13.0 1.0 1.8 1.5 60.2 4.7 6.7 0.7 2.1 1.9 0.8 52.6 43.1 11.2 0.5 1.3 1.3 13.2 1.4 9.9 11.4 0.9 3.3 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46447292-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 43.2;Oligodendrocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065295 Approved Nucleoplasm NA NA Nucleoplasm "HPA065295: AB_2685456" "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.87e-6)" "prognostic favorable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.17e-4)" 13.1 10.1 19.8 9.7 19.8 6.5 14.4 19.3 22.7 17.4 19.6 12.0 6.8 18.3 22.8 7.4 13.3 12.0 10.1 19.4 20.1 11.4 16.6 11.7 14.8 19.5 18.6 18.3 18.4 8.9 13.9 13.2 17.8 19.8 15.8 9.2 14.7 8.9 11.6 8.3 11.6 9.9 15.1 17.3 18.7 9.4 5.5 22.0 14.5 14.9 9.1 12.9 12.4 11.3 20.2 23.0 13.2 20.1 15.6 19.6 20.1 12.3 21.8 19.8 19.9 18.0 11.3 20.8 12.7 14.1 19.4 32.9 16.0 25.1 12.2 23.4 12.7 10.7 10.9 29.7 11.0 20.9 16.3 16.8 22.7 13.6 27.1 22.8 17.7 18.7 19.7 11.7 13.8 18.0 13.2 16.6 8.1 18.3 9.1 23.4 11.6 18.6 16.0 13.2 9.4 7.3 14.3 18.6 9.2 21.5 34.2 15.3 15.9 17.2 22.0 22.0 29.2 17.9 15.1 18.3 18.5 19.1 0.8 20.6 18.0 7.2 15.5 12.7 9.0 13.4 13.6 13.9 12.5 7.1 18.6 17.3 13.1 4.3 15.6 10.3 13.4 13.1 9.4 19.8 19.8 19.3 22.7 19.4 20.1 19.5 18.6 18.3 19.8 17.3 22.0 20.2 16.9 6.4 6.1 25.1 11.8 2.2 4.5 7.4 14.2 6.4 5.6 7.0 6.6 8.6 5.1 5.5 4.2 15.2 10.5 1.9 9.8 7.5 0.2 4.9 10.1 15.4 1.2 7.2 22.4 4.5 8.0 10.5 5.6 3.6 7.6 8.8 16.8 5.3 9.5 10.1 22.2 3.9 4.1 6.3 2.6 1.3 7.8 5.1 7.2 20.6 5.5 8.9 13.4 43.2 36.9 3.6 6.5 11.3 8.3 3.8 3.1 5.8 5.1 8.4 13.1 6.4 8.1 4.3 5.4 4.2 2.7 13.5 10.9 11.1 3.6 1.9 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145038 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 723.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria NA NA Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 71.7 135.1 138.7 73.9 140.9 134.3 90.8 146.2 172.0 75.2 150.7 113.5 97.6 54.9 105.5 96.0 84.9 46.6 212.2 139.9 140.7 104.5 165.8 62.7 91.1 144.5 138.0 133.8 59.0 159.6 124.0 93.4 62.9 142.3 74.6 99.2 59.7 129.3 80.0 723.8 73.5 96.9 72.9 138.5 75.1 98.6 27.0 145.3 98.7 96.4 381.8 107.2 68.6 67.0 145.3 173.5 297.9 198.7 242.4 173.6 166.1 221.1 125.2 180.5 231.5 224.4 292.6 224.2 218.5 101.8 163.4 222.3 216.2 267.0 157.3 162.0 212.4 663.1 129.5 371.2 271.3 184.7 203.2 188.2 176.9 140.0 191.2 126.8 137.8 193.9 286.8 158.6 282.6 139.3 437.2 269.1 622.5 308.5 219.2 517.2 259.7 210.9 513.6 254.0 210.1 391.2 283.1 231.9 289.2 198.8 259.8 418.2 279.7 130.3 152.7 190.5 239.1 149.0 244.0 270.0 258.5 155.0 138.4 204.2 255.4 410.3 188.6 294.2 306.5 362.1 541.7 408.9 342.6 491.6 470.0 454.3 359.3 84.9 279.7 233.8 636.5 476.3 626.1 138.7 140.9 146.2 172.0 139.9 140.7 144.5 138.0 133.8 142.3 138.5 145.3 145.3 154.0 105.8 132.5 16.6 270.9 259.5 252.1 514.5 267.5 89.2 343.7 520.1 236.6 265.9 284.7 290.6 37.5 456.9 227.6 400.0 583.0 314.9 5.2 193.4 229.7 165.6 330.7 246.3 10.2 369.1 429.2 192.1 200.8 267.1 194.1 219.2 203.8 657.2 391.0 55.5 16.7 495.1 333.7 321.7 290.9 16.3 181.7 229.1 265.1 12.2 336.9 238.9 183.4 14.1 25.3 291.8 391.2 176.4 445.1 258.6 360.1 756.8 180.9 109.8 164.3 157.6 248.9 16.8 36.9 358.0 290.5 450.9 228.9 342.6 447.4 334.9 ZNF41 "MGC8941, MRX89" ENSG00000147124 "Zinc finger protein 41" P51814 X 47445879-47482946 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 12.6;Inhibitory neurons: 18.6;Microglial cells: 17.8;Oligodendrocytes: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069102 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA069102: AB_2686086" "unprognostic (9.63e-2)" "unprognostic (1.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.72e-2)" "unprognostic (6.87e-2)" "prognostic favorable (8.32e-4)" "unprognostic (3.72e-1)" "unprognostic (5.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.17e-2)" "unprognostic (1.51e-1)" "unprognostic (4.23e-2)" "prognostic favorable (6.95e-4)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" 4.2 3.2 3.8 6.2 4.1 1.4 6.3 5.7 5.3 6.1 4.5 6.1 4.2 5.2 3.6 4.6 4.2 4.3 9.9 3.9 4.0 5.2 4.9 5.4 6.4 3.9 4.4 3.6 5.2 3.8 8.8 3.4 5.0 4.1 5.0 7.1 9.7 4.5 4.7 19.3 4.8 4.3 5.4 3.4 6.2 5.5 2.2 4.5 7.5 7.1 16.3 7.5 5.4 3.1 4.9 6.3 6.8 5.5 14.0 6.6 7.3 3.8 8.5 7.0 7.2 8.2 3.9 6.7 8.9 4.6 11.2 9.2 9.7 12.5 5.9 9.0 14.3 4.7 2.2 9.4 2.4 4.5 9.0 7.8 5.3 7.3 8.2 10.6 6.5 6.6 7.4 6.5 9.5 9.1 9.4 9.4 4.9 9.3 5.7 10.4 8.7 7.2 9.3 5.5 10.5 7.6 7.7 12.5 9.6 4.8 6.4 10.1 4.9 10.0 7.6 5.9 15.5 6.1 6.9 10.0 9.4 6.5 17.8 8.2 0.8 2.7 2.8 3.5 3.3 4.1 2.5 3.0 3.8 3.6 4.2 3.4 3.2 0.7 3.5 1.7 2.4 2.8 2.3 3.8 4.1 5.7 5.3 3.9 4.0 3.9 4.4 3.6 4.1 3.4 4.5 4.9 3.1 3.2 3.9 9.4 3.4 0.6 2.1 1.1 4.0 3.8 1.5 1.1 4.6 0.0 1.3 0.0 0.0 0.3 2.1 2.0 1.9 1.5 0.1 1.4 2.2 2.3 0.0 3.8 12.6 1.4 0.8 3.1 3.6 2.2 1.3 1.7 3.9 1.7 1.1 0.0 18.6 1.4 2.0 1.3 1.0 0.2 0.9 2.7 1.8 17.8 1.0 1.6 2.1 8.5 16.3 1.7 2.5 0.7 5.7 1.5 2.0 0.8 2.0 3.7 0.0 1.6 2.2 1.6 1.7 4.1 0.1 0.8 4.0 2.3 1.7 2.5 RAB41 ENSG00000147127 "RAB41, member RAS oncogene family" Q5JT25 X 70282093-70285002 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 66.1" "Cell type enriched" "Detected in some" 19 "Cone photoreceptor cells: 533.8" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 3.7;U-87 MG: 4.6" "HPA001510, HPA065289" Uncertain Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA001510: AB_1079733, HPA065289: " "unprognostic (1.32e-1)" "unprognostic (1.39e-1)" "unprognostic (3.36e-3)" "unprognostic (4.25e-3)" "unprognostic (1.18e-1)" "unprognostic (3.46e-2)" "unprognostic (6.33e-3)" "unprognostic (1.85e-3)" "unprognostic (1.38e-1)" "unprognostic (2.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.04e-3)" "unprognostic (7.63e-2)" "unprognostic (2.39e-1)" "unprognostic (9.78e-3)" "unprognostic (8.42e-2)" "unprognostic (9.89e-2)" 0.2 0.8 0.3 0.6 0.4 0.4 0.1 0.3 0.8 0.1 0.0 0.3 0.4 0.2 0.0 0.3 0.2 0.5 0.6 0.2 0.2 0.3 0.1 0.3 0.5 0.5 0.4 0.0 0.8 0.1 0.0 0.2 0.2 0.3 0.2 0.0 66.1 1.0 0.0 0.5 1.3 0.8 0.0 0.3 0.5 0.2 4.0 0.6 0.0 0.8 0.0 0.0 0.3 0.1 0.4 0.5 0.5 1.3 0.5 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.6 0.5 0.6 1.1 0.0 1.1 0.6 0.0 0.0 0.0 0.8 1.3 0.1 1.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.5 1.2 0.0 0.3 0.8 0.5 0.8 1.7 1.7 0.3 0.9 0.9 0.0 0.4 0.8 1.5 0.5 0.3 1.5 0.6 0.3 1.4 1.6 0.6 0.7 3.7 0.8 0.7 1.1 0.8 4.6 1.1 1.1 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.1 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.3 0.8 0.2 0.2 0.5 0.4 0.0 0.3 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 533.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 28.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZMYM3 "DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261" ENSG00000147130 "Zinc finger MYM-type containing 3" Q14202 X 71239624-71255146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 38.8;Theca cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003211, HPA075255" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003211: AB_1080661, HPA075255: AB_2732287" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.69e-3)" "unprognostic (2.03e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.18e-4)" "unprognostic (5.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-2)" "unprognostic (4.07e-2)" "unprognostic (1.17e-1)" "unprognostic (2.93e-1)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (4.42e-2)" "unprognostic (1.30e-3)" 9.5 29.5 19.0 8.7 19.1 7.1 10.3 10.6 17.9 17.2 9.0 13.5 7.2 16.1 18.8 10.0 19.4 10.0 9.7 17.4 18.0 13.2 13.7 11.1 12.2 13.3 13.6 17.7 37.4 10.9 11.7 18.3 8.0 14.0 15.7 7.9 13.5 11.7 17.2 10.9 11.5 12.1 14.7 12.6 15.6 12.3 20.6 21.7 16.1 15.9 5.7 11.0 13.4 13.4 14.6 15.4 27.9 66.2 35.2 18.8 18.9 16.7 14.0 20.8 29.7 27.8 31.1 22.9 39.0 34.1 25.3 26.8 14.2 57.1 21.2 22.3 13.1 30.6 33.9 25.6 27.9 8.7 31.9 20.3 22.3 12.1 21.6 13.4 52.8 25.2 30.8 39.7 20.9 22.0 25.5 38.6 40.6 65.9 19.0 24.2 47.7 20.3 28.7 22.0 18.6 31.5 21.7 23.8 14.7 13.7 47.8 21.7 20.7 19.5 14.6 26.7 21.5 12.8 18.9 12.1 32.9 17.6 42.9 16.4 6.1 5.2 4.3 4.2 4.8 4.8 7.1 4.8 3.9 4.8 6.6 4.0 4.0 0.3 4.9 4.2 10.1 4.8 4.0 19.0 19.1 10.6 17.9 17.4 18.0 13.3 13.6 17.7 14.0 12.6 21.7 14.6 5.6 12.8 11.9 14.7 6.9 3.8 2.7 12.2 6.8 12.9 9.2 10.0 10.6 7.2 15.0 31.3 10.4 8.5 4.7 3.3 1.9 6.7 1.1 12.0 8.5 7.5 4.8 7.6 15.8 8.9 7.0 7.0 6.6 9.4 2.5 38.8 8.9 15.3 9.8 13.5 17.3 9.2 6.1 11.9 6.7 4.0 13.7 6.6 3.6 6.5 11.2 9.5 7.2 7.1 12.3 5.5 8.8 23.3 4.9 1.9 4.5 15.1 12.0 7.7 6.6 5.3 9.9 1.5 4.0 9.3 3.8 4.2 5.2 40.0 7.1 2.0 TAF1 "BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250" ENSG00000147133 "TATA-box binding protein associated factor 1" P21675 X 71366264-71532374 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001075, CAB016283" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016283: AB_671202, HPA001075: AB_1080179" "unprognostic (2.95e-2)" "unprognostic (1.77e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "prognostic favorable (6.54e-4)" "unprognostic (2.68e-2)" "unprognostic (3.43e-2)" "unprognostic (2.03e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (1.14e-2)" "unprognostic (1.41e-1)" "unprognostic (1.82e-2)" "unprognostic (2.56e-2)" 11.0 8.7 10.5 11.5 12.1 12.9 12.5 13.6 11.7 11.2 10.7 10.1 6.7 13.9 13.1 7.6 11.2 7.9 7.1 9.3 10.8 7.6 7.9 9.2 14.2 11.6 11.5 6.4 14.5 9.9 12.3 8.4 10.1 12.9 10.0 10.1 27.6 7.8 10.2 10.6 13.4 9.3 11.0 8.7 15.6 10.7 7.2 11.5 14.9 12.8 10.4 12.5 9.3 8.7 16.9 18.6 15.9 18.2 12.4 14.6 23.2 11.0 13.3 12.1 13.7 11.1 12.3 11.3 17.6 11.5 14.9 12.3 17.5 24.1 11.0 17.0 11.2 21.9 20.1 22.1 13.1 11.1 39.7 19.4 14.1 11.3 14.2 27.2 12.8 14.7 13.2 28.2 41.1 14.4 14.5 22.4 25.4 20.9 23.5 20.8 19.8 35.8 21.6 11.1 25.0 9.0 14.5 37.7 13.6 18.7 14.3 9.6 22.9 18.6 16.5 14.2 13.4 9.7 17.5 17.4 21.4 9.0 33.2 12.5 1.6 1.4 0.7 1.4 0.9 1.3 1.0 1.4 1.4 1.5 1.5 1.6 1.8 1.8 1.5 1.6 1.4 1.0 0.7 10.5 12.1 13.6 11.7 9.3 10.8 11.6 11.5 6.4 12.9 8.7 11.5 16.9 26.7 32.1 26.7 44.7 21.2 11.9 8.9 10.4 18.2 37.5 12.5 13.3 17.2 10.0 23.9 3.7 81.3 8.6 21.5 7.8 1.9 6.3 2.5 17.0 23.4 24.6 11.4 28.6 54.3 7.0 5.9 17.6 12.2 18.9 23.4 23.9 18.9 12.6 8.8 16.8 52.2 14.6 6.1 16.2 20.0 2.6 22.1 20.4 5.4 47.8 23.9 17.0 29.9 49.3 79.1 7.6 13.3 22.2 18.7 11.2 13.4 5.2 14.8 67.9 0.0 27.4 18.0 9.3 10.7 17.8 17.3 5.7 23.8 25.9 13.6 9.6 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144688-79175318 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 17.1" "Cell type enhanced" "Detected in some" "B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "JURKAT: 42.3;MOLT-4: 75.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041025, HPA058306" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Plasma membrane" "Vesicles, Centriolar satellite" "HPA041025: AB_10794260, HPA058306: " "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 0.5 0.4 0.5 7.0 0.5 2.5 0.9 0.6 0.6 0.4 0.4 1.0 2.0 0.5 0.6 0.3 0.3 1.1 0.3 0.4 0.4 0.5 1.0 1.9 15.3 0.6 0.4 0.3 0.2 0.1 0.1 0.1 0.2 0.6 0.7 1.6 0.2 1.5 0.1 0.2 0.2 3.7 0.3 0.4 8.2 2.2 0.1 0.5 17.1 0.9 0.1 10.5 1.4 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 1.2 0.0 0.0 75.1 0.1 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.2 0.0 0.0 0.0 6.5 0.0 3.6 3.6 2.0 1.2 2.5 4.8 6.1 0.1 2.6 4.2 4.9 0.3 4.6 5.5 1.0 4.8 1.6 0.5 0.5 0.6 0.6 0.4 0.4 0.6 0.4 0.3 0.6 0.4 0.5 0.8 0.7 0.0 2.4 0.0 6.6 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.6 1.8 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.5 0.1 0.0 0.0 NONO "NMT55, NRB54, P54, P54NRB, PPP1R114" ENSG00000147140 "Non-POU domain containing octamer binding" Q15233 X 71254814-71301522 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022069, HPA054094, HPA054559" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles" NA NA 450000 Nucleoplasm "Nucleoli fibrillar center, Nuclear speckles" "CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522" "unprognostic (2.39e-3)" "unprognostic (2.22e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (8.87e-2)" "unprognostic (5.54e-2)" "unprognostic (1.02e-3)" "unprognostic (9.34e-2)" "unprognostic (2.32e-2)" "unprognostic (1.41e-2)" "unprognostic (3.12e-1)" "unprognostic (2.07e-1)" "unprognostic (7.29e-3)" "unprognostic (6.79e-2)" "unprognostic (5.73e-3)" "unprognostic (2.76e-2)" "unprognostic (3.04e-2)" 105.0 148.4 60.2 97.3 60.3 116.2 110.3 73.2 65.5 115.5 67.2 100.2 87.0 131.2 108.8 112.8 116.4 101.6 79.5 57.0 68.5 104.3 122.5 104.1 137.6 63.8 60.1 54.3 199.6 166.2 115.7 97.9 99.9 62.5 97.8 102.1 70.8 107.7 90.4 99.9 111.4 102.8 114.4 60.4 110.3 115.3 55.6 65.9 257.9 117.0 86.9 166.6 117.9 103.5 62.6 421.2 539.7 595.3 344.4 251.2 238.5 345.3 330.9 319.2 459.3 388.5 413.4 312.9 481.4 379.9 320.5 309.7 310.5 949.5 299.4 488.1 383.9 605.7 394.8 498.4 398.0 212.3 547.7 338.7 272.0 206.0 473.1 305.7 370.5 382.0 342.1 535.3 509.0 406.2 413.9 756.0 466.8 771.3 433.9 365.2 660.0 657.3 414.0 345.9 426.1 431.7 519.4 467.8 299.1 392.5 354.9 271.4 354.0 343.9 268.0 438.6 402.9 400.1 297.3 503.2 516.0 216.8 627.1 433.8 107.5 117.3 91.1 107.9 120.0 119.9 107.4 107.9 106.4 118.7 107.2 115.1 115.6 50.8 119.6 140.7 101.1 128.0 178.1 60.2 60.3 73.2 65.5 57.0 68.5 63.8 60.1 54.3 62.5 60.4 65.9 62.6 72.9 76.9 81.1 16.3 97.2 126.3 99.9 105.8 116.7 62.3 111.4 83.6 63.5 90.1 99.8 44.1 41.7 132.3 103.6 52.0 56.7 147.8 11.8 81.6 137.8 95.4 139.8 144.6 16.2 111.4 179.9 93.9 71.4 104.8 88.0 135.9 83.9 128.3 112.6 53.8 20.7 105.6 95.6 153.2 107.7 15.9 106.6 95.0 56.9 13.1 132.0 84.8 96.8 19.6 22.8 110.7 75.4 127.9 115.2 94.9 89.0 121.0 71.1 50.3 65.7 78.7 127.8 45.7 66.5 137.3 122.3 130.1 108.5 163.7 117.2 103.0 CCDC120 JM11 ENSG00000147144 "Coiled-coil domain containing 120" Q96HB5 X 49053572-49069857 "Cancer-related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.2;skin 1: 28.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 20.9;BEWO: 28.6;HaCaT: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000561 Uncertain Mitochondria NA NA Mitochondria "HPA000561: AB_2244190" "unprognostic (1.65e-1)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (7.59e-3)" "unprognostic (1.80e-3)" "unprognostic (1.08e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (4.85e-2)" "unprognostic (2.64e-2)" "unprognostic (3.82e-3)" "unprognostic (4.54e-3)" "unprognostic (2.34e-3)" 2.6 2.6 4.7 2.1 4.8 2.3 4.5 6.8 6.4 8.1 3.8 4.4 8.8 4.4 5.7 36.2 5.1 2.5 1.7 4.8 4.0 9.1 6.6 4.3 2.0 3.7 3.6 4.6 6.4 8.0 3.8 9.4 4.0 5.0 7.8 2.3 2.0 12.0 4.0 0.7 28.6 7.4 1.7 2.9 3.8 6.8 3.4 4.1 2.9 6.0 0.5 3.9 5.3 16.3 3.9 20.9 2.8 4.5 0.2 0.0 0.0 28.6 0.7 1.0 1.5 2.4 6.9 8.7 0.8 3.2 1.2 3.4 19.5 3.4 11.7 0.1 5.4 6.6 2.0 5.0 2.4 1.5 0.1 3.4 2.5 9.0 1.9 0.5 3.1 2.5 5.4 2.9 0.2 0.0 17.5 7.5 0.5 5.1 9.8 0.1 6.6 3.3 2.0 8.8 11.0 6.0 4.7 3.6 7.2 2.2 6.1 17.7 2.8 1.2 0.1 5.2 0.2 0.2 6.6 4.8 0.1 0.2 0.1 0.9 1.1 0.2 0.5 0.3 0.0 0.2 0.2 0.4 0.3 0.0 0.6 0.4 0.3 1.0 0.4 0.1 0.6 0.1 0.1 4.7 4.8 6.8 6.4 4.8 4.0 3.7 3.6 4.6 5.0 2.9 4.1 3.9 1.7 6.4 3.1 2.0 2.5 5.1 3.5 7.1 4.0 6.8 8.2 5.6 1.3 4.3 6.0 12.9 4.2 12.7 2.2 5.6 0.0 5.1 0.1 8.5 2.2 2.7 6.0 1.7 4.8 6.5 3.2 2.9 9.7 11.5 0.0 4.9 2.5 2.5 2.3 10.1 6.2 6.2 2.0 1.2 1.5 0.5 2.1 0.9 0.0 2.8 0.4 3.3 2.1 2.5 0.7 14.4 8.3 1.2 1.5 6.3 9.0 3.1 5.0 6.8 0.0 2.6 1.5 1.4 2.4 9.0 9.2 16.8 2.3 2.3 4.6 11.4 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;ovary: 3.6" "Cell type enhanced" "Detected in some" "Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "basophil: 6.3" "Lineage enriched" "Detected in single" 19 "granulocytes: 6.3" "Cell line enhanced" "Detected in some" "AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853" "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 0.5 0.0 1.7 0.4 1.3 0.3 0.8 1.4 1.7 0.6 1.0 0.3 0.0 1.1 0.3 0.6 0.3 0.8 0.7 2.8 1.5 0.1 0.1 0.1 0.0 1.8 1.7 1.0 3.6 0.4 0.0 0.1 0.0 1.2 0.2 0.4 0.1 0.3 0.1 0.0 0.5 0.3 0.5 2.5 0.1 0.4 0.3 1.2 0.7 0.1 0.3 0.4 0.4 0.2 3.8 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.6 1.0 1.2 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.6 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.1 2.1 0.0 0.4 1.7 15.2 0.0 0.2 0.8 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 2.6 0.0 0.0 0.2 0.0 0.6 1.2 0.0 0.7 0.7 3.7 1.5 6.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 1.3 1.4 1.7 2.8 1.5 1.8 1.7 1.0 1.2 2.5 1.2 3.8 1.2 0.0 0.0 10.1 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.1 0.8 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.5 20.2 0.1 1.8 1.0 0.6 1.0 0.0 3.5 0.1 0.0 0.0 2.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.3 1.5 0.4 0.0 0.4 0.2 0.0 0.2 EBP "CDPX2, CHO2, CPX, CPXD" ENSG00000147155 "EBP cholestenol delta-isomerase" Q15125 X 48521799-48528716 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Cataract, Disease variant, Dwarfism, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 331.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 674.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003130 Approved Supported "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "HPA003130: AB_1078717" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (2.80e-1)" "unprognostic (6.27e-2)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.47e-1)" "unprognostic (5.14e-2)" "unprognostic (4.04e-2)" "unprognostic (5.39e-2)" "unprognostic (4.13e-1)" "unprognostic (1.36e-1)" 10.3 73.9 16.5 17.3 17.9 48.7 17.6 18.8 18.4 13.8 20.6 51.1 86.3 11.1 17.4 41.6 14.4 10.6 32.8 17.9 17.4 44.4 331.2 24.6 18.9 23.4 18.1 17.3 12.8 26.2 44.4 7.3 8.2 25.4 41.0 58.1 10.8 25.2 11.9 9.6 28.0 54.6 15.1 16.0 17.0 31.8 14.4 18.3 28.5 14.5 10.7 32.9 14.2 23.5 25.5 224.5 96.4 107.4 77.0 74.5 39.2 50.5 48.2 43.6 64.3 93.9 169.9 382.7 115.9 35.2 41.3 83.5 230.3 217.5 293.8 49.8 85.8 149.7 50.1 115.2 139.3 57.8 179.2 138.2 51.3 108.6 112.9 86.4 22.5 46.5 98.1 77.6 119.5 50.7 163.7 119.1 199.9 118.2 88.3 199.1 93.8 10.3 363.7 175.6 68.8 110.0 59.6 175.4 122.6 31.2 91.5 122.9 71.1 46.6 33.1 56.2 132.9 63.1 47.5 72.1 107.7 78.7 239.7 40.6 96.1 37.7 97.1 129.4 53.4 104.5 71.5 90.5 116.7 53.5 57.2 76.5 99.7 7.3 63.9 57.2 105.4 103.1 93.6 16.5 17.9 18.8 18.4 17.9 17.4 23.4 18.1 17.3 25.4 16.0 18.3 25.5 15.2 32.1 49.8 2.9 38.9 37.1 58.2 245.6 23.3 23.8 57.8 26.2 49.9 77.2 116.6 53.3 8.4 55.9 74.5 140.3 39.2 91.7 10.5 30.5 14.7 26.1 30.0 48.8 7.4 239.1 113.0 21.4 36.2 56.5 40.6 41.2 27.1 674.6 65.0 8.4 10.3 96.8 93.6 30.2 36.0 11.8 13.4 31.9 37.4 4.7 34.8 19.3 101.0 5.0 5.1 156.7 137.3 14.7 54.4 46.4 171.9 99.7 34.8 23.3 13.1 12.5 23.6 8.7 22.7 47.6 45.5 37.5 57.1 128.7 149.1 71.1 AWAT2 "DGAT2L4, MFAT" ENSG00000147160 "Acyl-CoA wax alcohol acyltransferase 2" Q6E213 X 70040542-70049938 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 7.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 8.3" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062748 Approved NA NA "HPA062748: AB_2684862" "unprognostic (3.41e-2)" "unprognostic (1.06e-1)" "unprognostic (2.99e-2)" "unprognostic (4.11e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 8.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533104-71575892 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595" "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favorable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavorable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.85e-7)" 59.5 56.4 41.6 38.7 45.5 62.1 63.2 46.8 51.2 71.2 43.6 60.3 30.9 56.4 62.7 53.2 77.1 26.6 55.0 46.1 53.9 61.8 46.2 71.3 72.5 41.0 40.3 46.7 86.2 103.3 24.5 47.3 26.6 42.1 76.0 40.0 37.2 64.6 27.3 63.3 64.7 87.2 24.7 38.8 123.8 67.9 19.1 39.6 57.8 71.2 39.6 58.3 56.2 67.9 46.8 40.5 37.0 47.1 41.5 49.6 45.6 31.6 30.3 54.3 32.1 49.1 39.3 45.4 47.9 20.7 37.3 33.3 49.1 52.0 29.5 39.4 41.1 53.4 30.4 98.6 28.5 37.6 62.9 48.1 43.6 59.2 35.1 65.7 55.5 30.5 100.7 31.1 160.4 31.1 34.3 48.9 75.2 31.6 35.5 49.8 47.8 52.7 62.1 50.0 45.9 24.1 21.2 46.9 30.9 30.2 35.5 22.8 42.4 35.5 34.6 27.9 36.6 17.9 43.5 33.5 56.5 24.4 65.0 21.6 2.8 4.6 2.0 7.5 5.7 6.8 7.4 6.3 6.2 6.1 6.2 7.2 7.4 1.9 10.4 5.7 6.2 6.2 5.6 41.6 45.5 46.8 51.2 46.1 53.9 41.0 40.3 46.7 42.1 38.8 39.6 46.8 31.1 35.3 85.2 52.9 67.2 88.1 37.9 23.5 58.6 26.5 49.6 34.0 42.8 20.0 31.1 49.7 8.4 15.8 130.7 31.1 9.8 14.4 2.4 32.1 49.8 39.8 34.9 51.3 110.7 14.4 8.5 47.5 54.6 53.3 27.8 26.4 45.7 27.5 16.1 40.4 94.6 37.3 22.4 60.9 69.7 4.8 53.4 45.8 35.6 71.2 51.6 11.3 51.5 92.0 97.9 17.6 34.9 29.7 147.2 53.8 34.8 15.1 28.0 21.8 32.9 44.8 42.2 2.5 6.1 63.3 84.1 10.9 82.1 62.0 34.0 50.8 SNX12 ENSG00000147164 "Sorting nexin 12" Q9UMY4 X 71056332-71073426 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070423 Approved NA NA 89000 "CAB070423: AB_11153407" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.83e-3)" "unprognostic (9.88e-3)" "unprognostic (1.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" "unprognostic (9.55e-2)" "unprognostic (1.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (1.51e-7)" "unprognostic (3.52e-2)" "unprognostic (8.81e-2)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" 26.9 38.0 38.3 27.7 37.9 28.3 29.9 35.7 38.7 31.4 27.3 36.3 37.7 36.4 34.5 50.2 33.5 30.3 41.0 34.5 38.3 42.5 25.2 27.1 23.6 37.7 39.9 33.2 39.5 25.0 60.1 19.0 35.9 38.3 34.0 34.7 28.7 28.2 44.3 44.7 43.7 43.2 41.3 38.8 24.3 32.9 16.2 40.5 25.5 42.4 51.7 29.6 40.8 31.5 37.8 67.9 97.6 53.6 46.8 79.9 73.2 58.7 75.8 75.7 74.1 65.7 73.2 110.7 36.4 62.9 89.7 120.3 57.4 104.8 89.4 64.3 29.0 55.4 39.3 108.8 40.7 65.4 38.4 46.0 57.9 94.3 94.5 67.5 61.3 87.1 37.6 60.8 61.3 108.6 69.7 46.5 28.9 71.6 109.7 84.6 45.2 81.6 57.2 60.5 58.3 36.9 28.4 101.4 55.9 65.1 65.2 35.5 30.1 101.5 66.8 64.8 92.6 46.0 35.0 54.8 42.7 64.8 83.9 47.8 6.9 2.9 4.9 2.6 4.2 3.0 4.2 2.9 2.3 3.3 3.1 2.2 3.5 2.5 3.5 2.5 2.7 4.7 1.6 38.3 37.9 35.7 38.7 34.5 38.3 37.7 39.9 33.2 38.3 38.8 40.5 37.8 12.2 0.0 6.7 2.9 11.8 15.3 22.5 17.2 22.2 10.1 15.4 13.5 21.4 21.5 12.8 11.0 2.1 40.2 5.6 21.8 11.7 27.3 0.5 3.6 11.8 16.8 10.8 10.1 6.4 24.4 22.5 13.5 10.7 8.2 14.5 6.6 16.8 13.8 24.3 15.2 6.0 16.8 16.2 17.6 11.2 1.2 10.8 12.8 17.8 1.9 24.1 12.5 15.5 7.1 4.8 31.5 9.0 19.9 5.9 12.3 48.1 29.7 3.4 10.2 26.3 8.7 14.8 5.9 14.7 22.2 16.3 33.1 10.1 25.8 16.5 18.0 ITGB1BP2 CHORDC3 ENSG00000147166 "Integrin subunit beta 1 binding protein 2" Q9UKP3 X 71301750-71305371 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 83.6;skeletal muscle: 46.5;tongue: 53.4" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 80.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA040721 Approved Cytosol NA NA Cytosol "HPA040721: AB_10805827" "unprognostic (1.87e-1)" "unprognostic (2.65e-2)" "unprognostic (6.91e-5)" "unprognostic (1.95e-2)" "unprognostic (7.92e-2)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (9.02e-2)" "unprognostic (4.69e-2)" "unprognostic (2.15e-2)" "unprognostic (4.85e-2)" "unprognostic (3.17e-1)" "unprognostic (3.08e-11)" "unprognostic (4.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-1)" 0.8 0.6 0.8 1.5 0.7 1.6 0.5 1.1 0.9 2.3 0.6 4.9 1.0 16.7 3.0 4.1 3.3 2.5 83.6 0.8 0.6 0.8 1.4 1.0 0.9 0.7 0.7 0.5 1.7 0.5 0.0 0.5 0.3 0.9 6.1 1.8 1.8 1.3 10.4 46.5 0.6 2.1 16.5 0.7 1.2 2.0 1.4 0.7 1.0 0.7 53.4 0.6 5.6 1.6 1.2 0.5 1.4 2.1 1.8 0.1 0.1 0.4 0.7 1.0 0.5 0.5 0.9 1.1 2.1 0.2 1.1 0.5 0.9 1.9 0.6 1.1 0.7 0.9 1.3 1.5 0.4 0.2 0.4 9.3 1.1 0.7 0.2 0.3 0.4 0.8 2.2 1.0 0.5 1.1 0.4 0.8 2.3 3.1 1.4 0.9 1.4 1.6 0.8 1.0 1.3 1.0 0.3 0.5 0.1 0.6 1.4 0.5 0.3 0.0 0.9 1.8 0.1 0.4 1.8 2.8 3.1 0.2 1.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 1.1 0.9 0.8 0.6 0.7 0.7 0.5 0.9 0.7 0.7 1.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 1.7 0.3 0.3 80.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.6 0.1 0.2 0.2 0.8 0.0 0.4 0.2 0.0 0.1 2.3 0.0 0.2 0.0 0.4 1.1 0.8 0.2 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.3 0.1 1.0 0.0 0.5 0.2 0.1 8.6 0.0 0.3 0.1 0.5 0.3 1.1 0.0 0.6 2.5 0.5 0.4 0.0 0.3 0.0 0.1 0.6 0.3 0.1 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 119.1;lymphoid tissue: 349.6" "Cell type enhanced" "Detected in many" "B-cells: 186.1;dendritic cells: 199.0;Distal enterocytes: 202.0;NK-cells: 310.0;Paneth cells: 133.2;Plasma cells: 221.2;T-cells: 289.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "Karpas-707: 2316.2" "HPA046641, HPA049691" Enhanced Approved Vesicles NA NA 13000 Vesicles "HPA046641: AB_2679733, HPA049691: AB_2680851" "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 12.9 6.2 2.8 133.4 2.8 88.1 14.2 2.6 5.9 10.3 4.4 99.8 50.9 7.6 7.6 15.2 6.9 28.5 4.6 2.4 3.0 5.5 20.7 52.1 237.5 3.4 2.8 2.2 4.9 4.1 2.0 1.5 17.1 4.3 7.9 119.1 0.5 19.2 6.0 2.6 15.6 83.4 12.5 3.3 120.4 41.8 2.2 3.4 349.6 5.9 6.4 309.5 46.8 5.6 3.6 1.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 4.7 9.1 187.3 13.5 0.0 0.7 1.7 0.4 0.0 0.0 160.3 0.2 23.6 0.3 0.3 0.2 99.3 4.0 0.0 0.0 0.0 0.1 0.1 0.0 220.5 43.3 2316.2 0.0 0.0 356.4 193.7 0.4 0.9 0.1 79.5 0.8 20.0 0.0 0.7 0.2 0.3 2.3 0.1 0.5 0.0 0.0 3.5 0.4 0.0 1.0 0.0 0.5 132.1 242.2 119.6 2.1 397.4 0.9 540.5 102.2 169.7 1204.7 239.5 1179.9 604.7 1086.3 1250.7 243.5 603.0 742.0 943.1 773.0 1190.3 177.0 368.9 1422.2 1494.0 2.8 2.8 2.6 5.9 2.4 3.0 3.4 2.8 2.2 4.3 3.3 3.4 3.6 3.3 3.2 11.2 0.0 186.1 8.2 8.1 13.1 1.2 0.0 1.5 1.7 0.9 4.3 4.2 0.0 0.0 0.5 199.0 202.0 0.0 1.2 0.1 0.8 0.7 5.8 77.7 27.1 0.0 2.3 0.3 4.2 13.7 0.7 39.3 0.4 6.1 2.1 31.1 0.0 0.0 24.5 4.1 25.2 116.7 0.0 0.0 45.4 42.7 1.0 91.1 0.1 310.0 0.0 0.1 28.0 133.2 0.4 221.2 4.3 88.8 1.1 2.3 0.4 0.0 1.3 2.6 0.0 0.1 1.8 6.8 0.3 289.5 0.0 18.6 8.9 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.1" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 6.9;Endometrial ciliated cells: 2.9;Glandular and luminal cells: 7.0;Plasma cells: 3.3;T-cells: 4.7;Theca cells: 4.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA023476, HPA030870" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA023476: AB_1844530, HPA030870: " "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.7 4.6 4.8 1.3 4.9 1.3 1.4 5.5 8.8 1.9 4.3 1.5 0.8 1.3 0.9 1.3 1.5 0.7 1.8 5.6 4.7 2.2 2.6 2.4 2.0 5.2 4.2 4.4 1.8 2.5 0.2 2.0 0.4 6.0 1.8 0.7 2.2 1.3 0.4 4.2 1.3 2.4 0.7 4.5 4.9 1.8 11.1 4.8 1.1 2.3 1.2 1.0 1.5 1.7 5.5 0.3 0.5 1.1 1.0 2.2 2.0 0.6 1.8 1.0 0.6 1.0 1.0 0.7 2.9 1.4 1.0 0.6 1.4 2.2 0.1 0.9 0.5 1.5 0.6 2.8 0.3 0.6 0.5 2.6 0.8 3.5 0.5 0.5 2.3 0.4 2.2 0.8 1.8 1.3 0.3 0.2 2.1 1.1 1.3 1.3 0.5 0.0 2.1 1.4 0.8 0.6 0.1 0.6 0.3 1.6 1.1 0.2 1.8 0.7 0.7 1.3 0.9 0.5 0.5 1.4 1.1 1.2 1.1 1.1 0.2 0.1 0.0 0.1 0.1 0.3 0.3 0.4 0.8 0.1 0.1 0.2 0.2 0.2 0.3 0.0 0.1 0.8 0.1 4.8 4.9 5.5 8.8 5.6 4.7 5.2 4.2 4.4 6.0 4.5 4.8 5.5 1.8 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 2.8 0.0 0.0 0.0 3.7 0.0 0.0 6.9 0.0 0.0 0.8 0.0 2.9 1.5 0.5 0.0 0.0 0.0 1.0 0.1 0.9 0.0 7.0 2.5 2.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 4.7 4.0 0.0 0.0 ZNF711 "CMPX1, dJ75N13.1, MRX65, MRX97, Zfp711, ZNF4, ZNF5, ZNF6" ENSG00000147180 "Zinc finger protein 711" Q9Y462 X 85243991-85273362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 37.6" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 34.4;HAP1: 50.3;HEK 293: 46.0;Karpas-707: 30.7;MOLT-4: 28.4;RH-30: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030654 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030654: AB_10670561" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.07e-2)" "unprognostic (5.51e-3)" "unprognostic (1.75e-2)" "unprognostic (9.11e-3)" "unprognostic (7.40e-3)" "unprognostic (1.37e-2)" "unprognostic (2.96e-1)" "unprognostic (2.50e-3)" "unprognostic (3.25e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (6.62e-3)" 1.4 15.3 6.6 1.6 8.7 7.2 5.8 7.4 8.0 5.7 2.5 2.8 3.1 9.3 2.8 2.6 4.6 4.1 3.8 8.0 7.9 5.1 0.5 1.8 2.4 6.5 6.6 6.5 9.5 4.9 1.4 11.0 7.8 6.1 4.0 1.7 5.8 4.2 2.6 1.6 12.3 4.6 3.3 6.7 5.1 2.7 37.6 7.1 16.4 5.0 1.6 2.6 3.0 3.2 6.6 0.0 3.3 34.4 27.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 7.5 3.0 0.1 1.2 0.5 5.5 0.7 50.3 0.0 0.0 0.0 46.0 16.5 0.9 1.9 1.3 0.0 0.4 3.2 0.3 0.0 6.3 0.0 0.3 15.6 5.1 30.7 6.1 1.7 28.4 0.0 16.7 3.1 0.7 0.0 41.9 0.0 0.0 2.5 10.0 25.8 0.1 0.9 0.0 20.0 4.6 4.5 0.1 0.0 11.1 0.1 0.0 11.4 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 8.7 7.4 8.0 8.0 7.9 6.5 6.6 6.5 6.1 6.7 7.1 6.6 1.8 3.2 1.1 14.0 3.6 12.0 7.6 2.7 18.2 9.0 18.1 17.4 6.6 1.5 1.8 1.8 0.0 0.3 1.0 0.3 5.9 2.1 2.7 2.9 18.8 4.2 18.5 5.9 19.0 0.5 0.1 8.1 1.1 4.2 0.0 15.2 3.6 0.1 0.3 3.3 21.3 2.3 2.0 0.6 3.2 5.7 3.1 0.9 5.4 11.2 0.1 7.8 0.0 38.2 12.0 0.6 1.9 3.8 2.2 3.0 0.9 2.7 1.2 1.4 0.0 8.7 8.1 13.0 23.6 10.9 9.1 0.3 0.9 12.6 2.6 2.9 CPXCR1 CT77 ENSG00000147183 "CPX chromosome region candidate 1" Q8N123 X 88747225-88754785 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "testis: 6.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 80.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 171.0;Late spermatids: 177.8;Microglial cells: 301.7;Oligodendrocyte precursor cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 10.8 3.3 3.9 6.4 6.4 17.9 7.1 0.2 4.5 8.8 15.2 8.7 4.4 5.5 3.5 7.8 6.7 5.8 5.0 6.6 2.9 3.2 12.4 8.3 3.9 1.5 0.9 2.2 7.8 4.9 7.1 2.1 12.6 2.6 6.2 8.8 3.1 6.7 7.7 12.1 5.4 5.3 7.5 0.9 3.9 7.4 9.5 1.0 6.0 4.0 9.1 4.0 7.5 9.9 1.1 0.0 6.5 3.1 6.3 17.1 28.3 0.0 11.2 11.8 5.9 12.4 5.5 12.3 18.5 8.7 9.7 11.3 0.0 16.6 1.7 7.6 0.5 9.5 0.0 7.4 5.9 14.2 24.3 8.2 14.3 6.0 8.0 24.6 8.0 11.6 13.6 0.0 14.9 11.2 5.3 9.2 10.0 24.4 0.1 9.4 0.0 16.5 0.0 3.4 9.8 0.0 6.3 0.0 3.2 9.0 18.8 2.7 13.2 14.8 12.6 5.8 10.6 7.3 0.2 0.0 15.3 10.7 24.1 7.6 0.0 3.1 3.3 1.1 2.8 0.9 1.7 1.2 1.4 2.3 1.3 0.8 0.7 0.3 0.7 2.5 2.2 0.7 0.6 3.9 6.4 0.2 4.5 6.6 2.9 1.5 0.9 2.2 2.6 0.9 1.0 1.1 61.7 32.1 51.1 21.2 18.8 10.8 6.8 11.9 11.4 5.5 9.9 8.1 20.2 15.7 15.0 20.2 0.0 65.2 21.5 36.6 7.9 18.6 80.5 51.2 46.2 31.2 24.6 6.1 171.0 23.4 16.8 35.2 41.8 41.7 7.6 36.1 8.2 26.1 21.0 0.0 90.0 32.3 4.1 29.6 19.3 177.8 45.1 34.7 8.8 301.7 32.7 13.0 10.3 281.0 41.2 38.4 39.3 20.3 11.6 8.0 11.9 9.4 57.1 13.7 26.3 46.7 32.7 7.5 12.9 17.6 18.3 118.3 19.0 19.0 32.5 6.0 NXF3 ENSG00000147206 "Nuclear RNA export factor 3" Q9H4D5 X 103075810-103093143 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 25.2;testis: 58.2" "Cell type enhanced" "Detected in some" "Cholangiocytes: 2.8;Early spermatids: 2.4;Endometrial ciliated cells: 8.4;Hepatic stellate cells: 2.9;Kupffer cells: 2.6;Late spermatids: 4.2;Paneth cells: 3.9;Undifferentiated cells: 2.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 48.6;HL-60: 46.6;NB-4: 43.0;THP-1: 33.0;U-2197: 135.9;U-937: 101.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003132, HPA046757" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003132: AB_1079514, HPA046757: AB_2679789" "unprognostic (1.20e-3)" "unprognostic (6.72e-2)" "unprognostic (2.74e-1)" "unprognostic (3.05e-2)" "unprognostic (6.75e-4)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (8.86e-2)" "unprognostic (6.19e-2)" "unprognostic (3.13e-2)" "unprognostic (3.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-10)" "unprognostic (1.90e-2)" "unprognostic (4.51e-2)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 0.6 0.8 0.0 0.1 0.0 4.0 0.2 0.0 0.1 1.4 0.1 0.3 0.6 0.1 11.0 0.1 25.2 7.3 0.3 0.0 0.1 1.1 1.1 5.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.9 0.0 1.1 0.1 0.0 0.0 3.0 0.0 0.0 0.6 0.1 58.2 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.2 0.0 0.0 0.1 0.5 0.2 0.0 48.6 0.5 0.0 0.0 46.6 0.0 0.0 0.0 1.9 0.0 0.6 0.0 2.2 0.0 8.6 1.0 0.0 0.2 43.0 0.0 0.4 0.2 0.0 0.9 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.0 0.0 0.0 0.1 135.9 0.1 0.1 0.0 0.0 0.7 101.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 2.4 8.4 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.9 0.0 0.5 0.0 0.1 0.9 0.0 2.6 0.0 4.2 0.3 1.4 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.6 3.9 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.1 0.8 1.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 RIPPLY1 ENSG00000147223 "Ripply transcriptional repressor 1" Q0D2K3 X 106900063-106903341 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 2.1;liver: 5.8" "Group enriched" "Detected in some" 9 "Hepatocytes: 4.3;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in some" "liver cancer: 2.2;renal cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "RH-30: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052284 Uncertain "Intracellular and membrane" NA NA "HPA052284: AB_2681785" "unprognostic (1.48e-1)" "unprognostic (4.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.52e-3)" "unprognostic (7.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.42e-1)" "unprognostic (5.37e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-3)" "unprognostic (1.97e-1)" "unprognostic (1.97e-1)" "unprognostic (1.97e-3)" "unprognostic (1.31e-1)" 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.1 2.1 5.8 0.0 0.0 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PRPS1 "CMTX5, DFN2, DFNX1" ENSG00000147224 "Phosphoribosyl pyrophosphate synthetase 1" P60891 X 107628428-107651993 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043760, HPA051269" Uncertain Approved Vesicles NA NA 320000 Vesicles "HPA043760: AB_2678656, HPA051269: " "unprognostic (4.47e-2)" "unprognostic (6.18e-2)" "unprognostic (2.57e-2)" "unprognostic (4.19e-3)" "unprognostic (2.30e-3)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-1)" "unprognostic (9.73e-2)" "unprognostic (1.91e-2)" "unprognostic (4.11e-2)" "unprognostic (2.85e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.25e-2)" 23.1 28.3 35.6 30.5 37.0 58.5 21.2 35.0 35.9 19.7 55.0 16.8 11.1 24.0 15.0 13.9 26.1 14.0 22.4 35.3 38.2 27.9 51.9 21.7 43.0 36.6 40.3 33.0 30.4 21.9 27.4 23.4 14.8 38.5 21.4 18.0 30.4 16.4 17.6 49.5 12.3 16.9 29.7 35.4 26.4 15.6 13.5 36.9 52.4 44.5 38.2 46.1 23.8 15.4 39.1 93.5 128.9 56.4 69.9 32.7 26.5 18.6 253.2 55.8 146.0 122.6 55.5 36.6 156.9 111.7 94.9 104.1 36.6 176.0 53.8 148.3 79.9 150.9 84.2 140.0 100.3 28.8 153.1 55.6 28.2 30.6 90.2 56.2 96.7 52.3 108.2 137.4 183.5 69.0 51.0 101.2 113.6 213.5 77.2 141.4 117.6 96.3 125.4 60.7 54.2 96.2 52.5 131.5 77.6 57.3 106.4 36.0 61.7 31.2 93.2 45.0 108.3 109.1 61.8 115.1 172.7 50.1 163.6 61.6 8.8 8.9 22.6 26.0 14.3 30.8 29.3 31.7 32.2 11.4 31.0 36.1 30.7 4.7 28.5 15.7 16.3 35.5 21.1 35.6 37.0 35.0 35.9 35.3 38.2 36.6 40.3 33.0 38.5 35.4 36.9 39.1 21.0 6.4 10.0 4.6 44.2 31.1 18.4 13.2 12.0 28.4 8.3 9.4 12.1 15.7 12.6 16.5 4.2 8.8 29.3 3.0 25.4 18.3 1.2 11.5 13.3 18.1 16.2 52.2 4.8 20.2 11.5 22.2 10.2 5.7 26.6 13.2 14.6 57.5 35.3 15.2 10.0 6.5 6.1 18.6 34.8 3.9 14.0 16.8 26.6 6.5 24.9 20.0 27.8 3.5 4.8 19.1 3.7 17.0 35.7 16.2 1.5 29.4 27.1 14.1 0.0 18.1 30.7 3.6 10.9 10.8 22.3 1.8 45.0 19.7 8.0 9.7 RADX "CXorf57, FLJ10178, FLJ14191" ENSG00000147231 "RPA1 related single stranded DNA binding protein, X-linked" Q6NSI4 X 106611930-106679439 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;pituitary gland: 20.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 12.3;Extravillous trophoblasts: 4.7;Syncytiotrophoblasts: 22.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.8;NK-cells: 1.0;T-cells: 1.6" "Cell line enhanced" "Detected in many" "HEK 293: 37.2;RT4: 39.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA000896, HPA001010, HPA001374" Uncertain Supported "Nuclear speckles" NA No "Nuclear speckles" "HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (4.85e-2)" "unprognostic (8.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-1)" "unprognostic (5.49e-2)" "unprognostic (3.81e-3)" "unprognostic (1.17e-1)" "unprognostic (4.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.23e-3)" 0.9 7.3 6.7 1.4 6.0 0.6 1.4 2.9 4.8 3.5 2.1 1.1 1.1 3.2 2.2 1.0 3.8 0.6 0.9 3.7 21.6 2.5 1.4 2.4 3.3 4.7 4.7 3.8 6.8 1.9 0.8 20.5 3.6 5.4 0.9 0.8 1.8 0.9 1.2 1.9 2.5 1.8 0.9 3.6 2.4 2.6 3.9 15.1 2.4 3.0 1.0 2.2 2.5 1.9 5.7 7.2 0.0 7.2 10.1 4.0 3.4 10.8 0.3 1.4 0.0 0.1 1.6 1.5 15.0 0.0 0.8 7.7 2.0 18.6 3.2 0.0 0.0 37.2 5.0 0.0 0.4 0.2 0.0 3.2 2.0 2.2 0.5 1.3 1.9 0.0 13.1 0.2 19.1 1.6 0.0 14.0 0.0 6.5 4.8 1.1 0.0 6.7 0.0 3.1 39.9 11.8 0.0 0.7 0.2 4.3 5.5 1.8 0.2 0.0 3.1 2.6 0.0 4.5 6.8 3.1 18.5 5.5 0.0 5.3 0.0 0.0 0.0 1.5 0.0 1.1 1.8 1.3 1.0 0.0 1.3 1.6 1.3 0.1 1.0 0.0 0.1 0.5 0.4 6.7 6.0 2.9 4.8 3.7 21.6 4.7 4.7 3.8 5.4 3.6 15.1 5.7 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 12.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.6 1.0 0.0 0.0 0.0 FRMPD3 "KIAA1817, RP5-1070B1.1" ENSG00000147234 "FERM and PDZ domain containing 3" Q5JV73 X 107522450-107605251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;ovary: 5.7;thyroid gland: 4.7" "Cell type enhanced" "Detected in some" "Astrocytes: 6.2;Cone photoreceptor cells: 4.2;Excitatory neurons: 3.8;Inhibitory neurons: 17.6" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.9;SCLC-21H: 1.7;U-698: 1.6;WM-115: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003164 Uncertain NA NA "HPA003164: AB_1078260" "unprognostic (1.27e-1)" "unprognostic (3.36e-1)" "unprognostic (5.44e-2)" "unprognostic (2.48e-4)" "unprognostic (1.69e-2)" "unprognostic (6.19e-2)" "unprognostic (2.43e-2)" "unprognostic (4.35e-2)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-9)" "unprognostic (4.59e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-3)" "unprognostic (1.26e-1)" 0.0 0.3 4.8 0.5 4.4 0.1 0.3 4.8 2.9 0.2 1.6 0.1 0.0 1.1 0.0 0.1 0.4 0.3 0.1 3.7 5.8 0.0 0.0 0.2 0.8 9.0 6.1 1.8 5.7 0.1 0.0 0.7 0.0 6.0 0.4 0.2 0.7 0.8 1.3 0.0 0.1 0.2 0.6 7.2 0.2 0.3 0.4 5.5 0.1 4.7 0.0 0.5 0.3 0.1 5.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.2 5.9 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.2 1.7 0.1 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.4 4.8 2.9 3.7 5.8 9.0 6.1 1.8 6.0 7.2 5.5 5.8 0.0 0.0 0.0 6.2 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.1 1.0 0.0 0.0 0.0 4.2 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.4 0.0 0.0 0.4 0.0 0.0 0.1 1.8 1.9 0.0 0.2 0.0 1.0 0.8 0.1 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.5 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.2 0.3 HTR2C "5-HT2C, 5HTR2C, HTR1C" ENSG00000147246 "5-hydroxytryptamine receptor 2C" P28335 X 114584078-114910061 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "choroid plexus: 226.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 24.2;Inhibitory neurons: 55.3;Oligodendrocyte precursor cells: 10.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 2.7;RPMI-8226: 1.4;U-266/70: 4.8;U-266/84: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.14e-1)" "unprognostic (6.09e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (3.42e-2)" "unprognostic (9.22e-4)" "unprognostic (1.37e-1)" "unprognostic (6.84e-2)" 0.0 0.0 11.2 0.0 22.5 0.0 0.0 1.3 7.2 0.3 226.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 15.5 0.0 0.0 0.0 0.0 13.9 8.8 5.4 0.0 0.0 0.0 0.4 0.1 10.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.4 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 22.5 1.3 7.2 13.6 15.5 13.9 8.8 5.4 10.0 4.5 10.4 10.2 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 24.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 10.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DOCK11 "ACG, FLJ32122, FLJ43653, ZIZ2" ENSG00000147251 "Dedicator of cytokinesis 11" Q5JSL3 X 118495815-118686163 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 100.4;Kupffer cells: 47.5;Macrophages: 45.7;Microglial cells: 67.5;NK-cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 63.3;HMC-1: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059695 Uncertain NA NA "HPA059695: AB_2684104" "unprognostic (4.09e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.56e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.50e-1)" "unprognostic (5.56e-2)" "unprognostic (1.76e-1)" "unprognostic (6.37e-3)" "unprognostic (3.06e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.11e-2)" "unprognostic (8.16e-3)" 48.8 8.3 5.8 15.5 11.4 33.9 35.2 4.3 6.0 15.0 6.0 20.7 3.2 12.7 9.8 6.1 13.8 8.6 6.2 5.6 8.1 9.8 3.5 26.0 23.9 6.4 6.5 4.2 4.3 2.3 4.4 28.5 12.9 6.2 6.7 5.8 1.2 7.0 3.1 3.8 7.7 20.1 9.0 6.2 34.3 12.4 2.7 5.6 21.2 18.4 4.9 18.0 16.7 14.4 7.1 0.1 5.9 4.8 4.5 63.3 26.8 12.7 6.7 14.5 5.5 14.2 0.7 0.1 18.2 0.6 24.3 6.5 0.2 8.5 0.0 4.8 22.7 7.4 39.8 6.2 0.2 20.4 24.3 92.3 18.9 0.4 5.8 6.4 3.8 0.2 15.6 12.3 32.0 3.5 4.1 14.6 32.2 5.0 5.3 9.2 9.7 12.3 0.6 0.1 1.3 1.7 11.3 20.3 18.7 6.6 3.7 2.2 20.3 0.3 4.4 1.4 25.5 3.0 9.8 15.7 16.6 9.5 38.1 2.3 5.7 3.3 6.2 6.4 4.9 4.1 3.7 5.4 5.2 3.6 3.8 4.8 6.1 10.1 5.9 6.2 2.8 9.1 1.8 5.8 11.4 4.3 6.0 5.6 8.1 6.4 6.5 4.2 6.2 6.2 5.6 7.1 10.9 28.9 3.7 6.8 38.3 2.9 0.1 0.4 0.6 0.5 0.7 0.9 2.7 0.0 7.7 7.3 0.0 3.0 34.5 0.3 0.0 0.2 0.5 0.4 5.4 7.4 4.2 14.7 4.4 0.0 3.2 18.7 5.1 0.3 44.4 0.2 2.9 1.1 20.6 0.0 100.4 3.2 2.0 47.5 24.9 0.6 12.2 45.7 8.8 67.5 38.6 0.3 52.5 20.6 14.8 0.7 1.5 4.9 22.7 0.4 3.0 6.3 1.2 0.4 26.3 4.3 14.0 3.8 3.3 0.6 1.8 6.8 36.6 0.2 1.3 0.4 IGSF1 "IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2" ENSG00000147255 "Immunoglobulin superfamily member 1" Q8N6C5 X 131273506-131578899 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 50.9;pituitary gland: 169.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 3.9;Bipolar cells: 14.0;Breast glandular cells: 5.0;Horizontal cells: 3.3;Melanocytes: 3.6;Skeletal myocytes: 7.2" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 65.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 47.6;SH-SY5Y: 31.2" "Region enhanced" "Detected in all" "hypothalamus: 144.0" "Low region specificity" "Detected in all" "HPA012732, HPA035582" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 100000 Cytosol "HPA012732: AB_2732404, HPA035582: AB_2674687" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (4.25e-8)" "unprognostic (1.01e-1)" "unprognostic (2.40e-2)" "unprognostic (1.90e-3)" "unprognostic (2.52e-3)" "unprognostic (8.03e-3)" "unprognostic (9.36e-2)" "unprognostic (5.65e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.35e-1)" "unprognostic (5.13e-2)" 1.9 12.6 14.5 0.8 10.1 0.1 2.8 10.4 9.8 3.4 4.9 0.7 0.4 1.2 2.4 1.6 2.5 1.2 8.0 8.0 50.9 0.7 1.5 0.3 0.4 11.4 17.0 4.6 1.1 2.6 0.8 169.1 0.7 18.7 4.0 0.4 6.4 2.4 5.7 2.0 1.4 0.6 3.1 7.4 0.3 1.1 12.3 23.6 0.6 4.6 5.1 0.9 0.4 0.9 10.3 0.4 0.6 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.0 0.0 0.0 0.1 1.8 0.0 0.0 6.0 0.4 0.0 3.0 47.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 4.1 2.8 0.0 0.0 0.0 0.1 0.1 0.2 3.4 31.2 0.0 0.2 0.0 4.1 0.6 0.0 0.0 0.5 0.8 0.0 4.1 1.2 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 10.1 10.4 9.8 8.0 50.9 11.4 17.0 4.6 18.7 7.4 23.6 10.3 0.2 3.2 0.6 3.9 0.2 0.0 0.5 0.0 1.2 14.0 5.0 1.7 2.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.3 1.5 0.0 0.1 0.0 0.7 0.7 0.3 0.0 3.3 0.4 0.0 0.0 0.0 0.8 1.1 0.0 0.2 3.6 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.3 0.0 0.8 0.0 0.7 0.0 7.2 0.3 0.1 0.4 0.0 0.4 0.3 0.1 0.0 0.0 0.3 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058346-131089885 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "adrenal gland: 106.4;brain: 90.5;pituitary gland: 178.3" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 161 "SH-SY5Y: 176.9" "Region enhanced" "Detected in many" "hypothalamus: 89.4" "Low region specificity" "Detected in many" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 0.2 106.4 23.3 0.0 3.4 0.0 1.4 0.8 6.2 1.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 12.0 90.5 0.0 0.0 0.0 0.0 33.8 46.1 2.2 0.0 0.0 0.0 178.3 0.1 90.3 0.2 0.1 0.0 0.2 0.0 6.6 0.0 0.0 0.0 6.1 0.0 0.1 0.8 37.1 0.4 0.1 1.1 0.0 0.0 0.1 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 176.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 3.4 0.8 6.2 12.0 90.5 33.8 46.1 2.2 90.3 6.1 37.1 28.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985594 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 579.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 65.1;Extravillous trophoblasts: 61.0;Fibroblasts: 404.2;Muller glia cells: 88.9;Syncytiotrophoblasts: 148.6" "Cancer enriched" "Detected in all" 4 "liver cancer: 269.0" "Region enhanced" "Detected in many" "hypothalamus: 8.2" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.8" "Group enriched" "Detected in some" 5 "HAP1: 514.3;Hep G2: 1825.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006316 Supported "Plasma membrane" NA NA 27000 "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 80.1 23.0 0.7 3.5 1.0 0.0 62.4 0.5 0.3 10.0 0.3 6.4 1.7 9.3 41.5 6.8 14.0 13.9 16.3 0.2 8.2 87.8 5.1 124.0 2.5 1.8 2.1 0.2 15.6 21.4 4.1 47.4 579.7 1.7 8.4 4.2 6.3 13.8 9.3 4.5 14.7 5.7 7.4 1.5 3.7 13.7 2.8 1.8 8.1 22.6 28.8 11.0 14.8 9.4 1.1 0.0 0.0 21.8 1.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 154.0 0.0 0.0 0.1 0.1 0.0 0.0 514.3 0.4 0.0 0.0 22.6 0.0 0.9 1825.2 0.3 0.0 0.5 12.9 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.5 0.1 132.1 0.1 0.0 0.0 0.0 0.1 122.4 6.1 15.3 40.3 0.0 0.0 0.4 233.8 0.5 23.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.8 1.2 0.0 0.7 0.0 0.0 0.0 0.1 0.7 1.0 0.5 0.3 0.2 8.2 1.8 2.1 0.2 1.7 1.5 1.8 1.1 28.5 0.0 1.7 0.3 1.0 10.5 4.8 17.0 0.0 0.4 5.0 10.4 0.5 1.5 20.0 5.5 0.0 65.1 0.8 0.5 19.6 0.3 0.9 0.2 0.4 1.8 1.8 0.0 2.5 1.6 61.0 404.2 0.5 1.5 0.0 1.0 2.2 0.0 26.7 0.0 2.5 3.1 2.0 0.0 6.1 2.4 10.5 1.0 3.6 23.4 0.0 88.9 0.0 3.5 1.4 1.7 2.6 3.0 0.4 2.7 1.2 40.7 24.3 3.1 0.0 21.7 21.3 6.9 7.1 0.2 4.0 148.6 1.1 7.6 4.1 0.6 GPR119 "GPCR2, hGPCR2" ENSG00000147262 "G protein-coupled receptor 119" Q8TDV5 X 130384345-130385660 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "pancreas: 2.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "pancreatic cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "prognostic favorable (6.93e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMX "hnRNP-G, HNRNPG, RNMX" ENSG00000147274 "RNA binding motif protein X-linked" P38159 X 136848004-136880764 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Cancer-related genes, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA057707: AB_2683508" "unprognostic (1.53e-1)" "unprognostic (1.52e-3)" "unprognostic (2.12e-3)" "unprognostic (1.14e-2)" "unprognostic (2.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (5.59e-2)" "unprognostic (1.05e-2)" "unprognostic (1.68e-2)" "unprognostic (4.87e-2)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (1.57e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.64e-3)" 79.4 57.5 34.7 81.5 37.9 174.0 120.9 39.7 40.0 104.2 37.7 83.7 78.5 143.3 86.6 65.1 117.5 68.8 72.9 33.4 45.1 78.4 67.0 72.5 118.8 39.6 36.8 31.2 245.0 87.5 77.2 49.3 81.0 38.3 84.6 102.6 82.7 69.0 82.9 127.2 67.7 76.1 119.2 37.7 89.8 72.4 35.1 35.5 212.7 93.4 104.8 146.8 89.9 78.6 51.3 235.0 250.2 448.6 201.0 109.6 184.3 261.2 227.7 246.3 308.4 324.6 268.8 228.3 422.9 229.2 163.9 193.3 152.9 481.9 238.3 353.6 184.2 226.8 324.6 240.9 289.9 95.9 358.0 285.6 152.5 113.1 240.6 333.6 236.3 252.7 392.0 296.6 210.3 254.4 297.9 526.3 240.5 285.7 248.1 207.0 430.9 300.2 262.0 229.6 275.2 260.8 281.7 181.9 162.4 213.8 263.6 186.8 237.7 161.7 173.5 188.0 121.7 294.8 149.2 214.9 444.3 123.9 256.7 242.6 131.6 158.5 90.6 142.1 192.8 199.7 194.5 184.8 170.4 175.6 187.4 231.9 192.5 25.3 173.9 178.9 106.4 203.9 302.6 34.7 37.9 39.7 40.0 33.4 45.1 39.6 36.8 31.2 38.3 37.7 35.5 51.3 112.1 112.2 139.0 55.2 223.0 151.9 209.0 151.6 128.1 112.4 229.8 208.0 100.5 153.0 167.3 88.3 95.9 187.2 200.3 80.1 154.6 157.2 10.9 83.5 147.4 130.5 202.9 195.7 33.2 148.8 269.4 156.6 75.4 84.3 268.8 212.7 204.5 119.3 117.0 92.5 41.2 170.9 81.4 223.2 112.2 10.5 171.8 109.0 96.0 27.2 176.9 99.4 157.6 57.3 56.5 108.0 99.1 133.2 124.0 108.2 140.0 120.3 123.3 137.9 92.1 159.7 161.6 33.8 81.2 94.6 122.3 111.5 195.5 135.0 216.4 157.4 MCPH1 "BRIT1, FLJ12847" ENSG00000147316 "Microcephalin 1" Q8NEM0 8 6406596-6648508 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 107.5;Inhibitory neurons: 94.3;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008238, HPA012064, CAB012177" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: " "unprognostic (1.00e-1)" "unprognostic (2.17e-2)" "prognostic favorable (8.52e-4)" "unprognostic (6.45e-2)" "unprognostic (1.16e-2)" "unprognostic (1.19e-2)" "unprognostic (1.14e-2)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "unprognostic (4.79e-2)" "unprognostic (5.55e-3)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (4.79e-2)" "unprognostic (2.94e-1)" 5.6 3.7 2.0 3.0 2.1 12.4 5.7 3.0 2.5 5.5 2.4 4.7 2.5 5.7 2.6 4.7 5.3 2.5 4.3 2.0 2.1 3.8 3.9 4.5 4.8 2.1 2.0 1.7 5.5 5.2 3.3 3.8 4.0 2.1 4.7 2.8 3.3 5.9 2.8 9.9 5.0 4.6 3.4 1.8 4.7 4.7 6.1 2.2 5.6 4.7 4.0 4.2 5.4 5.1 2.8 4.5 3.9 7.0 4.9 3.4 6.1 5.9 6.7 5.8 8.3 6.2 5.0 3.3 8.7 1.8 5.5 7.6 5.1 8.9 6.3 9.8 3.6 4.9 11.1 3.9 6.7 5.6 5.6 8.4 5.8 6.4 5.7 8.1 5.8 6.2 9.2 13.7 8.5 6.4 2.9 15.1 6.1 12.0 8.2 3.9 8.9 6.6 5.3 4.8 8.2 4.8 6.4 4.9 5.2 7.4 7.7 4.5 7.8 5.2 6.4 3.5 2.1 6.4 3.9 5.7 12.7 5.9 6.4 9.0 1.6 2.1 8.7 3.1 2.5 4.1 4.0 2.7 3.7 2.1 4.4 3.4 3.7 0.3 4.3 3.2 2.8 3.0 2.1 2.0 2.1 3.0 2.5 2.0 2.1 2.1 2.0 1.7 2.1 1.8 2.2 2.8 21.3 3.2 16.1 50.6 28.3 4.6 14.5 7.1 10.8 13.4 9.7 9.0 13.7 10.0 17.7 14.7 16.7 10.9 28.2 4.6 3.9 10.9 46.6 20.0 21.2 15.6 0.0 17.9 107.5 10.5 10.6 14.2 14.8 25.9 19.7 15.5 11.4 6.9 7.0 30.3 94.3 6.1 2.0 12.2 2.7 30.6 12.2 12.1 0.0 69.3 14.2 13.1 19.6 78.4 79.5 10.4 7.8 13.2 27.0 9.7 6.3 8.7 25.6 10.6 6.6 20.2 13.8 29.5 12.6 10.9 6.0 12.3 23.5 12.8 7.2 10.1 MFHAS1 "LRRC65, MASL1, ROCO4" ENSG00000147324 "Malignant fibrous histiocytoma amplified sequence 1" Q9Y4C4 8 8783354-8893630 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 105.4;Glandular and luminal cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MOLT-4: 128.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051213, HPA054471" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051213: AB_2681391, HPA054471: AB_2682498" "unprognostic (1.33e-1)" "unprognostic (4.46e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.95e-1)" "unprognostic (8.91e-3)" "unprognostic (2.70e-2)" "unprognostic (2.68e-3)" "unprognostic (9.23e-3)" "unprognostic (7.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.81e-1)" "unprognostic (2.01e-3)" "unprognostic (5.93e-2)" "unprognostic (4.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.81e-1)" 5.5 2.0 6.9 7.9 6.5 12.0 3.6 7.3 8.3 6.4 4.1 11.0 6.1 5.1 3.3 5.4 6.6 5.5 5.3 7.7 6.3 10.8 6.0 10.0 10.5 5.9 7.2 6.1 3.4 4.7 5.7 2.0 8.9 6.6 5.3 11.5 5.4 3.5 4.4 2.4 6.2 7.0 8.3 5.9 11.2 6.3 6.1 7.8 9.0 5.4 2.7 8.6 9.2 3.5 6.0 19.5 14.4 8.6 6.6 8.0 10.1 28.3 7.9 17.0 5.6 7.6 23.3 3.7 28.5 9.5 7.6 16.2 6.5 9.1 7.3 4.9 37.0 8.1 2.1 5.3 15.1 9.5 8.2 2.9 5.5 15.0 7.6 7.5 6.0 12.5 34.8 13.4 0.0 4.7 7.0 128.0 7.2 16.8 25.8 6.1 17.4 13.1 4.4 39.3 20.0 13.6 11.0 4.6 7.2 12.7 14.6 4.9 11.1 5.3 6.8 10.1 27.3 15.4 1.5 6.9 21.7 12.6 10.8 4.2 0.0 0.1 0.0 0.9 0.0 0.7 0.4 1.3 0.8 0.2 0.3 0.6 0.5 0.0 0.1 0.0 0.0 1.2 0.3 6.9 6.5 7.3 8.3 7.7 6.3 5.9 7.2 6.1 6.6 5.9 7.8 6.0 10.7 54.5 43.9 105.4 6.5 37.5 24.5 6.0 2.8 19.0 6.2 3.2 17.2 20.0 16.5 31.3 4.2 3.7 6.5 30.9 13.7 12.0 2.5 50.8 20.3 19.2 18.8 71.4 46.9 15.4 3.2 17.8 8.2 119.2 22.2 5.4 25.4 17.8 31.8 3.3 56.8 29.3 10.2 27.5 21.0 3.4 11.5 13.0 10.6 61.8 8.0 24.3 14.4 38.2 6.2 28.5 20.7 8.2 2.1 47.5 6.7 16.5 5.4 8.1 0.0 4.5 24.1 1.9 21.7 2.4 50.0 2.3 24.0 1.7 36.3 16.9 FBXO25 FBX25 ENSG00000147364 "F-box protein 25" Q8TCJ0 8 406428-477967 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 98.7" "Cell type enhanced" "Detected in all" "Early spermatids: 625.7;Late spermatids: 312.5;Spermatocytes: 640.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 58.7;SK-MEL-30: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "prognostic favorable (5.38e-5)" "unprognostic (2.74e-2)" "unprognostic (5.11e-3)" "unprognostic (2.48e-1)" "unprognostic (1.25e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-3)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (2.39e-3)" "unprognostic (3.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.11e-3)" "unprognostic (2.41e-1)" 14.6 20.6 8.2 7.6 9.0 9.2 14.0 13.0 11.9 9.2 7.5 16.8 15.6 8.5 16.9 10.1 8.7 9.3 15.5 8.7 8.8 15.9 30.3 10.5 12.1 8.4 8.8 7.9 8.9 28.9 14.3 12.2 6.8 9.2 25.2 18.9 7.3 16.4 10.6 18.4 12.4 11.2 11.1 8.0 8.2 15.2 98.7 8.7 20.9 18.8 19.8 12.2 11.4 9.0 10.9 13.4 10.6 4.5 8.8 6.9 4.4 18.6 12.6 18.5 11.8 18.1 6.0 12.7 0.3 3.4 19.4 17.8 8.5 8.7 24.5 16.1 10.0 14.5 7.1 6.3 28.3 20.5 11.4 13.7 12.7 37.6 3.6 18.7 17.9 5.0 58.7 8.4 0.1 13.9 12.8 50.8 13.6 2.1 29.0 4.6 2.4 3.4 18.1 15.4 22.5 13.7 14.4 12.7 4.2 61.5 11.2 9.0 8.1 7.5 4.8 4.1 0.8 10.1 9.2 14.4 13.6 13.0 4.7 14.7 1.6 9.1 6.6 9.0 10.8 11.1 16.2 10.7 8.5 9.1 10.9 9.5 9.4 0.7 9.9 9.9 9.0 12.5 6.9 8.2 9.0 13.0 11.9 8.7 8.8 8.4 8.8 7.9 9.2 8.0 8.7 10.9 21.3 19.2 28.5 15.3 24.2 34.8 19.6 28.0 19.9 31.8 35.9 21.7 36.6 42.9 20.4 35.0 10.4 20.0 26.8 30.4 72.4 53.3 625.7 20.0 17.8 25.7 43.3 12.6 20.5 102.6 18.9 18.2 16.3 27.4 20.3 15.4 28.2 77.0 25.4 53.8 20.0 58.2 42.7 32.7 24.2 312.5 38.8 17.4 39.2 11.2 36.2 22.1 38.1 8.5 28.3 51.5 41.2 29.3 21.4 39.1 34.9 58.3 13.2 36.3 26.3 17.8 16.2 640.9 142.1 17.4 40.5 16.1 19.5 14.4 47.2 21.8 FATE1 "CT43, FATE" ENSG00000147378 "Fetal and adult testis expressed 1" Q969F0 X 151716035-151723194 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "testis: 240.9" "Cell type enhanced" "Detected in some" "Early spermatids: 23.6;Late spermatids: 73.0;Sertoli cells: 13.1;Spermatocytes: 10.3;Theca cells: 9.6" "Cancer enriched" "Detected in some" 5 "testis cancer: 6.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034604 Enhanced NA NA "HPA034604: AB_10602318" "unprognostic (1.82e-2)" "unprognostic (7.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.40e-5)" "unprognostic (2.10e-1)" "unprognostic (3.70e-3)" "unprognostic (2.58e-1)" "unprognostic (1.16e-1)" "unprognostic (5.07e-3)" "unprognostic (1.55e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (4.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.34e-2)" 0.4 0.3 0.5 0.1 0.5 0.0 0.2 0.3 1.1 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.6 0.4 0.4 0.5 0.1 0.2 0.1 0.5 0.4 0.4 0.1 0.1 0.1 0.5 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.5 0.1 0.3 0.0 0.4 0.1 0.2 240.9 0.4 2.3 0.6 0.3 0.1 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 1.1 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.7 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 3.8 1.8 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 73.0 7.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 5.3 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.3 0.0 10.3 5.9 0.0 0.0 0.0 0.0 9.6 0.0 0.1 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 23.8" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 20.2;Spermatocytes: 48.7;Spermatogonia: 179.8;Syncytiotrophoblasts: 33.0" "Cancer enhanced" "Detected in many" "lung cancer: 19.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 440.0;AN3-CA: 263.1;HMC-1: 496.1;U-266/84: 836.2" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.0 0.0 0.0 263.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.1 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.0 0.0 496.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.1 0.2 4.1 0.0 0.5 132.0 0.0 2.4 105.9 836.2 0.7 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 48.7 179.8 0.0 0.0 33.0 0.0 0.0 0.0 0.0 NSDHL "H105e3, SDR31E1, XAP104" ENSG00000147383 "NAD(P) dependent steroid dehydrogenase-like" Q15738 X 152830967-152869729 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 53.0;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000248, HPA000571" Enhanced Enhanced "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA000248: AB_1079507, HPA000571: AB_1079506" "unprognostic (1.84e-1)" "prognostic favorable (5.65e-4)" "unprognostic (2.66e-1)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.03e-1)" "unprognostic (5.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.62e-2)" "unprognostic (2.63e-1)" "prognostic favorable (6.09e-5)" "unprognostic (3.53e-2)" "unprognostic (1.36e-1)" "unprognostic (3.91e-2)" "unprognostic (4.79e-2)" 24.2 39.1 13.0 10.3 12.6 9.0 20.3 13.8 13.1 16.0 12.9 14.0 17.8 13.7 44.9 52.1 15.0 8.0 21.1 14.0 15.7 15.0 50.8 13.0 9.1 15.6 14.4 12.2 10.4 10.7 13.0 8.8 10.4 17.8 14.9 13.6 10.5 16.8 21.5 10.2 21.3 24.4 12.6 12.8 9.6 13.9 9.0 16.1 10.0 13.4 11.0 18.2 12.2 24.3 17.9 135.6 48.9 65.5 33.8 54.9 41.5 36.2 26.3 35.2 46.9 59.3 68.5 71.7 67.0 86.0 35.9 174.2 67.6 85.5 122.1 41.3 22.0 49.5 27.9 44.7 70.3 39.8 27.6 21.1 51.1 46.3 92.2 23.0 20.2 44.2 28.7 46.4 29.1 36.1 60.1 27.3 35.8 26.0 67.4 58.1 19.9 47.4 54.6 98.9 55.7 23.4 26.5 23.4 34.6 28.4 44.9 23.1 35.0 38.7 21.6 35.4 52.3 51.0 40.9 29.4 114.9 40.0 42.4 20.8 21.0 19.6 18.7 16.3 18.7 16.4 19.1 16.1 14.1 19.4 15.1 11.6 12.7 2.2 19.7 14.2 17.4 20.4 15.2 13.0 12.6 13.8 13.1 14.0 15.7 15.6 14.4 12.2 17.8 12.8 16.1 17.9 7.1 12.8 16.7 5.9 6.3 10.8 12.8 53.0 10.8 4.3 11.7 6.1 25.0 15.7 29.0 12.9 0.0 21.5 6.1 9.6 9.8 20.1 13.3 15.5 6.6 9.2 6.0 13.0 2.2 20.3 22.0 9.0 8.2 15.5 8.2 14.0 7.5 55.0 18.6 1.7 2.2 10.2 26.4 8.7 9.6 8.0 8.4 7.9 5.4 1.0 11.0 10.6 7.2 2.5 5.7 21.4 11.9 9.1 11.3 10.4 25.2 16.5 25.4 6.2 0.0 5.9 12.5 3.7 7.8 19.4 12.1 18.6 5.3 25.1 11.2 16.4 ZNF185 SCELL ENSG00000147394 "Zinc finger protein 185 with LIM domain" O15231 X 152914442-152973480 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 331.6;esophagus: 329.3" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 32.2;Pancreatic endocrine cells: 72.0;Squamous epithelial cells: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 51.8" "Group enriched" "Detected in many" 5 "granulocytes: 51.8;monocytes: 27.4" "Cell line enhanced" "Detected in many" "A-431: 124.4;EFO-21: 139.9;HBEC3-KT: 100.0;PC-3: 87.7;TIME: 236.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000400, HPA016438" Enhanced Supported "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" NA NA 220000 "Plasma membrane, Cytosol" "Actin filaments, Focal adhesion sites" "HPA000400: AB_1080685, HPA016438: AB_1859109" "unprognostic (1.34e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" "unprognostic (9.75e-3)" "unprognostic (2.69e-1)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (7.94e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (5.18e-2)" "unprognostic (8.12e-2)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" 4.4 11.8 4.1 5.7 3.9 8.8 12.3 4.8 3.7 67.4 9.5 4.5 1.8 22.1 331.6 329.3 16.5 6.7 1.8 3.3 6.4 10.9 2.1 12.2 4.6 3.5 3.9 2.9 6.2 4.3 3.7 8.5 25.2 4.1 24.7 4.3 3.4 45.2 145.4 2.9 54.1 2.6 10.4 3.8 4.6 7.4 3.4 3.9 3.6 21.5 2.9 41.3 11.7 118.5 4.0 124.4 25.9 2.4 1.6 3.0 4.0 5.5 6.0 0.4 14.8 2.2 0.9 36.7 1.6 139.9 9.0 1.4 17.3 3.7 100.0 60.1 1.5 2.4 7.9 9.8 4.1 7.0 0.5 0.6 2.9 70.2 1.6 57.0 14.6 76.5 1.6 0.5 1.1 0.4 29.1 0.5 0.7 1.9 31.4 87.7 0.5 0.4 0.9 7.7 11.5 1.0 8.2 0.2 22.7 3.6 23.3 23.3 2.7 236.2 0.8 50.5 3.0 4.5 1.2 1.0 1.1 1.6 8.9 1.7 51.8 27.4 11.4 1.0 24.4 0.6 0.7 0.7 1.2 7.4 0.6 1.1 0.7 18.5 0.5 21.1 4.9 1.0 20.7 4.1 3.9 4.8 3.7 3.3 6.4 3.5 3.9 2.9 4.1 3.8 3.9 4.0 1.1 12.8 2.6 1.3 0.7 9.2 6.2 5.7 4.6 0.5 5.7 7.6 0.9 1.5 9.4 9.2 2.1 3.8 1.7 1.0 0.0 8.6 0.6 14.1 4.2 1.1 0.0 0.0 1.0 3.0 5.0 2.2 2.6 32.2 1.3 3.9 1.4 0.1 9.4 0.0 1.7 2.5 2.0 11.3 4.0 0.3 1.2 9.5 3.6 0.0 14.4 4.0 0.0 1.0 1.4 72.0 0.3 1.2 0.1 7.6 0.3 1.2 6.9 0.3 0.0 0.5 1.9 4.2 5.8 69.7 21.2 0.7 0.8 0.4 2.4 21.3 CETN2 "CALT, CEN2" ENSG00000147400 "Centrin 2" P41208 X 152826994-152830757 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 245.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 639.9;Proximal tubular cells: 345.8;Respiratory ciliated cells: 1116.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001470, HPA028956" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA001470: , HPA028956: AB_10601798" "unprognostic (3.32e-1)" "prognostic favorable (7.54e-6)" "unprognostic (7.73e-2)" "unprognostic (2.14e-2)" "unprognostic (2.14e-1)" "unprognostic (5.73e-3)" "unprognostic (9.58e-3)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "prognostic favorable (9.97e-4)" "unprognostic (5.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-3)" "unprognostic (5.90e-2)" "unprognostic (1.25e-2)" "unprognostic (1.34e-1)" "unprognostic (2.20e-1)" 30.5 41.3 66.5 20.0 63.9 26.4 40.7 63.8 81.0 65.2 86.7 43.5 15.4 58.1 117.2 37.5 245.7 32.0 34.9 61.3 82.0 75.3 31.8 40.2 16.2 69.3 69.5 59.4 57.7 24.2 56.1 74.5 21.6 70.5 50.7 26.0 40.4 24.6 78.4 19.7 23.0 21.8 55.3 70.6 16.9 29.5 23.5 64.9 21.2 67.8 20.3 22.0 37.6 36.4 68.8 145.2 65.0 78.8 59.6 102.5 110.5 31.4 61.6 73.8 79.9 60.9 29.5 75.8 51.6 157.8 83.1 128.8 55.3 55.3 76.7 94.1 23.2 40.0 11.5 32.1 86.6 38.5 48.7 12.5 67.0 99.2 74.1 39.1 95.4 64.0 40.3 31.0 20.9 78.3 67.9 36.4 53.0 27.5 119.9 82.6 31.9 57.2 53.2 146.9 35.4 38.5 50.0 41.2 42.2 38.2 70.8 45.4 37.2 59.8 56.0 44.9 111.9 69.9 20.9 29.7 81.0 118.3 28.9 28.0 19.9 11.4 35.9 11.7 13.6 14.2 11.9 11.5 13.1 13.5 9.7 12.2 12.5 10.9 12.3 13.7 20.0 10.5 11.8 66.5 63.9 63.8 81.0 61.3 82.0 69.3 69.5 59.4 70.5 70.6 64.9 68.8 21.6 51.3 35.7 3.9 19.2 22.6 52.4 201.6 21.6 13.6 46.1 47.6 37.1 64.3 155.8 169.2 6.2 66.6 16.2 13.8 238.7 100.3 60.1 639.9 65.4 29.6 37.1 33.2 4.2 41.1 69.8 42.9 12.2 68.7 24.6 41.0 44.3 96.5 50.0 13.5 3.5 31.7 150.5 23.7 21.3 72.5 67.7 27.3 37.4 1.9 27.8 104.4 20.6 0.5 2.5 39.6 16.0 111.7 16.6 29.3 15.4 345.8 1116.5 29.4 19.7 22.7 64.2 76.5 70.4 33.7 30.5 41.5 19.7 51.8 29.2 42.4 RPL10 "DXS648, DXS648E, FLJ23544, L10, NOV, QM" ENSG00000147403 "Ribosomal protein L10" P27635 X 154389955-154409168 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010339, HPA011311" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 520000 "Endoplasmic reticulum, Cytosol" "CAB010339: AB_2181277, HPA011311: AB_1856431" "unprognostic (2.46e-3)" "unprognostic (3.57e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.25e-2)" "unprognostic (2.06e-1)" "unprognostic (6.11e-2)" "unprognostic (9.01e-3)" "unprognostic (1.91e-1)" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.67e-6)" "unprognostic (6.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.65e-2)" "unprognostic (5.68e-2)" 3789.9 2438.9 1365.3 2189.6 1386.8 4688.4 4886.6 1379.8 1640.7 4453.6 1438.3 2975.7 1978.5 3261.2 2348.2 3201.5 4472.8 2014.5 2795.5 1307.2 1445.3 2321.5 2477.6 2616.2 4484.4 1457.4 1397.0 1287.9 7962.9 8317.7 1587.8 1272.0 1895.0 1440.6 3023.7 2879.3 610.5 4026.0 2241.6 4799.8 4492.3 2666.7 2924.5 1508.6 3026.7 3289.1 375.7 1441.4 3725.1 2521.2 3917.1 5328.8 3424.5 3664.1 1474.3 5771.5 2604.6 2556.3 1973.1 5665.6 10627.4 2257.6 2147.4 4944.5 4036.4 5092.8 2323.7 2507.2 11250.6 5101.5 3609.5 4017.7 2175.5 5072.8 5166.9 3441.7 2507.6 4032.6 1534.4 1719.4 2591.8 6623.5 3314.4 2163.5 8104.7 8023.2 2435.8 7540.7 6953.8 6482.3 4734.1 2197.3 3482.7 4027.7 2869.8 3643.7 3212.1 2023.6 5617.9 4482.1 4301.7 2425.2 6334.8 4477.5 2015.0 2043.5 3397.3 526.0 4516.0 6630.0 2442.8 1643.7 4541.0 3144.3 1405.7 2655.1 3210.9 4865.5 8226.6 6458.7 11466.6 2139.0 4722.1 1803.6 2544.3 4388.3 622.1 4542.5 3596.8 7775.4 8121.0 7534.8 5653.3 4873.3 7698.6 8993.4 6990.0 410.0 5161.3 3275.5 5417.4 5907.4 18184.4 1365.3 1386.8 1379.8 1640.7 1307.2 1445.3 1457.4 1397.0 1287.9 1440.6 1508.6 1441.4 1474.3 5788.7 1791.6 2556.0 46.7 10527.8 12070.0 13158.5 11320.6 8610.2 480.8 13969.8 18711.5 332.5 4499.5 4867.7 2039.7 248.1 6871.3 8329.8 1997.2 6751.9 4614.2 76.2 2214.5 6544.8 5970.8 2893.6 4044.6 45.3 13505.4 10754.4 5761.0 3039.8 3854.9 2982.2 5292.3 6493.4 4196.6 7070.4 269.2 50.7 6837.3 3196.2 8756.2 13887.5 284.8 8462.7 6722.9 8167.8 49.6 10601.8 1879.6 6844.6 56.3 89.0 7721.0 5174.6 3567.3 7282.8 12796.7 5976.0 8673.5 1751.3 859.1 2991.1 7996.0 6645.8 94.6 354.5 9576.3 14556.9 7562.7 9597.3 5236.0 6657.3 13414.3 CSGALNACT1 "ChGn, CSGalNAcT-1, FLJ11264" ENSG00000147408 "Chondroitin sulfate N-acetylgalactosaminyltransferase 1" Q8TDX6 8 19404161-19758029 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 87.5" "Cell type enhanced" "Detected in many" "Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9" "Cancer enhanced" "Detected in all" "prostate cancer: 22.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 62.6" "Group enriched" "Detected in all" 5 "B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6" "Cell line enhanced" "Detected in many" "A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068462 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA Cytosol "Golgi apparatus" "HPA068462: " "unprognostic (8.90e-2)" "unprognostic (1.57e-2)" "unprognostic (4.66e-2)" "unprognostic (2.58e-1)" "unprognostic (6.03e-2)" "unprognostic (3.17e-3)" "unprognostic (9.78e-2)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.89e-1)" "unprognostic (2.38e-2)" "unprognostic (1.46e-3)" "unprognostic (1.02e-2)" 19.6 12.7 20.9 8.9 15.9 11.2 7.4 5.7 18.5 18.1 2.0 4.2 3.5 7.1 5.4 31.5 11.9 16.3 36.1 17.2 12.4 6.1 2.9 11.8 7.6 10.5 10.7 13.7 57.5 8.0 11.5 3.0 39.2 11.6 32.1 2.5 2.6 6.8 9.8 5.9 4.4 4.7 12.4 6.3 8.8 7.0 2.8 9.5 11.8 87.5 11.1 8.9 23.6 8.1 11.9 2.1 57.8 0.5 0.0 9.3 2.1 7.9 1.4 32.3 0.3 0.3 3.1 1.0 0.0 0.3 0.0 22.9 0.7 0.0 0.0 0.4 7.5 0.4 0.2 16.2 1.9 4.1 0.0 0.1 0.9 1.6 0.7 0.3 0.4 11.6 0.2 0.0 0.1 0.1 2.6 2.9 0.2 0.3 8.3 1.7 0.3 0.1 0.0 39.6 1.6 0.2 0.3 17.2 6.9 2.4 1.5 0.1 0.4 1.0 1.1 1.3 36.8 0.9 0.3 0.0 0.0 26.0 3.4 11.4 0.1 2.9 24.9 5.6 0.1 0.6 44.5 25.7 8.5 2.8 15.9 44.6 11.6 15.6 8.4 0.4 4.2 62.6 11.7 20.9 15.9 5.7 18.5 17.2 12.4 10.5 10.7 13.7 11.6 6.3 9.5 11.9 33.3 3.2 1.1 494.3 27.3 4.5 7.4 0.2 0.6 0.3 4.1 0.8 45.8 0.0 0.9 12.9 10.4 1.9 6.2 0.0 1.9 5.7 6.9 7.5 1.2 38.5 3.0 3.2 144.4 1.7 14.6 20.9 2.0 2.0 0.0 214.1 26.7 0.2 15.8 18.5 76.5 0.0 16.2 27.4 6.5 7.4 5.3 14.1 12.4 224.9 3.5 1.0 6.2 355.9 4.6 3.1 0.0 12.0 21.3 21.8 0.0 0.1 1.5 1.0 6.6 2.1 12.0 0.7 0.1 0.5 3.1 8.3 9.6 77.0 0.1 2.8 ATP6V1B2 "ATP6B2, HO57, VATB, Vma2, VPP3" ENSG00000147416 "ATPase H+ transporting V1 subunit B2" P21281 8 20197381-20226819 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 256.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1130.7" "Group enriched" "Detected in all" 10 "dendritic cells: 336.8;granulocytes: 1130.7;monocytes: 682.0" "Cell line enhanced" "Detected in all" "SK-MEL-30: 317.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008147 Enhanced Supported Vesicles NA NA 310000 Vesicles "HPA008147: AB_1845195" "unprognostic (1.90e-1)" "unprognostic (7.24e-3)" "unprognostic (3.62e-2)" "unprognostic (2.57e-1)" "unprognostic (2.84e-2)" "unprognostic (5.59e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (4.68e-2)" "unprognostic (4.23e-3)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "prognostic favorable (8.41e-4)" "unprognostic (2.41e-1)" "unprognostic (2.09e-2)" "unprognostic (2.47e-2)" "unprognostic (5.25e-2)" 45.0 77.2 104.2 72.5 122.7 46.1 35.6 83.6 132.2 30.4 86.5 38.4 44.3 29.6 31.3 51.7 33.1 39.3 38.5 126.4 136.2 147.1 49.6 73.4 54.6 111.0 131.5 123.2 27.7 34.7 72.0 75.1 50.9 131.4 28.3 43.4 207.5 40.7 27.2 67.3 61.1 58.2 40.5 99.8 66.6 33.1 68.4 124.6 50.7 33.7 65.3 49.3 45.0 36.4 190.7 44.2 71.5 87.4 29.2 117.7 72.3 79.1 96.6 61.5 121.5 125.2 81.7 25.4 77.7 38.4 93.1 123.7 36.8 70.1 64.6 129.0 32.9 47.2 54.2 29.9 63.6 137.6 39.0 108.0 65.0 57.9 76.0 69.3 134.1 77.2 101.2 82.0 72.8 132.5 25.0 114.6 46.2 65.6 64.6 31.5 46.6 113.4 40.8 112.9 68.2 68.0 97.9 46.9 62.7 317.9 72.4 81.6 70.7 82.8 61.1 46.3 101.9 78.5 29.4 42.7 90.9 84.6 91.6 158.4 183.7 682.0 485.9 52.9 618.6 57.7 50.2 54.1 56.8 336.8 44.5 54.4 53.7 1130.7 50.8 576.1 82.7 73.0 622.6 104.2 122.7 83.6 132.2 126.4 136.2 111.0 131.5 123.2 131.4 99.8 124.6 190.7 16.6 25.6 20.7 20.5 28.1 58.0 28.4 52.1 33.0 106.1 18.5 15.6 17.6 25.8 28.8 29.5 102.2 109.2 38.9 23.3 80.3 43.2 40.8 20.2 13.6 24.1 74.4 35.8 64.3 38.5 56.4 38.8 25.0 35.9 22.2 22.3 25.7 34.7 178.5 190.1 68.0 21.4 36.7 185.2 178.7 24.4 19.6 167.6 104.9 30.0 169.1 51.5 20.6 27.6 29.0 45.2 19.7 28.2 20.7 17.4 75.0 256.7 18.0 137.8 13.1 29.3 34.2 121.6 55.3 43.3 71.6 124.6 27.1 23.1 24.7 20.1 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733316-27772653 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favorable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 14.2 21.1 11.1 11.9 12.5 5.0 17.5 12.2 17.2 10.1 8.8 14.4 35.8 10.5 14.4 14.4 13.0 12.1 12.3 11.2 12.1 22.8 32.6 8.8 14.1 12.0 11.6 10.5 10.9 16.5 18.5 7.6 10.6 12.7 11.7 15.8 11.2 13.6 12.1 28.7 10.4 31.0 10.4 12.0 10.5 20.1 11.0 12.2 11.5 18.9 15.4 14.3 11.8 9.4 14.3 50.1 27.9 25.8 24.7 22.8 33.0 17.2 41.0 39.5 24.7 24.0 11.2 17.9 53.6 27.7 20.9 21.2 23.1 23.6 40.0 35.5 20.3 16.4 66.9 23.1 19.3 36.9 23.8 20.8 37.1 25.9 27.1 37.6 28.7 54.0 33.7 32.2 24.6 27.8 19.2 55.3 19.9 37.9 49.4 14.8 18.7 44.4 28.8 32.3 26.7 15.1 41.7 27.5 21.0 42.8 19.0 24.0 13.1 44.6 22.5 33.4 38.9 21.7 24.5 33.8 19.5 35.0 30.8 23.8 20.3 8.9 6.6 15.2 12.6 17.8 19.8 19.6 16.1 11.6 15.5 18.3 19.3 3.2 14.3 13.4 18.1 23.2 10.4 11.1 12.5 12.2 17.2 11.2 12.1 12.0 11.6 10.5 12.7 12.0 12.2 14.3 47.5 25.6 38.9 12.4 34.8 21.4 39.6 46.5 55.2 42.6 57.3 61.6 62.5 60.1 44.5 53.3 12.5 77.6 31.2 61.6 109.5 76.9 183.1 46.8 51.0 54.2 26.5 46.7 30.5 134.6 56.0 49.3 63.2 33.3 63.9 39.3 55.0 144.5 44.7 55.5 21.9 58.6 46.8 33.5 27.2 162.9 47.2 27.4 37.4 12.2 44.4 60.2 35.0 12.1 17.7 83.7 51.1 47.4 40.7 55.2 182.1 128.6 53.7 38.9 46.0 44.4 49.1 91.1 59.6 56.7 22.3 42.4 38.7 88.1 71.2 36.0 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890395-29064764 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764" "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 4.6 6.8 6.9 5.1 10.0 10.9 4.2 9.8 5.1 3.8 1.9 3.8 3.1 4.4 3.1 3.2 3.8 4.2 4.5 3.9 14.1 4.3 4.2 4.6 5.3 14.8 17.0 1.9 6.2 3.3 5.0 1.8 6.8 15.7 2.9 3.9 6.2 3.1 2.5 2.9 4.4 4.4 5.3 12.0 5.7 4.4 7.6 11.8 5.0 6.2 3.7 6.0 3.9 2.4 13.5 6.2 6.8 7.1 8.2 6.5 6.7 6.0 2.6 3.5 4.0 4.3 3.1 3.9 15.1 6.3 4.5 6.0 5.3 14.4 5.3 5.6 5.5 2.4 15.6 13.8 4.2 5.3 5.4 10.2 3.3 7.5 5.3 10.1 4.9 9.1 9.0 22.7 14.4 5.7 3.8 9.9 2.7 5.0 6.6 1.6 8.1 7.1 3.4 2.8 11.5 3.0 9.2 5.1 3.9 5.4 5.9 3.9 4.8 13.0 3.6 16.8 3.9 3.8 4.4 4.8 5.9 4.6 6.5 5.4 3.2 2.4 1.1 1.9 2.6 2.7 3.4 1.9 1.8 2.5 2.6 2.4 2.4 1.4 1.2 4.7 1.9 0.8 1.4 6.9 10.0 9.8 5.1 3.9 14.1 14.8 17.0 1.9 15.7 12.0 11.8 13.5 25.5 16.0 18.1 125.7 30.3 16.7 15.8 18.1 15.9 24.4 15.3 10.5 23.6 20.0 14.0 29.5 39.6 12.9 18.7 16.2 15.6 8.3 93.0 15.0 21.2 34.2 17.4 19.6 90.1 14.4 14.1 19.2 11.2 29.4 17.1 36.7 68.6 13.7 10.3 30.3 109.8 12.9 22.4 19.8 36.4 31.5 35.8 20.1 16.0 91.8 21.4 28.3 26.8 118.1 111.8 14.1 11.3 31.6 14.4 21.0 20.4 8.8 14.3 31.6 19.7 34.6 17.3 43.6 15.2 10.1 19.7 19.2 22.8 19.5 14.7 22.6 CHRNB3 ENSG00000147432 "Cholinergic receptor nicotinic beta 3 subunit" Q05901 8 42697366-42737407 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.0;retina: 3.8" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Bipolar cells: 1.5;Excitatory neurons: 2.2;Inhibitory neurons: 2.9;Microglial cells: 1.0;Rod photoreceptor cells: 1.1" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.6" "Group enriched" "Detected in some" 6 "cerebellum: 11.0;midbrain: 9.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 1.1;U-266/84: 2.7" "Region enhanced" "Detected in many" "midbrain: 6.9" "Low region specificity" "Detected in all" HPA045555 Enhanced NA NA "HPA045555: AB_10960891" "unprognostic (8.63e-2)" "unprognostic (4.12e-1)" "unprognostic (7.29e-2)" "unprognostic (1.62e-1)" 0.0 0.0 0.1 0.0 1.3 0.0 0.0 11.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.1 0.4 9.8 0.3 0.0 1.8 0.0 0.1 0.0 0.9 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.3 11.0 0.3 0.5 1.8 0.4 9.8 0.3 0.9 0.0 0.7 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CHRNA6 ENSG00000147434 "Cholinergic receptor nicotinic alpha 6 subunit" Q15825 8 42752620-42796392 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 8.3;retina: 3.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.0;Inhibitory neurons: 2.6;Late spermatids: 1.9;Rod photoreceptor cells: 1.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 8.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.2;HDLM-2: 2.7;HMC-1: 1.2;JURKAT: 1.2;RPMI-8226: 1.0;U-698: 3.6" "Group enriched" "Detected in many" 7 "midbrain: 20.2;thalamus: 6.3" "Region enriched" "Detected in all" 6 "midbrain: 76.1" NA NA "unprognostic (1.91e-1)" "unprognostic (7.49e-2)" "unprognostic (2.66e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (7.60e-4)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (7.73e-2)" "unprognostic (6.24e-2)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (2.63e-1)" "unprognostic (3.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.27e-3)" "unprognostic (3.66e-2)" 0.0 0.3 0.5 0.1 0.5 0.0 0.1 8.3 0.3 0.2 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 1.3 2.3 0.2 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 3.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.6 0.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.5 8.3 0.3 0.1 0.2 1.3 2.3 0.2 0.9 0.0 4.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GNRH1 "GNRH, GRH, LHRH" ENSG00000147437 "Gonadotropin releasing hormone 1" P01148 8 25419258-25424654 "Disease related genes, Human disease related genes, Predicted secreted proteins" Hormone "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 9.9;Peritubular cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 19.7;hypothalamus: 12.1;olfactory bulb: 6.7" "Group enriched" "Detected in some" 23 "basal ganglia: 14.1;hypothalamus: 32.3" HPA027532 Supported "Secreted to blood" NA NA "HPA027532: AB_10612111" "unprognostic (6.49e-3)" "unprognostic (7.62e-2)" "unprognostic (2.90e-1)" "unprognostic (5.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.53e-4)" "unprognostic (7.80e-3)" "unprognostic (2.97e-2)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.08e-9)" "unprognostic (7.98e-3)" "unprognostic (5.11e-2)" "unprognostic (3.49e-1)" "unprognostic (3.68e-2)" 4.7 2.4 5.3 1.4 8.1 3.0 4.9 7.1 6.8 8.7 5.8 6.5 1.9 4.3 4.8 5.8 6.3 1.9 6.9 5.1 15.0 6.0 3.2 6.9 2.2 7.1 5.9 4.5 8.7 4.0 0.6 4.8 1.4 6.3 8.4 1.8 9.2 5.4 1.7 3.1 8.6 6.0 1.0 4.9 7.1 4.3 4.6 7.4 1.9 4.4 1.1 1.7 5.7 8.6 7.9 1.0 1.5 4.0 2.2 1.4 4.7 1.7 3.7 1.4 1.1 1.7 1.5 1.1 1.3 0.8 2.1 2.6 3.8 1.2 0.3 2.7 1.7 3.3 1.4 5.9 1.5 1.1 0.2 1.4 2.6 2.1 0.8 0.7 3.6 0.9 1.3 1.5 1.1 1.8 0.6 1.4 3.2 1.4 1.2 0.5 0.9 0.6 0.6 1.0 0.7 21.1 0.7 1.1 0.7 1.4 1.5 0.7 1.8 3.4 3.1 1.5 3.8 1.5 0.3 0.2 1.8 1.5 1.0 1.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 5.3 8.1 7.1 6.8 5.1 15.0 7.1 5.9 4.5 6.3 4.9 7.4 7.9 2.4 0.0 0.5 3.3 1.1 5.0 1.9 1.7 5.2 3.6 2.5 1.3 1.8 1.5 1.4 3.7 4.2 0.1 1.0 2.3 0.0 0.2 0.3 0.7 0.6 2.1 1.8 0.0 3.0 0.6 0.4 3.1 0.0 1.0 0.0 1.0 1.4 0.3 0.5 0.0 2.8 0.5 0.0 0.8 2.2 0.5 9.9 0.4 3.6 2.8 0.8 0.6 4.1 1.5 1.7 0.6 0.6 9.8 1.8 3.7 1.8 0.2 0.9 3.9 0.0 2.4 1.9 1.8 1.2 3.4 2.4 0.1 1.4 0.5 1.4 1.8 BIN3 ENSG00000147439 "Bridging integrator 3" Q9NQY0 8 22620418-22669148 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Septation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 94.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023769 Approved NA NA "HPA023769: AB_1845361" "unprognostic (4.93e-3)" "unprognostic (4.42e-2)" "unprognostic (6.44e-3)" "unprognostic (1.44e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (7.36e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-2)" "unprognostic (1.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.53e-2)" "unprognostic (2.20e-3)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" 17.4 28.7 13.2 8.6 14.0 40.6 17.7 13.0 16.4 12.2 14.0 11.5 6.9 9.7 9.5 15.9 15.2 9.6 11.0 13.9 18.0 15.2 14.1 11.7 10.5 14.0 13.1 12.8 10.5 9.8 12.6 12.7 8.5 13.6 15.6 9.9 7.7 11.7 9.5 9.2 13.9 11.2 8.1 12.7 13.4 12.8 10.4 13.2 13.4 13.3 4.4 11.0 13.6 13.0 13.4 20.6 17.5 7.7 16.6 19.9 18.4 8.6 18.2 31.0 28.4 23.2 7.2 7.9 16.6 8.0 20.0 19.9 22.7 14.9 19.0 19.4 12.6 10.1 13.8 9.0 13.6 16.7 14.3 14.8 19.0 22.2 20.9 11.1 18.0 18.4 9.7 27.5 10.2 14.8 10.0 22.8 31.7 14.6 26.9 7.6 11.4 8.2 8.1 28.4 16.2 4.0 8.8 8.7 6.4 94.2 10.3 6.2 12.7 17.7 8.8 10.8 18.1 13.7 6.8 6.1 15.1 25.1 10.3 58.5 56.3 34.2 78.3 29.0 33.9 30.0 25.8 29.5 21.9 27.5 29.1 28.9 23.5 94.9 36.4 26.1 24.9 41.0 36.9 13.2 14.0 13.0 16.4 13.9 18.0 14.0 13.1 12.8 13.6 12.7 13.2 13.4 31.7 9.6 13.0 9.1 16.5 9.8 30.9 32.9 5.2 14.0 11.5 10.0 1.1 18.6 17.2 14.7 41.7 42.8 14.7 24.0 15.6 25.1 28.5 26.7 15.3 21.0 19.8 14.3 13.3 27.6 22.5 14.0 21.4 28.4 31.7 13.6 17.2 6.1 20.2 25.2 9.8 22.1 34.6 9.6 8.7 4.9 18.3 13.0 19.6 8.4 18.6 69.3 32.0 4.0 7.2 41.7 26.1 12.0 8.5 23.4 16.7 13.9 34.1 33.8 13.1 25.4 14.6 18.0 14.0 5.4 11.5 79.4 15.0 24.4 18.2 41.2 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913690 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 25.8;lymphoid tissue: 41.3" "Cell type enhanced" "Detected in many" "dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 1565.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004379, HPA005507, HPA066571" Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 220000 Cytosol "Nucleoplasm, Nuclear bodies, Golgi apparatus" "CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749" "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favorable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 9.6 5.0 1.2 26.8 1.2 19.7 5.1 1.2 7.2 1.8 4.2 5.6 7.1 2.2 0.5 2.3 3.5 6.6 3.3 1.8 1.9 3.0 6.2 25.8 26.5 1.5 1.3 0.8 1.4 1.9 0.5 1.1 8.0 1.4 2.3 3.6 0.0 3.4 1.5 2.1 2.3 9.6 6.9 1.5 41.3 6.9 1.6 3.8 16.6 2.4 1.6 7.8 8.5 2.3 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 54.3 0.0 0.1 0.0 0.4 119.8 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.8 5.0 0.0 0.0 0.9 8.7 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.3 0.0 0.1 0.2 0.1 0.2 0.1 0.3 1.4 42.0 0.2 577.6 484.3 1565.6 398.3 624.0 184.5 14.5 274.3 304.8 421.9 6.6 151.0 185.9 37.2 307.6 580.7 7.6 597.2 810.3 1.2 1.2 1.2 7.2 1.8 1.9 1.5 1.3 0.8 1.4 1.5 3.8 2.6 2.0 3.2 18.1 0.0 13.2 11.5 0.6 0.0 0.0 0.0 1.2 1.8 2.1 0.0 1.3 3.7 0.0 0.7 130.6 0.3 0.0 0.1 0.2 0.2 0.5 2.8 0.0 10.5 0.1 0.0 1.0 2.6 3.1 0.4 36.3 0.1 5.7 1.1 131.8 0.0 0.0 0.2 0.0 171.8 288.4 0.6 0.3 181.5 19.6 0.0 74.8 0.0 344.0 0.0 0.0 0.0 0.0 0.0 15.4 0.2 0.0 0.7 1.5 0.0 0.0 0.6 2.5 0.2 4.3 0.7 8.5 1.0 147.4 0.0 0.2 0.8 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528956-23575463 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 139.5" "Cell type enhanced" "Detected in all" "Early spermatids: 707.8;Erythroid cells: 4197.2;Late spermatids: 1087.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 19 "neutrophil: 57.7" "Lineage enriched" "Detected in all" 19 "granulocytes: 57.7" "Cell line enhanced" "Detected in all" "HEL: 118.7;hTERT-RPE1: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 11.4 42.3 13.8 16.7 17.0 139.5 18.1 14.0 20.3 25.3 18.1 10.8 51.0 9.9 6.1 10.0 17.3 6.7 15.2 13.8 18.0 20.2 25.4 26.6 6.0 15.4 14.3 13.3 23.2 29.7 11.0 15.1 8.1 15.8 35.8 5.7 10.4 37.0 7.6 16.3 9.5 22.0 5.8 13.1 46.5 11.2 6.9 14.8 2.8 14.7 12.8 5.0 13.5 20.6 15.8 9.6 10.3 10.7 9.9 13.7 16.8 15.7 7.4 9.6 5.3 5.9 10.4 19.9 15.3 8.7 6.3 34.5 12.0 9.9 20.0 7.2 2.3 4.9 118.7 19.4 3.7 11.5 6.7 4.4 14.5 19.2 11.6 11.5 65.9 8.4 12.3 26.3 7.5 8.5 4.2 8.1 28.1 5.4 11.6 7.5 8.3 5.3 6.0 16.4 5.2 3.2 4.6 10.1 15.2 7.6 10.0 4.4 10.3 13.3 25.6 3.8 15.3 14.5 5.9 2.4 9.4 24.1 16.1 16.5 1.4 3.0 2.7 1.1 1.1 0.9 2.3 0.6 0.5 2.8 1.5 2.1 1.2 57.7 1.3 1.5 0.6 1.3 1.4 13.8 17.0 14.0 20.3 13.8 18.0 15.4 14.3 13.3 15.8 13.1 14.8 15.8 43.5 38.5 61.7 36.6 45.5 93.3 125.2 95.8 28.5 35.6 120.0 49.1 35.6 61.5 75.8 77.3 68.8 44.6 19.1 78.4 15.6 93.8 707.8 33.1 68.6 94.5 20.4 4197.2 44.0 226.4 76.4 95.4 43.8 50.0 36.8 49.7 151.3 38.8 41.7 6.7 37.3 44.7 36.7 59.0 141.2 1087.9 52.5 86.8 69.4 73.1 45.5 30.5 10.3 16.1 21.9 176.9 47.7 37.2 24.0 347.1 189.0 34.1 42.5 59.7 19.7 55.9 52.3 24.6 42.3 23.3 53.8 18.3 32.4 86.7 70.3 137.6 CHMP7 MGC29816 ENSG00000147457 "Charged multivesicular body protein 7" Q8WUX9 8 23243637-23262000 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 33.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 10 "B-cells: 35.7;T-cells: 76.3" "Cell line enhanced" "Detected in all" "Daudi: 39.7;U-698: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036119 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036119: AB_10673000" "unprognostic (2.94e-3)" "unprognostic (1.64e-1)" "unprognostic (7.59e-3)" "unprognostic (4.51e-2)" "unprognostic (2.47e-1)" "unprognostic (2.83e-3)" "unprognostic (9.00e-2)" "unprognostic (1.84e-1)" "unprognostic (6.44e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (8.98e-3)" "unprognostic (1.88e-2)" "unprognostic (6.80e-3)" "unprognostic (2.06e-1)" "unprognostic (7.54e-2)" "unprognostic (2.30e-1)" 4.5 6.0 2.2 19.7 2.3 9.8 4.6 3.5 3.2 5.1 1.4 5.9 4.0 6.3 1.5 4.8 4.9 3.4 4.0 2.3 2.6 3.4 3.5 4.7 33.1 3.3 2.0 2.7 4.4 2.7 2.8 3.6 2.2 3.1 4.1 3.4 2.2 5.3 3.6 7.0 4.6 14.8 2.6 2.2 17.1 5.9 4.8 2.7 31.3 4.4 3.9 27.9 5.6 4.8 4.6 6.2 8.6 4.6 7.8 4.2 4.0 5.2 5.0 3.6 7.2 6.1 9.6 4.8 39.7 6.0 3.7 6.9 5.9 4.3 6.3 2.9 10.6 7.4 8.4 11.5 4.9 3.6 2.4 11.4 3.4 4.2 7.0 1.9 4.1 6.0 16.7 9.3 5.6 4.2 6.0 7.3 9.3 7.1 5.9 6.5 2.8 3.7 5.5 3.7 8.0 5.6 5.5 3.9 5.9 2.3 2.5 6.2 4.5 6.7 8.9 5.7 6.7 4.0 15.1 8.5 47.2 6.6 6.6 6.6 1.2 4.8 5.0 6.3 4.8 12.7 35.7 41.3 19.0 3.7 35.6 76.3 45.2 4.3 5.4 3.5 3.0 46.8 32.7 2.2 2.3 3.5 3.2 2.3 2.6 3.3 2.0 2.7 3.1 2.2 2.7 4.6 8.6 6.4 7.9 7.2 48.6 13.6 15.8 12.1 12.5 11.9 11.3 10.9 13.2 11.5 11.8 14.7 4.2 15.8 12.7 16.9 19.6 19.7 43.5 5.5 11.3 12.1 13.8 8.6 9.3 15.8 18.8 11.1 11.7 10.2 12.0 13.1 6.4 7.0 15.9 13.5 11.4 13.1 14.2 7.5 7.7 13.7 9.9 13.1 16.0 1.9 17.3 20.6 21.6 3.5 9.5 20.5 12.4 10.5 24.0 15.9 16.0 18.8 7.1 10.6 6.6 10.1 13.1 15.7 16.8 9.2 10.7 20.7 25.7 10.1 10.8 19.6 DOCK5 FLJ21034 ENSG00000147459 "Dedicator of cytokinesis 5" Q9H7D0 8 25184689-25418082 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 84.3" "Cell type enriched" "Detected in many" 7 "Oligodendrocytes: 789.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 30.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 30.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017719, HPA056837" Approved Enhanced Cytosol No No Cytosol "HPA017719: AB_1847820, HPA056837: AB_2683253" "unprognostic (2.16e-1)" "unprognostic (3.55e-3)" "unprognostic (1.25e-2)" "prognostic favorable (1.91e-4)" "unprognostic (8.44e-2)" "unprognostic (1.24e-1)" "unprognostic (2.61e-2)" "unprognostic (2.88e-2)" "unprognostic (1.69e-2)" "unprognostic (4.21e-2)" "unprognostic (4.18e-3)" "unprognostic (3.00e-1)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.81e-1)" "unprognostic (3.07e-1)" "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" 4.2 3.4 14.6 7.6 47.9 17.2 4.8 29.0 27.3 4.2 20.3 8.2 10.7 4.1 5.2 3.5 6.2 5.8 6.4 15.3 28.9 4.2 15.3 9.4 1.8 34.6 37.3 8.5 6.9 4.7 2.6 8.3 10.3 42.0 7.9 9.5 2.5 6.7 5.6 2.6 5.2 13.0 3.4 20.2 19.4 6.7 6.3 36.0 1.9 15.6 2.8 1.6 4.1 4.9 84.3 19.8 43.2 4.1 0.3 9.8 10.6 14.2 45.5 26.5 12.4 9.6 6.3 15.5 0.4 4.0 40.3 13.7 34.6 4.9 32.5 19.9 6.2 6.1 20.2 40.5 15.8 11.1 5.0 21.6 7.3 12.9 13.6 20.3 13.6 10.7 0.8 0.3 0.8 12.2 11.5 0.7 9.5 4.1 24.4 11.9 0.3 9.0 0.5 9.1 12.0 3.0 1.4 24.0 14.5 4.7 3.4 4.5 4.0 32.1 21.1 13.6 25.5 17.1 0.7 0.2 0.3 27.4 10.2 27.4 14.6 2.5 3.8 0.4 5.5 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.3 30.7 0.4 6.8 0.4 0.0 0.3 14.6 47.9 29.0 27.3 15.3 28.9 34.6 37.3 8.5 42.0 20.2 36.0 84.3 2.7 44.8 41.5 96.6 2.2 18.5 13.2 30.5 2.2 9.6 12.8 5.8 13.4 31.5 31.4 14.7 2.1 28.3 20.1 50.6 0.0 10.3 0.9 16.3 10.0 10.6 17.5 9.9 4.9 12.0 100.2 28.1 32.1 53.1 31.0 52.8 8.2 35.0 13.3 1.7 3.6 26.7 8.2 60.3 51.0 5.6 28.9 41.3 85.4 38.4 24.5 20.0 22.6 61.3 789.8 48.9 27.4 48.2 13.4 36.0 60.0 6.2 20.9 2.3 13.1 4.0 12.1 0.9 5.6 5.8 7.2 20.5 10.8 25.1 27.7 16.8 STAR STARD1 ENSG00000147465 "Steroidogenic acute regulatory protein" P49675 8 38142700-38150992 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Steroidogenesis, Transport" "Congenital adrenal hyperplasia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "adrenal gland: 5115.5" "Cell type enriched" "Detected in some" 44 "Theca cells: 2243.4" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "basophil: 2.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "K-562: 436.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023644, HPA027318, CAB032598" Enhanced NA NA "CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574" "unprognostic (1.60e-4)" "unprognostic (3.20e-2)" "unprognostic (9.17e-2)" "unprognostic (3.28e-2)" "unprognostic (9.22e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.12e-5)" "unprognostic (3.30e-2)" "unprognostic (2.36e-1)" "unprognostic (1.77e-3)" "unprognostic (6.65e-2)" "unprognostic (4.75e-9)" "unprognostic (1.58e-1)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (6.16e-2)" 1.7 5115.5 2.3 3.2 1.9 2.1 0.4 1.7 3.4 0.7 0.8 0.4 0.2 0.5 0.6 2.2 6.4 0.2 0.7 1.5 3.8 0.4 1.2 0.5 1.0 3.6 2.6 2.0 501.3 0.9 0.0 2.2 0.5 4.6 0.5 0.1 0.6 1.8 0.3 0.4 4.5 0.6 0.4 1.6 1.0 0.7 89.0 3.2 3.1 0.4 0.0 1.9 0.5 3.3 3.6 0.1 0.0 0.8 0.2 0.3 3.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.0 88.9 0.8 5.3 1.3 3.8 0.1 12.4 0.3 0.1 0.1 0.8 0.0 0.3 436.1 0.2 0.0 0.0 0.4 43.7 9.6 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.2 0.0 0.2 0.0 0.1 43.0 1.5 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.3 9.3 0.2 2.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 2.3 1.9 1.7 3.4 1.5 3.8 3.6 2.6 2.0 4.6 1.6 3.2 3.6 0.0 0.0 0.0 0.7 0.1 9.4 0.7 0.8 4.0 1.1 0.1 1.1 0.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 1.9 10.7 0.6 0.0 0.0 1.4 0.0 0.0 25.7 0.0 0.3 0.0 1.4 0.0 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.7 10.2 50.1 0.2 3.6 0.0 0.0 0.6 0.0 0.5 0.3 0.1 0.0 4.1 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.2 3.0 4.8 0.8 1.7 11.2 0.1 0.1 2243.4 0.0 0.1 PLPBP PROSC ENSG00000147471 "Pyridoxal phosphate binding protein" O94903 8 37762595-37779768 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 101.8;Exocrine glandular cells: 49.8;Hofbauer cells: 47.3;Proximal tubular cells: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017033, HPA023646, HPA023733" Approved Enhanced Cytosol NA NA 34000 Cytosol "CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742" "unprognostic (1.55e-2)" "unprognostic (2.17e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-2)" "unprognostic (1.34e-1)" "unprognostic (2.35e-2)" "unprognostic (2.36e-1)" "unprognostic (7.78e-3)" "unprognostic (1.80e-1)" "unprognostic (4.28e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (9.41e-3)" "unprognostic (3.16e-2)" "unprognostic (3.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.85e-2)" 34.5 23.3 23.3 21.4 24.8 14.7 23.5 25.9 27.6 22.3 28.6 47.6 34.8 19.4 23.5 20.4 27.8 19.3 39.6 24.6 27.8 59.0 78.8 25.9 25.2 25.6 23.7 22.1 25.0 40.6 37.7 16.3 20.3 24.5 20.4 38.2 11.0 28.6 28.1 46.9 17.2 37.7 26.1 25.7 25.2 33.8 8.5 24.7 27.7 32.1 42.5 29.2 23.1 16.3 28.9 50.3 45.4 35.1 32.0 25.9 31.1 31.6 55.2 45.8 34.7 38.9 51.6 24.3 58.4 61.9 39.9 55.5 41.4 65.4 52.5 56.6 49.9 34.3 79.4 16.4 51.7 51.6 36.8 52.5 22.9 49.8 33.0 52.0 37.6 52.3 78.3 42.8 42.1 28.7 34.8 116.4 32.4 43.0 92.8 41.9 73.6 46.6 34.8 56.5 60.0 21.5 25.1 45.4 20.0 56.8 25.4 44.2 48.6 52.1 19.1 60.7 69.8 38.1 43.3 90.9 43.0 27.4 51.8 35.0 164.3 109.6 136.1 85.6 130.0 90.0 77.8 87.8 83.6 115.2 61.9 77.0 74.3 46.9 75.9 147.4 66.5 116.7 110.2 23.3 24.8 25.9 27.6 24.6 27.8 25.6 23.7 22.1 24.5 25.7 24.7 28.9 35.9 9.6 26.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 27.8 23.0 0.0 0.0 8.1 31.3 0.0 21.2 20.0 0.0 101.8 38.2 0.0 12.8 20.7 13.5 0.0 0.0 0.0 49.8 31.6 13.9 0.0 19.6 12.6 14.8 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 11.9 0.0 0.0 0.0 0.0 33.2 0.0 0.0 1.8 0.0 0.0 82.2 13.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 12.9 9.8 17.1 0.0 0.0 ERLIN2 "C8orf2, Erlin-2, NET32, SPFH2, SPG18" ENSG00000147475 "ER lipid raft associated 2" O94905 8 37736601-37758422 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002025, CAB014894" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "CAB014894: , HPA002025: AB_1080077" "unprognostic (5.82e-3)" "unprognostic (2.45e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.39e-2)" "unprognostic (1.89e-1)" "unprognostic (3.77e-2)" "unprognostic (6.67e-2)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.78e-3)" "prognostic favorable (6.67e-6)" "unprognostic (4.78e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "unprognostic (2.33e-1)" 20.5 17.9 15.2 14.8 15.9 14.5 25.3 17.1 16.9 20.2 24.4 24.4 17.9 21.4 32.6 18.1 30.3 19.9 17.9 13.5 21.9 40.8 41.1 15.6 11.6 17.7 16.7 11.8 31.1 26.4 41.7 8.4 21.4 16.7 25.6 25.2 21.8 29.7 24.0 19.1 15.4 23.8 19.6 17.7 14.7 25.1 17.2 15.2 14.8 46.9 14.3 12.7 16.9 10.4 18.5 39.0 38.5 43.0 31.4 47.3 33.9 47.2 59.1 51.9 31.8 33.2 20.1 50.8 18.9 95.8 63.4 30.3 41.4 31.2 48.4 46.8 11.2 24.2 27.8 22.7 22.7 31.5 17.8 34.1 43.3 49.1 46.3 48.1 39.6 30.7 17.2 51.1 17.7 47.4 18.3 25.8 14.7 45.9 53.8 17.7 17.9 29.9 15.2 42.8 41.9 7.7 20.7 39.3 12.6 35.6 50.1 62.0 27.1 31.1 30.9 26.4 56.8 31.1 24.3 41.0 24.2 55.0 28.4 40.7 1.3 6.5 13.4 4.4 7.0 3.6 4.5 2.7 3.5 5.4 2.3 4.1 3.8 6.1 2.5 9.6 7.6 5.5 3.1 15.2 15.9 17.1 16.9 13.5 21.9 17.7 16.7 11.8 16.7 17.7 15.2 18.5 14.7 12.8 14.3 21.5 7.1 9.7 10.0 18.5 13.1 25.2 24.9 20.7 30.2 25.8 22.8 33.1 20.9 17.9 6.0 19.0 9.8 23.8 21.3 31.3 18.5 13.6 11.4 8.0 3.7 22.1 27.0 18.8 17.3 27.8 3.8 14.4 17.5 41.0 20.6 16.8 6.4 24.3 20.3 23.9 6.6 16.8 11.8 16.1 14.2 7.5 12.3 23.5 5.2 11.6 16.7 18.8 17.4 17.7 16.8 15.2 25.4 19.8 47.6 18.7 19.7 19.1 14.8 47.4 18.5 21.9 7.4 15.7 7.1 12.9 25.4 12.8 SNTG1 "G1SYN, SYN4" ENSG00000147481 "Syntrophin gamma 1" Q9NSN8 8 49909789-50796692 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;lymphoid tissue: 2.8" "Group enriched" "Detected in some" 25 "Excitatory neurons: 1498.8;Inhibitory neurons: 1490.6;Oligodendrocyte precursor cells: 1948.8" "Cancer enriched" "Detected in single" 5 "glioma: 2.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "RH-30: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072282 Enhanced NA NA "HPA072282: AB_2686506" "unprognostic (4.60e-2)" "unprognostic (1.72e-2)" "unprognostic (2.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.94e-2)" "unprognostic (2.03e-1)" "unprognostic (1.16e-3)" 0.0 0.4 1.2 0.0 4.6 0.4 0.0 1.3 11.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 5.8 2.5 0.3 0.5 0.0 0.1 2.2 3.2 2.5 0.0 0.3 0.0 1.4 0.0 2.8 0.0 0.1 1.7 0.0 0.1 0.0 0.2 0.0 0.1 0.0 2.8 0.1 0.7 3.9 0.1 0.1 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.1 0.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.2 4.6 1.3 11.0 5.8 2.5 2.2 3.2 2.5 2.8 0.0 3.9 5.4 0.0 0.0 0.5 27.7 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.4 0.0 0.6 1.8 0.0 0.0 0.2 0.0 0.0 0.0 21.5 0.1 0.0 0.1 0.0 0.0 1498.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.7 1490.6 0.0 0.0 0.0 0.0 56.2 0.6 0.1 0.0 64.6 0.0 0.4 0.0 1948.8 18.3 0.3 0.0 0.4 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.1 7.8 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.1 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319577-51809445 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "heart muscle: 38.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2" "Group enriched" "Detected in some" 4 "breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.6 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.1 9.5 0.2 0.0 0.1 38.9 0.2 0.3 1.4 0.0 0.2 0.3 0.5 0.3 0.1 0.1 0.0 0.2 0.0 0.0 0.8 0.2 0.1 2.9 0.4 0.0 1.4 0.2 0.2 0.0 0.1 0.4 0.0 5.1 0.2 0.5 0.3 2.1 0.5 0.0 0.0 0.4 0.5 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.6 0.2 0.3 0.5 0.3 0.1 0.8 0.1 0.2 0.4 0.3 0.0 0.0 10.7 0.0 0.1 0.1 0.0 0.0 1.2 3.7 0.1 42.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.9 0.0 43.8 0.0 0.0 0.3 0.0 0.0 25.2 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 68.8 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 16.9 0.0 18.6 0.0 14.1 14.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.8 24.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 ST18 "KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387" ENSG00000147488 "ST18 C2H2C-type zinc finger transcription factor" O60284 8 52110839-52460959 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 81.8" "Cell type enriched" "Detected in some" 39 "Oligodendrocytes: 4055.3" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5" "Region enhanced" "Detected in all" "cerebellum: 40.2" "Low region specificity" "Detected in all" HPA044919 Uncertain NA NA "HPA044919: AB_10959756" "unprognostic (3.66e-1)" "unprognostic (4.34e-2)" "unprognostic (7.47e-2)" "unprognostic (2.04e-2)" "unprognostic (2.78e-1)" "unprognostic (2.42e-2)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.55e-3)" "unprognostic (2.82e-1)" "unprognostic (2.53e-5)" "unprognostic (3.29e-1)" "unprognostic (1.35e-1)" "unprognostic (9.34e-2)" "unprognostic (9.84e-3)" 0.0 0.9 20.4 0.1 43.1 0.0 0.0 42.8 28.1 0.0 2.4 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 16.6 25.5 0.3 0.1 0.1 0.0 39.9 37.7 9.3 0.0 1.9 0.0 4.4 0.1 44.0 0.1 0.3 8.6 0.0 0.0 0.0 0.0 0.5 0.0 29.7 0.0 1.5 0.3 32.8 0.1 0.0 0.0 0.1 0.0 0.0 81.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 43.1 42.8 28.1 16.6 25.5 39.9 37.7 9.3 44.0 29.7 32.8 81.8 0.0 0.0 0.0 4.9 0.6 0.1 0.1 0.0 0.0 101.5 0.0 0.0 1.1 4.3 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.2 49.6 1.3 3.4 0.0 0.4 0.2 5.1 0.0 0.0 0.0 0.0 0.2 1.3 1.7 8.5 0.8 10.2 1.6 11.0 1.7 0.0 3.4 0.0 0.0 0.7 2.4 0.0 13.0 4055.3 0.3 0.0 0.0 0.1 0.3 0.1 0.8 0.0 4.5 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.1 0.1 0.0 0.3 0.0 RGS20 "RGSZ1, ZGAP1" ENSG00000147509 "Regulator of G protein signaling 20" O76081 8 53851795-53959303 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.4;retina: 4.9" "Cell type enriched" "Detected in some" 7 "Astrocytes: 238.6" "Cancer enhanced" "Detected in many" "melanoma: 12.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 27.7;SK-MEL-30: 30.4;U-87 MG: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070193 Enhanced NA NA "HPA070193: AB_2732150" "unprognostic (2.14e-2)" "unprognostic (2.87e-2)" "unprognostic (1.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (1.91e-5)" "unprognostic (5.03e-5)" "unprognostic (2.15e-1)" "unprognostic (1.57e-2)" "unprognostic (8.86e-3)" "unprognostic (5.28e-2)" "unprognostic (2.75e-8)" "unprognostic (3.71e-3)" "unprognostic (9.78e-3)" "unprognostic (8.32e-2)" "unprognostic (1.69e-2)" 0.1 0.0 6.7 0.0 9.7 0.0 0.1 4.9 11.4 0.4 2.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 6.5 5.1 0.0 0.0 0.0 0.0 5.3 3.5 6.3 0.0 0.0 0.0 0.1 1.2 5.1 0.0 0.0 4.9 0.3 0.0 0.0 2.2 0.0 0.0 3.6 0.0 0.0 0.1 4.1 0.0 1.3 0.0 0.2 0.0 1.0 6.4 14.6 10.1 19.3 0.3 0.7 2.3 0.0 7.9 4.6 6.7 4.0 0.0 8.8 0.0 0.4 2.2 27.7 10.6 0.4 12.8 4.5 0.0 1.5 2.5 1.5 1.7 3.1 0.0 0.9 0.4 8.1 5.5 16.0 14.9 2.6 0.0 0.7 0.0 11.3 0.0 0.0 0.4 0.3 2.1 4.0 0.0 0.6 0.0 12.9 0.9 12.0 1.1 0.6 0.0 30.4 2.8 0.0 0.1 8.5 1.7 0.0 14.4 5.9 2.4 0.0 0.0 28.9 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 9.7 4.9 11.4 6.5 5.1 5.3 3.5 6.3 5.1 3.6 4.1 6.4 0.2 0.0 0.0 238.6 0.1 2.0 0.5 10.9 0.6 1.3 0.2 0.0 0.8 0.0 2.7 0.0 31.3 0.7 0.0 0.1 0.0 0.6 0.5 4.2 1.0 0.2 0.0 0.0 3.2 0.4 0.8 0.6 0.0 5.5 0.0 0.0 0.0 0.0 0.2 0.0 6.0 0.0 4.1 0.0 0.0 0.0 0.3 0.1 5.4 9.4 0.0 5.5 0.0 5.0 0.7 1.3 0.0 0.0 0.0 5.1 0.0 0.0 2.6 13.7 0.0 0.1 0.5 0.1 1.3 0.4 0.4 0.7 0.1 0.0 0.0 0.6 TACC1 ENSG00000147526 "Transforming acidic coiled-coil containing protein 1" O75410 8 38728186-38853028 "Predicted intracellular proteins" "Cell cycle, Cell division" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 554.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 34.8;granulocytes: 31.5;monocytes: 14.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017041, HPA024702, HPA056841" Approved Approved Cytosol NA NA 47000 Cytosol "CAB017041: , HPA024702: AB_1857723, HPA056841: " "unprognostic (1.83e-2)" "unprognostic (3.07e-1)" "unprognostic (2.18e-1)" "unprognostic (8.31e-2)" "unprognostic (6.55e-2)" "unprognostic (5.30e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-1)" "unprognostic (7.85e-2)" "unprognostic (1.63e-1)" "unprognostic (5.94e-2)" "prognostic favorable (1.06e-5)" "unprognostic (1.03e-3)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.18e-1)" 153.2 31.8 32.2 39.9 40.8 69.0 68.3 26.2 35.6 74.4 32.6 64.0 21.7 84.8 14.2 71.2 64.6 47.9 42.8 30.2 70.4 52.1 24.0 68.3 42.2 30.8 37.8 23.4 36.2 44.8 29.8 14.2 75.0 36.9 55.3 44.4 16.1 19.3 76.2 20.5 17.7 40.6 91.7 26.5 61.8 39.0 29.5 33.9 27.3 34.7 56.9 35.2 59.1 37.1 52.0 39.4 74.2 53.2 16.6 55.9 38.9 34.8 50.1 64.4 46.8 47.6 34.6 5.9 40.1 29.9 49.5 40.5 36.7 32.0 22.7 96.5 28.8 12.1 155.5 22.8 22.4 65.8 31.4 69.0 71.2 20.6 76.2 24.1 48.5 169.8 47.5 16.4 97.9 143.0 29.2 74.4 17.9 7.6 63.5 35.0 16.7 120.3 7.1 15.9 38.2 3.8 4.2 40.6 41.5 33.9 31.6 19.3 23.9 138.0 56.5 34.3 72.8 40.9 50.5 35.5 35.2 51.4 35.7 69.8 13.7 11.7 15.7 6.0 10.5 6.5 2.0 4.0 5.0 7.6 2.3 3.2 3.6 31.5 3.8 14.3 34.8 3.4 5.8 32.2 40.8 26.2 35.6 30.2 70.4 30.8 37.8 23.4 36.9 26.5 33.9 52.0 554.0 218.0 152.9 67.9 66.7 35.2 55.5 9.3 148.0 35.2 14.3 25.1 53.9 191.6 32.7 46.0 62.6 66.2 122.9 30.0 119.3 176.4 4.3 34.9 51.2 251.0 37.8 79.3 109.1 60.2 64.3 147.5 25.0 79.0 115.8 42.1 350.5 39.2 79.0 109.4 73.8 121.2 6.1 90.9 158.7 11.5 168.4 128.8 40.9 203.3 87.1 59.8 51.5 44.2 134.3 47.5 44.2 206.1 73.7 62.4 3.4 23.5 7.7 44.2 190.7 150.0 223.3 42.9 62.3 45.5 18.9 94.0 81.5 43.4 48.7 40.0 GOLGA7 "GCP16, GOLGA3AP1, GOLGA7A, HSPC041" ENSG00000147533 "Golgin A7" Q7Z5G4 8 41490396-41510980 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain NA NA "HPA046878: AB_2679854" "unprognostic (2.93e-1)" "unprognostic (9.56e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.22e-1)" "unprognostic (3.01e-2)" "unprognostic (6.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.80e-1)" "unprognostic (4.36e-2)" "unprognostic (1.31e-1)" "unprognostic (1.68e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (1.88e-1)" 41.7 31.8 82.6 28.9 96.1 43.0 34.5 85.9 103.6 30.8 66.3 27.7 31.9 33.9 28.1 34.9 23.4 33.6 28.3 80.2 86.0 43.2 47.3 30.6 37.2 89.4 91.5 73.2 31.4 32.7 33.9 15.9 49.0 88.4 30.9 26.3 31.9 39.2 26.7 25.7 48.2 32.4 32.3 86.6 36.6 28.8 41.2 84.3 36.9 28.8 30.0 32.2 33.4 25.0 117.0 58.2 64.9 48.2 56.1 59.8 51.7 36.8 49.6 48.5 57.2 63.0 115.8 53.3 27.9 64.4 46.7 54.6 39.6 48.0 38.6 63.5 39.3 42.7 56.5 36.7 48.0 65.3 26.2 45.3 45.6 71.1 36.6 54.1 46.3 56.5 49.4 68.1 53.9 46.7 42.6 83.6 70.7 54.1 53.1 31.2 50.4 86.8 30.6 66.9 53.3 86.1 55.5 44.6 34.4 90.7 40.3 70.5 49.9 58.9 48.2 46.4 61.7 44.0 40.7 67.7 40.7 51.3 44.5 68.3 204.9 78.1 78.8 83.9 68.5 82.2 34.8 79.4 76.9 59.2 32.9 65.8 65.9 136.7 78.0 68.1 40.5 94.9 139.7 82.6 96.1 85.9 103.6 80.2 86.0 89.4 91.5 73.2 88.4 86.6 84.3 117.0 74.6 6.4 22.9 11.8 31.4 110.4 53.9 63.1 44.3 28.3 48.3 42.9 25.5 28.6 38.4 29.5 4.2 61.2 69.6 29.5 95.9 62.7 22.2 28.1 43.1 57.4 42.5 33.9 15.8 48.0 68.4 55.0 29.6 36.5 17.7 35.4 52.5 46.6 64.3 18.5 17.8 30.3 59.0 69.7 95.2 21.7 45.1 53.7 60.5 13.1 65.5 77.9 87.6 14.6 90.5 55.1 21.0 62.1 31.2 77.0 53.2 120.5 28.4 30.7 59.2 49.2 60.4 152.3 135.0 43.5 108.5 85.9 69.5 38.1 30.5 55.4 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 264.5;Prostatic glandular cells: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 80.2;memory B-cell: 211.8;naive B-cell: 305.9" "Group enriched" "Detected in all" 7 "B-cells: 305.9;granulocytes: 80.2" "Cell line enhanced" "Detected in all" "RPMI-8226: 140.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles NA NA Vesicles "HPA055777: AB_2682915" "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favorable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favorable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favorable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 12.6 18.8 12.8 21.7 12.6 16.8 24.6 15.3 16.2 29.6 31.7 30.4 42.0 16.2 82.4 14.0 28.5 28.1 8.4 12.3 15.4 22.6 33.3 16.2 28.3 12.1 13.2 12.4 18.7 115.4 13.8 52.8 14.1 13.7 75.1 35.8 8.6 86.4 30.8 4.8 10.3 40.6 11.5 11.3 28.2 46.6 7.9 13.1 10.3 29.4 3.0 32.6 21.4 14.2 12.6 15.1 29.7 17.4 35.7 33.2 32.1 23.9 42.1 52.7 21.0 27.3 13.8 22.7 1.0 35.1 43.8 30.5 16.5 14.5 30.9 18.2 9.6 9.3 26.6 13.1 40.5 56.3 7.8 30.8 25.3 31.5 29.4 38.3 37.2 34.7 34.9 1.3 67.2 25.9 31.2 17.7 13.0 26.5 61.2 10.0 19.1 12.8 140.0 53.3 19.4 13.6 20.8 17.3 26.5 25.4 15.4 56.9 15.0 21.2 14.8 13.1 25.2 11.3 41.5 29.4 4.5 41.0 20.5 26.1 80.2 12.9 23.4 13.4 13.7 23.0 211.8 17.8 17.7 12.2 305.9 8.8 8.5 8.0 22.4 19.7 26.0 18.0 17.0 12.8 12.6 15.3 16.2 12.3 15.4 12.1 13.2 12.4 13.7 11.3 13.1 12.6 22.2 9.6 46.2 0.0 110.8 0.0 81.8 0.0 25.6 5.9 49.4 42.3 0.0 32.9 21.7 75.4 16.7 45.1 14.8 12.4 43.0 68.0 30.6 70.3 27.3 27.9 44.9 9.9 0.0 89.9 43.5 41.5 50.4 54.8 31.5 38.1 17.5 23.4 36.5 62.2 0.0 62.6 0.0 10.1 0.0 8.9 17.7 23.0 0.0 0.0 12.0 37.4 18.6 0.0 0.0 57.2 31.1 9.4 264.5 146.3 74.3 24.9 55.4 3.6 13.1 22.8 18.9 31.4 12.3 20.8 0.0 88.1 25.2 18.5 44.1 59.1 GINS4 "MGC14799, SLD5" ENSG00000147536 "GINS complex subunit 4" Q9BRT9 8 41529218-41545030 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 6.2" "Cell type enhanced" "Detected in many" "Granulosa cells: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024663, HPA026580" Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA024663: AB_1857224, HPA026580: AB_1857225" "unprognostic (7.74e-2)" "unprognostic (3.72e-2)" "unprognostic (2.25e-3)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.70e-1)" "unprognostic (4.01e-2)" "unprognostic (1.71e-3)" "unprognostic (8.01e-3)" "unprognostic (4.03e-3)" "unprognostic (1.50e-2)" "unprognostic (4.34e-4)" "unprognostic (1.79e-1)" "unprognostic (3.67e-5)" "unprognostic (2.40e-3)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (3.22e-1)" 0.8 0.8 0.8 4.1 1.2 5.9 1.8 1.4 1.1 0.7 1.1 2.1 1.6 1.4 0.7 1.7 0.9 1.5 0.7 0.8 1.0 0.6 1.4 0.7 5.2 1.2 1.1 0.8 1.2 0.9 0.6 0.2 2.7 1.3 0.8 3.0 0.8 0.8 0.5 0.5 2.1 1.7 1.5 0.6 1.7 1.3 2.9 1.0 6.2 1.3 0.1 6.1 1.2 0.8 2.4 20.3 28.3 39.4 17.9 2.4 3.1 16.4 28.1 16.9 28.8 33.6 26.4 17.3 28.1 11.2 14.3 21.6 15.0 32.1 23.4 41.9 10.4 17.8 40.8 20.6 17.9 0.6 8.9 20.2 1.7 1.1 47.2 10.4 6.6 14.4 33.0 20.3 9.0 20.4 13.8 37.6 10.1 22.0 21.5 15.4 34.4 36.8 11.8 10.3 19.1 12.2 9.5 20.3 8.8 8.1 19.9 22.8 9.9 10.0 19.3 28.9 36.1 28.8 10.6 16.4 33.0 13.8 20.9 48.3 1.5 0.7 0.3 1.5 0.7 0.9 1.2 2.5 1.0 0.3 2.8 1.5 1.0 1.9 1.4 0.3 2.9 3.7 1.0 0.8 1.2 1.4 1.1 0.8 1.0 1.2 1.1 0.8 1.3 0.6 1.0 2.4 1.3 0.0 1.1 0.7 6.4 2.8 2.8 2.3 1.2 4.0 2.1 4.3 0.8 0.0 1.3 9.2 2.1 9.1 5.6 3.7 0.0 1.8 0.9 2.0 2.3 1.9 3.5 9.9 0.2 1.8 12.4 3.5 4.1 3.7 1.3 17.5 1.1 0.5 4.8 0.0 0.7 4.0 4.1 1.8 9.4 0.6 1.2 5.7 0.0 0.0 9.6 1.7 3.1 0.0 2.5 2.1 0.3 2.2 9.2 1.2 0.5 0.9 0.3 2.5 0.0 3.6 5.9 9.6 11.8 2.5 1.1 5.9 6.9 9.0 6.0 1.6 NSD3 "FLJ20353, KMT3F, WHISTLE, WHSC1L1" ENSG00000147548 "Nuclear receptor binding SET domain protein 3" Q9BZ95 8 38269704-38382272 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 173.8;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005659, CAB013721, HPA018893" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833" "unprognostic (6.21e-2)" "unprognostic (3.73e-2)" "unprognostic (2.18e-2)" "unprognostic (4.12e-1)" "unprognostic (2.25e-1)" "unprognostic (1.53e-2)" "unprognostic (4.35e-2)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (5.06e-2)" "unprognostic (5.60e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.60e-2)" 22.1 14.6 12.1 25.0 14.4 60.7 23.7 31.9 20.3 24.2 1.1 22.6 24.3 23.2 17.6 23.1 23.7 24.7 12.8 15.5 11.8 20.2 16.8 20.8 35.6 12.3 7.8 9.5 36.7 20.2 25.0 17.4 33.8 11.4 21.1 26.9 23.5 20.1 24.5 14.5 19.2 26.9 19.9 0.9 27.1 29.3 14.5 8.9 38.7 27.9 16.2 31.2 23.5 23.3 21.3 62.1 34.9 58.7 39.9 40.3 46.0 43.4 50.8 55.9 43.1 49.7 18.8 33.6 73.5 45.5 35.0 41.7 36.4 47.0 40.6 61.0 29.4 27.6 93.6 28.6 22.1 41.2 41.7 32.5 24.9 40.4 39.0 78.6 40.3 50.1 79.8 67.9 47.4 41.5 22.3 122.8 35.4 40.0 48.0 16.4 55.5 64.1 23.4 30.3 47.3 33.0 44.6 41.4 35.8 35.3 37.5 45.1 31.4 48.3 44.5 46.0 67.0 30.3 41.9 53.8 69.2 37.6 41.3 33.0 37.4 11.8 21.9 17.2 5.6 11.0 43.1 25.5 15.5 9.3 60.7 31.9 13.7 57.9 19.6 3.6 12.6 43.4 7.3 12.1 14.4 31.9 20.3 15.5 11.8 12.3 7.8 9.5 11.4 0.9 8.9 21.3 75.1 67.3 57.3 0.0 57.8 0.0 0.0 0.0 0.0 0.0 73.4 69.1 0.0 0.0 30.3 51.5 0.0 101.6 101.9 0.0 23.5 73.0 0.0 109.1 81.3 28.0 0.0 0.0 0.0 61.0 173.8 33.1 0.0 97.5 8.8 99.7 0.0 0.0 44.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 49.7 0.0 0.0 0.0 0.0 64.7 0.0 0.0 48.9 0.0 0.0 31.7 34.2 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 130.8 55.6 81.7 0.0 0.0 DNAJC5B "CSP-beta, MGC26226" ENSG00000147570 "DnaJ heat shock protein family (Hsp40) member C5 beta" Q9UF47 8 66021553-66101245 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 65.9" "Group enriched" "Detected in some" 71 "Early spermatids: 1010.5;Late spermatids: 2756.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Immune cell enhanced" "Detected in some" "memory B-cell: 5.7" "Lineage enriched" "Detected in many" 5 "B-cells: 5.7" "Group enriched" "Detected in some" 5 "HDLM-2: 13.9;RPTEC TERT1: 20.4;THP-1: 12.9;U-266/70: 11.3;U-937: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.01e-1)" "unprognostic (7.29e-3)" "unprognostic (7.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.76e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (7.78e-2)" "unprognostic (2.53e-3)" "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (8.38e-2)" "unprognostic (1.65e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (8.84e-2)" 0.3 0.0 0.1 3.0 0.2 0.4 0.6 0.1 1.2 0.3 0.1 1.1 1.2 0.2 0.2 0.3 0.5 0.6 0.4 0.1 0.1 0.3 1.7 6.1 7.8 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 1.3 0.0 0.3 0.3 0.7 0.0 1.5 0.1 0.1 1.5 0.7 65.9 0.1 1.2 0.1 3.2 3.8 1.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 12.9 0.0 0.5 0.0 0.0 0.0 11.3 0.0 0.4 0.2 11.1 0.0 0.0 0.6 0.0 0.0 0.5 0.0 5.7 0.0 0.0 1.2 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.1 1.2 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.0 0.0 0.7 7.5 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1010.5 0.0 0.0 1.3 0.0 2.7 0.3 0.0 0.1 0.4 0.5 0.2 1.3 0.0 0.4 0.3 6.8 0.0 1.0 0.0 2.0 10.1 1.0 2756.7 13.4 6.3 1.8 1.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 12.8 1.1 0.3 0.0 0.0 2.3 0.0 26.3 0.4 0.2 18.4 7.2 0.0 0.1 0.0 0.3 0.0 0.0 0.7 CRH "CRF, CRH1" ENSG00000147571 "Corticotropin releasing hormone" P06850 8 66176376-66178464 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 104.6" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 160.6" "Cancer enriched" "Detected in some" 28 "urothelial cancer: 34.5" "Region enriched" "Detected in many" 4 "medulla oblongata: 104.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "pons: 25.1" "Secreted to blood" NA NA 10000 "unprognostic (1.62e-1)" "unprognostic (9.68e-2)" "unprognostic (1.00e-1)" "unprognostic (9.55e-2)" "unprognostic (7.22e-3)" 1.5 0.2 9.7 0.0 2.8 0.1 0.0 0.1 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.5 0.0 0.0 0.0 0.0 104.6 10.7 1.9 0.0 1.6 0.7 0.2 6.6 17.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.9 24.3 0.0 0.1 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 2.8 0.1 6.4 1.4 7.5 104.6 10.7 1.9 17.0 0.3 24.3 13.1 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 31.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 160.6 0.0 0.0 0.0 0.1 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175485 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.3;liver: 38.2;skeletal muscle: 29.9;tongue: 34.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 426.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: AB_2682231" "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 1.4 0.0 0.1 0.1 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.1 0.1 3.5 0.8 5.3 0.1 62.3 0.0 0.1 4.9 38.2 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.4 0.0 0.4 0.7 0.1 0.0 1.3 0.2 29.9 0.3 0.1 0.1 0.0 0.1 0.0 7.4 0.1 0.2 0.3 34.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 7.2 0.1 0.3 0.1 0.0 0.4 0.5 0.6 0.0 60.5 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.2 426.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 1.5 27.6 0.0 2.4 0.0 0.0 0.1 0.0 91.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.0 0.6 0.0 0.1 2.8 0.0 0.0 0.1 0.0 108.9 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.8 64.7 0.2 1.2 0.0 0.0 0.2 0.0 0.1 3.8 0.0 3.5 0.0 0.0 0.7 30.4 0.1 0.0 1.5 0.0 0.0 1.3 0.0 6.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 7.4 15.4 0.0 6.6 31.0 2.9 23.8 1.2 0.0 0.0 3.8 0.3 0.0 0.0 0.3 ADHFE1 FLJ32430 ENSG00000147576 "Alcohol dehydrogenase iron containing 1" Q8IWW8 8 66432492-66468907 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 31.4;skeletal muscle: 29.5;tongue: 31.6" "Cell type enhanced" "Detected in many" "Astrocytes: 76.4;Cardiomyocytes: 41.6;Syncytiotrophoblasts: 116.4" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;RPTEC TERT1: 1.5" "Low region specificity" "Detected in all" HPA023062 Enhanced Approved Vesicles NA NA Vesicles "HPA023062: AB_1844611" "prognostic favorable (5.76e-5)" "unprognostic (8.69e-2)" "unprognostic (6.71e-2)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.90e-5)" "unprognostic (7.76e-3)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (9.43e-2)" "prognostic favorable (4.55e-5)" "unprognostic (1.37e-2)" "unprognostic (2.06e-1)" "unprognostic (4.66e-2)" "unprognostic (5.94e-3)" 7.0 2.3 8.7 0.3 8.6 0.0 3.9 7.3 10.5 2.3 9.8 3.3 0.6 2.1 1.4 1.3 5.7 0.7 20.9 8.1 7.5 6.7 31.4 2.1 0.3 9.2 8.4 7.4 5.1 9.5 5.1 2.7 1.1 9.9 5.3 0.8 1.5 2.3 1.5 29.5 1.1 2.5 0.2 7.6 1.8 11.1 1.7 8.7 0.3 2.8 31.6 0.3 4.4 1.8 8.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.0 8.7 8.6 7.3 10.5 8.1 7.5 9.2 8.4 7.4 9.9 7.6 8.7 8.5 1.5 9.6 20.1 76.4 1.8 1.0 4.1 2.7 3.4 1.7 4.6 4.6 41.6 14.3 9.6 9.2 10.4 8.8 6.5 1.0 11.7 1.5 0.5 2.5 1.6 3.3 3.6 2.5 8.3 0.6 0.9 5.3 8.6 2.5 8.8 6.1 6.1 27.1 2.5 0.0 13.2 2.0 4.1 2.1 2.8 1.6 23.9 2.1 0.0 14.0 2.0 7.6 6.2 21.6 19.2 0.9 5.8 27.1 3.0 3.5 4.1 14.8 14.3 8.5 0.0 7.8 5.2 0.5 0.6 1.9 1.0 116.4 10.0 2.5 2.4 2.5 MRPS28 "HSPC007, MRP-S28, MRPS35" ENSG00000147586 "Mitochondrial ribosomal protein S28" Q9Y2Q9 8 79918717-80030289 "Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 359.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027202 Approved Supported Mitochondria NA NA Mitochondria "HPA027202: AB_1854126" "unprognostic (3.63e-3)" "unprognostic (6.41e-2)" "unprognostic (9.61e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-3)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (4.55e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "prognostic favorable (1.20e-6)" "unprognostic (4.48e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-1)" "unprognostic (7.18e-2)" 47.9 89.7 63.9 33.2 67.6 29.4 48.0 70.2 85.9 33.5 70.2 53.4 31.1 27.6 38.6 41.3 35.5 29.1 104.9 63.1 73.1 80.0 111.8 30.6 38.0 69.0 66.8 62.4 28.9 32.5 70.2 40.7 41.3 68.9 31.6 41.4 52.2 35.7 33.7 161.9 28.9 29.6 33.1 70.2 26.9 35.7 24.5 68.5 45.3 54.1 138.9 38.3 39.4 31.0 74.3 85.2 84.1 73.0 17.3 60.9 77.2 79.8 94.3 85.7 122.1 104.2 74.0 66.4 107.2 105.3 75.6 124.2 68.5 102.1 105.5 99.0 85.3 89.8 128.8 74.8 114.4 67.7 57.6 55.3 66.4 88.9 71.8 97.4 67.1 81.0 85.2 93.4 42.3 123.7 81.3 133.8 93.5 29.8 219.5 139.5 89.9 58.1 62.0 158.0 81.8 34.8 58.6 41.1 359.5 91.1 83.8 86.6 68.1 59.0 45.8 116.4 81.6 82.7 46.5 81.4 97.2 77.4 66.7 36.8 95.4 53.8 29.1 48.2 77.3 52.3 51.2 52.8 59.4 98.8 54.4 64.1 62.1 11.1 71.5 70.1 111.1 73.0 49.8 63.9 67.6 70.2 85.9 63.1 73.1 69.0 66.8 62.4 68.9 70.2 68.5 74.3 32.5 22.4 22.2 57.8 20.8 35.2 19.5 124.5 36.5 10.9 23.4 28.1 51.6 42.9 67.0 33.1 4.2 78.7 20.9 18.1 101.8 67.3 15.1 28.5 16.1 26.2 37.3 21.7 39.0 47.4 74.3 21.2 17.9 24.1 50.0 10.5 23.9 65.5 49.5 5.0 42.5 23.5 69.2 25.5 28.5 10.4 17.7 26.9 44.4 70.3 40.0 23.7 26.8 93.5 81.8 36.0 20.6 22.2 19.9 13.4 24.5 126.9 79.7 17.2 32.9 31.1 26.1 18.6 33.4 41.6 37.8 59.4 20.0 23.2 36.4 16.0 PMP2 "FABP8, M-FABP, MP2" ENSG00000147588 "Peripheral myelin protein 2" P02689 8 81440326-81447439 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transport "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 59 "brain: 323.2;choroid plexus: 127.6" "Group enriched" "Detected in some" 16 "Astrocytes: 84.9;Muller glia cells: 48.5;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 90.3" "Cancer enriched" "Detected in some" 59 "glioma: 239.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "WM-115: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in all" 9 "spinal cord: 1313.6" NA NA "unprognostic (5.87e-2)" "unprognostic (5.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (8.03e-3)" "unprognostic (1.10e-2)" "unprognostic (8.45e-2)" "unprognostic (4.43e-2)" "unprognostic (7.21e-2)" "unprognostic (4.41e-1)" "unprognostic (3.27e-3)" 1.9 1.4 179.3 1.4 191.8 0.0 0.7 263.4 185.2 1.3 127.6 1.1 0.4 0.1 1.8 0.8 0.3 1.1 1.5 173.5 226.0 0.2 0.2 0.1 0.0 306.8 244.9 147.6 0.2 0.4 0.0 0.7 0.0 271.9 1.8 0.7 0.2 1.0 3.8 0.3 0.3 0.6 0.3 288.1 0.0 0.7 0.1 278.6 0.0 0.3 0.8 0.0 0.9 1.1 323.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 179.3 191.8 263.4 185.2 173.5 226.0 306.8 244.9 147.6 271.9 288.1 278.6 323.2 1.4 0.0 0.0 84.9 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.7 0.0 48.5 0.0 88.4 90.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669185 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.8" "Cell type enhanced" "Detected in all" "Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 437.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 37000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 20.5 39.6 6.9 13.0 8.4 3.3 18.6 9.1 9.1 10.9 9.3 22.1 39.1 9.7 11.6 10.3 9.4 28.9 30.0 6.6 8.8 77.7 96.8 20.3 15.7 8.8 9.1 6.0 10.1 14.9 21.2 8.4 10.7 9.6 15.5 21.5 12.8 15.1 9.3 28.5 12.5 34.1 15.8 8.5 11.6 16.1 63.8 8.3 14.6 20.4 32.4 13.6 13.4 7.9 11.5 65.7 66.4 20.8 8.6 35.6 53.7 12.5 36.0 20.7 37.7 28.2 32.3 72.3 0.1 14.4 17.4 75.7 45.9 25.0 38.0 30.2 38.8 26.6 30.5 8.1 18.0 74.0 30.1 25.5 64.6 44.8 18.6 28.2 18.0 10.0 23.2 53.4 60.1 50.6 19.6 17.1 5.5 22.3 88.2 60.3 15.2 12.1 14.0 146.3 33.8 29.6 10.3 79.7 437.8 41.0 27.0 72.7 40.1 16.0 3.0 20.8 67.4 29.4 47.7 38.1 0.2 21.1 50.6 28.7 15.8 13.8 13.0 8.5 16.8 10.6 12.6 8.8 8.4 17.3 11.7 8.3 9.2 5.8 11.0 16.7 11.9 13.4 5.9 6.9 8.4 9.1 9.1 6.6 8.8 8.8 9.1 6.0 9.6 8.5 8.3 11.5 15.1 57.7 45.1 3.6 16.0 16.4 22.1 58.9 12.5 15.4 12.1 15.1 38.4 18.6 43.9 18.4 8.4 25.1 12.0 27.2 76.3 51.2 286.3 29.4 11.7 15.3 12.1 19.6 3.9 117.2 15.3 15.1 20.4 31.5 9.5 8.7 19.2 76.1 48.0 8.4 4.6 25.8 34.6 34.5 11.2 40.9 20.5 24.2 16.0 3.7 19.4 35.3 8.2 2.5 10.3 70.2 25.1 15.1 18.3 16.0 59.8 325.7 44.9 14.7 6.6 9.6 14.4 263.1 25.0 12.4 16.8 19.4 13.9 34.2 34.7 11.0 PRDM14 ENSG00000147596 "PR/SET domain 14" Q9GZV8 8 70051651-70071693 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 658 "testis cancer: 34.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 93 "NTERA-2: 49.4;SuSa: 13.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019094, HPA057070" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA019094: AB_1855686, HPA057070: AB_2683327" "unprognostic (5.86e-2)" "unprognostic (9.32e-2)" "unprognostic (6.14e-3)" "unprognostic (1.37e-2)" "unprognostic (8.62e-2)" 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.6 0.5 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 13.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.4 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.3 0.6 0.5 0.1 0.2 0.3 0.1 0.3 0.4 0.1 0.2 0.7 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 TERF1 "PIN2, TRBF1, TRF, TRF1" ENSG00000147601 "Telomeric repeat binding factor 1" P54274 8 73008856-73048123 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048379 Approved "Nucleoli fibrillar center,Nuclear bodies" NA NA "Nucleoli fibrillar center" "Nuclear bodies" "HPA048379: AB_2680378" "unprognostic (1.02e-2)" "unprognostic (1.66e-1)" "unprognostic (7.24e-2)" "unprognostic (2.42e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (6.53e-2)" "unprognostic (9.55e-2)" "unprognostic (1.52e-1)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (2.34e-3)" "unprognostic (1.04e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" 13.5 15.3 6.4 4.7 7.6 8.8 13.2 10.8 8.1 13.9 7.1 11.9 8.6 13.9 7.0 9.4 14.8 7.4 11.2 7.2 7.2 14.3 11.3 9.3 7.6 6.3 6.7 6.4 17.9 10.2 12.4 11.6 6.7 6.9 12.8 7.4 9.1 10.4 9.5 11.2 10.0 9.5 8.6 7.4 8.1 14.6 10.5 6.8 7.5 11.9 4.8 4.6 18.3 12.5 8.5 17.1 15.5 14.6 12.8 11.0 7.3 14.5 18.4 7.3 10.2 10.7 10.0 13.3 9.4 27.6 9.9 22.2 13.9 19.9 11.3 10.5 14.8 31.7 13.6 3.8 6.9 9.5 7.7 15.9 11.6 7.4 11.2 18.8 14.7 11.0 23.8 14.8 12.3 9.6 10.4 31.3 8.8 60.7 37.7 14.7 21.7 7.0 9.9 17.0 8.7 11.9 15.2 13.6 49.8 14.4 42.6 19.9 5.6 7.5 7.8 13.5 17.0 15.3 15.9 16.0 18.1 10.9 12.0 16.7 11.9 6.5 10.7 11.3 6.0 10.1 12.0 10.5 11.4 7.5 10.7 12.1 12.7 3.6 9.7 7.8 11.4 11.4 6.7 6.4 7.6 10.8 8.1 7.2 7.2 6.3 6.7 6.4 6.9 7.4 6.8 8.5 41.5 28.9 29.1 39.5 47.8 27.9 39.6 45.8 35.3 77.6 22.5 32.5 23.2 21.5 27.3 31.3 85.5 53.6 109.4 27.5 25.4 35.8 16.2 24.0 41.1 38.7 92.1 31.6 52.7 37.8 62.4 52.3 24.5 27.1 36.8 44.5 41.7 31.0 34.2 70.7 58.3 26.4 36.7 25.5 26.6 8.1 74.3 27.7 30.2 22.5 32.3 85.7 72.1 48.7 55.3 25.6 21.5 85.4 34.2 30.2 17.9 65.7 24.8 55.4 59.2 63.3 49.1 117.6 131.7 23.6 24.3 31.9 52.6 62.0 28.2 27.6 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290242-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 17748.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 380000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: AB_2683694" "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 2140.2 1363.5 866.5 1334.4 910.0 3097.4 3332.1 882.9 1234.2 2391.3 906.5 1859.1 1328.8 1861.7 1855.3 2074.9 2074.9 1043.1 1331.0 835.1 953.0 1645.6 1607.0 1338.8 2304.3 890.7 870.9 824.0 4568.7 3093.0 1227.7 1204.3 1212.5 896.7 1664.5 1697.9 897.2 1859.5 1273.5 2411.3 2661.5 1432.4 1393.5 959.7 1400.1 1868.4 531.8 900.1 2245.7 1630.9 1848.4 2687.8 1995.3 2121.3 939.7 2902.0 2050.6 2163.3 2615.7 4308.7 5473.7 2120.8 3100.6 2474.6 2069.9 1621.0 2487.3 2940.4 8517.8 2467.6 2517.8 1409.2 2703.0 2888.8 3960.2 3204.7 2313.1 2394.1 4682.9 2687.5 2594.4 2583.2 3343.2 2298.0 5174.5 4574.0 1921.5 5950.9 3797.5 3412.0 2840.5 4261.7 3140.1 2980.2 2448.1 5345.2 5080.8 2528.5 5238.5 2182.9 3552.8 2474.4 3353.9 3241.5 2848.0 2977.1 2160.3 1454.9 17748.7 4599.1 1766.2 4497.4 4312.2 3227.1 1575.4 2407.3 2031.7 2913.1 1799.2 2782.6 5514.9 1649.7 4062.8 2654.8 3331.3 7192.1 1787.5 6932.4 5967.0 12630.9 14333.5 12042.7 9069.1 9565.2 12188.2 17585.4 12433.8 894.5 9240.8 5307.0 7970.3 10207.4 26909.6 866.5 910.0 882.9 1234.2 835.1 953.0 890.7 870.9 824.0 896.7 959.7 900.1 939.7 622.3 817.3 1610.8 26.1 2654.7 8054.8 9929.5 10766.1 1684.6 268.0 5251.9 4462.2 623.2 2396.3 3812.0 1311.3 125.1 4882.8 1798.3 926.5 5576.1 2795.4 1720.0 1068.3 2371.5 2338.1 1617.8 1779.1 27.0 5044.8 7032.5 2096.9 721.7 1300.7 1491.1 1110.8 2680.0 1876.1 3252.9 94.2 27.6 3112.1 3057.8 3661.5 5169.4 806.4 4246.4 1893.5 3705.1 25.3 4752.6 1792.8 3105.1 19.6 33.6 3149.3 2514.2 2310.6 952.9 5766.4 2274.7 5797.7 1454.2 380.6 1459.4 4118.3 2651.4 953.5 374.0 2143.1 9487.1 4878.7 2546.9 2145.3 4018.0 7816.6 SLC26A7 SUT2 ENSG00000147606 "Solute carrier family 26 member 7" Q8TE54 8 91209494-91398155 "Metabolic proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "thyroid gland: 333.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 23.9;Endometrial ciliated cells: 31.6;Endometrial stromal cells: 23.9;Enteroendocrine cells: 45.2;Glandular and luminal cells: 52.0;Hepatic stellate cells: 24.7" "Group enriched" "Detected in some" 11 "renal cancer: 8.7;thyroid cancer: 32.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (5.84e-2)" "unprognostic (8.04e-3)" "unprognostic (4.15e-3)" "unprognostic (1.51e-1)" "unprognostic (2.39e-3)" "unprognostic (2.94e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (8.26e-2)" "unprognostic (4.82e-2)" "unprognostic (3.31e-2)" "unprognostic (2.07e-1)" "unprognostic (5.19e-3)" "unprognostic (6.83e-3)" 1.5 0.1 0.1 0.0 0.2 0.0 0.3 0.2 0.1 1.4 0.2 0.2 0.1 2.7 0.1 0.0 0.5 0.6 0.8 0.0 0.6 24.0 0.0 0.1 3.7 0.1 0.2 0.0 0.1 1.2 0.2 0.3 0.3 0.2 0.1 0.4 0.0 0.4 0.2 0.1 0.1 0.1 0.2 0.2 0.1 6.1 0.5 0.2 0.0 333.5 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.1 0.2 0.0 0.2 0.2 0.2 0.4 3.9 0.0 1.5 5.9 0.1 0.3 0.4 0.2 0.0 0.0 1.9 0.6 1.1 0.0 0.3 23.9 0.0 0.0 0.0 0.3 13.7 0.1 11.9 31.6 23.9 1.5 45.2 0.0 0.5 0.2 0.0 1.5 1.5 52.0 0.0 0.1 24.7 0.1 0.1 0.0 0.7 0.7 2.0 0.6 0.3 2.9 3.7 0.2 3.6 0.0 0.0 0.1 0.0 0.0 3.8 1.4 0.2 0.0 0.0 0.3 0.0 0.3 1.9 0.2 0.0 0.0 4.4 0.6 1.1 0.0 0.1 0.0 0.4 0.5 0.3 0.1 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86047109-86088621 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "retina: 2.5" "Cell type enhanced" "Detected in single" "Rod photoreceptor cells: 2.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HEL: 9.4" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154225 "Metabolic proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 61.0" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 209.4" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.3;SuSa: 5.8;U-87 MG: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles NA NA Vesicles "HPA055327: AB_2682784, HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 0.1 0.0 0.5 0.7 1.0 1.9 0.8 0.2 0.6 0.4 0.2 3.1 1.6 0.3 1.4 0.7 0.1 0.5 0.4 0.5 0.5 61.0 0.4 2.6 1.3 0.4 0.8 0.3 0.0 0.4 1.3 0.0 0.8 0.5 1.4 3.6 14.1 1.1 2.5 0.0 1.8 1.3 0.4 0.2 1.1 0.3 0.2 0.8 0.5 1.0 0.0 1.1 0.5 0.0 1.2 0.4 0.6 0.3 0.4 0.0 0.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 0.1 0.1 0.0 1.4 1.2 0.4 0.9 0.2 0.2 0.0 0.5 0.7 0.1 0.0 0.4 0.6 0.3 0.0 0.2 0.4 1.1 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 2.0 0.1 0.0 0.4 3.3 5.8 0.9 0.0 0.2 0.3 0.4 0.2 0.3 0.2 0.1 0.3 5.1 0.3 0.4 0.7 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.0 0.5 0.2 0.4 0.2 0.1 0.5 1.0 0.2 0.6 0.5 0.5 0.4 0.8 0.3 0.5 0.2 0.8 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.4 0.1 0.0 0.4 0.0 0.1 7.3 31.3 0.0 0.0 0.0 209.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 30.5 0.0 1.1 0.0 0.0 6.9 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.0 1.0 0.0 11.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.2 SYBU "FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL" ENSG00000147642 Syntabulin Q9NX95 8 109573978-109691791 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 141.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 200.5;Horizontal cells: 95.9;Inhibitory neurons: 129.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 6.4;naive B-cell: 3.2" "Lineage enriched" "Detected in single" 27 "B-cells: 6.4" "Cell line enhanced" "Detected in many" "HaCaT: 24.4;PC-3: 25.7;SK-BR-3: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053057 Uncertain Supported Vesicles NA NA Vesicles "HPA053057: AB_2682028" "unprognostic (4.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-1)" "prognostic favorable (7.74e-4)" "unprognostic (1.22e-2)" "unprognostic (1.37e-1)" "unprognostic (2.16e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-1)" "unprognostic (6.05e-3)" "unprognostic (6.89e-2)" "unprognostic (4.27e-2)" 32.5 39.0 37.4 3.3 42.8 0.0 22.4 45.8 54.6 10.8 4.9 14.8 11.0 5.7 11.6 5.7 20.2 10.4 5.5 39.2 52.2 4.3 52.6 8.9 4.5 27.3 35.4 46.4 9.3 141.7 1.5 30.6 2.5 32.1 8.3 19.9 26.3 21.7 11.1 3.8 9.5 12.1 7.0 17.5 1.0 28.4 1.8 41.5 5.5 12.4 7.8 7.9 6.0 8.9 35.4 8.6 5.2 3.6 0.0 0.5 0.6 2.5 3.1 0.0 0.0 0.0 7.9 5.4 0.7 0.5 2.5 1.2 24.4 0.8 5.7 0.0 0.1 11.6 0.0 15.2 8.2 6.2 0.0 0.0 1.9 7.7 0.0 7.2 0.4 3.3 0.6 0.4 1.6 3.5 0.2 0.2 0.0 0.7 7.7 25.7 0.0 0.0 0.0 9.5 2.2 16.3 1.9 6.9 51.4 1.7 2.5 6.8 0.3 5.0 0.3 2.0 0.1 1.5 1.5 0.1 0.5 10.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 37.4 42.8 45.8 54.6 39.2 52.2 27.3 35.4 46.4 32.1 17.5 41.5 35.4 39.3 9.6 7.7 16.0 4.3 5.7 2.5 8.3 17.1 46.1 10.9 9.1 2.4 30.0 18.0 11.0 8.4 4.6 0.1 3.6 3.9 5.4 1.4 29.3 3.4 11.8 34.5 0.0 200.5 9.4 0.9 7.9 5.6 20.9 0.0 0.7 10.0 39.1 0.3 95.9 129.6 22.2 2.0 0.8 4.2 0.4 2.1 0.3 1.8 21.5 0.7 2.1 0.0 22.1 5.7 3.9 9.8 0.4 0.1 11.8 16.2 0.1 15.6 7.4 0.0 16.5 4.2 1.3 1.5 3.5 3.3 0.7 0.6 0.1 13.7 4.2 DPYS DHPase ENSG00000147647 Dihydropyrimidinase Q14117 8 104330324-104467055 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "kidney: 201.4;liver: 481.5" "Group enriched" "Detected in some" 12 "Hepatocytes: 459.5;Proximal tubular cells: 518.8" "Cancer enriched" "Detected in some" 5 "liver cancer: 57.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024785, HPA070814" Enhanced NA NA 820000 "HPA024785: AB_1847856, HPA070814: " "unprognostic (1.54e-3)" "unprognostic (2.33e-1)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-1)" "unprognostic (2.38e-3)" "unprognostic (4.16e-4)" "unprognostic (1.56e-1)" "unprognostic (3.53e-2)" "unprognostic (3.85e-3)" "unprognostic (2.43e-1)" "unprognostic (4.81e-2)" "unprognostic (9.56e-3)" "unprognostic (2.72e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-1)" 4.0 2.8 0.6 0.1 0.7 0.0 0.4 0.2 1.7 1.2 0.3 0.2 0.0 0.1 0.6 0.1 0.7 6.6 0.1 0.6 0.5 201.4 481.5 0.6 0.3 0.5 0.7 0.5 0.2 0.1 0.6 0.2 0.6 0.5 4.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.3 0.1 0.9 1.0 5.2 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.2 1.7 0.6 0.5 0.5 0.7 0.5 0.5 0.4 1.0 0.8 0.1 0.0 0.0 1.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 40.0 0.0 20.2 0.0 0.0 0.0 0.0 27.4 0.1 12.8 0.3 0.1 1.0 0.0 16.0 11.2 0.0 0.0 1.8 0.0 0.3 0.0 0.4 11.7 459.5 1.4 0.0 4.6 0.0 0.0 11.1 0.3 13.5 0.9 10.6 0.0 14.0 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 518.8 0.0 0.1 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 MTDH "3D3, AEG-1, LYRIC" ENSG00000147649 Metadherin Q86UE4 8 97644184-97730260 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010932, HPA015104, CAB068204, CAB068205" Supported Enhanced "Endoplasmic reticulum" NA NA 300000 "Endoplasmic reticulum" "CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173" "unprognostic (1.01e-3)" "unprognostic (1.41e-2)" "unprognostic (2.05e-2)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.25e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.84e-3)" "unprognostic (3.88e-2)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" 53.8 41.8 18.5 56.5 25.5 110.9 39.4 25.9 24.7 53.0 27.5 51.8 51.7 50.6 34.0 52.7 41.5 41.6 36.1 18.2 23.5 41.2 90.4 41.0 59.8 29.3 23.9 14.7 51.1 30.6 53.8 13.5 29.1 28.5 45.1 47.9 45.2 29.6 41.8 60.8 27.2 52.7 63.0 28.7 41.9 48.5 40.0 22.9 66.5 63.3 51.1 61.5 56.8 22.9 37.4 191.5 96.4 61.1 84.7 97.3 102.7 30.7 167.8 139.0 104.2 79.4 59.9 137.0 173.5 181.5 164.6 114.1 121.6 150.3 115.2 143.6 189.5 79.9 320.0 97.5 69.6 118.2 170.5 142.4 78.6 109.3 128.1 282.2 97.3 119.3 126.2 215.5 300.2 108.4 77.6 286.0 43.2 38.9 160.9 113.0 187.2 73.0 255.4 64.5 108.6 92.3 69.2 118.3 101.3 132.0 58.6 158.0 105.1 126.8 146.7 52.7 135.8 123.6 166.1 196.4 174.5 134.3 194.5 130.9 57.0 71.5 38.1 35.7 49.2 49.7 71.6 51.1 52.8 87.0 51.4 51.9 45.7 10.1 51.4 54.6 112.2 33.3 31.9 18.5 25.5 25.9 24.7 18.2 23.5 29.3 23.9 14.7 28.5 28.7 22.9 37.4 185.1 128.2 109.2 69.2 294.6 261.7 233.0 178.9 194.1 0.0 166.1 150.7 109.9 201.6 146.1 141.6 0.0 10.0 231.7 140.5 25.4 230.9 267.4 156.0 269.9 185.1 121.8 205.7 96.4 231.7 98.6 227.2 156.5 178.5 137.1 183.1 164.6 438.0 267.5 0.0 97.0 249.9 146.5 258.7 273.9 163.5 195.4 266.5 184.9 86.2 258.2 0.0 195.7 110.6 141.8 241.8 137.8 216.3 675.9 374.7 160.8 99.2 87.2 0.0 223.5 237.8 334.5 162.1 129.6 249.8 314.8 13.7 200.3 285.6 251.6 315.0 LRP12 "FLJ12929, ST7" ENSG00000147650 "LDL receptor related protein 12" Q9Y561 8 104489231-104589258 "Disease related genes, Human disease related genes, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 42.7;Excitatory neurons: 78.7;Inhibitory neurons: 53.7;Oligodendrocyte precursor cells: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "basophil: 47.0" "Lineage enriched" "Detected in many" 32 "granulocytes: 47.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017245 Uncertain Approved "Nucleoli fibrillar center,Plasma membrane,Mitochondria" NA NA "Nucleoli fibrillar center, Plasma membrane, Mitochondria" "HPA017245: AB_1857532" "unprognostic (2.17e-1)" "unprognostic (6.80e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.07e-1)" "unprognostic (2.15e-3)" "unprognostic (4.87e-4)" "unprognostic (2.96e-2)" "unprognostic (3.96e-1)" "unprognostic (4.59e-2)" "unprognostic (1.32e-1)" "unprognostic (3.39e-2)" "unprognostic (9.89e-2)" "unprognostic (7.56e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" 5.8 4.7 4.6 4.0 8.4 2.3 4.4 5.2 9.5 6.4 3.2 4.9 3.1 16.7 4.0 4.2 5.8 7.6 13.8 12.8 4.8 6.6 1.5 4.6 1.6 2.1 3.1 6.2 6.1 4.5 10.0 3.2 5.4 2.3 6.5 4.9 6.2 3.9 6.0 9.3 3.0 3.0 18.7 1.9 3.7 2.8 5.0 3.2 13.0 6.9 17.4 2.3 7.7 3.2 5.8 18.5 10.6 21.1 37.1 23.4 18.4 4.7 51.5 51.3 17.6 24.6 2.4 17.7 0.0 20.2 49.0 21.2 8.1 8.6 22.0 37.7 34.3 8.2 28.7 4.7 0.8 14.4 0.4 22.1 24.8 15.4 29.5 23.7 63.4 9.1 21.9 6.2 0.0 63.9 3.0 26.5 0.6 5.3 1.6 18.2 2.1 20.5 4.0 13.9 0.8 27.0 16.4 16.4 0.7 44.6 15.8 5.0 5.6 25.7 48.1 31.0 15.7 33.6 23.8 20.2 0.2 25.9 0.0 53.9 47.0 0.3 5.8 0.2 0.8 1.4 0.0 1.0 0.1 0.1 0.0 0.2 0.2 0.2 0.8 0.5 0.4 0.1 0.4 4.6 8.4 5.2 9.5 12.8 4.8 2.1 3.1 6.2 2.3 1.9 3.2 5.8 4.4 16.0 2.2 42.7 0.2 11.5 6.3 12.3 10.8 17.5 3.9 4.3 11.7 7.2 5.2 14.7 6.2 0.2 1.7 2.0 0.0 4.6 4.3 4.4 16.4 5.9 14.4 2.5 78.7 4.5 0.5 12.6 1.5 5.5 8.2 10.9 4.2 0.8 5.3 28.6 53.7 2.5 10.2 7.9 14.3 2.7 8.7 8.2 7.2 9.4 6.1 3.1 1.0 64.3 25.2 5.1 0.3 9.1 0.1 7.7 1.5 3.8 5.3 8.3 6.6 8.2 11.3 8.5 12.0 3.2 10.9 0.3 3.9 4.5 2.3 5.2 EBAG9 "EB9, RCAS1" ENSG00000147654 "Estrogen receptor binding site associated antigen 9" O00559 8 109539711-109565996 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021153, HPA021154, CAB072810, CAB072811, CAB072812" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152" "unprognostic (3.04e-2)" "unprognostic (9.99e-2)" "unprognostic (2.08e-1)" "unprognostic (1.99e-1)" "unprognostic (5.06e-2)" "unprognostic (8.13e-2)" "unprognostic (2.63e-1)" "unprognostic (3.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.22e-2)" "unprognostic (1.04e-1)" "unprognostic (3.72e-1)" "unprognostic (9.72e-3)" "unprognostic (6.46e-2)" "unprognostic (5.16e-1)" "unprognostic (3.53e-1)" "unprognostic (3.71e-2)" 23.5 28.6 20.2 17.8 21.7 17.1 32.8 25.3 26.5 36.4 21.4 28.9 23.7 23.0 45.1 17.1 27.9 19.6 24.9 20.6 22.9 37.4 45.6 28.4 25.6 20.8 20.8 19.8 22.4 37.0 35.1 20.7 18.2 21.1 23.5 31.5 32.8 43.2 27.9 53.7 18.1 21.2 17.1 20.7 20.8 27.5 25.6 20.4 20.8 57.9 42.7 27.2 17.4 15.4 21.8 36.7 25.2 25.3 17.3 15.3 24.9 19.7 19.5 14.6 27.0 25.4 25.7 38.1 51.7 33.0 13.8 21.8 25.2 24.4 31.3 28.5 57.6 26.9 56.9 15.8 39.6 34.3 20.0 16.1 19.9 60.1 23.4 47.2 21.9 25.7 45.8 59.8 37.0 24.0 55.8 58.2 31.5 15.8 70.1 25.2 30.9 20.1 43.7 31.4 23.7 27.6 22.1 21.3 22.6 27.6 18.4 44.7 25.6 17.5 20.9 15.0 19.1 14.4 54.9 38.3 48.7 21.2 52.7 19.6 5.8 13.4 14.7 19.3 19.5 34.1 40.7 27.1 27.0 22.5 40.3 33.5 30.4 2.8 29.4 17.3 23.8 33.4 14.7 20.2 21.7 25.3 26.5 20.6 22.9 20.8 20.8 19.8 21.1 20.7 20.4 21.8 32.0 121.8 102.4 12.7 40.2 21.7 28.6 51.8 44.9 34.5 36.8 46.0 37.6 54.3 65.1 29.5 6.2 50.2 24.0 33.6 64.6 47.3 134.7 42.9 26.7 34.5 31.8 36.0 16.1 65.8 34.0 28.8 22.4 33.0 46.9 16.0 23.2 48.8 32.7 50.5 16.1 39.4 50.8 24.7 22.1 115.0 29.2 27.9 19.6 11.2 25.3 53.4 27.8 18.1 16.1 38.5 41.3 23.0 53.8 36.8 50.5 58.5 61.8 34.7 32.9 35.1 32.1 101.6 50.4 40.5 19.9 22.2 28.5 34.7 46.0 31.7 RSPO2 MGC35555 ENSG00000147655 "R-spondin 2" Q6UXX9 8 107899316-108083642 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" "Developmental protein, Heparin-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;placenta: 17.4" "Group enriched" "Detected in some" 8 "Excitatory neurons: 75.3;Inhibitory neurons: 86.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;U-266/70: 4.2" "Group enriched" "Detected in many" 7 "amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2" "Group enriched" "Detected in many" 4 "amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7" "HPA024764, CAB025900, HPA053068" Uncertain "Secreted in other tissues" NA NA "CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031" "unprognostic (1.10e-2)" "unprognostic (2.18e-1)" "unprognostic (3.97e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.19e-1)" "unprognostic (8.33e-3)" "unprognostic (1.82e-1)" "unprognostic (9.48e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (8.45e-2)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" 0.1 0.1 6.3 0.7 7.0 0.1 0.0 4.2 14.9 2.5 5.0 8.4 3.4 0.0 1.7 6.0 0.0 3.2 0.2 8.7 11.0 0.0 0.4 7.2 0.0 5.1 24.2 6.2 0.3 0.0 0.0 3.0 17.4 8.1 8.8 7.9 0.3 0.0 2.3 0.0 0.0 4.6 0.3 4.4 0.0 7.7 0.7 5.8 0.0 0.0 0.0 0.0 1.8 0.8 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 7.0 4.2 14.9 8.7 11.0 5.1 24.2 6.2 8.1 4.4 5.8 8.4 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.3 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 86.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.0 1.7 0.0 0.0 1.0 0.0 0.2 0.0 0.0 POLR2K "RPB10alpha, RPB12" ENSG00000147669 "RNA polymerase II, I and III subunit K" P53803 8 100150623-100154003 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047477 Supported "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA047477: " "unprognostic (3.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-3)" "unprognostic (2.75e-2)" "unprognostic (4.68e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" "unprognostic (9.75e-3)" "unprognostic (5.73e-2)" "unprognostic (5.65e-2)" "unprognostic (3.46e-2)" "unprognostic (3.07e-2)" "unprognostic (9.16e-2)" "unprognostic (3.43e-2)" 55.7 74.4 70.5 41.3 72.8 67.4 71.1 74.5 111.9 55.8 68.9 51.9 38.1 50.1 71.8 45.4 40.2 41.9 64.3 71.3 76.8 75.2 70.5 49.0 58.4 74.0 73.8 69.7 43.8 34.1 81.5 48.8 48.5 74.9 52.5 54.6 61.9 47.9 54.8 45.9 37.6 39.1 47.4 73.8 43.0 47.6 33.5 71.8 64.7 63.9 59.2 58.7 62.0 36.3 76.7 152.7 75.8 95.3 67.3 100.3 91.0 63.9 109.9 90.5 110.1 132.6 46.7 101.5 100.7 214.7 87.8 64.1 67.8 103.4 91.1 144.3 164.8 114.5 138.3 88.8 100.4 79.1 90.3 95.2 74.6 119.0 87.3 88.7 71.1 101.4 116.6 109.7 96.0 108.6 96.5 228.0 132.5 98.9 216.5 148.1 88.7 55.1 146.5 138.4 84.5 199.3 130.1 75.6 65.9 169.9 92.1 134.7 136.0 78.7 64.1 92.3 100.4 119.0 98.1 169.2 160.6 121.8 156.3 102.4 72.5 33.3 50.4 47.8 44.6 58.3 65.6 61.5 60.5 43.1 46.7 54.1 57.9 12.6 58.0 42.5 67.4 70.3 55.7 70.5 72.8 74.5 111.9 71.3 76.8 74.0 73.8 69.7 74.9 73.8 71.8 76.7 120.5 67.3 57.8 8.8 101.3 162.6 162.9 263.8 82.6 57.5 115.9 123.3 93.4 82.9 152.2 147.1 16.7 134.7 126.5 75.0 440.3 146.0 6.3 113.1 80.9 101.5 122.1 95.9 18.2 130.1 197.0 105.2 60.1 95.2 109.2 52.1 79.2 122.7 154.1 48.8 17.9 116.9 213.6 72.2 103.9 17.6 117.1 78.6 136.9 8.4 144.3 115.7 122.6 12.1 17.4 141.3 72.0 121.5 127.2 224.7 108.1 388.5 127.8 64.9 72.3 96.8 148.0 139.1 166.6 103.0 170.1 137.6 127.9 92.9 98.8 261.3 MAL2 ENSG00000147676 "Mal, T cell differentiation protein 2" Q969L2 8 119165034-119245673 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 261.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 389.9;Distal enterocytes: 433.3;Pancreatic endocrine cells: 329.8;Suprabasal keratinocytes: 455.8;Urothelial cells: 594.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 1042.5;HaCaT: 451.8;OE19: 1132.4;RPTEC TERT1: 385.4;SK-BR-3: 1439.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043831 Uncertain NA NA "HPA043831: " "prognostic unfavorable (4.57e-6)" "unprognostic (3.12e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (2.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.03e-2)" "unprognostic (7.20e-2)" "unprognostic (5.86e-2)" "unprognostic (2.00e-3)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.09e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.48e-2)" "unprognostic (1.34e-1)" "unprognostic (3.33e-1)" "unprognostic (9.27e-3)" 14.2 1.8 6.4 10.7 15.7 0.0 66.2 18.5 26.4 29.6 0.0 103.9 64.9 6.8 14.4 261.3 54.9 33.4 2.0 19.3 18.6 86.5 47.4 82.3 1.3 0.9 7.5 14.6 0.5 37.7 43.9 36.0 12.1 5.8 27.1 95.1 2.6 63.1 41.5 0.4 121.9 53.4 2.6 0.0 0.4 138.8 12.6 8.2 4.4 148.8 0.1 56.5 69.7 103.5 9.5 1042.5 0.0 1.0 0.3 0.2 0.0 92.9 0.1 2.3 1.2 1.6 87.7 329.0 0.3 56.2 0.0 0.4 451.8 0.8 32.9 0.5 0.9 2.6 0.0 13.8 86.1 0.3 0.6 0.3 0.0 225.5 0.0 34.3 1.7 0.3 0.0 0.2 0.5 0.0 244.9 0.8 0.3 8.2 1132.4 309.2 0.6 0.0 0.7 385.4 257.4 56.7 0.3 17.8 1439.4 2.7 6.8 191.4 3.0 0.0 0.6 3.1 1.3 1.9 5.5 0.8 1.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 15.7 18.5 26.4 19.3 18.6 0.9 7.5 14.6 5.8 0.0 8.2 9.5 0.5 112.2 130.8 4.2 2.7 114.7 79.9 59.3 19.9 1.5 118.9 50.7 1.6 90.1 119.7 389.9 0.0 25.0 0.4 433.3 109.5 206.0 0.5 71.8 10.3 3.7 41.9 0.0 62.4 178.6 23.5 4.7 149.9 139.4 14.7 0.0 3.6 44.9 2.9 5.0 9.8 145.9 71.2 0.3 14.3 2.2 0.6 2.3 16.0 3.7 3.6 1.0 0.0 3.5 3.6 329.8 252.9 0.0 1.2 285.4 70.2 19.9 107.5 1.0 0.0 0.0 7.0 1.9 9.7 268.8 455.8 9.3 2.8 0.0 122.5 594.5 EIF3H "eIF3-gamma, eIF3-p40, EIF3S3" ENSG00000147677 "Eukaryotic translation initiation factor 3 subunit H" O15372 8 116642130-116766925 "Cancer-related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 1808.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023117, HPA023553" Approved Approved Cytosol NA NA 38000 Cytosol "HPA023117: AB_1848076, HPA023553: AB_1848077" "prognostic unfavorable (5.26e-4)" "prognostic unfavorable (8.07e-4)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (6.69e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.36e-2)" "unprognostic (1.48e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-1)" 211.3 165.5 110.4 170.2 120.5 344.0 249.3 113.8 139.6 261.4 111.0 208.4 174.3 214.7 181.6 233.9 213.2 160.7 225.7 105.9 121.4 184.8 182.5 150.5 285.5 117.9 113.1 99.9 396.1 252.1 185.6 148.7 163.0 120.5 181.0 203.8 132.1 221.8 159.6 375.7 193.4 169.3 184.1 127.7 172.9 196.9 145.7 116.6 293.7 217.4 280.8 309.6 223.6 239.0 130.3 455.0 256.2 302.2 264.9 390.3 678.0 300.4 292.5 374.4 316.7 306.5 266.1 521.6 719.4 288.6 307.2 230.4 284.4 335.5 445.2 395.5 468.5 271.9 636.0 212.0 400.6 487.8 278.1 325.7 630.0 606.4 287.0 659.5 536.4 348.8 555.5 548.2 370.1 360.4 335.7 778.2 388.1 308.6 995.6 404.5 443.6 201.8 517.6 479.8 327.8 341.6 412.4 153.5 1808.1 504.9 294.8 538.3 550.5 322.5 201.8 374.5 301.5 388.8 591.3 574.4 591.3 280.2 483.4 281.8 165.2 361.6 132.2 217.9 356.8 358.9 438.1 393.5 317.9 468.6 381.4 511.0 432.1 74.4 314.6 366.1 260.9 477.7 585.7 110.4 120.5 113.8 139.6 105.9 121.4 117.9 113.1 99.9 120.5 127.7 116.6 130.3 138.9 182.7 210.7 42.4 314.6 337.5 423.7 444.2 266.9 62.7 317.2 273.4 160.8 191.6 253.0 93.8 12.5 488.0 211.4 117.0 448.0 290.5 387.2 81.2 196.0 185.8 201.0 215.8 47.8 380.5 551.0 183.7 125.9 159.2 194.4 166.2 168.8 104.6 332.4 26.9 49.9 301.6 170.9 386.6 402.8 265.0 331.5 261.5 209.9 51.5 509.9 136.0 224.6 58.3 70.3 292.9 240.5 220.1 166.7 338.5 260.2 443.9 92.9 76.8 197.2 251.5 504.1 233.0 176.0 317.4 356.5 577.2 287.5 241.4 345.5 481.2 UTP23 "C8orf53, MGC14595" ENSG00000147679 "UTP23 small subunit processome component" Q9BRU9 8 116766505-116849463 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044418 Uncertain Approved Nucleoli NA NA Nucleoli "HPA044418: AB_10961139" "prognostic unfavorable (5.18e-5)" "unprognostic (2.30e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (9.45e-3)" "unprognostic (7.73e-2)" "unprognostic (7.78e-2)" "unprognostic (1.77e-1)" "unprognostic (1.34e-2)" "unprognostic (8.62e-2)" "unprognostic (1.75e-2)" "unprognostic (5.78e-2)" "unprognostic (2.03e-1)" "unprognostic (7.15e-3)" "unprognostic (9.27e-2)" 11.9 8.0 6.1 10.2 7.0 33.5 9.7 8.5 6.7 7.9 4.8 7.2 6.2 9.7 6.6 7.2 8.2 7.9 7.2 6.2 6.5 6.8 7.5 7.9 15.5 6.2 6.9 6.2 13.9 9.8 8.2 4.9 9.6 6.6 8.1 5.7 9.7 9.1 6.4 8.6 8.1 7.8 7.5 6.6 10.4 7.8 6.9 6.0 8.3 12.4 6.2 9.0 8.0 6.0 9.5 22.0 22.7 12.9 11.3 17.9 21.3 9.8 21.9 13.3 14.1 15.6 23.8 14.2 34.4 20.5 10.5 14.1 16.1 18.2 12.8 17.4 33.5 35.3 42.5 18.3 16.2 19.1 21.2 19.7 18.6 13.8 15.7 19.1 9.2 15.4 25.9 27.7 22.6 14.1 38.3 50.2 12.4 11.8 35.9 44.1 28.1 14.2 29.7 8.9 19.8 22.7 18.3 14.2 53.8 21.5 6.5 25.8 14.6 16.4 14.7 20.3 35.7 30.9 30.8 48.9 39.7 18.8 27.4 17.4 49.7 24.6 32.6 39.5 26.6 34.2 43.1 35.2 31.2 22.1 41.6 47.7 33.2 24.6 28.1 37.0 36.1 43.6 26.4 6.1 7.0 8.5 6.7 6.2 6.5 6.2 6.9 6.2 6.6 6.6 6.0 9.5 33.6 41.7 33.1 36.2 31.0 21.9 27.0 17.4 31.9 23.2 16.7 29.2 23.4 27.1 23.4 7.3 6.2 28.3 24.8 9.9 27.4 17.3 13.9 18.0 37.0 28.7 12.0 12.4 62.6 20.7 17.9 32.9 21.9 20.6 41.8 24.3 25.0 13.8 16.6 16.8 62.2 16.6 14.2 12.6 10.5 4.8 28.9 18.5 10.6 15.9 24.0 27.4 20.6 42.3 43.0 12.4 9.4 28.6 32.0 28.7 9.0 16.2 19.2 22.4 13.1 39.5 26.4 44.0 20.3 26.6 16.2 19.8 29.5 28.8 16.6 19.1 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539101-124580648 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1327.4;tongue: 1499.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 2950.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria NA NA Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 155.1 159.5 267.8 79.2 269.9 267.5 159.4 286.3 384.4 106.9 249.7 217.0 186.3 130.6 148.7 210.9 127.1 71.1 669.1 263.4 290.8 288.4 327.7 124.0 97.3 287.4 284.4 254.8 108.0 211.2 285.4 125.0 81.9 290.1 118.8 192.9 137.0 212.7 116.1 1327.4 149.6 164.2 112.1 262.0 117.7 243.1 206.3 285.6 103.8 155.5 1499.6 105.0 141.1 125.7 287.3 348.2 316.8 236.1 321.2 240.6 204.2 196.0 165.2 189.3 297.4 222.4 417.7 327.6 341.0 421.0 193.6 153.9 385.5 347.3 266.7 279.9 395.8 464.8 831.3 199.6 505.9 320.8 261.8 218.2 239.6 382.1 271.9 587.9 160.1 275.9 241.1 523.7 277.6 243.4 1089.0 415.8 522.7 237.5 1247.0 692.7 276.3 179.9 468.0 400.0 288.8 326.6 255.0 362.4 2950.7 382.8 141.1 407.3 348.2 219.7 172.5 444.1 162.9 399.5 354.8 517.7 392.5 298.6 515.4 233.1 302.2 253.1 136.2 210.5 179.2 209.6 260.9 275.8 237.1 247.5 201.4 269.1 223.9 49.2 188.9 136.1 183.1 346.0 345.8 267.8 269.9 286.3 384.4 263.4 290.8 287.4 284.4 254.8 290.1 262.0 285.6 287.3 169.0 125.0 124.8 7.8 147.7 217.8 277.5 448.3 178.7 77.4 247.3 313.0 1005.6 260.2 267.3 286.9 98.0 494.6 119.9 525.0 800.3 338.0 389.8 120.7 100.6 164.1 233.7 227.6 10.5 405.7 296.0 187.9 169.7 109.2 139.4 149.9 167.4 517.7 380.6 37.0 14.9 421.0 488.3 206.0 137.6 865.4 158.8 183.0 247.3 15.9 226.3 144.1 171.0 7.1 18.2 378.1 450.0 152.7 169.1 290.3 584.6 789.7 208.6 91.1 170.9 221.2 511.8 317.6 264.8 377.0 188.4 523.0 155.6 216.0 521.7 315.8 TATDN1 CDA11 ENSG00000147687 "TatD DNase domain containing 1" Q6P1N9 8 124488485-124539458 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023634, HPA053045" Uncertain Supported Nucleoplasm NA NA 660000 Nucleoplasm "HPA023634: AB_1857779, HPA053045: AB_2682024" "unprognostic (2.19e-3)" "unprognostic (3.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.23e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (2.53e-4)" "unprognostic (2.50e-1)" "unprognostic (6.33e-3)" "unprognostic (3.44e-2)" "unprognostic (4.30e-2)" "unprognostic (2.24e-1)" "unprognostic (5.12e-2)" 23.6 18.8 18.3 15.9 19.2 17.0 39.5 19.1 21.0 20.2 15.6 21.4 18.2 23.8 21.2 16.5 23.7 14.7 22.9 18.1 19.1 28.4 25.4 15.0 20.0 20.2 19.3 17.4 39.9 45.2 24.6 8.9 13.7 20.9 17.4 22.7 13.8 28.0 15.1 52.6 20.6 18.2 19.9 19.0 12.3 22.9 12.5 18.9 27.3 37.2 44.3 20.1 21.2 17.5 21.5 65.5 45.1 42.5 30.2 36.8 69.9 31.9 35.5 38.1 43.3 40.0 44.7 69.1 49.7 77.4 38.6 33.6 53.7 52.0 51.9 71.6 64.0 34.3 45.6 36.5 39.1 70.2 35.5 17.0 52.5 80.5 63.5 132.4 48.3 35.3 48.4 38.1 31.4 59.1 198.4 52.8 21.6 42.7 132.8 58.8 35.4 31.7 55.7 61.3 45.5 35.7 49.2 39.2 80.3 87.2 39.3 52.7 38.1 28.4 30.8 82.7 57.3 96.7 40.0 65.3 62.1 57.9 61.4 27.1 29.3 11.0 4.3 12.8 9.1 19.1 17.2 19.5 16.2 15.6 16.6 27.7 24.8 2.1 17.7 6.6 14.0 22.5 14.8 18.3 19.2 19.1 21.0 18.1 19.1 20.2 19.3 17.4 20.9 19.0 18.9 21.5 39.8 16.0 27.1 25.5 37.0 64.7 100.9 129.4 75.7 19.3 79.5 131.4 23.9 21.5 55.6 27.6 14.6 66.6 26.7 17.8 107.6 55.2 7.0 40.1 43.0 31.9 16.2 23.8 36.6 62.0 62.5 42.7 29.6 44.4 20.8 76.5 26.7 40.2 54.6 16.8 35.2 41.6 65.1 36.7 43.6 6.7 49.7 36.3 48.0 30.0 51.6 24.8 37.0 20.1 48.6 40.8 34.3 34.6 34.1 94.2 57.8 128.9 33.8 19.2 19.7 64.7 57.5 34.6 45.1 54.0 58.2 59.7 38.9 68.6 60.7 82.6 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "esophagus: 112.2;vagina: 56.3" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 71.2;Club cells: 58.2;Pancreatic endocrine cells: 28.7;Squamous epithelial cells: 19.3;Suprabasal keratinocytes: 15.2;Urothelial cells: 25.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 83.5;HBEC3-KT: 126.3;hTCEpi: 66.4;K-562: 206.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA052615 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052615: AB_2797244" "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.1 0.6 0.0 0.1 0.0 0.2 0.3 0.2 0.1 9.1 0.1 0.1 1.0 0.0 1.3 112.2 4.4 1.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.7 0.0 0.1 7.6 6.4 0.1 7.1 2.4 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.4 0.0 7.4 3.8 56.3 0.1 83.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.6 0.7 10.6 0.0 0.0 25.9 0.0 126.3 0.0 0.0 0.1 0.8 9.2 0.0 0.0 0.1 0.1 0.0 66.4 0.0 16.8 0.0 0.0 0.1 206.3 0.1 0.0 0.3 0.0 0.1 0.0 4.2 0.1 0.0 0.0 0.1 0.0 18.4 0.1 0.0 14.4 9.7 0.1 0.2 1.5 0.2 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 4.0 71.2 1.2 0.0 4.4 0.9 1.1 0.0 58.2 1.8 0.0 0.1 0.0 1.0 0.0 0.3 1.0 0.0 0.1 0.1 0.0 0.0 0.6 0.7 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 10.2 0.0 0.4 1.6 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 28.7 0.2 0.0 0.1 0.7 1.1 0.1 9.6 0.0 0.0 0.1 1.4 2.2 0.6 19.3 15.2 0.0 0.1 0.0 0.8 25.0 GSDMC MLZE ENSG00000147697 "Gasdermin C" Q9BYG8 8 129748196-129786624 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 33.4;lymphoid tissue: 12.9;skin 1: 24.8;vagina: 11.5" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 46.5;Basal squamous epithelial cells: 37.5;Squamous epithelial cells: 29.5;Suprabasal keratinocytes: 53.1" "Cancer enhanced" "Detected in many" "cervical cancer: 11.8;head and neck cancer: 19.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.2;HaCaT: 3.7;hTCEpi: 1.8;HUVEC TERT2: 2.0;TIME: 5.8" "Low region specificity" "Detected in many" "HPA023670, HPA024767, HPA026317" Supported Approved Mitochondria NA NA Mitochondria "HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008" "unprognostic (6.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.61e-3)" "unprognostic (4.23e-2)" "unprognostic (2.11e-2)" "unprognostic (4.22e-3)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (8.28e-2)" "unprognostic (7.51e-2)" "unprognostic (4.92e-3)" "unprognostic (5.71e-2)" "unprognostic (2.93e-3)" "unprognostic (1.87e-2)" "unprognostic (1.88e-1)" "unprognostic (8.66e-2)" "unprognostic (1.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 33.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 5.5 0.0 0.0 24.8 0.0 0.0 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 4.0 2.4 11.5 0.1 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.0 1.0 0.0 46.5 0.9 7.4 37.5 0.0 1.5 0.9 3.6 0.0 9.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.1 0.0 3.9 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 0.5 0.0 0.1 29.5 53.1 0.0 0.1 0.0 0.0 2.8 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138497261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;retina: 9.2;testis: 3.8" "Cell type enhanced" "Detected in some" "Astrocytes: 64.3;Early spermatids: 157.1;Excitatory neurons: 229.3;Inhibitory neurons: 267.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RH-30: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.0 2.6 4.8 0.1 4.5 0.0 0.0 5.8 10.8 0.0 0.0 0.8 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.7 2.4 0.3 0.0 0.0 0.0 4.4 3.2 3.4 0.0 0.4 0.0 1.3 0.0 5.2 0.2 0.6 9.2 0.0 0.2 0.0 0.0 0.3 0.0 0.8 0.0 0.6 3.8 4.1 0.1 0.0 0.3 0.0 0.4 0.1 7.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.5 5.8 10.8 6.7 2.4 4.4 3.2 3.4 5.2 0.8 4.1 7.3 0.0 0.0 0.0 64.3 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 1.4 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.1 1.8 0.0 229.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 267.0 0.0 0.0 0.0 0.4 32.7 1.5 0.1 0.0 8.4 0.0 2.9 0.0 34.2 17.5 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.3 0.1 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF7 "HF.16, KOX4" ENSG00000147789 "Zinc finger protein 7" P17097 8 144827464-144847509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059090 Approved Approved Mitochondria NA NA Mitochondria "HPA059090: AB_2683901" "unprognostic (1.11e-1)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-2)" "unprognostic (2.52e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-3)" "unprognostic (3.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.46e-8)" "unprognostic (1.15e-1)" "unprognostic (5.00e-1)" "unprognostic (5.43e-2)" "unprognostic (6.53e-2)" 16.8 14.2 11.0 10.8 11.7 14.6 18.5 18.2 12.9 20.2 11.2 17.2 10.4 18.1 15.4 14.9 17.6 10.6 13.5 11.1 10.3 14.9 15.7 14.7 15.1 12.1 11.5 11.4 19.6 17.6 15.4 16.9 14.4 13.9 20.7 12.9 14.0 16.6 13.8 26.9 21.2 17.3 12.8 10.1 21.9 15.4 17.1 11.5 16.1 19.4 17.6 15.8 18.5 17.3 14.0 16.7 22.2 21.4 21.1 17.9 27.2 19.6 17.4 22.0 23.1 19.7 11.4 20.9 23.1 19.9 19.0 12.6 14.2 19.5 25.4 25.1 15.4 16.2 41.3 30.6 13.3 20.7 12.1 18.5 26.1 30.3 18.1 44.2 22.4 14.5 19.2 41.9 16.1 26.0 27.3 33.0 13.1 21.8 22.0 26.6 22.6 19.0 18.4 16.1 22.6 21.0 25.6 38.1 21.6 21.3 20.4 26.1 19.1 16.4 17.3 30.9 13.2 16.9 13.0 9.9 25.0 18.0 15.4 21.7 34.3 10.7 10.9 13.5 10.0 16.9 18.1 15.4 12.0 12.2 17.4 20.1 13.8 10.4 16.6 19.2 9.6 16.3 9.2 11.0 11.7 18.2 12.9 11.1 10.3 12.1 11.5 11.4 13.9 10.1 11.5 14.0 11.9 19.2 11.6 6.2 16.4 7.0 18.2 12.7 8.6 34.2 9.1 8.0 11.4 7.2 11.3 3.7 29.2 17.3 16.6 6.6 5.9 14.1 18.4 6.3 10.4 10.6 9.6 15.6 11.3 11.2 12.9 14.7 10.2 7.7 3.8 16.7 15.0 8.2 9.1 28.6 10.7 9.1 6.1 9.0 11.1 4.9 17.7 10.2 8.8 3.7 12.9 20.0 22.6 10.6 11.4 13.7 5.6 15.8 7.8 18.6 12.4 7.1 9.2 30.1 6.6 19.3 10.4 44.1 26.7 9.1 9.2 19.4 16.9 19.8 10.2 13.8 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.0" "Cell type enhanced" "Detected in many" "Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.6 3.9 5.5 0.8 4.9 0.0 3.5 2.6 9.5 4.4 0.6 4.3 1.7 2.8 0.8 5.1 8.3 0.7 1.7 8.2 1.4 4.5 1.6 2.7 0.3 7.9 3.1 3.1 2.7 5.2 1.3 10.0 0.7 4.3 4.2 0.7 3.2 3.5 1.4 0.7 5.1 2.7 0.5 5.7 1.3 2.1 22.0 4.4 0.7 7.6 0.1 0.1 1.9 3.1 9.6 8.3 8.1 3.8 5.8 0.7 0.6 7.2 2.1 0.7 2.6 1.6 5.2 4.8 0.8 5.4 0.8 2.7 7.0 1.8 2.0 0.5 0.0 7.2 0.1 5.8 3.4 1.3 0.0 0.8 0.5 3.2 3.3 1.4 1.3 0.8 0.4 7.7 0.0 1.1 13.4 4.6 0.0 4.0 3.4 11.4 4.3 3.0 3.2 2.1 4.1 10.9 7.7 6.2 2.1 3.8 1.4 9.0 1.2 2.0 1.9 0.1 6.6 4.5 0.0 0.1 0.3 3.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 4.9 2.6 9.5 8.2 1.4 7.9 3.1 3.1 4.3 5.7 4.4 9.6 0.8 3.2 2.3 34.3 0.6 3.7 0.6 1.9 2.2 7.2 5.0 3.3 1.6 0.0 2.8 3.7 20.9 0.6 0.1 7.5 0.0 2.4 3.9 31.4 2.8 1.1 0.0 0.0 41.7 2.5 0.9 1.2 1.1 6.0 0.0 6.0 0.7 1.4 0.5 3.3 33.1 4.2 4.1 0.0 0.4 3.1 2.1 0.2 5.4 1.0 0.0 3.6 0.0 15.6 30.8 1.4 7.9 8.2 0.0 1.0 3.3 1.5 27.6 24.5 6.6 2.5 2.1 8.5 11.2 2.1 3.0 0.5 0.3 3.1 5.2 0.7 SLC39A4 "AEZ, AWMS2, ZIP4" ENSG00000147804 "Solute carrier family 39 member 4" Q6P5W5 8 144409742-144416844 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 88.9" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 406.4;Proximal tubular cells: 230.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CAPAN-2: 36.4;Hep G2: 97.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.59e-1)" "unprognostic (2.35e-3)" "unprognostic (9.16e-2)" "unprognostic (3.84e-2)" "unprognostic (5.63e-3)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "prognostic favorable (9.04e-4)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (9.04e-3)" "unprognostic (1.87e-1)" 0.1 0.2 0.1 1.4 0.3 0.5 0.3 0.0 0.7 0.5 0.0 18.4 88.9 0.4 0.1 0.2 0.9 0.5 0.0 0.3 0.0 18.0 1.3 3.2 0.1 0.2 0.0 0.0 3.4 1.4 0.0 0.2 1.0 0.5 1.3 0.5 0.0 1.2 0.3 0.0 0.4 75.5 0.1 0.0 0.7 3.0 1.3 0.0 0.0 4.0 0.0 0.0 0.6 0.6 0.7 2.3 0.2 0.0 0.1 0.0 0.0 2.5 0.1 0.0 0.0 0.0 2.1 36.4 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.8 1.6 0.6 97.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 2.2 0.0 1.7 0.0 0.4 0.1 0.5 0.1 0.4 0.0 1.1 0.0 0.4 0.9 1.9 0.2 0.4 0.1 0.4 1.7 0.1 0.0 0.1 0.2 0.0 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.7 12.4 19.2 24.8 0.3 21.3 18.7 36.6 46.9 38.7 0.2 45.0 50.3 7.4 20.0 24.1 42.3 0.0 17.0 15.4 112.8 50.9 40.0 1.4 41.8 12.9 10.9 42.6 26.3 1.0 42.9 69.7 16.8 29.6 51.9 37.4 8.5 8.9 27.4 32.1 3.3 0.2 95.0 30.5 18.2 21.0 2.0 8.1 23.5 21.4 0.0 25.9 11.3 23.7 0.0 0.1 75.6 135.0 6.4 31.9 60.8 406.4 230.3 26.9 1.0 6.6 7.5 11.1 2.9 33.1 46.4 30.0 11.2 15.4 23.2 98.2 46.3 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 61.9;liver: 63.6" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 597.2;Proximal tubular cells: 203.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 49.8;RPMI-8226: 73.4;SK-BR-3: 84.1" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 2300000 "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 15.5 13.7 2.9 6.4 3.3 22.0 14.7 2.7 8.8 13.2 3.3 16.6 61.9 9.7 1.7 37.4 10.7 5.9 9.5 3.4 3.9 15.7 63.6 14.0 6.6 4.2 3.0 3.3 9.6 12.5 5.0 6.0 5.5 2.8 11.4 3.9 0.2 29.5 10.6 10.2 28.0 47.7 3.0 3.0 19.6 22.7 10.6 3.6 4.2 9.8 4.7 5.3 13.3 18.3 3.2 14.8 7.2 0.6 1.4 3.2 2.0 4.0 0.7 7.5 4.5 1.7 5.6 34.3 1.8 7.8 0.5 0.0 25.6 1.8 34.6 0.4 4.3 12.1 16.7 25.5 1.9 42.5 2.1 14.8 3.2 16.6 0.3 0.0 0.1 18.1 32.9 21.5 8.8 0.1 11.1 6.7 8.0 5.6 49.8 4.2 13.8 0.3 73.4 16.0 2.0 7.4 0.9 9.1 84.1 30.7 0.6 2.1 20.3 3.8 0.9 10.1 8.0 2.9 0.8 0.8 3.1 1.8 41.8 16.1 6.9 11.4 14.1 2.9 12.7 1.9 2.0 4.4 1.9 6.7 1.3 1.3 2.4 10.6 0.8 23.0 6.9 1.9 5.8 2.9 3.3 2.7 8.8 3.4 3.9 4.2 3.0 3.3 2.8 3.0 3.6 3.2 50.6 35.3 23.1 7.5 16.2 0.0 64.9 0.0 24.5 12.1 18.3 14.7 10.0 54.3 9.3 75.4 18.8 48.8 21.8 88.0 68.4 62.7 44.2 18.5 26.0 32.7 10.9 63.8 3.8 54.3 74.8 20.6 100.9 26.8 7.6 21.7 49.6 117.4 80.6 16.8 3.2 70.4 0.0 89.7 0.0 59.8 32.0 55.0 0.0 7.5 108.9 23.7 28.8 1.5 2.8 111.7 124.6 21.8 12.7 44.2 597.2 203.7 1.5 13.4 13.1 15.8 16.5 41.7 16.0 35.9 0.0 56.2 17.2 29.7 100.9 73.9 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621182-2660056 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 78.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 78.1;Cone photoreceptor cells: 104.3;Oligodendrocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "eosinophil: 6.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 22.3;JURKAT: 20.5;THP-1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Uncertain "Vesicles,Cytokinetic bridge,Centriolar satellite" Yes NA 330000 Vesicles "Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 12.1 16.4 2.3 2.2 5.1 0.8 8.5 5.5 5.3 9.5 4.8 5.4 0.5 9.7 3.2 19.3 13.9 2.9 40.7 2.8 4.9 9.1 3.2 10.8 0.7 6.6 5.4 2.7 78.2 27.7 19.6 6.5 5.9 6.4 6.6 2.0 12.4 11.7 2.0 26.4 4.7 1.9 6.9 4.1 5.6 9.1 6.0 4.5 0.8 11.7 11.8 1.7 12.7 10.5 9.5 0.1 0.8 14.3 0.4 1.5 0.5 22.3 7.0 2.2 1.7 4.3 3.6 0.3 0.0 6.4 2.8 0.6 0.3 3.4 5.6 4.5 9.7 2.4 0.1 1.6 1.8 1.9 9.2 1.7 1.5 3.3 0.7 0.1 7.6 0.7 20.5 0.0 17.4 1.1 0.9 1.1 1.1 9.9 1.5 0.9 0.1 0.4 0.0 6.4 0.4 2.5 2.4 0.6 0.6 10.4 7.5 0.3 33.3 0.3 2.8 4.5 0.1 3.3 14.1 6.1 2.6 14.7 8.2 0.6 0.0 0.0 6.3 0.2 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 2.3 5.1 5.5 5.3 2.8 4.9 6.6 5.4 2.7 6.4 4.1 4.5 9.5 4.2 16.0 8.8 1.0 0.1 2.7 1.2 18.7 4.6 23.8 4.3 3.9 78.1 1.5 9.7 5.5 104.3 13.2 1.6 9.8 1.9 11.3 5.7 8.6 6.1 3.6 10.9 0.0 8.3 10.3 29.0 17.2 3.1 19.3 0.0 5.7 2.2 2.8 2.3 11.8 10.9 1.4 24.4 1.0 1.1 2.8 7.8 0.6 10.6 2.8 1.0 3.9 0.0 8.0 39.1 8.6 4.3 10.9 0.5 5.1 0.0 8.0 11.9 32.5 0.0 2.7 9.4 8.2 6.4 5.0 2.0 3.4 1.7 15.9 1.3 6.0 AK3 "AK3L1, AK6, AKL3L1" ENSG00000147853 "Adenylate kinase 3" Q9UIJ7 9 4709556-4742043 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 245.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 485.4;HEL: 273.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063324 Enhanced Supported Mitochondria NA NA 31000 Mitochondria "HPA063324: AB_2684985" "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-3)" "unprognostic (6.44e-2)" "unprognostic (2.81e-2)" "unprognostic (9.81e-3)" "unprognostic (1.90e-1)" "unprognostic (2.76e-2)" "prognostic favorable (6.07e-9)" "unprognostic (1.24e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.55e-3)" 76.2 63.5 31.0 23.9 36.7 20.3 40.1 35.5 35.2 38.3 51.6 68.0 68.9 42.3 31.5 61.7 34.7 36.2 101.5 28.1 46.2 102.3 201.5 35.2 29.9 36.5 36.5 23.7 48.2 39.3 67.4 22.3 35.4 35.6 49.7 60.1 16.9 39.0 43.0 245.1 47.8 63.1 42.0 34.6 33.3 70.2 11.3 39.2 35.4 50.4 161.0 34.7 49.1 40.0 37.8 44.1 30.7 55.5 22.6 75.3 55.5 4.9 60.4 116.1 30.4 45.5 5.7 43.6 39.5 20.4 63.5 16.6 29.3 40.8 48.0 51.2 485.4 37.1 273.3 56.1 91.3 58.5 28.7 14.1 87.9 41.4 26.4 36.0 70.4 91.2 38.2 22.1 49.6 91.8 22.5 27.5 65.6 53.3 77.1 15.4 38.2 21.1 19.2 82.1 55.7 98.3 63.6 65.7 18.5 35.1 53.7 26.5 53.2 65.9 25.7 28.8 70.1 43.6 15.5 10.5 50.3 46.9 19.9 18.9 13.3 10.2 32.2 27.6 8.1 25.5 12.1 21.6 25.7 19.6 12.3 28.4 29.2 2.8 27.4 6.5 26.3 31.8 21.1 31.0 36.7 35.5 35.2 28.1 46.2 36.5 36.5 23.7 35.6 34.6 39.2 37.8 58.3 57.7 80.3 78.0 34.0 74.2 76.4 87.4 84.2 10.7 58.8 28.3 182.9 68.6 71.0 66.2 22.9 95.5 34.6 129.9 258.2 84.8 3.7 40.7 30.6 65.7 109.6 68.1 23.4 69.6 17.0 83.4 87.1 37.8 46.2 75.8 79.2 305.6 47.5 15.2 55.8 104.2 73.2 46.9 41.4 4.5 108.7 34.7 74.7 22.5 40.9 28.2 33.0 44.7 87.0 67.3 78.7 149.7 62.8 166.7 111.8 183.5 52.8 11.0 105.2 76.0 60.8 6.4 14.1 152.5 104.4 214.0 36.4 68.5 145.5 151.6 UHRF2 "MGC33463, NIRF, RNF107, TDRD23, URF2" ENSG00000147854 "Ubiquitin like with PHD and ring finger domains 2" Q96PU4 9 6413151-6507054 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026633, HPA026697" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA026633: AB_2732431, HPA026697: AB_2732432" "unprognostic (1.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (8.40e-2)" "unprognostic (4.35e-3)" "unprognostic (4.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "unprognostic (5.69e-3)" "unprognostic (2.14e-2)" "unprognostic (6.21e-2)" "unprognostic (8.77e-2)" "unprognostic (7.42e-2)" "unprognostic (1.50e-1)" 10.0 8.1 7.6 10.0 10.3 45.0 9.8 14.8 9.8 13.0 10.9 10.3 6.2 13.0 10.1 8.3 9.9 8.0 7.0 8.4 10.4 8.2 7.9 7.8 17.5 9.7 9.0 8.8 12.5 10.8 9.8 5.5 12.2 10.4 15.4 9.3 9.3 8.5 12.7 11.1 7.7 8.5 14.1 7.8 10.5 8.4 8.5 10.0 21.4 8.1 12.0 16.7 11.5 10.2 14.3 18.1 18.8 26.7 11.9 21.4 30.7 20.5 43.9 23.4 23.7 41.2 12.4 12.0 26.9 9.2 19.2 21.8 11.9 24.6 22.5 36.0 53.6 14.9 46.3 36.2 19.7 17.8 19.3 16.1 13.5 14.1 18.4 44.5 44.4 93.2 25.4 5.1 24.0 56.0 5.9 37.0 79.2 10.8 24.8 14.8 43.1 12.4 8.7 17.2 11.3 24.8 9.4 16.6 11.0 25.6 32.1 14.0 41.9 78.6 25.2 10.0 11.0 34.4 7.2 23.2 30.4 12.4 18.2 10.2 4.0 0.5 2.7 1.2 0.5 0.8 1.8 1.8 1.0 0.3 2.9 1.0 1.2 0.5 0.6 0.9 1.2 1.9 0.6 7.6 10.3 14.8 9.8 8.4 10.4 9.7 9.0 8.8 10.4 7.8 10.0 14.3 27.5 6.4 14.4 24.2 33.9 21.5 10.2 6.2 12.0 22.0 13.8 13.1 59.0 4.3 8.4 12.9 31.3 13.2 31.3 9.1 1.9 5.2 23.6 12.8 22.9 24.1 7.1 34.9 44.2 4.0 9.9 16.0 20.9 24.5 17.7 27.8 12.8 14.6 10.7 28.6 53.3 14.8 4.1 12.6 9.3 8.1 19.3 15.6 21.4 51.5 12.5 6.4 16.5 46.8 78.6 6.2 14.4 14.7 30.1 16.0 10.2 7.3 6.3 34.8 13.1 14.4 18.8 46.2 23.4 16.1 19.0 5.9 29.0 13.7 12.6 9.8 NFIB "NFI-RED, NFIB2, NFIB3" ENSG00000147862 "Nuclear factor I B" O00712 9 14081843-14398983 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 542.6;Oligodendrocyte precursor cells: 565.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 160.3;HBEC3-KT: 65.9;HEL: 61.3;HUVEC TERT2: 64.8;TIME: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003956 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA003956: AB_1854424" "unprognostic (1.93e-1)" "unprognostic (3.18e-2)" "unprognostic (4.00e-1)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (2.55e-2)" "unprognostic (1.32e-1)" "unprognostic (4.72e-3)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (3.68e-1)" "unprognostic (1.12e-1)" "prognostic favorable (3.53e-4)" "unprognostic (4.69e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-2)" "unprognostic (1.62e-1)" 28.5 8.9 24.4 7.2 21.3 0.2 37.2 35.2 26.7 11.7 7.8 14.6 10.2 13.1 15.2 9.9 17.6 16.1 25.0 24.9 19.0 16.9 20.5 16.0 7.8 17.7 13.9 17.8 14.2 15.7 5.0 4.9 13.1 18.1 20.4 8.8 10.1 40.0 17.0 21.7 22.1 13.2 15.8 18.7 9.8 14.3 2.4 14.0 7.1 17.6 19.1 5.6 17.9 13.4 17.0 19.7 14.7 8.6 160.3 39.8 22.9 0.5 0.5 0.0 3.7 13.7 0.2 7.9 0.5 12.1 1.2 12.0 4.3 7.8 65.9 7.3 2.8 7.4 61.3 31.6 1.8 13.2 1.8 0.3 20.3 9.0 14.2 49.5 15.4 64.8 0.0 1.8 0.5 5.3 9.0 0.1 0.4 3.0 8.8 15.9 0.2 7.5 0.2 11.9 7.4 13.5 49.9 13.5 16.9 5.7 0.5 34.0 0.1 64.6 12.1 18.1 9.7 12.2 1.6 1.4 4.8 11.2 0.3 15.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 24.4 21.3 35.2 26.7 24.9 19.0 17.7 13.9 17.8 18.1 18.7 14.0 17.0 328.7 51.3 31.4 542.6 4.6 268.9 165.7 63.0 115.5 60.8 238.6 317.4 195.6 214.4 59.1 46.0 0.0 5.1 2.1 42.1 39.2 70.7 3.6 147.8 39.0 230.9 22.8 2.7 278.5 125.2 1.2 190.9 62.2 135.9 3.8 5.7 228.5 104.0 2.2 0.0 352.9 35.4 28.5 8.4 48.9 5.0 133.9 7.3 94.3 157.4 1.7 238.0 0.0 565.5 206.0 68.1 48.7 48.5 4.1 166.2 101.9 190.7 55.6 11.5 85.5 270.5 160.8 0.9 9.7 78.6 169.2 1.6 7.1 6.5 74.2 64.3 CER1 DAND4 ENSG00000147869 "Cerberus 1, DAN family BMP antagonist" O95813 9 14719724-14722733 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "epididymis: 1.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 82 "testis cancer: 17.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 4.0;NTERA-2: 7.0;SCLC-21H: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA019917 Uncertain "Secreted - unknown location" NA NA "HPA019917: AB_1846539" "unprognostic (2.98e-2)" "unprognostic (5.36e-2)" "unprognostic (5.99e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 PLIN2 "ADFP, ADRP" ENSG00000147872 "Perilipin 2" Q99541 9 19108375-19149290 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 619.5;liver: 912.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 743.3;Hepatocytes: 527.0;Syncytiotrophoblasts: 1815.2" "Group enriched" "Detected in all" 5 "liver cancer: 63.0;renal cancer: 136.9" "Region enriched" "Detected in all" 7 "hypothalamus: 289.4" "Group enriched" "Detected in all" 4 "basophil: 776.5;eosinophil: 581.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 776.5" "Group enriched" "Detected in many" 5 "ASC diff: 2345.1;HHSteC: 2025.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016607, CAB037331" Supported Supported "Lipid droplets" NA NA "Lipid droplets" "CAB037331: , HPA016607: AB_2669403" "unprognostic (2.02e-1)" "unprognostic (4.30e-2)" "unprognostic (3.47e-1)" "unprognostic (2.55e-2)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (3.02e-2)" "unprognostic (3.28e-3)" "unprognostic (4.92e-2)" "unprognostic (4.66e-2)" "unprognostic (1.40e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.14e-3)" "unprognostic (7.89e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.77e-1)" 619.5 128.5 15.4 45.2 17.1 120.3 464.0 15.4 41.3 77.1 17.4 50.2 187.8 56.6 13.7 20.7 60.5 71.9 180.0 15.2 289.4 171.0 912.8 127.3 38.7 18.2 15.8 12.7 44.6 29.8 18.9 34.7 157.2 19.2 30.8 23.4 13.2 47.7 28.2 439.1 101.9 165.7 35.8 17.8 44.3 44.6 24.5 43.4 34.1 32.7 128.5 32.7 108.5 62.4 27.8 0.5 35.0 39.3 28.9 2345.1 318.3 434.8 113.5 87.6 67.7 76.5 54.1 8.3 0.4 2.0 232.9 432.1 4.7 39.1 0.3 115.1 146.9 0.8 191.8 5.4 205.2 2025.0 23.3 336.2 338.2 39.7 165.7 0.4 54.4 84.8 0.1 35.3 40.6 266.2 10.0 53.5 79.4 52.6 1.1 69.5 127.0 18.4 1.3 0.2 133.2 3.0 64.7 52.8 13.2 113.6 49.6 27.0 50.8 134.1 0.1 20.6 105.6 0.5 24.4 26.7 76.2 0.6 39.0 10.9 776.5 111.0 581.9 80.7 149.5 69.9 23.6 69.8 57.9 63.8 25.8 67.3 57.6 6.7 17.2 169.0 7.9 74.7 106.5 15.4 17.1 15.4 41.3 15.2 289.4 18.2 15.8 12.7 19.2 17.8 43.4 27.8 280.4 19.2 51.4 7.5 43.9 206.2 507.2 69.5 42.1 2.4 213.3 24.1 62.3 91.5 62.1 12.9 0.0 173.6 77.5 43.3 27.4 105.6 3.6 83.5 188.1 91.2 14.9 78.5 0.6 16.0 743.3 182.0 24.5 232.5 422.1 8.1 94.9 527.0 410.7 11.8 0.8 26.1 26.4 214.1 81.1 12.3 39.7 277.1 87.2 10.3 50.2 44.4 30.9 3.5 2.6 37.4 45.7 69.2 45.3 109.0 382.5 267.9 16.9 4.8 13.1 36.1 68.8 8.0 25.9 12.3 108.5 1815.2 123.3 21.4 44.3 263.3 IFNA5 IFN-alphaG ENSG00000147873 "Interferon alpha 5" P01569 9 21304326-21305312 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAUS6 "dgt6, FAM29A, FLJ20060, KIAA1574" ENSG00000147874 "HAUS augmin like complex subunit 6" Q7Z4H7 9 19053141-19102904 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 124.9;Spermatocytes: 68.9;Spermatogonia: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 215.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020960, HPA020965" Approved Approved "Nuclear speckles,Centriolar satellite,Cytosol" No No "Centriolar satellite, Cytosol" "Nuclear speckles" "HPA020960: AB_1848393, HPA020965: AB_1848394" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (6.04e-3)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.21e-1)" "unprognostic (2.15e-1)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.52e-1)" "unprognostic (1.68e-1)" "unprognostic (3.13e-2)" "unprognostic (2.03e-1)" 5.1 6.6 5.8 8.0 7.6 17.2 9.3 9.5 7.5 5.4 4.7 5.9 4.1 7.1 6.3 5.2 4.8 5.1 5.3 5.6 6.5 4.1 7.0 4.8 11.5 6.8 6.8 5.2 8.3 3.9 6.2 3.0 6.9 7.0 5.7 6.2 9.1 4.5 5.6 4.5 8.2 5.3 7.2 7.0 7.0 4.4 24.2 6.3 15.3 5.3 7.3 10.8 6.2 4.3 9.9 34.7 23.7 46.4 36.3 17.4 20.9 25.1 36.5 25.5 32.7 49.9 12.2 15.4 40.5 13.1 21.1 25.0 14.2 43.3 21.3 50.4 36.8 20.9 215.8 42.1 27.8 11.6 29.0 46.7 13.0 21.5 30.9 66.9 16.9 24.0 40.4 29.8 25.7 37.8 11.3 56.6 49.1 49.9 19.4 23.2 43.3 31.8 16.4 18.0 19.8 27.1 37.3 16.4 15.0 23.6 29.5 11.6 36.1 24.1 29.3 17.7 25.5 42.2 10.2 24.0 39.7 27.3 24.0 13.0 9.8 1.5 1.6 2.8 1.5 3.9 2.3 2.8 3.6 1.5 2.3 3.3 2.9 2.3 5.0 1.4 1.8 3.7 1.7 5.8 7.6 9.5 7.5 5.6 6.5 6.8 6.8 5.2 7.0 7.0 6.3 9.9 15.9 19.2 12.5 7.8 14.3 9.7 12.6 8.7 9.1 11.8 9.4 9.3 8.4 5.7 7.2 9.2 10.4 10.5 21.9 5.6 0.0 9.8 124.9 11.8 14.4 11.6 2.4 34.1 10.3 6.1 15.3 9.5 5.6 15.3 11.4 23.8 3.9 6.8 8.2 11.8 10.2 4.6 2.0 5.8 7.7 28.2 11.8 14.5 8.8 10.3 8.2 13.5 12.3 7.1 16.8 9.0 3.4 8.2 17.3 14.6 4.5 3.2 3.6 9.7 6.6 16.2 10.1 68.9 56.0 9.1 8.1 4.9 18.2 11.0 9.4 9.4 CDKN2B "CDK4I, INK4B, MTS2, P15, p15INK4b, TP15" ENSG00000147883 "Cyclin dependent kinase inhibitor 2B" P42772 9 22002903-22009305 "Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.5;intestine: 31.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 240.7;Pancreatic endocrine cells: 164.5;Proximal enterocytes: 139.0;Squamous epithelial cells: 142.0;Urothelial cells: 241.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 3.3;intermediate monocyte: 3.3;non-classical monocyte: 9.0" "Lineage enriched" "Detected in single" 17 "monocytes: 9.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.1;HaCaT: 35.0;HeLa: 33.9;hTERT-RPE1: 60.1;SiHa: 48.0;SK-MEL-30: 35.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000349, HPA052838, HPA063327" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB000349: , HPA052838: , HPA063327: AB_2684987" "unprognostic (2.30e-1)" "unprognostic (9.23e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.47e-6)" "unprognostic (2.10e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.01e-1)" "unprognostic (3.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (9.14e-3)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.28e-2)" 18.9 1.9 1.8 2.9 1.8 0.4 8.7 1.2 1.9 5.5 7.7 22.6 21.9 3.8 0.6 36.5 1.7 2.4 0.9 1.6 4.2 0.6 1.2 12.7 1.1 2.7 1.5 1.3 0.9 1.2 3.4 3.5 2.3 2.6 3.6 19.9 2.8 6.8 4.8 7.3 12.6 31.1 2.1 1.8 4.6 6.1 5.4 2.0 0.8 1.1 1.1 8.1 8.0 20.4 2.1 0.0 0.0 0.3 2.1 28.2 38.1 0.7 1.8 0.0 4.6 12.6 3.6 10.3 0.0 3.4 2.3 0.0 35.0 0.8 6.9 5.5 2.6 9.7 0.0 33.9 1.5 14.4 1.1 6.1 8.1 0.0 6.5 25.8 60.1 4.4 0.0 0.0 17.1 7.3 2.8 0.0 0.1 1.7 1.7 19.5 0.0 2.4 0.7 10.0 0.0 5.4 0.1 48.0 11.5 35.7 25.8 3.0 0.0 14.8 0.0 0.7 0.1 0.0 13.5 8.4 0.1 0.0 1.0 0.0 0.0 3.3 0.0 0.1 3.3 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 0.0 0.0 9.0 0.0 0.0 1.0 1.8 1.8 1.2 1.9 1.6 4.2 2.7 1.5 1.3 2.6 1.8 2.0 2.1 3.5 67.3 6.7 0.3 2.9 5.4 27.0 40.5 5.7 3.2 6.4 9.8 3.1 1.5 37.5 5.5 0.0 1.2 3.2 240.7 0.0 57.7 11.3 31.8 7.5 4.1 7.7 0.0 0.1 38.2 0.8 11.5 30.5 37.2 0.0 0.4 1.8 0.1 1.2 0.0 0.5 31.6 14.2 17.6 3.8 2.7 0.6 5.6 3.6 2.8 3.2 4.8 0.0 1.0 0.5 164.5 75.6 1.2 2.1 65.3 139.0 0.1 17.9 7.2 0.0 2.7 8.9 13.8 3.5 142.0 24.2 3.1 2.9 1.2 23.3 241.6 IFNA16 IFN-alphaO ENSG00000147885 "Interferon alpha 16" P05015 9 21216373-21217311 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDKN2A "ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf" ENSG00000147889 "Cyclin dependent kinase inhibitor 2A" "P42771, Q8N726" 9 21967752-21995301 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 26.5;pituitary gland: 34.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9" "Cancer enhanced" "Detected in all" "cervical cancer: 49.9;ovarian cancer: 57.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 37.4" "Group enriched" "Detected in many" 6 "B-cells: 15.6;T-cells: 37.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7" "Low region specificity" "Detected in some" "CAB000093, CAB000445, CAB018232, HPA047838" Enhanced Supported Nucleoli NA NA 18000 Nucleoli "CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174" "unprognostic (3.41e-2)" "unprognostic (4.51e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (1.82e-7)" "unprognostic (5.22e-2)" "prognostic favorable (5.19e-4)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.41e-2)" "unprognostic (1.22e-2)" "unprognostic (3.05e-2)" "unprognostic (3.55e-1)" 3.7 10.2 7.1 1.7 7.4 1.3 3.1 5.5 8.0 1.0 26.5 1.7 0.8 0.7 1.0 7.4 2.3 0.5 0.6 6.3 7.3 0.4 0.8 2.3 2.2 7.3 5.7 5.8 0.8 1.5 2.1 34.0 2.6 7.9 2.1 0.7 0.1 1.6 1.6 0.6 0.9 3.6 0.3 5.9 5.5 3.9 14.9 6.0 2.1 1.3 0.0 2.6 2.4 2.4 8.3 11.8 0.0 1.7 82.2 0.8 0.9 39.1 15.9 0.0 111.7 196.0 19.1 289.2 47.1 167.7 9.5 0.0 36.0 34.3 211.0 91.4 212.2 389.7 0.1 311.1 13.6 8.8 22.4 17.3 21.2 0.0 112.2 61.9 236.3 11.7 0.0 0.1 188.4 105.7 0.8 1.9 0.0 2.6 24.2 185.9 0.2 80.2 166.3 23.4 0.0 195.2 14.0 219.9 36.6 318.7 9.4 42.8 0.7 39.5 0.9 2.6 0.3 0.5 84.7 49.6 177.8 0.2 62.9 1.0 1.5 2.1 0.3 9.9 1.3 14.1 11.1 11.4 17.6 0.3 15.6 0.6 6.7 0.5 0.8 4.2 0.0 37.4 3.6 7.1 7.4 5.5 8.0 6.3 7.3 7.3 5.7 5.8 7.9 5.9 6.0 8.3 1.6 0.0 0.0 1.0 11.5 1.8 2.3 170.1 0.0 0.6 6.1 10.4 4.2 0.0 145.9 11.0 0.0 27.9 6.2 8.1 0.0 29.7 227.5 36.4 6.7 2.6 70.9 0.0 1.2 26.4 43.8 7.7 0.0 6.2 4.5 4.6 1.4 0.3 7.6 0.0 3.5 6.3 122.1 10.5 4.2 447.9 3.1 2.9 8.8 7.5 16.2 0.9 5.2 4.5 6.6 417.7 12.1 1.9 38.7 35.4 32.8 0.0 221.9 0.1 0.0 1.1 20.8 7.2 6.2 7.2 0.4 9.2 12.7 11.0 3.8 54.4 C9orf72 "DENND9, DENNL72, MGC23980" ENSG00000147894 "C9orf72-SMCR8 complex subunit" Q96LT7 9 27535640-27573866 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 24.3;classical monocyte: 32.0;intermediate monocyte: 44.7;myeloid DC: 25.2;neutrophil: 34.3;non-classical monocyte: 36.9" "Group enriched" "Detected in all" 8 "dendritic cells: 25.2;granulocytes: 34.3;monocytes: 44.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023873 Uncertain Supported "Vesicles,Midbody ring,Cytosol" "Intracellular and membrane" Yes NA "Vesicles, Cytosol" "Midbody ring" "HPA023873: AB_1845834" "unprognostic (1.78e-2)" "unprognostic (5.01e-2)" "unprognostic (7.63e-2)" "unprognostic (9.78e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (1.99e-3)" "unprognostic (2.45e-1)" "unprognostic (2.05e-2)" "unprognostic (2.16e-2)" "unprognostic (9.81e-2)" "unprognostic (1.44e-2)" "unprognostic (9.29e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-2)" "unprognostic (9.13e-2)" 11.8 12.3 13.2 16.8 10.9 25.5 9.5 22.6 12.8 9.5 13.3 8.2 6.9 12.1 11.4 7.6 16.1 10.3 9.1 10.9 18.6 5.2 16.2 17.9 9.3 15.3 13.7 10.2 24.4 9.7 6.9 16.4 12.2 14.1 14.3 7.9 31.6 6.8 5.9 15.0 8.3 8.4 8.7 15.3 16.9 7.8 17.8 12.6 11.2 13.2 10.0 8.9 9.3 8.5 15.9 4.4 3.7 28.7 4.4 5.7 7.0 4.4 5.9 4.9 3.5 1.8 0.4 1.4 10.2 3.7 5.3 7.5 3.1 9.4 7.2 2.5 19.8 3.6 4.9 11.0 3.0 8.9 3.4 5.2 7.3 8.6 0.8 16.1 3.5 7.6 11.1 9.8 18.6 4.3 0.8 6.6 5.0 14.2 6.8 16.0 2.4 9.5 5.1 2.8 3.3 9.9 24.4 4.0 4.4 3.7 10.9 3.7 2.9 6.6 0.0 14.5 8.6 4.0 4.8 15.8 6.8 11.4 11.0 3.8 24.3 32.0 2.4 1.9 44.7 3.3 3.4 2.7 2.5 25.2 2.5 4.6 2.9 34.3 4.3 36.9 3.9 4.0 10.0 13.2 10.9 22.6 12.8 10.9 18.6 15.3 13.7 10.2 14.1 15.3 12.6 15.9 15.4 16.0 14.7 19.2 43.2 35.9 50.7 15.0 26.2 22.1 7.2 6.6 15.6 4.3 15.2 7.3 20.9 21.2 11.7 5.0 1.9 8.4 2.6 94.4 11.8 15.0 11.4 3.0 53.0 9.3 7.3 18.7 16.8 57.6 16.5 18.4 8.2 9.3 25.8 11.8 58.9 12.5 10.2 71.9 127.8 4.2 6.2 94.8 19.6 42.2 58.2 45.2 3.1 30.2 60.9 8.6 11.1 3.8 10.7 30.0 4.1 5.4 80.7 27.5 0.0 17.5 20.6 29.2 20.9 15.2 29.1 34.6 18.2 7.9 5.1 37.6 IFNK ENSG00000147896 "Interferon kappa" Q9P0W0 9 27524290-27526498 "Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "brain: 3.9;choroid plexus: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (5.58e-3)" "unprognostic (4.64e-3)" "unprognostic (1.06e-1)" 0.0 0.0 0.9 0.0 3.3 0.0 0.0 1.3 1.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 2.9 2.1 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.3 1.3 1.4 0.5 1.6 2.9 2.1 0.2 2.3 2.1 2.5 3.9 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZCCHC7 "AIR1, FLJ22611" ENSG00000147905 "Zinc finger CCHC-type containing 7" Q8N3Z6 9 37120574-37358149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 225.6;Inhibitory neurons: 229.6;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 250.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 124.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020600, HPA021088, HPA029522" Uncertain Enhanced Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029" "unprognostic (1.19e-3)" "unprognostic (1.21e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (7.21e-3)" "unprognostic (2.78e-1)" "unprognostic (4.27e-3)" "unprognostic (3.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.29e-2)" "unprognostic (7.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.58e-2)" "unprognostic (8.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.04e-2)" "unprognostic (5.49e-2)" 7.8 7.5 6.0 12.8 6.3 13.8 13.4 19.3 8.8 9.4 5.4 8.3 8.0 11.7 11.4 7.6 9.7 8.0 6.4 5.7 5.4 7.5 8.1 6.6 23.4 6.1 7.4 4.0 16.7 11.3 7.2 9.5 8.0 7.1 7.0 11.0 9.9 7.8 7.2 5.9 8.0 8.3 9.6 5.1 10.7 7.7 12.2 6.3 13.0 12.4 6.0 25.0 9.5 7.6 9.8 17.2 9.4 17.5 18.4 17.4 27.0 15.5 17.4 21.3 14.0 19.2 11.8 8.6 54.8 8.1 14.0 15.9 7.2 16.6 17.1 19.9 26.3 8.8 19.1 19.3 10.7 27.3 32.5 17.5 18.6 26.3 14.2 56.7 26.0 16.0 24.4 53.3 21.8 12.7 8.2 24.9 18.2 18.3 20.3 17.3 124.7 11.0 16.2 17.6 7.1 17.5 12.9 12.6 15.3 17.1 16.9 10.2 21.4 12.7 9.9 11.8 14.1 10.3 5.0 13.2 76.4 14.9 20.8 18.7 8.4 7.6 20.6 12.9 9.0 12.8 32.6 14.9 15.0 7.2 48.9 18.6 17.3 15.3 18.4 17.2 13.2 13.4 9.3 6.0 6.3 19.3 8.8 5.7 5.4 6.1 7.4 4.0 7.1 5.1 6.3 9.8 27.7 35.3 18.5 126.3 110.3 28.3 29.5 28.2 32.5 15.5 21.7 23.7 10.7 15.7 21.7 5.5 10.4 15.3 32.8 7.7 27.4 16.3 52.2 17.6 37.6 18.7 19.1 38.5 225.6 15.8 25.4 31.0 30.1 24.2 23.5 18.0 16.4 11.6 15.2 11.8 229.6 22.5 40.7 17.9 22.8 20.8 27.1 20.3 16.0 121.8 19.8 18.2 28.8 196.1 250.0 12.8 13.6 19.5 44.7 34.9 17.7 22.5 19.1 24.9 6.6 33.9 25.4 60.1 44.8 29.3 32.7 18.6 42.2 32.4 20.3 26.0 FBXO10 FBX10 ENSG00000147912 "F-box protein 10" Q9UK96 9 37510892-37576380 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 30.0" "Cell type enhanced" "Detected in many" "Early spermatids: 34.8;Excitatory neurons: 28.6;Inhibitory neurons: 28.2;Late spermatids: 45.7;Oligodendrocyte precursor cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.1;naive B-cell: 1.3" "Lineage enriched" "Detected in single" 5 "B-cells: 2.1" "Cell line enhanced" "Detected in many" "AF22: 24.0;HHSteC: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA002863, HPA072721" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002863: AB_10965996, HPA072721: " "unprognostic (2.40e-1)" "unprognostic (2.43e-2)" "unprognostic (5.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.98e-1)" "unprognostic (3.44e-3)" "unprognostic (1.96e-2)" "unprognostic (1.80e-1)" "unprognostic (5.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.93e-5)" "unprognostic (1.91e-1)" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (1.00e-1)" "unprognostic (2.74e-1)" "unprognostic (1.99e-1)" 2.7 8.0 5.6 3.3 6.3 0.8 2.4 2.6 7.5 3.3 3.4 6.0 1.8 4.5 10.8 3.2 2.5 2.7 3.5 8.5 5.4 3.8 3.7 2.3 5.6 3.8 4.9 6.3 2.5 6.6 3.8 16.6 2.0 4.7 3.3 1.8 1.6 8.6 2.9 30.0 1.9 4.7 3.2 2.8 10.1 3.3 9.5 6.4 2.1 7.7 14.0 5.3 3.0 2.7 5.8 2.3 5.6 24.0 6.2 11.1 3.9 2.0 4.2 7.6 5.3 7.7 3.2 1.5 14.4 1.4 4.6 2.1 0.2 8.8 2.1 3.8 8.2 5.8 2.9 5.3 2.8 33.8 7.9 1.0 9.0 1.7 4.7 3.1 3.4 7.5 1.4 10.4 3.9 9.4 2.0 3.0 2.6 11.2 3.3 2.1 5.5 10.4 1.8 3.0 1.5 5.1 12.8 2.8 3.4 3.2 7.1 1.4 8.0 6.1 3.7 6.3 3.4 3.1 4.5 3.9 2.3 3.1 3.0 3.5 0.0 0.0 0.0 0.2 0.0 0.2 2.1 0.4 0.2 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.2 5.6 6.3 2.6 7.5 8.5 5.4 3.8 4.9 6.3 4.7 2.8 6.4 5.8 0.7 0.0 1.1 12.4 6.7 0.3 0.1 0.4 0.6 3.9 1.2 0.8 1.7 2.8 0.5 1.8 4.2 0.3 0.3 0.1 0.0 1.1 34.8 1.1 4.3 1.4 5.4 0.4 28.6 1.5 0.8 1.8 0.5 1.3 0.0 1.9 3.9 1.2 4.1 3.3 28.2 0.5 2.0 0.3 0.0 45.7 0.9 0.6 1.8 4.7 0.7 1.6 0.0 16.6 7.0 1.2 0.2 1.5 5.7 0.9 0.2 1.3 1.1 1.0 0.0 3.1 1.0 4.2 1.9 0.7 0.6 0.3 1.3 5.0 0.3 0.3 SIGMAR1 "OPRS1, SR-BP1" ENSG00000147955 "Sigma non-opioid intracellular receptor 1" Q99720 9 34634722-34637844 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Receptor "Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 189.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 98.7;Hepatocytes: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013470, HPA018002, HPA024071" Enhanced NA NA "CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (8.06e-2)" "unprognostic (3.71e-2)" "unprognostic (4.89e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" "unprognostic (2.01e-3)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.42e-4)" 39.7 52.8 24.0 19.6 24.0 20.7 38.4 25.0 27.3 49.8 25.3 40.7 46.4 51.2 45.4 54.5 47.3 22.3 31.2 25.3 27.3 25.6 189.1 27.8 17.0 27.3 25.4 24.6 46.5 46.1 39.3 22.2 27.8 27.2 35.8 31.5 7.3 35.3 38.9 17.8 52.4 40.3 35.1 24.7 24.4 42.5 20.3 30.6 19.3 30.0 13.7 22.4 46.7 43.9 28.2 184.3 162.6 59.8 175.3 205.7 138.7 66.5 127.1 91.2 115.8 105.9 97.6 76.8 87.8 71.9 151.7 69.8 108.8 94.5 151.3 57.8 144.7 175.6 78.0 225.0 112.7 131.7 145.0 67.6 142.9 163.0 131.2 197.7 59.4 90.2 114.5 30.1 156.2 139.7 1.8 88.2 215.2 68.8 101.5 184.4 101.4 59.6 258.3 111.0 36.5 57.6 65.5 123.3 89.5 70.0 32.0 106.9 98.7 68.5 90.0 69.9 96.4 19.2 43.2 71.6 2.5 97.2 123.9 191.8 24.3 39.5 24.2 43.0 39.3 46.2 26.5 62.5 51.3 48.9 21.1 51.7 43.6 10.7 28.7 42.5 35.1 65.5 43.5 24.0 24.0 25.0 27.3 25.3 27.3 27.3 25.4 24.6 27.2 24.7 30.6 28.2 11.0 3.2 13.6 6.8 12.3 18.4 16.8 24.6 14.2 10.1 26.8 18.9 9.2 15.7 12.1 7.3 0.0 44.8 10.7 33.0 0.0 33.0 0.9 7.0 23.7 14.4 10.3 23.5 5.6 33.5 98.7 29.2 18.3 10.1 7.0 19.4 13.9 97.5 38.8 5.0 6.4 28.2 12.2 10.5 7.8 1.8 27.4 10.8 19.6 5.6 9.5 13.8 14.4 5.0 4.4 32.1 31.5 25.6 22.4 25.9 58.4 13.7 6.8 7.7 19.7 12.1 23.9 6.0 10.3 40.0 21.5 36.5 13.6 26.2 47.3 16.1 CBWD5 ENSG00000147996 "COBW domain containing 5" Q5RIA9 9 65668805-65734041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 178.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (8.18e-2)" "unprognostic (4.23e-3)" "unprognostic (5.25e-3)" "unprognostic (1.02e-3)" "unprognostic (5.32e-3)" "unprognostic (9.24e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-2)" "unprognostic (1.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-3)" "unprognostic (1.17e-1)" "unprognostic (5.68e-2)" "unprognostic (3.87e-1)" 9.2 15.4 20.9 8.4 21.3 7.1 17.1 21.9 26.0 11.3 20.8 10.2 11.1 6.5 9.1 15.6 11.0 5.2 12.0 21.3 22.2 23.8 42.2 9.7 6.7 21.3 21.7 21.0 10.7 19.6 7.8 16.9 6.8 21.8 17.5 10.6 8.7 9.7 7.8 8.4 10.4 14.0 6.0 21.0 21.4 11.5 11.5 21.5 4.6 15.7 4.2 9.8 12.8 9.9 21.9 37.7 40.1 14.0 17.3 20.8 9.5 16.4 26.0 17.6 20.2 20.6 5.2 33.6 51.2 16.2 15.3 29.1 27.2 64.1 21.3 38.2 8.4 15.4 14.4 69.3 91.0 16.2 32.8 8.9 16.9 23.9 18.7 14.8 25.0 37.3 19.4 20.5 36.9 21.1 45.8 16.4 34.2 16.3 64.4 42.4 28.1 19.2 49.9 32.4 23.9 18.1 18.3 21.2 16.1 8.0 24.5 76.4 21.3 10.6 9.1 33.6 27.7 30.2 12.0 34.8 11.8 37.4 35.9 35.3 1.7 11.8 8.8 3.2 15.0 3.7 5.3 5.3 4.6 12.4 3.0 4.8 4.0 7.8 2.8 9.8 5.2 4.4 10.6 20.9 21.3 21.9 26.0 21.3 22.2 21.3 21.7 21.0 21.8 21.0 21.5 21.9 17.8 41.7 51.8 13.4 58.4 65.1 31.8 24.6 178.7 37.7 59.4 36.7 33.6 25.8 38.5 20.2 68.8 44.0 10.6 33.2 21.5 33.1 10.5 17.4 8.4 22.8 16.8 25.9 60.6 39.0 23.0 20.1 49.5 15.4 10.1 16.3 16.4 48.0 15.9 35.3 60.8 32.6 12.2 25.1 36.6 4.6 21.1 27.5 30.2 20.6 45.2 13.5 7.2 37.2 32.2 33.7 51.1 17.3 143.5 32.3 76.9 42.7 27.8 62.4 6.6 10.4 18.8 35.2 25.5 119.4 85.5 50.5 29.6 12.3 34.2 30.5 CEP78 "C9orf81, FLJ12643" ENSG00000148019 "Centrosomal protein 78" Q5JTW2 9 78236062-78279690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Cone-rod dystrophy, Deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;dendritic cells: 106.8;NK-cells: 249.3;Spermatocytes: 82.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 39.1" "Group enriched" "Detected in many" 5 "NK-cells: 39.1;T-cells: 18.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048846 Approved NA NA "HPA048846: AB_2680537" "unprognostic (4.62e-1)" "unprognostic (6.33e-3)" "unprognostic (2.87e-2)" "unprognostic (1.36e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-2)" "unprognostic (5.13e-4)" "unprognostic (6.75e-2)" "unprognostic (8.48e-3)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (7.03e-2)" "unprognostic (1.25e-2)" "unprognostic (2.27e-3)" "unprognostic (4.93e-1)" "unprognostic (1.18e-3)" "unprognostic (3.34e-1)" 2.2 2.9 4.7 4.6 5.2 12.4 4.3 6.3 4.7 4.1 3.8 3.6 2.9 5.7 3.2 3.5 3.4 2.4 1.5 4.5 4.9 3.7 3.6 3.4 6.2 5.2 4.5 4.2 4.3 2.6 4.4 2.7 3.9 4.7 3.2 3.9 9.3 3.3 3.4 1.7 3.6 2.9 4.8 5.3 5.1 3.0 15.3 4.8 11.6 3.7 1.7 7.8 3.2 3.0 6.6 31.7 14.5 33.3 20.5 5.4 9.4 22.3 25.6 10.1 15.1 19.1 2.7 8.4 28.9 12.7 9.2 21.4 36.9 49.6 13.7 22.5 24.3 16.6 15.4 17.1 11.4 4.9 26.0 14.6 5.2 2.9 17.1 11.1 7.5 23.4 29.4 12.2 22.4 19.8 20.3 32.6 12.8 35.2 32.7 14.0 32.2 38.4 8.4 9.0 14.0 30.4 21.1 33.7 10.6 8.4 22.7 12.6 6.9 12.5 13.3 22.6 27.5 24.7 13.1 17.8 18.4 11.8 17.6 23.0 0.7 0.8 0.7 18.3 3.4 8.9 5.0 7.9 16.0 2.3 3.4 3.9 12.8 0.5 39.1 5.5 4.2 13.1 8.3 4.7 5.2 6.3 4.7 4.5 4.9 5.2 4.5 4.2 4.7 5.3 4.8 6.6 10.3 25.6 9.2 26.1 13.7 5.1 8.1 6.9 8.0 27.1 7.6 10.5 8.9 4.3 7.2 1.8 110.5 14.0 106.8 3.9 5.9 8.4 14.1 18.7 16.9 9.0 7.7 25.7 28.6 6.7 19.5 10.3 10.2 10.4 5.1 20.6 7.1 9.0 9.6 3.3 20.5 8.0 4.1 6.1 6.1 9.9 14.9 10.0 1.8 9.4 9.7 14.7 249.3 27.2 24.6 4.7 4.1 15.1 43.7 3.7 1.0 5.1 22.1 49.4 0.0 14.8 11.3 82.1 34.2 10.0 4.8 4.0 34.0 12.3 13.2 4.0 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027054 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 200.2;thyroid gland: 118.0" "Cell type enhanced" "Detected in many" "Astrocytes: 1144.3;Excitatory neurons: 750.1;Inhibitory neurons: 877.7;Oligodendrocyte precursor cells: 557.9" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;HaCaT: 3.0;RPTEC TERT1: 9.7;SH-SY5Y: 11.2;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346, HPA074873" Enhanced Supported "Plasma membrane" NA NA 20000000 "Plasma membrane" "CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: " "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 40.8 2.8 199.6 1.7 175.9 0.1 62.8 147.1 192.4 9.1 62.5 6.0 0.4 3.9 4.0 8.3 5.7 33.6 9.3 178.1 200.2 20.6 1.8 10.1 3.1 145.1 199.2 133.8 9.7 34.6 2.5 10.2 1.8 167.4 4.7 3.6 41.6 14.5 19.3 2.9 11.7 1.6 3.4 87.1 11.0 1.9 2.4 199.4 4.0 118.0 13.9 4.3 5.0 12.1 140.7 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 9.7 0.7 0.7 11.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 199.6 175.9 147.1 192.4 178.1 200.2 145.1 199.2 133.8 167.4 87.1 199.4 140.7 17.4 0.0 0.5 1144.3 0.7 56.6 1.0 1.8 93.9 30.3 144.1 116.8 11.4 0.0 0.2 9.2 6.2 0.0 1.0 8.7 27.4 36.1 1.8 1.2 0.4 8.0 0.0 0.0 750.1 0.7 0.1 76.6 0.0 2.3 0.0 0.1 5.0 0.0 0.2 242.3 877.7 0.7 0.0 0.0 14.2 3.6 104.1 1.4 17.8 65.6 0.6 241.0 0.0 557.9 109.5 0.5 7.0 48.2 0.3 0.9 0.0 7.1 1.7 12.2 124.9 9.9 114.4 0.8 2.3 5.2 24.6 0.0 3.3 0.2 7.2 0.9 IDNK "bA522I20.2, C9orf103, hGntK" ENSG00000148057 "IDNK gluconokinase" Q5T6J7 9 83623049-83644130 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 80.3;Proximal enterocytes: 84.2;Proximal tubular cells: 224.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020378, HPA058429" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA020378: AB_1845794, HPA058429: AB_2683716" "unprognostic (1.49e-3)" "unprognostic (7.94e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (5.41e-3)" "unprognostic (1.81e-2)" "unprognostic (6.08e-2)" "unprognostic (1.57e-1)" "unprognostic (2.61e-2)" "unprognostic (3.00e-1)" "unprognostic (5.86e-3)" "unprognostic (7.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.55e-1)" "unprognostic (3.11e-2)" 9.0 12.2 19.4 6.2 24.2 5.8 8.8 20.3 27.0 4.4 21.6 9.6 26.5 5.3 13.4 8.4 13.0 6.5 5.9 18.5 25.7 51.4 71.1 7.3 11.1 19.7 20.2 18.6 5.5 13.9 14.9 9.0 3.0 20.2 8.5 9.2 11.0 8.9 9.6 2.3 7.2 27.1 4.4 20.4 7.9 9.0 3.7 19.8 39.2 13.3 2.6 9.6 5.2 3.9 20.5 4.3 10.4 1.7 1.8 4.6 6.9 7.8 3.4 8.6 3.5 2.8 2.9 5.3 5.8 5.2 5.8 3.5 8.4 1.3 2.0 3.6 11.9 1.6 2.1 4.6 12.7 19.4 1.5 2.8 4.3 3.3 7.2 7.2 6.2 7.9 16.0 1.9 7.1 4.8 26.8 3.7 1.4 1.6 18.1 6.0 4.6 4.2 3.3 9.6 5.5 6.9 8.6 7.5 6.5 7.6 2.5 6.0 8.1 7.4 1.6 1.3 14.3 6.1 9.0 10.4 1.0 7.3 2.4 2.8 100.7 13.0 19.1 30.5 24.1 25.4 39.3 26.0 24.7 18.1 26.7 20.2 27.2 2.8 33.1 47.6 20.9 52.2 24.8 19.4 24.2 20.3 27.0 18.5 25.7 19.7 20.2 18.6 20.2 20.4 19.8 20.5 6.2 12.8 8.7 14.7 9.3 6.8 3.2 7.3 4.0 8.9 10.0 8.4 9.9 10.0 8.8 5.5 0.0 8.0 11.3 8.4 80.3 11.3 0.4 34.6 2.0 5.6 7.3 2.5 4.7 16.1 4.6 8.0 4.6 7.0 20.8 10.2 3.3 44.3 11.1 10.1 5.6 12.8 12.2 11.6 7.5 2.0 4.4 8.2 12.4 11.2 19.8 38.0 24.7 8.0 11.4 5.4 21.7 4.1 12.1 4.6 84.2 224.4 28.3 3.5 0.0 8.8 5.9 1.4 1.5 5.4 5.8 3.0 13.7 9.9 11.2 4.2 SHC3 "N-Shc, NSHC, SHCC" ENSG00000148082 "SHC adaptor protein 3" Q92529 9 89005771-89178818 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7" "Group enriched" "Detected in some" 10 "Excitatory neurons: 155.2;Inhibitory neurons: 179.2;Oligodendrocyte precursor cells: 333.8" "Cancer enriched" "Detected in some" 5 "glioma: 5.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 20.7;hTERT-RPE1: 22.6;RT4: 7.9;SH-SY5Y: 7.6;U-87 MG: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031427, HPA046656, HPA072448" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521" "unprognostic (6.22e-2)" "unprognostic (5.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (9.07e-4)" "unprognostic (2.70e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (3.09e-1)" "unprognostic (2.72e-3)" "unprognostic (7.39e-2)" "unprognostic (1.53e-7)" "unprognostic (8.33e-2)" "unprognostic (1.05e-1)" "unprognostic (9.01e-2)" "unprognostic (9.84e-4)" 1.0 9.1 14.0 0.2 26.5 0.0 1.7 0.0 27.7 5.1 0.0 1.3 0.4 1.7 0.9 1.0 1.7 1.8 0.7 24.1 6.6 0.9 0.2 4.6 0.2 5.2 2.3 19.9 0.2 4.1 2.7 1.1 0.2 7.0 1.0 0.7 2.3 5.1 0.7 0.3 1.7 0.7 1.0 0.0 0.1 0.8 0.3 2.7 0.0 0.6 0.6 0.2 1.4 2.9 18.1 1.4 0.4 20.7 0.0 4.5 1.4 0.0 1.5 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.4 0.5 0.2 0.0 3.1 0.0 2.1 0.0 22.6 5.5 0.1 0.0 0.0 0.0 0.2 0.0 1.3 2.7 0.3 0.3 0.3 0.0 4.5 4.5 7.9 2.8 7.6 0.5 0.0 0.0 0.2 0.0 0.4 3.2 0.8 0.1 1.3 0.1 0.0 0.0 0.0 11.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 26.5 0.0 27.7 24.1 6.6 5.2 2.3 19.9 7.0 0.0 2.7 18.1 0.3 0.0 21.0 17.6 0.0 0.1 0.3 0.1 1.2 7.6 1.1 1.0 1.1 0.0 0.7 0.0 0.0 0.1 0.2 0.0 1.9 0.1 1.1 0.4 1.8 0.5 0.0 0.0 155.2 0.9 0.1 4.4 0.0 0.2 0.0 0.3 0.0 0.0 0.2 3.3 179.2 0.0 0.0 0.0 1.1 1.6 1.5 0.3 1.8 15.0 0.0 7.2 0.0 333.8 9.6 0.1 0.0 3.8 0.0 0.0 0.1 0.6 0.9 0.6 0.0 0.9 0.9 0.3 0.6 0.7 0.6 0.4 0.3 0.8 0.0 0.8 AUH ENSG00000148090 "AU RNA binding methylglutaconyl-CoA hydratase" Q13825 9 91213815-91361918 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Branched-chain amino acid catabolism" "Lyase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 191.7;Inhibitory neurons: 137.0;Oligodendrocytes: 137.5;Proximal tubular cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004171 Enhanced "Intracellular and membrane" NA NA "HPA004171: AB_1845215" "unprognostic (4.10e-2)" "unprognostic (8.95e-2)" "unprognostic (5.56e-2)" "unprognostic (1.19e-1)" "unprognostic (1.54e-1)" "unprognostic (1.49e-1)" "unprognostic (3.24e-2)" "unprognostic (3.05e-2)" "unprognostic (3.57e-1)" "unprognostic (1.11e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "prognostic favorable (0.00e+0)" "unprognostic (8.23e-3)" "unprognostic (2.84e-2)" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" 17.3 42.3 12.0 6.4 12.5 4.8 16.0 16.0 15.2 13.7 16.6 17.4 24.0 10.3 14.4 8.6 12.5 10.8 39.2 12.7 14.6 63.5 26.6 10.3 7.6 15.1 13.8 11.1 13.5 25.7 45.8 10.5 16.2 15.9 28.5 17.3 21.6 26.3 14.9 24.5 8.2 20.3 8.6 12.3 8.0 22.9 5.6 14.4 9.1 21.2 29.5 7.8 9.2 9.9 17.0 9.1 8.7 12.0 6.2 14.5 15.5 18.5 8.0 10.0 6.1 7.0 5.0 11.4 10.6 8.1 8.5 18.2 13.0 18.1 10.1 8.7 82.6 15.4 7.3 9.7 29.6 11.1 10.6 7.3 13.1 12.5 4.9 16.8 14.3 7.6 10.7 10.3 15.5 7.2 8.8 14.6 23.8 15.0 22.2 12.5 8.5 9.6 18.6 26.6 4.8 12.2 8.8 11.9 28.3 15.6 27.1 5.2 6.9 7.8 6.1 7.6 9.0 7.8 17.7 16.1 3.6 9.6 8.5 4.2 17.9 5.2 18.2 7.2 3.6 8.1 8.4 7.8 10.4 4.6 11.8 9.6 9.1 7.4 10.8 2.5 6.3 10.8 6.5 12.0 12.5 16.0 15.2 12.7 14.6 15.1 13.8 11.1 15.9 12.3 14.4 17.0 9.6 0.0 7.7 75.1 11.2 5.2 24.5 27.7 12.5 18.7 15.8 13.5 37.2 27.1 19.1 27.6 25.0 44.6 11.5 27.0 191.7 29.6 3.1 11.5 11.1 11.1 22.9 28.8 101.2 16.1 28.9 14.2 19.4 16.0 1.3 14.5 11.0 18.3 13.4 13.5 137.0 17.3 38.7 8.9 4.7 1.1 14.3 8.9 12.4 67.5 29.1 9.5 18.6 100.5 137.5 12.5 23.5 11.3 18.4 36.8 59.4 120.0 15.8 34.4 13.1 11.9 11.5 8.7 10.5 16.1 4.1 36.4 12.9 11.6 25.0 24.2 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374569-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 24.6 32.6 28.5 26.3 30.8 18.6 24.8 30.2 31.0 24.1 36.2 24.6 19.0 24.3 29.3 40.5 26.9 20.9 21.0 27.3 31.2 22.1 15.3 32.3 29.6 32.1 31.8 26.1 19.2 18.2 95.8 12.8 33.6 31.1 21.5 28.7 18.0 20.9 21.5 12.6 42.7 21.5 24.0 32.0 25.4 25.2 14.3 30.1 31.0 25.9 14.2 34.9 35.0 27.9 33.2 76.4 48.3 36.9 28.8 79.3 56.4 58.4 72.5 62.7 63.3 61.6 24.4 88.9 91.2 42.2 63.1 73.0 163.9 44.6 46.3 61.0 65.7 23.9 31.6 43.0 36.8 56.2 100.0 55.8 52.2 68.5 67.1 51.2 35.4 54.9 49.3 60.6 52.5 85.2 57.8 73.7 56.6 54.2 111.0 38.4 36.6 84.6 29.6 68.2 57.8 35.4 46.4 61.6 71.6 79.6 44.0 32.9 58.3 59.4 65.6 46.1 102.1 68.2 57.6 77.2 24.8 58.6 48.1 60.1 0.5 6.1 4.9 4.1 9.2 3.7 3.3 3.6 4.2 6.2 2.1 3.6 5.1 8.0 3.1 6.3 6.0 4.0 3.0 28.5 30.8 30.2 31.0 27.3 31.2 32.1 31.8 26.1 31.1 32.0 30.1 33.2 21.6 6.4 20.0 0.0 17.3 0.0 23.2 0.0 22.2 12.2 29.4 15.6 0.0 14.3 6.8 44.1 4.2 14.2 20.6 16.2 7.9 16.8 3.6 32.2 20.7 18.9 7.3 30.7 0.0 19.0 26.4 17.3 16.3 32.7 3.8 14.1 26.4 13.5 28.9 5.0 0.0 22.9 0.0 66.1 0.0 3.1 16.8 31.0 0.0 0.0 39.1 19.5 15.5 0.0 0.0 26.7 12.1 16.1 12.7 38.5 11.7 7.6 7.3 9.9 13.1 18.1 14.9 14.1 18.2 37.6 0.0 19.2 15.7 17.7 14.4 42.6 AOPEP "AP-O, APO, C90RF3, C9orf3, FLJ14675" ENSG00000148120 "Aminopeptidase O (putative)" Q8N6M6 9 94726604-95087159 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 148.2;Cytotrophoblasts: 65.9;Extravillous trophoblasts: 43.7;Syncytiotrophoblasts: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HeLa: 30.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004633, HPA072729" Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA004633: AB_1078362, HPA072729: AB_2686553" "unprognostic (4.25e-2)" "unprognostic (1.07e-3)" "unprognostic (6.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (2.75e-2)" "unprognostic (9.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.80e-1)" "prognostic favorable (6.33e-5)" "unprognostic (2.31e-1)" "unprognostic (2.56e-1)" "unprognostic (3.29e-2)" "unprognostic (3.37e-2)" 5.6 6.6 12.4 4.9 18.7 2.2 7.1 16.3 16.2 8.1 22.0 5.7 4.3 18.7 8.4 17.1 10.3 12.2 29.7 15.9 19.3 7.2 7.7 10.5 2.2 23.5 15.6 9.4 8.2 11.3 16.4 5.7 24.5 19.6 14.4 5.8 4.8 12.3 15.3 30.8 38.9 5.0 15.9 13.2 5.0 5.8 6.1 15.2 2.6 11.3 15.5 5.7 7.8 6.9 40.9 6.8 27.6 3.3 5.3 3.4 3.8 12.4 6.4 3.0 6.3 4.1 6.3 8.7 2.1 5.3 9.8 8.7 24.8 5.7 6.1 3.4 13.2 4.9 2.0 30.1 5.8 6.1 1.8 1.4 4.4 23.7 5.5 4.1 17.7 3.5 3.3 3.4 3.0 11.4 10.1 2.8 2.3 4.4 7.8 10.7 4.2 9.4 2.7 11.0 6.4 6.6 9.7 11.2 9.4 2.5 8.5 10.8 1.5 2.7 2.9 2.8 10.8 3.4 2.5 3.6 1.0 9.8 1.7 4.8 0.0 1.4 0.9 1.4 1.0 0.8 0.9 1.1 1.2 2.2 2.2 0.8 1.0 0.5 1.4 0.7 2.1 0.8 0.7 12.4 18.7 16.3 16.2 15.9 19.3 23.5 15.6 9.4 19.6 13.2 15.2 40.9 20.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.2 0.0 0.0 0.0 0.0 65.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 43.7 13.8 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 88.2 0.2 0.0 0.0 0.0 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028727-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.8;choroid plexus: 5.9;kidney: 15.8" "Group enriched" "Detected in some" 4 "Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 3.7;SCLC-21H: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.0 0.1 10.0 0.0 12.8 0.0 0.7 7.2 11.9 0.1 5.9 0.2 0.0 0.0 2.8 0.0 0.2 0.0 0.0 10.4 9.9 15.8 3.6 1.4 0.0 10.4 9.7 8.8 0.0 0.3 0.0 0.1 0.0 10.2 0.2 0.1 1.5 0.3 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.1 0.6 10.6 0.4 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 9.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.8 7.2 11.9 10.4 9.9 10.4 9.7 8.8 10.2 10.9 10.6 11.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 2.3 0.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 37.2 0.0 12.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 39.0 0.0 1.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 OR13C4 ENSG00000148136 "Olfactory receptor family 13 subfamily C member 4" Q8NGS5 9 104526253-104527209 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF462 "DKFZP762N2316, KIAA1803, Zfp462" ENSG00000148143 "Zinc finger protein 462" Q96JM2 9 106863166-107013634 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 114.9;Oligodendrocyte precursor cells: 486.5;Oligodendrocytes: 152.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022283 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA022283: AB_2220602" "unprognostic (4.22e-2)" "unprognostic (3.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (2.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.01e-1)" "unprognostic (3.62e-2)" "unprognostic (1.84e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.96e-2)" "unprognostic (1.68e-1)" "unprognostic (9.00e-2)" "unprognostic (1.33e-2)" 3.3 8.4 10.8 1.9 18.0 0.1 3.8 13.9 11.1 6.5 5.4 4.2 1.0 4.3 1.8 7.8 5.3 3.0 5.2 7.8 16.0 4.0 1.6 3.1 0.8 15.2 14.2 5.3 7.4 1.1 6.1 4.1 3.1 20.3 6.9 3.8 8.2 7.8 4.2 13.3 6.7 2.2 6.8 9.8 3.0 1.7 6.0 18.0 2.0 7.3 5.8 1.3 3.9 6.3 16.4 4.8 12.6 22.5 14.0 6.9 4.9 3.2 3.2 4.0 2.8 3.0 14.8 5.7 0.1 8.3 2.9 13.8 7.6 14.9 12.4 3.5 0.1 2.1 0.0 5.3 0.1 2.6 3.4 0.4 4.6 6.0 6.8 18.0 7.4 1.3 6.0 0.0 6.7 7.3 8.2 2.7 0.1 16.0 0.0 10.0 0.0 15.4 0.3 7.8 4.4 10.6 12.3 6.3 0.1 4.7 13.7 11.2 0.1 1.3 3.8 13.2 8.1 9.8 0.0 0.1 0.1 5.8 0.3 13.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 10.8 18.0 13.9 11.1 7.8 16.0 15.2 14.2 5.3 20.3 9.8 18.0 16.4 25.6 22.4 29.1 114.9 0.9 33.6 10.8 10.6 44.9 60.7 21.6 18.7 27.7 25.8 10.3 7.3 31.3 14.4 0.2 14.7 5.9 7.9 63.1 7.6 25.5 23.3 16.8 2.1 18.4 2.6 7.3 14.1 4.1 10.1 17.1 18.7 40.4 0.0 1.8 18.5 91.6 15.5 12.2 0.8 4.2 16.8 14.6 1.3 12.4 15.9 2.0 19.8 0.0 486.5 152.2 7.7 5.3 27.1 0.0 15.1 6.3 17.4 15.2 39.4 26.3 21.5 22.1 1.3 24.7 24.0 11.5 3.1 1.1 22.0 17.5 6.6 INIP "C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C" ENSG00000148153 "INTS3 and NABP interacting protein" Q9NRY2 9 112683926-112718149 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020382 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020382: AB_1845840" "prognostic unfavorable (7.08e-4)" "unprognostic (1.67e-1)" "unprognostic (9.64e-2)" "unprognostic (2.35e-1)" "unprognostic (8.05e-2)" "unprognostic (8.56e-2)" "unprognostic (1.01e-2)" "unprognostic (6.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (4.47e-3)" "prognostic favorable (2.00e-8)" "prognostic favorable (2.53e-4)" "unprognostic (2.28e-1)" "unprognostic (3.50e-2)" "unprognostic (1.26e-1)" 7.5 8.8 9.6 8.5 12.2 10.5 11.5 11.5 14.3 8.1 8.3 10.2 10.4 7.2 8.7 9.9 8.4 8.7 7.6 11.0 11.2 10.9 11.1 8.5 14.6 11.1 10.6 9.2 8.2 5.0 10.8 6.6 6.2 11.0 7.0 11.6 10.4 8.2 6.5 6.6 9.2 11.0 7.7 10.4 9.8 7.4 5.4 11.4 14.6 10.7 10.1 14.2 9.4 6.2 17.3 16.5 15.6 21.4 31.0 18.2 19.2 21.9 22.7 12.4 19.4 19.3 19.7 13.2 43.8 13.9 15.7 14.6 22.9 21.0 10.9 25.8 53.0 12.3 18.2 17.6 18.0 11.8 37.1 13.3 10.4 14.7 20.6 16.6 9.5 18.2 22.1 31.7 27.5 21.4 27.8 33.3 19.0 11.1 29.8 28.8 36.5 45.1 18.9 22.2 21.9 27.9 20.9 28.7 18.1 15.7 14.2 27.1 23.1 15.4 16.1 24.7 30.9 22.4 13.7 62.4 37.3 20.4 21.3 27.7 30.4 24.8 32.5 15.7 29.3 20.7 15.5 20.1 23.4 27.1 20.0 21.8 18.9 19.8 18.4 27.0 9.7 20.8 20.3 9.6 12.2 11.5 14.3 11.0 11.2 11.1 10.6 9.2 11.0 10.4 11.4 17.3 15.6 22.4 15.6 9.1 19.1 36.7 18.1 31.4 13.1 17.1 19.2 16.5 15.5 15.7 22.4 14.7 16.7 21.4 20.6 19.4 56.7 23.4 3.9 21.0 18.8 18.1 22.3 19.4 18.3 16.1 32.0 14.9 12.8 18.7 26.6 11.2 15.7 17.7 26.1 43.7 15.4 17.1 32.6 24.5 33.5 3.2 14.0 26.2 19.6 3.7 42.3 24.7 34.0 16.6 25.2 24.2 12.3 12.0 11.8 17.9 21.7 31.7 13.0 16.9 0.0 17.3 13.1 17.4 15.8 19.4 41.8 14.8 23.0 12.4 19.8 25.2 UGCG GCS ENSG00000148154 "UDP-glucose ceramide glucosyltransferase" Q16739 9 111896814-111935369 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 114.0" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 294.5;Urothelial cells: 534.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 21 "plasmacytoid DC: 109.7" "Lineage enriched" "Detected in all" 21 "dendritic cells: 109.7" "Cell line enhanced" "Detected in all" "LHCN-M2: 195.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024124 Approved NA NA "HPA024124: AB_1858595" "unprognostic (1.22e-2)" "prognostic favorable (6.62e-4)" "unprognostic (5.39e-2)" "prognostic favorable (4.44e-5)" "unprognostic (1.53e-2)" "unprognostic (9.70e-2)" "unprognostic (3.20e-2)" "unprognostic (2.04e-1)" "unprognostic (3.40e-1)" "unprognostic (1.31e-1)" "unprognostic (1.95e-2)" "unprognostic (3.22e-1)" "unprognostic (9.84e-3)" "unprognostic (2.24e-2)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (3.77e-2)" 30.1 66.2 10.3 34.9 10.8 114.0 25.5 12.4 13.8 19.3 13.1 18.8 24.1 16.5 7.4 41.1 15.8 42.9 14.0 10.6 14.6 29.7 32.8 34.0 42.1 12.6 13.4 10.5 12.1 16.7 5.6 12.6 27.8 11.9 13.9 17.9 12.3 14.2 7.7 9.1 30.9 31.9 21.6 13.0 35.8 48.4 7.9 13.0 20.7 10.0 7.7 47.2 73.0 28.7 13.5 93.4 9.8 15.7 10.5 33.2 39.7 8.3 57.0 59.7 65.3 87.9 19.8 70.0 21.9 44.1 38.0 142.9 46.6 18.4 24.7 69.6 8.9 10.7 8.9 14.3 9.8 23.7 9.8 13.8 39.6 18.9 62.4 89.1 151.0 20.3 10.8 49.4 41.5 195.7 15.9 10.7 10.9 17.9 31.4 10.1 12.4 111.5 7.1 151.0 35.2 7.6 12.0 25.3 21.1 66.1 92.2 113.6 10.1 96.6 30.0 15.2 84.8 41.1 7.7 30.3 10.2 37.0 6.1 41.6 0.1 0.3 0.2 1.2 0.7 2.0 4.2 2.2 1.6 1.9 5.3 2.0 2.0 1.2 1.4 1.0 109.7 3.6 1.4 10.3 10.8 12.4 13.8 10.6 14.6 12.6 13.4 10.5 11.9 13.0 13.0 13.5 128.0 41.7 51.1 17.6 66.6 75.7 151.6 90.6 76.8 29.8 71.8 37.8 11.8 47.1 130.7 29.5 62.6 7.3 262.4 69.8 17.6 108.2 20.6 125.0 83.4 116.1 18.5 26.5 40.4 50.6 12.8 64.6 121.8 294.5 10.8 18.3 90.7 20.6 21.4 18.5 41.9 55.1 36.7 34.0 109.2 5.9 49.0 49.1 58.7 24.4 44.4 8.4 9.2 25.1 12.8 72.2 65.1 38.4 33.3 216.6 42.6 77.2 143.9 16.5 13.1 153.2 74.9 1.8 8.7 99.7 122.2 3.4 41.4 30.5 22.1 534.7 ACTL7B Tact1 ENSG00000148156 "Actin like 7B" Q9Y614 9 108854588-108855986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1098 "testis: 119.7" "Group enriched" "Detected in some" 19 "Early spermatids: 1697.8;Late spermatids: 449.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021803, HPA024664" Enhanced NA NA "HPA021803: AB_1844551, HPA024664: AB_1844552" "unprognostic (7.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.09e-1)" "unprognostic (3.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1697.8 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 449.1 9.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 54.6 4.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750760-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 77.9;Oligodendrocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 3.5 3.7 8.2 7.4 15.1 8.5 6.9 10.4 13.2 9.1 0.8 10.3 7.2 5.6 3.4 3.9 3.1 4.8 3.0 8.2 11.4 21.3 4.7 21.5 8.7 13.8 13.4 7.6 5.8 4.6 5.3 3.0 4.6 13.2 3.4 10.4 4.0 5.0 3.5 2.1 4.9 8.2 6.5 9.9 7.1 4.2 12.0 12.4 3.8 2.6 2.1 8.2 4.0 3.2 26.3 8.2 5.0 8.5 6.8 10.5 9.6 7.2 6.9 14.2 5.7 5.4 18.1 1.9 13.6 5.7 17.9 10.2 9.6 10.4 4.1 8.8 4.4 4.9 4.2 4.6 7.3 7.5 4.2 7.2 7.8 5.6 8.8 6.5 14.4 4.9 3.4 6.7 7.5 7.8 5.7 2.8 4.9 9.4 13.2 5.2 5.9 19.9 3.5 11.1 14.2 12.6 4.0 9.0 12.3 17.6 8.7 9.2 7.4 5.6 8.4 9.0 25.0 5.9 19.6 19.5 6.3 10.8 3.9 16.9 0.0 2.0 0.6 0.2 0.7 0.6 0.0 0.3 0.4 1.6 0.2 0.2 0.2 0.2 0.3 0.8 0.2 0.6 0.7 8.2 15.1 10.4 13.2 8.2 11.4 13.8 13.4 7.6 13.2 9.9 12.4 26.3 4.4 6.4 77.9 11.4 3.5 8.2 2.0 3.1 7.4 5.9 10.5 5.5 4.3 2.8 7.6 5.5 10.4 0.6 3.6 26.2 5.9 2.6 9.1 16.2 7.5 4.8 4.8 6.6 39.0 3.2 2.1 5.3 5.6 20.1 7.0 15.6 8.9 7.7 13.4 8.4 24.1 10.8 2.0 22.4 17.0 8.1 5.6 19.8 21.4 36.5 22.3 2.4 2.1 22.6 91.2 4.4 20.3 7.9 5.8 2.5 11.9 34.2 2.3 3.1 0.0 4.7 2.8 6.6 10.0 7.3 11.1 0.4 5.7 3.7 9.6 6.3 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338987-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 591.3;hTCEpi: 497.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 342.0 118.3 103.2 101.9 104.6 361.6 245.9 96.8 104.7 126.6 87.4 183.9 46.6 141.1 72.8 88.6 143.0 154.6 198.3 91.8 111.5 125.1 358.4 293.2 68.3 120.5 111.5 84.8 82.0 39.2 45.7 50.2 274.9 121.8 112.6 58.9 15.1 96.3 94.2 103.4 116.3 115.1 157.3 105.7 122.6 140.5 24.9 119.6 34.2 113.8 107.1 46.8 184.0 130.7 109.8 8.4 55.0 4.8 26.0 591.3 170.3 0.4 138.6 149.3 40.7 64.5 7.6 10.8 66.5 34.3 186.6 23.9 14.7 31.7 133.0 79.3 41.7 12.0 144.7 108.8 23.1 299.0 61.4 32.4 272.2 497.3 60.9 88.0 11.7 152.5 21.0 33.3 88.2 96.8 45.2 2.2 47.0 64.4 3.5 16.6 8.7 0.2 147.7 34.7 1.7 5.9 0.5 114.5 107.8 62.1 44.9 36.6 47.4 172.8 92.0 28.1 91.3 13.6 36.5 44.9 4.4 35.1 58.1 51.0 21.4 35.5 4.1 168.9 55.8 165.7 5.9 84.2 153.3 35.8 4.2 15.0 81.1 20.8 147.1 41.0 6.1 8.7 128.8 103.2 104.6 96.8 104.7 91.8 111.5 120.5 111.5 84.8 121.8 105.7 119.6 109.8 454.6 160.3 96.6 30.0 13.2 105.5 251.8 107.0 62.0 5.0 135.8 72.3 36.7 121.5 159.0 35.0 6.2 121.9 72.1 26.3 3.9 56.6 3.6 97.0 75.4 313.6 0.0 535.1 3.2 22.0 54.7 140.3 17.9 11.7 36.1 76.0 282.7 371.2 92.1 3.3 4.8 1.1 54.9 226.3 92.3 9.0 66.5 105.9 88.9 70.3 37.9 8.6 127.7 6.6 4.5 39.1 18.3 103.0 16.9 90.2 33.8 92.8 216.0 5.0 138.1 73.2 188.1 40.8 13.7 48.4 119.1 172.8 98.8 81.8 2.2 200.0 GSN DKFZp313L0718 ENSG00000148180 Gelsolin P06396 9 121207794-121332843 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cilium biogenesis/degradation" "Actin capping, Actin-binding" "Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 1649.5;Fibroblasts: 4145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 1135.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 1313.9;HaCaT: 533.6" "Region enriched" "Detected in all" 4 "white matter: 869.2" "Low region specificity" "Detected in all" "CAB010823, CAB016728, CAB036009, HPA054026" Supported Supported "Actin filaments" "Secreted to blood" NA NA 112000000000 240000000000 "Actin filaments" "CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347" "unprognostic (3.25e-2)" "unprognostic (4.44e-3)" "unprognostic (1.22e-1)" "unprognostic (3.10e-3)" "unprognostic (4.23e-2)" "unprognostic (4.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-1)" "unprognostic (6.54e-2)" "unprognostic (6.56e-2)" "unprognostic (3.06e-2)" "unprognostic (8.01e-3)" "unprognostic (4.98e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.79e-5)" 1655.4 163.9 153.5 110.7 280.0 176.6 1255.2 277.4 204.3 555.6 201.7 730.9 153.4 774.1 109.1 439.1 669.0 228.2 1759.3 140.7 334.1 154.3 41.0 311.4 93.9 361.0 268.3 104.9 306.4 141.9 71.5 262.7 79.6 322.4 346.9 206.5 58.3 512.9 404.6 423.9 558.2 387.3 353.1 290.2 137.6 473.7 78.7 239.9 100.6 708.4 693.9 88.0 904.7 661.1 371.8 38.4 60.9 39.0 129.8 1313.9 351.8 26.4 130.9 264.7 30.1 56.5 64.2 130.1 3.0 36.6 182.8 48.5 533.6 3.2 84.3 16.9 6.5 7.6 31.2 57.1 167.5 32.0 7.0 146.0 140.0 84.9 51.7 34.4 83.1 120.4 6.1 10.4 5.3 137.0 81.1 0.4 304.4 12.7 76.2 45.1 8.4 13.1 4.3 156.4 63.4 7.7 10.4 60.9 62.5 197.2 84.6 245.3 158.8 217.4 100.0 33.2 10.4 12.8 1.8 2.0 3.2 105.3 18.2 278.1 302.9 122.0 1135.9 1.9 84.9 0.8 17.6 0.8 1.4 345.3 6.7 0.8 0.7 307.1 217.8 23.7 243.2 4.2 105.4 153.5 280.0 277.4 204.3 140.7 334.1 361.0 268.3 104.9 322.4 290.2 239.9 371.8 1649.5 147.4 55.7 82.3 22.7 341.2 278.1 252.7 103.0 7.5 120.8 212.0 272.0 85.8 354.3 121.4 77.2 55.8 74.9 557.7 105.7 258.5 9.9 141.9 163.1 724.8 63.1 17.2 17.1 202.3 94.3 4145.2 322.7 220.6 104.0 31.8 273.5 16.5 492.6 1.7 9.0 762.9 512.7 139.0 798.7 20.2 588.7 273.7 537.2 155.5 487.5 220.6 55.6 33.2 443.1 315.8 590.5 671.8 24.1 91.4 77.4 39.8 583.7 86.5 611.4 362.4 740.4 8.7 13.7 175.9 299.1 84.0 58.7 34.3 52.2 144.7 MRRF RRF ENSG00000148187 "Mitochondrial ribosome recycling factor" Q96E11 9 122264603-122331337 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 210.0;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047177, HPA049987" Supported Approved "Microtubules,Cytokinetic bridge" Yes No "Microtubules, Cytokinetic bridge" "HPA047177: AB_2679970, HPA049987: AB_2680984" "unprognostic (8.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.40e-2)" "unprognostic (6.06e-3)" "unprognostic (3.64e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.71e-2)" "unprognostic (1.89e-2)" "unprognostic (4.44e-2)" "unprognostic (2.98e-1)" "unprognostic (9.01e-2)" "prognostic favorable (2.14e-8)" "unprognostic (3.89e-2)" "unprognostic (4.05e-1)" "unprognostic (8.02e-2)" "unprognostic (8.88e-3)" 18.5 19.5 11.2 12.2 11.3 14.3 19.5 12.4 13.4 13.1 15.0 25.4 23.9 10.2 13.2 25.7 11.5 8.9 23.5 11.3 12.0 23.1 24.5 13.4 14.1 11.9 11.6 11.2 11.4 18.4 23.4 12.6 9.1 12.1 14.8 28.9 14.7 15.4 10.7 40.9 21.8 18.7 10.2 11.3 15.7 14.5 18.2 11.9 13.9 16.4 32.4 20.6 17.0 16.5 12.2 34.7 45.8 25.6 43.0 35.7 32.5 48.7 33.7 43.0 44.5 26.0 55.0 40.6 75.0 16.7 27.0 35.5 99.3 74.1 78.8 36.3 25.2 30.3 25.6 53.4 30.5 23.6 72.3 32.7 30.5 52.7 40.0 70.8 22.4 50.4 29.6 44.2 27.8 45.1 55.1 36.2 23.6 30.0 86.0 45.7 26.8 48.8 79.7 76.6 34.8 30.3 19.9 36.2 58.3 27.9 24.3 62.8 18.2 27.1 19.5 29.6 51.0 42.0 19.1 50.1 33.0 36.8 42.4 22.8 4.7 17.5 6.0 13.3 29.0 14.2 15.6 13.3 12.5 29.8 12.7 13.8 16.5 2.0 22.9 31.3 12.9 16.3 11.1 11.2 11.3 12.4 13.4 11.3 12.0 11.9 11.6 11.2 12.1 11.3 11.9 12.2 22.7 3.2 9.1 21.9 18.8 15.4 22.1 30.3 26.2 13.2 20.1 17.3 21.8 18.6 17.8 14.7 12.5 29.0 10.8 21.4 35.2 36.0 210.0 16.2 15.7 22.5 7.8 29.3 28.6 29.5 49.2 11.1 23.9 12.1 24.7 14.5 14.3 19.2 30.4 5.0 39.1 22.0 18.3 17.0 16.5 191.7 9.6 16.0 14.2 20.6 18.3 6.3 11.3 22.1 31.0 24.0 20.6 7.5 19.4 18.1 41.2 37.3 16.2 23.5 19.7 15.1 11.7 30.2 16.6 32.5 22.4 37.1 12.3 31.1 33.9 22.7 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771311 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 23.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 105.5;Extravillous trophoblasts: 160.0;Inhibitory neurons: 114.7;Oligodendrocyte precursor cells: 112.6;Spermatogonia: 111.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 4.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.9" "Cell line enhanced" "Detected in many" "BEWO: 110.7;CACO-2: 26.5;Hep G2: 25.8;K-562: 34.1;NTERA-2: 39.2;U-266/84: 25.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.3 0.8 1.7 0.9 1.9 4.4 0.9 2.2 1.9 0.7 3.7 1.8 1.7 0.5 0.5 1.9 0.5 0.4 0.9 1.8 1.4 1.7 2.7 1.5 0.3 1.9 1.3 1.6 0.3 2.9 0.8 1.5 2.3 1.5 1.4 1.5 3.2 1.2 0.5 1.4 2.1 2.5 0.4 1.4 0.8 0.4 23.1 2.7 0.1 5.4 0.8 0.7 0.7 1.3 1.9 1.2 3.0 14.7 2.0 0.3 0.2 110.7 0.2 1.1 0.8 1.3 26.5 2.9 5.0 1.0 0.1 3.8 2.8 1.6 1.3 1.7 1.1 4.6 4.1 4.8 25.8 0.1 2.3 7.2 0.1 1.3 1.2 1.6 0.3 0.2 1.2 34.1 0.7 0.6 0.6 0.1 3.2 39.2 1.3 1.1 1.2 1.5 2.2 0.5 2.0 2.2 0.8 0.2 0.7 0.9 21.7 2.6 1.3 0.0 1.4 3.1 0.9 0.7 3.3 25.0 4.3 0.9 2.3 0.8 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 4.9 0.0 0.3 0.1 0.0 0.1 1.7 1.9 2.2 1.9 1.8 1.4 1.9 1.3 1.6 1.5 1.4 2.7 1.9 0.8 0.0 7.7 47.0 0.6 37.3 17.4 4.2 13.6 3.8 6.8 3.7 2.0 7.2 5.9 5.5 29.2 36.7 1.6 8.9 1.9 10.1 53.5 4.1 0.9 3.2 4.8 6.1 105.5 3.5 160.0 2.0 2.0 3.7 1.3 16.1 1.4 6.0 8.2 1.7 114.7 6.9 8.2 2.2 30.6 30.3 1.2 3.2 8.8 54.4 5.2 7.0 0.0 112.6 73.0 1.9 6.0 1.9 0.5 19.4 24.5 3.3 8.6 10.7 0.0 1.5 3.5 72.7 111.1 8.6 39.8 30.6 0.3 8.1 11.9 15.5 CRB2 "FLJ16786, FLJ38464" ENSG00000148204 "Crumbs cell polarity complex component 2" Q5IJ48 9 123356170-123380324 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Gastrulation, Sensory transduction, Vision" "Developmental protein" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 22.7;choroid plexus: 10.6;kidney: 5.6;retina: 8.1" "Cell type enhanced" "Detected in some" "Astrocytes: 40.5;Bipolar cells: 29.7;Cone photoreceptor cells: 118.9;Oligodendrocytes: 26.8;Rod photoreceptor cells: 110.1" "Group enriched" "Detected in some" 7 "glioma: 9.4;ovarian cancer: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 32.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043674 Approved Supported "Intracellular and membrane" NA NA 210000 "HPA043674: AB_10962974" "unprognostic (1.38e-2)" "unprognostic (2.39e-2)" "unprognostic (1.26e-1)" "unprognostic (2.83e-4)" "unprognostic (2.85e-2)" "unprognostic (1.14e-2)" "unprognostic (2.31e-1)" "unprognostic (3.69e-4)" "unprognostic (1.20e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-3)" "unprognostic (3.09e-1)" "unprognostic (5.56e-5)" "unprognostic (1.31e-1)" "unprognostic (1.55e-1)" "unprognostic (4.38e-2)" "unprognostic (3.38e-1)" 0.7 0.0 13.5 0.5 16.9 0.3 0.1 12.1 10.9 0.0 10.6 0.7 0.1 1.5 0.1 0.0 1.0 0.0 0.1 10.8 14.9 5.6 0.0 0.0 0.7 21.0 15.4 7.3 0.2 0.0 0.0 1.4 0.0 22.2 0.0 0.4 8.1 0.0 0.0 0.0 0.1 0.3 0.3 22.7 0.5 0.2 0.5 18.5 0.2 0.1 0.0 0.6 0.2 0.0 19.3 0.0 0.1 32.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.6 0.0 0.0 4.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 16.9 12.1 10.9 10.8 14.9 21.0 15.4 7.3 22.2 22.7 18.5 19.3 0.0 0.0 0.0 40.5 0.5 0.3 0.1 0.0 0.0 29.7 0.0 2.2 2.8 0.0 0.0 1.8 118.9 0.1 0.0 0.7 0.0 0.0 3.9 0.4 1.3 0.4 3.0 0.0 4.2 0.0 0.1 2.5 0.0 0.1 1.3 0.0 0.0 0.0 0.2 3.3 0.4 2.8 0.0 0.0 1.0 7.7 1.8 0.1 0.0 0.0 0.1 6.1 1.0 2.0 26.8 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 110.1 0.0 0.5 0.3 0.1 0.3 0.0 0.6 0.3 0.1 0.1 5.3 0.1 OR5C1 "hRPK-465_F_21, OR5C2P, OR9-F" ENSG00000148215 "Olfactory receptor family 5 subfamily C member 1" Q8NGR4 9 122788933-122789895 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALAD "ALADH, PBGS" ENSG00000148218 "Aminolevulinate dehydratase" P13716 9 113386312-113401290 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" "Allosteric enzyme, Lyase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 211.5" "Cell type enhanced" "Detected in all" "Erythroid cells: 147.8;Granulosa cells: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021023, HPA022124" Enhanced Approved Cytosol NA NA 44000000 Cytosol "HPA021023: AB_1844716, HPA022124: AB_1844717" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "prognostic unfavorable (7.33e-5)" "prognostic favorable (5.64e-4)" "unprognostic (4.16e-2)" "unprognostic (9.49e-2)" "prognostic favorable (8.80e-5)" "unprognostic (2.87e-3)" "unprognostic (3.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (3.31e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.75e-1)" "unprognostic (1.22e-1)" "unprognostic (3.40e-1)" "unprognostic (1.31e-2)" 55.2 155.2 82.3 16.9 87.4 82.9 23.4 84.4 79.0 18.6 62.4 26.0 29.7 16.4 26.8 35.3 15.7 27.7 47.2 73.9 81.5 73.9 211.5 20.8 15.8 94.6 91.6 68.1 29.1 46.9 73.8 16.0 25.1 91.5 34.4 24.7 19.2 99.5 24.4 29.0 39.2 26.9 17.7 89.5 13.7 50.8 13.2 92.2 20.5 26.1 24.1 18.8 18.5 19.4 92.8 8.1 14.8 11.0 15.7 71.2 48.4 67.8 21.9 35.4 13.7 17.2 19.2 16.7 11.7 12.7 30.3 11.0 29.1 8.1 14.6 8.3 29.5 10.2 22.0 18.2 26.2 16.4 21.2 19.0 41.2 10.8 12.7 5.5 53.9 27.1 18.6 8.9 16.5 23.7 61.8 23.8 21.2 5.4 57.9 27.4 19.5 18.7 19.8 21.4 16.6 10.2 9.4 27.2 32.5 20.1 19.2 34.1 23.7 30.7 12.5 9.3 25.1 12.4 23.8 26.0 9.8 34.1 18.9 13.6 10.2 13.7 23.6 11.3 15.5 6.0 6.8 9.3 6.0 14.6 10.2 8.7 9.9 6.2 6.9 17.4 6.0 10.8 9.7 82.3 87.4 84.4 79.0 73.9 81.5 94.6 91.6 68.1 91.5 89.5 92.2 92.8 7.2 16.0 15.6 18.6 10.4 7.0 8.9 7.1 8.0 12.9 16.7 11.6 50.3 25.8 12.0 14.7 27.1 48.2 7.4 27.7 13.7 20.3 5.4 17.7 9.2 11.5 9.1 147.8 10.0 26.3 23.2 10.2 15.3 27.7 14.5 86.5 11.0 70.0 17.0 5.0 10.7 12.5 10.2 15.1 6.4 10.8 11.8 12.4 12.4 9.4 12.4 6.4 8.2 7.1 20.0 15.0 35.3 14.7 11.0 7.6 32.6 59.0 10.6 15.7 6.6 8.9 24.6 6.8 9.5 22.6 9.1 11.4 8.8 11.7 16.7 9.2 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116423112-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.0" "Cell type enhanced" "Detected in many" "Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 3.3 9.9 29.3 2.7 26.9 3.7 4.3 38.1 36.7 5.1 8.2 4.4 3.4 3.2 3.9 2.2 8.1 2.5 13.4 27.8 33.1 5.3 4.1 2.3 2.4 31.2 29.6 20.3 2.8 6.7 3.1 11.7 1.9 29.2 25.5 3.2 13.5 5.8 11.4 7.4 2.4 4.1 2.9 22.8 2.4 5.7 17.8 32.7 6.1 1.8 5.7 1.9 3.2 3.6 40.0 3.7 12.0 4.3 7.1 7.6 7.0 15.4 5.7 2.3 2.5 2.8 8.1 4.4 8.8 6.1 3.8 9.3 1.3 11.5 0.6 3.1 4.8 2.9 3.1 5.8 17.0 3.0 1.8 6.2 9.5 1.1 7.8 0.7 5.4 1.8 10.5 3.9 5.9 7.9 3.8 4.1 1.4 13.2 10.6 6.4 4.9 27.5 2.5 8.0 12.3 6.3 37.9 6.8 2.0 4.8 14.5 15.5 1.3 3.5 5.9 9.1 5.6 4.9 9.0 5.0 8.3 10.5 2.0 25.8 2.5 0.4 0.5 2.8 0.3 3.6 1.5 3.1 2.4 0.2 1.6 3.0 2.5 1.9 5.9 0.6 0.9 8.8 1.0 29.3 26.9 38.1 36.7 27.8 33.1 31.2 29.6 20.3 29.2 22.8 32.7 40.0 0.6 6.4 8.9 354.6 1.1 1.3 3.2 0.4 1.2 4.9 4.2 4.8 22.7 2.8 5.0 1.8 10.4 0.4 1.0 0.4 3.9 0.8 122.5 4.7 5.5 1.3 12.6 0.4 370.0 1.1 0.4 4.9 4.1 0.7 6.3 37.0 0.7 2.9 3.2 10.1 1011.0 1.0 0.0 0.0 1.6 228.2 2.8 1.0 0.0 36.5 0.2 3.0 0.0 900.3 225.9 0.5 2.1 5.7 3.6 11.7 5.7 6.9 11.7 5.1 0.0 1.9 2.0 7.7 13.2 0.3 0.6 0.3 3.8 1.9 1.8 2.2 WDR31 FLJ35921 ENSG00000148225 "WD repeat domain 31" Q8NA23 9 113313222-113340298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 69.6;Cone photoreceptor cells: 29.2;Early spermatids: 29.5;Late spermatids: 27.2;Rod photoreceptor cells: 42.0;Spermatocytes: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019340, HPA019347" Approved Approved "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA019340: AB_1858800, HPA019347: AB_2215267" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.78e-3)" "prognostic favorable (1.85e-4)" "unprognostic (4.54e-2)" "unprognostic (1.59e-1)" "unprognostic (2.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.48e-1)" "unprognostic (2.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.90e-9)" "unprognostic (9.11e-2)" "unprognostic (1.65e-1)" "unprognostic (7.96e-3)" "unprognostic (8.50e-2)" 1.2 3.4 2.6 0.5 2.6 1.0 2.8 2.0 2.5 1.9 4.2 1.2 1.1 1.5 1.9 1.4 3.9 1.4 5.8 2.3 2.7 3.4 1.7 1.4 0.4 2.4 2.8 2.4 2.2 1.8 11.2 2.9 0.6 2.4 2.0 1.3 18.1 3.8 2.1 0.9 1.5 0.6 1.1 2.1 0.4 1.3 4.9 3.0 0.9 3.7 1.0 0.4 1.3 1.1 2.2 3.6 2.6 0.9 1.8 3.1 3.6 0.8 0.8 1.7 0.9 1.1 0.4 2.3 1.3 0.6 1.3 2.5 2.2 0.8 1.7 1.7 2.2 0.2 1.1 1.4 0.4 3.5 0.6 0.1 1.9 2.2 3.6 3.2 2.4 0.7 1.9 3.0 1.2 0.9 2.4 1.1 0.9 0.5 3.4 3.3 1.3 0.7 1.6 2.3 0.7 2.2 1.6 4.2 0.7 2.0 0.7 5.5 0.5 0.4 1.1 1.3 3.1 0.9 2.4 2.5 0.2 1.7 0.8 1.2 1.7 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.9 0.4 0.2 0.2 0.2 0.2 2.6 2.6 2.0 2.5 2.3 2.7 2.4 2.8 2.4 2.4 2.1 3.0 2.2 0.9 6.4 8.2 11.1 0.2 5.4 5.3 2.2 3.4 5.5 3.5 2.4 69.6 4.3 8.1 1.8 29.2 0.4 1.5 1.1 5.9 2.0 29.5 12.3 2.9 3.8 0.0 4.4 7.9 0.2 0.3 7.6 0.0 2.3 5.1 3.4 1.4 3.0 0.8 6.7 8.8 1.4 0.0 1.2 2.2 27.2 1.8 1.3 0.0 1.9 0.2 8.2 1.0 2.0 3.2 1.0 0.6 1.5 0.1 2.8 0.2 5.5 24.6 42.0 0.0 6.0 4.1 25.1 8.6 1.7 4.3 0.3 1.1 2.8 2.1 3.3 POLE3 "CHARAC17, CHRAC17, CHRAC2, p17, Ybl1" ENSG00000148229 "DNA polymerase epsilon 3, accessory subunit" Q9NRF9 9 113407235-113410675 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047945 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047945: AB_2680218" "unprognostic (9.55e-2)" "unprognostic (3.39e-3)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.04e-2)" "unprognostic (1.60e-2)" "unprognostic (1.10e-1)" "unprognostic (4.59e-3)" "unprognostic (2.31e-3)" "unprognostic (1.75e-2)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" 25.4 33.2 22.4 35.2 22.8 114.4 32.1 26.6 24.4 26.0 19.6 29.9 25.6 25.4 26.2 40.0 28.5 18.2 26.7 22.8 21.9 23.8 38.4 23.9 54.1 23.5 21.7 21.9 22.8 27.7 26.9 11.3 26.8 23.5 23.2 33.1 16.5 27.5 23.0 79.9 37.4 26.5 28.0 23.2 33.3 25.1 41.5 22.1 55.6 22.0 56.9 57.1 28.7 25.0 24.0 85.0 103.3 71.2 107.6 39.8 35.3 62.5 110.3 56.0 122.1 95.6 96.5 75.0 305.5 66.9 65.0 74.5 141.4 140.3 121.4 112.0 58.8 84.7 158.9 97.7 99.5 42.4 333.5 92.2 40.5 82.2 106.3 135.5 44.3 86.0 152.7 225.7 165.6 85.9 215.1 230.6 178.4 92.1 180.7 184.8 232.4 296.3 171.8 53.4 79.8 153.8 88.7 160.2 100.0 89.4 43.0 149.7 148.1 71.3 90.0 122.3 115.2 191.2 86.0 301.5 407.4 82.2 193.5 110.1 77.4 85.4 90.4 83.8 87.0 104.2 86.3 78.9 79.8 83.3 82.4 84.8 79.3 17.5 77.4 71.6 83.6 102.0 135.2 22.4 22.8 26.6 24.4 22.8 21.9 23.5 21.7 21.9 23.5 23.2 22.1 24.0 37.2 38.5 30.2 2.0 61.4 93.8 30.8 37.0 66.0 15.0 51.9 49.9 43.6 21.5 35.8 31.3 6.2 60.7 73.9 28.9 43.0 35.7 5.1 45.4 53.7 33.9 24.6 101.6 4.7 45.4 62.5 37.6 22.4 44.1 57.5 41.4 25.7 43.1 49.3 13.5 3.9 36.9 28.5 36.5 66.4 16.4 35.8 44.7 40.9 1.9 60.3 29.9 48.4 3.5 3.6 37.6 13.9 42.5 67.8 36.0 18.3 34.4 35.5 18.3 13.1 47.9 45.7 40.2 93.1 87.6 94.9 34.9 65.5 36.3 42.5 22.6 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361450-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 325.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved Supported "Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol" NA Yes 65000 "Nuclear membrane, Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA064613: AB_2685299" "prognostic unfavorable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.47e-5)" "prognostic unfavorable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 87.9 107.2 19.9 39.1 21.4 67.1 77.1 21.4 23.6 69.4 26.2 66.4 79.9 79.1 40.9 78.2 71.7 39.3 71.9 20.4 26.2 67.6 225.7 85.0 29.8 23.0 21.8 20.6 61.5 151.6 35.7 89.2 55.9 21.2 69.8 38.3 14.1 87.2 39.9 60.6 63.1 82.9 43.8 22.7 60.1 89.2 49.8 23.5 28.1 68.8 23.5 31.6 63.2 59.9 25.1 59.8 96.4 65.3 90.3 134.8 140.2 127.4 184.1 178.4 127.0 124.7 145.9 84.8 41.1 70.6 254.2 122.9 152.7 75.7 94.4 97.0 86.5 46.3 72.1 87.1 156.5 156.2 124.8 94.1 150.4 85.8 109.3 120.2 101.6 118.6 62.9 89.0 109.8 164.5 131.8 60.1 115.4 72.7 162.8 96.2 41.2 89.9 156.5 100.4 56.3 53.8 65.5 136.4 100.4 95.2 61.5 106.6 75.8 127.5 179.4 64.5 137.3 119.6 56.1 86.4 46.4 166.7 66.6 137.5 43.9 40.8 36.2 51.9 32.8 56.9 15.1 36.3 48.4 32.9 12.1 22.0 34.6 28.4 29.4 31.7 38.9 46.9 68.8 19.9 21.4 21.4 23.6 20.4 26.2 23.0 21.8 20.6 21.2 22.7 23.5 25.1 53.5 44.8 48.1 18.9 43.0 60.8 65.8 72.5 46.1 21.9 55.5 43.2 42.6 31.5 47.5 35.0 39.6 167.9 80.4 106.9 19.6 95.7 38.6 28.6 72.8 54.8 75.2 31.1 23.2 118.1 254.4 84.8 78.5 67.7 24.7 49.5 47.5 207.3 85.9 33.7 15.6 107.9 30.5 52.3 50.5 19.7 68.3 50.8 40.9 17.8 53.7 53.3 52.5 22.6 23.8 115.1 65.5 53.0 114.8 106.8 151.3 48.5 23.2 26.9 78.9 51.9 80.6 84.4 47.3 46.1 62.4 325.2 90.5 81.8 81.2 84.2 GBGT1 "A3GALNT, FS, MGC44848, UDP-GalNAc" ENSG00000148288 "Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)" Q8N5D6 9 133152948-133163933 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 16.4;Hofbauer cells: 21.3;Kupffer cells: 31.9;Macrophages: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 64.1;HMC-1: 57.1;HUVEC TERT2: 24.0;NB-4: 29.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051298 Approved "Intracellular and membrane" NA NA "HPA051298: AB_2681428" "unprognostic (4.63e-3)" "unprognostic (8.03e-2)" "prognostic unfavorable (6.22e-4)" "unprognostic (2.70e-1)" "unprognostic (8.87e-2)" "unprognostic (4.38e-1)" "unprognostic (2.97e-2)" "unprognostic (7.43e-2)" "unprognostic (9.04e-2)" "unprognostic (2.27e-3)" "unprognostic (2.35e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (2.92e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-2)" "unprognostic (6.35e-2)" 7.8 10.6 5.3 11.1 5.8 10.0 6.5 10.1 6.9 5.1 10.3 5.3 3.3 6.8 2.7 3.6 7.5 7.6 6.4 4.7 8.8 5.6 1.3 9.8 9.8 11.0 9.4 3.2 12.6 3.5 4.8 4.3 12.9 12.6 6.2 3.2 1.1 4.9 4.2 2.3 3.6 6.7 6.8 6.3 9.0 22.4 1.3 8.5 2.7 6.7 2.9 8.2 6.0 6.4 10.6 0.1 1.6 1.5 0.0 1.0 1.1 0.5 4.7 3.8 2.6 0.1 0.0 0.9 1.2 15.5 4.7 1.7 17.3 10.5 1.0 0.1 0.0 0.5 64.1 1.1 0.0 12.4 2.4 57.1 5.3 1.7 0.6 0.1 10.5 24.0 0.8 18.7 0.2 1.0 0.3 0.2 29.0 4.9 0.5 0.4 4.5 0.4 1.7 1.6 0.2 0.4 1.8 0.0 2.6 0.1 2.0 0.1 14.0 14.8 0.0 2.0 1.9 0.1 0.0 0.0 0.1 0.3 10.2 0.8 6.2 10.7 5.2 0.2 7.2 0.4 1.8 0.3 0.0 3.0 2.7 0.1 0.1 1.7 0.2 6.4 2.2 0.2 2.5 5.3 5.8 10.1 6.9 4.7 8.8 11.0 9.4 3.2 12.6 6.3 8.5 10.6 1.6 0.0 1.7 4.9 4.9 0.8 2.2 0.6 2.8 0.3 4.1 2.7 2.6 1.5 0.7 1.8 0.0 2.4 0.0 0.6 0.0 3.2 0.0 0.5 1.8 1.8 0.0 16.4 2.4 0.6 1.1 7.3 2.6 0.3 11.4 3.6 0.7 0.0 21.3 0.0 1.9 0.3 0.0 31.9 3.1 0.0 7.5 22.0 0.0 5.6 11.1 2.4 0.0 1.5 0.0 0.8 12.1 1.9 0.7 1.5 0.1 1.6 0.0 0.2 0.0 3.9 6.2 0.1 0.1 1.4 1.1 3.6 2.0 0.5 1.2 1.7 SURF1 ENSG00000148290 "SURF1 cytochrome c oxidase assembly factor" Q15526 9 133351758-133356676 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease variant, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033946 Uncertain NA NA "CAB033946: AB_2302648" "unprognostic (1.87e-1)" "unprognostic (7.76e-3)" "unprognostic (1.34e-2)" "unprognostic (4.26e-3)" "unprognostic (3.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.35e-1)" "unprognostic (7.68e-2)" "unprognostic (3.00e-1)" "unprognostic (4.75e-2)" "unprognostic (1.11e-2)" "unprognostic (2.66e-1)" "prognostic favorable (6.92e-9)" "unprognostic (3.91e-2)" "unprognostic (2.13e-1)" "unprognostic (4.58e-2)" "unprognostic (1.98e-1)" 40.9 54.7 32.1 9.8 33.0 16.9 40.2 33.0 41.6 32.1 33.9 50.4 18.9 33.1 38.8 35.2 34.7 12.8 61.4 31.3 32.8 59.0 93.8 33.7 16.8 32.4 32.6 30.9 31.9 80.1 35.1 41.5 12.0 32.3 42.9 21.0 9.0 42.7 21.6 80.8 41.0 41.4 13.9 32.4 40.2 66.0 34.1 33.3 20.4 44.1 41.6 21.9 46.0 32.0 33.1 9.6 21.8 16.5 23.5 39.7 22.0 35.6 11.5 27.8 18.9 16.5 29.6 32.6 13.0 16.3 18.2 27.6 27.8 20.4 27.6 15.0 23.8 13.3 13.2 31.5 23.4 46.9 21.1 13.5 26.3 47.8 13.2 32.1 23.1 14.9 33.2 13.7 26.3 21.0 42.4 26.7 21.8 18.6 86.9 22.1 18.2 24.7 40.8 31.4 20.4 16.2 45.0 26.2 34.2 30.6 22.4 50.1 15.8 12.2 23.3 14.3 16.1 11.6 32.2 51.9 16.3 22.1 10.3 24.0 10.7 11.6 24.1 6.6 7.8 7.9 23.9 9.8 9.0 10.2 19.3 14.0 7.7 11.1 6.5 7.1 13.4 14.9 5.6 32.1 33.0 33.0 41.6 31.3 32.8 32.4 32.6 30.9 32.3 32.4 33.3 33.1 46.2 28.9 29.6 5.2 55.6 46.5 54.9 56.1 43.3 24.4 85.5 97.3 94.6 75.8 44.0 68.0 6.2 93.4 55.7 114.0 137.0 90.4 48.3 54.5 25.2 36.8 53.8 32.2 4.8 101.0 87.5 38.3 41.8 36.9 22.9 44.3 50.3 158.1 101.1 28.6 5.6 74.3 99.7 93.2 83.6 127.1 52.2 60.3 69.4 4.7 96.9 95.2 62.8 4.5 10.4 71.9 102.1 48.2 74.3 56.1 215.0 174.5 45.1 25.3 32.9 41.5 56.6 66.2 94.4 50.4 49.0 80.6 51.5 52.6 79.6 63.4 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356550-133361158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 106.7" "Group enriched" "Detected in many" 4 "Early spermatids: 448.9;Late spermatids: 992.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 14.4 16.5 13.3 5.4 12.9 5.4 15.5 13.5 15.8 13.6 12.3 15.4 7.7 13.2 6.0 26.1 13.5 3.6 16.5 13.0 12.6 24.7 22.8 12.2 7.1 14.4 13.6 12.8 13.3 29.2 5.9 24.4 3.1 13.4 17.9 2.9 4.7 17.2 4.5 21.8 28.5 14.3 2.3 12.7 15.7 20.3 106.7 13.5 6.1 15.6 3.9 5.0 16.7 15.7 13.9 17.4 29.4 12.1 15.1 8.7 6.7 25.4 8.6 7.5 13.5 7.0 40.5 14.0 17.1 12.2 5.8 11.6 46.5 19.2 21.1 6.1 16.7 26.8 13.5 34.7 15.3 17.3 22.6 9.9 8.1 24.5 19.3 28.1 4.8 6.3 20.6 21.9 11.5 9.3 104.3 23.4 15.0 38.1 41.3 56.0 25.7 18.1 40.4 11.8 19.6 44.8 22.7 19.3 31.7 27.0 7.3 33.8 10.6 12.1 20.3 20.7 21.2 31.2 14.3 30.6 18.7 13.0 13.3 20.8 23.7 23.0 18.6 24.3 24.8 32.1 22.3 29.7 28.0 20.3 27.5 27.9 26.6 10.3 21.1 18.6 22.7 42.1 20.8 13.3 12.9 13.5 15.8 13.0 12.6 14.4 13.6 12.8 13.4 12.7 13.5 13.9 26.7 12.8 11.5 3.3 23.2 84.1 27.6 53.7 50.7 18.3 31.1 55.1 13.3 35.8 27.3 22.0 2.1 37.8 25.0 30.6 105.7 73.0 448.9 44.4 16.8 20.9 36.5 28.2 3.5 81.6 28.4 19.3 19.9 16.5 9.5 12.9 22.5 23.6 29.7 13.5 2.9 21.5 36.7 25.5 31.7 992.3 26.1 18.7 42.7 0.0 33.1 28.2 34.0 1.0 3.5 63.8 37.4 24.5 19.6 28.8 81.4 78.0 60.2 23.6 65.7 24.4 26.8 169.9 107.3 43.0 88.2 25.6 38.2 52.2 30.1 23.2 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328776-133336188 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA023608: AB_1857671, HPA074622: AB_2686703" "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favorable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 10.3 11.8 8.1 4.1 7.5 5.0 10.3 8.3 7.6 12.4 5.8 12.8 6.2 12.0 2.6 12.6 11.3 2.5 9.9 7.1 6.9 10.2 12.4 8.6 5.5 7.6 7.8 6.7 13.2 11.3 3.9 8.2 3.4 8.0 11.6 3.4 3.3 9.8 4.0 18.1 13.2 12.2 2.7 7.5 11.5 10.0 8.0 7.7 4.6 10.7 3.9 3.8 12.3 11.2 7.7 5.6 8.7 6.5 9.8 4.0 3.7 10.8 8.8 5.1 7.7 4.8 13.8 9.2 16.2 6.7 4.9 5.6 16.7 8.4 9.3 2.8 10.8 9.6 11.2 10.5 8.3 7.2 19.1 9.3 5.3 8.0 8.0 7.4 6.8 4.0 15.6 25.1 8.4 6.8 14.7 15.5 15.7 19.1 22.7 15.6 16.1 9.1 16.7 6.7 5.3 13.7 11.6 8.6 13.7 7.8 3.9 12.2 10.6 8.4 17.3 9.3 8.9 12.0 6.2 9.6 21.0 6.5 12.9 10.4 3.3 3.0 1.4 4.3 2.9 4.5 4.6 3.9 3.9 3.3 5.1 5.2 4.4 0.8 3.2 2.7 6.0 3.6 2.5 8.1 7.5 8.3 7.6 7.1 6.9 7.6 7.8 6.7 8.0 7.5 7.7 7.7 25.7 44.8 27.3 4.6 20.9 23.7 15.7 11.0 24.5 26.5 33.4 32.3 30.0 28.6 24.5 22.0 6.2 32.2 20.3 36.8 21.5 29.2 1.3 21.1 42.2 23.6 33.6 14.1 4.3 19.6 25.2 21.2 18.8 25.1 25.3 25.4 16.4 35.2 21.2 21.9 4.8 40.3 6.1 14.7 10.2 4.1 27.7 13.7 7.2 5.6 18.6 15.2 29.9 5.0 4.1 29.0 33.3 27.8 14.4 24.8 50.6 26.1 13.2 19.6 0.0 15.8 20.3 19.2 23.6 26.3 27.6 19.0 18.1 91.1 57.7 13.3 MED22 "Med24, SRB6, SURF5" ENSG00000148297 "Mediator complex subunit 22" Q15528 9 133338312-133348131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020391, HPA063694" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020391: AB_1857668, HPA063694: AB_2685093" "unprognostic (2.62e-2)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "unprognostic (7.53e-2)" "unprognostic (5.56e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (4.99e-3)" "unprognostic (3.23e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.46e-4)" "unprognostic (3.99e-1)" "prognostic favorable (3.76e-11)" "unprognostic (9.25e-3)" "unprognostic (2.66e-1)" "unprognostic (1.66e-2)" "unprognostic (1.62e-1)" 13.5 20.5 6.4 6.3 6.2 5.0 14.1 6.4 7.1 21.2 5.4 21.2 5.3 23.4 2.8 15.7 20.6 3.4 21.0 6.1 6.0 19.6 12.2 15.2 6.4 7.7 6.5 5.6 21.6 14.9 6.8 16.9 4.5 6.7 21.9 3.0 2.9 14.4 7.4 13.4 14.0 17.8 5.6 6.7 22.1 15.8 10.3 6.3 4.6 19.4 3.3 5.0 23.4 16.4 6.4 10.0 11.5 17.7 12.7 3.8 6.5 20.5 11.9 8.3 14.5 9.6 25.4 9.1 20.0 6.9 8.5 12.6 19.4 13.3 11.5 6.0 15.7 7.7 10.6 28.8 6.9 6.4 13.7 10.5 5.0 9.0 13.0 8.6 6.8 7.0 11.5 15.7 9.3 6.9 13.8 19.5 11.4 24.8 12.4 13.8 26.4 14.1 18.4 6.0 7.2 14.3 11.6 13.8 17.4 10.4 7.1 19.7 4.7 9.5 18.7 13.0 13.0 15.8 6.4 9.4 19.4 10.8 10.6 15.8 1.1 1.5 2.6 0.7 1.2 0.9 1.1 0.8 0.9 1.1 1.5 0.9 0.7 2.3 0.6 2.2 1.5 0.7 1.1 6.4 6.2 6.4 7.1 6.1 6.0 7.7 6.5 5.6 6.7 6.7 6.3 6.4 6.4 22.4 11.7 4.6 8.3 8.3 10.6 4.0 4.0 13.6 6.9 5.2 9.9 7.2 3.1 16.5 0.0 6.1 12.8 8.8 3.9 5.8 1.9 3.7 6.7 8.4 6.7 3.8 3.0 5.3 5.1 11.2 6.1 6.2 7.6 8.4 6.4 4.3 7.8 13.5 3.3 6.5 4.1 7.2 8.3 2.8 11.8 8.3 1.8 3.7 5.6 9.6 5.2 3.0 5.3 8.1 2.1 16.6 6.8 8.4 8.3 5.2 1.7 12.1 26.3 14.8 15.2 13.2 13.7 5.2 6.5 5.5 5.8 5.9 5.9 4.7 REXO4 "hPMC2, XPMC2H" ENSG00000148300 "REX4 homolog, 3'-5' exonuclease" Q9GZR2 9 133406059-133418096 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047006 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA047006: AB_2679900" "unprognostic (2.69e-2)" "unprognostic (3.76e-1)" "unprognostic (8.13e-2)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (2.15e-3)" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.14e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.25e-2)" "unprognostic (2.86e-2)" "unprognostic (9.20e-2)" "unprognostic (1.20e-1)" 12.3 15.8 8.7 6.7 8.8 5.1 12.4 9.0 9.5 16.0 7.9 14.8 5.8 12.8 3.8 18.3 12.3 4.6 14.1 8.6 8.2 14.3 22.8 10.6 8.8 8.7 8.6 8.5 18.1 21.6 5.1 13.1 5.9 9.0 15.9 3.9 3.5 13.2 4.7 35.7 17.1 14.4 3.9 8.7 18.9 14.2 18.4 8.7 8.3 12.9 9.8 6.7 16.3 15.3 9.1 9.8 22.2 10.3 15.1 10.5 10.7 18.2 16.4 9.3 17.0 11.2 26.8 12.3 31.5 11.0 9.0 13.9 26.0 21.5 17.2 9.7 20.5 19.8 17.2 23.7 21.1 13.0 39.4 16.1 10.1 14.4 17.9 24.4 13.0 12.6 16.8 38.3 13.5 11.0 28.1 27.9 23.7 20.8 35.0 32.2 19.7 16.7 31.5 10.8 9.1 29.1 15.9 17.4 20.2 19.4 10.1 24.7 15.7 11.1 30.9 16.1 14.7 20.3 8.8 11.5 21.6 11.5 22.5 18.7 0.4 1.3 2.0 1.9 1.3 2.2 2.4 2.0 2.0 1.1 2.8 2.5 2.7 0.1 3.9 1.1 1.8 2.0 1.0 8.7 8.8 9.0 9.5 8.6 8.2 8.7 8.6 8.5 9.0 8.7 8.7 9.1 16.8 22.4 15.0 4.9 29.7 25.0 22.3 12.9 10.2 26.6 27.0 23.5 9.9 21.5 8.5 25.8 22.9 37.5 27.8 24.2 19.6 29.2 38.2 36.6 34.5 17.4 13.2 7.6 4.4 28.7 36.2 14.7 7.1 32.7 17.7 24.2 19.6 26.8 21.3 16.8 4.6 22.2 4.1 22.4 11.5 83.3 28.9 13.2 7.2 1.9 37.9 17.6 51.5 1.5 5.0 30.6 21.7 24.0 18.4 25.3 30.8 28.2 10.4 34.1 19.7 13.1 16.9 51.6 65.9 10.7 27.6 31.5 24.9 16.4 35.8 13.7 RPL7A "L7A, SURF3, TRUP" ENSG00000148303 "Ribosomal protein L7a" P62424 9 133348218-133351426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046794 Approved Nucleoli,Vesicles NA NA 490000 Nucleoli Vesicles "HPA046794: AB_2732534" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (8.83e-3)" "unprognostic (1.07e-3)" "unprognostic (4.17e-3)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (1.98e-1)" "unprognostic (8.88e-2)" "prognostic unfavorable (3.60e-5)" "unprognostic (4.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (4.06e-2)" "unprognostic (1.92e-2)" "unprognostic (9.89e-2)" 1791.8 2116.2 548.1 503.6 550.0 1306.5 1873.6 544.8 620.8 2157.9 557.0 1625.6 549.1 1648.7 1074.4 2739.8 1844.5 502.6 1322.2 531.2 566.6 1387.0 1402.2 1268.3 1014.7 561.1 546.9 520.8 3892.7 4146.6 611.2 1335.7 538.7 557.2 1679.2 918.6 239.4 1772.4 616.2 2016.4 2671.0 1430.9 773.9 585.6 1555.1 1777.3 697.5 566.3 1119.0 1298.0 870.5 1365.1 1733.6 2089.8 574.5 738.0 1094.6 1223.6 1227.0 2101.3 3459.0 1165.5 904.3 1835.4 1592.3 882.0 1676.1 941.1 2286.8 542.9 1587.3 858.2 1754.6 1831.4 2172.0 1273.6 977.8 1036.3 807.6 1533.7 1656.6 1389.2 1932.4 915.0 3509.5 3187.7 1154.6 1984.2 2581.3 2055.4 1579.3 1573.5 1170.9 1855.9 2494.0 1509.9 2010.8 1336.2 3265.2 1067.1 1307.0 1533.0 2946.8 2077.6 925.6 1144.0 1009.2 739.8 1878.6 1209.1 1008.0 2050.7 2009.1 1133.2 1042.8 746.6 950.3 1094.7 453.3 975.5 1410.1 814.8 1328.8 830.2 115.2 309.8 65.6 395.1 280.0 583.3 624.2 535.6 488.8 452.9 544.4 591.3 560.4 43.6 433.2 255.0 449.1 453.7 959.4 548.1 550.0 544.8 620.8 531.2 566.6 561.1 546.9 520.8 557.2 585.6 566.3 574.5 2135.7 519.2 830.9 22.5 3484.9 3244.6 4561.0 2878.3 4056.7 324.7 4450.1 8182.0 389.0 1720.0 1397.0 597.7 143.9 3617.6 2668.7 1136.8 2122.9 2037.3 1992.4 1277.7 3110.1 1843.9 1503.3 2592.1 30.3 4412.9 5135.5 1931.5 1701.4 1613.2 851.9 3717.2 1779.5 1292.4 2514.0 131.2 28.5 2769.2 876.9 2202.6 2161.8 4012.3 3736.3 2023.9 1511.9 22.5 2569.6 1085.1 2398.6 22.6 34.9 2672.7 2176.1 1929.6 3366.8 4776.6 2603.2 2708.5 569.1 516.9 966.3 2340.4 2271.5 1087.3 793.2 6499.1 3980.6 3307.4 2539.1 5934.2 3443.7 5327.8 GTF3C5 "TFiiiC2-63, TFIIIC63, TFIIICepsilon" ENSG00000148308 "General transcription factor IIIC subunit 5" Q9Y5Q8 9 133030675-133058503 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067063, HPA069805" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067063: AB_2685773, HPA069805: AB_2686201" "unprognostic (1.07e-2)" "unprognostic (1.78e-3)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-1)" "unprognostic (7.97e-3)" "unprognostic (4.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (1.10e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-3)" "unprognostic (4.55e-3)" "unprognostic (1.13e-2)" "unprognostic (1.33e-1)" "unprognostic (8.73e-2)" 25.5 33.9 26.4 20.7 30.6 42.7 29.4 35.2 36.1 35.9 23.4 28.6 26.6 32.0 22.5 39.4 32.3 17.6 33.5 27.0 26.8 27.7 33.1 23.9 27.9 29.5 29.0 25.3 45.0 33.9 24.7 36.3 24.8 30.3 34.6 19.4 13.8 29.3 20.9 48.3 38.6 30.5 21.7 26.4 32.4 28.8 29.7 28.0 44.9 28.8 32.6 25.5 29.5 33.5 36.7 44.1 77.5 67.3 63.3 35.9 32.5 93.2 42.0 45.4 78.6 55.4 83.5 71.8 72.7 38.7 47.1 63.2 103.9 79.8 76.3 40.2 74.9 69.1 86.8 90.3 78.7 55.9 66.2 176.0 45.0 49.9 83.5 57.7 38.0 69.1 235.1 112.5 66.0 42.1 142.1 107.9 92.4 87.5 100.6 79.7 113.9 69.5 89.2 52.4 50.2 80.4 59.7 71.2 73.4 43.8 38.1 96.5 95.6 46.0 92.0 71.3 59.1 71.8 25.8 57.3 78.0 44.8 49.8 62.4 54.2 16.0 22.5 15.8 18.9 23.0 14.6 16.3 20.7 17.2 13.6 18.1 16.4 9.5 20.7 16.3 16.6 19.4 17.8 26.4 30.6 35.2 36.1 27.0 26.8 29.5 29.0 25.3 30.3 26.4 28.0 36.7 16.0 9.6 19.0 17.3 21.0 12.4 16.5 21.7 30.7 14.2 25.2 21.6 29.3 14.3 17.2 16.5 8.4 42.1 20.0 30.4 29.4 25.5 3.4 16.2 15.4 16.4 14.4 22.3 9.0 30.3 38.4 19.7 18.3 19.9 16.5 50.1 18.5 17.2 22.5 15.2 7.9 15.9 34.6 15.7 9.9 4.3 17.4 15.8 16.0 8.4 14.8 18.8 15.5 6.0 16.6 27.2 25.4 21.4 17.4 13.9 27.3 11.7 14.6 20.8 46.0 17.2 19.4 20.5 31.9 26.1 16.6 41.6 17.6 34.0 25.7 19.4 ASB6 ENSG00000148331 "Ankyrin repeat and SOCS box containing 6" Q9NWX5 9 129634604-129642169 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004341 Approved NA NA "HPA004341: AB_1845070" "unprognostic (1.60e-2)" "unprognostic (7.57e-2)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (1.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (5.61e-2)" "unprognostic (1.99e-1)" "unprognostic (1.34e-2)" "unprognostic (7.68e-2)" "unprognostic (3.38e-3)" "unprognostic (1.95e-1)" "unprognostic (2.07e-2)" "unprognostic (3.74e-2)" "unprognostic (1.71e-1)" "unprognostic (8.00e-2)" 11.1 22.1 15.7 8.8 15.5 27.1 11.6 14.7 18.0 13.5 15.1 11.6 7.6 13.2 6.2 17.5 13.1 6.3 10.4 16.6 13.9 15.6 12.0 10.9 11.6 16.1 15.3 15.9 10.8 15.6 9.2 14.2 7.4 15.6 14.0 5.4 4.5 14.3 8.7 9.9 21.4 13.2 6.3 14.4 19.4 16.3 14.1 15.4 11.3 12.2 5.8 9.0 12.3 13.9 14.5 10.9 16.9 12.6 28.5 13.4 12.9 20.8 20.8 13.6 20.8 12.9 19.2 15.5 9.4 11.7 26.0 29.4 29.4 17.6 20.3 9.1 18.6 25.9 8.6 36.1 9.8 19.4 20.4 16.6 17.0 13.9 26.5 12.6 11.8 16.8 25.2 19.5 13.4 15.0 26.7 21.0 16.3 21.9 21.4 39.8 19.1 13.7 19.2 19.2 10.2 26.2 32.4 19.5 25.8 16.1 9.6 21.2 12.7 18.4 28.8 15.6 35.2 21.7 18.1 20.7 15.9 22.8 14.1 19.6 6.6 6.5 7.1 10.5 6.4 9.4 6.3 6.9 10.1 7.3 5.2 8.6 7.4 3.3 11.3 6.6 6.6 8.9 7.8 15.7 15.5 14.7 18.0 16.6 13.9 16.1 15.3 15.9 15.6 14.4 15.4 14.5 7.1 0.0 5.5 11.8 8.9 22.0 4.5 9.4 19.4 6.5 11.1 9.0 10.9 10.0 3.5 9.2 6.2 12.9 12.4 14.6 21.5 15.0 1.9 10.0 7.2 9.4 7.2 21.9 9.7 10.7 9.8 8.0 14.8 14.9 2.5 6.9 8.6 3.4 8.6 10.1 6.5 7.3 6.1 5.9 8.2 3.0 8.7 6.9 3.6 7.5 6.1 7.6 4.1 7.1 7.6 13.0 9.1 7.9 9.5 8.5 8.3 6.7 3.4 6.5 13.1 6.2 7.7 8.0 10.2 12.0 20.2 14.2 11.1 6.4 7.5 5.9 PTGES2 "C9orf15, FLJ14038" ENSG00000148334 "Prostaglandin E synthase 2" Q9H7Z7 9 128120693-128128462 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 118.9" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 700.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020631, HPA020733" Approved Approved Mitochondria No No Mitochondria "HPA020631: AB_1855887, HPA020733: AB_2670508" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-2)" "unprognostic (5.13e-3)" "unprognostic (2.56e-1)" "unprognostic (1.57e-1)" "unprognostic (7.10e-2)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "prognostic favorable (5.83e-7)" "unprognostic (2.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" 15.5 50.2 27.5 15.7 30.0 6.6 16.2 25.0 46.2 17.8 26.5 27.5 27.8 21.8 4.1 35.6 17.7 11.5 81.5 31.1 28.8 36.6 38.0 15.0 17.7 28.2 29.5 29.3 16.3 37.9 35.6 41.7 9.8 29.0 24.8 9.3 10.1 26.3 17.0 118.9 19.9 24.0 7.6 22.8 21.3 29.8 14.6 28.0 12.0 23.7 79.4 9.8 22.5 22.2 29.6 46.1 114.0 15.5 54.4 13.5 12.8 47.9 30.7 20.6 48.6 24.9 86.9 75.6 43.5 45.7 15.9 36.9 108.8 22.5 47.1 6.5 28.3 62.3 21.0 92.7 79.5 41.0 42.1 39.5 18.6 32.3 39.5 26.9 14.2 31.6 47.8 50.2 26.4 16.7 130.0 56.9 75.6 42.7 58.7 113.9 39.6 26.5 111.6 32.8 33.1 69.1 45.6 47.3 86.3 34.2 6.7 78.7 23.5 34.0 46.3 50.2 62.8 63.1 48.9 25.5 38.3 39.1 33.2 44.5 1.4 3.3 0.7 3.1 3.7 3.8 3.8 2.2 3.5 4.3 2.7 2.4 3.0 0.6 2.7 1.8 5.8 3.1 1.9 27.5 30.0 25.0 46.2 31.1 28.8 28.2 29.5 29.3 29.0 22.8 28.0 29.6 18.8 16.0 6.4 10.4 32.0 22.9 38.1 32.7 25.0 37.8 34.2 36.3 700.2 51.5 25.9 23.9 20.9 82.1 30.8 86.1 146.8 74.6 2.1 12.7 20.9 29.4 45.1 13.2 15.5 51.8 62.1 32.7 46.4 17.3 14.7 31.9 13.9 37.8 57.6 37.0 15.8 62.2 46.8 25.3 43.6 4.8 30.7 30.8 56.9 3.7 105.7 21.9 38.1 12.1 7.2 57.6 60.4 21.8 45.4 68.0 93.4 99.3 9.3 44.8 19.7 17.8 37.2 3.6 45.6 48.3 24.6 66.6 25.6 84.1 105.5 52.9 NTMT1 "AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1" ENSG00000148335 "N-terminal Xaa-Pro-Lys N-methyltransferase 1" Q9BV86 9 129608884-129636135 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 391.4;Late spermatids: 761.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020092, HPA058420" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020092: AB_1853831, HPA058420: AB_2683713" "unprognostic (4.74e-3)" "unprognostic (1.77e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (4.17e-3)" "unprognostic (4.92e-2)" "unprognostic (1.24e-1)" "unprognostic (8.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.35e-2)" "unprognostic (1.00e-3)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (3.50e-3)" 23.9 69.1 19.5 19.4 19.9 24.7 22.3 21.9 27.2 22.5 20.3 22.1 18.5 19.7 16.1 20.3 19.1 20.0 59.9 19.8 21.7 28.8 42.0 23.0 20.4 21.1 22.2 19.3 19.9 31.4 22.6 23.5 19.8 22.1 22.9 11.3 6.3 22.6 16.8 99.9 24.6 19.6 13.8 19.9 30.0 25.1 94.0 21.7 16.3 18.1 85.0 16.2 24.1 20.2 22.5 57.8 117.2 47.9 82.2 30.0 44.6 50.2 107.6 63.5 108.1 92.8 96.6 74.0 74.8 53.7 78.5 76.7 110.1 101.8 96.4 66.8 56.3 50.9 31.2 106.3 100.4 96.3 63.3 45.0 47.0 48.6 113.5 56.0 34.2 60.1 64.1 116.5 54.2 57.5 194.1 72.0 85.6 62.6 105.4 96.6 66.8 55.8 150.4 43.7 32.4 96.5 48.5 53.1 97.3 74.7 30.2 81.4 32.4 41.8 129.1 64.5 118.7 115.3 41.2 53.7 115.2 59.0 64.4 75.0 32.9 49.7 39.2 43.7 55.1 43.7 43.2 43.5 46.5 49.2 50.4 43.9 36.3 13.6 30.6 70.9 52.8 44.5 36.4 19.5 19.9 21.9 27.2 19.8 21.7 21.1 22.2 19.3 22.1 19.9 21.7 22.5 35.6 3.2 13.9 5.9 45.9 99.8 85.7 50.3 16.5 18.3 33.4 33.8 4.1 20.0 35.7 22.0 22.9 72.6 23.1 49.7 97.8 60.5 391.4 21.4 29.8 38.3 20.3 23.4 6.4 55.9 86.8 41.1 21.9 23.2 30.4 20.5 20.0 52.7 67.0 42.1 6.5 44.0 42.7 27.6 80.3 761.6 35.1 34.3 55.2 3.7 33.1 23.3 25.7 4.5 9.2 69.2 29.9 24.8 41.0 105.7 84.5 89.6 22.5 23.6 26.3 34.1 58.8 129.2 43.2 19.2 99.3 135.6 38.3 39.2 48.4 70.7 CIZ1 "LSFR1, ZNF356" ENSG00000148337 "CDKN1A interacting zinc finger protein 1" Q9ULV3 9 128161251-128204383 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020380, HPA020387" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020380: , HPA020387: AB_2670425" "unprognostic (1.28e-1)" "unprognostic (5.77e-2)" "unprognostic (2.81e-2)" "unprognostic (3.33e-1)" "unprognostic (1.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.14e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-3)" "unprognostic (3.13e-3)" "unprognostic (8.05e-3)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.47e-3)" 51.3 39.2 36.2 28.7 35.2 55.7 48.7 34.6 46.8 60.1 20.2 58.0 34.8 53.9 24.6 46.6 48.1 34.2 44.1 36.1 27.5 31.8 21.6 38.3 35.4 36.5 32.4 30.3 70.4 71.3 35.3 34.0 28.2 40.0 41.2 27.0 27.1 45.0 33.9 91.2 65.6 42.2 37.2 25.3 35.8 51.7 56.9 34.4 35.6 37.3 42.8 29.7 58.3 50.4 45.5 72.2 85.5 70.7 67.5 71.8 85.6 69.9 55.6 82.2 99.5 56.1 79.1 60.4 84.1 46.1 93.7 82.0 102.1 55.3 59.4 53.9 76.7 64.2 80.2 106.7 51.2 82.5 75.1 91.0 83.7 104.5 109.1 91.9 71.7 68.1 52.9 199.0 70.4 60.5 169.6 98.2 76.1 61.6 96.2 87.4 83.4 74.8 86.5 45.0 48.7 88.4 68.5 123.3 85.8 73.7 31.5 89.7 96.4 72.9 105.7 74.4 120.4 105.6 81.3 99.1 80.2 74.4 49.9 115.1 2.6 2.2 2.6 2.4 3.1 2.2 2.7 2.9 3.1 2.4 3.9 3.0 2.6 0.5 4.9 2.3 2.4 4.8 1.9 36.2 35.2 34.6 46.8 36.1 27.5 36.5 32.4 30.3 40.0 25.3 34.4 45.5 15.4 3.2 12.9 14.0 19.4 23.2 23.2 12.3 21.6 25.9 16.7 17.0 10.8 18.6 11.7 18.4 29.2 23.3 23.6 20.8 13.7 26.0 77.3 10.1 19.9 18.7 22.8 31.5 20.6 44.7 28.8 22.6 25.0 14.8 9.5 25.3 18.5 6.1 22.6 16.8 19.3 19.1 16.2 20.7 18.2 79.2 34.8 17.7 19.6 19.7 19.1 19.6 16.5 11.6 15.9 28.0 15.6 31.2 25.5 15.4 31.6 18.0 8.4 25.0 13.1 23.9 19.1 37.5 26.0 23.8 24.9 20.8 18.2 15.7 25.4 20.0 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favorable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 46.0 23.1 15.9 12.6 14.4 9.6 23.1 14.2 20.9 32.6 9.1 17.1 12.0 27.0 3.3 35.3 41.1 40.2 10.9 17.1 28.2 28.5 137.6 28.1 11.3 18.0 16.5 13.0 25.6 83.3 19.7 46.1 11.6 18.3 15.4 7.8 31.4 16.6 14.3 82.7 22.2 18.5 26.5 13.5 15.7 23.9 7.6 17.8 15.4 19.0 21.3 6.2 19.2 21.6 17.8 9.5 9.8 13.6 19.8 10.1 8.6 9.0 19.3 17.8 15.9 10.5 17.7 9.7 12.2 5.8 9.0 8.8 16.6 10.8 6.3 6.0 14.3 8.9 7.1 21.6 10.7 16.0 8.3 15.7 11.0 6.0 15.5 11.3 5.2 10.9 20.1 26.1 25.7 10.1 22.9 14.7 8.4 13.8 30.5 15.1 14.3 11.6 26.1 6.1 9.8 33.6 14.5 20.2 12.9 27.8 5.3 14.2 4.7 7.0 17.9 10.6 13.6 19.3 22.3 42.2 13.2 12.1 4.4 15.0 2.6 1.7 0.9 3.0 5.1 1.6 1.2 3.4 3.1 3.1 1.8 2.7 4.9 0.3 1.0 6.1 1.0 2.7 3.2 15.9 14.4 14.2 20.9 17.1 28.2 18.0 16.5 13.0 18.3 13.5 17.8 17.8 59.3 22.4 34.2 17.6 9.3 26.1 46.2 24.3 56.3 18.8 71.7 73.5 3.2 58.6 22.8 20.2 127.2 10.1 7.6 45.6 11.7 11.2 0.3 72.0 34.5 44.7 51.7 11.0 19.7 11.5 12.9 21.0 43.8 110.3 8.2 18.7 26.0 84.5 9.1 18.5 20.5 26.5 28.5 20.1 42.9 1.5 9.3 16.8 21.4 13.1 12.6 15.2 12.3 11.1 2.4 12.1 42.7 8.2 14.5 28.6 47.7 10.2 30.8 70.4 19.7 48.1 40.3 5.6 7.9 89.5 43.0 23.0 14.2 11.9 22.3 58.3 SH3GLB2 KIAA1848 ENSG00000148341 "SH3 domain containing GRB2 like, endophilin B2" Q9NR46 9 129007036-129028331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 234.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021438, HPA024734" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021438: AB_1856820, HPA024734: AB_1856821" "unprognostic (2.59e-1)" "prognostic favorable (1.56e-6)" "unprognostic (1.88e-1)" "unprognostic (7.51e-2)" "unprognostic (2.94e-1)" "unprognostic (1.09e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (5.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.81e-2)" "unprognostic (6.25e-2)" "prognostic favorable (2.32e-4)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-3)" "prognostic favorable (4.28e-4)" 32.4 49.5 80.8 19.4 85.7 59.9 46.4 64.8 128.5 53.8 57.3 55.8 42.5 48.3 17.3 102.2 53.2 22.2 32.3 86.7 69.1 55.2 25.5 35.7 25.1 76.8 70.5 88.0 45.6 72.1 69.7 89.0 38.0 78.8 72.4 16.3 11.8 61.3 50.7 50.4 114.7 48.3 18.7 65.1 42.5 71.8 24.6 73.2 37.6 46.2 19.1 22.8 73.2 67.3 86.8 49.7 41.2 19.9 27.1 11.7 14.8 59.2 17.0 37.8 33.0 30.0 25.8 83.2 51.9 13.3 30.1 25.5 119.2 6.3 36.7 9.3 34.0 27.5 13.2 70.5 22.9 24.4 11.9 30.7 10.6 41.1 16.8 14.9 36.2 28.0 66.8 17.8 67.2 16.9 121.5 68.4 31.5 17.8 83.2 28.7 136.3 37.2 234.3 36.7 59.1 62.0 50.3 24.7 62.6 26.3 16.4 90.5 17.5 25.8 15.3 26.1 39.3 37.7 65.6 34.0 33.8 35.6 14.7 8.3 2.1 1.6 3.5 1.9 0.8 2.3 3.5 2.2 1.8 1.3 2.0 1.6 1.3 1.3 2.6 2.5 3.7 2.0 1.5 80.8 85.7 64.8 128.5 86.7 69.1 76.8 70.5 88.0 78.8 65.1 73.2 86.8 36.3 16.0 28.4 28.1 20.3 20.8 27.5 11.6 9.6 26.9 59.7 62.9 10.6 18.6 19.8 47.8 8.4 127.9 29.4 58.2 15.6 14.5 11.2 36.3 19.6 15.6 25.3 29.5 24.4 26.0 19.2 23.3 84.6 63.6 6.3 29.9 12.1 9.9 20.7 47.1 14.2 35.9 12.2 11.9 11.6 24.4 19.0 14.3 14.2 17.8 6.9 36.0 6.2 23.6 95.6 24.6 50.3 20.3 25.9 23.0 39.4 7.6 21.5 20.6 13.1 32.0 39.7 8.6 6.6 27.6 53.6 149.5 16.3 18.3 34.6 58.3 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 18.7;Theca cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" NA NA Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favorable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 6.7 13.7 6.9 5.4 6.2 12.7 5.9 7.0 8.2 6.0 3.8 11.0 15.3 7.3 2.9 12.0 6.7 4.0 15.9 5.8 7.2 7.5 7.8 4.9 4.6 9.2 7.2 6.1 6.9 4.7 6.7 8.2 1.6 7.8 9.4 3.2 2.3 7.3 6.9 9.9 10.0 14.2 4.3 5.8 7.0 10.2 4.6 7.9 4.4 9.3 7.8 3.7 9.4 6.3 7.1 4.8 9.7 2.9 14.9 7.9 4.1 6.5 8.4 6.3 9.5 6.0 8.4 9.8 7.2 3.7 6.6 8.3 22.3 4.0 6.3 1.4 6.6 5.9 5.2 20.4 6.3 8.7 6.0 11.5 5.8 4.9 8.6 4.4 3.1 6.6 6.7 7.7 2.9 5.2 12.7 6.0 12.3 6.7 11.4 13.9 12.2 8.7 12.0 5.0 9.2 9.3 6.6 9.4 14.7 5.2 1.7 10.6 6.4 6.7 6.1 7.0 10.4 6.5 4.0 6.2 6.7 8.7 4.7 7.4 7.2 1.5 1.4 1.5 1.6 3.3 1.2 1.1 2.0 1.6 1.3 1.1 0.7 2.5 0.6 0.9 2.2 1.0 1.2 6.9 6.2 7.0 8.2 5.8 7.2 9.2 7.2 6.1 7.8 5.8 7.9 7.1 7.1 3.2 7.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.1 7.2 0.0 0.0 3.1 7.3 0.0 3.3 8.1 0.0 1.9 5.4 0.0 4.2 4.4 1.8 0.0 0.0 0.0 4.7 2.6 2.4 0.0 7.3 0.0 18.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 5.8 0.0 0.0 1.8 0.0 0.0 4.5 2.9 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 5.6 3.0 22.1 0.0 0.0 PTGES "MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12" ENSG00000148344 "Prostaglandin E synthase" O14684 9 129738331-129753042 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 85.0;urinary bladder: 79.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 101.2;Cytotrophoblasts: 146.0;Extravillous trophoblasts: 293.1;Syncytiotrophoblasts: 276.2" "Cancer enhanced" "Detected in all" "urothelial cancer: 69.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "basophil: 28.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "ASC diff: 147.7;BEWO: 162.7;GAMG: 292.8;HaCaT: 216.3;SK-BR-3: 157.6;U-2197: 404.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045064 Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045064: AB_10795889" "unprognostic (2.92e-3)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (2.54e-2)" "unprognostic (1.94e-3)" "unprognostic (1.25e-1)" "unprognostic (5.38e-3)" "unprognostic (1.24e-3)" "unprognostic (2.92e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.22e-1)" "unprognostic (4.66e-2)" "unprognostic (9.78e-3)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.20e-2)" 27.3 1.4 4.0 14.0 3.3 7.8 25.7 3.5 4.6 24.0 3.0 7.9 2.9 3.7 19.2 18.0 5.5 9.1 6.1 3.9 4.3 8.1 0.7 7.9 7.6 5.3 5.0 3.1 2.2 1.6 42.4 1.9 58.9 5.9 13.8 4.3 0.0 31.0 85.0 1.3 39.9 9.1 4.1 3.7 2.5 7.2 17.0 4.6 4.2 3.7 1.2 31.0 79.3 20.2 4.4 1.5 94.9 0.1 46.6 147.7 51.9 162.7 7.4 64.2 1.1 1.7 5.6 71.7 0.1 2.7 18.0 292.8 216.3 0.7 7.2 0.6 0.3 0.5 0.0 62.5 0.4 3.5 0.0 0.0 30.9 49.0 0.9 0.3 1.4 0.0 0.9 0.0 0.1 0.7 1.7 0.2 0.0 1.2 46.7 8.2 0.2 0.0 0.3 5.3 102.2 0.8 3.6 87.1 157.6 0.8 6.3 83.3 0.0 0.5 0.1 0.4 404.8 0.0 0.0 0.0 0.0 78.8 0.1 0.7 28.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 4.0 0.0 0.0 0.3 4.0 3.3 3.5 4.6 3.9 4.3 5.3 5.0 3.1 5.9 3.7 4.6 4.4 3.4 0.0 0.0 0.3 0.3 17.8 8.9 101.2 10.8 0.0 29.7 19.7 0.1 0.0 53.2 3.7 0.0 146.0 0.6 0.0 1.9 13.4 0.6 1.6 2.3 4.0 7.3 0.0 1.0 1.1 293.1 70.7 0.0 5.0 1.3 61.5 0.0 0.0 17.5 0.0 2.8 6.6 30.5 0.0 21.6 0.4 0.3 13.2 14.2 7.5 7.2 0.0 0.0 0.0 0.2 8.1 0.2 0.0 0.3 8.2 0.3 0.5 6.7 0.0 0.0 0.8 13.5 0.3 0.0 5.5 43.0 276.2 0.8 0.2 0.4 49.2 LCN2 "24p3, NGAL" ENSG00000148346 "Lipocalin 2" P80188 9 128149071-128153453 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 2795.5;gallbladder: 2244.1;salivary gland: 1319.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 4054.2;Club cells: 5757.0;Ductal cells: 6457.0;Pancreatic endocrine cells: 5424.3;Respiratory ciliated cells: 3161.5;Urothelial cells: 7112.9" "Cancer enhanced" "Detected in many" "stomach cancer: 944.6" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 88 "basophil: 9.8;neutrophil: 11.9;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 83 "granulocytes: 11.9;monocytes: 4.7" "Group enriched" "Detected in many" 11 "CAPAN-2: 3623.8;EFO-21: 1450.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 149.7;spinal cord: 102.4" "HPA002695, CAB016549, CAB016550" Enhanced Supported "Endoplasmic reticulum" "Secreted in other tissues" NA NA 297000000 590000000 "Endoplasmic reticulum" "CAB016549: , CAB016550: , HPA002695: AB_1852758" "prognostic favorable (9.61e-4)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (7.38e-3)" "unprognostic (1.01e-2)" "unprognostic (4.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-1)" "unprognostic (1.79e-1)" "unprognostic (2.36e-2)" "unprognostic (2.83e-2)" "unprognostic (1.10e-3)" "unprognostic (6.15e-2)" "unprognostic (2.37e-1)" "unprognostic (3.15e-2)" "unprognostic (1.11e-2)" 5.0 3.6 0.0 126.7 0.2 2795.5 22.1 0.2 0.5 817.3 2.4 251.4 34.7 14.4 20.7 683.0 53.1 2244.1 2.8 0.0 0.1 31.0 68.3 76.7 1.1 0.3 0.4 0.1 1.1 75.5 7.4 21.4 2.6 0.4 75.2 132.3 0.0 1319.0 13.6 1.2 24.6 158.6 12.0 0.1 82.6 367.0 0.5 0.4 14.3 27.3 0.3 200.8 675.7 484.6 1.0 117.7 35.1 0.0 4.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3623.8 0.2 1450.9 0.0 3.7 236.4 0.0 6.9 0.1 5.3 0.0 30.4 0.0 0.8 0.2 0.0 1.1 0.1 230.4 0.0 12.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 1.9 80.9 0.2 0.2 0.3 0.3 1.0 20.1 0.1 0.1 2.0 65.3 1.0 0.0 8.4 1.8 0.0 2.9 16.9 0.0 2.9 0.6 4.6 4.7 0.2 0.6 2.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 4.7 0.0 0.0 12.1 0.0 0.2 0.2 0.5 0.0 0.1 0.3 0.4 0.1 0.4 0.1 0.4 1.0 0.2 0.0 20.8 0.0 15.9 0.3 376.6 4054.2 1.8 0.0 38.1 29.3 0.2 1328.2 5757.0 138.0 0.0 0.8 1.2 315.6 0.0 6457.0 2.0 25.6 4.3 11.5 57.9 11.2 0.0 1837.0 0.3 12.2 237.0 52.3 13.4 0.0 2.2 43.2 0.6 0.0 0.0 264.3 956.2 2.7 0.0 15.8 3.4 34.9 0.0 0.0 60.3 0.0 1.0 0.0 0.0 5424.3 183.4 0.0 1.4 420.6 509.8 1.6 3161.5 0.0 0.0 0.0 337.7 0.0 0.3 51.1 0.0 0.3 7.7 0.0 475.5 7112.9 LRSAM1 "CMT2P, FLJ31641, RIFLE, TAL" ENSG00000148356 "Leucine rich repeat and sterile alpha motif containing 1" Q6UWE0 9 127451489-127503499 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 32.0;Excitatory neurons: 28.6;Inhibitory neurons: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021403, HPA021844, CAB037304" Supported Approved Cytosol NA NA Cytosol "CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368" "unprognostic (8.83e-2)" "unprognostic (3.13e-1)" "unprognostic (7.48e-3)" "unprognostic (4.15e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (1.64e-1)" "unprognostic (5.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.72e-2)" "prognostic favorable (6.78e-6)" "unprognostic (1.27e-1)" "prognostic favorable (5.72e-4)" "unprognostic (1.94e-2)" "unprognostic (3.26e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-2)" 6.9 9.9 6.7 3.4 7.5 2.0 7.3 6.1 12.6 10.0 3.9 13.2 3.4 9.0 5.9 8.8 7.9 4.0 14.1 7.4 7.0 8.2 8.8 7.4 4.6 9.7 6.8 7.4 10.8 5.7 7.0 9.1 3.4 10.5 9.2 2.6 2.3 7.5 5.6 13.6 21.2 9.2 5.0 5.5 9.6 9.6 4.3 7.1 3.4 8.9 7.3 3.3 12.4 10.3 8.2 5.7 10.8 4.8 10.7 9.8 9.1 8.3 5.3 8.1 10.0 7.6 8.9 5.9 9.8 5.9 9.9 3.6 18.7 7.8 13.3 3.8 11.5 5.3 5.2 9.0 10.2 9.4 6.2 7.3 6.1 7.9 6.1 12.2 10.7 11.2 7.6 4.8 7.6 4.5 17.6 3.9 4.5 4.7 17.4 9.3 7.1 5.6 18.4 11.5 5.1 9.8 9.2 4.1 12.6 8.8 4.3 26.5 3.2 10.2 4.6 5.6 4.2 2.5 6.2 7.9 1.1 9.1 4.5 2.6 18.5 4.8 21.3 3.7 6.5 4.7 3.7 2.8 3.5 6.1 2.7 1.1 1.4 4.0 1.3 6.8 3.6 2.3 3.8 6.7 7.5 6.1 12.6 7.4 7.0 9.7 6.8 7.4 10.5 5.5 7.1 8.2 5.3 9.6 3.9 32.0 5.1 1.1 3.1 2.9 4.6 6.7 5.2 5.0 20.4 4.3 7.3 0.0 6.2 5.0 5.3 6.0 5.9 7.1 0.6 3.6 4.7 4.8 1.2 2.5 28.6 1.4 2.1 4.9 12.2 4.6 9.5 6.6 3.3 7.1 6.3 11.8 26.9 5.8 14.2 5.6 3.7 1.2 2.8 7.4 3.6 10.3 7.4 4.7 3.1 18.1 21.0 4.7 5.0 5.3 3.9 5.0 6.6 5.8 6.0 5.2 0.0 5.1 6.0 5.7 3.6 5.8 2.7 7.0 5.6 3.9 4.8 3.3 HMCN2 "DKFZp434P0216, FLJ23816" ENSG00000148357 "Hemicentin 2" Q8NDA2 9 130265882-130434123 "Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 34.2;intestine: 38.1" "Cell type enriched" "Detected in many" 8 "Skeletal myocytes: 283.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 7.8;RH-30: 18.0;SCLC-21H: 2.6;SH-SY5Y: 4.1;U-138 MG: 2.9;U-87 MG: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053903, HPA070647" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 27000000 Vesicles "HPA053903: AB_2682301, HPA070647: AB_2686290" "unprognostic (1.61e-1)" "unprognostic (8.05e-3)" "unprognostic (1.69e-1)" "unprognostic (5.53e-4)" "unprognostic (1.05e-1)" "unprognostic (1.12e-2)" "unprognostic (1.10e-1)" "unprognostic (8.78e-3)" "unprognostic (3.23e-1)" "unprognostic (3.97e-4)" "unprognostic (3.36e-2)" "unprognostic (3.93e-1)" "unprognostic (1.04e-3)" "unprognostic (1.53e-2)" "unprognostic (3.62e-2)" "unprognostic (8.96e-3)" "unprognostic (8.63e-2)" 9.9 1.3 0.4 1.5 0.5 0.0 3.9 0.0 0.6 17.2 0.2 38.1 5.3 34.2 0.1 4.9 10.2 0.7 10.0 0.1 0.6 1.6 1.2 3.8 1.2 2.0 1.8 0.0 2.6 0.9 0.1 0.3 0.2 2.2 9.3 1.9 0.0 2.3 2.3 25.2 3.8 21.7 4.3 1.0 0.4 4.9 5.7 0.8 1.2 4.8 6.3 0.2 9.3 12.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.2 0.5 0.0 18.0 0.1 0.0 0.1 2.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.6 0.1 0.6 2.0 1.8 0.0 2.2 1.0 0.8 1.0 1.2 3.2 7.5 2.3 0.5 0.9 0.4 0.0 0.0 1.1 0.2 0.3 4.8 0.0 3.7 0.0 0.0 0.1 0.1 22.9 1.9 0.0 17.0 0.0 0.2 5.0 0.0 0.0 1.3 0.0 0.1 24.8 0.0 0.1 7.6 0.1 0.7 2.3 0.4 1.7 5.8 3.6 2.0 0.8 0.8 10.6 0.0 2.3 1.8 1.0 0.0 0.0 0.0 0.5 0.7 0.1 8.3 0.0 0.1 0.8 34.1 1.2 4.0 0.7 0.0 283.7 4.5 0.9 1.1 0.0 0.6 0.3 1.6 2.9 5.5 4.7 GPR107 "FLJ20998, KIAA1624, LUSTR1, RP11-88G17" ENSG00000148358 "G protein-coupled receptor 107" Q5VW38 9 130053426-130140169 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031704 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA031704: AB_10601018" "prognostic unfavorable (3.56e-5)" "unprognostic (7.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (8.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.35e-2)" "unprognostic (2.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.59e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.87e-5)" "unprognostic (4.10e-2)" "unprognostic (5.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.34e-3)" 19.1 17.5 20.6 15.2 21.5 12.3 20.5 21.4 21.5 20.2 22.9 21.5 11.7 19.0 15.4 18.8 22.2 16.2 18.4 19.3 23.6 20.7 13.1 20.5 11.1 24.0 22.8 19.0 18.1 18.9 28.9 16.8 23.5 24.4 23.8 22.8 26.5 18.5 20.0 18.0 22.9 13.0 23.4 22.3 13.6 16.8 17.4 23.4 14.4 35.2 17.2 14.3 16.0 14.3 23.8 29.7 42.0 39.6 31.7 42.4 44.6 39.9 45.9 52.5 37.9 37.5 40.6 39.5 16.4 33.4 52.1 44.5 73.0 30.7 28.6 32.3 24.7 20.3 17.0 49.1 23.8 40.9 36.2 24.4 37.5 44.3 38.1 38.7 44.1 35.9 19.0 25.0 15.8 33.6 36.6 19.4 14.7 26.8 60.0 31.7 18.3 58.7 25.9 32.1 40.2 13.6 30.7 59.8 42.8 33.1 34.9 75.0 19.3 42.9 48.1 25.1 40.3 35.3 9.8 35.6 15.2 43.5 17.0 46.9 1.5 2.8 1.9 0.7 3.4 1.0 1.0 0.7 0.8 1.8 1.0 0.5 1.2 3.3 0.9 3.6 1.1 0.7 1.3 20.6 21.5 21.4 21.5 19.3 23.6 24.0 22.8 19.0 24.4 22.3 23.4 23.8 14.8 25.6 19.3 47.7 8.0 6.4 5.1 14.8 5.2 16.9 17.8 12.2 23.0 14.3 16.4 16.5 39.6 15.4 11.4 20.7 0.0 13.4 6.5 23.7 19.3 14.3 9.6 4.6 32.7 17.6 19.2 16.2 16.8 26.4 6.3 17.9 24.3 11.6 15.1 18.5 39.7 19.4 6.1 17.0 17.6 5.7 19.0 13.8 14.2 22.5 15.6 11.0 9.2 38.2 48.6 21.9 15.9 19.2 11.2 13.2 9.3 6.5 24.5 15.5 0.0 16.3 15.3 16.2 11.5 12.2 10.9 26.7 10.4 13.5 18.4 10.9 PAXX "C9orf142, XLS" ENSG00000148362 "PAXX non-homologous end joining factor" Q9BUH6 9 136992422-136993984 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 147.1;dendritic cells: 198.4;Distal tubular cells: 131.0;Extravillous trophoblasts: 216.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045268 Uncertain Supported Nucleoplasm NA NA 95000 Nucleoplasm "HPA045268: AB_10963079" "unprognostic (1.85e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.14e-3)" "unprognostic (9.88e-3)" "unprognostic (1.95e-1)" "unprognostic (2.15e-1)" "unprognostic (2.13e-3)" "unprognostic (3.22e-1)" "unprognostic (3.10e-1)" "unprognostic (1.00e-2)" "prognostic favorable (6.71e-4)" "unprognostic (3.54e-2)" "unprognostic (1.75e-2)" "unprognostic (9.64e-3)" "unprognostic (3.66e-1)" "unprognostic (9.31e-2)" "unprognostic (8.97e-3)" 21.4 25.1 14.5 8.2 13.0 17.8 23.8 15.5 27.5 28.1 6.8 25.4 11.9 23.7 1.7 29.7 24.9 4.3 29.1 11.0 13.6 34.7 45.1 28.7 11.9 18.8 15.2 9.2 21.7 38.0 5.6 37.7 7.5 17.1 34.8 2.0 1.2 20.3 7.4 15.1 30.8 29.0 1.9 18.4 48.7 31.5 15.0 17.1 10.1 32.6 2.2 4.0 25.9 25.7 20.4 27.6 30.3 4.8 18.4 8.5 7.6 70.5 20.7 12.3 13.7 7.4 13.5 19.8 24.6 35.3 5.4 5.4 43.5 1.7 15.6 1.1 63.3 42.7 19.3 16.2 11.4 12.7 27.6 41.2 5.6 14.6 4.7 6.3 2.4 12.5 44.1 29.4 7.1 3.1 61.2 29.0 45.6 28.7 32.6 91.5 37.7 9.8 70.4 9.5 14.2 22.6 28.2 17.8 44.0 24.9 0.8 52.5 23.4 16.6 6.5 19.9 31.2 25.1 13.1 12.5 16.9 11.6 31.6 24.8 25.9 44.3 18.7 142.3 54.9 122.5 33.8 78.3 123.9 46.2 30.5 42.4 99.1 14.9 87.7 29.0 238.2 66.0 62.2 14.5 13.0 15.5 27.5 11.0 13.6 18.8 15.2 9.2 17.1 18.4 17.1 20.4 65.5 16.0 27.6 0.0 20.2 0.0 0.0 0.0 0.0 0.0 76.8 95.0 0.0 0.0 7.4 40.5 0.0 147.1 198.4 0.0 131.0 54.3 0.0 45.3 34.0 22.6 0.0 0.0 0.0 43.4 216.7 25.0 0.0 44.4 12.6 66.5 0.0 0.0 77.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 35.2 0.0 0.0 0.0 0.0 40.0 0.0 0.0 21.5 0.0 0.0 82.4 11.7 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 88.7 72.3 59.1 0.0 0.0 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018910-1025859 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skeletal muscle: 276.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Glandular and luminal cells: 1.1;Horizontal cells: 1.7;Skeletal myocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041254 Uncertain Vesicles NA NA Vesicles "HPA041254: AB_10794270" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.8 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 1.2 0.1 0.0 276.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.1 0.0 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.4 0.4 0.1 0.1 0.3 0.0 0.3 0.0 0.7 0.4 0.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.9 0.5 0.4 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 INPP5E "CORS1, JBTS1, pharbin, PPI5PIV" ENSG00000148384 "Inositol polyphosphate-5-phosphatase E" Q9NRR6 9 136428619-136439845 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065758 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus, Focal adhesion sites" "HPA065758: AB_2685554" "unprognostic (1.99e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-2)" "unprognostic (4.00e-1)" "unprognostic (6.92e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-1)" "unprognostic (5.81e-2)" "unprognostic (2.65e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.03e-1)" "unprognostic (3.04e-2)" "unprognostic (3.76e-1)" "unprognostic (5.48e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" 12.1 10.9 14.5 6.9 14.2 6.4 11.8 14.0 20.1 14.5 9.9 12.0 5.8 15.3 2.3 10.7 17.8 5.3 12.0 13.1 13.3 13.0 12.3 12.1 8.3 14.3 12.8 13.7 16.3 10.9 6.6 14.4 5.8 16.0 12.4 3.3 7.5 9.6 5.3 8.6 11.0 11.8 5.6 10.4 21.0 9.0 20.2 14.5 6.4 15.3 3.8 4.7 12.3 12.1 14.3 8.9 10.3 12.6 13.2 6.5 7.1 14.9 10.7 5.7 7.4 5.1 12.5 6.0 10.8 10.5 11.1 11.9 25.2 6.2 8.6 2.8 36.8 25.4 8.5 27.1 8.4 10.3 9.5 11.9 10.9 8.8 9.8 7.2 10.3 8.9 14.8 14.5 14.0 7.0 22.3 11.4 19.9 8.1 5.3 16.0 21.1 8.7 8.3 7.4 9.8 14.1 12.2 10.4 8.5 7.6 7.6 15.1 15.6 11.8 24.1 9.4 10.1 18.2 11.6 10.6 4.5 12.0 7.8 9.7 0.0 0.1 0.5 0.5 0.0 0.3 0.7 0.6 0.4 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.1 14.5 14.2 14.0 20.1 13.1 13.3 14.3 12.8 13.7 16.0 10.4 14.5 14.3 14.7 3.2 6.9 17.0 5.0 5.5 1.8 2.6 5.7 7.4 6.5 6.9 5.0 7.2 3.4 3.7 2.1 2.3 7.6 4.0 1.9 4.8 0.9 11.8 8.1 7.4 6.1 0.8 12.2 5.6 2.8 5.7 3.6 6.8 8.9 8.3 6.1 3.8 3.2 15.2 12.9 2.6 6.1 3.5 3.5 1.3 7.5 3.7 5.4 6.5 3.5 8.9 1.0 8.5 8.5 6.7 1.6 5.7 2.5 3.3 3.4 2.4 10.0 10.8 0.0 5.5 7.5 15.3 9.1 5.4 4.8 0.8 5.3 5.6 3.9 1.6 LCN9 ENSG00000148386 "Lipocalin 9" Q8WX39 9 135663322-135666422 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "BEWO: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060941 Enhanced "Secreted in male reproductive system" NA NA "HPA060941: AB_2732654" "unprognostic (7.64e-4)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 48000 "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favorable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 16.4 18.3 4.8 16.7 5.6 35.6 17.3 6.0 9.5 15.9 14.9 17.4 15.1 18.0 9.1 18.0 16.5 12.5 14.4 5.8 4.4 13.9 38.3 19.6 17.1 3.6 3.5 5.5 16.3 29.5 14.2 24.5 10.9 4.2 18.9 10.6 9.3 26.0 13.2 23.7 19.9 19.3 10.8 1.0 20.8 27.4 17.8 4.1 17.5 15.4 12.0 12.4 16.0 14.6 4.6 26.5 57.7 28.5 47.2 29.6 30.3 33.6 32.1 27.9 23.4 17.8 41.9 22.1 26.4 22.1 39.2 28.8 71.3 31.8 46.2 12.7 56.2 20.7 26.9 55.1 33.7 28.6 46.2 45.8 32.8 32.5 32.7 38.1 18.9 32.2 34.5 34.1 35.6 25.0 114.3 31.2 24.9 25.1 79.0 40.4 44.3 35.2 45.0 23.8 35.0 40.0 26.6 41.6 62.2 19.8 13.8 63.6 35.9 47.0 37.6 28.1 30.8 25.2 16.9 27.7 33.4 29.2 20.6 38.3 1.7 2.8 1.2 2.5 3.1 2.7 2.3 2.6 3.0 1.6 1.4 1.6 2.8 2.0 1.5 3.4 2.6 1.9 2.4 4.8 5.6 6.0 9.5 5.8 4.4 3.6 3.5 5.5 4.2 1.0 4.1 4.6 20.0 25.6 41.7 16.6 16.4 24.9 15.3 18.4 10.8 20.2 38.7 30.6 11.5 12.8 23.6 12.9 25.0 8.1 17.5 30.1 7.9 14.2 5.1 26.9 19.5 18.2 40.7 12.0 27.4 16.4 11.8 16.0 46.9 38.2 23.5 25.4 17.9 62.2 16.5 33.7 19.2 65.5 20.3 23.4 19.5 6.0 13.1 22.3 14.2 17.8 19.5 13.0 11.3 9.5 14.7 22.8 14.7 16.6 25.1 26.3 22.3 10.1 34.7 17.1 13.1 20.5 16.6 24.4 16.1 17.2 26.9 15.1 17.8 15.8 22.8 22.1 DPH7 "C9orf112, FLJ90634, RRT2, WDR85" ENSG00000148399 "Diphthamide biosynthesis 7" Q9BTV6 9 137554444-137578925 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 189.9;Spermatogonia: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022911 Uncertain Approved "Nuclear bodies" Yes No "Nuclear bodies" "HPA022911: AB_1858823" "unprognostic (1.43e-1)" "unprognostic (4.81e-2)" "unprognostic (3.41e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.60e-3)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (2.14e-2)" "unprognostic (9.48e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.30e-3)" "unprognostic (3.06e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.23e-4)" 8.2 12.4 3.6 2.6 3.7 4.3 9.6 4.4 4.1 15.1 4.0 12.7 2.2 12.7 7.1 9.1 14.7 2.6 9.3 3.7 3.5 10.3 11.0 9.5 4.8 3.6 3.5 3.9 12.9 20.5 6.4 13.7 3.4 4.1 15.1 4.1 2.8 10.0 5.4 8.4 10.6 12.3 4.8 3.4 15.3 12.4 9.3 3.7 5.7 12.9 2.4 5.3 11.3 11.2 5.7 4.5 5.2 8.2 7.6 6.2 5.1 10.2 5.1 5.2 9.1 7.7 11.0 5.4 10.6 9.3 5.9 4.8 9.8 10.6 10.1 8.3 9.2 13.2 4.9 6.6 3.7 7.0 10.6 9.5 5.4 7.6 5.1 9.2 6.5 14.4 7.1 9.2 5.7 7.2 15.3 8.2 9.9 10.4 19.9 13.3 13.7 3.7 7.6 6.9 4.5 10.8 7.3 8.7 7.0 5.4 5.7 7.9 9.1 6.5 6.2 5.4 7.7 9.5 3.7 9.1 12.5 3.9 6.1 6.3 9.5 5.1 6.2 4.5 4.8 6.3 5.6 7.2 6.4 5.9 4.7 5.1 4.9 1.6 4.5 4.0 8.0 5.4 4.6 3.6 3.7 4.4 4.1 3.7 3.5 3.6 3.5 3.9 4.1 3.4 3.7 5.7 21.0 6.4 11.9 21.2 17.7 16.7 9.8 18.9 8.0 18.7 14.7 20.6 15.5 2.8 11.5 1.8 50.1 22.1 22.5 7.7 3.9 10.6 3.0 11.1 17.1 13.8 6.7 5.5 17.2 9.2 14.9 14.5 13.3 10.2 10.8 26.5 8.2 6.5 11.9 16.8 21.5 11.7 6.1 6.6 7.2 7.5 16.4 8.8 8.8 15.0 9.9 15.4 23.7 16.1 28.2 11.5 10.3 15.8 24.7 18.6 7.2 5.2 14.2 58.8 19.7 13.1 16.0 189.9 100.0 11.4 18.9 12.2 18.0 19.9 15.0 11.1 NOTCH1 TAN1 ENSG00000148400 "Notch receptor 1" P46531 9 136494433-136546048 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008112, CAB022466, HPA067168" Supported Approved Nucleoplasm NA NA 29000000 Nucleoplasm "CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795" "unprognostic (1.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.16e-1)" "unprognostic (8.38e-3)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-3)" "unprognostic (5.50e-3)" "unprognostic (8.78e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.14e-2)" "unprognostic (1.92e-1)" "unprognostic (5.65e-2)" "unprognostic (8.84e-2)" 17.7 4.2 9.7 4.9 12.9 4.3 15.1 11.9 6.9 13.4 3.8 18.9 4.3 12.8 0.2 16.4 12.0 0.9 13.7 7.1 5.8 11.6 9.3 22.4 3.0 17.3 10.5 1.8 5.1 14.1 0.7 6.3 2.6 16.4 15.5 0.6 0.6 10.8 3.1 5.0 24.1 14.4 1.3 9.1 25.0 10.0 2.6 10.8 4.0 11.3 1.2 0.9 14.3 16.6 10.4 8.8 10.6 4.0 2.6 0.0 0.4 17.7 3.3 0.4 1.4 0.4 1.8 0.9 13.3 10.3 1.3 1.6 47.0 1.0 8.6 0.1 32.3 2.0 5.5 6.1 0.6 2.1 6.9 39.7 0.3 16.7 1.4 1.9 0.7 9.0 3.7 3.6 1.1 0.0 9.0 72.3 13.1 8.4 2.9 7.7 15.7 9.2 19.3 0.6 4.2 0.0 0.7 6.1 4.3 3.4 1.0 3.2 10.4 22.7 5.0 9.3 5.9 4.3 2.4 2.6 4.1 3.7 5.0 26.1 0.2 0.4 0.6 0.3 0.1 0.1 0.1 0.1 0.5 0.3 0.0 0.1 0.3 2.3 0.7 0.1 0.1 0.1 0.5 9.7 12.9 11.9 6.9 7.1 5.8 17.3 10.5 1.8 16.4 9.1 10.8 10.4 56.2 9.6 21.9 67.3 8.4 24.9 12.3 35.1 23.9 0.8 10.7 12.4 11.0 5.7 16.3 1.8 2.1 1.1 14.2 11.8 0.0 5.1 0.3 12.3 9.9 53.2 2.4 5.2 0.3 4.0 2.2 6.4 1.1 17.3 34.9 1.0 68.2 7.7 9.3 1.7 0.4 14.8 18.3 10.1 17.5 0.3 1.2 15.2 7.2 18.7 14.3 46.6 24.7 33.7 19.6 2.1 11.5 0.7 5.7 8.4 4.1 3.4 3.8 2.0 6.6 14.7 18.4 0.2 3.3 20.6 29.8 1.1 15.0 1.4 28.8 15.6 CACNA1B "CACNL1A5, CACNN, Cav2.2" ENSG00000148408 "Calcium voltage-gated channel subunit alpha1 B" Q00975 9 137877782-138124624 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.8;pituitary gland: 6.9;testis: 5.1" "Group enriched" "Detected in some" 8 "Excitatory neurons: 388.8;Inhibitory neurons: 330.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022919, HPA044347" Uncertain Approved Mitochondria NA NA Mitochondria "HPA022919: , HPA044347: AB_10960837" "unprognostic (1.34e-3)" "unprognostic (2.70e-2)" "unprognostic (8.08e-2)" "unprognostic (2.51e-7)" "unprognostic (8.10e-2)" "unprognostic (1.51e-2)" "unprognostic (1.33e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.36e-2)" "unprognostic (9.73e-4)" "unprognostic (5.98e-2)" "unprognostic (6.63e-6)" "unprognostic (4.25e-2)" "unprognostic (4.72e-1)" "unprognostic (7.77e-3)" "unprognostic (8.69e-2)" 0.0 2.8 7.9 0.1 9.2 0.0 0.0 1.2 12.8 0.3 0.0 0.3 0.0 0.0 0.6 0.0 3.1 0.4 0.3 5.7 4.0 0.0 0.3 0.0 0.0 1.8 3.6 11.8 0.0 0.4 0.8 6.9 0.0 1.5 0.5 0.1 3.5 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.3 5.1 1.7 1.2 0.2 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 3.7 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 9.2 1.2 12.8 5.7 4.0 1.8 3.6 11.8 1.5 0.0 1.7 3.1 0.0 0.0 0.0 43.4 0.0 0.0 0.1 0.0 0.0 11.7 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.4 0.0 0.2 0.1 0.0 0.0 388.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.7 330.9 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 17.8 0.6 1.7 0.0 16.1 10.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.2 8.2 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 NACC2 "BEND9, BTBD14A, BTBD31, MGC23427" ENSG00000148411 "NACC family member 2" Q96BF6 9 136006537-136095289 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 131.0" "Cell type enriched" "Detected in many" 4 "Late spermatids: 305.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047924, HPA052962" Approved Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA047924: AB_2680212, HPA052962: AB_2681998" "unprognostic (1.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-2)" "unprognostic (8.73e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (9.25e-3)" "unprognostic (2.25e-2)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-1)" "prognostic favorable (8.28e-5)" "prognostic favorable (8.63e-4)" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (4.12e-2)" 12.4 11.5 92.6 8.8 88.9 2.0 8.0 113.9 77.2 8.9 25.1 24.8 6.3 21.0 4.1 8.6 12.9 7.2 14.6 53.1 73.3 7.6 9.7 9.6 3.4 124.4 101.7 46.6 7.7 7.7 4.6 6.5 2.7 131.0 11.9 3.8 5.0 8.0 17.4 17.2 4.3 10.0 15.7 90.4 8.1 13.7 6.6 107.8 1.0 5.8 6.8 2.0 23.4 7.4 123.8 6.1 32.7 3.6 49.0 15.4 8.6 4.5 14.6 9.7 4.6 1.6 14.0 10.6 0.0 17.1 23.2 7.4 23.3 7.9 7.9 1.5 18.6 7.1 4.1 33.3 17.6 15.6 0.0 7.4 14.4 7.2 4.3 4.3 18.8 13.0 0.0 12.8 0.1 9.0 20.5 0.0 11.6 11.0 9.7 20.2 0.0 3.8 10.0 19.2 6.9 1.2 1.5 20.6 17.0 18.2 16.2 17.4 37.9 21.6 12.3 13.9 10.5 10.1 0.1 0.0 0.3 16.2 1.4 25.2 1.9 2.2 0.8 0.8 1.7 0.3 0.0 0.3 0.7 1.2 0.0 0.2 0.2 2.7 0.2 1.7 0.1 0.2 0.8 92.6 88.9 113.9 77.2 53.1 73.3 124.4 101.7 46.6 131.0 90.4 107.8 123.8 14.3 12.8 5.0 69.9 0.8 4.6 4.9 9.0 3.4 3.4 6.7 5.6 28.5 7.2 7.9 5.5 0.0 0.7 7.0 12.4 0.0 12.6 76.2 18.9 9.8 18.5 2.4 1.7 2.5 13.4 2.1 10.9 7.7 6.0 2.5 1.5 17.9 33.2 7.8 3.3 21.1 4.4 0.0 38.4 8.0 305.5 18.0 16.6 5.4 21.5 45.3 17.1 12.3 40.7 45.1 18.3 9.2 19.2 2.1 11.8 6.7 13.6 12.5 1.9 26.3 14.0 15.8 2.4 12.6 6.8 5.1 0.4 5.7 1.4 5.3 7.6 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 41.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 28.4;Glandular and luminal cells: 28.4;Hepatocytes: 31.2;Prostatic glandular cells: 34.6;Urothelial cells: 69.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 86.5;CAPAN-2: 99.5;HBEC3-KT: 64.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 14.4" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA 220000 "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 4.2 1.6 2.2 1.0 1.7 10.4 4.1 1.3 2.1 3.2 5.0 2.3 1.2 3.4 0.5 9.9 3.8 1.7 1.7 1.4 1.6 9.7 41.3 9.9 0.3 1.8 2.2 0.8 2.4 7.6 0.5 1.9 7.3 1.9 9.2 1.8 0.1 7.0 2.2 2.1 5.1 1.8 1.0 1.5 7.4 6.6 6.1 2.7 1.9 6.8 0.4 2.8 4.1 6.0 2.2 86.5 12.1 0.7 0.3 2.5 3.1 4.9 3.8 1.8 3.0 1.5 28.1 99.5 0.0 15.1 0.3 1.3 22.1 8.4 64.2 1.5 0.1 20.3 9.8 4.8 18.4 14.2 0.0 5.9 3.6 13.6 17.8 19.9 0.3 9.2 1.6 15.0 0.1 4.3 11.7 0.0 3.2 5.3 11.3 6.9 13.9 11.3 0.0 6.6 4.2 0.1 1.1 6.5 24.9 11.1 4.1 13.1 5.3 6.8 0.1 19.7 33.2 0.4 0.0 0.2 0.1 0.1 3.4 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.2 1.7 1.3 2.1 1.4 1.6 1.8 2.2 0.8 1.9 1.5 2.7 2.2 3.0 9.6 5.9 1.3 0.0 5.7 28.4 8.2 8.6 0.0 5.5 5.2 1.1 18.6 6.5 5.5 0.0 5.5 0.2 3.2 5.9 11.6 3.0 18.6 2.8 3.7 1.8 2.5 0.7 3.8 18.3 3.6 6.1 28.4 0.0 1.9 1.1 31.2 0.8 0.0 0.7 1.3 2.0 0.3 0.7 3.0 1.8 3.7 3.6 6.5 0.1 0.1 0.0 0.5 0.4 20.0 1.5 4.5 0.0 34.6 0.2 0.8 6.8 0.1 0.0 0.6 1.3 3.7 5.6 4.6 4.7 0.7 0.5 0.7 2.6 69.4 USP6NL "KIAA0019, RN-tre, RNTRE, TRE2NL, USP6NL-IT1" ENSG00000148429 "USP6 N-terminal like" Q92738 10 11453946-11611754 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 145.2;Oligodendrocyte precursor cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 4.0;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 4 "B-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039196 Approved NA NA "HPA039196: AB_10795031" "unprognostic (1.64e-1)" "unprognostic (2.93e-1)" "unprognostic (6.84e-2)" "unprognostic (3.33e-2)" "unprognostic (1.35e-3)" "prognostic favorable (8.06e-4)" "unprognostic (2.39e-1)" "unprognostic (2.44e-2)" "unprognostic (4.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.86e-2)" "unprognostic (8.54e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-2)" "unprognostic (3.58e-2)" "unprognostic (1.49e-1)" "unprognostic (8.54e-2)" 5.5 6.9 5.6 7.3 5.1 8.7 5.6 6.7 4.8 5.2 6.3 5.9 5.5 6.0 7.8 23.1 9.0 5.7 4.5 4.7 5.6 5.7 16.4 6.5 15.0 7.5 6.2 3.1 7.6 5.1 5.5 4.7 6.9 7.3 4.7 7.5 13.1 6.9 5.3 1.7 8.1 5.8 5.7 7.1 13.7 7.4 24.8 6.7 7.5 5.3 2.2 18.6 5.6 9.7 8.0 26.9 11.6 24.5 10.7 6.1 7.4 11.9 7.3 6.3 8.2 11.3 14.3 24.8 33.5 7.0 6.3 6.7 14.6 11.2 7.9 12.0 0.1 8.7 14.3 6.6 25.5 7.3 4.2 2.0 4.2 11.6 9.5 5.6 9.5 19.8 11.5 22.6 0.8 7.0 18.6 11.6 3.1 12.5 25.0 6.0 22.2 6.4 4.3 11.6 7.9 7.8 13.7 7.9 24.0 25.3 10.2 17.8 4.4 10.8 4.2 15.4 10.9 7.1 0.0 0.9 22.0 7.1 5.1 11.5 0.8 0.5 0.8 0.0 0.9 0.1 4.0 0.1 0.1 0.7 3.4 0.1 0.1 0.3 0.5 0.6 0.6 0.0 0.3 5.6 5.1 6.7 4.8 4.7 5.6 7.5 6.2 3.1 7.3 7.1 6.7 8.0 12.0 3.2 17.5 23.2 37.7 6.8 20.6 7.8 13.6 6.0 9.6 6.6 7.8 2.8 12.4 1.8 29.2 7.6 0.5 8.2 7.9 10.8 17.4 32.5 9.7 11.1 13.8 14.3 16.0 10.6 7.5 6.8 20.4 33.2 0.0 11.8 5.7 14.1 8.6 6.7 24.3 14.0 8.2 16.3 8.7 15.4 4.7 12.7 12.4 145.2 7.5 11.2 3.1 68.3 29.4 16.1 6.8 4.9 20.0 20.8 4.2 9.0 15.6 14.6 0.0 5.2 9.1 21.5 7.2 20.1 9.9 7.3 3.9 7.7 7.1 48.3 COMMD3 "BUP, C10orf8" ENSG00000148444 "COMM domain containing 3" Q9UBI1 10 22316386-22320306 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 432.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 307.8;U-937: 403.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036584 Approved NA NA "HPA036584: AB_10670803" "unprognostic (3.11e-2)" "unprognostic (5.97e-3)" "unprognostic (6.43e-2)" "unprognostic (2.44e-1)" "unprognostic (7.42e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (5.46e-7)" "unprognostic (1.03e-3)" "unprognostic (1.57e-1)" "unprognostic (1.58e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "unprognostic (2.68e-3)" "unprognostic (1.70e-1)" "unprognostic (3.35e-1)" "unprognostic (5.71e-2)" "unprognostic (2.88e-3)" 31.2 35.6 35.6 38.6 38.0 38.5 53.2 38.4 45.3 29.3 36.8 38.5 37.9 31.3 48.2 38.5 35.0 33.1 80.5 36.5 41.4 39.1 63.3 28.5 45.8 38.1 37.1 34.7 23.6 52.1 53.9 25.1 23.0 37.3 37.0 37.2 29.7 52.3 31.0 76.1 36.9 37.1 39.3 39.4 32.8 33.3 32.4 36.1 61.8 33.4 76.9 43.8 40.0 21.2 42.3 53.8 65.0 23.5 14.4 91.0 97.0 22.7 48.1 48.3 45.8 60.4 16.9 77.8 61.6 47.7 58.8 41.8 33.4 37.8 68.5 34.8 307.8 44.1 80.2 23.1 62.7 87.8 29.0 66.5 86.3 74.6 35.7 35.2 67.8 92.5 93.7 55.0 70.6 103.5 47.8 126.2 29.6 5.7 69.0 101.5 54.9 57.5 89.0 64.8 30.2 14.4 54.3 38.1 71.8 85.8 20.2 48.8 199.1 82.4 30.3 77.3 73.0 42.1 94.4 93.0 63.9 67.5 403.0 28.7 154.6 98.0 73.1 48.5 97.8 56.8 93.2 63.3 52.0 117.8 85.2 39.9 48.8 15.2 83.2 87.6 140.3 83.2 118.3 35.6 38.0 38.4 45.3 36.5 41.4 38.1 37.1 34.7 37.3 39.4 36.1 42.3 37.6 41.7 31.7 0.0 59.0 38.2 48.4 148.4 18.2 42.0 52.7 82.5 98.8 30.0 73.0 33.1 14.6 61.0 55.2 20.9 117.4 83.0 432.9 42.2 35.7 37.9 41.3 69.2 0.0 82.9 53.4 42.6 19.4 27.4 54.5 43.7 30.7 61.5 99.0 45.4 0.0 43.4 118.0 51.8 48.3 97.0 58.7 47.6 53.4 0.0 103.6 71.4 52.5 0.0 0.0 67.0 36.7 56.8 63.2 29.1 67.1 102.2 72.1 65.2 46.0 45.7 66.6 35.6 42.9 20.5 51.1 26.1 34.7 51.4 40.7 44.7 MSRB2 "CBS-1, CBS1, CGI-131, MSRB, PILB" ENSG00000148450 "Methionine sulfoxide reductase B2" Q9Y3D2 10 23095579-23122013 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 269.1;Proximal tubular cells: 463.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027933 Enhanced "Intracellular and membrane" NA NA "HPA027933: AB_10601867" "unprognostic (4.89e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-3)" "unprognostic (3.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.26e-3)" "unprognostic (1.62e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (6.07e-3)" "unprognostic (3.47e-2)" "unprognostic (1.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.82e-2)" "unprognostic (6.74e-2)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" 16.3 17.5 29.3 6.6 30.3 7.8 11.1 29.5 40.9 13.2 26.9 19.3 9.5 15.9 17.0 10.9 17.8 7.8 54.0 29.6 31.3 19.1 31.2 9.8 3.9 30.7 30.1 28.6 12.0 5.5 23.3 14.5 8.3 30.1 14.4 11.5 13.2 9.2 19.7 42.6 5.5 12.0 16.4 29.2 9.4 11.5 4.0 30.4 8.5 14.2 52.2 4.1 17.2 11.1 30.1 7.3 10.4 19.0 11.6 19.3 17.3 5.7 11.5 6.4 7.2 8.3 7.2 15.5 5.9 10.0 24.6 10.9 4.6 6.3 8.6 5.9 40.3 7.0 4.3 17.7 4.1 27.2 0.9 5.0 22.2 14.3 8.4 2.0 15.7 10.4 11.5 5.9 10.3 16.0 21.9 7.0 5.5 10.5 41.4 6.0 8.0 10.9 1.5 9.1 2.8 3.8 26.1 14.2 12.4 23.9 15.9 8.4 17.1 7.7 6.2 5.8 14.0 6.9 13.3 4.4 0.2 8.8 12.7 5.3 0.9 1.4 2.3 0.3 1.1 0.3 0.2 0.3 0.2 0.8 0.0 0.6 0.4 3.4 0.2 0.8 1.6 0.4 0.2 29.3 30.3 29.5 40.9 29.6 31.3 30.7 30.1 28.6 30.1 29.2 30.4 30.1 29.0 0.0 16.4 27.1 11.4 18.2 52.1 33.1 59.2 68.2 69.6 79.1 269.1 80.1 21.1 90.1 22.9 116.1 10.6 86.7 176.1 130.4 1.4 49.3 71.6 34.4 55.7 30.7 9.5 63.4 61.2 70.7 23.4 46.5 29.2 114.0 42.1 195.4 109.6 112.7 16.9 54.8 26.4 70.5 25.1 4.4 49.7 54.2 72.9 11.2 29.7 126.6 7.2 14.6 26.1 90.3 79.6 62.4 24.7 34.9 80.8 463.9 24.3 57.5 59.2 52.6 71.6 4.4 7.7 66.7 17.5 69.6 13.5 60.9 71.0 54.3 PDSS1 "COQ1, COQ1A, TPRT, TPT" ENSG00000148459 "Decaprenyl diphosphate synthase subunit 1" Q5T2R2 10 26697701-26746798 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.3;lymphoid tissue: 13.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 32.5;Proximal enterocytes: 29.8;Undifferentiated cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038032, HPA042741" Uncertain Approved Cytosol NA NA Cytosol "HPA038032: AB_10670650, HPA042741: AB_2678139" "unprognostic (1.41e-2)" "unprognostic (3.92e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (1.66e-4)" "unprognostic (6.79e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.47e-2)" "unprognostic (9.43e-2)" "unprognostic (2.33e-2)" "unprognostic (2.20e-1)" "unprognostic (4.11e-2)" "unprognostic (2.99e-3)" "unprognostic (2.93e-3)" "unprognostic (8.85e-2)" "unprognostic (9.83e-2)" "unprognostic (6.36e-2)" 2.1 1.4 0.7 5.4 0.9 5.8 2.3 2.6 1.4 1.6 0.7 14.2 19.3 1.9 1.3 4.4 1.5 1.6 2.9 0.8 0.8 6.2 3.7 2.2 4.0 0.8 0.9 0.5 1.7 1.4 2.2 0.8 2.4 1.4 1.6 15.3 1.9 1.8 1.3 5.8 1.4 15.4 3.0 0.7 1.8 2.8 2.8 0.9 13.9 1.2 9.6 4.7 3.2 2.3 1.0 15.6 11.8 8.9 16.3 2.9 5.4 12.2 14.0 3.6 20.0 13.7 18.3 8.4 35.0 7.2 7.0 7.6 19.2 28.6 21.8 16.7 14.7 23.6 30.4 9.9 13.6 4.3 20.3 11.6 6.8 9.2 19.0 5.0 3.5 10.7 22.8 28.4 9.3 14.4 24.9 64.6 14.7 17.9 24.9 11.3 29.6 25.1 25.5 12.0 7.3 25.7 15.8 13.5 27.6 15.9 9.2 9.9 23.7 6.8 11.1 17.9 22.9 22.5 3.6 14.1 25.6 10.9 51.3 8.7 0.0 2.8 0.5 0.4 2.3 1.0 0.2 0.8 0.6 2.6 2.4 1.6 0.7 0.1 0.4 1.2 0.7 0.0 0.7 0.7 0.9 2.6 1.4 0.8 0.8 0.8 0.9 0.5 1.4 0.7 0.9 1.0 3.6 0.0 0.0 18.9 4.8 6.9 3.6 5.7 8.0 2.9 4.4 5.1 2.2 5.7 3.9 3.7 4.2 7.7 4.9 11.7 7.9 6.1 12.0 2.1 3.8 2.7 10.8 8.4 16.9 3.9 12.4 3.4 10.2 3.3 0.0 3.7 1.8 4.5 8.8 1.7 32.5 13.0 6.1 5.3 2.7 4.1 2.1 7.7 1.8 5.6 6.2 1.2 1.0 6.6 6.5 5.6 9.8 2.6 9.1 3.7 29.8 26.3 2.1 4.9 0.0 4.1 6.5 12.5 9.4 13.6 3.1 6.3 4.8 4.6 29.8 3.3 FAM171A1 "APCN, C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.4" "Cell type enhanced" "Detected in many" "Astrocytes: 263.8;Cholangiocytes: 98.7;Excitatory neurons: 166.9;Oligodendrocytes: 214.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 1.7;MAIT T-cell: 4.4;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 19 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "TIME: 105.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 130000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 9.9 5.1 60.7 7.6 71.6 0.5 8.8 69.9 61.3 11.6 25.5 21.8 19.2 12.9 6.5 6.4 15.7 13.0 10.3 68.2 54.6 22.9 15.5 7.4 6.1 75.1 66.7 51.2 14.3 22.6 11.0 3.7 4.1 72.4 11.3 17.7 2.7 14.2 12.0 7.7 4.0 13.1 12.4 69.1 12.5 13.5 3.5 69.0 4.0 7.0 6.2 6.7 9.1 6.4 86.4 0.0 16.2 33.3 12.6 13.2 24.9 0.4 19.5 3.9 10.2 8.8 3.0 19.2 0.1 21.5 53.4 22.7 1.4 24.0 0.2 11.5 5.9 33.4 46.7 5.2 48.1 14.3 0.0 36.0 19.7 4.9 27.8 4.0 36.8 51.4 6.8 17.5 0.2 32.8 1.4 7.7 0.1 30.4 9.3 7.8 30.4 17.0 5.1 12.7 0.0 22.4 27.6 10.9 0.2 0.1 35.0 0.2 0.6 105.6 13.9 53.6 50.4 20.8 6.3 2.1 0.1 30.3 0.0 10.8 0.0 0.0 0.0 1.7 0.0 4.4 0.0 2.5 2.2 0.0 0.0 4.7 2.4 0.0 0.2 0.0 0.0 0.5 0.9 60.7 71.6 69.9 61.3 68.2 54.6 75.1 66.7 51.2 72.4 69.1 69.0 86.4 11.1 0.0 0.0 263.8 1.0 1.3 4.0 3.1 8.0 4.0 7.6 5.7 6.8 98.7 1.7 14.7 0.0 0.1 0.2 25.4 3.9 21.1 0.7 5.9 12.5 43.7 21.0 6.5 166.9 12.2 0.2 12.3 35.7 14.6 1.3 14.4 49.2 24.7 0.4 6.7 76.6 23.7 4.1 2.8 1.7 1.1 5.3 0.3 1.8 33.7 0.7 1.5 0.0 44.2 214.4 17.5 16.1 5.7 5.2 16.5 7.3 4.5 2.4 1.1 0.0 7.5 5.9 2.3 5.7 8.0 1.8 0.1 2.0 11.4 38.8 3.6 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" NA NA 23000 "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: AB_2676001" "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 15.2 22.6 15.8 8.6 18.6 19.3 19.4 24.6 20.7 18.7 6.7 15.1 9.3 19.6 20.7 14.2 15.7 14.3 10.0 16.8 14.6 16.9 17.6 12.2 12.5 13.2 14.5 12.4 18.6 13.8 20.7 5.4 21.3 14.0 19.5 18.9 20.2 11.6 16.6 4.3 16.5 11.7 16.5 14.3 10.6 15.9 21.4 14.7 7.6 18.4 2.4 11.7 15.4 10.4 19.9 12.4 11.1 21.5 22.9 30.9 28.9 17.9 38.1 19.4 28.4 33.1 9.6 19.0 9.2 7.2 41.8 19.9 11.2 18.5 22.8 25.5 28.2 25.5 30.0 16.0 10.8 39.3 6.2 24.3 22.5 19.6 25.3 18.1 27.4 23.1 21.7 18.6 7.6 28.5 13.4 13.2 7.5 7.8 19.9 21.6 6.5 12.5 6.4 32.1 9.2 17.6 19.2 18.5 17.5 16.1 19.2 20.4 13.4 23.9 18.5 14.4 31.4 11.2 45.6 18.8 15.7 21.2 13.6 15.1 2.6 1.7 1.5 2.2 3.5 1.8 1.3 1.5 2.4 1.9 1.9 1.0 2.0 1.5 1.7 4.0 2.0 3.1 1.5 15.8 18.6 24.6 20.7 16.8 14.6 13.2 14.5 12.4 14.0 14.3 14.7 19.9 17.3 22.4 14.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 9.7 7.4 0.0 0.0 3.7 14.7 0.0 18.7 10.7 0.0 19.6 11.6 0.0 8.2 18.1 5.2 0.0 0.0 0.0 8.3 17.0 7.5 0.0 9.7 1.3 11.5 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 9.0 0.0 0.0 4.0 0.0 0.0 17.7 11.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 32.7 3.0 13.7 0.0 0.0 SLC39A12 FLJ30499 ENSG00000148482 "Solute carrier family 39 member 12" Q504Y0 10 17951839-18043292 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "choroid plexus: 310.5" "Group enriched" "Detected in some" 31 "Astrocytes: 133.5;Muller glia cells: 69.5" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (3.30e-1)" "unprognostic (8.70e-2)" "unprognostic (1.02e-1)" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.40e-6)" "unprognostic (1.94e-1)" "unprognostic (8.11e-2)" "unprognostic (3.76e-2)" 0.1 0.0 26.5 0.0 26.3 0.0 0.7 27.1 40.3 0.0 310.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 23.2 0.0 0.1 0.1 0.0 28.2 34.1 23.6 0.0 0.1 0.0 1.3 0.1 25.6 0.0 0.1 15.8 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.0 0.2 32.4 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 26.3 27.1 40.3 36.0 23.2 28.2 34.1 23.6 25.6 19.5 32.4 22.0 0.1 0.0 0.0 133.5 0.0 0.0 0.0 0.0 0.0 0.7 2.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.7 0.2 0.0 0.0 0.4 0.8 0.3 0.2 0.0 2.8 0.0 69.5 0.0 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752201-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 33.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 81.1;Enteroendocrine cells: 23.4;Intestinal goblet cells: 28.8;Paneth cells: 48.1;Proximal enterocytes: 96.5;Undifferentiated cells: 19.0" "Group enriched" "Detected in some" 4 "colorectal cancer: 1.7;pancreatic cancer: 0.5;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "MOLT-4: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045096 Enhanced NA NA "HPA045096: AB_2732516" "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.7 0.6 0.3 1.7 0.3 0.5 0.4 0.7 0.4 0.5 0.4 14.3 22.0 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.1 0.7 0.3 0.1 0.0 0.2 0.3 0.5 0.1 0.0 1.5 0.4 0.1 14.2 0.3 0.1 0.2 0.3 0.3 33.8 1.0 0.0 0.3 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.4 0.1 0.7 0.2 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 0.3 0.2 0.0 0.2 0.9 0.1 0.2 0.1 0.0 0.1 0.2 0.4 0.1 0.2 0.1 0.2 10.3 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.7 0.4 0.2 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.7 0.2 0.0 0.5 0.0 0.2 0.1 0.5 0.0 0.0 0.3 7.3 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.1 81.1 0.0 0.1 1.1 0.1 0.1 0.2 23.4 0.4 0.4 0.9 0.2 0.2 0.0 0.5 1.3 0.1 1.1 0.0 7.2 0.0 0.4 28.8 0.0 4.8 0.8 1.1 0.0 5.9 0.0 3.7 0.0 0.1 0.0 0.0 0.6 0.7 48.1 0.0 0.0 0.4 96.5 0.0 0.0 0.9 0.0 0.7 0.3 0.4 0.1 0.2 0.0 0.3 0.4 0.2 19.0 0.6 RSU1 "FLJ31034, RSP-1" ENSG00000148484 "Ras suppressor protein 1" Q15404 10 16590611-16817463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025927 Uncertain Approved Vesicles NA NA 33000000 Vesicles "HPA025927: AB_10610420" "unprognostic (7.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.08e-1)" "unprognostic (4.89e-1)" "unprognostic (9.56e-3)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (1.99e-1)" "unprognostic (3.83e-2)" "unprognostic (3.72e-2)" "unprognostic (3.30e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (4.53e-2)" 35.9 14.3 9.0 22.1 9.2 28.2 25.6 9.1 10.1 21.4 11.2 24.6 12.1 30.5 20.0 28.0 19.4 19.9 25.3 9.0 11.7 19.6 16.8 27.9 22.5 10.8 9.1 8.4 22.0 21.4 14.2 3.9 23.4 10.0 18.1 24.0 10.0 14.6 27.2 15.9 16.0 13.8 42.2 9.1 20.6 15.8 5.5 9.8 18.2 18.9 13.9 22.5 24.2 18.2 10.0 27.3 18.6 15.0 88.5 78.4 80.3 18.3 66.3 28.2 45.1 48.6 17.3 25.0 27.0 10.5 91.2 24.1 23.9 18.3 34.7 48.3 40.6 14.6 85.2 11.1 16.7 34.5 13.1 47.8 40.0 36.0 43.3 13.7 40.9 47.8 27.8 14.0 18.2 61.6 17.6 30.5 23.5 15.7 39.6 10.5 19.6 20.3 18.4 44.0 10.0 5.9 11.6 33.1 21.6 33.6 26.8 7.6 34.4 58.8 38.4 13.3 48.5 34.6 15.9 20.6 23.3 51.0 37.1 16.9 33.0 20.9 22.8 24.7 26.0 28.0 16.6 28.1 26.7 34.7 17.9 20.5 25.8 14.6 31.3 25.5 25.9 36.0 48.5 9.0 9.2 9.1 10.1 9.0 11.7 10.8 9.1 8.4 10.0 9.1 9.8 10.0 111.1 35.3 24.5 26.4 29.9 36.7 30.3 74.0 12.0 1.7 22.5 36.2 41.2 27.1 48.3 42.3 2.1 131.9 41.6 57.0 68.4 72.1 80.5 20.7 47.2 69.6 7.2 74.7 52.8 119.2 83.0 52.8 28.5 24.8 34.2 20.5 64.2 32.7 121.7 3.3 34.7 19.0 52.9 61.1 80.7 163.3 39.4 106.2 60.5 52.5 92.3 5.8 66.9 45.8 51.7 81.2 16.8 68.4 36.7 17.4 14.9 58.3 48.8 17.9 65.7 32.4 136.1 3.9 22.6 34.1 42.8 96.2 46.8 35.9 27.2 24.9 ST8SIA6 SIAT8F ENSG00000148488 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6" P61647 10 17315421-17454595 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lung: 5.9" "Cell type enriched" "Detected in some" 5 "Microglial cells: 137.7" "Cancer enhanced" "Detected in some" "breast cancer: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "HMC-1: 208.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011635, HPA072708" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011635: AB_2194921, HPA072708: " "unprognostic (4.86e-3)" "unprognostic (7.01e-2)" "unprognostic (5.85e-3)" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.11e-2)" "unprognostic (6.81e-2)" "unprognostic (2.32e-1)" "unprognostic (3.23e-2)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.43e-1)" "unprognostic (2.22e-1)" "unprognostic (1.07e-3)" 0.7 0.3 5.6 0.4 3.6 1.8 5.2 2.9 3.8 0.3 2.7 0.6 0.3 0.4 4.6 0.5 0.3 0.5 3.4 2.7 2.8 0.8 1.0 5.9 0.2 5.0 9.7 2.3 0.4 0.2 0.0 0.3 1.1 4.2 1.5 0.4 0.5 0.6 0.2 0.2 1.1 0.4 0.3 3.2 0.6 0.3 0.3 7.8 0.3 0.4 0.8 0.4 0.2 0.4 4.0 0.2 0.2 0.1 1.7 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.6 0.6 0.0 0.1 0.3 0.3 0.5 0.1 0.0 0.0 0.4 0.2 25.9 0.4 0.5 0.0 0.0 208.0 0.1 0.0 0.2 0.1 1.8 0.0 0.3 4.6 0.4 2.5 1.9 1.1 0.4 2.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 9.3 0.2 1.1 0.0 3.6 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.4 0.1 1.7 0.5 0.5 0.5 0.1 0.2 0.1 0.3 0.3 0.2 0.3 0.3 0.4 1.0 0.7 0.3 0.2 0.8 0.2 5.6 3.6 2.9 3.8 2.7 2.8 5.0 9.7 2.3 4.2 3.2 7.8 4.0 0.6 0.0 0.0 2.6 0.1 0.6 0.1 0.2 0.0 0.0 10.0 3.9 0.8 0.0 0.2 0.0 0.0 0.0 5.5 1.2 0.0 0.0 0.5 0.1 0.0 10.9 0.0 25.5 3.0 0.0 0.0 0.3 0.0 0.8 10.2 2.8 26.7 0.0 0.1 0.0 4.4 0.0 0.0 0.9 0.0 0.6 0.0 0.2 8.8 137.7 0.2 0.0 8.2 1.5 1.1 0.1 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.0 0.0 0.0 2.4 0.1 0.0 0.1 PARD3 "ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118" ENSG00000148498 "Par-3 family cell polarity regulator" Q8TEW0 10 34109560-34815325 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 50 "basophil: 9.6" "Lineage enriched" "Detected in single" 97 "granulocytes: 9.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030443 Approved Supported "Plasma membrane,Cell Junctions" NA NA 21000 "Plasma membrane, Cell Junctions" "HPA030443: AB_10600926" "unprognostic (9.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.62e-1)" "unprognostic (2.83e-2)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (3.48e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (5.82e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.54e-1)" "unprognostic (9.20e-2)" "prognostic unfavorable (4.41e-4)" 13.1 16.0 20.0 4.8 16.4 0.5 21.7 12.2 12.6 20.6 15.4 25.5 10.7 20.9 12.3 48.2 20.8 15.1 13.6 18.2 24.0 25.3 22.3 15.3 2.6 15.1 18.8 10.3 38.8 34.5 20.9 7.4 21.9 15.4 17.2 21.9 13.7 20.2 24.2 40.8 50.0 13.5 22.0 15.3 4.3 17.8 14.1 18.3 13.6 15.3 31.2 12.5 21.4 31.1 13.7 50.6 121.1 40.1 28.6 28.5 24.2 59.1 22.2 25.4 37.3 40.0 44.3 43.3 0.3 31.4 44.6 30.4 35.8 34.7 56.7 46.1 0.4 26.8 0.0 14.9 44.1 36.2 5.7 0.1 28.7 54.9 50.9 38.1 35.9 23.3 32.4 34.7 14.9 44.8 35.4 59.3 4.2 18.0 32.7 41.4 44.9 39.0 21.9 80.9 38.4 20.1 20.9 26.8 37.3 42.9 49.6 21.1 6.7 28.4 18.7 56.1 35.5 24.2 13.2 17.1 0.1 21.0 0.2 22.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 20.0 16.4 12.2 12.6 18.2 24.0 15.1 18.8 10.3 15.4 15.3 18.3 13.7 6.4 35.3 35.3 455.4 0.2 34.0 42.3 19.8 19.9 8.7 17.1 24.9 39.0 21.5 24.3 14.7 29.2 24.9 0.2 25.6 0.0 34.1 19.9 22.3 29.9 9.4 24.0 2.7 5.4 36.4 25.0 22.3 13.3 33.4 1.3 33.1 8.9 24.8 3.4 11.8 147.0 30.1 14.2 0.6 4.7 20.3 30.4 7.7 5.4 193.0 0.8 28.8 1.0 367.9 13.9 38.8 23.8 38.4 1.4 31.4 13.7 25.6 29.3 19.7 26.3 23.4 26.1 6.2 27.6 40.4 61.5 40.1 1.5 32.1 22.0 47.2 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125725-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "breast: 38.5" "Group enriched" "Detected in some" 4 "Breast glandular cells: 295.9;Breast myoepithelial cells: 84.8" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "A549: 2.7;U-266/70: 10.4" HPA071849 Uncertain Nucleoli NA NA Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 1.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 295.9 84.8 0.3 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 16.3 0.0 0.4 1.0 0.0 0.0 1.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 8.5 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 45.8 1.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 ZEB1 "AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a" ENSG00000148516 "Zinc finger E-box binding homeobox 1" P37275 10 31318495-31529814 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 113.1;TIME: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027524, CAB058686, CAB079943" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (4.85e-2)" "unprognostic (7.40e-2)" "unprognostic (1.34e-2)" "unprognostic (5.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.96e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (5.59e-3)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" "unprognostic (1.66e-2)" 26.8 8.6 18.1 13.0 18.5 8.6 17.0 15.9 20.3 33.5 13.5 35.8 6.0 39.1 13.5 11.8 18.7 20.1 35.1 17.2 23.5 7.6 10.5 16.1 9.6 21.9 20.6 13.9 9.3 3.9 3.4 8.0 17.7 23.0 14.6 12.5 14.9 8.0 27.2 54.9 6.3 11.9 40.2 19.7 8.2 18.2 10.2 21.9 30.1 11.3 61.0 9.8 24.6 16.6 21.3 0.1 11.1 35.1 43.9 58.4 113.1 0.0 32.7 44.9 6.6 9.3 0.2 0.1 11.3 15.6 39.6 9.3 0.0 14.9 0.0 11.8 19.1 7.9 0.0 7.0 6.3 44.4 9.8 0.3 53.4 0.1 19.6 17.6 21.4 54.9 9.5 7.5 14.4 42.7 0.1 33.7 6.2 2.3 0.0 6.6 11.6 66.0 5.1 12.9 0.0 0.9 15.6 11.1 0.0 0.0 7.2 0.0 6.7 87.7 40.8 9.4 10.0 16.7 9.1 6.3 12.8 10.9 0.0 4.2 4.9 0.0 5.4 2.4 0.0 3.2 4.1 3.2 1.7 1.3 3.1 6.8 3.5 8.5 6.6 0.0 3.1 5.0 1.6 18.1 18.5 15.9 20.3 17.2 23.5 21.9 20.6 13.9 23.0 19.7 21.9 21.3 104.4 0.0 7.7 212.9 34.6 11.2 3.0 2.0 0.6 42.7 1.4 2.8 106.3 1.5 3.6 1.8 45.9 0.3 22.0 0.0 0.0 2.1 110.1 7.2 287.8 110.6 0.0 12.2 276.1 2.7 0.5 66.1 2.0 6.5 1.3 17.0 49.6 13.4 1.2 10.1 261.9 0.0 0.0 3.8 25.6 141.8 30.7 6.3 26.6 479.7 10.7 7.2 7.2 968.6 7.3 2.5 0.0 102.0 33.2 3.7 0.0 1.6 1.5 43.4 78.9 99.2 74.2 17.4 15.7 1.1 8.7 0.7 36.2 12.0 0.0 3.8 FAM13C FAM13C1 ENSG00000148541 "Family with sequence similarity 13 member C" Q8NE31 10 59246130-59363181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.7" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 477.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037888 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA037888: AB_10962981" "unprognostic (3.68e-1)" "unprognostic (6.10e-2)" "unprognostic (2.46e-1)" "unprognostic (6.69e-5)" "unprognostic (8.54e-2)" "unprognostic (4.56e-2)" "unprognostic (3.30e-2)" "unprognostic (1.06e-2)" "unprognostic (6.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.27e-1)" "unprognostic (4.51e-6)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (1.94e-3)" "unprognostic (4.66e-3)" 12.5 16.3 21.3 3.9 44.0 0.0 9.4 32.3 38.2 8.8 4.4 6.6 4.2 8.8 8.1 13.9 14.7 11.6 8.2 21.9 33.6 3.4 2.2 10.0 4.8 42.5 37.7 20.5 21.4 2.3 4.7 4.8 2.6 40.6 17.4 6.3 10.0 5.7 8.0 17.3 7.3 6.0 12.3 37.4 5.2 3.8 5.3 36.5 5.2 6.3 23.1 2.3 4.4 8.0 69.7 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 1.3 0.2 0.1 0.0 1.2 0.0 4.1 1.9 0.1 0.0 0.0 5.1 0.6 0.2 0.0 3.4 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.8 0.0 0.0 1.3 8.6 5.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 2.5 2.2 0.1 2.1 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 44.0 32.3 38.2 21.9 33.6 42.5 37.7 20.5 40.6 37.4 36.5 69.7 47.8 0.0 0.0 33.6 0.1 4.8 9.3 0.3 8.0 10.5 0.7 2.7 2.5 0.0 0.7 0.0 6.2 0.0 0.4 0.1 7.9 0.0 49.0 18.6 1.5 35.2 0.0 0.0 66.8 0.0 0.0 19.8 0.5 5.3 0.0 26.9 3.9 0.5 0.0 3.3 73.2 0.2 20.3 0.0 2.5 22.1 23.0 0.7 3.6 7.5 0.0 8.8 0.0 56.8 477.1 0.0 0.0 21.1 0.1 5.4 0.0 0.6 20.7 13.6 39.5 23.4 36.2 1.4 0.7 2.4 6.3 0.0 1.2 17.4 0.2 1.1 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 687.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 687.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021670: AB_2670803, HPA059477: AB_2684032" "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 19.0 12.8 9.5 21.1 9.9 34.1 18.0 11.0 12.2 15.1 9.9 16.8 16.9 13.2 11.2 15.0 9.6 17.4 12.7 10.1 11.7 14.2 45.5 16.5 21.3 11.9 11.9 9.7 11.5 10.5 10.9 9.7 22.2 15.4 10.4 16.8 7.3 14.6 8.6 24.9 15.3 15.8 14.3 11.6 22.8 13.5 12.0 11.3 22.7 18.7 26.5 20.4 20.0 10.7 11.7 23.9 20.8 20.7 19.3 48.5 74.5 20.7 33.2 56.4 26.0 36.7 44.5 24.9 30.8 15.8 37.6 26.1 18.3 20.3 28.0 35.7 27.7 19.6 22.9 10.3 36.0 61.4 30.6 25.5 69.1 59.0 42.5 103.4 48.8 27.1 19.7 23.4 34.8 33.6 17.4 25.9 54.1 24.3 19.4 84.8 25.0 18.8 18.2 30.2 13.4 11.9 20.3 19.9 38.4 61.7 33.8 23.8 30.0 28.2 18.1 26.7 28.3 36.2 43.5 35.6 37.2 50.6 48.2 14.8 124.6 79.5 162.1 28.8 92.3 30.4 47.9 29.4 32.2 68.7 42.5 35.9 33.1 687.6 32.6 93.4 34.1 36.6 55.2 9.5 9.9 11.0 12.2 10.1 11.7 11.9 11.9 9.7 15.4 11.6 11.3 11.7 29.7 3.2 30.6 3.9 45.7 28.8 41.8 42.8 20.5 12.2 30.1 40.0 8.9 14.3 30.6 12.9 4.2 53.1 44.0 31.5 23.5 31.6 10.3 30.6 49.9 26.0 15.6 13.2 9.4 35.0 76.8 34.8 16.8 37.7 14.0 15.2 17.9 53.2 48.9 20.2 8.4 41.1 32.6 49.7 34.9 6.3 23.3 56.0 46.2 10.3 56.6 15.4 35.0 5.5 9.3 40.0 32.0 21.4 43.1 40.0 31.9 31.4 24.7 9.0 19.7 26.0 30.6 55.4 71.1 29.4 31.8 285.3 43.3 25.2 29.6 68.6 A1CF "ACF, ACF64, ACF65, APOBEC1CF, ASP" ENSG00000148584 "APOBEC1 complementation factor" Q9NQ94 10 50799409-50885675 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 145.2" "Cell type enhanced" "Detected in some" "Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4" "Cancer enriched" "Detected in some" 6 "liver cancer: 18.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "CACO-2: 23.5;Hep G2: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA037779, HPA044079" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037779: AB_10670529, HPA044079: AB_2678800" "unprognostic (3.87e-3)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-3)" "unprognostic (2.73e-1)" "unprognostic (4.61e-3)" "unprognostic (1.71e-1)" "unprognostic (7.38e-3)" "unprognostic (1.30e-2)" "unprognostic (2.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-3)" "unprognostic (1.97e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.50e-4)" 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 23.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 12.7 145.2 0.0 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.0 0.0 0.0 27.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 60.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 150.2 0.0 3.7 2.1 0.0 0.0 71.3 9.8 1.2 0.0 0.0 0.0 0.6 116.5 5.3 0.4 11.4 0.0 0.0 0.0 0.0 0.0 0.0 6.1 337.9 0.0 0.0 0.3 52.0 0.0 8.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.1 83.8 0.0 0.0 0.1 147.5 118.4 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 35.1 0.1 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194537-84219621 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 316.5;skin 1: 215.7" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "NK-cell: 7.5" "Lineage enriched" "Detected in single" 12 "NK-cells: 7.5" "Cell line enhanced" "Detected in some" "HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3" "Region enriched" "Detected in many" 21 "olfactory bulb: 333.0" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" NA NA 55000 "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.1 1.9 5.0 1.0 17.6 0.4 4.5 2.5 8.7 2.9 36.2 29.5 0.1 0.6 4.4 10.8 0.5 0.4 0.8 7.1 8.0 0.4 0.5 0.2 0.9 11.6 4.3 3.7 1.1 0.1 0.0 3.0 0.2 14.7 1.4 53.7 316.5 1.6 4.2 1.0 215.7 12.3 1.2 0.1 7.0 0.2 0.3 3.6 3.4 0.2 0.0 1.1 0.1 3.5 11.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 10.2 2.0 0.0 0.0 5.2 6.3 0.0 0.0 0.2 0.0 0.2 0.0 2.2 0.0 0.7 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.5 4.4 0.0 0.0 0.0 0.0 1.4 16.3 0.0 3.4 0.8 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.1 5.0 17.6 2.5 8.7 7.1 8.0 11.6 4.3 3.7 14.7 0.1 3.6 11.1 0.0 0.0 0.5 1.3 0.1 51.2 0.3 1.4 3.4 24.1 0.0 0.1 1.8 0.0 0.7 0.0 379.5 0.0 2.1 47.9 0.0 0.1 0.0 2.7 0.7 1.8 12.7 0.0 4.9 0.0 0.0 0.6 0.0 3.1 0.0 3.7 0.4 0.4 0.0 5.0 7.7 46.9 0.0 0.3 5.2 0.2 0.0 0.1 3.6 1.0 0.0 26.3 1.0 7.5 4.4 0.0 31.2 0.0 0.7 0.3 23.0 0.2 0.1 240.4 0.0 0.2 0.3 0.6 0.3 3.0 67.5 0.0 3.0 0.3 52.9 0.2 LRIT1 "DKFZP434K091, FIGLER9, LRRC21, PAL" ENSG00000148602 "Leucine rich repeat, Ig-like and transmembrane domains 1" Q9P2V4 10 84231520-84241546 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 25.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 13.6;Early spermatids: 31.2;Late spermatids: 38.5;Spermatocytes: 13.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.13e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 38.5 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 13.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RGR RP44 ENSG00000148604 "Retinal G protein coupled receptor" P47804 10 84230666-84259960 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 140.2" "Cell type enriched" "Detected in some" 29 "Muller glia cells: 1475.8" "Cancer enriched" "Detected in single" 4 "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3" HPA059149 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA059149: " "unprognostic (9.28e-2)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (9.53e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-1)" 0.1 0.0 11.0 0.0 10.9 0.0 0.1 3.4 14.7 0.0 12.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 6.4 6.9 0.0 0.0 0.2 0.0 4.1 6.5 7.5 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 140.2 0.1 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.2 0.9 8.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.9 3.4 14.7 6.4 6.9 4.1 6.5 7.5 5.8 1.7 8.6 5.0 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 20.6 0.1 0.1 0.4 0.0 0.0 0.0 31.3 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 10.6 0.3 0.0 0.0 0.0 0.0 1475.8 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.6 0.0 2.8 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POLR3A "C160, hRPC155, RPC1, RPC155" ENSG00000148606 "RNA polymerase III subunit A" O14802 10 77969251-78029515 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Nucleotidyltransferase, Transferase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 75.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037926 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA037926: AB_10672400" "unprognostic (6.83e-2)" "unprognostic (3.41e-2)" "unprognostic (4.54e-2)" "unprognostic (2.76e-2)" "unprognostic (6.41e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.64e-6)" "unprognostic (3.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (6.64e-2)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.34e-1)" "unprognostic (3.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.11e-2)" 4.3 6.1 4.9 5.3 7.1 3.9 6.3 6.8 7.8 5.0 4.1 4.8 5.2 5.5 7.6 5.1 4.9 3.7 4.6 7.3 5.0 5.3 5.6 4.1 5.7 5.5 3.8 6.5 6.5 5.4 6.8 10.4 6.1 5.9 5.8 5.8 12.9 5.1 4.5 11.6 6.8 4.8 5.7 1.9 5.1 4.7 6.0 4.5 7.7 5.6 8.7 6.3 5.1 4.9 7.6 14.2 16.3 17.4 28.8 11.2 14.2 11.6 16.0 20.7 20.2 19.8 22.1 10.0 17.6 9.7 14.0 11.5 15.7 30.3 17.5 24.4 13.0 22.2 14.2 13.6 26.6 10.5 24.6 11.5 12.2 12.3 35.9 33.0 19.4 18.0 14.1 26.8 10.6 19.9 10.6 18.7 15.6 19.0 11.0 75.1 17.5 11.0 11.5 10.0 8.6 15.5 20.0 15.4 28.3 16.6 15.5 21.0 12.7 19.8 12.9 12.5 14.2 32.0 16.4 18.6 21.0 23.0 25.4 6.4 5.4 2.6 1.5 3.5 3.1 3.5 2.6 2.8 3.4 2.4 3.2 2.5 3.0 1.5 3.4 2.9 2.6 4.6 1.9 4.9 7.1 6.8 7.8 7.3 5.0 5.5 3.8 6.5 5.9 1.9 4.5 7.6 8.5 0.0 9.1 17.0 8.7 9.9 5.1 5.3 11.4 28.3 9.6 8.3 11.7 8.6 9.5 0.0 64.6 8.0 12.6 6.1 1.9 7.0 1.6 8.3 14.4 8.1 7.2 11.6 26.4 6.2 6.9 8.2 8.2 8.9 6.3 15.7 5.3 9.5 5.5 15.2 26.3 10.2 0.0 6.9 3.7 1.2 13.1 5.9 1.8 10.3 7.8 13.0 12.3 16.1 18.7 8.1 8.3 8.2 11.2 4.7 8.0 5.0 10.4 31.5 6.6 13.6 8.3 12.5 18.0 10.1 9.1 4.1 7.8 13.7 8.6 3.6 HERC4 "DKFZP564G092, KIAA1593" ENSG00000148634 "HECT and RLD domain containing E3 ubiquitin protein ligase 4" Q5GLZ8 10 67921899-68075301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 209.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 201.4;fHDF/TERT166: 226.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045453, HPA070301" Uncertain Supported "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA045453: AB_10961917, HPA070301: AB_2686247" "unprognostic (3.66e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" "unprognostic (1.01e-3)" "unprognostic (3.54e-1)" "unprognostic (8.57e-2)" "unprognostic (4.94e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.86e-5)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (3.98e-1)" "unprognostic (2.31e-2)" 13.8 19.8 19.8 14.5 20.4 11.0 14.4 21.2 24.7 15.3 19.4 14.1 14.0 15.1 14.1 14.7 13.5 13.4 13.7 22.4 22.2 13.8 16.7 14.0 21.2 21.2 20.3 19.8 15.4 11.2 12.1 14.2 16.7 21.1 12.3 16.0 14.0 11.6 11.5 13.6 13.5 14.8 15.7 20.8 18.4 11.7 14.3 22.5 15.3 13.2 12.4 19.5 16.4 14.4 28.8 75.4 30.4 16.7 28.5 47.5 63.9 15.5 201.4 125.5 75.5 47.6 17.5 35.3 29.7 14.3 226.7 40.6 40.9 21.1 28.9 102.0 17.6 9.2 13.7 51.3 12.2 22.6 17.3 21.3 30.2 33.8 39.3 34.4 89.1 47.5 15.0 14.9 14.3 117.4 35.2 11.3 19.9 9.9 15.8 49.0 15.3 7.6 8.2 32.3 23.7 8.7 9.4 66.1 26.4 26.5 37.6 15.4 20.1 65.0 38.2 17.5 94.7 31.9 8.7 11.2 17.8 67.7 32.3 13.6 10.8 5.0 6.6 3.9 4.1 5.0 3.4 4.1 4.5 5.7 3.4 4.1 4.2 6.7 5.2 4.1 1.6 5.6 3.7 19.8 20.4 21.2 24.7 22.4 22.2 21.2 20.3 19.8 21.1 20.8 22.5 28.8 29.8 48.1 29.3 127.0 41.0 50.3 33.7 27.2 26.2 50.1 29.1 16.6 23.0 14.3 24.1 18.4 43.8 29.3 38.7 78.7 7.9 19.5 66.4 44.3 45.4 30.9 22.1 32.4 170.2 12.2 40.8 30.3 34.1 70.9 30.4 31.3 28.5 24.5 23.6 53.8 148.8 29.9 26.4 42.9 23.3 47.4 26.8 30.9 17.8 149.9 36.0 18.9 40.2 174.9 209.2 38.6 52.3 19.2 17.4 42.6 37.8 24.9 25.5 45.8 6.6 33.2 28.1 25.2 12.4 23.4 60.9 15.6 40.9 38.5 21.9 48.5 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431624-76560168 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 62.0;epididymis: 60.0" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1" "Group enriched" "Detected in many" 7 "dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6" "Cell line enhanced" "Detected in many" "Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 16.3 62.0 7.6 5.5 8.6 27.8 10.4 7.4 7.8 12.1 5.1 8.2 5.8 6.4 60.0 7.6 9.8 10.3 12.4 7.4 9.0 20.8 36.1 12.9 5.3 11.0 8.3 5.5 13.1 25.1 20.8 10.1 12.8 10.7 10.8 7.2 2.4 9.3 10.1 2.7 2.9 4.6 9.1 10.4 10.6 16.9 3.7 8.7 4.2 18.8 4.8 5.2 11.5 4.5 10.8 0.3 5.7 0.2 0.1 2.9 3.5 0.1 0.7 0.0 0.3 0.5 7.6 13.4 0.0 25.8 0.0 0.1 0.3 0.0 0.0 0.1 0.5 1.6 1.6 2.9 46.3 1.1 9.4 34.0 1.4 1.0 0.6 0.1 5.5 0.8 0.1 0.0 1.4 0.1 1.0 0.1 65.6 0.3 3.9 2.2 0.1 0.2 0.1 0.6 8.3 0.3 0.4 8.1 0.0 93.0 0.2 0.5 48.7 0.9 0.3 3.1 2.4 5.3 0.4 0.2 0.2 22.6 43.6 11.3 6.4 57.6 22.1 0.1 28.8 0.3 0.1 0.0 0.0 67.5 0.1 0.1 0.1 3.2 7.1 17.1 0.5 0.2 18.9 7.6 8.6 7.4 7.8 7.4 9.0 11.0 8.3 5.5 10.7 10.4 8.7 10.8 42.4 22.4 19.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 5.7 0.0 0.0 3.7 12.9 0.0 1.1 0.8 0.0 33.2 16.6 0.0 27.8 2.5 13.2 0.0 0.0 0.0 15.8 0.8 4.5 0.0 10.0 7.6 16.1 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.1 0.0 0.0 113.4 6.6 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 1.2 0.6 25.7 0.0 0.0 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.8" "Cell type enhanced" "Detected in many" "Astrocytes: 410.7;Cytotrophoblasts: 163.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 133.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 154.8;SK-BR-3: 177.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 200000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 18.4 14.1 83.9 17.2 92.7 34.8 15.4 84.2 139.3 23.1 46.9 77.4 34.5 45.6 14.6 35.0 30.9 17.9 11.4 90.2 77.7 19.4 14.6 19.0 16.3 91.9 87.8 79.4 12.8 10.4 12.4 14.2 27.5 95.6 31.4 26.4 42.8 23.1 50.1 155.8 16.4 41.9 44.2 85.5 25.1 30.7 6.6 101.1 15.8 13.7 85.6 15.0 58.9 26.0 92.8 35.7 24.6 22.5 43.9 16.7 26.1 26.3 25.8 41.0 31.9 26.1 39.8 37.2 27.4 25.7 32.4 12.4 54.9 17.5 20.5 25.3 24.0 22.2 18.2 20.4 17.8 8.1 24.7 29.1 14.4 17.7 32.5 22.1 50.4 28.3 32.5 19.5 37.9 19.0 25.2 41.7 37.5 16.5 21.3 154.8 36.5 25.3 13.7 17.2 51.5 11.5 28.4 15.0 177.4 11.9 16.5 33.2 15.0 36.7 24.9 40.0 13.4 33.3 11.9 14.9 24.8 26.5 69.2 8.8 31.0 17.9 133.9 23.1 7.9 28.5 13.9 26.3 25.0 23.0 12.7 24.5 24.1 115.8 34.0 15.1 7.9 27.7 17.5 83.9 92.7 84.2 139.3 90.2 77.7 91.9 87.8 79.4 95.6 85.5 101.1 92.8 19.3 16.0 11.7 410.7 22.2 9.4 8.7 9.2 14.2 63.3 14.8 16.3 6.7 12.8 15.5 7.3 100.1 163.6 21.3 46.2 13.7 13.3 2.0 6.3 6.4 20.2 23.9 13.3 107.9 19.6 45.2 12.0 14.8 7.5 16.5 20.2 16.4 9.6 27.2 26.9 89.7 24.8 10.2 18.9 16.3 3.1 12.8 15.8 12.4 43.1 18.3 17.7 26.8 61.9 16.9 22.0 65.5 18.8 13.6 8.2 77.1 26.9 10.4 77.0 46.0 11.2 50.8 0.8 13.5 26.5 12.6 81.1 30.3 5.2 32.1 13.7 ADIRF "AFRO, APM2, C10orf116" ENSG00000148671 "Adipogenesis regulatory factor" Q15847 10 86968432-86983934 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 1249.9" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 12067.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2" "Low region specificity" "Detected in all" HPA026810 Approved Supported Nucleoplasm,Cytosol NA NA 760000 "Nucleoplasm, Cytosol" "HPA026810: AB_2672003" 1249.9 59.3 198.2 51.3 182.0 1.0 248.6 170.8 383.2 189.9 183.8 115.2 481.2 115.0 49.6 115.2 237.9 47.2 91.4 198.2 245.5 148.6 83.1 211.3 15.6 205.1 183.0 180.4 254.9 73.8 27.1 55.5 28.6 186.5 315.3 48.6 29.3 299.3 235.9 88.3 104.4 495.7 76.4 188.8 74.2 75.8 27.4 195.0 26.0 117.5 133.0 45.1 245.1 172.5 191.8 259.8 4.9 0.1 0.1 123.3 224.9 16.1 97.0 166.9 1.7 0.4 6.5 29.5 0.0 3.4 209.9 8.4 847.5 0.0 39.7 1.0 9.1 0.0 0.0 22.5 1.8 19.9 0.2 3.4 1.9 132.0 0.6 70.1 6.7 50.4 3.6 0.3 36.3 4.0 130.4 0.6 6.5 0.0 6.4 680.7 0.5 0.0 3.4 14.6 1035.2 11.8 3.0 36.0 222.0 1.7 0.0 270.7 2.7 132.6 3.4 17.4 13.2 0.6 4.0 3.3 0.4 6.3 0.0 5.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.3 0.0 2.5 1.9 0.0 0.0 0.0 0.0 0.5 0.3 198.2 182.0 170.8 383.2 198.2 245.5 205.1 183.0 180.4 186.5 188.8 195.0 191.8 1215.2 1842.9 476.5 3.9 15.0 528.4 141.9 309.7 39.9 5.4 651.4 253.2 0.0 58.6 614.4 187.6 2.1 299.2 14.3 658.7 1352.0 29.9 9.6 55.7 63.9 944.9 30.0 37.5 0.1 272.1 16.9 508.0 121.3 195.1 48.9 11.7 1691.7 257.4 26.4 0.0 0.3 418.7 128.1 17.3 492.0 48.4 1309.5 25.3 610.1 10.3 99.9 703.9 0.0 1.0 0.2 336.8 1115.3 469.8 3.4 481.9 12067.2 1144.8 88.2 16.5 1472.6 705.4 2422.0 3.2 6.2 35.0 438.6 166.8 40.7 2.4 443.5 1160.7 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050202-87094843 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 823.1" "Cell type enhanced" "Detected in all" "Astrocytes: 294.1;Hepatocytes: 402.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 555.0" "Low region specificity" "Detected in all" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" NA NA 23000000 Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favorable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 70.7 93.8 218.5 45.2 216.1 29.5 97.3 187.8 218.6 48.2 138.8 64.0 81.7 48.5 30.3 77.6 47.8 53.7 76.3 197.9 224.8 251.5 823.1 58.2 43.2 223.4 221.2 192.7 72.2 66.7 39.3 37.4 59.3 223.3 111.5 62.1 91.0 56.0 53.7 51.5 83.0 89.3 53.8 220.7 46.8 57.5 22.5 243.0 45.2 68.7 65.0 59.7 68.7 56.1 204.8 127.1 100.3 77.1 131.5 143.0 174.5 84.0 97.7 167.8 92.4 100.5 233.0 120.6 141.5 77.8 143.4 53.0 194.7 101.4 98.5 98.0 102.7 79.8 69.0 55.9 555.0 318.1 163.2 95.5 121.3 181.5 103.2 304.9 140.3 112.0 109.3 70.7 124.0 101.0 92.1 148.1 145.7 88.2 136.9 79.8 110.4 98.3 93.1 267.4 101.8 39.7 73.9 87.8 68.8 126.1 73.9 94.3 112.8 112.4 47.8 42.5 98.2 101.0 73.6 81.4 167.5 115.3 182.8 29.3 9.1 14.2 9.7 8.3 11.1 10.3 9.8 11.2 10.1 15.9 11.3 9.9 8.0 1.2 13.6 16.0 5.9 12.6 6.5 218.5 216.1 187.8 218.6 197.9 224.8 223.4 221.2 192.7 223.3 220.7 243.0 204.8 49.3 22.4 23.9 294.1 56.6 106.0 57.5 32.2 105.3 22.5 83.3 38.2 60.2 57.2 47.3 60.7 37.5 95.7 45.6 56.1 156.5 32.5 14.2 37.3 44.0 54.1 39.4 52.6 35.8 33.8 63.8 89.0 86.2 59.7 43.2 33.6 50.7 402.3 69.1 15.2 38.0 49.5 36.7 74.1 184.5 26.0 88.0 81.4 104.9 42.2 50.6 140.0 39.1 48.7 42.9 50.2 38.3 90.7 75.7 103.4 124.2 175.5 21.6 68.9 65.7 41.3 55.9 11.4 8.6 189.5 122.3 47.6 84.6 70.9 49.6 107.3 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921087 "Metabolic proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "heart muscle: 6603.1" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 13820.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA038736: AB_2676184" "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 0.9 0.7 0.0 0.4 0.1 0.0 1.9 0.2 0.2 0.4 0.7 0.6 0.0 0.4 0.0 0.6 0.1 1.3 6603.1 0.0 0.9 0.6 1.6 49.0 2.6 0.2 0.2 0.0 0.8 4.8 0.2 1.2 4.2 0.2 6.8 0.0 0.0 8.8 0.1 575.7 1.6 0.6 2.1 0.0 0.6 1.0 0.9 0.7 1.5 1.8 20.7 0.0 1.2 0.5 0.1 37.2 10.8 6.6 0.3 5.8 6.7 0.5 21.5 2.2 6.0 10.8 474.5 17.9 0.3 1248.9 1.8 48.5 13.3 2.3 3.1 15.7 1.4 1.2 0.2 2.9 148.5 27.7 0.0 0.0 44.2 0.1 9.5 21.6 679.8 437.8 0.0 0.3 0.0 1573.6 0.4 0.0 0.0 1.3 2.7 0.3 0.0 104.3 0.0 3.9 0.5 0.1 0.0 0.3 0.4 1.2 469.1 0.3 1.9 2206.7 4.1 163.9 3.2 175.0 0.0 1.2 3.0 0.9 0.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.9 0.2 0.2 0.0 0.2 0.0 0.7 0.1 0.0 913.5 42.0 0.0 0.0 0.0 3.5 18.5 0.0 0.0 0.0 0.0 13820.4 7.2 6.6 0.0 0.0 0.6 0.0 0.0 0.0 66.3 5.7 9.4 0.2 83.6 0.0 0.0 0.0 0.2 0.2 243.5 0.0 4.6 3.8 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.0 0.0 74.5 100.9 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90858039 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.9;parathyroid gland: 13.2;testis: 8.8" "Cell type enhanced" "Detected in some" "Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "myeloid DC: 1.4" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: AB_2732228" "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 0.4 0.2 2.4 0.9 1.4 0.3 0.3 0.1 2.6 0.4 0.8 0.6 0.6 0.2 0.1 0.7 0.2 0.9 0.1 2.9 6.3 0.1 0.4 0.2 0.6 1.5 3.1 1.3 0.1 0.2 13.2 0.1 0.3 2.0 0.2 0.9 0.1 0.3 0.1 0.9 0.4 1.4 0.3 0.8 1.1 0.7 8.8 7.9 0.2 0.1 0.5 0.4 2.3 0.6 1.5 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.7 0.3 0.7 1.0 0.0 1.2 0.0 0.0 0.1 2.0 4.7 1.3 11.3 2.8 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.6 7.8 10.1 3.3 33.4 6.3 0.0 0.0 0.1 0.0 13.5 0.0 0.0 0.2 1.2 0.0 1.6 1.0 0.1 0.0 0.0 1.2 0.4 0.0 0.5 0.0 5.4 0.6 0.0 0.2 0.3 6.1 0.0 0.1 9.6 0.0 0.0 0.0 10.2 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 1.4 0.1 2.6 2.9 6.3 1.5 3.1 1.3 2.0 0.8 7.9 1.5 0.1 0.0 0.0 0.7 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.3 0.0 0.0 0.4 5.9 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.0 1.7 0.0 24.2 0.0 2.0 2.2 0.0 2.7 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.1 13.1 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871952-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 18.8 14.0 8.3 13.0 10.0 26.1 17.5 9.4 10.7 14.2 8.7 15.4 9.4 15.9 14.3 18.1 15.0 12.8 22.7 9.5 9.8 16.4 15.2 13.2 21.2 8.5 8.9 8.5 18.3 11.1 23.2 8.1 18.6 8.7 12.2 15.3 13.3 14.7 12.3 31.3 18.0 12.6 16.6 9.0 15.1 14.4 28.8 9.3 21.9 12.3 22.4 22.6 17.2 14.3 11.6 82.2 53.2 55.0 66.5 34.4 37.6 19.4 57.0 51.1 93.3 98.3 90.6 64.1 48.1 42.6 36.4 60.9 56.0 73.9 50.5 95.3 77.2 51.3 32.7 31.1 73.0 33.0 66.7 39.1 30.9 32.4 70.5 79.1 39.6 54.1 43.5 65.7 42.6 62.6 50.8 77.4 89.8 33.9 46.4 59.8 42.9 46.7 50.4 35.6 38.2 29.9 29.9 33.1 23.8 68.2 50.0 64.8 41.3 31.2 46.3 46.3 26.5 119.6 28.7 79.4 104.4 57.9 35.4 36.4 9.2 30.0 27.1 25.2 30.7 27.5 31.7 28.7 28.0 35.1 28.1 24.6 27.0 3.5 25.4 26.2 32.8 33.0 27.6 8.3 10.0 9.4 10.7 9.5 9.8 8.5 8.9 8.5 8.7 9.0 9.3 11.6 31.4 32.1 16.9 14.0 28.7 34.4 27.5 51.8 23.9 19.2 16.7 28.2 45.7 27.1 31.4 14.7 18.8 60.6 33.7 9.4 31.3 41.9 95.9 18.9 26.1 25.2 19.8 38.5 18.0 35.0 68.1 28.0 13.3 17.9 23.5 33.3 21.4 14.3 58.1 16.8 19.4 21.0 30.5 23.9 29.3 49.9 28.9 24.7 23.2 11.2 32.2 23.3 15.5 17.6 19.6 31.3 12.5 29.3 20.6 18.8 12.5 36.5 21.6 24.3 39.5 30.1 36.9 77.9 54.2 20.2 34.0 33.8 23.7 28.6 17.6 27.6 FRA10AC1 C10orf4 ENSG00000148690 "FRA10A associated CGG repeat 1" Q70Z53 10 93667883-93702592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039204 Approved NA NA "HPA039204: AB_10794426" "unprognostic (3.21e-3)" "unprognostic (1.61e-1)" "unprognostic (5.03e-2)" "unprognostic (9.91e-2)" "unprognostic (9.24e-2)" "unprognostic (8.30e-2)" "unprognostic (4.38e-2)" "unprognostic (2.89e-3)" "unprognostic (1.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.28e-2)" "unprognostic (3.64e-2)" "unprognostic (3.42e-2)" "unprognostic (1.27e-2)" "unprognostic (3.06e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" 9.3 8.7 21.4 6.4 22.7 7.1 8.7 22.4 24.1 10.2 16.8 8.8 5.9 10.8 8.5 6.6 10.2 5.3 11.8 20.6 21.0 8.5 8.4 6.4 8.3 21.5 21.3 19.2 12.3 10.4 8.4 10.3 6.0 22.1 9.1 6.4 12.4 12.5 7.5 12.3 9.9 6.7 6.8 21.6 7.3 7.9 10.6 21.4 7.4 9.2 12.8 7.4 8.9 8.6 23.3 15.9 11.6 10.7 29.4 14.3 17.1 6.9 13.4 9.5 7.3 8.4 5.3 12.9 11.9 9.7 8.9 11.6 19.1 13.0 10.0 11.5 22.4 14.4 8.9 9.0 12.0 20.1 17.5 5.8 11.7 5.9 7.9 18.8 23.1 15.3 13.6 13.0 14.3 13.1 7.6 16.2 17.9 8.5 8.3 11.1 10.6 13.4 5.1 8.8 5.5 10.5 10.0 6.8 6.1 28.1 11.1 24.2 14.2 15.9 5.3 9.5 4.4 15.6 11.5 16.2 11.6 13.5 28.4 3.9 4.7 2.7 5.6 4.4 3.1 6.0 5.7 6.5 5.9 2.2 6.3 7.8 6.7 2.0 4.0 4.1 3.6 5.5 1.4 21.4 22.7 22.4 24.1 20.6 21.0 21.5 21.3 19.2 22.1 21.6 21.4 23.3 39.6 16.0 45.4 28.1 25.5 20.6 29.6 37.7 32.5 36.2 24.1 43.6 109.7 34.3 28.9 14.7 22.9 29.0 18.7 13.4 37.2 35.2 75.8 29.0 35.8 35.1 43.0 24.6 44.2 43.7 21.0 37.1 21.4 24.6 25.3 34.5 29.6 77.1 19.6 50.5 45.6 51.7 20.3 20.0 14.6 26.2 30.7 18.4 16.0 34.7 26.9 47.9 29.9 44.7 48.2 36.0 16.1 28.2 19.0 32.5 14.8 43.1 23.7 33.0 13.1 57.2 43.0 151.3 69.0 20.3 22.3 14.1 23.1 33.6 25.3 21.8 ADD3 ADDL ENSG00000148700 "Adducin 3" Q9UEY8 10 109996368-110135565 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 449.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 313.2;ASC TERT1: 292.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009797, HPA035696" Supported Supported "Plasma membrane" NA NA 260000 "Plasma membrane" "CAB009797: AB_2223583, HPA035696: AB_2674740" "unprognostic (2.66e-1)" "unprognostic (2.63e-2)" "unprognostic (1.46e-3)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.75e-2)" "unprognostic (1.57e-3)" "unprognostic (6.42e-2)" "unprognostic (5.73e-2)" "unprognostic (2.37e-2)" "unprognostic (7.58e-2)" "unprognostic (9.12e-2)" "unprognostic (2.34e-3)" "unprognostic (1.36e-1)" "unprognostic (4.03e-1)" "unprognostic (3.68e-2)" "unprognostic (5.92e-2)" 58.2 21.9 114.2 39.2 102.7 37.8 90.3 100.5 130.5 58.1 76.7 58.7 72.5 25.1 62.9 39.4 48.1 72.6 60.5 123.4 124.9 103.6 28.1 38.8 71.5 116.6 101.5 98.4 46.9 68.4 18.9 25.5 36.9 108.3 33.0 66.6 100.2 59.6 32.1 9.7 33.1 86.1 24.1 114.3 40.3 64.3 51.9 100.2 88.2 88.6 25.8 65.9 42.7 40.4 132.1 29.2 6.0 41.7 19.8 313.2 292.1 17.7 41.2 110.9 25.4 49.9 60.3 90.6 89.9 45.2 63.9 26.4 10.0 37.3 27.1 39.5 9.0 46.5 8.8 28.5 45.9 35.5 30.5 66.0 142.5 12.9 63.3 2.6 96.4 37.8 109.9 23.5 48.7 46.7 0.8 32.3 31.0 25.8 69.2 15.3 27.7 58.2 4.8 65.7 14.2 6.1 67.9 27.6 8.9 66.5 62.2 10.7 11.4 9.5 16.0 42.0 33.5 9.1 68.9 31.5 82.7 47.8 16.2 27.7 139.5 29.6 98.0 68.8 26.5 55.7 51.4 72.9 59.1 24.8 42.9 83.2 67.6 47.1 73.4 32.6 16.3 73.3 94.9 114.2 102.7 100.5 130.5 123.4 124.9 116.6 101.5 98.4 108.3 114.3 100.2 132.1 67.3 22.4 52.9 449.2 110.6 55.7 35.9 77.4 38.7 26.8 56.0 34.4 128.2 74.4 85.5 36.8 60.5 55.6 112.7 125.2 60.7 27.2 51.4 70.3 76.0 77.7 102.4 32.6 83.4 61.1 12.1 182.4 100.9 56.0 26.0 18.8 126.7 12.2 25.7 116.1 141.1 71.6 48.8 88.5 41.1 25.7 226.5 66.3 58.7 70.3 65.3 339.0 151.4 236.8 279.6 59.8 167.1 251.3 68.4 38.4 135.2 162.2 151.9 121.7 65.7 27.6 36.2 122.7 62.1 53.2 50.6 22.3 111.5 30.9 166.7 98.6 HABP2 "FSAP, HABP, HGFAL, PHBP" ENSG00000148702 "Hyaluronan binding protein 2" Q14520 10 113550837-113589602 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 440.9" "Group enriched" "Detected in some" 5 "Cholangiocytes: 124.4;Hepatocytes: 221.4" "Cancer enriched" "Detected in many" 5 "liver cancer: 92.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "OE19: 64.7;RPTEC TERT1: 50.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019518 Uncertain "Secreted to blood" NA NA 20200000000 4400000000 "HPA019518: AB_1850467" "unprognostic (3.89e-2)" "unprognostic (6.15e-2)" "unprognostic (1.33e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-1)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (5.86e-3)" "unprognostic (1.67e-1)" "unprognostic (9.78e-2)" "unprognostic (5.10e-2)" "unprognostic (4.77e-2)" "unprognostic (9.18e-3)" "unprognostic (2.62e-3)" "unprognostic (2.11e-1)" "unprognostic (3.22e-1)" "unprognostic (9.05e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.5 0.0 0.0 3.1 2.9 1.7 0.0 2.3 36.3 2.1 0.2 0.0 13.9 440.9 0.8 0.0 0.0 0.0 0.1 0.0 17.5 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.1 12.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 64.7 0.0 0.0 0.1 0.0 50.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 2.3 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 124.4 0.0 1.8 0.0 0.0 0.0 0.0 3.9 31.4 0.5 10.8 0.8 0.4 0.0 5.3 1.0 3.9 0.0 0.0 17.9 6.5 0.0 0.0 5.3 221.4 1.0 0.0 0.0 0.2 0.0 5.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 12.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.1 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "brain: 3.7" "Cell type enriched" "Detected in some" 4 "Inhibitory neurons: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 3.1;WM-115: 2.3" "Group enriched" "Detected in some" 6 "basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5" "Low region specificity" "Detected in some" HPA028946 Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes NA "Nucleoli rim" Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.0 0.0 3.1 0.0 2.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 1.2 0.4 0.6 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.0 2.2 0.2 3.7 1.2 0.4 0.6 1.4 0.0 2.6 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355149 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 235.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 23.9 30.1 17.8 18.2 18.8 27.8 24.7 19.5 20.6 21.8 18.3 22.5 21.6 24.2 23.6 23.4 21.0 17.7 25.6 18.6 18.3 24.0 28.3 21.3 16.5 19.4 18.5 18.0 22.8 27.1 33.2 23.8 20.5 18.5 23.6 14.8 16.8 28.6 17.8 37.8 28.1 20.9 19.2 18.3 25.0 24.1 21.6 18.2 17.4 23.7 23.7 16.1 21.8 20.8 19.6 37.4 38.3 23.4 39.3 30.5 31.1 29.6 36.6 63.8 49.5 45.9 44.7 64.3 27.2 28.8 45.1 31.3 61.4 22.2 33.0 26.9 29.9 29.4 14.7 23.0 29.6 68.5 30.1 54.2 39.6 67.6 44.1 55.8 45.0 35.1 25.6 23.2 40.2 43.3 36.7 26.0 26.3 10.8 29.1 11.1 23.4 17.8 18.9 37.7 21.7 16.1 23.0 20.0 74.0 36.8 12.9 28.2 34.2 39.1 24.6 33.4 28.0 46.7 33.8 27.3 16.0 40.6 32.6 17.1 18.7 29.2 18.7 12.8 31.5 11.4 11.5 12.5 9.6 24.6 11.1 10.3 10.2 36.6 13.9 28.9 16.4 13.8 17.5 17.8 18.8 19.5 20.6 18.6 18.3 19.4 18.5 18.0 18.5 18.3 18.2 19.6 30.3 28.9 29.3 10.1 30.1 13.4 30.6 38.6 25.6 33.3 36.1 29.6 23.3 50.1 44.3 23.9 22.9 41.1 37.7 38.1 11.7 34.2 122.2 25.1 26.1 25.3 29.4 31.2 12.7 64.3 41.1 28.6 23.4 29.3 40.0 26.4 21.0 29.6 38.1 30.3 13.0 28.8 12.2 36.0 16.0 235.7 36.4 37.6 10.6 7.5 39.6 33.6 35.0 12.1 15.2 34.9 38.1 35.0 34.2 27.4 62.2 34.4 26.8 35.6 52.6 27.4 34.4 32.4 10.9 28.1 15.5 68.0 22.8 37.0 25.9 35.2 EIF4EBP2 ENSG00000148730 "Eukaryotic translation initiation factor 4E binding protein 2" Q13542 10 70404145-70428618 "Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019415, HPA037410, HPA061665" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580" "unprognostic (9.57e-2)" "unprognostic (3.22e-2)" "unprognostic (2.27e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-1)" "unprognostic (3.51e-1)" "unprognostic (3.84e-1)" "unprognostic (7.24e-2)" "unprognostic (8.24e-2)" "unprognostic (8.19e-2)" "unprognostic (2.87e-1)" "unprognostic (1.46e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.53e-1)" "unprognostic (4.61e-2)" 68.3 27.8 26.7 23.4 23.6 30.7 45.2 21.7 23.8 28.1 27.1 41.6 40.8 25.4 16.6 32.2 26.1 24.0 41.2 21.3 24.2 57.8 50.9 30.8 26.4 28.4 25.3 17.1 35.2 30.5 27.7 11.3 44.2 25.5 24.9 40.0 35.2 28.4 33.9 64.7 35.3 47.7 27.5 22.5 27.0 31.1 18.4 28.8 34.8 23.5 68.0 29.5 36.6 28.4 20.1 56.3 17.8 93.7 92.0 176.9 66.8 51.8 33.5 40.5 24.0 25.9 77.5 48.1 57.2 20.1 48.6 14.9 35.6 46.2 30.4 26.9 63.6 24.0 41.4 21.1 30.8 41.5 74.4 28.4 74.8 30.8 29.4 26.4 48.4 36.8 46.0 69.0 50.7 37.5 31.5 64.3 76.3 80.7 54.2 31.8 66.3 37.6 37.4 30.7 56.3 51.1 77.6 45.7 103.0 44.5 63.8 47.2 65.3 40.6 15.6 20.0 25.8 30.2 35.5 73.2 66.5 18.1 108.2 16.3 20.8 19.2 28.7 16.4 16.8 13.2 9.0 13.1 13.8 17.2 8.2 10.9 11.4 21.1 11.6 23.0 5.7 15.7 19.2 26.7 23.6 21.7 23.8 21.3 24.2 28.4 25.3 17.1 25.5 22.5 28.8 20.1 72.5 25.6 37.6 21.9 31.9 52.9 53.5 25.4 27.9 46.8 42.9 32.5 147.0 68.6 29.1 36.8 20.9 47.3 45.2 196.7 43.0 43.9 25.9 33.1 52.1 41.4 26.5 70.5 13.0 59.3 119.1 49.9 34.7 57.8 11.4 39.0 61.8 157.4 46.0 23.5 17.5 73.6 34.6 95.4 45.1 59.0 65.9 50.9 21.4 24.4 92.9 73.1 76.2 22.1 9.1 59.5 94.7 61.3 33.8 63.4 195.2 137.0 23.4 17.2 78.9 46.4 37.1 43.7 47.1 39.1 70.0 57.3 43.0 47.0 73.1 109.4 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70284004 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 8.7;retina: 3.1" "Cell type enhanced" "Detected in some" "Astrocytes: 6.5;Muller glia cells: 10.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basal ganglia: 15.7;hypothalamus: 6.3" "Low region specificity" "Detected in single" HPA037521 Uncertain NA NA "HPA037521: AB_2675520" "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.1 0.0 1.7 0.4 2.6 0.3 0.1 8.7 1.7 0.1 0.8 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.0 1.5 2.5 0.0 0.0 0.2 0.6 2.3 2.8 0.9 0.1 0.0 0.0 0.1 0.0 4.5 0.1 0.1 3.1 0.0 0.2 0.2 0.1 0.1 0.0 1.5 0.2 0.2 1.0 2.9 0.0 0.0 0.1 0.3 0.1 0.2 2.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.7 1.7 2.6 8.7 1.7 1.5 2.5 2.3 2.8 0.9 4.5 1.5 2.9 2.8 0.2 0.0 2.0 6.5 0.2 1.7 1.8 0.3 0.0 0.7 0.1 0.3 1.0 1.5 0.0 1.8 0.0 0.2 1.5 0.4 0.0 0.0 0.3 0.6 0.2 0.5 0.0 0.0 0.2 0.2 0.2 0.8 0.0 0.8 2.5 0.1 0.4 0.2 0.1 0.0 1.4 0.1 0.0 0.3 2.8 1.6 0.6 0.8 0.0 0.0 0.4 10.4 1.0 1.0 1.0 0.1 0.1 0.4 0.0 1.1 0.0 0.1 0.1 1.6 0.0 1.7 0.6 0.6 1.2 0.0 2.0 1.1 0.3 0.0 0.2 0.9 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751262-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 30.9;cervix: 64.1;intestine: 44.3;pancreas: 37.2;salivary gland: 57.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 35.1;Club cells: 70.7;Endometrial ciliated cells: 33.8;Exocrine glandular cells: 31.1;Ionocytes: 38.7;Proximal enterocytes: 42.1;Respiratory ciliated cells: 157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.1;OE19: 53.5;RT4: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA037583 Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favorable (1.03e-4)" 0.3 0.1 0.0 7.4 0.0 0.3 30.9 0.0 0.3 64.1 0.0 3.6 44.3 1.8 3.9 1.1 9.5 2.7 0.4 0.0 0.1 0.6 0.1 6.8 0.2 0.3 0.1 0.1 0.1 37.2 0.1 0.2 0.1 0.0 6.0 4.8 0.4 57.5 3.4 0.0 0.7 39.0 0.5 0.0 0.2 8.9 0.9 0.0 0.1 0.1 0.0 2.8 1.6 0.0 0.2 0.2 1.4 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.7 0.2 10.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 53.5 0.0 0.2 6.4 0.3 1.7 22.3 0.1 0.2 0.1 1.4 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.2 0.5 4.7 0.2 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.1 3.2 3.2 0.3 0.0 0.1 0.3 35.1 0.0 0.0 16.6 8.3 0.4 0.0 70.7 0.0 0.0 0.0 0.1 6.7 0.0 4.9 13.2 33.8 0.3 0.5 0.0 0.0 0.2 31.1 0.0 0.6 3.1 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 5.6 38.7 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.2 2.8 0.4 0.0 1.4 42.1 0.3 157.3 0.0 0.0 0.3 3.7 0.2 0.1 0.6 0.0 0.0 0.3 0.0 12.1 0.5 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950247-113167678 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 169.0" "Cell type enhanced" "Detected in many" "Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "thalamus: 169.0" "Group enriched" "Detected in many" 10 "intermediate monocyte: 28.9;non-classical monocyte: 86.6" "Lineage enriched" "Detected in many" 14 "monocytes: 86.6" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in all" 9 "midbrain: 67.2;thalamus: 86.6" "Group enriched" "Detected in all" 5 "midbrain: 146.8;pons: 97.8;thalamus: 164.3" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 24.6 9.5 43.5 8.7 14.2 7.7 25.3 2.7 12.7 18.3 3.6 21.8 20.5 25.3 6.7 10.0 18.3 9.4 10.1 5.1 39.0 8.9 22.5 14.0 5.5 6.4 94.1 1.4 23.1 12.5 11.2 9.7 17.8 26.8 12.4 21.5 4.7 14.6 13.3 8.5 16.0 19.5 16.5 1.7 22.4 23.5 7.7 169.0 5.8 13.1 6.9 3.7 13.9 14.4 4.5 15.0 37.8 40.7 39.6 20.8 13.7 48.5 10.3 20.0 7.1 8.5 24.9 45.3 0.1 11.3 19.4 9.6 10.5 14.0 17.6 9.1 1.7 13.1 10.4 25.2 23.6 22.0 4.2 3.7 24.4 6.3 11.0 18.2 29.7 12.0 8.8 11.0 0.7 8.2 28.0 6.7 2.5 29.2 16.6 21.6 19.0 29.8 6.9 15.2 20.4 0.8 12.4 15.7 15.4 17.0 31.5 10.0 2.2 27.9 6.8 18.7 16.9 21.3 2.6 0.3 0.4 6.5 8.7 14.9 0.4 4.5 0.4 1.5 28.9 0.9 0.0 0.4 1.2 4.1 0.0 0.4 0.6 6.0 0.0 86.6 0.2 0.0 3.5 43.5 14.2 2.7 12.7 5.1 39.0 6.4 94.1 1.4 26.8 1.7 169.0 4.5 62.0 22.4 26.5 264.8 3.3 42.6 27.3 35.8 64.9 2.8 53.0 54.9 13.6 52.9 35.5 40.5 6.2 44.2 9.1 260.0 11.7 39.3 8.8 40.1 140.6 46.1 19.8 4.8 35.1 43.6 231.4 90.8 90.2 64.2 0.0 37.6 52.8 74.2 17.5 5.0 16.6 87.7 16.2 99.9 20.6 5.0 59.0 54.6 32.0 107.7 22.4 34.4 5.2 192.5 34.9 59.0 211.1 48.5 6.0 38.4 75.3 16.2 26.8 6.1 92.1 37.3 51.3 9.4 28.9 61.1 39.8 28.5 6.7 13.1 73.9 49.0 MKI67 "MIB-1, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126423 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 46.7;lymphoid tissue: 53.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 5 "white matter: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.0 0.7 0.3 8.6 0.1 46.7 1.8 0.0 0.1 0.7 0.2 8.2 6.3 1.0 0.0 10.1 0.4 0.9 0.3 0.0 0.8 0.4 0.8 1.4 15.0 0.2 0.8 0.0 0.2 0.2 0.1 0.1 4.1 0.4 0.4 9.3 0.0 1.5 0.1 0.0 6.7 5.9 2.6 0.2 4.8 4.2 2.3 0.7 53.1 0.4 0.1 16.5 1.8 2.8 3.7 204.6 101.5 103.2 73.6 4.3 8.7 32.1 75.7 55.3 70.3 62.3 83.9 82.3 152.6 21.3 51.9 46.4 120.7 109.3 56.8 104.7 161.8 53.1 131.0 79.4 52.7 0.1 186.0 68.0 2.0 2.5 72.2 73.2 17.2 69.8 69.5 61.2 142.1 70.5 80.9 111.7 56.6 41.3 52.7 45.7 82.2 135.1 20.3 25.6 56.2 35.9 38.9 107.1 38.0 17.3 33.9 31.4 39.3 65.0 37.0 73.6 53.0 206.8 64.2 54.9 177.2 30.7 83.3 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.2 0.8 0.0 0.4 0.2 0.7 3.7 0.6 0.0 5.4 0.0 16.0 6.4 1.6 5.3 0.6 0.0 3.9 3.2 1.6 1.5 5.3 0.0 0.0 30.6 7.4 25.0 0.0 0.8 4.2 2.3 10.2 6.7 6.7 232.9 0.0 0.0 86.1 13.5 34.7 13.2 1.3 87.0 5.7 1.7 42.1 0.0 0.0 22.4 2.0 12.9 13.7 0.9 0.3 16.6 3.6 0.0 0.2 0.0 8.2 0.0 0.0 0.1 3.0 0.4 107.4 4.6 2.6 0.1 1.6 0.0 0.0 0.5 13.6 8.1 24.1 50.4 3.0 7.8 23.0 2.7 47.1 4.8 CYP17A1 "CPT7, CYP17, P450C17, S17AH" ENSG00000148795 "Cytochrome P450 family 17 subfamily A member 1" P05093 10 102830531-102837472 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Steroidogenesis "Lyase, Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 84 "adrenal gland: 8297.2" "Cell type enriched" "Detected in some" 17 "Theca cells: 1871.0" "Cancer enriched" "Detected in many" 5 "liver cancer: 22.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.0;SCLC-21H: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048533 Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA048533: AB_2680432" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (3.01e-2)" "unprognostic (9.08e-2)" "unprognostic (1.91e-1)" "unprognostic (6.29e-2)" "unprognostic (2.92e-3)" "unprognostic (2.39e-4)" "unprognostic (8.26e-2)" "unprognostic (2.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.07e-1)" "unprognostic (5.56e-2)" "unprognostic (1.66e-2)" "unprognostic (2.94e-4)" 0.4 8297.2 0.0 2.1 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.5 0.0 0.8 0.1 0.9 1.0 0.4 0.8 0.0 0.0 53.4 6.7 1.4 0.0 0.0 0.1 0.0 16.8 1.8 10.6 0.7 0.0 0.0 0.7 0.0 0.2 3.4 0.0 1.0 0.6 0.6 0.0 0.0 0.9 1.3 99.1 0.0 0.0 2.9 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.2 0.1 0.4 0.1 0.0 0.5 0.0 0.1 0.7 0.0 0.0 1.8 0.0 0.4 0.1 0.1 21.5 0.0 41.6 0.1 0.0 0.7 0.0 2.7 0.1 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.4 6.1 0.1 1.7 0.1 0.0 0.0 0.6 0.7 10.6 1.8 0.9 0.0 0.0 0.1 0.2 3.1 0.5 0.1 0.7 0.0 0.0 0.0 0.3 0.0 104.3 0.0 1.2 0.0 1.2 0.6 0.3 0.1 0.0 0.0 0.3 0.4 1871.0 0.0 0.1 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277138-103290346 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 304.2;retina: 98.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3" "Group enriched" "Detected in many" 4 "glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 0.2 12.3 42.4 1.2 44.2 0.0 0.0 70.6 166.4 0.0 0.5 2.6 0.6 0.0 0.0 0.6 0.0 0.1 0.0 36.8 83.7 0.0 0.0 0.2 0.1 106.6 80.0 48.1 0.0 2.0 0.4 41.7 0.2 112.3 0.2 1.2 98.1 0.1 0.0 0.0 0.8 1.1 0.8 31.3 0.0 1.1 2.7 115.5 1.7 0.1 0.0 0.2 1.1 0.6 304.2 0.0 25.4 11.8 0.0 0.1 0.0 19.3 13.3 3.3 3.1 0.3 0.0 0.0 0.0 5.4 0.9 1.5 1.9 11.0 0.0 0.7 24.6 4.9 0.0 6.8 0.1 0.2 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 13.6 0.0 53.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 103.3 58.7 71.6 0.1 0.0 2.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 3.4 3.1 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.4 44.2 70.6 166.4 36.8 83.7 106.6 80.0 48.1 112.3 31.3 115.5 304.2 0.1 0.0 0.0 6.2 0.0 0.3 0.1 0.0 0.0 62.4 0.0 0.4 0.5 0.0 0.0 0.0 22.9 0.2 0.0 0.1 0.0 0.1 41.4 0.4 0.2 0.9 7.8 0.0 28.7 0.0 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.5 45.4 39.8 0.0 0.0 0.0 0.0 26.5 0.3 0.1 0.0 2.8 0.0 8.7 0.0 1.0 5.4 0.4 0.0 0.4 0.0 0.5 0.0 0.0 0.0 48.2 0.0 0.0 0.6 20.3 4.1 1.0 0.4 0.1 0.1 0.1 0.0 0.6 FUOM "C10orf125, FLJ26016, FucM, FucU" ENSG00000148803 "Fucose mutarotase" A2VDF0 10 133355158-133358025 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 230.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 564.7;Hofbauer cells: 172.0;Proximal enterocytes: 690.7;Proximal tubular cells: 368.1" "Cancer enriched" "Detected in all" 5 "liver cancer: 61.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039207 Approved NA NA 2000000 "HPA039207: AB_10795033" "unprognostic (1.15e-2)" "unprognostic (1.16e-1)" "unprognostic (4.48e-2)" "unprognostic (7.19e-2)" "unprognostic (4.82e-1)" "unprognostic (2.66e-2)" "unprognostic (1.66e-2)" "unprognostic (2.45e-1)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" "unprognostic (4.50e-2)" "unprognostic (8.67e-2)" "unprognostic (3.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.50e-1)" "unprognostic (4.88e-3)" "unprognostic (1.65e-1)" 13.1 8.9 4.0 11.4 4.4 6.7 13.1 3.8 7.3 6.5 7.5 11.1 52.5 5.6 3.2 8.8 7.9 9.7 13.2 3.9 4.8 45.9 230.1 14.2 16.9 4.9 4.6 3.6 7.4 18.4 8.0 6.0 5.3 5.5 7.1 5.5 0.3 29.0 3.6 3.0 7.4 47.2 3.7 4.8 23.9 8.6 5.7 4.7 6.2 6.6 2.7 8.1 8.0 7.8 4.7 23.3 7.2 13.6 28.4 3.8 9.2 24.8 18.3 20.7 6.5 8.1 46.4 12.4 0.0 20.7 13.8 0.0 1.2 4.9 6.3 0.5 8.4 4.9 22.3 10.3 50.7 20.1 25.2 14.8 9.6 0.2 2.6 1.4 3.0 9.2 22.9 22.2 29.7 13.9 23.0 3.9 33.6 9.5 13.5 3.2 21.8 0.4 13.0 7.5 0.0 1.4 11.0 6.7 20.6 25.3 6.8 0.2 38.3 18.7 0.1 18.4 0.0 0.1 15.5 2.7 16.7 5.5 10.2 7.1 0.1 68.9 6.5 16.0 73.2 14.7 36.0 14.0 13.4 57.2 34.5 14.9 13.1 3.3 17.1 15.7 79.0 10.4 28.6 4.0 4.4 3.8 7.3 3.9 4.8 4.9 4.6 3.6 5.5 4.8 4.7 4.7 20.4 6.4 10.0 0.0 32.7 12.1 9.2 8.5 6.2 0.1 12.2 25.7 10.9 22.8 11.4 9.2 0.0 10.3 25.1 79.2 31.3 13.6 3.7 3.8 9.7 14.1 3.0 24.4 0.6 12.7 9.0 25.6 8.6 7.7 27.3 15.5 25.0 564.7 172.0 0.0 1.2 49.7 6.1 103.0 55.4 10.3 10.2 68.7 26.6 1.9 85.6 3.5 13.4 0.0 1.0 12.5 119.5 3.8 29.6 17.8 690.7 368.1 4.0 1.1 13.1 11.6 14.9 20.2 23.7 10.0 9.9 6.6 21.5 4.1 61.1 12.1 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132381508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 76.2" "Group enriched" "Detected in many" 6 "Early spermatids: 491.0;Late spermatids: 953.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;hTERT-RPE1: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: AB_2732766" "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 3.1 4.1 12.5 2.0 12.1 1.6 5.1 9.6 13.4 4.3 11.1 4.0 2.5 4.6 6.7 2.0 13.2 4.3 3.4 13.0 11.2 6.8 3.1 3.9 2.6 12.0 11.5 11.8 6.4 3.9 8.0 8.1 2.7 11.0 5.2 2.6 11.0 3.3 4.7 2.1 2.7 3.3 4.3 11.7 5.5 3.9 76.2 10.9 2.8 6.4 1.6 1.4 4.1 2.8 11.0 3.1 5.6 12.2 17.2 10.4 10.6 1.2 3.0 9.7 4.9 4.4 1.0 6.3 1.7 1.7 7.0 3.7 2.1 2.7 1.5 3.1 3.6 2.4 0.5 4.5 3.0 7.4 1.4 2.0 4.6 9.4 5.0 6.6 21.9 3.5 4.2 1.1 1.3 3.8 5.2 2.7 3.9 3.4 2.2 1.9 2.4 1.9 1.0 8.9 0.8 2.2 6.1 1.5 1.0 3.9 2.4 2.8 3.1 4.7 1.9 2.4 4.4 1.9 0.9 0.4 1.0 8.9 2.7 1.2 4.1 4.7 0.8 1.1 4.1 0.9 2.3 0.7 0.7 5.2 2.9 1.8 1.0 0.6 2.4 2.8 5.6 0.5 2.0 12.5 12.1 9.6 13.4 13.0 11.2 12.0 11.5 11.8 11.0 11.7 10.9 11.0 2.9 9.6 12.8 23.8 5.0 2.8 2.5 5.1 3.4 8.2 6.3 3.8 5.2 5.7 6.9 3.7 10.4 3.6 6.0 1.7 19.6 8.2 491.0 18.8 5.4 4.9 5.4 2.5 14.2 5.1 1.3 5.5 7.1 4.8 8.8 10.3 11.4 2.2 7.7 8.4 10.9 2.3 2.0 10.4 6.0 953.9 4.7 6.7 7.2 6.5 9.0 10.5 8.2 8.0 9.3 3.3 1.3 11.7 0.9 2.9 3.8 13.9 37.7 18.3 6.6 3.8 3.5 119.9 19.2 2.3 3.1 1.4 2.9 6.2 3.5 1.8 MTG1 GTPBP7 ENSG00000148824 "Mitochondrial ribosome associated GTPase 1" Q9BT17 10 133394094-133422520 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037826, HPA037827" Approved Supported Mitochondria NA NA Mitochondria "HPA037826: AB_2675692, HPA037827: AB_10670959" "unprognostic (2.94e-2)" "unprognostic (8.08e-2)" "unprognostic (5.90e-3)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-2)" "unprognostic (5.85e-2)" "unprognostic (6.20e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.08e-4)" "unprognostic (4.63e-3)" "prognostic unfavorable (6.79e-7)" "unprognostic (3.88e-2)" "unprognostic (5.96e-2)" "unprognostic (5.19e-2)" "prognostic favorable (1.03e-5)" 14.7 28.3 9.8 13.7 9.6 12.6 16.5 10.7 12.3 16.8 10.6 14.7 19.9 15.3 2.8 21.6 15.1 8.4 13.8 9.4 9.3 27.1 48.8 13.1 16.4 10.6 9.9 9.2 17.4 19.9 17.8 16.3 11.2 10.5 19.4 11.3 3.4 16.4 10.5 18.7 17.8 19.1 10.2 9.0 26.3 18.5 31.4 10.5 12.8 18.1 13.1 14.2 15.6 15.5 9.6 42.5 43.3 28.3 63.4 17.0 12.5 42.0 24.2 20.8 38.5 31.4 55.0 25.8 31.2 36.2 20.5 16.3 33.5 30.6 43.2 17.4 29.8 37.7 30.5 23.5 52.1 40.2 20.6 30.4 31.5 22.9 37.3 58.6 27.7 56.5 27.9 26.2 28.0 30.6 47.4 20.2 28.9 39.3 45.2 14.4 29.6 28.0 7.1 34.6 29.6 10.7 37.9 36.4 32.1 51.4 15.8 28.2 29.6 37.1 14.2 29.2 14.6 26.1 13.5 8.3 43.3 25.2 18.3 19.8 0.5 21.5 23.0 26.9 35.5 27.7 41.5 23.8 22.7 20.3 48.8 18.6 19.2 3.1 47.5 42.9 42.8 27.5 20.3 9.8 9.6 10.7 12.3 9.4 9.3 10.6 9.9 9.2 10.5 9.0 10.5 9.6 4.5 9.6 3.6 30.7 27.1 4.2 5.9 8.8 33.0 0.0 6.1 5.3 1.6 8.6 5.9 3.7 0.0 9.4 8.1 8.4 5.9 13.5 2.2 5.9 9.9 7.7 12.6 26.1 25.1 9.6 7.3 9.0 43.8 5.9 6.3 10.8 7.5 5.5 5.4 0.0 31.8 7.5 4.1 6.3 4.7 5.4 9.0 7.1 5.4 21.5 8.1 0.0 12.3 29.7 33.9 10.4 9.2 4.9 37.5 7.2 12.5 6.9 6.1 0.0 13.1 6.1 6.0 9.0 9.3 32.9 3.4 6.7 16.6 6.7 10.1 7.4 NKX6-2 "GTX, NKX6.1, NKX6B" ENSG00000148826 "NK6 homeobox 2" Q9C056 10 132783179-132786147 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding, Repressor" "Disease variant, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 109.2" "Group enriched" "Detected in some" 11 "Gastric mucus-secreting cells: 92.2;Oligodendrocytes: 121.6" "Cancer enriched" "Detected in some" 5 "glioma: 3.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "white matter: 15.7" "Low region specificity" "Detected in many" NA NA "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.57e-1)" "unprognostic (1.62e-1)" 0.1 0.0 48.5 0.0 60.3 0.0 0.1 55.9 42.0 0.1 12.4 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.2 32.2 47.2 0.2 0.0 0.1 0.0 69.2 66.2 23.3 0.0 0.2 0.0 0.1 0.0 67.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 52.2 0.0 16.5 1.4 55.2 0.0 0.0 0.0 0.0 0.1 0.7 109.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 60.3 55.9 42.0 32.2 47.2 69.2 66.2 23.3 67.0 52.2 55.2 109.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.1 92.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 121.6 9.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379261-133391694 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.6" "Group enriched" "Detected in many" 6 "Early spermatids: 143.4;Late spermatids: 456.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;K-562: 3.9;U-266/70: 13.7" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 1.9 2.3 0.5 0.5 1.0 0.0 2.0 0.9 1.5 2.7 0.9 2.6 1.8 2.5 0.0 6.3 2.8 0.1 1.3 0.7 0.8 3.3 7.8 1.5 0.5 0.8 0.7 0.5 2.4 2.5 0.3 1.6 0.1 0.8 2.7 0.0 0.0 3.2 1.1 3.1 2.7 4.4 0.3 0.9 4.9 2.5 27.6 0.5 0.1 1.7 0.0 0.4 2.9 3.3 1.6 5.7 0.0 0.3 1.2 0.0 0.5 0.4 1.5 1.1 1.7 0.1 0.5 0.1 0.0 0.4 0.7 0.4 1.8 0.0 0.7 0.3 2.7 0.0 0.4 0.0 0.0 1.3 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.0 3.9 0.4 0.0 0.1 0.0 0.2 0.6 0.0 1.9 3.3 0.0 0.0 0.1 0.0 0.1 1.3 1.1 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.6 1.1 0.0 13.7 2.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 1.0 0.9 1.5 0.7 0.8 0.8 0.7 0.5 0.8 0.9 0.5 1.6 3.8 0.0 4.6 4.2 17.5 3.7 8.5 3.4 8.6 4.0 4.2 5.0 1.7 8.6 1.9 1.8 0.0 1.1 5.8 4.3 5.9 5.4 143.4 4.0 3.0 3.3 0.0 1.3 3.3 3.3 2.3 3.6 5.6 3.9 5.7 2.5 3.3 13.5 4.6 5.0 1.7 4.0 4.1 14.5 2.3 456.3 9.6 9.0 0.0 3.7 12.3 9.2 2.1 3.0 9.7 3.4 3.4 7.9 22.0 8.7 29.9 18.0 3.3 3.0 19.7 2.4 3.6 46.9 6.0 12.8 3.7 0.3 5.4 3.7 4.1 10.5 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 663.1" "Cell type enhanced" "Detected in all" "Hofbauer cells: 676.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 1106.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced NA NA 120000000 "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favorable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 95.2 146.5 126.6 103.7 131.0 193.2 90.8 129.0 168.1 88.1 128.5 89.6 169.1 72.6 97.0 79.9 76.1 85.6 280.1 125.4 134.8 155.8 663.1 156.0 93.9 131.7 137.0 127.5 83.8 81.2 130.7 103.7 114.6 131.2 81.0 95.7 38.5 76.2 90.4 149.6 63.4 166.6 87.7 132.7 108.0 94.1 15.0 135.4 125.9 83.6 123.6 78.0 110.6 83.3 141.2 287.7 194.5 142.9 249.3 201.4 385.1 62.8 358.3 640.7 237.9 257.2 247.2 292.8 254.2 152.8 245.6 296.8 158.8 97.0 329.2 244.5 128.4 233.7 186.6 122.1 542.7 359.7 241.5 294.5 291.5 136.7 346.3 414.5 331.3 464.1 231.2 394.4 153.4 511.4 159.3 188.3 330.0 130.4 308.1 134.8 136.0 94.9 108.1 358.4 185.1 72.1 88.6 117.6 81.0 1106.0 238.2 92.0 192.7 426.6 276.9 143.6 427.3 328.4 2.7 3.3 2.0 517.7 416.2 112.0 842.8 532.4 157.9 133.0 457.0 164.5 148.8 164.6 172.9 429.3 111.9 143.0 144.3 151.8 185.0 369.1 203.0 204.8 632.1 126.6 131.0 129.0 168.1 125.4 134.8 131.7 137.0 127.5 131.2 132.7 135.4 141.2 107.4 76.9 72.6 8.8 64.8 93.7 328.2 297.6 51.2 36.9 63.5 105.5 328.2 218.8 113.3 101.2 20.9 394.2 82.0 101.6 332.6 341.0 22.4 68.1 79.6 164.5 103.5 192.8 12.1 248.4 176.6 173.0 49.5 81.7 146.3 107.6 388.0 628.2 676.5 23.5 11.7 163.8 124.1 321.8 223.6 17.3 114.6 484.5 126.3 8.4 277.7 81.2 95.8 8.5 21.8 347.6 150.7 112.8 39.9 169.4 483.2 538.0 114.3 29.8 151.2 85.3 176.1 5.7 5.1 55.8 78.7 111.0 81.4 224.8 196.6 204.9 TAF5 "TAF2D, TAFII100" ENSG00000148835 "TATA-box binding protein associated factor 5" Q15542 10 103367976-103389065 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 48.7;Spermatogonia: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006195, HPA006474" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006195: AB_1080188, HPA006474: AB_1080185" "unprognostic (3.09e-2)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (3.18e-3)" "unprognostic (3.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (5.36e-3)" "unprognostic (2.21e-1)" "unprognostic (1.18e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.36e-9)" "prognostic favorable (7.39e-5)" "unprognostic (2.79e-2)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" 2.2 1.8 2.7 2.8 3.0 5.0 2.3 5.2 3.4 2.5 2.5 3.1 3.0 2.3 1.7 2.4 2.3 1.5 1.8 2.8 2.7 1.7 2.6 1.9 4.4 3.0 3.0 2.8 3.0 3.0 1.7 2.1 3.6 3.6 2.0 3.1 3.5 2.0 2.2 3.0 2.5 2.4 2.1 2.8 3.1 2.1 11.3 2.8 7.1 2.0 3.6 4.4 2.2 2.5 3.3 9.7 4.4 10.6 19.2 5.9 4.8 12.4 6.8 7.7 9.6 12.0 8.7 5.0 23.0 3.8 3.6 5.6 9.6 18.1 3.7 12.2 8.5 15.6 10.6 5.0 8.7 2.7 20.6 11.0 2.2 2.7 5.7 6.1 3.9 7.3 10.1 15.4 11.2 6.5 6.4 16.8 26.9 12.9 12.2 5.7 14.2 12.9 7.0 2.7 2.8 7.4 8.2 4.4 3.2 4.1 10.1 3.7 8.5 4.3 5.6 7.1 6.3 12.2 6.3 8.1 14.0 3.1 24.2 3.6 0.2 0.6 0.8 0.4 0.2 0.3 0.1 0.4 0.8 0.3 1.3 1.0 0.5 0.0 0.3 0.3 0.4 1.1 0.2 2.7 3.0 5.2 3.4 2.8 2.7 3.0 3.0 2.8 3.6 2.8 2.8 3.3 5.8 6.4 2.6 3.6 6.9 14.4 4.5 1.7 6.2 6.9 3.0 2.7 2.9 1.5 2.5 1.8 6.2 5.6 8.3 2.7 3.9 2.8 19.7 1.8 3.8 5.2 2.4 11.2 4.9 2.2 9.3 5.6 2.0 2.1 8.9 4.1 2.9 2.8 3.8 1.7 5.3 2.9 4.1 2.8 6.3 14.1 1.8 3.6 1.8 3.7 4.9 1.3 4.1 3.5 5.8 1.9 3.3 2.6 14.9 4.3 3.3 1.0 0.7 7.5 0.0 7.2 6.5 48.7 52.3 5.9 14.2 6.8 8.6 3.0 4.0 3.8 PPRC1 "KIAA0595, MGC74642, PRC" ENSG00000148840 "PPARG related coactivator 1" Q5VV67 10 102132994-102150333 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038511, HPA057571" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038511: AB_10672521, HPA057571: AB_2683472" "unprognostic (2.27e-1)" "unprognostic (7.66e-2)" "unprognostic (2.35e-2)" "unprognostic (4.77e-2)" "unprognostic (1.63e-1)" "unprognostic (4.96e-2)" "unprognostic (4.29e-3)" "unprognostic (6.31e-2)" "unprognostic (3.95e-2)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (2.86e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (8.65e-2)" "unprognostic (4.22e-1)" "unprognostic (1.12e-1)" "unprognostic (4.93e-2)" 24.0 19.3 9.8 13.2 10.3 19.1 19.5 9.3 10.6 20.1 11.0 20.7 8.1 22.0 8.2 25.4 21.8 12.0 18.9 9.8 12.4 14.5 19.5 26.5 13.8 11.5 10.3 9.7 25.2 25.1 9.5 18.0 13.6 11.2 19.4 8.3 5.1 16.4 8.1 29.0 27.9 16.2 14.3 9.8 20.0 20.6 14.3 11.5 11.1 16.2 12.2 13.9 21.2 20.4 11.0 30.7 44.3 27.0 54.5 23.6 24.2 34.7 26.7 35.9 37.9 31.2 51.1 34.1 66.4 21.8 40.5 23.8 56.7 55.4 52.8 32.6 27.5 43.4 63.5 33.9 48.7 31.4 50.6 26.3 31.9 46.9 44.3 82.8 24.9 23.9 26.5 48.0 38.4 29.9 52.4 40.5 70.0 46.6 29.0 26.7 55.9 38.6 28.2 32.7 30.1 18.6 26.9 23.3 25.2 32.7 25.9 40.8 26.4 26.1 30.1 38.0 30.9 61.2 31.8 24.3 59.6 33.8 61.7 15.4 0.0 1.2 0.1 1.8 1.3 2.3 1.5 1.4 2.3 2.6 1.8 1.7 2.1 0.0 4.1 1.3 1.0 0.9 1.3 9.8 10.3 9.3 10.6 9.8 12.4 11.5 10.3 9.7 11.2 9.8 11.5 11.0 16.4 28.9 13.2 6.5 13.4 44.4 33.1 6.1 48.9 4.7 17.5 12.4 9.1 8.6 9.5 5.5 4.2 7.6 9.2 7.9 1.9 8.0 1.1 16.3 16.1 15.6 8.4 10.7 6.8 9.6 12.9 13.7 32.1 31.3 10.8 9.5 6.8 7.2 8.7 1.7 6.2 11.2 6.1 5.3 15.9 2.4 6.2 9.7 8.8 2.8 3.9 2.2 9.2 5.5 5.3 14.0 5.8 6.4 21.4 26.0 2.8 2.4 3.8 4.1 6.6 35.6 18.2 6.3 14.8 36.0 43.5 5.1 10.8 7.8 11.4 30.0 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 205.0" "Cell type enhanced" "Detected in many" "Adipocytes: 98.0;Hepatic stellate cells: 82.1;Squamous epithelial cells: 108.4;Suprabasal keratinocytes: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 103.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles NA NA Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 35.5 13.8 6.0 17.0 5.6 205.0 25.6 5.3 9.4 23.5 14.4 11.2 3.2 16.4 3.8 53.3 15.2 21.4 54.9 5.2 33.6 18.1 13.4 38.9 10.5 7.8 5.9 3.6 29.4 9.5 8.1 16.1 27.1 5.9 14.1 5.0 1.7 14.2 9.1 10.1 65.7 8.8 18.4 6.3 12.7 12.4 7.4 7.9 12.9 21.3 10.5 12.0 23.9 43.9 7.5 6.4 16.1 19.2 8.6 32.8 31.4 10.9 35.0 75.9 25.8 32.0 1.2 2.8 11.2 7.7 22.5 51.2 20.7 6.5 17.4 26.6 9.6 7.6 6.6 24.6 4.9 64.3 15.9 12.3 29.2 103.5 53.8 42.8 29.9 48.7 11.4 28.4 21.5 32.0 2.7 3.1 17.0 14.3 2.2 17.9 14.3 9.9 6.8 10.6 2.8 10.7 7.0 6.7 7.8 16.0 11.6 0.6 11.8 82.7 51.9 13.6 34.5 34.5 7.8 9.8 7.3 38.0 27.9 24.8 4.4 9.5 14.0 4.5 5.8 4.5 2.5 2.7 2.6 6.2 2.8 3.2 2.9 30.6 5.0 5.8 4.2 2.3 21.3 6.0 5.6 5.3 9.4 5.2 33.6 7.8 5.9 3.6 5.9 6.3 7.9 7.5 98.0 3.2 8.3 1.3 9.0 37.9 15.3 13.2 44.3 0.0 3.0 2.4 7.8 1.5 9.0 3.7 0.0 7.3 37.0 1.7 0.0 3.7 6.3 11.7 10.0 42.5 0.0 8.8 0.6 2.4 22.6 15.5 3.6 46.7 20.3 3.6 82.1 2.3 10.8 0.0 0.4 2.6 2.0 17.2 20.6 1.6 5.0 28.1 8.8 6.5 7.0 3.8 10.3 0.5 0.9 3.0 0.5 5.7 13.6 5.8 0.2 0.5 5.2 0.6 13.1 6.3 14.7 8.1 1.8 108.4 72.7 5.1 23.8 4.4 1.1 20.5 CNNM2 ACDP2 ENSG00000148842 "Cyclin and CBS domain divalent metal cation transport mediator 2" Q9H8M5 10 102918294-103090222 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 30.4;parathyroid gland: 31.8" "Cell type enhanced" "Detected in many" "Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059954, HPA071631" Enhanced Vesicles NA NA Vesicles "HPA059954: AB_2684177, HPA071631: AB_2686427" "unprognostic (2.18e-1)" "unprognostic (6.46e-2)" "unprognostic (1.24e-1)" "unprognostic (2.65e-3)" "unprognostic (3.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.93e-1)" "unprognostic (4.80e-2)" "unprognostic (4.51e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.39e-8)" "unprognostic (2.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.65e-3)" "unprognostic (1.56e-1)" 2.8 11.6 3.8 2.3 4.9 9.4 2.6 7.3 5.1 3.6 30.4 7.1 3.9 3.6 2.2 1.7 4.9 4.1 2.2 4.0 3.2 9.2 4.8 3.9 1.5 4.7 4.9 3.9 4.9 3.7 31.8 5.7 8.8 5.0 2.7 6.5 5.1 3.1 3.1 1.6 4.4 4.5 3.7 2.0 2.1 3.3 4.6 4.7 1.8 5.7 1.5 1.1 3.2 2.9 9.6 5.0 8.1 3.1 8.5 7.8 3.2 8.6 2.3 9.7 3.1 3.9 5.8 4.3 1.9 3.5 3.4 6.0 6.3 6.9 4.6 2.4 3.3 12.1 2.8 4.2 11.8 4.6 2.0 3.6 4.2 6.6 3.2 10.7 7.9 1.9 5.5 4.8 10.9 1.8 8.6 2.3 2.2 5.1 4.9 5.0 5.5 4.0 2.4 2.4 2.9 4.5 5.8 5.9 1.3 6.3 9.1 10.4 3.7 1.6 4.2 6.2 3.0 4.2 11.7 14.1 3.6 7.4 6.6 1.7 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.2 1.5 0.0 0.3 0.3 0.1 3.8 4.9 7.3 5.1 4.0 3.2 4.7 4.9 3.9 5.0 2.0 4.7 9.6 3.0 6.4 8.4 60.1 7.9 2.4 2.3 1.7 6.8 16.4 3.3 2.4 4.5 2.8 5.6 5.5 12.5 18.8 8.1 46.7 1.9 2.2 10.7 7.4 4.2 4.2 6.7 6.7 112.6 5.4 3.4 6.3 12.8 6.4 3.8 13.7 3.3 6.1 3.8 32.0 146.9 5.0 0.0 3.2 2.5 15.1 3.4 4.7 7.2 39.4 2.3 7.0 2.1 92.5 92.3 2.3 9.0 3.4 6.2 2.0 11.7 5.5 9.5 15.8 13.1 5.7 16.7 15.5 6.9 8.1 4.1 39.8 5.1 3.8 11.6 2.2 PDCD11 "ALG-4, KIAA0185, NFBP, RRP5" ENSG00000148843 "Programmed cell death 11" Q14690 10 103396626-103446294 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017924, CAB026472" Approved Supported "Nucleoli rim,Vesicles" NA NA "Nucleoli rim" Vesicles "CAB026472: , HPA017924: AB_10601045" "unprognostic (1.34e-1)" "unprognostic (6.84e-2)" "unprognostic (1.48e-1)" "unprognostic (2.31e-2)" "unprognostic (1.80e-1)" "unprognostic (8.94e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.16e-1)" "unprognostic (6.49e-2)" "unprognostic (3.25e-2)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (1.77e-1)" "unprognostic (6.28e-2)" "unprognostic (5.59e-2)" 7.8 7.9 4.3 10.1 4.9 7.5 9.5 4.6 4.5 8.6 4.3 7.4 5.9 10.0 5.9 11.8 9.1 4.5 7.1 4.5 4.9 6.6 9.2 7.3 11.1 4.5 4.6 4.0 10.5 11.7 8.5 6.4 7.6 4.7 8.0 8.0 6.2 7.2 6.3 16.0 15.6 7.8 9.2 4.3 9.5 7.3 15.0 5.1 12.0 6.9 8.2 11.9 10.0 8.5 5.1 27.4 39.8 27.2 77.0 23.3 20.9 30.5 29.6 20.7 29.2 23.7 54.7 26.3 74.9 20.5 21.4 18.0 48.0 70.6 37.1 32.5 34.8 47.5 43.7 26.0 44.2 27.7 88.0 28.7 21.8 33.3 44.8 101.3 21.0 31.6 19.4 71.5 32.7 28.4 30.9 44.5 49.9 55.9 21.7 37.9 44.3 39.0 34.1 18.1 26.6 18.2 34.1 19.9 23.2 32.6 26.4 22.8 24.8 34.5 21.5 27.0 29.0 55.9 41.2 61.8 69.5 19.0 83.3 16.2 0.1 2.8 0.9 3.2 2.6 5.2 3.4 3.1 2.7 2.8 2.2 2.7 3.2 0.3 2.1 2.3 3.3 2.3 2.5 4.3 4.9 4.6 4.5 4.5 4.9 4.5 4.6 4.0 4.7 4.3 5.1 5.1 8.8 12.8 14.1 5.9 13.6 16.4 9.3 10.8 8.0 15.0 18.6 15.6 14.6 20.0 17.4 9.2 29.2 12.8 18.1 9.6 13.7 23.6 61.2 12.6 25.4 14.4 9.5 14.9 11.8 15.8 15.8 14.0 5.6 11.7 18.9 18.5 8.9 24.5 10.9 6.7 9.3 12.9 4.1 7.7 5.2 19.6 11.1 10.7 10.6 8.4 9.8 4.9 9.2 7.5 7.6 29.1 4.9 10.1 9.6 17.9 4.4 8.2 20.2 13.8 6.6 16.8 11.0 27.5 30.7 14.0 16.9 8.2 11.6 19.0 19.9 8.7 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 167.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "MAIT T-cell: 6.1" "Lineage enriched" "Detected in single" 62 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA 14000000 "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 11.5 0.1 2.1 6.0 2.8 0.1 4.6 1.7 2.9 18.3 4.0 0.4 0.2 6.4 0.0 0.4 0.3 11.8 0.6 0.8 11.4 0.8 0.2 1.3 3.2 6.1 2.7 0.9 8.9 0.5 0.1 1.1 167.9 4.2 0.3 0.6 0.3 1.1 0.0 0.1 0.4 0.5 4.3 2.2 1.6 0.5 0.9 8.2 1.8 0.3 0.0 3.5 11.7 0.5 6.1 16.8 2.5 6.5 0.1 18.7 38.3 0.0 42.7 3.5 14.2 35.5 0.0 0.0 0.0 0.0 154.2 30.0 0.0 0.2 1.4 15.5 1.9 0.6 0.2 25.1 0.0 2.9 0.0 33.2 47.0 0.0 94.3 2.9 27.1 0.0 0.0 0.0 0.2 11.8 0.0 0.0 0.0 0.1 0.0 2.8 0.0 4.8 4.4 0.4 44.1 0.5 28.4 5.0 0.0 0.7 2.5 0.1 0.1 0.0 50.9 16.9 93.2 86.2 0.0 0.5 0.0 70.7 0.1 32.3 0.0 0.0 0.0 0.3 0.0 6.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 2.1 2.8 1.7 2.9 0.8 11.4 6.1 2.7 0.9 4.2 2.2 8.2 6.1 0.5 0.0 1.9 22.5 0.3 1.5 0.4 3.0 0.0 2.1 1.7 3.6 2.3 0.0 0.5 0.0 102.2 14.0 0.5 0.7 0.0 8.0 10.9 10.7 16.6 1.6 0.0 0.0 7.4 1.1 400.8 34.5 0.5 1.8 49.5 7.8 2.5 0.2 15.5 6.7 19.0 1.0 4.1 0.6 3.1 1.7 16.8 0.8 1.8 14.0 9.0 3.3 1.0 99.0 52.2 2.2 0.1 0.7 0.3 1.0 0.7 0.4 6.5 30.5 0.0 5.1 13.4 6.0 5.0 0.0 0.6 129.2 4.7 28.1 0.9 0.5 RGS10 ENSG00000148908 "Regulator of G protein signaling 10" O43665 10 119499817-119542719 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 224.9" "Cell type enhanced" "Detected in many" "granulocytes: 291.2;Hofbauer cells: 528.1;Kupffer cells: 297.2;Langerhans cells: 358.3;Macrophages: 529.3;monocytes: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 474.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004559, HPA021305, HPA058485" Enhanced Supported Supported "Nucleoplasm,Plasma membrane" NA NA 840000 "Nucleoplasm, Plasma membrane" "CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732" "unprognostic (1.64e-2)" "prognostic favorable (6.81e-4)" "unprognostic (7.98e-2)" "prognostic favorable (6.32e-4)" "unprognostic (5.21e-2)" "unprognostic (6.19e-2)" "unprognostic (4.32e-3)" "unprognostic (6.35e-2)" "unprognostic (9.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.20e-10)" "unprognostic (2.50e-1)" "unprognostic (9.20e-2)" "unprognostic (7.70e-2)" "unprognostic (7.92e-3)" 23.6 20.8 19.9 59.8 21.9 75.1 41.1 23.2 30.6 64.5 25.5 92.7 34.5 38.9 15.9 51.9 28.7 38.6 11.6 20.6 25.5 17.7 11.5 28.4 120.0 28.9 22.1 17.5 22.7 7.0 7.0 13.9 45.9 28.5 43.6 50.2 2.6 41.4 20.5 31.7 21.2 58.8 43.2 30.9 49.1 30.2 4.9 23.9 224.9 33.3 11.7 97.3 50.7 46.2 31.8 165.2 31.2 2.4 294.7 41.4 262.6 25.9 74.9 118.1 45.3 73.5 9.8 38.7 66.8 38.1 60.9 45.7 35.4 44.3 48.2 123.8 32.0 42.8 183.1 8.9 24.2 63.1 40.0 474.0 100.7 63.1 88.3 84.4 159.4 88.2 65.4 47.6 58.5 55.0 79.2 221.9 134.8 13.5 21.2 71.1 43.8 0.3 26.1 24.7 40.4 10.8 9.3 14.4 192.6 285.3 36.3 35.1 71.7 108.3 25.4 21.9 36.1 67.8 2.7 46.0 27.0 7.6 166.5 11.4 184.8 116.0 1.4 77.9 151.4 82.9 36.0 169.6 134.9 224.3 21.7 397.5 303.3 52.5 44.3 130.4 133.2 202.3 372.5 19.9 21.9 23.2 30.6 20.6 25.5 28.9 22.1 17.5 28.5 30.9 23.9 31.8 10.4 0.0 13.1 2.6 60.3 36.8 25.7 104.5 27.9 0.2 68.9 96.6 1.1 1.5 39.7 1.8 0.0 14.0 70.1 7.1 60.7 0.8 2.1 89.8 25.1 12.7 18.7 156.6 0.2 6.4 34.8 68.6 11.2 53.6 291.2 101.2 13.2 1.5 528.1 0.0 1.8 85.7 32.6 297.2 358.3 5.1 50.1 529.3 94.3 67.5 294.5 1.8 50.4 0.5 0.2 9.9 10.0 9.4 32.1 88.8 3.3 5.2 24.6 0.8 13.1 14.4 31.8 0.3 9.3 39.6 28.1 10.1 164.7 3.5 19.3 41.4 BTBD10 "GMRP-1, GMRP1, MGC13007" ENSG00000148925 "BTB domain containing 10" Q9BSF8 11 13388008-13463297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 116.5;Spermatocytes: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046777 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA046777: AB_2679801" "unprognostic (2.38e-1)" "unprognostic (4.25e-1)" "unprognostic (1.75e-1)" "unprognostic (9.76e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.07e-1)" "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (1.29e-3)" "unprognostic (1.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (1.27e-1)" 13.9 12.3 19.9 13.8 32.4 13.5 13.5 21.6 27.7 15.2 6.5 18.3 13.3 16.7 12.1 28.8 11.9 15.3 17.9 26.0 23.1 11.5 9.9 13.2 15.9 14.6 17.6 22.6 14.2 8.8 13.3 14.2 17.6 19.3 15.1 20.5 19.0 10.8 17.6 14.8 13.3 11.8 21.3 12.7 12.7 17.8 38.6 17.4 18.7 13.7 18.5 17.6 27.3 17.9 24.2 55.9 40.2 34.3 23.2 30.4 29.5 43.5 57.5 33.3 43.5 39.4 37.7 64.0 38.1 27.1 42.2 43.9 44.0 26.3 61.4 50.8 38.7 27.1 20.7 13.9 22.5 46.9 27.6 45.4 25.3 68.0 25.2 57.3 33.0 89.1 26.8 11.8 38.2 46.0 33.7 28.3 15.2 14.9 50.0 34.9 24.8 29.4 23.8 69.7 44.3 14.8 20.9 34.4 27.5 20.5 38.9 19.7 14.7 81.7 44.7 37.2 43.4 33.6 14.2 52.6 25.5 30.6 23.6 38.9 41.1 24.8 38.2 18.1 39.7 21.7 18.4 17.1 20.1 29.2 17.2 19.1 19.3 64.9 25.7 50.5 12.7 23.6 18.3 19.9 32.4 21.6 27.7 26.0 23.1 14.6 17.6 22.6 19.3 12.7 17.4 24.2 20.5 16.0 7.0 35.9 16.9 28.2 40.7 27.0 15.9 13.9 9.6 8.6 14.0 12.8 19.7 5.5 4.2 24.3 18.1 15.7 5.9 31.8 95.7 14.3 12.5 22.6 16.3 9.0 116.5 25.2 54.3 15.3 27.5 19.1 22.8 11.1 11.7 5.9 22.9 8.4 74.2 14.2 28.5 16.4 13.0 26.3 9.9 13.0 17.8 38.4 22.2 9.9 18.6 61.9 62.4 50.2 14.2 18.4 12.0 30.1 8.7 10.5 19.9 14.1 6.6 13.4 20.6 121.3 59.7 27.8 35.8 62.1 17.8 9.2 13.3 64.6 ADM AM ENSG00000148926 Adrenomedullin P35318 11 10305073-10307397 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 325.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 590.8;Extravillous trophoblasts: 1217.1;Syncytiotrophoblasts: 1084.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 18 "neutrophil: 242.2" "Lineage enriched" "Detected in many" 18 "granulocytes: 242.2" "Cell line enhanced" "Detected in many" "ASC diff: 684.6;fHDF/TERT166: 357.4;HSkMC: 410.9;U-138 MG: 390.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016075, HPA068955" Approved "Secreted to blood" NA NA 31000 340000 "CAB016075: AB_628693, HPA068955: " "unprognostic (1.67e-1)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (1.55e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.78e-3)" "unprognostic (1.06e-1)" "unprognostic (2.83e-1)" "unprognostic (8.13e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.33e-4)" "unprognostic (9.70e-3)" "unprognostic (2.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.62e-2)" 325.1 30.2 15.7 32.5 18.1 44.3 197.5 27.2 20.6 105.5 17.6 56.4 8.1 20.5 3.1 85.3 71.6 30.2 98.6 11.0 59.8 121.6 91.2 158.9 17.2 19.6 16.5 7.0 33.4 24.8 23.7 43.7 103.6 18.8 27.0 11.5 16.9 53.1 1.6 79.9 163.9 49.9 7.7 16.1 34.8 56.0 4.9 27.2 4.1 53.2 14.4 3.5 85.8 226.1 25.1 35.4 29.2 33.8 9.8 684.6 306.7 51.8 263.6 263.9 260.5 175.7 142.4 43.9 0.1 11.7 357.4 136.9 51.0 9.5 40.6 191.9 0.7 13.9 1.1 16.1 18.0 88.0 1.6 1.1 410.9 34.7 30.8 44.6 89.9 60.4 0.5 0.4 0.7 64.3 1.2 0.2 10.6 65.7 8.4 13.6 1.0 1.1 54.5 16.7 48.6 1.1 3.2 101.0 23.7 0.6 36.4 31.4 0.3 17.9 390.0 5.5 233.2 37.9 2.7 29.5 10.5 112.0 0.2 117.0 0.0 7.0 0.0 0.0 7.7 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.1 242.2 0.0 13.6 0.0 0.3 1.9 15.7 18.1 27.2 20.6 11.0 59.8 19.6 16.5 7.0 18.8 16.1 27.2 25.1 347.7 9.6 12.3 17.0 14.2 192.1 590.8 194.4 182.1 2.7 28.0 46.9 104.6 18.6 136.2 3.7 8.4 134.6 9.1 266.7 15.6 135.7 0.5 80.8 58.1 99.1 67.5 4.0 0.4 30.5 1217.1 202.8 55.0 210.9 9.5 30.1 95.7 18.6 71.4 3.3 3.0 127.6 181.0 69.6 57.7 2.6 132.7 107.9 40.9 6.5 8.1 4.9 1.0 1.5 0.1 61.7 298.3 19.2 20.0 218.9 14.0 60.1 38.7 15.3 0.0 73.3 76.5 5.1 4.9 182.3 125.6 1084.8 14.7 8.1 55.5 224.5 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625509-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 40.0" "Group enriched" "Detected in some" 4 "Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.4 0.8 3.8 0.3 1.8 0.2 0.8 4.4 5.4 0.9 0.0 0.6 1.8 0.8 0.0 0.8 1.2 1.6 3.5 0.7 1.7 5.4 40.0 1.0 1.0 6.4 5.9 1.0 2.0 9.7 0.1 2.5 0.4 6.5 1.0 0.5 2.2 1.5 0.6 4.7 0.8 1.7 0.3 5.0 1.4 2.6 0.9 7.7 8.3 0.8 1.8 0.7 1.0 0.7 6.6 0.0 0.1 1.7 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.7 0.4 0.2 0.0 43.2 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.3 0.0 24.0 1.6 85.2 0.0 0.4 0.3 0.1 0.3 2.4 0.0 0.9 0.5 4.4 0.0 1.1 24.8 1.3 0.0 0.0 0.5 0.2 0.1 0.0 1.8 0.0 0.4 1.1 0.0 1.1 30.7 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 1.8 4.4 5.4 0.7 1.7 6.4 5.9 1.0 6.5 5.0 7.7 6.6 0.1 0.0 0.0 39.8 0.4 0.1 0.4 0.1 0.6 1.9 0.4 0.1 12.7 10.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.3 1.3 0.1 0.4 0.0 0.0 114.9 3.3 0.0 1.0 3.1 0.7 0.0 0.2 0.7 22.9 0.0 0.0 141.9 0.6 0.0 0.0 0.0 5.4 0.6 0.0 0.0 9.4 0.2 0.2 0.0 18.6 83.9 1.6 1.4 0.0 0.5 0.1 0.1 3.2 4.0 1.2 0.0 0.3 0.8 0.4 1.1 0.6 0.0 0.0 0.4 0.1 0.9 0.3 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667020-26723427 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 48.2;intestine: 30.4;kidney: 173.2" "Group enriched" "Detected in some" 23 "Proximal enterocytes: 286.0;Proximal tubular cells: 181.0" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.1 0.1 0.3 0.0 0.4 0.9 0.1 0.8 0.4 0.0 0.2 0.2 4.9 0.1 48.2 0.0 0.1 0.1 2.1 0.3 0.4 173.2 1.7 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.6 0.4 0.1 0.2 1.0 0.1 0.1 0.1 0.3 30.4 0.0 0.0 0.6 0.3 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.1 0.2 1.7 0.3 0.0 0.0 0.0 0.3 0.0 0.5 0.8 0.1 0.7 0.1 0.0 3.3 1.2 0.2 0.2 0.2 0.1 0.2 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.8 0.4 0.3 0.4 0.2 0.1 0.2 0.4 0.0 0.2 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.1 3.7 0.0 0.1 0.0 2.4 9.8 0.0 1.4 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 6.7 0.0 0.0 0.0 0.2 0.0 0.7 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 286.0 181.0 0.1 0.3 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.6 4.5 3.5 0.1 LIN7C "FLJ11215, LIN-7-C, LIN-7C, MALS-3, VELI3" ENSG00000148943 "Lin-7 homolog C, crumbs cell polarity complex component" Q9NUP9 11 27494418-27506769 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051118 Approved NA NA "HPA051118: AB_2681347" "unprognostic (1.46e-3)" "unprognostic (1.54e-2)" "unprognostic (3.65e-1)" "unprognostic (7.57e-3)" "unprognostic (9.65e-2)" "unprognostic (1.68e-1)" "unprognostic (7.04e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (4.26e-2)" "unprognostic (3.14e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.09e-4)" "unprognostic (5.45e-2)" "unprognostic (1.50e-1)" "unprognostic (3.59e-1)" "unprognostic (1.51e-2)" 9.2 10.8 11.0 7.9 10.9 15.9 8.8 31.8 12.3 7.6 10.3 9.5 11.4 7.9 10.6 10.7 6.4 6.2 5.8 11.7 11.8 12.3 24.3 7.5 7.4 10.6 13.1 9.2 8.1 10.3 9.1 6.8 8.3 14.3 9.7 9.7 10.6 9.1 5.9 6.1 11.6 9.0 8.6 10.7 9.3 10.1 4.2 12.1 6.3 14.2 7.4 9.3 7.6 8.0 11.5 9.1 14.0 8.5 15.0 11.6 11.1 12.8 13.5 12.4 12.0 12.7 12.1 5.4 18.6 9.6 17.0 11.4 17.0 12.0 19.3 21.9 15.1 9.9 10.3 27.7 18.8 14.9 21.1 13.3 11.8 18.0 8.2 29.1 15.6 10.7 6.2 16.0 25.1 16.1 9.8 13.5 14.0 12.3 18.5 9.3 7.6 37.2 9.3 16.6 22.3 14.5 11.5 25.9 22.4 11.3 9.4 21.9 11.3 14.7 25.3 19.7 29.7 20.3 14.5 10.2 11.8 20.2 13.6 26.3 17.4 8.1 9.7 5.9 8.6 9.0 6.3 7.0 5.6 7.4 5.7 9.4 7.7 3.3 6.6 9.9 4.3 5.3 7.9 11.0 10.9 31.8 12.3 11.7 11.8 10.6 13.1 9.2 14.3 10.7 12.1 11.5 23.8 28.9 13.1 10.7 14.7 41.2 31.5 20.9 21.1 33.1 21.5 16.5 13.4 25.8 21.3 27.6 35.5 16.3 21.8 35.2 33.2 14.1 53.8 21.9 19.2 22.9 48.5 19.3 17.0 20.0 16.1 21.0 25.0 27.3 10.8 23.0 18.2 59.4 18.4 33.7 16.7 38.6 22.4 20.1 24.4 12.9 16.1 17.2 14.2 10.3 16.9 44.6 12.3 10.6 12.6 26.1 25.1 18.4 21.4 44.6 33.7 32.7 15.7 49.0 0.0 27.3 25.7 10.1 10.7 41.5 44.8 19.0 16.6 18.4 33.9 43.7 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.8;retina: 17.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 5497.5" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 19.1;U-2 OS: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Supported Approved Cytosol NA NA Cytosol "HPA054800: AB_2682603, HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 0.7 3.5 12.1 0.8 15.5 0.0 1.4 1.4 16.8 3.1 0.0 1.9 0.4 1.2 0.3 0.4 0.5 0.8 1.5 14.5 10.2 0.3 1.1 0.8 0.7 9.0 10.1 15.6 0.6 0.3 1.7 4.1 0.0 7.9 0.6 0.7 17.3 0.7 1.6 0.3 0.2 0.8 1.3 4.1 0.6 0.5 0.2 8.6 0.6 2.4 0.7 0.8 0.7 2.0 12.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 20.9 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 15.5 1.4 16.8 14.5 10.2 9.0 10.1 15.6 7.9 4.1 8.6 12.0 0.2 0.0 1.3 498.2 0.2 0.1 0.0 1.4 0.0 35.5 4.2 3.0 1.2 0.0 1.4 0.0 6.2 0.0 0.0 0.0 1.9 0.0 0.9 0.3 10.5 1.4 0.0 0.0 1171.8 0.0 0.0 5.6 0.0 0.9 0.0 0.1 0.0 0.0 0.1 8.4 1274.6 0.0 0.0 0.0 1.9 0.2 2.1 0.4 1.8 49.6 0.0 93.6 0.0 5497.5 221.3 0.3 0.0 1.5 0.1 0.1 0.0 0.7 0.0 99.7 0.0 2.0 0.7 0.3 0.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 IMMP1L "FLJ25059, IMMP1" ENSG00000148950 "Inner mitochondrial membrane peptidase subunit 1" Q96LU5 11 31432401-31509645 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038372, HPA058308" Approved Enhanced Mitochondria NA NA Mitochondria "HPA038372: AB_10669643, HPA058308: AB_2732620" "unprognostic (2.39e-1)" "unprognostic (1.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.17e-2)" "unprognostic (9.67e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (7.59e-2)" "unprognostic (4.66e-3)" "unprognostic (5.15e-3)" "prognostic favorable (6.72e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-2)" "unprognostic (4.66e-1)" "unprognostic (4.52e-2)" "unprognostic (1.37e-2)" "unprognostic (1.04e-3)" 10.6 15.7 39.7 6.4 40.1 11.2 19.5 42.2 66.9 12.9 38.4 12.6 8.7 11.6 30.0 11.8 10.5 5.1 25.6 39.4 39.3 25.9 18.7 9.0 9.6 39.2 39.0 39.1 17.7 16.6 18.0 23.5 7.0 39.4 14.4 10.1 38.0 11.9 14.3 50.4 11.6 9.6 10.8 39.4 10.9 15.2 16.8 39.7 25.0 13.4 42.5 13.2 11.0 12.7 40.0 22.9 26.9 95.6 21.0 14.9 9.9 15.3 19.9 8.7 16.2 11.7 21.0 17.5 20.7 18.7 15.9 32.5 25.8 37.6 28.8 23.8 24.9 52.6 29.4 45.5 32.3 15.8 29.6 19.9 8.0 27.1 8.7 19.2 29.5 17.5 48.8 38.0 23.2 15.9 28.2 48.5 48.9 15.8 114.6 26.3 41.1 72.2 20.6 54.6 26.2 22.5 27.0 32.5 11.6 32.5 61.9 37.1 35.1 2.6 15.3 27.2 16.2 42.2 17.2 58.2 47.5 24.9 24.9 18.5 21.9 3.0 32.2 28.9 3.4 26.3 34.1 25.3 29.5 8.1 32.1 32.0 39.8 0.8 37.3 3.0 40.2 35.4 13.6 39.7 40.1 42.2 66.9 39.4 39.3 39.2 39.0 39.1 39.4 39.4 39.7 40.0 29.2 35.3 14.6 30.7 22.4 18.2 26.8 60.5 12.0 30.6 44.6 55.1 56.8 18.6 26.8 60.7 33.3 36.3 17.6 21.7 119.3 17.0 39.8 30.2 16.9 19.4 56.5 47.4 40.6 24.5 32.5 19.7 20.9 33.8 22.7 22.7 18.2 45.0 21.3 43.7 48.0 30.6 52.9 7.7 11.4 10.5 13.4 9.4 8.8 24.4 10.3 85.3 30.9 51.3 60.7 15.8 26.7 20.7 22.0 26.0 18.6 98.4 28.9 38.5 32.9 19.1 51.0 61.6 23.0 19.6 27.3 23.7 24.2 16.2 34.7 26.2 SAA4 "C-SAA, CSAA" ENSG00000148965 "Serum amyloid A4, constitutive" P35542 11 18231355-18236802 "Plasma proteins, Predicted secreted proteins" "Acute phase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 124 "liver: 1959.7" "Group enriched" "Detected in some" 7 "Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8" "Cancer enriched" "Detected in many" 141 "liver cancer: 118.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "Hep G2: 28.8" "Not detected" "Not detected" "CAB026061, HPA060139" Supported "Secreted to blood" NA NA 65000000000 33000000000 "CAB026061: , HPA060139: AB_2684210" "unprognostic (4.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (4.83e-1)" "unprognostic (4.15e-2)" "unprognostic (6.05e-2)" "unprognostic (3.63e-3)" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (1.41e-1)" "unprognostic (7.35e-2)" "unprognostic (2.54e-8)" "unprognostic (2.49e-1)" "unprognostic (6.46e-2)" 7.4 0.5 0.3 0.4 0.3 0.0 6.7 0.3 0.6 15.8 0.3 0.2 0.0 0.0 0.2 0.5 0.5 1.0 0.1 0.3 0.8 0.4 1959.7 0.7 0.0 0.4 0.3 0.3 0.0 0.1 0.0 0.8 0.0 0.3 1.2 0.0 0.1 11.5 0.1 3.5 0.4 0.1 0.1 0.3 1.2 0.1 1.3 0.4 1.0 0.0 0.0 0.2 0.1 0.1 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.3 0.1 28.8 0.3 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.6 0.3 0.8 0.4 0.3 0.3 0.3 0.3 0.4 0.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 184.7 0.0 0.0 2.1 1.4 0.0 18.6 172.6 0.0 0.0 0.0 0.0 3.5 0.0 4.0 0.6 0.4 0.0 1.6 0.0 21.5 0.0 1.2 0.1 0.0 0.0 0.3 0.0 0.0 27.5 2132.8 0.1 0.0 0.0 0.0 71.2 38.0 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 706.8 0.0 0.0 0.0 23.6 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.5 PGAP2 "CWH43-N, FRAG1, MRT17, MRT21" ENSG00000148985 "Post-GPI attachment to proteins 2" Q9UHJ9 11 3797724-3826371 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "epididymis: 218.1" "Group enriched" "Detected in all" 4 "Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063099 Approved Approved Microtubules NA NA Microtubules "HPA063099: AB_2684940" "unprognostic (1.94e-1)" "unprognostic (1.14e-1)" "unprognostic (2.19e-1)" "unprognostic (3.18e-2)" "unprognostic (5.13e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (3.07e-1)" "unprognostic (1.11e-1)" "unprognostic (6.44e-2)" "unprognostic (3.85e-2)" "unprognostic (4.66e-3)" "unprognostic (4.13e-2)" "unprognostic (2.17e-2)" "unprognostic (2.67e-2)" 8.6 15.1 15.2 6.4 16.4 9.6 11.6 14.8 18.4 11.9 15.6 14.0 18.5 8.4 218.1 35.2 19.3 7.7 17.3 15.4 16.7 13.8 31.2 16.3 10.5 16.7 15.7 15.4 11.3 29.2 17.7 15.2 14.3 16.5 16.8 13.4 9.3 18.5 33.7 11.4 48.4 16.1 7.7 15.1 11.3 14.2 28.7 15.6 13.3 19.6 9.6 13.6 11.0 18.9 19.9 27.1 36.3 17.2 15.8 15.2 28.9 27.3 10.9 9.4 15.6 14.2 31.1 46.6 29.0 12.3 8.0 9.4 44.1 27.6 30.2 15.5 35.5 30.9 17.7 14.7 38.4 10.7 23.0 22.0 22.8 41.9 11.6 39.3 10.2 18.0 38.4 38.4 41.8 16.6 39.9 28.0 19.3 32.4 56.7 21.5 44.0 2.0 27.8 30.0 31.6 22.7 22.5 19.7 52.0 12.3 20.1 43.2 9.6 16.5 9.9 9.2 23.8 6.8 26.2 31.3 21.6 12.9 15.3 19.1 3.0 6.4 5.9 9.1 9.2 11.0 11.4 13.2 11.3 9.7 12.7 17.3 11.8 18.2 10.7 9.2 6.6 13.3 8.8 15.2 16.4 14.8 18.4 15.4 16.7 16.7 15.7 15.4 16.5 15.1 15.6 19.9 8.4 12.8 10.6 7.5 10.6 31.7 15.1 23.3 33.6 14.1 19.2 18.0 13.7 11.5 13.0 12.9 22.9 74.9 5.2 11.4 1.9 15.6 147.6 11.7 6.6 9.0 3.0 13.2 15.4 21.3 18.4 7.6 10.2 14.7 8.8 13.4 3.6 14.6 16.0 3.3 19.1 10.5 10.2 5.0 8.0 296.8 8.7 5.5 5.4 4.7 8.9 9.3 8.2 10.6 23.0 14.2 9.3 6.8 12.2 9.1 39.8 10.2 15.2 9.5 6.6 11.0 7.2 17.7 21.6 31.1 28.6 29.3 9.4 11.8 20.1 13.0 TUT1 "FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TENT1, TUTase" ENSG00000149016 "Terminal uridylyl transferase 1, U6 snRNA-specific" Q9H6E5 11 62575045-62591637 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 32.5;Early spermatids: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069055, HPA071838" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA069055: AB_2686075, HPA071838: AB_2686456" "unprognostic (3.81e-2)" "unprognostic (3.54e-2)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (2.71e-1)" "unprognostic (7.20e-3)" "unprognostic (1.03e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.97e-3)" 10.0 10.8 8.5 7.4 9.2 6.0 11.9 8.4 10.0 10.3 6.9 8.8 8.9 10.0 5.9 9.3 11.3 6.2 8.8 8.2 8.3 10.8 22.4 8.4 11.9 9.8 8.6 7.8 11.3 19.6 7.7 10.6 6.3 9.7 12.8 4.1 5.5 11.8 7.4 20.6 12.5 10.3 4.6 8.7 12.8 12.7 13.7 9.3 10.3 12.4 7.6 7.9 10.5 9.3 11.4 12.5 16.0 10.7 15.4 12.6 7.3 14.0 12.7 8.3 11.2 9.7 14.0 24.9 19.5 30.1 6.6 14.3 23.7 19.8 15.9 5.7 15.1 10.5 20.3 15.8 14.1 14.3 14.8 9.3 10.3 16.6 13.7 21.1 10.5 10.8 26.2 32.1 20.7 9.6 28.8 21.1 33.3 12.4 8.4 19.1 23.7 16.6 50.9 10.6 6.9 18.2 24.6 10.4 19.6 17.5 8.9 27.2 14.2 10.1 12.9 11.3 15.2 10.1 36.1 32.9 24.6 14.8 11.5 10.7 6.0 5.9 7.0 9.9 7.2 13.7 9.2 9.5 8.1 7.9 11.6 14.3 11.7 3.5 11.0 5.6 9.3 9.2 7.7 8.5 9.2 8.4 10.0 8.2 8.3 9.8 8.6 7.8 9.7 8.7 9.3 11.4 32.5 0.0 6.7 7.5 7.5 2.7 5.2 7.2 4.0 8.4 5.9 5.2 4.2 18.6 7.1 11.0 6.2 12.8 6.0 4.4 5.9 8.5 34.3 5.7 3.1 15.0 7.2 3.2 3.9 7.4 7.8 5.1 7.7 4.1 2.5 5.5 18.2 17.8 5.9 1.7 4.6 9.1 6.1 5.0 2.2 16.4 7.2 4.3 10.6 1.0 4.0 9.8 14.4 4.0 5.4 5.6 3.6 3.4 4.9 7.1 8.4 7.1 13.1 8.4 0.0 4.1 4.1 10.0 16.3 3.1 2.3 14.0 5.6 5.6 7.0 3.1 SCGB1A1 "CC10, CC16, CCSP, UGB" ENSG00000149021 "Secretoglobin family 1A member 1" P11684 11 62405103-62423195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Phospholipase A2 inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lung: 3106.6" "Cell type enriched" "Detected in some" 4 "Club cells: 43564.7" "Cancer enriched" "Detected in many" 8 "lung cancer: 215.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 71 "HaCaT: 1977.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025686, HPA031828" Enhanced "Secreted in other tissues" NA NA 13000000 "CAB025686: , HPA031828: AB_2674061" "unprognostic (2.40e-3)" "unprognostic (1.55e-2)" "unprognostic (5.46e-2)" "unprognostic (2.70e-2)" "unprognostic (4.69e-3)" "unprognostic (2.12e-2)" "unprognostic (1.23e-2)" "unprognostic (2.31e-2)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" 0.6 2.1 0.8 0.9 0.9 0.2 0.3 1.6 1.2 0.7 0.6 0.2 0.4 0.2 0.7 11.1 337.0 0.2 0.5 0.8 0.8 0.2 0.4 3106.6 0.2 0.8 1.2 0.7 2.1 1.9 0.0 2.4 1.7 1.1 85.9 0.0 0.2 0.5 0.9 0.4 0.2 1.6 0.0 0.7 7.3 4.3 0.2 1.0 2.8 0.4 0.0 6.0 0.2 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 1977.1 0.0 0.3 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 27.9 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.0 0.6 1.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.0 1.0 2.0 0.0 1.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 1.6 1.2 0.8 0.8 0.8 1.2 0.7 1.1 0.7 1.0 0.9 0.0 1125.0 2573.3 0.0 0.0 0.0 71.4 3938.5 0.0 0.0 0.0 0.0 0.0 0.0 43564.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 113.5 0.0 0.0 0.1 0.0 0.0 304.5 0.0 0.5 691.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4534.8 0.0 0.0 0.7 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 134.7 0.0 0.0 9997.0 0.0 0.0 0.0 850.3 0.0 0.0 3.9 0.0 0.0 83.7 0.0 0.0 800.2 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.5;skin 1: 63.8;urinary bladder: 40.9" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 184.7;Basal squamous epithelial cells: 520.2;Breast myoepithelial cells: 192.9;Cholangiocytes: 183.0;Extravillous trophoblasts: 201.8;Respiratory ciliated cells: 163.8;Squamous epithelial cells: 132.5" "Group enriched" "Detected in many" 5 "cervical cancer: 10.5;pancreatic cancer: 21.7;urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 32.2;hTCEpi: 50.2;T-47d: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047239, HPA052700" Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA047239: , HPA052700: AB_2681920" "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.2 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.1 0.0 0.2 0.5 0.0 0.5 29.5 1.0 8.7 0.0 0.0 0.0 0.3 0.6 4.7 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.2 1.6 0.0 2.5 0.0 0.0 21.0 3.0 0.0 63.8 2.6 0.0 0.0 0.1 2.3 0.2 0.0 0.0 0.0 0.0 0.1 40.9 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 32.2 0.0 0.0 0.0 0.6 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 50.2 0.0 5.8 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 1.0 0.0 0.3 0.0 2.7 0.0 0.0 13.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.0 3.9 0.0 0.3 184.7 5.6 24.9 520.2 0.0 3.2 192.9 0.6 183.0 39.1 5.5 0.0 28.7 0.7 3.4 0.0 31.1 0.0 15.6 0.1 1.7 0.0 0.0 0.0 9.7 201.8 1.6 12.2 0.6 1.3 0.0 0.0 0.1 7.1 0.0 0.0 1.3 16.2 0.0 14.7 0.0 0.0 1.3 10.6 0.0 0.0 0.0 0.0 0.0 0.0 28.3 3.5 0.0 6.2 1.3 18.3 0.0 163.8 0.0 0.0 0.0 7.0 0.0 0.0 132.5 47.2 36.8 0.6 0.1 1.7 31.5 ZNF214 ENSG00000149050 "Zinc finger protein 214" Q9UL59 11 6997085-7020346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 6.6;Endometrial ciliated cells: 6.6;Excitatory neurons: 10.5;Respiratory ciliated cells: 10.4;Spermatocytes: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 3.5" HPA055391 Uncertain Approved Nucleoplasm,Midbody Yes NA Nucleoplasm Midbody "HPA055391: AB_2682804" "unprognostic (3.01e-2)" "unprognostic (3.04e-1)" "unprognostic (1.56e-2)" "unprognostic (2.33e-1)" "unprognostic (8.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.28e-3)" "unprognostic (7.53e-4)" "unprognostic (1.71e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-1)" "unprognostic (1.29e-1)" "unprognostic (3.67e-3)" "unprognostic (3.00e-2)" "unprognostic (3.21e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-2)" 0.6 1.0 1.7 0.3 1.2 0.0 2.1 0.9 1.5 2.3 1.7 1.0 0.6 2.3 2.7 0.5 3.9 0.8 0.8 0.9 1.2 2.4 1.3 1.2 0.2 1.9 1.4 0.9 4.2 1.1 2.5 1.3 0.2 1.1 2.0 1.1 5.4 0.9 2.1 0.4 0.4 0.6 1.7 1.5 0.2 0.7 3.1 1.0 0.2 3.4 0.5 0.2 1.5 1.3 1.4 0.4 0.8 3.3 0.0 0.6 2.2 0.8 1.3 3.5 1.7 1.9 0.0 2.4 0.1 0.4 0.9 1.1 0.5 0.3 0.9 1.9 0.0 0.9 0.0 0.5 0.2 1.2 0.0 0.1 0.6 2.2 0.0 1.9 2.3 1.5 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 2.6 1.3 0.1 0.1 1.3 0.5 0.0 0.2 1.1 1.4 3.0 0.0 0.0 0.0 0.0 1.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.2 0.9 1.5 0.9 1.2 1.9 1.4 0.9 1.1 1.5 1.0 1.4 0.5 0.0 1.5 4.6 0.1 0.0 2.0 1.6 0.6 2.5 1.1 1.5 0.9 1.5 2.7 0.0 0.0 0.1 0.0 0.4 1.9 2.1 6.6 6.6 2.0 0.6 2.4 0.0 10.5 0.9 0.4 1.5 0.0 0.9 0.0 1.2 0.0 0.4 0.1 3.3 5.5 1.7 0.0 0.0 0.5 1.0 0.6 0.2 0.0 2.8 0.0 3.0 0.0 4.0 2.9 1.1 0.1 0.4 0.0 0.6 0.8 3.3 10.4 3.6 0.0 0.8 0.9 10.4 3.3 0.9 0.1 0.0 0.2 0.8 0.9 0.4 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 13.7;Inhibitory neurons: 8.5;Plasma cells: 27.5;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-698: 19.8" "Low region specificity" "Detected in many" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: AB_2681308" "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 0.4 0.4 0.3 1.3 0.3 0.7 1.3 0.1 0.4 0.8 0.0 2.0 2.2 0.7 0.6 0.9 0.4 0.5 0.3 0.4 0.4 0.9 0.3 0.5 3.5 0.5 0.3 0.4 0.8 2.3 0.0 0.2 0.2 0.4 0.8 2.6 0.4 1.4 0.5 0.2 0.5 1.9 0.5 0.2 1.6 0.8 1.5 0.4 1.2 0.8 0.1 4.2 1.1 0.7 0.4 2.9 1.1 1.8 0.2 1.2 1.7 6.4 7.0 5.7 3.6 6.5 0.2 0.0 10.1 2.1 3.2 4.3 3.1 4.8 6.4 6.3 0.0 7.5 0.0 0.3 0.0 1.2 6.5 0.0 3.2 3.1 0.1 7.0 1.4 5.3 0.1 11.5 3.1 1.3 0.0 0.1 0.0 8.9 0.0 1.6 0.0 0.0 1.3 0.1 5.3 0.0 0.2 0.0 2.4 0.0 4.4 0.1 2.4 2.8 2.0 5.8 2.4 0.0 0.3 0.1 19.8 4.8 0.0 1.9 1.5 0.4 0.1 0.1 0.2 0.0 0.6 0.1 0.3 0.4 0.5 0.3 0.1 0.6 0.2 0.1 0.7 0.2 0.3 0.3 0.3 0.1 0.4 0.4 0.4 0.5 0.3 0.4 0.4 0.2 0.4 0.4 0.2 0.0 0.0 0.3 2.5 0.4 1.7 1.0 1.8 0.6 0.7 0.3 0.2 0.0 0.9 7.3 6.2 0.4 0.1 0.9 1.9 0.1 0.3 0.8 1.8 0.6 1.2 2.5 13.7 1.8 2.6 1.1 0.0 0.9 1.3 0.6 0.0 0.9 0.4 3.3 8.5 3.5 0.0 0.3 0.0 0.3 0.0 0.8 1.8 3.7 0.0 0.1 0.0 1.5 0.4 0.3 0.8 0.0 27.5 0.6 2.0 1.1 0.4 0.0 0.0 0.2 0.7 5.6 9.1 2.3 0.3 0.0 0.8 2.2 2.2 0.8 HSD17B12 "KAR, SDR12C1" ENSG00000149084 "Hydroxysteroid 17-beta dehydrogenase 12" Q53GQ0 11 43680680-43856617 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016427 Approved NA NA "HPA016427: AB_1844347" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.99e-1)" "unprognostic (3.31e-2)" "unprognostic (9.16e-3)" "unprognostic (5.16e-2)" "unprognostic (7.54e-2)" "prognostic favorable (2.10e-8)" "unprognostic (6.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" 61.4 66.0 40.3 31.6 47.0 25.4 49.3 56.2 60.2 51.7 68.5 66.5 67.9 37.8 51.1 36.7 41.7 35.9 70.1 38.4 54.0 92.1 124.0 51.9 28.8 57.0 48.4 32.7 45.7 43.8 135.4 28.8 41.9 57.5 53.3 60.1 47.4 47.4 41.8 28.1 30.3 42.0 49.0 51.9 35.1 56.6 33.8 45.9 22.5 67.4 52.0 32.5 31.7 27.0 60.5 40.2 64.3 68.4 69.6 226.8 211.5 45.0 96.7 97.8 67.3 73.0 75.7 80.7 97.4 69.4 91.5 111.7 151.6 48.7 125.5 82.6 19.0 89.2 46.4 28.3 66.2 114.6 132.3 125.4 131.1 93.6 68.1 193.6 85.9 96.1 60.4 43.9 157.9 59.4 22.9 38.6 63.1 126.0 49.9 45.3 63.9 102.3 110.8 129.5 95.9 24.5 56.5 132.0 110.7 100.2 64.6 80.2 112.5 92.4 73.9 28.3 189.3 117.6 81.6 110.3 58.3 78.5 25.0 55.4 8.8 13.4 7.0 12.1 14.8 13.5 12.7 9.6 10.5 21.3 15.2 15.6 13.9 11.2 16.4 8.2 18.4 6.2 11.6 40.3 47.0 56.2 60.2 38.4 54.0 57.0 48.4 32.7 57.5 51.9 45.9 60.5 73.6 64.1 111.1 96.6 45.4 31.7 47.1 92.8 57.5 77.1 46.1 36.4 80.7 74.4 81.4 51.5 77.2 60.4 30.6 82.2 27.4 100.2 61.8 36.9 47.5 70.9 138.2 40.8 126.9 82.3 42.1 59.7 60.6 37.0 155.9 37.3 76.1 214.0 63.5 121.1 155.6 75.5 87.5 50.9 43.7 24.1 34.2 45.3 39.2 59.0 37.2 128.2 30.9 128.7 97.5 71.4 62.5 56.8 61.4 61.3 54.2 50.1 75.8 67.8 78.9 45.4 60.2 17.5 14.5 66.0 45.7 74.8 29.4 95.5 115.5 48.6 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916379 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol NA NA 52000 Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 30.7 25.6 15.5 20.9 17.7 14.6 20.9 18.4 17.3 18.2 15.4 20.1 13.8 15.1 15.1 13.9 17.3 18.7 20.2 14.8 19.7 27.2 19.6 21.4 20.4 19.7 17.5 14.3 12.4 17.3 15.9 9.2 13.4 18.9 17.0 19.7 16.9 32.0 23.8 66.2 10.0 16.5 12.4 18.3 15.6 18.9 10.8 16.9 31.6 24.9 38.6 16.5 19.3 9.6 21.9 25.1 27.3 33.5 8.3 27.7 26.8 14.5 36.8 38.0 38.9 44.4 15.6 21.3 77.1 21.7 15.5 40.3 28.8 56.1 24.9 53.3 49.9 56.3 39.5 27.8 42.6 41.2 111.3 28.9 23.6 20.6 22.1 40.7 19.1 29.8 49.8 94.2 45.2 27.6 24.2 59.7 57.7 25.1 39.6 61.7 36.4 89.1 29.6 46.8 36.3 28.5 13.6 45.0 37.2 50.2 17.4 38.9 34.3 24.1 29.2 26.9 68.1 9.0 43.9 36.1 89.4 32.2 27.3 37.2 11.3 27.3 25.4 17.2 30.0 21.3 24.5 21.1 18.8 42.7 24.3 21.4 18.3 6.7 31.4 36.8 27.2 27.2 18.4 15.5 17.7 18.4 17.3 14.8 19.7 19.7 17.5 14.3 18.9 18.3 16.9 21.9 24.7 35.3 30.1 42.4 27.9 25.0 37.5 62.7 19.4 28.8 73.8 36.2 23.1 37.1 63.0 18.4 4.2 37.2 25.5 49.5 187.9 30.2 8.0 33.4 23.9 22.8 35.5 42.5 28.4 32.4 23.4 24.4 29.6 24.8 20.3 22.0 21.0 26.0 76.5 18.5 35.2 41.3 87.5 47.1 31.8 8.3 23.9 47.6 21.4 17.8 59.4 23.1 25.7 51.3 108.8 25.4 28.4 24.8 44.2 33.0 35.0 101.7 56.8 21.6 39.5 37.8 30.1 32.4 22.3 31.4 26.3 26.4 25.8 27.1 50.1 50.4 PAMR1 "DKFZP586H2123, RAMP" ENSG00000149090 "Peptidase domain containing associated with muscle regeneration 1" Q6UXH9 11 35431823-35530300 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "Astrocytes: 380.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA 5600000 "unprognostic (3.38e-1)" "unprognostic (1.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.00e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.07e-2)" "unprognostic (6.92e-2)" "unprognostic (3.32e-2)" "unprognostic (4.07e-2)" "unprognostic (1.91e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (5.08e-5)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.08e-1)" "unprognostic (9.98e-2)" "unprognostic (8.25e-2)" 20.4 15.0 24.4 0.6 24.6 0.0 15.6 24.0 23.6 60.4 14.2 13.5 4.5 58.8 18.5 10.1 22.8 20.5 18.8 22.5 25.1 4.1 12.7 6.0 1.3 36.8 30.1 19.7 3.4 5.3 1.7 6.5 56.4 30.2 21.4 6.6 0.9 5.7 18.1 2.7 20.0 10.0 15.0 44.1 5.8 5.4 0.2 30.8 2.8 7.0 9.1 1.8 28.3 41.6 37.5 0.0 0.0 0.1 0.0 86.9 354.7 0.1 42.8 357.7 4.9 8.3 32.7 0.0 0.0 0.0 86.7 0.1 0.1 0.0 0.0 3.3 0.0 0.8 0.0 0.0 0.0 50.1 0.0 0.0 123.1 1.8 9.7 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.7 0.0 0.2 0.0 0.2 0.2 0.0 8.4 0.1 0.0 0.0 0.0 0.0 14.3 2.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 82.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 24.6 24.0 23.6 22.5 25.1 36.8 30.1 19.7 30.2 44.1 30.8 37.5 2.5 0.0 0.0 380.3 0.0 19.1 1.4 14.8 1.2 0.1 0.7 19.7 1.3 0.0 2.4 1.8 0.0 2.2 0.0 0.0 0.0 1.4 0.1 4.5 26.2 1.1 0.0 0.0 13.1 0.0 1.4 50.2 1.1 0.8 0.0 0.6 0.0 0.0 2.0 0.0 8.2 0.2 0.0 0.0 5.5 0.1 0.3 0.5 1.8 28.1 0.6 0.0 0.0 9.5 1.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 1.8 0.2 0.0 1.6 5.8 0.0 0.2 0.1 9.2 3.4 0.6 0.2 0.0 0.2 DGKZ "DAGK5, DAGK6, DGK-ZETA, hDGKzeta" ENSG00000149091 "Diacylglycerol kinase zeta" Q13574 11 46332905-46380554 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 144.6" "Cell type enhanced" "Detected in all" "NK-cells: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051336 Enhanced Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA051336: AB_2681448" "unprognostic (2.85e-2)" "unprognostic (3.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (4.12e-2)" "unprognostic (3.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (2.49e-2)" "unprognostic (3.66e-3)" "unprognostic (8.18e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.48e-3)" "unprognostic (7.75e-2)" "unprognostic (3.61e-2)" "unprognostic (7.84e-3)" 19.7 14.3 43.9 21.8 71.0 55.0 19.6 3.3 144.6 16.0 0.0 19.6 36.8 16.9 4.0 19.7 15.5 11.2 41.9 128.2 17.6 18.2 10.6 18.4 40.2 16.3 4.9 74.8 12.5 31.8 10.1 59.2 14.2 31.4 18.7 6.7 2.5 43.8 10.8 96.5 22.1 41.5 9.2 0.0 36.4 22.4 15.5 5.9 34.3 12.6 25.4 17.2 18.3 15.4 49.0 38.1 33.2 22.1 33.2 11.5 12.8 102.1 29.0 21.5 30.0 26.3 39.8 17.1 48.4 20.5 30.1 33.0 43.3 26.7 42.0 10.6 48.8 62.5 31.7 25.2 29.5 20.5 60.5 61.2 17.3 19.3 16.5 22.2 15.3 33.4 39.3 45.1 29.1 21.5 99.8 58.6 94.3 64.3 54.5 50.3 69.0 38.2 20.6 9.1 36.6 150.3 25.6 33.2 109.6 23.0 13.8 78.8 75.2 37.9 39.2 42.4 62.6 52.9 19.1 23.4 40.3 53.8 54.0 37.2 12.4 13.5 6.0 6.8 5.6 4.1 0.3 4.3 5.9 12.0 0.8 4.3 4.6 9.5 7.6 6.4 5.7 4.4 10.5 43.9 71.0 3.3 144.6 128.2 17.6 16.3 4.9 74.8 31.4 0.0 5.9 49.0 46.0 3.2 6.6 44.7 16.4 13.3 22.3 16.3 14.2 27.6 24.6 19.8 24.4 8.6 8.7 9.2 20.9 14.6 95.8 37.7 9.8 13.2 6.1 9.9 15.2 34.2 51.5 23.4 114.0 47.8 105.1 12.4 34.1 14.1 21.0 25.7 56.7 7.1 51.2 16.8 45.0 26.3 22.4 46.1 26.9 11.4 13.1 34.0 12.4 31.9 50.6 6.4 129.8 8.5 24.7 33.5 41.0 8.2 25.3 16.6 97.0 20.2 8.2 9.9 32.9 17.8 16.8 7.0 12.2 12.3 9.2 27.4 71.8 19.4 29.9 17.2 EIF3M "FLJ29030, GA17, hfl-B5, PCID1, TANGO7" ENSG00000149100 "Eukaryotic translation initiation factor 3 subunit M" Q7L2H7 11 32583798-32606264 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031063 Approved Approved Cytosol NA NA 130000 Cytosol "HPA031063: AB_10602128" "unprognostic (4.40e-2)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (7.16e-2)" "unprognostic (3.18e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.28e-9)" "unprognostic (5.79e-3)" "unprognostic (2.27e-2)" "unprognostic (1.83e-2)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (5.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-2)" "unprognostic (6.42e-2)" 88.4 106.0 54.4 73.1 57.1 142.6 136.5 56.3 72.2 90.4 57.7 81.4 77.8 97.4 107.5 95.8 147.7 71.4 86.9 55.5 58.6 113.8 109.3 60.6 123.7 56.7 55.2 51.9 164.4 132.7 65.2 49.8 80.4 55.7 71.9 99.4 43.7 79.3 83.0 104.0 103.3 60.7 99.1 58.2 71.7 88.7 75.0 56.8 132.4 108.5 83.1 147.8 114.6 80.2 60.2 173.6 219.0 171.0 218.8 222.7 318.2 251.5 176.1 242.7 264.5 255.6 284.5 124.1 445.6 118.1 201.6 226.7 214.1 301.1 319.4 328.2 151.4 372.3 201.2 164.5 303.4 322.1 473.9 276.4 287.4 355.1 178.8 434.6 221.5 301.3 234.6 403.8 151.2 293.8 204.1 238.3 494.4 188.4 230.8 334.2 192.0 430.7 209.9 291.4 321.4 131.3 203.0 125.2 233.5 279.9 187.0 259.3 279.6 142.1 164.6 188.0 353.0 540.2 183.5 248.8 324.0 148.2 284.3 166.1 71.9 211.7 65.7 99.7 189.3 137.6 144.9 136.9 127.3 258.4 117.9 141.1 129.9 24.8 142.3 142.8 154.8 156.5 186.0 54.4 57.1 56.3 72.2 55.5 58.6 56.7 55.2 51.9 55.7 58.2 56.8 60.2 82.7 83.3 66.4 19.2 147.5 212.9 256.2 372.8 189.0 44.7 112.9 132.3 41.1 81.5 168.0 60.7 20.9 261.8 127.8 47.1 131.0 187.3 154.9 76.4 168.8 106.3 72.4 148.5 23.8 250.7 284.0 121.9 103.0 104.3 158.4 123.6 98.6 73.3 197.1 10.1 23.5 132.3 156.6 250.6 209.6 55.2 133.9 153.6 110.3 12.2 283.6 70.0 131.8 20.1 21.6 171.8 87.4 120.4 132.4 212.0 86.3 220.6 87.6 42.5 72.3 140.1 254.9 109.4 72.6 159.5 225.0 243.0 154.1 228.3 169.9 252.9 TNKS1BP1 "FLJ45975, KIAA1741, TAB182" ENSG00000149115 "Tankyrase 1 binding protein 1" Q9C0C2 11 57299638-57324952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037929, HPA037930" Enhanced Uncertain "Plasma membrane" NA NA 180000 "Plasma membrane" "HPA037929: AB_10672613, HPA037930: AB_2675745" "unprognostic (7.31e-2)" "unprognostic (1.66e-2)" "unprognostic (5.38e-2)" "unprognostic (2.25e-1)" "unprognostic (3.13e-1)" "unprognostic (9.17e-2)" "unprognostic (2.47e-2)" "unprognostic (7.90e-2)" "unprognostic (4.27e-1)" "unprognostic (2.67e-2)" "unprognostic (4.22e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (2.46e-1)" "unprognostic (2.31e-2)" "unprognostic (2.41e-1)" "unprognostic (3.07e-1)" 63.3 27.6 11.6 17.4 10.2 3.3 42.3 4.9 9.4 40.3 17.6 23.5 29.0 40.6 30.6 55.8 35.6 28.4 23.0 11.1 20.3 14.3 31.9 40.7 6.7 9.5 8.5 8.0 32.5 31.2 19.1 17.3 29.7 7.6 33.9 16.3 3.3 44.6 40.6 67.8 83.6 26.8 29.7 4.5 18.2 53.2 10.2 10.6 22.5 25.2 30.1 14.4 38.8 46.0 6.6 89.5 58.7 41.2 33.6 127.8 97.1 31.0 61.5 113.8 46.3 42.5 26.1 59.5 2.0 38.5 101.2 49.6 151.7 31.4 105.3 30.1 34.2 10.4 11.5 38.2 12.2 86.6 14.4 4.3 96.8 123.5 70.9 54.6 57.5 60.0 12.4 13.2 9.3 65.3 45.4 11.0 14.7 45.8 46.5 45.9 16.9 57.2 25.9 53.5 116.6 14.6 22.6 81.5 121.5 44.3 29.0 182.2 11.9 115.1 47.3 45.8 56.6 35.2 15.0 4.1 11.3 107.0 4.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.6 10.2 4.9 9.4 11.1 20.3 9.5 8.5 8.0 7.6 4.5 10.6 6.6 38.1 12.8 35.4 12.7 1.9 83.6 28.0 61.9 40.9 4.8 24.8 23.9 7.9 38.6 39.0 44.1 2.1 16.8 1.3 27.3 0.0 31.8 1.8 18.5 25.4 25.9 18.0 7.4 7.2 22.3 3.2 31.2 49.5 38.4 2.5 3.7 19.6 46.0 3.9 8.4 4.8 25.8 18.3 1.5 25.4 2.9 48.1 3.8 17.8 1.9 0.7 4.0 0.0 4.5 2.4 38.8 14.3 49.2 0.6 41.2 18.2 2.4 15.4 1.3 32.9 41.2 26.9 1.5 3.0 68.9 88.2 24.5 2.3 23.4 14.5 36.8 GLYAT "ACGNAT, GAT" ENSG00000149124 Glycine-N-acyltransferase Q6IB77 11 58640426-58731974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Detoxification "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "kidney: 577.2;liver: 703.8" "Group enriched" "Detected in some" 6 "Hepatocytes: 346.7;Proximal tubular cells: 1261.0" "Group enriched" "Detected in some" 158 "liver cancer: 21.7;renal cancer: 25.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.4" "Not detected" "Not detected" "HPA040251, HPA044094" Enhanced NA NA 21000 "HPA040251: AB_2676902, HPA044094: AB_2678807" "unprognostic (2.15e-2)" "unprognostic (9.38e-4)" "unprognostic (4.60e-2)" "unprognostic (1.65e-3)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.69e-1)" 47.4 0.1 0.0 0.1 0.1 0.1 8.6 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.0 577.2 703.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.2 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 11.5 0.0 31.3 0.0 0.1 0.0 0.0 123.3 0.0 6.0 0.0 0.0 0.6 0.0 8.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 346.7 0.0 0.0 0.2 0.0 0.0 10.7 0.0 8.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1261.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 SERPING1 "C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2" ENSG00000149131 "Serpin family G member 1" P05155 11 57597387-57619171 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity" "Protease inhibitor, Serine protease inhibitor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 2644.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3" "Cancer enhanced" "Detected in all" "liver cancer: 609.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 65.2;plasmacytoid DC: 60.6" "Group enriched" "Detected in many" 243 "dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7" "Group enriched" "Detected in many" 6 "ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 194.1" "CAB026161, HPA048738" Supported "Secreted to blood" NA NA 28000000000 "CAB026161: , HPA048738: AB_2680505" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (4.26e-2)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (4.12e-3)" "unprognostic (2.13e-1)" "unprognostic (8.95e-2)" "prognostic favorable (8.03e-4)" "unprognostic (5.92e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.60e-2)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.17e-1)" 911.7 145.4 24.3 90.8 25.9 11.0 739.3 24.8 36.3 613.4 60.8 319.7 52.5 621.8 164.7 163.4 800.2 537.7 407.2 22.2 47.2 333.7 2644.0 791.8 148.8 66.4 30.6 20.6 926.0 269.7 55.6 139.3 200.5 30.5 332.1 98.0 34.8 252.6 260.6 153.1 268.9 285.9 228.8 39.2 242.7 347.7 51.0 30.2 36.5 341.0 174.9 64.9 560.6 524.2 37.8 0.0 0.0 48.2 0.0 1372.2 694.9 7.3 74.2 57.0 16.8 30.7 2.5 0.0 0.0 96.7 42.1 0.0 0.0 0.4 4.7 9.4 0.0 0.1 33.7 0.0 1.7 170.3 0.9 5.4 1159.0 15.5 5.7 0.2 6.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 1.3 46.6 0.0 0.0 4.3 4.0 0.7 7.4 0.0 0.2 14.4 0.3 0.0 0.9 41.8 0.2 3.3 0.0 0.8 21.2 0.7 0.0 0.2 0.4 0.6 0.2 0.5 0.0 0.0 18.3 0.3 0.0 25.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 65.2 0.2 11.5 60.6 0.0 5.7 24.3 25.9 24.8 36.3 22.2 47.2 66.4 30.6 20.6 30.5 39.2 30.2 37.8 162.1 118.6 110.8 5.5 8.0 75.8 61.2 7.1 24.5 0.8 24.2 57.7 28.7 726.4 57.5 158.2 0.0 37.1 15.3 0.0 43.0 604.0 4.8 76.0 297.4 150.5 0.0 69.2 3.6 44.0 93.4 793.6 8.6 69.6 7.6 8.3 260.5 2530.0 43.6 0.0 6.2 0.1 2.0 118.9 94.2 25.6 735.3 46.9 90.7 15.9 10.4 57.2 0.0 3.5 0.5 41.4 0.0 228.7 4.5 32.4 0.0 53.5 23.1 4.5 269.5 143.6 259.6 2.5 10.4 9.0 59.5 25.2 16.8 3.4 0.0 37.4 OR5F1 OR11-10 ENSG00000149133 "Olfactory receptor family 5 subfamily F member 1" O95221 11 55993681-55994625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059360 Uncertain NA NA "HPA059360: AB_2683990" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSRP1 FACT80 ENSG00000149136 "Structure specific recognition protein 1" Q08945 11 57325986-57335892 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002697 Approved Approved Nucleoplasm,Cytosol NA NA 42000 Cytosol Nucleoplasm "HPA002697: AB_1857509" "unprognostic (1.67e-1)" "unprognostic (3.21e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-1)" "unprognostic (2.84e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (4.03e-7)" "unprognostic (3.22e-2)" "unprognostic (1.96e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (5.92e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" 52.7 43.1 39.6 63.5 40.1 79.5 54.2 38.9 46.8 61.3 37.7 65.3 48.8 65.5 48.1 68.3 68.9 37.3 45.6 39.8 42.7 42.5 43.7 52.1 76.8 39.4 39.4 38.1 74.8 74.7 61.3 57.9 58.0 38.5 47.0 66.7 36.3 55.4 50.0 141.7 67.1 55.5 58.9 39.1 53.0 60.3 46.2 41.4 88.6 54.4 64.5 92.7 59.1 56.9 41.0 353.0 332.0 308.3 226.9 95.1 105.1 150.7 188.9 181.1 321.8 229.2 230.0 255.2 424.4 196.7 166.7 204.5 264.8 493.7 293.9 402.2 297.7 276.9 271.5 233.1 250.5 149.3 455.4 195.3 106.7 175.7 331.8 456.8 149.1 213.3 320.7 376.0 207.9 222.6 237.1 463.3 400.3 406.1 186.1 201.7 386.1 520.4 412.0 151.7 249.3 321.4 271.6 267.6 226.2 286.7 157.0 275.3 177.0 162.7 218.2 287.1 298.3 328.9 240.9 259.9 431.9 185.0 251.6 294.6 0.8 4.1 4.6 8.6 5.1 8.2 8.4 7.4 9.5 6.0 10.5 8.2 11.0 1.0 7.2 5.2 10.0 9.9 5.0 39.6 40.1 38.9 46.8 39.8 42.7 39.4 39.4 38.1 38.5 39.1 41.4 41.0 31.2 76.9 91.2 4.6 51.0 74.9 78.1 52.0 55.8 27.3 38.3 39.8 26.4 44.3 78.1 29.5 25.0 115.6 31.7 29.9 13.7 92.5 83.0 40.8 47.2 52.0 28.8 106.8 10.5 99.4 116.9 45.3 32.1 33.2 41.0 55.6 33.2 39.7 57.5 25.2 9.1 45.2 32.6 37.9 45.5 158.0 42.6 34.9 28.4 8.4 42.5 26.3 40.2 6.0 8.4 69.0 32.9 44.4 72.2 80.0 32.3 25.7 101.0 18.9 19.7 53.1 66.1 58.4 108.0 75.3 76.3 67.6 43.5 46.7 78.4 70.7 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515780 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 129.7;pancreas: 235.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2" "Cancer enhanced" "Detected in all" "liver cancer: 45.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 62.7;NB-4: 74.3;U-937: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 13.7 10.8 3.6 4.8 3.8 36.0 11.2 2.8 5.0 13.1 2.9 13.3 8.7 12.7 10.4 4.4 13.7 18.4 8.5 3.6 3.6 6.4 129.7 10.0 7.4 3.8 3.3 3.6 20.5 235.2 1.8 4.5 6.3 4.1 12.9 9.5 1.3 13.9 6.3 17.3 18.9 9.3 8.7 2.6 8.6 30.7 3.4 3.3 2.1 12.8 9.1 6.7 16.3 9.9 3.9 1.1 1.7 1.8 20.3 25.7 18.8 0.2 10.4 13.8 3.0 7.6 6.5 2.8 59.5 2.7 7.9 3.9 1.0 18.1 1.2 3.7 2.8 4.6 30.9 0.5 62.7 33.7 54.3 7.2 23.8 4.4 5.2 23.2 7.3 13.4 34.7 43.9 10.7 3.8 2.3 0.5 74.3 6.6 27.0 13.6 51.0 9.8 27.2 0.5 0.1 23.5 3.6 1.9 0.3 23.8 0.5 1.6 27.3 5.5 3.1 7.1 26.2 1.7 12.1 4.3 35.3 1.5 70.6 4.2 11.1 6.2 0.7 10.9 2.4 9.2 2.9 4.9 7.7 8.4 1.5 4.9 6.9 0.5 7.5 0.2 1.9 9.5 5.5 3.6 3.8 2.8 5.0 3.6 3.6 3.8 3.3 3.6 4.1 2.6 3.3 3.9 4.4 0.0 7.3 1.6 3.3 7.0 1.6 0.0 3.4 5.7 1.8 2.4 6.8 47.1 0.6 0.0 0.0 0.2 3.6 3.1 3.9 3.4 21.5 5.3 6.0 4.7 6.0 82.9 3.5 35.4 0.4 10.9 4.6 13.4 3.8 1.3 15.4 138.2 7.4 0.0 1.4 8.8 0.0 8.1 2.9 14.8 15.5 3.2 5.4 5.6 1.3 0.2 5.2 4.0 0.6 11.1 2.9 7.9 6.2 3.2 0.3 0.1 0.7 0.4 6.6 6.4 7.7 0.7 1.5 0.3 3.7 0.1 6.4 2.9 9.0 0.9 PTPRJ "CD148, DEP1, HPTPeta" ENSG00000149177 "Protein tyrosine phosphatase receptor type J" Q12913 11 47980558-48170841 "CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.5" "Group enriched" "Detected in many" 4 "granulocytes: 9.5;monocytes: 4.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006026 Approved "Intracellular and membrane" NA NA 670000000 "HPA006026: AB_1078446" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (3.20e-2)" "unprognostic (2.99e-2)" "unprognostic (6.58e-2)" "unprognostic (2.15e-1)" "unprognostic (9.64e-3)" "unprognostic (3.79e-3)" "unprognostic (5.16e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.13e-5)" "unprognostic (1.09e-2)" "unprognostic (7.98e-2)" "unprognostic (9.18e-2)" "unprognostic (2.00e-1)" 6.0 3.2 10.2 20.7 13.4 29.7 6.2 6.9 14.1 6.3 17.6 10.3 9.5 2.4 7.9 2.0 4.1 7.2 2.7 10.0 13.2 14.0 12.0 10.1 15.6 9.8 11.9 10.3 1.7 6.2 15.9 10.2 7.7 12.9 8.0 8.8 8.2 10.2 7.1 2.4 4.2 14.6 6.0 7.1 23.5 14.7 2.3 13.9 7.0 19.8 2.7 11.1 6.9 2.1 13.9 7.6 28.3 12.1 7.0 1.9 4.1 4.2 7.5 5.5 12.9 9.2 2.0 40.8 6.9 51.8 19.1 19.6 6.0 19.0 2.0 14.9 46.6 5.4 1.9 34.9 2.8 12.1 2.7 41.5 3.2 0.6 3.8 1.0 31.7 7.8 0.5 2.6 4.4 4.7 17.0 0.1 17.3 9.7 25.7 4.4 1.6 1.6 4.0 52.6 11.1 7.9 2.5 20.2 12.0 19.4 8.9 13.0 20.3 25.7 9.9 10.8 20.5 23.4 1.1 1.7 11.4 11.7 8.0 37.3 0.7 1.1 2.8 1.6 2.0 1.0 0.8 0.9 1.2 0.8 0.5 0.7 0.9 9.5 1.0 4.7 1.5 1.0 0.8 10.2 13.4 6.9 14.1 10.0 13.2 9.8 11.9 10.3 12.9 7.1 13.9 13.9 1.5 9.6 16.7 43.1 11.3 0.3 9.8 0.8 0.6 13.6 8.3 4.1 3.7 17.2 13.0 38.6 6.2 1.9 32.7 35.5 0.0 7.4 5.5 13.5 2.2 4.5 12.6 3.2 81.0 5.0 0.6 4.0 22.4 22.9 13.9 2.5 5.0 15.6 30.0 10.1 167.5 10.1 2.0 74.2 5.7 8.2 0.3 40.2 1.8 189.3 36.0 10.3 21.6 239.8 167.7 11.8 28.0 0.4 12.9 25.3 37.6 13.5 4.9 1.3 0.0 3.3 4.9 0.2 4.8 0.5 0.3 1.9 22.0 2.3 7.6 8.2 C11orf49 "FLJ22210, MGC4707" ENSG00000149179 "Chromosome 11 open reading frame 49" Q9H6J7 11 46936689-47164385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 140.0;Excitatory neurons: 140.8;Inhibitory neurons: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040051, HPA040280" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA040051: AB_10795412, HPA040280: AB_10795363" "unprognostic (3.11e-2)" "unprognostic (3.01e-1)" "unprognostic (2.15e-1)" "unprognostic (1.06e-2)" "unprognostic (6.65e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.18e-5)" "unprognostic (1.27e-1)" "unprognostic (2.76e-1)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.55e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.34e-3)" 7.9 13.5 46.5 6.3 48.5 3.4 10.1 43.1 55.1 15.7 40.8 13.6 11.3 16.9 14.2 9.7 32.8 9.7 12.2 47.8 48.8 15.5 3.9 12.2 6.4 43.9 50.3 46.5 15.0 12.8 22.8 30.5 6.9 45.6 12.5 11.5 22.0 11.1 13.4 7.4 31.4 12.0 12.9 42.4 7.0 15.5 20.3 47.0 13.8 16.3 6.5 7.3 12.0 11.5 47.3 10.9 30.6 37.9 27.9 17.8 25.7 9.5 11.7 26.9 24.6 29.9 6.9 17.0 9.1 12.3 24.4 29.7 14.8 18.8 28.7 20.9 18.1 27.2 12.2 36.6 12.6 30.5 14.6 16.2 17.5 19.1 11.2 16.4 47.0 27.6 22.1 10.3 11.7 18.2 22.8 23.0 16.2 14.3 26.5 16.4 8.2 9.5 10.1 43.3 11.7 25.5 36.5 13.4 14.9 14.7 19.7 25.0 8.5 6.5 13.8 11.0 22.0 17.7 10.4 9.2 7.5 33.7 3.0 17.5 12.7 10.2 9.0 19.2 13.7 23.0 24.1 18.1 22.7 24.6 17.6 19.1 20.3 0.3 25.2 10.3 21.8 19.0 18.3 46.5 48.5 43.1 55.1 47.8 48.8 43.9 50.3 46.5 45.6 42.4 47.0 47.3 6.6 9.6 26.7 140.0 9.9 13.0 16.4 30.6 12.0 22.9 12.0 13.0 9.4 12.8 24.0 23.9 18.8 19.4 5.6 18.3 46.9 30.2 53.2 42.8 20.4 10.2 19.2 8.0 140.8 20.4 13.4 18.0 25.5 14.1 16.4 23.3 8.6 2.4 9.9 37.0 112.7 12.8 22.4 3.3 7.0 35.8 12.8 6.2 12.4 41.2 10.9 45.0 7.2 93.0 71.9 16.2 21.2 20.3 5.8 8.1 22.1 33.4 66.7 53.1 6.6 12.2 13.5 63.3 7.6 10.5 18.0 10.0 10.8 32.6 13.7 12.1 ARFGAP2 "FLJ14576, IRZ, Zfp289, ZNF289" ENSG00000149182 "ADP ribosylation factor GTPase activating protein 2" Q8N6H7 11 47164299-47177125 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016649, HPA018152" Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA016649: AB_1844980, HPA018152: AB_1844979" "unprognostic (1.69e-2)" "unprognostic (9.11e-2)" "unprognostic (5.91e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-2)" "unprognostic (1.12e-1)" "unprognostic (4.81e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.41e-1)" "unprognostic (3.42e-2)" "unprognostic (7.00e-2)" "prognostic favorable (7.65e-7)" "unprognostic (2.05e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" "unprognostic (9.20e-2)" 36.3 51.8 63.0 36.6 64.8 82.9 42.2 64.6 68.9 41.4 57.8 47.8 40.4 43.6 35.9 61.3 49.7 32.4 50.8 63.9 61.8 42.5 77.4 41.1 52.3 66.6 64.1 63.9 45.0 70.3 48.6 39.0 40.2 63.5 51.8 39.8 39.2 56.6 42.1 116.8 79.3 44.2 39.1 62.6 51.6 56.2 30.9 64.1 50.3 47.9 82.1 50.9 45.1 43.6 71.6 55.7 36.4 54.9 43.3 45.9 37.3 51.6 51.2 48.1 64.1 48.4 41.3 45.3 91.3 32.4 58.7 40.8 82.3 47.2 74.6 40.3 45.0 46.1 77.6 85.5 50.8 53.7 107.0 84.4 56.7 82.3 33.3 71.1 46.1 60.4 65.6 111.8 67.8 58.5 102.5 50.8 87.8 43.6 98.3 48.4 78.8 94.8 116.8 60.3 79.3 53.0 47.0 58.7 81.7 38.8 26.1 126.8 78.8 48.7 55.2 43.3 50.5 68.6 58.6 60.7 78.3 38.6 81.2 56.4 108.5 69.1 92.8 74.0 77.3 66.6 59.0 57.1 66.2 65.9 63.1 63.0 63.4 41.8 69.2 98.4 35.4 71.8 108.1 63.0 64.8 64.6 68.9 63.9 61.8 66.6 64.1 63.9 63.5 62.6 64.1 71.6 23.8 35.3 45.9 25.1 46.5 22.2 31.4 22.1 29.6 73.6 30.9 25.8 13.0 20.0 41.2 31.3 114.7 64.3 40.7 38.6 25.4 38.7 2.7 20.3 26.4 29.8 45.4 47.1 16.2 36.6 47.1 29.7 34.1 27.0 60.8 44.9 31.1 44.0 36.8 74.0 15.1 35.0 38.7 33.6 25.4 6.6 34.2 28.6 28.4 15.9 58.1 51.1 71.1 13.0 23.7 39.2 45.0 26.4 31.7 26.4 41.0 26.3 34.1 115.4 39.5 33.0 28.0 24.7 35.9 30.3 26.7 91.8 43.7 40.3 36.3 34.0 CELF1 "BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR" ENSG00000149187 "CUGBP Elav-like family member 1" Q92879 11 47465933-47565569 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016114, HPA044597, CAB069989" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012" "unprognostic (1.05e-1)" "unprognostic (7.54e-2)" "unprognostic (3.24e-2)" "unprognostic (7.64e-2)" "unprognostic (2.69e-1)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.55e-4)" "unprognostic (3.84e-2)" "unprognostic (3.41e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-2)" "unprognostic (2.68e-1)" "unprognostic (9.58e-2)" "unprognostic (3.34e-2)" 27.4 32.5 38.4 32.2 43.4 46.4 26.0 60.9 37.8 29.7 36.0 31.7 22.6 32.0 24.1 32.3 28.6 24.6 30.3 36.8 31.4 27.1 56.6 32.4 39.7 26.0 29.4 37.1 26.2 28.2 48.3 23.5 27.9 35.8 23.8 26.1 29.5 26.3 22.8 75.0 30.9 30.9 29.3 24.1 34.9 26.8 30.1 29.4 29.2 29.0 58.5 38.8 29.6 29.7 31.6 48.6 84.4 68.8 71.0 52.9 55.8 58.5 51.0 52.5 62.9 65.4 72.3 56.0 127.6 34.6 55.2 75.6 70.6 107.5 72.3 104.9 53.5 46.9 39.2 117.3 52.2 51.3 62.2 41.4 43.0 43.7 68.5 82.5 44.4 58.0 54.2 75.0 50.5 40.6 64.8 64.5 49.3 96.5 60.0 49.3 65.5 54.8 49.9 54.3 85.4 64.3 54.3 67.9 62.0 41.1 70.0 87.8 40.5 67.0 71.3 69.7 69.1 70.0 42.9 42.2 99.7 57.6 29.2 59.3 13.9 11.6 22.8 12.5 10.2 15.8 14.4 13.3 14.6 13.1 15.0 14.0 11.9 14.9 7.9 17.7 8.0 10.1 9.5 38.4 43.4 60.9 37.8 36.8 31.4 26.0 29.4 37.1 35.8 24.1 29.4 31.6 56.2 54.5 41.9 90.8 74.6 107.7 78.0 82.1 79.6 82.4 78.8 59.3 51.1 72.9 56.2 79.1 95.9 52.6 84.1 51.6 21.5 57.3 16.3 76.5 68.4 73.2 85.6 81.0 134.4 56.1 48.8 48.8 57.1 94.4 21.5 92.6 92.4 233.5 72.4 127.9 108.5 62.3 52.9 123.2 98.2 12.4 52.8 81.3 42.7 91.8 106.2 52.2 98.9 76.4 65.8 86.5 53.7 55.3 55.3 103.5 46.2 43.5 106.1 42.9 52.6 52.3 72.0 50.1 69.7 70.2 109.1 36.0 68.8 50.2 70.0 101.1 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Heat shock protein nuclear import factor hikeshi" Q53FT3 11 86302211-86345943 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441" "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 34.4 27.2 49.3 18.0 49.5 19.2 31.7 50.6 70.9 34.0 49.1 33.1 10.5 32.6 24.9 33.7 31.3 15.2 51.8 49.9 50.1 17.1 24.9 24.1 26.2 50.0 50.1 48.2 37.8 23.0 23.1 31.8 28.6 50.4 24.7 19.3 32.7 20.0 28.9 60.4 29.5 21.0 31.4 53.0 28.7 23.7 19.2 50.3 33.2 17.9 58.4 31.1 33.1 32.1 53.5 28.6 30.5 72.7 40.5 59.9 74.2 38.2 43.2 52.0 44.2 52.6 90.8 77.8 29.0 96.9 57.4 83.9 59.9 54.2 95.1 47.0 62.0 47.6 47.0 47.5 68.2 80.8 58.0 36.8 52.7 94.9 52.8 62.5 56.9 85.9 54.7 51.1 64.6 91.5 78.0 69.6 136.7 59.5 186.3 20.1 53.0 35.7 65.4 77.2 53.2 44.8 38.7 53.8 39.8 31.1 72.7 64.1 38.5 44.2 52.1 36.4 105.8 32.7 27.7 68.3 57.6 26.6 54.4 52.6 47.8 53.4 44.4 48.6 52.5 54.3 61.8 59.1 53.6 68.9 52.9 51.1 52.3 11.2 57.9 53.9 53.7 84.5 43.2 49.3 49.5 50.6 70.9 49.9 50.1 50.0 50.1 48.2 50.4 53.0 50.3 53.5 59.9 38.5 32.1 0.0 16.1 0.0 0.0 0.0 0.0 0.0 53.4 81.3 0.0 0.0 14.9 27.6 0.0 129.6 28.7 0.0 41.1 76.1 0.0 41.4 60.4 28.7 0.0 0.0 0.0 66.3 146.2 30.2 0.0 36.8 22.7 52.1 0.0 0.0 94.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 50.1 0.0 0.0 0.0 0.0 49.8 0.0 0.0 4.1 0.0 0.0 43.2 27.7 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 77.6 18.1 59.3 0.0 0.0 CCDC81 "FLJ16339, FLJ23514" ENSG00000149201 "Coiled-coil domain containing 81" Q6ZN84 11 86374736-86423109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.5;fallopian tube: 27.6" "Cell type enhanced" "Detected in many" "Early spermatids: 37.5;Endometrial ciliated cells: 72.7;Extravillous trophoblasts: 35.8;Respiratory ciliated cells: 38.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.4;BJ hTERT+: 1.8;HBF TERT88: 1.9;SuSa: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.02e-1)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (7.00e-3)" "unprognostic (8.54e-3)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.14e-4)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" 0.6 0.3 2.8 0.2 1.6 0.2 0.4 2.2 1.7 1.5 8.5 0.4 0.0 1.6 0.5 0.2 27.6 0.4 0.3 1.7 4.0 0.4 0.3 1.4 0.4 3.5 4.3 0.7 0.8 0.2 0.1 1.8 0.6 3.6 0.7 0.2 1.0 0.2 0.7 0.8 0.4 0.3 1.1 3.8 0.4 0.4 5.9 2.3 0.8 0.7 0.1 0.3 0.6 0.6 2.4 0.0 0.1 1.1 0.0 0.3 0.1 0.4 3.4 1.8 0.5 0.4 0.4 0.3 0.2 1.3 0.6 0.1 0.2 0.6 0.1 1.9 0.2 0.2 0.3 0.1 0.3 0.1 0.2 0.3 0.0 0.6 0.9 0.3 0.6 0.6 0.2 0.2 0.0 0.4 0.5 0.4 1.0 0.1 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.2 0.0 2.1 0.2 0.4 0.1 0.8 0.4 0.8 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.6 2.2 1.7 1.7 4.0 3.5 4.3 0.7 3.6 3.8 2.3 2.4 0.1 3.2 0.5 4.6 0.0 0.3 0.2 1.0 0.0 1.8 0.7 0.6 1.1 0.0 5.2 0.0 0.0 4.0 0.2 0.1 0.0 0.1 37.5 72.7 1.0 0.4 0.0 0.0 2.3 0.0 35.8 1.0 0.0 1.3 0.0 0.3 1.8 0.0 2.1 0.0 3.8 0.0 2.0 0.6 0.7 5.1 1.5 0.5 0.0 1.0 0.6 0.4 0.0 2.5 3.5 0.0 0.1 0.7 0.0 0.6 0.1 0.1 38.4 1.0 13.1 0.7 0.9 5.8 0.3 0.0 0.6 2.7 0.2 1.0 0.1 0.2 SESN3 "MGC29667, SEST3" ENSG00000149212 "Sestrin 3" P58005 11 95165513-95232541 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 680.7;Late spermatids: 529.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.7;ASC TERT1: 50.7;SuSa: 110.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037935 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037935: AB_10670534" "unprognostic (2.72e-2)" "unprognostic (3.06e-1)" "unprognostic (2.67e-1)" "unprognostic (8.09e-3)" "unprognostic (5.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (8.19e-3)" "unprognostic (1.38e-1)" "unprognostic (3.78e-1)" "unprognostic (2.34e-3)" "unprognostic (4.43e-2)" "unprognostic (1.67e-3)" "unprognostic (1.69e-1)" "unprognostic (1.96e-1)" "unprognostic (1.76e-2)" "unprognostic (9.42e-2)" 9.7 17.6 44.7 14.4 54.5 18.1 14.9 27.2 54.0 11.9 34.9 5.7 6.6 11.5 14.2 9.0 8.5 12.5 5.4 37.6 37.0 10.6 7.6 9.2 24.6 30.5 39.6 33.1 22.1 3.1 26.0 11.3 7.2 28.6 10.3 6.6 23.6 10.0 5.6 5.3 10.8 12.6 9.3 31.6 17.4 5.0 58.2 52.0 22.0 21.9 13.3 24.4 11.3 8.9 35.5 0.0 1.0 28.2 0.1 46.7 50.7 0.1 0.2 0.0 0.0 0.1 1.2 0.9 7.7 3.4 0.1 1.3 5.7 17.3 12.5 0.0 6.4 9.0 3.9 15.4 1.2 0.9 3.4 0.7 28.1 21.4 0.1 6.3 8.7 1.1 4.5 0.4 1.4 2.3 0.2 2.5 9.0 11.5 0.2 1.2 5.7 1.7 0.6 6.2 19.1 3.6 7.9 0.3 0.2 1.6 110.9 0.0 11.0 0.3 3.2 7.1 0.6 1.1 0.3 0.0 1.0 1.4 4.0 6.9 0.5 0.3 0.2 0.2 0.7 0.3 1.8 0.8 0.5 0.3 1.1 1.6 0.6 0.3 0.3 1.5 0.4 1.7 0.3 44.7 54.5 27.2 54.0 37.6 37.0 30.5 39.6 33.1 28.6 31.6 52.0 35.5 13.4 25.6 7.9 152.8 97.6 23.1 26.2 38.3 76.2 48.2 16.1 25.5 7.6 2.8 15.6 35.0 22.9 0.7 7.1 6.9 1.9 6.0 680.7 7.7 45.4 36.4 7.3 73.4 130.8 2.3 0.6 36.5 10.7 14.5 7.0 28.0 35.3 6.4 23.4 0.0 95.1 11.4 8.2 54.8 58.8 529.5 40.7 36.7 32.0 97.4 82.0 98.9 10.3 48.2 37.2 2.2 7.3 87.3 11.9 13.6 27.7 22.5 4.5 14.8 6.6 31.5 28.9 45.4 11.1 38.2 12.5 1.6 41.3 76.4 14.8 14.9 ENDOD1 KIAA0830 ENSG00000149218 "Endonuclease domain containing 1" O94919 11 95089846-95132645 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 99.5;Granulosa cells: 93.4;Oligodendrocytes: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 194.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008932, HPA010517" Enhanced Approved "Nuclear membrane" "Secreted - unknown location" NA NA 5200000 "Nuclear membrane" "HPA008932: AB_2262252, HPA010517: AB_1852351" "unprognostic (8.81e-3)" "unprognostic (1.92e-2)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (2.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (2.84e-1)" "prognostic favorable (6.64e-7)" "unprognostic (5.92e-2)" "unprognostic (2.35e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (3.27e-4)" 19.2 17.4 33.4 10.8 53.9 5.9 16.8 46.5 44.2 21.5 16.6 35.0 10.9 17.7 15.2 24.9 18.6 16.0 13.2 30.8 47.3 24.5 6.0 14.0 10.3 53.0 51.9 26.7 14.8 5.7 36.5 15.0 16.0 54.6 47.9 39.0 3.5 17.2 28.6 52.8 29.7 19.6 21.0 45.0 32.8 10.4 10.4 48.1 4.1 16.4 35.1 8.9 13.7 23.6 79.8 3.7 5.8 7.0 4.3 194.4 61.9 29.3 27.2 6.0 7.2 7.4 28.3 48.8 26.4 32.7 21.7 16.0 36.0 6.9 37.3 2.8 21.3 5.2 57.4 2.6 12.1 21.3 10.7 71.0 56.3 47.6 4.1 13.3 48.5 24.9 24.8 11.8 16.7 26.8 9.9 4.5 0.4 1.6 41.2 18.2 19.5 0.0 11.1 21.0 30.6 3.7 2.9 11.5 11.4 21.2 9.6 11.6 2.9 17.9 38.6 11.3 26.1 11.7 13.8 11.0 2.2 11.7 5.6 87.8 1.2 0.8 0.6 3.6 2.2 3.4 4.6 2.3 3.1 1.9 4.7 1.9 2.3 0.4 2.2 3.9 0.8 1.5 4.2 33.4 53.9 46.5 44.2 30.8 47.3 53.0 51.9 26.7 54.6 45.0 48.1 79.8 34.1 9.6 19.4 22.9 15.6 8.0 18.9 14.9 7.4 2.4 8.4 15.9 10.9 20.0 16.2 11.0 0.0 3.6 9.9 99.5 1.9 5.5 2.7 7.1 13.8 32.4 16.2 29.9 24.9 8.9 7.8 16.9 10.2 22.9 14.5 93.4 43.2 3.9 3.1 0.0 30.2 22.2 8.2 3.4 4.9 4.4 10.2 15.6 28.4 16.9 4.3 2.2 23.7 19.1 122.9 7.9 44.5 15.1 3.3 17.7 26.9 9.2 5.8 0.8 39.5 15.9 34.5 0.4 2.5 27.8 12.5 12.4 8.8 18.5 21.0 8.8 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96349241-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 493.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 21.9 15.3 21.2 19.7 24.6 17.3 17.7 36.7 30.3 15.5 12.8 16.7 13.1 18.5 14.0 10.5 16.1 17.0 13.3 22.5 19.6 16.8 22.3 18.1 23.6 25.6 26.0 15.1 18.4 13.9 11.9 18.3 17.5 24.9 13.1 13.5 43.5 12.9 15.9 14.5 14.4 17.0 14.0 16.2 20.5 16.9 23.9 21.5 22.5 18.1 15.1 20.3 16.8 14.6 36.4 12.9 17.9 52.4 21.0 35.9 30.0 20.8 47.0 28.0 29.9 42.4 31.1 41.3 26.1 42.8 23.1 50.5 29.1 17.5 14.7 42.5 44.5 11.7 49.1 42.7 26.0 25.6 41.5 33.2 18.3 9.2 58.9 22.8 28.0 35.9 25.3 31.4 28.1 40.5 1.1 34.9 40.2 12.0 21.6 12.7 23.7 44.2 21.0 22.6 32.9 9.6 22.7 26.6 2.7 23.0 35.5 5.0 19.5 42.6 50.1 28.1 43.7 25.3 9.5 29.9 36.0 16.2 30.7 38.6 59.4 12.5 25.1 23.7 15.2 24.5 22.5 24.7 23.6 14.0 19.3 26.9 25.5 17.9 35.7 16.2 18.7 28.5 17.9 21.2 24.6 36.7 30.3 22.5 19.6 25.6 26.0 15.1 24.9 16.2 21.5 36.4 57.9 19.2 31.4 30.7 32.9 30.5 27.0 31.5 19.4 58.9 14.0 18.5 37.2 18.6 28.9 31.3 100.1 16.6 55.1 10.7 27.4 34.6 493.8 57.6 37.0 53.6 19.8 16.4 67.0 17.5 20.5 44.9 13.7 26.4 40.4 36.4 38.6 32.1 25.2 32.0 67.0 9.0 24.4 27.4 38.4 76.8 43.8 32.5 26.6 23.4 37.2 41.6 42.2 54.3 119.7 32.3 12.2 42.9 27.2 14.5 8.8 40.1 71.8 50.6 32.9 45.4 48.4 85.4 57.0 13.0 20.5 8.2 40.7 24.9 10.3 18.7 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75433203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 5.3;testis: 9.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 39.6;Early spermatids: 25.9;Late spermatids: 28.4;Spermatogonia: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 15.8;HMC-1: 10.3;PC-3: 8.9;SiHa: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favorable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 0.5 0.8 3.2 0.0 4.7 0.0 0.9 1.6 3.6 0.7 1.2 0.2 0.0 0.3 0.0 0.4 0.4 0.1 0.6 3.4 4.0 0.3 0.0 0.7 0.0 4.0 2.8 3.6 0.2 1.8 0.0 0.9 0.0 5.3 0.2 0.0 0.6 0.8 0.1 0.4 0.8 0.1 0.1 2.1 1.2 1.1 9.4 3.7 0.1 0.6 0.2 0.0 0.3 0.3 4.7 0.0 0.3 0.1 0.0 0.2 1.3 0.0 0.9 0.0 0.9 0.1 15.8 1.3 0.0 4.3 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.8 4.1 10.3 0.2 0.2 0.0 0.0 0.1 0.4 2.7 0.0 0.0 1.1 0.7 0.3 0.1 0.2 3.2 8.9 0.0 0.0 0.9 0.7 0.2 1.2 1.0 18.4 3.4 0.0 0.0 3.4 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 3.2 4.7 1.6 3.6 3.4 4.0 4.0 2.8 3.6 5.3 2.1 3.7 4.7 0.7 9.6 3.4 0.3 1.1 1.3 1.8 0.5 4.0 39.6 6.4 4.8 1.0 1.5 2.8 3.7 8.4 1.5 0.7 0.6 3.9 1.7 25.9 2.1 3.0 1.1 4.2 0.4 3.9 3.1 1.7 3.0 2.6 4.0 4.5 1.5 2.9 0.1 1.2 1.7 3.5 1.4 0.0 1.2 2.1 28.4 2.8 2.9 1.8 0.0 1.6 2.5 3.1 0.0 4.4 3.7 0.4 1.2 0.1 1.3 0.3 0.4 1.6 11.1 6.6 1.3 1.6 10.2 56.7 0.9 2.3 2.5 1.1 2.2 0.7 1.4 TENM4 "KIAA1302, ODZ4, Ten-M4, TEN4" ENSG00000149256 "Teneurin transmembrane protein 4" Q6N022 11 78652829-79441030 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;ovary: 16.7;parathyroid gland: 14.0" "Cell type enhanced" "Detected in many" "Astrocytes: 134.5;Early spermatids: 96.8;Excitatory neurons: 337.4;Inhibitory neurons: 297.7;Microglial cells: 117.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 9.1;hTERT-RPE1: 9.5;PC-3: 10.8;REH: 10.4;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "HPA019521, HPA065961" Approved NA NA "HPA019521: AB_2670171, HPA065961: AB_2685588" "unprognostic (2.81e-1)" "unprognostic (9.25e-2)" "unprognostic (1.64e-1)" "unprognostic (2.96e-3)" "unprognostic (1.87e-1)" "unprognostic (2.48e-1)" "unprognostic (1.18e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (3.79e-1)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "unprognostic (6.51e-3)" "unprognostic (5.40e-3)" "unprognostic (5.64e-2)" "unprognostic (7.07e-2)" "unprognostic (9.81e-3)" 2.0 1.4 9.0 1.0 12.7 0.0 0.7 1.8 12.7 2.5 0.0 0.4 0.1 1.3 0.2 2.0 2.1 0.4 0.3 9.4 10.4 1.5 0.0 0.4 0.5 11.6 8.3 8.4 16.7 0.3 14.0 7.2 0.1 8.4 0.4 0.3 2.6 0.5 0.2 0.4 3.3 0.3 1.0 13.0 0.3 0.5 1.6 11.5 1.9 5.8 1.0 1.2 0.5 1.5 17.7 0.0 0.0 3.4 0.0 3.7 5.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.7 0.0 2.1 5.0 5.3 0.0 4.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 9.1 2.3 2.5 4.5 9.5 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.0 1.8 0.3 10.8 10.4 0.0 0.0 6.4 1.1 7.1 17.4 0.0 0.0 0.0 6.2 0.0 0.1 0.5 0.1 1.2 0.1 5.9 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 12.7 1.8 12.7 9.4 10.4 11.6 8.3 8.4 8.4 13.0 11.5 17.7 0.1 0.0 0.0 134.5 0.2 0.9 0.8 3.4 17.1 7.5 0.1 0.0 1.9 4.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 96.8 1.1 1.7 0.3 0.0 0.0 337.4 0.0 0.2 2.6 0.0 0.8 1.3 0.8 0.0 0.0 0.1 0.0 297.7 0.0 0.0 0.6 0.4 56.6 5.3 0.7 0.0 117.1 0.4 13.9 0.0 58.3 21.3 0.0 0.0 1.9 0.0 0.4 0.0 0.4 7.0 1.0 0.0 25.1 2.8 4.8 1.0 7.3 2.0 0.1 0.1 0.3 0.0 0.6 SERPINH1 "CBP1, CBP2, colligen, HSP47, SERPINH2" ENSG00000149257 "Serpin family H member 1" P50454 11 75562056-75572783 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 473.6;Endometrial stromal cells: 273.3;Extravillous trophoblasts: 342.1;Fibroblasts: 287.6;Smooth muscle cells: 295.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 1018.3;fHDF/TERT166: 1215.2;HHSteC: 1029.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004441, HPA029198" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA Yes 920000 "Endoplasmic reticulum" "CAB004441: AB_627757, HPA029198: AB_10601712" "unprognostic (3.80e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (5.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.39e-2)" "unprognostic (1.72e-3)" "unprognostic (2.35e-2)" "unprognostic (7.40e-2)" "unprognostic (1.57e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.22e-15)" "unprognostic (2.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 159.9 102.8 87.0 107.5 48.9 3.8 108.0 52.1 238.7 135.6 64.3 87.5 23.4 162.1 27.8 42.0 120.4 72.7 151.1 121.1 65.6 81.5 52.9 201.1 21.3 73.2 48.1 40.9 158.7 40.5 18.3 51.2 253.4 84.9 66.6 37.1 2.0 41.1 53.7 22.4 47.2 51.8 209.1 53.6 54.4 77.6 27.9 87.1 21.8 91.9 33.5 18.3 158.2 86.6 114.4 57.7 192.9 349.5 722.0 528.8 484.2 162.2 514.3 349.6 380.4 483.5 1018.3 294.1 0.4 470.2 1215.2 3.1 337.2 242.2 163.2 182.5 27.5 47.0 42.7 174.0 216.5 1029.5 0.9 7.2 580.9 165.2 365.0 121.3 475.5 530.8 22.1 90.5 16.1 182.5 457.6 1.2 74.8 315.6 215.8 50.7 29.3 200.3 48.8 95.6 107.8 9.1 119.1 326.9 59.7 102.0 539.6 144.4 72.7 284.6 388.6 324.6 270.6 128.3 23.1 25.5 6.1 168.0 0.2 535.6 4.1 1.1 0.1 6.0 1.1 5.2 0.9 3.9 4.0 4.4 0.7 4.0 3.3 0.2 5.9 0.1 3.7 3.5 2.1 87.0 48.9 52.1 238.7 121.1 65.6 73.2 48.1 40.9 84.9 53.6 87.1 114.4 142.3 38.5 32.0 4.9 2.9 81.8 473.6 56.5 74.0 5.3 28.3 39.5 36.6 14.3 21.0 25.8 58.4 217.0 3.2 33.0 0.0 64.5 2.9 21.8 273.3 194.9 61.1 11.4 0.4 11.9 342.1 287.6 15.3 33.0 9.5 144.1 124.9 9.9 94.2 6.7 0.2 55.7 22.4 5.7 110.0 6.0 164.4 43.6 44.4 18.7 9.8 14.3 8.2 1.0 0.5 22.5 24.3 120.7 6.5 139.8 12.4 22.8 11.9 1.2 92.1 31.4 295.1 29.3 23.0 14.1 44.5 165.8 68.8 79.8 62.8 73.4 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066961-77126155 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 61.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: AB_2686512" "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 5.7 12.3 7.5 11.0 7.6 2.7 4.9 6.2 8.7 12.6 3.4 61.0 61.3 10.1 5.7 31.8 10.9 36.6 5.5 8.2 11.1 15.0 52.5 4.8 1.9 10.5 7.9 7.3 13.3 5.6 1.0 5.1 2.8 12.4 16.1 50.4 3.8 7.7 9.0 1.6 2.8 52.8 11.4 8.9 3.6 48.3 21.6 8.3 2.8 4.8 1.7 2.8 15.5 10.6 9.9 0.8 12.5 8.6 7.8 32.0 30.4 0.7 11.8 22.9 13.4 10.0 6.9 3.6 0.4 7.7 24.5 14.4 0.5 3.8 1.0 6.4 0.5 0.8 2.1 0.5 0.9 7.9 0.2 0.4 16.1 1.4 22.6 5.2 18.8 14.4 5.1 0.2 0.0 26.9 19.9 1.8 0.3 6.6 106.6 9.3 2.0 27.0 0.4 4.6 16.4 0.5 13.5 1.0 2.7 5.9 5.7 1.7 0.1 23.9 25.4 12.3 34.8 1.3 0.8 1.7 0.1 13.1 0.3 5.7 0.0 0.2 0.0 1.3 0.3 0.1 0.0 0.1 0.5 0.2 0.0 0.6 0.8 0.0 0.0 0.0 0.1 0.0 0.7 7.5 7.6 6.2 8.7 8.2 11.1 10.5 7.9 7.3 12.4 8.9 8.3 9.9 1.6 0.0 0.5 4.2 1.0 1.7 0.3 2.2 0.0 3.1 0.5 1.8 1.7 24.3 10.3 23.9 0.0 0.1 3.4 170.3 1.9 10.3 1.1 1.9 5.9 2.4 22.3 5.7 4.6 32.7 0.4 7.6 80.0 3.5 0.0 10.2 2.9 40.4 0.9 1.7 6.7 89.8 10.2 1.6 1.8 1.3 12.5 1.2 7.2 1.0 0.3 5.8 5.2 11.6 0.7 22.4 72.6 4.5 0.9 2.0 75.6 9.9 11.1 2.1 0.0 8.3 4.1 0.5 2.3 2.5 0.9 0.0 1.5 5.3 69.2 2.4 INTS4 "INT4, MGC16733, MST093" ENSG00000149262 "Integrator complex subunit 4" Q96HW7 11 77878720-77994671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042378 Uncertain Supported "Nucleoli rim" NA NA "Nucleoli rim" "HPA042378: AB_10797388" "unprognostic (2.72e-1)" "unprognostic (1.93e-1)" "unprognostic (4.07e-2)" "unprognostic (9.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (2.04e-2)" "unprognostic (1.17e-2)" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (4.20e-2)" "unprognostic (5.44e-2)" "unprognostic (4.20e-1)" "prognostic favorable (9.66e-4)" "unprognostic (9.39e-2)" 12.7 16.9 13.6 13.0 14.9 18.7 13.5 18.6 14.4 16.6 13.0 13.2 9.6 13.0 12.0 13.8 13.8 9.3 11.9 12.9 14.0 13.4 18.2 12.8 16.9 15.0 14.8 12.5 17.1 17.9 11.6 13.2 11.5 15.5 15.9 12.0 14.6 13.3 9.6 11.5 14.1 15.7 10.9 14.8 21.2 14.0 10.0 14.8 18.0 13.9 7.9 17.0 14.5 15.0 21.4 11.1 18.2 23.2 27.3 18.7 16.8 19.1 13.0 14.5 16.6 14.6 37.8 30.0 19.2 27.0 23.3 25.5 27.2 25.6 25.8 26.5 28.0 16.2 29.8 24.2 22.2 17.1 30.5 17.2 17.1 13.9 33.9 29.4 18.1 26.6 20.6 28.9 28.3 25.6 23.2 28.5 49.7 22.1 40.4 19.8 27.2 21.5 36.5 20.8 22.0 16.6 24.0 23.1 15.2 9.9 26.8 28.2 16.3 17.7 22.7 30.4 60.0 16.9 30.7 32.2 40.7 8.1 20.5 22.7 12.6 14.0 7.7 12.3 15.3 17.7 12.2 12.8 14.5 15.1 13.1 17.1 13.3 3.5 17.0 14.0 6.0 17.2 11.3 13.6 14.9 18.6 14.4 12.9 14.0 15.0 14.8 12.5 15.5 14.8 14.8 21.4 5.6 9.6 3.1 18.3 15.1 4.8 7.1 8.2 8.6 13.4 5.4 6.3 5.6 10.0 6.0 5.5 16.7 13.4 18.7 5.5 5.9 7.5 5.0 6.8 5.4 7.0 1.8 9.1 20.0 4.0 11.5 7.3 8.2 5.5 12.7 12.8 5.0 3.1 10.2 5.0 19.4 6.4 6.1 8.1 4.5 4.2 6.5 7.9 7.2 20.6 14.8 7.8 13.4 26.2 30.8 6.0 7.8 4.9 7.3 4.4 11.0 6.6 8.6 16.9 6.6 10.0 11.1 12.1 17.7 7.1 2.4 11.5 13.5 8.1 6.4 5.3 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77322017-77474635 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 9 "classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6" "Group enriched" "Detected in all" 11 "dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 560000 "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 12.8 13.5 21.2 34.2 49.1 59.5 18.4 18.3 58.6 21.3 0.6 43.6 43.5 21.1 30.1 21.6 22.1 31.2 8.0 54.6 30.8 26.3 14.7 16.9 20.6 23.2 18.6 49.8 21.2 17.7 20.6 20.9 14.8 32.0 19.3 46.9 25.3 20.1 19.9 87.8 16.3 46.1 27.2 1.4 29.6 41.5 25.9 25.1 29.3 41.0 19.0 23.2 28.0 20.8 50.4 39.9 26.7 56.7 25.5 22.8 37.6 45.9 44.6 32.1 42.0 48.7 38.7 52.8 36.3 16.0 39.4 54.4 20.2 40.2 47.8 65.5 41.4 32.6 38.2 17.6 2.3 15.3 64.3 53.5 28.2 28.8 49.2 73.1 36.6 10.1 41.3 25.5 61.2 77.6 2.9 42.3 30.2 84.5 166.2 22.5 62.6 72.3 1.4 10.6 32.9 24.6 23.9 23.6 9.7 19.5 55.0 45.4 29.0 0.9 27.3 47.5 148.9 37.9 165.7 92.4 23.4 23.0 42.5 30.6 2.5 182.2 292.7 11.2 177.7 9.4 16.8 8.4 10.7 264.3 12.9 7.4 14.5 431.8 28.4 202.6 22.9 7.3 92.3 21.2 49.1 18.3 58.6 54.6 30.8 23.2 18.6 49.8 32.0 1.4 25.1 50.4 3.1 3.2 20.5 24.2 23.9 11.9 33.3 28.2 23.9 51.6 25.1 19.7 6.2 35.8 30.8 25.8 8.4 25.4 10.2 78.6 45.0 32.4 38.8 37.3 13.5 3.2 37.8 30.5 219.1 56.3 53.5 24.0 45.9 39.7 132.2 35.2 3.6 11.4 49.8 1.7 118.5 50.8 28.5 59.6 152.9 28.3 14.3 80.0 30.2 54.4 121.7 14.9 10.3 53.3 70.7 50.9 57.9 13.2 28.6 28.7 47.9 55.7 39.0 6.4 13.1 13.8 25.2 50.4 53.8 23.6 10.4 95.0 19.3 10.3 52.8 33.2 RPS3 "FLJ26283, FLJ27450, MGC87870, S3" ENSG00000149273 "Ribosomal protein S3" P23396 11 75399515-75422280 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063339 Uncertain Supported "Endoplasmic reticulum,Cytosol" NA NA 560000 "Endoplasmic reticulum, Cytosol" "HPA063339: AB_2684990" "unprognostic (3.62e-2)" "unprognostic (6.94e-3)" "unprognostic (2.64e-1)" "unprognostic (1.44e-2)" "unprognostic (5.55e-2)" "unprognostic (1.08e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-2)" "unprognostic (3.27e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (6.92e-6)" "unprognostic (3.22e-1)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (2.19e-1)" 1062.1 753.9 446.7 964.7 457.6 2097.6 1969.4 443.1 580.3 1448.2 455.6 1232.0 954.6 1069.8 714.9 1683.2 1281.5 561.5 708.7 432.3 459.0 673.1 636.9 853.3 1677.1 458.9 446.0 426.0 2938.5 1776.6 359.4 665.6 766.9 456.9 937.1 928.1 355.7 1058.5 668.3 1136.2 1740.2 1137.6 746.0 462.4 1357.2 1091.1 289.9 461.9 1416.4 723.0 755.6 1371.7 1063.8 1396.1 463.2 1899.8 1145.7 1595.6 1767.5 1970.0 3482.1 2060.8 1763.7 2256.3 2289.4 1481.2 3331.6 2196.8 6547.1 2108.6 1598.8 1261.5 2672.3 2085.6 3290.7 2093.8 1749.1 1618.9 2688.6 1042.6 1490.2 2931.1 4398.6 1690.0 4124.1 4397.7 1568.8 4323.1 2684.0 3055.0 2876.5 2736.9 1809.7 2089.7 2071.2 2660.9 2112.4 2007.4 6591.3 1342.5 2482.3 5580.2 4834.0 2275.9 1551.8 1366.7 1933.6 1299.3 3050.2 1897.1 1535.9 3123.3 3289.9 2470.7 1099.6 1822.9 1515.3 1627.3 1647.2 2198.0 7283.3 660.4 2409.4 1138.1 430.3 770.8 245.5 1405.7 515.5 1924.9 1602.2 1823.1 1489.0 1099.3 1454.0 2102.1 1633.9 174.3 1142.6 512.4 960.4 1283.7 4244.2 446.7 457.6 443.1 580.3 432.3 459.0 458.9 446.0 426.0 456.9 462.4 461.9 463.2 1993.9 932.7 1604.3 18.6 4790.5 6297.7 7369.7 5554.5 4497.7 423.9 6945.0 9521.7 418.9 2088.9 2555.7 726.4 133.5 6188.6 4009.1 1694.4 2183.4 2376.0 430.9 939.2 3054.9 2780.8 2067.1 3428.9 28.3 5373.2 9079.0 2364.6 1651.9 1363.9 1641.6 4246.7 2916.7 1369.0 3662.5 132.9 32.6 4425.4 1621.5 3089.2 4666.7 968.5 3755.0 2393.1 2835.3 38.4 3626.4 957.1 4120.5 19.6 47.5 3805.0 3535.7 1803.2 2848.0 5827.8 2969.4 2226.4 797.6 505.5 1117.5 3204.8 3221.9 449.3 618.6 5734.6 7842.8 5867.5 4904.4 4865.2 5657.1 7206.9 ZC3H12C "KIAA1726, MCPIP3" ENSG00000149289 "Zinc finger CCCH-type containing 12C" Q9C0D7 11 110093392-110171841 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 5.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 5.9" "Cell line enhanced" "Detected in many" "HSkMC: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038836, HPA038837" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane, Golgi apparatus" "HPA038836: AB_2676229, HPA038837: AB_10675953" "unprognostic (1.22e-1)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (6.96e-3)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "unprognostic (8.91e-3)" "unprognostic (1.30e-2)" "unprognostic (3.20e-1)" "unprognostic (2.34e-2)" "unprognostic (8.90e-2)" "prognostic favorable (9.90e-6)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (8.03e-2)" "unprognostic (1.11e-1)" 4.6 4.2 4.5 2.4 6.9 3.3 2.5 6.4 3.9 4.1 3.0 4.7 1.7 3.7 1.7 3.2 3.3 4.7 4.4 3.8 5.1 3.5 4.1 4.0 1.5 6.7 4.7 2.1 6.8 3.5 4.8 3.2 2.7 5.1 3.5 3.8 4.2 2.4 3.3 10.6 5.9 2.7 4.5 3.9 1.8 2.5 3.4 4.6 1.5 8.2 13.3 1.4 5.4 2.1 6.5 6.1 3.6 14.0 0.0 6.4 14.8 2.7 2.3 15.7 4.1 6.8 4.6 5.6 0.1 8.7 7.1 10.3 5.8 2.8 8.5 8.1 23.2 2.0 9.7 4.5 1.7 7.2 0.0 4.4 23.8 8.0 7.2 11.7 8.1 5.8 0.0 0.9 1.3 8.6 0.9 0.0 0.0 2.2 0.1 12.7 0.0 4.9 0.6 4.6 12.4 6.4 11.5 5.6 0.4 10.5 2.7 3.5 3.6 9.8 9.1 4.4 4.8 5.2 0.5 0.0 0.0 5.5 1.7 10.8 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 6.9 6.4 3.9 3.8 5.1 6.7 4.7 2.1 5.1 3.9 4.6 6.5 21.1 35.3 8.6 102.2 1.1 47.4 4.8 19.1 7.4 8.8 3.5 5.0 15.5 2.8 9.1 5.5 4.2 1.5 0.2 17.0 0.0 6.1 10.6 8.6 6.7 14.9 8.9 2.1 23.8 3.5 0.5 8.9 5.6 14.1 0.0 5.2 13.6 6.4 10.9 15.2 50.0 8.1 0.0 5.7 39.3 11.8 9.6 9.9 23.2 26.2 3.9 5.6 0.0 52.3 56.1 3.4 15.2 8.2 0.6 21.0 5.7 6.6 8.9 2.7 0.0 9.1 5.7 4.6 0.8 3.2 66.5 0.8 1.1 5.6 8.0 7.8 TTC12 "FLJ13859, FLJ20535, TPARM" ENSG00000149292 "Tetratricopeptide repeat domain 12" Q9H892 11 113314579-113383544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.4" "Group enriched" "Detected in many" 4 "Early spermatids: 158.8;Late spermatids: 210.5;Respiratory ciliated cells: 62.0;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 26.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038542, HPA038543, HPA061364" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "prognostic favorable (3.14e-4)" "prognostic favorable (2.48e-5)" "unprognostic (2.11e-2)" "unprognostic (3.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.33e-3)" "unprognostic (7.67e-2)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (5.46e-2)" "prognostic favorable (5.95e-5)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.26e-1)" "unprognostic (1.35e-2)" 4.2 8.3 6.0 3.8 3.8 2.0 11.1 4.1 4.7 6.8 12.9 5.4 3.9 6.8 12.2 4.4 17.9 5.3 7.6 2.8 5.1 9.4 5.8 5.8 6.5 6.0 5.8 2.1 8.8 5.5 24.6 12.7 4.6 5.2 10.4 6.7 11.4 7.8 11.7 4.1 5.8 4.9 4.2 5.3 4.9 5.4 52.4 4.8 4.6 16.4 6.7 7.8 5.8 4.8 5.4 5.6 3.7 8.3 9.0 6.0 7.3 4.9 5.0 9.4 6.5 6.3 4.2 15.8 3.0 7.3 0.2 5.3 12.0 0.0 24.2 9.8 3.4 4.0 1.2 11.8 6.5 12.0 0.0 2.0 8.1 9.7 0.0 14.3 12.8 4.7 0.0 5.1 2.0 12.0 7.3 0.0 1.1 5.3 19.4 6.3 0.0 1.3 5.4 12.1 4.2 7.2 10.0 26.4 9.3 5.3 11.3 16.9 3.4 1.7 1.2 5.9 5.2 9.0 1.7 3.0 0.1 5.6 0.5 0.0 0.0 1.0 1.5 1.7 1.0 2.6 2.3 2.2 1.8 2.0 3.3 2.5 2.5 1.5 1.4 0.9 1.6 0.9 1.2 6.0 3.8 4.1 4.7 2.8 5.1 6.0 5.8 2.1 5.2 5.3 4.8 5.4 2.3 0.0 5.4 31.6 6.6 1.3 4.9 9.0 5.2 7.5 4.0 4.1 7.5 7.2 14.4 5.5 2.1 6.8 4.2 3.0 5.9 6.3 158.8 24.6 3.7 2.4 4.8 1.7 10.9 4.9 2.0 3.8 2.0 4.8 2.5 5.2 0.4 2.7 2.6 1.7 3.1 3.3 4.1 1.0 1.3 210.5 3.4 1.7 1.8 9.4 1.6 6.0 5.2 7.1 11.7 3.8 3.5 3.8 4.9 2.5 3.9 8.9 62.0 9.1 6.6 3.6 4.3 84.7 7.5 3.6 1.7 2.7 3.8 4.9 4.6 2.6 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 291.9;heart muscle: 135.3" "Cell type enhanced" "Detected in many" "Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "NK-cell: 53.7" "Lineage enriched" "Detected in many" 15 "NK-cells: 53.7" "Cell line enhanced" "Detected in many" "HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 1200000 2300000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 4.6 66.4 107.3 4.0 159.6 1.5 2.8 109.4 159.9 34.8 0.0 35.8 4.7 63.3 3.6 7.0 40.8 4.9 135.3 136.1 144.6 2.0 3.0 1.9 1.3 154.5 135.0 123.1 44.2 2.6 0.0 22.4 0.5 147.5 15.0 6.6 118.8 3.6 17.9 31.5 1.8 18.4 47.3 102.0 4.7 23.2 5.0 137.8 0.4 30.4 29.8 1.1 35.1 24.5 291.9 0.1 0.0 20.8 0.3 0.2 0.5 0.3 1.0 0.0 0.7 1.2 0.3 0.3 3.1 18.2 20.1 0.8 0.3 0.1 0.0 0.0 0.4 12.1 61.3 0.1 0.0 2.1 0.0 9.5 12.4 0.1 0.1 18.6 0.1 0.0 0.1 0.0 1.0 20.8 0.0 0.2 5.2 1.8 0.0 0.4 0.1 132.5 10.0 0.0 0.0 107.4 52.7 0.1 0.5 0.1 2.0 0.2 0.8 0.2 72.8 33.4 0.3 31.8 0.1 0.5 0.1 8.3 28.4 79.0 0.0 0.2 0.0 3.6 0.0 1.2 0.0 0.1 0.5 0.1 0.0 0.0 1.4 0.7 53.7 0.0 0.0 0.2 1.9 107.3 159.6 109.4 159.9 136.1 144.6 154.5 135.0 123.1 147.5 102.0 137.8 291.9 13.7 0.0 0.0 530.8 0.4 1.7 0.5 0.0 0.0 123.5 5.7 0.6 131.7 0.0 0.0 0.0 37.5 0.6 27.7 0.1 1.9 18.3 6.7 0.3 2.4 2.8 5.4 0.0 461.4 0.0 0.2 12.8 5.1 0.5 1.3 11.7 7.1 0.7 0.4 175.0 441.2 0.0 8.2 4.7 3.8 5.9 15.2 1.8 0.0 35.6 1.2 216.6 59.8 939.0 1013.5 1.3 0.0 10.1 5.6 0.4 0.0 0.2 0.7 98.0 0.0 107.5 4.8 1.0 2.8 0.4 1.7 0.1 13.4 5.6 0.0 0.2 DRD2 ENSG00000149295 "Dopamine receptor D2" P14416 11 113409605-113475691 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 64.1;pituitary gland: 60.0" "Cell type enriched" "Detected in some" 12 "Horizontal cells: 60.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 64.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 88.3" "Region enriched" "Detected in many" 10 "basal ganglia: 205.3" "Region enriched" "Detected in many" 4 "basal ganglia: 146.3" "HPA015139, HPA015691" Supported Supported NA NA "HPA015139: , HPA015691: AB_1847834" "unprognostic (8.49e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-4)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.40e-2)" "unprognostic (8.33e-4)" "unprognostic (1.10e-1)" "unprognostic (6.65e-3)" "unprognostic (2.29e-1)" "unprognostic (1.71e-1)" "unprognostic (4.82e-2)" "unprognostic (8.49e-3)" 0.2 8.5 5.1 0.1 64.1 0.0 1.3 0.1 15.0 1.0 0.0 0.3 0.0 1.1 0.1 0.5 1.3 0.2 0.1 1.5 7.1 1.2 0.0 0.2 0.0 15.0 36.5 3.8 0.2 0.2 0.0 60.0 0.0 16.5 0.9 0.3 11.8 12.0 0.7 0.8 0.8 0.2 1.5 0.5 0.0 0.1 1.0 14.1 0.0 0.0 0.3 0.0 0.2 0.6 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.6 0.2 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.1 4.9 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 1.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.1 0.4 0.0 0.0 1.0 0.1 0.0 0.0 9.6 0.0 0.0 0.1 88.3 10.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 64.1 0.1 15.0 1.5 7.1 15.0 36.5 3.8 16.5 0.5 14.1 7.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.7 0.1 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 60.6 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf52 "FLJ25219, MGC14839" ENSG00000149300 "Chromosome 11 open reading frame 52" Q96A22 11 111918032-111926871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.8;Breast glandular cells: 3.3;Cholangiocytes: 2.8;Endometrial ciliated cells: 3.1;Gastric mucus-secreting cells: 4.1;Respiratory ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;CAPAN-2: 23.5;Hep G2: 18.2;MCF7: 17.6;RPTEC TERT1: 27.1;SK-BR-3: 22.9;T-47d: 76.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038387, HPA038388" Uncertain Enhanced "Cell Junctions" NA NA "Cell Junctions" "HPA038387: AB_10670167, HPA038388: AB_2675987" "unprognostic (1.30e-2)" "unprognostic (1.13e-1)" "unprognostic (5.84e-4)" "unprognostic (1.48e-4)" "unprognostic (2.57e-1)" "unprognostic (8.04e-2)" "unprognostic (6.77e-2)" "unprognostic (2.07e-2)" "unprognostic (2.26e-1)" "unprognostic (2.77e-1)" "unprognostic (3.80e-1)" "unprognostic (5.38e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" 3.0 0.7 1.1 0.4 1.1 0.0 26.2 4.4 1.5 3.8 2.1 5.2 10.5 2.4 23.9 6.5 17.9 12.4 3.1 1.1 1.4 44.3 23.0 9.8 0.1 1.2 1.3 0.9 1.5 26.0 31.1 16.5 10.2 1.8 15.5 6.3 0.1 27.0 10.3 9.4 9.5 9.2 0.8 1.2 0.9 21.1 1.0 1.2 1.0 20.3 8.4 1.3 4.6 3.3 1.6 4.3 0.0 0.0 0.0 2.9 0.4 17.7 1.0 0.8 0.1 0.0 6.8 23.5 0.0 10.6 2.3 0.0 5.4 0.0 1.4 0.1 0.0 0.7 0.0 0.5 18.2 0.0 0.0 0.0 0.3 5.2 0.0 0.2 0.2 1.0 0.0 0.0 0.0 1.5 17.6 0.0 0.2 0.1 12.5 1.8 0.0 1.5 0.0 27.1 15.6 1.2 0.0 0.0 22.9 0.0 2.4 76.5 1.6 2.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 4.4 1.5 1.1 1.4 1.2 1.3 0.9 1.8 1.2 1.2 1.6 0.0 6.4 2.8 0.0 0.0 0.1 1.6 0.2 1.2 0.0 3.3 0.9 0.6 2.8 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.3 0.0 3.1 0.2 0.2 0.0 0.0 0.0 1.0 0.3 0.5 4.1 1.9 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 1.9 1.3 6.7 0.0 0.0 0.3 0.3 0.1 0.1 0.6 0.3 1.4 0.0 0.2 0.2 0.7 HTR3B 5-HT3B ENSG00000149305 "5-hydroxytryptamine receptor 3B" O95264 11 113904677-113949078 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.4;Oligodendrocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039559 Approved NA NA "HPA039559: AB_10672779" "unprognostic (1.60e-2)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.28e-1)" "unprognostic (1.71e-1)" "unprognostic (2.46e-1)" 0.0 0.1 0.8 0.2 0.6 0.5 0.0 0.0 2.3 0.0 0.0 0.1 0.1 0.1 0.2 0.5 0.0 0.1 0.0 1.3 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.9 0.4 0.1 0.3 0.2 0.1 0.8 0.6 0.0 2.3 1.3 1.0 0.0 0.0 0.7 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222638 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045908: AB_2679493, HPA066370: AB_2685665" "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 4.2 4.2 1.8 8.2 2.6 4.6 7.0 7.5 3.3 6.5 3.5 5.5 4.2 6.8 5.9 4.7 4.6 4.7 4.3 1.7 2.4 5.6 5.7 5.5 15.0 3.0 3.0 1.1 7.7 3.1 6.8 3.2 6.6 3.4 5.6 6.3 6.6 4.4 4.5 3.1 5.2 4.9 5.1 1.7 10.0 5.9 7.1 2.1 12.1 8.4 5.3 13.4 7.0 3.9 3.2 7.9 6.3 9.7 12.1 11.7 8.5 7.9 11.6 14.6 10.0 14.9 13.0 16.8 13.5 15.2 7.3 11.2 14.6 13.4 11.7 17.8 12.2 5.3 22.5 6.8 6.7 5.0 17.0 14.3 8.1 6.7 17.6 11.2 7.8 14.3 15.5 21.2 6.5 14.1 3.9 21.0 9.1 8.0 12.6 8.7 14.3 13.6 18.5 6.4 11.3 10.3 9.5 14.9 8.8 11.3 10.1 10.0 8.3 11.8 17.3 9.3 10.3 10.5 4.5 6.1 51.9 4.3 12.4 13.7 6.8 1.6 2.9 4.9 2.6 5.5 4.1 5.7 6.3 1.8 4.3 8.9 7.5 1.9 5.3 2.9 1.5 4.6 3.2 1.8 2.6 7.5 3.3 1.7 2.4 3.0 3.0 1.1 3.4 1.7 2.1 3.2 23.1 19.2 13.2 24.2 40.8 16.3 16.4 10.5 27.3 16.5 12.0 7.6 15.2 4.3 13.2 12.9 29.2 10.3 32.8 5.6 1.9 8.4 4.9 11.1 15.0 21.1 10.3 29.5 25.5 6.8 8.2 15.9 12.2 14.2 19.6 16.7 22.9 9.1 7.4 10.1 32.2 7.9 8.2 13.0 12.8 3.2 15.8 13.8 8.8 19.7 14.5 11.8 27.8 19.6 24.3 6.8 6.5 17.0 37.8 14.1 7.1 5.6 10.9 16.9 6.6 19.8 13.1 26.2 32.5 14.0 13.2 14.1 35.3 14.9 8.7 15.9 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222832-108369102 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB000102: , HPA067142: AB_2685789" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 6.1 7.5 8.4 17.6 14.5 16.3 8.6 17.1 12.4 8.7 17.9 6.3 5.2 10.1 10.0 4.0 7.6 8.2 6.3 6.9 13.6 5.8 7.8 7.6 34.0 14.8 12.5 6.0 15.9 14.9 9.4 12.2 8.1 16.1 6.4 7.1 20.8 11.5 6.1 4.4 7.5 12.7 6.9 11.4 22.4 8.7 5.2 12.0 18.4 8.8 6.0 26.1 7.2 7.0 29.1 4.3 6.8 14.8 7.6 20.2 29.1 3.1 10.9 13.5 6.4 11.3 7.1 10.3 18.3 14.0 10.2 9.6 7.7 11.6 10.8 9.0 12.3 5.7 15.2 8.7 10.2 10.5 16.4 17.0 18.3 6.3 10.0 21.2 15.2 14.1 16.5 12.4 9.9 14.3 3.4 10.6 18.5 9.8 8.6 7.4 9.7 9.7 24.9 8.1 7.5 9.0 10.5 11.1 4.7 20.6 13.2 9.3 10.1 23.7 15.8 8.4 7.3 9.0 6.2 7.0 78.3 7.0 19.0 18.8 21.3 5.5 4.0 16.5 5.7 11.1 11.6 11.7 12.5 2.6 13.0 21.1 20.4 9.9 9.7 13.3 6.2 6.1 5.3 8.4 14.5 17.1 12.4 6.9 13.6 14.8 12.5 6.0 16.1 11.4 12.0 29.1 23.7 38.5 20.8 62.7 146.4 12.6 17.5 21.1 28.5 111.0 19.6 14.2 39.9 12.8 19.5 22.0 210.6 16.9 140.2 4.2 5.9 9.9 19.2 14.4 52.1 25.9 20.4 39.1 70.2 12.3 13.2 39.0 12.8 20.9 13.3 45.9 32.9 23.3 29.1 60.6 82.8 14.9 26.4 96.4 34.0 5.1 39.4 69.2 26.6 178.9 63.2 27.3 339.8 85.5 217.6 7.6 7.6 27.8 96.5 9.1 8.9 11.1 16.0 200.1 26.3 41.4 29.2 31.5 37.4 15.8 12.4 4.2 147.7 52.3 11.5 10.2 AASDHPPT "AASD-PPT, ACPS, CGI-80, LYS5" ENSG00000149313 "Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase" Q9NRN7 11 106075501-106098699 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026687 Approved NA NA "HPA026687: AB_1844414" "unprognostic (1.96e-2)" "unprognostic (4.40e-1)" "unprognostic (8.71e-3)" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (9.04e-3)" "unprognostic (2.82e-3)" "unprognostic (1.41e-1)" "unprognostic (2.44e-2)" "unprognostic (7.92e-2)" "unprognostic (2.09e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.27e-4)" "unprognostic (2.13e-1)" "unprognostic (2.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-1)" 17.1 23.7 33.0 18.5 37.4 15.9 21.4 34.7 44.5 17.7 27.2 13.7 13.7 20.5 26.0 21.3 20.8 13.5 28.0 37.3 39.8 34.4 33.9 15.6 22.8 35.1 34.7 37.1 21.1 33.5 20.2 11.5 28.1 34.0 19.1 14.2 32.6 24.7 17.2 33.1 17.2 12.0 18.5 33.5 17.4 13.7 37.8 34.4 21.5 22.3 32.7 24.1 18.6 11.7 41.8 29.6 28.2 84.7 63.5 41.4 54.6 34.3 43.1 36.7 58.7 45.0 61.2 53.3 91.4 98.2 28.2 57.2 37.8 77.0 57.6 59.0 55.8 39.3 84.6 19.5 45.0 64.3 73.5 35.2 53.8 72.8 47.0 63.8 40.5 49.6 39.8 95.2 22.2 57.6 16.7 79.8 63.6 36.9 40.2 39.4 55.7 81.3 103.7 70.4 32.5 63.0 58.3 47.5 45.8 43.6 49.1 60.2 50.0 41.9 49.7 47.6 35.3 45.6 30.7 53.7 90.0 22.4 100.0 57.9 63.2 21.6 23.9 20.6 27.9 29.2 26.7 23.9 22.7 21.8 20.8 27.4 26.4 6.9 31.9 28.1 19.2 30.6 18.2 33.0 37.4 34.7 44.5 37.3 39.8 35.1 34.7 37.1 34.0 33.5 34.4 41.8 32.4 32.1 31.7 18.3 33.8 20.0 28.2 39.4 56.3 35.0 23.4 31.9 24.1 34.3 29.8 18.4 2.1 78.4 27.7 7.3 39.2 33.5 388.5 31.6 42.2 23.9 18.6 47.9 36.0 24.3 63.8 33.9 23.4 29.4 29.8 41.9 17.2 36.5 39.0 21.9 34.8 12.6 30.5 24.9 13.0 70.2 32.3 27.9 32.0 15.0 29.9 67.4 19.6 32.6 43.4 22.6 10.2 26.7 45.1 23.5 11.1 81.4 47.6 20.0 13.1 30.8 38.2 47.8 37.5 46.2 24.4 39.4 33.1 62.9 13.5 19.6 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 162.0" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 182.0" "Cancer enhanced" "Detected in many" "prostate cancer: 21.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.2;NK-cell: 3.1" "Group enriched" "Detected in many" 24 "NK-cells: 3.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 1.4 2.1 3.4 2.6 2.2 0.3 7.1 0.2 8.5 5.3 12.2 21.8 5.8 34.2 2.2 3.6 25.9 2.8 0.9 9.3 0.6 20.8 0.6 3.6 0.6 1.4 1.2 2.1 13.9 10.7 25.2 14.2 1.5 1.6 34.8 11.8 162.0 9.2 25.4 1.0 9.5 4.0 4.4 0.1 0.6 9.1 8.4 1.0 0.6 22.9 0.2 0.6 6.8 5.1 1.5 16.0 1.6 8.2 4.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 13.3 49.9 0.0 16.3 0.0 6.8 52.6 25.2 0.4 0.0 0.0 23.9 0.0 6.7 0.6 2.2 0.0 28.4 0.3 0.7 0.0 0.0 0.0 0.1 7.6 26.3 0.0 0.0 15.3 4.4 3.0 4.7 123.6 18.2 0.0 0.0 1.5 14.1 11.0 34.9 13.1 11.4 14.2 0.0 1.2 18.4 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 1.2 0.0 0.6 1.2 0.0 0.1 0.9 1.4 0.0 3.1 0.0 0.0 0.0 0.5 3.4 2.2 0.2 8.5 9.3 0.6 1.4 1.2 2.1 1.6 0.1 1.0 1.5 0.2 0.0 1.8 0.3 0.4 2.2 5.2 1.0 1.8 6.2 7.2 7.9 1.6 1.5 2.5 0.0 41.7 0.2 3.4 19.5 0.0 2.5 2.1 7.9 22.1 1.2 9.0 0.0 1.6 2.4 1.0 3.6 4.1 2.2 0.0 41.9 0.0 0.2 0.2 5.0 1.2 5.9 0.0 0.0 0.3 6.8 1.2 0.3 5.4 1.0 0.0 10.8 1.0 1.0 0.3 2.2 6.3 0.7 2.2 8.1 3.0 8.4 10.1 182.0 0.0 3.7 2.3 2.6 4.6 1.9 0.9 0.1 2.5 3.4 11.5 2.7 SLX4IP "C20orf94, dJ1099D15.3" ENSG00000149346 "SLX4 interacting protein" Q5VYV7 20 10435305-10636829 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 57.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046372 Approved Approved Cytosol NA NA Cytosol "HPA046372: AB_2679641" "unprognostic (4.96e-2)" "unprognostic (2.91e-1)" "unprognostic (2.34e-1)" "unprognostic (2.66e-1)" "unprognostic (1.05e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-3)" "unprognostic (1.58e-2)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (4.56e-3)" "unprognostic (3.91e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (6.52e-2)" "unprognostic (3.42e-1)" "unprognostic (1.30e-2)" "unprognostic (1.55e-2)" 1.5 2.0 3.3 1.7 3.9 1.7 2.1 3.4 3.3 1.8 3.4 2.1 1.9 1.2 4.8 2.7 2.2 1.9 1.3 2.9 3.8 2.3 3.2 1.5 2.2 3.8 3.8 2.8 1.6 2.9 3.3 4.7 1.6 3.8 2.4 2.3 5.4 1.9 1.3 4.2 3.7 2.1 1.0 3.4 2.5 2.3 2.4 3.8 2.6 2.7 0.8 2.5 1.7 2.3 5.2 3.3 6.1 3.0 8.2 1.7 2.3 2.5 1.6 1.8 2.5 2.7 4.6 4.1 5.2 2.6 1.9 3.5 6.4 4.6 4.8 4.0 0.0 1.7 4.7 2.1 6.2 2.9 5.1 2.7 3.2 4.1 3.2 6.2 3.3 2.5 4.5 3.9 4.3 3.1 2.8 7.7 7.5 5.5 4.0 2.0 5.5 8.0 4.7 3.7 3.2 5.4 4.1 4.7 7.3 4.9 4.2 8.0 2.6 3.7 2.0 4.2 2.5 1.9 4.5 11.1 6.3 1.5 4.8 3.6 0.3 1.0 0.4 0.7 1.3 1.2 1.1 1.1 0.9 1.2 1.2 1.0 0.9 0.8 1.3 1.7 2.0 1.5 0.5 3.3 3.9 3.4 3.3 2.9 3.8 3.8 3.8 2.8 3.8 3.4 3.8 5.2 3.2 6.4 6.4 57.1 6.9 0.6 5.6 5.1 3.4 11.8 6.9 5.0 3.6 8.6 7.6 1.8 16.7 11.3 2.9 7.2 11.7 9.8 2.1 10.5 7.3 5.9 10.2 7.4 33.6 3.9 8.3 4.8 8.2 7.4 8.2 12.3 18.9 6.4 8.1 10.1 40.7 8.1 4.1 6.5 2.3 4.2 5.0 4.7 5.4 53.4 11.0 10.0 11.3 55.3 111.8 3.9 8.4 4.5 5.9 3.7 6.8 10.8 3.3 19.6 0.0 6.3 6.6 8.0 10.6 8.4 1.6 6.6 5.1 8.6 8.1 4.8 LAMTOR1 "C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1" ENSG00000149357 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1" Q6IAA8 11 72085895-72103297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002997 Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA 160000 "Golgi apparatus" "Vesicles, Plasma membrane" "HPA002997: AB_1845531" "unprognostic (7.32e-2)" "unprognostic (1.79e-1)" "unprognostic (3.94e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-1)" "unprognostic (2.71e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-3)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" 99.1 145.0 170.7 69.7 169.7 119.7 97.1 169.0 181.8 86.1 154.5 87.9 68.1 87.2 90.7 115.0 75.6 66.4 119.0 158.5 163.2 130.1 115.1 92.1 81.3 173.5 170.0 151.0 82.2 86.3 87.7 92.7 67.9 170.9 103.2 77.3 47.1 86.5 72.3 127.5 89.7 83.2 74.3 170.4 131.9 97.3 41.6 169.2 76.1 113.3 110.3 80.0 89.3 78.5 172.5 94.2 181.0 97.3 132.0 224.7 152.3 97.6 129.0 201.6 206.2 151.7 230.9 139.7 93.1 162.3 216.9 214.2 138.1 171.1 260.1 155.8 117.8 99.3 245.6 108.5 156.5 291.4 97.2 147.7 252.3 199.2 224.4 224.0 116.4 173.1 102.5 104.1 96.0 211.4 295.6 86.2 146.1 93.9 291.8 194.9 73.7 178.9 78.8 246.8 195.1 65.7 103.3 127.6 127.5 343.7 106.4 192.6 93.2 125.3 137.5 98.0 323.8 93.0 111.6 139.0 80.4 81.8 81.8 113.0 113.4 414.3 274.1 80.6 228.8 77.7 132.1 75.6 81.1 332.6 146.2 63.4 77.9 229.5 122.8 180.6 197.1 98.8 397.5 170.7 169.7 169.0 181.8 158.5 163.2 173.5 170.0 151.0 170.9 170.4 169.2 172.5 132.6 44.8 71.6 9.1 109.7 55.7 161.7 271.1 117.8 58.5 159.9 195.7 66.4 121.5 120.2 128.8 12.5 266.5 110.7 235.4 295.4 276.4 12.4 61.2 98.9 134.9 116.4 133.5 9.8 340.2 300.1 111.6 71.4 85.2 97.7 71.5 142.1 86.9 468.0 77.4 12.9 140.2 170.9 248.5 111.6 19.2 107.8 311.5 113.8 8.4 413.6 223.7 177.1 10.1 24.2 307.3 202.6 102.7 87.9 193.4 230.3 370.9 61.0 56.1 111.7 102.5 116.3 58.7 103.3 126.1 55.4 282.0 89.4 178.5 170.8 157.2 P4HA3 C-P4Halpha(III) ENSG00000149380 "Prolyl 4-hydroxylase subunit alpha 3" Q7Z4N8 11 74235801-74311640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 10.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 25.6;Erythroid cells: 13.5;Horizontal cells: 18.5;Rod photoreceptor cells: 12.8;Spermatocytes: 13.1;Spermatogonia: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 19.5;fHDF/TERT166: 9.5;HSkMC: 9.1;HUVEC TERT2: 38.2;TIME: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA007897 Approved "Intracellular and membrane" NA NA "HPA007897: AB_2156427" "unprognostic (2.74e-2)" "unprognostic (1.37e-4)" "unprognostic (1.31e-3)" "unprognostic (3.19e-2)" "unprognostic (2.54e-4)" "unprognostic (9.65e-3)" "unprognostic (4.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.21e-3)" "unprognostic (1.38e-2)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.34e-9)" "unprognostic (1.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (7.83e-4)" 1.6 0.7 0.1 3.9 0.0 0.0 0.9 0.1 0.3 1.1 0.2 1.2 0.3 4.5 0.5 0.3 1.2 5.7 0.3 0.0 0.1 0.5 1.3 1.4 0.9 0.1 0.1 0.0 1.0 0.2 0.0 3.7 3.9 0.1 6.4 0.7 0.0 0.5 4.3 0.1 0.3 0.4 10.6 0.1 0.1 0.4 1.5 0.1 0.1 2.6 0.1 0.3 5.5 1.7 0.1 0.0 1.4 1.7 0.0 6.2 0.7 0.0 19.5 1.4 1.0 2.1 0.0 0.0 0.0 1.8 9.5 0.7 0.0 0.0 0.3 0.2 0.0 0.1 0.0 1.2 0.0 8.0 0.0 0.0 9.1 0.0 6.5 0.7 1.1 38.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 27.4 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.2 0.4 0.7 0.9 0.0 9.1 0.5 0.1 0.4 0.0 0.2 0.0 14.6 0.2 3.1 0.2 0.0 0.2 25.6 3.8 2.5 3.2 0.0 13.5 2.4 0.0 0.4 5.2 0.0 1.0 0.0 4.3 6.1 0.0 0.4 18.5 3.3 0.2 0.0 0.9 1.1 3.2 0.0 0.3 0.0 6.5 1.6 1.9 3.1 1.5 0.9 0.8 0.2 0.4 0.0 1.1 0.2 0.0 0.7 12.8 0.0 2.1 5.4 13.1 12.2 0.1 0.3 0.1 0.4 1.3 0.2 0.6 GRIK4 "GluK4, GRIK, KA1" ENSG00000149403 "Glutamate ionotropic receptor kainate type subunit 4" Q16099 11 120511746-120988906 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6" "Cell type enhanced" "Detected in some" "Astrocytes: 82.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 115.6;Inhibitory neurons: 43.7;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 108.3" "Cancer enriched" "Detected in some" 5 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.1;HEL: 18.9;T-47d: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074453 Enhanced NA NA "HPA074453: AB_2732255" "unprognostic (9.63e-2)" "unprognostic (4.96e-2)" "unprognostic (1.58e-1)" "unprognostic (2.49e-1)" "unprognostic (2.37e-1)" "unprognostic (6.64e-4)" "unprognostic (1.48e-2)" "unprognostic (7.26e-2)" "unprognostic (3.16e-1)" "unprognostic (2.38e-1)" "unprognostic (4.53e-2)" "unprognostic (2.50e-1)" "unprognostic (4.84e-11)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (4.47e-3)" "unprognostic (2.58e-2)" 0.0 1.7 6.8 0.0 6.4 0.0 0.4 5.7 6.5 0.1 0.8 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.3 9.6 6.2 0.1 0.0 1.5 0.1 6.9 6.9 5.6 2.8 0.0 0.0 1.6 0.2 7.2 0.3 0.1 1.0 0.1 0.0 0.0 0.2 0.1 0.1 4.7 0.4 0.0 0.8 8.1 0.1 2.1 0.1 0.1 0.1 0.2 5.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.6 18.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.6 4.7 0.0 0.2 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.4 5.7 6.5 9.6 6.2 6.9 6.9 5.6 7.2 4.7 8.1 5.6 0.0 0.0 0.6 82.9 0.1 0.0 0.1 0.0 1.2 0.8 0.5 0.5 1.6 0.0 0.0 0.0 35.5 0.0 0.7 0.0 0.0 0.0 4.4 0.3 0.0 0.2 0.0 0.0 115.6 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 43.7 0.0 0.0 0.8 0.0 7.5 0.3 1.0 0.0 4.7 0.2 0.0 8.2 196.1 108.3 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 7.8 0.2 0.8 3.3 0.1 0.0 0.1 0.4 0.1 0.0 0.5 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "ST14 transmembrane serine protease matriptase" Q9Y5Y6 11 130159782-130210362 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 146.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 25.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 25.0" "Cell line enhanced" "Detected in many" "CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA047014, HPA056258" Enhanced Approved Nucleoplasm,Vesicles NA NA 1100000 "Nucleoplasm, Vesicles" "HPA047014: AB_2679902, HPA056258: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favorable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 3.9 3.9 0.9 27.0 1.9 4.3 17.9 1.8 5.3 15.7 1.3 125.9 131.9 5.8 21.9 105.3 37.5 32.9 0.9 1.0 3.9 42.7 6.3 18.7 12.0 1.9 1.6 0.8 0.7 59.7 36.8 19.3 15.2 1.8 23.3 60.6 0.0 59.2 23.8 0.3 48.3 146.0 5.4 1.6 9.2 65.4 1.0 8.0 10.6 28.8 0.0 21.1 35.2 42.9 3.7 167.2 0.2 0.0 0.6 0.0 0.0 86.4 0.0 0.0 0.0 0.0 224.2 443.0 163.6 16.7 0.0 0.1 311.4 0.0 99.3 0.0 0.1 0.2 0.1 0.1 0.9 0.0 22.0 0.8 0.0 49.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 128.5 0.3 1.1 1.7 240.4 0.9 0.2 0.0 301.2 28.8 134.2 17.8 0.4 1.5 203.1 0.4 1.6 308.3 32.0 0.1 0.4 2.7 0.7 0.7 0.2 0.3 218.5 0.3 50.4 0.5 0.0 3.6 3.4 0.0 2.2 0.1 5.0 0.0 0.0 6.2 3.6 0.0 0.0 0.5 0.0 0.3 25.0 0.0 1.2 0.9 1.9 1.8 5.3 1.0 3.9 1.9 1.6 0.8 1.8 1.6 8.0 3.7 0.2 32.1 28.6 0.0 18.2 40.9 51.5 45.2 26.2 0.0 36.5 21.5 1.2 77.2 61.6 62.5 0.0 45.6 26.1 489.4 3.9 115.8 37.8 43.9 5.7 1.7 123.4 0.8 1.0 91.8 14.6 3.2 112.1 79.6 11.4 0.2 0.4 2.1 58.1 0.0 0.4 201.0 148.5 22.7 13.2 13.9 1.8 28.0 7.2 0.0 13.6 0.0 1.0 0.0 0.1 153.4 327.2 0.7 5.9 108.7 251.9 10.0 76.4 0.0 6.6 0.0 4.9 0.2 0.3 61.3 43.9 39.7 2.9 0.0 216.9 286.8 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044188-119057227 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 203.5" "Cell type enhanced" "Detected in all" "Plasma cells: 118.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 35.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 418.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 130000000 "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 31.2 48.9 30.0 27.4 31.0 18.8 31.3 27.8 34.4 36.5 25.2 34.1 18.2 45.0 51.7 47.8 41.2 14.1 56.1 30.9 34.8 62.8 203.5 48.1 17.6 31.2 33.0 30.8 36.4 167.3 19.0 100.9 20.1 33.3 48.4 21.5 12.0 46.7 20.9 19.3 24.3 39.3 19.2 27.8 48.0 60.8 86.4 34.5 21.9 87.9 8.5 21.1 40.2 31.9 38.6 40.5 34.5 77.2 224.4 41.2 19.7 107.7 56.1 38.0 63.1 47.2 105.0 103.0 85.3 418.9 40.7 122.1 59.5 71.5 69.3 53.8 92.8 26.1 151.8 32.6 76.7 187.7 88.6 73.5 23.9 91.1 55.2 185.3 57.9 100.2 57.2 53.5 136.8 33.9 97.8 59.4 49.6 55.5 83.2 33.6 63.1 55.9 144.3 48.6 67.8 45.7 70.0 80.4 103.8 53.3 65.5 78.8 82.9 75.0 59.9 46.4 27.2 77.5 88.1 64.0 61.2 53.8 76.2 135.6 4.4 4.5 2.2 11.7 6.1 12.6 5.4 6.4 8.7 5.0 4.0 4.0 6.1 1.3 7.6 4.4 35.9 5.5 4.7 30.0 31.0 27.8 34.4 30.9 34.8 31.2 33.0 30.8 33.3 27.8 34.5 38.6 16.4 9.6 14.1 6.2 22.7 17.8 18.5 17.5 14.2 11.5 28.5 21.1 12.4 15.7 16.8 25.8 43.8 11.2 36.6 35.3 9.8 20.7 74.0 20.4 29.1 20.0 35.8 17.0 12.0 18.8 26.6 21.0 39.8 38.1 15.8 43.1 13.9 49.9 22.2 25.2 13.7 52.1 18.3 8.2 21.6 38.8 13.1 17.8 23.2 5.6 15.5 8.7 17.5 4.5 9.3 31.4 24.2 13.5 118.7 44.4 14.9 17.6 16.7 14.5 13.1 16.4 15.6 27.8 29.1 16.2 19.9 19.3 20.8 14.8 27.3 24.7 GGTLC1 "dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4" ENSG00000149435 "Gamma-glutamyltransferase light chain 1" Q9BX51 20 23985050-23988779 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "lung: 32.6;testis: 18.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 137.8;Early spermatids: 45.2;Late spermatids: 130.2;Spermatocytes: 33.6" "Cancer enriched" "Detected in some" 8 "lung cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-2)" "unprognostic (5.32e-1)" "unprognostic (4.19e-1)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 32.6 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.7 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 137.8 15.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 33.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 244.8" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 40.8;Fibroblasts: 45.2;Leydig cells: 22.7;Microglial cells: 18.7;Smooth muscle cells: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 82.4;ASC TERT1: 104.9;BJ: 38.5;BJ hTERT+: 64.7;fHDF/TERT166: 38.9;U-2197: 50.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 50.2 3.8 6.6 10.6 6.1 0.1 47.8 4.4 12.4 244.8 7.7 112.2 11.1 153.0 19.2 31.9 107.8 33.1 25.0 5.7 7.6 3.9 2.1 18.2 6.3 12.7 7.6 5.2 59.2 6.0 0.5 6.9 12.8 15.9 87.7 12.2 1.0 19.7 58.0 9.2 21.5 43.8 53.5 4.6 8.4 45.2 22.7 5.5 0.9 18.6 14.3 2.3 126.4 160.3 9.1 0.0 0.0 0.2 0.0 82.4 104.9 0.2 38.5 64.7 11.2 21.3 0.1 0.0 0.0 0.2 38.9 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 13.0 0.0 0.0 18.2 0.0 4.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 2.8 0.2 2.9 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.1 0.0 0.2 0.0 50.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 6.1 4.4 12.4 5.7 7.6 12.7 7.6 5.2 15.9 4.6 5.5 9.1 3.9 0.0 0.0 7.2 0.1 5.5 0.1 0.0 0.6 0.0 0.3 0.3 3.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.5 1.8 40.8 2.4 0.0 0.0 1.3 0.0 0.1 45.2 2.6 1.2 0.0 3.1 1.8 0.0 0.5 0.0 11.4 0.0 0.0 0.3 8.8 0.8 22.7 0.8 3.6 18.7 0.0 2.2 0.0 8.0 0.1 0.0 0.0 10.1 0.0 0.2 0.0 0.9 0.0 0.1 6.6 6.8 17.1 0.7 0.5 0.3 3.1 0.5 0.7 0.0 0.0 0.1 SLC22A8 OAT3 ENSG00000149452 "Solute carrier family 22 member 8" Q8TCC7 11 62989154-63015841 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Detoxification, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "choroid plexus: 89.8;kidney: 338.1" "Cell type enriched" "Detected in some" 38 "Proximal tubular cells: 347.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enhanced" "Detected in some" "hippocampal formation: 3.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044174 Enhanced NA NA "HPA044174: AB_10963058" "unprognostic (5.35e-4)" "unprognostic (4.66e-1)" "unprognostic (6.88e-3)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 1.6 0.0 89.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 338.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 1.6 3.8 0.0 0.1 0.9 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 1.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 347.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KAT14 "ATAC2, CRP2BP, CSRP2BP, dJ717M23.1, PRO1194" ENSG00000149474 "Lysine acetyltransferase 14" Q9H8E8 20 18137228-18188387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 17.5;Extravillous trophoblasts: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068443 Approved NA NA "HPA068443: AB_2685990" "unprognostic (4.02e-2)" "unprognostic (1.17e-1)" "unprognostic (8.60e-2)" "unprognostic (9.38e-2)" "unprognostic (3.98e-1)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (3.21e-1)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.15e-3)" "unprognostic (1.96e-2)" "prognostic favorable (4.64e-5)" "unprognostic (4.51e-1)" "unprognostic (4.51e-1)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 6.0 8.4 9.0 4.6 10.0 2.0 8.0 9.4 10.0 7.7 7.7 9.1 8.9 7.9 10.6 7.2 9.5 5.3 7.1 9.9 9.9 9.1 8.3 4.8 7.4 8.5 8.5 8.9 10.9 8.0 10.3 7.9 8.4 8.6 7.6 8.9 7.3 7.9 8.1 20.9 9.9 8.6 7.8 8.5 7.7 11.3 8.7 9.9 11.4 8.3 16.7 7.9 8.9 7.5 9.7 8.9 12.9 10.1 9.7 13.4 11.2 87.5 8.4 12.1 11.2 11.1 46.7 11.8 20.7 5.1 7.0 15.9 10.8 10.3 8.9 8.9 8.0 4.1 13.0 3.6 7.4 11.0 12.4 8.5 9.2 16.1 6.7 12.7 10.0 9.1 16.9 7.4 10.6 11.1 10.7 22.1 7.0 14.9 20.4 12.2 11.1 25.1 8.2 10.7 5.3 13.8 8.7 10.8 24.8 13.8 9.2 10.4 11.1 7.7 10.5 4.1 7.4 6.3 9.2 19.0 11.1 3.4 6.0 11.3 0.6 5.7 1.8 9.1 5.7 10.8 7.9 9.2 10.8 8.5 9.8 12.9 10.0 0.5 10.7 11.1 5.9 5.9 8.4 9.0 10.0 9.4 10.0 9.9 9.9 8.5 8.5 8.9 8.6 8.5 9.9 9.7 3.1 9.6 6.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.3 3.9 0.0 0.0 4.3 1.8 0.0 17.5 1.6 0.0 1.9 4.5 0.0 6.9 5.8 2.1 0.0 0.0 0.0 6.4 38.2 2.3 0.0 5.8 3.8 8.3 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.0 0.0 6.9 4.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 4.1 1.6 7.9 0.0 0.0 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333220-61353295 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 194.6;liver: 116.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol NA NA 6800000 Cytosol Nucleoplasm "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favorable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 9.2 83.5 4.9 9.4 5.0 16.7 12.2 5.4 6.7 9.0 4.8 9.9 194.6 11.1 7.6 16.4 15.5 9.3 7.6 5.7 5.0 45.9 116.8 9.0 13.7 6.2 5.3 4.9 10.3 24.2 6.8 14.1 6.1 5.9 12.3 5.8 5.7 16.3 9.0 11.0 16.9 139.2 5.3 5.9 13.1 16.8 28.4 4.9 7.6 14.9 5.7 8.1 11.0 11.1 6.3 19.9 51.3 8.5 30.0 10.7 11.4 24.2 11.7 12.4 10.4 6.9 23.1 47.1 25.0 39.3 8.5 11.0 27.7 16.3 21.8 3.5 42.5 21.7 15.7 26.2 133.2 17.9 13.4 25.0 18.2 14.5 9.9 35.4 9.4 10.7 17.1 27.2 46.7 7.9 91.8 11.9 11.9 23.8 19.2 33.8 20.0 13.8 140.7 17.1 35.0 33.0 29.6 21.0 36.4 19.3 6.0 135.4 9.2 13.0 21.0 21.6 16.6 7.0 85.8 76.5 22.9 21.3 12.3 19.7 2.6 13.4 6.5 7.1 7.8 9.6 10.3 8.3 7.1 21.2 9.7 5.8 6.2 1.2 6.5 6.5 10.1 12.9 9.7 4.9 5.0 5.4 6.7 5.7 5.0 6.2 5.3 4.9 5.9 5.9 4.9 6.3 8.0 0.0 14.5 0.0 9.5 0.0 13.8 0.0 11.4 12.8 19.1 16.0 3.8 11.5 6.8 14.7 14.6 31.2 8.3 4.8 29.4 19.6 16.2 16.4 6.6 8.0 13.3 7.8 0.0 14.6 6.2 11.2 20.4 12.1 7.6 10.8 7.5 115.9 17.1 8.4 0.0 31.6 0.0 17.2 0.0 12.0 15.2 8.2 0.0 0.0 21.2 10.0 9.2 0.0 0.0 11.2 32.9 22.6 11.0 11.1 415.8 91.2 10.9 17.8 6.6 4.7 3.6 37.5 14.1 12.6 0.0 15.2 6.5 93.6 47.6 13.4 MTA2 "MTA1-L1, MTA1L1" ENSG00000149480 "Metastasis associated 1 family member 2" O94776 11 62593214-62601865 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005315, HPA006214, CAB017522, HPA072727" Supported Enhanced Nucleoplasm NA NA 10000 Nucleoplasm "CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: " "unprognostic (5.97e-3)" "unprognostic (1.63e-2)" "unprognostic (1.23e-1)" "unprognostic (3.04e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (4.82e-5)" "unprognostic (3.32e-3)" "unprognostic (1.95e-1)" "unprognostic (5.38e-3)" "unprognostic (3.09e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-3)" "unprognostic (3.16e-3)" "unprognostic (9.84e-2)" "unprognostic (2.23e-1)" "unprognostic (2.50e-2)" 41.2 34.7 41.8 46.7 43.9 61.3 36.0 43.2 45.7 37.9 37.2 40.3 31.3 37.5 28.9 80.0 33.7 32.9 26.9 41.6 49.3 26.1 30.6 38.1 70.7 46.4 44.1 38.9 38.1 23.2 30.4 32.1 39.4 46.3 37.4 47.9 120.9 37.6 37.0 21.4 75.3 40.5 44.2 45.5 61.2 34.2 30.7 44.0 91.0 27.0 24.3 92.5 52.2 47.6 51.6 97.1 83.4 129.8 171.1 57.0 53.2 88.8 80.0 112.3 157.5 114.7 79.7 82.7 137.0 84.0 106.3 84.3 127.2 177.2 222.1 132.8 136.4 87.9 146.4 91.2 81.0 88.3 167.2 180.0 59.6 122.6 111.3 164.1 74.8 148.3 140.4 164.2 106.1 114.6 189.0 213.9 212.1 112.3 91.7 95.1 201.5 92.4 160.6 112.1 143.4 102.9 94.2 83.5 118.2 67.6 102.4 138.9 113.2 104.5 87.9 80.4 100.4 94.0 78.3 109.4 191.8 64.4 120.4 86.9 7.3 7.2 9.9 18.6 12.6 15.6 13.9 15.2 13.5 11.8 10.0 14.0 14.3 3.1 12.1 16.4 13.8 13.5 6.7 41.8 43.9 43.2 45.7 41.6 49.3 46.4 44.1 38.9 46.3 45.5 44.0 51.6 22.9 3.2 3.9 2.3 16.9 13.4 4.2 4.2 34.1 0.0 11.3 7.9 3.7 1.5 4.9 1.8 0.0 15.3 16.5 12.1 5.9 5.1 0.8 5.2 10.0 12.0 12.0 20.8 1.5 9.5 8.3 8.6 15.3 9.5 10.8 7.5 13.2 8.2 8.9 0.0 1.6 11.9 4.1 12.8 7.6 0.7 5.0 8.9 1.8 2.8 8.9 0.0 9.2 2.0 2.7 9.7 8.2 4.1 24.1 4.2 6.6 2.7 0.9 0.0 0.0 8.2 11.7 5.9 5.2 32.5 11.2 18.9 18.1 13.6 12.2 4.5 TMEM138 "HSPC196, JBTS16" ENSG00000149483 "Transmembrane protein 138" Q9NPI0 11 61362344-61369509 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042373 Approved Approved Microtubules NA Yes Microtubules "HPA042373: AB_10793880" "unprognostic (1.30e-1)" "unprognostic (4.69e-3)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.15e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (2.28e-1)" "unprognostic (4.42e-2)" "unprognostic (3.49e-1)" "unprognostic (4.46e-1)" 13.8 40.9 10.0 11.6 8.9 18.3 14.5 10.7 9.8 16.2 9.8 13.2 10.9 17.6 26.1 10.9 17.4 11.7 9.2 9.2 9.7 18.1 22.4 15.5 18.1 9.3 10.2 9.0 23.9 14.0 18.5 12.7 15.0 9.3 17.3 18.8 51.1 11.2 14.0 6.8 18.8 16.1 18.8 9.6 18.5 13.6 12.6 9.4 14.1 13.6 8.6 23.0 18.0 13.4 9.9 16.3 35.5 14.0 20.3 48.9 20.1 16.5 24.9 30.7 36.2 32.8 17.7 24.6 14.0 21.0 29.7 56.5 30.2 26.0 31.0 39.8 18.0 14.4 10.1 28.7 21.0 35.0 21.8 26.3 32.4 47.7 60.5 39.4 13.5 31.4 16.7 29.8 23.0 60.1 45.4 17.3 21.6 22.8 28.2 34.5 11.9 10.3 30.4 32.3 39.6 14.9 11.1 31.7 30.4 34.2 12.8 47.3 19.0 18.7 45.2 18.7 31.5 24.7 24.0 24.6 13.6 23.7 26.5 24.0 41.7 26.0 26.5 23.1 26.6 25.3 26.1 21.7 22.3 15.9 24.1 24.0 21.4 5.3 27.8 18.2 28.0 30.2 24.1 10.0 8.9 10.7 9.8 9.2 9.7 9.3 10.2 9.0 9.3 9.6 9.4 9.9 12.6 16.0 23.2 16.0 23.1 19.9 16.1 49.8 25.0 28.9 15.7 17.1 4.2 4.3 26.2 20.2 81.3 54.8 27.3 13.9 15.6 17.1 21.7 22.0 16.6 18.7 9.6 22.1 12.5 16.0 39.9 20.5 9.2 7.0 37.3 17.8 13.6 16.3 45.7 15.2 12.1 11.6 16.2 15.6 10.7 7.6 31.7 35.6 37.4 3.7 25.5 25.9 36.0 10.1 8.1 18.6 11.5 28.6 18.1 22.1 26.7 20.8 59.6 194.1 0.0 15.3 14.3 24.9 16.2 16.3 20.5 27.5 23.3 56.9 14.3 12.9 FADS1 "D5D, FADS6, FADSD5, LLCDL1, TU12" ENSG00000149485 "Fatty acid desaturase 1" O60427 11 61799627-61829318 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 521.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042705 Approved NA NA "HPA042705: AB_10795709" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" "unprognostic (8.17e-3)" "unprognostic (1.40e-1)" "unprognostic (1.99e-2)" "unprognostic (3.23e-3)" "unprognostic (7.88e-2)" "unprognostic (1.94e-2)" "unprognostic (4.10e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (1.95e-9)" "unprognostic (2.29e-2)" "unprognostic (3.59e-2)" "prognostic unfavorable (2.79e-4)" "prognostic unfavorable (1.33e-4)" 25.0 68.4 43.0 20.0 41.4 9.8 13.7 42.1 47.8 18.0 61.5 8.0 5.6 21.4 6.6 5.3 17.6 14.6 22.8 41.0 57.8 8.0 53.3 20.5 9.8 59.9 58.7 39.7 27.7 10.1 27.4 21.4 21.3 51.4 19.8 4.9 35.4 6.4 16.0 17.6 10.6 6.8 20.7 44.3 8.1 9.5 12.0 65.8 8.2 6.1 7.9 9.3 12.8 10.2 58.2 66.3 170.1 159.1 41.1 313.2 521.2 46.4 42.0 204.5 69.9 118.9 53.3 143.2 2.3 43.4 60.5 177.2 84.7 130.8 114.1 51.7 12.2 18.4 107.9 191.2 98.9 169.1 23.4 10.4 238.1 38.3 154.7 74.7 73.8 64.1 104.7 59.9 118.6 70.1 18.6 78.6 23.6 94.2 5.5 63.0 85.4 162.5 231.2 81.5 29.0 80.7 89.6 106.7 1.7 90.0 58.4 38.6 98.6 62.1 71.8 70.8 74.2 50.6 112.9 111.3 55.4 42.6 108.9 61.4 7.5 33.2 6.2 12.1 40.4 2.6 2.5 4.0 4.9 28.0 8.7 2.3 5.4 2.6 6.9 17.4 23.6 2.9 15.7 43.0 41.4 42.1 47.8 41.0 57.8 59.9 58.7 39.7 51.4 44.3 65.8 58.2 10.3 6.4 77.9 28.7 3.2 2.7 2.5 48.5 1.2 78.9 2.6 3.7 30.4 8.6 25.3 12.9 27.1 9.5 12.4 0.9 0.0 15.2 8.7 4.9 30.7 16.6 9.7 46.3 9.4 33.4 50.0 34.9 6.1 7.8 37.9 65.3 9.3 74.5 37.2 69.0 14.7 0.6 16.2 21.7 21.0 16.4 29.8 27.6 32.0 12.2 32.0 70.5 6.2 13.6 27.4 7.6 0.0 21.4 2.1 6.4 0.1 1.1 8.0 91.9 0.0 40.3 31.9 6.5 17.5 2.3 1.4 9.3 5.5 75.2 1.4 1.6 TMC2 "C20orf145, dJ686C3.3" ENSG00000149488 "Transmembrane channel like 2" Q8TDI7 20 2536573-2643580 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lung: 1.1;pituitary gland: 1.8" "Group enriched" "Detected in some" 6 "Late spermatids: 11.4;Oligodendrocyte precursor cells: 32.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (8.30e-4)" "unprognostic (2.86e-3)" "unprognostic (3.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.07e-2)" "unprognostic (4.54e-1)" "unprognostic (1.41e-2)" "unprognostic (4.05e-5)" "unprognostic (2.90e-1)" "unprognostic (3.21e-7)" "unprognostic (2.47e-2)" "unprognostic (2.56e-1)" "unprognostic (1.93e-1)" "unprognostic (5.74e-2)" 0.8 0.1 0.1 0.1 0.2 0.1 0.5 0.9 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.4 0.0 0.2 0.1 0.0 0.0 1.1 0.1 0.1 0.0 0.2 0.2 0.2 0.0 1.8 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.2 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 32.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615116 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 17 "retina: 1197.3" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 3239.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 2.7" "Group enriched" "Detected in many" 4 "NK-cells: 2.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "HSkMC: 25.2;U-266/84: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 10.8 8.0 62.5 2.3 64.4 1.2 9.3 62.4 68.0 8.6 53.9 8.1 1.8 7.7 4.8 7.6 10.8 4.6 6.2 60.1 70.6 5.9 7.2 6.1 2.5 72.1 65.9 56.8 13.6 3.6 5.2 7.1 1.5 66.8 8.3 2.6 1197.3 4.3 5.0 3.3 5.4 5.4 5.4 66.2 7.5 7.1 6.2 66.6 1.6 6.0 3.7 2.5 9.7 7.4 69.3 3.2 1.9 3.1 6.6 4.5 22.0 0.6 2.1 3.7 4.3 2.8 0.9 5.3 3.0 15.9 12.2 2.0 4.1 1.5 4.2 1.1 5.3 3.0 3.1 8.6 4.0 13.0 1.1 0.9 25.2 5.9 4.5 9.1 15.1 7.0 1.2 4.0 6.5 9.1 8.3 1.7 2.3 0.8 1.7 5.9 1.6 2.6 19.1 5.0 1.8 3.3 5.1 5.0 5.8 2.5 0.5 8.1 1.4 8.3 7.2 2.7 8.3 2.5 2.9 31.9 2.4 14.2 3.1 1.5 0.0 0.4 0.3 0.3 0.1 0.9 0.2 1.2 0.3 0.2 0.3 0.5 0.6 0.1 2.7 0.4 0.3 0.4 0.5 62.5 64.4 62.4 68.0 60.1 70.6 72.1 65.9 56.8 66.8 66.2 66.6 69.3 19.9 0.0 4.4 4.9 0.6 3.7 5.7 5.0 7.4 356.6 3.8 7.2 2.5 2.8 2.3 5.5 594.2 1.0 0.6 2.4 1.9 1.6 2.0 1.0 4.1 31.3 4.2 0.0 0.2 3.1 0.2 4.1 1.1 1.0 1.3 1.2 21.8 1.7 1.1 171.6 0.5 2.8 0.0 1.9 0.8 7.9 19.0 1.2 3.6 1.9 1.3 516.9 1.0 1.0 6.5 2.1 2.5 5.7 0.6 3.1 3.1 4.7 2.7 3239.7 0.0 2.5 4.3 1.6 5.1 5.3 1.0 0.7 1.5 4.0 2.9 3.1 EML3 "ELP95, FLJ35827" ENSG00000149499 "EMAP like 3" Q32P44 11 62602218-62612775 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.08e-3)" "unprognostic (2.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-3)" "unprognostic (2.11e-1)" "unprognostic (4.56e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-2)" "unprognostic (1.07e-1)" "unprognostic (5.36e-2)" "unprognostic (9.46e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.13e-8)" "unprognostic (1.42e-1)" "unprognostic (2.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.52e-1)" 38.3 21.8 13.0 28.6 12.2 21.6 35.6 11.5 15.3 34.8 11.6 20.7 10.6 29.6 7.9 50.0 31.8 14.6 20.3 12.2 15.9 27.2 31.4 29.2 27.1 17.2 12.9 6.8 36.7 22.4 13.5 15.7 12.4 17.8 28.3 9.4 17.5 24.5 13.3 10.2 32.4 26.7 14.8 12.6 44.5 24.7 12.9 13.3 18.9 27.4 4.3 22.8 27.3 32.3 14.2 18.8 13.3 13.9 12.7 19.8 33.8 12.5 17.4 18.7 18.6 11.4 11.3 29.8 33.2 43.3 24.4 14.0 29.8 12.3 31.9 9.6 43.5 12.1 31.1 36.9 9.5 27.4 22.8 26.1 46.5 13.3 15.3 22.9 36.0 37.9 14.5 23.7 32.6 24.9 52.1 16.0 28.2 3.4 22.4 18.5 21.1 12.8 71.2 21.5 21.0 5.4 18.7 12.9 44.0 22.1 12.8 43.9 15.5 42.6 24.3 20.0 19.2 19.6 45.3 27.9 20.8 26.4 15.4 17.8 8.7 4.5 5.7 4.6 4.9 4.6 3.1 4.4 4.8 3.4 3.8 3.9 4.8 2.7 5.6 4.6 2.4 5.5 4.4 13.0 12.2 11.5 15.3 12.2 15.9 17.2 12.9 6.8 17.8 12.6 13.3 14.2 29.8 6.4 14.5 15.3 18.5 14.3 12.1 14.5 30.1 7.7 13.9 18.3 4.8 15.7 11.6 11.0 8.4 19.6 14.0 12.5 5.9 9.3 7.4 5.9 8.3 27.0 10.2 11.6 0.3 13.6 15.2 12.8 19.9 7.6 3.8 8.1 37.5 18.5 15.1 1.7 1.1 11.0 12.2 23.2 8.5 26.8 22.4 16.7 5.4 6.5 16.1 6.6 23.7 5.0 4.5 20.1 11.5 18.0 15.9 10.3 9.5 5.5 7.6 22.6 19.7 8.0 12.8 7.3 12.3 74.1 21.6 16.8 23.5 10.2 10.3 14.1 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123998-62153169 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.1" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 1.2;NK-cell: 1.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;NK-cells: 1.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 3.2 2.5 2.8 7.6 1.2 21.1 2.8 6.3 3.0 3.8 0.0 4.9 6.8 3.0 8.1 14.2 3.6 2.2 2.8 2.7 0.9 2.4 2.0 3.0 11.7 1.6 1.1 1.1 3.8 3.1 3.1 1.5 4.1 2.8 2.5 3.7 3.4 6.1 3.0 4.2 7.9 5.7 3.4 0.1 5.6 4.6 6.4 0.4 18.0 5.1 3.4 8.3 2.8 5.5 1.7 74.3 69.4 51.6 45.5 6.8 8.4 28.1 47.6 21.2 44.4 28.3 37.0 50.7 70.0 36.2 16.0 46.2 72.6 52.2 28.4 31.8 60.5 36.6 45.7 68.0 29.6 2.7 53.5 62.1 4.3 6.5 41.3 23.6 6.8 25.8 50.2 48.8 57.6 25.3 59.7 85.0 43.3 56.2 28.0 34.4 79.3 66.4 53.4 12.0 35.8 40.1 42.2 46.8 30.8 27.9 19.8 48.2 19.4 28.5 41.8 51.9 59.8 50.0 29.7 48.3 75.8 23.5 34.7 50.6 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.8 1.2 6.3 3.0 2.7 0.9 1.6 1.1 1.1 2.8 0.1 0.4 1.7 1.2 3.2 2.3 1.3 3.4 5.6 0.8 1.0 2.8 2.4 1.1 0.6 1.3 0.0 3.7 0.0 0.0 4.2 4.2 5.4 0.0 1.9 1.0 2.0 2.1 1.5 0.0 10.9 3.3 2.5 7.1 1.9 9.2 2.7 3.8 5.7 0.0 0.7 4.2 0.0 2.5 3.4 0.0 0.9 1.6 0.5 2.8 3.3 3.6 1.0 5.0 1.5 3.1 2.0 1.5 2.2 1.6 1.5 10.9 1.2 1.3 0.3 2.6 2.3 0.0 1.9 4.3 6.5 7.8 15.1 3.3 2.2 3.7 1.9 4.8 1.1 ZP1 ENSG00000149506 "Zona pellucida glycoprotein 1" P60852 11 60867562-60875693 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Early spermatids: 32.3;Late spermatids: 87.6" "Cancer enhanced" "Detected in single" "prostate cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 32 "plasmacytoid DC: 3.1" "Lineage enriched" "Detected in single" 32 "dendritic cells: 3.1" "Group enriched" "Detected in some" 40 "RPMI-8226: 12.4;SK-BR-3: 3.3" "Not detected" "Not detected" "Secreted in female reproductive system" NA NA "unprognostic (6.40e-3)" "unprognostic (2.18e-4)" "unprognostic (1.63e-1)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (9.95e-2)" "unprognostic (1.94e-2)" "unprognostic (8.15e-3)" "unprognostic (2.52e-1)" "unprognostic (9.25e-4)" "unprognostic (5.31e-13)" "unprognostic (4.13e-2)" "unprognostic (2.38e-1)" "unprognostic (6.27e-2)" "unprognostic (5.61e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 1.3 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.1 0.7 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 32.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 87.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.1 5.0 1.9 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.1 OOSP2 "FLJ36198, OOSP2A, PLAC1L, TMEM122" ENSG00000149507 "Oocyte secreted protein 2" Q86WS3 11 60040409-60048044 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 182 "testis: 18.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050914 Enhanced "Secreted in male reproductive system" NA NA "HPA050914: AB_2681271" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071115 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "bone marrow: 424.0" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 1478 "basophil: 2686.3" "Lineage enriched" "Detected in single" 4507 "granulocytes: 2686.3" "Cell line enhanced" "Detected in some" "HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.0 0.0 0.0 0.3 0.0 424.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.5 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.9 0.0 0.0 0.0 17.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 319.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 126.2 0.0 2686.3 0.1 1.8 0.1 0.1 0.3 0.2 0.4 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.5 0.2 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.8 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 PLCH2 "KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1" ENSG00000149527 "Phospholipase C eta 2" O75038 1 2425980-2505532 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2;skin 1: 52.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 102.5;Cone photoreceptor cells: 75.0;Oligodendrocytes: 37.4;Rod photoreceptor cells: 169.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBEC3-KT: 130.9;hTCEpi: 58.9;hTERT-HME1: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072705 Enhanced NA NA "HPA072705: AB_2732211" "unprognostic (2.06e-3)" "unprognostic (1.30e-2)" "unprognostic (1.09e-3)" "unprognostic (3.84e-3)" "unprognostic (1.99e-1)" "unprognostic (1.59e-2)" "unprognostic (7.39e-2)" "unprognostic (7.70e-2)" "unprognostic (7.58e-2)" "unprognostic (9.28e-2)" "unprognostic (2.26e-1)" "unprognostic (5.95e-2)" "unprognostic (6.61e-3)" "unprognostic (8.43e-2)" "unprognostic (1.07e-1)" "unprognostic (8.64e-2)" "unprognostic (5.80e-2)" 0.5 1.4 1.0 3.9 1.5 2.2 6.3 8.0 4.7 3.9 0.0 1.2 2.2 0.3 1.7 19.4 3.2 2.9 0.2 2.5 0.7 0.8 2.1 1.8 5.4 4.2 3.6 0.4 0.1 5.2 0.0 8.0 0.4 6.5 14.7 0.8 45.2 16.6 5.8 0.2 52.1 3.3 0.1 2.2 5.6 2.0 0.7 6.7 4.4 1.7 0.0 6.5 9.2 18.5 8.2 0.3 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.2 0.2 0.0 17.1 0.0 130.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 58.9 0.0 32.8 0.0 0.0 0.0 0.0 3.1 0.3 0.6 0.0 0.0 0.1 1.9 1.4 0.1 0.1 0.0 0.2 6.1 14.7 2.9 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.6 0.2 1.0 1.5 8.0 4.7 2.5 0.7 4.2 3.6 0.4 6.5 2.2 6.7 8.2 0.2 0.0 1.7 2.9 6.1 15.4 14.5 22.8 10.8 102.5 1.7 5.5 3.3 2.8 10.8 0.0 75.0 0.0 7.3 0.7 1.9 0.1 0.1 0.7 0.2 0.7 1.2 0.0 9.3 0.0 0.0 0.4 1.5 1.4 0.0 0.1 0.0 4.9 0.1 26.9 19.8 1.9 2.0 0.3 1.1 0.2 0.0 0.5 3.6 1.9 0.4 14.9 7.2 2.5 37.4 0.5 0.6 0.0 1.9 4.9 3.8 33.5 5.8 169.0 0.0 0.0 1.0 0.2 0.3 13.0 14.6 0.0 7.0 0.1 0.5 9.2 CPSF7 "CFIM59, FLJ12529" ENSG00000149532 "Cleavage and polyadenylation specific factor 7" Q8N684 11 61402641-61430031 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041094 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041094: AB_10794187" "unprognostic (6.87e-3)" "unprognostic (8.31e-2)" "unprognostic (1.94e-1)" "unprognostic (4.79e-3)" "unprognostic (1.07e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (9.83e-4)" "unprognostic (5.35e-2)" "unprognostic (2.07e-3)" "unprognostic (7.95e-2)" "unprognostic (2.59e-1)" "unprognostic (3.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.71e-1)" "unprognostic (2.38e-1)" "unprognostic (6.18e-2)" 43.1 44.5 36.8 36.3 37.1 55.5 44.6 36.8 48.8 55.2 36.5 46.1 32.3 55.3 44.5 47.0 55.5 27.6 36.3 36.0 35.9 44.4 63.3 38.3 43.6 38.8 36.7 34.1 56.1 49.7 35.2 79.7 38.1 36.9 47.8 34.6 41.0 41.7 35.0 68.6 52.2 49.4 44.0 30.1 57.9 47.7 42.3 36.3 58.4 59.4 48.6 44.1 47.8 46.1 41.7 72.5 71.0 98.0 78.2 52.0 45.8 68.7 58.9 56.2 76.7 58.4 83.7 60.6 107.7 61.4 63.6 65.0 87.4 94.7 67.4 93.1 71.8 48.4 90.9 95.8 68.0 52.5 111.4 77.9 48.7 54.3 81.3 118.4 46.7 52.8 69.1 111.2 67.1 56.2 87.7 110.5 90.9 96.2 50.5 55.6 102.8 77.1 88.9 57.8 87.9 66.3 67.6 78.2 68.4 74.3 59.7 94.4 47.6 53.2 84.4 71.6 79.0 61.4 92.0 116.5 122.4 49.3 53.2 63.0 15.1 5.6 7.1 8.1 6.0 8.7 6.9 6.4 8.4 7.6 6.5 7.0 7.2 9.8 6.7 4.6 6.4 4.8 5.7 36.8 37.1 36.8 48.8 36.0 35.9 38.8 36.7 34.1 36.9 30.1 36.3 41.7 23.3 35.3 21.2 56.8 29.0 23.2 18.4 15.5 26.7 21.4 26.1 24.9 11.4 11.5 16.0 16.5 39.6 26.7 29.4 22.6 17.6 15.7 41.8 17.1 21.7 22.6 22.2 20.0 29.8 13.8 17.5 20.7 22.4 21.3 23.5 26.6 22.9 27.2 19.6 32.0 31.0 21.9 16.2 31.0 19.0 29.1 27.4 23.4 3.6 37.5 39.7 24.2 22.6 31.7 39.8 19.5 13.6 25.2 28.6 25.0 22.3 14.3 19.9 21.7 39.5 28.8 22.6 37.5 27.1 25.0 26.3 27.5 22.1 17.7 23.0 23.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098467 "FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 12.7" "Cell type enriched" "Detected in some" 20 "granulocytes: 967.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 908 "basophil: 275.5" "Lineage enriched" "Detected in single" 1467 "granulocytes: 275.5" "Cell line enhanced" "Detected in some" "HEL: 2.7;THP-1: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 15.3" HPA059967 Enhanced NA NA "HPA059967: AB_2684183" "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 2.2 0.2 0.3 2.5 0.4 0.9 2.8 0.5 0.5 6.4 0.5 5.0 5.6 4.3 3.7 4.8 0.9 8.3 0.6 0.4 0.4 0.5 0.4 12.7 1.1 0.4 0.3 0.4 0.1 0.5 0.4 0.1 0.3 0.4 3.0 5.5 0.0 1.8 2.4 2.9 2.3 6.8 4.1 0.3 0.2 5.4 1.0 0.3 1.2 0.1 1.2 1.8 3.8 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 275.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.3 0.4 0.5 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.3 0.3 0.5 0.1 0.0 30.9 0.0 0.3 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.5 0.0 6.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.3 0.0 46.7 0.1 0.0 0.1 1.1 0.0 0.1 967.4 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.7 0.4 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.0 12.2 0.0 0.0 0.2 B3GAT3 GlcAT-I ENSG00000149541 "Beta-1,3-glucuronyltransferase 3" O94766 11 62615296-62622154 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051328 Approved "Intracellular and membrane" NA NA 990000 "HPA051328: AB_2681444" "unprognostic (1.55e-1)" "unprognostic (3.93e-2)" "unprognostic (8.45e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.11e-6)" "unprognostic (4.94e-2)" "unprognostic (2.42e-1)" "unprognostic (3.66e-2)" "unprognostic (1.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.58e-3)" "unprognostic (1.46e-3)" "unprognostic (6.00e-2)" "unprognostic (4.48e-2)" "unprognostic (2.58e-2)" 25.6 30.3 62.3 17.1 57.8 18.4 27.6 60.4 82.5 32.7 56.3 27.0 17.3 30.3 11.6 21.2 30.3 15.4 22.5 58.8 59.9 41.1 49.1 29.2 26.4 66.1 59.5 55.8 32.5 31.0 19.3 56.2 19.2 70.6 37.4 7.0 16.2 26.1 18.4 14.4 33.0 28.0 14.1 58.5 40.3 29.2 24.1 62.9 18.7 30.3 6.9 10.8 30.8 25.9 65.6 36.0 57.3 32.0 55.0 40.0 38.7 23.4 28.3 38.9 26.7 29.4 25.4 52.3 33.4 91.1 29.5 70.6 24.5 30.8 28.7 6.2 71.5 61.3 17.0 25.9 32.8 96.8 21.4 34.8 69.1 47.6 35.0 15.3 42.4 25.3 37.9 51.5 76.7 33.9 89.1 38.1 76.7 47.5 18.9 55.1 36.7 22.5 175.4 55.0 7.2 33.6 53.1 32.6 38.2 134.6 10.6 52.9 41.6 18.6 28.6 20.8 75.2 54.4 79.3 28.7 37.6 82.3 41.0 56.0 32.0 29.3 27.4 21.6 31.8 14.0 18.5 14.9 17.7 25.8 15.3 14.8 17.2 8.6 41.0 33.8 15.5 19.9 16.4 62.3 57.8 60.4 82.5 58.8 59.9 66.1 59.5 55.8 70.6 58.5 62.9 65.6 33.2 6.4 13.2 22.2 36.8 19.8 39.0 53.3 51.2 52.3 33.1 44.4 4.2 31.5 26.1 40.5 33.3 77.0 45.3 26.5 15.6 33.8 0.4 20.0 36.3 22.8 25.2 24.4 19.1 46.3 61.3 34.8 25.5 24.1 1.3 45.3 23.2 28.4 67.8 48.8 25.3 23.9 57.0 35.2 17.5 3.2 36.1 34.4 44.4 8.4 45.3 52.5 49.4 14.6 19.5 36.4 31.2 22.6 51.0 30.6 27.3 16.2 15.2 49.6 26.3 22.3 33.7 6.8 25.8 21.9 19.5 43.5 41.7 31.9 28.3 21.0 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24 autophagy associated transmembrane protein" O14681 11 125569280-125584684 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 465.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 575.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 760.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 53.9 32.9 61.0 36.5 62.4 23.4 73.3 59.4 73.0 51.7 59.1 78.5 50.0 46.6 57.9 81.4 51.2 46.8 56.3 60.2 61.1 61.6 250.5 45.4 28.6 61.0 62.8 58.6 42.7 102.7 465.3 30.8 49.0 61.1 50.0 81.2 39.7 76.0 58.5 120.5 70.3 49.7 63.0 62.2 30.8 60.3 33.4 63.3 35.6 40.8 105.5 42.6 79.6 48.8 60.9 156.6 115.6 129.5 160.5 207.7 155.9 162.4 159.6 116.8 104.3 93.4 178.9 303.4 158.0 264.0 146.5 110.8 176.1 199.0 326.8 135.2 42.0 142.6 760.9 77.2 179.9 154.1 170.9 78.4 147.5 292.7 157.4 230.2 102.8 223.9 85.1 351.1 61.1 149.4 113.8 79.0 96.4 173.6 398.3 139.5 113.9 155.4 132.8 177.0 272.4 120.1 116.9 187.1 215.5 63.4 212.3 436.4 165.7 195.2 133.8 93.3 94.7 128.7 39.7 84.8 200.5 58.5 256.1 182.2 4.3 7.0 5.9 7.2 6.7 7.2 8.4 5.7 9.0 10.9 6.3 8.1 6.7 0.8 6.5 4.9 14.5 9.1 5.3 61.0 62.4 59.4 73.0 60.2 61.1 61.0 62.8 58.6 61.1 62.2 63.3 60.9 73.5 32.1 38.3 13.4 34.8 120.6 130.3 132.6 120.1 58.9 148.8 100.6 61.9 124.4 69.5 110.3 37.5 166.9 32.4 66.4 144.8 178.6 31.1 34.4 59.3 87.1 98.4 102.7 25.1 181.8 201.2 80.1 87.7 46.5 27.3 76.2 74.6 575.0 110.5 82.4 24.0 115.3 105.8 49.8 96.1 49.7 71.4 40.9 90.7 11.2 40.9 107.1 50.4 13.0 23.0 182.1 67.6 72.2 79.1 270.0 68.5 122.7 43.9 36.9 46.0 60.8 80.1 95.9 112.3 176.3 181.4 140.1 31.0 71.3 135.7 189.4 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.6" "Group enriched" "Detected in many" 5 "Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 0.7 0.3 0.4 0.9 0.7 2.1 2.8 0.4 0.7 0.5 0.3 0.8 0.7 0.6 1.5 0.8 1.1 0.6 0.2 0.4 0.5 0.6 1.3 0.7 1.2 0.8 0.5 0.2 0.8 0.9 0.6 0.5 0.7 0.7 1.6 0.8 1.7 4.0 0.5 0.1 2.2 0.7 0.6 0.6 0.8 0.6 10.6 0.6 2.8 0.7 0.2 1.4 0.5 0.6 1.0 5.4 1.0 6.9 0.0 0.5 1.9 0.0 5.7 6.9 5.3 6.5 0.1 4.4 6.3 4.9 2.0 10.5 4.2 2.9 3.8 9.4 5.3 1.1 7.7 0.8 1.6 0.2 2.3 4.3 0.5 2.7 11.0 5.5 1.0 4.0 7.8 5.2 6.3 11.2 1.2 4.9 2.6 1.6 4.6 6.3 5.9 12.6 2.0 0.8 2.1 3.9 3.4 3.3 0.4 1.5 3.3 7.9 2.0 2.9 10.8 2.4 4.8 7.2 1.5 1.8 5.3 1.5 12.6 7.3 4.0 0.5 0.8 1.0 0.7 1.1 0.3 0.9 1.7 0.1 0.7 1.2 1.4 0.4 1.1 0.8 0.5 1.7 0.5 0.4 0.7 0.4 0.7 0.4 0.5 0.8 0.5 0.2 0.7 0.6 0.6 1.0 2.4 3.2 1.1 5.2 2.3 5.0 2.1 2.2 2.2 6.4 4.2 2.8 0.6 0.0 2.9 0.0 0.0 0.9 2.9 1.1 0.0 2.3 42.8 2.6 2.0 3.4 1.2 26.3 1.2 3.5 0.4 2.5 3.6 1.4 8.9 4.4 1.4 1.4 3.2 3.3 2.0 2.1 0.0 2.6 3.3 25.8 4.4 2.6 3.6 1.0 0.7 3.6 8.2 5.0 6.1 1.8 0.5 2.2 1.2 1.1 0.2 1.0 5.3 2.8 6.6 2.2 2.3 99.7 34.5 3.2 3.8 0.1 3.4 0.9 1.7 1.2 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625665-125676255 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.9;lymphoid tissue: 20.9;seminal vesicle: 30.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 6.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044364 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044364: AB_2678913" "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favorable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavorable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 1.7 1.3 0.6 8.2 0.9 25.9 2.6 0.6 1.3 1.4 0.6 8.0 6.8 1.7 6.7 4.1 1.1 1.8 0.8 0.7 1.0 2.2 2.2 1.3 15.0 0.7 0.8 0.7 1.8 2.0 13.2 1.7 4.8 0.8 1.6 8.8 0.7 1.5 30.1 0.6 3.6 7.3 3.4 0.6 2.2 2.6 9.0 1.0 20.9 1.0 1.3 14.0 3.3 2.1 1.0 48.5 37.0 81.1 47.4 13.5 28.9 35.7 61.1 28.7 41.6 40.1 88.0 100.3 120.7 63.5 24.9 53.7 52.6 54.2 33.2 50.1 81.4 24.8 224.2 27.2 44.7 4.3 121.1 39.6 15.7 6.0 47.6 36.0 19.9 44.7 84.1 117.3 102.7 51.4 23.8 181.3 65.0 86.1 77.1 33.2 104.7 74.4 67.2 37.9 63.2 50.5 53.6 45.2 35.4 15.2 57.3 93.9 40.6 28.4 51.0 47.3 29.6 60.8 21.9 45.4 187.5 20.5 86.6 67.6 1.7 0.2 0.0 0.4 0.1 0.2 0.7 1.6 0.4 0.6 0.3 0.4 0.3 1.1 0.3 0.1 0.7 6.2 0.4 0.6 0.9 0.6 1.3 0.7 1.0 0.7 0.8 0.7 0.8 0.6 1.0 1.0 1.1 3.2 0.5 1.6 5.5 6.2 3.9 5.8 5.2 1.7 3.9 6.0 4.6 32.9 4.1 7.3 0.0 17.3 6.0 4.5 3.9 3.4 7.8 5.5 8.0 3.5 1.8 34.5 3.3 1.1 35.6 5.3 6.1 9.9 0.0 21.1 3.6 1.2 11.1 0.0 2.5 9.2 2.0 0.0 5.2 3.1 1.5 3.2 0.0 2.8 3.2 2.8 3.1 1.5 1.6 2.9 3.9 1.2 17.7 3.1 8.0 9.4 2.5 1.7 0.0 3.1 7.8 48.9 49.8 9.5 4.8 7.8 5.1 4.8 16.7 3.0 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125442881-125592568 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 188.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 109.8;Horizontal cells: 166.5;Oligodendrocytes: 246.6" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 23.4;MAIT T-cell: 15.5" "Lineage enriched" "Detected in many" 23 "T-cells: 23.4" "Cell line enhanced" "Detected in many" "AF22: 48.3;HBEC3-KT: 66.0;NTERA-2: 68.6;SCLC-21H: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 16.1 5.5 114.9 3.0 139.7 0.9 11.4 144.4 126.4 21.4 58.5 29.8 1.7 23.7 2.3 6.2 14.8 6.9 27.6 99.3 123.4 6.7 5.6 34.5 1.9 144.8 143.5 89.5 12.8 2.5 1.9 17.7 3.8 138.2 15.5 3.3 18.9 6.5 7.6 6.0 7.4 12.7 8.4 153.7 8.8 16.0 12.8 132.2 0.5 10.3 3.1 1.4 26.8 17.0 188.6 0.3 0.0 48.3 0.2 39.2 25.3 0.0 10.3 14.6 3.8 0.6 0.2 0.3 0.1 16.3 21.1 11.4 0.5 31.2 66.0 2.4 2.3 0.5 37.6 0.1 0.0 25.3 0.0 0.6 23.1 17.6 11.5 29.3 0.4 32.0 0.0 4.5 0.6 3.8 1.5 0.2 0.0 68.6 0.5 1.2 0.0 0.1 0.2 0.0 30.3 54.3 5.5 0.3 0.1 1.4 27.3 4.9 26.4 19.3 0.4 2.4 0.2 11.1 0.6 0.5 0.1 7.9 0.0 26.6 0.2 0.8 0.0 23.4 0.1 15.5 0.1 0.9 5.1 0.4 0.0 0.6 5.5 0.2 1.0 0.0 0.1 0.0 4.4 114.9 139.7 144.4 126.4 99.3 123.4 144.8 143.5 89.5 138.2 153.7 132.2 188.6 4.9 0.0 5.2 53.2 0.8 8.0 4.9 96.9 6.2 23.1 0.5 10.3 109.8 2.8 9.6 0.0 2.1 8.0 23.3 0.1 27.4 2.8 68.6 0.8 14.2 13.9 5.4 0.0 41.0 0.4 1.2 43.0 0.5 0.5 0.0 11.1 58.9 1.0 91.6 166.5 48.7 0.0 16.2 24.9 15.5 65.9 25.4 2.3 78.2 12.2 1.9 97.1 74.2 32.2 246.6 0.3 0.0 35.3 0.9 12.7 0.0 2.1 3.8 17.8 19.7 25.4 35.6 28.8 7.7 0.2 5.5 4.2 7.8 5.5 0.1 3.5 ESAM W117m ENSG00000149564 "Endothelial cell adhesion molecule" Q96AP7 11 124752583-124762290 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.2;naive B-cell: 7.5" "Group enriched" "Detected in many" 9 "B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2" "Group enriched" "Detected in many" 10 "HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056293, HPA072563" Uncertain Approved "Cell Junctions,Cytosol" NA NA 82000000 "Cell Junctions" Cytosol "HPA056293: AB_2683089, HPA072563: " "unprognostic (1.52e-1)" "unprognostic (2.03e-1)" "unprognostic (1.05e-2)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.49e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (9.05e-2)" "unprognostic (2.99e-2)" "unprognostic (3.08e-1)" "unprognostic (3.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.24e-2)" "unprognostic (5.10e-2)" "unprognostic (2.29e-1)" "unprognostic (5.06e-2)" 93.9 17.9 36.8 9.1 32.5 1.9 80.1 34.1 47.3 32.2 29.8 19.8 7.1 36.5 7.9 22.0 34.5 20.1 65.4 30.9 33.7 40.8 11.6 113.5 8.7 37.1 34.3 27.5 14.5 13.7 13.3 14.9 107.8 37.5 20.0 7.9 2.5 15.8 15.7 27.3 16.8 21.0 29.7 32.2 17.4 23.6 4.3 38.0 5.4 96.7 50.2 8.3 31.0 30.4 36.9 1.2 1.6 0.4 1.2 0.0 0.3 5.1 0.1 0.1 0.0 0.1 2.7 14.1 1.2 3.2 0.0 0.2 0.0 3.7 0.0 0.0 1.8 1.3 218.8 0.1 8.0 0.6 0.4 3.6 0.0 0.0 0.0 0.0 0.2 277.9 0.1 0.2 5.9 0.5 1.8 0.0 0.0 0.6 20.8 2.1 0.0 1.0 0.9 0.0 2.4 0.2 0.8 0.1 16.1 0.0 7.5 3.3 0.8 142.0 0.4 0.4 0.5 0.0 0.2 0.2 0.2 0.1 0.5 0.4 8.2 0.6 0.0 0.1 0.3 0.0 2.1 1.5 0.1 0.4 7.5 2.2 0.8 6.5 0.0 0.0 0.4 0.4 24.8 36.8 32.5 34.1 47.3 30.9 33.7 37.1 34.3 27.5 37.5 32.2 38.0 36.9 405.9 38.5 56.0 2.0 4.5 15.2 0.5 0.2 2.8 18.5 2.5 3.2 11.2 0.0 3.0 14.7 4.2 1.8 2.5 3.5 5.9 7.6 5.0 1.1 1.5 301.0 0.0 5.3 1.5 2.4 18.7 13.8 3.6 1.4 3.8 0.1 138.1 1.7 1.1 0.0 0.4 0.4 0.0 5.3 22.1 26.3 0.9 25.7 12.4 20.6 1.2 0.7 0.0 0.5 0.4 46.5 2.1 0.4 2.8 1.8 0.1 0.1 1.9 1.3 151.2 4.6 89.4 0.1 0.9 0.8 10.9 37.1 2.0 2.4 1.6 2.3 KIRREL3 "KIAA1867, KIRRE, NEPH2" ENSG00000149571 "Kirre like nephrin family adhesion molecule 3" Q8IZU9 11 126423358-127003460 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 21.3" "Group enriched" "Detected in some" 16 "Excitatory neurons: 274.4;Inhibitory neurons: 482.6;Oligodendrocytes: 390.3" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "plasmacytoid DC: 8.3" "Lineage enriched" "Detected in single" 12 "dendritic cells: 8.3" "Cell line enhanced" "Detected in some" "BJ: 25.2;BJ hTERT+: 14.7;BJ hTERT+ SV40 Large T+: 9.3;BJ hTERT+ SV40 Large T+ RasG12V: 9.7;fHDF/TERT166: 18.3;U-138 MG: 11.3;U-251 MG: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053324 Enhanced "Intracellular and membrane" NA NA "HPA053324: " "unprognostic (1.92e-1)" "unprognostic (5.29e-2)" "unprognostic (1.06e-1)" "unprognostic (4.72e-2)" "unprognostic (2.50e-2)" "unprognostic (1.09e-1)" "unprognostic (4.49e-3)" "unprognostic (6.23e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (7.05e-3)" "unprognostic (3.81e-2)" "unprognostic (4.06e-6)" "unprognostic (9.91e-3)" "unprognostic (1.15e-1)" "unprognostic (2.76e-2)" "unprognostic (2.92e-1)" 0.1 1.4 17.3 0.5 21.3 0.3 0.1 4.0 19.2 0.5 0.1 2.8 0.4 0.1 0.0 0.4 0.1 0.2 1.3 14.4 8.1 0.2 0.1 0.0 0.6 10.1 14.0 15.9 0.5 0.2 0.0 0.1 0.3 11.4 0.3 0.4 2.6 1.4 1.1 0.0 0.1 0.8 0.5 5.9 2.5 0.6 0.2 15.6 0.0 0.1 0.2 0.5 0.6 0.3 17.9 0.4 3.0 0.2 0.0 0.0 0.1 0.2 25.2 14.7 9.3 9.7 0.0 0.1 0.0 0.1 18.3 0.1 0.1 0.0 0.0 5.7 0.1 0.0 0.1 0.4 0.0 0.0 0.3 0.7 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 6.1 0.2 0.4 0.5 0.0 0.0 1.3 0.0 0.1 2.8 0.2 0.1 0.2 0.0 0.0 0.1 0.4 0.0 11.3 7.8 4.5 14.1 0.0 0.0 0.0 0.1 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 17.3 21.3 4.0 19.2 14.4 8.1 10.1 14.0 15.9 11.4 5.9 15.6 17.9 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.2 0.0 17.3 0.1 0.1 2.2 1.5 0.4 0.0 0.0 0.0 5.4 0.9 0.0 0.1 5.2 0.0 0.1 0.2 0.0 0.0 274.4 0.0 0.0 0.5 0.0 0.1 1.3 0.3 0.4 0.0 0.0 0.0 482.6 0.4 2.0 0.0 0.3 12.9 0.0 0.2 1.8 18.7 0.1 0.5 0.0 23.1 390.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.2 0.1 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253416-118264536 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 224.3;urinary bladder: 157.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2" "Group enriched" "Detected in many" 10 "dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 38.8" HPA060740 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA060740: AB_2684352" "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.62e-4)" "unprognostic (2.08e-2)" 26.6 4.7 2.4 12.0 2.5 0.7 19.8 2.3 4.7 46.5 6.0 31.4 17.1 17.1 38.8 224.3 46.8 33.8 7.2 2.3 3.6 16.8 23.4 47.4 2.3 3.2 2.5 1.8 3.8 13.6 27.3 10.8 1.8 3.2 49.0 31.1 0.9 58.5 70.1 4.7 39.2 11.4 14.9 3.6 4.6 37.4 0.9 3.5 18.3 30.6 1.0 53.1 157.3 121.5 4.5 65.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 27.0 120.9 0.3 130.4 0.0 0.6 166.9 0.0 38.9 0.0 0.2 9.5 0.1 1.7 35.8 0.0 0.0 0.4 0.0 90.2 0.0 3.0 0.0 86.8 0.8 0.0 0.2 0.0 51.3 0.2 0.2 1.6 34.2 0.1 0.0 0.0 6.4 14.9 321.7 0.1 0.0 5.8 61.4 0.0 0.5 26.1 0.7 351.9 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 2.3 11.6 3.0 0.1 9.2 1.3 0.0 0.6 0.4 17.0 0.0 0.8 0.9 13.2 0.4 1.4 0.3 0.2 3.8 2.4 2.5 2.3 4.7 2.3 3.6 3.2 2.5 1.8 3.2 3.6 3.5 4.5 5.9 83.3 123.3 0.0 0.2 332.5 504.4 289.1 127.5 0.0 29.0 17.4 3.4 30.0 221.1 128.8 0.0 1.7 0.5 52.0 0.0 39.4 0.0 91.6 18.8 33.6 5.3 3.6 0.0 51.1 0.2 8.2 29.6 194.0 7.0 0.0 45.3 16.5 0.8 0.0 0.0 6.3 81.4 6.4 27.0 0.3 0.0 7.8 21.4 1.9 4.9 0.0 1.0 0.0 0.0 68.2 20.8 0.0 1.2 186.3 3.3 6.9 65.2 0.0 0.0 0.3 9.2 0.2 0.7 336.4 467.4 17.8 5.4 0.0 33.4 489.7 SCN2B ENSG00000149575 "Sodium voltage-gated channel beta subunit 2" O60939 11 118162806-118176639 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4;heart muscle: 12.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4" "Cancer enhanced" "Detected in some" "glioma: 1.3;thyroid cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.01e-2)" "unprognostic (3.50e-2)" "unprognostic (7.58e-2)" "unprognostic (2.12e-2)" "unprognostic (1.41e-2)" "unprognostic (4.02e-1)" "unprognostic (2.71e-4)" "unprognostic (5.17e-2)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (7.89e-2)" "unprognostic (1.61e-2)" "unprognostic (3.51e-2)" "unprognostic (1.27e-2)" "unprognostic (4.35e-2)" "unprognostic (4.55e-1)" "unprognostic (2.88e-3)" 0.6 1.5 15.1 0.3 21.0 0.0 0.7 16.3 34.4 1.4 0.0 1.3 0.6 1.6 1.4 1.8 1.3 1.3 12.9 22.0 13.5 0.4 0.0 1.2 0.0 7.4 15.3 21.4 1.3 0.1 0.0 0.8 0.0 14.6 1.1 0.7 3.7 0.5 1.2 7.3 0.2 1.1 1.9 3.0 0.1 0.3 0.2 20.0 1.8 0.7 7.6 0.0 0.3 0.4 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.1 21.0 16.3 34.4 22.0 13.5 7.4 15.3 21.4 14.6 3.0 20.0 22.6 0.1 0.0 0.0 3.9 0.0 0.4 0.6 0.7 1.8 8.8 0.1 2.0 16.8 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.5 0.2 0.0 0.0 21.9 0.0 0.0 1.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 13.5 32.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 1.9 0.0 0.9 0.0 2.5 7.4 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.1 1.9 0.0 0.9 0.8 0.1 0.6 0.0 0.1 0.0 0.1 0.5 0.0 0.3 SIDT2 CGI-40 ENSG00000149577 "SID1 transmembrane family member 2" Q8NBJ9 11 117178736-117197445 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 83.5;non-classical monocyte: 151.0" "Lineage enriched" "Detected in all" 7 "monocytes: 151.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052352 Approved NA NA "HPA052352: AB_2681797" "unprognostic (3.83e-1)" "unprognostic (4.30e-2)" "unprognostic (9.92e-2)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (1.69e-1)" "unprognostic (3.34e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (3.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (4.18e-5)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.36e-2)" "unprognostic (5.22e-3)" 40.6 25.3 23.8 21.4 27.4 12.5 36.6 26.4 26.8 31.5 19.3 29.0 44.6 30.8 16.1 15.2 31.6 18.6 28.0 23.8 23.9 20.6 41.1 36.7 23.6 34.0 28.8 21.4 60.7 114.3 13.7 36.0 22.6 32.3 49.0 23.3 14.6 31.8 21.4 25.4 32.1 42.7 20.9 31.4 34.8 76.6 28.7 27.8 10.1 32.0 12.4 20.6 26.4 20.5 49.1 8.7 8.8 10.5 15.4 34.4 30.7 34.8 14.8 19.5 9.3 8.6 25.1 32.8 8.9 23.1 39.1 11.7 9.0 10.2 11.5 7.6 13.2 12.4 6.3 15.8 17.3 17.8 5.3 15.5 38.1 12.8 12.0 12.9 28.6 19.1 11.4 12.0 19.2 22.1 18.2 7.5 6.2 4.9 45.6 6.5 5.6 7.2 25.5 12.2 9.1 3.2 7.9 15.8 38.1 2.6 11.7 30.8 6.3 11.9 12.3 7.9 8.2 3.4 13.6 5.3 9.4 7.1 10.8 9.2 0.3 14.2 0.5 1.9 83.5 1.5 18.3 1.1 1.3 11.5 21.2 1.7 1.3 1.7 1.5 151.0 6.2 1.4 9.6 23.8 27.4 26.4 26.8 23.8 23.9 34.0 28.8 21.4 32.3 31.4 27.8 49.1 12.2 6.4 12.3 11.8 24.1 67.7 25.4 4.1 4.0 13.0 11.1 13.0 7.9 4.3 4.5 11.0 6.2 9.2 6.7 16.7 0.0 4.4 7.4 11.6 22.2 12.7 11.4 8.2 7.7 9.6 33.4 19.7 61.2 11.2 2.5 43.5 16.4 25.6 16.9 18.5 8.8 32.9 2.0 54.2 29.3 11.5 13.4 30.6 19.6 7.5 13.6 6.1 7.2 12.1 16.8 8.0 9.4 13.5 6.6 20.5 40.7 1.8 6.0 12.1 19.7 46.1 18.7 5.8 4.8 4.2 42.9 32.3 9.5 38.2 13.5 15.5 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 6900000 "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: AB_2681535" "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 6.7 25.5 34.0 3.8 36.5 2.2 14.8 34.7 44.6 14.5 30.7 12.7 46.5 15.4 25.9 11.2 13.8 9.0 8.9 36.3 35.7 18.8 23.3 10.0 4.9 32.5 31.0 36.1 23.6 17.8 23.5 29.8 6.1 34.8 15.9 3.7 22.5 21.2 18.5 18.7 8.4 35.5 10.9 29.4 5.3 13.4 6.6 34.3 5.2 16.0 10.0 5.4 14.5 11.7 36.4 3.4 0.7 5.8 9.5 6.0 0.9 5.6 5.2 9.9 4.9 9.8 27.1 18.8 0.3 20.1 5.3 10.9 14.8 0.0 18.3 4.4 11.9 11.1 0.5 5.4 6.0 16.0 0.3 0.5 7.3 10.9 5.3 0.9 35.9 7.2 13.7 2.6 11.7 4.9 4.1 6.0 0.5 4.9 0.1 12.8 8.1 4.2 12.3 25.3 0.3 17.0 11.5 5.1 33.7 0.1 8.7 43.8 0.6 2.5 2.1 10.6 0.4 1.6 11.7 8.3 3.1 0.4 0.2 0.2 0.7 0.2 0.2 5.1 0.2 7.1 4.0 7.3 2.9 0.5 2.6 10.0 5.4 0.4 7.4 0.2 3.4 6.0 3.5 34.0 36.5 34.7 44.6 36.3 35.7 32.5 31.0 36.1 34.8 29.4 34.3 36.4 5.1 6.4 3.9 11.1 6.2 5.7 10.7 14.7 13.1 27.7 27.7 30.6 6.1 14.3 9.3 16.5 29.2 37.1 4.8 0.9 11.7 16.6 2.8 4.1 5.0 6.4 11.4 5.2 20.1 6.4 16.9 8.7 2.6 5.5 8.9 18.0 3.6 9.6 2.9 11.8 22.0 7.8 10.2 0.0 1.9 5.5 23.3 1.1 7.2 2.8 3.4 28.8 5.2 8.5 6.5 5.0 5.5 23.3 5.5 5.5 149.1 25.6 7.4 41.1 0.0 12.1 7.5 3.9 5.2 4.0 3.7 16.3 4.7 15.3 15.0 5.7 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199370-117207464 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 9709.3;intestine: 8197.3" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9" "Cancer enhanced" "Detected in all" "prostate cancer: 279.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 41.6;non-classical monocyte: 63.1" "Lineage enriched" "Detected in many" 12 "monocytes: 63.1" "Cell line enhanced" "Detected in all" "BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol No No 6300000 "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 1957.4 516.9 119.4 972.5 130.7 12.3 1695.0 123.4 200.7 3360.7 255.4 8197.3 455.2 9709.3 700.0 1972.9 4651.1 901.8 1034.7 116.3 122.9 774.0 305.3 1269.7 247.5 147.7 128.4 114.0 1657.2 220.4 65.8 256.6 350.9 130.8 4663.2 1165.3 23.1 465.6 6444.1 359.3 513.8 1965.1 7170.7 125.9 536.3 3175.0 204.1 129.0 52.6 729.2 153.8 60.4 5568.4 2351.1 127.0 17.5 5.5 293.3 8.2 140.0 123.8 226.7 1913.4 788.1 1641.8 609.0 1531.4 28.4 3.2 2145.6 2094.4 1.7 46.1 4.4 16.8 543.3 6.8 4.4 5.0 66.9 130.2 708.7 1.7 5.2 304.6 57.5 267.1 36.1 1499.7 3.3 4.5 3.3 6.7 1377.1 4.5 1.7 15.8 84.6 18.8 2.1 2.7 23.1 12.0 4.4 25.8 1.9 9.6 29.9 11.0 1.5 807.6 9.2 5.1 182.0 1598.8 276.9 14.4 86.6 8.9 8.8 21.7 9.1 7.7 6.2 1.8 2.7 0.1 0.3 41.6 0.5 3.6 0.1 0.0 3.2 5.1 0.2 0.1 0.3 0.0 63.1 1.6 0.5 2.1 119.4 130.7 123.4 200.7 116.3 122.9 147.7 128.4 114.0 130.8 125.9 129.0 127.0 264.8 38.5 6.1 4.6 10.3 63.9 453.4 248.6 10.8 9.9 74.0 2508.6 1.3 4.3 22.5 40.5 18.8 57.0 8.6 3.1 0.0 577.8 3.3 14.6 455.5 260.3 3.0 2.7 4.5 74.5 35.3 464.4 41.3 12.8 1.3 32.4 639.7 8.9 41.5 1.7 6.5 18.3 24.4 23.1 91.8 23.9 48.4 33.8 96.0 37.5 8.1 4.9 2.1 3.0 11.9 38.4 4.5 2306.4 3.2 414.0 12.1 2.2 23.0 9.9 2866.2 177.6 4563.9 6.0 13.7 8.6 60.9 32.2 15.1 8.3 3.1 62.0 JPH2 JP-2 ENSG00000149596 "Junctophilin 2" Q9BR39 20 44106590-44187188 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 69.5;skeletal muscle: 121.5" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 64.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9" "Low region specificity" "Detected in some" HPA052646 Approved NA NA "HPA052646: AB_2681899" "unprognostic (1.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.61e-4)" "unprognostic (4.71e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.06e-2)" "unprognostic (2.45e-3)" "unprognostic (6.87e-2)" "unprognostic (9.16e-2)" "unprognostic (2.57e-2)" "unprognostic (9.73e-2)" "unprognostic (4.76e-2)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "unprognostic (1.10e-2)" 5.4 1.9 0.6 4.5 0.5 0.1 5.8 0.4 0.9 14.4 1.3 44.0 2.1 52.1 3.0 12.0 30.3 3.5 69.5 0.4 0.4 1.4 0.3 5.3 0.2 1.2 0.9 0.4 3.9 0.4 0.1 1.2 3.8 0.8 24.0 4.5 0.2 5.8 22.3 121.5 3.3 11.9 27.8 0.8 1.3 16.2 0.8 0.7 0.1 1.5 48.7 0.1 40.8 10.7 0.6 7.5 0.8 0.4 0.0 0.3 0.4 1.5 2.2 4.1 5.4 2.3 15.3 5.9 0.0 15.0 19.1 6.1 10.5 0.0 0.5 2.1 0.0 0.0 0.0 12.6 0.1 0.1 0.3 0.0 0.7 1.1 2.7 3.7 3.3 0.0 0.0 0.0 0.0 7.3 4.3 0.0 0.2 0.3 0.0 0.9 1.7 3.4 0.0 0.4 0.1 0.0 0.1 12.9 3.1 0.1 8.6 10.8 0.1 0.3 2.4 2.7 0.5 4.7 0.1 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.9 0.4 0.4 1.2 0.9 0.4 0.8 0.8 0.7 0.6 0.2 0.0 0.0 0.3 0.0 6.6 0.5 0.9 0.0 0.0 0.4 5.1 64.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.8 0.0 0.5 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.2 0.0 6.6 15.9 12.8 0.0 1.5 0.0 2.0 0.5 0.1 0.0 0.2 0.1 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 212.2" "Group enriched" "Detected in many" 4 "Distal tubular cells: 273.9;Early spermatids: 288.8;Late spermatids: 979.4" "Cancer enhanced" "Detected in many" "renal cancer: 6.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.8;REH: 16.0;SH-SY5Y: 4.3;SK-MEL-30: 4.0;U-2 OS: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076649: AB_2686811" "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favorable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.6 6.0 5.8 0.2 6.3 0.1 3.4 10.0 5.9 5.4 3.8 1.6 0.5 3.4 9.0 1.0 1.5 0.7 6.1 4.2 7.4 50.1 0.7 1.6 0.6 14.5 7.8 4.2 5.2 2.4 13.1 8.7 0.7 9.3 6.6 0.1 0.6 2.1 3.1 0.9 1.2 1.5 0.3 7.2 2.8 2.4 212.2 6.7 0.3 9.7 0.3 0.2 2.5 2.7 8.3 0.2 0.2 0.1 1.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 4.8 0.1 1.0 1.9 0.2 2.6 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 3.4 0.6 0.0 0.0 16.0 1.8 0.1 0.0 0.0 2.1 4.3 2.6 0.0 4.0 0.1 1.1 0.9 0.0 0.0 3.6 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 6.3 10.0 5.9 4.2 7.4 14.5 7.8 4.2 9.3 7.2 6.7 8.3 2.9 0.0 0.0 1.3 0.8 0.6 1.3 0.0 0.0 0.6 3.6 4.4 2.5 1.5 0.0 18.4 4.2 0.0 0.4 0.1 273.9 2.4 288.8 0.6 4.0 2.2 1.8 0.0 1.7 1.0 0.1 2.9 1.5 0.6 0.0 7.0 1.8 0.1 0.6 6.7 2.6 0.4 0.0 0.6 1.9 979.4 8.7 1.2 7.2 0.0 0.6 2.9 0.0 3.0 4.7 0.6 0.0 10.9 0.0 0.9 0.0 55.3 0.1 0.3 0.0 2.5 3.3 121.5 6.0 0.3 0.1 0.1 0.3 7.5 0.7 0.4 COMMD7 "C20orf92, dJ1085F17.3" ENSG00000149600 "COMM domain containing 7" Q86VX2 20 32702699-32743467 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 225.9;Syncytiotrophoblasts: 264.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 331.1" "Low region specificity" "Detected in all" HPA054119 Approved Vesicles NA NA Vesicles "HPA054119: AB_2682388" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (9.90e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.31e-2)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.57e-2)" "unprognostic (2.98e-1)" "unprognostic (2.90e-3)" "unprognostic (5.04e-2)" "unprognostic (8.28e-2)" "unprognostic (8.52e-2)" "prognostic favorable (3.53e-4)" 34.4 39.0 59.0 23.3 60.2 40.8 36.9 57.3 87.8 27.8 56.3 37.9 18.3 29.4 49.5 27.4 27.5 25.9 52.3 59.3 58.2 51.6 44.9 29.7 30.2 57.4 61.0 58.5 24.3 37.1 41.1 17.8 38.8 57.7 35.9 30.6 24.9 31.9 31.5 67.0 36.2 26.6 33.5 56.4 37.1 36.3 11.6 59.1 26.0 50.2 54.9 34.2 38.6 28.6 58.1 69.9 45.2 43.6 30.9 32.4 58.7 80.3 59.8 96.8 96.4 66.0 88.0 44.0 55.3 51.1 71.4 80.3 30.6 38.0 49.7 72.0 22.3 25.2 154.8 25.3 65.6 83.6 63.5 84.2 45.6 61.1 73.9 43.3 76.1 95.9 30.1 55.8 26.7 62.4 51.4 55.4 133.2 37.4 68.6 43.9 51.4 4.2 19.0 103.2 46.6 26.8 41.3 59.1 81.6 101.3 47.5 48.3 101.6 65.3 97.3 54.0 61.8 61.3 29.8 25.6 18.6 119.0 331.1 39.6 116.9 105.8 162.7 76.5 144.0 67.7 63.5 61.4 70.9 122.7 61.2 67.7 64.6 10.4 99.9 165.2 82.2 75.1 166.2 59.0 60.2 57.3 87.8 59.3 58.2 57.4 61.0 58.5 57.7 56.4 59.1 58.1 71.3 22.4 17.9 10.1 43.2 16.6 31.4 44.4 23.9 56.8 58.7 50.2 48.3 47.1 32.1 36.8 68.8 225.9 70.5 33.6 88.0 102.8 3.1 27.7 25.8 54.8 33.0 36.6 19.6 118.5 116.5 36.8 31.1 31.1 53.3 49.2 44.3 39.8 124.3 67.3 25.4 44.4 59.0 46.4 30.9 4.6 37.6 69.6 56.9 16.9 92.7 81.8 123.6 4.5 10.3 118.7 47.0 47.8 35.3 32.8 27.6 124.3 23.3 74.3 46.0 27.0 49.3 13.1 19.1 36.8 28.8 264.5 75.6 36.9 45.8 37.9 C20orf144 "bclt, dJ63M2.6" ENSG00000149609 "Chromosome 20 open reading frame 144" Q9BQM9 20 33662327-33665619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1043 "testis: 179.0" "Group enriched" "Detected in some" 87 "Early spermatids: 2064.3;Late spermatids: 2549.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019029 Enhanced NA NA "HPA019029: AB_2670016" "unprognostic (2.16e-2)" "unprognostic (2.04e-2)" "unprognostic (2.32e-2)" "unprognostic (4.37e-2)" "unprognostic (2.09e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" "unprognostic (3.21e-2)" "unprognostic (2.13e-1)" "unprognostic (3.64e-2)" "unprognostic (4.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-1)" "unprognostic (3.36e-2)" "unprognostic (5.66e-2)" "unprognostic (2.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 179.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 2.3 0.0 0.5 2.9 0.7 0.1 0.0 0.9 0.3 0.3 0.3 0.0 1.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 2064.3 0.1 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 1.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 2.0 2549.4 16.4 1.6 12.4 0.0 0.0 0.4 2.1 0.0 0.1 0.2 0.1 10.9 0.5 1.0 0.0 0.2 0.1 2.6 6.6 0.9 0.4 26.5 10.2 0.0 1.6 0.3 0.5 0.3 0.1 0.4 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210503-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 95.7" "Group enriched" "Detected in some" 4 "Astrocytes: 63.3;Microglial cells: 67.5;Oligodendrocytes: 135.6" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 75.6;ASC diff: 11.3;ASC TERT1: 16.9;WM-115: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA051064: AB_2681331" "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 5.6 2.1 7.5 6.1 67.8 0.5 3.4 25.0 34.8 12.4 1.6 6.6 2.4 14.8 6.4 5.2 8.8 16.3 11.5 16.1 24.1 4.1 1.2 2.5 5.1 44.1 47.4 2.1 13.7 0.9 0.1 2.2 0.1 59.7 6.6 4.3 0.5 5.9 7.3 0.6 1.4 4.3 14.8 11.6 2.7 3.7 2.6 43.8 8.4 2.0 1.7 4.7 5.3 4.9 95.7 3.0 0.3 75.6 0.1 11.3 16.9 0.0 7.6 4.3 0.0 0.0 0.3 2.2 0.0 0.3 2.4 2.5 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.3 0.0 2.2 1.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 2.0 0.1 0.0 0.0 0.4 0.0 1.1 0.4 1.4 0.0 0.0 0.0 0.2 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 67.8 25.0 34.8 16.1 24.1 44.1 47.4 2.1 59.7 11.6 43.8 95.7 0.1 0.0 0.0 63.3 0.0 0.3 0.0 0.0 0.0 0.0 0.8 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.1 2.5 0.2 0.0 0.0 0.8 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.4 1.1 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.9 3.7 0.2 1.8 67.5 0.0 0.0 0.0 19.6 135.6 0.6 0.0 7.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 1.1 1.2 0.3 0.3 0.2 0.3 0.0 0.0 0.4 0.0 0.0 SPATA25 "C20orf165, dJ337O18.8, TSG23" ENSG00000149634 "Spermatogenesis associated 25" Q9BR10 20 45886489-45887635 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 304.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.7;HeLa: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA041386 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA041386: AB_2677446" "unprognostic (1.88e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-1)" "unprognostic (4.92e-3)" "unprognostic (2.36e-1)" "unprognostic (1.84e-2)" "unprognostic (2.75e-3)" "unprognostic (1.57e-2)" "unprognostic (2.57e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (1.67e-2)" "unprognostic (3.14e-1)" "unprognostic (5.07e-2)" "unprognostic (2.62e-1)" "unprognostic (5.93e-5)" "unprognostic (1.12e-1)" 3.0 1.8 1.5 1.8 2.5 0.6 1.6 4.2 2.4 2.4 3.8 2.6 4.6 3.2 2.3 2.2 2.8 2.1 3.2 1.3 2.6 5.4 5.2 1.1 1.5 2.2 1.9 1.1 6.5 2.4 2.5 1.6 1.8 1.8 2.1 2.2 4.3 2.5 3.1 10.0 2.7 3.3 3.6 1.2 1.8 1.6 24.2 2.2 6.8 2.9 3.4 1.1 3.1 2.1 2.5 0.6 2.1 1.5 1.7 2.3 1.4 1.7 0.4 1.8 0.9 0.3 6.7 3.7 1.2 0.5 0.8 1.9 2.8 0.8 0.5 0.3 0.4 1.4 0.6 6.2 4.4 1.7 0.1 1.0 3.2 1.0 0.4 0.5 2.4 0.6 2.0 0.9 1.6 0.7 1.4 0.8 0.0 0.9 0.6 1.1 1.6 1.0 0.8 0.1 0.9 2.9 1.6 1.9 1.3 1.9 0.6 2.2 1.6 0.5 1.1 1.2 0.8 0.6 1.4 0.9 0.3 1.5 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.5 4.2 2.4 1.3 2.6 2.2 1.9 1.1 1.8 1.2 2.2 2.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 304.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 58.3 2.1 0.1 0.0 1.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 1.1 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 OCSTAMP "C20orf123, dJ257E24.3" ENSG00000149635 "Osteoclast stimulatory transmembrane protein" Q9BR26 20 46540946-46550654 "Predicted membrane proteins, Transporters" Differentiation "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Langerhans cells: 1.9;Melanocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HMC-1: 2.2;Karpas-707: 1.3;NB-4: 2.5;RPMI-8226: 1.2;U-266/84: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA031116 Uncertain NA NA "HPA031116: AB_10600758" "unprognostic (2.77e-1)" "unprognostic (3.04e-1)" "unprognostic (8.80e-2)" "unprognostic (5.02e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "unprognostic (9.59e-2)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 component of MIS12 kinetochore complex" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 5.3 10.0 4.6 7.5 4.6 14.4 8.6 4.4 4.7 5.1 5.5 9.3 6.9 4.4 9.4 8.0 4.2 4.5 5.1 4.7 4.8 4.8 9.2 6.4 12.9 4.5 4.4 4.4 4.3 4.3 5.6 3.5 8.9 4.5 6.6 10.9 10.8 6.0 6.3 4.0 8.1 7.8 6.4 4.2 9.7 7.4 23.5 4.5 16.5 5.1 4.9 14.4 4.5 4.7 5.1 36.7 29.1 35.7 29.5 14.0 18.0 24.7 42.9 35.1 63.9 70.2 52.5 44.4 39.3 27.4 23.0 69.1 45.8 33.3 32.7 60.3 18.2 22.7 78.3 26.2 36.1 3.0 46.2 34.0 7.0 9.4 43.7 13.8 10.4 31.5 42.4 30.9 33.7 41.7 25.3 59.2 34.5 16.8 63.3 55.1 46.1 109.4 28.4 16.2 20.5 37.8 16.9 52.9 53.7 25.8 26.3 55.9 30.5 16.4 60.1 35.0 56.9 46.1 27.3 39.1 46.4 49.8 40.8 42.6 53.4 6.4 14.5 7.4 11.0 8.4 14.6 8.1 10.3 7.1 18.4 10.1 9.0 11.9 11.1 10.1 46.9 12.2 6.7 4.6 4.6 4.4 4.7 4.7 4.8 4.5 4.4 4.4 4.5 4.2 4.5 5.1 6.5 6.4 4.4 1.6 10.3 5.0 11.4 7.6 3.4 8.0 8.7 7.6 5.4 2.8 8.6 5.5 29.2 49.8 9.8 9.2 7.9 6.8 10.6 5.5 5.9 8.1 2.4 22.1 6.3 6.4 30.4 8.4 20.9 9.4 3.8 21.8 7.9 6.2 14.7 6.7 4.4 13.6 4.1 6.3 4.6 8.0 8.7 6.7 1.8 5.6 7.4 6.0 7.2 3.0 3.6 5.1 5.4 7.5 22.9 7.1 7.7 3.6 8.2 17.5 0.0 5.3 8.2 115.5 75.1 12.3 7.2 47.5 7.7 6.9 13.6 11.0 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777447-36863538 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 58.7" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 54.8;Oligodendrocytes: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.3 14.4 12.8 3.7 16.0 1.1 6.3 58.7 13.9 9.1 0.2 9.7 1.9 11.0 3.8 7.1 9.6 4.9 8.0 11.3 10.0 4.3 0.9 6.2 2.5 15.1 14.7 10.1 10.5 2.8 7.3 5.0 6.2 29.0 9.1 2.9 4.5 4.7 8.9 2.5 8.7 5.8 8.5 8.3 4.6 6.5 8.0 14.1 2.9 12.3 3.9 3.2 11.3 7.5 19.9 13.4 18.0 21.5 23.2 12.2 11.2 5.6 11.6 12.5 16.1 9.5 7.3 2.1 6.0 4.2 20.4 14.0 17.8 17.3 10.8 16.8 0.9 3.4 9.7 18.5 9.7 6.4 2.1 9.0 6.3 13.0 15.4 10.9 7.0 10.6 6.5 6.9 1.2 17.8 13.0 6.9 5.1 5.5 1.3 13.8 16.1 19.9 2.3 9.5 4.0 25.5 15.9 24.1 26.1 7.5 9.4 33.3 14.4 16.3 40.2 7.7 19.9 25.7 2.4 0.6 5.8 17.1 2.8 26.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 12.8 16.0 58.7 13.9 11.3 10.0 15.1 14.7 10.1 29.0 8.3 14.1 19.9 16.5 0.0 1.8 18.9 4.4 12.6 5.4 6.3 13.6 26.3 9.6 8.9 16.1 5.7 6.7 20.2 37.5 15.6 11.3 1.7 1.9 3.8 0.9 8.6 20.5 14.5 6.0 1.3 19.9 1.5 10.2 12.0 0.5 21.9 10.8 33.0 10.4 0.6 10.0 23.5 30.3 1.5 0.0 7.6 10.7 2.4 12.2 8.1 5.4 21.5 4.5 17.8 0.0 54.8 50.9 1.4 2.4 18.8 1.8 6.0 2.1 1.5 3.9 3.8 13.1 23.2 16.9 0.5 1.3 13.7 16.1 3.3 1.4 14.0 3.0 2.9 CNBD2 "C20orf152, CNMPD1, dJ954P9.1" ENSG00000149646 "Cyclic nucleotide binding domain containing 2" Q96M20 20 35954564-36030700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.1" "Cell type enhanced" "Detected in many" "Early spermatids: 173.9;Late spermatids: 99.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA043182 Uncertain NA NA "HPA043182: AB_10794389" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.58e-1)" "unprognostic (3.27e-2)" "unprognostic (2.81e-2)" "unprognostic (6.59e-3)" "unprognostic (2.77e-2)" "unprognostic (6.71e-2)" "unprognostic (2.22e-1)" "unprognostic (1.44e-1)" "unprognostic (4.82e-4)" "unprognostic (1.63e-1)" "unprognostic (1.29e-1)" "unprognostic (2.05e-1)" "unprognostic (2.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" 2.3 4.5 6.0 1.8 6.3 8.9 3.9 6.6 7.8 2.8 6.3 4.0 3.8 3.1 12.6 3.1 2.8 1.6 3.8 5.9 6.3 7.8 5.6 2.4 4.1 6.3 6.3 6.0 2.7 7.1 5.8 5.0 1.7 6.2 3.8 2.9 15.9 4.2 2.6 23.9 5.7 4.6 1.9 6.2 5.8 3.8 26.1 6.2 4.4 4.7 16.9 3.4 2.8 2.6 6.5 2.2 3.3 4.4 4.4 3.7 1.8 2.9 0.5 1.9 3.5 3.2 8.2 4.7 3.9 1.5 2.7 2.6 3.5 3.4 5.9 3.5 1.5 5.4 5.8 10.7 17.1 3.0 3.2 1.4 3.5 5.4 2.7 2.9 1.7 5.4 6.2 1.7 19.0 2.2 5.7 3.4 8.7 1.1 3.1 4.9 3.2 3.2 13.8 4.8 1.9 9.6 4.1 2.0 5.6 4.4 1.2 2.6 5.3 2.3 2.4 4.1 1.6 0.4 15.9 10.0 9.9 2.4 5.5 0.7 2.1 0.4 0.1 1.5 2.0 0.3 1.0 0.6 0.7 0.2 2.1 0.7 0.4 0.6 3.7 0.8 0.4 3.4 0.5 6.0 6.3 6.6 7.8 5.9 6.3 6.3 6.3 6.0 6.2 6.2 6.2 6.5 8.3 0.0 6.5 7.8 11.7 0.3 9.3 0.1 8.6 10.8 18.3 23.5 0.6 14.3 3.1 11.0 22.9 7.0 32.1 13.6 29.4 4.4 173.9 7.8 6.5 5.5 12.7 8.6 4.1 5.5 7.1 4.5 11.2 6.1 1.3 4.7 8.2 9.7 8.0 23.5 6.7 16.2 0.0 13.8 0.4 99.0 6.5 7.9 0.0 3.7 4.6 21.1 9.2 7.5 5.9 3.3 13.9 3.0 20.8 6.9 19.1 19.5 2.2 39.7 19.7 7.1 5.9 20.2 16.4 18.4 0.1 4.9 20.5 5.8 10.3 7.0 SPINT4 "C20orf137, dJ601O1.1" ENSG00000149651 "Serine peptidase inhibitor, Kunitz type 4" Q6UDR6 20 45722347-45725830 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 255 "epididymis: 281.3" "Cell type enriched" "Detected in single" 9 "Rod photoreceptor cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" HPA046703 Enhanced "Secreted in male reproductive system" NA NA "HPA046703: AB_2732530" "unprognostic (3.61e-1)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 281.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173739-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 18.8" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 48.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA012164, HPA012715" Uncertain Supported NA NA "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.1 1.5 10.7 0.0 5.8 0.0 0.1 18.8 15.3 0.2 0.0 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.6 6.3 2.2 0.2 0.0 0.0 0.0 1.1 2.5 7.4 0.3 1.7 0.0 1.4 0.0 6.5 1.1 0.0 1.2 0.2 0.5 0.5 4.1 0.1 0.0 0.7 0.0 0.2 1.1 3.0 0.0 0.1 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 5.8 18.8 15.3 6.3 2.2 1.1 2.5 7.4 6.5 0.7 3.0 3.4 0.0 0.0 0.0 1.3 0.0 0.8 1.3 0.0 1.8 9.3 0.0 0.0 3.5 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.4 4.0 0.0 0.0 0.3 7.1 0.0 48.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.4 7.2 0.3 0.0 0.0 4.7 0.0 0.8 0.0 12.1 1.7 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.3 0.6 0.3 0.0 0.1 0.0 0.1 0.0 0.0 LSM14B "bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B" ENSG00000149657 "LSM family member 14B" Q9BX40 20 62122461-62135374 "Predicted intracellular proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 16 "Early spermatids: 215.2;Late spermatids: 560.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041274, HPA061189" Approved Supported Vesicles NA NA Vesicles "HPA041274: AB_2677388, HPA061189: AB_2684448" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-2)" "unprognostic (1.20e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.61e-5)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (5.43e-2)" "unprognostic (4.93e-3)" "unprognostic (4.69e-2)" "unprognostic (3.34e-3)" "unprognostic (6.61e-2)" "unprognostic (2.00e-1)" "unprognostic (4.53e-3)" "unprognostic (1.98e-1)" 19.1 24.1 27.7 21.2 30.3 26.9 20.0 40.0 34.8 27.7 20.4 25.6 23.6 31.5 14.3 31.8 25.9 14.7 33.6 32.0 26.0 19.1 24.5 19.5 23.7 25.5 27.4 31.6 37.7 30.7 21.5 25.1 15.0 29.6 22.2 14.4 31.5 23.9 17.6 72.3 34.8 23.0 17.7 22.7 21.9 23.5 52.3 27.7 29.1 21.1 45.7 18.0 26.7 27.6 28.3 44.4 41.6 65.0 62.5 29.0 30.3 55.3 46.0 34.1 93.7 40.9 123.4 30.1 46.5 51.7 31.9 67.9 62.9 31.5 39.6 46.4 19.2 22.9 112.3 57.8 74.3 40.0 48.6 65.1 26.1 70.4 39.1 36.1 36.7 24.3 53.8 61.4 32.7 33.0 58.7 81.2 72.7 40.2 70.8 61.0 104.3 128.5 36.9 25.5 51.7 88.8 77.0 83.9 73.5 61.3 37.5 91.6 60.9 31.8 132.9 90.0 69.1 47.3 40.8 52.1 56.8 58.5 31.7 43.4 0.0 0.4 2.2 0.3 0.3 0.1 0.5 0.2 0.4 0.3 0.5 0.2 0.3 0.6 0.0 0.2 0.4 0.2 0.1 27.7 30.3 40.0 34.8 32.0 26.0 25.5 27.4 31.6 29.6 22.7 27.7 28.3 8.6 9.6 6.8 9.1 7.3 9.7 3.5 4.7 5.2 15.1 8.4 7.1 22.8 7.2 7.9 1.8 8.4 6.4 15.3 13.5 1.9 5.0 215.2 13.3 14.1 8.0 13.9 9.5 6.2 5.3 6.0 7.5 8.2 10.3 5.1 14.8 5.0 11.6 8.6 8.4 6.8 12.0 6.1 13.2 6.8 560.0 13.4 8.8 3.6 7.5 8.2 17.2 7.2 5.0 8.4 7.1 8.2 15.8 4.7 9.2 9.7 6.7 12.1 20.3 0.0 9.5 6.4 11.2 23.1 7.6 10.1 5.2 6.9 13.4 12.4 3.0 YTHDF1 "C20orf21, FLJ20391" ENSG00000149658 "YTH N6-methyladenosine RNA binding protein 1" Q9BYJ9 20 63195429-63216139 "Predicted intracellular proteins" Immunity RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 244.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (7.96e-4)" "unprognostic (2.52e-2)" "unprognostic (1.30e-1)" "unprognostic (3.47e-2)" "unprognostic (1.40e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (6.34e-2)" "unprognostic (1.98e-1)" "unprognostic (2.14e-1)" "unprognostic (1.75e-2)" "unprognostic (1.68e-1)" "unprognostic (1.13e-1)" "unprognostic (4.09e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.60e-4)" "unprognostic (3.37e-2)" 22.3 21.9 29.8 17.4 28.6 41.5 19.9 29.2 31.3 18.8 25.8 20.3 18.7 21.1 25.1 20.1 20.6 19.1 19.3 28.5 31.2 20.0 31.3 23.8 24.7 32.7 30.5 27.5 19.7 25.9 26.8 28.8 24.1 29.6 20.2 17.9 19.1 24.3 17.6 46.9 25.3 21.5 19.1 29.1 24.5 23.4 18.6 29.9 25.1 26.5 35.8 22.6 21.2 17.5 30.0 46.0 54.6 43.8 48.3 42.1 30.5 106.5 32.6 36.4 99.3 43.0 244.5 51.8 45.7 66.7 36.0 48.7 55.4 54.6 68.3 70.7 20.8 33.7 56.7 48.5 87.4 52.6 53.2 65.2 38.6 80.3 41.0 45.1 32.4 41.2 36.5 70.8 45.8 33.6 60.2 78.1 66.6 53.4 78.2 54.9 59.1 70.3 51.5 38.8 55.8 59.7 36.1 67.7 131.1 66.3 71.3 63.8 69.5 38.4 91.4 99.4 43.9 50.7 53.8 40.6 55.6 45.9 53.8 42.2 0.0 1.9 3.2 3.1 1.8 3.6 2.9 3.1 2.0 2.3 2.3 3.4 2.5 2.0 2.6 1.8 3.1 3.2 1.1 29.8 28.6 29.2 31.3 28.5 31.2 32.7 30.5 27.5 29.6 29.1 29.9 30.0 24.4 19.2 24.8 14.7 15.5 34.3 16.1 11.0 13.6 19.6 28.9 21.7 15.3 14.3 13.2 20.2 8.4 15.9 26.4 15.3 7.9 15.5 3.2 15.8 19.9 22.7 29.2 12.0 15.5 17.3 26.1 17.1 15.8 18.4 12.0 19.9 20.7 31.9 33.6 28.6 17.7 17.8 4.1 26.1 19.4 3.6 17.4 17.3 12.4 12.2 13.8 25.1 14.4 20.1 22.5 37.6 10.3 17.7 23.5 27.8 12.8 16.5 12.7 21.0 6.6 24.1 17.8 37.8 33.4 15.8 41.8 16.0 16.8 18.5 19.3 25.1 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.3" "Cell type enhanced" "Detected in many" "Early spermatids: 51.3;Late spermatids: 25.6;Spermatocytes: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.4 3.1 7.3 4.2 6.9 8.2 2.8 11.2 9.2 3.9 3.4 4.2 2.9 3.5 2.7 3.2 4.8 2.2 9.1 7.1 7.4 2.6 4.0 3.0 5.1 7.7 7.1 6.6 4.3 3.3 3.9 5.9 2.8 8.5 4.3 3.2 5.7 3.3 3.1 5.9 4.3 4.5 3.3 5.8 4.2 4.0 31.3 7.6 5.4 5.1 4.1 4.4 3.8 3.3 7.1 16.3 12.0 20.4 20.9 3.1 4.4 2.8 9.2 8.9 24.8 11.4 43.6 9.1 16.3 7.6 5.9 33.9 10.1 12.6 6.0 9.6 7.3 6.9 19.0 6.3 10.6 5.5 7.8 9.4 2.7 6.7 7.1 2.6 4.4 5.8 20.8 4.9 13.9 5.6 20.0 20.6 6.2 6.8 16.4 13.7 28.1 17.2 7.1 3.7 10.6 11.1 16.8 13.3 17.4 3.6 7.6 11.9 11.7 6.0 22.7 6.8 30.3 9.5 13.3 11.7 19.4 20.4 8.8 12.1 0.0 0.2 0.0 0.7 0.3 0.4 0.5 0.4 0.5 0.3 0.2 0.2 0.3 0.2 0.4 0.3 0.2 1.3 0.1 7.3 6.9 11.2 9.2 7.1 7.4 7.7 7.1 6.6 8.5 5.8 7.6 7.1 1.5 3.2 1.7 2.0 2.1 0.9 0.5 1.7 2.8 6.0 2.9 2.4 10.7 2.8 2.5 0.0 4.2 1.3 3.1 3.5 1.9 2.2 51.3 1.1 1.2 1.6 3.5 1.7 4.4 2.4 0.7 2.6 3.6 2.2 0.0 5.3 2.2 1.4 2.1 13.5 5.2 4.1 0.0 1.6 3.0 25.6 1.8 2.0 0.0 1.0 1.0 1.9 1.0 3.5 3.3 2.1 2.3 3.4 2.5 0.7 1.8 0.7 0.2 3.4 0.0 3.0 1.3 21.8 6.9 1.3 2.0 2.3 2.0 1.0 2.8 0.6 LTO1 "CIAB1, ORAOV1, TAOS1" ENSG00000149716 "LTO1 maturation factor of ABCE1" Q8WV07 11 69653076-69675416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 4.2;Cardiomyocytes: 2.7;Cytotrophoblasts: 7.9;dendritic cells: 3.6;Extravillous trophoblasts: 3.5;Hofbauer cells: 6.7;Syncytiotrophoblasts: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062696 Approved Nucleoplasm NA NA Nucleoplasm "HPA062696: AB_2684837" "unprognostic (2.15e-1)" "unprognostic (1.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (6.76e-3)" "unprognostic (4.65e-2)" "unprognostic (9.87e-3)" "unprognostic (1.82e-1)" "unprognostic (6.51e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (2.77e-1)" "unprognostic (5.19e-3)" 10.7 15.8 19.4 8.2 20.9 8.5 11.7 20.0 22.6 13.7 17.0 13.7 8.9 13.2 17.9 16.2 13.0 4.7 13.7 19.4 19.1 15.5 14.9 10.0 9.9 20.4 19.8 19.8 14.9 19.6 5.7 16.3 5.5 22.1 17.6 6.7 5.9 12.4 6.1 10.4 17.4 13.8 5.8 18.7 18.1 15.2 13.3 19.9 8.7 14.0 5.3 9.0 14.5 14.0 24.7 75.8 16.1 11.1 12.9 11.0 9.5 13.4 24.6 13.4 18.5 10.6 26.6 24.1 17.3 12.8 15.0 14.0 30.6 15.5 13.1 22.7 9.9 20.3 18.0 32.1 17.2 16.9 13.5 10.8 11.1 16.6 20.4 20.5 10.7 13.7 15.8 18.7 11.5 18.2 24.9 12.6 25.6 11.8 33.1 30.7 11.5 18.8 14.8 12.1 11.9 13.2 12.0 16.9 13.0 58.9 9.4 19.4 14.3 14.9 19.7 16.3 31.5 20.1 15.4 11.0 13.5 30.9 15.0 18.9 1.5 3.3 2.8 5.5 2.9 4.3 5.7 5.0 3.8 3.8 4.5 6.1 5.3 3.4 2.9 7.4 5.4 6.4 2.9 19.4 20.9 20.0 22.6 19.4 19.1 20.4 19.8 19.8 22.1 18.7 19.9 24.7 4.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 7.9 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.7 0.5 0.0 0.0 0.0 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone subunit alpha 2" Q96T91 11 64934471-64935893 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pancreas: 363.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.5;Exocrine glandular cells: 17.4;Pancreatic endocrine cells: 2.4;Spermatocytes: 7.7;Spermatogonia: 3.2" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Region enhanced" "Detected in some" "cerebellum: 3.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "Hep G2: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067068 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.0 0.1 0.4 0.2 0.5 0.1 0.1 3.0 0.6 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.4 17.1 0.0 0.3 0.2 0.8 0.7 0.3 0.6 0.4 0.5 0.2 2.7 363.5 0.0 28.2 0.0 1.5 0.7 0.0 0.1 0.3 0.5 0.0 0.5 0.5 0.0 0.2 0.6 1.1 10.9 0.2 0.1 0.3 0.0 0.5 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 21.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 3.0 0.6 0.3 0.2 0.4 0.5 0.2 1.5 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 17.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 7.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 SLC22A9 "FLJ23666, OAT4, OAT7, UST3" ENSG00000149742 "Solute carrier family 22 member 9" Q8IVM8 11 63369785-63410294 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 46.7" "Cell type enhanced" "Detected in some" "Erythroid cells: 2.7;Excitatory neurons: 5.0;granulocytes: 4.5;Hepatocytes: 15.4" "Cancer enriched" "Detected in single" 166 "liver cancer: 19.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.45e-1)" "unprognostic (7.24e-2)" "unprognostic (8.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (2.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.09e-2)" 0.1 0.0 0.5 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.3 0.3 0.2 46.7 0.0 0.1 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.5 0.6 0.0 1.7 1.3 0.3 0.0 0.1 1.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 2.7 5.0 0.2 0.0 0.1 0.0 0.0 4.5 0.1 0.0 15.4 0.0 0.0 0.3 0.0 0.0 0.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 TRPT1 MGC11134 ENSG00000149743 "TRNA phosphotransferase 1" Q86TN4 11 64223799-64226254 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.3" "Cell type enhanced" "Detected in many" "Early spermatids: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038705, HPA038706" Uncertain Approved Mitochondria NA NA Mitochondria "HPA038705: AB_2676161, HPA038706: AB_10671863" "unprognostic (2.50e-2)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" "unprognostic (3.59e-2)" "unprognostic (7.20e-2)" "unprognostic (1.53e-1)" "unprognostic (5.84e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-3)" "unprognostic (1.12e-1)" "unprognostic (7.71e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-1)" "unprognostic (1.99e-1)" "unprognostic (4.58e-3)" 26.9 39.2 31.0 14.2 32.4 8.5 27.8 34.4 36.5 26.5 31.4 33.2 22.4 23.3 21.5 35.5 26.5 15.5 77.3 29.7 32.3 52.3 46.9 20.5 16.4 33.3 32.0 28.0 26.2 51.8 19.3 35.4 10.9 32.0 36.3 18.5 12.8 39.3 28.6 175.3 27.5 30.5 12.1 31.9 31.0 42.2 51.5 33.9 21.3 33.8 117.1 17.7 30.3 26.0 32.6 25.1 24.5 26.5 43.0 32.0 23.5 32.2 16.4 31.6 28.7 24.0 16.1 37.1 24.7 63.6 27.4 22.2 34.1 11.8 35.7 10.1 23.8 14.2 12.7 23.8 28.0 46.4 16.2 21.4 17.7 20.7 31.6 28.1 52.7 20.4 49.0 22.3 27.1 24.2 59.4 30.3 33.7 16.8 33.3 26.1 39.3 19.5 71.4 74.4 29.1 23.0 33.4 13.2 32.1 47.5 18.0 37.1 25.8 23.9 19.4 14.9 37.9 16.4 53.0 14.3 16.3 46.7 8.3 32.1 11.0 16.9 28.5 18.8 31.2 15.0 38.0 18.5 19.9 24.4 39.9 20.1 23.3 15.8 26.1 27.4 59.0 25.2 12.0 31.0 32.4 34.4 36.5 29.7 32.3 33.3 32.0 28.0 32.0 31.9 33.9 32.6 17.1 9.6 23.1 9.8 31.4 13.3 18.7 32.7 28.5 8.9 40.4 45.3 42.5 32.9 25.5 27.6 0.0 44.4 17.0 66.3 95.9 41.4 147.5 41.3 20.1 17.5 26.9 14.9 2.8 58.4 46.7 19.8 41.8 27.5 24.6 10.0 21.0 30.0 25.5 10.1 4.9 111.3 30.5 18.9 12.8 82.1 19.9 15.0 37.4 2.8 27.2 32.1 15.5 7.5 6.8 46.6 60.5 17.0 47.1 24.0 92.0 82.9 48.2 11.6 6.6 22.4 29.3 59.6 13.4 42.8 18.5 36.0 21.8 20.2 40.3 22.6 NUDT22 MGC13045 ENSG00000149761 "Nudix hydrolase 22" Q9BRQ3 11 64225941-64230686 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039334, HPA053464" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA039334: AB_10795174, HPA053464: AB_2682160" "unprognostic (2.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.73e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-1)" "unprognostic (7.65e-2)" "unprognostic (6.61e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.76e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-1)" "unprognostic (8.54e-2)" 21.0 35.0 9.7 12.7 10.5 16.3 21.9 11.7 18.2 19.0 12.0 32.0 30.5 18.7 4.7 34.5 18.7 9.1 48.5 9.7 11.2 44.0 49.2 22.2 17.5 11.7 10.7 7.8 15.9 45.8 14.2 25.1 10.4 11.2 26.4 8.3 1.1 30.8 14.9 42.8 27.3 36.6 6.0 10.7 42.3 38.4 10.9 12.7 13.0 31.9 19.9 10.5 26.2 21.7 11.0 35.5 22.7 5.4 22.6 8.1 9.7 20.1 15.0 15.1 10.3 9.5 14.8 29.1 16.6 38.4 14.6 15.5 36.1 3.2 23.0 1.3 21.6 9.2 22.6 15.6 15.4 24.2 14.9 35.5 15.2 16.9 10.8 11.7 7.9 16.9 19.5 11.1 17.7 12.2 53.1 20.4 27.1 8.5 21.5 47.0 25.1 9.2 62.4 17.9 19.4 12.6 19.9 12.8 47.8 58.8 2.1 48.9 16.3 15.9 17.0 16.2 54.5 12.6 66.2 28.5 10.6 58.7 17.0 20.4 40.6 69.1 52.5 53.4 88.7 48.1 63.4 47.0 52.8 72.7 77.3 40.8 44.7 42.7 52.1 86.2 121.4 64.9 52.1 9.7 10.5 11.7 18.2 9.7 11.2 11.7 10.7 7.8 11.2 10.7 12.7 11.0 18.8 3.2 14.6 5.5 42.6 12.0 28.9 78.8 19.4 14.7 34.6 30.1 3.7 48.6 36.6 40.5 12.5 107.9 51.5 94.1 164.4 61.8 15.5 19.0 27.2 20.3 37.2 14.5 4.8 87.4 50.9 20.1 47.4 27.8 15.2 15.5 23.2 54.3 57.7 30.3 5.6 98.1 61.1 50.1 21.8 9.6 20.2 40.0 33.8 4.7 70.8 26.5 49.4 1.5 3.5 68.0 93.0 19.5 65.8 33.6 133.5 144.8 13.6 18.0 13.1 20.2 45.0 6.6 8.2 34.3 17.5 67.5 37.5 43.6 73.6 33.0 FERMT3 "KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2" ENSG00000149781 "Fermitin family member 3" Q86UX7 11 64206678-64223891 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 182.2;lymphoid tissue: 131.1" "Cell type enhanced" "Detected in many" "dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065231 Approved Vesicles NA NA 160000000 Vesicles "HPA065231: AB_2685439" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.38e-3)" "prognostic favorable (9.89e-4)" "unprognostic (8.77e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.46e-1)" "unprognostic (4.20e-1)" "unprognostic (3.98e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.12e-5)" "unprognostic (3.08e-3)" "unprognostic (5.25e-2)" "unprognostic (4.97e-2)" "unprognostic (1.75e-1)" 24.3 14.6 12.7 63.9 11.9 182.2 13.1 11.3 18.2 7.7 11.0 14.5 22.2 8.5 0.7 6.4 13.7 15.8 11.2 12.9 13.2 11.1 12.6 46.6 89.9 13.6 11.1 7.9 5.1 7.0 1.4 6.0 15.2 14.3 8.3 8.1 0.6 10.8 4.4 6.0 6.8 34.3 9.5 14.2 131.1 29.9 4.5 13.9 49.1 10.1 4.6 42.2 20.0 7.3 18.4 1.2 1.6 0.5 0.9 0.3 0.8 2.0 1.4 0.2 0.4 0.3 2.6 2.3 32.6 3.2 6.3 0.7 2.4 1.0 0.5 0.5 83.9 0.6 306.9 1.6 0.1 10.8 135.9 314.2 1.2 1.1 5.2 0.0 0.5 81.2 77.0 7.3 127.6 8.6 3.5 121.8 174.1 1.2 1.0 2.3 72.4 8.8 0.7 0.3 0.7 1.9 0.5 0.7 4.5 1.7 0.7 2.0 92.6 7.8 1.1 2.5 1.9 0.9 1.5 3.3 59.4 19.5 138.9 86.6 204.1 207.0 236.5 120.0 192.6 114.9 54.5 94.1 112.0 162.0 53.1 60.9 80.6 184.6 102.4 151.2 195.7 120.9 292.6 12.7 11.9 11.3 18.2 12.9 13.2 13.6 11.1 7.9 14.3 14.2 13.9 18.4 3.8 9.6 14.7 0.7 52.1 4.7 0.9 0.3 3.4 0.5 3.3 5.2 2.4 4.3 3.9 0.0 0.0 1.2 118.3 6.1 0.0 0.8 0.4 4.3 5.6 7.9 0.0 62.5 1.2 2.4 1.4 5.4 19.9 7.3 96.4 0.4 19.6 1.4 193.1 0.0 1.5 32.1 0.0 95.8 88.0 0.9 0.9 232.9 17.8 5.6 142.9 0.3 93.7 1.0 1.5 4.3 10.9 2.6 35.2 0.9 8.2 0.4 1.0 0.3 6.6 13.7 6.6 1.2 0.8 1.9 4.5 2.6 78.5 1.4 15.0 0.7 PLCB3 ENSG00000149782 "Phospholipase C beta 3" Q01970 11 64251530-64269150 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 114.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009257, HPA039279, HPA043907" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 210000 Nucleoplasm "Golgi apparatus" "CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "unprognostic (2.86e-1)" "unprognostic (2.35e-1)" "unprognostic (9.35e-2)" "unprognostic (6.23e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.44e-2)" "unprognostic (6.61e-2)" "unprognostic (1.26e-1)" "unprognostic (8.07e-3)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (5.04e-3)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (3.88e-2)" 12.6 19.2 5.9 9.8 6.0 7.5 11.3 7.7 8.1 18.3 6.1 18.7 114.8 18.0 3.7 35.6 16.6 7.2 10.8 5.4 6.5 10.7 6.4 15.8 4.4 8.1 6.7 4.4 15.9 8.7 10.0 5.8 10.4 7.0 13.3 12.6 1.5 13.6 10.5 6.8 20.4 102.4 11.5 7.1 14.6 14.8 9.6 7.8 4.0 10.4 4.2 5.4 13.9 19.0 7.2 45.2 24.9 24.0 36.0 24.6 18.9 23.8 35.3 26.4 29.5 17.9 22.1 33.5 3.2 20.8 44.4 25.4 75.9 27.2 33.0 10.1 21.8 15.1 35.1 54.9 16.7 17.0 8.6 22.3 16.0 21.5 32.1 23.6 32.2 43.5 13.4 17.6 3.8 37.9 54.5 10.9 17.9 38.8 56.9 26.9 23.5 54.0 13.3 18.2 46.8 6.4 26.4 52.0 64.4 25.2 14.8 33.9 16.4 76.4 27.1 32.0 62.7 23.2 4.6 2.4 3.6 44.8 19.9 25.5 0.0 0.4 0.0 0.2 0.4 0.2 0.0 0.2 0.1 0.4 0.0 0.1 0.1 0.2 0.1 0.4 1.2 0.0 0.1 5.9 6.0 7.7 8.1 5.4 6.5 8.1 6.7 4.4 7.0 7.1 7.8 7.2 11.2 3.2 7.9 7.5 1.8 13.0 6.0 6.4 6.2 1.2 6.1 4.6 3.3 8.6 6.3 16.5 0.0 9.2 8.3 52.3 1.9 7.8 1.3 3.5 8.7 13.2 2.4 7.8 0.6 7.7 19.1 7.6 28.5 7.1 5.7 20.2 18.2 3.4 9.8 3.3 0.9 46.2 12.2 10.1 13.5 1.4 9.9 8.8 8.8 8.4 22.1 4.7 2.1 1.5 0.6 17.3 23.8 12.4 2.6 7.4 161.7 4.0 2.8 1.1 26.3 6.0 9.8 3.1 8.3 19.4 11.8 14.6 2.7 6.8 65.5 8.3 MRPL49 "C11orf4, L49mt, NOF, NOF1" ENSG00000149792 "Mitochondrial ribosomal protein L49" Q13405 11 65122183-65127371 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 93.9;Syncytiotrophoblasts: 111.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046778 Approved NA NA "HPA046778: AB_2679802" "prognostic unfavorable (3.79e-4)" "unprognostic (2.21e-1)" "unprognostic (6.07e-3)" "unprognostic (1.05e-1)" "unprognostic (2.50e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-2)" "unprognostic (2.74e-1)" "unprognostic (5.36e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.53e-1)" "prognostic favorable (4.22e-15)" "unprognostic (9.09e-3)" "unprognostic (1.12e-2)" "unprognostic (6.68e-2)" "unprognostic (7.45e-3)" 21.8 88.1 26.0 22.1 27.0 27.0 35.6 24.6 27.7 28.2 28.4 33.9 28.4 28.5 42.1 43.3 42.5 21.5 32.7 26.5 28.1 55.6 51.3 28.3 31.1 26.4 26.6 26.0 43.2 27.1 43.2 36.2 27.2 27.7 35.7 35.1 17.1 29.4 39.8 38.3 40.0 28.5 30.3 25.4 26.2 29.4 18.2 28.3 34.2 46.3 36.8 44.5 31.4 28.8 26.3 68.7 64.0 48.0 44.0 39.7 26.4 47.9 49.4 73.8 98.9 70.2 77.4 95.2 68.7 70.9 56.2 93.6 69.3 97.7 71.1 78.9 57.5 33.5 64.0 43.3 62.0 63.7 65.8 54.6 43.3 61.7 81.6 119.7 54.6 61.2 82.4 82.7 40.1 59.2 99.4 82.3 70.9 79.8 77.9 87.5 71.2 46.0 91.0 81.5 51.9 69.3 48.9 76.7 98.2 89.3 38.1 174.4 51.1 31.2 41.7 62.5 61.6 46.5 75.5 110.0 141.4 57.2 44.7 72.7 133.5 39.3 78.4 68.2 39.5 77.8 77.9 73.6 83.8 52.1 74.8 81.2 69.3 32.7 95.8 56.8 50.2 74.8 96.2 26.0 27.0 24.6 27.7 26.5 28.1 26.4 26.6 26.0 27.7 25.4 28.3 26.3 19.8 16.0 15.9 2.3 20.6 11.1 22.8 21.1 13.1 15.3 22.7 21.6 16.6 20.0 16.6 12.9 10.4 60.4 21.6 23.1 93.9 31.6 1.0 17.4 11.2 16.0 22.7 44.8 5.3 20.3 51.1 14.9 10.2 16.2 12.6 21.6 12.8 17.9 21.5 11.8 4.8 23.5 18.3 6.5 9.9 3.4 14.6 12.4 23.2 1.9 35.4 31.1 13.4 0.5 4.3 28.2 16.6 24.5 24.3 20.8 22.3 49.2 28.6 17.9 6.6 10.4 24.6 5.9 15.6 12.8 16.1 111.0 24.6 77.9 22.9 21.4 CDC42EP2 "BORG1, CEP2" ENSG00000149798 "CDC42 effector protein 2" O14613 11 65314866-65322417 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5" "Group enriched" "Detected in many" 15 "granulocytes: 171.5;monocytes: 118.8" "Cell line enhanced" "Detected in many" "HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038562 Approved Supported Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038562: AB_10671745" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (4.73e-3)" "prognostic unfavorable (2.89e-5)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.01e-1)" "unprognostic (5.36e-2)" "unprognostic (8.57e-3)" "unprognostic (3.81e-1)" "unprognostic (1.68e-1)" "unprognostic (2.66e-2)" "unprognostic (3.67e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-2)" 37.5 5.7 14.4 7.7 21.8 0.4 23.3 16.8 16.3 12.7 4.7 14.3 9.2 16.8 1.7 7.8 15.5 15.3 18.5 11.5 15.3 12.7 4.2 19.2 1.8 20.1 21.0 7.5 10.9 5.9 0.6 5.0 11.7 21.9 10.3 1.6 1.9 4.9 4.5 6.7 5.5 13.1 6.9 16.3 18.5 14.6 2.1 17.9 0.4 17.0 5.6 1.2 18.8 9.5 41.0 7.1 6.6 0.9 4.3 14.6 26.4 1.3 7.4 28.8 5.5 6.2 19.8 16.7 0.5 20.9 19.9 2.0 8.9 2.5 26.0 1.2 1.0 3.8 1.3 12.8 14.8 51.5 0.4 0.5 11.5 2.7 20.3 28.8 4.5 22.4 1.0 2.6 4.3 7.1 10.7 0.8 1.6 3.7 18.5 61.0 0.8 0.7 0.5 19.5 4.9 0.5 1.7 18.0 14.7 1.1 0.7 2.5 0.4 30.6 6.7 5.6 55.9 3.1 0.1 1.7 0.6 11.2 0.3 2.7 0.0 50.4 2.1 0.1 118.8 0.1 1.2 0.0 0.1 9.9 0.0 0.1 0.0 171.5 0.0 88.5 0.4 0.0 17.8 14.4 21.8 16.8 16.3 11.5 15.3 20.1 21.0 7.5 21.9 16.3 17.9 41.0 25.8 0.0 0.0 0.0 1.5 12.7 11.0 25.8 6.8 15.3 12.1 6.3 6.3 2.8 17.0 12.9 0.0 0.5 1.6 10.0 3.9 50.5 0.5 6.0 11.6 36.4 1.8 2.7 0.6 40.3 3.5 32.3 9.7 11.1 5.7 1.5 26.7 0.9 1.3 3.3 0.4 8.0 8.2 18.7 77.7 1.9 18.6 33.3 12.4 1.0 18.3 1.0 0.0 0.0 10.6 65.1 15.6 13.5 1.8 7.4 21.2 3.7 6.3 5.3 39.5 16.6 16.2 1.7 3.4 4.8 10.1 1.6 1.4 1.8 8.4 36.4 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120630-65122177 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: AB_2683881" "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 818.5 793.4 883.5 661.4 900.8 1915.1 887.1 865.3 1222.1 982.4 829.7 829.2 609.5 787.1 540.0 725.8 915.4 595.4 837.2 835.2 877.4 634.9 762.5 619.4 1353.6 888.4 864.9 813.9 1416.5 1177.5 398.3 525.6 486.7 887.9 654.9 442.9 230.2 862.2 537.3 1202.5 898.7 718.9 445.5 936.7 790.8 802.8 339.2 917.4 851.2 625.5 647.8 825.3 803.5 800.7 923.2 1305.1 1040.6 658.8 1067.9 766.4 1142.2 1033.3 727.3 887.7 1327.5 832.4 1258.7 1232.1 1782.0 1782.3 744.2 701.5 1101.2 821.5 1287.2 419.3 1075.4 1494.0 1428.1 907.1 1607.8 1612.2 1546.9 1184.9 1583.3 1944.0 1106.3 1286.5 842.2 998.5 1416.3 1334.4 1578.6 644.9 2003.0 1579.6 2925.2 1850.4 1007.2 2027.5 1464.8 622.2 2980.1 1036.0 744.3 1054.4 949.2 663.8 1490.6 2131.0 399.1 1393.3 1829.5 771.2 868.6 954.8 1327.5 1150.0 1629.0 1943.6 2802.6 1042.6 1285.4 979.3 2638.2 2997.4 1808.3 2906.6 2694.0 3986.3 7025.5 4689.8 3729.6 3181.0 6502.9 5484.9 4364.5 1905.5 2994.7 2398.9 4141.8 3794.9 10270.4 883.5 900.8 865.3 1222.1 835.2 877.4 888.4 864.9 813.9 887.9 936.7 917.4 923.2 2252.8 641.0 1035.7 17.6 3768.6 3773.3 3059.7 1883.6 2632.2 351.8 3483.5 5942.5 507.2 1712.8 1280.4 958.2 196.0 2277.7 2670.7 1454.5 2050.4 1540.6 875.1 954.7 1569.4 1671.7 1226.4 1786.0 15.9 2689.2 2487.3 1531.1 923.5 1298.4 1370.0 1483.3 1755.9 2176.7 2188.0 190.1 18.2 2143.3 907.3 2643.8 3977.8 2397.4 2285.9 2349.4 2123.8 16.9 3121.9 935.5 2472.7 15.6 40.8 2042.7 2666.5 1229.2 2317.3 3295.5 2501.4 2615.9 826.4 513.6 1117.5 2227.4 2678.6 654.4 590.6 2506.0 4195.9 2793.0 2897.4 1470.6 2184.8 3518.0 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 248.0" "Cell type enhanced" "Detected in all" "Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 38.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 64.0 248.0 24.9 2.6 24.6 4.1 29.3 29.2 34.1 10.4 52.7 6.5 9.5 3.5 17.1 39.9 12.9 7.1 47.8 25.0 25.1 19.0 87.1 10.2 3.4 32.0 29.8 24.3 36.8 70.5 36.6 19.6 4.0 29.4 41.5 4.0 6.1 47.3 6.1 7.2 67.2 8.3 1.9 25.0 5.2 35.9 11.6 28.9 5.7 15.6 3.7 8.5 5.5 22.2 31.6 7.7 10.9 27.3 35.1 8.1 1.3 15.4 1.8 4.5 2.7 3.0 26.0 35.8 16.3 26.9 2.2 1.0 13.3 11.6 21.2 1.9 16.7 5.0 10.2 2.7 54.5 18.8 4.2 10.6 3.7 5.0 14.6 3.9 12.6 3.9 28.7 5.8 13.9 0.8 69.2 8.3 18.6 12.6 18.4 11.2 22.4 1.2 39.9 86.2 12.6 27.2 30.5 1.2 28.2 6.1 19.5 143.9 11.4 3.1 0.4 3.4 3.8 2.3 27.1 18.1 8.4 2.5 5.9 1.0 1.1 1.6 3.4 9.1 1.5 7.0 12.4 5.6 7.8 1.5 11.9 11.8 9.0 1.1 12.5 0.9 38.1 5.6 4.9 24.9 24.6 29.2 34.1 25.0 25.1 32.0 29.8 24.3 29.4 25.0 28.9 31.6 4.0 9.6 43.7 23.5 12.7 1.9 6.2 33.6 5.7 19.2 52.2 38.5 99.4 52.9 36.6 44.1 10.4 72.9 16.3 23.3 17.6 27.1 28.8 17.9 2.6 5.7 59.4 13.7 11.6 27.7 4.6 4.3 31.1 16.5 7.0 482.7 5.0 220.6 15.6 25.2 15.3 21.8 52.9 6.3 2.7 59.3 9.9 5.8 12.4 2.8 9.4 204.7 7.2 17.1 36.5 21.7 23.7 2.2 12.9 31.3 29.0 77.5 37.9 23.6 13.1 1.6 21.8 13.3 17.9 18.0 7.0 82.1 8.3 204.8 19.0 10.4 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51 subunit of GARP complex" Q9UID3 11 65089324-65111862 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: AB_2684521" "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 45.0 38.1 16.7 35.2 19.8 61.4 47.0 19.8 30.9 43.2 16.4 54.2 53.3 54.9 7.4 42.9 46.5 20.4 41.2 20.3 14.0 33.8 36.5 34.5 49.0 17.5 17.1 15.4 84.5 121.4 37.7 28.8 22.4 18.7 38.4 25.4 20.5 66.1 28.0 84.9 69.5 50.2 22.9 13.0 41.2 70.9 28.6 22.8 47.1 40.0 43.2 32.7 45.5 38.4 19.5 71.8 74.5 35.7 44.4 15.5 38.5 72.1 27.5 53.2 52.6 38.8 55.2 88.7 118.0 76.1 51.4 27.3 60.0 37.9 59.3 19.2 69.6 62.1 72.5 72.6 55.1 51.3 77.1 65.0 66.8 39.9 39.0 32.1 41.6 58.4 55.0 73.6 82.9 21.7 95.1 105.8 83.0 59.8 30.7 61.5 67.5 17.5 150.7 36.2 76.2 61.5 87.8 20.7 110.9 71.8 21.0 93.7 39.1 48.1 35.2 32.0 45.4 39.7 115.7 92.2 68.9 39.9 28.0 26.3 10.6 15.0 15.4 17.9 15.8 21.2 22.4 25.2 27.1 22.1 21.2 23.3 20.7 8.0 30.6 16.0 19.1 17.7 18.3 16.7 19.8 19.8 30.9 20.3 14.0 17.5 17.1 15.4 18.7 13.0 22.8 19.5 49.8 19.2 47.7 18.9 77.3 49.1 66.3 46.0 58.6 64.7 76.5 67.8 5.8 44.3 27.8 31.3 29.2 78.4 73.7 156.5 62.6 49.2 77.5 25.6 35.0 46.5 95.8 50.5 21.8 120.5 79.4 38.8 45.9 34.4 37.5 47.3 55.3 52.5 45.5 67.3 24.1 110.0 32.6 54.0 30.6 222.4 53.4 36.1 49.8 15.9 71.3 65.9 89.6 21.6 28.0 51.2 144.4 54.5 66.4 45.1 158.7 75.9 16.1 52.5 26.3 49.3 44.4 40.3 31.4 52.3 54.8 115.3 64.0 61.5 170.5 51.0 TBX6 ENSG00000149922 "T-box transcription factor 6" O95947 16 30085793-30091924 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4;Urothelial cells: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 4.1;RT4: 6.9;U-266/70: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm NA NA Nucleoplasm "HPA062498: AB_2732686" "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.0 1.9 3.3 0.7 3.4 0.5 1.4 2.8 4.1 2.8 2.1 1.6 1.2 1.1 0.7 13.9 1.8 0.9 1.2 2.8 2.7 2.3 1.9 1.5 0.8 3.3 3.3 2.4 1.8 4.4 1.0 1.9 0.3 3.8 3.4 0.3 1.7 2.8 1.2 2.0 3.2 1.7 0.4 3.2 2.4 4.7 1.8 3.3 0.9 2.8 0.5 1.5 4.4 7.4 4.2 0.6 0.7 0.4 0.7 1.0 0.5 0.5 0.2 0.1 0.0 0.1 0.9 2.9 1.2 1.5 0.1 0.1 0.8 0.3 0.5 0.0 0.9 0.5 0.8 1.4 0.7 0.7 0.1 1.7 0.2 0.8 0.1 0.3 0.6 0.4 2.7 0.1 2.9 0.0 2.6 0.5 0.3 0.6 4.1 0.6 2.0 0.0 2.1 0.0 6.9 0.9 1.3 0.1 0.5 0.8 0.3 1.2 1.2 0.3 0.8 0.4 0.4 0.0 6.9 1.7 0.2 0.8 1.2 0.2 1.2 0.6 0.2 0.4 0.6 0.3 0.3 0.2 0.3 0.3 1.2 0.4 0.4 0.8 0.3 0.2 0.2 0.5 0.3 3.3 3.4 2.8 4.1 2.8 2.7 3.3 3.3 2.4 3.8 3.2 3.3 4.2 1.0 0.0 0.6 2.6 2.7 1.1 3.4 4.2 4.0 1.9 1.2 1.4 0.5 0.0 3.7 1.8 8.4 1.7 0.5 0.7 0.0 0.8 0.1 0.9 0.8 1.9 0.0 3.2 0.2 1.2 0.8 1.1 3.6 1.0 0.0 1.1 0.4 0.4 0.5 0.0 0.4 1.2 4.1 0.8 1.7 0.2 0.9 1.2 0.0 1.9 0.6 1.9 2.1 0.0 2.7 3.5 1.6 1.2 0.2 3.2 2.6 0.7 3.0 3.4 6.6 2.7 1.4 2.6 3.9 6.2 1.0 2.3 0.8 0.5 1.6 9.4 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085376 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: AB_2678695" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 42.9 58.4 32.0 43.6 31.7 63.7 42.8 33.4 39.0 38.4 37.1 47.9 47.4 39.9 47.5 89.0 36.2 32.8 39.2 31.2 37.2 49.2 83.8 46.6 59.1 33.5 32.1 30.0 29.6 41.3 46.8 33.8 50.0 32.5 38.1 35.6 18.3 44.3 28.8 61.3 60.7 49.4 33.1 33.7 63.0 49.6 65.9 34.2 61.8 35.7 30.5 64.2 56.8 49.4 33.9 132.7 145.9 95.5 134.0 88.4 73.8 148.5 115.8 127.7 148.7 163.8 129.5 167.9 102.7 145.2 137.0 95.5 105.9 119.3 143.2 87.0 130.1 213.0 70.5 86.0 290.4 133.5 100.1 126.8 107.9 124.7 135.9 85.5 88.4 174.9 130.5 139.6 91.0 115.1 382.2 174.4 180.7 182.2 104.7 77.1 190.9 99.4 180.4 142.5 134.5 91.9 136.8 57.1 169.1 101.8 79.4 156.0 166.0 113.3 86.4 90.4 70.6 90.8 155.4 183.8 122.4 123.1 126.9 107.0 100.6 103.5 236.1 66.5 113.2 47.7 68.5 69.6 74.2 115.8 88.3 62.0 54.1 215.2 51.7 100.1 90.6 95.1 48.3 32.0 31.7 33.4 39.0 31.2 37.2 33.5 32.1 30.0 32.5 33.7 34.2 33.9 87.8 51.3 33.4 10.7 85.8 147.2 121.7 206.9 71.2 23.3 94.2 82.8 11.1 82.9 133.5 77.3 29.2 313.7 106.0 217.0 158.5 226.9 156.9 80.5 55.5 91.7 125.6 89.2 8.0 193.3 335.3 66.7 106.0 85.2 69.2 66.7 74.6 94.2 239.3 35.3 8.6 159.3 193.3 105.4 138.4 143.8 62.7 124.4 80.0 9.4 221.1 61.1 118.4 8.0 12.9 345.5 220.8 52.3 97.6 161.3 191.0 198.6 119.7 29.5 72.3 43.4 85.9 228.5 157.8 113.2 172.5 421.0 93.0 61.7 175.9 227.2 ALDOA ENSG00000149925 "Aldolase, fructose-bisphosphate A" P04075 16 30064164-30070457 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "skeletal muscle: 27009.6;tongue: 9261.7" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004177, CAB006252" Supported Approved Cytosol NA NA 640000000 Cytosol "CAB006252: AB_437007, HPA004177: AB_1078128" "unprognostic (2.63e-2)" "unprognostic (3.22e-2)" "unprognostic (6.80e-2)" "unprognostic (1.33e-1)" "unprognostic (6.74e-3)" "unprognostic (4.28e-3)" "prognostic unfavorable (5.79e-5)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.68e-1)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.19e-3)" "unprognostic (4.48e-2)" 570.9 702.2 622.3 447.1 706.9 739.1 517.0 618.1 725.6 478.1 552.0 768.8 522.6 538.2 202.7 1313.9 453.6 424.4 2217.4 701.2 658.1 685.8 218.9 429.3 361.1 729.4 660.9 657.8 514.7 393.8 950.9 529.2 354.3 782.0 461.6 403.8 469.2 912.3 603.1 27009.6 630.5 492.4 469.4 541.0 420.8 599.9 139.7 706.6 283.4 458.5 9261.7 482.2 768.3 746.5 833.4 2206.1 1620.4 477.9 1542.8 714.6 808.5 1520.8 1297.9 1336.2 1291.6 1603.0 1158.1 1643.6 1487.6 2072.2 1318.6 708.6 1632.6 966.8 2829.1 939.3 658.5 1272.9 1219.3 1202.7 2591.1 1112.5 1793.8 1251.3 1115.7 979.6 1455.4 968.9 2119.7 965.4 686.9 1070.0 951.1 1393.4 3136.7 1100.2 1477.0 1192.8 848.1 1346.6 1613.9 765.2 3353.2 1629.4 1230.5 950.7 668.5 808.6 3368.5 1213.9 591.2 1433.0 1194.7 1162.5 1892.3 750.3 1046.7 1430.0 1861.5 1387.3 1369.3 3524.5 1715.9 1532.9 2050.6 2694.7 2081.7 1008.7 2466.5 1138.1 908.5 1091.7 1047.0 2182.7 877.9 1027.4 996.9 2531.7 819.9 2780.2 824.0 1476.3 4372.2 622.3 706.9 618.1 725.6 701.2 658.1 729.4 660.9 657.8 782.0 541.0 706.6 833.4 17.0 12.8 32.4 83.2 281.2 792.0 716.4 3267.9 784.8 387.4 34.4 21.6 1968.4 273.1 1385.1 42.3 118.9 1194.1 107.9 1834.8 111.6 120.9 258.8 15.8 11.8 261.1 323.9 215.8 66.2 76.2 2322.1 329.7 513.3 16.1 196.5 18.7 289.5 102.0 1181.9 733.6 70.0 755.1 1265.4 632.2 715.4 1152.4 380.8 388.8 924.9 50.6 417.7 662.1 328.5 40.2 60.8 126.2 1497.1 405.1 409.4 676.9 1755.7 75.8 700.9 298.9 486.4 680.9 572.9 25.8 123.6 1174.6 684.5 1361.3 294.3 15.2 937.7 1146.2 TLCD3B "DKFZP434I2117, FAM57B" ENSG00000149926 "TLC domain containing 3B" Q71RH2 16 30024427-30052978 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 39.9;retina: 68.5;testis: 105.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 5 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 16.7;SCLC-21H: 89.2;SH-SY5Y: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.31e-2)" "unprognostic (9.72e-4)" "unprognostic (7.78e-3)" "unprognostic (1.13e-1)" "unprognostic (8.06e-2)" "unprognostic (2.45e-1)" "unprognostic (1.54e-2)" "unprognostic (9.72e-2)" "unprognostic (2.60e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (4.51e-2)" "unprognostic (2.40e-11)" "unprognostic (1.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.09e-3)" 0.0 2.0 12.4 0.2 12.0 1.3 0.2 25.6 39.9 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 16.4 12.4 0.1 0.1 0.1 0.3 27.2 10.2 12.6 0.0 0.3 0.0 21.6 0.0 32.4 0.2 0.1 68.5 1.3 0.0 11.6 0.2 0.2 0.0 9.1 0.1 0.2 105.7 22.3 1.1 0.1 1.7 0.2 0.0 0.1 30.2 1.9 0.6 3.3 1.5 0.0 0.0 0.0 1.5 0.0 1.0 0.1 0.0 2.4 1.2 0.1 0.0 0.4 0.8 0.2 0.1 0.9 2.8 0.4 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 1.1 0.0 9.7 0.1 9.6 0.2 0.8 2.9 0.6 16.7 0.2 0.9 7.4 1.2 1.2 0.0 0.0 89.2 33.9 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.4 2.3 0.4 0.4 8.8 0.3 0.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 12.0 25.6 39.9 16.4 12.4 27.2 10.2 12.6 32.4 9.1 22.3 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005514-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.8;testis: 38.1" "Group enriched" "Detected in many" 4 "Early spermatids: 284.7;Late spermatids: 200.4" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 13.1;MCF7: 10.8;REH: 11.0;SCLC-21H: 35.9;U-937: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.4 4.5 41.2 0.2 54.0 1.0 1.9 32.1 72.8 2.8 22.7 4.7 0.7 1.4 0.3 1.8 8.7 0.7 1.2 53.6 33.4 5.1 0.9 5.6 0.3 31.7 27.4 55.1 15.5 1.7 0.8 9.5 0.1 36.3 8.2 1.3 1.1 1.4 0.5 0.2 0.5 2.6 0.7 24.8 6.0 0.9 38.1 32.0 0.1 1.0 0.0 0.1 1.1 2.3 46.6 0.9 1.8 1.2 0.7 0.4 0.0 13.1 0.4 0.9 0.5 0.4 5.6 3.3 0.0 1.1 0.1 1.6 0.3 7.1 2.7 0.3 0.0 0.7 1.1 0.3 0.2 0.5 1.0 3.5 1.6 0.8 0.2 0.8 6.5 0.0 3.9 0.3 0.0 0.0 10.8 2.2 4.0 1.7 4.0 5.1 11.0 0.0 0.5 0.4 0.8 35.9 2.3 0.3 3.0 0.3 2.6 3.4 2.0 0.0 0.0 1.5 0.1 0.2 0.2 0.0 0.0 0.2 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 54.0 32.1 72.8 53.6 33.4 31.7 27.4 55.1 36.3 24.8 32.0 46.6 1.5 0.0 4.6 8.8 0.4 0.6 3.5 2.5 6.8 3.7 4.0 3.4 0.7 1.5 7.8 1.8 22.9 0.3 0.2 3.0 1.9 0.1 284.7 12.2 0.2 1.7 1.2 0.0 28.2 0.0 1.0 2.1 1.5 0.3 0.0 3.5 2.5 0.0 0.5 0.0 10.7 3.6 10.2 1.9 1.0 200.4 0.6 2.2 1.8 4.7 0.1 2.3 0.0 3.5 2.6 0.0 1.0 1.9 0.1 2.3 0.3 0.3 57.5 2.0 0.0 0.5 0.9 3.2 6.1 0.6 0.9 0.1 0.3 2.5 4.3 1.1 HIRIP3 ENSG00000149929 "HIRA interacting protein 3" Q9BW71 16 29992330-29996074 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 129.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051897, HPA063205" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA051897: AB_2681655, HPA063205: AB_2684963" "unprognostic (6.99e-2)" "prognostic favorable (2.74e-5)" "unprognostic (4.75e-2)" "unprognostic (2.83e-1)" "unprognostic (1.08e-1)" "unprognostic (4.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.80e-2)" "unprognostic (3.58e-2)" "unprognostic (8.53e-3)" "unprognostic (3.85e-2)" "unprognostic (2.07e-1)" "unprognostic (4.26e-3)" "unprognostic (5.22e-2)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.35e-2)" 11.4 11.7 24.4 9.1 25.4 15.9 11.9 24.3 24.9 13.4 19.4 13.9 8.4 13.7 10.7 9.6 12.3 7.2 17.7 23.1 23.2 12.1 15.0 11.7 13.2 25.8 24.7 22.4 17.0 11.1 15.7 14.7 6.8 25.7 12.0 7.4 20.2 11.2 13.0 33.8 14.5 11.0 8.7 24.4 13.0 10.7 39.0 24.8 25.9 11.8 21.9 12.4 14.4 11.6 26.0 27.4 27.7 44.2 28.5 13.9 14.8 13.4 20.9 16.1 21.2 18.2 24.8 26.8 52.7 42.5 13.7 15.3 19.0 28.8 26.6 15.8 47.8 28.1 56.7 36.2 26.9 11.5 50.3 42.4 7.4 19.4 20.9 32.3 12.4 13.4 50.6 27.2 57.0 12.9 20.0 66.1 26.3 13.0 17.8 15.5 65.9 52.6 52.5 14.9 12.2 28.6 34.7 21.7 16.3 14.5 11.3 24.2 30.6 15.4 28.4 21.8 20.3 20.5 37.1 31.0 31.4 26.8 43.2 38.1 4.6 7.5 15.0 16.7 12.0 11.4 19.1 18.6 15.3 6.3 14.6 19.3 17.9 3.4 14.3 20.8 19.1 22.9 10.8 24.4 25.4 24.3 24.9 23.1 23.2 25.8 24.7 22.4 25.7 24.4 24.8 26.0 19.1 67.3 26.3 2.0 14.9 12.7 17.1 11.2 14.8 36.4 14.6 19.6 30.4 10.0 15.8 9.2 14.6 30.6 18.7 12.5 29.4 10.5 27.6 12.6 10.9 15.4 9.6 27.0 2.1 12.1 28.9 14.6 4.6 10.9 31.0 12.1 10.8 16.7 18.7 15.2 2.7 10.8 14.2 8.2 11.9 12.0 20.5 9.8 5.4 1.0 8.8 37.3 32.0 3.5 4.7 6.3 11.4 22.6 22.0 6.7 25.6 19.9 19.9 49.4 13.1 14.7 18.6 129.5 46.2 10.2 11.4 11.5 20.9 12.1 14.0 8.3 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973868-29992261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 30.5 36.3 21.8 14.8 19.6 12.8 31.1 17.0 26.3 24.6 10.5 21.7 17.4 26.2 11.2 20.9 22.8 12.1 28.0 21.7 17.6 22.8 17.8 34.3 14.5 19.8 19.0 20.0 24.3 19.7 17.6 29.6 19.6 19.5 22.7 8.5 14.5 20.7 13.5 23.6 22.2 24.6 13.4 13.4 34.0 22.0 35.0 20.9 13.3 25.6 12.8 10.6 22.6 21.8 17.7 22.2 41.8 22.4 35.1 25.8 17.1 34.2 40.0 21.1 26.4 24.4 33.6 28.7 23.8 32.8 28.8 18.0 33.9 20.4 20.0 14.1 37.5 43.3 25.8 46.2 34.8 18.7 25.5 47.5 20.0 17.1 28.1 11.2 18.5 44.7 22.4 23.5 23.6 25.8 41.0 29.8 36.0 21.5 16.4 27.6 54.2 32.5 22.2 16.6 20.5 26.1 20.8 22.8 30.2 12.1 14.4 37.5 28.5 62.9 45.0 20.7 32.4 23.6 34.2 23.7 22.1 27.6 28.8 33.7 0.3 0.7 0.4 0.7 0.7 0.8 0.5 0.7 0.6 0.4 0.6 0.4 0.3 1.2 0.5 0.4 0.8 0.9 0.6 21.8 19.6 17.0 26.3 21.7 17.6 19.8 19.0 20.0 19.5 13.4 20.9 17.7 52.0 9.6 11.5 21.9 6.3 10.7 4.6 7.5 7.4 14.6 10.5 5.7 9.8 7.2 9.1 9.2 39.6 7.8 7.6 27.0 1.9 8.5 3.9 8.7 9.5 35.3 13.1 3.4 7.9 12.0 6.2 9.7 14.3 8.9 3.8 16.0 47.2 11.8 9.8 10.1 10.7 16.8 12.2 11.2 11.1 4.4 12.5 8.2 7.2 7.5 9.0 8.4 11.3 9.0 12.7 16.1 14.8 12.8 5.9 7.4 27.2 8.0 10.0 21.4 6.6 8.7 8.7 19.7 21.6 9.1 9.7 12.0 9.2 16.0 14.7 7.4 TMEM219 IGFBP-3R ENSG00000149932 "Transmembrane protein 219" Q86XT9 16 29940885-29973050 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 637.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059185 Approved NA NA "HPA059185: AB_2683941" "unprognostic (4.13e-2)" "unprognostic (1.94e-3)" "unprognostic (1.51e-1)" "prognostic favorable (5.79e-4)" "unprognostic (2.62e-1)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (9.83e-2)" "unprognostic (8.53e-2)" "unprognostic (1.71e-1)" "unprognostic (4.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-3)" 120.1 182.6 236.2 50.6 239.4 80.1 118.6 232.2 282.5 104.5 235.9 125.3 123.0 85.7 166.1 120.0 131.1 90.6 125.4 224.7 227.8 174.2 196.3 126.1 75.9 242.7 233.9 220.2 108.8 163.0 110.2 106.0 56.3 233.2 140.7 89.1 40.0 177.4 98.6 102.2 120.8 128.7 66.2 240.4 139.4 172.0 141.7 236.0 63.1 114.9 90.1 74.0 111.6 101.4 238.7 58.8 70.2 60.1 77.8 157.0 161.8 68.5 59.7 123.2 87.7 113.3 34.4 168.4 46.3 111.2 151.1 63.9 34.0 35.5 82.0 43.3 81.6 68.0 44.3 53.3 114.2 181.1 29.8 108.5 146.5 124.0 63.0 55.2 166.7 142.6 126.2 30.9 95.4 115.5 63.8 41.1 98.2 34.8 119.3 45.4 81.8 37.6 107.5 158.8 38.4 33.8 67.1 20.5 40.7 110.7 81.0 66.6 109.7 79.5 69.9 41.7 36.0 28.3 74.0 24.2 39.5 93.9 99.0 59.2 471.8 333.2 450.9 146.6 253.1 151.0 213.7 205.9 154.2 274.5 206.2 191.3 149.2 154.9 132.7 187.3 298.5 246.2 328.3 236.2 239.4 232.2 282.5 224.7 227.8 242.7 233.9 220.2 233.2 240.4 236.0 238.7 174.0 70.5 122.2 16.0 82.3 67.0 134.0 207.4 84.8 23.7 239.3 258.4 73.2 167.3 158.1 176.6 10.4 80.4 85.6 309.2 252.4 183.3 181.0 107.8 67.0 143.2 180.4 39.3 10.8 238.7 225.3 97.1 87.7 97.1 142.5 84.1 213.5 165.7 269.2 16.8 13.4 273.1 154.6 260.8 149.8 524.8 86.6 189.8 167.2 6.5 192.0 119.6 114.4 12.5 23.8 213.7 333.7 100.4 95.8 136.2 637.1 371.1 183.7 30.7 52.6 54.8 92.5 101.1 117.5 119.1 78.6 71.1 89.4 118.7 227.9 215.0 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824460-65966291 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.9;testis: 3.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 0.3 0.0 0.3 0.3 0.3 4.9 0.2 0.6 0.6 1.1 0.0 2.1 1.3 0.4 0.0 0.3 1.2 0.3 0.1 0.4 2.0 0.2 0.2 0.1 0.1 0.3 0.3 0.2 0.6 0.9 0.0 0.4 0.2 0.3 0.0 2.4 0.5 0.1 0.1 1.5 0.4 1.0 0.1 0.1 0.1 1.2 3.8 0.1 0.2 0.6 0.2 0.1 0.1 0.1 0.5 47.9 21.4 324.4 45.8 15.0 82.0 0.1 148.5 68.5 26.0 25.8 28.1 19.8 0.0 92.3 7.0 120.0 20.5 54.2 129.3 123.8 0.2 56.2 0.2 0.7 169.3 8.4 4.7 0.4 62.7 8.0 55.2 98.4 232.6 105.0 0.2 0.1 0.6 149.9 0.2 0.4 27.8 190.3 4.6 89.2 12.7 16.1 0.1 68.9 0.3 0.0 0.0 0.1 0.1 85.0 216.1 0.5 0.7 120.8 89.5 26.9 71.2 45.3 0.2 0.2 0.4 112.0 0.3 21.4 1.4 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.3 0.6 0.1 0.0 0.0 0.3 0.3 0.6 0.6 0.4 2.0 0.3 0.3 0.2 0.3 0.1 0.1 0.5 0.0 0.0 1.1 5.9 0.2 0.0 3.6 16.0 2.8 0.0 0.1 0.1 1.7 0.0 3.0 0.0 0.0 0.8 0.0 5.0 0.0 2.5 18.4 10.4 0.8 0.6 0.0 7.4 0.8 0.8 0.5 2.3 3.1 17.3 0.0 29.7 0.7 0.0 9.0 0.0 0.9 5.1 4.1 0.0 0.0 9.0 0.3 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.9 19.9 4.5 0.0 0.4 5.5 4.0 0.3 7.3 0.0 0.0 1.1 33.7 13.5 0.6 0.3 0.1 0.8 0.3 0.3 8.4 1.1 MMP3 "STMY, STMY1" ENSG00000149968 "Matrix metallopeptidase 3" P08254 11 102835801-102843609 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "salivary gland: 288.5" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 59.9" "Region enhanced" "Detected in some" "thalamus: 5.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 3.2" HPA007875 Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA 2540000 460000 Vesicles "HPA007875: AB_1079396" "unprognostic (2.27e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.63e-3)" "unprognostic (5.11e-3)" "unprognostic (3.78e-1)" "unprognostic (5.11e-2)" "unprognostic (5.26e-6)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (3.26e-2)" "unprognostic (1.22e-15)" "unprognostic (3.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (2.34e-1)" 50.5 0.1 0.2 20.2 0.3 0.0 36.9 0.2 1.8 0.2 0.1 5.6 2.4 38.5 0.2 0.8 0.2 2.0 0.2 0.3 1.2 0.3 1.6 0.3 0.0 0.4 0.3 0.2 0.1 0.3 0.1 0.9 0.4 1.4 2.2 2.3 0.0 288.5 2.2 39.9 37.3 4.6 1.6 0.3 0.0 10.5 0.1 5.7 0.1 2.6 0.4 1.3 14.1 0.5 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1545.7 4229.3 27.0 8.7 0.1 0.2 0.0 0.0 1846.6 96.9 0.0 0.1 0.1 45.1 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 4.6 0.2 122.0 5.3 0.0 0.0 0.0 0.2 0.3 4.7 0.0 0.0 0.0 0.2 0.4 0.9 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.9 0.0 0.3 0.0 140.5 13.1 1.6 0.5 0.0 0.0 0.2 56.8 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.8 0.3 1.2 0.4 0.3 0.2 1.4 0.3 5.7 0.3 0.0 3.2 0.0 0.0 0.0 8.4 20.4 25.8 0.0 0.0 0.1 0.1 0.3 4.3 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 24.2 0.0 0.3 0.5 0.0 0.0 0.2 1.4 13.4 17.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 0.0 2.2 1.2 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 4.0 0.0 0.0 11.9 1.0 0.9 0.1 0.0 0.0 1.8 10.2 0.0 1.8 0.0 3.4 0.3 0.6 0.0 0.8 7.4 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 24.2;retina: 18.1" "Cell type enhanced" "Detected in many" "Astrocytes: 111.7;Excitatory neurons: 497.7;Inhibitory neurons: 143.6;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 86.1" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.9;AF22: 4.0;NTERA-2: 8.9;PC-3: 4.8;RH-30: 8.2;U-251 MG: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 1.4 2.6 8.2 0.3 13.1 0.2 1.4 24.2 16.1 0.8 0.0 0.6 0.1 0.3 0.5 0.1 1.3 0.2 0.7 18.9 5.0 0.1 0.7 1.2 0.9 1.0 1.2 10.9 0.6 2.5 0.0 1.6 0.1 7.4 0.7 0.0 18.1 0.5 0.1 4.7 0.7 0.6 0.1 0.0 0.5 1.2 0.6 0.9 0.9 0.9 1.3 1.0 0.6 0.9 5.6 0.0 5.9 4.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 2.0 0.0 8.9 0.0 4.8 0.0 8.2 0.0 0.0 0.0 3.9 1.6 0.0 0.1 0.3 2.1 0.0 0.6 0.0 0.1 1.9 0.0 5.3 3.1 0.0 3.4 0.8 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 0.2 0.1 8.2 13.1 24.2 16.1 18.9 5.0 1.0 1.2 10.9 7.4 0.0 0.9 5.6 0.3 16.0 1.3 111.7 9.0 1.3 0.5 0.0 1.2 17.8 0.3 0.6 5.7 1.5 5.6 0.0 20.9 0.1 2.1 0.4 0.0 0.3 0.3 1.0 13.6 0.3 0.0 0.8 497.7 2.3 0.0 6.7 0.0 1.3 1.3 1.0 0.0 2.1 0.1 23.5 143.6 0.5 0.0 0.0 2.6 0.0 0.6 0.2 0.0 15.9 0.2 12.7 0.0 93.5 10.6 0.6 0.1 1.5 3.1 2.0 1.3 0.3 0.0 86.1 0.0 0.6 0.9 6.0 7.7 0.1 1.8 0.0 2.9 1.5 0.4 0.0 CNTN5 "hNB-2, NB-2" ENSG00000149972 "Contactin 5" O94779 11 99020949-100358885 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0" "Group enriched" "Detected in some" 14 "Excitatory neurons: 968.9;Inhibitory neurons: 2295.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039492, HPA041223" Approved "Intracellular and membrane" NA NA 480000 "HPA039492: AB_10795108, HPA041223: AB_10794549" "unprognostic (2.09e-2)" "unprognostic (3.40e-1)" "unprognostic (8.99e-3)" "unprognostic (4.20e-2)" "unprognostic (6.51e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.02e-2)" "unprognostic (8.72e-2)" "unprognostic (5.48e-3)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 4.3 1.4 0.3 0.0 0.1 0.0 0.2 2.1 2.5 0.0 0.2 0.2 0.5 2.6 0.7 0.0 0.0 0.7 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 0.0 3.8 4.3 1.4 0.2 2.1 2.5 0.7 0.0 1.9 2.4 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.7 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.5 3.5 0.1 0.0 0.0 0.0 968.9 0.0 0.2 1.1 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 2295.2 0.0 2.0 0.0 0.0 0.4 0.9 0.0 0.0 42.2 0.0 0.1 0.0 112.1 23.2 0.1 0.0 1.9 0.0 0.0 0.0 0.2 12.5 0.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 KLRF1 "CLEC5C, NKp80" ENSG00000150045 "Killer cell lectin like receptor F1" Q9NZS2 12 9827481-9845007 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;lymphoid tissue: 18.2" "Group enriched" "Detected in many" 7 "dendritic cells: 302.0;NK-cells: 963.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 7 "NK-cell: 664.4" "Lineage enriched" "Detected in all" 7 "NK-cells: 664.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;HAP1: 1.5;U-937: 4.4" HPA054038 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054038: " "unprognostic (2.96e-1)" "unprognostic (8.59e-2)" "unprognostic (3.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-4)" "unprognostic (6.06e-2)" "unprognostic (3.68e-2)" "unprognostic (9.95e-3)" "unprognostic (3.00e-1)" "unprognostic (2.90e-1)" "unprognostic (4.43e-2)" "unprognostic (6.53e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.89e-3)" 1.5 0.1 0.6 1.5 0.6 12.9 0.8 0.6 1.4 0.7 0.7 0.7 0.3 0.9 3.8 0.6 1.5 1.4 0.6 0.6 0.7 1.2 4.5 4.4 3.4 0.8 0.7 0.5 0.1 1.3 0.3 0.5 1.0 0.8 0.5 1.0 0.1 1.4 1.2 1.2 0.5 0.8 0.8 0.6 18.2 1.2 0.7 0.7 0.4 0.8 0.4 3.6 0.9 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.4 0.6 0.4 0.8 0.9 71.5 1.5 94.4 3.4 3.6 35.2 1.5 1.5 1.4 35.4 5.8 664.4 1.1 2.3 1.2 83.0 0.6 0.6 0.6 1.4 0.6 0.7 0.8 0.7 0.5 0.8 0.6 0.7 0.7 3.2 0.0 2.2 0.0 2.3 1.5 1.1 0.2 0.6 0.0 1.3 0.1 0.3 5.7 1.3 0.0 0.0 0.9 302.0 0.1 9.8 0.5 0.5 0.5 0.5 2.2 0.0 24.0 0.1 0.2 0.7 1.2 0.0 1.0 1.3 0.1 8.9 1.8 1.4 0.0 0.2 0.1 0.0 9.1 6.6 1.1 0.0 2.1 12.4 2.8 3.9 0.4 963.0 0.0 0.3 0.4 0.0 0.0 12.7 0.9 0.0 0.8 0.2 0.0 0.0 0.1 0.2 0.2 2.0 0.2 1.1 0.5 80.6 0.0 0.3 3.1 CLEC1A "CLEC1, MGC34328" ENSG00000150048 "C-type lectin domain family 1 member A" Q8NC01 12 10069554-10111627 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 50.7;placenta: 49.4" "Cell type enhanced" "Detected in some" "Adipocytes: 51.4;Cytotrophoblasts: 51.5;Endothelial cells: 38.1;Extravillous trophoblasts: 61.7;Syncytiotrophoblasts: 52.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 21.3;HUVEC TERT2: 18.3;SuSa: 5.6;U-266/70: 4.9;U-266/84: 11.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (5.96e-2)" "unprognostic (2.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (7.15e-2)" "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.94e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" 16.2 3.2 4.3 4.2 3.8 0.4 14.9 5.8 5.6 10.5 4.3 4.2 1.5 6.8 2.7 3.9 9.2 5.7 8.1 3.7 3.6 5.8 3.0 30.1 6.0 4.4 3.8 3.0 5.5 2.3 1.6 3.7 49.4 4.4 6.4 2.0 0.6 2.9 2.4 3.9 4.0 4.4 8.8 3.8 8.1 3.7 2.2 4.7 50.7 7.7 4.5 3.5 6.1 8.6 6.5 0.0 0.0 0.3 0.3 0.2 0.2 21.3 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 18.3 0.0 0.0 1.9 0.0 0.0 0.0 0.4 3.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.3 0.3 0.0 5.6 0.0 0.0 1.4 0.0 0.2 0.2 0.0 4.9 11.5 0.0 0.2 0.1 0.0 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 4.3 3.8 5.8 5.6 3.7 3.6 4.4 3.8 3.0 4.4 3.8 4.7 6.5 51.4 0.0 0.5 0.0 0.5 2.2 0.1 0.0 1.2 0.0 0.3 0.1 1.3 0.0 0.0 0.0 0.0 51.5 0.2 0.0 0.0 0.0 0.4 0.0 0.1 38.1 0.0 0.0 0.0 0.0 61.7 1.2 0.0 0.0 0.0 0.0 16.8 0.2 5.0 0.0 0.0 0.0 0.0 4.7 14.1 0.6 7.5 4.0 3.6 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.9 4.0 2.9 0.3 1.6 52.1 0.6 0.3 0.0 0.5 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672874-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.2;prostate: 15.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 39.1;Granulosa cells: 11.1;Inhibitory neurons: 15.7;Peritubular cells: 7.2;Respiratory ciliated cells: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 51.3;BJ hTERT+: 29.4;BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 22.6;fHDF/TERT166: 148.4;SiHa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 2.7 2.2 2.2 0.7 1.5 0.0 1.1 5.4 8.7 2.4 0.0 2.0 0.2 1.2 2.3 1.0 5.2 1.3 0.4 1.0 3.9 0.3 1.2 0.7 0.2 5.1 4.3 1.7 11.2 0.5 1.3 5.0 0.0 5.3 15.9 0.9 0.3 0.3 5.4 0.3 0.5 0.4 0.6 5.0 0.4 2.0 0.8 1.4 0.0 3.3 0.0 0.0 4.3 0.9 4.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 51.3 29.4 33.1 22.6 0.2 0.1 0.0 0.1 148.4 1.3 0.0 0.4 0.0 8.8 0.0 3.3 0.0 9.1 0.1 1.3 0.0 0.0 1.4 2.2 0.0 0.1 0.0 0.0 3.3 0.0 6.3 0.8 0.0 0.2 0.0 0.7 0.0 4.3 0.0 0.7 0.0 0.0 0.0 0.5 0.0 21.4 0.0 0.0 0.2 3.6 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 5.4 8.7 1.0 3.9 5.1 4.3 1.7 5.3 5.0 1.4 4.9 0.0 0.0 1.9 4.6 0.1 0.0 0.0 0.2 0.6 0.3 0.0 0.1 1.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 0.1 0.1 0.0 0.0 39.1 0.2 0.0 2.2 0.0 0.1 0.0 11.1 0.0 0.8 0.0 0.0 15.7 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.5 1.2 0.1 0.0 7.2 0.1 0.1 0.0 0.1 7.3 0.1 0.0 0.0 1.0 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 MPP7 FLJ32798 ENSG00000150054 "Membrane palmitoylated protein 7" Q5T2T1 10 28050993-28334486 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.5" "Cell type enhanced" "Detected in many" "Early spermatids: 82.3;Excitatory neurons: 76.7;Suprabasal keratinocytes: 61.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 5.2" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.3;CACO-2: 45.2;CAPAN-2: 27.9;T-47d: 89.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037597, HPA037598" Approved Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA037597: AB_2675569, HPA037598: AB_10696941" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "unprognostic (6.64e-2)" "unprognostic (7.78e-2)" "unprognostic (9.31e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.79e-14)" "unprognostic (2.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" 3.9 2.8 0.3 5.7 1.0 8.8 9.8 5.2 2.5 6.4 0.5 10.8 6.0 5.2 1.9 37.5 11.9 6.5 6.7 0.6 0.4 12.3 1.9 10.2 2.7 0.5 0.3 0.8 3.4 12.2 11.9 2.2 11.8 0.8 8.0 9.4 9.8 7.6 4.8 13.9 25.0 7.3 8.8 0.0 2.4 8.8 9.1 0.0 3.3 14.5 14.4 7.0 9.8 9.6 1.5 5.9 0.1 0.6 0.0 0.1 0.1 23.3 1.2 0.9 4.7 7.4 45.2 27.9 0.0 0.3 3.4 3.4 10.4 3.9 7.5 10.9 0.0 7.5 0.0 1.3 2.8 0.0 0.0 0.0 0.3 11.6 0.7 0.4 0.0 0.0 2.2 1.1 0.0 6.2 10.9 2.3 0.0 1.4 8.9 2.1 1.2 13.3 0.0 0.4 19.0 1.1 0.0 2.3 11.3 0.0 3.6 89.3 1.1 0.0 1.8 12.5 0.0 1.0 0.2 0.0 0.1 0.1 10.7 0.0 0.0 7.7 9.0 3.8 2.5 5.6 0.6 4.2 2.6 7.8 0.5 7.9 5.7 3.1 5.0 1.5 0.1 1.1 5.1 0.3 1.0 5.2 2.5 0.6 0.4 0.5 0.3 0.8 0.8 0.0 0.0 1.5 1.6 44.8 48.3 10.4 5.5 23.1 10.9 9.5 7.4 1.1 14.7 8.6 12.1 10.0 24.3 14.7 16.7 50.0 9.8 15.3 9.8 5.5 82.3 9.3 0.6 11.7 6.7 4.2 76.7 12.9 3.5 2.6 11.2 6.6 1.3 0.7 2.9 3.2 5.4 3.3 30.3 10.4 8.2 4.7 5.3 20.3 0.9 8.1 7.2 12.2 16.2 24.0 4.1 4.5 2.5 6.6 7.8 0.4 5.1 7.5 12.1 9.5 19.3 8.5 0.0 1.5 7.6 5.4 9.5 48.0 61.1 46.5 16.3 0.1 11.3 17.4 ITGB1 "CD29, FNRB, GPIIA, MDF2, MSK12" ENSG00000150093 "Integrin subunit beta 1" P05556 10 32887273-33005792 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 2711.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003434, HPA059297, HPA069003" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Focal adhesion sites" NA NA 270000000 "Plasma membrane, Focal adhesion sites" "Endoplasmic reticulum" "CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125" "unprognostic (3.07e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.67e-2)" "unprognostic (4.36e-1)" "unprognostic (1.20e-2)" "unprognostic (3.87e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.22e-1)" "unprognostic (2.36e-3)" "unprognostic (3.68e-3)" "unprognostic (2.42e-1)" "unprognostic (1.02e-3)" "unprognostic (1.25e-2)" "unprognostic (2.23e-1)" "unprognostic (2.48e-1)" "unprognostic (3.08e-2)" 496.3 181.0 74.8 243.6 84.2 82.3 218.0 82.6 91.6 261.4 88.2 229.8 148.7 333.5 173.2 170.2 173.5 350.4 393.9 68.3 103.8 182.0 289.5 235.7 119.0 97.1 88.5 57.8 158.5 136.4 146.6 60.2 463.4 95.9 250.3 225.7 28.0 131.9 431.7 159.2 92.9 152.1 716.4 87.9 206.5 161.5 92.0 86.6 78.2 163.0 196.2 107.1 360.8 120.2 97.0 638.0 907.0 495.4 559.6 1183.4 1019.5 398.1 2063.9 1239.6 999.0 903.9 215.9 1478.2 164.5 354.1 1830.9 638.0 438.9 149.1 1204.1 1122.0 163.1 112.7 195.8 416.3 253.6 826.4 48.3 195.5 1027.7 658.2 1040.8 426.0 2711.1 1263.6 81.0 136.6 76.5 1700.8 109.0 80.1 46.7 107.4 200.6 428.2 52.0 357.0 30.9 1454.8 186.2 108.0 271.4 649.9 114.6 498.2 813.7 153.9 175.0 1362.6 1280.0 712.2 904.2 719.7 64.7 14.8 91.2 956.6 198.2 518.5 7.5 35.1 16.1 83.4 69.8 22.8 109.6 191.8 138.7 33.9 40.3 24.9 68.4 9.0 90.3 108.2 11.4 266.8 117.2 74.8 84.2 82.6 91.6 68.3 103.8 97.1 88.5 57.8 95.9 87.9 86.6 97.0 631.5 342.9 143.8 26.4 118.0 546.7 435.5 531.6 208.3 32.8 147.1 307.5 210.8 241.6 268.1 226.2 31.3 210.3 217.8 179.8 13.7 1206.9 6.6 194.6 437.9 421.1 193.3 153.0 37.2 411.3 515.2 374.7 95.8 406.5 88.7 561.8 375.9 268.1 179.8 38.7 52.4 97.4 213.6 170.1 206.7 18.3 254.5 217.8 343.3 67.5 119.4 72.0 111.2 42.7 66.8 1393.7 128.5 601.8 181.2 412.5 75.6 68.7 171.5 45.5 637.7 236.3 724.0 10.1 76.0 84.4 170.5 219.7 211.3 225.6 127.0 296.1 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371636-43376335 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "kidney: 129.1" "Cell type enriched" "Detected in some" 107 "Collecting duct cells: 5039.3" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SuSa: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058421 Enhanced Uncertain Cytosol NA NA Cytosol "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 2.2 0.0 2.7 0.0 0.0 2.0 2.7 0.0 1.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.9 2.2 129.1 0.0 1.1 0.0 2.4 2.6 1.7 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 0.0 5.7 2.7 1.3 0.0 0.0 0.0 1.8 0.0 7.0 0.8 2.5 0.0 0.0 0.4 0.0 1.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.7 2.0 2.7 1.9 2.2 2.4 2.6 1.7 3.4 1.8 2.5 3.3 0.0 6.4 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 5039.3 0.0 0.5 0.0 0.5 46.9 0.0 2.6 6.4 2.6 0.0 0.0 0.0 0.0 0.2 0.1 0.4 9.2 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 11.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.1 0.1 8.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.4 0.3 0.1 1.0 1.4 TRIM48 RNF101 ENSG00000150244 "Tripartite motif containing 48" Q8IWZ4 11 55262155-55271114 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.04e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K1 ENSG00000150261 "Olfactory receptor family 8 subfamily K member 1" Q8NGG5 11 56345945-56347031 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055233 Uncertain NA NA "HPA055233: AB_2682749" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M9 ENSG00000150269 "Olfactory receptor family 5 subfamily M member 9" Q8NGP3 11 56462469-56463401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH15 "CDHR15, DFNB23, USH1F" ENSG00000150275 "Protocadherin related 15" Q96QU1 10 53802771-55627942 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 19.2;brain: 17.1;retina: 62.2" "Cell type enriched" "Detected in some" 13 "Oligodendrocyte precursor cells: 2965.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.1;U-266/70: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074437 Supported "Intracellular and membrane" NA NA 22000 "HPA074437: " "unprognostic (1.38e-1)" "unprognostic (3.39e-1)" "unprognostic (8.15e-5)" "unprognostic (3.07e-3)" "unprognostic (2.79e-1)" "unprognostic (9.15e-4)" "unprognostic (2.02e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.31e-3)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (7.66e-3)" 0.2 19.2 14.2 0.3 9.7 0.1 0.0 3.3 10.6 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.1 0.1 0.3 15.4 14.2 8.1 0.0 2.5 0.4 13.9 11.4 10.2 0.0 0.0 0.5 4.7 0.2 10.6 0.2 0.0 62.2 0.1 0.0 0.0 0.0 0.2 0.0 7.7 0.7 0.3 3.3 17.1 0.1 0.0 0.0 0.5 0.5 0.0 10.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.1 0.0 0.0 3.3 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 9.7 3.3 10.6 15.4 14.2 13.9 11.4 10.2 10.6 7.7 17.1 10.1 0.0 0.0 0.0 14.4 0.0 0.3 0.0 0.0 0.0 5.1 0.6 0.0 4.8 0.0 0.0 0.0 87.6 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 0.3 0.0 0.0 27.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 216.2 0.1 0.0 0.0 0.0 7.5 0.0 0.1 0.0 3.7 0.0 4.4 0.0 2965.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 92.8 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 CTF1 "CT-1, CT1" ENSG00000150281 "Cardiotrophin 1" Q16619 16 30896614-30903547 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 16.4;Cardiomyocytes: 11.4;Distal tubular cells: 31.3;Muller glia cells: 21.1;Proximal tubular cells: 14.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 13.6;ASC TERT1: 14.7;fHDF/TERT166: 11.9;HHSteC: 13.0;HSkMC: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025853 Uncertain "Secreted to blood" NA NA 11900 "CAB025853: " "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (6.81e-3)" "unprognostic (1.06e-3)" "prognostic unfavorable (7.22e-5)" "unprognostic (2.12e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.87e-4)" "unprognostic (4.47e-2)" "unprognostic (1.09e-1)" "unprognostic (6.75e-2)" "unprognostic (2.76e-2)" "unprognostic (1.76e-3)" "unprognostic (5.07e-3)" "unprognostic (2.06e-1)" "unprognostic (2.16e-2)" "unprognostic (1.79e-1)" 6.3 8.2 4.7 1.3 4.6 1.5 6.7 4.1 5.2 14.4 4.9 9.9 0.8 17.5 4.2 5.3 12.2 3.8 15.6 4.4 5.5 7.6 1.2 7.5 1.4 5.3 4.8 4.1 18.6 3.6 10.1 5.2 2.0 4.8 12.3 1.0 2.1 5.7 12.8 14.3 2.7 4.6 7.7 5.4 1.7 7.7 3.5 4.7 2.1 8.5 11.0 1.1 14.1 9.7 4.8 2.0 0.3 2.6 5.7 13.6 14.7 4.5 4.3 8.5 4.4 5.6 2.4 0.4 0.1 8.3 11.9 0.4 1.5 0.0 3.0 4.4 0.1 0.2 0.1 0.2 0.9 13.0 0.2 0.8 13.9 3.8 3.3 8.0 4.9 1.2 0.2 3.7 0.4 7.9 0.3 0.3 0.4 0.8 1.2 0.8 1.6 3.9 0.0 0.7 0.9 0.2 1.4 0.0 0.1 0.0 4.0 6.9 0.3 0.9 4.2 5.2 0.2 0.1 0.1 0.1 0.2 3.3 0.5 0.0 0.6 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.4 0.1 0.1 0.3 0.0 0.0 4.7 4.6 4.1 5.2 4.4 5.5 5.3 4.8 4.1 4.8 5.4 4.7 4.8 0.8 3.2 6.4 2.6 0.8 0.4 16.4 1.8 2.2 0.3 6.2 7.1 11.4 2.8 1.8 7.3 0.0 0.3 1.2 0.0 31.3 1.0 0.6 7.1 2.9 1.1 0.0 0.4 0.3 0.4 0.2 3.9 0.0 2.4 0.0 3.8 0.0 0.4 0.6 0.0 0.6 0.2 0.0 0.6 0.8 0.7 2.1 1.1 0.0 1.0 0.4 21.1 0.0 1.0 0.4 0.4 0.0 2.6 0.6 2.7 0.2 14.4 2.5 0.9 0.0 4.6 3.0 0.8 0.4 1.9 0.3 0.4 0.7 3.9 0.2 7.4 CWC15 "AD002, C11orf5, Cwf15, HSPC148" ENSG00000150316 "CWC15 spliceosome associated protein homolog" Q9P013 11 94962620-94973586 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 883.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039878 Supported Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles, Mitochondria" "HPA039878: AB_2676722" "unprognostic (1.97e-1)" "unprognostic (5.51e-2)" "unprognostic (1.66e-2)" "unprognostic (8.64e-2)" "unprognostic (3.81e-1)" "unprognostic (6.85e-2)" "unprognostic (1.29e-1)" "unprognostic (1.52e-1)" "unprognostic (4.84e-3)" "prognostic favorable (9.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.44e-1)" "unprognostic (1.34e-1)" "prognostic favorable (7.17e-4)" "unprognostic (5.23e-2)" 23.0 22.0 39.3 14.4 39.1 32.6 30.8 40.1 46.7 22.7 36.3 19.3 16.1 21.0 34.4 23.8 21.5 14.0 35.1 38.7 40.0 31.5 37.9 17.4 25.3 40.2 39.9 37.9 27.2 22.6 26.1 15.8 25.8 40.1 20.1 19.6 25.5 27.2 19.9 69.2 18.3 18.4 17.6 40.2 19.0 21.9 40.4 39.8 31.1 25.3 60.7 24.6 22.2 20.8 41.6 27.1 16.5 63.3 32.3 54.4 50.1 33.0 40.1 52.4 59.9 51.0 80.6 62.4 40.3 76.2 51.1 41.2 28.9 33.8 47.3 66.3 50.7 30.5 51.3 20.5 40.0 45.3 65.9 31.8 47.9 54.1 36.7 54.0 50.2 59.5 44.3 58.2 37.2 56.1 29.4 65.2 87.6 32.0 66.6 42.9 43.7 38.2 44.2 61.1 30.2 35.2 28.8 42.0 44.7 35.9 53.3 72.1 50.8 35.8 44.4 35.2 60.7 41.0 16.9 41.2 57.4 25.5 73.4 44.8 45.9 22.6 33.9 23.6 28.1 32.3 28.7 31.3 29.0 29.6 25.2 29.7 30.7 27.4 26.8 35.9 28.7 34.4 23.7 39.3 39.1 40.1 46.7 38.7 40.0 40.2 39.9 37.9 40.1 40.2 39.8 41.6 67.1 73.7 63.9 12.4 69.3 59.3 84.6 150.1 54.7 59.3 56.1 80.0 170.3 92.9 112.2 51.5 14.6 146.7 75.5 62.4 221.1 122.2 883.6 57.7 60.9 74.3 28.4 96.2 15.4 144.0 126.3 80.0 42.8 57.9 104.4 68.6 96.0 121.3 128.7 40.4 17.0 68.3 83.4 69.5 62.4 203.6 112.8 68.8 71.2 14.0 109.1 142.6 104.0 13.0 21.5 125.7 85.4 92.9 59.2 90.9 99.0 245.9 89.1 59.1 138.1 72.5 98.8 267.7 196.2 80.2 63.9 119.3 71.3 69.9 65.2 70.9 FCGR1A "CD64, CD64A" ENSG00000150337 "Fc fragment of IgG receptor Ia" P12314 1 149782671-149791675 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 94.1;lymphoid tissue: 41.7" "Cell type enhanced" "Detected in some" "Hofbauer cells: 283.3;Kupffer cells: 140.9;Late spermatids: 64.9;Macrophages: 94.9" "Cancer enriched" "Detected in many" 4 "glioma: 10.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 131.5;intermediate monocyte: 54.7;myeloid DC: 35.6;neutrophil: 93.4" "Group enriched" "Detected in many" 53 "dendritic cells: 35.6;granulocytes: 93.4;monocytes: 131.5" "Cell line enriched" "Detected in some" 5 "THP-1: 191.6" "Low region specificity" "Detected in all" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (5.27e-2)" "unprognostic (2.89e-2)" "unprognostic (2.34e-2)" "unprognostic (7.97e-2)" "unprognostic (8.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (4.83e-8)" "unprognostic (1.28e-1)" "unprognostic (4.51e-2)" "unprognostic (9.99e-2)" "unprognostic (9.03e-2)" 12.3 7.3 8.4 41.7 10.4 18.1 3.6 9.1 12.9 4.2 10.4 2.3 1.1 1.7 94.1 1.8 1.9 8.3 2.2 8.6 16.1 2.1 4.3 28.8 14.6 15.0 10.1 8.0 2.3 4.3 2.8 2.5 32.9 12.7 1.6 2.1 2.3 1.9 2.4 0.3 0.3 1.3 19.2 13.3 12.6 2.1 3.8 12.1 1.4 1.4 0.8 0.8 14.8 0.8 17.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 13.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.3 191.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 24.4 0.0 2.0 131.5 1.6 0.0 54.7 0.7 1.6 0.0 0.3 35.6 0.0 0.0 0.1 93.4 0.0 11.8 0.9 0.3 48.5 8.4 10.4 9.1 12.9 8.6 16.1 15.0 10.1 8.0 12.7 13.3 12.1 17.0 0.3 0.0 3.1 0.0 0.8 0.1 0.0 0.0 0.6 1.5 0.2 0.8 1.7 1.5 1.3 0.0 2.1 2.7 0.0 0.0 0.0 0.0 30.8 0.1 0.1 9.3 0.0 2.7 0.1 0.0 1.3 1.0 0.0 0.1 0.0 0.2 1.8 0.5 283.3 0.0 0.1 0.0 0.0 140.9 6.0 64.9 0.3 94.9 0.0 7.5 34.7 0.3 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.7 1.3 6.6 0.2 0.3 0.6 0.4 0.1 0.0 4.1 0.6 0.1 0.1 0.0 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901684-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 115.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 50.4 8.1 2.8 21.4 6.0 6.9 34.6 2.8 16.6 37.5 18.4 15.0 10.3 39.4 4.6 20.4 20.7 39.6 15.0 4.6 10.1 21.6 8.4 18.5 19.0 7.4 8.7 4.3 17.7 6.3 13.4 10.1 21.2 15.2 18.5 11.8 4.2 15.9 10.3 87.9 17.2 14.3 42.8 2.2 17.1 11.6 6.9 6.5 13.2 7.9 12.0 16.8 31.2 19.8 8.2 2.2 0.9 6.0 14.7 13.0 34.0 1.2 42.9 115.2 29.9 23.3 52.7 2.3 3.9 10.1 41.4 4.3 14.3 20.6 6.5 36.0 13.7 6.1 2.1 10.4 13.5 23.9 0.6 25.2 43.3 3.4 17.6 20.2 26.2 3.9 7.5 1.9 5.7 9.9 7.7 14.4 1.1 1.1 10.2 13.5 17.7 9.8 1.1 20.1 23.9 3.3 4.4 19.2 10.6 12.8 13.1 8.7 0.7 3.3 16.5 22.0 25.1 10.9 0.4 0.0 11.4 14.3 0.8 5.4 9.6 1.2 0.8 13.3 2.8 1.8 37.5 19.7 11.8 2.2 41.2 12.8 8.4 2.2 12.3 8.2 1.0 30.9 5.4 2.8 6.0 2.8 16.6 4.6 10.1 7.4 8.7 4.3 15.2 2.2 6.5 8.2 86.2 131.4 70.7 54.5 199.8 968.2 453.9 111.3 105.9 54.4 112.8 96.6 72.8 27.1 96.3 51.5 0.0 187.8 89.1 7.5 99.7 56.1 31.7 164.7 231.0 134.1 36.4 5.2 167.8 14.6 150.7 343.6 21.4 457.7 24.6 37.6 119.2 7.4 51.0 74.0 181.9 18.7 22.4 44.1 162.4 20.1 151.6 43.6 138.7 34.7 39.0 17.2 58.7 74.4 155.8 41.1 25.2 60.5 234.5 193.7 5.4 304.8 38.4 3.6 131.5 496.3 463.9 8.2 5.8 65.7 477.8 920.4 178.2 24.3 41.7 233.9 KLHL1 "FLJ30047, KIAA1490, MRP2" ENSG00000150361 "Kelch like family member 1" Q9NR64 13 69700594-70108493 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 26.3" "Cell type enriched" "Detected in some" 7 "Oligodendrocyte precursor cells: 206.1" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HeLa: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021196 Uncertain NA NA "HPA021196: AB_1852567" "unprognostic (5.81e-2)" "unprognostic (7.40e-3)" "unprognostic (2.43e-1)" "unprognostic (1.41e-1)" 0.0 0.1 3.4 0.0 2.1 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 8.9 0.0 0.0 0.0 0.0 7.6 26.3 1.5 0.0 0.0 0.0 0.4 0.0 7.3 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.2 18.6 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.1 2.7 2.3 1.1 8.9 7.6 26.3 1.5 7.3 3.8 18.6 7.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 206.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 23.1" "Group enriched" "Detected in some" 13 "Excitatory neurons: 220.8;Inhibitory neurons: 236.4;Oligodendrocytes: 145.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 7.0;fHDF/TERT166: 6.3;HaCaT: 14.4;LHCN-M2: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" NA NA 870000 "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.1 0.1 5.2 0.0 10.4 0.0 0.3 0.0 23.1 0.4 0.0 0.1 0.3 0.1 0.2 0.1 0.0 0.2 0.2 17.3 9.9 0.0 0.0 0.1 0.0 6.5 8.9 7.2 1.8 0.0 0.1 0.7 0.3 13.1 0.4 0.1 2.2 0.4 5.1 0.4 0.1 0.2 0.4 2.4 0.0 0.1 0.3 7.0 0.5 0.1 0.9 0.0 0.4 0.1 13.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.3 0.0 14.4 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 17.3 0.0 0.0 0.0 1.3 0.0 1.3 0.0 0.0 1.1 0.0 1.9 0.1 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 10.4 0.0 23.1 17.3 9.9 6.5 8.9 7.2 13.1 2.4 7.0 13.3 0.4 0.0 0.5 3.9 0.0 0.1 0.8 1.3 1.2 15.1 0.1 0.9 1.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.9 0.1 0.1 0.5 0.0 0.0 220.8 0.0 0.2 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 236.4 0.0 2.0 0.0 0.0 1.3 0.0 0.1 0.0 8.4 0.0 0.7 0.0 7.5 145.7 0.0 0.0 0.4 0.0 0.3 0.0 0.2 2.7 0.7 0.0 0.7 4.7 1.3 2.5 0.5 0.1 0.3 0.1 0.1 0.0 0.8 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490951 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 99.5;skeletal muscle: 109.8;tongue: 69.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 79.6;Excitatory neurons: 43.9;Inhibitory neurons: 37.9;Oligodendrocytes: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 11.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 11.3" "Cell line enhanced" "Detected in all" "SCLC-21H: 54.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favorable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 7.5 8.5 10.4 4.4 9.6 14.1 7.7 22.6 14.1 8.4 26.0 8.5 4.6 9.5 9.5 6.4 7.7 5.4 99.5 9.3 10.3 8.3 8.6 7.7 7.2 12.8 11.4 10.1 8.2 7.1 5.9 10.6 7.4 13.7 7.5 6.4 17.0 9.1 4.9 109.8 14.5 8.3 7.5 9.6 9.5 8.4 9.1 10.3 8.2 4.5 69.7 7.4 7.1 7.5 18.6 13.3 7.5 13.0 9.5 9.8 8.3 10.6 10.0 11.4 9.0 10.8 27.4 7.3 9.8 3.4 11.3 13.9 17.2 13.8 7.1 12.5 6.7 23.4 15.6 40.9 7.5 6.0 24.5 11.2 12.0 11.6 9.8 9.0 6.2 8.3 12.9 9.2 8.4 8.6 9.0 16.6 38.1 8.9 9.7 11.8 16.9 20.8 11.2 6.4 8.3 54.7 12.2 6.9 24.6 7.0 8.8 14.1 10.6 12.7 11.3 16.4 9.0 14.3 25.5 11.4 19.2 25.3 10.4 7.7 11.3 1.5 2.2 2.0 1.0 2.5 1.9 1.8 1.4 1.6 0.9 1.8 0.9 0.8 1.9 1.5 0.2 2.0 1.5 10.4 9.6 22.6 14.1 9.3 10.3 12.8 11.4 10.1 13.7 9.6 10.3 18.6 7.6 16.0 15.6 27.4 2.4 5.9 2.0 2.3 1.8 9.0 6.7 4.3 79.6 0.0 8.4 3.7 16.7 2.4 2.5 4.8 1.9 1.7 5.9 5.0 6.5 7.1 6.6 3.0 43.9 1.3 1.4 6.6 8.2 6.0 5.1 4.6 5.7 3.9 1.4 18.5 37.9 4.4 0.0 3.5 4.4 8.3 7.2 4.2 5.4 18.7 2.2 4.8 3.1 30.2 42.8 2.1 1.3 5.7 2.0 3.7 3.4 2.5 4.6 9.6 0.0 3.5 3.7 3.8 4.2 4.3 7.4 2.6 3.5 5.2 3.9 3.2 TMCO3 "C13orf11, FLJ20623" ENSG00000150403 "Transmembrane and coiled-coil domains 3" Q6UWJ1 13 113491021-113554590 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 20.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039561, HPA048126" Uncertain Approved Cytosol NA NA Cytosol "HPA039561: AB_2676573, HPA048126: AB_2680276" "unprognostic (7.89e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (6.78e-2)" "unprognostic (7.88e-2)" "unprognostic (2.89e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (2.93e-2)" "unprognostic (9.44e-2)" "unprognostic (3.08e-3)" "unprognostic (2.76e-2)" "unprognostic (8.47e-3)" "unprognostic (3.70e-3)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (6.27e-3)" "prognostic unfavorable (4.10e-4)" 23.0 27.2 20.6 18.7 18.4 77.4 22.9 29.1 20.8 31.4 44.1 22.6 21.2 33.4 20.2 14.6 25.4 27.9 28.4 17.3 18.2 24.4 14.4 24.5 16.4 19.5 18.3 16.2 25.4 41.1 35.4 23.3 30.3 20.2 22.3 22.2 18.3 39.0 21.8 19.3 13.5 22.9 29.9 20.4 20.0 44.7 16.2 18.9 12.5 10.8 15.3 13.2 19.8 19.1 22.4 97.8 32.6 46.3 32.0 93.1 136.4 25.0 105.0 99.6 45.1 45.3 35.7 41.9 23.1 25.9 115.7 61.7 38.5 24.8 38.0 70.0 48.0 25.1 20.9 52.2 36.0 87.9 34.3 41.7 112.0 88.5 33.9 68.9 116.7 74.5 14.3 30.3 31.6 79.6 17.5 18.0 20.6 23.2 46.5 50.9 22.4 28.0 16.7 74.3 12.6 40.4 33.5 32.3 70.3 33.6 65.3 41.5 64.6 117.4 50.3 53.5 36.9 44.8 39.2 23.9 14.8 167.2 17.8 24.6 3.1 8.3 8.5 1.3 5.6 1.5 3.1 1.5 2.0 6.0 1.8 1.7 1.7 20.2 5.0 11.3 1.3 1.5 2.7 20.6 18.4 29.1 20.8 17.3 18.2 19.5 18.3 16.2 20.2 20.4 18.9 22.4 34.3 12.8 15.1 21.5 12.5 9.8 37.2 25.8 21.6 16.4 39.2 17.5 20.3 24.3 27.8 25.8 14.6 21.6 13.5 37.1 5.9 46.8 14.6 28.2 39.2 31.3 34.2 23.5 42.9 37.4 53.8 35.0 39.3 28.6 26.6 18.4 35.0 12.4 19.1 21.9 41.0 69.2 12.2 31.3 18.8 37.1 36.7 24.5 17.8 12.2 31.4 25.9 17.5 24.6 31.9 52.6 28.2 47.8 19.2 64.0 20.0 11.2 45.2 19.0 6.6 26.2 31.9 17.6 12.2 15.9 7.1 13.0 11.8 34.4 17.7 31.3 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 17.9 18.3 5.1 9.6 5.5 5.4 14.1 5.7 6.5 15.6 5.3 12.9 8.5 16.7 6.9 11.7 14.9 7.5 8.8 4.6 6.7 12.8 13.0 12.1 10.6 6.0 5.2 4.0 15.1 14.6 10.4 15.3 5.9 5.7 13.2 6.1 6.5 11.0 6.9 9.3 8.7 11.9 8.4 6.2 16.7 13.3 5.6 5.3 8.5 11.0 5.7 7.0 14.0 13.3 6.4 12.5 24.0 14.9 18.2 13.5 18.6 9.0 12.2 9.2 9.3 12.0 2.5 35.9 15.6 29.9 7.5 14.2 14.2 9.4 11.6 12.2 22.0 13.5 35.1 6.1 10.0 13.3 11.1 12.6 14.7 15.2 16.5 19.6 14.9 13.7 19.1 14.4 19.4 16.2 6.4 2.9 23.3 12.2 34.0 22.6 16.3 18.0 12.0 8.3 12.3 12.9 19.4 16.6 6.6 9.1 8.7 31.3 15.7 17.6 11.4 10.3 13.4 13.5 11.1 10.1 12.9 9.1 22.9 20.3 43.7 40.1 17.4 21.6 31.6 18.7 29.6 20.5 20.5 47.4 23.9 17.2 20.4 15.7 32.5 30.9 41.1 20.5 27.0 5.1 5.5 5.7 6.5 4.6 6.7 6.0 5.2 4.0 5.7 6.2 5.3 6.4 21.0 19.2 13.4 7.8 17.8 12.1 19.6 34.6 19.4 7.0 22.1 24.6 8.1 15.7 16.6 14.7 0.0 28.0 18.1 5.7 27.4 20.5 3.4 23.1 22.4 15.8 10.8 14.5 4.4 16.2 18.4 21.1 8.6 10.6 3.8 22.2 18.5 15.1 42.2 23.5 7.4 11.7 20.3 21.0 17.5 1.9 10.2 21.9 17.8 14.0 26.0 26.0 18.6 9.5 11.2 13.1 3.9 16.6 15.8 9.4 8.5 19.7 29.4 12.4 26.3 16.7 18.3 16.6 13.8 18.0 14.2 9.7 14.5 27.0 13.7 16.6 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: AB_2682486" "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 4.3 4.4 1.5 5.0 1.4 2.9 4.5 3.0 2.4 5.4 3.0 5.4 7.7 4.5 2.5 4.4 5.3 4.6 5.4 1.3 1.8 3.9 6.3 4.3 4.2 2.0 1.7 1.3 8.0 4.7 7.2 3.6 5.0 2.1 5.8 5.6 3.1 8.1 6.5 5.4 4.3 7.0 4.8 1.2 5.1 4.4 1.5 1.4 3.2 4.8 4.9 5.1 4.6 3.3 1.5 2.2 7.0 3.7 6.2 6.2 8.5 4.4 5.7 9.3 3.9 3.7 11.0 8.3 5.7 9.6 5.9 6.9 6.2 3.9 4.4 1.5 15.3 3.7 15.4 4.2 7.1 4.9 9.6 7.9 6.4 6.0 7.4 5.1 4.7 6.5 4.6 4.2 12.9 4.6 4.0 0.3 1.5 1.7 15.9 6.3 2.0 1.0 5.4 3.1 7.8 4.6 5.8 6.8 6.7 4.6 4.8 18.2 4.9 6.5 2.2 2.1 4.5 4.3 3.6 5.6 4.2 3.4 7.5 7.0 5.3 5.8 2.9 4.0 4.5 3.7 2.1 3.1 4.2 4.6 3.8 2.5 2.4 4.9 2.6 3.2 3.2 3.5 3.7 1.5 1.4 3.0 2.4 1.3 1.8 2.0 1.7 1.3 2.1 1.2 1.4 1.5 1.7 6.4 2.6 2.3 3.7 0.4 1.8 2.0 4.0 3.5 2.7 2.0 1.3 2.8 2.8 3.7 0.0 3.4 2.2 4.2 0.0 3.3 0.0 1.1 2.3 3.2 1.2 0.8 3.7 4.0 4.9 2.7 2.0 1.7 1.3 2.0 2.5 4.8 5.2 3.3 5.0 3.9 2.0 4.4 0.8 0.3 4.7 3.7 1.8 3.7 2.1 3.6 4.1 3.0 1.8 3.6 8.1 4.5 9.2 2.0 6.5 2.2 1.6 2.5 0.0 2.0 2.5 0.1 0.6 3.5 0.1 2.6 4.2 2.3 2.4 1.5 EEF1AKMT1 N6AMT2 ENSG00000150456 "EEF1A lysine methyltransferase 1" Q8WVE0 13 20728731-20773961 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040417, HPA042543" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040417: AB_2676973, HPA042543: AB_2678045" "unprognostic (4.14e-1)" "unprognostic (5.11e-2)" "unprognostic (8.57e-2)" "prognostic favorable (1.82e-4)" "unprognostic (9.14e-2)" "unprognostic (3.44e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (2.39e-3)" "unprognostic (3.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.81e-2)" "unprognostic (4.31e-2)" 9.7 10.4 11.2 5.3 11.3 3.4 9.9 11.7 16.9 10.9 10.3 8.1 4.5 10.9 14.4 5.9 11.2 6.3 10.0 11.1 12.8 8.6 13.6 6.5 6.9 11.4 11.2 10.6 10.5 6.4 9.6 9.9 6.5 11.4 10.3 6.0 10.3 8.0 9.0 11.2 5.7 5.7 9.3 11.8 5.8 7.1 4.4 11.3 9.3 9.6 12.3 6.8 8.9 7.6 12.2 11.1 8.5 6.9 11.4 28.3 29.2 16.9 14.4 11.0 12.4 6.4 11.9 12.1 18.0 10.5 15.8 5.8 9.0 9.4 12.2 12.8 11.7 8.4 23.3 3.8 22.8 15.6 46.3 4.6 20.1 10.7 9.2 20.4 13.8 22.4 15.7 13.6 2.4 35.5 30.7 15.6 41.0 12.0 20.2 6.2 19.2 7.6 3.5 17.8 12.7 15.8 9.4 12.5 6.1 16.5 5.9 6.4 42.4 13.3 8.5 0.0 19.1 6.4 3.3 6.7 19.9 7.3 31.4 6.1 0.0 5.2 0.9 8.6 4.1 9.6 13.1 10.3 9.0 8.9 5.4 13.0 11.3 0.7 16.3 4.4 10.8 12.0 6.7 11.2 11.3 11.7 16.9 11.1 12.8 11.4 11.2 10.6 11.4 11.8 11.3 12.2 15.0 22.4 9.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.3 19.9 0.0 0.0 8.1 7.3 0.0 19.8 3.1 0.0 27.4 12.6 0.0 20.9 16.2 6.0 0.0 0.0 0.0 10.4 15.2 8.9 0.0 7.0 3.8 13.2 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 36.5 7.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 15.7 2.2 9.9 0.0 0.0 LATS2 ENSG00000150457 "Large tumor suppressor kinase 2" Q9NRM7 13 20973036-21061586 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 139.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039191, HPA049037" Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA039191: AB_2676385, HPA049037: AB_2680609" "unprognostic (2.77e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.22e-3)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (1.84e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-3)" "unprognostic (4.48e-1)" "unprognostic (6.57e-3)" "unprognostic (8.03e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (1.66e-2)" "unprognostic (1.25e-1)" "unprognostic (7.97e-2)" "unprognostic (1.11e-2)" 19.9 12.3 4.3 7.4 4.1 15.2 12.5 4.3 4.5 10.2 7.8 10.7 2.9 12.3 3.1 11.6 9.8 15.2 11.6 5.0 6.6 10.0 9.9 12.6 5.3 5.3 4.5 2.0 11.1 10.3 4.3 2.4 14.0 4.4 9.9 4.3 1.3 6.2 8.9 16.9 7.2 6.2 13.2 4.0 11.3 7.9 14.7 4.7 2.4 13.7 13.4 3.3 14.3 8.9 4.6 6.8 7.4 16.0 9.7 18.4 24.1 14.6 22.1 22.8 22.5 19.2 21.1 10.0 0.0 10.5 33.8 8.8 9.6 9.5 10.1 33.1 3.8 2.5 12.4 9.4 16.0 28.6 3.4 4.2 36.0 18.1 14.9 9.9 11.3 32.0 2.8 2.3 0.5 28.9 11.7 0.4 11.6 3.8 7.0 3.5 2.9 28.5 0.0 16.3 3.1 0.3 0.0 17.4 11.3 23.9 13.9 9.8 6.4 40.6 23.8 15.9 17.7 14.1 2.9 1.7 0.0 5.7 3.8 18.6 0.1 0.5 0.5 0.4 0.4 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.1 4.3 4.1 4.3 4.5 5.0 6.6 5.3 4.5 2.0 4.4 4.0 4.7 4.6 36.6 41.7 9.9 12.1 2.8 32.9 14.7 8.5 21.6 0.4 12.5 11.0 24.3 15.7 10.5 5.5 0.0 24.8 21.0 6.5 3.9 10.1 139.4 40.3 30.4 35.1 0.0 8.2 0.6 7.3 8.9 37.2 8.6 62.1 5.1 9.8 44.6 19.6 9.9 0.0 0.6 1.9 6.1 17.9 49.3 13.7 25.4 26.0 17.8 21.5 11.0 4.9 13.4 2.0 8.8 18.6 2.8 34.6 8.9 21.7 0.6 9.5 11.6 1.0 6.6 32.3 30.0 8.8 14.5 9.9 25.3 48.0 8.1 7.9 1.5 15.2 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 126.1 165.9 164.0 124.0 167.6 244.4 122.6 167.4 200.6 115.4 156.1 134.8 138.6 124.9 98.3 160.4 113.9 83.1 179.5 164.8 176.2 191.9 172.5 107.4 119.0 171.5 171.6 146.8 110.4 135.8 115.2 130.6 112.6 173.9 110.7 59.1 90.3 127.4 73.7 300.7 118.7 128.6 52.2 188.6 108.4 120.5 195.8 173.5 116.6 111.6 157.6 65.4 132.8 119.5 195.3 182.1 99.3 159.5 173.1 169.0 140.5 246.9 227.1 167.2 205.5 151.3 181.1 342.4 187.3 272.0 189.1 223.4 186.5 198.1 142.4 231.5 288.0 100.4 267.6 121.2 305.9 191.8 367.1 207.5 143.0 159.7 157.5 187.1 158.4 157.3 223.1 128.8 103.6 188.2 231.0 417.0 599.0 200.7 501.5 109.7 261.1 251.4 187.1 295.7 160.7 185.0 161.1 145.7 213.8 296.5 176.5 206.8 528.0 192.6 126.0 141.9 230.1 268.9 159.6 243.6 536.7 122.5 214.9 236.4 433.0 431.5 540.0 344.1 485.0 349.3 493.7 418.2 410.9 427.8 443.6 405.9 402.9 430.5 395.3 547.4 568.8 517.5 909.3 164.0 167.6 167.4 200.6 164.8 176.2 171.5 171.6 146.8 173.9 188.6 173.5 195.3 638.0 134.6 143.5 15.0 291.7 458.6 336.3 640.9 310.7 101.5 298.9 594.9 592.9 194.5 383.8 233.6 41.7 566.2 397.4 353.6 759.2 396.5 1259.5 334.1 231.1 273.1 234.5 214.4 20.8 365.6 528.0 374.0 170.2 256.2 258.6 176.6 180.2 242.0 396.0 119.5 23.4 364.5 468.0 189.5 440.9 206.0 342.3 260.4 407.4 17.8 385.0 370.8 233.8 19.6 26.2 401.9 417.6 303.6 182.3 325.9 475.0 1100.6 446.8 132.3 203.8 362.5 438.3 547.7 319.9 271.7 422.2 908.3 338.8 254.2 344.7 419.9 ADGRL3 "KIAA0768, LEC3, LPHN3" ENSG00000150471 "Adhesion G protein-coupled receptor L3" Q9HAR2 4 61201258-62078335 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Group enriched" "Detected in many" 11 "Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1" "Cancer enriched" "Detected in some" 9 "glioma: 5.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015027, HPA015762, CAB022698" Uncertain NA NA "CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245" "unprognostic (2.88e-2)" "unprognostic (1.12e-1)" "unprognostic (6.43e-4)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (7.56e-2)" "unprognostic (8.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (6.81e-2)" "unprognostic (1.28e-1)" "unprognostic (1.62e-5)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (9.85e-3)" "unprognostic (4.23e-3)" 4.7 6.2 26.3 1.2 27.4 0.0 2.5 15.6 30.0 5.5 0.0 4.0 2.5 3.9 1.8 1.0 2.4 1.6 2.6 28.9 26.0 1.6 0.4 2.6 0.4 17.1 25.7 25.2 1.1 0.3 6.8 0.9 1.2 16.1 1.3 3.9 10.1 0.6 4.3 0.7 2.8 3.6 3.0 12.5 0.3 3.2 4.2 28.7 0.4 0.7 0.4 0.1 1.7 3.4 17.3 0.0 0.1 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.1 0.0 3.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.0 0.0 4.0 0.5 0.1 0.1 0.0 4.8 0.2 0.0 6.3 0.3 0.0 0.0 0.0 7.6 0.1 3.2 0.0 0.2 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 27.4 15.6 30.0 28.9 26.0 17.1 25.7 25.2 16.1 12.5 28.7 17.3 0.4 0.0 0.0 584.1 0.0 0.0 0.0 0.0 0.6 12.4 4.9 1.8 3.3 0.0 0.0 0.0 4.2 1.0 0.0 0.0 9.8 0.0 46.4 1.3 17.7 1.9 0.0 0.0 696.1 0.0 1.3 3.3 0.0 0.4 0.0 0.4 2.5 0.2 0.1 1.7 737.4 0.0 0.0 0.0 0.0 33.2 0.0 0.5 0.0 70.3 0.0 31.3 0.0 1300.8 592.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.4 6.6 0.3 18.5 0.9 3.5 1.2 0.0 2.2 0.2 0.1 0.0 0.1 KIAA1328 ENSG00000150477 KIAA1328 Q86T90 18 36829106-37232172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 230.8;Alveolar cells type 2: 228.3;Inhibitory neurons: 113.9;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 178.0;Respiratory ciliated cells: 122.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040946 Approved Approved "Nuclear speckles,Vesicles,Lipid droplets" NA NA "Nuclear speckles" "Vesicles, Lipid droplets" "HPA040946: AB_10794998" "unprognostic (3.66e-2)" "unprognostic (5.37e-4)" "unprognostic (2.76e-2)" "unprognostic (1.55e-3)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (2.46e-2)" "unprognostic (1.51e-3)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (3.18e-3)" "unprognostic (4.85e-2)" "unprognostic (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (2.25e-2)" "unprognostic (3.36e-2)" "unprognostic (2.64e-3)" 7.0 7.2 30.5 7.8 39.8 22.2 5.7 57.2 70.7 5.1 11.1 6.3 9.1 9.6 9.1 6.6 6.2 7.3 6.7 34.0 17.6 7.3 7.1 7.4 7.6 16.8 16.3 29.2 13.8 5.4 5.1 2.8 8.4 24.3 7.6 5.6 38.2 9.5 3.9 11.1 13.7 9.4 5.5 1.3 8.4 9.1 16.9 8.0 4.1 7.1 4.1 4.6 4.6 3.6 80.8 26.2 7.4 11.2 13.5 3.8 5.8 10.5 10.7 4.0 5.1 3.4 12.9 16.4 18.1 32.8 4.1 8.6 11.7 4.2 4.7 6.4 15.3 5.0 22.9 24.6 9.3 3.6 16.0 11.9 5.4 5.8 5.6 5.0 5.5 4.4 10.9 18.1 40.7 5.0 23.0 10.6 10.6 25.0 9.6 11.4 14.0 11.9 12.8 4.2 22.2 11.7 13.5 12.8 15.9 6.7 20.4 23.3 8.3 13.8 22.4 29.5 13.3 11.2 32.2 43.8 14.4 11.0 11.3 15.4 23.8 6.7 9.9 8.2 5.0 9.8 7.4 7.2 7.0 3.2 11.4 9.3 7.5 13.2 7.4 8.0 5.5 9.4 4.0 30.5 39.8 57.2 70.7 34.0 17.6 16.8 16.3 29.2 24.3 1.3 8.0 80.8 10.9 230.8 228.3 85.5 13.3 5.7 7.9 7.0 6.8 36.1 6.5 7.1 6.0 7.2 106.8 5.5 20.9 8.8 6.5 1.7 5.9 7.6 51.9 6.8 10.5 18.2 3.0 5.5 83.8 5.8 7.8 23.9 5.1 6.9 107.9 13.5 9.7 3.0 6.6 16.8 113.9 3.2 2.0 4.4 4.6 13.0 9.3 18.3 7.2 94.6 5.0 10.1 19.6 117.6 178.0 6.3 3.7 7.9 8.0 3.6 4.4 4.4 122.7 30.9 0.0 14.3 11.0 45.3 19.6 6.6 7.0 3.8 20.6 11.5 4.5 5.0 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 59.2;choroid plexus: 21.9;retina: 26.0" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 232.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HAP1: 18.0;HUVEC TERT2: 10.6;NTERA-2: 35.1;SH-SY5Y: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048182: AB_2680301" "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 4.0 1.8 13.2 2.7 28.8 0.2 2.9 22.0 24.1 2.2 21.9 6.1 0.6 3.1 4.7 1.2 3.1 2.4 4.3 13.5 19.0 3.7 0.7 1.9 0.8 28.6 27.0 10.3 0.8 1.4 0.6 1.3 3.6 33.7 4.6 1.3 26.0 7.3 4.4 1.0 0.9 2.0 5.3 22.1 8.4 3.3 1.3 25.1 3.2 2.4 1.3 0.5 4.6 1.6 59.2 0.0 1.7 1.2 1.1 0.3 0.1 0.1 0.2 0.6 0.2 0.2 0.1 0.6 0.6 0.0 0.0 2.2 0.1 18.0 0.2 0.1 0.1 2.7 0.1 0.5 0.0 1.4 0.9 1.1 0.4 0.2 0.5 0.0 0.0 10.6 4.8 0.1 0.1 0.0 0.3 4.6 0.3 35.1 0.3 2.8 1.0 0.1 2.6 0.0 0.1 2.5 13.3 0.6 2.2 2.0 2.6 0.3 1.1 0.2 0.1 1.2 0.9 1.3 0.3 0.0 0.0 1.6 3.2 1.5 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 13.2 28.8 22.0 24.1 13.5 19.0 28.6 27.0 10.3 33.7 22.1 25.1 59.2 8.5 0.0 0.0 17.6 0.4 0.8 2.1 0.0 0.6 10.2 1.1 1.8 10.8 0.0 0.0 1.8 50.1 0.0 0.8 0.2 3.9 2.6 4.7 0.8 3.5 9.3 0.0 0.0 12.0 0.8 0.0 2.2 0.0 1.6 1.3 0.6 8.6 0.1 0.2 6.7 4.8 0.0 0.0 0.6 0.3 5.8 0.6 1.4 3.6 9.4 0.0 3.6 0.0 10.6 232.9 0.7 0.0 0.4 0.0 2.3 0.0 11.7 1.5 43.6 0.0 1.8 2.0 1.7 1.6 0.1 0.1 0.0 0.6 0.7 0.1 0.5 MIA2 "cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI" ENSG00000150527 "MIA SH3 domain ER export factor 2" Q96PC5 14 39230231-39388513 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 140.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 125.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000387, HPA000922, HPA054066, HPA055459" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819" "unprognostic (2.62e-1)" "unprognostic (7.17e-3)" "unprognostic (2.33e-1)" "unprognostic (5.27e-4)" "unprognostic (3.21e-4)" "unprognostic (2.63e-1)" "unprognostic (2.48e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.21e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.93e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-1)" "unprognostic (3.97e-2)" 12.2 26.8 6.0 17.0 7.1 23.8 22.3 5.8 7.9 29.9 48.8 31.1 81.2 15.8 40.6 27.1 22.4 30.6 16.7 9.7 7.2 79.1 140.1 15.6 16.3 5.4 5.5 5.0 9.7 44.0 40.8 15.6 11.3 6.1 21.3 34.9 12.9 52.9 19.3 55.0 9.6 79.1 12.4 4.6 14.6 45.7 21.2 5.8 14.4 47.1 20.9 19.9 16.4 17.3 6.8 23.0 25.1 10.4 18.5 20.6 23.2 14.5 13.3 13.9 9.3 9.6 19.7 125.4 27.5 40.1 15.0 18.9 34.1 12.7 15.0 11.0 21.4 10.6 17.2 11.5 106.1 48.2 23.2 30.7 14.4 83.7 9.2 69.2 59.0 15.3 31.8 16.6 68.3 14.0 22.1 14.9 18.9 12.0 87.2 20.8 15.2 18.3 34.9 42.7 24.7 8.7 5.1 31.0 32.5 20.4 13.1 31.2 24.8 24.3 14.1 9.2 10.4 8.8 38.7 35.7 27.2 7.9 14.5 12.0 40.9 16.3 25.9 15.4 18.0 14.0 11.7 11.6 14.4 17.8 13.1 14.2 13.2 34.5 14.6 21.0 12.3 11.8 11.8 6.0 7.1 5.8 7.9 9.7 7.2 5.4 5.5 5.0 6.1 4.6 5.8 6.8 26.7 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 33.1 19.9 0.0 5.7 0.0 44.1 0.0 5.6 35.9 0.8 7.9 42.9 0.5 78.7 30.7 7.1 0.0 0.0 0.1 42.7 5.0 4.6 0.0 93.5 0.0 10.3 0.0 3.8 7.6 0.0 0.1 1.8 0.0 0.0 0.0 0.6 0.0 12.7 0.0 0.0 23.8 0.0 1.0 0.0 0.0 41.3 0.0 0.0 8.1 0.0 6.6 61.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 7.0 13.6 20.0 0.2 0.0 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 247.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2" "Group enriched" "Detected in many" 23 "dendritic cells: 68.3;monocytes: 110.9" "Cell line enhanced" "Detected in many" "Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA 130000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favorable (4.68e-4)" 71.1 18.4 14.4 42.0 14.3 12.7 62.9 14.1 18.9 57.8 21.2 54.4 29.5 63.4 27.4 17.7 34.8 69.3 20.9 15.3 32.3 110.7 247.9 49.5 35.4 15.9 14.4 11.8 91.8 29.3 40.5 9.6 47.2 17.9 37.3 56.9 6.1 30.8 44.7 6.0 16.8 29.3 33.4 17.3 37.9 29.3 10.4 14.1 8.2 14.7 12.0 16.5 50.1 24.7 23.0 0.7 0.9 5.6 14.6 61.9 64.6 0.4 3.9 6.2 0.4 2.3 29.7 15.7 0.9 50.2 17.0 0.8 1.1 11.9 0.0 0.1 0.7 4.9 0.2 44.5 227.2 28.0 0.3 0.6 87.9 0.1 21.5 0.0 4.7 15.9 0.1 0.5 0.7 47.4 3.7 0.0 0.5 28.1 39.3 5.6 0.5 1.5 0.2 67.9 117.1 0.1 0.8 22.1 28.4 0.1 107.9 1.0 53.2 4.8 4.8 11.8 6.2 16.3 0.4 0.3 0.7 20.9 27.8 3.3 1.3 110.9 0.7 0.5 89.8 0.3 1.8 0.2 0.2 68.3 0.5 0.3 0.4 3.9 0.5 52.2 1.5 0.7 32.6 14.4 14.3 14.1 18.9 15.3 32.3 15.9 14.4 11.8 17.9 17.3 14.1 23.0 15.5 28.9 44.1 9.4 5.0 35.6 81.5 64.6 30.7 0.7 78.1 65.4 2.2 133.0 88.9 60.7 0.0 54.9 2.6 59.4 123.3 122.1 1.5 28.3 50.6 9.4 16.4 16.8 16.8 48.0 81.6 54.2 20.9 115.3 0.0 17.4 19.2 165.7 299.3 0.0 13.8 67.8 24.4 263.7 97.2 4.2 131.4 127.4 56.9 31.9 122.0 25.5 4.1 45.8 14.3 71.0 108.6 105.3 0.2 39.8 31.9 268.3 38.4 0.8 78.9 55.2 55.7 0.5 0.9 33.2 25.9 37.6 4.0 43.9 83.5 126.1 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132643286-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3;fallopian tube: 54.0;pituitary gland: 34.0" "Cell type enhanced" "Detected in some" "Ductal cells: 73.8;Exocrine glandular cells: 74.5;monocytes: 62.0;Oligodendrocyte precursor cells: 28.1;Pancreatic endocrine cells: 43.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 3.6" "Lineage enriched" "Detected in single" 22 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 41.6;HUVEC TERT2: 32.7;SK-MEL-30: 36.5;U-251 MG: 65.9;WM-115: 140.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 0.5 0.8 25.9 0.3 25.1 0.4 0.8 18.4 25.6 0.2 13.2 6.1 0.1 0.9 0.2 1.5 54.0 1.3 0.5 21.9 26.8 5.9 1.0 1.0 0.6 25.1 24.7 18.1 1.3 5.2 0.3 34.0 0.0 23.1 0.7 0.2 1.6 5.5 0.1 0.3 0.3 1.6 0.6 26.7 0.3 0.9 0.7 26.6 2.3 0.9 0.1 1.0 0.8 0.6 31.3 0.4 8.6 11.6 0.2 0.0 0.0 0.0 1.9 1.5 6.3 1.4 0.6 1.1 0.0 18.3 5.1 3.0 7.2 0.0 0.0 2.9 0.1 1.8 0.0 4.0 0.0 0.0 0.0 0.2 0.0 0.1 41.6 0.0 1.7 32.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 11.1 0.2 3.3 0.0 0.0 0.0 15.1 0.2 1.1 2.3 1.8 0.2 36.5 26.8 0.1 0.3 1.5 0.7 17.4 5.9 65.9 0.1 0.0 0.1 10.0 0.0 140.5 0.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 25.1 18.4 25.6 21.9 26.8 25.1 24.7 18.1 23.1 26.7 26.6 31.3 0.7 0.0 0.0 8.1 0.2 0.1 0.1 0.4 0.0 1.6 2.0 0.9 0.2 2.8 0.2 5.5 0.0 0.0 0.0 0.5 1.9 73.8 5.6 1.4 0.1 0.2 1.8 0.0 0.8 74.5 0.0 2.2 0.0 0.9 0.0 0.1 0.4 0.0 0.1 15.2 4.7 0.0 0.0 0.8 0.7 9.3 4.1 0.1 0.0 0.0 62.0 1.4 0.0 28.1 4.4 43.4 0.0 0.0 0.0 0.1 0.1 4.8 0.3 0.8 0.0 0.2 3.9 2.6 2.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 LYPD6B "CT116, LYPD7" ENSG00000150556 "LY6/PLAUR domain containing 6B" Q8NI32 2 149038107-149215262 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 87.0;stomach 1: 41.6" "Cell type enhanced" "Detected in many" "Early spermatids: 245.7;Gastric mucus-secreting cells: 87.7;Inhibitory neurons: 77.8;Late spermatids: 118.5;Suprabasal keratinocytes: 69.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 13.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 64.8;LHCN-M2: 102.3;NB-4: 34.7;RT4: 54.7;SK-BR-3: 32.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049239 Uncertain "Intracellular and membrane" NA NA "HPA049239: AB_2680688" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (3.12e-3)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (2.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.64e-2)" "unprognostic (7.95e-3)" "unprognostic (2.59e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (1.32e-3)" 0.2 0.3 3.4 0.4 2.6 0.2 16.5 1.6 5.5 2.9 1.7 1.7 2.7 0.9 1.2 4.1 23.6 37.6 0.0 4.4 3.3 7.5 0.9 1.7 0.4 2.4 4.5 2.4 0.4 12.4 16.2 0.4 0.9 2.4 11.2 3.4 1.0 5.9 15.3 0.2 87.0 1.2 0.3 1.9 2.8 41.6 34.4 6.1 0.3 0.2 0.0 1.9 14.4 6.3 2.3 1.4 0.0 0.0 1.5 0.0 0.1 0.1 8.0 1.5 6.6 2.5 1.0 0.0 0.0 0.0 64.8 0.0 14.0 1.5 1.3 20.6 0.0 7.4 0.0 1.9 0.0 0.2 0.0 0.1 0.6 21.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 102.3 24.3 0.0 34.7 2.0 14.6 0.3 0.0 0.4 4.3 3.2 54.7 3.9 0.1 0.4 32.1 0.0 6.3 4.8 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.8 13.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 2.6 1.6 5.5 4.4 3.3 2.4 4.5 2.4 2.4 1.9 6.1 2.3 0.5 0.0 2.0 2.3 5.5 29.8 21.0 30.6 6.2 0.0 23.4 17.1 1.4 42.9 23.9 46.0 0.0 0.1 0.1 4.0 7.9 12.4 245.7 5.2 0.3 1.0 2.4 2.7 4.6 19.1 0.7 0.8 87.7 5.7 0.0 0.4 0.0 0.1 0.1 0.0 77.8 3.9 8.2 0.0 2.8 118.5 2.1 0.4 5.4 0.0 0.6 0.0 0.0 0.0 0.4 30.9 6.0 0.0 4.5 40.6 5.7 0.2 21.4 0.0 0.0 0.0 1.3 4.2 1.7 3.5 69.0 0.3 1.1 0.0 3.5 53.7 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 509.7" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 786.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 295.6;U-266/70: 320.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 46.1 31.0 16.2 53.7 16.8 74.6 148.1 19.1 17.0 49.7 25.4 159.0 91.5 67.7 36.6 152.8 58.2 43.7 22.6 14.9 31.5 26.5 36.5 33.1 61.2 16.9 18.0 13.3 134.8 509.7 286.2 40.7 97.8 16.8 55.8 131.6 50.8 257.3 61.0 12.0 100.5 101.1 51.8 16.9 68.2 103.2 30.2 17.4 74.6 155.9 18.8 96.2 42.6 62.3 18.5 26.5 25.4 40.6 43.7 61.6 110.7 23.8 29.9 89.7 14.7 25.7 16.0 65.0 252.3 81.7 43.5 11.4 118.8 26.1 79.4 32.4 219.7 50.6 127.5 146.9 27.9 26.9 65.2 135.8 88.0 247.4 15.7 84.0 67.6 28.2 40.1 35.3 119.6 37.6 69.7 24.2 76.4 10.6 19.0 46.3 10.4 71.6 138.7 24.8 36.8 17.8 73.6 58.7 31.6 109.1 44.6 295.6 121.3 71.8 22.6 16.8 17.1 11.0 320.1 163.8 143.6 22.2 87.4 24.5 186.1 19.5 52.4 54.0 27.0 96.0 54.1 49.7 59.8 23.0 39.5 43.0 53.2 38.3 84.7 29.6 38.5 29.0 40.4 16.2 16.8 19.1 17.0 14.9 31.5 16.9 18.0 13.3 16.8 16.9 17.4 18.5 85.3 19.2 50.0 16.3 132.0 133.1 88.1 104.6 113.3 61.8 148.1 113.9 16.8 42.9 90.3 25.8 31.3 229.5 246.1 348.0 35.2 70.8 20.2 66.7 132.5 79.1 33.6 94.2 26.2 101.4 78.4 72.1 82.0 59.4 132.9 111.7 97.1 23.6 56.5 21.9 44.4 150.6 81.4 84.1 49.7 11.0 145.1 66.1 291.7 46.9 57.4 40.9 75.2 36.7 70.6 45.0 244.3 222.7 134.7 51.3 292.1 28.1 47.8 206.1 39.5 69.4 48.6 63.3 72.2 200.8 165.2 786.0 229.2 176.8 190.3 73.3 ADRA2A "ADRA2, ADRA2R, ADRAR" ENSG00000150594 "Adrenoceptor alpha 2A" P08913 10 111077029-111080907 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.4;cervix: 45.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 52.9;Paneth cells: 105.9;Smooth muscle cells: 118.7" "Cancer enhanced" "Detected in all" "pancreatic cancer: 17.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.5;ASC TERT1: 12.9;HEL: 20.3;HeLa: 10.7;HSkMC: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (1.63e-2)" "unprognostic (1.38e-1)" "prognostic favorable (8.06e-4)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "unprognostic (4.78e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-1)" "unprognostic (4.64e-3)" "unprognostic (5.86e-2)" "unprognostic (5.63e-2)" "unprognostic (3.08e-6)" "unprognostic (1.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-3)" 41.4 1.7 3.1 5.0 3.6 0.0 33.2 1.5 4.2 45.8 6.0 7.4 10.1 6.8 1.6 2.9 4.1 20.1 1.8 3.3 6.4 3.8 1.1 4.3 11.3 5.4 13.7 1.6 18.3 30.8 1.3 2.3 3.7 15.2 7.0 3.8 0.0 7.0 6.2 1.0 9.1 5.0 2.8 1.5 14.8 3.7 5.1 3.9 1.0 9.1 0.6 13.3 16.1 23.6 6.5 0.0 0.0 0.0 0.0 10.5 12.9 0.0 0.1 0.0 1.1 2.5 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 20.3 10.7 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.6 1.5 4.2 3.3 6.4 5.4 13.7 1.6 15.2 1.5 3.9 6.5 8.3 0.0 1.3 1.0 0.0 10.3 0.4 0.0 1.2 0.0 17.2 12.2 1.5 52.9 1.3 0.0 0.0 0.1 0.0 11.7 0.0 5.9 3.5 6.9 9.1 4.9 12.4 0.0 2.2 3.3 0.1 7.3 10.7 25.8 7.0 19.4 0.7 0.0 0.1 0.0 5.9 3.5 0.0 0.3 17.3 1.2 22.4 7.3 28.4 1.0 0.0 0.0 0.0 0.0 0.2 0.3 105.9 4.9 0.0 0.9 3.5 0.6 0.0 0.0 6.6 3.1 118.7 5.4 0.1 0.2 6.1 0.1 1.2 8.5 8.6 1.1 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "brain: 582.7;choroid plexus: 271.9;retina: 148.6" "Cell type enhanced" "Detected in many" "Astrocytes: 3712.4;Excitatory neurons: 833.0;Inhibitory neurons: 581.3;Muller glia cells: 459.6;Oligodendrocyte precursor cells: 1341.6" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 34.8;naive B-cell: 16.6" "Lineage enriched" "Detected in many" 12 "B-cells: 34.8" "Group enriched" "Detected in some" 10 "AF22: 49.9;Daudi: 43.0;HAP1: 17.4;U-251 MG: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported NA NA "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 2.4 4.2 396.1 1.4 484.5 0.5 2.5 466.2 582.7 6.8 271.9 18.9 1.9 7.8 3.0 1.9 7.6 4.4 2.3 483.0 336.0 7.2 13.5 20.3 2.6 268.0 310.7 468.8 12.5 1.9 0.8 7.8 0.3 330.2 5.7 6.0 148.6 0.9 7.0 0.6 0.8 3.4 11.1 263.9 16.0 1.2 1.5 300.1 0.3 12.0 0.7 1.3 2.7 2.9 423.9 0.3 0.7 49.9 0.5 0.0 0.0 0.2 0.1 0.5 0.2 0.4 1.1 0.7 43.0 0.2 0.2 1.8 0.9 17.4 1.5 0.1 0.2 4.0 0.5 3.7 1.4 0.1 0.4 0.7 0.1 0.0 0.1 0.2 2.0 0.0 0.1 0.4 1.7 0.0 1.2 1.6 0.6 1.2 0.0 0.6 0.2 0.2 0.3 0.1 2.1 0.5 0.4 0.2 0.9 0.2 0.3 0.6 0.1 0.2 0.9 0.6 0.6 50.8 1.6 0.1 2.6 1.8 0.4 1.1 0.8 0.1 0.1 0.1 0.1 0.1 34.8 0.1 0.0 0.2 16.6 0.1 0.1 0.4 0.1 0.2 2.9 0.1 0.8 396.1 484.5 466.2 582.7 483.0 336.0 268.0 310.7 468.8 330.2 263.9 300.1 423.9 0.6 96.1 8.7 3712.4 9.6 1.8 5.3 0.0 0.0 220.3 0.2 0.1 0.7 1.5 0.6 0.0 14.6 0.0 0.0 0.1 1.9 0.0 11.7 0.4 0.1 29.0 0.0 5.3 833.0 0.2 0.2 2.4 0.0 0.2 0.0 0.2 116.0 2.1 0.3 124.5 581.3 0.0 0.0 4.4 0.4 3.6 3.4 1.6 0.0 208.0 0.0 459.6 0.0 1341.6 37.3 0.0 0.0 1.5 0.1 9.0 0.0 3.4 0.0 30.5 0.0 15.3 3.3 0.5 0.4 0.2 0.9 0.1 1.2 3.0 0.0 6.5 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065841-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 11.5;retina: 28.8" "Cell type enhanced" "Detected in many" "Astrocytes: 183.1;Cone photoreceptor cells: 64.6;Excitatory neurons: 222.8;Inhibitory neurons: 127.6;Oligodendrocyte precursor cells: 125.2" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 5.6;SCLC-21H: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: AB_2732586" "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 0.8 2.9 4.9 0.9 8.7 0.6 1.3 3.7 7.7 1.4 0.0 1.9 0.5 1.8 2.4 0.6 1.9 1.1 0.6 8.0 4.5 2.5 0.3 1.4 0.6 0.9 0.4 7.8 1.8 2.2 7.0 11.5 0.1 2.2 0.8 1.1 28.8 0.9 0.8 0.2 0.4 1.2 1.1 0.0 1.1 1.3 1.9 2.0 0.3 4.3 0.3 0.6 1.4 1.0 6.6 0.0 2.5 5.6 0.0 0.1 0.4 0.2 0.1 0.0 0.6 1.9 0.2 0.0 3.7 0.0 0.1 3.0 0.0 2.4 1.4 0.5 0.0 2.0 0.0 0.5 0.0 0.2 2.0 2.8 0.8 0.7 0.1 0.3 0.7 0.0 4.3 0.0 0.3 0.5 1.1 2.4 0.1 1.2 0.0 1.4 0.0 2.5 0.0 0.2 0.0 7.6 4.8 0.0 1.4 3.8 0.7 0.4 0.0 0.0 0.8 1.0 0.0 3.4 2.7 1.8 2.3 4.2 0.0 1.4 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.0 0.0 4.9 8.7 3.7 7.7 8.0 4.5 0.9 0.4 7.8 2.2 0.0 2.0 6.6 0.3 0.0 5.8 183.1 2.4 0.1 0.5 0.1 3.4 16.9 0.6 0.9 0.9 1.5 1.3 0.0 64.6 0.0 0.0 0.1 1.9 0.3 1.5 0.5 0.6 0.7 4.8 1.7 222.8 0.6 0.0 2.0 0.0 0.0 3.8 0.1 2.2 0.1 0.2 21.9 127.6 0.1 0.0 0.6 0.6 1.5 0.9 1.3 1.8 23.4 0.6 10.2 0.0 125.2 40.0 0.2 0.0 1.5 0.2 0.4 0.0 11.6 7.7 36.6 0.0 3.0 1.9 2.7 5.2 0.4 0.0 0.0 0.3 1.4 0.1 0.3 SPATA4 "CFAP178, FAP178, SPEF1B, TSARG2" ENSG00000150628 "Spermatogenesis associated 4" Q8NEY3 4 176184579-176195585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 140.8" "Group enriched" "Detected in some" 12 "Early spermatids: 1074.2;Late spermatids: 496.7;Spermatocytes: 460.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "basophil: 1.2" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "GAMG: 1.4;U-87 MG: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019220 Enhanced NA NA "HPA019220: AB_1857420" "unprognostic (1.97e-3)" "unprognostic (6.08e-2)" "unprognostic (2.83e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-2)" "unprognostic (1.87e-2)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (3.09e-3)" "unprognostic (9.77e-2)" "unprognostic (4.38e-6)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.59e-1)" 0.0 0.4 1.6 0.0 0.9 0.1 0.6 0.9 1.0 0.3 1.2 0.3 0.0 0.3 3.6 0.1 8.8 0.2 0.4 0.7 1.4 2.3 0.0 1.2 0.0 1.5 1.3 0.6 0.2 0.4 0.4 1.0 0.0 1.1 0.2 0.0 2.3 0.3 0.5 1.1 0.1 0.1 0.2 1.3 0.0 0.1 140.8 0.8 0.0 1.7 0.4 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.9 0.9 1.0 0.7 1.4 1.5 1.3 0.6 1.1 1.3 0.8 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.1 2.2 0.0 0.5 1.0 1.4 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 5.9 0.5 1074.2 20.0 0.3 0.7 0.0 0.0 1.1 0.0 0.0 0.2 2.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.0 2.0 0.0 0.0 496.7 11.5 1.3 0.0 0.0 0.0 1.9 0.0 1.0 0.5 1.5 0.0 8.2 0.0 0.1 0.0 10.7 52.3 3.1 0.0 0.5 1.3 460.1 11.3 0.0 0.0 0.0 0.1 0.5 0.1 0.1 VEGFC "VEGF-C, VRP" ENSG00000150630 "Vascular endothelial growth factor C" P49767 4 176683538-176792922 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 39.3;Endothelial cells: 22.0;Leydig cells: 13.7;Microglial cells: 36.5" "Cancer enhanced" "Detected in all" "thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 146.5;HBF TERT88: 114.4;hTEC/SVTERT24-B: 116.5;LHCN-M2: 129.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 7.0" "Secreted to blood" NA NA 383000 340000 "unprognostic (4.18e-1)" "unprognostic (4.07e-2)" "unprognostic (4.84e-3)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (3.05e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (7.88e-5)" "unprognostic (4.53e-1)" "unprognostic (2.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.89e-3)" "unprognostic (4.41e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" 20.6 7.0 2.6 4.2 2.3 0.2 16.9 2.8 2.9 9.5 3.1 4.7 2.4 7.4 1.8 4.1 8.6 6.9 10.7 2.3 2.4 4.9 4.3 17.0 8.1 3.1 2.7 1.8 6.0 1.8 2.8 1.5 19.5 2.7 5.1 3.4 1.3 7.5 5.0 3.1 4.7 6.9 6.6 2.6 3.9 3.3 1.4 3.4 1.1 28.0 4.1 3.4 10.4 7.7 3.5 5.9 2.8 1.8 0.0 25.5 25.3 0.0 146.5 87.3 79.2 62.5 0.0 0.7 0.0 0.0 82.7 33.1 4.4 1.3 54.8 114.4 0.1 2.8 0.0 3.8 0.0 13.9 0.0 0.0 27.0 2.5 116.5 80.5 79.3 49.7 0.0 0.0 0.0 129.9 2.1 0.0 0.0 1.3 0.0 47.1 0.0 8.4 0.0 0.0 3.3 0.0 0.0 2.3 3.3 0.1 0.7 0.7 0.2 24.2 83.6 9.2 20.8 42.1 0.2 0.0 0.0 34.9 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 2.3 2.8 2.9 2.3 2.4 3.1 2.7 1.8 2.7 2.6 3.4 3.5 39.3 3.2 0.0 10.1 0.1 2.4 1.3 3.2 0.0 1.0 3.2 1.7 1.5 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.5 3.1 8.3 10.9 22.0 0.0 0.0 2.0 0.0 0.0 9.1 0.0 11.0 0.0 8.5 10.0 0.0 0.3 1.7 2.0 0.0 4.1 0.3 2.2 1.2 13.7 0.4 3.6 36.5 0.0 3.4 0.0 1.5 0.6 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.2 0.0 1.9 11.7 0.2 2.0 0.3 2.0 0.0 0.2 1.9 0.0 3.6 CCDC102B "ACY1L, AN, C18orf14, FLJ23594, HsT1731" ENSG00000150636 "Coiled-coil domain containing 102B" Q68D86 18 68715209-69055189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 28.6" "Cell type enhanced" "Detected in many" "Astrocytes: 72.8;Early spermatids: 138.2;Excitatory neurons: 80.8;Late spermatids: 83.3;Oligodendrocytes: 90.1;Sertoli cells: 78.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 9.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.2;BJ hTERT+: 29.0;fHDF/TERT166: 26.2;HSkMC: 15.4;Karpas-707: 10.2" "HPA040623, HPA048194" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA040623: AB_10805715, HPA048194: AB_2680309" "unprognostic (3.92e-2)" "unprognostic (1.62e-1)" "unprognostic (5.58e-2)" "unprognostic (9.50e-3)" "unprognostic (7.13e-2)" "unprognostic (3.50e-1)" "unprognostic (7.87e-3)" "unprognostic (1.36e-1)" "unprognostic (5.59e-2)" "unprognostic (8.62e-3)" "unprognostic (1.95e-1)" "unprognostic (6.04e-2)" "prognostic unfavorable (2.90e-6)" "unprognostic (2.21e-2)" "unprognostic (2.12e-2)" "unprognostic (8.00e-3)" "unprognostic (3.13e-3)" 7.2 2.9 1.6 3.8 1.6 0.7 2.8 0.4 3.4 2.8 0.1 3.8 1.5 1.7 1.2 3.4 1.9 13.8 3.3 1.4 1.8 4.4 1.7 14.4 8.7 2.1 2.6 0.6 0.9 1.5 2.6 0.9 28.6 3.0 1.2 4.5 2.2 1.3 1.3 0.6 1.0 2.7 3.7 1.6 2.3 3.6 2.1 1.8 1.5 5.3 1.1 2.0 10.7 1.5 3.5 0.0 0.0 4.0 0.3 3.6 14.2 0.2 0.8 29.0 0.3 0.5 0.1 0.4 0.1 0.6 26.2 0.5 0.4 0.1 0.2 0.4 1.2 0.4 0.8 0.0 1.3 7.0 0.1 0.4 15.4 0.6 0.4 3.5 0.6 0.2 2.0 0.0 10.2 2.4 0.0 0.6 0.3 0.8 0.2 0.5 1.3 0.2 0.5 0.1 0.0 1.7 1.5 0.1 0.0 0.1 1.6 0.3 1.3 4.0 0.6 0.2 0.2 0.3 4.4 0.3 0.8 2.1 1.7 2.5 0.0 0.1 0.3 1.0 0.2 0.9 0.5 0.6 0.8 0.2 0.6 1.8 1.1 0.0 1.0 0.2 9.1 0.3 0.3 1.6 1.6 0.4 3.4 1.4 1.8 2.1 2.6 0.6 3.0 1.6 1.8 3.5 11.5 0.0 2.2 72.8 4.4 0.6 0.8 0.8 0.6 6.4 2.7 2.9 10.0 0.0 2.1 3.7 6.2 0.8 12.4 0.4 5.9 0.7 138.2 2.9 6.7 6.8 0.0 3.0 80.8 1.8 0.6 15.3 0.0 1.1 2.5 5.7 8.6 0.8 3.2 6.7 33.6 0.2 0.0 1.9 1.8 83.3 32.3 3.3 0.0 44.0 2.1 11.9 7.2 36.2 90.1 0.2 2.6 9.1 2.2 0.4 0.3 5.3 1.5 13.4 78.9 3.8 37.3 1.9 5.7 0.7 0.6 0.3 3.8 3.7 0.4 0.6 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 20.4;parathyroid gland: 62.8" "Cell type enhanced" "Detected in many" "dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3" "Group enriched" "Detected in many" 11 "NK-cells: 29.7;T-cells: 36.6" "Group enriched" "Detected in some" 6 "HEL: 100.0;HMC-1: 42.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 20000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.1 0.6 1.0 5.8 5.4 4.4 1.6 1.4 1.8 1.1 0.3 1.8 2.3 1.4 0.5 1.6 1.4 3.0 0.5 0.6 1.9 1.5 4.2 4.2 9.7 3.1 3.2 0.4 0.9 0.6 62.8 0.6 0.5 2.7 1.0 2.4 1.4 1.5 0.4 0.7 0.3 3.1 1.6 1.7 20.4 3.2 1.2 5.7 6.5 0.7 0.6 7.2 3.2 0.4 3.5 0.0 0.1 0.3 0.3 0.0 0.0 0.1 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.4 0.2 5.3 0.1 100.0 0.3 0.1 0.0 0.7 42.6 0.0 1.1 0.2 0.6 0.2 0.0 0.9 0.3 9.3 0.4 0.0 0.8 0.4 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.8 0.3 0.1 0.2 11.5 0.4 0.0 0.3 0.2 0.5 0.3 0.1 1.2 36.6 1.0 13.4 0.8 28.8 22.5 2.9 0.1 15.8 17.3 1.6 29.7 1.3 0.1 11.3 13.2 1.0 5.4 1.4 1.8 0.6 1.9 3.1 3.2 0.4 2.7 1.7 5.7 3.5 0.6 3.2 3.6 3.3 3.2 0.0 0.3 0.0 0.0 3.4 0.5 0.8 2.5 0.0 0.7 0.0 0.0 0.1 52.1 0.2 0.0 0.0 8.4 0.9 1.7 1.0 0.0 3.2 4.6 0.4 0.0 1.3 3.1 0.5 13.9 1.3 3.3 0.4 1.6 0.0 3.1 0.1 0.0 16.7 2.7 8.2 0.9 24.4 0.0 22.5 14.7 0.8 90.6 2.0 26.6 0.2 0.1 0.7 13.4 0.3 0.0 0.3 1.5 3.6 0.0 1.8 0.6 0.4 0.8 0.0 0.4 0.0 43.2 0.5 0.1 0.2 CNDP1 "CN1, CPGL2, HsT2308, MGC10825" ENSG00000150656 "Carnosine dipeptidase 1" Q96KN2 18 74534500-74587212 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 97.4" "Cell type enriched" "Detected in some" 10 "Oligodendrocytes: 361.7" "Cancer enhanced" "Detected in some" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 38 "U-266/84: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008933, HPA073283" Enhanced "Secreted to blood" NA NA 2100000000 "HPA008933: AB_1847033, HPA073283: " "unprognostic (7.43e-3)" "unprognostic (6.00e-2)" "unprognostic (8.55e-3)" "unprognostic (3.93e-1)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-3)" "unprognostic (1.12e-2)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.16e-1)" "unprognostic (1.66e-1)" "unprognostic (6.90e-3)" "unprognostic (1.14e-1)" "unprognostic (3.30e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" 0.0 0.0 34.5 0.0 63.1 0.2 0.0 74.5 39.0 0.0 5.5 0.0 1.3 0.0 0.7 0.0 0.0 0.1 0.0 27.7 53.9 0.6 13.0 0.0 0.0 79.6 76.2 17.7 0.0 0.0 0.0 0.2 0.0 97.2 0.1 0.0 0.1 0.0 0.1 1.4 0.1 0.2 0.0 45.8 0.0 0.0 0.3 71.5 0.0 0.2 0.0 0.0 0.0 0.0 97.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 15.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 34.5 63.1 74.5 39.0 27.7 53.9 79.6 76.2 17.7 97.2 45.8 71.5 97.4 0.2 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.0 0.6 0.5 0.3 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 8.6 0.5 0.2 0.2 0.0 2.7 1.2 0.2 0.0 0.3 0.0 1.5 0.0 0.2 0.7 35.1 0.1 0.0 1.5 0.7 0.0 1.2 1.1 3.1 0.0 0.2 0.0 1.0 0.0 0.5 0.0 3.0 361.7 0.2 0.1 0.0 0.0 0.4 0.4 24.5 0.0 1.0 0.0 0.6 0.2 1.0 0.4 0.0 0.3 0.0 0.4 0.0 0.5 0.2 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 11.0;testis: 7.3" "Cell type enhanced" "Detected in many" "Early spermatids: 67.1;Excitatory neurons: 28.2;Inhibitory neurons: 21.5;Late spermatids: 48.3;Spermatocytes: 35.3" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041002 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.2 0.2 1.8 0.2 1.9 0.6 0.9 0.3 2.0 0.2 1.7 7.4 0.1 0.3 0.3 0.1 1.2 0.2 0.3 1.5 1.8 0.8 0.1 0.3 0.1 1.2 1.5 1.7 0.1 0.1 0.9 1.4 0.3 1.1 0.2 11.0 0.9 0.1 0.2 0.2 0.9 0.1 0.3 0.6 0.2 0.5 7.3 1.3 1.4 0.4 0.1 0.1 0.3 0.1 0.8 0.4 1.3 3.4 0.5 0.6 1.1 0.0 4.1 0.8 0.6 1.2 1.0 0.3 0.2 0.3 1.2 1.7 0.8 0.5 0.7 1.0 1.4 0.3 2.5 0.9 0.0 0.3 0.5 2.7 0.7 2.8 1.5 0.6 0.8 0.7 1.4 0.1 0.3 1.0 0.1 0.3 0.2 0.4 0.2 0.6 0.3 0.7 0.1 1.3 1.5 0.8 2.5 0.8 0.1 0.1 0.3 1.1 0.3 0.6 1.6 0.9 0.9 0.4 0.7 1.6 0.2 3.3 0.9 0.8 0.4 0.3 0.4 0.7 0.2 0.5 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.4 1.8 1.9 0.3 2.0 1.5 1.8 1.2 1.5 1.7 1.1 0.6 1.3 0.8 0.7 0.0 0.5 8.1 1.1 0.6 0.6 3.4 0.0 1.1 14.5 7.9 0.8 2.8 2.9 1.8 12.5 0.9 1.4 17.5 1.9 1.0 67.1 10.0 2.1 1.0 0.0 0.0 28.2 0.4 0.1 1.5 0.5 0.6 15.8 0.4 0.4 0.0 0.1 0.0 21.5 3.5 0.0 0.0 0.3 48.3 1.2 0.6 0.0 7.5 0.1 1.0 3.1 3.0 3.2 0.1 6.6 0.7 0.4 0.7 0.0 3.2 12.6 6.1 0.0 1.2 1.5 35.3 8.3 0.2 0.0 5.6 3.3 0.7 2.9 0.3 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.9" "Group enriched" "Detected in many" 4 "Excitatory neurons: 3292.3;Inhibitory neurons: 2602.7;Oligodendrocyte precursor cells: 2331.8;Oligodendrocytes: 4213.8" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 8.2;SH-SY5Y: 8.1;T-47d: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353" "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.0 11.1 21.6 1.1 47.5 0.3 2.1 5.7 51.9 1.8 0.0 1.8 1.2 3.0 4.1 7.6 5.8 2.2 3.0 64.6 19.5 3.7 2.9 1.7 1.2 24.3 12.7 47.9 5.8 3.4 7.3 10.1 2.4 22.2 4.0 1.4 25.6 3.1 4.7 0.8 20.4 1.2 2.3 9.8 2.5 1.5 8.2 12.2 7.3 15.7 0.7 2.9 1.7 2.6 89.9 0.6 0.3 0.9 0.5 0.6 0.7 8.2 0.2 0.5 0.4 0.3 7.4 1.1 1.3 1.3 0.4 0.5 0.8 2.3 0.7 0.4 0.8 0.9 1.3 5.0 0.2 0.1 0.4 1.1 0.5 0.5 1.0 1.0 0.4 0.5 1.9 1.2 3.5 0.7 0.9 0.6 1.3 6.0 0.8 1.3 1.4 2.0 0.9 0.4 0.3 5.9 8.1 0.8 5.1 0.4 7.2 21.2 0.0 0.3 2.2 1.8 2.1 0.3 0.8 2.9 5.6 0.8 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.1 0.2 0.0 0.6 0.6 0.2 0.0 0.0 0.1 0.5 0.0 0.0 21.6 47.5 5.7 51.9 64.6 19.5 24.3 12.7 47.9 22.2 9.8 12.2 89.9 7.0 3.2 10.4 742.8 1.3 3.3 3.6 0.3 9.1 298.1 4.4 5.2 8.3 2.8 1.8 7.3 275.2 7.9 1.8 1.5 9.8 0.7 21.5 1.3 2.7 3.6 4.2 0.0 3292.3 0.4 0.5 7.4 1.1 2.4 0.0 1.6 2.2 4.6 4.0 23.5 2602.7 1.1 0.0 0.3 0.0 16.4 7.8 0.8 1.8 487.2 0.6 11.0 0.0 2331.8 4213.8 0.4 0.1 6.4 0.1 2.0 0.6 2.7 0.9 48.2 6.6 7.1 4.1 11.3 3.2 6.2 8.5 2.1 1.7 12.1 0.9 0.8 CCDC83 "CT148, FLJ42119, KP-CoT-23, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 132 "testis: 35.8" "Group enriched" "Detected in some" 46 "Early spermatids: 222.2;Late spermatids: 194.2;Spermatocytes: 160.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "MCF7: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 194.2 4.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RGS18 RGS13 ENSG00000150681 "Regulator of G protein signaling 18" Q9NS28 1 192158462-192185815 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.3;lymphoid tissue: 25.7" "Cell type enriched" "Detected in some" 4 "Macrophages: 527.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 353.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 353.1" "Group enriched" "Detected in some" 5 "HEL: 60.2;HL-60: 46.7;NB-4: 43.6;U-937: 39.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028727, HPA045780" Uncertain Approved "Golgi apparatus" NA NA 340000 "Golgi apparatus" "HPA028727: AB_2797219, HPA045780: AB_10962728" "unprognostic (3.09e-2)" "unprognostic (4.32e-2)" "unprognostic (8.66e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.48e-1)" "unprognostic (2.18e-2)" "unprognostic (2.58e-1)" "unprognostic (1.87e-1)" "unprognostic (3.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.30e-3)" "unprognostic (8.21e-3)" "unprognostic (2.81e-4)" "unprognostic (1.73e-2)" "unprognostic (9.91e-2)" 4.3 2.3 0.6 14.2 0.8 13.3 2.4 0.9 0.8 2.4 1.1 2.5 2.9 1.0 0.5 1.9 1.3 5.4 0.8 0.6 1.1 1.0 5.4 4.1 8.5 1.5 1.0 0.4 0.8 0.8 0.4 0.3 2.2 1.4 1.1 2.9 0.6 0.7 1.0 0.9 0.4 5.8 2.9 1.3 25.7 1.9 0.4 0.9 4.3 0.8 3.2 4.4 4.8 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 39.9 0.0 195.5 50.7 353.1 0.8 66.7 6.8 0.1 0.8 1.3 51.0 0.2 0.1 0.2 164.8 0.6 82.1 12.0 0.0 94.4 0.6 0.8 0.9 0.8 0.6 1.1 1.5 1.0 0.4 1.4 1.3 0.9 1.6 0.3 6.4 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.4 0.0 1.8 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 16.0 0.0 0.0 0.0 0.8 0.0 0.0 24.7 0.0 5.7 1.1 7.3 0.0 0.0 0.0 0.0 124.9 27.3 0.8 0.3 527.4 0.0 15.9 128.3 0.1 28.8 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.3 1.5 0.3 13.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 7.6 0.0 0.1 0.0 PRSS23 "SIG13, SPUVE" ENSG00000150687 "Serine protease 23" O95084 11 86791059-86952910 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 251.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 367.1;Endothelial cells: 502.1;Granulosa cells: 347.3;Hepatic stellate cells: 591.8;Theca cells: 445.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 104.6" "Group enriched" "Detected in many" 25 "NK-cells: 34.2;T-cells: 104.6" "Cell line enhanced" "Detected in many" "GAMG: 1093.7;hTERT-RPE1: 1296.9;TIME: 1138.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030591 Uncertain "Secreted to blood" NA NA 440000 "HPA030591: AB_10602067" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (2.40e-3)" "prognostic unfavorable (2.12e-4)" "unprognostic (1.89e-2)" "unprognostic (4.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (5.35e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.13e-3)" "unprognostic (9.44e-2)" "unprognostic (1.99e-3)" "unprognostic (8.01e-2)" 55.2 21.6 7.8 35.6 7.9 2.2 43.5 7.0 9.1 251.2 16.0 83.0 19.4 104.3 13.5 22.3 25.1 84.5 21.0 7.8 13.2 42.8 15.1 63.9 22.0 14.0 13.9 6.4 27.0 30.0 36.3 16.6 62.2 8.8 61.8 50.8 2.7 52.9 129.5 80.3 17.4 29.2 116.5 7.1 18.2 54.7 32.1 11.9 17.6 41.2 18.8 10.3 100.6 79.8 7.6 62.7 153.3 161.1 1.0 70.4 172.3 0.7 269.0 244.4 293.2 232.6 368.1 484.7 0.2 208.2 414.7 1093.7 126.2 2.6 205.0 70.9 0.7 13.0 21.1 74.7 1.4 36.3 0.1 0.9 137.4 26.8 143.2 162.1 1296.9 604.8 0.9 1.3 0.3 223.4 87.7 0.2 0.3 9.8 211.7 16.8 0.0 0.0 0.7 111.5 82.3 1.5 1.0 59.9 4.5 18.7 397.6 6.0 0.6 1138.2 174.0 2.3 351.7 154.5 1.3 1.3 0.8 124.2 0.5 176.3 0.2 0.2 0.1 104.6 0.1 0.2 0.2 17.8 60.0 0.2 0.0 4.7 50.4 1.6 34.2 2.7 0.2 0.0 39.9 7.8 7.9 7.0 9.1 7.8 13.2 14.0 13.9 6.4 8.8 7.1 11.9 7.6 95.8 28.9 14.5 14.0 3.2 15.4 96.2 367.1 2.8 1.6 44.7 78.0 4.3 37.1 231.3 53.3 2.1 18.4 53.4 154.8 7.9 162.6 3.1 10.3 130.3 502.1 13.8 20.4 26.3 83.5 15.7 117.1 22.4 7.0 2.5 347.3 591.8 5.2 5.0 0.0 16.5 30.6 85.5 36.6 18.2 6.6 14.3 5.4 72.9 39.4 1.5 0.8 180.2 11.6 2.3 257.7 80.1 7.5 5.8 100.1 5.2 5.7 90.1 0.9 39.5 14.4 105.9 3.0 7.3 1.7 9.8 4.5 24.0 445.1 11.1 60.2 MTMR12 "3-PAP, 3PAP, FLJ20476, KIAA1682, PIP3AP" ENSG00000150712 "Myotubularin related protein 12" Q9C0I1 5 32226994-32312987 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051333 Supported NA NA "HPA051333: AB_2681445" "unprognostic (3.18e-3)" "unprognostic (6.29e-2)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (9.39e-3)" "unprognostic (6.15e-2)" "unprognostic (1.39e-3)" "unprognostic (3.15e-1)" "unprognostic (1.09e-1)" "unprognostic (7.46e-3)" "unprognostic (8.77e-2)" "prognostic favorable (1.29e-7)" "unprognostic (2.30e-2)" "unprognostic (3.22e-1)" "unprognostic (9.95e-2)" "unprognostic (2.09e-1)" 18.6 7.7 8.4 10.9 9.9 13.5 17.6 6.8 9.8 9.3 5.3 10.5 9.7 16.1 8.9 13.9 21.2 13.4 9.2 10.1 5.3 16.0 16.9 15.9 17.7 5.4 4.6 10.3 17.9 24.9 21.7 7.5 12.0 5.6 14.3 8.6 7.6 17.2 12.3 6.0 12.7 8.2 16.8 3.7 11.4 15.0 19.3 4.9 12.5 14.7 6.7 16.2 10.2 8.4 8.5 18.7 16.7 17.6 34.3 19.8 11.5 24.6 17.0 13.6 21.0 13.1 16.3 13.1 68.4 21.0 17.5 35.8 12.4 30.2 16.5 25.3 24.0 14.9 22.6 32.4 27.2 13.9 16.1 16.1 10.3 15.3 21.0 21.9 15.2 25.3 14.5 16.9 24.6 14.1 13.7 17.3 12.4 22.8 20.2 17.5 17.5 25.3 8.8 16.8 16.8 6.2 11.6 46.8 28.1 20.6 18.3 23.2 16.6 21.3 16.2 22.4 16.2 23.8 21.4 36.1 37.9 16.5 26.6 20.1 7.5 1.8 3.1 3.1 4.7 2.5 2.8 1.4 2.1 2.4 1.8 1.2 1.4 3.0 2.3 2.2 2.9 1.8 2.5 8.4 9.9 6.8 9.8 10.1 5.3 5.4 4.6 10.3 5.6 3.7 4.9 8.5 31.1 32.1 37.8 30.7 16.0 7.0 7.2 7.2 9.6 0.0 28.1 23.4 13.8 15.7 16.4 14.7 0.0 7.5 30.5 8.6 7.9 31.1 1.7 43.1 16.2 21.9 12.0 20.4 71.6 23.6 7.7 12.6 19.4 29.8 15.2 9.3 23.6 26.7 10.1 0.0 47.2 7.5 10.2 16.1 14.8 4.0 6.5 13.9 3.6 15.9 10.2 0.0 12.3 32.2 30.7 18.2 8.2 7.2 19.0 12.2 8.2 16.4 28.2 0.0 6.6 13.1 12.8 20.8 22.3 14.1 8.4 7.5 14.1 7.2 7.7 7.1 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 21.3" "Group enriched" "Detected in many" 4 "Early spermatids: 168.5;Late spermatids: 219.8;Spermatocytes: 145.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.5 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 21.3 0.4 0.9 0.0 0.8 0.1 0.0 0.7 0.6 0.1 0.0 0.3 0.0 0.4 0.0 1.5 1.0 0.0 1.8 0.1 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.1 0.7 0.0 3.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.5 0.5 0.4 0.9 0.7 0.6 0.1 1.5 0.2 0.1 0.4 0.1 12.8 8.7 6.2 0.0 0.3 0.6 1.2 2.8 1.1 0.3 0.3 40.6 17.2 8.1 3.7 0.0 3.1 0.0 0.5 1.9 2.5 168.5 1.7 0.1 0.6 6.1 0.0 1.1 11.0 6.6 2.4 4.6 0.8 0.0 0.0 0.0 18.5 0.6 0.0 19.4 0.4 10.2 0.8 0.0 219.8 5.9 0.3 3.6 1.9 3.6 12.0 0.0 3.5 0.7 23.1 0.1 0.7 0.0 0.3 0.0 0.7 1.6 1.7 0.0 0.4 0.8 145.1 2.6 1.3 0.3 2.5 0.0 0.8 0.6 1.0 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245726-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.4;testis: 5.6" "Cell type enhanced" "Detected in some" "Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "OE19: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 0.5 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.4 0.9 0.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.6 1.3 0.4 0.7 0.0 0.3 1.0 0.0 2.1 0.0 1.9 0.0 1.2 0.0 0.0 0.0 3.4 5.6 0.0 0.4 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 0.1 0.1 14.3 3.3 0.0 0.0 0.0 0.1 1.5 0.0 1.9 38.1 0.0 1.4 0.0 7.7 0.0 0.1 56.6 0.1 1.9 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 3.0 8.2 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.2 0.3 4.0 0.0 9.9 0.0 0.0 0.1 0.6 1.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 4.4 CCT5 KIAA0098 ENSG00000150753 "Chaperonin containing TCP1 subunit 5" P48643 5 10249929-10266389 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002238, HPA005958, CAB006271" Enhanced NA NA 1400000 "CAB006271: AB_425898, HPA002238: AB_1078427, HPA005958: AB_1846209" "unprognostic (7.02e-3)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (1.79e-2)" "unprognostic (3.46e-1)" "unprognostic (2.10e-3)" "prognostic unfavorable (6.57e-11)" "unprognostic (6.40e-3)" "unprognostic (2.04e-1)" "unprognostic (1.91e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (8.23e-6)" "unprognostic (1.02e-1)" "unprognostic (1.94e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-2)" 78.2 80.2 75.6 96.1 73.8 82.7 75.5 76.6 96.5 58.1 82.8 86.6 68.2 67.4 53.7 101.6 78.1 48.6 69.8 81.5 80.6 76.8 74.7 59.2 97.1 78.0 77.5 71.4 51.2 58.9 177.1 46.5 86.5 80.7 52.8 98.2 49.4 60.8 53.4 129.3 60.5 62.7 90.2 78.5 62.8 63.2 105.2 80.6 107.6 63.8 91.6 119.3 106.8 64.3 87.7 350.5 489.8 405.1 463.7 250.9 188.5 568.4 454.1 288.6 704.0 492.6 657.8 372.2 537.6 490.4 326.4 615.9 332.8 770.4 492.7 774.2 504.5 527.9 440.2 1063.7 510.7 293.8 667.6 303.7 221.3 300.3 556.8 368.9 191.4 422.7 343.6 597.5 188.2 453.3 494.0 481.4 659.7 432.6 348.3 579.4 437.9 304.4 275.8 447.3 359.1 304.8 335.3 953.5 424.6 335.6 316.9 327.2 490.9 285.2 576.4 517.7 214.1 687.9 192.2 322.7 570.1 323.7 955.4 470.8 125.6 181.5 139.3 117.5 248.8 155.7 151.6 131.3 130.7 188.9 125.6 121.8 123.7 101.4 147.3 286.1 69.5 150.3 255.3 75.6 73.8 76.6 96.5 81.5 80.6 78.0 77.5 71.4 80.7 78.5 80.6 87.7 81.7 67.3 41.3 12.1 71.5 88.2 172.1 206.6 60.3 46.7 50.7 54.6 23.6 51.5 116.7 49.7 18.8 214.2 60.7 81.4 49.0 217.4 235.1 127.0 107.5 92.8 70.9 98.2 16.8 162.8 271.8 81.8 62.7 101.1 48.8 100.7 40.0 52.5 175.7 35.3 19.3 89.9 116.0 69.2 64.7 93.1 83.0 84.0 40.9 13.1 92.1 56.6 72.1 19.1 22.9 199.0 81.8 75.6 59.6 128.5 61.0 99.2 131.7 60.8 72.3 81.0 272.5 282.3 184.4 93.1 74.6 155.4 66.5 170.2 126.9 126.1 ATPSCKMT "FAM173B, JS-2" ENSG00000150756 "ATP synthase c subunit lysine N-methyltransferase" Q6P4H8 5 10225507-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.1;Cytotrophoblasts: 5.9;Extravillous trophoblasts: 4.1;Fibroblasts: 2.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 2.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074513: AB_2686698" "prognostic unfavorable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 8.5 10.4 15.7 5.5 13.7 3.9 6.7 14.4 14.5 5.4 13.9 7.5 6.2 6.9 9.2 5.9 6.5 7.2 7.0 13.8 14.8 9.1 10.0 5.2 7.8 14.3 14.1 11.9 6.3 5.1 17.3 10.0 4.1 17.2 8.8 8.8 5.1 7.5 8.4 6.8 5.8 5.7 7.6 13.5 4.5 6.2 5.7 15.6 6.9 8.9 7.5 6.8 7.1 5.4 18.7 14.1 13.3 13.9 13.8 12.7 9.8 4.8 20.4 9.2 9.2 8.0 14.1 21.0 16.8 35.2 13.0 27.7 9.6 19.6 17.0 15.8 30.9 13.2 14.5 47.6 11.4 9.7 22.8 16.5 9.1 18.3 17.4 5.5 11.8 19.7 17.8 19.9 18.0 26.6 11.9 11.6 20.2 9.1 29.9 17.4 15.8 9.7 15.9 24.6 16.5 11.1 10.9 69.3 24.5 12.2 10.5 25.7 23.2 11.2 22.4 13.9 14.2 14.9 11.9 14.5 19.7 14.1 25.3 9.0 3.2 5.8 8.1 4.3 6.7 5.3 3.8 4.2 5.5 5.8 2.6 4.1 5.4 2.2 3.8 5.5 2.1 5.4 2.6 15.7 13.7 14.4 14.5 13.8 14.8 14.3 14.1 11.9 17.2 13.5 15.6 18.7 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 5.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 DOCK1 "ced5, DOCK180" ENSG00000150760 "Dedicator of cytokinesis 1" Q14185 10 126905409-127452517 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 186.4;Oligodendrocyte precursor cells: 331.3;Oligodendrocytes: 429.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004378, HPA048692, HPA053277" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097" "unprognostic (4.27e-2)" "unprognostic (4.22e-3)" "unprognostic (1.49e-3)" "unprognostic (8.98e-3)" "unprognostic (2.57e-2)" "unprognostic (3.31e-1)" "unprognostic (4.12e-1)" "unprognostic (4.80e-2)" "unprognostic (6.85e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-2)" "unprognostic (2.42e-1)" "unprognostic (2.61e-3)" "unprognostic (1.87e-1)" "unprognostic (3.85e-2)" "unprognostic (1.18e-1)" "unprognostic (4.83e-2)" 19.7 8.2 38.5 7.4 49.2 0.7 20.1 38.7 30.3 23.5 22.2 17.7 13.5 19.7 15.6 16.3 18.2 17.3 14.3 27.6 37.6 19.5 9.6 13.9 4.7 45.8 50.1 21.7 24.9 14.2 25.7 5.7 19.8 54.8 16.7 13.9 2.3 17.9 18.6 5.2 33.6 15.2 19.4 36.4 10.0 13.4 7.0 44.7 8.6 26.8 10.7 5.8 16.6 19.1 49.7 16.1 29.8 57.2 41.2 29.2 38.7 12.6 31.5 66.2 21.9 23.1 18.8 18.0 0.0 10.3 47.4 19.8 18.0 18.4 23.8 25.4 0.3 17.9 10.0 18.8 22.7 28.9 0.0 14.2 31.8 7.0 22.7 49.3 53.0 51.3 0.0 0.0 0.1 33.1 16.4 0.0 0.0 14.1 12.4 13.5 0.0 37.3 0.4 22.1 17.5 3.4 24.5 32.9 18.6 28.9 40.6 4.7 0.1 54.2 39.7 15.3 9.8 30.7 0.0 0.1 0.0 31.3 0.0 25.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 38.5 49.2 38.7 30.3 27.6 37.6 45.8 50.1 21.7 54.8 36.4 44.7 49.7 55.9 32.1 20.3 186.4 0.4 17.2 15.5 9.5 43.9 0.5 18.5 17.3 11.8 12.8 17.9 22.0 0.0 14.1 3.2 28.0 0.0 14.7 11.3 20.2 36.8 35.2 5.4 1.7 2.4 7.1 11.5 27.7 16.8 17.1 0.0 33.3 26.4 7.8 5.7 0.0 4.8 15.3 6.1 4.6 5.9 24.5 32.6 5.1 7.2 105.9 2.8 6.6 0.0 331.3 429.1 13.6 9.4 36.5 0.1 13.7 17.5 11.5 20.6 1.2 13.1 30.5 24.1 2.0 6.7 21.5 16.2 12.6 1.1 35.4 12.3 10.3 DIXDC1 "Dixin, KIAA1735" ENSG00000150764 "DIX domain containing 1" Q155Q3 11 111927144-112022653 "Predicted intracellular proteins" "Wnt signaling pathway" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 104.3;Horizontal cells: 121.1;Oligodendrocytes: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "eosinophil: 5.2" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 42.7;TIME: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039424, HPA039658, HPA061366" Approved Supported Cytosol NA NA Cytosol "HPA039424: AB_2676500, HPA039658: AB_2676611, HPA061366: " "unprognostic (1.93e-1)" "unprognostic (2.90e-2)" "unprognostic (8.93e-3)" "unprognostic (2.84e-1)" "unprognostic (2.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-1)" "unprognostic (1.41e-1)" "unprognostic (7.23e-2)" "unprognostic (1.59e-1)" "unprognostic (7.85e-2)" "unprognostic (5.11e-2)" "prognostic favorable (6.89e-5)" "unprognostic (4.10e-2)" "unprognostic (2.11e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (4.19e-5)" 18.0 17.9 19.1 8.7 24.2 0.7 15.1 38.6 22.5 18.8 22.0 22.6 5.7 25.0 18.8 12.8 20.6 12.8 23.5 19.0 18.7 11.5 7.1 9.5 2.7 21.8 23.9 15.7 15.9 3.9 17.2 7.1 10.9 23.1 23.6 10.1 22.1 7.9 36.1 13.8 4.9 9.2 25.8 20.8 3.0 15.1 19.2 21.8 2.6 10.8 12.4 2.5 25.5 12.1 36.6 0.8 3.7 9.9 18.5 29.9 17.5 2.1 7.7 5.3 2.9 5.2 0.6 2.0 1.6 2.0 21.5 3.4 0.9 4.4 2.4 2.9 6.4 3.7 0.8 5.8 10.3 4.6 5.3 0.7 14.2 19.3 6.3 42.7 21.5 30.6 4.0 5.2 0.6 11.9 0.9 3.3 4.6 5.9 0.8 6.6 1.6 2.9 6.1 12.1 0.3 8.0 16.7 5.7 4.6 2.5 4.3 6.8 2.0 50.4 13.1 5.6 2.4 12.9 1.2 5.5 0.8 7.2 13.5 4.7 0.0 0.1 5.2 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.1 19.1 24.2 38.6 22.5 19.0 18.7 21.8 23.9 15.7 23.1 20.8 21.8 36.6 12.8 16.0 10.3 40.1 0.4 6.4 16.3 4.1 11.4 22.3 23.7 28.8 35.6 7.2 10.1 18.4 104.3 1.4 0.9 2.6 15.6 6.4 23.1 32.1 48.6 28.1 2.4 2.1 47.7 7.7 5.1 32.8 11.7 11.3 1.3 6.3 62.8 19.3 1.7 121.1 83.8 13.9 6.1 3.4 5.3 17.5 39.7 1.5 12.4 20.6 1.0 30.2 0.0 34.7 140.4 7.0 6.2 36.9 2.0 10.8 2.7 15.4 35.5 69.2 13.1 25.3 31.8 62.3 16.4 3.3 4.1 1.4 2.0 3.5 4.5 3.1 DLAT "DLTA, E2, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112025408-112064404 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 90.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 100.5;Distal tubular cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Supported Mitochondria NA NA 44000 Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favorable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favorable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 25.0 16.6 9.2 13.4 9.6 8.0 14.6 11.0 10.6 11.1 10.7 24.9 18.4 10.1 13.6 19.7 13.1 8.6 70.0 9.2 12.3 34.1 15.7 11.9 16.2 9.6 10.4 8.1 9.6 6.8 32.0 8.6 13.2 10.3 14.6 26.2 10.9 16.9 15.0 76.1 10.4 16.7 13.5 9.5 10.0 14.4 10.0 10.4 12.8 20.4 90.2 18.4 14.3 8.2 13.6 18.7 16.4 28.2 34.4 41.6 30.5 26.5 26.6 18.2 34.8 38.7 52.8 56.7 85.4 46.0 28.7 42.6 41.0 65.7 34.2 38.9 27.3 30.2 51.9 17.9 39.2 29.0 64.9 26.6 36.9 37.7 32.0 35.2 24.2 33.9 41.7 88.4 42.6 41.2 16.6 25.4 66.9 30.3 58.6 35.4 45.4 38.0 93.3 64.4 21.4 51.2 27.8 30.7 93.4 20.5 30.9 67.4 42.9 17.8 29.1 29.1 29.1 33.0 11.1 19.4 127.5 7.7 73.0 22.7 9.1 3.8 3.0 4.3 5.8 5.4 5.6 4.9 5.1 5.8 4.0 5.6 5.1 0.3 4.7 6.1 4.5 5.8 5.0 9.2 9.6 11.0 10.6 9.2 12.3 9.6 10.4 8.1 10.3 9.5 10.4 13.6 7.6 12.8 14.5 15.3 13.8 11.2 9.2 18.2 14.2 8.1 9.2 5.8 100.5 15.7 13.2 11.0 0.0 21.2 6.4 26.3 74.3 18.7 3.9 15.8 11.6 9.6 17.3 18.1 18.0 11.4 39.6 11.7 11.7 12.1 3.8 13.5 7.5 15.5 18.7 8.4 24.4 17.8 24.4 8.8 7.5 3.2 6.2 9.5 17.8 9.4 16.7 10.4 4.1 11.1 19.7 14.1 9.2 10.9 19.4 7.0 19.0 37.6 30.3 11.1 0.0 14.2 19.9 25.1 18.3 21.1 9.8 17.4 8.5 26.3 26.7 9.3 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112063218-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 67.1" "Cell type enhanced" "Detected in many" "Early spermatids: 425.9;Endometrial ciliated cells: 68.8;Late spermatids: 157.5;Respiratory ciliated cells: 115.3;Spermatocytes: 215.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.8 1.0 2.7 0.5 1.7 0.4 2.0 2.2 1.8 1.8 8.0 0.8 0.5 1.7 4.8 1.2 15.0 1.6 1.1 1.8 5.5 3.9 0.7 2.9 0.4 3.6 3.7 1.1 1.2 1.1 4.2 3.3 0.7 3.0 0.9 0.8 12.5 1.3 1.4 1.1 1.2 0.4 0.6 3.7 0.3 1.0 67.1 1.9 0.6 5.4 0.4 0.4 0.8 0.8 2.4 1.9 1.1 3.1 1.6 0.7 0.8 2.3 0.7 2.2 1.8 2.3 3.0 6.4 0.9 2.4 1.8 2.5 2.6 0.6 1.8 1.9 0.9 2.1 1.3 1.4 1.6 1.3 1.8 0.3 1.2 2.3 4.7 2.6 1.6 0.9 1.3 2.0 0.6 1.3 0.7 0.7 2.5 1.0 1.0 1.6 1.1 2.0 2.6 5.6 0.9 3.6 1.0 2.9 0.5 1.0 0.7 8.0 0.5 0.1 1.6 1.4 0.8 0.6 0.4 0.3 1.3 1.9 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 1.7 2.2 1.8 1.8 5.5 3.6 3.7 1.1 3.0 3.7 1.9 2.4 1.4 6.4 0.5 10.1 0.0 0.6 1.6 7.8 1.8 2.6 1.9 2.2 3.1 5.7 9.9 3.7 2.1 0.9 0.0 0.5 15.6 3.8 425.9 68.8 2.8 1.3 3.0 0.0 5.1 2.3 0.7 1.5 0.0 2.6 1.3 1.5 1.1 0.2 0.7 1.7 5.8 0.5 10.2 0.3 0.4 157.5 2.8 0.8 3.6 1.9 0.6 5.6 0.0 4.0 3.9 1.6 0.4 1.5 0.0 0.6 0.2 10.4 115.3 16.9 0.0 0.7 3.3 215.5 8.4 0.4 1.0 0.3 0.6 1.6 0.4 0.9 NKAPD1 "C11orf57, FLJ10726" ENSG00000150776 "NKAP domain containing 1" Q6ZUT1 11 112074086-112085150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Endometrial stromal cells: 35.4;Proximal tubular cells: 32.9;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039493, HPA039892" Approved Approved Cytosol NA NA Cytosol "HPA039493: AB_10795036, HPA039892: AB_10795372" "unprognostic (5.93e-2)" "unprognostic (3.24e-1)" "unprognostic (6.45e-3)" "unprognostic (1.80e-1)" "unprognostic (1.45e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.45e-2)" "unprognostic (8.61e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (7.05e-3)" "unprognostic (1.15e-2)" "unprognostic (2.86e-1)" "unprognostic (8.24e-2)" "unprognostic (1.41e-1)" 14.3 11.5 9.5 11.7 10.1 13.1 16.9 13.1 11.9 12.2 8.6 12.3 11.4 15.5 11.9 14.0 13.8 11.9 12.6 9.5 10.3 14.7 11.9 11.1 14.3 10.2 10.0 9.0 20.3 12.4 14.2 7.8 16.0 10.6 10.8 11.7 33.7 13.9 11.3 18.8 12.2 11.1 12.6 10.0 12.7 11.7 13.7 10.0 17.1 16.1 10.2 14.1 11.6 9.7 11.5 19.5 12.8 26.6 42.9 26.8 31.0 19.5 28.0 23.8 23.1 26.4 39.8 34.2 54.1 41.8 25.3 26.1 27.4 32.1 30.1 30.0 39.0 22.3 41.6 12.7 19.2 24.8 63.3 26.3 31.8 40.5 27.8 63.7 35.1 20.9 44.0 62.4 32.5 23.4 11.8 57.0 39.2 26.5 32.7 28.3 43.5 32.7 44.6 26.6 17.3 22.1 40.4 29.0 35.3 26.1 23.3 44.2 25.9 21.4 30.7 34.4 19.1 24.5 24.5 58.4 111.4 13.0 58.6 31.7 9.1 7.3 4.8 9.8 7.8 10.2 8.4 10.4 6.8 8.1 9.1 10.9 9.5 4.2 13.4 8.9 20.6 9.0 4.8 9.5 10.1 13.1 11.9 9.5 10.3 10.2 10.0 9.0 10.6 10.0 10.0 11.5 19.9 32.1 20.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 24.5 21.0 0.0 0.0 17.3 16.5 0.0 19.6 15.1 0.0 13.7 20.2 0.0 26.0 35.4 8.7 0.0 0.0 0.0 21.4 17.8 11.3 0.0 20.9 8.8 21.8 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 13.9 0.0 0.0 0.0 0.0 20.0 0.0 0.0 5.0 0.0 0.0 32.9 17.5 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 20.0 6.0 35.6 0.0 0.0 TIMM8B "DDP2, FLJ21744, MGC102866, MGC117373, TIM8B" ENSG00000150779 "Translocase of inner mitochondrial membrane 8 homolog B" Q9Y5J9 11 112084800-112086798 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 577.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041173 Approved NA NA 11000 "HPA041173: AB_10796340" "unprognostic (1.36e-1)" "unprognostic (8.82e-2)" "unprognostic (1.19e-2)" "unprognostic (1.56e-3)" "unprognostic (6.45e-2)" "unprognostic (2.79e-2)" "unprognostic (4.38e-2)" "unprognostic (5.54e-2)" "unprognostic (1.19e-2)" "unprognostic (2.40e-3)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (3.48e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (2.44e-2)" 32.3 56.3 32.0 23.6 32.9 35.2 31.2 34.5 49.3 24.2 33.2 30.8 19.2 22.2 25.4 66.3 19.8 9.1 105.1 32.5 33.8 38.2 51.6 21.4 21.3 33.2 32.2 32.2 18.4 22.1 24.3 22.3 17.6 32.4 25.4 24.0 15.8 28.5 17.8 107.5 33.4 23.4 20.3 33.3 27.8 28.0 32.1 33.5 29.9 21.6 98.7 22.7 27.4 32.5 33.8 43.4 56.0 105.5 89.6 45.0 27.7 50.6 43.8 29.3 55.4 54.6 198.2 53.4 19.3 96.0 53.5 46.9 57.9 82.6 61.5 29.0 55.0 116.0 86.7 77.4 125.6 70.1 98.8 45.3 53.5 28.3 59.4 20.6 20.6 84.9 84.4 74.5 86.2 52.5 114.8 75.9 113.9 52.3 126.0 97.4 65.5 49.5 121.6 107.5 118.6 85.1 61.9 71.6 100.9 33.5 47.5 123.5 75.1 62.5 58.6 77.8 48.6 54.1 30.7 73.5 137.7 21.0 97.6 55.9 100.8 146.8 157.0 54.5 156.2 52.6 91.1 55.8 53.0 157.2 85.8 64.7 54.4 80.3 93.2 133.4 213.2 91.1 113.6 32.0 32.9 34.5 49.3 32.5 33.8 33.2 32.2 32.2 32.4 33.3 33.5 33.8 83.5 54.5 41.1 6.8 66.3 82.7 69.3 247.1 66.6 44.6 136.2 167.3 577.5 178.7 142.1 101.2 31.3 222.2 78.9 257.3 360.0 229.6 96.1 103.4 141.4 94.0 142.7 118.9 7.7 227.3 184.5 100.0 95.3 124.8 60.9 90.5 110.3 444.8 297.2 33.7 8.8 166.9 185.1 138.9 76.3 181.0 98.8 115.3 168.9 2.8 185.5 125.6 116.4 4.5 12.0 220.0 210.3 88.8 106.0 107.4 195.8 515.8 96.2 69.0 72.3 63.4 132.8 193.9 158.9 224.2 148.6 129.7 54.8 185.9 208.6 94.0 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143253-112164096 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 125.6;skin 1: 150.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 25.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 16000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 11.8 6.1 5.8 18.4 6.2 31.9 12.8 6.6 8.7 19.8 9.1 34.4 22.2 2.4 3.3 125.6 8.0 23.2 2.2 5.8 7.9 23.5 9.2 23.2 68.4 8.1 6.3 5.6 1.9 18.1 1.3 2.9 6.8 7.7 6.2 29.3 6.9 15.1 3.0 6.1 150.8 22.2 3.6 8.3 29.5 13.5 1.9 6.2 8.0 3.8 2.1 25.9 25.6 77.7 9.8 117.9 40.0 0.0 0.4 0.0 0.0 0.7 2.0 0.0 0.0 0.1 22.4 182.3 0.1 25.7 0.3 3.2 167.0 0.0 125.8 0.0 0.3 1.2 17.5 35.6 9.9 3.9 9.3 32.6 0.2 188.5 0.3 43.5 0.2 0.1 0.1 0.5 0.3 1.6 0.2 0.2 0.9 0.2 31.9 110.2 0.1 0.1 0.4 79.9 24.8 0.1 0.0 78.4 52.1 0.5 1.0 31.0 25.4 0.3 0.4 208.9 1.2 35.9 0.4 0.3 0.6 0.2 67.1 0.2 6.8 8.7 16.0 0.1 10.9 0.0 0.7 0.1 0.0 25.8 0.7 0.0 0.5 9.5 19.6 6.3 5.6 0.0 2.5 5.8 6.2 6.6 8.7 5.8 7.9 8.1 6.3 5.6 7.7 8.3 6.2 9.8 1.0 173.1 38.4 0.7 6.0 122.9 33.5 186.4 215.1 2.6 4.6 7.7 1.0 41.5 66.1 9.2 0.0 2.3 10.8 109.9 80.3 24.7 2.4 94.9 1.4 4.6 14.5 26.3 3.8 143.0 3.7 18.8 20.9 32.5 101.2 2.8 8.2 1.9 68.4 0.0 4.6 30.1 57.0 241.0 37.3 1.9 0.0 123.8 3.6 61.8 38.8 2.7 6.2 2.0 1.1 161.4 104.6 4.5 4.6 23.6 67.5 22.3 69.6 39.1 6.6 0.6 3.9 1.5 1.3 152.6 111.2 1.8 9.6 0.3 47.8 90.5 TEX12 ENSG00000150783 "Testis expressed 12" Q9BXU0 11 112167372-112172556 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "retina: 8.7;testis: 20.9" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 211.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038289, HPA038290" Enhanced NA NA "HPA038289: AB_10672742, HPA038290: AB_2675934" "unprognostic (1.49e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.92e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-3)" "unprognostic (2.03e-1)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (2.91e-1)" "unprognostic (9.20e-4)" "unprognostic (1.71e-2)" "unprognostic (2.97e-1)" "unprognostic (6.54e-2)" "unprognostic (4.10e-2)" "unprognostic (3.16e-3)" 0.3 0.0 0.1 0.1 0.1 0.4 0.4 0.5 0.2 0.2 0.1 0.3 0.6 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.2 8.7 0.2 0.1 1.0 0.7 0.4 0.2 0.0 0.2 0.2 20.9 0.1 0.1 0.1 0.7 0.2 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.4 0.7 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.5 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.7 0.1 0.4 0.2 0.2 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.2 0.1 0.0 0.0 1.4 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.0 0.5 0.1 0.3 0.4 0.0 0.1 0.0 4.2 0.1 0.3 0.3 0.0 0.2 2.0 0.0 0.1 0.1 0.0 0.0 1.7 0.2 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.4 0.3 0.0 2.2 0.1 0.0 0.0 1.9 5.1 0.9 0.3 0.0 1.0 0.6 0.3 0.0 0.5 0.2 0.1 0.1 0.7 0.1 0.2 0.3 0.1 0.0 0.4 6.6 0.2 0.4 211.7 36.1 0.0 0.4 0.0 0.3 0.2 0.2 0.3 PTS PTPS ENSG00000150787 "6-pyruvoyltetrahydropterin synthase" Q03393 11 112226367-112269955 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Disease variant, Phenylketonuria" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001481 Uncertain Approved Cytosol NA NA Cytosol "HPA001481: AB_1079716" "unprognostic (2.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.66e-3)" "unprognostic (8.38e-3)" "unprognostic (4.58e-1)" "unprognostic (3.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.74e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-2)" "unprognostic (3.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.97e-1)" "unprognostic (1.52e-3)" "unprognostic (1.65e-1)" 9.4 63.5 23.2 10.3 22.8 22.9 20.8 24.5 25.7 16.0 24.7 19.1 15.2 13.7 29.9 29.2 11.8 20.8 7.6 21.0 29.1 34.3 69.5 7.9 10.6 27.7 28.2 20.9 10.0 15.1 29.3 33.1 18.1 29.4 21.3 21.7 19.2 17.6 16.6 18.7 17.1 16.2 13.1 25.0 7.8 27.7 10.4 25.1 4.4 23.4 11.0 12.5 21.9 19.3 28.3 24.5 24.2 33.4 12.9 23.9 26.8 35.4 78.3 38.8 45.5 48.5 57.0 26.1 28.5 53.5 51.6 60.8 38.0 47.5 54.8 50.6 19.7 28.8 7.5 44.6 55.8 70.9 18.4 4.0 47.8 77.1 43.9 53.0 36.5 35.2 24.6 24.9 16.8 30.1 29.8 14.8 23.8 23.1 54.2 48.3 9.4 6.3 37.6 101.2 38.8 32.2 32.5 41.1 43.8 26.0 109.0 32.3 15.2 40.2 42.5 43.0 49.7 60.7 9.9 20.8 69.4 29.3 19.4 44.1 1.1 0.4 0.4 1.2 0.7 1.3 1.5 1.7 1.8 0.7 1.6 1.1 1.5 0.2 1.5 2.0 2.0 1.9 0.7 23.2 22.8 24.5 25.7 21.0 29.1 27.7 28.2 20.9 29.4 25.0 25.1 28.3 43.7 19.2 26.5 13.1 28.6 122.6 80.4 146.2 59.2 17.4 69.4 69.0 95.0 47.1 85.7 55.2 0.0 56.7 41.4 80.0 211.3 91.9 5.5 66.4 37.0 42.8 80.0 23.2 16.8 78.9 120.7 47.9 37.8 72.6 20.8 45.1 34.6 123.6 36.9 10.1 25.4 73.1 150.5 21.4 38.1 7.6 14.6 28.4 26.6 15.0 26.1 48.5 22.6 17.6 36.1 114.4 74.4 25.9 33.0 91.9 58.3 151.0 80.8 18.3 26.3 22.7 70.8 23.3 92.6 65.4 131.1 70.3 28.5 59.6 44.4 114.9 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534854-22714578 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 510.5" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 1585.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 4900000 "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: AB_2685490, HPA068771: AB_2686030" "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 28.6 15.6 177.0 48.3 322.2 45.2 15.1 248.1 229.0 26.7 78.1 18.0 13.3 21.3 11.9 20.0 15.3 33.2 13.4 179.7 220.5 16.7 18.8 26.1 81.9 260.2 291.8 130.5 8.9 11.0 24.9 8.6 23.8 291.0 9.4 19.3 15.5 7.9 13.1 5.2 7.9 20.7 31.8 213.5 63.2 19.5 12.6 253.1 60.9 12.9 11.0 89.2 24.3 10.6 510.5 30.2 29.2 33.4 10.8 52.3 70.6 25.3 55.0 58.1 29.1 35.7 27.6 47.2 63.2 19.4 111.0 63.7 10.4 29.2 15.4 29.2 140.5 30.4 118.7 21.6 60.9 92.5 23.1 89.1 35.6 13.7 39.7 38.2 44.6 43.7 83.5 67.4 119.1 54.5 12.5 92.3 20.5 13.7 14.5 20.7 36.9 47.8 86.3 43.0 5.8 6.1 13.9 17.7 9.0 86.4 37.6 7.6 39.1 53.0 22.3 32.8 41.7 33.9 75.1 46.3 45.0 60.5 68.3 17.6 72.6 32.6 104.0 119.5 57.9 164.0 52.1 94.2 139.9 43.7 33.1 62.8 118.2 40.5 144.2 67.3 44.8 75.9 183.4 177.0 322.2 248.1 229.0 179.7 220.5 260.2 291.8 130.5 291.0 213.5 253.1 510.5 22.5 3.2 6.7 84.9 43.2 17.6 4.0 2.0 3.4 5.7 12.9 5.5 8.1 14.3 5.6 18.4 2.1 8.6 196.9 3.4 11.7 9.7 22.9 7.4 15.7 29.2 4.9 236.9 65.6 10.7 5.4 19.6 6.6 24.8 22.8 13.4 62.4 8.7 31.8 13.5 62.0 2.9 0.0 98.6 80.0 34.5 16.8 82.8 104.9 142.4 81.3 5.0 159.6 167.9 1585.0 22.1 3.7 10.1 36.4 7.1 1.0 15.6 2.2 9.1 19.7 14.1 30.6 6.1 7.9 3.3 16.9 12.4 130.7 8.5 2.8 6.6 C2orf50 FLJ25143 ENSG00000150873 "Chromosome 2 open reading frame 50" Q96LR7 2 11133128-11151317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 4.6;fallopian tube: 7.5" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 8.4;Endometrial ciliated cells: 21.5;Excitatory neurons: 9.7;Respiratory ciliated cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" "HPA062894, HPA067681" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA062894: AB_2684897, HPA067681: " "unprognostic (6.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.53e-4)" "unprognostic (1.92e-3)" "unprognostic (3.35e-2)" "unprognostic (6.19e-2)" "unprognostic (3.55e-1)" "unprognostic (1.31e-1)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (2.00e-2)" "unprognostic (2.45e-1)" "unprognostic (3.97e-4)" "unprognostic (7.03e-2)" "unprognostic (2.92e-1)" "unprognostic (8.25e-3)" "unprognostic (7.36e-2)" 0.1 0.2 2.5 0.2 1.9 0.5 0.2 0.4 1.7 0.3 4.6 0.1 0.3 0.3 0.2 0.1 7.5 0.1 0.1 1.3 1.3 0.2 0.1 0.6 0.3 1.5 1.5 1.4 0.3 0.2 0.1 0.7 0.1 0.6 0.2 0.2 1.5 0.3 0.1 0.2 0.4 0.1 0.1 1.3 0.3 0.2 0.3 0.6 0.2 0.2 0.0 0.1 0.1 0.0 1.5 0.1 0.5 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.2 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.7 0.1 0.3 0.2 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.6 0.2 0.2 0.2 0.1 0.1 2.5 1.9 0.4 1.7 1.3 1.3 1.5 1.5 1.4 0.6 1.3 0.6 1.5 0.0 0.0 1.8 0.7 0.5 0.0 0.5 0.5 0.0 0.4 0.4 0.5 0.4 0.0 3.5 0.0 8.4 0.0 0.1 0.0 0.0 0.3 0.2 21.5 0.4 0.0 0.0 0.0 9.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.0 2.5 0.4 0.2 0.0 1.5 0.0 0.1 0.0 0.2 27.1 3.0 0.0 1.0 0.5 0.5 1.4 0.0 0.0 0.0 0.3 0.9 0.0 0.1 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix 2" Q5SZK8 13 38687077-38887131 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 7.8;thyroid gland: 4.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 27.2;Astrocytes: 46.0;Cholangiocytes: 15.7;Endometrial ciliated cells: 18.6;Glandular and luminal cells: 48.6;Oligodendrocyte precursor cells: 15.6;Proximal tubular cells: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.5;HAP1: 10.6;MCF7: 7.8;RT4: 7.2;SK-BR-3: 6.3;SuSa: 29.7;WM-115: 5.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 1500000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.2 0.1 0.4 0.0 1.1 0.0 0.2 0.2 0.8 0.3 0.0 0.3 0.1 0.5 0.2 0.0 0.4 0.8 0.0 0.6 0.1 7.8 2.0 2.2 0.0 0.2 0.3 0.3 0.7 2.7 0.0 0.3 1.5 0.3 1.8 0.1 0.3 0.0 0.7 2.8 0.1 0.2 0.3 0.0 0.1 0.9 0.3 0.0 0.2 4.9 3.6 0.0 0.2 0.0 0.1 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 10.6 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 2.3 0.0 0.2 0.0 1.4 0.1 2.3 7.2 0.2 0.1 0.0 6.3 0.3 29.7 1.1 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.2 0.8 0.6 0.1 0.2 0.3 0.3 0.3 0.0 0.0 0.1 1.8 0.0 27.2 46.0 0.0 0.6 0.1 0.7 0.0 0.2 0.4 0.5 2.7 15.7 1.4 1.8 0.0 5.9 0.0 0.3 5.9 3.2 0.5 18.6 4.5 0.6 0.0 0.0 0.5 0.2 0.4 0.4 0.0 48.6 0.0 0.5 0.0 1.3 0.8 0.0 9.1 0.1 2.0 0.3 0.0 0.1 0.0 0.2 0.0 3.7 0.0 3.3 0.0 15.6 9.7 1.0 0.1 0.0 0.0 0.0 0.0 24.8 2.9 0.3 0.0 3.1 0.7 0.2 0.9 0.0 0.1 1.9 0.5 2.9 0.1 0.1 FOXO1 "FKH1, FKHR, FOXO1A" ENSG00000150907 "Forkhead box O1" Q12778 13 40555667-40666641 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 91.8" "Cell type enhanced" "Detected in many" "Astrocytes: 177.3;Endometrial stromal cells: 161.0;Granulosa cells: 177.9;Oligodendrocytes: 131.5;Skeletal myocytes: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 40.4;Daudi: 45.3;HSkMC: 53.6;U-698: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001252, CAB022326" Approved Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022326: , HPA001252: AB_1078906" "unprognostic (4.72e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-2)" "unprognostic (4.35e-1)" "unprognostic (2.42e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (8.65e-3)" "unprognostic (1.71e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.33e-5)" "unprognostic (1.93e-1)" "unprognostic (5.44e-1)" "unprognostic (9.09e-2)" "unprognostic (9.63e-2)" 43.6 9.8 10.4 13.2 15.8 13.9 27.8 10.4 9.2 19.0 15.5 12.6 5.0 39.4 6.6 13.1 25.9 14.7 11.7 8.9 17.4 11.9 38.8 17.0 24.0 13.7 10.8 7.1 66.2 16.6 5.3 7.7 11.3 11.6 10.2 9.7 4.0 9.9 10.2 91.8 17.6 11.0 27.2 10.8 15.8 9.6 9.0 10.7 11.7 19.2 22.4 24.2 13.5 17.6 14.2 0.7 1.7 12.4 0.3 40.4 7.9 11.8 1.8 2.5 0.5 0.3 3.7 3.0 45.3 8.1 1.2 1.9 10.7 9.8 5.3 0.7 20.9 10.1 0.0 1.4 10.1 19.1 0.4 1.2 53.6 35.5 0.2 6.7 2.5 31.7 3.3 0.9 14.0 3.1 1.6 0.1 0.6 18.0 6.2 3.1 32.4 14.3 3.6 22.9 5.8 2.6 0.6 1.6 8.5 1.8 14.1 1.5 1.1 18.6 0.3 2.3 0.1 1.1 7.9 3.3 57.8 1.2 2.1 5.7 0.9 0.6 0.5 1.3 0.8 1.8 3.7 3.6 2.2 0.4 5.8 5.5 4.3 2.5 1.4 1.4 0.0 5.1 1.0 10.4 15.8 10.4 9.2 8.9 17.4 13.7 10.8 7.1 11.6 10.8 10.7 14.2 57.9 0.0 4.4 177.3 29.3 29.3 19.1 13.0 27.9 3.7 12.9 17.3 11.5 10.0 9.9 9.2 12.5 0.5 22.9 27.5 0.0 11.1 7.2 55.4 161.0 50.2 52.2 3.2 7.4 18.0 3.8 40.8 18.8 118.8 1.3 177.9 84.3 47.9 6.5 5.0 23.0 21.0 8.2 14.6 26.9 4.0 18.6 18.6 12.4 117.1 18.4 5.5 8.2 47.3 131.5 19.5 16.3 13.2 32.9 10.1 7.7 8.8 9.2 9.8 6.6 131.7 31.3 6.4 14.6 25.3 26.7 0.8 40.3 64.0 12.5 13.0 CRIM1 S52 ENSG00000150938 "Cysteine rich transmembrane BMP regulator 1" Q9NZV1 2 36355778-36551135 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 165.2" "Cell type enhanced" "Detected in many" "Adipocytes: 262.9;Hepatic stellate cells: 207.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 466.5;fHDF/TERT166: 462.5;TIME: 651.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000556 Enhanced "Intracellular and membrane" NA NA 170000 "HPA000556: AB_1078567" "unprognostic (2.15e-1)" "unprognostic (5.41e-2)" "unprognostic (6.39e-2)" "unprognostic (3.17e-3)" "unprognostic (3.88e-2)" "unprognostic (3.44e-2)" "unprognostic (1.88e-1)" "unprognostic (6.25e-2)" "unprognostic (2.32e-1)" "unprognostic (4.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.51e-4)" "unprognostic (1.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (6.67e-2)" 89.1 14.8 27.0 18.9 28.6 3.5 59.4 10.6 33.7 26.9 61.6 29.0 15.0 26.8 16.8 30.8 34.7 32.5 34.8 20.8 28.7 70.6 16.1 50.6 15.0 24.4 20.9 20.7 37.3 23.7 29.5 7.5 165.2 22.0 26.0 23.4 29.8 31.4 32.9 50.5 26.1 18.4 36.0 20.5 47.5 17.6 12.5 29.5 10.0 34.1 36.8 8.8 39.3 22.4 25.3 100.9 75.4 15.2 17.5 69.1 78.0 125.0 466.5 244.7 255.4 133.4 95.3 34.2 0.2 297.9 462.5 166.1 42.8 11.4 75.2 206.5 1.1 8.7 3.2 96.7 55.5 221.5 2.2 0.6 110.1 55.2 102.4 182.4 238.4 361.9 1.9 4.7 0.7 271.6 9.2 0.2 1.2 11.9 5.2 22.1 5.4 19.6 15.5 159.8 41.1 1.8 0.2 81.5 26.4 3.4 56.2 72.3 2.0 651.1 321.7 116.1 40.4 229.1 25.5 0.5 0.9 94.7 0.4 100.8 1.4 0.1 0.5 0.6 0.0 0.4 0.3 0.2 0.3 0.1 0.2 0.0 0.3 0.2 0.4 0.6 2.1 0.2 0.0 27.0 28.6 10.6 33.7 20.8 28.7 24.4 20.9 20.7 22.0 20.5 29.5 25.3 262.9 12.8 43.3 100.2 5.4 66.0 38.5 30.1 43.9 12.0 55.6 72.9 34.4 47.1 26.5 132.4 2.1 111.9 27.1 49.5 3.9 33.5 1.0 37.1 27.7 159.8 31.8 10.7 85.1 2.6 40.6 41.0 10.2 75.9 1.3 27.4 207.1 3.6 27.7 0.0 57.5 37.7 36.7 7.7 32.5 2.0 19.0 8.2 39.2 135.9 7.1 18.5 6.2 65.9 17.2 26.5 30.9 19.9 6.9 75.5 11.5 38.4 28.9 42.5 46.0 18.4 164.6 2.1 9.4 22.0 30.1 173.5 17.1 5.7 33.2 58.3 SEC24D KIAA0755 ENSG00000150961 "SEC24 homolog D, COPII coat complex component" O94855 4 118722823-118838683 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Craniosynostosis, Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 118.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041626, HPA053486" Approved Approved Vesicles NA NA Vesicles "HPA041626: AB_10796348, HPA053486: AB_2682166" "unprognostic (9.06e-2)" "unprognostic (3.11e-1)" "unprognostic (3.23e-2)" "unprognostic (8.60e-3)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (1.93e-1)" "unprognostic (2.58e-1)" "unprognostic (9.39e-2)" "unprognostic (3.23e-1)" "unprognostic (1.22e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (3.42e-6)" "unprognostic (1.09e-3)" "unprognostic (5.64e-2)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" 20.0 13.4 1.5 27.5 3.3 17.8 19.6 1.1 4.8 49.4 5.0 24.6 37.8 26.6 37.2 12.5 20.9 32.2 16.8 5.5 9.3 8.7 52.5 23.1 18.5 2.0 0.7 1.5 15.4 36.1 10.3 23.5 37.1 1.5 22.2 32.6 1.6 23.1 26.6 5.9 9.4 41.2 41.7 0.5 18.2 29.9 18.6 2.1 14.8 35.9 6.2 22.1 29.1 16.8 3.7 29.6 15.4 35.3 28.6 98.0 130.2 24.8 124.5 136.8 62.1 73.5 16.9 21.3 23.2 17.3 198.7 32.1 10.0 19.4 39.2 66.8 19.4 10.5 25.7 22.8 70.6 99.8 68.6 46.0 77.9 21.6 54.9 89.2 110.3 103.9 15.8 6.7 69.1 98.5 20.6 33.2 20.4 33.3 66.5 24.8 20.1 25.8 41.2 55.6 14.7 20.9 41.8 17.8 89.1 15.3 50.9 12.6 53.9 113.9 48.0 15.3 69.7 28.6 53.1 21.1 38.6 104.5 42.8 68.5 5.8 5.6 16.3 3.1 6.0 6.3 1.7 3.2 4.4 5.8 1.5 2.1 2.7 4.8 5.0 7.4 2.9 4.7 2.6 1.5 3.3 1.1 4.8 5.5 9.3 2.0 0.7 1.5 1.5 0.5 2.1 3.7 13.0 3.2 15.3 4.9 19.4 21.0 15.2 19.4 25.6 4.5 19.0 10.2 5.9 17.2 25.5 14.7 0.0 24.3 24.2 18.2 0.0 10.3 101.3 17.4 61.3 23.2 41.3 6.1 57.4 25.3 54.2 49.7 37.2 39.4 8.2 14.2 21.8 70.0 28.1 1.7 6.5 81.0 12.2 34.0 54.4 84.6 45.7 25.1 17.8 48.7 18.3 1.3 13.4 37.7 3.7 13.0 13.6 38.4 118.8 30.7 48.1 4.2 23.0 2.9 26.3 17.5 38.7 14.5 9.7 10.4 17.6 45.0 16.3 34.2 19.1 40.1 ABCB9 EST122234 ENSG00000150967 "ATP binding cassette subfamily B member 9" Q9NP78 12 122920951-122981649 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;testis: 17.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.3;Inhibitory neurons: 41.7;Plasma cells: 92.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6;memory B-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "GAMG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033052, HPA035113, HPA035114" Approved Supported Vesicles NA NA Vesicles "CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329" "unprognostic (1.47e-2)" "unprognostic (6.46e-4)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.46e-1)" "unprognostic (2.67e-2)" "unprognostic (2.35e-1)" "unprognostic (4.08e-2)" "unprognostic (6.07e-2)" "unprognostic (2.28e-1)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (6.97e-2)" "unprognostic (1.70e-1)" "unprognostic (3.58e-3)" "unprognostic (2.71e-2)" 2.7 3.1 9.4 1.6 10.7 3.4 3.9 17.0 20.9 3.0 0.0 2.2 2.7 3.1 4.9 2.9 3.0 2.5 4.6 8.2 7.6 3.6 1.2 1.7 1.6 7.8 10.9 12.1 4.1 3.2 2.8 11.6 1.8 13.0 3.5 2.1 7.4 5.6 2.8 1.6 3.3 3.4 2.0 1.7 3.6 3.4 17.9 10.5 1.3 3.0 1.2 1.9 1.9 3.1 11.0 4.7 8.6 4.7 4.5 2.0 3.8 2.2 3.0 4.3 5.1 3.2 3.7 5.3 5.2 3.4 2.8 25.9 4.3 3.5 7.2 2.0 1.0 7.0 22.9 7.7 5.9 2.2 1.1 9.0 5.3 2.8 7.5 2.3 12.5 5.7 5.1 4.6 3.8 2.9 10.6 1.7 2.2 1.5 5.0 8.4 6.4 1.3 5.0 2.6 3.1 5.0 1.5 1.5 10.7 10.7 1.8 12.6 1.6 2.5 3.6 12.2 11.5 8.8 12.3 7.4 1.5 6.3 2.5 20.2 2.6 0.3 0.3 0.3 0.1 0.8 2.5 0.3 0.3 0.2 0.5 0.6 0.6 0.7 0.2 0.1 0.1 0.2 0.8 9.4 10.7 17.0 20.9 8.2 7.6 7.8 10.9 12.1 13.0 1.7 10.5 11.0 9.7 6.4 4.6 13.4 15.9 3.2 2.8 1.5 8.6 10.7 3.9 5.0 2.0 0.0 2.5 3.7 14.6 5.2 3.4 1.9 0.0 3.8 8.9 2.6 2.6 4.0 1.2 2.1 46.3 1.5 1.8 2.0 4.1 5.6 2.5 3.0 2.9 1.2 1.1 6.7 41.7 1.1 0.0 1.0 2.1 23.2 2.8 1.8 5.4 7.5 0.3 20.0 2.1 4.0 18.1 2.5 0.1 2.6 92.2 2.1 4.1 0.9 0.7 5.3 6.6 2.1 3.7 9.6 3.5 3.3 3.1 1.4 3.9 2.9 2.6 1.8 RILPL2 "FLJ30380, FLJ32372, MGC7036" ENSG00000150977 "Rab interacting lysosomal protein like 2" Q969X0 12 123415039-123436684 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 117.3" "Cell type enhanced" "Detected in many" "B-cells: 149.8;Macrophages: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 103.8;NB-4: 235.2;THP-1: 149.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028958 Approved Supported Cytosol NA NA Cytosol "HPA028958: AB_10602124" "unprognostic (1.94e-3)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.24e-7)" "unprognostic (2.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.69e-2)" "unprognostic (4.08e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (2.10e-1)" "unprognostic (4.74e-2)" 21.6 7.5 8.9 27.7 9.4 117.3 16.0 8.0 11.2 26.5 13.4 6.4 5.5 19.5 11.3 7.7 18.5 15.8 8.3 9.2 10.8 18.7 12.0 24.3 24.0 9.5 9.1 8.6 13.2 8.1 11.5 3.5 14.5 8.9 18.8 5.8 1.4 23.4 23.9 4.7 5.6 6.6 13.9 8.9 27.0 10.4 3.2 9.5 15.3 28.1 6.0 17.8 20.7 7.0 9.0 14.2 12.7 4.6 21.8 29.8 23.6 13.3 16.1 41.0 15.3 12.7 16.2 5.5 7.6 15.2 25.1 8.4 9.2 10.3 12.3 14.2 29.1 9.8 103.8 9.9 24.2 33.2 81.2 50.6 18.3 9.3 16.0 11.6 19.8 15.7 20.4 11.1 3.8 12.4 9.4 28.0 235.2 2.9 4.5 13.9 19.8 14.1 15.4 16.0 26.1 1.0 6.7 21.9 0.7 16.9 9.2 19.5 149.0 17.0 12.5 9.2 22.8 9.9 6.2 8.0 18.2 12.3 55.1 5.3 98.6 133.3 159.3 24.0 106.0 22.4 55.8 51.1 42.7 98.7 41.9 19.7 22.5 176.8 22.4 121.5 46.7 67.7 63.8 8.9 9.4 8.0 11.2 9.2 10.8 9.5 9.1 8.6 8.9 8.9 9.5 9.0 75.7 35.3 75.2 7.2 149.8 24.5 68.4 67.8 32.5 1.4 45.3 35.9 5.1 17.2 43.3 22.0 2.1 10.1 75.0 2.4 25.4 20.1 2.1 51.9 24.8 73.2 4.2 24.2 7.5 21.0 5.4 28.2 9.2 27.0 62.6 8.4 84.3 13.3 72.9 1.7 2.6 8.1 0.0 112.5 129.7 2.7 50.4 288.7 37.4 10.3 117.8 18.7 42.2 5.5 2.3 22.7 6.4 66.2 25.7 82.6 1.5 63.5 47.1 2.1 6.6 13.1 30.1 1.4 13.0 12.5 15.3 8.1 92.5 10.1 4.8 69.2 DHX37 "DDX37, Dhr1, KIAA1517, MGC2695, MGC4322" ENSG00000150990 "DEAH-box helicase 37" Q8IY37 12 124946825-124989131 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047607 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA047607: AB_2680101" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.54e-10)" "unprognostic (2.38e-2)" "unprognostic (5.14e-2)" "unprognostic (2.90e-2)" "unprognostic (2.07e-1)" "unprognostic (3.16e-2)" "unprognostic (8.28e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (2.85e-2)" "unprognostic (2.73e-1)" 4.4 3.2 2.7 6.9 3.0 8.9 3.6 2.7 3.6 3.4 1.2 3.4 4.4 3.8 1.3 4.8 3.5 2.8 3.3 2.7 2.5 3.2 3.0 2.9 7.5 3.8 3.4 2.5 4.6 6.6 2.6 1.6 3.0 3.3 3.4 1.7 0.5 4.3 2.7 10.9 4.1 3.8 2.5 2.8 5.2 3.9 2.7 2.9 4.7 3.3 4.9 3.9 5.1 3.6 4.0 17.3 45.5 5.2 21.9 6.7 6.6 27.4 13.8 7.3 19.5 11.6 44.7 9.4 37.5 24.6 11.4 19.7 21.9 19.8 15.6 4.5 32.7 38.2 23.0 13.8 23.7 13.4 27.7 30.5 8.8 10.8 24.3 4.0 7.2 10.0 17.4 44.4 7.5 7.5 23.9 29.5 28.5 39.2 15.1 36.4 31.4 11.0 21.5 8.6 22.6 17.6 11.1 14.0 16.3 16.0 5.1 19.3 19.5 13.1 16.1 20.2 20.0 27.6 31.6 33.2 44.0 15.1 22.2 27.2 0.0 1.5 0.0 1.6 1.7 1.4 1.8 1.3 1.6 1.4 1.4 0.9 1.4 0.0 0.9 0.8 1.1 0.7 1.4 2.7 3.0 2.7 3.6 2.7 2.5 3.8 3.4 2.5 3.3 2.8 2.9 4.0 5.5 3.2 5.2 3.3 10.3 4.2 3.4 2.8 4.0 3.5 6.2 5.3 3.8 2.8 4.1 0.0 0.0 4.1 6.7 8.8 3.9 4.8 1.7 5.3 9.6 5.7 9.0 5.0 3.0 6.2 6.0 4.8 8.2 7.8 6.3 9.3 2.2 6.2 5.4 13.5 2.0 7.1 6.1 7.2 2.5 2.0 5.3 4.9 0.0 1.9 6.6 2.2 6.2 3.0 4.0 9.0 2.2 2.6 9.2 4.9 2.8 4.7 4.1 2.1 6.6 7.1 3.8 1.5 5.6 8.0 4.0 2.9 7.7 5.9 9.3 4.0 UBC ENSG00000150991 "Ubiquitin C" P0CG48 12 124911604-124917368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000362, CAB005419, HPA041344, HPA049132" Supported NA Yes "CAB000362: AB_2301097, CAB005419: AB_2180553, HPA041344: AB_2677422, HPA049132: AB_2680646" "unprognostic (7.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (8.64e-3)" "unprognostic (2.41e-2)" "unprognostic (7.38e-2)" "unprognostic (6.35e-3)" "unprognostic (7.60e-3)" "unprognostic (1.48e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (7.90e-7)" "unprognostic (6.69e-2)" "unprognostic (2.74e-1)" "unprognostic (5.64e-2)" "unprognostic (8.81e-2)" 1199.8 948.5 1219.0 705.6 1259.6 2830.5 949.5 1360.3 1606.9 854.8 1477.0 940.5 577.1 969.1 996.3 1656.5 1104.7 1368.2 1290.0 1265.7 1579.0 992.7 1666.6 1080.1 840.3 1401.9 1269.2 1138.8 826.7 929.6 658.5 516.9 833.3 1279.9 716.1 1071.1 982.5 1124.4 1147.2 3491.5 935.4 842.9 1289.4 1330.0 806.3 819.8 1269.0 1334.4 774.7 920.5 3206.0 1001.5 1155.9 1193.5 1645.2 1407.8 1259.6 1043.5 863.8 2845.1 1769.8 692.9 1750.1 2130.8 1259.1 1229.6 1129.7 1747.7 1272.9 1410.4 2133.4 2042.1 1026.2 2048.8 3325.1 1075.2 1480.4 760.1 971.1 831.8 2017.2 2199.3 1404.5 844.9 2035.2 2538.3 1500.0 2283.6 1644.8 1630.2 510.6 897.8 1259.9 1467.1 1270.4 1300.6 1641.0 966.5 835.3 1520.0 781.7 970.6 1182.5 1719.0 2164.3 1216.6 891.7 1691.7 1928.1 1622.1 619.9 1653.3 931.5 2019.6 2766.8 792.8 1496.9 1103.8 1460.9 1819.8 1608.8 1490.2 779.7 1805.4 335.0 532.6 606.0 431.8 517.4 412.7 315.8 375.2 450.0 310.2 295.5 292.5 350.7 989.3 401.3 653.5 432.6 499.4 1022.5 1219.0 1259.6 1360.3 1606.9 1265.7 1579.0 1401.9 1269.2 1138.8 1279.9 1330.0 1334.4 1645.2 2304.5 1451.9 1227.6 128.0 1287.0 1219.8 3858.3 4028.1 1915.7 618.9 843.1 1183.4 915.2 683.4 2496.6 660.3 333.6 841.0 1282.5 1499.3 892.1 1475.7 4437.0 1595.5 1062.5 1370.6 747.6 340.1 42.3 1128.2 1268.9 1662.4 1305.8 2615.6 911.9 698.7 637.9 442.9 1295.9 518.2 49.3 1067.2 1564.5 654.8 1858.6 4032.6 786.9 1668.6 1220.2 124.6 1728.7 1784.0 520.1 31.7 106.2 1334.3 1613.6 830.1 2420.4 1775.3 1850.8 1023.9 1700.8 1215.7 611.4 1695.6 2149.7 1135.2 429.9 1523.5 1048.6 1754.1 1980.7 752.4 845.9 2349.3 ITPR1 "ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29" ENSG00000150995 "Inositol 1,4,5-trisphosphate receptor type 1" Q14643 3 4493345-4847840 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 51.9" "Immune cell enhanced" "Detected in many" "naive B-cell: 13.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7" "Region enhanced" "Detected in all" "cerebellum: 697.2" "Region enhanced" "Detected in all" "cerebellum: 208.8" "HPA014765, HPA016487" Approved Approved Vesicles NA NA Vesicles "HPA014765: AB_1851843, HPA016487: AB_1851842" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (2.16e-2)" "unprognostic (3.61e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.92e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.40e-1)" 9.3 12.1 0.8 11.9 8.6 7.2 17.5 51.9 17.8 11.3 12.0 15.1 4.6 36.8 10.1 10.7 27.3 14.2 9.8 5.3 4.7 13.9 3.9 13.8 11.3 0.7 1.1 2.1 25.5 6.8 45.6 16.1 8.1 14.9 21.9 6.3 3.9 16.3 28.1 3.1 4.4 11.6 24.7 0.0 9.3 11.2 4.5 0.7 10.4 32.0 5.4 10.6 28.1 11.9 4.5 0.4 4.1 1.0 3.0 27.7 1.9 11.8 0.9 0.5 1.3 0.8 1.3 1.2 14.5 0.6 1.9 6.5 0.1 2.2 2.6 2.1 76.4 3.2 41.1 74.9 3.5 27.4 17.7 40.0 9.2 4.0 5.8 1.1 7.6 7.2 8.4 7.9 13.9 3.7 1.8 7.2 3.0 2.1 0.5 9.7 4.2 1.0 1.1 1.7 5.5 0.7 19.5 5.4 4.3 4.3 0.9 2.6 20.6 13.5 1.8 4.3 3.7 2.3 17.7 12.0 9.6 56.7 17.0 2.7 5.8 2.0 1.5 2.3 0.9 1.7 6.7 1.6 1.6 2.2 13.4 2.7 1.6 1.8 1.8 0.9 4.7 1.4 1.1 0.8 8.6 51.9 17.8 5.3 4.7 0.7 1.1 2.1 14.9 0.0 0.7 4.5 30.1 0.0 31.4 24.8 49.7 3.8 6.1 6.3 11.4 4.0 40.0 29.7 8.0 2.8 11.2 9.2 0.0 0.5 17.8 0.3 3.9 2.4 5.4 9.1 11.9 31.2 3.5 8.4 290.2 5.1 0.5 21.5 20.4 12.7 26.5 22.6 36.0 2.0 4.7 1.7 183.1 1.3 2.0 12.9 17.4 7.9 30.1 23.9 7.2 84.3 14.2 4.3 6.2 25.1 12.7 1.5 1.2 52.6 8.8 5.4 0.3 3.9 13.1 1.5 39.5 8.8 28.2 1.5 2.9 4.9 3.1 1.0 25.7 22.0 0.8 3.3 TKTL2 "DKFZP434L1717, FLJ32975" ENSG00000151005 "Transketolase like 2" Q9H0I9 4 163471095-163473754 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 375 "testis: 58.3" "Group enriched" "Detected in some" 26 "Early spermatids: 76.3;Late spermatids: 40.8;Spermatocytes: 156.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (8.62e-2)" "unprognostic (2.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (7.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 3.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS53 POL3S ENSG00000151006 "Serine protease 53" Q2L4Q9 16 31083425-31089628 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;liver: 10.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 6.3;Inhibitory neurons: 4.3;Oligodendrocytes: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.8;U-87 MG: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034955, HPA034956" Uncertain "Secreted in other tissues" NA NA "HPA034955: AB_2674380, HPA034956: AB_10696365" "unprognostic (3.13e-1)" "unprognostic (4.15e-1)" "unprognostic (3.88e-3)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-2)" "unprognostic (2.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.63e-4)" "unprognostic (2.53e-12)" "unprognostic (1.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" 0.2 0.1 1.5 0.4 1.6 0.0 0.2 1.7 3.3 0.5 1.3 0.3 0.3 0.3 0.1 0.3 0.1 0.3 0.2 1.6 1.6 0.6 10.0 0.4 0.4 1.5 1.5 1.4 0.3 0.6 0.0 0.8 0.1 1.7 0.9 0.1 0.1 0.4 0.2 0.1 2.5 0.4 0.4 1.5 0.5 0.5 0.0 1.5 0.1 0.4 0.0 0.0 0.4 0.5 1.9 0.3 0.4 0.1 0.3 0.0 0.5 0.8 0.4 0.8 0.5 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.8 0.0 0.4 0.3 1.0 0.0 0.4 0.1 0.9 0.2 1.1 0.4 0.0 1.0 1.0 0.0 0.0 0.0 0.0 4.8 0.3 0.4 0.0 0.4 0.0 0.5 0.2 0.3 0.8 0.5 1.6 0.1 0.7 0.2 0.1 2.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 1.7 3.3 1.6 1.6 1.5 1.5 1.4 1.7 1.5 1.5 1.9 0.2 0.0 0.0 1.6 0.2 0.4 0.2 0.2 0.0 0.4 0.1 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.4 6.3 0.2 0.2 0.2 1.1 0.3 0.0 0.3 0.4 0.7 0.1 0.0 4.3 0.1 0.0 0.0 0.4 0.2 1.8 0.4 0.0 0.0 0.0 0.1 0.0 0.5 4.4 0.4 0.0 1.2 0.2 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.1 0.5 1.4 0.0 1.0 0.1 0.1 0.3 SLC7A11 xCT ENSG00000151012 "Solute carrier family 7 member 11" Q9UPY5 4 138164097-138242349 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8" "Cell type enhanced" "Detected in many" "Astrocytes: 368.6;Microglial cells: 148.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "hTCEpi: 84.2;TIME: 95.2;WM-115: 138.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064215 Approved Vesicles NA NA Vesicles "HPA064215: AB_2685213" "unprognostic (3.55e-3)" "unprognostic (4.64e-3)" "unprognostic (2.43e-2)" "unprognostic (7.18e-3)" "unprognostic (2.59e-1)" "unprognostic (8.80e-3)" "unprognostic (2.07e-8)" "unprognostic (1.98e-2)" "unprognostic (1.09e-2)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (2.22e-8)" "unprognostic (3.81e-2)" "unprognostic (3.76e-2)" "unprognostic (2.29e-2)" "unprognostic (1.54e-2)" 0.2 0.1 18.6 2.3 15.8 1.0 0.4 18.5 16.7 0.9 7.1 0.7 0.4 0.3 6.8 2.6 4.5 1.7 0.9 16.6 24.8 0.1 0.2 1.7 0.4 24.6 20.0 11.5 0.5 2.7 0.3 0.8 0.7 18.7 0.6 1.1 4.3 0.7 0.1 0.0 0.6 0.4 0.1 19.3 0.4 5.0 0.8 20.0 0.3 4.6 0.0 0.8 2.8 0.5 20.7 5.2 42.1 18.4 14.5 3.9 5.0 5.1 23.2 15.9 5.2 11.8 4.7 17.7 9.7 29.5 80.8 27.6 6.7 10.0 19.8 21.7 18.5 2.1 6.9 37.7 10.7 59.6 18.1 6.3 11.9 84.2 14.6 64.6 7.6 65.1 9.6 9.5 24.4 27.3 3.7 2.5 1.7 3.6 25.1 11.9 2.8 6.1 11.5 3.1 20.1 7.6 1.5 10.1 2.9 35.4 3.9 4.4 38.1 95.2 6.7 18.8 10.2 18.3 20.5 10.3 9.7 11.4 9.7 138.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 18.6 15.8 18.5 16.7 16.6 24.8 24.6 20.0 11.5 18.7 19.3 20.0 20.7 0.5 0.0 8.4 368.6 2.5 4.6 7.5 8.8 1.8 7.3 2.2 1.3 5.4 1.5 8.1 0.0 2.1 3.6 28.5 7.9 0.0 4.4 3.2 3.2 2.3 27.8 27.0 0.8 12.5 25.1 0.7 5.7 65.2 18.3 4.5 1.0 2.9 0.4 0.6 1.7 7.3 19.8 22.4 0.3 63.5 0.8 2.5 18.3 5.4 148.9 51.7 47.9 0.0 12.1 8.6 30.4 1.5 2.2 4.1 58.5 0.4 0.1 7.3 2.0 0.0 2.1 4.0 1.1 0.7 1.9 3.1 1.1 0.9 7.0 4.2 37.6 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015781-139045939 "Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 5.9 2.0 1.9 3.2 2.6 36.7 4.6 1.7 7.3 1.4 0.5 1.8 1.2 1.6 0.5 1.9 1.0 5.5 2.7 4.1 4.5 3.5 14.1 2.9 2.1 1.6 2.1 2.9 0.6 3.0 1.7 2.2 5.6 2.1 1.0 1.6 3.5 1.6 0.5 6.5 2.1 2.2 3.0 1.5 1.8 1.7 2.2 4.0 1.9 1.5 6.2 2.6 5.0 1.3 2.9 6.5 7.1 2.9 5.7 6.6 2.7 17.2 9.4 6.9 13.7 10.0 10.3 2.8 22.7 7.4 7.3 18.4 4.5 15.8 8.9 13.7 9.5 6.1 10.3 4.4 8.7 6.2 15.3 6.0 3.2 4.4 15.4 10.4 2.7 6.3 4.3 18.6 7.0 6.6 8.0 10.0 7.8 10.1 3.0 8.1 8.5 8.6 7.7 9.4 4.3 11.3 7.3 6.0 6.8 5.6 11.2 5.0 11.2 8.7 7.7 9.4 7.2 11.8 5.9 5.5 14.0 7.0 29.8 9.9 0.8 0.5 0.3 1.0 0.6 0.5 0.4 0.4 0.5 0.2 0.7 0.3 0.6 2.7 0.6 1.6 0.6 0.3 0.1 1.9 2.6 1.7 7.3 4.1 4.5 1.6 2.1 2.9 2.1 1.5 4.0 2.9 10.9 9.6 1.1 0.0 2.8 0.0 2.7 0.0 5.7 5.6 2.7 2.5 0.0 1.5 0.6 0.0 14.6 6.1 4.7 0.6 1.9 2.3 0.7 10.4 6.3 2.6 0.0 1.7 0.0 0.2 11.8 2.9 6.1 20.6 2.5 0.8 1.1 2.6 1.5 1.7 0.0 0.4 0.0 1.6 0.0 0.1 0.9 6.9 0.0 0.0 0.1 0.6 4.1 0.0 0.0 2.5 0.0 0.0 5.5 2.5 2.6 4.0 0.7 5.2 0.0 5.4 4.3 1.0 3.9 6.5 0.0 12.0 4.3 0.8 0.2 2.3 ENKUR "C10orf63, CFAP106, enkurin, MGC26778" ENSG00000151023 "Enkurin, TRPC channel interacting protein" Q8TC29 10 24981979-25062279 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.8;choroid plexus: 12.8;fallopian tube: 44.0" "Group enriched" "Detected in many" 4 "Early spermatids: 73.9;Endometrial ciliated cells: 143.5;Respiratory ciliated cells: 288.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.1;glioma: 4.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;CAPAN-2: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037593, HPA037594, HPA061503" Enhanced NA NA "HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543" "unprognostic (2.33e-3)" "unprognostic (4.86e-2)" "unprognostic (1.13e-2)" "unprognostic (6.52e-3)" "unprognostic (3.31e-2)" "unprognostic (2.91e-2)" "unprognostic (1.38e-2)" "unprognostic (7.35e-2)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (6.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-6)" "unprognostic (3.94e-1)" "unprognostic (3.35e-2)" "unprognostic (3.45e-3)" "unprognostic (8.43e-3)" 0.1 0.4 11.9 0.5 8.8 0.4 0.1 11.7 9.1 1.4 12.8 0.3 1.3 1.6 0.2 0.0 44.0 0.3 0.1 8.8 19.8 0.4 0.7 4.4 0.0 13.6 13.6 6.2 0.2 0.0 0.0 5.6 0.7 13.7 0.1 0.1 1.9 0.1 0.0 0.2 0.1 1.6 0.2 14.4 0.3 0.3 6.9 11.0 0.1 0.5 0.1 0.1 0.0 0.0 13.2 0.1 0.4 0.4 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.7 0.2 0.3 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.8 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.3 0.0 6.2 11.9 8.8 11.7 9.1 8.8 19.8 13.6 13.6 6.2 13.7 14.4 11.0 13.2 0.2 0.0 1.1 19.2 0.6 0.0 0.7 10.7 0.0 0.3 0.1 0.4 0.3 0.0 27.3 1.8 0.0 0.4 0.2 4.0 0.0 2.5 73.9 143.5 2.3 1.0 2.4 0.0 8.1 5.1 1.8 1.4 3.6 1.8 1.3 0.3 0.0 0.2 0.0 0.0 3.3 0.6 8.2 0.0 0.0 12.6 1.2 25.0 0.0 2.8 2.0 18.7 4.1 2.0 3.1 11.2 0.1 0.7 0.0 0.7 2.0 0.9 288.8 1.6 0.0 0.7 2.9 35.8 4.9 0.0 0.1 0.3 0.3 0.7 0.5 0.2 GPR158 KIAA1136 ENSG00000151025 "G protein-coupled receptor 158" Q5T848 10 25174802-25602229 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 367.4;Horizontal cells: 144.7;Inhibitory neurons: 301.9;Oligodendrocyte precursor cells: 419.7;Oligodendrocytes: 101.6" "Cancer enhanced" "Detected in many" "glioma: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 21.3;T-47d: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013185 Uncertain NA NA "HPA013185: AB_2113957" "unprognostic (4.43e-2)" "unprognostic (3.14e-2)" "unprognostic (7.42e-2)" "unprognostic (2.66e-5)" "unprognostic (5.67e-2)" "unprognostic (9.37e-2)" "unprognostic (4.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (8.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.60e-6)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (3.90e-1)" 0.0 0.7 1.7 0.1 9.2 0.0 0.0 22.6 7.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 3.3 0.0 0.0 0.0 0.0 7.5 6.8 1.6 0.0 0.0 0.2 1.4 0.3 9.3 0.1 0.1 4.5 0.0 0.2 0.0 0.0 0.2 0.0 1.4 0.0 0.1 0.5 7.3 0.0 0.1 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 21.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.5 1.1 1.9 0.0 5.6 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.2 22.6 7.8 3.5 3.3 7.5 6.8 1.6 9.3 1.4 7.3 14.2 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 19.9 0.0 0.1 0.1 0.0 0.0 367.4 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 144.7 301.9 0.0 0.0 0.0 0.0 12.0 0.0 0.1 0.0 10.3 0.0 26.2 0.0 419.7 101.6 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 3.8 0.0 0.1 0.1 1.8 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 LYZL2 ENSG00000151033 "Lysozyme like 2" Q7Z4W2 10 30611779-30629762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 717 "testis: 71.7" "Group enriched" "Detected in some" 43 "Early spermatids: 786.1;Late spermatids: 204.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-BR-3: 3.0" "Secreted in male reproductive system" NA NA "unprognostic (2.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 786.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 204.1 7.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNA2D4 ENSG00000151062 "Calcium voltage-gated channel auxiliary subunit alpha2delta 4" Q7Z3S7 12 1791963-1918666 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "retina: 20.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 56.3;Cone photoreceptor cells: 156.4;Early spermatids: 56.3;Late spermatids: 117.6;Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2" "Cell line enhanced" "Detected in some" "Hep G2: 4.7;HL-60: 2.8;HMC-1: 14.0;NB-4: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA031952 Uncertain NA NA "HPA031952: AB_10600798" "unprognostic (5.04e-2)" "unprognostic (2.82e-2)" "unprognostic (5.32e-1)" "unprognostic (7.50e-2)" "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.10e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-1)" "unprognostic (3.30e-3)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (1.62e-5)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.04e-1)" "unprognostic (2.13e-1)" 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 20.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.7 0.2 2.8 14.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 4.4 0.0 2.1 1.7 4.2 0.0 1.0 1.5 2.9 0.0 0.5 0.3 0.1 0.4 0.5 0.1 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.2 1.7 0.0 1.9 0.7 2.4 0.9 0.4 0.1 1.2 56.3 0.7 1.0 0.9 2.8 0.8 0.0 156.4 0.1 5.5 2.4 0.0 0.8 56.3 0.2 1.2 1.5 1.2 0.4 0.8 0.4 0.2 1.8 1.1 0.2 15.2 0.8 1.4 1.2 23.7 0.0 0.4 2.1 0.0 29.2 5.7 117.6 0.9 23.2 3.6 0.0 17.3 6.9 18.6 0.0 1.8 0.3 3.4 0.4 0.8 0.2 12.2 1.3 1.1 98.5 0.0 0.3 2.3 9.0 4.9 0.4 0.6 0.1 8.6 0.6 3.4 0.3 DCP1B FLJ31638 ENSG00000151065 "Decapping mRNA 1B" Q8IZD4 12 1946053-2004535 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 36.2;Early spermatids: 55.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 27.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039709 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA039709: AB_10672901" "unprognostic (9.60e-2)" "unprognostic (7.19e-3)" "unprognostic (4.37e-3)" "unprognostic (2.13e-1)" "unprognostic (7.00e-2)" "unprognostic (1.08e-1)" "unprognostic (8.94e-2)" "unprognostic (3.26e-1)" "unprognostic (3.13e-1)" "unprognostic (1.53e-2)" "unprognostic (5.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.46e-1)" "unprognostic (1.84e-2)" "unprognostic (7.42e-2)" 8.5 16.6 3.3 3.4 3.1 1.6 8.9 2.9 3.6 14.5 3.6 20.4 3.0 22.1 5.9 6.7 13.9 4.0 4.2 3.2 3.2 8.0 10.0 8.0 4.9 3.0 2.9 3.0 13.2 9.1 5.6 13.7 3.7 2.9 14.5 5.1 5.0 7.8 6.8 10.6 8.0 10.3 9.2 2.7 9.2 12.0 20.9 3.3 6.7 9.5 5.1 4.6 18.4 11.0 3.0 0.1 3.8 6.9 5.3 8.5 10.7 11.5 4.7 9.2 5.8 7.1 0.6 6.0 9.4 1.6 6.9 5.0 0.0 4.6 5.0 5.1 15.8 5.0 3.9 3.0 5.6 11.3 5.6 4.5 8.1 8.1 5.2 4.5 12.0 9.6 7.2 2.5 3.7 7.1 4.5 7.8 4.6 15.0 3.4 1.4 4.6 3.3 1.7 6.8 0.0 1.0 5.0 4.0 3.3 3.4 15.4 3.4 5.1 5.7 2.8 10.0 6.4 4.9 3.1 2.5 6.5 6.6 3.8 7.1 5.3 2.9 0.3 10.0 4.2 12.5 5.1 10.3 9.8 5.4 4.9 7.8 10.2 0.5 5.9 5.0 2.6 27.3 5.5 3.3 3.1 2.9 3.6 3.2 3.2 3.0 2.9 3.0 2.9 2.7 3.3 3.0 4.9 6.4 4.6 36.2 6.4 0.9 4.1 7.5 5.2 6.4 4.0 5.0 2.5 1.5 5.7 7.3 10.4 6.5 5.1 4.0 13.7 7.3 55.2 6.6 8.7 5.8 2.4 3.0 24.3 4.2 4.8 7.6 8.2 2.8 5.7 12.2 3.3 5.9 5.7 6.7 28.9 4.6 14.2 3.5 0.9 19.8 5.6 3.7 1.8 17.8 6.5 4.1 2.1 37.7 35.3 4.9 5.8 9.4 5.8 3.0 8.1 7.2 5.2 7.0 0.0 3.7 7.1 23.6 10.2 4.5 2.4 2.9 8.6 10.3 5.1 2.9 CACNA1C "CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS" ENSG00000151067 "Calcium voltage-gated channel subunit alpha1 C" Q13936 12 1970786-2697950 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Host-virus interaction, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 20.9;heart muscle: 25.3;intestine: 21.1" "Group enriched" "Detected in many" 4 "Excitatory neurons: 606.7;Horizontal cells: 301.2;Inhibitory neurons: 476.2;Oligodendrocyte precursor cells: 194.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "HDLM-2: 87.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039796, CAB079031" Enhanced Approved NA NA "CAB079031: , HPA039796: AB_10673019" "unprognostic (1.76e-1)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (9.35e-2)" "unprognostic (3.71e-2)" "unprognostic (1.60e-2)" "unprognostic (4.68e-2)" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-5)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-7)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (6.90e-2)" "unprognostic (3.39e-2)" 2.8 0.9 5.1 1.4 1.3 0.0 2.0 0.0 3.7 4.9 0.0 21.1 0.7 20.9 0.5 2.1 4.2 2.3 25.3 2.2 0.7 1.8 0.4 4.6 0.3 0.0 0.9 2.1 1.9 0.9 0.1 5.2 2.1 0.7 6.6 1.3 1.7 1.0 3.3 0.9 1.1 5.0 10.3 0.0 3.0 5.4 2.5 2.1 0.2 1.3 0.8 0.3 12.4 3.4 1.0 0.0 0.0 0.1 0.0 3.3 2.0 0.2 3.4 4.1 2.2 1.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.8 87.0 0.8 0.1 0.0 0.0 2.1 0.0 0.1 5.1 0.0 1.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 5.4 0.6 5.2 0.0 0.1 0.2 0.0 4.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.1 1.3 0.0 3.7 2.2 0.7 0.0 0.9 2.1 0.7 0.0 2.1 1.0 2.2 0.0 0.0 96.6 0.2 0.6 1.0 0.0 0.0 20.7 0.8 8.3 48.8 0.0 0.0 0.0 2.1 0.2 1.3 0.6 0.0 0.1 35.6 5.1 14.6 5.2 36.6 0.8 606.7 0.0 0.4 4.2 2.0 0.9 0.0 2.7 2.2 0.1 0.3 301.2 476.2 0.6 0.0 0.0 1.1 90.3 0.9 0.2 0.0 72.1 0.0 6.0 1.0 194.5 21.7 0.4 1.2 4.1 0.2 1.2 0.0 0.1 0.0 1.3 13.1 1.6 26.7 3.4 5.8 0.1 0.1 0.1 1.1 0.2 0.5 3.1 KCNA6 "HBK2, Kv1.6, PPP1R96" ENSG00000151079 "Potassium voltage-gated channel subfamily A member 6" P17658 12 4809176-4813412 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 9.2" "Group enriched" "Detected in some" 8 "Astrocytes: 14.0;Excitatory neurons: 27.8;Inhibitory neurons: 53.3;Oligodendrocyte precursor cells: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.7;JURKAT: 2.4;NTERA-2: 4.9;SuSa: 8.3;U-2 OS: 3.9;U-698: 1.6" "Low region specificity" "Detected in many" NA NA 0.4 1.3 5.9 0.4 3.3 0.0 0.6 1.0 2.9 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.2 0.1 0.9 2.5 9.2 0.0 0.0 0.1 0.7 2.5 6.0 2.0 0.0 0.5 0.0 0.0 0.0 3.1 0.0 0.3 0.7 0.1 0.0 0.0 0.4 0.4 0.6 1.9 0.4 0.2 0.3 3.3 0.1 0.0 0.7 0.5 0.0 0.0 6.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.0 0.0 0.0 0.2 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.9 3.3 1.0 2.9 2.5 9.2 2.5 6.0 2.0 3.1 1.9 3.3 6.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THRB "ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2" ENSG00000151090 "Thyroid hormone receptor beta" P10828 3 24117153-24495756 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Deafness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basophil: 7.2;naive B-cell: 2.2" "Group enriched" "Detected in many" 15 "B-cells: 2.2;granulocytes: 7.2" "Cell line enhanced" "Detected in many" "K-562: 45.6;RT4: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002008, CAB002009, HPA061035" Approved Supported "Nuclear bodies" NA NA "Nuclear bodies" "CAB002008: , CAB002009: , HPA061035: AB_2684422" "unprognostic (1.82e-1)" "unprognostic (4.22e-1)" "unprognostic (2.83e-1)" "unprognostic (2.20e-6)" "unprognostic (3.37e-1)" "unprognostic (2.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-3)" "unprognostic (2.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.01e-2)" "prognostic favorable (9.46e-8)" "unprognostic (1.32e-3)" "unprognostic (6.75e-2)" "unprognostic (2.73e-2)" "unprognostic (3.34e-2)" 11.2 5.0 4.8 1.8 17.3 1.0 10.1 0.0 17.6 2.7 0.0 9.5 2.5 7.1 1.8 6.4 3.8 2.3 7.8 16.7 5.7 12.2 20.3 5.0 1.5 2.8 1.3 12.4 2.4 9.1 7.3 15.8 4.4 4.5 7.5 8.5 20.3 6.3 7.8 23.8 6.9 3.9 7.1 0.0 5.8 8.4 0.7 2.0 3.6 4.5 27.2 1.4 8.9 4.2 7.4 10.3 3.1 0.6 0.1 17.4 8.8 6.7 0.5 2.1 1.5 3.2 6.7 9.7 0.1 2.5 6.8 1.1 15.4 10.8 3.9 1.0 0.0 6.4 0.0 2.5 8.9 0.5 0.0 0.0 16.0 7.3 0.2 1.2 3.5 0.0 0.0 45.6 0.0 1.5 0.6 0.0 0.0 6.5 0.6 3.4 0.0 0.0 0.0 10.0 32.7 1.7 0.6 16.5 8.9 0.2 4.6 9.7 0.0 0.9 3.9 3.0 0.0 1.9 0.1 0.5 0.0 2.7 0.1 0.3 7.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 4.8 17.3 0.0 17.6 16.7 5.7 2.8 1.3 12.4 4.5 0.0 2.0 7.4 3.0 3.2 11.4 199.2 3.3 9.9 29.5 13.2 1.8 17.9 24.5 18.7 11.6 8.6 14.1 23.9 164.7 12.4 0.0 39.9 1.9 2.4 2.3 3.4 0.5 6.0 25.2 3.8 688.0 12.5 23.2 13.7 16.3 5.7 0.0 0.3 7.5 37.7 1.7 0.0 631.3 8.1 10.2 11.3 11.7 2.4 0.6 4.6 1.8 97.4 0.2 11.7 0.0 329.2 32.4 10.3 17.5 2.2 0.1 40.1 4.8 8.1 10.3 21.8 6.6 12.0 7.5 0.3 0.7 5.1 23.9 5.5 1.0 0.4 9.8 81.3 NGLY1 "FLJ11005, PNG-1, PNG1" ENSG00000151092 "N-glycanase 1" Q96IV0 3 25718944-25790039 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 594.1;Late spermatids: 963.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036825 Approved "Intracellular and membrane" NA NA "HPA036825: AB_10672231" "unprognostic (3.65e-2)" "unprognostic (8.65e-2)" "prognostic favorable (1.17e-5)" "unprognostic (2.96e-2)" "unprognostic (1.72e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (1.96e-6)" "unprognostic (2.20e-1)" "unprognostic (2.34e-1)" "unprognostic (3.73e-3)" "unprognostic (2.55e-1)" "unprognostic (4.23e-2)" "unprognostic (4.92e-3)" "unprognostic (1.07e-2)" "unprognostic (2.47e-1)" "unprognostic (9.08e-2)" "unprognostic (1.89e-2)" 10.5 13.8 6.7 15.3 6.7 25.8 15.8 9.7 9.3 12.4 9.6 18.0 14.8 9.8 16.3 12.4 11.6 9.9 16.2 7.2 6.8 17.9 22.6 11.5 26.1 7.7 7.5 7.0 11.9 16.1 11.7 6.0 12.0 7.8 14.3 20.8 13.7 15.1 10.0 49.9 9.9 15.5 12.2 6.3 15.6 15.5 56.3 8.4 27.7 13.7 38.5 25.5 16.3 10.0 8.4 27.6 24.2 12.8 27.4 23.5 22.7 15.0 21.6 20.4 29.7 25.5 14.8 20.9 64.3 24.5 19.9 28.3 12.1 45.5 14.0 39.2 27.8 18.5 49.9 15.1 24.8 29.0 48.3 25.7 20.3 17.5 33.6 31.5 32.2 31.3 32.8 47.9 49.1 30.3 11.7 60.7 26.8 17.4 33.2 43.5 54.2 16.5 54.6 27.1 31.1 8.3 9.5 35.1 33.3 23.3 24.0 31.1 40.6 15.7 15.5 20.1 27.5 29.9 60.4 60.7 48.8 25.1 52.8 18.1 48.8 19.7 27.8 22.9 19.4 26.0 42.2 23.2 23.5 31.6 33.4 21.8 23.6 18.3 45.0 16.0 65.1 19.0 20.7 6.7 6.7 9.7 9.3 7.2 6.8 7.7 7.5 7.0 7.8 6.3 8.4 8.4 24.3 19.2 17.3 34.0 84.1 12.6 23.7 25.0 16.5 22.3 19.8 16.8 30.3 27.1 21.4 5.5 12.5 40.5 74.7 25.0 35.2 30.6 594.1 20.0 19.4 20.9 7.2 26.9 51.7 44.2 31.7 19.2 17.3 19.2 20.8 77.7 17.5 25.1 23.4 11.8 64.2 29.3 14.2 22.2 63.6 963.6 14.9 33.6 24.9 31.9 30.0 20.7 45.3 54.3 59.4 27.2 27.3 15.8 87.1 27.8 26.0 38.2 25.2 22.7 0.0 26.0 17.9 105.7 52.7 18.8 13.8 56.6 41.1 26.3 30.3 20.6 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 59.5;Spermatocytes: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 11.1 3.6 5.6 3.9 4.1 9.3 4.0 4.7 4.9 5.4 11.2 9.5 4.6 14.0 8.6 6.9 3.9 13.1 3.8 4.0 13.8 22.2 4.9 7.9 3.7 3.8 3.7 5.0 10.6 10.1 5.8 6.0 4.0 6.0 12.4 10.3 10.2 6.0 14.8 7.8 7.8 5.3 3.9 8.0 8.3 11.8 3.8 7.1 8.6 15.8 8.9 5.6 5.3 3.9 11.0 18.1 3.8 10.5 10.7 11.6 10.9 8.6 12.4 15.8 11.2 13.8 12.9 20.4 11.5 8.0 9.2 11.3 15.7 16.6 14.9 12.3 16.0 22.5 15.2 16.9 13.1 18.4 13.7 11.0 20.4 12.7 13.3 10.3 13.8 18.9 23.5 16.0 13.7 16.6 13.6 14.4 0.7 8.8 20.6 17.8 9.9 33.7 23.3 6.8 5.4 9.7 13.8 23.6 18.3 6.0 25.5 16.9 8.5 10.0 11.9 13.1 12.7 15.1 18.8 6.6 13.9 16.0 10.4 2.1 5.1 3.7 8.6 6.0 10.1 7.9 8.8 10.8 8.4 8.9 10.2 10.7 0.8 11.4 6.8 8.8 6.0 6.3 3.6 3.9 4.0 4.7 3.8 4.0 3.7 3.8 3.7 4.0 3.9 3.8 3.9 5.9 0.0 9.4 3.9 9.3 3.1 5.9 23.0 4.0 6.5 8.7 13.2 13.3 10.0 12.0 11.0 4.2 19.5 7.1 5.4 11.7 13.5 59.5 7.8 7.2 4.9 2.4 2.1 4.5 6.8 16.9 5.9 4.6 6.4 10.1 13.0 7.5 17.4 8.5 5.0 5.1 9.8 14.2 3.8 3.2 15.1 7.2 6.8 5.4 1.0 5.2 9.1 6.2 3.5 3.8 7.5 8.9 4.1 7.8 6.5 10.6 18.4 9.2 7.4 0.0 5.3 5.8 48.0 12.6 7.2 4.4 14.1 5.9 19.2 8.8 3.6 UEVLD "Attp, UEV3" ENSG00000151116 "UEV and lactate/malate dehyrogenase domains" Q8IX04 11 18529609-18588747 "Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047134 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047134: AB_10960698" "unprognostic (1.05e-1)" "unprognostic (6.76e-2)" "prognostic favorable (7.07e-4)" "unprognostic (5.94e-3)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.38e-3)" "unprognostic (9.08e-3)" "unprognostic (9.81e-2)" "unprognostic (2.87e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (1.61e-3)" "unprognostic (2.65e-1)" "unprognostic (3.22e-1)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 10.2 8.5 5.6 8.9 8.0 4.5 11.9 7.2 6.7 11.6 6.8 13.6 11.2 8.9 8.7 10.8 8.9 9.5 9.3 5.9 8.4 12.4 9.0 9.1 7.1 8.4 7.5 5.3 8.1 7.3 10.0 4.2 9.5 8.3 10.5 14.2 9.8 7.5 9.6 11.1 15.0 10.1 11.1 7.2 7.0 9.8 5.4 7.0 7.7 11.0 10.6 8.7 10.3 7.0 11.5 16.2 19.6 8.9 8.6 28.2 25.1 8.3 17.5 24.3 22.7 21.6 8.1 4.6 5.0 9.4 20.7 19.8 24.8 8.2 18.1 25.8 14.6 10.7 7.5 8.8 9.1 12.7 11.5 10.4 17.4 18.3 11.2 15.5 15.9 21.2 0.4 5.7 4.7 29.3 12.3 0.3 3.7 2.4 24.9 19.8 1.8 20.7 6.2 26.9 25.4 3.7 7.9 19.1 23.8 15.1 11.0 19.1 6.8 16.2 20.7 11.1 34.0 17.2 0.9 11.3 1.1 17.7 8.7 21.3 4.6 4.9 3.1 4.2 5.1 4.0 2.6 3.1 3.5 3.4 2.7 1.8 2.6 6.5 5.2 4.2 4.2 2.3 2.4 5.6 8.0 7.2 6.7 5.9 8.4 8.4 7.5 5.3 8.3 7.2 7.0 11.5 10.3 16.0 19.3 18.9 4.5 6.2 6.3 9.9 8.6 9.3 11.2 6.3 10.1 5.7 12.4 23.9 10.4 8.4 9.4 27.3 3.9 10.8 3.3 13.6 12.4 11.6 9.1 4.8 14.7 13.3 7.4 8.7 10.7 12.9 6.3 11.6 13.6 13.5 12.5 15.2 14.4 15.4 18.3 18.6 10.3 2.0 8.1 11.0 7.2 20.6 11.9 13.3 11.3 25.1 34.3 14.5 10.3 18.4 3.4 8.3 12.8 12.8 23.9 11.1 13.1 10.2 8.7 7.1 7.2 10.1 9.2 7.7 6.6 11.7 15.7 7.6 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 15.4" "Cell type enhanced" "Detected in many" "Hofbauer cells: 40.6;Theca cells: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA057119: AB_2683342" "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 2.8 2.8 2.3 2.3 2.1 0.3 3.2 2.1 3.7 2.3 3.3 1.5 1.4 2.2 1.0 2.4 2.6 4.1 2.8 2.0 4.0 9.5 2.6 3.6 4.7 2.8 2.4 1.9 7.2 3.4 5.5 2.2 4.4 3.7 1.6 1.8 5.8 2.8 1.4 2.9 15.4 2.0 2.0 2.6 4.9 2.1 2.3 2.8 1.6 2.1 2.5 2.5 2.3 3.6 3.7 0.0 0.2 0.6 3.1 2.7 0.0 0.1 0.6 0.5 0.5 0.5 0.0 0.4 0.0 1.2 0.6 3.0 0.3 0.2 0.1 0.3 0.2 1.9 0.2 0.1 0.0 2.1 0.0 2.8 3.8 1.2 0.1 0.2 0.7 1.7 1.8 0.6 0.0 1.3 1.7 0.0 0.0 0.2 0.5 1.6 0.0 5.1 0.0 17.5 3.8 1.0 1.3 1.0 3.2 1.4 1.1 3.9 0.4 1.9 0.5 0.2 0.1 0.1 3.2 2.7 0.0 1.1 0.0 1.1 0.0 1.9 0.1 0.2 1.4 0.5 0.0 0.2 0.4 3.4 0.1 0.4 0.8 0.0 0.1 0.5 2.0 0.5 0.8 2.3 2.1 2.1 3.7 2.0 4.0 2.8 2.4 1.9 3.7 2.6 2.8 3.7 1.9 0.0 0.0 0.3 0.0 0.1 0.8 0.4 0.0 5.2 3.5 1.8 2.2 0.0 0.7 11.0 8.4 0.5 1.4 0.6 7.9 7.8 12.2 1.1 1.9 2.1 3.5 0.0 0.5 8.0 0.3 1.7 1.1 1.0 0.0 3.0 3.9 1.6 40.6 0.0 0.8 0.8 0.0 12.7 0.8 12.1 2.1 8.3 0.0 3.7 2.3 2.6 0.0 2.0 0.1 7.4 0.1 1.9 0.4 0.6 0.0 8.3 0.4 4.8 6.6 0.4 1.2 7.8 2.6 0.2 0.3 2.3 0.7 17.4 0.2 0.4 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986316-105074197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 462.1" "Lineage enriched" "Detected in all" 13 "dendritic cells: 462.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 10.8 8.6 10.9 10.6 12.8 12.3 10.6 16.5 21.2 11.9 6.6 9.8 10.2 8.3 6.0 10.4 7.4 4.3 9.1 11.4 9.6 7.6 14.7 7.3 11.2 8.6 8.4 10.9 9.0 24.9 2.4 7.9 4.4 10.2 9.8 7.6 4.5 14.9 4.3 7.5 9.2 7.8 6.4 5.0 11.5 15.2 6.4 9.3 9.3 11.1 2.1 11.1 9.6 10.4 15.1 23.3 32.4 15.3 39.2 12.7 13.0 70.9 20.6 5.2 12.2 6.8 32.8 11.4 44.2 20.1 9.3 30.5 15.2 12.9 31.1 13.5 12.6 22.9 29.5 14.9 45.4 18.4 44.4 22.1 19.1 12.9 18.5 19.7 20.4 20.0 36.4 24.7 11.1 12.0 38.5 29.2 75.3 29.9 34.6 46.2 39.0 18.6 99.9 16.9 29.9 19.5 14.2 20.0 41.9 32.7 27.8 34.8 17.8 9.9 30.2 20.1 26.3 31.6 23.2 28.5 47.5 14.1 30.7 29.2 8.3 34.0 0.6 13.6 30.7 17.1 34.6 18.1 17.3 106.0 25.4 18.6 17.9 3.3 27.8 17.2 462.1 32.9 21.0 10.9 12.8 16.5 21.2 11.4 9.6 8.6 8.4 10.9 10.2 5.0 9.3 15.1 15.7 6.4 33.4 1.3 30.4 39.0 44.2 52.8 23.3 11.5 23.4 31.8 37.9 20.0 39.9 33.1 25.0 34.7 66.9 15.8 27.4 27.2 20.8 33.8 25.0 18.0 12.5 12.4 3.8 55.3 63.7 23.0 15.8 40.7 20.3 17.5 11.0 48.2 37.7 3.3 4.2 20.5 30.5 24.2 69.6 10.6 15.2 37.8 39.2 1.0 42.0 18.9 9.2 2.5 4.0 39.0 14.5 10.1 65.8 39.2 12.8 43.7 25.9 11.9 0.0 22.3 24.9 15.9 31.3 19.2 32.7 22.0 23.4 18.1 28.4 39.3 TMEM263 "C12orf23, MGC17943" ENSG00000151135 "Transmembrane protein 263" Q8WUH6 12 106955719-106978778 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014453, HPA042339" Uncertain Approved Vesicles NA NA 14000 Vesicles "HPA014453: , HPA042339: AB_10795503" "unprognostic (2.56e-2)" "unprognostic (1.41e-1)" "unprognostic (8.99e-2)" "unprognostic (5.65e-2)" "unprognostic (3.90e-1)" "unprognostic (3.46e-2)" "prognostic unfavorable (7.84e-4)" "unprognostic (4.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.11e-2)" "unprognostic (7.07e-2)" "unprognostic (1.19e-1)" "unprognostic (3.05e-3)" "unprognostic (3.49e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.53e-1)" 20.8 27.4 15.8 20.5 16.9 7.4 22.5 15.5 18.3 42.0 21.3 17.6 17.5 28.6 33.7 9.6 16.3 30.7 28.9 16.0 20.5 29.7 45.0 15.4 21.3 14.5 15.4 15.6 29.6 23.6 20.9 37.8 43.6 15.7 28.7 19.4 16.9 21.2 21.8 11.6 8.6 15.4 30.2 14.5 16.6 31.2 19.5 20.7 31.2 33.9 14.3 19.9 22.4 14.0 14.8 32.7 28.2 54.1 37.4 125.8 141.6 23.5 123.1 114.0 59.0 74.6 30.1 14.0 3.2 37.5 174.3 33.3 14.9 34.4 48.6 80.9 61.5 38.0 45.5 41.0 65.0 65.1 2.4 28.3 98.6 23.1 63.9 53.8 137.3 73.4 35.1 22.1 12.1 83.6 26.7 35.4 21.4 17.7 21.1 60.3 77.1 41.3 7.9 60.7 27.3 28.2 38.6 67.3 31.2 51.2 41.9 36.5 13.7 86.7 50.6 30.7 66.9 31.6 50.8 31.5 30.3 39.2 7.7 79.4 11.7 1.4 1.6 15.8 1.6 18.3 15.7 15.2 13.7 4.3 16.8 26.8 24.9 1.0 19.8 0.6 14.8 17.4 13.9 15.8 16.9 15.5 18.3 16.0 20.5 14.5 15.4 15.6 15.7 14.5 20.7 14.8 31.6 9.6 23.6 12.1 33.5 0.0 52.0 0.0 53.5 24.4 47.7 25.8 55.4 22.8 11.2 23.9 31.3 40.4 54.3 12.4 92.0 19.2 34.8 19.9 75.7 26.4 28.8 10.9 15.4 33.0 72.6 61.5 50.0 32.4 29.9 33.7 33.2 44.4 13.5 11.8 16.5 65.1 0.0 6.7 0.0 37.2 47.2 10.4 0.0 22.5 9.6 34.1 22.6 24.1 8.4 17.3 13.2 43.6 68.3 48.6 23.0 47.7 12.4 21.0 26.3 39.1 41.7 51.2 22.5 12.7 0.0 36.0 36.3 30.6 16.4 44.2 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318421-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5;parathyroid gland: 101.1" "Cell type enriched" "Detected in many" 9 "Inhibitory neurons: 266.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055898: AB_2682964, HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.4 0.7 8.3 2.8 4.4 4.5 2.9 5.5 11.1 8.2 5.0 0.6 0.7 0.9 1.2 29.6 0.3 0.9 0.6 2.9 12.6 4.2 1.1 0.6 2.9 20.7 14.7 3.2 0.1 0.8 101.1 3.5 2.0 25.4 3.4 0.6 1.9 5.7 1.3 0.5 10.6 1.4 0.5 9.4 1.4 0.6 0.7 25.6 17.3 19.0 0.2 3.3 1.7 11.2 33.5 0.1 25.0 5.0 0.0 1.8 0.5 0.0 0.6 0.0 0.2 0.0 0.3 4.0 0.0 6.1 0.1 2.4 9.2 5.1 9.5 0.3 0.0 1.6 0.0 0.1 13.6 0.0 0.2 0.1 2.0 4.0 0.0 2.9 3.8 0.7 10.5 0.0 0.0 0.2 0.9 17.9 2.0 5.3 0.5 12.3 0.0 8.1 0.0 0.0 11.4 6.8 2.5 0.0 0.2 0.0 0.4 0.5 0.7 1.0 0.1 0.2 0.0 2.0 0.1 0.0 0.1 6.4 2.6 0.0 0.9 0.4 0.5 1.0 0.1 3.5 0.0 1.1 0.6 0.7 0.1 1.4 1.3 1.3 0.1 0.3 0.1 0.6 0.6 8.3 4.4 5.5 11.1 2.9 12.6 20.7 14.7 3.2 25.4 9.4 25.6 33.5 0.3 0.0 0.0 17.3 0.3 5.2 3.7 2.5 6.8 3.5 0.7 3.2 2.9 0.0 3.0 0.0 0.0 0.2 1.2 0.0 0.0 0.8 0.0 1.2 1.9 0.3 3.5 1.3 8.7 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.0 0.9 0.3 1.7 266.4 0.4 0.0 0.6 4.3 0.0 0.6 1.7 0.0 1.0 1.8 0.2 3.1 12.5 1.9 0.3 0.0 4.1 0.7 2.8 0.2 0.9 0.3 0.4 0.0 0.0 1.1 0.1 0.2 27.5 7.7 0.4 4.5 3.4 0.4 3.4 UBE3B ENSG00000151148 "Ubiquitin protein ligase E3B" Q7Z3V4 12 109477402-109536705 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041012 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA041012: AB_10964435" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.12e-2)" "unprognostic (7.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.19e-2)" "unprognostic (2.93e-1)" "unprognostic (4.46e-3)" "unprognostic (9.39e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.49e-5)" "unprognostic (3.35e-1)" "unprognostic (3.35e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" 13.7 16.7 14.6 10.8 16.2 9.3 13.8 13.4 16.3 14.1 16.1 17.5 13.0 14.2 13.5 18.7 16.4 12.2 26.4 14.6 12.9 16.9 16.1 13.7 12.7 14.9 15.2 15.2 15.9 14.5 22.8 13.7 13.3 15.9 15.5 18.2 15.1 14.6 14.2 34.4 19.3 16.0 14.8 13.0 15.9 16.7 13.0 15.2 12.7 18.3 30.0 13.6 17.2 14.6 20.6 17.1 26.4 20.4 14.8 33.9 27.1 17.9 22.1 25.1 26.2 17.4 28.0 17.1 10.6 16.0 36.3 22.5 21.5 20.9 28.3 25.1 23.4 14.7 20.3 17.6 25.5 21.7 16.7 16.2 31.0 25.8 25.4 30.2 39.5 28.7 24.8 22.7 9.7 30.2 26.6 11.5 24.2 21.0 19.1 31.6 18.8 19.2 20.9 22.4 30.2 19.1 34.9 25.8 34.6 17.3 23.7 35.3 17.6 26.5 32.3 9.2 16.8 16.0 21.8 19.4 18.6 32.1 13.7 27.4 22.9 12.9 12.8 12.6 14.5 12.4 13.6 12.1 9.0 12.4 10.0 10.0 13.3 16.1 13.1 12.0 11.4 16.2 10.7 14.6 16.2 13.4 16.3 14.6 12.9 14.9 15.2 15.2 15.9 13.0 15.2 20.6 11.9 12.8 15.1 34.0 9.7 5.1 11.8 13.9 6.8 19.3 14.4 12.8 35.4 11.5 17.1 16.5 33.3 17.9 12.8 21.0 11.7 17.7 15.7 12.6 12.5 14.2 9.0 13.0 24.5 15.3 11.5 11.1 18.8 12.2 9.5 20.0 11.7 18.8 12.5 21.9 23.6 15.9 18.3 19.2 6.1 32.0 12.5 14.2 10.6 13.1 17.7 13.6 32.0 21.1 38.3 25.3 13.7 9.8 15.6 17.2 19.6 19.9 18.4 25.0 6.6 9.4 13.0 10.4 13.2 13.4 7.2 23.7 10.7 17.7 16.8 18.4 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 50.3;SK-BR-3: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020" "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favorable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 6.3 6.8 47.7 6.5 84.7 2.2 21.7 146.3 92.9 12.1 0.0 26.3 39.7 23.2 126.3 17.1 19.3 21.7 81.9 68.2 87.4 96.3 16.7 24.8 6.1 86.3 66.1 54.3 11.7 11.3 132.8 14.6 15.7 112.9 20.2 21.1 124.3 43.0 40.8 81.2 40.2 27.4 13.3 20.5 10.9 15.6 8.1 86.5 9.2 42.0 95.0 7.5 10.9 14.2 116.8 8.7 4.9 30.3 0.4 0.0 1.8 23.3 0.6 0.4 0.1 0.6 22.2 16.6 0.5 9.8 0.6 0.9 12.1 16.4 14.9 0.5 0.5 11.0 0.2 9.7 0.1 6.2 0.1 0.4 14.6 9.3 7.8 0.4 26.1 3.6 0.0 4.3 20.6 6.9 29.0 0.2 1.0 13.8 23.3 26.6 0.1 21.7 4.3 5.4 50.3 15.6 2.8 0.6 49.4 0.0 33.6 28.7 0.1 10.0 0.9 2.9 13.3 1.5 0.9 0.2 0.2 5.5 0.2 18.9 1.6 0.2 0.5 2.7 0.2 2.4 4.1 4.6 1.5 0.1 1.1 5.0 1.2 0.7 1.5 0.3 2.5 0.8 1.0 47.7 84.7 146.3 92.9 68.2 87.4 86.3 66.1 54.3 112.9 20.5 86.5 116.8 0.9 44.8 174.3 20.2 14.5 19.1 21.9 17.8 38.7 490.2 26.8 20.6 189.3 12.8 42.5 53.3 225.2 38.8 3.4 62.9 19.6 10.6 28.3 139.8 26.2 3.9 30.6 0.0 859.2 8.6 9.9 13.2 15.8 153.3 12.6 66.9 7.9 0.5 4.7 43.7 881.3 12.1 14.2 4.8 1.4 11.5 28.0 3.3 8.8 23.4 4.4 41.4 0.0 592.6 1579.5 4.8 41.8 5.7 3.4 12.2 62.5 51.3 66.7 216.6 0.0 30.2 11.7 1.1 2.3 35.9 18.2 25.0 18.5 4.5 17.8 18.4 IPMK ENSG00000151151 "Inositol polyphosphate multikinase" Q8NFU5 10 58191517-58267894 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.0" "Group enriched" "Detected in many" 4 "granulocytes: 3.0;monocytes: 1.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037837, HPA057542" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037837: AB_10670166, HPA057542: AB_2683460" "unprognostic (4.52e-2)" "unprognostic (3.29e-2)" "unprognostic (4.22e-3)" "unprognostic (6.85e-2)" "unprognostic (2.41e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-3)" "unprognostic (2.10e-1)" "unprognostic (9.39e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.96e-7)" "unprognostic (1.79e-1)" "unprognostic (4.33e-1)" "unprognostic (1.27e-3)" "unprognostic (9.02e-3)" 4.9 3.2 3.5 5.9 3.6 2.5 4.7 4.6 4.6 4.4 2.8 7.1 8.0 2.3 3.4 5.2 3.0 7.0 1.7 3.4 3.7 4.2 18.2 3.3 4.7 4.1 4.0 2.9 1.8 3.8 12.2 1.9 8.8 3.7 3.4 6.0 4.8 2.8 1.8 2.7 5.1 10.5 1.9 3.8 6.5 3.5 2.3 3.8 4.5 4.1 3.2 4.5 5.2 2.5 3.7 16.3 4.1 5.9 5.8 5.7 6.6 5.1 4.2 9.0 3.5 7.1 8.3 10.1 13.0 8.3 5.0 3.4 4.9 5.0 5.6 11.2 5.9 3.8 3.2 3.9 7.9 3.4 5.1 7.1 7.3 4.9 6.0 12.0 4.0 7.7 3.7 2.1 6.5 6.3 4.1 7.0 9.8 3.8 6.6 3.8 0.5 12.8 6.0 6.6 4.1 4.1 7.1 5.5 14.4 4.3 9.6 12.0 6.1 6.7 3.8 7.4 8.1 5.4 13.8 8.7 10.1 7.2 5.3 1.5 1.7 0.7 1.6 0.1 0.7 0.1 0.3 0.1 0.1 0.4 0.2 0.4 0.1 3.0 0.2 1.0 0.2 0.0 0.1 3.5 3.6 4.6 4.6 3.4 3.7 4.1 4.0 2.9 3.7 3.8 3.8 3.7 8.9 6.4 4.2 16.6 16.9 54.0 10.0 8.4 26.2 10.0 11.6 8.3 2.8 4.3 13.3 1.8 6.2 10.5 8.1 29.3 3.9 4.2 3.0 24.3 9.7 9.9 8.4 3.0 21.8 4.9 22.5 15.7 8.2 22.8 7.0 2.5 8.2 13.2 10.0 13.5 27.8 10.6 10.2 22.8 40.7 1.4 2.8 29.1 26.6 24.4 16.6 5.4 2.1 30.7 23.6 6.2 21.7 1.9 8.5 9.6 28.6 9.1 29.1 5.8 6.6 10.2 8.5 10.0 5.1 20.1 58.1 9.4 10.1 4.1 11.1 17.5 RAD9B FLJ40346 ENSG00000151164 "RAD9 checkpoint clamp component B" Q6WBX8 12 110501655-110533556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 11.4" "Group enriched" "Detected in some" 21 "Spermatocytes: 91.5;Spermatogonia: 29.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "basophil: 4.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in some" "JURKAT: 2.7;SiHa: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040643 Approved NA NA "HPA040643: AB_10805716" "unprognostic (2.32e-1)" "unprognostic (2.55e-5)" "unprognostic (4.76e-2)" "unprognostic (1.30e-3)" "unprognostic (2.93e-1)" "unprognostic (6.27e-3)" "unprognostic (5.44e-2)" "unprognostic (2.00e-1)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (5.92e-2)" "unprognostic (2.26e-1)" "unprognostic (2.68e-3)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (2.15e-2)" "unprognostic (1.80e-2)" 0.2 0.1 0.3 0.2 0.4 0.3 0.4 0.4 0.4 0.3 0.2 0.2 0.0 0.4 0.4 0.3 0.3 0.1 0.7 0.3 0.4 0.1 0.3 0.3 0.5 0.4 0.4 0.3 0.7 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.5 0.4 0.3 0.2 11.4 0.4 0.4 0.2 0.5 0.3 0.3 0.2 0.7 1.6 0.1 0.1 0.4 0.1 0.3 0.1 0.7 0.2 0.7 0.6 1.6 0.1 1.2 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.4 1.5 0.2 0.0 0.2 1.9 0.3 0.2 0.2 0.6 0.5 0.2 0.1 2.7 0.3 0.9 0.9 0.2 0.4 0.5 0.1 0.5 0.5 0.1 0.4 0.3 0.3 0.2 0.3 0.1 2.9 0.3 0.4 0.0 0.6 1.0 0.2 0.3 0.0 0.3 0.2 0.6 0.3 0.7 0.3 1.0 1.0 4.7 0.5 0.2 0.2 0.4 0.2 0.4 0.3 0.1 0.9 0.3 0.2 0.1 0.5 0.2 0.9 0.5 0.1 0.3 0.3 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.7 0.2 0.0 0.0 1.6 0.7 0.5 0.4 0.5 0.0 0.3 0.3 0.3 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.9 0.3 2.8 0.2 0.1 0.4 0.0 0.4 0.7 0.0 0.1 0.7 0.0 0.3 0.0 0.9 0.4 0.3 1.3 0.0 0.7 0.0 0.0 1.2 0.3 2.0 1.5 0.5 0.0 1.9 1.9 0.6 1.0 0.5 2.8 0.4 0.0 0.0 0.5 0.2 0.0 0.1 2.4 0.8 0.0 0.5 0.2 91.5 29.0 0.0 0.4 0.1 0.3 0.1 0.1 0.2 PLBD2 p76 ENSG00000151176 "Phospholipase B domain containing 2" Q8NHP8 12 113358566-113391629 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 140.1" "Group enriched" "Detected in many" 5 "Early spermatids: 139.8;Late spermatids: 398.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 246.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017163 Approved "Intracellular and membrane" NA NA 820000 "HPA017163: AB_1853029" "unprognostic (8.28e-2)" "unprognostic (1.97e-1)" "unprognostic (1.50e-2)" "unprognostic (4.13e-1)" "unprognostic (2.36e-3)" "unprognostic (7.59e-3)" "unprognostic (5.92e-3)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.58e-11)" "unprognostic (7.55e-3)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" 27.0 140.1 26.4 16.9 21.0 9.1 16.5 29.7 29.1 20.7 5.9 12.6 8.1 19.8 26.2 12.7 14.0 20.4 26.8 22.8 28.3 11.9 23.5 21.1 10.9 43.7 32.8 22.4 49.0 26.3 17.6 27.4 12.9 43.5 18.1 13.0 13.1 18.0 16.1 24.0 19.3 11.5 27.4 26.4 13.6 13.3 51.1 40.9 5.8 18.1 14.4 10.9 20.7 15.5 49.6 20.1 36.2 15.4 58.6 246.3 136.9 20.9 41.6 82.0 28.8 35.7 30.9 11.8 9.3 34.0 113.1 46.9 21.3 14.9 24.6 32.0 19.0 10.9 16.4 21.5 37.3 76.9 19.8 49.3 115.8 32.0 34.6 20.5 87.4 45.4 8.3 49.9 22.1 44.9 34.1 3.7 21.2 17.1 16.2 16.6 15.8 16.2 25.0 33.8 27.7 15.5 15.3 57.3 44.6 25.5 26.5 29.4 18.8 73.5 67.9 26.3 68.9 24.4 11.8 21.9 11.4 112.3 16.5 40.6 0.0 3.5 0.2 1.2 2.1 1.0 0.4 1.4 1.5 3.5 0.4 1.0 1.4 0.3 0.9 1.5 1.3 0.9 2.0 26.4 21.0 29.7 29.1 22.8 28.3 43.7 32.8 22.4 43.5 26.4 40.9 49.6 6.5 9.6 6.4 11.8 5.3 5.4 4.6 2.1 5.7 9.8 5.4 4.3 10.0 5.7 1.4 1.8 6.2 4.6 6.4 3.6 0.0 20.5 139.8 2.6 13.5 7.0 5.3 13.9 12.4 13.8 11.1 29.5 6.6 5.8 10.2 13.3 8.2 16.1 32.5 20.2 14.2 2.9 0.0 25.8 8.4 398.5 40.4 27.0 21.4 3.7 39.4 3.1 4.1 9.0 11.8 11.5 3.4 48.2 5.9 6.4 6.4 5.0 2.2 5.2 6.6 10.7 11.3 11.1 8.1 6.2 1.8 4.4 5.3 33.6 4.0 3.7 DLG5 "KIAA0583, P-dlg" ENSG00000151208 "Discs large MAGUK scaffold protein 5" Q8TDM6 10 77790791-77926755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 112.5;Glandular and luminal cells: 139.6;Horizontal cells: 186.7;Syncytiotrophoblasts: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001746 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA001746: AB_2666418" "unprognostic (1.36e-1)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (6.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (5.38e-4)" "unprognostic (8.48e-2)" "unprognostic (6.41e-2)" "unprognostic (1.68e-2)" "unprognostic (2.02e-2)" "unprognostic (2.60e-1)" "unprognostic (8.00e-2)" "unprognostic (3.06e-1)" "unprognostic (5.13e-1)" "unprognostic (6.00e-2)" "unprognostic (2.74e-2)" 11.5 52.3 8.9 0.5 7.4 0.2 19.6 8.7 8.5 23.4 9.1 23.1 0.4 25.3 16.4 19.9 17.8 1.1 7.0 8.7 21.4 8.7 4.6 8.6 0.4 16.7 9.9 6.5 19.6 11.2 6.1 34.1 2.4 12.6 31.5 1.7 4.3 17.0 2.9 26.5 34.5 12.6 2.2 9.1 4.2 16.5 6.2 9.1 1.2 22.5 0.9 1.4 20.5 22.4 10.5 5.7 0.1 4.5 4.9 6.8 2.9 2.9 6.3 3.7 1.1 1.1 0.0 3.8 0.0 6.0 3.2 1.9 6.0 2.3 3.4 4.2 2.0 7.5 1.1 0.0 7.0 6.5 0.4 1.5 3.3 8.1 0.2 9.8 8.2 0.4 0.1 3.0 0.0 3.4 2.0 0.6 1.8 4.3 7.0 20.0 4.1 1.4 0.3 4.8 0.0 1.5 4.2 2.7 5.7 2.2 6.1 2.3 1.1 1.9 1.2 9.2 1.2 5.7 0.0 0.7 0.5 1.2 1.2 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 7.4 8.7 8.5 8.7 21.4 16.7 9.9 6.5 12.6 9.1 9.1 10.5 5.2 6.4 5.4 21.2 0.5 29.6 24.2 20.2 12.0 18.3 41.9 28.3 2.8 12.8 13.6 20.2 16.7 112.5 12.1 12.2 0.0 6.7 16.4 55.6 41.7 4.9 2.4 0.0 24.0 5.9 23.6 12.5 8.2 139.6 1.3 49.4 3.3 3.3 13.1 186.7 28.3 10.4 8.2 0.0 3.9 10.2 18.6 1.8 8.8 10.3 0.8 46.4 9.2 19.1 13.6 12.4 7.6 18.4 6.8 25.4 15.2 2.1 34.6 15.3 26.3 24.2 15.1 1.6 7.6 10.8 24.2 171.6 5.5 10.4 10.1 23.5 MAT1A "MAT, MATA1, SAMS, SAMS1" ENSG00000151224 "Methionine adenosyltransferase 1A" Q00266 10 80271820-80289658 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "liver: 1357.4" "Cell type enriched" "Detected in some" 55 "Hepatocytes: 5534.4" "Cancer enriched" "Detected in many" 54 "liver cancer: 209.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 94.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048627 Supported NA NA 1900000 "HPA048627: AB_2680465" "unprognostic (6.92e-2)" "unprognostic (2.63e-1)" "unprognostic (2.88e-2)" "unprognostic (9.43e-2)" "unprognostic (3.79e-2)" "unprognostic (2.49e-2)" "unprognostic (2.03e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-16)" "unprognostic (8.59e-3)" "unprognostic (9.90e-2)" "unprognostic (3.58e-1)" "unprognostic (5.98e-2)" 0.5 0.5 0.6 0.1 0.6 0.0 0.4 0.2 0.4 0.1 0.8 0.2 0.2 0.1 58.0 0.1 1.2 0.0 0.2 0.1 0.6 0.9 1357.4 0.4 0.1 0.4 0.7 0.1 6.4 44.1 0.1 0.9 0.1 0.5 0.0 0.0 0.0 0.3 2.0 0.0 3.8 0.0 0.2 0.9 0.6 0.2 3.7 0.4 0.4 0.4 0.0 0.0 0.5 0.1 0.2 6.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.0 3.2 0.1 0.0 0.0 0.0 0.3 0.5 1.6 0.0 94.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 1.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.2 0.4 0.1 0.6 0.4 0.7 0.1 0.5 0.9 0.4 0.2 0.0 0.0 0.5 0.0 8.8 2.0 0.1 0.4 0.0 0.0 0.2 0.6 0.7 67.2 0.9 1.8 0.0 0.0 0.0 0.0 1.9 0.1 23.9 3.0 0.0 5.3 0.0 69.5 0.1 4.6 0.0 0.0 0.0 0.2 0.0 7.6 76.8 5534.4 0.1 0.0 0.0 0.0 0.0 100.4 0.6 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.0 0.1 0.0 0.6 10.2 0.0 0.0 0.0 0.2 2.7 0.3 0.0 2.7 0.0 6.0 1.0 0.0 0.0 SLC2A13 HMIT ENSG00000151229 "Solute carrier family 2 member 13" Q96QE2 12 39755025-40106089 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.8" "Group enriched" "Detected in many" 4 "Excitatory neurons: 506.5;Inhibitory neurons: 465.0;Oligodendrocyte precursor cells: 351.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006584, HPA061679" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA006584: AB_1849755, HPA061679: " "unprognostic (1.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-1)" "unprognostic (3.31e-1)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-2)" "unprognostic (2.12e-3)" "unprognostic (4.07e-2)" "unprognostic (6.34e-2)" "unprognostic (1.24e-2)" "unprognostic (9.16e-2)" 3.8 7.3 5.4 3.5 11.2 0.9 2.6 0.0 14.0 12.5 13.9 7.9 6.3 5.9 5.1 3.5 2.6 3.9 5.1 9.6 11.7 10.8 6.4 3.7 1.6 1.1 13.0 14.3 2.1 5.1 22.8 4.0 4.7 4.1 2.7 7.1 3.2 4.7 2.3 0.6 1.4 8.5 4.3 0.0 2.2 5.7 1.8 12.6 1.7 1.6 1.4 1.1 3.7 2.9 6.7 0.6 3.6 2.6 1.2 18.0 7.4 5.1 5.7 4.2 2.6 3.3 0.0 1.7 2.2 4.1 4.7 3.5 0.3 1.8 1.8 2.1 1.9 5.1 1.8 9.1 1.3 2.8 5.1 2.8 3.7 1.7 1.2 2.2 1.5 1.2 2.2 0.7 5.7 6.0 0.7 0.7 4.3 2.8 0.0 2.3 0.0 3.9 1.3 4.7 2.3 3.3 3.3 2.3 4.5 1.5 3.9 2.5 4.5 1.0 3.4 1.2 12.4 3.4 4.1 0.1 1.4 6.2 2.9 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 5.4 11.2 0.0 14.0 9.6 11.7 1.1 13.0 14.3 4.1 0.0 12.6 6.7 6.5 9.6 14.7 31.3 5.4 4.1 1.6 1.2 2.2 5.3 3.7 2.0 4.4 12.8 2.2 9.2 0.0 6.3 3.9 58.3 0.0 5.6 3.8 2.2 7.7 4.6 20.4 5.7 506.5 12.6 2.9 14.3 23.0 1.3 10.2 3.7 11.0 9.1 8.6 92.5 465.0 33.1 4.1 10.8 4.1 3.3 23.0 10.3 16.0 109.6 7.1 2.5 8.2 351.8 14.4 10.5 40.2 7.5 6.4 2.4 28.2 8.3 7.0 1.3 6.6 5.2 6.6 3.3 2.3 3.4 5.3 3.7 6.0 21.0 16.7 2.1 GXYLT1 "FLJ43151, GLT8D3" ENSG00000151233 "Glucoside xylosyltransferase 1" Q4G148 12 42081845-42144874 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 3200000 "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (1.22e-1)" "unprognostic (9.89e-2)" "unprognostic (5.22e-3)" "unprognostic (1.77e-2)" "unprognostic (4.42e-3)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-2)" "unprognostic (8.16e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-2)" "prognostic favorable (3.91e-4)" 5.9 4.9 4.1 6.0 4.0 7.6 4.9 4.8 3.6 4.0 4.2 4.1 4.1 3.9 3.7 3.3 4.5 4.1 3.0 3.5 5.5 6.4 12.3 5.5 5.3 5.1 4.6 3.0 5.5 4.2 6.0 3.6 11.2 4.7 4.2 4.9 6.1 3.6 3.3 2.4 4.2 5.7 3.8 5.0 6.7 4.7 9.6 4.7 6.9 9.0 3.9 4.7 4.7 3.5 5.1 12.9 10.8 12.2 11.9 8.5 22.1 45.6 28.4 19.0 20.7 20.9 25.1 25.9 11.2 21.7 15.8 14.9 6.0 20.6 9.2 38.1 18.7 23.2 18.4 9.1 20.5 13.4 20.1 16.9 17.1 7.8 31.6 13.9 12.3 27.7 12.6 11.8 19.3 26.7 8.9 13.0 12.2 14.8 4.9 10.2 6.1 24.6 10.0 12.5 19.1 6.2 10.5 20.2 11.4 16.8 22.6 23.4 15.6 23.9 14.7 49.8 8.7 18.1 25.2 30.4 14.1 19.9 53.8 9.2 0.1 0.6 1.8 0.4 1.2 0.2 0.4 0.6 0.5 1.0 0.4 0.5 0.5 0.4 0.9 1.5 0.2 0.7 0.3 4.1 4.0 4.8 3.6 3.5 5.5 5.1 4.6 3.0 4.7 5.0 4.7 5.1 22.1 16.0 15.0 10.1 21.5 3.2 14.3 7.9 8.6 9.0 13.3 8.6 7.4 7.2 8.8 35.0 8.4 42.7 34.2 10.5 1.9 9.5 1.6 7.2 11.9 16.4 3.0 8.0 14.3 10.4 39.8 15.7 6.6 10.7 19.1 57.6 24.3 27.8 13.8 15.2 16.1 9.5 6.1 16.2 7.4 3.4 11.8 13.2 5.4 25.3 20.5 10.3 15.5 16.6 17.8 8.9 12.5 7.5 21.5 14.5 12.3 3.9 12.1 15.5 13.1 13.3 11.7 25.2 33.4 11.0 4.4 45.6 22.2 13.9 9.1 12.7 TWF1 "A6, PTK9" ENSG00000151239 "Twinfilin actin binding protein 1" Q12792 12 43793723-43806328 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018116 Approved Supported Cytosol NA NA 75000 Cytosol "HPA018116: AB_1855899" "unprognostic (3.06e-1)" "unprognostic (1.95e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.39e-3)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.19e-2)" "unprognostic (1.13e-2)" "unprognostic (7.30e-2)" "unprognostic (3.11e-3)" "unprognostic (2.51e-1)" "unprognostic (8.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (2.95e-1)" "unprognostic (2.62e-1)" 45.6 40.6 32.5 39.3 36.9 46.6 49.9 35.1 39.3 55.3 33.0 66.5 69.3 40.2 48.9 94.6 45.7 49.2 13.2 31.1 37.4 51.7 54.3 25.1 30.8 37.2 35.5 29.4 27.4 39.3 40.2 24.1 35.3 36.6 46.4 66.3 32.8 42.9 74.2 5.8 37.0 68.4 47.0 36.7 20.4 46.5 20.3 35.6 24.6 73.7 11.8 34.5 75.3 38.4 42.1 121.3 88.5 45.1 55.5 115.8 132.5 109.3 165.3 136.1 131.7 99.2 143.3 165.2 32.5 150.0 159.6 77.3 79.8 62.6 118.2 186.1 11.3 72.5 30.2 68.6 67.7 93.9 35.0 37.6 91.0 94.4 136.8 152.0 167.5 117.0 16.1 33.4 35.9 207.4 64.8 16.8 24.1 27.5 0.0 142.7 14.1 51.1 36.8 175.9 149.1 33.3 50.0 138.2 123.7 121.7 62.8 116.2 34.4 113.0 161.5 107.1 130.8 139.8 31.1 32.9 44.4 148.8 89.0 62.6 10.2 2.6 5.7 5.1 4.1 5.9 6.1 6.0 6.6 4.1 3.0 5.9 6.7 4.4 12.1 4.4 2.7 6.6 3.2 32.5 36.9 35.1 39.3 31.1 37.4 37.2 35.5 29.4 36.6 36.7 35.6 42.1 40.7 12.8 33.8 6.2 24.7 41.7 33.3 32.6 42.1 22.7 43.9 30.6 6.0 30.0 40.3 35.0 20.9 41.5 36.2 92.8 41.1 50.9 20.6 70.9 40.3 32.0 44.9 7.8 10.1 79.7 58.0 32.4 53.0 53.6 5.1 27.7 24.3 28.7 26.9 20.2 10.3 45.2 48.8 30.0 20.9 10.8 26.8 24.7 35.6 8.4 17.7 33.5 14.4 10.1 15.7 74.9 77.4 32.0 34.0 57.5 66.3 68.7 53.5 32.9 26.3 25.4 41.7 11.7 22.1 95.0 51.1 85.0 25.8 39.6 61.8 74.9 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-2197: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: AB_2683979" "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favorable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 12.8 7.8 14.0 3.7 18.3 0.2 8.4 18.3 17.3 10.6 0.0 16.6 4.5 12.2 5.5 9.2 8.9 8.6 14.3 13.2 12.4 14.9 8.9 4.9 2.5 16.5 14.9 11.8 13.4 8.0 8.2 6.2 4.7 18.8 8.5 4.4 9.5 4.2 9.2 34.8 4.4 7.0 12.5 9.4 3.3 7.4 7.3 16.4 2.1 5.3 21.0 1.5 10.6 7.6 32.7 0.7 6.3 11.5 6.1 19.0 20.5 9.5 13.9 8.6 10.5 8.5 1.8 1.9 0.5 3.6 22.5 2.7 0.1 7.1 1.2 6.4 0.3 6.4 0.1 4.5 2.0 9.2 0.0 8.6 16.9 5.5 6.6 0.0 16.4 2.3 0.1 0.0 1.2 8.0 17.4 0.7 0.0 3.0 5.4 2.6 9.9 4.8 2.0 7.5 7.2 5.8 8.2 2.4 5.0 20.1 6.0 6.6 0.0 0.1 11.1 2.9 33.3 4.6 0.8 14.3 7.2 13.9 0.3 6.4 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.2 0.2 0.0 1.0 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.1 14.0 18.3 18.3 17.3 13.2 12.4 16.5 14.9 11.8 18.8 9.4 16.4 32.7 12.6 9.6 5.8 125.4 4.0 7.9 5.4 2.2 7.4 18.6 11.8 10.0 30.3 17.2 4.7 3.7 22.9 5.2 0.6 2.2 0.0 8.5 19.0 7.9 18.5 7.8 10.8 0.0 219.3 4.0 5.8 15.4 10.2 8.8 20.3 16.3 10.4 24.2 6.2 1.7 269.9 6.2 2.0 3.5 5.2 6.1 11.5 3.6 23.2 44.0 0.6 19.4 1.0 216.2 421.7 7.7 1.3 19.5 0.9 7.7 10.2 17.0 5.3 20.5 6.6 22.7 17.6 21.7 22.5 4.3 3.8 3.8 2.0 5.6 5.7 8.9 EIF4E "EIF4E1, EIF4EL1, EIF4F" ENSG00000151247 "Eukaryotic translation initiation factor 4E" P06730 4 98879276-98929133 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Autism, Autism spectrum disorder, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 927.0;Late spermatids: 2284.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004077, CAB016316, HPA068358" Supported Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 450000 "Cytosol, Cytoplasmic bodies" Nucleoplasm "CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: " "unprognostic (3.07e-3)" "unprognostic (1.43e-1)" "unprognostic (6.53e-3)" "unprognostic (7.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-3)" "unprognostic (2.03e-5)" "unprognostic (6.55e-3)" "unprognostic (1.09e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (5.40e-2)" "unprognostic (1.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" 38.3 37.8 32.1 38.1 32.5 57.9 35.9 36.6 34.9 28.8 25.2 45.5 36.3 30.8 38.3 52.2 31.9 31.6 37.8 31.0 35.7 47.8 43.7 27.2 45.0 33.3 36.9 26.3 29.4 27.3 45.5 17.2 36.2 33.3 31.7 52.7 54.5 31.4 31.0 39.5 23.9 34.7 39.7 39.9 31.7 36.1 63.2 34.2 53.7 53.1 48.6 58.5 54.9 30.1 37.0 101.1 85.2 139.8 96.5 73.4 74.2 87.3 184.6 105.3 137.0 100.5 111.0 122.7 194.7 59.4 104.4 94.3 49.0 181.9 124.9 158.9 133.5 56.2 135.6 52.7 105.8 62.6 199.3 104.8 54.5 78.3 104.8 82.9 81.5 108.3 97.6 226.6 95.2 120.0 82.9 189.2 110.6 115.0 189.2 72.2 119.7 94.4 90.0 122.0 85.3 123.3 80.3 85.5 188.4 65.4 93.3 89.9 85.9 86.5 110.0 121.6 96.9 153.7 71.4 185.4 179.4 99.7 102.7 127.1 39.5 34.7 59.3 38.2 42.1 44.4 50.0 43.2 40.2 39.6 43.6 47.3 47.3 26.3 54.3 54.8 33.5 46.5 50.3 32.1 32.5 36.6 34.9 31.0 35.7 33.3 36.9 26.3 33.3 39.9 34.2 37.0 45.2 32.1 42.2 29.7 93.1 362.1 227.5 202.2 149.7 87.9 81.6 41.1 27.5 55.8 106.0 60.7 35.5 105.3 56.2 140.5 256.3 88.9 927.0 76.1 84.0 77.8 64.6 192.8 45.2 67.4 150.0 87.1 80.0 119.0 51.4 28.0 40.0 77.1 121.1 85.8 45.0 77.4 227.9 61.9 327.6 2284.9 50.7 122.1 193.9 25.3 69.8 82.0 57.7 35.2 50.9 83.8 107.1 49.2 113.0 191.1 83.2 189.2 76.8 64.7 52.6 78.7 151.7 98.7 87.1 171.2 370.9 119.0 82.2 39.8 97.3 224.3 MAGI1 "AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3" ENSG00000151276 "Membrane associated guanylate kinase, WW and PDZ domain containing 1" Q96QZ7 3 65353525-66038834 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031851, HPA031853, HPA077002" Supported Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: " "unprognostic (5.00e-2)" "unprognostic (9.84e-2)" "unprognostic (6.00e-3)" "unprognostic (1.73e-3)" "unprognostic (1.64e-1)" "unprognostic (2.17e-2)" "unprognostic (1.46e-3)" "unprognostic (9.46e-3)" "unprognostic (8.59e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (2.05e-3)" "prognostic favorable (4.55e-8)" "unprognostic (3.51e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-2)" "unprognostic (8.03e-2)" 10.5 5.1 3.8 1.3 5.2 0.0 12.6 6.6 6.4 4.8 3.6 9.0 5.1 6.3 2.0 8.1 5.8 5.4 8.7 4.7 4.8 9.4 13.5 8.9 1.1 4.1 4.4 4.9 2.7 12.7 5.9 7.8 5.3 3.0 7.1 4.3 7.0 11.7 4.9 3.9 12.2 6.4 3.2 2.3 12.0 14.8 10.4 4.4 2.0 13.5 4.1 1.8 5.4 7.2 5.4 4.1 2.2 12.3 1.3 2.4 1.7 5.5 7.0 5.9 2.6 4.0 15.1 3.5 0.0 1.0 8.3 2.1 1.2 3.4 2.4 4.1 0.0 1.9 36.1 4.3 10.2 1.5 0.0 1.1 2.7 2.0 8.9 1.8 6.8 6.0 4.7 15.6 0.0 2.8 3.1 0.0 0.0 16.6 12.2 2.1 0.0 3.5 0.9 3.1 13.5 3.9 10.8 2.7 3.3 0.1 8.0 6.4 0.0 1.6 8.2 6.0 2.1 2.9 0.0 0.0 0.0 4.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.2 6.6 6.4 4.7 4.8 4.1 4.4 4.9 3.0 2.3 4.4 5.4 102.8 76.9 29.8 204.7 1.3 22.3 17.7 7.9 26.2 98.3 46.5 37.5 35.6 102.9 22.5 23.9 75.0 20.2 0.5 51.0 3.9 44.3 179.1 35.8 35.5 55.5 36.5 2.7 497.7 31.8 2.4 9.6 47.4 50.8 1.3 78.4 82.5 60.9 4.8 232.2 809.8 40.3 12.2 5.0 3.6 27.0 6.5 1.8 5.4 170.5 0.6 15.2 0.0 368.4 532.1 40.3 25.4 8.6 0.2 14.7 33.2 12.2 40.3 26.4 32.9 7.0 17.5 44.7 12.3 12.7 18.8 5.1 2.7 27.1 26.3 11.9 TEX30 C13orf27 ENSG00000151287 "Testis expressed 30" Q5JUR7 13 102765888-102773811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "epididymis: 71.9;liver: 40.4;testis: 123.9" "Cell type enhanced" "Detected in many" "Early spermatids: 384.7;Spermatocytes: 958.6;Spermatogonia: 283.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 364.5" "Lineage enriched" "Detected in all" 13 "granulocytes: 364.5" "Cell line enhanced" "Detected in many" "NB-4: 295.3;THP-1: 188.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053545 Enhanced NA NA "HPA053545: AB_2682181" "unprognostic (5.26e-2)" "prognostic favorable (2.09e-5)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" "unprognostic (7.48e-2)" "unprognostic (1.54e-2)" "unprognostic (7.49e-2)" "unprognostic (9.86e-3)" "unprognostic (1.22e-1)" "unprognostic (1.25e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.89e-2)" "unprognostic (1.79e-1)" "unprognostic (8.66e-3)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" 7.9 6.0 9.4 6.8 8.8 14.5 7.7 9.7 11.9 7.3 8.8 5.3 5.5 10.5 71.9 8.4 6.2 5.0 8.5 8.7 8.9 19.4 40.4 6.0 11.9 8.8 9.5 8.5 7.3 5.7 4.4 7.3 15.1 9.2 4.7 4.6 7.6 5.3 13.2 9.8 7.6 5.4 7.3 9.0 6.5 5.8 123.9 9.6 16.3 5.5 9.4 7.4 6.9 6.5 9.6 44.0 16.1 39.0 30.8 23.3 16.8 0.4 59.0 14.9 39.9 35.6 41.2 43.0 25.6 25.0 22.4 52.5 23.8 35.3 21.0 53.9 53.8 21.3 44.2 34.9 0.4 15.7 92.5 86.0 8.9 13.6 33.2 20.8 14.4 30.8 64.9 27.6 0.0 47.6 24.5 61.0 295.3 14.1 63.4 38.3 37.8 18.0 18.4 61.7 18.5 51.2 22.1 33.3 42.9 37.8 23.0 30.0 188.3 12.0 27.3 21.2 44.0 63.7 23.9 30.3 0.1 46.9 54.0 45.9 364.5 7.6 79.4 10.6 9.4 15.2 12.9 11.6 13.6 8.8 11.8 13.1 11.2 3.9 28.5 9.7 17.8 18.8 8.8 9.4 8.8 9.7 11.9 8.7 8.9 8.8 9.5 8.5 9.2 9.0 9.6 9.6 12.4 0.0 3.7 1.6 15.0 23.7 16.2 35.3 12.0 7.4 12.1 21.5 12.2 7.2 14.3 12.9 4.2 110.9 10.9 3.4 37.2 16.0 384.7 11.1 10.2 15.5 3.0 34.1 5.1 9.7 113.9 15.7 5.1 6.7 27.3 11.3 13.6 39.5 46.6 6.7 6.3 4.9 22.4 5.3 18.9 79.2 30.4 11.7 28.4 4.7 17.7 8.0 14.4 5.0 4.6 9.7 2.2 18.8 15.8 16.0 8.1 100.8 11.2 5.9 92.1 15.4 29.7 958.6 283.2 16.9 19.9 142.3 20.2 5.0 8.3 10.9 CSNK1G3 ENSG00000151292 "Casein kinase 1 gamma 3" Q9Y6M4 5 123512099-123617045 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027010 Approved NA NA "HPA027010: AB_10602803" "unprognostic (1.28e-1)" "unprognostic (1.88e-1)" "prognostic favorable (9.90e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-1)" "unprognostic (3.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (9.92e-3)" "unprognostic (4.92e-1)" "unprognostic (1.05e-2)" "unprognostic (3.44e-1)" "unprognostic (2.52e-1)" "unprognostic (1.97e-3)" "unprognostic (4.38e-1)" 13.6 12.1 8.9 13.7 10.4 11.7 15.4 14.6 10.5 12.3 7.7 22.1 21.6 15.8 10.6 16.4 12.7 15.3 10.2 10.1 10.7 14.3 25.4 13.7 14.5 7.9 8.9 7.5 15.2 9.9 15.2 6.5 14.8 8.5 11.0 24.4 7.6 9.2 9.3 5.8 9.5 23.3 16.4 8.0 13.1 16.7 15.5 9.9 14.5 14.3 8.1 16.4 20.3 10.2 8.9 28.3 26.7 39.2 37.4 39.0 43.3 19.4 29.9 35.7 32.4 48.2 24.0 44.0 0.0 37.9 36.2 37.7 20.1 31.7 59.2 55.6 42.7 21.8 19.9 29.8 25.6 34.7 10.5 19.7 37.1 37.7 36.7 68.8 38.5 35.9 13.7 11.3 22.2 27.7 19.6 14.2 13.0 22.1 22.2 18.2 15.8 41.4 27.0 24.3 30.6 33.9 24.5 33.3 21.8 50.1 32.4 28.6 29.1 33.2 47.5 35.6 29.1 33.5 24.7 29.0 25.1 28.4 29.8 31.4 12.4 5.7 2.5 6.3 5.4 8.6 12.4 5.3 5.6 5.2 11.9 5.4 5.8 4.4 13.4 6.1 4.5 7.3 4.9 8.9 10.4 14.6 10.5 10.1 10.7 7.9 8.9 7.5 8.5 8.0 9.9 8.9 42.4 22.4 14.1 40.5 54.9 20.6 25.6 19.6 33.0 30.1 25.3 22.2 20.6 7.2 18.0 11.0 8.4 8.6 38.3 35.2 21.5 23.7 10.9 26.3 29.9 30.7 32.8 5.9 75.4 25.0 15.2 31.8 25.5 31.8 5.7 29.9 29.3 23.4 9.6 90.9 74.8 27.2 22.4 17.3 18.0 15.8 19.9 20.5 16.0 65.6 32.0 26.2 39.1 97.0 54.5 30.5 42.8 19.5 38.5 28.5 33.9 22.2 18.8 3.3 0.0 28.2 27.8 26.6 53.7 24.8 18.8 6.7 32.7 21.7 23.9 43.2 SRFBP1 "BUD22, FLJ25286, p49, Rlb1, STRAP" ENSG00000151304 "Serum response factor binding protein 1" Q8NEF9 5 121961975-122075570 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042737 Approved Approved "Nucleoli rim" NA NA "Nucleoli rim" "HPA042737: AB_10796583" "unprognostic (8.94e-2)" "unprognostic (1.80e-1)" "unprognostic (4.68e-2)" "unprognostic (1.61e-2)" "unprognostic (4.14e-1)" "unprognostic (1.18e-1)" "unprognostic (5.07e-3)" "unprognostic (2.03e-1)" "unprognostic (8.96e-3)" "unprognostic (6.31e-3)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (1.78e-1)" "unprognostic (4.71e-1)" "unprognostic (1.43e-1)" "unprognostic (8.45e-2)" 6.8 4.3 2.1 6.4 2.8 6.2 9.2 3.6 2.4 6.3 2.2 5.3 5.0 6.3 4.4 7.0 5.3 5.1 4.6 2.0 2.7 7.3 6.9 4.7 7.4 2.7 3.1 1.5 4.9 4.3 7.4 1.7 6.3 2.8 5.4 5.7 4.2 5.1 4.7 6.3 3.8 4.1 5.9 2.9 6.2 4.6 4.5 2.7 5.5 8.3 7.0 6.6 7.8 3.5 4.1 14.7 10.6 9.5 15.2 10.7 9.9 15.9 13.8 10.0 14.8 17.3 8.7 14.2 18.4 15.6 8.6 25.5 10.5 15.7 18.8 27.5 26.4 8.9 17.7 7.0 9.0 11.5 20.6 14.0 12.0 14.2 18.7 18.3 7.1 16.3 9.3 16.5 14.5 15.7 6.8 14.4 6.6 14.1 11.6 6.9 14.6 22.6 19.4 16.5 14.9 9.9 9.2 12.7 12.5 24.2 11.8 12.7 12.2 11.9 22.8 13.8 16.4 20.3 7.7 15.5 20.8 13.0 16.4 20.4 0.6 7.0 2.8 6.0 12.7 7.8 10.3 6.7 6.8 9.6 8.8 7.8 10.7 0.9 7.8 10.4 9.0 6.8 4.3 2.1 2.8 3.6 2.4 2.0 2.7 2.7 3.1 1.5 2.8 2.9 2.7 4.1 45.5 16.0 15.2 15.7 32.4 19.2 36.7 27.8 12.0 38.7 19.7 26.3 14.3 18.6 26.2 14.7 25.0 20.6 21.2 8.0 41.1 33.0 35.2 29.5 37.5 25.2 16.2 22.9 26.2 20.2 19.7 24.2 16.3 27.8 44.4 24.9 8.6 9.4 20.0 47.1 24.3 11.2 12.2 8.1 11.7 7.5 24.2 22.9 19.6 23.4 16.6 29.8 21.6 35.7 34.0 20.2 9.7 26.7 10.7 35.1 4.4 34.8 17.8 28.6 13.1 41.3 28.3 29.6 27.4 18.3 19.0 12.9 19.0 30.5 19.6 27.8 AKAP6 "ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6" ENSG00000151320 "A-kinase anchoring protein 6" Q13023 14 32329298-32837684 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.6;heart muscle: 55.1;skeletal muscle: 47.9;tongue: 51.2" "Group enriched" "Detected in many" 6 "Excitatory neurons: 601.6;Inhibitory neurons: 663.1;Oligodendrocyte precursor cells: 412.7;Oligodendrocytes: 1162.5" "Cancer enhanced" "Detected in many" "glioma: 2.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "naive B-cell: 3.5" "Lineage enriched" "Detected in single" 6 "B-cells: 3.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001983, HPA048741" Enhanced NA NA "CAB001983: , HPA048741: AB_2680506" "unprognostic (1.99e-1)" "unprognostic (9.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.37e-1)" "unprognostic (2.52e-1)" "unprognostic (4.33e-2)" "unprognostic (1.41e-4)" "unprognostic (1.81e-3)" "unprognostic (1.93e-2)" "unprognostic (4.49e-3)" "unprognostic (1.24e-3)" "unprognostic (3.54e-1)" "unprognostic (3.33e-16)" "unprognostic (8.57e-2)" "unprognostic (1.27e-1)" "unprognostic (5.14e-3)" "unprognostic (1.79e-3)" 1.6 5.7 15.8 2.5 27.3 0.5 4.7 15.4 26.9 1.6 0.0 4.1 1.8 4.0 5.7 5.5 3.0 3.7 55.1 15.5 37.9 3.0 2.1 2.3 0.8 48.8 33.4 16.1 2.5 0.9 3.5 3.6 4.6 52.7 2.0 2.2 13.8 2.7 1.2 47.9 1.3 2.4 7.8 22.3 0.8 2.0 6.0 36.6 0.9 4.8 51.2 0.7 4.3 1.5 58.6 0.3 0.8 1.0 0.9 0.2 1.7 0.2 1.3 3.6 0.2 0.4 1.1 1.0 1.4 0.9 15.8 0.6 0.8 1.2 1.4 0.5 1.3 1.0 1.3 1.5 1.1 0.5 0.1 0.3 1.8 1.3 0.0 0.4 0.6 0.1 2.1 0.3 4.1 1.1 0.8 0.7 0.2 0.2 1.1 1.1 0.7 4.9 0.6 0.4 1.2 5.2 4.2 1.1 0.7 3.2 0.7 2.9 0.1 0.3 0.2 0.8 0.8 0.5 2.5 2.4 0.6 1.5 0.1 5.4 0.3 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 3.5 0.4 0.6 0.5 0.1 0.1 0.4 0.0 0.3 15.8 27.3 15.4 26.9 15.5 37.9 48.8 33.4 16.1 52.7 22.3 36.6 58.6 0.6 6.4 2.7 111.3 2.2 2.3 2.9 1.0 5.2 49.2 8.7 3.0 108.0 0.0 4.9 1.8 50.1 0.8 0.1 1.1 0.0 0.8 32.4 6.7 0.4 1.7 1.2 0.0 601.6 0.5 0.3 6.3 0.0 1.4 1.3 0.6 1.1 2.7 1.2 26.9 663.1 0.6 4.1 0.6 1.6 13.7 14.6 1.1 7.2 23.4 0.7 2.5 0.0 412.7 1162.5 0.3 0.1 33.1 2.0 1.1 1.9 1.5 23.6 21.5 19.7 25.8 14.3 25.9 1.3 1.1 1.6 0.4 0.6 3.4 0.9 0.9 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934396-33820863 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in many" 6 "Astrocytes: 3405.1;Inhibitory neurons: 1408.3;Oligodendrocyte precursor cells: 1893.0;Oligodendrocytes: 1772.0" "Group enriched" "Detected in some" 4 "endometrial cancer: 6.4;glioma: 7.7;ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 9.3;U-266/70: 23.6;U-266/84: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 0.7 0.8 17.5 0.1 19.3 0.0 0.9 16.8 14.3 6.0 0.0 1.1 0.3 3.9 0.9 0.3 4.0 0.7 0.4 15.0 14.5 0.7 0.1 0.2 0.1 23.5 15.7 10.9 2.7 0.4 0.5 1.0 0.5 15.7 0.8 0.3 1.4 0.8 1.3 0.2 0.2 0.4 0.7 17.2 1.1 1.0 1.4 15.2 0.4 1.9 0.2 0.2 0.5 0.5 19.2 0.0 0.0 9.3 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 23.6 7.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 19.3 16.8 14.3 15.0 14.5 23.5 15.7 10.9 15.7 17.2 15.2 19.2 5.1 0.0 0.0 3405.1 0.1 1.0 1.0 0.0 0.6 8.9 3.8 5.1 2.1 0.0 0.1 1.8 0.0 1.5 0.1 0.1 1.9 0.1 22.2 24.6 5.7 3.2 1.2 0.0 341.9 0.0 0.1 3.5 0.0 72.3 0.0 0.7 4.2 0.1 0.5 10.1 1408.3 0.0 0.0 0.0 1.4 17.0 7.2 0.7 0.0 116.2 0.0 7.4 0.0 1893.0 1772.0 0.2 0.0 5.3 0.1 0.5 0.0 0.5 1.8 0.7 0.0 11.5 3.1 0.2 0.8 0.1 0.4 0.3 1.0 1.1 0.0 0.5 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 637.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 170000 Vesicles Nucleoplasm "HPA053222: AB_2682083, HPA055440: AB_2682817" "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favorable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 43.1 43.5 40.6 30.3 50.6 50.0 38.5 46.0 46.9 44.6 39.2 82.3 57.7 29.7 29.9 50.1 27.0 38.0 78.9 39.9 49.8 61.9 77.7 69.2 20.3 53.1 50.3 35.7 28.5 49.8 30.8 47.7 27.5 54.7 63.7 72.1 31.6 43.8 36.4 48.7 40.6 55.1 42.7 47.3 23.8 42.9 86.9 48.9 21.8 48.5 33.1 23.4 47.1 38.0 59.2 63.4 51.2 38.0 31.3 64.6 64.6 46.7 101.3 55.8 52.4 57.1 52.2 82.6 25.1 68.1 98.9 71.1 65.8 47.1 58.5 66.7 73.5 28.8 19.5 63.8 179.5 79.4 30.7 44.9 58.5 75.3 63.5 49.5 76.7 60.6 46.7 47.7 79.8 102.5 91.5 38.0 28.1 30.9 100.9 65.2 21.9 52.7 35.9 95.2 68.7 52.1 45.9 119.3 94.2 81.3 75.2 87.2 23.9 71.3 67.5 59.2 76.6 53.2 59.3 79.8 31.2 42.3 20.5 68.0 79.9 43.9 79.2 31.0 36.7 36.5 45.0 40.3 35.7 34.8 35.8 31.7 31.4 167.5 32.6 31.9 50.8 60.0 30.4 40.6 50.6 46.0 46.9 39.9 49.8 53.1 50.3 35.7 54.7 47.3 48.9 59.2 126.7 240.4 176.3 6.5 87.4 160.7 199.4 200.4 83.6 35.8 119.0 118.4 147.8 67.2 168.1 104.8 27.1 71.0 322.2 329.3 119.3 121.9 637.1 235.5 86.6 116.4 133.8 36.0 10.7 249.6 118.0 80.5 107.0 426.4 82.3 43.1 82.5 235.6 75.5 23.5 13.4 189.5 144.5 61.1 130.9 505.9 54.0 85.4 149.4 8.4 125.1 45.3 48.4 9.0 28.4 364.6 220.1 53.0 133.3 211.4 273.7 347.2 177.8 45.5 46.0 65.2 106.2 189.3 106.8 93.1 171.5 123.3 215.7 30.4 224.2 229.5 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298564-36320637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 30.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 16.4 19.6 19.6 12.2 19.7 35.5 25.1 22.3 22.2 28.1 19.2 17.1 17.1 26.8 21.5 16.7 16.6 16.6 14.3 18.0 25.3 26.5 29.2 77.4 17.6 17.5 19.1 18.2 32.5 17.8 19.8 22.6 19.2 18.0 18.7 22.4 22.5 16.1 16.4 7.3 28.7 17.4 20.4 17.7 15.7 31.5 18.3 20.3 18.0 82.4 9.4 16.2 15.3 13.6 23.0 29.6 15.4 31.7 32.1 31.3 30.0 24.1 24.8 30.7 32.2 33.6 31.2 28.9 28.0 36.8 32.1 16.8 22.1 33.7 22.9 39.3 40.5 25.5 16.4 14.7 55.0 33.9 33.8 17.5 30.8 35.1 21.1 27.2 33.2 20.4 38.3 28.4 33.8 24.2 28.8 32.5 27.7 26.9 25.2 44.6 15.4 27.7 19.5 37.2 22.7 47.3 18.8 20.4 19.5 33.4 27.3 31.9 21.6 16.0 35.6 23.2 26.3 26.0 27.8 34.5 44.0 13.6 17.3 25.3 2.0 12.6 3.0 14.6 9.9 18.5 16.4 17.6 18.0 12.8 12.3 22.6 18.5 7.0 12.9 8.1 14.5 23.6 13.3 19.6 19.7 22.3 22.2 18.0 25.3 17.5 19.1 18.2 18.0 17.7 20.3 23.0 16.0 218.0 316.0 18.3 14.9 90.2 30.7 41.5 22.2 24.9 15.3 23.0 10.7 10.0 106.7 25.8 2.1 24.7 12.2 16.1 58.7 21.2 4.2 20.9 28.2 18.3 31.5 9.7 21.2 19.0 21.1 29.7 13.3 35.6 13.3 30.2 16.1 25.2 18.7 92.5 24.8 15.5 20.3 9.5 15.4 4.2 32.0 14.5 21.4 9.4 11.5 29.0 12.3 31.7 27.0 17.8 18.6 27.1 18.9 29.0 18.9 49.6 34.9 24.1 13.1 18.0 27.8 50.1 35.5 17.9 65.5 19.8 20.6 25.5 21.1 21.4 MIPOL1 CCDC193 ENSG00000151338 "Mirror-image polydactyly 1" Q8TD10 14 37197913-37552361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 138.2;Excitatory neurons: 159.4;Inhibitory neurons: 141.1;Late spermatids: 129.2;Oligodendrocyte precursor cells: 91.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002893, HPA050179" Enhanced Approved Cytosol NA NA Cytosol "HPA002893: AB_1079386, HPA050179: AB_2681043" "unprognostic (3.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-1)" "unprognostic (4.30e-2)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "unprognostic (4.61e-4)" "unprognostic (2.37e-2)" "unprognostic (2.84e-2)" "unprognostic (2.39e-2)" "unprognostic (3.54e-2)" "unprognostic (8.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-1)" "unprognostic (9.78e-3)" "unprognostic (3.41e-3)" "unprognostic (1.85e-2)" 2.5 2.8 2.1 1.2 1.8 0.4 4.0 1.2 1.8 4.2 1.9 2.7 1.3 4.5 2.2 3.5 3.5 3.3 2.5 1.5 2.2 4.1 1.9 2.4 0.3 2.1 1.8 1.3 6.3 4.5 6.5 2.8 1.4 2.1 5.5 2.1 3.0 3.4 3.4 2.0 1.7 1.2 3.5 2.0 1.2 3.6 7.9 1.7 0.9 5.3 2.8 0.6 3.4 3.6 2.2 5.3 2.2 0.8 7.4 5.3 8.7 0.0 4.8 3.2 4.0 5.9 2.9 3.2 0.0 4.6 4.0 1.6 6.1 0.0 6.6 5.4 0.0 7.8 0.0 3.6 12.8 3.4 0.0 0.1 5.5 6.6 1.1 12.8 4.9 25.2 0.0 10.5 0.1 6.0 5.3 0.0 0.0 3.1 3.5 16.3 0.0 0.7 0.0 5.8 5.9 6.2 0.0 6.2 5.3 5.5 5.4 6.6 0.0 13.4 0.0 3.9 0.0 5.5 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 2.1 1.8 1.2 1.8 1.5 2.2 2.1 1.8 1.3 2.1 2.0 1.7 2.2 7.9 76.9 59.2 41.4 1.2 4.2 15.7 5.8 18.2 13.8 8.0 6.6 14.3 11.5 55.8 9.2 52.1 0.1 0.7 1.6 9.8 4.9 138.2 5.6 13.8 10.4 9.1 1.3 159.4 7.4 0.1 16.2 14.3 6.0 46.7 10.8 3.9 3.0 0.1 11.8 141.1 1.9 6.1 1.6 5.7 129.2 8.4 5.2 7.2 45.0 0.2 6.0 1.0 91.0 24.9 11.3 0.8 9.1 0.1 16.2 0.9 4.0 70.0 23.0 0.0 19.9 16.7 36.2 15.1 6.3 6.3 0.0 4.7 16.2 3.5 8.6 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095673-44251962 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" NA NA 39000000 "Golgi apparatus" "HPA078409: AB_2686884" "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 33.8 23.0 15.8 22.3 16.2 11.3 29.6 16.2 16.3 35.6 17.9 29.4 26.7 43.4 33.6 20.2 34.0 28.3 26.0 16.0 18.4 26.8 27.1 28.1 16.1 16.4 16.9 16.7 33.8 26.7 29.1 20.3 62.4 15.7 30.1 28.9 21.1 26.9 30.4 16.3 25.9 31.2 49.7 15.7 21.8 24.0 21.8 18.4 15.3 27.9 18.5 17.4 30.0 28.8 16.9 57.9 71.6 38.3 121.5 170.4 124.2 60.8 181.1 198.0 93.1 125.1 51.2 36.5 40.4 82.1 188.8 98.5 90.0 41.0 114.0 110.0 83.2 71.5 38.4 33.7 39.7 67.5 37.5 76.6 97.7 73.4 56.3 86.6 108.8 132.7 34.8 50.0 63.9 68.4 40.3 25.9 22.3 43.8 67.1 70.9 32.3 116.1 21.1 53.9 49.1 30.9 35.5 118.1 41.4 28.1 67.0 69.8 37.2 137.8 127.4 90.6 133.1 111.4 33.4 46.0 30.4 84.7 27.9 140.0 15.2 17.5 19.4 20.9 17.7 23.5 9.0 16.5 19.3 21.3 8.8 15.4 15.2 3.4 26.3 12.8 7.4 14.2 15.5 15.8 16.2 16.2 16.3 16.0 18.4 16.4 16.9 16.7 15.7 15.7 18.4 16.9 24.5 16.0 10.6 41.4 8.7 15.2 17.3 22.0 10.8 11.5 11.0 11.4 10.2 8.6 13.5 12.9 14.6 34.3 10.6 21.1 5.9 33.5 43.2 7.9 17.1 19.2 1.8 6.7 64.3 23.7 37.0 32.3 7.7 11.5 6.3 22.7 22.9 18.3 18.3 13.5 63.3 12.9 12.2 10.8 7.2 23.0 27.4 10.4 5.4 28.1 10.2 17.4 7.2 50.3 51.8 24.0 14.9 28.6 7.0 23.6 31.6 8.2 8.1 15.0 19.7 15.8 20.7 51.2 24.4 10.2 12.6 35.3 9.2 12.2 15.0 15.3 TMEM18 "DKFZp434C1714, lncND" ENSG00000151353 "Transmembrane protein 18" Q96B42 2 663877-677406 "Predicted membrane proteins, Transporters" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040233 Approved Approved "Endoplasmic reticulum,Mitochondria" NA NA Mitochondria "Endoplasmic reticulum" "HPA040233: AB_10794737" "unprognostic (9.01e-3)" "unprognostic (2.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-3)" "unprognostic (2.68e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-2)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (6.05e-2)" "unprognostic (1.86e-1)" "unprognostic (9.45e-2)" "unprognostic (8.20e-2)" "unprognostic (2.49e-1)" "unprognostic (3.65e-1)" "unprognostic (4.98e-3)" "unprognostic (8.08e-2)" 18.4 20.1 9.4 6.4 9.9 8.9 18.7 9.2 11.8 14.7 8.1 12.4 8.9 17.8 9.8 14.9 16.0 8.6 11.4 10.0 10.2 13.2 10.2 11.1 8.5 10.4 10.2 9.7 28.6 25.4 12.5 9.8 10.0 10.3 9.6 6.2 12.1 14.5 7.1 27.5 14.8 10.2 9.6 9.7 9.3 13.4 12.3 10.3 7.1 12.9 12.3 6.4 13.7 13.2 11.0 17.4 14.1 20.3 21.7 23.9 35.4 19.0 23.8 19.0 20.2 19.5 1.9 27.6 25.1 44.5 31.1 10.7 24.0 7.2 26.3 17.8 37.1 16.6 14.4 7.6 28.7 25.9 13.5 11.9 24.6 26.4 35.1 26.7 18.2 5.9 39.1 14.7 14.7 30.5 48.1 32.7 32.1 13.8 15.1 21.4 17.8 9.9 17.8 21.0 16.3 14.4 24.9 13.1 22.7 25.4 9.5 16.2 25.6 19.5 19.0 25.5 12.6 36.7 19.3 34.4 21.8 20.7 14.4 13.1 3.8 16.1 6.9 11.8 15.7 11.3 18.4 13.5 9.5 16.6 14.8 14.8 14.4 1.0 18.5 18.4 22.3 17.1 13.1 9.4 9.9 9.2 11.8 10.0 10.2 10.4 10.2 9.7 10.3 9.7 10.3 11.0 49.2 22.4 32.8 4.6 39.4 35.9 29.7 46.0 61.5 19.8 68.3 108.2 28.3 31.5 39.2 27.6 8.4 72.5 28.1 26.0 31.3 34.1 14.2 37.5 53.7 41.0 19.8 37.9 4.1 46.3 62.1 47.1 27.0 53.1 29.8 77.6 38.2 37.4 49.1 20.2 3.9 39.4 36.7 37.4 31.5 13.1 63.3 31.2 40.9 2.8 36.4 49.8 20.6 4.5 10.2 36.6 50.7 51.1 43.1 40.1 51.0 45.8 32.1 33.7 19.7 31.8 48.8 93.3 68.1 72.6 43.2 81.1 30.0 63.5 41.7 40.4 ALLC ALC ENSG00000151360 Allantoicase Q8N6M5 2 3658200-3702671 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 16.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 140.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "U-266/84: 6.1" "Not detected" "Not detected" NA NA "unprognostic (5.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.91e-3)" "unprognostic (4.75e-1)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-3)" "unprognostic (5.42e-2)" "unprognostic (1.74e-4)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.4 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.2 3.4 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.2 0.0 0.0 0.0 0.5 0.0 0.0 13.1 0.0 0.1 5.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 2.3 23.3 2.0 1.6 2.1 0.1 20.6 5.1 2.9 10.5 2.8 8.2 4.9 3.5 14.5 1.5 11.8 6.8 0.5 2.1 2.3 9.3 10.4 8.3 0.3 1.9 1.9 1.9 0.8 27.5 8.4 2.5 1.3 2.5 7.0 12.0 1.6 29.0 19.3 0.2 1.7 5.3 2.1 1.9 0.6 20.9 0.6 2.2 1.3 16.1 0.6 0.5 2.3 1.4 2.1 0.0 3.5 0.6 0.5 1.3 0.8 3.5 1.8 1.6 3.4 8.4 13.5 8.8 0.1 9.3 1.1 0.4 1.0 0.6 26.1 8.9 0.5 13.2 0.0 3.0 29.0 4.9 0.2 0.1 4.0 0.7 13.9 11.0 2.5 1.0 0.2 0.3 0.1 1.4 0.2 0.3 0.8 6.5 0.5 0.5 0.4 0.0 0.0 45.9 3.5 2.3 0.2 0.0 0.2 4.5 0.8 1.4 1.1 0.8 0.2 20.2 0.7 0.4 0.3 0.2 0.2 0.2 0.2 3.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.0 2.0 2.1 5.1 2.9 2.1 2.3 1.9 1.9 1.9 2.5 1.9 2.2 2.1 0.6 3.2 10.8 0.0 0.2 0.4 12.2 2.0 2.8 0.4 13.7 12.8 0.0 1.5 4.1 5.5 0.0 0.6 0.3 5.2 3.9 2.6 0.3 2.7 2.0 0.9 4.8 0.0 0.0 17.1 1.3 1.1 14.3 3.7 1.3 0.5 0.0 4.8 0.2 0.0 0.0 20.8 0.0 0.0 0.0 0.0 3.4 0.4 1.8 0.0 0.1 2.1 0.0 0.0 0.0 10.5 6.6 5.3 0.0 14.3 2.2 15.1 0.1 0.0 0.0 0.0 1.8 0.2 0.3 0.7 0.1 0.7 0.3 0.7 8.5 7.4 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 211.8;liver: 412.3" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 128.4" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enhanced" "Detected in single" "cerebellum: 2.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "ASC diff: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.69e-3)" 211.8 6.0 0.2 0.4 0.2 0.0 96.1 2.8 0.4 0.1 0.0 2.6 0.0 0.1 0.4 0.3 1.0 3.5 18.7 0.3 0.0 4.5 412.3 0.1 0.7 0.1 0.3 0.2 0.1 3.7 15.7 0.1 0.0 0.8 0.1 0.2 1.5 49.3 2.3 8.3 21.2 4.7 0.5 0.0 0.1 0.7 0.1 0.0 0.2 5.8 3.3 0.0 0.8 1.1 0.2 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 2.8 0.4 0.3 0.0 0.1 0.3 0.2 0.8 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 2.3 21.1 11.2 0.1 4.3 0.0 0.0 0.0 0.0 0.2 0.0 9.8 0.0 0.0 0.6 0.1 0.4 0.0 2.7 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.1 2.9 128.4 0.0 0.0 0.4 0.3 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068297-78079862 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 204.0 280.3 111.0 85.2 122.2 127.2 144.2 124.1 151.9 102.5 117.9 144.9 220.4 126.3 69.0 143.9 121.3 109.6 217.5 120.4 135.0 149.6 289.1 100.9 110.0 121.2 115.6 116.8 97.0 170.2 187.7 134.6 75.4 120.2 89.5 66.8 60.3 277.5 84.0 492.2 121.3 195.9 64.2 127.2 97.0 131.1 103.8 123.6 74.2 208.9 256.3 63.3 98.0 100.9 133.0 287.6 342.2 183.3 118.8 168.3 105.6 227.2 335.7 190.9 252.4 179.9 910.4 311.8 166.3 583.3 155.8 210.2 293.1 136.1 190.9 99.5 318.8 386.7 183.8 337.4 727.9 270.9 409.7 164.2 147.9 177.8 195.6 75.2 156.0 172.9 158.8 365.3 278.4 137.9 478.7 254.5 722.4 212.4 670.4 415.6 224.5 352.5 570.5 196.4 420.7 261.2 229.0 235.0 499.5 182.3 158.8 391.4 328.2 241.0 256.4 314.9 611.8 297.9 251.5 541.9 400.4 146.4 236.6 251.0 374.5 337.6 354.0 150.1 293.0 138.3 230.8 172.4 163.4 363.5 212.1 144.5 159.8 102.2 225.4 243.0 290.4 202.7 410.9 111.0 122.2 124.1 151.9 120.4 135.0 121.2 115.6 116.8 120.2 127.2 123.6 133.0 256.6 166.7 194.7 0.0 106.4 95.5 166.1 443.7 40.5 145.8 346.2 414.0 240.9 243.1 288.2 391.8 66.7 408.8 166.4 206.3 305.2 395.6 311.8 413.8 129.3 183.7 167.9 106.5 0.0 431.5 392.8 165.7 43.3 241.7 153.2 158.1 184.9 856.9 346.2 90.9 0.0 317.9 429.3 174.5 110.7 84.7 215.6 129.4 245.5 0.0 246.7 310.0 175.1 0.0 0.0 456.5 329.1 201.6 102.5 239.0 461.8 454.6 300.0 131.6 236.7 154.5 222.7 384.4 162.1 67.5 114.4 387.1 109.9 226.3 373.2 215.6 ME3 ENSG00000151376 "Malic enzyme 3" Q16798 11 86441108-86672636 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 54.2;Excitatory neurons: 103.7;Inhibitory neurons: 147.8;Oligodendrocyte precursor cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 54.4;hTERT-RPE1: 64.1;HUVEC TERT2: 36.3;TIME: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038473 Approved NA NA "HPA038473: AB_10672747" "unprognostic (1.83e-3)" "unprognostic (8.00e-2)" "unprognostic (1.99e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "unprognostic (5.74e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.73e-1)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" 17.6 24.6 20.5 5.1 26.2 6.2 19.7 11.3 31.2 24.2 11.6 15.5 7.1 16.8 5.6 4.2 13.7 11.6 21.8 26.5 14.0 20.2 6.3 11.4 4.2 22.9 23.9 28.8 28.1 16.0 16.3 22.6 4.8 23.3 20.1 13.8 10.9 12.7 9.1 22.2 4.4 8.9 14.2 3.7 11.0 21.2 13.1 19.6 3.5 12.6 19.7 2.4 17.2 14.3 26.4 0.0 18.1 5.2 0.0 7.9 16.6 0.1 5.9 9.6 12.9 16.0 14.0 54.4 0.0 5.3 5.7 31.5 0.2 0.0 0.1 5.6 9.2 0.0 9.6 16.8 0.0 11.9 1.2 0.0 11.8 2.8 10.2 0.1 64.1 36.3 0.0 0.2 0.0 9.1 1.8 2.7 0.1 1.2 1.7 7.7 8.3 0.0 0.6 11.4 21.4 6.2 0.1 3.8 0.1 0.0 2.1 0.9 1.5 40.0 1.5 1.2 26.3 0.9 0.1 3.3 0.0 1.4 17.1 1.6 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.7 1.2 2.3 0.0 0.9 1.1 0.0 1.0 0.1 0.3 0.0 0.5 20.5 26.2 11.3 31.2 26.5 14.0 22.9 23.9 28.8 23.3 3.7 19.6 26.4 13.6 3.2 3.3 30.3 1.1 2.3 4.6 5.4 5.7 16.5 7.5 9.1 54.2 2.8 8.1 3.7 0.0 0.3 1.9 19.2 43.0 9.1 0.7 3.2 6.1 11.5 9.0 4.2 103.7 7.9 0.4 8.4 19.9 1.6 0.0 33.4 14.6 1.6 6.8 20.2 147.8 14.8 4.1 1.6 3.5 2.5 6.2 1.8 1.8 14.0 1.1 2.0 1.0 75.4 4.8 11.5 21.1 6.4 0.5 6.4 3.5 6.5 14.9 2.5 13.1 7.0 8.2 0.4 0.2 2.6 1.6 0.0 1.6 38.8 11.0 6.6 MSGN1 pMesogenin1 ENSG00000151379 "Mesogenin 1" A6NI15 2 17816460-17817798 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "Basal squamous epithelial cells: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.63e-2)" "unprognostic (3.25e-2)" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS12 ENSG00000151388 "ADAM metallopeptidase with thrombospondin type 1 motif 12" P58397 5 33523535-33892019 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035973, HPA075079" Uncertain Approved Nucleoli,Mitochondria "Secreted to extracellular matrix" NA NA Nucleoli Mitochondria "HPA035973: AB_10669663, HPA075079: AB_2732278" "unprognostic (6.18e-3)" "unprognostic (3.12e-4)" "unprognostic (1.05e-1)" "unprognostic (8.37e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-1)" "unprognostic (2.60e-2)" "unprognostic (3.49e-3)" "unprognostic (3.78e-3)" "unprognostic (3.39e-2)" "unprognostic (5.63e-3)" "unprognostic (1.45e-1)" "unprognostic (4.27e-7)" "unprognostic (4.45e-3)" "unprognostic (1.47e-1)" "unprognostic (5.85e-2)" "prognostic unfavorable (6.78e-4)" 9.0 5.2 0.8 1.6 0.9 0.0 7.9 0.6 0.5 2.6 1.5 2.0 0.5 3.9 0.5 0.9 3.2 4.0 1.2 0.2 1.3 1.3 1.4 5.6 0.9 1.0 1.0 0.1 2.8 0.6 0.5 0.6 4.0 0.9 1.3 1.0 0.7 0.9 1.4 0.8 1.4 1.1 6.6 1.7 0.5 1.2 2.0 1.7 0.3 1.9 0.7 0.6 2.2 2.1 3.4 28.7 0.9 25.5 0.0 35.9 17.2 0.0 13.3 33.1 16.8 19.5 0.0 0.0 0.0 0.0 9.0 29.1 0.8 0.7 16.7 24.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 13.8 0.0 47.4 12.2 88.0 0.0 0.0 0.0 0.1 26.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 29.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 28.0 36.2 0.3 7.9 4.4 3.5 0.0 23.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.6 0.5 0.2 1.3 1.0 1.0 0.1 0.9 1.7 1.7 3.4 6.4 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.0 0.1 1.5 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 4.9 1.2 25.2 2.1 0.0 0.0 3.0 0.2 0.4 22.9 0.0 0.6 0.0 3.3 11.4 0.2 0.6 0.0 6.2 0.0 0.0 0.3 2.1 3.0 22.1 0.2 7.2 73.1 0.0 5.3 0.0 0.5 7.8 0.1 0.0 17.7 0.0 0.1 0.0 2.4 0.7 0.2 52.6 1.7 19.1 0.4 4.7 0.1 0.9 0.8 0.3 55.4 0.0 0.1 NUBPL "C14orf127, FLJ12660, huInd1, IND1" ENSG00000151413 "Nucleotide binding protein like" Q8TB37 14 31489956-31861224 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 68.2;Inhibitory neurons: 74.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 99.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029203 Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA029203: AB_10602810" "unprognostic (1.49e-1)" "unprognostic (1.71e-2)" "unprognostic (5.21e-3)" "unprognostic (8.28e-2)" "unprognostic (8.25e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "prognostic favorable (3.64e-8)" "unprognostic (2.82e-2)" "unprognostic (6.60e-2)" "unprognostic (3.67e-3)" "unprognostic (1.56e-2)" 9.8 6.5 4.5 3.9 4.9 1.8 9.0 4.7 4.8 4.9 4.4 7.7 5.0 5.8 7.6 4.6 6.5 5.4 17.2 4.4 5.1 12.3 12.4 4.2 5.8 5.0 4.8 4.5 6.8 5.5 8.0 3.8 5.5 4.8 6.4 7.9 5.2 12.0 6.2 12.0 4.8 5.9 5.5 4.6 6.7 4.8 3.6 4.9 5.6 8.0 17.5 5.4 4.2 3.3 6.2 13.6 8.5 6.4 3.3 8.9 16.4 11.5 7.3 8.2 8.9 10.2 5.9 15.3 9.8 9.2 9.1 7.5 11.7 8.6 15.5 15.3 7.1 11.1 3.5 6.3 30.4 8.8 10.4 3.0 10.7 17.0 6.0 12.8 7.3 5.0 7.0 6.4 4.9 9.8 7.4 7.7 7.1 5.4 10.8 13.1 8.6 13.4 5.3 10.2 10.0 6.0 6.2 12.2 10.8 14.5 7.2 21.1 5.4 4.9 8.6 5.9 5.6 6.8 8.1 9.7 9.3 5.5 7.3 7.9 0.0 1.1 0.4 2.1 1.2 1.7 2.6 2.7 2.3 4.4 1.7 3.0 2.4 0.4 2.5 0.7 2.2 1.8 0.9 4.5 4.9 4.7 4.8 4.4 5.1 5.0 4.8 4.5 4.8 4.6 4.9 6.2 6.9 12.8 9.8 68.2 10.1 9.6 8.6 5.4 9.1 15.3 10.2 7.1 36.9 15.7 10.6 9.2 20.9 11.2 7.5 6.3 7.9 6.8 24.1 12.6 10.8 6.3 7.2 6.7 48.2 5.7 10.2 12.0 7.1 5.4 14.5 16.4 4.6 15.3 4.9 10.1 74.8 12.0 2.0 4.1 16.1 7.4 6.5 6.1 12.4 54.4 2.8 16.2 5.2 87.9 99.6 5.2 5.8 11.7 8.0 4.4 5.1 19.1 18.7 28.4 13.1 11.8 9.8 15.7 5.2 7.3 11.6 5.7 6.4 23.1 18.2 5.9 NEK7 ENSG00000151414 "NIMA related kinase 7" Q8TDX7 1 198156994-198322420 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 141.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 554.5;fHDF/TERT166: 753.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015520, HPA018193" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA015520: AB_1854371, HPA018193: AB_1854372" "unprognostic (2.08e-1)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (5.38e-2)" "unprognostic (4.26e-2)" "unprognostic (3.00e-2)" "unprognostic (2.14e-2)" "unprognostic (5.47e-2)" "unprognostic (4.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-2)" "unprognostic (1.56e-1)" 64.4 50.4 57.1 29.6 60.3 11.2 28.0 54.9 49.4 26.3 43.0 25.3 21.3 26.9 19.8 31.5 22.5 27.4 141.7 45.2 59.4 29.5 30.2 41.9 31.1 69.5 57.3 39.0 29.8 20.5 25.3 12.4 42.5 64.7 27.3 23.6 19.8 22.5 36.8 57.1 15.1 25.5 32.5 68.5 32.4 20.2 13.8 58.6 28.0 27.0 64.3 23.8 31.2 20.3 68.1 47.8 12.3 14.8 6.0 37.5 42.6 17.4 554.5 227.6 218.7 102.9 23.0 46.2 17.1 39.4 753.3 12.6 29.0 22.7 30.3 220.8 56.0 32.7 23.6 48.7 9.6 45.3 40.2 46.3 26.7 25.3 144.8 43.5 82.2 42.4 140.0 18.8 41.2 102.3 15.1 34.7 23.4 8.4 37.5 9.9 18.5 36.5 30.7 37.3 24.5 9.5 17.0 92.1 53.0 63.5 20.6 38.8 36.0 95.7 61.8 52.0 178.6 58.9 29.3 28.5 11.8 26.9 36.3 48.7 1.8 2.2 3.3 2.9 1.8 12.8 1.4 3.2 4.1 2.0 1.9 2.7 3.1 6.0 3.6 1.6 1.3 6.0 1.4 57.1 60.3 54.9 49.4 45.2 59.4 69.5 57.3 39.0 64.7 68.5 58.6 68.1 34.3 28.9 30.7 78.0 32.4 51.4 15.0 10.2 33.6 8.2 22.8 18.2 172.6 10.0 18.7 18.4 14.6 15.0 32.9 25.8 11.7 10.6 2.8 21.6 20.9 29.3 19.8 32.6 17.0 19.6 15.9 30.0 18.8 19.6 8.8 11.8 40.4 23.5 17.5 3.3 34.6 19.5 8.2 49.5 51.6 3.3 29.2 35.5 30.2 124.6 29.0 11.4 15.5 131.2 153.5 50.1 19.3 38.4 28.5 30.6 25.1 16.6 27.9 24.2 19.7 28.1 35.9 7.7 6.0 29.2 49.2 64.3 41.6 28.7 15.6 33.1 ATP6V1G3 "ATP6G3, Vma10" ENSG00000151418 "ATPase H+ transporting V1 subunit G3" Q96LB4 1 198523222-198540945 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "kidney: 58.0" "Cell type enriched" "Detected in some" 48 "Distal tubular cells: 444.1" "Cancer enriched" "Detected in single" 140 "renal cancer: 11.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.5;BJ hTERT+: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.8;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA028701 Enhanced NA NA "HPA028701: AB_10611681" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 58.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 1.1 0.8 0.3 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.2 0.0 0.0 0.0 0.0 444.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 FER "PPP1R74, TYK3" ENSG00000151422 "FER tyrosine kinase" P16591 5 108747841-109196841 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Alveolar cells type 1: 80.1;Astrocytes: 207.3;Early spermatids: 158.1;Excitatory neurons: 266.3;granulocytes: 95.5;Inhibitory neurons: 313.8;Late spermatids: 182.4;Microglial cells: 227.7;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "RPMI-8226: 91.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007641, CAB022464" Approved Supported Cytosol NA NA Cytosol "CAB022464: , HPA007641: AB_1078845" "unprognostic (1.72e-1)" "unprognostic (1.66e-2)" "unprognostic (1.74e-1)" "unprognostic (2.46e-3)" "unprognostic (4.72e-2)" "unprognostic (5.65e-2)" "unprognostic (6.81e-2)" "unprognostic (7.39e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-3)" "unprognostic (7.36e-2)" "unprognostic (8.05e-2)" "prognostic favorable (5.55e-4)" "unprognostic (3.83e-3)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-3)" 4.3 3.7 3.5 3.0 3.4 1.6 3.6 3.1 3.7 3.8 1.1 3.2 1.8 3.7 2.9 4.2 3.0 3.3 3.0 3.2 3.8 3.5 2.3 3.8 1.4 3.8 3.4 2.8 4.7 1.9 9.5 2.5 4.2 3.9 3.1 2.4 5.7 2.5 3.9 1.3 4.6 2.0 4.9 4.0 2.7 2.2 6.8 2.9 2.8 6.4 2.0 2.0 3.6 3.2 5.3 9.8 3.4 11.0 18.0 6.6 10.1 7.2 11.4 11.0 6.5 7.6 19.0 5.5 15.3 6.9 13.8 8.4 6.3 6.2 14.4 14.7 6.5 8.4 9.8 14.5 7.0 4.4 5.6 8.2 6.2 7.9 15.8 17.5 6.4 9.8 14.6 12.9 11.1 8.4 2.7 4.4 1.7 1.6 0.9 7.0 3.3 10.7 91.7 6.4 3.3 3.8 5.6 18.6 1.0 11.4 7.0 4.4 2.4 14.7 12.5 10.2 6.5 9.0 9.4 14.9 5.9 7.4 1.9 6.0 8.9 3.7 4.6 1.2 2.5 2.1 10.3 0.7 1.4 2.3 3.4 1.2 1.5 0.3 1.1 2.0 4.5 1.7 0.9 3.5 3.4 3.1 3.7 3.2 3.8 3.8 3.4 2.8 3.9 4.0 2.9 5.3 23.8 80.1 28.3 207.3 9.5 29.2 15.8 9.5 25.6 17.6 6.6 8.5 21.9 10.0 21.8 14.7 18.8 3.9 7.5 4.9 1.9 13.6 158.1 13.1 17.2 19.7 8.4 10.7 266.3 6.0 10.7 31.4 16.8 12.6 95.5 21.8 18.9 2.3 8.2 18.5 313.8 4.5 8.2 9.5 13.4 182.4 19.3 14.1 14.2 227.7 12.0 10.5 4.1 284.0 216.0 9.1 4.7 17.7 13.7 12.1 1.7 6.9 27.9 16.3 6.6 30.7 23.8 7.7 11.5 13.2 17.6 3.1 10.4 10.2 4.1 6.9 VIPAS39 "C14orf133, hSPE-39, SPE-39, SPE39, VIPAR, VPS16B" ENSG00000151445 "VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog" Q9H9C1 14 77426675-77457952 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003589, HPA003593" Approved NA NA "HPA003589: AB_10599707, HPA003593: AB_10601879" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.79e-3)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (2.53e-2)" "unprognostic (1.67e-1)" "unprognostic (5.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-3)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (5.91e-2)" "unprognostic (1.09e-2)" 11.5 11.9 15.4 9.5 16.2 9.2 12.3 15.5 18.0 12.1 16.0 13.2 10.1 12.3 14.8 13.3 10.9 9.2 14.9 15.7 15.6 11.3 13.8 10.0 12.5 15.6 15.5 15.3 18.6 12.0 14.7 13.5 15.6 15.8 11.9 12.8 14.5 10.1 13.9 13.8 13.8 11.1 14.7 15.3 13.3 11.7 16.1 15.9 16.7 11.8 15.1 14.8 14.0 11.7 17.8 10.6 17.8 18.3 26.6 32.5 26.5 18.3 17.5 16.1 20.8 20.2 11.9 24.7 18.4 15.1 14.3 10.8 20.4 17.0 15.5 24.9 15.8 5.8 13.7 10.7 14.7 26.3 8.6 23.2 25.4 24.2 17.8 24.2 27.7 36.3 25.5 10.9 17.4 19.9 25.1 17.7 18.4 16.5 31.0 19.3 17.6 23.0 12.7 20.9 15.3 13.0 15.0 22.7 16.7 20.2 21.7 39.1 18.1 25.9 14.1 12.5 15.5 9.8 14.8 15.1 14.6 15.3 15.9 17.0 1.8 9.4 17.6 5.0 15.6 6.5 4.8 6.5 5.6 10.8 5.6 5.7 5.6 7.8 13.0 20.3 5.5 7.8 6.1 15.4 16.2 15.5 18.0 15.7 15.6 15.6 15.5 15.3 15.8 15.3 15.9 17.8 6.0 3.2 1.5 16.0 6.3 3.2 3.0 4.7 2.8 8.5 5.3 5.3 9.0 4.3 3.4 9.2 20.9 20.7 6.3 7.2 7.9 9.3 5.7 4.0 7.4 6.8 5.4 11.2 14.6 6.3 16.6 8.2 5.1 6.2 2.5 12.2 8.2 6.6 13.3 10.1 14.4 5.4 2.0 17.6 3.8 3.8 11.5 8.3 0.0 13.1 17.6 7.4 9.2 15.1 17.2 9.1 9.4 15.4 4.0 2.5 10.7 5.8 3.6 13.3 6.6 5.5 6.8 11.0 9.2 6.3 4.3 19.2 6.3 15.5 7.2 2.8 ANKRD50 KIAA1223 ENSG00000151458 "Ankyrin repeat domain 50" Q9ULJ7 4 124664048-124712732 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044008 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044008: AB_10961996" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (6.85e-3)" "unprognostic (5.90e-1)" "unprognostic (9.77e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (7.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (1.67e-1)" "unprognostic (8.25e-2)" "unprognostic (5.55e-3)" "unprognostic (4.82e-2)" "unprognostic (8.23e-2)" "unprognostic (8.16e-3)" 6.1 2.7 2.9 4.2 4.6 4.5 5.8 1.4 3.2 11.5 3.0 4.8 3.1 7.7 2.6 6.5 2.9 8.6 5.1 3.4 4.6 4.4 5.8 9.7 2.3 4.2 3.9 3.0 6.6 3.4 5.8 1.0 14.9 4.0 9.0 5.7 1.9 3.9 6.3 1.4 11.1 3.9 8.9 2.5 3.1 7.5 15.2 5.9 4.6 7.5 3.7 1.9 14.3 5.6 2.3 6.3 11.6 32.0 14.9 25.0 15.8 3.2 15.9 13.4 8.1 5.2 5.0 8.1 0.0 4.8 22.8 7.3 5.7 21.3 12.3 14.1 0.0 4.6 5.3 15.3 5.0 17.8 8.8 6.6 16.0 16.4 12.8 56.8 15.2 58.2 5.7 9.6 11.0 15.5 14.3 11.1 3.2 6.7 9.2 16.9 9.0 9.9 1.4 10.2 25.7 9.2 11.5 11.0 6.9 12.9 13.3 7.4 7.4 147.7 17.1 13.3 8.5 13.8 8.0 0.1 2.1 7.8 3.7 20.0 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.0 0.1 2.9 4.6 1.4 3.2 3.4 4.6 4.2 3.9 3.0 4.0 2.5 5.9 2.3 18.3 32.1 24.6 10.7 0.9 40.4 21.7 17.9 24.5 2.8 12.2 7.1 9.0 12.8 12.5 5.5 0.0 2.9 2.7 7.3 0.0 9.3 41.0 6.6 14.2 21.5 8.4 5.0 15.1 20.1 29.0 16.5 11.7 7.7 5.1 20.4 29.6 8.8 5.3 21.9 42.2 3.7 18.3 13.4 13.0 55.6 6.8 12.6 10.6 30.9 12.8 2.7 0.0 30.7 13.4 15.1 2.8 12.0 0.6 11.7 3.7 4.7 11.0 0.9 0.0 10.9 17.5 17.2 11.2 33.0 30.7 4.1 1.2 33.7 5.3 18.0 UPF2 "DKFZP434D222, KIAA1408, RENT2, smg-3" ENSG00000151461 "UPF2 regulator of nonsense mediated mRNA decay" Q9HAU5 10 11920022-12043170 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067008 Supported "Cytosol,Cytoplasmic bodies" NA NA Cytosol "Cytoplasmic bodies" "HPA067008: AB_2685762" "unprognostic (1.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.61e-2)" "unprognostic (2.48e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (5.48e-2)" "unprognostic (5.68e-2)" "unprognostic (9.27e-2)" "unprognostic (1.68e-2)" "unprognostic (3.01e-2)" "unprognostic (4.65e-3)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-1)" "unprognostic (8.48e-2)" 11.9 8.2 13.4 14.2 14.5 21.2 12.9 16.8 15.2 12.0 13.4 14.4 10.1 15.0 10.8 11.0 11.1 9.0 10.7 13.2 13.2 11.0 16.8 10.5 19.0 12.9 13.0 11.8 16.3 13.8 14.9 7.9 14.2 13.5 13.6 13.0 15.0 11.2 12.3 22.1 13.0 11.5 12.2 13.0 15.0 11.4 19.7 13.5 21.7 13.0 21.6 17.8 13.5 11.9 14.0 35.9 22.3 18.8 23.5 14.0 17.9 21.2 27.5 12.7 19.2 23.0 21.2 28.6 51.4 9.1 23.0 15.8 29.4 27.2 24.9 27.4 32.5 15.7 61.6 18.2 19.4 15.8 28.1 39.8 13.5 19.0 24.3 16.4 18.2 23.8 27.1 37.1 25.7 22.2 17.7 34.8 16.4 18.0 27.1 11.8 30.4 22.5 25.3 18.2 14.2 12.1 13.0 21.6 23.1 23.8 18.7 27.9 37.1 25.5 15.0 31.4 31.1 21.1 23.4 19.8 41.4 24.0 26.9 12.1 13.7 4.2 10.2 4.3 4.2 4.2 10.7 4.9 4.5 3.0 10.6 5.4 4.5 29.5 5.4 2.9 11.5 3.8 1.8 13.4 14.5 16.8 15.2 13.2 13.2 12.9 13.0 11.8 13.5 13.0 13.5 14.0 74.8 25.6 34.6 32.0 133.3 71.9 35.0 46.9 64.3 66.3 53.8 38.6 69.6 52.9 39.4 49.7 102.2 47.0 79.6 97.7 39.2 47.7 70.1 99.3 86.2 62.6 66.3 108.4 36.1 44.8 51.7 48.2 58.1 88.7 58.9 71.8 64.2 89.5 41.1 52.2 31.6 90.2 48.8 71.4 125.3 116.9 86.3 56.0 53.4 31.9 89.0 45.5 98.9 37.2 45.4 53.7 78.9 59.0 121.2 38.7 70.6 34.1 41.5 97.2 98.6 54.3 60.1 182.9 149.8 47.3 81.8 56.5 73.6 35.9 65.5 36.3 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: AB_2732614" "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 45.3 40.4 38.8 54.3 44.3 74.1 46.4 40.5 46.5 43.9 38.9 54.6 37.4 39.4 47.3 50.5 42.7 34.3 61.5 40.6 41.6 43.0 56.0 36.1 69.6 40.5 38.8 38.9 31.7 29.7 42.7 33.2 51.2 40.5 35.7 58.8 29.9 31.8 39.7 50.2 44.6 39.4 53.8 41.8 45.7 35.7 36.0 39.7 65.8 41.9 53.0 81.7 64.2 35.0 43.0 155.4 187.4 148.3 157.1 125.4 136.3 117.7 137.0 94.2 194.8 205.5 274.0 186.5 259.7 123.5 153.6 116.1 157.7 237.0 223.3 172.0 176.8 206.6 199.3 142.8 266.6 162.1 151.6 159.0 131.3 118.9 214.0 126.5 98.0 206.3 320.6 224.2 114.5 178.6 135.0 208.3 133.8 221.4 223.1 76.3 195.7 111.9 234.0 173.2 86.3 72.3 140.8 139.6 165.4 152.6 120.4 180.7 179.2 200.9 107.7 127.6 167.9 166.6 112.5 233.5 320.7 135.4 155.3 69.7 133.8 99.2 242.2 103.6 117.0 108.1 158.6 114.8 115.0 139.0 170.5 93.5 99.9 233.4 121.1 129.4 116.0 143.5 167.3 38.8 44.3 40.5 46.5 40.6 41.6 40.5 38.8 38.9 40.5 41.8 39.7 43.0 48.6 32.1 35.9 18.3 51.5 54.2 49.2 162.1 39.9 28.5 28.0 32.3 56.4 24.3 75.8 35.0 6.2 120.8 55.3 25.1 86.1 91.1 7.9 26.8 39.5 49.7 20.9 36.8 33.2 82.6 138.2 46.3 26.5 26.1 49.4 36.6 34.2 37.6 101.3 26.9 27.9 31.9 105.8 25.9 34.0 10.1 41.7 37.2 46.2 21.5 79.3 43.3 45.3 19.6 23.5 84.3 34.3 45.9 44.2 46.5 30.7 73.0 62.5 29.9 39.5 32.3 59.8 50.2 41.5 46.5 74.0 77.6 51.3 72.4 47.0 50.7 SCLT1 "FLJ30655, hCAP-1A" ENSG00000151466 "Sodium channel and clathrin linker 1" Q96NL6 4 128864921-129093600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 110.0;Excitatory neurons: 111.1;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 109.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 66.0" "Group enriched" "Detected in all" 5 "granulocytes: 66.0;monocytes: 31.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036560, HPA036561" Approved Uncertain Microtubules,Cytosol NA Yes "Microtubules, Cytosol" "HPA036560: AB_2675190, HPA036561: AB_10673658" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (5.05e-2)" "unprognostic (9.18e-2)" "unprognostic (1.33e-3)" "unprognostic (1.64e-2)" "unprognostic (1.94e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-1)" "unprognostic (3.09e-2)" "unprognostic (5.34e-4)" "unprognostic (6.54e-2)" "unprognostic (2.70e-1)" "unprognostic (6.05e-2)" "unprognostic (8.92e-2)" 3.7 3.1 3.7 6.5 4.5 14.6 3.5 7.8 4.7 3.4 1.6 3.8 4.3 3.5 2.2 3.9 3.1 4.7 3.6 2.7 3.5 2.6 3.5 3.5 7.4 4.7 4.4 2.1 4.5 3.3 3.0 3.0 4.7 4.2 2.4 4.5 3.0 2.6 2.7 1.6 3.2 3.4 3.6 3.7 7.6 3.5 4.9 4.8 8.9 3.0 1.8 6.7 4.4 3.4 4.6 19.9 5.3 18.8 12.4 6.5 10.5 10.3 16.5 14.8 17.8 16.3 5.7 17.1 17.0 10.4 9.3 12.4 7.4 12.5 12.2 18.5 38.9 10.0 22.7 10.2 6.5 8.9 27.1 17.0 6.7 4.3 14.2 14.2 8.5 14.0 8.6 25.7 39.8 15.6 8.8 20.8 13.0 8.4 14.2 10.5 12.2 19.2 10.6 11.4 5.5 28.1 8.2 12.7 11.5 11.1 8.2 6.8 10.8 13.2 14.5 17.6 19.7 22.3 19.3 15.5 29.0 8.1 29.7 22.2 18.3 16.9 36.8 3.8 24.6 2.2 3.9 2.6 2.7 9.5 3.7 2.5 3.4 66.0 10.2 31.1 4.4 3.7 6.5 3.7 4.5 7.8 4.7 2.7 3.5 4.7 4.4 2.1 4.2 3.7 4.8 4.6 16.1 12.8 9.8 110.0 18.0 11.1 8.9 5.8 8.0 15.2 6.1 7.4 21.2 15.7 9.0 1.8 29.2 13.8 34.8 9.1 3.9 6.5 63.2 20.3 18.4 11.9 5.4 9.0 111.1 6.3 21.5 16.3 28.1 14.3 12.0 16.5 9.3 1.6 13.3 16.8 116.0 8.1 8.2 21.6 18.0 51.8 10.8 28.4 8.8 87.1 33.8 8.9 82.4 109.1 90.5 9.0 9.8 9.1 24.0 2.7 8.2 3.1 16.7 21.6 13.1 14.4 16.5 19.6 12.1 13.1 13.9 9.3 21.2 30.5 10.6 5.6 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 133.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 50.1;Excitatory neurons: 100.2;Inhibitory neurons: 41.3;Peritubular cells: 60.5;Smooth muscle cells: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 10.4;HAP1: 19.1;HDLM-2: 32.4;hTERT-RPE1: 14.8;U-2 OS: 20.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 20.8" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 92.6 11.1 33.3 5.9 34.5 0.1 37.6 18.5 38.9 48.5 22.0 9.7 6.7 25.2 41.6 61.0 57.2 71.3 19.3 35.4 22.6 8.6 20.8 21.2 12.5 22.9 21.4 34.1 86.9 6.6 5.0 10.3 22.4 27.4 35.5 7.5 1.7 7.1 22.3 30.9 133.3 14.4 24.4 19.8 24.9 13.3 11.7 22.0 42.4 20.2 13.4 4.2 23.4 27.7 31.2 0.0 0.2 1.7 9.4 0.0 0.0 0.1 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.7 0.0 10.4 1.9 19.1 3.6 0.6 32.4 8.1 0.0 0.2 0.0 0.7 0.0 0.0 2.3 2.3 0.4 0.0 14.8 0.9 0.8 0.0 0.2 1.0 0.2 0.0 5.4 1.5 0.0 0.1 0.0 4.1 0.3 0.0 0.0 3.6 1.6 7.0 1.0 0.0 4.4 0.0 0.0 0.0 0.0 20.0 1.2 0.3 0.0 0.0 0.0 0.1 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.3 34.5 18.5 38.9 35.4 22.6 22.9 21.4 34.1 27.4 19.8 22.0 31.2 12.4 0.0 0.0 10.1 0.1 50.1 6.4 26.3 13.6 1.2 0.9 4.7 7.9 1.5 2.1 0.0 0.0 0.3 1.3 0.1 1.9 0.0 0.2 0.1 0.7 27.2 0.0 0.0 100.2 0.0 0.2 16.0 0.5 0.4 0.0 16.4 8.2 0.2 0.3 0.0 41.3 0.1 0.0 0.0 6.4 1.5 22.4 0.6 14.2 3.7 0.0 0.3 0.0 22.6 23.2 0.1 2.5 60.5 0.0 3.0 0.3 0.4 1.1 2.1 32.9 7.9 119.4 0.0 5.7 2.1 37.2 0.3 1.0 6.0 0.3 1.3 C4orf33 FLJ33703 ENSG00000151470 "Chromosome 4 open reading frame 33" Q8N1A6 4 129093317-129116640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA061199 Uncertain Approved "Nuclear bodies,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear bodies" "HPA061199: AB_2684450" "unprognostic (7.27e-2)" "unprognostic (8.84e-2)" "unprognostic (3.50e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.07e-2)" "unprognostic (5.82e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (1.34e-2)" "unprognostic (3.55e-2)" "unprognostic (5.14e-2)" "prognostic favorable (3.04e-4)" "unprognostic (2.09e-2)" "unprognostic (2.54e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.49e-5)" 7.9 10.4 4.4 6.4 5.0 16.3 9.6 11.0 5.7 5.4 4.1 20.7 17.2 4.9 9.5 9.2 8.4 9.3 5.2 4.5 5.3 14.3 10.0 8.5 6.6 6.1 6.1 4.0 11.2 9.5 6.1 12.3 9.5 6.9 4.6 16.9 13.5 6.7 4.2 2.6 6.9 15.2 5.8 6.2 8.0 16.3 5.6 5.7 9.0 12.1 2.7 5.9 10.0 5.8 6.9 7.7 4.3 9.7 9.8 7.8 7.5 15.7 7.2 10.0 8.4 10.8 2.2 36.1 6.4 17.8 10.4 13.0 4.8 11.2 11.5 6.8 38.3 8.6 15.7 11.4 3.0 9.5 7.8 16.0 7.6 10.2 10.0 4.0 15.5 6.9 22.9 20.5 26.9 8.6 3.1 12.7 6.2 0.5 16.2 5.4 5.3 10.3 8.3 23.7 8.7 12.4 2.8 5.5 13.1 8.7 2.2 12.2 5.9 5.0 7.4 2.7 5.5 5.8 14.4 6.8 11.3 15.4 20.4 6.4 18.7 11.7 30.3 3.3 11.6 2.5 5.6 2.6 4.0 11.8 2.7 2.7 4.3 5.7 9.3 12.3 6.4 4.8 4.9 4.4 5.0 11.0 5.7 4.5 5.3 6.1 6.1 4.0 6.9 6.2 5.7 6.9 10.7 6.4 14.1 11.8 9.2 10.5 7.4 22.9 10.8 15.1 13.4 8.3 4.2 18.6 16.3 12.9 8.4 21.5 19.8 24.7 50.9 10.4 6.9 34.8 7.4 7.9 4.9 8.2 12.8 9.3 18.9 8.3 18.8 17.5 14.5 5.9 8.6 5.2 14.2 1.7 11.2 14.7 22.4 18.1 16.7 3.0 2.1 18.6 12.4 10.3 13.3 11.8 7.2 12.1 21.5 8.1 17.9 2.2 9.6 2.7 25.6 30.9 36.9 11.5 0.0 5.0 12.9 4.6 5.4 13.5 9.2 18.9 12.2 15.5 16.4 8.9 FRMD4A "bA295P9.4, FLJ10210, FRMD4, KIAA1294" ENSG00000151474 "FERM domain containing 4A" Q9P2Q2 10 13643706-14462142 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.3" "Group enriched" "Detected in many" 7 "Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.3" "Lineage enriched" "Detected in single" 5 "B-cells: 2.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038449 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038449: AB_10669539" "unprognostic (6.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.51e-3)" "unprognostic (5.68e-2)" "unprognostic (1.55e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.21e-3)" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (9.20e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (8.16e-2)" "unprognostic (1.84e-1)" 61.3 5.3 24.5 11.8 28.7 5.5 18.9 0.0 29.9 8.4 0.0 11.0 5.8 5.8 4.0 9.5 8.8 9.6 15.2 25.6 4.0 12.7 12.3 14.3 9.2 14.9 9.0 22.5 6.9 15.6 2.4 8.8 22.7 10.7 10.4 6.5 14.2 13.7 10.3 8.2 32.3 7.5 6.5 8.1 33.1 8.0 8.9 14.8 15.7 8.2 7.3 8.5 10.5 9.0 26.7 7.0 7.1 90.1 0.5 12.3 22.0 16.9 40.8 36.5 35.2 48.7 12.1 4.2 0.1 28.3 21.5 48.6 13.5 0.3 3.3 30.7 0.3 9.9 1.4 0.9 0.2 11.0 0.5 1.1 12.8 3.2 134.0 16.4 98.9 105.8 3.1 13.6 0.4 64.7 8.5 4.6 0.8 24.6 0.3 9.6 0.4 30.8 0.2 16.6 5.8 4.3 15.9 0.2 32.7 64.4 16.1 18.5 3.3 191.6 48.8 17.4 47.6 49.3 0.3 0.4 0.3 41.7 1.0 163.4 0.1 0.1 0.0 0.0 0.1 0.1 0.8 0.3 0.1 0.0 2.3 0.3 0.0 0.3 0.2 0.0 0.4 0.4 0.0 24.5 28.7 0.0 29.9 25.6 4.0 14.9 9.0 22.5 10.7 8.1 14.8 26.7 48.6 32.1 2.6 168.1 1.7 35.1 13.1 3.0 9.1 54.2 17.1 14.4 11.4 45.8 4.1 33.1 18.8 69.6 0.4 1.1 11.7 15.8 42.5 13.1 5.5 44.0 4.8 81.7 1527.6 4.0 42.1 14.9 4.6 26.9 15.2 58.1 44.3 6.2 35.9 80.8 1622.8 3.4 6.1 95.6 19.9 98.8 2.1 25.5 16.0 1329.4 2.7 46.0 0.0 442.3 61.0 1.8 1.4 1.9 0.9 8.0 0.3 2.7 2.5 12.9 13.1 41.2 45.5 1.3 2.1 20.6 32.7 28.7 3.0 5.3 5.4 4.3 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730400-127774292 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Spermatogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 271 "testis: 47.7" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 198.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 13.5 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.2 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTPRO "GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2" ENSG00000151490 "Protein tyrosine phosphatase receptor type O" Q16827 12 15322257-15602175 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.1;kidney: 35.4" "Group enriched" "Detected in many" 7 "Excitatory neurons: 193.6;Inhibitory neurons: 231.1;Oligodendrocyte precursor cells: 126.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 8.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 9.9;NTERA-2: 5.8;SH-SY5Y: 6.1;THP-1: 2.7" "Region enhanced" "Detected in all" "olfactory bulb: 175.9" "Low region specificity" "Detected in all" HPA034525 Enhanced "Intracellular and membrane" NA NA "HPA034525: AB_10669785" "unprognostic (3.68e-2)" "unprognostic (3.49e-1)" "unprognostic (9.64e-2)" "unprognostic (1.25e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-1)" "unprognostic (5.93e-3)" "unprognostic (5.37e-2)" "unprognostic (2.03e-1)" "unprognostic (3.72e-2)" "unprognostic (2.00e-1)" "unprognostic (5.43e-2)" "unprognostic (4.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 1.8 0.9 9.5 3.0 10.1 0.2 0.8 0.1 11.1 1.3 0.7 10.5 1.7 4.8 1.4 0.4 1.0 1.2 0.5 9.8 7.5 35.4 1.3 6.8 3.1 3.3 4.2 9.1 0.4 0.4 0.3 2.4 4.4 3.9 0.5 27.1 7.5 0.6 0.8 0.3 0.4 2.0 6.7 1.2 3.5 0.8 0.5 7.7 1.3 0.3 0.5 3.2 1.5 0.4 4.9 0.0 0.1 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.5 1.3 0.0 0.0 0.1 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.8 1.2 0.0 0.0 0.0 0.0 0.1 0.2 1.5 6.1 0.9 0.0 0.1 0.1 0.1 2.7 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.3 0.0 0.1 1.2 0.0 6.0 0.0 0.0 12.3 0.0 8.9 1.7 0.4 8.5 8.6 2.8 1.2 0.1 0.1 12.7 10.9 1.4 3.2 9.5 10.1 0.1 11.1 9.8 7.5 3.3 4.2 9.1 3.9 1.2 7.7 4.9 0.2 0.0 0.5 7.5 7.0 0.3 1.3 0.5 0.0 25.2 0.0 0.1 0.7 0.0 1.8 16.5 0.0 0.2 4.0 3.9 0.0 0.4 0.0 0.8 0.2 1.1 3.6 0.0 193.6 0.0 0.2 0.9 0.0 0.6 0.0 0.0 1.1 0.2 26.1 25.2 231.1 8.3 0.0 21.1 10.6 0.6 0.6 10.5 0.0 17.8 13.8 0.6 1.0 126.7 6.3 0.1 9.8 0.4 1.0 0.1 0.1 0.2 0.0 4.8 0.0 2.1 0.7 0.6 1.1 0.1 0.4 0.3 1.0 0.1 22.4 0.8 EPS8 ENSG00000151491 "Epidermal growth factor receptor pathway substrate 8" Q12929 12 15620134-15882329 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 22.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 253.0;HHSteC: 218.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003897 Approved Approved "Golgi apparatus" NA NA 17000 "Golgi apparatus" "HPA003897: AB_1848224" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-2)" "unprognostic (5.43e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (5.81e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (3.33e-7)" "unprognostic (2.68e-1)" "prognostic favorable (1.45e-7)" "unprognostic (7.47e-3)" "unprognostic (7.20e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.79e-2)" 62.9 13.1 12.9 16.3 15.9 0.6 34.0 14.3 14.1 54.4 18.3 50.1 38.0 46.6 47.6 20.7 20.3 56.5 26.6 10.1 17.4 56.3 38.2 29.3 9.5 16.9 17.2 6.5 49.6 15.2 21.8 3.5 53.5 18.0 16.6 54.2 40.1 13.5 40.1 14.0 10.2 43.0 54.1 15.2 12.0 32.3 15.8 14.9 4.9 23.0 24.6 5.3 52.2 21.6 23.1 65.0 38.8 37.7 1.4 253.0 177.6 53.1 73.6 59.8 34.5 46.1 33.3 97.3 0.0 2.4 140.4 114.4 16.4 11.3 9.5 52.4 0.2 12.6 5.7 11.2 34.7 218.1 4.4 0.2 159.8 42.8 91.7 115.7 44.6 17.7 0.2 0.1 0.2 169.0 17.5 0.2 2.8 5.2 50.3 30.8 0.0 109.5 0.8 97.7 92.5 3.1 4.9 21.4 12.4 91.5 6.2 34.2 4.3 28.7 54.7 14.3 32.4 30.7 3.6 0.4 0.1 32.1 10.7 160.0 0.0 2.7 0.2 0.2 10.8 0.1 1.3 0.9 0.4 5.5 0.3 1.1 0.5 4.4 1.0 22.2 0.4 0.1 1.7 12.9 15.9 14.3 14.1 10.1 17.4 16.9 17.2 6.5 18.0 15.2 14.9 23.1 121.4 12.8 175.9 91.1 11.6 17.0 39.6 32.0 13.6 9.7 28.7 42.8 27.6 87.2 58.3 23.9 66.7 33.0 15.2 317.0 60.7 69.4 67.6 87.4 72.0 61.4 38.3 0.4 2.2 68.9 7.3 73.4 81.1 152.2 6.3 139.4 36.0 36.0 65.8 6.7 31.1 54.5 67.1 54.1 35.6 49.4 134.8 46.2 35.6 148.0 8.6 15.4 0.0 121.2 96.9 97.0 217.8 43.6 5.2 26.9 69.0 114.6 104.8 153.7 401.0 18.1 313.1 10.9 4.2 22.8 13.1 21.1 11.8 40.0 80.0 97.6 ACAD8 ENSG00000151498 "Acyl-CoA dehydrogenase family member 8" Q9UKU7 11 134253548-134265855 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Branched-chain amino acid catabolism, Transcription, Transcription regulation" "Activator, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040689, HPA043903" Enhanced NA NA "HPA040689: AB_2677080, HPA043903: AB_2678724" "unprognostic (5.00e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.62e-4)" "unprognostic (7.57e-3)" "unprognostic (9.83e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.53e-1)" "prognostic favorable (2.38e-4)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (7.81e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.42e-10)" "unprognostic (1.08e-1)" "unprognostic (1.17e-2)" "unprognostic (4.02e-2)" "unprognostic (1.03e-2)" 11.1 18.3 14.9 3.6 14.8 6.8 11.4 15.3 15.5 7.6 18.6 11.7 11.4 6.3 12.8 9.7 9.5 5.2 27.5 15.3 15.9 31.9 25.0 7.9 5.0 15.2 15.0 14.1 7.0 16.9 12.5 6.6 4.8 14.5 20.7 11.0 5.0 12.8 7.6 32.8 13.6 8.5 8.4 15.2 8.7 12.7 6.4 15.3 8.5 28.0 39.5 9.0 8.4 7.0 15.6 5.9 5.9 11.8 17.6 20.2 11.5 13.5 11.3 14.0 14.7 10.3 16.2 10.8 14.2 21.1 11.7 15.5 6.0 14.6 14.3 10.2 13.0 4.7 29.4 5.8 11.3 17.0 16.5 18.3 13.8 4.4 14.8 4.5 13.3 16.3 20.8 13.8 7.0 12.4 7.5 12.2 18.1 17.0 49.8 9.7 9.8 11.9 8.5 20.1 17.5 3.7 11.7 19.5 14.8 7.3 11.9 31.0 15.0 11.3 7.1 7.5 6.2 11.2 7.8 3.8 12.7 7.2 15.4 11.2 36.2 13.4 23.1 11.8 13.5 11.5 11.6 11.1 11.7 12.7 9.2 13.0 11.7 12.1 31.5 12.9 10.8 15.1 12.3 14.9 14.8 15.3 15.5 15.3 15.9 15.2 15.0 14.1 14.5 15.2 15.3 15.6 11.7 3.2 12.2 15.3 8.8 6.0 4.7 23.5 7.4 11.2 17.5 11.9 24.6 4.3 19.7 18.4 14.6 19.7 14.0 20.0 52.8 12.1 5.3 8.2 11.8 9.7 3.6 12.0 21.5 11.9 10.6 9.8 10.2 8.5 3.8 15.7 10.8 36.7 12.9 15.2 16.0 14.3 48.8 14.2 6.9 6.1 11.5 10.0 28.4 13.1 12.7 11.8 9.2 12.1 15.8 12.6 15.8 10.1 14.6 5.9 17.4 59.8 20.1 17.1 6.6 8.7 9.6 22.4 17.3 10.9 7.7 8.3 10.5 36.0 14.9 5.3 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: AB_2676183" "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 42.0 40.8 77.1 22.2 79.4 43.7 45.6 78.2 105.7 38.7 73.5 47.7 30.4 43.4 76.5 28.3 48.0 31.3 52.2 78.8 78.5 40.4 58.0 28.6 40.9 76.1 76.0 77.1 63.5 33.1 28.1 51.2 22.3 77.2 50.5 45.3 41.7 29.8 54.7 32.6 28.3 36.6 42.7 75.9 36.9 39.7 43.0 77.6 77.8 52.6 38.4 44.8 44.6 33.3 78.3 32.0 19.5 69.8 56.0 65.9 74.7 41.0 26.9 59.2 62.0 58.1 106.8 76.3 60.0 88.6 37.8 66.6 48.9 106.8 82.0 60.5 61.5 30.3 165.5 25.7 97.6 94.3 133.0 52.4 56.9 43.2 73.9 48.2 80.6 98.9 199.0 78.1 28.0 56.5 17.7 155.1 242.8 81.0 127.0 71.0 72.3 51.8 50.6 86.4 55.4 66.4 53.7 55.8 13.6 33.1 50.3 78.2 66.5 52.7 26.6 41.3 24.4 41.7 31.4 35.0 126.9 39.5 170.6 31.5 185.4 89.8 330.3 145.2 108.4 175.6 122.1 152.3 146.8 99.1 96.4 175.4 200.0 47.2 139.1 104.4 131.3 199.8 160.0 77.1 79.4 78.2 105.7 78.8 78.5 76.1 76.0 77.1 77.2 75.9 77.6 78.3 41.9 32.1 28.8 8.1 31.1 23.8 42.2 107.4 28.5 28.6 37.5 65.4 52.1 47.1 57.7 36.8 14.6 52.7 33.5 25.5 86.1 48.2 28.2 44.7 33.8 36.9 57.6 40.8 15.3 55.6 52.9 42.3 20.4 23.4 40.5 65.5 37.1 47.9 53.0 28.6 12.0 47.9 75.3 22.2 23.7 16.0 50.4 32.7 40.9 8.4 43.1 65.7 44.3 11.1 11.1 53.2 33.0 48.5 29.8 13.4 49.3 93.3 73.1 23.9 46.0 34.0 51.3 79.1 94.9 31.4 20.6 13.8 44.1 72.7 52.7 31.6 VPS26B "MGC10485, Pep8b" ENSG00000151502 "VPS26, retromer complex component B" Q4G0F5 11 134224671-134247788 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038172 Uncertain NA NA 8800 "HPA038172: AB_10675630" "unprognostic (1.55e-2)" "unprognostic (6.56e-2)" "unprognostic (7.02e-3)" "unprognostic (2.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (1.71e-1)" "unprognostic (3.54e-1)" "unprognostic (7.77e-2)" "unprognostic (6.97e-3)" "unprognostic (1.66e-1)" "unprognostic (3.42e-3)" "unprognostic (3.15e-2)" "unprognostic (7.05e-3)" "unprognostic (2.44e-1)" "unprognostic (2.13e-1)" 17.9 21.4 36.6 13.6 41.2 30.6 16.5 33.6 41.9 17.9 28.5 21.8 20.7 20.7 31.8 20.0 20.5 15.5 23.9 43.0 36.0 13.4 29.7 15.9 14.1 31.6 34.1 40.6 19.3 26.1 17.6 21.5 13.5 32.9 21.2 17.3 25.0 21.8 19.0 17.2 35.6 21.6 20.7 30.2 18.7 20.3 17.0 34.1 30.5 17.8 16.2 12.9 19.1 16.9 35.3 25.1 27.8 22.8 70.0 50.2 44.2 19.1 26.3 31.5 23.4 17.4 46.4 43.3 15.8 52.0 46.1 27.4 35.8 30.5 43.6 17.5 37.4 21.9 69.5 16.1 30.3 36.6 41.3 42.9 42.1 28.0 22.4 41.3 32.9 41.9 60.1 34.3 27.1 33.3 30.4 89.8 47.0 13.0 78.3 45.1 20.5 18.4 22.5 29.2 39.6 38.0 38.3 30.0 53.9 17.3 24.0 99.8 31.9 34.7 29.5 16.5 37.7 18.8 34.0 20.0 6.4 19.2 64.1 22.3 3.9 3.3 8.3 5.4 4.1 4.8 0.9 4.6 5.8 3.0 0.4 2.9 5.3 4.9 5.5 3.6 3.4 5.1 2.9 36.6 41.2 33.6 41.9 43.0 36.0 31.6 34.1 40.6 32.9 30.2 34.1 35.3 14.3 12.8 6.4 14.7 9.4 17.7 12.7 7.1 25.0 30.0 21.9 22.1 29.1 17.2 6.9 20.2 8.4 18.8 36.2 31.4 21.5 8.6 26.5 12.9 16.7 14.0 28.4 24.8 24.8 14.8 27.1 19.2 29.0 11.5 1.3 22.5 14.6 34.7 23.9 30.3 18.8 30.3 10.2 32.7 16.4 67.9 18.0 27.5 12.4 11.2 21.7 23.8 48.4 13.6 19.9 11.2 32.4 30.9 26.8 11.7 63.8 22.7 7.7 22.8 6.6 14.6 19.7 13.4 21.3 24.4 24.0 12.4 26.6 20.0 25.7 12.0 NCAPD3 "CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056" ENSG00000151503 "Non-SMC condensin II complex subunit D3" P42695 11 134150113-134225454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "prostate: 59.0" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 8 "prostate cancer: 50.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040286 Supported Nucleoplasm NA NA Nucleoplasm "HPA040286: AB_2676918" "unprognostic (4.27e-2)" "unprognostic (6.05e-2)" "unprognostic (7.78e-3)" "unprognostic (8.22e-3)" "unprognostic (2.79e-1)" "unprognostic (4.29e-2)" "unprognostic (2.15e-3)" "unprognostic (2.56e-1)" "unprognostic (4.32e-2)" "unprognostic (4.75e-1)" "unprognostic (2.79e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.93e-2)" "unprognostic (3.35e-2)" "unprognostic (3.94e-1)" "unprognostic (3.48e-1)" 4.5 5.5 1.9 3.1 2.1 10.1 4.9 4.0 4.0 3.9 2.2 4.0 3.6 4.0 3.3 7.2 3.9 2.6 4.5 3.2 1.4 3.6 8.9 4.9 4.2 2.2 1.4 2.3 3.4 4.5 2.0 7.1 3.1 2.2 59.0 1.5 4.5 5.7 0.9 3.8 9.0 5.5 1.4 1.1 6.2 5.2 9.6 1.8 3.1 6.0 0.9 1.7 3.8 5.3 3.2 5.5 1.9 12.3 25.3 1.8 1.3 10.6 11.5 1.9 3.5 4.0 5.6 3.4 6.1 11.1 3.5 9.8 6.1 3.5 5.2 4.4 9.2 21.7 26.6 5.1 8.5 2.3 13.1 15.4 1.7 1.1 5.1 2.0 3.6 2.6 11.6 7.1 4.7 4.2 6.0 10.9 15.1 8.6 5.5 13.8 2.9 13.7 8.5 4.1 3.2 22.1 13.4 9.1 5.9 1.7 10.0 9.7 6.9 1.7 11.8 5.7 11.8 9.9 4.5 4.5 5.5 8.3 16.4 15.2 1.6 3.3 1.6 5.7 2.7 2.2 2.3 3.7 3.8 2.5 5.2 5.5 5.8 1.6 1.7 2.2 8.0 6.5 1.9 1.9 2.1 4.0 4.0 3.2 1.4 2.2 1.4 2.3 2.2 1.1 1.8 3.2 7.7 3.2 8.1 8.5 12.1 9.2 4.4 6.0 8.0 20.2 9.9 8.6 6.7 2.8 7.0 12.9 10.4 13.0 13.2 5.4 0.0 2.7 7.2 7.8 12.8 5.6 7.8 32.8 19.7 2.6 9.9 7.5 7.7 9.0 2.5 19.6 5.7 9.7 8.8 11.8 16.7 7.2 10.2 6.4 8.7 10.4 4.7 10.9 1.8 15.0 17.1 9.0 17.5 11.1 16.0 2.8 1.6 4.1 22.9 8.8 3.2 3.6 4.9 20.9 0.0 9.5 9.2 21.5 14.4 10.7 9.1 4.5 14.2 11.3 11.6 3.4 VTI1A "MVti1, Vti1-rp2" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA054108: AB_2682382" "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favorable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 6.6 4.8 3.6 7.0 3.5 13.9 4.7 2.1 4.5 3.3 1.3 6.5 7.2 3.9 4.9 7.3 3.3 4.6 5.9 4.5 2.6 6.9 4.7 5.1 7.8 2.6 3.6 4.0 3.1 4.0 7.5 2.6 4.0 3.5 4.8 7.5 4.3 5.2 4.9 7.4 5.9 7.2 5.8 1.6 5.7 5.5 4.6 3.4 8.7 6.4 6.1 9.5 5.2 4.5 4.5 13.5 11.2 10.1 14.1 15.5 13.4 6.1 14.1 17.4 11.0 12.2 12.7 13.6 14.0 5.3 16.0 9.3 15.6 8.8 11.2 14.9 18.0 8.1 11.9 8.1 13.3 11.0 16.8 16.8 10.4 13.9 12.6 25.9 12.4 11.9 14.1 11.3 16.9 14.8 9.5 13.3 12.8 4.4 10.5 6.5 13.9 14.6 6.2 11.5 11.9 4.6 9.0 10.0 8.6 9.5 8.4 7.8 9.3 17.0 8.7 7.4 10.8 15.8 7.4 11.0 15.9 14.2 15.3 8.6 9.2 7.0 9.6 5.4 9.3 5.1 5.5 4.5 4.4 5.2 4.6 4.3 4.4 11.4 5.7 8.7 4.9 7.2 4.6 3.6 3.5 2.1 4.5 4.5 2.6 2.6 3.6 4.0 3.5 1.6 3.4 4.5 13.5 12.8 10.3 135.2 33.1 11.2 14.5 8.8 13.6 16.5 7.8 4.6 14.0 7.2 11.6 5.5 43.8 7.6 31.5 17.0 7.9 15.4 42.9 11.4 15.5 13.6 18.5 18.1 244.7 25.0 12.3 12.9 21.9 17.0 19.6 10.2 8.9 8.1 18.8 21.9 199.5 10.7 14.2 17.0 27.0 102.8 6.8 20.9 12.4 195.8 19.0 6.0 25.7 172.4 218.6 29.7 12.2 5.7 23.9 12.6 17.2 9.4 11.7 20.7 0.0 13.5 14.1 11.1 9.2 17.0 16.3 14.4 25.4 9.7 12.1 19.7 QDPR "DHPR, PKU2, SDR33C1" ENSG00000151552 "Quinoid dihydropteridine reductase" P09417 4 17460261-17512206 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Oxidoreductase "Disease variant, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 762.6;choroid plexus: 318.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 337.6;Muller glia cells: 387.2;Oligodendrocytes: 481.3;Proximal tubular cells: 527.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058951, HPA065649" Enhanced Approved Mitochondria NA NA 2500000 Mitochondria "HPA058951: AB_2683861, HPA065649: AB_2685526" "unprognostic (1.30e-2)" "unprognostic (4.29e-1)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (3.29e-3)" "unprognostic (3.80e-3)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "unprognostic (6.82e-3)" "unprognostic (2.07e-1)" "prognostic favorable (7.84e-6)" "unprognostic (1.58e-1)" "unprognostic (2.60e-1)" "unprognostic (9.01e-2)" "unprognostic (3.19e-1)" 67.2 75.0 544.2 10.3 697.8 15.2 26.6 691.2 576.7 15.6 318.6 21.4 25.8 16.6 40.4 15.8 17.4 17.9 43.8 462.2 588.1 111.1 198.8 23.6 12.0 688.6 762.6 427.4 18.5 29.1 50.3 33.0 11.9 681.0 28.9 17.2 40.4 36.7 19.7 109.7 16.0 24.1 18.0 552.8 14.4 23.9 12.5 619.6 13.7 22.3 61.7 13.4 14.6 15.2 690.3 33.1 62.5 30.2 35.8 66.1 32.3 41.5 43.2 22.3 47.5 41.6 52.2 46.4 12.2 28.0 30.3 50.8 18.4 40.3 58.4 33.7 35.3 7.3 34.8 33.4 128.3 37.3 46.2 2.9 40.8 35.6 31.6 40.3 25.9 24.5 33.2 37.0 29.0 50.6 19.2 65.0 77.8 44.8 36.7 45.4 27.0 21.0 52.2 48.2 17.5 47.1 64.3 31.9 6.7 156.6 35.0 15.7 19.0 37.7 23.6 41.1 26.5 38.2 43.1 67.7 85.3 52.0 43.1 41.7 0.3 38.9 3.0 31.3 61.3 29.8 18.6 33.1 32.3 48.3 18.3 37.4 32.6 1.1 29.8 48.4 115.1 20.3 34.4 544.2 697.8 691.2 576.7 462.2 588.1 688.6 762.6 427.4 681.0 552.8 619.6 690.3 20.3 28.9 31.5 10.7 14.8 20.0 21.3 32.2 18.8 36.2 37.6 28.3 74.4 50.1 19.5 38.6 8.4 69.6 22.8 13.7 109.5 41.1 1.0 11.8 19.1 17.2 174.3 30.1 23.1 23.4 34.2 27.1 27.5 17.8 25.4 42.3 20.7 337.6 80.3 82.4 21.9 31.1 34.6 38.1 23.9 4.8 22.7 32.2 152.9 12.2 23.4 387.2 16.5 15.1 481.3 16.9 11.6 38.0 23.6 23.2 41.4 527.2 6.2 31.4 26.3 27.5 25.4 3.3 58.9 29.7 16.1 18.3 18.5 90.0 35.7 17.3 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 14.2 11.8 9.3 10.1 8.9 53.8 12.1 6.9 8.4 11.8 6.5 9.7 12.8 16.1 10.1 7.4 12.4 10.6 13.4 8.3 7.3 8.0 19.2 11.7 12.7 6.5 7.1 8.8 14.5 9.9 12.0 7.4 15.1 6.9 10.6 8.1 11.6 8.5 11.4 20.5 8.6 13.3 17.1 5.5 11.5 10.2 19.0 8.3 11.3 11.8 12.5 9.7 12.0 10.1 6.6 16.7 8.9 9.6 14.3 22.9 26.0 11.2 29.7 28.8 16.8 13.4 3.1 6.3 9.9 9.1 27.2 4.3 11.0 4.7 11.9 19.8 36.2 10.2 3.9 16.5 7.2 16.7 10.6 12.8 20.4 11.3 12.5 20.2 36.0 22.9 20.0 5.6 24.4 31.7 7.7 19.0 10.5 6.3 4.8 6.6 16.3 16.3 6.6 11.3 9.9 2.1 8.6 13.2 13.6 15.5 11.3 5.4 6.0 23.1 10.4 6.6 30.7 10.4 10.0 3.0 11.2 13.4 26.0 10.0 19.9 3.2 4.7 5.4 2.4 4.0 3.7 7.4 9.2 3.6 3.6 4.0 5.5 15.2 4.9 2.8 3.7 10.5 2.7 9.3 8.9 6.9 8.4 8.3 7.3 6.5 7.1 8.8 6.9 5.5 8.3 6.6 25.9 16.0 8.1 20.5 10.9 7.0 7.9 8.0 14.8 13.9 9.4 6.7 19.5 4.3 8.4 3.7 12.5 12.7 14.1 9.0 1.9 10.2 26.7 12.0 26.2 19.8 7.8 9.9 26.5 9.6 10.2 19.2 23.0 16.8 2.5 29.6 23.9 31.3 6.3 10.1 27.4 9.2 4.1 15.6 6.8 36.0 28.6 11.3 3.6 25.3 11.4 8.3 25.7 28.1 13.8 15.1 3.7 22.2 20.1 19.5 20.8 6.6 8.7 16.9 6.6 13.2 14.4 14.9 6.4 8.9 4.8 12.6 17.5 15.0 5.8 14.8 ANO4 "FLJ34221, FLJ34272, FLJ35277, TMEM16D" ENSG00000151572 "Anoctamin 4" Q32M45 12 100717526-101128641 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.1;brain: 9.1;cervix: 7.7;ovary: 7.8;seminal vesicle: 8.2" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 536.3;Oligodendrocyte precursor cells: 276.9;Oligodendrocytes: 814.1" "Cancer enhanced" "Detected in some" "renal cancer: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 20.0;LHCN-M2: 9.5;SK-MEL-30: 15.5;TIME: 31.8;WM-115: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053412 Uncertain NA NA "HPA053412: AB_2682140" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "unprognostic (4.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (2.02e-1)" "unprognostic (3.76e-2)" "unprognostic (1.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-1)" "unprognostic (6.54e-2)" "prognostic favorable (5.48e-5)" "unprognostic (1.16e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.41e-1)" 0.2 12.1 4.9 0.0 8.7 0.0 0.1 1.5 5.8 7.7 0.0 0.1 0.3 4.4 0.3 0.0 0.2 0.0 0.1 4.7 6.0 0.0 0.0 0.0 0.0 6.5 6.6 2.9 7.8 0.5 0.1 0.8 0.1 9.1 4.9 0.1 0.8 2.0 8.2 0.0 0.0 0.2 0.5 1.3 0.0 0.0 1.0 6.4 0.7 0.1 0.0 0.5 0.7 0.3 8.0 0.0 0.0 2.2 0.0 1.1 1.4 0.0 7.0 6.2 5.7 2.8 0.0 0.0 0.0 0.0 20.0 0.0 0.3 7.2 5.9 5.3 0.0 0.0 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 9.5 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 15.5 7.6 0.0 0.0 31.8 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 8.7 1.5 5.8 4.7 6.0 6.5 6.6 2.9 9.1 1.3 6.4 8.0 0.3 0.0 0.0 31.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.1 5.7 0.3 7.8 0.1 4.2 0.0 124.9 0.4 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 536.3 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 6.5 0.0 0.0 0.0 276.9 814.1 0.0 0.0 0.4 0.0 0.3 0.1 0.1 0.0 0.3 0.0 0.2 0.6 0.6 1.8 0.0 0.0 0.0 0.0 3.6 0.0 0.0 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4" "Group enriched" "Detected in many" 12 "B-cells: 14.4;granulocytes: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.8 6.1 9.1 4.6 4.7 3.4 10.2 8.4 4.8 8.9 14.6 3.6 11.7 5.3 8.5 4.4 28.2 5.2 1.1 4.2 9.1 10.9 1.5 4.4 6.0 9.7 8.4 2.8 5.5 5.4 14.3 9.9 1.6 4.7 4.5 4.8 18.1 10.6 3.4 1.2 5.6 8.1 2.3 7.5 3.2 12.3 16.5 4.6 3.8 17.5 1.5 10.7 2.7 1.6 6.6 7.8 7.1 15.3 13.7 3.7 10.8 2.0 1.7 6.3 4.8 5.7 1.7 6.9 15.5 7.0 1.2 8.2 6.6 6.6 7.4 5.5 1.7 7.8 9.1 6.7 5.2 1.1 3.3 1.3 5.9 13.3 5.4 4.1 6.9 0.2 11.1 5.2 1.4 2.6 4.5 6.5 1.2 7.2 13.2 3.0 2.6 7.1 5.5 15.9 4.4 24.3 9.8 8.7 4.9 5.5 11.2 14.6 3.0 0.7 20.3 5.8 6.5 6.4 2.1 16.5 11.7 8.0 1.7 3.9 4.3 0.1 0.1 0.4 0.6 0.1 14.4 0.4 0.3 0.2 11.4 0.2 0.8 0.3 0.4 0.4 0.4 0.6 0.7 9.1 4.7 8.4 4.8 4.2 9.1 9.7 8.4 2.8 4.7 7.5 4.6 6.6 1.5 6.4 7.5 38.8 21.0 4.2 7.3 13.2 20.5 6.4 11.3 11.7 0.8 5.7 23.5 11.0 12.5 1.8 0.3 2.3 21.5 15.6 89.1 86.2 5.1 3.2 7.7 5.9 14.3 7.0 0.5 5.0 17.3 4.8 1.3 5.1 1.8 0.4 1.3 1.7 20.4 3.7 16.2 0.0 2.1 40.9 4.7 2.7 3.6 4.7 1.2 6.8 1.0 14.6 15.1 4.5 5.4 3.8 15.8 3.7 12.3 21.7 125.6 37.5 0.0 4.6 6.0 74.6 36.6 6.9 2.3 0.3 1.0 6.2 6.7 4.9 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036827: AB_2675336, HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 6.9 6.6 3.9 9.5 4.3 11.3 10.2 3.4 4.3 7.4 8.3 8.5 7.8 8.5 6.4 7.1 7.5 5.3 3.4 4.5 4.2 7.6 7.3 8.7 12.1 4.0 4.0 4.0 8.2 6.7 7.4 4.5 8.5 4.1 7.0 8.9 11.4 6.0 6.0 3.9 8.2 7.6 7.5 3.6 11.9 6.9 7.2 4.0 7.7 9.0 3.9 11.7 9.6 5.3 4.6 26.8 27.1 22.2 24.6 9.6 11.7 20.9 13.7 8.6 22.9 20.9 26.0 18.8 49.4 19.5 12.7 27.3 25.9 43.5 20.6 29.9 9.4 19.6 22.2 15.9 18.6 13.7 40.8 20.0 9.3 18.2 20.8 29.4 9.3 24.0 22.5 23.7 17.1 13.1 21.4 34.3 15.9 42.6 37.6 29.3 30.6 15.6 26.6 18.0 18.2 30.1 14.2 19.9 19.4 25.1 18.4 21.6 20.4 15.9 19.9 21.6 7.9 26.9 12.0 18.7 68.1 17.4 29.6 40.9 0.6 15.3 3.8 6.4 15.8 6.0 16.8 5.4 6.3 19.4 11.0 7.4 6.0 6.5 8.6 11.4 8.1 7.6 6.5 3.9 4.3 3.4 4.3 4.5 4.2 4.0 4.0 4.0 4.1 3.6 4.0 4.6 14.0 19.2 20.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 13.8 12.4 0.0 0.0 10.5 3.7 0.0 10.9 10.0 0.0 1.9 15.7 0.0 16.3 19.7 9.9 0.0 0.0 0.0 12.4 10.9 6.2 0.0 15.1 15.2 15.7 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 16.7 0.0 0.0 3.3 0.0 0.0 8.9 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 4.9 4.3 17.4 0.0 0.0 DRD3 ENSG00000151577 "Dopamine receptor D3" P35462 3 114127580-114199407 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "brain: 5.5" "Group enriched" "Detected in some" 12 "Early spermatids: 6.2;Late spermatids: 19.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 5.5;cerebral cortex: 2.1;hypothalamus: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 7.4" "Region enriched" "Detected in many" 10 "basal ganglia: 17.9" NA NA "unprognostic (2.32e-1)" 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 5.5 0.0 2.1 0.1 3.9 0.3 0.2 0.5 0.7 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMAA cblA ENSG00000151611 "Metabolism of cobalamin associated A" Q8IVH4 4 145599042-145660033 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 24.7" "Cell type enhanced" "Detected in many" "Hepatocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037361, HPA058187" Supported Supported Cytosol No No Cytosol "HPA037361: AB_10672107, HPA058187: " "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "prognostic favorable (3.38e-4)" "unprognostic (1.97e-3)" "unprognostic (1.44e-1)" "unprognostic (4.83e-3)" "unprognostic (1.31e-3)" "unprognostic (3.98e-1)" "unprognostic (7.03e-2)" "unprognostic (7.26e-2)" "unprognostic (3.19e-3)" "unprognostic (1.46e-1)" "prognostic favorable (2.23e-5)" "unprognostic (3.40e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.21e-4)" 4.1 3.2 1.6 3.0 2.0 1.8 4.2 2.7 2.4 3.0 1.2 5.9 7.5 2.4 4.0 4.1 2.8 3.8 3.3 1.5 1.8 7.4 24.7 3.8 3.2 1.5 1.5 1.5 2.3 2.0 4.2 0.7 2.9 1.6 2.3 5.4 1.9 3.5 2.8 4.8 3.8 6.3 2.6 1.0 3.5 3.7 4.5 1.6 5.2 3.1 6.0 3.7 4.7 0.8 2.0 2.5 1.4 4.0 2.1 8.4 9.8 1.1 7.1 4.0 2.3 1.4 1.7 4.3 12.1 2.1 4.4 1.1 2.2 2.0 4.4 1.7 7.5 0.8 4.0 1.3 1.5 6.5 5.6 3.3 5.5 6.1 2.6 5.8 3.7 7.2 8.1 1.1 4.6 5.1 3.4 7.2 1.4 1.5 6.2 2.7 3.7 2.2 1.4 13.3 1.3 1.9 1.4 3.5 6.0 3.3 2.4 3.9 1.5 7.0 2.8 1.4 5.0 1.6 2.2 2.0 3.3 4.4 5.5 2.8 3.9 3.1 3.0 4.5 6.1 4.0 3.1 5.3 4.6 3.2 2.6 4.0 5.3 0.5 4.8 7.4 3.3 5.2 2.3 1.6 2.0 2.7 2.4 1.5 1.8 1.5 1.5 1.5 1.6 1.0 1.6 2.0 3.6 12.8 5.6 5.5 3.6 2.9 10.4 7.7 5.7 3.4 3.0 2.4 7.6 14.3 13.0 11.0 2.1 7.9 6.5 7.7 15.6 11.1 10.5 5.0 4.5 4.1 2.4 1.7 5.7 12.5 2.8 4.8 7.1 5.7 8.2 3.4 7.9 31.8 4.9 0.0 5.7 6.5 8.2 4.1 1.6 6.3 4.7 3.6 1.8 3.7 5.6 2.3 9.2 8.0 7.4 8.4 7.3 3.0 2.8 6.5 10.9 21.1 6.8 1.6 0.0 4.2 3.8 8.7 5.2 4.4 1.1 7.7 4.5 5.7 6.7 12.2 ZNF827 ENSG00000151612 "Zinc finger protein 827" Q17R98 4 145757627-145938823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 96.3;Excitatory neurons: 77.5;Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 96.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021166 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021166: AB_2670608" "unprognostic (2.75e-2)" "unprognostic (3.46e-3)" "unprognostic (2.79e-1)" "unprognostic (3.64e-1)" "unprognostic (3.90e-2)" "unprognostic (2.40e-2)" "unprognostic (3.77e-1)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.90e-2)" "unprognostic (7.64e-2)" "unprognostic (3.47e-1)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (7.85e-2)" "unprognostic (4.03e-2)" "unprognostic (1.88e-2)" 2.8 7.1 2.4 3.2 5.6 2.2 4.5 9.3 4.6 5.6 0.0 6.0 5.3 8.2 2.9 2.2 6.1 3.7 4.6 3.1 1.9 4.5 0.6 2.8 3.8 2.4 2.6 3.3 7.5 3.1 7.1 8.4 1.3 3.0 15.9 3.9 1.3 10.8 4.8 8.0 2.7 6.5 6.0 0.4 4.0 3.8 3.5 2.4 7.3 7.7 5.4 4.5 6.6 3.8 4.3 4.4 3.5 12.8 7.3 5.2 5.4 0.0 7.7 7.6 5.7 4.2 1.3 10.5 0.6 2.0 12.9 4.4 2.2 6.9 4.9 4.6 7.3 2.5 3.9 4.8 3.7 4.1 3.1 0.0 8.1 4.3 4.6 11.7 10.9 9.2 2.1 0.4 5.6 4.8 0.0 3.0 0.0 5.1 0.0 7.5 10.6 6.0 1.9 5.1 4.7 10.5 9.0 6.0 9.4 13.3 5.6 5.5 0.1 17.8 13.9 10.9 1.0 8.1 4.6 0.1 3.4 4.7 11.7 49.2 2.9 0.0 0.0 1.8 0.0 0.9 1.6 0.9 1.8 0.0 1.2 0.9 1.7 0.0 1.9 0.0 1.5 0.0 0.6 2.4 5.6 9.3 4.6 3.1 1.9 2.4 2.6 3.3 3.0 0.4 2.4 4.3 7.3 12.8 19.8 96.3 12.3 6.4 8.3 16.2 22.8 12.7 19.2 19.2 22.4 2.8 16.9 23.9 10.4 2.3 10.3 14.9 3.9 12.1 17.1 11.9 10.8 8.7 25.8 5.9 77.5 7.1 0.5 7.8 14.3 14.6 2.5 17.4 8.2 1.3 1.3 18.5 64.3 18.6 10.2 1.2 0.8 7.8 9.0 1.2 1.8 8.4 0.7 4.7 8.2 174.9 96.6 14.2 9.5 17.0 13.7 30.7 20.1 12.3 19.3 1.5 6.6 20.6 7.1 2.1 5.0 5.8 4.8 1.4 9.4 18.7 19.5 11.6 POU4F2 "Brn-3b, BRN3B" ENSG00000151615 "POU class 4 homeobox 2" Q12837 4 146638893-146642474 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.3" "Cell type enhanced" "Detected in single" "Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.8" "Region enriched" "Detected in single" 6 "midbrain: 4.4" "Region enhanced" "Detected in some" "midbrain: 2.9" NA NA "unprognostic (4.18e-2)" 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 1.0 0.0 0.4 3.8 4.1 0.0 5.3 0.2 0.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EDNRA "ET-A, ETA-R, hET-AR" ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 115.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 14.1 5.5 2.8 3.3 2.5 0.0 8.3 2.6 4.2 57.5 2.7 3.3 3.5 45.1 23.5 4.4 18.6 12.8 26.3 2.2 3.9 4.1 3.2 22.9 3.9 3.5 3.0 1.5 37.8 1.1 3.4 2.8 12.2 3.3 31.0 3.4 0.3 6.4 115.0 4.0 4.5 2.9 45.4 2.5 8.4 5.4 6.3 2.7 5.0 6.9 5.5 2.6 11.9 24.2 4.5 0.0 1.2 5.2 0.0 9.4 18.2 0.0 2.9 3.8 0.4 0.1 0.2 0.0 0.0 0.0 0.9 0.6 0.0 0.4 0.7 0.2 0.0 1.9 0.0 2.8 0.0 9.3 0.0 0.0 6.9 0.6 0.5 0.0 3.4 0.0 0.0 0.0 1.4 22.7 0.3 0.0 0.1 1.5 0.0 1.1 0.0 0.9 0.1 1.3 1.0 0.0 16.3 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.6 0.7 0.0 0.0 1.3 0.4 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.5 2.6 4.2 2.2 3.9 3.5 3.0 1.5 3.3 2.5 2.7 4.5 7.7 3.2 5.3 1.0 0.0 3.1 0.8 1.7 27.3 0.1 0.8 5.2 24.9 0.0 4.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 2.9 3.4 117.1 8.0 0.0 0.0 5.3 0.0 0.1 15.9 0.0 2.7 0.0 14.3 0.0 0.0 0.6 0.0 22.5 0.0 0.0 0.0 3.9 3.5 43.8 0.8 3.6 9.4 0.0 0.1 0.0 2.0 1.0 0.2 0.0 68.1 0.0 1.4 0.0 0.5 0.0 0.5 52.6 0.6 108.6 0.7 0.7 7.1 2.7 0.1 0.9 0.3 0.0 0.4 NR3C2 "MLR, MR" ENSG00000151623 "Nuclear receptor subfamily 3 group C member 2" P08235 4 148078762-148444698 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 265.8;Excitatory neurons: 275.7;Inhibitory neurons: 269.9;Microglial cells: 176.1;Oligodendrocyte precursor cells: 230.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.8" "Lineage enriched" "Detected in single" 6 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.7;HUVEC TERT2: 6.0;Karpas-707: 6.9;PC-3: 6.1;RPTEC TERT1: 7.8;TIME: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009155, HPA074979" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009155: AB_2155949, HPA074979: AB_2686724" "unprognostic (2.75e-3)" "unprognostic (2.63e-2)" "unprognostic (6.70e-3)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (7.82e-3)" "unprognostic (1.04e-2)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.10e-11)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 4.3 4.6 5.0 3.7 5.8 1.0 4.8 9.4 11.8 5.6 3.7 22.0 8.8 6.3 3.8 3.1 5.9 5.8 9.5 12.4 4.0 12.2 8.6 7.3 3.1 3.3 5.6 3.6 14.9 7.7 12.6 5.6 1.8 4.9 3.8 26.5 8.5 10.7 4.4 12.3 2.9 15.4 4.9 2.7 5.2 8.4 4.3 5.2 2.9 19.9 14.3 2.2 5.9 3.3 5.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.4 2.6 1.0 0.2 0.0 1.3 0.7 0.1 0.2 2.3 0.2 0.6 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 9.7 6.0 0.9 0.0 6.9 2.0 0.0 0.0 0.0 0.1 1.2 6.1 0.5 0.0 0.1 7.8 0.1 0.1 0.0 0.0 1.4 0.6 0.1 0.7 0.0 8.7 4.3 2.5 0.1 0.8 0.0 0.0 0.1 1.4 0.6 1.0 0.0 0.0 0.0 0.5 0.0 1.8 0.1 0.7 0.4 0.0 0.2 1.0 1.1 0.0 0.0 0.2 0.0 0.2 0.1 5.0 5.8 9.4 11.8 12.4 4.0 3.3 5.6 3.6 4.9 2.7 5.2 5.0 11.9 28.9 13.9 265.8 5.1 2.0 2.2 0.4 6.2 10.3 6.2 5.8 20.3 7.2 6.7 11.0 18.8 0.9 1.0 76.1 9.8 3.0 68.2 2.1 1.1 8.2 18.0 0.0 275.7 5.8 0.5 5.9 13.7 2.6 5.7 6.4 8.6 7.0 0.6 13.5 269.9 44.6 6.1 2.9 2.4 41.8 4.4 1.7 7.2 176.1 1.2 8.1 1.0 230.2 95.7 3.2 26.8 3.8 0.8 1.8 26.4 2.3 4.7 9.6 0.0 14.7 5.1 1.8 5.6 2.6 1.7 0.1 4.9 1.8 21.5 2.1 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 324.5;liver: 485.9;skeletal muscle: 289.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 324.5 21.0 12.3 10.1 11.0 1.0 207.4 10.9 10.8 11.4 8.8 26.1 29.9 5.7 3.3 204.1 8.7 99.0 54.4 7.2 11.9 16.3 485.9 23.7 2.1 18.2 13.4 7.3 10.4 11.9 1.1 8.2 0.8 17.6 11.8 13.4 15.3 117.4 13.1 289.2 39.3 34.0 9.3 12.6 2.1 138.2 12.0 18.8 4.5 38.6 36.8 9.3 256.4 47.4 18.8 0.0 2054.8 2.4 214.1 2439.5 83.4 0.1 0.7 8.6 0.9 2.0 8.1 0.2 0.4 11.5 14.2 10.0 57.8 0.2 10.7 1.2 0.6 0.2 0.7 516.4 3926.2 4.6 0.4 0.9 218.3 126.4 10.5 10.4 0.7 0.9 0.3 81.9 0.3 20.4 3.3 0.2 0.0 0.7 2684.9 0.8 0.3 0.6 34.6 19.0 1178.9 1.2 0.4 21.2 0.3 0.1 0.4 0.5 4.0 8.6 5.1 1.8 74.6 0.8 0.6 0.6 0.3 25.9 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.3 11.0 10.9 10.8 7.2 11.9 18.2 13.4 7.3 17.6 12.6 18.8 18.8 15.2 12.8 2.8 0.0 0.9 11.9 9.5 141.7 20.5 1.9 0.8 1.4 5.5 102.9 128.8 0.0 0.0 0.0 0.0 10.3 0.0 18.3 17.3 0.7 0.5 7.5 1.8 8.0 2.6 103.3 0.1 44.2 133.5 0.8 0.0 0.1 10.8 397.4 0.1 3.3 4.2 5.4 46.8 12.0 7.8 7.8 79.2 1.0 8.8 19.7 0.6 39.6 0.0 5.5 0.3 90.0 6.6 78.6 0.8 23.7 15.9 3.6 40.3 3.0 0.0 5.3 13.9 0.2 0.3 112.9 13.5 0.0 1.3 0.4 8.5 271.9 DPYSL4 "CRMP3, DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186948-132205759 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;heart muscle: 20.8;retina: 16.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.9;Cardiomyocytes: 20.1;Cone photoreceptor cells: 58.4;Horizontal cells: 33.7;Oligodendrocytes: 18.4" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.2;AN3-CA: 70.0;SH-SY5Y: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA049066: AB_2680619" "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.11e-4)" 1.3 2.2 17.2 0.7 16.4 0.1 1.5 8.8 26.1 2.4 1.8 1.2 0.1 3.4 0.7 0.6 1.5 0.7 20.8 19.2 12.5 0.5 0.3 1.2 0.3 13.8 12.7 18.2 5.3 0.9 0.0 10.5 0.2 16.1 5.0 0.0 16.0 2.6 2.0 2.0 1.0 0.9 1.1 9.9 1.2 1.3 8.0 15.6 0.0 1.0 0.2 0.2 1.0 1.3 17.1 0.1 15.2 53.2 70.0 0.1 0.4 0.0 4.6 0.6 2.9 0.6 0.0 0.4 0.0 1.8 2.4 5.1 0.0 10.4 10.3 0.3 0.0 2.0 0.0 0.1 5.7 9.3 0.0 10.6 4.7 4.9 1.7 0.2 0.9 5.4 0.0 0.0 0.5 7.7 4.5 0.0 0.0 9.1 0.9 5.1 0.0 0.0 8.7 0.0 1.1 8.3 72.0 1.7 0.1 9.7 3.1 0.2 0.1 9.0 13.1 21.7 0.0 12.8 0.1 3.9 0.0 22.0 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.1 17.2 16.4 8.8 26.1 19.2 12.5 13.8 12.7 18.2 16.1 9.9 15.6 17.1 0.3 0.0 0.0 7.2 0.1 0.5 0.5 0.1 0.6 64.9 0.4 0.6 20.1 0.0 0.1 0.0 58.4 0.0 0.1 0.0 0.0 0.3 5.3 0.1 5.0 1.2 1.8 0.0 12.2 0.0 0.1 2.7 2.0 0.3 0.0 0.7 0.0 0.0 0.2 33.7 13.6 0.0 0.0 0.0 0.8 9.0 4.1 0.1 1.8 0.0 0.1 7.5 0.0 12.1 18.4 0.5 0.0 4.5 0.0 0.7 0.0 0.0 0.0 13.8 0.0 1.0 5.7 7.0 5.2 0.3 0.1 0.0 0.5 4.5 0.0 0.2 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237855-133241928 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2" "Group enriched" "Detected in some" 10 "NB-4: 18.2;NTERA-2: 10.9" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA050955: AB_2681288" "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 4.0 2.3 1.5 3.7 1.2 2.8 1.9 1.6 1.8 1.2 2.2 1.5 0.4 1.6 0.6 0.5 1.8 1.5 1.3 1.4 1.8 1.4 0.5 3.8 0.5 1.9 1.7 1.2 1.5 1.3 0.5 1.4 0.5 1.6 1.3 0.4 0.2 1.4 0.8 0.9 1.2 1.0 1.3 1.1 5.8 0.9 1.0 1.9 0.2 0.8 0.1 0.4 1.4 1.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.2 10.9 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 1.9 2.6 0.3 0.1 3.2 0.0 0.3 0.1 0.0 1.8 0.2 0.1 0.1 0.9 0.3 2.4 0.1 0.0 0.7 1.5 1.2 1.6 1.8 1.4 1.8 1.9 1.7 1.2 1.6 1.1 1.9 2.0 0.0 0.0 1.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 7.9 0.2 0.0 7.8 0.0 0.0 5.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ADAM8 "CD156, CD156A, MS2" ENSG00000151651 "ADAM metallopeptidase domain 8" P78325 10 133262420-133276868 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 69.2;lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" "dendritic cells: 54.7;Extravillous trophoblasts: 96.4;Langerhans cells: 124.9;monocytes: 81.3;NK-cells: 82.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 18.8" "Group enriched" "Detected in many" 5 "basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 259.0" "Cell line enhanced" "Detected in many" "A-431: 60.0;BEWO: 81.8;CAPAN-2: 70.4;HaCaT: 69.8;HDLM-2: 45.9;U-87 MG: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA064637 Approved "Intracellular and membrane" NA NA "HPA064637: AB_2685306" "unprognostic (8.24e-2)" "unprognostic (6.07e-3)" "unprognostic (1.27e-3)" "unprognostic (5.18e-2)" "unprognostic (8.26e-2)" "unprognostic (6.47e-2)" "unprognostic (5.59e-2)" "unprognostic (2.22e-1)" "unprognostic (2.57e-1)" "unprognostic (1.94e-3)" "unprognostic (3.37e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (3.99e-10)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.28e-1)" "unprognostic (9.32e-2)" 4.4 2.4 2.0 22.3 2.2 69.2 2.7 1.2 18.8 3.5 1.9 2.9 5.9 2.2 2.1 3.5 6.1 5.1 2.3 1.6 3.1 4.7 8.4 21.7 11.7 2.9 1.7 1.4 3.0 4.4 0.3 3.6 3.1 4.3 4.6 1.6 1.5 4.3 1.1 1.2 3.3 11.4 2.1 1.5 48.9 11.6 2.7 5.0 4.1 3.8 1.7 8.3 12.0 3.2 3.7 60.0 1.7 0.5 0.9 0.4 0.1 81.8 0.7 1.4 0.3 0.4 4.6 70.4 1.0 1.7 0.1 0.5 69.8 0.2 11.9 0.1 45.9 1.0 0.8 0.5 0.0 0.7 3.6 15.9 0.2 1.1 0.6 1.0 3.7 0.1 0.5 3.2 2.4 0.0 4.8 0.2 20.2 0.3 7.1 1.7 0.4 0.7 6.6 0.8 1.4 0.1 0.8 0.4 0.2 1.0 1.1 1.0 2.0 1.7 0.0 1.5 0.6 1.0 3.4 2.2 0.6 34.5 2.0 0.2 107.4 24.8 259.0 22.2 9.2 15.9 10.2 14.8 21.4 37.2 5.6 5.6 8.2 139.4 24.7 9.4 0.7 16.9 25.2 2.0 2.2 1.2 18.8 1.6 3.1 2.9 1.7 1.4 4.3 1.5 5.0 3.7 1.3 3.2 10.5 3.3 23.2 7.8 6.6 14.3 0.0 4.3 2.2 1.8 2.4 2.8 9.5 0.0 8.4 7.7 54.7 0.3 1.9 3.1 1.0 1.5 0.9 1.7 0.0 5.7 3.5 2.7 96.4 2.4 6.1 2.1 12.6 1.1 2.5 2.4 23.3 0.0 3.0 0.6 2.0 8.8 124.9 0.4 0.9 33.9 7.2 0.0 81.3 0.2 82.4 2.0 2.9 39.1 0.1 0.0 20.7 11.0 0.3 0.5 10.0 5.1 0.0 0.8 1.0 1.5 0.8 0.6 6.5 20.0 39.4 0.2 0.5 42.5 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703316-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 494 "liver: 2173.8" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 489.6" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Region enhanced" "Detected in some" "cerebral cortex: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 453 "Hep G2: 1103.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 32000000000 "Golgi apparatus" "HPA059150: AB_2683930" "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.1 0.2 0.4 0.1 0.8 0.1 3.1 1.4 4.3 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.4 1.0 0.8 2173.8 0.6 0.1 0.5 0.7 0.3 0.0 0.2 0.0 1.7 0.1 0.8 0.0 0.0 0.3 0.0 0.0 0.8 0.4 0.1 0.0 0.8 0.3 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 1103.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.1 0.7 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.8 1.4 4.3 0.4 1.0 0.5 0.7 0.3 0.8 0.8 0.7 1.3 0.1 0.0 2.2 0.7 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.4 117.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.1 0.0 0.0 0.6 0.0 2.7 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 8.2 489.6 0.1 0.0 1.4 0.0 0.0 9.4 0.0 2.1 0.0 0.0 0.0 18.7 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 KIN "KIN17, Rts2" ENSG00000151657 "Kin17 DNA and RNA binding protein" O60870 10 7750962-7787993 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016339, HPA038700" Enhanced Nucleoplasm NA NA Nucleoplasm "CAB016339: AB_627860, HPA038700: AB_2676159" "unprognostic (4.33e-3)" "unprognostic (1.24e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-2)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (3.17e-3)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (5.40e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (3.98e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-1)" "prognostic favorable (3.23e-5)" 2.0 2.4 1.9 2.6 2.1 3.2 2.6 4.4 2.5 2.8 1.9 2.2 2.4 3.3 2.8 2.0 2.4 2.1 2.0 2.0 2.0 2.1 3.3 2.2 3.4 2.0 2.0 1.9 3.0 2.7 2.0 2.6 3.0 2.9 2.5 2.2 3.5 2.5 2.1 2.8 3.4 2.4 2.2 1.6 2.8 2.5 2.1 2.0 2.5 2.9 2.2 2.7 2.2 2.4 2.7 4.3 2.7 4.1 2.5 3.3 3.9 3.3 3.8 1.7 4.5 4.8 5.2 4.2 3.3 1.9 2.3 1.4 4.0 3.5 2.3 5.1 3.8 4.0 5.2 2.7 5.1 4.6 1.9 4.1 3.3 2.5 3.4 2.2 3.7 3.4 4.1 5.3 3.1 3.5 3.9 3.8 2.9 3.9 4.5 1.6 4.8 2.9 3.1 3.8 2.3 1.7 3.8 3.0 2.9 6.2 3.8 5.5 3.8 2.5 2.9 3.2 5.1 3.1 4.0 4.7 4.1 3.6 2.9 2.0 15.9 3.9 7.1 3.7 4.3 3.7 5.9 3.3 3.1 3.0 5.4 3.6 3.8 8.8 4.9 4.1 5.8 3.0 1.5 1.9 2.1 4.4 2.5 2.0 2.0 2.0 2.0 1.9 2.9 1.6 2.0 2.7 31.5 35.3 27.2 12.1 20.7 17.3 14.6 31.3 13.6 54.8 17.2 20.1 13.0 20.0 24.8 18.4 39.6 36.7 32.0 20.4 13.7 32.9 5.7 21.7 28.4 25.6 23.3 30.3 17.4 21.5 23.8 24.0 14.3 27.9 16.4 22.9 21.0 11.9 32.1 63.9 14.8 20.3 18.3 16.9 22.8 6.2 27.7 21.8 16.0 11.2 30.7 28.7 38.1 13.0 19.4 21.2 23.6 30.9 18.1 18.9 18.2 16.9 26.0 54.7 13.1 27.8 29.7 29.1 19.0 12.1 14.3 38.4 25.7 30.1 14.7 17.3 PIGF ENSG00000151665 "Phosphatidylinositol glycan anchor biosynthesis class F" Q07326 2 46580937-46617055 "Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051389 Uncertain NA NA "HPA051389: AB_2681464" "unprognostic (3.85e-3)" "unprognostic (5.42e-2)" "unprognostic (1.11e-3)" "unprognostic (8.18e-2)" "unprognostic (2.56e-1)" "unprognostic (4.52e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.97e-2)" "unprognostic (9.29e-3)" "unprognostic (6.08e-2)" "unprognostic (5.89e-2)" "unprognostic (9.40e-2)" "unprognostic (1.02e-1)" "unprognostic (7.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.04e-2)" "unprognostic (6.71e-2)" 16.9 29.2 16.9 18.5 19.4 10.4 17.2 20.5 21.2 12.9 19.6 18.6 17.5 11.2 28.0 15.8 15.0 18.3 17.1 17.0 24.3 20.3 16.7 12.7 15.8 20.5 18.9 16.0 13.8 23.2 20.3 15.7 17.5 20.0 15.5 19.3 25.5 22.1 10.0 26.0 12.3 18.1 7.7 21.1 13.4 16.6 26.4 18.7 8.4 23.0 14.5 12.5 18.6 11.7 22.8 31.0 18.9 39.7 22.9 47.2 48.8 22.1 37.5 22.8 15.1 15.1 9.4 22.2 18.2 68.8 25.3 39.9 25.1 35.9 27.1 30.4 52.1 36.7 36.2 13.9 49.9 27.5 23.1 25.6 33.4 40.7 23.1 34.7 50.5 41.8 16.6 33.8 51.5 56.7 8.7 18.1 22.5 31.3 64.9 29.7 18.7 36.4 38.2 44.0 32.9 27.6 35.1 17.1 24.4 57.0 35.1 14.4 27.7 27.1 25.2 29.0 35.8 36.7 25.8 31.2 32.2 27.6 43.8 45.0 3.6 12.5 11.5 9.3 18.4 10.2 11.8 11.2 9.4 14.4 14.0 8.2 10.7 6.2 10.9 17.7 19.1 14.7 6.6 16.9 19.4 20.5 21.2 17.0 24.3 20.5 18.9 16.0 20.0 21.1 18.7 22.8 35.0 9.6 18.5 32.0 23.8 25.5 38.0 93.5 30.1 32.9 35.9 34.0 3.7 30.0 54.3 20.2 29.2 39.2 24.6 18.3 35.2 29.6 65.0 31.9 26.3 26.4 17.4 17.9 21.9 29.7 53.4 24.7 18.8 25.8 19.0 34.5 26.7 22.4 37.6 37.0 24.4 26.3 81.4 22.5 21.5 29.5 14.9 24.8 30.2 30.0 27.9 71.1 23.7 41.2 70.7 21.1 23.8 16.1 38.6 45.6 26.0 31.7 38.1 27.4 6.6 20.9 31.3 96.4 41.8 37.9 34.1 32.3 19.7 39.1 36.8 44.9 ANKAR FLJ25415 ENSG00000151687 "Ankyrin and armadillo repeat containing" Q7Z5J8 2 189674290-189761193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 5.8" "Cell type enhanced" "Detected in many" "Astrocytes: 82.9;Early spermatids: 88.8;Inhibitory neurons: 60.6;Oligodendrocyte precursor cells: 87.0;Oligodendrocytes: 80.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036168 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036168: AB_10673345" "unprognostic (2.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.06e-2)" "unprognostic (5.41e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (5.03e-3)" "unprognostic (2.89e-1)" "unprognostic (2.65e-2)" "unprognostic (6.34e-4)" "unprognostic (2.43e-1)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" 0.2 0.4 0.3 0.2 0.4 0.2 0.4 1.1 0.4 0.2 1.3 0.2 0.2 0.4 0.6 0.2 0.3 0.3 0.0 0.2 0.6 0.2 0.4 0.3 0.5 0.3 0.3 0.0 0.3 0.5 0.6 0.1 0.3 0.4 0.5 0.4 0.6 0.5 0.2 0.1 0.3 0.4 0.2 0.3 0.4 0.5 5.8 0.3 0.1 0.5 0.0 0.3 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.4 0.6 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.1 0.4 0.2 0.6 0.3 0.3 0.0 0.4 0.3 0.3 0.6 10.5 3.2 8.2 82.9 13.4 1.3 7.2 2.5 5.2 12.6 4.1 3.8 4.7 4.3 2.8 11.0 14.6 1.2 8.1 3.3 1.9 3.3 88.8 2.8 8.4 8.9 0.0 10.1 46.0 4.3 1.1 9.7 13.3 2.8 0.0 8.4 7.1 2.4 2.4 3.3 60.6 5.7 2.0 1.9 4.9 46.1 21.8 5.6 7.2 47.8 3.4 6.1 13.4 87.0 80.5 4.5 5.6 13.9 5.1 4.1 4.8 2.7 1.5 46.2 6.6 15.8 8.4 20.3 11.1 5.2 1.3 0.1 9.6 4.8 4.2 4.1 INPP1 ENSG00000151689 "Inositol polyphosphate-1-phosphatase" P49441 2 190343570-190371665 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 727.4;Late spermatids: 836.0;Urothelial cells: 229.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 96.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 96.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036698, HPA036699" Supported Approved "Centriolar satellite,Cytosol" NA NA 31000 "Centriolar satellite" Cytosol "HPA036698: AB_10672226, HPA036699: AB_2675260" "unprognostic (1.08e-3)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (2.70e-1)" "unprognostic (7.85e-2)" "unprognostic (3.67e-3)" "unprognostic (4.44e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (2.96e-2)" "unprognostic (7.28e-2)" "unprognostic (2.41e-1)" "unprognostic (2.54e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.12e-5)" "prognostic favorable (5.70e-4)" 21.6 35.3 40.5 11.5 45.1 14.9 20.9 40.3 45.4 24.4 30.7 21.6 37.1 18.3 12.6 72.5 19.1 23.7 25.4 40.8 43.3 16.1 33.3 28.1 9.4 44.3 42.8 38.1 11.9 26.8 41.9 29.8 13.5 45.5 18.3 21.2 17.2 17.2 13.5 21.4 37.7 25.5 19.7 40.1 26.1 18.3 53.4 42.5 23.9 19.2 36.0 21.1 42.6 36.1 59.0 26.7 7.4 13.9 0.0 15.0 31.8 0.3 30.9 41.5 28.8 37.5 28.8 16.5 0.2 36.3 30.5 9.3 35.8 5.4 19.9 35.0 32.8 11.7 19.5 22.1 17.5 31.5 15.2 6.0 21.6 30.6 32.9 18.6 20.7 54.7 0.3 48.6 16.3 51.3 0.1 1.1 14.3 4.2 42.3 40.4 0.7 11.2 0.3 22.6 62.2 20.6 7.8 21.7 1.4 31.7 14.4 0.1 21.0 51.0 18.4 13.2 33.3 18.5 3.1 3.5 0.3 5.7 6.0 14.9 26.2 8.3 96.0 6.9 8.1 6.3 3.3 4.3 4.7 8.7 4.4 2.4 3.6 3.9 16.2 4.7 0.2 20.3 5.1 40.5 45.1 40.3 45.4 40.8 43.3 44.3 42.8 38.1 45.5 40.1 42.5 59.0 63.0 3.2 5.5 44.1 8.0 86.4 155.4 33.2 50.7 15.0 9.9 14.6 20.9 38.6 27.5 11.0 6.2 6.9 9.7 50.4 7.9 33.4 727.4 18.8 16.0 59.6 31.1 1.7 30.3 85.4 2.6 30.7 29.6 26.9 8.8 3.8 88.5 21.9 8.8 16.8 36.7 23.7 20.3 10.7 27.3 836.0 26.8 14.0 26.6 17.8 12.2 73.2 14.4 29.7 125.6 53.1 40.8 23.7 12.9 90.7 50.6 20.8 13.0 11.9 26.3 26.0 19.4 18.1 11.4 170.2 97.3 4.0 10.4 37.8 35.4 229.0 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 110.6;Respiratory ciliated cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 79.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 21.0 40.7 26.9 12.8 34.6 7.7 21.5 37.8 45.1 22.0 0.1 32.1 20.0 10.6 33.1 41.0 19.7 16.0 18.0 39.5 34.8 10.9 2.3 26.6 14.9 46.2 51.2 32.6 4.2 17.0 65.0 35.7 8.6 53.9 23.2 29.2 15.0 31.1 32.6 6.5 29.7 24.8 14.5 31.0 21.1 32.4 7.9 41.9 20.0 39.3 14.3 20.7 23.1 21.7 54.7 25.1 15.2 0.5 5.2 10.6 13.6 20.4 12.7 25.3 8.4 10.5 5.6 31.1 39.1 5.8 26.4 15.6 41.5 7.4 22.1 9.5 79.7 11.6 20.9 14.2 2.9 4.2 8.3 6.4 2.1 39.3 12.5 8.1 27.1 3.0 30.5 5.4 42.2 2.2 9.7 38.8 1.8 3.4 27.1 16.1 8.6 1.2 34.1 15.9 45.1 47.5 12.2 17.9 41.7 24.9 1.7 13.6 9.5 12.6 1.4 2.9 16.6 19.7 19.3 8.6 13.8 13.5 16.9 6.9 4.6 1.1 0.4 1.4 0.3 1.5 1.6 1.8 2.0 1.5 0.7 0.9 1.9 0.1 2.1 0.5 0.7 3.5 0.8 26.9 34.6 37.8 45.1 39.5 34.8 46.2 51.2 32.6 53.9 31.0 41.9 54.7 48.6 32.1 20.0 7.2 7.6 6.4 11.5 11.7 10.8 9.7 16.8 9.8 21.4 5.7 30.3 23.9 8.4 0.2 14.9 25.1 0.0 13.2 46.8 27.9 5.9 26.7 35.4 7.8 55.7 20.5 0.2 8.9 31.1 22.5 24.0 8.7 16.1 0.8 4.0 28.6 47.9 42.7 12.2 4.0 8.0 13.7 5.6 12.3 8.8 11.2 9.7 6.8 3.1 41.7 110.6 24.9 20.8 5.3 14.9 13.5 13.6 1.0 88.5 7.9 0.0 16.7 7.2 1.0 1.4 28.8 18.3 0.0 17.0 18.6 21.1 22.7 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917412-7068286 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 6.1" "Group enriched" "Detected in many" 7 "granulocytes: 6.1;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Supported Vesicles NA NA Vesicles "HPA049939: AB_2680960" "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavorable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favorable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 9.3 28.7 17.1 4.2 43.6 14.0 10.2 56.9 38.3 21.9 0.5 5.3 2.6 26.5 7.8 4.3 7.8 7.2 7.9 17.6 24.3 6.9 1.3 5.4 6.0 30.7 26.1 16.7 19.5 31.0 38.4 13.0 6.0 29.9 9.2 5.4 23.2 4.7 6.4 9.7 5.5 3.8 11.7 20.9 23.2 2.6 4.8 31.2 7.6 3.4 10.2 5.6 4.5 7.6 71.2 0.8 5.8 30.1 6.2 6.6 13.6 23.0 0.2 0.0 1.1 2.8 0.1 0.7 2.9 3.3 0.3 8.7 0.7 10.0 0.0 0.0 1.6 2.6 39.7 0.3 11.8 0.3 0.7 127.9 21.7 0.1 2.2 0.0 0.0 0.0 9.9 17.3 0.6 0.0 4.9 20.6 1.7 11.0 0.7 13.6 15.9 21.8 2.6 1.0 10.2 9.9 39.0 0.5 4.0 39.8 3.9 1.7 2.6 0.1 3.9 10.0 10.7 4.5 10.4 3.5 0.1 14.7 8.7 14.3 1.3 0.0 6.1 1.2 0.0 1.8 0.0 1.3 0.9 0.1 0.1 2.4 1.7 0.3 0.5 0.0 0.0 0.6 0.4 17.1 43.6 56.9 38.3 17.6 24.3 30.7 26.1 16.7 29.9 20.9 31.2 71.2 27.8 3.2 4.2 34.3 2.4 2.4 0.7 0.0 1.8 4.6 2.5 2.5 11.5 2.8 1.9 0.0 75.0 2.4 5.3 15.4 1.9 3.3 5.5 6.1 15.4 13.9 25.4 18.5 176.6 5.8 3.1 10.4 2.6 10.7 8.9 31.5 23.2 1.1 4.9 10.1 101.7 2.7 0.0 1.0 1.7 14.2 4.4 1.7 24.9 17.8 1.2 7.6 10.3 194.5 330.3 3.0 11.1 10.5 3.1 3.0 2.0 0.3 1.5 39.8 0.0 16.1 5.2 1.8 6.6 5.2 1.6 1.1 9.8 19.1 2.7 1.7 ASAP2 "CENTB3, DDEF2, KIAA0400, PAP, SHAG1" ENSG00000151693 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 2" O43150 2 9206765-9405683 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 47.2" "Cell type enhanced" "Detected in many" "Astrocytes: 141.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "basophil: 2.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018615 Approved Supported Cytosol NA NA 260000 Cytosol "CAB018615: AB_2242947" "unprognostic (1.19e-1)" "unprognostic (2.66e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-3)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (8.33e-2)" "unprognostic (1.58e-3)" "unprognostic (3.14e-1)" "unprognostic (3.16e-1)" "unprognostic (2.64e-2)" "unprognostic (3.24e-2)" 12.5 3.3 3.0 5.7 9.4 0.7 6.8 10.8 9.3 11.5 4.1 17.8 13.9 12.9 10.1 8.9 10.8 10.2 9.7 6.4 6.9 24.0 3.9 10.1 2.8 7.5 6.4 2.1 7.8 7.8 9.9 9.5 10.5 9.1 5.2 16.2 8.9 5.7 9.3 2.5 13.2 13.8 14.0 0.8 1.5 24.5 47.2 3.1 2.7 19.3 6.4 3.1 8.6 7.9 7.8 34.8 19.9 35.8 21.2 26.0 35.9 5.9 34.4 27.7 24.9 24.9 13.9 51.0 0.1 29.8 39.2 54.7 32.8 19.9 60.6 30.6 25.1 8.1 8.0 15.4 24.1 63.1 0.0 2.4 13.6 24.5 30.1 96.8 74.5 51.9 6.4 3.7 3.6 97.8 21.1 10.2 2.0 16.9 49.5 23.2 19.5 53.7 6.5 48.7 26.7 15.6 59.6 28.7 18.9 30.7 18.7 13.1 5.5 81.8 41.6 1.9 32.5 31.7 0.0 0.2 0.1 30.4 0.2 54.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.0 9.4 10.8 9.3 6.4 6.9 7.5 6.4 2.1 9.1 0.8 3.1 7.8 41.0 19.2 8.3 141.0 1.4 37.2 22.8 16.6 14.8 28.2 8.4 7.7 1.6 4.3 12.9 35.0 0.0 1.6 0.3 60.7 50.9 15.4 67.0 14.9 20.8 36.1 9.1 0.0 76.2 14.0 0.3 26.0 52.5 26.8 1.3 9.7 51.8 4.4 12.8 6.7 46.5 40.8 20.3 4.4 12.9 50.7 2.8 10.6 33.8 39.4 7.9 20.4 0.0 48.2 55.0 62.1 45.4 3.8 0.2 33.8 21.6 31.1 12.9 5.3 26.3 24.9 35.3 39.8 8.9 5.5 32.1 0.4 1.2 1.6 21.4 53.3 ADAM17 "CD156B, cSVP, TACE" ENSG00000151694 "ADAM metallopeptidase domain 17" P78536 2 9488486-9556732 "CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010738, HPA051575" Approved Supported Cytosol NA NA 300000 Cytosol "HPA010738: AB_1078100, HPA051575: AB_2681539" "unprognostic (2.28e-1)" "unprognostic (1.29e-3)" "unprognostic (1.28e-1)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (5.15e-2)" "unprognostic (2.12e-3)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (3.69e-1)" "unprognostic (3.53e-3)" "unprognostic (3.13e-1)" "unprognostic (3.82e-3)" "unprognostic (8.63e-2)" "unprognostic (2.61e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (4.23e-5)" 10.2 5.5 9.6 9.2 9.9 5.9 10.5 9.0 10.6 8.8 10.5 5.5 4.1 7.2 11.5 10.1 6.6 9.1 6.3 9.5 10.8 4.7 4.7 14.8 8.6 10.3 9.3 9.1 9.0 4.2 8.0 4.2 20.2 10.3 4.1 6.9 4.5 6.2 6.4 6.9 11.2 6.2 8.6 9.5 9.3 5.1 10.0 9.9 9.7 6.7 6.9 12.8 10.4 7.2 10.8 10.0 18.2 23.2 25.9 45.9 34.7 45.4 8.6 25.4 16.1 24.6 19.2 31.6 33.4 18.1 18.8 42.1 21.9 16.4 29.4 22.6 8.4 12.1 15.8 14.7 13.9 68.0 20.7 17.8 41.2 32.2 25.1 47.5 26.6 46.0 8.7 30.0 12.3 17.3 8.7 8.5 23.4 19.2 13.7 4.6 14.3 21.6 20.5 25.8 18.7 11.7 28.6 14.9 16.5 30.1 27.0 6.6 19.4 29.0 25.5 12.0 19.1 22.1 15.1 17.5 29.6 20.2 11.1 31.1 5.0 3.7 2.8 1.0 3.7 1.9 1.7 0.9 1.1 2.3 0.9 0.9 1.0 5.5 1.2 2.5 0.7 1.1 0.9 9.6 9.9 9.0 10.6 9.5 10.8 10.3 9.3 9.1 10.3 9.5 9.9 10.8 53.8 48.1 66.9 19.6 34.5 130.0 48.2 37.0 19.9 25.2 40.8 26.4 3.6 27.1 38.8 31.3 54.2 29.8 37.7 20.7 5.9 23.7 72.1 30.0 32.0 45.1 19.7 16.8 66.7 19.4 45.1 44.1 13.7 51.5 30.9 31.3 41.4 13.5 34.6 10.1 46.2 13.8 12.2 80.4 84.5 16.0 19.0 76.9 40.9 42.2 40.3 12.9 16.5 26.7 41.5 20.9 18.3 16.1 23.2 57.2 12.9 7.0 37.2 41.4 39.5 79.4 27.3 35.7 35.2 33.7 154.7 56.0 30.1 17.7 15.4 104.3 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" "B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065030, HPA073099" Approved Supported "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA065030: , HPA073099: AB_2686572" "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 10.3 1.9 4.6 11.0 2.6 12.3 6.1 2.3 3.2 5.8 2.0 3.7 3.3 4.6 1.1 2.8 2.8 6.1 6.2 2.2 2.8 2.1 2.8 10.9 12.4 4.7 2.7 0.5 1.2 1.7 3.5 0.7 12.6 4.6 1.9 2.9 0.5 2.3 2.3 2.9 1.7 4.1 6.0 3.0 36.1 4.3 0.9 5.6 17.4 3.0 6.6 10.5 6.8 1.9 5.2 0.2 0.0 5.6 0.0 0.8 1.0 0.1 3.3 9.2 3.8 3.1 0.0 0.0 18.5 31.7 11.1 1.1 0.1 0.8 13.5 4.1 9.0 0.2 113.9 0.5 0.0 6.0 13.7 14.6 0.8 1.1 7.7 17.3 11.1 60.5 25.6 0.0 23.3 0.8 0.0 13.3 8.1 1.8 0.0 3.1 49.8 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 20.4 63.0 0.7 0.0 0.2 3.5 7.3 16.4 16.6 0.1 31.8 5.2 34.5 15.5 24.5 10.1 15.3 11.9 6.8 8.9 8.2 19.1 6.0 3.7 8.2 11.8 12.3 19.1 3.3 11.1 20.1 4.6 2.6 2.3 3.2 2.2 2.8 4.7 2.7 0.5 4.6 3.0 5.6 5.2 53.4 6.4 5.3 0.3 65.7 5.1 0.3 1.7 2.2 0.0 0.7 1.3 5.5 5.7 0.1 1.8 0.0 0.4 43.1 0.0 0.0 0.0 0.5 0.4 0.6 84.2 0.0 23.4 0.3 0.0 0.4 5.9 2.0 0.3 22.8 0.0 64.6 1.3 43.2 0.0 1.5 0.1 0.0 86.4 24.7 0.5 1.8 60.3 7.2 231.4 68.4 0.1 93.7 4.0 0.7 0.0 0.0 0.7 56.9 0.3 0.0 0.4 0.8 0.4 6.6 2.1 3.1 0.2 0.1 0.6 4.1 0.3 52.8 0.9 0.2 0.4 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium inwardly rectifying channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 132 "kidney: 199.8" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 195.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 39 "RPTEC TERT1: 116.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced NA NA "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.2 0.1 1.0 0.1 1.3 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 1.5 0.1 0.1 0.0 0.1 0.4 0.3 199.8 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.1 0.0 0.1 0.2 0.1 0.1 0.4 0.1 0.5 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 116.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.1 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.6 0.0 0.0 0.1 0.0 195.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815848-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 67.0;intestine: 137.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7" "Group enriched" "Detected in many" 14 "granulocytes: 11.7;T-cells: 3.6" "Group enriched" "Detected in some" 5 "OE19: 333.1;RT4: 133.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.7 0.7 1.2 8.4 1.3 1.1 13.3 1.7 1.6 7.3 6.1 96.0 137.6 1.1 13.7 67.0 21.8 24.3 0.1 1.8 1.7 17.9 24.9 6.1 0.9 1.3 1.2 0.9 0.2 1.2 12.5 4.3 1.4 1.4 3.6 95.5 0.4 15.5 8.3 0.3 23.5 128.4 2.8 0.8 0.8 24.5 0.3 1.7 0.4 6.6 0.0 15.1 31.1 27.6 1.3 0.1 0.1 0.1 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 39.1 16.8 0.2 7.0 0.0 0.2 22.3 0.0 0.0 0.0 0.1 0.5 0.3 2.1 40.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.2 0.2 0.1 0.0 13.3 0.2 1.5 0.2 333.1 49.2 0.3 0.1 2.6 21.0 133.1 4.1 0.6 0.2 10.8 0.1 0.1 37.1 0.2 0.3 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.1 0.3 0.1 1.2 0.5 0.1 0.2 0.1 0.2 0.2 3.0 0.8 0.0 0.4 3.6 0.6 11.7 0.5 0.1 0.3 0.5 0.9 1.2 1.3 1.7 1.6 1.8 1.7 1.3 1.2 0.9 1.4 0.8 1.7 1.3 0.1 19.2 12.5 0.3 1.1 3.3 16.4 29.1 0.0 0.1 6.7 2.5 0.8 18.6 68.8 46.0 0.0 3.8 0.0 325.6 13.7 26.9 0.4 27.7 2.9 1.0 55.4 0.0 0.8 8.6 0.8 0.8 17.9 29.5 2.5 0.3 0.4 8.4 0.5 0.0 0.4 49.3 20.3 0.6 0.4 0.3 0.3 2.9 3.6 2.8 0.1 0.1 0.0 0.0 0.3 50.2 221.6 0.0 0.0 23.8 288.7 1.4 133.9 0.2 0.0 0.7 3.6 0.1 0.2 4.4 20.9 0.4 1.8 0.1 122.2 162.0 WWC2 "BOMB, FLJ22029" ENSG00000151718 "WW and C2 domain containing 2" Q6AWC2 4 183099257-183320777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 262.8;Microglial cells: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 84.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044005 Uncertain Approved Microtubules NA NA Microtubules "HPA044005: AB_10960552" "unprognostic (1.07e-1)" "prognostic unfavorable (8.61e-4)" "unprognostic (7.16e-4)" "unprognostic (1.70e-1)" "unprognostic (2.00e-2)" "unprognostic (4.48e-3)" "unprognostic (2.05e-1)" "unprognostic (3.93e-2)" "unprognostic (4.42e-2)" "unprognostic (1.97e-1)" "unprognostic (9.52e-3)" "unprognostic (2.22e-1)" "prognostic favorable (9.29e-4)" "unprognostic (3.27e-2)" "unprognostic (3.44e-1)" "unprognostic (3.23e-1)" "unprognostic (2.52e-2)" 9.1 5.6 5.3 4.6 5.4 0.6 7.9 5.7 4.4 7.8 9.3 3.9 2.0 9.0 3.3 5.2 6.9 7.0 12.2 4.4 6.9 18.9 19.4 28.4 2.3 6.9 5.5 3.5 11.6 12.7 9.8 1.8 14.6 6.1 8.0 2.9 21.4 6.1 8.9 4.3 4.2 2.1 10.0 6.9 6.4 6.9 15.6 5.9 1.1 16.0 5.6 2.2 6.3 3.8 7.7 26.0 10.9 23.1 20.7 16.9 18.8 26.7 34.5 27.1 37.2 26.6 48.2 24.7 0.0 16.9 55.7 13.0 9.2 35.7 14.3 46.9 0.0 11.0 26.3 25.4 24.9 17.5 12.5 27.6 14.3 10.7 24.6 22.9 30.8 25.1 3.7 18.9 1.4 28.6 7.5 0.0 8.3 22.0 0.7 9.3 0.0 21.1 14.0 52.7 6.9 1.5 11.7 84.2 72.7 11.1 36.5 17.6 4.2 37.8 13.8 38.2 8.2 25.1 0.0 0.0 0.3 13.5 5.7 24.7 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 5.3 5.4 5.7 4.4 4.4 6.9 6.9 5.5 3.5 6.1 6.9 5.9 7.7 27.8 262.8 65.4 23.2 0.4 24.0 9.3 6.3 8.6 5.4 15.0 11.4 30.0 37.1 24.0 7.3 64.6 15.4 1.4 0.7 27.4 16.3 36.9 26.7 26.6 27.4 1.2 3.6 62.1 14.6 9.8 25.0 9.2 35.4 19.0 39.5 17.2 39.0 10.5 0.0 98.1 0.2 4.1 15.6 7.7 26.9 17.7 9.0 12.4 129.3 7.6 11.7 0.0 52.3 44.0 30.3 0.1 21.1 0.8 29.3 0.0 24.7 11.5 58.6 26.3 34.2 24.2 41.8 19.7 7.7 15.3 6.6 3.2 19.9 0.4 12.2 CENPU "CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1" ENSG00000151725 "Centromere protein U" Q71F23 4 184694085-184734130 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 63.2;testis: 29.8" "Cell type enhanced" "Detected in many" "Early spermatids: 489.7;Late spermatids: 900.3;Spermatocytes: 490.2;Spermatogonia: 215.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 20.7;eosinophil: 14.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 20.7" "Cell line enhanced" "Detected in many" "Karpas-707: 157.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022048 Supported "Nucleoplasm,Centriolar satellite" NA Yes "Nucleoplasm, Centriolar satellite" "HPA022048: AB_1853985" "unprognostic (1.47e-1)" "unprognostic (9.88e-2)" "unprognostic (5.02e-2)" "unprognostic (2.37e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (4.39e-3)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.67e-3)" "unprognostic (3.34e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.11e-9)" "unprognostic (2.19e-2)" "unprognostic (7.40e-3)" "unprognostic (4.46e-2)" "unprognostic (2.74e-1)" 1.5 1.1 0.1 5.4 0.3 63.2 5.8 0.7 0.3 1.4 0.2 7.9 5.1 1.5 0.7 10.5 0.9 1.2 1.5 0.2 0.2 0.7 3.7 1.8 16.3 0.2 0.3 0.1 0.6 1.0 1.4 0.2 4.9 0.6 1.3 8.1 1.6 2.7 0.4 0.9 15.4 5.4 2.7 0.2 2.4 3.7 29.8 0.3 12.9 1.4 0.1 13.7 2.1 4.0 0.5 57.8 17.1 67.9 35.8 4.3 6.4 37.6 40.8 19.4 32.2 21.2 24.8 32.1 45.9 3.8 18.7 20.2 23.0 52.4 33.2 30.6 23.4 23.0 50.4 17.5 12.6 0.7 71.1 29.3 2.7 2.1 33.3 8.4 9.4 32.1 53.9 44.1 157.3 51.1 38.2 111.4 53.0 33.8 12.7 21.5 74.5 24.3 15.6 17.1 26.7 52.0 49.0 31.4 39.4 23.9 25.0 44.1 50.2 20.9 23.8 31.3 23.5 39.7 26.5 29.5 37.6 37.2 55.4 94.5 20.7 0.7 14.2 0.5 2.0 0.4 0.9 0.7 0.8 0.4 0.9 0.6 0.8 0.1 3.5 2.8 1.9 2.5 0.6 0.1 0.3 0.7 0.3 0.2 0.2 0.2 0.3 0.1 0.6 0.2 0.3 0.5 1.4 9.6 3.2 0.3 6.5 13.9 6.0 11.5 3.4 0.9 11.5 7.9 2.3 4.3 8.7 1.8 0.0 31.5 5.4 8.9 3.9 4.8 489.7 9.5 4.0 3.8 0.0 115.7 0.4 2.5 48.4 7.3 9.2 6.6 8.9 27.1 1.1 0.9 21.6 0.0 0.4 10.0 10.2 5.1 7.3 900.3 9.0 15.3 0.0 1.0 5.3 0.2 4.1 0.5 1.9 3.0 1.0 6.8 28.3 2.6 0.9 0.7 5.6 1.4 19.7 2.0 7.2 490.2 215.1 29.1 21.5 7.5 6.3 4.4 18.1 11.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 777.2;liver: 1330.0;skeletal muscle: 737.8" "Cell type enhanced" "Detected in many" "Early spermatids: 355.8;Hepatocytes: 1170.0;Late spermatids: 456.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 9 "neutrophil: 475.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 475.2" "Cell line enhanced" "Detected in all" "ASC diff: 1124.0;ASC TERT1: 275.2;HSkMC: 609.5;RPTEC TERT1: 358.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011317, HPA011964" Enhanced Uncertain Vesicles NA NA 44000 Vesicles "HPA011316: AB_1844536, HPA011317: , HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 777.2 43.6 41.1 95.6 49.5 341.3 319.3 51.9 70.4 52.0 76.8 34.1 32.7 41.9 78.9 66.5 51.0 36.5 127.7 40.7 71.2 220.8 1330.0 175.2 20.9 70.5 51.4 36.4 15.6 49.7 57.5 39.9 30.3 60.7 92.1 16.4 28.7 84.9 30.4 737.8 162.2 34.8 43.2 59.0 133.9 54.7 42.3 62.3 12.3 51.7 446.0 24.9 73.9 58.2 67.6 51.6 15.9 9.7 24.6 1124.0 275.2 8.3 29.1 13.8 16.1 11.2 3.9 14.0 22.2 3.0 32.8 38.4 29.7 43.1 17.8 13.3 107.1 17.7 16.6 13.1 40.5 183.4 41.9 37.2 609.5 140.7 13.6 67.1 27.6 21.1 3.6 7.5 59.4 77.0 26.9 3.1 55.1 2.0 32.5 23.3 8.0 8.6 27.0 358.4 135.9 36.3 35.1 25.4 70.8 86.5 3.9 26.9 39.8 25.1 13.8 16.8 34.5 8.7 24.5 13.5 8.9 45.6 56.3 22.4 16.5 54.7 17.7 3.3 30.9 2.8 3.3 2.3 1.5 13.1 3.4 2.5 2.2 475.2 4.4 23.0 2.4 4.9 20.8 41.1 49.5 51.9 70.4 40.7 71.2 70.5 51.4 36.4 60.7 59.0 62.3 67.6 7.5 25.6 121.0 6.5 15.7 21.0 16.0 14.0 5.2 6.6 49.7 10.3 119.1 25.8 33.5 31.3 18.8 10.2 7.1 4.3 93.9 4.6 355.8 9.8 25.0 9.8 0.0 34.1 15.2 12.8 2.2 19.4 36.2 24.6 24.1 1.5 18.2 1170.0 41.8 3.3 22.8 4.7 85.5 140.7 14.6 456.6 19.3 170.1 32.0 6.5 40.5 3.1 1.0 8.5 89.8 8.6 1.6 16.6 8.6 51.3 1.5 111.1 26.8 11.4 13.1 11.1 12.4 10.5 16.7 26.4 41.1 3.4 10.6 1.8 3.2 23.1 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143266-185150382 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Host-virus interaction, Transport" "Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 201.5;skeletal muscle: 192.6;tongue: 349.7" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 4722.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 380000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favorable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 4.7 5.7 11.9 1.6 16.6 0.4 4.6 24.1 31.3 3.4 7.1 15.9 3.0 5.9 3.5 10.1 5.8 3.9 201.5 16.1 15.2 10.4 7.3 4.6 1.6 12.7 13.0 15.3 5.0 5.3 7.8 9.6 1.8 14.9 9.0 3.9 20.1 9.1 12.7 192.6 3.1 6.9 8.1 9.9 3.1 15.8 4.7 12.7 1.5 5.2 349.7 1.2 9.9 3.6 19.3 0.7 3.1 2.5 5.1 2.7 0.3 4.6 2.6 0.8 3.1 3.0 6.8 1.7 2.3 1.8 3.1 2.4 2.5 9.8 2.7 2.0 3.9 8.4 1.6 4.7 8.1 5.5 1.4 1.5 2.0 6.6 4.7 1.3 7.2 2.3 4.0 3.8 1.7 1.9 5.0 1.6 3.1 4.1 2.2 6.6 2.5 1.3 3.2 6.9 4.8 8.1 6.2 3.1 1.3 12.5 4.5 2.4 1.1 1.7 0.2 1.4 1.5 3.4 7.3 3.5 2.9 2.2 0.3 2.8 0.0 0.0 0.0 1.7 0.0 1.3 1.5 0.5 1.4 0.0 1.0 0.4 1.2 0.1 0.3 0.0 1.3 0.5 0.6 11.9 16.6 24.1 31.3 16.1 15.2 12.7 13.0 15.3 14.9 9.9 12.7 19.3 37.5 86.6 76.4 22.9 37.9 44.1 159.0 119.9 30.1 180.6 42.9 53.5 4722.0 115.8 80.0 71.7 104.3 69.2 41.1 44.4 988.0 75.3 20.6 77.8 7.4 80.1 53.8 3.0 35.1 74.1 56.5 120.1 54.0 33.6 12.0 18.6 27.5 92.1 65.9 159.9 43.7 40.6 215.7 8.5 13.8 16.7 46.6 6.8 190.3 19.7 9.0 541.2 16.5 26.7 29.2 51.4 28.5 112.8 76.4 59.1 113.8 178.3 144.0 221.0 105.2 134.5 402.7 28.0 34.0 33.2 18.2 40.5 27.7 23.7 54.2 50.7 AMN1 ENSG00000151743 "Antagonist of mitotic exit network 1 homolog" Q8IY45 12 31671142-31729121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.2" "Cell type enhanced" "Detected in many" "Early spermatids: 384.0;Late spermatids: 156.1;Spermatocytes: 232.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 51.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046157, HPA062290" Approved Approved Centrosome NA NA Centrosome "HPA046157: AB_10965846, HPA062290: AB_2684739" "unprognostic (2.11e-2)" "unprognostic (2.52e-1)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "unprognostic (2.80e-1)" "unprognostic (5.93e-2)" "unprognostic (8.60e-3)" "unprognostic (4.08e-2)" "unprognostic (6.48e-2)" "unprognostic (3.01e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-2)" "unprognostic (2.48e-1)" "unprognostic (4.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" 6.2 10.9 27.8 7.0 31.0 3.4 9.7 27.1 34.7 9.9 20.2 5.2 4.0 11.8 8.5 6.3 18.9 7.6 11.9 31.3 30.4 12.1 6.3 6.9 13.0 27.0 27.1 29.0 17.3 8.8 13.8 12.6 5.6 27.1 9.4 4.3 46.4 6.8 7.8 18.5 6.3 6.1 7.5 27.4 10.3 9.4 57.2 28.3 19.7 8.6 20.2 10.2 9.0 6.9 34.7 5.4 11.6 8.5 0.7 8.5 10.8 5.2 5.7 8.2 3.7 7.1 6.0 19.8 2.6 11.9 4.8 28.1 2.8 4.3 6.4 7.6 4.6 5.4 9.7 3.9 8.7 15.4 5.0 4.8 7.1 10.5 6.3 8.9 28.4 21.4 13.9 8.4 8.0 14.3 3.3 2.9 4.0 12.5 11.2 5.1 4.2 14.7 4.5 8.7 11.9 14.7 11.2 7.3 1.5 11.7 19.3 16.9 5.6 11.5 6.1 5.1 5.2 9.9 9.1 9.5 9.0 8.2 4.5 11.9 8.2 5.0 6.4 7.4 3.7 7.5 22.1 7.7 7.9 4.0 19.3 16.9 10.5 51.8 9.4 3.2 12.4 12.8 5.9 27.8 31.0 27.1 34.7 31.3 30.4 27.0 27.1 29.0 27.1 27.4 28.3 34.7 13.2 6.4 2.7 25.5 25.7 9.3 25.6 35.3 12.5 11.7 10.5 6.7 4.0 7.2 22.3 16.5 27.1 7.1 3.1 2.1 27.4 10.5 384.0 20.0 4.7 11.5 14.4 1.7 48.6 7.2 5.3 7.7 7.1 12.1 7.6 8.1 11.4 3.2 9.0 30.3 58.5 1.9 42.7 6.0 6.8 156.1 10.2 7.7 16.0 13.1 4.1 15.9 11.3 22.1 67.3 11.1 1.0 13.5 5.4 16.9 2.0 11.4 22.9 43.2 0.0 6.1 11.2 232.9 31.1 6.9 12.6 7.3 9.5 10.8 2.1 32.3 BICD1 ENSG00000151746 "BICD cargo adaptor 1" Q96G01 12 32106835-32383633 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Group enriched" "Detected in many" 5 "Astrocytes: 198.8;Excitatory neurons: 267.2;Inhibitory neurons: 331.5;Microglial cells: 96.5;Oligodendrocyte precursor cells: 167.4;Oligodendrocytes: 131.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 73.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041309 Approved Uncertain Vesicles NA NA Vesicles "HPA041309: AB_10804000" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-6)" "unprognostic (5.93e-2)" "unprognostic (4.57e-1)" "unprognostic (3.64e-1)" "unprognostic (8.19e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" 5.4 3.8 6.4 6.1 6.7 3.2 4.5 28.9 11.1 13.8 0.0 3.4 2.1 9.8 4.9 2.0 9.9 4.8 4.4 7.4 8.9 6.0 1.2 6.0 6.9 5.0 5.8 5.6 20.8 1.8 6.1 7.0 8.8 13.1 5.2 2.8 7.9 2.7 2.6 3.8 2.1 3.8 5.5 3.9 8.1 2.8 3.1 6.4 7.5 6.3 3.4 5.3 4.7 4.1 9.2 14.5 9.9 7.1 4.3 6.9 9.3 8.1 16.4 6.7 16.5 11.6 12.8 9.6 21.0 13.3 14.5 18.8 6.7 36.2 13.8 25.7 14.9 10.6 28.3 9.9 6.2 7.7 22.8 16.8 5.5 6.8 19.4 15.9 25.4 16.8 22.8 13.0 41.7 6.5 5.8 22.3 8.7 73.7 6.2 11.0 16.7 23.9 15.7 21.7 8.3 31.7 17.4 12.5 0.9 12.8 48.7 8.3 5.0 16.6 25.1 24.0 18.6 23.7 13.7 20.9 44.3 16.8 10.0 27.3 0.0 0.5 0.0 1.5 0.2 2.3 2.4 1.4 0.9 0.8 2.0 1.8 1.5 0.1 1.9 0.0 1.9 2.4 0.8 6.4 6.7 28.9 11.1 7.4 8.9 5.0 5.8 5.6 13.1 3.9 6.4 9.2 15.1 16.0 1.1 198.8 22.0 0.4 8.2 13.6 6.8 30.5 5.4 6.3 8.3 1.5 9.1 9.2 37.5 0.4 10.7 0.7 1.9 9.1 0.6 11.7 26.2 17.0 6.6 9.2 267.2 4.7 0.5 12.6 1.1 34.2 0.0 35.1 13.2 0.5 6.5 23.5 331.5 1.2 16.2 1.3 4.2 1.2 4.1 5.1 8.8 96.5 4.2 39.2 4.1 167.4 131.7 8.3 0.5 4.5 34.5 7.0 0.6 2.7 2.6 19.3 0.0 18.1 12.3 6.9 9.2 3.9 2.4 0.3 10.7 28.1 2.6 3.7 SAV1 "salvador, WW45, WWP4" ENSG00000151748 "Salvador family WW domain containing protein 1" Q9H4B6 14 50632058-50668306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001808 Approved Supported Cytosol NA NA Cytosol "HPA001808: AB_2666441" "prognostic favorable (2.92e-5)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-2)" "unprognostic (4.38e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-3)" "unprognostic (3.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-3)" "unprognostic (5.20e-2)" "prognostic favorable (3.83e-6)" "unprognostic (2.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.28e-2)" "unprognostic (1.90e-3)" 32.5 16.6 14.8 12.9 16.6 7.3 35.7 15.4 17.0 24.7 23.0 14.9 15.4 23.6 19.0 16.0 21.4 26.5 24.4 13.2 15.9 23.1 17.7 20.3 15.8 16.4 15.5 11.9 38.1 34.7 27.2 8.6 17.2 17.0 27.9 12.7 17.7 45.9 19.4 23.3 17.7 13.4 17.8 16.0 18.8 19.1 30.9 18.0 10.4 34.6 27.4 14.8 16.8 18.9 20.2 96.3 10.7 17.8 12.4 43.5 39.8 22.4 26.6 87.3 34.1 43.4 16.0 47.8 14.9 63.9 26.4 17.8 42.8 25.7 28.9 62.9 45.6 20.8 16.4 16.4 11.4 21.3 17.9 14.0 24.9 36.5 15.3 33.8 25.8 24.5 15.9 27.5 7.2 42.5 17.9 15.1 11.0 33.1 21.6 17.3 17.2 49.5 6.1 21.5 13.6 22.2 16.8 47.1 27.7 41.3 28.9 20.3 18.0 17.7 16.2 55.5 22.4 16.4 11.3 15.4 9.0 11.1 7.2 22.1 0.6 0.3 0.0 0.9 0.3 0.9 3.3 0.7 0.5 0.3 3.4 0.5 0.7 0.5 0.5 0.4 1.2 1.0 0.4 14.8 16.6 15.4 17.0 13.2 15.9 16.4 15.5 11.9 17.0 16.0 18.0 20.2 76.4 35.3 44.0 9.4 35.8 65.9 37.2 19.1 24.5 19.6 76.4 60.6 39.1 15.7 35.1 18.4 25.0 19.9 14.7 11.2 17.6 40.5 92.5 39.6 47.3 76.9 5.4 27.0 10.4 47.6 23.0 59.3 11.7 58.1 2.5 46.4 59.3 14.5 10.5 5.0 10.0 10.1 10.2 13.5 61.5 26.1 66.8 34.1 30.2 12.2 11.6 26.9 2.1 12.5 27.0 66.5 14.6 42.5 7.4 81.4 12.1 16.3 33.3 26.4 6.6 41.8 45.1 41.4 38.8 14.6 59.5 23.1 9.4 17.7 9.6 34.1 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 148.5;Spermatocytes: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: AB_2682665, HPA061456: AB_2684527" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 2.1 2.9 2.0 1.9 2.7 0.9 3.8 1.6 2.1 2.8 0.9 2.9 1.7 4.2 5.3 2.1 4.4 3.1 4.7 1.5 2.9 2.6 2.4 2.1 2.7 2.6 2.5 1.4 6.2 3.6 4.1 3.2 3.1 2.6 4.9 3.5 0.6 3.3 2.4 1.1 4.1 2.5 3.4 1.8 3.0 3.1 4.2 2.3 2.1 5.0 0.3 2.7 2.9 2.0 5.0 2.2 1.8 0.8 0.0 0.6 4.0 2.3 5.7 6.4 3.0 3.3 3.0 7.6 3.8 3.2 3.4 4.9 3.4 0.7 0.8 3.9 5.7 2.8 1.6 1.0 1.6 8.1 0.9 0.4 10.4 6.7 4.2 10.9 2.5 1.4 1.4 0.0 1.1 4.0 2.6 0.6 0.6 0.9 0.5 2.1 0.9 0.0 2.1 4.5 1.2 2.0 3.1 4.0 0.1 3.4 4.3 0.6 0.6 7.1 0.2 0.8 4.9 0.0 0.0 0.0 1.8 2.7 0.1 2.9 3.5 0.6 1.1 0.5 0.6 0.6 1.0 0.7 0.5 0.5 1.3 0.5 0.5 1.4 1.4 1.1 1.2 0.7 0.4 2.0 2.7 1.6 2.1 1.5 2.9 2.6 2.5 1.4 2.6 1.8 2.3 5.0 5.6 9.6 11.7 8.5 5.2 3.1 8.9 6.1 9.6 1.9 10.5 12.1 11.1 10.0 8.5 7.3 0.0 17.5 1.7 4.5 19.6 13.1 2.8 14.3 11.3 6.7 18.0 6.1 15.8 10.1 11.6 9.2 4.6 8.3 1.3 13.8 5.7 4.9 2.0 10.1 24.7 9.4 0.0 2.2 2.7 2.3 17.7 3.9 1.8 21.5 0.8 12.7 0.0 28.6 148.5 7.6 2.9 7.9 1.3 8.3 6.4 12.0 19.1 0.6 0.0 7.4 6.7 43.2 26.3 5.5 3.8 7.9 2.9 14.0 7.1 6.4 SERP2 "bA269C23.1, C13orf21" ENSG00000151778 "Stress associated endoplasmic reticulum protein family member 2" Q8N6R1 13 44373665-44397714 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 88.4;choroid plexus: 59.8" "Group enriched" "Detected in many" 11 "Early spermatids: 577.8;Late spermatids: 237.7" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.6" "Lineage enhanced" "Detected in single" "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "LHCN-M2: 3.7;SH-SY5Y: 5.1;U-2197: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (6.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (2.06e-1)" "unprognostic (9.62e-2)" "unprognostic (1.72e-2)" "unprognostic (2.85e-1)" "unprognostic (3.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.34e-3)" "unprognostic (1.12e-2)" "prognostic favorable (1.94e-4)" "unprognostic (1.48e-1)" "unprognostic (6.60e-2)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" 1.2 2.0 71.5 1.0 75.9 0.0 2.6 66.2 88.4 2.5 59.8 3.2 2.9 4.1 9.1 0.8 2.3 0.9 18.2 76.2 73.6 1.9 1.3 1.1 1.4 69.5 70.8 75.4 4.7 1.7 1.4 8.6 0.3 70.2 3.5 1.1 14.4 1.1 3.9 2.1 0.6 2.0 2.0 66.2 0.4 2.7 27.5 71.3 1.9 1.2 0.5 1.2 2.0 2.0 74.1 0.0 0.0 2.1 0.0 0.3 1.8 0.0 0.4 0.6 2.3 1.5 0.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.4 0.0 0.1 1.9 0.0 0.0 0.3 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.4 5.1 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.0 0.1 4.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 71.5 75.9 66.2 88.4 76.2 73.6 69.5 70.8 75.4 70.2 66.2 71.3 74.1 4.0 0.0 1.5 19.6 0.1 1.8 3.7 1.9 4.6 21.0 12.0 7.2 20.0 4.3 1.0 9.2 14.6 2.5 1.1 2.9 17.6 11.3 577.8 0.7 4.6 3.9 14.4 0.8 34.6 12.9 2.5 10.3 0.5 1.2 17.8 7.8 1.4 6.2 0.2 15.2 29.8 4.0 0.0 0.0 1.1 237.7 13.1 0.7 12.4 9.4 0.6 25.0 1.0 13.0 27.1 6.3 1.7 19.2 0.1 3.4 3.9 8.9 1.3 23.3 26.3 15.1 10.0 8.5 12.5 0.4 1.0 2.1 1.8 4.6 4.4 3.2 NBAS NAG ENSG00000151779 "NBAS subunit of NRZ tethering complex" A2RRP1 2 15166914-15561334 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 217.8;Inhibitory neurons: 187.9;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.4 21.2 34.4 7.3 37.0 16.2 16.0 36.3 43.0 18.3 33.3 20.4 8.3 18.5 13.8 17.3 19.0 8.2 31.8 34.8 36.2 20.0 21.8 16.0 9.5 35.8 33.4 34.5 22.7 34.7 16.4 29.9 10.1 37.2 19.1 10.6 13.5 15.6 10.5 30.7 21.5 20.3 11.9 32.9 21.3 24.7 41.5 35.3 14.6 17.5 17.9 9.2 19.8 16.7 37.1 10.5 13.7 14.8 10.7 37.8 41.5 15.2 19.1 20.8 14.5 14.6 13.8 15.0 13.4 4.3 29.3 15.1 12.5 16.5 23.9 17.2 13.5 10.4 51.3 11.5 38.8 38.8 13.4 25.1 27.3 18.9 19.2 32.8 30.2 30.4 18.7 40.6 15.0 22.4 13.0 11.2 30.1 12.8 17.1 12.8 11.7 26.0 16.2 30.5 14.0 8.7 14.2 16.2 13.4 25.2 18.3 9.4 12.0 26.6 18.5 11.2 13.5 13.9 22.1 20.3 18.7 33.1 15.5 16.8 1.5 4.4 2.5 5.7 3.1 6.7 4.1 4.2 7.3 4.0 3.4 4.2 4.3 0.8 7.2 7.5 4.5 5.3 2.9 34.4 37.0 36.3 43.0 34.8 36.2 35.8 33.4 34.5 37.2 32.9 35.3 37.1 16.1 19.2 13.8 96.6 15.1 7.4 9.3 11.9 12.0 17.3 11.7 9.4 32.3 17.2 13.8 18.4 29.2 11.5 15.1 9.4 0.0 11.1 39.3 22.2 21.3 14.6 7.3 38.7 217.8 14.0 13.1 13.4 20.9 14.8 38.6 30.2 8.9 9.1 9.0 13.5 187.9 14.8 10.2 6.9 8.0 61.9 11.5 11.6 5.4 106.8 18.4 12.5 9.2 159.3 159.2 8.6 9.5 16.6 27.2 9.2 39.3 8.5 26.0 25.5 0.0 24.7 16.3 33.7 22.4 12.9 11.2 10.4 19.9 70.0 12.5 7.6 ZNF385D "FLJ22419, ZNF659" ENSG00000151789 "Zinc finger protein 385D" Q9H6B1 3 21412218-22373321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.6;testis: 15.2" "Cell type enriched" "Detected in many" 5 "Inhibitory neurons: 1766.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "cerebellum: 41.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.8;hTERT-RPE1: 5.4;LHCN-M2: 5.3;PC-3: 5.3;RPTEC TERT1: 15.1;U-87 MG: 21.1" "Low region specificity" "Detected in all" HPA036190 Uncertain NA NA "HPA036190: AB_10602355" "unprognostic (4.07e-2)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (3.23e-2)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (8.20e-2)" "unprognostic (6.60e-2)" "unprognostic (7.84e-2)" "unprognostic (3.73e-1)" "unprognostic (2.35e-1)" "unprognostic (9.01e-2)" "unprognostic (3.49e-7)" "unprognostic (8.70e-3)" "unprognostic (5.38e-2)" "unprognostic (7.76e-3)" "unprognostic (2.15e-5)" 3.9 0.2 2.3 1.4 4.0 0.3 2.3 41.6 5.2 1.8 0.0 0.7 0.3 1.1 0.5 2.0 0.7 2.7 1.8 2.3 2.3 1.5 0.1 0.6 0.8 3.0 7.1 2.3 0.6 0.6 0.2 0.1 0.0 10.0 1.3 0.5 7.3 0.7 1.1 1.0 0.7 0.5 1.7 0.4 0.4 0.4 15.2 3.9 0.7 0.5 3.3 1.0 2.7 1.2 5.0 0.0 0.0 0.3 0.0 2.0 4.3 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 5.4 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 15.1 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 2.3 4.0 41.6 5.2 2.3 2.3 3.0 7.1 2.3 10.0 0.4 3.9 5.0 82.2 12.8 13.4 17.3 1.4 9.7 0.7 6.2 1.8 58.8 1.5 6.3 3.6 1.5 19.2 1.8 8.4 0.3 1.4 0.9 27.4 0.6 174.9 0.2 1.9 89.0 0.0 12.6 267.5 0.7 0.2 20.5 0.0 0.3 5.1 1.8 2.2 5.8 0.4 323.0 1766.6 0.7 0.0 0.0 14.0 274.5 16.8 4.9 12.4 64.6 0.6 114.3 1.0 159.3 12.7 1.4 0.6 13.5 0.3 1.7 2.3 6.6 4.4 31.0 13.1 22.0 20.2 50.4 2.0 0.6 7.7 0.1 1.5 34.3 0.7 1.0 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "liver: 804.5" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 1174.2" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3" "Group enriched" "Detected in some" 7 "cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9" "Low region specificity" "Detected in all" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 1.6 0.5 16.9 0.6 0.0 0.1 0.4 1.4 0.2 0.4 1.2 3.6 0.4 0.7 0.7 0.3 1.9 0.0 0.7 0.5 0.4 804.5 3.3 3.1 0.5 1.3 0.5 0.1 0.3 0.1 4.1 0.6 0.6 0.2 1.4 0.0 0.4 0.2 0.2 0.0 6.0 2.6 0.5 1.9 1.6 0.4 0.5 0.2 0.2 0.0 2.6 7.7 0.1 0.9 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 9.6 0.0 0.2 0.0 0.1 0.0 0.0 22.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 3.5 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 1.6 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 1.2 0.4 0.5 0.0 3.4 0.0 0.0 11.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.4 1.4 0.7 0.5 0.5 1.3 0.5 0.6 0.5 0.5 0.9 0.8 0.0 0.0 0.7 2.7 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.6 158.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.5 0.1 1.1 2.4 0.0 32.0 4.1 0.0 0.0 1.7 3.6 0.1 0.0 0.0 29.6 1174.2 0.9 0.0 0.4 0.0 0.0 31.7 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.6 0.0 11.3 0.4 1.1 0.0 0.0 0.3 2.3 0.3 0.0 0.1 GUF1 FLJ13220 ENSG00000151806 "GUF1 homolog, GTPase" Q8N442 4 44678420-44700928 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003934, HPA024222" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003934: AB_1079034, HPA024222: AB_2671488" "unprognostic (1.32e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-2)" "unprognostic (3.65e-3)" "unprognostic (7.56e-2)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.37e-2)" "unprognostic (3.03e-2)" "unprognostic (1.56e-3)" "unprognostic (7.38e-3)" "prognostic favorable (2.66e-6)" "unprognostic (4.98e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.65e-5)" "unprognostic (5.40e-2)" 5.2 4.1 2.1 3.9 3.3 6.3 5.3 4.4 3.6 3.3 0.6 5.7 4.7 4.8 3.8 5.3 4.1 2.8 6.2 3.1 2.6 7.0 7.1 3.2 4.8 1.6 2.3 2.5 4.9 3.7 4.4 2.4 3.7 2.1 5.0 6.0 6.8 4.1 3.5 15.9 4.8 6.4 3.5 2.1 4.9 8.0 5.9 2.2 4.4 5.3 17.1 4.6 3.9 3.8 4.4 11.9 6.0 10.9 13.9 4.4 9.0 24.0 16.1 8.2 16.2 12.4 10.5 8.3 25.8 12.3 7.7 14.9 9.2 18.7 18.2 18.2 8.7 12.2 30.7 5.3 7.2 14.3 33.4 12.7 9.2 8.1 12.1 10.5 7.6 11.8 15.0 31.7 4.9 13.2 5.9 19.1 7.0 7.0 8.5 13.8 13.5 22.5 11.0 4.8 4.6 14.8 11.1 10.1 4.2 11.2 8.4 6.8 9.6 11.7 11.0 12.7 14.8 19.1 17.9 17.4 18.3 11.9 19.7 9.6 0.5 2.2 2.3 2.0 2.9 2.6 2.1 2.1 1.8 2.1 1.7 1.9 2.0 0.0 2.3 1.9 2.3 3.6 1.9 2.1 3.3 4.4 3.6 3.1 2.6 1.6 2.3 2.5 2.1 2.1 2.2 4.4 7.2 6.4 9.5 9.8 11.6 4.0 9.6 6.0 5.2 10.5 9.8 7.5 22.8 7.2 9.1 7.3 2.1 13.1 10.1 11.5 13.7 10.3 2.0 12.0 14.3 8.1 11.4 14.9 20.3 10.2 17.6 9.7 18.3 8.8 1.3 16.6 7.9 13.9 12.1 11.8 19.5 12.4 4.1 11.7 5.4 2.9 5.6 9.0 7.2 9.4 9.2 9.2 14.4 18.6 19.0 16.4 6.6 7.2 13.9 9.8 11.3 12.2 16.7 10.3 0.0 6.8 10.0 12.3 14.6 14.9 7.1 13.4 9.5 18.9 13.3 10.6 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563920-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.8;retina: 6.5;seminal vesicle: 3.6" "Cell type enriched" "Detected in some" 12 "Inhibitory neurons: 166.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPMI-8226: 1.5;U-87 MG: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043853 Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.0 0.0 0.7 0.0 0.9 0.0 0.0 5.8 0.6 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.4 1.4 0.0 0.0 0.0 0.0 1.7 1.5 0.4 0.0 0.1 0.0 0.0 0.0 1.9 1.3 0.0 6.5 0.0 3.6 0.0 0.0 0.0 0.3 2.1 0.0 0.0 1.0 2.0 0.0 0.8 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 5.8 0.6 0.4 1.4 1.7 1.5 0.4 1.9 2.1 2.0 1.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 11.7 0.1 0.0 0.2 0.0 0.0 12.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 166.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 5.3 0.1 0.0 3.0 0.0 0.0 0.0 0.1 0.0 13.7 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor subunit alpha2" P47869 4 46243548-46475230 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.9;epididymis: 8.9" "Group enriched" "Detected in many" 5 "Astrocytes: 425.4;Excitatory neurons: 156.2;Inhibitory neurons: 111.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.6;glioma: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-2 OS: 4.2;U-87 MG: 2.1;WM-115: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 1.2 0.3 21.2 0.4 31.9 0.2 1.3 3.8 31.8 0.5 0.0 3.0 0.9 0.4 8.9 0.7 0.0 0.5 0.1 27.5 13.8 6.3 0.4 0.1 0.3 4.2 4.0 26.3 0.7 0.1 0.0 0.5 0.4 7.2 0.1 2.1 2.4 0.2 0.7 0.1 0.2 6.0 0.2 0.7 1.2 0.5 0.5 10.0 0.4 0.1 0.1 0.4 0.2 0.7 14.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.4 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 4.2 0.2 0.0 0.2 0.6 0.0 2.1 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.2 31.9 3.8 31.8 27.5 13.8 4.2 4.0 26.3 7.2 0.7 10.0 14.3 4.9 0.0 0.0 425.4 0.0 0.1 0.0 0.0 1.2 15.3 0.2 0.0 0.6 0.0 0.0 40.5 4.2 0.0 0.0 23.1 3.9 0.0 9.1 1.2 31.7 1.0 31.8 0.0 156.2 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 111.6 3.4 0.0 0.0 0.0 17.1 0.6 0.1 1.8 16.9 0.0 0.2 0.0 13.0 5.5 0.0 4.7 0.0 0.0 0.0 38.1 0.1 0.0 1.1 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.0 2.7 0.0 SACS "ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6" ENSG00000151835 "Sacsin molecular chaperone" Q9NZJ4 13 23328826-23433740 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 70.5;Excitatory neurons: 86.3;Inhibitory neurons: 108.2;Oligodendrocyte precursor cells: 76.4;Oligodendrocytes: 111.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017714 Uncertain NA NA "CAB017714: " "unprognostic (1.22e-1)" "unprognostic (2.18e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.26e-2)" "unprognostic (1.66e-1)" "unprognostic (2.05e-3)" "unprognostic (2.59e-2)" "unprognostic (2.49e-1)" "unprognostic (4.14e-2)" "unprognostic (5.05e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.21e-6)" "unprognostic (2.84e-1)" "unprognostic (4.06e-2)" "unprognostic (3.67e-2)" "unprognostic (7.65e-4)" 4.7 4.4 5.7 4.0 9.0 5.6 4.3 8.6 17.2 4.6 0.0 6.2 0.9 6.3 2.8 3.7 5.9 2.3 8.4 10.3 5.6 2.3 2.2 4.9 4.3 9.5 6.3 7.5 4.7 4.9 15.3 6.9 1.3 11.2 7.7 1.5 4.7 6.6 2.3 14.1 2.4 5.0 5.0 4.1 8.6 5.2 6.9 11.6 4.3 2.6 13.2 3.6 10.0 4.4 13.1 8.1 10.5 21.3 6.5 6.5 24.3 3.1 18.1 23.2 6.9 5.7 5.0 4.2 5.5 7.4 38.8 9.0 1.6 30.7 10.8 22.5 12.9 12.6 20.7 8.1 7.4 4.8 38.1 7.9 7.8 2.5 44.3 21.2 9.7 23.1 17.0 12.1 2.6 31.6 3.8 13.6 14.6 17.5 2.8 8.2 16.0 38.7 16.7 12.0 0.9 15.4 14.8 10.0 3.6 7.8 9.7 1.9 10.0 49.8 21.1 17.4 11.5 34.6 5.0 5.7 13.3 10.1 13.2 18.7 0.0 0.1 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.4 0.7 0.2 0.3 0.0 0.3 0.0 0.3 0.7 0.1 5.7 9.0 8.6 17.2 10.3 5.6 9.5 6.3 7.5 11.2 4.1 11.6 13.1 10.3 0.0 1.3 70.5 14.5 6.1 5.4 2.0 6.8 16.5 8.2 8.0 21.3 1.5 1.4 1.8 0.0 0.4 15.3 0.2 0.0 9.0 13.1 5.6 28.1 11.6 1.2 9.7 86.3 10.4 1.5 17.4 3.1 3.3 2.5 18.8 3.6 0.7 3.4 25.2 108.2 0.4 2.0 4.9 19.4 11.6 4.1 8.1 8.8 19.7 3.9 13.6 6.2 76.4 111.0 16.7 0.2 5.3 12.9 8.1 0.0 1.3 1.2 5.3 13.1 45.6 20.9 20.5 9.5 5.3 5.1 0.0 18.1 20.0 0.8 2.9 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 18.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Early spermatids: 11.9;Excitatory neurons: 15.9;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 11.4;Spermatocytes: 17.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "cerebellum: 18.7;pons: 6.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.0 0.0 0.9 0.0 0.3 0.1 0.0 18.7 0.5 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 18.7 0.5 0.1 1.5 0.6 0.9 0.0 6.0 0.4 0.2 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 8.4 0.0 0.0 1.1 0.0 0.0 11.9 5.0 0.1 0.0 0.0 1.7 15.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 1.5 4.8 0.0 0.3 0.0 0.0 0.1 1.5 0.0 5.0 3.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 7.4 11.4 0.0 0.4 0.3 17.7 4.4 0.0 0.0 0.0 0.0 0.1 2.4 0.1 PABPC3 "PABP3, PABPL3, tPABP" ENSG00000151846 "Poly(A) binding protein cytoplasmic 3" Q9H361 13 25096136-25099254 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 37.1" "Group enriched" "Detected in many" 14 "Early spermatids: 217.6;Late spermatids: 135.4;Spermatocytes: 190.8" "Cancer enhanced" "Detected in some" "stomach cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "U-266/84: 6.8" "HPA045423, HPA067156" Approved Approved Cytosol NA NA Cytosol "HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (2.17e-2)" "unprognostic (6.50e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.78e-1)" "unprognostic (2.98e-1)" "unprognostic (8.76e-3)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.00e-4)" "unprognostic (5.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" "unprognostic (5.18e-2)" "unprognostic (5.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.61e-3)" 0.4 0.2 0.1 0.0 0.2 0.0 0.4 0.2 0.2 0.3 0.0 0.3 0.0 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.0 0.2 0.2 0.1 0.5 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.7 0.0 0.1 0.5 0.3 0.0 0.2 0.2 0.3 37.1 0.2 0.0 0.2 0.0 0.0 0.3 0.6 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 6.8 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.4 0.3 0.3 0.3 0.2 0.4 0.2 0.4 0.4 0.1 0.3 0.4 0.2 0.3 0.5 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.0 0.0 1.3 11.7 9.9 2.8 0.0 0.1 0.4 0.0 5.3 0.0 1.3 0.0 0.0 2.0 4.0 0.9 0.0 0.3 217.6 0.2 0.4 2.5 4.2 2.7 0.0 0.4 1.8 2.0 0.0 0.1 4.5 0.1 2.5 1.0 1.6 1.7 0.0 1.6 2.0 5.7 12.7 135.4 3.1 1.9 5.4 0.0 2.1 1.3 0.0 0.0 0.0 0.1 3.0 4.9 0.0 4.5 0.5 2.0 1.0 0.0 6.6 4.8 10.5 190.8 5.1 0.0 12.9 2.9 2.5 0.2 2.7 5.0 CENPJ "BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4" ENSG00000151849 "Centromere protein J" Q9HC77 13 24882279-24922889 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.4" "Cell type enhanced" "Detected in many" "Early spermatids: 135.8;Spermatocytes: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076638 Supported Centrosome NA NA Centrosome "HPA076638: " "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (2.68e-1)" "unprognostic (1.01e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-2)" "unprognostic (2.15e-5)" "unprognostic (7.41e-2)" "unprognostic (1.50e-2)" "unprognostic (9.83e-2)" "unprognostic (2.44e-1)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.36e-2)" "unprognostic (5.51e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" 2.4 1.3 2.1 2.5 2.6 4.4 3.3 5.0 3.4 3.3 1.0 3.3 4.2 4.2 2.3 2.2 3.5 1.6 1.6 2.2 2.0 0.8 1.5 2.4 5.0 2.3 2.2 2.0 3.5 1.1 0.9 0.7 3.7 3.2 2.4 4.3 1.8 1.5 1.7 2.2 5.1 3.6 3.9 1.6 2.6 2.1 16.4 2.4 3.5 11.1 1.6 4.1 3.3 2.4 2.6 4.5 3.9 14.9 16.4 2.4 3.5 9.0 11.5 5.5 5.5 5.1 8.0 8.3 8.9 3.5 3.1 4.4 12.9 11.4 6.8 11.2 7.9 7.2 34.0 13.1 6.7 0.9 15.3 10.2 1.0 2.5 5.1 4.1 3.1 5.9 7.3 8.3 13.5 8.8 7.7 8.4 23.8 10.2 13.3 5.9 11.3 10.0 4.4 3.1 7.6 8.5 7.5 5.3 6.9 4.8 12.1 2.9 9.4 4.3 8.8 5.6 12.9 7.2 4.9 8.3 8.4 4.3 11.6 10.8 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 2.1 2.6 5.0 3.4 2.2 2.0 2.3 2.2 2.0 3.2 1.6 2.4 2.6 7.5 3.2 10.5 6.2 6.7 2.0 4.3 5.8 5.7 8.0 3.8 5.2 6.9 1.5 9.1 3.7 4.2 8.5 7.0 10.8 0.0 2.6 135.8 7.0 13.6 6.3 0.0 17.9 20.1 2.9 14.9 8.4 2.6 13.2 5.1 21.3 2.2 1.4 4.3 3.3 18.4 3.7 2.0 1.6 3.5 24.7 6.5 5.9 0.0 8.4 6.6 3.4 4.1 16.6 13.8 1.9 6.9 5.7 12.6 2.3 8.2 1.1 6.1 2.3 6.6 8.6 10.3 63.5 36.3 5.4 1.3 2.9 6.1 5.2 5.6 2.3 FBXO4 FBX4 ENSG00000151876 "F-box protein 4" Q9UKT5 5 41925254-41941743 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003362 Approved Nucleoplasm NA NA Nucleoplasm "HPA003362: AB_2666918" "unprognostic (1.43e-1)" "unprognostic (2.10e-2)" "unprognostic (9.25e-3)" "unprognostic (2.65e-2)" "unprognostic (2.50e-1)" "unprognostic (7.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.48e-2)" "unprognostic (1.62e-3)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.28e-4)" "unprognostic (8.57e-2)" "unprognostic (1.51e-1)" "unprognostic (5.39e-2)" "unprognostic (8.27e-2)" 8.2 7.6 2.3 6.8 2.9 8.5 12.6 3.0 3.6 8.9 2.3 6.9 8.0 6.2 16.0 6.4 8.4 6.7 5.3 2.4 2.7 7.5 11.3 6.6 11.6 2.8 2.5 2.3 7.4 11.9 7.0 4.4 6.1 2.7 8.4 8.1 4.9 7.3 8.2 4.2 6.4 7.0 6.0 2.7 9.4 8.0 8.4 2.5 11.2 12.8 4.9 12.6 6.4 5.6 3.2 9.0 6.5 1.2 16.4 8.5 13.9 9.6 7.4 13.9 12.3 16.8 3.2 23.9 22.6 9.7 10.5 2.8 2.3 3.9 2.5 10.3 8.0 1.5 11.5 22.8 8.2 16.6 19.4 7.4 8.4 5.4 6.3 23.6 4.6 9.4 10.2 10.8 7.1 14.4 3.6 12.6 3.9 0.5 12.9 5.4 2.3 2.5 5.9 8.5 8.7 2.5 4.8 29.0 2.3 11.2 0.6 14.6 22.2 6.8 13.9 3.8 9.3 5.9 10.7 9.8 1.6 13.9 21.7 7.2 2.9 5.4 1.3 8.9 8.7 10.2 12.5 9.7 9.4 10.6 12.0 9.8 9.2 0.4 9.4 20.1 9.4 8.4 7.3 2.3 2.9 3.0 3.6 2.4 2.7 2.8 2.5 2.3 2.7 2.7 2.5 3.2 12.3 9.6 11.9 12.1 18.5 12.6 13.3 20.1 13.6 6.1 14.8 10.7 3.7 15.7 9.6 11.0 0.0 26.4 11.4 2.9 11.7 13.7 0.7 12.9 12.0 10.2 1.8 20.4 14.7 16.0 27.9 13.1 9.7 13.7 5.1 12.9 16.1 17.6 16.3 3.3 15.6 10.8 12.2 6.5 12.3 1.5 10.5 10.0 19.6 5.6 5.8 8.7 8.2 25.1 26.7 9.8 6.8 10.5 17.4 5.1 9.7 24.8 14.7 8.7 6.6 11.4 18.9 24.9 23.8 15.8 14.2 12.4 12.7 16.5 10.5 9.4 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 38.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 20.2;Collecting duct cells: 16.5;Cytotrophoblasts: 26.3;Distal tubular cells: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059946, HPA072991" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA059946: AB_2684175, HPA072991: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 7.7 7.1 7.1 8.8 6.0 4.9 15.2 6.1 6.4 11.0 7.6 8.5 7.7 8.5 12.0 8.1 8.7 7.8 6.1 5.7 6.8 9.9 7.3 7.6 10.5 6.3 6.7 5.4 7.7 7.6 10.8 5.7 6.8 6.8 9.1 10.0 8.2 8.7 10.0 6.3 10.5 6.6 9.6 7.2 8.7 10.0 7.3 6.4 9.3 38.6 3.7 9.6 8.7 6.8 6.8 20.0 18.0 9.5 21.2 17.2 34.8 10.8 28.0 17.3 14.9 10.8 7.9 41.7 21.9 37.7 28.9 15.8 16.3 9.2 12.6 21.3 26.7 14.8 12.9 37.2 8.8 32.0 26.5 17.9 28.9 35.3 22.3 31.7 15.0 16.7 26.3 17.1 39.9 32.8 17.1 14.5 15.3 4.4 20.4 17.4 9.9 23.5 27.3 18.7 20.1 13.2 9.3 56.1 31.5 27.9 8.7 46.0 18.4 21.9 24.0 19.4 14.9 14.1 17.0 26.5 21.6 18.1 37.3 21.6 16.6 11.1 4.4 15.1 13.5 22.3 14.5 20.2 15.9 12.7 13.4 20.3 16.6 1.9 18.9 16.0 9.8 17.5 14.3 7.1 6.0 6.1 6.4 5.7 6.8 6.3 6.7 5.4 6.8 7.2 6.4 6.8 9.7 6.4 3.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 20.2 13.2 0.0 0.0 1.8 16.5 0.0 26.3 6.3 0.0 27.4 13.8 0.0 8.4 9.1 2.6 0.0 0.0 0.0 13.6 10.2 4.5 0.0 9.2 2.5 6.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.9 0.0 0.0 13.7 6.6 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 10.5 3.7 6.6 0.0 0.0 CCL28 "CCK1, MEC, SCYA28" ENSG00000151882 "C-C motif chemokine ligand 28" Q9NRJ3 5 43376645-43412391 "Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "salivary gland: 305.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 192.4;Breast myoepithelial cells: 147.4;Distal enterocytes: 172.9;Ductal cells: 110.1;Paneth cells: 117.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.7;EFO-21: 12.8;SiHa: 29.9;SK-MEL-30: 16.7;T-47d: 40.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077434 Supported "Secreted to blood" NA NA 700000000 "HPA077434: AB_2732346" "unprognostic (1.04e-2)" "unprognostic (2.66e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-2)" "unprognostic (8.85e-4)" "unprognostic (4.93e-3)" "unprognostic (1.20e-3)" "unprognostic (3.56e-2)" "unprognostic (4.91e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (2.52e-1)" "unprognostic (1.78e-1)" "unprognostic (6.53e-2)" 1.7 1.2 0.7 4.6 0.8 3.4 61.5 0.8 0.9 14.4 0.9 31.0 24.3 2.3 1.4 4.1 4.3 19.9 0.7 0.7 1.6 2.8 1.8 2.9 4.6 0.7 0.7 0.8 1.5 7.9 2.2 1.1 3.1 0.7 3.1 28.6 2.2 305.0 2.3 0.3 5.5 12.7 1.9 0.5 4.3 15.1 1.6 0.5 2.5 22.8 0.5 4.0 1.4 2.1 1.5 0.8 0.0 0.1 0.2 0.9 0.1 4.7 0.7 0.4 0.0 0.0 2.1 10.7 0.1 12.8 0.3 0.0 1.6 0.0 0.2 0.0 0.1 0.2 0.8 1.2 0.0 0.7 0.1 0.2 1.0 2.7 0.2 0.5 0.4 0.1 0.1 0.1 0.1 1.2 0.2 1.9 0.1 0.1 0.0 1.6 0.1 0.0 0.5 0.1 1.3 0.2 0.1 29.9 1.1 16.7 0.3 40.1 8.0 0.2 0.1 1.2 0.2 0.1 0.7 0.1 0.1 0.0 0.1 8.9 4.0 0.2 0.3 3.2 0.2 2.5 4.0 3.7 2.7 0.6 4.3 4.3 3.1 0.7 3.5 0.1 0.9 6.0 1.4 0.7 0.8 0.8 0.9 0.7 1.6 0.7 0.7 0.8 0.7 0.5 0.5 1.5 4.0 0.0 7.7 1.6 10.9 2.7 4.9 15.6 5.7 0.1 192.4 147.4 0.4 62.9 17.9 5.5 0.0 6.2 10.1 172.9 5.9 110.1 3.7 12.9 1.9 6.4 3.6 2.5 1.7 66.4 3.2 2.9 36.2 13.0 11.4 0.0 7.5 1.9 2.6 0.0 0.7 48.5 20.3 1.2 1.2 1.2 12.5 1.5 17.8 2.8 1.3 9.6 17.5 0.5 0.9 21.7 117.0 4.9 1.2 13.7 38.7 0.2 46.2 0.9 0.0 0.4 2.6 5.3 3.1 6.1 1.3 2.7 9.5 0.5 58.5 24.4 PARP8 "ARTD16, FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846519 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 78.9" "Cell type enhanced" "Detected in many" "dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 91.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Yes No Nucleoplasm "Midbody ring, Cytosol" "HPA049183: AB_2680667" "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favorable (1.12e-4)" 11.8 13.3 6.6 27.1 9.3 78.9 9.3 0.0 8.2 8.4 1.8 8.9 14.6 6.7 4.2 7.8 9.9 25.9 7.0 12.8 8.2 7.0 8.1 20.0 42.3 3.2 3.5 4.4 11.7 12.3 13.9 5.0 12.5 1.8 11.4 9.4 4.7 10.3 7.5 4.9 7.7 15.2 8.4 4.3 44.0 20.4 9.2 4.8 19.4 43.5 2.1 22.6 14.6 5.4 3.3 24.8 0.1 12.2 18.8 3.2 5.7 18.0 4.3 15.7 4.1 12.0 0.9 33.5 14.8 16.9 0.5 43.3 12.4 2.1 13.1 10.0 20.2 15.9 10.6 9.2 1.1 6.3 28.1 0.2 6.8 10.9 8.5 6.0 24.6 0.2 23.1 1.6 9.1 5.9 8.8 31.8 32.5 12.3 0.4 6.0 15.4 24.0 17.1 7.6 12.8 13.0 19.0 13.8 21.6 3.7 17.6 1.0 91.2 0.0 1.0 15.4 1.2 12.6 6.9 0.2 29.5 13.8 7.6 17.7 27.4 13.7 31.9 43.6 4.0 70.6 13.4 34.3 50.5 9.2 16.7 20.9 34.9 28.6 39.5 2.9 4.2 22.5 22.7 6.6 9.3 0.0 8.2 12.8 8.2 3.2 3.5 4.4 1.8 4.3 4.8 3.3 6.2 32.1 21.1 29.4 51.7 8.0 5.2 12.7 26.2 13.6 10.4 6.5 5.6 14.3 19.1 22.0 0.0 22.5 124.9 17.2 7.9 14.2 28.7 11.8 8.4 3.9 15.0 7.4 197.9 10.2 6.4 13.4 46.9 10.6 14.5 12.6 6.8 5.0 14.3 6.7 139.3 4.2 8.2 26.1 16.9 15.3 1.2 27.1 8.8 112.4 43.4 0.7 93.7 158.3 7.3 18.7 8.4 3.0 65.0 7.7 8.2 4.3 25.6 2.1 6.6 12.3 13.0 12.8 6.0 14.3 4.0 24.8 157.3 6.5 9.6 13.7 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273284 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 140000 "Golgi apparatus" Nucleoplasm "HPA043829: AB_2678689" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 10.8 3.4 7.9 4.3 11.7 0.0 23.4 2.4 9.6 8.4 0.8 14.0 1.7 4.9 20.7 7.0 17.4 5.7 4.0 9.5 13.9 6.0 16.1 2.9 4.0 7.5 25.0 5.0 4.6 6.7 2.8 3.2 0.0 8.0 4.6 4.0 3.3 6.1 5.5 4.3 6.7 8.3 4.8 5.8 3.9 8.2 3.1 7.4 4.2 2.8 14.0 6.5 7.1 9.2 6.1 0.1 3.7 12.2 0.0 0.0 0.1 0.0 7.9 0.4 44.7 77.2 0.0 0.0 0.0 46.5 89.3 0.0 0.0 0.1 0.0 63.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 11.5 0.0 3.9 0.0 9.1 0.0 0.0 5.6 59.5 7.6 0.0 5.0 0.0 0.0 0.0 1.9 0.0 5.0 0.0 1.6 0.1 0.0 0.0 0.1 2.1 0.4 0.0 0.4 0.0 0.4 0.1 53.5 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 11.7 2.4 9.6 9.5 13.9 7.5 25.0 5.0 8.0 5.8 7.4 6.1 6.1 0.0 0.0 40.5 0.5 5.7 0.0 0.0 1.8 4.1 33.1 11.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 13.2 0.0 0.2 3.2 6.0 0.0 5.1 13.5 0.0 51.2 3.1 0.0 6.3 0.1 0.4 42.2 0.0 0.0 6.6 0.0 0.0 1.0 9.6 12.8 8.1 1.0 5.4 1.9 0.0 12.6 0.0 91.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.5 0.0 100.1 16.7 0.1 10.4 0.7 4.5 0.0 0.7 0.1 0.0 0.2 CACUL1 "C10orf46, CAC1, FLJ40409, MGC33215" ENSG00000151893 "CDK2 associated cullin domain 1" Q86Y37 10 118674167-118755249 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 237.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050611 Approved Nucleoplasm NA NA Nucleoplasm "HPA050611: AB_2797238" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (3.44e-2)" "unprognostic (1.84e-1)" "unprognostic (9.35e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.68e-1)" "unprognostic (9.75e-2)" "unprognostic (8.48e-2)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" 6.1 7.0 6.9 4.0 7.3 11.7 7.8 5.5 6.5 5.9 5.3 6.6 4.6 7.4 7.0 7.3 5.7 4.0 5.7 7.3 7.2 5.0 6.6 7.3 4.1 6.0 6.5 6.6 5.1 5.6 7.2 5.0 6.4 6.3 5.4 5.4 5.6 5.4 5.5 10.6 6.1 5.0 6.2 5.9 5.9 6.2 6.7 7.6 5.5 5.3 10.6 5.2 8.4 6.1 6.4 14.8 8.6 6.4 11.8 15.0 10.2 6.6 6.2 17.2 8.9 11.2 9.6 12.3 10.5 4.6 10.3 7.3 12.8 13.0 11.1 11.8 4.2 7.1 9.7 8.5 11.9 9.9 8.9 6.1 8.2 12.2 11.5 17.2 13.4 10.2 11.5 4.8 10.5 10.5 11.4 8.5 14.1 6.2 6.3 4.5 4.8 26.7 6.5 13.0 11.2 3.4 10.8 6.0 15.0 20.4 6.9 8.4 7.2 9.7 6.1 6.9 7.7 10.7 9.1 10.4 7.2 7.9 17.2 3.8 25.3 9.0 16.9 5.2 15.6 5.1 4.0 4.9 5.1 8.2 4.0 5.4 6.4 20.3 4.4 17.1 3.9 4.1 5.2 6.9 7.3 5.5 6.5 7.3 7.2 6.0 6.5 6.6 6.3 5.9 7.6 6.4 29.6 60.9 21.7 58.8 42.7 74.8 30.5 38.5 50.1 33.6 58.3 34.9 44.8 45.8 27.8 36.8 73.0 73.4 39.2 32.5 23.5 52.4 237.7 53.3 24.7 36.8 68.6 37.0 65.8 59.4 33.4 34.7 18.8 46.9 15.8 68.7 33.2 27.4 46.5 92.5 64.7 34.0 34.6 77.6 127.6 36.1 29.5 56.7 28.4 49.6 59.4 40.9 34.0 40.2 62.5 50.0 26.5 24.0 24.4 56.5 28.2 43.2 36.7 50.1 13.1 52.1 32.3 81.4 83.8 43.2 78.8 102.3 32.8 29.0 41.7 74.7 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954830 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 488.1;hTERT-HME1: 371.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA 16000 "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 58.1 86.9 214.6 16.3 276.0 3.3 118.5 244.2 225.6 141.3 153.4 136.9 25.6 168.5 38.6 66.6 104.8 32.9 143.0 199.0 236.8 50.6 81.5 109.0 11.4 263.9 262.4 181.0 78.8 40.2 37.0 79.4 28.9 272.7 85.2 32.7 88.1 101.1 49.2 144.5 167.5 64.8 106.9 240.6 37.0 69.4 28.6 245.1 31.7 30.0 105.0 15.4 91.1 114.1 336.1 62.4 26.6 41.2 20.8 79.5 103.5 24.6 82.2 89.7 37.8 42.1 17.1 15.5 10.4 32.2 220.7 35.6 46.7 34.4 161.2 73.0 52.3 45.2 17.8 49.5 31.4 65.9 15.0 0.4 58.3 488.1 92.5 371.6 69.1 73.3 9.5 12.6 38.2 113.9 20.2 5.1 6.8 27.7 35.6 21.9 0.1 28.8 16.5 118.8 83.0 47.2 37.8 32.7 11.7 64.1 67.7 18.6 27.2 176.5 77.3 55.9 37.0 68.9 39.6 28.6 5.0 55.8 8.8 40.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.9 0.3 1.3 0.0 0.1 214.6 276.0 244.2 225.6 199.0 236.8 263.9 262.4 181.0 272.7 240.6 245.1 336.1 193.2 336.5 11.8 1048.7 5.6 2368.6 1651.4 250.1 3008.4 673.1 81.0 301.5 862.8 77.2 161.7 55.2 1401.1 61.5 7.8 357.8 7.9 204.3 53.6 133.8 218.4 122.7 44.9 12.4 550.4 66.3 11.6 212.5 71.9 166.8 17.1 478.7 60.7 80.3 21.8 307.9 591.7 100.3 118.0 74.2 124.6 15.5 133.3 56.6 215.3 215.5 46.6 200.8 2.1 630.3 1410.3 194.1 283.0 152.4 27.2 229.8 124.2 10.3 52.0 122.6 65.7 381.8 196.6 20.0 13.7 298.2 857.2 26.5 19.7 30.5 48.1 142.8 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955107-57027346 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 31.6;retina: 11.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 82.6;Excitatory neurons: 87.3;Horizontal cells: 42.1;Inhibitory neurons: 118.6;Oligodendrocyte precursor cells: 49.8" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 8.8" "Lineage enriched" "Detected in many" 6 "dendritic cells: 8.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.8;fHDF/TERT166: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: AB_2682002" "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.1 2.2 15.6 1.5 15.4 0.7 0.6 31.3 31.6 4.1 4.1 1.2 0.5 2.8 0.7 1.2 1.0 3.8 2.4 14.9 17.0 0.6 0.2 0.6 1.0 19.7 16.9 12.2 2.0 0.4 0.7 1.7 2.0 22.2 2.4 1.5 11.9 0.5 2.5 3.9 1.0 0.7 3.6 13.8 0.8 0.8 1.1 17.7 1.1 0.8 0.6 0.8 2.8 1.7 22.7 5.4 2.2 1.3 0.6 17.6 28.8 4.9 16.1 15.6 7.1 8.2 0.2 2.4 0.1 5.2 28.7 9.9 0.7 1.8 0.8 8.7 2.4 1.0 3.6 7.5 0.4 4.7 10.3 0.2 12.7 4.5 9.8 4.3 11.9 4.7 13.3 4.6 9.2 14.3 5.5 6.2 2.5 4.4 0.3 1.3 0.1 0.2 2.6 2.6 5.4 6.1 6.2 10.8 1.3 1.4 6.1 0.3 5.9 6.1 21.5 0.7 14.5 3.6 12.6 15.2 4.3 12.6 6.5 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 8.8 0.0 0.1 15.6 15.4 31.3 31.6 14.9 17.0 19.7 16.9 12.2 22.2 13.8 17.7 22.7 0.4 0.0 0.0 16.6 0.3 0.9 0.2 0.2 0.0 82.6 0.2 1.1 3.6 0.0 0.7 0.0 4.2 0.5 10.8 0.0 0.0 0.2 0.6 0.5 11.9 0.2 0.0 0.0 87.3 0.4 1.6 5.6 0.0 0.5 0.0 13.5 1.1 0.0 0.1 42.1 118.6 0.0 0.0 0.0 4.0 0.8 1.8 1.1 3.6 13.1 0.3 4.9 0.0 49.8 22.9 0.6 0.0 3.0 0.0 0.4 0.0 1.0 0.0 4.8 0.0 8.7 2.7 0.7 5.8 0.2 1.0 0.0 0.1 4.4 0.0 0.1 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 32.4 30.0 16.2 27.1 19.6 49.4 31.6 29.2 20.4 32.1 18.8 33.2 24.1 44.1 37.7 46.5 30.0 28.9 31.1 15.8 17.0 27.2 34.3 30.9 40.5 17.5 18.8 14.0 35.6 36.6 28.4 28.5 32.7 19.9 27.4 28.0 29.9 35.2 18.8 58.6 34.9 36.1 25.9 16.1 35.4 35.3 32.8 17.0 25.2 32.3 21.9 27.9 29.5 34.5 26.2 50.0 26.8 68.9 83.5 35.8 53.9 34.0 46.1 46.1 31.7 36.5 22.1 51.1 48.2 29.4 31.6 24.9 53.8 42.3 25.0 42.9 63.5 34.1 30.4 47.1 36.6 29.2 57.5 52.3 41.1 30.3 30.5 76.1 137.9 41.6 32.9 23.2 47.7 33.3 15.2 62.2 60.5 37.9 29.5 24.3 43.9 52.2 35.2 43.3 26.7 19.3 32.8 39.2 35.0 40.4 35.1 30.9 29.5 38.9 34.9 25.2 35.6 47.2 35.5 62.3 48.4 31.7 57.9 27.1 2.5 2.5 2.4 3.8 2.3 4.2 3.2 4.3 3.7 2.5 2.8 4.5 4.8 2.5 4.5 3.0 4.1 4.6 1.9 16.2 19.6 29.2 20.4 15.8 17.0 17.5 18.8 14.0 19.9 16.1 17.0 26.2 64.6 44.8 60.1 24.5 72.7 63.6 75.8 54.0 66.6 55.7 52.7 53.1 37.9 42.9 54.7 23.9 31.3 66.0 87.3 54.6 46.9 54.4 13.7 45.2 69.1 58.5 52.7 90.7 37.7 54.7 108.3 57.8 48.9 53.3 35.4 73.7 57.1 49.6 58.4 45.4 50.6 46.5 30.5 57.0 46.4 8.2 61.2 61.3 37.4 38.4 79.7 49.3 61.8 54.8 91.9 70.0 43.4 45.1 73.7 99.1 49.5 48.0 40.7 48.9 52.6 53.9 63.6 62.9 49.1 72.6 64.2 77.4 80.6 53.6 53.8 94.2 BAG3 ENSG00000151929 "BAG cochaperone 3" O95817 10 119651380-119677819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 473.9;skeletal muscle: 518.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 882.2;Basal squamous epithelial cells: 414.9;Squamous epithelial cells: 370.2;Urothelial cells: 488.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Lineage enriched" "Detected in single" 6 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Supported Cytosol NA NA 460000 Cytosol "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 57.1 40.6 203.0 16.2 82.7 5.1 40.9 96.1 266.3 34.9 68.8 58.5 12.4 45.6 20.6 86.7 38.1 35.4 145.8 218.9 158.5 42.5 38.7 78.6 8.3 211.5 81.9 60.2 33.6 20.7 54.1 36.9 36.3 198.9 39.5 12.7 12.7 50.5 24.8 518.6 61.5 26.1 43.6 128.9 16.0 73.0 23.2 184.3 5.7 31.4 189.5 17.4 60.9 55.8 473.9 100.1 111.2 30.5 39.6 77.2 53.9 56.9 89.1 74.7 66.6 56.8 47.5 47.6 3.8 41.4 76.9 86.6 145.2 31.5 157.2 45.7 49.1 51.8 5.4 28.6 60.1 65.2 0.3 22.1 54.6 89.0 48.6 76.2 70.5 75.5 17.1 43.3 24.0 67.2 142.7 5.5 22.3 12.0 33.1 125.8 0.3 43.2 17.2 50.7 22.3 5.6 5.1 35.4 61.9 47.2 32.9 38.8 13.4 94.8 35.0 30.1 47.8 129.5 22.1 14.0 2.4 65.2 1.5 27.1 0.0 0.6 0.0 0.6 0.7 1.1 0.1 2.4 0.8 0.4 0.0 4.1 1.4 0.2 0.1 0.3 0.1 1.7 0.6 203.0 82.7 96.1 266.3 218.9 158.5 211.5 81.9 60.2 198.9 128.9 184.3 473.9 77.8 22.4 43.2 34.9 10.9 79.4 882.2 51.0 414.9 6.1 48.3 62.9 196.0 18.6 48.1 7.3 18.8 41.4 4.9 61.7 27.4 19.4 29.3 56.7 60.0 107.0 38.5 0.8 1.3 25.3 57.0 142.7 51.5 89.1 23.6 7.3 22.5 15.3 33.7 1.7 2.5 87.0 46.8 8.7 95.4 32.8 22.4 146.9 55.2 10.3 4.7 32.6 3.1 1.0 1.2 37.3 69.2 24.0 29.5 225.1 8.3 42.8 39.4 1.7 19.7 141.6 134.3 21.8 18.7 370.2 76.1 73.5 85.6 10.0 53.9 488.1 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.3;liver: 27.8" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 6 "neutrophil: 36.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.4" "Group enriched" "Detected in some" 7 "MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted to blood" NA NA Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 2.5 0.2 5.0 6.8 8.0 28.3 0.2 2.0 10.4 1.8 5.4 0.4 0.1 3.7 1.0 0.5 3.0 1.7 0.5 6.7 8.5 0.8 27.8 2.9 0.3 3.2 3.3 6.9 0.2 0.9 0.6 1.4 0.7 5.4 0.8 0.3 5.7 0.2 1.5 9.1 1.0 0.3 3.1 0.8 12.8 0.3 15.7 3.9 0.9 1.7 9.7 0.4 1.4 0.5 7.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.5 3.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 36.4 0.0 2.0 2.3 0.0 1.6 5.0 8.0 2.0 10.4 6.7 8.5 3.2 3.3 6.9 5.4 0.8 3.9 7.4 0.0 0.0 0.0 1.6 0.4 0.9 0.0 0.0 0.0 0.8 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.0 4.7 0.0 0.0 0.1 14.6 0.6 2.3 0.1 0.0 0.0 37.6 0.0 0.0 0.4 0.0 4.8 0.0 0.1 1.1 10.4 1.4 0.0 30.2 0.0 0.0 8.5 0.0 41.7 0.3 9.4 1.8 6.5 12.4 10.4 1.0 34.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.3 0.0 0.2 0.2 4.0 0.6 0.0 0.3 0.1 0.2 0.0 0.0 0.0 TMEM132D "KIAA1944, MOLT, PPP1R153" ENSG00000151952 "Transmembrane protein 132D" Q14C87 12 129071725-129904025 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 5.0" "Group enriched" "Detected in some" 60 "Excitatory neurons: 448.6;Inhibitory neurons: 523.0;Oligodendrocyte precursor cells: 573.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.5;MOLT-4: 4.6;NTERA-2: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010739 Approved NA NA 110000 "HPA010739: AB_2204753" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.31e-4)" 0.0 0.1 1.1 0.1 5.0 0.1 0.0 0.0 4.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.1 0.1 0.0 1.0 0.3 4.1 0.0 0.3 0.0 0.4 0.0 1.4 0.3 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.6 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.0 0.0 4.8 2.5 0.9 1.0 0.3 4.1 1.4 0.0 1.8 1.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 1.8 0.0 448.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 523.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.4 0.0 0.2 0.0 573.0 7.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 27.9" "Group enriched" "Detected in some" 5 "Spermatocytes: 135.7;Spermatogonia: 82.1" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 8 "spinal cord: 12.9" HPA037746 Approved Cytosol NA NA Cytosol "HPA037746: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 27.9 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.6 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 4.3 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 9.7 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.6 135.7 82.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8;heart muscle: 81.1;skeletal muscle: 102.1;tongue: 93.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 46 "dendritic cells: 6.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 2.9 43.0 0.2 49.1 0.8 1.2 46.5 55.5 2.5 24.8 8.5 1.0 3.9 0.7 3.4 2.4 1.9 81.1 44.3 42.6 2.5 0.7 2.9 0.5 43.8 44.2 38.5 0.5 0.4 0.2 11.9 11.0 45.9 5.6 1.1 3.6 1.9 1.4 102.1 0.3 3.6 5.5 48.5 4.8 4.6 1.9 43.7 0.8 0.8 93.7 0.2 0.7 1.3 74.8 0.1 0.0 27.0 49.2 0.0 0.2 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 2.4 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.7 1.1 0.3 11.2 0.4 58.3 0.0 0.0 0.1 3.5 0.0 0.0 0.0 29.8 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 167.0 0.0 0.0 0.2 7.0 0.0 3.1 10.9 0.6 1.5 0.4 2.5 2.1 0.0 0.0 0.7 2.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 43.0 49.1 46.5 55.5 44.3 42.6 43.8 44.2 38.5 45.9 48.5 43.7 74.8 4.5 6.4 1.7 0.0 0.1 0.4 4.8 2.5 1.2 5.4 0.6 0.8 14.2 0.0 2.2 3.7 2.1 1.5 2.7 0.1 0.0 0.3 0.0 4.4 0.4 6.0 0.0 2.1 0.0 0.2 0.5 1.6 0.0 3.1 0.0 0.1 2.2 0.5 0.2 15.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 3.6 0.0 0.0 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.6 0.0 1.4 3.7 0.6 0.0 7.0 2.9 0.0 0.4 0.4 0.6 0.8 0.2 0.2 0.0 1.4 MCHR2 "GPR145, MCH2, MCH2R, SLT" ENSG00000152034 "Melanin concentrating hormone receptor 2" Q969V1 6 99918519-99994247 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 3.3;testis: 1.5" "Cell type enriched" "Detected in some" 27 "Excitatory neurons: 44.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.76e-2)" 0.0 0.0 1.0 0.0 2.6 0.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.7 0.0 0.0 0.0 0.0 0.4 0.1 2.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.0 3.3 2.7 1.7 0.4 0.1 2.4 1.4 0.0 0.1 1.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 37.8" "Cell type enhanced" "Detected in many" "Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 164.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011420 Approved Approved "Nuclear bodies,Microtubules" NA NA Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 12.9 3.4 10.3 11.1 8.2 0.5 7.0 7.3 10.2 5.0 7.6 6.4 1.3 31.0 2.3 5.1 8.0 20.5 10.4 9.2 9.4 4.2 5.2 3.1 5.7 11.2 7.8 7.6 12.4 10.4 1.8 10.4 6.8 10.1 4.5 2.0 3.4 2.7 5.6 5.4 2.8 3.6 37.8 8.7 4.5 12.6 1.1 8.7 0.7 9.5 3.2 1.1 10.8 3.8 11.7 0.0 0.8 0.0 164.3 36.6 3.7 0.2 4.0 3.8 0.8 1.8 0.0 0.2 0.0 0.0 2.5 5.8 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 4.5 0.0 0.1 6.3 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.2 6.7 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.1 0.1 0.4 6.4 0.1 12.1 0.7 0.1 0.0 0.0 3.8 0.1 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.3 8.2 7.3 10.2 9.2 9.4 11.2 7.8 7.6 10.1 8.7 8.7 11.7 8.2 0.0 2.2 4.2 0.0 3.8 0.4 0.2 0.0 0.1 1.8 0.4 4.9 0.0 1.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.8 16.3 19.8 4.8 0.0 0.0 0.0 0.2 32.3 9.2 0.6 3.8 0.4 3.9 0.2 0.1 3.3 0.3 0.0 2.0 0.0 5.8 0.3 21.1 1.0 32.0 5.6 0.0 6.1 0.0 1.0 0.0 0.4 0.1 17.0 0.4 1.4 0.0 0.0 3.7 0.7 118.3 1.7 128.3 0.1 0.2 0.4 3.1 0.3 0.6 0.1 0.2 1.8 AP1S3 ENSG00000152056 "Adaptor related protein complex 1 subunit sigma 3" Q96PC3 2 223751686-223838027 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Cytotrophoblasts: 48.2;Pancreatic endocrine cells: 44.2;Urothelial cells: 69.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.9;dendritic cells: 4.0;granulocytes: 4.9" "Cell line enhanced" "Detected in many" "CACO-2: 151.1;RPTEC TERT1: 56.8;RT4: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066782 Approved Supported Vesicles NA NA Vesicles "HPA066782: AB_2685720" "unprognostic (9.45e-3)" "unprognostic (1.79e-1)" "unprognostic (7.52e-2)" "unprognostic (5.80e-2)" "unprognostic (4.37e-2)" "unprognostic (4.89e-1)" "unprognostic (1.65e-3)" "prognostic unfavorable (3.36e-5)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.56e-1)" "unprognostic (2.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.32e-2)" "unprognostic (4.61e-2)" 0.7 0.8 3.5 3.3 3.1 4.0 2.1 3.8 3.6 2.3 0.6 2.7 5.4 0.9 53.3 4.9 2.3 5.3 0.5 2.6 3.2 5.6 1.4 4.8 4.3 2.7 1.9 3.5 0.5 2.5 3.8 1.1 6.6 2.1 3.0 2.6 5.7 1.7 5.4 0.9 1.9 5.0 0.7 0.8 2.9 9.9 0.9 2.5 1.7 14.6 0.3 5.2 8.2 1.2 3.4 28.7 17.7 2.4 12.0 1.5 0.6 13.5 11.5 2.4 4.9 4.2 151.1 21.8 11.0 8.0 1.7 5.8 43.8 6.4 30.3 6.8 15.3 8.9 1.2 33.7 15.7 0.6 3.4 1.3 0.6 31.2 9.1 30.1 11.2 3.4 5.8 1.8 2.9 2.9 12.3 0.6 0.9 3.8 32.8 15.5 4.3 0.1 4.5 56.8 52.1 7.4 2.1 5.4 11.8 3.8 6.1 5.0 6.3 2.0 1.6 4.6 3.1 9.2 10.2 9.0 28.2 4.4 2.0 6.0 4.9 0.5 0.3 0.6 0.4 0.5 4.9 0.4 0.4 1.2 2.7 0.4 0.5 1.8 0.6 0.2 4.0 1.0 0.4 3.5 3.1 3.8 3.6 2.6 3.2 2.7 1.9 3.5 2.1 0.8 2.5 3.4 0.4 35.3 6.7 8.8 24.2 4.2 32.6 15.3 4.0 3.3 4.3 1.8 1.7 0.0 15.8 11.0 64.6 48.2 13.6 3.6 9.8 17.5 0.2 8.1 2.1 2.1 2.4 0.0 19.3 18.1 3.4 3.5 11.7 26.1 3.8 0.8 0.7 0.4 4.7 6.7 9.6 3.6 16.2 1.6 38.1 0.0 0.3 7.5 3.6 4.7 7.4 1.9 6.2 10.6 4.0 44.2 4.6 0.0 10.7 26.6 5.4 4.5 10.3 5.9 0.0 1.1 1.8 0.3 1.9 6.3 4.1 13.1 6.9 1.0 4.7 69.6 RABGAP1L "FLJ38519, HHL, KIAA0471, TBC1D18" ENSG00000152061 "RAB GTPase activating protein 1 like" "B7ZAP0, Q5R372" 1 174159410-174995308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 120.5" "Cell type enhanced" "Detected in all" "Excitatory neurons: 551.4;Inhibitory neurons: 444.0;Microglial cells: 267.0;Oligodendrocyte precursor cells: 362.4;Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 136.9;Karpas-707: 87.6;U-698: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054695 Uncertain NA NA "HPA054695: AB_2682577" "unprognostic (2.57e-2)" "unprognostic (7.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.54e-2)" "unprognostic (6.96e-3)" "unprognostic (8.55e-2)" "prognostic favorable (1.16e-4)" "unprognostic (2.66e-2)" "unprognostic (3.51e-2)" "unprognostic (2.66e-2)" "unprognostic (1.98e-1)" "unprognostic (9.14e-3)" "unprognostic (6.69e-2)" "unprognostic (2.14e-1)" "unprognostic (5.03e-2)" "unprognostic (2.46e-1)" 11.5 8.6 15.6 23.0 20.3 31.3 15.8 49.1 22.5 15.1 46.6 20.6 22.2 13.3 16.5 18.8 19.2 22.3 120.5 20.0 17.7 17.0 16.5 26.7 42.2 13.5 16.1 18.7 29.1 20.1 10.5 20.6 18.4 19.8 10.5 21.4 16.4 23.9 10.6 6.6 16.7 24.5 13.5 7.2 26.6 22.8 31.4 17.6 20.3 10.1 7.5 50.5 20.1 10.4 21.4 15.6 8.0 6.0 6.2 16.4 23.9 13.3 18.1 16.0 7.9 10.6 7.5 56.0 136.9 12.5 14.0 9.3 19.6 5.2 12.1 11.0 37.7 8.5 34.2 11.0 11.5 10.1 15.1 13.2 18.9 8.2 5.7 8.5 13.3 17.7 12.6 20.2 87.6 12.8 5.3 11.9 14.4 37.2 20.9 4.8 41.0 12.0 45.7 15.5 70.9 17.5 10.4 17.2 28.8 12.1 18.4 14.0 18.1 24.5 9.9 8.9 11.0 10.7 75.6 26.3 85.7 10.9 10.1 7.5 16.7 50.0 110.2 25.7 86.5 22.7 34.7 31.5 31.5 40.3 26.4 15.2 23.5 89.6 80.3 180.8 53.6 42.3 32.9 15.6 20.3 49.1 22.5 20.0 17.7 13.5 16.1 18.7 19.8 7.2 17.6 21.4 23.1 73.7 106.1 143.7 63.8 12.4 11.4 19.9 39.3 38.7 20.7 13.2 263.0 47.1 38.6 33.1 31.3 39.1 101.2 43.3 13.7 28.8 117.2 59.0 18.6 17.6 49.1 33.8 551.4 36.9 9.5 35.3 46.9 46.8 24.6 8.9 23.9 16.3 38.5 21.9 444.0 37.8 18.3 57.0 16.2 121.3 15.5 63.1 16.0 267.0 100.4 17.3 68.0 362.4 342.8 24.5 36.0 18.8 81.8 11.5 39.8 13.3 100.3 23.8 6.6 15.0 25.1 91.8 18.5 36.9 13.1 28.2 74.6 26.1 27.0 27.5 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.8" "Cell type enhanced" "Detected in many" "Early spermatids: 322.3;Late spermatids: 129.6;Respiratory ciliated cells: 70.3;Spermatocytes: 142.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.2;SH-SY5Y: 14.8" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 1.2 1.9 6.6 0.3 3.4 0.0 2.5 3.5 4.3 13.2 6.5 1.3 0.2 9.0 0.8 0.4 14.2 1.4 1.1 3.8 6.9 2.9 0.1 2.8 0.3 5.2 5.6 2.6 5.1 0.8 11.2 19.9 0.2 4.8 7.2 0.1 0.6 0.6 2.8 0.2 0.9 0.7 1.2 6.7 0.4 1.5 55.8 4.2 0.6 7.0 0.0 0.2 2.4 3.6 3.7 0.0 1.9 2.8 0.1 2.5 5.4 0.6 2.2 1.1 0.3 0.5 0.9 0.7 0.1 3.5 2.0 3.2 1.0 0.2 0.3 0.4 2.0 5.5 0.0 7.0 0.1 0.3 0.1 0.2 1.1 0.0 0.9 0.0 3.4 0.1 1.3 0.1 1.7 0.8 2.1 0.0 0.0 5.7 0.5 5.9 4.6 0.0 3.2 1.7 0.0 10.2 14.8 1.6 0.1 0.2 0.6 5.9 0.7 0.4 1.1 4.8 5.9 0.5 0.1 0.3 0.0 6.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 3.4 3.5 4.3 3.8 6.9 5.2 5.6 2.6 4.8 6.7 4.2 3.7 0.2 3.2 0.5 1.6 0.1 0.5 3.0 6.3 1.2 0.5 6.1 9.5 0.4 1.5 4.3 5.5 0.0 0.2 0.2 0.1 3.9 1.5 322.3 42.8 9.9 0.2 11.4 0.0 1.6 0.2 0.8 3.6 0.0 2.2 0.0 7.8 0.0 0.0 0.3 3.3 1.1 0.1 2.0 0.0 0.2 129.6 10.2 0.6 0.0 1.0 0.0 6.2 0.0 0.5 0.3 0.0 0.1 12.4 0.1 3.9 0.0 1.2 70.3 0.1 0.0 0.9 3.2 142.7 16.4 0.7 1.1 0.1 0.3 28.8 0.1 0.7 TLCD4 "FLJ31842, TMEM56" ENSG00000152078 "TLC domain containing 4" Q96MV1 1 95117355-95197607 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 131.0" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 77.9" "Cancer enhanced" "Detected in many" "liver cancer: 13.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 22.4;RH-30: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046762 Approved "Nuclear speckles" No No "Nuclear speckles" "HPA046762: AB_2679792" "unprognostic (1.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.98e-3)" "unprognostic (2.79e-1)" "unprognostic (3.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.82e-3)" "unprognostic (3.63e-2)" "unprognostic (4.42e-3)" "unprognostic (2.69e-2)" "unprognostic (4.99e-2)" "unprognostic (4.40e-2)" "unprognostic (1.16e-3)" "unprognostic (1.10e-1)" "unprognostic (9.46e-2)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" 5.4 10.0 10.9 2.2 10.6 20.7 2.6 21.7 15.0 2.4 2.3 13.7 5.5 3.5 2.6 2.3 2.5 4.3 26.0 11.2 9.7 5.8 131.0 3.7 0.4 7.0 7.5 10.2 1.7 7.5 6.4 3.4 4.5 7.6 5.4 10.3 3.1 8.3 2.9 13.1 1.1 8.6 3.6 9.7 0.7 5.1 4.9 8.0 0.3 7.4 9.8 0.5 4.7 1.3 14.1 22.4 12.6 1.7 2.6 0.8 0.0 2.9 0.8 0.5 2.8 6.5 9.1 10.4 0.0 10.7 0.4 20.0 0.2 7.4 1.1 4.8 15.5 4.1 0.5 9.2 2.0 0.8 0.4 0.6 1.2 0.4 2.1 0.0 4.4 0.0 1.2 19.8 1.2 0.6 1.9 1.3 0.1 1.7 0.7 6.9 0.0 35.7 0.6 12.0 14.4 4.5 3.6 15.6 10.8 6.7 1.8 11.7 0.4 0.2 0.3 9.0 1.1 7.9 3.8 8.0 0.0 1.5 0.1 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.9 10.6 21.7 15.0 11.2 9.7 7.0 7.5 10.2 7.6 9.7 8.0 14.1 5.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.9 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.5 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 MZT2B "FAM128B, FLJ14346, MOZART2B" ENSG00000152082 "Mitotic spindle organizing protein 2B" Q6NZ67 2 130181737-130190729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 962.4" "Low region specificity" "Detected in all" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "unprognostic (8.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.40e-2)" "unprognostic (1.31e-2)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (9.37e-8)" "unprognostic (1.67e-1)" "unprognostic (2.04e-1)" "unprognostic (3.04e-1)" "unprognostic (2.09e-1)" 120.9 171.6 129.5 60.4 120.6 160.6 131.7 103.3 287.0 162.5 110.5 157.0 80.2 141.7 18.4 166.2 163.8 16.6 312.4 118.3 107.6 143.8 201.1 87.0 60.9 121.6 107.7 124.5 191.9 253.0 49.7 118.0 33.1 107.0 145.4 19.7 11.5 174.1 41.6 204.3 143.5 103.6 20.6 107.3 104.4 162.0 196.7 119.3 48.5 160.3 30.2 25.7 132.9 144.3 115.2 462.9 239.6 38.6 173.1 20.7 49.8 190.5 203.1 56.7 72.2 59.6 384.0 168.3 251.5 288.1 39.5 47.2 223.4 19.7 68.9 11.2 376.3 667.0 132.8 313.5 485.9 71.5 155.1 97.1 65.7 77.6 45.4 26.9 58.4 80.6 251.8 189.6 268.9 35.8 572.5 336.0 962.4 137.8 85.7 435.8 447.0 105.4 626.6 55.3 140.2 304.7 377.8 121.3 201.1 369.8 15.1 218.5 374.8 164.7 199.8 354.7 155.3 203.4 378.1 257.5 257.9 244.6 203.3 133.3 0.4 19.9 83.0 18.6 21.5 16.5 37.6 25.5 24.7 25.4 38.5 29.1 24.2 10.7 27.3 20.4 48.1 21.3 12.2 129.5 120.6 103.3 287.0 118.3 107.6 121.6 107.7 124.5 107.0 107.3 119.3 115.2 240.2 41.7 29.4 20.5 253.6 297.2 321.4 193.4 248.2 175.2 543.9 739.1 326.5 243.1 104.6 242.8 43.8 282.8 238.0 378.4 467.6 358.4 327.3 115.5 326.7 210.0 173.0 308.2 21.7 591.7 466.6 250.1 166.7 171.7 50.8 484.6 250.2 363.5 342.0 131.2 22.8 453.0 99.7 232.7 365.6 1258.6 249.8 202.4 268.6 14.0 179.7 358.3 150.4 16.6 24.5 584.9 281.6 143.7 278.7 375.9 181.7 801.3 61.7 110.6 164.3 169.1 277.3 165.4 183.3 418.2 377.2 165.1 282.3 338.4 360.7 358.0 TUBA3E ENSG00000152086 "Tubulin alpha 3e" Q6PEY2 2 130191745-130198439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 176.6" "Group enriched" "Detected in some" 6 "Early spermatids: 259.8;Late spermatids: 109.4;Spermatocytes: 415.4;Spermatogonia: 172.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 4.2;U-2 OS: 2.7" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA NA Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.02e-3)" "unprognostic (2.79e-1)" "unprognostic (3.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (6.81e-3)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (7.89e-2)" "unprognostic (2.65e-7)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (2.02e-3)" "unprognostic (8.94e-3)" 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.1 1.0 0.0 0.0 0.0 3.9 0.5 0.0 2.5 0.0 31.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 176.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 259.8 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 109.4 9.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.1 415.4 172.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.0;brain: 27.7;retina: 14.1" "Group enriched" "Detected in some" 6 "Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA074112: AB_2686662" "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 0.4 15.0 23.1 0.4 27.7 0.0 0.7 3.3 24.9 0.3 0.0 0.4 0.3 0.9 3.3 0.0 1.6 0.6 0.5 26.8 19.2 0.1 0.2 0.2 0.1 8.2 13.7 27.5 5.7 0.5 0.1 9.0 0.3 9.0 1.0 0.3 14.1 0.9 1.6 0.1 0.1 0.3 0.9 7.5 2.2 0.3 0.7 17.0 0.0 0.0 0.3 0.3 0.0 0.4 17.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 27.7 3.3 24.9 26.8 19.2 8.2 13.7 27.5 9.0 7.5 17.0 17.0 0.0 0.0 0.0 191.3 0.0 0.1 0.0 0.0 0.0 7.9 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.3 0.2 0.0 0.0 218.7 0.0 0.1 0.7 0.0 0.2 0.0 4.0 5.0 0.0 0.5 23.5 275.6 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 25.3 0.0 0.8 0.0 280.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.7 4.4 1.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 CFC1B ENSG00000152093 "Cripto, FRL-1, cryptic family 1B" P0CG36 2 130521197-130528604 "Predicted secreted proteins" Gastrulation "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pituitary gland: 2.4" "Cell type enriched" "Detected in single" 9 "Bipolar cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041773 Approved "Secreted - unknown location" NA NA "HPA041773: AB_2677664" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.4 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM168B "KIAA0280L, MANI" ENSG00000152102 "Family with sequence similarity 168 member B" A1KXE4 2 131047876-131093460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043778, HPA061659" Enhanced NA NA "HPA043778: AB_10964889, HPA061659: AB_2684577" "unprognostic (8.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.61e-1)" "unprognostic (3.26e-2)" "unprognostic (4.58e-2)" "unprognostic (6.90e-3)" "unprognostic (1.60e-2)" "unprognostic (2.10e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-1)" "unprognostic (4.84e-2)" "unprognostic (1.88e-1)" "prognostic favorable (5.30e-5)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (3.35e-3)" 41.8 34.0 58.0 27.1 65.4 46.7 32.4 52.5 60.7 34.3 35.8 48.5 26.6 51.8 26.8 34.8 38.3 23.9 43.0 59.4 54.8 38.7 31.2 27.8 28.0 54.4 57.1 53.3 47.3 30.3 47.1 20.5 29.6 57.3 37.8 32.2 49.0 28.4 47.2 70.5 29.6 34.6 41.2 56.9 24.4 36.6 27.0 60.3 38.9 36.5 53.4 31.5 48.0 28.2 57.7 74.1 47.6 98.2 67.7 82.2 62.4 74.0 75.2 54.9 46.3 39.7 88.1 40.0 78.6 61.1 79.8 31.8 57.1 83.8 83.8 66.2 64.8 62.3 72.1 49.8 67.4 83.0 84.8 58.6 63.6 82.4 94.5 81.0 62.3 65.5 72.3 70.3 28.9 72.2 53.4 68.0 55.3 61.6 60.2 57.5 85.0 82.5 70.2 63.7 84.0 71.3 100.0 58.2 58.8 80.1 46.0 52.4 79.2 70.8 77.3 78.9 58.0 73.9 67.9 81.2 98.1 65.9 49.3 70.7 2.5 2.2 4.3 4.4 1.5 4.0 3.0 3.6 3.7 2.0 3.0 4.7 3.4 2.1 2.5 3.4 3.3 3.2 2.8 58.0 65.4 52.5 60.7 59.4 54.8 54.4 57.1 53.3 57.3 56.9 60.3 57.7 24.4 35.3 27.4 25.1 19.0 22.8 18.3 24.5 16.5 32.2 28.6 23.6 51.4 24.3 21.6 35.0 37.5 27.0 22.5 38.8 5.9 24.8 12.3 28.0 21.6 22.8 31.8 13.3 47.9 30.8 24.8 23.8 19.4 29.0 19.0 34.7 22.1 39.8 20.1 30.3 52.2 29.8 14.2 25.1 16.0 11.1 29.2 19.2 24.9 28.1 20.9 27.0 14.4 18.6 38.8 38.0 25.3 49.7 25.1 33.3 27.3 26.8 19.5 42.3 13.1 27.5 27.4 18.2 22.8 20.0 25.1 38.3 19.0 23.2 36.7 31.0 PTPN14 PEZ ENSG00000152104 "Protein tyrosine phosphatase non-receptor type 14" Q15678 1 214348700-214552449 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011469, HPA053864, CAB069441" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281" "unprognostic (1.54e-1)" "unprognostic (8.19e-2)" "unprognostic (5.42e-5)" "unprognostic (1.42e-1)" "unprognostic (2.91e-1)" "unprognostic (5.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (2.84e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.29e-4)" "unprognostic (7.43e-2)" "unprognostic (8.34e-3)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "unprognostic (4.81e-3)" 7.6 8.0 3.3 1.9 1.8 0.2 10.7 2.1 4.2 5.2 12.9 5.8 0.9 8.2 2.6 6.1 7.4 3.3 5.2 3.6 2.1 8.3 0.7 4.6 1.3 2.9 2.1 1.0 6.6 4.4 3.4 1.8 7.9 2.8 6.7 2.3 0.6 6.6 6.7 19.9 16.3 2.8 8.0 1.4 3.5 4.5 4.0 3.6 2.2 5.4 10.3 1.8 5.6 5.6 2.3 21.1 9.2 7.2 10.6 12.3 20.9 21.6 23.2 21.3 17.3 14.4 18.8 10.7 0.1 25.3 53.6 10.0 18.1 10.0 25.7 29.0 0.2 7.7 1.9 26.6 3.5 22.2 0.2 1.0 15.6 26.1 30.0 47.4 28.1 33.8 0.6 0.1 0.2 41.8 2.3 0.2 0.2 16.2 3.7 9.9 0.3 36.3 0.1 30.6 10.5 0.1 1.7 28.7 18.4 11.6 25.1 18.4 0.7 61.4 40.3 15.9 14.6 33.3 1.2 0.1 0.2 21.6 0.3 34.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.3 1.8 2.1 4.2 3.6 2.1 2.9 2.1 1.0 2.8 1.4 3.6 2.3 60.3 73.7 12.6 47.3 1.3 56.5 32.1 39.4 45.5 0.6 20.3 29.8 20.5 14.3 32.7 29.5 0.0 38.8 1.3 1.0 7.9 12.9 8.8 42.5 25.9 53.5 3.5 0.0 47.9 11.0 14.2 20.8 9.2 55.2 1.3 13.5 40.0 0.9 4.5 0.0 6.0 4.1 4.1 1.5 7.7 4.4 26.1 2.4 10.6 91.8 0.3 3.9 3.1 39.2 2.1 31.2 0.3 29.3 1.6 30.6 0.3 14.4 18.5 1.3 19.7 38.0 20.1 1.2 10.6 18.3 36.1 24.2 3.7 46.3 2.9 28.9 MGAT5 "GNT-V, MGAT5A" ENSG00000152127 "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase" Q09328 2 134119983-134454621 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 109.5;Inhibitory neurons: 134.5;Microglial cells: 141.5;Oligodendrocyte precursor cells: 124.7;Oligodendrocytes: 495.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010919 Approved "Intracellular and membrane" NA NA 440000 "HPA010919: AB_10601864" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.21e-2)" "unprognostic (3.65e-1)" "unprognostic (3.76e-1)" "unprognostic (4.45e-3)" "unprognostic (3.41e-3)" "unprognostic (5.68e-2)" "unprognostic (8.63e-3)" "unprognostic (1.59e-1)" "unprognostic (2.64e-1)" "unprognostic (5.97e-2)" "unprognostic (1.81e-2)" "unprognostic (9.27e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-1)" 9.5 10.5 18.9 15.2 23.1 15.6 8.0 29.0 19.1 9.2 8.9 12.7 16.3 8.9 6.7 9.0 19.2 11.2 39.4 12.8 29.9 15.5 3.8 10.5 24.8 28.3 32.4 13.6 12.1 11.0 16.5 6.2 15.2 32.0 8.5 15.2 11.7 14.7 9.5 2.2 6.8 18.3 11.3 20.3 16.4 17.1 7.2 23.6 19.3 11.4 4.6 25.7 13.4 5.0 26.2 27.9 11.0 27.3 19.7 23.8 45.3 19.1 36.4 55.0 14.4 12.0 4.7 13.4 44.3 27.1 29.2 16.4 9.7 21.6 17.0 27.3 43.9 12.7 25.0 13.7 58.0 15.5 24.5 85.1 12.5 17.4 30.3 18.6 19.6 108.7 22.1 13.0 29.6 26.3 17.9 13.3 11.6 12.5 28.9 27.0 16.2 32.3 28.6 11.1 33.7 45.1 55.4 11.7 9.9 69.3 18.3 7.7 16.8 49.5 45.1 24.0 33.1 19.3 8.3 4.1 16.5 37.8 34.4 73.1 0.6 0.4 1.0 0.8 0.3 1.3 3.0 1.5 1.0 0.3 3.7 0.6 0.8 1.1 1.3 0.4 0.9 1.0 0.6 18.9 23.1 29.0 19.1 12.8 29.9 28.3 32.4 13.6 32.0 20.3 23.6 26.2 13.2 3.2 2.4 66.6 63.2 8.0 5.7 10.3 8.0 43.6 11.6 9.9 67.3 8.6 8.5 1.8 2.1 3.2 14.9 36.9 0.0 9.0 15.6 22.6 7.6 12.5 7.2 4.4 109.5 9.0 26.3 9.0 37.2 21.0 0.0 23.1 11.7 3.0 15.5 16.8 134.5 20.3 30.5 13.5 9.9 15.1 4.4 12.9 14.2 141.5 5.3 11.4 9.2 124.7 495.5 13.0 13.2 9.4 9.0 9.7 17.6 2.4 22.6 5.2 0.0 8.8 14.3 0.6 6.1 7.3 7.2 5.3 22.4 16.6 9.9 14.5 TMEM163 "DKFZP566N034, SV31" ENSG00000152128 "Transmembrane protein 163" Q8TC26 2 134455759-134719000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4;pancreas: 28.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 36.9;Excitatory neurons: 62.2;Exocrine glandular cells: 30.8;Oligodendrocyte precursor cells: 219.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 20.3;RPTEC TERT1: 67.3;SCLC-21H: 30.2;U-937: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007224 Uncertain NA NA "HPA007224: AB_2667780" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (7.25e-3)" "unprognostic (3.18e-1)" "unprognostic (1.47e-1)" "unprognostic (2.25e-1)" "unprognostic (6.08e-3)" "prognostic favorable (7.94e-4)" "unprognostic (9.05e-2)" "unprognostic (9.62e-2)" "unprognostic (6.02e-2)" "unprognostic (2.04e-1)" "unprognostic (2.60e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" "unprognostic (6.75e-3)" "prognostic favorable (3.15e-4)" 3.4 8.6 14.5 5.1 14.0 0.3 1.4 19.2 12.6 0.2 6.2 0.7 0.6 0.4 0.3 0.1 2.8 9.4 6.7 13.9 14.8 1.4 0.4 14.6 10.5 19.3 21.2 13.4 0.9 28.0 0.8 14.0 3.7 17.3 0.2 0.5 4.0 3.0 0.2 0.3 0.1 1.0 0.4 16.7 1.6 7.3 6.6 31.4 2.1 0.9 0.5 16.5 12.3 0.1 23.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.2 20.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 3.5 6.7 0.1 0.1 0.3 0.0 0.6 0.1 0.0 5.2 1.1 2.3 0.0 0.1 0.1 67.3 10.0 30.2 1.1 0.0 0.0 1.6 0.1 0.0 0.0 7.0 0.0 0.4 0.0 1.5 1.6 0.0 0.0 0.0 12.6 1.3 0.0 0.0 0.0 0.3 0.0 0.4 0.4 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.2 14.5 14.0 19.2 12.6 13.9 14.8 19.3 21.2 13.4 17.3 16.7 31.4 23.3 19.3 3.2 36.9 2.6 6.7 0.0 0.0 0.0 0.0 2.7 0.2 5.1 5.4 7.2 0.0 0.0 0.0 0.1 0.9 0.1 0.0 8.5 4.8 0.3 0.2 3.5 0.0 0.4 62.2 30.8 0.4 0.7 20.9 1.0 0.0 0.6 0.4 0.3 5.0 1.7 23.5 0.4 0.0 1.3 0.0 3.8 0.0 2.7 0.0 14.0 2.6 1.0 5.2 219.7 13.0 12.6 0.1 0.4 0.3 0.0 0.0 0.3 0.0 5.7 0.0 0.5 0.4 2.1 1.6 0.0 0.4 0.1 0.7 1.9 0.1 2.5 GPATCH11 "CCDC75, CENP-Y, CENPY, FLJ38348" ENSG00000152133 "G-patch domain containing 11" Q8N954 2 37084451-37099244 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038231, HPA038232" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA038231: AB_2675904, HPA038232: AB_10675788" "unprognostic (1.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.45e-1)" "unprognostic (1.80e-1)" "unprognostic (3.88e-2)" "unprognostic (2.23e-2)" "unprognostic (4.58e-3)" "unprognostic (2.40e-2)" "unprognostic (2.44e-2)" "unprognostic (4.39e-2)" "unprognostic (1.16e-1)" "unprognostic (1.26e-1)" "unprognostic (8.64e-3)" "unprognostic (4.31e-2)" "unprognostic (4.44e-2)" "unprognostic (3.40e-2)" "unprognostic (7.16e-2)" 23.2 6.3 7.7 7.9 8.7 10.1 7.0 9.0 10.0 7.0 6.5 4.6 4.9 4.9 3.7 5.1 3.7 4.5 5.5 7.9 8.8 5.6 5.8 6.3 12.8 8.6 9.0 7.3 6.0 3.0 5.5 3.6 5.7 8.8 4.1 4.9 21.2 3.8 4.2 2.4 5.9 5.0 4.3 8.7 8.1 4.9 11.7 8.4 10.4 6.5 5.5 11.8 5.3 3.1 10.6 12.5 7.4 12.4 9.7 25.7 11.9 13.2 22.1 8.9 13.1 10.7 9.4 5.2 14.4 12.1 8.3 11.4 8.8 14.8 5.3 19.5 24.7 16.1 26.3 9.8 9.6 8.3 31.7 27.5 7.8 9.4 18.0 10.1 8.6 11.6 9.0 25.0 65.8 15.4 6.3 20.6 17.4 5.3 20.5 10.3 16.9 26.4 40.7 5.7 5.3 14.9 13.9 11.6 7.4 11.2 9.9 7.6 14.6 12.9 23.7 13.1 17.4 24.7 25.6 28.2 21.6 16.9 26.2 21.3 5.9 2.4 2.2 4.4 2.0 4.4 8.7 3.2 3.7 3.6 6.8 3.4 3.5 0.8 6.7 0.7 12.2 2.6 1.5 7.7 8.7 9.0 10.0 7.9 8.8 8.6 9.0 7.3 8.8 8.7 8.4 10.6 14.7 12.8 8.1 3.9 23.3 4.2 2.7 5.7 7.4 24.3 6.2 7.0 14.1 8.6 5.0 11.0 25.0 8.8 48.7 12.1 11.7 9.3 32.9 12.6 20.0 12.8 3.0 22.1 14.3 14.1 30.5 12.2 8.6 13.9 12.0 8.7 17.9 15.0 13.4 13.5 12.1 9.1 6.1 18.8 15.0 10.5 16.1 21.1 3.6 5.6 12.7 28.9 22.6 10.6 12.5 14.8 4.9 22.2 23.2 1.6 9.7 13.2 11.5 52.7 13.1 13.4 21.7 75.5 43.6 7.8 5.4 3.8 16.8 13.7 6.0 2.0 HSPB8 "CMT2L, E2IG1, H11, HSP22" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119171555-119224855 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 904.6" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 49.4 14.0 156.1 34.8 159.0 0.0 33.7 190.2 142.9 49.6 134.9 260.1 9.0 115.4 10.2 164.7 59.2 43.5 456.7 140.4 266.0 62.1 4.8 96.6 11.5 220.5 169.3 113.4 23.6 31.1 184.6 17.6 92.9 203.3 144.8 36.1 28.5 51.3 291.7 904.6 68.8 50.9 115.1 203.1 56.7 111.3 12.1 189.1 40.6 29.4 452.5 99.5 241.2 101.0 236.1 21.1 16.1 0.3 0.0 14.4 11.5 60.2 32.5 28.7 5.9 0.3 40.0 0.6 0.1 89.6 42.4 48.0 2.4 0.3 0.0 0.6 0.1 1.2 0.0 66.0 3.2 11.2 0.0 0.1 14.1 4.1 22.3 1.3 21.6 12.3 0.0 0.2 0.0 13.0 130.5 0.0 0.2 5.7 0.0 23.0 0.0 22.9 2.9 38.3 6.2 0.4 1.0 13.5 1.6 6.8 50.5 29.0 0.2 20.4 15.8 39.8 21.7 1.7 0.0 0.2 0.2 67.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.1 159.0 190.2 142.9 140.4 266.0 220.5 169.3 113.4 203.3 203.1 189.1 236.1 2.7 44.8 48.2 42.1 0.7 102.3 108.5 4.5 126.3 0.7 95.2 17.5 599.1 7.2 5.4 5.5 8.4 149.1 1.0 0.0 0.0 59.7 12.2 98.1 20.2 27.4 0.0 0.0 6.2 11.4 17.5 82.2 5.6 142.7 1.3 0.0 25.4 0.0 19.4 1.7 6.6 0.0 2.0 1.0 9.4 11.0 1.5 1.6 12.4 2.8 1.0 51.7 0.0 0.0 0.9 12.9 0.0 0.4 0.3 24.6 0.0 52.0 3.1 2.1 6.6 39.8 76.9 0.9 0.2 38.0 28.7 1340.0 3.5 0.1 0.2 72.7 GEMIN6 FLJ23459 ENSG00000152147 "Gem nuclear organelle associated protein 6" Q8WXD5 2 38751534-38785002 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 164.5;Spermatocytes: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035726, HPA035727" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA035726: AB_10669528, HPA035727: AB_2674753" "unprognostic (1.97e-2)" "unprognostic (3.83e-1)" "unprognostic (2.32e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (2.10e-2)" "unprognostic (3.82e-3)" "unprognostic (3.10e-2)" "unprognostic (8.13e-2)" "unprognostic (3.53e-3)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.47e-1)" "unprognostic (2.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-2)" 6.1 10.2 8.6 7.8 9.1 3.6 8.4 9.0 11.0 6.3 8.7 6.7 9.0 6.6 10.4 7.2 9.1 5.5 5.4 8.8 8.4 12.6 13.9 5.4 10.9 8.7 8.8 8.7 9.9 6.9 7.5 6.3 7.5 9.6 5.7 8.6 6.2 6.1 5.2 13.3 5.4 7.8 8.8 8.0 8.0 7.2 19.7 8.8 8.2 6.7 7.0 12.5 7.7 5.8 11.4 38.8 31.2 21.3 24.9 27.3 23.8 36.4 32.4 16.1 28.1 23.3 33.1 18.1 52.8 36.3 16.8 39.4 18.1 33.5 31.6 40.7 45.5 42.3 34.4 17.9 54.4 18.7 29.0 17.2 16.3 22.9 37.6 18.5 19.2 29.9 14.1 35.9 17.9 28.4 27.4 35.1 37.0 36.6 45.4 37.0 24.1 37.6 28.9 25.8 13.4 26.6 41.9 8.3 31.1 25.3 24.7 16.0 9.8 16.4 27.1 34.6 21.4 49.1 36.7 77.4 50.6 21.8 43.0 27.7 3.1 24.3 7.8 19.6 28.6 21.7 32.4 20.3 20.3 24.0 29.5 24.4 25.5 3.6 26.3 26.6 17.7 31.3 22.4 8.6 9.1 9.0 11.0 8.8 8.4 8.7 8.8 8.7 9.6 8.0 8.8 11.4 11.8 12.8 24.0 1.0 18.7 8.3 10.3 31.5 7.4 6.9 13.9 21.1 9.1 14.3 22.3 11.0 4.2 29.7 7.5 7.5 29.4 22.2 164.5 28.6 21.3 14.9 1.2 18.5 1.7 17.8 37.8 16.1 16.8 8.3 12.6 19.0 16.8 33.5 26.4 11.8 1.8 10.7 6.1 19.5 15.5 29.0 20.5 15.0 10.6 1.9 23.4 9.2 15.5 1.5 1.2 19.1 11.4 11.3 13.3 10.7 21.2 68.5 32.6 7.9 19.7 10.7 15.7 87.8 18.3 16.1 11.5 7.3 12.5 30.5 17.7 7.7 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 143.7;choroid plexus: 48.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7" "Group enriched" "Detected in many" 4 "endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 138.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052128: AB_2681738" "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 5.1 7.7 67.5 0.6 79.4 0.2 6.3 143.7 91.3 4.0 48.1 7.1 2.0 3.6 1.5 1.8 6.4 2.8 4.2 81.0 62.2 42.6 10.0 6.7 0.5 74.6 68.0 75.3 5.9 4.6 2.3 13.0 3.2 88.1 11.7 1.7 15.8 22.1 1.6 2.8 3.2 3.3 2.4 79.0 2.6 8.7 2.2 64.0 0.5 12.4 1.9 0.5 3.9 3.1 119.0 0.0 0.0 138.7 0.1 0.1 3.3 0.2 0.6 0.1 0.0 0.3 0.0 0.3 0.0 3.7 0.0 0.0 0.3 4.5 0.0 0.5 0.3 0.1 0.0 0.0 0.4 1.1 0.1 0.0 2.6 0.3 0.0 0.4 4.3 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.2 17.7 0.2 0.1 1.7 0.0 0.0 1.0 0.2 25.7 0.6 0.0 0.6 0.3 23.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.5 79.4 143.7 91.3 81.0 62.2 74.6 68.0 75.3 88.1 79.0 64.0 119.0 3.2 0.0 2.0 14.7 0.0 0.4 0.5 0.6 1.8 9.1 1.1 32.4 3.9 0.0 1.3 12.9 6.2 0.3 0.1 0.8 0.0 0.2 0.4 3.0 1.2 4.3 16.1 0.0 109.1 0.2 0.0 2.6 0.0 6.5 0.0 1.4 0.7 0.5 0.2 1.7 109.2 0.4 2.0 0.0 0.4 0.1 0.0 0.2 1.8 7.5 0.0 1.1 0.0 33.7 19.3 0.4 0.3 0.0 0.0 3.7 0.5 0.7 4.3 6.1 0.0 0.9 0.6 0.2 0.5 0.1 0.6 0.5 0.1 0.5 0.4 0.3 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603552 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.9;retina: 2.6" "Cell type enriched" "Detected in some" 10 "Skeletal myocytes: 28.6" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "medulla oblongata: 7.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 14.1;HEL: 15.5;JURKAT: 12.2;REH: 10.9;RH-30: 17.9;SCLC-21H: 17.1;U-266/70: 16.1" "Group enriched" "Detected in some" 23 "midbrain: 2.5;pons and medulla: 2.1;thalamus: 2.2" "Region enhanced" "Detected in some" "medulla oblongata: 4.1" HPA068024 Enhanced Approved NA NA "HPA068024: AB_2685943" "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.0 0.0 2.0 0.1 0.7 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.5 7.9 4.6 0.1 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.9 1.5 0.7 0.0 0.1 0.8 0.0 0.0 1.0 0.0 0.7 2.7 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.6 0.0 5.1 0.0 0.0 0.0 14.1 15.5 0.0 2.0 0.0 7.7 4.4 0.0 0.1 0.0 0.0 0.0 0.0 12.2 3.1 0.0 0.7 0.0 1.2 1.4 0.0 2.1 0.0 10.9 17.9 0.0 0.0 0.0 17.1 0.2 0.0 0.0 0.7 0.2 0.0 1.5 0.2 0.0 0.0 0.3 0.0 16.1 5.1 0.0 0.0 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.4 0.3 0.3 0.7 7.9 4.6 0.1 2.2 1.7 1.5 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.8 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 2.0 0.0 28.6 0.1 2.5 2.7 0.0 0.4 0.0 0.1 0.0 0.1 0.0 OBI1 "C13orf7, FLJ13449, RNF219" ENSG00000152193 "ORC ubiquitin ligase 1" Q5W0B1 13 78614289-78659155 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 5.9 4.8 6.1 6.2 6.5 2.4 6.8 7.5 6.7 6.0 4.9 4.9 4.8 7.1 4.5 5.0 5.7 4.5 7.1 6.3 6.8 4.6 4.4 5.2 10.0 6.2 6.5 5.3 7.6 4.1 4.1 2.9 7.5 6.3 5.6 5.4 9.7 4.3 6.1 4.8 5.6 4.8 6.6 6.9 7.4 4.5 14.9 7.2 13.4 5.9 6.5 11.4 6.1 4.5 6.8 23.7 9.1 39.1 23.1 13.5 12.9 17.8 19.3 14.5 18.7 23.3 18.3 17.3 39.8 9.2 12.4 12.2 23.0 31.2 15.3 32.6 24.9 22.8 61.0 11.4 16.1 11.3 59.6 18.2 12.4 16.7 15.7 16.8 10.6 15.6 19.9 16.1 5.3 24.6 6.6 36.5 20.2 0.0 25.1 10.0 42.0 32.2 15.4 12.7 12.5 28.4 15.9 13.4 16.9 14.8 22.2 8.6 47.3 12.9 16.2 14.7 10.7 16.3 5.5 6.6 37.9 25.9 35.6 17.8 4.9 5.4 7.5 7.9 8.8 9.5 8.8 8.8 9.8 6.3 8.9 10.8 9.8 1.8 11.1 10.3 5.3 9.6 6.6 6.1 6.5 7.5 6.7 6.3 6.8 6.2 6.5 5.3 6.3 6.9 7.2 6.8 14.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 15.8 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 12.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.1 1.1 0.0 0.0 0.0 CYSLTR2 "CysLT(2), CYSLT2R" ENSG00000152207 "Cysteinyl leukotriene receptor 2" Q9NS75 13 48653711-48711226 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.0;seminal vesicle: 17.7" "Cell type enhanced" "Detected in some" "Hepatic stellate cells: 9.3;Macrophages: 13.1;Melanocytes: 5.4;monocytes: 4.8;NK-cells: 5.2;Sertoli cells: 13.1" "Cancer enhanced" "Detected in many" "renal cancer: 6.6;thyroid cancer: 7.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 13 "eosinophil: 100.6" "Lineage enriched" "Detected in many" 13 "granulocytes: 100.6" "Cell line enriched" "Detected in some" 47 "HDLM-2: 89.9" HPA046528 Approved NA NA "HPA046528: AB_2679687" "unprognostic (9.83e-3)" "unprognostic (2.72e-3)" "unprognostic (1.05e-2)" "unprognostic (6.81e-2)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.11e-1)" "unprognostic (7.41e-3)" "unprognostic (8.33e-2)" "unprognostic (1.83e-1)" "unprognostic (5.44e-2)" "unprognostic (5.93e-2)" "unprognostic (1.88e-3)" "unprognostic (3.79e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-2)" "unprognostic (1.18e-2)" 2.5 7.3 4.0 3.1 3.2 1.1 1.1 2.8 4.2 0.8 2.3 1.2 2.4 1.5 1.3 0.8 3.8 1.8 10.1 3.2 9.8 1.9 1.3 1.8 4.7 3.9 3.4 2.4 1.8 0.5 0.6 1.3 26.0 3.8 0.8 1.2 1.0 0.3 17.7 0.4 1.3 2.9 0.8 2.5 8.3 1.3 0.9 3.5 1.8 1.3 0.0 1.8 0.9 0.5 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.1 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.8 2.5 100.6 0.6 8.0 0.0 0.0 1.1 0.2 2.5 0.0 1.1 0.4 0.3 1.1 5.8 0.0 0.9 1.0 4.0 3.2 2.8 4.2 3.2 9.8 3.9 3.4 2.4 3.8 2.5 3.5 3.6 0.3 0.0 1.1 0.0 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 3.7 0.0 0.4 3.4 0.0 0.0 0.0 0.3 0.0 0.1 2.0 0.0 0.8 0.0 0.0 1.5 3.8 0.0 0.1 1.3 0.3 9.3 0.0 0.6 0.0 0.0 0.0 0.0 4.7 0.8 0.4 0.3 13.1 5.4 0.0 4.8 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 13.1 0.0 3.7 0.0 0.2 0.0 0.0 2.9 2.9 0.1 0.0 0.0 GRID2 "GluD2, GluR-delta-2" ENSG00000152208 "Glutamate ionotropic receptor delta type subunit 2" O43424 4 92303966-93810157 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 41.5;testis: 34.3" "Cell type enhanced" "Detected in some" "Early spermatids: 380.6;Excitatory neurons: 787.2;Inhibitory neurons: 982.0;Late spermatids: 674.2;Microglial cells: 382.2;Oligodendrocyte precursor cells: 2319.7;Oligodendrocytes: 453.5" "Cancer enriched" "Detected in single" 7 "glioma: 1.8" "Region enhanced" "Detected in all" "cerebellum: 41.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-2 OS: 7.7;U-266/70: 3.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 68.3" "HPA056253, HPA058538" Enhanced NA NA "HPA056253: AB_2683079, HPA058538: AB_2683747" "unprognostic (2.78e-1)" "unprognostic (1.29e-4)" "unprognostic (7.23e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (3.50e-2)" "unprognostic (3.34e-1)" "unprognostic (6.92e-2)" "unprognostic (7.96e-3)" "unprognostic (4.36e-2)" "unprognostic (9.31e-2)" "unprognostic (7.38e-3)" 0.0 2.3 4.8 0.0 6.1 0.0 0.0 41.5 4.2 0.4 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 3.1 8.7 0.1 0.0 0.0 0.0 4.7 5.6 4.1 2.4 0.0 0.0 0.0 0.0 11.6 0.0 0.0 4.9 0.0 0.2 0.0 0.0 0.1 0.0 3.1 0.0 0.1 34.3 10.9 0.0 0.0 0.2 0.0 0.1 0.1 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.7 0.0 0.0 3.5 0.0 0.3 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.1 41.5 4.2 3.1 8.7 4.7 5.6 4.1 11.6 3.1 10.9 3.9 0.0 0.0 0.0 86.8 0.0 0.0 0.0 0.0 2.2 108.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 380.6 0.0 0.1 1.5 0.0 0.0 787.2 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.1 28.6 982.0 0.0 0.0 0.0 0.0 674.2 5.0 0.2 0.0 382.2 0.0 115.3 0.0 2319.7 453.5 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 7.7 6.6 0.0 1.2 3.7 2.9 0.2 0.0 0.0 0.0 6.4 0.0 0.0 ARL11 "ARLTS1, FLJ33930" ENSG00000152213 "ADP ribosylation factor like GTPase 11" Q969Q4 13 49628507-49633872 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.0" "Cell type enhanced" "Detected in many" "B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 38.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040855, HPA040887" Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA040855: AB_10793864, HPA040887: AB_10796229" "unprognostic (1.19e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (2.82e-1)" "unprognostic (7.86e-2)" "unprognostic (1.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.72e-2)" "unprognostic (2.55e-1)" "unprognostic (2.27e-4)" "unprognostic (1.72e-2)" "unprognostic (5.60e-2)" "unprognostic (1.16e-1)" "unprognostic (3.14e-2)" 0.9 0.8 0.5 3.9 0.6 3.6 0.7 0.5 1.0 0.4 0.8 1.0 1.2 0.2 0.2 1.0 0.3 1.1 0.4 0.4 1.0 0.1 0.6 2.2 7.0 0.8 0.6 0.3 0.2 0.1 0.3 0.3 1.9 0.8 0.2 1.5 0.1 0.6 0.2 0.3 0.7 1.9 0.7 0.8 4.9 0.6 0.3 0.9 3.7 0.4 0.4 3.9 1.3 0.8 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.6 0.0 5.2 10.7 0.1 0.1 0.0 0.0 0.0 0.4 5.1 0.3 0.1 0.0 1.3 4.9 11.1 0.1 0.0 0.0 5.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 3.5 14.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.6 0.0 6.3 0.0 21.8 15.3 16.3 0.1 17.9 0.2 7.9 0.3 0.3 8.1 10.1 0.8 0.4 38.0 0.8 13.4 8.6 0.3 4.4 0.5 0.6 0.5 1.0 0.4 1.0 0.8 0.6 0.3 0.8 0.8 0.9 1.0 0.9 0.0 1.1 0.0 18.2 0.3 0.3 0.2 1.2 0.7 1.0 0.9 0.6 2.8 0.0 0.0 0.0 4.7 3.4 1.7 0.0 0.0 1.7 0.1 0.1 1.2 1.2 6.9 0.0 0.0 5.1 0.3 0.0 0.1 7.6 0.0 1.8 0.6 31.3 0.0 0.0 3.4 0.0 34.8 3.5 1.3 0.3 18.2 0.0 3.7 19.2 0.3 1.0 0.0 0.1 0.1 10.2 0.0 2.9 0.1 4.2 0.1 2.3 0.5 0.0 0.3 0.2 1.5 0.3 4.1 0.0 1.5 1.2 0.5 3.1 0.4 RIT2 "RIBA, RIN" ENSG00000152214 "Ras like without CAAX 2" Q99578 18 42743227-43115691 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 28.2;choroid plexus: 7.6" "Group enriched" "Detected in some" 5 "Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5" "Cancer enriched" "Detected in single" 49 "glioma: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA072174, HPA072526" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA072174: AB_2732195, HPA072526: " "unprognostic (1.37e-2)" "unprognostic (4.15e-1)" "unprognostic (2.14e-1)" 0.0 1.9 10.6 0.1 12.7 0.0 0.0 28.2 15.6 0.1 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 16.2 0.0 0.0 0.0 0.0 15.0 11.3 10.7 0.0 0.0 0.0 0.6 0.0 15.4 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.0 0.2 12.8 0.0 0.0 0.0 0.0 0.0 0.2 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 12.7 28.2 15.6 11.0 16.2 15.0 11.3 10.7 15.4 10.1 12.8 14.5 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.0 225.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 42.5 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 3.7 0.0 1.0 0.0 202.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 1.4 0.2 0.0 0.0 2.1 0.0 0.5 0.0 0.0 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.0;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 5 "B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 16.1;Karpas-707: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 66000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 6.5 1.9 2.1 3.7 4.1 1.8 6.3 12.7 5.5 11.0 0.9 8.5 1.7 8.3 7.2 4.6 7.2 5.1 3.2 2.9 3.5 7.5 4.7 6.7 5.3 1.1 0.6 1.5 7.8 5.9 3.8 2.7 7.3 3.6 7.9 3.6 3.0 4.4 9.2 10.8 4.3 4.7 7.4 0.0 3.7 5.7 1.8 0.5 4.5 5.1 9.8 4.8 8.1 8.6 4.4 0.0 2.4 16.1 0.0 4.1 1.2 1.0 1.3 3.0 1.5 1.3 0.2 0.0 1.0 0.5 1.8 1.0 4.8 1.8 4.9 1.0 1.4 0.8 0.0 1.8 1.2 0.0 0.0 0.0 3.8 2.0 0.0 3.0 2.7 0.5 0.0 0.1 44.7 0.4 0.8 0.0 0.1 2.0 0.0 1.1 5.6 0.0 5.5 4.9 3.9 8.2 4.2 0.0 0.0 0.9 7.1 2.2 0.0 0.0 9.5 3.3 0.0 7.7 8.6 0.5 0.0 5.8 0.2 5.5 0.1 0.0 0.0 0.4 0.6 0.0 2.0 0.0 0.2 0.0 3.0 0.0 0.1 0.0 0.0 1.0 2.8 0.0 0.1 2.1 4.1 12.7 5.5 2.9 3.5 1.1 0.6 1.5 3.6 0.0 0.5 4.4 7.6 0.0 1.8 85.5 42.4 15.4 8.6 8.3 7.4 12.5 11.0 12.6 3.9 14.3 4.2 16.5 18.8 1.5 25.5 1.6 3.9 4.5 1.3 12.9 15.6 8.3 12.0 0.8 349.0 3.5 1.4 29.3 4.1 14.8 0.0 0.7 17.9 16.5 2.0 3.3 548.3 4.4 10.2 2.4 8.7 3.7 62.7 4.6 3.6 88.1 1.5 10.7 6.2 170.4 62.9 3.7 9.1 39.9 29.6 8.1 0.4 10.5 5.8 18.2 6.6 18.4 28.6 0.3 0.8 4.0 15.2 0.8 5.9 0.1 4.7 1.5 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323104-30338223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" NA NA "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: AB_2676606, HPA048127: AB_2680277" "prognostic favorable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favorable (7.49e-4)" 14.0 22.7 15.2 13.3 16.5 8.1 20.2 17.2 17.1 17.2 15.7 10.5 9.6 19.1 23.4 11.7 16.6 13.2 23.1 16.3 15.2 17.5 19.9 11.0 22.6 14.2 15.0 15.6 20.7 13.1 26.3 12.1 11.6 13.9 19.8 10.9 16.0 19.2 20.1 20.8 12.7 9.8 14.6 14.6 21.0 15.8 14.8 14.2 15.7 25.0 20.9 21.6 14.6 8.2 15.3 10.8 15.4 16.9 14.8 27.1 29.2 8.5 20.8 26.0 18.4 20.2 8.5 4.1 43.8 13.9 15.0 20.5 17.8 24.8 17.5 25.9 35.2 30.7 13.3 12.0 15.0 42.6 24.0 14.7 30.5 34.7 8.7 32.8 26.7 20.6 17.9 21.4 23.2 32.5 10.4 21.9 19.6 19.6 24.1 21.3 18.8 41.2 18.0 24.7 14.8 19.2 20.4 16.2 21.4 25.8 15.0 22.8 13.4 18.1 20.8 11.2 41.7 20.1 36.0 21.9 28.5 20.0 14.8 20.4 12.7 19.2 6.4 23.3 20.0 55.5 35.9 28.2 25.9 26.3 28.9 25.7 25.0 3.5 52.9 15.5 18.9 20.3 23.1 15.2 16.5 17.2 17.1 16.3 15.2 14.2 15.0 15.6 13.9 14.6 14.2 15.3 27.3 28.9 33.6 14.4 39.7 12.4 46.6 35.1 8.0 34.0 19.9 30.4 68.1 24.3 23.8 25.8 14.6 19.1 29.2 5.9 76.3 27.3 130.1 25.8 41.0 29.2 14.5 13.2 31.1 22.5 12.7 33.4 12.8 19.0 27.8 33.5 15.4 29.8 25.7 32.0 26.4 11.7 32.6 27.1 29.3 66.3 27.4 28.4 26.6 18.7 45.4 36.1 38.1 27.6 19.9 21.9 8.4 25.2 25.4 46.0 9.4 42.1 27.5 32.4 13.1 33.1 29.8 111.4 37.6 13.8 11.1 11.1 29.6 33.0 12.6 28.4 EPG5 "hEPG5, KIAA1632" ENSG00000152223 "Ectopic P-granules autophagy protein 5 homolog" Q9HCE0 18 45847609-45967329 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 53.1;Oligodendrocytes: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "LHCN-M2: 55.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031689 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA031689: AB_10609997" "unprognostic (3.43e-1)" "unprognostic (1.20e-1)" "unprognostic (8.11e-2)" "unprognostic (6.84e-2)" "unprognostic (2.20e-2)" "unprognostic (4.59e-2)" "unprognostic (5.58e-2)" "unprognostic (1.02e-1)" "unprognostic (4.66e-1)" "unprognostic (4.87e-1)" "unprognostic (1.15e-2)" "unprognostic (7.50e-2)" "prognostic favorable (4.04e-5)" "unprognostic (5.71e-2)" "unprognostic (1.35e-1)" "unprognostic (4.05e-1)" "unprognostic (1.18e-1)" 6.1 6.9 5.6 4.5 6.2 13.9 6.8 6.5 6.3 6.9 5.6 5.6 3.2 6.1 5.9 7.2 6.1 3.3 8.4 6.3 5.7 6.0 6.1 8.9 5.8 5.4 8.2 6.1 8.9 6.3 7.0 7.6 4.6 5.6 6.0 4.1 8.7 6.0 3.7 8.7 10.2 6.0 4.1 4.9 9.6 5.6 4.9 5.9 8.5 9.4 6.7 5.9 5.5 6.7 6.6 5.3 4.1 4.1 3.0 13.8 16.6 4.1 33.2 13.7 18.7 19.4 1.2 3.9 5.4 2.0 25.0 22.5 4.9 5.5 6.6 23.7 4.5 2.3 4.2 4.7 4.2 13.1 7.2 10.4 11.2 6.0 20.6 14.0 16.5 9.4 4.7 3.7 2.8 55.8 3.7 3.2 6.9 2.0 1.9 2.5 3.0 5.1 3.8 8.8 7.3 4.4 3.4 5.9 2.4 7.0 5.8 3.4 5.1 23.0 23.2 4.9 3.4 9.2 5.7 4.3 3.0 9.9 6.2 7.7 0.4 0.7 0.7 1.5 0.7 1.4 0.4 0.9 0.8 0.5 0.6 0.7 0.9 0.8 0.4 0.6 0.6 0.5 0.3 5.6 6.2 6.5 6.3 6.3 5.7 5.4 8.2 6.1 5.6 4.9 5.9 6.6 8.8 19.2 10.5 24.5 9.0 10.3 4.6 6.8 8.0 16.7 11.9 8.3 17.1 10.0 7.4 11.0 25.0 7.6 15.7 5.8 1.9 6.5 4.6 9.0 9.8 9.3 8.3 11.4 53.1 3.6 4.4 7.8 6.1 16.9 7.0 14.4 13.6 10.3 12.2 13.5 46.5 6.9 6.1 16.0 6.2 3.0 12.5 11.5 14.2 40.3 16.6 6.5 27.8 40.2 51.4 7.8 6.5 11.7 10.0 9.1 6.2 8.3 10.5 17.4 13.1 9.8 6.7 8.4 7.1 5.9 13.2 9.0 15.4 9.8 6.5 9.4 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 73.1;lymphoid tissue: 63.9;skeletal muscle: 33.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 44.6;Erythroid cells: 46.7;Macrophages: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 112.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 102.0;HMC-1: 108.3" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" No No 1500000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.2 4.6 0.9 11.2 1.0 73.1 8.6 0.9 1.5 4.2 1.9 4.4 3.7 2.9 1.4 5.2 4.1 5.3 2.1 0.9 1.7 3.3 10.1 11.5 6.4 1.5 1.1 0.7 3.6 3.5 3.9 2.9 12.2 1.5 8.1 5.2 2.8 6.0 2.7 33.4 8.5 4.6 4.6 1.1 63.9 6.5 1.3 1.2 3.9 2.1 5.9 5.0 9.7 4.4 1.4 2.9 0.0 3.8 0.1 0.9 6.7 20.6 15.0 7.4 5.3 4.5 11.6 4.0 0.1 0.9 5.0 0.0 36.2 20.3 28.1 6.6 0.0 3.2 102.0 4.6 0.2 5.9 6.0 108.3 5.0 34.4 5.0 16.3 4.8 10.6 0.2 24.8 0.1 23.1 3.6 0.9 0.1 2.3 0.0 0.1 0.1 7.5 4.9 11.2 37.0 0.3 2.1 2.4 10.3 0.5 28.2 32.6 12.0 7.6 0.6 8.2 0.8 0.2 0.1 0.3 0.1 1.3 0.2 0.4 77.3 25.3 112.8 10.4 35.0 3.6 0.1 6.2 7.7 25.3 0.1 7.2 8.8 13.5 2.9 36.4 0.9 4.1 20.0 0.9 1.0 0.9 1.5 0.9 1.7 1.5 1.1 0.7 1.5 1.1 1.2 1.4 1.7 12.8 11.6 0.7 2.4 13.8 19.4 44.6 15.4 0.7 11.1 17.1 3.5 2.8 24.9 0.0 0.0 26.6 21.8 0.6 3.9 9.6 2.0 4.1 2.6 3.1 1.2 46.7 1.6 3.9 3.3 4.2 11.2 11.2 43.6 20.6 7.1 17.3 14.6 0.0 1.4 4.2 6.1 42.5 5.5 7.3 2.8 58.7 7.2 2.8 37.4 10.9 25.7 2.0 0.9 17.7 0.3 2.2 3.6 39.7 0.5 4.1 13.0 0.4 6.6 3.1 7.7 1.1 1.6 7.3 10.2 8.8 17.8 7.1 2.4 21.8 ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1775.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria NA NA 8800000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favorable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 253.6 457.3 202.6 179.3 207.1 212.3 263.1 231.5 249.9 197.1 361.2 417.9 442.9 194.2 227.5 365.5 229.2 147.7 1260.5 203.7 238.7 737.1 445.3 176.6 225.6 224.9 236.1 195.7 212.9 302.4 875.9 279.5 203.4 225.4 213.3 423.9 469.4 310.1 268.4 1617.2 292.5 337.7 235.0 201.9 228.6 422.6 169.1 225.4 279.9 263.8 1775.9 340.4 247.2 226.5 240.8 355.2 353.0 459.6 434.3 546.0 601.8 508.6 399.5 562.4 601.0 522.8 532.7 271.9 833.2 238.9 487.4 322.3 641.7 801.1 614.1 556.4 373.0 450.3 551.7 413.3 667.2 357.1 1182.7 501.6 559.2 422.3 434.6 448.2 481.3 630.4 442.5 454.0 477.2 521.8 367.6 612.8 579.7 432.3 344.5 367.6 596.5 533.8 1131.4 816.2 849.7 465.7 434.7 293.3 361.5 506.9 428.6 466.3 679.3 370.4 328.7 282.7 174.9 354.9 542.5 501.5 533.0 328.1 698.0 358.7 119.1 573.9 162.7 353.6 511.8 455.9 492.3 422.7 388.4 959.5 392.9 503.3 421.7 55.9 414.5 485.1 468.3 527.4 1339.1 202.6 207.1 231.5 249.9 203.7 238.7 224.9 236.1 195.7 225.4 201.9 225.4 240.8 79.2 169.9 167.8 0.0 49.9 0.0 0.0 0.0 0.0 0.0 205.7 169.8 0.0 0.0 100.3 171.0 0.0 784.3 86.3 0.0 1173.9 358.3 0.0 125.3 163.3 73.0 0.0 0.0 0.0 269.7 463.0 97.8 0.0 119.3 89.6 198.7 0.0 0.0 409.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 179.9 0.0 0.0 0.0 0.0 199.1 0.0 0.0 24.0 0.0 0.0 939.6 95.5 0.0 0.0 0.0 87.1 0.0 0.0 0.0 0.0 578.2 54.6 319.2 0.0 0.0 HAUS1 "CCDC5, FLJ40084, HEI-C, HsT1461" ENSG00000152240 "HAUS augmin like complex subunit 1" Q96CS2 18 46104378-46128333 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 111.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040601, HPA040652" Supported Supported Centrosome,Cytosol NA NA Cytosol Centrosome "HPA040601: AB_10794743, HPA040652: AB_10793966" "unprognostic (1.74e-2)" "unprognostic (1.89e-2)" "unprognostic (8.13e-3)" "unprognostic (1.92e-1)" "unprognostic (2.29e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.39e-1)" "unprognostic (4.76e-3)" "prognostic favorable (1.55e-4)" "unprognostic (3.75e-1)" "prognostic unfavorable (6.76e-4)" "unprognostic (5.97e-3)" "unprognostic (5.40e-2)" "unprognostic (9.79e-3)" "unprognostic (3.66e-2)" "unprognostic (7.96e-2)" 13.6 11.1 8.0 18.5 8.1 38.2 19.1 8.1 10.2 13.7 9.8 18.7 14.4 17.2 39.1 14.6 13.5 17.0 11.9 7.8 10.6 13.1 13.8 12.4 35.8 8.5 8.3 7.4 26.6 11.5 14.4 10.8 17.9 8.2 10.5 22.3 9.6 10.6 13.0 7.3 10.2 14.4 17.0 8.8 14.7 13.1 16.4 8.2 41.8 13.4 13.3 39.8 16.3 12.0 8.8 72.8 43.6 157.3 86.9 38.8 59.4 42.5 68.4 65.7 105.5 104.4 43.2 39.5 136.4 40.5 48.3 49.8 74.6 94.0 56.4 115.1 77.7 64.2 99.2 40.7 82.0 32.5 184.2 59.7 28.6 21.6 64.6 33.3 45.6 115.1 91.5 72.4 39.8 94.2 41.9 150.0 87.7 101.1 33.0 24.9 144.6 112.4 98.4 85.4 49.9 74.3 77.2 64.3 22.3 52.9 60.7 33.3 89.0 67.9 62.8 42.1 27.9 73.4 43.5 73.2 130.6 39.9 157.0 74.0 11.1 46.5 36.7 40.3 45.4 45.0 79.4 53.0 48.9 58.3 64.8 38.1 45.0 4.9 55.9 35.8 62.5 99.9 55.4 8.0 8.1 8.1 10.2 7.8 10.6 8.5 8.3 7.4 8.2 8.8 8.2 8.8 20.6 12.8 12.2 3.3 26.5 17.5 15.8 47.8 16.5 6.1 16.4 18.7 10.1 15.7 33.0 14.7 4.2 58.7 22.0 11.1 17.6 38.2 7.5 15.9 18.3 29.4 12.1 53.9 4.2 42.3 111.7 25.1 7.1 14.5 29.8 31.3 23.2 6.9 50.9 11.8 4.8 24.1 28.5 33.6 24.7 12.4 22.7 25.8 21.4 4.7 45.8 21.5 37.0 8.0 5.2 31.8 12.4 25.9 21.9 8.1 14.3 24.7 29.3 8.7 19.7 15.9 20.2 50.8 55.8 15.3 15.5 23.7 23.9 20.7 26.8 12.9 C18orf25 "Ark2N, ARKL1, MGC12909, RNF111L1" ENSG00000152242 "Chromosome 18 open reading frame 25" Q96B23 18 46173553-46266992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051314, HPA051899" Approved Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA051314: AB_2681438, HPA051899: AB_2681657" "unprognostic (1.44e-2)" "unprognostic (2.32e-1)" "unprognostic (2.08e-2)" "unprognostic (5.77e-3)" "unprognostic (4.46e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.97e-1)" "unprognostic (7.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.43e-1)" "unprognostic (5.80e-2)" "unprognostic (3.27e-2)" "unprognostic (1.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" 8.6 7.0 11.2 9.0 8.9 34.5 10.5 13.0 11.2 10.0 16.6 8.1 7.7 9.3 8.0 37.8 9.6 6.6 16.0 9.0 9.7 8.9 8.2 9.7 12.2 9.4 10.9 7.4 9.3 6.1 18.9 6.2 8.3 11.6 8.4 9.3 27.9 13.4 7.6 23.5 12.8 8.9 9.4 8.0 11.2 8.8 12.1 10.3 15.1 12.0 16.2 15.6 9.9 16.6 10.5 18.4 17.9 14.8 16.9 10.4 9.3 19.0 26.0 13.8 27.3 23.1 13.9 20.5 14.0 24.1 17.7 9.8 40.9 27.7 17.7 29.5 23.5 8.9 12.4 16.0 10.6 17.9 23.5 16.0 8.7 20.2 31.9 26.3 15.9 11.0 12.9 14.1 16.3 15.3 13.7 17.9 11.9 13.2 6.3 7.0 16.0 17.6 20.7 26.1 32.5 20.7 10.8 19.1 13.4 13.7 17.9 8.8 14.3 16.0 24.7 17.6 6.0 24.3 21.3 19.7 22.3 12.8 24.4 27.0 4.9 8.9 18.6 6.3 9.9 11.2 6.9 12.3 9.6 8.8 9.0 8.6 6.8 22.7 3.5 14.3 12.6 8.7 6.9 11.2 8.9 13.0 11.2 9.0 9.7 9.4 10.9 7.4 11.6 8.0 10.3 10.5 18.4 12.8 9.1 16.0 19.2 25.2 10.4 11.5 11.4 14.5 13.4 9.9 30.4 5.7 9.5 14.7 20.9 8.1 26.1 15.1 1.9 9.1 2.4 42.1 14.4 16.2 12.0 16.8 62.5 6.5 10.5 12.1 13.7 39.2 15.2 9.9 11.7 13.0 9.1 13.5 45.2 10.0 6.1 13.1 18.0 3.5 8.1 12.9 7.2 22.5 11.1 12.4 9.2 25.6 25.9 20.4 10.1 10.5 16.5 13.0 9.2 7.6 16.9 30.6 19.7 14.8 11.8 20.6 14.9 14.2 31.8 24.4 18.6 6.6 10.1 23.3 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25 component of NDC80 kinetochore complex" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.5;Erythroid cells: 29.9;Extravillous trophoblasts: 37.9;Muller glia cells: 17.2;Spermatocytes: 26.2;Spermatogonia: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA047144: AB_2679952, HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.74e-6)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.5 0.8 0.8 0.7 0.7 4.3 1.0 0.6 1.7 0.4 0.6 2.0 3.7 0.5 0.0 4.4 0.3 0.5 0.3 1.7 1.0 0.8 0.8 0.9 4.0 0.8 0.8 0.4 0.5 1.3 0.1 0.1 1.1 1.0 0.4 1.6 1.7 1.0 0.0 0.6 1.1 2.1 1.0 0.3 2.1 1.6 3.4 0.8 8.6 0.2 0.1 3.7 0.5 1.5 2.1 1.0 16.8 40.6 22.8 1.8 1.9 14.5 22.9 9.3 23.5 18.1 5.6 16.2 15.7 9.0 3.4 31.9 20.9 15.9 0.0 20.7 10.0 21.5 30.2 7.2 2.2 0.1 20.3 8.9 0.3 1.0 14.3 0.0 4.7 10.3 28.2 0.8 15.7 6.4 9.8 16.1 26.3 0.9 11.2 21.0 28.8 38.1 5.6 9.6 13.7 30.4 0.5 16.8 14.4 3.9 13.5 0.4 16.4 2.5 3.6 42.1 13.4 18.2 31.4 56.0 12.5 4.1 0.5 14.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.8 0.7 0.6 1.7 1.7 1.0 0.8 0.8 0.4 1.0 0.3 0.8 2.1 0.4 0.0 1.1 0.7 4.2 5.4 1.5 7.1 1.2 0.0 1.5 2.4 0.6 0.0 2.6 0.0 0.0 23.5 1.5 3.7 0.0 0.2 2.0 0.5 1.8 1.6 0.0 29.9 0.3 0.0 37.9 4.6 2.0 1.8 0.0 10.1 2.9 1.2 15.1 0.0 0.5 5.2 2.0 1.9 2.4 1.6 0.6 2.0 0.0 0.0 0.0 17.2 0.0 5.0 0.2 0.5 0.1 1.2 15.3 1.0 1.0 0.2 0.1 0.6 0.0 1.3 4.4 26.2 20.1 7.3 1.4 5.7 2.7 1.7 9.9 2.5 G6PC2 IGRP ENSG00000152254 "Glucose-6-phosphatase catalytic subunit 2" Q9NQR9 2 168901291-168910000 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Gluconeogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 37 "pancreas: 31.2;retina: 12.4" "Group enriched" "Detected in some" 13 "Early spermatids: 17.8;Muller glia cells: 53.0" "Cancer enriched" "Detected in single" 92 "pancreatic cancer: 9.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.04e-2)" "unprognostic (9.05e-2)" "unprognostic (2.97e-1)" "unprognostic (3.10e-2)" "unprognostic (1.54e-2)" "unprognostic (1.87e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 31.2 0.0 0.0 0.0 0.1 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.3 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 53.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDK1 ENSG00000152256 "Pyruvate dehydrogenase kinase 1" Q15118 2 172555373-172608669 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.4;Plasma cells: 144.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;granulocytes: 25.2;T-cells: 21.2" "Cell line enhanced" "Detected in all" "U-266/70: 71.8;U-87 MG: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017554, HPA027376" Approved NA NA "CAB017554: AB_2161138, HPA027376: AB_1855139" "unprognostic (2.14e-1)" "prognostic unfavorable (7.30e-5)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "unprognostic (6.47e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (9.69e-3)" "unprognostic (6.44e-2)" "unprognostic (5.44e-3)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.10e-8)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" "unprognostic (2.56e-2)" "unprognostic (5.34e-2)" 7.8 16.2 2.2 11.7 3.1 16.0 10.2 5.4 5.0 4.9 2.7 16.8 16.6 4.1 3.1 8.6 3.7 6.0 28.4 3.3 2.9 4.5 11.3 4.2 13.2 2.8 3.5 3.2 12.4 6.9 4.3 3.8 6.4 3.4 4.8 13.4 27.3 10.3 5.0 9.1 18.0 9.2 4.5 1.8 10.6 13.7 12.3 6.4 8.4 3.9 7.7 19.3 11.1 7.7 3.8 34.0 1.4 8.4 21.0 3.4 5.1 12.1 29.1 23.4 14.3 30.4 8.6 7.1 32.1 15.8 9.1 11.9 14.5 5.8 18.2 45.5 6.6 11.7 39.3 7.1 10.2 6.2 19.6 14.0 6.6 6.4 10.0 16.6 19.8 7.7 16.7 8.5 21.5 19.2 3.5 12.5 24.5 20.8 6.9 9.2 13.1 13.8 52.5 7.4 10.8 15.7 18.0 7.6 8.8 11.1 7.0 5.6 8.0 9.2 22.7 7.4 12.0 7.9 71.8 44.8 26.9 72.6 14.0 4.6 19.6 3.4 25.2 3.7 2.3 4.2 7.3 5.9 4.0 3.5 8.6 21.2 13.5 12.7 2.2 3.2 0.6 12.2 9.2 2.2 3.1 5.4 5.0 3.3 2.9 2.8 3.5 3.2 3.4 1.8 6.4 3.8 9.2 3.2 5.0 12.1 33.7 50.1 5.1 15.8 4.6 29.4 7.0 4.7 35.5 2.8 7.0 3.7 47.9 10.2 9.9 11.9 5.9 8.7 130.4 6.4 7.2 9.6 7.8 4.2 35.4 3.7 13.2 8.5 9.7 12.1 5.7 13.3 19.6 20.2 10.2 55.5 32.7 6.6 12.2 12.0 15.2 43.8 3.4 12.9 30.2 30.9 11.4 7.4 10.3 12.1 14.8 9.6 17.5 3.8 144.8 7.2 6.7 1.9 5.0 18.5 6.6 4.6 11.6 9.6 10.4 8.9 43.3 4.1 17.3 5.3 7.0 6.1 PTH PTH1 ENSG00000152266 "Parathyroid hormone" P01270 11 13492054-13496181 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 245 "parathyroid gland: 50596.1" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.0;Oligodendrocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000072, CAB023409, CAB026363, HPA048540" Enhanced "Secreted to blood" NA NA 28000 "CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 50596.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.2 206.7 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDE3B HcGIP1 ENSG00000152270 "Phosphodiesterase 3B" Q13370 11 14643804-14872044 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" Angiogenesis Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 65.1" "Cell type enhanced" "Detected in many" "Astrocytes: 171.7;Excitatory neurons: 140.5;Inhibitory neurons: 158.0;Microglial cells: 192.0;Oligodendrocyte precursor cells: 118.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 3.8;T-cells: 6.3" "Cell line enhanced" "Detected in many" "HL-60: 23.5;Karpas-707: 25.7;THP-1: 28.4;U-266/70: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056111 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056111: AB_2683041" "unprognostic (1.05e-1)" "unprognostic (2.86e-2)" "unprognostic (4.12e-2)" "unprognostic (2.76e-3)" "unprognostic (4.25e-1)" "unprognostic (1.84e-3)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "prognostic favorable (7.91e-4)" "unprognostic (1.77e-1)" "unprognostic (2.33e-2)" "unprognostic (1.39e-2)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (9.03e-3)" 65.1 1.1 1.2 12.5 2.0 10.2 12.3 13.5 2.9 3.5 0.6 20.5 3.0 0.7 0.5 2.9 0.5 3.7 4.8 2.0 5.0 3.1 26.0 10.3 15.1 2.7 2.4 1.7 0.5 8.4 0.2 4.4 7.6 4.5 8.8 10.8 0.5 14.1 1.6 0.4 0.5 6.1 1.7 2.4 9.0 2.6 9.7 2.0 7.4 0.8 2.4 7.9 8.6 1.9 1.8 0.0 2.5 5.6 9.2 10.9 0.1 2.2 0.6 0.1 0.0 0.0 8.5 0.0 0.0 0.1 0.0 2.6 0.0 8.5 0.0 0.0 0.2 18.7 0.3 13.1 17.5 3.9 23.5 0.1 0.8 0.0 0.0 0.5 0.0 0.1 6.6 20.6 25.7 0.0 0.3 4.7 11.4 7.6 3.1 4.1 11.0 2.5 17.7 0.0 1.9 8.5 15.8 2.3 14.6 5.1 2.5 0.0 28.4 0.0 0.0 1.3 0.0 0.0 28.8 9.4 0.7 0.2 4.0 1.7 0.0 0.5 2.5 1.0 0.6 2.1 0.2 3.1 2.4 0.3 0.1 6.3 5.7 3.8 0.1 1.0 0.1 3.5 1.5 1.2 2.0 13.5 2.9 2.0 5.0 2.7 2.4 1.7 4.5 2.4 2.0 1.8 1.5 16.0 8.9 171.7 6.4 0.3 0.9 0.0 0.6 1.0 0.3 0.3 11.1 0.0 6.2 1.8 0.0 1.4 26.7 11.5 1.9 0.0 19.0 0.3 5.1 4.0 1.2 12.8 140.5 5.0 2.8 9.7 7.7 0.3 36.1 0.5 4.2 64.1 7.6 0.0 158.0 13.7 0.0 13.1 3.7 13.4 1.5 15.6 0.0 192.0 10.8 6.3 8.2 118.6 5.4 1.8 22.3 9.1 28.9 3.3 0.7 2.0 3.6 0.5 0.0 3.4 3.0 48.8 19.5 0.1 0.1 2.5 60.9 0.0 9.4 1.1 TCF7L1 TCF3 ENSG00000152284 "Transcription factor 7 like 1" Q9HCS4 2 85133392-85310387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 49.2;Astrocytes: 76.4;Leydig cells: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 43.3;NTERA-2: 99.0;RH-30: 44.7;T-47d: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071298 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071298: AB_2686383" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.05e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (6.16e-5)" "unprognostic (1.79e-2)" "unprognostic (3.59e-3)" "unprognostic (2.73e-1)" "unprognostic (5.17e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.06e-4)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (5.38e-4)" 33.8 5.3 8.7 4.1 9.0 3.8 33.7 7.4 6.5 32.5 13.0 21.7 4.3 26.1 6.8 10.1 20.3 7.3 18.9 6.6 10.1 15.7 12.6 18.0 6.0 10.9 9.2 3.2 27.7 4.5 7.1 8.9 5.3 7.0 20.1 4.1 1.7 13.2 14.6 15.1 13.0 12.3 13.1 7.7 11.9 10.8 9.2 10.3 5.9 30.9 7.9 3.5 18.5 24.3 6.4 2.1 1.5 33.5 25.8 12.6 2.6 20.3 2.5 8.5 5.8 5.3 5.2 2.0 0.7 4.0 5.6 6.4 4.7 25.9 43.3 4.0 1.8 4.1 0.7 2.1 2.3 1.2 0.3 4.9 2.1 7.7 0.6 1.4 2.6 11.2 1.3 0.5 1.3 6.8 1.6 0.2 1.6 99.0 1.3 0.9 0.6 44.7 0.5 2.7 3.7 1.0 10.4 4.0 17.1 1.3 25.9 44.3 0.9 12.1 6.5 9.2 0.4 3.3 1.1 0.3 0.4 0.2 1.0 5.2 5.1 0.5 1.1 0.5 0.4 0.7 1.1 0.6 0.7 0.2 1.5 0.7 0.9 1.3 0.9 0.5 0.9 0.6 0.1 8.7 9.0 7.4 6.5 6.6 10.1 10.9 9.2 3.2 7.0 7.7 10.3 6.4 49.2 6.4 37.3 76.4 1.0 6.0 14.4 12.9 15.9 0.2 20.0 33.1 9.1 5.7 10.5 16.5 0.0 6.3 0.8 0.3 0.0 3.7 28.2 9.4 17.5 31.4 0.0 0.0 1.1 5.6 4.0 28.9 0.5 16.0 5.1 39.4 45.7 6.7 1.7 0.0 2.2 2.9 8.2 9.1 8.3 5.4 65.3 2.2 3.6 22.5 1.0 4.9 0.0 32.2 1.5 1.1 1.6 28.6 1.4 10.8 5.0 2.2 7.7 0.2 6.6 24.9 28.9 1.9 9.3 3.4 3.4 1.4 1.2 2.9 2.1 2.4 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328296 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA 12000000 "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 70.6 68.2 38.4 83.4 42.1 131.1 58.9 40.3 43.2 64.0 34.8 86.6 111.6 62.6 61.4 41.5 65.7 76.4 64.1 41.6 45.2 121.9 137.6 87.5 74.5 46.5 44.2 36.5 61.8 56.5 67.6 27.1 77.3 45.2 67.5 103.3 32.1 60.3 63.1 35.0 40.5 112.8 74.7 41.6 84.0 75.5 37.4 44.5 65.8 92.2 46.7 66.7 62.0 41.3 48.1 46.5 116.4 51.8 68.6 124.0 129.0 120.7 144.1 172.2 98.5 78.5 100.6 142.2 60.6 108.3 207.1 132.9 76.4 37.8 71.9 161.8 96.5 36.7 87.2 41.3 113.3 67.1 173.0 189.5 96.2 45.2 125.5 76.1 152.1 144.4 49.5 50.9 94.1 147.1 43.9 54.0 86.3 46.0 109.3 47.5 55.4 193.1 45.6 104.8 73.2 47.4 40.5 127.2 95.5 83.6 61.7 50.7 77.0 155.7 205.5 73.9 158.6 173.5 58.7 81.9 58.1 152.3 131.1 137.3 62.6 78.0 68.5 32.4 73.3 25.0 25.0 23.8 22.4 41.5 24.4 24.3 23.6 96.3 25.1 103.5 15.9 20.9 75.6 38.4 42.1 40.3 43.2 41.6 45.2 46.5 44.2 36.5 45.2 41.6 44.5 48.1 104.4 102.5 96.4 22.5 89.7 38.2 57.1 72.5 43.9 53.3 89.2 56.4 64.3 150.2 84.2 180.3 39.6 59.4 116.9 216.1 9.8 92.7 6.0 86.3 89.5 91.7 89.5 39.5 29.5 93.2 80.9 87.5 64.7 105.7 158.8 70.5 86.7 245.0 113.0 208.6 37.9 99.0 52.9 187.1 85.3 7.8 49.4 145.6 60.5 33.7 126.9 47.8 95.8 25.1 50.6 101.6 121.8 69.2 74.0 62.8 211.2 82.8 111.4 36.5 65.7 85.0 65.8 36.1 37.1 32.6 34.9 44.6 91.1 61.9 100.3 70.8 SH2D6 FLJ35993 ENSG00000152292 "SH2 domain containing 6" 2 85418931-85437029 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.9" "Group enriched" "Detected in some" 5 "Enteroendocrine cells: 10.7;Gastric mucus-secreting cells: 18.3;Proximal tubular cells: 16.7;Spermatocytes: 6.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "LHCN-M2: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA053873 Uncertain NA NA "HPA053873: AB_2682286" "unprognostic (4.70e-1)" "unprognostic (3.55e-2)" "unprognostic (3.30e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-2)" "unprognostic (7.95e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (1.46e-1)" "unprognostic (2.70e-1)" "unprognostic (2.49e-1)" "unprognostic (5.06e-7)" "unprognostic (2.54e-1)" "unprognostic (8.65e-2)" "unprognostic (1.23e-2)" "unprognostic (5.65e-3)" 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.4 0.0 0.2 0.8 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.4 0.3 0.3 0.4 0.4 0.2 0.5 0.3 0.4 0.6 0.0 0.0 0.0 1.3 0.2 0.0 0.5 0.0 0.0 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 1.9 0.0 0.3 0.1 0.1 0.0 10.7 0.0 0.6 0.0 0.0 0.1 18.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 2.0 0.0 0.3 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.0 2.4 0.1 2.3 0.4 0.1 0.3 0.6 16.7 0.0 0.2 0.0 0.8 0.2 6.8 2.3 0.0 0.0 0.1 0.3 0.1 1.5 0.0 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061994-90185853 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 4.6;parathyroid gland: 6.1;testis: 9.3" "Cell type enriched" "Detected in some" 4 "Microglial cells: 41.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.2" "Lineage enhanced" "Detected in single" "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "GAMG: 1.0;RT4: 1.9;SuSa: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" NA NA "Nuclear speckles, Cell Junctions" "HPA003514: AB_2666978" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.3 0.8 1.7 1.7 1.5 0.0 0.2 1.0 1.9 0.1 4.6 0.4 0.5 0.2 1.0 0.2 0.3 0.4 1.3 1.7 1.7 3.2 0.5 0.4 0.6 1.3 2.1 1.8 0.1 0.3 6.1 0.3 0.2 1.4 0.1 0.5 0.0 0.2 0.4 0.0 0.1 0.5 0.3 2.4 0.6 0.4 9.3 2.0 1.1 1.9 0.0 0.5 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 1.9 0.7 0.2 0.0 0.7 0.5 2.9 0.0 0.7 0.0 0.0 0.8 0.0 0.3 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.7 1.5 1.0 1.9 1.7 1.7 1.3 2.1 1.8 1.4 2.4 2.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.4 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 6.3 0.0 0.4 0.0 0.0 6.0 0.0 4.4 0.0 0.0 4.0 8.1 0.6 0.0 3.2 0.0 41.2 9.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.3 0.1 0.1 0.4 0.0 0.1 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529631 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077624 Supported "Nucleoplasm,Nuclear speckles,Vesicles" NA No "Nucleoplasm, Nuclear speckles" Vesicles "HPA077624: " "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 27.1 23.6 21.7 23.5 27.9 40.6 19.5 21.2 22.7 15.2 19.0 19.3 19.3 11.8 14.3 13.4 14.5 13.9 11.7 28.2 28.0 31.5 38.4 17.7 31.0 27.1 30.3 21.3 12.1 11.1 28.0 7.9 17.2 28.6 16.3 19.8 10.6 13.7 18.7 26.1 12.0 23.6 10.9 22.5 25.6 20.2 12.3 29.0 24.8 19.6 26.1 29.1 18.2 10.6 31.2 61.9 28.4 14.6 35.8 40.7 31.9 32.7 79.7 43.2 63.9 45.7 18.6 37.8 50.2 67.8 60.0 31.2 34.9 28.2 44.1 102.4 69.1 20.4 49.8 34.3 16.9 31.3 73.4 55.5 33.0 45.8 63.2 59.9 44.6 37.4 34.2 44.1 67.7 111.4 26.0 39.3 19.4 19.4 46.1 37.8 24.9 64.9 41.9 42.6 62.8 26.4 24.3 70.5 64.6 52.2 19.9 56.0 81.0 58.5 72.7 41.0 50.8 112.6 69.2 103.5 58.0 60.5 35.3 67.3 3.6 2.0 2.4 4.8 5.3 4.9 3.2 3.5 4.0 2.3 3.6 3.5 4.0 1.3 3.7 6.1 2.6 3.1 2.6 21.7 27.9 21.2 22.7 28.2 28.0 27.1 30.3 21.3 28.6 22.5 29.0 31.2 37.6 19.2 41.2 20.9 75.6 29.4 33.7 38.5 34.7 24.4 39.4 20.2 35.1 40.0 53.8 53.3 12.5 26.2 81.0 53.9 56.7 27.6 55.6 35.1 35.7 33.4 33.5 51.6 37.0 23.2 38.1 25.5 43.3 44.4 45.7 23.3 31.1 85.1 30.0 23.5 27.4 34.1 48.8 73.5 47.5 58.4 21.5 60.0 28.4 33.7 58.0 14.6 74.2 20.6 29.5 40.4 33.0 19.5 47.2 59.9 60.8 62.2 50.9 23.0 0.0 29.2 27.8 25.1 29.6 45.2 24.6 22.4 69.4 31.4 39.3 58.3 ATG10 "APG10L, DKFZP586I0418, FLJ13954" ENSG00000152348 "Autophagy related 10" Q9H0Y0 5 81972023-82276857 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044163 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA044163: AB_2678842" "unprognostic (1.20e-1)" "unprognostic (7.96e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (3.18e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (5.60e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.21e-1)" "unprognostic (9.62e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-3)" "unprognostic (4.43e-1)" 4.0 5.5 5.0 4.1 5.4 5.6 7.1 8.4 5.8 3.4 7.4 5.6 3.3 4.7 7.9 5.0 4.3 4.3 4.7 5.4 6.1 5.7 6.6 3.7 3.6 6.0 4.9 5.1 3.3 4.4 11.7 4.1 4.7 6.0 5.7 6.2 3.5 3.8 5.7 7.3 6.7 3.3 5.6 5.4 4.2 4.5 10.4 5.2 7.8 7.2 3.2 4.3 4.0 3.9 8.0 4.7 12.6 7.9 23.0 5.3 10.0 20.1 5.4 4.4 3.9 6.0 3.7 16.7 8.4 4.4 8.8 29.7 2.5 5.9 12.2 5.1 14.4 4.2 9.2 11.4 4.0 5.0 4.8 7.3 9.3 8.2 5.7 4.7 6.0 7.4 17.7 11.3 6.8 14.4 9.5 11.0 5.2 11.0 3.5 8.2 8.0 11.5 20.1 10.0 6.7 11.8 16.9 8.8 4.9 10.0 13.6 9.4 8.9 6.0 7.0 6.6 3.8 11.5 9.4 17.0 11.5 9.8 11.4 11.7 2.7 5.7 8.5 5.1 5.8 4.8 3.6 4.5 4.8 7.5 4.5 4.2 5.2 7.4 6.5 4.3 5.6 5.0 4.1 5.0 5.4 8.4 5.8 5.4 6.1 6.0 4.9 5.1 6.0 5.4 5.2 8.0 8.1 16.0 15.6 69.2 9.3 24.9 17.4 16.3 14.2 16.3 15.6 14.4 9.3 12.8 16.7 12.9 10.4 25.5 9.7 8.2 15.6 15.7 67.6 7.7 11.4 13.0 9.6 14.5 56.4 18.4 46.3 15.1 6.6 9.7 11.4 22.1 10.0 12.8 18.3 18.5 52.2 7.8 4.1 14.1 28.4 96.6 6.8 12.3 32.0 57.1 17.2 12.5 15.5 67.8 76.5 15.2 9.9 10.1 10.1 12.0 8.5 18.8 8.8 15.2 0.0 18.2 13.6 54.1 22.9 13.8 32.0 21.1 14.3 15.6 11.5 14.0 POC5 "C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444" ENSG00000152359 "POC5 centriolar protein" Q8NA72 5 75674124-75717448 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 102.7;Late spermatids: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037509, HPA037510, HPA061521" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263" "unprognostic (1.33e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-1)" "unprognostic (8.62e-2)" "unprognostic (1.26e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.60e-7)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (2.97e-1)" "unprognostic (4.62e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "prognostic favorable (1.09e-4)" 5.4 6.2 5.9 6.1 8.3 10.2 9.6 7.5 8.2 7.4 5.0 5.2 4.6 7.7 8.3 3.9 9.0 4.5 3.9 5.9 7.3 4.6 4.5 6.0 11.5 7.3 7.2 5.4 11.3 5.1 5.8 3.3 5.9 7.8 6.9 6.4 29.5 4.4 5.3 3.9 6.1 6.0 7.4 6.6 9.8 5.5 20.2 7.1 14.4 5.8 3.5 11.1 5.7 5.6 11.1 16.1 12.4 20.5 20.4 8.7 7.0 15.0 14.9 8.9 25.9 19.4 18.3 14.3 21.5 27.9 8.4 34.8 14.8 18.3 14.8 19.3 23.3 12.7 14.1 9.3 10.2 11.7 16.2 26.3 7.8 14.3 19.6 32.4 8.7 10.5 21.6 13.8 38.1 12.2 19.1 26.3 20.5 8.9 3.6 10.9 16.5 17.0 25.8 11.9 7.8 16.1 17.7 14.0 7.6 15.7 10.3 14.5 18.5 4.5 8.7 19.2 15.3 30.5 23.4 53.1 31.6 13.2 21.3 21.1 8.1 10.0 23.1 14.6 11.2 12.9 15.1 14.5 15.5 15.2 18.0 14.8 14.4 10.0 18.5 9.0 17.1 21.5 8.7 5.9 8.3 7.5 8.2 5.9 7.3 7.3 7.2 5.4 7.8 6.6 7.1 11.1 5.9 6.4 11.1 6.2 8.3 2.7 3.0 8.2 5.2 12.3 5.2 6.2 3.9 8.6 6.3 7.3 12.5 7.4 12.2 3.6 9.8 7.7 102.7 12.3 8.4 5.8 4.9 13.5 18.4 6.9 7.7 6.1 6.1 5.7 2.5 8.1 6.1 3.6 6.3 10.1 9.4 4.0 10.2 5.4 4.8 53.3 6.2 6.0 3.6 14.0 4.0 5.9 10.3 9.0 32.1 5.5 2.5 7.2 10.5 2.5 3.2 5.1 19.9 39.0 6.6 3.8 6.0 36.8 15.7 6.4 2.8 4.1 10.8 9.6 5.5 1.7 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 175.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 252.8;Inhibitory neurons: 349.9;Muller glia cells: 243.8;Oligodendrocyte precursor cells: 273.4;Oligodendrocytes: 913.1;Peritubular cells: 150.1" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 573.1;hTERT-RPE1: 1112.8;HUVEC TERT2: 594.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.77e-5)" "prognostic unfavorable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 25.1 41.8 70.4 4.1 100.9 0.3 19.2 125.3 118.9 25.8 20.0 18.7 1.2 44.5 34.6 6.1 18.7 18.7 54.7 104.9 84.2 24.5 0.2 2.9 0.6 94.8 106.0 69.9 4.9 5.6 13.9 9.9 9.3 99.5 66.2 3.2 49.1 7.7 25.7 17.7 7.6 4.6 31.0 72.2 8.6 9.1 21.9 110.6 7.5 9.5 7.2 0.4 11.4 21.9 175.0 4.6 0.9 299.4 0.4 573.1 116.0 0.4 100.6 90.0 207.7 115.9 0.0 0.6 0.4 0.2 206.7 53.3 4.4 1.4 70.3 65.3 17.8 0.6 0.2 16.7 0.0 4.0 0.0 0.4 203.8 28.5 128.6 23.2 1112.8 594.4 0.2 0.0 0.4 60.5 0.5 0.0 0.2 19.1 0.0 28.4 0.0 0.2 0.0 140.3 9.4 3.7 14.4 49.9 0.8 0.1 35.6 0.4 1.2 98.9 294.0 10.6 102.1 28.5 0.1 0.1 0.1 159.4 4.4 136.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 70.4 100.9 125.3 118.9 104.9 84.2 94.8 106.0 69.9 99.5 72.2 110.6 175.0 2.0 0.0 0.0 91.7 0.0 1.8 1.6 5.8 0.0 9.7 0.4 0.4 58.8 1.5 0.4 22.0 2.1 0.4 0.0 0.2 1.9 0.6 12.0 4.2 37.9 8.4 35.0 0.0 252.8 1.4 0.3 58.8 0.0 2.9 0.0 0.1 1.1 0.0 0.9 8.4 349.9 0.1 16.2 1.2 3.0 9.5 17.4 1.6 7.2 17.8 2.3 243.8 0.0 273.4 913.1 2.0 0.1 150.1 0.1 40.9 0.0 3.1 0.9 7.3 13.1 11.6 16.4 7.4 7.1 0.7 1.4 0.1 0.4 0.0 0.3 3.2 FAM151B UNQ9217 ENSG00000152380 "Family with sequence similarity 151 member B" Q6UXP7 5 80487969-80542563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.8;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 18.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043805 Uncertain Approved Cytosol NA NA Cytosol "HPA043805: AB_10794287" "unprognostic (1.29e-1)" "unprognostic (7.11e-2)" "unprognostic (1.67e-3)" "unprognostic (1.28e-4)" "unprognostic (1.90e-2)" "unprognostic (4.46e-4)" "unprognostic (2.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.10e-2)" "unprognostic (9.63e-2)" "unprognostic (1.20e-1)" "unprognostic (3.44e-2)" "unprognostic (6.86e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-1)" "unprognostic (2.50e-2)" "unprognostic (1.63e-1)" 0.7 1.0 0.8 0.7 1.0 4.7 0.7 0.4 1.0 0.8 0.4 0.4 0.4 0.6 0.9 0.5 1.3 0.9 0.9 1.0 0.5 1.2 0.9 0.7 0.3 0.9 0.5 0.7 0.6 0.6 1.1 0.7 1.8 0.4 0.8 0.6 1.1 0.4 0.5 0.3 0.3 0.3 0.9 0.4 0.7 0.5 0.7 0.8 0.2 0.8 0.3 0.4 0.7 0.5 0.8 0.1 1.5 0.7 3.2 2.6 3.7 1.0 1.3 1.9 1.1 2.4 0.1 1.2 0.0 0.2 3.4 3.4 0.8 1.1 0.2 0.9 0.3 0.7 0.3 0.5 0.3 1.1 0.5 1.7 1.8 1.1 1.2 0.1 2.1 1.7 0.4 0.1 0.5 1.8 1.1 0.2 0.2 0.1 0.3 0.6 0.4 2.6 0.4 1.3 0.5 0.3 0.7 0.4 1.2 1.1 0.3 1.7 1.4 0.7 0.2 0.2 0.0 0.5 0.0 0.7 0.0 1.8 1.4 1.1 0.0 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 1.0 0.4 1.0 1.0 0.5 0.9 0.5 0.7 0.4 0.4 0.8 0.8 0.3 0.0 0.0 3.6 0.4 0.3 0.5 2.2 0.6 1.0 1.4 0.8 1.8 2.8 1.7 3.7 0.0 7.9 0.1 0.3 0.0 1.5 4.1 3.9 1.3 0.9 0.0 0.0 17.8 2.1 6.7 2.0 1.5 2.6 1.3 1.1 0.4 0.3 5.1 1.7 21.6 0.5 0.0 4.8 1.2 1.9 1.2 3.6 0.0 6.5 2.2 1.5 0.0 18.6 8.5 0.3 0.3 0.4 1.3 0.7 0.6 4.3 3.7 0.8 0.0 1.2 0.8 4.7 0.9 1.0 1.0 7.9 0.1 1.3 0.2 0.6 TADA1 "ADA1, hADA1, HFI1, STAF42, TADA1L" ENSG00000152382 "Transcriptional adaptor 1" Q96BN2 1 166856510-166876264 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028651 Approved Supported "Nucleoplasm,Focal adhesion sites,Cytosol" No No Nucleoplasm "Focal adhesion sites, Cytosol" "HPA028651: AB_10602476" "unprognostic (9.53e-3)" "unprognostic (2.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (7.09e-2)" "unprognostic (5.99e-3)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.98e-2)" "unprognostic (3.64e-2)" "unprognostic (2.73e-2)" "unprognostic (6.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-2)" 5.2 9.0 10.2 6.2 11.5 19.6 9.3 11.1 12.3 7.8 9.0 8.5 7.7 9.4 7.6 8.4 8.7 5.3 8.7 10.9 10.7 11.7 27.0 6.2 10.5 9.3 10.0 10.6 11.1 6.5 11.0 6.3 8.2 10.0 8.0 9.2 17.1 8.2 7.2 9.9 8.0 8.5 7.6 9.6 7.0 7.6 10.9 10.1 13.3 7.6 10.7 10.2 6.7 5.8 12.4 15.7 14.9 27.4 16.3 8.1 10.4 16.2 8.1 9.9 13.2 11.4 13.7 12.5 29.9 15.4 9.6 10.7 11.8 22.3 14.3 10.6 18.9 21.3 9.9 11.9 22.5 12.0 28.3 17.4 7.9 16.3 8.0 19.9 9.6 11.0 22.2 35.9 17.6 10.5 10.9 34.9 22.5 41.6 25.2 16.5 29.1 12.0 37.9 18.0 20.9 17.5 30.6 14.6 18.7 17.5 25.0 25.3 29.3 8.3 10.8 12.4 11.9 17.3 24.9 36.3 56.3 7.5 12.6 10.4 2.9 12.7 13.8 20.7 12.9 22.9 20.2 22.2 23.6 20.7 20.8 27.9 22.3 2.1 27.5 10.4 13.3 23.4 24.7 10.2 11.5 11.1 12.3 10.9 10.7 9.3 10.0 10.6 10.0 9.6 10.1 12.4 2.7 9.6 2.7 7.8 8.4 6.1 4.7 3.9 6.2 7.6 4.9 4.6 10.3 2.8 4.1 3.7 8.4 6.1 4.9 4.4 5.9 3.9 4.0 4.8 4.6 4.3 7.2 13.7 9.6 4.0 7.7 4.8 6.6 4.4 5.1 6.1 3.3 20.3 4.2 1.7 10.5 6.1 0.0 5.3 5.1 1.7 4.4 2.6 1.8 3.7 6.9 6.8 4.1 7.5 17.7 3.8 1.7 3.0 7.5 6.2 5.3 7.0 4.3 6.0 0.0 6.1 4.1 5.2 12.9 7.6 5.1 7.3 7.3 1.9 5.9 4.2 GUCY1A2 "GC-SA2, GUC1A2" ENSG00000152402 "Guanylate cyclase 1 soluble subunit alpha 2" P33402 11 106674019-107018476 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.0" "Group enriched" "Detected in many" 4 "Excitatory neurons: 353.8;Inhibitory neurons: 141.8;Oligodendrocyte precursor cells: 208.6;Sertoli cells: 105.2;Smooth muscle cells: 107.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.8;BJ hTERT+ SV40 Large T+ RasG12V: 13.4;HBF TERT88: 7.1;TIME: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009534 Uncertain NA NA "CAB009534: AB_2279509" "unprognostic (7.53e-2)" "unprognostic (6.67e-2)" "unprognostic (7.99e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-2)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (6.53e-3)" "unprognostic (9.70e-3)" "unprognostic (8.00e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.48e-4)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" 3.3 2.0 3.1 0.6 13.9 0.0 1.9 1.8 14.1 12.8 0.0 0.6 0.2 12.4 3.2 0.4 6.0 1.5 1.8 8.0 14.9 1.8 1.7 4.6 0.7 4.6 3.2 6.0 1.2 4.3 0.7 0.5 18.0 6.5 1.9 0.5 3.5 0.6 6.8 1.8 0.5 0.4 13.2 0.5 6.0 0.3 1.7 8.7 0.2 1.4 3.6 0.3 0.9 2.8 7.8 0.0 0.2 4.0 0.0 0.2 2.4 2.2 0.3 11.8 1.5 13.4 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.1 0.0 7.1 0.0 1.1 0.0 0.1 0.0 0.2 0.0 1.6 0.6 0.0 1.8 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 3.6 0.0 0.7 0.5 0.8 0.2 4.6 3.7 3.0 0.8 1.2 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 13.9 1.8 14.1 8.0 14.9 4.6 3.2 6.0 6.5 0.5 8.7 7.8 29.5 0.0 0.5 20.2 0.5 1.7 2.2 0.0 1.2 24.0 0.4 0.9 5.1 0.0 0.0 3.7 12.5 0.1 0.0 0.1 0.0 5.8 2.5 0.9 24.2 12.5 0.0 2.7 353.8 0.2 0.0 8.2 0.0 1.1 0.0 42.7 2.2 0.2 0.4 18.5 141.8 0.0 0.0 0.8 1.5 6.5 24.5 1.1 3.6 18.7 0.0 29.3 0.0 208.6 10.7 0.3 0.0 25.2 1.2 2.4 0.0 0.1 0.0 4.8 105.2 20.7 107.0 1.6 1.5 0.7 1.1 0.3 0.5 19.6 0.0 1.5 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like cell cycle control factor 2" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 8.9 5.9 15.9 6.3 17.0 8.2 11.4 20.8 31.1 8.8 17.9 6.4 5.0 11.0 8.3 6.5 7.5 6.0 5.4 16.2 16.4 11.3 8.6 7.2 10.4 16.5 16.3 14.4 14.3 6.0 7.8 4.8 8.4 17.6 8.4 6.2 8.6 6.2 8.6 7.0 7.3 5.5 7.0 16.2 9.9 6.7 5.9 16.5 11.9 9.8 8.5 11.1 7.0 6.8 18.2 7.4 5.9 12.5 6.0 10.2 11.5 9.4 9.5 8.8 7.3 9.7 13.9 17.0 12.8 17.7 6.7 9.3 17.6 14.0 7.3 12.7 14.4 7.8 14.2 6.6 9.1 6.6 16.9 11.5 5.9 12.6 8.5 12.7 8.4 10.0 7.6 21.9 7.2 10.7 5.5 13.1 15.3 11.9 12.2 8.3 11.3 11.9 17.3 8.6 9.0 7.2 6.0 13.9 10.3 5.4 10.5 13.8 8.0 9.1 12.1 9.7 6.4 8.6 3.8 7.5 12.3 3.5 16.4 11.3 45.6 10.1 19.3 14.2 9.3 15.7 29.4 16.5 14.4 4.5 27.6 19.9 15.3 19.4 17.4 10.4 19.2 15.7 4.3 15.9 17.0 20.8 31.1 16.2 16.4 16.5 16.3 14.4 17.6 16.2 16.5 18.2 56.2 38.5 53.2 38.5 66.1 17.8 16.1 19.1 18.2 97.2 24.2 21.0 28.9 57.2 33.2 82.8 95.9 24.0 57.9 18.3 33.2 22.1 3.1 31.8 39.8 40.8 13.1 23.8 42.3 18.4 22.8 29.3 17.3 34.0 46.2 35.2 51.4 56.1 15.8 69.0 37.4 27.0 14.2 33.7 15.4 9.5 54.3 24.5 14.2 43.1 32.7 47.5 69.0 42.3 68.1 16.3 31.6 63.9 36.1 6.7 25.6 60.5 18.3 131.8 39.5 41.1 30.8 48.0 47.2 9.1 13.4 17.0 55.3 21.4 21.3 7.8 JMY "FLJ37870, WHAMM2" ENSG00000152409 "Junction mediating and regulatory protein, p53 cofactor" Q8N9B5 5 79236131-79327211 "Predicted intracellular proteins" "DNA damage, DNA repair" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 25.2;Karpas-707: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037508, HPA043308" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037508: , HPA043308: AB_10806502" "unprognostic (1.87e-2)" "unprognostic (2.12e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-1)" "unprognostic (4.30e-2)" "unprognostic (5.28e-3)" "unprognostic (2.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (3.03e-5)" "unprognostic (7.21e-2)" "unprognostic (3.22e-1)" "unprognostic (1.85e-1)" "unprognostic (4.15e-1)" 4.3 5.0 6.3 3.5 7.4 10.4 5.9 9.3 8.0 7.3 5.2 8.9 3.2 11.9 7.1 5.0 5.4 4.8 5.0 6.5 6.2 6.5 5.3 4.0 4.3 6.8 6.9 6.6 13.5 9.5 11.5 4.9 3.2 7.1 6.4 4.3 11.9 7.4 5.9 9.0 6.5 4.5 7.3 6.3 4.9 5.2 7.3 7.5 5.6 10.3 7.7 4.2 6.1 5.7 8.3 3.8 3.6 2.7 7.1 7.4 6.7 9.5 3.5 9.1 3.2 5.1 1.7 4.1 2.6 25.2 4.0 3.7 4.1 9.6 4.7 5.1 11.5 8.8 5.2 5.9 3.6 11.3 2.3 3.3 6.4 12.3 1.5 13.9 6.6 4.0 6.9 3.2 43.7 2.7 5.0 5.0 4.9 4.5 0.8 2.4 4.9 8.7 11.2 6.9 3.9 10.7 5.8 4.5 4.9 8.3 4.5 4.0 4.8 4.2 1.4 2.4 0.8 2.3 12.3 11.5 2.6 2.8 2.3 2.3 0.0 0.1 0.0 0.3 0.1 0.2 0.2 0.3 0.3 0.0 0.1 0.4 0.3 0.1 0.9 0.0 0.2 0.3 0.0 6.3 7.4 9.3 8.0 6.5 6.2 6.8 6.9 6.6 7.1 6.3 7.5 8.3 18.9 9.6 14.9 35.6 36.7 29.8 11.3 11.0 24.5 35.7 14.9 13.7 40.7 15.7 17.4 16.5 43.8 6.4 49.8 6.1 1.9 8.1 35.6 36.3 35.2 16.7 23.9 18.7 55.5 9.8 5.4 24.6 15.8 53.9 8.2 28.8 8.6 15.4 4.4 40.4 53.6 8.3 10.2 9.3 21.0 21.5 24.2 35.8 23.2 15.9 5.2 20.5 9.2 47.7 42.5 10.7 7.6 35.7 85.2 21.4 6.8 7.8 24.9 40.8 13.1 29.6 27.7 37.1 39.2 19.8 39.8 20.2 56.5 34.6 7.6 17.6 HOMER1 "HOMER-1B, SYN47, Ves-1" ENSG00000152413 "Homer scaffold protein 1" Q86YM7 5 79372636-79514134 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2;skeletal muscle: 34.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 440.0;Inhibitory neurons: 112.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004437, HPA036521, HPA036522" Enhanced Supported Approved Cytosol No No Cytosol "CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171" "unprognostic (2.80e-1)" "unprognostic (5.30e-2)" "unprognostic (4.00e-2)" "unprognostic (5.79e-2)" "unprognostic (8.83e-2)" "unprognostic (6.40e-2)" "unprognostic (2.00e-3)" "unprognostic (2.41e-3)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (3.07e-3)" "unprognostic (3.98e-1)" "unprognostic (7.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (2.83e-2)" "unprognostic (2.86e-3)" 2.9 1.3 2.9 2.3 11.5 0.3 2.5 10.7 28.2 3.9 0.0 1.1 0.7 6.8 4.1 4.7 1.7 6.8 20.7 16.7 5.6 5.8 1.7 5.1 1.1 1.4 3.8 7.9 3.9 2.2 4.2 2.3 5.5 5.8 1.7 1.0 5.8 1.3 1.7 34.3 2.4 0.8 4.8 0.3 0.9 2.0 5.4 3.0 1.4 15.2 13.0 1.5 8.1 1.7 12.4 14.6 9.8 14.5 23.1 5.4 3.6 33.5 9.0 7.2 9.0 9.6 15.5 9.9 0.2 26.9 7.8 16.2 7.7 18.2 24.5 15.4 2.2 14.3 17.3 3.9 15.7 8.8 8.3 5.4 5.8 15.4 8.1 22.4 3.6 4.3 26.4 21.7 9.3 11.7 20.4 34.8 5.7 24.5 5.2 8.4 22.4 23.8 22.2 9.6 22.3 14.7 8.8 17.2 12.0 9.3 16.0 16.5 7.2 0.7 6.6 16.7 8.0 16.1 4.5 10.8 8.5 18.8 3.3 13.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.1 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 2.9 11.5 10.7 28.2 16.7 5.6 1.4 3.8 7.9 5.8 0.3 3.0 12.4 4.3 51.3 9.6 21.9 12.1 64.2 28.0 8.5 20.5 24.4 25.6 18.2 95.2 7.2 12.1 16.5 27.1 58.4 20.3 4.3 11.7 4.8 4.7 30.6 24.9 9.5 11.4 0.4 440.0 4.3 44.8 19.3 5.6 39.9 5.7 16.9 4.6 6.9 11.9 52.2 112.1 7.5 10.2 9.6 29.7 5.5 5.6 13.9 21.4 31.9 3.0 4.4 8.2 86.0 19.3 5.5 2.7 8.6 8.9 23.3 3.1 7.0 10.8 8.1 13.1 29.7 19.3 6.9 10.3 23.9 54.8 84.4 9.8 10.2 3.0 25.2 XRCC4 ENSG00000152422 "X-ray repair cross complementing 4" Q13426 5 83077498-83353787 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 80.8;Pancreatic endocrine cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 61.6" "Low region specificity" "Detected in all" "HPA006801, HPA051538" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006801: AB_1858899, HPA051538: AB_2681526" "prognostic unfavorable (1.80e-5)" "unprognostic (3.05e-2)" "unprognostic (5.12e-2)" "unprognostic (3.91e-3)" "unprognostic (1.55e-1)" "unprognostic (1.69e-1)" "unprognostic (1.44e-3)" "unprognostic (2.23e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-2)" "unprognostic (2.38e-2)" "unprognostic (8.24e-2)" "unprognostic (4.46e-2)" "unprognostic (1.79e-1)" "unprognostic (1.97e-1)" "unprognostic (2.34e-1)" "unprognostic (6.91e-2)" 4.5 4.3 2.9 6.1 3.3 4.5 6.2 3.2 3.9 3.2 2.9 5.9 7.6 3.6 3.2 3.9 4.0 5.2 7.2 3.3 3.7 7.3 5.5 4.7 8.5 3.4 3.2 2.7 2.3 2.5 2.5 2.1 5.4 3.4 4.0 5.7 2.4 3.4 4.3 2.6 3.3 5.1 3.9 3.3 4.9 4.3 8.9 3.1 10.4 4.4 2.5 9.0 5.6 2.9 3.6 15.1 11.7 14.1 12.5 7.8 11.3 13.2 13.7 11.2 14.8 17.3 10.0 21.8 20.9 10.3 11.0 21.2 12.8 9.4 30.7 24.2 10.0 11.8 11.1 8.3 12.4 5.2 12.5 17.2 7.9 14.3 19.3 10.8 15.6 12.4 13.8 8.2 9.8 17.6 12.1 23.1 16.0 7.9 8.8 17.2 19.0 61.6 20.7 14.1 6.8 9.2 11.8 8.9 6.5 18.4 11.8 13.2 19.5 7.8 8.2 17.6 8.9 19.0 7.8 12.3 26.6 14.8 22.2 13.5 17.6 17.3 12.4 5.9 25.8 6.1 9.3 6.2 6.5 13.6 8.8 8.3 6.8 16.5 15.2 25.4 10.1 7.7 9.1 2.9 3.3 3.2 3.9 3.3 3.7 3.4 3.2 2.7 3.4 3.3 3.1 3.6 10.4 16.0 5.5 39.8 13.0 5.4 13.2 28.0 5.2 4.7 5.5 5.0 15.3 8.6 19.2 5.5 0.0 17.4 12.9 7.6 15.6 17.4 10.2 14.8 12.6 8.9 0.0 6.3 16.6 28.4 38.9 11.6 11.2 10.0 10.8 11.9 11.4 5.5 19.1 1.7 18.7 7.8 22.4 20.7 12.1 5.9 7.8 20.5 8.8 30.9 25.1 7.8 14.4 53.3 80.8 65.7 6.7 7.2 11.3 4.4 7.2 26.5 16.9 4.5 0.0 4.6 11.9 33.1 25.3 7.1 4.4 11.9 12.6 8.0 6.2 8.2 BOLL BOULE ENSG00000152430 "Boule homolog, RNA binding protein" Q8N9W6 2 197726879-197786762 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 49.4" "Cell type enhanced" "Detected in some" "Early spermatids: 178.2;Late spermatids: 129.3;Spermatocytes: 327.7;Spermatogonia: 63.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "T-reg: 1.5" "Lineage enriched" "Detected in single" 9 "T-cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018678, HPA048813" Enhanced NA NA "HPA018678: AB_1845411, HPA048813: AB_2680529" "unprognostic (3.55e-2)" "unprognostic (1.69e-1)" "unprognostic (6.05e-2)" "unprognostic (3.08e-2)" "unprognostic (7.93e-2)" "unprognostic (3.20e-1)" "unprognostic (3.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.08e-1)" "unprognostic (9.49e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 129.3 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.3 327.7 63.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 ZNF547 FLJ31100 ENSG00000152433 "Zinc finger protein 547" Q8IVP9 19 57363477-57379565 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 10.7;Excitatory neurons: 13.0;Inhibitory neurons: 13.2;Ionocytes: 8.2;Oligodendrocyte precursor cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 9.2" HPA056001 Uncertain NA NA "HPA056001: AB_2683005" "unprognostic (9.21e-2)" "unprognostic (6.44e-2)" "unprognostic (1.94e-1)" "unprognostic (4.33e-3)" "unprognostic (1.85e-1)" "unprognostic (4.97e-3)" "unprognostic (3.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.29e-1)" "unprognostic (5.23e-3)" "unprognostic (4.39e-5)" "unprognostic (7.16e-4)" "unprognostic (4.45e-3)" "unprognostic (1.69e-1)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (6.62e-4)" 1.5 3.7 4.6 1.6 4.8 0.9 2.6 8.6 5.2 1.2 4.3 1.8 0.9 1.3 3.4 2.0 1.8 1.7 2.7 4.5 4.5 2.4 1.8 1.5 2.5 4.1 4.9 4.5 2.1 2.1 2.4 4.9 2.4 5.3 3.0 1.6 5.2 2.0 2.5 2.4 4.2 1.9 1.3 4.0 4.5 1.5 3.2 4.6 2.4 3.2 1.4 3.6 1.4 1.1 4.9 1.0 1.2 3.3 4.3 3.9 1.7 1.5 2.5 3.1 2.3 5.8 1.2 0.6 2.8 1.5 1.3 1.1 0.7 2.0 1.0 3.5 0.6 9.2 1.9 4.7 2.3 1.1 1.7 4.0 1.8 4.3 1.3 2.9 4.7 1.3 3.0 0.4 0.1 4.0 0.1 3.0 1.1 1.5 0.1 2.6 1.3 3.7 0.7 1.8 4.5 3.0 2.3 1.6 0.4 1.3 2.7 1.7 2.6 3.9 4.2 1.2 1.5 2.2 1.9 1.0 1.6 1.8 1.1 2.1 2.6 1.7 1.2 1.1 2.5 2.5 4.8 1.7 1.7 1.9 3.2 2.3 1.8 1.2 2.7 1.4 2.4 0.9 1.4 4.6 4.8 8.6 5.2 4.5 4.5 4.1 4.9 4.5 5.3 4.0 4.6 4.9 1.4 0.0 0.0 10.7 2.6 0.6 0.9 1.9 0.6 1.6 1.3 2.3 2.3 0.0 2.0 1.8 6.2 1.7 2.3 0.1 1.9 0.8 3.3 0.6 0.5 1.8 0.0 5.3 13.0 0.2 0.3 0.8 0.5 0.5 7.0 1.5 0.7 0.6 1.2 0.0 13.2 0.3 8.2 0.8 0.0 0.5 0.0 0.5 0.0 2.8 0.1 1.3 3.1 8.5 4.8 0.5 0.3 1.2 0.3 0.8 0.2 0.4 1.9 1.4 0.0 0.5 1.1 3.8 3.4 1.6 0.6 3.0 1.2 1.3 0.4 0.5 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 3.7 4.4 4.5 3.1 4.2 6.7 6.1 6.5 4.8 2.9 3.1 3.7 4.6 3.3 5.6 2.8 4.3 2.9 3.2 4.2 4.0 4.2 2.5 3.8 4.9 4.1 3.4 5.2 6.0 2.4 7.0 4.4 4.5 4.7 4.9 3.6 5.2 3.9 3.8 4.6 5.3 3.5 3.8 2.7 5.7 3.6 4.5 3.7 5.4 6.2 3.3 5.6 3.3 2.7 5.2 2.3 4.3 7.0 9.7 4.9 6.4 0.4 7.1 10.0 6.1 24.8 4.3 3.6 4.5 3.7 4.3 4.6 1.8 3.6 7.6 9.0 0.2 22.8 8.0 0.6 2.7 8.9 5.9 6.2 14.0 9.9 4.5 15.8 7.8 4.4 8.2 0.3 0.8 7.8 0.6 11.3 4.3 7.7 1.2 12.8 6.4 11.6 6.9 4.3 8.7 7.4 9.4 1.3 3.2 6.9 6.6 5.4 10.7 3.7 9.5 4.3 2.5 7.5 10.9 12.7 7.3 3.8 5.7 8.3 30.4 6.4 10.7 10.6 5.0 17.7 15.3 13.2 11.7 8.8 19.2 21.4 17.2 2.8 13.0 4.4 9.3 10.1 7.9 4.5 4.2 6.5 4.8 4.2 4.0 4.1 3.4 5.2 4.7 2.7 3.7 5.2 3.2 0.0 2.6 2.9 6.6 1.0 2.7 1.8 1.8 5.2 2.0 2.0 1.3 2.8 3.9 0.0 6.2 3.0 2.3 0.0 3.9 2.4 0.6 1.3 1.7 3.4 0.0 2.1 6.2 0.7 0.9 2.0 1.5 1.0 1.3 3.9 3.6 0.9 0.9 6.7 5.1 0.9 4.1 1.6 1.2 0.3 1.2 1.5 1.8 0.0 1.7 4.2 3.1 3.5 3.6 1.1 1.7 3.8 2.1 2.3 1.0 0.8 0.8 7.5 13.1 2.3 2.6 4.5 7.7 2.0 0.6 2.9 5.3 4.8 0.9 2.3 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746815-57758148 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: AB_2686002" "unprognostic (6.73e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 4.4 6.5 5.4 5.2 5.7 17.4 9.2 10.3 6.3 6.7 4.9 6.0 6.4 5.1 21.8 5.1 7.0 4.0 7.1 5.5 4.4 7.8 6.8 6.3 8.4 5.0 4.6 5.2 8.3 4.7 10.9 8.3 7.8 6.8 8.5 6.8 20.9 7.9 7.7 9.2 6.5 6.0 4.2 3.9 8.2 7.7 6.7 4.7 12.7 9.4 10.4 8.3 5.6 5.4 8.3 6.2 5.3 16.7 11.2 2.6 8.2 7.2 5.0 8.3 8.7 5.6 3.2 6.8 7.2 4.4 4.6 4.6 4.1 8.8 8.7 13.8 6.5 32.1 9.8 12.6 3.7 6.2 5.5 7.5 9.5 7.1 5.8 6.2 9.2 6.7 11.6 6.6 5.0 11.2 2.9 18.2 4.9 9.7 2.8 11.0 11.6 12.7 8.3 6.4 20.0 18.7 13.7 9.3 7.7 5.5 9.0 7.9 7.7 6.2 9.2 4.9 0.8 7.6 13.8 16.8 12.1 5.5 5.1 7.7 6.6 1.8 8.9 1.1 1.3 2.7 2.4 1.9 2.4 1.7 3.7 2.8 2.2 4.6 5.6 1.7 1.9 1.8 1.6 5.4 5.7 10.3 6.3 5.5 4.4 5.0 4.6 5.2 6.8 3.9 4.7 8.3 3.3 3.2 4.1 7.2 7.1 2.7 4.1 3.9 1.8 8.7 7.7 5.3 12.3 11.5 3.2 9.2 2.1 3.1 2.5 3.9 5.9 3.3 1.4 8.3 3.7 6.5 8.4 8.6 7.1 1.3 2.3 2.8 4.1 6.9 3.8 6.9 10.4 8.1 3.5 11.8 7.7 4.1 6.1 6.0 1.8 0.6 1.2 3.6 0.0 6.5 3.1 12.0 5.2 8.0 9.1 2.5 2.1 4.9 3.9 4.1 3.9 2.8 6.0 7.5 0.0 2.6 3.9 2.9 4.8 3.1 1.7 2.9 3.3 2.9 3.2 5.5 ZNF256 BMZF-3 ENSG00000152454 "Zinc finger protein 256" Q9Y2P7 19 57940833-57947706 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8" HPA055390 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA055390: AB_2682803" "unprognostic (2.47e-2)" "unprognostic (3.43e-2)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (2.95e-2)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (3.38e-1)" "unprognostic (3.49e-3)" "unprognostic (2.32e-2)" "unprognostic (4.73e-3)" "unprognostic (2.83e-2)" "unprognostic (6.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.27e-1)" "unprognostic (3.28e-3)" 3.4 2.6 2.5 2.3 2.8 10.9 5.7 5.9 3.3 2.9 2.5 3.0 2.3 3.5 4.4 2.7 4.0 1.9 5.7 2.7 1.9 3.0 1.8 3.2 5.0 2.1 2.1 2.5 5.6 2.1 4.4 2.8 4.6 2.8 3.8 2.9 9.1 3.3 4.0 3.7 6.4 3.5 3.5 1.9 4.7 2.6 4.3 1.9 5.4 3.9 4.2 5.3 3.1 2.8 2.6 3.9 1.3 9.6 9.7 2.0 3.3 8.3 3.3 3.5 5.2 3.5 0.8 2.1 0.0 2.9 4.3 8.0 0.5 2.2 7.4 8.5 0.0 32.8 9.5 0.0 2.6 3.7 0.0 7.4 6.5 2.0 3.8 0.0 5.4 3.2 9.1 0.7 0.0 5.3 0.9 13.2 0.0 11.6 0.4 8.2 4.2 12.0 5.9 3.8 16.8 4.8 6.9 0.0 3.0 2.4 11.8 7.2 3.0 1.3 10.7 6.3 0.0 6.5 4.4 4.7 16.9 0.3 0.0 4.7 1.3 1.0 1.3 3.3 3.4 6.1 4.7 5.6 5.0 4.2 5.6 5.4 6.4 0.5 3.9 3.6 2.0 4.9 2.2 2.5 2.8 5.9 3.3 2.7 1.9 2.1 2.1 2.5 2.8 1.9 1.9 2.6 2.4 0.0 0.0 2.0 4.0 2.7 4.8 3.5 2.2 4.5 2.4 1.4 3.2 1.5 1.7 1.8 0.0 3.1 2.2 0.4 3.9 3.5 0.2 1.2 1.1 2.7 1.2 5.2 1.6 0.8 1.7 2.0 1.1 1.3 0.0 2.2 0.7 0.7 1.4 1.7 1.4 0.9 8.2 0.8 1.0 0.3 1.8 0.8 0.0 1.0 1.7 3.8 1.0 3.5 0.6 0.8 0.3 0.4 0.3 2.7 0.8 0.9 3.4 7.2 0.0 2.6 2.1 4.9 8.7 1.6 3.4 2.6 3.1 2.3 1.2 3.7 SUV39H2 "FLJ23414, KMT1B" ENSG00000152455 "Suppressor of variegation 3-9 homolog 2" Q9H5I1 10 14878820-14904315 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 39.6" "Cell type enriched" "Detected in many" 4 "Early spermatids: 421.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045901, HPA057554" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA045901: AB_10960702, HPA057554: AB_2683466" "prognostic unfavorable (5.55e-4)" "unprognostic (1.45e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-3)" "unprognostic (6.80e-2)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (3.59e-3)" "unprognostic (2.42e-1)" "unprognostic (4.13e-3)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" "unprognostic (5.55e-2)" "unprognostic (1.39e-1)" 2.2 1.5 1.7 2.4 1.8 4.7 3.9 8.2 3.3 1.5 1.6 3.0 2.1 2.0 1.6 3.2 2.1 1.7 1.0 2.6 1.4 2.3 3.2 1.3 2.5 1.6 1.7 1.4 2.5 1.9 1.9 1.3 3.9 3.2 2.7 3.5 3.4 1.8 2.3 1.4 1.9 2.6 2.4 1.3 1.5 1.9 39.6 1.4 6.1 1.5 1.3 3.1 3.1 1.4 3.4 28.6 20.8 40.8 24.1 7.5 10.7 16.9 14.8 8.1 24.1 34.6 29.5 15.2 22.4 13.4 5.8 22.6 21.3 27.7 16.4 31.6 22.9 15.1 29.4 14.0 21.5 4.3 14.8 16.2 4.1 5.3 24.2 5.4 6.4 19.0 37.4 41.9 15.2 20.3 19.3 31.3 4.4 28.8 26.6 5.9 38.4 28.1 20.7 10.9 11.0 13.8 16.8 23.9 16.6 11.1 23.8 24.6 11.0 11.6 21.4 31.7 22.9 23.1 9.5 36.1 47.9 12.1 14.8 13.5 0.2 0.3 0.2 1.5 1.1 1.9 0.4 1.1 1.7 1.1 0.3 1.8 1.8 0.3 3.0 0.4 1.8 2.0 0.5 1.7 1.8 8.2 3.3 2.6 1.4 1.6 1.7 1.4 3.2 1.3 1.4 3.4 2.0 0.0 1.5 4.2 2.6 8.3 10.2 6.7 9.1 7.5 4.0 3.7 2.9 2.8 7.5 1.8 10.4 13.9 1.7 1.1 5.9 4.4 421.0 3.4 5.1 4.3 3.5 16.2 8.0 2.2 25.6 5.1 4.1 4.0 2.5 7.8 1.8 3.0 5.0 11.8 7.9 3.1 6.1 1.6 2.8 104.4 4.7 1.8 1.8 2.8 0.7 4.2 3.1 4.5 4.5 2.1 1.7 2.6 7.1 14.5 1.0 7.4 3.5 10.2 6.6 5.8 6.6 47.5 46.6 8.3 8.8 8.9 3.4 8.7 4.5 10.9 DCLRE1C "A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C" ENSG00000152457 "DNA cross-link repair 1C" Q96SD1 10 14897359-14954432 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069295 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA069295: AB_2686112" "unprognostic (8.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.66e-2)" "unprognostic (2.40e-2)" "unprognostic (1.36e-2)" "prognostic favorable (1.30e-4)" "unprognostic (8.02e-4)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic favorable (7.98e-4)" "unprognostic (1.91e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (9.03e-8)" "unprognostic (2.43e-2)" "unprognostic (2.32e-1)" "unprognostic (2.51e-1)" "unprognostic (5.45e-3)" 3.7 3.3 2.3 8.1 3.2 14.1 6.1 5.5 3.4 4.2 3.6 4.3 5.3 4.4 3.8 7.2 3.7 4.1 2.3 2.3 2.6 3.0 2.6 4.9 14.2 2.8 2.9 2.2 4.5 3.1 3.8 2.3 4.5 3.5 4.1 5.2 4.9 4.5 3.8 3.0 6.9 5.4 3.9 2.7 10.5 6.0 1.9 2.8 12.4 5.5 2.7 12.9 5.4 5.1 3.7 16.2 7.8 6.9 13.8 6.4 8.2 6.6 9.7 5.3 13.0 13.5 8.9 13.4 21.7 3.8 7.6 9.2 13.7 7.6 5.1 10.9 13.4 8.0 16.7 8.9 6.0 5.1 10.0 18.4 6.6 4.8 12.7 5.3 8.2 7.4 13.9 10.5 17.4 8.6 7.4 14.9 9.9 4.7 14.4 3.5 17.2 9.2 12.1 6.5 6.0 3.6 6.9 10.7 10.2 27.5 5.3 12.8 18.5 6.0 8.3 11.6 17.1 10.8 9.9 19.1 21.5 8.1 10.5 11.8 27.4 13.9 20.0 12.1 18.9 14.5 25.1 14.1 15.0 20.9 28.1 12.2 13.2 13.2 11.0 17.5 22.4 11.9 8.9 2.3 3.2 5.5 3.4 2.3 2.6 2.8 2.9 2.2 3.5 2.7 2.8 3.7 6.6 3.2 6.9 17.9 27.6 17.3 20.8 10.9 5.7 24.8 7.8 4.3 4.4 11.5 26.1 14.7 62.6 15.1 21.8 10.9 3.9 9.9 26.8 8.5 8.6 8.2 6.7 22.7 12.4 11.1 21.9 10.2 7.1 13.1 6.3 14.1 10.4 1.9 10.2 32.0 10.6 7.3 10.2 19.8 20.6 2.3 12.5 13.3 19.6 16.9 21.8 10.4 35.0 12.5 11.9 14.9 15.5 11.3 13.4 21.5 12.3 2.7 22.3 47.9 19.7 18.1 11.9 13.9 18.5 7.3 21.2 5.1 14.8 12.4 8.6 41.4 OLAH "FLJ11106, SAST, THEDC1" ENSG00000152463 "Oleoyl-ACP hydrolase" Q9NV23 10 15032227-15073853 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 9.0;testis: 27.2" "Cell type enriched" "Detected in some" 4 "Early spermatids: 537.8" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.6" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037947, HPA037948" Enhanced NA NA "HPA037947: AB_10795028, HPA037948: AB_10805352" "unprognostic (2.01e-1)" "unprognostic (6.12e-2)" "unprognostic (8.20e-3)" "unprognostic (4.04e-3)" "unprognostic (1.92e-1)" "unprognostic (8.09e-2)" "unprognostic (7.12e-2)" "unprognostic (5.12e-2)" "unprognostic (4.55e-1)" "unprognostic (3.74e-2)" "unprognostic (4.70e-1)" "unprognostic (1.69e-1)" "unprognostic (5.22e-10)" "unprognostic (4.55e-2)" "unprognostic (2.09e-1)" "unprognostic (5.11e-2)" "unprognostic (9.78e-2)" 1.2 0.9 1.1 0.2 0.7 1.1 5.5 0.5 1.5 0.8 0.6 0.2 0.1 0.4 0.4 3.0 1.7 1.0 0.2 1.2 0.1 1.1 0.3 1.8 0.3 0.6 0.2 0.6 0.2 0.1 0.3 1.0 3.2 0.4 0.3 0.0 0.7 2.7 0.1 0.2 0.5 0.5 0.2 0.2 9.0 0.3 27.2 0.5 0.1 0.4 0.3 0.0 0.2 0.8 1.2 0.0 0.0 0.1 0.2 0.2 0.7 1.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.5 0.0 0.4 3.6 4.8 0.5 0.0 0.0 0.4 0.1 0.2 0.1 3.6 0.0 0.3 0.2 0.2 0.0 0.3 0.4 0.7 0.2 0.0 0.0 0.0 0.1 0.1 5.3 0.0 2.6 0.1 0.1 0.2 0.0 1.8 0.1 0.1 3.1 0.7 0.2 1.1 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.6 0.4 0.0 0.5 0.2 0.0 1.1 0.7 0.5 1.5 1.2 0.1 0.6 0.2 0.6 0.4 0.2 0.5 1.2 0.7 3.2 0.6 0.3 0.1 0.3 0.5 0.0 0.0 0.1 131.3 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 2.7 537.8 0.1 0.2 0.3 0.0 0.0 0.1 0.0 1.7 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.2 0.3 66.1 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 8.2 0.0 0.4 0.0 0.0 0.8 0.7 6.6 0.5 1.0 2.8 1.9 0.0 0.3 11.4 0.9 0.1 0.0 0.1 RPP38 ENSG00000152464 "Ribonuclease P/MRP subunit p38" P78345 10 15097180-15139818 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 555.3;Late spermatids: 231.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045128, HPA050398" Approved Supported Nucleoli NA NA Nucleoli "HPA045128: AB_2797230, HPA050398: AB_2732560" "unprognostic (1.75e-1)" "unprognostic (3.91e-2)" "unprognostic (3.76e-2)" "unprognostic (1.51e-1)" "unprognostic (9.93e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.41e-2)" "unprognostic (4.86e-1)" "unprognostic (1.57e-3)" "unprognostic (3.42e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (6.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.11e-2)" "prognostic favorable (2.89e-6)" 13.7 13.1 10.9 12.4 10.6 12.6 20.0 13.5 11.8 13.5 15.0 15.9 16.0 15.1 16.8 16.3 19.5 11.3 12.0 10.6 10.8 14.4 19.5 13.9 20.2 10.4 10.2 10.5 14.7 15.4 14.4 13.5 11.6 11.0 14.0 16.8 13.6 14.5 12.3 19.2 16.7 16.7 12.6 10.1 17.8 15.6 48.4 10.5 15.8 16.4 14.9 18.2 17.8 13.5 11.3 40.6 29.4 15.6 20.3 20.7 21.2 27.9 18.7 14.0 29.0 29.3 29.6 40.3 33.2 19.3 17.6 23.7 36.2 31.8 32.4 26.2 26.0 28.6 34.3 17.3 26.2 44.4 19.5 27.5 25.3 43.8 23.4 20.5 21.9 23.2 33.0 40.1 22.7 22.0 32.6 34.9 20.9 18.0 49.0 14.0 28.3 15.9 41.5 37.0 15.3 14.7 18.5 25.7 44.4 53.6 25.6 39.7 30.8 18.8 13.1 22.8 28.3 25.2 31.6 36.5 44.9 25.8 23.3 12.6 21.9 48.5 49.7 49.1 49.0 48.6 58.7 49.7 60.8 51.9 66.0 57.2 52.4 16.2 41.5 40.8 52.3 47.3 43.4 10.9 10.6 13.5 11.8 10.6 10.8 10.4 10.2 10.5 11.0 10.1 10.5 11.3 15.5 16.0 22.0 4.2 24.0 31.5 41.9 34.7 14.2 14.2 22.5 26.0 7.1 11.5 40.3 9.2 6.2 30.2 18.6 18.6 27.4 34.2 555.3 54.4 18.7 19.2 13.2 15.2 3.3 33.2 42.1 15.7 16.8 16.0 12.7 15.5 19.6 32.4 24.7 8.4 3.5 25.4 36.7 18.8 12.6 231.1 23.6 13.4 8.8 5.6 21.6 17.7 33.0 4.5 5.5 29.6 16.8 19.9 14.5 46.8 26.9 33.9 89.2 31.0 13.1 14.9 14.6 68.0 34.6 17.2 36.1 32.2 21.5 23.6 24.0 43.8 NMT2 ENSG00000152465 "N-myristoyltransferase 2" O60551 10 15102584-15168693 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 93.6;Hepatocytes: 141.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5" "Group enriched" "Detected in many" 8 "granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 102.6;TIME: 147.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001303 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA001303: AB_1079494" "unprognostic (1.08e-1)" "unprognostic (7.65e-2)" "unprognostic (8.78e-2)" "unprognostic (1.15e-3)" "unprognostic (6.97e-2)" "unprognostic (2.24e-1)" "unprognostic (7.11e-2)" "unprognostic (5.13e-2)" "unprognostic (3.20e-1)" "unprognostic (4.01e-3)" "unprognostic (3.31e-1)" "unprognostic (2.00e-1)" "unprognostic (7.06e-2)" "unprognostic (3.79e-3)" "unprognostic (2.00e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" 24.6 4.4 7.4 6.1 8.0 3.7 17.7 12.4 10.1 9.9 4.7 8.9 6.6 12.8 3.6 7.0 8.3 7.1 8.8 7.7 5.6 9.5 16.9 6.3 9.0 5.6 7.9 6.6 15.5 5.6 16.7 5.6 4.4 7.8 9.1 9.3 7.1 5.2 7.8 8.4 10.2 11.0 10.6 4.7 9.5 8.0 13.5 10.4 27.3 6.0 8.6 8.1 8.7 8.0 7.5 8.8 11.3 12.7 9.3 33.7 35.9 2.3 18.8 15.3 17.0 23.0 10.9 38.7 0.4 12.7 102.6 46.6 10.6 11.4 10.7 28.3 11.7 13.9 23.4 5.4 15.2 22.4 1.7 84.0 31.9 10.8 23.8 7.2 62.2 65.8 16.3 11.2 1.5 63.7 10.9 18.3 4.4 9.3 10.0 10.5 13.6 18.5 1.8 12.6 1.8 3.9 14.4 22.8 3.7 6.3 10.5 11.7 7.3 147.1 16.7 24.4 75.0 13.7 13.0 14.3 1.0 20.7 6.3 12.4 14.5 0.5 13.6 11.0 0.7 19.8 2.2 17.5 12.9 0.5 2.5 21.8 14.5 1.9 20.8 0.8 0.5 29.5 6.5 7.4 8.0 12.4 10.1 7.7 5.6 5.6 7.9 6.6 7.8 4.7 10.4 7.5 52.5 9.6 8.8 25.1 16.0 16.6 23.4 8.3 7.4 20.6 14.7 13.1 13.5 57.2 10.9 27.6 4.2 1.3 16.9 32.8 9.8 33.9 6.6 4.7 20.5 21.7 18.0 15.1 39.6 19.5 3.0 16.3 9.2 10.3 93.6 13.2 25.4 141.9 2.8 20.2 30.1 11.4 4.1 7.9 7.1 14.5 21.8 5.8 12.4 17.8 10.1 12.9 40.2 12.5 15.3 27.1 15.9 20.7 10.0 17.9 38.4 63.2 5.3 17.2 0.0 13.4 21.0 8.1 46.8 6.8 14.8 2.6 33.9 11.0 18.1 16.7 ZSCAN1 "FLJ33779, ZNF915" ENSG00000152467 "Zinc finger and SCAN domain containing 1" Q8NBB4 19 58034025-58054631 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.0;testis: 8.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 11.7;Early spermatids: 28.2;Endometrial ciliated cells: 21.8;Late spermatids: 19.6;Spermatocytes: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;HMC-1: 2.1;NTERA-2: 2.1;T-47d: 3.1" HPA007938 Uncertain Approved Nucleoli NA NA Nucleoli "HPA007938: AB_1080768" "unprognostic (1.60e-3)" "unprognostic (2.44e-1)" "unprognostic (2.21e-1)" "unprognostic (3.58e-1)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (1.97e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-1)" "prognostic favorable (7.36e-4)" "unprognostic (1.41e-2)" "unprognostic (3.81e-2)" "unprognostic (1.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.32e-1)" "unprognostic (2.47e-2)" "unprognostic (3.60e-1)" 0.1 0.9 3.8 0.0 2.7 0.1 0.9 3.3 4.6 0.9 0.9 0.2 0.0 0.6 6.1 0.1 2.1 0.2 0.4 3.5 5.9 2.6 0.1 0.5 0.1 2.8 3.8 2.3 0.6 1.0 2.6 16.0 0.2 2.5 2.4 0.0 2.3 0.4 0.8 0.0 0.2 0.1 0.1 1.5 0.2 0.1 8.8 3.4 0.6 5.9 0.0 0.0 0.5 0.3 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.6 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 2.7 3.3 4.6 3.5 5.9 2.8 3.8 2.3 2.5 1.5 3.4 1.2 0.1 0.0 0.0 3.6 0.0 0.0 0.4 0.2 0.0 3.4 1.8 2.2 1.1 1.5 0.2 1.8 2.1 0.0 0.0 0.0 11.7 1.7 28.2 21.8 3.1 0.5 0.0 0.0 3.8 0.0 0.0 0.8 0.0 1.7 0.0 3.2 0.4 0.0 0.1 3.3 5.4 0.0 0.0 0.0 0.0 19.6 0.9 0.1 1.8 2.8 0.0 8.1 0.0 4.0 1.8 0.3 0.0 0.0 0.0 0.9 0.0 0.2 4.3 2.6 0.0 0.0 0.6 13.7 2.7 0.0 0.0 0.0 0.1 6.7 0.0 0.5 ZNF837 ENSG00000152475 "Zinc finger protein 837" Q96EG3 19 58367618-58381030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 9.3" HPA042833 Uncertain Approved Nucleoli NA NA Nucleoli "HPA042833: AB_10806373" "unprognostic (2.61e-1)" "unprognostic (7.62e-2)" "unprognostic (1.33e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.07e-1)" "unprognostic (7.33e-3)" "unprognostic (1.02e-2)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.37e-3)" "unprognostic (6.02e-2)" "prognostic favorable (1.76e-5)" "unprognostic (2.35e-3)" "unprognostic (9.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.07e-2)" 1.1 2.5 2.6 0.4 0.9 0.1 1.8 0.9 0.8 2.1 1.4 1.6 1.0 2.4 0.0 2.4 3.2 0.1 0.6 0.7 0.7 3.3 5.0 1.0 0.4 1.2 1.4 0.3 2.9 3.1 0.5 2.9 0.1 1.2 2.8 0.1 0.9 2.4 0.3 0.4 3.1 1.9 0.1 1.8 2.2 2.0 2.1 0.7 0.5 4.1 0.0 0.2 1.5 1.8 1.3 1.5 0.7 0.9 1.0 0.1 0.3 1.6 1.4 0.3 0.0 0.1 0.3 1.5 1.8 1.2 0.0 0.6 0.4 0.1 0.0 0.0 0.9 9.3 0.8 0.2 0.1 0.3 0.6 0.5 0.5 0.3 0.1 0.1 0.3 0.1 2.3 1.1 0.5 0.1 2.0 4.2 1.7 2.4 0.6 2.4 3.6 0.4 1.8 0.2 1.1 2.8 3.6 1.1 0.9 1.7 0.1 1.1 0.8 0.4 2.1 0.1 0.6 0.5 2.2 1.8 1.6 1.3 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.9 0.9 0.8 0.7 0.7 1.2 1.4 0.3 1.2 1.8 0.7 1.3 1.1 3.2 1.8 0.0 3.2 0.9 1.2 2.2 6.2 2.6 2.9 3.2 1.4 1.5 1.7 3.7 0.0 1.7 0.4 2.3 7.9 4.3 4.3 2.3 1.8 1.4 1.2 0.8 1.1 5.2 1.2 1.6 2.6 2.0 0.0 4.8 1.8 4.0 1.0 1.7 1.0 3.2 4.1 0.8 0.3 0.6 1.8 0.8 3.6 0.0 3.0 2.2 4.1 2.5 1.1 2.9 2.4 1.2 0.3 2.5 3.0 6.8 0.6 0.6 0.0 2.1 1.8 2.5 5.8 2.6 1.7 2.2 2.0 4.7 2.8 1.1 USP12 USP12L1 ENSG00000152484 "Ubiquitin specific peptidase 12" O75317 13 27066156-27171811 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, HPA059492" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007288: AB_1080531, HPA059492: " "unprognostic (6.72e-3)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (5.85e-2)" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "unprognostic (8.38e-2)" "unprognostic (8.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.91e-1)" "unprognostic (6.77e-2)" "unprognostic (1.73e-1)" 19.9 13.7 23.8 21.1 25.5 76.3 15.4 25.1 24.9 12.2 19.5 30.3 18.3 13.3 15.2 17.2 13.7 18.0 14.3 26.2 24.4 25.0 35.2 23.8 29.6 22.7 27.7 21.3 14.9 15.5 16.6 13.9 17.8 24.4 14.1 25.8 38.4 10.2 12.2 13.2 24.2 24.5 18.8 23.8 17.4 17.9 15.7 24.7 12.3 16.2 16.1 26.7 22.0 13.6 25.1 24.9 15.3 28.6 14.9 18.8 23.8 10.2 34.1 23.9 18.5 13.7 27.7 37.8 35.1 16.6 27.0 44.9 15.0 18.9 19.8 39.4 57.0 16.1 54.3 19.2 19.6 23.6 31.8 36.5 14.9 28.3 21.0 23.9 23.4 43.3 23.8 18.4 16.5 38.9 14.4 19.6 42.0 20.5 31.5 26.7 22.1 36.5 8.3 36.3 17.3 31.5 19.0 29.3 24.2 28.2 35.5 11.4 30.4 51.6 19.3 18.6 41.6 31.4 12.6 15.0 24.6 32.4 18.5 22.0 0.0 0.5 2.2 0.5 0.5 0.9 1.2 0.9 0.8 0.6 1.6 0.6 0.6 0.5 0.9 0.8 1.1 1.4 0.4 23.8 25.5 25.1 24.9 26.2 24.4 22.7 27.7 21.3 24.4 23.8 24.7 25.1 54.2 28.9 29.9 19.6 42.1 91.6 29.4 7.0 34.7 23.8 30.6 24.0 23.4 17.2 9.1 23.9 39.6 15.4 26.5 47.0 29.4 12.8 19.2 29.1 26.4 42.0 20.9 60.6 37.0 16.3 7.0 34.2 23.9 68.9 13.3 15.7 21.4 23.3 14.0 28.6 29.0 27.5 10.2 20.8 153.8 10.7 7.8 47.8 39.2 42.2 33.6 13.8 9.2 43.7 65.0 24.4 37.4 6.4 37.1 34.0 34.3 21.3 12.2 32.1 32.9 114.7 42.8 2.7 12.9 23.1 79.0 10.9 27.2 9.3 24.1 40.6 CCDC50 "C3orf6, DFNA44, Ymer" ENSG00000152492 "Coiled-coil domain containing 50" Q8IVM0 3 191329085-191398659 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 363.7;Oligodendrocyte precursor cells: 365.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 630.7" "Lineage enriched" "Detected in all" 5 "dendritic cells: 630.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001336 Approved Supported Cytosol NA NA Cytosol "HPA001336: AB_1078421" "unprognostic (5.01e-2)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "unprognostic (8.77e-3)" "unprognostic (1.73e-2)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.03e-2)" "unprognostic (2.51e-2)" "unprognostic (4.48e-2)" "unprognostic (3.17e-3)" "unprognostic (2.05e-2)" "unprognostic (7.79e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-2)" "unprognostic (7.57e-2)" "unprognostic (4.19e-1)" 63.8 28.6 21.2 34.6 19.9 10.4 30.9 21.8 19.2 24.3 20.1 26.0 24.4 33.3 25.0 28.2 24.5 35.1 40.1 17.6 23.5 31.1 57.0 31.8 42.5 24.2 20.6 14.7 46.7 35.4 27.8 13.6 35.2 23.8 26.5 25.6 11.9 23.9 33.6 19.1 18.5 26.1 48.5 23.9 45.3 24.5 29.9 22.7 17.9 27.7 26.3 41.3 37.0 18.8 26.7 74.9 24.5 93.6 24.7 82.3 72.1 32.3 135.4 135.2 95.4 95.0 52.6 28.9 14.6 163.0 76.8 70.6 83.6 75.6 60.5 141.9 109.0 37.8 10.0 31.7 60.3 120.8 36.8 37.8 58.2 79.3 75.6 169.7 82.2 148.7 0.0 33.9 77.3 85.4 26.0 0.2 23.1 33.2 7.6 103.0 56.3 51.9 73.1 104.3 31.9 21.8 33.2 48.2 51.6 95.8 67.3 35.6 32.9 153.3 93.4 78.4 68.4 176.3 118.6 54.9 0.9 50.5 0.1 76.9 0.1 22.1 2.1 5.9 20.8 2.4 128.5 6.1 3.9 44.3 76.5 1.3 1.5 2.2 24.0 12.1 630.7 22.1 18.0 21.2 19.9 21.8 19.2 17.6 23.5 24.2 20.6 14.7 23.8 23.9 22.7 26.7 143.5 25.6 54.5 40.5 134.5 46.9 52.5 30.7 30.7 27.2 32.5 37.5 48.4 58.6 34.7 51.5 27.1 28.1 363.7 44.1 31.3 120.4 183.0 97.3 58.1 134.0 22.8 11.2 15.8 78.5 36.3 66.6 41.8 79.0 2.5 58.5 175.6 79.5 84.4 25.2 41.3 33.8 38.7 59.4 78.3 92.1 69.3 61.4 53.4 98.4 101.4 32.1 5.2 365.4 28.9 174.7 33.9 75.6 102.7 69.8 37.6 71.8 26.3 14.4 59.2 74.1 65.7 73.2 26.6 24.0 32.5 33.5 22.4 49.5 33.7 62.4 CAMK4 "CaMK-GR, CaMKIV" ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 72.4;lymphoid tissue: 55.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 70.9;Early spermatids: 306.2;Excitatory neurons: 212.2;Inhibitory neurons: 131.8;Late spermatids: 108.4;Oligodendrocyte precursor cells: 133.2;T-cells: 83.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 72.4" "Group enriched" "Detected in many" 4 "MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3" "Lineage enriched" "Detected in many" 23 "T-cells: 33.1" "Cell line enhanced" "Detected in many" "HDLM-2: 88.9;JURKAT: 61.3;MOLT-4: 27.9;SH-SY5Y: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 0.4 3.8 5.2 4.4 29.9 3.1 0.4 72.4 7.2 0.9 0.0 1.3 1.4 0.6 0.3 0.7 0.3 1.5 0.1 7.4 4.9 0.7 1.4 1.1 8.2 4.7 4.4 5.6 0.6 0.4 0.0 0.6 0.2 16.6 3.4 1.4 4.8 0.4 1.4 0.1 0.1 2.4 0.8 0.0 2.7 1.5 9.5 3.3 55.9 0.2 0.0 5.2 1.7 0.4 1.7 0.0 0.0 3.1 2.1 0.6 2.3 0.0 0.8 6.8 8.0 7.8 0.0 0.1 0.0 4.0 0.4 5.4 0.3 6.8 0.8 5.8 88.9 5.2 1.3 2.8 0.0 0.2 0.6 0.3 0.3 0.0 16.8 1.7 4.9 1.4 61.3 0.0 3.3 0.4 0.0 27.9 0.0 4.1 0.0 0.2 4.0 5.0 0.2 2.9 0.1 18.8 33.5 1.2 0.0 5.6 0.2 0.1 0.5 0.1 16.3 9.5 0.1 14.7 2.6 0.3 0.0 8.0 0.0 6.3 0.1 0.0 0.0 4.8 0.0 24.3 1.3 17.3 13.5 0.0 0.3 33.1 18.5 0.9 1.4 0.0 0.1 21.3 5.5 5.2 29.9 72.4 7.2 7.4 4.9 4.7 4.4 5.6 16.6 0.0 3.3 1.7 1.8 0.0 1.1 57.8 9.4 1.1 0.3 1.3 8.6 70.9 0.6 0.6 5.3 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.1 306.2 0.2 1.6 1.1 0.0 0.0 212.2 0.0 0.2 4.6 3.6 0.4 4.5 0.3 0.7 0.3 0.2 0.0 131.8 0.8 0.0 1.3 2.1 108.4 4.1 2.0 0.0 12.2 2.7 2.8 1.0 133.2 5.4 1.2 0.0 1.5 11.5 0.5 0.0 0.1 0.1 4.3 0.0 0.6 3.8 30.3 6.2 2.4 1.0 0.0 83.3 0.1 0.0 0.3 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "retina: 44.6;testis: 175.8" "Group enriched" "Detected in many" 26 "Early spermatids: 2120.7;Late spermatids: 4980.3" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 5.8;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 48 "dendritic cells: 5.8;granulocytes: 3.2;monocytes: 6.5" "Cell line enhanced" "Detected in many" "RH-30: 24.5;SCLC-21H: 28.3;SH-SY5Y: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061321 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA061321: AB_2684479" "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 0.5 1.3 14.7 1.6 19.2 0.5 4.5 5.7 14.1 2.4 9.6 7.5 14.2 0.9 0.6 0.3 2.2 0.5 0.2 19.2 14.4 0.3 0.4 1.8 0.3 16.5 15.5 14.3 4.7 1.6 0.2 13.5 1.1 17.5 10.1 7.6 44.6 0.5 0.6 0.2 0.6 13.9 0.8 12.0 0.5 4.6 175.8 12.3 0.7 0.2 0.4 0.4 0.4 1.3 21.6 3.6 0.9 1.6 8.4 0.2 0.1 2.0 0.7 2.8 1.5 1.7 1.2 1.7 0.0 1.4 0.1 11.9 1.1 7.9 1.5 1.1 0.6 2.7 6.0 3.3 1.7 0.3 6.0 4.8 0.1 1.4 0.7 2.0 1.9 0.1 11.2 0.2 7.9 2.3 4.6 1.6 5.4 6.7 0.6 3.8 1.3 24.5 1.9 0.9 0.1 28.3 19.6 5.3 0.5 3.2 0.8 5.8 7.4 0.7 2.3 1.8 1.7 2.7 1.2 0.8 0.0 2.5 3.4 1.1 0.0 1.2 3.2 0.0 1.3 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.3 0.0 6.5 1.2 0.0 0.6 14.7 19.2 5.7 14.1 19.2 14.4 16.5 15.5 14.3 17.5 12.0 12.3 21.6 0.4 0.0 3.4 1.0 0.1 2.3 0.6 0.2 0.6 5.0 14.8 9.3 2.3 0.0 0.5 1.8 56.3 0.0 1.8 27.6 0.0 0.4 2120.7 3.3 0.3 2.0 3.5 0.0 39.7 1.8 0.5 1.4 6.6 1.1 1.3 0.1 0.4 0.0 2.8 5.0 14.0 15.8 2.0 1.9 18.1 4980.3 14.9 6.0 8.8 29.0 3.4 6.9 0.0 2.5 53.4 1.5 20.4 12.8 0.1 12.1 28.2 0.2 5.0 76.8 6.6 2.0 2.3 136.2 26.9 1.2 1.3 0.3 0.7 0.1 8.8 0.2 ZFP36L2 "BRF2, ERF2, RNF162C, TIS11D" ENSG00000152518 "ZFP36 ring finger protein like 2" P47974 2 43222402-43226606 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1727.3;Basal squamous epithelial cells: 2181.9;Plasma cells: 2029.3;Suprabasal keratinocytes: 1549.6;T-cells: 1760.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047428 Approved NA NA "HPA047428: AB_10963428" "unprognostic (2.07e-2)" "unprognostic (1.81e-2)" "unprognostic (9.77e-2)" "unprognostic (6.10e-2)" "unprognostic (9.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-1)" "unprognostic (7.62e-3)" "unprognostic (2.04e-1)" "unprognostic (4.50e-2)" "unprognostic (9.67e-3)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (2.50e-1)" "unprognostic (4.52e-2)" "unprognostic (1.23e-1)" "unprognostic (2.98e-2)" 183.4 111.8 30.4 151.5 34.3 196.9 176.5 41.2 31.3 131.4 35.3 130.4 114.6 102.6 39.1 104.6 122.2 125.2 80.4 26.8 78.5 64.6 92.2 171.2 172.5 104.9 41.0 19.1 189.0 79.4 20.1 38.0 32.0 50.7 124.1 133.8 17.2 93.3 64.4 65.4 212.3 172.6 65.8 53.8 121.6 128.3 19.4 44.6 162.3 182.3 42.5 122.9 94.3 134.8 46.9 36.2 17.4 17.0 9.5 208.0 211.4 6.9 51.7 93.1 21.6 16.4 61.0 16.7 26.0 37.9 59.7 12.0 66.9 18.2 89.9 18.3 46.6 38.0 42.0 6.4 65.1 61.8 92.3 35.0 149.8 143.4 22.1 143.2 32.6 38.9 39.1 42.6 100.1 21.4 192.0 109.4 190.8 26.0 113.2 30.1 81.0 12.7 151.7 36.9 51.5 15.0 37.6 9.8 58.9 32.2 23.2 10.0 150.4 18.6 58.3 25.2 49.7 32.1 84.1 25.1 39.0 19.6 227.7 27.5 18.7 42.5 82.1 46.6 35.3 45.8 18.1 46.1 62.8 51.2 22.7 34.1 33.9 61.6 52.7 28.1 22.0 19.5 30.0 30.4 34.3 41.2 31.3 26.8 78.5 104.9 41.0 19.1 50.7 53.8 44.6 46.9 540.1 48.1 67.1 91.1 1144.2 1727.3 1232.0 76.3 2181.9 3.7 455.0 420.5 120.8 420.4 72.4 136.1 0.0 12.2 1167.2 470.8 84.1 37.2 2.4 192.4 241.9 371.7 187.8 340.6 0.4 37.0 22.2 635.9 562.7 292.0 138.5 497.7 185.6 146.8 236.5 0.0 0.6 538.1 26.4 436.2 435.2 12.5 311.9 579.7 302.4 97.4 318.5 214.2 620.0 29.7 13.8 41.1 378.8 259.9 2029.3 590.1 319.2 81.4 48.2 30.5 105.2 631.8 246.5 3.4 27.8 534.9 1549.6 17.0 1760.1 342.5 581.4 238.0 PAN3 ENSG00000152520 "Poly(A) specific ribonuclease subunit PAN3" Q58A45 13 28138506-28295335 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 154.6;Microglial cells: 209.9;Oligodendrocyte precursor cells: 171.4;Oligodendrocytes: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028817 Approved NA NA "HPA028817: AB_10602016" "unprognostic (3.25e-2)" "unprognostic (2.10e-1)" "unprognostic (3.55e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (7.39e-2)" "unprognostic (8.17e-2)" "unprognostic (1.52e-1)" "unprognostic (4.26e-3)" "unprognostic (5.78e-2)" "unprognostic (6.56e-2)" "unprognostic (2.29e-2)" "unprognostic (4.22e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (8.54e-2)" "unprognostic (2.42e-2)" 15.8 9.9 9.2 14.3 9.6 31.6 18.3 17.4 10.9 16.1 12.6 13.9 9.7 15.5 20.8 12.6 16.2 11.1 8.4 8.6 10.6 13.1 11.1 14.8 21.7 9.3 9.4 8.1 16.4 17.2 10.2 12.6 11.9 10.4 14.3 12.8 15.9 14.9 12.2 6.8 20.2 18.8 10.9 9.7 26.0 13.1 14.3 8.9 21.7 17.5 5.7 19.6 13.3 15.4 12.7 9.9 6.2 16.8 17.9 8.2 11.6 13.9 10.1 16.1 10.5 10.0 10.3 21.2 34.9 7.1 14.9 11.8 14.4 15.1 11.9 17.8 19.8 7.9 28.3 8.7 8.9 10.9 21.6 17.0 11.5 11.9 8.9 18.1 13.5 14.2 16.2 14.1 10.4 11.6 13.6 23.6 52.2 18.0 13.6 5.9 54.5 17.9 12.8 16.7 13.2 15.8 12.5 11.9 17.3 13.9 10.3 9.2 40.6 13.8 10.5 8.9 10.3 9.8 7.9 6.1 35.6 6.2 16.2 13.1 22.8 10.1 13.4 9.0 9.6 9.6 12.3 10.2 9.2 9.8 11.4 11.5 11.1 22.5 11.9 14.4 15.6 8.7 11.2 9.2 9.6 17.4 10.9 8.6 10.6 9.3 9.4 8.1 10.4 9.7 8.9 12.7 32.3 16.0 19.5 97.9 42.9 66.3 16.2 10.2 18.8 27.3 36.1 16.9 7.8 17.2 14.8 16.5 29.2 18.1 51.1 13.6 1.9 13.6 21.3 33.2 25.7 26.8 27.1 61.0 131.4 12.5 15.9 23.7 19.4 38.5 16.5 26.3 28.9 10.7 13.7 26.9 154.6 18.0 16.2 41.4 88.0 12.4 26.4 34.7 56.9 209.9 35.4 13.7 35.0 171.4 222.3 13.6 21.5 21.8 28.9 35.0 13.2 14.3 16.6 37.8 13.1 31.6 26.2 26.5 23.0 22.5 80.7 24.1 36.1 17.1 17.0 31.2 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637260-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 66.2;Endometrial stromal cells: 150.5;Oligodendrocyte precursor cells: 191.0" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.4;RPTEC TERT1: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: AB_2686828" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 11.7 3.0 3.0 1.7 2.8 0.1 8.9 3.6 2.9 20.8 7.6 9.7 3.8 19.9 4.4 4.7 16.0 7.4 3.5 2.6 3.0 8.4 1.7 27.9 2.9 3.2 2.6 2.5 23.2 2.9 5.4 2.0 3.8 2.9 5.1 4.3 1.7 4.9 5.1 1.8 7.8 6.5 9.9 3.0 5.4 5.1 3.9 2.8 0.4 5.6 2.5 1.8 6.3 8.5 3.6 0.5 4.0 1.6 0.0 3.1 7.4 0.3 0.5 2.0 0.8 2.0 0.0 1.3 1.0 0.2 0.6 3.3 2.6 0.5 0.6 1.5 0.0 1.1 0.1 0.6 0.1 0.5 0.0 0.5 2.2 0.6 1.9 0.1 1.1 1.7 1.6 3.9 0.1 0.7 1.1 0.8 0.1 0.9 0.6 3.9 0.0 4.6 0.0 6.3 0.2 1.2 0.6 0.4 0.0 3.9 1.1 0.5 0.1 0.2 4.5 1.3 0.2 1.4 0.9 0.2 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 2.8 3.6 2.9 2.6 3.0 3.2 2.6 2.5 2.9 3.0 2.8 3.6 4.6 38.5 8.7 19.2 0.9 8.7 17.5 5.8 6.8 1.0 5.3 8.3 2.9 11.5 12.9 66.2 6.2 0.3 1.3 0.1 5.9 6.2 1.6 5.9 150.5 3.8 0.0 0.0 15.6 1.4 0.3 57.4 3.1 8.8 1.3 42.6 2.2 0.0 0.8 0.0 4.3 0.3 2.0 0.3 8.6 3.3 35.8 1.2 12.4 15.9 0.2 5.8 0.0 191.0 52.7 7.2 0.0 50.4 0.4 9.2 0.3 4.1 7.3 4.1 46.0 40.7 24.6 10.8 5.9 2.6 8.4 0.5 3.6 13.1 0.6 8.7 PFKM "PFK-1, PFKX, PPP1R122" ENSG00000152556 "Phosphofructokinase, muscle" P08237 12 48105139-48146404 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 1585.1;tongue: 1406.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 345.9;Horizontal cells: 121.1;Muller glia cells: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002117 Approved Approved "Endoplasmic reticulum" NA NA 410000 "Endoplasmic reticulum" "HPA002117: AB_1855245" "unprognostic (4.60e-2)" "unprognostic (2.56e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (5.85e-6)" "unprognostic (4.97e-1)" "prognostic unfavorable (7.91e-5)" "unprognostic (5.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.80e-1)" "unprognostic (1.86e-1)" "unprognostic (2.29e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (1.53e-1)" "unprognostic (5.72e-2)" "unprognostic (1.30e-2)" 15.6 54.7 52.1 11.1 51.1 8.1 15.2 59.3 60.0 26.9 47.3 28.4 10.5 36.4 14.4 39.0 29.5 16.0 266.6 48.5 63.5 46.5 8.5 15.0 8.1 53.0 54.0 47.2 45.5 10.9 137.4 36.8 12.1 57.7 29.3 16.3 86.2 29.4 39.4 1585.1 13.6 16.2 35.4 45.4 11.9 23.2 51.2 60.2 9.4 21.7 1406.3 10.2 27.9 19.4 55.4 32.9 30.6 98.4 87.5 97.2 72.5 20.2 85.4 80.2 77.1 54.4 76.3 40.5 192.9 69.6 44.1 44.9 36.0 90.1 91.2 70.9 5.5 43.9 54.7 64.7 1.9 54.3 2.9 30.9 102.1 50.4 69.2 107.3 125.1 85.9 3.7 64.6 91.7 71.5 25.8 69.5 5.1 67.7 36.0 93.9 115.7 55.7 141.3 48.4 32.5 111.5 82.6 51.0 75.9 86.5 78.7 80.3 11.2 75.8 34.0 46.5 49.5 72.1 52.8 145.3 106.4 62.4 6.8 28.5 0.3 2.9 7.8 2.1 2.5 0.9 8.8 3.5 2.1 5.6 8.3 4.3 2.4 0.7 2.1 2.1 0.9 3.5 3.1 52.1 51.1 59.3 60.0 48.5 63.5 53.0 54.0 47.2 57.7 45.4 60.2 55.4 8.6 16.0 8.4 30.3 6.9 7.4 21.7 22.1 15.9 43.3 5.6 9.1 345.9 12.8 10.8 22.0 43.8 2.8 0.9 3.4 66.5 10.6 43.1 5.5 18.0 17.3 9.1 8.6 23.2 2.5 3.8 27.1 6.6 2.4 1.3 17.3 13.9 2.7 4.1 121.1 30.0 9.1 34.6 3.8 3.7 27.0 30.7 4.3 55.2 3.7 11.3 125.7 4.1 15.6 3.4 3.5 1.9 47.8 4.6 7.9 2.7 30.6 11.2 51.1 26.3 37.6 24.5 52.1 14.4 9.2 5.3 2.5 3.3 24.0 10.1 9.7 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 988.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: AB_2732691" "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 56.5 81.0 52.0 121.3 58.9 227.3 154.8 60.7 68.8 115.9 67.0 121.2 64.1 176.3 48.2 101.0 92.5 100.4 71.8 47.1 76.5 94.0 397.0 120.2 197.9 74.5 62.5 34.6 87.6 83.2 71.3 16.0 99.4 64.7 106.1 98.0 9.3 225.9 105.1 20.6 96.3 79.5 131.7 62.8 112.2 126.6 74.0 59.4 240.8 315.1 50.2 144.1 148.2 71.3 92.8 220.5 195.8 186.9 174.8 233.5 185.6 135.8 169.7 352.0 324.4 358.1 247.9 988.1 370.2 423.9 387.9 234.5 228.3 212.3 272.9 339.4 228.4 82.5 192.0 67.8 352.3 207.5 404.1 137.4 219.1 280.7 240.1 352.3 433.9 361.8 187.8 134.3 0.9 257.7 71.8 353.0 135.4 115.8 340.3 181.1 214.7 532.0 359.3 291.3 207.9 90.7 110.5 201.8 267.6 109.9 197.2 161.3 154.0 451.9 211.3 249.4 190.5 126.6 139.4 84.3 366.6 62.0 432.7 143.2 159.7 113.3 207.0 102.6 121.8 155.3 70.1 158.8 123.8 126.1 95.3 208.6 181.7 72.4 223.9 111.0 33.7 183.8 248.7 52.0 58.9 60.7 68.8 47.1 76.5 74.5 62.5 34.6 64.7 62.8 59.4 92.8 93.3 125.0 78.1 33.0 179.3 160.3 257.1 307.3 157.6 0.7 144.9 118.4 53.9 143.0 202.8 163.7 0.0 45.8 91.8 48.2 80.3 153.7 41.3 141.1 47.6 140.0 90.5 68.3 1.0 118.8 41.1 82.2 88.2 161.4 58.9 126.6 271.3 317.6 107.1 1.7 2.2 163.1 160.7 249.6 419.9 23.6 94.1 189.8 161.9 63.7 229.4 4.7 83.4 25.6 114.0 127.8 55.1 93.3 117.8 324.2 31.0 52.9 257.0 1.1 65.7 181.9 80.2 23.1 74.9 146.3 177.2 30.4 164.8 109.4 146.3 270.2 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 106.3;retina: 32.3" "Group enriched" "Detected in some" 5 "Excitatory neurons: 799.1;Horizontal cells: 471.1;Inhibitory neurons: 1045.0;Oligodendrocyte precursor cells: 755.5" "Cancer enriched" "Detected in some" 5 "glioma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.1;NTERA-2: 4.0;RPMI-8226: 2.4;SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 0.1 5.7 12.7 0.5 21.9 0.0 3.2 106.3 31.5 1.4 0.0 1.3 0.0 0.5 1.7 0.0 1.0 0.2 0.1 24.6 25.6 0.5 0.0 0.0 0.6 25.7 26.7 19.8 0.2 0.8 0.0 2.3 0.3 31.8 0.2 0.9 32.3 3.0 0.5 0.1 0.5 3.2 0.0 16.4 0.0 5.8 0.1 23.4 0.0 0.1 0.0 0.4 0.0 0.1 37.8 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 21.9 106.3 31.5 24.6 25.6 25.7 26.7 19.8 31.8 16.4 23.4 37.8 0.0 0.0 0.0 36.9 0.0 0.1 0.0 0.0 0.0 48.2 0.9 7.4 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 2.2 0.4 0.0 0.0 799.1 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 1.1 471.1 1045.0 3.7 0.0 0.0 0.4 0.2 0.6 0.0 0.0 100.2 0.0 20.4 0.0 755.5 129.9 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 8.9 0.0 1.6 0.2 0.0 0.3 0.0 0.1 0.3 0.1 0.0 5.2 0.0 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.9" "Cell type enhanced" "Detected in many" "Early spermatids: 170.5;Horizontal cells: 60.6;Late spermatids: 34.1;Microglial cells: 61.8;Syncytiotrophoblasts: 30.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 44.1;HL-60: 23.3;REH: 17.2;RPMI-8226: 55.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012655, HPA012921" Uncertain Approved Vesicles "Secreted - unknown location" NA NA 540000 Vesicles "HPA012655: , HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 3.9 4.0 1.5 1.0 0.8 0.6 6.1 0.4 1.2 0.4 2.7 1.3 0.5 1.4 1.6 3.0 4.4 9.8 3.9 3.0 1.4 0.2 0.3 8.7 1.4 0.2 0.6 0.6 17.9 0.7 1.3 1.7 0.7 0.4 0.1 1.3 0.2 5.2 0.2 0.1 1.9 1.2 1.6 0.3 0.9 0.7 0.9 2.5 1.4 1.5 0.5 2.6 2.2 0.3 0.7 0.0 0.1 0.3 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.1 0.0 0.4 0.0 0.0 0.3 0.3 7.5 44.1 0.0 1.6 23.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.2 0.1 55.1 0.1 0.1 1.0 0.0 5.9 0.0 0.0 0.2 0.0 0.2 0.0 0.1 1.1 0.0 0.0 2.4 0.0 0.0 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.8 0.4 1.2 3.0 1.4 0.2 0.6 0.6 0.4 0.3 2.5 0.7 2.0 0.0 0.5 1.0 0.6 2.4 1.2 0.5 2.8 15.8 0.6 0.9 1.6 2.8 6.3 1.8 4.2 21.7 2.7 0.2 0.0 0.1 170.5 11.4 4.0 0.9 6.0 3.4 2.4 1.3 2.9 20.4 0.5 0.5 0.0 0.0 0.0 0.1 1.3 60.6 2.8 0.7 4.1 0.8 3.2 34.1 6.8 2.9 3.6 61.8 1.1 25.6 0.0 0.5 0.7 0.4 0.1 1.2 0.3 0.7 0.0 0.3 12.5 2.4 0.0 0.5 2.2 10.7 7.9 0.8 2.4 30.9 0.6 2.5 0.1 0.2 SPEF2 "CT122, FLJ23577, KPL2" ENSG00000152582 "Sperm flagellar 2" Q9C093 5 35617844-35814611 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 104.6;Endometrial ciliated cells: 143.9;Excitatory neurons: 62.9;Respiratory ciliated cells: 238.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 3.2;MAIT T-cell: 3.9;memory CD4 T-cell: 1.9;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.1;naive CD8 T-cell: 2.6;NK-cell: 3.0" "Group enriched" "Detected in many" 8 "NK-cells: 3.0;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039606, HPA040343" Enhanced NA NA "HPA039606: AB_10671044, HPA040343: AB_2676930" "unprognostic (3.81e-2)" "unprognostic (3.17e-1)" "unprognostic (6.23e-2)" "unprognostic (8.71e-2)" "unprognostic (4.55e-2)" "unprognostic (8.23e-2)" "unprognostic (8.11e-4)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (9.96e-2)" "unprognostic (1.01e-4)" "unprognostic (4.50e-2)" "unprognostic (6.34e-3)" "unprognostic (1.53e-2)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (2.12e-2)" 1.5 3.7 5.7 1.1 3.5 1.5 5.4 2.3 3.1 13.2 17.6 1.8 0.9 11.2 7.6 1.1 16.0 3.2 1.7 2.7 4.2 7.8 1.4 4.6 1.6 5.4 4.8 2.7 5.7 4.4 8.7 6.5 4.8 4.1 4.1 2.0 10.3 3.3 4.5 0.4 1.2 1.5 4.3 5.4 2.4 2.2 7.1 3.2 2.1 8.7 0.5 0.9 2.4 5.0 2.8 0.8 1.3 1.6 4.2 1.0 1.2 0.1 2.1 1.2 4.7 3.1 0.0 2.2 0.0 1.1 2.8 5.2 0.1 1.3 1.9 4.6 13.3 0.4 0.0 6.2 0.4 1.3 3.5 0.0 1.8 3.4 2.6 1.4 5.7 0.1 0.8 1.6 0.8 0.8 2.3 0.0 0.0 0.1 3.1 1.2 3.1 0.0 0.0 3.3 0.4 0.1 1.2 0.0 2.4 0.4 0.9 7.5 6.7 0.0 1.3 1.8 2.7 0.7 0.0 0.0 0.3 3.8 0.1 0.0 0.0 0.3 0.0 3.2 0.3 3.9 0.2 1.9 3.4 0.4 0.3 2.1 2.6 0.3 3.0 0.1 0.1 0.5 0.8 5.7 3.5 2.3 3.1 2.7 4.2 5.4 4.8 2.7 4.1 5.4 3.2 2.8 2.4 9.6 6.4 36.9 1.1 1.7 2.4 4.7 3.4 15.6 9.2 10.0 6.7 11.5 28.8 5.5 37.5 1.7 3.1 1.5 5.9 4.7 104.6 143.9 23.3 5.2 2.4 6.5 62.9 1.7 0.8 9.7 1.1 9.1 5.7 6.7 5.3 1.3 1.2 20.2 27.6 3.5 8.2 0.8 1.4 25.2 10.2 2.3 1.8 6.5 21.7 13.7 4.1 16.1 11.5 1.2 1.5 7.2 0.7 1.6 0.5 14.2 238.4 41.9 0.0 9.4 5.6 36.1 11.9 0.7 1.0 0.8 9.2 9.0 3.1 0.2 SPARCL1 MAST9 ENSG00000152583 "SPARC like 1" Q14515 4 87473335-87531061 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 4430.9;Endothelial cells: 2372.1;Peritubular cells: 2523.5;Sertoli cells: 4674.1;Skeletal myocytes: 2379.0;Smooth muscle cells: 2781.9" "Cancer enhanced" "Detected in all" "glioma: 528.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 24.9;SuSa: 31.4;U-266/70: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026225 Enhanced "Secreted in other tissues" NA NA 630000000 "CAB026225: " "unprognostic (1.02e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (1.63e-3)" "unprognostic (1.73e-2)" "unprognostic (3.88e-2)" "unprognostic (6.04e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-1)" "unprognostic (2.45e-3)" "unprognostic (1.76e-2)" "unprognostic (5.72e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (3.33e-4)" 720.8 130.7 663.0 125.7 737.8 0.5 536.7 584.0 1066.7 738.9 566.6 485.3 126.2 1255.0 447.7 311.0 761.0 492.2 602.7 707.5 805.1 73.2 25.2 485.3 99.9 644.5 677.1 635.4 289.2 92.5 129.1 199.3 318.0 648.0 589.4 189.3 96.0 230.2 1008.7 246.9 117.4 282.5 1201.5 668.8 159.2 350.7 98.3 631.3 104.2 372.9 600.0 100.8 492.1 470.4 652.4 0.7 0.0 24.9 0.3 0.2 0.1 2.6 0.1 0.1 0.0 0.0 0.0 0.1 0.4 1.8 0.0 0.0 1.4 2.4 0.0 0.0 1.7 0.0 0.3 1.1 0.4 1.1 0.3 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.3 0.0 0.5 0.2 3.5 0.6 0.0 0.0 0.3 0.4 1.2 0.0 0.1 0.8 1.6 0.1 0.2 0.1 31.4 0.4 0.5 0.0 0.2 0.3 1.5 0.2 9.1 1.4 0.6 3.4 0.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 663.0 737.8 584.0 1066.7 707.5 805.1 644.5 677.1 635.4 648.0 668.8 631.3 652.4 4430.9 12.8 56.4 1155.7 6.2 46.3 187.2 0.6 59.7 10.7 24.4 251.6 334.2 4.3 43.3 7.3 2.1 2.2 8.6 0.0 13.7 0.8 11.8 34.9 935.8 2372.1 0.0 32.0 382.3 0.4 3.2 1413.1 6.1 46.7 7.6 1.4 899.5 9.1 9.2 3.3 450.1 0.0 0.0 5.3 55.2 47.0 659.5 31.6 56.9 261.4 0.0 179.4 0.0 210.6 53.8 0.1 0.0 2523.5 25.2 50.4 0.0 24.6 7.4 34.4 4674.1 2379.0 2781.9 5.7 7.9 56.8 39.9 2.5 26.9 38.8 0.0 124.2 DSPP "DFNA39, DGI1, DMP3" ENSG00000152591 "Dentin sialophosphoprotein" Q9NZW4 4 87608529-87616873 "Disease related genes, Human disease related genes, Predicted secreted proteins" Biomineralization "Deafness, Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036230 Uncertain "Secreted in other tissues" NA NA 27000 "HPA036230: AB_10672239" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.21e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMP1 ENSG00000152592 "Dentin matrix acidic phosphoprotein 1" Q13316 4 87650280-87664361 "Disease related genes, Human disease related genes, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037465 Approved "Secreted to extracellular matrix" NA NA 64000 "HPA037465: AB_10672492" "unprognostic (6.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-3)" "unprognostic (1.80e-1)" "unprognostic (4.96e-3)" "unprognostic (7.73e-2)" "unprognostic (3.88e-1)" "unprognostic (1.11e-1)" "unprognostic (1.35e-2)" "unprognostic (8.50e-9)" "unprognostic (5.82e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (1.74e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEPE ENSG00000152595 "Matrix extracellular phosphoglycoprotein" Q9NQ76 4 87821411-87846817 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 86 "brain: 8.6" "Cell type enriched" "Detected in single" 18 "Inhibitory neurons: 12.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 8.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038003, HPA038004" Uncertain "Secreted to extracellular matrix" NA NA 810000 "HPA038003: AB_2675780, HPA038004: AB_10670537" "unprognostic (2.88e-1)" "unprognostic (8.15e-2)" "unprognostic (3.62e-1)" "unprognostic (1.91e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.41e-1)" "unprognostic (5.64e-4)" 0.0 0.0 4.8 0.0 1.2 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.3 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.2 0.1 8.6 1.0 4.3 0.4 0.3 1.1 1.0 0.5 0.8 2.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MBNL1 "EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL" ENSG00000152601 "Muscleblind like splicing regulator 1" Q9NR56 3 152243828-152465780 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 537.7;Oligodendrocytes: 471.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016398, HPA035098" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016398: AB_784435, HPA035098: AB_2674461" "unprognostic (5.46e-3)" "unprognostic (6.01e-3)" "unprognostic (1.94e-3)" "unprognostic (1.99e-1)" "unprognostic (3.44e-2)" "unprognostic (5.82e-3)" "unprognostic (2.75e-2)" "unprognostic (9.49e-3)" "unprognostic (5.18e-2)" "unprognostic (1.70e-2)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (7.53e-3)" "unprognostic (6.15e-2)" "unprognostic (1.77e-1)" "unprognostic (2.98e-1)" 117.5 36.2 18.5 106.0 24.8 91.2 48.6 22.9 26.8 77.6 28.6 65.7 44.0 68.6 30.4 65.9 38.7 75.9 63.7 19.2 33.9 31.8 48.0 78.8 139.5 24.2 24.2 14.9 45.5 24.5 26.7 11.9 30.2 28.4 55.6 71.8 17.8 32.6 66.7 190.6 62.0 58.8 117.5 25.0 93.1 40.9 15.0 27.6 109.4 32.1 132.2 136.3 79.1 32.9 32.2 133.8 107.8 17.3 38.9 132.5 135.8 12.7 163.3 131.5 105.6 87.8 48.0 76.3 136.3 81.3 230.8 32.8 59.7 32.1 94.5 155.0 106.9 43.7 149.3 52.2 22.7 73.8 180.5 104.5 63.8 50.2 121.9 94.0 80.8 219.5 54.1 77.3 180.5 103.6 45.9 169.0 66.0 7.2 38.9 85.4 170.5 53.0 171.6 53.7 66.3 13.8 15.7 71.1 38.2 69.8 6.2 53.1 270.5 186.6 143.6 55.1 96.4 142.7 186.9 115.9 154.6 83.8 220.6 79.1 95.3 53.7 90.1 79.4 61.7 84.4 56.2 64.5 66.5 70.1 49.7 80.6 70.7 78.4 79.6 54.7 24.9 62.6 104.3 18.5 24.8 22.9 26.8 19.2 33.9 24.2 24.2 14.9 28.4 25.0 27.6 32.2 175.5 150.6 193.7 179.2 252.1 213.6 49.0 25.9 156.0 28.5 51.8 48.0 179.8 52.9 89.5 38.6 64.6 26.1 266.0 164.7 21.5 36.0 2.6 64.0 92.2 142.9 47.3 160.2 258.6 63.6 9.2 122.9 78.0 68.5 162.6 31.5 90.0 91.5 60.9 32.0 185.5 68.8 14.2 216.4 195.5 9.7 89.5 235.0 103.2 537.7 249.4 18.2 230.7 224.7 471.9 57.3 90.3 71.5 181.3 61.2 121.4 42.2 63.1 84.1 98.6 102.7 145.6 4.3 12.7 149.4 243.6 14.8 340.1 46.8 80.7 50.1 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904288-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 111.9" "Cell type enhanced" "Detected in some" "Early spermatids: 167.1;Endometrial ciliated cells: 400.1;Late spermatids: 148.9;Respiratory ciliated cells: 709.5" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 14.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.7;REH: 8.0;U-698: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules No No "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.0 0.0 10.1 0.0 3.0 0.2 0.1 3.8 2.1 2.3 21.6 0.0 0.0 2.0 8.5 0.0 111.9 0.0 0.0 1.8 6.6 0.6 0.0 7.7 0.0 9.4 7.3 0.9 0.1 0.5 1.2 13.7 0.0 7.4 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 11.1 0.0 0.1 10.0 3.3 6.7 5.4 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.3 6.2 0.0 0.0 2.2 0.0 1.0 0.1 0.0 0.1 0.0 4.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 1.2 2.1 0.0 0.5 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 3.0 3.8 2.1 1.8 6.6 9.4 7.3 0.9 7.4 11.1 3.3 8.2 0.0 3.2 7.3 0.3 0.0 0.0 0.1 58.0 0.0 0.0 0.2 0.0 0.0 0.0 66.2 1.8 0.0 0.0 0.0 0.0 1.9 0.1 167.1 400.1 2.4 0.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 4.7 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 65.1 0.0 0.0 148.9 0.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.5 0.0 1.6 709.5 0.0 0.0 0.0 19.2 21.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 NADK2 "C5orf33, FLJ30596, MNADK, NADKD1" ENSG00000152620 "NAD kinase 2, mitochondrial" Q4G0N4 5 36192589-36242279 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "liver: 330.7" "Group enriched" "Detected in many" 5 "Astrocytes: 105.4;Early spermatids: 324.5;Hepatocytes: 211.9;Late spermatids: 154.9" "Cancer enhanced" "Detected in all" "liver cancer: 36.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038366, HPA038367, HPA061492" Enhanced Supported Mitochondria NA NA 30000 Mitochondria "HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538" "unprognostic (1.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.01e-2)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (1.97e-2)" "unprognostic (4.06e-3)" "unprognostic (8.84e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-3)" "unprognostic (1.09e-1)" "unprognostic (1.76e-1)" "unprognostic (9.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" 13.7 20.3 25.5 9.4 22.6 10.7 15.6 23.1 23.1 13.8 13.3 14.1 16.8 13.4 8.0 10.5 12.8 12.0 20.3 21.4 27.4 23.4 330.7 8.5 9.6 24.6 24.4 19.5 19.8 27.1 10.8 5.6 17.1 23.3 19.1 13.9 11.3 13.1 16.4 29.7 6.7 13.0 14.3 29.9 8.6 17.3 18.4 22.8 10.4 17.5 30.0 11.5 28.2 8.9 29.7 21.5 14.6 22.4 23.5 32.2 27.2 27.5 19.5 13.2 17.5 13.2 41.4 27.4 74.3 14.0 23.3 23.0 14.9 20.0 14.3 24.2 21.2 16.3 22.0 43.1 23.9 22.7 46.5 8.0 28.9 22.5 21.6 29.9 22.4 18.4 30.2 52.0 27.8 18.0 9.0 42.3 18.2 10.7 18.1 19.2 40.2 51.6 15.8 24.2 18.2 8.7 20.1 102.0 32.4 10.5 16.7 22.9 39.8 15.1 34.1 18.2 27.0 23.9 23.7 30.3 23.2 14.5 57.2 14.2 8.2 1.2 1.1 1.3 1.4 1.8 1.3 1.9 1.5 2.3 5.3 1.6 1.4 0.1 6.7 3.3 1.2 2.1 1.4 25.5 22.6 23.1 23.1 21.4 27.4 24.6 24.4 19.5 23.3 29.9 22.8 29.7 9.6 3.2 6.9 105.4 7.5 6.8 6.8 5.4 6.2 5.7 18.3 11.2 29.3 25.8 7.1 5.5 8.4 9.2 9.6 7.4 25.4 5.0 324.5 6.1 9.4 6.8 7.2 13.7 23.8 9.5 8.9 12.5 5.6 7.1 1.3 10.0 12.1 211.9 8.9 3.3 18.3 11.7 4.1 10.4 9.6 154.9 19.9 6.4 14.2 11.2 3.7 16.9 5.2 21.1 23.6 6.9 8.8 23.0 14.3 14.9 6.6 23.1 7.2 5.4 0.0 11.6 13.5 35.1 11.0 7.7 5.7 7.3 6.9 26.4 11.6 12.3 GPD1L KIAA0089 ENSG00000152642 "Glycerol-3-phosphate dehydrogenase 1 like" Q8N335 3 32105689-32168709 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.9;tongue: 255.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 154.1;Distal enterocytes: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 136.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.23e-1)" "unprognostic (3.12e-2)" "prognostic favorable (7.05e-4)" "unprognostic (2.63e-1)" "unprognostic (9.67e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (5.71e-5)" "unprognostic (2.49e-2)" "unprognostic (1.74e-1)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.33e-15)" "unprognostic (1.50e-1)" "unprognostic (1.99e-1)" "unprognostic (2.31e-3)" "unprognostic (5.51e-3)" 39.4 45.1 17.2 8.3 19.7 7.0 30.9 16.5 21.4 23.0 24.3 40.4 26.7 11.7 9.9 41.3 19.2 9.3 126.0 19.9 19.9 34.6 2.8 31.6 9.1 19.3 18.1 16.7 16.8 21.7 33.1 5.9 20.9 19.3 60.4 37.1 9.9 22.2 41.6 159.9 10.4 29.2 16.7 20.4 12.9 30.0 6.1 18.1 6.9 40.7 255.3 10.3 31.2 13.0 21.2 11.1 10.0 3.5 15.3 49.3 11.9 136.1 8.8 3.1 9.2 7.1 10.7 5.2 19.4 13.2 6.2 11.3 12.6 23.4 9.3 11.6 8.3 21.4 11.3 13.2 16.8 12.4 29.4 39.3 35.5 12.1 8.9 12.5 9.4 16.3 15.7 8.0 6.1 7.3 15.1 12.6 11.0 2.1 27.6 44.8 23.1 15.7 40.0 14.6 66.8 15.1 15.0 6.7 61.1 25.0 4.8 38.7 14.1 8.6 10.5 4.9 16.3 23.6 4.3 2.0 19.3 24.0 22.3 6.0 0.5 2.8 5.7 3.3 3.2 8.0 1.5 4.1 4.0 5.6 1.2 2.5 3.7 1.4 7.4 2.1 4.4 8.8 2.8 17.2 19.7 16.5 21.4 19.9 19.9 19.3 18.1 16.7 19.3 20.4 18.1 21.2 10.2 28.9 41.8 1.3 4.1 4.6 5.3 3.5 8.6 4.1 20.3 10.7 154.1 2.8 18.6 9.2 2.1 36.4 10.8 75.2 39.2 2.0 8.0 5.3 4.4 10.5 7.8 6.9 23.1 3.7 6.1 10.5 17.3 9.2 39.3 9.8 13.2 0.7 10.0 1.7 23.7 21.3 26.4 6.3 5.7 20.7 5.9 4.4 8.8 24.4 2.3 32.9 7.2 3.0 11.1 4.3 21.6 12.8 8.7 13.8 33.9 18.4 15.0 3.9 0.0 8.0 8.7 0.8 2.1 32.3 7.0 27.1 10.4 3.3 26.9 8.5 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435595-121449727 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 83.8 290.0 323.8 24.9 301.5 0.9 61.2 296.4 412.6 263.9 199.1 17.5 18.4 99.6 10.7 75.6 33.0 100.8 170.6 287.8 432.8 21.4 10.7 68.5 21.2 360.7 340.5 256.4 43.9 19.6 237.9 31.5 292.6 311.6 84.1 19.8 3.3 35.9 149.3 10.4 391.3 24.9 113.5 318.9 4.2 30.9 37.2 369.5 24.5 170.6 22.3 35.2 117.1 186.4 343.4 0.1 43.5 186.8 0.4 99.7 61.5 0.4 142.5 286.9 46.9 113.7 0.7 0.4 0.0 15.8 55.8 40.2 18.3 5.1 87.4 151.3 0.1 51.6 2.3 15.7 0.0 124.1 0.0 0.4 164.6 92.1 172.5 61.7 462.7 362.3 0.0 0.1 4.3 9.4 8.4 0.1 80.6 365.8 0.1 47.2 0.1 0.0 3.7 188.6 21.0 0.4 2.9 0.0 0.3 0.1 453.4 14.9 0.3 269.5 143.8 39.4 122.8 93.5 0.1 0.1 0.1 350.4 0.1 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 323.8 301.5 296.4 412.6 287.8 432.8 360.7 340.5 256.4 311.6 318.9 369.5 343.4 152.2 250.0 80.0 276.2 0.1 234.9 133.6 71.1 77.4 0.3 9.5 20.1 199.7 0.0 17.5 1.8 2.1 53.4 0.4 0.0 0.0 76.9 0.5 21.5 215.5 166.6 0.0 0.0 0.3 4.2 7.9 124.4 0.5 51.7 8.8 494.3 33.9 0.1 8.6 0.0 0.6 0.0 4.1 0.9 55.3 1.7 2.5 3.6 44.4 15.0 0.6 0.3 0.0 4.0 1.0 10.8 0.0 4.1 0.1 29.7 0.0 0.1 6.2 0.3 0.0 5.9 80.2 0.9 1.8 68.3 378.2 20.0 4.9 127.1 0.4 52.7 CCNO "CCNU, FLJ22422, UDG2, UNG2" ENSG00000152669 "Cyclin O" P22674 5 55231152-55233608 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation" Cyclin "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.7;pancreas: 10.2;testis: 13.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 39.3;Club cells: 51.4;Collecting duct cells: 33.1;Endometrial ciliated cells: 38.1;Ionocytes: 61.1;Respiratory ciliated cells: 97.2;Spermatocytes: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 5.2;T-47d: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA050090 Uncertain NA NA "HPA050090: AB_2681011" "unprognostic (3.44e-2)" "unprognostic (5.20e-2)" "unprognostic (5.28e-2)" "prognostic favorable (6.78e-4)" "unprognostic (3.96e-2)" "unprognostic (2.60e-1)" "unprognostic (3.18e-3)" "prognostic favorable (7.60e-4)" "unprognostic (3.54e-2)" "unprognostic (2.10e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (3.03e-2)" "prognostic favorable (5.10e-4)" "unprognostic (1.81e-1)" "unprognostic (9.49e-2)" "unprognostic (8.88e-3)" 0.1 0.4 1.5 0.0 2.4 0.0 0.5 0.7 2.2 0.7 9.7 0.2 0.3 0.2 0.3 1.0 2.1 0.1 0.1 1.9 1.2 1.1 0.2 1.3 0.0 1.4 1.5 1.2 0.8 10.2 1.1 5.3 0.1 1.0 2.0 0.0 0.1 1.8 1.2 0.0 1.8 0.5 0.0 1.2 0.0 5.7 13.3 1.2 0.0 5.5 0.0 0.0 1.8 0.4 0.9 2.8 3.2 0.0 1.6 0.2 0.0 5.2 0.0 0.0 0.4 0.5 0.0 3.1 0.0 2.0 0.0 1.0 2.6 0.1 0.0 0.0 0.0 4.1 0.1 3.5 0.3 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.4 0.0 1.3 0.1 0.0 0.0 2.7 0.0 0.1 0.2 0.4 4.4 1.5 0.3 0.0 1.2 1.0 1.9 0.0 3.5 0.8 1.1 0.0 7.5 0.5 0.2 0.0 2.2 2.8 1.2 2.6 1.5 0.0 1.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.4 0.7 2.2 1.9 1.2 1.4 1.5 1.2 1.0 1.2 1.2 0.9 0.2 0.0 1.5 0.7 0.0 1.0 3.7 39.3 5.7 11.9 9.2 5.0 0.5 2.8 51.4 33.1 6.2 0.7 0.3 2.7 0.0 4.2 12.5 38.1 0.5 0.3 0.0 0.0 2.8 28.5 1.9 0.6 13.3 5.4 0.0 0.1 0.0 0.0 0.1 1.7 0.3 3.4 61.1 0.0 0.7 4.4 1.2 0.2 1.8 0.0 0.0 0.1 0.0 0.5 0.1 11.1 2.7 0.4 0.0 7.9 5.7 1.0 97.2 0.5 0.0 0.3 5.1 53.9 21.5 3.3 2.4 0.3 0.2 0.0 4.2 5.9 DDX4 VASA ENSG00000152670 "DEAD-box helicase 4" Q9NQI0 5 55738017-55817157 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 106 "testis: 151.1" "Group enriched" "Detected in some" 4 "Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9" "Cancer enriched" "Detected in single" 37 "testis cancer: 3.0" "Region enhanced" "Detected in single" "white matter: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.8;PC-3: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026170, HPA037763, HPA037764" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.58e-1)" "unprognostic (3.80e-2)" "unprognostic (3.03e-1)" "unprognostic (5.35e-2)" "unprognostic (3.91e-1)" "unprognostic (3.77e-2)" "unprognostic (3.28e-1)" "unprognostic (5.73e-2)" "unprognostic (5.43e-7)" "unprognostic (4.84e-2)" "unprognostic (1.12e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 151.1 0.4 0.3 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.1 0.3 0.3 0.0 0.1 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 565.1 0.0 0.0 0.4 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 12.2 0.0 0.0 184.1 5.6 0.5 0.0 1.0 0.0 0.0 0.0 1.5 8.7 0.1 0.0 3.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 320.9 83.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC4F "CLECSF13, FLJ39110, KCLR" ENSG00000152672 "C-type lectin domain family 4 member F" Q8N1N0 2 70808643-70820599 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 17.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 10.4;Horizontal cells: 5.0;Macrophages: 4.5;monocytes: 4.0;Rod photoreceptor cells: 6.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.0;non-classical monocyte: 4.4" "Lineage enriched" "Detected in single" 12 "monocytes: 6.0" "Cell line enhanced" "Detected in single" "AN3-CA: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056101 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA056101: " "unprognostic (8.14e-3)" "unprognostic (3.73e-2)" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (4.91e-2)" "unprognostic (5.41e-2)" "unprognostic (3.66e-2)" "unprognostic (2.07e-2)" "unprognostic (9.29e-2)" "unprognostic (3.45e-1)" "unprognostic (2.68e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-2)" "unprognostic (9.59e-2)" "unprognostic (2.44e-1)" 0.8 0.0 0.1 0.6 0.1 0.0 1.1 0.1 0.2 1.9 0.1 0.6 1.6 1.6 0.8 0.7 1.4 1.0 0.7 0.1 0.1 0.6 0.7 0.9 1.2 0.1 0.1 0.1 0.6 0.3 0.0 0.6 0.1 0.1 1.5 0.8 17.4 1.7 0.9 1.0 1.3 4.5 1.2 0.0 3.4 0.6 1.0 0.1 0.2 0.3 0.6 0.8 0.8 1.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.6 0.4 0.2 0.3 0.3 0.0 0.0 0.0 10.4 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 1.0 2.3 1.4 0.0 4.5 0.0 0.0 4.0 0.8 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 SLC30A6 "FLJ31101, ZNT6" ENSG00000152683 "Solute carrier family 30 member 6" Q6NXT4 2 32165841-32224379 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055032, HPA057328" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA055032: AB_2682677, HPA057328: AB_2683411" "unprognostic (5.61e-2)" "unprognostic (9.11e-3)" "unprognostic (1.05e-3)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (2.98e-1)" "unprognostic (9.47e-2)" "unprognostic (1.88e-1)" "unprognostic (3.30e-3)" "unprognostic (7.05e-2)" "unprognostic (3.06e-2)" "unprognostic (3.51e-1)" "unprognostic (3.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" 10.4 9.0 4.3 8.6 5.3 4.2 10.2 5.6 4.8 10.2 5.2 10.1 8.7 9.2 7.6 8.9 8.1 9.1 7.7 4.3 5.4 11.8 11.3 8.4 9.8 5.2 5.0 4.3 9.1 10.5 11.4 4.4 12.2 5.3 8.9 10.1 6.0 7.8 7.8 7.9 8.1 8.4 9.5 4.9 7.8 9.3 6.2 4.8 9.5 11.9 7.7 10.4 9.9 5.6 6.6 27.7 20.3 20.5 18.0 25.4 22.6 22.7 25.3 25.0 20.4 18.5 15.8 25.4 13.1 16.4 20.4 23.4 17.0 24.7 17.4 25.8 26.6 13.7 28.6 10.9 20.3 16.3 30.4 16.9 17.0 26.7 27.4 21.8 20.7 16.6 9.2 24.6 17.2 23.6 10.2 16.1 13.9 31.0 30.8 10.6 14.2 24.7 19.3 22.5 23.9 15.3 23.3 19.9 21.2 20.4 19.0 11.7 13.6 14.3 25.9 14.3 17.2 30.3 23.1 43.5 19.2 23.0 23.4 26.6 12.8 2.4 1.9 2.5 2.0 3.5 3.0 2.3 2.8 2.9 2.7 3.4 3.2 2.4 7.0 2.3 2.0 4.6 2.0 4.3 5.3 5.6 4.8 4.3 5.4 5.2 5.0 4.3 5.3 4.9 4.8 6.6 8.6 9.6 9.9 19.9 14.9 9.1 5.3 14.9 13.6 4.5 9.0 5.7 4.1 8.6 8.3 7.3 6.2 19.8 8.4 9.5 5.9 7.5 2.8 7.4 10.1 10.9 3.6 13.2 29.2 8.7 14.7 9.5 11.7 10.5 3.8 12.9 11.4 15.3 10.7 1.7 31.0 7.9 14.2 8.8 9.3 1.0 6.5 6.6 8.8 10.3 7.7 7.5 12.3 27.2 37.2 9.8 7.0 7.9 20.0 8.7 9.1 8.3 10.0 7.1 13.1 7.3 7.3 12.3 9.4 13.6 6.3 27.5 9.5 9.0 9.0 5.2 PELO ENSG00000152684 "Pelota mRNA surveillance and ribosome rescue factor" Q9BRX2 5 52787916-52804044 "Predicted intracellular proteins" "Cell cycle, Cell division, Translation regulation" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 90.7;Sertoli cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031458 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA031458: AB_10602141" "prognostic unfavorable (6.42e-4)" "unprognostic (2.44e-1)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (6.28e-3)" "unprognostic (1.71e-2)" "unprognostic (1.71e-2)" "unprognostic (6.13e-3)" "unprognostic (3.40e-1)" "unprognostic (3.72e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-1)" "unprognostic (2.33e-2)" "unprognostic (4.56e-2)" "unprognostic (2.44e-1)" "unprognostic (1.99e-3)" "unprognostic (8.21e-2)" 9.2 17.8 5.5 5.3 5.6 8.2 7.4 5.6 5.1 7.0 5.0 9.6 4.7 9.9 7.5 6.8 7.9 6.4 10.0 5.4 5.9 10.0 10.8 11.8 6.4 5.3 5.6 4.7 5.2 5.4 7.5 6.1 11.7 5.6 6.8 3.8 4.5 5.0 6.7 12.3 7.9 6.3 10.0 5.9 12.7 7.6 4.4 6.2 4.8 7.3 8.8 3.6 8.5 6.7 5.2 18.1 18.3 8.1 14.5 14.0 10.3 7.1 20.4 22.4 19.6 23.9 18.4 13.8 5.9 36.0 22.1 29.4 14.8 11.9 17.3 16.9 6.3 16.8 6.6 15.2 15.5 42.6 12.5 7.6 13.0 17.5 22.7 18.6 16.9 11.8 8.8 8.4 18.5 17.3 14.1 13.1 7.7 6.1 3.3 19.3 4.5 10.4 17.6 14.3 8.5 13.3 10.3 10.8 13.3 11.9 13.7 12.2 4.5 11.7 11.8 11.4 12.5 26.0 7.9 10.4 7.8 22.5 11.6 10.4 22.3 5.9 7.6 4.8 3.9 5.9 4.8 6.2 5.4 6.1 3.6 5.0 4.7 19.0 4.7 2.2 2.3 4.8 4.4 5.5 5.6 5.6 5.1 5.4 5.9 5.3 5.6 4.7 5.6 5.9 6.2 5.2 49.9 9.6 7.4 0.0 9.8 46.9 53.0 24.4 14.2 16.5 12.7 18.7 12.7 17.2 20.2 9.2 2.1 35.9 10.5 8.7 35.2 31.5 65.1 18.7 23.1 50.5 10.2 8.0 0.0 25.5 90.7 36.7 9.2 27.6 1.3 11.4 40.4 18.7 20.1 8.4 0.1 16.0 14.2 6.6 23.3 9.2 17.7 15.8 7.2 0.0 7.7 15.5 6.2 0.0 0.0 24.5 6.0 12.0 14.3 36.5 12.3 29.0 16.9 11.0 85.5 13.7 56.5 22.1 13.9 14.9 35.8 53.9 23.0 18.8 11.5 38.3 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.1;skeletal muscle: 42.4" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 186.5;Plasma cells: 64.8;Urothelial cells: 106.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 13.9;memory B-cell: 12.3;naive B-cell: 15.2" "Group enriched" "Detected in many" 16 "B-cells: 15.2;granulocytes: 13.9" "Group enriched" "Detected in many" 7 "Daudi: 88.7;HEL: 92.0;U-266/70: 143.5;U-266/84: 59.1;U-698: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA058937: AB_2683858" "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 3.0 22.6 15.2 31.6 4.9 5.3 28.9 20.8 3.8 10.3 4.7 7.3 2.6 1.1 2.4 2.6 6.6 34.5 14.6 21.3 6.6 5.5 7.8 28.1 33.1 27.5 11.4 1.0 3.4 6.9 2.4 11.1 32.8 1.6 6.7 1.0 6.2 2.0 42.4 1.7 4.7 4.8 30.2 14.9 7.4 1.0 29.0 4.3 6.7 17.8 33.9 6.8 1.2 57.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 1.2 0.7 4.3 12.4 2.3 0.5 88.7 0.4 0.7 1.0 0.1 0.0 0.0 1.1 9.0 0.8 92.0 0.6 0.0 1.3 0.4 12.4 0.1 0.0 0.1 0.2 1.8 5.3 0.8 0.3 4.8 2.0 0.0 0.7 7.2 0.4 0.5 0.1 0.2 4.1 0.1 1.0 5.3 0.6 0.0 0.0 0.3 4.6 0.1 0.1 0.4 1.7 0.3 0.3 0.4 0.8 143.5 59.1 38.7 0.2 0.4 0.3 13.9 0.0 0.0 0.3 0.0 0.4 12.3 0.6 0.6 0.3 15.2 0.9 0.2 0.0 0.3 0.1 0.0 0.8 1.1 22.6 31.6 28.9 20.8 14.6 21.3 33.1 27.5 11.4 32.8 30.2 29.0 57.1 41.4 0.0 5.8 2.0 46.7 5.4 31.2 0.9 0.0 1.6 4.8 2.8 50.8 1.5 3.7 5.5 0.0 0.5 3.6 1.1 11.7 21.1 1.6 10.0 3.9 57.9 0.0 7.4 4.9 54.6 1.3 4.4 3.6 31.0 17.8 2.4 60.7 6.0 44.5 0.0 3.5 0.0 2.0 9.4 26.1 0.8 0.9 29.1 40.9 34.7 13.8 0.2 0.0 2.5 186.5 44.8 0.1 1.9 64.8 37.0 0.2 14.3 3.9 1.3 0.0 5.5 4.1 1.4 2.1 0.4 3.7 0.5 8.1 3.8 0.4 106.4 SAR1B SARA2 ENSG00000152700 "Secretion associated Ras related GTPase 1B" Q9Y6B6 5 134601149-134649271 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 413.3;Hepatocytes: 267.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006923, HPA048368" Supported Approved "Endoplasmic reticulum" NA NA 430000 "Endoplasmic reticulum" "HPA006923: AB_1856577, HPA048368: AB_2680373" "unprognostic (6.14e-2)" "unprognostic (7.33e-2)" "unprognostic (5.32e-2)" "prognostic favorable (7.11e-4)" "unprognostic (1.23e-1)" "unprognostic (5.92e-2)" "prognostic favorable (6.59e-4)" "unprognostic (1.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" "unprognostic (4.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.87e-2)" 31.2 46.9 28.4 24.4 42.0 26.3 36.2 41.4 42.1 27.5 39.2 41.3 69.1 15.0 35.2 36.2 17.8 28.5 47.2 31.8 40.7 57.6 165.3 19.9 24.6 43.2 42.1 26.9 13.6 33.1 65.4 24.9 20.8 44.1 39.0 36.8 20.5 36.6 30.0 148.7 16.9 70.2 26.9 41.1 20.2 43.8 66.6 37.7 22.9 30.0 141.9 33.9 36.6 20.4 55.5 57.8 49.6 36.0 81.3 111.6 53.4 48.3 95.4 80.0 84.1 127.9 84.3 79.7 31.9 78.3 98.6 116.6 52.1 62.8 92.5 108.0 73.6 37.0 33.6 78.0 81.5 91.7 29.1 44.7 60.4 57.8 97.7 82.7 42.3 64.1 40.9 44.3 71.9 87.0 85.3 38.6 43.6 12.7 70.7 34.4 33.7 62.7 70.2 61.7 91.2 36.8 16.0 67.2 36.1 71.4 47.2 74.2 35.5 51.7 72.8 44.0 66.7 72.3 90.0 215.4 58.7 56.2 55.7 81.6 22.2 70.5 55.0 42.3 71.2 52.9 52.7 48.2 49.7 64.0 34.7 42.9 41.6 25.5 35.8 80.5 43.6 77.1 71.3 28.4 42.0 41.4 42.1 31.8 40.7 43.2 42.1 26.9 44.1 41.1 37.7 55.5 49.3 32.1 36.9 21.5 45.6 37.6 44.0 112.9 22.2 30.4 56.0 35.7 86.7 61.5 102.6 57.0 41.7 33.1 44.5 77.0 56.7 47.6 413.3 43.0 51.3 35.3 27.6 44.2 31.6 83.9 43.5 46.1 68.3 45.8 26.6 28.3 38.9 267.7 52.8 33.7 32.8 55.2 89.5 52.9 56.6 76.9 36.7 47.1 64.0 20.6 38.3 41.8 20.6 29.7 66.5 60.4 36.2 44.8 165.8 75.1 210.7 121.4 99.8 40.3 19.7 41.2 47.7 106.8 47.3 51.1 51.1 115.2 47.0 43.0 46.3 96.5 CATSPER3 CACRC ENSG00000152705 "Cation channel sperm associated 3" Q86XQ3 5 134967907-135011696 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 29.8" "Group enriched" "Detected in some" 5 "Early spermatids: 197.9;Late spermatids: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (2.59e-2)" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (1.57e-2)" "unprognostic (4.87e-2)" "unprognostic (2.63e-1)" "unprognostic (3.71e-2)" "unprognostic (8.00e-2)" "unprognostic (2.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (5.58e-3)" "unprognostic (9.39e-2)" "unprognostic (1.51e-1)" "unprognostic (4.96e-3)" 0.4 0.8 1.1 0.2 0.9 0.6 0.5 0.9 1.2 0.7 1.6 0.7 0.6 0.5 0.6 0.5 1.0 0.1 0.6 0.8 1.0 1.2 1.8 0.4 0.3 0.9 0.9 0.8 0.8 1.4 0.4 0.8 0.2 0.9 0.9 0.5 2.7 0.8 0.4 3.0 0.4 0.7 0.3 0.9 0.7 0.8 29.8 0.9 0.5 0.7 1.8 0.4 0.7 0.5 0.9 0.1 1.4 0.5 0.6 0.4 0.1 0.3 0.2 0.1 2.8 0.2 0.8 1.2 0.5 0.7 0.1 0.2 0.4 0.9 0.4 0.2 0.8 1.0 0.1 0.8 0.4 0.2 0.4 0.3 0.1 0.7 0.2 1.0 0.2 0.0 0.3 0.6 0.9 0.1 0.6 0.6 0.9 0.1 1.1 0.7 0.7 0.2 0.3 1.2 0.2 0.4 0.4 0.5 0.4 0.4 0.4 0.5 0.8 0.4 0.0 0.4 0.1 0.6 0.4 0.4 0.1 0.2 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.4 1.7 0.5 0.1 0.1 1.2 0.0 0.2 0.0 0.1 1.1 0.9 0.9 1.2 0.8 1.0 0.9 0.9 0.8 0.9 0.9 0.9 0.9 0.1 0.0 0.0 21.9 0.2 0.0 0.3 0.5 0.0 0.2 0.3 0.1 1.0 1.5 0.3 0.0 0.0 0.1 0.1 0.2 0.0 0.7 197.9 0.5 0.1 0.3 0.0 0.0 6.4 1.1 0.3 0.2 0.0 0.2 0.0 0.9 0.4 0.8 0.4 0.0 7.8 0.1 2.0 0.3 0.4 64.3 1.5 0.3 0.0 7.5 0.7 1.4 0.0 9.0 7.9 0.3 0.0 0.7 0.0 0.3 0.7 1.5 0.3 2.4 0.0 0.3 0.2 4.7 1.4 0.0 0.3 0.1 0.1 0.1 0.6 0.2 GPR180 ITR ENSG00000152749 "G protein-coupled receptor 180" Q86V85 13 94601857-94634661 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047250 Approved Approved Vesicles NA NA Vesicles "HPA047250: AB_2679998" "unprognostic (3.91e-3)" "unprognostic (3.28e-1)" "unprognostic (4.16e-3)" "unprognostic (2.95e-1)" "unprognostic (1.17e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (6.71e-2)" "unprognostic (1.47e-1)" "unprognostic (2.86e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (2.49e-2)" "unprognostic (1.10e-1)" "unprognostic (8.47e-2)" "unprognostic (2.80e-2)" 5.8 2.3 3.2 2.4 3.7 0.9 2.7 4.7 4.4 2.7 3.9 2.1 2.0 2.4 1.9 1.8 2.5 1.8 1.8 3.4 3.8 2.5 6.9 2.4 2.4 3.4 3.4 3.2 2.4 3.1 2.5 3.5 3.6 4.0 2.5 2.5 7.1 2.8 2.3 1.8 2.0 1.6 2.8 3.4 2.2 2.8 1.1 3.8 2.6 3.6 1.8 2.6 2.3 1.6 3.8 14.6 3.6 5.1 5.4 10.5 11.4 2.1 9.7 7.7 9.3 12.3 4.4 9.8 4.8 4.1 8.4 6.4 9.0 7.3 6.9 12.7 12.7 4.6 9.4 4.9 0.0 8.3 13.6 7.3 6.5 5.8 5.7 7.7 8.3 9.6 6.8 2.7 2.3 9.3 2.1 6.9 3.0 3.3 10.4 4.0 7.8 6.8 2.0 10.4 4.3 7.4 5.3 4.5 9.9 12.2 6.4 7.0 5.5 8.7 5.7 4.6 6.8 8.2 3.8 4.2 2.2 9.5 10.9 7.9 0.1 0.5 0.1 0.8 0.3 1.4 0.5 0.9 0.6 0.9 0.5 1.1 0.9 0.0 0.5 0.4 0.6 1.2 0.4 3.2 3.7 4.7 4.4 3.4 3.8 3.4 3.4 3.2 4.0 3.4 3.8 3.8 9.0 3.2 4.1 20.2 6.1 6.0 5.4 11.2 7.4 12.5 7.4 5.5 6.8 7.2 7.8 12.9 31.3 8.7 9.3 3.8 5.9 8.3 1.0 11.1 8.9 8.3 10.3 3.6 47.6 10.2 27.8 11.8 9.7 9.0 5.1 9.2 9.7 30.8 10.5 18.5 30.5 9.8 6.1 4.4 4.9 0.7 9.6 5.3 7.2 18.7 4.1 15.4 9.2 40.7 26.3 9.6 3.7 5.7 16.0 10.6 3.0 7.5 16.8 22.0 6.6 6.3 10.6 3.5 10.6 6.4 4.7 4.1 6.6 3.6 5.5 5.0 TCTEX1D1 FLJ40873 ENSG00000152760 "Tctex1 domain containing 1" Q8N7M0 1 66752459-66779047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.0;liver: 7.1" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 55.7;granulocytes: 25.9;Inhibitory neurons: 21.6;Respiratory ciliated cells: 104.2" "Cancer enriched" "Detected in single" 10 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 14.6;HUVEC TERT2: 13.4;THP-1: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028420 Uncertain NA NA "HPA028420: AB_10603995" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" "unprognostic (3.72e-4)" "unprognostic (1.22e-1)" "unprognostic (9.65e-3)" "unprognostic (1.81e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.01e-1)" "unprognostic (2.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.53e-6)" "unprognostic (9.28e-4)" "unprognostic (2.78e-2)" "unprognostic (6.13e-3)" "unprognostic (3.65e-2)" 1.1 0.3 3.7 0.4 2.4 4.4 1.0 4.1 2.3 0.8 5.9 0.7 0.2 0.4 0.1 0.3 9.0 0.3 2.1 2.1 5.3 0.6 7.1 2.5 0.0 6.1 4.6 1.6 0.0 0.2 0.0 0.7 5.8 4.8 0.6 0.3 0.9 0.5 0.6 0.7 0.5 0.5 0.4 5.6 0.2 0.4 0.0 3.5 0.1 0.5 0.2 0.1 0.7 0.7 5.2 0.0 0.0 0.2 0.0 0.2 2.3 0.0 0.3 0.7 0.3 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 13.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.4 4.1 2.3 2.1 5.3 6.1 4.6 1.6 4.8 5.6 3.5 5.2 7.5 0.0 3.2 2.9 0.3 1.3 0.0 4.5 0.0 0.3 0.1 0.0 0.6 0.0 11.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 55.7 0.5 12.5 0.0 0.8 13.2 0.0 0.0 0.5 0.0 0.5 25.9 0.0 0.7 3.5 2.7 0.0 21.6 0.0 0.0 0.6 0.8 0.1 0.0 3.0 0.0 1.9 0.3 6.1 0.0 0.5 0.5 0.0 0.0 0.4 1.2 0.5 0.0 0.0 104.2 0.6 0.0 0.4 1.3 0.0 0.1 0.0 0.6 0.0 3.1 0.1 0.0 0.1 DNAI4 "DIC4, FLJ23129, WDR78" ENSG00000152763 "Dynein axonemal intermediate chain 4" Q5VTH9 1 66812885-66924856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.0;testis: 35.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 3.8" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.0;RPTEC TERT1: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.26e-2)" "unprognostic (4.04e-1)" "unprognostic (1.58e-3)" "unprognostic (2.19e-2)" "unprognostic (1.85e-1)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (8.19e-2)" "unprognostic (4.00e-1)" "unprognostic (1.68e-3)" "unprognostic (2.08e-2)" "prognostic favorable (9.60e-5)" "unprognostic (1.98e-1)" "unprognostic (5.79e-2)" "unprognostic (5.03e-2)" "unprognostic (1.69e-1)" 1.5 1.7 10.0 0.5 3.3 0.1 3.0 4.2 2.3 4.0 16.5 5.5 0.7 3.0 5.1 0.5 28.0 2.5 1.1 2.2 11.6 6.4 1.2 4.2 1.0 12.4 8.7 1.0 3.0 1.4 7.0 2.8 2.1 7.3 1.8 4.1 4.1 1.1 2.0 0.5 1.0 0.6 1.3 12.7 0.9 0.8 35.5 4.3 2.3 5.9 0.3 0.7 0.9 0.9 9.1 2.9 1.2 1.6 2.1 4.8 7.0 0.6 1.3 2.2 1.6 1.7 0.3 2.4 1.5 0.3 1.3 5.0 0.2 1.1 0.3 2.5 0.2 0.4 0.4 0.7 0.2 1.6 0.1 0.0 3.3 3.5 6.0 1.2 5.8 0.6 1.5 0.4 0.1 2.8 1.1 0.7 0.5 2.1 1.0 0.6 0.7 0.0 0.0 11.4 0.0 1.9 0.9 1.4 0.5 1.1 1.7 0.5 1.0 0.2 0.7 0.0 4.7 0.7 0.5 0.0 3.2 1.4 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.1 0.0 0.9 0.5 0.2 0.1 3.8 0.0 0.0 0.1 0.1 10.0 3.3 4.2 2.3 2.2 11.6 12.4 8.7 1.0 7.3 12.7 4.3 9.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88819896-88851844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.1;skin 1: 29.2;stomach 1: 46.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 37.2;Distal enterocytes: 38.2;Gastric mucus-secreting cells: 49.5;Paneth cells: 51.5;Squamous epithelial cells: 35.8;Suprabasal keratinocytes: 102.9;Urothelial cells: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 14 "granulocytes: 6.4;monocytes: 3.1" "Cell line enhanced" "Detected in some" "A-431: 8.6;CAPAN-2: 26.1;HL-60: 9.4;NB-4: 8.7;OE19: 20.9;RT4: 16.4;T-47d: 12.2;U-937: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.3 0.3 0.6 9.6 0.6 5.4 2.6 0.4 0.9 3.9 0.4 7.2 2.7 0.2 0.3 34.1 0.3 3.2 0.1 0.5 0.9 4.7 2.0 1.5 4.2 1.0 0.6 0.5 0.3 13.0 0.8 0.3 0.2 0.9 2.6 7.2 0.1 5.0 0.1 0.1 29.2 2.2 1.6 0.5 6.4 46.7 0.1 0.6 5.6 0.1 0.0 7.8 4.8 14.0 1.1 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 0.0 0.0 6.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.6 8.7 0.0 20.9 0.1 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 1.3 0.0 0.0 12.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.9 0.0 0.0 2.1 1.1 0.0 3.1 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 6.4 0.2 0.6 0.2 0.0 0.6 0.6 0.6 0.4 0.9 0.5 0.9 1.0 0.6 0.5 0.9 0.5 0.6 1.1 0.0 0.0 3.7 0.0 1.0 37.2 18.6 7.6 1.8 0.0 1.5 0.9 0.2 5.7 4.5 7.3 0.0 0.0 0.0 38.2 0.0 3.2 0.0 0.9 0.5 0.3 1.8 0.4 0.0 5.9 0.0 0.6 49.5 4.8 0.0 0.0 0.0 0.6 2.2 0.0 0.0 14.9 16.2 9.3 3.1 0.2 0.3 8.5 1.8 0.0 2.2 0.0 0.0 0.0 0.0 5.7 51.5 0.0 0.2 10.1 0.6 0.0 1.7 0.0 0.0 0.1 0.3 0.1 0.2 35.8 102.9 0.0 0.8 0.1 25.7 30.3 FARP1 "CDEP, MGC87400, PLEKHC2, PPP1R75" ENSG00000152767 "FERM, ARH/RhoGEF and pleckstrin domain protein 1" Q9Y4F1 13 98142562-98455176 "Predicted intracellular proteins" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 191.3;Early spermatids: 207.8;Inhibitory neurons: 176.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 125.3;Hep G2: 130.5;SuSa: 110.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000760 Approved Cytosol NA NA Cytosol "HPA000760: AB_1078816" "unprognostic (4.78e-3)" "unprognostic (1.65e-1)" "unprognostic (3.07e-1)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (2.30e-1)" "unprognostic (7.73e-2)" "unprognostic (6.91e-2)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.08e-1)" "prognostic favorable (1.39e-5)" "unprognostic (4.89e-2)" "unprognostic (2.27e-1)" "unprognostic (2.18e-2)" "unprognostic (4.18e-2)" 17.1 35.6 38.8 10.2 42.1 1.5 24.6 24.2 39.7 24.8 17.1 35.1 8.0 19.9 23.9 9.0 18.5 18.7 13.9 39.4 32.1 69.1 68.3 33.1 7.0 34.0 31.9 37.0 16.3 45.4 14.3 23.3 28.4 25.2 41.6 12.7 8.9 37.5 25.9 19.9 14.0 13.7 23.6 31.6 13.1 33.2 14.1 32.7 3.3 44.3 15.2 3.8 27.2 16.2 29.2 0.7 10.7 47.1 66.7 13.3 26.0 22.7 72.0 46.9 39.8 34.8 83.9 31.9 0.2 27.0 125.3 9.8 1.5 20.1 19.9 66.4 1.3 20.5 0.4 38.9 130.5 35.3 0.3 0.6 30.6 8.9 11.6 2.6 23.0 26.5 1.0 0.1 0.7 27.8 18.6 2.8 0.4 22.5 40.7 12.5 25.4 18.3 1.4 88.0 46.8 20.0 43.5 8.8 18.9 51.0 110.8 26.9 0.1 25.6 42.8 16.1 29.2 37.0 0.7 0.7 0.5 19.9 1.4 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 42.1 24.2 39.7 39.4 32.1 34.0 31.9 37.0 25.2 31.6 32.7 29.2 37.3 44.8 24.8 191.3 2.6 6.9 60.2 8.8 15.4 13.9 73.3 40.8 8.4 123.0 27.5 57.0 45.9 6.7 4.0 10.9 80.3 47.5 207.8 70.3 90.5 23.9 31.1 2.7 75.3 35.1 6.4 29.9 23.4 100.7 13.3 44.5 23.2 58.4 53.5 30.3 176.4 10.1 24.4 22.7 9.3 125.9 19.0 14.0 28.4 44.0 17.5 29.6 2.1 104.5 3.7 47.0 4.4 29.3 3.1 56.8 0.3 139.6 38.6 15.7 19.7 18.7 55.4 9.2 15.9 3.2 2.8 4.5 6.4 60.4 12.6 47.2 IFIT5 RI58 ENSG00000152778 "Interferon induced protein with tetratricopeptide repeats 5" Q13325 10 89414568-89421605 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 109.1;BJ hTERT+ SV40 Large T+ RasG12V: 128.0" "Low region specificity" "Detected in all" "HPA037957, HPA062180" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA037957: AB_10672499, HPA062180: AB_2684705" "unprognostic (2.17e-1)" "unprognostic (1.85e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (1.67e-3)" "unprognostic (4.19e-2)" "unprognostic (2.88e-2)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (8.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-1)" 13.5 11.7 11.8 11.2 14.0 16.3 9.8 19.0 13.6 11.5 23.3 9.5 9.5 10.3 9.2 7.5 11.3 12.7 14.7 11.0 14.8 14.3 14.2 17.2 13.3 15.9 13.4 9.6 14.3 9.3 23.0 3.7 14.7 14.7 9.8 9.0 9.0 12.3 10.6 3.7 5.5 11.2 14.3 14.7 18.7 9.2 6.4 12.9 10.6 10.9 6.5 11.4 12.4 4.6 18.0 41.8 12.5 17.3 56.9 46.7 43.4 3.7 33.2 59.5 109.1 128.0 1.0 19.0 1.8 12.1 38.7 42.8 34.8 20.9 19.3 26.0 17.8 13.1 5.0 8.9 7.8 52.4 0.4 3.1 34.9 7.4 32.0 23.7 30.8 6.2 10.8 0.0 29.4 30.8 7.7 12.6 3.8 2.2 0.0 21.9 11.0 20.0 4.6 23.7 5.1 1.9 11.1 18.2 6.6 51.6 4.7 6.2 3.5 15.5 14.0 10.3 23.2 20.0 3.8 0.6 0.2 24.2 3.3 11.6 24.7 15.7 19.3 13.9 25.6 16.4 21.4 14.7 13.0 14.2 18.1 16.8 14.1 45.2 8.3 32.1 1.3 14.1 12.3 11.8 14.0 19.0 13.6 11.0 14.8 15.9 13.4 9.6 14.7 14.7 12.9 18.0 24.8 6.4 14.8 3.6 12.8 8.5 35.7 15.2 13.6 8.3 4.4 4.3 8.9 11.5 12.4 9.2 0.0 6.3 7.5 7.2 11.7 13.7 0.1 11.2 17.1 23.1 4.9 2.1 3.6 9.1 11.5 17.9 6.1 13.3 15.2 6.2 12.1 16.5 11.0 35.3 7.2 5.5 6.1 8.9 6.0 1.0 21.1 10.8 7.2 4.7 12.3 14.6 7.2 4.5 10.2 10.5 5.9 17.3 6.8 21.0 7.5 17.0 9.6 5.3 19.7 15.4 14.2 17.2 14.4 7.7 3.8 4.5 9.3 4.7 2.5 29.1 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" Q6ZSM3 10 89430299-89556641 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" Cataract "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 78.0;epididymis: 52.2;kidney: 86.0;pancreas: 25.5" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 18.1;Leydig cells: 27.1;Peritubular cells: 26.7;Proximal tubular cells: 69.2" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 23.0;HSkMC: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria NA NA Mitochondria "HPA037587: AB_2732475" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favorable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 1.5 2.5 1.2 0.1 0.7 0.0 1.9 1.1 2.4 9.3 78.0 0.6 0.1 1.4 52.2 0.3 4.1 0.1 4.9 3.1 0.2 86.0 2.0 2.6 0.1 0.5 1.0 0.1 1.3 25.5 0.1 3.5 11.7 0.9 0.6 0.2 0.0 0.4 14.2 1.6 0.5 0.3 0.3 1.5 0.0 1.0 3.4 1.1 0.4 6.2 2.5 0.0 0.4 0.7 0.5 0.2 0.0 0.0 0.0 3.0 23.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.5 0.0 3.7 0.0 0.0 8.2 0.2 1.2 1.5 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 2.8 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.7 1.1 2.4 3.1 0.2 0.5 1.0 0.1 0.9 1.5 1.1 0.5 0.8 3.2 3.9 3.3 0.6 0.0 2.2 0.1 0.0 0.1 4.6 0.1 3.3 1.5 2.9 14.7 0.0 16.4 0.1 0.0 15.6 0.0 8.3 11.5 0.8 1.3 18.1 0.0 0.3 4.1 1.1 2.2 0.0 1.0 1.3 0.0 0.4 2.2 1.2 3.3 0.4 0.2 0.0 0.0 0.9 4.8 27.1 1.0 0.0 11.2 0.1 0.0 0.0 0.0 0.4 2.1 0.1 26.7 0.0 0.7 0.0 69.2 6.2 0.6 13.1 3.4 7.8 0.2 0.5 0.0 0.3 9.0 0.9 0.1 0.0 1.8 PANK1 "MGC24596, PANK, PANK1a, PANK1b" ENSG00000152782 "Pantothenate kinase 1" Q8TE04 10 89579497-89645572 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 45.6;liver: 110.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 37.5;Distal tubular cells: 70.5;Hepatocytes: 149.8;Proximal tubular cells: 53.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.00e-1)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" "unprognostic (1.09e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "prognostic favorable (1.50e-4)" "unprognostic (1.59e-1)" "unprognostic (1.38e-2)" "unprognostic (1.61e-1)" "unprognostic (4.55e-4)" "unprognostic (4.61e-2)" "prognostic favorable (1.55e-10)" "unprognostic (3.49e-2)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" "unprognostic (6.64e-2)" 2.1 4.6 3.1 2.2 3.3 0.5 2.5 7.3 4.4 5.3 8.1 14.0 20.6 1.8 3.8 5.4 3.0 1.7 8.7 3.4 3.0 45.6 110.6 2.2 1.8 3.4 3.8 2.7 2.3 1.8 6.6 1.5 2.7 3.9 1.9 17.5 2.0 2.1 2.3 11.5 9.7 17.3 2.3 2.1 1.7 4.6 2.9 4.1 5.2 10.5 28.2 2.7 1.9 3.5 4.4 8.0 5.2 28.1 19.4 14.9 10.8 14.2 4.6 5.0 4.3 5.7 8.2 8.1 5.8 3.0 3.6 3.2 7.9 12.9 2.9 4.6 2.0 5.7 3.9 5.6 16.2 4.4 12.3 2.1 6.6 12.7 6.5 5.1 9.2 5.1 4.9 6.8 0.7 6.3 6.2 13.6 12.5 22.1 21.0 3.1 11.9 5.6 3.8 13.2 3.8 8.7 10.4 5.8 6.9 4.6 16.6 7.5 8.9 2.2 2.6 2.5 5.2 5.7 6.5 12.7 7.2 3.4 9.7 1.8 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 3.1 3.3 7.3 4.4 3.4 3.0 3.4 3.8 2.7 3.9 2.1 4.1 4.4 0.6 6.4 3.7 7.8 1.6 2.3 0.7 2.2 1.8 4.7 2.1 2.0 12.9 10.0 2.5 11.0 2.1 4.7 0.5 37.5 70.5 1.1 0.5 2.5 2.6 1.7 11.4 7.8 21.1 0.7 4.5 1.8 2.0 3.3 0.0 8.4 3.3 149.8 2.4 13.5 32.1 14.8 0.0 3.8 0.7 0.7 1.2 2.2 0.0 7.5 0.4 1.0 0.0 12.1 3.0 0.1 17.9 2.2 1.4 0.5 31.4 53.2 1.5 1.3 0.0 2.2 5.1 0.7 0.8 5.6 2.8 1.8 1.8 1.4 25.1 0.5 PRDM8 KMT8D ENSG00000152784 "PR/SET domain 8" Q9NQV8 4 80183879-80204329 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 26.3;retina: 24.3;seminal vesicle: 27.4" "Cell type enriched" "Detected in many" 9 "Bipolar cells: 271.5" "Cancer enhanced" "Detected in many" "prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3" "Region enhanced" "Detected in many" "hippocampal formation: 28.7" "Low region specificity" "Detected in all" HPA057253 Supported "Nucleoplasm,Nuclear bodies" No NA "Nuclear bodies" Nucleoplasm "HPA057253: AB_2683382" "unprognostic (2.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (1.65e-1)" "unprognostic (7.95e-2)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.89e-11)" "unprognostic (4.64e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-1)" 3.9 2.3 5.7 5.1 8.7 4.0 4.0 0.0 17.4 11.1 0.0 8.4 1.1 9.4 1.9 1.7 5.3 1.7 1.7 14.9 0.0 0.9 0.3 1.6 5.2 2.8 0.7 5.3 5.2 0.9 0.0 5.4 4.4 6.3 26.3 1.6 24.3 1.5 27.4 2.2 2.5 5.8 3.8 0.8 1.8 5.0 1.1 0.7 0.7 1.2 1.0 2.4 10.3 9.9 6.0 2.3 0.2 0.7 0.0 2.1 7.2 0.1 5.8 20.5 2.8 3.2 0.0 2.2 0.0 0.0 7.2 1.8 0.7 0.1 2.4 12.1 8.8 1.8 0.8 0.0 0.0 4.1 9.1 2.5 4.4 0.2 11.1 3.2 27.3 0.4 2.4 0.0 3.7 41.7 0.0 4.2 48.2 0.0 0.2 17.0 1.6 0.0 0.2 1.2 0.3 99.3 13.8 0.3 0.0 0.1 0.1 0.0 4.5 8.8 7.1 1.0 5.2 0.4 1.7 0.0 0.0 17.8 4.2 1.0 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.5 0.5 0.1 0.7 0.3 0.1 0.5 0.2 0.0 0.1 0.2 0.1 5.7 8.7 0.0 17.4 14.9 0.0 2.8 0.7 5.3 6.3 0.8 0.7 6.0 0.9 0.0 0.5 2.3 8.2 0.6 3.4 0.4 0.0 271.5 0.1 0.4 1.8 0.0 5.2 1.8 2.1 0.0 2.5 0.0 0.0 0.0 1.5 0.3 6.5 2.2 0.0 2.5 29.9 0.2 0.2 8.8 0.0 0.5 0.0 0.1 0.0 0.0 0.5 3.3 2.0 0.2 2.0 1.2 6.2 6.7 3.1 5.9 1.8 3.7 0.9 6.1 2.1 7.1 17.0 0.7 0.0 3.4 2.7 3.7 0.0 0.2 5.0 11.6 0.0 4.2 2.9 0.3 0.4 0.0 0.1 0.1 5.0 0.1 0.0 0.6 BMP3 ENSG00000152785 "Bone morphogenetic protein 3" P12645 4 81030708-81057627 "Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.1;lung: 5.5;urinary bladder: 9.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 32.2;Distal enterocytes: 68.9;Granulosa cells: 104.0;Paneth cells: 32.8;Proximal enterocytes: 25.2" "Group enriched" "Detected in some" 4 "lung cancer: 4.2;urothelial cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 10.3;Daudi: 16.3;RT4: 13.5;SK-BR-3: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (5.21e-3)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (3.36e-2)" "unprognostic (2.73e-3)" "unprognostic (9.11e-2)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.16e-4)" "unprognostic (2.26e-2)" "unprognostic (3.86e-1)" "unprognostic (1.11e-1)" "unprognostic (4.22e-2)" 1.2 0.4 0.6 0.3 0.3 0.8 1.2 0.2 0.3 0.4 0.1 8.1 3.2 0.0 0.1 0.0 0.9 2.0 0.0 0.1 0.6 0.1 0.0 5.5 0.3 0.5 0.8 0.3 2.5 0.0 0.0 0.0 0.0 0.5 0.2 6.8 0.5 1.3 0.0 0.0 0.3 7.3 0.5 0.6 0.0 1.1 0.1 0.8 0.0 0.0 0.6 1.5 9.5 0.2 0.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.3 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 13.5 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.3 0.1 0.6 0.5 0.8 0.3 0.5 0.6 0.8 0.5 0.0 3.2 32.2 0.0 0.2 0.1 0.5 0.7 0.0 2.2 0.1 0.0 1.3 0.0 15.1 0.0 0.0 0.0 0.0 68.9 0.0 0.0 0.0 0.9 0.1 0.3 0.0 0.0 1.6 0.0 0.0 2.1 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 5.6 5.0 6.1 0.0 1.2 0.0 0.9 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.2 32.8 0.0 0.0 0.5 25.2 0.1 9.4 0.1 0.0 0.3 1.2 0.2 0.3 0.0 0.4 0.0 0.0 0.1 14.1 3.8 HNRNPDL "HNRPDL, JKTBP, laAUF1, LGMD1G" ENSG00000152795 "Heterogeneous nuclear ribonucleoprotein D like" O14979 4 82422565-82430462 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056820, HPA063147" Supported Enhanced Nucleoplasm NA NA 330000 Nucleoplasm "HPA056820: AB_2683246, HPA063147: AB_2684950" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (1.38e-1)" "unprognostic (3.29e-3)" "unprognostic (1.11e-1)" "unprognostic (3.13e-1)" "unprognostic (6.30e-3)" "unprognostic (7.19e-2)" "unprognostic (4.05e-2)" "unprognostic (3.59e-1)" "unprognostic (3.46e-1)" "unprognostic (5.56e-3)" "unprognostic (4.07e-2)" "unprognostic (1.72e-1)" "unprognostic (2.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.03e-2)" 249.4 194.3 167.1 223.0 191.3 408.4 261.3 174.2 210.9 281.4 153.9 256.7 152.8 285.9 158.6 211.3 277.8 148.6 224.9 170.0 176.7 211.3 182.7 294.9 249.8 187.9 185.3 160.9 371.9 250.9 112.7 233.0 162.9 194.2 220.1 154.7 212.5 201.9 157.2 398.7 210.6 248.2 206.8 172.3 245.2 235.3 120.6 180.8 200.9 247.4 170.3 190.1 235.2 268.6 228.4 405.2 208.8 762.2 151.9 282.0 152.2 249.8 426.5 460.4 371.3 351.5 289.2 324.8 745.8 263.5 467.3 191.2 306.5 582.9 395.3 433.5 165.3 421.1 432.9 354.2 524.9 133.0 745.8 309.1 271.1 112.3 417.2 370.3 294.6 299.6 467.5 572.4 300.4 365.7 169.3 701.6 519.6 526.6 363.9 244.4 624.1 615.1 342.2 437.2 259.4 322.5 556.0 265.6 339.6 262.3 344.7 354.3 418.2 253.4 371.2 462.1 246.3 519.7 351.6 363.7 828.3 325.4 428.8 320.2 44.5 36.8 32.3 60.4 59.6 49.9 63.3 54.0 56.7 29.1 61.4 74.6 66.0 15.3 42.9 77.8 46.8 46.0 51.3 167.1 191.3 174.2 210.9 170.0 176.7 187.9 185.3 160.9 194.2 172.3 180.8 228.4 314.7 272.4 281.3 104.8 486.6 659.0 612.1 364.2 429.6 223.4 287.0 304.9 201.0 150.2 359.4 152.6 106.3 520.8 472.3 128.1 297.4 338.3 57.7 294.3 410.9 296.7 236.0 260.7 163.9 255.8 629.2 361.5 271.7 432.2 387.7 319.8 127.1 132.7 326.5 176.7 152.9 225.5 240.1 218.2 452.0 50.7 212.5 344.3 311.3 80.6 339.0 303.9 272.9 143.7 298.8 231.5 131.1 202.8 480.6 556.8 173.0 300.2 288.2 188.3 164.3 602.9 397.0 161.8 391.4 433.0 554.2 521.0 488.0 238.7 241.1 478.6 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689955-92695647 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 85.5;liver: 92.0;thyroid gland: 102.9" "Cell type enhanced" "Detected in many" "B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5" "Group enriched" "Detected in all" 5 "liver cancer: 20.1;thyroid cancer: 56.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 43 "basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7" "Low region specificity" "Detected in many" "HPA003257, HPA051894" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003257: , HPA051894: AB_2681653" "prognostic favorable (8.83e-4)" "prognostic favorable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 14.6 18.7 5.0 22.4 4.8 85.5 11.3 5.2 8.9 6.4 5.5 7.4 6.5 6.4 3.5 4.2 6.2 27.6 5.3 4.5 5.1 6.2 92.0 17.1 39.4 5.6 5.1 3.5 3.0 38.5 1.9 2.3 14.7 5.9 4.8 6.5 0.3 3.5 4.0 3.0 4.7 19.1 5.8 5.9 40.2 5.3 2.4 7.0 4.5 102.9 6.3 30.7 12.8 5.1 6.2 11.2 20.6 10.5 0.1 0.9 0.7 0.2 5.6 46.4 7.4 6.6 4.0 2.6 10.7 87.7 0.7 0.0 2.1 9.5 0.3 9.1 0.1 11.1 99.9 8.8 67.4 21.0 58.6 105.6 0.3 0.2 6.5 0.0 3.7 106.1 0.3 154.8 0.1 0.5 3.2 0.4 101.8 0.2 30.2 11.8 34.0 3.0 0.1 0.9 4.3 4.9 1.0 6.2 0.0 0.1 0.5 3.3 30.6 37.2 0.0 0.6 0.1 0.1 2.6 1.8 21.2 0.0 79.7 51.4 28.0 41.5 61.8 0.8 45.7 0.3 59.3 0.0 0.1 30.8 65.8 0.1 0.1 31.4 1.0 50.7 36.3 0.4 15.5 5.0 4.8 5.2 8.9 4.5 5.1 5.6 5.1 3.5 5.9 5.9 7.0 6.2 31.9 0.0 3.0 0.0 77.2 6.4 2.1 0.9 2.2 0.0 3.0 3.2 3.6 125.8 1.6 0.0 0.0 0.7 57.6 0.4 0.0 107.9 0.3 0.8 0.5 80.0 5.3 28.2 0.0 12.0 0.7 2.2 0.5 1.0 7.0 0.0 88.9 58.3 72.6 0.0 0.0 1.6 0.0 63.5 29.1 1.1 0.3 51.7 7.2 5.6 50.4 0.0 9.2 0.5 0.0 10.5 0.0 1.2 1.6 3.2 0.0 0.2 0.9 0.2 0.0 1.9 2.1 0.3 6.3 1.0 3.7 1.1 8.3 3.4 0.7 1.3 UTRN "DMDL, DRP, DRP1" ENSG00000152818 Utrophin P46939 6 144285701-144853034 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 410.3;Early spermatids: 527.1;Late spermatids: 332.1;Microglial cells: 425.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 219.4;HUVEC TERT2: 157.0;TIME: 203.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016348, HPA018894" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 4200 "Nucleoplasm, Plasma membrane" "CAB016348: AB_628424, HPA018894: AB_10600839" "unprognostic (3.47e-2)" "unprognostic (2.82e-1)" "unprognostic (2.32e-1)" "unprognostic (6.87e-3)" "unprognostic (1.75e-1)" "unprognostic (3.30e-2)" "unprognostic (3.99e-3)" "unprognostic (2.44e-1)" "unprognostic (9.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.10e-2)" "prognostic favorable (7.61e-5)" "unprognostic (6.32e-2)" "unprognostic (2.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 53.1 17.6 29.0 26.0 40.7 57.1 40.9 36.2 22.9 40.8 47.1 34.1 17.1 30.1 16.9 28.1 43.9 31.4 25.0 17.4 64.1 31.2 25.5 49.7 35.2 45.8 43.0 10.3 37.5 52.5 69.9 8.0 46.2 51.3 40.1 32.0 11.1 26.2 26.3 14.1 27.7 22.4 26.1 35.3 72.1 27.4 59.7 47.9 43.6 69.0 39.2 36.1 25.4 16.1 37.7 27.2 22.6 39.3 51.0 66.5 60.5 23.4 39.0 37.8 31.1 45.2 86.1 9.8 8.4 33.6 88.4 36.6 15.6 219.4 32.9 44.6 90.6 25.5 32.2 24.9 51.6 26.3 36.1 0.7 35.5 6.8 46.2 24.1 29.3 157.0 25.1 2.0 22.7 44.1 18.1 28.7 15.5 15.9 16.6 23.9 25.7 70.2 0.8 35.9 0.7 49.7 0.9 60.8 8.4 23.5 59.5 33.3 48.2 203.6 29.8 37.0 15.5 37.6 17.7 25.3 1.3 18.2 21.5 49.5 41.2 40.9 23.2 39.5 120.8 28.3 25.7 24.9 33.0 17.2 35.7 21.8 22.8 34.5 37.6 173.9 50.4 22.2 13.9 29.0 40.7 36.2 22.9 17.4 64.1 45.8 43.0 10.3 51.3 35.3 47.9 37.7 267.0 410.3 138.7 148.2 101.2 29.4 31.7 17.2 40.9 6.5 47.4 32.1 56.0 28.6 111.0 31.3 0.0 94.4 175.1 10.9 0.0 25.3 527.1 61.2 51.5 171.8 31.2 19.8 61.2 32.0 6.9 51.6 76.5 87.5 29.7 22.8 83.6 15.6 22.3 60.6 161.4 16.9 8.2 109.7 45.9 332.1 23.9 97.6 39.2 425.3 79.8 29.1 171.0 68.9 4.1 28.1 9.3 33.4 70.3 25.4 3.6 7.1 87.3 4.3 144.7 151.0 157.8 6.6 6.6 33.7 45.5 129.3 108.0 32.0 22.3 19.2 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437601 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 29.0" "Group enriched" "Detected in some" 6 "Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 29.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015701 Approved Supported Approved Vesicles NA NA Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.0 0.0 3.6 0.0 4.0 0.0 0.0 29.0 7.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 8.0 3.9 0.7 0.0 0.0 0.0 1.2 4.3 6.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.0 29.0 7.5 8.0 3.9 1.2 4.3 6.3 6.5 0.0 9.0 2.9 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 3.7 0.0 0.0 1.8 16.7 0.0 0.0 0.0 1.9 0.0 8.5 0.1 0.0 0.2 0.0 0.0 215.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.6 6.7 138.8 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.7 0.0 4.0 0.0 8.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 124.9 0.0 0.0 0.1 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase receptor type K" Q15262 6 127968785-128520616 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 1.6;naive B-cell: 2.9" "Lineage enriched" "Detected in single" 7 "B-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: AB_2682359, HPA054822: AB_2682614" "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favorable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 9.7 4.2 14.8 9.7 21.1 0.2 25.8 17.9 20.5 13.6 10.2 27.5 33.1 12.2 8.3 9.8 15.0 32.8 11.7 17.0 17.1 15.0 29.8 19.6 6.9 18.6 18.2 16.2 15.2 26.4 10.3 7.0 22.0 19.5 19.1 27.9 4.7 15.4 19.2 5.9 12.1 28.7 16.1 16.1 8.0 30.8 2.2 18.4 10.3 11.8 10.0 8.7 21.1 12.4 31.5 17.3 16.7 10.9 1.0 24.9 31.9 11.0 43.6 86.3 18.4 16.6 28.8 15.0 0.1 13.4 40.7 50.8 49.0 10.2 35.9 26.7 50.3 19.4 0.3 23.6 45.7 29.7 0.0 1.7 23.9 35.4 35.9 49.6 50.8 54.0 14.7 0.0 1.1 49.3 33.6 26.6 0.1 11.9 34.5 22.6 94.8 21.7 3.1 51.1 33.4 43.8 0.1 45.2 55.6 2.7 12.4 14.6 1.1 86.9 30.0 18.4 54.8 42.2 0.7 6.0 0.0 38.1 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.9 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.1 14.8 21.1 17.9 20.5 17.0 17.1 18.6 18.2 16.2 19.5 16.1 18.4 31.5 39.2 25.6 33.5 155.7 17.5 63.5 88.1 45.2 60.3 7.3 56.6 26.5 22.2 101.5 44.1 18.4 4.2 24.8 0.8 75.2 0.0 63.2 4.6 30.6 11.5 46.6 43.9 0.0 889.9 61.3 4.1 28.6 77.5 77.5 1.3 13.4 11.4 40.9 6.4 10.1 55.3 44.2 8.2 1.6 8.8 2.7 17.1 2.2 17.8 200.5 1.7 5.1 0.0 313.1 1278.1 124.2 53.8 18.0 1.0 115.8 68.7 13.4 25.9 0.7 59.2 20.1 41.5 11.3 8.9 27.0 38.1 26.8 3.4 14.1 56.6 157.0 GGPS1 GGPPS1 ENSG00000152904 "Geranylgeranyl diphosphate synthase 1" O95749 1 235327350-235344532 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isoprene biosynthesis" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 212.7;Late spermatids: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029472, HPA050727" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029472: AB_10696206, HPA050727: " "unprognostic (7.45e-2)" "unprognostic (3.18e-2)" "unprognostic (1.25e-1)" "unprognostic (2.23e-2)" "unprognostic (1.43e-1)" "unprognostic (3.10e-3)" "prognostic unfavorable (6.69e-4)" "unprognostic (4.50e-2)" "unprognostic (3.66e-2)" "unprognostic (3.77e-3)" "unprognostic (2.66e-2)" "unprognostic (8.77e-3)" "unprognostic (1.95e-2)" "unprognostic (1.99e-1)" "unprognostic (3.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-2)" 24.2 23.7 23.3 17.5 24.7 7.8 34.4 26.0 27.8 24.7 21.4 21.7 21.4 23.5 30.6 22.6 21.4 20.1 23.8 24.4 25.0 28.0 21.8 20.3 21.5 24.8 24.5 22.1 23.5 16.6 21.3 17.7 19.3 25.6 29.7 24.1 39.2 31.4 19.9 30.1 20.5 20.8 25.9 25.4 20.7 20.6 48.6 23.7 27.9 27.6 29.2 22.1 23.8 17.1 28.6 41.3 22.3 54.5 41.5 41.7 59.9 20.5 36.2 50.7 23.6 33.1 17.5 64.5 28.1 51.3 40.6 38.1 33.5 29.4 37.8 31.2 28.8 54.4 24.0 19.7 29.9 46.9 30.0 19.7 39.3 66.5 32.2 43.0 41.8 42.5 46.2 58.5 24.7 31.5 24.6 37.0 35.7 46.4 109.9 11.5 22.6 17.3 32.6 66.2 22.4 43.3 59.8 27.3 61.5 54.7 20.1 76.7 46.5 35.9 27.9 20.8 47.6 34.7 42.0 55.8 34.3 35.4 33.3 51.4 43.7 31.0 48.5 31.5 37.3 32.1 38.6 39.5 33.8 30.4 32.8 36.2 33.4 27.8 31.9 54.2 25.2 42.5 36.8 23.3 24.7 26.0 27.8 24.4 25.0 24.8 24.5 22.1 25.6 25.4 23.7 28.6 18.3 32.1 34.5 16.3 27.2 39.9 60.4 64.6 27.9 32.1 29.1 22.4 24.5 17.2 39.5 20.2 43.8 30.7 24.1 21.4 72.4 37.5 212.7 16.8 15.1 29.4 17.4 12.0 26.5 28.3 43.7 31.0 14.3 12.9 24.6 16.4 28.9 13.0 26.8 48.8 25.7 26.1 69.2 26.9 49.0 290.7 35.8 24.3 67.6 20.6 36.7 55.4 36.0 15.6 23.2 31.8 23.3 35.0 8.5 65.6 29.3 61.3 30.4 51.2 26.3 26.1 32.5 111.6 50.0 18.7 40.6 47.1 33.0 30.9 22.7 55.9 CNTNAP4 "CASPR4, KIAA1763" ENSG00000152910 "Contactin associated protein family member 4" Q9C0A0 16 76277278-76560757 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 121.0" "Group enriched" "Detected in some" 8 "Inhibitory neurons: 326.7;Oligodendrocytes: 1150.3" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Daudi: 11.0;HSkMC: 4.3;Karpas-707: 3.3;RPMI-8226: 7.1" HPA031859 Enhanced NA NA 2800000 "HPA031859: AB_10601360" "unprognostic (7.88e-2)" "unprognostic (7.19e-2)" "unprognostic (6.58e-2)" "unprognostic (2.46e-1)" "unprognostic (1.55e-2)" "unprognostic (1.50e-3)" "unprognostic (9.42e-3)" "unprognostic (1.91e-2)" "unprognostic (5.26e-4)" "unprognostic (1.83e-2)" "unprognostic (2.00e-2)" "unprognostic (4.56e-1)" "unprognostic (1.09e-1)" 0.1 0.9 34.5 0.0 51.9 0.0 0.1 44.5 39.9 0.2 5.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.9 51.7 0.0 0.0 0.0 0.0 69.5 55.2 20.0 0.0 0.0 0.0 0.5 0.0 68.3 0.2 0.0 7.5 0.0 0.3 0.0 0.0 0.1 0.0 60.9 0.0 0.0 0.7 54.3 0.0 0.0 0.1 0.0 0.0 0.2 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 51.9 44.5 39.9 23.9 51.7 69.5 55.2 20.0 68.3 60.9 54.3 121.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.1 0.1 0.0 0.0 87.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 326.7 0.0 0.0 0.0 0.2 9.0 0.0 0.0 0.0 7.5 0.0 4.6 0.0 15.6 1150.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.2 0.1 0.9 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 ZNF117 "H-plk, HPF9" ENSG00000152926 "Zinc finger protein 117" Q03924 7 64971772-65006684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 21.0;SuSa: 21.9;THP-1: 21.9" HPA031148 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA031148: AB_2673759" "unprognostic (1.04e-1)" "unprognostic (3.04e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.35e-2)" "unprognostic (1.45e-2)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-1)" "unprognostic (7.10e-2)" "prognostic unfavorable (2.17e-11)" "unprognostic (1.08e-1)" "unprognostic (9.19e-2)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" 20.8 28.3 4.2 7.1 3.4 5.5 17.2 3.5 4.5 11.0 4.7 5.7 2.3 8.4 11.3 12.1 8.3 10.3 6.8 3.6 6.5 6.0 3.5 10.9 6.0 4.5 4.1 2.6 10.7 5.3 3.7 9.4 10.2 3.7 7.7 4.7 11.9 7.9 4.9 2.8 8.3 5.0 5.7 4.1 9.0 4.6 12.4 3.2 4.7 8.6 1.4 5.7 6.8 11.7 4.6 1.7 0.1 20.0 21.0 7.4 3.4 11.2 4.4 1.0 1.1 2.1 0.9 8.6 7.6 3.6 2.2 3.2 1.3 2.3 0.5 2.4 2.3 2.0 3.5 0.5 4.2 0.6 0.0 2.0 4.3 0.8 0.8 0.8 8.0 3.4 8.8 14.4 5.1 5.0 3.8 8.0 7.9 8.4 2.5 0.3 10.4 1.3 1.5 2.7 3.3 3.1 16.9 2.2 0.9 0.9 21.9 3.8 21.9 10.2 6.0 0.7 3.6 2.8 3.4 6.7 3.9 2.2 9.7 3.7 0.2 0.2 0.3 0.2 0.7 0.2 0.3 0.1 0.1 0.2 0.3 0.1 0.1 2.4 0.3 0.2 0.2 0.1 0.1 4.2 3.4 3.5 4.5 3.6 6.5 4.5 4.1 2.6 3.7 4.1 3.2 4.6 10.3 3.2 43.0 35.6 4.2 3.3 5.8 6.2 0.6 14.3 15.5 10.7 7.3 12.8 23.2 5.5 0.0 5.4 5.4 3.3 11.7 10.9 3.1 7.5 10.4 10.9 5.3 2.1 11.4 28.5 2.5 9.6 3.1 8.9 10.8 21.1 17.5 4.2 6.6 28.6 11.6 4.1 10.2 7.9 7.5 3.1 8.7 11.8 5.4 9.4 4.1 7.1 7.2 19.6 7.2 17.7 1.7 5.3 2.3 4.6 1.6 3.3 20.2 7.7 6.6 7.1 7.9 7.2 8.4 3.2 4.7 11.1 3.8 10.3 2.4 12.3 RAB3C ENSG00000152932 "RAB3C, member RAS oncogene family" Q96E17 5 58582221-58859394 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 51.7" "Group enriched" "Detected in many" 4 "Excitatory neurons: 140.6;Inhibitory neurons: 509.9;Oligodendrocyte precursor cells: 131.2" "Cancer enhanced" "Detected in some" "glioma: 1.0;pancreatic cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;HEL: 2.5;NB-4: 1.6;SCLC-21H: 10.2;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, HPA048156" Enhanced Approved Cytosol NA NA Cytosol "HPA003160: AB_1079731, HPA048156: AB_2680291" "unprognostic (1.30e-1)" "unprognostic (3.35e-2)" "unprognostic (9.94e-2)" "unprognostic (2.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (8.73e-3)" "unprognostic (3.40e-2)" "unprognostic (6.90e-2)" "unprognostic (7.58e-2)" "unprognostic (9.52e-4)" "unprognostic (1.51e-3)" "unprognostic (3.70e-5)" "unprognostic (4.70e-2)" "unprognostic (1.05e-1)" "unprognostic (9.65e-2)" "unprognostic (3.61e-3)" 1.1 9.1 11.9 1.2 22.0 0.0 0.7 0.9 33.2 0.1 0.0 0.6 1.6 0.7 0.0 0.2 0.2 0.7 0.1 11.0 43.0 0.1 0.1 0.1 0.2 8.1 24.4 16.3 0.3 1.7 0.1 6.9 0.1 23.1 0.0 0.8 6.1 0.1 0.0 0.1 0.1 1.8 0.7 0.1 0.0 0.9 0.1 32.8 0.1 0.1 0.0 0.2 0.6 0.2 51.7 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 3.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 22.0 0.9 33.2 11.0 43.0 8.1 24.4 16.3 23.1 0.1 32.8 51.7 8.6 0.0 0.6 10.1 0.4 0.1 0.0 0.0 0.0 28.3 0.3 0.3 0.7 0.0 0.0 0.0 4.2 0.0 0.0 0.0 3.9 0.1 20.0 0.0 0.1 12.1 57.6 1.3 140.6 9.6 0.8 0.2 0.0 0.0 2.5 0.0 5.7 1.2 0.1 3.3 509.9 5.5 0.0 0.9 1.1 11.8 0.9 0.1 1.8 6.5 0.0 1.6 0.0 131.2 8.4 3.9 1.2 0.7 0.0 0.0 0.3 0.1 0.0 6.7 13.1 0.5 0.2 2.4 4.1 0.0 0.1 0.0 1.3 0.1 0.3 0.0 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 13.9;fallopian tube: 17.1;testis: 14.9" "Group enriched" "Detected in some" 4 "Astrocytes: 15.0;Early spermatids: 49.0;Endometrial ciliated cells: 17.6;Late spermatids: 40.6;Respiratory ciliated cells: 14.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;RT4: 7.7;SH-SY5Y: 7.6;U-2197: 26.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038640: AB_2676127" "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.1 13.8 0.7 5.9 0.3 1.0 6.3 3.8 0.5 2.9 3.6 1.4 0.7 0.6 0.3 17.1 0.8 0.2 4.8 13.9 0.7 0.2 1.3 0.3 11.7 10.8 2.7 0.2 0.6 0.0 0.7 0.2 7.4 0.2 3.4 1.2 0.0 0.2 0.2 0.4 0.6 1.1 10.0 0.6 0.6 14.9 5.7 0.2 0.9 0.0 0.2 0.3 0.0 10.0 0.4 0.3 0.0 0.2 0.2 1.6 2.7 3.3 6.2 1.4 0.2 0.0 0.4 0.2 0.1 0.0 3.9 0.1 0.3 0.1 0.3 1.1 0.1 1.1 0.9 2.3 0.3 0.1 0.1 0.5 0.2 1.8 0.5 0.1 0.1 0.0 2.3 0.4 0.0 0.5 0.0 0.4 1.8 0.1 0.6 0.5 0.2 0.2 0.2 7.7 0.2 7.6 0.1 0.4 4.3 0.9 0.3 1.8 0.3 0.2 1.0 26.8 0.3 0.8 1.6 1.8 0.3 1.8 2.9 0.5 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.2 0.3 0.5 0.1 0.0 0.5 0.1 0.1 13.8 5.9 6.3 3.8 4.8 13.9 11.7 10.8 2.7 7.4 10.0 5.7 10.0 0.1 0.0 0.0 15.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 0.3 0.6 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.9 0.0 49.0 17.6 0.1 0.1 0.0 0.0 1.5 0.0 0.3 0.3 0.0 0.2 0.0 0.7 0.0 0.4 0.1 0.0 1.0 0.0 0.0 0.3 0.0 40.6 0.0 0.3 0.0 5.6 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.1 14.6 0.0 0.0 0.7 0.1 1.1 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.9 MARVELD2 "DFNB49, FLJ30532, MRVLDC2, TRIC" ENSG00000152939 "MARVEL domain containing 2" Q8N4S9 5 69415065-69444330 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 15.8" "Cell type enhanced" "Detected in many" "Urothelial cells: 46.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3" "Region enriched" "Detected in some" 8 "cerebellum: 7.9" "Low region specificity" "Detected in all" "HPA018119, HPA061726" Uncertain Supported "Cell Junctions" NA NA "Cell Junctions" "HPA018119: AB_2669771, HPA061726: AB_2684595" "unprognostic (4.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-3)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" "unprognostic (8.84e-2)" "unprognostic (2.43e-1)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "prognostic favorable (2.84e-13)" "unprognostic (1.78e-1)" "unprognostic (1.19e-1)" "unprognostic (3.67e-2)" "unprognostic (1.82e-1)" 0.3 0.2 0.8 0.9 0.5 0.3 4.1 0.5 0.6 2.1 2.8 5.8 7.8 1.1 1.3 7.0 3.9 3.0 0.3 0.5 0.6 8.0 10.8 5.6 0.1 0.7 0.7 0.2 0.1 9.4 4.7 2.9 1.8 0.7 3.0 6.3 0.3 4.6 2.6 0.0 4.2 7.8 0.4 0.4 0.2 8.2 1.5 0.7 1.0 15.8 0.0 1.3 3.1 3.4 0.8 10.8 3.5 0.1 0.0 0.0 0.0 29.5 0.2 0.2 0.2 0.7 14.1 24.1 0.1 2.0 1.8 0.0 18.9 0.0 14.0 0.5 0.2 5.8 0.0 1.1 7.8 1.7 0.0 0.1 0.4 15.3 0.1 1.9 0.7 0.9 0.1 0.0 0.1 0.0 9.8 0.0 0.0 1.8 6.3 0.3 0.0 0.1 0.5 10.0 21.1 26.7 0.0 2.3 2.0 0.3 4.3 18.3 0.0 1.5 0.0 0.1 0.0 0.0 0.1 3.5 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.5 0.5 0.6 0.5 0.6 0.7 0.7 0.2 0.7 0.4 0.7 0.8 1.0 22.4 26.5 0.7 1.0 5.0 22.2 14.8 10.2 0.3 15.5 8.5 2.8 35.8 23.1 16.5 2.1 22.9 0.2 31.4 17.6 25.1 5.8 33.5 3.4 4.1 16.8 3.4 0.5 25.8 8.2 1.1 17.9 30.4 1.3 3.7 5.0 37.9 1.9 0.0 0.4 23.1 18.3 0.6 0.9 3.2 0.0 0.6 1.8 1.0 7.8 0.5 0.0 0.5 0.6 25.0 29.7 0.0 0.6 25.5 33.5 6.1 38.4 0.6 0.0 0.8 1.5 4.1 2.4 19.4 6.5 12.0 0.9 2.9 25.6 46.9 RAD17 "CCYC, RAD17Sp, Rad24" ENSG00000152942 "RAD17 checkpoint clamp loader component" O75943 5 69369293-69414801 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 121.6;Spermatocytes: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004551, HPA005448" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004551: AB_628195, HPA005448: AB_1079738" "unprognostic (1.25e-1)" "unprognostic (1.46e-1)" "unprognostic (3.28e-3)" "unprognostic (2.21e-1)" "unprognostic (2.30e-1)" "unprognostic (6.04e-2)" "unprognostic (7.75e-3)" "unprognostic (6.09e-2)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (1.59e-2)" "unprognostic (5.74e-2)" "prognostic favorable (5.79e-6)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-2)" 9.4 11.6 7.7 8.6 8.2 8.0 11.8 8.6 8.8 9.8 8.4 10.6 4.8 10.1 8.2 9.5 9.2 5.4 11.1 8.2 8.8 13.4 13.5 8.3 19.5 8.1 8.0 7.7 10.4 16.6 13.0 16.3 8.3 8.3 9.7 9.4 16.6 10.8 8.6 13.4 9.6 11.8 5.7 7.6 13.4 11.9 41.5 8.3 14.9 11.2 8.4 13.1 9.5 9.0 9.1 16.2 7.0 21.7 25.7 0.0 0.2 26.5 15.7 19.8 21.0 29.5 16.9 17.3 70.7 16.6 9.1 41.9 7.4 21.8 9.1 32.3 0.0 11.8 17.3 17.0 16.9 25.3 0.5 21.7 15.1 14.9 15.6 15.2 0.0 18.4 18.3 16.9 21.0 26.7 0.0 32.2 11.8 13.4 6.7 8.8 27.7 19.8 15.9 25.1 14.5 22.7 15.8 14.4 4.5 0.6 22.8 21.2 21.1 5.6 0.0 19.1 9.8 10.3 26.9 44.6 24.4 21.3 33.7 14.2 1.4 2.3 4.0 4.3 2.9 4.2 7.5 3.9 4.6 3.4 5.5 5.4 4.7 0.9 6.5 1.4 1.7 5.8 2.5 7.7 8.2 8.6 8.8 8.2 8.8 8.1 8.0 7.7 8.3 7.6 8.3 9.1 17.5 32.1 17.9 20.2 20.2 5.5 6.5 10.3 12.0 17.9 13.6 15.1 33.5 8.6 19.9 5.5 20.9 18.0 20.5 9.5 25.4 12.8 121.6 19.4 23.7 13.9 15.1 24.4 16.5 12.9 17.3 11.5 12.8 16.0 30.9 20.2 10.8 12.6 10.1 6.7 17.8 11.1 14.2 10.4 4.3 72.3 14.3 11.9 5.4 11.2 15.6 20.8 16.5 23.1 28.1 12.2 7.5 10.9 31.7 9.3 11.1 24.3 29.3 45.4 6.6 20.1 16.5 172.7 70.1 12.5 5.8 14.1 17.2 16.7 10.8 6.4 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 228.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 16.1 25.1 11.2 9.9 12.5 29.2 18.4 15.7 15.3 21.6 12.3 17.7 12.3 20.5 15.1 24.1 19.3 15.1 25.6 12.3 14.1 26.5 16.2 16.7 13.1 10.9 10.7 10.6 25.1 13.4 25.9 18.0 16.5 10.3 18.5 17.1 12.5 21.1 17.2 28.1 15.3 12.1 22.0 10.8 12.1 16.4 30.0 10.8 21.3 19.1 35.8 17.2 22.9 24.0 12.2 36.6 40.5 18.6 27.5 41.3 36.1 29.7 46.2 24.5 30.2 32.5 42.5 37.3 21.4 25.9 26.5 54.2 30.7 41.1 36.3 53.8 21.6 36.8 36.5 37.9 22.4 22.0 41.3 21.2 31.1 46.4 45.3 50.0 54.0 46.6 30.8 25.8 28.2 34.7 27.1 38.1 63.8 54.3 50.1 49.8 29.3 133.5 23.7 28.1 37.4 13.4 17.7 57.3 18.2 26.1 79.9 34.6 26.4 39.0 34.8 28.7 43.3 40.3 9.6 21.4 37.8 34.7 39.4 23.3 54.9 23.8 33.6 26.2 26.0 25.4 28.8 30.0 30.8 22.5 26.9 35.2 30.4 18.7 19.0 24.6 18.3 34.5 26.9 11.2 12.5 15.7 15.3 12.3 14.1 10.9 10.7 10.6 10.3 10.8 10.8 12.2 30.9 16.0 23.0 7.8 35.4 98.9 121.4 95.1 72.8 9.9 39.4 33.5 32.1 22.8 45.0 53.3 0.0 62.0 33.1 18.5 93.9 41.7 228.6 32.7 26.3 33.0 17.9 68.8 23.8 38.0 56.8 50.8 18.8 35.1 18.4 31.3 25.7 21.8 31.7 13.5 17.6 20.8 65.1 21.7 50.2 87.8 48.4 22.4 71.2 7.5 29.1 27.1 11.3 10.6 14.4 33.4 19.9 47.4 24.5 85.3 22.4 109.3 20.8 13.6 19.7 37.4 54.8 157.7 61.8 70.5 101.3 61.0 46.7 30.6 20.4 145.8 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 130.9;Basal respiratory cells: 115.1;Distal enterocytes: 143.7;Extravillous trophoblasts: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 636.0;hTERT-RPE1: 723.8;U-87 MG: 566.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA 21000 "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 63.7 20.3 14.8 35.9 14.5 1.1 18.8 16.9 17.4 9.5 21.0 36.5 42.6 23.7 13.5 18.4 11.5 41.8 17.6 14.4 25.7 26.3 57.8 13.1 3.9 24.9 16.1 12.9 20.7 18.9 16.7 7.9 81.2 17.2 13.4 30.2 57.1 9.6 16.3 3.0 3.6 35.3 47.2 19.4 5.5 20.3 8.6 20.1 10.5 90.9 4.0 5.5 25.9 10.1 32.9 134.5 94.3 29.0 9.5 102.5 109.6 73.2 465.5 141.6 247.7 463.0 7.2 13.4 0.0 88.8 79.5 113.1 27.8 34.0 400.5 636.0 0.6 53.5 33.3 84.3 66.9 262.5 0.1 0.6 192.9 56.5 215.2 104.1 723.8 347.7 0.1 45.1 1.8 441.6 48.8 0.3 0.6 18.5 0.3 40.0 0.2 19.2 0.6 105.0 6.5 14.5 0.5 370.3 39.4 39.9 135.1 107.5 4.2 440.4 304.2 92.2 97.8 280.7 138.9 20.9 0.5 566.5 0.4 55.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 14.8 14.5 16.9 17.4 14.4 25.7 24.9 16.1 12.9 17.2 19.4 20.1 32.9 29.1 16.0 11.4 130.9 0.4 7.0 6.4 115.1 30.1 17.1 23.7 10.2 14.3 44.3 47.0 27.6 35.5 9.2 0.3 143.7 9.8 64.5 0.5 35.4 13.8 24.3 19.8 4.6 22.8 53.1 130.6 68.1 19.9 38.7 0.0 42.7 21.0 65.2 5.1 0.0 46.4 19.5 22.4 1.0 2.5 1.2 13.1 3.0 14.2 21.5 0.7 53.8 0.0 64.3 6.0 82.4 48.8 4.9 1.3 8.9 50.5 8.2 33.0 24.7 19.7 36.9 47.2 11.0 18.0 27.5 5.5 18.7 1.0 24.5 25.1 5.6 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051480-5500994 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 15.1;lymphoid tissue: 19.7" "Cell type enhanced" "Detected in many" "Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4" "Cancer enhanced" "Detected in many" "renal cancer: 6.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 3.0 0.3 2.7 1.2 6.1 1.5 4.3 1.9 2.3 3.4 1.5 1.2 0.5 3.5 0.3 1.2 1.3 1.4 0.3 2.1 3.6 15.1 0.1 0.9 1.8 4.9 3.5 2.3 0.6 1.9 0.3 0.4 3.2 3.7 0.6 1.1 0.8 1.0 0.9 1.3 2.0 1.1 2.5 3.7 0.2 6.1 4.6 3.4 19.7 1.7 1.7 1.0 3.1 1.5 3.5 0.0 14.0 0.8 0.0 0.6 1.0 0.0 9.7 1.1 6.3 0.2 0.1 0.0 0.0 2.1 19.7 27.5 0.1 1.5 0.0 2.3 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.2 27.5 1.4 0.0 0.1 3.4 0.0 0.0 2.0 4.1 0.0 0.0 25.2 0.1 0.0 6.2 0.0 0.4 0.0 0.0 0.1 8.5 0.6 0.0 0.0 7.1 0.2 2.8 43.8 0.0 0.9 0.1 0.0 0.1 0.0 112.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 6.1 1.9 2.3 2.1 3.6 4.9 3.5 2.3 3.7 3.7 3.4 3.5 3.6 0.0 1.1 1.6 0.0 2.3 0.2 0.0 0.0 0.0 4.2 1.7 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 17.6 1.1 108.2 0.2 0.1 3.2 0.0 0.0 3.7 0.0 0.1 5.5 4.1 0.3 0.0 0.0 0.0 0.0 1.7 0.0 14.4 0.0 0.0 0.0 1.2 39.3 1.5 1.1 5.4 27.2 0.5 0.0 0.0 169.4 1.3 0.4 0.0 1.2 0.0 0.1 0.0 18.9 0.0 0.0 0.0 0.6 0.4 1.2 5.5 0.0 1.0 0.0 0.2 0.4 0.0 0.1 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126186-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "brain: 754.9;choroid plexus: 429.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 11.2;SH-SY5Y: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 0.0 5.0 305.9 0.4 257.2 0.2 0.0 104.4 259.7 0.1 429.8 0.9 0.4 0.2 0.0 0.1 0.0 0.2 0.0 135.4 264.6 0.1 0.0 0.0 0.1 287.0 271.8 45.3 0.0 1.2 0.0 23.7 0.0 563.0 0.0 0.4 22.8 0.1 0.0 0.7 0.1 0.3 0.3 206.0 0.1 0.4 0.3 476.2 0.0 0.1 0.0 0.1 0.0 0.1 754.9 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 11.2 9.2 0.0 0.0 0.2 0.1 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.3 0.5 0.2 0.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.9 257.2 104.4 259.7 135.4 264.6 287.0 271.8 45.3 563.0 206.0 476.2 754.9 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.1 0.0 0.0 139.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 121.1 111.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 23.7 0.0 69.9 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JAKMIP1 "FLJ31564, Gababrbp, JAMIP1, MARLIN1" ENSG00000152969 "Janus kinase and microtubule interacting protein 1" Q96N16 4 6026199-6200591 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.6;pituitary gland: 10.3;retina: 17.1" "Cell type enhanced" "Detected in some" "Astrocytes: 35.6;dendritic cells: 17.6;Excitatory neurons: 82.9;Inhibitory neurons: 53.6;Muller glia cells: 61.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "gdT-cell: 25.3;MAIT T-cell: 11.2;memory CD4 T-cell: 11.2;memory CD8 T-cell: 22.6;naive CD8 T-cell: 10.1;T-reg: 36.7" "Lineage enriched" "Detected in many" 33 "T-cells: 36.7" "Cell line enhanced" "Detected in some" "Daudi: 15.8;JURKAT: 14.3;MOLT-4: 45.2;SCLC-21H: 18.6;U-266/70: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044570 Uncertain NA NA "HPA044570: AB_2678995" "unprognostic (4.79e-2)" "unprognostic (3.46e-3)" "unprognostic (4.90e-2)" "unprognostic (1.73e-2)" "unprognostic (5.34e-2)" "unprognostic (3.86e-3)" "unprognostic (6.16e-2)" "unprognostic (6.69e-3)" "unprognostic (4.25e-4)" "unprognostic (7.14e-2)" "unprognostic (4.57e-3)" "unprognostic (1.13e-1)" "unprognostic (3.70e-8)" "unprognostic (1.85e-2)" "unprognostic (3.15e-1)" "unprognostic (4.23e-2)" "unprognostic (2.96e-3)" 0.3 4.8 20.5 1.0 29.6 1.3 0.1 8.2 33.6 0.1 1.7 0.9 0.2 0.1 0.1 0.3 0.2 0.5 0.1 24.7 21.0 0.2 0.3 0.9 3.1 15.1 14.8 21.9 0.5 0.6 0.0 10.3 0.0 14.4 4.2 0.2 17.1 0.7 0.1 0.1 0.1 1.1 0.2 8.2 2.7 0.6 5.2 16.0 0.3 0.7 0.0 0.6 0.7 0.3 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 8.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.4 45.2 0.0 3.4 0.0 2.6 2.3 0.0 0.7 0.0 0.0 18.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.3 0.0 11.2 0.3 11.2 22.6 0.0 0.2 0.8 10.1 0.1 1.1 0.0 0.1 36.7 5.4 20.5 29.6 8.2 33.6 24.7 21.0 15.1 14.8 21.9 14.4 8.2 16.0 23.2 0.2 0.0 0.0 35.6 0.8 0.0 0.0 0.0 0.0 1.5 0.2 0.1 0.8 0.0 0.0 0.0 2.1 0.0 17.6 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.4 82.9 0.0 0.0 0.5 2.6 0.8 0.0 0.2 0.0 0.0 0.1 3.3 53.6 0.0 0.0 1.3 0.5 2.4 0.0 0.5 0.0 7.5 0.3 61.2 12.3 7.1 3.1 0.1 0.0 0.0 2.3 1.3 0.0 0.1 0.0 5.4 0.0 0.0 0.2 0.9 4.6 0.0 0.1 0.0 16.2 0.4 0.0 0.0 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 563.5" "Group enriched" "Detected in some" 4 "Microglial cells: 25.3;Skeletal myocytes: 61.0" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 4 "cerebellum: 563.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 174.0;MCF7: 43.9;U-2197: 28.5" "Region enhanced" "Detected in all" "cerebellum: 207.4" "Region enriched" "Detected in all" 8 "cerebellum: 638.1" HPA004098 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 1.9 0.7 33.5 0.0 47.4 0.0 0.2 563.5 29.6 0.0 40.4 0.1 0.2 0.0 1.9 0.3 0.0 0.1 0.0 11.1 30.8 0.0 12.9 0.1 0.1 65.4 63.6 4.9 0.2 0.1 0.0 2.5 0.0 137.9 0.0 0.1 10.8 0.5 0.0 6.9 2.2 0.8 0.0 16.7 0.0 0.2 0.3 66.2 0.0 0.0 0.8 0.0 0.0 0.0 39.6 0.0 0.0 174.0 0.0 17.9 19.6 9.8 11.4 13.5 12.1 9.9 0.0 0.0 0.0 9.1 0.9 9.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.4 0.0 0.7 0.0 0.0 3.1 0.0 10.9 43.9 0.0 0.0 0.5 0.9 0.0 0.0 17.1 0.0 0.0 0.0 0.0 8.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 17.9 0.0 28.5 11.0 0.0 0.0 0.0 13.5 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 47.4 563.5 29.6 11.1 30.8 65.4 63.6 4.9 137.9 16.7 66.2 39.6 0.2 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.3 0.9 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.0 25.3 0.0 4.3 0.0 2.0 9.5 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 61.0 0.3 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 ADGRA3 "FLJ38547, GPR125, PGR21" ENSG00000152990 "Adhesion G protein-coupled receptor A3" Q8IWK6 4 22345071-22516066 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.7" "Cell type enhanced" "Detected in many" "Astrocytes: 221.7;Hepatocytes: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008904 Uncertain "Intracellular and membrane" NA NA 280000 "HPA008904: AB_1849258" "unprognostic (3.70e-1)" "unprognostic (9.01e-2)" "unprognostic (5.32e-3)" "unprognostic (8.27e-3)" "unprognostic (4.58e-2)" "unprognostic (1.55e-1)" "unprognostic (8.15e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (3.91e-2)" "unprognostic (8.77e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-3)" 8.2 9.6 21.4 3.7 19.0 1.9 11.0 22.6 20.1 11.0 37.1 17.3 7.3 15.2 9.7 5.2 21.8 7.7 10.9 20.5 23.9 10.5 58.7 5.1 1.2 25.6 27.0 15.8 9.0 12.6 12.3 7.3 9.3 26.6 12.1 17.3 6.0 8.3 11.6 17.7 4.4 7.0 14.1 25.9 2.7 9.7 6.9 24.1 5.2 25.4 11.5 2.6 5.7 4.9 23.8 19.6 14.4 36.5 30.6 29.0 13.0 32.7 23.5 25.7 15.5 8.4 16.5 38.1 3.0 11.7 11.2 21.5 21.1 23.2 33.4 22.1 0.0 16.3 1.7 11.3 37.0 9.7 17.1 0.0 12.3 40.9 10.1 17.5 29.5 23.7 12.2 17.9 0.6 26.1 8.7 15.3 0.5 40.3 18.3 14.6 70.7 74.6 4.9 18.8 19.9 27.1 31.3 9.8 0.8 16.7 25.1 10.1 14.8 0.5 23.2 16.6 10.6 22.4 2.7 0.0 0.1 12.7 12.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 21.4 19.0 22.6 20.1 20.5 23.9 25.6 27.0 15.8 26.6 25.9 24.1 23.8 2.4 3.2 4.1 221.7 1.1 0.0 13.4 0.0 11.4 11.8 12.0 14.6 14.5 21.5 5.0 16.5 20.9 21.8 2.3 18.8 0.0 18.4 7.9 50.1 23.2 3.1 12.2 9.1 12.3 11.8 7.9 10.2 10.2 41.4 0.0 28.5 6.1 120.4 3.4 0.0 18.9 18.8 0.0 5.4 0.0 7.4 9.6 1.8 0.0 9.4 0.4 6.2 0.0 54.3 3.5 20.3 12.2 9.8 0.2 21.0 10.6 5.4 2.2 13.5 0.0 25.7 8.0 1.3 7.2 2.5 0.0 7.3 1.3 11.7 22.2 11.1 CPB1 ENSG00000153002 "Carboxypeptidase B1" P15086 3 148791102-148860187 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1969 "pancreas: 228861.2" "Cell type enriched" "Detected in some" 12 "Exocrine glandular cells: 7306.0" "Group enriched" "Detected in some" 312 "breast cancer: 293.8;pancreatic cancer: 641.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.0;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026158, HPA038069, HPA046340" Enhanced "Secreted to digestive system" NA NA 88000000 "CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628" "unprognostic (6.90e-2)" "unprognostic (3.79e-2)" "unprognostic (3.34e-2)" "unprognostic (2.64e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (6.26e-4)" "unprognostic (1.90e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (7.59e-2)" "unprognostic (4.51e-2)" "unprognostic (5.50e-8)" "unprognostic (3.08e-1)" "unprognostic (1.60e-1)" "unprognostic (4.93e-2)" 12.1 83.7 0.4 5.1 1.5 2.5 79.2 0.5 1.0 3.6 0.2 2.7 31.5 4.8 0.3 3.5 1.8 0.1 41.1 0.5 0.7 2.0 7.1 1.7 8.2 1.0 1.1 0.2 116.2 228861.2 0.0 2.1 13.8 1.2 4.8 4.5 0.0 36.6 0.0 2.3 2.4 17.3 0.0 0.3 19.4 28.5 2.9 0.9 0.1 1.6 0.0 0.0 1.5 2.1 3.4 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 4.0 0.3 0.5 1.3 0.4 0.9 0.4 0.5 1.1 0.1 0.7 0.3 1.4 1.9 1.4 0.5 0.5 0.3 0.4 0.4 1.5 0.5 1.0 0.5 0.7 1.0 1.1 0.2 1.2 0.3 0.9 3.4 2.2 0.0 0.0 1.0 0.0 0.6 0.5 0.0 0.0 0.0 8.7 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.6 11.2 0.0 0.1 1.1 164.9 1.3 0.3 7306.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.0 1.0 2.5 0.6 1.5 0.0 0.0 18.1 0.0 0.0 0.0 29.8 590.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 4.2 2.5 0.0 1.1 0.1 0.3 0.3 0.3 1.1 0.2 0.2 SREK1IP1 "FLJ36754, P18SRP, SFRS12IP1" ENSG00000153006 "SREK1 interacting protein 1" Q8N9Q2 5 64718148-64768691 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 300.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045677, HPA062853" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045677: AB_10964635, HPA062853: AB_2684881" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (8.67e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.67e-1)" "unprognostic (8.39e-2)" "unprognostic (3.85e-2)" "unprognostic (1.99e-1)" 6.3 5.5 5.8 4.3 6.1 4.7 6.4 6.8 7.1 5.1 5.9 4.9 4.1 5.1 5.6 7.0 4.7 4.3 4.0 5.7 6.0 5.7 5.8 5.6 5.7 6.1 6.0 5.3 6.6 4.3 5.8 2.8 8.7 6.2 5.6 4.8 6.5 5.1 5.3 3.6 9.1 4.4 5.5 6.2 5.6 5.2 3.3 6.0 6.9 5.9 4.8 6.1 5.3 4.3 6.6 8.3 4.2 10.5 7.9 9.2 15.1 6.2 12.3 9.9 8.3 11.0 7.8 8.9 8.6 12.4 9.9 7.9 5.3 9.6 18.7 14.5 10.3 11.6 9.4 7.6 7.0 9.5 10.2 9.1 9.9 17.3 11.5 14.8 8.8 12.4 10.6 8.4 5.2 9.9 3.0 18.2 10.3 5.4 2.2 5.6 8.6 8.5 13.8 14.3 6.6 4.5 6.7 7.8 5.5 12.1 7.3 7.0 19.5 12.5 6.0 3.6 7.3 13.0 7.5 13.8 7.7 11.5 15.7 8.3 2.0 1.6 0.7 1.8 1.2 1.8 1.6 1.7 1.7 1.4 1.5 1.7 1.7 0.6 1.5 0.8 3.3 1.6 0.9 5.8 6.1 6.8 7.1 5.7 6.0 6.1 6.0 5.3 6.2 6.2 6.0 6.6 69.3 48.1 44.1 20.2 43.8 81.8 62.5 117.8 43.3 51.8 49.0 59.2 31.2 75.8 63.2 86.5 31.3 72.6 54.8 87.3 90.1 72.2 300.6 69.3 66.0 63.1 61.0 79.8 30.8 75.2 84.6 55.8 35.2 86.6 53.8 33.9 91.1 100.3 64.5 97.6 23.4 71.4 89.5 79.7 62.4 179.2 95.7 54.8 39.2 15.9 65.1 59.2 71.1 19.1 25.4 196.8 136.3 72.6 39.1 76.2 66.8 114.8 58.4 43.5 65.7 57.7 56.9 44.3 46.2 47.0 104.0 48.7 50.4 30.5 54.2 83.2 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030946 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "parathyroid gland: 128.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 5.5;Inhibitory neurons: 33.3;Oligodendrocyte precursor cells: 10.1;Skeletal myocytes: 8.6;Smooth muscle cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 28.2;HAP1: 5.2;RPMI-8226: 13.3;SCLC-21H: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 3.4 1.7 5.1 7.6 2.8 0.0 0.8 5.7 4.6 1.5 1.4 2.4 0.7 6.8 2.8 1.5 7.9 7.1 3.3 2.3 8.7 3.4 0.3 1.0 2.9 10.1 11.3 1.8 2.1 1.7 128.7 0.3 3.9 6.8 0.5 1.6 2.3 0.3 1.2 0.2 0.3 1.8 13.8 3.9 0.9 1.4 0.7 3.8 2.3 1.1 0.4 8.5 3.1 0.7 6.4 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.8 0.0 0.2 0.0 5.2 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.6 0.0 1.0 0.0 1.2 13.3 0.5 0.0 18.2 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.3 2.0 0.0 0.8 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 2.8 5.7 4.6 2.3 8.7 10.1 11.3 1.8 6.8 3.9 3.8 6.4 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.0 3.7 0.0 0.0 5.5 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.1 2.0 2.1 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.7 0.0 4.8 1.7 33.3 0.0 0.0 0.6 0.5 0.1 0.6 1.0 0.0 2.8 0.0 0.5 0.0 10.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 8.6 8.5 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.1 CWC27 "NY-CO-10, SDCCAG-10, SDCCAG10" ENSG00000153015 "CWC27 spliceosome associated cyclophilin" Q6UX04 5 64768930-65018750 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 255.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020344, HPA024149, HPA065809" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561" "unprognostic (1.71e-1)" "unprognostic (6.47e-3)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (8.91e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (5.27e-6)" "unprognostic (1.58e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.46e-1)" "unprognostic (2.05e-1)" "unprognostic (2.74e-1)" "unprognostic (7.45e-3)" 13.5 13.1 14.2 13.1 15.5 20.7 13.5 17.5 18.5 12.4 11.8 13.3 9.9 15.7 12.5 11.9 11.9 11.3 19.1 14.0 14.6 14.3 10.2 10.8 15.6 15.5 14.9 12.5 18.3 9.1 17.1 8.9 14.7 15.5 14.0 15.1 14.1 10.6 12.4 22.4 11.6 10.2 14.4 14.7 12.9 11.2 17.3 15.1 21.9 14.0 26.7 16.2 13.3 11.6 16.3 32.7 21.4 37.5 69.9 31.4 38.2 41.8 33.5 27.7 36.7 38.2 36.0 40.3 48.0 57.0 35.0 41.2 20.2 39.8 60.5 66.2 40.4 32.4 36.2 35.6 30.3 48.0 38.3 23.5 25.6 45.7 46.3 58.3 32.3 39.4 53.9 35.8 30.8 36.8 32.6 53.5 34.7 30.4 16.9 25.6 49.0 50.4 50.3 35.0 28.0 44.4 19.6 40.8 16.4 39.7 35.5 35.9 55.5 32.9 21.4 37.8 34.6 54.2 23.9 33.1 46.5 40.1 65.9 38.8 13.2 13.1 9.6 13.6 13.2 16.8 17.5 15.3 17.4 16.9 13.2 16.2 16.9 2.7 20.4 10.2 13.8 18.0 10.4 14.2 15.5 17.5 18.5 14.0 14.6 15.5 14.9 12.5 15.5 14.7 15.1 16.3 24.2 9.6 26.2 64.3 26.0 16.4 27.7 37.5 13.6 31.4 17.4 20.3 63.6 18.6 23.2 14.7 14.6 44.0 16.8 11.6 21.5 44.1 255.6 21.0 27.2 27.2 29.9 37.8 114.1 33.1 54.5 25.1 13.7 20.2 19.6 40.7 16.4 11.4 33.0 20.2 110.3 17.0 40.7 17.1 15.2 57.9 38.5 22.3 14.2 61.8 33.6 34.2 36.0 103.0 103.2 40.4 16.0 36.1 21.0 22.1 13.3 24.4 28.6 51.3 32.9 31.3 33.6 74.2 28.3 20.6 20.0 30.8 26.2 30.7 28.6 23.8 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA048304: AB_2680347" "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 8.6 9.7 3.3 14.3 3.7 11.2 9.8 2.4 4.1 10.3 5.9 6.4 7.4 9.6 9.7 9.7 10.5 12.8 6.0 3.2 6.1 10.0 10.6 18.2 14.7 5.0 3.2 2.7 13.8 3.7 14.1 9.0 13.6 3.6 11.0 8.2 1.5 5.9 10.6 2.1 8.8 7.0 12.6 3.7 12.4 8.8 2.7 4.2 20.3 16.9 3.9 15.4 16.5 7.5 4.9 7.9 5.4 0.1 4.6 32.2 38.8 13.9 15.5 42.2 12.7 21.5 2.2 31.9 9.7 31.6 28.1 9.9 20.5 0.7 18.3 11.1 29.6 5.2 14.2 5.6 9.8 10.8 11.5 40.6 25.2 49.6 18.9 20.3 23.7 1.3 17.8 26.7 25.6 24.9 8.8 12.1 8.3 0.1 0.1 0.8 13.7 0.3 27.3 13.9 23.1 0.2 0.3 8.2 14.8 10.9 6.0 15.4 24.6 8.1 12.5 1.7 21.8 7.7 42.2 15.3 17.9 11.7 14.7 1.2 32.6 21.8 22.9 16.3 27.4 14.6 14.3 14.6 14.6 18.8 18.3 10.8 16.2 14.7 19.0 23.6 10.2 17.0 15.2 3.3 3.7 2.4 4.1 3.2 6.1 5.0 3.2 2.7 3.6 3.7 4.2 4.9 4.4 19.2 32.4 8.8 14.7 5.0 8.3 32.6 12.0 0.8 7.7 6.1 4.1 8.6 20.9 14.7 0.0 17.5 15.9 1.6 5.9 10.8 0.3 5.9 12.1 4.9 2.4 11.4 3.1 6.4 9.5 12.8 2.6 7.3 17.1 13.5 3.6 8.9 25.8 0.0 1.7 2.7 32.6 25.2 9.1 0.4 10.8 25.3 7.2 11.2 30.8 4.1 26.8 0.0 0.5 7.5 4.5 12.0 9.1 7.4 2.2 2.4 15.3 0.6 0.0 8.6 9.2 0.4 1.6 10.9 5.4 24.5 15.7 22.4 3.5 13.4 SRP19 ENSG00000153037 "Signal recognition particle 19" P09132 5 112861188-112898371 "Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029272, HPA057315" Approved Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA029272: AB_10600910, HPA057315: " "unprognostic (4.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.37e-1)" "unprognostic (5.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.98e-3)" "unprognostic (5.55e-2)" "unprognostic (2.62e-2)" "unprognostic (3.62e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (3.72e-10)" "unprognostic (1.82e-1)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (2.69e-3)" 28.6 32.8 22.4 29.2 23.4 79.9 29.3 22.5 25.6 21.7 21.1 23.9 24.8 25.5 38.6 29.6 22.2 23.3 25.4 23.3 23.7 25.6 48.5 24.6 38.7 22.0 22.4 22.8 18.0 42.0 25.6 40.8 28.9 22.8 32.9 27.4 14.7 29.8 18.1 34.2 24.0 23.6 30.5 21.2 30.2 26.0 20.4 23.6 36.3 40.3 24.1 40.3 29.0 22.5 24.1 60.1 40.7 49.3 78.6 45.2 52.4 118.7 82.0 51.8 69.2 82.3 68.0 45.8 62.3 55.0 53.2 110.0 39.0 54.6 84.5 82.2 66.0 88.8 55.1 80.5 80.6 72.4 44.7 58.5 61.2 80.5 64.9 95.6 45.5 64.7 67.1 41.9 72.3 59.5 70.1 72.6 79.0 51.1 60.5 61.6 45.6 44.3 94.4 68.6 75.5 56.1 49.6 66.4 42.4 40.3 56.5 64.7 63.2 52.1 57.1 48.6 57.3 98.3 85.2 111.4 107.9 55.4 75.4 60.3 66.7 34.1 43.6 49.3 37.3 60.9 54.9 55.0 52.7 39.9 45.8 46.3 52.4 48.1 50.9 41.3 86.8 72.2 36.3 22.4 23.4 22.5 25.6 23.3 23.7 22.0 22.4 22.8 22.8 21.2 23.6 24.1 64.7 80.1 49.9 17.9 60.6 86.4 74.8 102.2 9.1 15.6 75.1 85.9 52.0 41.5 87.8 44.1 20.9 80.0 120.2 29.6 103.7 96.4 38.9 76.0 85.0 53.4 119.0 52.2 26.7 103.2 125.0 55.9 16.3 80.4 73.5 54.6 35.7 65.3 84.5 13.5 24.6 67.6 79.3 53.3 53.8 24.0 38.8 56.6 51.6 21.5 87.8 30.7 90.6 21.6 41.1 130.4 38.9 39.5 65.7 107.5 33.5 117.1 74.1 24.6 26.3 40.8 58.3 157.4 44.7 22.6 87.8 148.2 71.3 54.2 41.2 112.7 CENPH ENSG00000153044 "Centromere protein H" Q9H3R5 5 69189574-69210357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.0;testis: 30.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA036494 Approved Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "HPA036494: AB_10673354" "unprognostic (1.49e-1)" "prognostic favorable (6.86e-4)" "unprognostic (1.73e-2)" "unprognostic (3.16e-2)" "unprognostic (2.32e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.22e-5)" "unprognostic (6.14e-3)" "unprognostic (6.85e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.21e-2)" "unprognostic (8.80e-2)" "prognostic unfavorable (5.11e-15)" "unprognostic (1.17e-1)" "unprognostic (3.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" 3.4 2.0 1.5 7.6 1.8 34.0 7.8 1.8 2.1 3.5 1.1 7.4 6.6 4.5 2.1 7.6 4.0 1.8 4.0 1.7 1.6 1.6 3.7 2.8 17.9 1.8 1.7 1.6 4.0 1.5 2.0 1.4 5.3 2.0 3.3 8.2 2.5 2.9 2.3 4.1 9.2 5.9 3.8 1.5 5.2 3.7 30.0 1.7 18.7 2.5 4.0 19.0 3.9 4.5 2.1 64.6 19.4 88.6 70.2 5.8 18.3 48.0 31.2 32.6 66.9 71.8 26.5 79.6 138.9 36.6 18.1 39.1 47.0 59.0 70.4 85.1 42.7 41.4 32.7 32.5 26.4 2.0 47.1 32.1 7.1 14.6 43.6 47.7 18.9 23.2 73.7 58.7 53.3 52.2 35.6 152.4 67.3 78.1 20.7 17.0 93.2 118.2 108.2 21.1 22.9 61.6 81.9 34.6 22.8 27.5 47.7 31.9 31.4 11.4 33.4 56.1 44.5 78.7 65.5 106.3 111.8 51.1 94.2 64.7 1.0 2.0 3.0 4.7 3.5 7.7 13.3 7.9 6.0 3.1 14.1 9.9 8.6 0.4 8.6 4.2 6.7 9.7 4.8 1.5 1.8 1.8 2.1 1.7 1.6 1.8 1.7 1.6 2.0 1.5 1.7 2.1 4.8 0.0 2.6 1.0 18.3 36.7 17.7 17.4 9.6 3.4 10.8 11.7 3.3 4.3 7.1 0.0 0.0 37.4 9.2 5.1 0.0 12.3 26.5 5.5 5.1 6.9 1.2 74.5 1.3 9.1 49.0 7.4 2.6 4.8 5.1 22.4 4.6 1.1 17.0 0.0 1.1 9.5 12.2 7.5 18.2 22.5 3.7 6.3 8.8 1.0 4.3 7.3 6.2 1.0 0.9 7.0 2.5 4.9 14.4 6.9 1.4 3.4 10.8 3.5 19.7 6.4 9.3 222.7 222.8 12.1 19.2 10.0 12.0 6.9 15.9 15.2 CDYL "CDYL1, DKFZP586C1622" ENSG00000153046 "Chromodomain Y like" Q9Y232 6 4706159-4955551 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Lyase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035578 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA035578: AB_2674685" "unprognostic (1.25e-1)" "unprognostic (8.99e-2)" "unprognostic (6.03e-2)" "unprognostic (2.38e-3)" "prognostic favorable (1.53e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.62e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.09e-1)" "unprognostic (5.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (3.94e-1)" 12.6 6.0 6.9 10.3 6.7 20.2 11.6 5.2 6.9 13.6 5.1 12.6 7.1 15.3 10.6 17.0 10.7 8.4 10.5 6.1 7.7 7.2 5.7 8.9 12.2 6.9 6.3 5.6 10.0 7.5 12.5 5.2 18.3 6.3 7.7 13.3 6.7 9.1 12.0 19.7 17.2 9.1 14.6 6.1 9.7 9.3 9.0 6.2 9.4 9.8 12.8 13.0 15.7 13.1 7.1 23.7 22.1 30.1 25.5 23.3 15.9 34.4 23.1 17.9 21.3 22.9 18.0 17.2 5.3 22.1 17.6 33.3 19.8 24.2 28.2 24.9 16.4 20.2 20.9 21.0 16.4 28.5 27.9 21.7 12.5 49.8 25.0 37.5 12.9 20.6 19.2 37.9 16.2 10.8 22.9 14.8 25.9 32.6 17.9 21.3 19.0 26.2 43.7 14.7 20.5 25.5 15.4 28.5 24.9 36.9 86.5 15.0 26.3 28.1 25.2 21.6 18.5 26.8 33.7 57.8 18.4 8.3 17.7 28.1 5.3 1.3 0.6 1.5 0.6 1.1 1.0 1.1 1.2 1.6 1.1 0.7 1.1 0.4 1.6 0.8 6.8 0.1 1.3 6.9 6.7 5.2 6.9 6.1 7.7 6.9 6.3 5.6 6.3 6.1 6.2 7.1 32.7 19.2 9.4 28.7 18.4 37.3 23.9 11.9 10.8 16.7 31.2 35.8 18.8 14.3 12.0 14.7 22.9 12.9 64.5 44.7 15.6 10.8 62.8 26.9 43.2 22.9 32.3 41.5 52.3 10.4 22.0 18.7 6.1 60.3 5.7 24.3 18.9 11.7 10.5 45.4 41.5 26.6 6.1 17.3 57.9 74.9 5.9 28.1 8.8 101.2 22.7 25.4 19.6 54.3 64.1 16.8 41.8 8.2 22.3 30.1 4.6 10.7 12.1 25.7 6.6 29.7 20.9 10.4 25.3 9.8 41.9 63.8 17.5 10.9 22.6 56.9 CARHSP1 "CRHSP-24, CSDC1" ENSG00000153048 "Calcium regulated heat stable protein 1" Q9Y2V2 16 8852942-8869012 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 426.0" "Group enriched" "Detected in all" 7 "Early spermatids: 2062.2;Late spermatids: 6999.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051911 Enhanced NA Yes 280000 "HPA051911: AB_2681660" "unprognostic (4.08e-1)" "unprognostic (4.99e-2)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (2.08e-3)" "unprognostic (8.57e-2)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.61e-1)" "unprognostic (7.19e-3)" "unprognostic (1.76e-3)" "unprognostic (5.94e-2)" "unprognostic (1.10e-1)" "unprognostic (2.61e-1)" "prognostic favorable (7.24e-4)" 80.9 133.6 47.5 34.0 72.0 70.6 68.3 44.3 57.6 81.2 46.8 41.1 31.6 38.6 13.6 195.2 51.5 34.1 47.4 47.9 48.2 107.0 189.7 117.7 47.2 53.0 46.9 46.5 69.1 55.3 9.9 33.5 59.7 49.0 35.6 25.9 3.0 111.6 14.1 17.6 33.7 47.5 24.4 45.2 57.2 52.9 426.0 51.0 60.2 36.2 21.5 59.9 46.2 102.6 57.7 84.2 134.8 200.2 40.3 52.1 83.0 98.9 110.7 93.5 92.9 117.8 95.4 224.6 109.1 70.2 83.5 70.9 82.0 79.3 87.9 65.4 87.9 102.1 34.5 108.1 369.8 177.5 59.2 84.6 181.7 40.0 91.8 60.7 87.8 92.6 241.5 94.5 136.1 120.5 152.0 313.5 147.6 124.6 89.0 82.2 367.0 245.9 179.3 75.5 56.0 119.0 153.2 104.9 106.1 104.0 112.4 134.9 60.3 99.9 77.8 144.9 94.6 57.4 67.6 77.4 135.0 173.9 71.9 134.9 81.6 29.6 35.8 25.8 14.3 16.1 17.5 25.0 25.3 25.8 28.6 17.0 23.7 89.2 41.6 19.0 47.4 62.8 20.8 47.5 72.0 44.3 57.6 47.9 48.2 53.0 46.9 46.5 49.0 45.2 51.0 57.7 166.3 25.6 9.1 19.6 48.9 42.7 67.2 158.4 22.8 8.0 71.4 38.0 6.0 221.6 86.4 82.8 6.2 141.5 65.1 152.6 54.8 619.1 2062.2 101.9 82.0 145.3 144.9 147.5 4.4 241.8 312.6 86.4 42.8 114.4 39.3 118.0 128.8 323.5 70.5 11.8 5.9 107.7 91.6 62.4 55.3 6999.5 96.3 36.1 58.7 9.4 66.5 7.7 121.5 8.0 25.6 340.0 179.5 73.0 63.9 139.3 174.2 479.0 70.9 11.2 111.7 31.2 95.5 72.7 52.7 84.2 42.1 153.5 65.1 17.0 108.4 169.8 TEKT5 "CT149, FLJ32871" ENSG00000153060 "Tektin 5" Q96M29 16 10627501-10694930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 32.4" "Group enriched" "Detected in some" 75 "Early spermatids: 490.7;Late spermatids: 169.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "BEWO: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA043578 Approved "Actin filaments" NA NA "Actin filaments" "HPA043578: AB_10795772" "unprognostic (5.90e-2)" "unprognostic (1.37e-2)" "unprognostic (1.39e-2)" "unprognostic (7.53e-2)" "unprognostic (2.69e-2)" "unprognostic (9.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.39e-2)" "unprognostic (1.89e-1)" "unprognostic (5.09e-2)" "unprognostic (5.88e-2)" "unprognostic (5.02e-2)" "unprognostic (3.24e-7)" "unprognostic (3.80e-2)" "unprognostic (2.31e-1)" "unprognostic (3.76e-2)" "unprognostic (8.12e-5)" 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.9 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 1.0 32.4 0.2 0.0 0.1 0.0 0.2 0.6 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.7 0.2 0.3 0.1 0.0 0.1 0.9 0.2 0.0 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.4 0.1 0.2 0.2 0.2 0.4 0.1 0.2 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 490.7 0.1 0.0 0.2 1.8 0.0 4.4 0.0 0.0 0.0 2.6 0.1 0.0 0.8 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 169.6 4.1 0.7 0.0 1.9 0.0 0.0 0.0 1.5 0.8 0.1 0.0 2.2 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.3 1.3 0.0 0.3 0.0 0.0 0.1 0.1 0.3 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 24.4;lymphoid tissue: 97.2" "Cell type enriched" "Detected in many" 10 "B-cells: 455.9" "Cancer enhanced" "Detected in many" "prostate cancer: 6.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 14 "memory B-cell: 310.4;naive B-cell: 253.0" "Lineage enriched" "Detected in many" 16 "B-cells: 310.4" "Cell line enhanced" "Detected in some" "Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 19000 "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 8.6 3.6 0.6 35.4 0.5 6.3 2.2 1.5 0.9 2.4 0.3 2.8 2.4 0.8 3.3 0.9 2.3 3.0 0.6 0.5 1.3 3.2 0.3 8.1 82.9 0.7 0.9 0.4 0.1 0.5 0.4 1.5 0.8 0.9 5.8 3.3 0.3 2.4 4.8 0.1 0.7 24.4 1.0 0.7 56.6 7.5 3.0 0.8 9.8 13.0 0.2 97.2 7.6 0.7 0.7 0.0 3.0 0.0 0.0 3.4 1.4 0.1 0.1 0.1 0.4 0.6 0.1 4.6 13.6 1.2 0.0 0.0 0.2 0.1 1.5 0.4 0.0 0.0 10.6 2.6 0.0 0.1 9.6 0.0 0.6 0.4 0.0 0.0 1.2 0.1 0.0 0.1 4.0 0.6 0.5 0.0 0.6 0.0 0.4 5.7 0.2 0.6 0.0 0.4 6.1 2.6 0.0 0.3 0.2 0.0 0.1 0.5 2.5 1.3 0.0 0.6 0.0 0.0 31.0 0.0 2.2 0.1 5.3 0.0 10.8 1.7 19.7 0.4 0.5 0.1 310.4 0.1 0.2 10.5 253.0 0.1 0.1 0.9 1.5 0.2 5.2 0.2 11.3 0.6 0.5 1.5 0.9 0.5 1.3 0.7 0.9 0.4 0.9 0.7 0.8 0.7 3.5 44.8 27.1 6.8 455.9 0.1 2.2 0.5 0.0 0.2 1.7 0.4 0.5 0.0 10.0 3.7 0.0 2.1 5.8 0.0 0.0 0.2 2.8 13.1 1.0 1.3 0.0 6.1 7.3 0.2 0.6 1.4 6.1 15.2 1.3 0.1 0.0 0.1 1.5 0.0 1.6 0.4 2.0 2.9 25.1 2.0 0.0 13.0 5.4 4.7 2.8 1.8 1.0 1.0 1.3 4.1 1.3 0.4 13.7 4.4 0.2 4.2 2.2 0.1 0.0 0.1 0.8 1.9 5.6 0.8 1.1 0.3 12.9 2.1 1.1 4.3 TXNDC11 EFP1 ENSG00000153066 "Thioredoxin domain containing 11" Q6PKC3 16 11679083-11742857 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Plasma cells: 307.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 141.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041174, HPA041390" Supported Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA041174: AB_10794191, HPA041390: AB_10796670" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (6.82e-3)" "prognostic favorable (2.12e-5)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.68e-3)" "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (2.35e-2)" "unprognostic (9.96e-2)" "unprognostic (8.30e-2)" "unprognostic (3.23e-2)" "unprognostic (2.34e-2)" 15.8 14.4 4.5 22.7 5.4 55.9 16.7 7.6 5.9 20.9 14.3 30.3 38.8 15.3 23.8 13.2 16.3 17.5 13.8 5.0 7.3 25.9 44.7 35.2 25.5 5.0 5.0 4.5 16.8 26.7 45.4 12.6 17.2 5.7 24.6 30.1 15.4 35.1 15.0 30.4 11.9 32.3 15.8 4.6 22.6 36.4 8.6 5.0 20.8 34.8 15.0 28.1 25.6 11.9 5.2 26.1 17.7 8.2 11.2 21.6 18.0 14.4 25.3 34.5 22.7 29.1 8.8 40.5 65.2 41.6 32.0 30.9 22.9 10.2 21.4 18.5 29.4 13.5 13.9 19.4 43.8 31.7 20.6 27.1 13.7 23.6 25.4 39.9 17.6 28.9 14.6 21.5 81.8 20.2 23.7 16.1 7.9 10.7 18.6 9.1 20.5 16.5 141.9 26.0 13.7 11.5 10.9 49.6 38.2 27.3 9.1 23.4 28.1 30.1 10.5 12.0 49.8 14.7 110.5 64.8 39.5 22.3 25.7 17.9 3.5 2.4 7.7 1.8 1.7 4.5 3.8 3.3 4.1 2.6 4.6 3.2 2.1 0.7 5.6 2.2 2.0 6.8 2.8 4.5 5.4 7.6 5.9 5.0 7.3 5.0 5.0 4.5 5.7 4.6 5.0 5.2 16.2 44.8 46.2 21.9 49.2 14.7 24.8 12.9 23.3 16.2 16.1 18.0 9.1 18.6 24.6 18.4 50.1 21.1 27.2 45.8 15.6 20.4 3.1 19.9 14.6 15.2 24.5 6.5 23.0 39.7 29.8 14.0 45.3 28.5 15.2 13.0 15.7 39.3 30.3 23.5 25.5 44.0 8.2 18.1 26.9 1.4 20.2 29.2 23.2 18.7 21.2 16.4 15.5 22.1 18.6 26.1 21.0 13.2 307.9 28.0 37.1 15.2 15.9 23.4 6.6 13.8 16.2 11.6 13.1 17.5 11.8 25.0 25.2 11.3 27.7 32.1 DAB2 DOC-2 ENSG00000153071 "DAB adaptor protein 2" P98082 5 39371675-39462300 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 180.8;placenta: 228.5" "Group enriched" "Detected in many" 5 "Hofbauer cells: 1756.4;Proximal tubular cells: 1653.7;Syncytiotrophoblasts: 1324.5" "Cancer enhanced" "Detected in all" "renal cancer: 52.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "plasmacytoid DC: 48.7" "Lineage enriched" "Detected in many" 8 "dendritic cells: 48.7" "Cell line enhanced" "Detected in many" "ASC diff: 220.1;ASC TERT1: 234.5;fHDF/TERT166: 356.8;TIME: 211.1;U-138 MG: 237.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009314, HPA028888" Enhanced Enhanced "Nucleoli fibrillar center,Vesicles,Plasma membrane" NA NA 130000 "Vesicles, Plasma membrane" "Nucleoli fibrillar center" "CAB009314: AB_638976, HPA028888: AB_2672814" "unprognostic (1.24e-1)" "unprognostic (7.28e-2)" "unprognostic (2.16e-1)" "unprognostic (1.25e-1)" "unprognostic (5.37e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.38e-6)" "unprognostic (3.11e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (9.67e-4)" "unprognostic (1.27e-2)" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" 71.5 114.7 8.0 33.4 9.5 4.2 48.6 12.8 17.2 48.8 26.3 33.5 13.7 32.8 117.8 17.0 21.8 50.6 20.0 7.2 19.3 180.8 27.5 53.7 33.5 14.6 8.7 5.4 34.3 23.0 10.1 8.0 228.5 11.2 13.1 55.1 11.7 24.4 20.0 11.5 18.6 25.8 48.2 8.5 59.0 16.8 10.7 16.5 21.1 23.7 16.5 19.2 45.0 20.8 18.4 0.2 8.3 12.9 27.9 220.1 234.5 16.0 145.7 149.5 56.3 92.5 108.1 0.5 0.1 8.8 356.8 54.8 0.3 2.0 5.2 78.9 0.2 4.2 19.9 191.1 35.5 52.4 0.2 24.3 146.5 0.2 91.7 16.5 87.2 172.4 9.9 0.0 5.0 95.2 0.6 2.1 0.3 8.9 4.1 15.8 5.4 32.7 0.0 37.8 3.2 0.1 0.4 17.4 9.3 79.2 20.4 0.6 4.9 211.1 237.9 26.1 27.7 11.9 0.2 0.1 0.3 82.6 18.1 31.5 5.8 2.3 0.5 2.1 4.6 0.1 0.1 0.3 1.4 6.3 0.2 0.2 1.7 3.2 1.7 1.3 48.7 0.4 12.7 8.0 9.5 12.8 17.2 7.2 19.3 14.6 8.7 5.4 11.2 8.5 16.5 18.4 100.2 38.5 42.2 0.0 14.5 14.5 1.2 15.3 3.4 1.1 38.3 26.7 55.1 70.1 9.9 95.6 70.9 170.8 83.8 29.6 197.6 75.7 1.4 31.7 161.0 116.9 9.7 10.1 11.0 2.0 20.1 139.5 3.6 36.4 25.3 50.6 187.4 3.7 1756.4 8.4 2.8 7.6 2.0 175.2 77.9 4.5 122.4 287.4 12.4 92.8 10.9 81.5 63.8 27.2 0.3 6.5 10.2 64.3 1.4 7.0 33.8 1653.7 7.5 3.5 6.6 62.4 50.4 0.5 4.8 3.5 13.4 1324.5 13.4 104.8 27.5 1.3 ACMSD ENSG00000153086 "Aminocarboxymuconate semialdehyde decarboxylase" Q8TDX5 2 134838616-134902034 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "kidney: 142.4;liver: 163.8" "Group enriched" "Detected in some" 4 "Hepatocytes: 120.2;Proximal tubular cells: 408.1" "Group enriched" "Detected in some" 23 "liver cancer: 21.2;renal cancer: 19.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "RPTEC TERT1: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010533, HPA011179" Enhanced Approved Cytosol NA NA 12000 Cytosol "HPA010533: AB_1844517, HPA011179: AB_1844516" "unprognostic (1.06e-2)" "unprognostic (5.30e-2)" "unprognostic (1.40e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-1)" "unprognostic (5.35e-4)" "unprognostic (7.60e-2)" "unprognostic (5.17e-2)" "unprognostic (2.44e-3)" "prognostic favorable (2.39e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (2.65e-5)" 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.8 0.3 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.0 7.2 0.2 0.0 0.1 142.4 163.8 0.1 0.3 0.9 0.1 0.0 0.7 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.6 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.1 1.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.3 0.8 0.3 1.2 0.2 0.5 0.1 0.6 0.3 26.7 0.4 1.0 0.3 0.1 0.3 0.4 0.8 0.2 0.7 1.0 0.0 0.4 0.2 0.8 0.2 0.1 0.5 0.2 0.3 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.8 0.3 0.0 0.1 0.9 0.1 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.2 50.1 0.0 9.2 0.0 0.0 0.0 0.0 54.8 0.2 0.0 0.0 0.1 0.0 0.0 2.7 8.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 120.2 0.0 0.0 7.3 0.0 0.0 1.9 0.0 0.0 0.0 2.8 0.0 1.0 0.0 0.0 0.0 2.5 1.9 0.1 0.0 0.0 0.0 0.0 0.0 408.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732539-111120610 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 7.3;lung: 9.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 41.9" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 1.1 0.6 0.6 0.5 0.7 1.5 0.1 0.2 0.5 0.4 0.1 0.5 0.5 0.5 7.3 0.4 0.3 0.6 1.2 0.4 0.1 0.5 0.3 9.3 0.9 0.4 0.3 0.5 0.2 1.0 2.9 0.3 0.7 0.5 3.2 0.3 0.7 0.6 0.0 1.3 0.7 0.6 0.1 0.0 0.6 0.5 3.2 0.3 0.3 0.8 0.0 1.2 4.7 0.1 0.6 12.1 0.2 0.3 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.9 0.7 0.3 0.5 0.1 0.3 1.3 0.0 0.1 0.0 0.3 3.5 0.2 0.5 0.5 0.0 0.0 0.3 0.1 1.2 0.0 0.1 0.3 0.0 0.6 1.8 1.8 0.1 4.4 0.9 0.4 4.2 0.0 0.3 0.6 0.2 22.0 0.0 29.3 2.5 1.0 0.3 0.5 0.1 0.6 0.4 1.2 0.3 0.2 1.0 0.2 0.1 18.7 4.8 0.7 0.0 0.1 0.1 0.7 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.9 0.2 0.2 0.2 0.1 0.1 0.6 0.7 0.2 0.5 0.4 0.1 0.4 0.3 0.5 0.5 0.0 0.3 0.6 0.3 0.0 41.9 0.0 1.0 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.0 0.1 1.3 0.0 0.2 5.4 0.2 0.1 0.2 1.2 0.0 2.2 0.0 0.0 0.4 0.0 0.8 0.0 5.9 0.0 0.0 0.1 0.0 2.0 0.3 0.0 0.0 0.8 8.1 0.0 0.2 0.0 0.0 0.0 0.1 1.0 1.0 1.3 0.1 2.3 0.0 7.5 0.8 0.0 0.1 0.1 0.3 0.0 0.2 0.3 1.6 2.7 0.0 0.3 0.0 1.1 0.0 0.2 0.8 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168445 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 118.3;Plasma cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 91.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026332, CAB079899" Approved Supported Mitochondria NA NA Mitochondria "CAB026332: AB_566386, CAB079899: AB_10981505" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 8.0 7.5 4.6 16.6 5.0 39.1 12.7 4.0 4.6 6.9 5.2 11.1 7.2 6.5 4.9 9.8 7.1 8.9 5.2 3.5 5.9 10.8 14.4 8.6 24.4 4.5 4.0 3.4 10.4 10.4 18.9 9.5 6.0 4.4 7.9 12.0 12.2 10.2 7.1 12.4 5.7 11.8 4.8 4.5 16.4 7.1 8.2 4.3 19.0 16.7 7.3 23.1 8.9 8.3 7.0 8.0 2.4 10.8 10.4 9.1 4.7 29.1 1.2 2.3 3.3 3.3 6.6 24.9 32.0 6.5 1.2 18.9 9.5 10.0 3.9 2.0 24.9 18.2 39.7 8.1 10.5 3.9 14.6 8.8 4.8 10.5 3.7 3.8 7.0 4.6 14.2 20.8 46.6 0.7 5.2 15.3 14.7 13.2 6.3 7.5 19.5 10.3 40.7 4.5 13.0 9.3 24.0 11.0 14.5 8.3 7.1 5.0 31.2 1.9 1.7 11.4 3.7 4.3 91.2 19.5 45.3 2.7 10.1 1.5 5.2 3.7 1.8 1.7 2.6 1.8 3.3 2.3 1.9 1.9 1.9 1.5 1.5 5.2 1.7 5.7 0.4 5.9 1.5 4.6 5.0 4.0 4.6 3.5 5.9 4.5 4.0 3.4 4.4 4.5 4.3 7.0 33.9 3.2 9.9 2.9 61.3 17.5 18.2 7.0 34.7 7.4 19.5 29.2 19.3 12.8 10.3 9.2 10.4 4.6 43.9 37.6 13.7 9.7 118.3 36.6 10.8 18.0 21.5 26.5 2.2 6.5 7.8 11.6 8.6 54.7 11.4 5.9 14.6 11.3 10.9 0.0 4.8 15.2 12.2 26.8 52.6 39.2 5.9 34.8 23.2 6.5 41.0 12.1 5.2 3.0 5.3 8.8 16.4 3.8 137.9 15.9 16.6 6.4 15.2 21.1 0.0 11.8 11.9 7.3 17.7 66.1 10.9 5.7 41.0 2.5 12.3 16.0 ANAPC1 "APC1, MCPR, TSG24" ENSG00000153107 "Anaphase promoting complex subunit 1" Q9H1A4 2 111611639-111884690 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Cancer-related genes, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036329, HPA036330, HPA042998" Approved Approved Vesicles NA NA Vesicles "HPA036329: AB_10670714, HPA036330: AB_2675065, HPA042998: AB_2678263" "unprognostic (1.74e-1)" "unprognostic (5.04e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.49e-1)" "unprognostic (2.15e-1)" "unprognostic (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.94e-2)" "unprognostic (2.59e-1)" "unprognostic (3.65e-2)" "unprognostic (1.23e-1)" "unprognostic (2.13e-2)" "unprognostic (1.94e-1)" "unprognostic (1.98e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" 6.4 4.8 3.3 9.6 4.4 8.3 9.3 4.6 4.8 6.9 8.2 10.0 8.4 8.0 4.9 8.1 7.9 5.8 5.9 4.2 3.9 6.2 5.6 5.4 12.2 3.9 4.0 4.0 8.4 6.4 10.4 4.7 7.8 5.0 6.4 10.6 8.0 5.4 6.2 12.3 6.8 6.5 7.7 3.3 7.9 6.6 10.3 3.6 12.7 6.4 9.4 12.5 8.4 5.9 5.0 42.4 31.0 33.1 23.9 14.9 18.4 32.6 25.0 18.8 30.3 26.5 60.4 26.6 72.7 19.9 23.0 36.0 35.4 51.0 28.4 40.4 31.7 31.9 81.6 27.6 37.1 14.3 85.0 27.4 13.8 14.3 44.9 40.8 15.4 29.5 34.9 75.8 30.8 21.5 20.2 51.9 25.5 50.3 18.3 26.1 51.1 39.4 41.1 19.1 41.6 26.2 16.0 26.2 23.9 22.8 21.8 14.1 30.1 20.9 26.5 28.5 21.7 26.9 23.0 52.5 67.1 21.5 36.9 21.9 0.0 2.1 0.6 4.2 2.2 6.1 4.0 3.8 3.6 3.9 3.1 5.4 5.2 0.4 4.8 1.9 1.8 1.8 3.3 3.3 4.4 4.6 4.8 4.2 3.9 3.9 4.0 4.0 5.0 3.3 3.6 5.0 14.5 3.2 8.2 17.0 20.3 14.3 20.5 7.6 22.2 11.2 12.1 11.8 7.5 8.6 6.0 3.7 14.6 12.2 25.4 7.2 5.9 5.9 6.6 13.5 13.4 11.0 11.4 17.9 32.5 5.9 12.7 12.0 12.2 11.7 8.2 19.2 8.6 12.8 9.0 20.2 32.6 11.1 14.2 8.4 11.8 8.6 10.2 12.2 7.2 12.2 8.8 7.7 13.4 21.6 31.3 7.1 5.4 9.4 14.4 24.6 5.6 8.8 8.2 16.0 13.1 15.9 11.5 17.3 21.0 18.0 20.2 6.7 21.2 12.2 14.5 23.4 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 858.4;Early spermatids: 979.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882, HPA075906" Enhanced Enhanced "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 17000000 "Endoplasmic reticulum, Cytosol" "Plasma membrane" "CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (4.98e-4)" 141.1 68.9 36.5 86.8 39.0 120.1 105.0 39.6 41.1 111.8 58.1 161.6 121.6 84.5 49.5 346.0 80.4 79.4 306.5 33.8 54.0 81.1 117.8 113.1 53.3 50.2 42.3 26.3 83.9 56.5 112.6 51.6 117.1 48.2 101.1 149.7 17.2 131.0 79.4 319.9 158.7 138.3 93.0 42.8 64.6 101.4 99.7 41.1 43.5 98.8 167.8 105.2 130.7 218.2 60.6 300.3 239.7 42.6 112.1 240.1 390.1 145.4 220.9 288.8 169.1 215.8 60.4 189.6 44.1 189.8 286.1 263.1 465.6 81.3 283.5 202.8 292.4 78.5 65.9 251.0 71.1 172.9 38.9 100.1 201.8 254.8 239.6 375.0 222.9 194.8 33.5 51.7 144.5 196.4 98.0 17.9 2.0 35.4 85.0 89.9 18.2 141.9 78.3 327.1 114.1 179.6 45.0 222.6 118.2 142.5 94.0 77.4 39.5 263.9 239.0 94.6 154.9 211.4 51.2 140.4 22.1 264.7 21.8 67.5 10.5 156.6 24.1 75.6 85.3 74.1 79.4 68.2 76.9 107.5 79.1 34.8 45.7 38.2 61.6 109.8 28.8 79.2 108.1 36.5 39.0 39.6 41.1 33.8 54.0 50.2 42.3 26.3 48.2 42.8 41.1 60.6 251.6 403.8 221.4 58.1 153.8 239.6 439.8 223.6 169.0 39.4 133.6 84.5 858.4 163.0 277.0 108.5 18.8 181.2 227.1 484.0 133.1 263.6 979.7 348.0 213.4 188.5 142.1 229.3 60.2 249.7 96.2 259.0 153.4 327.8 177.1 71.8 138.8 169.3 113.7 13.5 53.0 253.9 103.7 209.4 259.1 414.4 172.1 243.8 131.6 63.7 354.4 36.9 293.6 33.2 70.2 325.1 346.8 146.3 126.3 314.7 302.9 152.3 379.0 19.5 92.1 267.8 175.0 23.6 17.9 348.9 251.7 140.8 207.7 69.8 221.2 548.5 SCOC "HRIHFB2072, SCOCO, UNC-69" ENSG00000153130 "Short coiled-coil protein" Q9UIL1 4 140257286-140385728 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061198, HPA070321" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 22000 "Nucleoplasm, Golgi apparatus" "HPA061198: AB_2684449, HPA070321: AB_2686252" "unprognostic (2.27e-2)" "unprognostic (2.26e-2)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (7.34e-3)" "unprognostic (1.37e-3)" "unprognostic (8.99e-3)" "unprognostic (1.13e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-1)" "unprognostic (4.03e-1)" "prognostic favorable (4.82e-12)" "unprognostic (2.98e-2)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-2)" 45.2 67.5 96.2 28.0 100.2 14.8 70.1 101.1 110.5 42.9 84.9 44.3 45.8 48.4 80.2 54.6 45.1 40.1 104.5 100.3 117.6 102.6 75.0 36.2 30.0 104.3 112.7 95.9 43.0 51.8 94.9 43.6 48.7 114.1 60.4 50.3 75.1 49.6 47.5 41.2 30.1 37.4 51.4 106.4 28.1 54.2 34.1 114.1 29.6 68.0 59.8 33.0 39.2 19.5 122.4 53.9 38.1 92.6 49.9 80.6 109.3 67.4 85.5 78.0 64.6 71.8 24.4 81.0 22.0 75.5 83.9 60.6 22.6 57.3 113.6 95.7 79.1 40.4 33.5 18.8 59.7 70.1 70.2 40.5 72.5 155.9 59.0 63.1 124.1 87.1 63.8 53.0 60.0 116.3 36.5 94.7 42.5 30.2 47.6 57.1 54.0 39.1 32.1 197.1 52.9 68.4 70.4 57.0 84.5 97.0 81.7 63.4 41.9 68.0 104.4 60.5 86.9 83.1 94.4 193.4 64.9 118.2 32.2 102.3 47.8 16.5 23.0 27.5 23.0 35.1 36.8 32.3 27.3 21.4 30.3 46.8 36.4 9.7 36.9 23.1 26.7 33.2 37.0 96.2 100.2 101.1 110.5 100.3 117.6 104.3 112.7 95.9 114.1 106.4 114.1 122.4 63.2 48.1 47.2 15.3 34.4 61.1 69.7 74.1 78.6 135.0 84.9 96.0 140.3 62.9 51.8 126.9 22.9 139.9 31.3 63.4 320.8 99.2 537.1 67.5 52.4 54.4 37.8 34.7 33.8 112.8 82.2 58.3 66.8 58.4 36.8 32.0 51.4 65.0 47.6 171.6 37.1 42.7 114.0 23.0 27.9 91.2 60.0 34.5 138.7 17.8 36.7 205.6 22.6 20.6 42.9 92.9 37.0 66.2 30.8 91.7 46.8 311.1 54.9 71.0 46.0 40.8 64.5 60.7 56.1 83.8 56.7 88.9 36.3 39.6 46.1 56.0 CLGN ENSG00000153132 Calmegin O14967 4 140388453-140427661 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 60.0;testis: 114.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020709, HPA048761, HPA058627" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782" "unprognostic (6.74e-2)" "unprognostic (8.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" "unprognostic (3.73e-3)" "unprognostic (6.14e-2)" "unprognostic (4.80e-2)" "unprognostic (3.11e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-2)" "unprognostic (2.45e-3)" "unprognostic (3.00e-3)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.01e-1)" 0.4 6.7 1.4 1.0 0.9 2.4 2.7 3.9 1.7 0.9 1.8 2.0 0.5 1.6 0.6 1.2 13.8 0.4 60.0 1.0 2.0 0.4 3.2 0.5 0.7 2.6 2.0 0.9 0.3 2.2 0.6 11.3 0.2 2.8 22.7 1.3 17.4 1.0 0.7 0.4 0.2 1.3 1.5 1.4 0.2 2.1 114.6 1.7 2.4 2.7 1.6 1.2 0.6 0.1 3.5 0.2 10.2 10.3 6.9 4.0 21.1 2.4 0.1 9.4 10.0 18.6 0.3 0.9 0.0 27.8 0.9 8.4 0.2 7.5 0.1 16.2 0.4 9.0 3.0 9.8 7.4 41.4 38.9 0.6 2.2 39.2 1.0 0.9 53.0 0.2 9.6 2.0 0.0 0.0 0.5 47.8 0.5 12.0 0.2 28.1 31.5 0.0 0.4 0.0 0.3 16.8 29.8 6.5 4.1 1.8 3.8 1.9 5.6 0.0 27.4 4.7 9.7 73.6 14.4 31.7 19.9 43.4 1.6 2.9 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 3.9 1.7 1.0 2.0 2.6 2.0 0.9 2.8 1.4 1.7 3.5 0.8 0.0 2.2 0.3 0.1 0.0 0.9 8.5 1.2 9.2 3.3 1.8 313.3 0.0 6.4 0.0 4.2 0.5 0.0 0.5 0.0 1.2 162.4 93.4 1.3 11.9 5.3 8.6 7.2 4.2 0.1 10.2 0.0 11.3 0.0 10.1 0.7 3.7 0.1 25.2 6.7 0.4 30.5 0.0 0.0 60.2 5.0 0.7 1.8 0.0 0.1 176.4 0.0 6.6 0.6 0.9 3.9 4.5 0.1 33.8 0.2 0.1 24.6 16.3 0.0 0.6 2.0 465.5 23.9 2.8 0.1 0.3 0.7 0.2 0.8 1.3 CETN3 CEN3 ENSG00000153140 "Centrin 3" O15182 5 90392257-90409766 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 131.5" "Cell type enriched" "Detected in all" 4 "Spermatocytes: 469.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035608, HPA063704" Enhanced Supported Centrosome NA NA Centrosome "HPA035608: AB_10601098, HPA063704: AB_2685097" "unprognostic (2.08e-1)" "unprognostic (7.31e-2)" "unprognostic (2.41e-1)" "unprognostic (1.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "prognostic unfavorable (2.22e-4)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (8.77e-2)" "unprognostic (5.03e-1)" "unprognostic (5.64e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.53e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" 17.6 21.8 20.1 14.8 21.5 7.7 24.3 20.5 26.5 20.8 20.0 17.1 9.7 20.2 22.0 13.6 22.8 10.4 22.3 19.3 19.9 20.0 13.6 13.5 19.3 21.8 22.3 18.4 31.2 9.3 24.6 16.9 19.4 22.3 19.2 19.8 35.6 15.3 14.9 14.5 15.5 10.7 14.0 20.6 15.2 13.0 131.5 21.3 20.8 15.3 14.2 21.1 11.4 11.8 28.8 38.4 18.7 66.2 13.4 38.8 49.2 39.5 41.2 25.4 39.7 47.1 25.5 45.3 71.7 40.4 20.2 76.9 26.2 58.5 57.4 63.5 59.6 27.2 36.4 26.9 32.6 27.3 26.9 22.2 32.7 36.6 29.4 49.1 42.5 24.1 56.8 47.2 30.9 44.3 26.5 46.2 42.6 23.2 14.0 42.6 40.6 45.7 37.0 35.1 14.5 36.0 37.2 40.2 19.9 31.7 59.1 37.7 36.6 28.0 22.6 32.7 32.0 55.7 28.6 55.5 63.6 26.9 60.5 23.3 19.7 9.9 14.8 12.9 13.1 13.7 27.3 14.3 14.6 11.3 21.8 20.4 16.3 1.2 17.3 16.6 30.6 13.3 6.9 20.1 21.5 20.5 26.5 19.3 19.9 21.8 22.3 18.4 22.3 20.6 21.3 28.8 19.5 19.2 38.7 13.4 17.8 14.3 34.3 70.3 22.2 19.3 23.5 25.7 53.0 27.1 37.5 36.8 18.8 69.4 13.4 11.9 95.9 21.8 20.2 41.4 26.6 22.4 24.0 54.1 8.4 10.0 69.5 33.0 6.1 24.4 6.3 19.6 48.5 42.2 26.0 21.9 12.6 21.2 48.8 19.2 5.1 38.5 44.1 10.3 19.6 8.4 19.6 84.0 17.5 15.1 34.1 12.8 21.4 32.4 8.4 16.5 8.5 46.2 75.9 24.4 59.2 14.2 23.8 469.5 66.3 19.6 15.8 41.7 15.0 17.2 24.8 21.6 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513702-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 307.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No No "Nucleoplasm, Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268" "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 17.1 26.3 15.8 21.3 20.2 33.0 17.8 18.0 17.4 18.3 14.4 17.4 15.0 20.5 20.7 14.2 14.7 19.5 17.3 14.0 19.3 16.8 17.0 28.2 27.2 18.6 17.8 12.1 21.4 16.5 22.7 13.6 22.9 19.6 18.2 18.1 26.6 12.5 17.1 15.4 11.2 16.5 18.6 19.8 23.0 16.4 32.8 17.5 30.1 23.3 15.4 25.9 22.9 11.1 27.1 33.4 25.8 92.5 58.5 53.4 38.4 55.5 41.5 49.4 59.5 50.0 44.3 45.8 90.0 27.9 35.7 23.7 26.0 85.9 38.9 57.1 60.2 30.2 67.7 36.9 36.7 39.3 84.2 38.3 34.0 27.8 42.1 36.0 34.5 46.9 45.1 62.0 55.4 39.2 30.1 98.7 29.4 75.7 55.6 36.6 108.2 59.1 29.4 46.6 40.4 73.6 62.2 54.0 37.9 49.5 69.2 27.4 39.1 50.0 38.9 29.7 41.0 41.2 60.0 77.4 106.8 30.6 69.5 40.3 5.8 10.7 16.0 12.7 12.8 15.3 11.4 13.1 14.2 13.3 11.2 13.4 13.6 9.4 15.8 21.5 10.0 16.7 11.5 15.8 20.2 18.0 17.4 14.0 19.3 18.6 17.8 12.1 19.6 19.8 17.5 27.1 77.3 307.7 291.0 30.7 95.7 46.4 78.9 50.6 55.2 93.9 56.4 49.0 104.1 31.5 96.9 44.1 64.6 70.6 125.6 39.8 39.2 77.9 63.2 104.5 127.1 74.3 79.9 85.4 42.5 61.4 66.4 73.8 46.4 94.2 103.1 97.3 39.3 25.4 44.8 85.8 41.7 41.3 69.2 51.9 49.4 27.9 60.3 79.2 30.2 27.2 98.6 84.7 55.6 37.7 85.2 66.0 35.3 62.1 93.9 57.7 36.6 36.8 109.6 116.4 52.6 113.9 88.3 144.4 130.8 47.4 40.9 102.1 107.9 118.7 46.2 71.2 SYCP2L "C6orf177, dJ62D2.1, NO145" ENSG00000153157 "Synaptonemal complex protein 2 like" Q5T4T6 6 10886831-10979320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "parathyroid gland: 69.2" "Group enriched" "Detected in many" 4 "Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7" "Cancer enhanced" "Detected in single" "testis cancer: 1.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 17 "dendritic cells: 4.2;granulocytes: 3.4" "Cell line enhanced" "Detected in some" "HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA034679 Supported Nucleoplasm NA NA Nucleoplasm "HPA034679: AB_10669729" "unprognostic (3.25e-1)" "unprognostic (2.58e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-5)" "unprognostic (2.20e-1)" "unprognostic (1.21e-2)" "unprognostic (5.57e-3)" "unprognostic (4.23e-1)" "unprognostic (6.03e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.04e-1)" "unprognostic (1.21e-3)" "unprognostic (1.07e-2)" "unprognostic (1.86e-1)" "unprognostic (3.85e-2)" "unprognostic (2.74e-2)" 0.6 0.3 0.6 0.6 1.0 0.7 0.5 0.9 1.5 0.4 0.0 0.3 0.1 0.4 2.6 0.2 0.4 0.5 0.9 0.9 0.4 1.1 0.1 1.8 0.5 0.3 0.4 0.5 0.8 1.7 69.2 0.4 1.1 0.4 0.6 0.2 0.7 0.3 0.2 0.2 0.5 0.3 0.2 0.0 0.6 0.3 3.3 0.3 0.1 1.2 0.9 0.3 0.3 0.3 1.3 0.0 1.0 1.9 0.1 0.1 0.0 5.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.5 0.2 0.2 0.1 6.4 0.0 0.0 0.0 0.0 13.4 38.7 0.0 1.0 0.0 0.0 0.3 0.0 0.4 10.7 0.1 0.0 0.1 3.4 15.3 0.7 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.7 3.5 0.0 3.5 0.0 8.1 0.1 11.4 0.0 0.0 0.7 0.0 0.2 0.3 0.0 0.1 0.1 0.1 1.1 1.7 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.6 1.0 0.9 1.5 0.9 0.4 0.3 0.4 0.5 0.4 0.0 0.3 1.3 1.1 0.0 1.3 21.5 0.3 0.1 0.0 0.2 0.0 2.1 0.3 0.0 0.4 0.0 0.1 0.0 0.0 2.9 9.5 0.0 0.0 0.2 17.1 0.1 0.4 1.4 0.0 2.1 28.5 0.2 2.0 2.9 0.0 0.4 10.8 1.5 0.0 0.0 0.5 3.3 23.1 0.0 0.0 0.0 0.5 3.2 1.2 1.0 0.0 13.1 1.0 0.6 0.0 14.1 12.4 0.6 0.0 1.5 0.0 0.5 0.0 0.0 0.7 0.1 0.0 0.6 0.3 3.1 8.7 0.0 0.0 1.4 0.6 0.1 0.0 0.1 BMP6 "VGR, VGR1" ENSG00000153162 "Bone morphogenetic protein 6" P22004 6 7726099-7881728 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.3" "Cell type enhanced" "Detected in some" "Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002773, HPA062683" Approved Approved Mitochondria "Secreted to blood" No No 4970000 46000 Mitochondria "CAB002773: , HPA062683: AB_2684832" "prognostic favorable (6.45e-4)" "unprognostic (2.99e-1)" "unprognostic (4.20e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (7.27e-2)" "unprognostic (4.66e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.29e-3)" 15.2 3.1 5.3 2.2 5.3 0.4 12.8 3.8 6.7 2.8 11.0 3.5 3.0 3.5 0.6 2.0 2.4 2.1 4.7 3.7 3.6 6.7 1.9 9.2 1.5 5.5 4.2 2.9 8.3 0.6 0.6 4.6 18.3 4.9 2.8 2.8 0.2 2.4 2.7 3.1 3.1 3.0 2.4 4.3 4.6 4.7 2.2 6.3 0.9 1.6 1.3 2.5 3.4 3.0 5.0 0.9 2.4 0.3 0.0 0.4 0.3 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 37.0 1.1 1.6 0.5 1.1 0.2 0.0 0.0 5.7 15.9 21.8 1.4 0.8 1.1 16.7 0.0 0.0 0.7 2.4 9.6 149.6 0.0 0.0 81.6 0.0 0.3 0.0 0.0 0.8 0.5 12.0 0.6 0.0 15.3 0.5 0.0 12.3 0.0 70.0 0.0 0.0 9.3 0.0 0.0 74.3 0.0 4.7 0.5 2.6 11.3 41.3 0.1 2.3 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 5.3 5.3 3.8 6.7 3.7 3.6 5.5 4.2 2.9 4.9 4.3 6.3 5.0 23.0 0.0 0.5 1.6 1.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 3.5 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.8 0.2 8.9 0.0 0.0 7.8 0.0 0.1 2.0 0.0 2.0 0.0 1.5 16.8 0.6 0.3 0.0 22.8 0.0 0.0 0.8 2.1 4.2 0.0 1.5 1.8 74.0 0.7 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.8 0.3 0.0 0.0 0.3 0.0 0.0 4.7 0.4 0.1 1.3 0.1 0.1 0.3 0.4 0.4 0.0 0.0 RGPD3 RGP3 ENSG00000153165 "RANBP2 like and GRIP domain containing 3" A6NKT7 2 106391290-106468413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 7.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 1.5;MOLT-4: 4.6;RPMI-8226: 1.4" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.4 0.1 0.4 0.4 0.2 0.4 0.6 0.1 0.8 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 0.4 0.7 0.7 0.2 0.1 0.8 0.6 0.4 0.2 0.2 0.2 0.5 0.2 1.1 0.2 0.1 1.0 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.6 0.1 7.0 0.6 1.9 0.2 0.1 0.2 0.3 0.1 0.8 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.1 0.6 0.1 0.2 0.1 0.0 1.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.4 0.3 0.0 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.6 0.4 0.4 0.8 0.6 0.4 1.1 0.4 0.6 0.8 0.0 0.0 1.1 1.6 0.1 0.1 0.1 0.0 0.0 1.6 0.0 0.0 2.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.1 0.5 0.0 0.0 2.4 0.2 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.3 4.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.4 3.2 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RASSF3 ENSG00000153179 "Ras association domain family member 3" Q86WH2 12 64507001-64697564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 149.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 124.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 124.1" "Cell line enhanced" "Detected in all" "SK-MEL-30: 145.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022664, CAB034035, HPA038469" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (2.55e-3)" "unprognostic (3.73e-1)" "unprognostic (2.37e-1)" "unprognostic (6.21e-2)" "unprognostic (3.66e-2)" "unprognostic (1.49e-1)" "unprognostic (1.45e-3)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.59e-2)" 33.4 23.1 13.7 43.7 8.6 17.4 15.0 7.6 9.9 19.5 29.6 79.3 21.3 24.1 15.2 37.2 13.4 29.6 44.7 7.5 19.2 6.4 11.0 32.8 37.3 11.3 19.8 5.8 19.8 13.2 3.3 4.7 39.9 12.2 33.3 42.4 1.5 35.9 49.2 45.4 6.8 26.5 60.7 11.6 48.0 34.7 13.6 23.7 15.5 6.6 13.2 33.5 50.7 14.2 12.7 28.1 30.9 9.6 18.6 10.2 14.7 58.3 11.9 61.8 15.8 18.6 22.3 28.9 43.6 24.8 8.6 19.0 12.1 29.6 12.5 19.0 35.5 11.3 28.6 13.0 25.5 27.9 30.5 19.3 10.0 10.7 36.2 26.7 46.1 68.0 20.7 15.4 21.0 18.7 26.5 20.2 19.9 21.4 65.8 18.8 32.5 30.9 18.4 20.8 33.6 21.7 22.7 20.0 3.8 145.5 23.0 17.3 19.0 98.7 12.8 15.6 13.5 13.1 19.5 22.0 28.0 15.4 26.2 37.8 19.6 16.6 12.5 13.2 17.7 11.1 14.1 19.4 14.9 9.1 10.1 19.1 20.3 124.1 12.0 17.7 8.4 22.1 2.8 13.7 8.6 7.6 9.9 7.5 19.2 11.3 19.8 5.8 12.2 11.6 23.7 12.7 30.7 3.2 15.4 4.2 32.7 16.3 15.0 5.5 2.8 0.0 12.4 13.7 56.5 30.0 8.9 5.5 0.0 35.5 39.0 67.4 0.0 12.4 0.3 14.4 4.1 31.2 26.4 16.4 8.7 21.2 19.1 14.5 20.9 28.3 6.3 4.7 20.7 4.6 24.1 0.0 16.2 15.8 2.0 69.9 149.3 0.8 2.5 55.7 48.0 49.6 72.7 2.8 32.0 3.5 4.8 24.0 14.5 14.3 9.8 25.5 13.3 1.7 3.9 0.2 13.1 9.2 27.0 0.6 19.3 5.9 11.9 19.7 30.7 1.6 20.7 21.1 HNRNPU "C1orf199, FLJ30202, FLJ37978, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A" ENSG00000153187 "Heterogeneous nuclear ribonucleoprotein U" Q00839 1 244840638-244864560 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011532, HPA041057, HPA058707" Supported Enhanced Nucleoplasm NA NA 2100000 Nucleoplasm "CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (1.99e-1)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.88e-5)" "unprognostic (2.26e-2)" "unprognostic (4.09e-3)" "unprognostic (1.87e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (7.45e-2)" "unprognostic (1.21e-1)" "unprognostic (3.01e-2)" "unprognostic (2.98e-1)" "unprognostic (4.62e-1)" 100.8 112.8 127.0 76.8 135.4 179.0 101.9 136.3 141.0 101.2 127.6 93.0 66.1 103.8 122.3 100.7 107.5 63.2 92.1 125.7 146.8 115.4 106.5 81.4 99.1 130.8 132.4 118.0 135.6 100.2 110.4 88.8 96.8 129.4 93.0 85.0 127.4 87.5 80.2 117.5 89.2 95.2 77.4 138.3 103.9 95.7 90.9 131.5 142.5 104.5 62.2 116.4 97.8 87.5 149.1 308.9 242.9 311.8 249.4 160.5 136.4 307.9 215.2 138.2 193.3 171.1 234.0 198.6 481.9 195.6 183.0 185.4 235.3 424.4 244.0 304.5 204.8 280.2 417.4 203.4 360.7 168.8 482.7 242.9 156.2 143.9 211.6 220.1 169.8 200.4 296.9 553.0 174.0 264.3 221.2 517.8 497.8 545.5 227.4 217.2 510.6 392.7 261.9 314.3 222.9 260.6 257.5 339.2 220.4 280.9 226.8 305.2 531.7 244.5 192.6 283.7 207.0 384.3 283.4 332.9 458.6 156.8 403.1 282.2 23.0 14.4 20.6 18.0 12.9 19.2 22.6 22.0 22.1 15.8 21.8 25.5 21.5 20.6 19.8 15.0 31.3 21.3 10.1 127.0 135.4 136.3 141.0 125.7 146.8 130.8 132.4 118.0 129.4 138.3 131.5 149.1 269.6 326.9 375.8 67.9 271.9 271.2 416.4 137.1 277.2 149.5 254.3 166.5 186.8 118.7 281.4 193.1 183.5 202.2 323.4 163.7 97.8 215.5 389.9 283.4 530.1 248.6 198.1 269.4 61.8 180.9 259.5 267.1 202.9 429.8 363.6 375.3 133.2 121.9 184.5 141.3 65.2 208.0 109.9 223.7 268.6 481.9 153.7 402.7 122.7 45.9 251.4 151.4 228.6 67.8 107.7 188.9 141.8 142.6 331.6 215.8 141.4 133.2 240.1 213.7 144.7 317.0 364.3 194.9 162.7 292.7 239.2 252.7 310.6 379.9 234.6 288.1 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719482-108785809 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA 160000 "Nuclear membrane" "Nucleoplasm, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.5 24.5 9.1 16.5 12.1 42.5 19.9 15.1 18.8 18.2 19.3 15.8 13.5 17.8 20.7 14.4 14.8 13.8 14.4 11.4 19.3 18.3 17.6 14.1 18.8 10.1 9.4 9.1 24.6 20.4 30.4 21.6 16.6 9.9 21.1 15.4 26.7 16.5 17.4 30.5 17.3 13.5 15.3 10.3 15.1 17.8 21.5 8.7 23.5 28.7 23.8 18.1 17.1 12.2 12.9 40.5 24.2 34.1 31.0 38.7 34.5 32.9 35.5 28.0 28.7 25.1 60.7 18.9 63.2 26.8 37.2 35.3 33.1 58.9 36.9 41.5 38.9 28.5 65.9 30.3 43.2 22.5 77.9 21.3 29.1 27.5 44.9 34.7 28.3 44.5 27.1 71.9 34.0 38.4 22.3 34.8 31.6 43.0 20.3 28.7 32.3 52.3 30.7 25.3 49.6 49.4 22.6 31.5 26.7 34.7 20.4 17.2 35.4 53.5 29.8 39.6 21.2 40.2 27.9 44.4 55.8 23.1 34.4 23.5 5.4 2.6 2.7 3.7 1.7 4.1 2.7 3.0 3.4 2.2 2.7 2.9 3.3 3.9 2.2 3.6 2.6 2.7 1.4 9.1 12.1 15.1 18.8 11.4 19.3 10.1 9.4 9.1 9.9 10.3 8.7 12.9 54.5 76.9 85.3 48.6 91.5 55.7 34.5 39.1 61.5 51.2 34.1 25.8 103.9 38.6 63.0 58.8 73.0 28.8 96.1 28.9 1.9 34.7 77.3 83.6 65.3 55.7 106.4 50.5 125.5 50.9 17.5 56.5 68.3 142.1 84.9 52.2 31.4 56.6 47.9 32.0 92.2 59.5 44.7 44.9 80.7 32.9 38.5 114.0 48.0 55.3 57.0 20.0 34.0 44.2 80.0 41.5 29.9 56.1 118.4 44.1 28.8 15.6 67.0 40.5 46.0 56.9 59.0 78.3 65.4 53.3 67.8 40.6 104.8 25.3 38.3 38.7 AHCTF1 ELYS ENSG00000153207 "AT-hook containing transcription factor 1" Q8WYP5 1 246839098-246931948 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 3.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031658 Uncertain Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA031658: AB_10601968" "unprognostic (3.10e-1)" "unprognostic (1.10e-2)" "unprognostic (2.20e-1)" "unprognostic (6.11e-2)" "unprognostic (7.96e-2)" "unprognostic (2.42e-1)" "unprognostic (3.12e-2)" "unprognostic (8.50e-2)" "unprognostic (2.06e-3)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.49e-8)" "unprognostic (7.65e-2)" "unprognostic (1.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.52e-2)" 12.7 7.5 4.7 8.5 6.4 17.1 9.8 11.9 6.9 9.2 6.8 8.0 6.6 8.9 6.7 9.3 7.1 7.5 6.7 4.7 6.4 9.9 11.0 7.2 9.2 4.1 5.8 4.2 16.4 10.0 13.2 6.4 8.9 5.6 7.7 7.0 8.1 6.9 7.9 11.1 8.0 6.6 7.9 4.1 9.3 8.6 32.8 6.0 12.3 13.9 15.8 9.1 10.4 7.2 5.1 37.9 25.9 24.6 20.7 24.3 23.6 32.4 24.2 19.3 29.1 24.2 26.5 19.4 37.6 24.6 21.6 16.4 34.1 40.3 20.9 49.7 21.0 9.0 26.4 29.0 24.2 17.4 40.8 17.8 22.8 18.5 37.9 38.4 13.9 21.9 18.5 61.2 24.4 27.8 12.5 31.5 19.2 42.4 34.1 18.4 30.4 32.6 32.1 18.3 28.0 22.1 28.6 34.9 19.5 20.3 18.3 22.1 29.2 20.1 26.3 22.5 33.2 55.7 25.8 38.9 45.4 19.5 27.0 26.2 0.3 0.2 0.7 0.5 0.1 0.5 0.7 0.7 0.6 0.2 0.4 0.8 0.6 3.0 0.4 0.4 0.4 0.8 0.3 4.7 6.4 11.9 6.9 4.7 6.4 4.1 5.8 4.2 5.6 4.1 6.0 5.1 53.7 35.3 35.0 37.2 32.9 30.0 22.4 10.3 40.5 19.8 15.9 21.7 21.1 7.2 20.7 5.5 8.4 14.1 27.4 15.7 3.9 12.5 63.7 29.1 30.9 25.9 21.6 20.8 62.2 12.4 10.8 30.5 21.9 28.8 12.0 20.3 17.2 14.3 9.3 18.5 55.7 12.9 10.2 13.2 13.8 23.7 36.1 57.4 3.6 29.0 17.7 8.9 26.8 46.8 51.3 16.2 13.0 39.1 35.8 27.7 11.9 8.8 20.4 17.1 32.9 70.9 26.1 116.7 37.6 27.3 30.7 13.5 31.3 21.4 12.4 26.2 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898607-112029561 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 8.6;non-classical monocyte: 5.5" "Lineage enriched" "Detected in single" 50 "monocytes: 8.6" "Cell line enhanced" "Detected in many" "CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" Yes NA 65000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: AB_2686759" "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favorable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.3 60.4 21.6 13.6 28.3 1.5 15.4 17.5 29.5 12.7 40.0 10.9 12.4 11.6 26.5 8.5 15.6 12.2 6.5 21.2 25.0 11.5 21.2 13.7 13.3 20.2 20.4 17.2 12.8 10.0 21.4 15.6 20.2 20.8 14.3 7.9 16.7 6.5 16.4 3.2 6.1 14.4 14.5 17.8 30.9 14.0 17.3 24.8 6.9 10.2 4.6 9.0 13.7 9.5 25.2 1.0 1.7 7.6 17.3 0.4 0.2 12.3 0.0 0.2 1.0 1.7 35.1 2.2 0.1 8.1 0.1 7.9 0.2 10.2 0.0 1.4 1.5 5.5 7.0 0.0 39.9 0.3 0.2 1.5 0.5 0.0 8.9 0.6 4.0 38.4 1.5 2.2 3.5 2.9 1.8 0.0 9.1 4.8 1.1 6.0 2.9 2.1 3.0 19.4 23.4 0.3 7.2 0.2 0.5 3.2 2.7 0.0 0.4 5.8 1.0 3.4 0.1 0.0 3.1 4.8 0.1 0.0 1.4 0.0 0.0 0.6 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.5 0.1 0.0 0.2 21.6 28.3 17.5 29.5 21.2 25.0 20.2 20.4 17.2 20.8 17.8 24.8 25.2 8.8 3.2 27.7 162.6 1.7 1.7 2.9 0.3 1.8 0.6 2.1 4.3 2.7 2.8 6.4 0.0 2.1 3.3 0.4 1.2 1.9 1.1 2.3 8.0 4.7 10.2 0.0 0.4 5.0 1.0 1.1 3.2 0.5 12.1 0.0 3.8 28.5 9.2 25.5 0.0 7.0 2.0 0.0 119.8 1.8 2.7 5.0 46.5 0.0 124.6 1.5 7.7 0.0 10.6 0.6 1.2 1.9 6.8 10.8 2.9 4.4 1.9 1.5 11.3 6.6 1.5 9.2 0.6 1.5 0.6 1.3 18.9 1.3 3.5 1.9 1.6 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055269-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.28e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.6 12.3 7.0 14.8 6.6 8.0 20.3 6.3 8.1 13.0 7.5 28.7 28.9 11.1 18.7 10.6 8.5 12.2 4.9 6.2 7.5 7.0 7.5 11.8 15.6 7.7 7.9 5.5 6.0 11.4 13.1 9.3 15.2 7.9 31.0 28.1 7.0 15.5 16.1 3.1 13.8 30.8 13.5 6.9 15.6 23.0 5.0 9.3 9.8 15.1 4.2 14.7 17.2 9.1 7.5 21.7 6.4 5.9 25.8 24.9 32.6 21.4 35.5 46.8 21.9 26.7 16.6 28.6 20.9 18.2 47.3 30.2 34.9 3.8 21.6 28.7 12.8 4.1 27.5 4.6 15.2 24.7 19.6 28.9 22.3 25.9 28.0 22.0 21.4 23.6 9.6 16.9 13.1 31.8 13.7 9.3 10.8 4.8 35.0 16.4 7.6 8.9 17.0 20.3 30.2 4.6 6.4 15.4 38.6 34.6 15.5 20.4 14.7 26.6 22.3 6.8 17.6 7.8 10.6 18.1 12.9 25.9 10.1 16.3 5.4 3.0 2.6 3.2 5.2 5.6 5.9 6.9 4.4 2.7 4.9 6.2 3.6 1.8 3.5 6.7 2.7 7.4 3.6 7.0 6.6 6.3 8.1 6.2 7.5 7.7 7.9 5.5 7.9 6.9 9.3 7.5 18.3 28.9 13.9 18.9 23.3 12.2 14.5 20.9 39.9 5.0 32.9 14.4 4.6 20.0 21.6 18.4 2.1 15.9 12.3 59.5 0.0 42.9 18.7 14.4 26.5 19.9 17.4 6.3 18.4 89.3 25.5 17.5 46.4 24.9 13.3 14.5 35.7 10.1 21.7 6.7 16.4 53.6 12.2 37.7 10.9 24.5 9.9 22.7 3.6 30.0 20.9 4.0 6.2 21.6 23.1 69.7 47.1 3.0 21.6 28.9 44.9 4.7 17.9 7.9 0.0 5.4 17.2 4.9 5.6 29.9 12.8 29.1 20.5 11.8 38.2 23.9 OR14K1 OR5AY1 ENSG00000153230 "Olfactory receptor family 14 subfamily K member 1" Q8NGZ2 1 247738615-247739559 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "GAMG: 5.2" "Not detected" "Not detected" HPA016643 Uncertain NA NA "HPA016643: AB_1854788" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase receptor type R" Q15256 12 70638073-70920738 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.7;endometrium 1: 5.6;intestine: 7.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 199.5;Inhibitory neurons: 160.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 20.0;RT4: 37.4" "Region enriched" "Detected in all" 5 "cerebellum: 89.6" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340" "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.40e-5)" 0.0 2.2 3.0 1.0 6.5 0.0 0.0 15.7 4.4 0.2 0.0 7.5 3.3 5.6 0.0 0.0 0.1 1.1 0.0 6.6 4.4 0.0 0.0 0.0 0.0 0.9 0.5 6.1 0.0 0.1 0.0 0.3 0.2 3.7 0.0 5.1 2.5 0.0 1.1 0.0 0.0 7.7 3.0 0.6 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 37.4 0.1 5.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 6.5 15.7 4.4 6.6 4.4 0.9 0.5 6.1 3.7 0.6 0.5 2.8 1.7 0.0 0.0 3.9 0.2 0.5 0.1 0.5 0.0 16.5 0.2 0.1 3.5 0.0 3.4 0.0 0.0 0.0 0.7 43.2 0.0 2.6 1.7 2.2 1.3 4.0 0.0 0.0 199.5 0.2 0.3 0.3 10.2 14.6 0.0 0.0 0.7 0.0 0.0 16.8 160.7 1.8 0.0 0.0 0.3 0.4 0.0 0.2 0.0 3.7 0.0 0.2 1.0 2.0 4.0 2.8 23.0 0.0 0.0 0.4 17.3 0.0 0.1 0.8 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.8 0.4 0.0 0.7 0.4 NR4A2 "HZF-3, NOT, NURR1, RNR1, TINUR" ENSG00000153234 "Nuclear receptor subfamily 4 group A member 2" P43354 2 156324437-156342348 "Cancer-related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 130.6;bone marrow: 131.9;ovary: 130.3" "Cell type enhanced" "Detected in many" "B-cells: 511.7;dendritic cells: 410.4;Langerhans cells: 782.3;Macrophages: 577.5;T-cells: 465.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.0;HMC-1: 10.9;SK-MEL-30: 8.1;U-266/70: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000543, CAB010481" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB010481: AB_2298676, HPA000543: AB_1854631" "unprognostic (4.26e-2)" "unprognostic (2.14e-1)" "unprognostic (3.42e-2)" "unprognostic (4.10e-2)" "unprognostic (3.04e-2)" "unprognostic (5.26e-2)" "unprognostic (2.30e-1)" "unprognostic (6.14e-2)" "unprognostic (8.63e-2)" "unprognostic (3.88e-2)" "unprognostic (1.60e-2)" "unprognostic (2.89e-1)" "unprognostic (2.39e-2)" "unprognostic (3.58e-2)" "unprognostic (3.43e-1)" "unprognostic (9.29e-3)" "unprognostic (1.11e-1)" 30.0 130.6 3.1 24.7 35.3 131.9 15.7 32.2 9.9 18.5 8.4 9.5 2.9 15.1 1.7 11.5 28.5 33.0 24.1 15.9 44.6 18.8 20.3 18.9 6.4 16.0 9.7 8.2 130.3 9.3 8.9 54.5 5.2 2.8 25.8 18.9 5.3 19.4 15.6 11.7 12.0 7.8 14.6 1.4 4.6 20.1 5.6 2.8 9.8 15.3 7.8 1.4 51.4 14.1 9.9 0.9 1.3 0.5 1.8 3.2 0.7 0.9 1.1 5.5 0.4 1.3 0.0 3.3 0.0 1.2 0.4 0.4 1.6 2.6 0.7 0.4 1.3 1.4 1.0 16.0 0.0 0.6 0.7 10.9 0.6 1.2 0.4 0.4 2.1 0.3 0.0 1.6 1.0 1.1 1.9 0.0 0.8 2.1 1.5 0.8 0.2 0.7 3.3 0.6 0.8 2.7 0.1 2.6 4.1 8.1 0.3 0.2 1.0 0.7 2.9 0.8 0.7 0.4 14.2 1.8 0.0 5.3 1.0 7.0 1.9 1.7 2.4 1.0 0.3 0.5 0.4 0.3 0.5 1.9 0.3 0.5 0.2 6.5 0.0 0.7 0.0 0.4 0.5 3.1 35.3 32.2 9.9 15.9 44.6 16.0 9.7 8.2 2.8 1.4 2.8 9.9 70.7 25.6 124.7 7.8 511.7 218.6 25.8 87.5 298.7 11.8 120.8 160.1 11.9 17.2 58.3 71.7 50.1 4.7 410.4 35.0 0.0 13.1 36.7 209.6 33.9 111.9 206.4 12.0 5.8 9.1 6.5 164.9 103.9 349.7 349.3 4.3 45.0 6.8 125.1 0.0 0.8 95.4 42.7 161.1 782.3 37.2 4.1 577.5 241.9 5.6 7.9 1.6 3.1 4.0 2.3 11.7 41.9 0.7 203.5 49.1 25.9 0.4 54.6 33.4 13.1 63.0 169.8 1.8 3.3 230.2 213.7 9.9 465.1 34.4 57.5 29.5 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171073-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Early spermatids: 39.4;Excitatory neurons: 33.6;Inhibitory neurons: 53.0;Oligodendrocytes: 38.6;Respiratory ciliated cells: 34.1;Rod photoreceptor cells: 30.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;HBF TERT88: 1.8;RPTEC TERT1: 1.9;SCLC-21H: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.3 0.7 0.0 0.6 0.0 1.0 0.9 0.4 0.8 2.5 0.0 0.0 0.4 1.2 0.1 1.8 0.3 0.1 0.4 0.9 2.2 0.1 0.4 0.0 0.8 0.8 0.3 0.7 0.2 2.5 1.0 0.0 0.5 0.4 0.0 2.0 0.6 0.4 0.0 0.2 0.0 0.1 0.5 0.0 0.1 3.4 0.4 0.0 1.0 0.0 0.0 0.1 0.2 0.6 0.7 0.0 0.4 0.7 0.0 0.0 0.0 0.5 0.0 0.5 1.1 0.5 2.7 0.0 0.1 0.4 0.2 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.2 2.0 0.1 0.3 0.2 0.2 0.6 1.2 0.1 0.0 0.2 0.4 0.1 0.1 0.3 0.6 0.0 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.9 0.4 0.4 0.9 0.8 0.8 0.3 0.5 0.5 0.4 0.6 1.1 0.0 1.5 13.4 0.2 0.0 2.6 4.2 1.2 10.9 3.8 4.6 3.0 0.0 3.0 7.3 56.3 0.0 0.0 0.0 13.7 5.5 39.4 15.2 0.6 1.5 0.0 0.0 33.6 2.0 0.0 0.6 0.0 2.8 0.0 1.3 1.1 1.3 0.1 5.0 53.0 0.0 10.2 0.3 0.0 7.7 0.9 1.0 0.0 5.6 0.8 6.0 0.0 19.6 38.6 2.6 0.0 1.9 0.0 1.2 0.0 6.4 34.1 30.8 6.6 1.6 0.7 22.6 4.0 0.6 0.4 0.0 0.2 1.3 0.1 1.7 PLA2R1 "CLEC13C, PLA2-R, PLA2G1R, PLA2IR" ENSG00000153246 "Phospholipase A2 receptor 1" Q13018 2 159932006-160062615 "Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 39.4;thyroid gland: 42.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 33.1;Excitatory neurons: 34.6;Inhibitory neurons: 43.5;Muller glia cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 14.5;ASC TERT1: 19.5;BJ hTERT+: 16.2;hTERT-RPE1: 26.3;TIME: 47.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB068217, CAB068218" Approved Approved Cytosol "Secreted to blood" NA NA 960000 Cytosol "CAB068217: AB_2665660, CAB068218: AB_2665661" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (4.91e-3)" "unprognostic (6.01e-2)" "unprognostic (9.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.38e-3)" "unprognostic (4.30e-3)" "unprognostic (2.82e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.62e-1)" "unprognostic (6.58e-2)" "unprognostic (2.02e-1)" 4.5 2.9 1.0 1.4 0.8 0.0 15.0 9.6 2.2 7.0 2.6 3.1 4.0 8.9 2.9 4.7 5.4 9.4 2.3 0.7 3.4 21.0 1.4 2.6 1.9 1.9 3.2 0.3 10.9 0.6 19.8 2.2 3.9 4.4 3.1 3.2 5.6 39.4 3.0 0.5 10.6 6.2 6.9 1.2 5.2 1.7 1.0 2.1 0.6 42.3 1.3 2.7 4.0 6.1 1.8 0.2 1.6 0.6 0.0 14.5 19.5 0.1 6.8 16.2 1.3 1.8 0.0 3.4 0.0 0.4 7.2 1.4 3.3 0.1 5.0 1.4 0.0 0.0 0.0 11.8 0.0 1.2 0.0 0.0 7.9 5.4 1.9 2.1 26.3 9.3 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 1.4 0.7 0.0 0.0 11.8 2.2 0.0 1.7 2.6 0.2 47.3 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 1.0 0.8 9.6 2.2 0.7 3.4 1.9 3.2 0.3 4.4 1.2 2.1 1.8 11.1 6.4 2.8 20.9 0.1 9.4 2.7 18.1 21.6 2.7 22.1 14.5 4.1 5.7 11.3 33.1 0.0 7.3 0.5 1.7 0.0 0.6 0.1 5.6 22.0 4.0 1.2 0.0 34.6 2.0 1.3 14.8 0.0 9.4 1.3 9.6 8.6 0.0 0.6 16.8 43.5 7.2 4.1 0.0 2.1 1.4 16.1 0.5 7.2 25.3 0.0 33.5 0.0 5.5 1.8 5.1 11.3 16.6 0.1 2.6 15.6 2.3 8.1 1.4 6.6 3.4 4.8 0.1 1.0 9.3 5.4 1.5 0.6 6.3 7.5 3.0 RBMS1 "C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1" ENSG00000153250 "RNA binding motif single stranded interacting protein 1" P29558 2 160272151-160493807 "Predicted intracellular proteins" "DNA replication" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 398.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047943, HPA061791" Enhanced Cytosol NA NA Cytosol "HPA047943: AB_2797235, HPA061791: AB_2684611" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (3.78e-2)" "unprognostic (1.38e-3)" "unprognostic (2.50e-1)" "unprognostic (6.81e-3)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (7.16e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (1.33e-7)" "unprognostic (1.84e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (2.32e-1)" 58.7 22.8 10.1 43.7 12.5 36.1 34.8 10.0 11.7 36.1 17.8 31.4 12.9 52.2 12.8 29.2 31.9 34.4 40.1 7.7 17.8 26.9 22.5 48.1 28.5 14.2 11.6 6.9 44.5 10.3 50.8 16.2 84.5 14.0 24.2 15.9 6.9 19.4 28.9 16.6 28.2 20.7 57.4 10.7 41.0 20.3 10.5 12.4 26.3 23.2 24.0 22.2 57.5 31.9 15.3 50.5 18.2 63.9 8.4 90.2 155.6 77.1 62.7 89.1 42.4 43.8 50.9 36.9 0.4 76.3 106.6 20.0 30.0 31.1 46.0 69.2 40.9 23.2 18.9 44.2 41.0 82.3 30.8 1.1 187.9 35.6 73.7 32.8 56.7 67.5 15.1 1.2 23.0 103.2 39.4 28.8 31.2 39.3 8.3 40.1 21.6 55.7 25.5 64.9 61.1 8.3 21.7 39.1 22.9 60.2 78.8 11.7 47.9 81.7 75.3 47.7 69.7 57.5 12.2 0.7 21.2 60.7 46.2 49.2 4.0 20.5 26.2 8.6 12.0 29.5 0.9 14.9 13.3 13.7 1.9 24.1 10.9 44.4 13.7 6.9 7.6 2.7 11.0 10.1 12.5 10.0 11.7 7.7 17.8 14.2 11.6 6.9 14.0 10.7 12.4 15.3 102.8 112.2 97.8 12.1 37.3 91.1 110.0 59.1 55.2 3.0 44.7 43.2 62.3 18.6 48.1 69.9 0.0 99.1 83.9 0.4 25.4 24.5 59.2 39.8 141.4 126.0 0.0 38.3 132.7 47.3 112.6 161.8 36.7 42.0 20.3 40.8 162.8 29.1 126.3 1.7 136.1 0.5 22.4 123.4 80.2 15.5 88.9 103.8 55.2 153.6 81.2 20.8 93.7 116.1 19.7 96.4 1.3 98.9 23.3 107.0 0.3 36.4 54.1 1.4 78.9 113.6 185.9 6.7 14.5 47.3 82.5 398.3 113.0 53.4 0.5 175.5 SCN3A Nav1.3 ENSG00000153253 "Sodium voltage-gated channel alpha subunit 3" Q9NY46 2 165087526-165204050 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 12.4;lymphoid tissue: 3.1" "Cell type enhanced" "Detected in some" "Early spermatids: 78.4;Excitatory neurons: 227.3;Inhibitory neurons: 169.4;Oligodendrocyte precursor cells: 358.4" "Cancer enriched" "Detected in some" 6 "glioma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 13.2;naive B-cell: 15.3" "Lineage enriched" "Detected in single" 32 "B-cells: 15.3" "Cell line enhanced" "Detected in some" "JURKAT: 5.9;Karpas-707: 10.3;MOLT-4: 30.3;RPTEC TERT1: 14.9;SH-SY5Y: 6.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035396 Uncertain NA NA "HPA035396: AB_2674607" "unprognostic (1.80e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (1.50e-2)" "unprognostic (6.69e-2)" "unprognostic (1.10e-2)" "unprognostic (4.96e-4)" "unprognostic (2.46e-1)" "unprognostic (1.48e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-4)" "unprognostic (4.55e-2)" "unprognostic (5.87e-3)" "unprognostic (2.88e-2)" "unprognostic (6.85e-2)" "unprognostic (2.66e-1)" "unprognostic (4.93e-2)" 1.0 1.5 8.0 0.5 10.9 0.2 1.0 7.3 12.2 0.6 0.0 0.7 0.3 0.4 0.1 0.4 0.4 0.5 0.6 8.7 12.4 0.5 0.2 0.2 0.8 4.9 6.5 9.4 0.6 0.5 0.4 0.1 0.1 6.3 0.2 0.7 1.0 0.1 0.4 0.9 0.0 0.6 0.5 1.4 0.5 0.9 0.5 10.6 3.1 0.2 0.6 1.2 0.5 0.0 8.5 0.0 0.2 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.6 2.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 4.9 0.0 5.9 0.0 10.3 0.1 0.0 30.3 0.0 0.0 0.1 2.4 0.1 1.3 0.0 14.9 0.0 3.8 6.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.2 0.1 0.8 0.0 1.4 0.6 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 15.3 0.1 0.0 0.0 0.2 0.0 0.4 0.1 0.1 8.0 10.9 7.3 12.2 8.7 12.4 4.9 6.5 9.4 6.3 1.4 10.6 8.5 0.9 0.0 0.5 8.5 6.5 0.0 0.2 0.0 0.6 4.4 0.1 0.4 6.5 0.0 0.0 1.8 12.5 0.0 0.0 0.0 0.0 0.2 78.4 0.0 0.0 2.9 8.9 0.0 227.3 0.0 0.0 0.5 1.1 0.0 0.0 0.3 0.0 0.2 0.1 5.0 169.4 1.2 0.0 0.0 0.3 11.5 0.3 0.2 1.8 19.7 0.0 0.3 0.0 358.4 9.2 0.1 0.0 0.7 5.3 0.0 0.0 0.0 0.0 0.8 13.1 0.3 31.8 0.7 2.4 0.0 0.1 0.0 0.1 0.3 0.1 0.1 FEZF2 "FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312" ENSG00000153266 "FEZ family zinc finger 2" Q8TBJ5 3 62369681-62374324 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "brain: 165.1" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 51.5" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in all" 5 "cerebral cortex: 165.1;hippocampal formation: 50.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.2;cerebral cortex: 12.1;hippocampal formation: 21.3" NA NA "unprognostic (2.37e-1)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" 0.1 0.0 11.6 0.0 15.3 0.0 0.0 2.7 165.1 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 4.4 0.1 0.0 0.0 0.0 19.1 4.3 9.9 0.0 0.0 0.0 0.7 0.0 10.5 0.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.1 0.2 0.0 3.8 2.8 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 15.3 2.7 165.1 50.0 4.4 19.1 4.3 9.9 10.5 4.3 3.8 20.1 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 51.5 0.9 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CD96 TACTILE ENSG00000153283 "CD96 molecule" P40200 3 111292719-111665750 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 62.4" "Group enriched" "Detected in many" 4 "dendritic cells: 96.8;NK-cells: 58.7;T-cells: 199.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4" "Group enriched" "Detected in many" 5 "NK-cells: 79.5;T-cells: 117.2" "Cell line enhanced" "Detected in some" "HEL: 15.9;JURKAT: 18.2;MOLT-4: 68.7;RT4: 58.2;U-937: 59.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066754 Enhanced NA NA 85000 "HPA066754: AB_2685714" "unprognostic (1.06e-3)" "unprognostic (3.95e-3)" "unprognostic (4.16e-3)" "unprognostic (1.91e-5)" "unprognostic (4.72e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.12e-2)" "unprognostic (3.48e-2)" "unprognostic (6.06e-2)" "unprognostic (4.84e-3)" "unprognostic (2.44e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.02e-6)" "unprognostic (3.12e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-2)" "prognostic favorable (5.23e-5)" 5.3 1.8 0.7 12.4 0.8 16.1 2.8 1.0 1.1 3.2 1.8 5.1 6.1 2.6 0.9 1.9 2.0 5.9 0.7 0.6 0.8 1.6 3.7 8.3 27.1 1.7 0.8 0.5 0.9 0.4 0.2 0.7 1.0 1.1 2.1 5.9 0.1 2.7 1.1 0.4 0.9 10.2 1.5 0.8 12.9 6.8 0.9 0.8 62.4 3.9 0.1 20.3 11.9 2.6 1.9 0.1 0.0 0.2 0.1 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.2 0.0 15.9 0.2 0.2 0.0 0.8 1.3 0.0 0.0 0.1 0.1 1.2 0.0 18.2 0.3 2.0 0.0 0.0 68.7 0.2 0.6 0.0 0.0 0.1 1.9 0.5 0.6 58.2 0.1 0.0 0.2 0.9 0.1 0.3 0.3 0.2 0.0 0.3 1.1 0.3 0.1 5.6 1.9 0.0 0.3 59.0 12.2 2.3 0.5 15.6 74.0 0.3 117.2 10.8 67.0 85.3 0.3 18.8 68.7 81.8 2.7 79.5 0.7 0.5 47.4 46.4 0.7 0.8 1.0 1.1 0.6 0.8 1.7 0.8 0.5 1.1 0.8 0.8 1.9 1.5 19.2 19.0 0.0 12.5 3.2 0.8 0.1 1.2 1.6 1.6 1.4 1.0 0.0 9.3 1.8 0.0 0.6 96.8 0.8 0.0 0.1 0.8 2.1 0.8 3.0 0.0 9.3 0.7 0.0 0.2 4.3 8.6 1.6 16.4 0.4 2.2 0.9 0.2 0.0 0.4 0.7 0.0 5.0 6.7 1.1 0.3 6.7 3.6 6.5 2.9 0.5 58.7 0.0 0.1 0.0 1.3 0.0 29.6 0.3 0.0 0.4 1.7 2.1 0.0 0.8 1.0 0.4 0.7 0.6 3.1 1.9 199.9 0.2 0.5 0.6 SLC25A27 "FLJ33552, UCP4" ENSG00000153291 "Solute carrier family 25 member 27" O95847 6 46652915-46678190 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 53.2;Excitatory neurons: 78.1;Inhibitory neurons: 78.1;Oligodendrocyte precursor cells: 127.2;Oligodendrocytes: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 53.6;hTCEpi: 24.2;U-698: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069732 Supported Mitochondria NA NA Mitochondria "HPA069732: AB_2686185" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (9.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.87e-1)" "unprognostic (2.03e-1)" "unprognostic (2.81e-1)" "unprognostic (1.24e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (3.82e-3)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.74e-1)" "unprognostic (7.47e-3)" 28.4 23.9 36.2 6.0 48.3 1.5 31.9 77.2 46.8 57.6 40.4 40.6 6.7 41.8 70.6 18.7 53.3 19.9 33.5 42.0 36.3 45.6 44.2 25.4 5.8 37.7 41.1 38.7 95.1 34.4 21.3 115.6 3.1 47.6 72.8 15.7 119.9 28.7 24.6 21.4 41.4 24.6 22.4 29.2 15.9 31.9 32.7 43.0 1.2 71.4 11.0 4.9 43.4 41.2 59.0 3.5 2.3 3.9 13.1 14.6 10.0 0.1 2.0 6.2 1.8 0.4 0.0 4.9 1.4 8.9 3.3 4.3 6.9 1.8 5.8 1.2 0.0 19.7 0.0 53.6 5.0 7.7 0.1 0.6 15.7 24.2 0.1 15.2 9.4 0.4 13.5 0.2 0.1 1.6 1.4 0.0 0.2 2.0 3.5 5.2 0.0 5.0 0.2 9.7 12.5 11.8 1.3 9.2 0.6 5.4 5.7 9.8 0.0 1.4 8.1 5.3 0.8 1.7 5.3 0.0 27.4 1.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 48.3 77.2 46.8 42.0 36.3 37.7 41.1 38.7 47.6 29.2 43.0 59.0 3.6 3.2 4.6 53.2 0.2 0.9 4.4 0.5 9.1 32.0 3.6 7.5 9.5 2.8 1.7 5.5 29.2 0.0 0.0 0.7 0.0 1.2 29.0 5.7 6.1 4.5 6.0 2.5 78.1 0.7 0.1 7.2 1.1 5.1 1.3 7.3 1.8 2.2 0.2 20.2 78.1 1.3 2.0 0.3 0.3 22.7 3.1 0.8 1.8 27.2 0.0 7.0 0.0 127.2 88.5 0.2 0.7 5.3 0.2 4.5 0.5 1.0 5.0 36.2 0.0 8.8 7.5 0.5 1.8 4.4 2.4 0.0 0.2 8.8 1.5 2.8 ADGRF1 "GPR110, hGPCR36, PGR19" ENSG00000153292 "Adhesion G protein-coupled receptor F1" Q5T601 6 46997708-47042350 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 17.6;kidney: 19.3;urinary bladder: 43.0" "Group enriched" "Detected in some" 4 "Collecting duct cells: 108.5;Pancreatic endocrine cells: 98.9;Urothelial cells: 363.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.2;CAPAN-2: 113.3;HaCaT: 25.3;PC-3: 36.6;RPTEC TERT1: 50.9;RT4: 132.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA038438 Approved "Secreted - unknown location" NA NA "HPA038438: AB_10672645" "unprognostic (4.83e-4)" "unprognostic (1.38e-1)" "unprognostic (1.64e-1)" "unprognostic (6.71e-3)" "unprognostic (1.95e-3)" "unprognostic (3.02e-3)" "unprognostic (7.76e-2)" "unprognostic (2.63e-2)" "unprognostic (2.90e-1)" "unprognostic (4.20e-2)" "unprognostic (3.64e-3)" "unprognostic (1.99e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.41e-2)" "unprognostic (8.39e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.3 0.0 0.2 0.1 17.6 0.8 6.1 0.0 0.0 0.0 19.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.0 0.1 0.0 3.2 1.7 0.0 0.0 3.3 0.0 0.0 0.0 1.5 0.6 0.0 0.1 6.2 0.0 5.9 43.0 6.5 0.0 31.2 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.3 0.0 2.0 0.0 0.0 25.3 0.0 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.5 36.6 0.0 0.0 0.0 50.9 132.6 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 21.8 0.0 0.1 0.0 25.4 0.0 0.6 0.0 5.5 1.9 0.7 12.8 13.6 108.5 0.0 0.0 0.0 1.5 23.5 30.8 0.0 7.0 5.0 0.7 0.0 0.0 0.1 18.9 0.1 0.8 3.6 46.9 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.9 0.0 0.0 0.0 39.1 1.2 0.7 14.6 0.0 0.0 0.2 1.1 0.0 0.2 2.6 0.0 0.1 1.0 0.1 0.2 363.7 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.4;skin 1: 39.1" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 15.1;Pancreatic endocrine cells: 20.5;Prostatic glandular cells: 6.0;Squamous epithelial cells: 14.4;Syncytiotrophoblasts: 7.3;Urothelial cells: 20.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.2" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 13.2;HBEC3-KT: 21.0;hTCEpi: 31.8;OE19: 18.4;U-87 MG: 26.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.1 0.7 0.0 0.2 0.0 0.0 2.2 0.3 0.1 2.3 0.0 1.2 0.0 0.3 0.0 18.4 1.1 0.7 0.6 0.0 1.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 2.0 0.1 0.2 1.5 0.0 2.5 0.0 0.6 39.1 0.2 0.1 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.9 4.2 4.4 9.7 0.0 8.9 1.2 0.0 0.0 0.0 0.0 1.0 0.0 5.1 0.1 0.0 2.4 0.0 0.0 0.0 0.0 8.2 13.2 0.0 21.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 31.8 0.4 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 18.4 1.2 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.0 0.8 0.1 1.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 4.4 0.0 3.5 0.7 1.6 0.3 0.2 0.0 0.0 0.6 3.4 15.1 0.4 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.5 0.0 0.0 6.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 14.4 0.0 7.3 0.0 0.0 0.1 20.5 FRMD1 "bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260" ENSG00000153303 "FERM domain containing 1" Q8N878 6 168053166-168101511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 6.8;lymphoid tissue: 13.2;stomach 1: 5.8;testis: 5.1" "Group enriched" "Detected in some" 4 "Distal enterocytes: 68.9;Paneth cells: 167.2" "Cancer enriched" "Detected in single" 6 "colorectal cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 1.9;RPMI-8226: 3.0" "Low region specificity" "Detected in many" HPA030347 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA030347: AB_10600207" "unprognostic (2.43e-2)" "unprognostic (2.74e-1)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.25e-1)" "unprognostic (2.58e-4)" "unprognostic (8.63e-2)" "unprognostic (2.62e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (8.23e-2)" "unprognostic (1.71e-2)" "unprognostic (1.01e-1)" "unprognostic (9.11e-3)" 3.6 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 6.8 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.2 0.0 3.1 0.1 0.0 2.1 5.8 5.1 0.0 13.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.0 68.9 0.0 0.0 15.3 0.0 0.0 0.2 7.8 0.0 0.0 1.8 0.0 0.4 4.6 0.1 0.0 0.3 0.4 0.6 0.0 0.0 0.0 16.0 0.0 0.0 0.0 20.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 167.2 1.5 0.0 0.0 19.6 23.8 0.0 0.0 0.0 0.3 0.7 13.4 8.2 0.0 0.0 0.1 0.1 15.2 12.6 0.2 CYRIB "BM-009, CYRI, CYRI-B, FAM49B" ENSG00000153310 "CYFIP related Rac1 interactor B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 200.4" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Enhanced Approved Nucleoplasm,Cytosol NA NA 1100000 Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 41.7 26.5 29.7 98.3 40.4 200.4 26.2 33.2 43.3 13.6 31.3 31.4 30.6 16.1 21.3 29.7 15.4 31.0 18.6 31.7 42.1 23.1 26.7 39.3 120.6 41.0 35.0 29.5 11.5 16.0 17.9 17.7 42.3 39.6 14.9 36.1 28.8 18.4 13.2 26.1 19.1 42.6 29.0 44.1 84.3 28.8 30.2 34.9 80.0 28.8 24.5 106.0 51.1 14.2 47.8 167.5 87.7 93.6 52.9 8.2 12.1 124.2 49.4 47.8 67.2 71.4 50.9 111.8 165.5 105.9 32.6 53.3 81.2 78.2 130.6 100.3 349.1 54.5 166.4 44.6 57.7 31.9 109.2 137.1 19.3 60.1 45.3 93.9 54.9 60.2 132.0 121.2 186.3 74.5 74.5 372.0 80.3 79.8 130.4 119.7 160.1 63.3 278.3 138.4 67.4 62.1 81.2 99.2 61.9 152.5 84.1 72.4 139.0 37.5 24.7 158.5 52.8 106.8 61.5 195.7 275.1 38.8 233.5 65.3 350.7 212.5 404.4 161.6 256.2 124.7 122.7 91.2 134.0 280.9 98.7 80.1 132.3 553.9 189.6 232.8 179.8 136.7 306.0 29.7 40.4 33.2 43.3 31.7 42.1 41.0 35.0 29.5 39.6 44.1 34.9 47.8 8.4 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 117.7 66.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 158.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 239.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 60.5 8.4 0.0 0.0 0.0 ASAP1 "CENTB4, DDEF1, KIAA1249, PAP, ZG14P" ENSG00000153317 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 1" Q9ULH1 8 130052104-130443674 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 11.6" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7" "Cell line enhanced" "Detected in all" "TIME: 167.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011136, CAB037292, HPA048565" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA 31000 "Plasma membrane, Centrosome, Cytosol" "CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.77e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.63e-8)" "prognostic unfavorable (3.56e-5)" "unprognostic (3.34e-1)" "unprognostic (5.27e-2)" "unprognostic (8.56e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.50e-7)" "unprognostic (3.79e-2)" "unprognostic (1.19e-1)" "unprognostic (7.38e-2)" "unprognostic (1.22e-3)" 30.7 22.3 16.6 12.3 15.1 48.2 24.2 7.9 22.0 16.9 4.6 12.0 5.5 19.1 12.3 10.8 17.4 14.7 24.3 14.8 12.8 10.2 9.4 30.4 18.2 14.5 20.0 10.4 18.4 7.8 18.2 10.6 28.0 15.1 12.8 9.0 8.7 8.5 11.5 13.5 16.8 12.3 18.1 9.9 30.2 10.6 28.8 30.7 16.4 16.5 10.4 19.2 16.0 15.7 22.7 48.9 31.5 41.1 27.4 46.7 61.9 37.1 44.2 83.8 57.2 62.3 17.5 18.2 14.4 31.8 67.7 38.6 13.2 24.7 41.4 86.3 20.6 15.9 22.6 20.7 23.6 119.9 10.4 6.7 61.7 15.3 33.6 50.3 66.9 60.2 7.7 13.0 45.7 54.0 15.1 13.3 9.8 13.1 24.1 30.5 13.6 9.6 7.0 18.1 25.2 14.6 44.4 32.4 20.5 26.5 42.5 17.0 22.4 167.5 45.9 28.9 20.6 69.8 42.2 12.0 9.7 34.6 14.6 50.3 0.0 2.2 1.5 0.5 2.1 0.3 1.3 1.0 0.9 3.7 1.0 1.3 0.8 11.6 0.6 6.7 0.4 0.8 1.1 16.6 15.1 7.9 22.0 14.8 12.8 14.5 20.0 10.4 15.1 9.9 30.7 22.7 97.2 3.2 6.3 206.6 22.7 47.7 21.9 12.0 29.6 25.0 12.4 14.7 33.7 27.1 11.5 3.7 16.7 42.2 14.6 3.6 3.9 10.5 159.7 14.3 34.2 109.1 13.1 98.9 345.8 8.7 37.6 43.7 4.6 27.7 9.5 30.1 103.9 8.2 64.0 62.2 225.8 4.3 8.2 56.1 168.8 460.2 39.1 73.1 44.4 181.8 71.4 9.5 15.5 622.3 245.9 12.5 4.7 54.9 13.7 37.9 5.8 4.3 4.2 7.8 78.9 28.5 90.1 61.4 95.5 25.2 44.9 46.7 23.1 58.9 4.8 22.0 TRAPPC8 "GSG1, HsT2706, KIAA1012, TRS85" ENSG00000153339 "Trafficking protein particle complex 8" Q9Y2L5 18 31829197-31953136 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 8.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041107 Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA041107: AB_10793869" "unprognostic (4.04e-1)" "unprognostic (4.35e-2)" "unprognostic (2.62e-3)" "unprognostic (9.80e-2)" "unprognostic (8.18e-2)" "unprognostic (4.06e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (7.67e-3)" "unprognostic (4.42e-2)" "unprognostic (3.00e-1)" "unprognostic (6.35e-3)" "prognostic favorable (1.85e-9)" "unprognostic (3.55e-2)" "unprognostic (7.03e-2)" "unprognostic (4.26e-1)" "unprognostic (2.92e-1)" 10.0 10.0 5.4 10.2 6.0 10.3 9.9 8.3 6.7 9.0 9.8 9.9 10.3 8.6 6.0 11.6 9.7 7.7 10.6 5.5 5.2 12.8 18.3 9.0 13.1 5.7 5.4 5.1 9.1 9.8 14.7 7.2 9.8 5.3 8.4 11.0 21.1 10.5 8.8 17.1 13.4 12.0 9.4 5.5 10.8 10.1 30.5 5.5 16.4 12.5 12.6 13.5 9.3 9.8 8.5 12.3 10.2 11.9 9.0 17.3 16.3 13.0 16.0 16.9 14.7 14.4 7.0 9.1 17.6 12.6 15.5 13.4 18.4 17.2 9.1 20.2 19.8 8.0 14.4 9.5 8.7 13.5 42.4 16.1 14.9 12.1 13.8 19.6 16.4 17.0 14.6 21.2 15.7 15.0 8.4 18.2 14.5 11.9 36.1 8.7 19.0 14.1 18.5 14.4 19.1 9.0 10.6 20.5 12.2 14.3 18.7 13.5 18.3 20.8 15.5 7.8 5.7 9.9 19.6 23.5 25.9 15.0 18.2 16.3 8.7 1.6 1.7 1.0 1.5 2.2 1.3 1.4 1.2 1.6 1.4 1.2 1.3 2.3 1.9 1.5 1.2 1.7 0.7 5.4 6.0 8.3 6.7 5.5 5.2 5.7 5.4 5.1 5.3 5.5 5.5 8.5 16.9 28.9 15.1 44.1 26.3 18.0 8.7 10.0 31.9 12.2 14.3 9.7 21.6 21.5 14.6 11.0 29.2 11.2 19.9 27.3 1.9 11.0 35.3 23.4 14.9 16.1 12.6 20.0 68.1 9.4 9.6 14.8 32.6 17.4 3.8 11.1 19.6 34.2 16.6 11.8 71.6 14.7 8.2 24.0 13.3 42.4 15.5 22.3 10.6 43.1 23.4 11.0 23.7 55.3 82.8 14.2 10.1 9.4 18.7 16.1 26.2 15.5 25.8 24.7 13.1 14.8 14.3 88.8 47.4 21.8 27.1 20.5 16.6 11.6 13.7 15.5 FAM81B FLJ25333 ENSG00000153347 "Family with sequence similarity 81 member B" Q96LP2 5 95391366-95450454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 48.7;testis: 84.1" "Group enriched" "Detected in some" 5 "Early spermatids: 854.5;Late spermatids: 1757.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 61 "basophil: 6.7" "Lineage enriched" "Detected in single" 61 "granulocytes: 6.7" "Cell line enriched" "Detected in single" 5 "CAPAN-2: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA072554 Approved NA NA "HPA072554: AB_2686533" "unprognostic (2.22e-3)" "unprognostic (8.86e-3)" "unprognostic (2.61e-3)" "unprognostic (1.37e-2)" "unprognostic (2.62e-1)" "unprognostic (2.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.83e-2)" "unprognostic (2.89e-2)" "unprognostic (5.70e-2)" "unprognostic (5.86e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" 0.0 0.1 2.6 0.0 1.1 0.6 0.3 2.0 1.2 1.1 13.5 0.0 0.0 0.9 3.8 0.0 48.7 0.2 5.4 0.7 5.2 0.9 0.0 4.4 0.0 3.9 3.3 0.2 0.1 0.4 2.5 3.8 0.0 3.2 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 4.3 0.0 0.2 84.1 1.7 0.1 1.6 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 1.1 2.0 1.2 0.7 5.2 3.9 3.3 0.2 3.2 4.3 1.7 4.8 0.0 9.6 1.8 0.0 0.0 0.4 0.0 9.5 0.0 0.0 1.0 0.6 6.1 0.0 23.9 5.5 0.0 0.1 0.1 0.0 0.0 0.5 854.5 158.5 0.8 0.5 1.8 0.0 0.9 0.7 0.1 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 12.2 0.0 0.0 1757.9 8.4 3.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.7 0.0 3.0 0.0 0.6 0.0 0.3 227.1 0.0 6.6 0.5 2.4 18.0 6.4 0.0 0.0 0.0 0.3 0.2 0.0 0.2 INO80C "C18orf37, FLJ38183, hIes6, IES6" ENSG00000153391 "INO80 complex subunit C" Q6PI98 18 35452230-35497979 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 184.7;Pancreatic endocrine cells: 165.1;Spermatocytes: 209.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049060 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA049060: AB_2680617" "unprognostic (3.40e-1)" "prognostic favorable (3.58e-4)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.62e-5)" "unprognostic (5.56e-2)" "unprognostic (9.68e-2)" "unprognostic (1.72e-3)" "unprognostic (2.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.08e-3)" "unprognostic (2.61e-1)" "unprognostic (6.94e-3)" "unprognostic (1.18e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-2)" "unprognostic (5.14e-3)" "unprognostic (5.38e-2)" 16.3 17.5 23.4 14.6 24.6 46.6 16.1 25.1 24.0 14.9 29.6 21.3 18.6 12.1 13.7 46.1 13.8 13.1 25.8 23.3 28.5 22.0 19.3 17.6 26.4 22.7 22.9 23.1 9.9 13.4 8.0 29.4 20.9 23.4 14.0 22.0 33.9 20.8 9.3 42.8 40.8 18.8 11.1 20.5 31.4 30.7 93.1 28.7 22.1 15.3 30.9 29.5 21.6 21.0 24.1 46.5 30.1 27.1 14.9 9.5 23.6 29.7 17.5 13.2 27.3 36.5 37.5 38.7 77.4 36.6 11.9 41.6 31.3 52.4 112.7 24.8 22.9 28.3 97.8 36.0 40.7 21.0 57.4 60.1 10.7 31.9 70.7 37.9 33.7 80.0 32.3 30.4 27.8 44.7 49.3 36.4 48.5 34.6 32.2 18.0 28.5 19.2 26.5 58.4 58.9 37.3 25.8 27.9 31.6 23.4 41.8 31.5 46.1 51.5 30.9 13.5 24.0 32.3 24.1 28.4 137.8 25.2 52.7 19.2 21.3 14.8 35.6 12.3 20.6 12.2 24.9 17.0 16.3 22.2 17.8 17.2 14.2 23.0 12.4 18.3 33.5 21.7 11.8 23.4 24.6 25.1 24.0 23.3 28.5 22.7 22.9 23.1 23.4 20.5 28.7 24.1 40.2 6.4 10.1 5.9 19.5 24.0 22.1 72.3 18.8 4.4 16.3 15.2 17.8 18.6 31.6 12.9 4.2 59.8 14.0 81.4 31.3 43.9 184.7 16.7 6.6 30.5 15.0 29.0 15.6 40.0 105.1 14.1 41.8 14.4 20.3 9.0 22.1 16.6 52.2 5.0 11.3 20.4 36.7 17.9 15.0 49.6 6.2 16.4 23.2 6.5 14.1 22.8 14.4 9.0 10.9 165.1 76.0 7.2 26.4 20.7 48.8 80.9 31.5 14.1 0.0 18.5 15.6 209.0 40.3 35.3 39.9 73.2 16.4 11.9 35.9 34.7 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523962 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 57.8;lymphoid tissue: 38.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 324.0;Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 148.2" "Cancer enhanced" "Detected in all" "lung cancer: 79.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 89.1;EFO-21: 82.4;PC-3: 60.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavorable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favorable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavorable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 10.9 9.5 2.7 2.4 3.6 1.5 8.5 0.7 12.6 10.3 2.9 8.0 0.8 12.5 0.1 4.7 10.9 0.8 6.9 6.0 6.2 6.1 3.9 57.8 1.6 3.3 5.1 3.6 8.7 5.2 0.6 10.0 1.4 3.9 6.9 0.1 2.1 8.4 0.8 2.5 4.9 11.3 0.4 1.9 38.5 7.0 2.9 4.5 0.5 7.4 0.0 0.3 11.6 7.0 3.1 5.5 8.1 1.5 8.6 1.0 1.3 89.1 19.2 1.1 1.0 0.9 3.1 2.6 17.7 82.4 0.5 3.8 15.7 1.7 0.5 0.5 41.5 36.1 4.4 12.7 5.8 1.7 4.7 11.8 1.5 0.4 1.0 0.2 1.3 1.1 6.2 9.8 3.5 0.0 11.8 17.3 7.3 31.2 0.5 60.7 32.2 1.5 13.7 3.6 7.5 11.5 11.1 16.5 14.8 5.1 0.9 6.9 7.4 9.8 1.6 19.0 6.1 7.3 10.9 11.0 4.4 3.7 7.7 5.5 0.0 0.2 0.2 1.1 0.5 1.1 0.2 0.2 0.5 0.1 0.1 0.0 0.3 0.8 0.5 0.4 0.0 0.2 0.2 2.7 3.6 0.7 12.6 6.0 6.2 3.3 5.1 3.6 3.9 1.9 4.5 3.1 12.6 86.6 324.0 18.9 41.9 6.2 2.5 5.3 6.8 65.8 8.9 6.3 4.0 5.7 14.4 14.7 146.0 9.0 97.4 6.7 0.0 22.4 1.7 4.8 13.7 13.5 14.9 3.6 13.9 13.6 81.9 13.1 7.1 5.2 8.2 44.7 16.4 5.2 27.0 23.5 16.7 9.6 2.0 29.2 20.5 2.8 10.8 42.6 7.2 22.5 15.7 30.3 96.8 14.1 1.7 20.3 0.3 15.4 39.9 6.2 2.0 4.6 5.7 148.2 0.0 6.3 11.5 3.4 12.2 1.5 4.0 31.7 30.7 22.5 5.3 1.7 PLEKHG4B KIAA1909 ENSG00000153404 "Pleckstrin homology and RhoGEF domain containing G4B" Q96PX9 5 92151-189972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 7.4" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 6.3;Club cells: 11.2;Collecting duct cells: 11.0;Glandular and luminal cells: 9.5;Respiratory ciliated cells: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.2;HAP1: 13.7;NTERA-2: 14.1;REH: 33.0;SCLC-21H: 14.0;SH-SY5Y: 12.6;SK-BR-3: 13.5;SuSa: 13.2;T-47d: 19.1" "Low region specificity" "Detected in all" "HPA036274, HPA058157" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036274: AB_10669668, HPA058157: AB_2683625" "unprognostic (3.60e-2)" "unprognostic (8.52e-2)" "unprognostic (5.44e-3)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.91e-1)" "unprognostic (3.59e-1)" "prognostic favorable (3.47e-4)" "unprognostic (5.96e-2)" "unprognostic (7.08e-2)" "unprognostic (2.56e-2)" "unprognostic (1.58e-1)" "unprognostic (9.98e-7)" "unprognostic (1.43e-2)" "unprognostic (7.00e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-3)" 0.0 0.1 2.5 0.1 1.1 0.6 1.5 0.7 0.7 0.8 7.4 0.4 0.2 0.8 0.1 0.3 1.1 0.0 0.0 1.0 1.0 0.5 0.0 0.6 0.2 0.9 1.5 0.4 1.0 0.4 0.1 3.6 1.4 0.6 1.8 0.0 0.2 2.6 0.3 0.1 0.4 0.1 0.2 1.3 0.1 1.0 3.0 2.7 1.0 3.1 0.0 0.1 0.1 0.4 1.7 0.0 1.4 10.1 15.2 0.0 0.0 0.2 1.1 0.3 1.0 2.2 1.8 0.2 0.2 3.3 1.4 0.9 0.6 13.7 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 4.1 0.0 0.0 0.1 0.4 0.2 0.0 14.1 0.0 0.2 33.0 7.1 8.6 1.2 0.0 14.0 12.6 7.9 13.5 0.0 13.2 19.1 0.0 0.1 0.4 3.7 0.0 0.3 0.2 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.5 1.1 0.7 0.7 1.0 1.0 0.9 1.5 0.4 0.6 1.3 2.7 1.7 0.1 0.0 3.4 0.3 0.0 0.4 3.8 0.1 0.0 0.4 6.1 6.3 1.6 0.0 11.2 11.0 0.0 4.6 2.8 0.0 0.0 0.4 0.3 4.8 3.7 0.7 0.0 0.0 1.0 0.2 3.7 1.0 0.0 9.5 1.3 4.4 0.0 0.0 0.7 0.0 0.6 0.2 0.0 0.0 0.8 0.3 0.3 0.4 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.1 14.0 0.2 0.0 0.1 0.9 2.4 5.9 0.0 0.3 1.8 0.3 0.4 0.0 1.0 NMRAL1 "FLJ25918, HSCARG, SDR48A1" ENSG00000153406 "NmrA like redox sensor 1" Q9HBL8 16 4461691-4495763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041353, HPA062287" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041353: AB_10796343, HPA062287: AB_2684738" "unprognostic (2.56e-1)" "prognostic favorable (3.33e-7)" "unprognostic (4.16e-1)" "unprognostic (4.04e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.20e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (2.86e-1)" "unprognostic (5.52e-2)" "unprognostic (8.48e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.79e-2)" "unprognostic (2.21e-1)" 20.1 39.9 42.3 8.9 43.8 13.5 25.7 42.7 49.8 25.4 38.3 23.5 16.2 24.2 24.9 27.6 24.0 16.3 22.7 42.4 41.6 36.4 57.8 20.0 18.2 44.0 42.5 41.4 30.6 44.4 16.3 27.5 14.0 44.1 37.0 11.6 5.1 33.0 19.5 5.2 33.3 23.8 13.7 42.0 26.4 41.7 11.6 42.4 18.8 27.6 4.3 15.0 22.4 24.2 45.1 36.7 47.6 10.3 28.5 26.1 23.7 34.9 26.5 12.0 32.9 25.3 44.3 69.2 0.8 46.2 41.8 9.9 35.3 26.3 43.7 15.7 28.5 10.5 31.1 38.0 24.5 50.5 36.5 22.2 32.4 54.4 41.5 16.7 28.6 39.8 116.3 32.7 0.9 19.2 116.0 81.7 39.2 31.4 55.8 39.7 73.7 0.7 42.4 42.1 21.2 12.9 26.6 50.4 78.1 27.4 6.5 66.5 39.4 17.9 17.5 0.8 14.9 0.3 0.9 0.6 57.1 8.9 35.6 31.5 13.1 59.3 6.1 61.1 35.9 45.6 38.9 42.6 57.2 53.9 35.0 43.2 44.3 32.5 27.9 26.6 52.7 42.3 53.7 42.3 43.8 42.7 49.8 42.4 41.6 44.0 42.5 41.4 44.1 42.0 42.4 45.1 16.2 25.6 26.0 11.1 19.3 27.3 38.1 48.8 43.3 11.7 48.7 46.4 22.6 40.0 38.7 42.3 0.0 105.8 30.6 29.1 52.8 34.6 12.5 24.9 21.8 19.0 20.4 20.8 9.1 49.8 102.5 23.8 46.4 34.4 20.8 41.3 26.4 78.7 67.1 5.0 11.1 38.2 30.5 29.5 18.7 35.7 29.2 23.1 35.6 8.4 30.9 45.5 54.6 7.5 19.0 37.4 36.5 30.5 27.8 29.0 46.3 114.5 35.7 10.0 26.3 10.6 24.0 5.4 37.3 29.6 30.5 64.2 32.9 37.9 38.5 32.8 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 110.3;Late spermatids: 129.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 8.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: AB_2685717" "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 24.1 28.6 16.9 11.2 14.2 26.4 24.8 16.8 39.8 29.3 2.8 36.8 14.3 38.9 2.7 33.0 32.2 6.3 36.0 18.6 7.7 39.1 71.1 30.1 8.7 13.5 9.9 13.3 29.4 30.4 5.1 25.2 10.7 12.3 40.0 2.4 4.8 23.9 9.6 51.5 31.4 25.7 6.9 7.1 29.6 35.2 29.4 11.9 5.6 35.7 8.7 4.4 33.8 27.8 19.0 13.5 38.2 8.9 14.2 6.0 7.6 39.4 19.7 8.2 7.6 11.0 18.6 15.5 19.8 21.6 6.3 5.7 36.5 5.7 20.4 2.1 42.4 57.4 18.7 42.8 29.6 12.1 11.8 30.8 10.8 14.9 11.6 5.7 8.7 8.3 15.0 28.7 20.4 3.0 66.0 19.5 63.6 33.3 12.0 33.4 27.9 11.1 65.6 6.7 19.0 25.7 23.7 23.5 35.9 33.1 5.1 23.2 18.9 24.4 15.2 17.2 61.5 13.0 38.8 34.2 22.9 6.2 15.8 8.1 0.9 1.6 8.7 1.6 2.5 1.0 1.3 1.3 1.7 1.9 1.2 1.3 1.4 2.7 1.1 3.3 1.2 1.7 1.3 16.9 14.2 16.8 39.8 18.6 7.7 13.5 9.9 13.3 12.3 7.1 11.9 19.0 12.0 9.6 8.2 3.3 14.3 110.3 55.8 32.7 29.6 9.7 23.7 20.6 4.2 15.7 17.9 18.4 4.2 65.8 15.1 26.4 31.3 21.1 37.6 29.1 16.2 16.8 84.6 26.1 6.2 23.6 60.1 16.2 43.3 28.7 10.8 13.6 16.1 32.4 23.6 10.1 6.1 34.4 28.5 14.7 25.9 129.1 16.1 14.5 21.4 1.9 19.4 13.0 23.7 3.5 8.1 22.4 19.0 19.9 22.2 37.6 24.4 57.0 7.3 11.5 46.0 15.2 25.1 18.6 14.6 20.2 102.9 107.8 15.9 14.0 22.0 33.1 C16orf89 MGC45438 ENSG00000153446 "Chromosome 16 open reading frame 89" Q6UX73 16 5044122-5066110 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 109.3;thyroid gland: 231.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Alveolar cells type 2: 268.1;Club cells: 70.4;Distal tubular cells: 113.5;Fibroblasts: 43.8" "Group enriched" "Detected in many" 14 "lung cancer: 64.7;thyroid cancer: 145.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;Hep G2: 2.5;HHSteC: 1.3;NTERA-2: 1.7;U-2197: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA013613, HPA016934" Enhanced "Secreted to blood" NA NA 1400000 "HPA013613: AB_1845584, HPA016934: AB_2732417" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (6.29e-2)" "unprognostic (3.79e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (1.01e-2)" "unprognostic (9.23e-2)" "unprognostic (2.65e-1)" "unprognostic (6.39e-2)" "unprognostic (3.25e-2)" "unprognostic (6.64e-3)" "unprognostic (3.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (8.48e-3)" 17.9 4.2 17.3 6.1 17.1 0.2 12.9 15.9 28.5 20.4 14.3 6.3 17.8 3.5 87.9 6.8 12.5 45.4 13.2 16.5 19.1 17.0 0.3 109.3 0.9 17.0 15.9 14.4 2.8 5.5 0.1 5.7 0.9 16.9 4.2 5.0 0.5 35.3 1.1 0.2 0.5 7.9 4.9 16.9 0.6 83.1 1.2 18.5 2.8 231.0 4.0 2.2 14.5 3.2 19.9 0.0 0.1 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.6 2.5 1.3 0.1 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.7 0.3 1.7 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.5 0.3 0.1 0.0 0.0 0.2 0.1 2.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.0 17.3 17.1 15.9 28.5 16.5 19.1 17.0 15.9 14.4 16.9 16.9 18.5 19.9 0.9 44.8 268.1 23.2 0.0 0.4 1.8 0.3 0.6 0.5 23.6 18.0 2.8 0.0 70.4 0.0 0.0 0.1 0.1 0.1 113.5 0.0 1.7 3.7 0.4 1.3 0.0 0.0 0.9 7.8 0.1 43.8 17.3 0.3 5.1 0.0 0.0 0.0 6.0 0.0 0.7 0.6 6.1 0.0 0.4 2.7 9.3 0.7 0.0 11.2 0.0 0.3 0.0 1.0 1.6 0.7 0.4 14.7 0.0 5.0 0.0 1.5 16.9 0.2 0.0 1.9 1.9 0.8 0.1 0.6 0.3 0.3 0.6 0.0 0.7 5.0 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93188463 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 113.5;Hofbauer cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 16.0 23.1 8.2 6.4 8.7 2.7 17.0 8.8 10.1 14.7 8.9 21.7 10.4 14.3 16.7 13.2 14.9 6.8 22.5 8.5 8.7 29.3 17.3 17.2 8.0 8.6 8.6 8.5 14.3 21.4 10.4 20.0 6.9 8.7 25.9 12.6 20.9 19.8 9.3 30.9 13.6 18.3 6.8 8.5 16.1 22.0 8.5 9.0 8.7 17.8 12.5 7.0 17.3 12.9 9.9 11.0 12.1 15.3 16.1 17.2 7.3 9.4 7.9 8.2 12.7 16.2 7.8 11.1 12.1 12.9 7.9 15.9 15.9 17.8 12.6 17.7 9.3 13.4 10.9 8.8 18.3 15.2 16.0 14.7 9.3 14.6 10.0 16.2 6.8 12.2 13.5 9.3 12.0 11.6 52.5 10.2 12.8 8.3 28.0 11.6 4.7 16.0 11.3 16.6 23.6 12.9 13.4 11.7 6.0 36.9 12.4 17.7 11.4 5.0 6.1 10.8 14.6 9.4 9.3 16.0 11.8 11.4 6.1 9.1 6.8 9.7 13.6 3.9 9.4 2.9 4.7 4.6 4.4 8.0 5.5 5.2 5.9 10.5 5.3 13.0 7.3 4.1 4.2 8.2 8.7 8.8 10.1 8.5 8.7 8.6 8.6 8.5 8.7 8.5 9.0 9.9 13.4 3.2 14.4 5.2 22.4 23.2 37.9 33.6 13.1 14.8 41.1 39.1 22.5 32.9 22.0 31.3 27.1 36.6 16.5 44.8 113.5 30.3 1.8 33.1 16.3 11.9 15.0 11.3 5.9 26.6 21.1 16.6 20.9 35.7 17.2 15.2 8.9 19.2 110.1 13.5 7.8 36.1 26.4 28.4 20.0 2.3 11.8 39.6 32.0 2.8 16.2 34.8 12.3 5.0 13.8 17.7 23.8 10.9 13.1 43.3 31.7 69.6 17.2 30.6 39.5 13.9 23.2 4.5 17.8 18.1 31.1 27.4 16.1 17.6 30.9 36.4 ING1 "p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a" ENSG00000153487 "Inhibitor of growth family member 1" Q9UK53 13 110712736-110723339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 212.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016136, CAB017773, HPA052591" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016136: AB_628077, CAB017773: , HPA052591: AB_2681876" "unprognostic (1.14e-2)" "unprognostic (3.25e-2)" "unprognostic (3.51e-2)" "prognostic favorable (5.81e-4)" "unprognostic (4.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.36e-1)" "unprognostic (1.87e-1)" "unprognostic (9.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-3)" "unprognostic (6.78e-2)" "unprognostic (2.40e-3)" 12.4 7.3 6.1 8.7 6.2 20.4 10.3 6.2 10.2 10.0 5.6 12.5 9.8 12.7 5.3 8.3 14.5 6.7 8.9 6.6 5.9 9.4 18.8 12.9 9.8 7.1 6.1 5.2 22.6 8.2 3.1 9.5 7.8 6.4 11.3 4.3 6.7 10.0 4.9 11.8 8.9 12.3 4.8 5.9 14.5 10.0 31.7 6.1 13.1 7.6 9.6 6.3 10.1 9.5 8.0 28.8 11.1 19.8 19.0 9.1 6.1 19.7 14.5 12.1 9.2 11.1 21.5 19.9 18.4 22.9 5.7 14.3 17.8 8.0 7.2 7.7 34.8 15.3 16.3 16.2 16.2 5.2 21.7 15.2 5.6 7.4 8.0 4.8 7.2 6.5 19.6 15.3 15.0 6.0 16.5 37.7 24.9 19.4 17.9 9.3 27.0 10.0 10.4 8.1 14.5 19.4 20.9 14.2 28.3 20.7 6.8 9.5 25.3 9.8 11.3 13.9 11.9 16.5 18.0 19.5 24.0 18.9 17.6 18.8 38.5 4.5 18.0 15.9 5.6 16.7 23.4 13.2 14.2 4.3 27.5 13.5 11.2 6.2 20.4 6.5 4.7 18.8 9.4 6.1 6.2 6.2 10.2 6.6 5.9 7.1 6.1 5.2 6.4 5.9 6.1 8.0 87.2 9.6 18.8 5.9 34.5 36.3 15.4 17.0 54.7 16.7 49.8 88.9 27.0 12.8 11.1 7.3 14.6 14.3 32.0 31.5 7.9 11.7 212.5 51.6 58.5 28.6 12.5 12.6 4.4 6.9 78.8 36.1 27.5 55.7 2.5 20.1 11.0 27.4 17.3 3.3 3.8 31.6 12.2 18.2 23.8 45.8 9.3 29.3 17.8 1.9 14.2 17.8 21.6 2.0 4.3 8.0 18.6 14.7 19.7 22.9 34.2 11.5 21.4 21.1 13.1 70.5 57.7 25.5 17.9 48.8 43.8 15.3 29.6 18.0 24.2 22.4 TEX29 "bA474D23.1, C13orf16, MGC35169" ENSG00000153495 "Testis expressed 29" Q8N6K0 13 111316184-111344249 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;testis: 52.2" "Group enriched" "Detected in some" 76 "Early spermatids: 712.6;Late spermatids: 248.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "U-698: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (2.93e-1)" "unprognostic (2.26e-2)" "unprognostic (8.62e-4)" "unprognostic (4.56e-1)" "unprognostic (7.26e-2)" "unprognostic (4.93e-1)" "unprognostic (2.08e-2)" "unprognostic (8.51e-2)" "unprognostic (5.45e-2)" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (7.86e-2)" "unprognostic (1.13e-9)" "unprognostic (3.41e-1)" "unprognostic (1.51e-1)" "unprognostic (5.07e-2)" "unprognostic (4.21e-2)" 0.5 0.3 10.2 0.0 10.2 0.0 0.5 10.4 14.4 0.7 9.5 0.5 0.0 0.4 0.4 0.4 0.5 0.3 0.4 10.3 9.8 0.8 0.9 0.5 0.2 9.6 9.6 10.0 0.4 0.6 0.0 1.5 0.1 10.4 0.9 0.1 0.1 0.3 0.1 0.6 0.3 0.6 0.0 9.6 0.7 0.4 52.2 9.6 0.1 0.5 0.0 0.0 0.5 0.4 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 20.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 10.2 10.4 14.4 10.3 9.8 9.6 9.6 10.0 10.4 9.6 9.6 10.6 1.5 0.0 0.0 1.3 0.4 0.3 0.3 0.2 0.0 0.2 0.5 0.5 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 712.6 0.1 0.2 0.4 0.0 0.0 6.3 0.7 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 1.6 0.2 2.0 0.0 0.0 248.1 4.7 0.7 0.0 1.0 0.1 0.2 1.0 0.0 1.3 1.3 1.2 4.1 0.0 0.6 0.1 0.2 0.1 0.1 0.0 0.9 1.5 2.8 3.3 0.0 0.4 0.5 0.3 0.1 0.2 0.5 SPACA7 C13orf28 ENSG00000153498 "Sperm acrosome associated 7" Q96KW9 13 112376355-112434689 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 84.7" "Group enriched" "Detected in some" 22 "Early spermatids: 1259.3;Late spermatids: 829.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA048349 Enhanced "Secreted in male reproductive system" NA NA "HPA048349: AB_2732548" "unprognostic (3.97e-2)" 0.0 0.1 0.2 0.1 0.5 0.6 0.0 0.8 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.3 0.0 0.2 0.0 0.2 0.3 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 84.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.7 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.8 0.6 0.3 0.3 0.3 0.2 0.4 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1259.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 829.7 6.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADPRHL1 ARH2 ENSG00000153531 "ADP-ribosylhydrolase like 1" Q8NDY3 13 113399610-113453524 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 36 "heart muscle: 388.4;skeletal muscle: 335.8;tongue: 245.2" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 148.6;Skeletal myocytes: 53.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.8;T-47d: 37.7" "Region enhanced" "Detected in single" "cerebellum: 2.3" "HPA066478, HPA072123" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA066478: AB_2685673, HPA072123: " "unprognostic (3.03e-1)" "unprognostic (1.38e-2)" "unprognostic (2.31e-1)" "unprognostic (8.88e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.35e-1)" "unprognostic (2.56e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-2)" "unprognostic (1.53e-2)" "unprognostic (4.99e-3)" "unprognostic (1.02e-1)" 3.1 3.9 3.3 0.8 3.6 0.5 3.6 2.5 6.6 1.8 5.2 3.1 4.3 1.7 1.0 8.0 8.3 3.3 388.4 3.9 3.2 1.3 2.2 1.3 0.8 4.0 3.1 3.7 2.1 6.8 0.7 4.2 1.9 5.1 4.4 2.5 1.1 8.8 0.8 335.8 4.2 4.1 0.9 2.4 1.4 6.4 2.8 4.5 1.6 1.2 245.2 0.4 1.7 1.5 5.2 5.9 13.9 1.4 4.3 4.3 6.9 3.8 2.3 1.0 0.7 0.5 3.9 14.3 2.1 8.1 2.5 4.0 3.2 5.4 0.3 0.6 2.1 2.3 6.1 3.3 1.1 1.4 0.4 2.5 2.4 3.3 4.5 0.6 0.6 0.1 5.1 1.8 0.6 5.7 12.9 1.0 3.6 3.1 15.3 7.3 9.4 3.6 5.5 1.5 0.6 20.8 4.8 1.5 6.8 1.8 1.6 37.7 0.8 0.5 0.2 2.6 6.3 0.8 2.1 1.8 6.9 4.1 1.1 3.0 0.1 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.5 0.6 0.1 0.3 0.3 0.3 0.2 0.3 0.1 0.3 0.2 3.3 3.6 2.5 6.6 3.9 3.2 4.0 3.1 3.7 5.1 2.4 4.5 5.2 1.3 0.0 4.6 4.9 0.5 1.3 2.3 1.0 2.8 1.6 5.5 5.2 148.6 0.0 3.0 0.0 0.0 3.6 0.4 3.2 0.0 3.6 1.4 16.6 8.1 2.8 4.2 0.0 5.4 3.2 2.5 6.8 2.6 12.4 0.0 0.6 1.1 1.0 0.6 1.7 4.0 4.8 0.0 0.6 0.3 3.8 0.0 1.3 1.8 1.0 0.1 2.6 0.0 1.5 2.3 1.2 7.4 1.5 0.1 2.0 7.8 0.5 5.9 1.7 0.0 53.7 2.8 1.8 2.7 2.0 2.6 2.5 0.8 4.2 3.2 3.2 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391698-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 102.3;Ductal cells: 105.6;Hofbauer cells: 120.3;Kupffer cells: 110.7;Langerhans cells: 102.8;monocytes: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 135.4;hTERT-RPE1: 135.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077409: AB_2686838" "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 19.9 10.5 7.6 20.9 7.8 44.0 32.9 8.6 13.0 15.3 9.5 8.5 5.4 11.2 11.0 4.0 39.0 16.2 9.5 7.5 9.0 22.1 10.2 33.3 32.5 9.0 8.0 7.0 5.5 20.1 4.1 3.8 19.3 9.1 12.2 9.3 0.6 13.2 20.1 4.0 10.1 18.4 10.6 8.9 49.7 13.5 8.6 9.0 46.5 20.6 3.1 31.7 24.3 7.3 10.2 0.4 15.8 32.8 40.2 29.8 29.0 93.4 15.5 18.0 26.5 24.3 18.0 135.4 0.1 46.7 18.1 33.0 17.4 40.6 69.1 23.2 0.0 32.8 18.5 0.1 40.6 120.8 4.7 29.0 31.0 9.0 27.2 42.6 135.1 60.0 0.2 15.8 40.9 19.6 0.4 0.2 42.9 39.7 7.0 71.7 90.5 12.3 85.0 37.7 30.9 1.6 33.9 2.0 2.6 80.8 13.9 21.3 48.7 36.2 25.3 25.5 27.9 54.4 11.6 4.6 0.2 9.3 57.9 54.2 32.4 198.7 110.8 21.3 196.8 12.7 44.2 72.1 44.2 106.8 34.7 76.5 54.1 77.3 21.6 173.6 45.0 164.1 112.6 7.6 7.8 8.6 13.0 7.5 9.0 9.0 8.0 7.0 9.1 8.9 9.0 10.2 10.3 25.6 16.7 1.0 65.5 9.8 20.2 102.3 1.8 0.5 63.4 86.0 2.1 28.6 51.9 18.4 0.0 22.2 25.0 2.0 0.0 105.6 0.2 17.4 12.8 24.2 17.3 11.6 0.5 15.5 10.0 15.2 26.0 33.1 29.8 29.0 20.7 1.3 120.3 1.7 1.4 4.4 40.7 110.7 102.8 1.2 1.5 77.2 24.9 20.6 108.1 1.4 12.3 1.0 0.3 91.8 8.1 1.2 62.9 42.0 1.2 27.5 23.3 0.2 6.6 1.2 13.5 1.2 10.4 0.9 5.5 6.8 57.4 6.1 2.8 16.3 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 48.8;Excitatory neurons: 125.0;Inhibitory neurons: 92.8;Late spermatids: 50.7;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 49.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 5.7;LHCN-M2: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003240, HPA061783" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003240: , HPA061783: AB_2684605" "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favorable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 0.8 1.3 3.4 0.4 4.0 0.3 1.0 2.4 3.9 1.0 3.7 0.9 0.8 1.0 2.2 0.5 1.6 0.6 0.8 3.4 3.8 1.4 0.2 1.2 0.3 3.0 2.5 3.9 1.4 1.1 2.8 2.7 1.5 3.5 1.0 0.2 4.2 0.8 1.6 0.2 0.6 0.5 0.8 1.7 0.5 0.8 1.1 3.2 0.2 2.3 0.0 0.2 0.8 0.9 4.4 2.7 0.7 1.0 1.0 1.5 2.4 0.4 2.0 1.6 1.8 2.6 0.5 3.1 0.1 0.6 1.3 0.8 0.5 0.9 2.1 1.2 0.2 1.1 0.4 2.3 0.5 1.8 0.2 0.4 0.9 1.6 1.1 0.8 5.7 3.3 1.9 0.5 0.2 6.2 0.2 0.5 0.3 0.7 0.3 0.6 0.1 0.6 0.1 4.6 0.7 1.1 1.1 0.9 0.5 0.8 1.7 1.3 0.7 2.5 0.8 0.7 0.6 1.1 0.2 0.1 0.1 0.8 0.2 0.6 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 3.4 4.0 2.4 3.9 3.4 3.8 3.0 2.5 3.9 3.5 1.7 3.2 4.4 2.7 3.2 7.3 22.2 1.0 1.1 7.6 5.6 1.8 15.3 3.0 3.7 2.4 2.8 4.8 5.5 25.0 0.5 0.4 0.1 3.9 3.9 48.8 18.8 3.6 3.8 0.0 0.0 125.0 0.4 1.5 5.0 5.6 6.2 0.0 6.2 2.2 0.1 0.5 18.5 92.8 0.3 8.2 0.8 2.4 50.7 1.5 0.5 1.8 22.5 0.1 6.6 0.0 55.8 49.6 4.2 0.1 4.1 0.3 4.2 0.2 3.2 16.5 17.7 6.6 3.6 3.9 21.3 8.6 0.7 1.1 0.7 1.5 3.5 0.1 3.8 UBP1 LBP-1a ENSG00000153560 "Upstream binding protein 1" Q9NZI7 3 33388336-33441371 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003967 Supported Nucleoplasm NA NA Nucleoplasm "HPA003967: AB_10601829" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.81e-4)" "unprognostic (4.64e-2)" "unprognostic (9.35e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (9.45e-4)" "unprognostic (6.67e-3)" "unprognostic (3.92e-2)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (1.88e-2)" 23.1 21.6 19.3 31.5 22.8 24.7 24.7 26.5 22.6 24.2 17.6 32.9 30.0 28.9 27.0 29.9 23.4 24.6 31.5 22.0 21.2 21.6 32.7 30.8 44.5 17.2 19.3 21.3 29.5 31.3 24.8 23.1 22.4 18.9 25.9 34.9 28.8 23.7 39.8 23.2 26.7 28.9 37.4 17.8 32.9 27.2 17.0 20.7 44.0 26.7 27.9 44.1 35.9 23.2 20.1 48.9 58.6 44.3 74.0 66.1 48.0 21.6 57.7 64.0 67.8 68.4 57.1 42.5 91.2 33.1 85.2 48.6 33.1 133.3 67.6 82.9 50.2 40.7 97.9 57.0 68.7 46.2 71.8 40.5 40.0 54.4 65.7 66.3 55.5 82.5 49.6 90.7 49.0 66.1 46.5 57.5 42.5 105.4 38.6 59.7 59.8 32.4 84.7 47.9 72.8 30.5 36.3 45.9 78.8 50.3 58.5 59.6 86.2 68.8 59.4 45.7 67.8 81.1 38.8 74.9 92.4 51.4 82.7 45.0 3.5 1.6 1.7 2.1 1.7 2.0 1.1 2.1 2.1 2.5 0.8 2.4 2.0 0.4 2.2 2.4 2.0 1.4 1.6 19.3 22.8 26.5 22.6 22.0 21.2 17.2 19.3 21.3 18.9 17.8 20.7 20.1 18.0 6.4 20.9 29.7 15.4 25.5 9.7 13.6 19.9 24.6 35.3 17.8 29.3 18.6 10.0 11.0 14.6 7.9 22.2 30.0 3.9 11.8 1.6 12.8 23.5 23.5 12.1 21.7 58.3 14.5 9.4 15.8 17.9 18.4 2.5 27.2 21.4 41.6 14.8 23.5 50.9 27.8 10.2 27.3 27.6 3.5 9.9 25.5 26.6 29.0 27.3 7.7 20.6 34.2 35.5 14.3 17.1 17.7 15.7 17.1 17.3 10.9 8.1 17.8 13.1 15.6 19.7 14.3 13.8 26.8 31.1 5.5 20.5 24.9 28.4 13.2 RMND5A "FLJ13910, GID2, GID2A, p44CTLH, RMD5" ENSG00000153561 "Required for meiotic nuclear division 5 homolog A" Q9H871 2 86720291-86778041 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046795, HPA060843" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA046795: AB_10963573, HPA060843: AB_2684378" "unprognostic (4.54e-2)" "unprognostic (9.23e-2)" "unprognostic (3.45e-2)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.32e-2)" "unprognostic (4.40e-2)" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (1.49e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-2)" "unprognostic (8.34e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.56e-1)" 18.0 11.3 21.3 9.4 25.8 31.4 16.3 56.7 24.7 10.7 20.0 19.9 16.5 13.1 13.4 31.5 13.0 6.9 38.6 23.2 19.6 18.4 43.2 10.6 11.7 20.1 22.8 19.7 11.1 11.7 21.0 7.9 11.7 28.4 12.5 21.4 19.1 11.5 11.2 64.2 22.5 15.7 13.8 22.0 14.4 12.3 7.9 20.6 31.7 13.1 37.3 14.1 10.1 17.2 30.3 19.4 10.2 17.6 10.5 22.9 10.1 36.3 7.5 6.1 9.7 11.0 37.6 20.3 66.7 22.4 6.9 11.3 22.6 45.1 15.8 15.0 19.4 34.4 58.7 21.8 34.2 23.1 43.2 18.6 15.4 30.5 10.2 35.2 11.0 17.0 48.7 37.7 37.3 7.9 12.6 40.1 36.9 29.8 23.1 13.0 47.3 54.2 42.3 20.1 22.8 32.6 25.1 16.9 33.5 27.9 24.8 16.8 36.8 16.3 6.7 12.9 12.2 11.7 16.7 18.8 45.0 5.6 51.3 7.8 37.5 11.9 8.1 8.1 10.1 9.7 4.7 6.2 9.1 9.4 6.4 8.4 11.6 27.5 8.8 12.5 7.4 4.7 8.6 21.3 25.8 56.7 24.7 23.2 19.6 20.1 22.8 19.7 28.4 22.0 20.6 30.3 32.8 12.8 15.9 15.3 27.0 41.9 23.4 10.4 46.7 26.3 25.5 15.6 93.2 24.3 10.5 11.0 6.2 21.0 36.2 73.3 23.5 13.1 13.7 33.8 28.7 26.0 39.5 105.2 27.3 14.1 18.6 20.1 24.5 35.3 8.2 16.3 25.0 76.7 15.1 23.5 27.2 57.4 14.2 34.4 42.7 5.6 19.3 26.3 32.0 14.0 23.7 15.3 30.9 10.6 42.3 21.9 30.9 17.3 30.1 34.8 38.1 34.4 26.6 16.3 6.6 22.7 20.1 17.9 27.8 50.0 54.8 24.6 31.4 24.6 28.7 34.0 CD8A CD8 ENSG00000153563 "CD8a molecule" P01732 2 86784610-86808396 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 372.4" "Group enriched" "Detected in many" 4 "dendritic cells: 111.7;T-cells: 242.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8" "Lineage enriched" "Detected in many" 19 "T-cells: 523.0" "Cell line enhanced" "Detected in some" "JURKAT: 4.0;MOLT-4: 15.2;RPMI-8226: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000012, HPA037756, CAB075722" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 490000 "Plasma membrane" "CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648" "unprognostic (1.29e-3)" "prognostic favorable (4.54e-4)" "unprognostic (9.26e-3)" "prognostic favorable (6.15e-6)" "unprognostic (7.28e-2)" "unprognostic (2.79e-3)" "unprognostic (1.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-2)" "unprognostic (1.56e-2)" 3.6 4.7 2.2 21.4 3.0 22.7 4.7 2.1 3.0 3.8 1.8 4.9 11.9 3.0 3.6 4.4 4.0 9.9 2.3 2.2 2.5 1.8 7.5 10.6 45.4 2.9 2.8 2.3 2.6 2.6 1.2 1.6 0.6 2.8 3.4 6.0 0.2 8.4 2.0 0.8 1.3 20.8 2.4 2.3 118.2 16.5 1.0 2.7 372.4 4.5 0.4 21.6 9.2 4.0 3.8 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.6 15.2 0.9 0.5 0.1 0.2 0.1 0.7 3.3 0.0 0.3 0.7 1.9 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 1.4 0.8 0.3 30.0 0.3 234.4 0.6 2.3 523.0 0.4 0.6 2.2 476.8 4.3 27.9 0.9 1.2 0.8 152.4 2.2 3.0 2.1 3.0 2.2 2.5 2.9 2.8 2.3 2.8 2.3 2.7 3.8 2.2 0.0 4.6 0.0 5.7 2.0 0.2 0.0 0.0 0.3 1.5 1.5 3.4 1.5 0.6 0.0 0.0 0.0 111.7 0.2 0.0 0.2 0.3 0.5 0.3 1.3 0.0 7.8 4.2 0.0 0.0 2.6 8.2 0.4 2.5 0.0 6.4 2.3 0.1 0.0 3.1 0.3 0.0 1.9 11.5 0.2 0.0 6.6 0.0 1.0 5.9 0.1 38.1 0.0 0.2 0.0 0.0 0.0 30.8 0.2 0.0 0.4 1.5 0.4 0.0 1.1 1.4 0.4 0.4 1.1 1.8 0.1 242.4 0.0 0.6 0.1 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691673-88750929 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.4" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA 2500000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: AB_2683563" "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 17.2 11.1 7.8 19.8 7.9 90.4 16.1 8.7 8.9 13.5 8.6 23.0 22.3 13.3 9.6 24.3 14.7 11.8 13.1 7.7 8.4 8.9 7.9 12.3 28.3 8.0 8.1 7.8 13.9 18.0 7.4 8.2 34.1 8.1 9.0 23.3 4.1 16.0 8.2 30.2 11.8 19.0 12.6 8.3 19.4 19.0 9.7 8.3 40.8 9.8 17.2 32.7 16.7 12.6 8.2 29.7 17.0 33.7 26.9 23.4 23.9 73.8 16.1 15.1 26.1 17.8 61.1 38.2 150.1 34.3 18.7 35.8 17.7 42.4 13.5 40.9 71.9 55.3 60.2 11.0 60.7 23.7 111.5 42.4 22.1 11.2 23.3 35.9 13.0 37.4 78.7 65.7 25.3 24.8 46.5 123.4 97.2 30.7 97.6 27.7 63.5 40.1 36.8 21.7 47.1 24.0 27.4 19.4 24.8 39.3 18.3 13.5 45.3 21.4 15.5 40.7 51.2 46.7 19.7 17.2 149.3 15.9 99.4 22.5 10.6 16.0 36.4 16.9 16.7 21.4 31.4 23.5 25.1 22.7 23.5 33.4 27.8 3.9 21.9 21.9 10.9 22.0 20.6 7.8 7.9 8.7 8.9 7.7 8.4 8.0 8.1 7.8 8.1 8.3 8.3 8.2 38.9 12.8 13.2 4.6 43.2 37.3 21.3 31.2 21.6 8.7 22.2 18.2 13.7 14.3 22.7 20.2 2.1 234.3 37.1 20.6 9.8 21.7 8.1 28.0 23.3 35.0 19.2 167.9 13.3 34.2 98.9 23.5 31.1 43.2 21.6 30.7 24.3 7.1 43.8 13.5 15.7 26.9 26.4 23.1 33.9 4.0 19.9 23.7 40.9 11.2 32.4 5.2 60.8 13.6 13.3 22.8 28.1 18.8 35.8 41.7 20.6 18.7 10.1 4.8 19.7 19.8 18.0 28.4 33.4 37.6 40.9 225.6 38.8 37.8 58.5 43.7 GOLGA8F DKFZp434P162 ENSG00000153684 "Golgin A8 family member F" Q08AF8 15 28378621-28392018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 203 "testis: 20.3" "Cell type enhanced" "Detected in some" "Early spermatids: 1.7;Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 2.1" NA NA "unprognostic (4.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase receptor type D" P23468 9 8314246-10612723 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.2" "Group enriched" "Detected in many" 12 "Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 20000000 Vesicles Nucleoplasm "HPA054829: AB_2682618" "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 1.8 0.6 6.0 0.3 21.9 0.1 0.9 8.4 33.5 5.5 0.0 2.9 1.8 2.4 0.3 0.6 2.2 1.0 2.2 13.6 12.9 6.6 3.6 4.7 0.0 13.1 12.8 11.2 12.2 1.3 18.8 4.4 5.3 19.4 1.9 2.6 6.4 0.5 0.6 0.9 0.6 5.1 1.0 5.6 0.4 0.9 1.6 15.3 0.8 3.4 0.8 0.0 2.2 3.4 70.2 0.0 0.1 21.1 0.0 0.3 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 2.7 3.6 0.5 0.0 0.0 0.0 0.1 6.3 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.6 0.0 3.4 0.0 3.2 2.3 8.1 0.0 1.8 0.0 4.8 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 21.9 8.4 33.5 13.6 12.9 13.1 12.8 11.2 19.4 5.6 15.3 70.2 0.5 0.0 3.2 199.2 0.1 0.5 0.4 3.2 6.2 134.2 0.3 0.1 6.5 27.1 1.8 5.5 16.7 0.3 0.0 16.4 0.0 3.6 15.8 0.8 15.0 1.2 35.4 0.0 4579.7 0.0 0.3 15.5 0.5 1.0 0.0 9.2 1.4 13.5 1.3 5.0 1152.9 13.2 0.0 0.8 0.0 6.5 15.8 1.6 0.0 85.3 0.1 36.1 0.0 1170.2 3151.1 0.2 9.2 0.0 2.7 2.1 18.3 26.3 0.2 7.8 0.0 4.0 5.8 2.4 3.2 0.4 0.9 0.3 0.8 6.0 8.7 0.1 LURAP1L "bA3L8.2, C9orf150, FLJ38505, LRAP35b, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775020-12823060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 90.2;Paneth cells: 88.8;Prostatic glandular cells: 104.3;Urothelial cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 100.6;hTERT-HME1: 81.9;T-47d: 118.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 13.3 9.3 4.7 5.6 5.0 0.1 10.7 12.5 6.1 11.0 4.2 18.6 4.1 6.2 3.3 4.7 6.6 11.9 4.4 4.4 6.0 4.7 32.5 25.2 3.9 6.0 5.5 4.2 4.3 19.7 0.8 5.6 21.2 6.0 7.0 9.5 4.7 27.9 6.8 2.5 11.8 9.3 8.3 6.1 10.5 12.6 0.5 5.2 1.2 8.8 3.4 2.0 12.2 12.5 6.5 2.2 7.1 0.0 2.3 11.0 15.1 0.0 3.9 20.2 5.1 5.4 0.0 2.6 0.0 1.5 20.6 24.3 3.0 0.0 0.4 3.9 0.0 0.8 1.1 6.7 4.0 100.6 0.0 0.0 6.0 9.7 17.4 81.9 8.6 3.3 0.0 0.0 25.8 3.1 1.8 0.0 0.0 0.1 9.6 7.8 0.0 1.3 0.1 20.7 1.2 15.5 1.5 4.7 2.9 3.8 1.7 118.5 0.4 1.3 4.5 0.7 11.7 2.8 0.1 0.0 0.0 7.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 5.0 12.5 6.1 4.4 6.0 6.0 5.5 4.2 6.0 6.1 5.2 6.5 9.6 9.6 18.4 1.3 0.7 90.2 34.4 19.3 5.2 10.2 60.1 26.2 7.1 20.0 40.2 1.8 2.1 1.0 0.5 58.7 7.9 66.6 5.0 11.5 3.2 7.8 26.7 0.0 18.4 11.8 2.7 19.7 10.2 29.2 10.8 12.9 1.8 30.2 0.6 18.5 41.6 12.8 24.4 0.0 8.4 0.8 9.3 2.3 26.6 6.5 0.0 4.3 0.0 8.0 44.1 27.5 88.8 3.0 0.0 104.3 20.7 5.5 16.1 10.2 39.5 8.0 47.4 0.1 0.6 2.9 64.4 1.1 1.9 1.3 49.5 140.4 CNKSR3 "FLJ31349, MAGI1" ENSG00000153721 "CNKSR family member 3" Q6P9H4 6 154387515-154510685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 109.6;Glandular and luminal cells: 155.4;Oligodendrocytes: 142.3;Skeletal myocytes: 211.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 21.1" "CAB037133, HPA049651" Approved Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB037133: AB_477217, HPA049651: AB_2680841" "unprognostic (3.07e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-1)" "unprognostic (2.34e-1)" "unprognostic (5.62e-2)" "unprognostic (1.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.78e-2)" "unprognostic (1.98e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-3)" "unprognostic (4.90e-2)" "prognostic favorable (6.00e-4)" "unprognostic (4.23e-2)" "unprognostic (8.79e-2)" "unprognostic (1.57e-3)" "unprognostic (3.38e-1)" 3.6 1.2 6.2 1.9 7.1 0.9 3.3 3.9 4.8 4.0 12.0 5.6 5.8 7.7 1.9 13.4 4.2 4.9 6.4 2.7 3.8 7.7 9.8 3.7 1.4 6.5 8.2 1.3 6.2 19.0 0.7 2.3 5.7 6.3 3.3 3.5 2.6 5.8 4.8 1.1 3.9 6.5 6.7 5.4 4.5 4.0 4.5 12.1 2.1 2.1 1.5 2.5 4.4 5.4 12.8 0.4 4.9 3.3 6.8 5.8 4.1 0.4 6.0 3.5 10.2 8.3 21.1 0.5 0.1 6.4 6.6 3.4 2.1 9.5 0.7 5.3 0.0 6.3 15.4 1.0 12.1 2.5 0.0 2.7 6.1 3.2 3.9 4.1 1.6 3.2 1.3 2.2 0.1 2.8 1.2 0.1 0.2 2.3 4.1 6.2 4.6 5.9 8.0 11.7 3.1 2.0 12.6 2.8 1.5 1.3 1.4 0.0 1.3 3.7 0.9 3.0 7.7 4.0 0.1 0.0 0.2 0.2 0.3 4.4 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.2 0.0 0.0 6.2 7.1 3.9 4.8 2.7 3.8 6.5 8.2 1.3 6.3 5.4 12.1 12.8 24.7 12.8 38.4 9.4 0.9 26.5 15.4 7.8 12.5 2.0 11.0 8.3 33.8 30.0 20.2 25.8 0.0 9.2 0.4 31.0 9.8 20.3 42.5 109.6 14.7 66.8 43.2 15.6 23.8 12.3 1.1 12.9 9.2 155.4 5.7 10.8 61.8 65.9 1.7 0.0 1.5 18.4 10.2 7.1 22.5 23.6 5.9 3.5 32.0 24.4 0.8 22.8 0.0 54.8 142.3 7.3 18.5 10.5 0.5 18.7 43.6 31.8 11.7 2.5 0.0 211.8 8.0 1.2 6.3 29.4 23.9 21.5 2.6 14.8 14.1 10.0 GTF2E1 "FE, TFIIE-A" ENSG00000153767 "General transcription factor IIE subunit 1" P29083 3 120742637-120783069 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009884, HPA056359, HPA066881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (4.36e-3)" "unprognostic (2.62e-1)" "unprognostic (2.64e-2)" "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (9.34e-3)" "unprognostic (5.10e-2)" "unprognostic (8.29e-3)" "unprognostic (4.94e-1)" "unprognostic (3.19e-2)" "unprognostic (2.97e-1)" 5.2 7.8 4.8 6.7 5.4 4.4 5.2 5.1 5.5 5.0 7.9 5.1 4.7 4.6 4.5 4.3 4.3 3.7 5.1 4.8 5.3 4.3 5.0 5.0 9.1 5.5 5.3 4.7 5.8 4.5 4.6 3.0 6.6 5.4 4.6 5.9 5.6 4.3 5.6 7.1 3.5 4.2 5.8 5.1 7.8 4.8 10.0 5.2 8.4 5.5 9.4 9.1 5.6 4.2 5.9 13.7 18.7 23.0 14.1 16.9 7.8 20.0 9.0 8.2 13.8 14.7 22.5 9.6 22.3 15.3 6.8 10.7 16.1 21.4 11.8 19.2 15.6 5.0 28.7 12.8 19.0 13.1 26.1 16.8 10.4 12.6 10.3 14.5 9.4 21.4 18.9 20.4 11.3 14.8 15.6 21.6 13.2 22.0 13.1 17.2 17.7 27.0 16.6 13.8 8.6 4.9 15.1 13.5 11.6 12.6 20.6 14.7 19.8 18.9 12.9 14.0 4.1 10.2 9.9 11.8 31.5 13.5 26.0 12.5 18.0 7.2 11.6 6.6 11.2 8.3 9.3 8.1 9.5 8.7 7.3 8.6 8.4 5.0 10.8 10.5 4.1 10.2 7.6 4.8 5.4 5.1 5.5 4.8 5.3 5.5 5.3 4.7 5.4 5.1 5.2 5.9 4.1 3.2 4.4 3.3 6.8 1.9 3.0 4.1 3.4 5.3 4.6 1.8 4.9 8.6 6.3 7.3 0.0 9.0 4.7 3.8 5.9 5.1 7.7 8.1 6.0 5.4 1.2 5.5 3.8 4.4 8.4 3.8 3.1 6.1 12.7 9.1 7.5 5.3 9.2 16.8 4.0 3.2 6.1 8.3 2.2 2.9 2.1 7.0 3.6 8.4 12.5 5.5 14.4 4.5 7.2 4.9 2.5 4.9 5.3 3.3 3.4 5.9 5.1 4.4 0.0 3.5 3.9 14.3 22.8 2.8 2.6 8.8 5.7 9.7 3.9 3.1 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433503 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: AB_2680327" "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 41.5 51.5 61.4 24.2 62.3 35.3 45.7 64.6 75.9 67.3 61.8 45.6 30.7 59.2 62.8 41.6 56.1 30.0 36.1 61.2 63.2 65.1 43.4 37.6 27.3 62.6 62.5 59.8 83.9 41.6 31.0 57.5 63.6 63.1 40.3 40.6 50.0 39.8 38.5 36.0 40.2 36.7 51.4 60.9 30.4 35.0 60.0 62.9 57.6 45.4 35.2 36.1 45.1 51.1 66.2 65.0 47.6 158.9 59.2 141.2 156.3 47.2 63.2 74.1 83.0 119.1 82.5 86.6 61.3 91.1 79.3 92.7 71.5 123.3 101.9 164.9 26.4 58.6 63.0 46.6 177.2 97.3 69.2 51.6 98.4 85.5 100.2 121.4 144.6 91.5 114.0 91.3 28.3 93.9 149.0 102.2 152.6 77.1 110.0 24.8 182.7 64.3 108.5 93.1 35.5 94.5 79.4 105.7 22.3 92.5 136.4 91.8 121.6 53.8 59.2 63.1 63.2 40.8 54.4 89.2 228.6 59.3 89.9 53.3 61.3 45.5 60.8 31.2 47.8 44.5 33.6 42.7 34.7 48.8 35.4 38.7 36.5 38.1 28.5 46.2 48.7 68.5 25.8 61.4 62.3 64.6 75.9 61.2 63.2 62.6 62.5 59.8 63.1 60.9 62.9 66.2 87.4 38.5 57.5 37.5 45.5 57.9 116.3 135.9 47.3 87.2 89.5 103.4 34.7 91.5 111.2 115.8 116.7 119.0 50.5 493.3 197.6 79.1 133.7 197.7 118.5 97.6 82.2 78.9 49.5 94.9 114.0 82.9 61.2 121.3 28.5 194.5 62.8 153.9 77.1 62.2 50.5 219.2 59.0 53.1 44.5 69.7 125.2 51.1 33.8 45.9 64.8 60.8 84.5 49.8 75.6 92.4 745.2 112.5 42.3 116.9 612.2 637.6 205.3 112.5 98.6 55.3 88.2 311.2 178.0 49.5 65.6 154.9 51.6 103.5 120.0 130.4 TGIF2LX ENSG00000153779 "TGFB induced factor homeobox 2 like X-linked" Q8IUE1 X 89921908-89922883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "testis: 8.8" "Group enriched" "Detected in some" 13 "Early spermatids: 74.1;Late spermatids: 45.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 10.9;U-2 OS: 12.4;U-266/84: 21.4" HPA034543 Supported Approved Nucleoplasm No No Nucleoplasm "HPA034543: AB_10603037" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 12.4 0.3 0.0 1.1 21.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type palmitoyltransferase 7" Q9NXF8 16 84974175-85011535 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059054, HPA059642" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093" "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 31.1 28.3 18.0 25.0 17.9 64.8 27.0 20.1 19.7 38.6 25.3 41.7 27.4 37.1 12.9 27.9 28.0 31.5 28.8 17.9 20.1 31.0 30.2 37.5 26.7 19.3 19.7 17.2 27.9 27.1 35.8 19.8 33.7 19.5 33.1 32.7 10.4 24.3 20.2 57.1 32.0 33.7 30.3 18.1 35.6 45.1 14.2 21.5 16.3 25.7 58.9 23.7 37.7 33.4 18.9 63.8 55.0 28.5 34.5 123.1 92.3 38.9 57.4 110.8 88.4 43.7 58.3 72.4 29.1 32.7 93.5 29.0 65.6 37.1 76.1 110.9 16.4 29.7 21.0 22.0 66.5 51.5 40.0 21.2 76.7 85.4 72.5 41.5 56.0 46.1 26.7 68.9 9.7 56.8 75.8 27.0 38.1 44.3 53.2 39.5 33.6 26.2 15.7 86.4 82.5 24.2 29.8 74.3 40.9 36.1 43.0 77.6 24.0 67.9 53.1 39.9 49.8 34.3 33.5 51.0 65.5 50.1 29.1 43.0 7.5 9.7 8.3 2.1 8.2 2.6 1.4 2.0 1.7 6.3 2.2 1.5 2.2 6.4 1.4 7.2 4.3 0.5 3.6 18.0 17.9 20.1 19.7 17.9 20.1 19.3 19.7 17.2 19.5 18.1 21.5 18.9 13.3 32.1 25.2 12.1 10.8 13.3 21.5 25.4 17.1 9.2 16.2 13.2 22.5 12.8 17.9 16.5 6.2 18.5 15.7 37.7 1.9 14.1 9.7 15.5 20.1 12.2 12.6 11.6 16.4 15.6 24.9 23.0 28.5 29.1 3.8 14.3 15.0 11.6 28.1 15.2 16.2 29.4 14.2 46.8 26.7 10.9 17.4 36.2 16.0 19.7 42.9 5.9 21.6 13.6 14.7 30.0 33.9 21.1 15.2 26.2 22.1 9.5 32.6 6.7 13.1 13.7 14.9 8.3 13.0 20.1 12.8 16.1 13.4 6.8 34.7 35.3 CIBAR2 "FAM92B, FLJ44299" ENSG00000153789 "CBY1 interacting BAR domain containing 2" Q6ZTR7 16 85098358-85112472 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 86.3" "Cell type enriched" "Detected in single" 8 "Plasma cells: 2.4" "Group enriched" "Detected in some" 5 "endometrial cancer: 5.4;lung cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041022 Enhanced NA NA "HPA041022: AB_10795500" "unprognostic (1.77e-4)" "unprognostic (7.44e-3)" "unprognostic (1.61e-1)" "unprognostic (2.11e-3)" "unprognostic (5.09e-3)" "unprognostic (1.14e-3)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (9.81e-2)" "unprognostic (3.70e-1)" "unprognostic (3.84e-2)" "unprognostic (2.05e-1)" "unprognostic (5.10e-13)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" 0.1 1.3 7.9 1.3 1.9 0.4 0.3 2.2 1.2 1.9 9.3 0.7 1.3 1.4 0.2 0.1 86.3 0.2 0.0 1.4 4.7 0.2 0.0 10.3 0.6 6.9 7.7 0.2 0.1 0.1 0.0 16.3 0.0 5.2 0.1 0.4 0.4 0.5 0.1 0.0 0.4 0.7 0.0 6.9 2.6 0.4 0.4 3.4 0.2 0.0 0.0 1.9 1.2 0.0 2.7 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 7.9 1.9 2.2 1.2 1.4 4.7 6.9 7.7 0.2 5.2 6.9 3.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134692-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 66.2" "Group enriched" "Detected in many" 17 "Early spermatids: 423.9;Late spermatids: 881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 19.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 3.0 7.9 1.2 3.3 1.8 1.9 2.9 3.2 1.6 3.3 1.7 6.9 4.5 3.8 1.7 2.5 3.5 2.5 1.7 1.2 1.7 2.4 1.4 2.6 3.3 2.0 1.4 0.7 5.5 2.1 4.0 2.2 1.3 1.9 2.8 4.6 2.7 3.5 2.5 0.9 2.2 3.9 3.0 1.4 4.1 4.5 66.2 1.6 4.3 4.2 1.1 4.0 3.8 2.8 1.9 3.2 2.1 5.2 5.4 2.0 0.9 2.5 1.3 4.7 3.7 5.5 4.4 3.0 8.1 2.0 2.6 16.5 1.2 5.3 1.5 4.0 3.8 5.1 4.1 0.3 5.8 4.4 7.0 8.5 3.2 4.6 3.0 0.8 2.8 0.7 6.9 5.7 4.7 1.3 0.0 5.5 7.5 2.1 6.4 2.3 8.7 5.5 1.3 2.7 3.8 1.3 4.1 1.2 5.2 5.1 6.7 0.9 9.2 0.9 2.6 6.6 0.1 2.2 19.3 7.0 11.6 0.7 5.7 10.4 0.4 0.4 0.8 0.6 0.2 0.7 1.0 0.3 0.4 0.6 0.6 0.9 0.7 0.0 1.0 0.3 1.9 1.0 0.3 1.2 1.8 3.2 1.6 1.2 1.7 2.0 1.4 0.7 1.9 1.4 1.6 1.9 2.6 0.0 5.0 2.6 8.4 1.1 2.4 0.8 2.8 1.1 1.6 1.8 1.6 4.3 0.3 0.0 0.0 3.4 7.0 6.5 3.9 1.9 423.9 0.9 1.9 2.5 4.2 3.0 0.8 3.9 2.9 2.5 4.6 1.2 0.0 3.4 2.2 0.8 2.5 0.0 1.2 3.5 0.0 6.1 3.1 881.6 7.2 3.8 3.6 7.5 6.1 7.7 13.4 0.5 4.3 3.9 6.1 5.3 8.9 1.3 2.2 0.8 3.2 0.8 0.0 3.0 2.8 37.3 15.2 2.5 0.6 2.3 6.6 2.4 7.0 1.3 TMPRSS11D "ASP, HAT" ENSG00000153802 "Transmembrane serine protease 11D" O60235 4 67820876-67884002 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "cervix: 24.6;esophagus: 72.4;lymphoid tissue: 34.7;salivary gland: 21.2;vagina: 76.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 24.4;Club cells: 13.8;Inhibitory neurons: 3.9;Oligodendrocyte precursor cells: 5.0;Urothelial cells: 12.0" "Group enriched" "Detected in many" 5 "cervical cancer: 36.0;head and neck cancer: 30.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077704 Enhanced "Intracellular and membrane" NA NA "HPA077704: " "unprognostic (1.19e-1)" "unprognostic (6.83e-2)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (4.79e-1)" "unprognostic (4.38e-3)" "unprognostic (1.96e-1)" "unprognostic (6.91e-2)" "unprognostic (4.48e-2)" "unprognostic (2.19e-3)" 0.0 0.0 0.9 0.0 0.7 0.0 0.0 0.3 2.7 24.6 0.7 0.0 0.0 0.0 0.0 72.4 0.0 0.0 0.0 1.5 1.5 0.0 0.0 0.0 0.0 2.7 1.6 0.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 21.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 1.1 0.2 0.0 0.0 34.7 0.6 76.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.3 2.7 1.5 1.5 2.7 1.6 0.9 2.8 0.6 1.1 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 24.4 0.6 0.0 0.0 0.0 0.3 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 5.0 1.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 12.0 JAZF1 "DKFZp761K2222, TIP27, ZNF802" ENSG00000153814 "JAZF zinc finger 1" Q86VZ6 7 27830573-28180795 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Lipid metabolism, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 84.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 160.1;Excitatory neurons: 316.6;Inhibitory neurons: 306.3;Microglial cells: 168.6;Oligodendrocyte precursor cells: 241.3;Oligodendrocytes: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 25.6" "Group enriched" "Detected in all" 4 "dendritic cells: 13.7;granulocytes: 25.6" "Cell line enhanced" "Detected in many" "Karpas-707: 53.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019271, HPA066967" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB019271: , HPA066967: AB_2685758" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.18e-2)" "unprognostic (7.48e-2)" "unprognostic (9.08e-2)" "unprognostic (1.14e-1)" "unprognostic (2.74e-1)" "unprognostic (8.88e-2)" "unprognostic (2.50e-1)" "unprognostic (1.44e-1)" "unprognostic (8.27e-3)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.18e-3)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-2)" 14.5 84.6 10.4 11.0 14.0 24.6 11.8 13.1 15.8 62.9 13.4 24.5 3.4 42.1 21.5 10.2 16.6 12.5 22.6 13.7 13.6 5.2 15.9 10.2 14.7 8.9 9.7 12.0 14.1 6.6 6.3 13.5 16.3 10.0 29.8 8.3 7.9 4.7 35.5 6.9 6.9 8.4 38.9 9.8 14.7 8.3 19.0 15.4 11.6 15.1 6.9 16.0 19.3 27.6 14.4 1.4 0.8 4.8 1.0 35.6 42.9 0.0 11.1 28.6 18.4 22.8 0.1 7.6 33.7 22.6 23.5 12.5 0.7 6.3 8.5 15.0 5.1 10.2 12.2 7.7 0.0 24.2 4.8 3.1 19.4 10.2 13.8 8.9 14.1 11.8 2.2 0.3 53.2 10.3 1.4 1.3 17.5 10.0 0.2 7.7 3.6 2.2 10.1 6.7 0.3 3.0 4.7 9.2 0.3 12.0 14.0 3.5 6.1 11.7 29.0 11.0 8.0 12.9 9.2 2.9 12.5 9.2 12.5 16.2 25.6 3.9 6.9 4.8 3.3 1.3 2.8 1.3 3.2 3.7 3.7 0.5 3.0 1.5 4.1 3.5 13.7 3.2 3.1 10.4 14.0 13.1 15.8 13.7 13.6 8.9 9.7 12.0 10.0 9.8 15.4 14.4 10.2 3.2 7.0 57.8 33.4 14.7 3.0 3.8 3.4 6.7 3.5 4.8 25.3 10.0 3.0 1.8 6.2 0.5 37.9 1.3 7.9 14.8 122.1 28.3 160.1 14.5 5.4 115.6 316.6 2.3 1.4 24.6 9.2 18.6 24.1 12.6 3.6 5.5 9.4 16.8 306.3 0.6 2.0 25.7 45.6 89.8 55.0 28.0 23.2 168.6 35.5 4.4 40.2 241.3 262.5 5.3 0.4 34.6 8.7 2.7 0.0 2.4 12.7 4.7 13.1 9.9 15.3 8.7 16.5 3.4 11.2 1.4 25.3 1.6 0.3 1.5 CMIP ENSG00000153815 "C-Maf inducing protein" Q8IY22 16 81444808-81711762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.0;neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HMC-1: 180.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054424, HPA066710" Approved Supported Nucleoplasm,Cytosol NA NA 83000 "Nucleoplasm, Cytosol" "HPA054424: AB_2682484, HPA066710: AB_2685708" "unprognostic (6.84e-2)" "unprognostic (1.99e-1)" "unprognostic (2.89e-2)" "unprognostic (3.76e-1)" "unprognostic (3.02e-2)" "unprognostic (9.83e-3)" "unprognostic (2.28e-2)" "prognostic unfavorable (9.47e-7)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (3.10e-2)" "unprognostic (6.04e-2)" "unprognostic (4.12e-2)" "unprognostic (3.42e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.59e-1)" 27.3 22.4 38.9 32.4 46.3 26.4 23.4 11.6 48.3 31.0 6.6 26.7 40.8 19.0 6.2 36.1 23.2 25.8 11.7 44.2 41.8 20.8 13.6 26.5 22.4 29.7 28.5 45.4 22.9 19.5 7.9 56.0 28.6 33.5 17.9 23.4 10.9 20.3 15.2 4.8 34.4 50.3 22.7 17.0 22.7 33.6 17.4 42.8 20.3 15.7 5.3 18.3 31.5 33.0 33.6 40.9 133.5 25.9 13.3 13.4 10.7 52.7 28.9 19.5 17.9 7.9 45.5 81.5 18.2 24.2 24.1 23.9 40.6 16.9 96.2 17.0 11.6 12.3 87.4 24.4 80.0 13.3 27.2 180.8 10.5 39.9 33.1 42.5 27.1 50.0 31.7 77.6 15.3 11.1 40.9 47.7 33.8 20.6 39.5 28.1 84.9 8.5 17.8 22.6 39.7 135.0 27.1 67.4 24.7 8.6 25.9 19.1 35.7 34.6 28.5 30.6 27.7 26.8 19.2 15.9 78.0 33.6 31.5 11.7 3.0 0.7 1.0 0.4 0.5 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.2 2.4 0.2 0.1 0.2 0.1 0.4 38.9 46.3 11.6 48.3 44.2 41.8 29.7 28.5 45.4 33.5 17.0 42.8 33.6 81.5 12.8 16.6 59.4 31.7 107.3 66.6 43.8 48.9 15.6 21.5 21.1 7.8 47.1 27.7 14.7 0.0 46.5 71.2 58.0 7.9 22.3 70.0 51.1 9.2 77.3 72.1 17.9 119.1 23.8 106.6 25.7 35.7 45.4 45.1 29.8 70.6 31.6 32.0 25.2 95.2 128.0 40.7 69.4 115.9 100.8 47.5 95.5 12.4 100.2 68.2 8.0 37.0 69.9 52.9 65.5 30.9 143.3 35.2 69.6 47.3 49.6 57.6 3.4 13.1 8.0 24.1 5.0 15.4 51.8 143.5 88.7 42.8 6.4 39.1 111.7 SPHKAP SKIP ENSG00000153820 "SPHK1 interactor, AKAP domain containing" Q2M3C7 2 227979955-228181687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "brain: 77.8;heart muscle: 29.4" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 82.2;Excitatory neurons: 67.7;Granulosa cells: 33.6;Inhibitory neurons: 128.6" "Not detected" "Not detected" "Region enhanced" "Detected in all" "cerebellum: 77.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "BJ hTERT+: 45.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042499, HPA048168" Enhanced NA NA "HPA042499: AB_2678027, HPA048168: AB_2680296" "unprognostic (4.91e-3)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-2)" "unprognostic (2.95e-2)" "unprognostic (2.09e-1)" "unprognostic (1.01e-3)" 0.0 0.1 9.7 0.0 8.2 0.0 0.8 77.8 49.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 39.7 4.5 0.0 0.0 0.1 0.0 6.6 19.2 5.8 2.2 0.0 0.0 0.0 0.0 14.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.2 7.9 0.3 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 45.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 8.2 77.8 49.2 39.7 4.5 6.6 19.2 5.8 14.5 1.8 7.9 3.6 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 7.2 2.6 3.0 82.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 67.7 0.0 0.0 2.1 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 9.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium inwardly rectifying channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 197.9;parathyroid gland: 271.5;thyroid gland: 140.7" "Cell type enhanced" "Detected in some" "Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 279.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.3 0.4 11.4 0.4 14.4 0.6 3.9 23.1 20.6 0.1 2.7 0.6 0.7 0.5 16.0 0.3 5.1 19.0 0.6 7.2 37.5 197.9 1.3 0.9 0.8 35.0 31.9 6.3 0.2 44.6 271.5 1.0 0.9 26.4 0.2 0.2 1.2 11.9 21.9 0.3 0.8 2.5 0.0 27.6 1.6 23.6 1.7 23.0 0.2 140.7 0.0 0.1 0.0 0.0 21.5 0.1 0.4 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 1.2 0.5 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.8 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.3 0.6 0.1 0.0 12.7 0.0 0.0 279.8 0.2 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.1 0.1 0.0 0.2 0.8 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.3 0.3 0.3 0.1 0.0 0.3 0.2 0.2 1.6 0.3 0.0 0.1 0.3 0.1 11.4 14.4 23.1 20.6 7.2 37.5 35.0 31.9 6.3 26.4 27.6 23.0 21.5 0.1 0.0 0.0 12.1 0.0 0.0 0.0 2.7 0.0 0.0 2.3 1.1 0.4 54.3 2.6 244.6 0.0 0.0 0.0 0.0 41.1 12.4 0.0 2.8 0.1 0.0 0.0 0.0 1.0 1.4 0.0 0.3 3.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 54.8 0.1 6.0 0.0 0.0 0.0 0.0 1.0 95.2 9.8 0.0 0.0 0.2 0.3 0.2 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 PID1 "FLJ20701, NYGGF4" ENSG00000153823 "Phosphotyrosine interaction domain containing 1" Q7Z2X4 2 228850526-229271287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 135.0;Inhibitory neurons: 142.2;Langerhans cells: 210.4;Microglial cells: 179.9;Oligodendrocyte precursor cells: 543.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 71.1;intermediate monocyte: 79.4;myeloid DC: 83.6" "Group enriched" "Detected in many" 53 "dendritic cells: 83.6;monocytes: 79.4" "Cell line enhanced" "Detected in many" "ASC diff: 54.5;hTEC/SVTERT24-B: 86.1;LHCN-M2: 57.3;REH: 62.3;RH-30: 90.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036103 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA036103: AB_10602144" "unprognostic (8.46e-2)" "unprognostic (2.96e-1)" "unprognostic (3.55e-2)" "unprognostic (5.52e-2)" "unprognostic (9.40e-3)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (6.36e-2)" "unprognostic (1.54e-2)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.46e-1)" "unprognostic (4.91e-3)" "unprognostic (9.98e-3)" "unprognostic (1.11e-1)" "unprognostic (5.34e-2)" "unprognostic (9.61e-6)" 29.0 29.8 19.7 14.1 22.0 2.9 26.0 10.0 19.1 30.0 9.7 33.8 5.6 23.1 9.0 12.1 34.2 12.8 15.2 20.7 17.8 5.7 62.7 24.7 4.5 16.0 28.6 20.5 31.3 13.9 1.5 8.8 26.3 15.9 19.4 21.7 3.9 10.2 14.9 13.3 18.6 25.4 16.8 12.1 20.5 25.7 5.5 20.3 3.5 16.7 21.0 3.6 31.2 27.2 16.7 0.0 1.9 0.0 0.0 54.5 10.5 0.1 9.2 34.7 5.8 7.1 0.7 0.0 0.0 0.2 13.0 18.0 1.7 0.0 1.7 7.8 0.0 0.0 0.0 4.0 0.1 22.3 0.0 0.1 19.8 15.5 86.1 14.0 16.1 0.0 0.0 0.0 0.1 57.3 0.1 0.1 0.0 0.9 7.6 5.2 62.3 90.7 0.1 1.1 0.0 1.8 2.3 19.4 1.8 0.1 0.7 0.2 0.0 0.0 22.3 8.3 21.1 8.8 0.1 0.0 0.0 29.3 0.1 3.7 0.0 71.1 0.0 0.0 79.4 0.4 0.2 0.0 0.2 83.6 0.0 0.0 0.0 1.5 0.0 16.7 0.4 0.3 28.4 19.7 22.0 10.0 19.1 20.7 17.8 16.0 28.6 20.5 15.9 12.1 20.3 16.7 4.0 6.4 70.9 53.8 1.6 15.6 6.1 13.5 6.8 5.7 0.9 1.7 2.6 8.6 11.1 0.0 0.0 1.9 0.2 75.7 0.0 2.5 0.1 1.4 37.8 4.1 4.9 0.4 121.0 4.0 31.5 107.3 1.1 4.4 6.3 7.8 4.2 135.0 3.3 0.0 142.2 11.9 4.1 42.5 210.4 1.9 88.0 50.1 21.4 179.9 35.2 14.0 1.0 543.4 3.5 1.6 24.2 75.2 0.5 21.9 39.5 0.3 2.5 1.3 0.0 4.8 8.7 0.4 2.1 1.4 14.5 4.8 2.4 41.0 36.0 1.4 TRIP12 "KIAA0045, TRIPC, ULF" ENSG00000153827 "Thyroid hormone receptor interactor 12" Q14669 2 229763837-229923239 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 251.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036835, HPA045893" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036835: AB_2675340, HPA045893: AB_2679486" "unprognostic (1.22e-1)" "unprognostic (4.87e-2)" "unprognostic (2.61e-1)" "unprognostic (3.33e-2)" "unprognostic (6.81e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.37e-3)" "unprognostic (3.49e-3)" "unprognostic (4.87e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (6.83e-2)" "unprognostic (8.80e-2)" "unprognostic (2.01e-2)" 48.7 32.6 21.5 47.5 26.2 54.3 33.9 21.3 31.6 35.1 14.7 41.1 25.8 31.1 33.7 48.1 28.3 34.2 41.9 15.8 26.1 41.6 43.2 33.6 48.6 23.5 20.6 9.7 33.0 29.5 45.3 25.0 45.0 22.5 40.3 34.3 35.1 30.4 33.3 82.4 28.9 27.9 38.6 17.4 41.4 39.5 128.8 21.4 60.8 44.9 59.5 56.8 46.7 26.7 33.6 97.1 100.7 96.2 79.0 94.9 106.2 88.3 144.5 103.0 106.9 118.7 80.5 75.3 37.8 96.2 135.6 129.5 76.3 140.5 105.9 159.3 132.4 52.9 264.1 84.4 78.3 76.4 195.8 163.2 88.1 80.3 174.9 108.5 74.9 145.1 88.2 188.2 38.2 122.5 72.5 105.3 68.5 77.0 50.3 47.7 94.8 189.8 33.6 75.7 156.4 94.4 67.5 1.6 51.9 97.7 85.1 48.2 118.3 188.8 133.9 94.7 84.9 115.5 66.4 79.3 119.0 103.8 77.0 116.6 34.0 14.2 23.6 12.9 16.2 13.1 9.6 12.0 12.7 13.4 8.9 9.5 9.7 36.0 13.9 18.7 12.6 19.5 9.8 21.5 26.2 21.3 31.6 15.8 26.1 23.5 20.6 9.7 22.5 17.4 21.4 33.6 78.3 89.8 51.2 85.8 43.4 31.0 32.8 36.3 25.6 31.2 41.2 29.8 91.0 34.3 52.8 31.3 52.1 27.0 60.8 57.3 15.6 37.5 119.5 63.5 65.2 59.3 18.6 40.2 147.6 45.1 25.1 43.7 56.6 73.5 39.2 53.1 50.0 54.3 35.1 42.1 130.3 32.5 30.5 89.6 32.2 102.1 34.8 70.8 26.6 122.7 63.9 25.8 56.7 127.2 251.3 57.8 35.0 45.5 52.1 44.7 25.7 34.5 73.1 32.1 19.7 57.5 45.0 137.2 59.3 43.1 36.2 42.4 47.0 60.2 31.9 54.5 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013119 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Early spermatids: 61.7;Endometrial ciliated cells: 40.8;Respiratory ciliated cells: 53.0;Spermatocytes: 55.8" "Cancer enhanced" "Detected in all" "testis cancer: 9.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA053865: AB_2682282" "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favorable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 1.7 3.7 5.3 0.7 4.1 0.8 3.5 4.6 4.5 3.0 3.5 1.2 1.4 2.5 2.8 1.7 11.1 1.7 1.2 3.6 5.7 5.1 1.6 2.3 0.9 5.7 5.3 3.3 2.4 1.6 4.3 2.7 1.6 4.9 2.9 1.2 9.1 2.3 2.5 0.8 3.0 1.4 1.7 5.8 0.8 1.7 6.1 4.3 1.5 7.5 0.8 1.0 1.3 1.5 5.1 1.0 1.9 2.3 0.9 1.1 6.8 4.6 1.2 3.2 1.7 2.9 0.7 3.1 0.1 0.6 2.2 2.1 0.8 1.1 0.6 2.9 0.3 0.7 0.4 0.6 1.2 4.4 0.8 0.3 7.2 5.2 3.2 2.4 2.2 1.8 3.4 1.4 0.6 2.0 4.2 1.7 1.9 6.1 2.2 2.2 2.0 0.6 0.5 3.0 0.8 2.2 2.8 2.0 1.6 0.8 2.6 3.4 1.4 1.3 2.8 1.0 4.6 0.5 2.1 1.8 0.7 3.4 0.4 2.1 0.0 0.5 0.0 0.8 0.4 0.6 1.1 0.6 0.6 1.3 0.7 1.4 0.8 0.2 1.0 0.3 0.6 1.2 0.5 5.3 4.1 4.6 4.5 3.6 5.7 5.7 5.3 3.3 4.9 5.8 4.3 5.1 3.1 9.6 1.1 11.4 1.1 3.8 2.9 8.3 1.2 8.3 4.3 4.3 3.7 0.0 9.9 11.0 35.5 1.9 0.6 2.3 15.6 6.2 61.7 40.8 4.9 2.3 0.0 2.5 19.5 6.6 2.0 3.7 3.1 4.7 0.0 4.2 1.4 2.7 1.1 10.1 22.1 1.6 14.2 1.6 3.0 10.5 3.4 1.2 3.6 5.6 2.9 7.5 4.1 12.5 12.5 6.2 0.5 4.1 0.7 3.0 2.2 12.2 53.0 28.8 6.6 2.8 4.2 55.8 8.6 3.2 4.5 2.2 1.5 9.1 1.4 1.9 CEBPG "GPE1BP, IG/EBP-1" ENSG00000153879 "CCAAT enhancer binding protein gamma" P53567 19 33373685-33382686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012024 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012024: AB_1846503" "unprognostic (5.56e-2)" "unprognostic (1.35e-1)" "unprognostic (3.29e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (8.12e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.16e-1)" "unprognostic (5.25e-2)" "unprognostic (8.87e-2)" "unprognostic (2.01e-2)" 19.3 8.9 19.0 14.3 17.2 15.5 15.3 19.0 21.4 11.1 14.4 30.5 34.4 12.1 9.1 20.2 12.0 11.5 13.4 17.0 19.5 13.0 34.9 16.2 12.5 19.5 18.6 14.9 5.4 28.6 15.2 11.1 16.9 18.5 12.1 29.1 17.4 13.6 9.5 47.9 27.9 35.5 14.7 21.4 9.8 19.0 12.6 19.9 14.2 25.9 44.6 13.9 16.5 14.4 19.7 33.4 29.7 30.9 31.0 14.8 21.6 41.8 24.8 22.1 21.9 26.4 35.3 14.4 54.0 19.1 11.8 26.2 16.6 54.8 25.0 37.5 91.7 23.3 29.1 15.6 34.5 49.3 49.1 31.0 28.6 121.0 27.7 86.7 11.1 27.7 45.1 39.3 49.7 17.9 20.4 33.0 25.7 17.5 94.2 18.2 35.1 21.0 22.5 12.4 19.9 61.1 37.2 25.8 26.7 61.3 22.6 22.7 96.8 26.7 22.2 26.3 23.8 39.6 28.4 27.0 32.4 23.4 53.2 31.4 7.5 9.7 4.4 3.6 11.8 4.3 4.6 4.9 5.6 10.3 3.7 5.2 5.0 0.8 3.0 19.1 3.2 6.0 5.6 19.0 17.2 19.0 21.4 17.0 19.5 19.5 18.6 14.9 18.5 21.4 19.9 19.7 61.3 19.2 13.2 2.6 30.5 124.3 95.8 51.5 67.7 11.3 32.8 31.9 15.1 48.6 29.6 14.7 8.4 42.6 27.6 160.5 19.6 37.0 90.3 43.2 14.9 50.4 35.3 22.3 11.7 54.1 71.5 26.1 34.1 26.6 26.0 9.5 31.4 66.2 45.6 3.3 8.3 81.8 34.6 35.4 65.1 74.5 6.8 34.4 28.4 10.3 63.9 27.7 28.8 6.0 3.9 75.8 107.7 9.1 30.5 70.2 115.7 30.4 49.4 12.9 6.6 24.7 31.5 76.4 45.2 57.8 155.7 74.8 29.4 5.1 67.8 120.4 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 16.6 6.4 27.1 11.4 25.8 6.1 14.3 24.6 35.2 38.2 15.4 32.2 7.1 43.4 3.2 35.1 36.4 10.9 18.2 26.6 25.1 15.0 13.0 24.9 3.0 25.5 25.4 22.3 22.9 32.7 4.6 10.4 11.1 21.2 25.2 6.0 15.3 11.7 19.2 6.0 73.8 15.8 20.9 23.6 17.6 23.5 10.6 27.2 1.3 23.2 6.5 4.2 32.3 31.5 20.9 16.7 37.5 33.2 50.8 10.8 5.7 26.2 21.6 4.0 11.7 6.1 21.2 11.1 0.1 47.6 30.3 5.5 19.3 24.3 16.9 4.4 18.1 42.7 68.5 25.3 20.7 29.8 13.3 12.0 11.2 69.4 4.5 26.5 0.0 23.2 9.8 17.3 0.4 2.0 42.0 0.5 37.8 30.4 27.9 62.8 32.0 17.9 6.3 13.3 7.5 25.7 88.0 42.0 59.0 80.0 14.1 43.7 34.7 38.3 54.7 48.9 1.1 3.8 40.9 2.3 27.2 0.1 23.0 68.4 0.6 1.8 5.9 0.0 3.3 0.1 0.0 0.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.7 27.1 25.8 24.6 35.2 26.6 25.1 25.5 25.4 22.3 21.2 23.6 27.2 20.9 17.8 0.0 1.7 44.4 0.3 15.8 3.3 4.1 10.8 3.5 5.4 5.0 3.2 1.5 2.9 0.0 10.4 0.2 0.4 0.9 3.9 0.7 0.7 3.4 15.1 15.3 1.2 4.2 1.9 8.4 0.4 5.5 1.5 2.5 8.8 94.8 27.8 2.0 1.2 1.7 5.3 3.6 0.0 3.7 5.4 1.9 4.4 3.7 5.4 4.7 3.1 5.0 0.0 11.1 0.3 2.1 1.0 9.1 0.1 3.9 0.3 0.2 0.7 11.7 0.0 3.1 8.7 0.0 1.9 14.3 19.5 0.3 0.7 2.4 1.9 3.1 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758073-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 33.2;Early spermatids: 81.4;Late spermatids: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 4.2 6.0 5.8 2.3 6.7 1.2 5.6 6.8 5.8 7.8 7.5 5.4 2.5 7.6 12.0 4.0 8.7 2.4 4.7 5.4 6.6 8.8 4.8 4.8 3.3 6.6 6.3 4.8 7.4 4.8 9.9 11.1 3.1 6.5 9.6 2.8 4.8 5.9 4.9 3.6 4.4 4.3 3.7 6.6 5.0 4.8 14.1 6.5 4.3 11.2 5.0 2.8 6.1 6.2 7.4 4.8 2.4 4.6 3.4 5.2 6.9 2.6 1.7 4.5 4.1 4.7 2.0 3.1 0.5 4.3 3.1 3.8 2.3 3.4 2.3 4.9 0.5 4.2 3.6 4.9 5.7 4.1 0.8 3.5 6.5 3.1 1.9 2.0 6.7 4.7 8.3 6.2 0.4 6.0 1.9 9.1 3.8 2.0 6.5 0.1 4.6 4.5 3.0 5.1 1.1 5.8 8.4 5.6 1.0 3.2 3.0 2.8 0.4 2.6 3.2 4.4 3.0 1.9 5.1 5.6 0.4 2.5 0.1 3.8 1.9 0.6 3.5 3.4 1.4 2.3 1.0 3.5 1.9 1.0 2.2 3.5 3.2 0.3 3.5 3.2 2.2 2.8 1.6 5.8 6.7 6.8 5.8 5.4 6.6 6.6 6.3 4.8 6.5 6.6 6.5 7.4 5.8 0.0 3.7 5.2 2.5 3.1 7.6 5.5 6.8 4.2 10.2 11.2 4.4 1.5 8.3 18.4 2.1 7.9 5.2 1.1 33.2 4.6 81.4 25.4 6.4 5.3 1.2 3.8 0.7 2.3 4.5 8.3 1.5 4.1 0.0 6.6 5.0 4.0 3.8 0.0 3.5 3.3 4.1 1.0 1.9 30.8 10.2 1.2 5.4 0.0 0.9 14.4 4.1 9.5 8.1 3.1 0.9 4.9 4.8 5.5 2.9 15.3 22.7 2.7 6.6 5.7 5.7 26.2 7.5 4.8 1.6 1.9 3.9 7.2 3.2 6.0 MCOLN2 "FLJ36691, TRP-ML2, TRPML2" ENSG00000153898 "Mucolipin 2" Q8IZK6 1 84925583-84997113 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.2;lymphoid tissue: 13.2" "Cell type enhanced" "Detected in many" "B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 29.7" "Group enriched" "Detected in many" 14 "B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9" "Cell line enhanced" "Detected in many" "Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA019114 Uncertain NA NA "HPA019114: AB_1853645" "unprognostic (3.02e-2)" "unprognostic (5.67e-2)" "unprognostic (3.07e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.38e-1)" "prognostic favorable (2.56e-4)" "unprognostic (8.92e-2)" "unprognostic (1.48e-2)" "unprognostic (6.84e-2)" "unprognostic (2.21e-2)" "unprognostic (3.12e-4)" "unprognostic (3.68e-2)" "unprognostic (4.69e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-2)" 0.5 8.9 0.2 5.4 0.3 2.9 1.0 0.8 0.4 1.1 0.7 10.3 1.8 1.0 4.1 0.7 2.6 1.7 0.2 0.3 0.1 1.1 0.7 5.5 13.0 0.3 0.1 0.1 0.5 0.9 1.1 0.6 2.6 0.4 0.7 15.2 0.1 0.8 0.2 0.2 2.1 5.5 0.6 0.1 6.8 2.2 1.5 0.2 2.3 0.5 0.2 13.2 1.6 0.7 0.4 1.5 1.6 0.0 4.0 0.8 0.2 0.3 1.0 5.5 1.6 2.0 0.0 0.1 21.9 0.5 0.0 2.6 0.1 14.7 1.8 1.5 26.9 13.6 1.9 0.4 0.0 1.3 0.0 1.8 0.3 0.0 1.3 1.0 0.1 0.0 5.1 0.0 0.0 0.3 0.5 0.3 0.0 1.6 0.0 2.9 0.0 3.3 0.0 0.1 0.2 0.9 0.0 0.1 0.2 9.2 0.2 2.4 28.5 0.1 1.3 2.1 0.0 4.2 0.0 0.0 18.5 1.2 0.0 4.0 0.1 0.3 0.0 5.9 1.1 2.1 10.3 5.0 8.9 7.1 3.7 0.6 4.5 0.2 0.4 0.2 29.7 0.2 2.6 0.2 0.3 0.8 0.4 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 0.4 0.4 0.0 0.6 0.0 26.3 4.5 0.4 0.1 1.2 0.0 1.1 1.8 0.5 0.0 1.3 1.8 0.0 0.1 43.6 31.4 0.0 0.1 53.1 12.3 6.0 0.4 2.4 1.3 0.9 1.4 0.1 1.5 1.5 24.5 0.0 0.1 0.7 0.0 0.7 0.0 0.5 4.5 0.0 1.3 100.8 19.6 0.0 14.4 8.8 2.8 32.3 0.0 1.0 0.0 1.4 0.4 4.7 0.0 13.8 0.6 0.0 2.3 1.5 0.0 0.0 0.7 0.3 1.6 4.3 0.0 3.3 0.3 21.8 1.6 5.4 0.1 LGI4 ENSG00000153902 "Leucine rich repeat LGI family member 4" Q8N135 19 35124513-35142451 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 74.7;Distal enterocytes: 33.1;Muller glia cells: 95.5;Sertoli cells: 78.9;Smooth muscle cells: 104.4" "Group enriched" "Detected in many" 6 "glioma: 4.5;melanoma: 11.5;renal cancer: 13.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "WM-115: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042116, HPA043556" Approved Approved "Golgi apparatus" "Secreted in brain" NA NA "Golgi apparatus" "HPA042116: AB_2677855, HPA043556: AB_2678550" "unprognostic (3.79e-1)" "unprognostic (6.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-2)" "unprognostic (3.71e-2)" "unprognostic (2.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.71e-2)" "unprognostic (4.47e-1)" "unprognostic (7.73e-2)" "unprognostic (7.13e-2)" 55.8 5.5 61.6 4.1 61.2 0.2 36.4 60.6 99.2 83.7 42.2 77.5 3.6 35.8 2.3 15.2 44.1 5.1 29.5 57.7 51.1 4.7 8.1 14.4 2.1 76.2 58.2 55.5 13.4 6.4 1.4 4.4 3.7 60.0 37.5 3.8 7.3 12.3 13.4 39.4 19.6 35.4 4.9 66.8 1.9 27.2 2.7 59.9 0.5 19.3 5.4 0.5 33.8 79.9 72.9 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 61.6 61.2 60.6 99.2 57.7 51.1 76.2 58.2 55.5 60.0 66.8 59.9 72.9 13.3 0.0 0.0 74.7 0.2 2.5 0.6 0.3 3.4 0.8 1.5 1.5 17.1 0.0 0.8 1.8 2.1 0.0 0.2 33.1 0.0 0.0 0.1 0.2 2.8 5.4 1.8 0.0 21.9 0.0 0.3 12.7 0.0 0.2 0.0 0.0 7.9 2.0 0.1 0.0 2.2 0.9 0.0 0.0 4.6 0.3 14.6 0.7 10.6 5.6 0.1 95.5 0.0 2.0 9.2 0.1 21.8 7.2 0.3 1.2 1.1 0.1 0.9 3.1 78.9 7.9 104.4 2.8 2.8 0.8 2.4 0.0 0.7 0.0 0.7 1.1 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 132.9;kidney: 126.0" "Cell type enhanced" "Detected in many" "Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 239.4;LHCN-M2: 179.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 350000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 10.4 28.9 98.7 12.9 102.2 0.6 19.0 67.1 132.9 22.6 71.9 45.5 40.5 10.9 77.2 12.7 36.8 25.7 17.6 99.8 87.9 126.0 80.2 26.6 2.6 66.5 83.1 92.3 2.9 27.7 21.2 6.3 11.7 65.2 28.8 45.7 34.9 17.9 18.7 30.7 5.6 40.0 16.6 59.6 10.7 30.0 19.3 96.5 1.0 29.2 14.2 2.0 19.4 2.7 90.5 63.1 7.6 36.0 6.9 84.1 78.0 9.2 155.9 120.0 63.6 75.6 89.9 16.5 0.1 39.2 239.4 38.3 17.8 79.7 15.0 93.0 0.3 29.5 0.2 22.3 31.8 40.9 57.6 3.2 60.5 2.0 50.4 24.9 85.5 75.9 0.0 0.1 6.0 179.7 7.5 3.0 0.3 25.5 124.6 22.6 0.0 63.1 0.9 113.4 46.3 59.2 115.0 18.0 56.3 9.1 38.7 29.6 4.9 107.7 31.6 27.0 11.7 57.8 0.0 0.1 0.2 1.6 0.1 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 102.2 67.1 132.9 99.8 87.9 66.5 83.1 92.3 65.2 59.6 96.5 90.5 14.1 35.3 43.4 364.4 2.6 13.8 4.6 6.8 5.7 4.5 31.2 13.8 11.8 61.5 13.6 69.9 4.2 2.7 0.4 75.3 125.2 15.9 22.5 36.9 9.8 7.5 34.2 2.7 197.4 31.2 0.9 13.9 47.9 24.2 0.0 59.3 8.2 102.8 1.1 0.0 51.0 86.9 8.2 2.2 5.5 25.6 15.8 2.4 12.4 23.4 0.6 68.4 0.0 182.4 9.6 44.5 69.4 74.9 0.0 33.6 68.7 283.3 36.5 9.4 13.1 15.3 18.6 4.6 5.4 32.6 14.3 0.8 2.5 13.5 106.7 8.3 SREK1 "DKFZp564B176, SFRS12, SRrp508, SRrp86" ENSG00000153914 "Splicing regulatory glutamic acid and lysine rich protein 1" Q8WXA9 5 66139971-66183615 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037673, HPA037674, HPA059332" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983" "unprognostic (1.38e-1)" "unprognostic (2.51e-1)" "unprognostic (6.16e-2)" "unprognostic (1.52e-1)" "unprognostic (9.40e-2)" "prognostic favorable (2.54e-4)" "unprognostic (1.29e-2)" "unprognostic (7.67e-2)" "unprognostic (5.66e-3)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (5.48e-2)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.63e-1)" "unprognostic (3.08e-1)" "unprognostic (6.76e-2)" "unprognostic (6.69e-2)" 5.3 6.6 8.2 4.4 8.2 20.4 6.0 9.3 8.6 6.9 10.3 6.5 4.5 8.1 5.2 5.4 7.1 4.2 4.7 7.5 7.9 4.8 6.2 6.3 6.0 7.5 7.3 7.7 6.4 8.6 6.7 8.2 5.2 7.5 5.5 4.3 9.6 7.1 3.8 4.7 9.1 7.5 3.2 7.4 7.4 6.6 4.8 7.7 5.8 8.1 3.3 4.1 5.6 5.8 8.6 5.5 6.7 8.5 5.5 3.9 7.5 9.5 6.1 3.3 3.1 3.4 9.5 6.3 8.3 7.4 4.5 4.1 7.4 4.3 5.7 5.3 6.0 10.3 7.9 18.0 7.2 3.4 7.0 8.9 4.5 5.6 3.7 4.2 6.4 5.2 4.6 7.4 5.5 3.4 5.6 7.2 16.2 4.8 2.1 3.3 10.2 4.1 6.3 5.6 9.2 10.3 7.3 5.8 2.7 5.1 6.1 7.2 8.7 5.9 5.2 3.3 7.3 6.4 6.0 4.5 8.9 5.1 11.2 5.5 4.9 2.7 2.8 2.4 2.1 2.6 3.2 2.2 2.8 2.3 3.8 2.6 2.6 2.1 3.8 1.9 3.1 2.4 1.5 8.2 8.2 9.3 8.6 7.5 7.9 7.5 7.3 7.7 7.5 7.4 7.7 8.6 72.6 93.0 143.5 70.2 67.6 66.0 84.8 69.3 58.6 64.3 64.1 51.4 80.8 60.1 98.8 46.0 116.7 84.6 72.1 59.5 37.2 59.3 46.5 91.2 124.1 83.3 77.8 65.6 71.4 55.4 86.7 80.1 72.4 107.5 97.0 80.5 55.0 68.3 50.2 67.3 73.3 64.2 79.3 54.4 50.2 62.3 83.6 55.4 42.7 40.3 62.3 63.4 53.5 98.0 85.2 54.7 41.8 76.8 70.7 83.7 49.8 32.8 112.2 89.8 46.0 92.3 87.2 78.9 62.0 49.1 69.3 120.7 63.7 85.2 62.5 91.2 CHD1 ENSG00000153922 "Chromodomain helicase DNA binding protein 1" O14646 5 98853985-98929007 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022236 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA022236: AB_2670915" "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (1.09e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (7.15e-2)" "unprognostic (6.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-1)" "unprognostic (4.94e-2)" "unprognostic (3.15e-1)" "prognostic unfavorable (7.25e-6)" "unprognostic (2.69e-1)" "unprognostic (3.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.17e-1)" 14.8 10.4 6.7 18.0 7.2 70.2 9.3 17.0 14.2 8.0 9.2 10.6 9.8 12.8 7.0 8.0 8.2 15.2 5.0 6.4 14.1 8.4 13.3 9.5 13.8 9.5 7.6 5.1 14.2 10.1 9.5 4.8 14.3 9.6 8.3 10.4 15.0 5.5 7.2 9.8 6.2 9.5 9.1 7.5 15.8 8.3 18.3 7.2 50.1 8.9 9.1 14.0 12.5 5.9 9.4 23.0 20.7 47.5 32.3 15.7 16.1 41.3 23.2 15.1 18.4 23.8 25.9 17.3 19.3 22.0 13.5 29.8 18.6 37.6 25.6 38.2 30.5 28.2 34.2 25.8 19.8 17.3 33.3 25.5 14.0 10.2 32.0 32.2 12.5 22.6 62.0 42.0 28.9 18.7 18.5 66.4 14.4 32.0 7.2 24.8 55.7 33.2 29.2 16.0 21.6 22.1 18.9 29.8 15.4 37.9 24.6 15.0 22.6 25.7 39.3 21.2 24.9 41.6 20.0 22.6 40.0 21.5 32.6 24.2 13.1 7.1 10.1 5.4 6.6 6.9 9.4 5.1 5.3 6.5 8.3 7.0 5.6 14.4 7.4 6.8 4.7 5.9 2.0 6.7 7.2 17.0 14.2 6.4 14.1 9.5 7.6 5.1 9.6 7.5 7.2 9.4 87.2 48.1 72.2 35.3 145.3 155.5 99.0 26.6 115.5 39.3 85.9 56.1 29.9 22.8 57.4 36.8 43.8 53.9 203.6 64.0 7.9 36.5 101.0 84.3 114.3 79.5 31.8 40.8 50.9 32.0 38.4 104.6 50.0 107.3 89.2 45.2 40.0 30.6 35.6 33.7 59.8 31.2 16.2 65.8 145.9 19.8 32.3 169.7 67.6 90.9 89.1 20.5 59.8 66.4 72.1 35.3 51.4 19.2 121.0 82.6 28.1 15.5 45.3 49.5 46.0 173.8 113.5 67.1 54.6 74.1 188.5 90.3 148.2 49.9 39.4 75.4 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.5;cervix: 9.2;fallopian tube: 5.3" "Cell type enhanced" "Detected in some" "Astrocytes: 138.4;Excitatory neurons: 27.2;Inhibitory neurons: 86.6;Oligodendrocyte precursor cells: 70.9;Respiratory ciliated cells: 31.0" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 6.8;MOLT-4: 15.4;T-47d: 5.0;U-2197: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 0.5 0.2 9.5 0.0 3.8 0.0 0.3 5.4 2.0 9.2 0.6 0.1 0.1 0.1 0.9 0.2 5.3 0.2 0.0 2.9 7.8 0.1 0.0 0.7 0.0 6.7 9.0 1.3 0.0 0.0 0.0 0.3 0.8 6.4 0.2 0.1 0.2 0.2 0.1 0.0 1.9 0.1 0.0 7.7 0.0 0.3 1.7 7.4 0.6 0.1 0.0 0.0 1.0 0.9 4.1 0.0 0.0 0.1 0.0 1.1 0.1 0.3 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.4 15.4 0.0 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 1.0 0.0 1.5 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.3 4.8 0.0 1.3 0.2 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 3.8 5.4 2.0 2.9 7.8 6.7 9.0 1.3 6.4 7.7 7.4 4.1 0.0 0.0 1.1 138.4 0.0 0.5 0.1 0.6 0.0 0.0 0.3 0.1 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 18.7 16.9 1.2 0.3 0.0 0.0 27.2 0.0 0.9 1.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 86.6 2.4 0.0 0.0 0.7 8.6 0.6 0.0 1.8 11.2 0.0 0.3 0.0 70.9 3.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 31.0 0.1 6.6 0.0 0.5 6.4 2.7 0.0 0.4 2.9 0.0 0.0 0.1 1.4 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834107-56869567 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 34.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 181.1;Cone photoreceptor cells: 189.7;Inhibitory neurons: 90.0;Rod photoreceptor cells: 165.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 84.8;MOLT-4: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 4.2 2.2 4.0 4.5 5.5 3.1 3.0 9.7 7.2 5.0 8.3 4.2 2.6 6.6 4.2 2.6 4.8 4.6 2.9 5.4 6.5 2.6 2.8 5.2 5.0 3.4 5.5 5.2 3.5 3.9 4.1 6.3 2.7 4.7 4.2 3.3 34.8 2.5 3.4 1.2 1.9 4.4 4.4 2.8 6.9 3.7 6.6 6.1 9.9 4.1 2.3 4.4 3.8 4.2 5.7 3.5 3.3 3.0 0.3 0.6 1.0 1.4 5.8 4.7 3.9 4.5 7.7 4.2 5.1 7.0 3.1 1.9 4.2 7.2 3.2 7.8 16.5 9.5 6.6 8.9 5.1 3.3 12.7 8.9 1.9 4.0 4.1 8.0 3.6 5.4 14.7 5.5 84.8 4.8 5.1 30.3 7.1 2.3 4.6 10.0 9.4 12.4 12.2 3.9 7.6 4.7 3.2 4.7 2.5 0.2 1.9 5.3 6.0 5.0 1.1 5.4 1.7 0.9 11.3 25.3 3.4 3.3 7.3 0.3 0.1 0.2 0.0 1.0 0.1 0.7 0.9 0.6 0.7 0.2 0.3 0.7 0.9 0.3 0.7 0.2 0.8 1.7 0.3 4.0 5.5 9.7 7.2 5.4 6.5 3.4 5.5 5.2 4.7 2.8 6.1 5.7 51.2 3.2 6.0 10.4 11.3 8.9 13.5 3.1 21.6 181.1 5.0 6.3 6.3 10.0 4.0 16.5 189.7 6.6 16.3 5.6 0.0 7.4 18.3 9.0 9.9 30.6 11.3 2.1 66.0 4.7 3.0 6.9 9.7 19.3 0.0 13.1 29.3 4.0 2.2 8.4 90.0 7.7 8.2 5.0 9.3 9.2 4.4 7.4 3.6 32.8 6.3 18.6 14.4 32.6 14.4 6.0 6.4 5.3 15.1 21.3 1.9 0.1 2.8 165.4 6.6 11.8 10.7 28.5 20.7 9.7 6.7 3.4 18.9 5.7 5.8 13.4 HS2ST1 KIAA0448 ENSG00000153936 "Heparan sulfate 2-O-sulfotransferase 1" Q7LGA3 1 86914635-87109982 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043069, HPA043603, HPA075001" Supported Approved Mitochondria "Intracellular and membrane" No No Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (1.28e-3)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.20e-2)" "unprognostic (5.34e-2)" "unprognostic (7.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.45e-1)" "unprognostic (5.80e-2)" "unprognostic (1.63e-2)" "unprognostic (5.07e-2)" "unprognostic (3.24e-1)" "unprognostic (7.58e-2)" 7.9 26.0 12.3 9.4 13.6 3.8 8.2 9.0 13.0 10.6 12.3 9.4 9.8 9.1 10.0 7.1 6.7 10.7 7.0 12.2 14.6 13.9 17.4 8.3 11.9 10.9 11.6 10.2 12.9 10.2 13.5 6.7 8.4 8.8 9.6 9.1 19.5 6.7 10.0 4.4 8.2 9.4 7.9 9.5 12.9 8.4 9.4 11.5 10.7 13.0 4.7 11.7 9.5 5.9 10.0 24.4 20.4 59.0 38.5 31.9 92.3 20.4 23.3 30.5 19.2 21.2 78.1 30.6 53.3 22.1 16.4 33.2 14.5 27.2 19.5 30.8 42.1 22.2 64.0 21.0 63.0 13.4 33.6 31.0 38.2 17.0 31.0 25.6 30.4 28.8 29.7 44.6 27.4 28.1 8.6 33.8 20.2 19.8 26.5 12.9 41.2 55.7 11.6 23.5 50.3 12.6 19.0 30.6 26.2 27.2 15.2 17.2 15.2 25.7 24.0 29.8 42.2 29.7 25.1 19.9 49.7 14.8 23.6 25.0 6.2 1.1 1.0 1.3 0.6 1.6 1.1 1.5 1.5 0.7 2.8 1.4 0.9 1.2 1.1 2.8 0.7 0.9 1.0 12.3 13.6 9.0 13.0 12.2 14.6 10.9 11.6 10.2 8.8 9.5 11.5 10.0 13.0 16.0 12.4 160.9 14.2 16.6 8.6 9.3 19.9 10.9 11.9 7.6 12.8 14.3 15.2 20.2 4.2 8.2 5.7 13.5 13.7 18.2 5.5 7.1 23.6 13.8 23.4 12.2 126.1 11.5 9.3 16.9 11.2 8.0 19.0 74.2 18.2 28.9 37.7 8.4 130.1 12.5 18.3 12.8 13.5 3.8 6.8 15.3 12.4 53.4 8.2 28.8 5.2 95.0 54.5 11.3 7.7 20.3 24.0 7.3 17.6 18.3 11.2 17.7 0.0 21.1 16.8 10.1 15.0 12.8 15.8 4.4 12.9 77.4 13.5 7.1 MSI2 ENSG00000153944 "Musashi RNA binding protein 2" Q96DH6 17 57255851-57684689 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 830.2;Cone photoreceptor cells: 754.8;Rod photoreceptor cells: 500.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 184.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022300, HPA068990" Approved Supported Cytosol NA NA Cytosol "CAB022300: , HPA068990: " "unprognostic (4.73e-2)" "unprognostic (2.28e-1)" "unprognostic (3.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.12e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (2.20e-2)" "unprognostic (4.89e-2)" "unprognostic (2.96e-1)" "unprognostic (4.17e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.22e-8)" "prognostic favorable (2.00e-4)" "unprognostic (4.87e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" 7.6 69.7 52.9 13.3 50.1 20.4 19.1 56.7 47.2 12.2 93.3 14.2 10.4 14.1 50.4 9.3 23.1 18.5 33.8 42.2 97.5 37.1 7.6 8.3 22.4 84.2 80.2 32.3 46.8 12.9 89.3 45.1 22.8 63.3 21.7 15.7 127.1 17.2 21.2 61.2 8.0 11.8 7.7 63.1 17.4 16.8 15.5 57.2 46.9 25.8 43.8 19.7 19.9 8.2 56.1 11.8 18.8 79.0 28.6 7.7 7.8 53.9 13.7 16.4 16.8 10.1 23.6 20.4 56.9 47.1 9.4 13.1 11.8 50.6 18.1 34.8 77.1 31.7 26.2 46.5 58.7 17.8 28.0 23.9 10.4 24.3 2.4 29.9 24.1 19.3 46.6 52.5 42.3 67.6 27.1 136.8 7.2 26.0 64.0 33.2 184.3 109.8 45.5 46.2 84.0 76.6 154.5 22.1 22.9 63.7 33.8 36.9 21.0 22.4 11.2 27.2 9.2 23.0 57.3 51.7 68.8 29.9 16.7 70.2 2.7 0.1 1.9 0.7 0.1 0.6 0.7 0.8 0.7 0.2 0.4 0.6 0.7 0.1 0.8 0.8 1.1 1.6 0.2 52.9 50.1 56.7 47.2 42.2 97.5 84.2 80.2 32.3 63.3 63.1 57.2 56.1 20.5 6.4 28.7 830.2 50.5 24.0 74.9 54.5 34.7 202.1 53.2 33.9 99.1 54.3 42.3 75.4 754.8 117.9 37.5 29.5 123.3 49.3 15.3 150.2 30.8 28.1 98.2 35.5 67.6 14.2 25.9 34.2 34.1 70.8 41.8 178.7 29.6 31.5 20.4 294.4 175.5 51.8 109.9 12.6 16.4 27.2 64.7 20.1 39.2 158.3 13.2 220.6 22.6 249.3 111.6 12.8 24.3 77.5 88.8 74.7 11.6 51.2 106.0 500.1 13.1 42.3 30.6 3.1 7.6 28.2 16.1 149.3 50.6 113.5 37.8 92.4 CACNA2D1 "CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3" ENSG00000153956 "Calcium voltage-gated channel auxiliary subunit alpha2delta 1" P54289 7 81946444-82443777 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 79.4;tongue: 99.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 543.1;Inhibitory neurons: 383.3;Oligodendrocyte precursor cells: 357.9;Oligodendrocytes: 662.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 127.4;HUVEC TERT2: 54.9;SH-SY5Y: 62.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008213, HPA008621" Enhanced "Intracellular and membrane" NA NA 390000000 "HPA008213: AB_1233654, HPA008621: AB_1845863" "unprognostic (5.07e-3)" "unprognostic (2.21e-1)" "unprognostic (4.27e-3)" "unprognostic (2.92e-2)" "unprognostic (2.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.70e-1)" "unprognostic (3.22e-1)" "unprognostic (3.76e-1)" "unprognostic (2.05e-1)" "unprognostic (6.24e-3)" "unprognostic (2.23e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (4.28e-3)" "unprognostic (2.13e-1)" "unprognostic (9.18e-2)" "unprognostic (1.03e-4)" 11.7 14.6 10.4 4.3 13.0 0.0 4.1 1.4 16.3 5.3 0.0 9.4 5.1 7.5 2.4 5.4 3.9 6.4 31.6 19.5 11.6 8.4 1.3 3.5 2.0 6.1 10.0 14.1 8.0 1.5 1.2 6.4 4.2 9.0 13.8 5.2 8.4 2.7 6.5 79.4 4.8 3.4 12.3 3.6 4.5 5.7 3.7 29.0 3.9 19.1 99.4 3.2 7.2 3.5 13.6 0.0 12.7 10.6 0.0 18.2 22.9 0.0 23.4 15.0 11.4 11.1 0.0 3.5 0.0 0.0 20.4 14.1 0.0 11.2 0.0 14.8 0.0 15.0 0.7 14.4 0.0 11.9 5.3 0.0 13.6 0.1 39.6 0.1 127.4 54.9 0.0 0.0 0.2 25.7 0.1 0.0 0.0 12.6 0.0 5.0 2.3 2.1 0.0 0.9 0.9 21.1 62.3 4.6 0.1 0.0 11.1 0.1 0.0 39.6 20.1 15.0 20.1 0.0 0.1 0.0 0.0 16.9 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 13.0 1.4 16.3 19.5 11.6 6.1 10.0 14.1 9.0 3.6 29.0 13.6 6.3 0.0 1.7 137.1 0.0 5.7 4.5 0.1 8.0 47.7 6.6 3.9 88.0 0.0 1.3 7.3 18.8 0.1 0.1 0.0 0.0 0.0 64.2 0.5 20.7 6.8 38.8 0.0 543.1 0.0 0.0 20.6 14.3 0.4 25.3 29.9 1.4 0.4 0.2 25.2 383.3 2.6 16.2 0.0 2.9 42.4 10.2 0.4 1.8 87.1 0.6 5.6 0.0 357.9 662.8 0.8 0.0 6.0 0.2 11.2 0.0 9.5 0.7 6.1 6.6 17.6 21.5 1.5 1.9 1.9 6.5 0.1 0.4 32.7 0.2 1.4 ZUP1 "C6orf113, dJ412I7.3, ZUFSP" ENSG00000153975 "Zinc finger containing ubiquitin peptidase 1" Q96AP4 6 116635618-116668794 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044426 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044426: AB_10960887" "unprognostic (2.28e-3)" "unprognostic (2.45e-3)" "unprognostic (3.91e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.27e-1)" "unprognostic (5.88e-2)" "unprognostic (2.83e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (1.90e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (7.33e-2)" "unprognostic (7.92e-3)" 4.4 4.6 4.4 6.3 4.8 13.6 5.7 7.4 6.3 4.0 3.5 5.2 10.6 3.7 4.1 5.6 3.2 5.5 2.7 4.4 5.0 4.7 4.3 5.0 8.8 4.6 4.9 4.3 2.6 5.7 4.3 3.9 5.3 5.0 5.0 5.7 6.1 3.8 4.1 3.2 5.4 7.2 4.2 4.7 6.0 4.7 6.1 4.8 7.6 4.6 3.3 8.7 6.1 4.2 6.1 6.6 6.3 13.9 26.2 7.9 10.3 10.4 14.0 13.3 13.5 16.3 11.5 7.3 23.3 11.6 8.9 15.2 10.3 15.8 10.1 17.9 14.0 18.1 18.0 9.5 20.0 12.3 21.1 21.3 9.2 15.7 11.0 18.7 10.0 12.5 17.4 32.1 11.6 17.9 10.7 10.2 16.0 10.3 9.9 6.8 13.9 12.1 9.6 15.0 6.6 12.1 14.0 10.0 8.3 8.6 11.8 4.9 15.9 10.7 8.6 5.8 5.3 11.9 10.7 14.9 24.0 7.7 12.8 12.8 19.5 7.5 7.6 7.0 8.9 8.2 9.5 7.9 8.1 10.1 10.4 8.6 6.4 2.9 8.3 11.0 6.9 11.7 6.5 4.4 4.8 7.4 6.3 4.4 5.0 4.6 4.9 4.3 5.0 4.7 4.8 6.1 6.7 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 5.3 5.2 0.0 0.0 0.0 1.8 0.0 10.4 12.8 0.0 9.8 9.7 0.0 7.4 8.7 2.2 0.0 0.0 0.0 8.0 8.3 2.2 0.0 8.4 0.0 10.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 12.4 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 9.3 4.4 6.0 0.0 0.0 HS3ST3A1 "30ST3A1, 3OST3A1" ENSG00000153976 "Heparan sulfate-glucosamine 3-sulfotransferase 3A1" Q9Y663 17 13494032-13601929 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 8.2" "Cell type enhanced" "Detected in some" "Astrocytes: 9.8;Granulosa cells: 11.6;Hepatic stellate cells: 7.1;Horizontal cells: 26.9;Leydig cells: 13.7;Squamous epithelial cells: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 2.2" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 2.2" "Group enriched" "Detected in many" 4 "PC-3: 40.9;U-251 MG: 123.0;U-87 MG: 73.2" "Region enhanced" "Detected in many" "olfactory bulb: 5.0" "Region enhanced" "Detected in some" "olfactory bulb: 5.3" "HPA062518, HPA071530" Uncertain Approved Microtubules NA NA Microtubules "HPA062518: AB_2684789, HPA071530: AB_2686411" "unprognostic (2.88e-3)" "unprognostic (4.21e-2)" "unprognostic (8.35e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-3)" "unprognostic (4.44e-2)" "unprognostic (2.01e-1)" "unprognostic (4.46e-3)" "unprognostic (2.12e-4)" "unprognostic (1.12e-2)" "unprognostic (8.52e-2)" "unprognostic (1.55e-1)" "unprognostic (1.85e-9)" "unprognostic (1.83e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (4.70e-3)" 0.3 2.0 0.2 1.9 1.1 1.0 0.4 0.1 0.6 4.1 2.7 1.0 1.4 0.7 0.1 4.6 1.3 0.3 1.7 0.2 5.4 1.4 1.9 1.2 2.7 6.1 1.7 0.5 8.2 0.3 0.0 0.7 2.7 1.1 3.2 0.3 1.4 2.0 5.0 0.1 0.6 1.2 0.2 2.0 6.5 0.6 2.3 1.4 0.3 0.3 0.0 1.6 0.5 3.4 1.2 0.1 0.3 3.3 0.0 2.7 6.8 5.1 18.2 4.4 3.2 2.0 0.0 0.6 0.0 2.6 11.2 0.0 0.0 0.1 0.0 3.1 1.1 18.3 4.9 1.5 2.0 1.6 0.0 1.2 4.9 0.1 8.5 2.2 5.5 0.0 0.2 19.2 0.0 3.8 2.5 0.1 3.3 3.5 0.0 40.9 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 2.0 0.1 0.6 0.2 3.1 0.4 0.1 123.0 0.0 0.0 0.0 73.2 0.0 9.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.5 0.0 0.0 0.5 0.5 0.2 0.3 0.0 1.7 2.2 0.3 0.2 1.1 0.1 0.6 0.2 5.4 6.1 1.7 0.5 1.1 2.0 1.4 1.2 0.2 0.0 0.0 9.8 0.0 0.6 0.0 0.0 5.7 0.3 0.0 0.3 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.4 0.3 1.1 0.0 0.0 1.8 0.2 0.0 4.7 0.0 0.2 0.0 11.6 7.1 0.0 1.6 26.9 4.1 0.0 0.0 0.8 0.3 0.1 13.7 0.0 0.0 1.9 0.0 2.4 0.0 0.5 0.2 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 4.0 0.3 0.4 9.3 0.6 0.1 0.1 0.0 0.0 0.0 GDPD1 "FLJ37451, GDE4" ENSG00000153982 "Glycerophosphodiester phosphodiesterase domain containing 1" Q8N9F7 17 59220467-59275970 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 34.3;Early spermatids: 47.2;Excitatory neurons: 65.1;Inhibitory neurons: 63.9;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 36.5;Spermatocytes: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.3;K-562: 12.5;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.33e-2)" "unprognostic (6.63e-3)" "unprognostic (2.68e-2)" "unprognostic (5.98e-3)" "unprognostic (7.12e-2)" "unprognostic (5.35e-2)" "unprognostic (4.85e-6)" "prognostic favorable (2.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.36e-2)" "unprognostic (1.24e-3)" "unprognostic (2.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-3)" "unprognostic (4.72e-2)" "unprognostic (1.32e-2)" "unprognostic (6.28e-3)" 0.8 1.8 4.2 0.9 4.5 1.5 1.8 7.3 8.5 1.1 1.9 1.9 5.8 1.5 0.7 0.8 1.5 1.8 1.1 5.2 4.7 2.1 1.0 2.3 0.9 5.8 5.6 4.7 0.9 1.1 5.9 1.8 1.4 6.6 2.0 1.6 5.9 2.3 1.5 1.7 1.4 4.2 1.3 2.6 1.5 5.2 8.7 5.3 1.6 2.6 0.7 1.1 1.3 0.8 7.7 0.8 1.0 4.2 3.2 0.6 0.2 2.6 0.5 1.6 0.4 3.3 0.0 1.3 2.0 4.7 0.1 3.0 0.6 6.6 1.1 1.9 2.6 6.8 22.3 0.7 3.2 2.0 1.0 3.2 0.6 5.4 2.1 0.6 1.9 1.9 4.9 12.5 1.3 0.8 1.0 3.9 0.4 0.8 6.6 1.1 2.4 0.4 2.1 2.0 1.2 12.5 3.4 1.0 0.4 4.6 1.3 3.0 1.4 1.6 0.2 1.3 0.2 0.4 3.7 2.3 0.7 1.0 1.2 1.4 2.4 0.5 0.3 0.5 0.7 0.4 0.3 0.4 0.6 0.2 0.5 0.5 0.7 0.9 0.8 0.7 0.7 0.3 0.3 4.2 4.5 7.3 8.5 5.2 4.7 5.8 5.6 4.7 6.6 2.6 5.3 7.7 1.6 3.2 8.2 34.3 1.3 0.5 1.5 1.2 1.8 6.1 1.6 1.0 3.1 0.0 8.7 5.5 10.4 0.4 3.2 0.9 0.0 2.2 47.2 1.8 0.4 1.4 1.2 11.3 65.1 1.8 5.5 1.1 9.2 0.7 0.0 4.0 0.7 0.6 1.9 6.7 63.9 3.1 6.1 2.6 1.0 8.3 0.6 3.0 1.8 2.8 2.7 2.3 3.1 34.2 36.5 1.6 2.0 1.5 0.9 1.2 7.6 0.5 5.6 4.4 0.0 1.6 5.7 52.4 17.7 0.5 0.4 2.3 2.5 2.2 1.2 1.6 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675469-117710727 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 17.9 20.2 13.0 22.4 14.4 19.6 22.5 12.8 15.7 60.8 16.6 20.0 16.7 20.8 28.6 15.9 18.6 16.2 11.8 13.8 14.7 28.7 31.9 18.4 21.6 12.6 13.8 13.0 16.6 20.6 30.0 12.0 21.8 13.0 20.8 20.5 12.6 30.7 17.7 10.1 11.2 17.7 18.9 13.1 18.0 24.4 12.7 14.2 18.6 35.7 12.7 20.7 23.8 11.8 13.5 27.1 19.5 41.3 46.4 40.7 52.9 101.0 48.3 50.1 39.5 45.1 44.6 29.5 63.4 51.1 44.7 50.0 24.0 62.1 47.2 73.0 47.9 57.0 72.8 31.5 80.2 62.6 92.8 41.2 46.6 52.5 43.3 87.7 40.3 41.3 46.5 88.4 54.9 59.7 30.5 43.9 58.8 48.0 36.9 35.3 41.7 29.7 45.7 79.0 26.6 48.7 38.5 29.1 37.4 36.9 45.6 23.8 95.9 36.4 24.3 30.1 39.2 70.5 75.6 60.8 66.8 57.6 70.0 49.7 1.9 1.3 0.8 1.3 1.4 1.9 1.1 1.6 1.8 1.5 1.0 1.3 1.7 0.1 1.9 2.5 3.8 1.7 1.0 13.0 14.4 12.8 15.7 13.8 14.7 12.6 13.8 13.0 13.0 13.1 14.2 13.5 18.7 0.0 22.3 30.3 28.5 60.5 41.9 32.6 19.4 15.3 26.6 13.7 6.3 15.7 24.0 25.8 10.4 26.8 38.1 26.4 27.4 23.4 16.0 15.7 28.9 24.3 13.1 19.1 33.4 30.2 63.6 22.8 38.2 21.4 31.1 15.8 28.2 39.7 35.3 15.2 37.1 29.3 20.3 37.0 42.2 14.0 18.0 30.2 32.0 20.6 28.4 8.3 24.7 35.7 36.5 37.4 22.7 20.3 57.5 73.1 18.6 33.6 23.1 9.6 6.6 21.3 25.9 24.9 25.4 25.7 56.1 57.9 26.2 14.5 26.1 77.5 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 48.2;thyroid gland: 45.8" "Cell type enhanced" "Detected in many" "Early spermatids: 157.4;Leydig cells: 52.5;Peritubular cells: 62.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 28.4;HaCaT: 28.7;TIME: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 120000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 3.2 2.9 6.4 1.0 2.3 0.0 5.9 1.6 4.7 5.7 0.0 2.8 1.8 2.4 2.7 1.7 5.1 1.8 2.2 6.3 4.1 3.9 1.1 3.7 3.4 2.2 5.0 4.1 1.9 0.7 0.2 0.5 0.7 2.8 8.4 3.4 2.3 4.4 1.9 0.0 2.4 3.4 1.5 2.4 48.2 3.3 3.9 3.3 0.3 45.8 0.9 1.4 3.1 0.8 3.6 0.0 0.0 12.1 0.0 0.0 0.0 0.5 7.6 8.2 8.8 4.2 0.0 0.0 0.0 2.2 28.4 0.2 28.7 3.1 0.0 5.8 0.0 5.8 0.0 3.1 0.0 0.1 0.0 0.0 0.1 0.0 1.5 7.2 10.1 13.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.6 7.5 2.1 8.9 6.8 2.8 0.0 0.1 1.1 0.0 0.0 0.4 13.8 0.4 0.0 44.2 0.0 2.7 0.4 0.0 5.4 3.4 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 2.3 1.6 4.7 6.3 4.1 2.2 5.0 4.1 2.8 2.4 3.3 3.6 2.8 0.0 3.3 18.3 1.8 3.6 2.4 0.1 0.0 2.6 0.8 8.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 157.4 1.6 0.3 14.8 26.5 0.0 12.3 0.2 0.0 15.3 0.0 4.3 2.5 0.2 2.9 0.0 1.3 1.7 5.1 0.7 2.0 0.0 5.7 23.3 52.5 0.5 12.4 19.7 0.0 1.9 0.0 3.0 0.9 0.0 0.0 62.4 0.0 5.8 1.9 4.7 0.8 4.1 0.0 0.7 2.0 0.7 0.8 0.1 2.4 0.0 0.5 11.2 1.0 0.4 PPP2R5E "B56E, B56epsilon" ENSG00000154001 "Protein phosphatase 2 regulatory subunit B'epsilon" Q16537 14 63371364-63543377 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 283.4;Horizontal cells: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006034, CAB072342" Approved Supported Cytosol NA NA Cytosol "CAB072342: , HPA006034: AB_1079670" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (2.26e-1)" "unprognostic (2.91e-1)" "unprognostic (1.57e-2)" "unprognostic (1.70e-2)" "unprognostic (4.62e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.23e-1)" "unprognostic (9.51e-2)" "unprognostic (1.92e-1)" "unprognostic (8.22e-2)" 12.8 12.6 8.5 13.7 11.4 14.6 12.7 10.6 11.2 14.7 7.9 17.2 10.8 15.0 10.3 20.0 11.8 12.1 15.8 10.5 10.4 14.8 15.9 12.8 15.5 8.1 8.3 9.3 12.7 11.0 17.7 6.7 16.1 8.0 12.9 20.2 26.9 9.3 12.7 18.0 11.9 12.4 15.2 6.8 14.4 12.1 14.4 9.7 19.3 20.4 16.7 17.1 17.3 9.9 9.2 90.5 26.0 46.7 22.1 31.6 37.0 44.5 37.1 30.4 39.5 39.1 33.1 35.4 39.6 22.1 38.1 29.3 36.2 48.1 34.4 67.8 36.2 11.8 25.7 18.1 27.7 33.7 41.7 30.4 27.1 37.7 38.8 42.7 28.8 40.2 39.8 33.3 41.9 43.8 60.2 41.8 18.7 35.3 37.7 46.8 41.9 47.8 30.1 38.2 68.1 26.5 51.6 47.7 39.1 25.0 40.1 57.4 20.8 37.8 61.7 68.6 31.7 33.0 15.2 24.4 50.9 28.4 26.3 42.7 1.4 1.3 1.3 2.0 1.4 1.9 1.1 2.2 2.5 1.2 1.7 1.7 1.9 1.0 4.5 1.9 1.9 1.4 0.6 8.5 11.4 10.6 11.2 10.5 10.4 8.1 8.3 9.3 8.0 6.8 9.7 9.2 52.1 89.8 55.5 54.2 52.8 80.4 56.9 34.0 60.3 65.0 49.3 27.8 61.7 44.3 35.3 22.0 64.6 27.2 54.8 55.0 29.4 46.4 283.4 65.1 57.2 52.5 27.1 41.2 110.4 47.7 41.5 44.8 33.1 74.6 24.1 48.6 41.0 45.1 29.8 262.5 131.6 51.6 28.5 38.7 49.0 46.6 43.8 42.3 37.4 59.0 49.7 38.4 61.8 93.5 91.8 41.4 48.1 43.2 55.9 58.5 24.9 41.2 41.6 81.2 26.3 51.5 71.1 74.9 22.5 63.1 91.6 30.6 57.0 47.8 70.2 46.9 ASB17 ENSG00000154007 "Ankyrin repeat and SOCS box containing 17" Q8WXJ9 1 75918873-75932404 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 50.4" "Group enriched" "Detected in some" 69 "Early spermatids: 1043.0;Late spermatids: 301.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1043.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 301.3 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 9.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRAP ENSG00000154016 "GRB2 related adaptor protein" Q13588 17 19020656-19047011 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell type enhanced" "Detected in some" "Adipocytes: 11.2;B-cells: 21.2;Endothelial cells: 19.8;Hepatic stellate cells: 30.7;Microglial cells: 9.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 99.7;T-cells: 133.6" "Cell line enhanced" "Detected in some" "Daudi: 87.1;HUVEC TERT2: 38.9;JURKAT: 30.1;REH: 47.8;TIME: 70.4;U-698: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046595, HPA066654" Uncertain Approved Centrosome NA NA 1400000 Centrosome "HPA046595: AB_10966385, HPA066654: AB_2685699" "unprognostic (3.02e-1)" "unprognostic (6.85e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (3.43e-2)" "unprognostic (3.86e-6)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (4.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (5.11e-2)" "unprognostic (2.67e-5)" "unprognostic (2.25e-1)" "unprognostic (1.57e-2)" "unprognostic (2.16e-1)" "unprognostic (5.77e-3)" 6.0 3.5 6.1 14.0 5.4 6.6 6.0 5.3 7.0 3.7 4.5 2.2 1.9 3.3 0.5 1.8 4.6 5.3 2.9 5.0 5.3 4.9 6.0 7.2 37.2 6.0 5.6 4.4 1.8 0.9 0.6 1.9 6.2 5.8 2.7 1.8 0.4 1.6 3.7 1.7 2.1 15.9 3.4 5.5 37.8 2.2 6.4 6.6 32.2 5.5 1.4 30.9 3.6 2.2 6.0 0.0 0.2 4.5 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.1 0.0 87.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 5.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 38.9 30.1 0.2 0.0 0.0 0.2 19.9 1.9 0.9 0.0 0.0 47.8 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 6.8 70.4 0.0 0.2 9.8 0.1 0.1 0.0 60.2 0.1 0.1 0.3 21.5 9.4 1.3 21.5 4.8 21.5 99.7 67.4 28.4 10.5 82.7 133.6 66.5 2.9 21.4 0.4 7.9 62.3 48.9 6.1 5.4 5.3 7.0 5.0 5.3 6.0 5.6 4.4 5.8 5.5 6.6 6.0 11.2 6.4 1.8 0.0 21.2 1.0 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.6 0.0 0.0 0.1 3.1 0.0 0.0 0.3 2.3 1.1 0.2 19.8 0.0 4.0 0.0 0.0 0.7 0.4 0.0 1.2 2.5 0.1 30.7 0.8 8.2 0.0 0.0 0.4 0.0 4.4 0.7 0.8 0.0 1.9 0.0 9.4 2.9 0.2 2.1 0.0 0.1 0.2 0.0 0.4 3.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.3 0.7 0.3 0.0 1.0 0.3 6.9 0.5 0.3 0.0 SLC5A10 SGLT5 ENSG00000154025 "Solute carrier family 5 member 10" A0PJK1 17 18950345-19022595 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "kidney: 42.0" "Group enriched" "Detected in some" 5 "Late spermatids: 33.7;Proximal tubular cells: 76.9" "Cancer enriched" "Detected in some" 11 "renal cancer: 6.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 1.8;non-classical monocyte: 4.8" "Lineage enriched" "Detected in single" 7 "monocytes: 4.8" "Cell line enriched" "Detected in some" 5 "U-937: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052014 Uncertain NA NA "HPA052014: AB_2681694" "unprognostic (3.74e-1)" "unprognostic (2.92e-1)" "unprognostic (3.04e-2)" "unprognostic (6.11e-2)" "unprognostic (6.56e-2)" "unprognostic (3.36e-4)" "unprognostic (7.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.52e-1)" "unprognostic (8.94e-2)" "unprognostic (3.24e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-2)" "unprognostic (2.61e-2)" "unprognostic (2.75e-2)" "unprognostic (2.11e-1)" 0.2 0.2 0.1 0.6 0.1 2.4 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.6 0.0 0.0 42.0 0.5 0.4 0.9 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.9 1.4 0.0 0.0 3.5 0.1 0.5 0.2 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 1.4 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.8 0.3 8.8 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.6 0.0 0.0 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 33.7 0.0 0.5 1.8 0.0 0.1 0.0 0.0 1.0 0.3 0.5 0.0 0.0 0.7 0.1 0.0 76.9 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.3 0.3 0.6 0.0 0.0 0.0 AK5 ENSG00000154027 "Adenylate kinase 5" Q9Y6K8 1 77282019-77559966 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 127.2" "Cell type enhanced" "Detected in many" "Early spermatids: 150.5;Excitatory neurons: 403.7;Inhibitory neurons: 167.3;Oligodendrocytes: 706.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 13.6;naive CD4 T-cell: 16.3" "Group enriched" "Detected in many" 12 "dendritic cells: 13.6;T-cells: 16.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 93.7;BJ: 67.8;fHDF/TERT166: 77.5;LHCN-M2: 189.9;U-2 OS: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019128, HPA057255" Enhanced Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA019128: AB_1844682, HPA057255: AB_2683383" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (1.13e-1)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (6.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.91e-2)" "prognostic favorable (3.88e-4)" "unprognostic (3.56e-3)" "unprognostic (6.17e-4)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (6.76e-2)" 1.0 1.6 84.6 1.5 102.8 3.9 19.1 27.3 105.4 1.3 10.3 1.8 1.1 0.7 0.6 1.0 1.0 1.0 0.8 127.2 48.7 1.4 0.1 0.4 2.3 55.8 40.5 106.5 0.5 1.6 0.7 3.4 1.2 50.6 2.4 1.0 3.0 3.0 2.1 0.3 2.0 1.0 0.8 35.8 2.1 2.4 9.5 41.1 0.8 1.1 0.8 1.5 0.7 0.7 93.3 0.2 3.6 2.9 0.1 34.8 93.7 1.2 67.8 14.4 10.8 4.6 0.5 1.7 0.6 0.5 77.5 4.4 0.4 0.2 0.0 5.5 2.6 0.7 0.5 1.2 0.4 1.8 0.6 0.2 11.6 0.5 2.1 4.3 37.9 31.5 0.3 0.9 0.7 189.9 0.7 0.0 0.6 3.9 18.4 24.5 1.7 7.1 1.6 29.3 1.1 15.3 3.5 0.2 0.2 4.4 0.3 0.3 0.5 7.9 26.1 58.4 1.6 2.2 15.2 14.7 0.3 5.2 3.5 9.8 1.2 0.8 0.1 3.8 0.2 0.5 0.9 3.6 1.9 13.6 0.9 16.3 9.1 0.6 0.2 0.2 1.5 1.7 2.3 84.6 102.8 27.3 105.4 127.2 48.7 55.8 40.5 106.5 50.6 35.8 41.1 93.3 0.7 0.0 0.0 10.7 0.4 0.3 0.4 0.0 1.2 1.3 54.0 27.3 1.1 0.0 0.0 1.8 0.0 1.9 5.6 0.3 7.9 0.3 150.5 1.1 0.1 1.3 12.0 0.8 403.7 0.6 56.3 1.5 1.1 1.7 0.0 0.0 0.4 0.0 2.4 13.5 167.3 0.3 0.0 0.0 0.6 29.2 1.2 0.4 3.6 41.2 1.9 0.0 47.4 60.8 706.6 0.1 1.1 0.7 0.1 2.9 0.0 7.8 0.0 0.3 0.0 1.2 6.3 10.2 91.0 0.0 0.3 2.9 4.2 0.1 0.2 0.1 CABYR "CBP86, CT88, FSP-2" ENSG00000154040 "Calcium binding tyrosine phosphorylation regulated" O75952 18 24138987-24161600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 28 "testis: 305.9" "Group enriched" "Detected in many" 18 "Early spermatids: 2505.6;Late spermatids: 3543.7" "Cancer enhanced" "Detected in many" "testis cancer: 8.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.8;memory B-cell: 4.7;naive B-cell: 5.0;neutrophil: 1.9" "Group enriched" "Detected in many" 6 "B-cells: 5.0;granulocytes: 4.8" "Cell line enhanced" "Detected in many" "SiHa: 26.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040703, HPA047801" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040703: AB_2677087, HPA047801: AB_2680159" "unprognostic (1.18e-3)" "unprognostic (4.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "unprognostic (5.26e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (7.24e-3)" "unprognostic (1.58e-1)" "unprognostic (3.21e-4)" "unprognostic (2.52e-2)" "unprognostic (5.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 1.4 3.4 6.2 1.2 6.7 1.1 5.3 3.8 10.0 6.8 9.4 1.2 1.0 2.9 2.0 1.7 3.7 1.8 0.8 9.8 5.0 0.8 1.1 1.0 1.2 7.1 5.5 6.4 1.8 0.7 0.4 8.3 0.9 8.5 2.4 1.1 5.7 2.1 1.6 1.0 2.1 1.2 3.6 4.8 1.2 1.5 305.9 5.5 1.5 1.0 0.1 1.0 2.4 1.4 11.0 4.9 11.9 3.4 1.7 3.4 9.1 14.7 8.2 5.4 10.2 10.6 2.5 9.2 0.2 6.8 12.6 0.5 4.5 3.4 6.9 10.7 0.6 5.6 0.3 6.9 2.3 4.8 0.4 0.5 11.2 11.1 12.7 3.3 4.8 2.9 0.6 0.0 0.3 2.6 1.4 0.1 0.4 11.3 0.5 7.4 0.7 0.4 0.2 4.2 5.5 7.2 8.3 26.8 5.2 0.5 2.0 11.3 1.2 1.7 0.8 2.3 3.4 0.2 0.3 0.3 0.1 4.7 0.9 0.5 4.8 0.3 0.6 0.2 0.2 0.1 4.7 0.3 0.3 0.1 5.0 0.3 0.6 1.9 0.8 0.4 0.4 0.2 0.4 6.2 6.7 3.8 10.0 9.8 5.0 7.1 5.5 6.4 8.5 4.8 5.5 11.0 1.1 0.0 0.0 1.6 1.0 0.3 0.9 7.2 1.2 2.0 3.1 7.1 0.8 0.0 1.9 0.0 2.1 0.2 0.3 2.2 0.0 0.8 2505.6 76.2 3.3 2.0 0.0 0.4 10.7 0.2 0.5 0.9 0.0 5.1 0.0 0.9 0.4 0.0 0.6 0.0 9.9 1.9 6.1 0.0 0.7 3543.7 23.3 2.4 1.8 2.8 0.0 0.0 1.0 7.5 12.6 0.4 1.3 21.8 0.0 0.1 0.2 0.1 2.8 2.1 19.7 0.7 2.0 166.3 19.1 0.5 0.0 0.0 0.5 0.9 0.4 0.3 IMPACT RWDD5 ENSG00000154059 "Impact RWD domain protein" Q9P2X3 18 24426634-24453531 "Predicted intracellular proteins" "Differentiation, Neurogenesis, Stress response, Translation regulation" "Actin-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 65.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 65.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041045, HPA041968" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041045: AB_10793866, HPA041968: AB_10795603" "unprognostic (1.13e-1)" "unprognostic (8.59e-2)" "unprognostic (1.15e-2)" "unprognostic (1.62e-1)" "unprognostic (5.12e-2)" "unprognostic (7.94e-2)" "unprognostic (3.29e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-2)" "unprognostic (2.15e-1)" "unprognostic (8.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (7.90e-4)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "unprognostic (1.99e-3)" "unprognostic (5.60e-3)" 19.5 21.2 11.3 12.2 11.7 15.9 25.3 11.8 10.5 15.6 10.2 18.1 16.2 16.6 19.1 21.9 14.3 12.8 19.5 8.9 17.1 24.6 22.5 15.8 11.6 13.4 12.8 8.3 17.2 20.7 28.0 10.0 15.1 12.6 18.2 15.1 10.2 25.2 16.1 20.5 11.5 16.7 13.1 12.3 15.4 16.0 34.8 18.9 11.3 32.8 13.3 12.1 12.8 8.1 13.9 27.8 15.6 26.4 33.0 25.2 37.8 43.1 36.4 43.1 20.1 19.9 5.4 23.8 16.7 35.8 38.9 12.4 31.9 9.1 40.3 29.7 0.1 8.2 24.9 14.9 8.8 38.0 99.0 23.1 33.0 30.6 13.4 82.1 24.2 38.7 0.0 21.2 0.2 33.6 25.6 0.2 17.5 44.0 48.8 17.1 0.1 51.6 8.4 22.0 43.2 21.8 26.9 51.6 22.6 37.7 20.8 31.9 33.2 48.0 80.5 10.4 15.3 15.6 31.0 43.0 0.3 32.4 12.3 35.5 65.8 9.6 18.4 4.2 12.2 5.6 4.0 5.5 4.1 12.3 5.3 5.6 4.7 1.5 9.0 9.0 8.5 8.0 6.0 11.3 11.7 11.8 10.5 8.9 17.1 13.4 12.8 8.3 12.6 12.3 18.9 13.9 20.8 19.2 14.9 11.1 10.9 11.3 11.5 23.5 18.2 11.3 34.6 26.0 30.4 17.2 22.9 14.7 2.1 30.7 11.0 10.8 37.2 19.5 17.2 21.2 24.2 18.8 15.6 23.3 7.6 22.4 20.2 20.1 16.8 13.7 20.3 43.3 15.0 33.5 26.4 5.0 13.7 25.6 26.4 19.8 10.4 21.0 16.1 21.6 19.6 5.6 25.3 41.7 7.2 10.1 9.9 20.2 7.1 27.1 11.1 15.1 17.3 47.8 25.4 11.0 13.1 15.3 21.0 83.9 75.6 27.0 14.5 16.4 10.3 52.5 21.9 10.2 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 163.8;Alveolar cells type 1: 218.0;Cone photoreceptor cells: 66.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.7;BJ hTERT+: 16.6;hTCEpi: 16.2;PC-3: 15.5;U-2197: 20.5;U-87 MG: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favorable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favorable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favorable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 17.5 7.3 14.2 3.6 6.3 0.2 15.9 9.6 13.5 11.9 10.4 4.1 1.5 15.9 5.3 9.5 13.9 5.6 6.2 12.8 9.5 3.0 2.0 31.6 20.3 10.6 13.8 5.8 14.6 1.0 25.0 8.2 0.1 11.6 8.3 2.2 5.0 7.6 8.9 4.4 4.2 6.7 11.8 6.2 2.6 15.2 3.7 9.5 3.8 3.4 3.9 14.4 6.7 13.2 10.1 2.4 6.7 0.0 0.0 1.6 16.7 0.1 6.6 16.6 2.6 3.3 3.0 0.6 0.0 0.9 3.2 12.9 3.4 0.0 8.7 0.6 0.2 5.9 0.0 4.3 0.2 0.3 0.0 0.5 4.4 16.2 2.6 4.4 2.4 1.7 0.0 0.0 0.4 4.4 0.7 0.0 0.0 1.2 5.7 15.5 0.0 0.4 1.5 4.1 2.4 1.0 8.0 1.7 0.3 0.1 0.3 1.9 0.1 3.9 0.4 2.3 20.5 6.0 0.0 0.0 0.0 21.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 14.2 6.3 9.6 13.5 12.8 9.5 10.6 13.8 5.8 11.6 6.2 9.5 10.1 163.8 218.0 38.7 27.4 0.2 5.1 10.1 5.0 5.2 6.0 5.1 16.6 9.7 8.6 6.3 1.8 66.7 0.0 1.1 0.3 5.9 2.5 40.0 10.2 18.7 39.0 1.8 0.4 22.1 1.1 0.0 6.6 25.5 0.8 3.8 9.7 15.4 0.9 2.3 42.1 27.6 1.7 0.0 0.8 3.3 25.2 7.2 3.6 7.2 22.5 0.2 1.3 0.0 8.5 1.3 11.4 1.2 20.3 1.5 5.1 11.5 10.1 1.6 4.3 13.1 12.1 40.6 2.3 2.6 20.1 2.8 0.0 0.8 21.5 2.5 3.6 SDHAF4 "C6orf57, Sdh8" ENSG00000154079 "Succinate dehydrogenase complex assembly factor 4" Q5VUM1 6 70566917-70589569 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031824 Supported Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA031824: AB_10602113" "unprognostic (8.72e-2)" "unprognostic (1.64e-1)" "unprognostic (4.95e-2)" "unprognostic (9.96e-2)" "unprognostic (4.58e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (3.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.95e-5)" "unprognostic (2.45e-2)" "unprognostic (9.37e-2)" "unprognostic (3.05e-1)" "unprognostic (9.94e-2)" 10.0 12.4 6.6 4.3 7.3 4.3 10.6 6.5 10.6 6.4 6.8 6.7 5.1 5.8 9.4 7.6 10.4 4.2 13.4 7.1 8.4 12.6 8.6 5.4 6.0 6.9 6.0 7.0 6.5 6.7 14.5 12.8 6.8 7.1 7.6 6.7 10.1 8.8 5.4 23.8 8.6 5.4 4.2 5.4 5.7 7.1 5.4 7.6 6.4 7.4 10.7 5.3 6.8 6.7 7.7 13.3 4.2 18.8 11.6 9.0 13.6 3.5 7.1 5.1 3.4 5.0 3.8 11.3 9.1 12.7 3.8 8.0 2.3 6.2 5.9 5.2 18.3 4.3 6.6 1.8 3.9 15.3 6.3 5.1 9.6 19.3 2.6 14.8 11.6 8.0 14.8 4.2 13.9 11.0 9.0 5.9 15.7 8.8 6.5 4.5 6.4 12.6 10.8 14.9 4.4 16.8 12.1 4.3 2.1 9.6 8.0 9.6 16.5 6.3 3.5 2.7 2.8 7.7 6.2 4.5 3.1 3.9 15.1 8.5 4.0 4.6 4.4 3.4 4.3 3.3 3.7 3.7 4.1 5.1 4.7 3.9 3.8 3.3 4.7 4.6 6.2 4.2 3.0 6.6 7.3 6.5 10.6 7.1 8.4 6.9 6.0 7.0 7.1 5.4 7.6 7.7 5.4 12.8 13.9 4.9 3.3 0.0 7.9 0.0 3.4 7.4 6.5 7.5 21.3 10.0 5.6 7.3 8.4 10.5 5.0 2.9 23.5 9.1 5.5 20.2 8.2 5.0 3.6 2.5 7.7 11.6 8.5 6.6 2.6 6.0 5.1 6.1 4.2 11.8 10.0 18.5 7.5 5.8 0.0 5.3 0.0 2.5 12.5 6.2 0.0 2.8 10.1 10.1 3.1 12.1 7.7 13.2 5.3 6.8 2.2 9.5 6.2 16.8 13.8 6.4 13.1 5.1 4.9 10.0 6.1 5.7 0.0 5.1 3.9 6.1 5.3 8.0 CHST9 "GALNAC-4-ST2, GALNAC4ST-2" ENSG00000154080 "Carbohydrate sulfotransferase 9" Q7L1S5 18 26906481-27185308 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 13.9" "Cell type enhanced" "Detected in many" "Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA011393 Uncertain "Intracellular and membrane" NA NA "HPA011393: AB_1846733" "unprognostic (9.24e-3)" "unprognostic (1.13e-2)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (4.53e-3)" "unprognostic (9.98e-3)" "unprognostic (9.21e-3)" "unprognostic (7.92e-2)" "unprognostic (1.61e-1)" "unprognostic (2.04e-2)" "unprognostic (3.54e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (3.93e-3)" 0.0 0.2 1.5 0.1 1.0 0.0 2.9 1.0 2.5 2.8 0.0 1.1 0.2 0.1 0.4 1.6 10.4 3.1 1.6 2.8 4.0 1.6 8.2 4.3 0.0 3.0 1.9 0.6 0.0 9.3 0.0 1.9 0.0 1.4 3.6 0.2 7.4 13.9 1.8 0.2 0.1 0.3 0.1 2.2 5.7 0.7 7.0 1.5 1.1 0.0 0.9 0.7 1.5 0.7 2.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 41.8 0.0 9.0 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 1.0 2.5 2.8 4.0 3.0 1.9 0.6 1.4 2.2 1.5 2.0 0.1 0.0 2.7 24.8 0.0 0.6 32.6 56.6 4.6 1.3 8.2 8.0 9.2 35.8 115.2 5.5 0.0 0.4 0.1 0.0 11.7 13.0 7.1 49.9 0.7 0.3 3.5 0.0 10.1 0.6 0.1 4.2 0.0 1.8 5.1 0.1 0.0 10.7 0.3 0.0 29.3 0.1 22.4 0.0 0.0 4.4 0.6 0.5 7.2 1.0 0.0 69.2 0.0 167.4 1.0 1.3 0.0 0.4 0.0 8.9 0.0 0.3 311.6 3.2 0.0 3.2 3.7 0.9 1.3 4.7 0.0 0.3 0.4 0.0 0.0 40.3 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119415476-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 310.2;smooth muscle: 307.4;urinary bladder: 218.8" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 14000000 Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 91.4 16.5 121.4 79.3 140.1 0.2 25.8 34.9 310.2 79.6 6.0 29.6 10.3 59.1 28.0 29.6 23.3 101.9 13.1 165.2 97.6 143.6 7.4 21.8 40.7 103.7 65.1 130.6 9.3 14.9 39.7 18.2 62.5 102.1 15.6 42.2 25.5 8.6 47.5 3.4 12.7 14.6 307.4 40.8 22.1 17.5 11.5 81.8 73.9 38.2 8.4 35.9 218.8 21.9 192.0 0.7 3.9 108.5 0.1 461.3 331.5 0.3 738.4 832.5 263.6 289.3 0.2 0.2 0.4 0.1 1330.6 121.9 0.9 4.3 1.1 200.7 65.1 0.0 41.5 14.4 0.0 142.7 0.0 0.2 247.5 0.0 335.6 11.6 355.2 0.3 22.6 0.0 0.6 206.5 0.1 0.6 0.1 173.9 0.0 1.4 0.5 50.7 0.3 0.1 0.2 18.1 47.9 0.1 0.4 0.2 32.9 1.0 2.1 0.0 368.6 120.9 107.3 110.1 0.3 19.7 0.4 1.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.4 140.1 34.9 310.2 165.2 97.6 103.7 65.1 130.6 102.1 40.8 81.8 192.0 68.2 0.0 1.8 17.3 2.1 17.7 0.3 1.7 0.0 27.2 1.6 40.0 0.9 0.0 0.0 9.2 0.0 1.9 0.2 0.0 21.5 0.9 1.0 5.1 141.6 69.2 0.0 0.0 116.0 0.0 2.6 201.9 1.5 3.2 1.3 0.0 17.5 0.1 4.0 32.0 104.1 0.0 0.0 0.0 25.0 2.7 96.3 2.7 17.8 21.5 0.0 108.1 0.0 64.3 22.7 0.4 0.0 77.5 0.1 0.3 0.0 199.9 0.0 27.5 32.9 9.3 226.6 0.3 0.6 0.2 17.6 4.0 4.5 6.2 0.0 0.6 DNAAF1 "CILD13, DAU1, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 22.9;testis: 45.7" "Cell type enhanced" "Detected in many" "Early spermatids: 116.2;Endometrial ciliated cells: 311.3;Plasma cells: 225.4;Respiratory ciliated cells: 494.5;Spermatocytes: 116.2" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 3.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 2.3" "Group enriched" "Detected in many" 4 "granulocytes: 2.3;T-cells: 1.0" "Cell line enhanced" "Detected in some" "Hep G2: 1.7;Karpas-707: 4.9;PC-3: 1.4;SK-BR-3: 1.4;U-266/70: 4.0;U-266/84: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: AB_2732250" "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favorable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.3 0.7 2.3 0.1 1.5 1.3 0.3 2.2 1.9 1.3 8.2 0.3 0.0 0.5 1.4 0.4 22.9 0.0 0.3 1.3 2.2 1.0 0.8 3.6 0.0 3.7 5.5 0.9 0.4 0.3 0.3 2.4 0.2 4.1 0.2 0.0 0.4 0.1 0.2 0.2 0.1 0.1 0.0 3.3 0.7 0.2 45.7 2.5 0.0 1.6 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 4.0 2.8 0.4 0.1 0.0 0.0 1.3 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.3 0.3 0.1 0.4 1.0 0.3 2.3 1.5 2.2 1.9 1.3 2.2 3.7 5.5 0.9 4.1 3.3 2.5 1.2 1.1 0.0 12.4 1.6 5.7 0.6 1.5 9.6 0.0 1.4 4.5 1.5 0.7 1.5 67.2 3.7 54.2 0.2 0.5 0.1 0.0 1.3 116.2 311.3 4.4 1.9 0.0 0.0 9.6 0.4 0.4 2.4 0.5 14.6 3.8 2.6 2.2 0.6 1.9 0.0 5.2 0.0 18.3 7.0 1.5 26.7 1.2 21.6 87.2 0.0 0.8 2.4 1.0 0.5 0.6 0.9 0.0 0.4 225.4 1.4 0.0 1.7 494.5 51.0 0.0 1.6 7.3 116.2 17.0 0.2 0.3 0.4 4.5 1.2 0.3 0.9 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.9" "Cell type enhanced" "Detected in many" "B-cells: 47.4;Basal prostatic cells: 56.7;Bipolar cells: 55.8;Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 87.8;Syncytiotrophoblasts: 74.3;Urothelial cells: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 96.1;hTCEpi: 80.8;T-47d: 84.5" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA049367: AB_2680730" "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 3.4 0.7 6.9 4.4 7.0 9.0 6.6 5.4 11.6 7.0 6.0 2.7 1.4 1.5 2.0 9.5 1.5 2.2 2.1 10.0 6.1 2.5 1.1 2.2 8.5 7.1 6.6 6.5 0.8 1.9 7.5 1.3 6.8 5.9 9.3 1.1 27.9 4.3 7.4 0.5 8.1 5.6 0.9 5.0 16.2 2.9 2.1 6.0 1.4 5.1 0.3 6.4 17.3 14.6 6.4 35.3 11.5 0.4 4.7 5.1 5.6 14.1 4.2 5.6 13.1 3.7 8.9 32.1 0.3 47.2 3.3 5.5 49.4 2.0 96.1 7.4 0.0 7.6 0.0 5.3 0.9 13.9 1.0 0.0 12.2 80.8 12.6 54.7 9.8 43.4 5.8 0.0 0.2 0.4 29.6 0.0 54.0 2.9 37.7 32.6 1.4 0.0 2.8 0.1 39.5 10.7 2.8 17.5 8.9 9.1 3.6 84.5 14.9 44.8 8.4 22.0 3.8 12.7 11.7 9.3 40.0 0.0 12.6 1.7 0.1 16.8 21.8 1.3 6.3 4.4 46.7 8.8 7.0 18.3 49.4 14.5 9.3 6.6 7.8 2.0 0.3 18.0 10.8 6.9 7.0 5.4 11.6 10.0 6.1 7.1 6.6 6.5 5.9 5.0 6.0 6.4 10.1 3.2 1.1 6.5 47.4 9.3 56.7 23.8 8.0 55.8 19.0 20.3 1.8 1.5 9.8 1.8 58.4 45.8 3.4 0.1 3.9 3.0 1.7 4.4 4.6 7.2 0.0 0.8 0.4 1.1 19.7 5.7 1.5 4.1 0.0 0.5 2.5 0.0 5.0 15.2 0.4 0.0 8.2 1.2 2.9 0.4 3.4 2.5 19.6 1.0 5.2 18.8 4.1 1.5 0.8 3.2 0.0 3.4 44.2 36.5 0.0 2.4 3.9 87.8 0.0 0.3 2.5 0.9 8.4 8.5 7.0 74.3 3.7 1.5 0.2 55.7 TBCEL "LRRC35, MGC10233" ENSG00000154114 "Tubulin folding cofactor E like" Q5QJ74 11 121024072-121090775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 104.0;Oligodendrocytes: 39.4;Plasma cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA038593, HPA038594" Approved Uncertain Cytosol NA NA 22000 Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" "unprognostic (9.06e-3)" "unprognostic (3.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.29e-1)" "unprognostic (5.80e-2)" "unprognostic (3.13e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.27e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.07e-3)" "unprognostic (1.86e-1)" "unprognostic (1.66e-2)" "unprognostic (1.02e-1)" 7.5 7.7 11.9 6.0 13.7 5.7 9.1 15.1 11.0 7.3 13.5 6.7 5.5 8.6 9.7 5.8 6.3 7.8 9.9 9.0 13.1 8.4 15.2 9.7 7.5 11.1 10.9 6.3 9.3 6.3 16.6 8.0 10.9 10.4 9.1 5.9 8.4 7.2 12.4 6.1 5.1 5.8 9.6 11.4 8.5 6.1 14.9 11.6 7.3 10.4 8.3 7.5 6.6 4.8 14.1 6.2 5.8 9.8 8.5 17.5 16.5 7.5 11.5 14.2 8.7 12.7 6.0 9.7 7.6 17.3 14.3 8.4 1.6 10.8 3.8 11.4 9.1 8.0 13.2 4.5 6.0 21.6 9.4 8.8 18.2 12.8 8.4 9.1 8.8 14.4 4.3 3.9 14.3 12.3 4.2 3.9 7.8 5.8 0.2 5.6 3.3 14.3 3.5 11.7 3.8 5.2 12.0 11.3 11.7 7.9 8.3 11.3 7.9 18.9 19.2 4.2 7.8 6.4 5.5 4.3 4.0 2.7 0.1 7.3 0.0 0.2 0.1 0.3 0.3 0.4 0.1 0.4 0.4 0.2 0.2 0.4 0.3 0.1 0.6 0.2 0.4 0.2 0.2 11.9 13.7 15.1 11.0 9.0 13.1 11.1 10.9 6.3 10.4 11.4 11.6 14.1 9.4 6.4 11.3 15.7 7.8 2.9 1.8 2.0 2.8 9.0 4.4 2.9 10.3 7.2 1.7 7.3 14.6 1.7 3.4 2.0 1.9 4.7 11.3 9.3 8.2 8.0 3.6 104.0 34.1 2.6 1.9 7.0 1.5 3.7 1.3 6.7 13.2 20.7 3.1 8.4 32.9 2.5 4.1 6.7 2.8 5.8 9.3 4.3 10.6 20.6 10.1 5.5 6.2 36.2 39.4 3.3 1.0 9.8 42.7 2.7 2.0 4.3 8.4 9.2 0.0 14.8 6.0 14.9 6.0 3.7 1.7 1.4 3.7 6.8 2.3 1.2 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 60.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 0.1 1.3 16.8 0.2 23.4 0.0 0.1 1.0 60.0 0.5 0.0 0.9 0.1 0.2 0.0 0.6 0.4 0.0 0.1 43.1 7.5 0.0 0.1 0.1 0.0 8.1 6.0 24.9 0.1 0.3 0.0 14.2 0.0 10.8 0.2 0.0 1.8 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.1 0.5 1.4 2.0 0.0 0.1 0.0 0.0 0.1 0.3 21.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.0 0.0 0.9 0.0 1.2 0.0 0.0 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.5 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.2 5.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 23.4 1.0 60.0 43.1 7.5 8.1 6.0 24.9 10.8 0.1 2.0 21.0 0.0 0.0 0.0 2.3 0.1 0.0 0.2 0.0 0.0 24.4 0.0 0.0 3.7 0.0 0.0 0.0 22.9 0.0 0.0 0.1 0.0 0.0 41.1 0.0 0.0 0.8 0.0 0.0 33.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.1 50.5 28.7 0.0 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.0 1.3 0.0 10.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.2 0.1 1.1 3.7 0.0 0.0 0.1 0.1 0.5 0.0 0.1 ANKH "ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1" ENSG00000154122 "ANKH inorganic pyrophosphate transport regulator" Q9HCJ1 5 14704800-14871778 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Phosphate transport, Transport" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 160.1;Hofbauer cells: 208.8;Inhibitory neurons: 214.5;Oligodendrocytes: 261.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068104 Approved Cytosol NA NA Cytosol "HPA068104: AB_2685954" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (6.58e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.83e-2)" "unprognostic (2.11e-1)" "unprognostic (2.38e-2)" "unprognostic (2.99e-1)" "unprognostic (1.54e-3)" "unprognostic (1.76e-3)" "unprognostic (1.71e-1)" "unprognostic (8.66e-2)" "unprognostic (6.46e-2)" 10.0 10.7 25.8 6.6 25.7 8.0 10.0 35.7 31.3 5.6 27.6 12.9 17.0 7.2 5.0 7.4 7.7 9.5 32.5 24.2 27.2 8.2 21.6 7.2 8.6 27.3 28.0 23.9 16.2 15.3 19.3 23.0 8.6 27.7 33.0 11.5 25.3 14.4 9.3 41.2 20.5 15.2 8.5 27.9 6.9 7.4 1.9 28.8 11.6 10.8 37.9 14.2 7.4 7.4 30.7 7.2 5.4 6.7 1.1 13.8 32.3 3.2 6.8 13.7 2.6 2.7 4.3 9.0 16.9 15.7 9.4 6.2 4.6 4.6 7.5 3.0 6.7 11.3 0.4 47.8 11.6 4.6 4.1 1.3 10.2 13.0 8.1 9.2 9.2 5.5 12.3 3.5 35.2 8.7 9.6 6.9 13.3 2.6 9.5 6.0 9.8 3.3 15.3 0.0 2.3 16.4 4.5 33.3 5.3 7.5 6.1 0.3 1.5 5.4 6.9 6.9 11.5 12.6 9.2 9.3 13.0 23.8 15.1 29.0 0.6 0.2 0.0 1.4 0.4 2.3 1.5 2.9 2.3 0.3 1.6 3.3 1.5 0.3 0.3 0.9 0.3 4.6 0.4 25.8 25.7 35.7 31.3 24.2 27.2 27.3 28.0 23.9 27.7 27.9 28.8 30.7 50.1 25.6 19.1 64.6 15.4 25.2 79.1 33.7 40.9 58.0 29.7 15.5 73.4 7.2 10.8 7.3 127.2 76.4 21.1 58.2 5.9 1.7 1.2 7.1 14.9 25.4 41.8 69.9 160.1 11.8 6.1 25.6 8.2 16.9 17.7 9.8 12.5 32.7 208.8 20.2 214.5 37.7 8.2 89.3 29.9 1.9 5.0 42.6 10.6 106.8 3.4 20.1 21.6 95.5 261.5 6.8 31.4 31.6 14.7 55.4 44.6 10.2 6.4 50.1 0.0 32.8 12.3 2.3 7.2 10.1 10.7 42.0 25.9 8.6 37.3 22.3 OTULIN "FAM105B, FLJ34884" ENSG00000154124 "OTU deubiquitinase with linear linkage specificity" Q96BN8 5 14664664-14699850 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 27.1" "Cell type enhanced" "Detected in many" "dendritic cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051074 Uncertain Approved "Plasma membrane,Mitochondria" NA NA Mitochondria "Plasma membrane" "HPA051074: AB_2681334" "unprognostic (4.81e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (1.19e-2)" "unprognostic (7.48e-2)" "unprognostic (1.91e-2)" "unprognostic (7.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.02e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.59e-7)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (5.02e-2)" 4.9 4.0 5.6 9.7 5.8 27.1 4.7 5.6 8.1 4.7 7.2 4.8 7.7 3.7 2.7 8.1 3.5 4.7 6.2 5.2 5.3 4.4 12.4 6.4 12.6 6.3 5.4 3.6 4.8 6.8 3.8 3.6 6.5 6.2 6.4 4.6 4.6 5.7 3.3 5.3 11.4 5.9 4.8 5.7 7.1 4.3 7.2 5.5 11.3 4.1 5.5 13.6 5.8 6.9 7.7 10.0 11.5 11.2 12.8 10.0 10.3 12.3 9.8 6.9 13.8 10.2 15.4 7.2 18.0 18.9 6.4 19.9 11.1 14.1 12.9 9.2 31.1 11.6 12.9 36.3 8.3 8.8 12.4 21.2 6.0 15.2 11.3 9.4 7.6 11.8 14.9 13.0 27.8 10.0 6.1 12.4 10.6 6.9 10.5 12.0 18.8 10.0 7.1 8.9 10.1 5.1 8.3 35.1 7.8 7.6 13.5 8.5 14.1 11.1 17.8 20.0 13.4 13.2 12.4 20.6 20.3 10.1 23.2 9.3 0.2 0.6 1.1 0.3 0.7 1.0 0.3 0.8 1.1 1.0 1.6 0.5 1.3 0.7 0.3 1.1 0.8 1.7 0.3 5.6 5.8 5.6 8.1 5.2 5.3 6.3 5.4 3.6 6.2 5.7 5.5 7.7 20.3 3.2 11.5 23.5 24.6 0.0 23.2 0.0 26.2 11.9 12.8 11.7 15.0 10.0 4.3 5.5 14.6 15.1 70.6 21.1 7.9 5.5 9.4 20.6 28.1 13.3 9.5 13.7 18.5 5.8 10.3 10.1 16.8 24.0 10.2 14.0 6.4 36.9 13.9 8.4 19.5 15.7 0.0 18.9 0.0 4.2 10.5 25.0 0.0 38.4 17.1 10.4 26.8 16.6 31.7 8.0 13.3 6.4 38.5 25.9 14.1 15.1 5.1 31.4 0.0 11.5 10.2 29.7 28.8 23.7 0.0 14.2 35.8 7.6 15.6 23.1 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655722-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.1;lymphoid tissue: 15.7;placenta: 13.9" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038606, HPA038607" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 23000 Cytosol "Nucleoplasm, Nuclear bodies" "HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112" "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 3.4 0.7 1.3 4.8 1.5 6.7 1.1 15.1 2.7 3.0 0.2 1.2 1.4 1.0 0.2 1.1 0.5 1.9 0.7 1.3 5.5 0.7 1.3 4.6 5.8 9.0 6.6 1.2 0.2 0.6 0.4 0.3 13.9 10.2 0.7 1.4 1.9 0.7 0.7 1.2 3.0 1.8 1.9 1.5 15.7 1.4 1.2 3.1 15.2 2.3 0.3 3.2 4.4 0.5 9.0 13.1 31.5 5.6 7.5 2.4 4.4 29.1 45.6 25.1 18.1 13.9 12.5 6.8 5.3 3.5 24.3 17.2 6.4 0.1 16.3 28.7 0.2 0.9 122.2 1.0 10.8 6.7 15.0 88.9 3.9 1.0 72.9 26.9 19.7 12.4 5.3 0.1 0.1 17.8 0.5 18.5 9.6 2.5 13.3 7.4 73.3 3.3 0.7 28.6 10.9 12.7 0.2 12.1 0.9 10.1 11.7 0.2 4.0 32.3 23.4 12.6 13.9 19.1 1.0 0.0 15.1 12.4 20.6 43.4 0.0 1.3 9.9 1.8 6.3 1.9 0.3 2.3 1.7 1.7 1.1 2.6 1.4 2.7 6.4 11.1 0.2 4.7 1.8 1.3 1.5 15.1 2.7 1.3 5.5 9.0 6.6 1.2 10.2 1.5 3.1 9.0 2.2 0.0 4.7 9.1 4.6 7.1 4.2 3.4 2.8 1.8 1.2 1.3 1.1 0.0 2.0 3.7 0.0 32.5 10.0 0.6 0.0 8.4 2.4 0.6 4.0 4.5 0.0 1.7 24.8 9.7 54.9 4.9 2.0 1.5 12.7 11.5 5.0 0.6 35.7 11.8 166.3 0.5 4.1 26.0 51.2 3.9 0.0 26.5 1.8 30.0 9.1 0.2 17.5 26.2 2.7 26.3 0.3 0.4 11.4 4.7 0.2 0.6 2.5 1.1 0.0 3.8 3.4 0.1 0.8 2.4 6.0 47.6 16.8 0.1 0.4 3.1 ROBO4 "ECSM4, FLJ20798, MRB" ENSG00000154133 "Roundabout guidance receptor 4" Q8WZ75 11 124883691-124898500 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 247.6;TIME: 224.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065212 Approved "Plasma membrane" NA NA 380000000 "Plasma membrane" "HPA065212: AB_2685434" "unprognostic (2.86e-1)" "unprognostic (9.35e-2)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (3.82e-2)" "unprognostic (6.97e-2)" "prognostic favorable (4.85e-4)" "unprognostic (7.94e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (2.17e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.55e-1)" "unprognostic (4.63e-1)" "unprognostic (5.15e-2)" 41.7 7.3 11.1 6.7 8.2 0.2 32.1 8.2 9.3 9.8 6.1 6.6 3.0 10.9 2.1 5.6 10.4 9.8 19.0 7.1 8.2 15.3 5.4 35.1 7.9 11.1 9.9 5.2 4.1 4.3 4.8 4.6 28.8 10.5 7.1 1.7 0.2 4.2 4.7 14.0 6.1 7.4 10.0 8.2 43.9 6.3 1.5 11.5 1.8 16.9 12.1 2.0 9.5 7.1 9.7 0.4 0.0 0.4 0.0 0.0 1.1 0.1 0.2 3.1 0.7 1.5 0.0 0.0 0.0 23.6 0.1 1.0 0.0 0.0 0.4 1.2 0.0 0.0 0.9 0.0 0.1 0.6 0.0 0.0 0.1 0.0 8.9 3.0 0.4 247.6 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.0 0.0 3.4 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 224.8 1.2 0.6 0.3 1.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 8.2 8.2 9.3 7.1 8.2 11.1 9.9 5.2 10.5 8.2 11.5 9.7 181.5 0.0 4.2 2.3 1.6 2.2 1.0 0.2 0.6 0.2 0.6 1.0 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.5 0.2 0.3 119.7 0.0 4.0 0.0 0.2 0.0 5.2 0.0 0.3 2.5 0.6 148.9 1.5 0.1 0.0 0.0 0.0 0.0 8.1 3.7 1.7 4.4 2.8 1.8 20.6 0.1 1.1 0.0 0.5 0.1 0.1 0.0 1.2 2.6 0.3 0.0 0.0 0.0 5.2 0.0 4.5 2.1 0.0 0.1 0.6 1.3 0.0 0.9 2.0 0.1 0.2 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865432-124881471 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 6.5" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Muller glia cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 5.0" "Region enhanced" "Detected in some" "cerebral cortex: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "AF22: 18.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low region specificity" "Detected in many" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.5 1.9 0.5 0.0 0.4 0.2 1.9 0.1 3.2 0.7 0.0 1.2 0.3 0.8 0.0 0.7 2.1 0.0 1.7 0.8 0.4 1.1 0.4 1.1 0.1 0.8 0.7 0.3 6.5 0.7 0.0 0.8 0.2 0.3 1.4 0.0 0.2 1.2 0.0 0.5 0.6 0.9 0.8 0.2 1.6 0.6 1.2 1.7 0.0 1.4 0.0 0.0 0.7 1.2 0.5 0.0 0.0 18.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.0 0.6 0.9 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.4 0.1 3.2 0.8 0.4 0.8 0.7 0.3 0.3 0.2 1.7 0.5 13.2 0.0 7.3 32.3 0.4 2.9 14.5 16.2 4.0 1.9 5.9 10.9 2.7 1.5 5.9 12.9 0.0 0.2 8.5 2.1 0.0 9.3 0.4 0.4 0.5 11.4 3.5 2.1 6.9 0.8 0.2 19.0 0.5 0.7 8.9 19.0 7.5 0.3 1.6 0.0 2.3 2.4 10.2 1.6 20.1 0.6 13.4 8.0 3.6 11.2 1.6 45.3 8.2 4.5 9.2 1.2 2.5 8.2 0.7 8.2 1.0 0.8 0.6 2.1 0.0 14.3 4.4 10.1 10.8 2.3 1.0 0.1 3.6 3.5 2.7 6.5 PANX3 Px3 ENSG00000154143 "Pannexin 3" Q96QZ0 11 124611428-124620356 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.80e-2)" "unprognostic (3.10e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TBRG1 "FLJ14621, NIAM, TB-5" ENSG00000154144 "Transforming growth factor beta regulator 1" Q3YBR2 11 124622836-124635926 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 21.6;HMC-1: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055645, HPA068022" Supported Nucleoplasm NA NA Nucleoplasm "HPA055645: AB_2682873, HPA068022: AB_2685942" "unprognostic (1.64e-2)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" "unprognostic (1.37e-2)" "unprognostic (9.21e-2)" "unprognostic (3.66e-1)" "unprognostic (1.03e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.40e-2)" "unprognostic (3.72e-3)" "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.83e-1)" "unprognostic (7.13e-3)" 5.0 7.2 7.3 5.5 10.1 4.1 4.3 6.6 9.4 3.7 7.2 5.3 6.3 3.9 4.0 5.0 4.1 3.1 4.1 8.5 7.3 6.2 8.2 6.1 6.5 7.2 6.6 7.5 2.7 8.2 2.3 4.2 3.8 7.2 5.2 5.5 1.8 5.6 3.0 10.2 5.1 8.5 2.5 6.4 8.4 6.8 3.5 9.9 3.9 5.7 4.0 6.1 4.4 4.1 8.4 3.7 3.1 2.7 1.5 4.6 3.1 2.7 3.7 2.5 2.0 1.8 6.0 2.7 4.4 4.5 3.7 4.0 4.5 3.5 4.8 3.8 4.5 2.7 21.6 1.8 3.9 3.2 6.7 20.9 3.2 8.1 3.7 2.8 2.3 3.6 3.6 7.4 4.8 5.1 1.7 3.0 6.6 2.9 8.6 2.1 2.7 3.6 3.2 3.3 3.6 2.2 2.3 2.1 3.5 2.5 2.5 5.6 3.3 5.5 4.5 1.8 1.5 3.2 3.8 6.2 5.1 2.5 7.8 3.2 30.5 24.3 35.1 25.6 22.9 19.1 34.0 25.9 22.1 14.8 30.6 27.4 22.1 33.1 14.6 21.7 23.9 27.5 13.1 7.3 10.1 6.6 9.4 8.5 7.3 7.2 6.6 7.5 7.2 6.4 9.9 8.4 37.9 44.8 56.5 37.9 67.2 46.1 52.0 37.5 67.2 19.2 34.8 30.6 24.0 40.0 39.5 23.9 12.5 32.9 58.0 46.4 52.8 38.8 61.3 25.1 31.1 42.7 28.3 43.3 113.8 47.4 28.8 45.9 39.3 25.9 72.1 23.6 31.8 69.7 36.2 30.3 53.6 46.7 30.5 45.8 66.8 11.5 37.9 55.9 33.8 41.2 53.6 33.5 64.9 33.7 50.1 58.5 43.2 33.4 62.1 88.7 61.9 90.4 33.9 19.5 26.3 39.3 83.3 52.0 24.7 42.5 48.2 48.3 65.7 27.7 33.4 68.6 NRGN RC3 ENSG00000154146 Neurogranin Q92686 11 124739942-124747210 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "brain: 1144.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 245.6;Macrophages: 214.7;Smooth muscle cells: 60.5" "Cancer enhanced" "Detected in all" "glioma: 39.8" "Region enhanced" "Detected in many" "cerebral cortex: 1144.8" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.8;granulocytes: 2.5;monocytes: 3.6" "Cell line enhanced" "Detected in many" "HEL: 154.7;PC-3: 122.8" "Group enriched" "Detected in all" 9 "amygdala: 785.5;basal ganglia: 687.3;cerebral cortex: 1219.9;hippocampal formation: 641.9;white matter: 422.3" "Group enriched" "Detected in all" 6 "basal ganglia: 2940.0;cerebral cortex: 4703.6;hippocampal formation: 2490.2" "CAB006908, HPA038171" Enhanced NA NA 5300000 "CAB006908: , HPA038171: AB_2675878" "unprognostic (1.37e-1)" "unprognostic (8.24e-3)" "unprognostic (3.95e-2)" "unprognostic (1.45e-2)" "unprognostic (3.49e-2)" "unprognostic (5.33e-3)" "unprognostic (1.02e-2)" "unprognostic (9.16e-2)" "unprognostic (2.87e-2)" "unprognostic (3.72e-3)" "unprognostic (4.14e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (1.52e-5)" "unprognostic (8.29e-2)" "unprognostic (2.12e-1)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" 13.0 4.4 70.6 7.9 345.7 36.6 9.1 0.0 1144.8 9.1 0.0 5.4 1.9 10.5 2.7 4.4 12.5 5.2 18.0 266.2 37.6 28.2 6.6 55.7 3.5 137.1 36.5 269.2 9.5 2.7 0.4 11.7 5.8 295.0 6.4 1.6 1.1 3.4 2.5 3.8 3.8 6.3 4.9 0.0 56.2 4.8 7.1 65.4 1.5 11.9 4.3 1.6 8.0 7.9 592.2 13.5 11.2 44.8 51.2 0.6 0.2 1.5 6.4 3.8 5.7 3.5 7.7 20.3 38.1 22.4 1.4 14.5 4.2 8.8 15.4 2.4 6.4 24.9 154.7 4.9 4.5 0.2 3.8 47.4 0.3 0.0 4.7 1.1 4.4 29.4 13.2 8.7 15.0 4.7 51.3 0.2 2.1 16.1 7.7 122.8 21.6 21.5 3.6 3.2 9.0 8.2 16.3 8.6 27.8 1.8 8.7 25.7 41.3 31.2 21.8 16.0 9.1 16.8 3.6 0.6 0.3 15.2 39.9 27.5 1.7 3.6 0.9 0.1 2.1 0.2 0.2 0.2 0.0 1.8 0.4 0.2 0.2 2.5 0.1 1.3 0.5 0.0 6.8 70.6 345.7 0.0 1144.8 266.2 37.6 137.1 36.5 269.2 295.0 0.0 65.4 592.2 12.5 0.0 41.9 35.9 4.3 3.6 0.9 0.6 0.6 5.3 2.1 2.7 2.3 1.5 0.1 0.0 0.0 1.6 4.7 2.2 3.9 0.9 3.1 1.7 1.4 20.8 6.0 5.5 245.6 0.2 2.7 3.8 1.5 1.5 1.3 0.9 15.7 1.0 13.0 0.0 14.4 1.7 0.0 43.4 15.2 7.2 0.6 214.7 5.4 42.2 45.4 0.1 25.7 29.7 33.4 0.3 0.3 0.7 3.4 0.6 0.3 0.1 0.2 1.8 19.7 1.6 60.5 3.6 6.5 1.3 1.4 0.1 4.6 0.8 2.2 1.6 RETREG1 "FAM134B, FLJ20152, JK1" ENSG00000154153 "Reticulophagy regulator 1" Q9H6L5 5 16473038-16617038 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 92.2;skeletal muscle: 143.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Cytotrophoblasts: 53.7;Exocrine glandular cells: 59.3;Glandular and luminal cells: 197.7;Pancreatic endocrine cells: 51.5;Proximal tubular cells: 152.8" "Cancer enhanced" "Detected in all" "renal cancer: 28.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.3" "Group enriched" "Detected in many" 6 "granulocytes: 2.3;T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 26.0;GAMG: 20.3;HSkMC: 28.8;MOLT-4: 20.4;RPTEC TERT1: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012077 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA012077: AB_2668621" "unprognostic (1.63e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-2)" "unprognostic (9.17e-3)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (4.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.37e-2)" "unprognostic (1.48e-1)" "prognostic favorable (5.25e-10)" "unprognostic (3.75e-1)" "unprognostic (9.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.58e-1)" 15.7 3.5 25.8 6.7 30.3 2.0 13.7 27.6 31.6 13.3 24.9 24.8 12.7 4.1 5.3 3.6 7.6 13.6 92.2 24.5 27.6 61.6 44.6 9.4 6.4 32.4 30.0 25.4 2.1 38.1 30.4 10.0 13.3 32.1 11.2 32.7 7.6 5.3 5.1 143.0 10.1 25.8 2.6 28.8 2.3 11.0 12.4 29.0 20.8 6.8 82.7 4.3 2.3 5.2 41.3 1.3 0.5 0.1 3.5 26.0 3.2 15.1 0.1 3.5 3.1 4.1 2.3 0.1 0.3 2.4 0.0 20.3 3.9 7.8 0.8 1.0 4.1 3.4 0.0 10.6 0.0 0.1 5.3 0.0 28.8 11.7 0.6 3.1 7.5 0.0 15.4 0.0 0.1 1.2 1.0 20.4 0.1 0.8 3.4 0.6 3.2 0.0 1.2 26.2 0.9 17.4 2.0 1.0 1.1 13.1 1.9 5.9 2.4 0.0 2.4 0.2 6.4 3.1 0.7 0.0 0.0 14.9 18.0 6.5 2.3 0.1 0.0 0.2 0.0 0.6 0.0 0.6 0.3 0.0 0.3 1.7 1.0 0.9 0.0 0.0 0.0 0.8 0.2 25.8 30.3 27.6 31.6 24.5 27.6 32.4 30.0 25.4 32.1 28.8 29.0 41.3 4.2 73.7 8.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 33.3 19.0 0.0 0.0 9.9 44.1 0.0 53.7 2.2 0.0 17.6 31.1 0.0 33.5 45.2 1.2 0.0 0.0 0.0 59.3 2.0 7.8 0.0 197.7 1.3 3.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.8 0.0 0.0 152.8 19.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 10.9 8.1 0.3 0.0 0.0 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853344 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.4;retina: 11.7" "Group enriched" "Detected in some" 15 "Excitatory neurons: 859.5;Inhibitory neurons: 887.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 2.2;SCLC-21H: 3.1;U-2 OS: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles NA NA Vesicles "HPA029325: AB_2672998" "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.0 2.0 0.6 0.0 5.4 0.0 0.5 0.5 4.5 3.0 2.1 0.0 0.0 0.3 0.2 0.0 2.2 0.0 0.0 2.2 0.2 0.1 0.0 0.2 0.0 2.1 0.1 2.4 0.0 0.0 0.0 1.4 0.1 1.4 0.0 0.1 11.7 1.4 0.2 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.4 0.5 4.5 2.2 0.2 2.1 0.1 2.4 1.4 0.0 0.0 2.6 0.4 0.0 0.0 41.4 0.0 0.1 0.0 0.0 0.0 25.1 0.4 0.6 0.9 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 2.1 0.0 0.0 859.5 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 20.2 887.7 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 15.9 0.0 2.2 0.0 31.2 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.1 0.0 0.2 0.0 2.6 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GPR15 ENSG00000154165 "G protein-coupled receptor 15" P49685 3 98531978-98534681 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 31.6" "Cell type enriched" "Detected in some" 8 "Plasma cells: 31.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 3.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 5.1;T-reg: 12.1" "Group enriched" "Detected in many" 26 "B-cells: 3.6;T-cells: 12.1" "Group enriched" "Detected in some" 5 "HDLM-2: 4.6;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA013775 Approved NA NA "HPA013775: AB_1849264" "unprognostic (8.03e-2)" "unprognostic (1.04e-2)" "unprognostic (3.72e-3)" "unprognostic (5.66e-2)" "unprognostic (9.48e-3)" "unprognostic (5.60e-5)" "unprognostic (5.17e-1)" "unprognostic (6.77e-3)" "unprognostic (3.96e-1)" "unprognostic (3.03e-2)" "unprognostic (2.82e-1)" "unprognostic (2.83e-1)" "unprognostic (4.04e-3)" "unprognostic (4.23e-3)" "unprognostic (1.89e-1)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.0 4.6 0.2 0.2 3.9 0.0 0.2 0.3 0.0 20.2 2.8 0.2 0.0 2.5 0.1 2.3 0.0 0.0 0.1 0.2 0.3 1.9 2.4 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 31.6 0.0 5.0 0.2 0.0 0.2 10.3 0.9 0.2 5.3 1.6 0.0 0.2 2.0 0.5 0.0 5.4 7.3 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 3.6 10.8 5.1 0.0 0.6 0.5 0.8 0.3 0.0 0.0 0.2 12.1 2.1 0.0 0.2 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.4 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401089 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234" "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 30.0 23.3 20.7 19.7 38.1 16.8 31.8 22.7 24.2 20.0 20.2 27.9 29.5 24.8 21.5 29.1 20.6 16.2 39.2 24.2 25.2 37.1 62.2 16.0 22.4 22.6 20.8 21.9 31.1 27.0 27.4 14.9 23.6 24.0 26.6 30.1 45.8 22.1 27.2 67.0 20.0 24.6 26.9 18.5 19.4 21.6 19.8 23.9 29.8 30.4 76.7 26.1 27.5 17.9 26.9 70.2 48.3 39.8 57.9 55.4 60.0 52.0 57.9 49.6 52.2 53.8 68.7 39.0 83.2 49.9 49.7 46.6 67.4 73.1 53.4 76.7 31.6 33.7 95.2 30.3 67.3 34.6 117.2 41.8 53.7 48.6 46.5 75.6 46.5 38.8 40.1 69.2 65.6 63.3 51.9 79.6 47.5 55.2 107.4 101.2 72.0 80.9 89.0 42.6 52.2 72.2 60.1 42.3 67.0 77.9 38.2 87.1 65.8 35.2 45.5 60.3 25.8 44.0 71.1 108.8 139.1 44.1 70.0 35.2 1.1 1.0 1.2 1.9 1.1 2.3 2.0 2.3 2.0 1.4 1.4 2.3 2.5 0.2 2.7 1.3 1.4 1.0 0.8 20.7 38.1 22.7 24.2 24.2 25.2 22.6 20.8 21.9 24.0 18.5 23.9 26.9 24.2 6.4 25.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 30.0 20.2 0.0 0.0 11.2 14.7 0.0 26.8 11.5 0.0 11.7 19.0 0.0 13.8 34.9 10.0 0.0 0.0 0.0 20.1 33.2 12.9 0.0 25.4 7.6 27.1 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.3 0.0 0.0 48.6 10.2 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 16.3 6.3 32.9 0.0 0.0 ABI3BP "DKFZP586L2024, NESHBP, TARSH" ENSG00000154175 "ABI family member 3 binding protein" Q7Z7G0 3 100749156-100993515 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8" "Cancer enhanced" "Detected in many" "renal cancer: 10.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0" "Group enriched" "Detected in many" 4 "amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0" "Low region specificity" "Detected in all" HPA044127 Uncertain "Secreted in other tissues" NA NA 550000000 "HPA044127: AB_2678823" "unprognostic (4.32e-2)" "unprognostic (3.32e-2)" "unprognostic (6.36e-2)" "unprognostic (3.41e-1)" "unprognostic (1.70e-1)" "unprognostic (7.20e-2)" "unprognostic (7.58e-2)" "unprognostic (6.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-1)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "prognostic favorable (6.14e-4)" "unprognostic (2.27e-2)" "unprognostic (2.69e-2)" "unprognostic (6.59e-2)" "unprognostic (1.07e-3)" 41.7 10.0 10.3 57.5 9.8 0.2 23.3 1.1 4.0 56.9 10.8 36.8 5.3 50.0 10.8 35.4 47.3 98.8 44.9 4.1 24.2 12.3 7.9 69.3 26.1 4.1 4.3 2.1 90.2 12.8 3.0 4.7 52.3 6.8 8.8 56.8 58.0 13.8 12.4 6.7 14.1 15.5 72.6 6.2 12.5 25.8 17.3 4.5 8.0 25.3 41.5 40.2 97.7 23.9 9.1 1.3 0.3 0.1 0.0 37.0 437.3 0.4 91.9 90.2 171.4 79.9 0.0 0.2 0.9 0.4 25.0 0.3 0.0 0.1 1.0 278.2 0.8 0.7 2.4 1.6 0.0 23.7 0.5 0.1 26.6 1.0 840.8 818.4 3.6 267.1 0.0 0.5 1.3 158.6 0.0 0.5 0.3 0.1 0.0 87.5 0.4 0.7 0.7 54.0 0.2 0.2 0.6 0.0 0.6 0.1 0.8 0.3 0.1 1405.8 37.7 0.4 311.0 19.7 1.0 0.0 0.0 43.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 9.8 1.1 4.0 4.1 24.2 4.1 4.3 2.1 6.8 6.2 4.5 9.1 9.1 57.7 5.5 26.1 0.3 15.9 1.5 5.8 4.6 1.2 0.6 1.8 9.7 10.0 39.8 18.4 2.1 0.5 0.1 0.4 0.0 0.3 10.3 1.2 30.6 23.6 1.2 0.0 2.6 0.4 0.4 213.8 9.7 2.4 3.8 0.2 16.1 0.1 0.9 0.0 47.0 0.8 0.0 0.6 23.2 8.8 97.3 1.8 19.6 7.5 0.0 93.7 0.0 1.5 3.3 1.9 5.4 27.8 0.7 1.5 0.2 9.0 5.0 3.7 0.0 106.8 17.5 0.1 0.3 3.9 19.9 0.7 2.1 3.6 1.0 2.9 ANGPT1 "Ang1, KIAA0003" ENSG00000154188 "Angiopoietin 1" Q15389 8 107249482-107498055 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 33.8" "Group enriched" "Detected in many" 4 "Astrocytes: 60.4;Fibroblasts: 20.4;Inhibitory neurons: 37.6;Smooth muscle cells: 48.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "neutrophil: 5.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.8" "Cell line enhanced" "Detected in many" "ASC diff: 87.9;HEL: 53.1;HSkMC: 145.5;U-138 MG: 70.5;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017815, HPA018793, HPA018816" Approved "Secreted to blood" NA NA 32000000 110000 "CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821" "unprognostic (7.71e-2)" "unprognostic (2.13e-1)" "unprognostic (6.37e-2)" "unprognostic (4.11e-3)" "unprognostic (7.36e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-3)" "unprognostic (3.29e-2)" "unprognostic (1.07e-2)" "unprognostic (5.54e-2)" "unprognostic (2.62e-1)" "unprognostic (1.44e-1)" "prognostic favorable (4.40e-4)" "unprognostic (4.56e-3)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" 25.3 5.7 4.7 2.6 4.5 0.7 4.6 4.5 2.8 5.8 3.6 3.4 2.3 3.5 4.8 3.5 3.1 13.3 4.8 4.6 10.4 11.2 2.2 21.9 1.4 8.1 3.2 1.5 9.6 1.6 1.2 5.9 20.6 5.1 17.8 3.3 0.6 12.1 33.8 23.6 1.0 2.6 3.4 4.6 11.1 4.1 2.3 2.4 2.1 3.6 7.1 1.0 3.9 3.7 12.0 0.0 2.4 9.3 5.3 87.9 30.2 6.6 30.0 25.8 8.1 11.9 6.2 0.1 0.0 0.1 16.0 0.0 0.0 4.2 0.1 10.5 0.0 1.4 53.1 0.6 0.0 24.5 0.7 0.0 145.5 0.0 4.9 0.6 7.5 0.6 0.0 28.2 5.1 10.9 0.0 1.1 7.9 9.6 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.1 4.2 1.1 0.6 0.0 11.6 2.2 0.0 0.3 70.5 0.9 2.5 0.7 0.2 3.2 0.0 9.7 1.1 47.5 0.1 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.0 0.6 4.7 4.5 4.5 2.8 4.6 10.4 8.1 3.2 1.5 5.1 4.6 2.4 12.0 9.0 0.0 2.3 60.4 0.0 0.6 10.1 0.4 5.2 0.9 0.5 2.8 3.3 0.0 2.2 7.3 0.0 5.2 0.0 0.0 1.9 0.3 8.1 0.7 9.1 5.6 0.0 10.1 6.5 0.0 7.6 20.4 1.5 1.9 0.0 0.0 3.3 0.1 0.5 0.0 37.6 0.0 2.0 0.3 1.0 2.4 2.5 2.9 0.0 6.5 1.5 0.5 0.0 3.0 0.6 0.0 0.0 3.8 1.1 1.2 0.0 2.8 0.8 0.0 6.6 3.5 48.6 1.6 5.4 4.0 0.1 2.7 0.8 1.7 0.1 1.2 PITPNC1 "RDGB-BETA, RDGBB, RDGBB1" ENSG00000154217 "Phosphatidylinositol transfer protein cytoplasmic 1" Q9UKF7 17 67377281-67697261 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.9" "Cell type enhanced" "Detected in many" "Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA026563, HPA031250" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026563: AB_1855409, HPA031250: AB_2673808" "unprognostic (1.33e-1)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.14e-3)" "unprognostic (4.17e-2)" "prognostic favorable (4.85e-5)" "unprognostic (6.57e-2)" "unprognostic (6.32e-3)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "unprognostic (5.70e-2)" "unprognostic (2.31e-2)" "unprognostic (1.34e-2)" "unprognostic (9.83e-2)" "unprognostic (7.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.16e-2)" 22.5 9.0 27.3 5.7 31.7 3.9 18.7 25.9 27.1 8.6 12.0 7.3 1.5 7.9 3.8 9.9 11.0 3.9 13.0 23.2 76.9 12.0 9.8 15.2 8.8 38.6 38.0 18.9 15.4 23.3 1.8 13.8 6.1 26.8 12.0 2.2 15.2 14.2 4.4 5.4 4.6 8.8 3.6 25.5 9.4 12.7 2.6 41.5 8.5 9.0 5.1 7.5 12.1 9.2 22.6 4.2 1.0 4.5 6.8 2.8 5.1 3.9 6.0 2.9 0.8 0.4 0.0 6.4 4.6 1.4 3.6 1.7 2.0 6.7 6.0 1.1 9.3 3.0 0.7 7.6 3.4 0.7 1.4 9.8 3.6 2.2 0.9 2.5 0.5 3.2 6.5 0.3 16.9 2.3 7.0 10.9 2.8 6.6 1.8 7.7 15.2 0.9 4.2 9.7 5.4 4.7 13.0 1.7 3.3 4.1 4.8 3.0 4.7 3.7 1.8 1.0 2.4 2.9 13.2 6.2 3.7 14.4 4.6 1.6 0.7 1.4 10.3 11.1 2.6 5.7 0.5 6.9 9.2 0.9 1.3 8.2 8.3 1.7 5.2 4.1 0.1 2.8 4.1 27.3 31.7 25.9 27.1 23.2 76.9 38.6 38.0 18.9 26.8 25.5 41.5 22.6 102.6 9.6 1.1 1255.9 9.6 5.4 55.6 4.6 8.0 15.2 7.7 4.1 6.9 21.5 4.6 0.0 2.1 7.9 84.0 5.8 21.5 43.3 0.2 13.7 5.7 59.8 6.0 4.0 88.4 49.1 13.6 18.9 8.2 30.9 5.1 7.7 21.4 10.1 13.8 74.0 330.9 1.3 4.1 21.4 22.3 1.4 5.0 17.7 10.6 103.0 20.2 34.6 84.5 281.5 9.7 38.7 4.4 14.7 28.0 32.9 0.1 21.2 3.4 21.8 26.3 66.5 25.7 0.4 3.8 9.0 4.3 3.4 75.7 2.7 3.8 54.3 CC2D1B "Freud-2, KIAA1836" ENSG00000154222 "Coiled-coil and C2 domain containing 1B" Q5T0F9 1 52345723-52366205 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 10.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027500, HPA031426" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA027500: AB_10600693, HPA031426: AB_2673876" "unprognostic (1.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.38e-2)" "unprognostic (2.50e-2)" "unprognostic (5.85e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (3.39e-2)" "unprognostic (4.75e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-2)" "unprognostic (2.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-2)" "unprognostic (1.87e-1)" 13.2 15.1 17.2 8.7 19.0 5.0 12.8 18.9 15.9 10.2 14.9 12.5 8.1 11.1 9.3 16.9 10.0 7.0 12.4 14.9 19.4 19.0 17.3 17.9 12.2 20.8 19.5 14.5 13.4 15.8 10.3 19.6 7.6 22.1 13.8 6.6 4.0 12.8 7.2 29.4 11.7 15.2 5.5 20.2 18.0 12.9 16.8 18.4 11.1 17.8 11.8 9.8 12.3 12.1 22.1 12.4 17.2 7.8 12.2 28.1 10.7 18.3 15.6 27.3 19.9 15.0 11.5 10.1 7.7 12.9 18.2 43.6 8.3 10.1 21.6 9.0 14.2 11.1 8.5 13.6 9.7 22.6 11.8 19.8 15.9 19.3 22.2 16.9 19.3 12.4 12.2 14.7 8.2 22.2 8.5 12.4 9.7 15.2 12.5 19.2 7.9 14.7 11.3 21.0 17.2 8.5 8.0 15.2 22.7 22.7 20.0 8.0 17.4 14.9 22.9 12.6 12.6 17.9 11.7 11.5 9.9 30.3 12.7 28.8 10.4 1.1 2.8 2.3 0.6 1.9 1.7 1.8 1.8 1.1 1.2 1.4 2.0 1.6 1.9 0.5 1.1 1.6 1.3 17.2 19.0 18.9 15.9 14.9 19.4 20.8 19.5 14.5 22.1 20.2 18.4 22.1 6.7 9.6 13.4 4.6 7.5 3.2 3.3 3.4 5.2 5.6 3.9 2.7 5.6 4.3 7.6 11.0 0.0 9.0 9.0 10.2 3.9 10.0 3.7 6.7 4.1 5.8 6.0 2.5 4.6 12.7 10.3 3.9 14.8 9.6 15.8 6.7 9.7 8.2 11.6 1.7 4.6 5.7 2.0 6.9 1.5 2.4 3.4 8.0 1.8 2.8 5.9 6.5 8.2 2.0 5.9 12.2 9.1 6.4 6.7 3.8 8.6 5.3 5.4 4.9 0.0 5.1 4.1 16.6 8.8 4.9 3.1 15.7 8.9 5.8 4.9 3.5 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 55.6;lymphoid tissue: 16.1;skin 1: 63.5;testis: 18.4;vagina: 30.5" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTCEpi: 65.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.1 0.0 0.0 0.0 0.2 0.2 3.3 0.3 0.2 7.2 0.0 0.0 0.0 0.1 0.5 55.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.2 0.6 0.0 0.1 8.5 0.1 0.6 63.5 0.1 0.0 0.0 0.1 0.1 18.4 0.1 0.4 0.1 0.0 16.1 0.3 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.0 18.9 5.0 3.9 39.3 0.4 0.1 0.3 0.5 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.5 0.2 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 2.1 17.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 2.0 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 28.2 0.7 48.3 50.2 0.0 0.1 0.0 0.0 6.0 PRKCA "PKCA, PKCα" ENSG00000154229 "Protein kinase C alpha" P17252 17 66302613-66810743 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.5" "Cell type enhanced" "Detected in many" "Astrocytes: 564.8;Excitatory neurons: 247.6;Inhibitory neurons: 400.0;Microglial cells: 281.1;Oligodendrocyte precursor cells: 849.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 157.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003844, HPA006563, HPA006564, CAB016290" Enhanced Approved Enhanced "Plasma membrane,Cytosol" NA NA 190000 Cytosol "Plasma membrane" "CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625" "unprognostic (3.06e-1)" "unprognostic (3.56e-2)" "unprognostic (1.38e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (7.41e-3)" "unprognostic (7.43e-2)" "unprognostic (6.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.35e-3)" "unprognostic (8.77e-2)" 2.9 21.2 37.5 6.9 30.5 1.8 2.3 21.9 52.4 7.1 11.2 14.8 12.0 11.8 4.9 3.3 4.6 7.6 4.4 68.5 34.0 12.9 7.4 4.6 4.9 37.5 33.2 24.9 15.9 5.1 0.9 6.4 5.0 26.3 13.1 8.7 30.3 2.3 17.0 5.8 2.7 10.7 10.8 28.6 6.6 8.5 2.6 30.6 3.1 3.2 4.4 4.6 9.0 5.7 26.9 7.3 38.0 7.7 7.8 18.2 46.0 1.0 40.8 26.4 28.8 24.3 4.5 4.6 9.6 10.9 65.9 48.1 0.9 3.9 4.8 61.9 16.4 9.3 0.0 22.2 20.2 24.9 12.2 62.8 20.2 1.8 36.0 30.5 41.8 25.0 45.6 25.8 0.2 44.8 2.3 24.9 7.4 3.1 18.9 20.2 4.5 56.5 0.2 10.2 6.4 4.6 25.6 13.5 7.7 0.4 8.0 0.8 17.0 75.1 49.6 28.6 31.4 25.8 0.1 0.0 1.2 157.6 0.1 25.1 0.0 0.2 0.0 0.1 0.2 0.5 0.0 0.8 0.4 0.3 0.0 1.2 0.7 0.0 0.0 1.1 0.4 0.1 0.3 37.5 30.5 21.9 52.4 68.5 34.0 37.5 33.2 24.9 26.3 28.6 30.6 26.9 10.0 0.0 8.4 564.8 5.7 10.6 15.0 10.3 13.6 198.3 7.9 11.2 9.8 45.8 7.2 40.5 2.1 4.1 24.6 27.1 7.9 16.1 3.2 5.5 40.1 5.6 8.4 5.7 247.6 6.8 3.4 17.5 23.9 6.3 20.3 39.9 27.8 14.7 25.4 10.1 400.0 38.4 2.0 11.9 7.6 3.0 53.4 20.9 10.6 281.1 6.8 34.3 12.3 849.0 198.3 8.8 21.0 48.5 11.8 12.8 27.0 21.3 7.0 77.1 26.3 6.5 41.4 1.3 3.9 6.1 10.4 15.2 36.9 47.1 26.4 17.2 LRRK1 "FLJ23119, KIAA1790, RIPK6, Roco1" ENSG00000154237 "Leucine rich repeat kinase 1" Q38SD2 15 100919327-101078257 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 64.6;Microglial cells: 107.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 2.6" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010537 Uncertain Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA010537: AB_1079283" "unprognostic (3.74e-2)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (3.72e-1)" "unprognostic (6.68e-2)" "unprognostic (6.35e-2)" "unprognostic (1.94e-1)" "unprognostic (4.75e-2)" "unprognostic (3.43e-2)" "unprognostic (3.34e-2)" "unprognostic (2.95e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-2)" "unprognostic (3.13e-1)" "unprognostic (5.25e-2)" 2.6 1.0 0.8 5.8 0.5 6.5 2.4 0.0 2.6 3.8 0.0 5.3 3.9 3.8 1.7 4.5 5.0 3.3 1.4 0.8 0.0 0.8 0.8 3.3 7.3 0.0 0.2 0.2 3.8 5.9 2.0 0.9 4.1 1.3 4.0 5.1 0.2 3.9 3.5 1.0 4.8 5.1 3.0 0.2 6.3 3.7 5.3 0.0 2.2 1.7 1.3 8.0 3.0 3.1 0.4 4.5 15.3 0.3 0.0 4.9 3.9 1.8 3.7 7.1 2.3 2.0 3.1 7.2 20.2 4.2 6.3 0.0 17.3 5.2 2.8 2.8 3.1 2.8 17.4 12.8 0.0 2.0 5.2 9.0 3.3 4.7 3.0 6.3 2.3 2.4 0.4 3.6 18.4 1.1 0.4 0.0 4.2 1.4 5.1 5.2 2.9 2.0 15.3 0.0 0.6 0.4 3.3 8.8 2.5 6.2 0.4 1.5 4.4 6.3 0.0 3.1 5.2 0.1 15.9 18.2 27.4 1.1 2.1 6.7 0.0 0.4 1.2 0.0 0.1 0.0 1.0 0.0 0.0 0.4 0.4 0.0 0.0 0.3 0.0 0.4 1.3 0.0 0.0 0.8 0.5 0.0 2.6 0.8 0.0 0.0 0.2 0.2 1.3 0.2 0.0 0.4 8.3 16.0 13.6 2.9 17.3 3.2 8.0 3.5 7.4 0.9 5.7 5.1 2.9 2.8 6.0 0.0 6.2 9.6 13.6 19.8 0.0 4.5 3.7 12.6 19.4 8.8 13.8 3.4 64.6 3.3 4.2 11.5 3.6 6.6 1.3 1.4 9.7 0.4 10.7 0.0 10.0 11.7 0.0 24.8 10.1 4.6 32.3 19.9 3.6 107.7 28.3 0.6 1.0 12.5 1.2 7.5 11.4 21.4 14.2 10.7 11.6 0.3 6.3 0.7 6.6 11.2 3.9 6.5 1.5 6.6 3.4 3.6 1.3 2.8 12.5 9.9 CEP112 "CCDC46, MGC33887" ENSG00000154240 "Centrosomal protein 112" Q8N8E3 17 65635537-66192133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.5" "Group enriched" "Detected in many" 8 "Early spermatids: 1061.4;Late spermatids: 1606.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 32.0;RH-30: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069724 Approved "Nucleoplasm,Midbody ring,Centrosome,Cytosol" Yes NA "Nucleoplasm, Centrosome" "Midbody ring, Cytosol" "HPA069724: " "unprognostic (9.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.11e-3)" "unprognostic (1.43e-2)" "unprognostic (7.99e-2)" "unprognostic (4.48e-3)" "unprognostic (3.37e-2)" "unprognostic (1.39e-3)" "unprognostic (3.50e-2)" "unprognostic (4.46e-3)" "unprognostic (1.02e-2)" "unprognostic (1.26e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" 11.4 3.9 6.4 2.8 6.3 1.7 9.5 7.6 6.0 8.2 11.3 6.1 2.0 8.6 8.2 4.3 8.3 7.0 8.1 8.3 7.3 5.6 3.2 7.5 2.5 6.0 6.6 3.9 8.3 4.6 8.8 8.4 7.3 5.7 7.3 3.1 25.6 3.0 8.0 8.9 3.3 2.9 8.1 4.4 8.9 4.2 49.5 5.6 2.9 7.1 14.1 1.8 5.4 6.0 6.6 5.0 10.5 13.3 3.8 6.9 14.0 0.4 4.5 7.7 5.5 5.0 1.5 2.0 1.6 4.3 9.8 15.5 0.6 2.9 2.9 7.8 2.6 4.8 0.3 4.7 1.9 2.9 0.6 0.2 8.4 4.8 5.2 1.6 11.0 16.8 2.7 0.3 5.0 32.0 0.7 5.3 0.4 1.3 1.1 4.4 1.5 75.9 0.4 6.0 0.3 3.5 7.4 4.7 0.5 3.6 11.4 3.8 0.4 7.9 14.3 8.2 3.9 6.7 2.3 2.1 0.2 4.4 0.2 5.3 1.3 0.4 0.4 0.3 0.2 0.6 0.3 0.8 0.3 0.2 0.8 0.5 0.3 1.3 0.8 0.2 1.4 0.5 0.1 6.4 6.3 7.6 6.0 8.3 7.3 6.0 6.6 3.9 5.7 4.4 5.6 6.6 39.7 9.6 35.8 83.6 1.1 2.5 2.9 2.2 2.2 36.7 2.7 5.5 28.3 4.3 15.3 1.8 20.9 0.7 0.8 1.5 1.9 7.4 1061.4 15.3 15.8 25.4 1.8 0.4 117.4 4.7 1.5 12.4 1.5 3.3 2.5 11.2 19.2 0.2 1.8 1.7 103.8 0.3 0.0 0.8 11.3 1606.0 24.8 2.3 14.2 99.3 0.0 14.7 1.0 29.7 6.6 4.4 0.5 19.9 0.4 1.5 0.0 4.3 23.7 154.3 13.1 43.7 12.5 40.6 16.5 2.4 1.6 0.1 2.5 3.1 1.5 1.3 GAL3ST2 GP3ST ENSG00000154252 "Galactose-3-O-sulfotransferase 2" Q9H3Q3 2 241776822-241804287 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "intestine: 9.5" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Oligodendrocyte precursor cells: 1.0" "Group enriched" "Detected in many" 6 "colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 3.7;HMC-1: 10.5" "Not detected" "Not detected" HPA071809 Enhanced "Intracellular and membrane" NA NA "HPA071809: AB_2686450" "unprognostic (5.22e-3)" "unprognostic (6.52e-2)" "unprognostic (1.85e-2)" "unprognostic (4.04e-3)" "unprognostic (3.04e-4)" "unprognostic (3.45e-2)" "unprognostic (2.48e-2)" "unprognostic (2.87e-1)" "unprognostic (4.13e-2)" "unprognostic (2.25e-3)" "unprognostic (2.58e-1)" "unprognostic (4.99e-2)" "unprognostic (2.87e-11)" "unprognostic (4.32e-2)" "unprognostic (1.55e-1)" "unprognostic (5.99e-3)" "unprognostic (3.49e-1)" 0.2 0.3 0.5 0.8 0.2 0.2 0.0 0.0 0.4 0.3 0.0 9.5 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.1 3.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 3.7 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.1 0.0 0.7 0.0 0.0 0.5 0.1 0.2 0.7 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 ABCA9 EST640918 ENSG00000154258 "ATP binding cassette subfamily A member 9" Q8IUA7 17 68974488-69060949 "Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 55.5;Fibroblasts: 86.6;Inhibitory neurons: 73.2;Leydig cells: 96.3;Microglial cells: 227.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "ASC diff: 21.8;ASC TERT1: 47.7;HSkMC: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052113, HPA054823" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA052113: AB_2732573, HPA054823: AB_2682615" "unprognostic (3.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.21e-1)" "unprognostic (9.75e-2)" "unprognostic (4.46e-1)" "unprognostic (5.64e-3)" "unprognostic (4.51e-4)" "unprognostic (1.83e-2)" "unprognostic (1.94e-3)" "unprognostic (7.86e-2)" "unprognostic (3.26e-3)" "unprognostic (3.51e-1)" "unprognostic (7.77e-6)" "unprognostic (5.32e-4)" "unprognostic (7.22e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-3)" 32.7 4.1 2.6 1.4 3.5 1.8 22.5 7.3 7.9 12.5 9.2 10.4 1.8 11.3 9.0 4.9 20.7 8.3 22.2 2.8 4.5 2.7 12.0 8.9 2.3 3.6 1.9 2.9 27.6 3.5 2.3 4.9 1.2 4.6 3.3 4.0 8.5 9.1 2.9 13.2 8.1 6.7 6.6 1.4 1.7 7.9 5.2 3.2 2.5 11.2 10.7 1.1 11.0 12.8 6.9 0.2 0.4 0.8 0.8 21.8 47.7 0.6 0.4 0.4 0.0 0.4 0.5 0.5 0.6 0.2 0.8 0.3 0.5 0.4 0.7 0.2 0.3 0.4 0.6 2.4 0.6 2.3 0.9 1.3 17.0 0.5 3.6 0.3 0.9 4.8 0.6 0.8 1.3 0.1 0.3 0.3 2.1 0.3 0.2 0.4 2.2 0.1 0.3 0.3 1.9 0.7 0.6 0.5 0.3 0.3 0.4 0.4 0.8 2.0 1.3 0.5 2.3 0.5 1.0 0.5 0.4 0.4 0.5 2.4 0.5 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.4 0.2 0.0 0.1 0.0 0.0 2.6 3.5 7.3 7.9 2.8 4.5 3.6 1.9 2.9 4.6 1.4 3.2 6.9 7.4 0.0 1.5 2.6 0.5 1.8 0.3 0.1 1.2 3.9 0.7 0.8 3.9 1.5 0.1 0.0 0.0 0.0 0.6 0.9 0.0 0.1 1.3 0.4 2.1 2.6 0.0 0.0 55.5 0.0 0.0 86.6 2.0 1.4 0.0 2.2 18.5 11.4 0.3 0.0 73.2 0.1 0.0 1.3 5.1 3.6 96.3 4.9 0.0 227.7 0.0 7.9 1.0 6.0 10.9 0.2 0.0 15.4 0.2 0.1 0.3 0.0 1.7 5.6 13.1 26.3 7.1 1.3 0.8 1.3 1.6 0.0 0.5 26.3 0.1 0.3 ABCA6 EST155051 ENSG00000154262 "ATP binding cassette subfamily A member 6" Q8N139 17 69078702-69141895 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 78.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 62.5;Fibroblasts: 117.6;Hepatocytes: 110.3;Inhibitory neurons: 77.8;Leydig cells: 51.3;Microglial cells: 93.7;Theca cells: 45.4" "Cancer enriched" "Detected in some" 7 "liver cancer: 4.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 39.9;ASC TERT1: 56.0;HSkMC: 25.3;HUVEC TERT2: 54.8;RT4: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA064878, HPA067180" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064878: AB_2685380, HPA067180: AB_2685797" "unprognostic (7.76e-2)" "unprognostic (6.80e-2)" "unprognostic (2.12e-1)" "unprognostic (8.01e-2)" "unprognostic (8.47e-2)" "unprognostic (9.82e-3)" "prognostic favorable (3.29e-4)" "unprognostic (1.35e-1)" "unprognostic (6.60e-2)" "unprognostic (3.00e-2)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (7.96e-4)" "unprognostic (1.61e-4)" "unprognostic (2.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.69e-1)" 21.0 5.6 1.0 2.6 5.1 0.0 16.0 4.9 3.2 9.5 3.4 6.9 2.2 6.0 2.8 6.0 11.4 10.2 14.4 1.2 10.7 3.6 78.6 11.0 5.1 10.5 3.8 0.4 30.1 2.3 1.4 2.1 2.1 8.5 2.9 4.4 0.8 9.1 2.0 5.5 6.1 5.6 3.7 6.5 1.6 5.7 1.8 5.2 1.4 8.6 11.8 3.2 14.3 9.0 20.9 0.0 0.0 0.0 0.0 39.9 56.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 25.3 0.1 3.2 0.9 1.5 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 5.1 4.9 3.2 1.2 10.7 10.5 3.8 0.4 8.5 6.5 5.2 20.9 12.5 0.0 0.0 2.9 2.0 3.1 1.5 0.4 4.0 11.6 1.8 2.2 6.0 4.3 0.9 3.7 6.2 0.0 1.7 1.8 0.0 0.5 3.3 0.7 5.1 3.2 2.4 2.7 62.5 0.2 0.0 117.6 2.0 2.5 0.0 4.0 3.3 110.3 1.6 0.0 77.8 0.7 0.0 2.5 42.1 2.7 51.3 20.3 5.4 93.7 0.7 3.2 0.0 4.5 33.4 0.4 1.1 12.0 1.2 0.1 0.5 0.9 0.7 13.3 0.0 20.0 14.3 2.0 0.9 1.4 2.8 0.0 1.2 45.4 0.3 0.5 ABCA10 EST698739 ENSG00000154263 "ATP binding cassette subfamily A member 10" Q8WWZ4 17 69147214-69244846 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 18.4" "Cell type enhanced" "Detected in many" "Early spermatids: 231.0;Excitatory neurons: 91.9;Fibroblasts: 64.3;Inhibitory neurons: 112.4;Late spermatids: 93.1;Microglial cells: 187.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.3;HUVEC TERT2: 1.3;RT4: 1.3;U-2197: 2.1" HPA014535 Uncertain NA NA "HPA014535: AB_1844426" "unprognostic (1.45e-4)" "unprognostic (3.17e-1)" "unprognostic (7.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.52e-2)" "unprognostic (1.17e-2)" "unprognostic (3.78e-2)" "unprognostic (1.40e-1)" "unprognostic (4.51e-3)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (4.91e-1)" "unprognostic (2.70e-4)" "unprognostic (5.23e-3)" "unprognostic (6.98e-2)" "unprognostic (4.37e-2)" "unprognostic (9.86e-3)" 8.6 1.7 2.8 0.0 3.6 0.0 10.5 5.1 7.0 3.5 3.1 2.7 1.1 3.2 2.7 2.7 12.8 3.5 6.5 3.4 2.7 1.8 4.5 3.0 0.6 4.6 3.2 2.8 18.4 2.8 0.4 2.7 0.2 5.3 2.2 4.0 3.4 5.6 0.6 6.4 4.6 3.0 1.9 2.1 1.1 2.4 3.5 4.9 0.8 5.6 2.3 0.7 3.3 4.2 4.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 1.3 0.2 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.6 5.1 7.0 3.4 2.7 4.6 3.2 2.8 5.3 2.1 4.9 4.1 4.3 0.0 3.2 2.6 0.3 1.0 0.5 1.1 1.2 6.7 1.8 2.3 3.9 1.5 0.2 0.0 25.0 0.0 1.2 6.9 0.0 0.6 231.0 2.1 0.7 1.9 4.9 0.0 91.9 0.2 0.0 64.3 2.0 3.3 0.0 6.9 0.4 1.8 0.1 0.0 112.4 3.7 0.0 0.0 3.3 93.1 51.0 1.0 1.8 187.4 1.6 1.9 4.1 26.2 13.5 0.4 0.4 11.7 0.7 0.3 5.6 0.5 3.1 9.0 0.0 6.1 4.5 8.1 2.6 1.1 0.4 0.0 0.6 18.9 0.7 0.5 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022032: AB_1844427, HPA062904: AB_2732692" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favorable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 7.7 7.8 3.7 2.9 4.6 6.5 12.3 26.2 9.8 7.9 8.5 9.5 9.6 5.5 7.1 7.0 6.1 4.3 4.8 4.8 7.8 7.0 21.5 4.0 3.4 6.7 5.7 5.1 5.7 18.1 11.5 12.6 3.4 10.0 6.0 10.1 27.6 6.7 6.4 33.7 23.8 13.7 3.1 3.8 3.9 8.7 9.2 7.4 5.9 7.4 14.0 3.9 3.5 7.0 8.4 5.1 2.3 1.8 2.8 8.7 6.3 0.6 5.1 5.6 5.3 7.8 0.7 1.8 0.0 2.7 4.5 4.2 7.3 1.2 4.3 5.9 0.1 3.4 0.0 6.0 3.4 11.6 0.0 3.1 6.2 5.2 2.2 6.0 1.1 11.7 1.8 0.0 1.9 0.5 4.3 3.2 0.0 1.8 1.9 3.4 0.4 0.1 0.4 1.0 8.3 10.0 1.5 18.6 8.4 5.0 1.6 8.7 3.2 8.6 6.0 1.7 5.6 1.1 10.3 0.3 0.4 2.4 0.0 5.5 0.3 0.3 2.1 1.3 0.0 1.8 1.1 1.7 1.5 0.2 2.3 0.9 1.4 0.9 1.5 0.0 1.8 1.2 0.6 3.7 4.6 26.2 9.8 4.8 7.8 6.7 5.7 5.1 10.0 3.8 7.4 8.4 17.7 19.2 20.3 14.4 12.5 65.4 34.9 35.1 31.3 122.3 33.9 42.8 26.4 30.0 27.8 38.6 116.7 17.3 17.7 126.7 5.9 15.6 18.9 38.6 17.4 18.3 112.7 8.4 143.1 9.8 6.0 33.1 32.6 61.8 14.0 90.3 17.2 94.4 7.4 106.0 184.6 73.7 32.6 3.7 24.4 14.4 63.6 7.0 101.4 20.6 29.9 45.6 11.3 79.9 105.3 9.3 45.6 45.9 23.4 32.1 151.1 9.4 66.0 113.4 92.1 28.7 30.3 200.8 78.1 33.8 53.6 23.7 18.2 80.7 30.4 41.8 ENPP3 "B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3" ENSG00000154269 "Ectonucleotide pyrophosphatase/phosphodiesterase 3" O14638 6 131628442-131747418 "CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 32.4;intestine: 44.9" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2" "Cancer enriched" "Detected in many" 8 "renal cancer: 49.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 86 "basophil: 30.6" "Lineage enriched" "Detected in single" 86 "granulocytes: 30.6" "Group enriched" "Detected in some" 18 "HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 4 "spinal cord: 2.6" HPA043772 Enhanced "Secreted - unknown location" NA NA 1100000 "HPA043772: AB_10795616" "unprognostic (2.74e-1)" "unprognostic (1.99e-2)" "unprognostic (1.84e-1)" "unprognostic (5.41e-3)" "unprognostic (6.07e-2)" "unprognostic (4.86e-5)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.80e-2)" "unprognostic (7.85e-2)" "unprognostic (2.29e-1)" "unprognostic (1.31e-3)" 1.2 6.3 0.4 1.1 0.3 0.1 6.7 0.9 0.5 32.4 0.2 9.3 16.3 3.8 1.2 0.5 2.3 1.3 0.1 0.3 0.4 10.1 5.0 1.0 0.5 0.4 0.5 0.3 0.5 0.1 0.3 0.1 0.1 0.6 2.4 8.5 0.3 18.2 15.8 0.1 0.6 44.9 0.8 0.4 0.3 0.5 0.8 0.4 9.7 0.3 0.2 0.4 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.4 0.0 14.6 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.9 0.5 0.3 0.4 0.4 0.5 0.3 0.6 0.4 0.4 0.3 0.4 0.0 1.1 5.2 0.2 0.0 2.6 0.7 1.2 0.2 1.0 0.6 0.3 0.0 2.5 0.0 0.0 0.0 0.2 9.2 1.9 0.0 1.6 160.0 46.3 1.4 0.0 2.1 2.1 0.0 0.1 0.5 0.0 387.2 36.0 0.1 0.7 1.7 0.1 0.0 4.1 1.5 0.0 0.6 1.1 0.4 1.2 1.5 1.8 2.8 0.0 0.1 1.0 3.5 0.9 0.0 1.9 0.7 0.3 2.7 53.3 9.1 5.4 0.1 0.0 0.2 1.0 2.5 0.8 0.0 0.6 0.1 2.2 0.1 4.9 1.1 C4orf19 FLJ11017 ENSG00000154274 "Chromosome 4 open reading frame 19" Q8IY42 4 37453925-37623495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.3" "Cell type enhanced" "Detected in many" "Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 8.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.6" "Group enriched" "Detected in some" 5 "OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043458, HPA052894" Enhanced Supported "Cell Junctions" No No "Cell Junctions" "HPA043458: AB_10960696, HPA052894: AB_2681982" "unprognostic (8.83e-2)" "unprognostic (7.86e-2)" "unprognostic (3.00e-3)" "unprognostic (2.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.59e-3)" "unprognostic (5.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.66e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.49e-11)" "unprognostic (1.33e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (8.19e-3)" 3.5 0.3 2.8 3.0 2.8 3.8 3.8 5.0 4.3 10.3 5.2 25.7 17.9 6.8 0.2 2.1 2.8 9.3 0.3 3.3 3.8 9.8 36.3 3.8 0.5 4.8 4.8 2.3 0.2 25.1 16.1 1.2 7.6 4.0 1.7 23.9 4.7 28.4 6.8 0.2 1.6 19.8 4.1 4.0 0.3 20.9 1.4 4.5 0.2 1.5 0.4 4.3 8.8 2.9 4.0 0.1 0.2 3.2 0.3 0.0 0.0 4.2 0.7 0.0 0.0 0.0 12.6 5.2 0.1 3.0 0.0 0.1 0.4 0.2 0.8 0.1 0.0 0.4 0.0 8.3 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 14.3 0.2 0.2 0.5 64.6 1.7 0.1 7.8 0.2 12.7 81.0 0.9 0.3 0.5 32.6 1.0 4.0 113.1 0.7 0.6 0.4 4.5 0.2 1.6 0.2 0.1 0.5 0.0 6.9 5.6 0.9 1.4 2.1 0.6 0.2 0.4 0.2 0.3 0.4 0.2 0.5 0.5 0.8 8.6 0.8 0.1 1.6 0.7 0.3 2.8 2.8 5.0 4.3 3.3 3.8 4.8 4.8 2.3 4.0 4.0 4.5 4.0 0.3 0.0 12.6 45.4 0.7 0.3 7.8 4.9 0.0 0.6 7.1 3.9 0.2 27.1 10.1 11.0 0.0 6.7 0.2 61.3 11.7 25.2 1.2 9.5 0.4 0.9 9.6 0.0 2.3 51.8 4.7 0.3 33.6 5.5 0.0 0.0 0.0 13.1 0.7 0.0 2.4 28.0 4.1 0.0 0.3 2.4 0.0 0.2 3.6 22.5 0.6 5.3 0.0 46.8 1.8 53.6 67.2 0.0 0.0 7.8 52.3 9.2 12.3 1.0 0.0 0.2 0.9 0.3 0.2 0.5 0.0 47.5 0.4 0.1 31.8 19.1 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 823.6;pituitary gland: 287.6" "Cell type enhanced" "Detected in many" "Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4" "Cancer enhanced" "Detected in all" "glioma: 129.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA 500000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.93e-4)" 26.4 105.4 187.7 19.4 236.0 0.6 13.7 130.1 375.1 14.9 0.0 39.6 9.1 13.3 3.3 3.3 9.8 12.4 17.3 296.5 341.6 41.1 1.6 8.3 13.0 278.1 360.6 331.5 35.9 11.6 0.7 287.6 2.5 415.5 12.5 7.0 38.6 3.7 5.9 27.7 4.3 19.0 9.2 145.1 2.8 14.6 16.6 345.0 4.1 9.9 7.7 7.3 32.0 29.4 823.6 3.3 712.8 146.8 0.4 18.9 19.7 0.4 681.4 352.8 236.0 243.4 149.0 0.9 0.0 1142.2 384.4 356.7 1.1 262.8 0.6 116.4 1.5 97.0 0.0 6.9 0.2 529.3 0.1 1.2 127.4 3.0 197.9 0.0 413.7 2.0 0.0 0.0 2.3 122.6 0.6 1.0 12.3 435.3 0.0 714.1 0.1 297.2 0.7 386.3 0.3 1160.6 765.7 5.1 2.8 1.8 165.4 0.8 5.0 3.3 16.8 5.2 0.4 1162.6 583.1 1138.4 3.1 1209.3 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 187.7 236.0 130.1 375.1 296.5 341.6 278.1 360.6 331.5 415.5 145.1 345.0 823.6 0.8 0.0 3.1 29.0 2.1 1.7 1.1 1.5 1.2 25.6 0.3 0.6 3.1 0.0 3.5 115.8 8.4 3.6 0.0 0.1 258.2 4.3 3.5 0.9 9.8 3.9 4.2 0.8 147.1 0.8 0.8 35.4 1.1 0.5 2.5 46.3 8.9 0.6 4.7 146.4 118.4 0.0 4.1 0.6 3.4 6.0 37.0 2.3 3.6 35.6 0.6 21.6 0.0 55.8 54.6 3.0 0.0 17.3 9.2 3.7 0.0 17.1 7.4 61.3 0.0 3.6 35.7 10.4 88.4 0.3 1.6 1.5 1.3 20.0 0.2 1.0 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA SH3 domain ER export factor 3" Q5JRA6 1 222618097-222668007 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles NA NA 1400000 Vesicles "HPA055922: AB_2682971, HPA056816: AB_2683243" "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 25.9 22.3 11.4 23.7 13.3 33.5 21.6 13.4 15.0 24.1 13.3 24.6 24.2 23.9 29.4 13.8 16.1 20.8 20.8 11.1 13.0 21.3 75.2 21.7 27.1 11.5 11.7 10.3 25.6 39.1 30.3 15.3 23.3 11.8 39.7 29.7 24.6 33.5 22.3 23.9 17.6 26.1 24.0 10.4 27.5 45.4 36.9 11.7 25.9 32.0 20.7 26.4 21.2 14.2 14.4 24.8 18.8 26.5 42.5 92.8 47.1 46.5 34.8 49.4 36.2 43.1 16.6 26.2 24.0 33.0 41.8 20.5 39.9 28.5 31.3 37.8 38.1 21.6 27.7 21.5 31.5 88.6 50.7 34.7 45.2 35.0 35.9 60.8 44.8 41.4 28.9 34.8 44.4 30.7 15.9 34.3 33.8 33.2 76.8 27.5 24.4 70.8 47.8 23.1 22.8 30.4 31.3 38.6 36.2 30.4 36.2 38.2 37.5 31.7 27.5 17.9 44.5 41.3 48.4 30.9 23.8 36.7 25.4 37.5 26.8 15.6 36.5 17.6 22.4 17.7 20.7 14.7 17.5 11.7 18.6 16.4 17.8 27.1 22.5 26.0 13.2 19.2 13.5 11.4 13.3 13.4 15.0 11.1 13.0 11.5 11.7 10.3 11.8 10.4 11.7 14.4 48.5 70.5 49.6 31.3 46.9 18.7 26.8 20.4 29.0 60.9 24.3 35.3 65.0 25.8 47.1 5.5 31.3 28.6 73.8 35.2 0.0 25.1 37.0 34.9 72.5 36.4 60.4 26.3 51.4 34.8 17.0 53.0 79.5 42.0 17.7 44.2 25.4 63.3 20.4 45.4 58.0 95.3 32.6 22.0 14.0 24.9 37.0 32.9 19.6 35.6 32.1 31.8 44.3 41.2 29.1 26.4 25.8 48.9 54.4 39.0 41.3 19.4 44.7 41.5 19.7 57.9 46.6 55.7 42.1 21.9 16.1 35.8 47.8 70.2 24.6 29.4 DISP1 "DISPA, DKFZP434I0428, MGC13130, MGC16796" ENSG00000154309 "Dispatched RND transporter family member 1" Q96F81 1 222815022-223005995 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.7;Gastric mucus-secreting cells: 48.4;Inhibitory neurons: 54.4;Microglial cells: 204.2;Oligodendrocyte precursor cells: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051411 Uncertain Approved "Nuclear bodies" No No "Nuclear bodies" "HPA051411: AB_2681475" "unprognostic (2.10e-2)" "unprognostic (3.31e-1)" "unprognostic (7.00e-2)" "unprognostic (7.81e-2)" "unprognostic (7.82e-2)" "unprognostic (2.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.27e-1)" "unprognostic (2.28e-1)" "unprognostic (3.28e-1)" "prognostic favorable (5.00e-4)" "unprognostic (4.13e-1)" "prognostic favorable (3.86e-5)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "prognostic favorable (4.16e-4)" "unprognostic (9.69e-3)" 4.9 5.7 1.7 1.6 2.0 0.2 3.0 3.9 2.3 3.2 3.0 6.8 2.6 4.4 2.1 1.9 2.4 4.6 3.8 1.6 1.3 4.8 2.7 9.2 1.1 1.2 1.3 1.7 4.6 2.4 5.2 2.5 4.7 1.4 2.4 2.1 1.3 2.0 2.0 4.1 3.2 3.8 4.2 0.4 2.6 5.4 6.6 1.6 1.4 5.3 3.1 1.5 5.4 2.6 2.6 0.9 2.2 5.6 3.8 10.1 6.1 2.4 3.2 2.7 1.1 1.1 2.6 1.6 0.1 4.2 1.5 2.2 0.6 1.6 1.3 1.6 8.1 2.4 1.1 6.3 1.2 4.4 0.2 1.1 4.8 1.9 2.3 0.9 5.8 2.3 1.2 0.0 0.1 3.9 1.5 1.4 0.3 4.0 6.1 1.3 1.7 15.1 0.2 6.8 0.8 1.6 2.5 1.8 0.7 2.3 2.7 2.7 1.4 4.2 2.3 1.5 3.9 3.6 1.2 0.5 0.3 3.2 0.8 5.1 0.3 0.2 0.0 0.7 0.4 1.6 0.5 0.6 0.7 0.6 0.9 0.6 0.5 0.1 1.0 0.2 0.3 0.5 0.4 1.7 2.0 3.9 2.3 1.6 1.3 1.2 1.3 1.7 1.4 0.4 1.6 2.6 4.6 6.4 1.7 42.7 3.6 0.5 0.6 1.2 5.7 2.7 3.4 1.5 7.8 7.2 3.3 11.0 0.0 1.4 2.1 1.0 0.0 1.9 2.1 1.9 3.4 4.9 0.0 0.0 47.7 2.8 1.8 5.6 48.4 4.1 0.0 15.8 6.8 3.3 5.9 0.0 54.4 2.6 4.1 1.6 0.9 3.7 1.5 4.1 0.0 204.2 1.4 0.9 5.2 199.6 15.4 1.3 3.1 3.4 0.7 0.7 6.4 5.8 2.7 2.3 0.0 4.0 3.7 2.1 2.3 5.4 1.1 0.8 1.7 2.8 1.6 0.3 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171058414-171460408 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.1" "Cell type enhanced" "Detected in many" "Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 65.2;HMC-1: 71.3;WM-115: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol NA NA 160000 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 1.3 4.4 28.3 6.3 36.1 4.5 2.2 7.0 20.4 1.1 0.0 8.3 21.2 3.5 0.9 4.1 2.8 5.1 9.5 23.0 33.5 3.8 3.2 9.0 6.8 28.0 14.7 14.1 1.5 3.8 0.5 8.5 2.0 22.9 3.6 6.7 19.5 1.9 4.6 23.4 1.0 21.5 4.4 16.5 4.6 7.0 7.8 13.1 7.1 6.4 23.8 5.3 4.9 2.1 13.1 0.9 1.2 43.4 4.7 0.8 0.1 10.4 9.3 2.5 7.3 4.8 41.5 16.9 0.0 3.4 9.0 6.9 14.1 6.3 2.6 7.3 0.3 9.8 65.2 3.7 0.0 19.0 13.0 71.3 6.1 5.9 4.3 0.9 15.7 43.6 10.5 23.3 0.1 1.1 1.1 4.1 13.5 18.2 30.6 17.9 0.0 11.8 16.6 12.0 0.1 2.1 2.3 5.8 0.4 9.6 4.1 20.4 2.9 0.5 0.0 7.9 20.5 7.1 0.1 0.0 0.1 1.8 13.8 52.1 4.6 0.1 10.5 3.5 0.0 4.4 0.0 4.2 3.2 0.0 0.2 5.8 3.1 0.1 2.4 0.1 0.0 5.3 1.0 28.3 36.1 7.0 20.4 23.0 33.5 28.0 14.7 14.1 22.9 16.5 13.1 13.1 0.7 6.4 50.4 1074.4 4.9 2.5 1.6 1.3 9.1 19.2 8.4 6.5 28.6 21.5 7.1 9.2 14.6 6.3 32.5 19.6 5.9 12.1 48.6 1.1 2.5 1.6 13.2 13.5 248.4 7.7 1.3 9.1 21.4 0.3 83.5 0.4 2.5 8.1 2.9 0.0 360.8 10.3 0.0 6.5 1.9 38.0 2.5 10.4 1.8 57.1 1.6 65.0 51.5 374.5 205.5 7.1 21.6 6.4 11.7 0.7 56.2 17.3 1.8 28.7 0.0 12.4 6.2 3.1 1.0 10.3 1.6 2.5 47.4 9.9 16.6 3.2 FAM167A "C8orf13, DIORA-1" ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421476-11475908 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1;thyroid gland: 53.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Astrocytes: 28.4;Distal tubular cells: 13.7;Early spermatids: 24.8;Enteroendocrine cells: 19.1;Late spermatids: 41.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 57.6;RPMI-8226: 61.5;SH-SY5Y: 44.4;U-698: 44.8;U-87 MG: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria NA NA Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.3 0.8 23.7 1.2 21.5 0.7 1.3 23.3 24.7 0.5 14.4 0.7 0.3 0.1 0.5 0.9 1.3 1.0 0.1 24.6 24.6 6.0 0.3 10.3 2.4 27.1 24.8 19.6 0.0 2.1 1.8 17.5 1.0 25.0 1.5 0.7 5.2 2.6 4.6 0.0 11.9 1.3 0.0 23.5 1.3 2.1 3.8 26.5 3.0 53.7 0.1 3.0 0.3 1.6 23.3 4.8 3.0 6.1 0.6 0.4 2.5 0.2 16.8 16.0 10.1 4.4 0.2 1.5 57.6 0.9 18.3 4.7 1.6 0.1 4.0 11.9 24.8 0.8 0.0 0.1 0.0 20.8 0.0 0.1 2.9 2.6 5.3 32.2 32.3 0.0 0.0 0.2 2.2 6.0 1.8 0.1 0.0 1.6 0.1 0.1 0.3 0.0 61.5 5.1 0.5 26.3 44.4 0.8 4.7 2.2 0.8 1.8 0.1 28.5 1.0 1.6 25.8 0.2 17.7 14.0 44.8 36.3 0.1 1.6 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 23.7 21.5 23.3 24.7 24.6 24.6 27.1 24.8 19.6 25.0 23.5 26.5 23.3 0.0 16.0 1.8 28.4 5.4 5.9 0.6 0.5 0.0 0.1 1.2 1.3 0.7 1.5 0.5 5.5 10.4 0.0 1.1 0.2 13.7 2.1 24.8 2.1 0.2 0.2 19.1 0.0 0.6 1.8 0.0 0.3 2.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 1.3 0.0 0.3 0.3 41.1 0.3 0.3 0.0 3.7 0.3 1.7 0.0 0.0 1.3 1.1 2.4 0.4 0.9 0.8 0.1 0.2 1.9 1.8 0.0 0.3 0.2 3.9 2.2 0.0 3.4 0.0 1.0 0.1 0.1 0.2 NEIL2 "FLJ31644, MGC2832, MGC4505, NEH2" ENSG00000154328 "Nei like DNA glycosylase 2" Q969S2 8 11769639-11787345 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 68.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA073029, HPA073916" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073029: AB_2732216, HPA073916: AB_2732245" "unprognostic (1.52e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (9.88e-2)" "unprognostic (2.18e-2)" "unprognostic (5.72e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (5.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (4.05e-1)" 9.4 28.0 30.5 6.0 26.6 2.4 9.6 27.0 27.0 12.4 23.0 7.7 2.8 9.5 12.6 7.0 15.1 5.7 14.5 28.2 33.2 10.4 16.5 7.5 7.2 31.2 31.3 25.9 11.2 11.3 9.1 18.1 6.5 33.2 11.4 4.9 13.5 10.1 8.1 24.8 15.9 6.9 8.6 31.1 12.5 6.9 26.3 33.4 4.7 11.9 13.9 7.0 9.9 8.9 29.9 8.2 22.9 14.1 27.7 6.6 12.2 6.3 13.0 10.6 12.2 8.4 7.1 8.8 3.2 4.9 15.7 26.3 7.1 13.5 14.1 16.7 9.7 6.7 11.3 5.7 13.9 5.3 5.0 8.2 10.8 20.7 10.7 9.9 11.8 11.6 3.7 16.1 10.8 15.0 8.6 0.9 5.2 12.6 33.9 12.1 14.4 18.1 8.8 14.4 12.3 21.5 17.0 10.2 5.3 19.1 11.2 8.4 0.7 14.3 13.9 19.8 3.8 18.4 10.0 22.3 5.7 36.6 16.7 28.8 0.7 2.2 0.2 12.7 3.9 17.5 21.9 12.9 15.3 4.6 16.9 18.7 16.8 1.3 15.1 2.0 8.3 9.3 7.0 30.5 26.6 27.0 27.0 28.2 33.2 31.2 31.3 25.9 33.2 31.1 33.4 29.9 7.2 0.0 5.8 6.2 14.0 8.5 17.1 8.0 13.6 32.3 13.1 7.7 19.6 14.3 7.0 7.3 16.7 18.6 5.6 1.5 33.2 21.1 1.1 6.9 8.4 8.9 10.1 10.3 6.3 23.3 15.8 10.3 3.1 3.8 2.5 14.9 7.9 23.6 15.1 8.4 6.9 6.1 14.2 6.9 6.6 2.1 14.0 6.8 14.2 0.0 6.6 38.9 11.3 6.0 3.7 15.1 1.0 24.5 3.8 15.3 0.8 32.2 6.8 17.1 6.6 11.8 10.2 19.0 68.1 8.3 12.8 5.3 9.7 8.9 6.2 12.0 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 216.0;urinary bladder: 218.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 450000 Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 26.5 61.6 3.5 12.7 3.4 0.0 21.2 5.4 3.9 46.2 4.3 191.7 15.5 155.3 41.2 99.5 97.3 19.8 127.2 2.7 3.9 10.5 5.1 14.7 5.8 4.0 4.5 2.0 20.0 2.7 5.1 4.3 5.9 4.2 160.5 34.5 8.0 6.8 216.0 37.9 9.8 72.7 133.6 4.1 10.9 65.8 3.0 5.2 2.9 13.2 30.8 3.0 218.5 41.0 4.0 0.2 0.2 0.0 0.0 0.7 0.0 0.3 8.2 6.3 3.8 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 9.2 0.0 9.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.1 0.0 4.1 0.1 0.7 0.0 0.0 56.5 0.0 38.8 1.8 1.5 0.0 0.0 0.2 0.1 47.8 2.8 1.2 0.0 0.0 0.1 0.0 5.7 0.3 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 3.5 3.4 5.4 3.9 2.7 3.9 4.0 4.5 2.0 4.2 4.1 5.2 4.0 21.6 0.0 1.7 0.7 0.2 2.3 5.6 0.0 0.6 25.3 0.2 1.5 107.2 2.8 1.8 12.9 4.2 0.0 0.1 0.1 1.9 0.1 1.8 3.7 2.8 36.6 0.0 4.0 1.4 0.0 0.2 12.4 0.0 1.1 0.0 18.7 39.3 0.1 0.1 0.0 1.7 2.7 0.0 4.0 2.8 0.5 8.1 2.1 3.6 124.6 1.0 8.3 0.0 1.0 2.3 0.1 0.1 4.9 0.0 2.1 0.8 1.2 0.8 1.9 52.6 1.7 35.9 0.1 0.2 0.4 2.4 0.0 0.6 30.0 1.6 1.5 WNT3A ENSG00000154342 "Wnt family member 3A" P56704 1 228006998-228061271 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 15.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Basal keratinocytes: 3.4;Basal prostatic cells: 3.1;Basal squamous epithelial cells: 8.6;Syncytiotrophoblasts: 2.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HEK 293: 1.1;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA049893 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA049893: " "unprognostic (9.84e-3)" "prognostic favorable (6.11e-5)" "unprognostic (2.40e-1)" "unprognostic (3.37e-1)" "unprognostic (7.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.96e-1)" "unprognostic (4.22e-2)" "unprognostic (4.12e-2)" "unprognostic (2.16e-1)" "unprognostic (4.80e-3)" "unprognostic (1.99e-1)" "unprognostic (7.26e-2)" "unprognostic (5.43e-3)" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.8 0.0 1.3 0.0 0.0 0.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 3.4 3.1 1.2 8.6 0.0 0.0 0.1 1.9 0.0 0.9 1.8 0.0 2.0 0.0 0.4 0.0 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.5 1.0 2.9 0.0 0.0 0.1 0.5 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208044-228378876 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 485.2" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 155.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 10.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" NA NA 4500000 "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 2.4 2.5 1.7 1.4 14.8 1.6 3.7 9.3 3.2 7.3 14.2 5.0 0.7 3.7 1.8 4.6 5.1 1.1 58.7 0.9 2.7 6.6 1.3 8.9 2.1 5.5 2.4 0.9 8.7 5.4 1.1 13.7 0.9 7.3 10.0 0.5 0.8 9.4 1.7 485.2 4.1 5.5 0.5 0.7 9.3 5.3 1.9 4.6 5.0 7.5 113.8 1.3 3.2 7.5 2.7 1.7 2.8 3.6 3.7 0.2 0.2 4.6 1.6 0.7 1.7 1.4 2.1 1.3 3.2 5.4 0.7 0.7 2.1 1.3 2.2 0.3 2.0 3.4 1.7 10.5 0.1 1.2 2.4 2.2 1.4 0.6 0.4 0.5 5.1 0.5 7.0 3.2 0.0 0.3 1.8 3.3 3.5 4.9 0.6 2.1 4.4 0.0 1.9 1.8 1.4 1.7 6.3 0.6 3.9 1.0 0.8 3.4 4.0 1.0 0.0 5.1 0.3 0.5 2.5 0.5 4.7 0.0 0.8 2.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.7 14.8 9.3 3.2 0.9 2.7 5.5 2.4 0.9 7.3 0.7 4.6 2.7 1.5 0.0 5.5 1.6 2.4 2.2 6.6 7.7 23.9 4.2 7.3 11.9 155.8 4.3 4.5 5.5 10.4 0.1 1.9 0.7 11.7 3.6 4.9 3.9 3.7 3.1 0.0 3.0 3.9 0.5 0.5 5.7 3.1 11.3 7.0 1.8 1.4 0.5 0.1 0.0 5.3 2.7 4.1 0.3 1.0 4.5 3.1 1.1 1.8 5.6 0.5 7.9 4.1 1.5 1.7 0.8 1.1 4.5 1.5 3.8 0.6 4.1 1.3 3.2 0.0 22.9 6.1 1.0 4.1 9.4 1.7 1.2 5.4 6.2 1.2 3.6 LONRF1 "FLJ23749, RNF191" ENSG00000154359 "LON peptidase N-terminal domain and ring finger 1" Q17RB8 8 12721906-12756073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023584, HPA024814" Uncertain Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023584: AB_1853233, HPA024814: AB_1853235" "unprognostic (2.59e-1)" "unprognostic (2.17e-3)" "unprognostic (1.35e-2)" "unprognostic (3.56e-1)" "unprognostic (9.09e-2)" "unprognostic (3.96e-3)" "unprognostic (3.13e-1)" "unprognostic (5.78e-2)" "unprognostic (2.74e-3)" "unprognostic (1.18e-1)" "unprognostic (5.83e-2)" "unprognostic (3.39e-1)" "unprognostic (5.46e-3)" "unprognostic (8.97e-2)" "unprognostic (8.90e-2)" "unprognostic (3.08e-3)" "unprognostic (1.15e-1)" 16.3 5.9 2.4 4.5 2.8 6.0 10.6 3.5 3.7 11.5 1.4 6.5 2.4 11.4 9.7 13.1 10.6 9.6 4.2 3.1 3.2 6.4 10.0 7.3 7.1 2.4 2.4 2.7 15.3 7.6 8.1 3.9 10.2 2.6 10.8 4.3 8.0 8.1 10.7 17.3 28.0 4.5 9.3 2.2 8.5 5.4 16.0 2.5 6.9 8.8 11.4 8.1 8.0 8.4 2.9 1.2 3.0 15.0 4.6 15.6 7.4 10.0 3.8 6.3 4.1 5.7 0.9 3.9 24.0 0.9 6.7 12.9 1.8 12.0 4.7 4.6 3.7 6.8 7.9 0.5 6.2 14.4 2.1 3.0 7.0 8.2 2.6 8.9 3.8 6.4 9.7 1.1 56.6 2.7 4.2 10.4 7.0 15.5 4.8 0.9 5.8 10.2 4.3 3.5 10.2 31.2 3.6 2.2 5.1 29.8 10.7 1.0 10.4 2.9 2.2 3.7 8.9 3.0 4.3 20.7 12.4 12.0 7.2 7.0 0.0 0.1 0.6 0.1 0.5 0.3 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 2.4 2.8 3.5 3.7 3.1 3.2 2.4 2.4 2.7 2.6 2.2 2.5 2.9 18.9 9.6 16.3 23.2 25.2 60.8 32.8 7.8 52.3 25.1 15.1 10.3 9.7 10.0 13.1 11.0 16.7 3.6 6.3 4.3 7.9 5.3 57.4 12.1 27.9 15.1 2.4 4.6 67.0 4.0 8.2 24.2 5.6 28.3 6.3 27.8 6.1 14.7 5.6 8.4 43.6 6.4 4.1 9.5 27.6 53.5 29.2 17.2 44.4 21.5 3.6 8.3 0.0 42.7 14.9 4.3 6.4 19.9 16.3 26.4 3.8 6.0 8.7 13.0 19.7 36.7 32.7 8.2 19.7 26.4 73.6 7.3 9.7 3.4 5.8 30.1 TRIM11 "BIA1, RNF92" ENSG00000154370 "Tripartite motif containing 11" Q96F44 1 228393673-228406835 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028541, HPA043879" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028541: AB_10600833, HPA043879: AB_2678711" "unprognostic (1.73e-1)" "unprognostic (9.73e-3)" "unprognostic (5.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.27e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.08e-1)" "unprognostic (9.74e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.89e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" 9.5 12.2 13.1 9.0 15.1 31.0 10.5 22.9 15.3 13.7 10.1 11.6 7.8 11.6 4.5 20.9 12.8 6.1 8.5 14.7 11.5 11.4 10.3 11.9 12.3 12.6 10.9 12.9 12.0 12.0 6.7 9.9 5.7 16.0 15.5 7.2 2.0 17.2 7.1 5.1 17.2 14.8 4.7 9.7 24.3 13.0 15.0 12.8 10.1 11.1 3.1 8.8 11.8 15.8 11.1 28.3 26.3 13.8 19.1 10.2 8.4 65.1 18.1 12.1 20.5 16.4 32.2 24.0 21.1 19.7 12.2 13.5 45.1 16.8 17.4 8.6 23.6 40.5 17.5 26.7 17.6 27.6 22.2 25.6 11.3 27.2 21.3 10.6 10.5 10.2 33.9 40.7 26.4 10.7 18.2 27.1 35.1 35.3 23.9 22.9 26.3 12.5 25.8 13.4 34.0 22.9 42.0 15.1 42.2 24.7 5.6 29.9 36.8 11.6 13.0 18.3 30.6 37.9 26.9 19.3 18.9 16.1 17.7 20.9 5.2 4.5 5.6 5.5 5.3 5.9 3.7 6.4 7.1 4.4 3.5 3.6 5.1 6.2 6.2 7.5 3.5 6.4 3.9 13.1 15.1 22.9 15.3 14.7 11.5 12.6 10.9 12.9 16.0 9.7 12.8 11.1 7.8 3.2 5.8 1.6 12.1 15.8 16.3 7.4 10.8 12.1 13.3 10.7 3.6 12.8 10.4 1.8 2.1 15.7 21.6 28.1 17.6 14.8 154.2 11.2 10.2 10.1 14.4 12.6 9.8 11.0 15.5 8.5 23.4 17.1 5.7 13.4 8.9 5.7 11.8 5.0 4.7 21.7 4.1 12.6 9.3 16.5 9.6 11.0 5.4 2.8 22.0 10.3 30.9 3.0 3.2 18.3 21.1 7.5 12.8 17.4 17.8 9.9 7.3 1.6 6.6 8.4 9.1 7.3 12.4 15.8 19.5 57.3 18.9 14.9 17.6 30.1 ENAH "FLJ10773, MENA, NDPP1" ENSG00000154380 "ENAH actin regulator" Q8N8S7 1 225486835-225653142 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028448, HPA028696" Enhanced Enhanced "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 15000 "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028448: AB_10600766, HPA028696: AB_10611249" "unprognostic (2.56e-2)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.61e-3)" "unprognostic (2.85e-1)" "unprognostic (1.21e-3)" "unprognostic (2.30e-1)" "unprognostic (2.23e-1)" "unprognostic (9.22e-2)" "unprognostic (4.71e-3)" "unprognostic (2.14e-1)" "unprognostic (2.24e-3)" "unprognostic (8.84e-2)" "unprognostic (5.83e-2)" "unprognostic (7.92e-2)" "unprognostic (2.93e-2)" 26.5 20.4 33.5 16.7 25.8 0.5 13.6 26.7 21.0 13.6 6.7 23.7 12.6 23.8 13.8 16.4 15.1 23.8 25.4 28.6 36.7 7.1 7.6 17.4 4.8 38.5 31.1 15.3 22.8 22.5 18.0 6.5 18.4 28.5 21.6 10.2 8.2 21.1 30.8 20.6 10.7 10.9 58.2 25.1 25.0 23.5 25.3 47.0 9.1 7.3 11.6 4.6 30.3 13.9 44.9 91.6 71.9 87.1 79.0 33.3 43.7 111.9 99.1 47.3 58.4 43.9 46.4 33.0 38.7 256.8 153.9 52.5 79.0 102.7 37.4 55.2 0.6 63.4 40.3 62.4 63.1 99.4 4.8 1.5 67.9 44.2 75.9 96.2 47.8 47.0 10.7 2.7 1.9 58.6 17.7 18.5 4.7 146.8 23.9 64.3 27.6 122.9 1.1 26.9 69.5 85.3 68.9 194.6 73.3 63.3 66.1 87.5 5.9 92.2 150.4 109.8 126.8 198.6 4.2 11.4 25.7 82.7 5.0 78.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.5 25.8 26.7 21.0 28.6 36.7 38.5 31.1 15.3 28.5 25.1 47.0 44.9 117.0 12.8 37.3 81.9 3.8 129.0 172.5 64.4 26.2 11.2 96.2 57.9 119.3 54.3 56.5 22.0 62.6 65.0 1.7 14.8 3.9 84.7 74.8 127.2 60.5 79.3 41.4 0.0 86.3 100.5 18.5 71.6 63.2 75.0 5.1 194.2 23.9 12.9 11.2 16.8 155.0 27.3 26.4 1.6 29.7 24.3 58.1 4.3 83.6 41.2 3.8 32.6 3.1 160.4 151.3 61.5 16.5 168.9 1.6 133.1 3.5 19.6 137.8 19.0 92.1 69.4 166.1 13.4 37.2 25.6 134.1 60.5 4.8 220.7 31.3 100.3 PPP1R3A "GM, PPP1R3" ENSG00000154415 "Protein phosphatase 1 regulatory subunit 3A" Q16821 7 113876777-114075920 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 64 "heart muscle: 41.2;skeletal muscle: 154.4;tongue: 105.0" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 157.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "THP-1: 14.6" "Region enriched" "Detected in single" 12 "thalamus: 1.1" "Not detected" "Not detected" "HPA070440, HPA073138" Enhanced NA NA "HPA070440: , HPA073138: " "unprognostic (8.96e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 154.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 105.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.8 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCSAP "C1orf96, CSAP, FLJ41471" ENSG00000154429 "Centriole, cilia and spindle associated protein" Q6IQ19 1 229321011-229343294 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 25.5;retina: 26.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 105.0;Oligodendrocytes: 52.7;Syncytiotrophoblasts: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 70.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028402, HPA043443" Enhanced Supported NA NA "HPA028402: AB_10603681, HPA043443: AB_2678485" "unprognostic (4.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.63e-1)" "unprognostic (1.18e-1)" "unprognostic (3.26e-1)" "unprognostic (4.97e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.50e-13)" "unprognostic (9.67e-2)" "unprognostic (4.93e-1)" "unprognostic (4.15e-2)" "unprognostic (1.03e-1)" 2.5 2.7 16.9 3.9 20.3 13.1 5.4 24.5 25.5 3.1 7.4 2.3 2.8 2.7 2.0 3.0 2.0 2.7 2.3 20.5 13.1 1.3 2.8 3.8 3.9 11.0 15.4 18.9 5.2 2.3 3.2 6.3 13.2 12.4 3.4 2.7 26.0 4.4 2.6 2.3 11.2 3.1 2.1 10.1 4.4 2.4 1.9 15.7 14.2 1.9 2.3 3.2 2.6 3.0 19.9 12.4 6.6 8.7 16.0 5.7 5.3 70.5 8.9 4.5 9.9 9.4 8.2 7.6 7.8 6.4 7.9 8.1 9.5 18.6 6.6 10.0 14.6 18.1 8.2 6.4 5.9 3.5 13.6 15.6 2.0 5.2 7.7 9.7 7.8 7.1 17.9 11.3 11.6 8.0 4.2 38.7 14.3 8.1 9.3 9.8 11.3 22.2 5.1 4.6 7.6 17.5 23.7 16.7 9.9 8.4 7.1 7.8 18.8 4.6 8.5 13.1 11.7 14.0 10.6 17.5 5.7 10.2 13.3 10.3 3.7 0.5 1.3 0.3 1.2 0.7 0.2 0.4 0.5 0.5 0.3 0.4 0.3 0.9 0.2 1.4 0.7 0.6 0.1 16.9 20.3 24.5 25.5 20.5 13.1 11.0 15.4 18.9 12.4 10.1 15.7 19.9 2.2 9.6 1.1 7.8 8.4 8.2 5.0 1.7 9.6 105.0 8.3 10.8 4.4 1.5 1.8 1.8 41.7 15.2 15.1 2.0 5.9 1.3 33.7 3.8 3.1 2.4 2.4 7.4 48.3 0.4 39.1 5.7 3.6 5.5 0.0 4.3 1.8 2.7 11.1 18.5 36.7 4.6 4.1 14.7 23.1 27.9 0.0 22.0 5.4 7.5 9.2 11.7 7.2 12.5 52.7 0.5 0.3 2.6 14.5 7.6 0.5 0.1 1.8 43.8 0.0 6.4 4.7 1.4 1.4 12.2 16.3 101.8 10.1 0.8 2.9 4.7 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 10.8" "Group enriched" "Detected in some" 8 "Spermatocytes: 89.0;Spermatogonia: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA020558 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 6.6 0.2 0.0 89.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SH3RF1 "KIAA1494, POSH, RNF142, SH3MD2" ENSG00000154447 "SH3 domain containing ring finger 1" Q7Z6J0 4 169094259-169270956 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 146.3;Oligodendrocytes: 213.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7" "Group enriched" "Detected in many" 15 "dendritic cells: 2.5;monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074783 Approved Supported "Vesicles,Intermediate filaments" No No Vesicles "Intermediate filaments" "HPA074783: AB_2732268" "unprognostic (4.14e-1)" "unprognostic (4.67e-2)" "unprognostic (1.23e-1)" "unprognostic (7.83e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (1.29e-1)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (9.58e-2)" "unprognostic (4.77e-3)" "unprognostic (7.88e-2)" "prognostic favorable (5.51e-8)" "unprognostic (4.43e-2)" "unprognostic (1.63e-1)" "unprognostic (5.99e-2)" "unprognostic (1.77e-1)" 9.1 3.7 9.1 4.5 10.4 3.5 8.3 8.1 13.5 5.7 6.8 15.3 13.9 4.4 5.7 6.0 5.6 12.0 5.7 18.4 12.4 12.3 8.0 9.5 3.3 9.3 10.4 8.9 8.5 10.5 3.7 3.7 7.4 9.6 14.5 13.8 2.4 15.9 8.5 9.5 5.1 13.3 4.0 9.2 3.9 25.0 6.1 10.0 2.0 20.1 10.1 3.2 9.4 4.4 13.5 15.2 12.2 11.0 31.9 11.5 14.3 14.1 40.5 19.7 30.0 13.8 12.5 17.8 0.0 1.9 43.1 8.1 9.8 8.9 16.2 32.4 0.1 5.2 8.7 27.4 6.5 26.0 3.1 0.3 8.5 8.6 25.7 19.9 37.3 18.7 3.3 0.1 0.0 27.8 6.0 3.1 2.9 5.6 19.2 10.5 4.5 3.6 0.6 13.6 11.8 8.3 9.9 10.4 15.7 4.2 4.7 5.2 1.3 17.1 14.2 11.0 23.6 14.7 1.1 0.0 0.1 16.0 3.0 17.3 0.0 1.0 0.0 0.0 4.2 0.0 0.3 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.2 6.7 0.2 0.0 0.6 9.1 10.4 8.1 13.5 18.4 12.4 9.3 10.4 8.9 9.6 9.2 10.0 13.5 28.0 64.1 37.7 146.3 3.4 34.3 48.3 11.9 13.6 3.5 21.1 15.6 11.2 44.3 34.4 27.6 0.0 12.7 0.4 69.3 11.7 42.2 5.5 28.5 14.2 13.0 31.3 2.1 54.9 63.7 22.1 16.5 65.7 46.5 10.2 5.6 11.4 12.4 7.4 0.0 54.9 27.1 12.2 9.3 5.3 3.5 12.2 11.1 3.6 52.5 3.9 11.3 0.0 89.5 213.0 68.4 37.2 12.0 2.4 63.2 28.9 18.4 31.7 1.2 65.7 24.1 36.9 5.4 10.7 9.4 12.6 13.1 1.7 6.5 34.4 72.0 GBP5 ENSG00000154451 "Guanylate binding protein 5" Q96PP8 1 89258950-89272804 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Antimicrobial, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.2;lymphoid tissue: 74.6" "Cell type enhanced" "Detected in many" "dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 243.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5" "Low region specificity" "Detected in many" HPA028656 Supported NA NA "HPA028656: AB_10601471" "unprognostic (2.72e-2)" "unprognostic (1.82e-2)" "prognostic favorable (9.54e-4)" "prognostic favorable (3.73e-6)" "unprognostic (8.33e-2)" "unprognostic (8.68e-3)" "unprognostic (3.71e-2)" "unprognostic (6.43e-3)" "unprognostic (2.37e-3)" "prognostic favorable (1.24e-4)" "unprognostic (3.47e-2)" "unprognostic (4.16e-1)" "prognostic unfavorable (5.53e-8)" "unprognostic (2.75e-2)" "unprognostic (3.68e-2)" "unprognostic (1.66e-1)" "unprognostic (4.11e-2)" 3.7 3.3 0.4 74.6 0.8 35.2 4.6 0.4 1.5 3.1 1.5 7.0 5.9 2.3 1.5 2.6 3.2 11.6 2.0 0.4 0.7 2.0 11.2 19.3 54.8 2.0 0.5 0.3 2.8 1.1 0.7 1.0 2.8 1.1 2.4 8.1 0.3 4.8 1.2 0.7 1.0 9.1 6.2 0.5 43.0 9.3 4.0 0.9 12.5 2.3 0.9 23.5 12.8 1.5 0.9 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.7 1.2 1.2 0.0 0.1 0.1 6.5 5.3 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.9 0.6 3.0 0.3 0.0 0.0 10.0 1.4 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.6 1.3 0.1 0.0 0.0 4.0 0.1 0.5 0.5 0.0 2.2 20.7 0.5 0.1 0.2 31.5 0.0 0.9 15.3 1.1 97.5 38.0 150.4 4.8 63.1 89.3 6.7 6.0 23.2 35.8 97.9 53.4 44.9 0.7 243.8 38.4 0.4 0.8 0.4 1.5 0.4 0.7 2.0 0.5 0.3 1.1 0.5 0.9 0.9 2.1 6.4 5.1 0.0 12.4 0.0 0.2 0.5 0.6 0.0 0.4 0.4 0.7 1.5 4.2 0.0 4.2 0.1 39.2 0.1 0.0 0.0 0.4 3.7 0.4 2.8 0.0 0.8 0.0 1.1 0.0 1.5 2.0 3.9 10.8 0.2 4.6 0.6 4.0 0.0 0.7 0.0 0.0 18.9 1.4 0.2 0.0 17.1 0.0 2.8 10.4 2.9 75.2 0.0 0.0 1.3 0.0 0.0 22.9 0.4 0.0 0.3 8.0 0.4 0.0 0.9 0.9 0.1 2.9 0.9 0.0 0.1 72.9 11.0 0.1 0.1 BUB3 BUB3L ENSG00000154473 "BUB3 mitotic checkpoint protein" O43684 10 123154402-123170467 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003601, CAB037075" Supported Supported Nucleoplasm NA Yes 39000 Nucleoplasm "CAB037075: AB_1078310, HPA003601: AB_1078309" "unprognostic (7.82e-2)" "prognostic favorable (2.04e-4)" "unprognostic (9.07e-2)" "unprognostic (1.83e-1)" "unprognostic (7.93e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (4.45e-5)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (6.30e-3)" "unprognostic (2.69e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.81e-7)" "unprognostic (8.80e-2)" "unprognostic (7.64e-2)" "unprognostic (1.51e-1)" "unprognostic (7.71e-2)" 36.5 50.2 29.8 63.9 34.4 103.8 41.5 35.7 34.0 34.6 32.9 49.5 42.6 36.1 35.6 57.0 37.9 36.1 28.2 32.5 36.2 32.8 35.2 33.8 100.7 35.1 37.5 28.8 43.3 30.4 32.8 36.3 38.5 37.3 30.9 49.6 25.8 39.9 29.1 37.2 44.2 48.1 36.7 37.4 53.3 38.8 59.0 34.4 101.6 37.7 33.8 87.9 49.9 40.8 49.8 309.8 302.5 190.4 211.5 105.4 100.3 166.2 316.2 329.5 340.3 268.8 266.3 203.2 275.9 116.3 145.2 163.6 195.9 285.1 343.0 349.9 228.8 294.2 173.0 355.1 291.8 110.1 338.1 206.8 86.5 132.9 307.9 382.4 182.1 232.7 228.9 216.1 266.7 308.4 264.1 281.8 206.9 117.6 159.0 293.0 378.6 96.2 175.7 156.3 333.1 141.4 143.1 179.2 116.6 151.9 77.5 135.0 173.4 188.5 262.4 163.9 167.6 473.8 143.0 220.6 433.9 143.0 333.2 113.2 200.3 113.2 165.7 246.0 122.2 224.1 216.7 223.0 251.0 119.1 209.7 237.9 249.3 56.1 241.6 112.3 127.6 366.9 294.0 29.8 34.4 35.7 34.0 32.5 36.2 35.1 37.5 28.8 37.3 37.4 34.4 49.8 55.8 25.6 36.5 15.3 99.7 130.5 65.5 154.6 73.4 30.8 53.4 48.8 39.2 44.3 66.9 38.6 10.4 108.1 119.0 37.1 70.5 68.8 160.8 26.1 41.4 62.1 40.7 93.6 14.4 58.9 136.5 62.6 34.7 28.1 50.7 56.3 45.0 43.0 80.7 10.1 12.9 57.3 118.0 58.1 68.6 159.3 45.1 53.1 96.0 16.9 140.4 55.7 97.9 21.6 35.9 64.1 40.2 46.3 107.1 64.7 44.5 78.4 51.2 25.1 105.2 42.2 70.6 199.8 145.4 86.3 133.3 65.0 150.3 84.1 67.8 62.9 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123697399 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "brain: 7.0" "Cell type enriched" "Detected in some" 6 "Excitatory neurons: 11.4" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 62.7" HPA062736 Enhanced NA NA "HPA062736: AB_2684855" "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 2.0 0.0 0.0 0.0 0.0 2.0 7.0 1.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.0 4.5 5.6 2.0 2.0 7.0 1.3 1.0 0.6 3.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CCDC173 "C2orf77, LOC129881" ENSG00000154479 "Coiled-coil domain containing 173" Q0VFZ6 2 169645425-169694405 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 81.0" "Cell type enhanced" "Detected in many" "Early spermatids: 939.2;Endometrial ciliated cells: 118.1;Late spermatids: 133.4;Respiratory ciliated cells: 232.6;Spermatocytes: 460.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042995, HPA048454" Approved NA NA "HPA042995: AB_2678260, HPA048454: AB_2680400" "unprognostic (1.66e-2)" "unprognostic (2.68e-2)" "unprognostic (2.27e-1)" "unprognostic (3.16e-2)" "unprognostic (9.20e-2)" "unprognostic (4.18e-2)" "unprognostic (3.56e-3)" "unprognostic (3.05e-1)" "unprognostic (3.14e-2)" "unprognostic (1.69e-1)" "unprognostic (5.26e-6)" "unprognostic (8.73e-2)" "unprognostic (1.20e-1)" "unprognostic (2.20e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-2)" "unprognostic (1.41e-1)" 0.3 0.3 12.9 0.7 7.9 3.6 1.3 6.4 11.7 1.0 19.2 0.2 0.6 1.2 1.2 0.2 15.0 0.5 0.1 9.1 11.1 1.0 0.4 2.5 0.2 12.2 14.0 5.2 0.8 1.4 1.6 2.6 0.1 9.5 0.4 0.4 6.7 0.2 0.8 0.1 0.2 0.4 0.6 13.4 0.1 0.4 81.0 8.3 0.2 3.4 0.0 0.0 0.2 0.2 10.0 0.5 0.8 0.8 0.2 0.0 0.1 0.9 0.4 0.0 0.4 0.1 0.3 0.1 0.1 0.1 0.0 0.7 0.6 0.7 1.0 0.7 0.1 0.5 11.1 0.7 0.3 0.0 1.1 2.5 0.0 0.1 1.4 0.0 0.6 0.0 0.6 2.5 0.1 0.0 1.2 0.2 0.3 0.2 0.3 0.6 0.0 0.0 0.0 0.3 0.5 2.7 0.7 0.1 0.0 0.0 0.3 0.6 0.1 0.0 0.2 0.1 0.7 0.4 0.4 0.3 0.3 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.9 7.9 6.4 11.7 9.1 11.1 12.2 14.0 5.2 9.5 13.4 8.3 10.0 1.5 9.6 8.3 12.7 1.6 0.1 2.5 3.8 1.2 13.3 2.2 3.9 0.6 0.0 31.7 1.8 8.4 0.2 4.1 0.1 5.9 0.4 939.2 118.1 3.3 1.2 0.0 0.0 5.8 0.4 2.6 3.5 1.5 2.3 2.5 0.5 1.4 0.8 0.0 0.0 2.3 0.7 8.2 0.3 0.2 133.4 7.5 1.0 1.8 2.8 0.0 7.3 0.0 1.5 0.5 0.1 0.0 6.8 1.9 0.5 0.0 3.2 232.6 13.7 13.1 21.2 1.8 460.3 13.7 0.0 0.0 0.1 3.3 0.1 0.1 0.9 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125753580-125775821 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" Heterotaxy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "epididymis: 54.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Granulosa cells: 1.4;Microglial cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.3 0.5 0.6 0.8 0.7 0.2 1.8 0.8 0.2 0.2 0.2 0.5 0.5 54.3 0.5 0.4 0.7 0.8 0.6 0.4 0.1 0.3 0.2 1.0 0.4 0.4 0.4 3.7 0.7 0.0 0.1 0.1 0.8 0.5 0.1 1.8 1.2 0.2 0.3 1.2 0.4 0.2 0.4 0.6 0.4 1.0 0.5 0.0 0.5 0.0 0.2 0.2 0.0 1.0 0.4 0.2 0.6 0.4 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.4 0.1 0.9 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.3 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.5 0.2 0.2 0.3 0.5 0.4 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 1.8 0.8 0.6 0.4 0.4 0.4 0.4 0.8 0.4 0.5 1.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126798708 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 109.1" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 819.4" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 0.6 0.0 28.2 0.1 61.1 0.0 4.7 35.2 32.9 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 22.5 34.2 0.1 0.1 0.0 0.0 53.2 50.1 11.6 0.1 0.2 0.0 0.3 0.3 84.9 0.0 0.1 0.0 10.7 0.0 0.1 0.9 0.1 0.0 34.7 0.0 0.0 6.5 53.9 1.2 0.3 0.4 0.7 0.0 0.0 109.1 0.3 0.1 0.0 0.0 0.8 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 2.3 0.0 1.6 0.0 0.9 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 118.8 0.0 0.0 0.2 0.0 4.7 0.0 36.1 0.7 0.0 27.2 0.0 37.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 61.1 35.2 32.9 22.5 34.2 53.2 50.1 11.6 84.9 34.7 53.9 109.1 0.2 0.0 0.0 24.5 0.1 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 120.5 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 142.7 0.3 0.0 0.0 3.7 0.0 0.0 0.0 181.0 819.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 1.3 0.5 0.0 0.0 4.2 0.1 0.0 0.0 0.0 DIPK1A "FAM69A, FLJ23493" ENSG00000154511 "Divergent protein kinase domain 1A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favorable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 19.0 4.3 22.7 14.7 25.9 10.1 10.0 24.3 29.5 7.9 16.5 14.3 11.8 15.8 4.8 12.1 9.6 14.7 6.7 23.8 23.4 7.9 33.1 6.0 15.1 23.8 24.6 22.8 7.6 4.5 15.3 3.9 17.1 24.8 11.9 16.1 8.4 7.6 13.9 11.4 7.4 11.1 25.7 23.0 10.7 12.0 8.7 23.5 16.2 8.1 7.6 12.3 15.0 6.2 33.6 11.2 12.6 4.6 11.5 17.6 33.5 5.9 33.9 69.0 18.6 37.8 6.7 2.3 38.3 6.0 62.1 38.0 13.6 0.9 25.3 30.5 15.7 12.2 1.2 9.2 17.1 6.3 3.4 2.1 19.6 19.8 40.8 9.7 31.8 0.3 22.7 13.4 37.7 24.1 4.0 12.4 3.1 8.6 18.4 4.6 11.4 36.2 11.5 2.6 11.2 11.8 9.5 9.7 9.2 12.7 10.6 4.3 1.1 1.3 22.1 17.0 43.0 12.0 57.7 60.2 44.0 10.4 2.2 2.0 0.1 1.8 0.1 19.3 0.9 15.5 43.4 22.3 15.5 8.6 26.9 25.6 22.2 0.5 24.2 0.6 14.1 21.9 12.3 22.7 25.9 24.3 29.5 23.8 23.4 23.8 24.6 22.8 24.8 23.0 23.5 33.6 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 30.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 25.3 0.7 0.0 0.0 0.0 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175181710 "Metabolic proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1017.9;tongue: 1098.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 880.5;Distal tubular cells: 2666.7;Extravillous trophoblasts: 1022.6;Hofbauer cells: 1008.2;Proximal tubular cells: 2131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favorable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 185.1 200.8 140.5 132.3 144.9 142.4 166.0 161.3 156.3 116.2 162.6 318.4 382.2 128.9 127.6 307.8 108.2 76.5 1017.9 144.1 163.9 425.7 388.4 119.1 128.3 154.5 147.5 141.3 100.6 121.2 555.5 140.6 103.2 158.7 110.9 318.1 127.6 186.5 115.6 785.3 162.9 299.8 123.2 151.3 132.5 274.7 62.8 153.5 190.6 136.2 1098.2 177.7 173.5 166.7 174.8 268.4 232.3 346.7 381.8 290.0 255.9 387.1 242.7 255.1 334.8 290.9 700.0 216.4 661.1 276.5 272.0 365.7 343.3 440.2 419.9 348.5 278.3 411.7 538.7 312.1 896.6 225.9 702.4 308.8 279.9 317.7 377.5 239.3 257.4 341.9 313.2 587.0 305.1 370.3 361.9 541.1 587.3 460.6 638.4 726.1 417.1 321.5 648.4 664.5 590.9 310.5 196.3 195.1 521.4 557.0 487.5 313.4 567.0 231.6 55.9 263.2 1.7 338.0 239.5 327.1 582.4 319.8 420.8 251.8 115.2 293.9 126.9 168.4 332.1 170.7 202.4 176.5 184.2 425.2 163.2 164.2 181.1 32.6 197.9 309.4 314.5 204.0 438.5 140.5 144.9 161.3 156.3 144.1 163.9 154.5 147.5 141.3 158.7 151.3 153.5 174.8 250.4 176.3 157.2 0.0 69.0 0.0 0.0 0.0 0.0 0.0 324.8 399.4 0.0 0.0 125.7 310.8 0.0 880.5 134.2 0.0 2666.7 479.0 0.0 271.2 264.1 79.3 0.0 0.0 0.0 375.2 1022.6 154.1 0.0 301.5 88.3 236.8 0.0 0.0 1008.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 205.5 0.0 0.0 205.7 0.0 0.0 0.0 0.0 391.9 0.0 0.0 26.5 0.0 0.0 2131.8 129.7 0.0 0.0 0.0 181.9 0.0 0.0 0.0 0.0 690.9 81.0 469.5 0.0 0.0 CNTNAP3B ENSG00000154529 "Contactin associated protein family member 3B" Q96NU0 9 41890314-42129510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 69.6;Hepatic stellate cells: 91.8;Inhibitory neurons: 161.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 38 "granulocytes: 3.7" "Cell line enhanced" "Detected in many" "A549: 29.9;AF22: 41.8;WM-115: 28.5" HPA047731 Uncertain NA NA "HPA047731: AB_2680137" "unprognostic (2.68e-2)" "unprognostic (9.63e-3)" "unprognostic (2.20e-2)" "unprognostic (2.87e-1)" "unprognostic (1.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.20e-3)" "unprognostic (5.70e-2)" "unprognostic (2.27e-1)" "unprognostic (7.20e-2)" "unprognostic (3.74e-3)" "unprognostic (1.64e-1)" "unprognostic (7.74e-2)" "unprognostic (5.78e-3)" "unprognostic (7.93e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-4)" 8.7 1.6 5.7 1.4 10.0 0.3 10.2 3.0 6.1 3.5 6.7 6.9 1.4 2.5 0.7 9.3 5.0 2.6 5.0 7.7 6.5 6.9 2.6 3.4 1.0 5.0 9.1 6.1 1.1 1.5 0.4 2.9 3.8 5.7 2.8 2.8 6.4 6.7 2.1 1.6 8.8 3.7 3.2 2.3 3.8 2.1 1.9 4.2 2.4 2.1 1.6 1.1 3.2 4.2 5.3 0.2 29.9 41.8 0.0 1.3 0.5 0.1 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.1 0.6 3.7 2.4 2.3 0.0 0.1 1.3 0.0 5.4 2.6 0.9 1.4 0.0 3.3 3.4 0.4 0.5 10.4 7.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 4.1 1.0 9.0 0.0 0.7 11.9 1.4 0.8 3.0 0.3 1.1 0.0 5.8 1.3 0.0 4.2 7.4 0.2 2.8 0.1 0.8 0.0 0.0 0.0 0.0 1.3 28.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 5.7 10.0 3.0 6.1 7.7 6.5 5.0 9.1 6.1 5.7 2.3 4.2 5.3 69.6 0.0 6.3 34.6 0.6 4.2 7.8 2.4 15.4 2.6 3.9 11.8 7.1 4.3 1.2 3.7 0.0 3.1 0.3 0.3 0.0 2.1 2.0 2.8 0.3 35.0 1.8 2.7 34.6 3.3 2.1 6.2 0.0 1.3 1.3 0.4 91.8 7.5 0.1 0.0 161.6 1.6 6.1 3.8 0.8 1.4 0.9 0.5 5.4 33.7 0.0 27.9 0.0 8.0 1.3 2.0 0.0 0.7 0.0 3.2 0.0 9.7 11.1 1.0 0.0 0.7 3.6 0.8 7.0 8.4 5.3 0.7 0.7 0.2 0.1 6.0 MAGED4 "KIAA1859, MAGE-E1, MAGE1, MGC3210" ENSG00000154545 "MAGE family member D4" Q96JG8 X 52184823-52192268 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "brain: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.0;ASC TERT1: 2.7;Hep G2: 7.7" HPA003554 Uncertain NA NA "HPA003554: AB_1853497" "unprognostic (7.71e-2)" "unprognostic (8.21e-2)" "unprognostic (4.07e-4)" "unprognostic (6.15e-2)" 0.1 0.2 2.0 0.1 1.9 0.0 0.3 0.7 3.9 0.2 0.9 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 1.7 3.0 0.0 0.0 0.0 0.0 1.4 1.6 2.3 0.2 0.1 0.0 0.3 0.1 1.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 3.0 0.5 0.5 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 7.7 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 2.0 1.9 0.7 3.9 1.7 3.0 1.4 1.6 2.3 1.2 1.2 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRSF12 "SFRS13B, SFRS19, SRrp35" ENSG00000154548 "Serine and arginine rich splicing factor 12" Q8WXF0 6 89095959-89118071 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 11.5" "Cell type enhanced" "Detected in many" "Early spermatids: 162.1;Late spermatids: 214.0;Spermatocytes: 65.7;Spermatogonia: 42.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.3;AN3-CA: 9.5;HAP1: 7.5;HEK 293: 7.6;REH: 7.6;SCLC-21H: 8.1;SH-SY5Y: 7.9;SuSa: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049782 Approved NA NA "HPA049782: AB_2680880" "unprognostic (6.18e-2)" "unprognostic (1.23e-1)" "unprognostic (7.66e-3)" "unprognostic (1.58e-4)" "unprognostic (4.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.11e-3)" "unprognostic (4.17e-2)" "unprognostic (9.53e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-4)" "unprognostic (2.83e-1)" "unprognostic (9.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.78e-2)" "unprognostic (2.04e-1)" "unprognostic (9.96e-3)" 0.5 0.4 2.9 0.6 4.0 0.4 0.5 4.7 3.4 1.0 1.1 0.5 0.1 0.8 0.6 0.2 0.9 0.9 0.3 3.7 4.3 0.8 0.3 0.4 0.2 2.4 2.8 3.2 1.6 0.6 1.5 2.6 0.3 2.8 1.0 0.1 2.4 0.3 0.7 0.2 0.4 0.2 0.9 2.5 0.1 0.4 11.5 3.9 0.4 1.3 0.1 0.2 0.7 0.5 2.9 0.0 0.8 9.3 9.5 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.2 0.1 0.0 0.8 0.0 0.3 0.0 7.5 0.2 1.0 0.1 7.6 0.0 0.1 0.6 1.0 0.0 0.0 0.1 0.4 0.2 0.5 0.0 0.0 0.7 0.1 0.2 0.2 0.1 0.0 0.3 2.1 0.0 0.2 7.6 0.5 0.1 4.6 0.0 8.1 7.9 0.2 0.1 1.4 5.5 0.0 2.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 2.9 4.0 4.7 3.4 3.7 4.3 2.4 2.8 3.2 2.8 2.5 3.9 2.9 0.6 0.0 1.1 9.1 0.8 1.0 3.9 1.0 0.6 9.7 1.4 1.5 3.3 0.0 0.2 0.0 8.4 0.8 1.5 0.1 1.9 5.4 162.1 1.9 4.3 1.2 0.0 0.0 20.1 3.2 0.5 2.5 2.6 3.9 0.0 2.9 0.0 0.2 0.3 0.0 18.9 0.0 0.0 0.0 0.4 214.0 3.4 1.0 3.6 1.9 6.2 6.6 0.0 14.6 3.4 3.3 0.0 2.6 0.7 4.7 0.0 3.6 0.0 1.3 6.6 4.5 2.7 65.7 42.6 1.1 0.6 0.3 1.5 0.3 0.0 1.6 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535507 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 4827.5;tongue: 1533.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol NA NA 240000 Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.78e-3)" 31.9 11.7 13.4 26.0 12.1 0.0 34.9 16.3 14.9 21.6 11.0 151.9 21.0 237.3 59.6 218.1 98.4 40.5 257.1 11.3 17.4 8.3 7.7 55.7 10.8 19.5 13.2 10.3 38.4 18.9 0.8 20.8 18.9 13.1 87.8 32.8 11.3 56.7 149.5 4827.5 10.9 69.6 128.8 16.6 24.7 96.6 8.2 13.0 4.2 33.0 1533.1 26.4 142.3 41.2 13.8 0.0 0.0 0.9 0.0 0.3 0.0 0.8 0.0 0.0 0.3 1.0 1.2 0.4 0.0 0.0 0.0 6.0 0.0 0.0 0.2 0.0 0.0 15.1 0.0 0.8 4.7 13.5 0.0 0.0 8.7 0.0 2.6 0.0 12.3 9.1 0.0 0.0 0.0 115.6 0.0 0.0 0.1 2.4 0.0 1.0 0.0 26.9 0.3 0.0 0.0 17.6 13.3 0.0 0.0 7.3 2.8 0.6 0.0 7.9 0.0 7.6 0.1 7.1 111.2 34.8 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.1 16.3 14.9 11.3 17.4 19.5 13.2 10.3 13.1 16.6 13.0 13.8 22.4 9.6 6.0 37.2 2.6 8.9 11.4 0.7 12.5 12.1 72.8 105.7 228.9 5.7 2.2 0.0 12.5 2.5 0.6 0.2 0.0 332.7 0.4 1.4 0.8 39.0 3.5 0.0 2.5 16.7 2.7 82.9 1.1 1.1 0.0 1.3 67.5 0.9 1.6 5.0 0.5 0.5 2.0 1.8 11.7 2.6 19.6 2.3 124.5 1.0 3.2 36.4 0.0 6.6 2.6 31.2 0.0 196.0 7.3 12.2 0.0 0.2 3.2 44.3 105.2 428.3 131.4 4.0 12.6 2.4 7.1 12.2 2.5 2.4 0.3 3.9 SORBS2 "ARGBP2, KIAA0777" ENSG00000154556 "Sorbin and SH3 domain containing 2" O94875 4 185585444-185956652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 580.5;thyroid gland: 280.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 557.8;Cone photoreceptor cells: 771.5;Excitatory neurons: 397.4;Rod photoreceptor cells: 815.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 241.1;TIME: 133.1;WM-115: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.30e-2)" "unprognostic (5.09e-2)" "unprognostic (1.20e-1)" "prognostic favorable (6.07e-5)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "prognostic favorable (1.47e-5)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (8.30e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.10e-6)" "unprognostic (1.26e-1)" "unprognostic (2.42e-1)" "unprognostic (2.79e-3)" "unprognostic (2.51e-2)" 27.7 168.2 37.3 11.6 54.1 0.1 39.3 0.2 42.4 32.0 14.4 61.0 10.6 17.8 34.6 36.8 37.3 29.3 580.5 37.3 7.0 32.7 127.5 19.4 5.3 22.3 3.2 42.6 17.7 118.3 101.2 29.3 69.5 25.1 56.6 26.1 157.4 75.1 62.9 7.0 6.9 16.2 31.9 0.2 26.4 40.8 3.1 5.3 31.4 280.2 12.9 11.4 50.6 16.5 31.2 0.4 0.5 241.1 0.2 33.6 59.4 12.0 0.5 0.2 0.0 0.6 6.8 19.4 0.0 25.8 2.2 1.6 0.0 0.0 9.1 0.2 0.1 3.6 3.8 18.4 16.0 0.0 0.0 0.2 22.0 2.7 37.1 2.9 31.7 44.8 6.7 0.1 0.2 2.7 0.0 0.0 0.7 23.4 0.0 0.0 23.9 0.0 0.2 32.8 5.9 30.2 9.0 0.0 0.1 14.9 23.3 7.3 0.0 133.1 18.2 2.4 0.3 9.4 0.3 0.4 0.3 39.3 0.0 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 37.3 54.1 0.2 42.4 37.3 7.0 22.3 3.2 42.6 25.1 0.2 5.3 31.2 71.1 22.4 41.4 18.9 2.4 6.5 18.5 44.1 21.6 99.7 81.4 45.6 557.8 228.8 85.5 64.4 771.5 12.8 1.9 8.5 5.9 166.1 3.2 80.8 4.0 69.6 41.9 5.3 397.4 110.1 2.6 30.7 30.1 75.3 2.5 102.4 26.7 206.6 1.6 5.0 247.3 14.0 61.1 4.1 8.0 6.9 5.6 2.5 19.6 150.9 3.1 265.7 12.3 204.1 7.2 57.7 27.1 3.8 5.3 25.8 15.8 25.8 149.3 815.8 118.3 4.4 297.8 0.3 1.4 12.4 5.5 10.9 1.8 13.2 26.8 19.3 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 266.1;Extravillous trophoblasts: 326.2;Hofbauer cells: 313.7;Pancreatic endocrine cells: 317.3;Proximal tubular cells: 341.3;Syncytiotrophoblasts: 332.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 140000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 69.8 84.5 92.3 45.4 96.4 93.9 60.4 96.0 117.0 43.6 87.4 55.7 30.5 48.5 67.6 75.9 46.6 39.6 126.3 97.6 95.8 72.5 76.7 62.5 52.9 90.9 91.6 96.9 46.5 41.4 59.0 57.7 56.4 91.8 45.5 45.2 70.0 47.1 44.1 191.9 47.7 41.0 55.3 91.4 48.6 57.8 112.1 91.7 65.0 43.7 126.7 66.2 70.0 52.5 96.3 211.2 169.2 151.1 110.2 113.0 146.7 108.1 203.6 165.3 194.8 199.0 151.1 178.2 106.3 160.7 181.9 263.4 147.2 168.7 203.6 256.8 123.2 141.5 185.7 174.2 243.0 147.3 120.4 133.6 149.4 159.9 177.0 226.8 144.2 184.8 180.2 166.2 137.8 260.2 155.9 311.7 214.9 137.5 341.9 271.8 111.9 95.1 100.8 216.2 181.9 142.1 134.3 85.2 458.9 202.4 155.1 169.2 127.9 142.2 140.1 160.6 156.1 208.1 155.6 204.5 198.9 169.6 130.2 175.0 138.6 66.4 85.6 62.0 78.6 68.3 83.1 74.2 70.8 73.6 73.9 66.5 67.5 79.8 73.4 77.3 118.4 99.1 60.0 92.3 96.4 96.0 117.0 97.6 95.8 90.9 91.6 96.9 91.8 91.4 91.7 96.3 236.0 67.3 98.9 0.0 24.8 0.0 0.0 0.0 0.0 0.0 147.6 185.4 0.0 0.0 49.5 119.5 0.0 220.1 74.5 0.0 266.1 216.7 0.0 147.9 98.9 77.1 0.0 0.0 0.0 227.2 326.2 66.0 0.0 168.8 69.4 65.9 0.0 0.0 313.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.9 0.0 0.0 112.7 0.0 0.0 0.0 0.0 317.3 0.0 0.0 12.1 0.0 0.0 341.3 63.4 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 332.5 40.7 98.8 0.0 0.0 LY96 MD-2 ENSG00000154589 "Lymphocyte antigen 96" Q9Y6Y9 8 73991392-74029079 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 570.8;Kupffer cells: 544.6;Langerhans cells: 155.4;Macrophages: 198.5;monocytes: 136.0;Plasma cells: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 627.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 627.0" "Cell line enhanced" "Detected in many" "GAMG: 75.1;Karpas-707: 184.9;RPMI-8226: 94.0;U-87 MG: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053060 Approved Vesicles "Secreted to blood" NA NA 250000 Vesicles "HPA053060: AB_2682029" "unprognostic (2.96e-1)" "unprognostic (2.64e-2)" "unprognostic (2.11e-1)" "unprognostic (1.85e-1)" "unprognostic (1.64e-2)" "unprognostic (2.87e-1)" "unprognostic (2.12e-3)" "unprognostic (1.42e-1)" "unprognostic (8.29e-2)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.38e-11)" "unprognostic (2.87e-2)" "unprognostic (1.29e-2)" "unprognostic (1.60e-2)" "unprognostic (5.90e-2)" 28.8 12.6 12.1 42.8 13.0 18.1 25.0 12.6 22.9 13.0 14.1 15.8 12.4 10.6 5.4 9.1 11.2 35.6 9.3 12.5 16.9 7.8 23.0 22.2 47.8 16.1 13.2 11.8 22.9 3.7 2.5 8.0 45.3 14.2 6.2 14.7 1.2 11.5 6.8 3.9 4.3 10.0 20.4 13.9 60.0 10.7 4.8 14.6 16.3 7.3 9.9 39.7 30.7 8.0 19.2 1.5 0.0 0.3 0.2 34.5 73.2 0.1 49.5 61.9 13.5 31.1 0.0 0.5 15.9 16.7 32.6 75.1 0.5 0.2 0.6 34.4 17.1 0.3 0.3 0.0 1.8 17.5 2.7 0.9 21.2 0.4 21.9 4.3 2.2 67.2 9.7 0.2 184.9 48.9 0.0 6.5 2.1 0.2 0.0 1.0 6.4 0.0 94.0 2.5 0.0 0.3 0.2 0.0 0.2 6.5 0.3 0.0 3.3 52.1 33.5 2.6 18.0 12.1 48.1 24.7 9.6 92.3 1.0 14.7 13.7 90.2 0.4 0.5 85.1 1.3 26.3 12.8 1.9 45.8 15.1 8.2 2.9 627.0 0.2 71.8 37.6 21.6 30.6 12.1 13.0 12.6 22.9 12.5 16.9 16.1 13.2 11.8 14.2 13.9 14.6 19.2 35.1 16.0 10.7 0.0 48.4 13.8 1.2 1.3 0.0 0.2 11.2 4.4 2.4 0.0 9.7 3.7 0.0 2.7 16.3 0.1 0.0 6.8 24.2 0.3 1.0 63.6 0.0 14.1 2.8 7.4 3.1 32.9 0.0 0.3 3.8 0.0 104.2 3.3 570.8 0.0 3.9 0.0 2.0 544.6 155.4 3.1 14.3 198.5 76.5 21.5 136.0 0.0 1.0 0.5 1.1 9.4 0.0 6.8 172.6 0.8 0.0 1.1 5.6 0.2 6.6 20.0 14.0 0.7 0.2 2.2 11.6 6.4 21.8 12.4 0.3 1.4 PSMA8 "MGC26605, PSMA7L" ENSG00000154611 "Proteasome 20S subunit alpha 8" Q8TAA3 18 26133852-26193355 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 17.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 229.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 72 "Daudi: 25.5;JURKAT: 7.1;U-266/70: 15.9;U-266/84: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.39e-3)" "unprognostic (7.45e-5)" "unprognostic (2.94e-1)" "unprognostic (3.04e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (8.30e-2)" "unprognostic (7.54e-4)" "unprognostic (4.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 17.1 0.0 0.5 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 17.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 1.4 0.8 1.2 0.0 1.2 0.9 1.9 0.1 0.4 0.0 0.7 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.4 0.1 0.0 0.0 10.3 0.0 0.0 0.1 0.0 0.4 0.6 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.7 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 6.9 1.2 0.3 1.8 1.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 1.5 2.4 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 229.1 37.2 0.0 0.0 1.0 0.7 0.5 0.0 0.0 TMSB4Y TB4Y ENSG00000154620 "Thymosin beta 4 Y-linked" O14604 Y 13703899-13706024 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 6.5" "Cell type enhanced" "Detected in many" "Langerhans cells: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 17.8;HEL: 14.7;RPTEC TERT1: 23.4;RT4: 7.9;U-698: 8.2" "Low region specificity" "Detected in all" NA NA 2400000 "unprognostic (7.27e-2)" "unprognostic (1.31e-1)" "unprognostic (5.79e-2)" "unprognostic (1.39e-5)" "unprognostic (1.46e-2)" "unprognostic (2.84e-1)" "unprognostic (3.39e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.64e-3)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" 0.7 0.8 1.1 0.5 0.9 2.8 0.8 0.7 1.5 0.0 0.3 2.8 1.0 0.0 3.1 2.0 0.0 0.9 0.5 0.9 0.7 1.5 1.1 0.5 0.4 1.5 0.8 0.7 0.0 1.2 1.0 1.2 0.4 1.8 3.8 6.5 0.5 1.2 2.2 0.2 0.9 2.7 0.0 0.9 0.8 1.0 3.8 1.5 0.0 1.3 0.5 1.1 1.7 0.0 3.4 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.6 1.2 0.0 0.0 0.0 0.0 0.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 4.2 0.0 1.2 0.0 0.0 0.0 0.0 2.8 23.4 7.9 5.6 0.0 0.0 0.0 1.1 1.5 0.0 0.9 0.4 0.8 0.0 0.0 0.1 1.7 3.9 8.2 0.0 0.0 0.0 0.0 1.3 0.5 1.3 1.3 0.7 1.0 1.4 0.2 2.9 0.7 0.9 0.4 0.6 0.8 0.4 0.7 0.5 1.4 1.1 0.9 0.7 1.5 0.9 0.7 1.5 0.8 0.7 1.8 0.9 1.5 3.4 0.0 0.0 2.6 0.0 1.9 2.5 4.5 4.5 3.4 3.4 0.0 0.0 1.2 1.5 1.7 1.8 4.2 5.7 2.7 1.7 3.9 1.6 0.5 0.0 0.0 1.4 0.0 5.7 0.4 0.0 1.0 1.4 2.6 0.0 2.5 0.0 1.1 0.2 3.2 3.3 0.4 3.4 0.0 7.2 9.2 2.3 1.5 5.2 0.0 0.0 2.5 5.5 3.1 1.0 0.6 0.2 4.4 1.9 0.9 3.0 2.2 6.2 1.4 1.1 0.0 1.1 1.2 1.1 3.5 3.4 2.8 1.1 2.1 0.0 4.6 6.8 CXADR CAR ENSG00000154639 "CXADR Ig-like cell adhesion molecule" P78310 21 17513043-17593579 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4" "Low region specificity" "Detected in all" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted - unknown location" NA NA 18000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 1.7 2.9 7.5 2.8 11.4 2.6 9.9 7.3 10.7 7.8 19.3 22.7 42.7 5.4 15.3 14.7 10.7 18.5 9.4 10.1 13.5 8.4 49.7 13.7 0.7 11.0 7.8 9.5 0.4 16.0 6.8 4.8 0.3 9.7 15.2 25.8 4.9 15.6 14.3 0.5 53.8 43.0 3.3 10.4 2.4 31.2 12.6 8.6 1.5 22.3 0.0 4.1 25.8 11.0 18.6 16.8 9.0 44.6 0.1 0.0 0.0 26.7 0.2 0.2 0.7 2.7 93.4 14.6 6.2 19.7 0.0 13.3 28.1 22.8 6.2 1.0 9.3 19.0 0.1 24.1 63.0 2.9 1.8 0.1 0.0 24.6 1.3 0.4 10.8 9.0 5.5 0.3 0.4 0.0 1.1 3.7 0.1 109.1 15.2 0.0 0.1 15.2 12.5 38.7 104.4 18.5 12.3 10.9 12.6 6.7 45.8 25.4 0.3 0.5 0.2 25.8 0.4 6.6 4.5 7.7 0.4 3.6 0.1 0.6 1.0 0.1 0.1 0.1 0.0 0.2 0.0 0.6 0.1 0.0 0.1 0.6 0.2 0.3 0.2 0.0 0.0 0.1 0.2 7.5 11.4 7.3 10.7 10.1 13.5 11.0 7.8 9.5 9.7 10.4 8.6 18.6 0.2 141.1 79.0 2.6 1.0 323.4 172.7 110.6 132.6 16.9 58.6 28.2 29.8 161.5 106.6 103.0 27.1 0.8 0.3 238.4 5.9 130.0 5.3 118.9 8.3 4.8 80.8 9.9 60.4 93.7 0.2 8.6 94.3 128.9 5.7 1.1 47.8 127.7 0.6 0.0 43.0 107.5 81.4 22.9 13.1 7.7 2.1 3.3 23.2 40.3 0.7 13.4 0.0 78.9 161.4 93.4 155.3 0.0 1.6 125.1 263.0 4.0 85.6 11.2 6.6 0.2 5.3 6.4 24.5 117.0 343.8 0.7 4.3 0.5 107.0 202.7 BTG3 "ANA, ANA/BTG3, APRO4, tob55" ENSG00000154640 "BTG anti-proliferation factor 3" Q14201 21 17593653-17612945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 526.3;Syncytiotrophoblasts: 1692.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 31.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018400 Approved NA Yes "HPA018400: AB_1845487" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.98e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (4.50e-3)" "unprognostic (1.75e-1)" "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.42e-2)" "unprognostic (3.08e-1)" "unprognostic (9.92e-2)" "unprognostic (2.40e-1)" 26.1 28.2 13.6 14.1 14.9 56.3 24.4 13.4 16.3 30.2 14.6 25.1 16.7 48.7 111.2 25.6 52.0 23.0 20.9 13.9 42.9 23.5 13.0 45.1 14.0 14.9 14.3 12.6 28.7 21.2 35.6 44.0 61.6 14.8 25.5 27.1 5.1 27.4 20.7 4.9 42.8 16.5 28.7 14.9 15.2 21.4 47.9 15.0 27.6 27.5 5.4 16.5 39.6 38.0 18.0 70.5 14.4 84.9 6.8 28.4 50.9 62.6 96.0 109.8 83.5 84.9 33.0 29.3 31.5 44.7 34.8 108.7 17.1 42.5 63.3 91.9 99.6 60.6 23.5 30.9 31.5 59.4 26.6 44.3 44.4 88.2 70.8 67.7 47.7 42.0 30.7 22.9 113.6 78.3 0.0 51.2 4.0 44.4 9.7 4.2 16.6 110.5 23.1 55.2 31.3 43.2 34.9 71.9 36.6 86.7 96.0 1.2 28.6 27.7 84.0 89.1 65.6 96.9 74.1 64.6 29.5 84.4 0.2 102.2 1.0 2.3 4.0 8.1 1.7 9.4 7.4 13.6 13.0 1.9 6.3 6.6 9.1 0.2 6.2 1.9 8.8 31.7 5.5 13.6 14.9 13.4 16.3 13.9 42.9 14.9 14.3 12.6 14.8 14.9 15.0 18.0 65.2 205.1 156.5 0.7 44.7 360.1 526.3 309.9 178.7 1.1 64.8 55.0 9.3 34.3 195.5 58.8 0.0 436.5 61.6 25.3 39.2 56.9 8.6 197.0 97.1 51.0 108.3 99.1 2.2 39.3 88.6 132.5 17.9 147.3 65.4 13.5 32.2 5.5 55.6 23.5 3.1 47.9 69.2 16.5 140.4 24.8 70.2 54.5 85.4 16.9 33.5 19.5 12.3 20.1 14.6 52.9 22.7 46.6 75.1 463.0 2.6 2.1 104.3 1.0 92.1 95.5 99.1 300.0 267.2 92.7 294.4 1692.7 99.2 47.5 48.6 470.3 C21orf91 "C21orf14, C21orf38, CSSG1, EURL, YG81" ENSG00000154642 "Chromosome 21 open reading frame 91" Q9NYK6 21 17788974-17819386 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.0" "Cell type enhanced" "Detected in many" "Early spermatids: 345.8;Late spermatids: 98.6;Oligodendrocytes: 103.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 111.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 107.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018288, HPA049030" Approved Approved "Microtubules,Cytokinetic bridge" Yes NA Microtubules "Cytokinetic bridge" "HPA018288: AB_1845710, HPA049030: AB_2680605" "unprognostic (3.28e-1)" "unprognostic (3.41e-2)" "unprognostic (3.12e-2)" "unprognostic (4.51e-2)" "unprognostic (6.19e-2)" "unprognostic (1.11e-3)" "unprognostic (2.42e-1)" "unprognostic (8.81e-3)" "unprognostic (2.79e-1)" "unprognostic (1.97e-1)" "unprognostic (3.25e-1)" "unprognostic (5.49e-2)" "unprognostic (1.24e-2)" "unprognostic (6.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.49e-2)" "unprognostic (9.90e-3)" 6.4 4.9 11.2 9.9 24.8 8.3 8.3 21.4 20.6 6.3 5.1 4.8 5.1 9.3 4.3 8.4 6.8 6.0 5.5 13.0 17.7 5.4 8.8 8.0 15.6 24.8 21.5 7.1 8.1 2.8 5.0 2.7 13.6 25.8 5.4 5.2 5.8 5.1 3.6 2.7 19.1 5.5 7.6 22.7 9.9 6.3 24.6 21.3 19.4 5.7 5.6 13.1 8.4 4.1 60.0 7.2 1.2 15.6 0.1 3.9 7.3 6.9 10.4 18.6 10.1 8.9 6.5 3.7 25.2 5.1 4.2 14.1 5.7 17.1 13.4 8.7 27.5 9.2 16.9 13.2 4.1 8.8 20.6 9.2 5.3 14.6 13.3 21.5 7.1 2.8 10.3 12.1 107.9 7.7 4.5 28.8 6.1 16.4 1.7 5.7 21.9 29.9 10.2 6.8 12.0 6.2 14.4 13.1 10.1 47.2 7.0 6.1 11.6 4.8 44.2 13.8 0.2 6.8 28.6 37.7 21.5 3.5 18.9 17.3 111.1 11.2 56.8 20.9 11.9 29.8 14.0 19.3 22.7 13.9 11.7 14.9 19.7 24.9 20.7 12.2 3.5 36.9 12.0 11.2 24.8 21.4 20.6 13.0 17.7 24.8 21.5 7.1 25.8 22.7 21.3 60.0 20.2 19.2 11.1 1.6 26.4 27.9 10.1 57.9 63.2 12.6 14.4 10.4 7.4 4.3 27.1 5.5 16.7 17.3 18.8 4.4 1.9 4.8 345.8 14.5 13.8 21.3 10.7 5.5 0.8 6.9 12.2 12.0 9.2 14.4 39.9 11.3 7.5 6.8 5.8 15.2 0.8 5.0 18.3 7.2 14.0 98.6 23.6 9.7 21.4 3.7 30.7 3.5 48.4 7.5 103.4 4.4 5.9 17.0 27.6 11.0 3.4 6.4 19.3 13.0 6.6 20.1 12.1 38.7 24.1 21.4 27.6 80.2 38.9 22.1 3.8 7.7 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.2;testis: 31.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 7 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8" "Group enriched" "Detected in many" 4 "basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9" "Group enriched" "Detected in all" 4 "olfactory bulb: 66.4;spinal cord: 38.6" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 1.7 2.1 2.4 1.1 1.4 0.0 1.1 0.7 3.5 0.2 0.9 2.6 1.7 0.6 1.1 0.9 0.5 0.9 2.0 1.8 4.3 3.6 0.0 0.3 0.4 8.6 3.0 0.9 0.6 0.1 0.3 2.5 1.9 10.3 5.6 3.5 0.6 0.6 1.8 0.6 2.3 1.0 0.3 1.7 14.2 0.7 31.3 6.8 0.3 1.1 1.7 1.2 0.7 1.1 4.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.4 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.6 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 2.8 7.2 0.2 7.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.5 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.3 0.1 2.4 1.4 0.7 3.5 1.8 4.3 8.6 3.0 0.9 10.3 1.7 6.8 4.0 1.7 0.0 0.0 5.2 1.0 4.0 0.8 0.8 3.4 1.1 1.0 1.3 0.5 0.0 0.9 0.0 0.0 0.2 0.9 0.0 1.9 0.4 5.0 1.4 38.6 1.5 0.0 0.0 5.5 0.0 0.2 4.6 0.0 0.8 0.0 12.3 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.8 4.0 3.1 0.1 1.8 4.7 0.0 0.4 0.0 12.5 50.1 0.0 0.0 1.9 3.1 0.2 0.0 0.3 0.3 0.1 0.0 28.3 10.5 1.3 1.7 0.5 2.3 0.5 1.3 26.7 0.1 0.3 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 523 "intestine: 988.7" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 28.0" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "U-138 MG: 50.8;U-87 MG: 141.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "olfactory bulb: 5.0;spinal cord: 1.8" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.0 0.0 0.9 0.2 0.7 0.0 0.0 1.8 1.7 0.0 0.0 0.1 988.7 0.2 0.0 0.1 0.0 0.1 0.1 0.8 0.3 0.0 0.0 0.0 0.7 0.6 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.2 22.0 0.0 0.0 0.0 0.4 1.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.3 0.0 4.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.3 0.0 0.9 0.0 0.2 141.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.7 1.8 1.7 0.8 0.3 0.6 0.6 0.3 0.7 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998409-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 12.1;brain: 22.3;liver: 6.8;testis: 6.4" "Group enriched" "Detected in some" 19 "Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6" "Group enriched" "Detected in some" 4 "breast cancer: 2.6;glioma: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" No No 120000000 "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: AB_2673650" "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 0.8 12.1 14.5 0.9 19.7 0.0 1.6 8.8 17.7 1.7 0.0 1.5 0.2 1.0 0.5 0.5 0.6 1.2 1.7 21.0 17.4 0.2 6.8 2.8 0.1 10.0 14.1 15.5 0.3 0.2 0.6 0.8 0.5 9.8 0.9 1.1 1.2 0.7 1.0 0.4 0.8 0.7 1.4 6.1 0.9 0.6 6.4 21.7 0.1 0.3 0.9 0.2 0.6 1.2 22.3 0.0 0.0 0.5 0.0 4.6 4.7 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.5 1.3 0.0 2.2 0.0 0.1 11.3 0.0 3.5 0.0 0.4 0.0 0.0 11.4 2.4 0.2 15.4 0.2 0.0 0.4 0.0 0.0 1.0 0.0 4.7 0.0 0.0 0.0 5.3 0.0 0.8 0.6 0.1 92.1 7.2 0.0 1.3 0.9 0.1 0.0 0.6 0.0 0.0 2.5 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.7 8.8 17.7 21.0 17.4 10.0 14.1 15.5 9.8 6.1 21.7 22.3 0.4 3.2 1.3 713.0 0.1 0.5 0.3 0.0 0.0 1.0 2.0 1.4 1.8 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 57.6 0.3 6.1 0.4 0.0 0.0 866.5 0.0 0.4 4.8 0.0 0.2 0.0 0.2 2.2 0.0 0.3 0.0 909.2 0.0 0.0 0.0 0.3 24.7 0.9 0.1 1.8 30.9 0.0 1.0 0.0 1729.1 1526.6 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.1 0.0 2.4 1.6 3.7 9.6 0.1 0.1 0.3 0.2 1.9 0.0 0.2 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL histone methyl-lysine binding protein 4" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 160.4;Late spermatids: 85.8;Microglial cells: 78.7;Oligodendrocyte precursor cells: 191.5;Oligodendrocytes: 252.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.4;Karpas-707: 4.8;RPMI-8226: 11.6;SCLC-21H: 5.3;SH-SY5Y: 5.8;U-2 OS: 3.4" "Low region specificity" "Detected in some" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064194: AB_2685208, HPA069042: AB_2686071" "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 2.7 4.3 6.9 1.8 9.3 1.6 4.9 1.2 7.0 3.5 1.0 2.1 3.0 3.3 3.6 3.6 4.3 2.6 3.5 3.8 9.8 7.2 8.9 3.9 2.0 3.9 7.3 4.3 8.6 6.5 8.5 3.2 0.7 8.2 2.0 2.0 1.7 3.4 2.9 1.0 7.0 3.5 1.3 2.0 3.0 3.2 12.8 7.1 2.9 5.8 1.3 1.6 1.4 4.2 12.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 2.4 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 1.4 3.1 0.0 11.6 0.0 2.0 5.3 5.8 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 3.4 0.1 1.4 0.1 0.0 0.0 1.3 0.0 1.7 0.3 1.1 0.0 0.7 0.3 0.0 0.5 0.1 0.1 0.7 2.5 0.1 0.2 0.1 3.6 0.8 0.1 0.0 0.5 6.9 9.3 1.2 7.0 3.8 9.8 3.9 7.3 4.3 8.2 2.0 7.1 12.2 6.5 3.2 12.2 56.2 4.8 7.8 7.0 0.8 10.2 2.2 4.5 4.8 6.4 11.5 4.1 5.5 16.7 0.1 2.7 0.3 3.9 7.4 62.5 8.1 1.2 3.6 11.4 0.8 33.9 5.2 0.0 3.4 1.5 16.9 1.3 15.4 2.5 10.0 3.2 0.0 160.4 1.5 0.0 3.2 5.3 85.8 10.2 2.9 1.8 78.7 27.2 1.8 25.7 191.5 252.9 3.5 1.9 12.8 1.5 10.3 3.5 8.1 1.2 0.6 6.6 6.9 7.2 9.3 2.4 6.5 8.2 0.1 2.1 0.5 2.5 4.6 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32428131 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 68.8;heart muscle: 59.1" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 1071.4" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm NA NA Nucleoplasm "HPA052375: AB_2681802" "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.2 1.8 16.4 2.5 41.5 0.0 4.4 19.9 32.1 0.6 0.1 2.7 1.4 2.5 6.1 6.4 10.6 1.5 59.1 17.9 27.0 4.1 0.1 5.0 0.6 29.6 28.7 16.0 3.9 2.6 0.3 1.3 3.3 34.2 2.0 1.8 7.4 1.8 3.3 0.6 0.4 3.3 5.1 16.8 0.6 4.0 3.8 29.8 1.6 3.2 4.0 0.1 9.9 1.4 68.8 0.3 5.8 15.5 0.0 0.6 0.4 0.2 44.4 18.3 20.8 17.1 0.0 0.0 0.0 0.2 148.3 0.0 1.2 0.0 0.0 27.1 0.0 0.0 1.3 1.4 0.0 0.1 0.0 31.9 1.9 0.0 4.3 0.2 44.9 7.1 0.0 0.1 0.1 1.7 0.0 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.0 22.5 0.0 6.8 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 22.8 8.6 0.4 77.9 0.4 0.0 0.0 2.4 0.5 105.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 41.5 19.9 32.1 17.9 27.0 29.6 28.7 16.0 34.2 16.8 29.8 68.8 1.2 0.0 0.0 7.5 0.1 0.0 0.7 0.1 1.2 69.5 2.8 17.1 136.0 0.0 0.7 1.8 52.1 0.0 0.1 0.0 0.0 4.8 53.4 0.2 0.1 3.9 0.0 0.0 70.8 0.4 0.0 8.7 0.0 0.4 8.8 0.2 0.0 0.0 0.1 3.3 169.2 0.0 59.0 0.0 0.2 50.3 0.3 0.5 0.0 15.9 0.0 0.9 0.0 196.6 1071.4 0.2 0.0 0.4 0.1 0.2 0.0 0.0 2.2 4.7 0.0 0.9 9.4 1.3 1.2 0.2 0.0 0.0 0.1 1.2 0.0 0.0 RABGEF1 "rabex-5, RABEX5" ENSG00000154710 "RAB guanine nucleotide exchange factor 1" Q9UJ41 7 66682164-66811464 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.4" "Cell type enhanced" "Detected in many" "Astrocytes: 91.4;Excitatory neurons: 124.5;Inhibitory neurons: 151.1;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 244.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001407 Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA001407: AB_1856024" "unprognostic (6.65e-2)" "unprognostic (6.44e-4)" "unprognostic (7.32e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (3.77e-1)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (3.32e-1)" "unprognostic (4.64e-4)" "unprognostic (6.45e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.43e-1)" "unprognostic (5.55e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" 16.3 14.2 16.0 11.3 16.0 77.4 13.1 16.0 18.9 13.2 16.2 10.8 8.0 11.6 10.1 19.8 8.9 14.3 9.9 16.0 17.2 11.6 14.9 10.6 11.6 16.8 15.8 15.5 12.1 9.7 14.9 4.5 13.3 17.0 12.1 12.0 50.2 8.7 17.4 13.1 24.0 9.3 12.5 15.1 9.5 10.6 25.3 16.0 13.3 16.1 13.4 17.0 19.3 14.2 18.6 47.5 10.2 10.0 16.9 32.1 45.2 10.4 40.9 52.8 42.6 40.2 12.2 28.5 22.4 13.9 60.7 28.2 17.7 16.8 22.3 59.0 14.9 11.2 12.5 14.6 11.8 25.5 21.5 16.9 22.2 28.5 54.9 60.4 33.2 11.3 13.7 21.6 13.9 42.9 19.2 13.2 27.7 15.0 20.2 19.3 12.2 20.1 14.7 37.4 19.5 12.2 17.8 16.8 37.5 19.6 15.6 19.4 12.3 14.0 65.8 12.2 42.4 32.0 19.8 28.7 25.1 31.6 23.0 18.6 18.3 6.5 7.8 7.4 5.7 8.1 9.1 6.3 8.9 6.1 12.5 6.3 6.3 11.8 13.8 12.9 8.1 5.1 6.4 16.0 16.0 16.0 18.9 16.0 17.2 16.8 15.8 15.5 17.0 15.1 16.0 18.6 7.3 12.8 12.8 91.4 11.5 4.1 11.4 3.2 10.2 9.9 11.5 7.7 4.8 4.3 10.9 5.5 16.7 3.8 13.2 10.0 11.7 5.4 5.4 13.6 12.5 5.7 18.0 3.0 124.5 5.5 3.8 14.6 8.6 22.0 14.0 8.8 5.7 8.0 4.8 8.4 151.1 4.3 2.0 15.2 5.0 2.8 5.9 19.9 1.8 60.9 6.2 5.5 7.2 100.5 244.1 18.1 13.4 9.4 15.2 13.4 4.4 5.5 11.9 18.9 0.0 10.6 8.5 8.4 6.5 8.3 6.7 13.5 9.5 7.0 5.5 12.3 MRPL39 "C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5" ENSG00000154719 "Mitochondrial ribosomal protein L39" Q9NYK5 21 25585656-25607517 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 241.5;Spermatocytes: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018331 Approved Supported Mitochondria NA NA Mitochondria "HPA018331: AB_1854111" "unprognostic (3.81e-3)" "unprognostic (5.34e-2)" "unprognostic (8.55e-3)" "unprognostic (4.61e-1)" "unprognostic (2.61e-1)" "unprognostic (4.32e-2)" "unprognostic (6.75e-2)" "unprognostic (2.35e-1)" "unprognostic (4.74e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (5.84e-4)" "unprognostic (7.48e-2)" "unprognostic (7.32e-3)" "unprognostic (9.81e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (6.89e-2)" 23.3 35.9 19.6 19.9 21.0 22.9 27.0 23.7 28.9 16.3 19.8 29.5 25.7 18.2 42.1 26.7 20.6 13.6 51.9 20.1 20.5 40.8 55.8 15.4 34.5 20.5 21.6 20.0 17.7 25.4 71.6 13.5 26.4 21.4 20.2 32.5 21.7 22.0 18.0 59.2 20.5 23.3 22.2 20.1 17.8 23.1 55.2 19.8 25.1 20.2 57.2 37.6 22.5 19.0 23.1 89.6 43.0 60.1 38.1 29.7 42.9 92.3 56.1 50.0 77.0 64.7 85.2 49.2 97.9 30.9 35.4 69.8 25.5 128.5 76.4 85.9 49.1 66.3 100.1 43.0 91.4 34.6 102.4 31.7 34.8 66.7 76.3 62.2 42.7 58.2 99.6 112.3 78.4 77.1 56.0 67.5 55.5 95.6 88.9 65.4 77.8 97.0 103.1 80.6 35.7 37.9 36.3 51.6 94.5 76.3 42.3 68.3 57.6 36.4 40.8 61.0 43.9 69.6 54.9 74.6 121.9 61.2 109.1 62.5 41.9 16.9 20.7 37.0 30.3 46.9 62.0 45.0 42.3 31.0 49.1 43.9 39.3 2.8 36.7 21.6 43.2 56.4 18.6 19.6 21.0 23.7 28.9 20.1 20.5 20.5 21.6 20.0 21.4 20.1 19.8 23.1 18.3 25.6 10.5 9.8 17.6 20.0 20.3 71.0 7.4 20.4 14.0 23.5 78.2 10.0 36.2 25.8 10.4 46.8 14.1 8.7 31.3 36.0 241.5 20.9 12.7 22.2 7.8 22.3 11.4 33.8 41.7 19.4 7.1 11.8 15.2 11.3 18.9 19.8 30.8 10.1 11.7 11.4 30.5 10.6 15.7 37.0 14.9 11.3 19.6 9.4 17.1 19.0 11.3 9.5 13.2 26.5 9.3 23.3 13.6 13.2 20.4 46.8 41.8 15.0 46.0 18.1 25.4 103.0 29.4 10.7 16.9 36.9 14.9 25.7 20.1 17.3 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639258-25717562 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.0" "Cell type enhanced" "Detected in many" "Adipocytes: 173.8;Astrocytes: 81.6;Endothelial cells: 148.7;Hepatic stellate cells: 112.8;Microglial cells: 82.4;Oligodendrocyte precursor cells: 76.9" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.5;BJ hTERT+: 16.5;HDLM-2: 16.7;hTERT-RPE1: 22.5;U-138 MG: 18.1;U-87 MG: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" NA NA 360000 "Plasma membrane" Nucleoplasm "HPA028789: AB_2732443, HPA077346: AB_2732341" "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 19.9 15.9 17.3 3.7 19.5 0.3 16.9 23.8 22.0 16.9 14.1 15.1 6.2 18.7 11.3 7.2 16.2 13.0 18.7 18.0 22.1 4.7 2.2 15.6 3.6 26.4 20.2 11.5 16.2 2.8 4.4 8.1 64.0 20.7 9.5 8.0 7.1 6.2 15.5 7.9 5.6 10.8 19.7 25.3 1.6 10.3 17.8 24.5 2.6 10.4 13.3 5.1 11.7 13.3 23.7 0.0 0.0 25.5 0.1 1.0 0.2 0.5 0.8 16.5 2.0 7.6 0.0 0.0 0.1 0.0 0.2 9.7 0.1 2.2 0.0 4.6 16.7 0.7 0.1 0.1 0.1 0.0 0.1 0.1 1.4 0.0 1.8 0.1 22.5 0.0 0.6 0.0 0.2 8.0 0.0 0.4 0.1 8.1 0.2 0.0 3.2 5.3 0.1 0.0 0.0 0.4 3.7 0.2 0.3 0.0 0.3 0.9 0.2 0.0 18.1 1.7 0.1 2.5 1.8 0.1 0.0 13.4 0.1 0.7 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.2 0.4 0.6 0.1 0.4 0.0 0.1 17.3 19.5 23.8 22.0 18.0 22.1 26.4 20.2 11.5 20.7 25.3 24.5 23.7 173.8 0.0 2.3 81.6 0.9 7.5 1.4 0.0 2.2 1.4 1.4 9.1 33.2 0.0 0.0 3.7 14.6 0.3 0.5 0.0 0.0 0.2 16.5 1.0 4.7 148.7 0.0 0.0 15.2 0.2 5.3 28.5 0.5 2.1 0.0 4.5 112.8 0.5 1.3 0.0 45.0 0.0 0.0 1.8 10.7 15.6 9.9 2.8 16.0 82.4 0.0 1.8 0.0 76.9 4.1 0.1 0.0 24.5 1.2 1.5 0.0 0.0 0.7 5.2 0.0 5.7 7.0 6.7 4.4 0.8 6.7 0.8 1.6 2.1 0.0 1.2 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1610.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria NA NA 820000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favorable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 277.1 279.0 310.3 137.7 313.5 176.6 207.6 319.6 427.9 157.6 329.3 336.6 278.9 130.0 371.3 260.5 131.1 130.9 1061.9 312.2 321.8 494.1 762.6 111.8 167.7 317.4 316.1 305.5 128.3 189.8 462.8 141.5 172.9 315.6 161.5 317.4 251.7 216.5 230.7 1172.7 113.0 252.7 191.5 318.1 112.1 228.7 132.7 317.0 219.5 167.5 1610.0 212.7 196.7 139.6 323.9 355.9 260.0 314.5 351.4 344.8 313.5 389.4 305.8 373.0 305.8 300.8 607.6 274.4 439.3 194.2 312.9 467.8 191.5 441.3 379.2 339.2 373.1 441.1 910.6 520.6 618.4 386.8 673.2 284.5 303.1 471.2 284.0 258.6 399.9 363.0 412.2 582.2 522.9 458.2 416.3 468.6 683.2 562.3 824.0 460.7 358.0 606.5 840.0 669.8 504.6 360.2 394.1 516.5 521.7 493.0 449.4 376.5 590.5 260.6 219.6 266.6 209.3 265.9 501.7 954.7 568.2 341.5 707.8 283.1 444.8 447.0 443.7 293.3 487.1 316.1 475.1 385.5 368.6 531.9 399.7 377.4 370.7 292.3 389.9 505.7 504.0 520.3 661.3 310.3 313.5 319.6 427.9 312.2 321.8 317.4 316.1 305.5 315.6 318.1 317.0 323.9 532.1 169.9 179.3 0.0 56.0 0.0 0.0 0.0 0.0 0.0 346.3 468.4 0.0 0.0 105.9 419.3 0.0 652.7 116.4 0.0 2375.2 447.0 0.0 299.2 257.6 150.6 0.0 0.0 0.0 472.5 522.8 135.6 0.0 308.5 109.7 341.2 0.0 0.0 522.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.2 0.0 0.0 226.4 0.0 0.0 0.0 0.0 427.1 0.0 0.0 21.4 0.0 0.0 1906.2 142.1 0.0 0.0 0.0 161.4 0.0 0.0 0.0 0.0 708.2 79.2 387.8 0.0 0.0 GABPA "E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A" ENSG00000154727 "GA binding protein transcription factor subunit alpha" Q06546 21 25734570-25772460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003258, CAB004411, HPA028791" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598" "unprognostic (5.50e-2)" "unprognostic (2.40e-1)" "unprognostic (3.74e-2)" "unprognostic (2.68e-1)" "unprognostic (3.98e-2)" "unprognostic (1.17e-2)" "unprognostic (3.01e-1)" "unprognostic (2.73e-1)" "unprognostic (2.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.62e-1)" "unprognostic (1.77e-1)" "unprognostic (5.70e-2)" "unprognostic (2.73e-3)" 17.1 14.0 7.5 14.3 9.9 16.1 15.1 8.8 10.3 14.7 8.4 12.6 13.1 18.5 15.2 11.4 12.5 13.5 13.0 7.1 9.6 13.9 19.4 13.5 20.5 9.1 8.5 6.2 18.2 10.3 15.4 6.7 24.7 8.7 12.5 13.9 11.6 10.5 10.4 10.7 10.4 13.5 15.4 8.8 18.8 12.0 15.1 8.2 22.3 21.4 16.7 19.7 13.1 10.1 11.2 22.2 9.2 25.8 18.2 25.4 33.9 20.0 17.5 18.7 13.7 13.5 11.4 18.2 45.7 13.4 19.7 13.9 9.7 28.5 17.2 22.7 27.6 26.8 32.9 11.9 10.7 17.1 35.3 21.2 25.1 16.3 18.5 17.2 22.9 25.6 24.9 30.8 27.5 23.2 11.0 37.9 15.1 35.9 23.6 12.5 31.1 37.5 28.7 15.9 14.3 16.0 21.1 30.9 19.5 22.0 15.5 17.2 26.8 26.5 16.9 15.5 18.7 14.8 22.2 20.3 40.3 17.2 26.5 21.1 8.8 4.7 7.4 4.3 5.5 5.8 5.6 5.1 5.3 4.7 5.4 5.9 5.2 5.5 6.7 4.3 2.6 5.8 4.4 7.5 9.9 8.8 10.3 7.1 9.6 9.1 8.5 6.2 8.7 8.8 8.2 11.2 43.2 9.6 12.0 14.0 20.7 11.6 12.2 7.0 15.4 7.6 13.0 10.8 9.1 14.3 11.8 22.0 0.0 18.1 18.4 19.0 3.9 7.6 13.2 12.0 22.6 26.3 9.0 11.6 21.0 8.1 12.4 23.7 12.2 14.8 6.3 21.1 27.8 18.7 12.7 13.5 19.6 11.1 6.1 19.0 10.1 3.6 17.7 16.7 7.2 22.5 16.0 23.2 10.3 21.1 43.4 7.9 10.2 22.2 15.3 11.9 11.4 10.4 9.3 10.2 19.7 26.1 18.4 34.0 19.5 12.6 12.6 25.2 19.2 14.2 11.3 14.4 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835755-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 317.1" "Cell type enhanced" "Detected in many" "Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "gdT-cell: 4.5;NK-cell: 6.6" "Group enriched" "Detected in many" 56 "NK-cells: 6.6;T-cells: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "spinal cord: 35.6" "CAB016394, HPA031498" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 4100000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: AB_2673907" "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 236.8 46.8 24.2 71.9 23.2 1.4 94.9 19.9 28.6 88.1 26.9 48.4 8.8 98.0 9.0 83.3 162.7 112.7 78.3 20.8 27.9 52.3 39.4 80.4 10.2 26.1 23.2 18.7 317.1 29.6 18.7 25.7 247.2 24.7 89.0 59.9 15.7 19.4 14.0 49.3 20.9 45.0 164.0 25.8 14.0 56.5 8.2 24.2 12.3 50.5 40.7 5.5 144.5 51.1 32.1 0.1 0.0 6.8 0.1 382.0 104.9 21.8 451.4 199.6 90.4 61.1 0.0 0.0 0.0 29.5 120.1 2.0 9.2 4.6 23.6 150.0 0.4 120.3 0.0 29.7 0.1 85.6 15.5 0.0 103.0 0.3 250.0 248.2 15.1 35.4 3.7 7.3 0.0 295.3 0.0 1.7 0.3 21.9 0.0 14.5 0.0 151.6 0.6 343.9 25.1 0.2 32.7 21.4 0.0 2.2 16.0 0.2 3.8 34.9 99.6 4.3 156.0 63.1 0.5 0.0 0.0 80.8 0.5 29.7 0.0 0.0 0.0 4.5 0.0 0.5 0.0 0.2 0.4 0.0 0.0 0.1 0.7 0.0 6.6 0.0 0.0 0.0 0.8 24.2 23.2 19.9 28.6 20.8 27.9 26.1 23.2 18.7 24.7 25.8 24.2 32.1 365.2 6.4 22.4 2.9 0.5 121.2 32.5 10.4 53.5 0.6 13.9 54.9 179.5 12.8 9.6 57.0 0.0 71.1 13.1 0.2 1.9 47.4 1.4 86.5 235.3 275.9 0.0 0.4 3.2 22.3 240.8 243.9 11.7 148.2 2.5 0.3 157.8 2.2 16.5 0.0 3.3 0.2 2.0 5.0 38.5 4.4 109.0 5.8 53.4 7.5 0.6 52.2 20.6 2.0 19.9 20.6 0.0 41.8 3.6 26.3 0.0 6.3 3.3 3.3 210.4 91.0 452.4 0.4 1.0 22.8 41.6 54.9 10.1 8.8 0.0 16.8 ADAMTS5 "ADAMTS11, ADMP-2" ENSG00000154736 "ADAM metallopeptidase with thrombospondin type 1 motif 5" Q9UNA0 21 26917922-26967088 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.4" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 38.2;Endometrial stromal cells: 72.1;Fibroblasts: 88.6;Leydig cells: 62.7;Skeletal myocytes: 110.2;Smooth muscle cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 31.6;ASC TERT1: 13.9;fHDF/TERT166: 11.9;RH-30: 33.1;U-87 MG: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA005661, CAB025996, HPA030906, HPA030908" Approved Supported Nucleoplasm "Secreted to extracellular matrix" NA NA 28000 Nucleoplasm "CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655" "unprognostic (1.97e-1)" "unprognostic (2.88e-3)" "unprognostic (2.69e-2)" "unprognostic (4.01e-2)" "unprognostic (4.67e-1)" "unprognostic (2.10e-2)" "unprognostic (4.38e-8)" "unprognostic (1.11e-3)" "unprognostic (7.66e-2)" "unprognostic (6.17e-2)" "unprognostic (8.13e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (6.69e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.15e-1)" 13.8 0.8 0.3 1.0 0.5 0.0 10.9 3.3 0.3 7.2 2.1 2.5 0.8 12.6 2.4 1.6 4.2 1.6 2.8 0.5 1.4 2.5 1.4 1.0 0.6 1.3 1.0 0.1 16.7 0.4 1.6 0.4 26.4 1.3 3.1 1.3 0.6 2.0 1.9 2.1 3.6 3.4 7.6 1.5 7.8 2.2 0.8 0.5 0.3 6.8 3.7 0.1 4.2 3.6 1.3 0.0 0.0 0.0 0.0 31.6 13.9 0.0 1.7 0.2 1.4 0.6 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 2.3 0.0 1.3 0.0 0.3 0.0 3.5 0.1 0.0 8.0 0.0 1.1 0.2 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.1 0.0 3.4 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 8.3 0.4 1.9 0.9 0.0 0.0 0.0 13.0 0.1 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 3.3 0.3 0.5 1.4 1.3 1.0 0.1 1.3 1.5 0.5 1.3 24.3 0.0 0.5 0.3 0.1 2.9 0.2 0.4 0.0 9.8 1.5 38.2 2.7 0.0 0.6 3.7 0.0 1.1 0.3 0.0 0.0 0.0 6.4 2.0 72.1 10.6 1.8 0.0 0.5 0.2 1.6 88.6 0.0 1.3 0.0 3.0 3.3 0.0 1.9 0.0 11.6 0.0 0.0 0.0 4.6 1.0 62.7 1.4 3.6 3.7 4.0 0.1 0.0 12.5 0.2 0.0 0.0 9.1 0.0 0.3 0.0 2.2 0.0 0.2 13.1 110.2 44.9 0.3 0.9 0.4 3.0 2.7 0.8 20.0 0.0 0.1 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484421-12541549 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.6 9.4 3.8 1.1 4.1 0.3 8.9 4.6 4.9 11.2 3.8 11.0 1.4 11.0 2.6 8.6 12.1 1.8 13.5 3.7 3.9 8.7 8.5 6.0 2.3 3.8 3.8 3.7 14.3 12.2 3.2 11.0 0.9 4.1 10.1 2.3 3.4 6.8 3.2 16.0 8.0 6.9 3.2 3.6 6.7 9.8 6.8 4.0 2.6 9.1 3.8 2.2 11.6 9.8 4.1 6.2 11.8 5.5 7.4 6.3 7.7 7.6 5.8 4.3 6.6 5.1 4.2 5.2 5.5 3.3 4.0 5.8 5.8 7.8 9.4 5.4 5.5 9.8 5.1 9.1 5.7 5.4 9.3 2.1 4.9 11.2 10.1 9.7 3.3 4.7 8.8 10.7 3.4 6.5 11.9 9.6 6.1 6.5 10.5 13.5 4.6 2.3 13.5 9.9 4.8 1.5 4.5 6.7 5.0 4.8 3.1 10.1 5.1 4.5 4.2 3.9 4.7 9.7 3.1 8.6 6.2 5.6 11.8 5.4 0.6 1.9 0.0 2.7 1.6 4.4 3.7 4.6 3.8 2.3 3.2 6.2 5.1 0.4 2.5 1.7 3.4 1.6 2.6 3.8 4.1 4.6 4.9 3.7 3.9 3.8 3.8 3.7 4.1 3.6 4.0 4.1 5.5 3.2 3.3 26.1 8.9 2.9 11.2 5.6 13.1 28.1 3.7 4.3 7.0 10.0 3.8 11.0 43.8 8.8 2.6 9.2 1.9 6.2 1.6 7.1 7.4 6.2 4.2 8.4 42.8 4.2 4.3 5.7 13.7 3.7 5.1 17.7 3.6 5.0 4.6 10.1 46.4 5.2 4.1 3.5 1.7 2.8 9.0 3.6 3.6 16.9 2.4 8.0 6.2 19.1 31.8 4.5 5.0 10.1 3.8 6.2 2.3 6.9 11.1 34.1 6.6 7.9 6.3 14.0 23.0 7.1 4.8 1.9 4.6 15.3 8.4 8.0 SLFN13 FLJ31952 ENSG00000154760 "Schlafen family member 13" Q68D06 17 35435096-35448837 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.9;salivary gland: 32.8" "Cell type enhanced" "Detected in many" "dendritic cells: 56.3;Endometrial ciliated cells: 59.9;NK-cells: 60.8;Plasma cells: 38.2;Respiratory ciliated cells: 75.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 5.3" "Group enriched" "Detected in many" 4 "granulocytes: 4.5;NK-cells: 5.3" "Cell line enhanced" "Detected in many" "EFO-21: 38.9;HL-60: 131.9;REH: 75.0;U-266/70: 63.2" "HPA022532, HPA023064" Uncertain Approved "Cytokinetic bridge" Yes No "Cytokinetic bridge" "HPA022532: AB_1856615, HPA023064: AB_1856616" "unprognostic (1.11e-1)" "prognostic favorable (3.82e-4)" "unprognostic (4.73e-2)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (5.74e-2)" "unprognostic (9.38e-3)" "unprognostic (1.32e-2)" "unprognostic (3.34e-1)" "unprognostic (3.55e-1)" "unprognostic (5.06e-3)" "unprognostic (2.33e-1)" "unprognostic (1.33e-1)" "unprognostic (3.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 3.1 0.9 1.5 9.2 1.1 25.9 10.0 1.0 1.0 6.2 4.8 5.8 8.5 4.8 2.9 3.5 17.0 6.7 1.9 1.0 1.7 2.6 2.1 6.5 10.6 1.3 1.0 0.5 1.1 3.3 14.6 0.5 1.9 1.2 2.1 6.6 0.1 32.8 4.2 0.7 2.3 4.6 4.2 1.0 13.9 11.4 0.6 1.2 10.1 8.0 0.8 11.7 2.5 1.5 1.7 0.2 7.0 13.7 0.1 0.4 1.4 0.2 1.7 0.5 6.7 10.6 0.0 0.1 0.0 38.9 1.3 0.3 11.7 1.4 4.9 7.6 3.9 2.2 37.2 6.5 0.1 0.6 131.9 1.0 0.4 0.6 3.6 0.1 0.0 2.2 0.4 0.1 36.8 0.2 0.1 0.9 28.4 6.8 0.0 0.0 75.0 0.5 3.8 11.6 34.1 0.0 0.0 0.0 6.2 0.3 0.9 9.8 20.9 0.3 0.1 2.0 10.1 0.5 63.2 9.5 0.2 0.2 20.9 1.0 3.7 0.2 4.5 1.2 0.3 1.0 0.9 0.5 0.6 0.2 0.9 0.4 0.3 0.8 5.3 0.1 0.1 0.5 0.4 1.5 1.1 1.0 1.0 1.0 1.7 1.3 1.0 0.5 1.2 1.0 1.2 1.7 6.2 0.0 3.7 0.0 7.3 1.0 3.1 4.7 5.7 0.2 14.5 9.1 0.8 27.1 12.5 5.5 0.0 0.8 56.3 2.1 1.9 1.2 0.1 59.9 3.6 3.4 3.0 19.1 0.1 0.4 0.4 1.6 8.2 11.7 3.8 3.8 1.8 0.6 1.6 0.0 0.1 4.5 12.2 1.0 1.7 0.0 0.9 3.2 0.0 2.8 1.8 0.2 60.8 0.0 0.1 1.3 0.6 0.4 38.2 1.0 0.5 1.3 75.4 0.2 0.0 0.4 3.8 0.2 0.6 6.7 1.1 0.0 16.6 3.3 4.2 1.4 WNT7A Wnt-7a ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880071 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;gallbladder: 2.3;placenta: 2.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2;ovarian cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" NA NA "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.0 0.0 3.5 0.1 3.1 0.1 0.0 1.0 3.7 0.2 0.4 0.0 0.0 1.1 0.2 0.4 0.1 2.3 0.0 2.3 2.3 0.2 0.0 2.0 0.2 5.0 1.8 3.3 0.0 0.1 0.0 0.0 2.7 2.5 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 3.2 1.3 0.0 1.3 2.0 0.0 0.0 0.0 0.1 0.3 0.1 2.7 8.6 0.0 0.8 0.0 0.0 0.0 59.8 0.0 0.0 0.0 0.0 0.0 7.6 0.0 56.0 0.0 0.1 11.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 1.7 100.3 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.5 3.1 1.0 3.7 2.3 2.3 5.0 1.8 3.3 2.5 3.2 2.0 2.7 0.0 12.8 0.0 8.5 0.0 5.9 2.8 2.6 0.0 0.0 0.0 0.0 0.7 8.6 1.4 0.0 0.0 68.7 0.0 0.0 0.0 13.8 17.3 14.5 0.4 0.6 0.0 0.0 4.0 9.1 147.5 0.4 0.0 17.9 0.0 0.0 0.0 0.0 7.4 0.0 2.4 0.0 0.0 0.0 0.0 5.6 0.0 0.1 0.0 1.0 0.0 0.0 0.0 4.5 0.3 98.8 0.0 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 6.0 2.3 0.0 1.3 185.7 1.5 0.0 0.0 6.0 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178621 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 20.3 17.3 15.2 16.5 17.4 10.3 23.1 16.0 14.9 26.5 15.5 18.7 19.1 25.1 17.8 16.2 25.5 16.8 12.8 13.3 16.7 25.1 24.4 20.8 24.7 17.3 17.5 12.6 34.9 21.8 24.1 26.0 15.7 17.6 23.1 15.8 15.4 18.7 23.8 21.5 32.1 24.2 17.6 15.8 24.4 17.5 12.5 16.5 21.4 26.9 9.9 21.9 23.1 20.5 18.8 14.3 33.8 36.7 22.6 51.0 35.8 124.8 33.6 88.7 29.9 22.3 11.8 14.7 46.6 14.5 37.5 14.7 15.6 23.6 49.3 23.6 21.5 24.7 24.9 35.7 21.7 45.0 16.8 42.2 50.1 56.4 39.7 77.4 34.2 34.5 19.0 31.2 22.5 32.5 27.2 17.9 16.3 23.5 20.4 21.2 19.3 17.9 33.7 36.2 36.9 8.8 29.9 36.1 27.2 23.5 54.6 29.9 13.8 57.1 11.2 32.1 18.4 15.4 54.5 46.4 25.4 26.5 19.4 41.6 41.4 20.2 26.8 23.2 16.6 22.7 27.1 26.7 23.5 17.9 25.0 28.3 20.8 73.1 24.3 23.3 17.4 24.7 16.9 15.2 17.4 16.0 14.9 13.3 16.7 17.3 17.5 12.6 17.6 15.8 16.5 18.8 26.0 60.9 63.2 16.6 39.9 13.8 20.4 25.5 59.2 35.6 19.0 25.9 11.8 31.5 47.7 16.5 39.6 42.5 38.9 13.4 35.2 19.3 2.3 32.2 44.8 29.9 16.3 20.8 18.0 19.2 20.3 29.2 15.3 25.5 47.4 25.0 22.9 40.5 18.2 26.9 22.0 13.9 20.3 23.9 14.9 2.7 30.7 19.6 8.8 15.0 40.1 24.9 54.6 17.1 27.5 19.5 15.0 28.2 29.1 18.9 32.7 66.1 55.0 51.0 26.3 43.3 27.7 28.7 54.9 21.4 11.1 32.0 42.3 26.3 18.1 10.5 CCDC174 "C3orf19, FLJ33839" ENSG00000154781 "Coiled-coil domain containing 174" Q6PII3 3 14651746-14672659 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 152.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043468, HPA060129" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043468: AB_2678493, HPA060129: AB_2684208" "unprognostic (6.10e-2)" "unprognostic (7.96e-2)" "unprognostic (2.92e-1)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (5.06e-2)" "unprognostic (6.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (5.29e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.15e-2)" "unprognostic (2.30e-3)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (3.81e-5)" 8.7 7.0 8.1 7.0 8.9 17.4 9.3 9.2 8.6 10.8 7.3 9.5 9.4 10.5 7.6 8.9 9.4 6.9 8.3 8.2 8.4 9.0 8.8 7.1 9.6 9.2 8.7 7.7 14.8 10.2 12.0 8.6 8.6 8.6 9.8 7.4 6.8 8.7 8.0 11.2 9.8 9.6 8.0 8.1 10.7 10.4 9.1 8.7 11.8 9.1 10.8 10.3 9.7 9.6 10.0 6.2 6.7 10.0 10.7 13.6 11.1 25.3 8.1 11.6 10.0 7.8 7.5 7.0 12.8 5.8 7.2 6.8 5.3 7.3 6.8 7.8 9.7 8.9 13.0 8.1 8.1 19.7 12.9 14.5 12.9 17.0 13.5 16.5 14.0 8.6 13.4 13.2 11.4 7.6 10.9 13.6 11.3 13.5 10.1 10.9 10.1 9.3 10.6 10.4 10.8 4.8 13.1 9.5 7.4 13.4 11.6 11.2 18.1 8.0 8.0 7.8 7.4 9.5 15.0 14.3 14.7 8.0 9.8 11.1 25.4 10.7 22.2 12.9 11.3 15.2 17.4 16.1 15.1 9.7 16.4 17.4 13.8 20.5 18.8 12.2 10.9 12.5 10.0 8.1 8.9 9.2 8.6 8.2 8.4 9.2 8.7 7.7 8.6 8.1 8.7 10.0 29.5 9.6 34.5 11.4 48.0 16.2 31.3 38.0 26.7 32.8 25.0 28.4 37.0 32.9 35.7 12.9 20.9 32.1 42.3 27.3 56.7 34.7 152.5 27.3 35.4 31.0 18.5 43.4 12.8 34.9 25.2 33.7 20.4 34.7 52.0 22.0 38.6 29.3 26.5 15.2 16.6 34.1 32.6 27.2 16.5 59.1 33.5 30.5 14.2 5.6 45.2 22.2 34.0 11.1 15.8 38.2 34.9 40.3 34.9 28.8 36.8 46.4 31.1 24.9 32.9 28.4 37.2 78.7 33.5 19.9 13.5 65.7 41.6 23.5 23.1 31.8 FGD5 "FLJ00274, FLJ39957, ZFYVE23" ENSG00000154783 "FYVE, RhoGEF and PH domain containing 5" Q6ZNL6 3 14810853-14934571 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 51.3;Endothelial cells: 44.7;Hepatic stellate cells: 55.6;Microglial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 94.9;TIME: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014436, HPA014536, HPA019191" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519" "unprognostic (2.57e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.28e-2)" "unprognostic (2.02e-2)" "unprognostic (1.03e-3)" "unprognostic (1.08e-1)" "unprognostic (4.10e-2)" "unprognostic (6.34e-2)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (6.84e-3)" "unprognostic (1.71e-2)" "unprognostic (3.46e-1)" "unprognostic (1.32e-2)" "prognostic favorable (7.50e-4)" 20.0 4.5 6.0 5.6 3.6 0.3 15.2 4.2 5.4 10.4 6.0 5.3 9.3 11.4 2.3 5.7 8.6 12.0 11.6 3.1 3.1 10.2 3.1 20.8 4.2 4.7 5.8 1.8 5.4 2.2 3.5 3.2 17.9 4.6 5.3 4.6 0.2 3.7 4.5 6.8 5.0 7.0 11.5 3.2 25.2 4.7 4.3 6.0 2.0 7.6 13.5 3.7 7.7 5.6 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 94.9 0.1 0.0 0.0 0.0 0.0 0.4 0.2 5.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.4 0.0 81.1 0.0 6.6 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 3.6 4.2 5.4 3.1 3.1 4.7 5.8 1.8 4.6 3.2 6.0 5.3 51.3 0.0 4.6 0.0 0.9 3.1 0.2 0.0 1.2 0.1 1.3 1.9 4.4 1.5 0.6 0.0 0.0 0.3 0.4 0.1 1.9 0.2 7.3 0.4 5.3 44.7 0.0 5.3 3.4 0.2 0.1 11.3 1.1 0.3 0.0 0.0 55.6 1.3 10.5 0.0 8.6 0.2 0.0 2.2 5.9 9.9 11.5 3.3 1.8 25.3 0.0 0.0 1.0 0.5 0.3 4.8 2.5 4.5 0.0 0.3 1.0 7.0 0.0 0.2 0.0 4.9 2.4 0.2 3.6 0.1 1.8 0.5 0.7 2.3 0.5 0.2 FLCN "BHD, DENND8B, MGC17998, MGC23445" ENSG00000154803 Folliculin Q8NFG4 17 17212212-17237188 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 79.2;Erythroid cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015158, HPA028760" Supported Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB015158: AB_2231645, HPA028760: AB_10601323" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.74e-1)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.73e-2)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (3.90e-1)" "prognostic favorable (4.49e-4)" "unprognostic (6.45e-3)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.65e-1)" 21.4 19.1 20.3 10.8 26.3 17.9 19.1 28.7 30.1 40.4 18.8 35.7 23.5 37.3 14.6 14.0 25.5 17.2 27.8 32.9 16.6 15.3 29.2 27.0 12.5 22.9 17.3 22.7 35.6 15.3 13.2 28.8 13.2 29.3 27.4 10.3 7.3 16.6 13.8 43.0 19.3 27.1 14.6 14.5 29.5 22.6 21.2 19.4 8.6 24.0 18.5 8.1 28.4 25.7 29.8 12.0 30.4 11.5 14.9 36.4 20.6 15.8 11.8 19.1 18.0 24.3 24.3 10.4 6.3 13.8 14.0 40.2 14.4 14.0 7.3 9.3 10.9 12.2 12.4 9.1 13.9 33.6 4.9 33.5 30.3 24.0 27.6 20.8 16.4 14.8 9.2 17.7 16.4 17.6 17.5 8.3 8.4 11.2 17.8 8.1 16.9 52.7 7.3 11.0 14.1 13.6 8.8 11.6 7.5 19.3 70.7 11.1 8.8 15.7 40.6 16.6 56.5 14.1 7.7 7.4 5.7 26.0 10.8 16.6 2.4 2.8 1.6 1.6 3.7 2.2 3.6 1.9 1.4 1.4 3.2 2.1 1.9 6.0 2.8 1.4 1.4 2.9 1.8 20.3 26.3 28.7 30.1 32.9 16.6 22.9 17.3 22.7 29.3 14.5 19.4 29.8 8.4 25.6 12.6 17.0 9.2 18.4 12.7 5.7 2.8 20.7 13.2 6.5 23.7 14.3 6.2 7.3 79.2 10.9 5.3 25.0 1.9 12.3 14.5 16.8 11.3 12.5 25.7 81.7 31.3 8.3 7.4 20.6 9.7 15.2 1.3 10.3 27.8 24.1 16.6 47.1 23.7 11.0 16.2 21.6 19.2 20.4 28.0 13.2 10.6 18.7 12.2 13.3 6.2 17.1 32.4 9.8 15.6 20.3 4.4 11.6 36.8 6.1 9.1 18.5 19.7 24.8 11.1 6.3 10.8 5.3 18.2 33.8 10.0 16.3 12.6 13.0 DPH3 "DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2" ENSG00000154813 "Diphthamide biosynthesis 3" Q96FX2 3 16257061-16264969 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035287 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035287: AB_10604113" "unprognostic (2.49e-2)" "unprognostic (8.80e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (2.83e-1)" "unprognostic (5.06e-2)" "unprognostic (5.83e-2)" "unprognostic (4.13e-1)" "unprognostic (5.90e-3)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (6.44e-2)" 14.4 12.0 13.5 9.7 14.0 8.5 10.4 15.2 14.4 10.3 14.3 10.3 10.8 10.1 11.1 9.5 9.0 10.2 14.0 12.8 16.6 13.2 15.5 11.2 8.9 16.4 15.1 12.1 6.1 7.9 9.1 8.5 13.4 15.7 9.4 8.8 13.5 5.8 11.2 29.6 4.9 13.4 15.4 16.1 9.2 9.5 8.6 14.8 11.6 12.5 20.2 8.2 12.6 5.8 16.5 10.5 14.6 31.9 18.9 58.9 39.7 24.8 29.9 24.4 28.0 31.3 18.1 5.8 10.0 9.3 37.5 24.0 6.2 29.4 17.7 32.6 50.5 20.4 16.6 11.5 21.0 36.7 24.5 15.6 28.6 23.6 36.0 15.2 17.6 25.5 17.4 26.9 16.4 39.9 14.1 19.0 16.5 25.6 15.9 14.7 12.9 20.7 15.4 24.9 8.0 7.2 20.2 13.8 6.7 35.4 25.6 12.5 23.9 29.9 22.9 15.0 41.7 24.0 12.6 44.5 12.8 33.6 27.2 20.7 27.1 16.7 25.7 11.3 22.8 14.0 10.1 11.9 13.8 15.9 9.9 9.9 11.9 35.5 10.7 21.6 6.2 11.9 12.7 13.5 14.0 15.2 14.4 12.8 16.6 16.4 15.1 12.1 15.7 16.1 14.8 16.5 32.3 19.2 22.4 10.1 31.0 51.6 42.9 41.0 29.0 11.6 32.9 34.7 34.9 25.8 32.4 16.5 12.5 47.9 28.1 43.0 41.1 49.5 109.1 27.5 35.3 32.5 17.9 32.0 12.0 57.2 80.6 34.4 30.1 33.3 52.0 11.2 26.7 41.6 101.6 6.7 10.3 22.6 26.4 45.5 61.7 63.3 20.5 46.4 28.4 3.7 71.5 24.8 29.9 6.6 9.2 66.6 32.4 15.8 42.2 42.6 79.1 45.4 33.9 15.1 13.1 33.4 36.7 80.4 40.1 31.3 52.4 80.9 34.5 18.7 19.0 47.1 OXNAD1 MGC15763 ENSG00000154814 "Oxidoreductase NAD binding domain containing 1" Q96HP4 3 16265160-16350299 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 67.0;Inhibitory neurons: 62.8;T-cells: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 81.0" "Lineage enriched" "Detected in all" 4 "T-cells: 81.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036830, HPA059160" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA036830: AB_2675338, HPA059160: AB_2683936" "unprognostic (4.49e-2)" "unprognostic (7.41e-3)" "unprognostic (2.71e-3)" "unprognostic (2.38e-3)" "unprognostic (4.65e-2)" "unprognostic (3.23e-2)" "unprognostic (1.46e-1)" "unprognostic (2.31e-2)" "unprognostic (1.23e-2)" "unprognostic (8.05e-2)" "unprognostic (1.46e-1)" "unprognostic (8.08e-2)" "prognostic favorable (1.00e-7)" "unprognostic (2.22e-2)" "unprognostic (1.03e-1)" "unprognostic (6.95e-3)" "prognostic favorable (7.63e-4)" 5.8 4.0 2.3 11.5 3.1 8.9 4.9 2.5 3.9 2.6 3.4 8.5 12.3 3.0 2.6 5.5 3.4 5.0 9.0 2.0 3.0 8.8 17.1 4.2 17.1 2.4 2.6 1.6 3.0 3.8 7.4 2.4 3.6 2.6 2.9 7.3 4.6 4.5 2.6 15.1 4.0 14.3 2.8 1.5 7.1 7.4 4.5 2.7 18.3 5.7 10.2 12.2 5.5 3.4 3.5 8.3 12.0 7.6 12.0 8.8 7.8 29.7 8.8 6.5 11.8 9.5 17.2 8.2 11.8 5.4 5.5 6.5 5.9 15.9 14.3 11.2 21.6 10.5 17.4 9.6 9.3 9.1 28.3 10.2 5.8 10.5 19.2 9.2 3.7 9.3 12.0 24.1 27.3 5.2 14.7 16.6 14.8 16.3 12.4 13.8 14.6 9.3 20.7 8.0 9.9 5.4 7.5 9.8 16.3 14.0 8.2 10.4 16.1 4.2 7.7 9.8 8.5 14.4 9.9 19.0 19.0 9.1 24.3 10.5 0.1 3.8 3.1 22.6 5.4 30.3 5.5 34.6 24.5 6.0 4.3 81.0 61.8 3.4 19.3 5.4 4.6 20.4 19.3 2.3 3.1 2.5 3.9 2.0 3.0 2.4 2.6 1.6 2.6 1.5 2.7 3.5 4.9 0.0 8.6 35.6 8.9 2.4 5.4 7.9 6.2 5.8 5.7 3.4 12.8 7.2 4.7 7.3 6.2 10.2 29.4 8.9 31.3 9.8 40.2 3.9 5.5 4.4 3.0 16.2 67.0 6.2 8.1 5.1 11.2 3.9 20.8 5.8 3.9 23.3 8.5 3.3 62.8 7.6 6.1 5.2 3.6 31.7 3.1 6.3 5.4 17.8 10.2 5.8 41.2 36.2 42.1 7.5 2.9 1.9 20.8 5.0 21.2 15.7 7.2 11.7 6.6 6.1 6.8 9.0 11.7 7.5 3.4 5.1 90.0 7.8 11.5 6.5 PLCL2 "KIAA1092, PLCE2" ENSG00000154822 "Phospholipase C like 2" Q9UPR0 3 16802651-17090604 "Metabolic proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 212.5;Extravillous trophoblasts: 73.0;Inhibitory neurons: 163.7;Microglial cells: 124.6;Oligodendrocyte precursor cells: 121.7;Oligodendrocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.1;Daudi: 24.7;HAP1: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047616, HPA061728" Enhanced NA NA "HPA047616: AB_2680105, HPA061728: " "unprognostic (2.95e-2)" "unprognostic (8.09e-2)" "unprognostic (3.96e-2)" "unprognostic (6.35e-2)" "unprognostic (1.59e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (3.22e-2)" "unprognostic (8.72e-2)" "unprognostic (5.93e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.98e-10)" "unprognostic (2.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.70e-1)" "unprognostic (9.97e-2)" 7.0 11.9 1.8 5.8 4.2 10.1 6.0 13.9 3.9 4.3 1.3 4.9 6.7 6.7 2.5 1.3 4.4 4.1 17.1 3.0 2.8 7.5 5.6 4.8 10.3 3.4 2.1 2.2 12.6 6.7 0.8 6.0 3.9 4.2 3.1 5.7 2.1 2.8 1.4 27.3 1.7 8.4 4.2 0.8 13.0 5.4 3.9 1.8 6.0 3.8 7.8 7.8 2.6 3.1 3.0 0.0 1.9 2.5 0.0 9.3 21.1 2.0 1.8 5.0 0.8 2.0 0.0 1.8 24.7 0.0 1.6 1.0 0.0 24.8 0.9 1.8 11.8 5.2 0.0 2.6 0.0 0.3 3.8 2.7 3.4 0.2 6.9 0.0 1.5 4.3 8.1 5.8 9.4 0.0 0.0 4.3 0.4 5.0 0.0 2.6 9.4 0.0 13.5 0.0 0.4 8.0 3.6 1.0 3.0 0.7 1.7 0.0 4.0 4.4 1.2 1.7 1.1 4.2 8.9 0.0 15.7 1.3 5.2 0.9 0.9 0.8 1.9 2.1 0.9 2.6 1.4 2.0 2.9 1.0 1.3 1.9 2.1 1.8 6.5 1.2 0.5 1.5 1.1 1.8 4.2 13.9 3.9 3.0 2.8 3.4 2.1 2.2 4.2 0.8 1.8 3.0 8.6 0.0 2.2 8.1 17.5 1.0 0.9 1.1 1.2 11.5 0.6 0.4 38.6 11.5 1.1 3.7 4.2 2.5 34.1 12.5 7.9 2.6 1.1 7.5 4.1 6.6 3.6 7.0 212.5 9.2 73.0 7.8 17.3 2.1 2.5 5.6 5.7 6.4 7.8 16.8 163.7 9.8 0.0 8.7 4.6 1.5 19.6 13.8 0.0 124.6 12.3 1.2 39.1 121.7 72.2 2.9 22.6 19.2 18.2 0.5 9.5 10.9 1.3 1.8 6.6 9.6 5.0 2.5 5.4 0.3 0.6 49.8 24.2 6.5 5.4 0.6 CXXC1 "CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1" ENSG00000154832 "CXXC finger protein 1" Q9P0U4 18 50282343-50287839 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044511 Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044511: AB_10963081" "unprognostic (4.47e-2)" "unprognostic (1.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (5.08e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.10e-2)" "unprognostic (1.00e-1)" "unprognostic (3.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-2)" 18.2 26.9 22.5 23.0 22.8 46.3 19.5 26.6 30.8 28.0 23.0 23.2 27.5 23.5 10.4 23.8 25.1 17.7 19.5 22.5 21.2 25.6 24.7 19.3 34.6 23.0 22.3 21.1 30.3 39.0 20.4 21.1 16.1 23.4 24.6 16.0 13.7 32.7 21.6 20.3 29.7 23.7 15.0 20.8 29.8 26.0 23.0 22.7 31.0 23.4 13.2 21.3 25.8 23.9 23.3 24.6 31.9 33.4 46.9 28.9 16.2 46.9 34.3 28.4 38.5 32.1 21.6 19.6 60.2 17.6 22.0 18.5 44.6 51.6 37.0 21.7 51.9 33.0 57.9 42.3 39.5 19.6 126.4 68.7 19.5 32.9 38.0 51.0 26.0 25.0 58.8 29.9 63.8 27.3 37.7 71.6 67.7 47.8 16.9 22.4 74.5 26.9 56.5 26.8 13.9 48.4 47.2 18.0 17.8 21.6 21.2 22.9 56.9 29.2 45.1 28.4 18.4 29.6 119.1 87.7 52.5 28.4 58.6 35.5 24.7 18.8 34.0 24.0 22.0 25.0 26.9 21.6 23.6 21.9 27.5 23.1 18.9 8.1 22.6 18.8 15.5 26.4 20.6 22.5 22.8 26.6 30.8 22.5 21.2 23.0 22.3 21.1 23.4 20.8 22.7 23.3 18.1 19.2 27.4 21.9 27.8 26.8 13.1 21.7 21.1 15.3 20.2 17.4 7.3 18.6 23.8 18.4 14.6 34.5 23.7 31.4 13.7 19.4 13.8 20.9 13.8 18.3 35.3 14.9 10.2 21.8 39.2 16.6 33.1 17.6 8.2 20.5 16.8 15.3 22.0 8.4 8.7 25.0 26.4 20.2 17.2 9.8 19.9 21.0 8.8 7.5 21.3 19.3 43.3 9.5 9.4 21.8 26.1 19.5 41.5 13.3 26.5 14.9 21.4 13.5 6.6 19.5 16.9 49.4 22.1 24.5 30.1 37.1 27.7 18.3 26.5 12.0 SKA1 "C18orf24, MGC10200" ENSG00000154839 "Spindle and kinetochore associated complex subunit 1" Q96BD8 18 50375040-50394168 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.1;lymphoid tissue: 4.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 22.3;Extravillous trophoblasts: 9.2;Plasma cells: 10.0;Spermatocytes: 16.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "Karpas-707: 82.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045495 Approved Approved Microtubules NA Yes Microtubules "HPA045495: AB_10960405" "unprognostic (2.18e-2)" "unprognostic (7.85e-3)" "unprognostic (7.66e-3)" "unprognostic (5.93e-3)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (9.60e-8)" "unprognostic (1.03e-3)" "unprognostic (1.16e-2)" "unprognostic (1.20e-2)" "unprognostic (1.18e-4)" "unprognostic (3.91e-3)" "unprognostic (0.00e+0)" "unprognostic (4.50e-3)" "unprognostic (4.66e-2)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" 0.4 0.5 0.8 2.2 0.6 12.1 0.3 2.0 1.0 0.3 0.7 1.7 1.7 0.6 0.2 2.6 0.2 0.3 0.2 0.8 0.5 0.1 0.3 0.4 4.9 0.8 0.6 0.6 0.2 0.4 0.1 0.0 1.6 1.1 0.3 2.1 0.4 0.3 0.1 0.6 1.5 1.4 1.1 0.3 1.3 0.9 4.3 0.8 3.7 0.3 0.2 4.8 0.5 0.7 2.2 27.1 10.8 18.6 19.0 1.2 2.1 9.9 30.7 10.6 29.9 28.5 4.7 10.6 21.1 7.6 11.0 25.8 23.6 25.6 13.0 31.4 34.6 2.6 27.0 5.5 18.3 2.3 42.2 26.8 1.5 1.3 20.7 8.2 3.2 20.0 20.0 30.8 82.6 26.4 5.7 34.6 12.1 14.2 6.5 6.4 17.3 18.3 23.5 8.5 1.6 13.7 10.9 17.2 9.9 13.6 15.3 11.4 20.2 10.1 32.8 19.0 12.8 31.8 27.5 41.6 32.4 18.2 34.9 33.3 0.9 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.2 0.3 0.2 0.1 0.6 0.6 0.2 0.2 0.4 0.2 0.8 0.6 2.0 1.0 0.8 0.5 0.8 0.6 0.6 1.1 0.3 0.8 2.2 0.2 0.0 2.2 0.0 2.8 1.0 0.2 0.4 0.0 0.4 0.7 0.6 0.4 0.0 0.8 0.0 2.1 4.4 0.7 1.6 0.0 0.1 4.5 0.5 0.7 0.4 1.2 22.3 0.2 0.0 9.2 1.4 0.5 1.1 0.0 4.9 2.2 0.1 5.3 0.0 0.1 2.7 0.0 0.8 0.9 2.2 0.3 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 1.1 0.0 10.0 0.4 0.1 0.1 0.2 0.8 0.0 0.2 1.4 16.7 13.5 3.7 0.3 1.5 1.4 0.5 3.4 1.0 PPP4R1 PP4R1 ENSG00000154845 "Protein phosphatase 4 regulatory subunit 1" Q8TF05 18 9546791-9615240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 36.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 36.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040905, HPA041089" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040905: AB_10794869, HPA041089: AB_10805836" "unprognostic (1.76e-1)" "unprognostic (5.33e-2)" "unprognostic (1.40e-2)" "unprognostic (5.14e-2)" "unprognostic (3.74e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-3)" "unprognostic (9.36e-2)" "unprognostic (1.16e-2)" "unprognostic (4.00e-3)" "unprognostic (3.13e-3)" "unprognostic (4.15e-1)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (2.76e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" 20.4 16.4 17.4 17.0 18.3 32.3 19.0 19.6 18.0 23.0 19.3 22.4 23.4 21.0 17.2 71.3 21.3 20.9 20.9 16.4 18.7 18.3 15.5 34.9 13.1 18.4 18.0 15.6 17.1 20.1 23.7 11.8 29.2 18.7 16.8 19.9 13.4 23.5 17.1 16.4 26.3 26.3 23.5 18.0 18.5 24.7 36.0 18.3 20.0 18.9 17.5 25.1 41.1 36.0 21.3 70.3 48.5 115.0 31.6 22.3 33.7 58.3 66.9 44.7 64.9 62.3 44.1 39.6 34.0 47.6 66.1 55.0 29.4 54.0 99.4 87.0 39.8 21.8 32.2 35.0 32.0 34.7 83.0 46.7 30.3 62.8 56.1 52.9 48.5 75.3 22.6 47.5 29.8 70.9 34.5 58.1 31.7 46.1 97.5 30.3 71.5 69.2 21.4 54.6 96.5 33.6 39.5 79.3 35.3 26.4 73.3 19.3 31.5 81.3 113.6 70.2 59.3 83.5 26.5 39.7 60.7 42.5 34.0 52.5 14.6 6.1 10.9 3.9 4.7 5.0 3.8 4.3 3.9 7.0 1.8 1.4 3.2 36.1 4.1 4.7 2.9 4.6 3.5 17.4 18.3 19.6 18.0 16.4 18.7 18.4 18.0 15.6 18.7 18.0 18.3 21.3 26.4 99.3 76.1 35.9 11.9 40.4 26.5 30.8 42.7 19.6 20.7 14.7 21.4 7.2 55.4 22.0 10.4 27.0 12.0 31.2 5.9 23.8 77.3 48.1 26.7 29.5 17.4 15.6 43.0 34.9 15.9 19.3 45.3 54.0 3.8 27.0 26.0 12.2 16.8 33.7 54.9 16.4 8.2 19.6 16.7 57.2 17.4 20.7 14.2 34.7 20.5 10.6 13.4 61.9 66.5 49.8 16.2 11.7 10.8 21.0 23.7 10.0 58.9 19.3 13.1 16.5 22.1 20.4 12.3 52.0 42.5 23.0 12.9 9.2 13.6 68.4 APCDD1 B7323 ENSG00000154856 "APC down-regulated 1" Q8J025 18 10454635-10489949 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 130.9" "Cell type enhanced" "Detected in many" "Astrocytes: 120.5;Cholangiocytes: 85.8;Endometrial stromal cells: 429.5;Melanocytes: 80.0;Oligodendrocyte precursor cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 32.0;BJ hTERT+: 70.4;HaCaT: 43.0;HHSteC: 18.9;HSkMC: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.21e-1)" "unprognostic (2.85e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.39e-4)" "prognostic favorable (8.23e-4)" "unprognostic (5.61e-3)" "unprognostic (6.79e-3)" "unprognostic (1.24e-1)" "unprognostic (5.59e-3)" "unprognostic (2.59e-2)" "unprognostic (3.14e-1)" "unprognostic (7.77e-2)" "unprognostic (2.04e-3)" "unprognostic (1.77e-1)" "unprognostic (3.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" 53.0 14.3 32.0 6.9 27.9 0.4 31.6 31.2 34.6 35.6 14.9 12.2 3.5 33.0 15.8 28.0 32.9 22.1 26.6 38.3 27.4 4.7 1.4 13.3 1.2 34.2 30.4 22.9 33.3 9.0 3.4 3.2 27.1 34.1 33.6 13.3 1.6 10.6 14.2 7.4 130.9 14.6 10.7 22.9 4.1 24.0 2.7 31.8 2.2 5.3 18.7 4.8 36.9 35.8 27.9 0.0 0.0 32.0 0.0 5.4 0.0 0.1 2.4 70.4 3.1 4.9 0.1 0.1 0.0 0.0 13.0 0.0 43.0 0.3 0.0 3.3 0.0 1.6 0.1 0.2 0.7 18.9 0.0 0.0 39.3 1.4 6.1 0.0 0.0 0.5 0.0 0.0 0.1 3.1 2.1 1.8 0.5 5.2 15.3 0.0 0.9 0.0 1.2 0.0 0.4 0.8 0.3 0.0 0.0 3.6 2.0 0.0 0.4 0.0 3.8 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.0 4.8 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.2 32.0 27.9 31.2 34.6 38.3 27.4 34.2 30.4 22.9 34.1 22.9 31.8 27.9 3.1 0.0 12.6 120.5 0.4 65.6 3.6 3.6 11.4 4.1 14.1 20.4 4.2 85.8 2.7 3.7 0.0 2.4 1.7 0.1 0.0 11.2 0.7 28.7 429.5 47.1 3.6 0.0 0.2 0.4 0.4 64.4 0.5 10.9 1.3 0.4 1.8 0.2 1.3 0.0 2.1 1.1 2.0 0.3 35.0 0.8 8.7 3.3 80.0 67.5 1.3 0.2 0.0 110.1 15.3 0.2 0.0 37.6 1.6 11.7 0.1 0.1 5.9 2.2 26.3 18.7 28.1 0.3 1.4 13.1 53.8 1.0 4.2 1.3 1.4 4.5 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11149569 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 56.6" "Cell type enriched" "Detected in many" 10 "Oligodendrocytes: 399.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA015986, HPA031974, HPA040616" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043" "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 1.1 0.5 7.3 1.3 15.9 0.4 1.8 12.0 14.4 1.1 0.0 2.9 0.4 0.7 1.6 5.1 1.1 5.3 0.2 5.6 10.5 1.1 4.1 6.7 0.9 14.1 13.4 2.4 0.7 1.8 0.5 0.9 0.0 18.0 3.0 1.4 0.1 0.3 3.0 0.1 1.1 1.1 2.1 10.6 2.7 1.6 1.2 13.4 0.8 1.5 0.2 0.6 5.4 0.7 56.6 0.0 1.8 15.1 0.0 0.0 0.0 0.0 0.8 4.4 16.9 23.1 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 10.6 0.0 0.5 0.0 38.1 8.8 5.2 0.0 0.1 0.1 0.3 4.3 1.2 0.1 5.2 0.6 0.0 0.3 2.7 0.0 0.3 0.0 4.5 6.7 0.0 0.0 0.0 7.0 0.0 5.3 12.7 0.0 0.1 0.0 0.8 6.7 0.0 4.5 0.0 0.0 5.8 0.3 0.9 23.0 0.2 16.2 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 15.9 12.0 14.4 5.6 10.5 14.1 13.4 2.4 18.0 10.6 13.4 56.6 3.3 0.0 5.3 2.0 0.0 0.8 0.3 0.0 0.0 0.0 2.3 0.8 1.6 10.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 31.7 0.2 0.2 9.9 0.0 0.0 2.5 0.2 0.0 11.2 2.6 0.0 5.1 0.1 17.2 5.9 1.0 0.0 37.0 0.0 0.0 3.2 0.8 11.9 0.0 0.6 0.0 9.4 0.0 0.0 0.0 2.0 399.6 0.1 0.0 0.0 0.4 0.1 0.0 0.1 7.3 0.0 6.6 0.9 4.5 0.3 1.4 0.2 0.9 0.4 0.6 32.9 0.0 0.1 MPPE1 "Cdc1, PGAP5" ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11908366 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 100.8;neutrophil: 293.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 293.9" "Cell line enhanced" "Detected in all" "OE19: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favorable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 14.8 13.3 11.1 20.2 11.8 28.6 15.5 10.9 12.2 16.3 11.7 21.7 17.9 17.2 20.8 17.4 16.5 22.0 18.8 10.8 12.6 29.1 24.0 25.8 16.2 13.1 12.3 10.2 12.8 32.1 20.3 15.1 14.2 13.4 16.5 21.6 16.1 15.2 19.2 23.7 29.2 20.5 16.0 10.4 16.0 23.0 8.6 11.7 16.1 47.5 11.8 14.8 15.1 13.8 13.0 7.8 11.1 8.4 19.9 22.9 26.7 7.9 18.6 26.0 10.6 16.5 20.8 21.6 15.8 39.2 17.6 10.7 8.6 5.8 10.1 9.9 17.7 10.4 4.6 22.9 4.9 31.9 20.3 30.9 40.1 13.3 9.4 6.6 15.7 6.5 13.9 5.8 14.5 17.8 18.1 15.1 13.6 5.6 65.9 3.1 6.0 5.4 18.8 17.2 11.9 11.8 6.7 17.1 13.5 16.0 9.3 9.8 25.9 13.5 21.4 8.3 20.5 10.3 22.6 21.5 19.7 15.8 10.4 21.5 20.6 42.9 100.8 24.8 34.5 18.1 17.9 15.2 23.9 37.3 21.7 18.5 23.8 293.9 29.2 24.6 29.6 27.0 31.8 11.1 11.8 10.9 12.2 10.8 12.6 13.1 12.3 10.2 13.4 10.4 11.7 13.0 19.3 57.7 33.0 13.4 24.5 18.0 16.2 20.7 12.5 17.4 14.6 11.6 2.4 24.3 23.1 22.0 12.5 27.9 35.7 43.9 21.5 30.5 20.5 17.9 14.8 15.5 9.6 13.3 20.9 41.9 32.5 16.6 29.6 22.6 27.8 23.5 15.7 27.6 25.4 8.4 21.4 23.4 14.2 33.2 25.7 36.0 12.8 24.8 19.6 20.6 24.2 23.3 52.5 12.5 24.4 36.3 18.4 15.1 16.0 10.1 36.3 27.0 26.7 20.5 13.1 17.2 13.9 7.0 8.7 21.8 20.0 16.7 33.7 16.4 16.1 22.0 USP43 FLJ30626 ENSG00000154914 "Ubiquitin specific peptidase 43" Q70EL4 17 9644698-9729687 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 37.9;Excitatory neurons: 35.5;Glandular and luminal cells: 52.5;Oligodendrocyte precursor cells: 73.4;Syncytiotrophoblasts: 73.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 11.7;SK-BR-3: 8.1;T-47d: 9.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA023389, HPA027762, HPA027763" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA023389: AB_1858691, HPA027762: AB_10603001, HPA027763: " "unprognostic (1.39e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-3)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (2.04e-1)" "unprognostic (6.40e-3)" "unprognostic (2.26e-1)" "unprognostic (3.05e-3)" "unprognostic (2.41e-2)" "unprognostic (7.49e-2)" "unprognostic (5.95e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.24e-1)" "unprognostic (2.06e-1)" "unprognostic (3.28e-1)" 0.2 0.2 4.1 0.6 3.5 0.8 1.9 1.7 4.2 2.9 2.5 3.5 4.2 1.9 1.0 6.6 4.2 1.2 0.0 3.0 1.4 3.8 9.2 3.2 0.1 2.5 2.6 3.7 0.1 5.1 1.1 3.5 8.4 2.5 9.9 3.3 1.4 4.3 2.2 0.0 2.2 3.5 0.2 3.2 0.3 2.1 3.2 2.9 0.3 1.7 0.0 0.7 1.1 2.4 3.0 5.6 1.4 0.0 0.5 0.0 0.0 11.7 0.1 0.2 0.6 1.6 2.8 4.5 0.0 1.8 0.2 2.5 6.8 0.6 5.3 0.6 3.6 1.8 0.3 3.0 1.0 0.1 0.5 0.0 0.0 6.8 0.3 2.8 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.9 4.6 0.7 4.8 0.3 3.6 0.0 0.8 4.1 3.0 0.7 0.0 2.4 8.1 1.0 3.7 9.9 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.5 1.7 4.2 3.0 1.4 2.5 2.6 3.7 2.5 3.2 2.9 3.0 0.0 3.2 3.1 1.6 0.3 4.7 7.8 4.6 5.2 0.5 7.0 2.4 0.6 4.3 7.4 11.0 6.2 26.2 0.6 14.3 1.9 4.4 1.1 37.9 4.2 0.5 2.4 3.2 35.5 4.7 23.7 0.8 7.7 52.5 0.0 0.9 0.4 15.6 2.7 0.0 4.0 8.3 2.0 0.9 0.3 1.1 0.0 0.6 5.4 0.0 0.3 8.4 0.0 73.4 1.2 11.3 3.5 0.0 0.2 10.6 8.7 1.8 30.2 1.5 0.0 0.0 1.0 1.5 0.3 12.3 3.3 73.2 0.7 0.0 9.7 11.8 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824235-133895882 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 146.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1" "Cancer enhanced" "Detected in all" "glioma: 18.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 47 "T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "HEL: 226.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" NA NA 2200000 "Golgi apparatus" "CAB017713: , HPA059131: AB_2683916" "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavorable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 6.9 11.2 43.8 2.9 80.6 12.1 4.4 3.6 146.8 2.8 0.0 5.5 2.5 3.0 2.1 4.2 16.4 3.3 21.0 84.7 42.5 3.6 0.9 3.1 3.3 77.4 28.7 72.4 2.1 4.4 25.1 12.1 1.7 73.2 2.8 2.1 29.6 10.2 5.9 2.7 1.5 3.0 8.5 4.6 5.9 5.5 4.1 54.0 1.4 5.3 2.9 2.0 1.7 2.2 97.2 0.1 3.0 5.8 14.9 10.1 10.3 0.5 3.0 6.3 7.2 0.8 1.6 1.5 0.2 6.3 2.4 21.2 0.4 13.8 0.4 3.6 0.2 8.6 226.6 3.5 0.5 1.2 1.4 8.5 3.1 2.9 1.1 0.2 0.1 2.9 8.3 53.4 0.6 1.1 5.5 0.7 21.3 18.0 10.8 2.2 0.2 0.4 2.3 4.0 1.3 47.2 10.1 4.4 4.2 26.7 22.5 16.8 9.7 3.7 6.5 15.5 3.2 5.4 5.6 1.5 0.5 0.7 0.5 5.6 0.0 0.0 0.0 0.6 0.0 7.3 0.1 0.1 1.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.8 43.8 80.6 3.6 146.8 84.7 42.5 77.4 28.7 72.4 73.2 4.6 54.0 97.2 2.0 0.0 0.0 25.8 0.2 1.3 2.2 0.5 0.6 10.5 2.0 2.3 30.8 1.5 2.8 1.8 2.1 0.3 0.6 2.2 3.9 3.6 0.1 2.3 0.9 3.5 0.0 79.2 60.5 1.3 0.7 3.7 2.0 1.3 0.0 12.4 7.9 0.1 0.2 67.3 54.1 0.2 0.0 0.6 1.1 0.2 1.8 0.4 1.8 16.9 0.1 10.2 0.0 17.1 9.6 2.5 1.1 6.8 0.1 2.0 0.0 1.5 9.3 21.3 0.0 4.1 13.8 0.9 12.7 0.8 1.4 0.3 1.1 2.2 0.0 0.6 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;epididymis: 6.4;testis: 5.8" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 18.6" "Lineage enriched" "Detected in single" 33 "granulocytes: 18.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 0.5 0.3 0.2 1.7 0.2 4.4 0.6 0.1 0.4 0.4 0.0 0.9 0.8 0.4 6.4 1.1 0.3 0.4 0.2 0.1 0.1 0.2 0.4 0.4 2.3 0.2 0.2 0.0 0.5 0.2 0.1 0.1 1.4 0.3 0.2 1.3 0.4 0.5 0.1 0.2 1.1 0.7 0.6 0.1 0.9 0.5 5.8 0.2 3.3 0.2 0.0 2.6 0.4 0.5 0.3 13.9 20.0 26.2 13.7 1.2 2.6 18.8 14.2 5.4 19.3 17.7 31.7 11.0 11.0 18.3 5.7 12.0 10.7 24.5 11.3 27.3 21.7 19.3 26.3 23.3 14.8 0.1 10.9 8.4 0.5 0.8 22.3 9.2 2.6 4.5 31.2 16.3 25.6 11.6 15.2 25.0 13.9 15.1 14.2 13.6 25.5 50.7 15.4 4.3 5.6 10.1 20.2 8.7 4.8 8.1 20.9 16.8 12.3 3.1 24.8 14.9 16.6 19.7 16.0 17.4 10.5 7.8 12.2 15.6 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.0 0.3 0.1 0.2 0.3 0.1 0.0 1.1 0.3 0.8 0.1 0.3 0.5 0.6 1.5 0.5 0.3 0.4 0.0 0.7 0.0 0.0 4.6 0.5 0.6 0.0 0.3 0.5 0.8 0.7 0.4 0.0 3.8 0.1 0.0 4.8 0.8 2.0 0.5 0.0 4.5 0.0 0.3 2.2 0.0 0.1 0.9 0.0 0.0 1.4 0.6 0.6 0.8 0.0 0.0 1.0 0.5 1.0 0.0 0.3 0.1 0.0 0.0 2.5 0.1 0.1 0.0 0.9 0.3 0.0 0.6 1.0 13.2 9.1 1.5 0.1 1.1 0.5 0.6 1.3 0.2 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8" "Cell type enhanced" "Detected in many" "Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 33 "neutrophil: 24.0;plasmacytoid DC: 23.3" "Group enriched" "Detected in many" 33 "dendritic cells: 23.3;granulocytes: 24.0" "Group enriched" "Detected in some" 5 "HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: AB_2685895" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 1.0 0.6 4.9 0.8 16.1 0.7 3.3 38.8 12.3 1.8 0.0 2.2 1.4 2.2 0.9 2.0 1.4 1.7 0.3 6.8 6.2 1.0 1.6 0.3 2.0 5.0 15.4 4.8 0.7 0.3 0.2 1.0 0.2 17.7 1.7 0.5 4.2 2.3 2.7 5.0 4.8 0.7 0.7 0.5 1.9 0.6 10.9 9.9 0.7 7.1 10.3 1.7 1.5 1.0 4.5 0.0 0.0 8.4 0.1 0.2 0.0 0.0 6.6 0.1 0.3 0.1 0.1 0.0 1.1 1.6 3.4 0.6 0.1 5.5 0.0 1.2 63.9 0.8 4.8 0.0 0.0 0.0 0.0 35.5 0.1 0.0 0.1 0.0 0.3 0.2 0.5 0.0 0.3 4.7 0.2 0.0 0.3 2.4 1.2 0.1 0.0 0.9 0.2 16.5 0.0 1.1 0.2 0.0 0.1 0.0 1.1 0.1 0.7 0.5 1.1 3.4 0.7 7.9 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 23.3 0.0 0.2 4.9 16.1 38.8 12.3 6.8 6.2 5.0 15.4 4.8 17.7 0.5 9.9 4.5 1.9 0.0 0.0 198.8 1.0 3.7 0.0 0.0 0.0 1.9 0.8 12.3 1.6 0.0 0.0 0.0 10.4 0.0 53.7 0.0 0.0 0.8 42.2 0.1 0.5 2.8 0.0 0.0 47.9 0.4 0.1 0.4 0.0 0.1 0.0 3.3 0.4 7.0 0.4 0.0 44.3 0.0 0.0 0.0 0.8 41.2 0.6 0.8 1.8 8.4 0.1 16.9 0.0 77.9 5.6 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 3.3 0.8 0.5 1.6 0.0 5.8 0.0 0.2 3.0 0.3 0.2 ACSS1 "ACAS2L, AceCS2L, dJ568C11.3, MGC33843" ENSG00000154930 "Acyl-CoA synthetase short chain family member 1" Q9NUB1 20 25006230-25058980 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 300.4;Cytotrophoblasts: 329.7;Syncytiotrophoblasts: 419.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 50.3;JURKAT: 51.2;MOLT-4: 49.6;OE19: 64.6;RPMI-8226: 75.1;U-937: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041014, HPA043228" Enhanced NA NA "HPA041014: AB_2677251, HPA043228: AB_2678372" "unprognostic (6.87e-2)" "prognostic favorable (9.37e-4)" "unprognostic (5.32e-2)" "unprognostic (1.54e-1)" "unprognostic (2.78e-1)" "unprognostic (3.03e-2)" "unprognostic (3.20e-3)" "prognostic favorable (8.33e-5)" "unprognostic (2.44e-1)" "unprognostic (2.17e-2)" "unprognostic (2.43e-1)" "unprognostic (7.72e-2)" "unprognostic (4.58e-3)" "unprognostic (5.85e-2)" "unprognostic (2.68e-1)" "unprognostic (3.69e-1)" "unprognostic (1.60e-1)" 11.9 9.5 65.2 15.6 68.0 33.6 14.2 58.0 67.7 15.1 113.2 26.9 49.8 16.2 19.8 14.5 19.0 15.2 61.1 66.2 56.0 43.1 14.0 20.4 25.7 65.6 65.1 57.1 22.8 57.9 34.3 11.4 119.4 66.5 29.4 20.8 4.0 40.1 12.1 44.9 17.8 47.2 13.3 53.0 33.8 63.4 38.9 66.4 31.2 30.1 41.7 21.5 15.8 14.7 61.6 0.1 11.8 3.4 0.0 10.6 4.0 0.2 1.3 5.1 5.0 3.3 12.0 1.6 21.0 2.0 4.8 21.5 5.9 17.1 2.6 1.0 0.0 1.6 36.0 0.2 50.3 11.1 8.5 0.4 7.0 8.6 0.5 0.0 0.0 10.9 51.2 1.9 39.0 0.4 1.3 49.6 14.6 0.2 64.6 18.9 38.2 1.1 75.1 7.3 9.4 8.3 0.2 2.3 4.6 33.5 0.2 22.5 19.1 1.7 0.1 0.1 0.1 0.6 26.7 1.9 0.0 0.5 51.5 13.0 5.6 2.8 7.2 4.2 5.1 3.3 4.0 2.7 3.6 3.5 5.1 2.3 3.5 0.5 10.2 3.4 2.1 2.7 2.3 65.2 68.0 58.0 67.7 66.2 56.0 65.6 65.1 57.1 66.5 53.0 66.4 61.6 10.8 12.8 15.1 300.4 29.8 5.2 6.7 3.1 5.2 2.2 15.1 8.0 73.0 45.8 7.7 11.0 0.0 329.7 26.4 27.2 76.3 6.5 87.7 14.3 5.0 9.7 0.0 42.9 0.9 7.7 10.9 14.0 26.5 7.2 5.7 20.4 9.3 6.2 53.2 0.0 1.8 28.5 10.2 11.2 8.8 16.2 34.5 12.0 7.2 41.2 12.3 14.8 25.7 32.2 31.4 1.9 15.8 32.4 42.2 14.0 90.6 16.7 13.8 1.0 19.7 8.8 12.0 1.1 2.0 9.5 4.3 419.5 22.6 60.2 23.4 4.1 ANKRD40 MGC15396 ENSG00000154945 "Ankyrin repeat domain 40" Q6AI12 17 50693198-50707914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 181.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021668, HPA021759, HPA074884" Uncertain Approved "Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli fibrillar center, Cytosol" "HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: " "unprognostic (2.73e-1)" "unprognostic (1.82e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (4.99e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.84e-2)" "unprognostic (1.53e-1)" "unprognostic (4.77e-2)" "unprognostic (1.00e-2)" "unprognostic (9.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" 43.1 19.8 155.0 15.6 171.3 7.8 26.0 149.7 142.6 20.6 84.2 26.3 11.9 24.0 13.9 18.6 19.5 16.3 24.3 116.8 133.7 18.0 17.9 22.7 16.8 169.3 170.4 101.7 20.8 19.6 27.1 10.9 23.3 181.4 18.5 16.4 20.9 15.1 25.0 108.0 14.4 16.4 28.2 164.0 20.7 18.8 10.4 157.2 17.1 17.0 84.8 14.6 25.5 17.0 179.0 41.1 38.6 34.2 34.6 48.2 39.8 29.9 36.2 39.5 41.3 38.7 82.6 20.5 43.3 49.2 46.4 44.3 22.8 49.3 29.4 66.8 40.0 31.7 59.1 25.1 40.7 26.4 41.6 24.0 34.3 29.5 40.3 50.1 30.2 32.9 35.1 34.0 42.3 34.4 32.0 52.2 15.1 38.0 33.0 36.1 35.2 61.9 30.8 32.5 34.8 18.1 50.5 20.2 27.2 39.6 59.1 31.4 27.4 40.4 55.8 44.1 29.2 46.7 44.3 43.4 38.3 30.6 15.9 46.4 7.4 7.0 3.1 10.9 11.2 12.5 9.8 12.0 12.3 7.1 9.2 11.1 13.4 1.8 10.7 12.3 14.2 9.3 4.6 155.0 171.3 149.7 142.6 116.8 133.7 169.3 170.4 101.7 181.4 164.0 157.2 179.0 39.0 16.0 11.4 11.4 13.9 45.0 24.2 6.1 11.4 14.3 19.8 11.7 31.7 12.8 4.9 18.4 4.2 14.9 19.9 13.5 27.4 16.6 1.8 10.4 20.3 31.4 6.0 7.4 16.0 17.5 18.9 19.6 5.6 16.1 9.5 14.3 32.9 21.9 19.0 35.3 15.6 12.3 6.1 32.4 25.1 3.1 34.2 16.3 26.6 11.2 13.2 19.6 8.2 12.1 32.2 19.9 8.4 37.6 4.5 30.5 9.6 24.8 5.0 12.0 46.0 39.1 27.3 17.5 21.1 10.4 33.2 10.7 15.7 9.7 12.8 24.1 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997475 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.0;Late spermatids: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favorable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favorable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 6.5 5.8 8.9 5.8 9.5 13.9 6.1 8.7 11.3 6.5 8.5 5.8 5.0 5.4 6.4 7.5 5.8 5.5 5.9 8.8 9.6 5.8 12.5 5.2 8.9 9.9 9.2 8.7 5.8 6.1 4.4 7.7 4.0 9.7 8.5 6.8 4.9 5.2 5.1 7.4 9.8 6.6 5.9 8.7 10.3 5.4 14.2 9.1 8.6 6.3 4.7 8.0 6.4 6.7 10.8 3.0 6.1 6.4 9.7 11.9 10.5 3.4 4.3 7.5 5.5 5.9 2.9 5.0 10.3 6.3 4.7 4.8 6.1 5.4 6.8 5.9 7.8 4.5 6.1 6.9 4.0 8.4 3.4 7.8 8.7 10.8 4.2 7.6 6.3 8.4 12.0 3.6 4.7 7.6 3.1 11.5 6.9 4.8 10.9 2.8 9.4 6.5 4.6 8.0 3.6 2.5 5.4 7.3 3.6 5.9 37.2 5.1 3.2 6.7 6.5 3.2 2.9 3.3 5.2 4.1 5.1 7.5 7.9 7.8 10.5 5.9 6.9 10.3 5.9 9.6 9.0 9.3 9.7 5.8 7.2 10.0 10.3 19.1 7.7 8.2 8.6 11.1 6.1 8.9 9.5 8.7 11.3 8.8 9.6 9.9 9.2 8.7 9.7 8.7 9.1 10.8 2.5 0.0 2.0 10.1 3.8 2.0 1.7 4.2 4.6 2.0 2.0 1.4 1.6 2.8 2.1 1.8 2.1 2.4 3.5 2.5 1.9 3.1 23.0 1.8 2.8 1.9 1.2 5.2 7.4 0.9 2.2 2.7 2.0 1.8 2.5 5.1 2.5 3.7 4.3 1.7 8.4 4.2 6.1 3.8 1.8 27.3 3.4 3.2 1.8 8.4 3.4 2.0 5.2 7.5 9.3 2.1 5.0 3.4 2.3 1.6 3.9 3.1 2.5 1.2 0.0 2.5 2.3 9.6 4.9 5.0 2.3 1.5 4.7 2.8 3.1 1.1 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 56.1;cervix: 22.0;retina: 44.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 1607.5" "Cancer enriched" "Detected in some" 4 "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 1.2;RT4: 2.1;SCLC-21H: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA054825: AB_2682617, HPA057837: AB_2683542" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.0 3.2 24.3 0.0 22.4 0.0 0.0 56.1 27.4 22.0 9.6 0.3 0.3 0.2 0.0 0.0 0.4 0.1 0.0 23.4 24.5 7.3 0.0 0.0 0.0 31.7 22.6 22.7 1.9 0.2 0.0 4.0 1.0 35.2 0.0 0.1 44.9 1.2 0.0 0.0 0.0 0.5 0.1 19.5 0.0 0.1 10.3 27.8 0.0 0.0 0.0 0.0 0.1 0.1 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 2.1 6.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 22.4 56.1 27.4 23.4 24.5 31.7 22.6 22.7 35.2 19.5 27.8 34.1 0.0 0.0 0.0 8.8 0.2 0.0 0.0 0.0 0.0 211.9 0.0 0.0 0.4 0.0 0.0 3.7 4.2 0.0 0.1 0.0 15.6 0.0 134.5 0.0 0.0 0.3 0.0 0.0 343.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 17.0 0.0 0.0 0.0 0.2 84.4 1.2 0.1 0.0 14.0 0.0 5.1 0.0 1607.5 4.2 0.0 0.0 0.7 0.1 0.2 0.0 0.2 0.0 11.9 0.0 0.1 0.0 1.5 1.3 0.0 0.0 0.1 2.2 0.0 0.0 0.1 VOPP1 "DKFZp564K0822, ECop, FLJ20532, GASP, WBP1L2" ENSG00000154978 "VOPP1 WW domain binding protein" Q96AW1 7 55436056-55572988 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 253.8" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 212.7;Plasma cells: 278.9;Rod photoreceptor cells: 220.7" "Cancer enriched" "Detected in all" 4 "glioma: 56.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 487.6;HDLM-2: 423.4;Karpas-707: 523.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.60e-2)" "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.35e-5)" "unprognostic (8.65e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-2)" "unprognostic (1.91e-3)" "unprognostic (5.15e-2)" "prognostic unfavorable (6.99e-8)" "unprognostic (3.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.23e-1)" "unprognostic (4.60e-2)" 30.5 17.6 62.6 67.7 52.2 38.5 24.1 49.5 51.9 35.6 53.9 41.8 35.9 30.3 27.5 20.7 39.2 33.2 21.3 50.8 59.9 32.8 23.4 33.7 100.0 57.8 67.0 48.7 28.9 22.3 27.4 57.8 21.0 54.5 23.7 42.8 253.8 39.1 21.5 49.1 13.8 47.8 29.1 60.8 77.0 40.0 10.4 71.9 115.4 21.2 36.6 79.2 40.2 23.6 65.0 487.6 92.3 48.0 46.7 104.0 58.5 21.1 121.0 109.3 102.7 102.1 43.6 118.3 107.6 81.6 109.3 168.9 76.6 50.8 101.1 109.6 423.4 29.1 0.2 53.1 60.7 23.9 39.1 46.7 50.5 52.1 92.9 35.7 69.3 137.2 35.7 27.9 523.5 175.5 36.0 15.7 26.8 105.9 60.7 55.3 25.6 48.9 260.1 114.4 46.0 97.1 36.9 70.1 49.2 25.5 80.4 55.0 47.4 119.0 104.8 157.5 140.7 128.3 250.0 191.2 115.6 44.7 35.6 163.2 17.7 10.0 35.7 24.9 11.5 19.4 75.0 31.6 33.3 25.8 38.6 24.3 26.8 25.7 30.1 19.8 28.2 41.9 25.3 62.6 52.2 49.5 51.9 50.8 59.9 57.8 67.0 48.7 54.5 60.8 71.9 65.0 43.7 3.2 9.8 47.7 113.8 12.6 25.6 14.3 12.0 56.3 10.7 5.1 7.9 27.1 17.0 49.7 212.7 1.8 56.7 44.0 9.8 38.9 11.5 27.1 18.0 40.8 53.3 13.9 44.9 32.5 7.1 20.5 19.9 21.8 6.3 21.3 44.3 25.1 38.5 42.1 71.2 45.7 16.2 105.6 145.9 11.8 19.3 64.4 39.2 87.1 131.3 86.5 81.4 19.1 16.8 59.5 41.3 22.6 278.9 28.2 39.9 10.0 18.7 220.7 32.9 12.4 19.4 3.7 27.0 8.6 8.4 1.2 51.0 5.9 34.6 27.4 SEPTIN14 "FLJ44060, SEPT14" ENSG00000154997 "Septin 14" Q6ZU15 7 55793540-55862755 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 22.7" "Cell type enriched" "Detected in single" 5 "Extravillous trophoblasts: 1.1" "Cancer enriched" "Detected in some" 10 "glioma: 6.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 6.2;U-266/84: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA073255 Enhanced NA NA "HPA073255: AB_2686590" "unprognostic (1.29e-1)" "unprognostic (3.50e-1)" "unprognostic (1.98e-2)" "unprognostic (1.57e-1)" 0.9 0.6 1.1 1.4 1.2 2.3 1.0 1.5 1.5 0.7 0.4 0.6 0.5 1.0 1.0 0.7 0.7 0.9 0.6 1.1 1.0 1.1 2.3 0.7 1.0 1.0 0.8 1.0 1.1 0.6 1.2 1.4 1.1 1.4 1.2 0.8 2.0 0.8 0.5 0.6 1.4 0.5 0.7 0.6 1.2 0.9 22.7 1.0 1.3 1.2 0.6 0.9 0.8 0.0 1.7 1.2 0.3 1.3 2.9 1.3 1.0 6.2 0.8 0.7 0.6 0.9 0.2 0.8 0.9 0.2 0.5 1.3 1.1 1.4 1.0 1.7 1.6 0.7 0.6 2.3 2.3 2.8 1.3 1.4 1.1 1.8 0.8 1.5 1.2 0.7 2.2 2.3 1.3 1.0 0.6 1.8 1.7 1.1 2.0 0.2 0.7 1.2 1.4 1.0 0.9 1.0 1.3 0.3 0.7 1.2 1.4 0.8 1.8 0.6 0.8 0.8 0.9 0.6 1.7 5.7 1.3 0.7 4.6 1.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 1.1 1.2 1.5 1.5 1.1 1.0 1.0 0.8 1.0 1.4 0.6 1.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOOL "AAIR8193, CXorf33, FAM121A, Mic27, MICOS27, UNQ8193" ENSG00000155008 "Apolipoprotein O like" Q6UXV4 X 85003877-85093316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000612 Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA000612: AB_1078594" "prognostic unfavorable (2.68e-5)" "unprognostic (2.72e-2)" "unprognostic (6.16e-2)" "unprognostic (5.71e-3)" "unprognostic (4.27e-3)" "unprognostic (1.47e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (8.35e-2)" "unprognostic (1.10e-1)" "unprognostic (2.77e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.35e-12)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "unprognostic (7.11e-2)" "unprognostic (7.51e-2)" 5.9 6.6 3.3 3.7 3.9 3.7 6.7 4.1 5.7 4.4 5.2 5.9 6.0 4.4 4.8 6.2 5.2 4.1 11.6 4.7 4.2 11.3 14.6 4.3 3.3 4.8 4.7 3.5 4.1 6.1 11.7 3.2 4.1 4.8 6.0 6.6 6.8 5.9 4.5 18.0 6.7 4.6 5.9 3.3 3.5 6.9 2.2 4.9 3.7 8.4 18.1 3.5 4.2 4.0 5.3 11.4 6.5 6.0 8.2 16.9 11.7 6.4 7.4 6.9 6.2 6.0 7.0 6.3 8.3 6.9 8.4 11.7 8.8 18.3 7.0 9.3 8.4 8.0 8.8 10.2 7.2 11.0 17.5 9.1 11.8 11.8 10.4 18.4 7.2 8.8 10.7 15.2 10.7 10.8 6.1 7.2 7.1 4.9 6.8 12.1 7.9 14.6 8.6 7.8 8.3 0.6 9.8 14.1 12.7 8.8 6.4 7.7 8.3 9.2 8.5 8.3 17.5 8.6 6.9 24.4 7.1 10.9 12.4 7.3 2.4 2.0 0.6 1.9 2.8 1.7 2.1 1.7 1.4 2.1 1.9 2.1 2.0 0.4 1.2 2.5 2.6 1.0 1.0 3.3 3.9 4.1 5.7 4.7 4.2 4.8 4.7 3.5 4.8 3.3 4.9 5.3 16.7 16.0 19.1 25.8 10.7 5.6 13.3 5.3 6.2 26.7 16.8 11.9 45.4 15.7 7.7 20.2 14.6 15.3 9.3 10.6 13.7 18.1 0.2 17.0 15.4 13.0 37.1 14.9 32.3 14.0 11.3 13.9 17.3 17.4 21.5 18.3 15.0 51.6 12.0 21.9 26.2 15.3 4.1 15.2 2.3 0.8 13.7 11.4 0.0 21.5 9.5 13.6 8.2 30.2 36.2 17.5 14.6 15.4 8.7 19.6 15.6 43.7 7.6 16.8 19.7 19.3 16.9 3.1 8.2 11.5 3.4 19.4 6.6 16.8 15.4 17.8 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 15.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 0.9 0.8 0.5 0.4 0.9 0.0 3.0 0.2 4.5 15.3 6.9 1.3 0.0 1.0 0.5 1.2 0.5 0.7 2.2 0.6 0.6 0.2 0.2 5.4 0.7 1.0 1.9 0.4 4.5 0.2 0.6 1.5 2.8 0.4 2.3 0.5 0.4 1.4 1.7 1.9 4.7 0.3 0.6 0.3 1.3 0.1 0.1 2.7 1.0 0.9 1.2 3.0 0.2 0.8 0.6 0.0 0.0 3.6 0.0 0.6 0.3 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.2 4.5 0.6 0.6 1.0 1.9 0.4 0.4 0.3 2.7 0.6 2.6 0.0 0.0 0.3 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.1 5.4 0.0 0.0 5.2 0.0 0.2 18.7 0.0 0.1 0.0 0.0 3.3 0.0 16.8 0.0 32.5 0.0 0.0 0.3 11.8 0.0 4.1 0.3 7.2 2.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 7.4 0.0 0.8 2.0 0.0 0.0 CYP2U1 "SPG49, SPG56" ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931549-107953461 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 85.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 30.2;Inhibitory neurons: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 7.8 6.5 6.8 4.0 8.2 0.5 4.5 7.7 7.4 5.1 9.2 4.8 3.4 6.7 3.6 3.5 7.9 5.6 7.8 6.6 9.6 5.4 5.9 5.7 6.4 9.2 7.7 6.0 9.6 2.3 10.8 4.7 2.4 8.0 10.0 3.9 5.9 3.4 8.7 3.6 2.7 4.7 10.3 7.9 7.7 3.2 3.1 8.0 85.7 3.6 7.3 4.7 4.7 3.9 9.7 4.0 1.9 5.2 9.5 28.6 13.4 0.8 16.8 25.3 10.2 15.7 0.1 2.5 10.8 1.1 10.1 7.8 0.2 8.1 6.4 15.4 3.0 2.5 2.3 3.5 0.5 11.3 3.2 0.0 15.3 5.3 4.7 3.2 20.8 4.0 12.0 0.1 5.0 8.4 2.9 11.8 0.0 5.4 0.4 4.7 6.5 6.3 0.1 3.3 6.7 10.0 7.6 4.2 7.3 18.6 4.3 3.6 1.5 10.6 6.5 0.8 9.3 6.9 21.1 21.2 3.4 5.5 0.0 7.4 0.0 0.1 0.3 0.4 0.5 0.3 0.8 0.3 0.4 0.9 1.1 0.7 0.5 0.0 0.7 2.8 1.1 0.0 0.2 6.8 8.2 7.7 7.4 6.6 9.6 9.2 7.7 6.0 8.0 7.9 8.0 9.7 5.5 3.2 3.9 18.6 12.9 1.1 4.6 2.2 15.4 4.1 2.8 5.8 6.2 1.5 2.4 9.2 4.2 0.4 10.1 1.4 0.0 0.9 13.2 6.9 6.3 5.8 3.0 1.7 30.2 2.0 0.3 12.6 3.1 6.2 4.5 2.5 8.6 7.3 2.3 1.7 34.3 1.2 0.0 6.2 3.3 9.5 17.7 4.7 19.6 5.6 3.7 9.5 1.0 20.1 12.1 0.4 0.1 17.7 4.2 1.5 9.9 3.0 8.6 3.1 0.0 20.0 8.1 1.0 4.2 2.0 1.4 0.3 3.6 5.1 3.1 0.8 RSPH10B ENSG00000155026 "Radial spoke head 10 homolog B" P0C881 7 5925550-5970683 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "fallopian tube: 8.4;testis: 19.9" "Group enriched" "Detected in some" 8 "Early spermatids: 59.2;Late spermatids: 143.2;Respiratory ciliated cells: 41.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049182 Supported NA NA "HPA049182: AB_2680666" "unprognostic (4.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.47e-1)" "unprognostic (5.31e-2)" "unprognostic (9.41e-3)" "unprognostic (2.80e-1)" "unprognostic (2.88e-3)" "unprognostic (1.11e-3)" "unprognostic (2.93e-3)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (1.76e-3)" "unprognostic (1.75e-2)" "unprognostic (4.06e-2)" "unprognostic (5.80e-2)" "unprognostic (1.31e-3)" 0.1 0.3 3.0 0.0 0.8 0.0 0.1 0.9 0.8 0.5 3.2 0.1 0.0 0.3 0.2 0.1 8.4 0.0 0.0 1.0 1.4 0.2 0.4 1.4 0.0 2.2 2.8 0.4 0.2 0.1 0.9 1.1 0.0 1.6 0.2 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 2.5 1.0 0.1 19.9 1.3 0.0 0.2 0.1 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.8 0.9 0.8 1.0 1.4 2.2 2.8 0.4 1.6 2.5 1.3 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 59.2 10.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 143.2 0.3 0.1 1.8 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.1 4.9 1.1 0.0 0.3 0.0 0.1 0.9 0.0 0.0 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513809 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA036049: AB_2674918" "unprognostic (2.86e-3)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 2.3 1.9 6.7 2.1 7.0 2.8 1.2 2.7 12.9 1.0 1.5 1.3 1.7 1.5 1.2 2.0 1.1 0.9 1.7 10.4 2.9 1.3 1.2 1.3 1.9 5.4 2.9 8.0 1.2 2.6 2.1 1.4 1.3 5.5 1.5 0.9 1.4 2.0 1.2 3.6 3.8 1.5 1.3 0.6 1.5 1.6 1.6 4.3 1.4 1.4 2.0 1.6 1.3 1.0 6.3 11.0 15.2 3.7 9.7 5.7 4.2 6.9 6.5 2.9 4.0 3.9 12.0 7.4 5.2 7.5 4.0 7.4 17.3 4.9 14.7 2.8 3.5 6.3 2.8 10.7 4.7 4.2 4.9 4.3 4.3 7.9 6.4 3.6 3.8 5.0 3.0 8.0 3.5 3.7 16.4 3.0 5.3 13.7 5.1 12.1 6.8 7.8 3.6 4.0 6.1 7.9 12.2 10.2 18.1 3.5 4.5 17.9 4.4 11.4 12.9 16.6 10.1 9.9 5.2 7.5 3.8 7.1 7.1 16.1 6.3 2.1 0.9 1.4 2.1 1.3 1.3 0.9 1.4 1.6 1.8 1.0 1.2 5.0 2.3 2.9 1.4 1.2 1.5 6.7 7.0 2.7 12.9 10.4 2.9 5.4 2.9 8.0 5.5 0.6 4.3 6.3 4.8 6.4 4.8 6.2 2.6 2.5 3.0 0.9 1.2 9.7 3.9 9.1 5.3 2.8 5.8 0.0 4.2 3.9 5.5 4.8 0.0 2.4 1.5 7.6 3.5 2.8 4.8 0.4 10.8 2.6 2.7 2.7 4.6 7.3 2.5 3.0 2.5 1.8 1.5 1.7 8.5 1.9 4.1 3.5 2.9 0.5 1.5 2.4 0.0 7.5 3.2 4.7 5.2 4.0 7.8 2.2 2.1 0.7 1.4 2.4 2.4 1.2 3.2 6.6 0.0 4.7 3.0 2.7 4.9 2.4 3.3 2.2 2.9 1.5 4.8 1.8 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein family member 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 11.2" "Group enriched" "Detected in some" 49 "Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.0 0.5 2.3 0.0 0.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.7 3.5 0.1 0.0 0.0 0.0 6.9 2.6 2.3 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 7.0 5.7 3.5 6.9 2.6 2.3 8.2 0.0 7.8 11.2 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.1 0.0 0.0 554.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 906.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 9.4 0.0 1.0 0.0 760.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274449-95291308 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.8;skin 1: 60.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: AB_2685104" "prognostic unfavorable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.6 0.3 1.1 1.5 1.1 0.3 10.4 0.9 2.1 12.6 0.2 11.6 10.6 1.9 28.1 88.8 5.5 27.2 1.1 0.9 0.9 23.2 0.8 1.8 0.1 1.4 0.9 1.1 1.1 10.2 25.7 1.5 4.5 1.5 24.9 9.9 0.4 35.5 27.9 0.7 60.4 4.9 0.8 0.3 0.6 26.5 0.6 1.0 2.0 12.0 0.2 8.0 25.9 38.2 2.1 79.5 0.1 0.2 0.8 0.3 0.1 38.5 0.1 0.2 0.3 0.4 0.8 135.9 0.0 0.0 0.1 0.1 73.2 0.0 42.4 0.4 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 78.4 0.1 0.4 1.9 0.0 0.1 0.0 0.1 0.0 62.1 0.4 0.5 0.1 3.7 0.5 0.2 0.0 0.1 0.2 83.8 0.6 0.2 0.0 117.7 0.1 0.9 37.2 0.1 0.0 0.2 0.4 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.9 2.1 0.9 0.9 1.4 0.9 1.1 1.5 0.3 1.0 2.1 0.4 3.2 4.2 1.3 0.1 6.6 25.2 27.6 14.2 0.4 29.1 14.9 1.7 37.1 39.9 33.1 4.2 19.0 0.1 8.0 11.7 15.6 0.5 2.7 0.6 0.9 3.6 0.0 0.6 11.0 3.5 0.6 25.5 5.5 0.0 0.7 0.0 0.0 2.4 0.0 1.2 10.4 12.2 0.0 0.8 1.4 0.3 0.2 7.2 0.0 0.6 0.1 0.0 1.5 3.2 17.5 12.4 0.7 0.0 14.1 0.7 0.1 12.3 1.1 0.0 0.4 2.2 0.6 0.1 37.2 12.8 11.2 0.2 0.8 17.4 37.5 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.6" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265" "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 3.5 3.2 7.8 3.3 9.8 3.8 4.9 13.6 17.3 3.4 9.2 4.2 3.6 4.3 7.7 4.3 7.9 3.5 4.9 6.5 8.2 5.3 3.1 4.1 4.2 8.9 9.3 4.8 3.6 3.4 9.2 7.8 3.1 10.3 3.9 4.5 14.2 5.2 4.0 4.8 3.9 3.6 3.9 10.6 4.0 4.5 16.8 8.7 7.6 6.9 3.6 3.6 3.4 3.2 13.4 2.3 1.6 6.6 11.5 6.1 3.7 4.8 3.5 4.3 3.6 4.9 2.6 4.6 4.9 1.7 3.4 7.9 3.7 1.9 3.9 7.6 10.2 4.0 3.8 3.8 2.6 4.8 4.4 2.3 3.1 7.3 6.6 8.6 8.8 4.2 7.2 3.6 4.0 2.7 4.7 4.1 3.2 1.5 5.1 2.5 5.5 3.7 4.7 5.0 4.3 7.8 6.4 4.2 3.9 5.9 3.7 5.1 5.8 5.2 3.1 2.2 5.1 2.3 2.0 1.8 2.8 6.8 5.9 2.0 17.1 2.8 7.1 5.1 1.5 4.4 13.1 4.9 6.2 2.1 10.8 6.2 5.4 5.6 5.6 4.8 3.1 3.9 1.6 7.8 9.8 13.6 17.3 6.5 8.2 8.9 9.3 4.8 10.3 10.6 8.7 13.4 13.3 28.9 17.2 21.2 13.6 2.7 7.7 14.7 3.4 18.3 10.4 6.7 18.9 5.7 19.9 9.2 14.6 3.4 8.6 13.1 0.0 9.1 70.9 76.3 5.4 10.0 19.8 4.2 34.8 4.5 1.5 6.0 12.2 7.3 22.1 10.6 8.9 2.1 3.6 20.2 37.0 15.5 14.2 5.3 3.9 41.7 7.5 5.6 5.4 25.3 5.0 12.6 18.6 22.6 46.9 7.4 8.9 6.4 5.5 5.6 22.9 6.8 152.0 50.7 26.3 9.1 6.9 174.3 34.1 4.0 2.6 5.6 10.3 4.7 11.4 7.9 ODF1 "CT133, HSPB10, ODF27, ODFPG, RT7" ENSG00000155087 "Outer dense fiber of sperm tails 1" Q14990 8 102551589-102561018 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 590 "testis: 400.2" "Group enriched" "Detected in some" 19 "Early spermatids: 208.2;Late spermatids: 322.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064295 Approved NA NA "HPA064295: AB_2685235" "unprognostic (3.79e-3)" 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.3 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.1 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 400.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.6 0.4 0.5 0.3 0.3 0.4 0.4 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 208.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 322.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.0 0.0 6.6 0.0 0.0 13.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLF10 "EGRA, TIEG, TIEG1" ENSG00000155090 "Kruppel like factor 10" Q13118 8 102648784-102655725 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 409.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.67e-2)" "unprognostic (1.29e-2)" "unprognostic (4.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.42e-3)" "unprognostic (7.76e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.61e-5)" "unprognostic (4.88e-1)" "unprognostic (2.74e-2)" "unprognostic (3.44e-2)" "unprognostic (3.77e-1)" "unprognostic (6.60e-3)" "unprognostic (3.27e-2)" "unprognostic (8.23e-2)" "unprognostic (7.51e-3)" "unprognostic (1.06e-1)" 59.8 29.0 6.4 25.6 7.7 154.2 40.6 5.5 15.2 38.0 8.9 49.9 28.6 41.1 17.1 40.0 42.8 65.5 31.3 7.5 9.1 40.4 96.5 71.9 22.7 6.8 6.9 6.3 25.2 127.3 15.3 16.5 71.7 5.9 45.8 46.6 11.5 32.3 33.6 160.2 71.8 26.4 60.8 6.5 35.2 41.5 26.9 7.8 46.0 30.2 124.0 22.5 46.8 27.6 8.3 22.3 32.4 17.3 15.7 30.4 66.3 30.8 43.0 22.9 26.8 12.8 17.3 42.2 35.5 38.2 39.1 49.4 24.0 10.0 106.5 35.4 20.3 17.4 27.6 24.4 15.9 24.7 16.3 41.3 94.5 105.2 36.8 42.1 62.1 60.0 6.8 18.2 68.3 87.2 36.2 17.8 28.3 13.5 58.5 78.8 7.2 59.7 34.0 38.8 67.6 25.4 27.6 64.0 26.3 35.0 25.0 25.4 19.1 67.0 55.9 39.5 65.3 44.0 61.6 51.7 32.6 52.1 20.1 32.2 17.2 52.5 14.3 16.5 48.2 9.0 17.1 12.5 17.2 57.2 5.8 3.1 12.7 5.3 15.6 26.0 10.1 18.4 34.7 6.4 7.7 5.5 15.2 7.5 9.1 6.8 6.9 6.3 5.9 6.5 7.8 8.3 195.5 141.1 74.9 1.0 49.2 137.1 167.6 117.3 409.8 3.5 115.9 119.6 117.9 40.0 56.6 44.1 6.2 52.3 41.7 74.6 9.8 58.3 8.5 110.1 121.6 134.7 94.2 11.2 6.7 43.3 87.7 147.7 46.4 183.3 100.1 34.9 94.2 53.5 61.1 8.4 0.6 49.2 93.6 73.1 185.6 10.4 66.5 117.6 76.5 7.5 83.7 7.7 8.2 0.5 0.5 42.7 41.2 29.3 51.4 136.7 35.5 43.8 50.7 2.6 26.3 157.1 124.1 18.7 30.7 222.9 164.8 72.7 47.8 40.6 48.1 58.8 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase receptor type N2" Q92932 7 157539056-158587823 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.7;pancreas: 98.9" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 23.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 23.6" "Cell line enhanced" "Detected in many" "AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles NA NA 1600000 Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 3.3 16.7 27.4 2.7 36.5 1.3 3.0 0.0 53.7 2.1 0.0 7.8 8.4 3.0 4.3 2.0 10.9 7.6 2.9 38.1 18.3 3.9 1.6 4.8 3.4 11.2 8.3 42.2 8.8 98.9 1.1 41.3 2.1 13.3 17.4 6.2 9.3 13.0 3.6 1.2 0.8 6.7 2.1 0.0 13.6 40.6 6.2 11.4 1.6 8.8 1.9 2.5 4.3 2.2 23.3 0.1 0.4 45.5 3.6 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.0 4.0 0.0 1.2 0.5 9.4 0.3 1.0 0.0 0.0 42.0 0.8 0.0 0.0 7.3 1.1 0.0 0.1 2.0 0.8 0.1 0.5 0.3 0.0 3.4 0.1 0.3 0.0 0.7 22.1 43.0 5.7 13.7 3.2 0.0 2.7 0.2 0.2 0.0 23.8 25.4 0.0 0.1 0.0 0.0 0.0 20.9 6.2 9.2 4.3 0.1 1.5 0.3 0.1 0.0 27.7 17.4 6.8 14.1 1.5 2.8 1.3 0.2 0.5 3.5 2.1 1.4 2.1 4.2 2.4 1.4 23.6 2.4 0.0 0.6 5.3 1.3 27.4 36.5 0.0 53.7 38.1 18.3 11.2 8.3 42.2 13.3 0.0 11.4 23.3 40.7 3.2 12.9 16.3 18.4 2.3 12.7 1.3 4.0 30.2 1.9 2.2 3.1 10.0 9.1 40.5 10.4 0.4 8.7 5.9 35.2 22.9 51.9 8.7 2.5 26.3 131.1 6.6 439.6 13.1 0.4 13.0 41.8 0.8 19.0 14.1 44.3 0.8 44.5 11.8 433.4 43.3 6.1 7.0 11.3 19.3 12.5 7.9 12.4 27.2 5.7 67.3 15.5 138.2 11.0 7.3 7.0 19.5 5.4 15.0 6.5 3.8 52.6 8.0 26.3 1.4 7.0 62.8 16.3 4.8 1.4 0.7 14.8 32.7 9.7 24.8 AZIN1 "OAZI, OAZIN, ODC1L" ENSG00000155096 "Antizyme inhibitor 1" O14977 8 102826308-102893864 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 261.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027948 Approved Approved Vesicles NA NA Vesicles "HPA027948: AB_10602391" "unprognostic (1.16e-2)" "unprognostic (4.81e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (8.55e-2)" "unprognostic (3.41e-2)" "unprognostic (7.19e-2)" "unprognostic (1.51e-2)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (2.07e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-2)" "unprognostic (1.08e-1)" "unprognostic (2.83e-1)" "unprognostic (3.08e-2)" "unprognostic (1.68e-1)" 62.2 48.6 49.7 48.6 53.3 142.4 58.4 50.2 58.3 55.8 52.1 49.5 67.2 44.8 30.6 53.2 64.6 44.0 52.0 52.7 55.1 39.8 78.6 40.4 58.6 61.2 50.4 47.7 39.1 137.7 38.6 31.8 83.5 49.8 53.0 54.1 58.3 48.1 49.9 42.3 32.9 81.4 44.9 58.7 36.3 52.7 36.0 50.5 59.2 68.1 31.2 61.1 62.9 27.5 62.3 320.4 81.7 129.0 92.6 122.7 83.3 77.6 145.4 168.5 103.5 106.8 87.1 217.5 148.0 111.0 121.9 64.3 119.5 113.8 114.5 165.8 244.7 57.4 147.4 30.1 72.3 156.0 81.0 120.7 58.9 136.1 72.5 182.4 92.2 72.8 86.0 112.6 124.0 165.2 92.6 201.8 59.3 144.9 239.3 123.0 87.3 136.5 84.2 108.2 146.7 208.2 327.3 49.1 100.0 144.3 209.9 131.7 84.7 85.9 83.2 83.9 135.7 118.6 122.3 104.2 207.4 98.3 120.1 117.0 73.3 57.7 68.0 31.2 64.1 36.7 43.7 40.8 29.9 55.9 27.5 33.1 32.1 68.5 40.1 64.5 44.3 50.0 65.7 49.7 53.3 50.2 58.3 52.7 55.1 61.2 50.4 47.7 49.8 58.7 50.5 62.3 56.3 60.9 27.7 30.0 59.6 93.8 121.1 52.8 93.4 31.5 64.0 39.8 46.3 28.6 52.8 42.3 37.5 148.7 54.0 48.4 52.8 39.6 62.6 95.1 37.9 34.9 84.9 62.7 35.9 50.5 55.0 55.5 59.1 85.4 68.5 31.9 33.5 65.0 54.7 23.5 31.9 77.3 63.1 72.8 127.2 107.9 49.7 86.0 64.0 23.4 53.0 50.4 32.0 30.2 23.7 66.6 44.0 32.4 97.6 106.7 114.6 52.6 167.6 42.3 19.7 36.0 57.1 34.5 30.7 90.8 82.3 261.9 71.6 26.2 66.0 117.0 ATP6V1C1 "ATP6C, ATP6D, VATC, Vma5" ENSG00000155097 "ATPase H+ transporting V1 subunit C1" P21283 8 103021063-103073051 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 162.7;Late spermatids: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023943, HPA057297" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023943: AB_1845197, HPA057297: AB_2683402" "unprognostic (5.73e-3)" "unprognostic (3.30e-1)" "unprognostic (1.09e-2)" "unprognostic (1.93e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.29e-2)" "unprognostic (3.87e-1)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (3.98e-2)" "unprognostic (1.23e-1)" "unprognostic (3.85e-1)" "unprognostic (3.88e-1)" "unprognostic (2.83e-1)" 24.0 32.6 28.0 24.0 39.2 9.8 21.8 20.7 38.6 18.0 23.6 15.2 16.3 19.2 14.3 15.7 16.9 19.9 30.3 37.7 34.6 52.2 27.8 18.8 26.4 26.6 27.1 35.2 17.9 18.9 39.3 22.4 30.4 30.0 18.4 19.0 37.0 15.4 16.3 17.3 11.9 17.9 20.8 23.4 20.1 17.6 21.1 28.5 22.1 38.1 24.6 24.7 25.4 14.2 38.7 68.4 38.6 20.2 15.6 54.6 39.3 27.7 49.0 49.7 60.6 68.9 30.4 76.7 41.2 58.2 40.8 97.5 29.6 42.4 41.0 87.8 30.3 26.4 39.2 28.0 35.8 59.5 20.8 52.5 28.8 55.4 77.4 36.2 35.6 43.9 28.7 54.6 37.3 71.4 32.1 46.2 16.7 19.1 67.9 37.6 24.6 36.0 36.4 70.3 48.8 28.5 22.6 26.9 26.9 102.0 40.5 58.9 27.8 44.4 33.2 36.1 74.3 35.0 45.1 17.7 42.1 60.2 47.2 33.2 16.8 30.5 38.1 15.1 44.9 17.2 18.7 12.7 15.1 29.0 18.7 14.4 16.0 50.2 18.7 42.7 15.8 23.1 21.1 28.0 39.2 20.7 38.6 37.7 34.6 26.6 27.1 35.2 30.0 23.4 28.5 38.7 31.3 32.1 26.4 38.2 22.9 34.9 33.1 31.2 21.1 32.3 21.9 20.6 43.3 15.7 26.5 31.3 16.7 35.4 15.5 14.7 64.6 36.9 162.7 18.3 19.5 25.5 15.6 33.6 64.9 31.5 35.6 28.4 12.2 16.4 24.1 14.0 17.5 19.0 101.8 37.0 56.6 12.4 46.8 47.6 99.6 166.9 24.2 62.8 19.6 36.5 34.3 34.5 14.4 39.2 44.7 30.4 18.2 18.4 25.1 34.7 19.2 139.1 41.2 25.3 19.7 20.7 45.5 11.1 23.4 19.5 32.8 74.8 18.5 17.4 13.5 27.4 PIP4P2 "DKFZp762O076, TMEM55A" ENSG00000155099 "Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2" Q8N4L2 8 90993802-91040872 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 26.2;Cytotrophoblasts: 32.6;Distal tubular cells: 49.0;Extravillous trophoblasts: 31.1;Hofbauer cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 76.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014591 Approved NA NA "HPA014591: AB_1858124" "unprognostic (6.09e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.54e-4)" "prognostic unfavorable (3.76e-5)" "unprognostic (3.76e-2)" "unprognostic (1.08e-1)" "unprognostic (7.58e-2)" "unprognostic (4.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.59e-1)" "unprognostic (9.05e-2)" "unprognostic (7.99e-2)" 12.0 14.1 15.7 6.7 18.7 30.3 7.5 18.8 20.3 9.3 20.7 11.1 2.9 10.6 4.3 5.9 7.3 11.1 20.9 16.5 22.0 10.1 3.8 5.5 6.9 18.9 19.5 15.9 10.7 3.4 11.0 8.0 8.9 20.6 8.8 4.8 11.1 7.4 12.3 13.7 6.0 5.3 13.6 18.6 8.4 6.6 7.0 19.3 9.6 6.6 14.9 5.5 10.0 6.7 23.4 4.8 2.9 16.8 10.2 27.2 30.6 3.5 19.3 24.2 10.2 15.1 1.9 8.1 9.4 2.6 19.9 10.3 1.1 4.2 7.0 13.6 8.1 7.3 13.9 2.9 1.5 23.6 3.3 12.2 17.2 4.4 12.8 9.6 27.4 9.8 2.7 7.4 31.0 35.6 3.3 10.4 9.5 8.6 0.0 9.8 3.9 6.9 11.2 14.9 3.0 2.0 9.7 1.5 6.6 28.4 11.4 0.2 6.3 15.1 18.5 7.1 11.2 9.0 12.0 7.0 6.0 31.6 6.4 25.2 0.9 11.6 10.8 1.3 5.9 2.3 2.7 3.1 1.7 10.8 1.9 4.8 1.9 76.9 2.4 2.2 6.0 2.8 6.1 15.7 18.7 18.8 20.3 16.5 22.0 18.9 19.5 15.9 20.6 18.6 19.3 23.4 26.2 0.0 2.8 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.5 11.2 0.0 0.0 3.1 9.2 0.0 32.6 7.7 0.0 49.0 18.0 0.0 0.8 11.7 5.2 0.0 0.0 0.0 8.9 31.1 18.7 0.0 1.0 8.8 4.1 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.8 0.0 0.0 2.1 0.0 0.0 13.1 1.5 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 10.9 3.7 14.3 0.0 0.0 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU deubiquitinase 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavorable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 6.7 6.3 7.0 6.4 7.4 6.0 7.2 7.2 8.5 4.9 6.3 4.9 4.2 6.0 4.6 6.4 4.2 3.9 6.6 6.8 7.5 5.4 5.4 4.8 7.4 7.4 7.6 6.3 5.4 4.7 4.0 3.5 8.1 7.5 5.9 5.4 3.2 4.3 4.8 10.3 6.5 4.4 5.6 7.8 5.0 4.4 6.4 7.4 5.8 6.1 9.3 6.2 6.3 5.5 8.8 27.6 11.1 12.8 10.4 6.4 5.6 14.5 19.1 7.4 19.1 12.6 8.6 16.6 25.6 9.0 10.2 7.6 9.1 26.4 16.1 31.6 21.6 16.9 34.5 11.7 8.3 13.3 18.7 21.0 7.2 9.8 14.0 35.5 11.6 17.5 19.4 36.5 19.1 18.9 9.6 31.7 17.5 8.1 20.3 27.3 19.4 11.2 28.9 18.9 15.1 3.5 14.6 2.6 55.9 22.7 16.3 25.5 11.8 15.8 12.3 17.2 20.6 20.5 17.1 29.5 37.2 16.8 26.2 23.1 1.7 1.9 1.1 1.5 2.7 2.0 2.0 1.4 1.7 2.6 1.8 2.1 1.9 0.2 3.4 2.1 4.0 0.8 1.0 7.0 7.4 7.2 8.5 6.8 7.5 7.4 7.6 6.3 7.5 7.8 7.4 8.8 11.9 9.6 11.3 9.8 13.7 23.2 6.5 4.0 10.8 13.0 6.5 5.2 14.3 8.6 9.2 1.8 33.3 10.8 16.5 5.1 9.8 4.8 0.9 10.6 9.9 10.9 10.8 8.2 18.0 4.9 10.0 9.0 7.7 8.6 18.4 10.7 8.9 11.7 8.1 11.8 15.5 4.9 4.1 8.7 12.5 2.2 9.6 8.3 3.6 12.2 10.2 12.2 11.3 18.6 21.6 6.6 3.7 4.1 12.0 8.9 2.8 8.2 8.8 15.3 0.0 8.2 9.6 3.2 7.0 12.5 18.2 6.7 10.7 9.9 6.4 5.9 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell type enhanced" "Detected in all" "Late spermatids: 137.1;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 476.3" "Cancer enhanced" "Detected in all" "prostate cancer: 23.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007053, HPA007062" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA007053: AB_1233803, HPA007062: " "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 6.2 3.4 23.9 7.3 33.6 11.8 6.5 20.4 27.0 6.7 11.4 7.0 5.4 10.3 3.8 8.2 5.4 8.4 4.5 23.3 23.3 6.5 5.0 6.8 9.5 29.1 28.0 19.1 9.9 3.9 6.5 2.3 11.6 27.0 27.0 6.5 8.9 4.5 6.0 3.3 8.6 6.8 7.4 22.6 8.1 7.2 18.7 26.1 13.8 6.2 5.4 9.3 5.4 6.7 43.6 5.7 6.1 21.8 26.4 11.1 15.6 10.8 18.8 19.4 6.7 8.8 7.6 6.4 14.7 6.5 13.2 13.9 3.2 8.0 3.9 15.4 18.2 4.5 26.0 8.8 8.9 6.8 10.5 18.2 10.7 8.6 9.7 14.1 17.0 6.8 12.3 7.6 20.2 14.5 9.7 14.3 15.0 2.0 8.1 4.1 14.8 11.3 5.8 7.8 11.0 10.6 19.8 14.4 11.3 17.0 7.2 3.9 37.1 7.7 14.2 7.6 29.6 11.4 2.1 3.2 12.8 15.6 13.7 14.9 2.1 1.2 0.9 0.4 0.7 0.4 0.6 0.3 0.3 1.0 0.6 0.2 0.3 4.6 0.7 0.4 0.5 0.4 0.3 23.9 33.6 20.4 27.0 23.3 23.3 29.1 28.0 19.1 27.0 22.6 26.1 43.6 15.9 3.2 17.8 50.6 19.2 9.8 14.4 6.7 12.0 19.2 14.6 9.4 8.2 18.6 8.7 16.5 16.7 7.0 17.8 27.0 1.9 10.5 102.3 13.7 16.5 13.6 12.6 21.6 85.3 4.7 18.4 12.0 13.7 25.6 7.0 23.0 20.0 12.2 16.4 23.5 51.5 13.5 8.2 33.9 19.9 137.1 10.8 22.1 26.6 62.8 19.6 33.9 22.6 154.8 476.3 7.0 20.0 16.1 5.9 30.0 16.1 7.7 6.9 13.9 6.6 11.2 12.3 56.6 15.8 20.3 16.2 7.9 13.3 10.1 13.8 11.1 GTF3C6 "bA397G5.3, C6orf51, TFIIIC35" ENSG00000155115 "General transcription factor IIIC subunit 6" Q969F1 6 110958706-110967890 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056179, HPA061345" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA056179: AB_2683058, HPA061345: AB_2684485" "unprognostic (6.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (3.04e-1)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (2.08e-2)" "unprognostic (9.79e-3)" "unprognostic (2.89e-1)" "unprognostic (5.42e-2)" "unprognostic (7.75e-2)" "unprognostic (1.42e-3)" "unprognostic (9.31e-2)" "unprognostic (1.69e-1)" "unprognostic (2.39e-2)" "unprognostic (1.14e-2)" 53.7 55.5 72.9 54.0 74.2 54.0 47.5 75.6 115.8 42.3 74.3 67.5 52.7 31.1 46.2 45.1 45.6 58.3 87.5 72.4 78.9 76.9 51.7 34.2 56.3 74.3 73.4 70.2 28.5 31.1 65.8 37.4 32.7 74.4 95.4 66.0 39.4 38.6 42.0 233.4 31.4 47.1 49.1 75.1 33.8 50.2 62.4 75.2 50.2 40.6 169.5 58.6 61.7 27.8 76.9 85.8 154.0 166.5 155.7 59.9 121.9 145.4 143.8 105.1 131.9 109.2 229.0 74.7 121.1 137.8 132.9 30.4 38.6 141.1 120.0 145.5 175.9 205.3 234.2 145.9 347.5 113.4 360.9 190.8 121.4 103.3 115.2 112.8 89.7 155.2 154.3 281.7 79.4 246.8 166.5 198.6 371.4 169.9 109.6 121.0 183.2 95.6 109.7 221.5 214.7 105.4 148.5 107.0 16.8 133.0 98.6 58.7 244.2 163.0 38.2 112.0 260.5 232.3 51.7 127.2 235.9 39.7 208.1 191.3 112.6 116.9 71.0 104.2 170.7 117.9 164.1 130.0 131.0 158.3 133.7 100.9 118.9 18.5 116.2 141.1 173.4 292.4 167.5 72.9 74.2 75.6 115.8 72.4 78.9 74.3 73.4 70.2 74.4 75.1 75.2 76.9 58.0 70.5 47.1 12.7 67.1 30.3 70.9 169.2 34.1 37.6 85.3 90.4 279.1 203.0 99.5 104.8 16.7 94.6 75.0 138.8 305.2 190.4 169.1 119.1 82.0 66.0 109.8 86.9 4.9 293.0 251.1 66.4 47.9 167.8 54.4 71.2 55.6 94.5 284.6 26.9 6.7 98.6 144.5 79.8 50.1 223.9 65.0 104.5 55.2 6.5 172.4 133.2 81.4 7.1 13.4 210.8 125.2 68.4 78.3 126.9 118.9 404.7 74.9 37.0 65.7 63.5 88.1 153.1 105.8 72.5 29.7 90.4 72.3 120.2 121.4 117.8 TTC39B "C9orf52, FLJ33868" ENSG00000155158 "Tetratricopeptide repeat domain 39B" Q5VTQ0 9 15163622-15307360 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 64.4;Paneth cells: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 2.0;gdT-cell: 2.9;MAIT T-cell: 3.9;memory CD4 T-cell: 4.0;memory CD8 T-cell: 4.6;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.9;NK-cell: 6.3;T-reg: 3.8" "Group enriched" "Detected in many" 6 "granulocytes: 2.0;NK-cells: 6.3;T-cells: 4.7" "Cell line enhanced" "Detected in many" "HEL: 40.9;RT4: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063162 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA063162: AB_2684952" "unprognostic (1.64e-1)" "unprognostic (9.32e-3)" "unprognostic (1.47e-2)" "unprognostic (7.89e-2)" "unprognostic (7.47e-2)" "unprognostic (1.06e-1)" "unprognostic (4.12e-2)" "prognostic favorable (9.64e-6)" "unprognostic (5.99e-2)" "unprognostic (4.77e-2)" "unprognostic (1.59e-1)" "unprognostic (6.89e-2)" "prognostic favorable (4.08e-7)" "unprognostic (3.31e-3)" "unprognostic (2.12e-2)" "unprognostic (5.19e-2)" "unprognostic (1.48e-1)" 1.9 2.6 2.4 4.0 2.8 1.5 4.8 10.9 7.3 3.7 1.8 6.8 5.7 3.6 1.9 8.9 3.3 7.0 1.2 1.6 4.5 9.0 5.5 4.7 6.1 6.4 4.5 1.3 3.0 3.9 1.9 4.0 1.3 7.6 2.3 5.7 2.9 3.0 1.9 1.8 9.7 5.6 4.2 2.0 3.9 5.6 5.8 5.6 3.4 2.6 1.3 6.1 3.6 4.8 8.3 3.9 0.8 1.2 5.6 5.3 9.9 1.2 5.0 9.1 3.9 9.3 0.8 1.6 0.0 0.6 6.3 4.6 3.4 0.9 6.2 3.3 4.5 0.8 40.9 1.7 7.3 8.8 0.0 0.8 9.7 4.7 8.1 9.0 2.8 5.6 3.3 0.1 9.1 10.0 1.3 2.2 0.2 1.6 12.3 1.2 0.4 3.0 1.9 8.3 23.0 2.9 0.5 1.2 2.9 0.9 1.8 12.7 2.5 4.2 2.2 1.8 3.1 1.4 0.1 0.1 0.0 2.1 0.5 1.1 2.0 0.7 0.9 2.9 0.5 3.9 0.2 4.0 4.6 0.4 0.6 4.7 2.9 0.4 6.3 0.7 0.1 3.8 2.5 2.4 2.8 10.9 7.3 1.6 4.5 6.4 4.5 1.3 7.6 2.0 5.6 8.3 7.5 12.8 19.8 10.4 7.0 17.3 7.8 19.1 10.8 25.5 9.0 4.4 4.1 10.0 15.8 7.3 0.0 3.2 18.0 40.6 17.6 6.6 43.2 11.8 10.1 7.4 12.7 0.4 44.0 21.8 1.1 10.0 22.4 7.7 29.1 3.6 7.5 11.6 4.1 13.5 64.4 16.1 24.4 3.1 9.2 33.2 7.2 16.7 7.2 12.2 2.9 14.9 11.3 24.6 2.3 10.5 65.0 12.8 5.5 11.5 30.3 35.5 25.3 4.3 0.0 9.4 12.4 4.7 3.0 8.6 21.5 4.1 22.3 6.8 17.3 14.4 AGPAT5 "FLJ11210, LPAAT-e, LPAAT-epsilon" ENSG00000155189 "1-acylglycerol-3-phosphate O-acyltransferase 5" Q9NUQ2 8 6708642-6761503 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010644, HPA010950, HPA011646" Approved Supported Mitochondria NA NA Mitochondria "HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: " "unprognostic (1.05e-3)" "unprognostic (4.69e-1)" "prognostic favorable (8.82e-4)" "unprognostic (2.05e-2)" "unprognostic (2.99e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (4.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.98e-2)" "unprognostic (6.33e-2)" "unprognostic (2.91e-1)" "unprognostic (6.62e-2)" "unprognostic (2.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (5.09e-3)" 5.4 11.9 7.4 3.0 7.6 2.3 5.0 8.0 8.4 6.1 6.6 5.8 3.1 6.7 8.0 8.5 7.5 1.8 3.2 7.2 9.5 6.7 10.1 4.5 4.1 8.4 7.6 6.5 5.9 6.5 3.3 10.4 4.2 8.2 6.1 4.2 5.3 5.1 5.6 11.3 3.4 6.7 2.9 8.4 4.9 7.0 22.7 7.7 4.8 4.1 2.7 3.8 4.8 5.8 9.6 8.5 7.0 15.3 6.8 3.4 5.2 9.4 4.3 4.6 7.9 7.0 4.6 7.3 21.8 3.2 3.3 10.8 11.0 9.5 9.5 11.2 4.6 6.6 27.4 7.0 10.5 9.1 12.4 10.0 7.6 10.0 6.7 9.8 8.2 13.6 9.5 19.9 10.7 11.4 6.3 23.5 20.1 20.4 13.6 5.8 15.0 15.0 8.2 7.9 13.1 24.4 14.8 4.1 7.9 9.4 8.1 3.6 20.5 5.5 10.8 5.4 4.4 12.4 4.0 12.8 11.3 7.3 13.8 12.9 1.8 1.9 1.2 0.7 2.4 1.6 4.4 1.3 1.4 1.2 5.1 0.9 1.1 0.2 2.7 2.2 4.4 1.2 1.4 7.4 7.6 8.0 8.4 7.2 9.5 8.4 7.6 6.5 8.2 8.4 7.7 9.6 15.7 3.2 4.4 58.8 46.5 9.1 18.8 14.2 19.4 7.8 14.2 10.5 5.8 11.5 9.0 7.3 2.1 9.4 23.5 17.4 3.9 11.2 40.0 30.0 27.9 22.3 22.1 50.0 45.0 10.0 14.2 10.4 27.0 83.6 18.9 10.6 10.4 41.9 12.2 6.7 46.8 10.1 14.2 16.0 4.6 34.7 15.8 12.6 7.2 33.7 7.5 42.3 6.2 56.8 60.2 10.2 16.0 15.4 22.3 30.4 9.8 22.5 14.6 9.8 6.6 14.0 24.7 26.2 10.9 30.9 10.4 18.5 17.4 15.0 25.2 11.9 MMS19 "CIAO4, hMMS19, MET18, MMS19L" ENSG00000155229 "MMS19 homolog, cytosolic iron-sulfur assembly component" Q96T76 10 97458324-97498794 "Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051936, HPA056299" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051936: AB_2681668, HPA056299: AB_2683091" "unprognostic (8.57e-2)" "unprognostic (2.38e-3)" "unprognostic (9.34e-3)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (4.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.06e-3)" "unprognostic (6.79e-2)" "unprognostic (6.49e-2)" "unprognostic (4.06e-1)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.39e-4)" 25.7 23.5 46.8 15.1 48.7 16.5 27.2 46.9 66.9 27.6 46.1 25.1 14.3 24.8 18.5 33.0 25.0 13.2 33.1 48.5 45.7 32.1 24.1 25.4 22.4 46.3 46.6 47.1 30.5 30.8 17.3 36.0 20.7 46.8 23.7 17.7 29.0 26.9 15.9 38.3 44.5 28.6 17.9 44.6 33.7 28.2 47.5 47.1 26.0 23.7 29.5 22.9 25.8 30.6 46.4 39.1 36.5 43.3 61.1 41.4 49.9 26.3 30.7 61.6 45.8 53.5 48.9 49.7 59.9 32.5 42.1 30.4 43.5 71.5 82.7 43.1 26.3 54.5 32.0 30.5 51.8 31.3 42.7 29.9 41.5 35.7 40.7 86.3 88.8 78.2 44.7 45.5 32.8 45.1 35.1 40.5 77.3 24.6 39.0 29.8 32.1 33.0 27.1 55.0 27.9 17.8 29.5 17.8 23.4 48.3 53.7 47.9 37.8 45.0 21.1 26.0 14.2 35.6 29.5 35.0 34.6 31.5 62.3 17.3 10.5 6.1 4.6 5.4 6.6 9.3 6.0 7.2 6.8 8.5 5.0 8.7 7.1 1.2 5.7 5.2 6.3 7.2 6.3 46.8 48.7 46.9 66.9 48.5 45.7 46.3 46.6 47.1 46.8 44.6 47.1 46.4 9.4 22.4 16.0 21.2 10.0 10.5 6.2 11.3 12.5 10.6 9.2 11.2 18.0 12.8 8.2 5.5 18.8 13.7 13.4 8.7 11.7 11.1 9.6 5.6 12.1 13.0 10.2 11.6 32.8 8.1 18.8 9.9 16.8 9.0 3.8 12.8 15.4 14.4 12.4 10.1 29.7 14.6 4.1 12.6 9.6 7.4 15.5 9.0 14.2 7.5 15.6 6.4 6.2 27.6 38.6 9.7 4.1 11.3 10.7 6.1 9.1 6.7 7.6 22.2 13.1 9.1 8.8 22.2 28.5 12.7 11.5 8.8 9.7 9.7 13.1 4.9 OR4K1 ENSG00000155249 "Olfactory receptor family 4 subfamily K member 1" Q8NGD4 14 19930917-19936757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028877 Uncertain NA NA "HPA028877: AB_10600923" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PI4K2A "DKFZP761G1923, PI4KII, PIK42A" ENSG00000155252 "Phosphatidylinositol 4-kinase type 2 alpha" Q9BTU6 10 97640686-97676434 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB030649, HPA076857" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB030649: , HPA076857: AB_2686817" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (4.21e-5)" "unprognostic (1.80e-2)" "unprognostic (2.12e-1)" "unprognostic (1.75e-2)" "unprognostic (2.84e-3)" "unprognostic (1.60e-2)" "unprognostic (1.39e-3)" "unprognostic (1.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.65e-1)" "unprognostic (9.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" 11.5 25.9 15.8 10.1 15.3 24.3 9.4 15.3 18.7 11.7 13.3 9.9 9.9 12.8 13.1 20.8 9.6 14.1 13.9 15.8 16.8 12.8 15.1 14.3 11.3 19.2 18.7 15.2 10.1 8.5 16.8 15.9 18.1 20.7 11.0 8.8 13.0 10.6 10.5 12.8 16.4 10.9 13.2 15.7 14.7 9.4 10.9 19.4 9.9 9.6 13.1 10.7 14.6 12.8 21.7 28.7 21.3 17.2 30.7 36.0 25.8 13.8 28.0 61.5 43.3 45.7 19.4 27.7 10.4 16.2 35.8 31.8 27.1 19.3 55.9 35.8 12.6 16.4 9.3 14.6 17.7 34.5 8.4 12.7 27.3 46.9 45.4 80.1 47.4 22.4 19.9 14.7 16.5 30.4 14.6 18.4 6.4 11.1 14.7 19.8 8.6 17.8 10.3 29.7 26.6 5.8 18.9 23.9 5.9 35.5 24.0 16.4 13.2 25.0 20.6 15.2 24.6 22.1 14.6 18.4 16.9 38.1 5.0 6.8 0.0 1.2 0.0 1.3 0.8 1.0 1.4 0.5 1.1 1.3 0.6 0.4 0.9 0.4 0.7 0.6 0.6 1.2 0.6 15.8 15.3 15.3 18.7 15.8 16.8 19.2 18.7 15.2 20.7 15.7 19.4 21.7 4.9 3.2 5.4 9.8 12.0 13.4 4.5 6.5 8.0 14.7 10.7 8.9 10.4 10.0 4.3 5.5 12.5 14.0 12.5 8.6 3.9 4.9 2.4 6.8 15.4 6.9 3.0 8.2 10.9 4.9 6.4 12.0 7.1 7.6 1.3 5.7 3.6 9.9 38.1 11.8 10.9 4.0 6.1 15.0 24.7 2.2 4.4 19.0 10.6 12.2 15.0 8.0 18.6 5.5 6.0 7.2 0.8 9.1 9.4 5.8 9.0 7.3 4.8 15.1 6.6 11.9 8.0 11.0 6.1 6.3 14.3 27.1 9.7 12.4 3.6 7.8 MARVELD1 "bA548K23.8, FLJ22343, FLJ23440, GB14, MGC4415, MRVLDC1" ENSG00000155254 "MARVEL domain containing 1" Q9BSK0 10 97713173-97718150 "Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.2;intermediate monocyte: 2.7;myeloid DC: 3.1" "Group enriched" "Detected in many" 18 "dendritic cells: 3.1;monocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 141.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.28e-2)" "unprognostic (2.11e-2)" "unprognostic (1.26e-3)" "unprognostic (3.05e-2)" "unprognostic (1.36e-3)" "unprognostic (8.82e-2)" "unprognostic (7.40e-3)" "prognostic unfavorable (5.85e-5)" "unprognostic (1.54e-2)" "unprognostic (7.44e-3)" "unprognostic (3.40e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (3.92e-3)" "unprognostic (7.02e-2)" "unprognostic (1.50e-1)" "unprognostic (3.86e-3)" 32.6 9.0 5.3 12.7 5.8 5.2 26.9 5.1 5.4 55.6 21.9 47.3 7.8 60.5 16.8 19.9 48.5 20.6 20.4 5.0 7.1 12.4 5.6 29.9 6.9 7.3 6.0 4.3 40.9 7.1 11.3 20.2 25.2 5.5 44.7 24.7 2.0 19.2 49.0 6.2 28.8 22.5 48.1 6.1 16.1 23.9 6.8 6.3 5.4 16.0 7.1 6.0 46.9 41.6 6.3 42.0 30.7 26.1 99.9 97.8 94.0 27.0 56.4 141.3 51.6 34.5 13.5 70.4 0.0 44.5 105.1 7.3 50.3 22.4 53.5 25.9 3.2 28.0 20.3 24.6 0.0 40.9 28.6 0.0 82.7 137.5 33.2 38.3 95.3 65.0 17.6 5.7 0.1 57.7 24.1 3.8 9.9 19.5 4.5 30.6 26.1 22.4 7.0 27.4 8.9 16.9 17.8 34.0 0.3 59.7 16.0 13.4 33.7 65.8 51.9 21.2 50.7 21.4 0.0 3.1 0.1 26.5 0.1 40.2 0.0 3.2 0.0 0.0 2.7 0.1 0.0 0.0 0.1 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 1.0 5.3 5.8 5.1 5.4 5.0 7.1 7.3 6.0 4.3 5.5 6.1 6.3 6.3 7.0 9.6 6.3 10.7 0.9 7.6 31.4 13.4 9.6 2.5 7.1 21.0 4.4 11.5 5.7 12.9 6.2 10.5 0.1 31.9 0.0 8.3 0.7 3.1 32.3 10.5 3.0 4.6 2.3 0.9 21.0 29.9 2.0 6.3 2.5 86.6 12.8 0.6 12.9 0.0 2.8 28.9 4.1 32.6 13.4 2.9 23.0 15.6 12.4 7.5 11.7 13.7 0.0 2.5 0.6 1.9 7.0 38.7 0.3 4.0 2.0 0.2 0.7 3.2 0.0 10.0 31.9 0.3 1.6 1.0 5.4 3.4 1.2 13.1 9.4 6.9 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 14.5 28.2 31.3 13.0 31.7 23.4 16.0 28.7 35.4 19.6 32.3 21.4 25.0 16.7 23.1 16.6 20.5 12.2 17.6 35.2 32.7 27.9 32.8 17.9 16.2 32.3 30.6 32.3 26.1 23.9 19.4 38.6 9.6 32.7 22.2 16.5 28.6 19.1 10.4 12.9 18.2 30.8 8.6 27.9 29.4 20.0 23.2 31.9 12.8 20.6 5.9 13.2 16.9 17.2 32.5 17.7 21.4 12.6 28.1 14.1 9.8 17.2 17.7 18.5 20.3 19.7 19.1 35.9 27.2 19.8 12.8 25.9 38.8 18.4 17.2 10.6 28.3 18.6 12.9 23.1 18.1 18.1 20.9 24.9 16.0 20.4 19.9 15.2 32.4 11.5 22.5 19.6 17.9 15.3 13.8 16.9 39.4 10.3 15.3 16.4 19.2 12.7 13.0 19.5 10.8 10.1 19.7 11.9 9.9 47.2 11.5 21.8 20.5 12.4 10.2 11.9 15.6 34.2 20.6 18.6 14.3 25.3 26.5 11.9 4.8 5.8 9.3 9.6 6.2 8.2 7.1 6.6 7.9 5.4 6.7 7.5 8.3 8.2 6.8 9.2 5.6 9.5 8.3 31.3 31.7 28.7 35.4 35.2 32.7 32.3 30.6 32.3 32.7 27.9 31.9 32.5 10.0 3.2 11.4 14.0 22.1 8.2 12.8 11.3 18.8 29.9 11.1 8.9 7.2 14.3 9.7 14.7 58.4 7.4 21.2 33.9 7.9 14.9 5.2 14.3 7.8 11.0 20.3 14.3 33.6 16.0 5.7 10.1 19.4 11.4 14.0 17.3 10.8 10.9 8.2 37.0 35.2 15.6 14.2 8.8 5.7 1.5 9.6 11.0 10.6 16.9 11.2 14.8 15.5 12.5 20.2 13.9 26.1 9.1 13.4 13.8 35.5 8.6 16.6 43.7 19.7 6.7 9.9 8.9 7.6 10.4 5.5 13.5 17.9 10.9 14.7 17.7 GOLGA7B "bA451M19.3, bA459F3.4, C10orf132, C10orf133" ENSG00000155265 "Golgin A7 family member B" Q2TAP0 10 97849843-97871580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3;choroid plexus: 23.6;epididymis: 23.6" "Cell type enhanced" "Detected in many" "Astrocytes: 25.5;Excitatory neurons: 33.6;Inhibitory neurons: 21.2;Late spermatids: 16.6;Rod photoreceptor cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.3;GAMG: 14.5;HDLM-2: 5.7;SK-MEL-30: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain NA NA "HPA046878: AB_2679854" "unprognostic (7.90e-2)" "unprognostic (1.70e-3)" "unprognostic (7.10e-3)" "unprognostic (1.06e-2)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-4)" "unprognostic (1.95e-1)" "unprognostic (4.45e-1)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (4.13e-2)" "unprognostic (1.15e-7)" "unprognostic (2.12e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-3)" "unprognostic (5.90e-3)" 0.9 2.3 25.5 0.9 29.1 0.2 1.1 32.1 36.3 0.7 23.6 0.9 1.5 0.2 23.6 2.6 0.4 0.4 3.0 31.2 25.9 0.2 0.6 0.7 1.4 27.8 27.5 28.1 0.1 8.1 0.0 9.4 0.2 28.2 0.5 0.5 17.1 0.7 0.5 4.7 14.6 2.0 0.1 23.1 0.5 1.0 1.4 26.8 0.3 0.9 3.3 1.1 0.7 2.0 28.8 5.3 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.1 0.0 14.5 1.9 0.0 0.4 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 1.0 0.3 0.0 1.8 0.1 0.1 0.3 0.8 1.4 0.0 1.0 22.6 0.0 2.1 0.1 0.1 0.1 0.0 0.0 0.2 1.7 0.8 0.0 3.9 2.3 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 25.5 29.1 32.1 36.3 31.2 25.9 27.8 27.5 28.1 28.2 23.1 26.8 28.8 0.2 0.0 0.5 25.5 0.0 12.5 0.1 0.7 0.0 6.4 0.6 4.4 2.3 12.8 0.2 1.8 2.1 0.0 3.2 0.3 0.0 6.4 5.4 0.3 0.4 0.5 12.0 0.0 33.6 4.3 0.0 0.6 0.0 0.4 0.0 0.0 0.4 0.0 5.1 3.3 21.2 1.1 0.0 0.0 1.2 16.6 0.3 0.2 7.2 5.6 0.6 3.2 3.1 2.5 1.9 7.4 0.1 0.4 0.0 0.3 1.2 0.0 0.0 18.7 0.0 1.5 0.3 3.9 2.3 0.0 5.1 0.0 2.9 0.0 0.4 0.3 GPR78 ENSG00000155269 "G protein-coupled receptor 78" Q96P69 4 8558725-8619761 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 1.4;placenta: 3.1" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 5.2" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 25.8" HPA013209 Uncertain NA NA "HPA013209: AB_10601657" "unprognostic (6.41e-2)" "unprognostic (1.77e-2)" "unprognostic (1.17e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-2)" "unprognostic (3.70e-2)" "unprognostic (3.82e-4)" "unprognostic (6.46e-3)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.29e-1)" "unprognostic (4.88e-15)" "unprognostic (5.55e-3)" "unprognostic (3.93e-2)" "unprognostic (9.90e-3)" "unprognostic (8.15e-2)" 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 4.9 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.8 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 TRMT44 "C4orf23, FLJ35725, METTL19, TRM44" ENSG00000155275 "TRNA methyltransferase 44 homolog" Q8IYL2 4 8436140-8493531 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045461 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045461: AB_10961276" "unprognostic (1.50e-1)" "unprognostic (1.65e-3)" "unprognostic (3.47e-1)" "unprognostic (1.01e-2)" "unprognostic (2.06e-1)" "unprognostic (1.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.78e-2)" "unprognostic (3.46e-1)" "unprognostic (8.13e-2)" "unprognostic (3.44e-3)" "unprognostic (2.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (6.76e-2)" "unprognostic (8.34e-3)" 5.4 3.5 2.2 3.9 2.7 7.2 7.0 2.8 3.1 5.1 1.1 4.3 3.7 6.3 4.4 6.6 5.4 3.4 4.0 2.6 1.4 3.2 4.2 4.2 5.0 1.9 1.2 2.7 7.7 4.6 4.3 3.3 4.9 2.2 4.9 3.2 3.7 5.6 3.8 6.0 8.7 3.7 4.4 0.5 4.1 5.3 5.0 1.3 3.8 4.6 2.6 5.3 5.0 5.7 3.0 5.2 5.1 6.4 7.5 6.5 6.3 15.2 5.9 4.2 7.6 6.7 6.8 7.0 6.9 3.1 2.3 6.4 4.1 9.3 5.4 6.7 3.7 5.9 6.9 8.9 5.1 6.0 11.4 4.9 3.9 7.7 5.8 6.3 6.4 8.1 4.8 10.2 7.2 5.0 3.2 9.5 8.3 7.4 6.5 8.5 6.9 6.9 4.9 6.6 6.0 6.9 4.7 3.8 3.4 5.5 7.2 2.9 4.7 5.2 4.6 2.5 4.4 9.3 8.4 6.0 6.2 5.1 10.7 4.7 0.1 0.3 0.0 0.6 0.3 0.3 0.2 0.5 0.6 0.5 0.5 0.7 0.2 0.0 0.2 0.6 0.4 0.0 0.1 2.2 2.7 2.8 3.1 2.6 1.4 1.9 1.2 2.7 2.2 0.5 1.3 3.0 4.4 9.6 7.3 12.7 4.9 6.8 4.2 3.1 2.8 7.8 6.8 5.1 3.3 7.2 3.2 7.3 25.0 10.2 4.1 2.6 5.9 5.0 3.8 16.2 13.0 4.7 1.8 1.7 21.3 4.5 6.2 7.5 14.8 25.6 5.1 18.8 5.0 3.8 4.6 3.3 18.4 2.0 2.0 3.1 2.4 2.8 5.9 3.7 1.8 8.4 4.1 2.6 3.1 8.5 12.3 4.5 7.2 3.8 5.3 5.3 3.0 2.7 8.1 10.8 0.0 6.3 6.5 9.2 5.8 8.2 5.8 16.3 5.2 4.8 3.8 7.6 SLC25A28 "MRS3/4, MRS4L" ENSG00000155287 "Solute carrier family 25 member 28" Q96A46 10 99610522-99620609 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 148.9;Late spermatids: 390.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.87e-3)" "prognostic favorable (2.18e-6)" "unprognostic (8.59e-3)" "unprognostic (6.86e-2)" "unprognostic (4.29e-1)" "unprognostic (1.43e-2)" "unprognostic (3.39e-2)" "unprognostic (9.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.40e-2)" "unprognostic (9.80e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.12e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (7.62e-3)" 54.4 74.6 108.1 33.1 111.5 86.8 51.5 105.0 126.4 60.2 99.3 69.9 23.2 47.3 46.8 71.0 59.5 25.1 63.3 107.5 109.6 54.0 97.5 74.1 42.0 109.6 112.8 106.5 61.4 66.5 32.6 56.1 28.4 108.5 79.3 34.1 54.9 52.1 46.2 101.1 55.6 56.8 36.2 106.4 81.0 59.0 91.0 108.7 31.2 49.0 45.8 38.1 90.6 63.4 113.0 28.7 28.5 17.8 42.8 32.3 40.1 18.1 33.8 40.4 45.2 37.0 22.4 35.2 36.9 19.9 30.8 20.5 47.6 22.1 31.6 27.8 27.5 28.3 16.3 46.4 23.9 31.8 29.3 21.6 33.9 46.0 29.4 58.1 58.9 32.4 32.1 11.7 27.9 23.5 39.6 25.4 66.1 4.2 23.1 21.9 31.9 21.2 20.6 30.0 31.1 11.9 14.9 19.2 20.7 25.4 23.1 37.3 28.8 19.9 27.6 19.0 36.9 41.0 22.8 15.5 18.3 26.5 55.8 11.7 0.0 1.4 4.0 2.7 1.3 1.2 1.7 1.9 1.6 2.1 1.6 1.4 1.2 1.2 1.6 1.3 5.8 2.4 0.7 108.1 111.5 105.0 126.4 107.5 109.6 109.6 112.8 106.5 108.5 106.4 108.7 113.0 30.4 12.8 11.0 37.2 11.8 25.4 16.4 17.5 4.6 30.7 12.5 14.1 19.7 15.7 7.3 5.5 20.9 21.0 18.3 9.2 7.9 3.8 148.9 11.1 13.6 17.1 4.2 4.8 34.1 8.0 8.7 15.8 4.1 13.2 6.3 36.2 9.7 19.1 9.8 43.7 34.0 11.9 6.1 9.2 20.0 390.1 12.8 16.2 19.6 20.6 10.6 29.0 8.2 28.6 36.3 6.3 9.6 18.0 10.6 31.1 7.2 8.3 4.0 29.2 13.1 20.5 15.6 63.4 9.2 13.6 27.4 14.5 12.2 58.2 11.4 20.6 HSPA13 STCH ENSG00000155304 "Heat shock protein family A (Hsp70) member 13" P48723 21 14371115-14383484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 231.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014797 Approved "Intracellular and membrane" NA NA 3300000 "HPA014797: AB_1857567" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.72e-1)" "unprognostic (2.85e-3)" "unprognostic (1.41e-2)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (5.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.65e-1)" "unprognostic (2.29e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-2)" 13.6 24.2 13.9 17.8 16.3 23.7 15.8 13.4 16.2 19.3 10.7 12.5 10.1 22.1 26.7 9.1 8.6 12.5 13.9 15.1 21.8 16.5 13.4 13.0 15.9 15.1 17.5 14.3 16.6 9.4 24.2 17.4 23.0 17.0 15.6 12.8 23.5 9.5 17.0 3.4 3.8 10.0 19.4 14.9 15.3 12.8 22.9 17.6 17.0 27.9 8.1 17.5 18.6 5.0 19.8 21.2 17.0 65.7 38.2 46.6 37.4 41.8 58.6 68.9 47.8 54.5 16.1 22.8 36.7 40.3 42.4 71.1 9.1 30.8 20.1 79.6 38.5 24.0 35.8 16.4 30.4 119.5 58.8 44.0 33.4 64.4 68.4 117.0 60.5 40.6 32.6 30.5 231.9 52.7 21.2 39.6 17.9 49.0 9.9 23.2 36.6 57.8 81.2 25.1 8.1 15.0 36.7 43.6 22.6 84.6 33.4 31.1 38.7 40.7 62.1 51.7 49.3 43.4 87.5 70.5 29.2 69.9 37.2 79.5 23.1 4.8 4.9 6.6 5.4 11.4 7.1 7.0 7.1 5.5 3.7 7.7 7.4 1.9 12.1 4.9 8.3 6.0 6.1 13.9 16.3 13.4 16.2 15.1 21.8 15.1 17.5 14.3 17.0 14.9 17.6 19.8 14.0 9.6 14.1 11.4 29.7 12.7 14.7 16.9 20.5 41.0 15.6 8.6 14.6 4.3 10.8 3.7 14.6 22.1 25.1 5.1 0.0 8.6 6.8 6.6 31.4 14.6 14.9 26.7 21.0 10.4 31.1 26.4 5.6 15.1 19.0 21.2 12.5 11.8 14.5 60.6 28.2 8.1 4.1 15.8 28.9 2.8 9.9 16.7 23.2 12.2 8.6 34.8 8.2 31.7 15.5 9.3 3.7 19.2 131.4 15.2 2.9 7.5 7.8 21.9 13.1 23.6 25.0 40.2 12.7 12.9 10.2 64.2 24.6 11.9 4.1 13.6 SAMSN1 "HACS1, NASH1, SASH2, SH3D6B, SLy2" ENSG00000155307 "SAM domain, SH3 domain and nuclear localization signals 1" Q9NSI8 21 14485228-14658821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 194.8;lymphoid tissue: 80.8" "Cell type enhanced" "Detected in many" "granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 314.2" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HEL: 273.7;K-562: 331.6;Karpas-707: 137.3" "Region enriched" "Detected in many" 6 "olfactory bulb: 20.7" "Low region specificity" "Detected in all" "HPA010645, HPA017055, HPA046639" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732" "unprognostic (7.62e-3)" "unprognostic (1.46e-2)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.13e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (9.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.17e-1)" "unprognostic (1.68e-2)" 32.6 6.7 2.7 80.8 3.6 194.8 4.8 3.6 4.8 5.8 5.5 11.1 7.1 3.5 2.0 5.4 6.4 22.9 3.2 2.7 9.0 4.2 17.6 23.1 35.7 6.6 3.6 2.2 1.3 3.1 2.0 2.2 15.6 5.9 3.9 15.5 12.8 2.9 2.2 0.7 1.4 15.2 10.9 6.8 32.3 9.3 1.2 4.0 22.7 2.2 1.3 41.3 40.0 2.5 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.1 0.0 0.0 0.0 0.0 1.8 0.0 14.0 0.0 273.7 0.0 0.0 0.0 32.5 12.7 0.1 0.0 0.0 37.9 10.2 3.6 4.8 331.6 137.3 0.0 0.0 15.9 39.5 0.1 0.0 0.2 26.8 0.3 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 35.0 0.0 0.0 0.0 0.0 58.2 0.5 0.3 1.4 20.7 0.0 314.2 38.7 234.6 22.1 52.3 15.4 27.3 42.8 33.3 25.0 15.4 26.8 19.1 49.4 18.0 83.0 0.9 60.3 33.6 2.7 3.6 3.6 4.8 2.7 9.0 6.6 3.6 2.2 5.9 6.8 4.0 8.3 4.8 22.4 54.9 0.7 127.5 15.6 1.1 0.0 1.8 64.9 2.7 3.0 1.2 1.5 11.2 36.8 0.0 0.5 147.9 0.7 0.0 0.6 0.0 0.8 0.2 8.0 0.0 13.7 1.0 6.5 0.7 11.3 10.7 0.6 1174.1 0.1 4.6 1.8 62.0 0.0 0.8 0.8 0.0 183.7 317.9 0.4 0.6 414.6 21.4 131.2 829.9 1.6 24.7 2.5 0.6 0.7 1.1 0.0 119.3 0.5 0.0 0.5 8.0 4.7 0.0 2.2 3.7 0.1 0.2 1.2 13.2 0.5 332.8 0.1 0.9 0.9 USP25 USP21 ENSG00000155313 "Ubiquitin specific peptidase 25" Q9UHP3 21 15730025-15880069 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in all" "Early spermatids: 166.7;Excitatory neurons: 148.0;Late spermatids: 192.8;Oligodendrocyte precursor cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018297, HPA024142" Approved Supported Cytosol NA NA Cytosol "HPA018297: AB_1858672, HPA024142: AB_1858673" "unprognostic (6.35e-2)" "unprognostic (1.50e-1)" "unprognostic (6.90e-2)" "unprognostic (6.29e-2)" "unprognostic (1.39e-1)" "unprognostic (2.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "unprognostic (1.40e-1)" "unprognostic (8.24e-3)" "unprognostic (2.34e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-2)" 26.1 13.0 13.0 17.0 18.0 27.2 17.8 12.9 15.9 18.2 11.7 15.5 12.7 27.1 18.8 21.6 16.9 12.5 28.4 14.5 6.7 21.6 20.4 24.2 20.2 7.4 5.0 12.1 14.2 16.1 14.4 7.6 29.6 7.0 18.1 16.2 9.6 17.7 24.8 122.1 13.2 13.4 36.7 4.3 19.6 13.2 55.0 4.4 25.8 15.7 75.8 19.4 15.7 17.5 11.6 31.2 23.1 21.5 3.2 38.7 57.5 25.3 22.0 21.8 16.0 20.1 20.5 17.4 33.6 31.5 34.9 24.3 16.4 16.7 29.1 22.0 33.5 19.1 27.5 23.5 15.8 64.3 36.6 12.1 37.6 34.7 25.8 74.0 41.7 57.0 30.0 35.9 61.4 29.1 13.0 42.1 7.1 26.6 12.5 20.3 31.8 20.0 25.8 43.5 8.3 4.7 12.8 31.4 26.2 20.9 25.9 14.0 21.3 54.6 24.8 16.0 26.2 12.5 17.7 11.9 26.8 16.0 16.1 18.6 0.0 1.4 1.9 1.8 1.4 2.0 1.6 1.5 3.2 1.2 1.1 1.4 2.1 2.9 1.1 1.3 1.3 2.2 0.8 13.0 18.0 12.9 15.9 14.5 6.7 7.4 5.0 12.1 7.0 4.3 4.4 11.6 30.4 57.7 29.5 47.3 21.7 17.1 18.8 9.7 15.9 6.2 17.4 11.8 55.7 15.7 24.2 22.0 4.2 39.0 21.4 20.3 5.9 9.4 166.7 24.0 19.0 19.7 9.6 21.5 148.0 13.4 8.4 19.4 17.9 34.6 6.3 14.4 17.9 18.0 13.3 5.0 98.4 12.8 8.2 24.2 16.0 192.8 19.0 24.2 16.0 86.2 23.7 4.0 23.7 150.3 72.4 13.4 8.4 12.8 15.9 22.0 11.9 15.1 23.4 6.7 19.7 26.1 17.2 11.2 5.8 22.7 19.2 33.1 26.9 18.5 11.6 20.4 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 73.2;Club cells: 45.8;Endometrial ciliated cells: 51.8;Endometrial stromal cells: 49.0;Extravillous trophoblasts: 46.5;Glandular and luminal cells: 153.2;Respiratory ciliated cells: 48.8;Syncytiotrophoblasts: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.9;MAIT T-cell: 2.8;memory CD4 T-cell: 1.6;memory CD8 T-cell: 2.3;myeloid DC: 1.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 1.8;NK-cell: 1.1;plasmacytoid DC: 4.3;T-reg: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;NK-cells: 1.1;T-cells: 3.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 114.1;CAPAN-2: 73.6;fHDF/TERT166: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 11.7 16.2 56.1 7.0 54.2 1.6 39.1 58.7 55.5 32.5 46.9 28.9 29.9 29.7 15.7 9.0 34.6 11.0 11.8 51.5 54.4 33.2 24.6 11.4 7.5 60.1 58.1 40.1 30.5 9.0 8.8 10.0 24.9 54.0 17.0 30.1 6.7 23.3 23.9 3.9 25.8 36.3 22.2 61.7 6.1 16.6 4.1 53.1 13.3 40.7 5.6 11.3 14.0 16.4 62.2 66.1 3.7 3.0 14.6 62.4 21.5 19.4 71.2 114.1 28.7 37.2 2.6 73.6 0.0 26.4 75.4 0.7 17.5 0.9 27.6 30.9 6.1 4.8 3.1 8.2 3.9 14.2 0.0 2.3 34.6 10.4 29.2 9.4 36.4 0.2 0.0 0.0 0.0 50.7 6.7 0.0 0.9 3.1 13.7 4.6 1.3 17.6 14.3 38.8 69.1 1.1 0.1 11.9 6.0 21.2 12.8 22.9 4.2 6.6 6.6 2.1 11.6 12.7 3.9 3.5 0.1 1.4 0.0 19.2 0.2 0.4 0.0 2.9 0.4 2.8 0.5 1.6 2.3 1.7 0.2 3.0 1.8 0.3 1.1 0.3 4.3 2.4 1.2 56.1 54.2 58.7 55.5 51.5 54.4 60.1 58.1 40.1 54.0 61.7 53.1 62.2 10.2 16.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 25.5 73.2 0.0 0.0 45.8 40.5 0.0 32.3 10.0 0.0 23.5 14.1 0.0 51.8 49.0 3.2 0.0 0.0 0.0 8.7 46.5 8.7 0.0 153.2 3.8 4.9 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 2.8 0.0 0.0 18.3 48.8 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 58.6 4.7 2.8 0.0 0.0 ZCCHC10 FLJ20094 ENSG00000155329 "Zinc finger CCHC-type containing 10" Q8TBK6 5 132996985-133026604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038944 Approved Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA038944: AB_10673601" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-2)" "unprognostic (2.30e-2)" "unprognostic (4.77e-1)" "unprognostic (1.90e-3)" "unprognostic (1.23e-3)" "unprognostic (8.80e-2)" "unprognostic (1.89e-3)" "unprognostic (1.69e-1)" "unprognostic (2.03e-1)" "unprognostic (8.30e-3)" "unprognostic (1.36e-2)" "unprognostic (1.27e-1)" "unprognostic (8.85e-2)" "unprognostic (1.62e-1)" "unprognostic (8.89e-3)" 15.1 14.6 9.6 18.7 9.8 38.5 16.3 12.3 12.6 12.2 11.9 26.1 19.4 14.9 14.0 23.5 12.5 14.1 17.5 9.1 10.5 16.5 22.1 13.3 29.7 9.2 9.2 8.0 12.8 15.2 14.2 12.4 19.9 9.9 11.2 22.6 19.1 15.0 10.3 25.1 13.6 18.5 14.4 8.3 16.9 17.9 21.4 9.9 24.3 11.6 24.2 28.6 21.3 14.4 10.5 28.0 29.4 37.7 30.5 18.2 15.9 48.3 29.1 21.1 35.2 40.1 74.2 33.6 75.1 43.5 18.3 28.9 35.3 46.3 35.9 38.5 46.3 62.0 45.0 35.4 54.4 26.4 36.8 50.5 14.0 41.0 21.8 35.5 19.8 35.2 37.6 47.7 41.3 25.9 36.1 62.7 45.1 40.5 29.7 30.5 54.1 43.5 33.8 32.8 40.8 28.7 24.1 46.6 18.2 55.0 50.5 40.9 50.4 37.6 30.7 37.0 20.2 43.5 35.4 60.6 107.9 24.7 69.6 36.7 49.8 65.6 41.6 44.4 61.7 47.0 102.3 54.1 54.0 66.5 122.4 47.4 48.5 34.7 59.9 66.2 58.3 70.2 48.4 9.6 9.8 12.3 12.6 9.1 10.5 9.2 9.2 8.0 9.9 8.3 9.9 10.5 47.4 28.9 37.5 11.8 76.2 33.3 37.5 48.9 26.2 28.2 33.3 22.7 55.7 50.1 42.6 12.9 8.4 46.8 43.6 72.1 33.2 38.6 7.3 39.1 28.8 39.9 37.8 40.4 13.6 67.2 56.7 37.2 27.5 30.9 33.0 29.0 39.7 65.2 47.0 28.6 13.8 57.9 67.1 54.4 61.9 6.3 24.5 37.2 35.6 15.0 48.8 24.3 53.5 16.6 14.4 54.5 77.6 29.7 30.6 31.0 47.4 90.5 42.9 27.9 13.1 34.0 33.0 60.3 72.8 31.5 37.8 61.6 45.2 24.1 52.2 50.6 C16orf87 ENSG00000155330 "Chromosome 16 open reading frame 87" Q6PH81 16 46796603-46831180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 129.3;Spermatocytes: 194.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041179 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041179: AB_10795002" "unprognostic (2.44e-1)" "unprognostic (4.21e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (7.95e-5)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (3.21e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (9.90e-2)" "unprognostic (1.35e-2)" "unprognostic (2.08e-2)" "unprognostic (2.66e-1)" "unprognostic (6.61e-3)" "unprognostic (1.84e-2)" 3.6 4.8 2.2 3.3 3.3 12.0 3.4 1.6 3.1 3.6 1.9 4.1 2.7 4.2 1.7 4.6 3.3 2.7 6.1 2.6 1.6 7.4 13.2 4.0 6.2 1.3 1.2 2.5 3.1 2.5 5.3 3.9 3.7 1.3 3.0 2.3 2.4 3.4 2.0 13.8 3.4 4.8 2.9 0.9 3.9 2.9 18.5 1.7 3.7 2.9 7.6 4.1 4.2 3.4 2.5 8.2 3.2 14.3 7.7 3.0 3.4 12.1 8.3 6.3 6.2 3.3 5.4 6.1 10.0 9.7 4.7 4.5 5.3 13.2 3.8 7.3 9.9 8.0 6.9 6.1 6.8 6.2 8.3 11.3 4.1 4.1 8.0 7.9 10.3 4.4 13.7 6.9 2.1 7.3 4.6 11.5 11.2 11.2 5.2 5.4 19.3 15.0 8.3 10.6 4.0 7.5 7.5 9.8 9.6 4.8 25.7 5.1 12.5 7.0 7.0 6.6 7.5 4.4 9.7 10.2 29.7 2.7 6.8 7.0 2.6 6.4 8.1 4.6 8.8 2.4 11.9 6.3 5.6 9.7 7.4 5.5 4.0 0.9 3.3 8.2 5.3 13.6 4.0 2.2 3.3 1.6 3.1 2.6 1.6 1.3 1.2 2.5 1.3 0.9 1.7 2.5 13.9 16.0 11.5 9.4 26.0 47.2 16.9 19.2 61.5 8.9 17.1 17.8 38.2 21.5 11.6 16.5 22.9 68.9 15.5 6.7 31.3 20.4 45.1 28.0 35.1 16.0 19.1 14.1 28.2 12.2 53.4 21.8 9.7 30.8 14.0 20.6 15.0 40.7 22.7 30.3 14.5 12.4 22.4 23.9 71.5 25.9 17.1 27.8 33.8 9.4 23.9 24.2 13.4 24.6 9.8 12.4 7.5 14.3 27.9 24.4 32.9 129.3 6.0 10.5 32.9 15.3 26.5 194.6 93.2 42.8 41.9 34.3 22.0 13.7 14.0 16.0 MOV10 "fSAP113, gb110, MGC2948" ENSG00000155363 "Mov10 RISC complex RNA helicase" Q9HCE1 1 112673141-112700746 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031627 Approved Cytosol NA NA Cytosol "HPA031627: AB_2673966" "unprognostic (1.44e-2)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" "unprognostic (6.82e-3)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.44e-4)" "unprognostic (9.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.58e-3)" "unprognostic (2.85e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.48e-11)" "unprognostic (4.01e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-3)" "unprognostic (1.21e-3)" 7.3 13.3 3.4 9.8 3.2 4.7 7.7 2.7 3.4 10.3 4.6 11.0 22.3 10.3 9.6 13.3 13.6 9.5 4.6 2.8 7.5 10.2 19.6 9.2 8.5 4.5 3.2 2.3 9.7 8.2 12.9 11.3 23.8 3.6 11.6 10.8 3.1 14.4 11.3 3.2 27.4 20.4 10.9 3.1 12.2 10.8 16.7 4.4 16.4 9.9 4.3 7.0 9.4 10.9 4.4 29.5 17.9 10.4 40.2 8.3 23.5 39.1 19.8 46.5 56.9 80.7 33.2 31.7 0.0 13.2 27.4 21.1 30.5 39.7 47.4 19.6 32.4 24.2 20.2 26.7 37.8 35.3 8.5 19.3 39.9 14.2 34.6 10.9 37.4 49.2 40.7 27.2 9.8 17.8 54.7 32.7 6.6 23.4 12.2 18.1 57.9 26.2 1.3 26.4 31.9 4.4 15.0 40.9 27.5 31.5 20.2 21.4 19.4 29.7 17.6 31.0 12.4 17.8 11.3 3.3 0.1 34.9 17.4 51.4 0.9 3.5 0.7 12.5 10.3 12.4 2.1 10.8 11.1 6.8 1.5 10.3 8.0 1.1 12.7 12.2 1.0 10.2 7.6 3.4 3.2 2.7 3.4 2.8 7.5 4.5 3.2 2.3 3.6 3.1 4.4 4.4 13.0 9.6 10.5 26.4 6.3 8.8 10.4 15.5 8.0 2.4 7.8 7.0 4.1 8.6 17.4 16.5 0.0 54.7 5.6 29.2 3.9 15.5 5.9 5.8 7.3 16.9 15.0 3.8 4.1 15.5 18.4 9.4 23.9 7.0 1.3 36.5 16.8 18.3 15.8 5.0 2.3 18.0 12.2 7.5 6.0 6.2 9.3 10.3 3.6 12.2 14.4 15.1 10.3 18.1 3.3 12.4 26.9 7.5 3.6 11.1 46.2 13.9 18.4 1.1 13.1 4.0 7.4 2.7 3.4 11.7 7.0 38.2 9.2 22.4 15.5 12.1 RHOC "ARH9, ARHC" ENSG00000155366 "Ras homolog family member C" P08134 1 112701127-112707434 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1020.9;Pancreatic endocrine cells: 1304.7;Paneth cells: 945.4;Proximal enterocytes: 952.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 1396.1" "Lineage enriched" "Detected in all" 4 "monocytes: 1396.1" "Cell line enhanced" "Detected in all" "WM-115: 2444.5" HPA051461 Uncertain NA NA "HPA051461: AB_2681493" "unprognostic (2.31e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (1.93e-1)" "unprognostic (8.34e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.68e-4)" "unprognostic (2.08e-2)" "unprognostic (9.90e-2)" "unprognostic (1.40e-2)" "unprognostic (6.79e-3)" "unprognostic (3.95e-2)" "prognostic unfavorable (3.65e-5)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (3.08e-2)" "unprognostic (2.51e-3)" 253.1 203.3 166.0 123.8 161.9 21.0 241.3 161.7 209.3 201.0 158.1 300.0 295.8 256.8 315.4 106.1 202.3 187.5 308.8 158.1 220.0 305.6 145.9 281.3 55.7 191.5 169.0 149.5 190.7 121.1 648.5 110.8 228.8 168.2 234.1 252.9 88.4 150.5 285.3 86.5 164.0 314.0 255.2 173.3 233.5 151.5 94.6 181.5 89.6 162.1 121.0 50.9 220.9 181.3 173.3 774.3 314.4 178.1 203.7 334.3 571.7 204.7 672.2 825.1 476.1 402.8 253.8 236.1 10.6 281.8 1000.8 221.5 217.5 136.2 630.2 456.9 181.7 83.9 89.1 201.2 202.9 559.5 14.3 394.1 687.8 421.1 804.3 535.4 543.3 1286.4 108.3 180.5 157.1 876.7 410.2 38.7 72.4 49.5 300.7 567.0 65.7 208.7 34.8 572.1 212.8 8.3 79.6 346.2 218.5 436.6 348.5 482.0 66.6 1113.9 651.1 459.7 905.9 505.9 99.8 90.4 33.0 739.2 59.1 2444.5 1.7 68.8 1.8 216.7 805.0 144.6 49.5 41.6 87.5 244.1 65.9 10.1 65.9 18.2 346.9 1396.1 185.7 51.3 315.6 166.0 161.9 161.7 209.3 158.1 220.0 191.5 169.0 149.5 168.2 173.3 181.5 173.3 576.7 16.0 33.3 10.4 28.2 184.4 308.2 443.8 63.2 2.2 224.6 231.8 84.4 92.9 180.1 239.1 4.2 328.5 118.2 1020.9 164.4 755.7 13.2 73.0 132.3 424.6 84.9 21.0 0.2 839.7 495.0 181.4 62.2 102.4 62.7 75.5 335.2 50.3 162.4 6.7 0.2 248.7 166.8 92.7 290.7 39.2 150.1 146.3 245.5 11.2 299.1 550.3 289.4 11.1 1.1 1304.7 945.4 206.9 12.6 380.2 952.7 705.3 71.1 15.3 216.9 95.3 292.6 13.6 42.0 54.8 168.6 258.6 108.8 205.5 209.6 422.0 PPM1J "DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ" ENSG00000155367 "Protein phosphatase, Mg2+/Mn2+ dependent 1J" Q5JR12 1 112709994-112715477 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 18.9;skeletal muscle: 69.0;skin 1: 18.2;testis: 64.3;tongue: 25.8" "Group enriched" "Detected in many" 4 "Early spermatids: 123.6;Late spermatids: 281.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 67.9" "Lineage enriched" "Detected in many" 15 "dendritic cells: 67.9" "Cell line enhanced" "Detected in many" "T-47d: 19.5" "Region enriched" "Detected in many" 7 "olfactory bulb: 27.3" "Low region specificity" "Detected in all" HPA046045 Uncertain Approved Vesicles NA NA Vesicles "HPA046045: AB_2679516" "unprognostic (8.68e-2)" "unprognostic (5.65e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.93e-3)" "unprognostic (2.34e-2)" "unprognostic (3.55e-2)" "unprognostic (3.74e-2)" "unprognostic (2.55e-1)" "unprognostic (9.30e-3)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (1.46e-1)" "unprognostic (2.28e-2)" "unprognostic (9.96e-4)" 1.0 2.6 6.3 1.0 6.1 0.7 2.2 6.0 6.2 2.1 3.6 1.2 0.6 1.9 18.9 4.6 2.8 1.0 7.9 5.5 5.4 2.7 0.7 1.6 3.3 5.7 7.2 6.1 2.3 1.7 5.6 2.6 0.5 4.7 3.3 0.6 7.0 2.8 2.2 69.0 18.2 1.4 1.3 4.5 1.4 1.2 64.3 9.2 2.3 3.1 25.8 2.2 1.1 4.0 4.9 2.7 0.1 1.5 1.7 0.8 1.5 1.1 0.3 0.7 0.3 1.0 1.2 0.8 0.4 0.4 0.8 0.8 4.9 1.1 4.6 0.4 0.0 2.6 0.8 0.2 0.2 0.9 0.0 0.2 1.7 3.0 0.9 4.6 1.0 2.1 0.2 1.0 0.0 1.2 2.9 0.0 0.0 1.6 1.4 2.3 0.1 0.1 0.0 2.7 0.1 0.8 0.2 0.6 4.3 1.3 2.2 19.5 0.0 1.1 0.3 2.8 0.0 0.2 0.1 0.0 0.0 2.3 0.6 2.6 0.0 0.3 0.0 0.0 1.5 0.1 0.7 0.0 0.1 7.1 0.7 0.0 0.0 0.0 0.0 4.3 67.9 0.0 0.8 6.3 6.1 6.0 6.2 5.5 5.4 5.7 7.2 6.1 4.7 4.5 9.2 4.9 1.2 0.0 0.5 0.3 2.0 2.2 4.7 8.7 10.2 5.7 4.2 4.6 5.8 0.0 2.7 1.8 10.4 1.0 41.3 0.7 9.8 3.2 123.6 3.2 0.3 1.5 0.0 0.0 1.8 4.3 1.4 1.1 1.1 0.6 0.0 5.6 0.7 0.1 0.7 0.0 1.5 0.9 2.0 1.3 11.5 281.6 3.1 2.0 0.0 0.0 1.6 25.4 0.0 0.0 0.2 2.1 2.4 2.6 0.0 6.7 0.3 0.6 1.8 9.1 6.6 1.1 2.8 2.8 16.9 3.5 2.8 0.5 0.9 3.2 0.8 2.9 DBI "ACBD1, ACBP" ENSG00000155368 "Diazepam binding inhibitor, acyl-CoA binding protein" P07108 2 119366921-119372560 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 2215.1;Proximal tubular cells: 2834.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 2479.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051428 Approved NA NA 9100000 "HPA051428: AB_2681482" "unprognostic (1.24e-1)" "prognostic favorable (5.77e-5)" "unprognostic (4.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.71e-2)" "unprognostic (1.92e-2)" "unprognostic (7.28e-3)" "unprognostic (1.70e-3)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.45e-1)" 360.1 155.2 483.7 160.2 474.5 123.0 724.5 498.7 732.7 145.4 458.6 325.8 315.7 74.2 659.4 673.1 86.5 130.9 422.7 495.2 496.6 539.2 979.0 238.1 184.4 506.1 498.6 464.2 86.7 145.0 874.5 77.5 117.3 513.4 455.5 300.2 117.3 372.9 217.1 275.6 438.3 231.6 98.1 521.9 116.5 186.8 202.9 506.5 174.9 134.8 464.6 327.1 137.8 330.4 523.6 543.0 276.9 557.1 257.2 1339.7 1131.9 350.7 281.3 708.7 387.0 746.1 580.6 427.8 747.3 312.1 440.6 938.5 277.9 397.0 588.3 345.9 498.2 262.1 641.4 279.9 775.8 335.6 206.1 2479.2 648.2 376.5 596.2 222.1 255.4 464.3 358.8 77.0 679.2 558.8 559.1 436.5 585.9 370.2 349.7 429.7 157.4 541.4 658.5 948.1 816.5 263.2 210.1 235.3 548.5 634.9 388.8 338.0 952.8 332.5 259.3 329.8 288.8 346.3 220.9 170.5 610.0 365.7 364.8 315.3 1180.7 439.9 1077.9 472.9 489.1 347.3 461.4 367.8 465.2 748.8 505.3 279.1 419.2 285.8 450.7 402.5 791.0 615.7 792.2 483.7 474.5 498.7 732.7 495.2 496.6 506.1 498.6 464.2 513.4 521.9 506.5 523.6 505.2 150.6 613.0 46.0 256.7 289.2 249.4 724.2 190.1 37.9 806.5 1025.9 1079.6 663.4 390.0 310.8 14.6 796.5 395.6 737.5 1197.4 466.9 844.4 154.8 194.7 206.2 371.3 108.8 5.2 670.3 643.2 258.2 243.1 185.6 433.4 219.4 167.8 2215.1 1069.4 30.3 3.9 495.0 524.9 305.0 785.7 325.7 152.2 476.1 1058.3 15.0 871.5 928.6 552.0 33.2 25.0 372.7 612.0 127.5 192.0 355.0 753.6 2834.8 340.5 59.1 151.2 267.2 289.9 462.0 30.1 972.6 684.9 516.3 260.8 456.0 673.2 361.0 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957593 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 13.5 10.5 35.0 11.9 36.2 4.3 7.6 37.7 71.5 7.0 35.9 47.3 32.8 28.8 23.0 15.4 13.2 15.0 68.5 33.5 37.3 11.5 56.1 4.9 9.6 39.0 38.9 28.3 8.0 2.0 10.1 5.2 34.3 38.5 14.5 35.6 69.5 3.5 11.3 68.1 13.1 16.7 39.5 36.1 6.7 26.8 30.1 37.4 11.8 8.7 60.1 11.7 12.0 7.2 37.8 111.1 24.0 86.9 74.3 61.9 52.1 272.7 64.6 51.1 52.0 80.9 85.4 67.1 113.8 82.3 61.6 32.6 113.1 126.3 124.8 96.8 75.6 105.2 108.9 63.4 112.9 104.6 123.2 9.9 72.2 144.6 75.7 146.4 79.2 131.4 53.8 131.3 78.0 61.9 19.9 70.2 70.1 271.4 36.7 74.5 67.9 130.7 92.8 67.3 1.9 86.9 46.5 121.8 3.8 97.5 130.0 3.7 48.9 80.9 45.4 72.0 89.3 93.1 39.7 33.9 116.7 137.1 78.5 56.0 0.0 1.4 0.0 1.5 1.6 1.7 0.9 1.8 2.0 2.5 0.3 0.8 1.5 0.1 0.6 0.3 0.2 6.1 0.8 35.0 36.2 37.7 71.5 33.5 37.3 39.0 38.9 28.3 38.5 36.1 37.4 37.8 15.1 0.0 2.6 8.5 16.5 89.3 6.5 39.9 87.6 16.9 16.5 9.9 126.3 10.0 5.7 0.0 158.4 77.4 20.3 99.8 0.0 2.5 107.2 14.3 70.7 22.8 3.5 20.2 9.8 3.3 67.6 32.8 67.2 35.8 8.9 322.8 6.4 37.5 15.4 20.2 11.6 17.3 20.3 9.0 15.7 118.3 11.8 12.8 39.2 20.6 4.3 184.8 0.0 9.0 23.8 7.4 7.7 7.5 25.5 16.5 9.3 10.8 3.9 277.5 0.0 38.2 22.1 45.3 23.6 29.6 39.5 46.0 20.9 49.6 23.3 1.3 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065970-50107272 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: AB_2683762" "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavorable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 6.9 8.2 4.4 9.1 4.4 5.7 5.3 5.2 4.5 5.0 4.7 6.4 5.0 5.0 4.5 8.1 4.9 4.2 5.8 4.1 4.5 5.1 10.3 6.4 6.7 4.7 3.8 4.3 3.3 8.1 4.8 6.6 5.9 4.2 4.9 6.3 4.9 6.0 3.4 12.1 6.3 7.1 5.3 3.6 12.7 6.7 5.9 4.4 4.7 3.7 6.3 6.2 5.1 5.1 4.5 13.0 12.8 11.8 18.6 7.0 9.6 12.6 15.5 10.1 15.0 6.0 15.9 9.4 24.4 10.9 14.7 5.6 15.1 14.1 11.3 17.2 6.1 15.4 12.1 9.0 20.4 10.2 21.1 23.5 7.5 7.8 10.4 6.2 6.6 12.2 12.6 15.5 3.9 14.9 7.8 16.2 26.4 13.8 15.5 13.1 17.6 15.8 19.8 8.4 10.4 15.1 8.0 14.8 18.9 10.0 8.8 8.5 15.4 16.1 12.0 8.0 9.1 11.8 9.8 8.0 21.3 11.7 20.9 12.0 0.5 2.4 0.5 0.9 2.8 1.0 0.6 0.5 1.0 1.7 0.8 0.8 0.9 0.5 0.7 2.6 1.5 0.9 1.0 4.4 4.4 5.2 4.5 4.1 4.5 4.7 3.8 4.3 4.2 3.6 4.4 4.5 4.2 3.2 5.8 7.8 4.6 3.2 1.4 1.5 3.4 7.8 3.1 2.0 6.0 2.8 1.8 1.8 16.7 3.5 7.1 3.3 7.9 2.4 10.7 3.7 6.8 4.6 3.5 3.8 21.2 3.1 3.6 4.7 7.7 3.8 1.3 6.5 1.8 9.6 9.4 1.7 16.7 3.2 4.1 22.2 4.7 18.3 3.4 13.9 1.8 7.5 13.3 2.4 3.1 20.1 12.8 2.9 2.5 2.2 7.2 1.9 4.7 4.1 2.8 8.1 0.0 2.5 4.2 5.3 4.8 7.6 1.7 1.0 5.8 6.7 5.8 1.5 TRIM74 "MGC45440, TRIM50C" ENSG00000155428 "Tripartite motif containing 74" Q86UV6 7 72959485-72969466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 10.3;testis: 6.7" "Cell type enhanced" "Detected in some" "Microglial cells: 1.9;Respiratory ciliated cells: 2.1;Spermatocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.8;Hep G2: 2.8" HPA047843 Approved Cytosol NA NA Cytosol "HPA047843: AB_2680176" "unprognostic (8.78e-3)" "unprognostic (3.78e-4)" "unprognostic (5.84e-3)" "unprognostic (1.95e-2)" "unprognostic (1.03e-1)" "unprognostic (8.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.26e-3)" "unprognostic (1.65e-2)" "unprognostic (3.68e-1)" "unprognostic (8.13e-3)" "unprognostic (1.98e-2)" "unprognostic (7.78e-2)" "unprognostic (7.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (1.12e-3)" 0.9 1.7 1.1 0.6 1.3 1.1 1.2 2.2 1.4 1.7 0.7 0.7 1.3 1.2 1.2 0.5 2.5 0.5 0.6 1.1 1.1 1.7 2.6 0.7 1.2 1.3 1.1 1.0 1.8 2.6 0.5 1.7 0.1 1.4 1.9 0.3 0.6 0.7 0.5 0.5 0.9 1.3 0.4 1.0 1.2 10.3 6.7 1.0 0.6 1.6 0.3 0.3 0.8 1.2 1.5 0.0 0.1 0.7 0.7 0.2 0.0 0.0 0.4 0.0 0.1 0.2 1.0 0.7 0.5 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.4 3.8 0.6 0.0 2.8 0.1 1.3 1.6 0.3 0.2 0.0 0.2 0.5 0.0 0.9 0.5 2.2 0.0 1.1 0.4 1.9 0.0 0.0 0.8 0.9 0.3 0.4 1.1 0.4 0.3 0.3 0.4 0.0 0.8 0.1 0.0 0.6 1.4 0.1 0.5 0.2 0.0 1.7 1.4 0.3 0.5 0.7 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 1.3 2.2 1.4 1.1 1.1 1.3 1.1 1.0 1.4 1.0 1.0 1.5 0.0 0.0 0.5 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 NIFK "hNIFK, MKI67IP, Nopp34" ENSG00000155438 "Nucleolar protein interacting with the FHA domain of MKI67" Q9BYG3 2 121726945-121736911 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015382, HPA035735, HPA035736, CAB075728, CAB075729" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.21e-1)" "unprognostic (4.15e-3)" "prognostic unfavorable (2.92e-6)" "unprognostic (7.74e-3)" "unprognostic (4.63e-2)" "unprognostic (3.21e-2)" "unprognostic (6.02e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (5.01e-11)" "unprognostic (1.72e-1)" "unprognostic (1.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" 27.0 25.0 19.0 32.1 19.4 31.7 37.7 19.6 22.0 25.3 18.9 25.1 25.3 28.7 22.1 34.9 27.8 25.3 23.1 20.2 20.2 20.5 34.4 18.1 47.6 19.4 19.2 18.0 36.8 32.8 18.1 16.8 25.8 19.4 24.8 25.8 23.2 18.1 18.0 38.7 34.8 20.3 25.0 20.4 22.4 22.7 22.0 19.2 33.2 25.4 18.4 42.8 43.8 24.7 21.0 118.4 37.6 68.8 68.3 57.9 80.6 90.2 90.6 75.2 105.0 113.2 105.9 55.0 152.4 111.4 66.9 93.1 72.9 149.4 116.4 153.4 101.3 85.7 155.0 44.5 92.9 82.6 141.1 81.7 80.6 126.7 137.4 184.4 48.7 75.9 60.3 174.5 73.9 90.5 58.2 109.5 140.9 175.3 132.4 122.5 102.5 80.7 191.2 92.1 72.4 88.1 91.8 56.6 105.1 200.7 62.2 52.0 123.1 45.7 72.8 123.5 85.6 129.3 87.5 150.6 182.1 55.7 143.9 101.5 41.8 54.2 28.8 59.2 65.3 83.4 73.6 72.3 68.6 72.1 74.8 84.5 79.4 4.0 81.5 62.5 64.0 68.9 75.1 19.0 19.4 19.6 22.0 20.2 20.2 19.4 19.2 18.0 19.4 20.4 19.2 21.0 51.1 44.8 25.9 8.1 56.3 98.4 128.9 87.0 81.4 25.8 51.2 88.8 21.5 24.3 62.2 14.7 12.5 74.9 62.7 18.9 46.9 64.2 23.7 43.8 126.9 47.7 28.1 41.8 8.2 45.2 90.6 68.7 32.6 39.9 54.5 47.9 26.0 33.2 54.4 13.5 7.2 41.3 42.7 34.5 32.8 8.0 57.5 39.0 23.2 10.3 59.1 48.0 54.6 13.0 8.0 51.5 28.4 45.1 33.3 107.0 18.4 58.4 41.9 45.8 39.5 72.7 54.3 81.1 83.9 79.3 101.4 48.8 52.5 97.7 60.5 125.2 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L mitochondrial inner membrane protein" Q15070 14 22766522-22773042 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria NA NA Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favorable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 75.2 91.4 27.0 41.2 27.3 72.6 68.2 30.7 29.0 58.4 43.3 72.7 66.9 55.4 48.5 77.2 56.3 50.1 138.8 26.7 30.6 71.4 109.5 55.3 70.5 29.8 28.4 25.2 71.8 98.8 106.2 27.7 38.3 30.8 45.4 58.3 42.3 64.7 45.2 236.9 68.0 59.4 46.5 29.0 62.8 84.6 25.2 29.7 64.2 55.4 274.9 76.1 61.9 60.9 29.5 89.3 121.3 48.8 82.1 146.7 217.4 94.4 64.0 138.1 94.3 107.9 91.1 96.4 167.0 86.4 75.0 73.0 121.0 103.0 126.3 90.0 67.6 65.4 79.1 73.2 329.7 165.5 150.9 88.4 211.0 137.6 75.4 114.9 114.7 273.3 93.8 62.2 124.0 103.4 130.0 91.8 51.3 53.2 118.5 150.0 92.9 87.2 128.3 117.9 103.4 35.1 67.0 94.6 205.7 129.7 58.4 89.2 122.7 86.2 52.7 62.2 98.5 75.4 94.0 84.7 78.1 41.6 83.6 60.0 11.9 68.1 18.5 29.5 71.6 36.0 51.0 42.5 37.4 95.1 54.4 47.4 35.6 15.1 41.7 58.5 26.9 55.8 53.7 27.0 27.3 30.7 29.0 26.7 30.6 29.8 28.4 25.2 30.8 29.0 29.7 29.5 30.6 48.1 44.0 7.8 83.7 69.5 61.1 89.0 92.8 31.0 52.1 46.5 118.0 72.9 62.1 29.5 10.4 72.8 32.5 48.9 74.3 85.2 10.2 20.4 40.3 58.6 40.7 64.3 6.8 161.3 113.0 47.6 66.8 23.1 80.4 56.5 64.2 102.9 143.4 18.5 7.5 75.3 38.7 148.1 76.8 13.3 57.2 85.6 51.6 3.7 133.4 22.9 74.2 4.5 8.0 86.3 69.7 36.9 84.2 45.6 101.4 116.0 42.6 38.3 39.5 39.4 43.0 31.8 28.4 112.9 67.3 57.2 57.9 70.6 112.1 74.9 SLC7A7 "LPI, y+LAT-1" ENSG00000155465 "Solute carrier family 7 member 7" Q9UM01 14 22773222-22829820 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 132.7;kidney: 303.4" "Group enriched" "Detected in many" 4 "Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1" "Lineage enriched" "Detected in many" 5 "monocytes: 457.1" "Group enriched" "Detected in many" 4 "BEWO: 217.2;CACO-2: 385.7;OE19: 329.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036227 Enhanced NA NA "HPA036227: AB_10696653" "unprognostic (1.34e-1)" "unprognostic (7.65e-2)" "unprognostic (4.25e-2)" "unprognostic (2.52e-1)" "unprognostic (6.12e-2)" "unprognostic (3.69e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.60e-3)" "unprognostic (7.15e-2)" "prognostic unfavorable (6.28e-6)" "unprognostic (2.68e-3)" "unprognostic (1.86e-2)" "unprognostic (2.61e-1)" "unprognostic (1.12e-1)" 15.2 9.1 3.8 37.7 4.1 19.8 6.9 4.7 7.5 7.3 5.6 13.9 108.0 5.4 2.0 3.8 7.9 17.1 4.4 3.3 9.0 303.4 16.5 54.5 29.3 6.8 4.6 2.6 2.1 5.2 79.0 1.4 18.4 6.2 3.6 15.2 1.0 5.4 2.9 2.1 3.0 132.7 15.7 6.7 57.3 8.7 33.1 6.8 9.7 4.6 2.8 25.4 14.9 4.1 8.3 0.2 11.2 1.2 0.5 1.9 3.7 217.2 2.2 16.3 0.4 1.4 385.7 34.4 17.0 72.2 1.4 1.2 13.3 0.1 0.0 0.6 0.6 0.2 0.9 0.4 3.7 9.1 1.9 1.6 7.1 1.0 1.0 0.5 1.8 25.3 1.5 0.1 12.8 2.9 0.6 0.4 1.7 3.6 329.0 0.1 2.9 35.5 9.8 0.8 1.3 0.4 0.8 0.6 0.5 2.5 9.4 0.4 8.3 1.3 0.8 1.7 0.6 0.5 2.7 0.9 8.9 0.9 0.8 0.2 0.2 299.9 1.1 0.5 410.0 0.4 19.1 0.2 0.2 99.5 13.8 0.7 0.4 36.5 0.3 457.1 3.4 0.9 155.1 3.8 4.1 4.7 7.5 3.3 9.0 6.8 4.6 2.6 6.2 6.7 6.8 8.3 5.3 12.8 7.1 2.0 14.3 1.0 0.2 6.7 1.8 0.2 0.5 1.7 0.9 67.2 5.6 3.7 0.0 1.2 5.7 3.0 11.7 8.2 61.1 1.7 1.2 5.0 1.2 0.0 0.6 6.4 5.2 4.4 2.6 0.4 1.3 0.7 16.1 3.0 216.5 0.0 1.4 7.2 2.0 410.6 16.8 11.8 3.7 146.2 5.4 20.6 164.0 0.4 4.1 0.0 0.8 8.9 12.5 0.0 20.1 0.1 423.1 327.6 9.2 1.3 6.6 0.8 1.4 17.8 2.2 0.4 0.4 1.8 2.7 38.8 6.4 0.1 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909374 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 7.3" "Group enriched" "Detected in some" 9 "Sertoli cells: 6.6;Spermatocytes: 17.1;Spermatogonia: 13.7" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 54.3;Karpas-707: 51.6;U-2 OS: 33.8;U-2197: 65.4;U-266/70: 46.5;U-266/84: 44.4" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.6 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 51.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.1 33.8 65.4 0.1 46.5 44.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 17.1 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LARP1 "KIAA0731, Lar1, LARP, Lhp1, MGC19556" ENSG00000155506 "La ribonucleoprotein 1, translational regulator" Q6PKG0 5 154712843-154817605 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 12000 "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 41.5 50.4 31.8 36.8 28.9 37.3 36.7 12.4 45.0 37.1 12.8 37.5 34.2 44.0 37.7 52.0 40.3 29.6 48.5 35.6 23.7 40.4 37.0 35.1 41.4 28.9 27.5 28.2 45.4 103.9 70.8 40.1 38.2 36.8 31.5 34.9 32.4 57.9 33.3 79.4 45.1 38.0 39.0 7.5 36.0 44.4 38.5 29.8 42.4 54.3 46.8 45.2 38.3 40.3 37.5 93.3 140.3 107.6 124.1 93.3 73.1 103.1 99.0 101.8 114.7 110.0 218.1 116.8 252.2 128.0 127.5 168.5 92.9 196.1 185.9 135.7 83.4 94.1 187.1 143.8 106.1 117.6 250.6 81.2 91.2 108.4 144.5 185.2 66.4 103.9 114.0 149.2 180.2 111.9 102.9 156.5 100.0 107.3 89.8 60.5 158.8 97.5 120.5 74.1 120.7 180.7 93.5 132.2 215.4 112.3 112.9 126.0 119.0 130.4 140.3 83.0 106.2 170.3 136.8 126.0 219.5 92.1 134.8 99.1 2.2 2.4 0.7 2.6 3.0 3.3 2.5 3.0 3.0 2.4 3.3 2.5 2.6 1.4 5.9 5.6 3.9 2.1 1.7 31.8 28.9 12.4 45.0 35.6 23.7 28.9 27.5 28.2 36.8 7.5 29.8 37.5 37.6 44.8 33.8 67.9 37.2 78.3 39.7 38.0 34.7 64.4 45.1 33.0 104.4 50.1 33.7 40.5 37.5 43.7 35.3 45.1 29.4 42.2 14.4 70.1 70.6 48.8 43.9 73.4 72.0 82.5 35.2 46.2 46.9 65.5 17.2 63.2 47.8 66.9 57.9 87.5 92.5 49.6 18.3 53.3 42.6 12.1 69.6 43.6 37.4 46.9 49.1 26.5 33.0 47.7 69.5 62.1 37.7 80.1 47.3 75.2 53.0 50.1 46.5 38.7 13.1 63.6 39.4 56.2 40.5 54.6 84.5 23.9 34.6 71.6 68.8 53.6 CNOT8 "CAF1, CALIF, hCAF1, POP2" ENSG00000155508 "CCR4-NOT transcription complex subunit 8" Q9UFF9 5 154857553-154876792 "Enzymes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 124.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051398 Approved NA NA "HPA051398: AB_2681468" "unprognostic (2.51e-1)" "unprognostic (4.26e-1)" "unprognostic (1.69e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.19e-1)" "unprognostic (3.62e-2)" "unprognostic (2.35e-2)" "unprognostic (1.79e-2)" "unprognostic (2.80e-1)" "unprognostic (3.32e-3)" "unprognostic (2.19e-1)" "unprognostic (1.84e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.41e-4)" 52.2 40.2 35.5 38.8 36.2 119.4 47.0 37.1 43.7 42.3 49.0 41.5 33.8 34.2 37.3 26.8 29.7 30.1 25.7 34.6 35.8 29.1 29.4 49.7 59.2 38.2 37.7 33.5 30.5 23.0 40.3 18.4 42.6 38.9 29.0 47.0 25.3 35.3 28.4 21.9 40.9 37.3 32.2 40.3 50.2 31.0 39.3 39.6 70.3 35.9 26.3 53.6 36.2 30.1 41.2 33.4 36.6 64.3 71.2 60.6 55.1 49.1 51.4 55.9 54.8 83.9 47.7 73.5 58.9 61.8 43.6 43.2 36.2 45.2 62.3 61.8 29.3 47.4 49.8 55.7 42.9 38.5 114.3 86.5 37.5 54.5 49.0 42.2 57.0 68.5 81.5 44.6 43.1 58.4 39.4 100.3 118.5 35.6 39.4 21.4 85.7 55.2 61.6 43.7 44.5 50.9 74.4 68.0 54.2 64.9 35.7 50.4 92.7 52.9 57.1 35.3 32.2 34.0 41.4 56.8 91.0 40.1 89.5 36.1 277.6 127.3 269.5 72.3 91.6 79.8 79.9 87.4 86.9 133.2 81.5 115.5 84.6 126.2 91.7 74.6 70.5 107.8 169.6 35.5 36.2 37.1 43.7 34.6 35.8 38.2 37.7 33.5 38.9 40.3 39.6 41.2 29.1 19.2 39.7 14.7 39.8 31.9 16.5 37.4 23.9 12.1 23.4 17.5 12.8 12.8 31.5 16.5 0.0 32.5 37.5 17.8 17.6 25.1 124.5 21.5 36.7 35.1 27.6 37.0 15.2 20.2 44.6 28.8 18.8 23.0 17.7 33.2 28.2 13.8 27.1 18.5 11.4 32.1 26.4 49.1 47.1 54.6 45.4 32.5 28.4 26.2 51.2 12.1 23.7 15.1 23.3 31.5 18.7 38.0 21.3 24.2 22.6 13.0 19.9 8.0 6.6 19.6 25.7 29.6 23.1 21.1 41.8 22.8 38.1 29.8 27.7 27.2 GRIA1 "GluA1, GLUR1, GLURA" ENSG00000155511 "Glutamate ionotropic receptor AMPA type subunit 1" P42261 5 153489615-153813869 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 88.1;retina: 32.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 322.4;Inhibitory neurons: 608.8" "Cancer enriched" "Detected in some" 15 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.6;ASC diff: 3.5;BJ: 5.5;BJ hTERT+: 2.9;LHCN-M2: 8.1;U-266/70: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035202 Enhanced NA NA "HPA035202: AB_2674516" "unprognostic (2.51e-1)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (4.20e-2)" "unprognostic (6.95e-2)" "unprognostic (2.43e-1)" "unprognostic (2.61e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (2.35e-2)" "unprognostic (5.14e-4)" "unprognostic (7.97e-2)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (2.80e-1)" "unprognostic (7.61e-2)" 0.9 0.4 40.0 0.1 46.3 0.0 0.4 50.7 88.1 0.2 0.0 0.5 0.2 0.1 0.7 0.1 0.1 0.0 0.8 79.1 27.2 0.1 0.0 9.4 0.0 7.8 5.1 40.0 0.2 0.3 0.2 1.2 0.0 12.8 0.1 0.1 32.9 0.1 0.5 0.2 0.3 0.3 1.0 2.0 0.0 0.6 0.9 22.6 0.1 0.3 0.4 0.0 0.1 0.3 22.6 0.0 0.0 11.6 0.0 3.5 2.3 0.0 5.5 2.9 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 46.3 50.7 88.1 79.1 27.2 7.8 5.1 40.0 12.8 2.0 22.6 22.6 0.2 0.0 0.0 43.1 0.0 0.0 0.0 0.0 0.0 36.3 0.3 0.0 1.2 0.0 0.0 0.0 6.2 0.0 0.0 0.2 0.0 0.0 5.1 0.1 5.6 0.4 0.0 0.0 322.4 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 608.8 0.0 0.0 0.0 0.0 3.4 0.0 0.9 0.0 7.5 0.0 49.0 0.0 94.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRGUK "CFAP246, FLJ32786" ENSG00000155530 "Leucine rich repeats and guanylate kinase domain containing" Q96M69 7 134127299-134264591 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 4.3;fallopian tube: 3.7;testis: 4.8" "Cell type enhanced" "Detected in some" "Early spermatids: 27.6;Endometrial ciliated cells: 13.8;Excitatory neurons: 21.8;Inhibitory neurons: 13.9;Ionocytes: 12.2;Respiratory ciliated cells: 21.5;Spermatocytes: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SH-SY5Y: 1.8;SK-MEL-30: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029505, HPA029506" Uncertain NA NA "HPA029505: AB_10599606, HPA029506: AB_10601752" "unprognostic (4.08e-3)" "unprognostic (1.87e-1)" "unprognostic (6.94e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-2)" "unprognostic (2.64e-2)" "unprognostic (7.85e-4)" "unprognostic (6.92e-2)" "unprognostic (2.43e-1)" "unprognostic (4.28e-2)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (1.27e-3)" "unprognostic (2.22e-3)" "unprognostic (3.83e-2)" "unprognostic (3.01e-3)" "unprognostic (2.10e-2)" 0.2 0.3 2.3 0.2 1.0 0.5 0.4 0.6 0.8 0.4 4.3 0.2 0.1 0.3 1.5 0.1 3.7 0.2 0.1 1.2 1.9 0.5 0.4 0.5 0.1 2.6 2.0 0.5 0.1 0.8 0.1 0.7 0.0 1.6 0.6 0.2 2.1 0.5 0.1 0.0 0.4 0.2 0.1 2.5 0.5 0.2 4.8 1.0 0.2 0.5 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.0 0.1 0.2 1.9 0.0 0.4 0.2 0.0 0.0 0.3 0.1 0.6 1.8 0.5 0.0 1.9 0.2 0.1 0.4 0.0 0.1 0.2 0.1 0.2 0.4 0.6 0.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.6 0.8 1.2 1.9 2.6 2.0 0.5 1.6 2.5 1.0 0.6 0.2 0.0 0.0 5.5 0.1 0.0 0.1 0.4 0.6 0.0 0.8 0.5 0.4 1.5 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 27.6 13.8 0.5 0.3 0.0 0.0 21.8 0.4 0.0 0.4 0.0 1.2 0.0 0.8 0.0 0.4 0.2 0.0 13.9 0.0 12.2 0.0 0.3 2.1 0.3 0.2 1.8 5.6 0.0 0.9 0.0 5.0 2.5 0.0 0.0 0.4 0.1 0.1 0.0 0.2 21.5 2.1 0.0 0.3 0.6 8.6 0.9 0.3 0.4 0.3 0.1 0.5 0.0 0.2 SETD9 "C5orf35, MGC33648" ENSG00000155542 "SET domain containing 9" Q8NE22 5 56909260-56925532 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.0" "Group enriched" "Detected in many" 7 "Early spermatids: 691.8;Late spermatids: 372.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 5.2" "Group enriched" "Detected in many" 4 "granulocytes: 5.2;monocytes: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049936 Approved Nucleoplasm NA NA Nucleoplasm "HPA049936: " "unprognostic (1.13e-1)" "unprognostic (3.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-1)" "unprognostic (2.29e-1)" "unprognostic (7.37e-2)" "unprognostic (8.75e-3)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-2)" "unprognostic (1.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" 5.1 2.9 1.0 1.0 1.3 2.6 5.1 1.2 1.4 1.6 1.1 5.9 5.3 3.1 3.9 3.0 2.3 2.6 6.0 0.9 1.3 6.3 10.0 2.1 2.7 1.4 1.3 0.9 3.2 4.4 3.6 0.7 2.4 1.4 2.3 4.6 1.1 6.3 1.3 3.7 1.4 6.7 2.8 1.4 1.8 3.2 19.0 1.2 1.2 4.9 7.3 2.9 3.0 0.9 1.7 6.8 1.6 5.9 3.3 5.1 3.7 3.9 4.8 3.1 5.2 7.2 4.9 5.1 4.5 10.3 5.1 8.1 6.4 3.9 2.6 7.3 4.1 6.9 0.7 1.7 6.6 5.1 3.6 4.7 3.6 3.8 8.7 7.3 4.8 7.8 2.3 5.1 3.1 8.0 11.0 0.5 3.5 7.0 0.0 8.1 5.9 2.2 8.0 5.8 3.0 4.5 6.7 1.1 3.4 10.3 3.7 8.3 4.1 6.1 2.9 9.2 5.0 6.0 4.0 12.8 9.1 3.5 2.5 0.7 5.2 1.0 1.9 0.4 0.9 0.7 0.2 0.8 0.2 0.6 0.3 0.3 0.6 1.8 0.6 3.2 0.2 0.9 0.4 1.0 1.3 1.2 1.4 0.9 1.3 1.4 1.3 0.9 1.4 1.4 1.2 1.7 10.7 3.2 2.7 1.0 7.8 17.5 15.6 17.9 1.8 2.8 32.2 30.5 14.7 12.8 9.0 7.3 0.0 15.5 7.6 24.5 56.7 14.6 691.8 10.4 7.7 9.6 18.5 5.2 0.7 17.4 21.4 12.2 9.2 7.6 14.7 7.1 8.2 27.4 14.8 0.0 1.4 10.4 14.2 13.5 35.4 372.2 10.2 11.9 28.4 2.8 13.6 6.9 8.2 2.0 8.6 9.8 20.7 5.7 9.0 28.4 24.7 52.7 9.9 3.1 0.0 14.5 12.7 67.0 13.5 4.8 15.3 14.4 6.8 10.3 14.3 19.2 MIER3 "DKFZp686L09111, DKFZp781I1119, FLJ35954" ENSG00000155545 "MIER family member 3" Q7Z3K6 5 56919602-56971675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Distal enterocytes: 128.8;Paneth cells: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058349, HPA065946" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058349: AB_2683688, HPA065946: AB_2685583" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "unprognostic (4.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-2)" "unprognostic (2.47e-1)" "unprognostic (1.61e-2)" "unprognostic (3.36e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-2)" "unprognostic (9.31e-3)" "unprognostic (5.53e-2)" "unprognostic (3.76e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-3)" 6.9 6.8 5.3 7.5 6.3 11.1 8.9 13.3 6.5 8.0 5.0 30.9 23.0 10.2 8.9 6.4 7.5 6.4 5.1 4.5 6.5 7.6 11.2 5.3 8.5 5.6 5.9 4.4 11.8 8.3 12.6 4.7 6.9 7.1 8.1 22.2 17.0 5.9 6.6 6.3 6.5 15.7 9.2 5.4 6.9 7.2 15.9 5.2 10.1 9.2 10.8 8.0 7.6 6.0 8.7 10.0 14.2 19.5 36.9 12.8 10.0 26.9 9.2 11.9 17.1 19.0 22.9 8.3 10.7 10.8 10.8 15.6 12.3 24.9 9.8 18.3 5.7 11.4 9.2 17.6 11.0 9.6 12.6 18.3 11.7 12.2 12.7 10.6 10.5 11.3 13.0 12.2 17.9 10.0 11.0 19.3 14.5 15.5 4.5 8.3 31.9 18.4 11.1 8.2 19.7 16.2 25.8 28.0 10.2 14.2 15.5 14.8 12.0 10.9 4.9 15.2 8.8 16.8 11.1 16.0 26.7 9.3 9.6 10.9 0.2 0.9 1.6 1.1 1.6 1.6 1.3 0.9 2.0 1.3 1.3 1.5 1.1 0.8 1.5 1.2 1.6 0.9 1.3 5.3 6.3 13.3 6.5 4.5 6.5 5.6 5.9 4.4 7.1 5.4 5.2 8.7 7.7 16.0 5.4 14.0 7.8 13.5 4.7 4.6 13.1 8.0 11.1 5.8 8.2 11.5 6.7 3.7 14.6 3.9 8.5 128.8 5.9 4.0 15.4 12.0 13.6 7.5 12.0 1.7 11.5 5.9 3.6 8.8 5.1 15.5 4.5 8.3 7.5 9.1 4.1 10.1 12.1 17.4 10.2 5.5 10.7 8.5 5.9 6.2 1.8 14.0 8.6 7.1 5.2 17.6 18.1 7.1 78.7 8.6 9.0 9.4 18.1 6.1 5.9 13.9 13.1 10.8 10.7 11.3 6.0 6.6 9.8 6.8 8.4 4.8 14.0 8.0 NUP205 "C7orf14, KIAA0225" ENSG00000155561 "Nucleoporin 205" Q92621 7 135557917-135648757 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 24000 "unprognostic (3.64e-2)" "unprognostic (2.13e-1)" "unprognostic (6.05e-2)" "unprognostic (3.66e-3)" "unprognostic (4.00e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (1.90e-7)" "unprognostic (2.33e-2)" "unprognostic (2.12e-2)" "unprognostic (3.27e-2)" "unprognostic (7.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.22e-2)" "unprognostic (3.23e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (1.35e-2)" 7.6 6.7 1.9 13.2 2.9 10.8 11.6 6.5 2.6 8.9 3.4 10.1 8.0 10.8 7.3 11.1 10.5 6.4 4.9 1.5 4.2 8.1 6.7 8.5 15.1 2.5 2.6 1.4 11.9 6.2 15.2 5.3 11.1 3.5 8.7 12.4 14.9 11.9 9.1 8.1 9.7 8.4 12.8 2.6 10.4 9.1 11.7 3.0 22.0 8.5 8.1 17.4 10.0 6.9 4.2 66.4 52.8 69.5 68.2 16.2 26.6 45.4 41.0 31.5 62.4 69.1 55.1 46.8 84.2 31.7 24.6 63.0 50.1 88.5 46.0 80.1 41.9 63.3 48.9 52.1 25.1 12.2 96.5 37.0 14.5 20.5 61.4 40.8 21.9 47.3 58.9 115.6 39.1 47.6 45.0 105.0 29.4 107.0 51.6 46.3 77.6 64.6 66.6 18.8 52.4 69.3 70.4 67.8 54.8 31.8 52.4 31.6 36.5 38.6 51.0 25.3 62.7 79.5 28.7 57.2 112.3 51.7 74.3 70.1 1.6 1.3 0.4 2.4 3.1 2.8 2.3 2.9 2.5 3.0 2.1 2.3 2.7 0.5 2.9 1.7 1.9 2.9 1.4 1.9 2.9 6.5 2.6 1.5 4.2 2.5 2.6 1.4 3.5 2.6 3.0 4.2 7.9 12.8 13.4 24.8 15.3 13.0 6.8 10.3 11.4 6.3 8.6 5.2 5.3 7.2 10.6 16.5 12.5 13.1 7.5 8.2 3.9 7.8 0.9 7.4 8.1 9.3 9.1 21.3 22.7 9.6 9.3 9.4 13.3 8.4 8.2 18.5 7.9 10.7 10.3 5.0 24.1 10.4 6.1 14.1 11.7 2.4 8.1 12.2 10.6 17.8 11.4 4.9 3.1 26.2 23.3 11.9 6.4 7.5 17.4 10.3 3.9 4.6 12.4 9.7 0.0 12.6 8.2 14.5 10.8 14.8 15.5 7.7 11.9 6.1 10.9 9.4 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257845 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Cone photoreceptor cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: AB_2680652" "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 1.2 1.4 2.1 0.9 2.0 1.9 1.7 2.0 2.0 2.1 0.6 1.1 0.6 2.3 1.2 0.6 1.7 1.0 1.9 2.1 2.3 1.5 1.6 1.2 1.2 2.1 2.1 1.8 3.8 1.1 3.0 1.6 1.6 2.1 1.6 1.0 4.1 1.2 1.7 3.2 0.5 1.0 1.9 1.9 1.1 1.1 4.2 2.7 2.4 2.1 4.7 1.1 1.2 0.9 2.1 2.0 1.9 8.6 5.4 3.4 3.2 3.5 2.1 3.2 3.1 3.0 5.0 1.4 6.5 2.2 2.5 3.4 1.4 5.8 2.8 3.7 3.6 3.9 3.8 3.4 7.7 4.5 3.1 1.9 4.3 3.3 2.9 4.9 3.2 2.4 4.6 7.0 3.1 2.9 2.0 7.7 3.3 4.7 0.7 1.8 9.0 6.3 1.4 2.5 2.8 6.8 6.8 2.6 2.3 2.3 4.1 2.8 5.0 2.4 5.0 3.3 2.0 3.3 4.1 3.6 7.5 1.7 2.5 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.1 2.1 2.0 2.0 2.0 2.1 2.3 2.1 2.1 1.8 2.1 1.9 2.7 2.1 1.2 16.0 2.3 4.2 2.4 0.8 2.7 1.3 0.6 7.4 2.0 1.9 3.8 0.0 0.6 1.8 14.6 3.4 1.5 1.1 0.0 1.6 4.4 2.4 3.9 2.1 4.9 0.4 3.3 0.9 2.1 2.5 0.5 2.9 1.3 7.2 0.7 3.2 1.6 6.7 4.9 1.7 2.0 2.4 1.5 2.1 5.0 1.3 1.8 2.8 1.7 4.1 2.1 1.5 4.1 2.2 0.8 3.8 4.1 2.5 1.1 1.4 2.3 8.9 0.0 3.6 1.9 11.4 8.2 1.0 0.6 4.1 1.5 3.9 1.3 1.4 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 112.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 7.2 6.7 7.8 6.5 9.2 6.1 8.9 8.7 7.8 8.2 5.7 7.8 12.0 7.4 5.8 9.9 6.6 6.9 6.2 7.5 7.8 7.1 7.9 5.1 8.8 8.2 8.2 6.7 9.6 7.9 4.9 6.0 8.5 8.6 7.3 7.6 6.3 9.0 5.1 8.8 11.3 8.3 6.4 7.1 6.7 6.9 5.4 8.4 8.5 8.6 8.4 8.1 9.9 8.5 13.4 11.6 7.5 12.6 10.4 12.7 23.4 12.8 13.8 22.0 11.1 11.0 1.5 6.4 18.5 6.9 12.1 11.7 20.1 13.4 13.6 15.4 12.9 6.5 11.3 10.3 9.5 13.9 16.7 8.5 19.2 18.2 11.4 25.2 17.5 13.8 17.1 13.8 11.8 14.5 5.7 20.4 11.8 11.6 17.8 17.6 11.6 22.4 0.5 16.3 16.7 10.1 13.9 7.0 17.8 25.0 13.8 6.0 9.6 12.1 10.2 13.3 23.7 10.6 12.0 21.7 8.5 14.0 12.6 6.5 15.1 6.6 10.6 9.9 7.5 10.5 8.7 8.4 8.5 7.3 8.6 10.2 10.8 7.6 13.0 6.8 10.5 8.4 7.4 7.8 9.2 8.7 7.8 7.5 7.8 8.2 8.2 6.7 8.6 7.1 8.4 13.4 19.2 6.4 17.0 35.6 15.7 7.6 13.6 12.8 25.6 10.9 13.9 22.9 14.0 8.6 12.6 5.5 8.4 20.3 18.4 25.2 21.5 14.2 10.8 9.4 19.7 15.0 6.6 8.2 27.4 19.9 19.0 14.1 19.9 10.8 18.4 13.7 18.5 9.7 14.8 5.0 19.2 23.4 10.2 16.1 8.9 7.5 20.8 15.2 3.6 24.4 17.7 12.5 33.0 44.2 112.1 17.8 30.6 13.2 9.5 12.7 29.3 22.8 8.4 13.0 13.1 19.3 17.3 20.6 14.6 23.2 9.8 10.8 16.2 21.9 16.8 27.0 XAGE2 "CT12.2, GAGED3, XAGE-2, XAGE2B" ENSG00000155622 "X antigen family member 2" Q96GT9 X 52369021-52375680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 201.2" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 1027.3;Extravillous trophoblasts: 1890.1;Syncytiotrophoblasts: 1367.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 96.3;SK-BR-3: 22.7;SuSa: 27.9;T-47d: 20.1" "HPA052507, HPA060900" Supported Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (1.21e-1)" "unprognostic (9.67e-2)" "unprognostic (1.49e-1)" "unprognostic (4.47e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 201.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 96.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 22.7 1.2 27.9 20.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.5 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1027.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1890.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 1367.6 0.0 0.0 0.0 0.0 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593315-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 83.9;lymphoid tissue: 62.8;salivary gland: 74.3" "Cell type enhanced" "Detected in many" "B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0" "Group enriched" "Detected in all" 6 "B-cells: 48.3;monocytes: 123.0" "Cell line enhanced" "Detected in many" "Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 8.2 4.6 1.9 51.5 2.6 47.9 4.8 2.5 3.4 2.9 3.9 7.4 6.8 2.1 1.7 2.4 2.2 25.0 2.5 1.9 9.1 12.0 83.9 16.9 61.7 6.8 3.8 1.8 6.1 22.9 2.0 1.4 14.2 5.0 2.9 8.6 3.1 74.3 2.4 0.7 1.0 7.8 8.3 5.6 62.8 6.9 3.0 4.8 8.8 4.1 3.1 58.2 15.3 0.6 8.9 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.2 2.8 1.5 85.3 8.5 0.0 1.3 0.1 17.7 0.0 0.6 48.0 3.0 13.0 0.0 1.7 0.1 36.1 6.7 0.0 0.0 0.1 0.0 0.1 0.0 3.1 0.9 0.1 0.1 0.4 1.1 62.1 0.8 24.3 1.0 183.5 4.3 20.0 0.2 0.1 3.6 2.0 0.2 0.2 1.1 0.3 0.2 92.9 0.0 0.0 2.8 0.1 0.7 0.7 0.2 114.7 0.0 95.2 0.0 6.1 16.0 10.5 13.3 44.7 4.7 48.3 0.3 4.1 12.9 44.5 0.1 3.3 13.5 14.0 123.0 11.3 0.5 14.4 1.9 2.6 2.5 3.4 1.9 9.1 6.8 3.8 1.8 5.0 5.6 4.8 8.9 0.5 3.2 3.9 1.3 53.7 1.5 0.1 0.1 0.6 0.6 2.2 2.3 2.6 32.9 2.2 1.8 2.1 0.5 41.5 8.1 1.9 40.0 4.3 0.3 0.1 1.8 1.8 10.3 0.8 29.1 0.9 0.7 0.0 0.2 14.0 0.2 5.7 70.7 47.7 0.0 0.8 2.8 4.1 127.0 32.5 1.0 1.2 89.8 5.4 60.9 57.4 0.2 58.7 1.0 0.3 16.4 21.2 2.2 9.4 0.4 1.6 18.3 1.1 3.4 0.0 0.6 0.8 0.8 0.2 0.3 1.1 2.3 18.3 0.4 3.8 0.3 RBM45 "DRB1, FLJ44612" ENSG00000155636 "RNA binding motif protein 45" Q8IUH3 2 178112424-178139011 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020448 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA020448: AB_1856133" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (6.56e-2)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (5.74e-9)" "unprognostic (1.66e-1)" "unprognostic (4.25e-2)" "unprognostic (2.71e-2)" "unprognostic (2.42e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (5.34e-9)" "unprognostic (3.26e-1)" "unprognostic (2.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.94e-1)" 4.8 6.6 13.6 5.6 14.1 4.1 8.6 13.4 18.6 5.7 13.5 8.4 5.9 6.3 9.3 6.1 7.3 4.7 5.8 13.7 13.9 6.6 8.1 5.5 8.2 14.2 13.7 13.4 5.7 7.9 8.9 6.5 3.4 14.0 5.9 9.4 9.9 6.2 5.3 4.9 8.2 6.8 5.8 13.7 7.8 6.6 6.6 13.7 8.9 7.0 3.2 10.0 5.6 5.1 14.5 9.5 10.1 15.7 6.5 13.6 15.7 9.8 12.8 14.5 12.9 14.2 10.7 7.7 15.8 8.4 15.3 12.9 8.4 13.1 16.7 15.7 12.7 11.2 12.2 6.3 16.1 14.3 14.9 11.6 12.7 13.7 13.2 11.0 12.5 13.7 8.7 11.5 12.6 16.2 15.1 15.5 10.0 11.1 14.2 12.8 12.4 11.1 15.7 19.0 21.8 9.7 10.1 9.0 8.8 11.8 17.7 12.9 13.9 11.7 9.1 8.6 10.7 12.7 11.7 14.4 20.3 8.9 11.9 12.8 3.8 5.3 1.9 6.2 8.6 7.1 12.5 6.5 6.8 7.2 8.6 5.9 7.3 1.0 11.3 10.2 7.7 10.9 5.3 13.6 14.1 13.4 18.6 13.7 13.9 14.2 13.7 13.4 14.0 13.7 13.7 14.5 5.2 3.2 4.2 8.5 6.3 2.5 3.5 11.3 5.2 7.1 4.3 3.6 4.2 8.6 6.6 1.8 10.4 5.6 8.1 5.0 7.9 7.3 3.8 4.8 5.4 5.9 6.0 8.6 10.2 6.6 10.3 5.7 7.7 3.5 8.2 8.2 3.3 5.1 8.2 10.1 13.1 7.6 4.1 8.1 3.3 4.3 4.4 5.3 1.8 6.5 8.1 7.6 6.2 15.1 13.7 5.2 6.5 5.7 8.0 1.7 6.1 7.0 9.6 9.1 6.6 6.1 6.1 11.4 5.6 6.2 3.4 1.8 6.2 9.1 4.9 2.7 TTN "CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD" ENSG00000155657 Titin Q8WZ42 2 178525989-178830802 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 929.2;tongue: 372.8" "Cell type enriched" "Detected in many" 16 "Cardiomyocytes: 24394.9" "Cancer enriched" "Detected in single" 4 "head and neck cancer: 1.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 1.9" "Not detected" "Not detected" "HPA007042, CAB022682, HPA030048" Enhanced NA NA 16000000 "CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451" "unprognostic (1.00e-2)" "unprognostic (3.92e-1)" "unprognostic (1.77e-1)" "unprognostic (7.11e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (6.62e-2)" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (1.86e-1)" "unprognostic (2.79e-1)" "unprognostic (2.65e-1)" "unprognostic (3.49e-4)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-2)" 0.7 0.4 3.2 0.5 5.5 4.3 0.5 3.5 5.2 0.3 0.0 0.3 0.4 0.4 0.2 2.7 0.3 0.7 140.0 2.7 2.0 0.2 0.3 1.3 1.4 11.7 4.8 1.5 0.7 1.8 0.0 0.8 0.5 7.8 2.8 0.0 1.9 7.0 0.0 929.2 0.8 0.6 0.0 4.3 0.7 0.4 1.6 4.4 0.7 0.6 372.8 0.4 0.2 0.3 6.8 0.3 0.1 0.7 0.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.7 0.1 1.0 0.2 0.0 0.7 0.7 0.0 0.0 0.0 1.0 0.8 1.5 1.3 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.7 0.6 0.7 0.9 0.5 0.1 0.2 0.7 1.0 0.2 0.1 0.7 0.5 1.9 0.6 0.0 0.2 0.4 0.7 0.1 0.5 0.0 0.6 0.3 1.0 0.7 0.0 0.0 0.3 0.2 1.4 0.2 1.4 0.0 0.5 0.3 1.8 0.2 0.5 0.4 0.2 0.1 6.1 0.9 0.7 0.1 5.7 2.0 2.6 1.0 3.6 0.2 0.2 6.0 0.1 3.2 5.5 3.5 5.2 2.7 2.0 11.7 4.8 1.5 7.8 4.3 4.4 6.8 10.9 16.0 173.4 43.8 32.1 0.9 1.6 0.0 2.8 102.7 1.7 0.5 24394.9 30.0 6.2 0.0 20.9 0.7 6.8 0.1 1.9 14.1 43.2 3.4 6.8 99.1 4.2 3.0 25.1 28.3 0.3 502.5 3.6 7.2 10.1 0.7 2.5 0.6 0.3 16.8 31.3 0.1 0.0 0.8 0.8 6.4 1.2 26.2 0.0 25.3 0.6 12.0 2.1 11.6 4.9 0.5 0.1 4.5 10.6 0.2 0.3 0.4 2.9 27.8 0.0 1466.9 104.7 9.3 1.5 2.3 0.1 0.4 24.3 2.8 0.5 0.1 VSIG4 "CRIg, Z39IG" ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 167.5" "Group enriched" "Detected in many" 5 "Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4" "Cancer enriched" "Detected in all" 5 "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8" "Group enriched" "Detected in many" 31 "dendritic cells: 17.8;monocytes: 18.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 59000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 136.6 69.3 18.6 44.6 22.1 7.9 44.6 17.9 36.9 14.2 28.8 36.7 22.7 15.7 5.4 15.6 67.4 40.0 26.2 18.8 50.0 17.5 51.4 167.5 28.0 25.7 21.0 17.6 13.1 14.4 6.9 7.0 140.8 21.1 10.7 32.0 2.2 24.7 9.4 8.2 10.0 44.3 109.4 19.8 69.9 23.0 7.3 32.2 5.4 12.4 12.6 1.8 62.1 11.7 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 18.7 0.1 0.0 11.1 0.0 0.0 0.0 0.2 17.8 0.1 0.0 0.0 0.5 0.0 0.4 0.1 0.0 5.6 18.6 22.1 17.9 36.9 18.8 50.0 25.7 21.0 17.6 21.1 19.8 32.2 26.2 1.3 3.2 16.1 0.0 1.2 2.3 0.3 0.0 0.0 0.0 2.6 0.5 1.8 7.2 3.1 0.0 0.0 5.3 0.3 0.0 0.0 0.1 7.9 0.0 0.0 10.4 0.0 0.0 0.0 0.0 4.9 2.7 0.0 0.0 3.8 0.0 5.0 3.2 989.8 0.0 0.0 0.0 0.0 590.9 111.8 16.6 1.5 328.4 3.6 12.2 1.5 0.5 0.0 0.5 0.0 0.0 0.1 0.4 0.3 0.3 0.0 0.1 4.4 0.0 6.6 0.6 2.0 0.3 0.9 0.5 1.7 12.3 1.5 0.0 0.0 0.2 PDIA4 "ERP70, ERP72" ENSG00000155660 "Protein disulfide isomerase family A member 4" P13667 7 149003062-149028662 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 386.7;Hepatocytes: 595.4;Plasma cells: 556.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006139, HPA006140, CAB017368" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 15000000 "Endoplasmic reticulum" "CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257" "unprognostic (1.98e-1)" "unprognostic (1.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.11e-2)" "unprognostic (5.11e-2)" "unprognostic (3.24e-3)" "unprognostic (6.08e-3)" "unprognostic (3.20e-2)" "prognostic unfavorable (5.20e-9)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" 50.7 30.3 26.7 92.3 26.1 36.0 38.6 31.7 27.5 93.6 33.3 85.6 74.8 59.2 165.0 39.2 82.3 54.0 34.9 21.1 36.9 49.2 243.7 48.9 59.4 35.9 27.6 18.0 47.7 113.6 26.6 45.0 92.8 32.5 70.0 86.3 8.5 56.6 47.8 9.4 30.2 66.9 72.5 33.1 64.1 96.4 31.1 34.0 47.2 236.2 10.2 73.0 66.2 33.6 49.9 251.3 236.0 249.8 703.3 223.2 158.2 358.2 343.5 230.5 194.8 314.5 196.6 661.5 179.4 748.2 287.0 532.2 160.1 170.6 329.1 168.9 129.0 99.0 86.6 62.7 436.6 298.4 198.5 233.9 156.4 145.1 213.6 169.8 251.7 401.0 90.6 143.6 476.1 173.4 276.4 190.9 226.0 371.1 510.9 134.0 123.6 192.5 440.5 228.2 194.9 79.1 207.6 313.0 223.7 124.1 295.7 127.4 151.9 220.6 152.1 84.5 372.0 247.5 357.5 173.7 125.5 354.2 231.1 528.9 74.4 80.5 51.0 130.4 85.6 135.4 99.1 83.7 100.8 77.6 58.2 77.4 82.7 11.0 91.9 91.4 251.8 68.7 160.6 26.7 26.1 31.7 27.5 21.1 36.9 35.9 27.6 18.0 32.5 33.1 34.0 49.9 43.3 28.9 36.2 6.8 87.9 34.7 88.0 142.5 29.0 4.2 50.8 31.5 31.0 95.8 92.4 42.3 4.2 177.8 86.9 135.4 15.6 129.0 3.1 91.1 93.1 57.0 61.6 41.2 3.2 91.0 386.7 102.8 119.8 107.1 57.8 72.0 81.4 595.4 147.9 0.0 5.7 282.9 61.1 84.7 49.6 5.5 59.0 55.3 87.2 9.4 51.8 15.6 68.0 4.5 11.9 94.5 88.6 42.9 556.7 108.1 71.3 66.3 114.8 6.7 32.9 35.2 66.0 47.6 86.1 29.2 28.6 230.4 46.7 52.4 155.6 72.4 KDM8 "FLJ13798, JMJD5" ENSG00000155666 "Lysine demethylase 8" Q8N371 16 27203508-27221768 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 81.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 56.4;Proximal enterocytes: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026545 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026545: AB_1852015" "unprognostic (1.39e-1)" "unprognostic (1.37e-3)" "unprognostic (2.80e-1)" "unprognostic (2.16e-2)" "unprognostic (3.21e-1)" "unprognostic (1.22e-2)" "unprognostic (2.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.95e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.75e-2)" "unprognostic (5.33e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (3.92e-3)" 2.0 3.5 3.9 3.1 3.9 1.3 2.3 5.3 4.2 2.5 3.2 2.5 13.4 3.0 1.8 2.1 2.5 2.2 2.2 4.1 4.0 2.9 81.0 2.2 3.4 3.7 3.7 3.8 3.0 5.1 2.5 4.0 1.5 3.9 3.7 1.7 2.3 2.3 2.2 4.6 1.7 12.7 1.6 3.7 4.6 2.6 2.7 3.9 3.5 3.1 3.0 2.6 2.7 2.3 4.0 1.4 3.0 5.0 2.7 1.1 1.5 2.7 1.7 1.9 3.8 3.3 2.6 2.4 7.6 2.9 2.5 1.9 1.6 3.0 2.7 2.2 9.2 4.4 4.9 3.3 6.2 2.7 3.6 5.5 1.9 2.1 2.4 1.7 2.2 3.1 3.5 6.1 4.8 2.4 2.3 3.4 6.4 8.5 1.1 1.8 5.2 3.1 6.9 1.4 1.6 4.8 2.9 0.7 2.5 1.9 1.7 2.7 4.8 3.4 4.5 2.2 1.7 1.8 2.9 3.1 6.3 1.9 3.3 0.4 0.2 2.1 0.8 2.5 1.9 2.1 1.9 3.6 3.5 1.9 4.3 3.4 4.9 0.1 1.3 1.9 4.0 2.3 2.3 3.9 3.9 5.3 4.2 4.1 4.0 3.7 3.7 3.8 3.9 3.7 3.9 4.0 0.7 0.0 1.7 3.3 2.4 0.3 0.2 0.7 3.4 1.9 0.7 0.6 1.5 1.5 1.6 0.0 2.1 2.0 2.4 1.0 3.9 1.3 0.6 0.5 1.2 1.6 5.4 0.8 2.4 0.7 0.7 1.0 3.1 0.4 0.0 1.5 1.1 56.4 2.0 0.0 2.5 1.6 2.0 1.9 1.2 0.9 0.3 1.3 0.0 1.9 1.4 1.4 1.0 1.5 3.2 0.7 0.5 1.2 3.0 0.5 25.4 1.4 5.9 2.5 0.0 0.9 1.4 1.1 2.5 0.6 0.0 1.4 2.0 1.6 1.2 0.2 PDZD9 "C16orf65, MGC50721" ENSG00000155714 "PDZ domain containing 9" Q8IXQ8 16 21983865-22001116 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 31 "testis: 11.2" "Group enriched" "Detected in some" 17 "Early spermatids: 105.2;Late spermatids: 189.0;Spermatocytes: 78.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.66e-2)" "unprognostic (6.23e-4)" "unprognostic (2.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-3)" "unprognostic (8.29e-3)" "unprognostic (2.05e-3)" "unprognostic (3.93e-2)" "unprognostic (1.11e-2)" "unprognostic (3.85e-3)" "unprognostic (1.42e-2)" "unprognostic (1.97e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (1.63e-1)" "unprognostic (4.69e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.1 11.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.2 0.0 0.0 0.1 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 189.0 0.9 0.1 0.0 1.0 0.0 0.0 0.0 4.0 3.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 78.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOA "CT108, DFNB22" ENSG00000155719 Otoancorin Q7RTW8 16 21663968-21761935 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 1.9;testis: 4.0" "Cell type enhanced" "Detected in some" "Hofbauer cells: 111.8;Kupffer cells: 60.5;Late spermatids: 18.7;Macrophages: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041405 Enhanced "Secreted in other tissues" NA NA 51000 "HPA041405: AB_10796344" "unprognostic (7.96e-2)" "unprognostic (2.44e-4)" "unprognostic (1.66e-2)" "unprognostic (9.69e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (5.11e-1)" "unprognostic (4.71e-2)" "unprognostic (7.92e-2)" "unprognostic (3.58e-1)" "unprognostic (1.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.08e-4)" "unprognostic (1.83e-1)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (2.18e-2)" 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.0 4.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.2 8.4 0.0 0.5 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.9 0.0 0.0 1.8 0.0 0.4 0.1 0.3 0.0 0.2 11.6 0.3 0.2 1.0 1.2 0.0 2.6 0.4 0.8 0.3 0.0 0.5 5.7 0.1 0.7 0.4 111.8 0.0 1.8 0.1 0.0 60.5 3.7 18.7 0.3 34.4 1.8 0.0 1.9 0.0 0.0 0.5 0.2 0.1 1.4 0.0 0.1 0.2 0.0 0.7 0.0 0.0 6.6 0.2 0.7 9.4 7.4 0.0 0.1 0.5 0.2 0.1 0.2 0.2 KCTD18 "6530404F10Rik, FLJ31322, FLJ37818" ENSG00000155729 "Potassium channel tetramerization domain containing 18" Q6PI47 2 200488958-200519784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045498, HPA058028" Approved Approved Mitochondria NA NA Mitochondria "HPA045498: AB_10959387, HPA058028: AB_2683583" "unprognostic (2.90e-1)" "unprognostic (1.81e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-1)" "unprognostic (4.01e-1)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.40e-2)" "unprognostic (1.18e-2)" "unprognostic (5.21e-1)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" 9.6 8.9 8.9 7.6 9.9 9.9 10.3 9.6 9.3 8.5 9.5 9.0 8.7 8.5 8.3 9.0 8.9 7.3 8.5 8.4 9.1 10.0 10.1 8.5 11.1 10.2 9.7 7.9 10.5 12.0 10.5 6.3 6.2 10.0 11.2 8.5 5.7 10.7 9.5 10.7 9.2 8.0 7.8 9.9 10.3 9.4 7.2 9.4 10.7 14.0 9.0 11.1 9.9 8.0 10.1 10.2 9.3 4.5 16.9 21.2 26.2 11.6 12.3 15.4 7.7 10.1 7.5 11.4 7.1 9.1 12.4 12.6 9.6 4.5 14.8 9.8 17.3 4.9 10.2 6.7 5.3 14.4 8.4 11.6 17.6 27.4 8.9 16.9 17.9 6.7 10.5 7.1 9.5 13.9 10.5 18.2 8.2 2.5 8.7 8.3 12.5 10.2 8.4 10.1 10.0 5.1 7.1 9.7 8.2 15.1 9.7 10.9 13.4 11.4 15.7 3.6 8.0 5.9 18.1 14.0 8.0 18.0 8.8 11.3 7.8 3.2 6.4 3.2 4.7 4.9 4.0 4.1 4.8 3.4 4.0 5.1 5.1 2.5 4.6 3.2 4.1 5.0 3.2 8.9 9.9 9.6 9.3 8.4 9.1 10.2 9.7 7.9 10.0 9.9 9.4 10.1 7.8 6.4 9.4 7.2 11.3 4.5 5.9 5.7 10.8 7.2 9.1 6.9 6.2 8.6 6.5 3.7 0.0 8.0 10.8 5.6 1.9 7.2 22.7 8.8 7.3 5.7 1.2 3.4 10.1 8.4 7.8 8.6 8.2 5.3 2.5 11.8 8.6 9.4 7.2 10.1 9.5 8.4 6.1 11.4 6.6 4.2 11.8 11.2 7.2 6.5 16.7 11.1 18.6 6.6 18.3 6.5 7.4 12.4 7.5 5.8 8.5 13.5 9.8 10.5 19.7 12.2 7.9 19.0 16.5 12.8 4.0 5.1 10.1 11.0 7.3 4.0 FAM126B "HYCC2, MGC39518" ENSG00000155744 "Family with sequence similarity 126 member B" Q8IXS8 2 200973718-201071671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 164.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in all" 4 "neutrophil: 25.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 25.7" "Cell line enhanced" "Detected in all" "U-266/84: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036166, HPA036167, HPA067307" Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821" "unprognostic (7.47e-3)" "unprognostic (5.54e-2)" "unprognostic (2.52e-1)" "unprognostic (9.08e-2)" "unprognostic (8.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.11e-2)" "unprognostic (2.61e-3)" "unprognostic (1.34e-1)" "unprognostic (1.48e-2)" "unprognostic (1.79e-2)" "unprognostic (1.90e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" 7.9 4.6 3.7 6.4 5.8 17.6 4.9 16.5 8.0 3.6 3.0 7.3 6.8 4.0 4.0 8.2 3.2 4.3 3.3 6.3 6.1 7.9 7.5 5.4 6.0 3.9 4.7 5.1 3.9 4.9 4.9 3.8 5.0 4.7 3.7 6.5 10.5 4.4 2.8 3.1 7.1 6.6 3.9 0.8 6.8 7.6 4.5 6.3 5.9 7.0 3.6 6.1 3.8 4.5 6.5 5.4 2.8 3.9 4.2 4.0 5.3 8.2 5.0 3.0 4.0 3.7 7.2 6.2 4.9 4.8 5.1 3.7 6.5 8.1 3.1 6.0 7.1 4.9 14.3 7.6 6.7 3.3 17.6 11.9 2.3 3.9 5.5 3.3 3.1 3.9 5.2 13.4 17.6 4.1 3.3 10.5 11.4 2.8 3.5 4.7 6.1 5.9 4.6 3.7 5.9 7.7 3.8 5.3 6.0 4.7 5.1 4.2 7.7 7.9 7.5 5.3 3.7 4.6 13.1 58.8 10.5 4.3 6.7 5.4 2.6 1.8 6.3 3.8 2.4 4.0 2.6 3.2 3.0 1.6 2.7 3.1 3.7 25.7 3.1 2.7 1.1 2.4 1.9 3.7 5.8 16.5 8.0 6.3 6.1 3.9 4.7 5.1 4.7 0.8 6.3 6.5 21.5 28.9 23.9 45.1 29.3 52.6 10.7 17.0 23.3 52.9 16.3 9.4 17.2 27.1 20.4 20.2 164.7 16.6 38.3 59.1 17.6 10.6 9.1 12.7 16.4 22.7 37.1 23.1 113.4 10.5 10.1 15.9 24.5 16.2 24.7 19.9 35.3 21.0 12.0 26.9 98.3 23.4 22.4 33.9 51.6 6.6 31.7 21.1 30.2 45.0 41.5 20.3 73.2 57.8 64.6 21.3 31.1 25.6 34.0 13.2 47.3 16.4 23.1 42.7 19.7 14.8 15.9 32.8 22.9 31.6 74.2 17.4 35.6 15.3 22.0 19.6 FLACC1 ALS2CR12 ENSG00000155749 "Flagellum associated containing coiled-coil domains 1" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.2" "Cell type enriched" "Detected in single" 8 "Cardiomyocytes: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.4;U-2197: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035793 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.9 1.1 6.7 1.0 3.9 5.0 0.5 2.8 4.0 0.6 8.2 0.8 0.5 0.7 1.1 1.2 8.4 1.1 4.5 4.6 3.1 1.3 0.7 2.5 1.6 5.7 5.4 3.2 0.4 0.9 0.7 1.1 0.8 3.2 0.5 1.0 3.4 1.1 0.8 1.8 1.2 1.0 0.6 5.4 0.8 0.5 17.2 3.2 0.7 1.6 0.4 0.5 0.6 0.4 4.2 0.1 0.2 1.1 0.7 2.7 1.1 0.0 0.8 0.3 0.7 0.4 0.0 0.3 0.2 0.6 1.2 0.4 1.1 0.4 0.1 0.3 0.7 0.1 0.1 1.7 0.4 0.6 1.2 1.0 0.5 0.3 0.7 0.1 0.8 0.1 1.2 0.5 1.6 0.6 0.0 0.6 1.0 0.3 0.4 0.6 0.3 0.5 0.7 0.4 0.2 0.2 0.7 0.7 0.0 3.4 1.0 0.4 1.4 0.9 1.5 0.7 5.9 0.5 0.8 1.8 0.5 1.2 0.6 0.7 3.1 0.4 0.4 0.7 0.3 0.3 0.3 0.4 0.4 0.2 0.7 0.6 0.7 3.6 1.3 0.3 0.2 0.3 0.2 6.7 3.9 2.8 4.0 4.6 3.1 5.7 5.4 3.2 3.2 5.4 3.2 4.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2CD6 "ALS2CR11, FLJ25351" ENSG00000155754 "C2 calcium dependent domain containing 6" Q53TS8 2 201487421-201619178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 40.2" "Cell type enriched" "Detected in some" 21 "Theca cells: 41.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;HSkMC: 2.0;hTEC/SVTERT24-B: 2.0;SCLC-21H: 2.3;THP-1: 2.0;U-2197: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-1)" "unprognostic (1.14e-1)" "unprognostic (8.77e-3)" "unprognostic (7.13e-6)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (2.16e-1)" "unprognostic (4.81e-2)" "unprognostic (3.15e-2)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (2.10e-1)" "unprognostic (5.13e-10)" "unprognostic (1.95e-1)" "unprognostic (6.35e-2)" "unprognostic (2.00e-1)" "unprognostic (2.18e-1)" 0.6 0.7 2.3 0.0 2.1 0.0 0.3 2.2 1.0 0.1 0.7 0.1 0.1 0.2 0.1 0.2 0.1 0.4 1.2 0.6 2.0 0.1 0.1 0.3 0.2 4.6 2.5 0.1 0.7 0.0 0.0 0.7 0.1 4.1 0.3 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.2 5.2 0.1 0.0 40.2 2.9 0.0 0.1 0.0 0.0 0.1 0.1 6.5 0.0 0.0 0.0 0.0 0.2 1.9 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.2 0.1 0.0 2.0 0.0 0.0 0.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 2.1 2.2 1.0 0.6 2.0 4.6 2.5 0.1 4.1 5.2 2.9 6.5 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 TMEM237 "ALS2CR4, JBTS14" ENSG00000155755 "Transmembrane protein 237" Q96Q45 2 201620184-201643570 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 90.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052596, HPA054732" Enhanced NA NA "HPA052596: AB_2681879, HPA054732: AB_2682587" "unprognostic (1.70e-1)" "unprognostic (7.10e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (1.73e-1)" "unprognostic (4.06e-1)" "unprognostic (8.30e-6)" "unprognostic (4.15e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.96e-6)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" 4.2 15.3 6.5 1.7 6.4 2.3 11.1 7.1 7.9 5.1 5.7 2.5 0.9 6.1 4.6 6.0 5.8 4.1 7.8 6.4 6.8 5.4 1.9 5.1 2.4 6.9 6.9 5.6 8.5 2.0 5.0 3.0 5.2 6.3 7.9 3.7 90.1 5.2 4.9 7.7 18.7 1.8 5.8 6.9 1.4 2.2 3.0 6.2 7.1 4.6 9.3 3.1 4.1 3.4 6.2 3.7 7.2 32.3 16.4 7.8 10.1 3.1 22.6 9.9 14.7 28.4 5.9 5.3 3.7 6.9 21.9 12.7 6.8 5.6 24.4 27.1 6.9 20.6 10.7 21.4 19.4 15.1 10.4 2.1 9.0 5.0 20.4 5.1 24.8 25.5 23.4 7.8 13.0 29.8 5.2 29.7 16.3 32.7 1.9 23.8 43.9 30.8 7.6 12.2 9.7 33.7 47.4 21.4 8.4 12.6 20.3 12.5 18.7 6.8 26.8 7.3 8.6 9.5 6.0 14.9 11.4 22.7 9.7 17.0 0.0 0.0 0.0 1.0 1.1 0.9 0.7 1.0 1.6 1.3 0.1 1.1 1.4 0.0 0.9 0.7 0.3 1.8 0.5 6.5 6.4 7.1 7.9 6.4 6.8 6.9 6.9 5.6 6.3 6.9 6.2 6.2 6.8 6.4 9.6 12.4 1.6 71.2 81.7 46.7 50.7 33.3 17.1 41.4 20.2 2.8 18.9 18.4 41.7 21.0 3.1 0.6 13.7 11.1 8.9 16.3 10.9 11.6 4.8 8.6 16.5 7.6 26.8 25.8 3.1 7.7 5.1 19.9 10.4 2.7 9.4 32.0 15.3 4.5 18.3 2.2 12.2 7.0 21.8 2.9 12.4 4.7 5.7 38.5 0.0 14.1 10.8 6.5 1.9 21.4 3.0 36.9 0.7 3.9 19.8 160.3 6.6 33.2 20.6 33.3 22.0 30.0 45.3 15.1 4.2 39.8 5.3 29.2 FZD7 FzE3 ENSG00000155760 "Frizzled class receptor 7" O75084 2 202033855-202038441 "G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 30.9;Breast myoepithelial cells: 37.0;Cardiomyocytes: 21.1;Fibroblasts: 23.5;Proximal enterocytes: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 42.8;BJ hTERT+: 48.4;CAPAN-2: 62.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059979, HPA069165, HPA076183" Approved Supported Vesicles NA NA Vesicles "HPA059979: , HPA069165: AB_2686096, HPA076183: " "unprognostic (3.44e-2)" "unprognostic (6.89e-2)" "unprognostic (9.30e-3)" "unprognostic (2.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.71e-5)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-3)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (4.16e-2)" "unprognostic (2.05e-3)" 8.4 3.1 4.5 5.7 4.7 0.4 15.7 30.7 4.4 12.0 6.1 27.4 7.0 18.5 14.2 9.5 16.9 6.4 14.6 7.6 8.4 8.2 1.2 5.4 3.9 5.4 6.1 3.4 25.3 1.7 1.1 9.3 5.7 12.1 19.3 5.6 1.3 21.8 23.7 27.0 10.4 10.9 11.2 5.1 1.9 6.0 2.1 4.6 1.1 5.2 9.6 3.9 27.3 15.5 5.7 10.3 5.2 33.2 10.8 10.6 7.9 14.8 42.8 48.4 11.9 13.9 32.2 62.7 0.1 25.1 26.2 7.9 10.6 6.0 1.3 13.7 5.4 8.6 1.1 2.1 2.7 7.2 2.1 2.1 7.6 1.0 6.4 3.7 9.5 0.0 0.7 2.9 2.6 9.8 4.2 0.0 5.7 36.6 2.0 3.5 4.2 6.4 1.1 1.9 6.1 5.5 12.6 5.4 0.4 6.8 26.7 3.8 2.5 0.1 23.8 8.8 15.0 5.4 2.7 2.2 0.1 4.9 0.5 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.7 30.7 4.4 7.6 8.4 5.4 6.1 3.4 12.1 5.1 4.6 5.7 3.5 0.0 8.1 3.6 2.0 10.3 8.3 1.9 14.8 0.0 30.9 37.0 21.1 1.5 0.3 1.8 0.0 0.5 2.0 4.7 1.9 1.6 0.1 1.5 2.0 1.7 1.2 0.0 1.5 0.2 1.1 23.5 2.6 3.6 1.3 7.5 0.7 0.7 1.5 0.0 0.2 9.9 0.0 0.8 5.7 0.5 5.3 2.0 3.6 0.0 0.1 7.5 0.0 0.0 0.1 0.6 2.1 4.9 1.7 6.9 21.3 0.1 0.9 0.6 6.6 13.5 16.3 1.6 2.9 11.4 9.8 0.8 2.5 0.5 7.6 1.8 SPAG17 "CT143, FLJ34497, PF6, RP4-776P7.2" ENSG00000155761 "Sperm associated antigen 17" Q6Q759 1 117953590-118185228 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 22.2;testis: 15.1" "Group enriched" "Detected in many" 5 "Early spermatids: 263.7;Endometrial ciliated cells: 180.7;Late spermatids: 370.9;Respiratory ciliated cells: 300.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.9" "HPA028597, HPA028666" Enhanced NA NA "HPA028597: AB_10600221, HPA028666: AB_10602281" "unprognostic (3.67e-2)" "unprognostic (4.86e-3)" "unprognostic (3.42e-1)" "unprognostic (1.50e-2)" "unprognostic (1.56e-2)" "unprognostic (6.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.20e-2)" "unprognostic (3.19e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.76e-5)" "unprognostic (4.81e-1)" "unprognostic (9.90e-2)" "unprognostic (8.23e-2)" "unprognostic (9.67e-2)" 0.5 0.1 7.5 0.0 1.7 0.0 0.7 2.6 1.3 1.2 22.2 0.0 0.0 0.3 4.5 6.2 8.5 0.3 0.0 1.6 5.4 1.7 0.0 1.8 0.0 6.2 7.1 0.1 0.1 0.4 0.0 3.8 0.1 5.0 0.1 0.0 0.4 0.3 0.1 0.2 0.2 0.0 0.0 7.2 0.0 0.5 15.1 3.0 0.0 0.9 0.0 0.5 1.0 2.7 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 1.7 2.6 1.3 1.6 5.4 6.2 7.1 0.1 5.0 7.2 3.0 3.3 0.1 6.4 3.9 0.7 0.0 0.4 0.2 2.8 0.6 0.5 1.2 0.6 0.6 0.0 45.3 11.0 33.3 2.3 0.1 0.1 1.9 0.6 263.7 180.7 1.1 0.6 0.0 0.0 2.7 0.7 0.5 4.6 0.0 4.0 1.3 0.2 0.0 0.0 0.2 0.0 2.2 0.0 4.1 0.0 0.4 370.9 1.5 0.7 0.0 1.0 0.1 1.1 0.0 0.5 0.9 0.2 0.0 1.2 0.0 0.1 0.0 1.0 300.1 0.1 0.0 0.4 1.1 48.2 6.2 16.1 0.3 0.7 0.4 1.5 0.0 0.9 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.7;tongue: 123.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "myeloid DC: 20.3" "Lineage enriched" "Detected in many" 11 "dendritic cells: 20.3" "Cell line enhanced" "Detected in many" "Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear bodies" "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 11.4 53.3 11.8 3.0 16.4 2.0 20.9 11.9 13.9 39.5 3.9 18.3 17.0 16.6 11.1 15.4 27.4 10.9 5.1 9.2 25.0 37.2 16.5 5.3 10.2 15.4 12.1 6.7 25.0 12.0 17.0 11.5 4.9 14.8 12.2 10.0 2.1 107.3 15.7 159.7 6.6 14.6 15.7 13.4 9.6 40.4 2.9 15.8 5.1 98.9 123.4 2.9 5.6 7.0 24.0 0.1 3.5 0.3 1.1 21.0 6.2 0.3 0.1 0.3 0.6 0.5 2.4 0.4 105.1 2.3 1.2 0.3 0.3 5.4 0.2 0.4 2.3 2.7 14.2 0.9 0.6 12.8 3.0 23.7 5.5 9.5 0.8 0.6 0.1 0.0 1.8 0.1 16.9 0.3 7.1 0.1 2.5 1.3 45.5 3.7 0.4 4.9 193.2 149.3 4.1 3.2 0.7 1.7 11.0 3.2 2.8 9.6 0.5 0.0 0.4 0.9 21.4 0.5 45.4 11.4 55.2 6.5 3.9 0.6 0.0 0.9 0.0 0.2 1.7 0.8 0.1 0.4 0.7 20.3 0.1 0.8 0.6 0.3 0.4 0.2 1.0 0.4 1.0 11.8 16.4 11.9 13.9 9.2 25.0 15.4 12.1 6.7 14.8 13.4 15.8 24.0 23.1 6.4 9.3 4.9 2.9 5.2 15.4 3.8 27.3 2.1 16.5 10.4 2.4 15.7 8.4 25.8 0.0 0.6 0.8 2.7 86.1 5.7 2.2 19.0 9.7 7.5 16.7 12.4 14.5 11.8 4.1 10.0 29.6 66.1 12.0 5.4 2.5 12.7 3.3 0.0 31.0 7.7 0.0 16.0 39.5 2.2 11.8 14.9 14.2 46.9 1.5 1.2 2.1 9.5 123.9 1.1 36.5 3.4 6.4 7.1 21.0 33.6 1.1 0.7 0.0 8.1 5.7 3.6 3.8 16.5 5.5 0.4 1.3 6.0 16.5 21.9 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475187 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6;parathyroid gland: 19.8;retina: 16.8" "Cell type enhanced" "Detected in many" "Astrocytes: 758.1;Excitatory neurons: 537.5;Horizontal cells: 124.5;Inhibitory neurons: 366.7;Oligodendrocyte precursor cells: 154.3" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 70.8;BJ hTERT+: 39.4;fHDF/TERT166: 73.8;LHCN-M2: 87.9;U-138 MG: 48.9;WM-115: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA050649: AB_2681202" "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 0.8 5.1 27.2 0.2 28.9 0.0 0.5 12.0 47.6 0.3 0.0 5.0 0.2 1.4 0.9 0.7 1.9 1.2 0.1 28.4 19.3 3.5 0.0 0.3 0.0 21.8 28.0 20.5 2.4 1.0 19.8 9.1 0.2 19.2 1.6 1.6 16.8 0.3 2.6 0.1 0.2 0.9 1.8 12.8 0.2 0.7 2.3 36.1 0.0 0.5 0.2 0.1 0.3 0.3 32.1 0.0 2.1 6.6 0.0 20.2 15.3 0.0 70.8 39.4 31.0 16.3 0.0 0.0 0.0 0.0 73.8 1.2 0.0 1.3 0.0 28.8 0.0 5.8 0.0 0.7 0.0 0.1 0.0 0.0 1.7 0.0 8.5 1.9 17.0 0.0 0.0 0.0 0.0 87.9 0.0 0.0 0.1 2.3 0.0 2.2 0.0 0.2 0.0 0.0 0.0 12.0 10.6 0.0 0.1 0.3 0.2 2.1 0.1 0.3 48.9 0.2 16.0 18.2 0.0 0.0 0.0 10.4 0.0 69.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 28.9 12.0 47.6 28.4 19.3 21.8 28.0 20.5 19.2 12.8 36.1 32.1 0.0 0.0 0.0 758.1 0.0 0.1 0.0 0.0 0.0 30.6 0.2 0.3 1.6 0.0 0.0 1.8 50.1 0.1 0.0 4.7 0.0 0.0 15.2 4.3 0.7 0.5 12.1 0.0 537.5 0.0 0.1 1.4 0.0 1.1 0.0 0.8 2.9 0.1 0.1 124.5 366.7 0.5 0.0 0.6 0.6 3.0 0.3 0.1 1.8 31.9 0.0 2.3 0.0 154.3 17.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.3 1.8 4.4 0.0 0.0 0.5 0.0 3.1 1.6 0.0 RNF20 "BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779" ENSG00000155827 "Ring finger protein 20" Q5VTR2 9 101533853-101563344 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012478, HPA051773" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB012478: , HPA051773: AB_2681604" "unprognostic (7.02e-2)" "unprognostic (2.21e-1)" "unprognostic (9.04e-2)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (2.90e-1)" "unprognostic (2.01e-1)" "unprognostic (5.47e-2)" "unprognostic (7.27e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.64e-6)" "unprognostic (2.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-1)" "unprognostic (9.54e-3)" 18.0 18.0 22.4 16.4 25.4 15.0 19.2 23.7 23.9 17.1 22.6 17.9 11.2 19.2 19.4 21.8 20.0 14.2 26.7 21.6 26.7 21.5 15.9 16.5 18.7 24.6 24.6 20.3 21.7 21.5 28.3 10.4 14.7 24.7 21.1 17.0 30.7 16.9 18.0 29.9 17.5 12.4 19.0 24.1 17.8 14.6 32.8 23.5 20.0 23.7 25.1 21.2 15.2 15.1 28.1 25.8 64.2 36.4 40.0 43.8 34.4 31.0 44.1 35.3 43.1 37.6 39.2 26.8 56.8 23.2 34.3 36.0 64.0 42.6 37.5 44.1 59.7 19.8 30.5 55.9 39.7 32.2 53.0 35.2 34.0 39.4 38.2 49.2 32.4 25.7 20.7 29.5 32.5 47.4 33.6 41.4 14.0 80.5 57.8 32.3 39.4 125.7 28.3 17.8 24.5 38.7 48.6 62.1 32.9 36.1 36.3 29.7 24.7 36.6 39.8 39.7 28.6 37.3 35.1 118.0 30.4 35.1 19.6 49.2 24.5 15.2 23.7 20.4 20.3 15.5 15.3 16.7 15.4 14.6 12.4 17.3 16.4 15.7 17.1 30.0 9.2 14.7 13.4 22.4 25.4 23.7 23.9 21.6 26.7 24.6 24.6 20.3 24.7 24.1 23.5 28.1 15.9 25.6 31.2 10.7 16.8 6.4 9.7 13.7 17.1 32.4 11.6 11.4 49.5 8.6 23.9 22.0 6.2 16.7 10.2 17.9 5.9 18.3 54.5 20.3 18.5 18.7 24.6 22.3 16.3 13.8 11.5 16.9 10.2 11.5 22.1 19.7 11.7 18.1 16.4 43.7 18.7 12.1 16.2 27.4 4.3 21.4 18.0 20.0 10.6 8.4 31.4 31.4 33.0 11.1 21.9 11.0 13.0 23.7 13.1 9.3 10.1 11.5 28.5 26.5 32.9 21.8 17.5 76.0 16.7 18.3 5.8 7.7 16.1 15.4 15.3 6.4 CYLC2 ENSG00000155833 "Cylicin 2" Q14093 9 102995311-103018488 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 271 "testis: 47.0" "Group enriched" "Detected in some" 113 "Early spermatids: 2079.6;Late spermatids: 2578.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2079.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2578.8 11.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPARGC1B "PERC, PGC1B" ENSG00000155846 "PPARG coactivator 1 beta" Q86YN6 5 149730298-149855022 "Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 12.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 111.8;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 72.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 9.8" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050543 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA050543: AB_2681165" "unprognostic (2.86e-1)" "unprognostic (1.07e-2)" "unprognostic (5.09e-3)" "unprognostic (1.13e-3)" "unprognostic (2.63e-1)" "unprognostic (2.00e-3)" "unprognostic (4.51e-3)" "unprognostic (6.55e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (9.01e-6)" "unprognostic (8.45e-2)" "unprognostic (5.09e-2)" "unprognostic (1.51e-1)" "unprognostic (2.77e-3)" 1.9 0.9 2.0 2.4 2.3 2.0 1.4 9.8 3.2 1.3 0.0 6.5 7.1 2.2 1.1 4.2 2.2 1.3 4.8 1.7 1.4 0.8 1.6 3.6 1.4 1.7 1.0 2.0 1.4 1.0 4.4 0.6 1.5 2.4 1.8 6.1 12.5 1.4 3.3 6.2 3.3 6.4 2.8 0.4 2.1 3.8 0.8 1.0 0.9 0.4 2.5 1.8 3.8 2.6 2.0 0.5 1.9 0.7 4.5 1.8 0.6 7.3 0.3 0.0 0.5 0.7 8.5 1.8 9.2 1.3 0.0 2.1 5.5 6.9 3.5 0.6 0.5 5.9 8.6 3.6 1.8 0.5 12.0 3.2 0.9 4.6 1.8 3.0 0.2 1.0 4.0 6.0 2.9 0.4 2.3 4.4 5.4 2.9 2.6 4.8 8.3 5.0 5.1 1.4 11.2 2.4 0.5 1.2 9.8 1.5 1.3 2.5 3.9 1.3 1.0 1.6 3.6 1.8 3.6 2.8 5.3 2.2 7.4 0.9 0.5 0.9 0.1 0.1 1.7 0.3 0.8 0.1 0.1 1.1 0.3 0.2 0.2 0.6 0.3 3.1 0.1 0.1 0.3 2.0 2.3 9.8 3.2 1.7 1.4 1.7 1.0 2.0 2.4 0.4 1.0 2.0 6.1 0.0 1.1 1.6 3.0 5.1 3.9 17.9 12.0 111.8 2.5 3.2 22.3 1.5 7.4 1.8 135.5 1.8 0.7 15.4 1.9 0.5 0.3 1.7 4.1 5.4 5.4 5.7 29.2 0.8 1.6 2.7 18.8 2.5 1.3 2.1 4.2 3.5 7.6 8.4 26.2 10.3 0.0 12.5 4.7 0.2 1.5 12.1 3.6 12.2 6.1 4.0 2.1 12.1 0.9 0.5 6.7 0.4 5.5 5.1 19.6 3.0 2.9 72.0 6.6 3.0 8.9 0.2 3.2 23.1 10.7 4.9 2.0 2.1 24.9 6.1 ELMO1 "CED-12, CED12, ELMO-1, KIAA0281" ENSG00000155849 "Engulfment and cell motility 1" Q92556 7 36852906-37449223 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 236.7;Microglial cells: 519.0;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 1412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 129.9;JURKAT: 122.0;Karpas-707: 118.0;U-698: 141.7;U-937: 123.4" "Low region specificity" "Detected in all" NA NA "unprognostic (1.77e-2)" "unprognostic (8.29e-3)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (3.69e-1)" "unprognostic (4.09e-2)" "unprognostic (3.01e-2)" "unprognostic (3.53e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "prognostic favorable (4.62e-4)" "unprognostic (3.59e-1)" "prognostic unfavorable (3.27e-5)" "unprognostic (1.65e-2)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (3.16e-3)" 27.3 14.7 71.7 32.7 117.4 59.9 22.0 85.4 109.1 13.0 33.4 11.9 6.7 7.9 4.5 11.0 10.5 21.3 16.2 76.5 96.6 6.9 28.2 29.2 49.6 115.0 104.8 60.5 13.5 13.4 4.9 12.1 38.4 120.0 10.9 13.1 13.1 9.4 10.0 7.3 9.3 19.2 16.0 86.2 56.9 9.0 6.5 105.2 29.7 82.8 16.7 51.8 18.9 15.6 220.6 0.2 4.1 7.6 0.0 0.0 0.0 16.4 0.2 0.1 0.0 0.0 0.2 0.0 129.9 2.2 0.0 1.0 0.5 0.0 0.0 0.0 72.7 4.7 94.6 0.3 0.0 0.0 60.5 38.0 1.6 0.0 0.0 0.0 0.0 49.8 122.0 1.5 118.0 0.0 0.8 69.8 84.0 19.4 0.2 0.0 77.5 10.1 72.3 0.2 0.0 8.5 40.3 0.3 24.1 0.5 27.3 0.1 43.3 14.4 0.2 1.4 0.3 0.6 98.8 90.1 141.7 21.1 123.4 6.0 49.9 52.8 164.1 33.2 45.7 33.8 49.8 52.1 36.6 78.2 39.7 47.1 36.3 107.0 41.6 40.6 40.1 47.8 55.6 71.7 117.4 85.4 109.1 76.5 96.6 115.0 104.8 60.5 120.0 86.2 105.2 220.6 60.4 0.0 4.8 10.4 53.3 5.0 4.5 0.0 3.4 13.7 2.0 2.8 3.5 7.2 0.6 0.0 0.0 1.5 26.8 0.4 0.0 0.2 1.0 1.8 2.4 44.6 3.6 24.6 236.7 1.1 26.7 14.6 0.0 1.1 34.9 6.9 37.1 15.4 20.4 0.0 106.7 0.9 0.0 50.7 58.3 1.5 6.2 44.8 7.2 519.0 34.6 1.1 41.2 284.0 1412.3 0.6 0.8 24.8 31.7 1.9 0.0 2.0 0.0 1.8 13.1 9.5 2.7 1.4 4.6 0.8 4.3 19.7 35.6 15.2 0.2 1.8 SLC26A2 "DTD, DTDST" ENSG00000155850 "Solute carrier family 26 member 2" P50443 5 149960758-149993455 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "intestine: 213.9" "Group enriched" "Detected in many" 4 "Distal enterocytes: 2026.2;Glandular and luminal cells: 684.5;Syncytiotrophoblasts: 808.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "EFO-21: 66.1;RPTEC TERT1: 151.7;TIME: 80.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041957, HPA058090" Enhanced Approved Vesicles NA NA Vesicles "HPA041957: AB_10795646, HPA058090: AB_2683602" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-2)" "prognostic favorable (7.29e-4)" "unprognostic (2.59e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (1.19e-1)" "unprognostic (7.43e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.70e-1)" "unprognostic (1.77e-1)" "unprognostic (8.12e-2)" "unprognostic (1.06e-1)" 5.2 31.0 2.6 7.9 2.7 2.5 9.3 9.7 3.8 6.3 4.4 213.9 13.0 9.4 23.0 10.8 5.1 5.6 2.6 2.4 8.1 3.7 1.7 7.4 4.0 4.1 3.3 2.3 4.9 3.4 38.0 7.2 34.3 6.1 12.3 191.4 21.0 36.1 18.6 3.9 7.2 16.3 9.4 4.1 3.8 3.3 4.2 3.9 4.2 4.6 3.7 5.9 4.8 3.0 4.1 9.5 8.6 10.5 17.3 12.6 8.8 2.5 8.9 8.0 7.0 8.5 44.7 5.1 7.4 66.1 9.5 16.8 6.8 10.0 20.5 12.4 6.0 6.4 9.3 6.7 5.2 9.4 17.3 15.2 9.8 11.8 11.7 15.2 17.3 16.8 9.0 2.4 7.1 29.6 3.0 6.6 9.1 3.2 3.2 13.5 9.5 16.3 3.9 151.7 41.6 3.2 8.1 15.6 3.6 27.2 8.1 7.3 10.0 80.4 16.0 11.8 14.2 10.7 5.2 7.3 4.3 14.7 20.6 23.5 4.9 0.5 0.3 0.9 0.3 1.1 0.5 0.5 0.8 0.7 0.5 0.8 0.9 0.3 1.1 1.6 0.7 1.1 0.5 2.6 2.7 9.7 3.8 2.4 8.1 4.1 3.3 2.3 6.1 4.1 3.9 4.1 47.4 44.8 11.3 3.3 8.5 4.6 13.2 22.9 7.4 17.1 23.8 14.6 7.8 7.2 24.2 33.1 16.7 219.2 11.5 2026.2 1.9 6.1 32.7 237.0 92.3 29.8 21.1 16.6 5.4 9.9 7.7 21.5 5.1 684.5 90.0 29.6 17.2 2.0 30.4 6.7 7.9 52.5 20.3 15.3 11.8 15.7 17.4 17.4 90.7 17.8 19.6 15.2 15.5 16.6 6.0 12.1 177.4 12.4 15.2 15.1 91.7 5.1 26.6 84.5 0.0 18.7 13.9 8.7 11.4 73.9 5.1 808.9 14.0 26.3 208.9 5.5 LSM11 FLJ38273 ENSG00000155858 "LSM11, U7 small nuclear RNA associated" P83369 5 157743712-157760709 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039587 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039587: AB_10796330" "unprognostic (3.99e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (6.90e-2)" "unprognostic (2.32e-2)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (9.68e-3)" "unprognostic (1.70e-1)" "unprognostic (2.89e-2)" "unprognostic (3.77e-2)" "unprognostic (3.57e-1)" "unprognostic (1.62e-3)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (3.01e-2)" 1.7 2.1 2.7 1.9 4.1 1.7 2.2 4.0 5.0 4.0 0.4 4.9 2.3 5.4 1.5 2.3 3.1 2.3 1.2 3.9 3.5 1.3 1.3 1.8 2.1 2.8 3.4 4.0 3.5 1.9 1.8 2.2 2.1 3.6 4.3 2.6 7.2 1.8 4.8 1.4 2.2 2.3 3.3 2.4 1.6 2.3 4.1 3.4 1.8 1.2 1.4 2.2 9.9 3.5 4.5 3.2 2.3 6.2 6.6 2.7 3.5 5.4 4.3 1.9 3.6 4.7 6.9 3.1 7.0 4.9 2.5 2.5 3.7 8.1 4.7 3.9 5.0 7.6 2.9 8.6 4.4 1.0 8.7 3.5 1.6 3.1 4.3 4.4 4.0 5.9 5.7 5.5 3.7 3.9 3.0 4.9 5.1 1.8 2.6 6.9 7.7 7.7 2.9 1.8 2.9 3.6 5.7 2.8 3.8 3.8 4.5 3.2 5.3 4.2 6.9 2.7 4.1 6.9 3.0 2.0 6.9 2.8 8.9 3.1 0.4 0.1 0.0 0.2 0.1 0.3 0.1 0.3 0.2 0.1 0.1 0.2 0.2 0.1 0.4 0.0 0.0 0.2 0.1 2.7 4.1 4.0 5.0 3.9 3.5 2.8 3.4 4.0 3.6 2.4 3.4 4.5 3.6 6.4 4.1 2.3 2.7 3.6 3.5 1.3 2.2 26.1 3.3 2.5 2.2 1.5 3.1 3.7 6.2 2.1 4.7 3.1 0.0 1.7 10.6 0.8 3.7 3.2 3.0 1.3 11.7 0.9 4.8 3.6 2.0 1.6 1.3 5.5 3.9 2.2 2.2 8.4 11.8 2.0 0.0 4.2 5.7 15.7 1.5 2.6 0.0 1.0 3.5 2.2 4.1 1.5 2.4 1.8 6.2 4.1 2.4 3.7 2.1 1.5 1.9 7.8 0.0 4.3 9.1 10.5 10.9 1.9 4.3 1.2 2.8 2.1 5.5 4.0 MED7 "CRSP33, CRSP9" ENSG00000155868 "Mediator complex subunit 7" O43513 5 157137424-157159019 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 314.5;Late spermatids: 289.0;Spermatocytes: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067181 Supported "Nuclear bodies" No No "Nuclear bodies" "HPA067181: AB_2685798" "unprognostic (1.63e-1)" "unprognostic (1.29e-1)" "unprognostic (7.81e-3)" "unprognostic (8.12e-2)" "unprognostic (1.45e-3)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.37e-5)" "unprognostic (7.32e-2)" "unprognostic (1.11e-1)" "unprognostic (5.01e-2)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" "prognostic favorable (8.69e-5)" "unprognostic (9.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" 10.2 11.5 8.6 9.3 9.2 10.6 12.8 10.6 11.2 8.5 10.4 10.6 6.3 9.3 13.6 8.6 8.0 7.6 10.3 9.1 9.2 14.1 10.1 8.1 13.0 9.5 9.0 8.2 10.9 6.9 11.0 8.0 8.2 9.3 10.4 11.1 12.1 7.7 7.2 14.4 6.0 8.8 9.0 8.7 12.4 10.0 26.7 9.2 9.8 11.9 11.0 11.7 9.4 6.5 9.8 13.2 15.3 20.6 14.5 17.2 12.2 15.3 20.5 11.8 15.2 19.2 20.7 24.8 23.4 17.8 15.4 29.1 16.3 11.5 23.0 22.2 10.1 11.1 8.7 15.3 11.1 15.4 12.6 11.9 14.5 16.5 13.5 14.8 13.3 19.5 15.2 8.1 17.4 24.5 12.9 12.5 11.0 6.1 18.3 18.9 11.2 17.9 12.9 32.6 18.2 15.9 11.9 13.8 14.1 19.7 16.1 36.0 12.8 14.7 22.3 18.3 11.6 18.6 16.7 19.4 11.3 14.0 17.7 18.1 40.9 22.3 30.8 19.3 24.6 23.0 35.4 23.2 24.4 16.1 34.5 34.4 24.8 19.3 26.1 35.7 15.0 28.3 22.2 8.6 9.2 10.6 11.2 9.1 9.2 9.5 9.0 8.2 9.3 8.7 9.2 9.8 12.3 9.6 10.1 6.2 17.1 7.1 14.8 52.4 7.4 22.7 9.6 11.3 20.8 10.0 26.6 23.9 22.9 38.0 10.7 15.3 52.8 28.0 314.5 10.7 12.9 12.3 11.4 17.7 9.1 18.7 22.9 14.4 13.3 9.4 20.3 15.7 16.4 9.4 22.8 18.5 9.5 12.0 32.6 19.9 12.0 289.0 18.6 13.8 3.6 5.6 20.4 22.0 35.0 4.5 10.7 18.9 14.1 16.6 11.8 11.3 16.1 40.2 21.7 14.3 6.6 10.5 18.1 112.9 43.0 7.5 6.0 30.5 16.1 22.4 11.5 14.2 SAXO1 "C9orf138, FAM154A, MGC35182" ENSG00000155875 "Stabilizer of axonemal microtubules 1" Q8IYX7 9 18858906-19049358 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "testis: 38.8" "Cell type enriched" "Detected in some" 8 "Early spermatids: 572.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023899 Enhanced NA NA "HPA023899: AB_1845813" "unprognostic (4.23e-4)" "unprognostic (1.59e-1)" "unprognostic (3.38e-1)" "unprognostic (3.17e-2)" "unprognostic (5.28e-3)" "unprognostic (8.64e-2)" "unprognostic (3.89e-1)" "unprognostic (2.90e-3)" "unprognostic (1.38e-2)" "unprognostic (4.97e-3)" "unprognostic (1.51e-1)" "unprognostic (3.61e-1)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "unprognostic (2.79e-1)" "unprognostic (4.36e-2)" "unprognostic (5.40e-2)" 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.1 38.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.0 0.0 5.2 0.2 0.0 0.1 0.0 0.6 0.2 0.7 0.9 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 572.8 1.2 0.4 0.6 0.0 0.0 1.0 0.4 0.0 0.3 0.0 0.1 0.0 0.1 0.0 1.0 0.2 0.0 1.1 0.1 0.0 1.2 0.0 65.8 4.7 0.2 0.0 1.0 0.3 0.2 0.0 1.5 3.7 0.1 0.0 2.6 0.2 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.2 11.6 2.4 0.2 0.0 0.1 0.3 0.1 0.1 0.2 RRAGA "FIP-1, RAGA" ENSG00000155876 "Ras related GTP binding A" Q7L523 9 19049427-19051025 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Supported Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (6.30e-2)" "unprognostic (4.65e-1)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (3.13e-1)" "unprognostic (2.65e-1)" "unprognostic (1.74e-2)" "unprognostic (4.88e-2)" "unprognostic (2.10e-3)" "unprognostic (1.05e-1)" 77.2 74.3 78.8 40.0 80.0 30.4 73.4 81.9 83.2 67.1 76.4 67.2 39.0 95.6 78.1 62.6 75.3 50.1 87.9 80.1 84.3 68.3 68.9 52.4 46.8 80.2 79.4 81.9 83.7 47.1 47.9 69.2 71.6 81.9 58.6 46.0 40.1 53.7 74.4 130.0 71.3 57.5 83.4 82.1 53.3 57.6 40.5 81.9 53.7 57.6 105.4 48.3 71.3 58.5 90.9 115.2 92.7 74.9 78.4 263.8 167.0 51.5 112.7 134.4 96.2 117.7 35.8 34.7 22.6 61.1 190.8 86.7 42.8 64.8 106.6 101.2 97.7 72.8 145.3 122.6 139.0 172.8 20.3 52.7 148.8 101.3 82.2 55.7 132.4 116.1 36.9 33.4 32.1 202.5 72.5 56.2 118.8 41.9 59.5 70.6 43.0 48.8 32.6 147.9 98.8 61.4 76.6 61.9 55.5 60.4 67.5 71.3 54.0 91.0 116.2 44.6 83.6 85.3 22.5 39.4 51.6 127.9 30.8 43.1 155.3 85.6 147.8 74.5 98.0 72.7 49.4 77.1 74.6 81.0 50.4 70.1 69.8 58.9 81.9 109.3 58.2 100.0 107.8 78.8 80.0 81.9 83.2 80.1 84.3 80.2 79.4 81.9 81.9 82.1 81.9 90.9 84.3 25.6 27.7 16.0 35.0 61.1 123.7 138.8 50.7 47.8 43.2 57.9 51.8 41.5 63.8 53.3 18.8 130.9 28.1 32.9 105.7 95.9 92.5 74.0 70.6 86.5 17.5 38.1 17.5 61.4 98.6 80.3 28.1 47.2 33.6 38.0 71.4 61.9 64.6 48.8 20.0 29.8 81.4 37.1 33.2 28.3 93.8 39.2 56.9 20.6 51.0 95.4 49.4 21.1 29.6 52.3 44.3 103.0 24.0 50.8 51.4 130.1 75.4 37.0 32.9 65.3 79.1 113.8 22.9 47.7 59.2 121.4 37.3 61.6 34.8 74.8 SLC24A2 NCKX2 ENSG00000155886 "Solute carrier family 24 member 2" Q9UI40 9 19507452-19786928 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 108.6" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 2710.1" "Group enriched" "Detected in some" 4 "breast cancer: 0.5;glioma: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 2.6;SCLC-21H: 2.2;U-87 MG: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079359 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA079359: " "unprognostic (1.30e-1)" "unprognostic (8.57e-2)" "unprognostic (4.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "unprognostic (1.48e-2)" "unprognostic (8.46e-2)" "unprognostic (8.37e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-2)" "unprognostic (6.51e-2)" "unprognostic (1.57e-2)" "unprognostic (2.08e-4)" "unprognostic (1.58e-1)" "unprognostic (2.11e-3)" "unprognostic (1.51e-2)" 0.1 6.0 21.1 0.0 49.8 0.1 0.0 29.1 62.5 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.5 0.1 0.0 19.6 28.7 0.1 0.0 0.0 0.0 69.7 37.7 4.5 0.0 0.0 0.0 0.8 0.1 77.8 0.1 0.0 18.9 0.0 0.0 0.1 0.1 0.0 0.0 14.7 0.1 0.1 0.2 59.0 0.0 0.0 0.3 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.0 21.1 49.8 29.1 62.5 19.6 28.7 69.7 37.7 4.5 77.8 14.7 59.0 108.6 0.0 0.0 0.0 18.9 0.1 0.0 0.0 0.0 0.0 58.7 0.0 0.0 2.3 0.0 0.0 0.0 273.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 668.6 0.0 0.1 0.9 0.0 0.1 0.0 0.0 1.4 0.0 0.1 97.6 637.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 25.3 0.0 4.1 0.0 217.6 2710.1 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 10.4 0.0 3.2 0.2 0.2 0.7 0.0 0.1 0.3 0.0 0.0 0.1 0.0 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678064-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 16.8" "Group enriched" "Detected in some" 118 "Early spermatids: 245.8;Late spermatids: 157.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 245.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PXYLP1 "ACPL2, FLJ23751" ENSG00000155893 "2-phosphoxylose phosphatase 1" Q8TE99 3 141228726-141367753 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 149.5" "Cell type enhanced" "Detected in many" "Early spermatids: 196.8;Late spermatids: 131.1;Spermatocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017243 Uncertain "Intracellular and membrane" NA NA "HPA017243: AB_1844509" "unprognostic (9.55e-2)" "unprognostic (3.48e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (8.45e-2)" "unprognostic (8.04e-3)" "unprognostic (4.05e-3)" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (6.95e-2)" "unprognostic (5.07e-3)" "unprognostic (4.67e-2)" "unprognostic (1.29e-2)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (8.56e-2)" "unprognostic (8.17e-3)" 4.3 6.3 6.1 4.3 7.1 5.1 8.4 2.5 14.9 7.4 0.7 5.5 5.6 8.8 149.5 2.7 6.5 8.3 13.9 6.4 13.0 7.5 5.1 4.9 9.2 3.1 3.8 6.0 8.7 9.3 16.3 7.5 18.3 2.5 10.2 5.7 18.4 6.7 29.2 2.9 4.6 6.5 7.2 3.6 5.3 5.0 9.0 3.3 53.8 5.9 2.0 10.0 7.0 4.7 7.1 5.3 5.5 23.3 18.5 9.0 7.7 5.6 3.6 9.0 9.1 12.5 9.2 1.8 0.3 4.9 8.2 1.9 1.2 24.7 2.3 8.7 17.4 16.3 1.9 7.5 7.4 19.2 4.8 1.0 7.3 10.4 2.8 1.0 11.3 0.6 17.8 0.9 2.1 4.1 4.5 25.8 6.0 9.7 13.2 3.1 3.5 13.6 3.2 6.5 22.8 10.1 17.8 9.3 2.9 7.6 4.2 9.7 2.8 1.1 11.6 6.9 8.0 3.5 4.9 0.4 0.7 10.7 6.5 10.4 15.2 6.0 9.4 13.4 4.0 8.6 0.7 7.5 8.9 5.3 0.5 21.6 17.6 3.8 19.3 2.0 1.9 4.3 8.9 6.1 7.1 2.5 14.9 6.4 13.0 3.1 3.8 6.0 2.5 3.6 3.3 7.1 1.1 9.6 8.7 14.0 2.2 0.0 4.6 0.0 6.2 3.3 9.5 6.7 7.6 2.8 1.8 46.0 6.2 2.1 3.4 2.1 0.0 3.2 196.8 1.0 9.3 1.4 4.2 4.4 41.3 3.7 8.2 7.9 1.1 1.8 2.5 5.4 1.4 3.8 0.7 6.7 31.8 3.9 0.0 1.8 0.0 131.1 20.2 2.0 0.0 1.0 3.5 8.0 3.1 32.6 6.5 3.0 8.6 15.1 2.7 7.6 4.2 11.7 2.9 5.2 13.1 6.6 4.2 95.9 13.8 2.2 0.0 1.1 4.9 0.9 4.7 6.6 ADCY8 "AC8, ADCY3, HBAC1" ENSG00000155897 "Adenylate cyclase 8" P40145 8 130780301-131040909 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 30.3;epididymis: 23.0" "Group enriched" "Detected in some" 5 "Astrocytes: 151.8;Inhibitory neurons: 250.9;Oligodendrocyte precursor cells: 138.7" "Group enriched" "Detected in some" 5 "glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;GAMG: 8.2;U-138 MG: 17.6;U-87 MG: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018652, HPA024291" Supported NA NA "CAB018652: AB_633654, HPA024291: AB_1844597" "unprognostic (5.59e-3)" "unprognostic (3.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "unprognostic (8.22e-3)" "unprognostic (4.91e-2)" "unprognostic (7.39e-3)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" "unprognostic (6.67e-2)" 0.0 0.0 15.5 0.0 13.6 0.0 0.5 22.3 9.8 0.4 1.6 0.0 0.0 0.0 23.0 0.0 3.9 0.0 0.0 11.3 13.0 0.2 0.0 1.2 0.0 17.1 19.6 8.1 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 3.1 1.1 1.4 0.1 2.0 0.0 0.5 23.4 0.0 0.1 0.5 30.3 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.1 1.3 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.6 0.4 0.0 0.0 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 13.6 22.3 9.8 11.3 13.0 17.1 19.6 8.1 16.8 23.4 30.3 24.2 0.0 0.0 1.5 151.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 250.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.1 0.0 138.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RASA2 GAP1M ENSG00000155903 "RAS p21 protein activator 2" Q15283 3 141487027-141615344 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035374, HPA035375" Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA035374: AB_10602122, HPA035375: AB_2674596" "unprognostic (1.85e-1)" "unprognostic (8.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.36e-3)" "unprognostic (9.62e-3)" "unprognostic (2.57e-1)" "unprognostic (1.38e-1)" "unprognostic (9.21e-2)" "unprognostic (4.23e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (7.62e-7)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.34e-5)" 7.2 4.8 5.1 15.5 6.8 22.1 10.1 7.7 6.8 9.4 4.8 6.5 5.3 8.5 7.4 7.3 7.8 6.7 4.4 5.8 5.7 5.4 5.2 9.8 21.5 5.4 4.8 5.9 9.8 5.3 4.4 6.2 8.3 5.5 6.5 7.3 14.8 8.2 5.0 3.8 11.3 8.6 6.1 3.5 12.5 5.4 4.7 5.2 13.4 6.1 3.4 17.4 8.9 8.9 6.5 24.6 4.5 9.5 7.2 10.2 12.6 13.5 17.4 34.0 11.0 13.5 10.5 7.9 15.6 11.7 15.2 10.6 10.0 6.8 7.5 20.0 8.5 6.7 8.4 3.8 3.8 5.4 16.1 21.0 7.3 6.6 10.0 11.8 13.3 14.1 13.1 7.7 19.7 11.0 3.6 21.2 13.0 11.1 8.1 3.2 7.9 16.0 19.5 10.9 8.7 3.3 6.9 13.8 12.1 13.0 9.8 6.0 12.0 11.9 12.9 5.9 18.1 7.8 31.9 10.0 20.9 11.3 10.8 6.4 12.8 4.9 5.3 14.8 5.0 14.8 8.9 13.2 15.3 4.6 13.5 21.6 17.2 19.2 15.7 8.9 3.6 13.2 8.0 5.1 6.8 7.7 6.8 5.8 5.7 5.4 4.8 5.9 5.5 3.5 5.2 6.5 24.2 44.8 23.6 59.4 55.1 21.5 52.0 15.8 21.1 16.2 22.0 17.5 7.4 8.6 21.4 12.9 37.5 20.0 104.9 21.7 1.9 16.8 120.3 26.3 19.7 22.7 15.7 17.5 196.9 16.5 6.6 20.4 11.2 60.7 31.6 29.6 20.3 9.6 12.5 30.3 123.1 15.2 8.2 32.5 24.6 12.7 13.7 34.3 12.4 94.6 19.8 15.3 68.0 112.1 94.4 31.8 21.7 14.3 94.9 53.4 10.4 9.1 15.5 50.7 6.6 26.4 27.2 28.2 15.3 17.5 27.4 13.1 88.3 4.6 18.7 62.5 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452158 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria NA NA Mitochondria "HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 11.9 14.0 7.9 6.5 8.3 4.4 13.8 7.9 9.0 10.0 8.3 10.4 13.5 9.0 11.9 7.5 12.0 8.1 12.3 7.9 9.0 37.3 30.7 7.5 9.3 8.4 8.2 7.8 14.8 9.6 8.9 6.4 9.7 8.7 6.9 11.4 7.2 7.2 7.7 11.0 7.7 12.2 7.5 8.2 7.4 8.1 9.2 8.4 8.1 18.8 10.1 10.2 9.3 8.2 8.0 16.0 7.2 15.1 32.3 20.6 46.7 21.3 24.6 23.4 18.6 25.4 21.5 11.7 14.9 17.4 16.1 23.1 13.5 29.3 14.9 32.1 17.7 23.8 24.1 11.0 44.5 43.4 53.9 7.2 33.4 19.5 26.9 39.7 22.8 25.0 22.6 26.3 11.5 29.0 54.1 18.6 18.1 11.1 16.8 14.3 21.0 19.7 18.2 26.7 7.2 26.1 25.5 17.9 22.2 29.5 18.6 36.6 34.8 13.8 14.6 19.0 30.6 20.0 12.1 17.5 17.6 36.7 42.3 17.5 1.9 5.6 7.1 6.4 8.2 10.4 11.6 7.6 9.1 7.0 8.9 10.1 9.3 2.8 13.3 13.3 3.2 11.8 4.5 7.9 8.3 7.9 9.0 7.9 9.0 8.4 8.2 7.8 8.7 8.2 8.4 8.0 11.6 0.0 11.2 12.1 6.9 3.8 6.4 10.2 9.1 8.9 15.4 13.7 11.9 5.7 11.9 12.9 12.5 27.0 7.4 7.6 17.6 15.6 9.4 10.9 18.4 7.8 3.0 8.0 22.4 10.7 21.7 8.8 4.1 12.4 9.5 25.0 10.8 16.7 13.7 5.0 20.6 9.7 6.1 12.5 5.7 6.4 6.8 9.8 3.6 8.4 12.3 7.7 10.3 15.6 21.7 9.9 11.2 6.4 5.8 3.6 33.8 45.1 9.3 6.9 0.0 6.7 14.9 13.0 16.8 8.3 2.7 16.8 8.4 27.3 15.3 5.3 RAET1L ENSG00000155918 "Retinoic acid early transcript 1L" Q5VY80 6 150018334-150025532 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 58.5;vagina: 17.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.4;Basal prostatic cells: 11.3;Basal respiratory cells: 6.4;Prostatic glandular cells: 7.1;Squamous epithelial cells: 7.2;Suprabasal keratinocytes: 17.0;Urothelial cells: 8.1" "Group enriched" "Detected in many" 4 "cervical cancer: 4.8;head and neck cancer: 10.1;lung cancer: 4.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 14.3" HPA066741 Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA066741: " "unprognostic (1.80e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (1.84e-1)" "unprognostic (4.24e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (8.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (7.48e-2)" "unprognostic (1.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.29e-1)" "unprognostic (5.14e-2)" "unprognostic (7.43e-3)" 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.3 0.3 17.4 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.2 0.0 0.7 14.3 0.3 0.4 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 2.6 0.7 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 11.3 6.4 1.2 0.0 0.4 0.3 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.8 0.5 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.1 0.0 0.2 0.9 0.0 0.0 0.0 0.4 0.0 0.1 7.2 17.0 0.0 0.0 0.0 0.1 8.1 SLA "hSLAP, SLA1, SLAP, SLAP-1" ENSG00000155926 "Src like adaptor" Q13239 8 133036728-133102912 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 98.4;lymphoid tissue: 158.0" "Cell type enhanced" "Detected in many" "dendritic cells: 224.2;Hofbauer cells: 67.4;Kupffer cells: 199.4;Macrophages: 154.2;NK-cells: 109.2;Plasma cells: 83.0;T-cells: 160.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 47.9;JURKAT: 201.5;Karpas-707: 129.2;MOLT-4: 35.8;U-266/84: 76.1;U-937: 55.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012296, HPA074192" Enhanced Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA012296: AB_1856946, HPA074192: AB_2686673" "unprognostic (1.19e-2)" "unprognostic (6.29e-3)" "unprognostic (2.73e-3)" "unprognostic (6.07e-3)" "unprognostic (1.66e-2)" "unprognostic (1.10e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (9.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.66e-1)" "unprognostic (3.05e-2)" "unprognostic (8.60e-2)" "unprognostic (1.65e-1)" 25.4 13.2 9.4 83.6 6.9 98.4 9.6 6.3 9.9 11.2 9.3 10.9 8.0 5.3 3.0 9.5 7.0 21.1 4.4 8.0 13.4 6.4 17.0 26.1 79.2 11.8 7.8 5.6 3.0 5.8 3.1 3.1 15.3 9.4 5.3 8.5 1.3 4.7 3.6 1.5 4.0 20.9 12.6 9.4 70.9 12.6 1.4 13.0 158.0 27.8 4.4 71.6 22.2 4.2 11.9 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.9 0.1 2.3 0.0 0.0 0.0 6.3 47.9 0.8 0.0 0.6 0.0 0.2 0.0 201.5 0.1 129.2 0.0 0.0 35.8 9.3 0.0 0.0 0.0 0.2 0.3 7.8 0.0 0.0 0.0 1.0 0.0 0.1 0.1 3.1 0.0 15.3 0.0 0.1 0.3 0.2 0.1 6.9 76.1 0.0 0.6 55.6 0.0 0.7 110.2 203.6 87.6 123.1 110.1 41.0 79.7 88.2 79.8 48.3 75.3 77.4 262.3 132.6 148.4 6.3 124.4 158.9 9.4 6.9 6.3 9.9 8.0 13.4 11.8 7.8 5.6 9.4 9.4 13.0 11.9 2.4 9.6 19.1 0.7 36.6 2.2 0.3 0.0 0.0 9.7 0.9 1.3 3.3 1.5 10.5 0.0 0.0 0.4 224.2 0.2 0.0 0.2 0.2 0.7 0.7 5.9 0.0 13.2 1.0 0.0 1.2 4.5 3.6 0.5 37.2 1.7 8.9 2.9 67.4 0.0 1.3 0.5 0.0 199.4 15.0 1.0 0.3 154.2 5.4 14.0 36.7 0.1 109.2 0.0 0.1 0.0 0.0 0.0 83.0 0.1 0.0 0.3 5.1 0.3 6.6 1.4 1.9 0.0 0.1 0.3 2.7 0.1 160.0 0.1 0.1 0.2 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA077642: AB_2686849" "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 80.4 89.4 26.6 76.0 32.8 62.1 82.2 33.0 30.0 67.9 44.3 91.3 60.0 61.6 69.2 63.2 66.3 70.8 71.4 26.3 42.7 94.8 110.6 77.4 75.1 37.0 31.5 22.9 57.2 104.4 105.6 40.4 74.8 37.2 73.4 70.9 40.0 90.1 74.4 47.2 52.6 70.3 59.0 34.6 75.0 94.2 85.9 31.8 63.7 98.8 62.1 56.5 80.7 43.2 40.7 49.1 62.4 39.7 72.8 131.4 122.7 41.9 74.4 129.1 56.7 45.8 32.8 78.7 45.6 86.3 105.2 42.6 78.9 20.1 65.7 36.6 74.5 27.3 87.7 30.0 38.6 66.6 106.9 109.2 86.9 92.8 27.7 31.1 79.0 87.2 51.8 65.9 160.3 94.3 79.5 41.1 37.5 47.4 76.1 63.3 21.5 26.5 50.8 126.8 80.3 20.1 47.6 84.5 154.5 102.3 34.2 146.3 146.7 106.0 69.1 25.9 50.5 44.8 82.7 48.5 32.2 94.8 103.7 84.1 420.7 372.7 371.6 136.0 381.4 137.9 205.9 139.7 139.4 256.2 196.6 157.9 139.1 662.3 135.3 434.3 171.7 159.8 483.9 26.6 32.8 33.0 30.0 26.3 42.7 37.0 31.5 22.9 37.2 34.6 31.8 40.7 232.8 150.6 147.2 34.0 131.3 0.0 64.1 0.0 84.2 47.8 202.2 152.1 37.0 0.0 66.2 244.6 45.9 137.0 128.2 191.4 103.7 213.8 330.6 116.2 96.4 114.5 74.7 32.0 15.8 338.1 116.9 140.7 85.1 105.8 179.0 72.7 0.0 0.0 210.7 45.4 25.2 172.4 0.0 0.0 0.0 143.8 104.4 193.2 0.0 62.8 205.5 114.1 123.6 42.7 77.0 202.9 176.9 91.0 126.8 87.9 128.9 214.5 99.1 65.9 59.2 67.8 75.7 391.0 40.8 112.5 0.0 130.8 99.3 142.7 182.2 62.8 VBP1 "PFD3, PFDN3" ENSG00000155959 "VHL binding protein 1" P61758 X 155197007-155239841 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006260, HPA023230" Approved Supported Vesicles,Cytosol NA NA 15000 Cytosol Vesicles "CAB006260: AB_425740, HPA023230: AB_1858727" "unprognostic (1.55e-3)" "unprognostic (1.12e-3)" "unprognostic (3.35e-1)" "unprognostic (1.35e-2)" "unprognostic (3.78e-2)" "unprognostic (1.85e-3)" "unprognostic (5.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (9.80e-2)" "unprognostic (1.15e-1)" "unprognostic (5.76e-2)" "unprognostic (3.76e-2)" "unprognostic (4.54e-2)" "unprognostic (9.30e-2)" "unprognostic (3.80e-1)" 32.4 32.8 53.8 29.7 55.2 51.0 31.9 59.1 60.9 24.4 49.0 30.3 23.2 25.5 26.8 31.3 23.8 21.3 66.3 54.6 58.9 40.8 31.4 23.5 41.7 58.1 58.2 52.2 25.7 19.9 38.5 30.0 30.5 58.5 31.2 33.3 48.6 20.8 25.7 102.5 19.5 24.5 29.1 60.9 25.1 22.8 16.0 56.5 46.3 31.8 122.3 40.7 32.5 20.0 66.4 162.8 57.6 122.1 81.1 49.6 68.0 35.2 78.8 60.7 99.7 155.3 69.1 80.8 207.1 163.6 66.8 154.1 62.4 179.3 74.0 129.5 110.0 123.9 87.6 86.0 54.2 58.9 142.6 65.5 51.0 84.7 84.7 105.6 53.1 93.7 101.0 173.4 119.9 113.6 67.7 134.3 120.9 71.0 149.1 122.1 114.0 97.0 121.4 86.8 73.0 132.0 80.0 54.1 62.7 90.1 83.4 53.8 107.5 55.6 80.5 100.0 138.3 198.0 133.9 209.0 361.3 71.6 173.1 101.0 22.5 23.0 75.8 26.3 25.1 30.2 28.6 30.5 31.7 36.2 23.7 34.5 37.5 26.3 28.2 21.9 29.5 43.2 33.0 53.8 55.2 59.1 60.9 54.6 58.9 58.1 58.2 52.2 58.5 60.9 56.5 66.4 40.7 51.3 29.1 12.1 55.1 57.4 81.2 89.9 33.6 54.9 33.2 30.2 80.5 30.0 48.0 38.6 20.9 73.7 60.4 27.9 191.7 65.8 2.5 32.8 41.3 47.3 23.4 128.6 12.7 57.6 101.4 52.6 28.5 28.9 47.5 36.6 30.7 24.9 67.6 32.0 14.2 30.0 75.3 29.5 64.4 4.6 42.0 40.7 46.2 6.5 80.1 78.7 47.4 6.6 21.3 52.7 43.1 39.9 56.8 78.0 29.3 126.3 37.2 46.3 46.0 45.1 52.8 80.7 88.2 37.1 52.6 68.7 60.0 81.6 45.9 63.0 RAB39B "MRX72, WSN" ENSG00000155961 "RAB39B, member RAS oncogene family" Q96DA2 X 155258235-155264491 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Autism spectrum disorder, Disease variant, Mental retardation, Parkinson disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;retina: 10.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 11.8;Horizontal cells: 10.1;Inhibitory neurons: 9.8;Muller glia cells: 11.6;Oligodendrocytes: 10.3" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.8;Karpas-707: 35.6;U-266/70: 35.5;U-266/84: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001114, HPA042505" Approved NA NA "HPA001114: AB_1079732, HPA042505: AB_2678030" "prognostic favorable (8.95e-4)" "unprognostic (1.20e-3)" "unprognostic (3.52e-2)" "unprognostic (7.10e-5)" "unprognostic (1.77e-1)" "unprognostic (7.47e-4)" "unprognostic (2.19e-1)" "unprognostic (6.00e-4)" "unprognostic (1.78e-1)" "unprognostic (5.64e-2)" "unprognostic (3.87e-4)" "unprognostic (5.41e-2)" "unprognostic (1.72e-1)" "unprognostic (7.21e-2)" "unprognostic (4.94e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" 0.2 1.9 7.1 2.9 8.0 0.9 0.7 8.2 10.2 0.4 4.2 0.7 0.6 0.3 6.4 0.3 0.5 0.6 0.3 8.4 8.4 0.7 0.3 0.6 5.3 7.7 7.8 7.7 0.4 2.5 3.8 6.6 0.2 8.7 1.9 0.6 10.0 0.4 1.3 0.0 0.0 1.2 0.2 7.5 3.1 1.4 0.9 8.9 5.4 2.5 0.0 5.9 0.8 0.1 9.9 0.0 0.4 5.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 27.8 1.2 0.1 14.9 0.0 0.0 0.2 0.1 11.8 0.5 2.3 0.0 0.0 1.7 0.0 4.8 0.1 0.0 0.4 7.8 0.9 0.0 10.3 0.0 35.6 0.1 2.1 10.3 0.0 6.9 0.0 0.6 0.0 0.0 2.3 0.0 0.0 13.4 10.3 0.0 0.0 6.4 1.8 0.4 0.2 0.0 0.7 2.2 0.0 1.1 35.5 26.7 6.2 6.2 0.0 0.0 0.8 0.3 2.2 4.6 0.2 4.7 4.2 6.0 6.0 4.6 2.8 6.1 6.9 2.7 3.3 0.4 1.1 4.8 3.2 7.1 8.0 8.2 10.2 8.4 8.4 7.7 7.8 7.7 8.7 7.5 8.9 9.9 0.9 0.0 0.0 2.6 7.9 0.5 0.5 0.0 0.0 11.8 0.6 0.9 2.4 0.0 0.0 1.8 8.4 0.0 7.6 0.0 0.0 0.2 0.2 0.0 0.7 0.8 1.8 3.0 7.7 0.9 0.0 0.7 1.1 0.1 0.0 2.6 1.8 0.0 0.1 10.1 9.8 0.0 0.0 0.3 3.1 0.0 0.0 1.5 3.6 1.0 2.2 11.6 6.2 8.0 10.3 0.4 0.0 1.9 9.2 0.6 0.0 0.9 0.0 8.0 0.0 0.1 2.4 0.4 0.8 0.0 0.1 0.0 9.1 8.2 0.0 0.0 CLIC2 "CLCNL2, XAP121" ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 18.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2" "Group enriched" "Detected in many" 16 "dendritic cells: 47.9;monocytes: 18.6" "Group enriched" "Detected in some" 5 "HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 150000 "Plasma membrane, Cytosol" Nucleoplasm "HPA047381: AB_2680022, HPA060101: AB_2684204" "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 23.3 7.2 7.1 16.8 7.2 9.8 16.8 6.7 14.9 20.2 10.1 11.0 8.7 22.8 7.9 9.5 12.7 19.2 14.7 8.4 7.9 5.9 12.9 30.8 30.4 7.5 6.9 5.9 21.8 3.5 4.6 4.5 9.4 7.3 4.6 13.8 2.5 6.3 6.4 4.5 5.9 10.4 17.9 7.6 50.5 8.6 3.3 8.4 14.6 32.1 14.5 25.8 16.1 10.8 7.7 0.7 0.0 1.0 0.9 1.0 4.7 0.0 0.2 2.8 0.0 0.4 0.0 0.2 0.1 0.4 0.0 0.2 0.1 0.3 0.0 0.0 103.3 0.5 16.4 0.3 0.0 0.0 0.4 0.6 1.4 0.0 0.0 0.1 0.5 0.1 0.5 60.4 53.4 0.3 0.2 0.1 1.3 0.2 0.1 0.4 0.4 0.0 92.2 0.2 0.2 0.7 0.9 0.0 0.1 0.4 0.2 0.0 1.0 0.0 5.3 1.6 2.0 0.9 3.3 4.6 0.0 2.7 2.6 1.7 0.0 3.5 0.2 0.0 18.6 0.3 0.0 0.1 0.1 47.9 0.0 0.0 0.0 1.4 2.0 14.2 5.2 0.0 2.1 7.1 7.2 6.7 14.9 8.4 7.9 7.5 6.9 5.9 7.3 7.6 8.4 7.7 51.2 89.8 54.9 3.9 1.1 13.3 0.8 0.2 2.2 1.2 0.7 1.3 3.2 0.0 5.8 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.5 11.3 60.4 1.2 70.7 8.6 0.2 0.1 25.6 0.5 0.4 3.8 0.5 27.1 1.2 4.7 0.0 7.0 0.6 0.0 73.5 135.0 1.1 13.7 34.5 17.8 8.4 71.4 0.2 0.0 3.0 2.4 0.1 0.0 9.4 2.0 0.5 0.0 0.6 1.5 0.3 6.6 2.5 4.6 0.3 0.3 0.4 13.8 0.0 2.6 5.2 0.1 1.9 AFF2 "FMR2, FRAXE" ENSG00000155966 "AF4/FMR2 family member 2" P51816 X 148500617-149000663 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.1;brain: 21.9;epididymis: 12.0;placenta: 14.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 22.9;Excitatory neurons: 29.7;Granulosa cells: 24.6;Inhibitory neurons: 140.2;Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 1.0;neutrophil: 1.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 74.2;HL-60: 31.7;U-698: 106.4;U-937: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003139 Approved NA NA "HPA003139: AB_1078107" "unprognostic (5.68e-2)" "unprognostic (1.96e-1)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (1.88e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (5.00e-2)" "unprognostic (5.37e-2)" "unprognostic (1.59e-1)" "unprognostic (1.08e-2)" "unprognostic (5.31e-2)" "unprognostic (6.80e-2)" "unprognostic (9.78e-5)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (9.34e-2)" 0.8 0.2 7.5 1.6 6.1 12.1 0.5 18.6 20.4 3.5 0.0 0.2 0.0 0.5 12.0 0.2 0.1 2.2 0.3 21.9 7.0 0.2 0.1 2.0 5.5 6.2 4.6 2.1 0.9 0.1 0.0 3.6 14.8 3.5 0.6 0.1 8.3 0.3 1.5 0.0 0.5 0.1 0.1 2.8 0.4 0.1 2.1 7.5 5.4 0.5 0.0 6.3 0.3 0.2 3.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 74.2 0.1 4.3 0.0 0.0 9.9 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 31.7 0.9 0.3 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 2.2 0.0 4.2 9.6 2.7 0.0 0.0 7.9 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.1 0.0 1.3 4.1 0.0 0.9 0.0 3.4 0.4 0.3 106.4 0.0 22.9 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 7.5 6.1 18.6 20.4 21.9 7.0 6.2 4.6 2.1 3.5 2.8 7.5 3.0 0.2 0.0 0.0 2.3 0.1 0.4 0.0 0.1 0.0 4.7 0.0 0.3 1.5 0.0 0.0 0.0 22.9 0.2 0.0 0.0 0.0 0.5 8.9 1.8 0.3 0.1 0.0 2.5 29.7 0.0 0.2 1.0 0.0 3.4 5.7 24.6 0.0 0.0 0.1 1.7 140.2 0.0 0.0 0.0 0.8 6.4 7.8 0.3 0.0 4.7 0.8 1.3 0.0 38.2 3.3 0.0 0.0 17.7 0.6 0.2 0.0 0.6 0.0 15.3 6.6 0.1 1.4 0.3 0.2 0.0 0.0 0.3 0.2 2.0 0.0 0.0 MICU3 "DKFZp313A0139, EFHA2" ENSG00000155970 "Mitochondrial calcium uptake family member 3" Q86XE3 8 17027238-17122642 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 82.9;Excitatory neurons: 161.4;Inhibitory neurons: 167.3;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 141.9;Rod photoreceptor cells: 82.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.7;HBF TERT88: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024771, HPA024779" Uncertain NA NA "HPA024771: AB_1848022, HPA024779: AB_1848023" "unprognostic (2.99e-2)" "unprognostic (7.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.80e-2)" "unprognostic (1.19e-1)" "unprognostic (7.49e-2)" "unprognostic (2.25e-2)" "unprognostic (9.01e-5)" "unprognostic (9.82e-2)" "unprognostic (2.80e-1)" "unprognostic (1.11e-3)" "unprognostic (8.45e-2)" "unprognostic (2.32e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (4.65e-2)" 6.4 7.6 9.7 1.5 14.3 0.6 4.5 26.9 22.1 6.3 2.3 2.9 1.0 6.8 4.2 3.0 4.6 3.7 4.5 13.1 12.6 4.5 10.4 3.4 2.6 10.0 10.1 12.0 8.2 3.0 7.8 8.3 6.7 10.7 5.9 1.9 15.0 3.2 4.5 3.7 1.6 2.1 4.8 7.8 4.6 2.6 5.4 12.0 1.4 5.0 6.6 1.9 4.9 4.3 14.9 0.0 1.2 6.0 2.3 4.5 6.7 1.5 9.0 12.7 6.8 5.5 0.0 0.2 0.2 1.8 4.7 4.8 0.0 2.7 1.8 12.7 0.0 1.6 0.0 0.0 2.2 7.8 0.0 0.3 5.1 0.0 5.7 5.7 6.3 2.6 4.6 0.4 1.7 6.4 0.0 0.8 1.1 4.2 0.0 1.5 0.0 2.7 0.0 4.7 0.0 9.8 4.6 0.0 0.0 3.7 2.6 0.0 0.0 3.4 2.9 1.1 0.4 1.6 1.7 1.4 3.1 5.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 9.7 14.3 26.9 22.1 13.1 12.6 10.0 10.1 12.0 10.7 7.8 12.0 14.9 18.2 6.4 6.0 68.9 12.3 0.9 8.1 0.4 12.0 82.9 5.8 12.7 15.5 10.0 2.0 5.5 41.7 1.8 2.9 0.0 7.9 5.4 6.8 0.9 30.2 10.0 0.0 4.2 161.4 2.9 1.2 19.0 2.6 1.0 8.2 14.3 7.1 14.1 0.6 74.0 167.3 0.0 0.0 2.2 1.5 7.2 27.4 2.7 1.8 68.4 1.6 24.0 3.1 96.5 141.9 2.8 0.0 24.0 0.9 5.6 0.0 3.9 1.7 82.2 39.5 14.9 40.1 23.7 11.8 3.1 1.6 7.3 4.6 34.1 0.0 2.7 GRIP1 ENSG00000155974 "Glutamate receptor interacting protein 1" Q9Y3R0 12 66347431-67069162 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 16.5" "Cell type enriched" "Detected in many" 7 "Inhibitory neurons: 2829.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "myeloid DC: 4.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 4.9" "Cell line enhanced" "Detected in many" "BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038856 Uncertain NA NA "HPA038856: AB_10673297" "unprognostic (6.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.52e-2)" "unprognostic (8.25e-2)" "unprognostic (1.50e-1)" "unprognostic (5.12e-2)" "unprognostic (2.42e-1)" "unprognostic (4.21e-3)" "unprognostic (4.25e-1)" "unprognostic (1.60e-2)" "unprognostic (1.00e-2)" "unprognostic (4.14e-1)" "unprognostic (2.82e-3)" "unprognostic (7.44e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" "unprognostic (8.57e-3)" 0.3 4.4 4.1 2.7 6.6 0.5 3.0 0.0 14.4 1.2 0.0 2.5 1.1 3.6 4.8 7.4 4.3 1.6 2.7 4.6 7.9 3.4 0.3 0.8 0.7 0.6 4.7 4.5 1.2 2.0 16.5 3.3 8.3 1.2 4.6 1.7 4.8 6.1 9.4 1.0 9.9 1.9 2.9 0.0 2.6 0.8 6.2 2.9 0.7 5.1 0.6 1.3 2.6 2.0 3.2 11.1 10.1 17.7 2.1 0.0 0.0 44.4 3.2 0.0 5.4 2.5 0.3 3.3 1.4 4.2 0.0 9.5 48.7 4.9 3.3 2.4 0.0 12.0 0.0 0.1 0.3 0.0 1.2 0.1 0.0 8.0 0.0 0.8 8.3 0.0 8.0 0.0 0.1 0.0 4.0 0.4 0.4 16.1 1.4 3.6 30.7 0.1 0.6 5.6 31.0 10.8 1.4 14.8 7.1 1.4 11.3 8.7 1.8 0.0 0.0 12.7 0.1 9.0 1.5 0.3 1.0 12.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.1 0.1 0.2 0.0 1.0 0.0 0.3 0.0 0.1 4.1 6.6 0.0 14.4 4.6 7.9 0.6 4.7 4.5 1.2 0.0 2.9 3.2 0.1 0.0 1.1 74.7 0.1 13.3 2.3 2.9 2.2 5.5 4.1 2.4 3.4 1.5 1.7 7.3 0.0 7.8 0.7 0.3 0.0 2.2 38.5 8.1 2.2 0.4 1.8 0.0 390.2 1.5 4.3 1.1 0.0 13.7 0.0 2.3 0.0 0.0 1.0 47.1 2829.7 0.7 0.0 2.4 1.6 34.0 0.6 2.1 7.2 20.6 1.0 0.5 0.0 158.3 44.4 1.9 0.5 0.7 0.1 3.8 0.2 0.4 1.1 1.8 0.0 1.0 0.6 0.3 1.2 2.3 17.8 16.6 0.8 1.2 0.7 3.1 VPS37A "FLJ32642, HCRP1, PQBP2, SPG53" ENSG00000155975 "VPS37A subunit of ESCRT-I" Q8NEZ2 8 17246931-17302427 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024705, HPA024781" Supported Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA024705: AB_10601776, HPA024781: AB_10602100" "unprognostic (8.28e-2)" "unprognostic (1.84e-1)" "unprognostic (9.39e-3)" "unprognostic (3.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.31e-2)" "unprognostic (5.88e-3)" "unprognostic (2.28e-2)" "unprognostic (1.43e-1)" "unprognostic (3.17e-1)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (2.18e-1)" 19.1 19.5 13.0 15.0 16.3 15.6 18.6 29.3 17.6 21.3 6.3 15.4 21.1 19.6 14.4 20.4 13.9 17.0 36.6 11.6 12.2 25.3 28.0 16.4 14.4 12.3 14.0 10.5 18.6 17.6 34.0 12.5 29.9 15.9 20.3 17.4 55.4 12.6 23.4 39.7 14.6 17.6 24.6 11.9 12.4 14.6 32.6 13.5 17.7 19.1 31.5 15.3 25.3 15.1 17.9 17.2 27.3 24.0 21.7 51.8 41.5 25.8 60.8 50.2 53.9 45.9 17.6 16.2 14.6 31.6 48.7 50.1 16.7 27.2 26.4 63.8 15.1 7.8 26.5 13.7 20.2 59.7 11.3 25.1 39.7 50.2 50.4 51.5 38.0 38.7 22.7 20.2 36.8 57.7 11.7 32.0 26.9 23.4 38.2 14.2 15.4 26.5 17.6 45.8 23.4 27.1 14.4 23.8 23.9 37.9 47.1 15.6 22.2 33.4 33.1 16.7 47.6 32.0 12.0 25.0 17.2 37.5 19.9 33.8 34.0 17.2 16.5 13.9 13.1 17.1 10.5 13.4 13.6 13.4 10.8 12.0 14.8 17.6 24.5 12.4 11.8 13.3 14.1 13.0 16.3 29.3 17.6 11.6 12.2 12.3 14.0 10.5 15.9 11.9 13.5 17.9 31.8 16.0 15.6 19.6 21.2 39.5 32.7 33.1 18.8 26.4 19.3 13.5 40.7 14.3 25.8 7.3 58.4 36.1 20.5 15.8 37.2 29.3 93.2 20.9 29.0 24.6 18.0 26.1 32.4 15.5 59.2 27.0 15.8 28.4 9.5 16.8 24.3 23.1 44.6 21.9 30.7 16.6 30.5 17.5 22.7 39.6 25.7 25.3 21.4 20.6 22.4 25.8 15.5 24.1 34.0 31.2 13.1 25.9 21.5 50.6 27.8 48.8 18.8 60.2 26.3 21.5 36.6 111.6 43.4 22.5 37.8 113.0 22.7 17.1 14.6 52.6 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57546026-57586633 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 26 "brain: 1641.9;choroid plexus: 910.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 0.4 10.7 1130.4 4.7 1181.5 4.3 0.5 1001.1 1641.9 1.8 910.0 3.7 3.7 3.8 1.5 1.4 0.6 0.7 0.5 1194.0 1053.3 0.8 0.2 0.8 0.7 1074.0 1058.6 1130.1 0.6 2.6 9.1 21.5 0.1 1113.0 0.9 1.9 48.4 1.1 0.6 0.3 1.1 2.5 2.0 945.6 0.8 1.3 4.9 1000.5 0.1 2.3 0.1 0.4 0.5 1.6 1257.6 0.5 0.1 7.2 5.7 0.0 0.0 0.6 1.4 1.3 2.2 3.5 1.2 0.2 3.2 0.4 1.9 1.3 0.8 3.8 0.1 2.5 33.2 4.1 0.5 1.8 7.0 1.9 1.5 1.3 1.0 0.4 1.6 0.1 0.5 0.5 2.8 15.3 9.4 0.0 0.6 0.8 0.0 17.7 0.0 0.0 0.5 0.2 0.3 1.1 0.5 34.4 9.1 0.0 1.6 0.0 2.0 0.9 0.2 0.9 0.6 5.3 1.1 2.1 5.3 7.7 1.9 14.5 0.1 0.6 0.2 0.4 0.1 1.0 0.5 1.6 0.7 0.7 1.2 0.3 0.5 0.9 2.2 1.1 0.3 1.1 0.3 1.0 0.4 1130.4 1181.5 1001.1 1641.9 1194.0 1053.3 1074.0 1058.6 1130.1 1113.0 945.6 1000.5 1257.6 0.1 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.0 40.7 0.1 0.9 2.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 12.2 0.5 12.9 0.7 0.0 0.4 28.4 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.1 26.9 21.7 0.2 0.0 0.0 0.2 15.2 0.0 0.1 0.0 0.0 0.0 6.4 0.0 8.5 3.9 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.7 3.3 7.9 0.0 0.1 0.0 0.3 0.0 0.1 0.1 NAT2 AAC2 ENSG00000156006 "N-acetyltransferase 2" P11245 8 18391282-18401218 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 33.8;liver: 129.6" "Group enriched" "Detected in some" 4 "Distal enterocytes: 14.8;Hepatocytes: 59.0;Paneth cells: 15.9;Proximal enterocytes: 36.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.0;liver cancer: 4.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 1.0;RT4: 1.6;SCLC-21H: 2.2;SK-BR-3: 1.4" HPA043704 Uncertain NA NA "HPA043704: AB_2678625" "unprognostic (2.74e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.61e-5)" "unprognostic (1.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" "unprognostic (2.52e-2)" "unprognostic (2.67e-2)" "unprognostic (1.27e-1)" "unprognostic (1.33e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-3)" "unprognostic (1.02e-1)" "unprognostic (3.40e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" 0.1 0.1 0.2 1.6 0.2 0.0 1.1 0.2 0.6 0.6 0.1 15.1 33.8 0.9 0.7 0.1 0.2 0.2 0.2 0.1 0.4 1.9 129.6 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.6 0.3 0.4 13.4 0.0 0.0 0.5 0.0 0.0 25.8 1.6 0.1 1.3 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 1.0 1.6 2.2 0.0 0.0 1.4 0.0 0.1 0.3 0.2 0.5 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.1 0.4 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 1.0 0.0 14.8 5.9 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.4 59.0 0.2 0.0 0.0 7.4 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.9 2.6 0.0 0.0 36.0 0.8 0.3 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 4.4 0.1 0.8 6.7 0.1 MAGEA8 "CT1.8, MAGE8, MGC2182" ENSG00000156009 "MAGE family member A8" P43361 X 149881141-149885835 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 13.4" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 74.6;Extravillous trophoblasts: 35.2;Syncytiotrophoblasts: 77.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-2 OS: 33.8;U-266/70: 63.6" HPA003998 Enhanced NA NA "HPA003998: AB_10965020" "unprognostic (6.81e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.27e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-2)" "unprognostic (2.49e-2)" "unprognostic (5.07e-3)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 63.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.9 6.3 0.0 0.0 77.7 0.0 0.0 0.0 0.0 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527303-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.1" "Cell type enhanced" "Detected in many" "Astrocytes: 558.3;Early spermatids: 686.7;Excitatory neurons: 284.7;Oligodendrocyte precursor cells: 488.1;Oligodendrocytes: 584.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 53.8;hTERT-RPE1: 48.0;LHCN-M2: 47.3;U-87 MG: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Nucleoplasm, Vesicles" Cytosol "HPA002455: AB_2666597" "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favorable (7.55e-4)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.5 18.0 23.1 3.1 48.7 1.2 6.0 67.1 43.8 12.0 0.0 6.7 4.8 8.9 3.8 5.3 2.6 7.4 27.7 44.2 18.3 1.9 19.1 4.7 2.5 3.7 14.4 33.4 18.1 10.0 18.5 7.4 6.6 28.6 4.0 7.4 20.1 4.2 5.9 1.3 4.5 5.0 5.8 1.1 10.5 9.9 16.5 10.5 2.2 6.2 2.3 3.5 5.9 4.3 22.3 11.0 5.7 25.0 0.1 8.8 53.8 1.3 5.7 8.9 5.1 10.5 3.3 4.3 6.5 3.6 23.8 22.3 0.9 7.3 10.1 9.7 0.0 6.6 0.6 4.6 0.5 15.9 0.2 0.4 14.2 6.2 28.2 4.9 48.0 6.8 1.6 0.8 4.9 47.3 3.7 0.0 1.2 4.9 9.6 14.7 5.2 21.4 3.0 12.7 14.0 10.7 11.8 2.5 1.1 3.8 5.4 0.3 2.6 28.0 15.7 10.8 37.5 5.1 0.4 0.7 14.8 49.5 2.7 5.4 0.7 0.2 0.2 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.5 0.1 0.1 0.3 0.3 0.2 0.1 0.4 0.1 23.1 48.7 67.1 43.8 44.2 18.3 3.7 14.4 33.4 28.6 1.1 10.5 22.3 8.1 3.2 2.7 558.3 3.3 21.9 13.7 26.4 13.6 191.9 14.4 10.7 119.2 7.2 23.9 9.2 118.9 3.2 0.1 48.5 1.9 13.5 686.7 12.5 69.9 8.2 6.1 0.0 284.7 8.7 1.7 44.3 43.8 6.6 0.0 87.2 4.2 42.9 13.1 18.5 121.6 20.0 44.7 16.0 25.9 217.9 33.2 9.0 1.8 148.9 59.7 78.0 0.0 488.1 584.6 27.0 13.5 53.8 0.1 11.2 20.3 0.3 41.0 52.0 13.1 29.3 17.7 16.5 17.7 32.4 9.9 1.1 1.1 114.9 17.2 23.7 CARNMT1 "C9orf41, FLJ25795" ENSG00000156017 "Carnosine N-methyltransferase 1" Q8N4J0 9 74980790-75028423 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Early spermatids: 256.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 25.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026756 Uncertain NA NA "HPA026756: AB_1845824" "unprognostic (1.59e-1)" "unprognostic (1.02e-1)" "unprognostic (2.99e-2)" "unprognostic (4.81e-2)" "unprognostic (3.48e-1)" "unprognostic (1.56e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (3.94e-2)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (1.45e-2)" "unprognostic (3.00e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" 5.2 6.2 2.8 7.0 11.3 8.4 7.0 25.9 5.9 5.8 0.5 9.3 12.8 6.2 8.4 10.1 6.3 6.9 5.5 4.2 2.7 12.3 17.2 5.4 9.8 2.9 3.9 2.7 6.2 9.1 11.3 3.9 5.4 7.1 6.5 8.5 7.9 9.2 5.3 8.7 8.5 12.5 6.1 0.8 6.8 7.8 16.6 2.2 8.5 13.7 8.6 8.6 9.2 5.2 4.6 27.6 16.1 6.6 17.0 10.3 22.4 24.6 24.4 10.0 9.0 8.2 4.1 17.9 43.7 12.9 17.4 19.2 26.7 20.0 25.3 25.5 40.0 17.4 22.3 15.5 18.4 12.6 40.7 21.2 15.0 12.4 17.0 17.3 13.3 18.6 15.6 19.1 36.9 17.4 7.3 29.8 10.8 31.4 33.0 14.7 14.4 20.2 25.4 23.5 19.0 6.5 3.6 18.7 46.2 9.2 11.8 23.5 11.7 14.8 14.8 19.9 18.2 21.3 28.2 38.3 13.1 22.9 27.6 9.8 0.0 0.4 1.0 1.3 0.8 1.9 1.7 1.3 2.0 0.6 0.9 1.6 1.5 0.1 1.5 0.4 0.6 2.0 0.7 2.8 11.3 25.9 5.9 4.2 2.7 2.9 3.9 2.7 7.1 0.8 2.2 4.6 8.5 6.4 11.7 0.0 10.2 0.0 11.6 0.0 21.6 14.5 16.6 8.0 0.0 11.5 6.8 27.6 10.4 7.0 18.6 4.5 25.4 7.5 256.8 11.2 19.6 9.4 7.3 6.3 0.0 11.9 13.0 6.6 13.7 14.8 2.5 8.7 8.9 29.8 8.1 20.2 0.0 12.8 0.0 9.1 0.0 44.3 7.5 8.5 0.0 0.0 8.9 5.6 17.5 0.0 0.0 9.3 8.8 10.9 17.4 17.7 22.6 37.3 4.4 10.4 0.0 9.3 5.6 17.7 10.3 33.5 0.0 5.1 17.1 16.2 13.2 15.0 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 54.1" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria No No 17000 Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favorable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 5.8 3.8 3.1 7.4 2.6 20.1 5.8 10.5 5.0 8.4 6.1 28.9 28.1 9.0 3.1 14.3 10.9 12.8 7.9 4.7 3.5 10.7 7.0 10.3 5.0 3.5 3.5 2.6 5.0 5.6 10.0 1.9 12.9 5.4 5.8 31.1 2.3 6.8 5.7 42.2 6.8 24.7 13.6 3.4 5.0 43.6 4.3 3.4 5.8 6.4 54.1 7.8 15.1 5.1 3.2 41.7 66.1 16.8 12.2 25.0 28.0 17.1 25.0 35.5 24.5 26.0 39.6 38.6 17.7 19.6 30.8 13.3 36.9 22.2 29.8 32.5 19.5 20.8 22.1 23.5 22.1 19.5 56.0 17.9 28.7 24.9 22.0 46.6 38.4 29.8 18.5 14.0 12.9 23.0 24.3 15.2 12.0 18.5 45.2 13.6 15.7 35.8 4.7 32.7 22.4 17.8 7.9 30.8 34.1 7.5 20.2 6.8 14.5 24.3 11.8 19.9 25.7 16.9 9.4 12.8 12.1 15.8 27.5 9.2 1.8 6.7 18.6 3.0 7.3 3.1 3.5 2.9 3.6 5.8 1.7 2.3 2.6 8.8 2.2 8.9 2.0 5.2 4.2 3.1 2.6 10.5 5.0 4.7 3.5 3.5 3.5 2.6 5.4 3.4 3.4 3.2 13.7 35.3 17.0 21.2 4.2 11.7 14.4 8.9 10.8 3.0 5.9 3.9 6.6 8.6 22.0 18.4 2.1 7.3 4.8 38.2 1.9 11.1 14.5 23.3 9.9 9.7 8.4 10.8 58.2 25.2 10.1 7.2 68.3 26.4 8.2 3.4 8.9 5.8 6.7 0.0 65.6 28.2 12.2 6.0 2.9 7.2 5.3 6.7 8.8 37.5 5.7 5.4 2.1 72.4 40.3 40.7 15.6 4.1 5.7 9.7 19.8 8.6 22.6 3.9 13.1 6.8 12.1 5.1 5.2 6.2 12.4 9.3 5.0 12.7 24.5 26.8 MIDEAS "C14orf117, C14orf43, ELMSAN1, LSR68" ENSG00000156030 "Mitotic deacetylase associated SANT domain protein" Q6PJG2 14 73715122-73790285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HMC-1: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003111 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003111: AB_1078329" "unprognostic (1.54e-3)" "unprognostic (2.69e-1)" "unprognostic (2.83e-1)" "unprognostic (9.69e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.12e-1)" "unprognostic (8.55e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.02e-1)" "unprognostic (2.89e-1)" "unprognostic (3.36e-3)" "unprognostic (7.35e-2)" "unprognostic (2.44e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-1)" 9.1 5.1 3.7 9.3 4.0 14.6 6.7 3.4 3.4 5.8 0.5 7.2 7.7 7.4 1.3 9.4 6.7 9.3 6.7 2.2 15.9 3.1 4.7 6.9 9.4 4.7 1.9 1.0 11.4 5.9 9.8 2.6 8.8 4.4 5.8 4.0 2.9 7.9 5.9 10.2 11.6 8.8 6.6 0.2 13.8 7.6 5.4 9.9 5.8 6.2 5.9 5.6 5.7 6.3 6.1 12.8 14.1 5.0 9.4 4.6 7.8 9.6 5.1 8.7 7.0 6.3 12.5 14.8 18.5 5.6 7.0 7.3 19.3 8.3 14.5 2.8 24.6 5.1 29.7 12.8 4.5 7.4 5.2 61.9 10.4 8.8 6.1 7.6 6.1 11.2 6.4 15.5 16.7 3.4 29.7 12.0 8.3 1.6 6.4 11.7 13.8 27.0 4.9 10.4 13.5 6.4 5.3 19.3 26.4 10.3 2.8 20.3 10.8 22.6 14.3 16.3 10.8 5.6 13.0 6.7 20.4 11.7 6.3 17.0 0.6 0.5 0.2 0.3 0.2 0.4 0.4 0.1 0.3 0.6 0.7 0.2 0.2 0.8 0.5 0.3 1.2 0.4 0.4 3.7 4.0 3.4 3.4 2.2 15.9 4.7 1.9 1.0 4.4 0.2 9.9 6.1 59.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 41.3 15.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 32.5 9.4 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 29.4 3.6 0.0 0.0 0.0 CFAP70 "FLJ25765, TTC18" ENSG00000156042 "Cilia and flagella associated protein 70" Q5T0N1 10 73253759-73358859 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 20.8;testis: 21.0" "Cell type enhanced" "Detected in many" "Astrocytes: 68.6;Early spermatids: 61.9;Endometrial ciliated cells: 153.6;Respiratory ciliated cells: 179.3;Spermatocytes: 60.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037582, HPA070304" Enhanced NA NA "HPA037582: AB_2675560, HPA070304: AB_2732153" "unprognostic (2.29e-3)" "unprognostic (4.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.43e-2)" "unprognostic (2.41e-1)" "unprognostic (9.94e-2)" "unprognostic (2.81e-1)" "unprognostic (4.60e-2)" "unprognostic (2.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-3)" "unprognostic (5.95e-3)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" 1.4 4.5 7.6 0.5 4.5 0.3 3.2 5.9 4.9 2.2 20.8 0.6 1.2 1.7 11.4 0.6 14.9 1.4 1.3 4.7 9.3 3.9 2.3 3.1 0.7 9.2 9.3 3.7 3.2 2.9 4.7 13.6 0.5 7.9 4.3 0.6 10.6 2.3 1.9 0.9 2.9 0.7 0.5 9.4 1.4 1.3 21.0 5.4 0.6 6.4 0.6 0.8 0.9 1.1 6.4 1.1 1.3 1.4 1.2 2.4 2.1 0.4 0.5 0.1 0.3 0.4 1.0 4.6 0.5 0.7 0.2 0.9 0.7 0.8 1.0 0.5 1.0 2.3 1.0 1.0 1.1 0.2 0.5 0.6 1.3 2.3 0.7 0.6 1.7 0.0 3.1 0.4 2.9 0.4 1.8 1.3 1.0 0.5 1.1 5.4 0.8 1.2 2.4 2.3 0.3 1.9 0.2 0.4 0.9 0.9 0.8 1.8 0.8 0.8 0.3 1.2 0.5 1.3 3.0 1.8 1.5 1.7 1.0 0.4 0.0 0.0 0.4 0.3 0.1 0.7 0.5 0.6 0.5 0.2 0.8 1.3 1.1 0.1 0.5 0.1 0.4 0.6 0.2 7.6 4.5 5.9 4.9 4.7 9.3 9.2 9.3 3.7 7.9 9.4 5.4 6.4 2.0 9.6 8.4 68.6 2.2 0.0 3.6 0.0 2.8 15.3 6.7 3.9 2.1 1.5 36.5 5.5 29.2 1.4 0.3 0.3 3.9 1.9 61.9 153.6 3.3 1.8 4.9 0.4 29.5 0.6 0.2 3.2 3.1 7.4 2.5 3.2 4.6 2.6 0.5 6.7 37.6 0.5 0.0 0.3 0.0 39.0 4.7 1.1 0.0 5.6 0.1 16.0 0.0 12.1 22.4 0.2 0.1 3.0 1.3 5.5 0.5 2.8 179.3 28.0 6.6 5.3 1.1 60.4 14.8 2.0 0.0 0.3 1.3 8.1 0.8 2.5 GNA14 ENSG00000156049 "G protein subunit alpha 14" O95837 9 77423079-77648322 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 219.1;Early spermatids: 50.2;Hepatic stellate cells: 61.4;Late spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 95 "basophil: 27.3" "Lineage enriched" "Detected in single" 95 "granulocytes: 27.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.3;HUVEC TERT2: 1.6;PC-3: 3.2;THP-1: 1.6;U-2197: 2.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048886 Approved NA NA "HPA048886: AB_2680544" "unprognostic (7.80e-3)" "unprognostic (1.10e-2)" "unprognostic (1.09e-2)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.53e-4)" "unprognostic (2.48e-6)" "unprognostic (6.35e-3)" "unprognostic (3.34e-1)" "unprognostic (9.04e-2)" "unprognostic (1.21e-1)" "unprognostic (2.43e-1)" "unprognostic (2.92e-2)" "unprognostic (1.04e-3)" "unprognostic (1.79e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-1)" 3.2 2.2 7.3 4.0 6.6 0.0 2.5 2.7 8.4 3.2 10.7 5.0 1.7 15.7 5.3 4.8 3.6 5.0 3.0 9.0 7.2 7.8 6.1 8.9 3.3 8.2 4.5 5.8 6.1 1.4 1.4 3.1 7.1 6.8 6.8 6.1 0.1 8.1 13.9 0.6 0.9 3.1 13.9 9.7 7.4 3.3 2.1 5.4 0.7 17.8 0.6 2.1 7.7 4.8 14.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.3 1.0 0.3 0.0 0.6 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.4 3.2 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.8 0.4 0.0 1.2 0.3 1.6 0.4 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 27.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 7.3 6.6 2.7 8.4 9.0 7.2 8.2 4.5 5.8 6.8 9.7 5.4 14.6 2.3 0.0 1.1 219.1 0.2 0.6 2.0 0.2 0.0 0.0 1.0 0.4 0.8 0.0 6.5 0.0 0.0 0.1 0.0 2.6 0.0 0.7 50.2 1.7 4.9 12.8 3.0 2.7 15.8 1.0 0.1 4.2 0.0 1.8 4.5 0.1 61.4 1.2 0.3 0.0 4.4 13.7 2.0 2.5 1.1 38.8 3.7 0.2 1.8 15.9 0.0 0.0 0.0 7.1 12.4 0.1 2.7 1.9 0.0 1.0 0.5 7.1 20.8 0.0 0.0 19.4 0.9 0.4 0.7 0.3 0.6 0.1 0.2 0.5 2.9 4.9 FAM161B "C14orf44, FLJ31697" ENSG00000156050 "FAM161 centrosomal protein B" Q96MY7 14 73931501-73950414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 62.9;Late spermatids: 142.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019125 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA019125: AB_1845570" "unprognostic (1.50e-1)" "unprognostic (9.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.99e-1)" "unprognostic (9.51e-2)" "unprognostic (1.79e-2)" "unprognostic (1.76e-3)" "unprognostic (5.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (1.53e-1)" "prognostic favorable (6.78e-4)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (1.60e-1)" 2.7 8.8 6.2 1.7 6.9 1.2 4.9 5.8 8.2 4.9 3.5 3.4 3.3 5.3 4.3 4.2 5.5 2.7 4.5 6.3 6.6 5.1 5.2 2.9 1.9 6.9 6.2 6.8 12.9 2.2 4.3 7.7 2.4 7.5 6.0 2.7 10.2 2.8 5.3 8.0 2.1 3.3 3.4 5.1 3.1 3.4 18.9 6.1 2.0 4.3 4.8 1.8 5.5 3.8 7.1 2.1 1.6 2.2 3.4 4.7 3.5 2.0 3.6 2.8 6.0 5.8 1.5 2.6 3.3 2.3 4.2 2.5 3.9 0.9 1.7 4.1 9.2 1.8 1.6 1.6 1.7 4.0 1.1 2.3 2.6 3.4 6.1 2.2 4.4 2.7 3.4 1.0 1.6 4.3 3.3 3.1 4.2 0.5 1.4 3.5 2.1 2.9 1.3 3.1 3.1 2.7 2.5 5.1 2.3 3.1 1.6 8.1 1.5 2.9 12.4 5.6 3.1 2.2 3.3 2.2 2.1 6.3 1.9 2.2 3.2 1.3 1.9 1.1 0.3 1.3 0.7 1.2 1.7 0.2 0.9 0.6 0.4 0.4 1.3 0.4 0.3 0.7 0.9 6.2 6.9 5.8 8.2 6.3 6.6 6.9 6.2 6.8 7.5 5.1 6.1 7.1 3.5 3.2 4.8 4.9 3.0 0.6 2.1 1.0 3.4 8.9 3.7 3.8 3.4 0.0 3.2 1.8 4.2 1.5 1.9 3.5 0.0 1.0 62.9 5.9 3.9 2.2 0.0 1.7 7.3 1.6 1.1 4.6 7.1 4.5 0.0 5.0 2.5 0.7 2.9 3.3 8.6 4.1 2.0 1.2 0.7 142.7 3.4 1.4 1.8 2.8 2.2 8.0 6.2 5.5 2.9 1.2 0.8 9.4 1.4 0.8 4.3 4.2 9.4 16.7 6.6 5.2 4.2 11.0 6.1 0.6 0.9 2.2 3.3 9.6 1.4 0.9 GNAQ "G-ALPHA-q, GAQ" ENSG00000156052 "G protein subunit alpha q" P50148 9 77716097-78031811 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 556.6;Excitatory neurons: 405.6;Microglial cells: 394.4;Oligodendrocyte precursor cells: 338.3;Oligodendrocytes: 495.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 27.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010036, HPA048886" Uncertain Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA 800000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB010036: AB_631536, HPA048886: AB_2680544" "unprognostic (2.10e-1)" "unprognostic (8.53e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (1.87e-1)" "unprognostic (6.83e-3)" "unprognostic (1.05e-1)" "unprognostic (3.84e-2)" "unprognostic (2.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.11e-7)" "unprognostic (1.90e-1)" "unprognostic (3.13e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" 23.7 21.5 41.8 19.0 47.0 44.2 20.4 40.1 51.8 21.3 26.8 30.6 14.6 23.9 18.8 23.4 17.0 20.3 8.7 53.4 44.5 21.1 22.2 31.4 10.0 44.1 45.1 42.0 22.6 14.7 16.4 12.6 21.9 44.7 21.4 27.5 10.5 17.0 26.0 10.6 8.6 16.9 27.6 46.3 11.4 28.1 11.6 49.3 19.9 23.3 12.0 9.1 23.7 13.9 53.2 30.6 34.1 29.8 32.0 34.9 35.5 42.8 40.7 29.7 16.6 20.6 10.5 24.1 0.1 32.0 35.5 24.5 48.5 22.5 23.4 20.6 1.1 12.5 83.0 29.0 21.4 31.4 51.8 30.0 24.3 28.0 33.9 32.5 34.3 42.7 70.3 14.8 0.2 29.5 38.5 58.8 31.0 24.0 46.5 4.7 22.0 36.5 0.3 37.8 64.5 33.1 49.6 29.3 23.3 30.5 27.5 22.2 18.3 55.0 29.2 1.9 41.9 24.0 0.2 0.1 0.3 20.3 28.9 32.0 27.0 2.5 5.7 0.8 2.2 1.7 0.9 2.0 1.1 2.8 0.9 2.1 1.7 8.9 3.6 4.5 3.2 2.2 1.5 41.8 47.0 40.1 51.8 53.4 44.5 44.1 45.1 42.0 44.7 46.3 49.3 53.2 117.7 176.3 97.5 556.6 4.8 47.3 38.4 42.7 39.3 34.0 75.6 54.5 6.0 58.6 48.3 77.3 16.7 47.4 33.4 137.0 7.9 36.2 18.9 57.5 64.2 107.3 92.3 58.0 405.6 39.7 53.2 51.7 70.8 76.0 50.7 40.2 98.6 64.0 53.7 82.4 242.0 92.5 30.5 139.5 173.9 11.1 39.4 128.8 48.0 394.4 114.6 40.5 8.2 338.3 495.2 54.2 60.7 52.3 6.2 70.5 52.9 45.4 67.0 5.0 26.3 62.3 40.8 5.6 13.2 46.3 21.6 29.0 25.0 45.2 75.4 70.1 WIF1 ENSG00000156076 "WNT inhibitory factor 1" Q9Y5W5 12 65050626-65121305 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 232.4;retina: 605.0" "Cell type enriched" "Detected in many" 13 "Muller glia cells: 2736.1" "Group enriched" "Detected in many" 5 "endometrial cancer: 16.9;lung cancer: 14.6" "Region enriched" "Detected in all" 5 "hypothalamus: 232.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.2;LHCN-M2: 1.0;NTERA-2: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "unprognostic (5.96e-3)" "unprognostic (2.00e-1)" "unprognostic (4.29e-3)" "unprognostic (3.26e-3)" "unprognostic (9.66e-2)" "unprognostic (1.91e-1)" "unprognostic (1.26e-2)" "unprognostic (7.94e-2)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (3.17e-1)" "unprognostic (2.30e-5)" "unprognostic (3.02e-1)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (7.24e-3)" 0.6 2.7 21.6 0.3 31.6 0.0 23.1 14.2 45.0 1.6 13.7 0.3 0.0 8.7 24.0 4.7 1.6 0.0 0.3 23.5 232.4 0.7 0.0 118.5 0.1 17.4 14.4 21.9 1.2 0.3 0.0 46.8 0.0 18.9 14.4 0.3 605.0 45.5 2.8 0.1 6.6 2.2 0.9 13.6 0.1 1.4 0.7 18.5 0.2 0.0 0.7 0.0 1.7 2.2 18.7 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 31.6 14.2 45.0 23.5 232.4 17.4 14.4 21.9 18.9 13.6 18.5 18.7 0.0 35.3 197.8 186.1 0.0 12.6 34.5 0.0 2.2 25.0 0.7 13.7 1.6 0.0 26.6 1.8 8.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 4.7 0.0 0.0 0.6 0.0 0.0 27.8 0.5 0.1 7.6 1.0 0.0 0.0 0.0 15.2 46.5 0.0 0.0 0.0 20.4 0.0 0.0 0.8 23.2 12.2 0.0 2736.1 0.0 1.5 0.9 0.0 0.0 0.4 0.2 25.5 0.0 1.2 34.2 80.8 0.0 1.8 1.5 2.5 2.0 0.4 10.5 0.0 1.2 0.0 0.0 0.8 UGT2B4 UGT2B11 ENSG00000156096 "UDP glucuronosyltransferase family 2 member B4" P06133 4 69480165-69526014 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 106 "liver: 1284.2" "Cell type enriched" "Detected in some" 22 "Hepatocytes: 883.5" "Cancer enriched" "Detected in some" 96 "liver cancer: 351.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "RH-30: 4.6" "CAB033260, HPA045108" Enhanced "Intracellular and membrane" NA NA "CAB033260: AB_2241496, HPA045108: AB_2679218" "unprognostic (7.46e-2)" "unprognostic (1.50e-1)" "unprognostic (9.37e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-2)" "unprognostic (1.47e-1)" "unprognostic (9.43e-3)" "unprognostic (3.52e-1)" 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.0 0.0 0.0 1.3 1284.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 10.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 11.7 883.5 0.1 0.0 0.1 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 GPR61 BALGR ENSG00000156097 "G protein-coupled receptor 61" Q9BZJ8 1 109539872-109548406 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.2;pituitary gland: 3.6;retina: 3.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 18.9;Cone photoreceptor cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007326, HPA026088" Supported NA NA "HPA007326: AB_1849308, HPA026088: AB_10602323" "unprognostic (1.70e-1)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (2.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.70e-2)" "unprognostic (7.51e-2)" "unprognostic (3.63e-3)" "unprognostic (2.94e-2)" "unprognostic (4.50e-2)" "unprognostic (1.46e-4)" "unprognostic (3.27e-1)" "unprognostic (4.08e-4)" "unprognostic (1.33e-1)" "unprognostic (1.07e-1)" "unprognostic (6.72e-2)" "unprognostic (3.85e-2)" 0.0 0.7 0.7 0.0 1.7 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.8 0.0 0.0 0.0 0.0 0.1 0.5 1.8 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 3.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.7 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 0.2 3.2 1.5 0.8 0.1 0.5 1.8 0.7 0.0 0.9 2.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 18.9 0.2 0.0 0.6 0.0 0.0 0.0 6.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.1 1.7 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032011-88328025 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4" "Cell type enriched" "Detected in many" 5 "Oligodendrocyte precursor cells: 2402.1" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.4;HUVEC TERT2: 12.8;SH-SY5Y: 16.2;U-138 MG: 13.7;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 0.7 0.3 4.0 0.3 6.4 0.0 1.8 2.9 5.6 1.7 0.0 0.6 0.1 1.6 0.6 0.4 0.6 2.6 0.8 5.3 3.9 0.1 0.1 0.2 0.2 2.1 2.0 5.0 1.0 0.6 0.2 0.5 1.0 3.0 1.0 0.4 0.4 0.3 0.7 0.1 0.2 0.3 1.3 1.4 0.4 0.3 0.4 2.8 0.4 1.0 0.5 0.2 0.9 0.5 4.4 0.0 0.2 7.9 29.4 1.0 2.0 0.0 10.9 1.6 3.0 1.8 0.0 0.1 0.0 0.0 4.9 1.8 0.0 5.8 0.0 3.7 0.0 3.4 0.0 0.0 0.0 2.4 0.0 0.5 1.4 0.0 4.4 1.3 5.4 12.8 0.1 0.0 1.1 1.7 0.0 0.0 0.0 1.7 0.0 3.0 0.3 0.6 0.0 0.6 0.1 0.2 16.2 0.0 0.0 0.2 2.2 1.1 0.0 7.1 13.7 7.7 0.2 4.2 0.0 0.0 0.0 5.7 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.4 2.9 5.6 5.3 3.9 2.1 2.0 5.0 3.0 1.4 2.8 4.4 2.2 0.0 0.0 20.5 0.1 1.1 0.0 0.0 0.6 4.4 0.8 1.4 1.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 1.9 0.0 6.5 0.5 15.9 5.2 0.0 0.0 443.4 0.0 0.1 16.0 0.0 0.4 0.0 1.9 1.4 0.0 0.4 1.7 300.3 0.0 0.0 0.0 1.6 6.5 0.9 0.4 1.8 10.3 0.0 3.0 0.0 2402.1 13.0 0.1 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.7 2.9 0.0 1.1 0.2 0.1 0.0 0.2 3.4 0.0 0.1 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151202-74709963 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 152.4" "Cell type enhanced" "Detected in all" "Excitatory neurons: 245.3;Inhibitory neurons: 287.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 24.1 15.6 13.1 17.1 18.5 28.9 27.7 13.4 17.9 14.2 11.4 18.0 17.0 10.9 16.7 47.8 16.6 11.5 27.4 13.3 14.4 36.1 152.4 24.6 22.9 13.7 14.2 12.5 8.3 19.0 44.6 15.0 26.8 15.4 15.1 19.7 16.2 20.1 16.2 41.9 34.1 12.5 14.9 14.3 15.2 12.2 15.6 13.8 27.3 38.5 47.6 34.7 24.7 24.9 15.5 177.3 37.4 37.2 50.5 37.1 54.7 88.2 140.8 105.4 103.8 114.5 114.0 172.6 86.3 34.2 57.7 51.3 151.1 44.1 150.1 167.0 59.1 51.3 55.6 59.8 122.8 41.7 87.6 22.5 51.1 95.5 77.4 191.7 79.0 91.2 38.7 41.8 28.4 78.8 101.7 102.5 129.0 9.9 80.0 276.3 100.6 63.7 69.4 117.1 92.7 29.5 33.8 63.6 239.7 49.5 34.7 159.7 69.3 82.8 34.3 67.0 93.2 123.0 40.5 48.3 98.1 65.0 127.6 22.1 2.3 34.2 4.1 12.9 65.5 29.9 103.7 28.2 24.1 83.1 155.0 21.3 19.2 11.1 20.7 80.4 57.6 55.7 36.3 13.1 18.5 13.4 17.9 13.3 14.4 13.7 14.2 12.5 15.4 14.3 13.8 15.5 9.8 83.3 75.8 136.5 84.2 94.2 73.5 102.0 105.9 16.3 26.2 26.0 67.8 38.6 72.4 31.3 56.3 136.7 25.9 11.0 92.0 83.2 80.7 40.6 18.8 14.9 10.8 27.7 245.3 67.5 139.5 27.0 23.0 55.6 21.5 9.7 17.2 130.1 39.3 11.8 287.7 12.1 44.7 25.2 50.0 26.9 16.8 33.7 48.0 198.6 44.1 14.1 11.3 140.8 165.4 62.7 10.4 12.0 39.1 92.1 5.0 64.5 33.5 25.0 6.6 20.4 26.0 17.4 14.3 96.7 97.0 107.3 32.7 17.0 20.5 66.3 KCNMA1 "KCa1.1, mSLO1, SLO" ENSG00000156113 "Potassium calcium-activated channel subfamily M alpha 1" Q12791 10 76869601-77638369 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 139.9" "Cell type enhanced" "Detected in many" "Astrocytes: 471.1;Bipolar cells: 409.8;Excitatory neurons: 1023.7;Inhibitory neurons: 635.9;Oligodendrocyte precursor cells: 708.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4;non-classical monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 2.4" "Cell line enhanced" "Detected in many" "BJ: 100.8;hTERT-HME1: 115.3;PC-3: 159.6;U-138 MG: 112.6;U-87 MG: 109.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054648 Approved NA NA "HPA054648: AB_2682556" "unprognostic (1.25e-1)" "unprognostic (2.23e-2)" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (9.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" "unprognostic (2.81e-2)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (4.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.42e-2)" "unprognostic (5.19e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-3)" 9.7 12.7 37.7 8.9 39.2 1.0 15.9 1.8 48.4 47.3 5.0 88.0 7.3 139.9 31.7 34.0 48.2 22.6 3.7 36.3 14.6 4.4 19.3 9.6 7.8 13.1 18.9 33.3 14.0 8.1 0.2 27.1 4.9 15.2 48.8 21.3 40.6 43.2 76.9 97.4 4.2 23.5 93.6 4.7 24.3 33.9 5.9 13.9 2.1 3.0 18.9 3.5 44.7 24.8 28.4 0.3 30.3 0.1 0.3 4.6 24.8 0.3 100.8 89.2 23.9 11.8 6.7 0.6 0.0 0.7 75.9 56.8 0.2 0.0 59.0 14.6 60.9 0.6 0.0 0.0 0.0 45.0 0.0 0.4 17.4 10.7 38.3 115.3 84.0 9.8 0.5 0.0 0.0 42.6 1.2 1.9 0.2 1.8 0.2 159.6 0.1 3.6 0.1 15.3 0.2 9.1 1.1 0.0 2.5 0.1 11.9 12.2 0.1 65.4 112.6 12.7 20.6 90.0 0.0 0.2 0.0 109.8 0.1 45.1 0.0 0.1 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.1 37.7 39.2 1.8 48.4 36.3 14.6 13.1 18.9 33.3 15.2 4.7 13.9 28.4 0.9 0.0 4.3 471.1 2.8 2.0 71.7 5.7 17.6 409.8 30.4 43.9 3.5 5.7 4.8 1.8 60.5 0.3 0.5 2.8 29.4 3.3 74.4 20.9 17.9 3.4 4.9 0.0 1023.7 10.7 0.2 16.2 0.5 29.7 0.0 1.9 2.5 27.3 10.8 6.7 635.9 59.6 46.8 106.0 3.9 63.1 3.7 36.7 48.0 133.0 4.0 52.3 0.0 708.2 33.9 8.7 1.4 1.2 8.7 64.0 1.4 0.9 0.1 17.2 6.6 20.6 19.2 3.4 2.5 7.7 0.3 0.3 0.7 177.2 1.7 2.4 BATF "B-ATF, BATF1, SFA-2" ENSG00000156127 "Basic leucine zipper ATF-like transcription factor" Q16520 14 75522455-75546993 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.9;lymphoid tissue: 30.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 105.4;Breast myoepithelial cells: 73.9;granulocytes: 243.7;NK-cells: 103.0;T-cells: 116.5;Urothelial cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "T-cells: 130.3" "Cell line enhanced" "Detected in many" "HDLM-2: 368.9;MCF7: 134.7;RT4: 83.3;SK-BR-3: 64.8;U-937: 101.6" "Not detected" "Not detected" "HPA059588, HPA064962" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059588: AB_2684074, HPA064962: AB_2685392" "unprognostic (3.33e-3)" "unprognostic (4.87e-3)" "prognostic unfavorable (8.30e-4)" "prognostic favorable (5.35e-6)" "unprognostic (3.02e-2)" "prognostic favorable (7.91e-5)" "unprognostic (1.14e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (6.72e-2)" "unprognostic (7.17e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (3.74e-9)" "unprognostic (4.74e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-1)" "prognostic favorable (4.30e-4)" 5.1 1.3 0.9 20.7 1.4 21.9 7.8 0.8 1.4 2.3 1.2 2.8 2.6 1.3 1.1 3.0 1.9 5.8 1.9 0.8 2.1 1.4 2.9 8.0 30.9 1.4 1.2 0.7 0.5 0.9 8.1 0.5 4.1 1.3 5.6 1.4 0.0 6.5 1.8 0.4 2.9 9.8 2.3 1.0 27.1 7.9 0.6 1.8 7.3 1.9 1.0 20.6 18.4 3.0 2.5 4.7 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 368.9 0.0 7.5 0.0 1.6 11.5 10.0 36.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 2.0 10.3 0.0 134.7 4.7 30.8 0.2 54.9 0.0 1.1 0.0 6.3 0.0 83.3 0.1 0.0 0.0 64.8 2.7 0.0 6.1 18.7 0.0 0.0 0.0 4.4 0.3 32.8 36.9 0.3 0.0 101.6 0.1 3.6 25.5 8.2 55.0 13.7 43.4 21.3 59.7 74.2 25.2 17.5 23.1 50.4 14.4 21.3 13.2 2.9 130.3 27.8 0.9 1.4 0.8 1.4 0.8 2.1 1.4 1.2 0.7 1.3 1.0 1.8 2.5 2.9 9.6 29.3 0.0 17.1 5.4 50.8 5.7 0.6 0.0 105.4 73.9 0.3 1.5 13.5 3.7 0.0 0.4 36.9 0.0 0.0 0.8 0.5 0.9 0.6 5.0 0.0 7.2 0.2 2.5 0.4 4.4 10.2 1.9 243.7 0.0 2.5 0.7 61.3 0.0 0.1 0.0 34.6 15.4 10.7 0.6 0.0 21.7 5.4 1.0 16.7 0.0 103.0 0.0 0.1 11.0 0.1 0.0 29.9 22.1 0.0 0.2 12.8 0.0 0.0 1.0 2.0 0.0 0.1 0.4 3.4 1.1 116.5 0.2 0.5 74.3 DCK ENSG00000156136 "Deoxycytidine kinase" P27707 4 70992538-71030914 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 106.8" "Cell type enhanced" "Detected in many" "B-cells: 105.7;Erythroid cells: 284.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 232.9;U-698: 191.8" "Low region specificity" "Detected in all" "HPA059609, HPA062773" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA059609: AB_2684082, HPA062773: AB_2684865" "unprognostic (9.16e-2)" "unprognostic (2.44e-1)" "unprognostic (5.24e-3)" "unprognostic (4.77e-2)" "unprognostic (3.95e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (6.90e-7)" "unprognostic (3.04e-2)" "unprognostic (7.19e-2)" "unprognostic (8.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.33e-1)" "unprognostic (3.37e-2)" "unprognostic (4.47e-2)" "unprognostic (6.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.27e-2)" 11.2 15.3 11.5 36.6 13.2 44.3 12.6 11.3 13.7 10.0 12.1 15.9 13.8 13.6 7.2 14.7 9.8 12.5 10.5 11.8 11.9 9.9 9.2 13.5 93.6 12.4 11.8 11.1 10.7 8.3 8.9 3.5 15.4 12.1 10.3 19.0 17.2 7.7 7.2 9.6 14.8 16.1 14.0 13.8 32.6 14.3 9.1 11.6 106.8 15.8 12.2 80.3 14.3 6.1 14.4 25.8 17.2 38.5 23.9 12.4 20.4 21.0 65.3 25.6 53.3 43.6 11.3 56.1 232.9 24.7 28.3 31.0 14.8 34.6 21.4 71.0 43.5 16.2 46.6 18.6 20.5 11.8 95.8 58.5 11.2 25.5 32.2 19.5 26.0 31.0 64.4 19.0 93.2 62.0 15.5 126.6 39.5 17.2 45.6 15.6 96.0 74.0 18.6 26.6 18.8 35.1 31.8 24.9 49.6 29.7 17.4 22.3 54.3 22.0 60.1 41.8 47.6 37.1 31.7 21.2 191.8 40.7 60.0 45.0 25.6 17.2 28.9 24.2 20.5 32.0 44.5 33.0 30.6 23.8 41.1 34.2 34.2 8.1 34.4 21.0 63.6 41.2 45.1 11.5 13.2 11.3 13.7 11.8 11.9 12.4 11.8 11.1 12.1 13.8 11.6 14.4 16.4 0.0 8.6 6.8 105.7 43.0 10.1 11.9 27.9 16.1 10.4 5.2 6.5 7.2 7.5 12.9 6.2 11.9 97.7 10.4 29.4 19.2 0.7 5.9 7.0 16.3 21.0 284.8 17.1 6.2 19.3 11.0 8.6 7.4 22.9 7.5 22.9 7.2 38.2 18.5 21.0 16.4 22.4 63.2 74.5 2.3 8.4 56.0 46.2 18.7 61.4 15.8 84.5 8.0 11.1 10.5 8.0 10.1 24.6 11.6 7.1 10.0 4.7 10.7 6.6 9.3 15.9 52.0 33.9 28.0 43.3 4.5 62.4 4.8 16.5 8.4 ADAMTS3 "ADAMTS-4, KIAA0366" ENSG00000156140 "ADAM metallopeptidase with thrombospondin type 1 motif 3" O15072 4 72280969-72569221 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 8.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Excitatory neurons: 50.2;Leydig cells: 19.9;Rod photoreceptor cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.2;AN3-CA: 7.8;HEL: 14.1;K-562: 12.3;SH-SY5Y: 7.0;U-2 OS: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021368, HPA021369" Uncertain Approved "Intermediate filaments" "Secreted to extracellular matrix" NA NA "Intermediate filaments" "HPA021368: AB_2670681, HPA021369: AB_2670682" "unprognostic (1.93e-1)" "unprognostic (3.47e-3)" "unprognostic (1.41e-1)" "unprognostic (1.05e-3)" "unprognostic (6.11e-2)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (1.60e-3)" "unprognostic (5.92e-4)" "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (8.63e-3)" "unprognostic (1.65e-3)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" "unprognostic (1.50e-4)" 1.9 0.8 0.6 1.0 2.0 0.8 3.2 0.1 1.4 0.4 0.3 0.3 0.1 1.9 1.7 0.2 3.0 0.6 0.5 1.4 0.6 0.7 0.2 1.1 0.8 0.5 0.3 1.4 2.1 0.3 2.7 0.2 0.7 0.8 0.8 0.3 8.5 0.4 1.1 0.2 0.4 0.2 1.7 0.0 0.7 0.5 1.9 0.3 0.7 1.2 0.3 0.3 1.3 0.4 0.5 0.0 0.0 13.2 7.8 0.1 0.3 0.1 0.7 2.1 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.8 0.0 1.8 0.0 1.8 14.1 0.9 0.0 0.2 0.0 0.0 1.7 0.1 0.6 0.1 3.3 0.0 0.0 12.3 0.0 0.0 0.0 1.3 0.0 2.2 0.0 4.0 0.0 2.6 0.0 4.6 0.0 0.5 7.0 0.0 0.6 0.2 1.4 0.1 0.2 0.1 5.6 8.5 0.0 0.7 0.0 0.0 0.0 1.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.1 1.4 1.4 0.6 0.5 0.3 1.4 0.8 0.0 0.3 0.5 1.8 0.0 3.4 7.5 0.0 0.5 0.9 0.0 0.0 0.9 0.8 3.2 1.2 1.5 1.3 1.8 14.6 0.0 0.0 0.0 0.0 0.0 4.1 2.2 5.1 3.7 0.0 2.5 50.2 0.0 0.3 3.3 0.0 0.7 1.3 1.9 3.9 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.7 1.9 19.9 0.3 0.0 1.0 0.0 1.8 0.0 7.1 1.3 0.0 0.0 4.5 0.0 1.1 0.0 0.3 0.5 12.9 0.0 0.3 1.2 1.2 0.8 0.3 0.0 0.0 0.0 2.8 0.0 0.1 ALX3 FND ENSG00000156150 "ALX homeobox 3" O95076 1 110059870-110070672 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 7.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.1;Cone photoreceptor cells: 4.2;Microglial cells: 1.0;NK-cells: 1.0;Rod photoreceptor cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in many" 8 "olfactory bulb: 16.7" "Not detected" "Not detected" HPA074290 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA074290: " "unprognostic (4.28e-1)" "unprognostic (4.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" 1.1 2.0 1.8 1.5 2.0 1.4 0.1 1.7 2.3 0.1 2.8 0.6 2.1 2.4 0.0 2.5 2.2 1.8 1.1 1.3 1.3 1.0 0.1 1.3 2.9 2.8 1.7 1.0 2.8 1.6 1.2 0.9 1.0 2.6 1.0 0.0 5.5 2.5 0.0 3.2 7.3 2.9 0.2 1.4 2.7 1.1 1.9 2.1 0.0 2.3 0.4 0.0 0.8 0.1 1.8 3.6 2.5 4.0 6.5 0.0 0.0 8.5 8.7 12.1 0.0 0.0 3.7 1.7 2.1 3.3 0.1 1.4 5.2 0.0 0.0 0.0 5.0 6.7 1.1 4.3 2.3 0.0 2.0 0.9 0.0 0.0 0.0 0.0 4.7 0.0 3.8 3.0 0.5 0.0 4.0 1.5 2.1 4.6 2.6 5.0 3.2 5.2 1.5 0.0 5.0 5.6 7.7 4.2 6.0 5.7 4.5 2.7 3.4 3.6 4.6 4.3 6.4 2.4 3.6 1.2 2.0 5.3 5.0 3.6 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 1.7 2.3 1.3 1.3 2.8 1.7 1.0 2.6 1.4 2.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.2 0.1 0.4 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 DPY19L4 ENSG00000156162 "Dpy-19 like 4" Q7Z388 8 94719703-94793836 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024339, HPA024780" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA024339: , HPA024780: AB_10600869" "unprognostic (1.45e-1)" "unprognostic (2.89e-3)" "unprognostic (3.41e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.28e-1)" "unprognostic (5.54e-2)" "unprognostic (4.94e-2)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (4.72e-2)" "unprognostic (9.38e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" 11.6 12.4 8.1 6.6 11.2 5.1 12.6 10.4 9.5 13.7 8.6 8.6 6.8 12.4 10.6 7.6 11.3 10.1 15.6 7.3 10.6 14.6 16.0 9.2 6.9 10.5 9.9 6.5 16.9 9.5 26.6 6.5 12.7 10.6 11.8 9.1 13.1 10.3 9.0 7.2 9.5 7.9 9.6 10.6 11.2 13.2 9.7 9.7 7.1 16.2 9.4 5.8 8.7 8.5 15.4 24.4 15.5 26.1 16.4 25.9 33.3 14.4 21.5 20.3 19.8 19.4 7.3 35.0 5.4 25.8 20.8 13.3 25.0 16.0 16.9 32.7 12.2 12.8 25.3 15.1 12.2 30.1 10.9 5.1 22.2 14.0 16.8 16.2 23.2 24.3 16.0 18.0 9.0 23.3 15.3 20.9 20.5 10.2 27.9 17.2 14.8 17.9 10.9 19.1 18.9 12.8 28.7 17.2 3.6 16.8 15.9 22.8 13.6 24.0 20.5 12.6 23.1 18.1 9.9 13.1 14.8 15.4 18.7 29.6 0.7 0.5 0.0 1.0 0.6 1.4 1.2 1.0 1.6 1.0 0.3 1.1 1.4 0.4 1.4 0.6 1.2 0.4 0.7 8.1 11.2 10.4 9.5 7.3 10.6 10.5 9.9 6.5 10.6 10.6 9.7 15.4 21.1 16.0 16.3 20.5 6.3 9.8 14.1 11.6 15.9 19.6 16.2 12.1 26.0 11.5 13.0 40.5 4.2 16.7 3.7 8.5 1.9 8.9 2.1 13.7 20.3 19.0 7.3 9.7 13.2 10.0 11.9 20.4 12.2 13.7 3.8 23.1 65.0 27.5 9.6 13.5 18.3 11.5 10.2 14.8 11.9 5.0 17.4 8.3 10.6 25.3 5.5 11.9 9.2 23.6 39.7 13.0 6.4 18.4 7.9 15.6 10.7 10.7 18.8 17.6 6.6 13.4 14.9 11.9 9.8 16.6 12.1 9.2 7.8 32.6 12.0 14.1 NDUFAF6 "C8orf38, MGC40214" ENSG00000156170 "NADH:ubiquinone oxidoreductase complex assembly factor 6" Q330K2 8 94895767-95116455 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047148, HPA050545" Approved NA NA "HPA047148: AB_2679954, HPA050545: AB_2681166" "unprognostic (1.97e-3)" "unprognostic (1.62e-3)" "unprognostic (2.46e-1)" "unprognostic (1.29e-3)" "unprognostic (8.73e-2)" "unprognostic (3.45e-2)" "unprognostic (7.62e-3)" "unprognostic (2.52e-2)" "unprognostic (9.61e-2)" "unprognostic (3.85e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (4.04e-3)" "unprognostic (9.44e-2)" "unprognostic (1.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-3)" 4.7 3.1 7.2 4.1 7.9 5.6 5.4 9.1 8.1 1.9 5.3 4.5 2.2 3.2 5.8 4.4 4.3 1.9 7.3 6.9 8.2 4.5 11.0 2.6 4.9 7.3 7.8 7.0 4.0 3.1 3.5 2.6 3.6 8.2 3.5 5.5 7.4 2.2 3.5 14.7 5.6 3.1 3.3 7.1 3.1 4.3 4.0 7.6 4.8 6.3 14.0 5.3 2.5 1.8 9.2 7.7 4.5 5.4 5.1 3.5 4.3 11.1 8.0 5.0 6.6 4.8 3.6 3.7 14.8 5.3 3.7 2.0 6.3 7.8 5.4 4.9 3.7 15.1 13.7 10.0 6.7 5.4 5.1 6.9 6.5 9.0 3.8 6.1 3.0 3.8 12.1 9.9 8.0 8.0 6.8 13.0 16.5 5.9 10.0 10.6 8.6 4.3 11.3 6.1 7.3 10.1 5.5 4.1 2.5 10.8 6.5 10.1 4.2 4.8 4.7 3.7 3.7 5.8 10.7 8.5 12.4 3.9 13.5 2.7 1.9 1.8 3.0 2.3 1.1 2.9 5.8 3.2 2.2 2.4 5.4 3.1 2.3 0.9 2.9 2.2 2.1 2.9 1.9 7.2 7.9 9.1 8.1 6.9 8.2 7.3 7.8 7.0 8.2 7.1 7.6 9.2 23.4 12.8 15.9 35.3 23.6 9.7 10.1 21.5 19.4 22.7 25.7 27.4 32.0 28.6 21.2 12.9 16.7 24.0 14.3 18.5 43.0 15.8 28.5 13.5 9.1 14.8 12.5 23.3 31.8 34.7 30.2 9.4 10.7 9.8 31.8 21.5 12.1 28.3 22.6 25.2 37.0 15.3 24.4 7.3 5.6 8.1 10.5 10.1 14.2 33.7 12.0 25.6 6.2 43.2 58.3 19.3 18.2 13.9 53.1 11.2 23.2 38.2 24.7 23.6 13.1 11.9 21.4 28.4 43.9 17.9 11.9 10.9 13.0 16.5 19.4 9.5 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117163-111140203 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: AB_2684590" "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 38.3 23.3 15.0 33.4 15.9 18.1 27.1 19.0 20.0 23.3 23.9 26.9 28.9 17.9 17.7 15.2 30.3 36.7 23.9 14.8 17.6 26.8 25.1 25.2 55.8 16.9 16.6 13.9 24.5 25.8 28.5 4.7 41.5 17.2 18.0 31.0 17.0 26.0 16.9 16.8 18.0 26.5 17.1 17.4 45.7 23.7 10.4 15.9 28.1 22.1 23.8 50.8 29.7 4.3 18.9 38.0 12.9 24.0 10.8 57.3 56.2 23.4 28.7 29.9 24.7 24.9 12.5 38.2 28.7 17.2 25.6 12.1 37.4 30.5 24.0 31.9 26.8 25.6 16.8 18.4 16.4 41.4 19.4 15.4 38.5 41.4 18.3 38.4 53.6 29.9 29.1 34.1 19.6 30.1 19.6 16.6 28.8 14.5 43.3 13.2 11.1 40.0 14.0 42.5 25.8 19.1 18.2 16.8 52.4 80.1 33.1 16.7 84.6 24.8 20.6 13.8 16.2 18.9 25.7 9.6 29.8 33.4 34.7 29.6 41.7 47.3 11.5 14.2 61.0 19.4 65.7 17.5 15.3 45.1 54.1 22.3 19.0 7.2 25.0 49.8 28.6 17.7 35.5 15.0 15.9 19.0 20.0 14.8 17.6 16.9 16.6 13.9 17.2 17.4 15.9 18.9 34.5 12.8 12.0 17.3 146.2 47.0 54.4 82.5 34.1 11.6 53.6 43.9 29.7 32.9 53.1 44.1 2.1 98.1 38.9 41.2 43.0 59.2 8.5 51.7 19.5 36.4 13.2 28.6 20.6 46.6 102.3 39.2 24.5 17.6 23.6 18.5 42.8 26.0 183.1 20.2 31.7 45.7 77.3 189.4 97.8 7.8 33.5 110.3 81.8 39.4 89.0 27.1 56.7 31.7 42.6 41.9 64.3 24.8 54.7 46.3 88.4 80.4 95.8 10.1 39.5 26.4 32.5 4.7 14.6 40.8 53.0 73.3 38.6 26.3 43.7 70.1 C8orf37 "BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64" ENSG00000156172 "Chromosome 8 open reading frame 37" Q96NL8 8 95244913-95269201 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024198 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA Cytosol "Plasma membrane, Cell Junctions" "HPA024198: AB_1845775" "unprognostic (7.90e-2)" "unprognostic (1.98e-2)" "unprognostic (5.68e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (2.72e-3)" "unprognostic (4.20e-3)" "unprognostic (2.04e-2)" "unprognostic (8.94e-2)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (6.11e-3)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (6.72e-3)" "unprognostic (2.02e-1)" "unprognostic (1.33e-2)" "unprognostic (3.29e-1)" 1.8 1.8 2.5 1.3 2.0 0.9 2.3 2.4 2.2 2.3 3.0 0.9 0.9 2.4 3.1 1.0 3.9 1.4 2.7 1.7 3.5 2.4 1.8 1.6 2.2 2.5 2.7 1.6 4.8 1.2 3.5 2.3 1.8 2.2 2.0 0.9 5.1 1.5 1.7 1.1 1.5 1.0 2.3 3.2 1.7 1.1 1.7 1.9 2.4 2.5 1.9 1.9 1.2 1.4 3.0 2.8 4.5 3.6 1.9 1.2 3.3 1.0 1.2 2.7 1.5 2.0 0.7 6.0 5.6 2.8 2.0 3.8 2.3 1.5 3.1 3.3 1.8 1.4 4.4 2.7 2.0 1.4 0.9 2.3 3.3 1.4 1.8 5.0 3.9 2.3 3.3 2.3 3.2 2.0 2.1 4.8 1.1 1.1 5.6 3.0 2.5 1.9 1.4 3.4 1.2 3.5 3.4 2.5 0.5 2.1 2.7 4.2 0.8 2.0 1.9 2.4 1.6 1.2 2.9 3.0 3.8 3.6 2.1 2.4 0.3 0.3 0.1 0.2 0.2 0.5 0.4 0.3 0.3 0.5 0.8 0.3 0.5 0.4 0.7 0.1 0.2 0.1 0.2 2.5 2.0 2.4 2.2 1.7 3.5 2.5 2.7 1.6 2.2 3.2 1.9 3.0 2.4 3.2 2.6 6.8 2.5 0.9 3.7 2.9 4.0 2.7 1.3 2.4 5.3 0.0 3.3 7.3 2.1 2.5 1.8 0.1 7.9 1.8 10.2 3.4 1.3 1.5 0.0 0.4 6.8 2.7 2.9 2.8 1.1 1.0 0.0 1.9 1.1 3.8 1.3 3.3 5.2 0.1 2.0 1.6 1.2 8.7 3.1 0.8 1.8 1.9 1.8 5.3 0.0 8.5 5.7 1.2 0.2 3.0 0.7 1.9 0.1 4.7 7.9 4.1 0.0 2.5 4.2 6.0 3.5 0.9 1.8 0.8 1.1 3.0 0.5 1.8 PPEF2 PPP7CB ENSG00000156194 "Protein phosphatase with EF-hand domain 2" O14830 4 75859864-75902571 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 462 "retina: 240.8" "Group enriched" "Detected in some" 25 "Cone photoreceptor cells: 166.8;Rod photoreceptor cells: 576.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.19e-2)" "unprognostic (2.92e-1)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (1.53e-1)" "unprognostic (9.02e-2)" "unprognostic (3.32e-4)" "unprognostic (2.74e-2)" "unprognostic (4.54e-8)" "unprognostic (2.89e-1)" "unprognostic (5.98e-2)" "unprognostic (5.16e-1)" "unprognostic (3.66e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 240.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.4 0.1 0.1 0.4 0.0 0.0 0.0 166.8 0.0 0.1 0.1 0.0 0.0 6.3 0.0 0.1 1.5 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 1.9 0.1 14.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 576.7 0.0 0.4 0.1 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149179 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 26.4;fallopian tube: 16.0" "Cell type enhanced" "Detected in some" "Early spermatids: 18.1;Endometrial ciliated cells: 26.5;Late spermatids: 5.4;Respiratory ciliated cells: 23.3;Spermatocytes: 15.6" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HEL: 84.4;K-562: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076975 Supported NA NA "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.4 0.1 2.3 0.1 1.1 0.6 0.2 4.3 0.9 0.4 26.4 0.1 0.0 0.6 0.6 0.1 16.0 0.2 0.6 1.2 1.8 0.2 0.2 2.7 0.1 2.0 2.8 0.1 0.1 0.2 0.3 1.7 1.3 1.7 0.1 0.0 1.3 0.2 0.2 0.2 0.5 0.1 0.2 3.0 0.5 0.2 6.5 2.0 0.0 0.6 0.8 0.2 0.2 0.1 0.9 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 84.4 0.2 0.2 0.0 0.0 11.0 0.0 0.0 0.3 1.0 0.0 1.7 0.0 29.2 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 1.2 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.4 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 3.4 2.3 1.1 4.3 0.9 1.2 1.8 2.0 2.8 0.1 1.7 3.0 2.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 26.5 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 2.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 23.3 0.6 0.0 0.0 0.0 15.6 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654088-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 141.1;Alveolar cells type 2: 111.8;Astrocytes: 86.5;Club cells: 61.7;granulocytes: 63.1;Inhibitory neurons: 91.6;Oligodendrocytes: 75.2;Respiratory ciliated cells: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 12.1;hTERT-RPE1: 3.6;RPTEC TERT1: 14.0;TIME: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 270000 Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.4 4.2 2.0 1.0 1.6 0.0 1.7 1.7 1.4 3.1 4.4 7.9 1.4 7.0 1.6 3.3 4.5 1.1 7.9 1.2 1.2 3.3 10.5 7.4 1.1 1.4 1.1 0.8 1.2 7.3 0.9 1.4 10.5 1.6 6.6 3.2 0.3 2.4 7.1 2.6 1.4 1.9 4.8 1.5 1.9 4.7 2.7 1.2 1.0 2.6 4.9 0.5 5.2 2.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 1.7 1.4 1.2 1.2 1.4 1.1 0.8 1.6 1.5 1.2 3.1 8.7 141.1 111.8 86.5 0.1 7.0 5.2 1.7 0.6 0.2 0.2 0.3 9.4 0.0 61.7 1.8 0.0 0.1 0.8 0.0 0.0 0.5 14.9 0.6 0.4 10.6 0.0 0.0 31.3 2.4 0.2 29.0 1.5 1.2 63.1 0.1 1.1 10.2 0.2 6.7 91.6 0.0 0.0 0.6 0.5 16.9 49.4 5.9 0.0 5.6 0.0 0.1 1.0 4.5 75.2 1.0 0.0 17.0 0.4 2.4 0.0 0.6 56.4 0.2 26.3 13.0 8.3 2.1 2.8 0.6 1.1 0.1 5.0 0.4 0.0 2.3 ART3 ARTC3 ENSG00000156219 "ADP-ribosyltransferase 3 (inactive)" Q13508 4 76011184-76112802 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 61.5;skeletal muscle: 222.2;testis: 97.3;tongue: 102.5" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 76.2;Spermatocytes: 262.8" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "NB-4: 5.5;NTERA-2: 14.1;SK-MEL-30: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA011268 Enhanced "Intracellular and membrane" NA NA 48000000 "HPA011268: AB_1845059" "unprognostic (2.45e-1)" "unprognostic (2.84e-2)" "unprognostic (3.12e-2)" "unprognostic (2.77e-3)" "unprognostic (4.53e-2)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.85e-4)" "unprognostic (2.35e-1)" "unprognostic (5.10e-2)" "unprognostic (1.64e-2)" "unprognostic (2.95e-1)" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-1)" "unprognostic (2.58e-2)" "unprognostic (6.61e-3)" 0.8 0.4 4.0 1.1 4.7 0.0 0.9 7.6 7.9 2.0 4.3 2.8 0.3 0.3 0.5 4.8 0.9 0.2 61.5 5.0 5.5 0.2 0.2 0.4 0.3 3.5 3.3 4.2 0.4 7.9 0.1 2.5 0.1 5.2 2.0 2.3 0.2 3.1 1.3 222.2 0.8 2.3 0.4 3.9 2.7 1.9 97.3 3.6 0.6 0.3 102.5 0.1 0.7 1.7 10.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 14.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.7 7.6 7.9 5.0 5.5 3.5 3.3 4.2 5.2 3.9 3.6 10.3 0.4 0.0 0.0 0.7 0.1 0.5 0.5 1.1 0.0 0.5 0.2 0.3 76.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.3 2.1 0.4 0.8 0.0 0.0 37.9 0.0 0.1 2.6 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.4 13.5 1.8 0.2 1.8 0.0 0.0 0.3 0.0 5.0 7.3 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.1 0.3 0.0 21.7 2.7 262.8 24.2 0.0 0.3 0.0 0.2 0.1 0.8 0.4 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945798 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 49.5;kidney: 48.4;liver: 112.2" "Group enriched" "Detected in some" 5 "Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.0 38.2 0.0 0.6 0.1 0.7 0.2 1.0 0.1 0.2 48.4 112.2 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.2 0.2 1.2 0.6 0.0 0.0 0.0 0.1 0.0 1.5 0.0 49.5 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.8 0.3 0.0 0.6 0.5 0.2 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.3 2.2 4.3 0.6 7.3 0.0 0.5 0.0 0.0 11.7 3.0 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.0 0.5 0.4 0.0 0.6 0.0 0.0 0.4 38.6 54.3 0.0 0.5 2.8 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.5 1.1 0.3 2.5 0.0 0.0 0.0 86.9 93.4 1.4 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.3 1.5 0.1 WHAMM "KIAA1971, WHAMM1, WHDC1" ENSG00000156232 "WASP homolog associated with actin, golgi membranes and microtubules" Q8TF30 15 82809628-82836108 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039690, HPA040231" Approved Supported Cytosol NA NA Cytosol "HPA039690: AB_10795405, HPA040231: AB_10795361" "unprognostic (7.98e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (8.56e-2)" "unprognostic (6.68e-2)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.37e-2)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.20e-2)" 7.2 4.9 4.4 4.0 4.5 30.0 7.2 6.2 4.8 6.5 8.0 6.5 4.6 5.5 2.8 7.3 6.2 3.0 5.5 4.4 4.0 6.5 8.9 7.9 5.5 4.5 4.4 3.9 7.3 7.5 6.2 5.5 4.6 4.6 7.8 4.1 4.0 6.7 3.5 17.8 8.7 7.3 3.3 4.2 8.5 6.3 3.7 4.6 5.1 6.6 7.9 4.7 7.6 6.5 5.8 4.0 4.1 2.5 3.6 7.9 5.5 4.2 5.5 5.5 6.0 5.9 2.6 7.2 8.7 6.7 5.2 5.6 8.8 7.7 4.5 3.9 2.9 4.4 5.0 4.5 3.9 8.0 3.6 5.7 5.4 6.0 2.8 5.9 6.0 4.3 4.1 4.6 11.3 6.0 3.1 3.0 5.2 1.0 5.0 2.4 4.4 5.3 2.5 10.4 16.1 2.3 1.9 8.5 5.5 5.8 5.1 3.7 7.7 6.8 7.9 2.7 5.3 6.3 12.0 7.3 4.2 5.6 4.9 5.0 2.6 0.5 0.5 1.2 0.4 1.0 1.0 1.1 0.8 0.3 1.1 1.0 1.0 1.3 2.3 0.4 0.9 1.0 0.4 4.4 4.5 6.2 4.8 4.4 4.0 4.5 4.4 3.9 4.6 4.2 4.6 5.8 36.6 16.0 17.3 18.9 37.1 26.5 42.8 6.6 34.1 16.2 16.7 17.7 15.6 17.2 7.6 20.2 14.6 14.5 47.3 18.1 5.9 8.9 6.9 19.6 13.9 23.2 6.7 31.5 10.1 10.3 16.6 18.7 23.9 29.4 10.8 12.6 19.2 13.8 19.9 23.5 15.9 19.4 6.1 15.8 41.4 5.5 17.4 25.4 19.6 15.0 19.3 17.9 61.8 14.1 23.4 13.0 15.5 23.7 24.1 49.0 16.8 11.2 7.1 18.0 32.9 24.5 19.5 29.8 31.1 29.2 25.1 25.4 36.1 15.5 13.8 75.1 CXCL13 "ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13" ENSG00000156234 "C-X-C motif chemokine ligand 13" O43927 4 77511753-77611834 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 527.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 242.2;Breast myoepithelial cells: 72.4;Endometrial stromal cells: 101.0;monocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052613 Uncertain "Secreted to blood" NA NA 93700 "HPA052613: AB_2681885" "unprognostic (5.25e-3)" "unprognostic (1.19e-2)" "prognostic favorable (9.12e-4)" "prognostic favorable (5.52e-4)" "unprognostic (1.53e-2)" "unprognostic (1.17e-3)" "unprognostic (1.49e-1)" "unprognostic (6.41e-3)" "unprognostic (9.82e-3)" "prognostic favorable (5.41e-4)" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.16e-10)" "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (6.68e-3)" 2.6 0.4 0.1 128.9 0.4 0.1 15.5 0.5 0.3 1.4 0.1 13.4 2.0 3.6 1.7 2.4 0.8 5.8 1.2 0.1 1.4 0.6 28.8 2.9 527.3 1.5 0.1 0.5 0.7 0.3 0.2 3.2 0.7 0.2 27.6 16.6 0.2 8.6 1.4 0.0 0.4 69.1 1.2 0.5 341.3 35.2 1.5 0.2 16.4 2.4 0.0 445.0 30.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.3 0.1 1.4 1.5 0.1 0.5 0.2 0.5 0.2 0.2 0.9 0.0 0.5 1.3 0.3 0.1 15.8 3.9 0.0 0.0 242.2 72.4 0.0 1.5 0.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.6 101.0 1.7 0.0 10.7 1.9 0.2 0.3 6.3 0.5 1.8 1.3 0.0 3.6 21.3 10.2 0.0 3.9 0.0 0.0 3.4 0.0 0.0 0.0 0.9 0.0 1.9 38.8 0.0 0.0 1.0 0.4 0.1 0.0 0.0 0.2 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.3 7.8 0.0 0.1 4.5 N6AMT1 "C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC" ENSG00000156239 "N-6 adenine-specific DNA methyltransferase 1" Q9Y5N5 21 28872191-28885371 "Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034133, CAB034135, HPA059242" Approved Approved Nucleoplasm,Centrosome Yes No Centrosome Nucleoplasm "CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: AB_2683957" "unprognostic (2.20e-2)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (7.46e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.64e-1)" "unprognostic (1.04e-1)" "unprognostic (1.94e-2)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (5.24e-2)" "unprognostic (6.99e-2)" "unprognostic (5.43e-2)" "unprognostic (5.51e-3)" 2.4 5.1 5.3 2.5 5.6 0.9 5.0 4.7 5.6 6.0 4.2 3.3 3.2 6.4 6.1 2.5 4.7 2.9 5.3 4.5 4.7 4.2 2.9 2.5 3.5 5.6 5.0 4.6 8.0 2.9 5.7 4.4 6.4 6.1 4.6 3.4 8.5 3.1 4.0 6.2 3.8 2.8 3.5 4.7 3.7 3.1 3.7 5.2 2.2 5.4 5.7 3.3 3.9 4.1 8.8 2.8 2.5 6.2 8.6 5.1 5.6 4.8 6.1 2.5 3.5 2.0 3.2 5.0 3.1 3.0 3.3 6.2 3.3 5.4 3.0 4.3 4.0 4.1 6.7 4.2 4.0 4.5 4.0 2.5 2.9 6.4 3.5 2.4 6.3 2.6 3.8 8.4 5.5 7.3 2.9 1.9 3.2 7.9 6.0 3.5 2.8 5.9 2.4 6.0 4.1 4.7 6.6 5.5 1.9 2.3 5.6 2.7 3.5 5.4 2.9 5.2 5.4 3.7 3.3 4.0 1.7 4.6 10.4 5.5 0.3 0.4 0.6 0.5 0.7 0.6 0.7 1.0 0.7 0.6 0.6 1.4 1.0 0.1 1.4 0.5 0.5 0.4 0.5 5.3 5.6 4.7 5.6 4.5 4.7 5.6 5.0 4.6 6.1 4.7 5.2 8.8 7.8 3.2 5.4 5.2 7.1 1.9 5.8 10.3 1.8 10.8 6.3 6.5 17.0 7.2 8.7 12.9 8.4 18.3 4.0 1.5 7.9 11.0 2.9 10.7 9.6 6.9 0.0 13.0 4.6 6.4 12.2 7.9 8.6 4.2 1.3 15.1 5.3 3.5 7.2 10.1 5.1 3.0 10.2 1.3 0.9 4.5 9.6 2.6 1.8 1.0 2.7 11.1 4.1 6.6 15.1 7.7 4.3 10.1 1.2 4.5 2.5 9.3 15.8 10.5 0.0 7.7 8.9 4.5 10.5 4.2 3.7 14.9 5.1 20.1 3.1 4.8 RWDD2B "C21orf6, GL011" ENSG00000156253 "RWD domain containing 2B" P57060 21 29004384-29019360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Spermatocytes: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018316 Uncertain NA NA "HPA018316: AB_1845702" "unprognostic (1.96e-1)" "unprognostic (1.89e-2)" "unprognostic (1.42e-1)" "unprognostic (6.14e-2)" "unprognostic (6.67e-2)" "unprognostic (5.02e-2)" "unprognostic (1.75e-1)" "unprognostic (2.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.92e-2)" "unprognostic (2.07e-1)" "unprognostic (2.15e-1)" "unprognostic (1.16e-1)" "unprognostic (6.77e-2)" "unprognostic (2.38e-1)" "unprognostic (1.98e-1)" "unprognostic (2.75e-2)" 0.5 0.9 0.6 0.5 0.4 0.3 0.7 0.9 1.0 0.7 0.1 0.5 0.3 0.6 1.0 0.7 0.6 0.7 1.4 1.0 0.4 0.9 1.2 0.5 1.0 0.7 0.5 0.3 0.5 0.8 1.0 0.7 0.6 1.0 0.7 0.7 1.1 0.9 0.7 3.5 1.3 0.4 0.8 0.2 0.7 0.6 0.9 0.6 0.6 1.0 2.9 0.8 0.6 0.4 1.1 1.2 0.6 1.0 1.6 4.6 1.9 0.2 1.2 1.9 1.6 1.9 1.4 1.0 2.1 1.3 2.1 1.0 0.7 1.4 1.4 1.4 1.3 1.0 3.0 0.7 1.0 2.4 0.3 0.1 2.1 1.3 1.8 2.5 1.7 2.0 0.9 1.2 2.0 2.2 2.4 0.6 1.2 1.4 3.4 1.1 0.4 1.2 2.8 1.7 1.4 1.8 2.6 3.0 1.6 3.2 0.7 2.8 1.7 1.5 2.1 1.2 1.5 0.5 2.7 2.7 1.2 1.7 1.9 1.9 3.0 0.4 0.3 0.6 0.3 0.4 0.8 0.3 0.5 0.3 0.6 0.2 0.4 1.1 0.4 0.7 0.5 0.1 0.3 0.6 0.4 0.9 1.0 1.0 0.4 0.7 0.5 0.3 1.0 0.2 0.6 1.1 9.0 16.0 14.3 2.6 5.3 3.3 3.2 12.0 7.4 2.4 11.0 11.6 29.9 21.5 7.7 12.9 0.0 12.6 8.7 3.2 29.4 9.0 14.7 6.4 12.9 8.3 12.0 6.5 5.2 9.2 11.2 10.7 7.1 6.1 1.3 5.0 5.7 23.1 8.2 0.0 4.7 7.0 10.2 6.0 3.9 12.5 11.1 4.6 8.8 1.9 12.9 6.9 16.5 5.5 2.9 8.0 8.3 13.5 5.3 4.9 6.7 27.4 4.5 1.3 6.6 10.3 9.6 41.5 17.7 13.2 4.7 6.4 6.2 22.9 6.1 3.3 USP16 Ubp-M ENSG00000156256 "Ubiquitin specific peptidase 16" Q9Y5T5 21 29024629-29054488 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 514.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021140 Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021140: AB_1858668" "unprognostic (6.06e-2)" "unprognostic (3.14e-1)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (5.92e-2)" "unprognostic (5.79e-3)" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (5.78e-2)" "unprognostic (7.40e-2)" "unprognostic (8.73e-2)" "unprognostic (8.65e-2)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-1)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" 27.2 23.2 19.9 23.6 24.1 29.5 27.6 22.4 21.2 22.9 20.3 24.9 25.4 25.5 25.4 25.4 20.1 20.6 29.5 18.9 21.7 22.3 31.0 21.1 28.2 22.1 22.2 18.5 22.5 26.2 34.6 16.8 24.4 22.6 25.9 26.6 42.6 24.9 23.9 35.0 20.0 23.0 22.8 21.4 22.1 23.7 25.9 20.8 30.3 34.1 37.8 32.5 27.4 14.2 28.9 59.9 23.4 36.5 33.0 25.4 41.5 34.2 56.9 37.9 38.5 36.4 29.5 38.3 60.5 16.8 54.8 58.7 26.5 45.6 41.5 50.1 58.6 48.4 80.9 27.3 33.1 37.6 80.3 43.0 35.9 42.9 50.3 46.4 28.7 37.5 33.9 67.7 103.8 45.3 27.3 49.7 29.3 39.2 48.4 29.9 33.0 89.7 69.6 31.7 42.5 39.4 41.9 36.8 58.1 51.1 24.9 40.2 54.2 38.0 44.8 55.7 41.8 59.3 87.8 129.3 62.5 46.8 57.3 45.6 37.4 24.1 33.6 36.3 24.9 28.6 40.7 34.1 33.6 23.1 46.0 36.9 35.8 23.5 31.5 34.0 36.2 38.9 17.2 19.9 24.1 22.4 21.2 18.9 21.7 22.1 22.2 18.5 22.6 21.4 20.8 28.9 60.3 86.6 91.9 27.4 114.4 57.2 132.5 68.9 55.2 161.0 65.8 58.7 84.2 64.3 83.1 53.3 89.6 81.7 108.2 90.2 133.1 77.9 514.9 85.9 82.6 55.0 82.6 40.8 18.2 119.9 79.7 68.3 55.0 107.7 141.8 61.5 45.7 86.2 59.9 72.3 27.6 100.4 44.7 62.0 53.1 117.0 87.7 69.4 62.2 25.3 117.3 94.1 96.8 28.1 47.3 94.0 99.2 86.9 106.8 100.1 74.8 91.8 94.1 183.5 59.2 133.4 83.2 100.4 82.4 68.4 64.4 162.0 105.3 72.8 90.6 141.9 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No 1100000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 73.4 126.2 64.7 100.0 69.3 100.4 101.4 72.5 84.6 79.2 79.8 88.7 78.6 75.5 89.0 84.5 81.7 64.9 117.4 67.1 74.3 103.6 93.5 70.7 141.9 67.0 66.6 64.3 88.8 96.1 100.8 40.9 107.9 69.4 77.8 103.1 71.9 71.3 73.2 122.2 75.6 79.3 86.3 70.1 89.7 69.4 79.8 70.3 142.5 79.2 146.5 155.5 123.5 50.8 76.1 437.4 243.1 319.4 233.3 220.4 302.3 350.9 340.5 219.1 386.2 317.5 548.6 269.0 858.8 229.1 237.1 466.8 174.4 632.2 391.7 441.1 364.0 348.1 1185.2 289.8 384.3 227.0 609.0 335.6 229.0 244.9 448.6 372.6 278.6 368.1 379.7 935.8 519.0 404.1 270.9 456.6 359.4 572.6 433.6 310.6 411.7 596.5 547.4 409.1 283.2 316.7 231.6 334.1 356.6 364.7 347.5 319.9 526.7 267.4 221.3 613.7 216.7 439.7 329.2 651.8 695.1 256.3 704.5 339.0 79.9 110.1 54.4 56.9 120.9 79.6 79.8 76.3 73.4 133.3 61.8 85.5 82.1 11.5 87.7 132.2 83.5 92.7 127.4 64.7 69.3 72.5 84.6 67.1 74.3 67.0 66.6 64.3 69.4 70.1 70.3 76.1 66.9 64.1 61.7 15.0 120.1 143.1 197.6 278.6 70.0 85.6 88.4 76.5 75.7 90.1 150.0 75.4 18.8 268.9 122.1 67.3 144.8 194.1 17.0 106.6 92.8 94.8 97.0 150.2 26.7 138.0 275.8 93.4 52.0 73.7 112.8 135.6 55.3 53.4 170.5 77.4 31.3 106.2 201.4 115.6 122.4 20.5 84.2 109.9 115.6 26.2 226.6 96.1 97.9 13.6 21.4 131.2 92.1 92.9 130.7 185.9 107.4 189.7 147.7 84.6 105.2 88.7 214.7 170.1 176.8 90.2 131.4 285.3 105.1 254.5 161.1 170.6 MAP3K7CL "C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4" ENSG00000156265 "MAP3K7 C-terminal like" P57077 21 29077471-29175889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.6;tongue: 46.0" "Cell type enhanced" "Detected in many" "Macrophages: 77.2;monocytes: 24.7;Smooth muscle cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 53.1" "Group enriched" "Detected in all" 8 "B-cells: 22.8;granulocytes: 53.1;monocytes: 14.1" "Cell line enriched" "Detected in many" 4 "RH-30: 231.7" "Not detected" "Not detected" "HPA030079, HPA042439" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030079: AB_2673299, HPA042439: AB_10794422" "unprognostic (2.23e-1)" "unprognostic (2.06e-1)" "unprognostic (9.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.98e-2)" "unprognostic (7.00e-3)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.28e-3)" "unprognostic (4.39e-3)" "prognostic unfavorable (8.31e-6)" "unprognostic (2.68e-3)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (8.10e-2)" 5.5 7.2 6.2 8.4 5.2 4.3 3.8 3.3 6.5 4.4 4.3 3.5 2.4 6.0 5.0 3.7 4.8 5.6 29.5 5.1 4.9 5.0 5.4 10.6 9.6 6.4 5.4 4.9 5.1 8.0 3.0 3.9 2.9 7.1 7.1 3.7 2.6 2.6 3.3 41.6 4.9 5.0 5.8 5.6 6.2 3.5 5.4 4.3 3.8 3.3 46.0 9.2 5.2 3.1 6.5 3.3 1.0 0.4 1.3 0.6 18.9 0.7 5.1 11.6 10.6 29.4 5.5 1.4 22.5 1.6 19.7 0.4 0.0 0.4 15.5 51.8 6.1 0.2 3.0 3.1 0.4 2.8 0.0 0.2 6.5 26.8 37.6 38.5 5.4 2.2 0.9 3.1 12.0 55.9 0.7 0.8 0.2 1.6 2.5 1.3 0.1 231.7 0.4 1.4 0.9 1.7 0.9 0.0 0.0 1.6 4.3 0.3 1.6 2.3 23.5 18.8 5.5 0.8 5.6 1.8 1.2 4.1 2.2 5.3 53.1 14.1 3.4 1.7 11.3 3.9 18.0 1.2 1.7 2.0 22.8 1.8 3.1 21.1 2.1 5.3 2.2 3.1 95.7 6.2 5.2 3.3 6.5 5.1 4.9 6.4 5.4 4.9 7.1 5.6 4.3 6.5 4.0 0.0 3.0 5.9 9.4 8.5 7.5 5.8 2.8 2.5 1.7 1.1 1.5 2.8 1.2 0.0 2.1 0.4 3.3 0.7 0.0 1.4 1.2 2.0 2.3 4.9 4.8 0.8 4.0 1.5 0.5 3.7 0.5 1.8 1.3 1.7 1.4 4.5 3.3 0.0 6.2 2.9 0.0 16.5 5.8 1.3 0.6 77.2 5.4 16.9 24.7 1.4 19.6 14.1 3.6 4.0 3.1 4.5 1.0 3.1 4.8 3.9 2.0 1.7 19.7 19.2 47.7 1.2 1.7 3.1 9.5 0.4 4.9 3.4 1.8 2.9 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N-alpha-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326061 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 2.7;placenta: 4.2;testis: 6.2" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.1" "Region enriched" "Detected in single" 5 "cerebellum: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 2.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 4.2 0.5 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.3 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.0 32.9 11.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.7 0.1 0.1 0.2 0.4 0.3 0.0 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 15.9 0.0 0.0 13.3 0.0 0.0 0.0 0.0 BACH1 "BACH-1, BTBD24" ENSG00000156273 "BTB domain and CNC homolog 1" O14867 21 29194071-29630751 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.2" "Cell type enhanced" "Detected in all" "Early spermatids: 164.4;Late spermatids: 422.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 150.2" "Group enriched" "Detected in all" 4 "granulocytes: 150.2;monocytes: 51.1" "Cell line enhanced" "Detected in all" "Karpas-707: 129.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034949 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034949: AB_2674376" "unprognostic (1.57e-1)" "unprognostic (8.08e-3)" "unprognostic (2.64e-1)" "unprognostic (2.33e-2)" "unprognostic (6.00e-2)" "unprognostic (2.99e-1)" "unprognostic (9.84e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "unprognostic (5.79e-3)" "prognostic unfavorable (3.11e-5)" "unprognostic (5.63e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.60e-1)" "unprognostic (4.19e-2)" "unprognostic (8.70e-2)" 16.0 12.2 15.8 28.1 13.0 90.2 13.4 28.1 15.4 18.2 12.1 13.5 17.6 20.0 9.8 23.2 9.2 26.4 13.3 10.6 24.0 16.1 30.8 21.6 17.1 22.9 26.1 7.3 11.7 17.4 8.4 3.4 51.0 25.0 13.4 13.3 12.1 17.6 8.7 26.6 23.5 17.5 16.1 14.6 20.9 13.6 27.5 19.0 14.4 12.7 12.9 14.9 30.0 13.2 23.8 21.5 8.6 26.1 6.8 20.2 57.7 16.3 23.0 55.0 21.8 24.3 18.1 28.9 25.5 18.0 21.1 22.7 11.1 15.7 30.9 38.6 21.3 13.3 78.7 18.9 18.6 26.8 22.8 28.1 30.3 46.4 42.8 63.4 25.7 11.7 13.9 40.6 129.7 30.2 7.6 19.5 13.0 40.3 8.4 8.9 19.8 61.8 33.1 11.5 16.8 10.8 12.2 12.6 23.5 29.0 26.0 17.1 27.1 29.6 21.3 29.4 23.1 11.8 74.9 51.9 26.9 17.3 27.8 64.9 72.4 51.1 38.6 5.0 40.1 4.1 10.3 8.3 4.3 24.9 13.7 11.9 6.0 150.2 7.1 46.0 6.0 14.8 15.3 15.8 13.0 28.1 15.4 10.6 24.0 22.9 26.1 7.3 25.0 14.6 19.0 23.8 31.9 28.9 15.3 12.1 90.6 59.0 53.2 17.9 19.4 16.6 18.3 15.1 20.7 15.7 23.1 14.7 18.8 13.7 33.0 30.7 7.9 19.8 164.4 32.2 45.9 26.0 30.9 33.0 5.1 16.6 15.7 31.3 30.5 64.1 48.6 13.6 22.1 20.9 22.0 13.5 36.9 24.7 12.2 57.1 113.8 422.4 13.4 113.8 21.4 68.4 109.1 10.2 24.7 33.7 25.0 28.2 38.2 14.3 87.8 50.7 25.5 12.8 15.7 12.6 32.9 54.7 36.6 31.5 28.4 34.7 58.1 39.7 31.3 17.4 11.7 48.4 CLDN17 "MGC126552, MGC126554" ENSG00000156282 "Claudin 17" P56750 21 30165565-30166805 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 6.2;salivary gland: 6.5;vagina: 7.3" "Cell type enriched" "Detected in single" 4 "Early spermatids: 4.4" "Cancer enriched" "Detected in single" 5 "head and neck cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045903 Enhanced NA NA "HPA045903: AB_2679491" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CLDN8 ENSG00000156284 "Claudin 8" P56748 21 30214006-30216097 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 69.6;intestine: 51.3;kidney: 69.9;salivary gland: 40.5" "Group enriched" "Detected in some" 5 "Collecting duct cells: 224.3;Distal enterocytes: 110.2" "Cancer enhanced" "Detected in many" "prostate cancer: 31.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HaCaT: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA060605 Approved NA NA "HPA060605: AB_2684331" "unprognostic (3.74e-2)" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (1.62e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 69.6 0.0 0.0 0.9 0.0 27.5 0.0 0.1 9.4 3.9 1.1 0.0 0.0 0.0 0.0 69.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.5 0.0 7.6 51.3 0.0 40.5 14.0 0.0 7.3 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 22.1 0.0 0.3 0.4 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 10.8 2.7 0.0 0.0 29.9 11.6 0.0 0.0 10.5 224.3 0.0 0.0 0.1 110.2 11.7 0.1 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.4 0.0 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 15.9 0.6 0.4 20.3 0.0 0.0 0.0 0.3 0.0 0.0 4.6 8.4 0.0 0.4 0.0 18.0 23.1 TSPAN7 "A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2" ENSG00000156298 "Tetraspanin 7" P41732 X 38561542-38688920 "CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 546.7" "Cell type enhanced" "Detected in many" "Astrocytes: 274.9;Excitatory neurons: 215.6;Hepatic stellate cells: 407.3;Inhibitory neurons: 249.8;Oligodendrocyte precursor cells: 353.4" "Cancer enhanced" "Detected in all" "glioma: 71.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 109.5;JURKAT: 380.9;MOLT-4: 239.7;SCLC-21H: 129.0;U-266/70: 163.2" "Low region specificity" "Detected in all" "HPA003140, CAB062566, CAB068245" Enhanced NA NA "CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454" "unprognostic (1.12e-2)" "unprognostic (1.42e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.40e-4)" "unprognostic (5.06e-2)" "unprognostic (3.90e-3)" "unprognostic (3.88e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.54e-1)" "prognostic favorable (5.48e-7)" "unprognostic (5.65e-3)" "unprognostic (9.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-3)" 56.7 126.8 308.4 17.3 398.6 1.3 33.8 356.8 546.7 43.0 254.4 68.7 36.6 44.2 37.9 33.9 36.8 26.0 71.0 385.0 329.4 56.7 45.4 67.9 41.4 272.3 290.6 365.6 19.8 20.0 14.0 28.3 25.3 292.3 19.0 65.2 289.4 12.7 27.0 155.3 19.6 34.3 51.5 259.9 97.2 14.6 4.8 292.9 15.9 51.7 234.3 29.1 30.0 17.0 364.3 0.1 0.0 2.9 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 3.8 1.6 0.0 109.5 14.9 0.5 0.0 67.2 0.0 0.1 1.2 1.5 0.0 0.0 0.0 0.0 0.0 380.9 0.0 0.4 1.7 0.4 239.7 0.0 11.2 0.1 0.0 14.6 4.6 0.0 11.0 1.4 129.0 14.4 0.0 0.0 4.3 6.5 0.0 0.3 0.0 0.1 3.1 0.1 1.0 163.2 54.8 0.0 5.4 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 308.4 398.6 356.8 546.7 385.0 329.4 272.3 290.6 365.6 292.3 259.9 292.9 364.3 116.1 12.8 23.8 274.9 1.1 10.6 2.7 6.3 6.2 92.0 1.0 3.8 34.1 1.5 4.6 11.0 43.8 0.4 0.2 69.1 23.5 0.4 0.0 2.1 1.6 153.3 18.7 5.3 215.6 0.6 0.4 14.0 4.6 5.6 10.1 108.1 407.3 4.8 45.1 97.6 249.8 23.5 0.0 15.0 10.0 1.9 0.6 1.5 14.2 46.9 0.0 102.3 0.0 353.4 50.6 0.9 21.9 3.0 1.5 2.4 40.3 9.8 1.2 107.4 59.2 26.5 11.7 0.6 3.3 9.9 6.5 0.8 2.6 27.0 35.7 0.9 TIAM1 ENSG00000156299 "TIAM Rac1 associated GEF 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 203.5" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3" "Cancer enhanced" "Detected in many" "testis cancer: 15.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 245.9" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" Yes NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 6.6 12.8 40.7 6.7 35.9 2.9 5.5 203.5 49.6 15.2 14.8 4.6 1.7 10.0 3.3 40.0 11.1 4.6 3.8 51.8 29.0 5.4 7.9 5.9 11.2 28.0 41.7 33.6 3.4 2.2 0.3 13.0 4.3 76.2 9.1 3.1 8.7 5.7 3.4 0.9 26.6 5.0 11.1 29.5 5.2 2.4 10.5 36.1 18.9 2.0 0.8 11.2 12.2 18.7 30.3 2.9 1.0 21.7 1.3 0.4 4.9 34.5 0.0 0.0 2.7 0.9 0.2 3.9 7.6 1.5 0.5 4.0 5.1 2.5 4.4 4.3 0.6 12.0 34.7 0.7 0.2 0.5 0.0 29.1 2.2 1.5 14.7 5.9 2.6 0.0 11.3 0.0 10.9 11.1 14.7 5.4 0.2 7.1 5.3 9.4 7.0 6.8 0.0 3.3 35.5 32.6 8.1 1.5 11.4 1.3 7.5 4.7 0.1 0.2 3.1 12.5 0.0 1.5 12.3 9.9 6.6 7.2 2.6 24.2 1.5 17.4 0.0 0.5 15.3 3.1 0.1 12.5 2.4 9.6 0.0 16.2 1.0 1.0 11.3 22.0 0.5 27.8 5.9 40.7 35.9 203.5 49.6 51.8 29.0 28.0 41.7 33.6 76.2 29.5 36.1 30.3 3.7 3.2 2.3 21.2 1.7 83.7 65.6 3.0 22.8 8.9 4.9 1.9 1.1 1.5 11.8 0.0 2.1 10.1 8.0 1.3 0.0 1.8 11.7 25.2 2.2 31.4 5.4 2.7 43.9 0.7 29.7 11.4 2.0 28.4 24.1 2.0 35.0 5.5 8.1 74.0 327.3 0.4 10.2 22.9 73.4 11.3 34.5 26.3 10.6 133.0 37.3 35.2 4.1 120.6 124.6 1.8 11.6 58.3 3.2 30.8 0.0 0.5 1.2 4.6 6.6 0.9 2.1 1.3 9.8 60.2 143.3 10.7 16.3 82.6 1.2 106.7 SCAF4 "DKFZp434E098, KIAA1172, SFRS15, SRA4" ENSG00000156304 "SR-related CTD associated factor 4" O95104 21 31671000-31732118 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018319, HPA018668, HPA021504, HPA028807" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927" "unprognostic (9.18e-2)" "unprognostic (1.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (3.99e-3)" "unprognostic (4.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (3.28e-1)" "unprognostic (6.11e-2)" "unprognostic (1.85e-3)" "unprognostic (2.87e-1)" "unprognostic (7.65e-3)" "unprognostic (1.10e-1)" "unprognostic (2.16e-3)" 14.1 10.7 6.5 12.8 7.0 13.9 13.3 8.9 9.1 14.4 5.3 14.1 12.4 14.7 9.2 16.2 12.9 8.6 11.2 6.8 7.1 9.7 17.3 14.4 18.5 8.2 6.7 5.0 16.3 11.9 11.5 11.3 12.8 7.5 12.6 10.2 10.7 13.1 9.1 18.1 18.4 16.4 9.6 5.5 16.5 13.5 17.6 6.8 19.1 11.5 10.9 17.4 13.5 15.2 7.8 31.4 20.5 40.3 29.4 21.4 16.1 27.4 22.6 23.8 23.7 22.0 39.5 22.2 63.9 13.4 22.3 25.9 18.9 44.3 22.1 25.8 28.6 25.8 50.9 16.8 33.4 24.5 54.8 20.5 18.2 24.6 31.6 27.1 15.1 20.9 25.0 68.4 32.4 19.9 41.7 58.4 39.7 51.7 30.5 17.3 57.1 44.8 21.1 16.5 24.3 27.5 29.7 34.9 26.8 19.7 22.1 20.7 36.7 24.4 24.5 23.6 23.5 23.5 20.6 20.7 72.0 17.6 43.4 23.3 6.6 7.9 10.9 9.7 10.6 9.6 10.9 5.6 9.3 9.7 9.7 6.5 7.2 4.0 7.6 9.6 6.8 5.2 8.1 6.5 7.0 8.9 9.1 6.8 7.1 8.2 6.7 5.0 7.5 5.5 6.8 7.8 16.5 6.4 14.5 25.8 46.5 46.7 35.5 15.2 53.5 22.8 23.0 13.8 9.4 18.6 13.8 11.0 25.0 16.6 31.2 39.4 3.9 16.4 9.9 14.9 26.7 19.9 19.8 48.4 34.9 14.0 17.8 21.6 19.4 22.9 11.4 21.9 18.9 24.4 15.7 21.9 34.5 18.7 22.4 23.1 37.8 3.8 22.1 22.7 33.8 36.5 24.5 12.5 32.0 34.7 45.5 17.9 23.4 14.3 23.9 31.2 31.6 6.7 18.2 24.6 13.1 29.9 18.3 25.6 23.9 41.7 41.1 18.9 33.1 12.5 22.2 33.5 RPGR "COD1, CORDX1, CRD, RP15, RP3" ENSG00000156313 "Retinitis pigmentosa GTPase regulator" Q92834 X 38269163-38327544 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 14.6" "Cell line enhanced" "Detected in many" "HL-60: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001593, HPA073455" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA001593: AB_1079835, HPA073455: AB_2686603" "unprognostic (3.22e-2)" "unprognostic (1.16e-2)" "unprognostic (5.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.20e-1)" "unprognostic (9.94e-2)" "unprognostic (3.46e-2)" "unprognostic (6.32e-2)" "unprognostic (2.04e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-6)" "unprognostic (1.93e-1)" "unprognostic (7.59e-2)" "unprognostic (8.96e-3)" "unprognostic (1.61e-3)" 18.5 5.8 8.0 4.4 5.2 12.3 16.9 6.3 5.5 10.0 14.4 8.9 3.0 11.7 2.5 5.5 15.1 5.6 9.4 5.2 9.0 6.2 3.7 15.0 3.8 7.5 7.4 3.9 6.2 7.5 2.6 33.2 3.7 6.2 6.9 3.7 12.2 5.3 2.6 12.2 6.0 9.4 4.6 8.3 5.2 6.8 8.1 6.2 4.7 9.7 3.8 3.2 8.7 8.3 6.5 4.7 6.0 3.4 3.2 3.6 5.2 2.7 5.8 6.5 4.1 4.8 2.7 2.6 7.1 1.8 3.9 3.4 4.4 4.1 1.8 5.6 7.5 7.9 2.5 2.7 5.5 3.3 31.8 5.8 8.0 2.4 8.7 9.2 1.6 18.9 7.5 3.3 0.0 5.7 1.5 9.1 17.7 8.7 2.9 7.5 6.8 11.7 6.4 3.6 3.0 2.7 5.2 6.4 2.6 7.2 5.1 1.7 5.4 22.4 4.5 8.0 10.7 7.2 1.9 3.9 6.0 10.6 6.1 6.2 1.3 2.6 5.9 1.3 2.4 2.9 1.9 1.5 1.8 2.6 1.5 2.2 1.8 14.6 1.7 2.0 1.8 1.9 1.8 8.0 5.2 6.3 5.5 5.2 9.0 7.5 7.4 3.9 6.2 8.3 6.2 6.5 75.2 16.0 32.6 21.2 21.8 7.9 13.5 6.6 7.4 29.5 8.8 8.8 8.0 8.6 18.0 1.8 62.6 5.8 14.0 12.6 3.9 15.3 51.4 146.1 30.4 61.3 17.4 5.5 21.8 8.6 9.5 11.8 9.2 21.0 20.3 73.5 121.7 9.7 7.8 35.3 20.0 13.5 10.2 16.2 8.4 9.1 7.8 14.5 5.4 18.7 15.5 9.4 14.4 9.0 17.1 9.9 8.9 4.5 11.0 10.2 5.0 3.1 119.2 85.7 0.0 23.1 12.9 24.9 25.3 4.8 5.8 8.2 17.2 6.6 8.9 11.2 CDK20 "CCRK, p42" ENSG00000156345 "Cyclin dependent kinase 20" Q8IZL9 9 87966441-87974753 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 21.9;Spermatocytes: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 3.6" "Group enriched" "Detected in many" 7 "NK-cells: 3.6;T-cells: 2.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 18.2;THP-1: 29.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007666, HPA027379, HPA027401" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553" "unprognostic (4.60e-2)" "unprognostic (6.48e-2)" "unprognostic (1.69e-2)" "prognostic favorable (2.59e-4)" "unprognostic (2.32e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-4)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "unprognostic (2.83e-3)" "unprognostic (4.04e-2)" "prognostic favorable (2.12e-5)" "unprognostic (8.24e-3)" "unprognostic (5.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.42e-2)" 2.4 14.9 8.0 1.6 10.1 1.0 3.1 5.9 9.7 6.3 10.0 5.9 3.6 5.7 3.8 2.3 13.4 3.5 2.8 9.6 9.8 7.6 3.4 3.1 1.2 6.7 7.2 9.1 7.9 6.1 8.5 12.8 1.9 6.9 5.2 2.3 8.5 3.3 5.5 1.1 3.2 4.8 3.6 5.7 1.4 4.4 16.0 9.4 1.3 5.4 1.3 0.6 7.7 3.7 7.3 3.1 3.6 3.2 9.5 2.6 3.5 1.2 2.7 5.4 7.7 6.9 1.1 4.6 0.0 3.7 4.6 13.0 3.7 0.0 2.8 3.2 7.3 3.2 0.0 1.9 0.0 9.2 3.7 4.4 2.6 5.5 12.0 5.1 5.9 0.0 6.7 0.4 0.0 2.2 9.1 2.2 1.2 2.4 7.2 1.1 0.0 0.0 0.1 9.6 2.8 18.2 5.2 2.9 3.9 4.9 1.1 3.9 29.8 0.0 3.4 1.3 0.6 3.0 4.2 4.6 0.0 11.7 2.4 3.5 0.0 0.3 0.2 0.6 0.4 0.3 0.0 1.4 1.0 0.3 0.0 2.3 1.6 0.0 3.6 0.3 0.3 1.5 0.6 8.0 10.1 5.9 9.7 9.6 9.8 6.7 7.2 9.1 6.9 5.7 9.4 7.3 0.3 3.2 4.4 5.2 0.2 2.2 2.3 2.2 5.7 6.1 3.0 3.2 2.0 2.8 4.0 1.8 2.1 4.6 0.8 5.8 1.9 5.2 6.3 15.8 6.7 0.8 0.0 0.8 8.3 1.5 2.3 3.4 4.1 5.8 1.3 4.0 0.7 0.8 0.9 8.4 6.7 2.8 4.1 0.0 0.2 4.3 4.4 1.1 0.0 1.0 0.3 5.0 2.1 3.0 2.9 1.4 1.6 6.8 0.3 3.0 7.3 6.3 21.9 15.0 6.6 1.1 3.2 30.2 3.4 0.8 2.3 4.0 1.1 11.6 3.4 1.2 PCGF6 "MBLR, RNF134" ENSG00000156374 "Polycomb group ring finger 6" Q9BYE7 10 103302796-103351144 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.73e-2)" "unprognostic (8.93e-3)" "unprognostic (1.72e-1)" "unprognostic (7.74e-2)" "unprognostic (1.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (1.71e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (4.54e-9)" "unprognostic (5.14e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-3)" "unprognostic (4.53e-2)" 7.4 4.7 3.8 5.1 4.0 4.5 6.3 4.2 4.8 6.7 3.5 6.6 4.4 7.5 3.3 4.5 6.1 4.4 5.5 3.8 4.1 4.5 11.7 4.1 5.6 4.1 4.1 3.7 5.6 6.7 4.3 3.4 4.8 4.3 4.9 4.4 2.7 4.2 5.3 11.0 4.0 4.7 7.6 4.3 4.4 5.1 9.0 3.9 5.8 3.9 7.0 5.0 6.3 5.4 4.5 29.8 11.6 16.3 33.7 7.3 12.2 15.3 19.9 20.0 21.0 16.9 14.7 10.6 22.4 9.1 18.3 9.3 16.2 18.5 14.8 21.5 15.1 34.2 20.2 11.6 19.3 17.7 29.9 9.4 16.3 13.5 19.1 23.7 12.1 13.5 19.2 30.1 13.6 14.9 22.1 21.3 32.0 16.4 8.6 16.4 23.4 24.3 11.7 7.0 12.3 5.8 14.5 14.8 7.5 21.8 8.7 8.0 19.4 10.5 15.8 19.1 17.8 34.5 14.9 19.9 30.5 13.5 32.3 6.9 5.4 1.9 1.4 2.3 2.3 3.4 1.7 3.1 2.9 2.7 2.6 3.7 3.2 0.2 3.6 1.7 2.5 4.1 1.7 3.8 4.0 4.2 4.8 3.8 4.1 4.1 4.1 3.7 4.3 4.3 3.9 4.5 10.5 3.2 3.6 12.7 8.9 9.6 5.6 5.9 12.0 12.4 6.4 7.2 5.5 10.0 4.4 11.0 12.5 14.6 9.4 4.1 11.7 7.4 7.9 5.4 12.7 11.1 4.2 15.6 23.9 7.3 20.3 12.8 5.1 4.2 3.8 10.7 10.8 12.2 8.7 6.7 21.3 4.8 2.0 8.8 7.0 5.3 10.2 7.9 8.8 7.5 7.0 6.8 15.5 17.6 11.8 5.7 4.6 7.2 11.1 8.1 4.9 12.4 5.0 13.2 6.6 5.5 12.7 76.2 39.3 15.3 8.8 4.5 11.5 12.8 7.3 4.1 ANKRD9 ENSG00000156381 "Ankyrin repeat domain 9" Q96BM1 14 102501767-102509799 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 93.6;skeletal muscle: 156.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 198.8;Early spermatids: 161.0;Erythroid cells: 146.5;Proximal enterocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055985 Uncertain NA NA "HPA055985: AB_2682996" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (3.05e-2)" "unprognostic (1.26e-2)" "unprognostic (7.76e-2)" "unprognostic (7.31e-3)" "unprognostic (6.78e-2)" "unprognostic (3.97e-2)" "unprognostic (3.35e-1)" "unprognostic (2.99e-1)" "unprognostic (3.68e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.17e-7)" "unprognostic (3.89e-1)" "unprognostic (4.74e-1)" "unprognostic (1.32e-2)" "unprognostic (1.15e-1)" 10.1 21.3 26.1 3.1 16.1 18.2 10.5 23.1 43.0 7.8 22.4 26.0 50.7 7.7 1.9 19.7 7.0 4.6 93.6 18.4 18.4 23.7 16.1 16.0 0.8 36.6 23.5 14.0 10.3 11.5 8.9 7.4 5.0 32.0 20.3 10.1 2.4 26.3 4.1 156.0 23.7 32.9 2.5 25.2 9.2 22.7 40.9 36.8 0.4 11.3 26.6 1.7 13.0 15.1 23.1 16.0 7.5 13.3 12.6 13.6 5.6 20.8 18.7 7.0 8.3 8.1 1.9 10.5 0.0 20.5 5.2 9.2 25.8 6.5 3.8 4.2 11.3 26.7 4.2 14.7 3.6 7.0 1.5 13.5 2.8 22.6 4.5 4.5 5.4 3.6 2.1 8.2 1.4 4.0 14.0 2.2 4.4 6.3 24.6 33.5 21.5 12.5 1.0 8.5 16.2 10.8 11.5 13.3 8.6 24.4 7.8 13.1 6.0 8.3 8.4 10.9 41.4 14.7 11.9 6.9 0.5 9.9 2.9 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 26.1 16.1 23.1 43.0 18.4 18.4 36.6 23.5 14.0 32.0 25.2 36.8 23.1 10.8 19.2 4.5 41.4 2.7 13.0 37.5 1.5 6.8 11.0 32.3 22.5 40.3 15.7 5.0 14.7 2.1 9.7 30.4 198.8 92.0 3.9 161.0 11.4 6.4 9.8 16.7 146.5 12.6 4.8 30.5 13.5 34.7 21.5 31.8 20.1 8.6 11.8 29.5 16.8 14.1 42.5 2.0 7.5 7.8 23.9 5.6 25.4 10.6 5.6 0.7 16.8 2.1 4.0 3.4 5.3 73.7 9.8 10.2 37.8 129.2 16.7 1.1 7.7 13.1 26.8 10.8 6.6 6.7 14.1 20.2 18.3 9.3 18.3 56.7 54.8 SFR1 "bA373N18.1, C10orf78, FLJ41960, MEI5, MEIR5" ENSG00000156384 "SWI5 dependent homologous recombination repair protein 1" Q86XK3 10 104122058-104126385 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Spermatocytes: 233.6;Spermatogonia: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039617 Uncertain NA NA "HPA039617: AB_10805482" "unprognostic (2.79e-2)" "unprognostic (2.58e-3)" "unprognostic (1.94e-2)" "unprognostic (3.78e-1)" "unprognostic (8.54e-2)" "unprognostic (4.42e-3)" "prognostic unfavorable (2.59e-5)" "unprognostic (6.20e-2)" "unprognostic (9.39e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-3)" "unprognostic (2.21e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (8.44e-2)" "unprognostic (2.24e-2)" 4.9 4.4 6.4 7.3 8.6 10.0 6.6 7.7 7.9 3.8 6.9 5.3 4.7 5.4 7.4 4.9 5.4 4.9 7.6 6.2 7.9 5.0 3.1 6.4 9.1 8.2 7.8 6.0 9.0 5.9 3.6 2.9 4.0 8.2 3.9 6.5 4.3 4.1 3.4 4.1 4.4 6.1 5.7 7.6 6.3 5.5 18.5 7.4 11.8 7.4 5.3 7.6 5.5 3.2 12.1 22.2 12.4 13.1 5.5 5.0 8.9 7.7 11.6 14.0 7.4 9.7 5.5 45.7 17.7 10.9 3.1 15.5 18.4 6.6 15.8 11.8 15.6 7.5 13.3 5.4 7.0 9.3 15.7 8.5 4.9 5.8 14.8 20.3 9.9 15.3 18.2 8.6 12.5 9.3 6.8 16.0 28.3 6.2 13.0 9.0 19.8 19.1 9.4 16.0 5.9 7.2 7.4 7.4 4.0 9.9 10.9 10.1 6.9 7.1 4.2 15.2 12.9 18.8 14.9 19.2 18.0 12.2 16.6 5.7 23.6 16.8 10.4 14.3 16.5 14.6 16.6 14.9 15.2 11.9 19.2 21.7 18.3 5.4 12.8 12.1 10.3 13.5 14.9 6.4 8.6 7.7 7.9 6.2 7.9 8.2 7.8 6.0 8.2 7.6 7.4 12.1 12.1 3.2 11.8 1.3 9.9 21.5 14.6 10.4 2.8 3.5 6.8 7.0 8.5 8.6 13.8 1.8 0.0 9.7 9.8 4.7 17.6 12.1 20.0 8.0 6.3 13.7 3.0 21.8 1.3 12.3 13.7 10.2 2.6 7.8 12.0 8.1 18.2 1.9 17.6 5.0 2.6 6.3 18.3 16.3 12.4 11.3 9.6 12.5 3.6 4.7 17.8 9.6 15.5 1.0 14.0 19.1 5.1 6.0 4.5 5.1 5.7 10.1 5.3 4.9 0.0 13.0 9.0 233.6 76.7 5.5 7.4 3.8 10.4 5.6 7.2 8.7 SORCS3 "KIAA1059, SORCS" ENSG00000156395 "Sortilin related VPS10 domain containing receptor 3" Q9UPU3 10 104641290-105265242 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 2.0;brain: 7.8" "Group enriched" "Detected in some" 15 "Excitatory neurons: 270.4;Inhibitory neurons: 193.7;Oligodendrocyte precursor cells: 462.9" "Group enriched" "Detected in some" 13 "glioma: 1.8;renal cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-2)" "unprognostic (8.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-1)" "unprognostic (1.98e-1)" "unprognostic (3.63e-1)" "unprognostic (4.78e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.63e-2)" "unprognostic (1.97e-1)" 0.2 2.0 4.8 0.1 6.5 0.0 0.1 2.2 7.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 7.1 7.8 0.2 0.0 0.0 0.0 4.9 4.9 7.2 0.8 0.0 0.0 0.2 0.0 1.6 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.2 0.2 1.5 0.0 0.1 1.0 7.8 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.5 2.2 7.6 7.1 7.8 4.9 4.9 7.2 1.6 1.5 7.8 5.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.1 0.1 0.0 0.0 270.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.7 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 462.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SFXN2 SLC56A2 ENSG00000156398 "Sideroflexin 2" Q96NB2 10 102714538-102743492 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 18.1;parathyroid gland: 12.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Hepatocytes: 21.2;Proximal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 38.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018150, HPA026834" Enhanced Approved Mitochondria NA NA Mitochondria "HPA018150: AB_1856790, HPA026834: AB_1856791" "unprognostic (1.70e-2)" "prognostic favorable (2.28e-4)" "unprognostic (3.30e-2)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "unprognostic (1.44e-2)" "prognostic favorable (9.95e-4)" "unprognostic (4.24e-2)" "unprognostic (9.69e-2)" "unprognostic (3.98e-2)" "unprognostic (1.32e-1)" "unprognostic (8.98e-3)" "prognostic favorable (2.28e-5)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (3.77e-2)" "prognostic favorable (6.52e-4)" 1.5 1.1 1.0 1.9 2.4 3.0 2.8 3.9 1.7 1.7 3.0 2.0 2.5 2.7 3.6 1.4 3.6 1.1 0.6 1.9 0.7 18.1 4.3 1.6 2.6 1.3 0.8 1.5 3.4 3.2 12.8 2.7 3.4 2.4 2.3 3.1 2.7 5.0 1.3 0.7 1.9 1.9 1.1 0.0 2.1 3.4 1.2 1.2 3.2 3.9 0.2 1.9 0.9 0.8 2.2 4.2 2.3 3.5 3.7 1.3 0.9 5.1 1.4 0.6 1.8 0.9 7.2 1.9 9.1 2.7 1.2 1.0 3.0 0.7 4.8 1.0 1.6 2.8 13.1 4.4 4.5 0.6 7.5 1.1 1.0 0.7 1.8 1.8 1.1 1.7 7.7 6.0 4.2 1.1 4.0 11.5 2.5 2.3 4.0 0.8 5.5 4.3 1.3 1.7 3.5 2.6 2.5 1.2 3.1 0.6 1.4 38.4 1.6 1.2 1.4 4.4 1.8 3.1 4.6 6.5 7.9 1.7 9.0 1.2 1.6 0.5 0.2 1.9 0.2 1.7 0.8 1.9 2.0 0.7 2.5 3.0 2.5 0.9 1.9 0.3 1.7 2.0 0.7 1.0 2.4 3.9 1.7 1.9 0.7 1.3 0.8 1.5 2.4 0.0 1.2 2.2 1.0 0.0 10.1 5.2 3.8 0.9 3.0 0.8 4.0 6.1 7.3 5.2 2.5 4.3 2.0 1.8 33.3 9.1 2.4 2.5 9.8 1.9 0.8 7.3 4.2 2.2 3.6 4.2 5.4 2.8 4.4 3.2 8.2 10.0 0.0 9.2 5.0 21.2 9.6 0.0 5.5 5.0 0.0 7.5 0.6 0.5 2.1 2.4 0.0 8.4 0.8 1.1 4.1 7.1 2.9 1.4 0.8 1.5 6.7 4.4 2.4 43.1 0.4 15.1 0.0 2.7 1.7 1.2 1.3 3.3 1.3 4.5 2.8 2.6 7.3 2.9 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 99.8 168.2 318.8 76.4 331.9 178.9 128.8 317.5 450.3 89.6 314.4 166.8 166.6 81.2 140.9 160.7 87.8 49.2 474.6 330.0 326.4 183.0 183.4 80.6 95.2 316.3 312.5 323.9 99.1 114.8 259.6 161.1 77.7 315.3 109.4 169.1 171.3 101.7 88.6 494.3 103.4 130.0 79.6 314.5 109.6 136.7 84.0 316.1 136.3 112.4 475.8 123.5 103.9 101.9 325.9 244.6 278.5 233.6 222.8 275.0 284.2 228.5 185.2 211.7 228.6 199.5 240.6 167.4 254.4 187.9 191.2 183.4 201.1 306.4 225.3 310.0 207.9 306.8 280.4 227.5 380.4 180.4 346.2 188.4 298.6 301.5 155.7 164.2 260.8 264.4 330.6 176.7 264.7 253.7 730.8 333.1 493.9 182.1 560.5 523.7 211.5 202.7 231.2 358.4 345.0 201.2 238.4 155.9 289.0 371.4 256.2 355.3 401.7 142.7 87.9 137.9 242.0 153.2 199.3 372.5 360.2 207.8 195.7 152.3 405.1 512.8 336.0 204.9 409.1 232.9 309.5 261.1 234.1 367.0 261.9 295.5 260.0 517.5 206.2 401.4 355.4 282.2 656.9 318.8 331.9 317.5 450.3 330.0 326.4 316.3 312.5 323.9 315.3 314.5 316.1 325.9 88.0 221.2 225.1 0.0 47.9 0.0 0.0 0.0 0.0 0.0 369.7 334.4 0.0 0.0 92.2 413.8 0.0 609.1 63.1 0.0 1602.3 504.6 0.0 341.3 245.9 104.1 0.0 0.0 0.0 572.6 671.4 113.8 0.0 297.7 93.4 207.9 0.0 0.0 920.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.3 0.0 0.0 335.5 0.0 0.0 0.0 0.0 570.5 0.0 0.0 0.0 0.0 0.0 1883.7 146.5 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 710.1 70.2 228.6 0.0 0.0 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830408-5839722 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;kidney: 35.3;salivary gland: 46.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "Hep G2: 10.5;RPMI-8226: 4.0" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 51000 "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.1 0.0 0.1 2.6 0.1 0.4 1.7 0.2 0.1 9.3 0.3 17.5 28.9 0.3 0.0 80.1 0.6 9.4 0.0 0.1 0.1 35.3 12.5 0.2 0.1 0.1 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.1 0.2 11.7 2.1 46.0 2.5 0.0 0.1 27.2 0.4 0.1 0.1 4.9 0.2 0.1 0.0 0.0 0.0 6.7 0.0 26.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.2 10.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 4.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.5 0.0 0.7 0.0 0.4 3.5 0.0 0.4 3.7 1.9 0.3 18.6 15.7 1.8 0.0 0.2 0.3 35.6 3.9 6.8 0.3 0.6 0.7 0.3 4.9 0.0 0.1 0.4 0.1 0.3 0.0 0.7 0.0 0.2 0.7 5.1 0.1 0.0 0.1 39.4 8.2 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.5 0.1 2.7 21.5 0.0 0.0 0.2 101.4 45.3 6.4 11.5 0.0 0.3 0.7 1.0 0.6 3.6 0.1 0.0 0.5 0.1 29.0 1.7 TDRD9 "C14orf75, DKFZp434N0820, FLJ36164, NET54" ENSG00000156414 "Tudor domain containing 9" Q8NDG6 14 103928456-104052667 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "parathyroid gland: 30.8;testis: 41.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "classical monocyte: 1.6" "Lineage enriched" "Detected in single" 6 "monocytes: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-1)" "unprognostic (2.74e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-4)" "unprognostic (1.60e-2)" "unprognostic (4.57e-3)" "unprognostic (8.97e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.41e-2)" 0.4 0.5 0.9 0.6 0.8 1.7 0.5 1.2 1.0 0.3 1.1 0.3 0.1 0.4 0.4 0.2 0.9 0.9 0.6 0.8 0.9 2.2 0.3 1.0 0.5 1.6 1.1 0.8 0.2 0.5 30.8 1.0 0.5 2.0 0.3 0.2 3.5 0.3 0.5 0.1 0.1 0.3 0.6 1.2 3.1 0.8 41.1 1.2 0.3 5.4 0.5 0.6 0.4 0.2 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 21.5 0.0 0.0 0.0 94.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 8.7 0.0 0.0 0.6 13.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.8 1.2 1.0 0.8 0.9 1.6 1.1 0.8 2.0 1.2 1.2 2.3 0.9 6.4 2.0 2.3 0.0 0.0 0.1 0.1 0.0 4.3 1.0 0.4 12.4 0.0 0.7 0.0 4.2 0.0 0.5 0.0 1.9 0.6 13.1 43.2 1.5 0.9 0.0 1.3 9.1 0.0 0.0 0.7 0.0 3.7 0.0 0.3 0.4 0.1 1.9 6.7 4.6 0.0 2.0 1.8 0.0 7.3 0.9 1.5 0.0 2.8 2.9 0.6 0.0 1.0 4.6 0.5 0.0 2.2 0.3 0.5 0.0 2.5 0.2 2.3 6.6 0.9 0.8 63.2 38.6 0.0 0.0 0.0 0.3 11.7 0.0 0.1 FGF18 "FGF-18, ZFGF5" ENSG00000156427 "Fibroblast growth factor 18" O76093 5 171419647-171457626 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 10.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 19.8;Cardiomyocytes: 24.4;Endometrial ciliated cells: 13.0;Glandular and luminal cells: 24.9" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.0;ovarian cancer: 21.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 55 "EFO-21: 188.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA018795 Uncertain "Secreted in other tissues" NA NA "HPA018795: AB_1848523" "unprognostic (3.01e-1)" "unprognostic (2.38e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-3)" "unprognostic (6.62e-3)" "unprognostic (1.50e-1)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-3)" "unprognostic (3.65e-2)" "unprognostic (3.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.37e-8)" "unprognostic (7.33e-2)" "unprognostic (2.58e-1)" "unprognostic (3.19e-1)" "unprognostic (2.76e-2)" 2.9 0.3 1.0 0.3 0.9 0.0 2.1 0.9 2.3 0.7 2.4 0.7 0.6 0.9 0.1 0.3 1.5 0.7 10.3 1.0 1.0 0.5 0.1 2.6 0.3 1.2 1.1 0.8 0.4 0.5 0.1 1.6 0.5 1.4 1.2 0.1 0.1 1.1 0.3 3.9 1.2 0.7 0.4 0.8 0.5 0.6 0.8 1.4 0.3 1.9 0.4 0.3 0.9 0.5 1.0 0.0 0.3 0.3 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.1 3.4 0.4 0.2 188.2 0.0 0.2 0.2 0.0 0.1 0.0 3.1 0.3 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.9 0.1 3.4 0.0 0.1 0.0 0.3 2.1 0.1 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.5 0.1 0.5 0.0 0.2 0.6 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.9 2.3 1.0 1.0 1.2 1.1 0.8 1.4 0.8 1.4 1.0 6.9 6.4 0.0 0.0 2.0 2.4 2.6 0.5 6.2 0.1 6.6 19.8 24.4 1.5 1.3 1.8 0.0 0.1 3.4 0.5 0.0 0.0 6.2 13.0 3.1 4.2 1.8 0.0 0.8 0.0 0.3 9.4 0.5 24.9 0.0 0.0 2.9 0.0 0.1 0.0 2.1 1.0 0.0 0.0 2.1 0.7 0.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.4 3.2 1.1 0.0 0.0 0.0 0.0 5.4 4.6 0.7 1.6 5.6 3.1 0.0 2.4 0.5 1.8 0.9 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853090-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 2500000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 24.3 4.0 11.7 7.7 16.7 1.2 23.0 2.5 14.0 9.5 0.0 23.3 21.6 9.2 6.5 42.0 9.2 6.6 13.8 16.4 4.7 20.7 19.5 27.9 2.0 2.0 0.8 13.5 2.5 13.9 3.8 6.6 19.4 3.0 10.9 14.4 3.4 29.0 11.3 8.3 26.1 17.3 7.3 0.6 1.9 23.8 1.1 2.6 1.0 12.7 11.2 9.2 9.9 19.4 6.1 18.9 1.0 7.7 8.5 0.3 0.0 5.5 0.2 0.2 0.1 0.0 4.5 86.1 0.1 43.7 0.6 1.0 108.0 9.9 7.9 0.0 0.1 0.3 0.0 0.4 0.1 6.9 0.0 0.3 0.0 17.8 0.1 1.2 18.1 56.2 0.0 0.1 9.2 0.0 15.1 0.3 0.0 32.5 77.8 14.6 0.3 0.1 13.2 6.3 74.2 0.9 1.8 0.5 23.3 20.0 21.6 18.8 0.4 74.5 0.1 0.7 0.1 6.9 0.0 0.1 0.2 0.5 0.0 52.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 11.7 16.7 2.5 14.0 16.4 4.7 2.0 0.8 13.5 3.0 0.6 2.6 6.1 61.5 0.0 5.3 3.6 0.2 1.0 12.0 4.6 0.0 9.6 9.5 4.7 4.4 20.0 8.6 12.9 0.0 0.7 2.0 66.4 3.9 15.3 1.3 10.1 2.1 34.2 7.7 2.7 12.3 46.3 0.3 2.6 21.9 21.3 0.0 0.0 7.5 30.1 0.2 26.9 6.1 21.3 12.2 1.4 2.3 2.5 0.6 0.5 0.0 6.5 0.0 4.8 7.2 5.5 7.2 65.2 30.3 0.4 1.4 25.8 36.4 5.2 7.1 0.5 13.1 0.9 18.5 0.3 0.2 7.4 2.6 20.1 0.9 0.5 18.9 54.5 SH3RF2 "FLJ23654, Hepp1, POSHER, PPP1R39, RNF158" ENSG00000156463 "SH3 domain containing ring finger 2" Q8TEC5 5 145936578-146081791 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 42.2;skeletal muscle: 42.7;skin 1: 57.2" "Cell type enriched" "Detected in many" 5 "Late spermatids: 7869.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 70.3;GAMG: 29.8;hTERT-RPE1: 33.5" "Region enriched" "Detected in many" 14 "basal ganglia: 26.7" "Region enhanced" "Detected in many" "basal ganglia: 9.7" "HPA035903, HPA058119" Uncertain Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA035903: AB_10696515, HPA058119: AB_2683611" "unprognostic (8.90e-3)" "unprognostic (2.00e-3)" "unprognostic (5.11e-3)" "unprognostic (1.66e-2)" "unprognostic (1.45e-3)" "unprognostic (1.47e-2)" "unprognostic (9.96e-3)" "unprognostic (8.22e-2)" "unprognostic (3.92e-1)" "unprognostic (7.37e-3)" "unprognostic (2.44e-3)" "unprognostic (1.66e-1)" "unprognostic (2.98e-2)" "unprognostic (5.21e-2)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.13e-3)" 1.9 0.9 0.9 2.5 5.9 0.0 4.7 0.0 4.5 4.2 1.1 14.4 16.1 1.1 3.7 34.3 6.2 12.1 42.2 0.9 1.4 0.9 7.1 2.7 0.2 1.7 0.3 0.7 0.4 15.6 0.0 1.6 0.1 3.2 2.7 14.5 0.5 12.2 0.6 42.7 57.2 13.8 1.1 0.0 0.0 20.6 6.9 1.5 1.0 6.3 8.9 7.8 1.2 20.8 0.4 21.0 5.7 0.2 1.1 0.0 0.0 0.0 0.2 1.7 4.1 1.7 70.3 19.0 0.0 10.5 0.9 29.8 18.9 0.0 22.4 4.0 0.3 0.3 0.0 8.5 9.5 1.2 0.0 0.0 0.2 11.9 6.4 14.8 33.5 0.2 0.5 0.0 0.0 1.8 0.1 0.0 0.0 1.6 17.3 1.5 0.0 0.2 0.0 8.7 2.0 0.0 0.0 1.2 0.4 0.5 1.0 6.6 0.1 9.8 0.8 17.3 1.5 6.7 0.0 0.0 0.0 10.6 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 5.9 0.0 4.5 0.9 1.4 1.7 0.3 0.7 3.2 0.0 1.5 0.4 4.1 16.0 2.3 1.6 0.0 55.1 5.4 14.5 38.7 0.4 3.9 3.3 510.0 8.6 6.7 1.8 0.0 0.2 0.2 38.9 0.0 5.7 1511.3 11.9 0.9 9.7 1.2 0.0 10.5 8.7 0.0 15.4 50.4 26.7 1.3 0.1 0.7 8.4 0.2 0.0 2.2 16.1 8.2 0.0 4.9 7869.1 25.7 2.6 8.8 10.3 0.6 1.6 0.0 1.5 0.7 21.4 22.9 34.6 0.6 2.2 26.6 0.9 4.4 0.1 13.1 1.6 6.3 31.4 20.7 70.9 50.0 0.0 0.7 2.9 33.2 6.6 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142333-96160806 "Disease related genes, Human disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 11.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4" "Cancer enhanced" "Detected in some" "renal cancer: 2.8;thyroid cancer: 2.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "midbrain: 1.2" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 0.9 0.1 0.3 0.9 0.3 0.0 0.4 0.4 0.7 0.2 0.0 0.6 0.3 1.4 0.4 0.4 0.5 2.4 1.7 0.3 1.6 0.2 0.4 0.2 0.1 0.6 0.3 0.2 0.1 0.7 0.1 0.1 11.0 0.9 0.3 0.3 0.0 0.0 1.5 0.0 0.0 0.9 1.1 0.3 0.0 0.7 0.6 0.6 0.1 0.6 0.1 0.0 0.8 0.9 0.4 0.0 0.0 0.2 0.0 1.1 0.6 3.9 2.6 0.0 2.3 2.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 3.2 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 3.0 0.0 20.4 0.2 0.0 0.0 0.0 33.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.8 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.4 0.7 0.3 1.6 0.6 0.3 0.2 0.9 0.3 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.8 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.0 2.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 UQCRB "QCR7, QP-C, UQBP, UQCR6" ENSG00000156467 "Ubiquinol-cytochrome c reductase binding protein" P14927 8 96222947-96235546 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1318.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 5409.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043060 Approved NA NA 2200000 "HPA043060: AB_10806376" "unprognostic (5.48e-2)" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (9.47e-3)" "unprognostic (2.15e-1)" "unprognostic (8.41e-2)" "unprognostic (2.79e-1)" "unprognostic (9.20e-2)" "unprognostic (3.98e-1)" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (2.90e-4)" "unprognostic (1.01e-1)" "unprognostic (7.54e-2)" "unprognostic (1.07e-1)" "unprognostic (5.66e-3)" 200.6 244.5 211.1 129.9 217.5 180.9 148.0 220.9 356.2 177.1 223.3 227.7 173.6 148.9 186.4 149.8 152.6 80.8 896.8 205.8 226.6 275.7 225.5 120.8 151.2 219.3 216.4 201.4 245.1 187.0 254.7 199.7 98.4 221.8 138.8 157.4 237.8 208.2 101.3 1318.4 99.0 156.9 130.3 227.1 129.9 194.7 68.3 216.6 146.5 122.1 829.5 161.3 177.5 154.8 224.2 338.9 150.1 202.0 126.9 280.8 287.7 129.6 267.9 202.2 147.6 158.0 132.3 157.2 146.2 395.7 218.5 153.0 162.1 187.1 252.1 193.2 221.6 136.6 483.3 312.6 235.6 208.9 269.5 197.0 337.3 217.3 170.1 258.8 469.7 214.5 246.7 258.2 244.2 225.2 206.1 432.6 406.1 117.8 705.2 227.7 190.4 131.0 274.3 290.5 258.5 182.1 181.3 163.0 60.8 434.5 268.5 250.1 440.2 260.0 92.7 144.4 165.8 288.6 211.2 172.2 344.5 153.2 353.9 104.4 134.4 143.7 141.5 123.0 240.0 152.2 211.3 194.1 156.2 162.1 165.5 235.4 224.3 102.5 130.5 290.1 139.4 241.3 224.4 211.1 217.5 220.9 356.2 205.8 226.6 219.3 216.4 201.4 221.8 227.1 216.6 224.2 361.3 445.5 566.8 40.8 601.2 302.2 509.6 1261.7 333.5 299.0 330.1 403.9 5409.1 859.3 687.3 332.9 116.7 637.3 578.6 812.3 2484.8 893.3 1127.8 663.6 588.1 474.6 730.7 467.4 42.9 926.7 513.3 508.6 372.6 525.9 587.0 399.0 732.5 1069.1 1143.8 126.2 50.7 1074.2 608.3 1670.2 624.3 290.2 863.9 661.6 820.0 22.5 1280.8 555.2 748.7 19.1 27.9 791.9 949.4 720.7 415.0 378.9 1166.7 2205.9 482.9 436.7 539.0 745.3 650.7 358.2 245.9 444.4 291.1 598.4 675.0 401.5 1078.0 588.9 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007355 Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA007355: " "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavorable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 14.7 16.4 17.9 15.4 18.7 11.6 18.1 20.5 22.0 14.1 21.9 13.6 12.8 13.7 23.1 11.7 12.8 12.5 23.6 18.3 18.8 16.1 23.3 12.2 18.4 18.7 19.2 18.5 12.2 15.6 22.5 12.7 16.8 19.1 13.6 14.5 16.2 13.0 17.4 30.5 17.1 11.6 16.8 17.5 16.1 12.8 11.9 18.5 16.8 12.0 38.6 19.6 16.5 12.1 19.8 41.1 25.9 38.1 30.3 26.4 27.4 17.5 30.8 25.0 43.9 44.2 18.8 29.6 36.5 63.3 18.2 22.5 22.8 39.7 24.1 53.2 35.6 29.3 52.5 20.6 22.8 37.1 17.9 20.7 27.5 35.4 35.6 33.5 22.9 36.5 39.0 45.1 18.7 44.7 26.9 76.6 52.8 19.8 71.6 39.8 45.9 31.2 28.8 32.7 21.8 25.9 20.4 23.0 6.6 33.8 24.5 34.3 25.0 16.3 30.9 20.8 36.0 27.7 21.3 28.9 43.2 33.4 47.3 41.3 39.5 13.4 6.1 15.6 15.9 22.6 20.4 17.7 17.8 20.2 17.7 19.8 20.2 2.2 23.8 15.8 24.3 18.6 10.1 17.9 18.7 20.5 22.0 18.3 18.8 18.7 19.2 18.5 19.1 17.5 18.5 19.8 10.4 3.2 6.9 7.8 10.8 0.0 21.2 0.0 10.8 0.0 6.6 8.5 31.2 5.7 5.6 5.5 0.0 30.4 10.8 0.9 13.7 12.5 5.6 6.2 10.1 8.1 0.0 12.4 12.9 9.8 21.0 12.7 4.1 5.4 6.3 11.2 6.1 8.0 16.2 0.0 12.6 3.6 0.0 5.2 0.0 4.1 13.7 7.1 0.0 4.7 16.0 0.0 15.5 7.5 14.2 7.7 3.3 13.9 7.0 22.9 3.3 11.1 5.1 0.0 13.1 10.3 9.9 28.2 21.2 9.1 0.0 17.4 8.8 9.5 5.3 11.7 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261902-96336995 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavorable (1.08e-5)" "prognostic unfavorable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 1.6 2.2 0.9 3.5 1.9 4.9 3.1 1.2 2.5 3.5 0.7 3.5 4.1 2.1 2.9 3.7 2.6 3.1 7.3 1.5 1.5 3.8 4.6 2.6 5.7 0.5 0.7 1.5 3.7 2.7 8.0 0.6 4.6 1.3 1.9 2.9 0.9 2.0 3.5 2.9 3.2 3.2 3.6 0.1 2.6 1.4 1.9 1.4 3.7 4.5 3.0 5.2 2.6 1.1 1.5 14.9 11.6 2.0 5.5 4.2 8.5 3.4 10.6 15.5 10.6 7.5 4.6 4.2 24.9 9.5 10.5 2.1 6.0 14.1 11.1 16.1 12.5 10.3 24.5 19.8 2.5 4.3 17.8 8.1 7.2 10.9 14.4 10.2 2.7 7.0 7.6 12.5 12.3 9.7 4.4 14.0 3.0 3.1 5.1 11.1 10.9 10.1 18.8 5.7 12.5 8.6 3.5 3.9 3.4 1.4 2.3 8.2 6.3 11.8 9.1 5.5 6.3 12.3 2.5 13.3 11.8 5.7 19.3 7.5 10.5 2.6 1.5 1.7 1.6 2.5 1.7 2.8 2.2 4.0 2.2 2.5 1.8 0.9 3.2 1.7 1.2 1.7 6.7 0.9 1.9 1.2 2.5 1.5 1.5 0.5 0.7 1.5 1.3 0.1 1.4 1.5 12.4 19.2 9.1 8.8 50.5 31.6 18.9 22.6 42.7 10.2 22.9 18.4 94.5 14.3 15.6 11.0 10.4 78.4 23.6 11.9 1.9 20.5 60.1 6.6 9.1 22.9 5.4 38.3 29.3 44.9 54.1 18.0 14.8 9.3 32.4 17.6 34.2 32.1 45.9 5.0 29.2 17.1 10.2 45.3 31.5 52.2 23.3 36.0 19.6 15.9 39.3 4.7 29.9 21.1 8.7 23.9 11.9 25.9 45.5 21.4 16.6 19.0 5.2 4.7 0.0 13.8 15.8 12.1 18.8 33.1 33.5 80.9 34.3 14.6 34.8 16.3 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146580742-147084784 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 77.8;retina: 43.3" "Cell type enhanced" "Detected in many" "Astrocytes: 1539.0;Excitatory neurons: 846.0;Inhibitory neurons: 788.8;Late spermatids: 876.4;Oligodendrocyte precursor cells: 1035.4;Oligodendrocytes: 4480.1" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 5.2;MAIT T-cell: 4.1;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.2;naive CD8 T-cell: 3.8;NK-cell: 2.9;T-reg: 3.4" "Group enriched" "Detected in many" 9 "NK-cells: 2.9;T-cells: 6.2" "Cell line enhanced" "Detected in some" "HaCaT: 7.2;HDLM-2: 24.2;RT4: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 1.0 7.9 54.8 0.9 72.4 1.9 0.8 44.5 77.8 1.1 8.2 4.9 1.0 0.4 0.5 1.3 3.7 1.8 1.4 59.7 51.2 3.0 0.7 0.8 1.7 58.3 59.7 55.1 0.4 1.9 2.8 14.9 0.7 66.2 1.9 2.0 43.3 1.0 1.0 0.3 3.0 2.3 1.3 44.9 1.8 1.1 19.0 56.1 0.8 3.1 0.3 0.8 7.5 2.0 73.4 0.2 0.0 1.3 2.0 0.2 0.0 0.4 0.7 0.3 0.7 0.2 2.3 1.9 0.2 0.2 0.1 0.0 7.2 0.5 0.4 1.8 24.2 0.4 0.4 4.8 0.6 0.4 0.1 0.4 0.2 1.2 0.0 0.4 0.8 0.3 0.7 0.7 0.5 0.9 0.3 0.2 0.1 2.3 0.0 0.9 1.6 0.2 0.0 1.9 12.5 1.3 0.2 0.3 0.0 0.3 1.4 0.7 0.0 0.4 0.1 0.3 1.7 0.6 0.1 0.4 0.2 0.9 1.9 2.0 0.5 0.0 0.0 5.2 0.0 4.1 0.1 2.4 6.2 0.0 0.0 0.6 3.8 0.1 2.9 0.1 0.0 3.4 1.4 54.8 72.4 44.5 77.8 59.7 51.2 58.3 59.7 55.1 66.2 44.9 56.1 73.4 0.5 3.2 1.8 1539.0 0.3 2.0 1.1 2.3 4.6 90.5 0.5 3.6 1.6 10.0 0.9 9.2 150.1 18.9 30.2 0.0 21.5 1.7 295.3 1.0 0.1 2.0 13.1 1.3 846.0 0.0 0.3 1.1 1.1 0.4 0.0 0.0 0.0 0.0 0.9 47.1 788.8 0.0 0.0 1.2 4.7 876.4 3.4 1.4 5.4 58.1 0.3 45.0 57.7 1035.4 4480.1 0.6 0.0 2.2 3.3 1.0 0.0 5.5 0.1 275.4 0.0 0.7 11.0 4.8 2.2 1.6 1.4 5.3 31.0 0.1 0.0 0.9 RPL30 L30 ENSG00000156482 "Ribosomal protein L30" P62888 8 98024851-98046469 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002651 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 310000 "Endoplasmic reticulum, Cytosol" "HPA002651: AB_1079842" "unprognostic (3.28e-2)" "unprognostic (2.19e-1)" "unprognostic (7.36e-2)" "unprognostic (2.42e-2)" "unprognostic (3.48e-3)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (3.34e-1)" "unprognostic (2.89e-1)" "unprognostic (2.49e-2)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.41e-9)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (5.97e-3)" 2160.8 1297.3 1566.7 1416.8 1624.0 3798.9 4118.8 1569.4 2196.2 2554.8 1547.4 1888.5 1181.7 2009.5 2445.3 1923.2 2615.4 1331.2 1487.8 1514.0 1640.7 1381.5 2371.4 1490.2 3323.2 1609.7 1565.5 1481.5 5667.1 2605.5 1425.6 1087.8 1352.3 1632.0 1788.8 1986.0 640.2 2166.8 1544.6 2801.5 2839.1 1803.3 1632.0 1652.3 1999.8 1857.0 664.7 1616.6 3141.6 1759.6 2464.5 3931.1 2136.9 2162.5 1681.8 3358.5 2302.6 2395.7 2319.1 3463.7 6460.5 2290.5 1929.4 3501.7 3277.9 2880.0 2560.3 3121.6 4403.5 4934.1 2851.4 1408.4 2158.4 3072.1 3675.9 3436.7 1734.7 2547.3 3817.6 2173.7 3445.6 5063.9 2047.0 1830.0 5463.0 5859.2 2408.7 6912.4 3818.6 3479.7 3804.8 2814.6 2850.5 2866.9 4562.1 4848.6 3870.2 2142.9 8254.3 3304.7 2578.5 1815.0 4130.4 2718.3 3174.1 3464.7 2947.9 1117.1 2785.7 4699.0 2414.5 3667.8 4793.0 1873.6 1253.2 1328.9 1885.1 2357.7 2931.8 2681.4 3686.5 1758.0 4203.3 1869.4 1087.1 1542.9 674.9 2014.7 1325.2 2975.8 3533.8 3482.3 2704.0 1937.3 3224.2 4471.8 3686.3 520.5 2037.1 1212.6 1921.8 2476.6 4634.7 1566.7 1624.0 1569.4 2196.2 1514.0 1640.7 1609.7 1565.5 1481.5 1632.0 1652.3 1616.6 1681.8 3373.1 852.5 1462.3 22.2 6269.8 3791.4 4320.2 2146.2 5538.1 251.5 4342.6 9218.9 66.3 1441.3 1424.1 555.4 139.7 2675.7 4184.6 1233.9 1792.1 1872.1 1333.5 1359.6 3432.8 2196.1 1647.4 2350.9 24.2 3733.5 3914.4 2206.6 1829.8 1820.2 1560.7 3526.6 2224.6 2204.3 2298.9 144.7 28.3 3237.2 642.9 2912.4 4020.1 2532.2 4373.5 3115.9 1988.6 33.7 3957.1 1623.5 3901.2 18.1 54.5 2580.0 2676.0 2403.1 3084.7 4207.4 2142.3 2511.0 640.5 392.2 1406.8 3481.1 2754.6 926.1 635.4 5831.2 4174.6 2901.7 5319.1 2561.6 3407.3 4410.9 KCNS2 Kv9.2 ENSG00000156486 "Potassium voltage-gated channel modifier subfamily S member 2" Q9ULS6 8 98426958-98432853 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.7;Endometrial stromal cells: 3.0;Excitatory neurons: 4.5;Inhibitory neurons: 1.7;Leydig cells: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebral cortex: 5.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 2.1;SCLC-21H: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051417 Uncertain NA NA "HPA051417: AB_2681478" "unprognostic (7.83e-2)" "unprognostic (9.39e-3)" "unprognostic (5.25e-2)" "unprognostic (2.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (4.27e-2)" "unprognostic (4.58e-2)" "unprognostic (1.47e-1)" "unprognostic (5.30e-5)" "unprognostic (2.43e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-3)" 0.5 0.4 0.5 0.1 0.4 0.0 0.2 0.0 5.6 0.6 0.0 0.3 0.0 0.3 0.5 0.2 0.3 0.4 0.0 0.7 0.6 0.1 0.0 0.2 0.0 0.0 0.1 0.7 0.7 0.2 0.1 0.4 1.6 1.2 0.2 0.2 0.7 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.9 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 5.6 0.7 0.6 0.0 0.1 0.7 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.0 0.1 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 FAM122C RP3-473B4.1 ENSG00000156500 "Family with sequence similarity 122C" Q6P4D5 X 134796395-134854835 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 12.6" "Cell type enhanced" "Detected in many" "Early spermatids: 57.8;Granulosa cells: 39.0;Theca cells: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059961 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA059961: AB_2684181" "unprognostic (1.32e-2)" "unprognostic (3.50e-2)" "unprognostic (7.63e-2)" "unprognostic (3.38e-3)" "unprognostic (1.08e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-1)" "unprognostic (3.76e-3)" "unprognostic (3.50e-2)" "unprognostic (7.20e-3)" "unprognostic (2.28e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-2)" "unprognostic (5.93e-2)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" "unprognostic (4.16e-3)" 2.3 1.8 2.4 2.6 2.2 5.9 1.3 3.1 3.8 1.7 4.1 1.8 0.9 3.8 1.8 1.8 2.6 1.8 1.5 2.2 3.4 1.6 1.8 2.2 4.4 2.4 2.0 2.6 12.6 0.7 1.6 1.5 1.6 1.9 1.8 1.7 5.7 4.1 1.6 1.7 1.7 1.4 3.1 2.0 3.9 2.8 6.2 2.1 4.3 1.6 1.4 2.2 2.0 1.1 3.6 1.1 1.3 4.1 4.2 1.0 1.6 2.4 3.6 3.1 3.2 4.3 3.0 4.2 1.4 5.3 1.5 6.8 1.6 3.4 1.3 2.3 3.7 1.4 2.5 15.3 1.3 1.2 3.8 2.1 1.6 0.6 3.1 1.9 2.0 2.7 11.0 10.8 8.1 2.3 6.5 3.9 3.1 2.2 1.1 3.1 6.7 2.8 3.2 1.0 0.9 1.6 2.8 2.2 0.6 3.4 2.9 1.0 1.0 0.8 1.9 1.2 2.9 2.3 3.0 3.0 6.1 2.6 4.2 2.1 1.8 1.2 3.5 1.1 1.4 1.2 2.3 1.3 1.7 0.9 1.6 1.6 1.4 2.1 2.2 3.0 3.3 1.2 0.9 2.4 2.2 3.1 3.8 2.2 3.4 2.4 2.0 2.6 1.9 2.0 2.1 3.6 2.9 6.4 4.5 14.7 4.8 1.3 2.1 1.8 0.0 4.1 1.9 1.9 2.1 0.0 2.9 1.8 14.6 1.7 2.9 1.7 1.9 1.3 57.8 4.4 3.9 6.5 1.2 6.9 6.7 1.8 2.7 4.3 6.6 6.9 12.7 39.0 7.5 0.9 2.2 3.3 7.0 3.0 0.0 4.1 3.0 9.6 4.1 3.4 3.6 12.2 3.8 3.8 3.1 11.1 12.1 1.9 1.7 2.2 5.9 1.5 4.5 1.7 8.8 14.1 0.0 3.2 3.9 10.4 2.6 1.5 1.1 1.9 11.7 35.5 1.8 2.8 SUPV3L1 SUV3 ENSG00000156502 "Suv3 like RNA helicase" Q8IYB8 10 69180234-69209099 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038380, HPA038405" Supported Supported Mitochondria NA NA Mitochondria "HPA038380: AB_2675983, HPA038405: AB_10675797" "unprognostic (4.70e-2)" "unprognostic (1.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.74e-2)" "unprognostic (3.32e-2)" "unprognostic (1.44e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (9.47e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (5.48e-3)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (5.27e-2)" "unprognostic (1.33e-1)" 10.2 11.0 7.5 8.8 8.3 24.4 11.6 10.4 10.4 7.8 7.5 11.7 9.0 9.4 8.0 8.9 8.4 6.1 15.9 8.4 8.5 13.0 18.0 6.2 12.1 8.1 7.8 7.8 10.7 9.4 16.7 7.5 8.7 8.5 8.1 12.8 11.2 8.9 8.6 26.2 10.4 8.6 9.4 6.8 10.0 9.0 16.0 7.9 11.1 11.0 29.4 12.3 9.6 7.8 9.3 28.9 19.9 17.4 53.5 19.1 16.1 22.7 17.5 27.1 34.7 32.6 51.4 23.8 51.5 14.0 17.6 24.8 32.3 42.2 27.4 33.1 21.5 33.1 22.6 14.9 27.2 48.1 54.3 16.5 20.5 33.7 31.9 72.6 23.6 20.3 32.2 59.6 26.1 19.2 18.7 33.1 33.5 20.8 27.2 106.7 30.1 24.7 22.6 15.6 13.9 24.7 18.7 24.2 49.7 46.7 19.1 15.5 23.5 12.7 13.7 24.7 21.1 34.3 20.5 25.4 47.5 22.6 56.4 8.9 8.9 5.1 4.7 11.1 7.3 12.5 9.0 7.9 9.5 7.1 7.3 8.7 9.6 0.9 7.7 5.4 3.9 8.8 6.2 7.5 8.3 10.4 10.4 8.4 8.5 8.1 7.8 7.8 8.5 6.8 7.9 9.3 11.2 6.4 7.4 15.3 21.7 23.8 11.6 16.6 21.6 21.6 10.8 9.5 22.5 5.7 15.1 7.3 4.2 17.8 49.3 11.7 11.7 11.6 13.4 17.2 17.6 10.1 9.0 10.3 29.6 8.6 11.4 12.6 14.8 28.8 7.6 15.1 5.7 12.0 9.6 11.8 28.2 9.0 16.2 6.0 10.0 4.5 6.8 9.4 5.4 15.0 7.2 11.3 19.6 14.1 17.6 8.5 8.1 9.1 37.0 10.8 8.5 14.3 12.6 12.5 6.6 17.2 14.6 38.6 26.6 23.6 22.3 22.4 28.8 16.1 14.1 10.7 FAM122B "DKFZp686L20116, RP11-308B5.5" ENSG00000156504 "Family with sequence similarity 122B" Q7Z309 X 134769566-134797232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000266 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA000266: AB_1078801" "unprognostic (2.10e-3)" "unprognostic (1.55e-2)" "unprognostic (4.53e-3)" "prognostic unfavorable (7.19e-5)" "unprognostic (1.67e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-2)" "unprognostic (3.07e-2)" "unprognostic (1.50e-2)" "unprognostic (2.15e-1)" "unprognostic (7.64e-2)" "unprognostic (1.53e-3)" "unprognostic (2.26e-3)" "unprognostic (2.60e-2)" "unprognostic (7.96e-2)" "unprognostic (2.11e-2)" "unprognostic (3.19e-3)" 16.0 19.7 28.7 18.5 30.0 31.9 15.9 25.8 30.5 18.3 30.3 18.1 15.5 21.0 26.2 17.8 22.8 13.2 14.3 28.3 29.1 16.9 11.3 17.7 30.0 27.9 28.2 26.4 29.0 16.9 21.2 21.5 15.6 28.3 17.7 22.9 8.9 18.9 16.1 7.9 19.5 22.3 19.6 29.0 27.7 20.3 35.6 32.4 26.1 21.1 7.2 27.5 18.9 17.8 29.7 51.0 46.2 36.2 25.9 18.2 23.6 25.4 39.5 34.5 43.9 41.3 41.1 44.3 49.7 76.2 28.9 61.3 33.5 54.0 32.6 79.2 61.8 37.4 50.2 94.6 13.4 11.2 92.9 61.2 15.5 31.6 48.3 21.0 28.5 25.9 50.0 33.2 61.9 46.8 68.8 58.1 80.1 19.8 58.3 49.1 58.0 39.5 43.6 26.6 52.1 32.9 23.3 21.2 28.3 14.8 31.1 15.2 47.4 18.6 36.4 23.5 93.3 87.1 34.1 42.2 63.2 39.0 105.8 46.2 0.0 0.4 2.6 0.8 0.2 1.1 0.7 0.7 1.0 0.5 0.6 0.9 1.2 0.5 1.2 0.5 1.5 0.8 0.5 28.7 30.0 25.8 30.5 28.3 29.1 27.9 28.2 26.4 28.3 29.0 32.4 29.7 4.7 12.8 10.4 6.2 17.4 13.5 15.0 9.2 12.0 4.0 11.8 7.6 10.8 2.8 11.7 16.5 12.5 9.3 15.3 14.4 17.6 8.0 1.3 10.4 6.7 12.5 6.0 32.6 15.2 13.8 10.2 11.0 15.3 11.5 23.6 32.9 9.7 7.4 14.7 13.5 10.5 13.2 18.3 21.4 21.7 5.8 10.5 17.9 17.8 12.2 16.6 6.4 20.6 8.0 16.8 12.2 20.2 6.4 13.8 14.7 12.9 8.0 8.2 5.5 0.0 6.6 8.8 3.7 4.4 14.4 11.2 8.8 20.1 17.7 12.2 19.1 EEF1A1 "EE1A1, EEF1A, EF1A, LENG7" ENSG00000156508 "Eukaryotic translation elongation factor 1 alpha 1" P68104 6 73489308-73525587 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "Elongation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051759, HPA053862, HPA056990" Supported Supported Cytosol NA NA 82000000 Cytosol "HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (6.47e-2)" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (9.64e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.13e-1)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (1.41e-1)" "unprognostic (3.47e-1)" "unprognostic (8.61e-2)" "unprognostic (1.65e-1)" "unprognostic (8.00e-2)" "unprognostic (2.04e-1)" "unprognostic (7.73e-2)" 6979.2 5790.5 2484.7 4618.7 2644.6 10578.3 10610.6 2537.8 2805.5 8020.3 2943.7 6363.5 4826.8 7467.3 7266.8 6352.8 9113.7 4945.3 3439.2 2304.5 2975.3 7590.0 6512.1 4934.8 8885.3 2783.8 2610.6 2181.1 12740.0 10456.7 6998.6 3805.8 5591.7 2733.2 5687.7 7003.4 2220.1 8453.9 6102.9 1695.9 6909.8 5119.2 7761.3 3028.5 5963.9 5824.2 1716.6 2845.1 8165.9 8422.9 1956.0 11387.9 7059.3 6524.7 2913.7 5218.1 8235.8 8697.0 13940.8 18183.0 32963.3 7874.7 7061.7 21384.2 10632.9 10044.2 12591.7 8020.5 20786.6 9976.7 13824.2 6089.1 5849.1 11729.0 15249.9 9969.0 3868.8 7099.6 7824.7 6142.2 13619.5 14708.8 15773.6 9201.9 26454.1 27514.4 7357.6 24803.6 17437.1 14783.4 8434.8 15242.2 7357.1 13131.5 8385.7 7184.5 17411.3 10348.2 6259.3 4400.0 14212.5 15389.7 26105.5 12201.5 14719.8 8337.9 8853.1 3931.6 10026.7 17535.8 9067.6 6928.7 24671.0 11535.0 4637.5 6195.9 3343.0 9206.4 7296.2 6913.1 5011.8 4780.9 12625.1 7404.1 2888.1 8472.3 895.8 7474.9 7600.7 14243.9 10580.7 12006.0 10174.3 8618.3 8426.8 13912.6 12049.7 681.7 9555.0 7680.9 6461.2 9278.5 26796.5 2484.7 2644.6 2537.8 2805.5 2304.5 2975.3 2783.8 2610.6 2181.1 2733.2 3028.5 2845.1 2913.7 4915.6 3169.9 6059.2 107.4 11291.6 9829.9 12187.6 10417.5 11667.5 978.9 10528.4 9476.3 160.6 6258.2 5739.8 2637.3 546.3 9401.2 8653.6 2189.4 10344.0 5796.3 1373.9 4535.2 6754.2 5952.7 3862.8 6396.8 84.5 10404.1 12700.2 5756.1 4472.5 5831.2 3736.3 5732.4 6124.7 3323.0 6415.2 494.6 109.3 6969.3 3289.7 7779.7 8970.1 2325.8 8931.5 6705.0 5112.0 175.2 18016.6 3733.0 8468.7 76.9 162.0 7231.8 5821.6 7213.5 6811.7 11638.2 7494.7 14215.0 2974.6 1469.9 3536.8 7040.7 7075.1 1092.8 703.6 12784.4 10055.1 11086.8 9616.5 6982.9 8574.9 16180.0 FBXO43 Fbx43 ENSG00000156509 "F-box protein 43" Q4G163 8 100133351-100145817 "Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 3.6" "Cell type enhanced" "Detected in some" "Early spermatids: 11.6;Erythroid cells: 9.9;Late spermatids: 6.9;Spermatocytes: 43.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.6" "Not detected" "Not detected" "HPA024292, HPA024295, HPA024824" Uncertain NA NA "HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464" "unprognostic (4.94e-2)" "unprognostic (4.35e-2)" "unprognostic (2.09e-2)" "unprognostic (4.34e-2)" "unprognostic (5.06e-2)" "unprognostic (3.51e-2)" "unprognostic (1.07e-5)" "unprognostic (4.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (7.97e-2)" "unprognostic (2.52e-2)" "unprognostic (5.91e-2)" "unprognostic (8.09e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.7 0.0 0.0 0.0 0.1 0.4 0.3 1.0 0.0 0.1 1.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 0.6 0.0 0.3 0.6 0.0 0.9 0.2 0.0 0.1 1.4 0.0 0.0 1.5 1.1 0.0 0.1 0.2 0.0 0.6 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.2 0.5 0.6 0.8 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 1.8 1.6 0.3 0.9 0.6 0.3 0.6 1.4 0.5 0.6 0.4 0.0 3.2 0.0 0.0 0.6 0.4 0.2 0.0 0.0 11.6 1.5 0.4 0.6 1.2 9.9 0.3 0.4 0.3 1.4 0.0 0.3 1.3 6.2 0.0 0.2 0.5 0.0 0.4 0.1 2.0 0.3 1.1 6.9 0.0 0.7 0.0 1.0 0.1 0.6 1.0 0.5 0.5 0.1 0.1 0.4 0.8 0.3 0.2 0.2 1.2 0.8 0.0 1.4 0.5 43.8 4.5 0.7 0.4 0.3 1.6 0.3 0.4 0.2 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220332-69267552 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.0;retina: 47.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 31.5;Distal enterocytes: 29.0;Ductal cells: 32.6;Endometrial ciliated cells: 50.0;Glandular and luminal cells: 55.2;Muller glia cells: 126.9;Proximal enterocytes: 56.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 3.1;naive CD4 T-cell: 5.8;naive CD8 T-cell: 2.3;T-reg: 5.4" "Lineage enriched" "Detected in single" 23 "T-cells: 5.8" "Cell line enhanced" "Detected in some" "A549: 40.1;CACO-2: 57.5;CAPAN-2: 111.4;EFO-21: 33.9;GAMG: 45.4;Hep G2: 33.6;RPTEC TERT1: 81.9" "Region enhanced" "Detected in many" "cerebral cortex: 11.9" "Low region specificity" "Detected in all" "HPA064198, HPA064230" Enhanced Enhanced Mitochondria No No Mitochondria "HPA064198: AB_2685210, HPA064230: AB_2685219" "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.1 0.0 1.8 2.8 1.1 0.0 0.0 1.4 1.0 1.1 1.2 6.8 54.0 1.0 0.0 0.1 4.7 6.9 0.0 0.8 1.2 13.2 4.7 1.6 1.0 1.1 1.5 0.7 0.0 6.2 0.0 0.3 0.0 1.6 0.0 4.2 47.2 0.1 0.1 0.0 0.1 48.4 0.6 1.7 0.3 1.1 1.0 1.1 5.2 9.3 0.0 0.2 0.0 0.1 1.2 1.2 40.1 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.1 57.5 111.4 0.0 33.9 0.3 45.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 33.6 2.7 0.0 0.0 0.0 0.3 0.4 3.2 0.6 0.0 11.3 0.0 0.0 0.7 0.1 0.2 0.1 0.0 11.9 1.3 0.0 1.2 0.1 81.9 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.4 1.6 0.2 0.8 0.0 0.1 0.0 8.1 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.5 0.0 3.1 1.0 0.0 0.0 5.8 2.3 0.0 0.2 0.0 0.0 5.4 1.0 1.8 1.1 1.4 1.0 0.8 1.2 1.1 1.5 0.7 1.6 1.7 1.1 1.2 0.0 3.2 4.8 11.8 0.7 0.0 0.0 0.3 0.0 1.9 0.0 0.0 1.0 31.5 1.0 16.5 0.0 0.0 0.2 29.0 1.9 32.6 0.6 50.0 4.5 0.5 0.0 0.0 0.4 7.3 0.0 0.2 1.5 55.2 0.0 0.0 0.0 0.4 0.1 3.3 0.5 5.6 0.0 0.3 0.0 0.2 0.3 0.4 0.0 0.0 0.0 126.9 0.0 0.0 0.5 25.5 12.7 0.0 0.3 0.0 56.3 15.7 0.3 5.1 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 1.3 0.1 5.6 0.3 HK1 ENSG00000156515 "Hexokinase 1" P19367 10 69269984-69401884 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycolysis, Immunity, Inflammatory response, Innate immunity" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 374.0;Horizontal cells: 304.5;Late spermatids: 1034.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007043, HPA007044, CAB010052" Supported Supported Mitochondria NA NA 560000 Mitochondria "CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049" "unprognostic (8.80e-2)" "unprognostic (1.78e-1)" "unprognostic (2.03e-1)" "unprognostic (2.00e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-3)" "unprognostic (1.12e-1)" "unprognostic (1.37e-3)" "unprognostic (7.25e-2)" "unprognostic (1.40e-2)" "unprognostic (2.00e-3)" "unprognostic (3.86e-2)" 43.1 24.6 50.5 45.4 63.7 60.8 40.9 56.5 74.6 45.3 57.3 52.8 13.2 41.7 11.3 130.9 37.3 26.0 144.1 61.7 61.2 32.8 8.5 48.6 34.3 52.6 58.3 57.2 20.1 12.4 25.2 45.2 49.7 60.2 53.4 32.3 148.9 67.7 53.6 195.0 99.8 29.5 50.3 37.6 40.7 62.1 77.8 50.0 45.3 71.6 148.0 48.0 75.0 81.6 69.7 101.6 56.6 74.2 71.1 81.0 60.4 47.1 98.3 256.5 128.5 138.0 16.3 11.0 7.3 75.8 165.9 92.9 86.2 69.9 220.0 122.0 67.5 54.5 250.0 58.3 1.1 91.7 5.1 181.2 91.5 125.8 184.5 407.6 160.8 135.4 36.8 424.5 51.3 178.7 167.7 29.7 13.1 113.8 51.7 247.0 44.8 45.0 0.6 88.7 117.4 75.7 88.7 112.6 215.4 65.2 104.3 117.7 16.5 140.4 190.5 86.4 106.5 139.6 61.1 42.8 17.4 247.3 130.4 56.1 68.7 88.8 44.6 41.5 125.2 69.0 33.5 47.9 47.6 81.0 19.9 41.7 33.9 20.9 31.2 135.4 9.1 58.1 110.4 50.5 63.7 56.5 74.6 61.7 61.2 52.6 58.3 57.2 60.2 37.6 50.0 69.7 26.1 25.6 32.4 38.2 26.5 48.3 50.5 37.8 43.9 83.9 33.1 21.7 130.6 4.3 34.2 27.6 54.2 70.6 14.6 30.3 13.7 28.6 374.0 32.6 28.0 37.9 18.7 104.8 53.8 30.6 93.3 30.3 41.3 34.5 23.4 72.6 26.7 1.1 49.4 304.5 49.8 28.7 44.7 41.7 21.9 1034.1 15.2 51.3 37.4 29.0 35.3 32.9 20.6 14.1 3.5 54.6 11.1 18.4 19.1 29.1 0.7 1.1 30.7 95.5 19.7 22.2 43.1 5.3 6.2 86.0 51.7 118.9 30.5 28.3 19.3 43.5 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin like peroxisomal matrix peptidase 1" Q2T9J0 10 70137981-70146700 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 120.7;Late spermatids: 227.4;Spermatocytes: 124.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 27.5;PC-3: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 5.7 6.1 1.3 1.9 1.2 0.9 5.5 1.7 1.9 5.1 1.0 4.1 3.3 4.1 0.6 11.9 4.5 0.6 2.8 1.1 0.9 5.1 6.5 2.8 1.8 2.1 0.9 1.6 4.2 6.3 1.3 3.4 1.3 1.3 5.8 0.6 0.2 5.7 1.5 3.3 11.3 5.0 0.3 0.5 5.4 3.9 14.3 1.0 1.2 4.7 0.5 0.9 4.8 6.6 1.4 16.0 10.2 0.8 6.2 1.0 0.9 3.7 2.2 1.4 2.0 1.8 6.2 9.6 13.8 6.0 0.5 0.6 27.5 1.0 3.9 0.4 8.9 9.5 0.7 2.9 3.3 2.4 1.2 0.1 2.0 7.6 1.7 3.1 1.2 1.4 4.9 0.1 4.3 0.8 6.3 5.3 5.6 3.3 3.5 41.7 8.9 2.6 6.2 0.9 2.6 7.4 3.8 6.7 14.8 6.1 0.2 9.4 1.1 2.6 2.5 1.7 4.8 8.7 14.9 9.9 7.0 2.9 6.2 1.8 0.0 0.8 0.7 3.8 1.2 2.4 3.0 2.2 2.8 0.9 3.3 3.0 2.6 0.3 2.0 0.7 0.7 2.6 1.4 1.3 1.2 1.7 1.9 1.1 0.9 2.1 0.9 1.6 1.3 0.5 1.0 1.4 6.1 9.6 5.3 4.9 12.6 14.3 14.5 13.3 14.8 6.9 14.8 16.9 4.2 27.1 7.8 11.0 0.0 35.2 15.5 14.6 17.6 7.8 120.7 5.5 6.8 6.3 14.3 5.0 6.7 9.5 9.8 7.5 5.1 6.3 13.4 9.3 6.8 16.5 12.1 0.0 6.0 12.1 16.2 10.7 6.6 227.4 9.3 8.2 12.4 6.5 6.1 7.0 12.3 11.6 5.5 5.5 11.6 7.9 7.5 14.5 19.2 16.5 3.9 4.4 6.6 6.9 6.1 124.7 12.5 22.4 18.5 16.7 14.0 10.6 21.0 8.8 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373312-134428791 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 6.8 18.2 7.6 14.4 8.8 8.5 11.0 11.5 9.4 8.3 7.7 9.1 9.0 9.8 33.0 8.3 7.9 6.7 6.7 7.8 9.5 10.3 7.8 6.8 25.5 8.9 9.0 6.8 33.6 9.5 16.4 6.3 9.4 9.4 9.3 10.4 12.1 13.3 11.1 5.0 8.4 8.9 8.2 9.4 13.4 9.4 9.3 8.9 21.0 13.3 6.9 30.1 8.6 7.2 12.6 28.2 22.9 98.7 40.8 17.9 22.9 18.7 27.6 22.1 29.1 35.6 13.9 28.5 45.1 61.8 16.9 28.3 24.6 69.4 31.3 48.6 37.2 32.1 44.3 37.7 16.1 19.2 44.2 23.3 15.3 23.2 31.7 39.2 29.1 41.1 43.1 32.6 21.8 35.8 18.7 71.3 21.8 30.1 38.3 31.0 69.6 36.0 34.5 30.7 33.8 34.1 39.9 21.2 19.3 29.5 29.0 18.0 24.0 31.5 26.8 19.2 34.0 42.9 11.1 27.3 60.5 17.7 51.4 34.3 5.9 6.3 4.1 8.0 6.6 8.7 18.7 8.2 7.3 9.5 12.4 9.6 8.2 2.6 11.0 8.4 11.7 9.1 5.5 7.6 8.8 11.5 9.4 7.8 9.5 8.9 9.0 6.8 9.4 9.4 8.9 12.6 25.5 22.4 18.4 13.1 42.7 13.0 14.3 28.7 22.2 22.4 17.5 20.3 16.3 11.5 17.8 16.5 18.8 11.8 27.1 9.9 23.5 14.2 3.7 13.0 29.1 18.7 11.4 31.3 27.8 13.8 7.6 17.2 14.8 18.7 24.6 149.5 20.0 15.2 15.1 18.5 23.4 12.5 10.2 15.5 10.2 3.1 20.8 20.2 7.2 29.0 25.3 27.9 21.6 33.2 46.7 14.4 18.7 15.4 23.1 12.3 9.5 19.8 16.5 19.7 26.3 21.0 21.9 10.3 22.0 25.7 11.5 4.7 22.6 69.3 17.7 11.5 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "parathyroid gland: 332.8" "Cell type enhanced" "Detected in many" "Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 206.4;BJ hTERT+: 126.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane,Cytosol" NA NA 180000000 "Plasma membrane" Cytosol "HPA008992: , HPA015723: AB_2732415" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (4.68e-4)" 7.3 1.1 2.6 2.4 2.5 2.8 5.5 2.6 2.1 10.0 0.9 5.2 1.3 12.6 5.6 10.3 3.2 4.1 5.8 2.2 4.9 7.1 1.1 6.6 1.1 3.2 2.9 1.4 0.8 0.5 332.8 0.4 6.5 3.3 3.6 3.0 0.2 3.4 2.6 1.2 19.1 2.2 12.7 4.0 2.1 1.1 1.8 2.8 3.1 1.3 3.3 2.2 4.5 7.5 3.3 35.6 29.4 1.5 0.1 48.2 206.4 0.0 30.5 126.0 9.0 18.4 0.1 20.2 0.0 19.7 63.5 19.5 96.5 3.5 60.9 12.1 8.5 5.5 11.5 21.0 5.8 10.1 0.0 0.3 60.7 52.4 18.6 68.7 34.2 71.6 3.9 0.0 0.2 45.0 0.8 0.8 0.0 2.4 0.3 18.9 2.6 8.4 40.6 4.8 3.6 0.0 0.1 68.6 0.7 30.8 1.3 0.8 5.8 68.7 96.8 10.1 17.2 28.5 0.7 17.9 0.1 40.3 0.1 89.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 2.6 2.5 2.6 2.1 2.2 4.9 3.2 2.9 1.4 3.3 4.0 2.8 3.3 65.3 3.2 1.7 39.8 1.1 41.4 8.4 62.8 35.9 0.3 2.2 2.2 13.0 0.0 16.3 0.0 0.0 0.4 1.2 0.1 1.9 0.1 23.4 10.8 10.5 38.0 0.0 7.6 4.0 0.0 0.5 25.0 0.5 15.0 2.5 0.0 21.0 0.6 45.0 0.0 3.3 0.1 4.1 2.7 28.5 21.0 0.6 13.5 23.2 19.7 3.3 0.0 0.0 1.5 1.0 0.4 0.0 0.0 1.7 10.8 0.0 23.5 16.0 0.2 0.0 7.4 13.2 1.0 3.5 51.4 43.8 1.4 4.6 1.4 0.2 7.2 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391591-40587364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.7;retina: 3.2" "Cell type enhanced" "Detected in some" "Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 1.7;SH-SY5Y: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076660 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA076660: AB_2686812" "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.0 0.3 1.1 0.0 5.5 0.3 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 1.6 0.0 5.6 0.5 0.2 0.8 0.3 0.0 2.2 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.1 0.7 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 5.5 0.0 6.7 1.5 0.7 1.6 0.0 5.6 2.2 0.0 0.3 2.1 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 10.8 0.1 0.3 0.6 0.0 0.1 0.0 62.6 0.4 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.1 4.2 0.0 111.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 62.8 1.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 3.7 0.0 0.8 0.0 49.8 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.3 0.2 0.0 0.1 0.1 NODAL ENSG00000156574 "Nodal growth differentiation factor" Q96S42 10 70431936-70447951 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.3;skeletal muscle: 2.3;testis: 1.9" "Group enriched" "Detected in some" 26 "Early spermatids: 15.4;Late spermatids: 38.5" "Cancer enriched" "Detected in some" 10 "testis cancer: 20.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;SH-SY5Y: 1.4;SuSa: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA045201 Uncertain "Secreted to blood" NA NA "HPA045201: AB_2679252" "unprognostic (3.07e-2)" "unprognostic (2.10e-1)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (5.66e-3)" "unprognostic (3.12e-2)" "unprognostic (8.77e-2)" "unprognostic (1.61e-1)" "unprognostic (1.63e-5)" "unprognostic (4.37e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (2.02e-1)" 0.5 0.0 0.6 0.0 0.5 0.6 0.5 2.3 0.5 0.4 0.0 0.3 0.2 0.3 0.0 0.3 0.3 0.2 0.2 0.4 0.5 0.1 0.1 0.4 0.2 0.6 0.8 0.3 0.3 0.1 0.0 0.1 0.2 1.1 0.2 0.0 1.3 0.2 0.0 2.3 1.0 0.2 0.0 0.5 0.2 0.2 1.9 0.5 0.2 0.1 0.0 0.0 0.4 0.4 0.5 0.3 0.2 0.8 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.2 0.5 0.2 0.0 0.2 0.2 0.5 0.0 0.1 0.1 1.4 0.4 0.1 0.0 3.5 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.5 1.1 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 2.3 0.5 0.4 0.5 0.6 0.8 0.3 1.1 0.5 0.5 0.5 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 38.5 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PRG3 "MBP2, MBPH" ENSG00000156575 "Proteoglycan 3, pro eosinophil major basic protein 2" Q9Y2Y8 11 57376769-57381150 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "bone marrow: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 46 "HMC-1: 198.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory bulb: 3.5" HPA064183 Enhanced "Secreted in other tissues" NA NA 680000 "HPA064183: AB_2685205" 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 198.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2L6 UBCH8 ENSG00000156587 "Ubiquitin conjugating enzyme E2 L6" O14933 11 57551656-57568284 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 165.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003328, CAB073407" Enhanced Approved Cytosol NA NA 15000 Cytosol "CAB073407: , HPA003328: AB_1858539" "prognostic favorable (6.75e-4)" "unprognostic (2.10e-2)" "unprognostic (1.09e-2)" "unprognostic (2.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (1.36e-2)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.88e-4)" "unprognostic (3.07e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" "unprognostic (6.42e-2)" 58.9 60.9 82.4 93.1 80.5 86.3 51.5 76.5 96.0 52.6 71.6 46.7 48.0 44.5 69.1 43.1 66.7 67.2 35.5 75.9 95.8 51.8 122.0 91.9 120.9 91.2 80.5 74.1 62.1 24.5 40.2 37.0 53.5 82.3 47.4 44.0 23.8 104.1 49.7 14.5 36.4 58.1 67.9 81.2 127.5 56.1 17.3 91.3 114.4 37.7 29.6 87.4 76.7 44.8 100.9 55.6 26.2 85.8 29.0 179.2 222.3 9.7 30.2 178.8 261.3 337.0 9.8 140.9 169.3 110.3 92.5 223.3 43.7 38.0 99.4 55.4 163.9 1.5 169.2 0.0 38.0 330.7 38.8 54.3 238.9 22.9 122.8 33.6 96.2 83.9 173.2 7.9 118.5 47.8 67.6 280.1 92.2 23.3 0.5 33.3 243.1 52.9 118.4 71.0 58.5 2.1 45.2 60.3 5.4 139.9 15.3 68.3 20.3 30.9 56.3 19.6 43.6 10.2 162.1 176.6 3.4 161.0 98.8 12.3 508.1 534.8 487.8 359.2 638.4 394.1 379.2 368.2 377.9 401.3 310.9 315.1 331.1 838.8 486.9 556.7 256.3 513.7 1060.5 82.4 80.5 76.5 96.0 75.9 95.8 91.2 80.5 74.1 82.3 81.2 91.3 100.9 94.6 28.9 22.2 2.9 53.5 23.3 26.2 75.7 26.2 12.4 31.9 38.7 6.0 24.3 38.2 12.9 4.2 4.2 59.3 16.4 64.6 95.4 4.9 16.6 83.4 65.5 23.9 53.0 2.0 65.2 38.1 43.8 23.0 16.4 53.9 41.3 53.2 35.3 165.3 13.5 4.8 38.6 48.8 77.4 36.9 10.9 48.1 73.1 8.8 9.4 79.0 54.0 97.9 3.5 2.0 37.3 48.1 33.4 51.4 52.8 47.7 32.3 33.3 4.4 26.3 15.4 33.8 2.4 9.8 25.6 27.7 3.4 68.8 26.9 22.7 33.3 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type palmitoyltransferase 5" Q9C0B5 11 57667747-57701182 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 29.3 21.9 7.9 27.4 7.5 29.5 26.0 8.0 9.6 27.2 10.4 36.7 29.9 22.5 24.3 61.5 25.2 28.2 28.2 7.1 8.4 28.4 37.0 29.3 24.6 8.1 8.5 6.5 20.9 31.8 45.6 12.7 37.0 8.3 28.3 34.7 36.2 35.3 26.9 41.3 45.6 31.3 29.3 6.6 25.7 30.5 36.5 10.1 30.8 37.2 45.9 35.3 42.7 28.9 9.1 80.3 86.2 33.7 34.7 74.9 57.4 64.9 72.8 89.8 61.8 46.3 52.3 97.0 53.4 91.9 89.5 53.1 110.1 53.6 88.9 55.4 66.5 24.4 45.8 40.1 49.3 81.5 85.9 73.7 81.3 79.3 88.8 92.9 51.1 71.0 45.6 61.5 66.2 79.7 48.4 49.1 29.3 41.1 61.0 52.2 47.8 66.6 67.1 74.8 115.2 25.3 30.7 67.6 77.0 78.5 45.4 81.9 52.6 80.7 76.5 40.7 82.9 52.2 48.2 63.0 45.9 59.1 44.4 68.0 11.6 5.2 7.1 6.9 6.8 8.3 5.8 6.7 6.0 5.4 5.7 6.7 6.9 6.9 5.0 8.1 9.0 7.0 6.8 7.9 7.5 8.0 9.6 7.1 8.4 8.1 8.5 6.5 8.3 6.6 10.1 9.1 28.8 16.0 10.5 14.7 13.4 16.2 12.7 13.7 16.5 21.4 20.4 15.2 21.6 12.8 19.8 12.9 37.5 10.1 20.3 41.3 3.9 14.4 21.3 19.9 22.1 17.1 11.5 10.8 16.4 18.2 9.9 15.5 15.8 35.5 19.7 24.9 16.1 15.1 13.0 13.5 17.9 17.5 18.3 16.3 10.2 9.8 11.8 18.4 1.8 14.0 16.0 14.0 17.5 17.6 14.7 26.0 20.8 7.5 12.4 15.1 22.9 11.4 17.4 47.7 0.0 18.4 18.5 13.3 7.1 31.5 19.9 18.6 15.9 16.8 19.7 20.5 MED19 LCMR1 ENSG00000156603 "Mediator complex subunit 19" A0JLT2 11 57703714-57712323 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039912, HPA040860" Uncertain Enhanced "Nuclear bodies" NA NA "Nuclear bodies" "HPA039912: AB_10795262, HPA040860: AB_10794153" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (5.01e-2)" "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.40e-1)" "unprognostic (4.87e-3)" "prognostic favorable (1.76e-6)" "unprognostic (3.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "unprognostic (4.91e-2)" "unprognostic (1.38e-2)" 11.3 18.3 22.4 6.3 23.3 6.9 11.7 20.1 41.8 11.0 20.2 9.2 9.7 11.7 13.5 15.6 9.3 6.2 10.5 22.6 21.7 13.7 13.3 9.0 7.6 20.9 22.4 22.9 9.7 11.7 9.9 16.1 10.3 21.6 12.6 7.9 12.1 12.2 9.0 10.7 15.6 9.7 8.2 21.4 10.9 11.2 23.0 23.9 8.3 13.7 9.3 9.5 10.1 12.0 22.9 30.3 19.1 22.7 21.0 23.6 21.4 27.0 25.4 19.7 23.9 24.0 13.6 23.0 16.6 38.5 24.4 21.0 22.6 17.1 16.1 21.0 21.8 18.6 14.3 11.3 12.7 35.5 15.7 16.4 17.5 28.9 23.8 46.6 16.7 31.1 13.3 15.9 16.1 29.1 14.5 22.3 29.2 19.8 21.4 37.7 21.1 32.2 20.2 15.9 12.6 17.6 24.7 20.5 20.7 47.2 19.1 43.8 16.0 25.7 20.7 24.8 49.2 22.6 19.9 20.5 15.7 28.3 11.5 22.1 27.9 25.8 31.3 29.2 37.2 31.6 45.0 32.8 31.4 25.6 39.4 34.0 32.0 16.4 24.6 39.2 36.9 33.9 26.0 22.4 23.3 20.1 41.8 22.6 21.7 20.9 22.4 22.9 21.6 21.4 23.9 22.9 40.7 9.6 27.1 4.6 32.5 87.6 60.9 72.0 62.0 38.6 37.4 39.8 14.7 30.0 40.2 51.5 35.5 58.2 32.2 36.2 39.2 44.1 12.2 33.3 37.8 39.3 23.3 21.4 9.2 45.4 48.6 38.1 20.9 34.0 22.2 39.2 36.0 26.3 29.3 37.0 8.3 38.3 54.9 17.6 31.4 15.4 28.3 18.6 37.4 2.8 26.3 37.4 24.7 5.5 7.2 40.6 33.2 29.7 22.9 53.6 32.9 47.2 42.1 59.7 19.7 31.3 50.5 111.7 97.9 42.7 82.3 73.1 35.8 37.5 31.8 52.8 ZFAND3 "FLJ13222, TEX27" ENSG00000156639 "Zinc finger AN1-type containing 3" Q9H8U3 6 37819727-38154624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 821.8;Late spermatids: 3021.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016755 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA016755: AB_1859011" "unprognostic (3.32e-1)" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" "unprognostic (2.89e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (1.07e-1)" "unprognostic (1.36e-2)" "unprognostic (9.30e-2)" "unprognostic (1.48e-2)" "unprognostic (9.60e-3)" "unprognostic (1.01e-1)" "unprognostic (2.94e-1)" "unprognostic (7.41e-2)" "unprognostic (4.33e-1)" 42.0 42.6 36.2 32.0 36.6 43.0 36.7 36.6 36.7 43.0 33.1 44.1 39.7 41.5 35.6 37.7 33.7 36.7 50.6 36.1 50.6 48.2 53.7 38.2 28.3 46.2 38.5 30.0 32.6 39.3 57.0 34.0 49.2 40.4 35.6 32.4 39.7 33.1 46.5 139.0 32.6 39.8 47.3 39.1 31.9 42.3 113.8 35.1 40.1 52.5 67.9 29.6 49.8 31.5 44.1 59.1 33.8 116.8 82.8 72.4 75.9 42.5 88.6 115.6 87.3 92.8 68.4 33.4 24.6 71.8 106.8 96.2 39.5 48.3 73.4 122.3 102.2 30.6 75.6 17.3 65.3 171.0 29.5 59.4 96.1 93.7 91.7 157.0 101.6 76.8 56.9 37.3 48.1 68.4 50.6 50.2 27.0 33.4 84.5 38.4 52.4 48.4 29.6 79.5 94.0 74.2 63.2 54.6 43.6 151.5 98.1 70.2 61.5 81.5 87.2 66.2 47.5 58.8 47.3 47.7 74.2 32.4 47.1 91.9 0.5 1.7 6.1 1.5 1.7 1.1 1.3 1.1 1.2 0.9 1.9 0.9 1.5 6.0 1.6 1.3 2.9 1.5 0.9 36.2 36.6 36.6 36.7 36.1 50.6 46.2 38.5 30.0 40.4 39.1 35.1 44.1 25.4 22.4 11.5 241.0 27.0 27.3 30.9 20.0 52.9 25.8 19.8 19.4 23.0 25.8 11.6 47.8 22.9 35.0 23.2 55.2 74.3 27.3 821.8 25.4 26.6 28.1 16.2 22.5 332.7 29.3 33.1 27.2 31.6 33.2 5.1 33.9 27.5 48.8 33.8 30.3 262.9 30.5 6.1 43.7 44.3 3021.1 38.8 49.2 14.2 283.9 32.9 47.4 34.0 276.0 316.4 38.9 29.1 55.3 28.3 52.3 57.6 38.2 17.2 21.6 32.9 32.9 31.2 63.5 54.1 41.3 30.1 86.1 31.2 21.1 21.5 61.2 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Plasma membrane" NA No 15000 "Plasma membrane" "HPA051497: AB_2681507, HPA072453: AB_2686523" "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 85.4 96.6 108.0 76.6 132.6 33.0 83.4 82.3 184.3 113.4 95.4 134.3 136.1 182.4 152.2 135.1 136.2 98.0 198.2 137.0 129.3 127.7 74.6 111.5 49.1 69.3 74.1 136.9 79.8 97.4 168.5 47.4 124.1 82.0 172.3 143.3 136.7 101.9 206.3 51.7 68.6 126.0 300.9 49.9 72.4 97.3 69.8 97.5 43.0 113.4 70.7 70.0 142.0 85.6 137.2 101.9 179.1 100.9 74.5 201.6 180.7 141.1 229.1 373.5 258.3 228.4 122.4 317.7 58.7 133.0 331.2 319.2 411.1 164.4 191.3 147.6 105.6 109.3 46.7 83.3 110.2 143.1 72.6 124.9 149.1 165.2 167.4 100.7 254.8 139.5 52.0 26.7 65.2 187.2 81.2 32.4 45.3 93.5 127.3 63.3 52.1 115.8 49.9 353.7 148.3 61.6 19.2 222.4 122.4 151.3 249.6 110.9 97.7 159.0 199.7 133.8 116.0 135.8 56.5 113.8 51.4 185.8 111.0 140.0 5.9 13.5 13.8 6.4 18.5 5.2 3.8 3.6 5.9 5.3 2.9 3.6 4.2 28.0 3.9 14.8 5.5 4.3 13.6 108.0 132.6 82.3 184.3 137.0 129.3 69.3 74.1 136.9 82.0 49.9 97.5 137.2 67.1 76.9 66.0 72.1 18.3 65.0 27.0 43.3 51.2 93.0 50.5 45.7 106.9 48.6 60.6 82.8 50.1 7.0 28.8 133.8 1.9 18.1 3.7 73.4 46.7 44.6 103.0 7.4 216.6 24.0 9.2 64.5 41.3 92.1 28.4 33.9 50.0 43.1 25.0 38.7 162.7 90.9 42.7 77.4 46.6 9.9 15.2 61.8 42.7 86.2 43.4 41.2 12.3 63.8 67.4 41.4 66.7 38.4 20.2 26.9 52.3 20.7 92.1 49.7 19.7 35.5 74.0 11.7 10.8 61.9 54.6 6.8 23.9 35.3 52.6 30.7 KAT6B "Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B" ENSG00000156650 "Lysine acetyltransferase 6B" Q8WYB5 10 74824927-75032624 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006104 Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA006104: AB_1079445" "unprognostic (4.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.82e-1)" "unprognostic (2.32e-2)" "unprognostic (7.83e-2)" "unprognostic (2.85e-2)" "unprognostic (3.56e-1)" "unprognostic (2.62e-1)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (9.47e-2)" "unprognostic (8.78e-2)" "prognostic favorable (4.82e-4)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (3.15e-1)" 7.2 6.4 5.4 3.1 5.9 8.8 7.4 6.0 5.8 10.0 2.3 8.6 3.2 9.3 5.3 6.9 8.3 3.8 7.2 6.2 4.2 4.3 4.7 6.6 4.4 4.8 3.9 4.4 12.3 8.7 10.6 7.4 4.4 3.8 6.5 4.1 6.4 7.3 4.3 11.9 8.0 8.1 6.0 3.3 5.4 9.4 7.8 5.0 9.8 7.4 6.0 4.1 9.2 8.9 5.5 4.7 4.4 8.0 6.9 6.2 9.2 4.1 4.1 7.5 3.4 3.6 3.4 5.3 9.8 2.1 7.1 3.5 3.8 4.2 3.3 5.6 4.2 6.8 3.6 3.9 4.5 4.5 8.6 2.4 5.9 5.3 4.5 6.9 10.5 3.8 7.7 3.9 9.0 4.2 4.7 8.2 4.3 5.0 4.9 25.7 12.7 4.3 2.4 2.3 2.3 4.2 6.9 4.1 7.4 3.7 2.8 4.5 3.2 4.7 4.6 5.5 3.1 3.8 6.4 8.1 6.4 5.0 8.9 1.3 1.7 1.3 1.6 2.3 1.0 2.6 2.2 1.9 2.1 1.1 2.8 2.9 2.6 1.8 4.4 1.1 1.7 1.7 1.0 5.4 5.9 6.0 5.8 6.2 4.2 4.8 3.9 4.4 3.8 3.3 5.0 5.5 34.5 44.8 53.7 90.1 48.1 19.9 20.8 16.3 74.6 52.8 36.7 27.3 53.9 12.8 29.3 9.2 68.8 10.4 51.8 22.5 9.8 12.7 6.2 41.1 72.7 24.9 23.8 32.0 130.2 18.0 10.6 44.4 57.6 50.8 41.7 68.0 18.9 16.0 11.0 43.7 131.2 21.7 12.2 12.3 15.0 8.3 42.3 24.1 14.2 41.2 13.6 45.5 42.2 101.0 92.1 10.5 19.4 40.3 62.5 21.0 17.8 10.2 28.6 52.5 26.3 55.3 44.1 33.1 32.2 46.6 17.5 22.7 59.7 27.1 17.5 23.5 SAMD8 "FLJ25082, SMSr" ENSG00000156671 "Sterile alpha motif domain containing 8" Q96LT4 10 75099586-75182123 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044402 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044402: " "unprognostic (4.32e-1)" "unprognostic (3.14e-1)" "unprognostic (3.24e-2)" "unprognostic (7.87e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-2)" "unprognostic (1.61e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (3.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (4.16e-3)" "unprognostic (3.89e-2)" "unprognostic (3.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.26e-3)" 14.1 10.9 19.1 7.3 23.6 17.2 10.5 22.5 19.3 13.3 12.6 6.5 6.2 11.2 7.3 15.7 10.8 9.3 11.4 18.6 19.5 7.3 7.5 10.2 6.9 27.6 26.6 15.9 13.7 5.1 9.6 9.3 11.6 23.2 8.2 5.0 22.8 7.7 8.0 27.4 6.8 6.9 10.2 26.7 8.0 5.7 15.3 22.4 6.3 7.8 14.8 6.1 9.6 13.0 32.3 8.7 7.8 12.7 10.0 28.1 25.8 15.1 14.8 29.9 9.1 11.7 12.8 12.4 5.9 9.4 14.3 10.5 15.3 6.8 11.3 15.9 7.2 8.3 2.6 8.0 8.6 15.6 2.7 6.8 24.4 11.2 18.0 24.8 24.6 14.1 6.7 5.6 10.4 21.0 6.1 5.1 4.1 5.7 6.4 23.9 4.4 10.6 2.8 10.3 7.8 1.8 8.7 13.9 17.8 15.1 13.6 7.4 3.1 22.6 10.5 13.7 12.6 10.4 6.9 6.9 6.0 16.4 7.0 6.7 3.1 3.7 2.5 2.9 4.8 1.8 5.5 3.2 3.4 3.4 5.9 2.7 3.1 19.2 4.0 6.6 3.8 3.0 1.3 19.1 23.6 22.5 19.3 18.6 19.5 27.6 26.6 15.9 23.2 26.7 22.4 32.3 24.6 9.6 12.5 25.1 25.0 42.3 28.1 34.2 23.9 20.9 21.4 11.3 26.7 10.0 26.5 14.7 14.6 10.4 18.1 10.0 0.0 10.9 47.6 17.3 29.8 24.3 23.4 4.4 50.9 10.2 12.5 29.4 10.2 23.1 12.7 18.5 23.2 10.9 13.2 18.5 37.2 3.3 26.4 16.3 48.4 10.9 25.1 27.8 12.4 35.6 27.8 20.5 12.3 38.2 77.1 16.3 11.4 25.2 22.2 22.3 11.8 7.7 35.4 32.7 32.9 30.9 23.9 54.7 24.3 42.9 42.9 68.0 20.2 12.4 5.2 40.3 RAB11FIP1 "FLJ22524, FLJ22622, Rab11-FIP1, RCP" ENSG00000156675 "RAB11 family interacting protein 1" Q6WKZ4 8 37858618-37899497 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 798.0;Endometrial ciliated cells: 622.9;Glandular and luminal cells: 969.7;Urothelial cells: 613.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 101.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 101.9" "Cell line enhanced" "Detected in many" "K-562: 73.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017037, HPA023904, HPA024010, HPA025960" Enhanced Enhanced Vesicles No No Vesicles "CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992" "unprognostic (1.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.22e-3)" "unprognostic (2.87e-1)" "unprognostic (1.06e-1)" "prognostic favorable (6.61e-4)" "unprognostic (4.32e-1)" "unprognostic (4.50e-3)" "unprognostic (1.58e-1)" "unprognostic (4.72e-2)" "unprognostic (2.82e-3)" "unprognostic (2.73e-2)" "prognostic favorable (1.14e-6)" "unprognostic (4.94e-2)" "unprognostic (8.41e-2)" "unprognostic (9.99e-2)" "unprognostic (1.50e-1)" 7.6 5.7 4.0 17.8 2.9 59.0 22.0 4.0 3.6 8.4 33.3 41.1 41.6 5.9 14.9 47.5 17.1 21.9 12.1 4.6 3.5 13.8 7.3 74.7 17.3 3.3 3.3 3.4 4.6 42.9 12.1 8.7 26.0 2.8 8.8 47.5 6.2 24.0 13.6 4.6 18.0 54.0 7.1 2.9 12.1 45.9 6.5 3.2 15.5 13.1 2.7 31.4 23.8 15.0 3.2 41.8 18.1 1.9 8.0 0.4 0.1 54.1 4.2 6.6 7.5 9.6 40.6 23.2 17.0 12.7 5.1 0.4 31.6 14.5 9.4 11.3 44.2 13.5 3.3 9.0 11.9 20.9 7.3 36.3 4.8 12.2 2.8 7.9 11.1 0.1 22.2 73.1 8.2 3.8 9.9 12.4 10.7 12.0 40.9 5.3 3.9 9.7 13.2 39.4 42.2 7.4 8.5 10.6 52.3 13.0 36.8 35.2 14.0 0.6 0.2 23.1 0.6 0.7 16.5 20.7 4.5 0.3 9.8 5.7 24.0 20.5 38.1 4.4 9.4 9.9 6.0 3.2 3.1 18.3 3.8 2.0 2.2 101.9 10.9 20.2 11.0 7.7 10.7 4.0 2.9 4.0 3.6 4.6 3.5 3.3 3.3 3.4 2.8 2.9 3.2 3.2 7.6 798.0 112.9 1.0 128.5 15.9 113.5 49.5 24.5 5.4 113.6 58.5 15.8 84.4 228.0 64.4 16.7 44.9 123.6 385.5 15.6 170.2 0.9 622.9 71.4 25.3 243.7 3.8 7.9 248.9 8.1 28.7 272.7 969.7 30.4 2.8 32.2 15.3 32.1 6.7 8.6 312.3 95.6 59.1 174.7 1.8 1.8 121.1 16.0 2.8 95.2 18.6 120.5 0.0 1.0 364.6 299.1 1.5 48.2 192.7 331.9 16.5 348.8 21.0 6.6 9.0 23.3 2.4 5.2 124.2 30.5 96.0 83.8 2.8 256.6 613.9 UNC5D "KIAA1777, Unc5h4" ENSG00000156687 "Unc-5 netrin receptor D" Q6UXZ4 8 35235475-35796550 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.7;intestine: 6.0" "Group enriched" "Detected in some" 5 "Excitatory neurons: 638.7;Inhibitory neurons: 768.3" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4;renal cancer: 1.0" "Region enhanced" "Detected in many" "hypothalamus: 13.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.5;HeLa: 2.9;NTERA-2: 8.6;SH-SY5Y: 2.9;SuSa: 2.8;U-251 MG: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042940 Uncertain NA NA "HPA042940: AB_10959525" "unprognostic (7.88e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-2)" "unprognostic (2.29e-1)" "unprognostic (7.60e-2)" "unprognostic (1.87e-1)" "unprognostic (8.47e-2)" "unprognostic (3.82e-2)" "unprognostic (2.04e-1)" "unprognostic (4.13e-2)" "unprognostic (1.99e-1)" "unprognostic (4.48e-8)" "unprognostic (1.34e-1)" "unprognostic (9.15e-2)" "unprognostic (4.28e-1)" 0.0 1.7 1.8 0.0 3.0 0.0 0.0 0.0 3.7 2.3 0.0 0.3 6.0 1.7 0.0 0.0 0.1 0.0 0.0 2.4 13.7 2.1 0.0 0.0 0.0 1.4 3.1 3.1 0.0 0.1 0.1 3.3 0.0 0.3 4.9 0.6 5.0 0.0 0.2 0.0 0.0 1.9 0.9 0.0 0.0 0.1 0.7 4.9 0.4 0.8 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.5 0.2 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.0 0.0 3.7 2.4 13.7 1.4 3.1 3.1 0.3 0.0 4.9 0.3 0.0 0.0 0.0 129.6 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.1 0.1 0.0 0.0 638.7 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 40.4 768.3 0.7 0.0 0.0 0.0 4.4 0.0 0.0 0.0 42.2 0.0 1.8 0.0 43.2 10.2 0.0 0.0 0.0 0.0 1.8 2.0 0.6 0.0 2.6 0.0 0.0 0.7 0.7 1.2 0.1 0.1 0.0 0.0 0.0 2.6 0.0 GLYATL2 "BXMAS2-10, MGC24009" ENSG00000156689 "Glycine-N-acyltransferase like 2" Q8WU03 11 58834065-58904215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 12.1;cervix: 20.1;salivary gland: 33.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 4 "breast cancer: 16.7;endometrial cancer: 15.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6" "Low region specificity" "Detected in many" "HPA060292, HPA065454" Uncertain Approved Mitochondria NA NA Mitochondria "HPA060292: AB_2684245, HPA065454: " "unprognostic (1.02e-2)" "unprognostic (3.79e-3)" "unprognostic (8.11e-4)" "prognostic favorable (9.05e-7)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "unprognostic (2.66e-2)" "unprognostic (9.98e-3)" "unprognostic (1.27e-1)" "unprognostic (9.18e-3)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (7.42e-5)" "unprognostic (7.79e-3)" "unprognostic (8.28e-2)" "unprognostic (9.11e-3)" "unprognostic (2.31e-2)" 0.1 0.1 0.3 0.1 0.3 0.1 12.1 0.3 0.5 20.1 0.1 0.1 0.3 0.4 0.3 0.9 0.1 7.6 0.3 0.2 0.4 0.2 0.1 0.0 0.3 0.6 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.9 0.2 0.3 33.7 0.1 0.0 1.1 0.1 0.3 0.9 0.3 0.1 0.0 0.3 0.1 0.1 0.5 0.4 0.1 0.3 1.1 0.0 0.0 0.4 0.0 0.7 2.6 0.0 1.7 5.3 2.3 3.7 0.0 0.0 0.1 0.0 1.4 1.0 0.4 6.0 0.0 1.9 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.5 0.2 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 14.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 6.6 2.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.5 0.2 0.4 0.6 0.4 0.2 0.6 0.9 0.3 1.1 0.2 0.0 0.0 0.0 0.0 1.0 2.3 1.4 0.0 0.5 14.8 2.2 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 1.1 0.0 0.0 1.5 1.4 0.0 0.5 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 3.0 0.4 0.1 0.0 0.0 0.0 3.6 0.0 0.2 0.1 0.1 6.6 0.2 0.6 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1.9 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023, CAB079950" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 11.6 7.9 6.0 12.0 7.5 9.9 13.4 6.2 8.1 10.2 6.0 9.8 7.3 11.3 11.1 11.7 10.8 7.7 7.6 6.1 7.0 6.9 8.3 7.5 13.8 6.8 7.1 5.7 12.8 16.2 9.6 5.2 10.2 7.6 8.2 12.1 5.1 8.7 8.4 12.6 9.5 8.3 11.8 5.8 9.6 10.2 2.2 7.1 12.9 9.3 6.3 17.3 14.3 9.9 7.2 34.7 38.0 19.9 52.9 32.7 33.2 33.5 37.6 28.5 37.0 29.4 39.0 33.5 81.6 73.7 27.3 40.2 43.4 80.6 40.8 45.1 27.2 40.1 46.6 32.9 29.8 36.9 66.7 34.5 40.9 35.1 50.2 52.6 23.7 29.5 29.9 47.3 25.0 32.1 57.1 48.4 50.6 41.6 65.5 42.1 37.5 30.1 56.0 25.4 26.1 20.8 54.7 21.3 38.9 45.2 26.1 21.0 38.4 25.8 16.2 21.2 45.8 73.2 30.8 38.4 71.1 24.4 81.2 37.4 29.2 9.4 5.0 13.9 16.8 16.1 12.3 11.5 13.1 13.8 14.1 14.4 13.5 1.1 18.5 15.4 11.0 17.6 8.8 6.0 7.5 6.2 8.1 6.1 7.0 6.8 7.1 5.7 7.6 5.8 7.1 7.2 10.1 12.8 15.6 3.6 11.2 8.4 17.0 11.1 17.6 5.3 10.2 13.2 10.5 11.5 20.6 0.0 4.2 24.1 16.8 7.2 13.7 16.8 0.2 12.7 24.0 10.1 7.7 12.2 7.8 12.6 20.0 11.9 9.7 15.7 14.0 10.6 6.8 5.1 13.6 1.7 7.2 10.4 12.2 9.5 5.5 0.5 6.2 11.1 5.4 3.7 17.8 6.5 16.5 3.5 8.4 13.0 9.7 7.2 14.7 12.2 4.9 9.1 8.1 5.2 13.1 17.9 13.2 1.3 2.2 18.9 8.0 40.6 13.1 13.1 13.8 11.4 AIFM1 "AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130124666-130165879 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 165.4;Proximal tubular cells: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 230000 Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 19.5 65.7 11.6 17.8 12.1 11.9 18.0 13.0 12.7 15.8 23.2 28.9 53.4 15.5 9.0 21.0 22.3 10.2 89.0 11.9 12.5 96.1 111.5 14.0 16.3 12.2 12.1 11.6 12.0 28.1 30.0 16.4 10.4 12.5 14.9 16.0 8.5 18.7 7.6 69.4 14.7 30.2 10.2 12.2 20.4 41.6 30.6 12.8 18.7 14.8 25.4 11.0 18.6 13.5 12.6 52.8 95.4 22.6 85.2 24.1 14.6 50.0 28.6 19.0 33.5 25.2 55.8 36.4 105.0 113.3 17.5 39.3 47.2 61.3 33.3 12.7 48.2 73.4 61.6 59.1 68.9 34.0 51.5 63.5 26.1 21.7 34.5 22.0 12.1 27.2 83.4 62.6 50.7 13.1 96.7 57.6 74.5 24.4 53.6 65.1 55.6 31.7 132.7 60.8 36.6 46.0 28.2 35.5 68.0 67.5 13.2 46.0 40.8 31.7 20.5 20.4 63.9 58.7 24.2 45.0 47.5 25.3 86.4 33.4 4.1 21.0 14.1 11.8 26.6 13.1 14.6 12.8 14.6 31.7 10.3 12.7 12.6 2.4 20.7 24.8 14.7 17.9 12.4 11.6 12.1 13.0 12.7 11.9 12.5 12.2 12.1 11.6 12.5 12.2 12.8 12.6 12.6 16.0 20.1 17.0 17.1 8.7 8.2 25.0 9.1 19.3 13.0 8.3 165.4 22.8 21.2 40.5 22.9 58.0 14.2 31.6 92.0 24.9 1.8 36.7 17.3 11.5 9.6 26.3 10.8 20.5 29.0 16.4 27.0 50.4 10.8 33.1 14.3 92.3 38.0 15.2 12.1 24.0 34.6 14.4 7.4 4.9 17.4 16.8 10.6 8.4 16.6 17.2 20.6 8.0 19.6 18.0 18.9 17.3 19.2 7.9 45.6 326.1 21.3 48.1 6.6 11.3 39.3 10.2 32.0 17.1 6.8 39.7 15.8 45.9 37.2 9.8 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 146.2;Late spermatids: 282.5;Proximal enterocytes: 178.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 63.8;RPMI-8226: 40.2;RT4: 47.0" "Low region specificity" "Detected in single" "Region enriched" "Detected in all" 14 "cerebellum: 37.5" "HPA007667, CAB025854" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favorable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 7.4 56.4 2.0 8.9 3.3 9.5 14.3 0.6 4.4 12.8 0.0 26.7 31.2 3.4 11.6 103.3 7.6 7.5 2.1 3.3 1.7 17.4 6.7 24.0 7.9 0.8 0.2 3.1 5.5 48.1 39.2 33.5 5.7 2.0 16.8 24.6 2.7 49.9 15.7 1.2 73.7 40.4 2.0 0.0 16.2 24.3 40.3 3.3 6.9 19.0 1.0 12.5 12.3 39.7 3.1 31.4 0.3 0.7 0.5 2.4 11.2 4.3 3.3 0.4 0.3 0.8 22.3 28.4 7.0 2.0 2.5 4.6 24.4 0.3 63.8 0.7 20.0 7.9 0.2 1.2 22.8 4.0 0.4 2.2 9.2 25.9 4.3 1.0 4.5 4.1 1.2 0.6 9.4 0.9 12.7 0.4 2.6 0.4 30.9 0.4 21.0 0.5 40.2 11.6 47.0 30.5 0.7 2.5 0.5 0.2 1.3 33.0 4.1 6.3 2.4 0.4 1.0 0.7 0.8 12.7 2.3 0.1 1.3 0.2 7.6 0.4 6.5 18.3 0.1 12.3 13.9 14.5 15.4 0.1 22.0 12.8 14.4 4.6 3.8 0.1 0.2 38.0 8.6 2.0 3.3 0.6 4.4 3.3 1.7 0.8 0.2 3.1 2.0 0.0 3.3 3.1 1.5 28.9 33.0 1.0 16.4 27.3 43.5 24.9 15.4 0.7 58.8 17.7 1.7 25.8 27.3 29.5 6.2 55.3 14.9 146.2 15.6 56.9 110.3 9.1 2.8 2.1 65.5 0.0 10.0 115.9 11.8 5.0 32.1 26.2 2.5 21.1 1.1 1.7 40.3 0.0 6.7 83.2 34.6 6.8 3.3 282.5 7.2 8.8 17.8 3.7 14.2 2.1 21.6 1.5 1.2 103.6 102.2 9.8 11.4 37.1 178.4 11.5 3.7 2.4 0.0 2.2 3.4 56.6 2.9 62.6 53.3 32.3 18.5 2.5 93.0 59.9 BAG4 SODD ENSG00000156735 "BAG cochaperone 4" O95429 8 38176533-38213301 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013716, HPA018951" Approved NA NA "CAB013716: , HPA018951: AB_1845260" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.22e-1)" "unprognostic (5.23e-2)" "unprognostic (4.44e-2)" "unprognostic (7.27e-2)" "unprognostic (3.20e-1)" "unprognostic (2.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.66e-2)" "unprognostic (2.50e-3)" "unprognostic (4.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.28e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-2)" 10.4 5.8 9.2 6.0 14.1 28.8 7.8 12.3 17.3 7.3 4.4 5.6 5.8 6.7 6.9 6.8 5.3 5.5 4.9 13.5 12.1 9.7 16.9 5.8 7.4 10.0 9.1 13.0 11.1 5.2 8.1 4.6 11.5 11.3 7.6 5.9 9.6 6.8 7.9 14.6 7.3 5.6 6.1 5.1 6.5 5.6 4.4 11.5 7.5 6.8 6.9 7.7 6.4 5.6 14.6 16.3 18.4 14.9 22.7 27.8 18.5 13.8 16.5 20.3 17.6 19.4 19.0 9.5 19.5 18.1 14.2 11.9 16.4 25.0 14.4 24.2 9.0 14.0 32.8 10.6 27.3 14.0 15.3 13.4 15.5 16.1 18.4 17.7 12.1 10.1 14.0 34.8 11.5 14.7 9.7 27.3 18.0 32.5 12.7 8.2 18.9 17.7 8.9 16.1 17.8 11.4 15.6 13.7 8.9 13.5 13.4 10.7 9.0 14.4 16.3 16.9 27.6 11.1 10.4 16.5 22.9 9.7 17.4 17.2 17.1 13.9 15.1 8.2 11.6 9.7 7.5 7.2 7.9 12.5 7.4 9.3 8.6 8.7 5.6 21.3 6.5 8.4 9.4 9.2 14.1 12.3 17.3 13.5 12.1 10.0 9.1 13.0 11.3 5.1 11.5 14.6 10.6 12.8 12.4 15.3 14.7 43.1 13.2 12.7 38.1 18.9 13.1 10.8 11.1 12.8 12.1 20.2 27.1 23.5 10.8 10.4 17.6 11.0 4.0 13.5 14.6 10.9 5.4 19.4 30.6 11.6 19.0 16.2 13.7 16.0 7.6 11.4 12.8 25.5 24.5 13.5 27.5 8.9 6.1 26.7 30.8 4.4 15.2 19.4 37.4 13.1 23.9 10.4 9.2 7.5 20.8 9.1 8.3 13.2 20.6 19.2 15.3 21.1 10.9 11.8 6.6 16.1 12.7 13.3 11.5 24.0 33.8 12.2 14.8 15.7 12.0 18.7 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455846-60470752 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 678.9" "Cell type enriched" "Detected in some" 35 "B-cells: 970.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 96 "memory B-cell: 625.4;naive B-cell: 627.0" "Lineage enriched" "Detected in many" 96 "B-cells: 627.0" "Group enriched" "Detected in some" 26 "Daudi: 731.3;U-698: 364.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 3.6 0.4 0.0 151.1 0.0 19.3 0.8 0.0 0.2 0.5 0.3 9.1 3.1 2.2 1.0 4.2 0.5 8.5 1.8 0.0 0.1 3.4 2.2 4.0 504.4 0.2 0.2 0.0 0.3 0.2 7.4 0.3 0.9 0.1 5.2 10.7 0.0 9.0 0.3 0.8 0.1 124.5 1.2 0.1 256.0 18.6 1.2 0.1 51.0 6.7 0.1 678.9 16.4 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 731.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.5 0.2 0.0 0.1 0.0 364.1 0.0 0.2 0.0 0.8 0.5 0.3 2.4 0.1 3.7 625.4 2.8 5.5 0.5 627.0 0.5 2.1 2.0 6.5 0.6 0.5 0.8 32.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.0 3.8 0.0 970.5 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 4.5 0.7 0.1 0.3 0.0 7.0 0.0 0.0 0.1 1.8 2.0 0.1 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.2 0.0 0.6 0.3 2.0 0.0 4.6 7.2 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.2 0.1 0.8 0.1 0.0 27.3 0.7 0.2 0.0 TBC1D31 "Gm85, MGC21654, WDR67" ENSG00000156787 "TBC1 domain family member 31" Q96DN5 8 123041968-123152153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.7" "Cell type enhanced" "Detected in many" "Astrocytes: 19.9;Excitatory neurons: 23.4;Inhibitory neurons: 32.0;NK-cells: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 83.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023710 Approved Approved Centrosome NA NA Centrosome "HPA023710: AB_1858819" "unprognostic (1.39e-1)" "unprognostic (5.44e-3)" "unprognostic (7.21e-2)" "unprognostic (3.18e-5)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.53e-2)" "unprognostic (6.59e-2)" "unprognostic (8.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.18e-4)" "unprognostic (1.78e-3)" "unprognostic (1.57e-1)" "unprognostic (1.76e-2)" "unprognostic (2.33e-1)" 3.9 2.5 5.8 6.1 7.3 7.5 2.1 20.7 6.5 1.7 5.0 4.2 5.5 2.4 1.4 2.5 4.3 2.2 2.3 7.2 5.0 2.8 3.2 2.5 7.2 4.5 6.5 5.5 1.7 3.9 2.9 3.5 1.9 7.9 2.3 3.6 4.9 2.4 1.7 4.5 2.9 4.8 2.8 4.2 5.9 3.4 5.2 6.3 14.6 3.1 2.6 6.1 2.3 1.7 6.3 30.6 19.5 15.4 12.9 5.1 5.5 10.9 17.5 6.4 14.0 12.7 17.9 11.4 11.2 21.5 4.7 9.5 21.1 14.3 7.2 19.7 31.3 31.6 28.8 13.5 8.3 7.7 11.9 20.3 4.4 4.2 11.6 11.9 4.1 10.2 31.0 24.0 23.1 10.2 50.5 37.2 8.1 12.8 26.5 29.8 21.2 14.5 16.8 9.4 11.1 16.8 14.7 31.5 83.2 9.7 9.8 15.8 9.2 8.8 12.8 31.9 11.9 22.1 34.5 58.1 15.1 13.2 20.1 19.0 9.1 10.0 10.6 17.4 12.6 26.6 9.2 10.6 14.3 8.8 8.4 10.8 12.3 5.8 20.5 11.2 7.9 11.6 15.6 5.8 7.3 20.7 6.5 7.2 5.0 4.5 6.5 5.5 7.9 4.2 6.3 6.3 2.7 0.0 3.4 19.9 3.7 0.5 1.0 2.4 1.2 2.7 1.0 1.3 14.0 0.0 1.4 1.8 6.2 1.6 10.4 2.4 0.0 1.8 4.9 3.4 3.2 2.4 3.0 12.8 23.4 1.1 2.6 2.6 2.6 1.2 7.6 4.2 1.1 1.8 3.9 0.0 32.0 2.0 0.0 6.6 1.9 2.9 1.5 3.8 1.8 14.0 4.6 1.3 24.7 11.1 13.4 1.0 0.6 1.5 5.8 0.7 1.2 2.2 3.7 5.9 0.0 2.4 2.3 10.9 2.7 4.1 1.3 0.1 12.5 2.5 3.5 0.6 NTAQ1 "C8orf32, FLJ10204, WDYHV1" ENSG00000156795 "N-terminal glutamine amidase 1" Q96HA8 8 123416726-123470028 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024823, HPA053680" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA024823: AB_1845773, HPA053680: AB_2682228" "unprognostic (9.97e-2)" "unprognostic (4.82e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.69e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "unprognostic (5.39e-2)" "unprognostic (7.46e-2)" "unprognostic (2.37e-1)" 6.7 11.0 18.1 5.1 18.0 5.9 13.6 17.9 24.1 12.9 17.5 7.6 4.3 8.2 8.9 7.0 7.6 6.8 20.3 16.7 19.1 11.0 6.8 6.8 7.4 18.8 19.8 16.7 18.3 9.7 11.1 10.6 6.8 19.2 10.3 7.9 15.1 7.0 8.9 16.1 7.7 4.5 9.6 18.0 5.2 8.6 12.8 20.7 7.2 12.9 17.8 10.2 8.9 7.2 19.5 26.6 26.9 39.2 18.1 15.3 40.9 14.5 19.1 21.3 23.4 26.1 15.8 17.8 19.7 19.8 23.8 32.7 12.8 25.8 29.7 31.4 53.1 15.8 25.6 13.2 22.4 21.2 12.7 10.9 24.1 16.0 29.3 32.8 27.1 22.6 41.2 18.8 29.0 33.5 84.3 30.2 14.4 12.3 65.6 20.5 13.5 20.0 20.4 31.1 22.6 18.6 34.1 20.7 109.0 35.8 44.5 17.6 12.2 9.8 26.5 46.2 19.7 26.4 17.4 38.1 24.1 18.8 14.1 19.1 16.3 5.7 2.1 6.2 8.7 7.4 5.0 7.3 7.7 9.0 4.1 6.2 6.9 1.5 16.0 3.8 5.2 10.6 4.6 18.1 18.0 17.9 24.1 16.7 19.1 18.8 19.8 16.7 19.2 18.0 20.7 19.5 5.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 13.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 10.0 0.3 0.0 0.0 0.0 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family AAA domain containing 2" Q6PL18 8 123319850-123416350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 28.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 294.4" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 3.0 3.4 3.8 7.8 3.5 26.7 6.9 2.8 3.9 12.9 2.3 5.3 5.0 4.4 3.8 6.9 3.4 3.3 5.8 3.4 3.9 1.4 9.9 4.1 14.5 3.4 3.9 3.0 7.1 3.3 1.9 3.9 4.8 3.1 10.4 6.9 1.5 4.3 4.7 9.4 6.9 5.3 4.1 3.0 5.0 4.8 19.1 4.9 28.5 3.9 3.2 12.9 4.9 3.9 3.4 103.7 39.6 55.0 19.0 9.7 12.3 24.3 79.2 27.2 66.8 73.9 30.1 43.8 67.2 23.6 25.2 26.5 48.3 74.2 25.6 106.1 94.3 39.0 121.2 41.0 61.4 3.8 44.6 57.4 4.1 3.8 63.6 21.0 14.3 20.7 38.6 57.7 66.4 50.4 107.1 129.5 32.8 10.0 77.8 38.4 66.5 65.6 36.4 23.8 46.7 70.2 30.5 114.4 294.4 20.8 22.1 60.2 41.2 13.0 50.4 69.3 40.2 96.6 21.2 40.7 60.8 32.9 72.9 40.4 5.3 0.8 3.3 1.6 0.8 2.2 2.6 2.3 2.7 1.4 1.5 1.5 1.7 0.2 2.5 1.9 0.1 4.6 1.0 3.8 3.5 2.8 3.9 3.4 3.9 3.4 3.9 3.0 3.1 3.0 4.9 3.4 4.8 6.4 11.0 9.4 18.5 15.8 27.9 9.1 14.2 2.8 17.3 21.2 27.3 2.8 10.2 3.7 4.2 14.9 15.3 9.0 1.9 3.5 54.9 7.9 17.3 9.6 1.2 79.1 25.6 2.2 26.2 17.1 13.3 17.5 14.5 37.9 7.1 16.3 11.2 1.7 16.4 13.1 4.1 8.2 6.9 24.4 7.5 11.7 1.8 14.0 6.3 6.3 17.5 11.6 2.8 3.5 4.3 13.9 34.0 20.7 3.1 1.0 5.4 1.9 0.0 9.5 17.5 106.0 82.4 23.7 12.1 13.5 22.8 3.7 14.6 24.5 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 654.8" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 247.5;Cardiomyocytes: 286.5;Prostatic glandular cells: 225.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 2.5;MAIT T-cell: 2.5;memory CD4 T-cell: 3.6;memory CD8 T-cell: 3.8;naive CD4 T-cell: 4.2;naive CD8 T-cell: 5.4;NK-cell: 3.2;T-reg: 3.8" "Group enriched" "Detected in many" 8 "granulocytes: 2.9;NK-cells: 3.2;T-cells: 5.4" "Cell line enhanced" "Detected in many" "GAMG: 49.3;HDLM-2: 176.1;hTERT-RPE1: 58.3;U-251 MG: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 8.8 2.7 14.2 14.0 18.9 2.2 29.5 21.5 16.2 12.1 36.8 97.8 6.7 87.6 15.0 16.4 60.0 32.7 78.6 11.7 16.4 2.7 1.1 3.8 6.0 28.3 21.2 8.0 25.1 4.6 11.8 9.0 7.8 32.3 26.0 20.9 18.1 23.2 44.2 654.8 12.3 23.7 95.7 27.7 4.0 32.1 1.7 17.6 9.3 24.4 106.5 5.1 74.0 14.0 33.2 5.3 0.9 0.2 0.0 10.6 2.5 1.9 1.0 11.4 0.6 1.1 0.0 2.9 0.0 3.1 8.5 49.3 0.3 0.2 1.0 0.9 176.1 4.0 0.0 6.3 0.0 14.5 0.1 0.7 21.1 7.4 2.6 3.2 58.3 0.8 2.5 0.3 1.5 0.8 1.3 0.7 0.1 0.1 2.1 0.9 0.0 0.2 1.1 1.9 1.7 0.3 1.1 1.2 19.2 21.5 1.1 18.9 0.4 0.7 3.1 0.8 1.1 51.9 17.4 2.6 0.4 12.7 0.2 2.5 2.9 0.2 0.0 2.5 0.1 2.5 0.4 3.6 3.8 0.2 0.4 4.2 5.4 0.1 3.2 0.2 0.1 3.8 1.1 14.2 18.9 21.5 16.2 11.7 16.4 28.3 21.2 8.0 32.3 27.7 17.6 33.2 6.8 0.0 3.7 7.5 6.1 11.5 184.8 113.3 64.9 17.7 44.9 247.5 286.5 4.3 63.6 7.3 35.5 17.8 27.9 153.0 9.8 14.4 4.7 22.2 88.2 13.0 102.4 8.0 52.2 30.7 17.5 28.9 14.8 76.0 0.0 30.3 2.2 2.9 5.3 21.9 30.9 63.6 111.9 5.9 3.4 3.5 39.7 5.6 44.4 14.0 2.4 58.6 25.7 9.5 117.2 51.7 189.5 61.3 38.3 225.2 36.9 5.2 19.9 100.1 19.7 75.2 61.3 15.9 2.9 49.9 6.3 109.2 32.5 3.7 21.1 90.8 NSMCE2 "C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7" ENSG00000156831 "NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase" Q96MF7 8 125091679-125367120 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway" Transferase "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 136.1;Excitatory neurons: 150.1;Inhibitory neurons: 156.8;Microglial cells: 157.4;Oligodendrocyte precursor cells: 139.2;Oligodendrocytes: 386.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051614, HPA065734" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA051614: AB_2681551, HPA065734: AB_2685549" "unprognostic (1.14e-3)" "unprognostic (1.29e-1)" "unprognostic (6.56e-2)" "unprognostic (1.22e-3)" "unprognostic (8.65e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (7.54e-4)" "unprognostic (3.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.09e-2)" "unprognostic (1.17e-1)" "unprognostic (7.53e-2)" "unprognostic (2.61e-2)" "unprognostic (6.85e-2)" 18.1 18.3 11.1 14.2 12.7 30.6 23.9 12.5 12.9 17.1 13.5 16.8 12.7 16.0 18.8 17.1 13.5 16.1 24.1 11.6 12.5 19.0 17.9 14.3 21.9 12.4 12.2 10.8 19.2 13.0 17.9 11.3 19.7 12.6 13.3 17.6 16.9 16.1 14.0 33.9 15.4 12.4 16.3 12.5 14.6 16.7 15.6 12.4 26.2 18.2 27.4 26.4 20.9 14.8 16.3 43.0 36.3 42.3 26.9 32.7 48.9 20.5 33.5 62.5 58.2 67.0 23.4 39.9 53.2 38.5 32.0 42.9 31.1 33.4 28.2 58.8 60.0 32.4 75.4 20.0 34.1 47.7 22.8 22.1 36.5 38.4 33.6 43.6 38.8 53.2 27.5 44.1 34.2 51.4 74.3 58.9 20.9 9.3 48.4 48.0 33.3 29.4 48.6 35.5 32.1 28.0 29.7 40.1 119.2 56.3 24.9 50.9 25.9 33.3 22.3 62.9 27.8 48.3 45.1 86.6 67.6 35.4 43.4 35.3 12.9 23.9 69.4 22.0 21.7 24.3 25.0 23.1 24.8 24.4 25.5 23.7 25.9 11.3 22.0 23.3 14.2 37.6 24.5 11.1 12.7 12.5 12.9 11.6 12.5 12.4 12.2 10.8 12.6 12.5 12.4 16.3 21.8 9.6 13.1 136.1 22.0 23.8 36.3 39.1 21.1 23.8 23.3 24.8 20.1 21.5 26.0 11.0 16.7 34.2 20.3 16.2 27.4 33.1 28.0 26.4 19.7 23.0 13.8 36.2 150.1 42.5 27.8 21.4 13.7 20.7 25.4 24.1 23.2 13.7 44.3 15.2 156.8 17.7 18.3 26.5 24.3 9.9 23.3 24.4 17.8 157.4 29.4 18.4 20.6 139.2 386.0 34.2 19.5 24.5 20.2 28.1 20.6 35.2 23.4 26.4 6.6 20.7 23.4 44.4 31.7 16.0 18.9 46.7 24.6 20.9 19.8 37.6 ZNF689 "FLJ90415, TIPUH1" ENSG00000156853 "Zinc finger protein 689" Q96CS4 16 30602558-30624012 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 19.7" "Cell type enhanced" "Detected in many" "Early spermatids: 53.0;Late spermatids: 52.0;Spermatocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054095, HPA055385" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Nucleoplasm, Nucleoli fibrillar center" "HPA054095: AB_2682377, HPA055385: AB_2682801" "unprognostic (5.62e-2)" "unprognostic (2.36e-2)" "unprognostic (2.77e-3)" "unprognostic (2.73e-2)" "unprognostic (7.73e-2)" "unprognostic (3.74e-2)" "unprognostic (1.57e-1)" "unprognostic (8.38e-2)" "unprognostic (5.83e-3)" "unprognostic (2.26e-1)" "prognostic favorable (9.89e-4)" "unprognostic (3.21e-1)" "unprognostic (1.58e-3)" "unprognostic (3.93e-2)" "unprognostic (5.23e-1)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" 3.6 3.6 3.3 3.5 3.5 6.7 10.3 3.4 3.7 3.9 2.4 4.2 4.8 5.4 2.7 2.3 4.1 2.9 3.7 3.3 3.2 3.0 4.3 3.5 4.1 3.4 3.3 3.3 5.4 4.8 7.1 3.5 3.2 3.3 3.6 3.2 2.9 3.4 4.7 5.2 2.6 4.3 4.1 3.2 4.8 3.8 19.7 3.3 6.0 3.9 5.5 4.1 4.3 3.0 3.5 4.6 8.1 11.1 11.6 4.7 4.6 5.5 5.6 8.2 9.0 8.7 9.5 3.5 13.2 8.6 5.0 6.5 3.5 14.0 6.1 7.1 10.9 23.6 11.2 7.1 14.7 5.0 11.1 8.2 4.4 5.7 6.2 6.1 4.9 6.4 12.0 13.4 7.4 5.8 6.9 20.6 10.4 12.6 3.6 8.2 25.7 10.7 11.9 3.8 4.5 13.8 8.4 4.1 7.4 6.4 5.5 7.7 9.6 5.0 11.6 4.9 5.6 7.8 13.6 16.8 15.7 4.2 12.0 11.5 0.1 6.2 2.5 5.1 9.3 3.7 3.8 4.2 5.2 8.9 2.9 3.6 3.5 0.4 8.8 10.3 3.2 4.5 4.4 3.3 3.5 3.4 3.7 3.3 3.2 3.4 3.3 3.3 3.3 3.2 3.3 3.5 10.5 3.2 2.0 1.3 8.4 1.7 4.9 2.6 1.8 10.0 25.4 20.7 4.7 11.5 1.2 1.8 6.2 4.3 10.2 5.9 0.0 6.2 53.0 2.3 5.7 8.6 6.0 6.1 2.4 6.9 3.2 6.3 3.6 3.3 14.0 8.0 8.6 6.9 5.1 10.1 2.7 6.5 6.1 8.6 4.3 52.0 8.1 6.6 0.0 3.7 6.9 5.8 8.2 2.0 3.0 5.2 4.8 10.5 6.6 5.5 7.9 4.3 1.5 6.1 0.0 11.5 5.8 87.7 8.9 2.1 1.0 0.8 8.8 6.6 6.6 3.0 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656413 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 20.2 20.3 14.5 14.0 14.2 23.8 20.5 16.3 21.9 25.6 11.1 27.8 13.9 30.0 7.1 22.6 26.3 6.6 15.8 13.8 13.6 22.2 21.5 24.3 14.3 16.3 14.2 12.3 25.3 25.1 13.1 21.3 8.4 14.7 26.5 7.9 9.5 19.3 13.9 15.2 26.2 25.8 11.0 13.0 32.8 26.2 12.6 15.1 18.9 23.6 9.7 10.7 24.7 22.9 14.9 18.2 20.3 17.1 18.2 15.2 11.7 11.9 17.6 11.8 18.1 17.2 9.3 17.3 30.5 15.3 12.9 8.4 17.7 14.4 20.4 9.8 41.5 36.0 17.9 19.6 21.4 23.6 16.1 43.3 9.8 23.1 13.0 13.7 18.9 23.1 8.2 22.8 24.3 10.0 42.2 36.7 28.4 6.2 12.4 10.3 29.4 8.4 44.2 13.7 7.3 14.5 32.4 7.1 26.8 18.2 5.3 29.9 13.1 18.1 16.3 17.7 17.0 18.4 44.1 29.4 21.3 11.0 33.0 14.7 11.4 6.0 23.7 9.6 6.5 7.4 7.0 8.0 9.7 5.7 10.5 7.3 7.2 22.5 8.6 10.9 7.6 10.3 5.5 14.5 14.2 16.3 21.9 13.8 13.6 16.3 14.2 12.3 14.7 13.0 15.1 14.9 18.1 9.6 10.4 13.7 23.2 22.8 26.1 28.8 33.6 13.9 19.1 18.7 6.6 25.8 13.2 12.9 14.6 15.8 31.9 24.1 15.6 22.3 6.7 8.8 13.0 20.9 12.6 15.4 7.5 22.2 15.3 15.3 27.5 15.1 12.0 15.4 18.9 10.1 18.2 1.7 7.7 18.3 20.3 16.0 34.1 2.5 19.3 20.2 8.8 8.4 30.2 13.1 33.0 5.5 8.7 20.4 14.6 21.1 17.3 23.6 23.6 15.1 10.0 14.2 19.7 12.8 19.9 17.2 27.2 28.5 23.0 14.1 26.5 11.7 19.8 17.3 FBRS "FBS, FBS1, FLJ11618" ENSG00000156860 Fibrosin Q9HAH7 16 30658431-30670810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044117 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044117: AB_10794394" "unprognostic (1.87e-1)" "unprognostic (8.48e-3)" "unprognostic (2.41e-2)" "unprognostic (9.52e-3)" "unprognostic (1.03e-1)" "unprognostic (4.80e-2)" "unprognostic (2.07e-3)" "unprognostic (7.01e-3)" "unprognostic (6.32e-2)" "unprognostic (7.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.01e-1)" "unprognostic (1.25e-2)" "unprognostic (2.13e-1)" "unprognostic (4.16e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" 25.7 34.6 20.0 24.6 18.9 56.4 26.0 18.4 24.8 32.9 11.0 37.6 21.4 35.9 5.5 57.6 36.3 9.5 26.8 20.0 14.0 33.5 30.1 29.5 22.0 21.5 17.6 12.9 34.1 30.0 16.7 58.1 12.7 20.5 37.6 6.5 6.6 30.5 15.7 38.7 52.5 40.3 9.8 13.8 53.8 34.0 118.2 18.0 21.5 36.9 11.5 16.1 35.0 33.4 18.6 28.8 30.2 15.6 12.9 15.3 15.5 39.5 20.9 16.9 17.7 13.3 17.8 25.9 26.8 34.0 17.0 16.0 23.6 16.6 19.9 8.3 72.7 41.5 36.0 29.3 33.0 37.4 26.5 52.3 23.1 26.4 34.3 16.6 19.8 22.0 24.4 32.0 50.2 13.1 59.1 33.7 51.7 4.4 12.9 19.0 48.5 11.8 29.4 18.8 21.2 21.8 24.5 16.4 31.2 22.9 6.7 70.5 34.6 34.3 40.0 24.2 25.0 27.8 58.6 30.5 25.4 38.4 25.6 24.1 0.0 1.0 0.8 0.8 0.4 0.8 0.6 0.7 0.8 0.5 0.7 0.2 0.9 2.1 0.5 0.6 1.0 0.0 0.9 20.0 18.9 18.4 24.8 20.0 14.0 21.5 17.6 12.9 20.5 13.8 18.0 18.6 21.2 16.0 21.8 9.8 30.0 18.7 15.9 13.2 38.7 22.3 26.8 19.3 9.3 11.5 11.0 7.3 33.3 10.2 38.1 36.3 5.9 11.0 82.2 33.4 25.1 18.2 16.8 4.6 9.5 14.7 9.3 15.8 29.0 32.2 19.0 21.5 19.2 9.4 14.0 43.7 8.7 21.5 10.2 15.8 22.0 109.9 17.1 25.8 10.6 7.5 20.1 14.7 15.5 7.5 14.5 21.1 26.3 16.1 13.3 22.2 33.5 8.9 24.4 25.7 0.0 19.0 17.7 69.1 23.9 37.8 24.3 33.0 28.8 22.2 19.3 27.9 FRRS1 "SDFR2, SDR2" ENSG00000156869 "Ferric chelate reductase 1" Q6ZNA5 1 99703970-99766635 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 10.8;Microglial cells: 13.1;Squamous epithelial cells: 7.2;Theca cells: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 8 "eosinophil: 12.6" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "HEL: 34.7;K-562: 23.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017883 Approved NA NA "HPA017883: AB_2294223" "unprognostic (3.97e-2)" "unprognostic (8.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (8.54e-3)" "unprognostic (7.00e-2)" "unprognostic (2.64e-1)" "unprognostic (8.25e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (2.65e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (3.54e-2)" 1.8 3.2 0.9 1.2 1.2 2.9 3.3 1.0 1.7 2.8 1.8 4.3 3.1 1.9 7.4 6.1 2.2 3.4 1.7 0.9 1.1 1.6 28.9 2.5 1.1 1.3 0.8 0.8 2.5 1.1 1.2 0.3 10.2 1.3 2.4 4.2 1.1 1.5 2.6 1.0 9.3 2.3 2.0 0.3 1.2 4.8 1.2 1.1 1.2 2.3 1.7 2.4 2.7 3.9 2.5 6.9 1.2 2.9 2.7 8.5 4.3 14.2 1.9 3.2 1.8 6.8 8.1 9.0 3.8 6.9 2.0 3.0 16.0 4.3 6.8 2.3 8.1 2.9 34.7 3.9 8.7 1.2 4.4 9.2 6.6 8.6 4.0 1.7 0.5 0.4 2.6 23.4 2.0 1.3 2.2 1.4 2.7 2.1 15.2 5.9 0.3 10.8 1.7 1.2 17.3 0.8 0.3 3.0 13.1 6.9 2.1 5.0 4.9 0.8 3.8 5.0 3.3 2.0 3.1 0.4 6.7 8.1 1.9 1.9 1.3 1.0 12.6 0.3 1.4 0.2 0.9 0.2 0.3 1.3 0.6 0.2 0.5 0.8 0.6 0.3 1.0 0.3 0.3 0.9 1.2 1.0 1.7 0.9 1.1 1.3 0.8 0.8 1.3 0.3 1.1 2.5 1.1 0.0 0.0 0.0 1.2 1.9 1.9 1.9 10.8 0.1 0.9 1.3 1.5 0.0 1.2 1.8 0.0 3.1 0.3 1.3 0.0 0.3 0.2 1.9 6.2 0.5 0.0 2.1 0.5 0.0 1.8 4.0 6.6 3.1 0.0 6.2 0.4 2.8 1.0 0.0 0.6 0.4 0.0 2.2 0.0 0.4 0.9 2.1 0.0 13.1 1.1 1.0 0.0 1.0 0.2 0.4 1.4 0.0 3.1 1.2 1.7 0.3 2.2 0.1 0.0 0.5 1.1 0.0 0.2 7.2 2.7 3.7 0.3 12.3 0.5 3.1 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748293-30761176 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 131.1" "Group enriched" "Detected in many" 5 "Early spermatids: 397.0;Late spermatids: 1576.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol NA NA Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favorable (7.90e-4)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favorable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favorable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 8.8 16.0 18.1 11.6 17.5 30.3 10.0 17.8 18.8 9.3 15.6 12.0 11.1 10.1 9.6 10.3 11.8 8.2 11.6 18.9 17.2 14.7 19.2 10.1 12.6 18.0 17.5 17.4 8.4 9.8 19.0 16.0 7.8 20.1 14.9 12.1 8.9 11.6 12.2 13.3 14.7 12.1 10.0 17.0 13.0 13.9 131.1 17.7 11.7 13.7 8.9 12.8 10.2 9.3 19.9 24.7 16.3 13.1 16.2 11.8 9.4 29.8 17.2 24.6 22.1 25.1 13.5 12.6 21.0 19.3 17.1 11.5 24.0 13.5 21.5 17.6 11.4 38.2 11.9 28.8 38.7 18.1 18.1 16.9 12.9 11.2 21.4 9.9 10.7 22.8 15.3 16.1 11.7 16.3 55.5 22.3 27.1 18.0 17.6 18.0 29.4 20.0 28.2 25.7 27.2 17.5 11.9 13.5 38.1 16.6 11.8 30.1 15.5 13.6 14.4 15.1 17.2 16.0 24.1 14.4 14.8 27.3 35.2 11.4 44.0 55.8 114.9 37.8 56.5 30.9 21.1 27.1 38.8 52.0 21.5 24.2 27.7 44.7 63.8 42.3 46.1 43.3 49.0 18.1 17.5 17.8 18.8 18.9 17.2 18.0 17.5 17.4 20.1 17.0 17.7 19.9 10.4 12.8 21.7 13.7 18.5 21.0 15.2 28.7 22.8 8.8 21.8 17.1 15.9 10.0 32.0 18.4 10.4 29.6 32.2 32.1 27.4 11.9 397.0 35.8 13.0 10.0 16.3 20.2 14.7 24.4 41.5 11.8 44.4 38.8 13.3 16.1 10.4 24.1 28.2 20.2 14.5 21.4 26.4 19.1 27.2 1576.6 17.4 26.4 12.4 11.2 40.3 13.7 39.1 9.0 8.1 19.6 18.5 23.3 20.5 31.5 27.8 47.3 33.0 9.9 0.0 8.9 14.8 180.5 22.9 20.5 23.0 75.5 25.9 20.8 27.0 16.9 MFSD14A "DKFZP564L0864, HIAT1" ENSG00000156875 "Major facilitator superfamily domain containing 14A" Q96MC6 1 100038095-100083377 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 132.5" "Group enriched" "Detected in many" 5 "Early spermatids: 303.1;Late spermatids: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA073127, HPA073681" Approved Approved Vesicles NA NA Vesicles "HPA073127: , HPA073681: AB_2686625" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.18e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (2.16e-1)" "unprognostic (7.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (3.84e-1)" "unprognostic (1.05e-1)" "unprognostic (5.15e-2)" 29.3 28.8 20.9 26.5 23.4 91.1 27.6 23.3 24.9 26.1 22.7 24.3 19.8 35.6 26.2 29.3 26.8 25.5 19.8 20.6 23.7 29.9 29.7 29.1 28.6 25.3 23.1 19.9 30.8 31.8 132.5 18.9 34.4 24.7 33.7 22.0 19.8 23.2 31.7 15.1 24.4 19.7 35.8 23.9 28.6 22.6 35.6 22.7 31.4 28.2 20.3 29.4 33.9 24.2 28.2 54.3 22.2 48.9 25.4 56.0 52.8 41.3 38.9 65.9 51.5 59.9 18.9 37.0 40.5 61.7 50.6 34.1 51.0 44.0 42.8 49.2 35.6 34.8 40.1 32.8 28.6 49.4 65.0 50.2 43.3 64.1 45.5 57.9 45.3 40.2 45.1 49.8 77.2 48.1 16.0 49.3 38.1 56.4 26.2 32.4 34.1 59.6 39.8 54.8 46.9 50.7 45.2 43.8 63.0 66.6 30.9 24.6 65.3 44.5 42.3 29.6 44.9 40.9 72.8 82.4 56.0 46.1 46.6 18.6 80.1 56.0 54.6 49.5 51.4 55.9 46.2 49.6 54.4 55.2 38.8 54.8 51.5 94.8 59.9 45.2 25.6 60.3 72.0 20.9 23.4 23.3 24.9 20.6 23.7 25.3 23.1 19.9 24.7 23.9 22.7 28.2 4.5 6.4 11.5 0.0 33.5 0.0 47.5 0.0 43.3 17.8 3.4 1.5 0.0 27.1 3.7 3.7 10.4 37.5 7.8 6.5 1.9 10.1 303.1 1.0 1.7 20.8 13.3 35.8 0.0 7.2 33.5 19.5 18.3 1.5 2.5 0.6 19.6 17.1 23.1 13.5 0.0 9.4 0.0 26.4 0.0 373.8 22.7 15.8 0.0 0.0 22.2 25.1 33.0 0.0 0.0 6.5 17.1 30.5 41.9 56.3 8.1 1.1 5.8 11.6 13.1 25.6 12.8 28.2 22.5 43.4 0.0 58.3 33.7 0.4 9.6 52.3 SASS6 "DKFZp761A078, FLJ22097, SAS-6, SAS6" ENSG00000156876 "SAS-6 centriolar assembly protein" Q6UVJ0 1 100083563-100132955 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028187 Uncertain NA NA "HPA028187: AB_10602220" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (3.07e-2)" "unprognostic (2.06e-2)" "unprognostic (1.31e-1)" "unprognostic (3.02e-3)" "unprognostic (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (8.43e-3)" "unprognostic (4.73e-2)" "unprognostic (6.56e-2)" "unprognostic (3.71e-2)" "unprognostic (7.76e-8)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.54e-1)" 1.3 1.3 1.2 2.9 1.4 6.0 2.8 1.8 1.4 1.6 1.0 2.2 2.8 2.0 2.2 2.1 1.4 1.0 1.0 1.1 1.5 1.0 1.5 1.3 4.2 1.4 1.5 0.9 1.8 1.4 4.0 1.6 2.0 1.4 2.1 3.0 5.8 1.8 1.5 1.3 2.2 2.2 1.8 1.3 2.1 2.1 6.7 1.3 4.4 1.6 0.9 3.6 1.4 1.6 1.6 17.0 5.2 13.1 11.5 1.5 2.6 19.3 10.7 4.7 13.5 15.6 9.0 8.5 18.5 8.0 3.7 8.0 14.8 18.0 6.5 18.6 8.9 17.8 16.2 10.9 11.3 0.9 26.8 14.5 1.3 2.8 11.4 9.0 2.7 7.3 12.2 25.8 17.6 6.7 4.8 22.2 12.9 17.5 11.1 10.7 16.1 25.9 9.4 6.5 8.1 9.5 14.0 9.9 17.0 8.7 9.4 8.6 15.9 3.8 9.5 11.6 10.9 14.9 7.4 18.5 24.6 7.7 17.7 5.3 3.9 0.1 1.0 0.7 0.6 0.9 1.6 0.8 0.7 0.5 0.7 0.7 0.6 0.7 0.6 0.5 0.2 0.9 0.3 1.2 1.4 1.8 1.4 1.1 1.5 1.4 1.5 0.9 1.4 1.3 1.3 1.6 7.2 0.0 2.3 8.5 12.8 4.0 2.8 7.1 6.8 19.4 8.4 9.4 2.9 7.2 5.9 1.8 16.7 13.6 13.5 2.4 1.9 7.5 15.7 7.4 5.8 5.8 4.2 33.2 7.6 5.6 17.3 7.0 7.1 5.4 5.7 15.0 6.8 3.1 9.1 8.4 9.6 4.8 14.2 8.4 4.7 6.2 8.1 5.8 1.8 5.6 6.1 13.3 20.6 5.0 16.1 6.2 2.7 10.9 19.7 4.5 2.2 4.3 4.9 23.0 0.0 12.6 5.9 77.4 36.0 11.9 4.1 5.1 7.9 4.0 8.8 2.1 COX6A2 ENSG00000156885 "Cytochrome c oxidase subunit 6A2" Q02221 16 31427731-31428360 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 43 "heart muscle: 2939.2;skeletal muscle: 6806.0;tongue: 2114.7" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 4861.8" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 150 "NK-cell: 15.0" "Lineage enriched" "Detected in single" 150 "NK-cells: 15.0" "Cell line enriched" "Detected in some" 4 "U-266/84: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.66e-1)" "unprognostic (1.73e-3)" "unprognostic (2.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.68e-2)" "unprognostic (3.88e-1)" "unprognostic (5.61e-2)" "unprognostic (7.20e-2)" "unprognostic (8.71e-2)" "unprognostic (6.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-1)" 1.5 0.9 1.6 0.1 1.0 0.0 2.9 2.1 2.3 0.4 0.2 1.1 1.1 1.1 0.0 75.5 0.9 0.0 2939.2 0.8 1.5 4.4 16.0 3.4 0.4 1.4 1.7 0.7 1.2 3.0 2.9 12.0 0.1 5.2 39.2 0.0 1.0 92.8 0.1 6806.0 2.4 1.2 0.0 0.7 0.5 1.3 1.3 2.4 0.5 2.0 2114.7 0.1 0.3 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.1 1.6 1.0 2.1 2.3 0.8 1.5 1.4 1.7 0.7 5.2 0.7 2.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.4 4861.8 2.8 0.0 3.7 0.0 0.0 0.4 0.0 5.9 0.0 0.0 0.0 0.1 48.8 0.0 0.0 0.0 0.4 0.0 96.2 0.0 0.1 0.0 0.2 0.4 75.7 2.9 3.3 0.0 0.1 0.0 1.6 0.0 0.8 0.3 1.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.1 1.3 24.9 0.0 4.2 19.7 258.0 53.7 0.2 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 ITGAD "ADB2, CD11d" ENSG00000156886 "Integrin subunit alpha D" Q13349 16 31393335-31426505 "CD markers, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 20.7" "Cell type enhanced" "Detected in some" "dendritic cells: 1.1;Kupffer cells: 4.2;Late spermatids: 1.0;Macrophages: 1.6;T-cells: 2.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 10 "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026786 Uncertain NA NA "HPA026786: AB_10603773" "unprognostic (2.79e-2)" "unprognostic (2.39e-4)" "unprognostic (2.88e-2)" "unprognostic (3.24e-2)" "unprognostic (6.17e-2)" "unprognostic (1.79e-2)" "unprognostic (7.44e-4)" "unprognostic (6.99e-3)" "unprognostic (6.89e-3)" "unprognostic (5.02e-4)" "unprognostic (5.50e-2)" "unprognostic (1.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (3.17e-1)" "unprognostic (8.10e-2)" "unprognostic (5.51e-2)" 0.2 0.0 0.0 0.8 0.0 3.1 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 1.3 0.3 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 20.7 0.1 0.2 0.0 1.2 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.4 0.0 0.8 0.0 0.2 0.0 0.0 4.2 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 ADGRG4 "GPR112, PGR17, RP1-299I16" ENSG00000156920 "Adhesion G protein-coupled receptor G4" Q8IZF6 X 136300963-136416890 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 1.0;intestine: 2.5;retina: 1.2" "Group enriched" "Detected in some" 10 "Horizontal cells: 42.1;Paneth cells: 47.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035324 Uncertain NA NA "HPA035324: AB_10671512" "unprognostic (3.40e-3)" "unprognostic (7.68e-5)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.2 0.3 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.1 0.1 2.9 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 ZIC3 "HTX, HTX1, ZNF203" ENSG00000156925 "Zic family member 3" O60481 X 137566127-137577691 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.5;choroid plexus: 3.5;retina: 2.7" "Cell type enhanced" "Detected in some" "Microglial cells: 4.7;Muller glia cells: 9.6;Rod photoreceptor cells: 1.3;Spermatocytes: 2.0;Spermatogonia: 3.7" "Cancer enriched" "Detected in single" 14 "testis cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 35 "AF22: 38.8;NTERA-2: 42.8;SuSa: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052936, HPA069523" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052936: AB_2681993, HPA069523: AB_2732136" "unprognostic (3.55e-5)" "unprognostic (3.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" 0.0 0.0 3.1 0.0 3.8 0.1 0.0 13.5 2.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.8 0.0 0.0 0.0 0.0 3.4 3.6 1.5 0.0 0.0 0.0 0.7 0.0 5.8 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 42.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 24.8 0.6 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.8 13.5 2.8 2.0 3.8 3.4 3.6 1.5 5.8 2.2 4.1 3.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 4.7 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MALSU1 "C7orf30, mtRsfA" ENSG00000156928 "Mitochondrial assembly of ribosomal large subunit 1" Q96EH3 7 23298739-23311729 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "AN3-CA: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020487, HPA052210" Approved Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA020487: AB_1845757, HPA052210: AB_2681762" "unprognostic (3.62e-1)" "unprognostic (3.68e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-3)" "unprognostic (5.24e-3)" "prognostic unfavorable (9.71e-4)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (9.79e-2)" "unprognostic (1.83e-3)" "unprognostic (3.15e-2)" "unprognostic (7.15e-2)" "unprognostic (2.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.68e-1)" 2.4 3.3 2.9 1.7 2.8 2.0 2.2 3.4 3.8 1.8 3.5 2.4 1.1 1.8 2.3 3.9 2.4 1.4 4.5 2.9 2.8 3.2 5.6 2.0 2.9 2.9 2.7 2.8 2.6 2.9 2.3 2.0 3.4 2.9 1.6 1.7 1.8 1.9 2.3 6.4 1.8 1.9 1.8 2.6 1.9 2.2 4.9 2.8 1.6 3.3 6.4 2.0 2.1 1.9 3.2 9.2 11.4 8.8 47.8 7.8 5.4 7.6 6.1 5.0 6.2 5.7 19.7 8.1 8.8 7.0 4.4 27.5 8.7 7.9 4.3 7.6 4.2 12.9 5.2 15.0 30.4 5.0 12.2 3.2 4.6 6.5 5.3 5.8 41.5 5.8 8.5 16.5 2.3 7.9 6.4 8.4 37.2 15.1 18.0 29.0 6.5 6.7 12.4 6.1 8.1 7.0 8.5 5.0 8.9 16.1 17.2 4.5 7.3 9.8 5.2 4.0 10.0 12.5 2.6 8.6 14.7 20.6 15.0 17.3 0.7 1.0 0.7 0.8 0.8 1.0 1.0 1.2 1.0 1.0 1.0 1.4 0.9 0.7 0.9 0.7 0.9 1.2 1.0 2.9 2.8 3.4 3.8 2.9 2.8 2.9 2.7 2.8 2.9 2.6 2.8 3.2 40.5 38.5 41.7 12.7 32.1 43.7 54.8 58.3 30.1 29.1 38.6 60.8 97.1 37.1 40.0 44.1 16.7 77.6 25.7 22.3 115.4 90.6 168.5 50.2 31.9 38.9 19.2 35.3 14.7 96.3 68.7 44.9 16.3 31.7 14.5 41.5 44.3 106.8 54.0 18.5 16.6 32.5 50.8 26.3 15.1 33.6 49.4 22.3 35.6 8.4 44.5 46.8 30.9 18.6 20.2 73.2 28.2 49.2 34.9 61.2 38.1 117.6 44.6 35.8 32.9 35.6 65.6 82.2 75.2 42.4 44.2 49.8 25.2 61.7 44.4 49.2 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8 subunit of CORVET complex" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 154.1;Granulosa cells: 124.3;Inhibitory neurons: 132.2;Oligodendrocytes: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 11.0 9.7 18.1 10.1 23.1 23.4 10.7 26.3 25.0 12.8 28.0 11.5 8.4 12.4 16.4 10.2 9.1 11.2 19.0 19.8 25.8 10.7 8.6 10.8 10.6 25.0 23.5 18.1 14.4 9.0 15.9 16.4 12.2 25.6 11.0 14.8 16.5 7.9 10.2 28.8 13.0 9.4 13.0 20.4 13.4 13.1 17.1 24.3 11.7 15.1 15.4 10.8 10.5 10.4 34.0 18.0 10.7 15.9 15.9 32.5 28.8 10.6 17.7 18.8 12.3 17.0 13.6 9.0 19.1 29.3 26.9 50.4 20.8 17.3 21.0 23.6 34.8 15.4 20.4 13.0 8.1 20.0 14.3 27.0 20.6 19.4 17.6 17.5 22.6 31.4 17.7 10.9 13.5 22.7 12.8 11.6 8.5 10.5 18.4 10.1 14.1 30.6 15.0 12.2 30.8 16.2 10.6 19.9 20.8 15.6 23.6 33.2 7.5 27.9 18.8 10.5 19.6 15.3 16.5 21.5 25.9 21.6 17.7 15.5 19.0 6.6 22.9 5.0 5.2 4.9 4.4 5.4 5.2 8.1 5.5 8.0 5.4 23.9 5.7 6.6 2.3 4.8 4.3 18.1 23.1 26.3 25.0 19.8 25.8 25.0 23.5 18.1 25.6 20.4 24.3 34.0 11.8 12.8 11.5 66.3 17.9 10.5 9.2 8.3 11.4 24.5 8.7 8.3 24.6 11.5 9.7 9.2 18.8 12.8 10.8 17.3 7.9 7.7 22.2 11.0 17.5 12.8 18.0 11.6 154.1 4.6 6.7 14.7 21.9 14.3 2.5 124.3 12.5 7.7 20.2 11.8 132.2 16.6 12.2 19.1 16.7 16.5 10.5 21.2 10.6 89.9 32.0 10.1 32.0 86.5 149.2 6.4 12.7 12.8 14.4 9.4 9.2 8.8 14.4 17.3 6.6 13.0 10.0 94.3 27.8 15.8 16.1 7.7 17.8 11.8 13.2 13.0 GALK2 GK2 ENSG00000156958 "Galactokinase 2" Q01415 15 49155656-49367869 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 92.2;Inhibitory neurons: 90.1;Oligodendrocytes: 109.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043564, HPA048267" Uncertain Approved Nucleoplasm,Cytosol NA NA 24000 "Nucleoplasm, Cytosol" "HPA043564: AB_2678557, HPA048267: AB_2680335" "unprognostic (2.27e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "prognostic favorable (7.31e-4)" "unprognostic (3.04e-1)" "unprognostic (9.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.95e-1)" "unprognostic (2.30e-1)" "unprognostic (8.67e-3)" "unprognostic (2.25e-2)" "unprognostic (2.43e-1)" "prognostic favorable (1.88e-5)" "unprognostic (2.33e-1)" "unprognostic (9.79e-2)" "unprognostic (2.13e-2)" "unprognostic (1.93e-1)" 9.4 16.9 8.5 8.6 10.0 6.6 11.3 10.5 9.4 12.6 14.0 15.4 20.4 8.6 8.7 8.2 12.3 9.0 12.9 8.8 9.5 30.7 21.2 10.6 8.4 9.0 9.3 8.2 9.4 12.3 17.7 9.7 10.0 9.7 9.8 16.3 7.8 10.0 11.0 10.6 8.5 16.7 10.8 9.4 9.0 13.3 7.0 9.1 12.7 15.0 17.1 10.1 9.4 8.6 11.6 14.7 17.1 7.5 10.1 19.1 29.7 21.9 14.7 20.2 14.7 17.2 21.6 15.0 4.8 11.6 15.9 18.0 20.5 30.2 21.6 20.6 26.2 9.1 26.8 15.7 18.4 20.9 19.2 8.2 15.4 38.4 15.7 37.4 16.8 30.2 11.0 27.4 25.5 16.1 15.9 13.9 15.3 3.3 44.0 15.9 16.7 9.5 71.0 27.3 13.8 9.1 6.0 16.6 33.3 29.6 15.0 16.9 18.3 16.6 14.1 9.6 58.4 14.3 20.9 76.2 8.9 22.2 70.1 19.8 45.4 15.3 28.4 18.1 16.7 18.9 14.0 18.0 17.3 15.2 11.1 14.2 14.3 7.6 19.6 17.2 13.3 35.3 13.1 8.5 10.0 10.5 9.4 8.8 9.5 9.0 9.3 8.2 9.7 9.4 9.1 11.6 13.6 3.2 14.9 48.6 12.7 5.6 13.6 16.8 9.1 13.3 12.1 10.3 3.1 27.1 14.5 5.5 37.5 14.8 10.6 14.5 29.4 20.0 12.0 19.2 15.7 12.0 9.0 12.0 92.2 13.1 29.0 12.7 18.3 12.0 2.5 9.8 22.9 25.7 20.4 15.2 90.1 25.1 20.3 16.8 5.7 4.8 11.5 12.6 14.2 63.7 16.5 11.6 20.6 41.7 109.5 10.7 16.2 11.3 27.9 8.3 30.5 56.5 34.1 25.8 0.0 13.4 11.6 22.3 5.9 9.0 6.3 25.7 13.9 13.8 19.0 9.7 LHFPL4 GARLH4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553822 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 16.6;pituitary gland: 12.3;retina: 9.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4" "Group enriched" "Detected in some" 4 "glioma: 6.8;testis cancer: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.0 2.0 11.2 0.0 12.2 0.0 0.0 8.1 16.6 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.0 12.6 0.0 0.0 0.0 0.0 10.7 9.1 13.7 0.0 0.5 0.1 12.3 0.0 12.3 0.0 0.2 9.4 0.0 0.0 0.0 0.1 0.2 0.0 3.1 0.0 0.2 0.7 10.4 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 11.3 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 12.2 8.1 16.6 12.0 12.6 10.7 9.1 13.7 12.3 3.1 10.4 11.5 0.4 0.0 0.0 4.6 0.5 0.0 2.9 0.0 0.0 42.4 0.4 0.3 0.8 0.0 0.0 0.0 18.8 0.6 0.6 0.6 0.0 0.3 0.6 0.7 1.1 0.8 1.2 0.0 60.0 0.2 1.4 0.6 0.0 1.3 1.3 0.5 4.2 0.2 0.3 15.2 67.2 0.7 0.0 0.3 0.0 0.7 0.0 0.8 0.0 1.0 0.1 2.0 3.1 34.2 5.6 0.4 1.7 0.0 0.0 6.3 0.8 0.2 0.0 17.4 0.0 2.7 0.4 1.7 1.1 0.0 0.0 1.4 0.4 0.3 0.8 2.5 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395710-231401164 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 272.8;Intestinal goblet cells: 145.2;Paneth cells: 126.4;Undifferentiated cells: 354.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 32.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.5;HEL: 15.6;THP-1: 14.0;WM-115: 23.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" Yes NA 3600000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 1.9 13.0 5.7 2.8 4.9 14.3 3.9 3.6 5.4 2.5 4.1 56.7 25.4 1.9 6.9 2.9 4.6 14.1 3.5 5.3 5.0 2.3 1.2 15.5 1.6 5.5 6.2 4.3 16.8 25.6 14.4 8.9 5.4 6.1 3.2 71.8 2.1 7.6 4.4 0.4 5.1 28.7 2.3 3.9 5.1 35.9 1.3 6.0 2.4 8.5 0.3 1.5 3.7 0.6 5.3 0.7 2.8 0.3 0.6 0.1 0.2 1.0 0.2 1.1 0.1 0.1 1.4 19.5 2.2 5.8 0.3 0.2 5.1 0.2 0.0 0.1 0.3 0.5 15.6 0.5 0.9 0.1 0.1 0.8 0.1 1.4 0.2 0.3 1.1 0.2 0.4 0.5 0.4 0.1 0.9 0.2 0.7 6.3 7.7 3.3 0.3 0.1 0.4 0.6 1.7 0.5 0.8 0.3 1.7 0.7 6.9 0.6 14.0 0.2 0.4 0.4 0.2 0.2 2.3 0.9 0.7 0.3 0.2 23.7 0.7 0.1 0.7 2.9 0.5 0.5 9.9 0.1 0.4 6.5 7.0 0.1 0.7 0.2 32.1 0.6 3.1 0.2 1.0 5.7 4.9 3.6 5.4 5.3 5.0 5.5 6.2 4.3 6.1 3.9 6.0 5.3 0.9 41.7 30.2 0.3 8.7 2.3 1.7 8.7 0.0 0.4 5.2 2.5 1.1 95.8 29.7 1.8 2.1 0.6 61.7 272.8 0.0 16.1 0.4 13.3 2.2 4.7 103.0 0.4 0.5 84.3 64.9 2.3 51.5 18.5 9.5 17.3 3.3 0.2 11.2 0.0 0.4 145.2 18.3 10.1 38.6 1.2 1.5 9.7 3.6 0.0 2.9 0.5 10.3 55.3 0.2 69.8 126.4 8.2 5.5 11.6 93.2 0.4 82.2 1.8 0.0 0.5 2.3 0.9 1.4 0.0 2.7 2.1 10.0 0.4 354.6 16.2 MPV17L "FLJ39599, MLPH1, MLPH2, MPV17L1" ENSG00000156968 "MPV17 mitochondrial inner membrane protein like" Q2QL34 16 15395754-15413271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 14.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 29.5;SK-BR-3: 8.2" "Low region specificity" "Detected in all" HPA041180 Approved Supported Vesicles NA NA Vesicles "HPA041180: AB_10794266" "unprognostic (9.65e-2)" "unprognostic (8.74e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (2.73e-1)" "unprognostic (4.38e-3)" "unprognostic (8.41e-2)" "unprognostic (8.99e-3)" "unprognostic (8.70e-2)" "unprognostic (6.36e-3)" "prognostic favorable (1.48e-11)" "unprognostic (2.84e-1)" "unprognostic (7.60e-2)" "unprognostic (6.61e-3)" "unprognostic (3.87e-2)" 1.5 2.5 1.3 1.8 0.5 4.4 6.5 1.5 2.3 2.8 0.0 2.1 3.4 2.0 0.3 1.0 1.8 2.4 1.6 0.1 0.3 3.3 9.2 0.9 2.3 0.6 0.1 0.0 2.2 14.2 2.4 3.3 0.6 0.8 2.0 1.0 4.4 7.1 1.8 8.0 4.5 2.3 0.8 0.0 1.8 1.8 1.0 0.4 0.2 2.2 2.4 0.6 1.9 1.3 0.4 1.0 1.9 0.8 0.8 0.2 0.1 1.2 0.5 0.0 0.0 0.0 1.9 3.4 1.5 1.3 0.6 0.5 1.5 3.0 0.0 0.0 1.2 0.8 5.9 4.6 3.9 0.3 3.6 29.5 0.3 0.4 0.1 0.2 0.5 0.0 1.6 2.3 3.3 0.1 1.9 1.4 2.3 1.7 0.3 0.1 2.0 0.6 1.6 0.5 0.8 4.8 1.6 2.7 8.2 0.2 0.9 1.8 2.6 2.6 1.3 0.8 1.1 1.1 1.4 0.6 1.7 0.7 1.7 0.5 1.7 1.2 0.2 0.8 0.9 0.6 0.8 0.5 0.8 0.4 1.2 0.4 0.8 1.8 1.1 0.4 0.7 0.4 0.6 1.3 0.5 1.5 2.3 0.1 0.3 0.6 0.1 0.0 0.8 0.0 0.4 0.4 2.5 6.4 8.8 3.9 2.0 7.9 14.4 8.2 0.0 12.8 11.4 6.0 6.0 14.3 13.1 0.0 10.4 0.5 4.1 2.7 15.6 7.5 4.6 5.4 9.2 6.6 1.2 2.1 5.6 12.9 0.5 8.1 2.0 10.7 6.3 7.6 4.2 29.1 1.0 8.4 5.9 8.7 2.0 13.6 20.6 0.8 7.2 6.0 21.4 2.8 0.7 6.2 0.0 7.5 3.2 5.9 15.3 14.3 1.4 9.6 9.3 19.9 21.0 16.6 0.0 23.5 6.7 9.0 2.0 0.6 11.5 0.5 9.9 4.4 12.1 10.1 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221123 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 18.0;lymphoid tissue: 36.0;testis: 22.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008419 Supported Cytosol Yes Yes Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 0.4 0.5 0.1 6.7 0.1 18.0 1.6 0.3 0.2 0.6 6.3 4.6 4.7 1.2 0.3 5.2 0.6 0.6 0.3 0.3 0.2 0.3 0.4 1.0 12.7 0.1 0.2 0.1 0.2 0.2 0.2 0.2 3.4 0.2 0.4 6.1 0.1 0.9 0.2 0.0 3.6 4.1 2.1 0.1 3.1 2.4 22.4 0.2 36.0 0.5 0.0 15.1 1.5 1.8 0.5 66.5 32.8 103.0 41.5 2.5 7.1 33.2 60.9 34.2 64.6 55.7 48.1 25.0 59.7 33.5 22.7 59.0 72.6 98.8 33.2 70.5 51.8 52.1 86.4 83.6 45.5 0.2 79.0 45.7 1.6 2.0 39.2 37.1 12.9 47.7 66.5 76.4 61.7 65.6 22.5 62.5 48.9 70.2 55.6 36.8 66.5 83.7 45.2 19.9 33.1 67.1 40.8 38.0 35.9 13.3 45.1 41.9 40.9 27.6 49.3 51.8 49.2 55.5 32.1 58.2 95.6 26.3 87.8 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.3 0.2 0.3 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.5 0.1 3.2 1.1 0.3 1.8 0.8 0.3 1.0 1.8 0.7 0.9 2.0 0.8 0.0 1.9 0.0 0.0 5.4 0.6 1.8 0.0 0.4 3.0 0.9 1.4 1.0 0.0 23.5 0.7 0.0 6.7 2.4 5.6 2.1 0.0 12.9 1.1 0.3 5.2 0.0 0.7 2.5 0.0 1.9 1.7 3.3 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.5 0.4 12.6 0.3 0.3 0.1 0.2 0.2 6.6 0.2 1.7 79.2 26.8 6.9 0.3 0.8 1.8 0.8 5.4 0.6 PDE6D JBTS22 ENSG00000156973 "Phosphodiesterase 6D" O43924 2 231732433-231786272 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 211.9;Late spermatids: 147.9;Spermatocytes: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037433, HPA037434" Uncertain NA NA "HPA037433: AB_2675475, HPA037434: AB_10672490" "unprognostic (1.95e-1)" "unprognostic (2.33e-2)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (7.07e-2)" "unprognostic (5.41e-2)" "unprognostic (1.15e-1)" "unprognostic (9.48e-2)" "unprognostic (3.91e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-2)" "prognostic unfavorable (4.02e-5)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (1.46e-1)" "prognostic favorable (4.97e-4)" 16.9 28.3 43.0 16.4 46.1 14.7 16.5 47.0 51.1 18.2 37.3 18.2 13.5 17.7 15.0 16.4 15.7 14.4 17.8 43.8 44.9 18.1 15.5 15.3 23.5 45.2 45.8 41.9 13.5 13.3 23.7 25.2 23.2 45.4 13.8 17.8 70.2 14.3 17.8 13.8 16.4 15.8 22.2 45.3 19.0 16.3 28.1 45.3 32.7 14.2 16.8 24.2 18.1 16.5 49.4 26.3 20.3 37.0 28.2 43.7 36.1 15.7 27.0 44.6 40.8 56.9 8.1 24.5 21.4 22.7 23.2 74.9 20.4 22.3 30.2 52.6 63.5 26.4 31.2 12.4 13.0 20.2 20.6 17.2 25.5 26.4 39.8 30.4 27.5 44.1 68.3 9.1 23.5 27.5 52.0 67.7 64.4 28.6 39.6 28.1 45.7 17.0 32.9 42.8 19.5 36.4 32.6 23.0 19.4 46.3 36.1 17.5 43.0 19.5 26.5 7.3 57.9 21.4 57.9 26.3 52.6 27.4 38.6 42.5 84.4 48.2 68.4 46.3 48.7 36.3 50.4 46.0 47.3 49.3 55.5 31.7 44.3 42.0 34.4 64.9 55.8 84.4 43.1 43.0 46.1 47.0 51.1 43.8 44.9 45.2 45.8 41.9 45.4 45.3 45.3 49.4 20.8 0.0 8.7 18.3 19.5 13.8 12.4 23.6 21.1 14.7 13.3 17.7 13.1 12.8 15.8 12.9 16.7 16.4 18.2 10.2 25.4 23.1 211.9 6.8 9.2 19.6 17.4 15.8 13.4 23.9 21.9 14.7 13.3 6.5 14.5 7.3 19.2 5.0 18.9 11.8 18.1 10.0 14.2 14.4 15.1 147.9 13.1 17.5 23.2 16.9 24.6 22.0 17.5 48.7 34.0 26.0 14.9 12.4 17.0 10.5 11.2 18.4 11.8 29.0 19.7 10.7 24.9 236.8 65.1 20.3 14.2 13.5 18.5 11.5 10.5 11.0 EIF4A2 "BM-010, DDX2B, EIF4A, EIF4F" ENSG00000156976 "Eukaryotic translation initiation factor 4A2" Q14240 3 186783205-186789897 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011690, HPA068286" Uncertain Approved Cytosol NA NA 1600000 Cytosol "CAB011690: AB_732123, HPA068286: AB_2685968" "unprognostic (1.49e-1)" "unprognostic (9.62e-2)" "unprognostic (3.78e-2)" "unprognostic (9.50e-3)" "unprognostic (2.82e-2)" "unprognostic (1.10e-2)" "unprognostic (4.46e-2)" "unprognostic (6.27e-2)" "unprognostic (4.32e-3)" "unprognostic (1.00e-1)" "unprognostic (6.39e-2)" "unprognostic (3.99e-2)" "unprognostic (6.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.03e-1)" "unprognostic (4.67e-2)" "unprognostic (2.62e-2)" 172.8 291.3 273.8 106.8 308.9 7.4 245.8 333.7 356.6 276.8 268.1 236.8 144.6 328.1 198.0 179.8 324.8 207.2 387.5 302.6 330.2 290.4 204.2 157.6 193.9 277.1 275.4 273.3 612.2 274.4 190.8 294.8 220.6 293.1 251.9 181.4 313.0 215.3 265.4 680.9 94.3 167.0 255.0 277.8 160.4 197.6 156.7 306.2 179.7 296.4 558.1 171.4 226.2 188.4 308.3 95.4 44.6 179.1 30.2 624.9 589.3 59.3 158.9 138.5 159.1 202.1 159.9 34.2 200.0 812.8 213.7 283.4 146.8 255.2 66.5 272.0 182.6 134.8 304.8 54.4 214.5 249.6 68.3 209.0 402.5 291.8 47.8 368.3 764.1 275.2 161.6 109.6 311.9 496.8 14.2 112.5 31.2 183.7 337.0 199.4 143.3 124.1 122.2 305.9 110.4 331.8 71.9 241.4 175.4 356.9 427.3 269.6 244.3 205.6 122.8 63.0 123.9 87.7 252.1 374.8 85.9 86.9 71.0 63.9 233.4 78.5 88.5 125.8 87.5 200.8 245.4 183.2 154.5 91.0 203.0 273.4 224.2 50.5 169.6 125.3 85.4 187.3 282.3 273.8 308.9 333.7 356.6 302.6 330.2 277.1 275.4 273.3 293.1 277.8 306.2 308.3 265.3 118.6 220.2 68.6 416.9 690.3 770.9 595.8 412.6 267.4 396.7 308.2 271.3 327.5 447.9 261.1 64.6 450.1 370.8 306.7 661.2 254.3 33.0 287.9 297.5 319.2 407.8 221.4 146.8 94.5 251.2 367.8 250.2 344.2 312.1 267.2 258.1 142.4 226.6 390.3 138.0 372.9 455.7 228.6 385.2 56.8 385.8 242.9 345.1 92.8 318.1 383.9 256.4 73.9 118.7 136.0 410.8 472.8 235.7 737.4 567.9 665.2 337.8 192.8 236.7 409.7 489.9 223.8 165.4 314.8 618.0 615.5 449.2 345.6 380.1 879.5 BRPF1 BR140 ENSG00000156983 "Bromodomain and PHD finger containing 1" P55201 3 9731729-9748015 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003359 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003359: AB_1078217" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (6.47e-2)" "unprognostic (9.10e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (3.00e-1)" "unprognostic (3.72e-1)" "unprognostic (3.26e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.51e-3)" "unprognostic (4.86e-2)" "unprognostic (3.55e-1)" "unprognostic (6.87e-2)" "unprognostic (9.67e-3)" 8.0 7.2 4.5 7.0 6.4 23.8 7.8 9.7 7.3 8.0 3.4 8.0 4.9 9.6 4.5 8.7 8.9 5.6 6.9 6.5 3.5 6.3 5.6 8.0 9.0 4.4 4.3 3.9 9.4 7.4 7.7 6.8 6.6 5.2 7.5 4.1 4.0 9.2 5.1 9.6 10.9 8.3 5.4 3.7 10.6 7.6 14.5 4.5 12.0 9.1 6.9 7.7 7.9 7.9 5.3 9.9 17.2 12.5 8.2 8.9 8.6 82.4 12.6 7.5 14.3 10.2 12.1 8.3 18.6 6.0 11.6 13.5 8.2 15.3 12.0 9.0 20.1 17.9 21.4 33.8 9.8 11.4 30.6 20.0 8.5 9.8 19.8 13.1 7.2 10.8 17.5 25.2 15.9 8.3 24.3 19.8 25.7 20.6 6.7 15.9 28.7 10.6 12.3 6.7 14.5 8.9 15.2 12.7 9.0 10.1 8.2 9.8 31.4 14.1 15.9 13.6 14.5 24.0 13.4 18.1 31.5 13.1 25.9 15.1 1.0 0.9 1.4 1.3 0.8 2.0 0.6 0.9 1.2 0.8 0.5 1.1 1.3 0.8 4.2 0.7 1.9 0.7 0.8 4.5 6.4 9.7 7.3 6.5 3.5 4.4 4.3 3.9 5.2 3.7 4.5 5.3 7.9 16.0 10.0 2.6 6.8 14.1 5.1 3.9 8.0 4.6 9.2 7.0 3.7 2.8 6.2 7.3 6.2 4.2 13.0 9.4 0.0 4.1 3.9 4.2 6.9 9.7 10.2 9.7 3.4 5.5 5.5 5.8 7.7 7.0 8.8 7.3 11.0 3.5 6.4 8.4 2.4 5.0 2.0 5.6 9.2 1.2 6.5 6.9 1.8 2.8 6.3 5.2 5.2 4.0 2.9 6.1 3.1 6.0 7.9 5.1 4.9 2.1 4.3 5.1 6.6 11.3 7.7 16.6 13.9 9.9 18.5 3.7 10.8 5.6 6.1 6.8 RPUSD3 MGC29784 ENSG00000156990 "RNA pseudouridine synthase D3" Q6P087 3 9837849-9844602 "Predicted intracellular proteins" "mRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 249.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037551, HPA037552" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA037551: AB_2675538, HPA037552: AB_10672600" "unprognostic (1.57e-1)" "unprognostic (8.88e-2)" "unprognostic (5.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.31e-1)" "unprognostic (2.36e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (5.17e-3)" "unprognostic (2.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.94e-2)" "unprognostic (8.83e-2)" 18.4 29.1 25.5 13.3 25.9 21.5 19.9 24.8 31.5 19.4 22.3 24.1 17.7 21.7 14.9 32.6 20.2 8.8 33.7 27.0 24.9 24.7 31.0 16.2 17.5 24.1 24.8 26.5 18.0 24.7 26.3 20.4 16.8 25.5 20.1 16.7 15.6 20.0 17.6 73.3 27.3 20.3 16.8 21.9 21.1 23.0 54.7 25.7 15.4 16.1 48.6 21.5 24.4 21.1 26.5 30.5 44.8 33.6 21.7 55.1 40.5 249.3 25.9 36.7 41.9 44.3 39.4 30.6 52.4 31.6 29.0 61.7 25.6 75.2 46.3 33.2 40.7 78.9 69.8 39.6 42.5 43.1 43.5 42.3 50.0 63.3 48.9 56.5 34.2 55.9 69.3 52.7 35.4 41.9 72.0 59.6 78.9 36.4 44.4 66.3 41.5 27.5 88.5 46.2 23.0 25.9 21.5 32.6 41.0 69.9 47.9 70.3 46.3 33.6 16.7 30.0 29.8 38.4 52.3 67.4 70.0 35.1 81.3 39.5 35.4 51.0 26.5 44.1 38.2 45.7 50.3 41.4 42.3 46.8 41.9 46.3 41.7 12.3 84.9 26.7 45.0 64.9 41.5 25.5 25.9 24.8 31.5 27.0 24.9 24.1 24.8 26.5 25.5 21.9 25.7 26.5 11.8 19.2 9.6 10.1 19.5 8.0 21.4 27.8 13.1 22.8 17.1 21.5 25.4 21.5 20.8 14.7 20.9 44.3 19.8 16.4 46.9 31.1 80.3 6.9 13.7 15.8 13.2 24.6 9.9 31.6 48.6 16.3 15.8 9.7 21.0 20.1 22.1 28.3 39.1 11.8 10.6 17.0 12.2 14.7 7.3 59.5 21.5 15.2 16.0 3.7 27.2 20.6 54.6 8.0 6.3 25.8 20.6 21.4 18.8 19.5 28.1 55.4 12.9 22.2 6.6 13.3 17.2 100.7 20.6 22.3 12.8 17.2 20.5 33.9 28.6 16.2 SST SMST ENSG00000157005 Somatostatin P61278 3 187668912-187670394 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 337.9;intestine: 390.1;pancreas: 483.4;stomach 1: 421.4" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 1039.3" "Region enhanced" "Detected in all" "hypothalamus: 337.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000075, HPA019472, CAB034105" Enhanced Supported "Secreted to blood" NA NA "CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360" "unprognostic (2.44e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.12e-3)" "unprognostic (1.54e-2)" "unprognostic (4.69e-1)" "unprognostic (3.31e-2)" "unprognostic (8.16e-3)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (8.47e-2)" "unprognostic (4.19e-1)" "unprognostic (3.27e-1)" "unprognostic (1.45e-1)" 5.6 43.4 64.1 4.7 61.7 4.3 0.5 2.0 68.2 0.5 3.3 32.1 390.1 0.7 0.1 1.6 0.4 1.1 1.3 31.5 337.9 6.2 0.3 0.3 1.5 109.9 64.0 39.0 2.4 483.4 0.0 9.4 0.1 58.4 1.3 24.0 6.3 0.1 21.8 0.1 9.0 134.4 2.8 57.1 0.2 421.4 0.2 127.5 1.2 1.0 0.0 0.0 7.4 1.9 43.7 0.0 0.0 0.8 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.5 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 44.7 0.4 7.6 0.0 2.9 11.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 61.7 2.0 68.2 31.5 337.9 109.9 64.0 39.0 58.4 57.1 127.5 43.7 0.0 0.0 0.0 9.1 0.5 0.0 0.0 3.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 5.5 0.0 0.1 0.0 4.3 0.0 0.0 0.3 0.3 0.5 0.1 1404.1 0.0 1.7 0.0 0.2 0.7 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 146.2 460.2 215.7 0.0 0.0 0.1 0.0 0.0 0.0 9.4 3.6 0.0 0.0 3.0 9.1 0.0 0.6 0.0 0.0 0.0 11.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.9 13.8 0.2 TATDN2 KIAA0218 ENSG00000157014 "TatD DNase domain containing 2" Q93075 3 10248023-10281218 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA036822 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036822: AB_10671972" "unprognostic (4.51e-2)" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (4.23e-2)" "unprognostic (9.88e-2)" "unprognostic (1.58e-2)" "unprognostic (2.57e-3)" "unprognostic (8.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.63e-1)" "prognostic favorable (4.66e-4)" "unprognostic (3.25e-1)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (1.70e-1)" "unprognostic (3.33e-1)" "unprognostic (2.48e-2)" 15.2 15.9 19.4 14.9 20.4 34.7 15.5 17.4 20.2 19.8 17.1 15.3 12.8 17.5 15.7 20.1 15.8 10.4 16.2 20.5 18.0 17.0 14.1 17.5 21.8 17.6 17.2 20.8 24.9 20.0 18.1 17.9 9.9 18.0 21.1 14.8 9.0 17.8 12.4 15.1 20.6 18.9 13.6 17.1 24.1 16.8 8.6 18.8 32.8 21.0 11.0 22.3 16.7 18.6 19.6 19.4 32.1 16.9 14.3 21.2 22.9 73.3 23.2 22.5 28.8 18.8 23.6 17.0 45.6 17.0 32.1 30.7 14.3 29.1 20.9 22.5 29.5 36.5 24.3 30.8 24.9 13.7 34.6 24.8 17.6 22.9 40.2 13.6 18.8 23.6 28.3 27.9 40.7 26.4 37.2 45.4 29.6 23.9 25.2 31.9 24.8 18.0 26.5 18.2 26.8 18.7 22.6 19.4 21.8 10.9 15.6 22.2 32.4 18.8 33.1 21.6 28.1 41.6 25.5 43.6 80.6 30.0 35.6 23.1 1.3 0.6 0.5 1.6 1.0 1.6 0.8 1.4 1.3 0.5 1.4 1.4 2.1 0.5 0.9 0.5 1.3 1.7 0.9 19.4 20.4 17.4 20.2 20.5 18.0 17.6 17.2 20.8 18.0 17.1 18.8 19.6 6.3 6.4 11.0 4.9 8.2 12.6 4.6 4.8 9.1 4.4 9.4 6.3 6.9 7.2 4.3 11.0 6.2 3.8 9.3 12.7 1.9 5.1 2.0 4.1 7.0 7.9 16.8 6.1 8.8 9.2 4.0 6.8 5.1 5.9 5.1 9.1 7.9 10.2 10.3 5.0 5.9 8.7 2.0 15.6 21.0 1.8 7.2 9.1 14.2 6.5 9.0 5.2 18.6 4.5 5.0 8.6 3.1 7.5 8.8 9.3 8.0 5.4 2.4 2.8 6.6 5.8 4.7 2.1 5.6 6.4 12.4 2.5 10.7 8.7 10.8 7.1 GHRL "ghrelin, MTLRP, obestatin" ENSG00000157017 "Ghrelin and obestatin prepropeptide" Q9UBU3 3 10285666-10292947 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "stomach 1: 359.0" "Cell type enriched" "Detected in many" 52 "Gastric mucus-secreting cells: 1123.8" "Cancer enhanced" "Detected in some" "stomach cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 17.5;classical monocyte: 11.0;eosinophil: 12.4;myeloid DC: 41.8;neutrophil: 25.7;plasmacytoid DC: 28.5" "Group enriched" "Detected in many" 6 "dendritic cells: 41.8;granulocytes: 25.7;monocytes: 11.0" "Cell line enhanced" "Detected in many" "Karpas-707: 14.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA014246, CAB022731" Enhanced "Secreted to blood" NA NA 2580000 350000 "CAB022731: , HPA014246: AB_1849659" "unprognostic (1.74e-2)" "unprognostic (3.01e-4)" "unprognostic (3.75e-1)" "unprognostic (1.05e-2)" "unprognostic (2.94e-2)" "unprognostic (1.60e-3)" "unprognostic (2.12e-1)" "unprognostic (1.06e-3)" "unprognostic (3.85e-1)" "unprognostic (5.45e-3)" "unprognostic (1.54e-3)" "unprognostic (2.71e-2)" "unprognostic (1.64e-3)" "unprognostic (4.52e-2)" "unprognostic (8.56e-2)" "unprognostic (2.14e-1)" "unprognostic (1.79e-4)" 0.6 0.5 3.6 3.1 3.9 4.5 1.6 4.3 6.0 0.5 3.0 1.4 19.1 0.7 4.8 1.8 0.7 2.3 1.3 3.4 2.7 0.9 1.4 1.1 7.5 3.3 3.0 3.4 1.3 4.1 0.7 0.8 0.5 3.9 1.0 0.6 2.0 1.4 0.3 2.1 2.1 3.2 0.9 2.2 2.5 359.0 1.1 2.8 1.3 1.3 0.2 3.1 1.4 0.5 3.7 0.6 0.2 2.6 2.0 1.8 0.0 4.8 2.4 0.0 0.7 0.2 2.9 0.5 1.5 0.9 0.1 2.1 0.4 0.0 0.6 0.0 0.4 2.9 3.1 2.1 6.3 0.0 3.2 5.3 0.3 0.0 0.0 0.1 0.2 0.5 1.9 1.3 14.4 0.0 0.7 1.2 4.3 1.3 0.5 5.3 0.8 0.2 0.8 0.0 2.4 1.9 0.3 1.6 1.1 0.1 1.7 1.1 3.8 2.6 1.2 0.7 1.1 1.7 1.7 2.6 2.9 0.4 3.5 0.5 17.5 11.0 12.4 0.2 5.5 0.1 2.1 0.2 0.0 41.8 1.0 0.3 0.1 25.7 4.4 0.4 28.5 0.2 3.8 3.6 3.9 4.3 6.0 3.4 2.7 3.3 3.0 3.4 3.9 2.2 2.8 3.7 0.6 0.0 1.1 1.3 4.9 1.3 4.6 0.2 0.0 7.8 0.8 0.6 0.3 0.0 0.2 1.8 10.4 1.7 10.5 0.5 0.0 1.0 0.3 0.2 0.7 1.5 0.0 0.0 1.0 1.3 1.5 1.0 1123.8 0.8 0.0 0.6 1.8 0.1 1.8 3.3 0.6 0.1 0.0 3.8 8.8 1.0 0.3 5.7 1.8 2.8 7.4 2.2 21.6 0.0 0.7 0.9 0.1 0.4 0.7 4.9 1.5 0.2 0.2 9.1 6.6 4.0 0.9 1.7 1.3 0.0 0.6 0.3 4.0 0.7 0.8 2.2 SEC13 "D3S1231E, npp-20, SEC13L1, SEC13R" ENSG00000157020 "SEC13 homolog, nuclear pore and COPII coat complex component" P55735 3 10293131-10321112 "Metabolic proteins, Predicted intracellular proteins, Transporters" "ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035292, HPA057943" Approved Supported Nucleoplasm,Vesicles NA NA 35000 "Nucleoplasm, Vesicles" "HPA035292: AB_10959451, HPA057943: AB_2683560" "unprognostic (3.33e-3)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (4.95e-2)" "unprognostic (4.22e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (2.43e-1)" "unprognostic (2.67e-1)" "unprognostic (1.69e-1)" "unprognostic (4.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" 61.7 72.1 50.0 62.4 54.4 58.9 59.4 54.7 58.0 84.4 57.2 69.5 115.7 66.9 59.9 73.1 57.9 47.9 67.7 51.5 57.4 67.4 92.9 64.8 55.1 53.5 53.5 48.6 53.0 85.9 65.1 110.1 69.0 54.0 54.3 66.3 21.4 97.0 65.5 112.4 62.1 97.4 77.3 53.5 59.9 67.9 39.7 53.8 70.9 58.1 88.0 66.0 70.6 59.7 57.0 122.6 182.1 142.9 55.2 228.0 251.6 474.4 243.8 296.1 279.3 319.8 150.3 97.6 110.7 109.6 390.1 156.8 49.0 186.4 218.3 142.4 97.8 194.5 136.2 137.3 363.7 311.8 156.7 115.5 224.7 173.1 292.6 181.5 205.6 337.0 146.2 148.4 159.8 219.5 250.2 153.8 169.9 160.9 158.0 218.7 148.1 102.4 198.2 172.4 90.2 80.3 99.4 107.3 98.7 101.3 119.3 127.5 150.8 253.6 114.2 130.2 172.6 213.3 131.7 198.4 258.6 215.5 217.5 193.0 127.3 163.2 106.6 84.4 144.9 94.6 96.5 83.6 82.1 222.5 82.6 68.0 71.2 105.8 93.9 116.4 198.3 106.1 176.5 50.0 54.4 54.7 58.0 51.5 57.4 53.5 53.5 48.6 54.0 53.5 53.8 57.0 23.9 48.1 61.9 14.0 45.8 39.4 50.4 73.6 31.3 16.2 29.5 26.4 40.2 30.0 68.3 27.6 10.4 119.9 36.5 60.1 66.5 79.3 25.6 31.8 44.0 51.0 41.4 33.0 17.3 109.2 166.6 74.1 73.9 47.1 43.1 35.5 33.9 57.3 104.9 11.8 13.7 108.2 50.8 33.0 46.7 10.2 53.4 45.0 26.6 12.2 64.2 37.4 35.0 11.6 12.6 81.8 56.1 52.6 203.2 52.4 187.5 112.0 64.5 21.1 13.1 37.7 63.6 54.9 38.9 43.7 40.2 168.6 36.5 35.8 74.2 62.3 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 59.8;Rod photoreceptor cells: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 3.8 5.1 5.9 4.0 5.9 4.0 3.4 8.4 6.9 4.9 3.9 4.5 2.1 4.8 3.5 2.6 3.8 3.5 11.3 6.5 5.5 3.8 3.4 3.8 6.0 5.5 6.0 5.7 3.9 3.9 3.3 5.6 2.9 5.6 4.8 3.2 5.4 3.2 3.7 3.2 1.9 4.5 4.5 4.9 5.6 3.6 3.9 5.5 5.0 4.6 3.2 4.7 4.4 3.6 6.9 4.3 7.6 8.7 7.6 5.7 8.4 3.5 13.9 8.7 11.6 12.9 6.8 4.3 15.1 3.5 5.5 3.3 4.3 11.0 4.7 9.8 17.5 10.2 11.4 12.7 7.6 7.0 12.7 9.5 6.4 5.2 10.3 5.4 5.5 16.2 8.6 5.2 9.9 18.2 2.9 8.6 4.2 8.3 3.7 9.8 5.8 4.6 6.7 6.0 5.5 4.0 2.0 8.5 2.1 3.8 3.9 2.9 6.1 13.3 9.5 7.2 10.8 11.2 5.7 10.3 13.3 7.4 10.9 7.1 0.9 10.0 4.5 26.6 9.8 23.8 60.3 25.8 26.4 7.2 47.1 25.9 25.2 0.6 27.8 11.6 14.4 12.9 5.5 5.9 5.9 8.4 6.9 6.5 5.5 5.5 6.0 5.7 5.6 4.9 5.5 6.9 9.8 6.4 4.5 15.3 24.9 2.9 6.5 13.4 8.0 49.9 4.4 3.7 33.0 7.2 5.8 11.0 56.3 12.3 23.8 5.4 0.0 8.5 3.7 3.2 9.7 12.9 16.9 13.7 23.5 5.3 2.1 10.8 4.6 3.6 1.3 14.0 9.7 5.7 7.0 40.4 29.1 7.5 10.2 8.3 6.2 3.7 27.1 6.0 12.4 15.0 16.0 13.0 59.8 31.7 23.5 6.4 7.4 17.7 19.1 5.5 4.3 4.0 8.0 78.3 13.1 11.6 9.5 36.5 28.0 4.6 1.0 1.9 22.9 14.0 9.7 6.3 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037854-15056079 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 17.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 18.5;REH: 9.2;U-266/84: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavorable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 35.1 10.3 4.0 0.5 3.4 2.3 28.4 4.0 9.0 24.8 2.7 26.7 0.1 20.8 1.4 19.5 19.0 1.2 19.0 3.6 3.9 16.0 15.4 21.8 0.7 4.0 3.7 3.2 19.9 11.1 0.5 6.5 0.4 4.1 20.4 0.3 1.3 16.0 0.4 24.7 21.4 15.7 0.8 3.4 20.7 18.1 20.5 4.0 0.8 13.6 0.6 0.4 28.1 22.0 3.6 3.6 0.0 1.8 0.7 1.2 0.6 0.6 6.2 2.6 1.0 2.8 0.0 0.0 3.2 2.5 4.7 1.7 0.1 0.9 0.7 0.9 5.0 5.9 0.3 0.0 0.0 1.1 1.7 4.3 0.8 0.4 3.4 1.5 1.5 1.3 2.6 0.5 3.2 0.9 0.3 5.3 18.5 1.1 0.0 0.2 9.2 0.1 1.3 1.2 0.0 0.7 2.1 0.0 0.1 1.5 0.4 0.0 0.6 4.1 1.1 3.8 1.1 1.1 4.2 10.1 2.5 1.5 1.3 2.2 4.9 1.3 17.5 2.8 1.7 3.0 4.2 3.4 2.6 1.9 3.8 3.9 1.3 1.6 3.8 2.0 5.7 5.9 3.1 4.0 3.4 4.0 9.0 3.6 3.9 4.0 3.7 3.2 4.1 3.4 4.0 3.6 79.7 3.2 3.9 7.8 24.7 33.6 16.4 24.1 7.4 6.1 20.2 33.4 3.2 12.8 13.8 18.4 10.4 77.4 30.4 25.1 45.0 49.3 48.9 8.8 29.3 55.0 6.7 25.3 12.6 23.6 23.8 51.3 8.2 12.7 8.8 22.0 62.8 23.0 116.6 25.2 15.6 7.2 30.5 75.0 48.3 32.4 83.0 53.9 58.7 12.2 46.0 15.2 37.0 3.0 6.6 56.9 14.6 75.2 37.6 21.2 9.6 38.6 6.0 9.4 39.5 20.8 52.3 33.3 30.7 16.0 21.7 56.9 25.6 23.5 13.5 23.9 SHCBP1L C1orf14 ENSG00000157060 "SHC binding and spindle associated 1 like" Q9BZQ2 1 182899865-182953525 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1157 "testis: 115.6" "Group enriched" "Detected in some" 6 "Early spermatids: 593.7;Spermatocytes: 593.1" "Cancer enhanced" "Detected in single" "cervical cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036124, HPA036125, HPA064821" Enhanced NA NA "HPA036124: AB_2674953, HPA036125: AB_10671834, HPA064821: AB_2685360" "unprognostic (1.29e-3)" "unprognostic (1.03e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (6.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 593.7 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 86.9 6.8 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.1 593.1 16.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NMNAT2 "C1orf15, KIAA0479, PNAT2" ENSG00000157064 "Nicotinamide nucleotide adenylyltransferase 2" Q9BZQ4 1 183248237-183418380 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4;heart muscle: 18.5;pituitary gland: 18.5" "Cell type enhanced" "Detected in many" "Early spermatids: 54.3;Excitatory neurons: 195.5;Inhibitory neurons: 265.4;Oligodendrocyte precursor cells: 98.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 26.2;SCLC-21H: 80.6;SuSa: 25.1;U-2197: 45.8;U-87 MG: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015708, HPA061714" Enhanced Approved Cytosol NA NA Cytosol "HPA015708: , HPA061714: AB_2732669" "unprognostic (3.70e-1)" "unprognostic (7.98e-3)" "unprognostic (8.83e-2)" "unprognostic (4.16e-2)" "unprognostic (8.95e-2)" "unprognostic (9.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.35e-1)" "unprognostic (7.92e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.73e-3)" "unprognostic (2.90e-3)" "unprognostic (1.87e-1)" "unprognostic (7.51e-2)" "unprognostic (1.02e-1)" 8.6 6.0 8.4 0.8 16.7 0.0 5.2 20.7 47.4 2.1 0.0 1.8 0.5 1.3 1.5 0.8 2.4 2.9 18.5 15.4 17.3 0.4 0.0 0.7 0.7 2.1 13.9 20.0 0.4 1.7 0.2 18.5 0.9 6.8 0.2 1.0 6.6 0.5 2.5 0.5 0.8 0.9 1.5 0.0 0.1 1.1 8.9 5.4 0.5 6.1 1.4 0.6 0.7 0.9 22.5 1.4 0.5 5.5 0.0 3.1 12.5 4.6 3.4 8.9 1.8 0.6 2.7 5.4 0.0 14.2 0.8 1.5 2.2 0.2 0.1 3.3 0.0 0.1 0.0 2.2 0.0 0.5 0.0 0.1 26.2 1.1 2.1 0.5 11.1 0.5 0.0 0.0 0.1 2.1 0.1 0.0 0.5 9.7 0.1 5.4 0.0 0.2 0.0 5.9 4.5 80.6 6.2 0.7 0.3 0.0 25.1 0.7 1.5 3.0 2.5 0.9 45.8 3.3 0.6 0.0 0.0 35.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 16.7 20.7 47.4 15.4 17.3 2.1 13.9 20.0 6.8 0.0 5.4 22.5 21.4 0.0 1.5 3.9 0.0 0.8 0.2 0.6 0.6 12.1 0.2 0.1 35.2 0.0 2.0 0.0 0.0 0.7 0.1 0.1 0.0 0.2 54.3 2.7 0.3 5.2 0.0 0.0 195.5 0.0 12.9 5.7 0.0 7.4 0.0 0.2 0.0 0.0 0.7 20.2 265.4 0.0 4.1 1.0 0.0 42.3 0.0 0.5 1.8 11.2 0.0 0.3 0.0 98.5 6.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 3.4 2.9 19.7 0.3 12.0 0.4 0.2 0.1 0.3 1.4 0.2 0.0 0.0 0.0 ZFYVE9 "MADHIP, PPP1R173, SARA, SMADIP" ENSG00000157077 "Zinc finger FYVE-type containing 9" O95405 1 52142089-52348671 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 131.0;Inhibitory neurons: 162.6;Oligodendrocyte precursor cells: 80.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017702, HPA065852, HPA065862" Approved Enhanced Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570" "unprognostic (5.05e-2)" "unprognostic (4.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-3)" "unprognostic (6.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (2.47e-2)" "unprognostic (5.36e-2)" "unprognostic (1.17e-3)" "unprognostic (2.14e-1)" "unprognostic (3.69e-1)" "unprognostic (1.99e-3)" "unprognostic (1.73e-2)" 9.4 8.3 12.7 3.3 15.0 1.1 11.3 21.2 17.1 12.5 26.5 7.4 5.8 12.1 7.3 9.2 10.1 6.9 7.3 14.9 16.1 13.0 9.3 9.9 2.2 13.5 13.5 13.2 16.4 15.2 25.9 9.0 6.3 15.1 11.2 8.3 13.8 9.2 11.2 26.0 10.8 5.6 11.3 11.0 3.6 7.5 13.9 13.0 5.3 17.1 20.4 3.5 9.0 8.7 14.2 17.9 8.3 11.7 15.1 27.5 25.0 19.2 14.2 18.8 16.5 18.8 9.6 1.4 0.0 8.7 20.0 22.7 6.5 20.8 22.5 25.1 0.1 14.6 5.1 9.3 11.4 18.0 4.5 2.9 16.7 24.9 14.2 31.9 20.1 24.0 11.8 8.0 3.2 22.2 3.9 6.5 3.3 15.4 4.7 14.8 5.7 20.1 1.7 9.4 38.5 9.9 10.2 15.9 13.4 18.4 23.2 6.2 5.9 22.3 16.6 6.7 12.8 8.6 4.5 2.9 2.2 11.8 5.4 6.8 1.3 0.0 0.1 0.2 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.1 12.7 15.0 21.2 17.1 14.9 16.1 13.5 13.5 13.2 15.1 11.0 13.0 14.2 11.5 9.6 5.9 61.7 0.7 5.1 10.0 4.0 10.8 19.9 6.6 5.7 13.6 7.2 9.4 1.8 4.2 5.5 1.1 8.8 7.9 6.4 12.6 6.3 19.1 9.3 17.5 0.0 131.0 7.4 5.3 11.0 23.4 7.9 1.3 16.0 5.0 8.5 0.5 23.5 162.6 8.1 2.0 0.6 1.3 17.3 15.2 0.5 7.2 45.9 0.2 10.0 1.0 80.9 37.5 4.1 7.9 16.6 3.5 7.8 8.2 10.2 2.5 14.3 13.1 20.9 8.3 45.5 46.8 11.7 7.4 2.9 3.8 15.0 6.3 6.4 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 102.2;choroid plexus: 33.7;salivary gland: 33.5;skeletal muscle: 37.8" "Cell type enhanced" "Detected in some" "Astrocytes: 117.5;Bipolar cells: 87.7;Excitatory neurons: 323.2;Horizontal cells: 104.3;Inhibitory neurons: 230.5;Oligodendrocyte precursor cells: 58.3" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Region enhanced" "Detected in many" "cerebral cortex: 102.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced NA NA "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 0.0 0.6 9.0 0.0 12.9 0.0 0.1 39.3 102.2 2.0 33.7 0.1 0.0 2.2 0.2 0.1 3.7 0.0 0.0 17.8 4.3 0.2 20.5 0.0 0.0 2.8 11.1 9.5 0.0 0.2 2.0 3.5 0.0 23.1 0.0 0.0 13.6 33.5 0.0 37.8 0.4 0.1 1.4 0.0 0.1 0.1 0.6 17.3 0.5 0.0 5.0 0.1 0.0 0.1 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 12.9 39.3 102.2 17.8 4.3 2.8 11.1 9.5 23.1 0.0 17.3 30.2 0.1 0.0 0.0 117.5 0.1 0.5 0.0 0.0 0.0 87.7 3.6 0.3 12.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.7 0.8 0.7 0.0 0.0 323.2 0.0 0.0 0.5 0.0 14.1 2.5 0.1 0.4 27.1 0.0 104.3 230.5 0.0 0.0 0.8 0.7 7.5 0.0 0.1 3.6 14.0 0.0 16.4 0.0 58.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.2 0.0 2.3 0.5 0.1 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 LYZL4 "LYC4, MGC26768" ENSG00000157093 "Lysozyme like 4" Q96KX0 3 42397083-42410610 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "testis: 52.6" "Group enriched" "Detected in some" 46 "Early spermatids: 386.3;Late spermatids: 158.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "OE19: 3.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA038806 Approved "Secreted in male reproductive system" NA NA "HPA038806: AB_10674841" "unprognostic (4.03e-1)" "unprognostic (5.68e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.4 0.4 0.1 0.3 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 386.3 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 158.8 3.1 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039247 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.6;liver: 88.0;retina: 37.3" "Group enriched" "Detected in some" 4 "Astrocytes: 221.0;Inhibitory neurons: 332.3;Microglial cells: 108.7;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 107.9" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced NA NA "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.6 0.8 51.1 0.4 46.2 2.3 1.0 42.2 67.6 3.1 0.0 1.0 0.4 1.2 2.9 9.2 1.2 1.2 3.9 34.4 43.8 1.3 88.0 2.1 0.5 65.3 60.7 29.4 2.1 0.3 16.1 3.6 0.8 62.1 2.4 0.5 37.3 0.4 4.1 2.7 1.2 0.9 0.5 26.7 0.7 0.5 4.2 65.3 17.8 0.7 0.8 0.4 0.9 2.6 39.6 0.2 0.2 0.5 0.3 0.4 0.1 0.3 0.2 0.0 0.2 0.3 0.4 0.3 0.4 0.1 0.1 0.5 0.4 0.6 0.2 0.2 0.0 0.5 0.4 1.6 0.8 0.2 0.6 0.6 0.3 0.0 0.0 0.3 0.1 0.1 0.5 0.3 1.0 0.0 0.3 0.2 0.5 0.2 0.3 0.4 0.3 0.0 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.0 0.3 0.3 0.3 0.1 0.2 0.1 0.2 0.2 0.3 0.1 0.3 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 51.1 46.2 42.2 67.6 34.4 43.8 65.3 60.7 29.4 62.1 26.7 65.3 39.6 0.3 0.0 0.5 221.0 0.0 0.3 0.0 0.0 6.2 26.6 0.1 0.0 2.1 14.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 2.6 0.0 0.0 3.7 0.0 0.0 1.4 0.0 0.0 2.5 0.2 0.0 25.2 0.0 0.0 332.3 0.0 0.0 0.8 0.0 1.6 5.6 0.2 0.0 108.7 0.0 36.6 0.0 130.2 107.9 0.0 0.0 10.1 0.0 0.0 0.0 0.2 0.0 3.7 13.1 9.4 6.8 3.8 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 SMG1 "ATX, KIAA0421, LIP" ENSG00000157106 "SMG1 nonsense mediated mRNA decay associated PI3K related kinase" Q96Q15 16 18804860-18926408 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Nonsense-mediated mRNA decay" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 31.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006870, HPA031623, HPA073972" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006870: AB_1079725, HPA031623: AB_2673962, HPA073972: AB_2686648" "unprognostic (6.34e-2)" "unprognostic (5.88e-2)" "unprognostic (5.98e-2)" "unprognostic (2.66e-1)" "unprognostic (2.44e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (8.32e-3)" "unprognostic (7.28e-2)" "unprognostic (1.05e-1)" "unprognostic (2.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" 12.2 8.5 12.3 16.3 12.4 39.4 19.7 40.2 13.8 13.5 13.9 14.5 11.7 14.3 15.9 14.3 12.2 10.9 12.9 12.3 9.1 14.7 17.9 11.5 21.7 9.1 9.0 10.5 18.8 13.1 15.3 10.3 11.6 15.4 12.2 16.1 21.1 12.1 11.0 53.5 42.4 13.7 13.3 3.6 16.0 12.9 14.6 12.9 30.2 18.3 35.7 19.3 15.5 13.3 17.9 42.2 27.5 25.5 18.1 28.6 29.9 18.8 19.1 18.8 20.4 22.7 24.4 15.1 57.5 26.8 26.8 21.5 23.3 29.6 16.7 32.3 37.2 18.4 26.2 25.8 31.4 23.1 35.7 19.9 17.7 27.5 42.4 50.5 20.1 29.1 30.7 41.0 31.0 22.8 22.0 24.8 20.9 27.2 15.3 15.7 28.4 34.2 19.8 17.6 32.1 23.0 17.6 29.9 19.9 20.8 20.8 15.9 22.3 37.0 30.2 20.4 19.0 28.7 15.8 21.8 37.0 20.2 27.1 18.6 31.7 2.7 4.2 6.6 3.2 3.2 4.0 4.4 4.8 2.9 7.6 5.7 5.1 8.4 2.6 7.2 5.3 4.5 1.4 12.3 12.4 40.2 13.8 12.3 9.1 9.1 9.0 10.5 15.4 3.6 12.9 17.9 83.2 76.9 85.4 58.4 98.8 193.2 73.0 26.9 112.1 52.0 71.3 40.5 48.1 32.9 67.1 27.6 75.0 21.3 97.4 65.5 3.9 21.7 20.3 88.1 81.1 66.5 39.4 44.8 81.5 23.6 19.0 57.3 90.7 140.0 39.3 66.1 37.9 46.1 24.1 42.1 75.2 41.8 36.7 48.0 112.8 24.9 29.8 82.5 39.2 68.4 61.4 20.5 72.1 48.7 87.5 34.6 76.9 26.4 82.2 94.2 43.0 15.6 45.9 44.8 46.0 118.2 63.1 49.6 32.2 107.1 204.4 30.0 97.6 37.6 46.4 95.4 FCHO2 ENSG00000157107 "FCH and mu domain containing endocytic adaptor 2" Q0JRZ9 5 72956041-73090522 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 19.3;neutrophil: 20.6" "Group enriched" "Detected in many" 9 "granulocytes: 20.6;monocytes: 6.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037685, HPA037686, HPA077850" Enhanced Approved Vesicles,Centrosome,Cytosol NA NA Centrosome "Vesicles, Cytosol" "HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: AB_2686860" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "unprognostic (1.01e-2)" "unprognostic (1.10e-1)" "unprognostic (6.59e-2)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (6.25e-2)" "unprognostic (1.31e-1)" "unprognostic (5.67e-2)" "unprognostic (6.56e-3)" "unprognostic (1.21e-1)" "prognostic favorable (7.00e-5)" "unprognostic (1.43e-1)" "unprognostic (3.27e-3)" "unprognostic (9.59e-2)" "unprognostic (1.76e-1)" 16.1 9.9 5.9 11.4 7.3 10.8 15.1 10.9 10.9 14.6 13.5 16.5 17.2 16.3 9.1 29.9 11.4 17.1 10.7 6.3 7.7 19.8 18.0 22.0 11.1 7.8 6.8 4.8 15.0 9.2 15.4 4.2 21.4 7.2 13.1 17.3 9.2 11.7 12.7 10.5 12.4 18.8 13.5 6.4 17.2 13.8 7.3 8.8 5.3 24.2 12.3 9.3 15.1 16.6 10.6 15.0 11.8 11.3 9.9 15.6 20.5 33.0 12.9 19.0 9.6 15.1 6.0 25.6 3.5 17.6 18.0 17.8 11.1 9.6 22.6 13.0 3.8 11.3 7.3 9.9 7.6 7.8 1.5 7.3 13.8 11.5 12.8 20.6 21.9 22.3 3.5 8.4 6.2 20.2 7.0 0.0 7.3 3.6 3.0 6.1 3.2 10.8 4.4 23.4 20.8 4.5 7.1 17.7 12.6 8.3 15.7 15.1 10.4 23.1 12.5 5.8 13.9 9.3 2.2 4.4 0.7 8.1 1.1 15.8 19.3 3.2 8.8 1.5 4.6 1.0 0.4 0.5 0.6 1.4 0.9 0.2 0.5 20.6 0.9 6.6 0.5 0.4 0.8 5.9 7.3 10.9 10.9 6.3 7.7 7.8 6.8 4.8 7.2 6.4 8.8 10.6 51.8 57.7 44.3 34.9 3.8 10.5 15.6 12.0 12.5 11.1 16.5 12.3 15.1 14.3 23.1 35.0 4.2 14.2 7.0 25.6 13.7 16.0 2.4 24.3 17.0 36.8 14.9 12.6 78.2 17.5 8.9 22.8 17.3 38.3 18.3 9.5 52.1 11.0 19.8 11.8 51.5 14.8 8.2 81.0 13.0 2.8 13.4 45.8 16.0 71.2 12.9 15.4 3.1 62.4 59.1 30.7 29.4 13.9 3.5 22.5 21.0 21.8 21.5 8.9 26.3 25.1 21.3 16.9 14.3 15.0 15.3 13.7 4.4 9.1 14.0 30.2 RBPMS HERMES ENSG00000157110 "RNA binding protein, mRNA processing factor" Q93062 8 30384511-30572256 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "ASC diff: 324.1;RPTEC TERT1: 232.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056999 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056999: AB_2683306" "unprognostic (1.65e-1)" "unprognostic (7.81e-2)" "unprognostic (1.53e-1)" "unprognostic (2.23e-3)" "unprognostic (8.66e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-2)" "unprognostic (3.47e-3)" "unprognostic (4.63e-2)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (2.88e-2)" "unprognostic (1.76e-2)" "unprognostic (4.76e-2)" "unprognostic (2.52e-1)" "unprognostic (4.91e-2)" "unprognostic (2.16e-3)" 216.1 97.5 24.6 44.2 24.3 1.4 196.4 18.8 24.3 193.0 28.1 256.6 25.4 202.4 90.7 100.8 202.2 96.3 164.0 15.5 26.0 192.6 109.7 120.7 23.5 23.9 24.6 12.9 191.6 69.3 69.2 33.2 105.9 24.0 184.2 47.1 10.5 92.9 195.5 31.4 48.4 108.6 173.4 16.5 57.2 161.2 45.8 32.3 23.7 141.8 31.9 20.1 326.2 135.2 41.2 0.7 54.5 58.5 0.4 324.1 96.4 145.8 74.8 101.8 90.2 74.6 76.2 31.2 0.5 39.3 96.7 82.5 29.9 68.0 54.4 107.9 0.1 14.6 1.8 24.7 80.5 139.4 0.5 12.0 112.8 13.8 86.7 11.5 100.8 52.8 2.5 0.5 0.4 44.6 32.6 0.3 1.2 150.9 62.3 34.6 3.5 16.2 4.7 232.2 88.9 1.1 11.6 7.7 55.2 37.7 192.3 11.7 0.0 48.8 44.3 4.2 77.3 12.8 0.1 0.2 0.4 72.8 0.2 20.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 24.6 24.3 18.8 24.3 15.5 26.0 23.9 24.6 12.9 24.0 16.5 32.3 41.2 104.0 54.5 98.9 36.6 4.5 9.3 61.8 22.7 14.2 6.7 45.8 64.3 114.4 75.8 48.5 141.6 2.1 108.7 4.1 1.8 113.5 100.0 104.7 31.2 86.3 69.7 1.8 5.0 6.4 94.8 184.8 66.7 18.8 48.2 10.1 18.0 44.3 55.2 39.9 0.0 5.2 0.1 20.3 1.9 10.2 31.5 171.2 4.3 14.2 71.2 2.1 1.0 1.0 2.0 1.6 67.0 0.0 180.2 0.5 101.5 2.0 242.2 30.9 5.7 111.7 6.6 149.9 35.3 22.0 27.8 8.0 41.2 4.4 28.1 1.0 151.7 TMEM171 PRP2 ENSG00000157111 "Transmembrane protein 171" Q8WVE6 5 73120569-73131809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 36.0;kidney: 10.9;lymphoid tissue: 14.5;stomach 1: 25.6;thyroid gland: 31.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 28.6;Distal enterocytes: 106.0;Gastric mucus-secreting cells: 29.6;Ionocytes: 40.7;Paneth cells: 63.4;Proximal enterocytes: 41.9;Undifferentiated cells: 51.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "MAIT T-cell: 24.1;memory CD8 T-cell: 8.2" "Lineage enriched" "Detected in single" 89 "T-cells: 24.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.0;LHCN-M2: 66.1;RPTEC TERT1: 51.5;WM-115: 177.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "spinal cord: 3.7" HPA042308 Approved NA NA "HPA042308: AB_10796901" "unprognostic (7.34e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (7.74e-3)" "unprognostic (2.81e-5)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.44e-3)" "unprognostic (1.77e-1)" "unprognostic (1.85e-1)" "unprognostic (4.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (3.93e-10)" "unprognostic (6.13e-3)" "unprognostic (2.43e-1)" "unprognostic (9.10e-3)" "unprognostic (1.57e-1)" 0.1 0.1 2.2 3.2 3.4 0.0 1.6 1.9 3.1 0.3 1.6 36.0 27.9 0.0 0.7 4.8 0.4 0.8 0.0 2.3 2.6 10.9 2.2 0.3 0.4 2.4 3.2 2.1 0.1 0.8 0.9 0.1 0.5 3.0 0.1 33.4 0.1 0.5 3.8 0.7 1.0 19.9 1.3 1.7 14.5 25.6 0.6 2.8 0.5 31.4 0.6 3.1 0.7 0.2 4.0 23.4 1.0 0.0 0.2 7.3 10.3 0.0 7.1 35.0 13.6 23.1 0.7 10.7 0.0 15.0 9.4 2.7 17.3 0.3 1.1 11.2 0.0 3.7 0.0 0.2 0.0 2.7 0.0 1.1 2.2 0.9 18.9 1.6 5.3 8.7 0.0 0.0 0.3 66.1 2.3 0.0 0.1 1.9 0.3 1.4 0.0 0.0 12.5 51.5 0.3 0.1 0.0 5.4 0.2 0.1 3.9 1.2 0.1 0.0 0.2 1.2 19.8 0.4 0.0 0.0 0.0 18.1 0.0 177.2 0.0 0.0 0.0 1.6 0.0 24.1 0.0 0.9 8.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.8 2.2 3.4 1.9 3.1 2.3 2.6 2.4 3.2 2.1 3.0 1.7 2.8 4.0 0.2 0.0 0.0 0.0 0.6 1.8 0.6 25.4 1.2 0.0 6.8 0.4 0.3 28.6 9.2 7.3 0.0 0.2 0.0 106.0 15.6 6.9 0.0 0.2 0.1 0.9 2.4 0.0 0.3 9.9 0.4 1.4 29.6 0.5 0.0 0.0 0.7 1.5 1.3 0.0 0.3 21.2 40.7 0.0 0.4 0.0 0.0 0.1 1.8 1.9 0.0 0.0 5.2 1.0 9.7 10.4 63.4 0.0 0.1 0.8 41.9 8.9 4.4 0.0 0.0 0.0 0.4 0.2 1.7 6.5 1.7 0.5 1.0 0.0 51.4 1.0 KLHL40 "KBTBD5, NEM8, SRYP" ENSG00000157119 "Kelch like family member 40" Q2TBA0 3 42685537-42692544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "skeletal muscle: 434.7;tongue: 163.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.0;Late spermatids: 10.7;Skeletal myocytes: 16.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024463, HPA052201" Enhanced NA NA "HPA024463: AB_1852095, HPA052201: AB_2681759" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (2.50e-1)" "unprognostic (4.04e-1)" 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 3.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.1 4.3 0.0 434.7 0.4 0.0 0.0 0.1 0.0 0.0 1.8 0.2 0.1 0.1 163.7 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.3 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.3 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8A ENSG00000157131 "Complement C8 alpha chain" P07357 1 56854797-56918223 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 194 "liver: 641.0" "Cell type enriched" "Detected in some" 36 "Hepatocytes: 296.4" "Cancer enriched" "Detected in single" 279 "liver cancer: 85.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "Hep G2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 6400000000 "unprognostic (3.73e-3)" "unprognostic (2.44e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "unprognostic (9.82e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 641.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 5.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 296.4 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 TIMP4 ENSG00000157150 "TIMP metallopeptidase inhibitor 4" Q99727 3 12153068-12158912 "Plasma proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 179.3;breast: 120.6" "Cell type enriched" "Detected in many" 10 "Adipocytes: 363.9" "Cancer enriched" "Detected in many" 13 "glioma: 66.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 212.9;ASC TERT1: 53.0;HSkMC: 91.9;NTERA-2: 50.7;U-87 MG: 53.6" "Region enhanced" "Detected in all" "cerebellum: 106.1" "Region enriched" "Detected in all" 9 "cerebellum: 47.7" "Secreted to extracellular matrix" NA NA "unprognostic (2.99e-2)" "unprognostic (5.14e-3)" "unprognostic (1.02e-2)" "unprognostic (2.10e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-4)" "unprognostic (9.33e-3)" "unprognostic (4.26e-3)" "unprognostic (1.36e-1)" "unprognostic (1.74e-2)" "unprognostic (3.78e-1)" "unprognostic (6.81e-2)" "unprognostic (4.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (6.66e-5)" "unprognostic (2.86e-1)" 179.3 8.4 8.1 3.9 8.5 0.6 120.6 49.7 7.4 9.3 4.6 11.9 1.4 8.1 1.0 2.9 6.9 4.4 28.3 7.1 8.7 2.7 1.1 6.6 0.6 14.0 9.5 7.0 3.8 4.0 1.4 12.4 10.0 17.3 5.5 4.3 1.1 9.0 2.4 16.8 7.5 11.1 4.5 10.9 3.4 9.3 0.7 7.0 2.1 23.3 30.4 0.1 9.9 8.8 11.7 0.7 24.2 0.7 0.0 212.9 53.0 26.4 0.8 8.9 1.0 1.3 0.5 0.1 0.0 2.2 0.9 0.8 0.9 0.0 0.8 0.4 1.0 0.0 0.0 12.7 0.9 33.2 0.0 0.1 91.9 2.2 5.8 0.2 1.6 0.0 0.0 0.5 17.3 0.2 0.6 0.0 0.0 50.7 0.0 6.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 5.0 0.0 0.0 6.1 0.0 0.0 1.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 53.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 8.5 49.7 7.4 7.1 8.7 14.0 9.5 7.0 17.3 10.9 7.0 11.7 363.9 0.0 0.0 0.0 0.4 0.1 1.3 0.3 0.6 0.4 12.4 2.8 7.0 0.0 0.2 0.0 0.0 0.4 1.4 1.3 0.0 0.6 1.6 0.2 2.1 33.6 6.6 5.3 0.1 2.6 2.7 15.7 0.0 0.0 0.0 0.2 22.5 0.0 3.4 0.0 0.2 2.8 0.0 1.2 0.3 7.5 12.2 0.8 3.6 0.0 0.0 0.7 0.0 9.0 0.1 4.6 4.8 2.6 0.0 4.2 2.7 0.5 5.5 0.0 32.9 3.1 29.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 2.0 2.2 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" Q92777 3 12004388-12192032 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Schizophrenia "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 95.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 338.3;Inhibitory neurons: 543.3;Oligodendrocyte precursor cells: 128.2" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;HMC-1: 4.5;NTERA-2: 3.3;SCLC-21H: 2.7;SH-SY5Y: 11.1;SuSa: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB079005: , HPA037012: AB_2675431" "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 6.9 3.1 61.9 0.4 86.1 0.1 7.2 7.3 95.6 1.3 0.0 1.8 0.4 2.0 1.0 0.3 1.2 0.4 0.9 88.4 41.2 1.5 0.0 1.1 0.0 21.3 10.6 95.8 1.6 0.5 4.1 3.5 2.9 37.1 0.5 0.5 7.9 2.4 0.2 0.9 2.3 1.6 1.8 0.0 0.6 1.8 3.6 15.3 0.1 0.2 0.4 0.0 0.3 1.4 66.2 0.0 0.2 0.0 0.0 1.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.0 0.2 2.7 11.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 86.1 7.3 95.6 88.4 41.2 21.3 10.6 95.8 37.1 0.0 15.3 66.2 43.4 0.0 0.0 7.8 0.0 0.0 0.4 0.0 0.6 13.9 0.4 2.4 1.4 0.0 0.0 0.0 6.2 1.7 0.1 0.0 0.0 0.0 0.6 0.2 0.1 4.5 0.0 0.0 338.3 0.0 0.4 0.9 0.0 0.3 0.0 0.2 0.7 0.0 0.6 13.5 543.3 0.0 0.0 1.8 0.0 1.8 0.0 0.3 0.0 4.7 0.1 2.5 0.0 128.2 8.3 0.3 0.0 0.0 0.0 0.3 0.0 2.7 0.0 3.7 0.0 0.7 0.7 4.9 6.9 0.0 0.0 0.8 0.1 0.1 0.0 0.2 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639222-32855666 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Group enriched" "Detected in many" 17 "Excitatory neurons: 1466.4;Inhibitory neurons: 411.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "classical monocyte: 55.3" "Lineage enriched" "Detected in many" 5 "monocytes: 55.3" "Cell line enhanced" "Detected in many" "A549: 132.5;BJ: 91.3;fHDF/TERT166: 98.1;GAMG: 95.4;U-2197: 84.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.5 1.3 3.4 6.1 4.4 1.4 5.8 8.5 13.3 7.3 2.7 3.3 2.9 1.2 0.6 2.9 1.2 2.3 1.4 1.7 11.1 8.7 17.1 3.8 0.4 29.5 11.1 2.8 1.9 0.7 0.6 3.8 0.2 36.1 2.6 3.3 11.7 2.6 1.0 0.1 4.5 2.5 1.0 2.3 1.6 2.5 5.4 8.9 0.8 10.0 0.0 2.1 9.5 3.5 40.8 0.4 132.5 1.8 0.0 0.9 2.5 0.2 91.3 60.0 65.3 55.8 0.0 2.9 0.0 16.4 98.1 95.4 76.7 0.3 34.5 69.4 0.2 0.7 1.3 1.8 2.0 0.4 0.1 0.2 1.3 3.4 81.1 74.6 5.7 41.2 0.1 0.0 0.7 24.4 0.1 0.0 0.1 2.5 0.0 0.0 0.1 0.9 0.0 52.9 3.6 3.4 4.0 7.5 0.0 0.1 5.0 0.0 0.3 34.7 50.7 15.8 84.4 53.6 0.1 0.0 0.9 28.2 0.1 6.6 0.2 55.3 0.9 0.2 4.7 0.2 0.1 0.1 0.0 12.1 0.1 0.0 0.0 2.0 0.2 0.2 0.2 0.0 14.2 3.4 4.4 8.5 13.3 1.7 11.1 29.5 11.1 2.8 36.1 2.3 8.9 40.8 0.1 38.5 2.7 29.7 0.8 26.0 48.0 5.1 21.1 11.0 4.3 18.2 2.0 8.6 7.9 3.7 8.4 0.0 1.3 0.0 9.8 1.8 41.5 0.1 1.9 5.7 0.0 0.0 1466.4 0.2 0.0 10.5 0.0 0.2 1.3 3.2 7.1 5.3 0.5 28.6 411.8 0.0 2.0 10.2 1.9 23.5 0.3 22.1 1.8 36.5 49.2 5.0 0.0 54.3 19.2 0.9 0.0 0.4 0.0 42.9 0.0 18.7 2.4 3.1 0.0 0.1 9.3 11.3 5.0 3.2 6.1 0.0 0.6 0.0 0.0 6.5 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 12.0 14.5 7.7 7.2 9.4 15.1 14.1 10.6 10.2 13.4 8.7 10.9 13.6 9.5 17.3 7.8 8.9 10.7 10.1 7.8 8.7 16.9 21.9 9.6 6.8 9.1 9.5 8.2 10.4 29.3 32.6 12.5 14.3 9.2 16.8 12.8 15.4 21.8 12.3 9.0 10.4 13.7 8.8 8.5 8.5 13.3 8.4 8.5 6.5 20.1 9.5 7.1 11.6 8.3 12.2 12.6 13.9 15.1 12.1 17.5 16.3 28.8 19.9 12.2 12.7 12.8 28.2 29.7 8.7 23.5 9.9 11.6 32.3 11.4 10.9 12.5 7.1 10.9 8.2 17.7 15.9 16.4 13.8 9.6 12.5 21.3 15.4 24.1 13.2 13.8 9.0 32.1 17.3 15.3 13.5 9.7 14.3 21.6 46.0 5.0 11.2 10.5 25.0 26.1 12.9 11.0 17.2 15.1 33.0 24.5 26.9 29.1 12.4 13.2 18.1 11.5 12.2 18.9 20.2 13.3 13.3 9.8 7.4 16.7 1.4 9.0 2.5 3.0 8.9 4.5 3.6 3.8 4.2 7.6 2.3 4.7 3.6 3.9 10.0 11.4 4.8 5.7 3.9 7.7 9.4 10.6 10.2 7.8 8.7 9.1 9.5 8.2 9.2 8.5 8.5 12.2 28.1 28.9 37.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 18.8 16.5 0.0 0.0 29.7 25.8 0.0 22.0 12.6 0.0 9.8 22.8 0.0 26.8 27.0 9.8 0.0 0.0 0.0 25.4 25.7 12.3 0.0 38.6 12.6 26.4 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 6.7 0.0 0.0 0.0 0.0 24.7 0.0 0.0 4.0 0.0 0.0 10.7 15.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 28.0 6.9 29.0 0.0 0.0 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196792-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 92.0" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 85.1;Hepatocytes: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 13.0 14.4 6.0 9.5 7.3 5.5 13.7 7.2 7.3 10.4 14.2 35.8 32.7 6.9 10.5 14.4 10.6 9.6 19.6 5.2 6.4 35.4 92.0 11.6 10.6 7.4 6.9 4.8 10.2 21.9 27.5 6.7 18.2 7.5 12.4 33.1 7.1 14.7 11.9 17.5 6.8 25.1 11.5 6.2 8.8 18.6 13.0 6.7 10.3 12.6 33.4 13.3 11.2 4.6 9.6 16.0 8.3 17.2 17.8 14.6 11.3 17.5 9.8 13.2 17.5 17.5 8.6 14.5 28.9 14.6 9.2 20.1 19.1 35.1 25.1 15.1 17.0 16.0 21.8 9.9 6.4 25.9 15.9 19.5 23.0 23.2 13.8 11.1 18.6 15.4 26.5 20.9 9.9 13.1 12.8 10.7 13.0 29.8 38.4 20.0 13.2 16.2 34.4 22.9 22.0 25.3 14.4 22.1 30.3 39.7 36.6 32.3 32.2 8.7 8.4 6.1 16.5 8.5 26.3 19.8 16.2 11.6 20.6 12.4 5.6 14.1 14.6 7.2 20.0 8.1 5.3 6.3 8.4 17.9 7.4 10.5 7.2 5.3 6.9 20.5 8.9 9.9 10.3 6.0 7.3 7.2 7.3 5.2 6.4 7.4 6.9 4.8 7.5 6.2 6.7 9.6 5.0 12.8 24.1 4.2 7.8 1.8 5.2 20.5 5.2 6.0 7.5 7.0 18.1 15.7 11.4 11.0 14.6 85.1 4.5 49.3 25.4 12.9 1.1 10.9 8.1 5.9 14.5 9.4 1.5 10.5 20.3 7.2 18.3 10.3 2.5 12.7 8.9 88.8 26.3 15.2 2.0 26.6 16.2 15.1 7.2 2.8 6.8 10.5 7.2 1.9 20.2 11.6 6.2 2.5 4.5 10.5 25.6 5.3 9.1 4.9 38.6 41.0 7.6 11.0 6.6 7.5 8.4 49.9 31.3 13.8 2.6 54.6 6.9 25.6 29.5 5.7 NECAP2 FLJ10420 ENSG00000157191 "NECAP endocytosis associated 2" Q9NVZ3 1 16440721-16460078 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 314.8;monocytes: 202.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028077 Approved Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA028077: AB_10601273" "unprognostic (6.92e-2)" "unprognostic (4.45e-2)" "unprognostic (1.11e-1)" "unprognostic (2.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.35e-1)" "prognostic unfavorable (6.13e-4)" "unprognostic (5.48e-2)" "unprognostic (1.57e-1)" "unprognostic (3.38e-1)" "unprognostic (6.72e-2)" "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (1.39e-1)" "unprognostic (2.17e-1)" "unprognostic (5.58e-2)" "unprognostic (2.58e-2)" 38.2 38.3 26.5 52.2 28.3 29.2 34.6 29.4 33.1 30.0 29.3 31.2 23.6 23.0 19.3 43.8 33.1 30.8 20.7 25.4 33.6 33.4 32.0 52.1 78.3 32.4 27.8 22.9 37.1 22.3 23.9 19.9 60.4 28.9 25.6 29.8 14.3 26.8 21.2 8.7 45.1 32.2 30.4 31.1 73.9 30.7 34.0 29.1 56.4 25.9 12.9 63.8 44.8 31.4 31.9 54.1 29.2 30.5 36.0 60.6 65.0 17.9 59.6 83.3 76.8 67.9 32.1 87.1 47.8 70.4 111.2 35.4 35.8 43.1 60.3 63.9 100.0 44.3 46.7 33.4 44.6 78.9 59.8 41.7 73.0 61.6 54.7 44.9 66.2 129.1 54.4 67.0 153.7 69.1 35.3 55.8 63.3 26.6 41.1 41.9 61.2 27.0 79.6 76.9 30.5 19.1 48.6 46.4 27.1 61.9 45.1 30.9 66.1 148.0 49.2 26.8 57.4 41.1 72.5 74.5 47.9 41.6 85.7 49.0 90.2 173.1 112.3 96.1 241.2 95.6 108.8 165.8 114.5 120.1 98.8 168.2 106.6 68.2 121.6 274.7 71.0 214.7 269.9 26.5 28.3 29.4 33.1 25.4 33.6 32.4 27.8 22.9 28.9 31.1 29.1 31.9 53.6 22.4 25.0 10.1 47.6 52.3 34.1 60.4 27.3 25.7 37.9 35.1 7.0 22.8 32.2 20.2 314.8 49.0 42.5 34.6 23.5 71.3 61.1 27.0 29.5 67.8 18.7 40.8 7.0 54.2 62.0 33.3 23.9 27.6 27.8 33.0 96.4 11.0 125.7 15.2 7.7 31.8 36.7 94.5 81.8 34.3 29.8 60.5 24.9 7.5 202.0 23.8 55.6 11.6 11.4 121.9 45.8 33.8 24.3 46.6 30.8 22.8 37.4 54.3 39.5 14.7 27.2 26.8 27.4 33.3 56.0 49.4 59.4 72.7 24.0 58.8 LRP8 "APOER2, HSZ75190, LRP-8, MCI1" ENSG00000157193 "LDL receptor related protein 8" Q14114 1 53242364-53328469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3;thyroid gland: 41.9" "Cell type enhanced" "Detected in many" "Astrocytes: 30.7;Bipolar cells: 45.3;Excitatory neurons: 35.9;Granulosa cells: 67.0;Inhibitory neurons: 116.4;Microglial cells: 43.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073031 Enhanced "Secreted in other tissues" NA NA 2000000 "HPA073031: AB_2732217" "unprognostic (3.83e-2)" "unprognostic (6.06e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (3.46e-1)" "unprognostic (6.13e-2)" "unprognostic (1.03e-3)" "prognostic unfavorable (7.02e-4)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (8.88e-16)" "unprognostic (7.73e-3)" "unprognostic (5.47e-2)" "unprognostic (6.98e-2)" "unprognostic (3.00e-2)" 2.0 1.4 12.7 4.9 13.1 5.4 1.5 12.3 14.5 1.5 13.4 1.4 1.4 1.7 1.8 7.6 2.7 1.3 1.2 12.7 10.1 1.3 0.3 2.9 5.2 10.8 9.9 11.5 1.1 0.7 0.4 5.3 2.0 13.5 1.1 1.9 12.0 1.5 1.2 0.7 1.7 2.1 2.0 5.8 2.6 1.0 24.3 12.3 2.8 41.9 0.4 4.8 1.6 2.7 12.4 22.2 37.4 18.0 22.5 10.1 10.3 22.9 30.5 19.1 32.4 24.2 10.4 23.2 29.3 29.5 13.3 48.0 35.7 13.3 25.2 15.9 22.2 11.4 20.8 43.3 20.2 9.5 38.2 31.9 3.4 2.7 33.1 17.0 5.8 26.6 24.8 7.5 14.6 6.5 23.6 21.1 19.8 34.8 21.0 27.4 32.1 25.8 31.6 15.6 15.3 38.7 15.3 13.1 67.0 14.6 11.3 8.4 25.1 25.5 9.5 14.6 23.1 51.4 25.6 37.5 12.8 47.9 54.4 53.3 1.4 0.4 0.2 0.5 0.1 0.4 0.3 0.3 0.3 0.2 0.4 0.2 0.3 1.3 0.4 0.1 1.3 0.5 0.2 12.7 13.1 12.3 14.5 12.7 10.1 10.8 9.9 11.5 13.5 5.8 12.3 12.4 0.8 0.0 6.1 30.7 2.2 1.5 2.5 1.6 0.0 45.3 1.2 0.8 2.6 0.0 4.3 0.0 0.0 2.1 8.9 0.3 0.0 2.1 7.4 4.4 2.5 4.1 2.4 3.4 35.9 2.4 1.8 1.7 0.0 10.1 1.3 67.0 0.7 0.1 1.9 26.9 116.4 2.2 2.0 3.2 2.1 5.1 0.6 2.4 0.0 43.1 7.0 1.5 5.2 17.6 2.4 4.4 0.2 2.6 4.4 13.7 0.0 0.1 10.2 2.8 0.0 2.8 2.2 3.6 1.1 4.4 1.4 9.7 3.0 1.8 0.8 8.1 CDCP2 ENSG00000157211 "CUB domain containing protein 2" Q5VXM1 1 54132968-54153770 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA031143 Uncertain "Secreted - unknown location" NA NA "HPA031143: AB_10611819" "unprognostic (1.08e-1)" "unprognostic (5.16e-2)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-2)" "unprognostic (4.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.86e-2)" "unprognostic (2.57e-1)" "unprognostic (1.33e-1)" "unprognostic (1.67e-2)" "unprognostic (7.67e-6)" "unprognostic (2.37e-1)" "unprognostic (1.48e-1)" "unprognostic (5.12e-1)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003124 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 4.2 4.0 2.1 5.9 2.3 9.9 5.4 11.7 2.7 4.7 2.4 5.0 4.8 4.6 4.9 5.5 4.2 4.4 3.9 2.1 2.6 4.3 5.7 4.3 8.8 2.3 2.7 2.0 5.8 4.4 6.3 3.8 6.2 5.8 4.4 5.0 4.0 5.7 3.6 6.0 6.6 5.7 3.7 2.3 5.6 5.2 8.8 2.5 26.8 5.5 4.6 6.1 5.4 4.7 2.6 17.7 14.2 18.4 31.2 7.8 6.5 16.4 7.6 8.0 10.3 11.9 15.7 13.6 22.9 9.4 9.1 21.3 13.6 23.7 12.1 12.7 23.0 18.4 17.4 10.7 13.6 5.5 23.9 22.3 6.3 9.0 10.3 4.2 5.8 9.9 22.8 24.3 15.1 10.4 24.3 51.1 19.9 29.8 17.1 9.5 28.8 18.7 24.8 10.7 14.6 14.6 9.4 20.3 14.9 9.5 16.6 11.4 20.1 5.1 8.6 1.5 12.3 18.6 15.2 9.5 31.0 21.1 27.7 23.6 0.2 0.9 0.5 0.9 1.1 1.4 0.5 1.5 1.1 1.0 0.9 2.4 0.7 0.5 1.3 1.3 1.2 1.2 0.9 2.1 2.3 11.7 2.7 2.1 2.6 2.3 2.7 2.0 5.8 2.3 2.5 2.6 5.2 6.4 6.3 18.9 5.8 6.4 5.1 4.7 4.0 18.9 8.9 6.6 6.9 7.2 7.1 9.2 10.4 9.0 3.8 6.8 5.9 3.9 2.3 5.5 6.9 5.2 2.4 10.3 21.4 3.3 8.0 6.9 5.6 6.5 2.5 8.8 5.0 9.2 4.4 3.3 24.2 8.4 2.0 6.1 7.1 2.8 8.7 4.8 3.6 15.9 6.3 8.0 7.2 27.2 27.4 4.4 4.3 9.4 4.9 8.0 5.2 4.2 4.3 12.3 0.0 11.1 5.1 22.6 18.7 8.9 7.0 6.2 4.9 6.3 9.8 4.5 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "prostate: 128.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 68.0;Inhibitory neurons: 53.0;Prostatic glandular cells: 102.9" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 22.5;CAPAN-2: 48.1;U-138 MG: 27.4" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles NA NA Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 13.7 3.7 8.3 12.0 13.1 0.0 13.2 10.9 17.6 8.0 8.1 13.7 6.2 7.1 2.7 6.9 14.5 10.2 10.4 12.5 10.6 6.9 4.0 20.7 0.5 6.5 7.4 11.8 17.3 8.2 10.2 19.6 0.2 7.3 128.8 7.7 3.9 12.0 6.9 1.4 4.5 9.1 10.9 6.9 2.7 11.1 1.1 7.5 3.3 8.0 1.6 1.7 16.0 9.1 8.5 3.2 22.5 0.5 6.3 11.5 11.1 0.3 2.8 5.8 0.4 0.8 4.2 48.1 0.0 0.3 7.5 8.8 1.8 4.9 3.5 0.8 0.0 4.7 0.0 0.1 1.1 1.0 0.0 0.1 8.1 0.8 11.5 2.3 9.4 6.1 0.0 0.0 0.4 6.6 0.0 0.0 0.7 9.1 0.0 2.5 0.0 0.0 0.2 10.3 6.6 0.7 2.1 3.5 0.0 0.1 1.0 16.8 0.0 5.1 27.4 6.0 3.8 2.4 0.1 0.0 0.0 11.7 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 13.1 10.9 17.6 12.5 10.6 6.5 7.4 11.8 7.3 6.9 7.5 8.5 0.6 0.0 1.1 18.6 0.2 4.8 21.6 20.6 9.1 7.5 16.1 10.3 18.0 18.6 19.4 12.9 2.1 0.0 0.1 15.9 0.0 1.1 0.5 2.8 3.7 2.2 15.7 2.7 68.0 7.4 0.0 27.6 10.7 2.9 0.0 30.4 3.6 5.8 0.0 1.7 53.0 9.8 10.2 0.0 6.2 0.8 15.5 0.7 0.0 2.8 0.0 23.1 0.0 27.6 2.6 11.4 24.0 15.4 0.0 102.9 13.1 10.8 16.0 1.3 0.0 14.7 5.8 3.1 6.2 4.1 5.4 0.0 0.5 9.8 13.8 25.3 SSBP3 "CSDP, FLJ10355, SSDP, SSDP1" ENSG00000157216 "Single stranded DNA binding protein 3" Q9BWW4 1 54225433-54413479 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (1.44e-2)" "prognostic favorable (2.48e-9)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.94e-1)" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.59e-2)" "unprognostic (3.93e-2)" "unprognostic (3.34e-1)" "unprognostic (7.08e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-3)" "unprognostic (2.50e-1)" "unprognostic (6.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.96e-1)" 26.5 46.6 24.7 21.4 46.3 42.3 15.3 32.1 69.5 49.8 7.4 29.9 28.8 48.9 20.2 31.5 40.6 26.6 25.2 41.6 20.4 19.8 27.8 20.3 20.1 18.0 23.4 30.7 104.7 21.5 13.9 5.6 28.1 24.7 33.1 25.8 38.1 23.2 36.3 31.0 40.1 29.6 35.6 13.6 28.4 46.2 27.3 18.2 68.4 15.6 15.9 20.0 19.3 19.6 41.4 13.4 9.6 91.9 56.9 43.2 26.1 153.4 30.0 31.3 13.1 11.2 18.9 11.2 8.6 45.9 31.1 11.7 39.6 49.1 19.1 16.0 69.9 21.7 96.5 47.0 28.0 36.8 25.1 47.4 39.1 20.1 23.1 6.0 25.3 66.4 64.7 97.5 17.2 18.1 19.4 136.2 66.6 161.2 51.4 40.8 94.5 37.7 33.0 24.2 15.2 117.1 70.1 35.3 59.9 19.7 83.1 27.0 38.6 61.7 24.9 36.9 37.1 20.2 29.3 32.7 20.5 43.3 90.8 10.9 0.0 1.2 3.3 5.6 0.7 3.5 0.9 4.4 4.9 1.1 0.3 5.8 5.8 0.1 0.6 0.7 0.4 0.4 1.7 24.7 46.3 32.1 69.5 41.6 20.4 18.0 23.4 30.7 24.7 13.6 18.2 41.4 31.8 12.8 12.1 31.6 6.8 29.7 37.2 13.8 15.9 97.4 16.9 36.6 17.4 41.5 14.9 23.9 8.4 56.9 36.1 73.6 9.8 30.2 36.5 65.5 38.4 37.4 111.7 60.8 100.0 25.2 46.9 41.4 47.4 48.2 7.6 93.1 47.5 97.8 26.0 42.1 37.1 78.5 14.2 33.9 25.4 42.5 91.6 19.2 23.2 38.4 21.5 68.5 51.5 45.2 78.4 64.6 33.9 136.9 10.0 20.4 38.7 10.8 27.7 48.5 26.3 21.2 37.2 2.9 35.8 27.2 25.9 23.7 20.2 144.9 46.2 30.8 HTR5A 5-HT5A ENSG00000157219 "5-hydroxytryptamine receptor 5A" P47898 7 155070324-155087392 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 3.9" "Group enriched" "Detected in some" 4 "Early spermatids: 8.7;Excitatory neurons: 7.6;Inhibitory neurons: 10.0;Late spermatids: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB017467 Approved NA NA "CAB017467: AB_2122566" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.0 0.0 1.2 0.0 1.7 0.0 0.0 3.9 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 0.0 0.9 1.2 1.6 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.5 0.8 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 3.9 2.9 1.2 1.5 0.9 1.2 1.6 1.8 0.2 1.5 2.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN12 ENSG00000157224 "Claudin 12" P56749 7 90383721-90513402 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Early spermatids: 354.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026945 Approved NA NA "HPA026945: AB_10603786" "unprognostic (1.45e-2)" "prognostic unfavorable (6.36e-4)" "unprognostic (3.84e-2)" "unprognostic (4.87e-2)" "unprognostic (7.28e-2)" "unprognostic (1.86e-2)" "unprognostic (6.47e-2)" "unprognostic (3.41e-2)" "unprognostic (3.67e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (7.66e-2)" "unprognostic (2.37e-1)" "unprognostic (9.49e-2)" "unprognostic (1.30e-1)" 8.4 22.2 17.2 7.1 18.2 3.2 21.3 19.7 20.6 13.8 16.7 22.4 18.9 14.2 20.0 12.0 15.5 19.2 18.5 16.9 19.6 24.3 52.4 12.2 2.0 17.8 17.2 16.0 20.7 14.7 21.8 22.7 10.2 16.4 24.3 24.1 31.6 19.8 12.5 17.5 8.4 21.5 13.3 15.5 4.6 21.8 12.9 19.8 5.8 17.3 23.2 5.1 15.9 10.5 19.7 25.5 22.6 26.3 17.8 27.1 22.2 14.3 30.3 33.6 19.9 33.2 21.7 65.0 4.1 24.1 18.2 43.9 21.2 23.4 27.9 39.8 6.0 22.1 2.5 19.9 23.8 26.8 5.1 2.8 27.8 29.7 33.3 52.3 35.9 10.5 5.0 14.8 14.3 30.0 12.1 6.8 12.0 44.7 32.6 14.4 3.4 37.9 6.2 31.0 17.0 21.4 39.1 16.8 15.6 51.7 42.1 18.2 16.4 25.8 46.6 29.2 36.6 33.5 7.8 8.1 0.6 33.1 3.6 24.0 0.0 0.2 0.0 0.3 0.3 0.3 0.3 0.6 0.1 1.0 0.1 0.2 0.3 0.0 0.0 0.0 0.3 0.5 0.2 17.2 18.2 19.7 20.6 16.9 19.6 17.8 17.2 16.0 16.4 15.5 19.8 19.7 3.6 32.1 10.3 21.2 0.9 9.8 14.8 23.5 8.6 34.5 21.8 10.9 15.7 20.0 23.4 18.4 20.9 8.7 0.7 19.1 7.9 18.9 354.5 13.4 9.5 4.8 16.7 1.3 35.9 41.0 10.0 13.8 10.7 18.1 0.0 5.7 8.6 51.2 7.2 20.2 33.4 18.8 18.3 0.8 5.7 31.2 10.5 2.8 19.6 9.4 2.7 49.6 1.0 28.1 3.9 32.3 13.0 10.5 3.3 48.7 13.4 26.4 36.3 20.9 13.1 8.4 10.1 22.3 6.7 11.9 10.9 5.1 1.6 5.0 18.7 51.8 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836560-22849041 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" No No 1400000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: AB_2681484" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 127.6 32.0 4.7 60.4 4.7 1.6 102.4 5.6 11.0 164.8 50.8 75.7 39.8 168.6 19.2 92.8 82.8 149.5 34.7 5.9 14.7 35.6 13.3 92.6 25.0 11.3 7.2 2.4 91.0 36.3 65.8 14.3 119.8 8.6 60.4 37.0 9.7 78.7 45.9 18.9 116.9 70.0 106.9 9.2 31.1 58.2 11.8 10.1 13.1 50.4 16.2 31.0 104.7 112.1 8.2 90.6 1.2 26.3 2.0 923.8 651.6 455.9 270.1 606.4 93.3 158.5 21.3 337.4 0.9 146.4 301.9 24.6 216.3 0.3 262.2 99.7 1.1 0.6 37.2 1.7 5.0 794.2 0.4 1.3 887.0 148.7 334.7 288.3 925.5 492.9 0.6 0.8 2.1 185.1 0.7 0.4 79.4 14.7 17.7 52.4 2.1 96.0 0.2 61.4 148.1 0.3 0.6 187.3 0.3 574.2 104.4 1.0 79.5 436.8 724.9 53.7 198.2 329.6 0.8 1.6 1.1 410.9 0.6 396.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 4.7 5.6 11.0 5.9 14.7 11.3 7.2 2.4 8.6 9.2 10.1 8.2 13.9 12.8 3.0 2.0 3.4 34.0 23.4 105.4 39.3 0.0 14.1 17.5 4.7 50.1 42.2 7.3 0.0 105.6 0.3 19.9 11.7 63.0 0.4 16.1 81.6 35.2 7.8 0.0 0.0 28.7 244.0 84.0 25.5 14.8 3.8 9.3 32.9 2.7 89.5 0.0 0.0 24.5 34.6 20.2 32.7 2.4 72.1 38.0 37.4 4.7 21.5 14.3 0.0 0.5 0.1 144.7 33.0 54.9 0.3 21.8 19.9 11.7 46.8 0.8 39.5 11.1 73.9 0.8 0.8 33.7 34.2 122.7 2.5 15.6 18.6 37.9 FZD1 DKFZp564G072 ENSG00000157240 "Frizzled class receptor 1" Q9UP38 7 91264433-91271326 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 44.9;Cholangiocytes: 45.8;Horizontal cells: 141.3;Peritubular cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.0;non-classical monocyte: 2.8" "Lineage enriched" "Detected in single" 5 "monocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 24.8;HSkMC: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013008 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013008: " "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (4.51e-3)" "unprognostic (2.09e-1)" "unprognostic (5.29e-3)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (5.48e-3)" "unprognostic (2.14e-1)" "unprognostic (7.39e-3)" "prognostic favorable (8.87e-7)" "unprognostic (1.05e-2)" "unprognostic (4.16e-2)" "unprognostic (5.53e-2)" "unprognostic (4.13e-2)" 5.3 4.5 2.5 2.7 2.4 1.1 10.8 6.0 2.7 8.6 9.8 5.6 5.1 8.6 4.3 5.3 5.6 5.7 12.8 4.3 3.2 9.7 2.5 10.7 1.4 2.6 5.8 2.2 10.2 4.8 2.4 3.9 10.1 3.4 10.3 3.7 2.0 9.0 16.6 1.9 10.1 5.1 5.3 2.6 3.2 4.6 1.6 3.0 1.9 20.7 2.4 1.3 6.4 11.3 2.3 0.8 2.5 24.8 2.6 19.8 17.0 4.5 9.2 5.8 3.3 2.3 1.1 4.3 0.0 2.2 5.9 4.2 4.7 3.9 2.0 2.2 0.0 4.9 0.2 4.6 1.3 1.4 4.2 1.0 32.3 3.6 7.6 2.4 12.6 0.7 2.8 1.5 3.6 9.7 6.2 0.8 1.1 6.4 1.3 4.2 5.1 15.3 0.4 5.3 11.8 3.4 6.5 7.0 5.6 1.6 5.7 3.0 3.8 3.8 13.9 10.4 15.0 3.8 3.3 2.5 0.4 15.0 3.5 16.5 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.2 2.5 2.4 6.0 2.7 4.3 3.2 2.6 5.8 2.2 3.4 2.6 3.0 2.3 5.7 3.2 1.5 4.6 1.1 4.2 44.9 7.0 10.8 1.6 27.7 29.5 18.5 45.8 4.6 12.9 2.1 3.4 0.6 7.4 0.0 4.3 0.3 12.0 13.1 4.5 3.5 0.8 0.6 2.0 2.2 18.5 2.0 15.7 12.7 1.8 15.4 0.9 3.5 141.3 1.0 3.0 4.1 17.4 16.2 1.1 33.2 14.3 17.8 1.9 4.6 3.0 1.0 1.0 0.2 1.9 4.8 45.1 0.4 11.7 6.0 11.6 2.4 2.9 0.0 6.2 10.3 0.5 3.7 9.1 5.1 2.1 0.6 2.6 4.6 7.3 GATAD1 "FLJ22489, ODAG, RG083M05.2" ENSG00000157259 "GATA zinc finger domain containing 1" Q8WUU5 7 92447482-92460075 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 234.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006105, HPA072785" Enhanced Nucleoplasm Yes No Nucleoplasm "HPA006105: AB_1078956, HPA072785: AB_2686556" "unprognostic (8.37e-2)" "unprognostic (1.01e-1)" "unprognostic (7.31e-3)" "unprognostic (6.24e-2)" "unprognostic (6.03e-2)" "unprognostic (1.36e-1)" "unprognostic (8.65e-3)" "unprognostic (6.43e-2)" "unprognostic (5.16e-2)" "unprognostic (4.30e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.91e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-1)" "unprognostic (3.44e-2)" "unprognostic (1.98e-3)" 21.4 22.3 9.9 7.3 12.4 6.3 22.4 10.3 11.3 26.0 10.1 21.0 11.3 21.6 18.5 14.7 26.7 11.9 15.7 9.7 10.6 21.6 20.3 20.3 8.8 11.9 11.7 9.3 33.9 29.7 15.6 23.3 12.5 12.7 24.1 11.4 13.3 18.5 12.6 10.9 14.1 18.7 11.8 10.9 20.4 21.8 10.2 11.6 6.8 26.2 5.7 7.4 22.2 20.4 16.5 12.3 7.5 15.3 16.1 19.7 22.4 12.1 11.9 17.8 12.4 16.9 8.5 18.5 9.1 15.9 8.9 28.9 14.3 10.7 8.1 13.0 15.8 11.3 11.6 8.0 11.6 27.4 14.1 30.0 16.8 19.3 9.5 27.4 22.3 14.2 6.6 24.2 19.0 13.8 17.7 5.5 20.2 20.8 19.9 14.4 7.2 18.1 12.1 13.6 13.4 13.4 21.4 15.7 16.5 23.7 19.0 9.2 18.8 13.0 19.7 14.9 30.0 15.5 15.2 5.5 10.0 16.6 9.0 27.6 2.9 1.1 1.2 0.7 0.7 0.7 0.9 0.5 0.5 0.6 1.4 0.6 0.9 1.0 0.9 0.8 1.2 0.6 0.4 9.9 12.4 10.3 11.3 9.7 10.6 11.9 11.7 9.3 12.7 10.9 11.6 16.5 59.0 48.1 64.6 98.9 26.5 13.3 37.8 14.6 26.7 79.0 33.3 35.1 16.3 24.3 26.6 47.8 70.9 25.7 28.8 30.2 3.9 22.4 3.8 46.7 48.3 34.7 16.8 24.6 77.8 22.0 23.4 38.1 30.5 51.6 53.2 115.1 37.1 21.7 24.6 62.2 70.4 33.3 2.0 30.8 23.7 5.0 45.4 40.2 21.4 54.4 25.8 65.3 32.0 108.6 234.9 27.0 30.7 35.0 13.6 45.9 33.2 18.2 36.1 114.1 19.7 54.3 36.7 14.1 10.4 23.6 17.8 20.7 24.7 56.0 31.9 35.7 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085133 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 57.7;testis: 77.8" "Cell type enhanced" "Detected in many" "B-cells: 32.4;Granulosa cells: 30.8;Hepatocytes: 66.6;Hofbauer cells: 49.4;Proximal tubular cells: 59.4;T-cells: 37.5;Theca cells: 34.7" "Cancer enhanced" "Detected in all" "breast cancer: 50.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 150.7;Karpas-707: 32.6;MCF7: 36.8;NB-4: 78.0;RPMI-8226: 82.5;THP-1: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042310 Uncertain NA NA "HPA042310: AB_10796902" "prognostic favorable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 3.5 1.9 4.0 17.8 4.3 41.6 15.6 4.6 4.3 14.3 4.4 3.8 4.9 20.0 10.1 4.3 35.7 4.3 1.0 4.0 6.3 21.4 28.0 4.2 57.7 6.2 5.9 2.8 40.5 1.1 1.3 5.5 2.0 6.1 2.4 2.2 6.5 11.5 3.2 1.2 3.7 18.9 6.2 8.1 36.6 4.5 77.8 6.1 32.1 4.2 0.6 30.8 4.4 6.1 6.2 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.5 0.6 0.3 3.4 1.3 150.7 0.6 0.6 0.1 0.3 2.4 0.1 0.0 13.4 0.1 20.7 0.1 2.4 9.5 0.1 4.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 6.2 32.6 0.0 36.8 0.2 78.0 1.8 1.1 4.6 6.5 0.0 82.5 0.0 0.0 0.2 0.2 0.1 1.1 0.0 1.7 19.4 34.6 0.5 0.0 0.0 0.0 0.0 6.6 3.8 9.7 0.0 0.0 0.2 0.6 16.7 79.1 24.0 15.5 27.4 88.7 124.8 43.4 41.1 70.1 214.8 87.7 5.8 11.2 3.0 3.6 182.9 68.3 4.0 4.3 4.6 4.3 4.0 6.3 6.2 5.9 2.8 6.1 8.1 6.1 6.2 2.6 0.0 6.7 0.0 32.4 0.6 0.2 0.3 0.0 0.5 24.2 11.0 0.8 17.2 0.2 0.0 4.2 1.0 2.4 0.4 9.8 0.7 3.0 0.4 2.9 3.4 0.0 2.5 0.1 0.2 2.1 9.0 1.1 0.3 3.8 30.8 1.4 66.6 49.4 0.0 0.1 0.4 8.2 10.5 9.2 11.2 5.6 29.1 1.8 17.8 8.3 1.7 2.1 0.5 0.1 0.6 0.1 5.3 17.9 1.4 0.2 59.4 0.7 9.2 0.0 0.1 1.6 3.4 3.9 0.1 0.3 1.4 37.5 34.7 0.7 0.2 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343250-69351786 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 301.4" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 28.3;Exocrine glandular cells: 36.6;Pancreatic endocrine cells: 12.8;Paneth cells: 10.6;Proximal tubular cells: 19.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 15.5;OE19: 7.4" HPA012532 Approved NA NA "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favorable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.5 0.6 0.3 0.7 0.5 1.1 0.6 0.8 0.7 2.5 0.2 4.3 12.6 0.9 18.3 0.4 22.7 0.7 0.4 0.5 0.1 16.3 5.5 1.9 1.3 0.3 0.2 0.2 0.6 301.4 0.1 0.2 0.4 0.3 0.7 7.9 1.0 0.5 2.4 0.3 1.0 7.8 0.5 0.2 0.9 61.7 0.4 0.3 0.2 0.6 0.0 0.6 0.3 0.2 0.7 0.6 1.6 1.4 1.0 0.1 0.0 0.9 2.0 0.1 0.0 0.3 2.2 0.8 4.2 0.7 0.0 0.6 1.1 0.2 0.2 0.4 0.6 1.7 2.1 0.6 15.5 0.1 2.7 0.9 0.2 0.8 0.1 0.3 0.8 0.1 1.9 1.4 0.5 0.3 1.6 1.1 2.9 1.9 7.4 1.4 2.3 1.2 1.6 0.4 1.7 3.2 1.3 2.7 0.9 1.0 0.5 0.5 1.7 1.9 2.2 1.3 0.8 1.4 1.4 1.3 4.5 1.2 2.2 0.7 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.8 0.7 0.5 0.1 0.3 0.2 0.2 0.3 0.2 0.3 0.7 0.1 0.0 0.5 1.3 0.5 0.0 0.1 0.1 0.6 0.5 0.5 0.3 0.2 1.5 0.1 1.8 2.1 0.1 0.0 5.0 0.0 6.6 0.1 28.3 0.7 0.4 8.4 3.2 1.4 36.6 0.0 0.1 9.7 5.0 1.3 0.1 0.4 4.7 0.3 0.0 0.8 2.6 0.0 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 1.0 12.8 10.6 0.0 0.3 0.3 8.0 19.1 0.4 0.6 0.0 0.5 0.2 0.1 0.1 0.6 0.0 0.1 0.5 0.1 7.0 0.2 CLEC18A MRCL ENSG00000157322 "C-type lectin domain family 18 member A" A5D8T8 16 69950705-69964452 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 23.2" "Cell type enriched" "Detected in some" 23 "Proximal tubular cells: 78.0" "Cancer enriched" "Detected in single" 7 "renal cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (1.68e-1)" "unprognostic (3.06e-2)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (3.14e-2)" "unprognostic (4.62e-2)" "unprognostic (1.36e-1)" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-4)" "unprognostic (6.73e-2)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (9.03e-4)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" 0.2 0.9 0.1 0.0 0.3 0.3 0.3 0.7 0.5 0.2 2.3 0.3 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.3 23.2 0.2 0.4 0.1 0.3 0.3 0.0 0.2 0.4 0.1 0.4 0.0 0.4 0.3 0.1 0.1 0.6 0.0 0.2 0.3 0.7 0.0 0.3 1.2 0.5 3.2 0.2 0.3 0.4 0.1 0.1 0.3 0.1 0.4 0.0 0.1 0.7 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 0.5 0.2 0.3 0.3 0.3 0.0 0.4 0.3 0.2 0.4 0.3 0.0 1.1 0.0 0.9 0.1 0.0 0.2 0.0 1.6 0.3 0.4 0.5 2.8 0.4 0.0 2.1 0.1 0.3 3.3 1.9 0.3 0.4 0.4 0.1 0.4 0.0 0.0 0.3 0.2 0.1 0.3 2.0 0.5 0.0 0.6 2.5 0.4 0.4 3.3 0.4 1.0 0.0 0.6 0.3 0.8 0.3 1.1 0.0 0.0 0.9 0.9 1.0 0.0 0.0 0.5 0.4 0.0 0.2 0.2 1.5 78.0 0.7 1.3 0.0 0.7 1.3 0.5 0.2 0.0 0.0 0.3 0.6 0.6 1.3 0.2 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953734-23969279 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favorable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 34.1 46.2 8.0 10.5 8.6 6.9 34.8 8.5 9.8 28.9 9.3 41.5 34.3 27.3 5.3 46.2 23.8 5.9 43.1 7.8 8.4 90.9 110.6 28.3 10.3 8.8 8.1 7.3 33.3 40.7 8.9 19.4 5.4 8.6 32.1 13.6 3.9 31.4 8.5 62.8 44.3 38.9 8.4 8.6 32.4 34.0 38.2 8.4 9.7 25.6 14.2 8.6 30.8 33.4 9.2 15.1 29.6 10.4 17.2 16.6 18.5 0.1 27.4 15.3 11.5 9.1 6.5 16.5 13.3 14.3 14.6 7.6 18.1 8.6 12.3 10.1 34.6 16.5 7.8 23.5 36.6 9.5 11.6 45.2 18.0 14.8 9.2 20.8 12.3 14.4 19.6 11.8 30.4 15.8 52.3 21.1 10.7 9.9 18.9 30.3 33.8 18.0 41.4 12.1 17.1 19.9 16.1 27.7 17.6 13.8 6.8 16.0 14.6 25.5 13.3 13.8 13.9 9.0 22.8 22.8 3.5 11.8 12.6 13.6 5.4 54.4 6.0 18.0 45.8 21.4 21.5 20.3 18.2 47.4 18.5 20.1 19.5 2.3 18.1 25.5 39.4 19.4 36.2 8.0 8.6 8.5 9.8 7.8 8.4 8.8 8.1 7.3 8.6 8.6 8.4 9.2 16.6 16.0 30.5 6.2 12.5 12.5 10.4 15.7 55.2 5.1 22.2 31.9 35.4 17.2 21.3 14.7 0.0 9.6 17.8 34.2 78.2 6.4 50.4 13.1 11.6 14.6 19.2 20.8 2.6 9.8 6.0 23.7 34.7 7.8 13.9 10.5 20.0 68.1 30.4 6.7 2.1 50.1 8.2 29.2 13.5 66.1 11.1 35.9 5.4 3.7 33.2 18.1 47.4 4.0 5.0 5.3 22.3 17.3 24.6 11.2 51.8 235.4 23.2 1.8 6.6 13.5 18.1 59.4 1.9 61.6 13.4 3.8 18.1 22.9 71.8 9.0 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746200-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 14.9;fallopian tube: 26.9;testis: 49.3" "Cell type enhanced" "Detected in some" "Early spermatids: 223.3;Endometrial ciliated cells: 50.3;Late spermatids: 92.8;Respiratory ciliated cells: 88.1;Spermatocytes: 70.7" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 5.9 0.0 1.2 0.3 0.0 2.1 0.6 0.6 14.9 0.0 0.0 0.4 0.1 0.1 26.9 0.0 0.0 1.0 5.0 0.0 0.0 1.9 0.1 3.6 5.2 0.3 0.1 0.1 0.0 0.6 0.1 3.3 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.0 4.2 0.1 0.1 49.3 1.8 0.0 0.6 0.0 0.0 0.0 0.0 3.8 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 5.9 1.2 2.1 0.6 1.0 5.0 3.6 5.2 0.3 3.3 4.2 1.8 3.8 0.0 3.2 0.5 0.3 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.3 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 223.3 50.3 0.4 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 92.8 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.1 88.1 0.0 6.6 0.1 1.3 70.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CLEC18C "MGC34761, MRCL3" ENSG00000157335 "C-type lectin domain family 18 member C" Q8NCF0 16 70173322-70187361 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "kidney: 17.2;testis: 4.3" "Cell type enriched" "Detected in single" 46 "Proximal tubular cells: 23.3" "Cancer enriched" "Detected in single" 9 "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (3.90e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-4)" "unprognostic (5.55e-2)" "unprognostic (5.72e-3)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (6.98e-2)" 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 17.2 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.9 0.4 0.3 0.2 0.2 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 64.7" "Group enriched" "Detected in some" 96 "Early spermatids: 503.3;Late spermatids: 1116.3" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.9;HSkMC: 6.1;MOLT-4: 4.8;U-698: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 1.5 1.7 4.5 0.6 4.4 0.9 1.5 4.1 5.4 2.4 4.8 1.3 0.0 1.7 5.8 0.8 2.8 0.7 0.6 4.2 4.6 1.5 4.6 1.3 1.3 4.6 4.2 4.0 3.1 1.3 0.5 11.3 0.2 4.3 3.6 0.3 1.3 0.6 0.8 1.9 1.1 1.7 0.7 4.3 2.9 1.2 64.7 4.3 3.0 2.4 0.5 0.7 1.1 1.7 4.7 0.0 0.3 2.1 2.7 4.9 2.3 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.6 0.1 0.1 1.2 0.6 0.3 0.1 0.0 2.4 0.0 0.0 6.1 1.5 0.1 0.9 2.5 0.5 2.0 0.0 3.2 0.8 0.3 4.8 0.6 0.4 0.0 0.1 2.2 0.0 0.0 0.5 0.0 0.6 2.0 0.0 0.0 0.4 1.0 1.4 0.2 0.0 0.4 0.2 0.1 0.0 0.7 0.2 5.4 0.2 2.8 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.2 0.9 0.0 0.0 0.0 0.8 0.0 0.1 4.5 4.4 4.1 5.4 4.2 4.6 4.6 4.2 4.0 4.3 4.3 4.3 4.7 0.8 0.0 0.0 4.6 0.1 0.9 1.9 0.2 1.2 0.0 0.3 0.4 0.2 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 503.3 0.4 0.4 0.8 0.0 0.4 0.3 0.0 0.0 0.6 0.0 0.3 0.0 2.4 0.4 2.8 0.0 0.0 0.5 0.2 0.0 1.2 0.8 1116.3 8.4 1.3 0.0 0.0 0.1 0.8 0.0 0.5 0.3 0.0 0.0 4.1 0.0 0.7 0.2 0.3 0.2 0.2 0.0 0.5 0.4 8.1 6.0 0.7 0.1 0.0 0.3 0.2 0.2 0.4 DDX19B "DBP5, DDX19" ENSG00000157349 "DEAD-box helicase 19B" Q9UMR2 16 70289663-70335305 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 207.8;Spermatocytes: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037229, CAB037284, HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: " "unprognostic (2.91e-2)" "unprognostic (5.37e-2)" "unprognostic (6.48e-2)" "unprognostic (3.55e-2)" "unprognostic (3.98e-2)" "unprognostic (4.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.98e-2)" "unprognostic (1.40e-1)" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (4.07e-1)" "unprognostic (7.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-1)" "unprognostic (1.04e-1)" "unprognostic (6.32e-2)" 24.4 20.6 7.4 14.9 7.9 29.8 24.0 12.8 9.3 15.1 8.5 19.0 19.0 16.5 13.3 18.7 16.7 15.3 17.4 7.4 9.7 20.7 40.3 19.3 22.2 7.8 7.9 6.7 15.8 21.2 19.1 14.5 14.9 9.2 16.2 23.5 19.6 19.1 17.7 31.9 29.6 19.6 20.3 7.7 18.3 22.3 46.3 7.6 23.2 20.2 23.2 25.9 20.2 16.4 9.3 5.3 31.8 44.3 40.3 23.9 31.6 38.0 25.3 36.0 54.6 56.6 67.7 38.5 41.9 23.5 32.2 22.3 31.2 0.2 14.7 56.1 17.7 28.5 25.0 20.0 56.5 51.4 53.7 22.9 39.3 28.0 41.5 31.2 22.5 42.5 12.7 25.1 17.3 33.7 37.1 0.1 77.0 27.6 19.9 13.1 73.9 23.8 59.9 33.2 29.5 29.0 37.1 60.0 13.7 33.1 19.3 30.5 47.1 25.8 25.8 22.6 21.6 23.6 37.6 20.7 96.4 8.7 41.1 33.8 80.6 46.4 42.0 46.5 61.1 45.0 45.8 41.3 50.6 44.6 45.3 36.4 35.1 8.7 52.6 40.2 14.2 77.8 54.6 7.4 7.9 12.8 9.3 7.4 9.7 7.8 7.9 6.7 9.2 7.7 7.6 9.3 16.7 12.8 21.8 7.5 21.4 9.4 16.5 20.3 11.4 18.4 12.4 11.2 8.0 14.3 20.8 11.0 12.5 19.7 19.5 25.4 31.3 42.3 207.8 10.6 8.1 19.6 22.0 8.6 11.7 66.1 24.4 16.7 13.7 10.6 11.4 13.8 12.5 15.5 29.3 10.1 12.4 18.4 16.2 21.0 21.6 46.7 20.8 17.1 3.6 6.5 33.6 17.0 28.8 7.5 11.0 45.8 35.3 15.8 13.2 28.6 49.3 23.5 24.4 17.9 13.1 9.7 13.7 101.7 7.4 9.2 10.4 31.6 19.0 13.9 22.2 20.4 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375977-70439237 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favorable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavorable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 8.6 8.4 4.5 6.4 5.2 7.5 7.3 7.9 6.3 8.8 1.7 7.8 3.5 12.6 1.2 2.7 8.3 2.5 9.5 6.9 2.7 7.9 10.4 9.1 6.4 3.0 2.7 3.9 7.3 3.6 2.6 6.5 3.2 4.3 7.2 1.6 1.7 3.2 2.9 15.9 4.1 7.1 4.1 1.7 13.3 4.7 6.8 3.3 3.7 6.1 3.1 3.4 8.5 5.6 2.8 1.7 8.6 7.7 11.2 3.9 5.4 2.3 6.1 6.0 6.2 3.0 5.5 4.0 4.6 9.8 6.3 5.8 1.9 3.2 2.5 3.3 9.9 5.0 18.0 4.5 8.7 4.7 6.7 29.4 4.1 1.5 6.7 1.3 8.2 8.6 7.6 25.1 4.2 3.7 1.5 7.5 19.8 10.1 2.9 4.5 13.9 2.9 5.9 5.1 1.5 3.7 9.4 15.8 0.6 7.1 8.1 2.4 7.3 9.9 9.0 10.0 4.0 4.7 8.6 3.9 9.7 10.0 5.9 12.5 4.2 1.9 5.2 2.0 1.8 1.7 2.0 2.3 2.0 1.0 2.9 3.8 3.0 10.1 2.8 1.3 14.3 2.6 1.1 4.5 5.2 7.9 6.3 6.9 2.7 3.0 2.7 3.9 4.3 1.7 3.3 2.8 15.4 9.6 5.2 13.4 12.6 3.3 4.2 2.1 2.2 15.7 2.8 3.0 6.8 10.0 1.9 9.2 14.6 4.7 56.1 4.5 0.0 5.7 16.9 1.7 6.5 15.0 13.2 24.8 21.3 4.4 2.5 11.0 2.6 2.2 17.7 19.7 18.2 13.1 13.7 18.5 15.2 4.5 2.0 15.4 35.1 33.2 11.8 11.9 1.8 17.8 24.9 5.6 23.7 16.6 7.4 1.8 1.5 8.2 13.5 3.0 6.8 5.7 1.3 11.1 6.6 8.5 8.8 9.3 8.9 1.1 2.4 1.8 11.5 4.7 5.6 2.3 FCSK "FLJ39408, FUK" ENSG00000157353 "Fucose kinase" Q8N0W3 16 70454595-70480274 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 2.7;Cardiomyocytes: 4.2;Cytotrophoblasts: 5.5;Extravillous trophoblasts: 3.0;Hofbauer cells: 5.0;Syncytiotrophoblasts: 5.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041971 Approved Approved Vesicles NA NA Vesicles "HPA041971: AB_10795648" "unprognostic (4.55e-1)" "unprognostic (3.21e-1)" "unprognostic (1.73e-2)" "unprognostic (3.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.79e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (4.82e-3)" "unprognostic (4.85e-2)" "prognostic favorable (8.91e-4)" "unprognostic (2.49e-2)" "unprognostic (9.68e-2)" "unprognostic (8.89e-2)" "prognostic favorable (8.38e-4)" 3.7 7.3 5.4 5.4 7.0 5.0 4.9 7.4 7.2 5.4 6.5 6.7 10.2 5.0 2.4 5.6 5.6 3.9 4.3 4.9 5.3 8.9 8.3 4.9 5.4 6.1 5.0 5.4 6.6 8.4 9.1 9.9 3.7 5.5 6.3 3.9 3.0 6.0 4.4 5.6 7.2 7.5 3.1 4.7 6.4 6.7 4.5 5.1 3.8 8.0 2.4 2.8 4.8 4.8 11.0 3.4 4.6 2.5 5.8 1.5 1.8 10.0 1.8 2.8 2.2 3.0 4.2 10.0 2.3 8.8 1.7 0.7 4.8 1.8 4.7 1.6 4.4 6.5 2.9 8.9 4.5 3.7 3.8 2.3 3.0 5.4 2.1 4.4 3.3 4.3 4.6 5.9 2.6 1.8 10.3 4.6 9.2 1.6 5.5 2.7 7.0 0.6 10.4 5.9 5.5 4.0 5.3 10.1 3.7 5.3 1.9 14.8 7.5 5.0 1.8 2.4 4.0 2.2 9.5 5.1 4.8 3.3 3.8 4.2 0.2 1.9 0.8 1.9 1.0 1.6 0.8 1.9 1.9 1.1 1.5 2.6 1.2 1.6 1.2 1.2 1.3 1.4 1.2 5.4 7.0 7.4 7.2 4.9 5.3 6.1 5.0 5.4 5.5 4.7 5.1 11.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 5.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 IL34 "C16orf77, IL-34, MGC34647" ENSG00000157368 "Interleukin 34" Q6ZMJ4 16 70579895-70660682 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 107.2;skin 1: 58.9" "Cell type enhanced" "Detected in many" "Leydig cells: 18.3;Peritubular cells: 40.6;Sertoli cells: 19.7;Suprabasal keratinocytes: 20.5;Theca cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 13 "eosinophil: 18.5" "Lineage enriched" "Detected in single" 185 "granulocytes: 18.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;Hep G2: 2.7;HSkMC: 2.4;NTERA-2: 5.3;U-138 MG: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 57100 "unprognostic (3.76e-3)" "prognostic favorable (7.41e-4)" "unprognostic (5.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.27e-2)" "prognostic favorable (9.69e-4)" "unprognostic (8.19e-2)" "unprognostic (1.59e-3)" "unprognostic (3.83e-2)" "unprognostic (6.11e-3)" "unprognostic (3.18e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.52e-8)" "unprognostic (6.47e-3)" "unprognostic (4.58e-2)" "unprognostic (5.83e-2)" "unprognostic (4.37e-2)" 4.2 23.1 16.8 4.0 18.3 0.1 8.7 8.4 23.5 8.1 19.8 4.0 5.2 2.9 1.0 25.8 3.2 6.7 3.8 22.4 14.5 5.6 2.6 5.0 9.1 12.1 10.8 18.5 1.6 1.9 1.0 12.6 0.5 14.0 6.3 2.2 1.2 16.1 3.8 9.7 58.9 6.5 2.5 8.2 107.2 2.4 3.5 14.8 3.9 5.2 2.6 5.1 4.9 13.5 13.1 0.0 0.6 0.1 0.1 0.2 2.1 0.2 0.1 1.8 0.2 0.2 0.4 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.9 0.0 1.6 2.4 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.3 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.1 0.2 0.0 0.0 0.3 0.7 0.1 1.4 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 18.3 8.4 23.5 22.4 14.5 12.1 10.8 18.5 14.0 8.2 14.8 13.1 2.8 0.0 1.8 2.9 0.1 8.3 1.6 3.4 2.2 1.2 15.7 14.7 0.4 1.5 4.9 0.0 4.2 0.1 0.5 0.0 0.0 7.4 0.2 0.5 0.3 6.1 0.0 0.0 12.7 2.0 0.9 9.0 0.0 0.1 0.0 0.0 3.6 0.1 3.8 5.0 11.4 0.1 2.0 0.0 4.2 0.3 18.3 0.4 12.4 5.6 0.0 15.2 0.0 1.5 1.0 0.8 0.1 40.6 0.1 2.4 0.2 0.3 1.2 0.8 19.7 2.0 8.1 0.1 0.4 7.8 20.5 0.8 0.3 18.8 0.5 1.9 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299780 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 69.4;liver: 61.7" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 10.7 14.9 2.0 2.8 2.1 4.5 13.5 2.3 2.8 13.5 2.6 14.0 21.7 11.6 5.9 69.4 9.5 5.3 5.2 2.0 2.7 14.8 61.7 9.8 4.4 2.4 2.1 1.9 7.0 7.8 13.6 8.9 3.5 2.3 10.2 6.6 1.2 26.5 7.5 3.0 37.6 19.9 5.7 2.3 10.6 11.5 5.5 2.1 4.9 11.8 2.8 9.6 9.0 25.6 2.7 16.6 4.0 4.2 1.7 9.4 10.0 1.1 5.9 12.7 13.4 14.6 1.7 15.7 7.7 2.5 9.3 2.2 14.0 3.2 26.5 6.6 5.4 3.6 2.4 9.1 27.2 4.5 4.8 1.9 8.9 15.9 3.4 2.5 11.2 10.2 6.5 4.9 7.4 11.4 7.0 1.8 1.8 0.7 13.4 6.1 6.0 3.0 10.8 10.5 6.4 3.8 2.7 8.2 11.1 3.0 3.0 5.8 1.4 4.0 1.1 2.6 1.7 2.0 4.1 3.5 3.8 4.9 4.1 1.3 15.1 9.0 18.4 6.5 10.2 7.2 9.9 7.2 6.2 11.1 6.3 7.0 4.0 5.9 5.0 6.2 6.8 12.3 5.2 2.0 2.1 2.3 2.8 2.0 2.7 2.4 2.1 1.9 2.3 2.3 2.1 2.7 17.8 22.4 17.1 8.5 18.4 32.9 26.9 89.9 28.5 12.3 32.4 27.3 19.0 50.1 36.1 35.0 18.8 48.3 26.2 59.6 39.2 27.1 21.7 14.2 6.7 17.1 19.2 16.2 6.9 30.4 9.5 16.5 19.4 18.0 6.3 14.6 14.6 105.4 28.1 15.2 9.2 39.8 40.7 14.6 18.0 34.8 20.2 17.0 46.2 4.7 15.2 16.5 24.7 7.1 14.2 64.1 50.3 20.7 21.8 17.9 178.8 74.8 22.6 47.7 26.3 10.4 16.3 27.3 14.0 80.5 45.7 26.1 23.4 13.7 41.3 35.9 CACNA1D "CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2" ENSG00000157388 "Calcium voltage-gated channel subunit alpha1 D" Q01668 3 53328963-53813733 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "basophil: 3.7" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020215 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA020215: AB_1845860" "unprognostic (5.85e-2)" "unprognostic (4.90e-3)" "unprognostic (5.09e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (2.32e-2)" "unprognostic (2.95e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-3)" "unprognostic (1.53e-1)" "prognostic favorable (8.34e-8)" "unprognostic (1.14e-1)" "unprognostic (3.05e-2)" "unprognostic (8.09e-3)" "unprognostic (6.70e-3)" 0.1 6.6 8.0 0.2 5.4 0.7 1.9 2.7 10.2 6.1 0.0 1.5 1.7 3.8 7.3 0.5 7.8 2.1 0.4 4.3 1.6 2.2 1.0 3.7 0.1 0.8 1.3 5.5 0.5 2.8 1.2 3.5 0.6 3.9 3.0 1.6 4.4 0.5 1.8 0.2 0.7 2.4 0.7 2.1 1.8 0.8 1.6 6.2 0.2 2.9 0.2 0.1 0.6 0.1 7.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.1 0.1 0.0 0.4 0.9 0.0 0.0 0.2 55.5 0.5 3.6 4.7 2.1 0.3 10.1 1.1 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 5.4 2.7 10.2 4.3 1.6 0.8 1.3 5.5 3.9 2.1 6.2 7.0 0.6 3.2 36.2 7.8 0.6 0.9 0.8 4.6 2.2 33.3 7.2 1.8 2.3 10.0 9.1 1.8 35.5 0.9 0.5 3.0 0.0 7.2 4.9 4.3 40.1 2.4 59.4 2.7 251.2 2.3 0.2 3.4 5.1 3.3 12.6 1.7 0.0 3.4 0.2 8.4 354.1 3.8 2.0 0.8 4.0 8.3 4.4 2.1 5.4 126.5 0.5 4.0 0.0 197.5 29.9 3.8 5.6 27.1 0.1 1.7 9.5 2.7 9.5 12.9 0.0 0.2 8.6 1.0 3.7 0.5 1.0 0.3 1.7 9.6 7.6 0.9 ARSL "ARSE, CDPX, CDPX1" ENSG00000157399 "Arylsulfatase L" P51690 X 2934521-2968475 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 37.0;liver: 87.0;pancreas: 106.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "liver cancer: 34.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.4 0.7 2.2 2.2 2.3 0.3 1.1 2.0 2.8 1.7 4.2 21.0 18.0 3.2 2.2 0.4 4.2 8.3 1.0 2.4 5.5 37.0 87.0 2.7 0.1 2.5 2.4 1.8 7.2 106.1 0.0 0.8 0.7 2.8 0.5 16.8 0.3 1.3 2.9 0.2 0.2 13.7 1.9 2.1 0.0 2.9 0.4 2.3 0.0 0.2 0.3 0.1 0.5 1.6 2.1 4.5 68.9 8.2 0.0 3.3 4.0 1.3 3.9 6.4 4.0 4.0 42.7 0.0 0.0 13.7 0.1 30.8 0.0 0.0 0.9 2.3 0.0 4.5 0.0 0.0 64.1 1.8 0.0 0.1 9.6 0.0 3.8 0.0 7.3 3.8 0.0 0.0 0.1 10.5 0.1 0.0 0.0 33.6 2.4 0.2 2.8 1.1 0.3 7.1 0.0 0.1 0.2 0.0 0.0 2.6 13.7 0.0 0.2 5.0 0.1 0.2 0.0 7.4 0.0 0.0 0.1 9.1 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 2.0 2.8 2.4 5.5 2.5 2.4 1.8 2.8 2.1 2.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KIT "C-Kit, CD117, PBT, SCFR" ENSG00000157404 "KIT proto-oncogene, receptor tyrosine kinase" P10721 4 54657918-54740715 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 116.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7" "Cancer enhanced" "Detected in many" "testis cancer: 28.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1" "Group enriched" "Detected in many" 7 "granulocytes: 20.3;NK-cells: 13.1" "Group enriched" "Detected in many" 13 "HEL: 247.2;HMC-1: 496.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003288, HPA004471, CAB068253, CAB072867, HPA073252" Enhanced Supported Supported "Plasma membrane" NA NA 49000000 "Plasma membrane" "CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (4.04e-2)" "unprognostic (8.19e-2)" "unprognostic (3.96e-2)" "unprognostic (2.18e-2)" "unprognostic (2.33e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.20e-1)" "unprognostic (1.92e-2)" "prognostic favorable (5.63e-4)" "unprognostic (1.34e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 5.8 1.9 7.7 5.4 4.9 6.5 116.1 21.5 6.4 17.7 4.3 13.7 9.3 9.7 6.0 13.1 2.9 20.5 3.4 20.0 5.7 12.5 0.8 22.0 3.4 5.9 13.8 3.7 45.4 2.6 1.7 1.9 10.1 8.6 5.7 16.1 3.2 21.5 8.8 1.1 24.7 13.5 10.2 4.2 5.0 17.5 6.3 15.8 3.1 47.6 7.0 6.3 14.6 4.9 4.9 0.0 0.0 3.9 0.0 0.7 0.3 0.0 3.3 4.6 12.6 15.8 0.0 0.0 0.0 0.0 7.3 0.6 0.3 2.6 0.0 10.8 0.0 5.9 247.2 0.0 0.0 0.0 0.0 496.2 0.0 0.0 0.0 0.0 0.0 28.4 4.3 3.5 0.5 0.0 0.0 1.4 2.5 6.9 0.0 0.0 0.8 0.0 0.0 0.0 24.2 6.0 2.1 0.0 0.0 0.0 14.1 0.0 2.6 0.3 0.5 0.0 4.9 0.1 0.4 0.0 0.0 0.5 0.9 0.6 20.3 0.0 12.8 0.1 0.0 2.3 0.0 0.4 0.9 2.3 0.0 0.0 0.0 1.0 13.1 1.4 0.1 0.0 0.2 7.7 4.9 21.5 6.4 20.0 5.7 5.9 13.8 3.7 8.6 4.2 15.8 4.9 7.3 6.4 21.9 9.8 1.0 14.3 0.9 0.4 2.2 4.5 83.1 59.2 0.7 4.3 3.6 3.7 0.0 0.1 5.2 0.4 3.9 1.0 0.0 0.2 0.7 9.2 5.4 15.5 0.9 0.0 0.1 2.8 8.6 0.7 529.3 0.5 1.8 0.0 0.3 0.0 111.2 0.5 101.7 0.3 4.2 0.4 1.2 1.6 211.7 14.0 0.2 2.4 0.0 16.1 3.7 0.0 0.1 0.0 3.2 0.5 0.0 0.8 0.1 0.2 0.0 0.7 0.8 0.1 12.3 2.2 3.8 0.3 8.8 63.7 0.6 0.3 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN axonemal central pair apparatus protein" Q4G0P3 16 70802084-71230722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;choroid plexus: 20.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 150.6;Excitatory neurons: 49.2;Respiratory ciliated cells: 153.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.8;RPTEC TERT1: 2.8;SiHa: 5.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA067155: AB_2685792, HPA074129: AB_2686665" "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.2 0.3 8.7 0.3 3.4 0.5 0.5 3.1 2.7 1.0 20.1 0.5 0.2 0.9 2.0 0.1 5.3 0.5 0.4 3.8 10.3 1.3 0.5 1.4 0.3 7.8 8.1 1.6 1.1 0.7 2.5 4.4 0.1 5.4 0.8 0.1 6.4 0.3 0.3 0.1 0.5 0.3 0.1 9.9 0.4 0.2 4.7 3.5 0.0 1.9 0.0 0.0 0.5 0.4 4.7 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.1 1.8 0.3 0.1 0.1 0.6 0.2 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.4 0.0 1.1 0.2 0.0 0.0 0.0 0.4 0.4 0.7 0.0 0.4 0.1 0.1 0.4 2.8 0.4 1.1 0.2 5.3 0.1 0.2 0.1 0.3 0.0 0.2 0.1 0.4 0.0 0.1 0.9 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.7 0.1 0.3 0.2 0.1 0.0 8.7 3.4 3.1 2.7 3.8 10.3 7.8 8.1 1.6 5.4 9.9 3.5 4.7 0.1 3.2 2.6 35.3 0.0 0.0 0.2 2.6 0.0 17.0 1.5 1.1 2.5 0.0 18.3 9.2 52.1 0.0 0.4 0.0 1.9 2.5 35.4 150.6 6.5 0.7 3.5 0.0 49.2 0.6 0.0 1.4 0.0 4.0 0.0 5.0 0.0 0.0 0.1 0.0 25.9 0.1 4.1 0.0 0.0 31.5 2.5 0.3 3.6 3.7 0.0 9.3 0.0 26.2 21.8 0.3 0.1 4.5 0.1 0.6 0.0 1.8 153.2 30.5 0.0 2.0 1.7 17.7 7.5 0.0 0.0 0.0 0.5 1.6 0.1 0.2 AASDH "ACSF4, LYS2, NRPS998" ENSG00000157426 "Aminoadipate-semialdehyde dehydrogenase" Q4L235 4 56338287-56387508 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036472, HPA036473" Approved NA NA "HPA036472: AB_2675142, HPA036473: AB_10673656" "unprognostic (1.95e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (5.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (8.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-3)" "unprognostic (1.59e-1)" "unprognostic (1.73e-1)" "unprognostic (4.52e-2)" "unprognostic (1.85e-3)" 4.3 5.0 4.0 4.7 4.3 4.6 8.5 5.9 4.2 5.9 3.7 4.5 4.5 6.5 8.2 4.6 7.0 4.4 3.8 3.4 3.9 6.7 6.5 4.6 6.5 4.5 4.3 3.2 8.5 3.8 7.2 4.2 5.0 4.4 6.5 5.8 11.9 5.6 5.5 4.2 7.2 4.2 5.7 3.9 5.9 4.7 5.1 3.7 6.2 7.2 4.2 6.8 4.3 4.4 5.2 5.0 3.3 8.6 6.6 12.8 14.7 5.3 6.2 7.5 6.3 5.4 3.8 10.2 10.9 5.7 6.8 4.8 3.1 6.3 6.3 7.0 4.4 6.3 5.1 6.3 4.9 11.4 9.4 3.7 8.5 10.2 6.7 10.0 9.1 9.8 6.9 11.9 5.4 7.2 4.9 11.1 7.8 4.8 9.1 4.8 8.2 4.2 5.1 9.0 4.2 5.7 5.5 7.1 11.2 7.2 8.1 8.9 6.0 6.7 4.2 5.6 4.4 4.5 4.3 3.6 7.1 6.6 8.4 4.6 0.0 2.0 1.6 2.8 2.5 3.7 2.4 2.8 2.4 2.2 3.0 4.0 3.0 0.4 2.8 1.6 1.9 2.9 1.3 4.0 4.3 5.9 4.2 3.4 3.9 4.5 4.3 3.2 4.4 3.9 3.7 5.2 14.1 6.4 16.2 59.4 17.3 10.1 13.9 26.0 13.6 38.7 21.7 21.2 10.1 14.3 17.3 18.4 27.1 40.7 22.8 9.4 25.4 9.9 26.0 22.0 28.6 13.9 12.1 24.0 26.9 7.6 19.4 17.9 14.8 21.0 20.3 26.4 19.6 21.9 15.4 35.3 36.7 14.7 22.4 17.6 8.7 5.2 16.8 12.6 10.6 19.7 21.5 31.3 20.6 36.2 39.1 6.0 13.4 18.0 9.9 14.2 8.0 29.2 11.2 56.4 6.6 22.5 11.9 43.3 35.0 13.6 15.6 23.9 16.5 23.8 15.9 8.1 ZNF19 "KOX12, MGC51021" ENSG00000157429 "Zinc finger protein 19" P17023 16 71464555-71565089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.9;Spermatocytes: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA063685 Approved Approved Mitochondria NA NA Mitochondria "HPA063685: AB_2685090" "unprognostic (5.59e-4)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-4)" "unprognostic (6.02e-3)" "unprognostic (4.92e-2)" "unprognostic (3.34e-2)" "unprognostic (6.97e-3)" "unprognostic (2.23e-1)" "unprognostic (4.84e-2)" "unprognostic (8.90e-4)" "unprognostic (1.31e-1)" "unprognostic (3.04e-6)" "unprognostic (3.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.83e-2)" "unprognostic (4.87e-2)" 3.4 3.2 3.0 2.4 3.4 2.6 3.6 2.5 6.2 2.1 2.7 2.4 3.8 4.0 8.4 4.4 8.3 6.5 4.4 4.8 1.1 3.6 2.3 4.4 3.1 2.1 0.6 2.1 4.2 6.3 4.4 5.3 1.9 1.6 3.3 2.1 11.4 3.4 2.1 9.8 6.5 3.2 1.5 0.0 2.7 2.9 16.3 1.1 1.1 8.3 1.8 1.4 1.7 0.7 5.9 1.2 1.0 2.9 2.8 1.3 0.9 2.0 1.9 0.9 1.1 1.2 2.1 3.9 1.7 2.1 0.9 2.0 1.4 1.4 1.7 0.4 1.3 1.3 2.3 2.2 3.2 0.8 2.3 1.9 2.1 1.8 1.5 3.2 2.5 0.5 3.0 1.3 2.1 1.4 1.8 1.6 1.5 1.5 0.7 2.5 1.0 2.5 0.6 1.6 2.2 4.0 3.0 3.3 1.1 2.6 1.9 2.2 1.8 1.0 3.3 1.7 2.1 1.8 1.9 1.9 0.4 2.7 1.3 1.8 2.3 0.9 0.8 1.1 0.8 0.3 2.1 1.2 1.1 0.7 2.4 1.5 1.4 1.7 0.9 1.0 1.3 0.5 0.6 3.0 3.4 2.5 6.2 4.8 1.1 2.1 0.6 2.1 1.6 0.0 1.1 5.9 1.4 0.0 3.2 3.9 3.7 0.3 2.0 2.1 1.2 3.8 3.1 1.8 1.2 1.5 2.3 1.8 10.4 1.4 2.3 1.8 5.9 4.4 7.3 6.3 1.3 1.6 1.2 3.6 1.7 1.4 0.8 2.1 0.5 1.2 0.0 5.0 2.2 4.1 1.4 10.1 1.6 2.0 2.0 1.0 1.6 4.4 0.6 0.9 0.0 2.8 1.3 3.5 0.0 2.0 2.1 2.2 1.7 1.9 0.8 1.3 3.6 3.3 10.0 25.9 6.6 2.2 2.0 15.3 7.6 0.8 0.6 0.5 1.8 3.4 1.5 1.0 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.5;skeletal muscle: 10.0;tongue: 10.8" "Cell type enhanced" "Detected in many" "Astrocytes: 160.9;Excitatory neurons: 828.3;Inhibitory neurons: 456.4;Oligodendrocyte precursor cells: 317.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.1;HAP1: 1.9;HeLa: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm NA NA 69000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 0.2 4.1 5.6 0.1 10.0 0.0 0.2 0.1 17.5 0.2 0.0 0.4 0.1 0.1 1.3 0.5 0.4 0.2 2.0 11.2 6.1 1.3 0.0 0.5 0.6 3.6 12.3 7.4 2.5 0.0 0.3 0.8 0.5 4.0 1.0 0.3 2.9 0.4 1.5 10.0 0.0 0.3 0.6 0.1 0.2 0.4 1.4 4.4 0.1 0.5 10.8 0.5 0.1 0.4 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.1 0.1 9.2 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 10.0 0.1 17.5 11.2 6.1 3.6 12.3 7.4 4.0 0.1 4.4 11.5 0.5 0.0 0.0 160.9 0.6 0.3 0.4 0.2 7.4 10.8 0.2 0.5 30.2 0.0 0.7 0.0 8.4 9.9 5.5 0.1 7.9 0.0 83.4 0.9 0.8 0.6 0.0 1.3 828.3 0.6 3.2 3.4 1.5 1.8 0.0 1.1 0.4 0.0 5.9 0.0 456.4 0.0 2.0 8.9 2.7 56.1 2.8 11.0 0.0 97.4 22.2 5.0 0.0 317.7 11.3 1.2 0.0 1.5 0.1 0.4 0.0 0.2 0.8 1.4 6.6 1.7 1.9 5.7 2.9 3.4 0.1 68.0 0.7 0.8 0.0 0.4 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 81.6;Inhibitory neurons: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 8.3 7.6 1.2 11.9 2.3 17.4 7.9 8.0 5.0 8.7 0.7 7.2 8.4 9.1 6.8 11.5 8.7 9.3 7.4 2.2 2.7 8.9 10.6 8.5 10.9 0.8 1.3 0.4 11.5 9.3 12.0 4.3 11.5 2.3 8.8 7.3 12.7 8.2 8.4 9.6 7.9 8.0 8.4 0.7 11.1 9.1 9.5 1.8 11.6 11.7 11.9 13.4 10.4 7.3 3.4 13.8 31.3 19.6 16.8 16.6 18.5 16.7 17.6 20.6 17.2 22.0 13.9 8.9 16.8 19.4 24.8 14.7 26.3 5.3 13.1 21.3 17.6 11.1 20.9 12.6 10.7 18.0 12.3 22.6 14.7 14.0 18.6 20.4 15.6 19.5 15.4 19.7 16.4 21.5 6.7 16.3 7.9 16.1 4.3 12.0 16.2 27.9 13.8 13.1 24.2 16.0 23.3 15.8 15.5 14.7 22.7 12.2 14.9 22.6 27.4 22.8 14.5 17.1 11.8 17.3 19.9 16.7 19.5 21.1 11.4 15.0 15.7 7.0 11.0 7.1 11.8 7.2 6.5 8.3 10.9 7.9 6.3 41.0 5.6 13.0 7.9 10.0 3.4 1.2 2.3 8.0 5.0 2.2 2.7 0.8 1.3 0.4 2.3 0.7 1.8 3.4 11.7 3.2 14.4 34.6 31.9 20.1 12.3 7.3 26.7 12.2 13.0 10.2 19.7 7.2 10.6 12.9 8.4 9.0 12.8 10.0 3.9 12.6 27.6 14.4 15.1 15.3 16.2 11.6 81.6 6.9 10.5 15.0 17.3 15.8 15.8 12.3 17.9 11.2 13.4 10.1 80.4 10.0 12.2 19.8 15.7 7.5 7.8 21.2 12.4 56.2 22.7 8.4 16.5 65.4 66.2 12.9 11.4 14.7 19.5 14.5 11.6 9.9 14.9 13.6 26.3 15.1 13.6 13.8 8.9 27.3 19.9 32.0 21.4 11.8 9.2 21.2 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105126-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 75.3;lymphoid tissue: 73.8;testis: 70.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 5 "T-reg: 22.7" "Lineage enriched" "Detected in many" 6 "T-cells: 22.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 1.0 1.1 0.5 12.3 0.9 75.3 3.0 0.6 0.6 1.8 0.9 14.5 14.2 2.6 0.3 16.3 1.1 1.9 0.6 0.4 0.8 1.1 1.4 2.2 33.3 1.0 1.1 0.0 0.8 0.7 0.2 0.3 11.5 1.1 1.6 17.0 0.4 2.8 0.4 0.7 9.5 12.1 6.5 0.7 7.2 5.6 70.1 0.9 73.8 1.0 0.4 44.0 3.7 5.6 2.1 132.5 112.1 188.6 47.1 8.5 16.6 97.5 104.8 69.9 165.2 135.6 187.8 81.1 122.1 75.4 71.8 97.2 160.1 181.4 92.6 157.8 124.1 92.4 153.1 127.3 108.1 2.5 118.1 98.6 6.3 12.6 71.4 91.9 32.7 114.1 147.0 163.1 194.5 128.2 96.5 137.9 177.2 138.6 58.5 65.2 157.5 260.0 124.4 53.3 91.9 115.2 75.9 148.9 80.2 97.3 147.9 139.4 120.4 58.5 81.6 134.4 90.5 210.5 84.2 133.2 213.8 53.6 267.1 117.9 0.0 0.1 0.7 0.1 0.0 0.3 2.1 4.6 5.0 3.0 1.7 0.0 0.1 0.8 3.6 0.1 0.1 22.7 2.1 0.5 0.9 0.6 0.6 0.4 0.8 1.0 1.1 0.0 1.1 0.7 0.9 2.1 0.3 0.0 0.6 0.0 6.8 4.8 2.8 11.5 1.8 0.2 2.5 3.3 0.5 0.0 3.2 0.0 0.0 67.9 1.6 4.1 0.0 0.7 228.5 5.3 3.1 3.9 3.0 123.6 0.7 0.2 128.3 7.2 7.1 5.9 0.0 29.9 6.1 1.1 29.9 0.0 0.8 10.1 20.3 10.6 3.3 53.5 4.4 7.9 0.0 0.0 2.4 0.2 1.0 0.0 1.4 0.4 1.9 1.9 18.7 2.3 2.1 0.0 1.8 0.3 0.0 1.0 5.7 288.7 32.1 20.3 6.1 16.3 4.4 4.1 23.4 5.0 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523555 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2" "Group enriched" "Detected in many" 5 "Collecting duct cells: 31.3;Excitatory neurons: 83.0;Inhibitory neurons: 67.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 5.1;plasmacytoid DC: 11.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.7" "Cell line enriched" "Detected in many" 4 "Daudi: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 0.4 0.1 6.6 2.4 12.9 0.2 1.4 0.2 17.2 6.7 0.7 4.3 2.4 2.5 4.4 0.4 6.2 1.6 1.5 10.8 5.4 6.8 0.4 0.7 4.9 2.7 1.3 8.2 0.6 1.9 1.1 2.6 0.8 3.5 2.4 5.2 1.3 2.6 1.5 0.5 0.9 1.4 1.2 0.1 1.4 2.4 1.8 5.0 0.5 2.1 2.8 5.6 0.4 0.4 9.9 10.5 15.0 1.1 0.2 0.4 0.2 6.0 0.6 0.0 1.0 2.8 1.8 1.7 66.5 0.3 0.2 14.1 7.8 8.3 2.5 1.9 0.7 4.3 0.0 10.6 0.8 0.0 5.7 1.3 0.0 1.5 0.4 0.8 0.8 0.1 2.7 0.1 0.0 1.0 3.5 0.1 0.1 0.9 2.7 5.4 1.5 14.8 1.7 3.3 3.8 3.0 0.8 6.0 0.3 9.9 0.6 2.5 3.4 0.3 2.4 7.4 2.9 11.4 0.1 0.0 0.8 2.5 2.2 6.7 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.1 2.3 0.0 0.0 0.3 0.1 0.0 11.7 0.0 0.3 6.6 12.9 0.2 17.2 10.8 5.4 2.7 1.3 8.2 3.5 0.1 5.0 9.9 0.2 0.0 1.3 11.4 2.5 0.5 1.4 0.2 0.6 0.0 2.4 2.4 6.9 0.0 1.0 31.3 0.0 0.1 0.0 1.7 5.9 0.5 0.5 11.2 0.9 0.7 1.2 1.3 83.0 0.2 1.6 0.6 1.1 1.5 1.3 0.2 0.4 0.2 1.3 10.1 67.0 1.9 2.0 0.6 1.5 1.4 0.3 0.7 8.8 4.7 0.7 1.1 0.0 2.5 8.1 0.4 1.9 0.0 1.2 1.4 0.8 0.3 8.4 0.2 0.0 1.1 3.1 0.2 1.6 1.5 0.4 0.0 0.4 0.2 4.0 1.0 MYO1E "HuncM-IC, MGC104638, MYO1C" ENSG00000157483 "Myosin IE" Q12965 15 59132434-59372871 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 319.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 23.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 224.1;HaCaT: 208.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003003, HPA023886" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 13000 "Nucleoplasm, Plasma membrane" Cytosol "HPA003003: , HPA023886: AB_1854253" "unprognostic (7.90e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.49e-1)" "unprognostic (3.59e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (5.38e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (2.41e-1)" "unprognostic (7.92e-2)" "unprognostic (7.31e-2)" "unprognostic (9.71e-2)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" 26.4 7.2 28.3 33.2 35.3 1.8 19.6 36.3 31.0 27.8 45.7 54.8 25.5 31.3 29.9 37.9 17.5 39.0 12.2 22.4 29.5 37.5 52.7 20.0 37.2 39.7 38.0 15.7 10.4 12.1 22.6 9.3 35.0 39.8 23.1 34.8 10.0 18.9 21.8 12.0 41.1 44.5 22.4 35.9 17.2 32.8 8.4 34.2 7.7 15.4 11.0 41.5 38.5 28.4 61.5 133.3 224.1 12.1 8.2 92.4 74.8 62.2 52.9 25.7 28.8 33.6 55.7 50.5 52.7 37.0 41.3 117.5 208.6 18.9 81.5 38.2 24.1 10.5 0.5 178.4 50.3 85.5 0.3 7.2 103.4 48.8 37.0 107.4 90.7 47.8 0.9 0.3 0.8 49.2 12.4 0.6 1.2 29.3 21.5 49.8 0.2 53.8 32.4 156.9 61.8 6.5 21.9 117.1 24.2 45.8 36.5 16.3 5.8 58.4 57.5 16.6 177.1 52.0 0.3 3.3 1.3 105.4 0.6 53.2 0.0 4.5 0.0 0.2 4.6 0.0 9.2 0.0 0.0 15.4 8.6 0.0 0.0 0.6 3.6 1.6 23.7 0.5 2.5 28.3 35.3 36.3 31.0 22.4 29.5 39.7 38.0 15.7 39.8 35.9 34.2 61.5 31.0 6.4 7.7 27.1 19.6 24.9 40.0 24.7 24.5 0.2 9.3 10.2 3.9 17.2 15.4 25.8 0.0 4.3 19.9 73.6 3.9 39.8 4.2 49.4 30.2 30.4 19.7 2.5 9.3 18.1 23.8 14.9 86.6 47.3 4.5 6.7 5.0 13.0 33.5 0.0 8.7 31.2 8.2 5.0 50.1 8.5 9.3 17.6 19.6 56.2 9.0 11.3 3.1 6.6 319.1 64.0 60.0 12.0 9.2 28.3 37.4 3.1 40.9 0.9 13.1 33.7 25.0 1.3 5.1 30.1 24.0 12.9 4.7 6.7 29.3 56.9 APPL1 APPL ENSG00000157500 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1" Q9UKG1 3 57227726-57278105 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive B-cell: 28.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011138 Approved Approved "Vesicles,Plasma membrane,Actin filaments,Cytosol" NA No 10000 "Vesicles, Plasma membrane" "Actin filaments, Cytosol" "HPA011138: AB_1844959" "unprognostic (1.39e-1)" "unprognostic (3.45e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (3.68e-2)" "unprognostic (2.31e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (5.55e-2)" "prognostic favorable (7.26e-5)" "unprognostic (3.99e-2)" "unprognostic (8.76e-2)" "unprognostic (1.12e-2)" "unprognostic (1.55e-1)" 15.7 11.7 10.8 14.9 11.0 15.2 19.1 14.1 11.4 17.2 8.1 14.4 12.7 17.3 10.7 17.1 11.9 13.1 24.9 10.6 12.4 16.6 13.0 13.7 16.8 10.8 11.7 9.2 22.9 29.8 25.3 7.8 14.4 11.4 15.1 14.1 13.6 15.3 14.5 44.6 20.3 14.7 15.4 11.4 15.9 15.3 8.0 11.3 19.1 19.9 26.8 19.7 13.5 12.0 11.9 30.2 12.9 12.2 45.4 21.2 29.7 26.2 15.5 9.5 15.4 17.8 14.9 17.5 47.3 6.2 24.6 24.7 5.9 33.7 27.3 26.6 36.1 15.0 27.6 19.5 16.1 22.7 59.6 19.1 21.8 24.3 19.3 21.3 31.3 25.3 30.2 9.0 30.0 17.8 10.4 48.7 15.4 19.5 21.6 21.7 1.7 49.1 26.1 27.7 16.7 12.5 26.5 21.1 32.3 21.0 16.7 15.7 39.6 23.4 25.1 17.5 37.4 29.9 27.0 41.8 33.2 27.4 29.1 17.1 2.0 5.3 3.8 3.7 4.5 4.9 17.9 3.8 3.3 10.9 28.3 3.3 2.5 1.4 7.4 3.6 18.0 1.9 2.7 10.8 11.0 14.1 11.4 10.6 12.4 10.8 11.7 9.2 11.4 11.4 11.3 11.9 82.9 51.3 45.5 19.6 106.6 52.9 47.3 46.9 83.6 40.5 67.2 92.8 100.1 47.1 47.4 42.3 31.3 46.9 70.9 29.0 58.7 58.6 42.5 35.4 92.8 66.2 45.6 20.0 49.7 60.3 44.7 68.6 40.2 59.4 23.4 60.8 40.0 44.1 52.2 52.2 50.4 36.2 42.7 68.6 50.6 22.1 73.0 71.0 19.6 33.7 87.8 56.6 56.7 43.2 62.2 51.7 25.5 76.0 62.8 38.7 41.0 58.8 18.1 55.4 52.6 94.3 61.2 64.9 44.2 105.7 69.6 28.0 45.4 73.7 49.1 25.8 PWWP3B "FLJ33516, MUM1L1" ENSG00000157502 "PWWP domain containing 3B" Q5H9M0 X 106168305-106208956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "ovary: 191.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.2;Cytotrophoblasts: 1.9;Endothelial cells: 1.7;Fibroblasts: 4.0;Syncytiotrophoblasts: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;HHSteC: 1.6;HSkMC: 2.9;LHCN-M2: 5.5;NTERA-2: 2.1;SuSa: 1.5;T-47d: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000168, HPA020464" Enhanced NA NA "HPA000168: AB_1079431, HPA020464: AB_1854209" "unprognostic (2.79e-1)" "unprognostic (1.08e-2)" "unprognostic (3.83e-2)" "unprognostic (6.08e-2)" "unprognostic (5.06e-2)" "unprognostic (4.12e-6)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.86e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (8.43e-3)" "unprognostic (2.11e-5)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.53e-2)" 1.9 3.7 5.2 0.0 4.7 0.0 1.0 0.8 6.8 11.2 0.9 0.1 0.0 16.0 9.4 0.3 13.6 1.2 4.4 4.7 9.4 1.4 1.6 0.5 0.0 3.5 3.4 4.2 191.6 28.3 0.7 6.2 0.5 5.1 2.4 0.1 0.1 0.2 3.6 11.0 0.1 0.1 3.2 1.2 0.0 1.2 18.2 7.7 0.0 10.4 9.3 0.0 0.3 2.2 4.9 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 1.5 1.9 0.0 0.0 0.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.7 0.8 6.8 4.7 9.4 3.5 3.4 4.2 5.1 1.2 7.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 AFAP1L1 FLJ36748 ENSG00000157510 "Actin filament associated protein 1 like 1" Q8TED9 5 149271859-149343637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 31.9" "Cell type enhanced" "Detected in many" "Adipocytes: 62.4;Cardiomyocytes: 39.3;Early spermatids: 105.4;Endothelial cells: 72.0;Extravillous trophoblasts: 47.1;Hepatic stellate cells: 47.2;Late spermatids: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 42.6;HUVEC TERT2: 20.8;TIME: 33.9;WM-115: 79.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.91e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.20e-1)" "unprognostic (3.44e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-3)" "unprognostic (5.25e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" "unprognostic (4.00e-1)" "unprognostic (9.64e-2)" "unprognostic (3.07e-3)" "unprognostic (1.52e-3)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (9.88e-2)" 21.5 2.8 2.0 2.2 0.9 0.1 15.3 1.0 1.2 3.9 0.8 3.3 0.8 7.2 0.6 4.3 10.2 4.0 26.3 0.8 1.0 4.1 2.1 13.4 2.3 1.4 1.0 0.4 3.3 1.0 6.1 2.4 14.5 1.1 3.3 0.7 1.4 3.4 1.9 31.9 5.2 3.4 3.5 0.9 2.9 2.4 2.3 2.4 3.4 7.4 16.7 0.8 4.7 3.7 1.6 7.0 2.4 0.1 0.3 9.9 2.1 42.6 1.5 5.5 5.4 8.9 0.1 4.1 0.0 3.3 2.5 13.7 1.4 0.8 6.2 2.2 0.0 1.0 1.6 0.9 0.0 5.2 0.0 0.1 7.3 1.0 3.0 11.6 4.3 20.8 0.0 0.0 0.2 2.1 0.0 0.0 0.0 1.0 0.0 5.4 0.0 0.0 0.0 3.5 1.1 0.7 1.1 4.4 0.1 14.8 1.5 0.2 0.4 33.9 2.5 7.7 0.1 1.2 0.0 0.0 0.0 0.5 0.1 79.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.0 0.9 1.0 1.2 0.8 1.0 1.4 1.0 0.4 1.1 0.9 2.4 1.6 62.4 0.0 1.3 0.3 0.2 1.5 1.4 4.6 0.0 0.3 0.4 0.5 39.3 1.5 4.1 0.0 0.0 14.2 0.2 0.0 0.0 0.3 105.4 0.3 0.4 72.0 0.0 0.0 2.9 0.0 47.1 4.5 0.0 0.2 1.3 0.0 47.2 0.6 2.7 0.0 1.2 0.0 0.0 4.2 1.3 50.4 9.6 0.7 7.2 10.3 0.0 0.5 0.0 2.0 0.3 0.0 0.0 15.8 0.0 4.0 0.0 0.8 6.4 5.3 13.1 4.6 4.0 0.5 4.8 0.3 1.4 6.4 0.5 1.8 0.0 5.4 TSC22D3 "DIP, DSIPI, GILZ, hDIP, TSC-22R" ENSG00000157514 "TSC22 domain family member 3" Q99576 X 107713221-107777342 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 1234.8;dendritic cells: 1146.4;Plasma cells: 2348.5;T-cells: 1479.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 380.5;ASC TERT1: 259.7;HHSteC: 628.0;hTCEpi: 572.7;Karpas-707: 364.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001916, CAB034364" Approved Approved "Nuclear speckles,Golgi apparatus,Cytosol" NA NA Cytosol "Nuclear speckles, Golgi apparatus" "CAB034364: AB_2272198, HPA001916: AB_2666504" "unprognostic (3.67e-2)" "unprognostic (3.90e-3)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.49e-2)" "unprognostic (3.21e-2)" "unprognostic (3.73e-3)" "unprognostic (4.40e-2)" "unprognostic (9.42e-2)" "unprognostic (5.32e-2)" "unprognostic (3.25e-1)" "unprognostic (7.47e-2)" "unprognostic (6.38e-2)" "unprognostic (1.37e-3)" "unprognostic (6.41e-2)" "unprognostic (4.14e-1)" "unprognostic (9.64e-2)" 468.6 242.8 98.2 398.3 98.4 437.3 451.1 105.3 105.8 337.5 113.0 291.3 88.0 271.5 72.6 303.2 373.0 168.5 258.6 90.5 106.3 191.6 178.9 527.2 283.3 106.4 113.4 84.6 374.2 114.8 56.2 137.3 165.1 117.9 407.8 185.3 22.7 336.1 162.0 735.3 487.1 429.9 180.2 99.1 411.5 393.6 44.1 107.3 205.0 315.6 189.4 341.1 512.6 491.0 105.7 10.9 18.2 9.3 25.7 380.5 259.7 3.7 16.9 14.1 7.8 8.6 0.1 35.8 23.4 40.1 13.7 5.5 53.5 19.1 54.2 3.3 7.0 9.0 11.5 76.9 1.0 628.0 2.5 37.7 238.8 572.7 6.1 158.7 78.8 29.3 2.5 3.6 364.1 67.2 37.8 0.7 40.5 16.3 11.5 11.7 1.2 23.5 51.3 26.1 7.3 2.4 20.3 16.6 89.2 128.8 16.9 17.0 52.4 44.1 23.6 7.1 4.8 3.4 79.6 37.8 11.2 12.0 46.7 6.7 668.9 417.2 1653.1 649.7 524.1 484.2 584.0 740.6 641.5 399.5 559.6 686.3 643.0 2396.6 968.4 851.8 81.4 1080.9 1624.1 98.2 98.4 105.3 105.8 90.5 106.3 106.4 113.4 84.6 117.9 99.1 107.3 105.7 423.5 64.1 164.7 10.4 1234.8 110.0 82.8 129.7 435.4 52.0 97.0 47.5 31.8 70.1 106.9 47.8 0.0 3.2 1146.4 26.2 232.8 28.3 28.8 24.2 40.9 171.7 64.2 481.5 13.1 22.2 140.5 454.2 200.3 29.7 353.2 15.3 247.0 95.6 121.3 62.2 12.9 32.9 83.4 396.3 191.8 41.2 230.5 539.1 437.6 16.9 126.0 8.9 234.8 37.7 23.7 22.7 19.6 319.7 2348.5 106.5 58.6 48.6 61.0 19.1 433.9 245.4 248.3 24.1 15.3 182.6 79.1 9.9 1479.6 89.6 33.0 42.2 VPS26C "DCRA, DSCR3" ENSG00000157538 "VPS26 endosomal protein sorting factor C" O14972 21 37223420-37267919 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 26.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 26.4;Hofbauer cells: 32.7;Pancreatic endocrine cells: 33.2;Proximal tubular cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023288 Uncertain Approved Mitochondria NA NA Mitochondria "HPA023288: AB_1847872" "unprognostic (1.01e-3)" "unprognostic (6.42e-2)" "unprognostic (7.96e-3)" "unprognostic (2.15e-2)" "unprognostic (4.10e-3)" "unprognostic (2.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "unprognostic (7.76e-2)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.54e-4)" "unprognostic (1.72e-1)" "unprognostic (3.24e-1)" "unprognostic (5.24e-2)" "unprognostic (3.16e-1)" 18.9 24.7 14.8 18.7 15.6 21.6 15.9 16.5 15.9 16.4 15.7 26.9 28.2 14.9 11.5 21.4 13.9 19.8 25.1 14.1 15.3 33.2 29.8 22.3 22.7 16.1 15.8 13.6 17.6 22.8 17.8 8.7 21.5 16.2 14.4 26.3 13.8 17.1 15.9 31.8 15.0 27.2 20.0 16.9 20.4 21.4 7.6 16.8 28.3 18.3 38.1 23.8 22.1 14.3 17.5 31.8 13.8 30.2 26.5 55.4 49.4 34.3 29.9 66.2 26.6 40.2 19.2 32.7 22.0 11.7 70.0 63.9 15.0 32.6 32.1 26.1 52.8 23.5 37.6 13.6 18.7 49.1 27.8 24.3 43.5 31.2 31.0 50.4 48.1 51.4 40.5 24.0 46.8 52.5 14.1 47.2 23.7 34.4 48.7 13.8 44.8 14.5 32.5 32.8 23.7 24.4 32.6 20.6 40.9 65.5 39.0 38.4 22.0 41.0 30.6 10.8 33.2 18.5 71.3 78.0 30.3 48.3 47.9 35.2 58.6 48.6 84.9 50.7 60.5 46.8 37.5 43.1 45.4 47.7 29.4 39.8 41.0 50.1 52.9 55.7 19.4 54.9 54.1 14.8 15.6 16.5 15.9 14.1 15.3 16.1 15.8 13.6 16.2 16.9 16.8 17.5 18.1 9.6 21.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 14.5 13.3 0.0 0.0 6.8 9.2 0.0 16.0 23.8 0.0 21.5 26.4 0.0 12.5 12.7 8.4 0.0 0.0 0.0 28.0 26.4 5.4 0.0 16.1 8.8 19.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 16.5 0.0 0.0 0.0 0.0 33.2 0.0 0.0 3.1 0.0 0.0 29.7 4.4 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 14.6 8.5 10.1 0.0 0.0 DYRK1A "DYRK, DYRK1, MNBH" ENSG00000157540 "Dual specificity tyrosine phosphorylation regulated kinase 1A" Q13627 21 37365573-37526358 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 156.7;Inhibitory neurons: 158.4;Microglial cells: 176.1;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 157.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015323, HPA015810" Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA015323: AB_1847922, HPA015810: AB_1847921" "unprognostic (2.71e-1)" "unprognostic (3.35e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-2)" "unprognostic (4.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.67e-1)" "unprognostic (9.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (9.95e-2)" "unprognostic (7.39e-2)" "unprognostic (9.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (3.14e-1)" "unprognostic (1.40e-2)" 21.8 20.6 17.6 22.7 21.2 72.0 22.5 30.7 21.8 24.1 22.6 21.1 18.9 26.9 22.2 19.0 22.8 20.1 29.2 21.2 18.2 20.0 19.9 22.5 30.3 14.3 16.1 19.3 29.8 21.7 28.0 20.4 23.2 16.4 19.0 21.8 28.0 21.5 19.4 49.8 24.2 21.9 24.3 12.9 30.6 23.0 30.1 18.0 46.2 25.9 45.6 26.9 24.5 21.3 22.0 23.5 18.2 36.3 25.6 17.1 18.8 32.7 20.8 26.0 20.3 22.0 25.7 19.7 31.7 13.8 37.0 27.1 15.8 27.3 21.2 24.4 49.7 11.6 93.6 30.9 16.1 26.5 36.9 32.3 18.7 24.3 26.5 41.2 23.5 22.3 44.2 36.4 70.4 22.2 23.6 49.3 25.9 38.5 24.1 10.8 62.8 19.7 29.6 22.3 30.4 36.5 20.4 47.1 31.6 33.2 12.2 29.9 34.8 27.8 27.6 8.3 17.2 17.4 47.7 41.6 44.9 22.0 41.8 30.7 3.1 0.5 0.8 1.2 0.8 0.7 1.1 1.3 1.0 0.7 1.0 1.4 1.3 2.3 0.5 1.1 1.3 1.3 0.3 17.6 21.2 30.7 21.8 21.2 18.2 14.3 16.1 19.3 16.4 12.9 18.0 22.0 36.8 19.2 25.5 114.3 28.8 37.5 24.1 15.7 18.2 32.7 28.3 18.0 73.0 20.0 23.0 11.0 27.1 10.3 43.0 30.1 0.0 13.5 29.7 44.2 39.3 31.9 21.4 26.1 156.7 14.6 12.4 25.2 21.4 71.4 24.7 35.9 27.1 18.1 15.8 47.1 158.4 18.8 14.2 25.0 27.7 22.2 16.1 32.4 24.9 176.1 18.8 16.4 21.6 158.3 157.2 21.2 22.4 19.5 33.8 29.8 17.1 9.9 27.9 21.8 13.1 38.4 32.5 15.3 24.7 24.6 31.7 15.3 36.8 21.3 19.3 37.2 KCNJ6 "BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2" ENSG00000157542 "Potassium inwardly rectifying channel subfamily J member 6" P48051 21 37607373-38121345 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Congenital generalized lipodystrophy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 22.5" "Group enriched" "Detected in some" 4 "Excitatory neurons: 152.6;Horizontal cells: 245.6;Inhibitory neurons: 146.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 22.5" "Immune cell enhanced" "Detected in some" "basophil: 2.2;eosinophil: 1.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 2.2" "Cell line enriched" "Detected in some" 7 "LHCN-M2: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (1.96e-1)" "unprognostic (7.71e-2)" "unprognostic (1.26e-3)" "unprognostic (6.75e-2)" "unprognostic (3.59e-1)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" "unprognostic (8.76e-2)" "unprognostic (1.64e-2)" "unprognostic (3.49e-1)" "unprognostic (1.96e-10)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (9.87e-2)" "unprognostic (1.21e-1)" 0.0 0.1 1.5 0.1 3.2 0.1 0.0 1.9 11.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 1.8 0.0 0.0 0.1 0.2 2.2 22.5 3.0 0.0 0.4 0.0 1.8 0.4 2.8 0.2 0.0 1.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.2 0.4 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.7 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 1.6 0.0 0.0 0.0 3.5 0.1 29.2 0.1 0.0 0.0 0.3 0.0 2.8 0.0 0.1 1.0 4.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.3 0.1 0.1 0.2 4.3 1.2 0.0 0.0 0.0 0.0 2.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.0 0.0 1.5 3.2 1.9 11.0 10.4 1.8 2.2 22.5 3.0 2.8 0.1 1.0 4.2 0.2 0.0 1.1 2.3 0.0 0.1 0.4 0.1 0.0 25.4 0.2 0.3 34.3 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.4 0.1 0.2 1.6 41.4 0.0 152.6 0.0 0.4 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 245.6 146.2 1.8 2.0 0.0 0.0 0.0 0.6 0.0 3.6 16.9 0.0 1.2 0.0 38.2 1.5 0.6 0.0 0.0 0.0 0.3 0.2 0.0 0.1 2.6 0.0 0.2 1.1 0.0 1.7 0.0 0.1 0.3 0.1 0.0 0.4 0.4 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium inwardly rectifying channel subfamily J member 15" Q99712 21 38155549-38307357 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 243.8;thyroid gland: 130.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 20 "neutrophil: 395.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 395.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favorable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favorable (1.95e-4)" 8.8 0.5 1.0 20.9 0.7 14.2 2.8 1.0 6.0 12.8 1.5 0.9 1.5 0.5 11.1 8.6 1.2 30.6 0.8 0.8 1.3 243.8 2.8 42.6 1.2 0.9 0.8 0.4 0.3 58.3 0.7 0.4 4.7 1.9 2.6 0.4 0.5 25.7 14.8 0.5 3.0 0.7 2.4 0.4 11.8 40.9 1.8 4.4 1.9 130.7 3.0 1.9 25.3 8.2 1.4 1.6 0.0 0.3 0.6 13.7 68.7 0.6 1.0 4.8 0.0 0.0 0.0 0.6 0.2 0.0 7.5 103.6 23.5 0.0 69.6 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.1 21.0 7.2 17.8 3.8 1.5 3.2 0.1 0.2 0.7 31.6 0.0 0.1 0.2 0.0 0.1 0.7 1.5 0.3 0.7 67.5 80.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.0 1.5 0.4 3.5 0.2 1.7 0.4 0.1 5.6 4.3 0.4 0.3 19.3 0.1 0.0 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.3 395.3 0.0 0.0 0.4 0.0 4.6 1.0 0.7 1.0 6.0 0.8 1.3 0.9 0.8 0.4 1.9 0.4 4.4 1.4 2.9 60.9 197.9 0.0 1.1 2.8 10.4 20.7 13.6 0.0 0.5 0.0 1.6 88.6 33.1 31.3 0.0 0.1 0.0 0.0 17.6 27.8 1.9 0.0 0.0 4.6 0.0 0.0 0.3 8.6 0.8 1.5 15.8 0.1 6.3 0.0 0.7 0.4 0.4 0.0 0.1 0.0 2.0 2.9 3.0 2.2 0.6 5.9 1.8 0.0 2.1 0.0 0.0 0.0 0.1 44.7 0.0 0.0 0.1 0.7 0.0 236.9 7.0 0.0 0.0 1.5 0.8 1.1 1.1 16.8 1.6 0.1 1.7 0.1 0.0 9.0 ERG "erg-3, p55" ENSG00000157554 "ETS transcription factor ERG" P11308 21 38380027-38661780 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1" "Cancer enriched" "Detected in all" 4 "prostate cancer: 18.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018377, HPA046598" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018377: AB_675518, HPA046598: AB_2679715" "unprognostic (2.14e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (6.44e-3)" "unprognostic (8.64e-3)" "unprognostic (5.65e-2)" "unprognostic (1.91e-1)" "unprognostic (9.03e-4)" "unprognostic (4.30e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (4.31e-3)" "unprognostic (3.88e-2)" "unprognostic (2.64e-2)" "unprognostic (5.63e-3)" 24.8 4.2 5.6 7.2 5.1 7.7 20.2 5.0 5.7 10.1 4.6 5.3 3.4 11.7 1.9 5.3 9.2 12.1 11.1 4.5 5.0 8.9 6.2 19.8 7.6 5.9 5.4 3.4 4.5 4.9 2.4 2.5 24.5 5.8 7.1 3.5 0.5 3.7 4.3 8.0 4.5 6.5 12.1 4.5 26.8 4.7 1.6 6.6 4.2 10.1 10.0 3.7 9.3 7.0 5.4 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.2 22.3 0.0 0.1 0.9 0.0 0.0 138.3 0.1 0.0 0.0 0.0 1.0 47.7 0.0 0.5 0.0 0.0 151.5 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 113.4 0.7 2.2 0.5 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 5.1 5.0 5.7 4.5 5.0 5.9 5.4 3.4 5.8 4.5 6.6 5.4 94.4 0.0 3.9 0.3 0.7 3.4 1.7 0.6 3.4 0.0 0.6 4.3 3.8 4.3 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.7 0.7 0.4 105.5 0.0 13.5 13.3 0.0 0.0 5.7 0.0 2.1 24.0 4.4 69.9 1.3 0.3 0.0 1.7 0.4 0.0 5.9 3.4 2.1 0.9 0.9 3.6 88.1 0.2 0.0 0.0 7.1 1.4 0.0 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.1 0.0 2.4 3.7 0.3 1.4 0.5 3.4 0.0 0.6 0.5 0.3 0.6 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805183-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4" "Cell line enhanced" "Detected in many" "HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: AB_2666824" "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 103.2 30.0 50.2 96.4 42.0 168.7 88.4 30.8 68.3 88.3 59.7 120.4 132.5 78.3 28.1 91.4 73.2 133.2 64.4 48.5 60.0 66.0 232.7 187.2 38.3 43.8 48.9 40.3 66.3 37.8 62.4 57.0 74.2 43.9 80.8 147.9 7.5 50.8 46.2 150.9 222.9 181.2 78.7 41.9 202.7 73.4 7.6 59.0 44.1 63.0 43.2 35.1 212.2 104.5 42.0 120.1 26.2 16.6 5.6 18.8 61.3 49.2 27.4 154.1 36.2 46.5 23.0 35.1 24.7 13.3 25.0 48.5 35.7 28.0 71.2 63.8 24.5 12.0 309.0 152.6 62.2 196.9 18.4 28.2 39.8 269.6 49.6 210.2 22.0 28.3 17.2 31.3 0.2 14.4 20.1 54.1 22.2 56.0 39.3 18.2 189.6 10.2 25.2 50.2 74.4 14.2 18.4 78.4 32.8 6.2 5.7 1.9 36.3 30.8 83.0 13.0 55.3 60.5 0.5 0.3 25.2 20.7 69.4 70.8 21.0 19.5 7.0 3.2 24.9 3.9 0.4 3.0 4.7 33.6 0.4 3.2 3.2 37.0 0.3 32.4 8.1 0.3 8.9 50.2 42.0 30.8 68.3 48.5 60.0 43.8 48.9 40.3 43.9 41.9 59.0 42.0 253.0 51.3 156.6 6.2 10.8 427.4 701.0 150.8 863.4 2.1 84.2 69.7 25.6 51.5 141.9 51.5 0.0 58.4 17.5 150.7 11.7 73.7 4.0 241.1 127.4 312.7 91.8 36.4 39.6 108.5 109.3 98.7 161.1 497.9 51.3 0.9 242.0 262.4 62.1 0.0 10.7 266.0 79.3 150.8 291.7 2.0 18.0 253.4 67.6 74.0 41.0 1.5 3.1 4.0 3.1 127.6 175.1 24.8 21.0 184.0 162.2 47.2 107.9 1.6 52.6 81.8 108.8 0.6 3.3 522.6 486.4 177.6 28.8 8.2 243.3 338.7 TSPAN18 TSPAN ENSG00000157570 "Tetraspanin 18" Q96SJ8 11 44726465-44932423 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 84.2" "Group enriched" "Detected in many" 6 "Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (1.97e-1)" "unprognostic (8.53e-3)" "unprognostic (3.48e-2)" "unprognostic (6.30e-2)" "unprognostic (8.64e-2)" "unprognostic (7.17e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.04e-3)" "unprognostic (6.78e-3)" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-2)" 22.4 46.5 5.3 10.5 4.0 1.2 10.1 27.6 8.7 13.2 4.7 35.1 6.8 47.1 3.6 21.2 21.0 13.4 84.2 26.8 4.4 14.3 4.9 22.6 7.7 4.4 9.8 4.3 7.5 1.7 4.0 5.5 30.5 13.5 16.0 10.0 1.0 3.3 41.8 14.9 6.3 16.6 47.0 5.7 14.2 16.8 4.1 9.6 4.0 14.9 20.1 4.2 23.3 10.3 2.7 0.0 0.6 36.7 0.5 0.0 0.0 0.0 0.6 0.5 2.3 0.1 7.3 61.5 0.0 16.4 1.0 35.2 0.0 6.6 0.2 0.6 48.7 2.4 0.2 5.0 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.0 0.0 14.3 0.2 1.1 0.0 0.1 0.0 0.0 0.1 33.0 0.1 1.0 0.1 38.4 0.2 0.0 0.0 31.9 36.2 0.4 0.1 0.1 99.8 0.2 0.1 1.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 1.6 1.0 0.0 0.0 1.6 0.1 0.0 0.8 0.2 1.1 0.5 0.0 0.0 1.3 0.2 0.3 0.5 0.0 0.0 0.3 1.7 5.3 4.0 27.6 8.7 26.8 4.4 4.4 9.8 4.3 13.5 5.7 9.6 2.7 72.2 0.0 3.7 5.5 1.5 1.7 0.1 0.0 0.6 1.8 1.0 0.3 22.3 0.0 0.0 7.3 0.0 0.1 1.1 0.0 0.0 0.4 29.7 0.7 0.9 51.8 0.0 3.6 2.7 0.2 0.2 6.8 0.5 1.4 1.3 0.0 70.3 1.0 0.4 1.7 4.1 0.0 0.0 2.5 2.6 5.6 2.8 3.4 7.2 2.8 0.2 0.1 0.0 4.0 1.3 0.7 0.0 1.5 0.6 0.2 0.0 20.2 0.0 0.5 0.0 4.9 2.0 0.6 1.0 0.0 1.1 0.3 3.0 3.2 0.0 0.1 LCA5L "C21orf13, MGC33295" ENSG00000157578 "Lebercilin LCA5 like" O95447 21 39405728-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 111.4" "Group enriched" "Detected in many" 11 "Early spermatids: 1312.6;Late spermatids: 472.4;Spermatocytes: 465.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.7;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.7 2.3 0.4 0.8 0.3 1.7 1.4 0.8 1.8 2.6 0.5 0.4 1.2 7.7 0.4 7.3 0.8 0.5 0.7 0.8 2.5 0.7 1.5 0.3 1.5 1.7 0.1 0.9 1.3 2.3 2.0 0.3 1.3 0.8 0.5 10.9 0.9 0.9 2.2 0.9 0.4 0.6 2.3 0.4 0.8 111.4 0.9 0.3 4.4 1.5 0.2 0.5 0.5 1.8 0.9 1.0 0.6 1.7 0.8 0.7 0.1 0.2 0.4 0.5 0.0 0.5 1.0 0.7 0.7 0.9 0.2 0.2 0.1 0.5 0.3 0.3 0.8 0.4 0.8 0.1 0.7 1.1 0.0 0.6 2.3 1.6 1.7 1.1 0.3 1.0 1.7 0.6 0.6 3.7 0.3 0.4 3.2 0.6 1.0 0.2 0.2 0.7 1.7 0.3 1.1 0.5 2.0 0.8 1.4 0.3 3.9 0.1 0.1 0.3 0.2 0.9 0.2 1.8 1.1 0.1 1.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.8 1.4 0.8 0.7 0.8 1.5 1.7 0.1 1.3 2.3 0.9 1.8 1.1 3.2 0.5 5.5 0.3 0.5 0.9 2.7 1.2 2.0 4.5 5.0 2.6 1.5 16.8 7.3 6.2 1.1 0.1 0.4 19.6 3.5 1312.6 34.9 2.4 1.6 4.2 0.0 3.8 2.2 0.2 2.2 0.5 2.8 0.0 1.8 1.4 1.6 0.5 1.7 2.6 1.4 0.0 0.6 0.7 472.4 6.5 1.3 1.8 1.0 0.6 3.2 0.0 0.5 2.1 1.6 0.5 7.9 0.0 0.6 0.2 12.0 68.0 17.4 19.7 3.6 1.7 465.8 26.7 0.3 0.6 0.3 0.3 3.2 0.9 0.7 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles NA NA Vesicles "HPA029638: AB_10602402" "prognostic unfavorable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favorable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 20.0 37.0 26.3 19.8 30.2 18.6 25.4 32.0 36.4 23.0 29.0 27.4 19.8 28.7 29.7 17.6 26.4 30.3 26.7 24.7 28.1 27.0 30.9 21.9 21.7 35.4 30.5 22.9 21.5 42.1 42.8 14.7 25.2 30.4 24.2 29.1 14.8 46.8 27.6 22.5 21.4 24.1 29.9 30.6 24.9 30.9 14.8 28.3 18.7 24.7 23.9 22.5 28.4 19.7 36.6 87.2 48.8 61.4 117.6 106.4 102.3 44.1 95.1 152.3 89.3 109.4 43.3 79.3 19.2 81.9 117.3 97.7 81.1 42.5 106.3 64.4 57.4 53.3 39.8 37.9 59.5 94.1 85.2 61.5 107.0 112.1 85.5 43.1 129.1 67.4 43.2 56.8 81.4 112.5 106.9 32.5 71.0 27.2 271.3 58.9 30.9 38.3 100.2 100.3 65.5 75.4 71.4 45.9 52.2 109.6 37.6 93.3 75.7 65.8 71.0 46.2 71.3 83.3 62.4 75.7 45.6 95.6 67.6 147.5 51.9 14.5 23.5 33.1 11.4 28.3 19.7 18.6 25.2 12.9 13.2 16.6 22.0 1.3 20.3 3.9 23.5 16.4 17.7 26.3 30.2 32.0 36.4 24.7 28.1 35.4 30.5 22.9 30.4 30.6 28.3 36.6 8.0 6.4 11.5 8.5 19.2 13.5 32.0 58.3 23.9 9.7 31.6 30.1 7.8 37.1 34.8 27.6 2.1 59.2 15.3 15.2 13.7 84.0 0.6 16.0 17.8 11.1 19.7 10.5 3.5 73.8 52.1 27.5 14.3 19.5 34.9 11.9 13.6 18.7 38.4 10.1 4.3 21.6 57.0 11.4 10.8 2.3 23.3 22.0 53.4 4.7 22.0 38.8 23.7 9.5 13.8 67.4 25.9 19.9 23.3 36.3 18.8 13.5 18.4 12.5 0.0 18.3 24.5 21.0 60.8 17.4 13.9 35.2 14.0 14.8 31.5 24.2 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Distal enterocytes: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 59.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 59.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favorable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 17.0 10.4 11.2 9.7 11.4 19.2 12.5 7.0 9.6 5.5 13.9 19.0 21.7 5.4 6.1 13.9 8.2 5.1 20.9 8.8 12.6 10.2 2.0 18.1 6.7 13.3 12.3 8.9 13.9 25.6 8.4 9.6 5.2 9.4 9.0 21.4 3.6 9.9 14.6 27.8 20.4 19.4 7.0 7.7 8.4 14.1 1.9 12.0 12.8 13.9 19.5 8.1 5.9 6.8 8.6 10.8 24.3 19.5 12.8 23.7 17.3 11.9 5.3 12.4 11.0 7.1 19.1 16.6 8.6 35.2 8.3 27.1 15.6 17.1 27.9 10.8 23.9 11.7 58.5 13.0 8.1 13.9 26.1 80.1 24.0 48.4 19.9 27.2 30.2 21.8 15.2 18.4 10.2 19.7 21.6 27.4 33.1 17.5 36.9 17.3 12.4 15.1 7.2 17.5 11.3 18.2 20.3 34.0 33.1 15.9 18.1 9.6 25.7 49.0 9.3 6.8 11.0 7.7 5.9 7.9 6.9 24.3 32.0 25.3 59.7 3.3 14.2 0.6 2.9 1.6 0.2 0.7 0.6 2.7 0.6 0.4 0.5 16.3 2.3 1.8 0.5 1.0 1.8 11.2 11.4 7.0 9.6 8.8 12.6 13.3 12.3 8.9 9.4 7.7 12.0 8.6 2.9 3.2 36.1 84.5 3.7 4.8 3.7 4.7 4.6 1.2 11.7 9.1 21.3 11.5 6.9 16.5 2.1 2.7 3.5 53.0 3.9 4.6 0.5 6.7 3.8 6.0 27.6 14.5 22.9 11.4 6.3 3.1 7.7 10.7 3.8 4.3 6.4 1.7 13.6 0.0 31.4 12.7 10.2 25.1 9.4 1.3 1.8 12.5 1.8 24.4 28.1 1.0 4.1 34.2 7.6 13.5 15.0 1.5 1.6 9.0 31.9 3.3 5.4 1.3 0.0 6.4 4.1 0.2 0.3 10.4 8.0 2.7 5.2 3.8 21.2 12.3 MX1 "IFI-78K, lncMX1-215, MxA" ENSG00000157601 "MX dynamin like GTPase 1" P20591 21 41420020-41470071 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 136.3;salivary gland: 128.0" "Cell type enhanced" "Detected in many" "Adipocytes: 101.8;Extravillous trophoblasts: 77.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "white matter: 136.3" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 820.2;BJ hTERT+ SV40 Large T+ RasG12V: 734.3;Karpas-707: 160.6;SK-MEL-30: 259.3" "Low region specificity" "Detected in all" "HPA030917, HPA030918, HPA049724" Approved Approved Supported "Nuclear membrane,Cytosol" No NA "Nuclear membrane, Cytosol" "HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862" "unprognostic (3.62e-1)" "unprognostic (6.84e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (2.27e-1)" "unprognostic (1.35e-3)" "unprognostic (5.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (6.88e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.95e-2)" "unprognostic (8.10e-2)" "unprognostic (3.24e-1)" "unprognostic (1.81e-1)" 25.0 15.1 22.7 29.3 24.9 52.2 24.0 19.2 27.7 26.6 15.4 19.1 31.0 16.0 20.7 42.8 25.4 38.1 20.1 13.5 29.6 27.6 25.5 31.9 39.2 33.9 20.4 12.7 27.3 13.2 15.4 30.5 20.9 30.9 15.3 11.7 4.3 128.0 16.6 7.6 10.9 29.1 24.6 22.2 75.9 35.6 8.7 22.5 65.7 26.9 9.8 37.1 29.9 24.7 136.3 16.4 0.5 0.7 1.2 0.6 6.8 0.2 1.0 25.6 820.2 734.3 5.3 33.6 0.2 6.5 2.7 7.8 1.6 0.3 0.8 15.9 4.2 0.2 0.9 2.3 1.9 7.3 0.4 0.4 7.4 2.3 48.8 1.1 0.4 2.8 2.7 0.0 160.6 0.4 1.3 14.5 1.8 2.6 0.5 8.3 12.6 0.1 26.4 3.3 9.9 0.7 0.3 1.1 1.3 259.3 0.1 10.6 6.7 1.7 0.8 0.7 0.1 0.7 35.9 37.6 1.0 0.9 2.2 1.8 31.6 45.0 25.6 17.9 47.6 25.8 38.6 27.3 21.9 31.0 36.7 23.3 16.9 64.7 18.9 44.5 44.7 51.9 35.0 22.7 24.9 19.2 27.7 13.5 29.6 33.9 20.4 12.7 30.9 22.2 22.5 136.3 101.8 32.1 25.3 2.6 41.9 6.4 17.6 13.0 15.9 3.7 8.0 8.9 8.8 11.5 22.4 23.9 0.0 3.2 47.2 10.1 19.6 38.6 0.7 16.0 11.1 66.8 0.0 2.1 7.7 56.1 77.3 21.5 34.1 15.9 1.3 38.1 20.3 5.8 53.3 1.7 7.1 16.7 2.0 20.8 16.2 1.2 10.8 50.9 19.6 24.4 32.0 6.8 11.3 2.5 1.2 38.8 4.3 16.6 28.7 9.9 29.2 5.0 32.1 2.4 0.0 7.7 17.8 0.4 4.0 32.6 3.4 4.1 28.3 13.4 7.5 34.2 CREB3L1 OASIS ENSG00000157613 "CAMP responsive element binding protein 3 like 1" Q96BA8 11 46277662-46321409 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 135.1;salivary gland: 83.7" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 89.2;Gastric mucus-secreting cells: 105.0;Glandular and luminal cells: 120.5;Intestinal goblet cells: 280.5" "Cancer enhanced" "Detected in all" "prostate cancer: 87.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 134.3;BJ hTERT+: 130.7;BJ hTERT+ SV40 Large T+: 120.6;fHDF/TERT166: 321.8;OE19: 129.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA024069, CAB026151" Enhanced NA NA "CAB026151: , HPA024069: AB_1854750" "unprognostic (2.46e-2)" "unprognostic (2.80e-1)" "unprognostic (1.34e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.66e-3)" "unprognostic (2.93e-1)" "unprognostic (5.41e-2)" "unprognostic (2.75e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (1.54e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.97e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (1.12e-2)" 8.7 15.2 3.4 8.1 3.4 0.1 10.8 0.8 4.2 43.6 1.8 41.6 28.0 20.5 2.4 3.2 5.2 25.2 11.8 7.5 2.7 2.8 1.1 14.9 0.7 2.1 4.5 3.0 9.4 135.1 2.3 10.8 26.9 3.1 42.7 43.8 0.1 83.7 27.0 4.4 5.3 30.8 13.4 0.8 3.3 68.6 4.0 5.7 1.1 4.5 4.2 4.8 21.6 15.5 3.8 0.9 0.8 1.3 26.1 81.9 77.9 0.6 134.3 130.7 120.6 83.3 13.7 0.3 0.0 0.7 321.8 8.3 0.0 1.6 0.4 66.6 0.1 1.5 2.0 0.8 0.0 113.5 0.0 1.9 75.2 0.0 68.6 2.5 109.0 1.0 0.5 11.2 0.0 102.5 0.0 0.1 0.4 17.0 129.0 13.7 0.1 18.0 0.2 0.2 0.0 0.0 0.2 0.9 3.4 0.2 23.3 0.1 4.9 0.0 62.7 18.3 48.6 83.4 0.1 0.1 0.0 75.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.4 0.8 4.2 7.5 2.7 2.1 4.5 3.0 3.1 0.8 5.7 3.8 10.3 0.0 46.4 0.3 0.6 1.5 44.4 2.6 0.0 0.0 52.0 5.1 15.9 25.8 10.0 29.5 0.0 1.2 0.1 56.8 3.9 42.0 2.1 37.2 24.1 9.0 9.1 0.0 2.1 89.2 2.3 49.4 105.0 120.5 4.5 1.9 3.3 0.0 1.9 0.0 1.0 280.5 6.1 0.0 3.5 6.6 83.6 1.0 10.6 2.8 2.0 0.0 0.0 19.6 0.1 49.2 59.8 44.4 0.2 40.4 9.5 0.7 3.6 0.0 0.0 0.7 29.3 1.0 1.5 0.6 2.3 3.4 1.8 10.7 57.7 51.3 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41954018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 127.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 51.6;Cone photoreceptor cells: 83.4;Granulosa cells: 100.0;Theca cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 79.1;SK-BR-3: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA030922: AB_2673660, HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 40.2 127.4 18.3 8.4 17.5 1.3 23.5 18.6 20.0 11.8 16.5 10.9 4.9 8.3 8.5 10.8 9.5 8.3 7.4 16.1 18.6 8.9 8.7 7.9 9.8 21.4 19.8 15.7 19.0 11.4 29.4 7.2 5.3 20.0 17.4 5.8 24.8 10.9 11.6 2.9 15.4 9.1 7.9 21.7 41.8 11.8 3.3 22.9 6.7 8.6 4.2 7.9 12.9 11.5 26.4 13.4 5.5 3.9 8.9 79.1 21.7 15.1 9.3 14.4 5.7 5.2 8.7 15.0 0.2 5.0 18.0 14.0 1.5 13.9 9.7 7.2 0.9 6.2 2.3 7.1 7.1 10.6 1.0 0.0 14.0 8.9 30.3 11.7 12.5 27.1 0.7 8.4 0.1 15.3 1.2 1.9 2.7 21.4 5.7 18.7 1.4 5.7 8.0 8.5 27.8 6.3 2.8 10.1 44.6 8.1 7.6 11.7 5.9 9.3 13.5 1.9 4.5 7.6 5.0 7.9 1.1 39.2 7.7 2.8 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.5 0.3 0.1 0.3 0.1 0.0 0.3 0.1 18.3 17.5 18.6 20.0 16.1 18.6 21.4 19.8 15.7 20.0 21.7 22.9 26.4 24.8 3.2 15.5 20.5 4.4 4.1 9.1 7.6 15.9 51.6 8.2 7.0 3.1 8.6 8.3 3.7 83.4 12.8 4.4 3.4 0.0 5.6 0.3 6.0 6.7 19.3 4.9 5.9 20.3 8.5 4.8 11.9 17.9 8.3 0.0 100.0 46.1 5.2 3.6 1.7 14.4 6.9 6.1 7.0 10.5 0.2 3.7 5.6 1.8 24.4 2.5 3.6 3.1 11.6 18.8 8.1 5.0 2.2 8.1 15.9 3.0 2.5 7.7 36.9 13.1 7.4 17.9 0.1 3.0 14.3 2.6 9.3 2.8 82.4 6.9 16.6 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 (MAP3K7) binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: AB_2674394" "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favorable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 8.2 7.7 4.0 8.1 4.9 16.9 9.0 4.2 7.0 7.5 18.0 9.7 7.8 18.2 8.9 16.7 9.8 8.2 8.7 5.8 4.0 14.5 27.3 9.1 9.0 5.2 6.6 3.7 12.3 25.1 32.0 6.5 11.7 5.2 14.8 9.6 24.1 9.7 12.7 10.8 9.8 7.9 13.4 3.5 8.6 12.6 15.5 4.5 9.8 10.1 9.0 12.7 7.3 8.4 5.9 40.2 9.5 9.6 9.8 7.3 11.0 10.1 12.2 15.3 8.0 9.1 10.8 33.5 18.1 7.3 14.2 15.5 20.4 14.8 31.0 11.6 31.2 14.2 16.9 10.9 26.4 6.3 18.0 12.7 8.0 18.2 13.8 35.0 13.9 13.5 13.5 19.7 14.4 10.6 19.4 14.4 9.1 11.5 7.2 15.9 9.1 16.8 13.5 13.3 11.6 8.0 11.3 13.6 20.3 26.0 17.8 17.5 7.1 13.0 8.9 13.0 44.8 11.3 18.6 15.3 17.8 13.9 8.3 12.7 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.9 0.2 0.0 0.1 0.1 4.0 4.9 4.2 7.0 5.8 4.0 5.2 6.6 3.7 5.2 3.5 4.5 5.9 9.6 12.8 13.2 14.0 10.2 9.1 7.9 7.2 6.8 7.4 10.0 5.3 11.4 20.0 10.5 11.0 12.5 15.1 11.0 12.3 3.9 8.4 1.5 13.0 23.0 8.8 7.2 39.2 23.2 6.9 4.9 5.6 12.8 11.9 14.5 28.6 10.0 26.0 7.7 11.8 22.3 10.8 6.1 16.0 13.7 3.4 10.8 12.6 5.4 20.6 11.5 6.7 3.1 21.6 21.2 9.9 11.2 16.1 7.3 12.6 7.3 11.2 19.6 20.4 0.0 6.3 6.7 3.3 2.2 9.6 10.1 22.4 10.9 24.4 9.8 13.2 SLC38A10 "MGC15523, PP1744" ENSG00000157637 "Solute carrier family 38 member 10" Q9HBR0 17 81244811-81295547 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021374, HPA023161, HPA024631" Enhanced Enhanced "Golgi apparatus" NA NA 70000000 "Golgi apparatus" "HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860" "unprognostic (2.18e-2)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (3.00e-3)" "unprognostic (2.06e-2)" "unprognostic (1.69e-1)" "unprognostic (2.12e-1)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.92e-4)" "unprognostic (8.39e-2)" "prognostic unfavorable (5.34e-7)" "unprognostic (6.55e-2)" "unprognostic (3.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" 35.5 37.3 11.1 23.6 11.8 31.1 31.5 11.4 13.9 31.0 12.8 29.6 32.1 35.6 17.4 24.2 32.0 26.0 34.7 8.3 15.1 31.6 75.8 31.7 21.5 19.0 12.2 7.2 38.0 92.2 15.7 62.6 24.8 14.5 34.5 9.6 4.4 51.6 21.0 20.1 24.6 35.0 15.6 12.5 44.2 39.1 30.7 13.5 13.0 41.7 6.4 10.6 37.9 27.1 17.6 45.2 77.5 13.3 70.2 49.8 23.3 77.6 53.7 48.2 32.5 38.2 36.1 73.0 34.4 59.2 37.3 36.0 53.0 13.5 27.1 12.0 34.7 40.0 34.6 28.5 61.2 44.4 34.1 78.4 40.7 19.7 29.2 18.9 26.2 62.2 24.5 26.3 51.3 24.6 56.5 21.0 59.4 12.9 41.3 37.6 33.8 27.8 34.8 22.2 42.3 25.7 65.7 43.2 26.9 59.2 18.3 38.1 70.0 61.9 52.2 29.9 38.9 29.4 44.6 21.4 20.0 30.9 51.8 54.5 12.7 10.6 18.6 7.4 11.9 8.7 6.2 7.1 9.1 6.2 7.0 4.8 5.4 8.0 4.6 15.9 9.8 5.6 9.5 11.1 11.8 11.4 13.9 8.3 15.1 19.0 12.2 7.2 14.5 12.5 13.5 17.6 24.4 25.6 35.6 25.8 28.6 8.3 12.3 21.9 13.6 10.9 25.3 18.0 19.3 31.5 24.6 11.0 18.8 61.0 29.8 66.4 5.9 31.9 25.4 17.3 13.7 22.4 45.0 22.3 12.3 26.9 62.4 35.9 44.9 32.8 15.2 64.6 27.5 79.2 49.3 25.2 14.3 58.8 12.2 40.6 15.1 75.6 32.9 35.7 14.2 28.1 29.1 27.7 23.7 9.0 20.5 25.1 53.1 27.4 96.5 16.0 59.1 23.9 21.4 9.1 32.9 17.0 21.2 19.7 22.8 11.8 7.2 62.5 25.0 39.9 48.2 11.4 C9orf43 MGC17358 ENSG00000157653 "Chromosome 9 open reading frame 43" Q8TAL5 9 113410054-113429690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.9" "Group enriched" "Detected in some" 8 "Early spermatids: 114.2;Late spermatids: 226.0;Spermatocytes: 91.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA021310 Approved Cytosol NA NA Cytosol "HPA021310: AB_1845825" "unprognostic (2.91e-2)" "unprognostic (9.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.58e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (8.90e-2)" "unprognostic (1.97e-2)" "unprognostic (5.96e-3)" "unprognostic (1.51e-1)" "unprognostic (7.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-2)" "unprognostic (1.63e-1)" 0.3 1.5 1.2 0.1 0.9 1.9 0.5 1.0 1.2 0.2 0.7 0.2 0.1 0.2 1.2 0.3 0.7 0.3 0.2 0.9 1.0 0.8 1.5 0.2 0.4 1.2 1.1 0.7 0.8 0.8 0.9 1.4 0.2 1.1 0.5 0.2 1.2 0.7 0.4 0.1 0.5 0.2 0.0 1.3 0.4 0.5 45.9 1.1 0.4 0.8 0.3 0.4 0.2 0.2 1.5 0.5 0.4 0.2 0.7 0.6 0.3 0.3 0.2 0.4 0.7 0.5 0.5 0.4 1.3 0.4 0.1 1.4 0.9 0.2 0.6 0.2 1.1 0.2 1.1 0.8 0.2 0.5 0.2 0.1 0.7 1.0 0.8 1.0 0.4 0.6 1.5 0.7 1.2 0.3 1.0 0.5 0.3 0.3 0.6 1.6 0.3 0.2 0.7 0.7 0.2 1.2 0.3 1.2 0.5 0.7 0.5 1.6 0.1 0.0 1.0 0.2 0.6 1.0 0.7 1.5 2.0 0.5 0.4 0.3 0.0 0.1 0.0 0.3 0.3 0.0 0.3 0.1 0.4 0.2 0.1 0.3 0.4 0.4 0.2 0.0 0.3 0.0 0.1 1.2 0.9 1.0 1.2 0.9 1.0 1.2 1.1 0.7 1.1 1.3 1.1 1.5 0.4 0.0 0.0 4.9 1.5 0.6 0.6 0.5 1.2 1.7 0.8 0.9 0.1 0.0 1.6 0.0 0.0 0.5 0.3 0.2 1.9 0.3 114.2 3.0 0.7 0.7 0.0 0.8 0.6 0.2 0.4 0.2 0.0 0.6 0.0 0.7 0.0 0.9 0.3 0.0 0.7 0.1 0.0 0.3 0.4 226.0 2.1 0.5 0.0 0.0 0.7 1.8 0.0 0.5 1.8 0.9 0.0 1.5 1.8 0.3 0.1 0.9 6.7 2.8 0.0 0.7 0.3 91.5 17.9 0.7 0.0 0.0 0.4 0.7 0.2 0.6 PALM2AKAP2 PALM2-AKAP2 ENSG00000157654 "PALM2 and AKAP2 fusion" "Q8IXS6, Q9Y2D5" 9 109498325-110172512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 10.6;naive B-cell: 10.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 97.9 13.7 22.2 37.6 22.1 10.0 17.7 7.4 20.4 28.7 4.4 17.6 14.9 29.0 8.5 26.8 14.8 37.8 94.7 15.2 18.2 31.1 38.5 69.7 32.4 19.7 25.3 14.5 9.4 13.2 14.1 0.1 98.7 20.6 15.1 18.2 3.3 38.4 25.4 17.2 10.2 13.4 49.0 8.6 38.8 18.6 4.6 39.0 45.8 25.9 24.5 32.0 43.4 0.4 24.1 20.6 7.7 112.5 0.1 110.8 93.0 33.4 116.0 141.3 101.6 93.4 134.6 17.9 92.1 30.6 129.6 146.2 28.9 9.5 98.8 185.4 68.9 12.5 9.2 30.4 11.0 75.9 12.4 256.2 109.8 24.7 183.3 280.4 62.5 150.9 14.5 0.3 76.2 204.7 1.2 61.9 31.1 47.2 9.1 62.6 5.5 98.2 25.3 72.4 2.8 25.2 1.5 10.3 9.5 26.4 87.8 4.1 22.2 240.0 94.0 77.9 137.5 108.8 52.5 89.1 52.5 81.4 51.3 73.9 2.9 0.1 1.3 1.0 0.2 0.2 10.6 1.2 1.4 1.2 10.3 0.7 0.8 0.5 2.2 0.0 2.4 3.9 1.4 22.2 22.1 7.4 20.4 15.2 18.2 19.7 25.3 14.5 20.6 8.6 39.0 24.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF618 "KIAA1952, NEDD10" ENSG00000157657 "Zinc finger protein 618" Q5T7W0 9 113876282-114056591 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 33.0;REH: 31.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023116, HPA061732" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023116: AB_10964204, HPA061732: AB_2684596" "unprognostic (1.92e-1)" "unprognostic (3.22e-2)" "unprognostic (2.29e-2)" "unprognostic (4.17e-3)" "prognostic unfavorable (6.34e-4)" "unprognostic (3.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.61e-1)" "unprognostic (6.43e-2)" "unprognostic (2.38e-2)" "unprognostic (1.56e-2)" "unprognostic (8.24e-2)" "prognostic favorable (5.22e-7)" "unprognostic (4.57e-2)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (3.51e-2)" 3.2 4.6 2.6 2.1 2.5 2.7 3.7 4.3 2.2 5.5 4.6 1.8 2.2 6.4 2.9 2.3 5.5 4.0 2.0 1.7 2.7 7.3 5.6 3.5 1.2 2.9 2.9 1.4 9.7 5.5 6.9 3.9 2.2 2.8 3.0 1.6 2.0 3.4 2.9 2.3 2.0 1.6 4.5 2.0 4.0 4.3 2.6 3.0 3.5 5.5 1.8 1.1 2.1 2.6 2.6 7.4 22.5 33.0 14.4 7.8 9.1 1.6 4.8 7.9 9.5 8.4 0.2 5.2 4.1 4.5 8.4 2.7 0.2 16.6 8.3 3.7 0.1 6.6 0.0 1.7 0.1 5.8 4.4 7.4 8.8 3.3 10.1 2.2 8.6 24.2 0.5 0.0 0.0 4.3 12.1 0.2 5.6 16.4 0.6 4.9 31.8 19.2 0.1 10.2 8.1 10.2 24.2 13.7 8.7 8.7 9.4 0.7 8.9 19.8 12.6 9.9 7.1 5.9 0.0 0.0 0.0 0.9 6.6 9.0 1.6 0.4 0.2 0.3 0.2 0.1 0.0 0.0 0.3 1.4 0.5 0.2 0.2 0.0 1.1 0.3 1.7 0.0 0.4 2.6 2.5 4.3 2.2 1.7 2.7 2.9 2.9 1.4 2.8 2.0 3.0 2.6 9.1 3.2 13.2 4.9 2.1 2.0 4.8 3.7 12.0 14.9 12.6 17.1 2.7 24.3 4.2 11.0 4.2 0.2 3.1 0.5 7.9 16.0 7.6 7.4 22.8 10.0 2.4 7.6 14.6 8.2 0.1 12.7 10.7 12.2 21.0 26.9 11.0 10.9 3.4 58.9 30.6 2.1 2.0 5.4 8.5 4.8 15.2 7.2 0.0 38.4 12.1 10.1 4.1 24.1 8.7 9.7 1.9 15.4 0.4 1.8 0.1 10.8 2.3 1.6 26.3 10.1 19.2 0.4 11.4 3.6 3.7 0.3 2.0 40.0 2.8 1.9 DGKI DGK-IOTA ENSG00000157680 "Diacylglycerol kinase iota" O75912 7 137381037-137847092 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.4;choroid plexus: 6.6;retina: 6.6;thyroid gland: 15.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 606.4;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 329.2" "Group enriched" "Detected in some" 4 "glioma: 0.8;melanoma: 0.6;renal cancer: 1.0;thyroid cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.0;GAMG: 3.6;hTEC/SVTERT24-B: 3.2;SCLC-21H: 5.0;U-2197: 14.1;U-87 MG: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-3)" "unprognostic (1.76e-1)" "unprognostic (6.08e-2)" "unprognostic (1.42e-1)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.01e-2)" "unprognostic (8.74e-2)" "unprognostic (4.46e-2)" "unprognostic (5.98e-5)" "unprognostic (2.85e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "unprognostic (1.73e-3)" 0.5 0.3 2.2 0.2 13.4 0.0 0.2 0.9 10.9 0.1 6.6 0.2 0.0 0.3 0.1 0.1 0.1 0.6 2.8 5.4 3.2 0.5 0.0 0.0 0.0 3.5 4.5 3.5 0.0 0.0 0.2 1.3 0.0 3.3 0.1 0.1 6.6 0.3 0.1 0.0 0.1 0.1 1.3 0.0 0.0 0.1 0.6 6.1 0.0 15.7 0.0 0.0 0.2 0.0 7.0 0.0 0.0 0.4 0.0 0.8 0.6 0.0 3.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.9 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.2 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.3 0.0 0.0 0.5 0.2 0.0 0.0 0.1 1.3 0.5 14.1 0.6 0.1 0.0 0.0 5.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 13.4 0.9 10.9 5.4 3.2 3.5 4.5 3.5 3.3 0.0 6.1 7.0 0.3 0.0 0.0 7.5 0.3 1.1 0.2 1.4 0.6 53.1 1.0 0.1 11.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.4 1.3 1.1 0.0 0.0 606.4 0.0 0.0 2.1 0.0 0.3 0.0 0.1 0.4 0.0 0.6 45.4 414.6 0.0 44.7 0.0 0.7 3.6 0.9 0.2 0.0 60.9 0.0 2.1 1.0 329.2 84.4 0.0 0.0 1.5 0.0 0.2 0.0 0.3 0.2 3.3 0.0 0.8 2.2 0.2 0.5 0.2 0.6 0.0 0.1 0.5 0.0 0.0 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 10.3;Breast glandular cells: 8.8;Endometrial stromal cells: 8.9;Glandular and luminal cells: 8.8;Granulosa cells: 9.6;Hofbauer cells: 8.9;monocytes: 19.1;Syncytiotrophoblasts: 8.8;Theca cells: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 7.4 7.8 7.9 6.9 12.8 3.6 7.6 3.2 16.6 6.5 5.9 6.0 3.4 6.9 6.3 4.3 4.7 3.7 2.7 13.3 7.2 3.3 5.3 5.3 9.5 5.8 6.0 10.4 8.5 4.7 14.3 4.1 4.9 7.2 12.3 5.4 4.6 8.9 6.6 4.6 4.2 6.3 6.9 4.1 13.4 7.3 3.9 7.3 8.7 6.3 4.3 9.5 6.4 5.1 11.6 4.7 7.1 3.8 8.2 10.1 7.6 2.9 4.3 7.9 6.0 6.1 5.1 2.0 19.5 3.5 4.8 17.0 8.1 7.4 3.7 5.2 9.9 4.6 6.5 5.8 4.0 17.9 13.6 3.0 6.7 6.5 7.8 8.4 7.7 4.1 24.9 12.3 51.5 4.4 13.6 15.4 4.5 9.8 6.0 7.8 17.4 4.5 17.7 3.5 3.4 12.5 8.4 14.4 18.8 41.3 2.4 25.2 12.2 2.5 6.0 6.8 2.3 8.3 27.8 27.5 20.7 3.1 11.4 11.0 0.3 1.3 0.2 0.6 1.0 0.2 1.3 0.7 0.4 0.7 2.2 0.9 0.8 1.0 0.8 1.0 4.7 0.1 0.5 7.9 12.8 3.2 16.6 13.3 7.2 5.8 6.0 10.4 7.2 4.1 7.3 11.6 1.7 0.0 10.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 8.8 5.2 0.0 0.0 1.3 0.0 0.0 4.7 3.0 0.0 0.0 1.4 0.0 5.0 8.9 0.5 0.0 0.0 0.0 4.6 1.2 1.3 0.0 8.8 0.0 9.6 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 19.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.6 0.0 0.0 1.9 4.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.8 1.1 9.7 0.0 0.0 SVOPL MGC46715 ENSG00000157703 "SVOP like" Q8N434 7 138594285-138701362 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 4.2;salivary gland: 4.0" "Cell type enriched" "Detected in some" 8 "granulocytes: 76.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 14 "eosinophil: 2.1" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HMC-1: 8.8;MOLT-4: 2.0;NTERA-2: 1.9;RT4: 2.0;T-47d: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA018035 Uncertain NA NA "HPA018035: AB_2197028" "unprognostic (6.70e-5)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (2.49e-1)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "unprognostic (7.69e-3)" "unprognostic (2.59e-3)" "unprognostic (7.16e-2)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (5.03e-3)" "unprognostic (2.22e-4)" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (8.51e-2)" 0.0 2.0 0.5 0.1 0.5 0.2 0.9 0.3 0.4 0.5 1.9 0.9 0.1 0.2 0.8 0.1 1.9 0.0 0.2 0.3 0.5 1.6 0.0 0.2 0.1 0.7 0.7 0.2 0.5 0.5 4.2 0.9 0.6 0.5 0.4 0.3 3.3 4.0 0.8 0.0 0.2 0.2 0.0 0.5 0.1 0.1 0.9 0.6 0.5 0.7 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 2.0 1.1 1.9 0.0 0.0 0.5 0.0 0.1 0.0 2.0 0.1 0.6 0.0 0.4 0.0 0.3 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.4 0.3 0.5 0.7 0.7 0.2 0.5 0.5 0.6 0.7 0.0 0.0 1.9 0.7 0.0 0.1 1.9 2.0 0.0 0.6 1.2 1.4 2.1 0.0 3.1 1.8 0.0 3.7 0.4 0.4 0.0 0.0 0.7 8.2 0.1 0.1 0.0 5.5 1.1 0.0 0.8 0.3 0.0 0.9 76.0 1.2 0.0 0.1 0.1 0.0 1.8 0.1 4.1 0.0 0.2 0.5 0.6 0.1 0.0 0.0 0.1 0.5 0.0 1.0 1.5 0.1 0.0 0.4 0.1 0.2 0.1 0.0 5.6 8.6 0.0 0.0 0.3 2.2 0.7 0.0 0.1 1.9 0.7 0.3 0.5 0.5 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;thyroid gland: 39.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;B-cells: 33.4;Erythroid cells: 136.8;Oligodendrocyte precursor cells: 95.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 3.3;naive B-cell: 6.1" "Lineage enriched" "Detected in many" 6 "B-cells: 6.1" "Cell line enriched" "Detected in some" 5 "Daudi: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038470: AB_10673174" "prognostic favorable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.74e-2)" 0.4 0.4 11.6 3.8 12.6 6.6 0.5 12.2 11.8 0.4 5.5 0.3 0.6 0.2 1.9 0.3 0.2 0.3 6.5 11.6 11.6 0.7 3.0 5.8 7.3 17.9 13.7 9.2 0.1 1.7 0.0 3.2 0.2 14.6 4.2 0.2 0.0 1.4 4.5 0.1 0.2 3.4 0.2 14.5 5.4 2.3 0.4 12.9 2.6 39.1 0.0 8.7 0.5 0.3 17.2 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.4 17.5 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 1.7 0.3 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 2.6 0.0 0.7 0.2 0.0 1.3 0.2 0.2 3.7 0.1 0.7 0.8 0.1 3.8 0.7 0.0 0.5 0.0 0.2 1.5 0.0 0.0 0.1 1.0 0.0 0.1 3.1 1.3 3.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 6.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 11.6 12.6 12.2 11.8 11.6 11.6 17.9 13.7 9.2 14.6 14.5 12.9 17.2 0.7 28.9 8.8 0.0 33.4 1.5 2.3 1.3 1.2 0.9 3.2 3.2 21.0 0.0 1.4 0.0 4.2 3.3 2.0 1.5 0.0 0.6 1.6 0.5 1.6 1.0 0.0 136.8 0.1 3.8 8.6 4.1 2.6 1.3 2.5 1.9 1.4 4.3 4.6 0.0 0.3 1.2 0.0 1.9 7.4 1.7 0.6 2.5 3.6 3.7 1.9 0.5 1.0 95.5 17.7 1.3 0.6 0.4 9.5 6.2 0.6 1.6 0.5 2.0 0.0 3.1 1.9 1.4 2.1 1.3 2.8 4.0 3.0 0.3 0.8 1.6 UBN2 "FLJ25778, KIAA2030" ENSG00000157741 "Ubinuclein 2" Q6ZU65 7 139230356-139308236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 140.7;Late spermatids: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "basophil: 8.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019743, HPA020122, HPA020124" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202" "unprognostic (1.96e-1)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-3)" "unprognostic (9.88e-2)" "unprognostic (1.65e-1)" "unprognostic (4.96e-2)" "unprognostic (3.65e-2)" "unprognostic (4.54e-3)" "unprognostic (2.95e-1)" "unprognostic (2.91e-2)" "unprognostic (1.05e-2)" 3.3 4.6 4.6 2.4 3.4 5.9 4.8 13.0 6.4 5.7 2.0 4.1 2.4 4.7 6.9 4.4 5.3 2.7 3.7 3.7 2.5 3.3 4.4 3.7 2.6 2.9 2.6 1.7 6.2 6.6 4.0 8.5 3.0 5.1 4.6 3.3 13.6 5.0 3.0 7.4 9.8 3.8 3.0 0.2 3.5 4.0 14.6 2.3 3.3 5.8 4.9 2.5 4.1 5.1 8.5 3.3 3.1 4.9 6.1 3.8 3.5 3.7 1.8 2.7 1.6 2.0 3.7 3.2 5.5 3.4 2.3 4.2 3.0 6.3 1.5 2.9 2.8 3.7 4.2 5.8 4.1 2.2 8.2 3.1 2.4 4.3 2.2 3.4 3.0 3.3 2.9 9.9 4.1 2.1 5.0 5.9 9.4 6.9 3.3 2.2 3.4 4.6 3.9 2.3 2.4 8.0 5.8 5.7 3.9 2.7 4.5 2.5 5.4 3.7 2.0 2.3 3.1 2.4 4.8 5.8 9.5 3.4 4.9 3.0 8.5 0.6 0.0 0.3 0.2 0.2 0.5 0.3 0.3 0.2 0.6 0.4 0.3 0.5 1.9 0.2 0.7 0.2 0.1 4.6 3.4 13.0 6.4 3.7 2.5 2.9 2.6 1.7 5.1 0.2 2.3 8.5 21.0 6.4 23.6 58.1 11.7 23.3 18.6 9.9 15.4 54.0 23.2 13.6 27.2 21.5 15.0 22.0 93.8 9.0 21.8 16.5 7.9 8.0 140.7 58.3 38.2 17.7 23.4 24.8 97.5 6.9 8.9 20.2 14.3 68.8 11.4 28.7 17.5 22.6 7.1 45.4 95.1 16.7 10.2 11.5 17.9 178.6 22.4 15.4 8.8 53.4 19.0 23.6 16.5 79.4 84.9 9.2 14.0 21.4 16.2 41.5 15.7 11.0 36.5 58.2 19.7 37.6 22.8 44.6 31.6 20.9 28.8 14.6 14.3 27.2 13.5 28.4 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924929 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 252.3;Inhibitory neurons: 242.4;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol No No Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: AB_2686336" "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 8.5 5.9 5.9 5.6 8.4 16.0 8.9 13.4 9.9 8.3 5.7 7.8 4.7 8.4 8.3 7.5 8.0 5.9 7.3 8.2 6.7 7.4 6.7 10.0 7.0 4.8 5.3 7.2 9.9 8.4 11.5 9.0 7.3 6.2 8.3 5.4 17.1 7.3 5.9 8.7 10.5 6.9 6.1 2.9 6.8 7.9 13.9 5.3 8.8 10.3 8.5 6.5 10.0 8.6 7.8 6.3 5.2 7.7 9.4 9.1 11.8 12.3 6.8 7.5 5.4 7.6 5.7 6.7 10.8 5.0 7.3 8.4 3.4 6.8 5.5 10.0 9.8 5.4 7.1 5.1 5.2 7.6 11.7 6.8 7.9 6.1 6.0 12.0 8.2 6.6 7.7 11.3 19.1 9.8 3.3 15.6 12.0 6.9 6.2 3.1 10.1 6.5 8.9 5.3 11.9 8.9 7.3 7.9 4.9 7.3 7.5 4.5 7.8 9.7 5.9 4.3 12.9 5.5 21.6 12.9 16.7 9.7 11.3 6.6 1.9 1.0 4.1 1.5 0.9 1.0 1.3 1.5 1.2 0.8 1.1 2.6 1.3 2.0 3.5 1.3 1.0 1.5 0.6 5.9 8.4 13.4 9.9 8.2 6.7 4.8 5.3 7.2 6.2 2.9 5.3 7.8 43.4 22.4 45.7 151.1 58.4 21.5 24.6 6.0 23.3 29.7 31.2 21.2 19.8 10.0 18.7 25.8 35.5 15.7 73.5 8.8 7.9 14.3 68.6 50.6 37.4 23.4 19.2 14.9 252.3 9.8 12.9 22.0 21.9 69.2 24.7 45.5 9.3 9.6 9.4 25.2 242.4 9.8 8.2 13.6 37.1 36.5 16.4 30.1 16.0 126.5 14.6 11.3 15.5 206.1 202.6 15.4 8.1 10.1 48.7 23.8 8.0 13.4 20.0 33.0 6.6 24.1 24.7 43.8 26.0 14.5 24.0 75.5 41.4 30.9 8.7 33.4 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lung: 759.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0" "Group enriched" "Detected in many" 4 "lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 82 "BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.3 0.8 0.0 0.3 0.0 0.0 19.3 2.1 0.2 67.1 5.5 0.0 16.6 34.9 0.1 1.5 70.5 9.1 0.1 0.1 0.6 16.8 1.2 759.7 0.1 0.0 0.2 0.0 1.4 7.3 0.0 2.1 4.8 0.2 1.0 0.0 0.5 91.0 16.9 0.1 2.3 4.4 0.2 0.0 0.7 2.5 2.7 0.2 2.1 33.9 0.0 7.5 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.2 0.1 0.2 121.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.4 0.1 0.0 0.2 0.1 0.1 86.8 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.7 0.9 0.0 0.5 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.1 0.6 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.2 477.5 1315.9 0.0 0.1 0.0 0.1 79.1 0.0 0.0 41.5 7.5 0.8 34.3 179.9 20.2 0.0 1.4 0.0 0.0 5.9 72.2 5.4 78.6 30.3 2.5 0.0 0.0 0.1 8.5 0.0 2.6 0.0 241.3 29.0 0.0 0.0 0.0 0.2 0.0 0.1 1.2 26.4 0.0 0.0 20.8 1.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 2.5 0.0 0.0 11.8 13.6 3.4 217.0 0.0 0.0 0.0 5.8 2.1 0.1 0.0 0.0 0.3 4.8 0.0 1.8 4.0 ACAN "AGC1, CSPG1, CSPGCP, MSK16" ENSG00000157766 Aggrecan P16112 15 88803436-88875353 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;seminal vesicle: 3.1" "Group enriched" "Detected in some" 15 "Extravillous trophoblasts: 127.1;Granulosa cells: 132.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "WM-115: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016377, HPA038241, HPA038242" Enhanced "Secreted to extracellular matrix" NA NA 17000000 "CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910" "unprognostic (2.69e-3)" "unprognostic (4.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.13e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (7.12e-2)" "unprognostic (8.57e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (7.79e-2)" "unprognostic (1.53e-1)" "unprognostic (7.71e-2)" "unprognostic (7.27e-2)" 1.2 0.2 0.6 0.9 0.9 0.1 0.1 2.1 1.8 0.9 1.3 0.3 0.1 0.4 0.2 0.1 0.2 0.7 0.5 0.6 4.7 0.7 0.1 0.7 0.1 2.0 1.2 0.6 0.4 0.2 0.1 0.4 0.2 1.6 0.5 0.3 0.1 0.1 3.1 0.2 0.2 0.1 0.5 1.3 0.2 0.2 1.4 1.2 0.0 0.3 0.0 0.0 0.8 0.7 1.4 0.0 0.0 0.0 0.0 0.8 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 2.1 1.8 0.6 4.7 2.0 1.2 0.6 1.6 1.3 1.2 1.4 0.1 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 1.2 0.0 127.1 0.7 0.0 0.4 1.3 132.4 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.5 2.1 0.0 0.2 1.8 1.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 8.4 2.3 6.3 0.0 0.4 3.6 0.1 1.8 0.0 0.4 PSMG3 "C7orf48, MGC10911, PAC3" ENSG00000157778 "Proteasome assembly chaperone 3" Q9BT73 7 1567332-1571005 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023876 Approved NA NA "HPA023876: AB_1844356" "unprognostic (3.08e-1)" "unprognostic (9.21e-2)" "unprognostic (4.40e-3)" "unprognostic (5.02e-2)" "unprognostic (3.10e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.12e-1)" "unprognostic (4.82e-1)" "unprognostic (1.65e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (5.13e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" 25.1 27.9 41.0 15.6 41.6 46.5 25.9 41.1 45.7 25.3 40.6 26.9 23.0 22.8 16.5 53.3 29.2 15.1 22.5 43.0 41.4 37.3 33.4 22.7 25.9 41.5 41.7 43.0 19.3 28.0 14.9 30.1 15.9 42.6 28.5 17.6 13.5 31.1 18.5 27.8 57.2 31.6 12.3 40.2 38.6 31.2 18.4 43.0 26.1 23.9 13.9 20.9 25.9 33.5 43.6 130.1 81.6 58.7 57.1 44.8 51.8 57.7 29.2 51.8 72.8 61.7 75.8 82.7 41.1 34.0 49.4 102.3 99.5 75.0 77.2 33.1 39.1 131.1 44.0 176.9 66.5 70.4 58.2 39.6 44.2 93.1 55.2 62.5 31.9 29.7 98.6 121.0 61.4 54.3 220.5 38.0 189.4 117.3 89.3 150.3 63.1 31.4 91.8 59.7 64.6 87.6 75.1 35.8 127.3 80.8 14.6 90.1 108.2 20.6 67.1 97.9 83.9 86.8 69.2 69.4 110.8 39.7 183.3 143.0 54.9 47.6 51.3 40.0 50.2 47.7 41.2 40.5 36.4 47.6 33.4 38.8 38.8 12.3 36.3 54.6 71.1 35.5 38.4 41.0 41.6 41.1 45.7 43.0 41.4 41.5 41.7 43.0 42.6 40.2 43.0 43.6 28.5 19.2 15.1 2.3 23.9 53.3 26.4 46.1 48.9 17.5 36.8 40.9 11.4 34.3 30.4 35.0 4.2 49.2 28.7 42.9 84.1 49.5 7.1 62.3 30.0 29.3 28.8 65.0 9.7 51.4 88.2 30.8 30.1 38.5 15.2 25.1 24.3 36.0 56.3 6.7 8.6 64.0 38.7 26.8 31.6 5.8 36.1 24.0 39.2 4.7 37.5 28.0 36.0 7.5 8.2 61.8 40.4 25.9 31.2 41.0 44.1 85.3 50.0 18.6 26.3 22.4 29.7 24.8 36.3 56.9 58.4 39.4 26.4 31.9 48.2 29.0 CABP1 ENSG00000157782 "Calcium binding protein 1" Q9NZU7 12 120640552-120667324 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 334.3;choroid plexus: 111.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 126.7;Excitatory neurons: 296.9;Horizontal cells: 323.0" "Cancer enhanced" "Detected in some" "renal cancer: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;NTERA-2: 6.8;RT4: 3.9;SCLC-21H: 3.2;U-87 MG: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051438 Uncertain "Intracellular and membrane" NA NA "HPA051438: AB_2681486" "unprognostic (2.57e-1)" "unprognostic (4.79e-2)" "unprognostic (1.92e-4)" "unprognostic (1.16e-1)" "unprognostic (4.13e-3)" "unprognostic (6.28e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-1)" "unprognostic (8.12e-3)" "unprognostic (7.59e-2)" "unprognostic (1.04e-2)" "unprognostic (6.60e-2)" "unprognostic (7.73e-3)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (3.61e-2)" "unprognostic (2.85e-1)" 10.7 1.7 145.0 0.6 197.6 0.0 5.1 131.8 334.3 2.9 111.0 2.8 0.8 2.8 3.2 1.4 3.1 1.0 7.6 184.9 136.1 9.4 0.2 0.6 0.3 137.3 137.0 179.5 1.3 1.5 7.4 5.5 1.2 167.3 3.7 1.5 25.9 0.4 3.7 2.8 0.8 2.3 2.3 118.4 1.2 2.9 1.5 118.7 0.2 1.3 5.5 0.2 6.2 3.0 236.2 0.1 0.5 2.8 0.9 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.2 0.0 0.0 0.5 0.0 1.2 0.2 2.5 0.0 0.1 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.3 0.3 0.0 6.8 2.2 0.4 1.7 0.0 0.0 2.7 3.9 3.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 145.0 197.6 131.8 334.3 184.9 136.1 137.3 137.0 179.5 167.3 118.4 118.7 236.2 43.4 0.0 0.0 9.1 0.0 0.1 0.2 0.1 0.0 126.7 0.4 0.3 2.6 0.0 0.0 1.8 0.0 0.1 0.0 0.5 31.3 0.1 2.1 0.0 0.1 8.9 0.0 0.0 296.9 0.0 0.4 2.8 3.1 0.1 0.0 0.0 0.0 0.0 0.3 323.0 44.2 0.5 0.0 0.0 2.0 3.6 0.3 0.3 0.0 9.4 0.0 9.9 0.0 22.6 8.5 0.0 0.0 2.2 0.0 0.3 0.0 3.7 0.0 10.9 19.7 0.5 12.6 0.4 1.8 0.0 0.3 0.3 0.2 0.1 0.0 0.2 WDR19 "DYF-2, FAP66, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp" ENSG00000157796 "WD repeat domain 19" Q8NEZ3 4 39182504-39285810 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 61.8;Inhibitory neurons: 82.5;Respiratory ciliated cells: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 45.3;ASC TERT1: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039616, HPA058847" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA039616: AB_10796331, HPA058847: AB_2683834" "unprognostic (1.80e-1)" "unprognostic (9.32e-2)" "unprognostic (6.40e-2)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (1.26e-3)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "prognostic favorable (2.70e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (5.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.56e-2)" 7.6 8.1 3.8 5.3 2.1 3.8 9.3 4.7 3.2 10.6 8.8 5.5 1.9 16.1 13.4 4.0 20.5 8.5 4.2 1.9 3.8 8.8 6.3 8.9 4.8 5.1 2.8 1.7 18.0 5.4 8.1 9.2 6.3 2.4 7.7 4.2 13.1 5.8 8.5 2.3 5.5 4.7 9.2 3.4 4.6 6.3 14.1 2.0 7.0 16.8 2.4 4.9 6.3 6.9 3.2 6.1 5.2 10.3 12.1 45.3 47.0 4.7 7.5 17.2 8.1 10.6 2.8 6.5 10.4 4.1 7.8 17.2 4.0 10.9 5.4 8.6 0.5 8.5 2.2 10.3 6.1 16.1 9.6 2.6 30.5 11.1 11.9 7.2 24.6 10.7 11.0 8.7 9.1 9.9 2.1 7.7 8.1 3.5 3.7 5.6 8.2 10.4 4.2 7.0 2.9 11.5 10.4 10.2 2.4 6.1 13.1 5.5 3.6 7.9 7.9 5.3 17.5 7.8 7.2 7.6 7.6 11.9 3.3 3.7 0.1 0.3 0.2 0.3 0.5 0.3 0.8 0.5 0.6 0.3 1.2 0.5 0.6 0.3 0.8 0.5 0.1 0.3 0.2 3.8 2.1 4.7 3.2 1.9 3.8 5.1 2.8 1.7 2.4 3.4 2.0 3.2 5.5 12.8 9.3 26.1 5.4 4.8 4.9 4.6 2.2 10.1 7.3 7.4 4.5 2.8 9.4 18.4 10.4 1.2 1.8 0.7 0.0 5.5 5.1 32.3 14.6 6.7 2.4 4.0 61.8 3.6 3.2 10.8 2.0 12.0 2.5 13.4 4.2 10.0 3.2 25.2 82.5 2.0 12.2 3.2 3.6 3.4 16.4 3.0 1.8 19.7 1.8 6.7 1.0 18.1 19.7 2.9 0.2 18.8 3.9 3.0 0.3 4.0 46.6 21.7 0.0 10.9 7.9 33.8 10.2 3.9 4.7 1.4 2.9 13.1 1.1 1.9 SLC37A3 DKFZp761N0624 ENSG00000157800 "Solute carrier family 37 member 3" Q8NCC5 7 140293693-140404433 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-1)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.44e-1)" "unprognostic (5.59e-2)" "unprognostic (2.69e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.78e-5)" "unprognostic (1.97e-1)" "unprognostic (2.94e-1)" "unprognostic (3.78e-2)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-2)" "unprognostic (3.31e-1)" "unprognostic (3.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.50e-2)" 19.0 10.3 12.0 10.7 12.8 12.4 21.7 12.4 14.2 28.4 9.1 26.7 14.2 44.4 24.1 11.5 23.6 19.3 11.6 11.8 12.6 15.8 12.9 16.7 9.2 11.7 11.2 11.3 20.9 25.9 35.2 17.3 22.0 11.8 14.9 24.8 11.4 23.5 12.9 7.9 13.1 16.5 32.2 10.4 15.8 18.6 7.5 12.1 11.8 21.5 10.0 10.7 22.4 18.4 12.5 18.0 29.9 30.3 53.3 42.7 46.6 36.2 26.3 30.8 17.9 26.6 23.9 38.1 2.7 32.6 24.0 45.8 14.5 18.5 32.0 27.3 40.6 27.1 3.5 7.8 24.1 35.9 0.2 9.7 36.8 32.3 19.0 22.0 31.2 27.9 15.5 18.2 7.3 27.8 34.3 17.5 1.6 44.9 43.2 18.4 9.5 8.1 8.2 34.5 37.0 29.8 36.7 7.3 29.5 29.7 32.3 15.9 1.7 32.0 20.4 14.8 51.8 27.3 14.0 28.4 6.9 21.6 0.2 47.7 7.6 3.6 3.7 6.5 2.0 3.5 2.3 6.9 5.1 3.0 1.7 7.3 5.5 12.3 5.9 1.3 0.9 8.6 3.6 12.0 12.8 12.4 14.2 11.8 12.6 11.7 11.2 11.3 11.8 10.4 12.1 12.5 8.5 9.6 12.4 14.4 6.0 15.2 39.8 11.8 8.6 11.4 12.1 8.6 5.1 10.0 16.1 12.9 10.4 17.5 5.8 21.0 1.9 22.3 1.6 24.9 43.8 11.6 21.6 6.1 37.1 26.9 26.4 30.6 19.9 21.3 8.2 15.0 13.2 7.3 4.0 13.5 29.0 22.2 14.2 5.1 9.7 2.3 20.2 3.3 19.6 13.1 7.4 3.6 11.3 26.7 22.4 28.6 14.7 13.5 4.2 31.4 11.2 5.7 18.4 9.0 6.6 15.1 16.9 4.6 5.9 8.5 12.4 13.1 10.6 5.1 18.1 37.4 AP3S2 sigma3b ENSG00000157823 "Adaptor related protein complex 3 subunit sigma 2" P59780 15 89830599-89894638 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA Vesicles "HPA049270: AB_2680696" "unprognostic (1.46e-1)" "unprognostic (1.60e-2)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (2.68e-1)" "unprognostic (3.78e-2)" "unprognostic (5.27e-2)" "unprognostic (3.03e-1)" "unprognostic (7.59e-2)" "unprognostic (1.22e-1)" "unprognostic (4.31e-2)" "prognostic favorable (5.55e-16)" "unprognostic (7.97e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (8.67e-3)" 24.5 20.5 14.9 11.3 15.7 10.5 19.6 14.7 18.2 17.4 12.5 19.5 11.0 13.2 16.4 20.8 17.4 17.7 31.0 14.7 16.1 36.8 40.8 16.4 13.0 15.6 18.1 14.6 20.1 19.1 32.8 9.0 18.7 16.9 15.4 19.4 44.4 13.6 21.6 45.2 8.3 10.3 18.1 14.8 12.8 10.1 12.6 16.3 20.3 26.4 45.6 17.8 15.5 6.9 16.5 13.5 60.6 33.4 35.6 66.7 45.6 28.0 58.8 75.2 74.3 59.7 26.0 34.8 12.1 51.3 39.1 48.9 31.0 57.4 33.1 58.3 51.2 29.0 37.3 25.4 33.6 28.1 16.1 22.3 30.9 40.4 20.7 41.6 40.6 38.8 30.8 29.1 32.8 48.0 27.7 27.6 8.7 37.2 68.5 11.6 15.9 33.8 25.0 42.1 35.9 25.5 22.3 69.4 43.1 40.4 69.8 26.9 14.1 16.3 40.0 19.2 62.1 19.6 28.3 94.5 28.9 35.8 18.7 24.1 6.3 16.6 7.8 5.0 15.4 7.8 4.5 7.2 7.4 11.6 6.3 5.7 4.0 16.1 8.3 19.9 7.4 8.4 10.6 14.9 15.7 14.7 18.2 14.7 16.1 15.6 18.1 14.6 16.9 14.8 16.3 16.5 5.9 12.8 15.4 0.0 5.9 3.3 4.0 6.0 5.2 22.0 8.0 5.7 18.2 10.0 11.2 5.5 35.5 8.9 6.1 34.4 9.8 13.4 3.1 5.9 10.8 7.2 14.4 5.0 0.0 16.1 4.2 9.0 8.2 7.1 8.2 15.4 8.9 17.0 6.4 18.5 0.0 11.4 2.0 12.0 6.4 3.2 7.2 9.7 8.8 0.0 16.9 17.3 9.2 0.0 0.0 13.4 16.4 7.5 8.6 5.8 15.8 13.7 9.8 30.6 0.0 6.1 6.0 11.6 8.3 6.1 2.8 6.4 6.2 28.5 15.2 4.2 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335174-152649826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 233.0" "Cell type enhanced" "Detected in many" "Astrocytes: 668.0;Excitatory neurons: 574.9;Inhibitory neurons: 321.9;Oligodendrocyte precursor cells: 371.0;Oligodendrocytes: 2442.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 5 "monocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 191.4;hTERT-HME1: 123.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 25.4 25.4 101.4 11.2 152.2 0.7 20.9 141.5 117.2 17.8 81.1 14.6 9.0 20.9 15.0 8.6 15.4 16.9 10.5 99.1 115.4 20.2 8.2 32.5 14.3 165.8 146.8 83.2 54.5 18.2 23.3 28.6 58.7 162.0 15.3 12.4 10.7 32.4 11.8 24.3 11.0 11.7 16.5 155.3 20.0 17.5 9.1 136.6 14.9 33.4 19.4 8.4 19.5 18.4 233.0 14.5 15.1 45.9 25.5 54.5 58.3 191.4 14.4 29.4 24.9 34.8 16.3 0.9 0.3 29.8 12.6 53.7 16.2 22.4 45.8 39.6 0.1 23.4 0.2 10.0 70.2 15.7 4.0 0.8 38.4 27.8 48.2 123.5 48.3 44.7 6.6 0.6 0.3 13.9 4.0 0.8 4.5 29.5 12.4 30.0 25.9 9.9 20.9 72.9 9.9 46.6 38.0 12.2 4.5 51.4 38.7 1.1 1.5 49.9 37.4 1.0 12.7 25.0 1.3 0.5 0.1 34.7 3.3 77.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 101.4 152.2 141.5 117.2 99.1 115.4 165.8 146.8 83.2 162.0 155.3 136.6 233.0 21.5 25.6 25.9 668.0 2.7 26.4 23.0 14.0 19.4 23.8 11.4 10.0 3.8 1.5 16.4 11.0 0.0 36.1 4.5 2.6 13.7 20.4 24.5 14.1 10.8 29.1 8.3 0.4 574.9 6.9 17.8 36.2 8.2 27.0 1.3 36.0 20.0 1.3 40.6 0.0 321.9 3.3 10.2 64.8 53.0 10.5 35.1 31.5 7.2 245.4 4.4 3.9 1.0 371.0 2442.0 10.0 2.1 41.3 5.6 33.5 0.7 8.9 8.5 2.0 6.6 18.7 13.2 6.7 8.0 6.3 16.9 27.0 2.1 13.0 6.1 13.2 GAREM2 "FAM59B, FLJ00375, GAREML, KIAA2038" ENSG00000157833 "GRB2 associated regulator of MAPK1 subtype 2" Q75VX8 2 26173088-26189663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.4;choroid plexus: 10.5;parathyroid gland: 23.0" "Group enriched" "Detected in many" 4 "Distal tubular cells: 46.9;Muller glia cells: 19.5;Proximal tubular cells: 42.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 16.8;SH-SY5Y: 10.2;U-2 OS: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071575 Approved Cytosol NA NA Cytosol "HPA071575: AB_2686420" "unprognostic (1.70e-2)" "unprognostic (5.62e-2)" "unprognostic (7.61e-4)" "unprognostic (1.56e-2)" "unprognostic (8.27e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "unprognostic (1.99e-1)" "unprognostic (2.12e-2)" "unprognostic (2.65e-1)" "unprognostic (1.33e-1)" "unprognostic (3.94e-2)" "unprognostic (1.15e-3)" "unprognostic (1.35e-1)" "unprognostic (3.22e-1)" "unprognostic (1.46e-2)" "unprognostic (1.04e-1)" 2.2 0.9 26.3 1.2 27.7 0.4 1.9 30.7 23.2 2.2 10.5 3.0 0.6 3.3 0.9 1.5 2.5 1.7 2.4 21.2 24.9 1.6 0.2 1.0 1.5 37.4 31.3 18.2 3.7 3.0 23.0 2.3 0.8 30.7 1.8 1.8 3.3 1.4 2.1 2.7 1.5 1.6 2.3 27.2 1.4 2.0 2.6 34.9 0.6 1.7 2.6 1.2 2.7 2.1 24.2 3.0 4.4 5.2 0.4 0.9 1.8 0.4 1.6 0.0 0.5 0.4 8.5 1.0 0.0 2.1 3.4 5.3 0.1 16.8 0.0 0.7 1.9 6.2 1.5 1.5 0.5 6.2 0.1 0.3 2.5 0.8 2.5 0.2 0.3 2.0 4.1 8.1 0.1 3.1 0.0 0.4 0.6 5.6 0.5 1.2 1.7 0.0 0.1 2.7 0.9 1.1 10.2 3.7 0.4 3.2 1.5 0.2 9.0 0.9 2.3 13.8 4.1 0.1 0.3 0.0 1.9 0.1 0.0 3.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.5 0.0 0.0 26.3 27.7 30.7 23.2 21.2 24.9 37.4 31.3 18.2 30.7 27.2 34.9 24.2 1.2 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 1.0 0.5 0.9 0.0 1.5 0.0 3.7 2.1 0.4 1.2 1.3 46.9 2.2 4.4 0.5 2.2 1.7 0.0 0.4 0.0 1.6 2.6 3.8 3.6 0.5 0.0 0.8 0.4 0.0 0.6 0.0 0.0 0.7 0.0 0.3 0.0 7.6 2.1 1.1 0.0 0.0 0.6 19.5 2.1 0.0 0.0 1.6 1.2 3.4 0.1 1.1 0.1 42.1 0.0 1.2 6.6 1.6 1.7 1.9 6.2 0.1 0.0 0.3 2.3 0.4 1.5 0.3 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904358 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA004194: AB_2667171, HPA059958: AB_2684179" "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavorable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 21.1 15.0 25.7 12.0 28.3 21.1 24.5 29.9 27.7 26.1 14.0 27.0 18.3 26.6 15.9 44.7 28.9 18.9 18.2 26.1 26.2 23.0 19.4 20.5 16.0 26.6 26.4 23.4 31.7 21.5 50.0 14.0 28.7 25.6 20.8 27.5 15.6 20.4 27.2 15.9 55.6 18.9 29.8 25.2 24.5 15.4 39.3 26.9 33.0 31.5 19.8 28.1 28.8 34.5 31.4 30.0 29.2 43.4 27.4 56.2 37.7 30.5 22.5 66.6 47.4 37.9 30.5 29.9 27.4 0.1 39.4 42.0 35.6 44.8 48.4 48.9 21.9 27.5 23.6 16.2 23.4 59.2 27.4 29.3 38.1 75.9 40.7 38.1 56.0 47.1 41.5 26.5 13.4 41.2 26.3 36.7 22.0 29.2 27.8 20.6 21.6 36.6 19.7 36.8 83.8 29.7 31.9 42.8 19.6 34.7 46.1 58.9 18.7 35.4 21.9 29.5 13.6 17.1 30.9 60.3 26.4 32.5 22.3 36.9 4.8 1.2 1.1 1.3 1.2 1.8 1.3 1.6 1.7 2.1 1.6 1.5 1.7 2.2 1.3 1.1 2.7 1.4 0.7 25.7 28.3 29.9 27.7 26.1 26.2 26.6 26.4 23.4 25.6 25.2 26.9 31.4 35.2 19.2 20.8 79.3 25.3 55.1 32.3 29.4 43.3 37.8 35.2 24.1 21.2 20.0 19.8 40.5 27.1 42.0 21.2 47.2 1.9 19.3 8.6 20.9 26.9 33.0 27.1 14.5 97.2 24.7 29.0 33.2 25.0 29.7 4.5 68.7 37.5 33.1 38.3 37.0 112.6 33.7 22.4 38.1 39.3 8.0 28.6 34.5 26.6 79.6 26.6 23.0 16.5 141.3 192.3 22.8 34.9 35.0 22.0 33.4 34.0 18.1 18.1 22.4 13.1 32.3 27.4 55.6 41.1 76.9 84.7 64.6 22.4 35.0 35.4 37.6 DPYSL5 "CRAM, CRMP-5, CRMP5, CV2, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 118.8" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: AB_2686516" "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 0.0 1.9 29.9 0.3 49.4 0.0 0.0 56.1 39.9 0.1 4.6 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 17.7 43.6 0.0 0.0 0.0 0.0 68.7 51.1 17.8 0.1 0.0 0.0 7.9 0.0 66.5 0.1 0.2 15.9 0.0 0.0 0.1 0.0 0.3 0.3 71.6 0.0 0.1 7.8 58.0 0.0 0.0 0.0 0.0 0.0 0.1 118.8 0.0 3.0 141.0 0.1 0.6 0.0 3.3 0.0 0.0 0.0 0.0 13.2 0.0 0.0 1.0 0.0 3.9 0.0 118.7 0.0 0.0 0.0 26.2 0.0 0.1 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 31.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 167.3 99.0 3.8 0.2 0.0 3.3 0.0 0.0 0.0 0.0 4.1 0.1 3.8 0.0 5.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 49.4 56.1 39.9 17.7 43.6 68.7 51.1 17.8 66.5 71.6 58.0 118.8 0.1 0.0 0.0 13.4 0.1 0.0 0.3 0.0 0.0 12.1 0.1 0.0 6.0 0.0 0.0 0.0 85.5 0.1 0.0 0.0 0.0 0.0 45.6 0.1 0.1 0.4 0.0 0.0 18.3 0.0 0.0 0.3 0.0 0.2 2.5 0.2 0.0 0.2 0.1 8.4 40.5 0.0 0.0 0.0 0.7 134.3 1.5 0.2 1.8 2.8 0.1 17.2 0.0 18.1 331.2 0.0 0.0 1.2 0.1 0.2 0.0 0.1 0.0 12.1 0.0 0.7 0.3 2.9 4.6 0.0 0.3 0.0 0.2 0.7 0.0 0.1 DRC1 "C2orf39, CCDC164, CILD21, FLJ32660, MGC16372" ENSG00000157856 "Dynein regulatory complex subunit 1" Q96MC2 2 26401920-26456711 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 39.6;testis: 21.0" "Group enriched" "Detected in some" 5 "Early spermatids: 142.0;Endometrial ciliated cells: 112.8;Late spermatids: 321.2;Respiratory ciliated cells: 260.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 6.9" NA NA "unprognostic (2.28e-3)" "unprognostic (2.68e-2)" "unprognostic (5.36e-2)" "unprognostic (5.27e-3)" "unprognostic (3.41e-3)" "unprognostic (8.56e-3)" "unprognostic (7.02e-4)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (7.26e-2)" "unprognostic (1.97e-3)" "unprognostic (2.99e-1)" "unprognostic (3.06e-3)" "unprognostic (8.19e-2)" "unprognostic (9.91e-3)" "unprognostic (2.16e-1)" "unprognostic (1.30e-2)" 0.0 0.0 6.3 0.0 2.4 0.7 0.0 2.6 1.4 0.8 8.5 0.1 0.0 0.9 0.1 0.0 39.6 0.0 0.0 1.7 5.8 0.1 0.0 3.1 0.0 4.9 4.7 1.0 0.0 0.0 0.0 3.2 0.0 4.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 21.0 2.9 0.3 0.1 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 6.3 2.4 2.6 1.4 1.7 5.8 4.9 4.7 1.0 4.3 5.6 2.9 5.0 0.2 0.0 1.1 1.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.3 0.5 0.0 17.9 1.8 0.0 0.0 0.0 0.1 0.0 0.0 142.0 112.8 1.2 0.3 0.0 0.0 4.3 0.7 0.0 0.5 0.0 1.5 1.3 0.0 0.0 0.0 0.1 0.0 4.8 0.1 10.2 0.0 0.0 321.2 2.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 1.2 0.4 0.0 0.2 1.3 0.1 260.8 0.0 0.0 0.0 2.4 39.5 1.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 RAB28 ENSG00000157869 "RAB28, member RAS oncogene family" P51157 4 13361354-13484365 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 119.9;Inhibitory neurons: 140.4;Spermatocytes: 123.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044575 Approved NA NA "HPA044575: AB_10959460" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (2.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.69e-2)" "unprognostic (2.09e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (5.31e-3)" "prognostic favorable (1.61e-4)" 17.3 19.1 27.6 12.9 27.6 19.5 20.5 42.0 29.6 15.4 25.7 15.2 11.1 22.7 19.0 12.1 22.1 15.6 30.7 26.0 30.7 16.6 12.0 16.2 18.4 26.8 30.4 26.3 22.6 10.1 24.1 19.4 19.6 29.1 16.3 18.3 55.9 12.2 16.1 7.3 20.0 11.4 17.4 26.9 17.3 14.7 38.0 30.5 18.6 19.7 13.4 16.9 13.3 13.4 31.0 22.0 11.4 36.3 18.6 18.7 34.8 19.0 19.7 22.7 21.7 28.9 11.3 22.7 26.0 12.5 19.3 46.0 11.1 31.4 17.6 39.3 16.7 15.7 18.6 20.1 10.8 18.3 21.2 10.9 16.0 23.3 19.8 18.7 26.5 23.9 32.9 37.0 97.1 30.4 8.8 45.3 52.7 50.7 16.4 19.9 28.6 22.8 21.5 18.7 11.9 28.7 17.3 17.0 12.2 28.1 28.2 13.7 23.8 16.5 28.8 12.6 23.8 30.7 24.0 18.0 34.6 25.7 38.3 38.6 21.0 16.2 26.1 16.5 15.6 17.0 18.4 15.3 16.2 16.8 17.9 20.3 16.5 15.1 20.6 14.4 12.9 17.2 10.6 27.6 27.6 42.0 29.6 26.0 30.7 26.8 30.4 26.3 29.1 26.9 30.5 31.0 17.8 6.4 6.4 81.0 22.3 27.4 26.7 38.7 22.2 31.0 15.6 14.0 18.2 2.8 16.7 7.3 33.3 23.3 15.1 7.9 19.6 12.9 19.1 19.6 17.7 18.4 10.3 9.9 119.9 14.2 22.7 27.5 11.7 8.2 5.1 12.4 12.8 6.8 17.0 32.0 140.4 11.0 32.6 15.1 18.2 20.6 18.6 14.2 30.2 49.6 16.7 44.5 19.6 97.0 79.8 11.2 7.8 24.0 19.2 21.4 6.3 18.8 36.5 44.1 19.7 24.1 20.1 123.9 63.7 20.6 30.0 27.9 21.3 10.6 11.6 19.0 PRXL2B "C1orf93, FAM213B, MGC26818" ENSG00000157870 "Peroxiredoxin like 2B" Q8TBF2 1 2586491-2591469 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 5.0;Endothelial cells: 2.1;Hofbauer cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 51.8;U-2197: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006403 Approved Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006403: AB_1853870" "unprognostic (1.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (2.83e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.24e-3)" "unprognostic (2.76e-1)" "prognostic favorable (1.28e-4)" "unprognostic (5.22e-3)" "unprognostic (2.03e-1)" "unprognostic (7.91e-3)" "unprognostic (2.20e-2)" 8.0 18.7 8.8 4.9 11.3 3.2 9.3 5.2 16.5 8.6 1.8 19.4 18.9 9.3 1.4 12.4 11.0 6.0 6.2 10.9 10.2 14.3 7.0 11.8 5.1 8.7 9.3 11.2 6.3 6.9 5.4 8.8 6.8 9.0 10.1 5.9 2.8 7.8 5.7 1.4 7.6 20.7 3.7 6.1 15.4 14.4 6.7 9.2 4.1 8.2 0.7 3.9 11.8 8.2 7.6 15.8 8.7 9.8 9.1 3.8 4.6 1.2 5.4 6.2 13.6 5.6 6.7 18.0 4.2 13.9 9.5 5.4 12.6 8.2 9.5 4.5 11.8 3.8 9.9 6.1 11.3 10.3 5.3 3.0 6.4 5.2 9.8 3.2 6.7 19.0 6.8 13.3 6.4 13.9 7.7 12.2 2.5 10.4 19.8 31.6 14.2 12.8 10.1 14.2 8.3 11.7 18.0 12.2 51.8 16.8 2.2 9.3 2.2 28.1 11.2 12.7 46.3 5.4 5.2 8.1 3.0 11.0 19.9 2.8 1.9 1.5 0.8 2.5 1.5 4.2 1.2 2.8 2.9 1.6 0.9 2.5 3.7 1.1 4.8 1.4 0.7 4.4 2.4 8.8 11.3 5.2 16.5 10.9 10.2 8.7 9.3 11.2 9.0 6.1 9.2 7.6 5.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 TNFRSF14 "ATAR, CD270, HVEA, HVEM, LIGHTR, TR2" ENSG00000157873 "TNF receptor superfamily member 14" Q92956 1 2555639-2565382 "Cancer-related genes, CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 16.2" "Low region specificity" "Detected in all" "HPA006404, CAB026150, CAB030007" Approved NA NA 110000 "CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348" "prognostic favorable (4.39e-5)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "prognostic favorable (8.01e-6)" "unprognostic (1.11e-2)" "unprognostic (6.83e-3)" "unprognostic (9.62e-3)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (1.62e-1)" "unprognostic (2.31e-1)" "unprognostic (1.64e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-2)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" "prognostic favorable (7.79e-6)" 34.6 72.4 3.1 6.3 3.1 5.0 35.1 3.0 6.7 51.8 4.7 49.3 17.1 33.2 1.2 26.6 40.2 4.4 22.0 3.5 3.3 56.9 62.3 58.5 10.1 3.2 3.1 2.8 33.3 20.6 3.9 24.5 2.9 3.2 50.8 5.6 0.7 35.6 2.4 6.5 20.5 68.1 1.2 3.1 101.5 46.3 7.6 3.4 2.8 29.7 1.0 4.0 33.9 37.6 3.5 0.6 0.3 0.3 8.7 2.3 9.1 2.7 2.5 8.5 4.9 6.5 0.7 6.3 2.4 0.5 7.7 2.8 4.4 0.0 3.2 0.7 11.4 0.0 6.1 0.8 1.0 9.1 3.3 6.8 4.4 2.6 2.6 0.6 4.3 5.8 0.4 1.9 11.9 4.5 0.0 4.4 0.3 0.1 2.4 4.4 2.8 0.0 0.6 0.4 3.7 0.1 0.2 0.0 0.4 16.2 0.0 1.5 0.7 5.9 0.3 1.8 0.8 0.4 8.1 2.2 1.2 0.5 2.7 1.5 2.2 31.4 5.5 40.2 68.2 23.3 42.4 47.2 27.0 23.2 50.1 51.3 39.4 78.4 12.8 50.9 33.2 62.8 39.3 3.1 3.1 3.0 6.7 3.5 3.3 3.2 3.1 2.8 3.2 3.1 3.4 3.5 63.7 19.2 38.0 5.5 97.6 16.4 31.2 50.3 23.3 1.5 36.0 33.8 8.3 47.1 51.5 35.0 0.0 1.2 90.9 94.7 3.9 16.8 0.3 19.9 18.4 52.7 36.1 18.7 8.8 32.9 1.5 27.1 77.5 25.8 53.2 8.3 41.4 20.0 88.8 0.0 0.9 78.4 22.4 80.1 59.3 2.6 20.8 91.3 46.2 17.8 106.1 15.9 131.8 2.5 1.3 24.6 115.8 13.9 70.4 29.8 219.6 35.5 34.7 0.7 19.7 9.0 22.0 0.1 0.4 15.6 13.4 1.2 84.4 16.0 101.4 44.3 PANK4 FLJ10782 ENSG00000157881 "Pantothenate kinase 4 (inactive)" Q9NVE7 1 2508537-2526597 "Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011723, HPA012036, HPA027961" Uncertain Approved Cytosol NA NA Cytosol "HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042" "unprognostic (1.23e-1)" "unprognostic (2.31e-1)" "unprognostic (3.36e-1)" "unprognostic (1.13e-1)" "unprognostic (4.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-1)" "unprognostic (6.51e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.57e-5)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (2.25e-1)" "unprognostic (8.15e-2)" 9.9 11.1 1.2 2.7 1.9 4.7 9.7 1.2 5.2 10.7 2.1 13.2 4.2 11.5 0.0 9.2 10.1 0.0 20.8 1.5 1.2 10.8 12.8 12.0 2.7 1.3 1.6 1.2 9.5 8.8 1.2 13.7 2.6 2.1 10.4 2.8 5.7 10.1 1.7 33.1 12.2 11.7 1.8 1.6 13.8 11.6 9.0 1.5 2.8 11.6 20.7 2.7 12.6 10.5 1.4 2.2 6.3 4.9 13.8 9.4 5.2 4.5 0.0 1.7 0.1 2.2 12.6 18.5 2.2 0.7 4.3 8.1 4.6 0.2 7.8 5.5 0.0 12.3 7.4 1.6 5.7 0.7 5.7 0.1 8.0 7.0 11.6 2.3 0.6 5.6 2.7 0.1 14.9 0.7 5.5 11.8 7.7 0.0 3.1 12.5 13.4 0.7 5.3 0.0 3.8 10.8 6.1 0.5 10.7 11.9 3.2 5.4 0.0 1.1 15.1 2.3 5.0 5.7 4.6 0.3 4.7 6.9 7.3 3.6 0.5 0.0 1.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 1.2 1.9 1.2 5.2 1.5 1.2 1.3 1.6 1.2 2.1 1.6 1.5 1.4 4.7 6.4 5.1 7.5 6.1 4.1 5.6 7.4 6.2 7.2 3.7 2.4 23.3 2.8 6.4 3.7 10.4 7.8 5.9 7.9 7.9 5.7 1.4 3.8 4.2 5.4 3.0 11.6 6.1 6.9 5.0 6.4 4.6 5.0 1.3 5.3 3.6 7.9 5.3 3.3 6.4 4.5 6.1 5.0 3.0 0.6 5.9 5.0 5.4 1.9 7.4 4.6 11.3 5.5 3.5 5.3 8.8 9.1 7.1 4.0 4.7 4.8 3.1 13.9 19.7 2.6 6.3 6.3 6.1 3.9 4.4 9.7 8.9 3.2 5.9 4.2 CIB4 ENSG00000157884 "Calcium and integrin binding family member 4" A0PJX0 2 26581205-26641366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.5" "Cell type enriched" "Detected in some" 7 "Early spermatids: 181.0" "Cancer enhanced" "Detected in some" "renal cancer: 0.7;thyroid cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036130, HPA036131" Uncertain NA NA "HPA036130: AB_10670709, HPA036131: AB_2674959" "unprognostic (3.63e-3)" "unprognostic (1.78e-1)" "unprognostic (2.61e-4)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (4.29e-4)" "unprognostic (1.57e-1)" "unprognostic (3.19e-5)" "unprognostic (1.20e-2)" "unprognostic (3.63e-1)" "unprognostic (1.76e-3)" "unprognostic (3.50e-1)" 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.5 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.1 0.2 0.0 0.8 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 17.5 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.2 0.1 0.2 0.5 0.2 0.1 0.8 0.1 0.3 0.6 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 14.6 0.0 0.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 181.0 0.0 0.3 0.3 1.8 0.0 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 24.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 11.9 0.7 0.0 0.0 0.8 0.0 0.5 0.0 0.0 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.4;fallopian tube: 7.9;kidney: 8.2;retina: 14.4" "Group enriched" "Detected in many" 9 "Early spermatids: 175.8;Horizontal cells: 126.2;Late spermatids: 177.8;Oligodendrocyte precursor cells: 460.4" "Group enriched" "Detected in some" 5 "endometrial cancer: 0.7;glioma: 2.3;renal cancer: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEK 293: 2.7;RPTEC TERT1: 9.2;SCLC-21H: 7.2;U-698: 2.0" "Region enriched" "Detected in all" 4 "cerebellum: 35.0" "Region enriched" "Detected in all" 7 "cerebellum: 25.8" NA NA "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.0 0.1 8.0 0.2 4.9 0.3 0.1 22.4 6.5 0.1 0.1 0.1 0.0 0.1 0.8 0.1 7.9 0.1 0.1 9.0 6.7 8.2 0.0 0.5 0.1 6.1 8.2 4.2 0.3 0.2 0.0 3.1 0.0 9.8 0.1 0.0 14.4 0.1 0.1 0.1 1.3 0.1 0.0 4.7 0.2 0.3 3.9 6.5 0.1 0.1 0.0 0.0 0.0 0.1 7.0 0.0 0.1 0.3 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.2 0.0 0.2 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.2 0.0 0.0 9.2 0.2 7.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.0 4.9 22.4 6.5 9.0 6.7 6.1 8.2 4.2 9.8 4.7 6.5 7.0 0.2 0.0 3.7 5.2 0.4 2.2 0.7 1.0 0.6 5.3 0.8 0.0 1.4 0.0 0.3 3.7 8.4 0.3 0.4 0.0 0.0 0.1 175.8 0.3 0.3 1.5 0.0 0.4 9.5 0.2 0.1 0.7 2.6 0.8 0.0 0.2 2.9 0.0 0.1 126.2 18.4 0.0 0.0 0.3 3.5 177.8 2.5 0.4 0.0 1.0 0.0 4.4 0.0 460.4 1.7 0.1 0.1 1.5 1.3 0.6 0.0 2.2 0.8 25.7 0.0 1.0 0.5 2.9 1.9 0.6 3.8 0.5 0.9 0.1 0.0 0.5 C12orf43 "Custos, FLJ12448" ENSG00000157895 "Chromosome 12 open reading frame 43" Q96C57 12 121000486-121016502 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046148, HPA061739" Uncertain Supported "Nucleoli,Golgi apparatus" NA NA Nucleoli "Golgi apparatus" "HPA046148: AB_10965169, HPA061739: AB_2684597" "unprognostic (1.51e-1)" "unprognostic (5.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.75e-2)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (6.44e-4)" "unprognostic (3.53e-1)" "unprognostic (5.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.95e-1)" "unprognostic (2.45e-3)" "unprognostic (9.70e-2)" "unprognostic (2.49e-1)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" 9.6 8.2 10.2 6.9 12.0 7.5 9.4 8.8 13.7 7.8 7.2 9.6 5.0 9.6 4.4 7.3 9.1 5.1 7.5 11.8 10.4 7.6 10.6 6.8 8.7 10.8 10.1 11.7 11.3 7.6 9.1 7.5 7.2 11.6 7.8 5.4 6.1 8.7 6.3 7.3 6.6 6.8 8.5 8.3 7.9 8.3 6.1 9.3 7.3 6.5 6.0 7.5 9.7 7.0 11.2 14.2 31.4 16.2 12.8 14.0 11.0 17.8 17.2 17.5 28.3 17.9 22.8 13.0 26.2 17.2 16.8 15.0 15.7 19.2 26.3 16.8 31.6 21.4 21.1 12.4 17.1 16.7 28.1 16.2 12.9 13.6 26.0 16.4 17.9 16.4 27.0 25.5 6.7 15.1 23.3 30.9 22.0 28.8 11.1 23.2 27.4 19.0 19.8 17.5 20.8 22.0 14.0 23.0 9.9 18.6 13.4 27.0 13.1 15.9 15.6 18.7 12.8 18.4 12.3 19.1 20.5 20.5 16.5 23.6 5.7 15.6 9.0 23.8 21.3 21.8 23.8 23.5 23.2 16.1 19.0 27.5 23.6 2.2 18.4 18.5 13.3 23.8 20.6 10.2 12.0 8.8 13.7 11.8 10.4 10.8 10.1 11.7 11.6 8.3 9.3 11.2 16.1 25.6 18.1 3.3 17.3 8.8 16.4 12.2 6.8 19.6 12.4 12.4 7.0 11.5 9.6 18.4 20.9 24.3 13.9 8.6 23.5 16.5 5.9 9.8 17.1 16.0 2.4 10.7 6.8 18.5 22.3 16.3 8.2 10.1 14.5 22.3 12.5 11.7 16.7 16.8 6.4 9.5 10.2 10.4 7.3 13.8 13.7 13.2 14.2 3.7 21.7 18.8 24.7 4.0 4.8 15.6 12.3 12.8 11.3 13.8 5.3 16.7 16.3 15.7 19.7 19.6 16.9 16.3 16.4 12.7 7.7 13.7 17.6 16.0 10.9 14.0 PEX10 RNF69 ENSG00000157911 "Peroxisomal biogenesis factor 10" O60683 1 2403964-2413797 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 194.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049458, HPA049755" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049458: AB_2680775, HPA049755: AB_2680867" "prognostic favorable (4.50e-6)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (1.81e-2)" "unprognostic (2.91e-1)" "unprognostic (9.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.16e-6)" "unprognostic (4.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" 14.3 29.2 20.7 2.3 21.3 3.1 14.0 22.1 26.0 10.6 16.8 11.4 6.8 11.5 8.6 17.4 10.1 4.3 14.4 18.9 20.4 18.2 22.1 8.9 4.4 23.0 20.9 17.7 13.0 19.9 10.5 18.7 3.8 21.8 16.3 4.5 4.7 14.4 6.9 18.8 14.0 9.7 4.2 21.9 10.3 12.8 22.1 20.7 3.7 13.2 10.3 3.4 13.0 11.4 23.8 18.6 16.9 13.2 7.4 7.9 9.7 11.5 9.6 10.9 14.2 11.3 27.2 13.9 10.8 27.1 11.9 8.7 12.1 11.6 16.3 8.1 16.8 21.9 8.5 17.2 55.3 16.4 14.2 4.2 9.0 9.3 10.8 16.0 10.4 13.9 12.5 9.9 7.4 14.7 26.2 9.1 6.0 9.6 8.0 31.3 7.8 13.8 18.9 17.8 6.3 18.2 15.3 13.0 8.2 29.2 7.1 8.3 3.5 14.8 6.7 5.9 17.2 10.8 19.0 7.6 8.6 17.6 10.9 6.1 1.6 5.8 1.7 3.8 8.7 4.4 5.9 3.3 5.1 9.4 4.9 3.8 3.0 0.6 3.6 7.6 7.8 2.1 4.2 20.7 21.3 22.1 26.0 18.9 20.4 23.0 20.9 17.7 21.8 21.9 20.7 23.8 12.8 3.2 4.4 3.3 9.5 8.8 13.7 15.4 15.9 16.8 16.4 15.4 1.1 11.5 8.9 14.7 0.0 26.7 6.7 8.3 35.2 26.8 51.7 8.5 9.0 11.2 13.2 9.2 5.1 30.3 25.2 11.5 12.8 10.3 0.0 22.8 7.5 10.5 22.9 13.5 5.6 10.3 12.2 11.2 7.2 194.7 10.5 9.6 23.2 2.8 18.7 45.2 8.2 8.0 6.7 21.0 7.7 13.5 14.9 14.6 17.5 27.8 8.6 14.8 0.0 15.5 10.9 28.9 22.8 22.4 6.1 27.5 6.9 30.2 14.6 14.1 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405442 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 101.4 155.5 58.2 90.1 65.4 82.3 98.1 64.7 63.4 94.4 72.8 138.7 115.9 75.1 123.7 177.8 86.9 87.7 74.4 59.3 69.4 107.3 226.7 80.3 95.3 65.5 63.5 57.4 93.7 123.3 101.7 83.5 99.9 65.2 95.2 152.9 74.5 102.0 105.1 106.1 102.5 121.0 105.5 64.3 103.0 119.7 108.0 64.8 95.4 86.7 85.8 144.7 102.0 107.4 74.4 203.1 111.0 131.1 146.8 233.7 275.7 100.9 297.1 261.1 254.3 253.2 157.6 299.3 143.9 242.7 297.7 205.1 213.3 152.2 176.7 322.2 180.8 156.1 163.9 247.2 153.0 252.5 181.3 188.6 225.0 176.1 264.3 233.1 175.4 235.8 160.3 197.8 232.6 299.8 141.5 127.2 127.3 87.5 314.1 279.0 146.0 131.9 183.7 227.5 94.3 109.9 126.2 167.9 376.9 242.9 143.7 149.6 127.4 171.8 197.3 114.1 355.9 219.5 223.0 270.2 255.3 209.6 254.8 102.8 239.1 235.5 284.5 195.9 268.2 180.0 169.0 169.8 210.0 221.2 151.7 127.0 155.9 351.3 164.8 275.9 256.1 244.5 309.0 58.2 65.4 64.7 63.4 59.3 69.4 65.5 63.5 57.4 65.2 64.3 64.8 74.4 88.7 64.1 50.0 23.5 73.1 53.2 84.4 214.2 50.1 33.6 111.9 123.6 41.6 118.7 131.4 104.8 33.3 233.8 97.5 218.9 66.5 213.4 475.6 89.5 93.5 68.2 36.5 57.2 16.7 258.4 321.8 94.3 71.9 118.8 44.3 76.5 82.1 233.5 217.9 37.0 16.8 158.6 122.1 104.3 73.2 464.0 82.6 99.9 62.2 15.9 126.1 97.0 114.4 19.1 25.8 256.4 195.4 76.0 145.1 142.5 238.7 119.6 136.3 62.6 111.7 60.9 141.6 291.4 145.2 103.4 67.1 467.9 74.3 159.0 162.0 141.0 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883716 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.5" "Cell type enhanced" "Detected in many" "Astrocytes: 10.1;Early spermatids: 9.2;Horizontal cells: 13.5;Microglial cells: 14.0;Spermatocytes: 17.0;Spermatogonia: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;HEK 293: 6.5;NTERA-2: 7.3;SCLC-21H: 8.9;SH-SY5Y: 19.0;U-2197: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA051776: AB_2681605" "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 3.1 0.6 2.8 0.2 1.9 0.0 3.3 10.5 2.7 3.7 0.4 2.6 0.2 3.3 0.2 0.8 3.8 0.7 3.9 1.9 4.0 0.4 0.1 4.5 0.1 3.4 2.9 0.5 1.5 3.3 0.3 2.9 2.7 4.7 2.0 0.2 0.3 1.1 1.2 2.8 1.1 1.3 1.0 1.9 0.5 1.3 8.2 2.8 0.2 2.5 2.0 0.1 2.3 3.0 4.6 0.0 2.1 4.4 7.8 0.2 1.9 0.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.8 1.5 0.0 3.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.7 4.2 0.0 0.4 1.9 0.0 0.0 7.3 0.1 1.6 5.0 0.5 0.0 0.0 0.0 8.9 19.0 0.0 0.0 0.0 1.8 3.2 0.6 0.0 0.0 0.0 6.1 1.9 0.2 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.9 10.5 2.7 1.9 4.0 3.4 2.9 0.5 4.7 1.9 2.8 4.6 1.8 3.2 1.5 10.1 0.0 0.8 0.0 0.0 0.6 2.1 3.4 1.8 2.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.2 1.1 2.6 2.2 0.0 0.0 2.6 1.7 0.0 3.9 0.0 0.1 0.0 0.2 0.4 0.0 0.1 13.5 3.6 0.3 0.0 0.6 1.2 5.1 3.4 1.0 7.2 14.0 0.0 4.7 0.0 7.1 3.5 0.3 0.1 3.8 0.0 0.4 0.0 0.0 1.5 0.9 6.6 4.7 4.1 17.0 11.7 0.0 0.6 0.1 2.1 0.3 0.0 0.0 SKI ENSG00000157933 "SKI proto-oncogene" P12755 1 2228319-2310213 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Craniosynostosis, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010449, HPA066567" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB010449: AB_2187342, HPA066567: AB_2685692" "unprognostic (3.99e-2)" "unprognostic (3.81e-2)" "unprognostic (1.44e-1)" "unprognostic (5.42e-2)" "unprognostic (4.66e-2)" "unprognostic (7.32e-2)" "unprognostic (1.88e-1)" "unprognostic (9.14e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (4.94e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-3)" "unprognostic (1.88e-1)" "unprognostic (7.82e-2)" "unprognostic (9.69e-2)" "unprognostic (5.24e-3)" 37.4 14.5 21.5 14.2 21.5 11.5 31.7 56.1 23.6 36.8 8.1 29.8 9.3 42.3 8.4 23.7 34.4 14.8 30.9 22.7 17.0 16.5 24.5 34.2 11.7 20.7 17.5 17.7 36.8 13.2 7.3 23.2 14.0 30.9 27.0 7.1 5.1 25.4 20.0 22.3 36.9 24.3 16.9 16.9 23.1 22.8 13.3 19.3 8.7 25.6 11.8 10.3 31.0 29.5 16.7 18.3 10.4 24.5 23.9 40.0 23.8 16.1 26.7 14.8 16.3 11.9 15.8 13.7 11.5 19.5 34.4 6.8 21.0 13.8 21.6 15.0 12.7 30.0 29.0 16.4 22.5 26.7 16.5 29.8 25.8 11.8 24.5 18.2 30.0 20.2 4.8 16.6 8.6 20.2 11.6 2.0 18.1 24.8 12.0 19.8 9.1 15.5 9.6 13.9 7.0 35.0 22.9 26.0 22.9 26.7 15.6 7.7 20.9 36.9 27.7 17.5 39.6 21.1 6.7 5.2 10.5 14.8 28.2 11.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 21.5 21.5 56.1 23.6 22.7 17.0 20.7 17.5 17.7 30.9 16.9 19.3 16.7 44.2 9.6 12.6 18.9 18.8 47.0 13.1 7.0 32.5 8.9 20.3 25.8 12.7 11.5 6.7 7.3 0.0 7.3 32.2 7.3 1.9 8.2 0.8 10.1 28.9 34.3 6.0 14.7 22.6 6.9 15.5 35.5 9.7 18.5 13.3 6.4 33.9 23.0 13.7 11.8 24.1 14.3 0.0 16.4 29.5 5.0 49.7 28.9 16.0 48.7 9.4 11.1 12.3 11.6 11.4 13.0 9.4 55.3 16.9 14.9 8.1 6.0 4.0 4.4 46.0 36.2 37.3 4.7 12.8 32.2 45.0 16.3 33.4 6.7 10.7 11.4 WIPI2 "ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984" ENSG00000157954 "WD repeat domain, phosphoinositide interacting 2" Q9Y4P8 7 5190196-5233840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 255.9;Spermatocytes: 233.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019852, HPA021488" Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019852: AB_1846589, HPA021488: AB_1846591" "unprognostic (5.79e-2)" "unprognostic (1.47e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (7.69e-5)" "unprognostic (1.96e-3)" "unprognostic (9.27e-3)" "unprognostic (4.60e-3)" "unprognostic (4.96e-2)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "prognostic favorable (9.78e-4)" "unprognostic (1.20e-1)" "prognostic favorable (2.05e-6)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (7.41e-2)" "unprognostic (6.98e-2)" 31.1 31.2 37.0 23.1 39.5 47.4 31.1 34.1 39.9 27.4 34.1 30.9 24.9 32.4 26.5 36.1 29.3 23.4 38.4 40.4 37.4 32.1 36.0 26.6 30.5 36.5 38.6 39.1 28.5 37.5 38.6 30.8 33.1 36.7 28.9 20.4 19.2 43.9 28.5 41.7 44.8 26.9 27.1 35.7 29.8 33.9 54.3 37.4 37.1 27.6 45.4 29.5 27.3 30.3 37.6 67.5 42.1 40.4 69.4 60.7 63.3 62.0 58.7 66.9 61.2 64.2 41.2 60.9 47.7 43.9 73.8 76.0 48.2 41.2 47.8 47.4 24.9 64.1 32.7 39.7 45.8 59.9 51.8 34.4 66.9 56.4 69.7 38.3 60.9 86.3 64.3 94.2 41.9 56.2 69.9 39.6 90.0 84.3 35.9 61.1 64.3 57.7 79.5 40.4 32.3 50.3 75.4 43.0 72.8 52.4 67.3 44.8 97.2 69.2 38.9 80.9 65.6 44.4 75.0 75.2 54.7 63.4 59.3 58.8 0.4 4.7 13.6 4.4 6.0 2.8 5.7 5.8 8.0 4.2 6.2 7.5 4.7 9.1 2.6 4.2 6.4 9.0 2.2 37.0 39.5 34.1 39.9 40.4 37.4 36.5 38.6 39.1 36.7 35.7 37.4 37.6 40.2 38.5 31.5 16.3 51.6 54.9 39.5 13.9 39.3 71.5 49.4 50.5 37.0 42.9 17.6 18.4 62.6 89.4 62.7 42.6 72.4 43.0 195.8 50.0 38.1 37.9 39.5 125.0 19.7 41.8 96.6 43.1 34.7 48.0 31.1 54.8 54.7 60.4 69.1 47.1 19.6 42.6 18.3 61.4 44.8 255.9 42.6 55.9 44.4 20.6 64.5 89.5 44.3 13.6 23.5 55.6 37.0 56.1 67.7 97.7 48.7 80.6 26.4 52.8 52.6 39.7 39.4 233.0 117.3 49.8 71.0 150.8 46.8 44.1 43.0 69.8 LDLRAP1 "ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705" ENSG00000157978 "Low density lipoprotein receptor adaptor protein 1" Q5SW96 1 25543606-25568886 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Atherosclerosis, Disease variant, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 7 "NK-cells: 39.5;T-cells: 107.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003705, HPA050358" Uncertain Approved Microtubules NA NA Microtubules "CAB003705: AB_425923, HPA050358: AB_2681103" "unprognostic (2.52e-2)" "unprognostic (5.39e-3)" "unprognostic (7.49e-3)" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.70e-2)" "unprognostic (7.27e-3)" "unprognostic (4.79e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-3)" "unprognostic (9.96e-2)" "unprognostic (6.49e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.74e-2)" "unprognostic (4.24e-1)" 10.7 19.8 16.7 18.9 23.2 8.6 11.8 28.7 17.8 10.9 24.0 18.4 11.4 8.8 8.1 19.6 9.9 8.0 10.7 14.1 17.8 14.4 27.5 15.9 37.5 26.9 25.4 11.8 9.4 39.9 14.8 19.6 21.2 25.5 21.7 16.5 5.5 31.2 9.9 13.2 21.3 17.0 10.5 25.4 58.6 15.9 5.6 22.3 14.3 17.4 9.4 22.2 9.7 15.5 37.6 32.2 12.5 17.5 18.5 10.7 12.3 14.1 20.0 19.5 30.0 20.8 5.1 26.0 7.1 14.2 27.4 20.9 33.3 11.9 20.3 15.1 8.5 18.5 11.4 14.5 9.8 17.0 13.1 16.4 13.4 28.6 24.2 9.0 7.3 26.1 7.1 16.0 68.1 10.0 18.6 0.2 22.4 22.2 25.7 13.2 1.9 19.7 57.6 11.2 6.6 8.7 4.9 27.8 43.9 32.3 14.1 20.0 22.2 15.7 13.1 19.1 25.0 14.1 64.8 81.6 20.2 44.2 10.9 16.3 0.0 7.0 0.3 23.6 5.7 27.1 10.5 55.2 43.4 9.4 5.4 107.3 89.8 3.1 39.5 5.9 1.3 49.7 50.6 16.7 23.2 28.7 17.8 14.1 17.8 26.9 25.4 11.8 25.5 25.4 22.3 37.6 9.8 0.0 11.0 2.6 11.5 8.3 20.6 21.5 15.4 4.0 10.3 13.3 3.6 5.7 21.1 7.3 18.8 35.2 13.3 33.6 3.9 9.7 0.2 2.9 4.1 10.8 6.7 3.8 2.3 17.8 8.6 8.9 4.6 5.4 2.5 8.6 12.1 25.6 11.0 70.7 1.2 23.9 10.2 6.0 3.5 0.0 10.2 23.7 17.8 11.2 6.9 4.0 22.6 2.0 50.1 12.9 23.4 8.6 19.3 19.1 11.9 5.9 6.1 19.5 26.3 16.9 9.1 3.2 10.1 12.4 5.7 23.7 28.7 9.7 22.0 20.0 AGAP1 "CENTG2, GGAP1, KIAA1099" ENSG00000157985 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 1" Q9UPQ3 2 235494043-236131800 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.0;retina: 55.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 304.0;Cone photoreceptor cells: 329.4;Excitatory neurons: 289.3;Oligodendrocyte precursor cells: 1438.1;Oligodendrocytes: 997.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "SCLC-21H: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.69e-1)" "unprognostic (2.32e-2)" "unprognostic (3.42e-1)" "unprognostic (5.43e-2)" "unprognostic (1.19e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.36e-1)" "unprognostic (6.91e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.10e-1)" "prognostic favorable (6.52e-5)" "unprognostic (5.56e-2)" "unprognostic (2.44e-2)" "unprognostic (6.32e-2)" "unprognostic (1.32e-2)" 4.8 4.8 30.3 3.4 29.4 1.9 8.4 5.9 30.8 5.8 0.0 11.3 7.1 5.2 9.0 6.7 6.7 5.6 5.9 34.1 19.8 7.8 2.7 5.7 1.7 43.0 30.3 26.3 5.6 6.5 9.0 7.2 6.9 45.9 4.8 11.3 55.1 4.2 5.1 8.5 3.7 8.7 10.6 12.5 1.9 6.8 6.7 27.1 1.6 9.2 9.3 2.0 6.3 3.4 54.0 17.3 13.6 20.9 9.8 15.1 9.7 13.1 8.6 9.1 9.9 7.5 14.0 31.3 0.1 3.6 14.9 37.2 4.3 15.8 20.4 12.3 0.3 8.1 26.4 12.5 10.5 6.0 0.1 17.5 14.1 19.3 20.4 15.9 7.1 6.8 6.1 13.8 1.0 12.6 22.2 0.5 3.0 9.1 14.9 6.2 3.6 10.6 16.8 10.8 20.4 78.9 19.9 7.3 17.1 9.5 11.4 9.8 4.1 6.8 11.8 12.0 9.8 11.7 5.4 0.1 0.8 18.4 0.2 12.7 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 30.3 29.4 5.9 30.8 34.1 19.8 43.0 30.3 26.3 45.9 12.5 27.1 54.0 16.0 6.4 15.5 100.6 0.2 4.1 3.7 6.2 5.2 304.0 19.4 11.7 22.9 2.8 8.7 11.0 329.4 9.7 5.5 23.3 3.9 21.4 9.4 24.0 12.0 13.3 16.3 0.4 289.3 15.0 1.5 19.5 4.6 15.8 20.8 12.7 7.9 6.3 1.4 119.5 219.0 17.8 12.2 0.6 3.8 2.9 5.0 2.1 1.8 139.6 1.6 33.3 9.2 1438.1 997.9 19.1 20.7 13.5 0.8 4.9 21.1 14.0 14.4 142.0 26.3 20.4 22.5 4.8 20.7 7.1 4.3 6.6 3.0 7.0 21.8 4.9 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 182.0;Proximal enterocytes: 168.7;Undifferentiated cells: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.8;memory B-cell: 4.5;memory CD4 T-cell: 5.6;memory CD8 T-cell: 2.6;naive B-cell: 6.4;naive CD4 T-cell: 6.6;naive CD8 T-cell: 2.7;T-reg: 4.4" "Group enriched" "Detected in many" 13 "B-cells: 6.4;T-cells: 6.8" "Cell line enhanced" "Detected in many" "A-431: 84.6;CAPAN-2: 122.5;OE19: 46.6;SCLC-21H: 60.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 2.2 2.7 3.7 6.4 3.6 3.1 16.2 5.3 5.6 11.9 3.3 39.9 44.7 5.9 1.8 18.5 25.1 9.6 0.7 3.4 2.8 8.0 9.9 11.4 3.3 4.0 3.5 2.6 2.4 45.0 18.7 14.2 2.9 4.3 21.1 28.1 7.3 38.9 12.8 3.3 14.2 45.9 1.7 3.3 3.1 42.8 2.2 3.2 3.7 11.6 0.0 5.2 10.0 11.3 4.8 84.6 1.2 6.1 2.7 0.3 0.6 17.4 0.9 0.3 1.0 0.9 32.7 122.5 1.0 1.1 0.2 0.5 28.4 0.9 25.0 0.3 1.0 0.6 2.2 1.9 2.7 0.0 0.3 3.9 1.1 2.7 0.6 1.5 1.2 1.0 2.8 1.8 1.5 0.9 27.2 0.9 7.8 27.7 46.6 1.1 0.8 1.8 2.5 1.7 2.4 60.2 2.2 2.3 25.4 3.6 2.0 2.5 1.4 2.4 3.4 5.4 1.2 1.1 7.0 5.9 1.1 2.3 1.1 0.8 0.0 0.0 0.0 0.6 0.0 6.8 4.5 5.6 2.6 0.0 6.4 6.6 2.7 0.0 0.5 0.0 0.0 4.4 1.5 3.7 3.6 5.3 5.6 3.4 2.8 4.0 3.5 2.6 4.3 3.3 3.2 4.8 1.1 22.4 27.9 2.6 2.9 23.3 125.1 135.4 71.7 4.9 100.9 105.2 0.5 88.6 92.5 42.3 8.4 17.0 1.9 74.2 5.9 105.4 6.4 50.9 3.8 2.7 62.0 3.6 1.2 182.0 27.6 3.4 68.3 47.9 4.5 0.9 1.4 15.2 2.1 1.7 1.1 123.6 105.8 1.0 2.5 4.7 0.3 2.0 7.2 1.9 2.9 1.9 2.1 1.5 1.3 108.7 112.9 0.0 0.7 123.7 168.7 7.7 85.2 5.9 0.0 0.9 6.9 3.8 29.4 48.0 15.5 7.9 3.0 0.7 190.2 144.2 ANKRD61 ENSG00000157999 "Ankyrin repeat domain 61" A6NGH8 7 6031376-6036552 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 6.1;testis: 5.7" "Group enriched" "Detected in some" 21 "Early spermatids: 58.5;Late spermatids: 23.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029511, HPA050732" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029511: AB_10602430, HPA050732: " "unprognostic (1.40e-1)" "unprognostic (1.03e-3)" "unprognostic (9.32e-2)" "unprognostic (5.67e-2)" "unprognostic (1.73e-1)" "unprognostic (2.56e-2)" "unprognostic (6.76e-2)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.98e-1)" "unprognostic (6.68e-2)" "unprognostic (2.73e-2)" "unprognostic (5.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.63e-1)" 0.4 0.4 0.2 0.6 0.4 6.1 0.5 1.1 0.3 0.4 0.6 0.3 0.5 0.4 0.0 0.3 0.4 0.2 0.4 0.1 0.3 0.2 0.4 0.4 0.8 0.4 0.3 0.2 0.5 0.7 0.0 0.4 0.4 0.4 0.3 0.0 0.7 0.6 0.0 0.5 1.3 0.6 0.1 0.2 0.7 0.6 5.7 0.5 0.1 0.6 0.2 0.0 0.3 0.4 1.1 1.4 3.4 1.2 1.7 0.2 0.1 1.6 0.9 0.2 0.3 0.3 1.7 3.5 0.7 0.3 0.1 1.6 1.3 0.6 0.0 0.3 0.2 0.4 1.0 9.3 0.2 0.1 1.0 1.5 0.2 0.7 0.3 0.6 0.8 0.3 1.1 1.2 1.0 0.4 2.3 0.2 1.1 0.6 0.3 0.4 1.0 0.3 0.2 0.3 1.7 0.8 1.5 0.9 1.0 0.1 1.7 1.7 0.6 0.7 1.4 2.9 1.7 1.0 0.9 1.1 0.5 0.4 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.1 0.3 0.1 0.3 0.4 0.3 0.2 0.4 0.2 0.5 1.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 58.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.9 0.0 0.2 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 PAFAH2 HSD-PLA2 ENSG00000158006 "Platelet activating factor acetylhydrolase 2" Q99487 1 25959767-25998117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.2" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018157 Approved NA Yes "HPA018157: AB_1854928" "unprognostic (9.89e-2)" "unprognostic (2.60e-1)" "unprognostic (3.63e-3)" "prognostic favorable (3.28e-6)" "unprognostic (5.19e-2)" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "unprognostic (1.78e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (4.46e-2)" "unprognostic (2.62e-1)" "prognostic favorable (0.00e+0)" "unprognostic (8.15e-2)" "unprognostic (8.17e-2)" "unprognostic (1.59e-2)" "unprognostic (7.27e-2)" 4.6 7.4 5.0 6.6 6.4 6.9 9.3 6.2 6.1 8.8 6.2 16.5 17.6 4.9 10.0 7.9 8.3 10.5 9.8 4.4 5.8 19.5 18.5 8.7 8.5 6.4 6.4 4.1 4.8 31.5 23.1 5.9 9.3 6.3 8.8 16.8 14.2 10.1 6.3 18.2 11.5 19.2 7.0 5.6 7.6 15.8 7.8 5.8 49.2 16.5 10.8 7.5 7.1 5.6 8.3 8.6 10.7 6.7 7.6 13.9 10.9 13.7 9.6 5.0 8.6 5.7 4.4 18.1 3.8 11.7 5.7 8.1 7.5 10.1 9.3 11.0 7.8 6.1 6.3 4.6 8.8 8.4 3.3 52.5 7.2 21.2 13.2 8.7 4.7 8.3 8.9 8.9 7.1 11.7 3.8 10.3 3.3 13.4 29.9 5.9 8.4 6.3 8.7 13.9 3.0 8.0 6.8 5.7 7.7 18.2 11.0 12.7 6.0 7.8 5.9 7.4 12.5 7.7 13.0 18.1 4.8 12.5 13.2 20.0 36.2 6.7 60.2 23.7 6.4 15.3 3.5 8.3 15.4 5.0 4.4 10.6 14.9 5.8 17.4 2.4 39.0 9.0 8.7 5.0 6.4 6.2 6.1 4.4 5.8 6.4 6.4 4.1 6.3 5.6 5.8 8.3 4.6 16.0 12.8 9.8 3.2 1.5 2.1 5.3 1.8 9.5 9.4 4.8 6.8 11.5 11.9 18.4 27.1 11.2 37.7 34.9 3.9 11.1 1.1 8.6 4.5 5.6 7.8 3.2 4.0 7.3 9.5 3.5 12.2 13.2 27.8 7.3 5.7 21.4 11.2 5.0 3.6 18.2 4.1 11.6 1.6 1.0 2.5 7.1 8.8 5.6 7.3 6.3 23.7 4.0 10.0 10.6 15.8 2.6 6.5 4.2 43.1 18.3 8.9 8.8 6.6 5.3 4.1 19.9 8.9 4.5 3.8 10.0 9.0 4.4 19.4 4.9 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 14.3;skeletal muscle: 12.8;tongue: 30.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.3;Breast glandular cells: 8.8;Excitatory neurons: 22.7;Horizontal cells: 10.1;Melanocytes: 7.2;Oligodendrocyte precursor cells: 10.6" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 150.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010726, HPA037749" Uncertain Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 79000 Centrosome Vesicles "HPA010726: , HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.2 1.0 10.1 0.0 9.2 0.0 0.8 0.0 14.3 0.4 0.0 0.7 0.1 3.7 0.1 0.5 0.7 0.3 3.4 11.1 2.5 0.4 0.0 0.2 0.2 1.8 0.8 10.5 1.1 1.5 0.0 0.9 0.3 5.1 0.4 0.0 0.9 0.5 0.2 12.8 2.2 0.3 1.3 0.0 3.5 0.3 0.6 2.2 0.0 0.2 30.0 0.0 0.3 0.4 9.4 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.2 0.6 0.0 0.2 2.4 0.2 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 150.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 9.2 0.0 14.3 11.1 2.5 1.8 0.8 10.5 5.1 0.0 2.2 9.4 0.1 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 15.3 8.8 1.8 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 22.7 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.1 10.1 5.1 0.0 0.0 0.0 0.3 0.6 1.5 0.0 7.2 2.8 0.0 0.4 0.0 10.6 1.9 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.4 0.4 0.2 0.2 0.0 0.0 1.0 0.0 1.1 0.1 0.1 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046118 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 100.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 31.0;Endometrial ciliated cells: 30.5;Glandular and luminal cells: 93.7;Proximal tubular cells: 36.2;Syncytiotrophoblasts: 85.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.1;RPTEC TERT1: 4.5;WM-115: 3.5" "Region enriched" "Detected in single" 5 "olfactory bulb: 1.2" "Not detected" "Not detected" HPA017979 Approved Vesicles NA NA Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 1.2 0.4 0.3 0.6 0.6 1.1 1.7 1.0 0.1 0.5 0.5 0.5 0.5 0.3 0.1 0.4 6.7 4.2 0.5 0.4 19.7 0.1 0.2 0.2 0.2 0.1 0.8 0.1 100.6 2.2 0.0 4.5 0.7 0.2 0.1 0.5 1.6 2.3 3.9 1.0 0.8 0.1 0.0 0.3 0.3 0.2 1.1 0.0 20.0 0.7 0.1 0.5 0.0 0.8 0.1 0.1 0.0 0.4 0.1 0.0 2.1 0.1 0.1 0.0 0.0 0.3 0.4 0.1 0.4 0.0 0.1 0.3 0.1 0.2 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.7 0.0 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.3 0.3 4.5 0.1 0.4 0.1 0.3 0.5 0.1 0.7 0.3 0.1 0.2 0.2 0.5 0.2 0.1 0.3 0.2 0.3 0.2 0.2 3.5 0.9 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.3 0.1 0.2 0.1 0.0 0.4 0.6 1.7 1.0 0.5 0.4 0.2 0.1 0.8 0.7 0.0 1.1 0.8 0.2 3.2 3.0 0.0 0.6 0.4 0.7 0.0 0.0 4.5 9.1 0.4 13.9 8.6 0.0 9.2 0.0 31.0 0.1 0.5 5.9 11.5 0.0 30.5 9.7 1.0 0.0 0.0 0.0 21.1 2.8 0.5 0.0 93.7 4.5 0.1 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.3 0.9 3.6 0.0 1.0 0.7 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 3.9 36.2 0.0 2.3 6.6 2.1 1.0 0.2 0.4 0.0 0.9 85.1 0.9 0.1 1.1 0.7 BABAM2 "BRCC4, BRCC45, BRE" ENSG00000158019 "BRISC and BRCA1 A complex member 2" Q9NXR7 2 27889941-28338901 "Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "adrenal gland: 383.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Distal tubular cells: 84.1;Ductal cells: 53.4;Proximal tubular cells: 84.1;Syncytiotrophoblasts: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017926, HPA048867" Enhanced Supported Cytosol NA NA Cytosol "HPA017926: AB_1845443, HPA048867: " "unprognostic (1.28e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-3)" "unprognostic (1.61e-3)" "unprognostic (1.89e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.03e-1)" "unprognostic (2.38e-2)" "unprognostic (8.98e-2)" "unprognostic (2.13e-1)" "unprognostic (6.52e-2)" "unprognostic (4.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.74e-2)" "unprognostic (2.91e-2)" "unprognostic (1.22e-2)" 30.1 383.2 21.1 21.4 25.2 41.9 27.7 22.2 28.6 31.1 27.6 26.0 18.5 32.4 33.8 24.7 31.3 32.3 54.3 26.1 45.2 51.0 28.9 25.1 20.7 21.0 19.3 22.8 36.6 21.9 35.4 33.1 23.5 26.1 25.1 26.5 26.4 20.6 29.2 74.4 25.0 23.1 37.3 17.7 28.8 25.5 27.4 20.6 21.6 24.2 55.3 26.5 31.5 25.5 21.4 39.5 42.8 33.6 35.7 42.4 56.5 33.2 19.4 49.0 36.0 37.2 36.5 39.4 44.4 64.1 47.3 28.9 25.7 27.7 50.9 52.5 37.8 37.1 53.2 17.5 40.9 61.3 28.1 41.5 139.0 43.6 50.3 51.9 45.1 38.7 41.0 27.7 47.3 50.7 33.3 32.8 34.2 25.7 51.4 27.8 29.9 53.6 42.9 104.2 20.4 22.0 35.0 23.0 39.9 40.3 33.9 28.6 36.5 31.7 34.1 45.2 31.7 27.1 53.5 55.8 57.7 63.5 75.6 36.4 106.3 65.6 27.8 57.9 53.1 64.6 50.6 48.7 55.3 86.3 37.6 45.7 43.6 34.3 59.0 55.3 34.4 62.2 56.9 21.1 25.2 22.2 28.6 26.1 45.2 21.0 19.3 22.8 26.1 17.7 20.6 21.4 26.7 3.2 19.6 0.0 7.0 0.0 0.0 0.0 0.0 0.0 16.0 18.0 0.0 0.0 5.6 40.5 0.0 46.1 19.0 0.0 84.1 53.4 0.0 22.6 17.4 10.0 0.0 0.0 0.0 44.3 36.8 11.0 0.0 32.5 31.5 23.1 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 25.8 0.0 0.0 0.0 0.0 20.2 0.0 0.0 4.0 0.0 0.0 84.1 8.7 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 48.2 9.7 44.5 0.0 0.0 TRIM63 "IRF, MURF-1, RNF28, SMRZ" ENSG00000158022 "Tripartite motif containing 63" Q969Q1 1 26051301-26068436 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Muscle protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 1951.6" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 272.2" "Cancer enriched" "Detected in some" 10 "melanoma: 31.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "ASC diff: 16.1;SK-MEL-30: 55.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 5.1" NA NA "unprognostic (1.10e-1)" "unprognostic (4.80e-4)" "unprognostic (1.45e-2)" "unprognostic (7.52e-3)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (2.16e-2)" "unprognostic (5.90e-2)" "unprognostic (1.33e-2)" "unprognostic (2.32e-1)" "unprognostic (5.58e-2)" 0.9 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.1 1.5 0.0 0.6 0.3 8.9 0.3 7.2 0.6 2.7 195.8 0.0 0.0 1.5 0.4 1.3 0.0 0.2 0.1 0.0 0.2 0.8 0.0 0.2 4.0 0.0 1.5 0.2 0.1 9.7 0.5 1951.6 3.0 0.9 3.5 0.0 0.2 0.8 0.2 0.2 0.3 0.5 391.0 0.2 9.0 1.1 0.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.0 272.2 5.7 0.0 1.8 0.0 0.5 0.0 0.0 1.9 1.8 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 8.1 0.0 0.1 10.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 12.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 3.3 29.7 0.0 0.0 0.0 34.7 1.4 0.0 0.0 0.0 0.1 1.6 6.1 0.0 0.1 0.1 CFAP251 "CaM-IP4, MGC33630, WDR66" ENSG00000158023 "Cilia and flagella associated protein 251" Q8TBY9 12 121918592-122003927 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.5;testis: 20.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.7;Fibroblasts: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 31.8;hTCEpi: 30.8;hTERT-HME1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.1 0.8 3.8 0.3 2.7 0.1 1.3 2.1 2.1 3.5 11.0 0.2 0.1 2.0 4.7 0.3 22.5 1.2 1.3 2.7 3.9 2.5 1.4 3.0 0.6 5.1 4.8 1.9 2.2 1.7 2.9 6.5 0.9 3.5 0.7 0.1 4.7 1.1 1.7 0.3 1.5 0.2 0.6 3.2 1.7 0.4 20.1 2.9 0.6 4.8 0.4 0.9 0.3 1.4 1.8 4.7 0.4 0.4 0.2 0.5 0.5 0.5 0.3 2.5 1.2 3.0 0.3 1.4 0.2 3.7 0.2 0.7 0.9 0.3 31.8 4.4 0.2 0.5 0.2 0.6 0.3 3.7 0.1 8.6 1.8 30.8 2.4 19.9 0.7 1.3 0.5 7.5 0.1 1.9 0.9 0.3 0.6 0.4 0.4 0.2 0.4 0.8 0.0 5.4 0.5 2.5 0.1 0.2 0.1 0.2 0.8 0.9 0.1 1.0 2.5 3.9 0.5 0.5 0.5 0.2 3.8 2.9 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 3.8 2.7 2.1 2.1 2.7 3.9 5.1 4.8 1.9 3.5 3.2 2.9 1.8 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 MRPL17 "MRP-L26, RPML26" ENSG00000158042 "Mitochondrial ribosomal protein L17" Q9NRX2 11 6680385-6683340 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043666, HPA050552" Uncertain NA NA "HPA043666: AB_2678607, HPA050552: AB_2681172" "unprognostic (1.12e-1)" "unprognostic (2.10e-1)" "unprognostic (1.33e-2)" "unprognostic (8.26e-2)" "unprognostic (3.70e-3)" "unprognostic (5.93e-3)" "prognostic unfavorable (2.59e-5)" "unprognostic (4.12e-2)" "unprognostic (2.83e-1)" "unprognostic (2.77e-3)" "unprognostic (1.66e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (3.15e-7)" "unprognostic (2.61e-1)" "unprognostic (2.14e-1)" "unprognostic (6.36e-3)" "unprognostic (2.71e-1)" 16.8 32.3 8.9 16.5 9.2 9.4 15.6 8.3 10.8 11.9 8.9 14.5 15.1 12.9 4.9 29.2 11.1 17.4 29.5 8.6 9.5 22.4 14.8 15.7 22.6 9.5 8.5 9.3 10.6 20.4 9.0 26.9 15.0 9.0 12.5 6.4 7.5 19.8 7.9 25.6 14.6 12.2 7.8 8.9 18.9 16.7 12.1 10.1 8.3 20.9 10.4 8.5 15.8 13.9 9.9 108.9 77.6 20.0 11.3 18.8 21.8 45.4 107.0 35.7 43.5 58.3 56.2 70.9 46.5 59.7 21.1 21.7 54.4 17.9 41.6 22.2 75.6 57.7 40.5 45.2 51.8 13.4 41.3 36.3 14.1 18.3 29.9 23.5 17.1 38.3 27.4 20.7 25.1 32.5 79.8 60.4 41.6 41.0 20.6 69.0 43.7 26.6 31.2 29.2 50.5 39.7 30.9 59.3 49.7 65.5 6.4 41.3 35.0 84.7 50.6 49.4 106.8 77.8 33.7 72.9 55.8 89.8 73.9 43.3 6.5 26.8 15.7 25.0 36.3 32.2 39.0 41.5 30.5 35.6 34.1 40.8 28.6 3.6 28.2 24.7 63.5 42.3 30.3 8.9 9.2 8.3 10.8 8.6 9.5 9.5 8.5 9.3 9.0 8.9 10.1 9.9 66.8 16.0 17.2 4.6 26.7 52.9 44.2 75.4 38.7 18.0 35.3 46.9 57.1 30.0 42.9 33.1 8.4 101.0 28.4 20.3 121.3 64.8 54.3 38.0 50.5 62.6 21.0 27.3 5.1 72.5 141.5 39.5 30.5 30.8 8.2 34.7 75.7 30.3 89.4 33.7 6.1 44.9 59.0 28.5 23.6 29.5 39.1 27.8 42.7 5.6 39.0 35.1 32.0 5.0 5.8 61.6 27.6 27.1 42.8 53.9 31.1 155.2 38.6 26.7 13.1 23.0 40.9 82.7 35.9 63.7 54.7 36.7 20.4 118.7 49.4 37.4 DUSP2 PAC-1 ENSG00000158050 "Dual specificity phosphatase 2" Q05923 2 96143169-96145440 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 130.6" "Cell type enhanced" "Detected in many" "dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebral cortex: 59.2" "Immune cell enhanced" "Detected in all" "gdT-cell: 199.3" "Group enriched" "Detected in all" 10 "NK-cells: 148.1;T-cells: 199.3" "Cell line enhanced" "Detected in many" "Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA071920 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA071920: AB_2686472" "unprognostic (2.69e-3)" "unprognostic (6.70e-3)" "unprognostic (1.15e-1)" "unprognostic (5.46e-3)" "unprognostic (3.32e-2)" "unprognostic (8.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.15e-1)" "unprognostic (2.86e-1)" "unprognostic (3.66e-2)" "unprognostic (3.10e-1)" "unprognostic (6.30e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (1.82e-1)" "unprognostic (2.41e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-3)" 10.9 6.1 7.7 18.8 9.8 130.6 5.5 7.4 59.2 8.2 11.5 3.4 1.6 7.0 7.7 6.9 7.7 12.6 15.6 11.8 10.2 12.6 7.5 18.4 47.5 8.7 6.5 8.2 7.8 2.3 1.7 35.4 1.3 6.6 17.8 2.0 0.4 3.9 62.1 2.8 25.6 11.9 3.4 6.4 42.3 7.4 3.6 7.6 47.7 6.8 3.8 24.8 39.9 9.1 9.1 3.2 0.0 0.2 0.2 0.4 0.5 4.4 3.7 0.0 5.3 5.1 8.9 0.6 30.4 10.6 4.1 0.0 2.2 7.5 0.0 1.0 0.5 0.0 0.7 29.7 0.0 1.9 12.8 2.6 0.9 2.0 0.9 0.0 0.1 0.0 27.6 0.0 33.8 0.2 5.2 25.5 29.1 6.5 0.8 10.6 0.0 0.4 24.3 0.2 34.2 29.6 1.5 1.4 0.3 5.6 0.0 2.0 14.4 0.1 0.0 7.9 0.0 1.7 2.3 3.9 43.2 0.0 13.9 0.3 2.3 4.3 1.0 199.3 10.5 95.4 17.5 46.7 176.2 10.7 13.9 32.0 99.3 6.1 148.1 9.1 3.0 16.1 40.5 7.7 9.8 7.4 59.2 11.8 10.2 8.7 6.5 8.2 6.6 6.4 7.6 9.1 50.8 0.0 7.7 0.7 303.7 96.7 155.0 31.3 70.6 27.8 65.8 72.0 37.8 2.8 12.0 9.2 22.9 0.9 919.7 20.4 1.9 0.9 0.9 115.6 62.7 28.7 87.8 50.5 5.2 1.4 1.7 22.8 86.6 321.1 104.3 7.4 12.8 3.9 80.2 0.0 1.4 37.5 8.2 40.4 924.0 1.4 1.8 353.9 144.1 1.9 3.4 1.5 90.6 1.0 0.5 1.0 2.5 1.9 268.5 70.4 1.6 1.4 2.7 3.6 0.0 14.7 26.6 0.6 4.8 50.4 109.7 1.6 764.7 3.0 51.6 41.1 GRHL3 "SOM, TFCP2L4" ENSG00000158055 "Grainyhead like transcription factor 3" Q8TE85 1 24319357-24364482 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 121.8;skin 1: 52.0;vagina: 48.1" "Group enriched" "Detected in some" 5 "Squamous epithelial cells: 113.5;Suprabasal keratinocytes: 99.3;Urothelial cells: 78.4" "Group enriched" "Detected in many" 4 "cervical cancer: 13.3;head and neck cancer: 16.1;urothelial cancer: 28.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 46.1;HaCaT: 36.6;MCF7: 58.5;OE19: 21.2;RT4: 64.8;SuSa: 33.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059960 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA059960: AB_2684180" "unprognostic (8.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.95e-2)" "unprognostic (7.83e-3)" "unprognostic (7.58e-3)" "unprognostic (6.28e-3)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (9.01e-3)" "unprognostic (4.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.36e-2)" "unprognostic (8.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (6.97e-3)" "unprognostic (7.42e-2)" 0.2 0.1 0.5 0.3 0.5 0.1 1.9 1.4 2.1 11.1 0.1 0.1 0.6 0.1 1.6 121.8 0.6 0.7 0.0 0.4 1.2 0.2 0.3 0.1 0.0 5.2 2.1 0.0 0.0 0.2 0.9 0.2 1.4 5.0 1.5 0.3 0.1 16.8 1.6 0.1 52.0 0.3 0.0 2.2 0.0 0.5 2.4 1.1 1.0 0.0 0.0 25.3 35.0 48.1 1.8 1.2 2.7 1.0 0.0 0.0 0.0 46.1 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 36.6 0.1 3.3 0.0 1.2 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 14.2 0.2 2.7 0.0 0.0 0.0 0.2 0.1 0.0 58.5 0.0 0.2 2.4 21.2 0.0 0.0 0.0 0.2 4.6 64.8 0.3 0.0 0.2 6.3 0.0 33.3 4.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 1.4 2.1 0.4 1.2 5.2 2.1 0.0 5.0 2.2 1.1 1.8 0.0 0.0 0.6 0.0 0.0 14.4 13.2 5.2 8.6 0.0 1.1 0.3 0.5 0.0 6.4 1.8 0.0 4.1 0.0 0.9 0.0 0.4 0.5 3.8 0.1 0.3 0.0 0.0 0.1 0.0 0.8 0.3 0.0 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.1 2.0 0.3 2.1 0.3 0.0 0.3 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.1 0.2 0.0 3.3 0.0 0.0 0.0 0.3 2.6 0.0 113.5 99.3 18.5 0.0 0.0 0.1 78.4 UBXN11 "SOC, SOCI, UBXD5" ENSG00000158062 "UBX domain protein 11" Q5T124 1 26281328-26318363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 131.1;Late spermatids: 327.4;Respiratory ciliated cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 93.2;intermediate monocyte: 82.6;myeloid DC: 48.4;non-classical monocyte: 72.2" "Group enriched" "Detected in all" 4 "dendritic cells: 48.4;monocytes: 93.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028600, HPA031357" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028600: AB_10604001, HPA031357: AB_2673840" "unprognostic (1.78e-3)" "prognostic favorable (2.54e-5)" "unprognostic (8.18e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.53e-1)" "prognostic favorable (4.90e-4)" "prognostic unfavorable (5.90e-6)" "unprognostic (8.41e-2)" "unprognostic (2.70e-1)" "unprognostic (4.41e-2)" "unprognostic (1.79e-3)" "unprognostic (1.89e-2)" "unprognostic (5.59e-3)" "unprognostic (5.00e-2)" "unprognostic (2.20e-1)" "unprognostic (3.25e-1)" "unprognostic (1.31e-2)" 10.3 10.8 27.8 9.6 22.1 19.5 10.7 17.1 35.4 10.4 37.7 8.0 3.4 9.6 14.8 6.3 31.5 5.2 10.5 24.7 22.1 19.1 7.9 17.9 8.0 21.3 24.9 20.4 13.5 11.2 8.0 31.6 4.3 20.6 11.6 2.7 15.1 9.5 6.5 5.7 7.2 8.1 4.1 23.2 22.0 8.9 48.7 19.9 6.8 25.3 3.4 3.9 8.5 7.5 17.5 26.4 11.7 5.7 11.6 4.1 3.1 19.7 5.7 8.8 15.6 11.3 4.6 22.8 15.3 8.5 3.6 10.3 14.0 3.5 9.3 3.9 7.7 13.6 2.6 18.1 11.5 7.2 11.2 5.0 4.7 9.9 26.3 6.7 4.9 4.3 11.1 10.2 10.3 5.4 11.8 6.4 5.4 11.5 7.4 8.8 13.1 4.2 13.8 8.7 3.8 26.9 6.3 14.1 13.1 10.2 2.9 10.3 10.7 4.2 8.9 13.4 13.4 8.7 9.7 29.8 17.7 11.0 15.4 7.5 2.2 93.2 4.6 9.0 82.6 11.4 12.7 13.6 10.8 48.4 16.2 15.2 9.7 6.8 6.1 72.2 7.5 12.5 41.7 27.8 22.1 17.1 35.4 24.7 22.1 21.3 24.9 20.4 20.6 23.2 19.9 17.5 4.3 0.0 1.1 5.5 18.8 21.4 15.7 23.4 5.2 11.9 13.2 15.5 1.3 5.7 16.2 23.9 22.9 9.9 10.0 5.5 13.7 14.7 131.1 78.6 9.2 5.1 9.0 6.7 7.0 8.7 20.8 10.0 17.9 8.3 10.2 11.9 6.1 3.0 20.9 23.5 5.1 5.9 18.3 62.4 35.3 327.4 12.8 59.9 10.6 2.8 41.9 24.2 12.3 2.0 1.6 7.6 2.5 10.1 9.5 9.8 1.2 26.7 121.2 54.9 19.7 6.6 11.5 26.1 24.0 5.1 13.4 7.3 23.7 8.7 8.3 12.1 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020479-7071526 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 2.3;Bipolar cells: 2.2;Cone photoreceptor cells: 2.1;Distal tubular cells: 1.9;Early spermatids: 2.2;Excitatory neurons: 2.2;Rod photoreceptor cells: 3.2;Spermatocytes: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.1 0.3 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.3 0.2 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.1 2.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTPDC1 "FLJ37312, PTP9Q22" ENSG00000158079 "Protein tyrosine phosphatase domain containing 1" A2A3K4 9 94030794-94109856 "Metabolic proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 36.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 36.1;Oligodendrocytes: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016747, HPA026832" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016747: AB_1855908, HPA026832: AB_10602917" "unprognostic (3.99e-2)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.91e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-3)" "unprognostic (4.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.56e-1)" "unprognostic (3.49e-2)" "unprognostic (3.55e-2)" "unprognostic (2.48e-2)" "unprognostic (2.45e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (2.61e-2)" 3.5 5.8 7.2 2.3 14.1 0.7 3.1 9.2 11.0 3.1 2.9 3.8 1.4 3.1 2.3 2.0 3.4 2.3 6.8 8.4 36.0 3.4 1.5 4.4 1.9 10.8 11.7 7.4 3.0 5.9 3.6 6.8 1.8 12.0 3.2 2.8 4.5 2.9 2.0 4.8 3.1 2.4 4.1 7.9 1.9 4.4 7.8 10.1 1.8 3.3 6.8 1.9 2.6 2.8 18.4 6.1 2.7 4.7 6.1 5.8 7.9 6.2 4.4 3.0 4.4 3.7 2.6 5.0 5.1 2.9 3.4 10.1 4.7 4.9 2.8 4.3 6.8 1.3 1.2 7.7 2.8 7.4 1.4 3.8 7.9 10.0 6.7 9.2 2.6 4.7 8.3 3.0 0.0 8.4 3.3 5.2 2.2 3.3 5.0 4.8 5.6 9.3 0.0 2.4 1.5 4.1 5.1 6.1 5.7 9.5 6.2 3.1 2.5 6.7 5.8 3.5 9.1 5.4 7.2 8.4 0.7 4.3 2.5 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 14.1 9.2 11.0 8.4 36.0 10.8 11.7 7.4 12.0 7.9 10.1 18.4 5.7 0.0 7.7 19.2 4.7 4.8 3.0 2.2 5.7 10.7 2.3 3.3 11.3 5.7 1.4 5.5 10.4 0.4 2.6 2.1 3.9 3.1 11.7 2.3 7.3 5.8 3.5 0.8 36.1 2.9 2.0 8.1 14.3 3.1 5.7 6.7 4.2 1.0 3.1 5.0 27.0 2.6 4.1 1.0 4.6 6.2 3.7 3.6 3.6 14.0 0.5 2.2 0.0 18.6 82.6 6.1 2.9 14.3 2.0 1.4 1.1 1.7 2.1 9.8 19.7 7.4 5.5 21.0 20.8 4.7 4.3 0.3 4.0 2.3 2.3 1.8 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.7" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.5" "Cell line enhanced" "Detected in many" "A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 27000 "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.3 1.5 4.0 1.0 8.4 5.9 0.8 2.2 3.1 0.9 3.0 0.3 0.5 0.3 0.3 11.9 1.2 2.2 0.2 3.1 3.0 41.7 1.3 0.6 2.3 3.1 7.0 4.3 0.1 3.1 4.1 5.9 0.0 1.7 1.6 0.1 0.6 1.2 0.0 0.1 2.1 3.3 0.7 1.0 2.4 0.5 2.5 11.3 0.4 0.9 0.4 4.8 2.3 1.3 3.5 23.6 28.6 0.0 0.0 0.0 0.0 0.0 7.9 4.1 4.9 0.6 0.0 0.0 22.1 7.8 0.4 0.0 0.0 1.0 1.0 0.8 0.6 2.8 12.1 0.0 0.0 0.0 18.2 0.0 0.1 4.5 0.0 17.0 0.2 0.0 0.6 0.0 19.0 0.0 10.7 0.1 0.0 12.6 0.0 0.0 15.5 0.0 32.3 41.3 35.3 24.4 18.3 0.0 0.0 0.1 4.4 0.1 0.0 0.0 0.0 19.6 0.0 0.5 1.9 6.2 0.1 0.0 11.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 4.0 8.4 2.2 3.1 3.1 3.0 3.1 7.0 4.3 1.7 1.0 11.3 3.5 2.2 0.0 0.0 1.0 1.4 2.8 4.1 5.3 21.6 0.3 0.6 2.4 1.1 0.0 6.2 9.2 0.0 0.0 0.0 0.3 13.7 2.9 5.7 0.0 0.1 1.2 0.0 0.0 29.1 0.4 0.0 1.1 0.5 0.4 0.0 0.0 8.2 0.2 0.1 0.0 79.2 0.9 2.0 0.6 0.3 12.0 0.0 0.4 0.0 2.8 0.0 0.2 0.0 4.0 8.7 2.6 0.0 0.0 3.1 14.2 21.9 45.5 1.1 0.4 6.6 0.4 2.2 3.4 6.9 9.2 0.9 0.0 0.4 0.2 1.8 5.1 NCK1 "NCK, NCKalpha" ENSG00000158092 "NCK adaptor protein 1" P16333 3 136862208-136951606 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005063, HPA030766" Supported Approved "Plasma membrane,Cytosol" NA NA 17000 "Plasma membrane, Cytosol" "CAB005063: AB_562169, HPA030766: AB_2673602" "unprognostic (7.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.98e-2)" "unprognostic (3.03e-2)" "unprognostic (1.06e-2)" "unprognostic (8.77e-3)" "unprognostic (4.24e-3)" "unprognostic (8.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.14e-5)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.64e-1)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (4.17e-2)" 31.7 18.1 13.6 26.4 13.7 32.3 28.8 17.5 15.4 27.1 20.7 28.0 15.5 23.9 17.1 39.0 20.6 20.3 20.4 13.0 18.0 16.3 31.1 27.3 42.2 14.4 13.8 11.6 23.5 17.3 24.4 13.8 30.9 14.5 21.6 28.1 18.5 24.8 19.3 27.8 30.3 15.9 23.9 14.0 29.1 18.6 19.7 14.1 53.4 27.1 29.4 44.8 29.6 36.5 16.6 50.1 22.0 28.4 23.4 65.3 62.7 31.5 36.6 65.3 41.8 43.4 32.3 49.9 49.0 74.9 43.0 54.5 37.9 40.3 37.1 54.3 35.7 16.3 43.0 31.1 25.4 106.0 31.3 28.2 57.4 47.3 40.8 80.0 41.9 64.4 46.1 26.3 42.7 44.2 28.2 71.8 25.3 26.8 45.6 27.6 37.6 26.4 47.6 38.9 34.4 19.8 19.2 66.5 28.1 62.2 34.2 42.0 33.8 32.5 27.1 17.1 38.8 21.3 42.2 36.6 62.5 27.8 27.6 29.3 61.1 22.3 24.7 32.8 50.5 33.6 13.9 25.7 33.7 24.4 14.2 20.8 24.5 12.8 21.6 26.4 9.4 27.6 23.6 13.6 13.7 17.5 15.4 13.0 18.0 14.4 13.8 11.6 14.5 14.0 14.1 16.6 58.6 9.6 15.9 25.5 41.6 74.8 77.1 225.1 79.6 20.1 23.7 19.9 11.1 27.1 144.3 9.2 6.2 45.4 54.0 29.6 15.6 50.4 11.6 27.9 31.9 61.4 13.8 17.5 28.6 27.3 52.7 42.8 9.2 31.2 9.5 14.9 31.8 37.5 48.3 25.2 37.9 17.7 46.8 36.6 62.8 8.9 44.1 38.0 42.7 70.3 49.6 20.2 88.6 42.7 36.9 37.9 25.3 26.7 36.2 98.0 15.6 23.9 75.7 14.6 13.1 24.9 32.1 55.2 36.6 66.1 83.3 61.0 70.4 21.8 18.8 142.9 HPD "4-HPPD, 4HPPD, GLOD3, PPD" ENSG00000158104 "4-hydroxyphenylpyruvate dioxygenase" P32754 12 121839527-121863596 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 2551.0" "Group enriched" "Detected in some" 9 "Hepatocytes: 1373.6;Proximal tubular cells: 2144.0" "Cancer enriched" "Detected in many" 100 "liver cancer: 540.9" "Region enhanced" "Detected in many" "hippocampal formation: 8.0" "Immune cell enhanced" "Detected in some" "eosinophil: 7.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;granulocytes: 7.8" "Cell line enriched" "Detected in some" 31 "Hep G2: 516.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038321, HPA038322" Enhanced Uncertain "Nuclear speckles" NA NA 26000000 "Nuclear speckles" "HPA038321: AB_2675957, HPA038322: AB_10670778" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.81e-3)" "unprognostic (1.42e-3)" "unprognostic (1.10e-2)" "unprognostic (9.08e-2)" "unprognostic (1.13e-2)" "unprognostic (8.84e-2)" "unprognostic (5.58e-2)" "unprognostic (6.14e-3)" "unprognostic (9.72e-3)" "unprognostic (8.61e-3)" "unprognostic (7.16e-2)" "unprognostic (1.97e-1)" "unprognostic (4.12e-1)" "unprognostic (3.06e-2)" "unprognostic (2.34e-1)" 2.1 5.3 0.5 0.7 0.3 1.0 4.7 3.1 1.6 1.7 96.2 1.0 0.1 4.2 0.7 0.7 6.4 1.1 2.5 8.0 1.7 536.0 2551.0 2.0 0.3 1.4 2.0 0.2 4.8 4.0 0.1 1.1 0.3 1.0 2.3 0.5 0.3 0.2 7.4 2.2 0.2 0.9 1.4 0.6 2.3 1.9 10.3 2.8 0.1 0.8 0.1 0.1 3.7 1.9 0.9 0.3 0.9 0.6 0.6 0.3 0.6 0.6 0.0 0.1 0.0 0.0 0.2 0.5 0.2 0.6 1.1 0.2 0.4 0.2 0.0 0.0 0.3 0.8 1.2 5.4 516.4 11.5 1.8 16.4 3.6 0.3 0.0 0.0 1.3 0.0 0.5 0.8 0.0 1.3 1.3 0.2 0.4 9.9 0.4 0.0 0.3 1.6 0.5 0.0 1.4 0.1 0.1 1.5 0.1 0.1 6.9 1.1 0.9 0.2 0.0 0.3 0.1 0.1 0.8 0.6 0.7 0.2 1.2 0.0 0.0 0.6 7.8 0.0 0.8 0.0 0.1 0.1 0.1 1.0 0.1 0.2 0.2 3.9 0.0 1.3 3.8 0.0 0.3 0.5 0.3 3.1 1.6 8.0 1.7 1.4 2.0 0.2 1.0 0.6 2.8 0.9 0.0 0.0 0.0 0.7 15.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 55.8 0.0 92.0 0.0 0.8 0.0 0.0 193.7 0.5 38.0 0.1 0.0 2.6 0.0 80.2 1.0 16.2 0.3 0.4 0.0 0.1 0.0 0.0 38.9 1373.6 0.3 0.0 1.0 0.0 0.0 37.8 0.3 121.0 2.5 10.8 0.0 0.0 0.4 0.0 0.0 1.5 0.7 0.2 0.0 5.3 0.0 0.0 0.0 2144.0 0.0 0.0 0.0 2.0 0.2 1.8 1.4 0.0 0.0 1.1 8.0 7.1 0.0 0.0 RHPN1 "KIAA1929, ODF5, RHPN" ENSG00000158106 "Rhophilin Rho GTPase binding protein 1" Q8TCX5 8 143368876-143384221 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.2;thyroid gland: 20.6" "Cell type enhanced" "Detected in many" "Astrocytes: 47.0;Collecting duct cells: 38.6;Cone photoreceptor cells: 31.3;Respiratory ciliated cells: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 28.3;MOLT-4: 25.8;RPMI-8226: 19.0;T-47d: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024288, HPA024671" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024288: AB_1856274, HPA024671: AB_1856275" "unprognostic (2.04e-1)" "unprognostic (3.71e-1)" "unprognostic (1.54e-2)" "unprognostic (2.20e-1)" "unprognostic (5.82e-2)" "unprognostic (6.38e-2)" "unprognostic (2.07e-3)" "unprognostic (3.12e-1)" "unprognostic (3.57e-1)" "unprognostic (1.02e-1)" "unprognostic (8.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-3)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-2)" 2.3 1.6 10.8 0.9 8.1 2.1 4.8 7.0 13.0 2.5 6.3 1.8 0.1 1.4 1.3 2.5 5.1 0.7 1.0 12.8 8.0 13.7 1.3 3.5 1.1 7.5 7.1 8.5 0.7 4.2 3.0 20.2 0.1 7.1 4.0 0.1 0.6 3.7 1.9 0.3 2.5 3.0 0.3 4.6 5.4 3.0 4.0 7.6 8.9 20.6 0.0 0.5 2.6 1.9 6.4 2.9 4.9 1.2 3.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 1.9 0.2 9.8 0.0 0.2 1.3 0.0 0.0 0.0 0.6 4.4 0.0 3.5 0.3 0.4 0.3 3.1 0.0 0.8 0.0 0.0 0.9 1.0 11.5 1.1 5.8 0.0 28.3 25.8 2.6 1.7 5.9 13.4 7.0 0.0 19.0 3.9 4.6 7.2 2.7 1.5 8.1 1.8 0.0 44.2 0.0 0.0 0.0 5.1 0.1 0.2 1.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 8.1 7.0 13.0 12.8 8.0 7.5 7.1 8.5 7.1 4.6 7.6 6.4 6.7 6.4 7.5 47.0 2.0 2.5 2.7 3.9 3.4 3.4 13.4 8.9 1.0 2.8 5.9 38.6 31.3 1.6 3.3 2.4 11.7 8.7 5.1 21.9 1.2 5.7 22.7 1.7 20.2 2.8 0.2 1.1 11.7 4.1 0.0 6.6 5.3 1.4 3.2 6.7 10.2 3.1 6.1 1.3 6.0 11.2 0.3 1.6 7.2 3.7 1.4 11.5 0.0 15.1 3.6 3.3 1.2 1.5 1.4 3.2 0.0 15.8 38.6 25.2 0.0 0.7 1.5 7.6 7.2 2.5 1.4 1.9 5.5 1.1 4.3 3.7 TPRG1L "FAM79A, FLJ21811, RP11-46F15.3" ENSG00000158109 "Tumor protein p63 regulated 1 like" Q5T0D9 1 3625015-3630127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063163, CAB079051" Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB079051: , HPA063163: AB_2684953" "unprognostic (1.92e-1)" "unprognostic (3.26e-3)" "unprognostic (4.46e-2)" "unprognostic (7.99e-2)" "unprognostic (4.50e-2)" "unprognostic (3.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-3)" "prognostic favorable (1.76e-9)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" 40.0 37.7 81.4 21.6 90.1 35.7 36.8 64.6 96.1 37.8 62.8 49.8 50.6 36.8 41.1 57.3 48.5 38.0 53.0 89.7 88.2 66.2 86.2 34.7 27.6 84.0 80.0 89.3 49.5 38.4 38.7 47.4 24.2 88.1 33.6 46.9 50.2 40.2 47.4 68.2 52.5 54.9 36.0 66.6 30.4 40.8 18.8 84.1 25.3 43.9 70.6 38.9 42.0 40.2 92.4 31.3 22.0 13.3 23.9 98.1 67.8 12.2 45.4 62.4 41.3 27.2 41.5 27.9 11.5 39.6 62.5 22.2 48.1 16.1 42.0 34.7 36.7 25.7 16.0 24.4 48.4 59.4 23.6 18.3 51.3 60.7 34.2 34.7 50.2 59.0 19.7 11.6 39.8 58.3 14.3 17.1 24.2 17.9 71.5 50.9 14.2 19.8 27.8 42.5 32.3 37.1 36.6 24.3 49.8 50.6 30.2 31.2 20.3 67.7 34.5 10.2 79.3 13.1 35.9 49.8 13.0 20.4 51.2 4.6 20.7 3.6 5.6 5.9 2.9 7.6 4.9 6.7 6.0 3.2 6.2 6.2 7.2 18.9 3.2 3.1 8.9 4.1 3.8 81.4 90.1 64.6 96.1 89.7 88.2 84.0 80.0 89.3 88.1 66.6 84.1 92.4 21.1 16.0 17.8 9.4 9.3 12.0 10.1 9.2 6.8 50.4 15.6 16.9 39.7 12.8 8.8 11.0 8.4 10.6 23.0 69.8 11.7 18.0 3.0 30.1 13.3 16.8 19.2 11.0 12.8 35.4 12.3 20.3 11.7 19.5 8.2 8.2 28.2 61.4 15.7 126.2 10.1 29.2 20.3 18.6 9.7 4.1 18.6 12.8 7.2 2.8 14.0 71.3 20.6 4.5 6.6 33.8 27.4 21.4 9.7 10.8 62.3 37.6 22.9 38.0 6.6 16.3 19.9 7.0 12.8 21.0 18.9 9.2 12.9 21.8 28.4 9.4 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 13.2;fallopian tube: 19.2" "Cell type enhanced" "Detected in some" "Early spermatids: 23.2;Endometrial ciliated cells: 21.8;Late spermatids: 43.5;Proximal tubular cells: 15.9;Respiratory ciliated cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.1;HSkMC: 1.3;HUVEC TERT2: 2.7;SCLC-21H: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039425: AB_2676501" "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.5 0.3 3.8 0.0 2.2 0.5 0.3 2.1 2.1 0.6 13.2 0.2 0.5 0.8 1.8 0.1 19.2 1.0 0.7 2.2 3.9 2.1 0.1 1.6 0.0 2.8 4.3 1.1 0.3 0.6 1.9 2.2 0.1 2.4 0.7 0.1 0.6 1.1 1.2 0.1 0.3 0.1 0.2 3.5 0.3 0.2 6.5 2.4 0.0 1.6 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.7 0.2 0.2 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.1 0.0 0.2 1.3 0.0 0.4 0.0 0.0 2.7 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.1 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.9 0.2 0.2 0.0 0.2 3.8 2.2 2.1 2.1 2.2 3.9 2.8 4.3 1.1 2.4 3.5 2.4 1.4 0.0 6.4 0.0 4.6 0.1 0.0 0.1 1.0 0.0 0.4 0.3 0.3 0.5 0.0 2.7 1.8 4.2 0.1 1.7 0.2 1.9 0.1 23.2 21.8 0.4 0.1 0.0 0.8 3.5 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 2.8 0.0 2.0 0.0 0.3 43.5 0.6 0.3 0.0 1.0 0.0 0.9 2.1 2.0 0.7 0.0 0.0 0.4 0.1 0.1 0.0 15.9 35.2 0.1 0.0 0.1 0.5 8.2 1.2 0.0 0.0 0.1 0.5 0.0 0.1 0.1 PRXL2C "AAED1, C9orf21" ENSG00000158122 "Peroxiredoxin like 2C" Q7RTV5 9 96639577-96655317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.8;Cardiomyocytes: 18.3;Cytotrophoblasts: 15.7;dendritic cells: 22.5;Extravillous trophoblasts: 69.9;Hofbauer cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 45.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 45.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021294 Approved NA NA "HPA021294: AB_1845818" "unprognostic (4.17e-2)" "unprognostic (1.21e-1)" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (1.85e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (4.83e-2)" "unprognostic (4.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.13e-2)" "unprognostic (1.66e-1)" "unprognostic (8.38e-3)" "unprognostic (3.70e-2)" 12.5 5.7 3.8 6.2 4.3 11.6 10.2 3.9 4.3 6.6 4.4 6.4 3.8 8.0 2.9 5.5 8.0 8.5 10.9 4.0 4.9 5.6 6.9 9.8 4.9 5.4 4.3 3.7 5.1 6.1 3.3 3.1 6.5 4.9 5.4 4.3 1.2 4.0 3.8 11.4 4.8 5.6 11.0 4.6 7.1 5.6 5.2 4.3 3.5 8.2 8.0 5.4 8.5 5.2 5.2 11.0 5.6 2.7 9.6 22.5 38.4 10.7 12.1 18.1 10.0 9.6 12.7 12.2 0.3 9.8 19.8 19.4 10.4 9.5 5.8 6.0 11.3 5.9 6.3 4.9 10.5 17.2 5.1 17.3 18.3 10.0 7.0 8.8 9.9 8.8 4.4 12.6 4.6 10.4 7.8 0.2 9.0 3.7 4.5 10.5 0.2 8.0 0.2 14.2 2.5 4.3 5.4 8.8 7.4 6.5 8.0 2.9 9.0 16.1 16.8 7.0 16.4 8.0 12.2 5.8 4.2 7.2 4.7 15.7 45.7 9.6 23.2 10.1 11.4 10.6 10.1 9.4 10.1 8.7 7.6 4.9 8.2 2.0 5.8 11.1 5.6 10.6 3.5 3.8 4.3 3.9 4.3 4.0 4.9 5.4 4.3 3.7 4.9 4.6 4.3 5.2 23.8 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 15.7 22.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 69.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 6.3 8.9 0.0 0.0 0.0 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414742 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 42.7;intestine: 49.9;liver: 69.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" No No 77000 Nucleoplasm Nucleoli "HPA062641: AB_2684816, HPA069323: AB_2686121" "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favorable (8.73e-6)" 0.2 0.0 0.0 4.8 0.0 0.1 42.7 0.2 0.1 0.3 0.3 11.2 45.3 0.9 2.3 9.8 0.1 4.6 0.0 0.0 0.2 0.2 69.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.1 1.3 9.6 0.1 3.6 0.1 0.5 1.0 49.9 0.7 0.0 0.0 3.2 0.1 0.0 0.2 0.3 0.0 2.3 2.7 2.0 0.1 2.0 0.4 0.0 0.0 0.0 0.1 0.1 8.2 4.7 1.0 1.4 0.3 2.3 0.1 1.6 0.3 0.8 4.2 0.0 20.0 1.0 1.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 1.8 1.1 31.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.4 1.2 0.2 0.0 1.4 4.5 5.7 5.2 0.0 0.1 0.1 0.3 0.0 1.7 0.0 0.0 0.0 3.8 2.4 0.2 8.9 2.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 2.4 0.0 0.2 0.5 6.0 5.5 2.8 0.3 262.1 6.5 0.4 2.8 3.6 0.0 0.0 0.3 1.1 143.5 0.0 3.9 0.3 7.9 2.8 0.3 11.9 0.0 0.2 8.2 0.6 0.2 2.0 37.0 0.0 0.0 1.4 46.9 0.0 0.0 0.2 8.4 2.0 1.9 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 48.8 0.0 0.0 2.2 96.8 0.0 1.0 0.7 0.0 0.3 0.7 0.0 0.2 1.2 0.1 0.4 0.7 0.2 22.2 16.9 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959588-27968093 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "eosinophil: 202.8;neutrophil: 101.6" "Lineage enriched" "Detected in all" 13 "granulocytes: 202.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA049984: AB_2680982, HPA053529: AB_2682179" "prognostic favorable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 5.8 4.5 17.7 8.7 18.0 22.9 6.6 18.6 19.2 6.3 17.8 6.1 7.1 5.7 8.2 5.3 7.7 6.8 8.2 18.3 18.6 6.2 15.4 7.5 8.9 18.8 18.1 17.3 9.1 14.2 9.7 4.6 15.3 17.9 6.3 6.1 5.4 10.4 8.1 6.2 5.7 6.1 9.4 17.5 9.4 9.0 6.4 18.3 6.9 6.5 11.8 7.5 7.0 4.7 17.7 10.9 8.6 12.4 13.4 10.5 15.5 13.5 8.8 17.1 19.5 18.7 18.2 7.6 4.1 9.1 21.1 14.5 4.6 19.0 9.5 9.8 15.0 18.2 13.8 5.2 15.4 15.7 6.8 4.7 16.9 18.8 21.8 15.2 19.7 19.3 12.5 21.6 8.9 14.1 10.0 8.5 19.7 40.3 9.1 12.6 15.1 4.0 8.8 15.6 6.3 2.9 4.1 3.8 9.6 6.2 21.7 6.2 16.8 8.0 11.4 10.2 23.9 8.0 13.1 13.6 6.5 29.3 9.2 8.7 20.3 11.9 202.8 15.1 11.9 14.8 7.6 15.7 14.1 13.0 7.1 14.4 13.5 101.6 14.0 10.2 6.3 14.8 11.2 17.7 18.0 18.6 19.2 18.3 18.6 18.8 18.1 17.3 17.9 17.5 18.3 17.7 4.4 3.2 1.1 2.6 8.8 1.9 3.8 3.5 1.8 4.5 5.2 3.4 3.3 5.7 4.4 3.7 0.0 62.0 15.5 4.7 3.9 7.8 0.5 1.8 2.9 6.8 1.8 2.1 2.2 11.4 15.8 6.1 5.6 2.4 1.3 5.2 8.6 5.6 14.0 3.3 2.2 6.1 2.0 6.6 3.7 0.9 3.4 8.0 1.8 1.0 21.1 14.0 16.5 3.5 5.5 7.2 2.8 3.8 14.0 5.1 7.2 4.5 1.7 1.3 6.6 5.1 4.0 0.6 7.8 2.2 3.0 22.4 9.1 4.4 5.2 4.1 CNNM4 "ACDP4, KIAA1592" ENSG00000158158 "Cyclin and CBS domain divalent metal cation transport mediator 4" Q6P4Q7 2 96760902-96811874 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Biomineralization, Ion transport, Sensory transduction, Transport, Vision" "Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 39.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "SK-BR-3: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017732 Enhanced Uncertain "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA017732: AB_1847395" "unprognostic (1.98e-3)" "unprognostic (8.95e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (3.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.54e-3)" "unprognostic (3.36e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.75e-4)" "unprognostic (4.75e-3)" "unprognostic (3.72e-1)" "unprognostic (8.14e-2)" "unprognostic (3.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" 2.8 3.6 4.4 6.1 6.1 5.0 7.1 10.9 5.3 5.3 3.0 32.7 6.3 4.0 4.7 7.1 10.5 4.5 12.0 4.6 4.8 4.9 4.4 8.1 4.6 4.2 4.5 5.0 5.1 7.5 6.4 9.2 5.8 6.0 5.8 34.6 39.1 6.9 5.1 25.1 7.2 11.3 4.8 3.2 5.4 12.9 7.9 4.2 3.5 9.6 13.2 4.9 5.5 6.5 5.5 11.1 7.2 5.7 10.5 5.8 3.9 15.6 4.8 6.8 6.9 9.3 13.2 11.8 8.1 13.5 5.0 9.5 14.1 14.9 8.1 6.3 16.3 11.7 6.4 4.8 7.2 8.1 3.1 6.2 3.8 10.0 11.0 6.6 4.6 3.8 8.0 3.3 22.3 3.6 15.7 6.6 4.5 7.5 20.5 9.8 9.7 2.6 9.3 6.9 8.6 26.7 8.0 9.1 45.7 6.8 15.9 22.3 5.3 3.4 4.0 8.9 8.8 5.4 7.7 6.6 4.0 5.9 6.1 7.2 1.2 0.4 0.1 0.8 0.4 0.2 0.9 0.4 0.4 0.6 0.5 0.2 0.5 0.2 0.2 0.7 0.4 0.2 0.3 4.4 6.1 10.9 5.3 4.6 4.8 4.2 4.5 5.0 6.0 3.2 4.2 5.5 4.5 38.5 7.7 12.4 6.4 5.7 4.9 4.0 4.6 43.1 14.7 11.2 14.1 4.3 11.6 7.3 112.6 5.4 6.1 103.4 0.0 3.2 4.9 14.3 4.4 4.0 10.1 0.8 9.8 4.2 1.7 3.2 12.2 16.1 1.3 5.9 2.2 3.3 3.3 33.7 8.3 26.4 6.1 5.4 4.8 1.6 0.9 5.9 0.0 8.4 2.3 8.3 2.1 11.1 14.6 5.2 21.3 1.2 4.5 4.1 22.3 1.2 10.6 51.5 0.0 4.6 4.3 4.6 2.5 7.3 4.1 6.7 5.4 6.7 26.5 6.1 EYA3 DKFZp686C132 ENSG00000158161 "EYA transcriptional coactivator and phosphatase 3" Q99504 1 27970344-28088637 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052432, HPA062889" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "HPA052432: AB_2681831, HPA062889: AB_2684895" "unprognostic (3.57e-1)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.11e-4)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (9.13e-2)" "unprognostic (8.98e-2)" "prognostic favorable (3.15e-6)" "unprognostic (5.17e-2)" "unprognostic (2.79e-1)" "unprognostic (7.60e-2)" "unprognostic (6.11e-2)" 4.7 4.9 7.4 8.3 6.9 5.2 7.2 8.7 8.0 7.5 9.3 5.6 5.9 6.1 6.4 10.0 6.2 4.3 6.3 6.6 7.2 11.8 6.0 6.0 9.5 7.1 7.1 6.6 6.4 6.6 8.4 7.6 7.7 7.9 6.1 6.3 10.6 5.6 5.5 7.2 9.1 6.4 5.6 6.6 7.2 5.5 11.5 7.7 9.5 9.3 8.4 14.6 7.2 6.2 8.7 16.3 6.6 13.1 9.7 14.9 11.6 7.3 11.8 11.0 13.2 12.9 6.4 9.5 25.5 12.3 7.8 4.9 15.3 24.4 9.5 15.6 13.4 13.5 28.2 14.4 11.6 8.8 27.9 25.2 7.0 8.3 14.6 9.7 11.3 17.0 9.0 26.9 9.6 11.9 7.0 18.0 18.5 27.5 12.6 8.6 13.2 24.9 16.8 15.3 8.8 14.9 8.2 12.6 7.6 11.0 10.5 6.2 7.3 16.6 15.9 8.4 15.1 9.4 13.9 15.2 22.0 11.5 26.7 7.0 5.7 6.8 7.3 7.5 6.9 6.7 5.2 5.8 5.4 8.3 4.6 4.9 5.6 6.4 7.1 6.1 5.1 5.4 1.9 7.4 6.9 8.7 8.0 6.6 7.2 7.1 7.1 6.6 7.9 6.6 7.7 8.7 12.6 9.6 10.8 46.4 17.5 17.8 11.3 10.0 9.6 18.3 12.0 7.1 9.2 12.8 7.9 25.8 16.7 13.0 10.6 8.2 15.6 13.5 80.2 13.6 13.2 12.9 20.4 9.9 66.0 8.9 14.4 11.6 16.8 15.3 12.0 15.8 14.6 8.7 9.7 18.5 58.8 9.1 12.2 13.3 46.1 39.1 10.2 14.6 12.4 39.4 12.9 8.1 10.3 45.2 80.5 14.5 10.9 6.0 13.7 12.0 13.8 18.0 5.7 20.6 13.1 11.1 8.4 98.7 50.6 10.7 22.9 10.9 15.8 9.6 10.5 11.7 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 4.5 1.5 5.2 2.2 3.2 8.9 4.7 6.2 2.8 8.3 13.8 4.0 2.3 8.1 1.9 2.5 12.9 5.8 3.2 2.3 4.5 4.2 1.0 5.8 0.9 4.8 5.4 1.2 7.0 6.4 2.7 2.2 2.0 4.1 4.2 1.5 4.6 2.1 3.4 1.0 7.9 2.2 4.6 5.8 2.6 7.3 4.1 2.7 0.4 3.6 0.9 0.7 6.1 5.3 2.1 5.4 3.1 6.1 5.1 3.8 5.1 1.4 8.6 5.1 5.0 6.3 2.0 0.4 0.0 4.3 8.0 7.0 1.7 4.5 2.0 2.4 1.2 4.4 2.4 7.5 0.3 3.1 1.8 4.0 5.4 2.0 5.5 2.6 5.1 2.8 1.4 1.8 0.0 6.9 0.3 0.0 0.8 7.4 0.0 1.1 0.0 7.1 0.0 2.3 8.5 2.1 4.8 8.9 0.0 4.3 3.4 2.3 3.7 2.2 12.3 5.6 6.0 4.5 0.0 0.0 0.1 4.9 2.6 4.8 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.2 3.2 6.2 2.8 2.3 4.5 4.8 5.4 1.2 4.1 5.8 2.7 2.1 1.4 3.2 2.0 4.2 0.0 3.6 0.6 1.9 7.4 8.6 0.2 2.5 2.9 7.2 7.7 1.8 8.4 0.1 0.0 0.0 5.9 3.8 17.4 58.8 8.5 2.6 0.0 1.3 4.0 1.2 0.1 6.5 7.1 1.1 0.0 7.4 0.0 0.0 1.4 3.3 2.9 0.0 2.0 3.2 2.6 1.8 6.2 3.5 0.0 3.7 0.6 2.7 0.0 2.5 0.2 5.9 0.0 4.1 0.0 0.4 0.0 0.8 74.0 19.4 0.0 7.2 9.8 0.6 2.3 1.7 4.3 0.0 0.5 1.7 0.0 0.1 TMSB15A "TMSL8, TMSNB" ENSG00000158164 "Thymosin beta 15A" P0CG34 X 102513682-102516739 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;prostate: 15.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 12.8;Granulosa cells: 25.9;Prostatic glandular cells: 13.8;Smooth muscle cells: 13.5;Spermatogonia: 19.8" "Group enriched" "Detected in many" 4 "glioma: 20.1;prostate cancer: 56.4;testis cancer: 14.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 571.5;HAP1: 110.2;MOLT-4: 113.4;NTERA-2: 148.0;RH-30: 259.9;SH-SY5Y: 148.1" "Low region specificity" "Detected in all" NA NA 130000 "unprognostic (5.33e-3)" "unprognostic (3.09e-2)" "unprognostic (1.70e-2)" "unprognostic (5.82e-3)" "unprognostic (1.34e-1)" "unprognostic (4.03e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-3)" "unprognostic (2.96e-4)" "unprognostic (2.14e-1)" "unprognostic (7.83e-2)" "unprognostic (2.07e-1)" 1.0 1.0 1.0 1.1 1.2 1.0 5.1 1.7 2.1 4.7 1.2 1.0 0.4 5.1 0.7 0.3 1.9 1.2 1.3 1.1 1.2 2.4 0.2 7.1 4.1 1.2 1.1 1.1 4.8 0.9 0.8 0.8 0.5 1.3 15.9 1.1 1.4 4.0 1.3 0.3 0.5 0.6 2.4 1.0 0.4 0.5 4.8 1.1 13.1 6.0 0.3 2.8 0.7 2.3 1.4 0.1 0.0 571.5 107.7 2.4 0.3 0.2 12.4 0.7 1.7 4.8 0.0 0.7 0.0 1.3 2.1 28.5 0.0 110.2 0.7 1.2 0.0 5.6 10.3 1.7 0.3 0.3 0.2 10.1 1.4 0.0 1.1 0.0 14.3 6.7 5.5 1.0 0.0 41.2 0.1 113.4 0.2 148.0 0.0 1.4 0.2 259.9 0.0 11.7 0.2 98.1 148.1 14.0 0.9 0.3 22.0 1.4 3.2 2.4 0.3 62.6 1.4 10.5 11.8 2.1 0.0 6.7 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.0 1.2 1.7 2.1 1.1 1.2 1.2 1.1 1.1 1.3 1.0 1.1 1.4 1.4 0.0 0.0 0.0 0.0 0.8 0.9 0.1 1.8 0.3 7.3 12.8 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.0 0.5 0.3 0.5 5.6 1.2 0.0 0.8 0.0 0.0 0.5 4.6 0.0 1.2 0.0 25.9 2.5 0.0 0.5 0.0 0.0 0.6 0.0 0.6 0.5 0.1 0.3 0.1 1.8 0.0 0.0 0.7 1.0 0.5 0.0 0.0 0.1 2.6 0.3 13.8 0.1 0.4 0.0 0.1 6.6 1.2 13.5 3.4 19.8 1.8 0.0 0.3 0.7 0.9 0.9 1.0 FANCC "FA3, FAC, FACC" ENSG00000158169 "FA complementation group C" Q00597 9 95099054-95426796 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 24.8" "Cell type enhanced" "Detected in many" "Early spermatids: 178.6;Hepatocytes: 42.6;Late spermatids: 87.8;Microglial cells: 49.6;Oligodendrocytes: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "basophil: 8.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.8" "Cell line enhanced" "Detected in all" "RH-30: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017793, HPA030771" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB017793: , HPA030771: AB_2673604" "unprognostic (1.48e-2)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (2.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.32e-2)" "unprognostic (3.41e-3)" "unprognostic (1.26e-2)" "unprognostic (7.45e-3)" "unprognostic (1.37e-1)" "unprognostic (8.00e-3)" "unprognostic (3.19e-2)" "prognostic favorable (6.03e-6)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.71e-2)" 2.5 1.7 1.7 3.1 2.2 3.3 3.4 8.3 2.6 4.1 1.5 4.1 5.5 3.3 1.1 3.5 2.8 3.7 2.5 1.8 2.9 6.8 24.8 4.0 2.7 3.8 2.5 1.1 2.3 4.4 1.5 3.5 3.1 4.0 3.6 4.3 2.4 3.1 1.5 3.7 5.9 6.3 2.2 2.0 2.3 3.6 9.5 2.3 4.3 3.1 1.2 2.7 3.0 3.3 3.8 21.5 14.6 18.7 16.9 2.0 5.4 11.7 8.1 5.7 14.1 13.9 16.2 9.3 12.7 6.4 7.2 10.6 25.5 21.1 8.5 8.4 12.9 10.1 9.8 16.6 9.6 2.7 11.6 11.3 4.9 3.8 11.1 5.4 3.9 8.4 10.1 14.9 5.7 10.3 17.1 9.7 5.8 9.6 23.2 8.9 17.3 47.1 7.0 6.4 6.8 26.2 13.1 18.9 7.4 4.2 8.2 6.9 8.6 4.0 13.0 17.1 14.5 14.1 5.9 12.0 6.8 6.6 9.8 15.9 8.8 0.3 0.0 0.9 0.6 0.9 0.6 0.4 0.9 0.3 0.6 0.7 0.7 0.1 0.1 1.3 0.9 0.4 0.5 1.7 2.2 8.3 2.6 1.8 2.9 3.8 2.5 1.1 4.0 2.0 2.3 3.8 3.0 3.2 2.2 9.4 2.2 2.5 2.7 1.2 2.8 6.1 3.5 3.7 1.9 5.7 2.3 0.0 4.2 3.0 2.7 3.3 1.9 4.4 178.6 3.5 5.5 4.3 0.0 3.0 22.1 4.1 5.0 3.3 2.0 4.7 5.7 3.9 5.0 42.6 2.0 10.1 13.8 4.0 0.0 3.5 1.3 87.8 6.5 1.6 1.8 49.6 2.8 2.1 1.0 32.2 48.9 3.1 1.0 2.2 4.4 3.0 5.6 8.9 1.0 4.5 0.0 4.1 2.3 19.4 13.2 4.0 2.7 2.3 2.1 4.5 4.7 2.5 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 163.3;heart muscle: 127.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "non-classical monocyte: 25.0" "Lineage enriched" "Detected in many" 9 "monocytes: 25.0" "Cell line enhanced" "Detected in many" "BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 92.8 68.2 112.0 10.9 125.3 1.7 47.1 121.7 105.1 15.6 51.7 18.3 3.3 28.9 7.1 8.0 26.6 12.1 127.8 103.4 125.6 22.8 5.5 18.5 5.2 123.4 125.2 97.5 49.0 5.7 8.3 17.8 10.7 112.9 15.4 4.2 16.0 13.5 15.2 81.1 11.2 8.8 23.4 105.4 12.3 12.1 9.7 163.3 4.9 26.6 48.4 3.4 29.3 12.2 99.3 0.8 7.9 15.8 24.5 59.6 29.2 40.0 92.9 16.0 7.3 8.2 3.3 3.1 0.3 113.7 70.4 18.6 0.1 9.0 1.8 6.1 7.7 3.1 0.5 4.8 20.1 15.9 0.0 1.9 41.5 5.9 0.7 1.4 13.6 1.3 0.0 10.7 0.8 31.4 3.7 0.0 20.4 19.1 0.0 2.7 1.1 33.8 0.2 30.4 2.0 18.6 42.0 62.8 0.7 45.9 10.9 16.1 37.7 0.6 23.7 25.3 24.3 2.4 0.1 1.0 1.2 21.4 0.1 11.4 0.2 2.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.8 25.0 0.1 0.0 0.8 112.0 125.3 121.7 105.1 103.4 125.6 123.4 125.2 97.5 112.9 105.4 163.3 99.3 8.9 9.6 1.5 54.2 0.8 2.2 3.0 3.4 1.2 5.6 28.8 34.8 121.7 2.8 3.5 9.2 10.4 20.1 0.2 0.0 58.7 8.6 11.6 1.0 21.4 14.5 1.8 0.0 25.5 3.2 3.2 23.0 2.0 1.5 6.3 35.2 12.8 1.6 26.3 28.6 20.6 0.0 2.0 15.1 18.4 40.0 23.3 18.2 28.4 20.6 12.2 24.3 0.0 28.6 11.0 3.8 0.0 34.3 0.1 3.3 0.0 27.5 1.3 9.6 6.6 20.8 18.9 7.3 18.6 0.4 1.0 14.4 0.8 59.1 0.0 0.6 WASF2 "SCAR2, WAVE2" ENSG00000158195 "WASP family member 2" Q9Y6W5 1 27404230-27490167 "Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022632, HPA045288" Enhanced Approved "Plasma membrane,Cytosol" NA NA 84000 "Plasma membrane" Cytosol "CAB022632: , HPA045288: AB_2679287" "unprognostic (9.58e-2)" "unprognostic (8.93e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (4.40e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (5.29e-8)" "unprognostic (3.94e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (7.60e-3)" "unprognostic (1.10e-1)" "unprognostic (9.15e-3)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.26e-2)" 55.7 34.4 36.3 44.5 43.9 60.3 46.3 40.9 33.9 39.8 31.6 46.6 27.8 54.3 21.8 90.5 46.7 31.4 32.3 29.7 41.7 28.6 15.1 46.1 48.4 56.3 46.2 24.2 64.0 35.5 31.3 17.1 52.7 49.0 33.4 39.7 9.2 38.7 42.3 18.6 56.1 42.6 52.4 46.3 48.0 40.6 37.1 44.0 55.1 35.9 28.0 52.7 48.2 40.2 48.8 75.4 35.3 80.3 73.4 57.1 74.3 46.5 59.9 55.5 64.7 57.9 30.8 79.2 52.1 56.6 94.4 44.1 58.8 65.5 98.4 77.1 73.3 41.1 113.5 60.5 36.7 76.9 91.9 62.8 68.5 105.1 70.7 130.8 70.0 82.3 56.8 92.3 26.3 89.0 27.1 68.7 42.1 64.9 38.3 53.7 141.8 98.5 53.3 46.3 42.0 39.9 43.8 104.6 46.3 78.3 48.6 38.7 55.1 109.1 53.4 54.8 112.1 47.8 53.6 76.0 67.7 63.0 111.2 61.3 50.0 65.4 54.7 33.3 79.8 27.2 37.8 26.3 23.5 41.7 46.6 26.9 21.2 100.7 24.4 112.7 60.5 28.8 58.6 36.3 43.9 40.9 33.9 29.7 41.7 56.3 46.2 24.2 49.0 46.3 44.0 48.8 243.0 67.3 57.5 58.1 112.7 148.1 221.8 245.9 104.2 24.4 143.0 201.9 39.6 75.8 144.1 90.1 14.6 219.2 145.1 147.0 62.6 111.0 51.4 86.6 167.7 194.8 108.5 195.1 19.1 101.7 118.9 157.9 85.1 174.2 58.9 77.7 163.5 48.4 151.2 20.2 12.8 101.9 93.6 250.4 129.2 75.9 165.0 162.7 76.5 93.7 207.6 61.2 142.2 29.1 67.1 164.9 131.8 182.4 74.2 281.7 139.1 50.7 104.4 19.2 138.1 206.1 180.6 120.7 118.1 216.3 194.5 143.5 104.5 79.3 120.3 372.5 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3, phospholipase" Q8WU67 18 21650901-21704780 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 187.7;Paneth cells: 126.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 209.6;RPMI-8226: 233.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Vesicles "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 17.3 7.4 15.1 25.4 15.5 17.7 15.9 17.2 25.6 11.3 23.0 64.1 44.5 8.1 9.2 18.2 12.1 21.0 7.0 21.3 16.1 14.6 39.6 15.8 30.0 17.2 16.0 11.8 12.7 12.4 16.1 11.5 20.0 16.7 11.2 66.4 5.8 14.6 6.2 14.5 6.3 56.7 9.8 15.0 24.2 35.9 6.3 17.7 21.6 23.1 7.9 26.0 15.5 12.9 23.8 29.0 20.6 19.8 12.7 12.3 8.2 0.1 18.6 7.6 13.1 17.6 21.6 29.1 82.3 33.2 6.2 58.6 93.6 32.5 15.3 18.1 52.1 21.9 9.0 35.7 37.5 18.7 39.6 28.9 7.3 17.7 19.2 8.8 6.5 8.7 28.0 23.4 47.9 11.6 11.7 38.5 43.6 9.7 92.1 47.8 209.6 15.0 233.5 36.4 27.6 16.6 7.5 42.5 37.6 11.2 21.3 11.7 68.9 6.9 12.7 18.2 22.6 29.3 53.1 37.5 84.9 16.1 50.9 29.4 89.3 24.7 29.3 25.3 44.4 19.8 16.2 22.7 24.8 15.2 12.6 18.2 23.2 81.6 18.6 61.8 10.2 44.9 24.3 15.1 15.5 17.2 25.6 21.3 16.1 17.2 16.0 11.8 16.7 15.0 17.7 23.8 8.4 9.6 9.3 42.4 22.8 33.4 40.8 21.6 18.2 14.3 12.9 6.2 4.6 40.0 25.4 3.7 47.9 30.6 24.4 187.7 1.9 52.9 4.1 32.6 9.9 9.5 36.4 10.3 27.2 27.5 22.7 10.6 32.1 49.4 11.4 1.2 10.4 31.6 68.5 0.0 30.9 57.9 52.9 31.9 47.2 1.5 7.5 26.4 32.0 33.7 29.6 7.8 26.8 17.1 10.7 51.1 126.6 6.4 45.5 32.0 93.8 8.8 40.8 15.7 13.1 6.8 13.2 4.1 9.7 22.4 15.2 94.3 38.3 5.4 36.8 36.8 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.6;skin 1: 6.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 37.7;Excitatory neurons: 9.4;Inhibitory neurons: 9.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;NTERA-2: 3.3;SCLC-21H: 3.5;SK-MEL-30: 1.7;SuSa: 1.4" "Region enhanced" "Detected in many" "hypothalamus: 7.3" "Low region specificity" "Detected in all" HPA039200 Approved NA NA "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favorable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.1 0.1 2.0 0.0 2.2 0.0 0.8 5.1 2.4 0.7 0.4 2.6 0.0 2.2 0.0 0.4 0.2 0.3 0.4 2.3 7.6 0.6 0.0 4.8 0.0 2.2 2.4 2.1 0.5 1.0 0.8 1.9 0.3 2.9 0.2 0.2 0.1 0.3 0.0 0.4 6.7 0.3 1.5 1.4 0.0 1.7 0.5 2.1 0.0 4.8 0.0 0.4 1.0 0.7 2.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.8 0.8 0.1 0.2 1.3 0.0 0.0 0.2 0.0 0.1 0.4 0.5 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.5 0.0 1.2 0.1 1.7 1.4 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.2 5.1 2.4 2.3 7.6 2.2 2.4 2.1 2.9 1.4 2.1 2.3 0.1 38.5 37.7 4.2 0.1 0.8 0.8 0.5 1.2 1.9 0.9 1.3 2.5 1.5 4.5 1.8 4.2 0.8 0.0 0.1 0.0 1.0 0.2 1.5 0.8 0.7 0.0 0.0 9.4 0.9 0.4 0.9 3.6 2.2 0.0 0.5 0.4 0.1 0.2 0.0 9.7 0.0 0.0 0.0 0.4 0.2 0.3 0.2 1.8 1.0 0.0 0.3 0.0 2.0 0.5 0.7 0.1 0.0 0.0 1.1 0.0 0.3 0.8 3.9 0.0 1.4 0.3 1.5 1.7 0.5 1.6 0.7 0.1 0.7 0.2 0.1 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 237.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 173.3;Rod photoreceptor cells: 228.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 135.7" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042440: AB_2677999, HPA052209: AB_2681761" "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favorable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 18.5 8.7 17.6 6.9 19.1 4.1 15.8 18.6 21.5 31.9 16.0 9.4 6.5 12.7 19.7 12.3 38.5 12.2 6.1 17.1 18.7 15.5 8.3 10.6 10.9 19.9 18.5 16.3 10.9 38.4 8.5 10.5 8.5 20.3 15.0 8.0 237.1 9.7 21.9 5.5 8.6 6.2 9.7 20.0 5.0 9.9 7.4 18.2 20.0 20.5 5.5 13.8 13.6 10.5 20.9 80.8 15.5 1.7 13.9 14.7 27.2 55.4 24.4 14.7 25.2 21.5 26.8 23.2 0.2 21.0 32.0 29.0 20.9 66.8 13.9 28.2 66.2 69.8 15.1 42.9 39.1 16.3 0.0 4.8 38.4 26.5 9.4 14.4 15.4 27.5 5.7 10.0 20.0 15.8 30.7 0.4 68.3 30.1 2.5 15.3 81.4 18.0 2.1 40.4 39.5 26.0 22.1 43.2 23.8 64.6 16.4 40.1 20.0 16.9 5.1 11.9 25.9 12.0 0.0 0.4 135.7 20.8 0.2 21.0 16.8 2.9 2.2 10.5 3.3 9.6 17.0 5.8 8.4 6.3 12.0 3.8 9.8 0.4 18.8 2.2 4.3 6.9 4.3 17.6 19.1 18.6 21.5 17.1 18.7 19.9 18.5 16.3 20.3 20.0 18.2 20.9 16.4 19.2 22.9 9.1 12.7 10.8 30.3 35.2 14.2 31.9 14.3 21.5 5.3 68.6 32.4 25.8 66.7 42.0 14.7 5.9 31.3 63.1 12.0 173.3 29.8 14.5 21.1 7.2 7.7 50.0 33.3 16.8 8.2 41.3 41.2 17.2 8.9 9.4 25.2 15.2 6.1 8.8 14.2 3.2 5.7 16.5 17.4 6.5 16.0 1.9 15.6 45.3 21.6 11.1 16.5 31.3 4.4 19.9 14.2 22.1 2.2 28.1 77.5 228.3 0.0 25.0 22.6 14.1 4.2 16.6 13.1 14.6 10.8 14.6 11.7 21.6 TENT5B "FAM46B, MGC16491" ENSG00000158246 "Terminal nucleotidyltransferase 5B" Q96A09 1 27005020-27012850 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 112.7;skin 1: 114.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 26.8;Breast myoepithelial cells: 24.8;Distal tubular cells: 23.5;Endometrial ciliated cells: 11.7;Glandular and luminal cells: 10.8" "Cancer enhanced" "Detected in many" "testis cancer: 87.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 62.0;hTERT-HME1: 31.6;NTERA-2: 32.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (1.67e-2)" "unprognostic (5.94e-3)" "unprognostic (1.61e-1)" "unprognostic (5.28e-3)" "unprognostic (3.20e-2)" "unprognostic (2.22e-2)" "unprognostic (2.44e-4)" "unprognostic (4.05e-2)" "unprognostic (1.39e-1)" "unprognostic (6.02e-3)" "unprognostic (1.34e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (5.82e-2)" "unprognostic (4.85e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" 6.8 0.9 0.4 2.6 0.4 0.0 15.8 1.5 0.8 19.0 0.7 32.3 1.1 25.0 0.8 112.7 16.5 1.8 26.0 0.4 0.7 4.9 0.4 12.9 0.2 2.2 1.0 0.4 3.6 1.9 2.0 2.6 3.2 1.1 12.4 1.7 3.0 27.9 15.6 2.2 114.9 10.7 12.3 0.3 0.6 17.5 6.4 0.7 0.6 5.1 1.7 5.5 37.6 47.7 0.5 3.9 0.6 7.6 2.3 0.9 1.2 1.9 5.5 1.8 21.5 8.5 15.3 5.0 0.0 9.1 3.0 4.8 12.4 1.3 20.1 5.8 0.0 1.2 0.2 2.9 2.6 10.6 0.1 0.3 4.8 62.0 6.6 31.6 0.0 0.3 0.0 0.4 0.0 2.8 3.0 0.0 1.2 32.8 2.8 1.5 0.4 0.0 0.2 21.3 0.0 0.9 0.6 10.6 23.4 14.3 15.9 18.6 0.3 0.5 5.2 18.0 0.6 1.1 0.3 0.8 0.0 1.1 0.1 3.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.5 0.8 0.4 0.7 2.2 1.0 0.4 1.1 0.3 0.7 0.5 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.8 24.8 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 23.5 1.8 0.0 11.7 1.8 0.5 0.0 0.0 0.0 1.9 3.1 0.5 0.0 10.8 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 18.4;brain: 25.4;ovary: 65.2" "Cell type enriched" "Detected in many" 4 "Excitatory neurons: 552.2" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 130000 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 18.4 4.9 10.2 0.3 15.1 0.0 8.9 0.0 25.4 3.6 0.0 1.3 0.5 5.1 0.7 1.0 4.7 2.1 5.5 24.4 3.9 4.4 0.8 1.1 2.7 14.4 3.5 9.3 65.2 1.7 0.8 0.9 0.9 10.7 5.4 0.8 2.8 1.3 1.1 1.6 1.8 1.3 6.9 0.0 0.1 1.0 0.6 2.3 0.7 2.8 2.2 0.3 1.6 3.2 14.5 0.0 0.0 5.1 0.0 2.2 0.6 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.1 0.0 32.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 2.1 0.0 0.0 0.0 42.7 2.2 9.4 0.0 1.0 0.5 1.4 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 15.1 0.0 25.4 24.4 3.9 14.4 3.5 9.3 10.7 0.0 2.3 14.5 2.1 0.0 0.0 18.3 0.0 0.5 0.3 0.0 8.6 1.8 10.9 2.2 8.0 0.0 0.6 3.7 0.0 0.2 0.1 0.0 1.9 0.2 39.8 0.5 8.9 0.8 0.0 0.0 552.2 0.2 0.0 9.1 0.0 0.2 0.0 25.0 2.2 0.0 0.1 0.0 111.5 0.0 0.0 0.3 1.5 31.1 28.0 0.8 0.0 5.6 0.0 0.8 0.0 108.6 29.4 0.0 0.0 0.7 0.0 5.0 0.0 32.3 3.0 3.8 0.0 28.3 13.7 0.8 0.8 0.4 0.0 0.0 0.7 0.5 0.0 0.3 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316737-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 104.4;Cytotrophoblasts: 149.0;Fibroblasts: 79.6;Hofbauer cells: 155.9;Microglial cells: 245.4;Muller glia cells: 74.5;Syncytiotrophoblasts: 111.2" "Cancer enhanced" "Detected in all" "prostate cancer: 14.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 24.3;BJ: 12.1;HSkMC: 20.0;U-2197: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" NA NA 580000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: AB_2680208, HPA071056: AB_2686338" "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.01e-3)" 10.0 1.7 5.7 2.4 4.7 0.2 5.6 5.1 5.8 24.6 9.6 4.9 1.5 9.0 1.0 2.0 6.6 4.4 6.2 4.7 8.7 1.2 0.3 11.5 2.0 7.6 6.4 4.1 2.0 1.1 0.9 0.9 20.2 5.2 4.0 2.5 5.4 4.1 1.4 3.1 3.4 3.6 5.1 4.3 0.3 3.4 1.4 7.0 1.3 5.3 2.0 2.5 8.2 4.0 5.7 0.0 0.0 2.1 0.0 2.3 24.3 0.8 12.1 4.2 1.7 3.1 0.0 0.0 0.0 0.1 2.0 0.1 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.1 0.0 0.0 20.0 0.0 1.0 0.0 0.7 4.7 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.0 6.5 0.0 0.0 0.1 0.3 0.0 0.1 0.0 1.9 0.1 0.0 0.0 2.8 0.4 31.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 5.7 4.7 5.1 5.8 4.7 8.7 7.6 6.4 4.1 5.2 4.3 7.0 5.7 6.8 3.2 104.4 34.3 2.1 4.1 3.2 0.0 1.2 6.4 2.6 1.7 4.0 2.8 10.7 3.7 10.4 149.0 1.4 0.3 0.0 0.2 11.1 0.5 3.9 15.8 15.7 2.7 0.5 0.0 5.3 79.6 0.0 0.8 13.9 1.2 5.7 0.4 155.9 6.7 1.4 1.0 0.0 4.9 8.9 31.4 61.5 32.1 1.8 245.4 16.2 74.5 3.1 2.0 10.4 0.3 0.6 7.2 1.2 6.5 1.4 0.2 1.7 12.4 0.0 13.2 21.6 1.3 2.5 1.8 3.8 111.2 4.8 11.6 0.8 1.3 RNF207 "C1orf188, FLJ32096, FLJ46380" ENSG00000158286 "Ring finger protein 207" Q6ZRF8 1 6205475-6221299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 31.8;Basal respiratory cells: 31.7;Club cells: 28.3;Urothelial cells: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.2;HaCaT: 7.6;HeLa: 7.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA028378, HPA042535" Uncertain Approved Cytosol NA NA Cytosol "HPA028378: AB_10601157, HPA042535: AB_2678042" "unprognostic (5.53e-3)" "unprognostic (1.23e-1)" "unprognostic (1.62e-2)" "unprognostic (4.46e-2)" "unprognostic (4.84e-2)" "unprognostic (5.91e-3)" "unprognostic (9.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.74e-2)" "unprognostic (9.93e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.76e-2)" "unprognostic (2.93e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" 2.4 3.3 3.1 1.3 3.1 0.0 3.2 3.8 4.3 8.4 5.1 5.2 2.0 4.4 1.5 5.9 8.0 0.9 30.6 3.1 3.0 9.9 7.6 1.7 0.9 3.5 2.7 3.4 2.6 7.0 1.2 5.6 1.2 3.7 11.9 1.4 2.1 6.7 3.8 1.8 1.1 4.5 1.2 2.3 1.5 4.1 1.2 2.9 0.5 6.8 4.2 1.3 6.4 5.4 3.1 2.6 4.5 0.4 2.9 0.2 0.3 3.1 1.3 1.0 0.2 0.3 2.2 17.2 0.2 1.3 1.1 0.0 7.6 0.4 1.0 0.1 2.8 1.7 0.1 7.0 2.2 1.3 1.7 0.1 1.1 0.2 0.0 0.0 3.8 0.1 0.3 0.7 3.6 0.1 1.8 0.2 0.3 0.2 0.3 3.8 0.0 0.7 2.9 2.2 3.9 0.4 1.1 2.8 1.5 1.1 0.7 2.7 0.1 0.5 0.0 0.8 0.4 0.0 3.9 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 3.1 3.8 4.3 3.1 3.0 3.5 2.7 3.4 3.7 2.3 2.9 3.1 2.9 9.6 3.9 2.0 1.7 0.3 31.8 31.7 6.2 4.0 4.4 4.3 19.5 14.3 28.3 18.4 2.1 15.6 0.4 8.5 0.0 15.4 0.7 2.3 6.8 2.9 3.6 0.4 13.2 9.8 6.3 4.6 17.3 2.7 0.0 1.7 1.1 3.9 1.1 3.3 13.2 15.6 10.2 0.0 0.7 0.2 0.0 1.6 0.0 0.0 2.2 7.5 0.0 3.5 1.7 19.0 3.5 1.2 1.5 21.3 9.5 3.5 10.1 16.3 6.6 1.5 5.0 0.1 2.8 3.8 0.4 5.6 1.9 2.0 6.4 37.1 CUL4B ENSG00000158290 "Cullin 4B" Q13620 X 120505920-120604074 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 106.9;Late spermatids: 169.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003046, HPA011880, CAB017786, HPA058979" Enhanced Enhanced Nucleoplasm NA NA 18000 Nucleoplasm "CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868" "unprognostic (2.34e-2)" "unprognostic (2.74e-2)" "unprognostic (2.69e-2)" "unprognostic (7.73e-3)" "unprognostic (9.66e-2)" "unprognostic (3.91e-1)" "unprognostic (3.88e-3)" "unprognostic (8.99e-2)" "unprognostic (8.12e-3)" "unprognostic (3.20e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (2.87e-3)" "unprognostic (3.83e-2)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" 18.0 20.7 15.7 14.5 17.6 9.9 20.3 19.1 19.5 24.8 16.6 17.8 12.4 18.8 27.5 23.6 19.8 15.6 14.0 16.5 18.9 18.2 19.6 14.7 20.7 15.8 15.6 16.2 25.4 17.1 24.3 27.1 15.6 16.5 18.4 13.6 20.1 15.3 22.7 10.0 15.3 15.5 15.7 14.3 17.8 15.6 28.2 16.8 25.6 16.0 12.7 22.0 18.4 20.5 17.3 41.9 37.3 28.7 31.4 129.5 57.0 22.4 89.8 104.1 71.3 69.4 30.4 110.6 40.1 35.5 206.8 127.7 29.9 61.1 27.7 84.8 26.1 26.6 20.5 42.1 25.9 50.6 22.6 28.1 65.6 22.2 45.1 37.5 134.8 133.2 22.6 33.6 31.7 78.4 24.5 30.7 19.0 45.4 52.6 39.5 23.4 27.1 43.4 23.2 19.5 32.9 27.4 74.2 36.8 36.5 35.0 28.8 20.9 177.6 57.1 30.5 76.3 88.6 21.2 50.0 52.2 59.9 28.2 55.2 6.6 3.8 8.1 5.6 3.1 6.1 5.7 5.2 5.2 4.4 4.4 6.0 6.2 14.4 4.4 2.4 7.0 6.9 4.1 15.7 17.6 19.1 19.5 16.5 18.9 15.8 15.6 16.2 16.5 14.3 16.8 17.3 18.7 22.4 14.4 11.8 15.5 15.2 9.6 12.9 12.5 15.7 17.3 14.7 14.6 8.6 11.7 14.7 14.6 10.1 19.9 14.7 13.7 10.1 106.9 12.4 15.6 18.2 24.6 13.3 18.4 8.9 25.0 21.2 14.3 15.8 14.0 20.5 40.7 16.4 17.5 25.2 20.9 13.9 8.2 30.5 13.9 169.3 21.5 18.4 12.4 14.0 17.6 15.0 7.2 23.1 21.0 16.7 7.3 21.4 18.9 9.5 11.0 14.4 17.8 14.1 13.1 17.0 16.6 12.6 13.9 23.0 13.8 10.0 14.1 21.7 12.7 9.5 GPR153 PGR1 ENSG00000158292 "G protein-coupled receptor 153" Q6NV75 1 6247353-6261098 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hepatocytes: 33.2;Horizontal cells: 63.9;Intestinal goblet cells: 52.5;Urothelial cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 26.1;PC-3: 68.6;RH-30: 32.2;SCLC-21H: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007159 Approved NA NA "HPA007159: AB_1849268" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (5.74e-3)" "unprognostic (3.33e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (8.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.31e-1)" "unprognostic (1.51e-2)" "unprognostic (1.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" 13.3 2.0 18.1 2.9 7.3 0.3 10.4 0.7 9.5 10.8 0.8 9.2 4.0 9.4 11.4 7.8 8.8 3.9 9.3 7.8 8.5 2.9 7.2 10.6 1.9 4.7 11.5 11.0 9.0 1.5 5.6 12.1 6.9 6.8 6.4 5.2 3.2 3.1 3.4 1.9 8.8 22.1 4.8 2.3 6.9 3.5 2.2 26.5 1.4 1.9 1.4 1.4 6.9 8.0 4.6 6.1 1.0 14.4 17.4 26.1 10.3 1.2 4.0 3.6 1.5 1.7 2.5 2.4 0.0 6.0 4.2 3.3 7.8 0.8 17.2 0.6 4.0 3.5 0.1 2.4 0.5 5.1 0.6 2.3 6.3 4.5 1.1 0.9 2.7 1.2 5.3 0.9 0.0 5.0 6.7 2.0 4.7 1.1 3.5 68.6 7.5 32.2 0.4 0.6 3.4 32.7 11.8 2.7 10.0 8.4 3.9 3.9 3.2 3.5 3.5 3.3 0.5 1.8 0.3 0.3 1.4 1.6 8.0 1.4 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 18.1 7.3 0.7 9.5 7.8 8.5 4.7 11.5 11.0 6.8 2.3 26.5 4.6 0.7 0.0 0.0 0.3 0.1 3.4 1.8 8.9 1.2 6.2 1.3 2.2 6.2 4.3 5.5 0.0 0.0 0.2 5.9 3.3 0.0 0.2 1.2 0.6 8.5 1.6 3.5 2.7 1.7 0.0 0.3 9.9 1.1 0.4 1.3 0.7 0.7 33.2 1.1 63.9 3.0 52.5 6.1 1.0 3.7 2.5 4.7 1.5 5.4 1.0 2.2 2.7 3.1 6.6 0.1 0.6 9.2 7.5 1.3 1.6 9.6 2.0 1.7 1.6 0.0 9.6 4.7 0.1 1.7 1.1 7.4 0.4 1.2 1.3 2.0 17.2 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 411.3" "Cell type enhanced" "Detected in many" "Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4" "Cancer enhanced" "Detected in many" "liver cancer: 11.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 1.2 2.4 13.1 0.7 20.8 0.2 1.9 15.7 15.8 2.0 5.7 0.7 0.3 1.8 1.0 0.9 2.4 1.9 0.9 9.8 15.9 411.3 21.8 1.4 0.6 16.5 19.8 10.0 4.5 9.1 0.3 2.6 43.5 21.0 6.3 0.5 1.1 4.9 0.8 1.0 2.3 0.4 1.9 13.1 0.6 4.8 8.8 19.3 1.2 1.4 0.3 0.7 1.9 1.4 38.0 0.1 0.0 1.6 5.6 8.3 7.7 16.1 3.5 2.0 1.9 1.4 0.0 0.1 0.2 18.8 0.2 0.1 2.1 0.1 2.6 4.5 0.0 0.6 6.8 0.4 56.1 18.4 0.1 4.8 10.5 7.5 10.9 5.4 5.4 0.0 0.0 15.3 0.3 0.0 0.6 0.1 0.7 10.3 0.2 0.0 0.2 0.0 0.1 1.2 0.4 0.7 0.2 0.0 4.0 0.8 1.0 2.9 0.3 0.2 0.1 4.0 8.7 0.1 0.5 1.2 0.1 0.6 0.0 0.4 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.5 0.0 0.0 13.1 20.8 15.7 15.8 9.8 15.9 16.5 19.8 10.0 21.0 13.1 19.3 38.0 0.3 0.0 2.2 53.8 3.8 1.3 1.0 0.8 6.2 0.7 1.2 1.7 1.7 0.0 0.5 7.3 0.0 106.6 0.0 0.1 15.6 0.2 23.3 0.5 2.0 0.6 0.0 0.0 65.0 0.9 7.1 2.3 3.1 0.8 0.0 3.0 0.4 17.5 9.5 0.0 40.3 0.0 0.0 0.3 0.7 27.8 3.1 2.0 0.0 11.2 0.0 0.4 0.0 24.1 178.1 0.9 0.0 0.4 1.2 3.5 0.0 245.9 6.4 0.2 0.0 0.4 1.0 6.6 1.2 1.2 0.6 79.4 1.5 2.2 0.0 0.6 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.6;Cardiomyocytes: 16.4;Horizontal cells: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favorable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (6.63e-5)" 5.1 15.2 19.0 2.1 21.6 0.4 7.9 12.9 22.9 12.8 9.2 5.9 1.7 17.8 9.1 4.3 10.8 5.2 14.6 19.7 29.0 10.3 6.8 5.1 1.8 16.3 16.1 19.1 30.4 9.3 15.0 20.1 3.8 17.6 12.6 3.1 12.9 9.3 11.9 7.6 5.8 3.2 10.4 13.0 4.2 4.0 4.7 23.4 4.5 15.4 6.6 1.8 6.5 6.5 23.0 0.6 6.8 17.8 13.8 5.5 6.5 1.3 10.3 9.3 8.7 16.9 2.3 3.1 0.0 3.5 10.8 4.3 2.4 21.5 5.6 11.0 0.0 8.3 0.9 2.0 0.5 4.0 1.7 1.2 6.9 5.8 9.7 0.4 10.1 6.2 1.7 2.7 0.7 10.6 3.2 4.9 0.7 8.9 2.2 9.3 6.4 2.9 0.0 5.4 2.5 3.9 12.2 10.4 2.0 1.5 5.4 5.7 3.6 5.6 6.1 12.9 12.5 9.9 0.3 0.4 0.0 8.2 1.1 3.5 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.4 0.2 0.1 1.4 0.6 0.0 0.8 0.0 0.5 0.5 0.4 19.0 21.6 12.9 22.9 19.7 29.0 16.3 16.1 19.1 17.6 13.0 23.4 23.0 4.3 0.0 1.5 0.0 0.5 2.3 5.1 2.1 4.0 19.6 3.5 4.1 16.4 7.2 3.6 5.5 2.1 6.2 0.3 0.6 9.8 1.6 0.5 0.7 4.1 4.3 3.0 0.0 0.0 0.9 0.5 6.6 0.0 0.6 0.0 13.2 8.2 7.3 0.9 16.8 0.0 1.4 2.0 0.6 0.8 1.1 12.2 0.6 0.0 0.0 0.5 12.2 0.0 0.0 0.0 1.1 1.8 12.4 0.0 3.2 0.3 10.8 0.8 6.8 6.6 8.9 4.9 13.4 9.1 2.4 3.0 2.2 0.7 8.0 1.1 1.5 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941830 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 24.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 74.6;Club cells: 44.8;Distal enterocytes: 52.2;Ionocytes: 46.8;Oligodendrocytes: 53.9;Pancreatic endocrine cells: 53.0;Urothelial cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 12.7;CAPAN-2: 41.7;HaCaT: 21.7;RT4: 40.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043807 Approved NA NA "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 2.2 0.4 4.4 1.7 8.0 0.4 2.0 5.3 6.4 2.4 0.2 18.1 1.3 0.6 0.2 24.6 1.1 3.4 7.8 3.8 4.0 0.8 0.4 1.0 0.8 9.7 8.1 3.1 0.3 0.6 0.3 1.3 1.1 10.0 1.8 18.2 1.2 7.9 0.5 0.5 16.7 0.8 1.1 4.6 0.4 15.9 7.4 6.4 0.8 0.7 0.0 7.2 9.8 12.9 11.4 12.7 4.3 0.4 0.2 0.2 1.2 1.2 0.7 0.1 0.9 0.1 0.9 41.7 0.3 3.0 6.3 4.2 21.7 0.0 7.1 0.6 0.3 0.2 0.2 2.9 2.5 0.5 0.1 0.5 0.9 1.0 6.0 0.1 4.0 1.0 0.4 0.0 0.4 0.9 0.0 0.1 0.3 0.2 1.3 1.2 0.2 0.2 0.0 0.0 40.4 0.4 0.3 5.0 11.4 0.4 0.6 5.6 0.4 0.9 4.4 0.5 0.3 0.3 0.4 0.5 0.5 4.1 0.8 0.2 1.5 0.6 0.4 0.2 0.4 0.1 0.7 0.2 0.1 0.7 0.3 0.2 0.2 1.7 0.3 0.2 0.7 0.3 0.3 4.4 8.0 5.3 6.4 3.8 4.0 9.7 8.1 3.1 10.0 4.6 6.4 11.4 1.3 0.0 0.5 11.1 0.7 17.7 8.0 74.6 5.2 2.7 3.9 2.4 0.4 5.7 44.8 3.7 0.0 0.4 0.2 52.2 0.0 12.4 3.9 4.7 3.4 1.4 2.4 0.0 19.0 15.8 0.3 2.1 27.5 8.4 4.5 1.6 1.8 0.0 0.2 1.7 21.9 17.3 46.8 0.0 2.7 1.0 0.6 0.4 1.8 4.7 0.6 1.3 0.0 10.6 53.9 53.0 22.3 0.0 0.2 13.4 0.2 0.3 33.2 1.8 6.6 1.2 4.0 0.3 0.1 19.0 28.4 0.7 0.5 0.2 30.2 49.9 AUTS2 "FBRSL2, KIAA0442" ENSG00000158321 "Activator of transcription and developmental regulator AUTS2" Q8WXX7 7 69598296-70793506 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Autism, Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.6" "Cell type enhanced" "Detected in many" "Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 8.1;naive B-cell: 9.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000390 Approved Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000390: AB_1845218" "unprognostic (8.73e-3)" "unprognostic (2.24e-1)" "unprognostic (4.62e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.07e-3)" "unprognostic (3.33e-2)" "unprognostic (3.52e-2)" "unprognostic (8.46e-2)" "unprognostic (3.29e-3)" "unprognostic (1.76e-2)" "unprognostic (2.47e-1)" "unprognostic (3.04e-1)" "unprognostic (7.33e-2)" 8.5 5.2 53.8 9.2 34.0 8.6 17.4 12.4 16.6 7.5 0.0 11.4 6.8 7.5 6.3 11.6 7.1 13.5 5.5 24.6 19.1 11.0 20.4 10.9 4.8 54.6 26.9 11.8 14.7 5.8 11.4 9.8 4.1 35.1 11.4 10.1 11.1 48.6 5.8 15.3 20.2 15.8 7.6 13.1 6.6 10.6 7.9 38.0 10.8 5.9 5.3 6.4 10.6 10.6 24.2 0.3 7.5 82.8 4.3 5.4 3.2 0.9 5.2 0.0 0.4 0.5 29.1 0.3 13.0 1.9 5.0 0.5 27.1 10.0 11.5 2.3 60.5 22.4 6.2 7.8 0.3 2.4 0.1 0.4 8.6 15.2 12.5 3.1 3.0 0.0 13.5 0.6 6.5 7.2 4.8 1.2 2.4 59.0 18.9 0.1 84.1 40.0 39.8 0.0 12.5 112.5 61.3 5.3 9.2 0.2 35.4 80.0 0.1 0.0 0.3 27.1 8.8 52.6 0.2 0.2 43.1 0.1 0.2 0.2 1.0 0.2 0.1 1.4 0.1 1.9 8.1 0.9 1.4 0.6 9.4 0.1 0.8 0.4 1.5 0.1 2.8 0.2 0.6 53.8 34.0 12.4 16.6 24.6 19.1 54.6 26.9 11.8 35.1 13.1 38.0 24.2 13.7 19.2 38.2 598.7 19.9 28.6 21.1 25.0 34.7 37.2 72.9 41.5 20.8 11.5 22.2 9.2 16.7 1.2 103.2 23.5 5.9 13.1 31.8 11.5 36.0 15.9 28.9 5.2 871.5 1.3 0.1 19.3 4.1 11.0 0.0 44.4 12.1 28.8 0.8 63.9 1405.7 23.4 38.7 2.6 17.1 27.7 15.8 5.5 17.8 583.7 0.8 11.2 25.7 292.0 1231.2 3.9 15.3 14.7 37.7 32.6 15.3 12.4 20.3 20.7 26.3 13.7 17.2 10.1 16.9 20.3 16.1 1.4 35.5 10.4 25.3 26.6 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591642-50814302 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Group enriched" "Detected in many" 5 "Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA "Focal adhesion sites" "Nucleoplasm, Vesicles" "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 8.2 1.8 11.1 1.9 16.9 1.2 5.4 15.3 11.1 3.3 2.1 1.7 1.2 3.6 1.6 2.8 2.3 3.0 6.1 7.0 11.6 5.3 0.9 13.4 0.9 19.4 16.6 3.9 1.3 0.9 1.9 2.0 9.0 19.0 2.2 1.4 1.3 2.0 1.8 3.7 1.7 1.5 4.1 15.9 1.0 1.3 0.6 16.3 0.6 3.3 5.0 1.0 3.5 2.3 29.8 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.2 0.0 6.7 0.9 0.0 0.6 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 5.0 0.0 5.5 2.5 0.1 0.0 0.0 0.8 1.5 3.6 0.1 0.1 10.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 1.3 0.2 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 16.9 15.3 11.1 7.0 11.6 19.4 16.6 3.9 19.0 15.9 16.3 29.8 45.0 25.6 18.6 3.3 0.0 3.6 2.0 1.9 2.2 0.3 1.0 1.5 4.2 0.0 2.0 5.5 0.0 0.6 0.2 1.1 3.9 0.7 0.1 2.8 5.4 46.5 3.0 0.0 1.1 0.2 3.0 3.0 0.0 2.9 3.8 2.3 30.7 0.9 0.5 0.0 1.1 2.8 0.0 2.4 2.7 0.6 1.2 0.6 0.0 51.5 0.0 3.6 0.0 126.7 463.4 2.3 1.0 1.2 0.0 1.2 0.3 3.5 2.5 0.6 0.0 2.5 2.6 0.0 1.0 2.0 3.1 0.3 0.6 3.0 3.2 1.6 H2BC5 "H2B/b, H2BFB, HIST1H2BD" ENSG00000158373 "H2B clustered histone 5" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 145.3" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 22.4;Syncytiotrophoblasts: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 117.9;U-266/84: 134.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 14.1 13.5 15.6 7.7 20.3 54.3 18.7 47.5 16.3 129.7 37.6 25.7 11.1 6.3 27.9 37.9 53.9 15.4 28.1 18.2 31.9 62.4 63.5 37.1 9.2 17.5 20.9 10.3 102.7 15.8 2.1 30.7 9.4 20.6 145.3 17.2 9.8 29.1 3.7 18.7 34.5 23.4 4.3 25.1 35.7 26.3 11.4 22.6 35.6 25.4 7.3 4.1 18.1 96.3 31.5 17.9 39.7 12.0 6.8 91.2 8.3 3.6 15.5 8.9 19.6 12.3 13.3 14.5 8.1 95.2 18.5 21.8 27.9 6.8 6.6 9.2 36.6 16.9 5.4 33.7 14.5 9.8 7.2 14.7 59.7 10.3 5.5 7.7 7.6 4.9 7.5 57.1 43.3 3.6 64.2 16.4 18.1 12.6 76.1 18.2 6.5 7.6 54.4 18.7 12.8 38.1 16.1 96.8 25.1 15.9 23.1 63.4 2.6 3.0 24.4 63.4 9.9 3.3 117.9 134.9 20.5 3.1 33.2 5.0 35.3 2.3 16.9 8.1 5.1 10.4 13.4 12.3 13.5 5.6 20.0 11.4 8.7 24.8 10.5 6.9 19.3 8.9 2.4 15.6 20.3 47.5 16.3 18.2 31.9 17.5 20.9 10.3 20.6 25.1 22.6 31.5 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 7.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 39.4 0.3 0.0 0.0 0.0 CDC25C "CDC25, PPP1R60" ENSG00000158402 "Cell division cycle 25C" P30307 5 138285269-138338355 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.9;lymphoid tissue: 9.0;testis: 18.2" "Cell type enhanced" "Detected in many" "Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB003800, HPA066991" Approved Enhanced "Nuclear speckles" No Yes "Nuclear speckles" "CAB003800: AB_562081, HPA066991: AB_2685760" "unprognostic (2.45e-3)" "unprognostic (5.89e-3)" "prognostic favorable (2.49e-4)" "unprognostic (9.72e-3)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.03e-6)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.56e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-3)" "unprognostic (1.00e-1)" "unprognostic (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.43e-1)" "unprognostic (2.59e-1)" "unprognostic (3.06e-1)" 0.2 0.2 0.1 2.1 0.2 5.9 0.7 0.3 0.3 0.2 0.1 3.4 3.1 0.4 0.2 1.5 0.2 0.2 0.1 0.2 0.2 0.1 0.5 0.3 3.2 0.2 0.3 0.2 0.0 0.4 0.1 0.1 1.2 0.2 0.2 4.1 0.1 0.3 0.1 0.0 1.4 3.0 0.8 0.1 0.9 1.1 18.2 0.2 9.0 0.1 0.0 4.6 0.5 0.5 0.4 27.9 11.0 38.4 28.9 0.9 3.6 9.9 16.4 17.5 36.2 50.3 27.3 52.8 13.3 13.8 10.1 40.5 14.9 31.7 25.9 34.9 11.1 21.5 9.6 15.0 21.2 0.3 6.3 10.0 0.8 0.9 22.0 18.0 3.8 24.6 28.9 14.8 24.2 22.9 15.5 19.3 16.7 9.7 22.3 12.2 11.9 34.2 15.0 6.4 8.4 19.2 11.9 36.8 11.0 16.9 32.6 18.7 13.9 7.2 19.9 16.8 13.9 26.5 15.0 13.4 13.0 8.3 14.3 15.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.1 0.1 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.4 0.1 0.0 0.0 1.3 0.9 0.6 0.3 1.1 1.8 0.0 0.9 0.8 0.3 0.0 0.2 0.0 0.0 5.0 0.5 1.8 0.0 0.1 41.4 0.4 0.9 0.6 0.0 9.5 1.3 0.0 6.9 1.1 3.6 1.2 0.0 5.5 1.4 0.4 2.7 0.0 1.0 3.9 2.0 0.6 0.5 42.1 1.8 1.2 0.0 1.0 0.6 0.0 0.0 1.0 0.3 0.0 1.4 0.4 4.5 0.3 0.9 0.1 0.1 0.0 0.0 0.2 0.9 53.6 13.0 4.3 0.4 1.4 0.6 0.2 4.9 0.6 H4C8 "H4/h, H4FH, HIST1H4H" ENSG00000158406 "H4 clustered histone 8" P62805 6 26277609-26285638 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 50.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.8;dendritic cells: 3.4;Extravillous trophoblasts: 1.5;Hofbauer cells: 1.8;Plasma cells: 1.3;Syncytiotrophoblasts: 10.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 50.3" "Group enriched" "Detected in some" 7 "eosinophil: 4.2;neutrophil: 8.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "MOLT-4: 17.5;U-266/84: 29.8" "Low region specificity" "Detected in single" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (4.39e-1)" "unprognostic (1.62e-1)" "unprognostic (3.08e-3)" "unprognostic (5.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.40e-2)" "unprognostic (1.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.71e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (7.44e-2)" "unprognostic (8.16e-2)" "unprognostic (6.55e-2)" "unprognostic (6.36e-2)" 0.4 0.2 3.5 0.1 4.2 0.9 0.3 50.3 8.9 0.6 1.6 0.9 0.6 0.2 0.0 1.2 0.2 0.7 0.7 3.1 4.9 0.2 0.6 0.5 0.0 4.2 8.1 2.7 0.4 0.3 0.0 0.1 0.2 6.6 0.4 0.0 0.0 0.3 0.0 2.5 0.8 0.2 0.0 11.6 0.1 0.2 0.4 4.7 1.1 0.3 0.0 0.7 0.2 0.6 10.6 3.1 3.6 0.4 0.4 1.0 0.0 2.4 4.7 0.0 0.0 0.0 3.5 0.9 2.1 5.8 0.3 0.1 1.9 0.0 0.7 0.3 3.6 1.5 3.8 8.3 4.2 2.2 1.4 2.7 2.7 0.0 1.7 1.5 0.0 3.5 0.9 4.2 0.0 1.9 3.5 17.5 10.9 1.6 0.2 3.6 11.5 2.3 1.4 0.0 3.1 2.8 1.2 4.9 4.9 2.4 0.0 6.0 5.7 0.8 2.5 6.3 1.7 7.7 2.9 29.8 3.1 1.1 7.4 2.6 0.0 0.2 4.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 8.9 0.0 0.0 0.5 0.0 1.1 3.5 4.2 50.3 8.9 3.1 4.9 4.2 8.1 2.7 6.6 11.6 4.7 10.6 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.4 0.3 0.0 0.0 0.0 MITD1 LOC129531 ENSG00000158411 "Microtubule interacting and trafficking domain containing 1" Q8WV92 2 99161427-99181058 "Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036162, HPA036163" Approved Enhanced Vesicles NA NA Vesicles "HPA036162: AB_10672236, HPA036163: AB_2674978" "prognostic favorable (5.96e-4)" "unprognostic (1.67e-2)" "unprognostic (3.09e-1)" "unprognostic (2.79e-1)" "unprognostic (2.02e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.39e-1)" "unprognostic (5.35e-2)" "unprognostic (1.01e-2)" "unprognostic (1.09e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.32e-11)" "unprognostic (2.38e-1)" "unprognostic (2.40e-1)" "unprognostic (6.91e-2)" "prognostic favorable (5.46e-8)" 17.2 16.9 13.0 25.4 13.6 13.3 17.3 13.1 15.6 17.3 12.7 17.6 15.5 16.9 14.4 18.0 15.9 12.8 13.7 12.7 13.3 16.2 17.4 14.3 36.8 13.5 13.6 12.0 17.1 11.8 9.2 11.1 16.7 13.8 13.6 20.1 22.3 13.6 12.0 10.8 15.9 19.3 17.2 13.3 22.5 17.5 7.0 13.5 27.2 15.2 11.3 29.3 16.9 16.3 14.6 58.0 15.3 30.5 11.8 35.1 45.2 41.9 27.1 37.8 37.2 50.3 18.8 47.6 40.0 30.4 22.2 84.9 43.0 30.0 29.9 61.7 57.2 20.6 35.4 22.3 40.4 52.2 60.2 20.1 35.9 25.4 32.6 31.2 34.3 42.4 37.8 29.6 24.1 34.0 13.8 57.8 88.5 25.8 37.1 30.0 32.4 43.8 34.7 47.2 32.1 10.0 14.7 26.5 24.3 35.0 52.8 12.9 47.1 32.1 23.0 30.2 24.3 34.1 28.2 23.6 55.5 41.7 50.2 23.4 19.2 24.7 18.2 17.5 22.8 19.7 30.6 24.8 20.8 22.0 28.4 23.6 19.3 28.0 26.0 21.8 29.8 23.1 12.8 13.0 13.6 13.1 15.6 12.7 13.3 13.5 13.6 12.0 13.8 13.3 13.5 14.6 31.0 25.6 19.9 22.9 51.2 18.9 30.3 78.2 22.2 13.4 19.5 22.9 12.3 31.5 41.6 35.0 14.6 48.2 39.1 28.1 45.0 46.9 18.8 28.2 34.8 33.1 15.7 27.3 18.3 61.2 34.9 27.6 19.9 24.7 30.4 20.2 30.0 31.2 51.0 11.8 16.9 25.5 40.7 24.5 22.3 6.2 51.0 31.0 23.2 11.2 50.5 26.2 40.2 15.6 38.4 57.3 33.5 39.5 23.3 20.2 32.9 63.4 34.5 55.4 39.5 22.4 24.4 14.4 15.5 20.0 17.5 22.6 42.4 26.4 27.5 19.6 EIF5B "DKFZp434I036, FLJ10524, IF2, KIAA0741" ENSG00000158417 "Eukaryotic translation initiation factor 5B" O60841 2 99337371-99401326 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 769.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034648, HPA040095" Approved Approved "Plasma membrane,Cytosol" NA Yes 210000 Cytosol "Plasma membrane" "HPA034648: AB_10601902, HPA040095: AB_2676843" "unprognostic (1.23e-1)" "unprognostic (6.94e-2)" "unprognostic (2.01e-1)" "unprognostic (5.03e-2)" "unprognostic (4.65e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (7.15e-10)" "unprognostic (6.80e-2)" "unprognostic (9.84e-3)" "prognostic favorable (8.99e-4)" "unprognostic (1.68e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.42e-6)" "unprognostic (6.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.43e-1)" "unprognostic (7.93e-3)" 39.8 31.8 55.4 33.1 56.8 21.0 34.2 55.4 89.5 31.2 54.4 47.2 23.3 35.5 42.1 44.8 29.9 18.7 77.9 52.9 54.7 32.9 38.7 31.2 32.9 59.1 56.5 48.8 27.3 49.0 32.3 28.4 29.8 60.2 44.4 30.3 24.0 36.8 33.8 103.7 39.7 29.3 29.0 57.4 30.9 42.5 49.0 58.1 26.4 29.6 56.7 36.9 48.2 34.0 58.2 117.0 57.2 63.8 83.5 75.5 88.7 105.4 100.4 62.9 65.3 64.6 132.5 80.9 132.5 84.6 75.2 77.4 64.9 112.6 97.3 114.6 80.8 67.4 159.6 57.7 175.9 59.7 158.0 94.3 60.2 66.8 91.0 92.1 55.9 96.6 80.0 179.6 64.4 95.2 94.9 100.8 145.7 99.5 76.2 83.0 86.8 94.7 108.2 134.9 96.2 53.8 50.9 54.6 123.8 85.3 120.4 50.5 103.0 106.9 100.7 99.3 53.2 90.7 47.4 72.0 106.0 73.3 172.0 75.9 19.8 11.0 13.7 15.5 12.5 18.2 20.9 16.3 15.5 8.4 19.8 15.9 17.0 2.9 18.3 17.3 26.2 12.5 6.4 55.4 56.8 55.4 89.5 52.9 54.7 59.1 56.5 48.8 60.2 57.4 58.1 58.2 121.7 109.0 219.6 23.8 152.4 321.3 200.4 209.0 84.8 103.8 159.1 112.1 579.1 135.8 198.6 343.9 50.1 143.7 142.9 135.0 144.8 210.5 769.9 143.1 175.0 153.2 157.9 154.2 27.4 235.1 205.3 130.4 82.0 157.5 172.7 90.0 146.3 480.9 134.7 77.4 28.3 206.7 144.5 123.5 128.9 144.0 124.5 95.7 142.3 18.7 157.7 91.8 145.2 21.6 36.7 282.6 93.8 175.7 183.2 253.9 102.7 226.2 165.4 111.3 276.1 167.3 157.7 575.3 505.0 99.1 324.8 181.4 133.4 101.7 185.1 244.7 RIBC1 FLJ32783 ENSG00000158423 "RIB43A domain with coiled-coils 1" Q8N443 X 53422690-53431120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.7;testis: 39.6" "Group enriched" "Detected in many" 5 "Early spermatids: 249.1;Late spermatids: 609.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 6.1;T-47d: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001150 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001150: AB_2666211" "unprognostic (1.08e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.25e-1)" "prognostic favorable (9.66e-4)" "unprognostic (1.11e-1)" "unprognostic (2.39e-3)" "unprognostic (9.88e-2)" "unprognostic (3.97e-4)" "unprognostic (2.25e-2)" "unprognostic (7.89e-3)" "unprognostic (3.79e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" 0.7 3.9 4.7 0.7 2.9 0.6 1.5 3.4 3.4 2.0 8.5 0.9 0.9 2.4 2.9 0.7 27.7 1.4 1.1 2.5 6.3 2.9 0.7 3.4 0.9 6.5 4.9 1.8 2.7 1.9 2.6 6.6 0.3 4.2 1.8 0.5 11.5 2.0 1.7 0.7 1.2 0.8 0.6 5.6 0.9 0.9 39.6 3.7 1.7 3.6 0.5 0.7 0.8 0.9 4.6 1.3 3.5 1.3 0.9 0.4 0.9 0.8 0.4 0.2 0.7 0.7 1.3 2.1 1.3 2.3 0.1 2.3 2.4 0.3 0.7 0.9 0.8 2.3 0.8 6.1 0.6 0.2 0.8 1.3 0.3 0.3 2.0 0.5 1.7 0.6 1.0 0.6 1.5 0.5 0.9 1.5 0.7 1.7 0.6 0.9 1.1 0.9 1.0 2.0 0.7 2.9 0.5 3.4 1.2 0.8 4.1 7.8 0.3 0.2 0.3 1.7 1.0 0.5 1.4 1.1 0.7 1.3 0.3 0.6 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.2 0.5 0.3 0.3 0.1 0.1 0.8 1.2 0.4 0.2 0.5 0.2 4.7 2.9 3.4 3.4 2.5 6.3 6.5 4.9 1.8 4.2 5.6 3.7 4.6 0.3 0.0 0.5 1.0 0.2 1.3 2.1 3.7 1.8 2.2 1.7 2.2 1.2 2.8 6.5 0.0 4.2 0.5 0.2 0.3 1.9 1.4 249.1 73.2 1.0 0.8 1.2 0.0 0.2 0.2 0.5 0.9 0.0 1.6 2.5 0.5 0.0 0.7 0.1 1.7 0.3 0.1 10.2 0.6 0.3 609.6 2.5 0.5 1.8 0.0 0.0 5.5 0.0 0.0 0.5 0.5 0.1 1.9 0.0 0.8 0.7 7.2 71.4 11.3 0.0 1.6 1.0 14.2 6.4 0.4 0.9 0.4 0.6 2.1 0.3 0.7 TMSB15B MGC39900 ENSG00000158427 "Thymosin beta 15B" P0CG35 X 103918896-103966712 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 75.3;REH: 58.7" HPA064607 Uncertain NA NA "HPA064607: AB_2685298" "unprognostic (7.47e-2)" "unprognostic (1.69e-1)" "unprognostic (2.52e-2)" "unprognostic (1.58e-6)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (1.43e-1)" "unprognostic (4.42e-2)" "unprognostic (1.14e-1)" "unprognostic (1.38e-2)" "unprognostic (4.68e-2)" "unprognostic (9.33e-4)" "unprognostic (1.16e-3)" "unprognostic (1.07e-1)" "unprognostic (3.00e-1)" "unprognostic (2.72e-1)" "unprognostic (5.09e-3)" 4.4 1.7 3.0 2.9 2.9 5.5 7.4 7.3 4.1 11.9 0.9 5.3 2.6 11.3 5.6 2.4 7.3 3.8 1.9 2.9 3.3 2.0 0.7 3.2 5.0 2.7 3.8 3.0 16.0 1.6 7.1 3.1 2.3 4.5 6.5 4.4 5.4 2.7 4.8 0.7 3.6 4.0 7.9 2.3 2.4 4.1 1.7 3.1 8.4 2.3 1.5 6.2 5.3 7.8 3.1 0.0 4.1 75.3 32.7 7.3 7.4 2.1 7.0 7.7 20.2 34.0 5.8 2.4 7.1 5.2 8.1 9.2 0.3 1.1 1.3 20.4 2.8 29.5 11.0 0.1 0.3 5.8 1.6 1.2 5.5 6.1 11.9 3.4 10.7 34.6 7.3 5.1 23.3 24.5 1.3 24.6 0.3 12.4 0.1 8.9 58.7 20.3 3.0 14.3 8.1 17.0 26.4 1.0 0.3 10.1 22.1 3.5 6.2 41.8 10.0 11.4 9.0 11.8 2.9 1.6 29.6 12.4 1.4 2.5 3.3 1.0 2.6 2.5 1.6 1.7 10.7 2.9 1.8 2.3 9.5 6.0 3.9 0.8 4.5 0.6 11.4 7.7 1.7 3.0 2.9 7.3 4.1 2.9 3.3 2.7 3.8 3.0 4.5 2.3 3.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CATIP "C2orf62, MGC50811" ENSG00000158428 "Ciliogenesis associated TTC17 interacting protein" Q7Z7H3 2 218356857-218368099 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 20.2;testis: 7.4" "Cell type enhanced" "Detected in some" "Distal tubular cells: 11.7;Early spermatids: 13.6;Endometrial ciliated cells: 36.1;Late spermatids: 18.6;Proximal tubular cells: 11.3;Spermatocytes: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "BEWO: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044818 Supported NA NA "HPA044818: AB_10959301" "unprognostic (7.11e-3)" "unprognostic (2.37e-1)" "unprognostic (3.95e-2)" "unprognostic (1.70e-3)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-2)" "unprognostic (1.69e-2)" "unprognostic (3.44e-1)" "unprognostic (1.95e-3)" "unprognostic (1.46e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (1.19e-1)" 0.1 0.1 2.9 0.0 0.8 0.1 0.0 1.3 0.7 0.7 5.0 0.0 0.0 0.4 4.9 0.0 20.2 0.3 0.0 0.7 2.7 3.4 0.0 2.2 0.0 2.0 2.7 0.3 0.1 1.1 1.8 1.3 0.8 1.9 1.2 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 2.7 0.2 0.1 7.4 1.1 0.0 3.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.9 0.8 1.3 0.7 0.7 2.7 2.0 2.7 0.3 1.9 2.7 1.1 1.4 0.1 0.0 0.5 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.7 2.8 0.0 5.5 0.0 2.2 0.0 0.0 11.7 1.4 13.6 36.1 0.4 0.2 0.0 0.0 0.9 0.2 1.3 0.1 1.1 0.8 0.0 0.1 0.7 0.1 1.3 0.0 0.6 0.0 0.0 2.7 0.0 18.6 0.6 1.8 0.0 1.0 0.7 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 11.3 0.7 0.1 0.0 0.2 0.2 10.2 0.1 0.0 0.0 4.7 0.1 0.3 0.0 0.1 CNOT11 "C2orf29, C40" ENSG00000158435 "CCR4-NOT transcription complex subunit 11" Q9UKZ1 2 101252886-101270316 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069823, HPA074943" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA069823: AB_2686209, HPA074943: " "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (5.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.02e-2)" "unprognostic (1.13e-3)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.33e-6)" "unprognostic (4.19e-2)" "unprognostic (2.35e-1)" "unprognostic (3.62e-3)" "unprognostic (2.72e-3)" 15.6 20.5 18.8 26.5 18.8 35.0 19.3 20.0 21.2 22.8 21.3 31.7 33.4 20.0 25.0 36.7 21.1 25.2 38.0 19.3 19.1 23.3 31.0 19.9 38.0 19.2 18.7 17.9 14.3 31.2 22.0 14.6 34.4 20.4 20.2 36.5 16.2 25.0 19.3 33.3 25.5 31.8 21.0 19.4 30.0 30.5 29.8 19.3 32.1 17.4 26.6 41.2 24.6 20.4 20.4 42.6 29.1 46.2 64.1 38.2 46.0 137.4 43.1 54.6 52.5 55.4 64.2 47.8 75.0 49.7 39.1 66.1 50.6 56.0 51.7 63.4 51.4 47.6 62.6 32.1 96.6 42.5 76.2 59.5 36.5 46.3 37.7 40.0 43.1 59.7 41.8 71.1 44.4 48.0 44.5 74.8 82.0 58.0 67.5 40.6 47.5 50.3 58.1 72.3 79.4 69.1 44.1 26.1 76.6 72.4 52.6 48.5 69.2 40.3 40.7 47.2 35.4 36.4 63.2 63.5 58.8 45.0 84.4 48.6 9.6 2.0 3.9 3.1 2.9 2.1 2.0 3.2 3.8 1.7 3.1 3.0 4.1 7.9 1.2 2.8 2.6 4.5 1.3 18.8 18.8 20.0 21.2 19.3 19.1 19.2 18.7 17.9 20.4 19.4 19.3 20.4 13.4 6.4 13.4 11.1 17.3 11.7 24.7 13.8 14.2 10.7 18.1 10.7 27.8 28.6 14.6 40.5 14.6 65.8 21.1 32.1 31.3 52.1 8.7 53.3 14.0 19.1 10.8 9.4 12.5 41.3 52.6 12.9 25.0 41.8 6.3 13.8 16.8 32.1 23.0 6.7 12.5 26.2 12.2 17.9 8.9 9.3 9.6 16.8 5.4 14.0 29.3 19.9 21.6 9.5 18.2 43.6 18.6 12.0 25.6 32.7 24.6 34.8 24.1 11.3 39.5 10.6 22.4 34.1 15.7 26.9 12.8 57.6 22.1 30.0 25.7 39.3 KCNB1 Kv2.1 ENSG00000158445 "Potassium voltage-gated channel subfamily B member 1" Q14721 20 49293394-49484297 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Exocytosis, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "retina: 114.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 115.6;Cone photoreceptor cells: 212.7;Excitatory neurons: 150.6;Inhibitory neurons: 89.9;Rod photoreceptor cells: 386.9" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.4;CACO-2: 2.2;HL-60: 1.1;hTCEpi: 1.2;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001979, HPA042434" Enhanced NA NA "CAB001979: , HPA042434: AB_2677996" "unprognostic (4.51e-1)" "unprognostic (1.72e-1)" "unprognostic (6.54e-3)" "unprognostic (4.87e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (8.09e-2)" "unprognostic (6.22e-2)" "unprognostic (5.31e-1)" "unprognostic (8.32e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (9.35e-2)" "unprognostic (5.25e-4)" 10.8 1.5 2.4 0.3 6.3 0.0 2.8 0.0 18.2 1.1 0.0 4.4 0.2 7.3 0.8 1.8 6.0 0.6 0.8 5.8 3.5 0.3 2.4 0.3 0.0 1.7 0.4 6.4 0.4 0.3 0.2 2.7 0.1 6.2 2.2 0.6 114.3 1.6 3.1 7.4 0.5 2.0 5.0 0.0 0.3 3.4 0.4 0.0 0.1 0.2 4.4 0.0 3.8 0.9 8.3 0.0 0.0 0.3 0.0 1.4 0.1 0.0 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.9 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.9 0.7 0.6 0.9 0.0 0.0 0.7 0.0 0.0 0.9 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.3 0.0 18.2 5.8 3.5 1.7 0.4 6.4 6.2 0.0 0.0 8.3 20.2 0.0 2.2 7.8 0.5 0.8 0.2 0.0 0.0 115.6 0.9 0.5 3.4 1.5 0.7 0.0 212.7 0.0 0.4 0.0 0.0 0.0 0.7 19.8 2.9 8.0 0.0 0.0 150.6 0.0 0.0 1.4 0.0 4.2 3.8 1.5 0.0 5.7 0.1 18.5 89.9 0.0 0.0 0.0 0.3 0.8 4.4 0.4 0.0 12.2 0.0 38.2 0.0 43.2 3.3 0.1 0.0 34.6 0.1 0.1 0.0 0.2 4.0 386.9 0.0 0.9 7.0 0.2 0.5 0.2 0.3 0.1 0.4 0.2 0.0 0.1 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144707-129169699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 65.1" "Cell type enhanced" "Detected in many" "B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules NA NA Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favorable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 3.1 4.5 7.9 9.2 7.7 4.0 3.0 7.3 6.7 1.9 5.4 5.8 3.7 1.5 11.0 4.0 2.1 3.1 7.6 6.5 11.4 65.1 28.5 5.0 16.4 10.9 11.6 5.4 2.4 21.4 11.2 20.0 3.8 11.0 7.5 3.4 1.3 19.0 7.1 13.1 7.6 12.4 2.2 10.2 17.1 6.2 11.5 11.8 6.7 8.4 4.5 14.5 8.0 3.9 10.0 1.5 4.3 1.0 23.2 0.0 0.0 0.9 0.0 0.2 0.5 0.1 0.7 2.1 18.4 1.8 0.4 12.9 1.7 12.3 4.0 0.5 18.7 14.0 38.2 0.8 8.2 0.9 5.5 0.8 0.9 3.8 0.2 1.2 0.0 0.5 9.4 0.4 2.6 0.0 4.6 11.5 0.1 8.5 0.8 4.5 3.9 0.5 0.4 1.4 5.0 5.8 6.9 2.3 0.7 13.6 5.3 4.7 2.4 0.1 0.1 1.8 1.9 0.6 48.8 5.8 8.1 0.4 18.4 2.7 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.6 1.3 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.4 7.9 7.7 7.3 6.7 6.5 11.4 10.9 11.6 5.4 11.0 10.2 11.8 10.0 0.9 0.0 0.6 3.3 27.8 2.5 0.7 0.8 0.6 3.5 10.5 9.8 6.2 0.0 0.2 5.5 4.2 0.1 7.6 0.7 13.7 2.2 2.5 2.7 0.5 1.4 3.5 5.2 3.6 8.7 0.2 6.7 0.0 1.6 0.0 1.4 0.4 15.8 8.4 0.0 1.7 0.6 0.0 23.6 84.0 4.2 2.8 32.0 1.8 3.7 44.8 8.4 0.0 3.5 0.1 2.4 1.1 32.7 1.3 1.9 1.0 59.2 2.2 1.7 0.0 11.3 1.0 0.8 4.1 0.4 3.0 0.1 2.2 8.4 0.4 1.3 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted in other tissues" No NA Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 2.2 3.5 2.7 0.5 2.6 0.0 3.3 7.8 3.2 5.9 0.0 1.6 0.2 1.2 1.1 1.6 3.3 1.2 1.0 2.1 2.4 0.8 0.1 0.4 0.9 2.7 2.7 1.8 7.6 2.7 8.2 3.5 0.3 4.6 3.1 0.1 1.3 6.6 2.0 5.1 3.5 0.8 0.3 1.0 1.7 0.8 2.1 2.7 0.5 0.7 0.1 0.4 3.1 1.8 3.4 0.0 1.6 0.1 6.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.0 2.8 2.1 0.3 0.1 0.1 4.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.1 0.1 0.0 4.4 0.0 0.2 0.0 0.0 0.1 0.0 11.1 0.1 0.0 0.0 5.8 1.5 4.2 2.5 0.0 2.7 2.6 0.0 0.0 0.0 0.1 1.9 0.3 0.0 1.3 0.8 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.6 7.8 3.2 2.1 2.4 2.7 2.7 1.8 4.6 1.0 2.7 3.4 15.9 0.0 0.0 71.5 1.6 2.8 9.7 0.9 29.0 16.6 4.0 16.0 2.2 0.0 0.5 1.8 0.0 0.1 3.2 0.1 1.9 0.4 0.6 2.6 8.2 2.6 0.0 0.0 89.9 2.2 0.0 2.7 0.5 0.4 0.0 1.3 1.8 0.0 0.1 6.7 136.6 0.1 0.0 0.3 1.3 0.6 9.6 0.6 3.6 8.4 0.3 11.2 5.2 142.2 50.8 0.5 0.0 10.1 2.7 2.6 0.0 1.7 1.0 1.0 6.6 10.9 2.2 2.7 9.4 1.0 0.3 0.0 2.8 4.0 0.1 6.2 AHCYL2 "IRBIT2, KIAA0828, long-IRBIT" ENSG00000158467 "Adenosylhomocysteinase like 2" Q96HN2 7 129225023-129430211 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "choroid plexus: 410.4;intestine: 179.1" "Cell type enhanced" "Detected in all" "Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 8 "HDLM-2: 235.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053128 Uncertain Approved Nucleoplasm,Cytosol NA NA 500000 Cytosol Nucleoplasm "HPA053128: AB_2682050" "unprognostic (1.57e-1)" "unprognostic (2.91e-1)" "unprognostic (8.52e-3)" "unprognostic (1.71e-3)" "unprognostic (7.44e-3)" "prognostic favorable (4.17e-4)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (3.35e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-1)" "unprognostic (6.79e-3)" "prognostic favorable (1.08e-7)" "unprognostic (4.70e-3)" "unprognostic (2.46e-1)" "unprognostic (7.21e-2)" "unprognostic (2.62e-1)" 7.1 10.3 25.9 15.7 33.8 3.2 8.4 28.6 37.6 10.1 410.4 158.8 58.3 9.2 7.3 9.7 7.4 56.3 4.5 48.1 42.9 28.7 7.8 66.4 10.8 31.9 27.9 25.8 11.5 13.9 19.3 21.4 12.2 26.3 9.4 179.1 58.3 30.9 7.1 37.7 24.5 38.9 11.9 26.8 7.1 42.3 10.6 33.4 9.5 43.0 28.0 9.5 16.2 7.7 24.9 8.7 13.5 25.4 15.3 6.8 9.9 5.4 6.8 9.4 7.5 6.6 7.9 5.7 5.3 6.9 7.4 15.9 6.0 12.8 10.7 8.3 235.7 16.0 12.4 14.5 6.4 4.0 9.3 15.4 9.1 13.5 6.0 9.1 12.7 15.1 10.1 5.8 28.7 9.9 8.2 13.7 12.1 12.7 8.6 9.5 9.0 6.9 14.4 15.0 11.5 11.6 7.3 15.5 6.5 9.3 21.0 6.1 6.6 8.6 6.4 3.6 16.9 7.2 12.0 14.6 7.2 16.4 9.8 9.9 0.1 0.4 0.7 0.3 0.9 0.4 0.3 0.5 0.2 0.4 0.1 0.4 0.1 0.1 1.3 0.4 0.1 1.8 0.2 25.9 33.8 28.6 37.6 48.1 42.9 31.9 27.9 25.8 26.3 26.8 33.4 24.9 4.7 60.9 98.6 567.4 9.3 15.6 5.1 7.2 31.3 10.8 4.8 4.3 7.3 18.6 16.4 5.5 6.2 12.5 2.2 334.0 11.7 4.5 61.7 5.9 5.3 5.2 9.1 3.4 131.2 5.3 2.9 3.6 30.1 8.7 5.7 6.0 5.7 6.0 4.7 5.0 115.5 32.9 6.1 10.0 6.1 30.6 4.1 7.3 24.9 99.3 7.7 91.0 2.1 127.2 77.5 6.2 71.8 6.8 7.4 6.2 27.0 17.1 8.7 5.9 6.6 5.1 4.3 5.1 2.3 17.8 9.8 15.2 7.3 8.3 46.1 15.1 B4GALT5 beta4GalT-V ENSG00000158470 "Beta-1,4-galactosyltransferase 5" O43286 20 49632945-49713878 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 6.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077777 Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA077777: " "unprognostic (7.98e-2)" "unprognostic (5.27e-2)" "unprognostic (2.62e-1)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (3.30e-2)" "unprognostic (5.41e-1)" "unprognostic (2.07e-1)" "unprognostic (2.69e-2)" 28.9 48.2 13.5 21.9 14.7 94.6 18.8 13.9 14.9 21.4 8.4 25.1 25.5 23.7 8.7 37.6 18.7 31.7 18.1 14.7 16.7 23.0 26.0 27.5 9.7 15.2 19.8 15.4 19.1 12.7 11.4 12.6 27.4 14.9 17.2 23.9 7.7 19.2 22.1 67.7 7.8 21.5 37.9 14.9 27.8 26.0 22.5 17.7 8.1 11.6 24.6 11.6 51.9 17.3 15.4 48.8 55.0 71.4 30.4 72.8 49.3 62.4 23.5 43.7 104.8 50.0 71.1 59.0 14.8 98.0 39.0 99.1 75.4 45.5 35.0 61.3 45.6 12.5 39.4 28.8 42.9 22.9 51.6 73.7 74.3 32.2 45.5 21.8 96.5 64.8 25.9 64.5 8.9 30.8 24.1 3.1 47.3 37.4 47.8 35.3 26.6 61.9 21.4 50.6 34.0 84.9 43.0 83.6 105.3 47.8 52.5 24.1 70.0 50.1 62.7 50.5 33.6 49.8 10.9 10.0 35.2 32.6 48.5 40.7 1.4 1.0 2.6 1.4 1.0 1.5 0.2 0.6 1.3 0.7 0.3 0.1 0.9 6.6 1.2 1.1 0.6 0.8 0.4 13.5 14.7 13.9 14.9 14.7 16.7 15.2 19.8 15.4 14.9 14.9 17.7 15.4 39.5 16.0 43.1 36.2 5.8 18.9 27.3 39.7 7.4 8.3 17.3 18.2 18.3 42.9 84.5 36.8 10.4 23.4 21.3 61.3 1.9 35.3 5.2 59.1 28.4 42.7 34.3 33.2 52.1 19.7 27.7 27.3 17.9 100.8 83.2 36.2 58.5 22.7 24.5 11.8 59.5 21.3 40.7 28.2 81.5 6.8 19.9 45.0 21.4 30.9 21.4 5.6 20.6 25.6 42.5 39.7 34.1 32.7 7.3 66.8 13.4 33.5 57.0 4.9 26.3 29.9 25.9 10.3 16.0 27.5 17.5 5.6 17.4 33.1 20.0 128.9 CD1D ENSG00000158473 "CD1d molecule" P15813 1 158178030-158186427 "Cancer-related genes, CD markers, Predicted membrane proteins" "Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 18.4;liver: 15.5;lymphoid tissue: 24.1" "Cell type enhanced" "Detected in many" "B-cells: 22.2;Kupffer cells: 54.6;Macrophages: 40.8;monocytes: 45.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 139.0;intermediate monocyte: 63.8;myeloid DC: 139.3" "Group enriched" "Detected in many" 8 "dendritic cells: 139.3;monocytes: 139.0" "Cell line enhanced" "Detected in some" "HHSteC: 10.2;JURKAT: 49.4;MOLT-4: 13.6;THP-1: 8.8" "Low region specificity" "Detected in all" "CAB016107, HPA072662" Enhanced Supported "Endoplasmic reticulum" NA NA 880000 "Endoplasmic reticulum" "CAB016107: AB_626960, HPA072662: AB_2686545" "unprognostic (8.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (3.85e-1)" "unprognostic (9.67e-3)" "unprognostic (2.37e-1)" "unprognostic (3.52e-1)" "unprognostic (2.23e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (9.31e-3)" "unprognostic (2.35e-1)" "unprognostic (2.32e-2)" "unprognostic (3.38e-1)" 2.3 2.0 0.2 7.6 0.2 3.2 2.0 0.1 0.4 1.2 0.6 3.2 7.5 2.2 0.5 0.8 2.2 1.9 2.7 0.1 0.3 2.1 15.5 3.5 4.8 0.3 0.2 0.1 0.6 2.0 0.3 1.0 0.4 0.3 2.2 2.9 0.3 1.1 0.7 1.2 0.3 18.4 2.3 0.2 24.1 2.3 2.5 0.2 9.5 2.7 0.6 3.0 1.8 1.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.0 3.5 0.0 6.0 0.0 0.0 0.1 0.2 0.0 0.0 10.2 0.1 0.0 3.9 0.6 0.0 0.7 0.0 0.0 49.4 0.0 0.0 0.0 0.0 13.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 8.8 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.3 0.0 3.7 0.4 0.2 139.0 0.4 0.2 63.8 0.5 17.6 0.1 0.1 139.3 13.4 0.1 0.0 7.2 0.3 11.0 1.4 0.2 80.7 0.2 0.2 0.1 0.4 0.1 0.3 0.3 0.2 0.1 0.3 0.2 0.2 0.4 9.4 0.0 3.6 0.0 22.2 0.3 0.5 0.8 0.6 0.7 0.1 0.9 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 5.6 0.4 2.0 2.4 2.4 1.7 0.0 0.0 0.2 0.5 0.0 0.3 1.3 0.1 3.3 6.3 11.3 1.7 0.2 2.0 0.0 54.6 0.8 2.1 0.0 40.8 0.0 0.0 45.4 0.6 1.0 0.0 0.0 0.0 6.4 0.0 3.7 0.1 7.3 0.1 0.0 0.3 0.0 1.2 0.4 1.0 2.1 0.0 0.1 0.1 0.6 0.1 4.5 0.1 CD1A CD1 ENSG00000158477 "CD1a molecule" P06126 1 158254424-158258269 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 320.9" "Cell type enriched" "Detected in some" 20 "Langerhans cells: 151.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "classical monocyte: 6.4;intermediate monocyte: 4.2;memory B-cell: 10.1;myeloid DC: 11.4;naive B-cell: 5.3" "Group enriched" "Detected in many" 37 "B-cells: 10.1;dendritic cells: 11.4;monocytes: 6.4" "Group enriched" "Detected in some" 81 "JURKAT: 41.4;MOLT-4: 66.4" "Not detected" "Not detected" "CAB000009, HPA010734" Enhanced NA NA "CAB000009: AB_2073290, HPA010734: AB_1078452" "unprognostic (7.21e-5)" "prognostic favorable (6.37e-4)" "unprognostic (1.37e-5)" "unprognostic (2.55e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-2)" "unprognostic (9.93e-4)" "unprognostic (1.49e-2)" "unprognostic (3.12e-1)" "unprognostic (3.86e-2)" "unprognostic (6.99e-2)" "unprognostic (5.12e-2)" "unprognostic (5.49e-5)" "unprognostic (5.58e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.0 1.6 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 10.5 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.4 0.0 0.1 27.3 0.2 0.0 0.0 1.3 0.8 0.1 0.0 320.9 0.2 0.0 3.9 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 41.4 0.0 0.0 0.0 0.0 66.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.4 0.0 0.0 4.2 0.2 10.1 0.0 0.0 11.4 5.3 0.1 0.0 0.0 0.0 0.2 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 151.7 0.0 0.0 4.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.0 0.0 0.2 0.0 0.0 0.0 SPATA2 "KIAA0757, PD1, PPP1R145, tamo" ENSG00000158480 "Spermatogenesis associated 2" Q9UM82 20 49903391-49915529 "Predicted intracellular proteins" Necrosis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 45.2;Late spermatids: 62.5;Spermatocytes: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048581, HPA052224" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Nucleoli fibrillar center" Nucleoplasm "HPA048581: AB_2680449, HPA052224: AB_2681769" "unprognostic (4.02e-2)" "unprognostic (5.98e-2)" "unprognostic (8.26e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (3.25e-3)" "unprognostic (8.77e-2)" "prognostic favorable (9.08e-4)" "unprognostic (8.33e-2)" "unprognostic (6.45e-3)" "unprognostic (5.99e-2)" "unprognostic (4.89e-2)" "unprognostic (9.57e-2)" "unprognostic (4.38e-1)" "prognostic unfavorable (4.53e-4)" "unprognostic (2.52e-1)" 3.5 5.8 19.1 3.7 20.3 12.3 3.7 16.7 21.1 3.7 7.5 7.1 7.8 5.3 3.6 5.6 4.8 3.4 5.8 20.3 15.4 5.1 5.9 4.1 3.6 18.1 18.4 17.7 4.5 8.1 5.6 8.0 3.6 19.0 5.9 6.4 6.6 5.9 3.9 13.2 5.0 7.6 3.1 17.7 11.5 5.7 14.4 20.6 3.9 8.1 7.9 3.6 4.1 3.7 21.2 7.8 9.4 6.3 5.7 7.0 5.0 10.3 4.9 7.2 16.7 7.0 29.7 6.1 5.9 10.1 4.9 8.6 14.1 4.7 8.1 8.8 8.3 4.5 3.1 5.6 19.5 6.6 8.5 12.2 5.0 9.6 8.6 5.4 5.5 3.6 8.2 10.8 6.6 4.0 16.5 8.7 21.5 9.5 10.5 11.3 6.5 6.8 6.2 5.4 6.1 6.0 6.4 9.8 29.6 7.8 4.9 7.2 7.3 5.1 11.9 9.8 9.9 7.0 16.2 13.4 6.3 9.3 4.4 5.4 0.1 1.5 1.4 1.4 1.1 1.3 1.3 1.3 1.7 1.3 2.1 1.6 1.9 2.5 1.5 0.5 0.6 1.5 1.0 19.1 20.3 16.7 21.1 20.3 15.4 18.1 18.4 17.7 19.0 17.7 20.6 21.2 5.4 9.6 2.2 2.9 7.8 7.4 6.6 4.3 12.5 7.4 11.9 8.6 4.9 10.0 2.8 0.0 8.4 11.0 8.3 34.7 3.9 6.0 45.2 11.4 4.7 6.3 26.4 1.7 6.8 8.0 13.4 5.4 9.7 9.0 4.5 5.4 10.4 7.1 4.8 6.7 5.0 22.2 2.0 4.4 5.4 62.5 5.0 3.6 5.4 1.9 7.0 5.4 4.1 2.0 8.5 8.3 16.1 5.7 6.4 7.4 20.7 4.8 6.7 7.6 6.6 5.8 6.6 41.3 16.9 7.8 7.2 30.1 6.8 10.3 18.4 8.5 CD1C CD1 ENSG00000158481 "CD1c molecule" P29017 1 158289923-158294774 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 131.6" "Cell type enriched" "Detected in some" 6 "Langerhans cells: 551.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory B-cell: 84.1;myeloid DC: 324.9" "Group enriched" "Detected in many" 8 "B-cells: 84.1;dendritic cells: 324.9" "Group enriched" "Detected in some" 10 "JURKAT: 14.8;MOLT-4: 49.4" HPA068359 Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA 200000 "Golgi apparatus, Vesicles" "Endoplasmic reticulum" "HPA068359: " "unprognostic (2.55e-3)" "prognostic favorable (1.79e-5)" "unprognostic (1.75e-5)" "unprognostic (3.09e-5)" "unprognostic (3.12e-2)" "unprognostic (8.13e-3)" "unprognostic (2.01e-1)" "unprognostic (3.80e-3)" "unprognostic (7.11e-3)" "unprognostic (1.87e-1)" "unprognostic (7.41e-2)" "unprognostic (1.93e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (8.05e-2)" "unprognostic (1.99e-1)" 2.7 0.8 0.0 17.5 0.0 1.2 5.1 0.0 0.3 2.3 0.0 3.5 2.0 2.4 0.6 4.6 1.9 7.8 2.1 0.0 0.1 1.3 4.2 6.5 26.4 0.0 0.0 0.0 0.9 0.7 0.6 0.2 0.1 0.0 1.8 9.5 0.0 2.9 1.3 1.0 12.3 12.1 3.1 0.0 23.2 3.7 1.0 0.0 131.6 0.7 1.1 38.5 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 49.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 0.6 26.8 0.1 0.1 24.7 0.3 84.1 0.1 0.0 324.9 49.1 0.2 0.0 1.1 4.1 3.7 1.5 0.5 15.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.2 0.0 26.6 13.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.1 0.0 0.1 1.5 0.0 0.8 0.0 0.0 0.1 1.4 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 7.1 551.4 4.5 0.0 91.2 19.6 0.0 11.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.5 0.0 0.0 0.2 0.4 0.1 0.3 0.0 7.4 0.0 1.9 0.0 0.0 0.0 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 158 "lymphoid tissue: 533.8" "Cell type enriched" "Detected in some" 21 "Langerhans cells: 153.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "myeloid DC: 19.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 19.2" "Cell line enriched" "Detected in some" 5 "MOLT-4: 587.9" HPA021824 Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.1 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.1 0.2 1.0 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 3.3 0.2 0.1 0.0 1.0 0.7 0.0 0.0 533.8 0.3 0.1 1.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 118.6 0.0 0.0 0.0 0.0 587.9 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.9 153.1 0.2 0.0 7.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;fallopian tube: 5.1;testis: 4.4" "Cell type enhanced" "Detected in some" "Early spermatids: 42.7;Endometrial ciliated cells: 31.0;Late spermatids: 17.1;Respiratory ciliated cells: 77.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.5 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.2 0.6 0.0 0.0 1.2 0.0 1.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 4.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.5 0.1 0.2 0.6 1.6 1.9 0.0 1.3 2.0 0.7 0.5 0.0 0.0 1.1 0.7 0.0 0.3 0.7 2.0 0.0 0.0 0.1 0.1 1.7 0.0 6.3 0.0 0.0 0.3 0.0 2.0 0.0 0.0 42.7 31.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 3.6 1.3 0.0 0.0 0.0 17.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 2.5 1.7 0.0 0.8 0.0 0.0 0.5 1.3 0.0 77.8 0.0 0.0 0.2 1.0 0.9 8.8 0.5 0.6 0.0 0.1 0.0 1.9 0.3 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 69 "lymphoid tissue: 971.4" "Cell type enriched" "Detected in some" 13 "Langerhans cells: 549.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 14 "myeloid DC: 62.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 62.5" "Cell line enriched" "Detected in some" 43 "MOLT-4: 1276.2" "Not detected" "Not detected" "HPA057769, HPA070634" Uncertain Supported "Nucleoli,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" Nucleoli "HPA057769: AB_2683522, HPA070634: " "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 0.7 0.5 0.0 4.5 0.0 0.0 1.8 0.0 0.0 2.1 0.0 2.1 2.2 1.1 0.4 8.0 0.9 4.9 1.0 0.0 0.1 0.8 1.5 3.1 6.5 0.0 0.0 0.0 0.6 0.4 0.5 0.1 0.0 0.0 1.1 5.7 0.0 1.5 0.6 0.4 14.1 2.8 0.9 0.0 5.2 4.8 0.5 0.0 971.4 0.8 0.2 9.9 2.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.1 0.0 0.0 0.5 1276.2 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 2.5 0.2 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 0.8 8.4 0.0 0.0 0.6 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.8 549.5 0.0 0.0 41.7 8.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 7.1 0.1 0.7 0.0 0.0 0.0 HMHB1 "HB-1, HB-1Y" ENSG00000158497 "Histocompatibility minor HB-1" O97980 5 143812161-143820719 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.4;testis: 1.3" "Group enriched" "Detected in some" 4 "Early spermatids: 10.8;Late spermatids: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 25 "plasmacytoid DC: 19.8" "Lineage enriched" "Detected in single" 25 "dendritic cells: 19.8" "Group enriched" "Detected in some" 7 "Karpas-707: 3.2;REH: 4.6;RPMI-8226: 1.2" NA NA "unprognostic (1.99e-1)" "unprognostic (6.19e-2)" "unprognostic (2.67e-2)" "unprognostic (6.33e-5)" "unprognostic (7.45e-2)" "unprognostic (1.44e-1)" "unprognostic (4.86e-3)" 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.4 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CPA2 ENSG00000158516 "Carboxypeptidase A2" P48052 7 130266863-130289798 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 416 "pancreas: 45745.7" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 4973.8" "Cancer enriched" "Detected in many" 60 "pancreatic cancer: 411.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA020342, HPA021317" Enhanced Approved "Golgi apparatus" "Secreted to digestive system" NA NA 1500000 "Golgi apparatus" "HPA020342: AB_1846007, HPA021317: AB_1846008" "unprognostic (1.12e-1)" "unprognostic (3.97e-1)" "unprognostic (4.21e-2)" "unprognostic (1.82e-2)" "unprognostic (1.38e-1)" "unprognostic (6.76e-2)" "unprognostic (4.65e-2)" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.66e-1)" "unprognostic (3.84e-5)" "unprognostic (7.52e-2)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (8.48e-2)" 4.7 1.0 0.6 0.7 1.0 0.4 2.6 1.2 0.9 1.2 0.4 1.2 17.6 0.8 0.1 1.5 0.7 0.0 8.5 0.5 0.9 0.9 2.6 0.7 1.5 2.9 1.5 0.4 19.8 45745.7 0.0 1.5 3.2 2.3 1.5 0.4 0.8 7.8 0.0 0.8 0.9 30.9 0.0 1.8 1.2 109.9 2.2 1.1 0.1 0.6 0.0 0.0 0.5 0.8 3.4 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 3.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.6 0.4 0.3 0.0 0.4 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 1.2 0.9 0.5 0.9 2.9 1.5 0.4 2.3 1.8 1.1 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 1.9 8.1 4.3 0.0 0.0 0.9 0.0 0.0 0.1 4973.8 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 10.5 0.3 0.5 0.0 0.0 13.9 4.6 0.0 0.5 1.0 471.3 52.9 0.0 0.0 0.0 9.9 0.0 0.0 0.3 0.0 0.0 1.3 0.4 2.0 0.0 0.1 0.3 0.0 0.2 1.5 0.2 NCF1 "NCF1A, NOXO2, p47phox, SH3PXD1A" ENSG00000158517 "Neutrophil cytosolic factor 1" P14598 7 74773962-74789376 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 87.2;lymphoid tissue: 98.2" "Cell type enhanced" "Detected in many" "B-cells: 293.0;dendritic cells: 157.3;Kupffer cells: 119.9;Macrophages: 153.4;monocytes: 329.9;Plasma cells: 205.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 1165.0;classical monocyte: 673.5;eosinophil: 1467.3;neutrophil: 2128.0" "Group enriched" "Detected in all" 5 "granulocytes: 2128.0;monocytes: 673.5" "Group enriched" "Detected in some" 5 "Daudi: 96.2;HMC-1: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004524, HPA047836, HPA052095" Enhanced NA NA "CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721" "unprognostic (4.93e-2)" "unprognostic (8.34e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-2)" "unprognostic (8.67e-2)" "unprognostic (3.55e-3)" "unprognostic (7.60e-2)" "unprognostic (4.75e-2)" "unprognostic (6.23e-3)" "unprognostic (9.99e-2)" "unprognostic (6.61e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-3)" "unprognostic (3.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-1)" 5.8 3.8 2.6 39.1 2.9 87.2 2.7 4.6 4.0 1.7 2.9 7.3 7.7 1.3 0.5 3.3 3.2 5.5 2.6 3.0 2.8 2.8 5.0 17.9 57.3 5.6 3.0 2.0 1.1 1.5 0.7 1.3 5.1 4.9 2.2 4.5 1.6 4.3 1.4 1.5 1.8 26.8 4.0 5.1 98.2 6.7 0.8 3.7 7.5 2.7 4.8 37.8 7.7 1.8 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 96.2 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.6 2.9 1.4 0.9 0.0 0.8 130.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.1 16.8 0.3 0.0 0.0 1.6 0.0 3.4 0.2 0.4 0.0 0.1 0.0 0.1 0.1 0.1 0.0 20.6 0.2 0.1 0.3 0.2 0.0 0.6 0.3 16.5 0.2 8.1 0.2 1165.0 673.5 1467.3 4.2 242.3 9.8 257.0 10.0 6.7 77.7 276.6 15.4 9.4 2128.0 10.7 60.2 280.9 11.1 514.1 2.6 2.9 4.6 4.0 3.0 2.8 5.6 3.0 2.0 4.9 5.1 3.7 5.8 5.0 0.0 2.8 0.0 293.0 3.1 1.1 29.6 5.2 0.2 3.1 3.2 0.6 4.3 10.9 3.7 0.0 0.6 157.3 0.0 0.0 1.3 8.7 0.8 1.0 3.6 0.0 6.1 0.0 0.6 12.2 1.5 10.2 2.5 14.5 0.1 3.9 3.6 39.3 3.3 0.1 0.3 2.0 119.9 23.4 6.4 0.0 153.4 10.6 1.0 329.9 0.3 10.3 0.0 0.1 1.2 4.2 0.4 205.7 1.0 0.4 1.9 17.6 0.5 0.0 1.4 1.5 0.2 0.7 5.0 1.7 4.5 63.6 0.1 0.3 2.2 CPA5 ENSG00000158525 "Carboxypeptidase A5" Q8WXQ8 7 130344816-130368730 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 33.9" "Group enriched" "Detected in some" 23 "Early spermatids: 76.1;Late spermatids: 144.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 16.8;naive CD8 T-cell: 42.5;T-reg: 56.4" "Lineage enriched" "Detected in single" 102 "T-cells: 56.4" "Cell line enhanced" "Detected in some" "RH-30: 7.3;RT4: 3.4;U-266/84: 6.0" "Not detected" "Not detected" HPA020322 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA020322: AB_10960562" "unprognostic (2.44e-1)" "unprognostic (3.76e-1)" "unprognostic (1.50e-1)" "unprognostic (5.94e-2)" "unprognostic (4.96e-2)" "unprognostic (7.10e-3)" "unprognostic (1.64e-2)" "unprognostic (1.41e-2)" "unprognostic (3.26e-1)" "unprognostic (5.02e-2)" "unprognostic (5.83e-4)" "unprognostic (1.43e-1)" "unprognostic (8.88e-13)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (8.81e-2)" "unprognostic (3.08e-2)" 0.3 0.2 0.3 0.1 0.3 0.2 0.1 0.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 1.9 0.4 0.4 0.2 0.0 0.5 0.0 1.2 0.7 0.4 0.1 0.0 0.0 0.0 0.0 0.2 1.0 0.7 0.0 0.3 1.8 0.0 33.9 0.4 2.3 0.3 0.0 0.9 0.6 0.0 0.5 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.3 2.1 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.9 0.0 0.6 0.0 1.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 7.3 0.2 1.0 3.4 0.9 0.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.6 0.0 16.8 8.6 0.0 0.0 4.2 42.5 0.0 0.0 0.0 0.0 56.4 5.8 0.3 0.3 0.2 1.0 0.4 0.5 0.4 0.4 0.2 0.4 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.3 0.0 0.0 1.8 0.0 3.1 0.0 0.0 0.0 0.1 76.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 144.1 0.9 0.1 0.0 0.0 0.9 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 3.8 2.6 0.0 0.0 4.7 4.0 0.0 0.0 0.1 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2 ribosome maturation factor" Q969E8 X 54440404-54448032 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favorable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 34.2 45.5 55.3 11.3 52.8 12.0 35.9 48.0 55.3 35.4 43.6 38.6 10.3 35.2 23.2 34.9 32.5 7.7 44.0 50.8 51.4 43.3 37.0 30.7 12.7 53.6 52.6 48.5 34.9 30.5 25.2 47.5 14.7 54.9 33.5 13.4 27.7 32.9 17.1 52.2 40.9 31.6 13.3 54.5 32.7 39.1 16.6 54.3 15.1 41.5 18.8 15.9 36.6 35.3 52.3 24.1 26.6 23.9 20.6 19.9 13.0 18.7 22.4 17.5 19.6 17.3 26.2 24.1 23.5 15.8 18.2 35.7 24.9 47.9 28.3 24.8 29.8 26.8 19.3 20.8 19.6 12.5 32.7 19.4 12.9 18.0 26.4 27.1 19.7 13.8 22.9 20.5 16.9 19.3 37.9 27.4 29.9 34.6 23.6 33.0 26.5 38.2 19.6 20.6 18.3 25.9 20.5 42.1 19.9 28.0 38.0 45.4 14.7 21.0 16.2 27.1 38.0 19.9 19.8 32.3 29.7 24.4 27.5 23.2 29.7 16.6 32.0 36.3 23.1 30.0 44.8 34.0 33.6 15.1 46.3 42.6 32.3 10.4 29.7 26.0 16.7 40.8 24.9 55.3 52.8 48.0 55.3 50.8 51.4 53.6 52.6 48.5 54.9 54.5 54.3 52.3 39.1 25.6 30.2 1.6 39.8 32.8 43.0 42.7 26.7 61.6 27.4 28.6 49.0 28.6 38.6 35.0 27.1 98.5 36.0 26.3 125.2 43.9 1.2 17.7 23.7 35.6 18.1 18.1 5.7 32.9 71.5 33.8 16.8 22.9 45.0 20.3 31.8 25.2 46.6 57.2 5.6 35.5 61.1 18.2 31.4 2.8 34.8 24.6 40.9 6.5 48.6 85.6 44.3 2.5 6.5 38.1 29.5 45.1 22.3 36.7 32.6 64.6 33.8 67.0 46.0 29.8 38.0 20.5 43.3 25.4 31.7 75.9 37.8 36.2 30.9 33.9 PPP1R9A "FLJ20068, KIAA1222, Neurabin-I" ENSG00000158528 "Protein phosphatase 1 regulatory subunit 9A" Q9ULJ8 7 94907202-95296415 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in many" "Astrocytes: 294.1;Excitatory neurons: 262.8;Inhibitory neurons: 201.5;Oligodendrocyte precursor cells: 593.1;Oligodendrocytes: 308.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 6.8;NK-cell: 10.3" "Group enriched" "Detected in many" 9 "granulocytes: 6.8;NK-cells: 10.3" "Cell line enhanced" "Detected in many" "HAP1: 12.2;RH-30: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027726, HPA075591" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA027726: AB_1855653, HPA075591: AB_2732296" "unprognostic (1.05e-1)" "unprognostic (6.59e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (6.19e-2)" "unprognostic (1.45e-1)" "prognostic favorable (7.17e-4)" "unprognostic (2.26e-2)" "unprognostic (1.89e-1)" "prognostic favorable (8.63e-6)" "unprognostic (2.74e-1)" "unprognostic (4.85e-2)" "unprognostic (8.47e-2)" "unprognostic (8.79e-3)" 1.7 7.1 10.7 0.9 19.5 0.2 5.0 7.0 15.9 2.7 0.4 6.5 1.7 3.1 4.9 1.6 5.7 2.4 5.2 15.3 10.2 4.7 0.4 3.8 0.3 7.4 7.3 12.2 3.3 8.9 6.7 4.6 2.6 9.0 2.3 3.9 18.7 9.7 2.8 5.0 0.5 2.2 2.2 4.5 1.8 4.9 6.7 9.2 0.5 6.6 5.0 0.4 2.6 0.5 14.6 0.0 11.0 6.6 7.6 0.0 0.0 5.3 0.5 0.1 1.0 0.8 6.1 3.7 0.0 9.0 0.5 0.6 0.0 12.2 0.0 1.2 0.0 4.5 11.4 4.5 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.8 4.8 0.1 0.0 5.5 4.9 1.8 0.0 11.8 0.0 10.7 9.2 7.3 7.4 0.0 0.9 1.4 4.0 2.1 0.0 0.0 0.1 4.4 0.1 4.0 7.3 11.5 0.0 0.2 0.0 0.9 6.8 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 10.3 0.1 0.3 0.0 0.1 10.7 19.5 7.0 15.9 15.3 10.2 7.4 7.3 12.2 9.0 4.5 9.2 14.6 4.5 41.7 66.6 294.1 2.4 0.4 0.9 0.0 0.6 58.2 24.4 12.2 127.7 18.6 16.5 47.8 56.3 21.6 3.3 15.7 3.9 25.1 17.9 40.3 4.5 6.8 38.9 2.5 262.8 7.0 3.1 9.4 21.4 57.1 5.7 39.5 7.9 1.5 1.7 1.7 201.5 15.0 4.1 0.6 0.3 15.3 2.5 0.8 7.2 41.2 0.0 46.9 3.1 593.1 308.4 6.6 14.4 0.7 2.7 4.8 1.8 9.6 20.6 88.9 0.0 118.4 9.2 25.1 12.6 0.5 0.9 33.1 1.7 22.9 15.7 2.6 ZC3H18 NHN1 ENSG00000158545 "Zinc finger CCCH-type containing 18" Q86VM9 16 88570403-88631964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040847, HPA041327" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA040847: AB_10794865, HPA041327: AB_10795005" "unprognostic (3.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.88e-1)" "unprognostic (2.90e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (1.10e-2)" "unprognostic (7.37e-2)" "unprognostic (2.89e-2)" "unprognostic (2.79e-1)" "unprognostic (2.07e-3)" "prognostic favorable (3.68e-4)" "unprognostic (5.83e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (4.01e-1)" 13.9 11.1 10.5 18.9 11.5 25.7 13.7 13.6 14.3 14.4 5.5 15.7 15.0 17.5 4.3 14.7 14.4 8.9 12.8 10.4 9.6 10.1 12.1 13.2 18.5 10.2 9.4 7.6 14.2 13.8 12.4 10.2 12.0 10.8 11.6 8.2 9.1 13.8 8.3 23.0 15.4 15.7 10.2 7.5 17.6 14.6 25.5 9.8 19.3 13.2 10.1 12.4 15.4 13.8 12.0 45.3 59.6 42.6 42.8 20.7 17.7 68.3 44.5 24.1 40.8 18.5 58.8 38.3 55.1 36.9 21.1 27.3 53.0 40.3 33.7 25.6 32.5 51.2 36.6 29.2 50.6 26.2 28.5 30.7 16.1 25.2 43.3 20.8 16.9 25.5 37.8 101.4 17.8 20.4 87.4 91.6 50.5 66.7 35.3 35.5 111.0 29.3 40.4 18.5 28.3 44.9 38.7 85.2 23.5 25.2 24.8 53.3 38.1 35.1 43.6 45.2 32.0 45.5 39.5 67.2 130.8 38.6 65.7 47.0 2.3 2.0 2.0 2.5 2.3 2.8 2.3 2.4 2.7 1.9 1.9 2.1 1.7 3.4 3.1 5.4 2.8 3.3 2.1 10.5 11.5 13.6 14.3 10.4 9.6 10.2 9.4 7.6 10.8 7.5 9.8 12.0 24.9 28.9 24.2 11.1 29.6 16.8 17.0 11.1 13.1 26.6 13.8 14.4 10.2 20.0 23.9 16.5 35.5 24.1 45.6 30.1 7.9 16.5 76.2 21.9 28.7 21.3 25.0 28.6 12.0 16.6 22.1 18.7 22.4 32.1 20.8 26.6 16.4 12.9 18.2 28.6 11.9 18.5 10.2 20.1 21.1 10.0 21.8 30.5 14.2 12.2 23.9 18.1 46.4 7.1 15.7 17.5 21.7 17.0 35.5 20.5 20.3 8.4 13.1 44.0 6.6 28.8 19.5 41.4 37.5 19.6 22.3 25.2 39.2 25.1 24.7 16.6 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 144.0;Proximal enterocytes: 170.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA035159: AB_2674499, HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 27.8 26.8 30.8 20.9 31.2 38.6 28.5 31.2 44.0 36.1 25.4 37.3 41.8 29.9 18.2 49.1 28.7 20.2 26.6 30.4 30.9 44.0 65.0 32.6 28.6 34.4 31.2 30.2 29.2 41.0 27.0 36.5 17.6 33.2 31.6 25.2 10.9 27.9 17.8 34.6 42.6 45.8 16.0 31.0 46.2 37.7 15.7 32.1 38.2 50.2 15.7 23.5 33.3 35.8 34.7 23.0 14.4 17.2 23.7 17.6 18.5 23.5 22.8 26.3 32.1 31.7 34.8 18.9 16.5 23.0 39.2 26.0 15.5 15.4 28.9 25.5 27.8 25.2 41.8 25.6 30.3 36.3 22.9 45.3 15.3 62.2 31.9 75.0 17.7 21.2 40.0 25.0 38.9 31.9 40.0 37.9 47.9 8.9 31.7 17.5 22.4 8.3 31.6 29.6 17.7 33.7 16.3 10.9 17.3 24.8 19.3 15.4 47.3 22.5 32.2 29.5 37.2 33.3 20.2 6.6 34.1 31.5 44.2 25.6 30.8 34.8 48.6 49.1 46.0 42.5 43.6 44.2 48.0 26.7 53.0 39.9 48.9 58.3 53.5 38.3 33.5 51.6 44.3 30.8 31.2 31.2 44.0 30.4 30.9 34.4 31.2 30.2 33.2 31.0 32.1 34.7 30.4 22.4 21.2 17.6 43.5 27.1 26.3 34.0 19.9 14.9 37.1 33.7 12.7 44.3 24.5 20.2 14.6 26.9 52.4 144.0 56.7 44.1 4.9 14.6 17.7 26.4 40.2 15.2 17.8 66.0 24.3 19.6 42.3 20.7 32.4 11.6 23.6 39.4 34.9 8.4 16.1 67.5 36.7 32.4 31.3 7.8 32.0 35.6 35.6 5.6 24.4 21.5 44.3 6.0 15.3 60.3 101.1 29.7 39.5 25.1 170.6 79.5 13.8 17.2 26.3 15.9 28.7 6.2 22.9 27.6 36.1 51.3 46.7 27.8 54.4 28.8 POM121L2 POM121-L ENSG00000158553 "POM121 transmembrane nucleoporin like 2" Q96KW2 6 27285903-27312170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 77 "testis: 8.4" "Cell type enriched" "Detected in single" 6 "Spermatocytes: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046150 Uncertain NA NA "HPA046150: AB_10960993" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-2)" "unprognostic (5.88e-3)" "unprognostic (3.48e-2)" "unprognostic (1.93e-1)" "unprognostic (3.51e-2)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525941 "Enzymes, Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 117.5;retina: 84.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.7" "Group enriched" "Detected in many" 6 "granulocytes: 7.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 29.5 8.7 18.9 4.9 18.3 12.9 24.8 15.9 12.5 12.5 8.4 6.7 2.8 18.0 1.8 3.3 10.4 4.4 8.2 10.0 13.7 7.8 8.2 15.3 6.7 12.6 26.7 11.6 7.4 38.4 0.8 19.3 14.1 9.5 11.6 1.6 84.2 21.5 5.3 13.2 6.9 10.1 6.5 6.7 117.5 4.8 39.3 42.7 3.1 7.8 8.8 4.7 12.7 10.0 12.0 2.1 7.5 3.2 3.7 2.2 1.1 11.1 2.3 3.1 1.1 0.7 10.0 4.4 14.2 32.8 32.4 8.1 4.7 4.0 3.8 0.6 66.9 3.1 2.6 11.7 21.2 3.2 1.6 10.7 2.4 2.0 0.8 1.6 3.2 26.7 12.7 4.7 6.3 1.5 4.5 3.9 7.1 5.7 3.7 10.6 4.5 0.9 3.9 0.9 3.6 1.7 1.2 4.8 18.3 9.3 4.1 2.7 6.3 7.9 7.5 30.4 5.8 2.6 1.6 0.3 2.8 1.7 8.5 0.8 7.7 0.8 0.5 1.2 0.3 1.7 0.6 1.3 0.9 0.2 0.2 0.7 0.9 0.1 0.0 0.0 0.7 2.0 0.5 18.9 18.3 15.9 12.5 10.0 13.7 12.6 26.7 11.6 9.5 6.7 42.7 12.0 4.2 6.4 0.0 1.6 5.4 1.0 0.3 0.7 0.6 60.9 3.6 3.4 3.0 1.5 1.3 0.0 148.0 3.2 9.1 0.5 0.0 4.2 52.1 1.0 10.4 7.0 0.0 8.2 5.0 9.3 1.5 6.6 1.1 1.5 4.5 1.6 20.7 2.4 1.9 5.0 15.8 0.7 0.0 2.8 3.7 178.0 5.9 3.1 5.4 8.4 4.9 8.9 1.0 1.0 0.8 4.7 0.3 2.6 5.0 0.8 0.3 0.1 0.8 88.4 0.0 4.6 1.9 12.9 8.2 0.1 1.1 46.0 7.0 0.9 2.0 0.6 DYNC1I1 "DNCI1, DNCIC1" ENSG00000158560 "Dynein cytoplasmic 1 intermediate chain 1" O14576 7 95772506-96110322 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 457.5;Inhibitory neurons: 374.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 213.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 14.0;SH-SY5Y: 10.3;U-266/84: 9.5;WM-115: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061689 Enhanced Supported NA NA "HPA061689: AB_2684586" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" "unprognostic (3.83e-2)" "prognostic favorable (3.79e-4)" "unprognostic (6.27e-2)" "unprognostic (2.11e-4)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (2.18e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.86e-2)" "unprognostic (2.24e-4)" "unprognostic (2.25e-4)" "unprognostic (1.63e-1)" "unprognostic (7.81e-4)" "unprognostic (1.10e-2)" 2.4 12.9 21.2 1.6 35.0 1.1 2.7 38.3 57.5 2.2 18.4 13.1 1.4 2.7 5.1 3.5 2.6 2.0 18.3 37.5 32.0 2.2 0.3 1.0 0.8 37.3 36.2 33.5 7.9 2.0 0.6 19.7 0.8 44.7 7.5 3.0 27.6 1.5 8.3 9.7 2.5 2.3 3.6 10.2 1.4 5.6 2.4 29.6 3.9 2.9 12.5 0.6 19.9 3.5 71.8 0.4 0.3 0.1 1.3 0.2 0.1 0.5 0.2 0.0 0.7 0.2 1.7 1.1 0.5 14.0 1.9 1.0 0.6 4.9 0.3 0.3 0.1 1.1 3.5 0.6 0.0 0.1 0.4 4.6 0.2 0.3 0.3 0.5 0.6 0.3 2.1 0.6 0.5 2.2 3.2 0.4 0.6 0.9 0.3 2.9 0.8 0.4 2.0 1.8 1.6 1.8 10.3 0.1 0.2 2.3 7.5 1.0 0.9 0.4 4.0 2.8 2.2 2.2 7.3 9.5 0.4 4.6 0.5 9.2 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.2 1.4 0.6 0.1 0.8 0.2 0.2 21.2 35.0 38.3 57.5 37.5 32.0 37.3 36.2 33.5 44.7 10.2 29.6 71.8 1.6 0.0 0.0 21.5 0.2 0.8 1.3 0.0 1.2 49.6 3.6 1.3 30.9 0.0 0.0 0.0 50.1 1.3 0.0 0.0 0.0 0.3 6.8 22.3 1.7 4.2 1.8 0.0 457.5 1.1 0.1 6.7 0.0 24.4 0.0 3.8 15.0 0.5 0.5 1.7 374.1 0.0 0.0 0.3 0.8 5.2 19.0 3.0 21.4 30.9 0.1 83.5 0.0 91.0 213.8 0.9 0.0 11.7 1.4 0.7 0.0 0.3 0.0 24.8 6.6 19.4 9.1 1.2 4.0 0.4 1.1 0.1 0.4 1.2 0.0 0.6 PFKFB1 PFRX ENSG00000158571 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1" P16118 X 54932961-54998534 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adipose tissue: 28.6;liver: 50.7;skeletal muscle: 112.6;tongue: 41.1" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 15.9" "Cancer enriched" "Detected in some" 11 "liver cancer: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 8.5;Hep G2: 3.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (2.51e-1)" "unprognostic (2.39e-2)" "unprognostic (1.17e-2)" "unprognostic (4.38e-3)" "unprognostic (1.64e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "unprognostic (3.33e-1)" "unprognostic (3.26e-3)" "unprognostic (2.88e-1)" "unprognostic (5.36e-3)" "unprognostic (5.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.16e-4)" "unprognostic (1.96e-3)" 28.6 0.5 0.4 0.1 0.5 0.4 9.3 0.4 0.5 0.1 0.2 0.4 0.1 0.1 0.6 1.1 0.1 0.3 0.2 0.4 0.4 1.1 50.7 0.2 0.5 0.5 0.5 0.3 0.0 1.3 0.3 0.5 0.2 0.5 0.3 0.5 0.4 0.7 0.2 112.6 0.8 0.5 0.1 0.4 0.3 0.4 0.4 0.4 0.4 1.0 41.1 0.6 0.2 0.2 0.6 0.2 0.1 0.2 0.4 8.5 0.1 0.6 0.0 0.1 0.1 0.0 0.5 0.1 0.4 0.1 0.0 0.4 0.3 0.1 0.2 0.3 0.3 0.7 0.2 0.1 3.2 0.0 0.0 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.8 0.1 1.4 0.1 0.5 0.4 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.3 1.0 0.1 0.7 0.2 0.0 0.1 0.1 0.3 0.2 0.1 0.7 1.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.5 0.4 0.4 0.5 0.5 0.3 0.5 0.4 0.4 0.6 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 15.9 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 ALAS2 ASB ENSG00000158578 "5'-aminolevulinate synthase 2" P22557 X 55009055-55030977 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "bone marrow: 611.2" "Cell type enriched" "Detected in some" 166 "Erythroid cells: 2366.7" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.6" "Group enriched" "Detected in some" 93 "HEL: 71.7;K-562: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.82e-2)" "unprognostic (2.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-3)" "unprognostic (5.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (8.68e-2)" "unprognostic (4.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.45e-1)" "unprognostic (2.32e-2)" "unprognostic (6.63e-3)" "unprognostic (4.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" 1.2 0.5 1.1 0.4 1.7 611.2 0.6 1.6 8.5 0.2 11.8 0.5 0.6 0.1 0.0 0.8 1.1 0.8 2.5 0.9 1.3 2.4 3.3 5.2 0.3 2.3 2.4 0.7 0.4 0.3 0.0 1.2 45.2 2.0 0.2 0.0 0.2 1.0 0.2 0.5 0.6 0.3 0.1 1.8 25.4 0.2 0.2 1.7 1.0 1.2 18.4 0.0 0.6 0.7 3.0 0.1 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.6 71.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 85.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.6 0.0 5.9 1.1 1.7 1.6 8.5 0.9 1.3 2.3 2.4 0.7 2.0 1.8 1.7 3.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.3 1.8 2366.7 0.0 0.2 1.8 0.3 0.0 0.1 0.0 0.0 1.4 1.3 2.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 7.3 14.2 1.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.1 TMED4 "HNLF, p24a3, p24alpha3" ENSG00000158604 "Transmembrane p24 trafficking protein 4" Q7Z7H5 7 44577894-44582287 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved "Intracellular and membrane" NA NA 24000 "HPA014650: AB_1858066" "unprognostic (7.34e-2)" "unprognostic (1.68e-3)" "unprognostic (1.46e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.09e-3)" "unprognostic (4.50e-3)" "unprognostic (2.54e-2)" "unprognostic (3.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.61e-1)" "unprognostic (2.42e-3)" "unprognostic (4.65e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.21e-1)" "unprognostic (6.12e-2)" "unprognostic (4.11e-1)" "unprognostic (6.61e-2)" 35.2 52.1 43.3 32.4 48.8 50.0 43.3 46.1 43.3 47.7 51.4 46.5 88.7 51.7 79.3 37.6 54.3 37.5 65.6 42.0 51.7 89.1 49.4 42.5 37.4 47.7 46.4 40.7 72.6 73.6 140.6 68.9 62.4 47.3 58.0 48.5 92.8 67.9 65.7 62.1 40.2 93.5 44.6 46.2 38.8 52.2 31.6 45.0 38.7 115.0 42.0 38.4 42.7 40.8 57.8 47.2 57.0 80.0 90.8 70.7 41.8 68.6 55.7 68.8 56.4 70.1 62.2 114.1 44.5 90.9 60.0 120.8 74.9 42.5 46.7 67.9 59.3 69.0 39.5 100.4 59.6 63.7 63.8 72.8 54.5 69.7 59.7 48.4 103.8 50.7 68.9 62.8 96.4 67.6 42.4 61.8 86.2 51.5 73.1 57.5 52.6 37.2 87.4 81.7 76.6 64.0 91.3 59.4 132.7 64.4 90.7 103.8 64.1 47.3 41.3 61.0 47.8 88.1 143.9 140.0 53.6 84.6 67.5 148.8 95.3 60.2 87.2 85.3 63.3 103.4 67.4 85.0 82.2 55.1 54.5 69.5 77.8 58.5 82.8 71.3 120.7 79.2 56.6 43.3 48.8 46.1 43.3 42.0 51.7 47.7 46.4 40.7 47.3 46.2 45.0 57.8 41.4 118.6 74.0 11.8 70.3 56.2 53.5 61.0 44.9 150.5 83.2 77.2 69.8 62.9 66.0 154.5 75.0 176.0 83.5 79.7 41.1 79.4 54.9 79.3 61.7 36.8 62.9 49.2 25.5 60.6 57.4 75.2 45.9 92.9 41.1 89.9 36.4 55.5 70.7 112.7 30.2 75.0 63.1 45.9 55.0 100.4 78.3 50.4 40.9 12.2 56.9 115.7 41.2 25.1 31.0 79.0 78.6 81.3 142.7 75.6 267.7 140.9 69.4 135.9 59.2 87.1 65.8 51.8 60.8 47.0 56.8 159.9 74.1 60.3 79.6 76.3 PPP1R15B FLJ14744 ENSG00000158615 "Protein phosphatase 1 regulatory subunit 15B" Q5SWA1 1 204403381-204411817 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 126.8" "Cell type enhanced" "Detected in all" "Langerhans cells: 171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061088 Approved "Golgi apparatus" No No "Golgi apparatus" "HPA061088: AB_2684426" "unprognostic (2.91e-3)" "unprognostic (8.61e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-3)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (5.31e-2)" "unprognostic (2.66e-2)" "unprognostic (7.37e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.74e-5)" "unprognostic (9.52e-3)" "unprognostic (2.47e-1)" "unprognostic (2.99e-2)" "unprognostic (7.50e-2)" 41.0 23.3 13.5 31.3 15.1 126.8 23.2 18.4 15.6 19.8 16.4 23.6 22.6 21.6 13.2 26.1 21.7 31.1 13.1 13.1 16.5 21.2 48.5 24.4 29.3 15.0 15.7 10.4 24.7 37.2 18.9 10.6 32.8 15.0 22.7 24.3 16.1 22.3 16.0 13.3 16.7 24.5 30.1 16.3 24.0 27.3 11.8 15.5 33.6 28.5 18.3 24.9 53.7 14.9 20.4 29.3 23.0 26.9 22.8 34.1 23.2 108.7 23.6 28.3 31.9 28.7 27.6 40.3 48.2 16.0 28.9 22.2 36.3 40.2 23.9 29.5 37.3 28.7 28.5 55.7 17.8 41.5 49.1 49.0 29.3 30.4 31.4 34.5 22.9 35.1 40.4 44.4 92.8 21.8 29.1 47.1 30.6 46.2 26.8 32.9 33.2 48.9 49.8 32.0 35.4 25.7 39.3 42.6 59.8 49.3 36.0 39.4 50.2 19.8 22.2 31.3 28.6 40.3 62.5 30.0 47.3 20.0 33.1 23.4 13.1 5.5 5.7 3.2 5.1 3.4 2.0 3.2 3.0 5.0 2.1 4.9 3.5 11.8 3.2 6.2 2.0 4.4 2.9 13.5 15.1 18.4 15.6 13.1 16.5 15.0 15.7 10.4 15.0 16.3 15.5 20.4 72.2 48.1 37.9 15.3 40.8 73.7 43.0 23.1 48.3 18.5 43.7 24.6 15.6 32.9 25.9 18.4 20.9 22.9 40.3 70.4 3.9 15.9 9.0 72.0 90.8 50.9 44.7 27.3 12.3 24.0 42.7 54.7 76.5 146.7 49.4 31.0 28.9 48.6 31.8 8.4 13.0 43.3 22.4 42.0 171.9 4.6 13.1 97.9 49.8 10.3 36.8 14.4 11.3 18.1 23.2 30.3 40.5 12.8 50.9 55.0 39.5 11.0 43.0 18.5 6.6 72.7 48.6 17.2 13.2 39.8 64.2 49.3 46.8 31.2 35.6 104.5 COPG2 2-COP ENSG00000158623 "COPI coat complex subunit gamma 2" Q9UBF2 7 130506238-130668748 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 50.6;Oligodendrocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045712 Approved NA NA "HPA045712: AB_2679428" "unprognostic (9.48e-2)" "unprognostic (3.31e-2)" "unprognostic (7.98e-2)" "unprognostic (9.40e-2)" "unprognostic (3.26e-1)" "unprognostic (9.96e-2)" "unprognostic (1.74e-3)" "unprognostic (1.11e-1)" "unprognostic (6.26e-2)" "unprognostic (1.53e-1)" "unprognostic (4.41e-2)" "unprognostic (2.50e-2)" "unprognostic (6.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.23e-1)" "unprognostic (4.25e-2)" "unprognostic (2.23e-1)" 12.2 21.5 15.2 9.4 16.9 12.5 20.5 3.5 13.0 13.1 2.5 12.3 9.4 16.6 17.1 14.7 19.3 12.8 15.9 14.4 28.3 12.4 9.2 9.9 9.4 9.8 10.7 13.6 39.6 9.7 26.0 14.0 15.9 11.5 12.0 13.9 28.3 9.6 14.5 17.4 21.0 8.8 14.0 4.8 9.9 9.8 24.8 27.3 15.8 18.5 14.5 15.4 12.8 12.2 16.6 44.2 24.8 44.7 22.5 19.3 34.2 11.6 20.2 30.5 33.2 32.2 15.4 23.8 30.4 16.6 26.3 36.7 21.9 15.0 38.0 43.3 33.2 31.1 31.0 12.1 22.2 30.6 40.9 27.6 27.5 18.9 27.0 41.1 32.2 31.7 30.5 50.3 8.8 42.6 44.2 39.6 31.9 56.4 29.2 19.9 37.9 58.6 18.2 40.2 57.9 34.3 49.4 42.1 38.9 32.7 37.3 25.3 13.2 28.1 29.8 15.4 25.0 30.2 19.4 25.4 35.2 33.2 33.3 26.3 1.2 1.5 2.6 0.7 1.4 0.6 1.6 0.7 0.5 1.8 0.8 0.7 0.6 0.4 0.8 2.0 0.7 0.7 0.7 15.2 16.9 3.5 13.0 14.4 28.3 9.8 10.7 13.6 11.5 4.8 27.3 16.6 4.9 0.0 2.0 23.2 6.5 9.1 7.7 9.4 7.4 13.8 8.8 6.3 5.1 5.7 8.3 14.7 14.6 18.5 4.5 4.1 11.7 9.5 3.5 7.6 6.4 5.5 2.4 5.0 42.9 24.1 13.4 6.5 7.1 4.8 1.3 11.6 11.7 5.0 9.0 5.0 50.6 7.0 6.1 10.7 7.5 2.3 5.9 7.8 8.8 22.5 9.9 9.3 2.1 39.7 52.0 9.2 2.2 6.8 6.8 3.5 2.8 8.1 9.2 13.1 13.1 9.9 7.5 18.6 26.5 11.0 10.1 22.4 6.0 9.6 7.1 6.8 EMSY C11orf30 ENSG00000158636 "EMSY transcriptional repressor, BRCA2 interacting" Q7Z589 11 76444923-76553025 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012234, HPA050777" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012234: AB_449325, HPA050777: AB_2681232" "unprognostic (1.69e-2)" "unprognostic (8.15e-2)" "unprognostic (1.51e-3)" "unprognostic (3.66e-2)" "unprognostic (2.60e-2)" "unprognostic (1.54e-2)" "unprognostic (3.32e-2)" "unprognostic (3.87e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" "unprognostic (5.37e-2)" "unprognostic (2.99e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (6.64e-2)" "unprognostic (8.74e-2)" 6.8 5.9 5.4 7.8 7.5 13.2 8.8 15.2 9.4 8.2 6.7 7.6 5.2 10.1 7.6 6.2 8.7 6.4 9.1 5.5 5.9 7.4 5.7 9.0 9.0 6.4 6.6 3.9 11.5 8.9 9.9 5.7 12.3 7.8 7.7 8.8 17.9 7.2 7.8 9.4 5.7 6.6 10.2 4.3 7.9 6.7 8.8 6.5 13.4 8.3 12.7 8.5 7.4 7.5 12.5 8.6 11.9 26.8 16.5 9.9 9.8 11.8 13.5 13.3 17.3 18.9 20.3 11.5 11.7 12.7 14.7 14.3 16.8 21.9 13.0 26.6 18.7 8.2 18.2 18.5 8.8 6.3 20.0 15.8 8.9 8.5 19.8 16.3 11.0 15.8 19.6 12.9 20.0 14.1 22.8 26.9 12.0 11.7 26.9 15.6 17.1 49.2 16.4 12.0 10.0 16.7 7.3 19.0 12.8 4.1 16.5 25.9 12.2 11.9 16.2 21.8 42.0 9.6 11.1 12.8 33.1 5.4 12.0 12.1 11.9 3.5 7.5 4.5 3.3 4.3 4.3 4.3 5.5 2.6 4.9 3.9 3.7 7.3 3.6 2.7 4.2 4.7 3.0 5.4 7.5 15.2 9.4 5.5 5.9 6.4 6.6 3.9 7.8 4.3 6.5 12.5 14.0 16.0 7.8 0.0 15.1 0.0 7.5 0.0 17.1 19.7 12.1 10.2 0.0 2.8 6.2 12.9 35.5 15.6 14.0 4.8 13.7 6.2 1.8 13.7 14.0 10.7 7.3 13.5 0.0 4.3 7.7 9.2 10.2 10.1 2.5 17.2 12.8 7.3 8.6 15.2 0.0 12.0 0.0 7.9 0.0 2.0 11.5 9.0 0.0 0.0 7.3 8.9 14.4 0.0 0.0 5.9 4.4 12.4 20.1 14.1 8.4 10.1 6.6 22.8 13.1 11.5 10.6 25.8 12.3 15.0 0.0 21.1 13.3 12.3 8.1 11.7 PAGE5 "CT16.1, CT16.2, PAGE-5" ENSG00000158639 "PAGE family member 5" Q96GU1 X 55220346-55224108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 26.7" "Group enriched" "Detected in some" 7 "Spermatocytes: 131.0;Spermatogonia: 158.8" "Group enriched" "Detected in many" 6 "liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 13 "T-cells: 1.9" "Group enriched" "Detected in some" 170 "Karpas-707: 437.8;U-266/84: 992.7" "HPA052619, HPA055869" Supported Approved Mitochondria NA NA Mitochondria "HPA052619: AB_2681887, HPA055869: " "unprognostic (4.03e-1)" "unprognostic (4.51e-2)" "unprognostic (7.86e-4)" "unprognostic (1.39e-2)" "unprognostic (7.21e-2)" "unprognostic (1.06e-4)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.3 26.7 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 437.8 0.0 0.0 1.2 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.5 1.3 1.6 4.2 992.7 0.5 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 1.9 0.1 1.6 0.7 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 19.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 11.9 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 0.1 0.0 6.6 0.0 0.1 131.0 158.8 0.0 0.1 0.0 1.4 0.0 0.0 0.1 GPAT4 "AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7" ENSG00000158669 "Glycerol-3-phosphate acyltransferase 4" Q86UL3 8 41577187-41625001 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016471 Approved NA NA "HPA016471: AB_1844649" "unprognostic (3.05e-2)" "unprognostic (4.05e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (7.45e-2)" "unprognostic (2.99e-3)" "unprognostic (5.08e-2)" "unprognostic (5.11e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.98e-2)" "prognostic favorable (4.15e-4)" "unprognostic (1.73e-3)" "unprognostic (3.16e-2)" "unprognostic (3.35e-1)" "unprognostic (2.04e-2)" "prognostic favorable (5.65e-4)" 23.8 33.9 13.8 28.3 14.8 28.6 42.8 29.6 16.8 24.7 22.9 21.5 19.9 28.9 13.0 16.5 21.1 23.3 20.6 13.4 15.8 30.4 33.0 24.1 22.5 16.4 16.6 12.2 23.2 23.3 40.8 16.4 27.4 18.8 18.4 21.9 15.5 25.6 20.5 58.1 18.4 19.2 33.5 16.0 21.4 27.1 24.4 16.1 22.3 20.2 40.3 27.7 24.8 19.0 16.7 39.0 42.4 49.7 38.9 53.1 64.1 43.7 82.7 70.8 61.4 63.6 28.7 76.1 53.8 56.6 68.7 75.4 22.0 58.7 37.3 78.8 58.0 32.4 63.0 49.0 26.5 31.0 6.8 87.1 40.6 26.9 64.0 23.0 52.5 64.1 52.7 47.9 61.5 63.4 16.5 60.0 17.3 53.1 71.3 22.5 34.7 49.8 29.2 36.4 57.5 32.4 44.7 32.2 43.9 89.1 56.5 60.9 42.4 47.0 63.0 43.8 73.0 62.6 33.0 47.9 58.7 51.9 36.9 63.1 16.0 17.0 7.8 12.5 15.9 11.6 8.6 9.6 12.6 21.0 9.9 8.5 8.5 3.8 5.8 14.3 8.0 9.7 13.8 13.8 14.8 29.6 16.8 13.4 15.8 16.4 16.6 12.2 18.8 16.0 16.1 16.7 20.0 3.2 31.2 0.0 14.5 0.0 13.2 0.0 11.4 16.9 50.2 19.6 0.0 27.1 13.6 11.0 10.4 33.9 18.4 10.8 3.9 41.3 40.6 14.1 19.4 21.7 17.0 21.5 0.0 39.8 42.5 13.1 27.0 29.2 2.5 21.2 18.2 62.4 27.1 15.2 0.0 14.2 0.0 28.1 0.0 58.7 12.8 31.7 0.0 0.0 31.2 11.8 9.2 0.0 0.0 44.9 11.3 10.5 23.9 27.7 13.3 28.2 5.8 15.1 6.6 20.3 11.6 4.3 14.8 10.1 0.0 40.4 16.7 23.0 11.1 18.2 PKD1L1 PRO19563 ENSG00000158683 "Polycystin 1 like 1, transient receptor potential channel interacting" Q8TDX9 7 47740202-47948466 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "tongue: 3.3" "Cell type enhanced" "Detected in some" "Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7" "Not detected" "Not detected" "HPA020422, HPA022424" Uncertain NA NA "HPA020422: AB_1855434, HPA022424: AB_1855435" "unprognostic (5.47e-2)" "unprognostic (5.33e-3)" "unprognostic (1.49e-2)" "unprognostic (9.74e-2)" "unprognostic (4.03e-2)" "unprognostic (6.31e-2)" "unprognostic (2.52e-2)" "unprognostic (1.11e-1)" "unprognostic (9.63e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (1.88e-4)" "unprognostic (1.88e-3)" "unprognostic (2.56e-1)" "unprognostic (2.50e-1)" "unprognostic (1.90e-1)" 1.8 0.1 0.7 0.4 0.9 1.1 0.5 2.1 1.9 0.1 0.0 0.4 0.9 0.3 0.6 0.4 0.3 0.4 1.8 0.3 0.8 0.2 0.8 0.4 0.9 0.6 0.6 0.5 0.3 0.3 0.1 0.4 0.6 1.1 0.3 0.5 1.8 0.4 0.1 2.8 0.5 0.4 0.4 0.0 0.3 0.4 1.5 0.6 1.5 0.4 3.3 0.6 0.6 0.1 1.2 0.4 0.7 0.6 0.8 0.1 0.0 1.2 0.3 0.2 0.2 0.4 0.8 0.4 0.3 0.3 0.4 0.4 0.8 0.5 0.6 0.6 0.2 0.4 0.3 0.3 0.8 0.0 0.5 0.3 0.2 0.1 0.3 0.2 0.2 1.1 0.4 0.4 1.1 0.5 0.2 0.3 0.3 0.4 0.0 0.2 0.2 0.3 0.3 0.1 0.7 0.5 0.4 0.5 0.3 0.4 0.5 5.9 0.1 0.1 0.5 1.1 0.2 0.3 14.7 5.7 0.5 0.2 0.2 0.3 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.7 0.9 2.1 1.9 0.3 0.8 0.6 0.6 0.5 1.1 0.0 0.6 1.2 9.1 0.0 0.0 13.4 0.3 0.1 0.0 0.0 0.0 3.1 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.8 0.5 0.1 3.7 0.0 0.0 25.7 0.2 0.2 1.7 0.0 0.3 0.0 0.2 2.2 0.1 1.4 1.7 37.9 0.7 0.0 0.3 0.0 5.3 0.3 0.2 0.0 15.0 0.0 0.5 0.0 11.6 17.1 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.5 0.0 0.4 0.2 1.4 0.6 0.0 0.0 0.0 0.1 0.3 0.8 0.0 ZSCAN12 "dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96" ENSG00000158691 "Zinc finger and SCAN domain containing 12" O43309 6 28378955-28399734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006637, HPA007018" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA006637: AB_1080646, HPA007018: " "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (8.35e-4)" "unprognostic (1.51e-2)" "unprognostic (9.99e-2)" "unprognostic (1.00e-3)" "unprognostic (4.73e-2)" "unprognostic (9.96e-2)" "unprognostic (1.91e-2)" "unprognostic (2.35e-1)" "unprognostic (4.44e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" 2.1 2.4 1.9 2.6 2.1 2.2 5.7 3.7 2.5 3.7 1.6 2.6 2.5 4.4 3.7 1.8 3.0 2.3 2.4 1.9 2.3 2.9 1.6 3.0 4.7 2.0 2.2 1.8 5.5 3.3 4.0 2.0 3.6 2.3 4.4 3.0 6.8 3.1 3.8 0.9 1.8 2.7 3.6 1.7 3.9 2.9 4.1 2.1 5.2 5.2 1.8 4.1 3.1 2.9 2.1 5.5 1.8 8.1 0.1 4.1 3.2 5.7 3.7 5.1 5.5 7.6 1.2 2.0 5.3 6.8 2.6 2.8 2.4 0.0 4.6 5.6 0.0 6.6 7.6 5.6 3.8 3.8 2.7 1.8 4.2 4.3 5.5 9.9 6.0 1.5 0.0 11.4 1.1 3.5 0.6 0.0 6.1 5.1 0.5 0.9 9.2 7.3 1.4 4.1 3.5 9.8 10.0 1.9 4.3 6.4 8.0 1.7 6.7 1.5 2.2 4.6 1.7 3.0 3.1 3.4 1.0 1.9 0.7 3.4 2.4 0.7 1.5 1.5 0.4 1.4 1.8 1.1 1.8 1.0 2.7 1.8 1.6 0.2 1.8 0.8 0.9 0.9 0.8 1.9 2.1 3.7 2.5 1.9 2.3 2.0 2.2 1.8 2.3 1.7 2.1 2.1 2.1 6.4 5.1 4.6 4.0 0.4 1.1 0.9 0.6 6.1 2.6 2.5 3.2 1.5 6.5 0.0 4.2 1.5 3.6 0.3 1.9 1.7 31.8 0.6 2.4 1.9 1.2 2.1 6.9 2.6 1.0 2.7 1.5 0.9 1.3 5.5 3.3 1.0 1.0 6.7 7.0 1.2 0.0 1.3 1.1 9.7 1.8 1.1 1.8 1.0 1.8 4.9 2.1 10.1 6.2 1.3 0.3 3.4 2.4 1.5 1.5 1.2 0.6 6.0 6.6 1.7 2.4 12.6 3.9 1.2 0.3 0.5 1.5 4.2 2.1 0.7 TAGLN2 "HA1756, KIAA0120" ENSG00000158710 "Transgelin 2" P37802 1 159918107-159925507 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 2404.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA001925 Approved Approved "Actin filaments,Cytosol" "Intracellular and membrane" NA NA 270000000 Cytosol "Actin filaments" "HPA001925: AB_1857756" "prognostic unfavorable (2.06e-5)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (7.07e-5)" "unprognostic (4.61e-2)" "unprognostic (1.50e-1)" "unprognostic (3.21e-1)" "unprognostic (3.56e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.92e-10)" "unprognostic (1.81e-1)" "unprognostic (9.22e-2)" "unprognostic (3.95e-2)" "unprognostic (2.50e-2)" 380.4 155.9 103.9 359.2 100.9 441.1 358.5 107.2 115.9 248.7 106.1 340.6 317.2 222.3 95.7 498.0 234.0 285.1 343.9 98.5 178.7 269.3 256.5 693.7 323.7 139.6 114.3 93.5 172.3 287.0 81.7 100.8 381.4 123.7 210.3 310.9 46.5 391.9 207.1 84.1 409.5 359.3 256.7 122.5 483.6 705.1 128.0 129.1 312.4 211.9 140.8 389.5 440.3 352.9 117.8 1382.3 723.7 22.3 8.3 266.8 646.6 835.4 760.0 872.6 1635.2 799.8 786.6 1049.3 862.0 628.0 954.9 495.0 1054.3 378.1 1039.9 978.8 974.3 355.5 1140.7 651.8 50.0 322.7 808.2 1221.4 667.4 776.9 1030.4 504.3 1134.7 1029.0 260.3 494.8 578.9 586.1 563.0 378.1 601.2 619.3 947.6 1457.7 2.9 391.7 1275.3 376.6 527.7 340.7 325.6 900.7 1435.1 410.3 1190.6 756.5 814.2 1147.3 955.1 1134.4 876.9 2078.0 230.8 110.6 525.0 1238.3 541.3 603.8 1458.4 742.0 3160.6 558.9 449.7 499.9 866.5 620.0 544.6 1177.7 680.2 321.6 360.3 3746.8 817.6 356.9 1966.4 756.1 2257.9 103.9 100.9 107.2 115.9 98.5 178.7 139.6 114.3 93.5 123.7 122.5 129.1 117.8 617.1 179.5 130.5 0.3 507.8 549.1 330.6 454.3 307.9 31.6 257.0 201.8 12.8 121.5 221.4 183.9 18.8 497.4 567.6 371.0 74.3 1273.4 54.3 289.4 145.9 509.6 317.8 197.6 0.1 1206.9 2404.5 405.2 545.3 242.7 418.8 32.0 265.2 64.1 443.7 3.3 0.6 445.5 284.8 285.9 952.4 85.9 118.7 651.5 334.4 16.9 911.4 66.3 186.4 0.5 1.6 877.4 263.2 63.9 393.4 337.5 324.2 208.2 275.9 25.6 184.1 358.3 324.3 14.3 20.7 494.1 572.5 230.4 393.6 136.7 271.7 405.9 ELK4 SAP1 ENSG00000158711 "ETS transcription factor ELK4" P28324 1 205597556-205632011 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 104.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 6.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028863 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA028863: AB_10602492" "unprognostic (2.08e-1)" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (2.15e-1)" "prognostic favorable (4.65e-4)" "unprognostic (2.97e-1)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.27e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.94e-6)" "unprognostic (2.21e-2)" "unprognostic (1.26e-1)" "unprognostic (1.08e-1)" "unprognostic (5.58e-3)" 8.9 5.0 7.5 11.6 10.6 11.8 8.1 12.6 8.4 7.9 8.7 6.8 6.1 7.7 7.2 8.0 6.8 9.3 6.9 5.6 7.7 7.9 13.3 9.8 17.6 8.6 9.3 5.1 6.8 8.2 7.9 5.5 8.0 10.3 26.2 6.9 9.3 8.2 5.7 10.7 13.6 9.7 6.1 9.7 15.9 7.7 7.4 9.6 14.3 7.0 8.8 17.0 9.7 9.4 13.8 14.9 13.2 5.1 13.3 11.9 15.2 12.9 9.8 10.1 7.6 8.9 5.7 14.6 31.3 9.0 12.2 5.7 18.0 10.9 12.0 13.1 35.9 7.7 13.6 22.0 12.2 16.1 25.7 51.8 13.4 14.5 12.0 24.4 14.7 32.3 14.8 12.7 25.6 10.7 20.1 21.3 9.5 8.5 3.4 7.8 15.7 31.2 25.4 10.2 32.0 5.9 7.0 25.2 13.7 17.3 8.9 12.7 8.5 23.5 15.3 17.8 13.7 18.8 19.1 18.9 21.1 13.3 10.3 18.2 6.6 0.4 0.7 0.8 0.5 1.1 0.7 0.9 1.1 0.6 1.1 1.1 1.6 0.2 0.6 0.3 0.8 1.0 0.4 7.5 10.6 12.6 8.4 5.6 7.7 8.6 9.3 5.1 10.3 9.7 9.6 13.8 50.7 9.6 16.2 7.2 39.3 39.4 35.3 19.0 9.6 104.8 15.1 11.9 20.8 34.3 17.8 31.3 12.5 15.6 34.0 13.8 3.9 14.7 17.4 37.7 37.4 40.1 13.1 21.4 22.8 17.8 6.2 23.2 18.3 82.5 28.5 12.8 36.4 30.2 10.0 25.2 11.7 18.3 14.2 23.5 39.1 19.5 25.4 22.3 30.2 27.2 22.3 11.2 39.1 17.6 28.0 17.5 9.0 15.4 18.6 71.3 14.4 17.5 24.9 26.9 26.3 28.5 21.4 24.6 11.6 19.2 48.6 18.3 32.6 16.7 17.5 103.1 SLAMF8 "BLAME, CD353, SBBI42" ENSG00000158714 "SLAM family member 8" Q9P0V8 1 159826811-159837492 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.1" "Group enriched" "Detected in some" 9 "Hofbauer cells: 36.9;Kupffer cells: 19.8;Langerhans cells: 61.8;Macrophages: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 14.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.7;HL-60: 1.4;U-138 MG: 1.9;U-87 MG: 1.0;U-937: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067601 Enhanced NA NA "HPA067601: AB_2685870" "unprognostic (1.04e-1)" "unprognostic (8.80e-3)" "unprognostic (5.12e-2)" "unprognostic (2.14e-3)" "unprognostic (3.07e-2)" "unprognostic (3.22e-2)" "unprognostic (7.87e-2)" "unprognostic (4.29e-1)" "unprognostic (2.20e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.50e-1)" "unprognostic (4.42e-2)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" 6.9 3.7 2.0 30.0 2.2 0.9 3.1 1.8 6.3 3.9 5.5 7.7 6.7 1.5 0.7 4.3 2.8 8.1 2.3 1.6 8.6 3.9 3.3 16.2 33.1 5.2 3.3 1.2 2.9 2.2 0.6 3.5 5.6 3.5 2.5 9.6 0.3 3.5 1.4 0.9 2.8 9.4 7.6 2.3 11.8 5.0 0.8 7.8 10.6 3.0 0.6 17.8 10.4 2.2 9.3 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 1.0 1.2 0.0 0.0 5.8 0.0 3.5 8.0 0.2 0.0 1.2 4.6 14.3 0.0 0.2 2.7 0.5 8.8 0.5 0.1 0.0 3.1 2.0 2.2 1.8 6.3 1.6 8.6 5.2 3.3 1.2 3.5 2.3 7.8 9.3 0.3 0.0 2.3 0.0 1.0 1.8 0.0 0.0 0.0 0.4 0.1 0.4 0.3 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.0 0.4 0.1 0.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.2 36.9 0.0 0.1 0.0 0.0 19.8 61.8 0.0 0.3 41.1 0.0 1.0 1.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 2.9 0.1 0.0 0.0 1.0 0.5 1.3 0.0 0.0 0.0 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680509 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "prostate: 309.1" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 19.9;granulocytes: 119.2;Oligodendrocytes: 47.1;Prostatic glandular cells: 67.2" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 382 "basophil: 40.5" "Lineage enriched" "Detected in single" 382 "granulocytes: 40.5" "Cell line enriched" "Detected in many" 29 "HMC-1: 834.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.33e-5)" 1.3 3.6 6.2 3.2 14.9 0.8 1.6 14.6 9.7 3.8 0.3 4.8 4.6 1.7 0.5 1.6 2.1 3.9 1.5 5.1 10.2 2.2 11.3 3.5 2.7 18.4 15.4 2.2 2.7 0.8 0.3 4.7 0.5 18.9 309.1 3.2 0.2 2.8 0.6 5.7 1.4 4.8 1.0 13.7 12.5 17.0 1.4 13.3 0.5 1.0 2.3 0.8 2.8 1.1 42.3 9.7 3.0 2.8 2.7 0.0 0.1 2.2 1.3 0.3 3.3 2.7 7.1 18.0 2.7 4.6 0.3 3.0 3.5 1.6 3.3 0.5 3.9 2.9 29.0 0.6 2.0 1.9 5.0 834.2 0.3 1.1 2.3 0.0 2.2 9.4 4.5 4.9 1.7 1.4 2.3 0.8 8.5 12.2 16.7 10.7 1.0 4.1 1.5 3.7 13.7 1.2 2.9 1.5 20.6 3.9 2.3 4.7 1.4 9.6 1.4 9.5 3.5 7.1 0.4 0.6 0.4 1.8 1.5 7.1 40.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.2 14.9 14.6 9.7 5.1 10.2 18.4 15.4 2.2 18.9 13.7 13.3 42.3 0.2 0.0 3.2 1.0 4.0 0.0 1.0 0.6 0.0 0.4 1.5 1.8 2.0 2.8 1.0 1.8 0.0 0.5 0.1 5.7 0.0 1.7 0.2 1.9 0.2 1.7 0.0 3.4 0.2 0.5 0.1 0.7 19.9 0.2 119.2 0.2 0.7 6.6 1.9 0.0 0.3 6.9 2.0 1.0 0.3 0.4 1.8 2.0 0.0 0.0 0.6 0.1 0.0 2.0 47.1 3.9 8.0 1.5 0.3 67.2 0.9 1.8 3.2 0.1 6.6 0.1 0.8 0.0 2.6 0.4 0.1 0.0 0.9 0.2 6.7 0.9 DUSP23 "DUSP25, FLJ20442" ENSG00000158716 "Dual specificity phosphatase 23" Q9BVJ7 1 159780932-159782543 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 458.5;Proximal tubular cells: 800.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 142.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028211, HPA045792" Approved Supported Nucleoplasm NA NA 22000 Nucleoplasm "HPA028211: AB_2672522, HPA045792: AB_10961133" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-2)" "unprognostic (4.36e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.16e-1)" "unprognostic (4.62e-1)" "unprognostic (3.33e-3)" "unprognostic (4.72e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (8.58e-2)" "unprognostic (2.84e-2)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" 74.7 123.4 26.7 15.5 28.9 20.7 100.8 29.3 38.8 53.0 27.6 38.4 27.0 55.4 15.7 82.6 52.7 13.5 35.7 29.0 28.7 197.8 190.8 55.8 10.5 29.7 27.4 26.0 35.9 77.4 34.9 20.9 5.9 29.5 55.8 14.0 8.2 153.7 15.4 66.0 58.1 43.3 12.1 30.6 39.5 40.1 18.3 30.1 15.4 59.3 16.8 9.2 45.5 54.0 28.9 39.5 42.2 0.3 0.2 39.5 33.5 0.4 15.8 13.0 18.4 14.3 17.3 44.7 0.1 90.9 17.6 4.2 1.5 10.8 14.5 10.0 9.9 4.6 54.4 14.7 0.0 58.6 33.3 40.4 142.8 38.3 12.1 43.0 13.2 71.0 0.1 25.2 19.4 26.3 72.5 3.5 1.4 71.3 71.6 58.7 0.1 0.0 18.8 22.7 6.9 17.8 39.4 28.6 63.0 78.5 7.3 40.6 51.7 51.7 15.3 0.8 1.9 0.2 13.5 34.8 0.5 25.8 26.5 11.7 111.8 181.7 229.1 97.9 153.4 54.6 60.5 72.7 92.8 261.3 43.7 44.0 65.1 185.6 100.5 105.6 59.2 70.8 112.2 26.7 28.9 29.3 38.8 29.0 28.7 29.7 27.4 26.0 29.5 30.6 30.1 28.9 100.4 41.7 58.7 3.3 23.8 74.6 129.2 151.8 100.7 8.5 110.6 112.1 29.5 95.8 122.2 51.5 6.2 16.1 28.4 97.7 262.2 210.7 48.3 47.5 30.8 155.8 35.4 37.5 1.4 458.5 29.2 31.2 32.1 130.9 54.5 66.1 75.0 249.4 170.3 1.7 0.5 124.9 91.6 94.3 72.9 8.4 26.4 92.2 42.7 4.7 58.9 74.8 69.0 1.0 4.4 208.4 112.2 15.8 14.6 121.5 140.4 800.7 54.8 10.0 13.1 16.0 34.9 5.4 19.9 123.2 74.4 5.7 43.6 72.3 109.5 116.1 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696499-88706408 "Enzymes, Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 92.0;lymphoid tissue: 102.4" "Cell type enhanced" "Detected in all" "dendritic cells: 132.3;NK-cells: 111.2;T-cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 108.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 20.8 18.5 12.9 29.1 13.5 92.0 16.2 11.7 24.7 16.7 13.0 18.1 14.3 16.7 3.2 11.9 20.1 14.1 20.0 12.2 12.9 20.8 23.5 48.7 40.7 15.6 12.7 11.3 18.0 19.6 5.4 17.8 8.3 17.6 19.9 5.0 3.5 15.0 5.9 21.5 11.5 37.5 6.4 12.4 102.4 17.9 12.9 14.2 18.2 19.0 8.3 21.2 18.3 14.6 16.1 10.3 15.9 12.5 18.4 5.8 5.0 23.3 10.3 6.5 11.8 5.3 11.1 6.4 12.4 13.0 6.0 6.8 11.1 7.2 6.8 4.7 6.4 21.7 16.7 12.4 18.7 15.9 16.7 20.4 6.0 6.4 9.4 8.2 6.9 12.4 20.6 28.6 8.8 5.0 20.3 38.9 108.0 20.3 4.4 21.5 36.3 7.8 32.2 5.3 4.5 11.8 12.3 23.9 4.8 12.1 5.9 13.4 53.3 18.6 8.7 13.4 13.5 12.5 19.9 13.5 31.6 7.8 62.8 12.4 7.0 25.6 61.3 31.6 19.1 27.7 4.2 19.3 27.6 23.8 3.9 15.7 22.9 40.4 11.3 22.7 14.8 21.8 21.6 12.9 13.5 11.7 24.7 12.2 12.9 15.6 12.7 11.3 17.6 12.4 14.2 16.1 15.2 9.6 3.6 7.8 23.5 4.8 4.6 2.4 6.2 10.1 6.0 7.1 2.8 4.3 3.1 7.3 6.2 8.8 132.3 2.3 9.8 6.5 1.4 5.2 7.4 11.0 4.9 13.7 6.5 9.2 9.6 8.8 8.2 4.9 21.0 12.3 8.6 4.8 38.8 8.4 4.8 3.1 2.0 46.7 32.4 2.5 9.3 52.4 10.6 15.0 41.5 11.7 111.2 3.5 4.5 5.5 1.0 7.9 55.1 4.5 1.8 7.0 4.7 9.6 6.6 8.9 10.0 9.1 9.9 4.8 5.8 3.7 73.1 12.2 3.7 1.9 NBL1 "D1S1733E, DAN, DAND1, NB, NO3" ENSG00000158747 "NBL1, DAN family BMP antagonist" P41271 1 19596979-19658456 "Predicted intracellular proteins, Predicted secreted proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 395.1;Leydig cells: 386.8;Paneth cells: 313.2;Peritubular cells: 356.9;Prostatic glandular cells: 293.3;Proximal enterocytes: 413.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 431.7;HSkMC: 305.6;SK-MEL-30: 473.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007394, CAB026132" Uncertain "Secreted in other tissues" NA NA 8100000 "CAB026132: , HPA007394: AB_10601272" "unprognostic (1.65e-1)" "unprognostic (1.65e-2)" "unprognostic (9.03e-2)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (3.92e-1)" "unprognostic (7.88e-2)" "unprognostic (3.10e-2)" "unprognostic (1.92e-2)" "unprognostic (1.39e-2)" "unprognostic (1.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.21e-2)" "unprognostic (2.26e-2)" 164.5 28.0 107.9 61.9 107.3 5.7 184.9 83.8 157.2 620.9 121.8 231.1 196.8 256.0 48.7 208.5 283.9 204.3 112.9 134.7 105.5 66.7 5.9 314.7 57.8 94.3 99.1 98.5 641.2 27.3 48.7 126.3 21.8 100.7 379.2 110.4 14.6 65.9 114.5 26.8 198.1 316.7 114.0 82.5 26.0 141.1 44.8 104.6 25.5 86.6 28.7 22.6 248.6 377.0 99.5 138.8 42.9 7.2 38.5 431.7 222.7 19.7 195.5 238.6 64.1 64.7 11.8 242.6 0.2 122.2 245.7 44.8 153.4 40.8 180.1 19.6 132.9 23.0 6.8 40.5 72.4 69.4 0.5 3.1 305.6 162.0 94.6 57.6 19.1 48.7 8.0 1.4 0.4 20.6 20.4 0.4 11.7 2.9 142.3 65.2 6.4 0.1 4.7 122.5 16.6 3.1 102.2 31.2 1.2 473.8 7.1 160.2 24.3 68.9 62.4 49.7 180.0 30.3 0.9 1.1 0.8 45.4 0.6 19.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.4 0.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.1 107.9 107.3 83.8 157.2 134.7 105.5 94.3 99.1 98.5 100.7 82.5 104.6 99.5 150.4 3.2 2.3 0.0 2.9 174.6 237.3 22.6 107.0 35.5 41.5 32.8 43.5 55.8 11.9 36.8 6.2 1.0 5.1 395.1 3.9 43.0 2.0 15.6 55.7 84.3 54.5 3.4 0.0 7.7 2.6 241.4 39.8 10.1 13.4 80.9 47.8 1.5 54.6 6.7 0.0 244.6 12.2 2.2 76.6 13.1 386.8 6.6 60.5 0.0 5.8 13.4 0.0 0.0 0.0 97.5 313.2 356.9 1.1 293.3 413.8 19.7 24.5 10.2 131.5 14.0 142.9 1.4 7.6 61.4 202.4 1.4 29.6 15.1 220.4 206.5 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19664875-19680966 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "brain: 7.7" "Cell type enhanced" "Detected in single" "Excitatory neurons: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enhanced" "Detected in many" "basal ganglia: 7.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 2.0" "Low region specificity" "Detected in many" HPA068165 Uncertain NA NA "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.0 0.0 0.7 0.2 7.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.2 1.9 0.0 1.8 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.7 0.0 2.2 0.6 1.5 1.9 0.0 1.8 3.7 0.0 0.8 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITLN2 HL-2 ENSG00000158764 "Intelectin 2" Q8WWU7 1 160945025-160954809 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "intestine: 411.7" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 76.9" "Group enriched" "Detected in many" 4 "colorectal cancer: 2.8;testis cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 11.9;HHSteC: 1.9;HMC-1: 3.4;SK-MEL-30: 4.0;SuSa: 3.8" "Low region specificity" "Detected in all" "HPA006683, HPA067326" Enhanced "Secreted to digestive system" NA NA "HPA006683: AB_2129681, HPA067326: AB_2732764" "unprognostic (1.42e-1)" "unprognostic (9.62e-3)" "unprognostic (4.61e-2)" "unprognostic (7.45e-2)" "unprognostic (2.25e-1)" "unprognostic (6.84e-4)" "unprognostic (2.47e-2)" "unprognostic (5.74e-2)" "unprognostic (1.31e-2)" "unprognostic (1.36e-1)" "unprognostic (5.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.49e-1)" "unprognostic (2.31e-1)" "unprognostic (4.91e-2)" 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 240.9 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.4 11.8 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.2 411.7 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 1.9 0.0 3.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 4.0 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.9 5.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.3 1.4 0.0 0.2 0.0 0.4 11.0 0.3 0.1 0.0 0.0 5.0 0.0 0.3 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 5.3 0.0 0.6 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 6.3 17.5 0.4 F11R "CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1" ENSG00000158769 "F11 receptor" Q9Y624 1 160995211-161021343 "CD markers, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 253.2;Urothelial cells: 242.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 165.5;neutrophil: 113.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 165.5" "Cell line enhanced" "Detected in many" "HaCaT: 205.4;OE19: 202.4;SuSa: 232.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004671, HPA043616, HPA061700" Enhanced Supported "Cell Junctions,Microtubules" NA NA 1900000 Microtubules "Cell Junctions" "CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589" "unprognostic (1.60e-2)" "unprognostic (5.78e-3)" "unprognostic (1.78e-3)" "unprognostic (2.24e-1)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (2.28e-1)" "unprognostic (2.55e-1)" "unprognostic (6.35e-2)" "unprognostic (1.98e-3)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (1.59e-1)" "unprognostic (9.72e-3)" "unprognostic (5.01e-2)" 20.6 24.7 6.4 21.0 6.3 21.5 27.0 5.8 8.3 20.7 9.3 53.1 56.4 12.0 21.3 86.2 33.4 28.9 12.4 5.8 7.8 36.7 74.2 67.7 13.3 7.0 6.2 5.1 14.1 42.1 36.6 18.9 51.1 6.8 28.9 52.2 2.2 49.8 21.4 6.1 45.4 64.5 9.1 6.5 21.7 53.1 13.1 7.5 16.6 39.6 6.3 32.2 52.7 44.5 8.0 122.9 15.5 4.7 1.4 3.3 0.2 95.5 0.6 0.1 4.0 4.1 113.5 155.9 8.9 78.6 0.2 22.6 205.4 25.3 105.2 6.4 6.9 17.8 25.8 6.2 52.3 4.8 24.2 72.6 1.4 132.5 0.6 32.7 24.1 98.6 18.8 35.6 2.5 0.6 53.5 7.6 13.6 80.1 202.4 21.9 11.3 0.0 39.2 67.2 94.4 34.3 8.8 29.2 123.4 26.2 232.8 132.6 41.7 58.8 0.3 3.0 0.4 1.2 28.2 59.3 3.1 18.0 23.4 7.5 34.6 31.0 165.5 12.6 16.3 6.7 4.7 11.7 8.0 24.6 2.9 11.1 8.8 113.4 8.2 13.0 18.7 5.7 25.1 6.4 6.3 5.8 8.3 5.8 7.8 7.0 6.2 5.1 6.8 6.5 7.5 8.0 27.7 253.2 137.2 0.0 9.8 35.2 119.7 86.2 64.3 0.9 35.0 15.5 3.3 67.2 136.2 77.3 2.1 78.6 10.2 154.9 7.9 76.8 7.2 120.8 13.9 41.5 62.2 10.3 2.7 71.0 176.2 9.1 66.8 150.9 18.3 13.7 34.2 68.8 31.0 0.0 1.1 71.5 46.8 14.4 25.5 2.1 2.1 24.7 8.8 7.5 48.7 1.5 13.4 3.0 0.4 91.4 114.1 0.7 10.8 135.3 82.5 12.6 178.8 2.4 0.0 5.1 6.2 13.4 2.9 102.3 50.6 63.1 12.3 8.1 50.7 242.0 USF1 "bHLHb11, MLTFI, UEF" ENSG00000158773 "Upstream transcription factor 1" P22415 1 161039251-161045977 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001480, HPA036233, HPA036535" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178" "unprognostic (3.66e-2)" "unprognostic (2.79e-2)" "unprognostic (9.12e-3)" "unprognostic (2.17e-1)" "unprognostic (9.40e-2)" "prognostic favorable (8.70e-4)" "unprognostic (1.59e-3)" "unprognostic (2.94e-2)" "unprognostic (3.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (6.01e-12)" "unprognostic (1.24e-3)" "unprognostic (3.29e-1)" "unprognostic (4.08e-1)" "prognostic favorable (1.95e-5)" 15.2 18.4 25.1 19.0 25.4 17.6 14.0 25.4 26.4 14.9 24.8 18.6 18.7 14.4 14.4 13.9 17.0 14.8 18.6 25.4 25.6 15.8 21.2 18.5 28.0 25.2 24.8 24.9 16.9 11.5 20.7 11.5 18.2 26.0 15.2 18.4 17.1 14.1 18.4 33.0 15.4 19.8 18.3 25.2 30.8 15.0 7.7 26.4 36.3 13.0 29.7 32.9 20.9 13.8 25.9 17.2 25.5 29.9 35.0 39.4 22.3 39.9 14.0 30.3 42.9 33.3 17.9 21.2 22.1 29.0 23.5 18.6 21.0 35.6 22.3 24.0 20.6 21.2 19.1 20.9 18.9 23.0 26.7 25.4 18.3 22.0 31.1 25.1 27.3 40.7 36.8 31.7 23.1 27.2 20.1 41.5 29.2 61.8 37.0 32.9 35.6 23.3 26.9 21.0 26.8 16.9 32.3 25.5 32.8 18.1 42.9 27.5 85.5 24.0 21.5 13.5 13.2 23.1 19.5 26.6 34.3 18.3 25.9 16.7 2.5 2.6 1.4 1.9 2.1 1.1 1.5 1.1 1.3 2.6 1.7 1.2 1.2 4.1 0.9 2.1 2.7 1.3 1.3 25.1 25.4 25.4 26.4 25.4 25.6 25.2 24.8 24.9 26.0 25.2 26.4 25.9 13.1 6.4 6.9 3.6 18.0 2.3 0.6 3.1 9.1 3.3 2.7 3.9 1.0 0.0 3.2 3.7 2.1 2.2 14.5 7.1 1.9 2.1 0.4 5.5 8.1 6.0 3.0 5.0 6.3 1.3 4.4 4.6 14.8 5.6 11.4 4.0 1.1 0.4 3.1 5.0 5.4 3.4 6.1 2.1 3.5 0.2 0.3 12.4 5.4 4.7 4.7 1.6 4.1 4.0 5.8 2.3 7.1 0.0 20.0 1.6 7.3 3.1 7.9 3.5 6.6 3.3 4.9 0.5 0.4 8.5 1.8 3.4 9.3 7.7 4.9 1.9 PLA2G2F ENSG00000158786 "Phospholipase A2 group IIF" Q9BZM2 1 20139323-20150381 "Enzymes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Innate immunity, Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "lymphoid tissue: 8.0;skin 1: 14.6;urinary bladder: 11.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.7" "Cancer enriched" "Detected in some" 18 "urothelial cancer: 17.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 69 "RT4: 139.2" "Region enriched" "Detected in single" 4 "hippocampal formation: 3.0" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.79e-2)" "unprognostic (5.11e-2)" "unprognostic (4.63e-2)" "unprognostic (4.83e-2)" "unprognostic (1.51e-1)" "unprognostic (1.61e-2)" "unprognostic (3.36e-5)" "unprognostic (7.06e-2)" "unprognostic (1.84e-1)" "unprognostic (4.69e-1)" "prognostic favorable (3.86e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 8.0 11.8 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.9 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696357-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 5.3 5.1 5.1 2.4 6.1 5.0 4.9 3.6 8.4 3.8 4.0 5.2 6.0 6.1 0.7 5.8 6.3 2.3 4.5 7.2 7.1 9.4 13.7 7.1 1.6 4.3 3.3 6.5 5.5 14.3 2.2 16.8 1.8 4.2 6.0 0.9 0.6 5.7 1.3 1.3 7.4 7.1 1.4 2.6 6.0 7.0 4.9 5.1 1.8 7.1 0.3 0.8 3.8 3.5 5.7 7.4 5.8 2.0 9.6 1.5 1.6 10.7 4.9 2.3 2.3 1.5 11.1 6.2 2.5 6.6 1.6 3.1 12.5 1.8 2.8 0.5 2.5 19.9 1.7 2.2 15.3 5.1 1.3 5.0 1.6 3.5 3.6 1.1 2.6 2.6 2.9 7.7 1.7 1.6 34.0 4.3 8.0 5.4 7.6 7.5 9.4 1.0 7.4 3.4 2.6 11.0 7.0 5.3 5.4 6.5 0.9 14.0 5.7 6.7 2.3 8.5 0.4 2.3 4.2 2.8 2.3 6.9 4.1 4.4 2.8 4.0 5.3 5.5 6.5 3.9 3.7 3.9 4.2 4.4 4.1 3.5 3.9 13.7 2.1 4.9 4.6 3.7 4.1 5.1 6.1 3.6 8.4 7.2 7.1 4.3 3.3 6.5 4.2 2.6 5.1 5.7 5.9 3.2 0.5 2.3 10.8 15.7 18.7 7.7 5.2 9.5 11.0 6.6 0.4 7.2 3.1 11.0 0.0 8.7 18.4 27.8 1.9 13.7 7.4 7.6 3.2 6.3 23.8 0.0 13.6 13.8 5.7 6.4 9.2 9.3 4.5 2.1 6.1 5.7 7.4 3.3 7.1 7.6 14.2 6.1 13.2 1.5 2.8 9.1 8.8 2.8 4.3 6.6 8.2 2.5 1.3 12.7 21.8 2.2 8.6 12.7 32.3 10.3 1.5 8.0 0.0 9.3 7.0 2.7 2.5 2.6 19.9 24.9 10.5 4.7 9.3 11.7 NIT1 ENSG00000158793 "Nitrilase 1" Q86X76 1 161118086-161125445 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 101.5;Proximal tubular cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006657 Approved NA NA 89000 "HPA006657: AB_1079485" "unprognostic (3.66e-2)" "unprognostic (1.15e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-2)" "unprognostic (1.55e-1)" "unprognostic (2.16e-1)" "unprognostic (4.70e-2)" "unprognostic (2.52e-3)" "unprognostic (2.18e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (2.00e-1)" "unprognostic (1.76e-1)" "unprognostic (2.52e-2)" "unprognostic (2.94e-2)" 21.5 62.2 21.8 12.6 22.2 9.4 22.0 22.2 23.7 22.2 23.4 27.3 27.0 20.1 17.6 22.7 19.9 11.1 26.1 22.0 23.8 39.8 63.8 21.0 14.6 23.2 21.9 22.0 21.2 30.0 29.8 28.3 11.9 23.5 24.6 19.4 12.4 20.4 18.3 22.9 20.7 32.9 15.1 21.6 26.8 23.3 16.9 22.6 17.9 25.7 17.5 14.8 22.3 20.3 22.9 19.5 27.0 26.7 7.6 34.7 20.7 15.7 15.5 21.2 18.0 16.6 18.3 35.8 21.1 24.3 21.1 25.1 19.8 15.7 34.2 14.9 18.1 13.5 14.3 17.3 20.3 26.4 9.0 10.9 25.4 33.4 34.2 35.2 29.3 25.7 31.1 15.6 12.7 28.4 17.1 17.7 11.1 11.8 35.5 22.8 18.9 14.5 26.5 37.3 12.1 10.8 14.6 20.9 31.9 20.9 51.7 35.1 20.1 15.6 7.9 18.1 13.8 11.7 41.3 25.3 18.5 16.5 8.3 11.4 43.0 20.5 19.3 10.3 18.7 10.7 11.5 10.9 8.5 17.0 11.2 10.2 8.9 15.5 9.1 25.5 18.3 12.0 11.7 21.8 22.2 22.2 23.7 22.0 23.8 23.2 21.9 22.0 23.5 21.6 22.6 22.9 18.7 19.2 15.6 13.4 15.1 8.7 22.3 32.6 18.2 13.3 17.3 19.3 6.6 35.8 20.6 23.9 18.8 47.4 19.3 43.0 64.6 31.6 7.0 17.8 11.6 16.5 11.5 13.9 11.4 30.9 29.0 15.6 20.4 15.9 12.0 20.2 17.2 63.8 40.3 18.5 11.9 24.9 20.3 15.2 12.3 4.9 16.1 19.7 16.0 15.9 21.8 24.6 13.4 8.0 19.0 25.7 25.9 22.6 17.6 14.1 101.5 116.1 25.9 17.7 39.5 12.9 16.7 33.5 22.5 15.6 12.8 56.0 12.5 35.2 28.8 21.0 DEDD "CASP8IP1, DEDD1, DEFT, FLDED1, KE05" ENSG00000158796 "Death effector domain containing" O75618 1 161120974-161132688 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064486, HPA065101, HPA073628" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA064486: , HPA065101: , HPA073628: AB_2732230" "unprognostic (2.24e-1)" "unprognostic (2.38e-1)" "unprognostic (4.81e-2)" "unprognostic (5.09e-2)" "unprognostic (4.20e-3)" "unprognostic (5.94e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.52e-1)" "unprognostic (8.70e-2)" "unprognostic (7.66e-3)" "unprognostic (2.33e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (1.53e-1)" "unprognostic (1.34e-1)" "unprognostic (4.06e-2)" "unprognostic (1.43e-2)" 33.2 21.5 20.6 19.6 21.6 30.1 29.2 21.7 20.9 25.7 18.8 27.8 21.0 24.9 15.0 26.1 26.8 21.4 23.2 20.1 22.7 20.9 24.5 28.8 21.3 20.9 20.7 19.9 28.3 21.4 18.3 18.1 22.3 20.7 23.2 13.9 24.2 20.8 15.9 57.2 28.9 23.7 21.2 21.2 28.1 22.6 28.3 20.8 22.7 24.4 35.3 18.5 27.1 25.3 22.2 24.7 24.0 27.7 24.3 21.0 22.2 19.1 20.7 29.3 23.5 26.1 16.7 41.5 26.2 20.4 31.2 17.2 22.0 21.2 32.5 15.1 26.3 23.1 24.5 30.2 22.7 37.0 17.3 35.5 26.8 34.2 25.3 40.1 31.2 38.5 35.6 21.3 38.3 27.8 38.8 42.4 18.9 46.5 49.1 24.5 34.1 19.1 35.0 23.8 29.6 29.3 44.2 21.1 55.1 37.0 29.9 33.0 34.8 27.3 25.6 27.2 30.0 30.6 52.2 35.6 46.9 30.6 18.5 18.6 64.0 36.9 52.8 27.8 34.6 23.7 24.0 27.4 27.9 33.3 22.7 30.6 25.1 41.2 27.7 38.0 29.2 38.4 31.4 20.6 21.6 21.7 20.9 20.1 22.7 20.9 20.7 19.9 20.7 21.2 20.8 22.2 27.8 25.6 9.3 8.5 16.7 25.2 13.9 11.5 14.2 6.8 10.5 8.0 10.6 18.6 10.1 9.2 6.2 19.6 16.2 12.9 23.5 13.6 42.6 9.5 8.3 22.3 11.3 13.7 4.8 19.3 19.6 13.3 15.8 11.3 16.5 7.7 21.0 10.7 14.8 13.5 5.1 8.1 2.0 19.8 27.2 43.5 11.8 16.2 14.2 4.7 20.9 6.7 8.2 5.0 10.8 15.6 13.2 9.8 24.2 10.2 12.5 13.7 7.4 13.2 6.6 12.0 16.5 23.5 18.4 22.2 24.9 27.0 15.0 5.7 9.7 17.4 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 63.5;NK-cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 12.6 12.8 11.1 14.2 21.1 10.4 13.0 16.0 12.4 9.5 11.5 10.8 10.1 3.5 19.2 14.6 5.3 9.2 12.0 11.7 11.9 14.4 12.1 17.0 15.0 13.4 11.7 16.1 13.7 4.4 14.7 4.9 16.5 13.5 5.8 3.8 11.8 4.2 10.7 17.5 19.7 4.5 11.6 27.1 12.1 9.4 13.8 8.2 12.9 4.6 10.7 10.9 14.5 19.9 6.6 5.5 4.8 11.8 3.7 5.4 7.9 5.2 3.0 4.6 1.7 7.4 7.4 8.4 4.6 5.2 2.1 12.1 6.0 5.6 3.1 5.4 25.8 7.9 12.0 3.1 6.8 7.7 9.7 7.3 7.2 6.2 4.7 4.5 5.9 7.7 13.9 7.8 1.9 9.9 9.1 19.3 3.2 7.1 10.6 14.4 5.5 6.0 5.5 3.9 11.5 10.0 9.4 8.8 6.0 2.8 11.8 11.0 7.6 6.3 9.1 5.2 4.3 24.4 8.5 4.7 6.2 14.5 7.2 3.8 1.2 1.5 6.6 1.1 3.3 1.2 3.7 5.4 0.7 1.7 3.7 4.9 3.1 3.8 1.0 1.2 2.7 2.0 12.8 14.2 13.0 16.0 12.0 11.7 15.0 13.4 11.7 16.5 11.6 13.8 19.9 17.1 9.6 13.3 15.7 20.8 11.5 8.3 11.2 14.8 15.8 13.9 11.7 2.6 12.8 10.7 11.0 20.9 4.6 63.5 16.8 1.9 7.6 1.9 11.5 14.7 13.6 7.2 13.5 17.6 6.6 3.9 9.5 15.8 14.4 12.6 14.3 20.0 11.5 9.0 6.7 14.6 14.5 2.0 9.8 9.8 2.3 11.5 19.7 8.8 18.7 13.5 9.7 89.6 25.1 30.6 9.2 13.2 10.5 25.4 12.9 19.8 3.4 10.1 21.6 13.1 12.3 8.7 17.0 9.7 15.5 16.1 4.0 39.0 24.0 15.7 11.0 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.1;parathyroid gland: 39.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041070: AB_2677285" "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favorable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favorable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.4 18.5 9.0 0.1 19.4 1.2 2.1 9.4 45.1 4.5 3.3 1.0 2.2 5.1 0.9 1.0 3.2 1.9 1.7 14.4 11.2 6.7 1.6 1.8 0.6 9.6 10.9 18.6 1.5 11.1 39.5 18.6 0.5 11.7 6.7 1.1 5.7 2.8 1.4 0.3 1.8 1.2 3.6 1.3 12.6 1.9 5.2 7.9 3.0 25.5 0.3 0.4 2.1 2.3 16.9 3.9 0.5 0.2 0.2 0.9 0.0 1.5 0.5 0.5 2.4 4.9 1.6 3.6 0.0 1.1 0.0 0.2 17.7 0.5 0.0 1.4 0.1 0.5 14.5 1.0 32.4 3.1 1.9 1.3 0.5 2.3 0.0 0.3 3.7 0.0 9.5 0.5 0.0 0.1 0.0 0.2 3.9 0.7 6.4 0.4 0.3 1.4 0.8 5.6 0.1 3.8 0.2 0.0 0.1 4.6 0.0 0.7 11.2 0.0 0.0 0.3 0.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 0.0 0.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 9.0 19.4 9.4 45.1 14.4 11.2 9.6 10.9 18.6 11.7 1.3 7.9 16.9 0.1 0.0 1.1 1.0 0.7 0.1 9.7 3.7 0.6 29.4 3.1 5.2 2.1 5.7 8.8 0.0 20.9 0.1 0.5 0.6 3.9 9.4 15.1 1.1 0.3 0.6 11.4 0.4 21.3 8.0 0.2 1.7 1.5 1.1 0.0 1.4 2.5 0.5 4.6 6.7 21.9 2.1 2.0 0.0 0.3 14.4 0.6 0.9 10.6 1.9 1.0 0.9 0.0 2.5 1.6 4.3 0.8 0.4 0.6 3.4 0.5 14.6 7.7 4.2 0.0 0.4 1.6 0.5 0.9 1.1 1.1 0.3 2.7 7.6 1.2 5.8 EDA "ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED" ENSG00000158813 "Ectodysplasin A" Q92838 X 69616067-70039472 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.2;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 5 "monocytes: 1.2;T-cells: 1.3" "Cell line enhanced" "Detected in many" "EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA037972, HPA037973" Supported "Vesicles,Lipid droplets" "Secreted - unknown location" NA NA Vesicles "Lipid droplets" "HPA037972: AB_2675761, HPA037973: AB_2675762" "unprognostic (3.76e-2)" "unprognostic (8.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.59e-3)" "unprognostic (7.85e-2)" "unprognostic (1.25e-4)" "unprognostic (4.33e-4)" "unprognostic (5.03e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-2)" "unprognostic (2.01e-1)" "prognostic favorable (1.04e-9)" "unprognostic (8.63e-4)" "unprognostic (7.64e-2)" "unprognostic (9.85e-2)" "unprognostic (2.79e-1)" 3.9 8.6 2.4 0.7 2.9 0.1 2.8 2.2 2.4 4.7 4.6 2.5 0.5 3.0 3.2 1.5 3.8 2.0 8.0 2.0 2.4 3.7 2.1 3.3 0.8 2.8 2.7 2.0 5.0 4.3 9.7 1.3 1.8 2.9 3.4 1.1 0.3 2.2 2.3 1.7 4.2 1.1 2.1 2.3 1.4 3.9 1.2 2.6 1.2 6.0 2.1 0.6 2.3 3.9 4.5 0.0 0.6 0.3 2.8 0.5 0.0 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 5.2 0.2 0.2 0.5 3.8 1.4 0.0 0.0 4.5 0.0 0.0 17.9 1.0 0.0 1.1 1.8 1.3 0.0 0.9 0.0 0.5 3.5 0.0 4.9 0.0 1.2 0.0 0.0 2.8 5.1 0.3 0.0 1.2 6.0 0.1 0.0 1.5 0.0 0.1 0.3 0.1 2.0 0.3 0.1 0.5 1.7 2.2 2.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.1 2.4 2.9 2.2 2.4 2.0 2.4 2.8 2.7 2.0 2.9 2.3 2.6 4.5 3.3 3.2 0.5 21.2 0.3 3.8 2.6 2.0 6.8 0.2 0.9 1.5 12.1 0.0 1.1 5.5 0.0 0.2 0.1 1.0 0.0 1.3 21.3 4.6 1.2 2.2 1.8 0.0 17.9 1.3 0.2 6.0 5.6 12.2 0.0 0.5 11.0 1.2 4.1 0.0 9.6 0.6 0.0 4.8 1.2 9.2 4.7 2.8 1.8 84.3 0.1 1.3 0.0 30.2 45.9 1.1 0.1 2.2 0.2 2.3 0.4 3.1 1.3 0.1 6.6 10.7 5.4 1.7 3.5 3.2 4.1 0.0 2.1 0.4 0.9 1.5 FGF17 FGF-13 ENSG00000158815 "Fibroblast growth factor 17" O60258 8 22042398-22048809 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;choroid plexus: 9.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 9.3;Cone photoreceptor cells: 14.6;Excitatory neurons: 10.6;Inhibitory neurons: 13.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.6;testis cancer: 3.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;RPMI-8226: 1.8" "Region enriched" "Detected in single" 4 "basal ganglia: 2.1" "Region enhanced" "Detected in single" "cerebellum: 2.1" HPA052600 Uncertain "Secreted in brain" NA NA "HPA052600: AB_2681881" "unprognostic (3.45e-2)" "unprognostic (1.64e-2)" "unprognostic (3.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (7.92e-5)" "unprognostic (6.85e-2)" "unprognostic (2.58e-4)" "unprognostic (6.55e-3)" "unprognostic (7.18e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-3)" 0.3 3.9 11.8 0.0 13.5 0.1 0.4 19.7 25.9 3.0 9.1 0.3 0.0 1.1 0.1 0.2 1.5 0.2 0.4 13.0 11.9 1.4 0.4 0.7 0.0 10.8 11.0 12.9 1.5 1.2 0.8 5.1 0.1 15.9 2.8 0.0 1.2 0.7 0.1 0.1 0.4 0.4 0.3 9.0 3.6 0.5 0.7 11.6 0.4 4.9 0.0 0.0 0.6 1.3 13.2 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 13.5 19.7 25.9 13.0 11.9 10.8 11.0 12.9 15.9 9.0 11.6 13.2 0.2 0.0 0.0 2.3 0.0 0.0 0.3 0.1 0.0 9.3 0.2 0.4 1.1 0.0 0.2 0.0 14.6 0.1 0.0 0.1 0.0 0.1 1.8 0.0 0.1 0.1 0.0 0.0 10.6 0.2 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 1.7 13.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.8 1.0 0.0 0.6 0.0 2.0 2.4 0.1 0.0 1.2 0.1 0.2 0.0 0.0 0.2 1.3 0.0 0.3 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.4 0.0 0.1 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;choroid plexus: 15.5" "Cell type enhanced" "Detected in some" "Astrocytes: 2.6;Early spermatids: 10.9;Inhibitory neurons: 1.8;Late spermatids: 9.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 1.2" "Low region specificity" "Detected in many" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" NA NA Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363" "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 0.4 3.8 0.1 1.0 0.0 0.0 1.0 0.7 0.0 15.5 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.0 1.2 2.4 1.3 0.0 0.1 0.1 2.7 5.3 0.1 0.0 0.0 1.1 2.9 0.1 3.1 0.0 0.0 0.1 1.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.3 2.4 0.0 0.2 0.4 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.0 1.0 0.7 1.2 2.4 2.7 5.3 0.1 3.1 2.0 2.4 0.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20589086-20618903 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 195.3;esophagus: 87.8;liver: 87.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 1234.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 1234.7" "Cell line enhanced" "Detected in many" "A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064202 Enhanced Approved Nucleoplasm NA NA 3700000 Nucleoplasm "HPA064202: AB_2685211" "unprognostic (2.38e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 6.6 3.0 8.6 9.7 8.3 195.3 3.7 8.5 10.7 14.6 8.8 23.9 6.4 5.3 5.5 87.8 6.5 4.4 6.6 8.1 8.4 13.9 87.4 7.2 1.5 9.3 8.3 7.4 1.5 0.8 3.2 1.2 10.9 9.3 4.3 28.1 0.5 15.1 3.1 1.7 17.2 16.4 11.4 8.5 23.6 2.1 1.0 9.3 2.0 4.6 6.5 4.4 5.5 38.8 10.9 200.3 21.4 0.0 0.0 0.2 5.5 0.0 16.7 4.3 4.1 16.2 1.0 141.9 0.0 8.1 30.8 8.7 63.9 4.5 46.8 10.7 0.1 3.9 0.0 207.1 34.4 1.4 0.0 0.0 8.8 8.9 31.4 0.0 0.5 2.7 0.0 0.0 0.0 1.6 0.2 0.0 1.0 0.1 24.7 107.0 0.0 0.1 3.4 1.5 0.0 0.1 0.0 249.9 0.0 0.3 2.2 0.0 4.3 3.4 0.2 8.3 18.5 1.2 0.0 0.1 0.0 2.4 96.9 0.0 216.2 207.2 471.1 0.5 124.7 0.8 0.1 0.4 0.9 12.7 0.2 0.3 0.4 1234.7 0.4 110.8 3.1 0.7 86.8 8.6 8.3 8.5 10.7 8.1 8.4 9.3 8.3 7.4 9.3 8.5 9.3 10.9 9.9 3.2 1.1 0.3 1.2 1.5 0.1 2.4 0.0 0.2 0.2 0.3 2.6 1.5 2.7 5.5 0.0 1.1 0.0 364.9 43.0 7.5 0.8 2.1 2.6 42.7 0.0 6.1 0.2 1.5 6.4 9.1 0.0 20.3 0.0 0.0 47.2 107.8 5.9 0.0 0.3 23.1 85.5 60.7 0.9 1.0 0.3 36.6 0.0 5.6 61.5 0.1 0.0 0.5 0.0 120.2 400.5 0.0 3.0 2.1 137.6 0.6 0.4 0.1 0.0 1.3 1.3 0.0 1.2 6.3 1.1 2.5 1.7 0.0 19.8 0.8 PINK1 "BRPK, PARK6" ENSG00000158828 "PTEN induced kinase 1" Q9BXM7 1 20633458-20651511 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 387.6;tongue: 395.8" "Cell type enhanced" "Detected in many" "Late spermatids: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 8.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001931, CAB026191" Enhanced NA NA "CAB026191: , HPA001931: AB_1079620" "unprognostic (3.73e-3)" "unprognostic (2.29e-2)" "unprognostic (3.22e-1)" "unprognostic (4.33e-2)" "unprognostic (4.91e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-2)" "unprognostic (3.36e-2)" "unprognostic (3.51e-2)" "unprognostic (4.06e-3)" "unprognostic (3.34e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (6.57e-2)" "unprognostic (1.08e-1)" 47.4 128.2 112.9 13.8 94.4 13.1 42.3 98.6 104.9 36.5 58.7 56.8 32.5 44.3 18.9 49.1 34.7 23.7 120.3 97.8 97.2 56.4 77.5 30.4 10.9 113.8 117.4 90.7 30.4 53.2 67.1 33.7 21.5 113.8 37.4 15.2 29.6 55.4 30.0 387.6 51.4 35.5 20.1 109.3 28.1 47.1 95.6 111.7 12.4 41.9 395.8 8.3 47.8 43.0 89.3 49.9 22.2 10.3 29.6 34.6 32.8 10.7 68.2 67.9 32.4 56.1 7.7 39.3 11.7 52.6 69.9 75.4 22.5 15.0 36.2 16.0 14.0 56.8 5.9 60.3 12.1 26.8 6.3 17.7 30.8 38.5 40.6 13.9 36.2 21.3 10.7 14.5 14.5 23.6 21.2 9.2 14.1 4.6 12.9 72.2 7.9 18.0 9.4 20.1 11.5 37.8 14.8 74.4 24.2 20.8 12.3 8.0 21.6 32.6 29.1 14.9 49.2 9.7 16.7 3.6 5.4 63.1 17.9 14.0 3.6 1.6 3.7 0.8 1.1 1.0 0.2 0.7 1.1 0.5 1.4 0.5 0.8 8.1 0.6 3.9 1.0 1.5 0.6 112.9 94.4 98.6 104.9 97.8 97.2 113.8 117.4 90.7 113.8 109.3 111.7 89.3 38.7 22.4 19.2 16.3 9.1 15.7 36.0 7.9 10.8 50.1 31.5 24.4 1.1 37.1 9.2 44.1 37.5 26.3 9.2 107.4 80.3 24.0 77.7 22.3 16.1 48.5 20.0 56.0 27.2 28.0 31.8 27.4 12.2 26.4 0.0 36.7 84.3 110.5 23.7 28.6 24.4 30.2 12.2 27.1 16.3 151.4 35.4 22.7 21.4 25.3 10.1 69.7 12.3 8.5 14.3 56.6 67.9 56.8 27.0 67.5 66.9 109.2 7.6 69.0 85.5 30.9 32.2 120.8 24.6 19.3 24.0 34.2 10.6 34.2 24.4 47.9 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 114.8;Syncytiotrophoblasts: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 246.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 130000 "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 21.9 22.0 18.8 16.2 19.5 19.2 21.8 17.0 21.3 19.9 17.8 18.1 17.4 14.9 18.5 25.3 19.1 14.5 22.7 19.4 20.1 27.9 22.7 25.3 23.6 17.7 18.1 18.9 29.3 34.3 22.1 32.8 21.9 17.8 22.0 17.6 8.1 32.6 12.5 24.8 23.9 18.7 10.7 16.9 31.4 27.9 19.6 20.5 17.1 22.1 16.4 20.9 23.9 21.6 18.3 35.2 22.3 32.8 43.6 47.5 24.7 52.5 19.2 34.7 39.6 36.3 44.8 68.4 32.2 54.2 22.1 37.8 34.3 34.9 21.7 22.8 34.1 42.5 18.6 14.2 35.8 34.1 37.0 48.6 33.7 31.1 36.5 39.6 47.0 45.2 41.3 60.3 69.3 32.2 35.4 24.1 34.4 40.9 70.3 48.0 28.5 18.2 79.4 33.5 20.9 46.6 54.7 19.7 50.4 41.7 44.2 50.7 64.8 18.9 19.5 35.4 22.4 57.7 246.6 146.5 43.0 28.5 31.2 32.0 10.7 14.9 12.6 27.0 17.2 24.3 26.2 25.9 26.0 18.0 21.2 25.0 23.2 9.7 25.9 23.3 37.4 43.1 21.0 18.8 19.5 17.0 21.3 19.4 20.1 17.7 18.1 18.9 17.8 16.9 20.5 18.3 18.1 19.2 20.0 1.6 34.7 38.5 36.6 26.2 19.9 17.3 32.8 19.9 10.2 15.7 17.7 25.8 2.1 44.8 30.3 15.3 5.9 28.7 10.1 8.2 7.8 24.4 28.8 34.5 6.2 22.9 91.7 24.7 15.3 10.9 9.5 21.0 27.8 13.2 29.7 26.9 7.1 20.7 26.4 16.6 17.9 5.7 9.6 16.2 23.2 4.7 10.2 9.4 47.4 5.0 4.5 31.4 20.0 7.2 114.8 46.1 19.0 20.9 12.4 8.6 26.3 11.1 24.7 14.9 46.9 21.7 41.9 114.2 29.5 11.8 22.7 51.4 DMTN "DMT, EPB49" ENSG00000158856 "Dematin actin binding protein" Q08495 8 22048995-22082527 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 194.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 248.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 1.6;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.5;neutrophil: 1.2;T-reg: 3.3" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;T-cells: 3.8" "Cell line enhanced" "Detected in many" "A549: 68.9;HEL: 225.9;Hep G2: 63.9;HMC-1: 65.6;OE19: 67.3;RPTEC TERT1: 87.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024290, HPA058487" Uncertain NA NA 2400000 "HPA024290: AB_1847601, HPA058487: " "unprognostic (6.74e-2)" "unprognostic (1.51e-1)" "unprognostic (3.48e-2)" "unprognostic (1.24e-3)" "prognostic unfavorable (7.92e-5)" "unprognostic (2.88e-1)" "unprognostic (3.85e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-2)" "unprognostic (2.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.97e-1)" "prognostic favorable (3.85e-9)" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "unprognostic (8.07e-2)" 36.0 30.1 108.1 6.1 136.9 137.8 22.0 0.0 194.1 12.5 0.0 30.3 9.3 15.4 14.5 19.1 30.6 13.6 72.1 132.3 67.2 66.0 28.4 20.2 3.4 35.0 20.7 134.9 3.5 29.9 55.4 110.5 7.5 63.0 25.2 15.3 23.2 23.1 20.6 67.1 24.2 14.1 14.1 0.0 19.4 24.0 11.7 30.8 3.1 39.5 41.8 3.7 13.0 12.5 95.4 44.1 68.9 0.5 1.4 1.1 0.3 5.4 4.6 4.3 14.5 4.3 29.9 26.7 0.4 43.8 0.8 0.9 14.8 2.1 2.7 6.5 0.4 13.0 225.9 5.3 63.9 1.3 0.1 65.6 0.7 29.3 0.2 0.3 8.5 14.7 2.0 21.7 2.2 0.1 18.9 5.7 0.5 1.8 67.3 6.1 0.0 0.6 3.1 87.2 12.3 15.6 21.8 7.3 0.9 3.2 3.5 11.2 2.2 26.1 0.0 22.0 0.3 24.0 0.1 0.2 0.7 0.3 0.2 15.4 0.0 0.1 0.2 1.7 0.0 1.7 0.0 3.8 1.6 0.1 0.0 1.5 1.5 1.2 0.0 0.0 0.3 3.3 9.3 108.1 136.9 0.0 194.1 132.3 67.2 35.0 20.7 134.9 63.0 0.0 30.8 95.4 9.3 3.2 10.7 10.7 1.5 2.3 4.0 3.9 1.2 34.6 9.9 5.7 37.8 0.0 5.1 7.3 12.5 0.1 2.7 15.3 19.6 11.4 12.7 11.2 1.7 10.2 20.5 248.6 45.7 11.4 1.7 2.4 7.7 12.7 0.0 4.1 3.9 15.8 0.5 28.6 29.7 8.7 0.0 1.0 1.6 7.7 0.3 44.5 14.2 5.6 1.3 2.6 0.0 1.5 4.3 18.2 10.0 2.6 1.4 3.7 1.8 29.6 9.3 7.3 0.0 1.4 5.7 1.4 2.4 3.8 5.7 0.1 6.4 0.3 13.3 4.8 ADAMTS4 "ADAMTS-2, ADMP-1, KIAA0688" ENSG00000158859 "ADAM metallopeptidase with thrombospondin type 1 motif 4" O75173 1 161184302-161199054 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 96.7" "Cell type enhanced" "Detected in many" "Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 4.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.4" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025876, HPA051296, HPA068374" Uncertain Supported "Nuclear speckles" "Secreted to extracellular matrix" NA NA 11000 "Nuclear speckles" "CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978" "unprognostic (2.70e-2)" "unprognostic (8.10e-3)" "unprognostic (3.00e-3)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.19e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.20e-2)" "unprognostic (9.59e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.27e-7)" "unprognostic (1.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-3)" "unprognostic (3.13e-2)" 72.2 9.9 5.8 16.4 25.4 0.7 43.8 26.8 18.5 16.1 4.5 14.3 0.8 15.1 0.2 6.2 35.0 14.4 42.5 5.4 17.3 12.3 8.7 50.8 1.6 44.3 28.4 3.3 96.7 9.0 2.1 13.1 3.2 35.1 17.1 2.0 1.5 5.2 0.5 13.4 4.9 9.5 10.6 31.3 1.8 23.0 1.8 21.4 1.1 21.5 0.4 0.3 32.1 12.3 47.0 0.0 0.0 0.2 0.1 6.4 4.0 0.6 5.4 0.2 0.5 3.0 0.2 0.2 0.2 4.4 1.7 0.0 0.1 0.0 0.0 1.9 0.1 0.3 0.2 0.5 1.3 0.6 0.0 0.1 4.5 0.0 11.8 0.1 0.0 14.4 0.1 0.2 0.3 0.4 0.1 0.0 0.2 5.3 0.0 0.0 0.1 5.1 0.1 0.0 0.1 0.1 7.9 0.0 0.1 0.1 0.3 0.2 0.5 12.2 7.4 0.1 0.4 10.8 0.2 0.1 0.1 2.2 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.0 4.4 0.2 0.1 5.8 25.4 26.8 18.5 5.4 17.3 44.3 28.4 3.3 35.1 31.3 21.4 47.0 80.3 0.0 4.1 0.0 0.2 31.2 3.2 0.0 2.2 2.2 8.6 5.5 5.5 0.0 0.6 0.0 0.0 0.3 0.5 0.2 0.0 0.3 0.0 0.3 13.0 115.5 0.0 0.0 0.4 0.0 0.3 88.8 0.5 0.5 0.0 0.3 43.2 0.9 1.0 3.3 0.1 0.0 0.0 1.0 32.6 0.2 0.3 3.2 35.6 2.8 1.0 0.5 0.0 0.0 56.0 0.0 0.0 1.2 0.7 9.8 0.0 0.1 0.0 1.0 52.6 21.2 313.7 2.7 0.6 2.7 19.0 0.4 3.7 1.6 0.3 7.7 FAM160B2 "FLJ21801, RAI16" ENSG00000158863 "Family with sequence similarity 160 member B2" Q86V87 8 22089150-22104911 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025040 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025040: AB_1856049" "unprognostic (3.45e-1)" "unprognostic (2.08e-3)" "unprognostic (1.60e-1)" "unprognostic (8.85e-3)" "unprognostic (2.28e-2)" "prognostic favorable (4.56e-4)" "unprognostic (2.35e-2)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (8.38e-3)" "unprognostic (7.67e-3)" "unprognostic (3.38e-2)" "unprognostic (6.30e-2)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" "unprognostic (2.75e-3)" 14.0 11.6 4.0 3.9 3.6 3.7 15.9 3.1 5.5 12.2 3.0 15.0 5.8 12.4 5.0 13.7 12.8 5.6 20.5 3.0 3.2 14.5 10.6 10.7 6.4 4.6 3.9 3.3 10.1 22.5 8.3 13.3 5.3 4.7 14.7 2.5 3.0 16.8 10.7 17.9 14.0 13.6 7.0 2.8 11.5 17.5 6.1 4.2 4.3 15.5 7.2 2.2 16.3 12.1 4.3 4.4 8.7 4.3 6.8 9.2 8.1 7.8 8.0 13.6 8.6 5.8 3.9 4.7 4.9 7.7 19.7 7.8 6.3 3.3 9.3 1.9 4.1 4.2 7.3 2.8 2.2 12.4 1.9 5.7 13.6 6.9 6.6 4.4 8.9 9.1 8.8 4.6 3.3 8.3 8.0 5.0 2.9 2.1 8.0 3.8 5.1 3.7 2.5 7.4 8.9 1.8 5.8 4.6 6.6 5.2 4.5 4.3 3.2 10.3 8.4 7.2 8.0 4.6 3.5 0.9 0.9 9.0 3.1 9.7 0.0 0.4 0.1 0.8 0.2 0.5 0.7 0.5 0.6 0.2 0.5 0.4 0.7 0.0 0.4 0.4 0.2 0.0 0.7 4.0 3.6 3.1 5.5 3.0 3.2 4.6 3.9 3.3 4.7 2.8 4.2 4.3 16.4 12.8 17.2 17.0 11.6 5.9 10.1 9.9 12.5 22.0 16.4 13.5 26.1 12.8 8.8 12.9 27.1 8.5 10.1 15.5 0.0 9.7 3.7 8.9 14.5 16.8 13.2 1.3 12.3 15.0 15.5 12.5 23.0 11.8 7.0 19.1 16.8 13.6 7.4 23.5 12.0 10.8 0.0 9.4 4.7 2.5 10.8 8.2 1.8 8.4 4.4 8.7 9.2 12.1 11.0 17.1 17.1 5.7 6.3 15.1 14.7 5.0 10.8 23.8 0.0 11.0 14.7 1.5 7.0 16.1 7.5 14.9 11.2 9.6 9.9 12.4 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214723 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 469.2;tongue: 639.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria NA NA 25000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 60.7 99.0 35.5 37.8 38.7 39.9 50.1 42.3 46.9 40.5 64.4 97.4 103.3 41.8 33.7 62.5 52.9 37.1 276.2 38.2 42.7 138.2 178.9 48.9 42.7 45.1 42.8 35.6 52.0 48.1 157.9 36.1 41.9 48.4 46.1 102.7 36.5 54.0 49.5 469.2 51.3 82.1 59.1 35.9 44.0 73.9 29.8 42.3 48.8 45.4 639.4 60.6 58.1 40.4 50.1 101.8 129.4 95.2 104.0 115.1 102.8 77.0 85.7 105.8 139.6 107.5 143.9 98.5 108.4 168.1 113.0 81.3 135.9 129.1 131.8 122.1 84.2 108.0 105.9 109.5 136.5 117.7 116.0 105.3 147.2 112.3 121.1 137.2 96.8 160.5 115.4 139.9 72.7 132.5 93.5 81.7 58.4 175.3 288.5 116.5 72.0 83.3 172.0 157.8 109.4 97.2 152.0 93.0 237.0 151.5 116.4 221.7 342.2 108.6 84.5 66.3 65.5 123.7 125.2 172.0 95.1 123.6 109.3 105.4 150.0 159.3 85.7 82.0 193.2 82.6 81.4 86.6 86.3 217.8 68.4 86.6 88.1 86.7 93.5 190.7 128.7 130.8 167.5 35.5 38.7 42.3 46.9 38.2 42.7 45.1 42.8 35.6 48.4 35.9 42.3 50.1 70.5 35.3 45.7 30.7 47.1 38.9 52.4 277.8 52.9 74.6 58.9 50.7 232.6 74.4 148.4 77.3 31.3 146.8 47.6 187.5 332.6 184.3 11.3 43.5 57.0 67.5 72.0 78.9 28.0 143.2 111.3 69.7 80.5 41.3 69.7 99.7 65.7 206.5 150.5 92.5 30.1 122.6 242.1 87.8 42.0 7.8 43.5 66.5 83.6 14.0 97.9 57.0 35.0 18.1 48.3 147.7 105.1 33.4 49.5 25.6 221.9 345.5 103.0 57.3 46.0 41.9 176.6 42.0 27.5 68.8 43.3 158.4 50.0 192.0 172.5 57.5 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Metabolic proteins, Predicted membrane proteins, Transporters" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 46.1" "Cell type enriched" "Detected in some" 19 "Oligodendrocytes: 677.9" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 8.3;Karpas-707: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.1 0.1 11.9 0.0 24.6 0.0 0.6 23.9 21.4 0.0 8.7 0.2 3.3 0.0 0.0 0.0 0.1 0.2 0.0 11.8 20.5 3.0 0.8 0.1 0.0 26.1 24.8 9.9 0.1 0.3 0.0 0.3 0.0 29.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 8.2 0.0 23.3 0.2 0.1 0.4 23.5 0.0 0.1 0.2 0.0 0.1 0.1 46.1 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 24.6 23.9 21.4 11.8 20.5 26.1 24.8 9.9 29.4 23.3 23.5 46.1 0.0 0.0 0.0 2.9 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 2.3 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.0 2.0 1.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 677.9 0.0 2.4 0.0 0.1 0.0 35.2 7.2 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.2 0.6 0.0 FCER1G ENSG00000158869 "Fc fragment of IgE receptor Ig" P30273 1 161215234-161220699 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 445.8;lymphoid tissue: 473.9" "Group enriched" "Detected in many" 9 "dendritic cells: 726.6;granulocytes: 705.6;Hofbauer cells: 2318.6;Kupffer cells: 1950.8;Langerhans cells: 1526.3;Macrophages: 1971.3;monocytes: 808.9;NK-cells: 1037.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 11 "basophil: 1987.3;classical monocyte: 3240.2;intermediate monocyte: 5333.6;myeloid DC: 2386.3;neutrophil: 1831.0;NK-cell: 1750.9;non-classical monocyte: 6984.5;plasmacytoid DC: 3315.6" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 77.8;HMC-1: 301.7;THP-1: 276.1;U-266/84: 90.1;U-937: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022108, HPA026872" Supported NA NA 270000 "CAB022108: , HPA026872: AB_1848473" "unprognostic (3.71e-2)" "unprognostic (2.52e-2)" "unprognostic (2.40e-2)" "unprognostic (8.73e-3)" "unprognostic (1.46e-1)" "unprognostic (4.28e-2)" "unprognostic (3.10e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-1)" "unprognostic (9.63e-2)" "unprognostic (2.28e-2)" "unprognostic (5.67e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.99e-1)" "unprognostic (6.28e-2)" "unprognostic (2.04e-2)" "unprognostic (7.87e-2)" 254.0 87.3 32.6 278.1 39.0 445.8 63.4 34.9 66.5 52.9 51.3 83.5 45.3 31.0 39.1 30.9 72.6 102.4 43.3 32.5 53.2 37.0 178.7 289.2 162.3 52.9 41.2 30.3 20.1 22.5 27.0 27.1 212.8 48.4 31.3 114.3 8.4 43.2 39.2 12.0 20.2 61.1 161.8 45.8 473.9 39.7 14.6 49.1 63.3 25.7 34.9 83.1 257.1 21.9 52.6 0.2 0.0 0.7 1.3 1.8 0.7 0.4 0.5 0.2 0.5 0.8 2.2 0.1 0.5 0.7 0.0 0.3 0.2 0.5 0.0 0.4 0.3 1.5 77.8 0.6 14.0 0.3 16.1 301.7 6.0 3.3 2.3 0.2 0.7 0.4 1.8 0.1 7.3 2.4 0.5 1.4 37.9 1.6 0.0 0.0 0.1 6.7 0.2 0.5 0.4 0.3 1.0 0.6 0.1 2.7 1.4 0.2 276.1 0.4 1.8 0.4 0.9 1.1 3.0 90.1 0.9 1.7 87.1 0.5 1987.3 3240.2 307.3 13.6 5333.6 15.9 28.2 10.6 10.6 2386.3 9.0 17.3 45.0 1831.0 1750.9 6984.5 3315.6 21.8 4265.5 32.6 39.0 34.9 66.5 32.5 53.2 52.9 41.2 30.3 48.4 45.8 49.1 52.6 12.8 86.6 147.7 0.7 35.9 39.6 1.5 0.2 1.8 0.1 5.2 22.1 6.8 15.7 27.3 18.4 0.0 14.5 726.6 1.0 0.0 1.9 3.0 1.0 0.9 38.6 1.8 79.3 0.1 1.0 18.8 18.3 1.1 1.0 705.6 0.5 41.0 13.6 2318.6 0.0 0.2 0.5 0.0 1950.8 1526.3 9.4 5.3 1971.3 80.0 12.2 808.9 0.2 1037.1 0.0 0.1 1.0 1.4 1.2 10.1 1.3 0.4 5.4 15.3 2.3 72.3 3.8 11.2 1.0 2.5 1.4 35.9 23.7 133.3 0.4 0.6 1.8 APOA2 ENSG00000158874 "Apolipoprotein A2" P02652 1 161222292-161223631 "Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction, Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1385 "liver: 36306.5" "Cell type enriched" "Detected in some" 75 "Hepatocytes: 50065.8" "Cancer enriched" "Detected in many" 329 "liver cancer: 11230.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Hep G2: 16822.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025885, HPA072575" Supported "Secreted to blood" NA NA 115000000000 92000000000 "CAB025885: , HPA072575: " "unprognostic (2.05e-1)" "unprognostic (4.70e-2)" "unprognostic (1.12e-1)" "unprognostic (2.99e-1)" "unprognostic (9.82e-2)" "unprognostic (1.92e-1)" "unprognostic (3.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (4.40e-3)" "unprognostic (3.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" 2.1 1.1 0.6 0.7 0.5 26.2 1.8 0.4 1.1 0.7 0.8 0.7 0.0 0.7 0.1 1.0 1.9 0.0 1.7 0.5 1.7 9.6 36306.5 2.1 0.3 0.7 0.6 0.2 0.7 2.1 0.0 1.2 1.3 0.7 0.6 0.5 0.0 0.6 0.0 0.6 0.8 0.9 0.0 0.6 7.7 1.9 1.2 0.8 0.4 0.9 0.0 0.3 0.4 0.8 1.2 0.0 0.6 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 1814.4 0.0 3.6 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 5.8 10.0 16822.4 0.0 19.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.7 0.7 1.5 0.0 1.1 1.3 14.6 0.3 0.0 11.3 0.8 0.0 7.8 0.0 0.2 5.2 0.1 0.0 4.1 0.0 0.1 0.0 0.0 3.8 0.0 5.2 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.6 0.5 0.4 1.1 0.5 1.7 0.7 0.6 0.2 0.7 0.6 0.8 1.2 0.0 0.0 0.0 0.0 40.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 480.4 0.0 0.0 0.0 0.8 0.0 0.1 1.9 0.0 1.7 0.0 0.0 22.5 0.0 323.6 0.0 0.6 6.4 0.2 0.0 0.0 0.0 0.0 425.9 50065.8 4.7 0.0 0.0 0.2 0.0 665.8 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 9.8 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 5.6 26.0 0.0 0.0 0.0 TOMM40L "FLJ12770, TOMM40B" ENSG00000158882 "Translocase of outer mitochondrial membrane 40 like" Q969M1 1 161225939-161230746 "Predicted intracellular proteins" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 51.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051304 Approved NA NA "HPA051304: AB_2681432" "unprognostic (1.18e-2)" "unprognostic (1.58e-2)" "unprognostic (7.65e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.58e-1)" "unprognostic (2.71e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (8.46e-2)" "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (1.93e-2)" "unprognostic (2.89e-2)" "prognostic favorable (7.80e-4)" "unprognostic (2.29e-1)" "unprognostic (8.71e-2)" "unprognostic (4.61e-2)" "unprognostic (1.14e-1)" 7.9 7.1 12.0 7.2 12.7 15.1 6.7 10.9 17.2 5.3 7.5 11.8 14.0 7.5 2.8 10.2 5.3 4.1 24.4 11.9 10.7 9.9 17.6 7.8 6.8 11.3 11.9 12.3 3.6 3.8 15.1 5.9 6.0 12.2 6.4 10.8 11.2 5.8 8.9 23.5 7.3 12.0 8.6 10.5 7.9 8.1 2.2 13.4 7.3 5.7 51.9 7.6 8.7 6.2 12.3 7.6 7.2 11.8 12.9 19.2 10.1 9.1 11.2 13.7 21.6 18.6 41.7 9.8 22.5 13.4 14.9 8.0 9.9 22.6 22.3 12.4 18.9 15.5 21.2 10.5 21.0 8.5 40.8 34.0 11.0 14.0 24.0 12.9 11.0 24.8 23.4 30.0 18.7 15.3 12.3 16.5 6.0 12.9 17.2 20.4 18.7 8.6 21.3 16.2 16.2 28.2 11.8 10.7 30.1 9.9 12.6 23.0 30.9 19.1 11.2 7.7 9.7 16.5 16.5 15.0 16.1 11.6 24.6 11.8 2.5 1.6 1.4 1.0 1.9 1.4 0.8 0.7 1.3 3.0 0.5 0.7 1.7 0.7 1.9 1.5 3.4 1.6 1.5 12.0 12.7 10.9 17.2 11.9 10.7 11.3 11.9 12.3 12.2 10.5 13.4 12.3 4.1 0.0 3.3 2.3 3.5 0.5 1.4 1.6 3.4 6.0 2.9 2.3 4.0 1.5 1.7 1.8 6.2 2.4 2.8 8.7 7.9 4.0 4.1 0.7 2.3 4.1 7.7 3.4 5.3 7.8 3.2 3.3 3.6 1.3 3.8 2.2 1.4 7.4 9.7 5.0 5.9 2.6 4.1 5.0 2.7 1.9 2.1 14.8 0.0 1.9 5.6 2.4 4.1 2.0 1.6 4.6 4.1 0.7 4.6 1.1 11.4 5.1 1.2 9.7 0.0 2.2 5.2 0.9 1.8 5.2 1.7 0.8 3.8 3.6 7.0 1.4 MPZ "CMT1, CMT1B, CMT2I, CMT2J, HMSNIB, P0" ENSG00000158887 "Myelin protein zero" P25189 1 161304735-161309968 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 6.6;Skeletal myocytes: 9.3" "Cancer enriched" "Detected in many" 11 "melanoma: 83.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "WM-115: 139.3" "Group enriched" "Detected in some" 4 "olfactory bulb: 2.9;pons and medulla: 1.3" "Region enriched" "Detected in some" 10 "spinal cord: 2142.4" HPA068925 Enhanced NA NA "HPA068925: AB_2732123" "unprognostic (6.77e-2)" "unprognostic (2.98e-1)" "unprognostic (9.27e-2)" "unprognostic (1.46e-1)" "unprognostic (3.35e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "unprognostic (7.88e-3)" "unprognostic (1.51e-1)" "unprognostic (6.62e-8)" "unprognostic (6.75e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (8.32e-2)" 13.0 7.0 2.0 2.1 2.9 1.2 12.8 2.3 2.8 8.1 1.3 17.1 1.6 2.0 2.1 4.4 5.4 2.4 10.7 1.9 3.6 3.1 5.4 2.9 1.1 3.1 2.0 1.7 3.1 2.3 0.6 6.2 0.6 8.6 12.3 2.7 1.2 16.0 8.1 5.2 7.8 8.5 0.8 3.2 4.5 7.7 2.4 1.8 1.4 3.7 18.6 0.9 9.6 16.1 3.2 0.4 0.0 0.3 0.1 2.7 1.3 0.3 0.3 0.5 0.1 1.6 0.0 0.1 2.3 1.5 0.4 0.5 0.1 1.8 0.6 0.1 1.1 0.0 1.0 0.4 31.0 1.2 4.7 3.7 4.2 0.0 6.2 0.3 0.0 2.8 1.9 9.9 0.0 4.3 0.0 0.7 7.6 1.4 0.0 0.0 0.3 0.2 1.4 0.3 0.1 2.0 0.3 0.0 0.0 14.0 0.8 0.1 9.5 2.7 0.3 0.4 2.7 0.2 0.9 0.9 1.2 4.8 17.5 139.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 2.9 2.3 2.8 1.9 3.6 3.1 2.0 1.7 8.6 3.2 1.8 3.2 1.7 3.2 0.6 1.0 2.1 0.5 3.1 0.4 4.0 2.5 0.4 1.3 0.7 0.0 0.5 3.7 2.1 0.5 1.6 0.1 0.0 0.2 5.5 0.3 0.2 1.5 1.8 1.3 1.7 1.2 0.7 2.5 0.0 0.1 0.0 0.8 1.8 1.0 1.6 1.7 2.2 0.7 2.0 1.9 0.8 1.8 1.5 2.0 3.6 1.0 3.8 0.5 0.0 0.5 1.6 0.1 0.1 0.4 1.4 0.9 0.3 1.0 0.6 1.1 6.6 9.3 3.9 0.4 0.6 1.1 0.4 0.3 1.6 0.4 0.4 2.0 WFDC8 "C20orf170, dJ461P17.1, WAP8" ENSG00000158901 "WAP four-disulfide core domain 8" Q8IUA0 20 45551153-45579326 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 517 "epididymis: 413.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-87 MG: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042710, HPA071119" Enhanced "Secreted in male reproductive system" NA NA "HPA042710: AB_2732501, HPA071119: AB_2732172" "unprognostic (5.63e-3)" "unprognostic (1.09e-2)" "unprognostic (2.34e-1)" "unprognostic (9.96e-2)" "unprognostic (1.07e-2)" 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 413.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CCAR2 "DBC-1, DBC1, KIAA1967, NET35" ENSG00000158941 "Cell cycle and apoptosis regulator 2" Q8N163 8 22604632-22621514 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Metalloenzyme inhibitor, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019907, HPA019943, CAB072827, CAB072828" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA 19000 "Nucleoplasm, Nuclear bodies" "CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454" "unprognostic (3.42e-2)" "unprognostic (5.78e-3)" "unprognostic (2.46e-3)" "unprognostic (1.33e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-2)" "unprognostic (5.13e-2)" "unprognostic (8.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (1.54e-2)" "prognostic favorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (2.46e-1)" "unprognostic (7.54e-2)" "unprognostic (1.77e-1)" 59.1 68.9 37.7 76.1 42.1 146.8 65.0 38.2 51.5 65.8 39.1 69.1 52.6 75.6 33.3 63.9 68.5 60.2 48.8 44.9 35.9 51.0 41.4 61.9 87.4 36.6 38.8 47.1 75.2 56.9 60.2 65.6 54.4 37.8 61.6 46.1 60.3 62.0 47.3 102.3 86.5 69.8 45.3 33.1 86.3 60.5 90.1 38.9 96.8 61.1 43.9 75.0 66.0 58.1 46.8 133.7 242.8 230.8 120.8 89.5 74.7 154.0 127.7 124.9 184.3 163.9 219.5 107.4 218.6 156.4 140.5 169.6 163.2 214.5 151.9 132.9 89.2 128.2 259.1 189.5 172.8 82.9 143.6 212.0 77.8 133.1 147.0 90.0 106.4 134.4 194.4 276.2 134.8 138.0 157.5 435.0 150.5 337.6 143.2 88.1 286.7 190.7 116.8 95.2 311.7 115.1 267.6 143.7 163.0 112.6 110.7 148.8 133.2 219.3 135.8 178.4 165.3 171.1 98.5 134.0 261.4 152.7 123.4 215.7 25.9 16.2 23.5 34.8 26.6 29.4 18.7 26.5 26.6 16.6 17.5 25.7 28.4 5.7 19.9 35.6 15.5 32.6 25.8 37.7 42.1 38.2 51.5 44.9 35.9 36.6 38.8 47.1 37.8 33.1 38.9 46.8 14.4 16.0 4.2 11.1 14.1 13.9 9.5 12.2 17.6 12.9 13.5 13.1 7.5 15.7 9.4 16.5 16.7 27.3 19.4 24.1 9.8 18.1 4.7 14.1 12.3 13.1 22.2 16.4 12.5 18.0 22.2 12.8 18.8 14.3 8.8 20.2 11.7 12.0 15.7 10.1 11.9 19.6 14.2 11.9 8.5 7.3 14.9 11.0 12.4 10.3 11.2 15.9 20.6 11.1 10.3 23.6 10.4 12.0 14.8 11.7 14.4 9.4 19.5 12.9 19.7 12.4 12.2 30.0 24.1 16.9 15.3 23.7 19.3 23.5 21.7 10.5 WNT9B "WNT14B, WNT15" ENSG00000158955 "Wnt family member 9B" O14905 17 46833201-46886730 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "parathyroid gland: 14.1;seminal vesicle: 9.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Microglial cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SuSa: 7.4" "Region enriched" "Detected in single" 7 "thalamus: 5.8" "Low region specificity" "Detected in all" "HPA058361, HPA059572" Approved "Secreted to extracellular matrix" NA NA "HPA058361: AB_2683691, HPA059572: AB_2684067" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (7.48e-3)" "unprognostic (3.37e-3)" "unprognostic (1.78e-1)" "unprognostic (8.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.66e-2)" "unprognostic (6.19e-4)" "unprognostic (1.13e-1)" "unprognostic (3.69e-2)" "unprognostic (7.52e-4)" "unprognostic (1.27e-1)" "unprognostic (2.70e-1)" "unprognostic (1.37e-1)" 0.3 0.3 0.6 0.0 0.8 0.1 0.3 0.4 0.8 0.1 0.0 0.0 1.8 0.2 1.2 0.1 0.1 0.1 0.5 0.3 0.5 2.6 0.7 0.2 0.1 0.7 1.2 0.4 0.0 0.1 14.1 0.0 0.6 0.4 0.1 0.0 0.1 0.0 9.8 0.1 2.4 0.9 0.2 0.4 1.0 0.0 0.1 1.8 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.8 0.4 0.8 0.3 0.5 0.7 1.2 0.4 0.4 0.4 1.8 0.5 0.1 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" Q5VU97 1 64470129-64693058 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Astrocytes: 283.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA 310000 "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 11.0 13.2 18.4 2.0 17.3 0.1 11.9 8.4 11.4 12.0 20.5 2.9 1.6 10.9 9.2 3.8 14.5 4.5 3.4 13.9 15.6 6.4 1.9 9.0 2.0 13.8 17.9 12.0 22.8 7.3 7.0 9.2 10.2 8.9 8.2 2.7 6.4 8.2 7.6 2.9 7.6 3.5 9.7 7.3 4.5 6.7 2.3 21.3 5.1 6.4 5.4 1.6 6.0 10.7 7.5 0.3 1.7 41.3 6.1 16.1 5.6 0.0 5.9 7.8 10.0 9.7 24.8 0.2 0.0 16.8 9.7 8.0 3.1 23.4 5.0 10.4 4.6 12.2 8.9 2.9 0.0 0.0 3.8 0.1 5.0 3.4 1.2 6.2 6.0 5.7 6.0 0.0 0.0 0.0 0.7 0.8 0.0 56.5 0.3 4.2 5.2 4.2 0.0 0.0 1.3 2.1 23.5 12.7 0.0 5.2 35.4 1.7 0.5 3.7 1.0 7.3 29.1 5.3 0.0 0.0 0.0 1.0 0.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.4 17.3 8.4 11.4 13.9 15.6 13.8 17.9 12.0 8.9 7.3 21.3 7.5 25.2 6.4 49.9 283.7 0.1 17.3 7.5 6.1 6.8 15.5 8.3 7.0 1.3 0.0 11.5 3.7 0.0 0.0 0.2 0.1 0.0 2.3 9.5 14.0 8.1 20.2 0.0 0.0 19.4 2.7 0.1 11.1 5.6 16.9 2.5 26.0 4.2 1.3 0.2 0.0 6.9 0.2 4.1 0.3 6.1 4.1 14.3 0.8 1.8 24.4 0.2 6.4 0.0 57.8 1.8 1.2 0.1 3.0 0.0 2.0 0.5 4.2 10.2 1.3 6.6 25.2 6.4 0.5 0.8 2.9 14.8 0.0 0.9 0.8 0.5 5.1 CDC42SE2 "FLJ21967, SPEC2" ENSG00000158985 "CDC42 small effector 2" Q9NRR3 5 131245493-131398447 "Predicted intracellular proteins" "Cell shape, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-cells: 242.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038624 Enhanced NA NA "HPA038624: AB_10670783" "unprognostic (1.26e-1)" "unprognostic (1.19e-2)" "prognostic favorable (4.50e-5)" "unprognostic (2.37e-3)" "unprognostic (7.38e-2)" "unprognostic (4.31e-2)" "unprognostic (2.91e-3)" "unprognostic (2.11e-1)" "unprognostic (2.37e-1)" "unprognostic (8.65e-3)" "unprognostic (2.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-3)" "unprognostic (5.44e-2)" "unprognostic (3.31e-1)" "unprognostic (1.67e-1)" "prognostic favorable (7.50e-4)" 16.7 10.7 34.7 54.0 37.8 79.5 23.0 31.8 40.6 22.3 25.7 47.0 39.6 18.8 21.2 13.3 16.8 27.7 11.3 39.4 35.0 31.1 21.9 24.9 81.9 33.5 35.0 35.3 19.0 27.5 24.1 12.4 15.3 34.0 20.6 48.8 7.2 16.6 16.1 13.0 17.0 45.9 17.3 34.6 58.3 32.3 31.1 33.9 49.1 37.0 11.1 67.0 29.6 9.9 41.9 31.6 33.8 22.4 33.4 22.4 11.5 42.2 23.0 14.8 15.4 15.9 37.4 86.7 49.5 50.5 16.4 25.9 22.1 17.6 43.4 22.4 88.2 11.1 39.9 13.9 24.0 27.9 48.2 51.5 15.2 81.2 21.0 46.7 15.9 23.3 56.5 27.2 67.1 26.5 20.4 84.1 51.8 18.2 21.6 10.1 43.5 38.1 63.2 67.6 51.3 23.8 18.1 32.1 20.4 29.6 31.9 24.4 55.9 29.3 21.3 18.4 12.8 28.9 42.1 66.4 62.4 19.1 54.0 18.9 233.4 42.8 134.4 111.5 44.7 131.1 74.9 131.4 137.7 64.1 51.5 131.6 148.6 114.7 113.4 44.6 54.6 117.9 181.4 34.7 37.8 31.8 40.6 39.4 35.0 33.5 35.0 35.3 34.0 34.6 33.9 41.9 38.0 32.1 20.6 44.1 166.8 54.2 38.5 45.6 21.6 9.2 30.6 22.4 14.4 52.9 30.0 104.8 8.4 35.4 211.5 148.6 99.7 50.9 29.2 73.7 27.2 33.7 85.6 37.5 84.3 51.0 106.0 18.3 33.6 104.1 54.5 30.6 35.0 35.5 37.9 6.7 78.8 65.7 40.7 111.9 192.3 21.9 14.0 77.6 46.2 72.1 119.9 21.7 134.9 51.8 149.2 66.3 60.6 17.3 113.1 54.4 79.3 148.0 27.3 7.5 0.0 17.7 22.1 58.7 57.7 11.8 45.5 24.8 242.7 15.7 67.2 60.8 RAPGEF6 "PDZ-GEF2, PDZGEF2, RA-GEF-2" ENSG00000158987 "Rap guanine nucleotide exchange factor 6" Q8TEU7 5 131423921-131635231 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.7" "Cell type enhanced" "Detected in many" "Astrocytes: 119.1;Excitatory neurons: 243.0;Inhibitory neurons: 253.7;Microglial cells: 182.7;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 479.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037982, HPA037983" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" "unprognostic (1.86e-1)" "unprognostic (5.16e-2)" "unprognostic (5.64e-2)" "unprognostic (2.69e-1)" "unprognostic (3.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (3.72e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (3.57e-1)" "unprognostic (4.10e-2)" "unprognostic (6.31e-2)" "unprognostic (2.81e-4)" 3.9 5.1 8.0 12.8 8.6 12.7 7.5 35.7 12.1 4.7 0.5 5.0 3.9 4.8 4.8 4.1 4.0 5.7 3.1 10.4 11.5 4.2 6.5 7.0 21.3 16.4 12.7 5.7 6.0 4.2 6.8 2.9 5.9 19.8 4.9 5.7 8.2 4.1 3.5 3.5 4.7 4.2 4.1 4.7 8.9 4.8 12.2 12.0 15.2 5.0 3.4 18.2 5.7 3.5 17.4 9.6 6.6 9.8 9.4 5.1 5.6 9.4 10.5 8.4 8.6 13.1 13.0 6.6 22.2 6.7 7.4 14.1 8.5 13.1 11.9 17.8 11.1 7.6 13.8 9.6 7.6 4.3 9.9 14.3 4.3 6.4 12.8 12.9 6.2 7.9 12.6 8.0 13.2 8.0 5.1 10.3 9.2 4.6 5.5 5.2 15.0 13.5 12.2 6.8 7.5 34.5 7.5 11.3 5.3 13.4 10.9 6.8 8.7 7.8 11.6 8.1 9.5 11.9 7.7 9.7 23.9 6.7 13.2 10.0 2.3 2.1 7.8 6.8 2.4 11.6 5.0 9.2 7.5 1.6 5.8 15.4 11.2 9.9 6.4 1.9 1.9 11.7 7.1 8.0 8.6 35.7 12.1 10.4 11.5 16.4 12.7 5.7 19.8 4.7 12.0 17.4 5.8 12.8 15.5 119.1 29.1 15.8 5.2 3.7 14.8 11.7 7.2 5.5 4.1 1.5 6.6 7.3 20.9 6.1 7.7 6.0 1.9 4.7 36.4 5.8 5.1 7.0 13.8 13.3 243.0 2.8 3.2 7.0 8.2 9.9 2.5 9.7 7.9 6.0 7.8 1.7 253.7 7.9 0.0 11.4 23.1 16.4 4.4 12.0 14.2 182.7 10.2 3.0 13.4 189.0 479.5 4.1 5.8 5.3 19.1 7.1 3.4 2.3 7.8 8.5 0.0 6.2 6.1 12.7 9.7 10.9 17.5 7.0 28.4 4.0 6.2 6.2 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 80.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 41.2" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 136.3;K-562: 136.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 105.6" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 1100000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 11.1 10.3 2.7 22.1 15.0 63.9 14.3 41.2 6.0 14.6 6.8 23.8 17.8 10.3 5.4 16.8 6.4 15.1 9.8 1.7 6.5 12.8 21.9 15.2 37.7 7.2 7.7 2.2 16.4 19.0 15.7 4.7 7.3 16.6 15.2 23.3 80.7 19.3 9.1 16.0 15.4 23.5 10.0 4.4 23.1 27.2 10.5 5.4 69.7 15.4 13.9 37.3 15.6 1.9 5.8 27.0 6.9 62.3 29.4 5.2 0.8 19.5 6.9 10.1 8.4 10.5 16.8 31.2 49.1 17.2 9.2 13.5 11.9 78.7 6.6 8.6 86.4 23.8 136.3 19.7 28.6 10.1 45.8 88.2 1.7 18.4 8.2 13.8 19.9 14.1 73.5 136.5 36.2 0.1 8.8 72.3 30.4 62.0 44.1 10.0 110.9 28.2 68.3 7.7 33.3 78.0 60.5 19.7 19.2 43.3 21.7 14.7 18.2 1.2 0.3 13.3 12.9 13.4 52.5 72.4 85.2 12.1 47.8 6.8 33.3 3.2 21.4 12.9 1.1 15.4 17.2 18.3 14.1 4.4 13.6 22.1 12.7 44.2 10.9 1.5 4.4 28.9 15.3 2.7 15.0 41.2 6.0 1.7 6.5 7.2 7.7 2.2 16.6 4.4 5.4 5.8 25.3 19.2 71.7 20.2 58.2 10.5 8.6 7.8 15.4 151.6 20.0 12.2 21.5 20.0 16.8 16.5 137.6 2.4 75.3 26.5 17.6 17.1 16.4 11.3 4.1 15.1 41.6 187.1 76.3 18.7 4.2 7.9 29.6 29.1 24.1 24.9 17.5 30.0 7.1 21.9 61.7 29.0 16.2 23.7 9.0 22.7 2.1 32.4 0.0 78.7 29.3 15.7 85.5 7.5 4.8 28.6 20.3 2.2 46.7 12.2 32.8 13.4 15.2 171.4 13.1 2.8 8.5 39.3 55.7 14.9 16.8 4.1 71.6 4.2 33.0 12.6 MIS18A "B28, C21orf45, C21orf46, FASP1, hMis18alpha" ENSG00000159055 "MIS18 kinetochore protein A" Q9NYP9 21 32268228-32279049 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 109.9;Spermatogonia: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA018286, HPA020585" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA018286: AB_1845693, HPA020585: AB_1845694" "unprognostic (1.19e-1)" "unprognostic (1.55e-2)" "unprognostic (4.44e-2)" "unprognostic (1.98e-3)" "unprognostic (3.45e-2)" "unprognostic (2.29e-2)" "unprognostic (1.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.19e-2)" "unprognostic (4.39e-3)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" "unprognostic (3.34e-2)" "unprognostic (1.85e-2)" "unprognostic (1.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.28e-1)" 4.4 5.4 4.7 7.5 4.7 17.0 7.7 5.5 5.6 4.1 4.3 9.6 8.4 6.7 6.3 8.6 5.7 3.3 3.6 5.1 4.5 6.4 6.2 3.8 11.2 4.5 4.5 4.7 9.7 4.3 4.0 3.0 7.5 4.7 5.4 10.7 4.2 5.3 4.0 3.2 8.3 9.2 5.0 4.4 6.1 6.7 21.6 4.5 16.6 3.7 2.5 12.2 4.9 5.1 5.3 63.6 15.5 43.8 42.2 6.5 11.2 67.0 32.6 16.8 31.5 27.1 31.0 34.2 69.0 23.6 12.5 37.8 21.1 43.3 24.8 37.6 39.7 48.3 79.3 16.8 40.4 4.3 68.7 25.8 4.9 10.6 26.5 18.9 10.3 22.4 68.9 93.9 56.3 31.1 43.5 79.0 61.9 90.7 43.7 45.0 68.1 65.4 64.4 22.1 21.4 52.4 25.8 49.9 41.7 30.9 31.3 50.8 41.4 13.2 39.2 72.6 30.9 34.1 30.3 51.8 86.8 25.0 108.9 36.4 4.6 7.7 13.0 14.3 10.6 14.4 30.0 15.7 16.6 7.4 29.6 21.4 15.7 2.5 16.9 19.8 20.0 23.5 9.3 4.7 4.7 5.5 5.6 5.1 4.5 4.5 4.5 4.7 4.7 4.4 4.5 5.3 8.4 19.2 8.9 1.6 9.5 15.6 7.7 16.9 9.1 9.2 15.0 17.5 5.3 11.5 10.9 11.0 4.2 36.8 11.2 5.6 13.7 13.2 7.5 16.6 12.8 8.4 6.1 22.9 6.8 12.3 53.1 12.4 5.1 15.0 3.8 29.7 12.5 7.4 16.6 8.4 5.2 21.1 14.2 6.3 6.2 7.4 10.5 6.5 5.4 2.8 7.8 10.1 18.6 5.5 6.5 10.8 6.2 10.1 13.9 5.6 3.0 17.2 10.6 7.3 19.7 16.1 12.0 109.9 86.0 20.1 14.8 14.6 7.8 16.5 20.0 5.9 ALG8 MGC2840 ENSG00000159063 "ALG8 alpha-1,3-glucosyltransferase" Q9BVK2 11 78095244-78139660 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA051898: AB_2681656" "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 21.6 33.3 13.7 13.5 15.1 9.3 25.9 14.7 16.5 18.7 15.7 17.6 13.4 16.1 33.5 19.2 19.0 12.1 17.6 13.7 15.1 22.6 47.5 15.2 14.7 14.8 14.1 13.9 22.3 24.0 23.9 19.9 18.8 14.7 19.3 22.0 10.5 21.9 18.1 12.2 16.3 15.6 16.5 14.6 18.5 20.3 43.9 14.3 17.9 22.6 9.0 20.0 18.6 16.1 16.0 27.8 74.4 62.8 56.6 63.7 42.5 37.6 38.6 57.8 68.6 67.4 127.9 102.0 61.4 74.5 51.5 92.3 86.5 87.0 56.5 111.9 46.3 50.8 74.3 56.5 62.2 38.9 71.8 39.6 34.4 36.4 81.8 37.9 37.5 50.3 58.0 98.2 65.8 97.7 38.6 53.3 61.9 81.9 200.5 38.1 63.6 32.6 168.3 70.0 40.4 20.2 44.8 62.0 102.2 29.4 65.6 106.5 50.8 32.0 43.5 50.6 102.5 35.1 46.6 88.0 80.3 26.7 71.4 84.4 1.2 30.0 5.4 25.1 34.5 29.1 37.2 25.5 25.7 34.2 31.3 29.7 26.2 2.6 29.1 39.9 33.1 22.5 27.6 13.7 15.1 14.7 16.5 13.7 15.1 14.8 14.1 13.9 14.7 14.6 14.3 16.0 11.9 12.8 11.6 12.4 21.0 10.5 23.3 49.6 26.2 14.7 18.3 16.3 6.9 20.0 35.2 20.2 18.8 53.8 9.1 7.0 5.9 24.4 18.9 11.0 16.9 17.2 7.8 9.9 21.3 25.4 59.5 19.4 11.7 13.8 11.4 36.4 9.3 40.2 31.4 16.8 18.0 15.9 32.6 17.0 10.8 14.0 18.0 15.3 26.6 12.2 12.3 8.2 21.6 13.0 20.7 17.7 6.4 15.8 43.1 16.9 7.7 15.8 21.7 13.5 0.0 14.2 19.6 105.0 37.8 20.9 8.9 32.7 15.2 16.9 16.8 15.2 FBXW5 "DKFZP434B205, Fbw5, MGC20962" ENSG00000159069 "F-box and WD repeat domain containing 5" Q969U6 9 136940435-136944738 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 253.8" "Cell type enhanced" "Detected in all" "Early spermatids: 581.9;Late spermatids: 1900.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046615 Approved Approved Mitochondria No No Mitochondria "HPA046615: AB_10965648" "unprognostic (1.11e-1)" "unprognostic (1.10e-2)" "unprognostic (1.56e-2)" "prognostic favorable (1.02e-4)" "unprognostic (4.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-2)" "unprognostic (7.16e-3)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (3.51e-3)" "unprognostic (3.23e-2)" "prognostic favorable (4.74e-4)" "unprognostic (1.73e-2)" "unprognostic (3.64e-1)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" 54.1 58.6 23.4 23.5 19.0 29.0 47.8 19.9 32.7 35.9 19.3 70.0 43.3 44.4 9.5 71.4 34.2 17.9 97.5 30.7 20.1 54.1 133.5 37.9 22.3 22.8 24.1 21.1 29.4 76.3 19.1 41.5 15.6 22.2 56.7 13.5 3.9 55.3 27.1 190.3 42.4 59.8 17.4 20.8 48.0 65.6 253.8 28.5 24.9 42.8 66.6 17.8 59.9 41.9 20.3 39.2 65.5 14.9 36.7 36.6 23.6 85.7 40.6 27.5 27.7 15.3 42.9 48.8 27.0 46.0 42.0 21.5 48.0 13.6 35.3 4.6 35.4 47.2 22.9 88.8 46.8 40.0 34.2 55.2 26.9 31.0 25.4 21.1 21.9 28.9 19.5 46.0 42.7 21.3 98.3 26.2 36.4 26.7 48.1 70.6 28.7 22.5 46.3 24.5 37.9 30.9 30.0 49.0 52.8 54.4 5.7 60.3 52.4 55.8 39.5 35.1 75.1 35.1 33.6 45.1 17.0 55.0 29.7 30.5 62.8 62.1 88.0 97.7 74.3 75.3 39.2 73.9 83.3 59.6 31.1 32.0 53.7 32.9 55.4 61.2 98.8 96.8 72.8 23.4 19.0 19.9 32.7 30.7 20.1 22.8 24.1 21.1 22.2 20.8 28.5 20.3 61.3 19.2 45.4 13.1 40.7 28.7 44.5 129.0 26.7 29.9 50.1 48.8 86.9 50.1 72.8 23.9 16.7 68.3 108.0 336.5 74.3 111.7 581.9 29.1 27.5 53.6 67.3 36.8 15.9 148.1 132.9 38.9 98.4 38.6 28.6 116.2 46.1 113.3 88.0 60.6 15.3 153.7 65.1 62.6 49.3 1900.7 51.6 69.2 69.4 8.4 124.9 59.1 83.4 11.1 17.1 132.5 238.0 71.1 59.4 84.6 420.9 134.1 43.5 37.3 59.2 33.5 59.0 224.3 47.4 47.1 35.9 101.4 66.6 49.4 127.6 70.0 CFAP298 "C21orf48, C21orf59, CILD26, FBB18, FLJ20467, Kur" ENSG00000159079 "Cilia and flagella associated protein 298" P57076 21 32592079-32612603 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.0;Distal tubular cells: 78.2;Ductal cells: 78.5;Endometrial ciliated cells: 272.0;Extravillous trophoblasts: 70.2;Proximal tubular cells: 95.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA018453, HPA019055, HPA028849, CAB034170" Enhanced NA NA "CAB034170: AB_1564311, HPA018453: AB_1845700, HPA019055: AB_1845701, HPA028849: AB_10602111" "unprognostic (9.76e-2)" "unprognostic (2.99e-1)" "unprognostic (2.39e-1)" "prognostic favorable (8.90e-4)" "unprognostic (1.55e-1)" "unprognostic (2.80e-2)" "unprognostic (5.05e-3)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.81e-3)" "unprognostic (2.07e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.74e-2)" "unprognostic (1.04e-2)" "unprognostic (1.21e-1)" "unprognostic (4.37e-2)" 22.1 29.4 30.7 12.3 29.2 14.1 25.2 34.4 37.3 27.8 35.3 26.4 14.2 27.2 21.4 31.0 35.9 12.1 25.5 29.5 29.6 32.7 29.2 25.3 16.7 28.8 29.9 29.4 27.2 36.6 21.4 49.1 12.4 30.1 31.0 13.9 27.8 29.0 10.6 35.5 26.6 23.1 11.5 28.1 23.9 29.5 62.6 30.1 16.1 33.8 11.8 16.7 24.9 26.5 28.5 47.5 26.1 21.4 37.3 11.9 9.2 43.6 23.9 16.1 22.8 15.0 41.9 33.2 36.3 26.4 18.3 24.6 21.9 30.9 29.5 19.5 25.8 53.6 44.5 37.1 57.6 17.2 50.8 31.8 7.8 28.5 37.6 22.8 22.4 16.1 40.6 96.8 18.9 16.4 56.9 49.7 86.8 99.2 63.1 31.6 37.2 24.0 76.5 50.9 26.3 113.8 49.4 35.1 46.5 65.2 21.9 48.6 54.3 24.6 19.6 24.0 32.6 30.4 43.7 66.9 66.0 38.5 68.4 25.3 12.8 13.9 16.2 13.4 15.3 11.1 20.8 17.9 19.0 17.1 24.6 19.9 18.2 1.3 19.9 19.6 23.8 21.4 18.8 30.7 29.2 34.4 37.3 29.5 29.6 28.8 29.9 29.4 30.1 28.1 30.1 28.5 38.3 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 35.8 40.4 0.0 0.0 0.0 46.0 0.0 74.0 28.0 0.0 78.2 78.5 0.0 272.0 34.3 13.2 0.0 0.0 0.0 53.2 70.2 11.1 0.0 45.8 0.0 22.5 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 19.7 0.0 0.0 0.0 0.0 50.9 0.0 0.0 4.3 0.0 0.0 95.1 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 38.0 12.3 28.3 0.0 0.0 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728040 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.3;retina: 48.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 7.0 6.9 10.6 5.3 23.9 24.0 6.5 2.6 48.3 6.2 4.4 5.7 4.0 5.2 5.2 4.6 5.0 5.2 6.3 23.3 13.0 7.4 5.7 8.1 6.3 21.4 9.7 22.6 4.8 4.9 8.5 13.9 9.8 28.1 4.6 5.5 48.8 4.8 3.7 7.7 5.1 6.3 5.0 0.0 8.0 5.0 10.3 12.1 7.2 7.4 6.5 4.8 5.6 5.5 37.7 5.5 2.9 5.0 5.7 8.9 7.1 10.3 11.3 6.2 6.8 5.7 6.1 2.6 2.0 3.8 6.9 8.9 5.0 8.9 6.8 8.4 6.8 8.1 13.8 8.7 3.5 4.8 5.6 11.7 4.1 4.9 12.0 6.1 5.8 10.8 7.3 10.6 11.6 9.0 5.5 5.5 5.1 3.4 6.4 6.0 6.1 11.1 7.4 7.5 4.3 5.6 4.5 14.0 8.4 5.6 6.9 7.8 7.2 11.2 10.0 5.3 8.2 6.4 6.0 7.8 4.4 8.0 10.7 8.7 3.4 2.9 6.9 1.2 5.2 2.0 0.1 1.9 2.0 2.5 0.3 2.2 2.2 9.1 0.5 4.7 1.4 2.6 1.1 10.6 23.9 2.6 48.3 23.3 13.0 21.4 9.7 22.6 28.1 0.0 12.1 37.7 10.2 6.4 5.4 22.9 3.9 4.8 1.9 3.1 8.0 24.8 3.8 2.5 10.0 2.8 4.0 1.8 45.9 17.7 7.0 4.8 5.9 2.0 19.9 2.4 4.7 11.9 3.0 5.0 110.9 1.3 9.8 5.3 4.1 3.6 3.8 2.2 11.0 4.2 10.1 10.1 91.5 2.0 0.0 18.6 5.7 11.3 2.8 15.7 1.8 31.9 6.5 21.8 4.1 49.3 61.0 2.8 5.3 4.5 8.6 2.7 6.2 6.5 4.6 45.4 6.6 6.1 5.8 22.1 13.3 6.7 3.3 38.0 9.9 2.8 5.4 4.3 PAXBP1 "C21orf66, fSAP105, GCFC, GCFC1" ENSG00000159086 "PAX3 and PAX7 binding protein 1" Q9Y5B6 21 32733899-32771792 "Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 155.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003757 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003757: AB_10600796" "unprognostic (8.21e-2)" "unprognostic (7.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (6.53e-2)" "unprognostic (2.03e-3)" "unprognostic (2.38e-3)" "unprognostic (2.54e-2)" "unprognostic (6.89e-2)" "unprognostic (2.65e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (9.43e-4)" "prognostic unfavorable (1.50e-5)" "unprognostic (3.16e-1)" "unprognostic (3.78e-2)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" 5.6 6.3 8.3 6.4 9.0 28.9 7.3 10.8 9.8 7.2 9.1 6.6 10.3 8.4 7.3 5.8 7.5 5.0 4.6 7.8 10.0 6.7 6.6 6.3 9.5 9.0 8.7 7.9 11.0 7.0 4.8 5.9 6.4 8.9 5.9 7.6 13.2 5.7 5.2 9.4 8.1 8.0 5.3 8.5 7.5 5.6 8.3 8.7 10.2 6.2 6.8 8.1 6.4 6.0 11.3 14.5 11.5 24.4 19.7 9.2 7.4 32.0 10.4 7.0 13.7 10.0 24.3 12.8 16.9 7.9 6.2 10.9 14.1 23.7 9.8 14.5 14.0 18.2 29.6 19.7 17.9 4.5 33.6 17.1 3.9 14.5 16.0 7.5 9.7 9.5 18.4 34.3 15.9 10.3 12.6 23.1 19.8 64.5 16.4 11.0 21.1 22.0 25.0 11.0 13.1 19.3 11.2 15.2 17.3 12.1 15.1 11.3 18.7 8.2 10.5 13.7 11.8 16.5 15.5 19.8 31.0 7.8 30.0 10.7 0.0 0.3 0.1 0.6 0.1 0.8 0.5 0.7 0.5 0.4 0.6 0.7 0.7 0.0 0.2 0.2 0.3 0.4 0.1 8.3 9.0 10.8 9.8 7.8 10.0 9.0 8.7 7.9 8.9 8.5 8.7 11.3 28.9 12.8 21.6 62.3 22.0 25.5 21.5 5.6 31.3 50.6 26.0 20.2 12.3 21.5 15.3 20.2 62.6 16.7 39.2 19.4 5.9 7.4 36.8 47.8 51.6 22.3 22.1 17.9 61.6 8.0 12.1 27.1 30.1 45.6 12.0 42.4 15.4 12.7 10.2 21.9 66.1 23.7 6.1 13.9 19.3 32.8 14.6 24.3 21.4 55.3 14.1 28.6 24.7 117.6 155.4 6.8 12.8 17.0 29.1 25.1 17.4 7.9 24.5 81.6 32.9 51.5 23.5 32.2 18.2 26.5 25.4 17.8 29.4 26.3 21.7 32.4 IFNAR2 IFNABR ENSG00000159110 "Interferon alpha and beta receptor subunit 2" P48551 21 33229901-33265675 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 211.2;U-266/70: 261.6;U-266/84: 145.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1500000 "unprognostic (2.00e-2)" "unprognostic (7.83e-3)" "unprognostic (4.98e-2)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-3)" "unprognostic (8.05e-2)" "unprognostic (4.17e-2)" "unprognostic (2.11e-2)" "unprognostic (7.65e-2)" "unprognostic (4.42e-1)" "prognostic unfavorable (7.54e-7)" "unprognostic (9.70e-3)" "unprognostic (2.39e-1)" "unprognostic (5.12e-3)" "unprognostic (1.85e-2)" 21.5 9.1 13.4 33.5 13.0 29.4 16.5 11.4 15.0 12.8 12.2 16.9 17.5 11.8 8.3 8.1 11.8 21.2 13.1 10.6 15.6 12.7 29.0 22.8 33.8 16.8 13.5 8.8 11.9 10.1 12.6 10.2 23.1 14.5 10.2 17.6 8.4 13.8 11.4 9.1 7.1 16.4 18.5 13.0 41.4 14.9 5.4 16.9 34.2 10.8 10.9 36.7 38.6 9.1 17.1 17.0 18.4 9.9 23.7 11.9 27.3 16.2 18.1 45.1 14.2 15.7 24.4 20.8 28.3 12.8 25.4 22.8 10.9 15.2 9.2 15.0 18.3 19.9 100.9 19.1 22.2 17.5 17.5 38.0 20.7 8.7 16.8 18.5 24.8 46.0 41.5 30.2 211.2 13.7 9.1 44.0 19.6 18.3 24.2 11.7 14.9 53.4 50.7 30.8 31.9 26.6 14.2 29.5 28.2 23.9 10.4 4.4 30.5 32.2 15.3 9.3 12.5 10.1 261.6 145.3 64.3 20.5 60.3 37.5 44.5 38.5 63.8 31.2 65.0 32.2 25.7 37.9 29.3 36.6 17.1 27.5 30.8 101.2 35.2 73.4 101.0 65.8 41.3 13.4 13.0 11.4 15.0 10.6 15.6 16.8 13.5 8.8 14.5 13.0 16.9 17.1 35.6 60.9 16.1 19.6 49.4 6.8 43.8 41.7 2.8 6.6 11.4 12.4 2.2 20.0 23.6 11.0 6.2 28.9 64.4 6.0 3.9 67.5 3.0 6.7 10.0 39.0 3.0 27.6 44.4 62.7 72.1 15.4 4.6 8.5 31.7 11.8 44.6 19.6 44.9 20.2 42.3 4.4 4.1 73.5 17.1 3.3 7.5 58.5 19.6 74.9 47.9 6.4 89.6 51.3 29.4 73.8 5.9 9.1 188.8 89.5 17.3 10.2 35.2 5.6 0.0 16.8 12.5 4.2 19.9 4.3 5.7 23.5 43.9 2.5 4.9 83.2 MRPL10 "L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8" ENSG00000159111 "Mitochondrial ribosomal protein L10" Q7Z7H8 17 47823272-47831541 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021234, HPA029885" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA021234: AB_1854098, HPA029885: AB_2673233" "unprognostic (6.84e-3)" "unprognostic (1.03e-1)" "unprognostic (8.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.97e-1)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.21e-2)" "unprognostic (1.03e-1)" "unprognostic (8.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.16e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-1)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.87e-2)" 31.1 33.1 35.7 14.5 36.3 24.9 29.9 36.5 40.0 30.3 33.3 37.0 25.9 31.7 23.0 27.3 30.1 22.1 55.5 34.7 36.7 31.5 30.1 20.3 26.4 36.3 35.9 34.3 49.3 41.4 29.1 17.4 23.4 36.0 25.0 23.4 21.9 22.2 25.8 64.8 23.3 26.9 26.7 35.5 28.4 36.5 20.2 36.3 26.2 23.2 52.9 27.1 38.2 25.6 36.6 36.8 80.0 33.4 33.0 78.3 71.3 61.6 32.2 54.0 54.2 46.4 155.7 49.2 59.1 71.9 42.0 36.0 33.6 48.3 62.6 48.0 57.6 76.4 47.2 41.7 110.0 67.4 42.8 25.5 80.8 53.2 64.4 90.7 63.7 52.9 58.4 64.8 56.6 42.3 73.3 43.2 55.0 55.1 64.0 76.5 34.7 63.7 66.5 59.9 35.8 39.2 63.2 23.9 26.9 68.7 62.9 81.2 45.5 32.3 47.5 39.0 32.3 45.1 100.1 82.4 48.0 41.4 32.3 32.4 29.8 37.3 18.5 61.6 39.6 59.1 31.8 42.4 55.3 43.0 36.6 35.6 42.2 14.5 26.6 32.9 26.0 52.5 42.0 35.7 36.3 36.5 40.0 34.7 36.7 36.3 35.9 34.3 36.0 35.5 36.3 36.6 17.1 6.4 13.6 4.2 19.2 12.5 20.8 42.5 27.9 15.3 25.3 31.5 31.5 20.0 19.5 14.7 6.2 90.5 50.9 17.9 46.9 43.8 22.0 7.9 16.3 21.7 8.5 30.3 5.4 54.7 60.0 23.3 20.4 11.0 8.8 31.8 20.7 15.6 41.7 32.0 6.6 20.7 32.6 31.4 10.8 30.5 24.5 17.3 16.0 2.8 31.8 24.4 44.3 7.1 8.2 40.4 14.7 24.0 22.8 18.4 30.8 47.5 6.1 13.7 6.6 17.5 28.0 23.2 29.2 24.1 12.5 77.3 48.5 49.4 31.9 18.8 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33403413-33479348 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Prostatic glandular cells: 433.1;Urothelial cells: 602.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 661.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 73.1 41.4 6.8 8.6 6.4 47.0 66.2 2.5 13.2 47.2 12.7 41.5 14.4 31.5 3.5 67.9 38.2 11.7 44.6 7.1 12.7 48.3 43.5 62.3 10.7 9.0 5.0 6.0 39.1 32.3 5.7 38.1 18.8 6.7 48.6 8.0 1.0 65.1 6.3 30.2 53.7 52.0 8.7 11.8 81.4 36.1 29.8 9.4 8.2 52.7 10.3 11.9 46.8 57.3 11.8 10.1 10.2 5.9 9.7 16.6 28.2 13.1 30.4 30.0 8.9 13.8 11.3 7.7 15.6 19.8 23.8 24.2 8.6 10.9 25.6 3.1 76.3 44.9 6.0 5.0 12.2 11.0 19.5 17.7 21.4 17.0 14.7 16.6 15.9 20.1 9.9 33.4 11.9 10.2 4.4 5.0 23.2 18.1 15.8 48.0 20.2 14.1 19.6 8.5 10.8 7.9 15.5 19.3 1.9 38.4 1.5 7.1 17.7 30.8 10.1 22.0 8.9 8.8 24.6 28.2 25.4 8.5 23.3 44.7 221.7 283.8 181.7 0.9 281.2 1.2 145.6 16.4 1.7 104.0 158.2 37.7 16.3 661.8 3.5 314.8 31.9 19.2 198.5 6.8 6.4 2.5 13.2 7.1 12.7 9.0 5.0 6.0 6.7 11.8 9.4 11.8 72.2 41.7 20.5 9.1 101.4 72.0 225.1 164.8 147.4 9.0 69.3 39.2 18.4 38.6 58.2 27.6 8.4 33.6 11.2 185.3 27.4 117.8 44.6 32.1 51.0 55.1 51.6 17.7 18.7 55.7 86.1 66.8 62.7 50.4 60.3 52.1 40.0 29.6 167.6 15.2 18.9 56.2 57.0 154.5 146.7 60.8 42.0 190.8 56.9 45.0 246.6 8.7 6.2 15.6 5.0 138.6 150.3 32.7 67.9 433.1 151.9 50.1 25.4 8.4 13.1 61.3 33.7 13.4 2.8 90.5 70.0 17.4 16.9 3.4 41.3 602.7 GART "GARS-AIRS-GART, PGFT, PRGS" ENSG00000159131 "Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase" P22102 21 33503931-33543491 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Ligase, Multifunctional enzyme, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002119, HPA005779" Approved Approved Mitochondria,Cytosol NA NA 300000 Cytosol Mitochondria "HPA002119: AB_1849482, HPA005779: AB_1849484" "unprognostic (3.77e-2)" "unprognostic (2.25e-2)" "unprognostic (4.51e-3)" "unprognostic (1.72e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (5.05e-5)" "prognostic unfavorable (9.82e-5)" "unprognostic (2.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.98e-3)" "prognostic unfavorable (3.95e-6)" "unprognostic (1.36e-2)" "unprognostic (2.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" 24.3 20.4 9.4 24.5 11.8 19.0 24.6 11.0 12.0 16.6 9.9 23.4 22.3 18.4 17.2 25.0 22.0 16.0 20.9 8.5 11.5 21.1 29.9 16.1 30.6 11.1 10.8 8.4 19.2 22.5 20.0 12.9 26.3 11.4 17.1 29.4 21.0 17.0 16.9 29.3 17.5 19.6 26.5 11.1 20.2 19.9 29.6 11.0 34.7 21.0 22.1 38.9 32.5 16.6 14.0 132.2 61.5 90.3 98.8 61.1 64.2 100.3 82.6 70.8 96.8 101.5 117.7 108.9 174.8 48.5 55.6 124.9 67.9 189.0 130.4 138.3 91.3 111.7 265.2 68.5 78.6 85.2 148.6 66.3 57.3 86.5 113.3 162.5 48.1 91.5 138.4 312.4 108.5 84.9 63.6 158.2 100.0 194.4 186.3 71.8 131.1 166.6 246.7 74.7 69.4 93.1 84.1 116.9 89.1 107.1 81.0 113.0 93.9 68.7 64.9 76.9 56.1 90.9 106.8 159.6 193.0 67.1 171.3 96.2 9.0 24.0 16.3 25.9 33.9 31.4 29.7 25.2 27.1 31.6 24.5 26.4 26.2 10.6 43.9 30.6 23.2 34.1 22.8 9.4 11.8 11.0 12.0 8.5 11.5 11.1 10.8 8.4 11.4 11.1 11.0 14.0 21.1 19.2 19.8 17.3 30.1 46.0 50.3 34.1 38.1 18.5 18.6 17.3 19.3 11.5 28.0 14.7 35.5 41.2 21.8 12.4 23.5 28.4 21.7 23.3 36.9 21.9 13.1 40.3 19.1 24.2 37.4 27.2 21.4 23.4 7.6 31.8 16.1 18.0 23.6 5.0 21.1 17.1 22.4 17.0 12.0 6.6 17.4 17.0 12.4 10.3 19.8 13.3 22.6 17.6 19.3 31.5 12.7 18.0 22.7 54.3 16.4 14.3 17.8 28.5 13.1 23.0 23.9 57.2 27.6 34.4 45.9 25.6 21.2 55.0 24.1 46.6 SON "BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP" ENSG00000159140 "SON DNA and RNA binding protein" P18583 21 33543038-33577481 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, mRNA processing, mRNA splicing" "DNA-binding, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023535, HPA031755, HPA031756" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030" "unprognostic (1.58e-2)" "unprognostic (2.08e-1)" "unprognostic (4.69e-1)" "unprognostic (2.30e-1)" "unprognostic (5.63e-2)" "unprognostic (2.75e-1)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (2.31e-2)" "unprognostic (2.02e-1)" "unprognostic (1.24e-1)" "unprognostic (9.75e-2)" "unprognostic (4.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.19e-1)" "unprognostic (2.54e-1)" 68.0 63.0 46.7 58.3 53.5 163.4 65.6 57.9 59.1 59.6 69.8 62.5 45.3 67.5 62.1 61.2 69.1 43.6 59.5 45.1 56.1 49.8 60.8 65.7 81.7 49.9 48.8 41.6 77.3 63.9 93.5 64.3 61.4 53.3 61.7 56.9 92.6 64.9 53.1 90.2 63.7 68.4 51.5 50.0 72.1 67.4 48.5 48.9 93.7 64.9 54.2 76.8 63.4 56.4 67.2 105.7 59.7 126.1 72.7 108.1 98.3 89.2 77.2 88.1 73.0 69.6 89.5 75.2 163.8 45.9 114.8 86.6 76.4 152.4 113.0 109.7 85.4 77.9 220.0 78.2 111.3 79.3 215.0 110.8 100.6 128.7 88.0 124.5 91.3 110.1 91.2 172.9 150.9 101.1 101.6 121.0 112.9 136.0 108.5 60.7 121.5 133.8 118.1 109.7 102.1 84.1 77.6 124.2 100.3 91.3 103.6 93.6 128.3 116.0 83.4 73.1 66.6 87.0 144.8 143.2 193.9 84.7 172.3 78.9 33.7 20.3 28.7 20.7 18.4 20.8 30.4 22.9 22.1 15.8 28.2 22.7 22.3 37.4 22.3 24.5 38.5 22.1 15.8 46.7 53.5 57.9 59.1 45.1 56.1 49.9 48.8 41.6 53.3 50.0 48.9 67.2 374.1 410.3 298.2 201.4 355.2 433.1 312.2 310.6 250.4 389.7 213.1 219.2 351.5 320.3 298.0 301.6 221.0 224.1 423.2 276.8 193.7 209.7 97.0 296.9 412.2 342.1 186.8 375.8 93.1 207.3 164.7 333.4 208.0 335.8 418.2 216.1 304.8 344.6 170.1 455.9 105.8 256.0 219.7 237.2 307.4 66.0 393.9 261.0 218.7 146.1 256.8 335.7 347.1 131.7 162.3 190.0 217.2 393.4 294.4 250.7 198.0 225.7 288.3 372.0 381.3 505.0 399.2 470.1 334.6 197.8 394.2 327.1 378.2 183.2 246.3 226.5 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "DNA replication fork stabilization factor DONSON" Q9NYP3 21 33559542-33588706 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: AB_2676570, HPA049033: AB_2680608" "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favorable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 5.0 3.0 6.7 5.5 6.7 11.0 4.1 8.3 7.6 7.8 4.8 5.3 5.5 5.8 2.4 5.0 7.0 5.5 4.2 5.8 6.8 3.1 8.0 4.6 10.6 7.0 7.1 5.9 10.9 3.5 5.7 5.5 6.7 7.4 4.8 6.4 13.4 3.5 3.4 4.4 8.6 6.1 4.6 6.4 3.7 4.9 21.4 7.0 10.7 3.5 4.9 9.3 4.8 6.3 9.0 67.9 15.5 34.8 30.4 10.7 18.5 23.9 53.7 23.2 41.2 45.1 41.9 19.7 40.5 13.9 28.3 30.6 20.0 43.6 20.2 45.1 36.5 36.5 73.8 34.9 41.5 8.1 39.0 18.2 13.9 5.7 44.4 11.1 13.1 25.1 19.8 67.0 65.2 35.4 14.7 34.0 17.2 35.9 34.8 17.3 33.2 68.4 41.3 21.3 19.0 36.0 14.8 82.1 25.3 23.1 17.1 34.9 19.4 16.4 38.0 25.3 28.6 37.7 56.8 58.1 59.3 22.1 52.1 43.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.7 8.3 7.6 5.8 6.8 7.0 7.1 5.9 7.4 6.4 7.0 9.0 6.3 3.2 1.9 10.4 4.8 8.2 8.1 3.1 5.2 2.8 5.6 5.7 3.9 7.2 2.3 3.7 10.4 13.2 7.8 3.0 1.9 3.3 57.3 3.0 6.6 8.0 1.2 42.1 9.7 4.7 27.9 6.9 7.1 4.4 8.2 7.5 7.5 6.2 8.9 6.7 11.2 4.2 6.1 3.4 6.3 25.3 10.2 5.5 7.2 4.7 4.0 2.1 4.1 7.5 12.7 3.9 2.5 13.9 19.3 5.7 2.9 4.4 2.8 3.6 0.0 4.4 7.6 62.3 33.5 7.6 9.8 16.6 7.6 3.0 6.8 9.2 SV2A "KIAA0736, SV2" ENSG00000159164 "Synaptic vesicle glycoprotein 2A" Q7L0J3 1 149903318-149917844 "FDA approved drug targets, Predicted membrane proteins" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 130.0;parathyroid gland: 48.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 111.9;Excitatory neurons: 63.4;Horizontal cells: 95.9;Inhibitory neurons: 107.2" "Cancer enriched" "Detected in many" 6 "glioma: 27.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 66.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002226, HPA007863" Enhanced Approved Cytosol NA NA Cytosol "CAB002226: AB_564144, HPA007863: AB_1080135" "unprognostic (8.05e-3)" "unprognostic (3.86e-3)" "unprognostic (2.24e-1)" "unprognostic (5.39e-2)" "unprognostic (2.66e-1)" "unprognostic (2.02e-1)" "unprognostic (6.24e-2)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (9.00e-3)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.44e-2)" "unprognostic (9.86e-2)" "unprognostic (1.95e-2)" "unprognostic (4.81e-3)" 1.5 9.0 44.3 2.9 67.8 6.1 1.6 31.7 130.0 6.0 0.0 4.1 1.5 8.4 23.6 1.6 4.9 3.3 1.1 60.0 62.3 1.7 0.5 2.0 2.1 67.1 50.4 68.3 3.5 1.5 48.8 23.1 1.4 83.3 4.3 1.8 38.9 1.3 3.8 0.5 0.9 3.1 8.0 9.9 1.7 2.5 1.1 61.6 3.8 4.4 0.5 1.7 3.1 3.9 128.0 0.3 0.0 26.0 0.1 2.6 7.4 2.8 11.2 38.8 32.6 46.7 0.8 1.2 0.3 9.9 16.9 34.3 0.6 0.3 2.4 27.9 0.1 6.2 35.2 2.0 2.0 24.5 0.3 0.5 16.7 0.2 52.3 3.9 36.2 2.9 31.7 0.4 35.8 21.8 0.3 34.8 1.7 66.3 0.0 0.2 12.0 16.4 0.7 0.2 0.9 54.2 43.8 0.1 0.4 25.6 24.6 0.4 21.4 0.2 30.1 29.9 1.2 41.3 0.2 0.5 0.2 53.0 0.3 12.3 0.4 0.1 0.0 0.3 0.0 0.3 0.1 0.3 0.2 0.0 0.2 0.1 0.4 0.3 0.3 0.0 0.1 0.6 0.1 44.3 67.8 31.7 130.0 60.0 62.3 67.1 50.4 68.3 83.3 9.9 61.6 128.0 0.8 0.0 1.1 12.4 0.3 0.1 1.9 0.7 4.6 111.9 0.7 4.2 0.8 1.5 0.1 0.0 4.2 0.3 0.7 0.3 0.0 0.1 0.6 0.4 4.6 2.4 4.2 2.1 63.4 0.4 0.6 3.3 1.5 1.3 0.0 10.9 7.5 0.1 0.3 95.9 107.2 0.4 0.0 0.0 0.9 0.2 0.0 0.3 0.0 7.5 0.0 22.9 0.0 28.1 15.7 0.2 0.1 5.7 0.5 0.9 0.1 0.1 0.9 16.1 0.0 2.7 4.9 1.3 0.9 0.4 0.4 0.4 2.7 3.0 0.5 0.7 LAD1 ENSG00000159166 "Ladinin 1" O00515 1 201380833-201399915 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 365.1;skin 1: 217.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 174.7;Ductal cells: 178.0;monocytes: 248.6;Pancreatic endocrine cells: 227.0;Proximal enterocytes: 214.7;Squamous epithelial cells: 265.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 159.9;CAPAN-2: 158.5;HaCaT: 220.4;HBEC3-KT: 190.3;hTCEpi: 181.5;MCF7: 218.3;OE19: 246.5;RT4: 164.7;SK-BR-3: 250.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007256, HPA028732" Enhanced Enhanced "Actin filaments" "Secreted to extracellular matrix" NA NA "Actin filaments" "HPA007256: AB_1852681, HPA028732: AB_10602916" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (3.82e-1)" "unprognostic (7.55e-3)" "unprognostic (4.66e-2)" "unprognostic (7.41e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.06e-1)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (9.11e-2)" "unprognostic (2.31e-2)" "unprognostic (3.71e-2)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (3.28e-1)" 0.5 0.1 0.0 16.0 0.1 0.1 15.9 0.0 0.1 33.2 0.0 68.2 76.3 5.0 11.1 365.1 14.8 50.7 5.9 0.1 0.6 34.9 21.7 10.7 2.9 0.0 0.0 0.1 0.4 51.2 2.4 0.7 4.1 0.0 15.8 51.5 0.0 52.4 22.9 5.1 217.0 75.1 2.9 0.0 1.4 67.5 0.3 0.0 6.2 3.6 0.2 48.1 72.1 136.3 0.0 159.9 1.3 0.0 0.3 0.0 0.0 57.0 0.0 0.0 0.1 0.1 127.3 158.5 0.0 8.9 0.0 0.0 220.4 0.0 190.3 0.1 0.2 0.0 0.0 0.1 79.3 0.0 0.1 0.2 0.1 181.5 0.1 36.8 0.0 0.1 0.0 0.1 0.7 0.1 218.3 0.2 0.4 3.7 246.5 2.6 0.2 7.4 2.3 126.0 164.7 9.1 0.2 0.1 250.6 3.1 5.4 37.6 0.4 0.0 0.1 0.5 0.5 0.6 0.1 0.4 0.2 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.2 35.4 0.0 0.9 88.5 112.1 47.2 46.7 0.0 15.4 14.1 2.1 110.1 31.3 31.3 0.0 3.8 0.5 174.7 45.0 178.0 1.1 26.2 2.6 1.6 18.1 0.0 0.0 121.9 5.9 2.6 85.1 34.5 0.0 0.0 0.4 9.0 0.5 0.0 0.0 53.8 18.3 0.6 16.0 3.6 0.0 2.6 10.6 0.0 248.6 0.0 0.0 0.0 0.0 227.0 109.6 0.4 2.9 77.1 214.7 71.8 4.8 0.0 0.0 0.0 3.2 0.0 0.3 265.6 152.7 10.4 1.5 0.0 136.2 150.2 STC1 STC ENSG00000159167 "Stanniocalcin 1" P52823 8 23841929-23854806 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 64.8" "Cell type enhanced" "Detected in many" "Adipocytes: 162.2;Collecting duct cells: 97.5;Endometrial ciliated cells: 84.0;Endothelial cells: 242.0;Glandular and luminal cells: 301.5;Theca cells: 214.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 348.4;hTEC/SVTERT24-B: 201.7;U-251 MG: 145.4;U-87 MG: 623.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB018625, HPA023918" Approved "Secreted in other tissues" NA NA 240000 "CAB018625: AB_2197536, HPA023918: AB_1857566" "unprognostic (1.18e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (6.44e-5)" "prognostic unfavorable (6.32e-4)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.53e-4)" "unprognostic (4.82e-2)" "unprognostic (1.44e-2)" "unprognostic (7.61e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.23e-6)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.79e-1)" "unprognostic (1.19e-3)" "unprognostic (8.95e-3)" 29.8 3.1 3.6 2.6 2.0 0.1 26.5 2.3 5.3 49.9 12.6 6.0 1.7 32.7 0.6 7.1 5.9 14.9 23.6 4.4 9.9 17.8 4.0 10.5 0.7 4.6 3.5 1.7 2.8 13.8 10.6 29.1 29.4 4.6 9.4 1.9 8.4 10.4 7.4 2.7 2.7 2.9 7.5 3.0 0.2 10.4 0.2 7.8 1.6 64.8 6.4 1.3 44.8 10.3 16.8 1.5 1.3 1.9 0.0 13.0 14.3 0.3 20.6 348.4 6.7 31.5 0.1 0.0 0.1 30.0 6.8 116.6 1.1 0.8 5.1 58.0 2.2 0.4 0.1 0.0 0.0 0.9 0.0 0.5 65.1 0.0 201.7 0.5 96.4 2.8 0.0 0.6 0.5 28.8 0.0 0.0 0.1 8.4 0.0 1.0 0.0 0.3 0.0 11.7 0.0 0.8 0.0 31.4 2.1 2.1 2.3 21.3 0.4 27.0 82.3 3.1 1.6 145.4 0.0 0.1 0.1 623.7 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.0 2.3 5.3 4.4 9.9 4.6 3.5 1.7 4.6 3.0 7.8 16.8 162.2 3.2 13.6 0.0 0.2 22.7 2.4 15.7 0.0 3.1 75.3 8.0 3.3 32.9 3.7 97.5 0.0 0.9 0.0 0.8 0.0 37.0 0.1 84.0 42.7 242.0 0.0 0.0 0.2 0.2 6.1 67.9 2.6 301.5 1.3 0.2 23.2 0.0 2.5 8.4 0.3 0.0 0.0 0.3 25.8 0.2 5.0 1.5 17.8 0.0 0.0 0.9 0.0 0.0 0.1 6.7 0.0 0.0 1.2 7.6 0.0 0.1 0.5 2.1 0.0 0.5 7.4 0.0 0.0 0.3 20.6 1.9 2.6 214.5 1.0 9.6 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 40 "skeletal muscle: 12681.1;tongue: 3186.3" "Group enriched" "Detected in some" 17 "Cardiomyocytes: 74.7;Skeletal myocytes: 176.2" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 491.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 74000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.1 0.4 0.0 0.1 0.0 0.1 1.6 0.1 0.1 0.3 0.0 0.8 2.1 1.2 0.4 195.9 0.4 1.2 60.6 0.0 0.1 10.6 1.9 1.1 0.3 0.1 0.0 0.0 0.5 1.5 0.0 0.3 0.1 0.1 86.6 0.0 0.0 57.1 0.0 12681.1 1.7 2.5 0.1 0.0 0.3 1.3 0.5 0.1 1.6 1.4 3186.3 0.4 0.2 1.5 0.1 0.9 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.6 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 491.6 0.9 0.0 0.8 0.3 0.0 0.1 0.1 0.1 4.9 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 74.7 0.0 0.0 0.0 0.0 0.4 0.0 0.7 5.9 0.0 3.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 3.6 0.0 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 176.2 2.2 0.0 0.2 0.0 0.0 0.5 1.0 0.0 0.9 0.1 CSRP1 "CSRP, CYRP, D1S181E" ENSG00000159176 "Cysteine and glycine rich protein 1" P21291 1 201483530-201509456 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 2595.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 341.2;Breast myoepithelial cells: 737.5;Extravillous trophoblasts: 388.5;Smooth muscle cells: 419.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045617 Uncertain NA NA 11000000 "HPA045617: AB_2679391" "unprognostic (7.08e-2)" "unprognostic (1.59e-2)" "unprognostic (4.86e-2)" "unprognostic (9.89e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (2.87e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (9.24e-2)" "unprognostic (2.58e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.96e-3)" 300.4 128.4 725.1 226.5 839.2 41.4 324.6 771.7 702.6 501.0 508.0 1949.3 182.2 1920.5 311.1 892.4 1034.6 154.0 145.0 672.8 737.6 194.0 115.7 389.4 65.5 855.7 857.9 602.1 321.7 115.6 189.5 117.9 119.3 785.8 955.6 436.0 24.5 252.2 2595.6 64.5 190.9 507.9 2026.8 717.2 167.0 754.6 44.5 819.1 48.4 188.0 54.2 66.3 1507.0 473.1 799.0 83.0 195.3 52.0 116.4 83.2 107.7 273.6 605.7 514.3 455.3 360.9 211.1 57.7 78.7 36.1 325.0 96.7 144.7 32.7 120.3 321.2 169.5 29.3 90.7 220.1 30.7 387.4 72.1 10.2 99.3 105.3 373.0 163.1 253.1 508.1 34.9 4.5 71.9 302.1 232.9 46.6 11.8 0.8 99.0 73.2 18.3 304.9 266.8 212.6 129.7 27.1 22.5 238.0 503.8 163.9 25.6 87.0 74.3 610.6 303.7 195.7 206.6 250.6 40.5 82.6 30.6 303.5 137.6 202.6 75.5 49.8 65.6 37.4 49.3 36.9 25.0 35.8 34.9 65.0 18.1 20.5 25.2 5.0 34.3 54.2 5.2 54.1 46.5 725.1 839.2 771.7 702.6 672.8 737.6 855.7 857.9 602.1 785.8 717.2 819.1 799.0 151.8 38.5 47.8 86.5 21.8 49.2 341.2 24.6 207.7 3.4 123.7 737.5 24.8 21.5 36.9 47.8 0.0 88.8 23.3 96.6 49.0 165.1 21.5 30.1 73.6 86.9 57.9 19.1 2.4 171.7 388.5 86.7 36.7 38.9 27.9 13.9 91.1 28.3 66.0 0.0 2.1 80.0 14.2 29.1 55.8 44.9 41.0 37.0 126.3 10.3 73.5 137.4 15.5 6.6 114.8 140.5 71.4 292.3 61.5 113.8 97.2 28.4 25.2 3.1 144.7 37.7 419.9 2.4 3.2 75.3 34.9 160.9 31.2 30.4 69.7 103.6 PRAC1 "C17orf92, PRAC" ENSG00000159182 "PRAC1 small nuclear protein" Q96KF2 17 48721719-48722518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "intestine: 208.4;prostate: 109.9" "Group enriched" "Detected in some" 5 "Distal enterocytes: 326.1;Enteroendocrine cells: 908.1;Intestinal goblet cells: 717.3;Paneth cells: 328.7;Undifferentiated cells: 624.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 291.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 32 "PC-3: 379.0" HPA047871 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047871: AB_2680195" "unprognostic (7.59e-2)" "unprognostic (2.43e-2)" "unprognostic (2.04e-1)" 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.2 0.3 2.1 0.1 107.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 109.9 208.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 12.5 12.9 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 379.0 11.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.4 0.3 0.1 0.1 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.0 0.0 110.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 326.1 0.0 0.0 0.7 0.0 0.0 0.4 908.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 717.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 328.7 0.0 0.0 101.9 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.9 0.0 624.3 63.1 HOXB13 ENSG00000159184 "Homeobox B13" Q92826 17 48724763-48728750 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 41.5;prostate: 83.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 144.7;Enteroendocrine cells: 195.2;Intestinal goblet cells: 77.0;Paneth cells: 71.3;Prostatic glandular cells: 61.9;Undifferentiated cells: 81.6" "Cancer enriched" "Detected in many" 17 "prostate cancer: 187.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 13 "PC-3: 173.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004438, HPA062852, HPA065019" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406" "unprognostic (4.81e-2)" "unprognostic (2.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.33e-2)" "unprognostic (5.85e-3)" "unprognostic (1.88e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (1.17e-2)" "unprognostic (6.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.27e-2)" "unprognostic (4.73e-11)" "unprognostic (1.39e-2)" "unprognostic (4.50e-2)" "unprognostic (1.12e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 83.0 41.5 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.6 4.6 0.0 1.9 6.0 0.0 13.2 0.0 0.0 0.5 0.6 0.0 0.2 0.0 2.5 3.0 0.0 3.0 0.0 1.4 0.0 8.7 0.0 0.1 1.0 4.2 2.5 1.5 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.7 0.0 0.0 0.3 0.0 2.2 173.0 0.0 1.4 0.1 0.0 0.4 0.0 0.0 2.7 0.0 4.4 0.5 0.0 0.5 0.0 0.5 4.7 4.7 1.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 144.7 0.0 0.0 0.6 0.0 0.0 0.2 195.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 77.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.1 0.2 0.1 81.6 14.6 C1QC C1QG ENSG00000159189 "Complement C1q C chain" P02747 1 22643633-22648110 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 959.1" "Group enriched" "Detected in many" 7 "Hofbauer cells: 1356.5;Kupffer cells: 2134.6;Macrophages: 1040.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "intermediate monocyte: 57.2" "Lineage enriched" "Detected in single" 541 "monocytes: 57.2" "Cell line enhanced" "Detected in some" "NB-4: 1.0;RPMI-8226: 2.6;U-266/70: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001471, CAB009828" Supported "Secreted to blood" NA NA 513000000 2100000000 "CAB009828: AB_2067541, HPA001471: AB_1078553" "unprognostic (2.97e-1)" "unprognostic (6.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (7.40e-2)" "unprognostic (2.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.40e-1)" "unprognostic (1.66e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" 287.8 197.9 53.0 161.2 77.3 43.8 71.1 63.7 97.9 52.4 117.0 134.5 181.6 36.6 13.6 55.8 68.0 156.8 52.8 48.7 158.2 40.9 171.0 293.3 373.3 119.4 75.5 43.6 32.4 37.8 22.2 39.9 206.6 98.0 38.1 92.1 3.9 52.1 44.9 13.0 17.1 197.4 166.3 104.7 959.1 95.7 34.2 114.0 76.4 29.4 32.1 51.2 193.6 24.8 147.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 1.0 0.2 0.0 0.0 0.6 0.2 2.6 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 1.2 53.0 77.3 63.7 97.9 48.7 158.2 119.4 75.5 43.6 98.0 104.7 114.0 147.5 13.4 6.4 5.2 0.3 13.7 8.9 1.1 0.0 2.8 0.6 4.9 24.5 1.6 15.7 3.1 0.0 0.0 5.8 2.3 0.4 0.0 0.0 3.2 0.0 0.1 34.5 0.0 27.2 0.0 0.2 9.5 4.4 0.0 0.1 5.1 0.1 25.4 6.6 1356.5 0.0 0.1 0.1 0.0 2134.6 202.4 3.6 6.2 1040.7 7.2 29.0 23.6 0.4 0.0 0.0 0.0 0.0 1.1 1.2 0.9 0.4 0.0 0.4 0.7 0.6 46.0 2.5 1.8 0.4 0.8 3.3 6.5 9.9 3.5 0.0 0.0 0.7 KCNE2 "LQT6, MiRP1" ENSG00000159197 "Potassium voltage-gated channel subfamily E regulatory subunit 2" Q9Y6J6 21 34364006-34371381 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "stomach 1: 318.8" "Cell type enhanced" "Detected in some" "Early spermatids: 35.0;Gastric mucus-secreting cells: 109.1;Late spermatids: 20.1" "Cancer enriched" "Detected in some" 6 "stomach cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;SCLC-21H: 1.9" "Region enhanced" "Detected in many" "pons and medulla: 29.0" "HPA029706, HPA051553" Enhanced NA NA "HPA029706: AB_2673159, HPA051553: AB_2681532" "unprognostic (5.29e-4)" "unprognostic (3.13e-1)" "unprognostic (6.69e-2)" "unprognostic (2.65e-5)" "unprognostic (7.45e-2)" "unprognostic (7.33e-3)" "unprognostic (5.77e-3)" "unprognostic (6.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.33e-2)" "unprognostic (9.30e-2)" "unprognostic (3.41e-2)" "unprognostic (2.19e-3)" "unprognostic (1.48e-1)" "unprognostic (3.97e-2)" "unprognostic (2.02e-1)" "unprognostic (8.81e-2)" 0.5 0.4 1.0 0.3 1.1 0.1 0.4 0.8 1.3 0.5 1.1 0.9 7.1 0.3 0.8 0.4 0.4 0.5 0.4 1.0 1.1 1.0 1.3 0.5 0.1 1.0 1.1 1.0 0.5 0.7 0.0 0.5 0.3 1.1 0.5 0.3 0.4 0.3 0.3 0.8 0.3 0.2 0.0 1.0 0.2 318.8 4.2 1.2 0.0 1.0 0.3 0.0 0.6 0.3 1.0 0.3 0.1 0.8 1.5 0.0 0.0 1.0 0.3 0.2 0.0 0.0 0.3 0.4 0.3 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.4 0.3 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.1 1.6 0.1 0.6 0.0 0.3 1.1 1.1 0.6 0.2 0.2 0.4 0.1 0.1 1.9 0.1 0.5 0.2 0.5 0.9 0.5 0.4 0.0 0.4 0.2 0.2 0.1 1.6 0.9 0.3 0.1 0.8 0.4 0.0 0.3 0.5 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.1 1.0 1.1 0.8 1.3 1.0 1.1 1.0 1.1 1.0 1.1 1.0 1.2 1.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 35.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.3 109.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.0 ATP5MC1 "ATP5G, ATP5G1" ENSG00000159199 "ATP synthase membrane subunit c locus 1" P05496 17 48892765-48895871 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 883.0;tongue: 1307.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 387.6;Distal tubular cells: 1449.8;Proximal tubular cells: 913.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 2026.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "prognostic favorable (3.88e-4)" "unprognostic (6.60e-2)" "unprognostic (2.09e-1)" "unprognostic (8.73e-2)" "unprognostic (4.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (9.42e-3)" "unprognostic (9.78e-2)" "prognostic favorable (8.24e-6)" "unprognostic (2.07e-2)" "unprognostic (5.60e-2)" "unprognostic (1.95e-1)" "unprognostic (2.33e-1)" 93.9 161.8 229.3 98.4 236.9 117.5 135.4 248.0 267.7 99.2 230.1 362.9 217.1 114.2 181.4 199.3 122.5 59.3 692.0 238.6 244.6 270.3 260.4 82.1 104.3 236.9 228.7 232.9 89.1 118.3 270.7 126.6 83.1 236.0 102.1 347.7 118.1 128.2 119.5 883.0 129.1 188.7 151.2 229.0 99.8 197.0 47.5 237.7 130.7 134.3 1307.8 174.6 114.8 119.7 251.0 477.3 631.0 196.6 287.1 212.4 257.7 284.6 257.0 214.9 334.5 329.8 415.1 333.9 514.1 597.5 224.2 357.5 422.5 353.9 449.8 496.5 434.6 475.0 507.8 379.7 848.2 148.9 611.0 244.4 209.4 302.3 353.7 393.3 180.4 384.8 420.5 305.4 344.4 393.5 484.9 586.6 285.5 122.5 2026.7 617.4 364.0 511.3 832.9 645.8 266.7 290.8 210.7 192.0 409.1 227.3 296.6 602.2 411.3 214.2 210.3 288.3 322.3 333.1 309.0 382.7 706.8 302.5 476.7 255.7 75.4 328.5 91.8 193.7 299.5 236.9 463.9 220.0 209.5 448.5 375.2 293.6 253.9 18.2 270.6 179.2 555.2 211.7 341.6 229.3 236.9 248.0 267.7 238.6 244.6 236.9 228.7 232.9 236.0 229.0 237.7 251.0 139.6 48.1 87.9 0.0 43.2 0.0 0.0 0.0 0.0 0.0 214.6 312.5 0.0 0.0 49.5 274.0 0.0 387.6 48.6 0.0 1449.8 185.5 0.0 101.4 144.9 61.6 0.0 0.0 0.0 298.1 283.3 82.6 0.0 126.3 73.2 129.8 0.0 0.0 270.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.9 0.0 0.0 72.4 0.0 0.0 0.0 0.0 196.4 0.0 0.0 11.4 0.0 0.0 913.9 53.2 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 222.3 36.5 327.9 0.0 0.0 RCAN1 DSCR1 ENSG00000159200 "Regulator of calcineurin 1" P53805 21 34513142-34615113 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 457.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 245.5;Endometrial ciliated cells: 336.9;Glandular and luminal cells: 504.9" "Cancer enhanced" "Detected in all" "glioma: 41.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "SK-MEL-30: 1323.8;WM-115: 815.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037218, HPA068436" Enhanced Approved Cytosol NA NA Cytosol "CAB037218: AB_2179743, HPA068436: " "unprognostic (3.83e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (9.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.82e-3)" "unprognostic (5.27e-2)" "unprognostic (7.99e-2)" "unprognostic (4.83e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.07e-3)" "unprognostic (1.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-2)" "unprognostic (2.60e-3)" 59.0 22.2 70.8 50.7 75.6 6.4 65.6 72.5 76.6 87.2 75.0 38.4 31.9 29.0 8.9 24.7 12.5 57.9 61.5 65.6 196.5 90.7 258.4 39.0 13.0 76.4 74.5 61.6 8.8 64.6 457.0 30.9 96.4 75.8 24.3 39.9 13.2 20.5 15.2 34.7 29.2 27.8 49.1 79.1 14.7 35.2 10.6 79.4 82.9 61.5 32.1 9.8 102.3 21.0 85.0 47.7 9.5 47.9 29.6 25.7 15.9 29.1 175.8 181.3 71.1 70.5 54.1 44.7 0.8 8.1 103.4 139.5 4.1 34.4 35.6 94.5 26.8 21.2 9.5 16.5 25.8 98.1 15.3 28.9 41.4 31.9 84.4 58.7 17.9 23.8 32.5 18.1 45.7 47.7 23.1 145.4 12.2 27.4 48.0 23.5 53.9 37.5 22.2 22.8 81.1 23.0 10.1 128.4 82.2 1323.8 43.3 111.4 25.4 25.8 237.5 24.7 39.9 43.1 38.9 26.4 8.5 77.4 44.4 815.5 0.0 1.1 5.0 0.7 2.1 1.0 1.1 0.8 0.7 1.6 0.8 0.3 0.7 0.5 0.1 2.4 3.0 1.1 0.5 70.8 75.6 72.5 76.6 65.6 196.5 76.4 74.5 61.6 75.8 79.1 79.4 85.0 158.3 96.1 52.4 15.3 8.2 94.6 20.7 20.5 38.1 19.4 245.5 142.4 24.9 21.5 32.7 206.0 27.1 10.9 11.8 204.9 21.5 82.0 48.3 336.9 46.4 175.4 3.6 7.4 28.3 18.9 15.3 60.3 23.4 504.9 8.8 3.9 25.0 187.8 58.9 3.3 54.2 30.7 4.1 19.6 74.0 13.1 7.2 39.8 56.9 15.9 29.5 10.9 3.1 41.7 71.3 26.3 140.5 9.8 6.1 16.3 41.2 142.3 14.1 7.5 0.0 30.3 68.9 10.8 2.6 12.3 79.3 11.1 11.5 10.5 16.3 50.4 UBE2Z "FLJ13855, USE1" ENSG00000159202 "Ubiquitin conjugating enzyme E2 Z" Q9H832 17 48908407-48929056 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007922 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007922: AB_1858551" "unprognostic (6.85e-2)" "unprognostic (5.72e-3)" "prognostic favorable (4.62e-4)" "unprognostic (9.11e-2)" "unprognostic (3.71e-3)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.32e-2)" "unprognostic (5.26e-2)" "unprognostic (8.66e-2)" "unprognostic (9.17e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (2.63e-2)" "unprognostic (2.11e-2)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" 33.7 46.3 38.4 38.1 40.5 33.7 36.4 37.3 44.9 41.3 31.8 37.9 34.9 40.1 60.8 45.7 44.8 34.9 33.7 39.6 41.7 37.7 33.4 35.2 45.3 41.3 38.2 38.7 36.5 34.8 47.2 31.6 43.0 41.8 39.4 40.8 38.7 38.8 47.4 30.1 43.8 36.0 49.8 38.2 42.2 36.1 28.2 40.0 45.6 50.6 29.1 59.8 46.2 39.4 58.0 101.2 122.4 45.1 43.0 111.8 107.7 61.6 107.6 131.1 126.1 120.7 153.8 84.8 81.6 150.5 133.1 158.0 64.0 57.1 100.7 159.7 271.7 61.8 73.9 80.3 96.8 128.8 53.0 76.3 92.4 109.5 103.1 132.3 134.7 94.0 38.1 55.2 103.0 137.4 160.8 57.5 52.4 42.1 122.4 105.7 45.7 114.6 46.6 98.7 97.6 46.4 70.1 73.2 38.8 76.5 100.7 107.7 41.4 111.2 187.2 89.9 62.0 89.4 77.8 79.5 47.6 91.8 38.2 83.2 5.2 7.7 5.7 8.3 9.9 6.8 6.2 7.3 8.4 5.4 8.6 6.9 7.6 7.3 5.4 9.5 6.8 8.2 6.4 38.4 40.5 37.3 44.9 39.6 41.7 41.3 38.2 38.7 41.8 38.2 40.0 58.0 36.6 25.6 19.2 17.9 32.7 52.8 50.3 47.1 27.3 56.4 40.6 32.9 37.9 21.5 25.8 36.8 41.7 34.2 40.0 42.1 21.5 44.2 1.6 48.8 40.8 44.0 48.6 23.4 22.5 54.7 32.7 35.1 20.9 59.5 6.3 37.6 37.5 25.8 24.8 43.7 20.8 35.9 20.3 28.1 54.0 5.1 28.0 35.6 30.2 12.2 48.6 31.6 26.8 13.6 52.7 75.8 25.6 29.0 23.7 89.5 34.7 27.5 42.1 34.4 32.9 25.8 39.3 21.6 26.0 35.9 57.0 42.8 30.7 50.4 30.8 66.7 CIART "BC017397, C1orf51, CHRONO" ENSG00000159208 "Circadian associated repressor of transcription" Q8N365 1 150282543-150287093 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.7;Bipolar cells: 43.1;Cone photoreceptor cells: 102.2;Muller glia cells: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.2;memory CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.4;Karpas-707: 36.8;U-266/84: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027515, HPA054349" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA027515: AB_10600757, HPA054349: AB_2682457" "unprognostic (1.77e-1)" "unprognostic (5.63e-2)" "unprognostic (4.15e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (4.42e-1)" "unprognostic (5.99e-3)" "unprognostic (2.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (1.89e-1)" "unprognostic (4.54e-2)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.34e-2)" 6.2 13.6 13.8 3.1 17.6 0.4 7.6 19.1 18.4 6.4 15.6 16.4 3.3 9.6 9.4 8.3 10.3 4.5 29.6 14.3 14.6 10.2 13.8 5.8 2.6 14.1 13.7 13.5 10.2 5.0 32.3 17.8 2.7 14.4 9.4 2.8 22.4 17.9 24.1 54.7 37.4 6.4 9.1 12.2 2.8 13.9 9.9 15.5 2.0 19.2 46.8 3.6 11.9 8.3 14.8 0.2 1.0 6.7 3.4 3.0 1.3 6.6 4.8 11.8 6.2 8.2 1.8 26.4 0.1 8.3 10.4 14.1 4.5 0.2 4.8 9.3 0.1 0.6 0.2 0.4 0.1 10.5 1.6 3.7 4.0 7.1 15.8 3.2 14.4 1.2 0.1 0.2 36.8 3.6 21.8 0.0 0.8 8.9 4.9 19.9 1.1 0.0 0.3 6.2 1.0 4.1 1.5 7.9 0.7 14.6 1.7 6.7 0.6 2.1 17.3 0.2 0.7 10.5 8.2 29.6 0.2 16.0 0.1 10.5 0.0 0.0 0.0 0.1 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.1 13.8 17.6 19.1 18.4 14.3 14.6 14.1 13.7 13.5 14.4 12.2 15.5 14.8 2.8 0.0 1.5 5.5 0.6 0.0 5.5 0.0 30.7 43.1 5.5 7.7 7.3 4.3 1.3 0.0 102.2 0.2 0.6 0.4 9.8 3.2 0.6 2.9 2.5 3.0 2.4 0.0 3.1 1.5 0.1 4.8 3.6 2.1 0.0 3.5 0.7 4.2 1.3 6.7 3.9 0.9 0.0 0.3 0.0 1.4 5.3 1.9 0.0 0.0 1.0 28.2 0.0 1.5 1.1 4.1 1.2 9.4 0.2 4.4 7.7 3.9 0.7 18.1 0.0 4.6 4.5 7.2 10.9 11.2 0.0 0.0 0.9 4.1 0.7 2.7 SNF8 "Dot3, EAP30, VPS22" ENSG00000159210 "SNF8 subunit of ESCRT-II" Q96H20 17 48929316-48944842 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 341.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059320 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA059320: AB_2683977" "unprognostic (7.85e-3)" "unprognostic (3.97e-3)" "unprognostic (2.25e-2)" "unprognostic (1.73e-1)" "unprognostic (4.39e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (3.52e-1)" "unprognostic (1.38e-1)" 29.0 31.9 24.2 26.3 25.6 35.5 26.8 24.5 27.3 20.8 23.6 28.3 27.8 21.5 32.4 27.1 20.5 20.7 39.2 22.9 24.4 33.3 33.3 22.1 25.0 24.7 25.0 22.4 18.6 30.0 26.3 18.5 22.1 24.9 20.2 31.0 18.3 29.9 21.7 49.1 23.7 24.6 26.0 24.7 22.9 30.3 18.5 24.6 28.0 25.8 48.9 32.8 26.9 20.7 28.2 60.9 119.3 73.2 93.3 73.7 42.4 114.0 49.9 68.1 95.0 84.8 294.6 61.5 55.3 85.5 94.3 106.0 39.8 68.0 70.1 105.4 80.1 110.7 61.6 158.7 126.1 64.2 83.8 66.6 52.7 68.9 91.0 69.2 70.5 90.4 71.7 61.4 54.7 98.2 120.7 90.8 71.4 35.6 139.1 101.3 58.9 132.8 65.8 57.1 67.4 48.0 96.3 60.1 28.1 73.5 125.2 70.9 101.3 77.2 103.6 81.1 65.3 95.1 79.6 97.5 66.0 92.1 45.1 81.5 0.9 4.4 9.2 2.5 5.0 1.3 4.4 3.5 2.8 5.0 5.4 2.3 1.9 1.9 1.6 5.7 6.2 4.7 1.1 24.2 25.6 24.5 27.3 22.9 24.4 24.7 25.0 22.4 24.9 24.7 24.6 28.2 77.4 44.8 34.4 14.7 60.0 59.8 76.5 46.4 26.2 67.9 75.0 80.9 49.0 68.6 34.4 64.4 14.6 119.6 71.3 126.4 148.7 147.8 111.9 48.3 57.6 63.5 70.8 71.8 21.4 218.4 175.7 62.8 52.5 41.7 43.1 87.5 61.8 75.2 149.1 25.2 22.7 93.2 48.8 84.4 96.2 341.1 62.7 82.7 85.4 8.4 137.9 95.1 80.3 12.1 17.6 166.6 78.7 62.1 88.6 100.0 125.4 210.1 33.7 86.7 46.0 51.9 123.3 68.0 76.3 58.6 72.5 95.1 57.7 75.0 98.9 95.9 CLIC6 "CLIC1L, CLIC5" ENSG00000159212 "Chloride intracellular channel 6" Q96NY7 21 34668994-34718227 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "choroid plexus: 195.1;stomach 1: 139.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 30.0;Club cells: 41.6;Gastric mucus-secreting cells: 26.5;Respiratory ciliated cells: 81.1;Skeletal myocytes: 24.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 12.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.6;NTERA-2: 3.6;T-47d: 7.3;THP-1: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065285 Enhanced NA NA 180000 "HPA065285: AB_2685454" "prognostic favorable (6.11e-5)" "unprognostic (2.17e-2)" "unprognostic (1.65e-2)" "unprognostic (4.27e-2)" "unprognostic (2.93e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-2)" "prognostic favorable (3.15e-5)" "unprognostic (4.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.43e-3)" 7.4 0.1 2.0 4.4 0.8 0.1 12.0 2.6 3.4 15.9 195.1 3.7 2.1 2.1 2.7 2.6 11.5 8.9 11.2 12.4 1.3 2.1 0.9 9.9 1.2 2.6 4.6 0.2 4.9 3.2 28.6 3.3 0.1 2.5 9.8 2.9 0.2 25.6 7.0 1.6 5.4 3.1 0.7 1.9 1.0 139.6 0.3 4.0 8.5 13.3 4.4 3.9 13.0 5.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.9 7.3 3.4 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.8 2.6 3.4 12.4 1.3 2.6 4.6 0.2 2.5 1.9 4.0 0.8 0.3 6.4 20.7 1.3 0.0 0.6 5.1 7.3 4.0 0.0 15.6 11.0 11.4 30.0 41.6 9.2 0.0 0.0 0.2 2.2 1.9 8.0 0.1 15.1 0.3 0.4 4.9 0.0 0.3 0.9 0.0 3.7 26.5 2.2 1.3 11.8 0.0 0.0 0.1 0.0 0.6 1.4 16.2 0.0 0.4 0.3 0.3 0.4 7.2 0.0 0.6 0.0 0.0 0.0 0.1 17.2 0.6 3.0 0.4 10.2 0.1 0.2 81.1 0.0 0.0 24.0 2.4 0.2 0.2 0.6 0.4 0.0 0.4 0.0 2.8 20.4 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 36.4;Respiratory ciliated cells: 57.6;Spermatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.0;intermediate monocyte: 2.2;memory B-cell: 3.5;naive B-cell: 2.2;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 5 "B-cells: 3.5;granulocytes: 1.0;monocytes: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: AB_2684591" "prognostic favorable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favorable (3.18e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.5 4.9 9.7 1.3 9.5 0.4 3.3 9.0 16.0 4.9 9.6 3.3 1.9 3.2 1.9 2.1 11.3 3.1 1.1 9.3 10.0 10.3 3.6 3.0 1.4 9.1 9.3 9.2 2.4 5.7 6.2 13.0 1.0 9.3 7.2 2.1 6.7 4.5 5.0 0.9 1.1 2.4 1.3 9.3 2.4 3.8 19.3 9.4 1.0 9.2 0.2 1.0 4.2 2.4 9.0 4.7 2.8 1.2 1.4 1.2 0.8 2.7 0.2 1.9 1.4 2.4 1.8 13.4 3.8 5.0 0.5 4.0 4.7 0.7 6.5 1.3 3.9 1.6 1.9 1.7 0.5 1.3 0.6 3.2 0.3 0.6 4.5 0.4 4.3 1.1 1.4 0.8 1.4 2.0 4.0 0.2 1.4 2.7 4.2 2.2 1.3 0.0 0.7 5.5 1.8 2.9 2.6 4.0 2.3 2.6 2.5 6.7 0.1 0.3 2.1 5.9 1.5 0.7 0.5 1.8 0.8 5.3 0.5 1.7 0.0 0.4 1.0 0.3 2.2 0.2 3.5 0.1 0.1 0.4 2.2 0.0 0.0 0.4 0.3 1.8 0.3 0.0 0.2 9.7 9.5 9.0 16.0 9.3 10.0 9.1 9.3 9.2 9.3 9.3 9.4 9.0 1.7 3.2 7.2 17.0 2.3 1.1 7.9 26.5 9.1 8.9 13.3 12.1 1.0 12.8 22.0 9.2 6.2 5.6 0.9 11.3 21.5 9.4 20.7 30.9 2.4 2.1 36.4 1.3 17.7 7.2 2.2 2.5 21.9 6.9 2.5 1.6 2.5 2.6 3.3 3.3 10.0 13.6 14.2 2.0 2.2 11.7 2.1 3.6 3.6 1.9 2.7 10.2 0.0 5.0 2.4 6.5 8.3 3.0 1.8 5.7 6.3 11.5 57.6 15.4 0.0 2.9 3.8 50.6 19.9 3.9 0.9 2.5 1.3 3.9 10.2 11.4 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "RUNX family transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 23.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.9" "Cell line enhanced" "Detected in many" "HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: AB_2675733" "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 13.9 3.8 2.4 20.5 3.0 45.9 27.4 2.7 5.0 15.4 6.4 6.4 5.1 3.3 3.2 9.3 4.7 16.1 5.3 2.5 10.7 3.9 7.0 22.6 11.4 4.9 3.5 1.2 6.4 4.0 1.5 5.1 8.6 4.6 13.6 6.5 0.3 39.6 3.6 19.0 11.3 6.9 9.3 6.0 10.3 17.1 3.9 7.1 28.5 4.9 1.4 10.0 21.0 12.9 5.8 50.9 3.8 0.1 0.3 12.5 16.0 32.0 28.1 28.4 15.3 11.6 2.5 37.7 24.9 1.8 24.9 25.5 45.0 3.0 33.6 21.4 38.7 3.8 251.3 10.1 11.6 22.9 29.4 145.3 30.9 19.8 46.6 45.6 21.2 8.8 226.3 17.3 14.1 32.7 10.7 119.3 46.5 2.2 27.4 14.5 119.2 84.6 15.3 20.7 19.9 1.4 0.0 28.9 7.2 10.5 6.8 14.7 67.8 37.0 25.1 32.4 37.8 42.8 46.4 20.7 23.3 31.2 63.4 37.4 23.9 3.1 7.1 3.4 1.4 3.2 4.1 3.0 3.2 0.9 3.6 4.5 3.7 3.4 1.5 4.7 3.4 4.5 2.2 2.4 3.0 2.7 5.0 2.5 10.7 4.9 3.5 1.2 4.6 6.0 7.1 5.8 6.2 54.5 35.4 1.6 27.0 41.6 52.7 61.2 54.7 2.3 175.5 94.6 3.2 28.6 60.8 20.2 0.0 2.1 39.5 18.7 1.9 39.7 19.4 89.6 21.5 9.2 6.0 47.3 3.5 28.1 21.4 49.2 84.6 155.8 17.7 29.2 4.6 5.4 68.4 0.0 3.2 12.4 28.5 77.0 122.5 27.1 4.7 84.4 28.4 195.8 42.2 0.5 39.1 1.5 1.6 101.0 15.8 4.5 27.7 43.6 8.3 1.6 78.6 0.8 0.0 111.3 51.2 29.0 28.0 53.7 20.2 2.5 41.6 2.7 17.0 75.3 IGF2BP1 IMP-1 ENSG00000159217 "Insulin like growth factor 2 mRNA binding protein 1" Q9NZI8 17 48997385-49056145 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 5.5;testis: 4.8" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 37.3;Spermatocytes: 30.4;Spermatogonia: 21.7" "Cancer enriched" "Detected in many" 16 "testis cancer: 28.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 146.7;CACO-2: 238.7;Hep G2: 112.0;K-562: 124.4;NTERA-2: 117.6;REH: 140.0;SuSa: 111.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021367, HPA062273" Enhanced Supported Cytosol NA NA 13000 Cytosol "HPA021367: AB_1851480, HPA062273: AB_2684733" "unprognostic (6.79e-4)" "unprognostic (2.76e-1)" "unprognostic (4.86e-3)" "unprognostic (2.30e-6)" "unprognostic (1.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.80e-2)" "unprognostic (1.01e-2)" "unprognostic (9.55e-3)" "unprognostic (2.58e-1)" "unprognostic (2.86e-2)" "unprognostic (5.91e-2)" "unprognostic (2.80e-6)" "unprognostic (2.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.32e-3)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 59.5 146.7 0.1 5.2 7.6 105.0 8.5 0.2 12.1 20.1 238.7 4.0 12.4 0.9 1.0 3.6 0.0 91.4 0.0 21.1 0.0 52.9 91.3 33.6 112.0 6.9 48.8 23.6 10.4 0.0 2.9 0.2 4.1 24.9 16.6 124.4 0.0 16.6 0.9 0.1 42.9 117.6 0.2 0.2 140.0 48.3 0.0 0.0 0.1 0.0 0.0 5.1 0.1 3.6 111.4 0.2 13.5 0.5 0.0 1.4 12.5 0.0 0.1 0.1 80.7 0.1 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 1.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 5.5 0.0 0.6 0.0 0.0 3.5 0.2 0.0 0.0 0.0 5.3 0.1 0.1 3.9 0.0 2.7 0.2 0.0 37.3 3.7 0.0 0.1 1.3 0.0 0.0 0.0 6.9 0.0 0.2 0.0 0.0 0.0 0.8 4.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.1 0.0 0.0 0.1 0.0 5.3 0.7 0.0 0.0 1.1 1.1 30.4 21.7 0.0 0.1 2.9 0.3 0.1 0.0 0.3 GIP ENSG00000159224 "Gastric inhibitory polypeptide" P09681 17 48958554-48968596 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 209 "intestine: 261.9" "Cell type enriched" "Detected in single" 4 "Intestinal goblet cells: 1.9" "Cancer enriched" "Detected in some" 63 "testis cancer: 74.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 6.6;BEWO: 5.9;Hep G2: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021612, HPA064596" Enhanced "Secreted to blood" NA NA 33900 540000 "HPA021612: AB_1849506, HPA064596: " "unprognostic (2.95e-1)" "unprognostic (2.70e-3)" "unprognostic (4.42e-2)" "unprognostic (1.82e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 261.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.0 0.0 0.0 1.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.3 0.5 5.9 0.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 9.8 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CBR1 "CBR, SDR21C1" ENSG00000159228 "Carbonyl reductase 1" P16152 21 36069941-36073166 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 589.2" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 524.2;Distal tubular cells: 757.2;Proximal enterocytes: 1270.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018433, CAB034291" Enhanced Approved Nucleoplasm,Cytosol NA NA 12000000 Nucleoplasm Cytosol "CAB034291: AB_2070856, HPA018433: AB_1846109" "prognostic favorable (2.18e-4)" "unprognostic (9.78e-2)" "unprognostic (3.25e-2)" "unprognostic (2.14e-1)" "unprognostic (6.47e-3)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (6.37e-2)" "unprognostic (4.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (4.00e-1)" "prognostic favorable (4.75e-4)" "unprognostic (2.37e-1)" "unprognostic (2.47e-1)" "unprognostic (6.13e-3)" "unprognostic (2.47e-2)" 32.6 96.0 150.7 25.8 195.3 10.2 29.8 185.2 175.6 45.3 196.3 63.5 589.2 41.6 51.0 191.0 34.9 47.5 29.4 154.8 168.0 109.8 254.8 41.4 28.5 176.5 179.7 138.4 29.1 36.4 39.0 35.6 27.8 195.3 49.2 51.4 10.3 102.6 42.6 33.9 112.7 348.8 34.7 168.7 40.2 134.7 18.3 179.1 22.9 46.8 23.5 37.0 51.5 86.0 272.6 114.4 180.4 22.6 55.9 115.0 115.3 1.2 123.6 97.0 72.4 86.4 68.9 67.8 28.2 78.7 128.1 137.3 84.6 46.3 132.3 55.7 133.8 95.3 82.5 105.1 48.1 65.7 49.1 77.5 56.1 165.6 70.7 30.8 83.0 78.4 0.0 0.0 21.3 67.6 121.2 24.7 50.7 0.4 0.0 123.3 0.4 0.4 80.5 195.7 60.9 60.5 52.1 121.3 186.3 157.3 17.6 86.1 69.4 71.1 78.8 30.8 202.9 96.1 131.8 268.9 0.7 144.0 48.6 115.6 7.1 134.0 68.6 64.4 198.5 54.6 67.2 79.7 60.8 109.6 61.2 102.6 75.4 9.2 77.3 156.9 39.6 89.0 162.1 150.7 195.3 185.2 175.6 154.8 168.0 176.5 179.7 138.4 195.3 168.7 179.1 272.6 26.4 121.8 69.3 17.9 22.5 128.2 63.1 295.2 524.2 11.6 27.7 98.8 20.9 77.2 117.1 95.6 2.1 116.6 15.7 91.2 757.2 93.7 8.9 31.7 45.5 23.1 38.6 32.0 6.5 70.0 80.4 65.7 127.4 45.1 34.9 30.8 41.7 277.2 85.1 3.3 6.8 94.4 396.7 66.6 27.5 4.3 122.7 49.5 90.7 4.7 79.2 69.8 23.7 16.6 128.2 91.8 146.6 132.4 41.3 66.4 1270.3 326.0 121.2 8.3 26.3 51.3 90.7 5.8 17.4 403.5 123.6 89.2 30.7 55.6 145.8 55.0 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36135079-36146562 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 56.8;salivary gland: 41.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 102.5;Basal squamous epithelial cells: 107.0;Peritubular cells: 75.6;Squamous epithelial cells: 230.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 9 "B-cells: 23.9;NK-cells: 11.5;T-cells: 33.7" "Cell line enhanced" "Detected in many" "RPMI-8226: 64.9" "Region enhanced" "Detected in all" "basal ganglia: 48.6" "Low region specificity" "Detected in many" HPA018434 Uncertain Supported Nucleoplasm,Cytosol Yes NA 2800000 "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 14.6 2.3 12.2 4.1 13.8 1.4 15.4 13.4 20.0 10.7 11.0 6.9 3.0 7.6 11.1 56.8 8.9 6.6 5.9 12.6 12.2 2.7 0.8 4.7 2.9 12.1 11.8 12.2 11.3 1.6 0.6 2.4 3.0 12.3 10.0 3.7 0.6 41.7 5.1 3.1 21.7 5.5 6.1 11.2 3.1 5.2 3.2 11.8 2.0 4.6 7.8 7.7 11.7 17.0 12.4 33.5 9.5 4.0 8.2 31.0 47.8 5.9 35.4 42.4 40.6 32.1 0.4 6.9 0.0 10.2 37.2 13.7 15.0 5.5 7.2 16.2 45.3 17.2 1.4 10.0 0.3 2.6 0.1 0.1 6.8 0.8 28.1 3.6 19.1 24.9 3.7 0.0 0.3 12.1 25.4 3.1 14.7 3.2 10.3 41.5 6.7 7.6 64.9 13.7 14.2 2.1 2.9 27.3 32.6 53.3 2.2 9.8 3.9 17.1 25.7 2.2 28.8 35.0 1.5 0.6 0.0 26.9 0.9 47.3 0.0 0.6 0.1 2.2 0.5 3.0 23.6 25.1 7.7 2.4 23.9 33.7 23.5 0.9 11.5 1.0 0.7 10.9 11.5 12.2 13.8 13.4 20.0 12.6 12.2 12.1 11.8 12.2 12.3 11.2 11.8 12.4 41.7 0.0 3.2 6.8 5.2 71.0 22.1 102.5 107.0 0.8 23.1 38.6 0.2 2.8 23.0 0.0 0.0 1.2 2.9 1.9 9.8 4.7 0.7 13.1 7.5 26.5 0.0 1.7 3.9 0.7 0.3 53.4 7.7 14.7 5.7 1.1 14.3 0.3 8.4 0.0 5.5 12.6 69.2 3.8 41.3 4.0 67.7 5.8 65.8 2.8 20.9 1.9 0.0 1.5 0.5 2.6 1.7 75.6 1.4 43.4 1.3 0.2 13.1 0.6 0.0 21.4 19.7 0.4 0.2 230.4 46.7 0.3 7.0 1.0 8.1 21.1 GJD2 "CX36, GJA9" ENSG00000159248 "Gap junction protein delta 2" Q9UKL4 15 34751032-34754998 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.0;pituitary gland: 7.6;retina: 21.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.2;Cone photoreceptor cells: 39.6;Horizontal cells: 6.7;Rod photoreceptor cells: 13.7" "Cancer enriched" "Detected in single" 32 "pancreatic cancer: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.30e-2)" "unprognostic (2.87e-2)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" 0.0 6.0 0.8 0.0 0.7 0.0 0.0 1.1 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.8 0.3 0.0 0.0 0.0 2.5 1.3 0.7 0.0 3.9 0.0 7.6 0.0 1.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.8 0.7 1.1 1.5 0.6 0.8 2.5 1.3 0.7 1.0 0.1 1.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 2.8 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTC1 "ACTC, CMD1R" ENSG00000159251 "Actin alpha cardiac muscle 1" P68032 15 34790230-34795549 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "heart muscle: 11516.0" "Cell type enriched" "Detected in some" 30 "Cardiomyocytes: 9746.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB037330, HPA041264, HPA041271" Enhanced NA NA 2400000000 "CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (8.18e-3)" "unprognostic (3.74e-2)" "unprognostic (4.82e-3)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (3.26e-1)" "unprognostic (2.05e-3)" "unprognostic (2.26e-1)" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (2.10e-3)" "unprognostic (5.68e-4)" "unprognostic (8.79e-2)" "unprognostic (1.65e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (9.32e-4)" 51.6 1.8 2.0 24.9 1.9 0.0 12.0 2.2 5.6 8.3 6.7 4.1 0.8 7.0 1.1 23.0 1.7 12.0 11516.0 1.9 2.4 1.5 0.6 4.0 2.6 2.7 2.9 1.8 3.2 13.0 1.0 2.3 9.0 3.2 73.7 3.6 31.8 11.6 543.1 136.3 3.3 0.6 8.9 1.4 1.3 9.4 0.6 3.4 11.4 2.4 196.8 0.2 444.1 16.3 2.8 0.0 0.2 0.1 0.0 0.2 3.3 0.2 2.2 0.7 5.2 1.3 0.0 0.0 0.0 1.3 1131.8 0.2 0.0 0.4 0.0 1.3 0.0 0.0 0.1 23.9 0.0 0.1 1.4 0.0 457.2 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 4544.5 0.0 0.0 0.0 3.8 0.0 0.0 0.0 2053.3 0.0 0.0 0.0 0.1 0.1 4.0 0.0 0.0 31.2 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.9 2.2 5.6 1.9 2.4 2.7 2.9 1.8 3.2 1.4 3.4 2.8 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 11.9 0.1 0.0 9746.1 0.0 0.0 0.0 20.9 0.1 0.0 0.0 1.9 0.0 5.0 0.0 0.1 69.2 0.0 0.0 0.2 0.2 4.3 315.2 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 63.4 86.5 1.0 0.7 0.0 0.4 0.3 0.1 0.1 0.0 0.0 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: AB_2674359" "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 11.3 7.6 5.6 17.5 6.9 34.8 14.0 12.9 7.5 12.9 6.0 11.0 11.0 17.5 9.5 17.8 12.1 12.8 11.7 5.6 6.2 9.5 14.3 13.0 20.5 6.7 6.8 4.9 24.0 11.2 10.5 6.5 17.3 7.5 13.7 11.7 7.8 11.6 11.9 17.9 15.1 11.1 14.0 7.7 18.8 13.1 10.9 6.3 19.6 11.9 16.0 20.2 15.6 13.9 11.1 19.7 7.8 19.1 12.8 16.5 16.3 25.1 17.9 30.0 20.3 17.5 12.8 12.9 9.4 7.0 19.9 21.0 9.8 12.9 16.9 18.8 18.7 10.3 37.2 8.2 7.2 11.4 23.4 34.7 12.0 21.3 18.3 26.5 22.2 14.5 14.6 31.0 24.3 14.9 5.8 14.1 9.8 14.2 24.9 7.9 16.4 7.5 17.8 6.6 20.1 7.1 17.4 22.2 12.3 22.8 14.3 14.9 16.3 23.3 17.7 4.9 14.3 15.2 10.9 9.8 8.9 12.7 32.3 13.2 32.5 8.9 19.5 9.1 10.9 9.0 11.3 9.9 8.6 8.8 12.6 12.6 9.1 13.5 9.9 13.6 5.7 13.4 7.9 5.6 6.9 12.9 7.5 5.6 6.2 6.7 6.8 4.9 7.5 7.7 6.3 11.1 29.0 28.9 24.1 44.4 49.6 68.3 65.7 33.1 36.5 19.4 19.6 17.4 20.4 14.3 28.9 22.0 8.4 16.1 44.3 14.7 3.9 17.8 51.7 20.9 30.1 24.1 11.4 63.3 36.4 12.5 19.7 31.0 19.4 28.0 47.5 22.4 16.8 16.5 17.5 16.8 37.1 17.1 18.3 26.8 56.8 18.3 18.6 35.8 24.9 52.5 41.4 12.2 40.2 41.7 55.3 23.3 14.5 26.7 17.1 42.0 9.5 7.1 33.5 12.2 13.1 44.8 41.5 33.5 31.4 45.8 81.7 25.2 44.6 16.7 11.1 68.1 CHAF1B "CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7" ENSG00000159259 "Chromatin assembly factor 1 subunit B" Q13112 21 36385392-36419015 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 15.7" "Cell type enhanced" "Detected in many" "Spermatocytes: 14.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA021679, CAB033604" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB033604: AB_2229411, HPA021679: AB_1846621" "unprognostic (2.28e-2)" "prognostic favorable (5.44e-5)" "prognostic favorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (3.28e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (6.14e-6)" "unprognostic (2.14e-2)" "unprognostic (1.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-2)" "unprognostic (6.27e-2)" "unprognostic (7.66e-6)" "unprognostic (5.89e-2)" "unprognostic (5.00e-3)" "unprognostic (9.12e-2)" "unprognostic (1.36e-1)" 1.1 0.6 1.5 2.5 1.2 6.9 2.6 2.3 1.6 1.2 0.3 1.9 1.6 1.7 1.5 2.5 1.3 0.9 0.6 1.5 0.9 0.7 0.7 1.0 3.0 0.7 0.6 1.4 1.4 3.3 1.6 1.0 1.1 1.2 1.7 2.2 1.7 3.0 0.9 15.7 2.7 2.0 1.5 0.1 1.3 1.2 4.2 0.7 4.2 0.9 1.8 3.6 1.0 1.5 1.3 25.5 15.0 25.3 14.4 1.9 5.0 13.8 17.6 10.1 21.4 22.2 17.1 13.3 19.9 7.6 9.2 21.7 8.2 26.3 11.7 17.2 20.2 20.5 30.9 15.5 12.2 1.3 19.8 14.4 3.1 2.8 20.0 8.6 4.1 10.2 24.1 27.3 18.0 11.0 17.7 31.0 11.5 17.6 23.0 10.8 45.0 13.6 11.4 7.5 12.4 15.2 12.6 27.0 20.3 9.8 10.1 15.9 13.4 6.3 17.2 8.5 15.4 20.8 13.1 26.0 23.1 11.0 21.5 22.3 1.5 0.2 0.3 1.4 0.1 1.2 1.0 1.0 1.0 0.3 1.1 0.6 1.0 1.2 1.7 0.2 0.4 2.2 0.7 1.5 1.2 2.3 1.6 1.5 0.9 0.7 0.6 1.4 1.2 0.1 0.7 1.3 1.3 0.0 2.7 2.0 1.8 2.8 6.2 3.7 5.2 1.6 2.8 3.4 1.3 2.8 3.4 3.7 0.0 7.6 2.5 1.7 0.0 7.3 9.1 2.5 1.2 2.5 0.0 10.7 4.4 2.2 9.7 2.6 4.1 2.4 2.5 9.4 1.4 0.5 4.5 1.7 3.1 2.3 10.2 0.9 1.6 6.7 0.6 1.2 5.4 1.9 1.5 1.5 5.2 1.0 2.5 2.2 0.2 0.0 4.4 4.6 0.4 0.3 3.1 2.6 6.6 3.4 2.5 14.4 11.8 7.4 2.4 2.5 2.4 0.5 4.7 3.4 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 39.8" "Cell type enhanced" "Detected in some" "Cholangiocytes: 7.2;Distal tubular cells: 19.6;Ductal cells: 11.8;Exocrine glandular cells: 8.2;Hepatocytes: 22.2;Pancreatic endocrine cells: 21.3" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "HDLM-2: 224.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles NA NA Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favorable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.2 0.3 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.3 0.1 0.1 0.0 7.0 39.8 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.2 0.1 0.0 0.1 0.3 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 224.1 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.7 2.1 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 2.5 15.8 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.1 7.4 4.2 0.1 0.7 0.4 6.7 15.7 0.0 1.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.4 1.0 0.6 0.0 0.0 0.8 0.4 0.7 7.2 0.1 1.8 0.0 0.1 0.0 0.7 19.6 11.8 0.6 0.3 0.2 3.6 0.0 0.0 0.6 8.2 1.3 0.1 0.0 3.4 0.0 0.0 0.4 22.2 0.1 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.2 3.6 0.0 0.6 0.0 0.0 1.5 1.0 21.3 0.0 0.4 6.9 0.6 0.0 0.7 0.0 0.0 0.0 0.0 2.0 1.2 0.0 0.0 0.3 0.8 1.4 0.0 0.3 2.3 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "SIM bHLH transcription factor 2" Q14190 21 36699115-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 31.4;kidney: 16.7;skeletal muscle: 10.7" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.2" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favorable (2.88e-4)" 0.2 0.3 1.8 0.0 1.1 0.0 0.4 0.6 1.4 2.4 0.3 0.4 0.0 0.5 0.8 31.4 0.6 0.0 0.2 1.5 2.4 16.7 0.4 0.2 0.0 0.9 1.3 0.4 0.2 0.3 1.8 1.6 0.0 0.7 6.6 0.0 0.0 0.6 0.0 10.7 0.3 0.3 0.0 0.5 0.3 9.6 0.5 1.9 0.0 0.4 0.0 3.5 0.7 0.7 0.8 6.4 9.6 0.0 0.3 0.0 0.0 9.4 0.0 0.0 0.9 0.0 5.0 14.7 0.0 8.6 0.2 17.0 3.2 4.8 0.0 0.5 7.8 15.0 0.0 14.3 0.3 0.0 0.0 0.0 1.6 1.4 0.0 2.6 24.9 0.0 0.0 0.0 0.0 16.0 3.7 0.0 0.0 0.0 6.4 43.0 0.0 0.0 0.0 54.3 33.5 0.4 0.0 15.7 0.0 0.9 1.6 4.1 0.0 0.6 0.0 2.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.1 0.6 1.4 1.5 2.4 0.9 1.3 0.4 0.7 0.5 1.9 0.8 0.2 0.0 0.0 0.0 0.0 0.3 19.1 0.0 100.7 0.2 0.1 0.1 2.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 9.8 0.1 2.2 0.3 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.8 12.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 5.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 7.1 1.1 0.0 0.0 0.0 1.3 9.5 0.1 0.2 0.0 0.5 0.0 1.5 0.9 0.5 0.2 68.3 0.4 0.0 0.4 0.0 0.2 4.0 HLCS HCS ENSG00000159267 "Holocarboxylase synthetase" P50747 21 36748626-36990236 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ligase, Multifunctional enzyme" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 86.2;Inhibitory neurons: 99.7;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017379 Approved Approved Cytosol NA NA Cytosol "HPA017379: AB_1850768" "prognostic unfavorable (7.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.93e-2)" "unprognostic (2.05e-1)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-1)" "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.44e-2)" "unprognostic (2.43e-1)" "unprognostic (2.55e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-3)" "unprognostic (3.02e-1)" 5.0 5.1 4.9 4.2 4.9 3.3 7.5 8.5 5.8 5.1 8.1 4.7 4.2 4.1 7.1 6.1 5.4 4.2 3.7 5.8 5.3 6.4 10.7 5.0 3.7 5.7 4.8 4.2 3.8 7.7 10.6 8.8 4.1 6.0 9.0 4.5 6.2 8.5 6.6 13.4 2.9 4.9 4.6 3.9 3.1 5.7 5.8 5.2 3.3 10.8 6.3 4.4 5.5 2.9 5.6 23.8 10.4 13.0 9.6 14.8 13.7 13.3 13.0 12.7 7.1 7.0 10.8 11.0 10.6 6.4 21.4 13.0 8.2 5.9 11.6 5.5 21.0 9.2 16.4 9.6 6.7 14.9 8.6 11.0 10.2 17.0 10.6 23.6 15.5 9.0 12.0 19.7 31.9 17.4 14.2 4.6 5.4 21.8 16.7 11.3 7.1 7.5 11.2 10.8 24.8 8.3 9.9 16.7 8.8 14.8 10.0 16.2 9.1 10.5 9.1 2.7 8.9 7.8 25.6 19.8 7.1 14.6 11.1 10.7 1.9 0.8 0.8 3.6 2.0 2.9 1.2 1.9 2.3 0.8 1.3 2.4 2.2 1.2 4.8 5.1 1.9 1.6 1.8 4.9 4.9 8.5 5.8 5.8 5.3 5.7 4.8 4.2 6.0 3.9 5.2 5.6 3.0 9.6 12.5 46.4 4.1 3.3 9.2 5.3 6.8 12.8 9.4 7.4 4.5 8.6 8.4 12.9 22.9 8.9 5.1 3.5 7.9 7.8 5.6 8.0 8.0 3.8 6.0 7.4 86.2 8.1 5.4 5.1 9.7 8.0 5.7 7.9 4.2 18.5 4.6 18.5 99.7 5.2 4.1 5.1 2.1 4.3 4.4 4.0 0.0 45.9 3.2 5.6 8.2 79.9 80.1 9.0 2.9 7.2 4.2 7.8 8.0 6.1 9.2 14.2 0.0 9.0 6.8 5.2 11.5 8.7 4.0 5.1 5.5 11.1 5.4 6.9 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "liver: 4.1;testis: 15.2" "Cell type enriched" "Detected in some" 8 "Early spermatids: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 15.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCUBE1 ENSG00000159307 "Signal peptide, CUB domain and EGF like domain containing 1" Q8IWY4 22 43197280-43343372 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 26.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Extravillous trophoblasts: 13.3;Granulosa cells: 37.2;Peritubular cells: 45.5;Theca cells: 14.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 9.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HMC-1: 49.8;THP-1: 20.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003190 Approved "Secreted to blood" NA NA 2170000 190000 "HPA003190: AB_1079882" "unprognostic (5.29e-2)" "unprognostic (7.15e-6)" "unprognostic (6.03e-3)" "unprognostic (8.33e-2)" "unprognostic (3.65e-1)" "unprognostic (4.55e-2)" "unprognostic (1.34e-1)" "unprognostic (5.76e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-2)" "unprognostic (1.02e-2)" "unprognostic (2.70e-1)" "unprognostic (2.30e-1)" "unprognostic (6.87e-3)" 1.9 6.2 0.6 0.8 1.1 0.1 1.2 0.1 1.2 0.7 4.2 3.8 6.0 1.1 0.1 3.7 1.2 0.8 0.1 0.6 4.1 3.5 5.2 6.9 0.0 1.8 9.6 1.0 26.6 0.1 9.2 3.8 2.6 4.5 1.9 2.0 0.4 3.7 0.5 9.7 0.5 7.8 0.5 0.3 5.7 7.1 7.2 0.8 0.1 3.1 1.9 0.0 3.4 0.7 1.4 0.0 0.0 2.2 7.8 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.1 0.3 0.1 0.7 0.0 0.0 0.1 0.7 0.0 0.1 0.7 0.2 0.2 49.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.1 0.1 0.2 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 1.2 0.0 0.1 0.0 0.3 0.1 20.4 0.0 0.3 0.2 0.6 0.0 2.1 4.3 0.0 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.1 1.2 0.6 4.1 1.8 9.6 1.0 4.5 0.3 0.8 1.4 0.2 9.6 1.7 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.9 0.1 1.4 0.0 0.6 0.0 0.0 0.2 0.2 0.0 1.9 0.1 3.0 1.3 1.2 1.3 0.0 0.0 0.4 0.0 13.3 2.6 0.5 3.4 1.3 37.2 0.4 1.9 0.8 0.0 0.3 0.2 0.0 0.0 0.4 4.6 7.8 0.2 0.0 0.0 0.1 4.1 0.0 0.0 0.3 0.1 0.0 45.5 0.4 0.0 0.0 0.4 0.7 0.2 0.0 0.4 1.2 3.8 2.0 0.0 0.1 0.4 2.8 14.3 0.0 0.1 ARHGAP27 "CAMGAP1, FLJ43547, SH3D20, SH3P20" ENSG00000159314 "Rho GTPase activating protein 27" Q6ZUM4 17 45393902-45434421 "Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 99.1;Paneth cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.7;OE19: 20.5;RT4: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023919, HPA053053" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023919: AB_2059402, HPA053053: AB_2682027" "unprognostic (9.80e-2)" "unprognostic (1.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.89e-3)" "unprognostic (4.66e-1)" "unprognostic (2.69e-2)" "unprognostic (7.69e-2)" "unprognostic (6.89e-2)" "unprognostic (2.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.49e-2)" "unprognostic (1.96e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.21e-4)" 15.7 7.4 4.2 8.7 6.2 11.7 15.9 3.9 4.2 18.9 3.1 24.8 10.6 8.8 1.7 98.8 11.8 3.2 19.3 3.4 4.1 20.5 6.6 28.6 9.2 5.1 4.1 3.0 3.6 7.7 3.2 10.4 4.0 4.8 17.1 9.0 0.5 38.0 1.6 4.4 27.1 52.1 2.4 3.9 63.5 12.8 8.9 5.1 6.4 16.8 1.8 6.7 17.8 44.6 4.5 6.1 6.0 0.1 1.7 0.8 0.4 16.7 0.0 0.3 0.4 0.1 5.3 11.9 5.5 11.4 0.4 2.6 3.8 0.8 1.1 0.2 11.3 3.7 0.3 2.7 3.5 0.1 0.0 15.7 0.8 4.7 0.0 1.7 0.5 3.6 5.9 1.5 9.8 0.5 4.2 5.3 1.9 0.3 20.5 4.9 4.4 0.2 1.9 3.9 26.1 0.8 0.5 0.7 5.0 0.3 2.0 3.9 10.2 5.6 0.0 1.4 0.1 0.5 12.0 8.4 1.2 0.3 1.5 0.1 1.0 5.2 4.4 2.4 8.6 1.5 3.6 1.5 2.7 4.3 2.7 1.2 1.3 10.0 1.8 11.4 7.2 2.1 4.0 4.2 6.2 3.9 4.2 3.4 4.1 5.1 4.1 3.0 4.8 3.9 5.1 4.5 19.9 6.4 17.8 2.9 23.1 10.3 15.2 9.3 2.8 3.3 11.4 7.4 10.6 15.7 13.0 18.4 4.2 7.7 38.0 99.1 3.9 6.0 1.1 11.0 2.5 20.8 19.2 1.7 3.6 3.4 11.5 3.1 31.6 18.4 4.5 0.5 17.5 2.1 15.0 1.7 8.8 34.2 10.2 47.1 13.4 1.1 0.3 33.1 7.2 19.7 26.0 1.6 23.7 3.0 2.5 19.1 79.6 0.0 15.9 28.3 57.0 6.4 11.7 1.6 0.0 3.0 2.9 6.7 2.0 9.7 8.7 14.1 14.2 1.0 43.4 57.4 ADPGK "ADP-GK, DKFZp434B195" ENSG00000159322 "ADP dependent glucokinase" Q9BRR6 15 72751369-72785846 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 140.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045194, HPA058525" Approved Approved Centrosome "Intracellular and membrane" NA NA 66000 Centrosome "HPA045194: AB_10964638, HPA058525: AB_2683742" "unprognostic (5.96e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (8.50e-2)" "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.22e-4)" "prognostic unfavorable (4.52e-7)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.07e-2)" 10.1 7.6 2.7 15.5 2.8 23.9 8.7 2.9 3.8 7.3 8.1 10.4 8.0 5.5 12.2 7.6 9.6 7.0 4.4 2.6 4.0 11.9 10.8 17.1 13.6 3.7 3.5 2.3 6.0 7.9 6.6 3.9 16.7 4.1 12.2 11.9 4.4 9.7 5.4 4.8 7.0 8.7 7.9 3.6 13.7 9.9 7.3 3.5 15.4 9.3 5.3 16.5 13.8 5.9 5.4 18.5 37.8 19.8 23.5 43.8 33.2 26.6 52.7 51.0 54.0 74.4 21.5 47.6 34.7 38.3 33.1 53.6 49.0 56.6 27.7 40.2 34.5 38.8 26.0 9.9 20.3 28.2 60.3 37.3 36.2 15.7 28.6 26.4 26.4 31.8 26.7 27.7 57.6 33.1 11.6 18.8 27.0 29.6 36.7 17.6 21.9 32.3 48.5 27.9 21.3 14.3 14.7 48.2 19.7 26.3 30.8 18.9 71.9 26.4 27.0 22.4 103.2 48.5 57.8 119.3 34.6 47.2 58.4 45.7 56.8 69.2 51.6 22.4 48.4 27.9 30.4 20.6 22.8 72.5 26.7 17.7 20.2 27.2 32.0 41.5 55.4 17.9 59.6 2.7 2.8 2.9 3.8 2.6 4.0 3.7 3.5 2.3 4.1 3.6 3.5 5.4 19.3 19.2 34.3 22.5 61.7 15.3 20.9 22.7 17.1 15.6 20.1 14.7 3.9 8.6 23.8 20.2 14.6 38.2 75.6 15.1 7.9 25.8 14.9 18.2 22.6 20.2 7.8 10.5 13.0 17.4 62.0 27.4 23.4 17.5 48.9 31.6 21.4 23.9 80.4 15.2 17.5 17.0 24.4 101.3 51.6 6.4 21.8 68.5 26.6 31.9 140.6 11.7 42.2 13.0 22.1 22.3 16.9 15.4 34.9 34.4 15.6 10.7 24.8 24.4 19.7 19.2 16.4 24.4 31.3 11.8 18.2 41.7 36.0 22.9 20.9 31.2 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 569.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 25.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 25.6" "Cell line enhanced" "Detected in all" "HDLM-2: 672.8" HPA038186 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes 300000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 133.9 79.1 111.7 37.3 105.9 14.4 122.5 105.2 123.3 183.4 75.2 220.7 33.3 245.9 29.3 129.1 146.6 29.1 95.9 111.1 60.6 156.6 569.8 175.0 22.9 51.0 49.9 91.9 241.9 50.7 83.1 97.0 49.8 55.6 196.0 29.1 65.2 95.2 87.6 56.9 116.2 102.0 99.6 34.8 61.9 110.4 32.9 63.7 16.5 110.4 16.4 20.3 178.1 138.6 68.6 49.2 250.8 324.8 320.3 149.8 126.2 127.5 210.9 189.2 157.6 130.1 153.8 190.2 19.5 151.8 321.7 143.2 104.6 178.7 159.3 61.9 672.8 219.1 27.5 160.6 58.1 174.1 7.7 56.6 123.7 68.8 121.4 245.6 237.7 175.3 8.6 175.5 50.6 139.8 144.1 9.2 40.7 347.6 92.2 180.8 4.2 99.8 39.6 124.7 12.5 107.4 363.6 254.7 86.9 186.1 230.0 75.9 23.4 296.7 239.6 344.2 36.6 195.2 42.4 19.3 25.4 196.5 18.1 183.6 25.6 0.4 3.6 1.3 0.1 0.6 0.1 0.1 1.1 0.3 0.0 0.0 0.1 1.3 0.1 0.0 4.4 0.5 0.4 111.7 105.9 105.2 123.3 111.1 60.6 51.0 49.9 91.9 55.6 34.8 63.7 68.6 370.5 0.0 14.1 9.4 22.8 289.5 328.0 44.6 257.8 325.5 239.2 275.5 10.4 88.6 16.7 154.5 200.1 153.6 88.4 99.8 234.8 61.9 6.6 73.1 494.8 342.7 513.3 248.6 28.7 34.0 404.0 292.4 66.3 117.5 52.8 216.3 325.2 710.0 491.3 116.1 15.2 229.4 22.4 100.4 309.4 23.1 489.6 136.8 227.7 12.2 76.7 512.6 4.1 13.0 3.1 38.3 141.3 692.1 38.8 399.9 244.2 547.6 11.4 357.7 598.2 232.0 411.7 7.4 32.8 259.4 249.2 163.2 81.3 122.5 198.9 206.7 PLA2G4D cPLA2delta ENSG00000159337 "Phospholipase A2 group IVD" Q86XP0 15 42067009-42094562 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "prostate: 19.3;skin 1: 16.1;vagina: 22.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4" "Group enriched" "Detected in some" 4 "cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "RPMI-8226: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA074206 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA074206: " "unprognostic (1.16e-1)" "unprognostic (1.10e-2)" "unprognostic (2.91e-2)" "unprognostic (9.16e-3)" "unprognostic (9.33e-3)" "unprognostic (4.35e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.84e-1)" "unprognostic (1.28e-2)" "unprognostic (2.75e-1)" "unprognostic (2.64e-7)" "unprognostic (2.54e-2)" "unprognostic (2.34e-1)" "unprognostic (3.47e-2)" "unprognostic (4.32e-2)" 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.3 2.5 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 19.3 0.0 0.2 0.8 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.4 22.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 15.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.1 0.4 PADI4 "PAD, PADI5, PDI4, PDI5" ENSG00000159339 "Peptidyl arginine deiminase 4" Q9UM07 1 17308195-17364004 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "bone marrow: 106.1;lymphoid tissue: 30.1" "Cell type enhanced" "Detected in some" "dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0" "Group enriched" "Detected in all" 9 "granulocytes: 183.0;monocytes: 71.3" "Cell line enhanced" "Detected in some" "HEL: 1.2;RPMI-8226: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017007, HPA042825" Enhanced NA NA 29000 "HPA017007: AB_1854921, HPA042825: AB_2678189" "unprognostic (1.70e-1)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (2.98e-1)" "unprognostic (1.27e-1)" "unprognostic (1.13e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (8.49e-2)" "unprognostic (5.22e-2)" "unprognostic (8.55e-2)" "unprognostic (1.81e-1)" "unprognostic (1.66e-3)" "unprognostic (1.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.56e-2)" "unprognostic (1.80e-1)" 1.3 0.1 0.3 0.7 0.3 106.1 0.3 0.2 0.8 0.1 0.6 0.1 0.1 0.1 0.0 0.4 1.0 0.4 0.9 0.3 0.3 0.5 1.7 7.9 0.3 0.3 0.2 0.4 0.1 0.3 0.0 0.2 0.5 0.4 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.3 0.4 0.1 30.1 0.4 0.1 0.2 1.6 0.3 0.3 0.2 0.7 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 79.9 71.3 97.5 0.4 5.7 0.2 1.1 0.5 0.7 13.9 1.8 2.6 4.5 183.0 4.5 1.8 6.2 0.4 35.8 0.3 0.3 0.2 0.8 0.3 0.3 0.3 0.2 0.4 0.4 0.1 0.2 0.5 0.0 0.0 3.7 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.6 0.6 0.0 0.0 12.6 0.1 0.0 0.4 0.2 0.0 0.4 0.0 0.0 3.3 0.4 0.2 0.0 14.6 0.0 0.0 22.3 0.0 20.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 4.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 ADIPOR1 "ACDCR1, PAQR1" ENSG00000159346 "Adiponectin receptor 1" Q96A54 1 202940826-202958572 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 329.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-1)" "unprognostic (1.58e-1)" "unprognostic (3.81e-2)" "unprognostic (2.74e-1)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.27e-4)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.13e-1)" "unprognostic (1.79e-3)" "unprognostic (5.90e-2)" "unprognostic (1.75e-1)" "unprognostic (2.84e-1)" "unprognostic (8.63e-2)" 60.3 59.1 57.4 49.5 60.6 217.1 64.2 59.6 64.7 53.8 83.8 56.1 46.9 41.3 92.2 111.8 69.2 48.6 93.4 57.4 60.5 71.1 107.0 81.2 48.4 61.7 59.7 56.2 48.1 92.5 108.0 45.9 100.9 61.1 54.1 60.4 136.8 107.5 47.8 137.8 106.7 47.8 51.3 62.3 66.3 63.8 49.1 59.3 50.7 57.2 141.4 78.5 71.6 69.8 66.2 97.0 87.2 53.4 59.9 111.4 85.4 276.8 103.4 123.9 108.8 99.4 88.7 114.7 63.5 75.3 120.6 86.3 118.0 81.3 145.5 96.5 118.5 93.5 48.6 104.3 72.6 109.7 101.6 71.6 101.7 235.0 115.9 118.3 108.4 108.8 111.7 128.1 133.5 111.2 105.6 85.3 77.4 119.7 87.1 103.1 66.7 128.7 125.7 106.5 111.0 89.2 90.8 109.6 166.5 135.5 143.6 121.1 99.4 95.7 78.9 62.2 39.4 117.3 137.8 197.4 71.4 113.5 58.9 94.5 362.2 361.8 455.4 136.0 253.6 143.8 157.9 143.4 134.1 209.8 165.2 141.5 124.3 825.9 126.0 259.6 146.1 179.5 557.4 57.4 60.6 59.6 64.7 57.4 60.5 61.7 59.7 56.2 61.1 62.3 59.3 66.2 40.7 35.3 52.5 6.8 46.8 235.0 95.2 109.8 75.7 24.8 81.9 54.2 59.7 32.9 79.3 53.3 29.2 112.7 42.8 49.3 68.4 73.8 68.2 58.8 24.5 53.4 49.1 329.0 13.7 86.3 172.4 40.9 37.2 54.3 37.3 18.8 58.5 60.8 104.2 11.8 15.1 49.1 85.5 148.5 89.7 62.5 28.6 107.6 85.4 15.9 85.0 38.0 42.2 9.5 20.0 120.0 43.5 24.5 116.0 133.1 67.3 65.9 82.5 54.9 39.5 29.2 61.7 26.4 27.2 79.3 228.9 202.8 47.1 29.2 41.7 206.6 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961873-202967275 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 610.1" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 187.2;Extravillous trophoblasts: 196.5;Syncytiotrophoblasts: 293.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 187.3;hTCEpi: 188.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 37.8 57.8 37.1 23.2 38.4 19.9 44.1 41.9 40.9 46.0 53.8 32.2 19.5 41.6 132.6 62.1 68.8 27.5 151.0 37.2 43.9 65.1 50.6 44.4 25.4 43.4 48.0 35.2 42.1 45.5 83.6 46.5 67.2 49.4 41.5 21.4 34.6 57.4 40.4 610.1 124.8 26.0 37.8 39.6 39.4 93.6 51.1 40.0 40.5 40.9 310.7 39.1 53.1 46.2 43.6 34.8 21.3 18.3 37.7 166.0 37.9 178.5 68.3 63.4 43.2 38.4 17.5 39.9 21.5 56.5 68.1 24.0 187.3 14.9 58.0 28.2 31.2 37.8 12.4 24.0 20.4 59.7 10.5 29.6 61.2 188.3 47.5 25.8 36.4 28.9 25.8 37.0 37.6 157.8 40.4 13.6 9.5 12.1 31.0 40.1 21.9 87.6 45.7 41.1 40.8 15.7 19.1 38.0 124.0 57.4 39.4 57.7 23.4 28.5 49.0 20.8 18.7 38.3 34.9 44.5 10.0 53.6 16.2 37.1 24.4 56.7 46.6 27.4 42.6 36.3 23.4 30.9 28.9 37.6 35.0 41.9 29.6 46.0 32.2 29.4 25.9 34.2 52.6 37.1 38.4 41.9 40.9 37.2 43.9 43.4 48.0 35.2 49.4 39.6 40.0 43.6 33.0 22.4 29.8 10.1 15.5 187.2 38.5 89.5 42.1 21.0 46.1 41.9 119.3 37.1 60.5 29.5 29.2 171.1 15.8 10.6 7.9 38.3 5.0 58.7 17.3 30.0 19.2 30.7 8.9 48.3 196.5 28.9 31.6 34.9 28.5 13.6 32.9 44.6 63.5 10.1 11.3 10.8 105.8 45.4 29.7 8.6 29.8 39.5 64.0 8.4 20.9 65.9 11.3 11.6 8.1 72.8 11.3 31.2 12.5 25.8 16.0 38.9 75.9 35.0 13.1 49.1 30.0 23.0 4.3 40.6 157.4 293.5 19.5 27.9 14.7 48.2 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254709-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 69000 Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 104.7 118.9 205.3 78.5 210.0 90.2 98.7 210.1 290.4 86.3 202.5 120.3 69.6 100.3 115.3 116.4 91.8 58.8 169.0 208.8 210.8 104.1 171.9 82.4 96.5 214.7 221.1 207.0 86.5 114.9 92.3 80.1 91.8 215.9 92.1 82.9 65.1 84.6 87.2 407.4 103.9 92.1 91.8 212.1 110.4 116.4 153.2 210.3 115.4 77.4 189.7 114.9 119.6 88.9 212.9 251.4 294.8 213.4 175.2 227.4 167.0 231.9 166.0 202.1 258.6 205.1 388.3 278.2 202.2 396.2 235.4 178.7 255.4 277.1 250.6 219.6 331.9 236.6 197.8 256.2 396.6 250.8 234.7 220.5 182.5 204.2 296.3 271.4 193.3 229.5 222.4 313.6 247.9 220.2 723.5 217.4 276.7 406.0 384.3 293.4 181.6 207.7 364.7 252.7 210.6 166.7 283.8 184.5 266.3 222.7 313.0 278.9 452.3 203.4 128.1 201.2 159.2 288.2 295.1 397.7 430.3 212.6 218.1 238.7 439.4 439.0 713.9 247.3 478.1 281.2 399.0 287.4 274.4 398.4 426.1 261.0 258.1 580.2 351.2 502.3 240.3 476.6 651.0 205.3 210.0 210.1 290.4 208.8 210.8 214.7 221.1 207.0 215.9 212.1 210.3 212.9 90.1 57.7 62.9 15.7 78.5 88.6 111.9 249.0 58.1 50.9 60.9 69.3 245.2 82.9 125.0 60.7 27.1 328.6 74.0 104.1 168.3 177.3 279.1 91.5 63.0 95.8 84.2 107.3 25.3 186.9 234.1 88.5 46.9 59.1 83.6 88.8 83.2 116.0 184.5 33.7 24.2 94.1 156.6 104.0 98.0 243.2 105.3 90.3 104.9 11.2 256.6 91.9 115.4 16.1 23.2 172.2 129.1 98.6 67.0 121.4 168.6 206.6 148.3 54.6 118.3 79.0 221.1 234.8 83.5 66.7 86.5 414.6 77.7 105.6 114.5 107.2 ATP13A2 "CLN12, HSA9947, PARK9" ENSG00000159363 "ATPase cation transporting 13A2" Q9NQ11 1 16985958-17011928 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 118.1" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 20.6" "Lineage enriched" "Detected in many" 6 "dendritic cells: 20.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037038, CAB037111, HPA050910, HPA054717" Enhanced NA NA "CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583" "unprognostic (3.81e-2)" "unprognostic (1.84e-2)" "unprognostic (5.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.33e-7)" "unprognostic (1.04e-1)" "unprognostic (9.71e-3)" "unprognostic (4.51e-1)" "unprognostic (9.85e-3)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (3.25e-2)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (6.84e-3)" 14.2 18.8 42.4 20.4 41.1 11.7 14.4 25.7 75.4 10.2 1.4 15.8 12.8 12.2 6.6 23.7 9.6 9.4 10.2 44.4 45.4 16.6 6.2 18.0 17.8 95.9 57.4 44.8 8.8 56.2 13.0 57.5 12.7 99.4 14.4 9.9 23.0 27.7 7.9 17.3 16.2 16.9 8.7 25.0 26.2 19.5 10.3 77.4 9.5 16.8 5.3 10.4 13.1 12.2 118.1 28.3 27.4 14.7 60.8 13.8 12.2 40.8 15.8 15.4 17.1 16.6 48.9 31.4 12.5 65.9 26.9 14.6 43.1 32.1 59.5 6.2 17.2 58.5 43.7 28.0 27.2 17.5 15.6 19.6 10.0 31.6 47.1 36.6 55.0 32.3 32.2 28.2 22.6 70.2 22.2 18.4 8.8 23.2 66.3 20.0 20.0 60.1 50.7 19.0 42.8 40.9 27.4 73.8 87.7 60.2 18.8 29.9 19.6 34.4 18.0 34.5 30.8 33.1 4.8 6.1 14.0 34.6 85.2 30.3 0.0 1.6 0.3 2.6 3.7 2.9 1.3 2.1 2.2 0.4 3.1 1.0 1.5 0.5 2.7 3.6 20.6 1.8 1.4 42.4 41.1 25.7 75.4 44.4 45.4 95.9 57.4 44.8 99.4 25.0 77.4 118.1 18.9 0.0 2.2 14.4 8.3 6.5 6.9 5.7 6.2 35.9 16.9 11.3 3.6 7.2 6.8 7.3 35.5 5.8 33.4 44.6 5.9 15.1 1.4 6.7 3.8 14.4 7.7 4.2 53.1 25.1 33.6 6.0 18.8 19.0 8.9 20.5 6.1 3.7 10.4 47.1 61.8 15.0 0.0 17.3 2.8 1.7 5.3 10.1 5.4 11.2 6.1 34.0 8.2 20.1 18.1 57.0 49.0 6.4 5.4 12.3 18.2 5.3 4.3 38.4 0.0 4.6 5.7 13.6 16.4 11.6 5.3 9.3 11.1 4.8 21.7 12.8 M1AP "C2orf65, D6Mm5e, SPATA37" ENSG00000159374 "Meiosis 1 associated protein" Q8TC57 2 74557883-74648338 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.1" "Group enriched" "Detected in some" 4 "Spermatocytes: 16.2;Spermatogonia: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 2.1;RT4: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045420, HPA059302" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045420: AB_10961177, HPA059302: AB_2683972" "unprognostic (1.76e-1)" "unprognostic (6.58e-3)" "unprognostic (1.26e-2)" "unprognostic (2.87e-1)" "unprognostic (9.15e-2)" "unprognostic (1.35e-3)" "unprognostic (1.86e-1)" "unprognostic (2.17e-3)" "unprognostic (3.42e-1)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (6.11e-2)" "unprognostic (7.74e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" 0.3 0.2 1.1 0.1 0.5 2.5 0.5 0.0 1.1 2.5 0.7 0.1 0.1 1.1 0.3 0.1 2.6 0.1 0.0 1.0 0.4 0.8 0.0 0.4 0.1 0.3 0.1 0.6 0.0 0.3 1.3 1.8 0.1 0.5 0.1 0.0 0.5 0.9 0.3 0.0 0.0 0.0 0.1 0.6 0.1 0.4 8.1 1.2 0.6 2.1 0.0 0.3 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 1.1 1.0 0.4 0.3 0.1 0.6 0.5 0.6 1.2 0.6 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.4 0.4 0.0 0.1 3.7 0.0 0.5 0.1 0.2 0.0 0.3 3.1 2.2 0.1 0.0 0.0 0.4 3.1 0.0 1.6 0.0 0.0 0.9 0.0 0.0 0.0 0.1 3.8 0.0 1.0 0.8 0.0 1.6 0.8 3.9 0.0 2.0 0.0 2.8 0.4 0.5 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.2 0.0 0.1 1.8 1.4 0.0 0.1 0.0 16.2 22.5 0.0 0.0 0.3 0.1 0.0 0.1 0.1 PSMB4 "HN3, PROS26" ENSG00000159377 "Proteasome 20S subunit beta 4" P28070 1 151399560-151401937 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006700, HPA073499" Approved Uncertain Nucleoplasm,Mitochondria NA NA 12000000 Nucleoplasm Mitochondria "HPA006700: AB_1079704, HPA073499: " "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.63e-1)" "unprognostic (5.74e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (2.27e-1)" "unprognostic (1.69e-1)" "unprognostic (4.37e-3)" "unprognostic (3.73e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (2.90e-10)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (3.82e-2)" "unprognostic (5.85e-2)" 184.2 244.7 198.7 158.1 200.0 174.3 175.7 208.2 214.0 167.9 199.4 182.2 151.4 197.2 227.6 171.7 179.9 140.3 244.1 197.3 213.3 197.5 271.7 144.4 215.8 207.0 201.9 194.4 181.2 165.4 220.4 169.3 188.7 209.0 163.7 168.0 95.1 171.1 192.4 301.6 183.0 154.1 193.4 210.6 175.2 173.2 69.5 203.2 235.7 157.5 239.6 237.3 198.5 152.5 215.7 428.3 451.9 373.0 447.8 412.9 392.3 507.8 247.6 549.2 719.3 503.1 608.6 569.5 384.1 730.7 424.3 379.1 419.7 383.2 472.7 407.6 535.6 391.1 268.6 320.8 463.3 444.4 377.0 355.7 431.7 444.8 672.5 276.2 364.8 506.1 419.1 434.3 740.0 512.7 1174.2 463.5 452.0 952.8 638.6 576.2 433.8 266.9 688.2 594.4 354.2 408.6 488.0 283.6 626.5 879.8 459.1 564.1 594.6 320.7 310.4 326.1 333.8 557.0 726.9 902.5 769.1 459.5 337.8 667.8 291.8 343.4 227.0 265.0 342.2 314.8 293.6 303.7 301.0 421.7 257.5 260.4 272.8 251.5 347.3 270.5 468.1 405.1 395.2 198.7 200.0 208.2 214.0 197.3 213.3 207.0 201.9 194.4 209.0 210.6 203.2 215.7 72.2 153.8 127.4 10.1 82.2 76.6 81.9 131.5 82.0 56.3 62.0 71.6 128.0 68.6 123.2 71.7 16.7 209.8 79.7 87.8 103.7 127.9 16.0 118.1 107.5 97.7 66.4 87.1 10.4 195.8 146.7 91.9 47.4 110.0 111.1 81.1 92.8 151.7 125.0 48.8 11.5 80.5 89.5 108.1 88.8 15.6 104.4 89.4 96.0 12.2 186.2 89.5 64.9 6.6 14.7 131.7 75.0 105.3 89.1 75.5 117.5 148.9 141.5 62.8 65.7 86.0 127.5 54.5 49.7 80.0 75.9 267.3 80.2 124.5 96.0 89.1 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55324203-55330756 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.9;heart muscle: 9.7;skin 1: 8.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.5;Collecting duct cells: 5.5;Hofbauer cells: 4.7;Late spermatids: 5.1;Melanocytes: 3.6" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HEK 293: 1.9;RPTEC TERT1: 7.1;SK-MEL-30: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favorable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 9.9 0.1 0.2 0.0 0.6 0.0 4.8 1.1 0.2 2.3 0.0 0.1 0.0 0.2 0.0 0.5 0.1 0.1 9.7 0.0 0.7 0.8 0.0 1.8 0.1 0.5 0.7 0.2 0.2 0.1 1.7 0.2 0.1 0.6 0.2 0.0 1.6 1.9 0.0 2.8 8.7 0.3 0.1 0.1 1.3 0.0 0.4 0.4 2.2 0.6 1.3 1.1 0.0 0.5 0.5 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 7.1 0.0 0.1 0.1 0.0 1.1 4.8 0.0 0.3 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 1.1 0.2 0.0 0.7 0.5 0.7 0.2 0.6 0.1 0.4 0.5 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.5 0.0 7.5 0.4 0.6 1.3 0.0 1.2 5.5 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.8 0.0 0.6 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.7 5.1 0.0 0.1 3.6 0.0 0.6 1.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.3 0.1 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 965.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 161.8;HMC-1: 160.8;RT4: 131.3;U-266/70: 259.8;U-266/84: 141.2" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favorable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 277.0 246.9 42.5 125.4 40.8 312.0 120.1 55.5 53.5 102.6 41.1 188.3 89.3 92.8 41.8 316.2 358.2 159.2 193.9 36.6 159.8 133.5 20.9 106.0 123.0 64.3 43.8 34.7 559.7 493.0 37.7 210.8 107.6 43.8 268.2 207.6 154.0 75.8 184.6 212.5 121.0 112.1 215.5 49.7 107.9 246.5 10.3 42.8 337.7 203.1 289.7 133.3 282.6 79.8 49.4 4.3 6.1 10.9 4.5 13.4 9.8 92.9 11.2 21.4 2.8 10.5 8.8 1.6 161.8 7.8 3.5 1.8 69.5 39.6 42.6 5.2 10.8 20.3 84.5 12.3 18.4 29.5 0.4 160.8 10.1 76.7 10.3 18.7 9.5 57.6 8.2 40.6 106.9 28.1 3.6 18.1 5.4 4.9 1.7 1.2 11.4 36.5 84.3 5.3 131.3 1.9 11.3 8.6 3.6 1.4 80.0 9.0 10.1 14.3 0.3 18.2 2.9 0.6 259.8 141.2 103.4 2.2 4.1 6.3 8.4 19.7 23.1 10.0 27.1 14.8 29.9 10.9 10.2 11.5 29.0 17.5 12.6 77.1 12.7 35.6 38.6 11.2 19.7 42.5 40.8 55.5 53.5 36.6 159.8 64.3 43.8 34.7 43.8 49.7 42.8 49.4 555.8 157.0 241.8 6.5 330.1 230.2 464.4 311.4 548.7 25.4 355.1 276.7 274.8 48.6 128.5 187.6 29.2 50.0 343.9 345.8 15.6 113.2 1.4 336.7 211.7 196.4 965.1 127.6 2.9 163.7 16.6 352.8 562.2 643.2 369.3 40.6 148.2 6.5 120.1 3.3 2.0 617.1 264.5 98.8 183.6 3.1 72.7 227.0 120.9 25.3 47.5 478.8 58.7 4.5 10.4 55.9 399.9 55.3 725.2 230.1 397.5 13.9 88.5 38.9 124.9 537.5 305.0 1.8 1.7 343.8 447.9 138.0 300.8 278.6 360.7 211.8 CES5A "CAUXIN, CES4C1, CES5, CES7, FLJ31547" ENSG00000159398 "Carboxylesterase 5A" Q6NT32 16 55846154-55956031 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "epididymis: 68.1" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Collecting duct cells: 5.5;Excitatory neurons: 1.4;Hepatocytes: 6.9;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 4.0" "Cancer enriched" "Detected in single" 5 "liver cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 46 "U-266/70: 7.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "unprognostic (2.07e-1)" "unprognostic (2.55e-1)" "unprognostic (6.34e-2)" "unprognostic (4.82e-2)" "unprognostic (3.78e-1)" "unprognostic (2.33e-1)" "unprognostic (3.12e-2)" "unprognostic (1.72e-7)" "unprognostic (1.55e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 68.1 0.0 0.0 0.6 0.1 0.2 0.2 0.0 3.9 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HK2 ENSG00000159399 "Hexokinase 2" P52789 2 74834127-74893359 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 145.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 216.4;Early spermatids: 89.5;Paneth cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 51.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 172.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028587, HPA061711" Enhanced Supported Vesicles,Centrosome,Mitochondria,Cytosol NA NA 100000 "Mitochondria, Cytosol" "Vesicles, Centrosome" "HPA028587: AB_10602605, HPA061711: " "unprognostic (1.28e-1)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (2.85e-2)" "unprognostic (2.57e-1)" "unprognostic (2.17e-1)" "unprognostic (4.43e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.20e-1)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (7.67e-2)" 58.7 2.7 2.5 14.8 3.7 46.2 16.1 4.6 4.6 5.1 2.9 47.0 2.8 5.1 66.7 20.1 9.8 9.6 7.9 3.4 6.0 1.9 2.8 15.4 5.8 10.7 4.3 1.5 15.0 2.9 2.5 1.9 13.2 7.5 5.0 37.7 145.2 14.9 1.1 46.0 14.5 13.1 3.3 6.8 6.9 18.9 33.1 6.3 3.8 14.2 84.5 7.9 27.4 16.0 7.8 55.9 0.4 12.5 45.4 103.3 10.8 46.5 21.3 30.6 23.4 33.4 44.0 9.8 40.7 20.1 9.9 30.2 19.0 57.0 44.7 67.0 11.6 12.5 55.1 12.4 61.0 32.5 80.8 86.3 18.2 47.3 44.5 77.1 26.3 11.3 23.0 49.2 0.2 6.9 39.6 19.8 82.0 45.3 52.4 38.2 31.8 26.2 31.7 14.2 77.2 9.2 44.6 13.5 67.4 27.4 17.8 3.6 12.8 9.4 74.0 13.4 31.2 39.2 27.1 8.2 20.2 172.5 57.9 19.9 16.8 14.0 51.7 0.2 11.0 0.6 1.2 0.8 0.1 11.8 1.3 1.2 1.2 11.2 0.0 7.7 0.3 1.5 4.7 2.5 3.7 4.6 4.6 3.4 6.0 10.7 4.3 1.5 7.5 6.8 6.3 7.8 1.6 16.0 45.3 4.9 5.7 51.6 9.5 26.7 5.7 14.8 16.0 5.6 7.2 4.3 24.2 5.5 83.4 2.3 0.6 216.4 0.0 4.6 89.5 5.8 4.1 4.4 39.0 4.2 0.2 4.5 33.5 6.4 14.8 15.0 22.2 27.2 1.4 0.3 15.8 21.9 0.1 37.7 6.1 20.8 35.1 46.0 14.6 22.8 23.2 25.3 18.9 6.3 2.1 0.5 0.7 25.6 108.3 7.9 4.7 34.3 5.4 0.2 15.2 42.1 13.1 19.9 3.3 3.9 4.2 10.7 57.0 8.2 3.6 5.8 51.7 70.0 C1R ENSG00000159403 "Complement C1r" 12 7080214-7092540 "Human disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 1437.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 442.3;Fibroblasts: 684.4;Hepatocytes: 1444.2;Leydig cells: 1142.6;Peritubular cells: 388.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1089.8;ASC TERT1: 546.0;BJ hTERT+: 461.9;BJ hTERT+ SV40 Large T+ RasG12V: 303.4;HSkMC: 672.1" "Low region specificity" "Detected in many" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 479.6 205.3 14.9 123.5 15.0 1.1 404.0 15.2 23.5 453.6 29.4 253.3 38.7 356.8 81.5 119.9 530.9 281.6 312.0 14.1 35.1 146.4 1437.3 343.3 73.0 23.0 16.6 13.4 649.7 88.7 11.1 64.4 52.8 17.2 207.0 101.9 5.9 159.6 87.9 69.9 169.5 230.0 159.2 17.2 193.6 244.8 47.0 19.4 35.0 225.3 74.8 76.0 472.3 397.7 17.8 1.2 8.9 0.9 9.1 1089.8 546.0 0.4 108.9 461.9 143.0 303.4 1.4 2.4 0.5 4.5 108.8 11.8 2.3 11.8 5.5 18.3 18.3 1.1 0.5 4.1 3.6 226.5 0.8 2.3 672.1 3.2 74.7 4.7 121.0 2.9 0.5 0.3 20.5 21.2 0.1 8.0 0.8 3.1 0.1 0.9 8.6 3.8 0.8 0.9 5.5 0.4 2.3 95.1 3.7 2.8 1.3 0.2 0.2 0.4 38.3 6.3 152.1 0.8 1.1 3.0 0.2 53.1 1.0 5.4 0.0 0.0 0.6 0.3 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.6 0.6 0.5 0.8 0.0 0.0 0.3 0.1 14.9 15.0 15.2 23.5 14.1 35.1 23.0 16.6 13.4 17.2 17.2 19.4 17.8 45.4 22.4 90.5 3.6 7.1 54.7 58.8 76.6 33.6 0.3 5.9 30.9 20.8 183.0 22.9 18.4 2.1 4.1 1.8 0.7 3.9 280.8 4.6 13.3 442.3 45.4 0.0 40.6 0.9 44.5 3.7 684.4 16.3 11.6 10.1 24.9 114.9 1444.2 11.2 0.0 0.3 0.7 0.0 40.9 66.9 29.2 1142.6 7.0 53.4 13.1 1.6 16.0 0.0 2.5 0.1 51.1 1.3 388.1 6.2 17.7 0.3 6.1 5.3 1.4 170.9 87.5 140.4 6.8 6.7 5.6 40.1 5.2 11.5 15.2 0.7 11.2 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151700058-151716803 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 71.3;pituitary gland: 109.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 42.1;SH-SY5Y: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 0.1 11.3 42.9 0.2 41.7 0.3 0.0 20.9 71.3 0.0 0.1 2.0 3.0 0.0 0.0 0.0 0.8 0.0 0.1 50.2 27.6 0.1 0.0 0.1 0.0 13.6 8.5 43.0 0.0 6.2 0.0 109.9 0.1 16.6 0.1 0.7 23.8 0.0 0.0 0.0 0.1 2.1 0.2 1.8 0.0 4.9 3.1 19.8 0.0 0.1 0.0 0.0 0.1 0.2 23.8 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 42.1 29.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 41.7 20.9 71.3 50.2 27.6 13.6 8.5 43.0 16.6 1.8 19.8 23.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 101.4 0.0 0.0 0.9 0.0 0.0 0.0 39.6 0.1 0.0 0.3 0.0 0.0 13.1 0.3 0.0 0.0 52.8 0.0 21.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.2 20.4 1.5 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 6.0 0.7 0.1 0.1 0.0 0.0 0.1 0.0 0.8 0.0 5.5 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 ALDH4A1 "ALDH4, P5CDh" ENSG00000159423 "Aldehyde dehydrogenase 4 family member A1" P30038 1 18871430-18902724 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 202.2;liver: 440.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6" "Cancer enhanced" "Detected in all" "liver cancer: 72.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 83.7;SK-BR-3: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004645, HPA006401, HPA072759" Enhanced Supported Mitochondria NA NA 58000 Mitochondria "CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: " "unprognostic (1.17e-1)" "prognostic favorable (5.06e-4)" "unprognostic (1.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.15e-1)" "unprognostic (7.67e-2)" "unprognostic (1.28e-1)" "unprognostic (6.18e-2)" "unprognostic (1.92e-1)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-3)" "unprognostic (9.41e-3)" "unprognostic (3.83e-1)" "unprognostic (2.69e-3)" "unprognostic (9.34e-2)" 71.4 16.2 63.4 4.0 73.4 11.8 21.8 66.2 96.7 9.3 90.5 6.2 1.6 9.9 4.8 36.6 8.4 5.5 33.3 59.4 64.2 202.2 440.2 6.3 3.4 63.2 73.2 54.8 7.4 4.7 23.2 9.8 13.3 63.7 29.7 2.7 6.5 9.2 27.3 74.9 19.3 4.7 7.1 54.1 7.6 12.6 3.2 76.8 11.8 7.2 75.4 4.3 19.4 16.9 59.7 12.7 17.8 9.5 29.2 40.0 5.7 25.2 13.1 7.1 11.8 9.5 13.7 8.9 8.8 16.6 15.6 5.7 34.0 16.7 35.4 4.5 4.8 15.9 5.9 5.0 83.7 12.6 4.4 15.1 15.6 19.2 6.5 6.6 9.0 13.5 14.0 21.0 5.7 8.1 32.3 4.3 20.2 4.7 26.0 10.1 27.9 8.4 10.0 12.1 32.0 19.6 7.6 21.9 85.0 16.1 14.7 38.7 6.3 11.3 10.2 14.0 12.2 4.5 7.1 17.9 2.5 3.4 33.7 13.5 0.0 2.7 1.5 0.6 3.6 0.5 0.8 0.3 0.8 4.4 0.7 0.2 0.5 0.3 0.1 2.0 1.5 0.6 1.5 63.4 73.4 66.2 96.7 59.4 64.2 63.2 73.2 54.8 63.7 54.1 76.8 59.7 2.6 0.0 2.8 27.1 4.3 7.5 17.9 12.5 17.6 3.7 9.8 8.5 20.9 34.3 2.9 46.0 10.4 78.0 2.0 2.0 46.9 6.5 0.5 1.1 1.7 3.1 2.4 32.2 1.2 0.9 12.6 3.2 7.7 3.9 4.5 2.1 15.4 385.1 13.8 20.2 1.6 3.6 6.1 17.2 1.4 0.6 1.2 4.7 3.6 1.9 10.9 14.0 1.0 5.5 1.3 2.5 1.8 2.6 4.4 12.0 0.3 279.4 1.7 4.8 6.6 2.6 4.7 2.2 3.9 21.7 5.4 86.6 2.6 4.5 4.0 9.5 STARD9 "KIAA1300, KIF16A" ENSG00000159433 "StAR related lipid transfer domain containing 9" Q9P2P6 15 42575606-42720998 "Metabolic proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Early spermatids: 52.8;Excitatory neurons: 39.3;Oligodendrocytes: 80.9;Rod photoreceptor cells: 57.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA014562 Uncertain NA NA "HPA014562: AB_10603033" "unprognostic (2.69e-2)" "unprognostic (2.93e-1)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (6.74e-2)" "unprognostic (5.54e-5)" "unprognostic (7.45e-2)" "unprognostic (1.59e-1)" "unprognostic (1.01e-1)" "unprognostic (1.94e-2)" "unprognostic (1.91e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-3)" "unprognostic (1.53e-2)" "unprognostic (3.92e-2)" "unprognostic (3.13e-1)" "unprognostic (1.83e-3)" 4.9 0.5 0.9 1.2 4.3 0.6 4.3 2.4 3.4 5.4 1.7 6.8 1.3 5.3 3.0 2.2 3.4 2.4 3.0 0.9 1.5 0.8 0.4 4.6 1.2 3.9 2.5 0.5 6.0 0.4 0.4 0.9 4.0 4.6 2.7 2.8 13.0 1.5 3.2 2.5 2.4 3.2 4.8 1.2 2.0 3.2 8.6 3.3 3.5 1.7 3.6 1.1 4.4 5.0 9.6 0.9 0.5 5.9 2.3 3.1 4.5 0.3 1.0 1.3 1.8 2.7 0.0 0.0 0.7 0.1 1.1 1.2 0.1 2.0 0.9 2.4 3.5 1.7 0.3 4.3 1.3 1.3 0.9 1.1 2.6 0.4 1.5 1.0 1.5 1.8 2.5 1.6 3.8 1.5 0.0 0.7 0.7 0.9 0.0 1.1 5.1 3.2 1.1 0.7 0.0 1.2 2.9 1.3 0.0 0.4 0.7 0.1 0.4 3.6 2.5 1.9 0.9 2.4 3.8 2.2 1.3 1.0 2.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 2.4 3.4 0.9 1.5 3.9 2.5 0.5 4.6 1.2 3.3 9.6 26.1 12.8 2.8 7.2 2.9 3.6 1.2 0.8 1.2 8.1 0.6 1.0 6.8 0.0 0.7 1.8 52.1 0.2 4.2 0.3 0.0 0.3 52.8 3.5 12.2 19.8 8.4 3.2 39.3 0.0 0.3 15.2 2.6 0.6 2.5 3.6 9.7 0.5 2.8 11.8 33.5 2.8 0.0 2.4 7.7 15.4 24.5 2.3 8.8 24.4 2.4 2.9 11.3 20.1 80.9 0.2 0.0 22.2 2.7 0.9 0.1 0.3 9.1 57.7 19.7 11.8 13.7 3.9 8.0 0.3 3.1 0.3 6.3 7.8 0.4 0.7 THEM4 CTMP ENSG00000159445 "Thioesterase superfamily member 4" Q5T1C6 1 151870866-151909637 "Enzymes, Predicted intracellular proteins" "Apoptosis, Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 30.3" "Low region specificity" "Detected in all" HPA028161 Approved NA NA "HPA028161: AB_10603454" "unprognostic (2.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.50e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.15e-3)" "unprognostic (2.23e-2)" "unprognostic (1.07e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (3.02e-2)" "unprognostic (9.25e-2)" "unprognostic (1.91e-1)" "unprognostic (5.93e-3)" 4.2 8.3 3.2 5.5 3.9 3.2 4.9 4.6 4.0 4.6 3.6 3.7 4.1 5.2 6.9 3.2 4.3 3.7 6.1 2.7 3.0 9.3 7.9 3.6 6.1 4.5 3.5 2.8 4.4 9.0 8.5 6.1 2.6 4.7 4.4 4.4 16.0 4.1 6.2 10.5 3.4 4.6 3.2 2.3 5.0 4.7 6.1 3.7 3.2 5.8 3.1 6.2 5.3 3.1 6.0 5.4 5.9 1.1 5.2 5.2 3.9 5.2 4.7 3.7 3.7 3.7 5.7 4.0 10.5 7.2 4.3 2.8 5.6 2.5 12.1 5.0 11.8 3.5 16.5 9.4 5.5 4.2 16.0 8.0 7.5 5.6 4.5 5.3 5.2 7.8 0.4 19.4 9.4 7.3 7.4 0.3 5.2 18.6 5.4 10.9 0.2 1.0 2.5 5.6 4.9 6.3 11.2 2.8 5.0 30.3 10.3 9.8 9.4 9.3 0.8 4.8 4.0 2.2 18.5 21.2 7.5 7.8 11.8 24.9 2.6 0.8 2.3 7.2 2.4 10.5 3.9 14.4 7.1 2.4 2.1 14.9 10.5 1.1 7.9 0.8 6.8 22.2 3.3 3.2 3.9 4.6 4.0 2.7 3.0 4.5 3.5 2.8 4.7 2.3 3.7 6.0 9.6 6.4 15.1 11.4 20.5 5.6 8.0 9.6 17.6 36.4 17.3 19.3 19.1 12.8 9.9 14.7 104.3 29.7 32.6 4.6 41.1 19.1 39.8 19.0 12.8 13.5 18.1 22.1 18.1 19.5 21.5 16.1 13.7 36.6 23.5 22.4 23.9 17.6 12.8 13.5 21.6 7.4 20.3 5.1 12.3 30.4 16.8 8.7 21.4 5.6 10.4 25.5 26.8 30.2 24.9 15.1 9.2 16.1 18.5 6.3 13.6 27.8 4.9 73.3 13.1 21.2 9.7 37.4 24.5 11.7 4.4 10.3 37.9 31.6 12.2 5.5 TCHH THH ENSG00000159450 Trichohyalin Q07283 1 152106317-152115454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 24.9" "Cell type enhanced" "Detected in some" "Kupffer cells: 26.2;Langerhans cells: 9.5;Macrophages: 21.8;Spermatocytes: 22.6;Spermatogonia: 29.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;SCLC-21H: 1.1;THP-1: 2.0" "Low region specificity" "Detected in many" HPA028375 Approved NA NA "HPA028375: AB_10601722" "unprognostic (7.70e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-3)" "unprognostic (1.14e-1)" "unprognostic (2.07e-1)" "unprognostic (2.30e-2)" "unprognostic (4.97e-3)" "unprognostic (2.15e-2)" "unprognostic (1.84e-2)" "unprognostic (7.12e-5)" "unprognostic (2.03e-1)" "unprognostic (6.55e-2)" "unprognostic (5.90e-6)" "unprognostic (5.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.71e-2)" "unprognostic (9.28e-7)" 0.5 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 24.9 0.2 0.0 0.1 2.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.7 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.3 2.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.0 0.1 5.3 0.0 0.0 0.0 0.5 6.4 0.1 0.5 2.8 0.5 1.2 2.5 2.0 0.0 0.3 1.8 0.0 0.6 0.0 0.3 0.0 0.0 0.2 1.4 0.2 3.5 1.8 0.0 0.5 0.2 7.5 0.9 0.0 0.8 0.0 0.1 2.5 0.0 0.6 0.0 0.5 0.5 0.0 26.2 9.5 0.2 0.3 21.8 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 1.3 0.0 0.0 0.7 0.0 0.0 3.2 1.4 22.6 29.1 1.0 2.4 5.2 0.8 0.1 0.0 0.1 LCE2B "LEP10, SPRL1B, XP5" ENSG00000159455 "Late cornified envelope 2B" O14633 1 152686123-152687397 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 572.7" "Cell type enriched" "Detected in some" 17 "Suprabasal keratinocytes: 31.5" "Cancer enriched" "Detected in some" 5 "melanoma: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" 0.3 0.1 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.2 572.7 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 31.5 0.0 0.1 0.0 0.0 0.0 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038838, HPA038839" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA038838: AB_10673120, HPA038839: " "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 9.1 8.0 11.8 8.9 26.1 25.1 9.4 10.5 16.0 10.0 5.0 8.4 7.8 10.8 7.5 5.9 8.0 8.7 13.8 10.4 20.7 9.3 7.1 8.6 11.0 22.0 16.9 6.8 7.8 9.6 14.4 6.7 10.6 18.8 10.1 8.1 14.4 6.4 10.6 12.1 5.7 7.9 9.7 10.2 9.6 7.3 10.1 17.8 13.4 12.7 14.1 8.8 9.2 5.8 48.4 7.4 10.2 11.6 9.6 17.1 14.7 10.7 17.6 19.4 15.9 19.2 13.3 5.5 8.6 10.1 18.4 18.9 12.4 17.1 15.5 18.1 18.0 8.4 33.1 20.4 6.3 12.3 23.0 14.4 15.3 8.4 18.8 14.8 14.6 17.0 16.7 19.6 12.3 18.7 4.5 12.7 6.8 6.5 18.9 10.6 16.4 15.7 6.4 14.9 16.6 12.0 10.3 22.7 12.0 7.7 13.1 10.9 12.2 24.3 17.9 11.1 16.7 18.0 14.6 26.4 23.6 12.2 14.6 16.6 3.7 1.5 2.5 2.4 1.8 2.9 1.9 2.6 2.9 1.4 2.3 2.6 3.2 2.9 3.2 1.7 2.2 1.9 0.9 11.8 26.1 10.5 16.0 10.4 20.7 22.0 16.9 6.8 18.8 10.2 17.8 48.4 46.4 48.1 30.7 73.1 28.9 10.6 11.6 9.3 17.1 27.5 15.4 10.8 28.0 12.8 19.1 9.2 27.1 14.7 35.8 12.8 0.0 10.8 16.8 13.4 27.4 24.5 14.4 23.8 108.9 14.4 7.7 25.6 20.9 18.2 28.5 22.8 17.2 9.9 8.1 32.0 108.8 10.9 14.2 16.4 10.6 16.9 16.1 17.1 8.8 73.1 15.6 13.5 23.7 102.1 127.6 10.3 8.2 20.7 33.2 7.7 12.3 9.2 15.7 38.8 13.1 34.7 36.5 27.0 17.8 8.6 7.2 36.9 31.4 16.5 10.6 9.8 AMFR "gp78, RNF45" ENSG00000159461 "Autocrine motility factor receptor" Q9UKV5 16 56361452-56425545 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.5;Hepatocytes: 166.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026381, HPA029018, HPA077835" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856" "unprognostic (1.72e-2)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (2.43e-2)" "unprognostic (3.60e-3)" "unprognostic (6.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (4.16e-2)" "unprognostic (5.52e-3)" "unprognostic (1.45e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (2.28e-1)" 29.8 53.6 48.2 23.0 54.5 37.3 27.7 55.3 45.2 34.7 68.7 29.3 47.9 33.9 52.0 44.6 31.9 29.5 32.4 46.9 55.9 65.4 76.0 27.4 40.6 58.6 54.5 44.3 40.5 29.5 71.2 24.4 41.4 58.2 28.2 25.3 58.1 25.9 37.8 160.7 23.6 36.3 34.2 66.0 27.2 24.8 84.5 53.3 20.8 34.1 57.0 43.8 26.0 29.7 76.2 55.5 75.2 32.4 59.2 98.2 54.7 28.4 56.8 71.2 77.0 60.1 66.4 49.4 142.0 65.3 79.1 45.2 50.3 49.9 45.1 72.9 31.7 51.2 40.9 29.2 73.4 85.7 33.2 45.6 64.1 64.3 61.7 73.1 53.6 45.6 41.0 45.7 18.8 56.9 33.7 50.7 35.8 15.3 28.2 51.1 57.0 64.8 53.6 47.9 57.0 32.2 24.6 135.6 47.3 45.5 30.3 142.3 35.0 59.4 72.3 39.4 36.9 39.7 40.7 38.5 75.8 52.7 23.4 33.7 37.1 10.0 14.4 7.9 12.5 11.2 21.7 9.9 8.3 9.9 17.9 10.1 10.9 12.5 14.2 17.9 13.2 11.4 5.5 48.2 54.5 55.3 45.2 46.9 55.9 58.6 54.5 44.3 58.2 66.0 53.3 76.2 25.7 9.6 9.0 23.8 34.0 25.7 18.1 11.0 10.8 17.7 58.9 23.0 19.9 28.6 11.7 99.3 39.6 27.5 17.4 53.6 25.4 20.8 154.5 16.4 26.4 23.5 24.7 29.0 20.5 43.0 6.8 31.9 8.6 32.4 8.8 31.8 38.9 166.4 17.0 32.0 23.7 23.6 12.2 69.1 33.2 118.7 41.0 25.5 30.2 23.4 25.5 50.1 10.3 27.6 31.5 35.6 25.3 34.3 12.0 36.0 53.4 54.3 9.2 43.3 13.1 29.4 24.1 30.5 11.7 12.0 20.9 24.4 17.1 34.1 22.9 29.7 MED8 "ARC32, MGC17544, MGC19641" ENSG00000159479 "Mediator complex subunit 8" Q96G25 1 43383917-43389808 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028377, HPA028438" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA028377: AB_10600112, HPA028438: AB_10600057" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (1.49e-2)" "unprognostic (2.37e-2)" "unprognostic (8.58e-3)" "prognostic unfavorable (2.04e-7)" "unprognostic (2.60e-2)" "unprognostic (1.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.17e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.11e-7)" "unprognostic (7.08e-2)" "unprognostic (3.28e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-1)" 29.7 28.1 24.1 21.0 25.2 27.2 26.8 24.6 29.4 23.2 26.6 24.9 23.3 21.9 24.2 43.9 20.8 16.9 20.3 24.9 25.6 27.5 43.9 24.6 21.9 26.8 25.2 24.6 22.1 29.7 21.1 36.6 25.7 25.8 23.9 25.0 40.6 27.1 20.7 22.6 35.8 23.1 24.5 25.0 26.1 28.4 22.5 26.1 17.6 25.9 14.6 28.3 24.3 27.5 27.2 56.8 35.3 31.8 38.0 48.7 48.2 42.7 56.5 51.4 65.8 69.3 65.7 40.7 33.2 39.7 71.8 43.2 34.7 50.2 47.7 62.9 47.9 48.5 56.5 60.5 82.8 82.3 50.7 57.5 47.5 60.6 71.2 84.6 39.4 53.3 31.1 50.8 57.1 42.9 36.4 26.1 40.8 30.5 52.3 39.9 30.9 37.3 53.6 43.5 35.8 33.2 25.1 33.2 53.7 111.9 43.6 36.3 97.8 39.9 29.2 52.0 55.9 80.5 67.5 83.4 40.2 60.8 61.2 39.0 44.7 57.0 54.9 33.6 53.1 32.1 44.5 30.5 38.0 57.0 36.8 30.7 32.0 45.3 32.6 48.4 26.2 43.3 38.8 24.1 25.2 24.6 29.4 24.9 25.6 26.8 25.2 24.6 25.8 25.0 26.1 27.2 25.6 16.0 12.9 5.9 25.8 18.7 23.2 35.6 11.4 27.7 23.9 23.4 12.6 27.1 28.2 14.7 14.6 52.9 26.2 26.4 33.2 51.1 13.6 16.3 23.9 25.1 19.3 42.5 11.5 75.6 72.3 30.3 23.0 19.7 31.7 21.8 16.4 27.8 60.4 16.8 8.0 29.2 28.5 18.2 32.0 22.8 24.5 26.2 19.6 4.7 35.9 32.3 28.8 6.6 13.8 57.9 30.0 21.8 41.2 24.6 40.8 48.5 16.0 58.7 26.3 12.3 42.9 64.6 45.0 24.3 25.4 88.4 23.3 31.9 22.6 39.9 TGM7 TGMZ ENSG00000159495 "Transglutaminase 7" Q96PF1 15 43276271-43302255 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.6" "Group enriched" "Detected in some" 11 "Early spermatids: 62.0;Late spermatids: 16.7" "Cancer enriched" "Detected in single" 13 "endometrial cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "EFO-21: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.5 RGL4 Rgr ENSG00000159496 "Ral guanine nucleotide dissociation stimulator like 4" Q8IZJ4 22 23688136-23699176 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "bone marrow: 165.9" "Group enriched" "Detected in some" 4 "dendritic cells: 23.8;Early spermatids: 18.1;NK-cells: 52.5;T-cells: 51.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "eosinophil: 393.6;neutrophil: 516.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 516.3" "Group enriched" "Detected in many" 5 "MOLT-4: 26.3;U-937: 61.0" HPA035979 Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA035979: AB_10673227" "unprognostic (1.48e-4)" "unprognostic (2.75e-4)" "unprognostic (4.44e-2)" "unprognostic (1.11e-4)" "unprognostic (3.10e-1)" "unprognostic (2.93e-4)" "unprognostic (4.92e-2)" "unprognostic (2.06e-2)" "unprognostic (2.78e-1)" "unprognostic (3.11e-1)" "unprognostic (4.25e-2)" "unprognostic (3.80e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-3)" 3.8 3.1 0.1 7.7 0.3 165.9 0.5 2.0 0.7 0.3 0.2 1.2 4.1 3.1 0.0 2.0 0.9 4.7 2.8 0.2 0.0 1.5 1.3 4.9 11.6 0.5 0.2 0.0 4.0 3.4 0.1 0.5 1.7 1.0 1.4 1.1 10.7 4.6 0.2 3.0 5.6 4.1 0.7 0.1 19.9 2.4 3.8 0.1 8.5 3.2 0.9 8.1 3.9 0.5 1.0 1.6 0.5 5.8 2.5 0.0 0.0 2.5 1.8 0.0 0.0 0.0 1.3 1.1 1.9 0.4 0.0 1.0 2.8 0.0 0.0 0.0 2.0 3.6 0.9 2.5 0.3 0.0 3.4 3.8 0.0 0.0 0.0 0.0 2.9 0.0 2.0 2.1 3.0 0.0 1.0 26.3 3.6 0.4 0.6 0.8 9.3 2.0 1.4 0.0 1.7 1.8 2.7 1.7 3.7 0.6 3.1 1.2 2.0 2.5 3.2 1.9 2.2 1.1 5.3 0.8 1.3 1.9 61.0 1.6 98.0 2.9 393.6 57.4 20.8 59.6 6.5 74.1 66.2 5.4 5.2 104.6 93.8 516.3 35.2 84.6 0.7 114.2 37.4 0.1 0.3 2.0 0.7 0.2 0.0 0.5 0.2 0.0 1.0 0.1 0.1 1.0 0.7 0.0 4.4 0.3 5.9 0.9 0.0 0.0 0.0 0.5 0.4 0.5 0.5 1.5 1.3 0.0 2.1 0.0 23.8 0.0 0.0 2.4 18.1 0.1 0.3 0.3 0.0 8.8 0.4 1.7 0.1 0.6 2.6 0.2 1.3 0.1 0.4 0.3 0.1 1.7 0.5 0.0 0.0 1.6 0.7 2.0 0.0 3.5 1.8 0.0 2.5 0.0 52.5 0.5 0.4 2.2 0.0 0.0 3.4 0.0 0.0 0.3 0.0 2.8 0.0 0.3 0.5 5.9 0.0 0.0 0.3 0.0 51.8 0.1 0.1 0.1 SPRR2G ENSG00000159516 "Small proline rich protein 2G" Q9BYE4 1 153149582-153150890 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "skin 1: 679.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 2.8;Early spermatids: 5.1;Extravillous trophoblasts: 12.9;Late spermatids: 10.1;Suprabasal keratinocytes: 5.5" "Group enriched" "Detected in many" 15 "head and neck cancer: 256.0;melanoma: 131.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "hTCEpi: 3.3" NA NA "unprognostic (3.93e-1)" "unprognostic (1.90e-1)" "unprognostic (3.25e-1)" "unprognostic (2.44e-1)" "unprognostic (1.69e-2)" 1.5 0.0 0.2 0.0 0.2 0.2 14.4 0.0 0.4 2.6 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.2 0.4 0.0 0.1 0.1 0.0 0.3 0.2 0.1 0.2 0.2 0.0 0.1 2.7 0.2 0.1 0.0 0.0 8.9 0.0 0.5 679.0 0.1 0.0 0.2 0.0 0.1 2.6 0.6 2.1 0.1 0.6 28.2 0.0 34.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.2 0.4 0.3 0.2 0.1 0.2 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 10.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 5.5 0.8 0.0 0.0 0.0 0.0 PGLYRP3 "PGLYRPIalpha, PGRP-Ialpha, PGRPIA" ENSG00000159527 "Peptidoglycan recognition protein 3" Q96LB9 1 153297862-153310718 "Metabolic proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 39.3;skin 1: 74.3;vagina: 21.6" "Cell type enriched" "Detected in single" 12 "Squamous epithelial cells: 4.9" "Cancer enhanced" "Detected in many" "cervical cancer: 8.9;head and neck cancer: 16.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "HaCaT: 3.8;HDLM-2: 1.6;hTCEpi: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA030369 Uncertain "Secreted in other tissues" NA NA "HPA030369: AB_10603984" "unprognostic (6.34e-2)" "unprognostic (1.60e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-2)" "unprognostic (2.46e-1)" "unprognostic (5.42e-2)" "unprognostic (3.88e-3)" "unprognostic (1.28e-1)" "unprognostic (1.82e-1)" "unprognostic (2.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 74.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 7.7 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.4 0.0 0.0 0.0 0.0 0.0 ISL2 FLJ10160 ENSG00000159556 "ISL LIM homeobox 2" Q96A47 15 76336773-76342475 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.6;prostate: 2.3;vagina: 3.5" "Cell type enriched" "Detected in some" 7 "Cone photoreceptor cells: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 9.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 15.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "spinal cord: 1.8" HPA075192 Approved "Rods & Rings" NA NA "Rods & Rings" "HPA075192: AB_2686738" "unprognostic (7.30e-2)" "unprognostic (7.96e-2)" "unprognostic (9.01e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-1)" "unprognostic (7.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.45e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-1)" "unprognostic (9.03e-2)" "unprognostic (3.93e-2)" "unprognostic (3.55e-15)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "unprognostic (4.07e-1)" "unprognostic (2.26e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.8 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.2 2.3 0.0 1.4 1.8 0.0 0.0 0.2 1.2 0.0 0.1 0.5 1.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.8 1.5 1.8 0.0 1.7 0.1 0.1 1.5 4.5 2.1 1.2 1.5 3.4 0.7 3.3 2.1 0.0 1.1 1.9 6.4 0.1 0.2 3.2 15.4 1.6 4.0 4.1 1.4 3.6 4.3 0.0 0.8 0.0 0.0 0.0 0.0 4.8 5.1 2.6 0.3 0.1 4.4 8.4 0.0 0.6 2.8 2.7 2.0 4.4 0.0 0.6 4.9 5.0 3.0 0.0 0.0 0.9 0.3 8.2 0.0 1.5 3.2 0.6 4.3 3.8 4.1 2.0 1.1 2.5 0.0 0.0 0.8 0.0 0.1 0.9 0.0 0.8 0.0 0.5 0.1 1.7 0.1 0.0 9.5 0.0 3.5 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.8 0.3 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 27.1 0.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.6 0.0 0.0 0.0 2.1 0.0 0.2 0.5 1.5 1.0 0.0 0.0 0.3 0.2 0.0 0.0 3.0 RSPRY1 KIAA1972 ENSG00000159579 "Ring finger and SPRY domain containing 1" Q96DX4 16 57186137-57240469 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003729 Approved "Secreted to blood" NA NA "HPA003729: AB_10964215" "unprognostic (2.73e-2)" "unprognostic (7.10e-2)" "unprognostic (1.32e-3)" "unprognostic (5.32e-2)" "unprognostic (1.63e-3)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.84e-2)" "unprognostic (1.36e-1)" "unprognostic (4.63e-2)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (1.01e-1)" "unprognostic (4.89e-2)" "unprognostic (4.68e-2)" "unprognostic (3.35e-1)" "unprognostic (6.47e-2)" "unprognostic (4.81e-3)" 10.2 9.0 8.6 10.2 9.6 7.0 13.3 9.3 9.5 15.2 17.2 14.5 16.2 13.2 12.7 11.8 11.8 16.2 8.7 8.1 10.7 16.3 19.9 9.6 13.5 9.6 9.4 6.9 14.5 18.7 15.4 8.4 15.2 9.9 13.9 16.4 8.5 11.6 14.2 9.2 9.5 16.4 15.5 8.5 9.8 13.6 22.0 10.2 17.7 17.5 10.7 17.4 16.3 9.3 11.2 17.0 25.7 39.5 20.4 24.6 30.8 23.5 29.7 30.5 39.1 31.0 27.4 21.8 23.8 37.6 39.7 27.0 21.6 34.7 28.6 44.4 16.2 14.4 12.7 18.9 39.5 32.1 22.7 33.5 37.3 27.7 38.4 53.6 29.6 53.5 27.2 21.3 9.6 34.3 9.9 38.7 15.3 25.6 28.4 29.1 48.9 27.2 22.0 46.6 17.1 13.4 29.8 47.8 17.8 12.3 22.4 17.5 22.9 37.8 27.9 27.2 17.6 24.6 25.0 24.7 38.6 24.5 22.0 30.3 27.6 22.5 30.1 24.8 24.7 22.6 26.1 22.7 22.9 26.0 24.0 26.2 25.2 24.5 26.4 36.3 16.5 30.0 18.2 8.6 9.6 9.3 9.5 8.1 10.7 9.6 9.4 6.9 9.9 8.5 10.2 11.2 18.6 32.1 13.1 22.5 24.0 34.0 21.0 27.5 38.7 17.1 28.5 17.3 17.5 42.9 23.2 18.4 10.4 26.9 18.9 27.4 25.4 25.2 107.2 22.2 36.7 23.8 21.5 24.8 22.0 23.4 37.7 29.2 25.5 28.9 10.8 31.1 22.5 41.8 17.3 15.2 25.6 32.9 28.5 22.9 23.8 65.9 20.2 19.8 14.2 19.7 25.1 19.7 15.5 36.2 35.8 25.5 15.5 21.4 21.2 29.1 29.5 28.1 23.3 18.2 6.6 25.5 25.2 60.9 52.3 27.9 37.1 27.9 21.8 37.7 23.5 23.0 CCDC17 FLJ33084 ENSG00000159588 "Coiled-coil domain containing 17" Q96LX7 1 45620044-45624057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "fallopian tube: 36.3" "Cell type enriched" "Detected in many" 5 "Respiratory ciliated cells: 374.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028338 Enhanced NA NA "HPA028338: AB_10669641" "unprognostic (3.53e-5)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (3.55e-3)" "unprognostic (3.31e-1)" "unprognostic (9.21e-3)" "unprognostic (6.97e-2)" "unprognostic (1.30e-2)" "unprognostic (8.55e-2)" "unprognostic (1.07e-1)" "unprognostic (4.46e-3)" "unprognostic (2.91e-1)" "unprognostic (8.37e-7)" "unprognostic (1.20e-1)" "unprognostic (1.96e-1)" "unprognostic (2.92e-1)" "unprognostic (5.91e-3)" 0.0 0.1 0.2 0.1 0.2 0.4 0.0 0.2 0.8 1.1 0.1 0.1 0.2 0.1 0.0 0.0 36.3 0.0 0.1 0.1 0.2 0.1 0.2 3.4 0.1 0.6 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.8 0.1 0.2 0.6 0.4 0.1 0.5 0.2 0.3 0.2 3.1 3.2 4.1 1.0 0.4 1.1 0.3 14.2 0.6 0.1 2.4 1.7 1.6 0.0 23.4 0.0 0.0 0.6 2.0 4.6 5.9 0.5 0.0 74.5 1.1 2.1 1.2 0.4 0.1 0.9 0.2 1.9 1.1 3.2 1.3 0.3 1.1 0.9 0.6 0.0 0.1 2.3 10.2 0.6 1.4 0.4 1.2 1.8 0.0 1.0 1.0 0.4 0.0 0.0 1.7 1.3 3.2 2.2 0.3 0.6 4.2 1.1 374.1 0.5 0.0 0.9 5.2 0.8 0.7 0.9 0.6 0.5 0.8 0.7 2.6 0.4 GPBP1L1 SP192 ENSG00000159592 "GC-rich promoter binding protein 1 like 1" Q9HC44 1 45627304-45688113 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028593 Approved Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028593: AB_10602906" "unprognostic (1.39e-1)" "unprognostic (8.41e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (6.35e-2)" "unprognostic (1.97e-3)" "unprognostic (2.42e-3)" "unprognostic (9.79e-2)" "unprognostic (3.91e-2)" "unprognostic (1.94e-3)" "unprognostic (1.12e-2)" "unprognostic (4.11e-1)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (4.51e-1)" "unprognostic (7.56e-3)" "unprognostic (6.13e-2)" 28.9 26.9 26.1 31.3 29.9 49.7 41.3 28.3 28.3 34.2 28.2 57.8 54.5 35.9 37.9 45.4 36.6 30.6 42.1 24.7 28.1 47.4 66.9 39.5 40.3 29.2 29.4 23.6 30.9 39.6 42.1 25.7 34.4 29.4 36.1 61.7 27.6 42.8 36.4 46.7 47.6 57.2 36.7 28.5 37.2 43.0 58.5 28.8 55.2 49.1 55.4 49.9 36.0 37.1 34.0 41.1 24.7 42.1 44.9 48.4 47.1 57.5 31.9 52.2 44.8 56.1 25.2 44.8 56.3 40.5 43.7 46.9 42.0 46.6 47.8 56.3 64.4 33.4 73.7 28.9 39.2 66.7 74.2 65.1 34.6 102.0 35.3 99.4 60.2 57.7 71.0 63.7 48.7 51.6 22.0 66.2 65.8 60.4 54.8 27.7 43.0 55.1 41.9 51.5 40.2 51.9 34.7 52.6 76.6 83.5 81.6 35.1 86.2 49.8 32.0 33.6 35.2 48.9 47.2 46.9 41.3 34.0 60.6 34.5 24.0 21.6 40.3 21.6 27.3 22.9 16.5 20.9 21.1 23.0 14.1 22.6 22.4 22.6 26.6 30.6 13.1 26.4 21.1 26.1 29.9 28.3 28.3 24.7 28.1 29.2 29.4 23.6 29.4 28.5 28.8 34.0 43.3 60.9 24.4 54.5 45.1 64.9 41.2 28.3 59.2 23.5 51.3 33.5 46.9 41.5 34.3 60.7 35.5 26.2 47.5 96.8 50.9 33.0 23.4 38.1 32.2 38.6 38.3 62.1 48.5 38.9 33.7 25.4 44.9 47.5 59.6 24.3 37.5 81.3 25.0 37.0 49.0 67.2 32.6 49.9 51.6 17.6 20.5 46.1 23.2 70.3 41.3 18.2 45.3 50.8 93.8 51.2 57.0 21.4 36.6 62.8 75.5 58.7 33.0 32.9 19.7 22.4 42.0 78.9 75.3 71.7 67.8 45.4 47.1 27.7 68.6 78.2 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatogonia: 219.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome NA NA 100000 Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favorable (9.44e-5)" "unprognostic (1.97e-1)" 23.7 28.5 27.0 26.3 27.0 39.2 32.8 29.7 29.8 22.8 27.2 32.2 32.7 33.2 35.5 30.6 27.1 24.5 30.0 26.3 27.6 26.7 28.8 22.7 36.4 27.3 27.2 26.8 36.0 27.5 41.8 22.8 28.6 28.1 29.1 35.7 34.2 26.1 26.9 35.3 33.4 33.4 30.6 27.8 22.4 21.8 47.5 28.0 35.3 32.5 33.2 31.8 28.8 22.3 31.4 107.6 81.1 140.4 139.4 55.1 78.9 116.9 79.9 80.3 115.6 139.8 99.5 80.9 118.1 89.1 60.4 74.8 105.6 107.7 96.5 162.0 43.8 122.1 83.9 53.6 153.9 63.2 157.3 100.7 64.0 69.6 92.8 80.7 61.0 82.5 141.2 201.9 40.3 89.9 37.5 165.7 177.7 196.2 83.4 144.6 175.7 167.8 157.7 89.1 92.6 151.3 110.6 239.5 50.7 94.7 86.0 54.2 105.2 64.7 80.2 80.1 84.7 93.9 75.3 125.3 423.8 72.3 103.0 99.7 2.8 6.0 13.4 27.3 5.8 34.9 18.2 29.0 30.1 8.2 14.4 31.0 31.4 2.7 17.1 6.5 12.2 27.4 18.3 27.0 27.0 29.7 29.8 26.3 27.6 27.3 27.2 26.8 28.1 27.8 28.0 31.4 29.2 32.1 32.2 23.5 30.1 33.0 66.6 87.2 17.1 52.0 28.4 31.4 30.7 18.6 53.4 31.3 12.5 101.3 33.9 28.0 39.2 70.0 4.6 27.7 23.2 30.7 22.9 38.9 41.3 60.2 70.9 38.4 20.9 22.9 35.4 55.9 19.2 21.3 28.6 50.5 40.7 33.3 67.1 10.4 13.5 14.3 48.7 16.2 49.8 17.8 25.7 68.4 51.5 33.2 39.8 65.0 114.3 54.2 32.0 68.8 34.7 48.2 44.8 35.9 19.7 41.0 63.7 145.4 219.3 33.6 32.1 52.4 36.9 49.4 42.5 49.5 TMEM69 "C1orf154, FLJ21029" ENSG00000159596 "Transmembrane protein 69" Q5SWH9 1 45688181-45694436 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026993 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026993: AB_10601824" "prognostic favorable (2.24e-4)" "unprognostic (2.47e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.66e-8)" "unprognostic (4.05e-2)" "unprognostic (1.59e-3)" "unprognostic (5.17e-2)" "unprognostic (3.98e-3)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (1.49e-2)" "unprognostic (1.96e-1)" "unprognostic (4.41e-3)" "unprognostic (3.65e-2)" 17.5 19.7 13.0 17.4 13.1 9.5 21.2 13.9 14.5 14.7 15.5 19.2 22.9 15.8 26.9 21.7 17.2 15.9 32.1 12.9 13.4 16.5 19.5 12.2 27.2 13.4 13.6 12.6 23.7 14.1 32.2 6.0 19.9 13.7 19.3 23.1 16.7 21.3 15.5 24.2 21.4 17.1 14.0 12.6 16.3 15.3 13.4 13.7 21.4 21.3 25.7 27.9 26.2 8.8 13.9 50.1 13.2 33.9 25.9 25.1 32.6 81.6 31.6 37.1 52.5 50.7 34.2 24.8 59.8 20.4 30.9 38.1 64.9 26.5 77.2 56.3 40.1 31.6 126.2 30.6 38.2 45.3 59.6 58.2 38.8 75.5 50.7 32.6 34.3 44.7 57.8 75.5 37.4 32.4 17.9 32.9 41.3 77.8 30.0 33.4 51.1 29.2 59.9 56.7 57.2 36.8 34.6 32.8 88.8 56.2 61.2 47.0 59.1 32.5 23.9 40.0 49.8 38.9 29.9 41.6 44.8 32.5 43.0 36.5 12.2 25.0 10.2 9.0 25.8 11.7 16.6 12.8 10.5 22.1 15.5 14.5 11.4 9.6 9.2 34.6 12.5 12.8 13.6 13.0 13.1 13.9 14.5 12.9 13.4 13.4 13.6 12.6 13.7 12.6 13.7 13.9 10.8 0.0 14.9 9.8 22.4 20.1 22.8 49.2 37.5 11.0 19.1 21.7 9.1 12.8 26.8 18.4 0.0 61.4 7.7 16.7 43.0 22.7 1.9 13.4 12.6 14.3 24.0 32.4 9.1 17.8 36.1 17.1 35.7 11.6 6.3 12.1 14.6 14.4 37.7 6.7 9.7 21.3 34.6 38.9 11.9 4.4 18.6 21.8 17.8 2.8 23.9 14.5 14.4 9.5 14.6 14.8 16.1 12.8 16.3 22.7 31.0 39.0 18.8 9.8 13.1 10.8 13.0 21.7 16.9 53.5 26.0 59.7 13.7 16.3 25.0 22.4 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542643-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 3.9;lymphoid tissue: 10.6" "Cell type enhanced" "Detected in some" "dendritic cells: 32.0;Microglial cells: 11.2;NK-cells: 43.3;Plasma cells: 16.4;T-cells: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 125.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 39.4;OE19: 13.2;RPMI-8226: 6.2;THP-1: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.3 0.3 0.2 5.1 0.3 1.4 0.7 0.3 0.3 0.2 0.2 1.7 3.8 0.3 0.1 0.6 0.5 0.1 0.0 0.3 0.4 0.0 0.2 0.9 10.6 0.6 0.4 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.3 1.3 0.0 1.3 0.3 0.1 0.1 3.9 0.3 0.5 5.9 0.4 0.5 0.5 1.6 0.3 0.0 10.6 1.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 3.6 3.6 13.2 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 0.1 125.9 33.3 0.1 16.9 12.0 4.8 19.1 2.4 8.6 1.2 11.2 0.5 29.9 0.1 68.8 0.2 9.0 0.2 0.3 0.3 0.3 0.3 0.4 0.6 0.4 0.1 0.6 0.5 0.5 0.6 0.3 0.0 1.3 0.3 5.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.2 32.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.6 0.0 0.3 0.0 3.2 0.0 11.2 1.7 0.0 43.3 0.0 0.3 0.0 0.0 0.0 16.4 0.1 2.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 7.1 0.0 0.7 0.0 DRC7 "C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50" ENSG00000159625 "Dynein regulatory complex subunit 7" Q8IY82 16 57694793-57731805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 21.3;testis: 46.5" "Group enriched" "Detected in some" 4 "Early spermatids: 119.1;Late spermatids: 134.4;Spermatocytes: 48.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.1" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 8 "basophil: 10.9" "Lineage enriched" "Detected in single" 43 "granulocytes: 10.9" "Cell line enhanced" "Detected in some" "Hep G2: 3.0;HMC-1: 1.6;JURKAT: 1.8;NB-4: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.04e-3)" "unprognostic (1.54e-1)" "unprognostic (4.11e-2)" "prognostic favorable (3.61e-4)" "unprognostic (9.96e-2)" "unprognostic (5.14e-2)" "unprognostic (1.80e-1)" "unprognostic (3.04e-1)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (1.04e-2)" "unprognostic (1.09e-1)" "unprognostic (5.34e-4)" "unprognostic (2.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.80e-2)" "unprognostic (5.53e-2)" 0.0 0.0 4.8 0.3 1.9 1.0 0.0 2.9 1.8 0.5 9.5 0.0 0.0 0.6 0.8 0.0 21.3 0.7 0.0 1.6 6.8 0.8 0.3 1.9 0.1 4.8 6.6 0.6 0.2 1.2 0.7 1.0 0.1 4.2 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.1 5.0 0.2 0.2 46.5 2.9 0.2 0.1 0.0 0.1 0.0 0.0 3.0 0.0 0.7 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 1.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.3 0.3 1.6 0.6 0.0 0.2 0.0 0.6 0.2 1.8 0.7 0.0 0.0 0.0 0.3 1.4 0.1 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 10.9 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.1 4.8 1.9 2.9 1.8 1.6 6.8 4.8 6.6 0.6 4.2 5.0 2.9 3.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.4 119.1 25.1 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 134.4 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.8 21.9 0.0 0.0 0.1 0.1 48.2 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 267.3;testis: 102.7" "Group enriched" "Detected in many" 20 "Early spermatids: 543.6;Late spermatids: 1322.9;Proximal enterocytes: 1172.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "ASC TERT1: 63.3;HUVEC TERT2: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" NA NA 104000000 170000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197" "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 12.7 4.9 0.9 4.9 6.3 0.1 8.1 0.1 2.5 18.3 1.8 11.3 178.0 8.2 3.5 4.2 6.4 8.3 10.4 1.1 1.5 10.9 1.9 49.5 5.0 2.8 0.7 1.3 1.9 6.2 18.8 9.3 11.7 2.1 9.0 6.2 0.4 7.7 24.0 16.2 3.5 267.3 9.7 0.4 2.9 8.3 102.7 1.3 0.9 19.3 10.1 2.1 5.6 3.8 1.4 0.0 0.0 0.0 0.0 2.6 63.3 0.6 2.4 4.7 0.0 0.0 0.9 5.1 1.3 1.8 11.4 0.1 0.0 3.1 0.0 0.0 0.0 1.4 6.6 0.0 0.0 1.4 0.0 0.0 4.2 0.0 0.1 0.0 1.2 33.8 0.0 5.8 0.0 0.1 1.1 0.0 1.4 0.4 11.7 0.7 0.1 0.5 0.9 0.0 0.0 8.2 5.6 0.0 0.0 0.0 1.3 2.9 0.4 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 1.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 6.3 0.1 2.5 1.1 1.5 2.8 0.7 1.3 2.1 0.4 1.3 1.4 50.0 0.0 3.3 0.0 0.5 1.5 2.6 0.1 1.2 4.0 3.6 1.9 2.1 1.5 0.7 0.0 0.0 0.1 0.3 11.9 0.0 5.9 543.6 10.8 8.0 34.7 18.0 0.0 4.7 0.4 0.1 11.5 2.0 36.3 7.0 24.1 3.6 0.8 4.2 0.0 1.8 39.8 0.0 33.7 3.5 1322.9 4.4 13.6 3.6 4.7 0.0 1.8 0.0 1.0 0.2 0.7 40.9 2.6 0.1 4.2 1172.8 21.7 0.0 1.1 0.0 2.0 4.2 13.5 6.4 0.2 0.1 0.1 2.2 0.3 26.2 2.1 TEPP ENSG00000159648 "Testis, prostate and placenta expressed" Q6URK8 16 57976435-57988116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 14.3" "Group enriched" "Detected in many" 12 "Early spermatids: 317.5;Late spermatids: 440.1" "Group enriched" "Detected in some" 4 "thyroid cancer: 3.2;urothelial cancer: 1.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 6 "T-cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA062092 Enhanced "Secreted in male reproductive system" NA NA "HPA062092: AB_2684679" "unprognostic (4.86e-2)" "unprognostic (2.72e-1)" "unprognostic (4.12e-2)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (8.04e-2)" "unprognostic (3.67e-1)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.46e-1)" "unprognostic (3.97e-3)" "unprognostic (2.59e-1)" 0.0 0.4 0.2 0.0 0.3 0.0 0.2 0.1 0.4 0.4 0.1 0.1 0.0 0.2 0.2 0.4 0.3 0.0 0.2 0.2 0.3 0.1 0.0 0.5 0.0 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.0 0.2 0.4 0.0 0.2 0.3 0.4 0.0 0.2 0.1 0.0 0.1 0.1 0.0 14.3 0.3 0.1 2.2 0.0 0.1 0.9 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.9 0.0 1.1 0.8 0.0 0.2 1.1 1.7 0.0 0.1 0.0 0.1 0.6 0.4 0.2 0.3 0.1 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.1 0.5 12.8 5.9 0.0 0.2 0.1 8.2 24.4 2.2 0.1 1.0 8.6 30.4 1.5 8.7 1.8 0.0 2.7 0.5 0.0 0.0 0.0 317.5 0.4 0.1 1.4 0.0 0.0 0.2 0.6 4.1 1.4 0.0 0.2 2.5 0.2 2.5 0.0 0.5 0.0 0.1 0.0 4.1 0.0 0.6 440.1 3.7 0.3 1.8 0.0 0.0 0.8 0.0 0.5 0.1 0.1 0.0 0.4 0.0 1.6 0.0 0.0 3.0 1.1 0.0 0.2 3.1 2.7 3.3 0.3 0.0 1.1 1.7 2.9 0.0 3.6 UROC1 "FLJ31300, HMFN0320" ENSG00000159650 "Urocanate hydratase 1" Q96N76 3 126481166-126517773 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 391 "liver: 117.6" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 62.2" "Cancer enriched" "Detected in single" 100 "liver cancer: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069863 Enhanced NA NA 670000 "HPA069863: AB_2732143" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-2)" "unprognostic (6.43e-2)" "unprognostic (1.43e-1)" "unprognostic (2.23e-3)" "unprognostic (2.95e-1)" "unprognostic (2.57e-2)" "unprognostic (7.71e-2)" "unprognostic (9.97e-2)" "unprognostic (3.04e-1)" "unprognostic (3.65e-5)" "unprognostic (3.97e-2)" "unprognostic (2.66e-1)" "unprognostic (5.52e-2)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 117.6 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.1 3.3 62.2 0.3 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46674659-46719146 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 160.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 110000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 50.2 24.0 24.0 25.7 32.1 8.6 30.7 30.9 19.7 42.7 14.9 37.8 30.4 32.0 24.9 40.0 38.7 33.6 36.4 18.8 28.7 44.6 30.8 43.4 26.4 37.3 31.8 13.2 36.2 23.3 160.8 18.2 43.9 31.5 30.9 39.7 12.4 30.7 40.4 34.9 28.7 31.8 39.2 29.7 31.9 66.5 27.5 26.8 34.4 44.3 46.3 35.5 40.5 27.3 37.1 34.9 20.3 13.4 23.8 75.2 48.6 37.3 35.4 56.7 40.3 40.6 22.4 23.1 26.5 38.5 51.6 53.7 41.0 28.1 41.3 51.7 62.4 16.9 33.8 15.1 8.7 26.9 44.3 67.1 43.9 61.5 31.4 28.2 37.4 52.6 26.3 23.5 37.9 37.7 12.4 30.6 10.6 22.2 39.8 21.1 22.1 45.9 25.2 37.6 68.4 7.4 9.9 47.7 64.2 29.9 43.3 29.0 38.6 46.0 33.1 16.8 38.1 37.0 38.0 65.2 22.7 43.6 34.5 25.9 23.4 22.6 36.8 25.3 28.0 34.0 18.0 23.0 22.9 19.5 17.0 21.0 21.7 15.4 21.8 26.3 14.1 21.1 24.3 24.0 32.1 30.9 19.7 18.8 28.7 37.3 31.8 13.2 31.5 29.7 26.8 37.1 152.3 73.7 84.6 31.3 45.9 31.7 52.3 32.0 44.9 31.6 56.3 34.0 44.9 47.1 46.1 114.0 31.3 40.6 64.4 80.8 31.3 36.2 70.6 36.1 37.4 74.8 37.8 31.1 20.3 38.4 32.0 48.8 79.0 52.2 101.8 27.4 50.7 57.9 42.2 47.1 27.8 64.6 54.9 75.5 44.0 18.9 47.2 52.0 26.6 29.0 65.0 50.6 84.5 29.7 46.2 48.5 61.3 49.7 34.8 73.8 50.5 34.4 49.9 18.6 26.3 50.2 49.9 51.3 27.7 46.5 43.5 59.0 52.0 30.4 46.2 128.4 SPON2 DIL1 ENSG00000159674 "Spondin 2" Q9BUD6 4 1166932-1208962 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 188.7" "Cell type enhanced" "Detected in many" "dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8" "Cancer enriched" "Detected in all" 7 "prostate cancer: 243.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 255.9" "Lineage enriched" "Detected in all" 5 "T-cells: 255.9" "Group enriched" "Detected in many" 5 "HHSteC: 303.8;HSkMC: 546.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040170, HPA066095" Approved Approved Vesicles "Secreted to blood" NA NA 2600000 Vesicles "HPA040170: AB_2676868, HPA066095: AB_2685615" "unprognostic (1.22e-1)" "unprognostic (3.56e-1)" "unprognostic (3.07e-2)" "prognostic favorable (2.03e-4)" "unprognostic (7.64e-2)" "unprognostic (6.28e-2)" "unprognostic (2.70e-3)" "unprognostic (2.28e-3)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.23e-2)" "unprognostic (2.74e-3)" "unprognostic (1.22e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (9.22e-4)" 57.2 40.7 4.0 18.9 6.0 19.6 51.1 15.2 3.9 157.3 3.9 51.3 18.7 188.7 4.4 41.0 50.1 32.5 33.2 3.1 6.4 36.4 79.7 63.6 4.0 2.3 4.3 2.4 34.7 18.9 0.9 15.2 19.3 3.4 112.7 7.3 0.8 29.1 8.5 19.3 37.5 64.1 43.1 0.2 27.2 44.1 4.8 1.8 1.8 16.4 6.7 1.0 68.9 94.8 2.3 0.4 0.6 0.0 0.0 10.2 79.0 3.0 6.2 5.0 0.8 1.0 0.0 0.1 1.8 9.7 26.9 0.9 45.0 0.0 0.2 0.0 0.3 0.1 0.2 3.0 12.7 303.8 0.2 1.5 546.6 0.0 0.6 0.0 0.0 0.0 4.1 0.3 9.2 0.0 0.3 5.3 12.2 3.5 9.7 0.7 1.0 3.3 7.9 0.0 0.0 1.7 1.1 1.1 0.0 2.9 1.7 0.4 1.5 0.1 0.2 0.9 20.5 0.0 1.3 2.7 0.6 0.1 6.5 0.0 3.7 0.9 1.0 255.9 1.1 5.5 0.7 33.1 105.8 0.4 1.0 14.4 96.8 9.8 50.4 2.2 42.9 0.1 123.2 4.0 6.0 15.2 3.9 3.1 6.4 2.3 4.3 2.4 3.4 0.2 1.8 2.3 9.8 0.0 5.6 1.3 6.6 36.8 2.0 82.5 2.2 3.7 5.1 3.8 4.0 24.3 43.0 1.8 0.0 3.4 427.0 9.7 1.9 3.8 0.2 12.7 256.6 5.7 13.8 4.0 8.4 1.3 355.8 257.7 10.7 6.6 6.3 0.2 15.4 40.4 12.8 0.0 0.6 9.7 73.2 5.8 15.4 0.5 29.8 9.5 26.6 6.5 9.2 0.9 1096.8 0.5 0.7 1.5 6.7 9.4 64.0 15.8 16.3 28.3 32.6 0.4 6.6 22.5 89.9 0.2 0.5 21.3 21.5 38.9 100.8 8.1 7.9 13.2 CHCHD6 "CHCM1, MGC13016, Mic25, MICOS25, PPP1R23" ENSG00000159685 "Coiled-coil-helix-coiled-coil-helix domain containing 6" Q9BRQ6 3 126704240-126960420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.5" "Cell type enhanced" "Detected in many" "Hofbauer cells: 178.2;Late spermatids: 106.6;Melanocytes: 172.5;Spermatocytes: 119.7" "Cancer enriched" "Detected in all" 4 "melanoma: 34.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047673, HPA051975" Approved Supported Mitochondria NA NA Mitochondria "HPA047673: AB_10961761, HPA051975: AB_2681679" "unprognostic (3.94e-2)" "prognostic favorable (7.46e-4)" "unprognostic (6.20e-2)" "unprognostic (1.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (6.83e-3)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (6.76e-4)" "unprognostic (6.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.11e-3)" 9.5 13.0 19.5 3.8 23.4 4.2 10.9 16.5 34.5 12.9 14.4 10.2 3.9 11.6 5.1 11.0 13.8 5.0 12.0 32.0 21.6 14.5 7.5 10.8 3.9 17.5 19.2 21.6 17.9 15.0 15.7 16.7 4.1 18.3 10.6 3.0 8.4 14.2 7.8 4.7 16.4 6.2 5.4 16.3 7.0 11.8 53.5 19.5 4.9 13.1 3.3 2.9 11.2 11.5 20.5 37.1 21.1 18.4 44.7 6.4 9.8 10.5 14.1 9.5 16.0 15.5 29.3 15.8 16.3 31.8 8.5 17.5 21.3 13.9 38.3 7.9 4.5 37.7 13.5 15.8 29.0 19.0 29.2 8.5 9.9 22.9 7.8 16.3 13.1 10.6 28.4 12.2 9.4 14.2 27.7 43.2 29.1 22.3 20.9 23.7 22.8 28.0 38.9 14.3 15.8 33.6 21.0 14.5 24.3 45.4 9.0 14.2 10.8 9.7 17.9 22.2 24.5 14.6 12.0 5.9 20.4 20.1 9.6 17.0 0.0 2.4 2.1 6.8 4.1 8.8 8.4 9.9 8.4 6.8 11.6 9.4 11.2 0.0 7.7 3.7 4.8 10.0 4.6 19.5 23.4 16.5 34.5 32.0 21.6 17.5 19.2 21.6 18.3 16.3 19.5 20.5 8.9 19.2 12.5 20.5 7.1 29.6 21.7 35.5 9.6 15.4 20.0 31.5 18.5 8.6 24.0 14.7 18.8 40.8 3.4 6.4 58.7 22.7 99.0 18.6 8.8 7.3 7.7 8.2 48.1 24.2 12.1 14.8 9.7 5.8 14.0 45.6 6.8 7.2 178.2 20.2 45.1 10.8 28.5 10.1 15.6 106.6 15.8 33.0 172.5 12.2 2.7 20.2 2.1 22.6 22.0 18.9 9.0 22.2 7.1 29.6 2.6 27.9 56.1 16.1 0.0 10.9 17.9 119.7 51.4 16.0 30.1 15.5 8.2 14.1 13.3 21.1 CTBP1 BARS ENSG00000159692 "C-terminal binding protein 1" Q13363 4 1211445-1249953 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004217, HPA018987, HPA044971" Approved Enhanced Nucleoplasm NA NA 16000 Nucleoplasm "CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161" "unprognostic (6.19e-2)" "unprognostic (4.78e-2)" "unprognostic (9.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.52e-2)" "unprognostic (1.04e-2)" "unprognostic (9.65e-2)" "unprognostic (2.24e-2)" "unprognostic (6.35e-3)" "unprognostic (3.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.46e-2)" "unprognostic (3.00e-1)" "unprognostic (3.22e-2)" "prognostic favorable (8.94e-4)" 76.0 88.8 87.8 86.9 88.2 72.2 73.4 89.9 103.9 91.7 66.6 92.4 91.8 99.2 47.9 85.6 89.9 61.9 94.3 91.3 90.8 89.1 110.1 83.3 109.6 96.0 92.5 91.2 94.3 142.3 59.2 141.1 46.0 96.8 95.6 42.3 39.1 91.7 51.3 171.7 72.7 97.9 48.6 73.0 119.6 80.2 47.6 86.7 99.0 86.9 92.3 62.9 88.3 80.5 88.5 108.5 156.8 118.4 146.6 81.5 58.6 101.7 83.4 76.8 101.8 102.8 135.0 255.1 131.0 93.8 97.5 156.6 84.1 72.3 109.9 30.4 101.0 86.6 119.1 185.6 177.1 135.7 108.4 163.3 101.3 82.5 86.5 49.8 97.8 76.8 147.1 138.1 219.6 56.9 178.1 351.4 338.3 140.5 87.8 148.4 244.4 71.4 173.2 65.8 135.9 222.0 138.1 79.6 85.2 114.5 70.9 187.2 164.5 99.7 168.5 94.2 97.8 182.1 157.7 164.3 155.2 133.4 166.4 135.6 12.6 15.6 17.4 31.8 23.1 24.0 20.1 22.3 27.4 20.6 19.3 17.1 25.1 12.7 23.9 23.9 34.6 20.9 16.1 87.8 88.2 89.9 103.9 91.3 90.8 96.0 92.5 91.2 96.8 73.0 86.7 88.5 33.3 41.7 39.0 17.9 36.8 34.2 21.1 22.1 13.1 32.1 52.0 39.5 54.9 37.1 19.2 36.8 4.2 25.4 72.4 57.2 11.7 29.4 4.0 34.0 46.4 35.7 46.1 42.3 19.4 40.6 32.0 37.5 37.8 41.6 24.1 31.2 45.0 85.0 43.0 40.4 21.2 49.7 20.3 72.9 31.8 5.5 45.1 37.7 46.2 21.5 45.9 46.8 82.4 19.6 17.7 45.0 35.7 35.7 42.0 36.9 42.8 37.4 25.7 17.8 6.6 31.2 32.9 10.8 13.4 30.3 37.8 19.8 41.1 32.0 57.5 27.9 LRRC36 FLJ11004 ENSG00000159708 "Leucine rich repeat containing 36" Q1X8D7 16 67326798-67385204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 35.6" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 94.7;Early spermatids: 192.8;Late spermatids: 118.0;Spermatocytes: 68.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 7 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 7 "dendritic cells: 9.7" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.4;JURKAT: 1.3;TIME: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058479 Enhanced NA NA "HPA058479: AB_2683728" "unprognostic (4.59e-2)" "unprognostic (6.84e-2)" "unprognostic (2.17e-2)" "unprognostic (2.26e-5)" "unprognostic (5.27e-2)" "unprognostic (4.32e-2)" "unprognostic (5.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.65e-1)" "unprognostic (3.32e-3)" "unprognostic (4.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.26e-1)" "unprognostic (3.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.88e-2)" 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 3.0 0.1 0.0 0.1 0.3 0.3 0.0 5.0 0.2 0.4 0.3 0.1 0.1 0.3 0.0 0.1 6.1 0.3 0.0 0.5 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 35.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.2 0.2 0.3 0.2 0.1 0.3 0.4 0.3 0.1 0.3 0.1 0.2 0.1 0.4 3.2 94.7 0.0 0.3 0.3 0.4 0.2 0.0 0.8 0.3 0.3 0.7 0.0 0.8 0.0 0.0 0.1 6.7 0.5 0.0 1.9 192.8 15.4 0.2 3.2 2.4 0.0 1.2 0.0 0.1 1.4 0.0 0.4 8.8 1.5 0.0 0.0 0.2 0.0 2.6 0.6 0.0 0.0 0.7 118.0 2.1 0.7 7.2 1.9 0.7 1.5 0.0 2.0 0.4 0.1 0.3 1.5 0.0 0.1 0.5 1.3 12.0 0.2 0.0 0.7 0.4 68.2 15.1 0.0 0.3 0.3 0.3 0.6 1.7 0.3 TPPP3 "CGI-38, p20, p25gamma" ENSG00000159713 "Tubulin polymerization promoting protein family member 3" Q9BW30 16 67389809-67393518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 866.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 61.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 65.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047629, HPA061691" Enhanced Approved "Nucleoli fibrillar center" NA NA 43000 "Nucleoli fibrillar center" "HPA047629: AB_2680108, HPA061691: " "unprognostic (1.63e-1)" "unprognostic (6.62e-3)" "unprognostic (1.35e-1)" "unprognostic (7.28e-3)" "unprognostic (4.48e-3)" "unprognostic (1.59e-3)" "unprognostic (9.22e-2)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.84e-4)" "unprognostic (3.51e-2)" "unprognostic (9.44e-2)" "unprognostic (9.46e-2)" "unprognostic (1.86e-3)" 42.3 27.4 246.3 8.1 187.4 1.0 81.9 195.1 227.4 46.5 150.6 77.5 23.9 29.6 9.7 100.2 866.0 22.1 58.2 177.3 237.5 59.6 4.5 149.3 4.5 227.5 212.4 149.8 8.7 24.1 13.7 41.0 79.1 216.2 19.1 14.2 9.7 39.8 13.4 72.8 169.2 38.3 21.6 223.5 17.8 44.0 15.5 199.5 4.7 18.6 56.2 9.2 33.1 36.8 289.0 0.4 59.9 0.6 0.4 0.4 9.4 0.2 1.7 0.4 0.4 0.9 3.9 12.0 0.0 0.9 0.8 0.2 11.3 9.2 0.0 0.1 0.0 3.5 0.0 1.5 1.7 0.1 0.0 0.0 2.4 0.3 3.6 0.0 1.8 0.6 0.0 0.1 0.0 5.4 0.3 0.0 0.2 1.9 40.8 0.0 0.0 31.1 0.2 0.0 0.0 47.8 20.7 0.0 0.1 2.4 1.5 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.1 0.0 0.0 2.9 0.0 0.9 0.0 25.4 12.4 0.0 37.6 0.2 0.0 0.0 0.0 33.1 0.1 0.0 0.0 5.8 0.0 65.8 0.3 0.0 9.4 246.3 187.4 195.1 227.4 177.3 237.5 227.5 212.4 149.8 216.2 223.5 199.5 289.0 14.7 16.0 129.8 17.0 0.2 303.9 8.8 92.5 5.7 3.8 5.9 5.0 4.1 30.0 160.4 18.4 4.2 8.3 0.2 28.4 5.9 166.8 60.1 962.0 30.9 31.6 177.9 0.0 0.5 1.8 4.3 141.9 7.1 14.7 25.4 1.0 5.0 0.1 2.9 0.0 0.7 65.1 132.2 3.8 82.5 23.7 29.2 13.7 501.6 1.0 10.7 68.7 1.0 1.0 30.0 8.4 39.7 3.4 0.0 5.6 29.8 0.9 1825.2 8.9 236.7 259.3 163.7 8.1 5.8 1.6 495.3 80.0 5.5 0.8 27.3 10.1 ZDHHC1 "C16orf1, HSU90653, ZNF377" ENSG00000159714 "Zinc finger DHHC-type containing 1" Q8WTX9 16 67394152-67416833 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 84.6;Late spermatids: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 11.4;ASC TERT1: 11.3;U-138 MG: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042531, HPA048659" Uncertain Approved Cytosol NA NA Cytosol "HPA042531: AB_2678041, HPA048659: AB_2680483" "unprognostic (8.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.05e-3)" "prognostic favorable (1.25e-6)" "unprognostic (1.68e-2)" "unprognostic (9.33e-2)" "unprognostic (6.03e-2)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" "prognostic favorable (5.99e-4)" "unprognostic (2.17e-1)" "prognostic favorable (1.55e-6)" "unprognostic (2.10e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (5.63e-3)" 15.6 11.0 4.1 1.8 3.0 0.2 18.0 3.4 5.6 25.5 6.0 12.5 2.3 21.9 4.0 6.9 22.5 6.4 9.9 3.0 4.6 19.3 4.4 12.5 1.4 4.0 5.1 2.5 23.7 17.9 7.9 20.6 3.2 3.9 19.7 1.7 0.9 17.1 6.8 10.8 17.4 7.4 4.0 4.3 15.0 10.7 20.5 3.4 0.6 29.7 3.0 0.8 12.9 16.4 2.6 5.2 6.0 1.4 7.3 11.4 11.3 0.0 3.2 9.0 2.6 2.8 0.0 2.6 0.0 1.3 4.2 2.5 3.3 0.4 0.6 0.5 1.6 4.6 0.5 0.1 0.4 5.2 0.2 4.0 6.0 5.3 2.7 0.6 6.0 3.3 0.0 0.0 0.0 1.8 0.3 0.0 0.0 2.9 1.8 0.1 0.0 0.0 0.0 3.5 2.9 2.1 7.4 0.5 0.1 6.5 0.4 1.9 1.1 5.8 11.7 2.0 5.6 3.3 1.4 0.3 0.0 7.2 0.1 4.7 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 4.1 3.0 3.4 5.6 3.0 4.6 4.0 5.1 2.5 3.9 4.3 3.4 2.6 7.0 0.0 0.0 10.4 0.9 7.1 6.7 1.3 10.8 2.2 7.5 7.0 1.1 10.0 1.4 7.3 4.2 2.0 0.3 5.2 9.8 3.4 29.3 84.6 10.9 5.2 9.0 0.4 5.7 4.0 0.2 13.6 8.6 7.3 0.0 8.5 6.1 2.0 2.0 3.3 5.0 12.9 2.0 16.4 6.8 53.0 14.6 9.3 5.4 2.8 8.2 7.9 1.0 4.0 2.5 2.2 4.9 10.9 0.7 7.2 2.0 6.6 5.5 0.5 0.0 5.1 9.4 12.4 8.6 6.2 7.1 5.7 0.7 10.4 6.8 4.8 ATP6V0D1 "ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD" ENSG00000159720 "ATPase H+ transporting V0 subunit d1" P61421 16 67438014-67481181 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 380.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016938 Uncertain NA NA "HPA016938: AB_1845191" "unprognostic (1.12e-2)" "unprognostic (1.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.79e-3)" "unprognostic (8.57e-2)" "unprognostic (2.93e-1)" "unprognostic (1.20e-2)" "unprognostic (8.30e-2)" "unprognostic (3.68e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.20e-5)" "unprognostic (5.72e-3)" "prognostic favorable (1.76e-8)" "unprognostic (2.72e-1)" "unprognostic (6.42e-2)" "unprognostic (2.63e-2)" "unprognostic (4.33e-3)" 51.5 113.9 94.4 67.5 109.0 83.0 50.8 85.0 118.3 60.6 80.9 85.3 69.7 69.8 57.1 89.3 58.3 56.4 66.7 119.3 129.4 86.1 73.6 79.4 67.5 109.8 106.1 107.9 35.4 59.7 117.3 108.5 56.3 121.3 61.0 73.4 41.8 63.4 55.5 128.6 83.4 80.5 80.3 85.4 96.8 70.0 70.1 112.5 65.3 75.8 85.5 64.5 67.4 62.8 146.2 78.9 111.6 67.3 87.5 167.2 91.2 64.3 92.7 149.1 187.0 224.3 116.5 82.6 33.0 74.2 134.7 125.3 91.9 99.0 117.7 108.8 40.3 90.5 60.5 58.4 97.6 159.4 60.5 243.3 139.8 115.1 187.4 44.5 68.2 117.9 38.0 69.7 41.9 151.9 193.7 45.7 134.9 65.2 70.6 77.9 80.2 78.5 92.1 113.3 129.3 130.4 60.4 244.0 65.8 103.1 52.3 104.8 91.1 114.4 93.4 38.6 113.9 49.8 69.5 106.8 94.9 130.1 63.8 56.3 312.7 732.5 542.4 130.1 511.7 89.9 189.4 96.3 120.3 469.2 174.5 73.1 91.3 936.5 155.5 485.5 168.4 128.0 742.7 94.4 109.0 85.0 118.3 119.3 129.4 109.8 106.1 107.9 121.3 85.4 112.5 146.2 46.0 16.0 47.2 11.1 80.1 73.8 61.5 138.2 45.5 73.3 65.7 50.5 38.8 54.3 78.0 68.0 73.0 112.1 74.7 258.8 181.9 127.7 109.6 93.3 46.4 42.6 121.9 68.8 22.7 111.0 73.1 61.5 68.3 74.5 50.1 44.2 42.5 50.2 380.4 82.4 25.7 160.2 154.6 149.4 186.7 50.1 58.7 183.1 124.5 7.5 260.9 70.6 77.2 13.6 23.1 102.0 179.5 53.0 57.0 38.8 203.1 173.6 92.7 52.9 118.3 26.6 53.2 125.7 64.0 55.0 87.5 283.6 54.7 91.3 101.6 63.2 AGRP "Agrt, ART, ASIP2" ENSG00000159723 "Agouti related neuropeptide" O00253 16 67482571-67483547 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 81.8;epididymis: 37.4" "Group enriched" "Detected in some" 5 "Distal tubular cells: 3.9;Hofbauer cells: 8.8;Leydig cells: 3.1;Macrophages: 4.5;Peritubular cells: 2.6;Theca cells: 5.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 40 "hypothalamus: 81.8" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "CACO-2: 1.2" "Region enriched" "Detected in single" 16 "hypothalamus: 16.0" "Region enhanced" "Detected in single" "hypothalamus: 2.0" HPA041017 Enhanced Supported "Secreted in brain" NA NA 255000 "HPA041017: AB_10795498" "unprognostic (1.32e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-1)" "unprognostic (3.15e-1)" "unprognostic (1.10e-1)" "unprognostic (3.61e-1)" "unprognostic (3.34e-1)" "unprognostic (4.68e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (3.17e-1)" "unprognostic (2.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-2)" 0.0 12.5 1.1 0.2 1.1 0.2 0.0 0.7 2.0 0.0 1.3 0.1 0.0 0.0 37.4 0.0 0.0 0.0 0.1 0.9 81.8 0.6 0.1 3.7 0.4 1.6 0.8 0.4 0.1 0.0 0.2 0.7 0.1 1.2 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.3 0.0 0.4 0.6 0.3 0.4 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.1 0.1 0.0 1.6 0.5 0.9 1.1 0.3 0.7 0.2 0.3 0.7 0.4 0.6 0.6 0.2 0.0 0.4 0.5 0.3 0.4 1.1 1.1 0.7 2.0 0.9 81.8 1.6 0.8 0.4 1.2 0.4 1.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.6 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.6 0.0 0.4 3.1 4.5 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 5.0 0.0 0.0 ZFYVE28 "KIAA1643, lst-2" ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418651 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 44.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.8;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 5.4 8.8 5.8 3.1 7.5 2.2 5.5 44.9 19.3 5.5 0.6 6.1 6.2 4.9 1.6 4.8 5.5 3.4 3.6 8.3 2.9 7.3 6.6 6.2 4.0 10.3 5.9 7.4 4.6 5.0 4.3 10.8 1.0 24.4 4.0 2.9 4.0 5.6 2.8 2.9 4.9 8.9 1.5 1.5 6.8 7.2 8.1 8.3 2.6 7.7 1.8 2.0 4.9 4.7 7.7 0.9 1.2 0.2 4.2 2.4 0.8 0.2 2.1 3.5 1.1 0.3 0.1 7.6 0.0 2.2 3.7 2.9 4.4 1.4 0.3 0.7 11.7 1.5 0.3 5.3 0.3 4.8 0.8 12.6 3.3 0.7 1.3 0.1 7.7 3.5 1.1 2.2 9.2 1.0 2.6 0.1 14.2 0.2 2.4 9.3 0.0 0.0 4.7 1.7 0.6 6.6 0.5 2.1 0.1 1.2 0.1 2.8 0.3 0.6 2.0 0.1 6.2 0.2 14.8 11.7 0.2 6.0 2.8 2.0 0.4 0.2 0.0 1.9 0.0 0.8 0.4 1.0 1.3 0.3 1.8 1.3 1.4 0.0 0.2 0.1 0.1 1.9 0.5 5.8 7.5 44.9 19.3 8.3 2.9 10.3 5.9 7.4 24.4 1.5 8.3 7.7 12.2 0.0 1.7 41.4 3.7 5.9 3.4 2.1 5.7 12.2 7.6 6.2 3.4 7.2 2.9 11.0 18.8 0.3 25.4 32.3 7.9 3.4 29.1 5.1 4.8 8.0 2.4 1.3 133.9 2.3 0.3 3.6 11.7 6.3 8.9 2.6 5.3 3.7 1.9 8.4 93.2 7.8 2.0 2.2 33.0 8.9 1.5 5.1 7.2 32.8 4.0 1.6 48.4 23.6 36.4 2.6 16.8 2.2 9.8 1.7 18.1 4.2 3.0 17.8 0.0 2.3 3.0 3.1 8.0 6.2 4.8 0.3 31.6 8.2 6.6 5.4 CARMIL2 "LRRC16C, RLTPR" ENSG00000159753 "Capping protein regulator and myosin 1 linker 2" Q6F5E8 16 67644988-67657569 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;intestine: 13.6;lymphoid tissue: 21.8" "Group enriched" "Detected in some" 4 "B-cells: 3.6;dendritic cells: 3.7;T-cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 64.2;JURKAT: 47.3;MOLT-4: 64.6;REH: 105.6;RPMI-8226: 58.4;U-698: 107.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041402 Approved NA NA "HPA041402: AB_10795591" "unprognostic (1.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.35e-2)" "unprognostic (6.37e-2)" "unprognostic (5.47e-3)" "unprognostic (4.27e-4)" "unprognostic (1.38e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.90e-5)" "unprognostic (4.07e-2)" "unprognostic (5.14e-10)" "unprognostic (2.25e-1)" "unprognostic (1.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.57e-2)" 0.6 0.5 5.7 12.6 6.1 5.9 0.5 4.5 11.5 0.4 2.5 1.3 1.9 0.3 0.1 0.9 0.5 1.2 0.2 9.3 4.7 0.9 0.8 1.7 21.8 5.4 4.1 5.9 0.2 0.4 0.1 4.5 0.2 5.7 0.8 0.7 0.3 1.4 0.1 0.0 0.4 13.6 0.2 3.1 20.1 1.9 0.9 4.8 21.1 1.2 0.0 11.0 1.5 0.7 6.6 0.2 0.1 0.1 0.3 0.0 0.1 18.1 0.6 0.0 0.5 0.0 9.6 0.6 64.2 1.1 0.0 0.1 0.1 6.0 0.0 0.0 14.3 7.5 3.8 0.3 1.2 0.5 7.1 0.6 0.1 0.0 0.0 0.1 0.1 0.0 47.3 0.9 1.0 0.0 1.1 64.6 32.2 10.7 0.3 0.3 105.6 0.1 58.4 0.0 0.0 15.9 1.7 0.1 0.2 0.5 1.5 0.4 1.9 0.2 0.9 2.0 0.1 0.4 17.6 33.4 107.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.7 0.1 0.0 0.4 0.2 0.1 0.0 0.4 0.0 0.3 0.7 0.1 5.7 6.1 4.5 11.5 9.3 4.7 5.4 4.1 5.9 5.7 3.1 4.8 6.6 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 C16orf86 FLJ41802 ENSG00000159761 "Chromosome 16 open reading frame 86" Q6ZW13 16 67666814-67668757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 40.1" "Group enriched" "Detected in many" 4 "Early spermatids: 136.7;Spermatocytes: 100.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 3.3;T-47d: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA073475 Enhanced NA NA "HPA073475: AB_2686607" "unprognostic (1.01e-2)" "unprognostic (1.38e-2)" "unprognostic (6.33e-2)" "unprognostic (5.20e-2)" "unprognostic (2.16e-1)" "unprognostic (9.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.87e-2)" "unprognostic (4.05e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.47e-4)" "unprognostic (1.59e-1)" "prognostic favorable (2.12e-7)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "unprognostic (5.92e-2)" "unprognostic (3.05e-1)" 3.3 2.8 1.9 0.9 1.8 0.6 3.4 1.7 2.8 2.9 1.7 3.1 0.3 3.5 0.3 1.4 3.6 2.2 3.1 1.4 2.0 3.9 2.2 2.0 1.5 2.3 1.8 1.2 2.1 2.4 2.6 2.4 1.2 1.9 2.4 0.5 0.7 1.7 1.5 4.7 1.7 1.8 0.6 1.8 2.4 2.0 40.1 1.9 1.9 2.6 2.8 0.5 3.3 2.1 2.3 0.1 0.3 0.6 0.2 0.9 0.8 0.6 0.8 1.8 0.4 0.6 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.9 3.3 0.0 0.5 0.1 0.6 0.7 1.2 0.1 2.0 0.9 0.0 0.1 0.4 0.3 0.3 0.0 1.3 0.0 1.5 1.8 0.1 0.4 0.2 0.0 0.0 0.0 0.1 2.1 0.3 0.0 0.1 0.0 0.4 0.0 0.3 0.6 0.6 0.7 0.1 0.1 1.1 2.3 3.0 0.7 0.7 1.2 1.9 1.8 1.0 3.8 3.6 0.5 1.1 0.8 0.8 0.7 7.4 1.2 1.8 1.9 1.8 1.7 2.8 1.4 2.0 2.3 1.8 1.2 1.9 1.8 1.9 2.3 6.2 0.0 3.7 5.5 5.8 1.5 2.4 2.6 3.4 7.5 3.6 4.1 1.9 4.3 2.7 5.5 6.2 1.5 5.2 0.3 7.9 3.3 136.7 1.3 3.5 4.8 3.0 0.8 1.1 0.7 0.4 5.6 0.0 0.9 11.4 2.6 5.7 3.1 6.2 5.0 1.9 0.8 2.0 6.0 4.7 25.7 5.6 5.9 3.6 4.7 5.4 13.5 5.2 2.0 2.3 0.9 0.2 7.5 4.5 0.7 0.2 17.8 1.7 8.4 0.0 5.4 4.0 100.9 3.0 1.1 1.6 0.8 2.5 9.2 0.3 0.9 PIP "GCDFP-15, GCDFP15, GPIP4" ENSG00000159763 "Prolactin induced protein" P12273 7 143132077-143139739 "Plasma proteins, Predicted secreted proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "salivary gland: 16928.3" "Group enriched" "Detected in many" 4 "Breast glandular cells: 1117.6;Breast myoepithelial cells: 324.2;Melanocytes: 403.8" "Cancer enriched" "Detected in many" 70 "breast cancer: 672.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 333 "T-47d: 703.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB002661, HPA009177" Enhanced "Secreted in other tissues" NA NA 66000000 "CAB002661: , HPA009177: AB_1845459" "unprognostic (2.80e-1)" "unprognostic (2.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.25e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.14e-1)" "unprognostic (3.49e-2)" "unprognostic (5.55e-1)" 5.2 3.6 2.2 0.2 3.9 0.1 3493.6 1.9 2.3 5.6 0.0 0.5 0.0 0.1 2.7 1.3 4.2 0.1 4.9 0.5 3.1 0.5 2.0 6.5 0.8 6.3 3.7 0.0 3.8 21.3 0.4 1.9 2.3 5.8 33.6 0.0 0.0 16928.3 3170.8 1.7 157.4 0.6 0.0 4.2 0.6 0.6 0.7 3.7 0.3 0.7 0.0 1.8 0.7 1.5 10.9 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 703.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.9 1.9 2.3 0.5 3.1 6.3 3.7 0.0 5.8 4.2 3.7 10.9 6.9 0.0 2.0 0.0 3.6 10.8 6.6 18.8 0.0 0.0 1117.6 324.2 0.1 0.0 48.2 1.8 0.0 0.0 7.0 0.0 0.0 9.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.5 0.0 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.4 0.0 1.6 0.0 0.0 1.5 403.8 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 0.0 13.1 0.0 0.1 147.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 1.7 0.0 2.5 0.0 0.0 13.7 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 33.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 18.6;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 33.6" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;hTERT-RPE1: 8.5;NTERA-2: 22.3;PC-3: 21.5;SCLC-21H: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 0.6 1.0 17.1 1.1 23.7 0.0 0.5 23.5 33.7 1.5 0.4 2.5 0.8 6.8 0.2 0.8 0.9 0.6 0.3 20.2 15.5 0.2 0.0 0.6 0.5 22.8 20.2 21.2 0.2 0.0 2.8 0.5 0.1 25.8 0.2 1.2 1.8 0.1 0.2 6.9 0.1 1.1 4.1 18.0 0.2 0.5 0.4 15.4 0.4 0.2 1.0 0.2 0.6 0.6 32.4 0.0 0.2 6.6 0.0 5.3 6.6 0.0 0.3 1.7 1.0 0.3 14.0 0.0 0.0 0.0 0.4 0.0 0.3 2.7 0.6 0.9 3.4 0.0 0.4 0.0 0.0 0.1 0.1 0.0 7.5 0.0 0.1 0.0 8.5 1.2 0.1 0.0 0.0 0.9 0.0 0.0 0.4 22.3 0.0 21.5 0.0 0.0 0.0 0.0 0.0 21.7 0.7 0.3 1.6 0.0 1.4 0.0 0.0 1.0 0.4 2.1 0.2 0.0 0.0 0.0 0.0 0.1 4.5 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.1 23.7 23.5 33.7 20.2 15.5 22.8 20.2 21.2 25.8 18.0 15.4 32.4 0.1 0.0 0.0 1.6 0.0 0.1 0.2 0.6 0.0 0.9 0.1 0.5 0.6 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.9 0.2 0.8 0.1 3.0 0.3 2.4 0.0 18.6 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.7 0.0 0.1 0.0 12.0 0.1 0.0 0.3 0.5 3.4 0.0 0.2 0.0 2.8 0.6 0.1 0.0 11.1 33.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.6 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 7.6 6.5 12.6 2.9 37.7 2.3 8.8 9.3 18.0 14.2 9.0 7.4 4.8 8.7 4.8 30.7 10.0 4.0 6.1 12.2 8.4 11.1 17.5 10.7 3.5 17.6 7.2 18.6 12.6 4.9 3.4 13.9 3.7 9.4 16.8 1.9 3.8 9.5 4.7 12.4 20.7 6.2 2.6 7.1 6.1 6.8 10.4 7.2 3.7 8.1 4.6 3.4 10.5 20.4 9.6 4.8 6.0 11.9 8.6 3.9 3.1 4.9 5.1 4.1 5.2 3.8 4.9 2.8 1.1 3.1 4.5 7.6 4.6 2.3 16.3 1.7 0.1 1.9 0.5 3.6 12.0 3.5 0.3 6.5 2.6 10.9 2.7 3.6 4.6 11.5 4.2 5.6 0.2 4.8 4.1 0.8 13.1 5.6 2.7 5.7 12.3 4.6 4.0 2.7 14.1 13.3 13.8 3.2 2.2 11.4 2.9 5.4 8.2 8.7 10.0 6.5 2.0 5.5 5.9 4.9 2.7 5.9 7.2 7.3 0.4 0.3 0.0 0.2 1.1 0.0 0.0 0.2 0.1 0.4 0.2 0.3 0.1 0.4 0.0 1.1 0.2 0.2 0.2 12.6 37.7 9.3 18.0 12.2 8.4 17.6 7.2 18.6 9.4 7.1 7.2 9.6 16.1 6.4 6.4 66.9 2.6 84.4 142.0 69.3 71.2 17.3 11.0 14.9 8.6 8.6 28.6 5.5 29.2 6.2 1.3 6.4 3.9 10.4 5.0 22.8 13.3 26.6 14.9 4.8 44.3 10.4 1.3 14.6 7.7 11.8 14.0 57.7 27.8 28.8 20.8 10.1 170.1 10.8 8.2 12.4 11.3 5.5 14.9 21.7 17.8 47.8 7.8 29.3 2.1 71.4 25.5 14.7 2.7 7.9 0.8 53.9 6.0 23.9 34.6 18.9 0.0 12.5 12.7 24.0 15.3 84.4 110.0 6.7 4.3 11.8 9.0 153.8 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893254-67929676 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053927, HPA062763" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA053927: AB_2682312, HPA062763: " "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favorable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.4 18.7 11.7 9.7 13.3 5.3 14.1 11.6 12.4 12.4 16.8 18.0 13.8 19.4 10.1 17.0 18.9 10.2 17.8 10.4 12.1 20.3 16.7 12.8 10.7 14.5 14.2 9.5 19.5 26.5 33.2 13.3 7.7 14.1 15.2 10.9 4.0 18.2 12.8 15.4 13.9 15.9 15.8 12.5 12.9 21.6 21.9 12.6 12.1 15.1 13.6 8.6 16.6 9.6 14.2 13.0 22.7 25.2 28.1 38.4 19.3 16.3 15.2 23.0 15.8 14.0 17.2 18.2 12.2 22.7 25.7 12.7 19.2 14.7 15.6 5.3 4.8 16.4 13.9 16.8 22.0 26.3 13.4 8.0 35.7 26.7 18.8 19.6 21.3 23.3 22.5 21.6 5.1 16.7 28.7 18.3 8.6 24.2 14.0 13.9 27.7 9.7 25.3 18.6 16.0 21.8 26.0 47.3 12.8 15.8 9.9 23.5 23.9 20.8 17.7 6.2 15.0 7.7 15.3 8.7 26.2 21.4 8.8 19.9 0.0 2.0 1.9 2.0 2.2 1.4 1.5 1.5 2.0 2.1 1.2 1.2 1.7 1.0 2.1 1.5 1.5 0.8 1.7 11.7 13.3 11.6 12.4 10.4 12.1 14.5 14.2 9.5 14.1 12.5 12.6 14.2 5.5 0.0 3.6 4.6 2.9 1.1 3.1 5.2 2.2 11.1 5.3 4.6 2.3 7.2 3.8 5.5 6.2 6.2 3.0 11.5 11.7 6.0 14.4 5.8 6.5 5.2 10.8 3.0 4.6 7.4 4.8 5.4 5.1 4.8 6.3 13.0 5.3 10.3 4.8 6.7 6.1 6.2 10.2 6.3 1.6 22.1 4.7 2.9 5.4 3.7 4.8 11.0 3.1 5.5 9.2 7.6 4.5 7.9 3.0 3.6 10.0 8.1 4.9 6.9 13.1 6.3 6.1 6.7 6.1 5.4 1.6 5.9 3.8 10.7 7.4 2.2 ZYX ENSG00000159840 Zyxin Q15942 7 143381295-143391111 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 601.6" "Cell type enhanced" "Detected in many" "Macrophages: 207.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 163.3" "Group enriched" "Detected in all" 4 "dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004835, CAB009321, HPA073497, CAB075747" Enhanced Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 180000000 "Focal adhesion sites" "Plasma membrane, Actin filaments" "CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611" "unprognostic (1.96e-2)" "unprognostic (5.35e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (2.21e-3)" "unprognostic (1.66e-3)" "unprognostic (2.60e-1)" "unprognostic (4.22e-1)" "unprognostic (1.98e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (7.92e-5)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (1.95e-1)" "unprognostic (6.72e-2)" 211.6 76.0 20.7 83.3 22.7 107.3 192.6 21.7 33.7 256.5 23.9 293.6 28.4 601.6 16.6 137.8 297.5 57.5 148.9 19.5 23.9 100.2 90.6 319.6 54.4 24.3 22.4 17.8 170.1 79.2 85.0 52.8 38.7 24.7 173.4 20.4 5.2 109.0 76.0 114.3 120.5 150.0 128.9 23.7 215.4 155.3 99.6 24.0 27.8 89.8 19.3 31.4 304.2 187.5 29.3 73.9 39.3 50.6 70.5 93.9 208.2 63.4 152.1 158.9 146.5 122.7 135.4 42.6 4.6 57.5 168.5 84.1 55.8 31.7 138.0 67.8 81.6 18.7 105.9 45.7 46.9 163.8 86.4 162.6 222.9 60.5 160.1 54.0 90.5 187.9 9.1 28.0 42.8 159.6 73.4 1.3 165.9 110.0 25.4 273.1 16.3 28.0 6.4 112.2 34.6 2.8 39.5 112.3 99.2 57.0 45.9 12.1 80.5 343.7 176.5 74.1 187.9 152.4 15.6 20.4 11.7 154.6 87.4 119.8 18.9 70.8 48.2 20.2 70.4 16.2 3.1 19.4 23.3 58.4 2.0 11.7 13.8 163.3 14.7 83.6 14.5 19.1 44.1 20.7 22.7 21.7 33.7 19.5 23.9 24.3 22.4 17.8 24.7 23.7 24.0 29.3 51.6 6.4 6.4 8.1 26.7 33.8 174.0 78.4 26.7 3.7 40.2 85.3 11.6 25.8 45.4 35.0 0.0 40.6 51.7 40.1 7.9 100.3 1.5 23.4 172.6 58.2 38.2 19.3 36.9 94.1 95.8 66.6 44.9 42.0 36.8 13.7 55.3 32.0 164.6 0.0 18.3 26.7 24.4 195.7 95.1 6.8 28.6 207.1 14.2 7.5 171.9 15.1 40.2 7.5 5.2 169.8 48.2 55.3 20.3 61.3 19.8 19.6 9.9 3.0 85.5 48.7 103.9 7.3 9.9 46.3 20.2 28.0 91.9 8.8 28.6 106.4 ABR MDB ENSG00000159842 "ABR activator of RhoGEF and GTPase" Q12979 17 1003518-1229738 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 171.7;Late spermatids: 164.0;Microglial cells: 146.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons: 21.7" "Immune cell enriched" "Detected in single" 14 "basophil: 9.0" "Lineage enriched" "Detected in single" 17 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "Daudi: 31.3;hTERT-RPE1: 38.6;LHCN-M2: 24.6;RPMI-8226: 21.5;TIME: 41.3;U-251 MG: 42.0;U-698: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053618: AB_2682208, HPA054824: AB_2682616" "unprognostic (1.69e-1)" "prognostic favorable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favorable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 22.1 21.9 1.6 5.6 4.5 1.3 20.2 0.3 11.5 25.0 0.9 42.0 1.9 28.8 0.1 42.3 23.1 0.6 35.5 1.8 1.6 9.7 3.0 28.7 1.1 5.6 2.4 1.0 14.8 8.6 1.2 22.6 1.6 21.7 18.4 7.0 1.2 28.3 0.4 9.0 25.0 40.8 8.2 3.9 21.2 19.7 14.0 3.7 4.9 10.6 0.0 5.8 22.1 25.0 4.4 1.0 1.3 0.3 0.1 1.3 0.2 1.7 0.2 0.3 0.1 0.0 0.6 0.0 31.3 0.7 0.3 1.7 0.1 4.0 0.1 0.9 11.8 14.5 0.0 0.4 0.1 0.8 2.7 9.5 0.4 0.0 0.3 12.7 38.6 0.0 0.0 0.1 0.0 24.6 1.2 0.1 3.4 0.2 0.7 0.2 0.2 0.0 21.5 0.2 0.4 0.3 0.6 0.1 0.0 1.8 0.1 11.5 3.0 41.3 0.3 0.4 3.0 42.0 0.1 0.6 29.5 1.9 5.1 0.8 9.0 0.2 0.6 0.1 0.5 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.5 0.0 0.2 0.0 0.5 0.0 1.6 4.5 0.3 11.5 1.8 1.6 5.6 2.4 1.0 21.7 3.9 3.7 4.4 20.0 32.1 24.6 171.7 9.6 17.1 18.2 19.0 11.4 75.5 11.3 8.3 23.7 22.8 21.0 1.8 2.1 2.4 13.3 61.0 0.0 17.7 37.0 14.3 6.1 22.1 15.0 2.5 80.5 6.3 3.0 13.7 18.8 9.7 19.6 16.3 18.2 0.6 30.4 11.8 67.6 37.2 16.2 31.9 49.4 164.0 13.7 31.0 19.6 146.1 25.5 25.8 34.0 41.7 5.2 48.3 38.4 9.4 4.2 21.8 36.8 7.9 26.7 20.0 39.5 19.9 25.3 2.7 8.3 22.3 16.9 2.2 15.5 0.6 53.2 25.1 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43785874-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 50.1" "Cell type enhanced" "Detected in many" "Early spermatids: 33.0;Late spermatids: 81.8;Melanocytes: 17.8;Syncytiotrophoblasts: 21.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 5.0;HaCaT: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: AB_2682567" "unprognostic (4.27e-3)" "prognostic favorable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 0.9 0.6 3.5 1.4 2.3 0.1 2.9 1.5 5.8 4.8 0.0 1.9 0.1 0.9 1.4 11.5 0.8 1.1 1.3 2.8 2.7 0.9 0.4 4.0 0.7 6.3 3.3 2.9 0.4 0.3 0.6 1.6 1.0 6.9 1.3 0.8 2.0 3.2 0.8 0.2 50.1 1.2 1.1 1.4 4.9 1.0 3.8 5.1 0.9 1.4 0.4 1.7 1.9 9.0 4.7 3.5 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.5 0.6 0.4 1.2 0.2 0.7 0.4 1.4 5.2 0.0 0.7 0.3 0.6 0.0 0.1 0.4 0.0 1.5 0.1 0.0 1.7 1.5 0.2 0.7 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.3 1.9 1.2 0.0 0.0 0.0 0.3 0.6 0.2 0.1 0.7 0.7 0.0 1.1 0.4 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.1 3.5 2.3 1.5 5.8 2.8 2.7 6.3 3.3 2.9 6.9 1.4 5.1 4.7 0.5 0.0 0.0 4.6 0.0 3.6 2.6 1.6 4.0 1.4 1.8 1.5 0.7 0.0 0.4 0.0 0.0 1.6 0.1 3.7 3.9 0.6 33.0 0.2 0.1 3.1 0.0 0.0 7.7 0.9 8.4 1.2 0.0 0.2 0.0 0.5 0.7 0.0 2.4 0.0 8.8 1.9 0.0 0.6 0.8 81.8 0.3 0.5 17.8 1.0 0.0 0.9 0.0 9.5 7.8 0.3 2.3 1.2 0.0 1.4 0.2 0.0 1.4 0.9 0.0 1.0 0.2 9.9 2.6 3.7 2.8 21.6 0.1 0.1 0.8 6.2 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 104.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 9.6 10.3 13.2 12.9 12.9 22.0 12.1 16.3 18.8 14.3 14.3 11.3 11.9 11.6 8.1 8.3 9.2 9.6 7.9 14.6 12.5 9.9 24.4 9.5 18.3 12.6 12.4 11.6 12.6 9.4 12.7 6.8 19.3 13.3 9.9 11.3 10.7 18.4 9.4 17.0 8.2 9.5 9.8 12.2 12.7 10.1 36.9 13.4 18.0 11.0 20.9 20.4 10.7 7.6 18.2 19.9 16.0 32.2 31.7 20.6 18.0 25.5 19.7 23.9 33.4 29.2 24.6 9.4 61.7 8.6 18.0 14.2 20.2 47.8 7.8 31.6 33.6 31.4 25.2 17.3 36.6 14.1 40.6 30.9 12.2 16.8 19.3 11.9 14.9 23.5 20.0 36.0 26.6 15.2 25.6 24.1 32.8 26.4 35.3 7.7 48.1 50.8 27.0 14.9 7.6 12.3 16.4 30.4 28.0 12.7 38.0 34.9 17.4 13.7 41.7 28.3 13.3 15.3 61.7 68.9 51.2 14.6 21.9 18.1 13.5 14.6 15.3 10.0 13.2 10.2 10.0 8.3 9.8 14.6 12.4 14.5 11.8 6.7 25.3 12.9 12.7 11.6 14.9 13.2 12.9 16.3 18.8 14.6 12.5 12.6 12.4 11.6 13.3 12.2 13.4 18.2 11.1 22.4 14.3 4.2 18.3 10.6 14.4 4.3 6.2 7.7 21.9 14.2 10.4 15.7 8.5 14.7 14.6 16.5 20.4 13.2 7.9 9.9 104.0 20.7 32.5 15.5 20.4 17.4 6.6 10.0 17.8 14.3 6.6 31.0 17.2 11.9 10.8 42.3 9.3 3.3 7.1 12.3 4.1 18.9 19.0 38.2 12.8 15.4 17.8 7.5 14.7 6.2 21.6 4.5 12.8 9.7 8.9 7.9 26.4 22.6 9.0 12.5 13.8 15.2 0.0 9.6 16.1 49.5 48.5 9.5 10.9 24.6 14.7 9.0 12.4 22.3 ZNF230 FDZF2 ENSG00000159882 "Zinc finger protein 230" Q9UIE0 19 44002957-44013924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA006172 Approved Mitochondria No No Mitochondria "HPA006172: AB_2667532" "unprognostic (3.55e-3)" "unprognostic (5.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-2)" "unprognostic (3.89e-2)" "unprognostic (3.79e-2)" "unprognostic (1.35e-1)" "unprognostic (4.08e-4)" "unprognostic (2.45e-2)" "unprognostic (1.14e-2)" "unprognostic (8.59e-2)" "unprognostic (1.68e-1)" "unprognostic (4.62e-2)" "unprognostic (1.42e-5)" 1.9 2.2 1.4 2.2 1.6 3.3 3.2 3.1 2.0 2.1 1.7 1.9 1.3 2.4 2.1 1.4 2.5 1.6 1.7 1.4 1.8 1.8 2.1 2.4 3.4 1.6 1.7 1.4 4.2 1.5 2.7 2.7 2.4 1.9 2.2 2.0 4.7 1.9 2.5 0.8 2.9 2.4 1.8 1.6 3.9 1.9 1.8 1.6 4.1 3.0 1.9 3.9 2.1 1.7 2.1 2.1 1.7 3.4 3.5 2.7 3.3 1.3 2.9 2.9 2.6 4.7 1.0 1.1 1.7 1.9 2.1 1.6 1.7 2.9 2.6 3.9 2.1 3.6 2.9 4.1 1.2 1.5 3.8 2.4 2.5 2.4 2.9 3.0 3.5 1.8 2.0 0.5 0.0 2.7 1.1 4.3 2.7 2.0 1.4 1.6 3.1 4.7 0.8 1.5 2.4 1.9 4.3 4.1 1.4 2.1 2.3 1.2 8.7 2.3 4.1 3.0 1.2 2.2 2.1 2.2 0.3 2.0 2.8 2.6 6.2 3.3 8.7 3.6 4.0 3.8 4.2 4.1 3.7 3.6 4.2 4.5 4.2 11.5 2.9 2.0 2.2 3.7 2.9 1.4 1.6 3.1 2.0 1.4 1.8 1.6 1.7 1.4 1.9 1.6 1.6 2.1 4.7 0.0 2.2 1.6 8.3 2.8 2.6 3.0 4.6 8.5 3.3 3.9 6.0 10.0 3.5 3.7 16.7 4.0 9.9 2.7 3.9 3.0 2.7 2.9 3.3 4.2 1.2 2.1 4.6 2.4 3.2 4.4 2.6 1.7 1.3 4.8 3.9 2.7 3.2 8.4 3.8 2.4 10.2 4.4 3.3 1.7 6.5 3.6 3.6 3.7 7.9 5.4 7.2 2.5 4.0 1.2 0.8 4.5 1.4 2.0 4.1 1.6 2.9 9.6 6.6 3.9 4.3 13.7 7.9 2.8 2.7 3.1 6.7 3.7 3.2 2.0 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 87.6 61.5 35.3 19.3 34.7 7.8 75.9 37.3 40.9 47.5 36.2 92.4 19.4 74.8 31.4 25.3 61.1 15.4 89.9 34.6 35.2 37.8 50.7 44.0 15.5 35.5 35.3 33.9 32.6 63.3 13.0 33.3 14.0 35.9 56.4 16.9 14.0 26.8 29.5 64.9 32.1 47.5 28.4 34.5 41.6 75.0 17.2 37.8 26.2 31.6 22.6 14.5 77.2 39.5 36.2 17.9 15.7 12.8 16.3 63.3 40.3 7.4 29.5 26.4 18.5 17.2 7.2 5.2 11.5 12.8 38.9 47.6 5.9 9.6 14.2 13.6 34.4 15.3 5.5 25.1 18.3 15.0 8.5 20.1 24.1 16.6 19.8 15.3 34.4 13.1 19.2 7.2 21.7 23.4 11.6 9.5 12.6 9.5 12.6 48.2 13.7 2.9 9.3 62.8 9.6 8.4 14.0 15.2 21.1 15.4 9.5 11.1 10.4 16.7 29.5 16.3 21.6 27.3 9.6 15.4 23.1 54.6 13.5 26.2 33.3 39.3 20.1 128.7 43.2 168.8 79.5 111.6 113.8 45.0 79.5 53.2 74.2 7.8 69.3 25.9 123.8 140.8 75.1 35.3 34.7 37.3 40.9 34.6 35.2 35.5 35.3 33.9 35.9 34.5 37.8 36.2 68.7 67.3 25.0 11.1 104.8 70.2 38.0 76.9 8.6 31.9 39.2 65.3 0.7 60.1 48.4 82.8 8.4 15.0 175.2 143.9 17.6 74.1 7.6 33.5 34.1 36.1 88.1 15.8 8.6 140.2 66.2 60.0 121.8 30.5 34.3 24.4 53.9 77.3 90.9 32.0 10.2 100.5 69.2 46.9 185.9 28.3 59.4 82.0 113.8 13.1 43.5 57.2 133.9 7.5 10.8 86.7 108.6 102.3 53.3 45.3 146.7 66.9 48.2 34.1 118.3 33.7 135.3 37.9 63.1 17.8 66.9 13.8 132.7 44.9 51.7 29.5 ZNF222 ENSG00000159885 "Zinc finger protein 222" Q9UK12 19 44025342-44033110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004086 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA004086: AB_2273259" "unprognostic (1.91e-3)" "unprognostic (3.41e-2)" "unprognostic (8.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (7.45e-2)" "unprognostic (1.75e-3)" "unprognostic (6.75e-2)" "unprognostic (1.58e-2)" "unprognostic (7.58e-2)" "prognostic favorable (5.56e-7)" "unprognostic (2.19e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-1)" "unprognostic (8.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-3)" 2.7 4.2 3.6 3.0 3.8 5.3 4.6 5.9 5.4 3.2 3.6 2.4 1.7 2.8 3.9 1.9 3.0 3.4 4.3 3.5 4.5 2.8 2.8 3.2 4.4 4.3 4.0 3.5 4.7 3.1 3.8 5.2 3.1 4.4 3.6 2.7 6.9 2.6 3.3 2.3 2.6 2.7 3.3 3.4 4.6 3.2 9.2 4.1 5.8 4.1 2.3 4.3 3.9 2.0 4.9 3.8 4.5 7.4 6.7 5.5 5.5 0.3 4.1 7.3 4.7 7.4 2.1 2.4 1.2 6.1 4.4 5.5 1.3 5.2 3.6 5.9 4.9 4.7 6.4 6.5 3.8 7.0 0.2 5.2 4.2 5.4 3.9 6.5 7.4 4.5 5.2 1.2 2.4 5.9 0.5 4.3 2.4 4.5 1.8 1.7 0.1 7.7 2.1 3.8 12.1 4.0 9.0 6.4 1.2 5.4 6.3 1.6 6.2 3.3 5.1 4.9 2.9 5.0 10.6 9.1 0.1 2.7 0.1 5.8 7.7 2.4 5.0 5.9 1.6 4.8 4.7 5.4 5.7 2.5 5.9 6.2 4.6 4.8 4.9 2.0 2.9 4.2 2.8 3.6 3.8 5.9 5.4 3.5 4.5 4.3 4.0 3.5 4.4 3.4 4.1 4.9 2.1 0.0 1.5 1.0 1.9 2.5 1.9 2.3 0.0 5.3 2.1 2.0 1.9 0.0 1.8 5.5 0.0 1.8 3.1 0.8 7.9 2.4 78.5 1.6 1.7 2.4 3.0 4.8 3.7 1.2 1.1 3.0 1.5 2.7 4.5 3.5 3.3 1.1 2.3 6.7 4.2 2.1 6.1 1.3 1.5 6.9 1.8 1.5 1.8 1.0 1.7 6.3 3.1 3.5 3.6 0.8 0.4 2.2 1.5 0.8 1.1 1.3 0.3 2.8 0.0 2.8 3.0 9.9 3.5 0.7 1.7 1.1 3.7 3.5 1.2 1.1 NPR2 "AMDM, ANPb, ANPRB, GUCY2B, NPRB" ENSG00000159899 "Natriuretic peptide receptor 2" P20594 9 35791591-35809732 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Osteogenesis" "Lyase, Receptor" "Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 35.6;Excitatory neurons: 69.1;Inhibitory neurons: 68.9;Microglial cells: 34.7;Oligodendrocyte precursor cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 30.9;ASC TERT1: 21.1;BJ hTERT+: 20.2;HHSteC: 20.1;HSkMC: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.93e-2)" "unprognostic (8.22e-3)" "unprognostic (9.25e-3)" "unprognostic (3.59e-2)" "unprognostic (6.13e-2)" "unprognostic (2.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.40e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-1)" "unprognostic (3.99e-2)" "unprognostic (6.99e-3)" "unprognostic (7.10e-2)" "unprognostic (3.24e-1)" "unprognostic (7.86e-2)" 12.4 8.3 9.2 1.8 8.8 0.3 10.4 14.6 10.0 24.5 7.6 12.8 1.8 20.7 8.7 3.2 15.2 3.2 12.3 8.9 10.4 6.7 8.7 9.2 2.3 11.0 9.4 8.5 9.5 3.2 1.3 13.9 4.7 11.4 11.0 2.9 4.2 5.4 6.6 10.9 7.4 7.6 10.0 7.8 4.9 7.8 4.8 9.3 2.2 6.1 8.7 1.7 12.2 14.8 9.8 0.0 2.9 2.2 0.0 30.9 21.1 1.9 9.3 20.2 7.0 6.4 4.5 4.3 1.8 3.0 17.9 12.8 1.2 3.6 0.2 6.1 2.2 1.0 1.8 4.3 3.4 20.1 0.4 0.0 23.8 1.8 8.9 0.6 7.6 12.7 2.5 0.7 0.2 13.4 1.0 0.5 0.8 3.5 1.0 3.7 2.4 0.2 0.5 1.8 1.4 1.1 0.7 0.4 0.1 0.6 3.8 0.2 0.0 8.2 8.5 7.8 3.2 1.2 0.5 0.6 4.8 10.4 0.6 5.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 9.2 8.8 14.6 10.0 8.9 10.4 11.0 9.4 8.5 11.4 7.8 9.3 9.8 2.7 3.2 3.4 35.6 0.0 1.1 0.6 0.6 1.2 5.1 0.7 1.4 0.7 1.5 0.3 0.0 2.1 0.4 0.5 0.7 0.0 0.6 0.3 1.4 9.2 4.4 0.0 0.0 69.1 0.8 0.2 7.2 0.5 2.0 1.3 9.6 6.1 4.5 0.4 3.3 68.9 0.7 0.0 0.3 2.1 0.3 9.3 0.3 0.0 34.7 0.0 6.8 0.0 51.8 16.3 0.6 3.6 7.9 0.2 2.7 0.2 0.6 1.1 2.2 0.0 5.1 3.4 4.5 3.1 0.1 1.6 0.3 0.7 0.8 1.1 0.4 ZNF221 ENSG00000159905 "Zinc finger protein 221" Q9UK13 19 43951223-43967709 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA059435 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA059435: AB_2684016" "unprognostic (2.06e-1)" "unprognostic (8.35e-2)" "unprognostic (2.65e-2)" "unprognostic (1.63e-1)" "unprognostic (3.17e-3)" "unprognostic (2.11e-1)" "unprognostic (1.81e-2)" "unprognostic (3.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.17e-2)" "unprognostic (5.02e-2)" "unprognostic (1.91e-1)" "unprognostic (1.84e-2)" "unprognostic (3.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" 0.9 1.2 1.5 0.6 1.9 0.6 1.2 4.9 1.6 1.0 1.1 0.7 0.5 1.1 0.8 0.8 1.3 0.6 1.2 1.3 1.5 1.1 1.1 1.0 0.7 1.6 1.7 1.3 1.9 0.7 2.3 0.9 1.3 2.2 1.6 0.8 3.0 0.7 1.1 0.4 1.2 0.8 1.4 1.0 1.0 0.9 1.1 1.9 1.2 1.8 0.7 0.7 1.0 0.7 3.8 1.4 1.2 3.6 2.8 1.2 2.4 1.0 1.5 2.3 1.3 2.0 1.6 0.5 0.0 0.8 1.5 0.9 0.6 1.4 1.0 2.3 0.0 2.9 3.8 5.1 0.6 1.2 0.4 1.6 3.5 0.9 2.2 0.8 2.7 2.4 0.0 0.2 0.0 1.7 0.1 0.0 0.6 3.3 0.5 1.2 0.1 4.0 0.4 0.8 4.6 2.9 2.5 3.0 0.2 0.3 2.1 1.0 3.5 4.1 1.6 3.6 0.8 1.2 1.9 2.6 0.0 0.5 1.5 1.9 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.2 0.1 0.3 0.6 0.1 0.3 0.1 0.1 1.5 1.9 4.9 1.6 1.3 1.5 1.6 1.7 1.3 2.2 1.0 1.9 3.8 1.4 0.0 2.0 1.0 0.2 0.0 0.1 1.1 0.6 2.8 0.5 0.3 0.7 0.0 0.4 0.0 2.1 0.3 0.2 0.1 0.0 0.4 0.3 0.8 1.8 0.8 0.0 1.3 2.7 0.4 0.2 1.4 1.5 0.8 1.3 1.3 0.7 0.1 0.3 0.0 2.1 0.0 0.0 0.0 0.3 0.5 1.2 0.2 1.8 0.0 0.0 1.3 1.0 2.5 2.6 0.5 0.0 0.4 0.4 0.1 0.0 0.4 0.3 2.3 0.0 0.9 1.1 0.9 0.7 0.7 0.1 0.3 0.4 1.3 0.1 0.4 ZNF233 FLJ38032 ENSG00000159915 "Zinc finger protein 233" A6NK53 19 44259880-44275317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.4" "Group enriched" "Detected in some" 4 "Early spermatids: 40.9;Spermatocytes: 38.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 6.9;U-266/84: 7.6" HPA020975 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020975: AB_1859145" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-1)" "unprognostic (1.60e-1)" "unprognostic (3.72e-2)" "unprognostic (7.37e-3)" "unprognostic (2.77e-2)" "unprognostic (9.07e-3)" "unprognostic (1.48e-1)" "unprognostic (4.20e-3)" "unprognostic (1.65e-1)" "unprognostic (6.28e-3)" "unprognostic (6.88e-2)" "unprognostic (3.47e-2)" "unprognostic (2.71e-4)" "unprognostic (1.55e-1)" 0.4 1.1 1.6 1.1 1.9 1.8 1.5 2.6 2.9 0.7 0.2 2.3 0.9 0.4 1.6 0.6 1.3 0.9 3.2 1.6 1.0 1.2 0.5 0.6 1.4 1.6 0.3 1.5 0.6 0.8 1.7 3.2 1.3 1.7 2.7 1.3 4.9 0.9 1.0 1.7 1.7 1.0 0.4 0.3 1.3 1.1 14.4 0.6 1.5 1.9 0.6 0.6 0.9 0.4 3.3 0.4 1.8 2.0 1.9 2.2 0.4 0.5 0.7 0.6 0.7 1.2 1.5 2.1 0.6 1.9 0.6 1.1 0.6 0.0 0.5 0.8 0.3 2.4 1.0 2.5 1.7 1.5 0.7 0.8 0.5 0.3 0.5 1.3 2.9 0.9 0.7 0.8 3.8 0.1 0.7 0.6 0.5 2.1 0.4 0.3 1.2 0.2 0.8 0.4 1.2 2.8 4.4 0.7 0.5 1.3 3.7 3.5 1.0 0.3 0.6 0.4 0.4 0.4 6.9 7.6 1.2 3.0 0.5 0.9 1.5 0.3 0.2 0.5 0.3 0.4 0.9 0.4 0.3 0.1 1.3 0.6 0.7 0.7 1.1 0.3 1.3 0.7 0.1 1.6 1.9 2.6 2.9 1.6 1.0 1.6 0.3 1.5 1.7 0.3 0.6 3.3 0.5 0.0 0.5 2.6 0.4 0.0 0.2 0.2 0.0 3.7 1.1 0.4 4.6 0.0 0.3 0.0 0.0 0.5 0.2 0.3 0.0 0.6 40.9 1.3 0.3 0.9 1.2 0.4 9.0 0.0 0.1 0.6 0.5 0.5 0.0 0.7 0.0 0.0 0.6 0.0 7.9 0.2 2.0 0.0 0.0 8.5 0.6 0.1 0.0 1.0 0.0 1.9 0.0 4.5 5.7 0.1 0.1 0.7 0.0 0.5 0.8 0.0 0.4 4.0 0.0 0.6 0.4 38.6 1.9 0.0 0.0 0.0 0.3 1.1 0.4 0.1 ZNF235 "ANF270, HZF6, ZFP93, ZNF270" ENSG00000159917 "Zinc finger protein 235" Q14590 19 44228729-44305046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 8.3;Oligodendrocytes: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045582 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045582: AB_10963792" "unprognostic (2.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.11e-2)" "unprognostic (9.91e-3)" "unprognostic (2.04e-2)" "unprognostic (1.23e-4)" "unprognostic (4.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (3.37e-1)" "unprognostic (1.46e-5)" "unprognostic (1.20e-2)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-3)" "unprognostic (3.38e-2)" 2.0 1.3 3.3 2.2 3.1 0.7 2.7 3.1 3.5 1.9 2.8 2.3 1.7 2.0 2.1 1.6 2.3 1.7 2.4 3.3 2.9 2.2 1.8 2.3 2.8 3.1 3.3 2.7 2.6 1.8 2.8 1.9 2.4 3.2 2.4 2.0 3.1 1.7 2.6 2.7 1.4 2.0 2.3 3.0 2.7 1.5 2.4 3.1 4.5 2.3 3.0 3.3 1.7 1.4 4.3 1.6 2.6 4.7 5.1 3.7 2.2 1.6 1.0 3.1 1.8 2.1 1.6 2.8 2.9 2.5 1.9 2.8 1.5 4.4 2.1 2.2 0.0 5.3 5.8 4.0 2.4 3.0 3.5 3.6 2.1 2.7 2.0 2.4 2.9 2.9 4.9 1.3 0.0 1.8 1.4 5.4 0.7 6.0 2.8 1.5 2.7 4.7 2.4 3.2 4.0 3.6 10.1 2.7 3.2 2.4 4.9 2.4 4.1 3.6 1.8 2.4 0.5 1.1 6.0 6.4 1.9 1.4 1.0 2.8 20.7 3.5 3.5 6.3 3.1 4.2 6.9 4.6 5.3 2.7 10.1 6.8 5.8 1.8 6.2 3.0 8.1 3.7 2.4 3.3 3.1 3.1 3.5 3.3 2.9 3.1 3.3 2.7 3.2 3.0 3.1 4.3 3.5 0.0 0.0 6.2 5.6 0.5 0.5 1.5 4.6 1.7 1.5 1.5 2.3 1.5 0.7 0.0 6.2 1.5 2.5 1.3 0.0 1.4 1.5 1.7 1.8 2.4 0.0 5.2 8.3 0.0 0.4 1.4 2.0 1.2 2.5 2.5 1.8 1.4 1.4 1.7 6.7 1.1 0.0 2.2 0.9 0.3 0.6 2.2 1.8 1.0 1.4 1.1 3.1 5.0 9.2 0.6 3.6 3.4 3.2 0.6 2.0 0.9 0.9 1.6 0.0 1.8 2.0 2.3 5.6 1.8 0.6 1.5 4.1 1.3 0.8 0.2 GNE "IBM2, Uae1" ENSG00000159921 "Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" Q9Y223 9 36214441-36277042 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "intestine: 48.8;liver: 91.3;salivary gland: 55.8" "Cell type enhanced" "Detected in all" "Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 107.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007045, HPA027258" Approved Supported Cytosol NA NA Cytosol "HPA007045: AB_1079003, HPA027258: AB_1849873" "unprognostic (7.54e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-3)" "unprognostic (7.28e-2)" "unprognostic (7.00e-2)" "unprognostic (1.85e-2)" "unprognostic (2.78e-3)" "unprognostic (5.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.88e-3)" "unprognostic (4.20e-2)" "prognostic favorable (9.28e-11)" "unprognostic (2.90e-1)" "unprognostic (8.28e-2)" "unprognostic (2.95e-1)" "unprognostic (1.72e-2)" 12.0 9.1 5.4 8.8 6.8 15.7 16.0 8.7 6.5 11.4 6.9 34.3 4.3 10.4 3.5 11.7 9.2 7.4 7.8 5.3 7.2 10.1 91.3 6.9 7.3 7.2 6.8 5.7 14.9 10.3 6.2 4.8 14.3 8.4 15.5 48.8 8.1 55.8 7.2 7.9 3.5 7.7 11.8 6.4 6.2 4.6 4.8 7.1 6.3 7.0 15.4 9.6 14.3 7.6 10.3 9.9 44.4 20.1 17.1 22.5 22.4 29.9 13.5 17.9 19.5 25.1 10.5 32.6 13.5 14.2 24.2 50.5 3.9 15.3 4.6 21.8 25.1 1.4 11.0 26.0 15.2 15.4 0.2 31.2 14.4 4.6 32.0 30.6 14.3 8.4 20.7 14.4 27.3 19.3 1.8 19.1 6.3 11.8 6.7 23.7 15.5 16.3 3.8 107.7 19.4 16.7 15.2 13.7 5.3 12.6 7.1 4.8 12.0 12.2 12.7 12.9 15.5 12.2 11.7 26.0 7.0 17.0 9.8 18.2 0.2 0.5 0.2 0.7 0.6 0.5 0.6 0.9 0.8 0.4 0.9 1.0 1.2 0.3 0.7 0.8 0.6 0.4 0.6 5.4 6.8 8.7 6.5 5.3 7.2 7.2 6.8 5.7 8.4 6.4 7.1 10.3 9.7 9.6 10.0 9.4 7.1 1.9 3.1 6.7 1.8 8.4 8.2 7.5 6.7 10.0 16.9 9.2 6.2 8.6 4.3 59.3 1.9 10.4 3.4 7.2 12.1 6.3 11.5 7.8 12.8 6.0 9.5 8.3 2.6 10.6 10.1 9.1 7.1 119.3 2.9 11.8 15.6 88.1 16.2 7.8 4.4 2.4 10.8 5.4 1.8 5.6 6.1 1.9 2.1 32.2 28.2 5.3 20.3 6.4 7.9 6.9 2.9 2.2 18.8 6.9 13.1 10.0 6.3 1.8 2.7 1.2 1.6 19.8 5.7 2.3 26.8 13.4 TNFRSF13C "BAFFR, CD268" ENSG00000159958 "TNF receptor superfamily member 13C" Q96RJ3 22 41922032-41926806 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 34.0;lymphoid tissue: 58.6" "Cell type enriched" "Detected in some" 10 "B-cells: 194.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "memory B-cell: 22.5;naive B-cell: 29.1" "Lineage enriched" "Detected in single" 40 "B-cells: 29.1" "Group enriched" "Detected in some" 6 "REH: 21.0;U-698: 10.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA003246, CAB008380" Enhanced NA NA "CAB008380: AB_590602, HPA003246: AB_1078264" "unprognostic (3.43e-4)" "prognostic favorable (4.44e-7)" "unprognostic (6.52e-2)" "unprognostic (9.10e-2)" "unprognostic (7.64e-3)" "unprognostic (4.83e-3)" "unprognostic (2.89e-2)" "unprognostic (3.78e-3)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (2.51e-2)" "unprognostic (1.66e-1)" "unprognostic (4.79e-8)" "unprognostic (2.21e-1)" "unprognostic (1.89e-1)" "unprognostic (1.77e-1)" "unprognostic (9.44e-2)" 0.8 0.8 2.0 17.9 1.4 6.0 0.5 1.3 1.6 0.2 0.6 1.3 1.2 0.3 0.3 1.5 0.4 1.0 0.4 1.9 1.6 0.8 0.3 1.0 39.3 3.5 2.8 1.2 0.1 0.1 0.1 0.2 0.3 2.5 0.5 1.1 0.4 1.7 0.1 2.3 3.3 34.0 0.1 2.8 58.6 2.5 0.7 1.8 3.4 1.1 0.5 55.0 1.8 0.5 1.9 0.3 0.2 1.1 2.3 0.0 0.0 0.4 0.2 0.1 0.2 0.8 0.9 0.5 1.9 0.4 0.2 0.2 0.4 0.7 0.0 0.3 0.4 2.3 0.2 0.4 0.2 0.1 1.7 0.4 0.1 0.0 0.4 0.1 0.1 0.0 0.7 0.4 1.9 0.2 0.7 1.6 1.8 0.7 0.1 0.1 21.0 2.4 1.6 0.0 0.2 1.3 0.3 0.1 0.4 0.3 0.2 0.4 2.2 0.2 0.5 2.5 0.9 0.3 2.0 1.1 10.9 0.1 1.8 0.5 0.7 0.1 0.2 0.2 0.2 0.3 22.5 0.3 0.2 0.1 29.1 0.4 0.4 0.3 0.3 0.3 0.4 0.2 1.1 2.0 1.4 1.3 1.6 1.9 1.6 3.5 2.8 1.2 2.5 2.8 1.8 1.9 0.1 0.0 1.1 0.0 194.5 0.1 0.4 0.0 1.2 1.0 1.6 1.3 1.4 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 0.1 2.6 0.5 0.3 1.2 0.4 0.0 0.0 0.2 0.7 0.5 4.3 0.0 1.5 0.0 0.2 0.1 8.4 0.1 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.0 6.5 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 18.0 0.3 0.1 0.2 0.0 0.4 0.0 0.5 0.4 1.5 1.4 0.3 0.0 0.1 3.4 0.2 0.4 0.2 OR3A3 "OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P" ENSG00000159961 "Olfactory receptor family 3 subfamily A member 3" P47888 17 3411370-3424070 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "dendritic cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 24 "plasmacytoid DC: 7.9" "Lineage enriched" "Detected in single" 24 "dendritic cells: 7.9" "Not detected" "Not detected" NA NA "unprognostic (2.01e-1)" 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 7.9 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 ARHGAP35 "GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP" ENSG00000160007 "Rho GTPase activating protein 35" Q9NRY4 19 46860997-47005077 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, GTPase activation, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 186.4;Late spermatids: 651.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037311, HPA055184, HPA056470" Approved Supported "Nuclear bodies,Aggresome" NA NA "Nuclear bodies" Aggresome "CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142" "unprognostic (5.47e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (2.40e-2)" "unprognostic (2.01e-2)" "unprognostic (7.78e-3)" "unprognostic (9.82e-3)" "unprognostic (4.41e-2)" "unprognostic (2.71e-1)" "unprognostic (2.73e-2)" "unprognostic (3.25e-2)" "unprognostic (1.92e-1)" "prognostic favorable (5.55e-8)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" 13.7 10.2 35.0 8.1 31.1 5.4 16.2 16.7 31.0 13.0 8.5 14.2 13.0 12.9 10.7 15.9 12.9 9.2 26.0 36.3 27.5 19.3 22.5 15.1 8.7 25.1 31.3 29.5 17.5 13.7 31.6 14.3 7.9 29.4 13.5 12.4 16.8 15.8 15.9 29.7 11.7 16.4 13.0 18.8 8.9 11.0 40.6 30.3 10.9 20.4 24.4 9.1 13.2 9.1 25.0 52.0 56.7 37.9 34.0 33.9 27.9 6.4 27.3 38.7 27.1 31.0 30.6 18.0 27.4 19.1 112.0 41.2 30.8 34.8 35.3 36.9 19.3 14.7 37.2 40.1 24.1 31.7 22.3 30.4 28.3 35.1 30.6 32.5 37.9 24.7 18.2 25.2 9.9 31.4 30.3 21.8 35.4 19.9 37.4 20.8 24.1 26.0 8.5 23.0 100.0 37.9 36.1 50.5 47.5 20.0 23.4 44.6 27.1 31.3 23.9 18.9 26.2 33.0 10.1 19.6 21.7 53.6 22.8 59.7 0.3 0.2 0.2 0.6 0.2 0.6 0.1 0.6 0.7 0.3 0.2 0.2 0.2 0.1 0.2 0.3 0.3 0.2 0.3 35.0 31.1 16.7 31.0 36.3 27.5 25.1 31.3 29.5 29.4 18.8 30.3 25.0 15.7 44.8 38.4 47.7 8.6 15.2 13.9 20.1 19.4 31.9 35.2 23.0 58.2 27.1 21.4 25.8 25.0 3.7 14.8 61.0 7.9 14.6 186.4 17.8 19.0 19.5 31.2 16.6 42.4 20.0 1.0 19.1 19.9 34.1 9.5 30.9 27.8 89.7 15.0 69.0 48.8 18.5 14.2 19.5 7.8 651.3 23.3 11.0 21.4 32.8 14.2 28.2 18.6 37.2 58.2 20.9 21.4 25.6 6.7 23.3 44.5 22.6 10.4 22.0 19.7 22.6 24.9 45.9 23.5 24.4 16.6 1.6 16.1 29.5 25.7 17.0 PTGIR IP ENSG00000160013 "Prostaglandin I2 receptor" P43119 19 46620468-46625089 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 56.0" "Group enriched" "Detected in some" 5 "Langerhans cells: 177.2;monocytes: 160.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "classical monocyte: 28.2;intermediate monocyte: 65.3;myeloid DC: 20.9;non-classical monocyte: 38.7" "Group enriched" "Detected in many" 11 "dendritic cells: 20.9;monocytes: 65.3" "Cell line enhanced" "Detected in some" "BJ: 10.8;BJ hTERT+: 12.2;fHDF/TERT166: 15.4;HDLM-2: 7.6;HEL: 28.3;HHSteC: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (3.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (3.49e-3)" "unprognostic (4.22e-2)" "unprognostic (6.09e-2)" "unprognostic (2.12e-1)" "unprognostic (7.45e-2)" "unprognostic (4.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.09e-8)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.16e-1)" "unprognostic (5.66e-2)" 10.7 6.8 0.5 6.0 0.4 3.4 5.2 0.3 0.9 5.0 0.6 4.8 2.0 4.6 0.3 2.1 4.6 2.9 21.3 0.6 0.4 14.3 9.2 56.0 3.6 0.6 0.5 0.4 2.4 5.8 0.6 1.9 4.5 0.5 2.6 1.0 0.0 4.1 0.9 2.9 4.3 5.9 2.9 0.5 10.9 6.7 0.3 0.4 1.6 16.7 0.8 2.6 6.0 5.2 0.4 0.0 0.0 0.0 0.0 0.2 5.5 0.0 10.8 12.2 1.5 4.3 0.0 0.0 0.0 0.9 15.4 0.1 0.0 0.0 0.0 0.9 7.6 0.0 28.3 0.0 0.0 7.2 0.0 0.0 1.7 0.0 3.9 0.2 0.0 3.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.7 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.7 0.7 0.0 28.2 0.0 0.0 65.3 0.4 1.5 0.3 0.0 20.9 0.7 3.3 0.1 1.1 0.0 38.7 2.0 3.9 17.6 0.5 0.4 0.3 0.9 0.6 0.4 0.6 0.5 0.4 0.5 0.5 0.4 0.4 1.5 0.0 0.6 0.3 3.7 4.2 0.8 0.4 0.0 0.4 0.2 0.5 0.9 0.0 0.1 1.8 0.0 0.1 2.7 0.2 0.0 0.3 0.2 0.1 1.5 2.3 0.0 0.4 0.7 0.4 0.1 10.3 0.5 0.1 3.8 0.1 4.2 0.2 2.6 0.0 0.6 0.0 0.0 7.9 177.2 0.0 2.1 23.7 7.2 0.0 160.9 0.1 1.0 0.5 0.3 0.4 0.0 0.0 0.1 0.8 0.0 0.2 0.7 0.8 6.6 1.1 30.9 0.1 0.4 0.0 4.4 0.3 2.0 0.1 0.0 0.7 CALM3 PHKD ENSG00000160014 "Calmodulin 3" P0DP25 19 46601074-46610782 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 854.0" "Cell type enhanced" "Detected in all" "Early spermatids: 1863.5;Late spermatids: 2674.8;Spermatocytes: 875.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044999 Approved NA NA "HPA044999: AB_2679177" "unprognostic (3.39e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" "unprognostic (9.81e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.01e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-1)" "unprognostic (1.07e-1)" "prognostic favorable (9.10e-4)" "unprognostic (2.72e-1)" 136.6 188.4 207.3 155.3 419.1 196.1 114.2 27.1 854.0 180.8 0.0 180.4 205.4 176.8 98.4 119.4 150.1 137.1 269.6 525.3 309.8 176.9 138.3 126.8 180.8 234.8 105.4 462.7 190.7 117.3 111.2 139.7 134.4 322.9 144.8 159.7 153.3 73.7 159.2 343.3 86.3 230.8 168.3 12.9 123.1 144.6 472.6 235.9 273.3 119.2 255.2 173.6 174.7 152.0 516.2 392.6 437.1 493.9 174.6 256.1 338.9 119.5 405.8 333.6 358.0 473.1 374.8 342.5 322.3 185.2 599.0 249.7 297.6 496.9 322.0 453.5 498.0 387.6 433.7 201.8 404.5 139.0 324.5 596.5 334.6 106.9 281.1 218.3 274.2 450.6 353.4 335.7 447.0 345.3 250.1 354.3 818.1 251.6 575.7 192.3 644.7 254.5 121.9 341.4 463.3 253.6 279.7 304.6 194.1 123.7 484.3 227.9 364.7 329.2 197.6 366.2 150.5 298.5 370.2 280.6 262.1 197.9 279.5 255.7 190.6 158.2 262.4 67.2 193.9 61.0 74.7 95.5 90.0 93.5 68.6 112.0 71.6 433.7 103.6 194.3 55.1 195.6 150.7 207.3 419.1 27.1 854.0 525.3 309.8 234.8 105.4 462.7 322.9 12.9 235.9 516.2 77.6 41.7 56.8 23.8 101.8 57.2 82.8 82.0 32.5 136.2 82.4 86.1 177.5 87.2 59.9 69.9 12.5 202.9 120.0 301.1 260.3 265.0 1863.5 101.6 76.4 88.7 122.4 318.4 114.1 221.5 545.1 112.3 89.2 82.4 106.0 130.6 125.7 106.4 760.3 89.2 89.4 178.2 59.0 307.8 112.7 2674.8 106.9 349.8 92.5 32.8 525.0 184.2 225.6 23.1 30.2 205.1 273.5 122.6 143.3 67.6 457.2 365.6 85.4 88.2 92.1 47.8 130.9 875.3 157.4 64.6 65.9 184.8 161.1 192.7 208.8 111.9 DFFA "DFF-45, DFF1, DFF45, ICAD" ENSG00000160049 "DNA fragmentation factor subunit alpha" O00273 1 10456522-10472529 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002679, HPA018859, HPA019938, HPA025230" Supported Supported "Plasma membrane,Cytosol" NA NA 8700 "Plasma membrane, Cytosol" "CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623" "unprognostic (1.23e-1)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" "unprognostic (3.59e-2)" "unprognostic (1.57e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.55e-1)" "unprognostic (9.24e-3)" "unprognostic (3.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.21e-2)" "unprognostic (3.46e-2)" "unprognostic (3.89e-2)" "unprognostic (1.88e-1)" 13.4 12.7 17.7 12.1 17.7 6.6 12.8 19.8 16.7 11.1 13.8 10.8 12.3 11.8 9.9 16.8 13.1 10.9 12.2 15.9 17.0 17.0 13.3 11.4 12.5 18.4 18.7 13.3 15.5 11.5 18.1 9.3 20.2 19.1 11.9 12.3 12.3 11.0 12.5 12.4 10.9 11.2 16.2 16.6 10.8 12.3 9.9 18.5 13.5 12.4 14.0 16.3 14.5 10.2 20.9 37.8 36.8 31.0 35.4 25.7 24.3 15.1 52.5 33.6 53.4 39.6 88.4 48.4 79.9 33.1 44.5 29.7 30.3 60.5 62.2 53.7 31.9 41.8 39.9 37.6 35.8 41.8 49.3 25.4 30.5 30.6 84.4 67.4 29.1 41.3 39.3 72.6 17.6 38.4 48.0 48.8 22.2 27.2 28.3 42.4 41.3 37.1 40.1 48.5 28.6 36.5 35.6 48.9 42.1 58.0 26.6 27.0 17.0 43.4 24.9 34.0 46.4 35.0 21.6 32.5 114.3 26.5 45.7 38.5 1.8 11.2 8.6 15.2 9.1 11.7 16.6 10.3 13.5 10.6 15.8 10.7 13.0 1.4 17.5 12.3 12.4 16.2 10.5 17.7 17.7 19.8 16.7 15.9 17.0 18.4 18.7 13.3 19.1 16.6 18.5 20.9 26.9 44.8 34.3 3.3 23.5 34.4 39.0 43.8 30.1 21.1 20.5 25.0 23.7 32.9 36.6 18.4 108.4 91.1 22.8 12.6 37.2 46.5 32.0 22.4 31.6 34.0 34.2 15.6 6.5 39.1 64.9 25.1 20.9 23.8 24.7 35.6 31.4 31.0 41.8 20.2 8.3 17.3 28.5 22.9 13.8 73.2 30.1 17.0 10.6 3.7 37.4 23.3 28.8 5.0 6.9 49.1 10.6 32.4 19.3 48.1 25.0 57.8 26.0 34.0 19.7 29.9 26.9 35.7 28.4 32.0 40.6 66.4 18.5 43.9 27.9 38.9 CCDC28B "MGC1203, RP4-622L5.5" ENSG00000160050 "Coiled-coil domain containing 28B" Q9BUN5 1 32200595-32205453 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 227.5;tongue: 75.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 90.1;monocytes: 65.5;NK-cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 124.9" "Low region specificity" "Detected in all" HPA028589 Uncertain NA NA "HPA028589: AB_10602175" "prognostic favorable (2.92e-4)" "unprognostic (6.01e-3)" "unprognostic (1.04e-1)" "unprognostic (2.61e-2)" "unprognostic (2.59e-3)" "unprognostic (5.18e-2)" "unprognostic (7.50e-3)" "unprognostic (7.87e-2)" "unprognostic (5.15e-2)" "unprognostic (1.79e-2)" "prognostic favorable (1.10e-5)" "unprognostic (2.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.44e-2)" "unprognostic (1.67e-1)" "unprognostic (7.83e-2)" "unprognostic (1.07e-2)" 3.4 14.1 12.7 7.2 11.3 6.8 3.3 13.0 18.9 6.3 10.3 6.1 1.7 5.4 1.7 5.6 5.6 4.9 21.0 11.5 11.6 6.6 2.4 3.9 14.2 11.1 11.7 11.0 6.0 5.6 19.4 21.3 5.0 10.7 5.4 2.5 5.2 3.7 4.1 227.5 2.7 4.3 6.2 11.1 5.5 3.9 21.0 14.8 12.5 6.3 75.6 9.5 5.0 4.4 11.6 10.6 4.5 20.8 22.7 6.8 8.5 1.2 8.2 11.9 13.2 9.3 9.0 13.2 23.3 14.2 9.3 1.7 0.5 18.7 9.2 2.6 27.0 25.5 29.9 20.7 4.1 10.1 0.2 13.7 10.5 3.5 15.5 0.2 9.2 19.3 40.5 20.5 0.5 9.6 1.3 43.2 8.7 29.4 2.8 5.8 46.5 10.4 19.2 12.2 0.0 45.6 22.9 11.9 3.2 16.3 12.0 12.0 11.5 11.4 7.1 9.5 8.7 7.6 2.1 1.6 0.9 11.7 43.9 10.3 9.7 13.7 3.0 36.3 6.9 17.6 22.0 19.4 34.3 30.6 31.5 28.4 29.3 1.9 46.7 2.1 37.1 26.9 21.8 12.7 11.3 13.0 18.9 11.5 11.6 11.1 11.7 11.0 10.7 11.1 14.8 11.6 10.5 0.0 6.1 3.9 11.1 9.1 4.4 17.9 5.7 33.3 9.6 12.7 16.1 11.5 5.3 12.9 22.9 1.9 25.8 1.6 35.2 17.5 13.8 8.1 18.1 15.2 90.1 30.7 3.1 7.6 4.0 19.0 5.6 5.1 3.8 8.0 12.1 0.6 11.7 23.5 3.9 5.7 54.9 4.2 39.2 32.8 20.2 5.7 17.8 0.0 65.5 23.9 106.1 5.5 1.7 7.8 1.7 17.0 1.8 3.4 0.3 4.9 4.2 45.9 0.0 12.5 18.0 3.9 13.3 3.5 7.7 2.2 15.3 48.1 3.4 2.6 IQCC FLJ10547 ENSG00000160051 "IQ motif containing C" Q4KMZ1 1 32205671-32208682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 22.2;Spermatogonia: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028602, HPA028686" Approved Approved Vesicles NA NA Vesicles "HPA028602: AB_10600298, HPA028686: AB_10601985" "unprognostic (1.45e-3)" "unprognostic (4.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (2.56e-1)" "unprognostic (4.00e-3)" "unprognostic (7.81e-6)" "prognostic favorable (5.65e-4)" "unprognostic (4.97e-2)" "unprognostic (2.97e-2)" "prognostic favorable (8.23e-5)" "unprognostic (2.00e-1)" "unprognostic (3.28e-1)" "unprognostic (3.12e-3)" "prognostic favorable (3.79e-4)" "unprognostic (4.22e-2)" "unprognostic (1.66e-1)" 0.9 1.8 2.7 1.0 2.6 2.1 2.2 3.5 3.1 1.5 4.6 1.5 0.9 1.5 4.4 1.2 3.5 1.4 1.2 2.7 2.4 1.8 0.8 1.1 1.7 2.0 2.1 2.5 2.1 2.5 2.9 3.7 1.1 2.4 1.6 1.5 2.8 1.8 1.7 1.6 2.1 1.2 1.2 2.1 1.3 1.9 8.9 2.1 2.1 3.4 1.3 1.7 1.2 1.3 2.5 6.6 2.3 5.1 4.8 0.9 1.9 3.3 3.7 4.2 7.8 7.2 5.3 5.7 2.3 3.9 1.1 1.3 5.5 5.4 3.3 6.5 3.2 5.6 4.2 5.2 2.3 1.2 4.5 2.7 1.3 3.5 6.9 3.1 2.9 1.6 8.9 7.6 0.5 3.5 4.6 7.7 4.7 3.3 3.6 4.9 10.4 3.1 5.5 2.9 2.3 7.3 2.9 7.4 4.2 4.1 4.7 5.1 4.5 2.2 2.8 5.1 4.1 6.2 2.9 2.1 2.1 3.9 4.2 5.9 0.8 0.3 0.1 1.1 0.4 1.0 2.3 1.2 0.9 0.7 0.8 1.3 0.7 1.1 1.6 0.4 1.0 1.6 0.5 2.7 2.6 3.5 3.1 2.7 2.4 2.0 2.1 2.5 2.4 2.1 2.1 2.5 1.7 0.0 2.3 2.0 0.7 0.3 1.0 0.9 1.2 5.4 2.9 1.9 1.6 7.2 0.4 3.7 6.2 1.9 2.1 2.3 3.9 1.8 1.7 8.5 2.0 1.6 3.0 7.0 2.0 1.4 1.6 2.0 1.5 2.1 1.3 2.1 0.0 0.4 0.9 6.7 1.9 4.8 0.0 0.0 1.1 1.8 1.2 0.7 0.0 0.0 1.2 2.6 1.0 0.5 1.3 1.1 1.8 2.6 0.6 0.6 0.9 0.6 3.6 8.6 0.0 2.4 1.7 22.2 11.6 1.1 0.9 1.0 1.3 1.8 2.0 0.3 TMEM234 "C1orf91, dJ622L5.7, FLJ90779, RP4-622L5" ENSG00000160055 "Transmembrane protein 234" Q8WY98 1 32214472-32222359 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA015049 Uncertain Approved Vesicles NA NA Vesicles "HPA015049: AB_1856409" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.44e-3)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.67e-1)" "unprognostic (1.07e-2)" "unprognostic (6.49e-2)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.12e-5)" "unprognostic (1.95e-1)" "unprognostic (2.44e-1)" "unprognostic (7.92e-2)" "unprognostic (2.37e-2)" 6.0 7.5 5.7 2.6 5.4 2.8 6.9 4.6 6.4 7.8 6.5 6.3 2.3 7.6 9.4 9.1 7.3 3.4 9.2 5.3 6.5 9.5 6.3 6.4 3.5 5.3 5.5 5.3 10.0 5.9 6.9 12.4 6.0 5.3 8.6 4.1 6.1 7.2 7.0 3.0 4.5 5.3 4.4 5.1 7.5 5.6 9.0 5.1 3.1 12.4 1.7 3.5 6.7 7.7 5.9 10.0 7.5 4.2 4.4 12.0 9.4 4.4 14.6 10.5 7.3 5.5 5.4 9.8 3.1 16.1 13.5 5.7 8.0 5.4 10.5 6.2 6.4 5.9 6.1 11.9 6.2 8.7 7.4 4.0 11.9 10.5 7.6 5.5 12.8 10.7 3.3 5.9 1.9 12.4 3.0 2.9 6.2 7.6 2.5 5.7 4.0 3.3 3.6 16.3 5.1 5.3 5.4 10.6 5.7 5.0 13.6 2.8 2.3 12.9 2.6 4.1 10.3 10.6 3.1 1.8 1.3 8.0 2.6 9.8 25.9 11.9 19.1 5.8 13.3 9.3 6.9 4.6 6.6 11.4 6.9 3.3 4.2 35.8 10.8 9.3 8.6 3.1 6.7 5.7 5.4 4.6 6.4 5.3 6.5 5.3 5.5 5.3 5.3 5.1 5.1 5.9 7.5 9.6 1.5 10.4 8.3 2.7 6.6 14.5 5.2 5.3 9.0 9.1 3.6 4.3 11.4 23.9 2.1 26.0 5.0 17.4 1.9 20.9 27.8 17.9 9.1 7.5 6.0 7.4 10.8 15.5 23.0 9.1 16.3 10.0 3.8 10.8 6.4 5.6 19.3 1.7 7.8 11.8 10.2 8.3 3.2 55.6 9.3 8.2 14.2 8.4 11.4 8.6 9.2 3.5 2.8 18.4 12.2 7.9 5.1 5.6 12.5 11.0 23.7 13.5 6.6 5.7 9.2 31.8 15.0 5.9 3.1 21.3 6.9 15.2 9.9 8.0 BSDC1 "FLJ10276, RP4-811H24.7" ENSG00000160058 "BSD domain containing 1" Q9NW68 1 32364633-32394731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 37.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031358, HPA031360" Approved Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA031358: AB_2673841, HPA031360: AB_10601120" "unprognostic (1.42e-1)" "unprognostic (8.97e-2)" "unprognostic (2.91e-2)" "unprognostic (3.86e-2)" "unprognostic (2.48e-1)" "prognostic favorable (8.82e-5)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.56e-3)" "unprognostic (5.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.92e-3)" "unprognostic (2.68e-1)" "unprognostic (2.37e-1)" "unprognostic (2.07e-1)" 36.8 63.6 28.3 17.5 29.5 77.8 38.1 32.5 30.8 38.4 27.0 36.0 25.6 35.6 25.1 37.0 35.6 23.5 34.8 30.8 28.1 38.6 73.8 34.0 22.6 33.3 28.8 29.8 55.0 56.5 42.7 46.9 22.3 30.0 41.3 22.7 21.8 45.4 24.5 37.0 47.0 35.1 20.9 29.2 36.1 41.3 51.7 28.9 19.7 38.2 16.4 22.0 33.5 36.9 36.6 24.3 16.2 32.8 25.2 38.6 29.6 25.6 23.0 43.9 39.8 41.0 18.1 19.9 17.8 27.0 41.3 22.6 26.1 23.4 21.6 25.6 33.4 33.3 14.2 35.5 22.1 33.2 17.6 24.7 35.5 46.4 30.7 23.2 47.8 24.8 28.0 36.4 30.8 22.3 10.7 18.7 10.3 20.8 14.1 19.0 18.8 18.8 24.7 22.6 19.5 34.6 25.0 22.1 22.7 25.2 37.7 21.4 13.9 30.1 22.1 19.8 28.3 22.6 42.2 41.6 15.9 25.8 22.3 13.5 37.4 5.1 18.3 6.2 5.9 6.1 7.0 5.5 5.2 4.9 8.3 6.0 5.6 8.4 6.1 5.0 6.5 7.3 6.2 28.3 29.5 32.5 30.8 30.8 28.1 33.3 28.8 29.8 30.0 29.2 28.9 36.6 24.6 32.1 18.6 23.5 42.8 28.4 56.6 31.5 25.6 53.6 38.9 26.7 19.4 55.8 21.9 25.8 83.4 51.1 38.8 59.3 19.6 37.8 88.9 23.7 26.3 35.2 40.1 76.0 25.6 44.1 31.0 32.7 27.0 34.4 21.0 36.1 50.0 56.7 20.0 85.8 31.6 47.8 28.5 25.8 13.1 100.7 54.7 20.1 32.0 25.3 28.0 30.3 57.7 29.1 35.0 45.6 40.0 47.4 32.1 58.4 63.9 28.0 18.4 69.8 39.5 33.1 38.1 42.9 45.9 21.2 25.9 96.5 34.6 60.5 39.3 57.2 ZBTB8A "BOZF1, FLJ90065, ZBTB8, ZNF916A" ENSG00000160062 "Zinc finger and BTB domain containing 8A" Q96BR9 1 32539427-32605941 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031768, HPA031769, HPA031770" Approved Approved "Nuclear speckles,Focal adhesion sites" NA NA "Nuclear speckles, Focal adhesion sites" "HPA031768: AB_10610568, HPA031769: AB_2674036, HPA031770: AB_2674037" "unprognostic (1.71e-1)" "unprognostic (1.98e-1)" "unprognostic (1.01e-1)" "unprognostic (7.40e-2)" "unprognostic (7.21e-2)" "unprognostic (2.85e-2)" "unprognostic (9.45e-5)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (7.83e-3)" "unprognostic (4.23e-3)" "unprognostic (1.78e-1)" "unprognostic (8.10e-2)" "unprognostic (2.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.47e-1)" "unprognostic (3.15e-2)" 3.9 2.3 1.6 1.6 1.6 1.2 3.4 3.3 1.7 6.3 1.2 3.0 1.9 6.1 3.3 3.4 3.3 2.8 2.4 1.4 1.1 2.4 2.1 2.9 0.9 1.5 1.4 1.5 3.4 2.7 3.7 1.8 2.7 1.8 3.0 3.0 1.5 2.5 4.0 2.8 1.7 2.0 5.1 1.0 1.3 3.2 2.4 1.4 1.3 5.5 6.2 1.5 3.8 3.0 2.6 6.4 1.8 7.2 7.8 5.0 6.7 5.4 6.2 4.9 5.7 5.8 0.8 5.0 5.3 4.2 6.7 2.5 4.9 7.2 5.0 5.0 1.4 4.8 0.2 5.7 2.7 6.5 1.2 0.3 4.5 7.0 4.2 11.0 5.7 6.5 4.5 1.0 3.6 5.8 6.5 3.5 0.6 6.5 3.1 2.5 6.3 10.4 4.1 3.5 6.4 6.0 5.5 8.8 4.3 8.4 3.8 5.7 2.9 6.8 7.6 6.2 10.5 4.6 6.5 3.3 3.9 5.2 1.3 3.2 1.5 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.2 0.3 0.1 0.2 1.0 0.7 0.2 0.5 0.1 0.1 1.6 1.6 3.3 1.7 1.4 1.1 1.5 1.4 1.5 1.8 1.0 1.4 2.6 17.0 16.0 13.8 5.9 1.4 4.1 7.8 8.0 5.2 11.7 7.4 5.8 4.1 4.3 5.8 7.3 22.9 3.5 3.8 6.5 1.9 6.9 5.9 7.5 30.0 20.1 4.9 6.1 9.4 5.1 6.7 14.5 9.7 11.8 2.5 11.2 30.4 5.2 1.6 6.7 7.8 5.4 2.0 4.1 7.4 7.2 19.9 2.3 3.6 15.9 1.8 4.0 0.0 21.6 20.6 6.0 4.7 35.3 3.2 10.7 3.3 3.0 3.6 10.8 32.9 23.3 12.9 2.0 6.4 3.8 3.8 1.5 2.3 4.1 8.8 6.4 ATAD3B "KIAA1273, TOB3" ENSG00000160072 "ATPase family AAA domain containing 3B" Q5T9A4 1 1471765-1497848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA058968, HPA064867, HPA065305" Approved Enhanced Mitochondria NA NA Mitochondria "HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459" "unprognostic (6.05e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (1.30e-1)" "unprognostic (1.97e-2)" "unprognostic (3.68e-1)" "prognostic unfavorable (1.81e-5)" "unprognostic (1.51e-1)" "unprognostic (2.27e-2)" "unprognostic (2.17e-2)" "unprognostic (8.24e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (5.48e-9)" "unprognostic (2.38e-2)" "unprognostic (2.80e-1)" "unprognostic (3.00e-2)" "unprognostic (1.68e-1)" 8.1 10.1 4.6 3.7 4.7 5.0 8.6 4.4 9.7 9.8 4.7 8.7 2.5 7.3 0.0 12.5 9.1 0.7 7.5 4.6 4.6 10.5 15.8 8.6 3.5 4.9 4.5 4.6 10.3 9.8 0.4 13.7 1.3 4.9 11.8 0.3 0.1 7.6 0.7 6.3 10.5 9.3 0.5 4.2 14.2 8.7 10.9 4.9 2.3 9.6 0.2 0.7 10.0 8.7 5.1 13.4 0.1 3.2 21.9 1.3 1.4 29.0 20.7 4.8 20.7 15.7 47.8 38.6 16.9 6.7 7.9 13.4 21.8 28.1 13.6 4.7 16.3 29.0 12.2 32.9 31.9 5.3 20.4 14.3 4.7 0.7 35.9 1.5 0.0 7.6 7.1 37.2 3.2 8.1 5.4 26.3 28.7 44.1 9.8 51.7 21.5 6.3 12.0 6.2 7.7 15.6 13.2 14.0 18.7 20.2 2.4 2.4 7.5 7.5 4.5 12.0 32.4 23.0 12.2 18.5 45.7 17.7 35.1 5.8 0.2 0.2 0.4 0.4 1.1 0.5 0.1 0.3 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.1 4.6 4.7 4.4 9.7 4.6 4.6 4.9 4.5 4.6 4.9 4.2 4.9 5.1 8.6 6.4 22.1 17.6 9.4 26.3 7.8 5.2 10.2 16.0 9.3 7.1 5.9 8.6 7.5 9.2 20.9 15.3 12.9 17.8 1.9 7.7 3.6 10.1 7.8 8.2 7.2 7.6 13.3 7.9 40.3 8.7 23.9 10.2 11.4 16.7 4.2 7.6 12.4 13.5 12.9 13.8 6.1 4.7 12.3 3.8 4.4 7.9 10.6 8.4 5.4 5.8 1.0 4.5 8.3 11.3 9.7 3.0 22.8 14.4 6.7 2.6 8.3 17.1 6.6 8.3 10.2 5.4 10.6 11.1 23.4 17.8 9.9 15.0 20.6 10.8 SSU72 HSPC182 ENSG00000160075 "SSU72 homolog, RNA polymerase II CTD phosphatase" Q9NP77 1 1541673-1574863 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 700.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069290, HPA070604" Supported Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA069290: AB_2686108, HPA070604: AB_2686285" "unprognostic (3.33e-2)" "unprognostic (2.79e-2)" "unprognostic (6.37e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "unprognostic (9.84e-2)" "unprognostic (2.40e-3)" "unprognostic (2.43e-2)" "unprognostic (3.23e-1)" "unprognostic (3.23e-1)" "unprognostic (6.75e-2)" "unprognostic (1.36e-1)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "unprognostic (8.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.06e-1)" 94.8 77.9 102.2 64.6 106.3 61.5 95.7 101.6 120.6 78.1 109.1 95.4 75.8 81.1 89.1 124.3 81.4 53.2 119.3 104.4 110.1 106.4 123.4 88.7 74.9 105.4 106.0 101.5 82.6 116.0 63.9 100.6 52.5 107.0 87.5 63.3 52.6 101.5 54.1 248.7 99.1 91.6 54.3 105.9 106.7 96.9 59.3 112.4 65.7 108.7 137.5 68.3 84.4 88.0 111.4 204.6 127.6 90.2 140.3 152.1 145.4 92.2 172.8 134.1 147.6 152.5 120.8 229.7 205.4 92.1 137.0 143.7 155.0 147.4 142.5 142.8 172.8 173.9 129.3 110.7 193.8 171.5 165.6 108.4 130.7 117.8 158.4 149.8 123.2 140.1 122.6 227.9 154.1 118.6 181.4 190.8 264.5 158.5 198.9 191.5 149.5 145.5 289.8 163.7 61.8 166.1 114.0 117.1 296.3 535.3 152.0 154.6 142.0 107.8 140.8 89.2 160.9 150.7 186.5 241.2 258.1 148.0 260.1 69.9 143.4 93.0 188.6 80.0 98.9 99.3 120.7 105.9 95.9 100.2 117.7 127.6 105.1 204.1 75.3 91.7 62.9 161.5 101.0 102.2 106.3 101.6 120.6 104.4 110.1 105.4 106.0 101.5 107.0 105.9 112.4 111.4 107.5 28.9 72.7 14.7 130.6 186.2 138.9 100.0 108.1 95.9 169.6 173.7 92.4 151.5 69.2 101.2 20.9 208.6 129.9 171.2 291.6 76.3 283.0 107.8 77.6 91.5 142.0 78.8 23.3 106.6 239.4 84.4 89.7 101.0 61.5 90.6 98.6 132.7 141.1 112.7 23.8 165.8 83.4 178.4 130.0 700.2 104.7 123.3 167.2 15.9 144.8 152.3 193.6 25.6 20.1 91.9 206.7 85.7 132.5 199.6 242.8 325.8 59.0 73.4 59.2 77.6 136.6 97.1 157.4 155.9 220.4 245.3 128.1 86.2 172.1 153.2 UBE2J2 "NCUBE2, Ubc6p" ENSG00000160087 "Ubiquitin conjugating enzyme E2 J2" Q8N2K1 1 1253909-1273864 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Unfolded protein response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 261.9;Late spermatids: 452.3;Spermatocytes: 261.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (4.46e-2)" "unprognostic (1.67e-3)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (9.57e-2)" "unprognostic (1.28e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.09e-2)" "unprognostic (6.19e-2)" "unprognostic (1.87e-1)" "unprognostic (3.46e-2)" 30.6 36.6 23.7 24.8 21.7 23.0 30.0 24.8 26.5 30.0 20.6 35.8 23.4 34.2 12.3 44.4 33.1 16.7 34.0 23.0 20.8 35.2 46.2 30.3 25.8 22.9 21.6 20.1 29.8 36.0 20.3 35.5 20.0 23.6 32.4 16.1 15.0 31.1 15.2 51.3 39.5 35.0 19.5 23.0 45.0 37.5 106.0 22.5 24.1 29.7 21.5 22.9 30.8 29.6 25.6 70.0 30.3 40.4 39.6 31.9 32.1 31.6 50.8 44.3 73.0 53.5 54.3 50.2 37.4 52.6 50.4 40.0 49.6 42.6 55.0 57.5 64.5 68.8 58.2 64.3 47.9 62.9 56.1 50.6 31.1 30.1 58.1 42.2 39.6 53.3 52.1 80.0 38.7 43.2 38.1 82.4 63.8 45.3 47.3 67.7 74.3 40.8 63.8 37.9 25.3 140.9 73.9 38.5 80.4 89.8 36.9 42.9 62.2 36.5 44.8 40.9 53.0 56.2 79.2 88.9 114.3 58.9 83.5 36.8 83.4 36.5 69.3 33.7 37.0 31.3 37.1 35.4 35.3 36.1 32.5 32.7 32.5 54.0 39.7 38.7 34.5 42.4 29.5 23.7 21.7 24.8 26.5 23.0 20.8 22.9 21.6 20.1 23.6 23.0 22.5 25.6 32.8 9.6 17.3 18.9 34.0 42.7 51.7 71.4 23.9 31.3 28.5 29.5 18.9 32.9 40.8 29.5 8.4 71.7 53.3 44.0 56.7 70.9 261.9 25.3 28.5 34.3 17.5 45.6 12.8 93.2 71.5 34.5 33.1 25.3 16.5 32.6 31.8 30.3 52.1 23.5 14.3 35.6 54.9 31.1 41.2 452.3 37.6 31.7 40.9 12.2 44.3 33.2 70.0 8.5 16.4 105.4 33.8 37.6 50.9 76.6 54.4 73.2 23.4 29.9 32.9 29.8 40.1 261.0 100.6 38.3 43.8 87.3 35.7 40.6 40.7 61.8 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256492-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA059239: AB_2683955" "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 14.4 12.1 16.8 8.6 17.0 6.7 15.7 15.3 23.3 18.8 8.4 15.5 7.3 22.1 10.3 12.7 16.4 9.2 18.8 15.6 12.1 15.5 9.0 12.7 9.5 17.6 13.9 13.3 17.1 13.6 12.0 17.8 11.4 16.1 20.3 5.5 6.4 16.5 13.5 19.9 17.5 11.7 11.8 10.9 16.3 13.8 7.7 15.1 12.3 16.4 11.4 6.7 18.8 15.1 14.6 6.3 10.3 43.7 17.4 11.3 7.9 27.8 8.6 10.3 10.7 11.3 10.6 21.2 3.0 17.1 11.2 3.3 20.6 10.2 5.0 4.5 18.0 7.5 16.1 6.1 13.2 10.1 7.3 12.3 16.9 12.2 4.7 4.1 10.8 14.8 21.2 1.6 5.5 8.3 15.7 23.9 12.9 23.9 3.9 8.4 39.4 10.4 1.5 8.6 10.2 15.4 46.4 24.8 7.8 39.9 18.5 7.7 19.9 21.0 6.5 8.2 15.2 5.6 15.8 15.3 3.4 5.1 6.7 19.4 1.9 1.9 2.6 1.8 1.7 1.3 1.1 1.3 1.6 1.4 2.9 1.2 1.2 1.4 1.7 2.0 3.5 1.1 1.3 16.8 17.0 15.3 23.3 15.6 12.1 17.6 13.9 13.3 16.1 10.9 15.1 14.6 15.6 9.6 12.4 13.1 9.2 10.1 4.7 6.2 20.5 12.8 11.0 11.2 25.5 5.7 7.9 11.0 0.0 11.7 16.6 2.6 1.9 6.6 2.5 5.2 12.0 13.9 1.8 3.4 14.3 7.3 5.9 11.8 3.6 7.6 10.1 15.3 18.2 6.9 10.2 8.4 17.7 4.4 6.1 13.9 5.0 8.0 13.7 11.2 8.8 19.7 9.9 9.2 10.3 26.7 14.3 4.3 10.7 21.4 7.5 1.9 7.3 11.4 2.4 4.9 6.6 12.4 16.7 1.2 5.0 11.4 9.5 3.6 10.6 7.7 6.1 2.9 FNDC5 FRCP2 ENSG00000160097 "Fibronectin type III domain containing 5" Q8NAU1 1 32862268-32872482 "Predicted membrane proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 326.1;tongue: 482.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 71.3;Cardiomyocytes: 64.9;Early spermatids: 28.1;Granulosa cells: 38.6;Muller glia cells: 44.1" "Group enriched" "Detected in many" 7 "glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RH-30: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051290 Enhanced "Intracellular and membrane" NA NA "HPA051290: AB_2681422" "unprognostic (4.36e-2)" "unprognostic (9.08e-3)" "unprognostic (7.62e-4)" "unprognostic (1.03e-2)" "unprognostic (3.77e-2)" "unprognostic (6.26e-2)" "unprognostic (5.68e-2)" "unprognostic (2.76e-2)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-3)" "unprognostic (1.63e-1)" "unprognostic (9.07e-2)" "unprognostic (7.07e-3)" "unprognostic (1.13e-1)" "unprognostic (3.37e-3)" "unprognostic (1.33e-2)" 1.3 12.9 9.5 0.1 4.4 0.2 0.8 20.5 9.7 1.2 36.9 1.1 0.8 3.3 2.4 11.7 4.2 1.8 42.6 6.2 13.6 0.7 18.5 1.1 0.2 8.0 14.5 2.5 4.7 0.5 10.5 5.3 0.5 8.1 3.7 0.5 8.1 25.8 1.1 326.1 0.4 1.3 2.0 3.7 0.2 5.2 2.8 30.8 0.6 1.2 482.6 0.1 1.2 0.8 6.6 0.0 0.1 1.1 0.4 0.0 1.2 0.2 0.5 0.1 0.7 0.1 0.9 0.3 0.2 0.8 0.4 0.2 0.1 4.7 0.1 0.1 0.1 0.3 0.1 0.4 0.2 0.0 0.2 0.0 1.8 0.0 0.3 0.0 0.6 0.0 0.2 0.9 0.1 0.8 0.1 0.1 0.1 1.4 0.0 0.1 0.6 48.2 0.3 0.0 0.1 6.9 1.1 0.5 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.8 2.2 0.4 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.4 20.5 9.7 6.2 13.6 8.0 14.5 2.5 8.1 3.7 30.8 6.6 1.1 0.0 0.0 7.5 0.0 0.1 0.2 0.0 0.0 71.3 0.6 0.5 64.9 0.0 0.0 1.8 4.2 0.0 0.0 0.0 1.9 0.0 28.1 0.3 4.6 1.4 0.0 0.0 10.3 0.0 0.0 14.5 0.0 0.5 0.0 38.6 0.7 2.0 0.9 0.0 15.8 0.1 0.0 0.0 0.5 5.9 5.3 0.8 0.0 5.6 0.0 44.1 0.0 3.0 0.7 0.1 0.0 5.7 0.0 0.2 0.1 0.2 0.0 7.4 0.0 12.9 1.7 0.5 1.0 0.0 0.0 0.3 0.2 0.5 0.5 0.1 CPAMD8 "K-CAP, KIAA1283, VIP" ENSG00000160111 "C3 and PZP like alpha-2-macroglobulin domain containing 8" Q8IZJ3 19 16892951-17026815 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3;prostate: 34.4;seminal vesicle: 36.4" "Cell type enhanced" "Detected in many" "Adipocytes: 19.5;Alveolar cells type 1: 22.4;Alveolar cells type 2: 29.8;Collecting duct cells: 27.6;Leydig cells: 31.4;Prostatic glandular cells: 19.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 19.5;EFO-21: 12.6;T-47d: 34.4" "Region enriched" "Detected in single" 8 "spinal cord: 5.6" "HPA031327, HPA031328, HPA031329, HPA031330" Uncertain Uncertain "Focal adhesion sites" "Secreted to blood" NA NA 2700000 "Focal adhesion sites" "HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788" "unprognostic (4.71e-3)" "unprognostic (1.07e-2)" "unprognostic (4.20e-2)" "unprognostic (2.76e-2)" "unprognostic (4.32e-2)" "unprognostic (4.06e-3)" "unprognostic (7.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-2)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" "unprognostic (8.69e-2)" "unprognostic (1.01e-3)" "unprognostic (2.08e-1)" "unprognostic (8.45e-2)" "unprognostic (1.80e-2)" 5.8 2.5 6.7 0.5 13.9 0.5 6.2 41.3 3.9 6.6 6.5 1.0 0.3 2.2 10.5 0.5 1.8 0.3 14.7 2.3 5.6 16.1 0.8 15.2 0.2 20.2 18.9 0.7 1.6 0.4 3.3 4.1 4.2 21.2 34.4 0.1 0.5 2.8 36.4 2.8 1.5 1.2 0.4 25.7 1.7 0.8 2.3 13.4 1.3 21.2 3.0 0.3 1.6 3.1 36.3 0.0 0.0 0.8 0.0 0.0 0.0 19.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 12.6 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 3.2 0.7 0.0 0.0 1.9 0.0 0.1 0.5 2.8 0.1 0.0 0.0 0.6 0.0 0.1 34.4 0.2 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 13.9 41.3 3.9 2.3 5.6 20.2 18.9 0.7 21.2 25.7 13.4 36.3 19.5 22.4 29.8 3.6 0.5 0.9 10.1 5.8 1.2 2.3 7.5 9.0 6.1 1.5 10.7 27.6 0.0 9.1 0.4 1.0 0.0 0.9 1.8 3.1 3.2 15.1 0.0 0.0 0.8 0.0 6.1 2.8 2.0 6.1 2.5 1.8 11.7 0.3 3.1 0.0 0.8 0.7 0.0 6.3 1.4 4.3 31.4 5.8 0.0 1.9 3.3 0.1 2.1 1.5 1.0 1.2 1.4 6.4 3.4 19.3 0.0 0.1 4.7 0.1 0.0 1.6 2.1 6.2 1.2 0.4 0.6 6.0 0.4 1.7 0.2 6.0 NR2F6 "EAR-2, EAR2, ERBAL2" ENSG00000160113 "Nuclear receptor subfamily 2 group F member 6" P10588 19 17231883-17245919 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 104.8" "Cell type enhanced" "Detected in all" "Distal enterocytes: 206.0;Hepatocytes: 148.4;Horizontal cells: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 187.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079917 Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "CAB079917: AB_2635238" "unprognostic (1.48e-1)" "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.07e-1)" "unprognostic (3.67e-1)" "unprognostic (7.20e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (6.62e-2)" "unprognostic (9.68e-2)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (7.28e-3)" "unprognostic (1.37e-3)" 15.0 21.9 19.5 5.1 16.3 1.2 17.8 15.2 22.3 17.7 20.9 31.6 31.4 20.0 14.4 47.8 19.3 2.9 32.1 16.1 19.5 32.9 104.8 17.6 1.8 23.2 20.4 17.4 12.2 45.0 10.5 22.2 13.2 20.5 25.5 9.4 6.7 28.2 9.9 28.2 22.9 25.6 4.6 16.4 9.9 38.9 14.5 20.8 1.8 21.7 10.0 2.7 25.7 22.4 16.3 65.0 38.1 20.3 37.2 7.9 8.8 187.2 35.7 12.9 15.2 13.1 26.1 55.5 15.2 108.8 16.0 8.9 31.9 15.6 20.5 6.7 20.4 90.0 13.9 24.4 47.3 17.3 6.7 18.8 11.6 23.2 7.0 11.3 15.9 9.5 6.8 33.3 3.7 6.7 34.7 5.9 24.7 55.8 48.1 58.5 11.6 12.7 13.2 21.2 41.3 16.3 46.7 19.9 68.7 43.1 19.6 38.2 21.1 15.8 10.7 26.1 20.6 28.8 21.0 7.9 10.9 13.1 9.9 13.4 0.0 0.6 1.1 1.7 0.0 1.4 0.3 2.3 1.5 1.1 2.3 3.8 1.3 0.1 4.6 0.1 0.5 2.4 0.8 19.5 16.3 15.2 22.3 16.1 19.5 23.2 20.4 17.4 20.5 16.4 20.8 16.3 21.2 9.6 22.9 6.8 4.7 10.6 14.1 12.8 11.4 71.9 65.9 54.7 36.4 34.3 20.8 25.8 77.2 65.4 3.7 206.0 29.4 23.2 13.3 51.7 32.5 20.8 46.0 4.4 7.2 47.8 65.3 17.6 47.4 60.0 1.3 26.1 15.0 148.4 16.3 151.4 7.6 80.2 24.4 4.7 4.6 6.0 17.7 5.2 10.6 8.4 2.4 45.7 1.0 6.6 5.8 50.4 78.5 18.8 1.2 23.2 72.3 30.2 25.9 54.3 6.6 17.3 24.5 1.6 9.0 24.3 10.5 79.8 4.2 44.3 75.3 18.2 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.8;brain: 9.2" "Cell type enriched" "Detected in some" 10 "Erythroid cells: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 77.2;HL-60: 34.6;NB-4: 41.7;U-937: 57.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026789, HPA073498" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: AB_2686612" "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavorable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.7 0.9 5.0 2.3 3.2 25.8 0.6 9.2 6.2 0.6 0.6 0.5 0.9 1.0 1.3 0.7 0.6 0.7 1.0 3.7 1.7 0.4 0.6 0.8 4.1 2.4 1.4 3.9 1.5 1.7 0.4 0.5 1.2 4.1 0.7 0.5 3.7 1.5 0.6 0.3 2.4 0.8 0.8 0.4 2.2 0.8 1.5 2.4 1.3 0.9 0.5 3.1 0.7 0.5 4.3 0.9 0.8 3.7 1.7 0.4 0.6 3.2 1.1 0.3 0.6 0.6 17.1 1.5 77.2 0.7 0.5 0.6 1.5 28.4 0.4 0.6 22.3 3.4 29.1 13.1 0.6 0.3 34.6 12.5 0.3 1.0 2.7 0.2 0.9 0.6 6.4 4.2 9.2 0.4 0.9 24.2 41.7 10.2 0.3 2.6 17.3 1.0 8.7 0.4 1.7 1.2 7.1 6.8 0.9 0.7 1.5 0.6 20.1 1.4 1.0 1.2 1.4 1.0 1.3 0.9 27.8 0.7 57.2 1.3 0.9 0.9 0.6 0.5 1.9 0.3 1.6 0.4 0.5 1.1 0.9 0.5 0.4 1.5 0.3 1.4 0.9 0.4 0.6 5.0 3.2 9.2 6.2 3.7 1.7 2.4 1.4 3.9 4.1 0.4 2.4 4.3 0.4 0.0 0.5 0.7 1.1 0.8 0.8 0.3 0.0 1.9 0.5 0.6 0.8 0.0 0.1 0.0 0.0 1.6 0.4 0.4 0.0 0.2 0.3 0.2 0.4 0.4 0.0 70.7 1.4 0.2 0.7 0.6 0.0 0.8 1.3 1.1 0.0 0.1 0.8 0.0 1.6 0.5 0.0 0.9 1.3 0.0 1.8 1.1 0.0 1.0 3.0 0.5 1.0 1.0 1.6 0.3 0.1 1.5 0.9 0.5 0.0 0.1 0.9 1.5 6.6 0.6 0.4 0.5 1.0 0.0 0.4 0.4 0.5 0.3 0.3 0.2 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051965 Approved Approved Nucleoli,Mitochondria No No Mitochondria Nucleoli "HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favorable (7.29e-4)" 14.4 21.2 18.0 15.8 18.7 18.2 19.2 19.1 28.4 10.8 19.2 28.8 22.7 11.9 24.8 23.4 10.7 13.5 26.9 18.5 18.6 47.3 50.2 9.1 23.5 18.7 18.4 17.7 13.2 13.9 15.0 7.9 14.6 19.2 11.2 29.3 17.2 11.4 10.7 79.5 15.2 18.7 11.5 18.8 12.2 16.5 9.5 19.6 16.4 18.5 47.6 21.6 22.8 12.6 20.5 135.1 41.9 78.2 50.2 28.5 39.8 100.6 50.5 54.3 119.4 116.4 118.4 66.4 98.0 84.6 38.6 92.7 91.9 127.9 86.3 142.5 34.1 45.3 115.9 28.5 145.6 47.5 174.5 39.5 33.0 43.9 73.5 79.8 50.7 55.9 85.8 133.6 41.6 63.7 67.2 111.7 123.6 150.0 147.2 78.1 72.8 92.9 120.1 83.7 70.3 78.8 38.4 58.5 61.5 150.5 65.3 61.2 112.8 32.6 66.4 86.1 28.6 102.3 32.9 47.5 217.4 75.7 83.3 60.0 0.9 7.7 2.7 15.2 16.7 18.0 20.9 19.9 20.1 16.5 19.2 23.0 22.2 1.4 19.2 14.2 29.2 17.2 6.7 18.0 18.7 19.1 28.4 18.5 18.6 18.7 18.4 17.7 19.2 18.8 19.6 20.5 5.7 3.2 17.0 8.1 18.1 15.3 19.1 21.4 21.1 10.5 14.1 10.4 32.0 20.0 22.2 12.9 10.4 21.8 8.4 19.6 54.8 31.4 0.5 24.7 20.5 13.7 5.4 14.1 11.3 30.0 44.7 12.8 16.8 26.2 21.5 14.4 10.8 50.5 17.8 0.0 13.2 27.7 16.2 8.7 7.6 1.5 12.8 8.9 8.8 2.8 19.8 9.7 16.5 11.6 11.8 31.9 14.7 8.2 12.5 30.7 23.9 114.0 22.5 9.6 13.1 15.1 41.8 23.1 31.0 30.8 18.5 15.2 10.9 11.8 35.1 23.0 VMA21 "MEAX, XMEA" ENSG00000160131 "Vacuolar ATPase assembly factor VMA21" Q3ZAQ7 X 151396515-151409364 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010972 Uncertain NA NA "HPA010972: AB_1853034" "unprognostic (1.17e-1)" "prognostic favorable (2.30e-5)" "unprognostic (6.75e-2)" "unprognostic (9.78e-3)" "unprognostic (6.48e-2)" "unprognostic (4.68e-2)" "unprognostic (1.88e-3)" "unprognostic (4.36e-2)" "unprognostic (5.16e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-1)" "unprognostic (8.30e-2)" "unprognostic (7.88e-2)" "unprognostic (4.17e-2)" "unprognostic (3.21e-2)" "unprognostic (3.90e-2)" "unprognostic (2.76e-1)" 10.5 12.3 17.8 7.7 18.0 23.0 10.7 17.4 17.3 9.7 18.1 6.5 6.3 9.1 14.2 9.3 13.8 6.7 7.3 18.7 22.9 12.9 9.9 8.1 11.5 19.7 21.3 15.6 10.6 8.8 11.7 11.0 12.1 19.9 8.7 6.7 15.8 8.2 8.3 8.0 12.6 6.6 7.8 21.1 10.0 7.0 8.4 18.6 10.4 13.4 7.1 12.5 8.6 7.7 20.8 21.5 23.5 26.7 28.3 25.9 24.7 26.2 23.7 25.4 21.4 21.1 17.8 27.5 63.1 75.3 24.2 24.0 19.1 37.5 22.6 33.2 22.2 18.6 27.5 25.9 32.3 34.6 52.4 30.4 25.8 27.4 24.3 34.1 22.8 24.9 27.2 14.9 32.2 40.6 20.4 35.8 51.9 33.3 25.7 24.5 35.9 31.8 40.6 25.5 17.3 9.6 20.3 18.4 24.3 29.0 24.4 14.9 34.1 25.4 34.6 15.6 44.3 38.5 27.1 50.8 91.7 35.2 63.9 35.4 11.9 12.4 7.7 6.5 14.4 8.5 7.7 8.5 8.3 13.6 6.0 11.3 10.5 2.8 12.8 13.1 12.2 9.4 10.6 17.8 18.0 17.4 17.3 18.7 22.9 19.7 21.3 15.6 19.9 21.1 18.6 20.8 38.5 22.4 24.4 9.1 46.5 44.9 28.0 35.3 42.7 40.2 35.8 31.1 46.8 30.0 21.0 31.3 18.8 33.2 62.9 21.0 19.6 28.2 50.6 44.1 22.4 34.6 22.1 52.5 16.4 33.0 66.7 28.0 15.8 24.1 24.1 25.7 32.2 38.9 143.7 20.2 19.1 22.5 20.3 150.3 86.6 51.5 18.3 89.8 39.2 5.6 142.9 49.9 53.5 13.0 14.3 47.7 17.6 22.6 50.9 43.8 26.8 33.5 28.6 26.2 52.6 31.7 34.5 27.4 58.8 46.0 51.6 31.9 41.6 37.0 21.8 30.5 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2" "Group enriched" "Detected in many" 5 "Excitatory neurons: 1434.2;Inhibitory neurons: 480.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "T-reg: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 57.4;HEL: 35.3;OE19: 20.1;SH-SY5Y: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol NA NA 83000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 7.7 6.3 10.4 2.2 26.7 0.3 6.8 0.0 35.2 7.0 4.7 2.0 2.5 7.8 1.9 9.6 4.6 2.9 12.9 22.5 9.3 3.9 5.9 4.4 0.9 3.0 7.5 24.8 3.1 8.9 3.5 4.2 4.2 7.2 2.9 1.8 4.5 2.9 4.9 27.4 1.9 2.1 6.3 0.0 8.5 12.2 2.6 11.5 0.5 5.1 19.4 1.6 2.6 6.1 25.2 0.7 1.1 6.2 1.3 0.9 0.2 8.1 2.5 1.5 2.4 1.1 57.4 4.5 0.2 0.8 6.4 3.9 0.4 1.4 0.0 2.0 0.0 0.7 35.3 0.4 8.9 0.1 0.0 0.0 0.4 0.0 0.5 0.1 2.6 2.9 0.1 8.3 0.2 0.7 4.2 0.0 0.0 3.5 20.1 5.4 1.8 2.8 0.0 0.2 0.5 2.1 15.9 0.7 0.5 0.5 6.0 1.2 0.1 14.4 7.0 2.8 1.0 1.1 0.0 0.6 0.0 0.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 1.6 0.4 10.4 26.7 0.0 35.2 22.5 9.3 3.0 7.5 24.8 7.2 0.0 11.5 25.2 56.2 3.2 3.9 191.3 0.6 1.7 1.5 0.3 0.6 61.2 6.1 7.1 32.1 18.6 0.5 16.5 6.2 8.0 2.5 40.5 1.9 5.0 57.0 15.0 18.8 23.2 9.6 5.3 1434.2 8.4 1.7 5.9 29.0 7.4 3.8 4.4 45.3 21.7 1.0 0.0 480.8 16.4 0.0 1.6 1.1 64.0 3.7 5.3 3.6 48.7 0.0 4.7 8.2 162.3 63.1 4.4 21.0 33.1 0.3 2.6 34.8 3.6 8.4 2.7 19.7 8.8 21.8 5.2 2.6 4.9 1.1 14.2 1.0 17.5 12.3 1.6 CILP2 MGC45771 ENSG00000160161 "Cartilage intermediate layer protein 2" Q8IUL8 19 19538248-19546659 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.6" "Cell type enhanced" "Detected in some" "Early spermatids: 26.2;Late spermatids: 21.8;Sertoli cells: 6.6;Spermatocytes: 27.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.6;HEK 293: 2.8;NB-4: 2.2;THP-1: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "medulla oblongata: 2.7;spinal cord: 7.3" HPA041847 Uncertain "Secreted to extracellular matrix" NA NA 22000000 "HPA041847: AB_10795599" "unprognostic (6.51e-2)" "unprognostic (2.54e-2)" "unprognostic (5.42e-4)" "prognostic unfavorable (3.22e-6)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (4.31e-2)" "unprognostic (4.13e-3)" "unprognostic (4.48e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.09e-2)" "unprognostic (1.41e-2)" "unprognostic (0.00e+0)" "unprognostic (1.59e-2)" "unprognostic (3.19e-2)" "unprognostic (3.12e-3)" "unprognostic (1.36e-2)" 0.7 0.0 0.3 0.2 0.5 1.0 0.3 0.1 0.5 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.4 1.6 0.3 0.4 0.9 0.0 0.2 0.4 0.3 0.9 0.1 0.4 1.6 0.0 0.1 0.3 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.1 0.1 0.2 0.0 5.6 0.6 0.0 1.0 0.0 0.1 0.3 0.2 0.3 0.0 0.1 0.1 0.1 4.6 0.1 0.6 0.6 0.0 0.3 0.0 1.3 0.5 0.0 1.2 0.2 0.0 0.5 0.1 0.0 0.0 0.3 2.8 0.0 0.1 0.1 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.2 1.7 1.5 0.9 0.3 0.0 0.0 0.0 0.0 0.1 1.2 0.3 1.5 0.1 0.2 0.3 2.8 0.0 0.0 0.5 0.2 0.1 0.4 1.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.5 0.4 0.9 0.9 0.1 0.4 0.2 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.0 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 26.2 0.3 0.3 0.1 0.0 0.0 0.2 0.0 0.2 1.5 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.3 21.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.4 0.0 0.1 0.0 0.0 6.6 0.4 0.3 27.8 4.0 0.7 0.6 0.0 0.2 0.1 0.0 0.5 ABCG1 ABC8 ENSG00000160179 "ATP binding cassette subfamily G member 1" P45844 21 42199689-42297244 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 35.5;neutrophil: 36.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 36.6" "Cell line enhanced" "Detected in many" "hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031470, HPA031471" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA031470: AB_10599188, HPA031471: AB_10600201" "unprognostic (2.89e-2)" "unprognostic (2.53e-2)" "unprognostic (9.96e-2)" "unprognostic (4.20e-3)" "unprognostic (2.87e-1)" "unprognostic (3.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (3.66e-3)" "unprognostic (6.37e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.40e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.42e-2)" 17.3 38.0 16.7 12.2 24.2 8.2 15.3 13.3 16.3 8.2 17.6 14.3 17.7 4.9 3.9 4.2 6.3 13.9 8.9 14.3 17.6 7.9 6.4 29.6 18.3 13.2 18.0 13.7 6.4 5.3 24.6 10.7 13.8 22.7 6.2 15.2 29.4 16.3 7.0 19.8 14.9 22.2 4.0 10.3 31.5 16.1 1.1 18.9 19.1 8.6 6.3 12.2 13.0 5.0 22.0 0.0 6.0 4.6 2.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 3.1 1.9 0.8 0.0 0.7 0.9 0.0 8.8 0.0 8.5 0.5 10.2 19.2 0.0 17.4 0.0 0.4 2.0 25.5 0.1 3.9 0.0 18.2 38.4 0.0 0.1 0.0 33.2 31.5 0.2 1.4 54.9 10.3 0.4 0.0 25.8 0.0 2.8 22.3 5.8 3.7 13.5 0.0 0.4 5.7 0.9 11.8 0.0 4.7 0.1 0.0 13.1 4.2 0.0 0.1 3.3 0.5 1.7 1.7 35.5 3.0 0.5 5.6 5.5 6.1 6.0 1.1 7.0 5.8 5.0 36.6 7.4 0.3 2.5 7.4 2.1 16.7 24.2 13.3 16.3 14.3 17.6 13.2 18.0 13.7 22.7 10.3 18.9 22.0 38.2 6.4 8.2 0.3 21.3 8.9 6.9 3.2 5.7 48.4 4.1 6.9 9.5 4.3 5.9 25.8 50.1 7.0 7.0 33.4 3.9 2.6 4.5 21.6 6.3 33.8 3.5 5.7 13.2 1.2 1.8 7.5 11.2 45.3 0.0 1.2 42.8 0.6 16.0 11.8 17.8 12.1 8.2 44.5 23.4 7.6 0.3 20.9 3.6 7.5 4.3 16.1 3.1 43.2 40.6 2.3 8.3 1.9 4.0 3.0 36.6 1.1 4.5 122.6 6.6 1.6 3.5 0.6 0.5 1.0 6.7 63.1 21.4 10.4 1.1 9.1 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" Q07654 21 42311667-42315651 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 308.4;intestine: 358.6;salivary gland: 343.0;thyroid gland: 420.1" "Cell type enriched" "Detected in many" 10 "Intestinal goblet cells: 33890.3" "Cancer enhanced" "Detected in all" "colorectal cancer: 765.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 18 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" No NA 151000000 6500000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: AB_2674636" "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favorable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 8.7 6.0 0.1 28.0 0.1 2.2 26.5 0.3 0.2 308.4 0.2 358.6 209.9 2.8 0.5 22.9 50.2 83.5 3.1 0.1 0.1 3.4 6.6 10.0 3.5 0.1 0.8 0.0 3.5 6.2 0.0 1.4 0.1 0.2 9.9 308.6 0.1 343.0 1.6 0.9 6.6 293.1 8.5 0.1 23.3 7.4 0.5 0.2 1.8 420.1 1.7 0.9 3.6 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.7 0.0 0.7 0.1 126.6 12.1 0.0 9.0 0.3 0.1 0.0 16.1 0.1 0.0 1.7 0.0 0.0 27.8 0.0 105.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.8 0.0 0.2 0.1 0.2 0.1 36.9 16.0 25.3 0.0 15.4 41.6 15.1 196.3 3.4 0.1 804.5 444.7 21.6 919.3 595.9 22.0 0.0 0.6 3.4 2188.7 0.0 9.4 0.5 29.3 1.4 322.8 770.9 0.0 0.0 67.8 0.7 21.5 71.4 11.4 59.2 2.0 170.3 5.8 2.1 5.0 0.0 33890.3 3263.2 3.4 42.4 9.0 2.5 2.8 96.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 1855.5 7.9 6.1 73.0 2788.7 0.1 453.2 0.1 0.0 1.1 28.2 1.0 0.3 4.3 38.6 0.8 14.9 0.6 1376.3 107.7 TFF2 SML1 ENSG00000160181 "Trefoil factor 2" Q03403 21 42346357-42350997 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "stomach 1: 6912.3" "Group enriched" "Detected in some" 5 "Cholangiocytes: 2057.4;Gastric mucus-secreting cells: 7217.7" "Group enriched" "Detected in many" 11 "pancreatic cancer: 320.9;stomach cancer: 244.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.4;Karpas-707: 20.0;OE19: 55.4;PC-3: 145.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025834, HPA036705" Enhanced "Secreted to digestive system" NA NA 890000 "CAB025834: , HPA036705: AB_2675263" "unprognostic (3.95e-2)" "unprognostic (9.87e-2)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.89e-2)" "unprognostic (5.55e-2)" "unprognostic (1.27e-9)" "unprognostic (1.99e-1)" "unprognostic (2.07e-1)" "unprognostic (1.28e-1)" "unprognostic (5.26e-3)" 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 3.5 1437.5 0.1 0.0 3.4 1.2 106.4 0.1 0.0 0.0 0.2 4.1 1.1 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.2 1.0 0.0 0.1 4.2 0.0 2.9 0.0 0.1 0.1 0.5 0.2 0.0 2.7 6912.3 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 35.4 0.0 0.2 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 2.9 0.0 2.6 55.4 145.2 1.1 0.0 8.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.1 0.0 0.0 2.7 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 3.6 0.5 0.2 2057.4 0.0 0.0 0.0 0.0 0.0 3.4 0.0 104.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 93.8 0.2 1.3 7217.7 0.0 0.0 0.5 0.0 6.1 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 2.9 5.4 0.0 0.6 0.0 0.0 0.0 0.0 833.8 5.5 0.0 11.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.0 0.1 11.8 TFF1 "BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2" ENSG00000160182 "Trefoil factor 1" P04155 21 42362282-42366535 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "stomach 1: 8044.5" "Group enriched" "Detected in many" 9 "Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3" "Group enriched" "Detected in many" 10 "breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 42 "MCF7: 13512.4;OE19: 5337.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002170, HPA003425" Enhanced "Secreted to digestive system" NA NA 950000 "CAB002170: AB_563985, HPA003425: AB_1848260" "prognostic favorable (5.00e-4)" "unprognostic (8.81e-3)" "unprognostic (9.82e-2)" "prognostic favorable (5.67e-4)" "unprognostic (2.42e-1)" "unprognostic (1.72e-3)" "unprognostic (8.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.52e-1)" "unprognostic (6.62e-2)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (7.72e-3)" "unprognostic (1.07e-1)" 1.1 0.3 0.0 20.5 0.0 0.0 26.9 0.0 0.0 9.8 0.0 115.8 35.1 0.2 0.0 18.5 0.9 168.8 0.4 0.0 0.0 0.9 0.8 1.3 0.2 0.0 0.0 0.0 0.2 10.8 0.0 0.2 1.1 0.0 25.3 109.5 0.0 32.6 0.7 0.2 0.1 69.0 4.8 0.0 3.1 8044.5 0.1 0.0 0.2 5.3 0.0 0.2 30.9 2.2 0.0 0.0 42.7 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 16.2 5.7 0.0 1.1 0.0 1.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 13512.4 4.6 0.5 5.5 5337.9 223.4 1.7 0.0 0.2 0.0 1.4 0.3 0.2 0.0 5.0 0.0 1.3 5.0 0.1 0.0 0.0 3.5 0.1 0.0 3.6 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 18.7 0.0 6.1 5.9 0.0 0.0 432.7 197.2 0.0 564.7 12.1 35.0 0.0 0.1 3.1 601.9 0.0 245.7 0.0 1.8 0.2 3.5 430.2 0.0 0.0 821.8 3.1 5.1 12908.9 2.9 13.4 0.0 0.0 1.6 0.2 0.0 0.0 1395.6 111.9 0.0 0.0 0.0 0.0 9.2 0.0 0.0 10.3 0.0 0.0 0.0 0.0 14603.3 500.9 0.0 40.6 432.4 78.0 0.0 2.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 8.9 0.0 80.0 232.6 TMPRSS3 "DFNB10, DFNB8" ENSG00000160183 "Transmembrane serine protease 3" P57727 21 42371887-42396091 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.9;stomach 1: 14.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 16.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 6 "T-cells: 3.1" "Cell line enriched" "Detected in some" 4 "U-266/84: 274.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (8.47e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.85e-1)" "unprognostic (2.45e-3)" "unprognostic (3.97e-2)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (9.62e-2)" "unprognostic (4.81e-2)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.66e-2)" "unprognostic (2.73e-1)" "unprognostic (8.00e-2)" "unprognostic (1.33e-1)" 0.2 0.3 3.4 0.2 3.3 0.1 8.8 3.6 3.7 6.3 1.5 0.2 1.3 0.7 0.0 0.2 23.9 8.7 0.0 2.9 3.3 2.4 0.5 3.4 0.5 4.1 3.7 2.7 0.0 3.0 0.0 1.5 0.2 3.2 0.4 0.1 4.0 9.3 0.4 0.1 0.1 1.1 0.0 2.7 0.4 14.6 0.0 3.4 0.9 2.9 0.0 0.4 1.0 0.0 2.5 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 32.9 0.0 66.2 26.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.6 0.0 14.0 0.0 1.5 3.5 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.8 1.5 0.0 0.0 33.9 1.6 0.0 0.0 3.2 0.3 0.1 0.0 1.7 0.0 0.2 0.7 274.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.1 0.0 1.7 1.8 0.0 0.0 0.3 0.9 0.3 0.0 0.5 0.0 0.8 0.5 3.4 3.3 3.6 3.7 2.9 3.3 4.1 3.7 2.7 3.2 2.7 3.4 2.5 0.1 12.8 3.7 2.3 0.4 0.3 2.3 8.1 0.0 0.2 17.7 9.9 0.6 24.3 10.8 7.3 0.0 0.0 0.1 1.4 5.9 16.1 1.4 17.1 0.4 0.2 0.0 2.7 0.0 13.8 0.1 1.3 23.4 5.2 0.0 0.2 0.4 0.0 0.1 0.0 0.0 2.0 16.2 0.0 0.5 0.6 0.3 0.3 0.0 0.0 0.0 20.4 0.0 0.0 0.1 11.8 1.4 0.0 0.4 2.4 2.9 0.0 39.8 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.4 0.1 2.5 5.0 UBASH3A "CLIP4, STS-2, TULA" ENSG00000160185 "Ubiquitin associated and SH3 domain containing A" P57075 21 42403447-42447684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 19.1" "Cell type enhanced" "Detected in some" "dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9" "Lineage enriched" "Detected in many" 12 "T-cells: 32.2" "Group enriched" "Detected in some" 7 "HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035367 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA035367: AB_2732466" "unprognostic (5.14e-4)" "unprognostic (3.91e-4)" "unprognostic (1.57e-2)" "unprognostic (4.10e-5)" "unprognostic (4.33e-2)" "unprognostic (1.85e-6)" "unprognostic (5.54e-4)" "unprognostic (1.46e-3)" "unprognostic (6.17e-4)" "unprognostic (2.47e-3)" "unprognostic (1.94e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-6)" "unprognostic (1.65e-1)" "unprognostic (7.96e-2)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" 0.3 0.6 0.0 5.2 0.0 2.6 0.2 0.0 0.1 0.5 0.1 0.8 1.6 0.5 0.0 0.4 0.4 2.0 0.4 0.0 0.1 0.4 0.7 1.7 11.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.1 0.4 0.9 0.0 0.9 0.2 0.2 0.3 2.5 0.1 0.1 4.4 1.9 0.1 0.1 19.1 0.5 0.1 5.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 23.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.4 0.0 0.0 0.0 47.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 12.9 0.0 22.9 0.1 28.2 24.8 0.0 0.0 32.2 24.0 0.5 2.5 0.1 0.1 27.9 10.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.8 0.0 0.0 0.2 0.3 1.0 0.0 0.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 3.8 0.0 0.0 0.0 0.4 1.1 0.5 1.3 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.3 0.0 20.5 0.0 0.0 0.0 RSPH1 "CILD24, FLJ32753, RSP44, RSPH10A, TSGA2" ENSG00000160188 "Radial spoke head component 1" Q8WYR4 21 42472486-42496246 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 162.9" "Group enriched" "Detected in many" 8 "Endometrial ciliated cells: 857.0;Respiratory ciliated cells: 1058.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 3.0" "Group enriched" "Detected in some" 4 "MCF7: 11.0;OE19: 39.0;RPTEC TERT1: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016816, HPA017382" Enhanced Supported Centrosome NA NA Centrosome "HPA016816: AB_1858393, HPA017382: AB_1858392" "unprognostic (1.76e-3)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.12e-3)" "unprognostic (5.48e-2)" "unprognostic (2.43e-1)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-1)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (1.10e-2)" "unprognostic (8.41e-2)" "unprognostic (2.58e-2)" "unprognostic (5.22e-3)" "unprognostic (1.99e-1)" 0.2 3.5 18.8 0.8 12.7 0.3 2.1 13.4 11.9 6.7 25.9 4.0 7.6 5.4 17.2 0.9 162.9 3.0 0.1 10.8 18.1 5.3 0.6 14.3 0.3 17.6 20.1 9.1 1.3 3.2 5.1 26.1 0.1 19.6 3.2 3.7 12.5 1.4 3.3 0.7 3.6 5.7 1.0 18.4 0.2 5.3 31.1 13.2 1.5 8.0 0.1 0.3 1.5 0.8 15.1 1.6 1.2 0.1 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 3.4 0.1 0.5 0.0 0.4 1.9 0.0 0.5 0.0 0.2 0.1 5.4 0.5 0.0 0.0 0.1 0.2 0.3 0.8 0.0 0.1 0.0 0.0 0.9 0.0 0.2 0.0 11.0 0.1 0.2 0.3 39.0 0.5 0.0 0.4 0.0 15.4 1.3 2.5 0.9 2.4 3.7 0.3 0.0 4.2 0.4 0.2 0.0 0.1 0.1 0.0 0.4 2.5 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.0 0.1 0.1 18.8 12.7 13.4 11.9 10.8 18.1 17.6 20.1 9.1 19.6 18.4 13.2 15.1 0.4 0.0 6.2 6.5 0.9 5.1 4.5 64.6 2.8 13.3 7.2 5.8 0.6 24.3 107.1 18.4 37.5 0.1 2.9 10.5 39.2 12.6 73.9 857.0 6.2 1.3 9.0 0.0 11.5 3.8 0.0 2.7 4.6 13.9 0.0 0.4 0.0 0.2 0.1 3.3 5.9 13.5 61.1 0.0 0.0 113.4 1.8 0.9 0.0 0.0 1.0 19.9 0.0 0.5 0.3 1.9 11.2 2.6 0.8 9.5 21.4 15.7 1058.1 28.1 0.0 0.9 23.9 79.3 16.8 0.7 4.5 0.8 1.3 2.1 10.6 6.4 SLC37A1 ENSG00000160190 "Solute carrier family 37 member 1" P57057 21 42496008-42581440 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.2" "Group enriched" "Detected in many" 5 "Early spermatids: 308.6;Late spermatids: 319.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 125.4;MCF7: 50.1;OE19: 54.0;SK-BR-3: 42.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030418, CAB034154" Approved NA NA "CAB034154: AB_2190373, HPA030418: AB_10601602" "unprognostic (1.44e-2)" "unprognostic (2.93e-2)" "unprognostic (2.12e-1)" "prognostic favorable (9.22e-5)" "unprognostic (1.59e-2)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (7.99e-2)" "unprognostic (5.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.16e-1)" "unprognostic (4.08e-2)" "unprognostic (7.94e-2)" "prognostic favorable (3.43e-5)" "unprognostic (1.61e-2)" 4.1 9.0 7.0 10.4 5.8 12.6 9.1 5.6 6.5 5.5 2.3 24.1 46.2 3.3 6.4 13.8 9.7 13.7 3.5 5.1 7.9 6.0 5.7 11.8 9.8 4.6 4.5 5.6 3.9 6.6 3.8 18.1 5.4 6.1 15.3 19.7 6.5 19.5 5.1 9.6 6.4 39.6 3.4 4.5 9.3 24.2 8.4 5.2 7.2 12.4 3.4 9.4 12.6 8.7 4.2 13.7 5.3 1.4 2.5 0.1 0.2 11.5 0.5 0.0 0.5 0.3 3.3 27.0 9.6 13.7 0.0 8.2 5.4 2.7 6.9 0.0 4.5 6.6 125.4 4.6 0.2 3.2 2.7 11.9 0.7 4.0 0.1 0.3 0.0 4.0 10.8 2.5 12.9 0.0 50.1 9.7 7.0 9.3 54.0 3.1 9.9 0.0 0.3 11.2 25.8 14.1 1.7 8.0 42.4 3.5 1.3 16.1 14.0 7.1 0.0 2.5 0.1 0.0 24.7 16.4 9.2 0.0 20.6 1.4 5.4 4.9 37.1 7.5 13.2 9.5 11.1 5.2 6.7 7.0 7.4 4.3 6.1 5.7 6.9 17.0 19.8 3.0 6.8 7.0 5.8 5.6 6.5 5.1 7.9 4.6 4.5 5.6 6.1 4.5 5.2 4.2 6.7 19.2 27.7 11.8 17.7 2.2 8.5 9.9 0.6 3.0 36.6 7.0 4.1 17.2 17.6 12.9 6.2 7.1 20.9 59.5 0.0 26.1 308.6 34.1 3.6 5.2 30.1 11.0 18.6 30.9 6.0 3.1 52.5 18.9 1.3 3.2 3.9 5.5 8.8 3.3 16.0 39.6 14.2 9.1 3.0 319.3 7.2 12.3 7.2 18.7 15.2 36.6 1.0 6.0 1.5 33.8 56.2 2.6 17.2 27.0 61.9 2.2 32.9 4.1 0.0 2.2 5.4 51.7 5.4 4.7 1.6 8.6 10.6 2.7 37.9 20.8 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653621-42775509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5" "Cancer enriched" "Detected in all" 5 "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011380, HPA011978" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA011380: AB_1855132, HPA011978: " "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 9.5 11.2 11.5 3.9 14.0 0.5 10.9 13.4 13.0 6.5 7.8 69.8 3.0 5.1 19.6 3.7 10.7 6.9 3.8 10.1 11.6 17.6 4.3 4.9 4.8 13.0 13.3 9.1 3.5 4.1 6.6 10.0 10.4 12.9 38.8 16.5 10.8 12.8 15.9 2.5 6.5 47.7 8.9 10.4 18.5 13.5 1.9 14.3 7.9 6.6 4.8 3.2 19.1 6.2 11.4 0.0 2.8 29.7 3.7 0.0 0.8 0.5 0.0 0.0 0.0 0.0 3.2 18.2 0.0 30.0 0.0 2.2 0.0 2.7 9.8 0.0 0.0 10.4 0.0 0.0 6.4 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 23.2 1.5 34.7 41.2 14.6 0.0 0.0 0.0 1.2 20.4 7.6 22.5 13.5 5.2 0.0 0.5 7.0 0.2 19.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.1 0.2 3.1 0.6 0.4 0.9 0.0 0.4 1.0 0.3 11.5 14.0 13.4 13.0 10.1 11.6 13.0 13.3 9.1 12.9 10.4 14.3 11.4 18.6 3.2 5.0 43.4 1.6 1.0 10.9 4.2 6.2 26.4 13.4 12.6 1.6 5.7 2.4 18.4 0.0 0.0 1.0 90.8 29.4 7.3 0.6 18.1 8.5 11.9 13.1 3.2 5.6 2.4 0.1 5.9 1.5 26.8 1.3 6.1 5.7 0.9 7.5 35.3 10.8 25.8 8.2 1.3 0.8 2.2 11.8 1.6 28.4 31.9 1.1 11.0 0.0 29.1 16.6 5.3 105.3 6.0 0.2 28.1 233.5 8.9 1.3 2.8 13.1 0.5 6.4 0.4 2.3 0.5 0.6 0.4 3.8 16.9 24.4 15.0 WDR4 "TRM82, TRMT82" ENSG00000160193 "WD repeat domain 4" P57081 21 42843094-42879568 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, tRNA processing" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 25.8;Prostatic glandular cells: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017381 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017381: AB_1858807" "unprognostic (3.47e-2)" "unprognostic (2.15e-2)" "unprognostic (4.32e-2)" "unprognostic (2.13e-2)" "unprognostic (2.95e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.48e-7)" "unprognostic (2.85e-3)" "unprognostic (5.37e-2)" "unprognostic (2.27e-2)" "unprognostic (4.25e-1)" "unprognostic (4.78e-2)" "unprognostic (2.65e-2)" "unprognostic (1.74e-3)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (4.46e-2)" 4.1 4.7 3.8 7.3 3.9 6.7 3.9 3.7 4.8 4.1 3.0 3.4 5.0 5.1 1.9 9.1 4.2 1.8 3.2 3.8 3.4 3.7 6.1 3.8 9.3 4.2 3.9 3.7 4.3 5.6 3.0 2.3 4.2 4.6 3.4 3.1 1.6 3.6 2.6 6.8 5.0 4.0 3.4 4.1 5.4 3.7 4.7 4.2 5.3 4.1 3.3 7.4 5.7 5.1 4.7 35.7 48.5 12.9 18.5 6.9 8.2 30.7 20.2 7.3 16.9 10.7 48.9 18.1 58.8 11.5 14.5 24.5 19.3 44.7 25.5 11.8 19.2 42.0 59.7 52.0 41.9 13.3 36.8 14.5 4.7 11.2 22.9 16.4 6.3 22.1 20.9 72.6 22.0 14.8 29.4 38.5 20.9 32.3 26.4 47.0 41.6 7.8 58.4 12.8 21.2 30.4 19.5 21.2 31.1 10.2 4.1 20.4 28.2 16.4 25.9 17.3 12.1 41.0 28.9 21.6 48.1 12.5 57.2 31.1 0.0 3.9 0.2 2.4 6.8 3.6 5.4 3.4 3.1 7.1 4.9 3.4 3.5 0.0 3.6 4.2 3.5 4.4 3.5 3.8 3.9 3.7 4.8 3.8 3.4 4.2 3.9 3.7 4.6 4.1 4.2 4.7 3.6 0.0 4.8 5.5 10.3 8.5 12.7 7.3 4.0 4.1 5.3 4.6 2.5 0.0 3.2 0.0 2.1 16.3 5.5 5.9 0.0 7.4 4.8 2.8 5.8 5.2 5.4 8.4 4.8 6.7 25.8 4.7 6.1 3.4 10.2 5.4 3.6 7.0 12.5 3.3 4.5 6.0 4.1 3.5 4.0 3.8 2.8 4.7 7.2 2.8 1.9 3.8 2.1 1.5 5.1 6.9 1.0 3.0 15.3 24.6 3.5 6.8 2.1 4.6 6.6 2.7 6.1 10.4 8.4 7.5 10.9 11.5 3.6 8.2 7.7 10.7 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 770.8;Early spermatids: 502.9;Late spermatids: 1712.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 19.7 18.3 9.6 3.3 9.2 6.8 17.7 9.4 9.0 16.7 7.2 22.1 5.2 19.3 8.0 19.1 17.5 2.5 41.9 8.0 7.4 17.9 27.1 13.8 3.1 9.9 10.0 7.1 19.2 24.2 7.6 16.7 3.0 10.9 16.5 4.2 7.8 17.5 4.0 88.7 19.1 16.2 3.6 8.6 17.1 19.9 21.0 9.3 2.6 15.0 21.3 3.2 18.5 16.0 9.1 3.3 4.9 9.1 8.1 7.9 5.0 10.4 6.6 4.2 5.2 3.4 10.6 6.2 4.9 4.2 4.1 11.7 5.4 8.8 8.1 3.5 2.8 7.4 20.1 8.7 9.0 9.4 6.0 7.8 8.0 8.2 6.9 12.0 4.2 6.1 5.6 13.5 7.3 5.6 10.5 3.7 6.2 10.2 15.7 6.9 4.6 5.3 12.3 9.5 7.5 5.8 4.7 9.0 10.3 4.8 4.4 10.2 4.6 8.9 3.2 3.0 4.4 4.8 12.1 7.1 3.5 5.7 7.7 4.6 3.1 5.7 3.8 2.8 7.1 2.4 2.9 2.4 2.2 5.0 3.5 2.9 2.8 3.3 4.4 6.6 4.4 2.7 2.8 9.6 9.2 9.4 9.0 8.0 7.4 9.9 10.0 7.1 10.9 8.6 9.3 9.1 42.8 54.5 46.7 14.4 36.5 19.9 53.7 97.7 24.5 81.2 64.9 65.7 770.8 92.9 58.6 90.1 68.8 57.5 32.5 89.3 230.9 86.5 502.9 84.5 64.9 48.1 78.3 112.4 19.4 101.5 59.5 57.2 55.5 56.9 31.6 45.5 68.2 334.5 114.4 57.2 22.1 114.8 87.5 88.3 38.1 1712.0 66.5 62.3 37.4 17.8 86.4 88.7 49.4 15.6 19.5 98.6 80.9 62.4 39.0 109.3 176.4 372.6 85.9 104.7 72.3 54.0 66.1 243.5 77.1 50.0 23.4 89.9 29.9 83.8 95.4 65.3 PKNOX1 PREP1 ENSG00000160199 "PBX/knotted 1 homeobox 1" P55347 21 42974510-43033931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 106.8;Early spermatids: 121.1;Spermatocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004285, HPA057215, HPA065017" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.59e-1)" "unprognostic (8.39e-2)" "unprognostic (1.90e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (4.54e-8)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (3.67e-2)" "prognostic favorable (6.71e-4)" "unprognostic (9.45e-2)" "unprognostic (3.94e-2)" "unprognostic (1.85e-1)" "unprognostic (1.21e-2)" "unprognostic (6.16e-2)" "unprognostic (4.31e-3)" 4.3 4.2 6.5 4.1 6.5 2.5 3.9 9.3 7.2 7.7 5.8 5.8 2.9 8.3 5.5 4.2 6.6 4.8 3.5 6.6 6.5 4.7 4.5 4.5 5.1 6.7 6.5 6.3 8.7 3.9 3.4 4.7 5.3 7.0 5.1 3.9 4.7 4.3 6.7 7.7 5.4 4.3 6.1 7.0 4.7 4.4 8.3 7.0 5.3 11.5 5.9 4.6 7.0 4.6 7.5 8.8 3.0 3.9 3.8 7.3 11.0 4.8 11.0 7.6 6.5 5.6 5.2 6.6 12.2 8.9 9.7 5.1 4.6 9.1 7.0 8.6 8.4 7.3 7.2 5.7 4.9 7.5 6.6 5.4 8.3 11.3 8.1 6.6 6.8 6.3 4.1 5.8 8.8 15.1 5.2 6.2 7.3 6.1 12.4 6.5 9.8 17.7 6.7 13.0 6.9 12.6 7.5 7.8 5.6 7.6 4.5 4.7 8.4 7.5 10.2 5.0 5.7 7.1 5.1 6.1 6.2 12.9 11.6 5.5 0.3 2.1 1.7 3.9 2.9 4.1 2.8 2.8 3.2 1.9 2.2 3.3 3.0 5.7 2.3 1.9 1.7 3.3 2.4 6.5 6.5 9.3 7.2 6.6 6.5 6.7 6.5 6.3 7.0 7.0 7.0 7.5 18.4 6.4 15.7 28.1 12.5 17.5 106.8 13.7 17.1 23.7 12.4 11.7 7.4 12.8 18.2 16.5 4.2 14.9 11.1 12.3 9.8 17.1 121.1 15.1 37.7 16.0 14.9 11.0 30.3 12.6 28.8 22.3 3.6 23.8 6.3 17.3 10.0 8.4 12.6 13.5 27.2 11.8 14.2 8.4 22.5 40.8 18.6 15.3 14.2 16.9 20.8 9.5 11.3 27.6 40.8 14.5 7.0 29.3 8.6 32.2 8.5 7.5 16.3 11.5 32.9 27.3 20.8 99.7 26.4 17.1 13.8 29.0 17.1 24.2 10.8 45.2 CBS HIP4 ENSG00000160200 "Cystathionine beta-synthase" P35520 21 43053191-43076943 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 176.3;pancreas: 99.9" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 51 "neutrophil: 5.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.0" "Cell line enhanced" "Detected in many" "BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4" "Low region specificity" "Detected in all" HPA001223 Supported Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 5.5 2.8 37.3 1.0 35.2 0.2 3.4 54.9 55.7 11.7 25.6 4.6 3.1 4.5 0.0 2.0 5.9 1.2 7.2 38.1 36.2 3.8 176.3 10.3 2.7 41.2 41.1 31.4 30.5 99.9 2.5 8.9 1.2 50.0 12.8 0.9 2.5 20.0 1.1 1.1 2.0 7.0 2.3 34.5 1.7 16.7 2.0 40.9 0.7 17.6 1.2 1.4 11.7 6.2 41.9 30.0 17.0 31.3 113.4 48.9 31.5 177.5 39.5 10.0 15.6 15.4 53.7 1.5 0.1 19.2 67.2 0.3 1.5 172.8 13.2 3.1 0.0 20.5 12.3 73.1 63.8 224.1 7.9 19.1 21.7 1.4 16.0 16.4 13.2 38.6 85.6 138.7 118.1 11.1 197.7 16.1 0.1 20.3 65.7 29.4 0.0 0.2 197.4 0.5 15.5 57.8 85.1 78.5 5.4 44.4 18.4 27.0 91.2 5.4 0.8 42.5 0.3 4.8 34.8 30.2 41.2 19.0 11.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 37.3 35.2 54.9 55.7 38.1 36.2 41.2 41.1 31.4 50.0 34.5 40.9 41.9 0.2 0.0 0.5 0.7 0.0 0.4 0.0 2.3 0.0 0.2 0.5 0.1 4.9 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.8 1.2 0.0 0.1 0.0 0.1 0.0 3.6 0.2 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.9 0.2 5.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.2 1.7 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.6 0.0 1.0 0.1 0.1 0.0 0.2 0.1 U2AF1 "RN, RNU2AF1, U2AF35, U2AFBP" ENSG00000160201 "U2 small nuclear RNA auxiliary factor 1" Q01081 21 43092956-43107570 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 607.7" "Low region specificity" "Detected in all" "HPA044833, HPA052083" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (5.98e-2)" "unprognostic (2.87e-2)" "unprognostic (1.36e-1)" "unprognostic (8.06e-2)" "unprognostic (2.76e-2)" "unprognostic (4.29e-4)" "unprognostic (4.81e-4)" "unprognostic (3.42e-2)" "unprognostic (2.31e-3)" "unprognostic (8.85e-2)" "unprognostic (2.14e-6)" "unprognostic (1.08e-1)" "unprognostic (1.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-2)" 59.8 48.0 39.7 31.4 39.3 86.6 59.3 40.2 47.3 56.8 38.6 72.0 26.0 69.4 28.0 64.8 61.3 18.8 41.7 38.1 39.7 41.1 48.4 57.8 45.5 38.6 40.9 35.6 69.9 42.1 32.9 60.5 34.9 46.0 48.4 27.0 29.2 49.5 41.2 75.5 47.2 57.6 36.1 39.5 66.0 58.7 54.8 41.0 62.4 63.2 25.1 56.3 61.2 51.1 44.6 101.1 27.7 250.5 71.3 28.7 38.8 248.1 88.2 82.4 105.4 115.3 486.0 59.8 20.8 35.1 54.3 125.6 33.0 161.1 36.3 104.9 114.6 134.0 607.7 61.2 117.9 77.0 264.0 115.2 45.5 90.6 177.1 100.6 43.5 62.8 238.0 105.8 113.4 97.2 324.4 271.1 358.1 287.6 123.4 108.3 485.1 166.9 211.9 99.8 15.4 125.9 77.6 212.6 98.6 147.6 36.5 125.5 147.5 12.1 79.2 59.6 82.0 236.3 191.4 178.3 48.8 80.3 333.6 118.6 211.9 141.0 153.1 101.2 140.4 106.7 140.2 112.7 95.5 150.4 134.2 112.9 109.1 213.1 93.1 196.9 240.7 149.3 188.7 39.7 39.3 40.2 47.3 38.1 39.7 38.6 40.9 35.6 46.0 39.5 41.0 44.6 9.5 19.2 18.1 3.9 37.8 492.9 32.5 406.9 86.6 23.9 5.7 2.8 5.0 17.2 153.5 1.8 43.8 19.5 15.3 16.5 1.9 5.2 3.1 4.2 4.4 51.7 18.2 45.0 5.2 6.0 20.7 51.8 44.4 4.2 28.4 3.8 31.8 16.2 23.2 18.5 4.6 17.0 266.5 33.0 374.7 4.1 18.3 30.6 202.7 4.7 19.3 13.0 27.8 3.0 6.2 4.8 17.0 22.6 60.3 31.1 43.2 3.1 107.6 60.7 6.6 39.1 110.7 16.4 18.9 79.8 433.6 23.8 46.6 1.3 20.2 39.1 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 50.7;retina: 56.0" "Cell type enriched" "Detected in single" 5 "Muller glia cells: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 148 "Hep G2: 38.0" "Region enhanced" "Detected in some" "hippocampal formation: 3.9" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" "unprognostic (3.68e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 50.7 6.7 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.5 0.3 0.3 0.2 0.1 0.2 0.2 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSF2BP MEILB2 ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529186-43659488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 24.3" "Group enriched" "Detected in many" 7 "Early spermatids: 125.5;Late spermatids: 49.0;Spermatocytes: 132.4;Spermatogonia: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.3 0.3 0.4 0.1 0.5 0.1 0.5 0.3 0.9 0.5 0.2 0.3 0.2 0.6 0.5 0.3 0.6 0.2 0.2 1.3 0.5 0.3 0.2 0.2 0.3 0.7 0.5 0.2 0.7 0.2 0.8 0.8 0.9 0.8 0.4 0.2 0.9 0.4 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.2 24.3 0.5 0.1 0.5 0.1 0.2 0.3 0.4 0.7 4.6 0.9 1.2 0.5 0.2 1.1 1.1 1.6 0.9 1.6 1.4 6.1 4.5 3.5 2.4 0.9 5.7 1.8 0.6 12.8 0.5 0.9 1.1 0.6 1.9 0.3 1.4 1.5 0.4 0.7 8.2 0.7 3.8 7.5 0.4 2.0 1.3 1.1 3.9 0.8 2.0 1.4 3.9 1.1 1.9 2.9 1.2 0.5 2.0 0.8 1.3 1.0 3.3 1.6 1.7 0.5 1.7 1.7 2.6 0.9 3.0 0.2 2.4 1.2 0.9 2.8 0.8 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.3 0.0 0.3 0.7 0.7 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.5 0.3 0.9 1.3 0.5 0.7 0.5 0.2 0.8 0.3 0.5 0.7 0.2 0.0 0.0 2.6 0.1 0.9 1.5 4.7 2.8 1.0 1.3 1.7 0.7 0.0 2.0 0.0 0.0 1.8 0.2 0.2 0.0 1.1 125.5 0.5 1.4 0.5 0.0 0.0 3.0 0.2 2.8 2.1 0.0 0.4 0.0 2.4 0.4 0.3 0.7 0.0 1.7 0.1 0.0 0.0 0.7 49.0 1.8 0.5 0.0 0.0 0.0 2.1 0.0 3.0 4.4 2.7 0.3 1.5 0.0 0.8 0.0 1.1 2.8 2.5 13.1 0.5 0.9 132.4 63.1 0.6 0.4 0.8 0.2 3.8 0.3 1.0 RRP1B "KIAA0179, Nnp1, PPP1R136, RRP1" ENSG00000160208 "Ribosomal RNA processing 1B" Q14684 21 43659560-43696079 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017893, HPA020324" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA017893: AB_1852274, HPA020324: AB_1852276" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (4.03e-1)" "unprognostic (1.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-2)" "unprognostic (7.19e-2)" "unprognostic (1.98e-2)" "unprognostic (5.55e-3)" "unprognostic (1.08e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (4.24e-2)" 8.9 6.0 7.7 12.3 8.7 6.2 9.2 6.9 7.4 7.3 5.8 7.3 6.7 9.1 5.6 8.7 9.2 6.2 4.9 7.2 7.5 4.9 8.8 6.8 17.6 7.6 7.7 6.5 13.3 10.2 7.3 4.3 5.9 7.3 7.6 7.3 28.7 10.3 6.9 12.2 8.9 6.5 8.9 7.2 11.1 7.9 12.1 7.5 16.2 6.6 8.9 15.0 9.9 6.5 8.4 52.5 30.4 31.8 48.1 20.2 21.5 26.0 27.0 19.3 29.3 24.0 69.4 22.2 101.9 17.2 21.5 33.9 22.8 78.9 46.5 34.6 34.6 62.8 60.3 34.8 43.9 27.9 95.0 22.9 22.4 29.2 35.1 40.3 18.1 33.1 43.2 96.0 29.1 26.1 27.4 76.1 28.9 108.4 33.7 33.4 98.7 32.1 71.2 21.2 24.8 62.7 33.6 50.6 36.9 37.9 11.7 24.2 29.4 29.7 9.0 28.3 24.0 49.8 39.1 53.8 119.3 28.5 100.7 30.1 2.0 2.5 0.7 6.2 2.5 7.3 5.6 7.9 7.5 3.0 4.3 7.2 8.6 0.1 5.8 2.2 2.4 6.6 5.5 7.7 8.7 6.9 7.4 7.2 7.5 7.6 7.7 6.5 7.3 7.2 7.5 8.4 15.5 32.1 16.4 8.8 32.7 22.8 17.7 15.0 28.5 30.3 13.8 11.0 13.4 17.2 21.0 5.5 131.3 8.6 27.1 5.7 1.9 17.0 213.2 10.5 28.8 19.1 5.4 23.7 19.0 15.6 17.0 18.9 14.8 10.8 36.0 25.5 12.8 18.4 18.7 25.2 20.0 9.2 6.1 13.9 12.7 222.8 22.4 13.4 8.8 21.5 17.0 17.9 35.0 18.6 22.2 20.9 3.7 26.7 48.5 23.6 6.8 9.9 16.7 143.5 0.0 29.9 18.1 26.3 33.6 32.0 31.7 4.4 35.7 32.6 16.5 17.4 PDXK "C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79" ENSG00000160209 "Pyridoxal kinase" O00764 21 43719094-43762307 "Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 82.4" "Group enriched" "Detected in all" 4 "Early spermatids: 1717.4;Late spermatids: 4366.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030196, HPA030197, HPA030198, CAB033918" Enhanced Enhanced Nucleoplasm NA NA 830000 Nucleoplasm "CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570" "unprognostic (1.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.88e-2)" "unprognostic (1.87e-1)" "unprognostic (8.29e-2)" "unprognostic (4.31e-3)" "unprognostic (3.64e-3)" "unprognostic (1.32e-1)" "unprognostic (8.66e-2)" "unprognostic (9.34e-2)" "unprognostic (2.10e-1)" "unprognostic (3.54e-1)" "unprognostic (3.70e-2)" "unprognostic (1.31e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.51e-3)" 25.9 22.0 68.6 7.7 57.0 13.0 18.5 20.4 82.4 13.3 14.0 13.7 14.3 12.4 10.3 19.9 14.1 7.1 15.0 57.6 46.2 28.9 21.6 21.1 7.1 44.0 54.1 59.0 19.2 21.5 17.9 37.5 7.8 54.5 17.4 9.5 10.1 22.9 10.7 6.8 13.2 19.8 7.0 24.2 12.6 16.8 24.1 62.9 10.3 19.2 5.4 9.3 11.0 12.7 52.8 43.4 51.9 8.1 15.5 19.4 27.3 9.9 15.2 23.8 14.5 12.1 42.5 65.7 14.4 15.7 21.9 20.0 31.9 15.8 43.4 9.5 16.2 13.4 14.7 60.9 31.7 38.1 14.0 20.6 38.9 40.7 15.3 16.9 23.6 6.9 6.3 26.2 31.9 13.8 29.1 2.0 24.9 22.3 41.9 19.7 16.7 4.8 40.4 62.9 51.9 7.8 9.3 63.3 57.7 23.2 3.3 19.0 19.4 12.5 10.5 20.3 14.2 14.4 19.3 9.8 8.4 43.2 39.9 10.3 0.6 2.4 0.1 0.8 2.2 1.5 0.6 0.8 0.9 1.3 1.7 0.8 0.6 0.6 0.9 4.3 0.6 0.7 1.4 68.6 57.0 20.4 82.4 57.6 46.2 44.0 54.1 59.0 54.5 24.2 62.9 52.8 15.8 80.1 66.6 44.1 37.7 28.4 142.4 72.2 27.3 46.3 74.8 53.5 48.0 34.3 73.2 101.2 22.9 42.9 23.6 97.6 180.0 146.4 1717.4 66.9 28.3 36.1 30.1 15.8 49.3 196.6 86.3 39.4 63.2 73.2 31.8 23.8 17.2 54.2 207.6 52.2 48.7 55.4 12.2 58.2 101.0 4366.5 50.1 118.7 42.7 61.8 38.4 14.9 20.6 16.6 13.5 223.4 36.4 54.2 146.4 184.7 108.4 95.7 71.1 43.3 6.6 17.0 35.0 678.1 30.4 60.7 28.4 124.1 27.3 22.1 57.5 239.8 G6PD G6PD1 ENSG00000160211 "Glucose-6-phosphate dehydrogenase" P11413 X 154531391-154547572 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Oxidoreductase "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 106.9" "Cell type enhanced" "Detected in many" "monocytes: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 412.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 412.7" "Cell line enhanced" "Detected in all" "A549: 2333.8;MCF7: 883.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000247, HPA000834" Enhanced Enhanced "Centriolar satellite,Cytosol" No No 2400000 Cytosol "Centriolar satellite" "HPA000247: AB_1078978, HPA000834: AB_1078977" "unprognostic (1.73e-2)" "unprognostic (1.53e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (7.78e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (9.45e-13)" "unprognostic (2.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.66e-1)" "unprognostic (2.89e-3)" "unprognostic (2.83e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (7.25e-2)" 41.0 39.4 17.7 30.5 19.4 106.9 32.2 18.2 28.6 20.8 17.3 14.0 13.3 21.7 13.5 54.8 19.5 46.9 10.9 19.2 26.3 12.6 6.5 29.7 29.1 23.2 19.4 18.0 24.3 13.2 9.7 27.7 13.8 20.9 12.3 13.2 26.3 21.3 14.6 4.3 21.5 12.5 25.8 17.6 27.1 18.3 54.5 21.7 26.5 46.3 5.1 37.5 34.1 22.6 22.2 168.5 2333.8 49.7 189.7 207.2 281.7 43.5 116.0 341.7 120.0 205.8 111.2 61.9 110.9 174.1 274.3 475.9 146.3 79.3 202.5 60.3 111.4 55.0 116.8 517.2 244.6 401.6 117.8 373.5 136.6 58.5 233.9 49.8 185.6 252.5 79.8 69.6 46.3 218.4 883.9 77.5 93.0 35.3 549.5 172.2 74.9 28.4 120.5 357.1 210.9 49.6 62.0 115.9 444.5 99.9 65.0 67.1 99.4 289.8 73.1 250.0 102.5 181.8 58.2 80.0 189.8 200.6 77.5 150.9 166.1 84.9 412.7 50.3 72.1 32.1 16.0 13.7 36.7 40.1 17.0 16.5 28.2 137.4 69.3 63.5 18.9 18.7 72.8 17.7 19.4 18.2 28.6 19.2 26.3 23.2 19.4 18.0 20.9 17.6 21.7 22.2 7.9 0.0 17.0 4.6 21.5 12.5 24.3 46.6 8.6 6.2 14.6 8.6 1.1 14.3 22.9 11.0 18.8 29.6 58.9 25.5 29.4 39.3 10.3 7.7 13.7 13.2 9.5 37.7 2.9 29.3 41.2 19.6 23.4 10.7 37.5 26.1 18.2 1.6 45.6 33.7 2.3 11.5 24.4 58.2 26.0 20.8 26.1 56.6 19.6 5.6 112.3 13.6 83.4 3.5 3.7 31.0 11.4 16.1 21.6 23.9 18.5 18.3 10.9 32.5 6.6 7.5 23.6 10.9 32.8 34.4 13.8 36.3 33.8 11.6 13.5 30.5 CSTB "CST6, EPM1, PME, STFB" ENSG00000160213 "Cystatin B" P04080 21 43772511-43776330 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "esophagus: 11408.8" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 2798.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017380, CAB047320, HPA058557" Enhanced Supported Nucleoli,Cytosol NA NA 8700000 Cytosol Nucleoli "CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755" "unprognostic (1.69e-1)" "unprognostic (3.35e-1)" "unprognostic (2.09e-1)" "unprognostic (3.05e-2)" "unprognostic (3.05e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (6.66e-5)" "unprognostic (1.90e-1)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (3.63e-1)" "unprognostic (4.88e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" 226.4 167.2 235.9 142.9 233.5 74.5 163.6 237.3 317.1 345.6 254.5 246.1 124.0 91.0 176.6 11408.8 155.4 152.1 194.0 232.2 254.6 146.0 191.0 292.7 177.9 240.3 233.5 227.7 137.3 117.2 155.7 70.6 133.2 239.0 138.6 196.6 79.6 744.2 139.9 101.1 258.9 136.7 111.4 241.3 126.9 252.1 72.3 241.3 270.6 149.3 199.1 1497.6 617.7 1010.1 270.6 1573.6 495.5 146.3 188.1 874.5 742.6 379.6 310.1 431.0 230.7 230.6 401.6 868.6 123.0 245.8 570.1 1814.0 260.5 384.4 405.7 153.5 529.0 388.4 332.4 385.3 473.8 753.0 85.5 267.1 754.5 439.6 621.2 314.7 389.3 331.2 111.8 276.9 681.1 359.7 431.4 100.1 267.6 336.0 1052.6 791.5 169.7 80.5 1472.0 669.1 2798.2 141.8 121.6 420.2 229.2 928.8 75.7 210.4 214.0 426.3 347.7 162.7 305.5 211.8 148.5 347.4 251.1 1432.5 430.2 242.3 390.1 505.5 313.1 242.9 840.3 224.5 198.5 315.4 255.4 766.1 172.7 221.0 217.6 445.6 152.4 1322.9 93.4 406.9 475.2 235.9 233.5 237.3 317.1 232.2 254.6 240.3 233.5 227.7 239.0 241.3 241.3 270.6 210.1 176.3 298.4 43.4 140.5 385.3 460.6 5910.7 191.2 69.8 317.8 345.1 105.7 268.8 4352.8 415.6 35.5 310.4 126.5 803.9 538.1 588.4 10.4 388.8 205.1 307.8 239.3 61.4 17.0 488.2 1199.4 238.6 297.7 458.8 228.2 131.5 250.6 464.5 2827.7 67.3 18.4 308.6 1462.8 483.4 1256.2 40.8 381.1 806.9 471.4 24.4 915.9 160.6 255.4 11.1 32.4 810.9 735.6 330.2 167.7 674.3 524.9 469.9 1997.3 72.9 118.3 86.5 320.0 33.7 111.7 4910.2 596.0 402.5 202.8 170.9 367.2 3198.3 RRP1 "D21S2056E, NNP-1, Nop52, RRP1A" ENSG00000160214 "Ribosomal RNA processing 1" P56182 21 43789513-43805293 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016818, HPA018166" Approved Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA016818: AB_1854561, HPA018166: AB_1854562" "unprognostic (5.38e-2)" "unprognostic (3.48e-1)" "unprognostic (3.43e-1)" "unprognostic (2.53e-2)" "unprognostic (9.44e-2)" "unprognostic (1.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.26e-1)" "unprognostic (7.63e-3)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (6.29e-5)" "unprognostic (1.13e-1)" "unprognostic (9.21e-3)" "unprognostic (2.64e-1)" "unprognostic (1.88e-1)" 7.6 8.3 7.9 6.5 8.5 5.3 7.3 7.2 10.3 6.9 4.7 6.2 5.0 7.2 3.4 16.1 6.4 4.0 6.4 9.1 6.9 6.4 13.1 5.4 8.2 8.8 8.1 8.0 8.1 9.8 4.8 5.5 4.9 8.1 7.2 3.1 1.7 8.1 4.2 13.0 11.9 6.0 3.4 6.6 8.3 7.6 8.0 8.3 5.1 6.0 5.3 6.2 7.3 8.0 10.6 37.6 19.6 13.5 22.6 7.3 8.2 25.6 18.5 10.9 25.7 18.1 52.1 21.6 35.5 14.9 10.4 23.8 18.8 25.2 18.5 11.7 17.7 47.9 50.4 18.8 32.1 14.9 32.6 17.5 11.0 17.0 26.0 20.6 6.7 13.7 32.9 67.3 26.9 12.2 43.2 28.7 44.7 44.8 26.1 28.7 52.0 10.7 66.4 13.4 20.5 31.6 18.8 19.3 21.0 25.3 3.8 21.5 22.1 15.6 17.2 19.1 18.2 33.0 32.1 29.8 37.1 25.7 53.7 22.6 0.1 5.0 1.7 10.7 4.8 13.4 11.0 11.0 11.1 10.2 13.0 11.9 8.0 1.1 13.1 2.3 8.8 6.8 7.0 7.9 8.5 7.2 10.3 9.1 6.9 8.8 8.1 8.0 8.1 6.6 8.3 10.6 12.9 16.0 19.4 9.4 17.3 72.3 40.2 55.9 23.3 18.7 14.4 12.7 6.1 18.6 45.3 7.3 20.9 31.4 12.7 18.6 7.9 40.0 4.2 14.9 15.5 18.8 20.9 19.0 6.2 33.1 39.0 24.5 18.8 16.1 20.3 20.1 9.3 16.0 32.7 8.4 6.3 19.3 32.6 8.4 35.0 2.7 19.3 13.6 42.7 2.8 15.3 12.3 13.4 2.5 11.6 41.4 9.1 20.7 19.2 59.4 10.5 21.0 24.3 17.6 32.9 23.8 20.6 21.4 30.0 32.2 70.2 30.4 15.0 21.4 29.5 46.1 AGPAT3 "LPAAT-gamma, LPAAT3" ENSG00000160216 "1-acylglycerol-3-phosphate O-acyltransferase 3" Q9NRZ7 21 43865223-43987592 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 183.5;Early spermatids: 219.0;Late spermatids: 219.3;Rod photoreceptor cells: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 9.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.36e-2)" "prognostic unfavorable (8.31e-4)" "unprognostic (5.50e-2)" "unprognostic (4.56e-3)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (4.88e-2)" "unprognostic (9.72e-3)" "unprognostic (2.14e-1)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (2.84e-1)" "prognostic favorable (2.29e-4)" "unprognostic (1.50e-2)" "unprognostic (8.91e-2)" "unprognostic (1.80e-1)" "unprognostic (4.60e-2)" 21.1 21.1 40.4 19.3 41.8 11.2 15.3 42.6 33.6 11.1 13.3 22.2 45.1 10.4 12.7 25.9 12.4 13.9 23.6 36.4 32.6 53.9 53.7 19.0 16.5 50.1 40.9 26.7 10.5 21.5 24.8 14.8 12.3 39.4 14.0 12.0 62.4 30.8 11.7 62.8 22.4 52.8 8.8 45.9 19.2 18.1 26.6 44.1 15.6 21.6 50.7 10.4 15.6 15.2 48.0 73.0 40.0 10.0 27.5 17.8 20.4 7.7 32.6 40.6 40.8 25.1 40.3 51.4 24.5 24.3 39.3 38.4 27.8 17.3 36.5 11.8 117.2 45.8 10.8 24.4 54.8 33.6 39.6 23.5 25.1 30.4 36.1 15.0 35.1 31.2 8.0 61.4 39.1 15.0 31.2 0.4 22.9 4.7 28.2 28.5 40.6 11.3 65.9 29.7 70.2 34.0 24.7 40.0 45.0 29.9 3.9 31.3 42.9 46.6 25.9 0.3 39.1 34.0 31.0 50.3 15.3 33.3 78.3 23.9 0.0 3.3 2.2 1.1 7.4 1.2 0.9 1.6 1.7 3.8 1.1 1.3 1.5 0.9 0.6 9.6 0.9 3.0 1.8 40.4 41.8 42.6 33.6 36.4 32.6 50.1 40.9 26.7 39.4 45.9 44.1 48.0 17.0 12.8 25.4 33.0 7.0 8.0 9.3 14.5 7.4 40.3 19.8 12.3 33.4 25.8 21.0 25.8 183.5 15.9 10.8 45.1 9.8 25.7 219.0 17.7 16.6 16.3 13.8 12.8 34.3 29.5 1.1 10.4 19.9 18.5 5.1 24.6 15.4 68.7 19.0 65.6 37.9 19.7 12.2 32.6 27.3 219.3 7.8 25.7 1.8 17.8 38.5 34.1 9.2 19.1 28.7 26.8 18.8 5.7 11.8 18.6 60.5 52.6 31.0 184.0 6.6 14.9 24.4 7.0 2.4 17.4 11.1 12.0 14.4 22.0 22.5 15.7 TRAPPC10 "EHOC-1, TMEM1, TRS130" ENSG00000160218 "Trafficking protein particle complex 10" P48553 21 44012309-44106552 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 81.2;Oligodendrocytes: 132.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "basophil: 9.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 9.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050423 Supported NA NA "HPA050423: AB_2681123" "unprognostic (1.82e-2)" "unprognostic (4.89e-3)" "unprognostic (3.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.79e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (4.00e-1)" "unprognostic (9.70e-2)" "unprognostic (3.07e-3)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (2.76e-1)" 5.7 4.4 3.1 7.4 5.9 17.5 4.7 4.5 5.1 5.0 3.9 7.1 5.3 5.2 7.9 5.6 5.3 5.4 4.8 3.5 5.1 7.1 6.1 5.9 10.0 5.1 5.4 3.4 3.6 5.0 7.5 3.4 6.0 6.2 3.8 7.5 6.1 5.4 4.2 6.3 5.5 6.8 5.4 4.2 7.6 6.8 7.7 4.8 10.2 7.0 5.6 12.0 5.4 4.2 11.0 12.1 5.8 8.7 6.0 15.7 8.0 8.7 10.8 10.7 10.9 11.5 12.8 6.8 15.1 3.6 10.5 20.7 5.6 8.5 11.7 16.0 9.8 8.2 20.7 6.2 4.8 7.2 14.0 12.1 6.3 12.4 14.0 11.0 8.3 12.3 9.3 15.4 15.7 18.4 8.6 8.0 6.7 10.1 8.8 8.8 8.9 5.7 12.4 6.1 8.2 12.4 7.2 9.8 10.8 10.1 4.5 5.9 11.9 12.9 11.2 7.6 12.8 10.5 14.8 14.3 10.8 6.9 13.2 8.7 9.7 0.4 0.9 0.6 0.6 0.1 0.3 0.7 0.6 0.3 0.5 0.3 0.5 0.8 0.4 0.7 0.7 0.0 0.2 3.1 5.9 4.5 5.1 3.5 5.1 5.1 5.4 3.4 6.2 4.2 4.8 11.0 17.1 0.0 3.6 26.1 28.9 16.6 12.5 6.9 4.6 29.2 12.0 9.4 10.0 4.3 5.5 12.9 39.6 4.2 81.2 25.1 9.8 1.8 14.3 19.7 20.2 10.6 8.3 4.2 35.8 2.2 4.3 9.5 10.2 29.8 8.2 11.7 10.4 11.1 7.5 18.5 33.3 11.0 10.2 9.4 19.1 33.8 7.8 17.6 12.4 32.8 10.3 11.3 65.9 24.6 132.9 4.8 15.7 7.2 28.0 13.1 7.9 12.4 12.0 39.4 0.0 17.4 13.1 25.4 20.6 5.5 23.3 7.7 37.0 23.1 11.5 19.5 GAB3 ENSG00000160219 "GRB2 associated binding protein 3" Q8WWW8 X 154675249-154751583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 20.4;dendritic cells: 32.0;Erythroid cells: 20.4;granulocytes: 20.8;Kupffer cells: 24.7;Microglial cells: 30.9;NK-cells: 39.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 21.3;HMC-1: 23.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA010090 Approved Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA010090: AB_1849362" "unprognostic (2.67e-2)" "unprognostic (1.04e-2)" "unprognostic (4.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (3.63e-3)" "unprognostic (1.20e-1)" "unprognostic (5.90e-3)" "unprognostic (1.87e-1)" "unprognostic (1.43e-1)" "unprognostic (2.04e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.22e-1)" "unprognostic (2.84e-2)" "unprognostic (5.87e-2)" "unprognostic (2.19e-1)" 3.8 2.2 1.7 7.0 3.2 12.6 2.3 2.2 3.1 1.8 2.1 2.6 3.4 2.0 3.9 1.7 1.9 3.7 7.5 1.7 3.2 1.0 1.9 6.0 7.6 3.9 2.4 1.1 1.3 1.0 2.8 0.4 3.7 4.3 1.3 3.4 1.2 2.1 1.9 1.4 3.6 4.2 3.5 1.9 14.1 2.6 4.9 3.0 5.3 3.6 1.6 6.7 3.1 1.1 8.5 0.8 0.0 0.7 1.0 0.9 2.3 0.5 0.3 0.6 0.2 0.3 0.0 0.5 2.5 0.7 0.0 1.5 0.4 0.6 0.4 0.0 2.9 1.0 21.3 2.9 2.4 1.6 6.5 23.3 0.9 0.2 2.0 0.8 0.8 5.2 2.0 4.8 7.3 1.0 0.3 2.4 6.6 0.2 0.0 0.1 3.5 0.0 0.3 1.3 0.0 3.0 0.4 0.3 0.3 0.4 0.5 0.9 3.7 4.8 1.2 1.9 0.8 0.6 8.0 7.0 2.5 2.0 8.4 0.6 26.4 5.9 8.7 13.3 5.7 10.2 1.0 3.5 9.7 5.8 1.3 1.2 6.8 9.0 2.5 3.6 3.3 0.8 5.0 1.7 3.2 2.2 3.1 1.7 3.2 3.9 2.4 1.1 4.3 1.9 3.0 8.5 9.9 0.0 6.7 0.7 6.0 0.6 0.0 0.3 0.0 0.1 0.2 0.6 20.4 0.0 1.3 0.0 0.0 0.1 32.0 0.0 0.0 0.8 0.3 0.5 1.2 8.3 0.0 20.4 0.3 0.5 0.6 2.3 0.0 0.1 20.8 2.2 6.1 0.3 13.8 0.0 0.3 0.0 0.0 24.7 5.8 1.7 1.8 18.8 0.0 30.9 16.1 2.6 39.1 8.5 0.3 0.4 0.0 4.5 7.5 0.1 0.0 0.2 1.7 0.4 6.6 0.7 6.6 0.1 1.0 0.2 1.0 0.1 18.6 0.5 0.0 0.1 GATD3A "C21orf33, D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI" ENSG00000160221 "Glutamine amidotransferase like class 1 domain containing 3A" P0DPI2 21 44133610-44210114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 180.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 7.0;Granulosa cells: 4.6;Hofbauer cells: 8.6;Proximal tubular cells: 4.8;Theca cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 156.3;U-266/70: 128.2;U-266/84: 117.9" HPA018517 Supported Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (9.61e-3)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-3)" "unprognostic (6.57e-2)" "unprognostic (8.19e-2)" "unprognostic (1.36e-2)" "unprognostic (8.61e-3)" "unprognostic (9.43e-2)" "unprognostic (4.60e-3)" "unprognostic (1.97e-3)" "unprognostic (1.40e-1)" "unprognostic (6.96e-2)" "unprognostic (1.30e-2)" 21.5 25.5 19.3 7.8 22.8 1.3 18.7 20.4 41.2 18.9 15.8 16.3 2.0 12.3 25.9 19.9 27.6 1.3 53.1 17.8 20.1 49.8 78.8 12.4 8.0 25.8 27.2 17.0 19.0 18.3 18.4 16.1 5.8 27.3 16.8 1.0 6.2 18.3 7.9 60.7 17.2 15.8 1.0 20.2 16.4 19.4 11.4 24.8 8.3 15.3 180.1 20.9 18.4 15.2 55.9 1.8 3.7 2.6 0.7 34.4 34.0 52.0 64.2 39.7 49.2 38.9 82.4 0.6 156.3 0.9 0.2 1.6 0.8 0.4 35.3 25.1 35.0 77.7 8.0 11.3 49.0 38.3 3.1 1.1 0.4 2.8 15.7 1.9 29.5 2.2 40.0 31.7 56.5 19.7 6.5 1.6 3.9 1.4 4.9 9.0 1.6 0.8 28.4 2.6 1.2 55.8 0.6 1.3 1.6 52.7 1.0 2.8 4.4 33.8 22.7 1.4 38.1 0.8 128.2 117.9 2.5 1.7 10.2 29.5 10.8 16.4 9.6 16.9 24.9 15.6 27.4 21.5 21.3 3.7 28.1 17.6 15.1 7.6 21.0 40.4 17.6 18.5 23.1 19.3 22.8 20.4 41.2 17.8 20.1 25.8 27.2 17.0 27.3 20.2 24.8 55.9 4.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 7.0 2.5 0.0 0.0 0.0 0.0 0.0 2.6 3.4 0.0 3.9 1.6 0.0 2.6 1.1 2.1 0.0 0.0 0.0 2.5 3.6 1.9 0.0 1.9 0.0 4.6 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 4.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.8 11.9 0.0 0.0 ICOSLG "B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.4;brain: 29.1" "Cell type enhanced" "Detected in many" "B-cells: 28.5;Glandular and luminal cells: 22.7;Langerhans cells: 39.0;monocytes: 21.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 19.9" "CAB026037, HPA029179, CAB079997" Approved Approved "Plasma membrane,Cytoplasmic bodies" NA NA 130000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , CAB079997: , HPA029179: AB_2732445" "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.7 3.6 11.4 4.9 19.1 18.4 2.6 9.2 13.6 3.4 1.6 2.1 2.5 2.0 1.4 5.5 3.4 4.1 4.3 10.1 15.0 7.1 3.3 3.1 8.1 17.4 17.1 6.5 0.8 2.1 0.7 1.4 3.1 20.7 3.3 1.8 1.4 3.0 1.4 1.6 6.6 3.9 1.3 9.3 4.4 5.0 1.4 15.1 2.6 2.3 1.8 5.6 3.2 3.6 29.1 0.5 4.6 0.2 3.9 1.0 1.5 10.4 1.0 0.9 0.5 0.3 7.9 0.6 19.9 2.9 0.5 1.8 5.8 2.7 1.6 0.3 2.0 2.0 0.6 4.0 2.3 0.9 8.7 14.1 1.4 2.6 1.2 1.3 0.3 1.1 0.7 3.3 1.7 0.3 5.2 0.4 11.4 2.7 13.2 4.8 17.1 1.3 11.6 0.8 10.3 2.0 0.1 12.9 18.2 0.4 1.4 5.1 12.2 1.1 0.6 4.4 0.4 0.4 16.4 12.2 16.2 5.8 8.0 2.5 0.3 0.3 0.2 0.1 0.3 0.1 1.8 0.3 0.1 0.2 2.4 0.3 0.4 0.3 0.2 0.2 0.7 0.1 0.2 11.4 19.1 9.2 13.6 10.1 15.0 17.4 17.1 6.5 20.7 9.3 15.1 29.1 1.2 0.0 1.5 0.3 28.5 7.5 5.8 8.4 3.4 1.7 8.7 5.8 0.6 1.5 2.4 9.2 0.0 0.4 2.0 7.9 0.0 2.0 1.9 9.8 2.1 4.6 5.3 0.8 0.0 0.7 1.1 5.6 4.6 22.7 0.0 0.2 1.4 2.8 3.7 0.0 0.0 4.5 8.2 8.8 39.0 4.0 3.1 15.6 8.8 0.0 21.0 1.2 2.1 0.0 0.5 0.8 3.8 10.9 4.7 16.0 3.6 3.5 0.6 1.2 0.0 4.5 6.1 0.1 0.2 4.7 6.5 0.5 2.9 0.3 4.5 7.9 AIRE "APECED, APS1, PGA1" ENSG00000160224 "Autoimmune regulator" O43918 21 44285838-44298648 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.2;lymphoid tissue: 1.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.1;Excitatory neurons: 1.1;Microglial cells: 1.9" "Cancer enriched" "Detected in single" 14 "testis cancer: 6.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (3.24e-2)" "unprognostic (2.37e-2)" "unprognostic (1.77e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.68e-1)" "unprognostic (1.37e-2)" "unprognostic (1.43e-1)" "unprognostic (8.53e-3)" "unprognostic (3.69e-3)" "unprognostic (1.79e-1)" "unprognostic (6.29e-7)" "unprognostic (5.04e-2)" "unprognostic (3.18e-1)" "unprognostic (2.27e-1)" "unprognostic (3.57e-2)" 0.0 0.0 0.8 0.1 0.6 0.1 0.1 0.4 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.2 0.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.6 0.4 0.9 0.6 1.1 0.7 0.8 0.6 0.7 0.4 1.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.9 0.7 0.2 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 CFAP410 "A2, C21orf2, LRRC76, YF5" ENSG00000160226 "Cilia and flagella associated protein 410" O43822 21 44328944-44339402 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 30.8;Extravillous trophoblasts: 15.7;Hofbauer cells: 35.5;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.9 22.4 13.3 5.1 12.7 11.5 19.7 12.8 18.7 21.3 10.9 20.6 6.5 23.6 2.3 12.6 26.5 3.9 19.2 13.7 13.3 26.1 27.1 18.7 6.6 15.4 15.5 13.4 22.5 24.2 7.5 34.7 3.3 14.5 26.6 1.4 10.0 18.7 5.1 16.2 17.9 19.4 2.4 12.9 21.1 20.9 31.1 15.3 4.3 33.1 5.0 2.4 19.4 14.9 15.0 12.9 5.2 4.9 6.3 3.2 2.0 19.3 6.4 3.7 2.5 1.3 9.4 3.7 9.1 12.5 2.2 5.1 6.0 0.9 1.2 0.6 14.2 12.9 9.5 4.3 11.2 4.1 10.2 9.8 2.9 2.2 1.0 2.2 4.4 1.6 6.7 11.6 15.1 1.6 15.5 11.2 25.0 12.2 6.4 7.8 28.6 6.3 20.3 2.9 18.0 12.9 12.2 8.9 2.1 11.0 2.9 9.3 22.0 7.5 5.4 6.9 5.8 4.9 25.1 14.2 6.4 13.2 20.4 9.9 1.7 10.2 1.6 9.4 12.6 11.3 16.6 10.0 13.2 10.5 11.6 11.3 11.1 1.3 17.3 9.5 31.3 6.1 7.6 13.3 12.7 12.8 18.7 13.7 13.3 15.4 15.5 13.4 14.5 12.9 15.3 15.0 5.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 30.8 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 15.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 32.7 1.1 0.0 0.0 0.0 ZNF66 "FLJ16537, ZNF66P" ENSG00000160229 "Zinc finger protein 66" Q6ZN08 19 20776304-20809995 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in many" "B-cells: 8.3;Erythroid cells: 7.4;Granulosa cells: 8.2;Plasma cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 18.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 18.6" "Cell line enhanced" "Detected in many" "RT4: 20.0" NA NA "unprognostic (4.67e-2)" "unprognostic (6.81e-2)" "unprognostic (1.63e-1)" "unprognostic (2.41e-3)" "unprognostic (1.30e-2)" "unprognostic (8.88e-2)" "unprognostic (3.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.57e-2)" "unprognostic (2.43e-2)" "unprognostic (5.88e-2)" "unprognostic (4.62e-3)" "unprognostic (1.58e-1)" "unprognostic (3.22e-1)" "unprognostic (1.77e-1)" "unprognostic (4.25e-2)" 2.2 1.9 15.2 2.5 13.6 7.9 2.4 26.0 26.0 1.4 2.0 2.1 3.0 2.6 3.1 1.9 1.9 2.5 1.4 13.7 5.1 1.9 2.4 2.0 3.7 10.5 8.8 15.2 9.0 3.3 1.1 0.5 2.4 16.3 2.4 2.2 10.8 2.6 1.9 3.1 4.8 3.4 1.5 1.7 2.6 4.1 3.2 6.8 2.6 3.4 0.6 2.1 2.8 1.3 21.0 6.6 2.3 4.6 9.6 1.4 1.0 8.1 3.1 0.9 3.2 2.8 4.5 6.5 5.7 13.0 1.4 3.2 2.7 0.5 1.1 2.4 3.8 3.4 5.0 6.2 3.1 0.2 2.9 2.5 1.0 1.7 2.0 1.5 1.6 0.5 3.9 5.5 10.1 1.9 9.1 7.0 4.5 12.2 3.1 2.7 6.1 5.8 4.2 3.5 20.0 6.6 5.8 2.0 4.5 2.0 9.9 8.8 4.2 2.9 5.7 8.0 6.9 5.0 9.4 12.1 5.7 2.1 2.0 3.3 13.0 2.5 3.4 2.7 1.2 2.0 3.3 2.5 2.1 1.1 4.5 3.1 2.9 18.6 4.4 2.2 3.6 2.1 0.8 15.2 13.6 26.0 26.0 13.7 5.1 10.5 8.8 15.2 16.3 1.7 6.8 21.0 2.2 3.2 1.1 0.0 8.3 0.1 0.6 0.0 6.2 1.3 1.4 1.7 1.0 0.0 1.3 3.7 2.1 0.6 3.0 0.1 1.9 0.6 0.1 2.4 3.4 2.7 3.0 7.4 0.0 0.6 0.6 2.4 3.1 3.0 1.3 8.2 1.8 0.1 0.4 1.7 0.0 0.1 0.0 1.3 0.5 0.7 1.2 1.7 1.8 0.0 0.2 0.3 1.0 0.0 0.0 0.7 2.6 0.4 6.9 0.4 0.0 0.3 0.0 1.9 0.0 1.2 2.5 3.1 3.5 5.9 0.4 0.1 4.4 3.8 0.4 0.5 LRRC3 "C21orf102, C21orf30, DKFZP434C128, LRRC3DN" ENSG00000160233 "Leucine rich repeat containing 3" Q9BY71 21 44455510-44462196 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.6" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 30.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "hypothalamus: 5.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 8.7;U-2 OS: 6.3" "Low region specificity" "Detected in all" HPA017975 Uncertain NA NA "HPA017975: AB_1853307" "unprognostic (1.36e-2)" "unprognostic (5.48e-3)" "unprognostic (1.49e-2)" "unprognostic (2.10e-4)" "unprognostic (1.55e-1)" "unprognostic (1.74e-2)" "unprognostic (7.20e-3)" "unprognostic (2.59e-1)" "unprognostic (4.61e-1)" "unprognostic (7.43e-2)" "unprognostic (1.37e-1)" "unprognostic (1.38e-2)" "unprognostic (1.74e-5)" "unprognostic (6.44e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-2)" "unprognostic (6.66e-3)" 1.9 1.4 0.7 0.8 0.5 0.6 1.5 0.1 0.6 1.4 0.3 5.1 1.7 1.3 0.4 1.1 1.5 2.2 1.7 0.5 5.7 0.6 15.6 1.6 0.5 0.6 0.5 0.5 3.4 0.8 0.3 1.3 0.9 0.5 0.8 0.8 0.3 1.1 0.6 0.5 1.8 1.6 1.5 0.2 1.1 3.9 1.7 1.0 0.5 0.6 1.0 0.3 2.0 1.3 0.6 0.5 0.4 3.5 2.9 0.0 0.0 8.7 1.5 0.0 0.1 0.0 1.3 1.2 0.0 2.6 0.7 1.9 0.1 1.7 0.0 0.0 0.2 3.8 0.0 0.4 4.0 0.6 0.0 2.3 1.1 1.4 0.0 0.0 0.0 1.4 0.6 0.3 4.5 0.0 1.3 0.5 0.2 0.9 4.5 1.4 1.9 0.0 1.5 0.1 0.1 2.8 3.2 1.3 0.3 0.6 1.9 0.8 1.9 2.8 0.0 6.3 0.0 0.0 2.5 5.2 0.0 0.0 1.6 0.5 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.1 0.6 0.5 5.7 0.6 0.5 0.5 0.5 0.2 1.0 0.6 2.6 0.0 1.5 0.0 0.8 0.6 1.1 0.0 3.4 1.1 0.6 0.9 2.0 1.5 0.0 1.8 0.0 0.2 0.3 1.6 0.0 0.3 0.3 0.2 0.4 0.6 4.2 2.7 0.0 0.4 6.6 2.5 1.5 0.9 1.3 2.4 1.1 30.7 2.5 0.0 0.1 1.8 0.0 2.5 0.5 1.5 0.6 1.1 0.0 0.0 3.2 1.4 1.0 0.0 0.1 1.7 0.3 0.7 0.2 1.3 1.8 0.0 0.0 0.0 0.0 0.8 1.4 0.9 2.0 0.6 0.6 0.3 0.8 0.3 1.7 0.7 ITGB2 "CD18, LFA-1, MAC-1, MFI7" ENSG00000160255 "Integrin subunit beta 2" P05107 21 44885953-44931989 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 379.5;lymphoid tissue: 176.8" "Group enriched" "Detected in many" 6 "dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "THP-1: 812.4;U-937: 615.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008877, HPA016894" Enhanced Supported "Plasma membrane,Rods & Rings" NA NA 3300000 "Plasma membrane" "Rods & Rings" "HPA008877: AB_1846256, HPA016894: AB_1846257" "unprognostic (1.94e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (2.95e-2)" "unprognostic (9.73e-3)" "unprognostic (2.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.18e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (4.42e-2)" "unprognostic (2.65e-2)" "unprognostic (4.83e-2)" 55.0 23.5 7.4 176.8 13.9 379.5 15.5 13.4 18.6 15.6 20.9 25.4 24.0 8.6 2.9 16.4 17.1 36.7 11.9 6.4 39.2 8.4 23.6 78.7 170.4 29.7 12.3 2.3 7.2 11.3 5.1 4.6 44.7 22.4 8.9 14.1 1.1 19.6 9.3 6.8 9.4 33.1 46.8 28.4 138.4 29.3 6.0 26.6 88.0 7.4 7.7 69.0 46.7 6.0 28.4 1.9 4.8 0.0 0.0 0.0 0.3 1.7 0.0 2.7 0.1 0.0 0.4 0.4 17.9 128.1 0.2 0.6 0.5 0.0 0.2 0.0 1.5 1.4 18.2 0.0 3.2 0.1 106.6 27.5 1.6 0.1 0.5 0.3 0.1 0.3 58.0 0.7 1.4 7.0 4.0 117.8 126.1 0.4 0.4 2.4 1.5 23.2 64.6 4.7 0.0 0.6 1.3 3.4 2.5 1.7 0.0 0.4 812.4 2.5 0.2 6.6 0.4 3.7 0.8 5.9 2.9 0.1 615.0 0.9 186.6 1848.8 1224.1 726.7 1144.9 326.6 86.1 349.7 506.5 1031.4 115.2 233.1 396.5 1386.1 585.5 1183.5 165.5 288.0 3034.2 7.4 13.9 13.4 18.6 6.4 39.2 29.7 12.3 2.3 22.4 28.4 26.6 28.4 7.1 16.0 29.6 0.3 81.7 5.5 0.5 9.6 0.6 0.0 4.1 6.5 4.0 14.3 18.6 5.5 0.0 4.0 417.6 0.3 0.0 3.4 1.0 0.6 0.5 16.8 0.0 19.6 0.5 0.4 4.8 5.3 2.6 0.7 24.1 8.2 9.7 8.6 652.4 0.0 0.3 0.2 2.0 485.9 259.1 2.8 0.6 527.4 5.4 27.2 463.8 0.4 959.9 0.0 0.2 0.6 0.1 1.5 50.5 0.6 1.8 4.2 3.6 0.8 6.6 2.1 3.2 0.2 1.0 0.9 5.1 5.6 254.5 0.0 0.3 0.7 FAM207A "C21orf70, PRED56" ENSG00000160256 "Family with sequence similarity 207 member A" Q9NSI2 21 44940012-44976989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034178, HPA036354, HPA036559" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: " "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "unprognostic (4.99e-3)" "unprognostic (1.05e-2)" "unprognostic (1.37e-2)" "unprognostic (1.14e-3)" "prognostic unfavorable (7.04e-4)" "unprognostic (3.23e-2)" "unprognostic (4.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.84e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (4.12e-1)" "unprognostic (5.77e-2)" 17.7 21.1 9.5 11.4 9.1 12.8 17.8 12.5 16.3 14.1 4.4 20.2 11.2 15.3 2.1 18.1 14.6 2.2 37.6 9.4 8.5 18.1 31.4 13.1 9.4 10.1 9.6 8.8 11.7 21.7 6.0 9.5 5.4 10.8 14.3 3.7 6.1 15.9 5.7 43.7 18.1 14.4 4.9 6.2 24.0 20.3 27.5 10.9 9.5 10.5 14.5 6.5 21.6 13.5 9.3 48.4 51.9 17.2 22.2 8.3 11.4 40.9 32.4 8.7 24.4 19.6 88.1 14.8 49.0 68.7 11.5 35.5 31.8 23.9 35.5 9.7 35.9 72.8 144.6 36.4 75.2 33.1 47.7 18.1 19.9 20.4 22.0 19.2 10.5 26.7 41.6 83.9 33.5 18.6 86.7 45.2 74.3 58.2 36.0 72.1 44.0 18.4 85.7 23.5 19.0 84.0 35.7 43.0 50.7 51.4 12.2 35.4 33.8 35.2 20.4 42.3 27.5 70.8 70.0 65.5 47.6 16.3 81.1 29.1 3.1 4.0 4.1 1.8 4.1 1.8 7.7 3.2 4.3 3.8 5.0 3.5 3.5 2.4 4.4 4.7 8.9 4.0 2.3 9.5 9.1 12.5 16.3 9.4 8.5 10.1 9.6 8.8 10.8 6.2 10.9 9.3 13.8 0.0 7.5 5.5 25.6 19.2 31.7 35.3 27.9 22.7 41.4 57.7 22.6 34.3 22.7 18.4 4.2 36.9 28.8 60.0 46.9 68.1 14.8 30.6 30.1 23.3 26.4 29.2 3.2 63.5 70.7 23.3 16.8 20.9 10.2 48.6 26.4 56.3 68.4 6.7 3.8 34.3 12.2 33.3 18.4 38.5 14.6 24.9 24.9 1.0 51.7 36.9 41.2 6.0 2.9 59.3 34.8 12.8 29.4 77.9 84.1 90.2 15.2 18.3 32.9 17.7 36.2 82.0 42.0 35.1 21.0 30.8 19.5 70.7 44.3 39.9 RALGDS "RalGEF, RGDS, RGF" ENSG00000160271 "Ral guanine nucleotide dissociation stimulator" Q12967 9 133097720-133149334 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 116.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 24.0;MAIT T-cell: 9.7;memory CD4 T-cell: 10.9;memory CD8 T-cell: 17.6;naive CD8 T-cell: 9.1;NK-cell: 9.0;T-reg: 20.8" "Group enriched" "Detected in many" 7 "NK-cells: 9.0;T-cells: 24.0" "Cell line enhanced" "Detected in all" "HDLM-2: 152.4;SH-SY5Y: 92.0" "HPA025961, CAB032582" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB032582: AB_2238105, HPA025961: AB_2671795" "unprognostic (1.01e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.35e-2)" "unprognostic (7.92e-3)" "unprognostic (8.20e-2)" "unprognostic (7.95e-2)" "unprognostic (5.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.91e-2)" "unprognostic (2.88e-1)" "unprognostic (2.69e-3)" "unprognostic (5.03e-2)" "unprognostic (9.54e-3)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" 34.0 29.9 66.3 20.4 76.2 42.2 35.8 68.0 76.3 20.7 30.6 25.8 17.5 19.2 12.9 40.8 24.1 31.5 25.8 59.7 60.1 14.8 13.5 36.1 27.9 81.4 81.4 54.2 33.3 23.1 16.7 69.1 11.0 86.8 25.2 10.2 7.3 32.0 20.5 32.7 57.9 25.4 13.8 76.3 22.4 21.5 6.1 75.3 16.0 23.7 16.4 17.0 39.1 29.9 111.9 7.5 10.9 22.2 27.8 8.3 12.1 18.7 8.8 13.0 8.8 5.7 9.5 16.1 11.3 8.0 15.1 13.4 33.8 22.7 16.1 2.9 152.4 16.3 9.6 22.0 13.8 10.8 15.6 16.9 14.2 22.1 4.7 9.7 23.7 18.2 21.7 19.3 68.4 8.3 24.6 22.2 15.0 15.3 33.3 27.6 22.2 5.4 18.9 10.8 13.0 70.1 92.0 10.5 15.4 14.0 8.6 16.0 15.9 9.5 9.8 10.3 7.4 6.1 3.2 9.2 14.0 8.6 17.4 11.2 2.3 0.6 0.9 24.0 0.3 9.7 1.7 10.9 17.6 0.8 0.5 2.4 9.1 0.4 9.0 0.3 0.8 20.8 6.1 66.3 76.2 68.0 76.3 59.7 60.1 81.4 81.4 54.2 86.8 76.3 75.3 111.9 83.9 32.1 11.3 43.4 17.2 55.4 46.3 19.5 40.5 16.6 55.5 40.5 7.2 12.8 21.4 9.2 12.5 5.5 45.7 40.6 3.9 11.4 0.6 100.2 11.7 54.1 37.0 14.3 34.1 6.7 4.5 21.8 26.0 93.1 15.8 26.9 36.4 3.8 12.5 62.2 29.8 14.4 22.4 9.8 51.1 1.8 13.4 33.6 23.2 12.2 4.9 16.3 46.4 32.2 86.4 11.5 31.5 9.1 26.5 43.9 26.7 2.5 34.5 9.3 0.0 43.7 15.4 2.5 5.1 47.6 101.4 5.9 41.6 19.6 17.6 116.6 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155579 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 947.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "Hep G2: 92.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" No NA 1600000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favorable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.3 1.7 4.8 0.2 5.7 0.0 0.4 2.9 8.5 1.3 2.4 1.0 1.3 1.2 0.4 0.3 0.9 0.1 1.3 4.3 3.9 151.3 947.4 0.2 0.3 4.0 3.7 4.3 3.0 4.0 0.0 3.4 0.0 4.9 4.2 0.0 0.0 0.2 0.6 0.5 0.3 1.7 0.0 2.8 0.5 0.5 14.0 3.6 0.0 0.9 0.0 0.0 1.3 1.0 6.5 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.0 92.9 0.0 0.6 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.9 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.5 0.0 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 4.8 5.7 2.9 8.5 4.3 3.9 4.0 3.7 4.3 4.9 2.8 3.6 6.5 0.0 0.0 0.0 1.0 8.1 0.1 0.0 0.0 0.0 1.3 0.2 0.5 1.5 131.5 0.0 9.2 0.0 0.0 0.1 0.0 46.9 0.0 104.7 0.1 0.4 1.8 0.0 61.5 10.5 0.0 0.0 0.6 0.0 0.2 0.0 0.6 30.4 444.9 0.1 3.3 5.9 0.1 0.0 28.9 0.0 124.3 3.1 1.6 0.0 1.0 0.0 0.2 0.0 1.0 18.5 0.0 0.1 2.6 0.0 0.5 0.3 395.1 0.0 0.4 0.0 0.2 0.5 39.2 17.9 0.2 0.4 0.0 3.6 0.1 0.2 0.1 SPATC1L C21orf56 ENSG00000160284 "Spermatogenesis and centriole associated 1 like" Q9H0A9 21 46161148-46184476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 49.3" "Group enriched" "Detected in many" 5 "Early spermatids: 208.9;Late spermatids: 472.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 36.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 37.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018979, HPA019165, HPA029394" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148" "unprognostic (1.46e-2)" "unprognostic (3.88e-2)" "unprognostic (3.95e-2)" "unprognostic (4.86e-2)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "prognostic favorable (2.16e-4)" "unprognostic (5.56e-2)" "unprognostic (2.35e-3)" "unprognostic (1.07e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-2)" "unprognostic (2.58e-1)" 7.2 23.6 3.5 1.0 2.6 1.4 8.6 0.0 4.9 10.8 0.0 8.9 1.3 9.9 0.6 7.8 6.9 1.4 11.3 2.2 0.4 7.4 1.3 5.9 1.6 1.2 0.2 1.1 14.0 11.4 1.6 14.3 1.1 1.8 32.7 0.7 0.3 6.7 2.5 5.6 9.9 6.9 0.8 0.0 8.4 8.3 49.3 0.6 1.0 6.3 0.8 1.0 9.9 11.8 2.4 2.9 0.0 3.6 6.7 2.0 4.7 1.9 4.1 2.2 2.2 1.7 0.0 1.8 9.0 8.0 5.0 2.6 0.5 0.0 3.2 0.6 8.3 6.6 21.6 1.3 5.0 0.1 0.0 8.5 5.0 1.5 0.0 0.0 4.2 7.2 10.1 37.8 13.2 3.1 5.7 7.0 2.5 15.0 4.0 18.0 15.4 4.9 10.0 3.4 0.8 1.1 6.9 3.2 1.7 8.6 2.5 5.6 8.3 0.4 6.5 8.0 9.3 6.3 21.9 12.6 6.6 8.6 11.9 6.1 1.5 5.7 36.1 4.3 6.8 5.6 7.6 6.2 5.9 8.6 7.6 9.7 9.2 0.3 6.6 4.7 7.2 7.0 3.6 3.5 2.6 0.0 4.9 2.2 0.4 1.2 0.2 1.1 1.8 0.0 0.6 2.4 20.5 0.0 0.0 3.6 13.5 23.6 11.6 21.4 18.2 6.8 11.9 14.6 1.9 12.8 6.9 3.7 0.0 3.4 10.1 7.7 15.6 16.8 208.9 6.3 14.6 15.4 60.4 12.8 2.6 20.5 17.7 18.1 13.7 8.8 0.0 18.8 14.6 0.6 13.7 3.3 2.0 16.4 8.2 8.8 24.4 472.3 32.3 9.9 28.4 1.0 5.9 5.8 6.2 3.0 3.1 17.8 6.6 31.6 28.0 24.1 6.8 13.4 2.8 3.1 19.7 12.0 14.0 17.8 14.7 17.0 40.1 3.1 11.7 4.0 18.3 8.1 LSS OSC ENSG00000160285 "Lanosterol synthase" P48449 21 46188141-46228824 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Isomerase "Cataract, Disease variant, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 132.0;Oligodendrocytes: 158.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 234.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032060, HPA032062, CAB034116" Supported NA NA "CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134" "unprognostic (2.78e-3)" "unprognostic (8.53e-3)" "unprognostic (6.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "unprognostic (1.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-2)" "unprognostic (1.68e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.92e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.07e-4)" 27.2 39.2 19.5 10.9 27.8 5.8 22.4 35.6 25.7 18.4 4.6 20.9 28.8 26.9 12.2 40.0 18.2 9.1 23.1 12.1 29.4 10.7 55.3 24.3 9.5 56.2 37.4 11.4 30.6 19.6 12.3 26.1 8.1 57.9 24.2 10.8 6.9 16.2 12.5 29.3 27.8 17.5 12.3 32.5 7.7 23.5 17.6 34.9 12.4 10.3 19.7 8.1 20.3 19.8 56.0 70.4 22.2 70.9 30.6 94.1 90.6 20.3 26.8 186.4 32.1 62.7 73.9 54.4 15.4 22.3 51.7 234.6 32.7 63.2 110.9 12.9 14.9 34.5 37.7 38.6 48.3 85.5 13.7 25.1 89.0 41.4 59.7 25.6 22.2 26.9 72.1 37.4 87.3 27.8 23.8 29.9 19.7 115.4 11.3 20.1 34.9 21.9 92.2 82.8 38.1 41.4 36.7 31.4 24.0 27.5 30.6 38.0 33.7 40.8 37.9 30.2 33.8 21.1 31.8 29.5 30.6 39.7 59.4 16.6 4.6 2.1 2.2 4.0 1.8 2.8 3.1 2.9 4.9 2.4 1.5 2.4 3.6 0.0 1.7 1.5 5.0 1.4 3.6 19.5 27.8 35.6 25.7 12.1 29.4 56.2 37.4 11.4 57.9 32.5 34.9 56.0 13.8 12.8 36.8 66.6 7.2 37.0 3.8 30.2 8.0 16.0 15.3 8.0 13.7 14.3 18.7 11.0 4.2 3.7 11.8 10.4 0.0 10.5 6.5 6.6 16.4 10.3 19.7 16.8 21.2 17.2 6.7 19.7 13.3 14.6 3.8 20.6 11.4 132.0 9.7 23.5 24.2 11.6 16.2 7.5 13.7 6.6 21.1 4.9 21.4 21.5 12.0 7.5 5.2 22.1 158.8 14.0 2.7 13.5 6.3 16.2 5.0 4.1 11.0 16.4 0.0 9.8 8.5 20.3 18.1 12.6 54.0 6.3 7.9 18.0 10.9 4.6 VAV2 ENSG00000160293 "Vav guanine nucleotide exchange factor 2" P52735 9 133761894-133992604 "Plasma proteins, Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 48.3;Inhibitory neurons: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.3" "Group enriched" "Detected in many" 22 "B-cells: 3.3;dendritic cells: 1.1;monocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003224 Uncertain Approved Vesicles NA NA Vesicles "HPA003224: AB_1080554" "unprognostic (1.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (6.57e-2)" "unprognostic (1.16e-3)" "unprognostic (1.83e-2)" "unprognostic (3.74e-3)" "unprognostic (4.73e-2)" "unprognostic (9.16e-2)" "prognostic favorable (7.39e-7)" "unprognostic (8.64e-3)" "unprognostic (3.00e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (3.97e-2)" 7.8 27.0 8.5 10.8 8.4 3.1 7.7 7.3 9.9 11.2 9.4 10.7 21.1 9.9 7.3 6.7 12.3 10.9 6.6 11.3 9.4 21.5 46.5 16.9 13.4 11.1 14.3 7.2 5.5 38.9 10.9 8.0 13.2 10.6 10.3 9.7 3.0 13.3 8.9 2.0 5.8 22.6 7.0 7.9 14.0 9.6 4.5 8.2 6.3 14.0 2.4 13.4 11.5 8.0 8.2 12.5 21.6 33.3 13.5 9.0 15.1 85.8 24.6 13.5 20.3 12.2 33.0 19.0 3.6 19.6 24.6 26.2 72.8 31.6 53.0 10.4 21.3 7.3 4.2 28.3 37.2 33.4 10.3 1.6 15.0 33.5 17.9 25.3 13.6 22.9 7.3 7.3 6.0 14.2 63.5 0.8 5.1 16.3 54.3 20.5 33.9 28.2 12.1 46.1 22.4 36.9 24.9 64.7 42.7 8.8 21.3 26.0 14.5 18.7 28.6 16.0 28.7 34.5 0.4 0.3 6.8 19.1 8.8 18.0 0.0 0.8 0.0 0.0 2.0 0.0 3.3 0.0 0.0 1.1 2.1 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.5 8.5 8.4 7.3 9.9 11.3 9.4 11.1 14.3 7.2 10.6 7.9 8.2 8.2 4.8 0.0 5.4 20.5 11.2 5.1 3.0 10.1 4.0 1.9 6.7 5.6 4.7 21.5 7.5 36.8 0.0 1.3 0.6 27.0 3.9 9.2 2.5 6.9 6.4 6.6 28.2 0.4 8.5 12.5 18.3 5.0 9.7 13.9 0.0 24.6 6.8 48.3 6.2 0.0 40.9 9.8 6.1 5.4 7.2 7.9 7.2 7.7 1.8 8.4 9.3 4.2 2.1 31.2 2.6 24.7 15.6 6.0 3.3 6.3 35.7 13.6 3.3 1.8 13.1 6.4 8.8 0.1 3.8 2.1 2.7 1.0 1.7 12.0 13.5 2.1 MCM3AP "GANP, KIAA0572, Map80, SAC3" ENSG00000160294 "Minichromosome maintenance complex component 3 associated protein" O60318 21 46235133-46286297 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Immunity, mRNA transport, Protein transport, Translocation, Transport" "Acyltransferase, Transferase" "Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021527, HPA032103" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA021527: AB_1853626, HPA032103: AB_2674152" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (6.31e-3)" "unprognostic (1.48e-2)" "unprognostic (2.06e-1)" "unprognostic (4.17e-2)" "unprognostic (4.76e-3)" "prognostic favorable (2.05e-4)" "unprognostic (1.96e-1)" "unprognostic (2.81e-3)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (2.28e-1)" 16.9 12.1 9.1 20.5 10.8 19.9 13.7 8.5 9.2 14.8 15.8 15.2 14.1 16.6 8.3 14.4 15.4 14.3 15.3 8.0 8.5 13.2 9.8 16.2 21.2 10.3 10.2 6.5 17.8 15.5 17.0 9.3 16.4 11.5 14.3 15.1 12.9 13.9 13.6 41.7 13.9 16.2 17.2 8.7 19.7 15.5 14.3 10.4 21.9 16.1 29.0 21.7 13.7 11.3 13.8 38.0 36.3 41.8 45.5 33.1 41.4 38.0 40.8 48.1 37.1 30.2 33.1 21.9 53.6 32.9 43.2 40.3 21.9 55.9 34.0 32.7 55.7 50.8 87.9 35.0 25.9 29.6 40.6 47.7 31.7 28.7 51.2 35.2 25.4 40.7 31.7 107.3 39.6 43.3 21.1 43.5 26.8 72.3 40.0 30.2 56.3 26.6 48.9 17.8 34.1 35.2 37.6 52.4 33.7 39.0 31.5 46.0 41.2 51.6 39.1 29.7 33.1 31.0 71.8 86.2 33.0 35.3 38.0 51.8 0.6 2.0 1.6 2.3 1.9 2.4 1.1 1.3 2.6 1.9 1.6 1.2 1.3 1.2 1.1 1.1 1.6 1.8 2.1 9.1 10.8 8.5 9.2 8.0 8.5 10.3 10.2 6.5 11.5 8.7 10.4 13.8 17.3 9.6 18.9 28.1 21.3 7.0 7.1 9.0 22.2 21.8 13.8 13.0 4.7 14.3 12.7 11.0 20.9 11.4 20.6 17.5 1.9 11.3 3.5 16.8 23.7 14.8 12.0 18.5 28.0 14.2 11.7 12.8 27.0 17.7 8.8 20.1 11.7 18.6 15.4 16.8 34.2 19.2 10.2 19.7 8.4 4.3 18.3 18.6 10.6 34.7 24.3 9.3 16.5 37.2 35.3 15.9 8.6 14.3 21.6 14.0 13.8 6.6 15.5 21.7 19.7 17.9 12.9 19.7 15.0 21.2 10.4 9.3 19.1 16.0 17.9 7.9 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.7;pituitary gland: 20.9" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "REH: 62.0" "Not detected" "Not detected" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.4 1.7 1.8 3.6 2.4 13.2 2.0 2.2 2.3 3.1 2.3 2.7 4.7 2.1 0.7 3.9 26.7 1.0 1.2 1.5 1.6 1.4 1.7 4.8 6.3 2.3 2.2 1.2 2.6 2.5 1.2 20.9 2.0 2.6 2.9 2.6 2.5 2.3 1.5 1.8 5.4 4.4 1.3 1.7 3.4 3.5 7.1 2.3 13.0 2.2 0.7 3.8 2.1 2.7 2.8 26.0 11.6 30.2 19.0 2.9 4.0 16.7 15.7 5.7 10.8 10.5 5.4 18.6 18.6 3.8 4.4 12.5 20.3 8.1 6.7 3.2 19.9 17.8 29.9 35.2 3.1 0.7 8.6 16.6 1.7 1.4 7.7 1.9 4.0 6.8 45.4 17.4 48.1 8.9 10.6 42.7 11.6 13.0 7.2 5.7 62.0 13.6 16.6 3.4 4.8 24.7 15.4 11.7 8.3 3.7 6.4 20.5 17.1 4.7 6.6 18.4 6.6 9.6 19.3 9.3 8.8 11.6 37.1 17.4 4.4 0.2 0.6 0.4 0.1 0.2 0.1 0.5 0.6 0.0 0.9 0.9 0.7 0.3 0.3 0.1 1.0 0.8 0.5 1.8 2.4 2.2 2.3 1.5 1.6 2.3 2.2 1.2 2.6 1.7 2.3 2.8 2.1 3.2 2.6 4.2 3.1 0.9 1.6 7.0 2.8 19.5 6.2 8.8 3.0 0.0 16.6 1.8 27.1 7.7 9.4 13.9 0.0 1.7 17.3 141.9 7.7 2.3 69.4 80.2 2.7 1.0 5.9 5.9 11.7 4.5 2.5 21.4 2.2 1.5 4.0 5.0 2.5 12.8 14.2 1.6 1.9 32.5 5.3 6.2 0.0 0.0 1.3 5.9 5.2 1.5 4.2 1.2 4.1 2.6 4.8 2.0 3.0 0.7 164.1 28.2 0.0 2.6 5.5 80.8 45.3 8.5 1.4 1.4 3.7 3.9 16.8 0.9 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324141-46445769 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 241.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Uncertain Supported "Centriolar satellite,Centrosome,Cytosol" NA NA Centrosome "Centriolar satellite, Cytosol" "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151" "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 9.2 11.2 8.5 6.0 10.3 17.9 8.9 4.9 10.6 8.4 6.0 10.4 4.2 8.2 4.3 11.8 8.6 3.6 21.9 6.9 5.6 7.8 11.0 8.3 8.3 9.5 6.6 5.9 9.7 7.9 4.4 20.5 3.5 10.4 8.3 4.4 4.6 9.8 4.3 241.2 12.4 10.2 4.5 3.4 11.6 9.6 25.8 5.7 12.7 8.4 52.4 5.5 9.7 9.3 8.3 15.4 11.6 18.0 11.1 8.9 8.8 11.3 11.6 8.0 11.3 10.0 14.2 9.7 15.2 7.3 13.4 15.3 10.8 14.6 9.9 7.8 44.9 20.4 40.2 24.1 11.3 3.1 20.6 16.1 4.8 7.5 15.2 7.6 5.5 8.8 15.8 20.9 22.4 15.8 25.4 20.6 21.3 18.0 13.9 8.0 25.3 7.2 13.5 8.7 16.3 22.1 9.8 25.4 15.7 8.0 4.4 14.8 16.0 12.1 20.4 10.2 11.7 18.9 19.3 17.2 16.4 12.6 19.9 11.1 6.0 0.6 1.2 1.5 0.5 4.6 0.3 0.7 4.8 2.0 0.1 0.5 8.8 0.4 0.4 1.0 4.6 0.8 2.0 8.5 10.3 4.9 10.6 6.9 5.6 9.5 6.6 5.9 10.4 3.4 5.7 8.3 10.5 28.9 32.0 19.9 8.6 8.3 5.7 7.0 13.6 15.0 8.9 8.6 35.7 10.0 15.3 0.0 6.2 6.4 36.7 14.0 0.0 7.1 20.4 17.0 19.9 10.1 15.6 36.2 38.1 7.6 7.4 13.1 25.0 17.8 16.4 25.4 7.1 9.0 23.3 23.5 39.0 11.2 4.1 6.9 5.5 25.6 12.8 12.7 0.0 17.8 14.7 6.8 25.7 10.6 21.9 5.7 5.7 12.0 31.4 4.2 5.7 4.1 13.0 11.1 26.3 61.3 14.2 40.5 39.8 25.0 7.1 6.4 18.8 15.1 10.4 5.1 DIP2A "C21orf106, Dip2, KIAA0184" ENSG00000160305 "Disco interacting protein 2 homolog A" Q14689 21 46458891-46570015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Ligase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 159.6;Oligodendrocytes: 143.0;Rod photoreceptor cells: 206.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052516 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052516: AB_2681859" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (6.52e-2)" "unprognostic (3.88e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.35e-5)" "unprognostic (1.37e-1)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (3.86e-2)" "unprognostic (1.70e-2)" "unprognostic (6.05e-3)" "unprognostic (1.05e-1)" "unprognostic (8.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-3)" 5.7 5.4 3.6 6.1 6.5 9.9 5.2 4.3 5.4 6.4 2.5 6.0 6.7 5.8 2.2 6.7 6.3 4.5 8.5 5.1 8.0 3.5 3.0 5.6 7.3 6.6 6.8 1.5 7.3 6.8 5.2 5.0 6.0 7.3 7.0 4.1 10.7 6.9 4.0 6.8 6.8 7.4 5.1 3.6 9.0 7.3 7.4 5.7 6.5 5.2 6.6 4.8 5.2 6.2 15.0 14.3 9.5 17.4 8.2 7.9 7.4 10.8 9.7 7.4 9.5 7.7 17.0 10.5 5.9 9.1 10.1 9.8 7.3 7.9 13.4 5.6 23.4 11.1 20.1 15.8 10.1 5.4 7.3 10.3 6.8 8.8 10.2 11.2 7.3 14.1 11.4 13.4 13.9 7.9 13.3 11.7 10.9 9.5 12.6 9.4 11.6 7.0 12.4 5.6 13.2 9.3 5.8 15.0 9.8 8.4 4.6 10.3 7.0 19.0 7.8 5.5 11.2 7.2 13.9 7.6 5.4 8.3 12.3 12.8 11.9 5.2 12.4 14.4 6.5 9.4 3.3 6.5 9.9 2.9 3.6 4.5 9.3 10.3 10.1 7.4 10.6 5.8 4.6 3.6 6.5 4.3 5.4 5.1 8.0 6.6 6.8 1.5 7.3 3.6 5.7 15.0 35.3 41.7 19.2 40.8 18.6 14.7 9.3 13.8 23.9 55.9 18.0 16.6 30.7 18.6 20.5 14.7 116.7 11.3 97.0 23.9 9.8 10.7 18.8 21.3 32.8 33.2 24.0 12.8 86.9 11.0 9.5 23.2 50.0 25.7 13.3 34.9 34.2 11.2 18.0 18.5 101.8 21.7 4.1 39.9 17.3 25.6 23.9 26.5 7.2 119.9 21.4 16.3 159.6 68.9 143.0 20.9 15.7 22.2 58.4 19.3 23.4 8.0 26.4 206.8 26.3 31.4 18.3 54.2 38.3 20.7 17.6 11.2 63.1 19.1 23.1 13.3 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598604-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 1576.0;choroid plexus: 797.0" "Cell type enhanced" "Detected in many" "Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 360.9" "Lineage enriched" "Detected in all" 6 "T-cells: 360.9" "Group enriched" "Detected in some" 7 "SK-MEL-30: 547.1;WM-115: 992.8" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 300000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 152.5 26.0 895.8 10.6 1057.3 2.3 87.8 1260.8 1200.9 25.0 797.0 88.1 7.5 2.5 12.2 14.7 6.9 14.4 18.4 874.8 1068.7 3.3 3.2 6.4 21.6 1398.0 1078.4 792.9 5.7 5.0 0.3 45.0 0.8 1308.0 29.6 14.3 14.3 19.5 26.4 3.6 14.3 36.6 6.8 1307.6 26.5 23.8 2.4 1022.1 18.6 5.2 6.5 20.5 16.0 27.2 1576.0 0.5 0.0 110.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 15.9 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 2.5 0.0 0.0 547.1 0.0 0.1 0.5 0.0 0.3 0.3 0.0 3.2 0.0 0.3 0.0 1.4 6.7 992.8 0.1 0.5 0.2 360.9 9.5 103.3 0.2 1.0 67.6 16.3 1.4 3.2 153.1 3.2 58.7 10.1 3.9 0.0 63.6 895.8 1057.3 1260.8 1200.9 874.8 1068.7 1398.0 1078.4 792.9 1308.0 1307.6 1022.1 1576.0 4.5 3.2 4.8 126.3 4.6 16.8 0.7 0.0 17.6 1.3 41.2 124.8 6.0 0.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.1 0.4 0.1 0.1 2.7 0.0 2.7 0.9 0.0 0.1 4.4 0.5 0.2 0.0 261.7 4.6 0.4 9.3 0.0 1.4 0.0 0.0 38.6 206.8 1.7 5.6 37.0 99.6 9.4 33.3 25.7 63.8 83.4 332.1 0.1 0.0 0.0 2.2 0.1 0.0 0.1 0.0 4.7 0.0 5.6 7.8 0.1 0.1 0.7 12.6 0.1 37.9 0.0 0.2 0.4 PRMT2 "HRMT1L1, MGC111373" ENSG00000160310 "Protein arginine methyltransferase 2" P55345 21 46635595-46665124 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 451.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018976, HPA029591" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA018976: AB_1855719, HPA029591: AB_10601250" "unprognostic (1.82e-1)" "unprognostic (2.96e-1)" "unprognostic (8.61e-3)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-3)" "unprognostic (1.34e-1)" "unprognostic (2.23e-1)" "unprognostic (6.78e-2)" "unprognostic (4.34e-3)" "unprognostic (1.72e-1)" "unprognostic (4.62e-3)" "unprognostic (8.76e-3)" "unprognostic (2.86e-2)" "unprognostic (1.91e-3)" "unprognostic (2.23e-1)" 37.8 25.6 87.4 42.7 82.5 37.7 39.4 86.2 84.6 43.9 74.5 43.4 27.3 43.6 27.0 55.7 47.4 42.9 56.8 77.0 94.1 36.7 14.5 41.1 57.6 97.4 95.2 74.0 83.3 27.6 30.1 28.2 49.7 97.7 38.4 30.7 23.3 38.9 48.8 20.6 51.6 37.0 50.9 95.7 50.2 32.4 16.5 97.7 45.7 36.3 22.0 53.2 44.7 38.6 105.3 75.7 63.4 130.2 48.1 94.0 90.1 31.1 70.6 79.0 77.4 70.2 88.8 60.4 44.5 85.6 126.9 104.3 22.0 59.3 87.4 44.7 110.1 57.2 115.8 55.0 67.4 43.3 34.9 51.7 56.1 85.0 93.4 66.6 87.6 114.5 61.2 74.5 80.4 121.0 84.1 50.3 63.9 69.3 47.5 73.6 63.2 33.2 29.6 61.1 63.3 89.4 56.6 73.8 33.0 135.0 18.5 44.1 35.2 104.8 75.2 50.5 40.4 47.4 21.2 21.0 28.6 70.4 92.4 115.3 256.5 91.9 314.2 261.8 128.4 192.0 93.6 176.3 227.2 131.5 82.7 215.9 248.8 122.3 262.0 135.3 112.7 142.3 223.2 87.4 82.5 86.2 84.6 77.0 94.1 97.4 95.2 74.0 97.7 95.7 97.7 105.3 71.5 93.0 36.2 54.5 74.4 46.1 69.8 79.1 66.6 47.7 93.2 103.5 69.5 67.2 61.8 75.4 29.2 64.3 192.9 49.4 90.1 79.1 3.5 51.9 60.2 82.9 35.8 27.3 39.2 52.9 43.5 68.0 48.9 46.1 117.0 132.0 142.8 42.1 107.2 37.0 42.6 32.6 52.9 133.7 102.1 9.0 55.6 109.3 87.2 74.0 182.9 61.1 451.1 69.4 160.6 74.9 40.0 62.1 64.6 94.0 44.0 113.5 71.4 57.7 65.7 53.2 77.2 22.0 39.0 75.0 45.0 69.2 167.1 55.0 38.3 72.9 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 45.3" "Cell type enriched" "Detected in many" 9 "Early spermatids: 344.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056971 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA056971: AB_2683294" "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 5.0 4.6 9.6 2.0 9.1 9.7 4.2 10.5 12.3 3.7 7.9 4.3 4.6 2.7 0.1 2.7 3.7 1.6 3.1 9.8 9.4 3.8 4.7 3.3 2.0 9.8 9.3 8.9 4.4 5.3 1.0 3.4 0.9 10.1 4.3 1.2 1.9 4.4 1.5 2.5 1.8 4.4 0.6 8.8 6.6 2.9 45.3 9.4 1.0 3.5 2.7 0.5 4.9 3.3 10.7 2.0 5.5 2.0 2.7 2.8 2.5 1.1 0.9 0.4 0.9 1.2 0.6 6.4 5.1 1.1 0.5 0.6 2.5 0.6 0.3 0.2 3.6 8.6 4.5 9.1 11.0 1.1 1.3 1.3 1.9 0.9 0.2 0.5 1.3 0.6 2.5 3.0 3.7 0.8 1.2 1.1 7.5 0.8 5.6 6.9 1.0 4.5 2.1 1.5 1.4 1.1 1.3 2.3 0.5 1.8 1.0 1.4 0.3 1.2 1.9 3.9 2.0 0.8 3.4 3.9 2.0 4.7 5.1 1.2 3.0 0.4 2.1 1.7 1.0 0.9 0.8 0.4 2.2 0.7 0.4 0.3 0.7 0.2 2.9 0.4 1.5 0.6 0.3 9.6 9.1 10.5 12.3 9.8 9.4 9.8 9.3 8.9 10.1 8.8 9.4 10.7 4.3 0.0 3.7 8.5 3.1 1.7 5.6 1.3 5.7 5.4 7.8 8.3 6.9 12.8 1.2 16.5 0.0 1.8 8.1 4.9 3.9 1.0 344.4 0.9 3.0 2.4 10.3 8.2 2.1 0.7 1.7 3.4 6.6 1.5 15.8 1.8 5.3 17.4 2.6 3.3 4.3 16.8 4.1 4.1 4.0 36.1 6.2 3.7 1.8 4.7 2.4 2.5 9.2 0.5 3.2 0.7 5.8 6.4 3.7 3.4 13.3 5.5 6.0 2.3 0.0 5.4 5.4 23.5 1.3 7.5 2.7 0.8 4.4 1.4 12.3 5.5 ZNF208 "PMIDP, ZNF95" ENSG00000160321 "Zinc finger protein 208" O43345 19 21932958-22010949 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3" "Group enriched" "Detected in some" 4 "ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2" HPA077100 Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA077100: " "unprognostic (4.06e-3)" "unprognostic (2.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.75e-1)" "unprognostic (7.46e-2)" "unprognostic (1.66e-1)" "unprognostic (2.87e-1)" "unprognostic (6.23e-2)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.29e-2)" "unprognostic (1.66e-1)" "unprognostic (4.94e-2)" "unprognostic (7.21e-3)" "unprognostic (1.70e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-3)" 4.2 1.1 4.5 2.0 7.0 1.5 3.4 3.2 4.9 4.1 3.1 3.6 1.4 6.7 4.7 2.3 4.9 3.5 11.5 6.5 7.4 3.4 0.7 1.4 2.8 9.4 7.0 3.6 3.4 2.6 13.4 7.1 2.7 8.6 3.6 1.5 2.4 2.8 3.3 1.0 4.1 2.2 6.0 3.7 2.7 1.7 8.7 6.1 0.5 8.0 1.3 1.7 3.2 2.7 7.5 0.4 0.3 0.5 1.1 0.0 0.2 1.5 0.3 0.1 0.2 0.1 1.8 0.6 0.6 0.3 0.3 9.3 0.7 1.2 0.2 0.4 0.2 0.2 0.6 1.5 0.8 0.0 0.4 0.2 1.0 0.3 0.0 0.2 0.7 0.4 0.4 0.5 1.6 0.0 0.5 0.4 0.6 33.1 0.0 1.1 0.2 0.0 1.9 1.1 1.8 0.8 1.6 0.2 0.8 0.3 6.9 0.9 0.8 0.0 0.5 0.3 1.9 0.1 1.0 11.2 0.2 0.1 0.4 0.7 2.4 0.6 0.7 0.8 0.4 0.4 1.3 1.5 0.5 0.3 1.6 0.6 0.9 2.6 1.0 0.3 1.6 1.5 0.3 4.5 7.0 3.2 4.9 6.5 7.4 9.4 7.0 3.6 8.6 3.7 6.1 7.5 6.7 0.0 0.0 11.4 4.3 0.0 1.0 0.0 0.6 6.6 4.2 2.5 11.4 0.0 1.3 5.5 0.0 6.8 0.5 0.0 3.9 6.6 15.4 0.2 3.7 3.4 0.0 1.3 11.5 0.2 3.1 5.9 0.5 0.1 0.0 2.7 1.1 0.5 0.7 3.3 1.7 0.0 0.0 0.0 0.7 14.1 1.5 0.2 0.0 9.4 0.0 0.8 1.0 11.1 26.3 0.7 0.0 1.2 0.4 1.2 0.0 2.6 0.0 0.4 0.0 2.5 1.7 8.7 6.2 0.9 0.3 5.3 2.2 0.3 0.0 2.0 ADAMTS13 "C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP" ENSG00000160323 "ADAM metallopeptidase with thrombospondin type 1 motif 13" Q76LX8 9 133414358-133459402 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 64.3" "Cell type enhanced" "Detected in many" "Astrocytes: 16.0;Early spermatids: 19.3;Excitatory neurons: 12.4;Inhibitory neurons: 12.4;Late spermatids: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042014, HPA042844, HPA052077" Approved Approved Vesicles "Secreted to blood" NA NA 1300000000 120000000 Vesicles "HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: " "unprognostic (1.09e-1)" "unprognostic (1.45e-1)" "unprognostic (8.75e-4)" "unprognostic (1.49e-2)" "unprognostic (1.83e-1)" "unprognostic (3.02e-1)" "unprognostic (4.76e-2)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.88e-1)" "unprognostic (4.52e-5)" "unprognostic (1.11e-1)" "unprognostic (9.91e-2)" "unprognostic (4.78e-2)" "unprognostic (3.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.30e-3)" 2.2 2.8 7.2 0.5 7.5 0.6 2.9 8.0 10.1 4.3 5.6 4.0 3.3 4.3 2.9 2.5 5.7 1.3 5.7 7.4 6.7 7.6 64.3 2.8 0.9 7.5 7.2 7.3 6.8 6.3 1.5 12.6 0.8 8.0 6.4 0.9 1.1 2.5 1.4 4.3 2.4 4.5 0.6 6.5 2.6 9.8 13.6 7.5 0.8 6.1 1.5 0.5 4.4 3.1 7.7 0.0 0.8 1.9 2.6 1.5 1.3 0.8 0.7 0.5 0.2 0.3 0.3 2.1 0.2 0.9 0.4 0.6 0.3 0.1 0.4 0.1 1.2 1.7 0.2 0.9 0.4 1.1 0.0 0.7 3.6 0.9 0.2 0.7 1.2 0.1 1.3 0.0 0.8 0.3 3.3 0.0 0.9 2.0 1.1 1.1 0.2 0.2 0.9 0.8 0.8 1.3 4.0 1.4 0.6 1.2 3.9 3.7 0.4 0.5 1.5 0.8 0.9 0.0 1.7 0.3 0.3 1.1 0.2 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 7.5 8.0 10.1 7.4 6.7 7.5 7.2 7.3 8.0 6.5 7.5 7.7 0.9 0.0 2.0 16.0 1.2 0.3 0.3 0.9 0.0 1.7 1.4 1.9 4.2 4.3 2.4 0.0 0.0 0.2 0.2 1.0 1.9 0.6 19.3 3.6 1.6 0.9 1.2 0.0 12.4 0.4 0.3 1.5 4.6 3.3 0.0 3.0 5.0 1.6 0.2 3.3 12.4 1.3 0.0 0.6 0.0 13.6 0.9 0.3 0.0 7.5 0.0 1.7 0.0 2.0 5.5 0.3 3.0 1.5 0.4 0.4 1.5 0.9 0.7 1.8 0.0 0.4 0.7 6.0 3.9 0.3 0.4 0.1 0.5 1.7 0.9 0.3 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 59.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 75.5;Gastric mucus-secreting cells: 67.2;Hepatocytes: 47.9;Paneth cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.8" "Group enriched" "Detected in many" 4 "B-cells: 2.0;granulocytes: 3.8" "Cell line enhanced" "Detected in many" "T-47d: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm NA NA Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 4.9 11.4 8.0 1.9 6.2 2.4 7.0 7.6 7.0 8.5 6.4 15.8 5.8 9.9 5.3 9.9 9.3 4.5 10.9 7.0 5.8 27.2 59.1 13.0 1.5 7.6 6.3 5.3 10.8 19.1 7.9 19.2 1.2 7.3 13.4 2.8 2.1 16.0 4.1 9.1 5.3 15.1 2.4 6.2 7.4 28.6 24.1 6.5 0.9 17.5 1.8 1.7 11.9 7.0 11.0 0.4 2.1 4.3 2.7 0.8 0.1 2.5 2.0 2.9 1.5 0.3 5.7 4.8 0.2 4.2 2.0 2.6 1.2 2.2 1.6 0.0 1.1 1.4 0.6 4.8 2.5 2.5 0.0 0.6 0.0 3.2 1.3 1.0 4.8 1.8 1.1 0.8 1.8 2.4 3.7 0.3 0.7 3.4 3.3 1.5 1.4 0.6 9.3 2.9 1.7 4.9 9.1 2.5 5.6 0.9 2.6 9.5 1.6 0.4 3.5 2.2 0.6 0.1 3.4 4.8 2.4 1.1 0.3 1.1 3.8 0.5 1.6 0.2 0.0 0.0 2.0 0.1 0.4 0.4 0.7 0.1 0.5 0.0 0.6 0.2 0.2 0.2 0.1 8.0 6.2 7.6 7.0 7.0 5.8 7.6 6.3 5.3 7.3 6.2 6.5 11.0 1.7 19.2 19.6 3.3 5.5 2.8 5.5 5.0 3.4 4.6 13.0 8.9 9.8 21.5 8.8 20.2 12.5 1.9 1.0 75.5 3.9 22.0 13.4 9.8 5.4 3.8 29.2 0.0 5.8 33.1 3.3 4.0 67.2 15.1 4.5 5.9 5.3 47.9 3.6 3.3 4.8 43.1 10.2 5.6 2.2 8.1 8.1 2.1 5.4 1.9 5.9 6.7 2.1 4.5 4.7 26.2 53.2 7.5 3.9 7.0 31.7 16.5 5.2 9.8 0.0 3.4 4.4 13.7 14.7 2.9 1.6 2.9 1.9 2.9 24.5 6.2 SLC2A6 "GLUT6, GLUT9, HSA011372" ENSG00000160326 "Solute carrier family 2 member 6" Q9UGQ3 9 133471094-133479127 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;lymphoid tissue: 13.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;granulocytes: 47.4;monocytes: 60.4;Paneth cells: 39.8;Rod photoreceptor cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 73.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.1;HMC-1: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042272, CAB046014" Uncertain NA NA "CAB046014: AB_2270444, HPA042272: AB_2677924" "unprognostic (2.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.87e-3)" "unprognostic (1.71e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.26e-1)" "unprognostic (2.23e-1)" "unprognostic (5.93e-2)" "unprognostic (1.05e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (1.02e-11)" "unprognostic (7.24e-2)" "unprognostic (3.43e-2)" "unprognostic (9.36e-2)" "unprognostic (6.28e-3)" 3.7 3.9 5.9 4.7 5.6 4.4 3.0 6.4 9.1 1.3 2.3 2.3 0.9 2.5 0.7 1.1 1.5 0.8 4.4 6.1 6.2 2.8 3.5 8.4 4.1 10.7 7.1 6.1 0.9 2.7 0.5 2.3 0.7 11.8 1.9 0.4 0.7 1.5 0.4 1.1 0.9 6.8 0.9 4.4 13.4 2.5 1.6 8.7 0.5 1.8 0.3 2.3 4.5 1.4 10.5 5.7 9.6 3.2 9.4 1.8 2.7 2.8 5.2 8.5 4.9 5.2 4.3 7.5 4.5 14.0 4.8 23.3 8.3 2.0 5.7 1.1 33.1 1.9 5.5 6.8 5.2 6.3 0.1 67.8 3.7 0.9 7.2 0.8 0.3 5.0 5.3 0.8 4.3 3.4 12.4 2.9 5.3 4.8 2.2 12.0 2.3 5.8 23.3 6.8 14.5 4.0 5.5 8.2 3.9 2.6 1.7 14.9 2.4 13.9 12.3 5.0 14.0 4.2 2.4 2.0 6.3 3.2 1.3 2.8 46.3 18.2 1.8 1.6 36.9 1.1 9.3 0.3 1.1 16.3 8.8 0.5 1.3 0.9 1.2 73.2 17.3 0.2 9.3 5.9 5.6 6.4 9.1 6.1 6.2 10.7 7.1 6.1 11.8 4.4 8.7 10.5 6.2 3.2 4.1 9.1 24.6 0.4 1.2 17.3 0.6 25.9 1.1 0.1 1.8 5.7 6.2 3.7 52.1 0.4 31.3 2.8 0.0 36.0 6.0 1.2 1.1 9.6 3.6 0.4 21.7 8.9 0.7 2.6 5.1 1.9 47.4 1.2 2.5 0.6 4.5 23.5 15.6 2.4 2.0 15.6 10.3 2.4 0.9 30.6 3.6 1.9 60.4 5.6 4.1 3.5 6.9 21.5 39.8 0.0 10.8 1.0 1.9 0.3 3.3 46.0 32.9 3.8 7.6 2.2 6.8 0.2 0.4 0.3 5.5 5.2 2.3 0.6 ZNF761 "FLJ16231, FLJ35333, KIAA2033" ENSG00000160336 "Zinc finger protein 761" Q86XN6 19 53431984-53461862 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "prostate: 74.6" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 45.3" "Cancer enriched" "Detected in all" 5 "prostate cancer: 31.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.89e-2)" "unprognostic (1.39e-1)" "unprognostic (7.03e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (4.68e-2)" "unprognostic (3.74e-3)" "unprognostic (1.12e-1)" "unprognostic (2.19e-3)" "unprognostic (1.59e-1)" "unprognostic (2.33e-3)" "unprognostic (1.19e-1)" "unprognostic (4.13e-1)" "unprognostic (8.71e-2)" "unprognostic (1.38e-3)" 8.4 9.9 8.8 6.4 10.2 10.7 10.7 14.9 10.6 7.3 9.9 7.2 6.6 6.3 11.1 5.7 9.2 6.5 5.2 9.3 9.2 6.7 6.1 7.2 8.7 10.2 9.5 8.5 12.3 11.9 12.0 7.3 17.1 10.6 74.6 8.8 7.3 8.7 6.3 4.7 11.2 6.9 6.7 8.3 8.2 9.3 6.2 10.1 8.3 8.2 4.8 8.4 8.4 7.8 13.1 17.3 9.6 6.9 14.4 21.0 17.2 25.1 11.0 9.9 7.9 12.0 11.9 6.9 16.2 6.1 10.7 11.4 11.8 18.2 11.9 12.5 2.2 25.9 15.5 12.7 15.4 12.9 1.5 18.4 17.1 13.5 9.5 16.8 11.1 8.9 15.7 16.4 10.7 14.5 10.6 19.0 15.3 12.0 17.1 14.5 15.2 15.2 17.2 8.7 48.9 8.9 6.8 13.2 18.6 8.0 22.4 10.1 14.4 7.6 12.3 9.5 1.7 13.0 13.0 27.6 26.6 0.5 8.8 10.8 7.2 4.4 5.8 5.1 4.8 6.3 6.6 5.9 6.4 4.8 6.4 6.4 6.8 3.8 12.8 4.7 5.2 8.4 4.5 8.8 10.2 14.9 10.6 9.3 9.2 10.2 9.5 8.5 10.6 8.3 10.1 13.1 6.7 3.2 7.3 3.6 6.4 0.0 12.0 0.0 2.8 1.1 7.5 6.1 6.6 12.8 4.3 3.7 0.0 17.3 4.9 4.9 23.5 4.3 0.5 6.2 4.9 5.3 2.4 7.8 2.5 2.9 14.3 7.5 6.1 6.3 9.5 12.0 9.7 10.0 8.6 5.0 5.0 11.5 0.0 7.1 0.0 1.3 12.5 5.0 0.0 3.7 3.5 1.8 5.2 1.5 7.0 5.4 6.1 7.9 9.2 19.6 5.2 11.5 2.2 0.9 19.7 3.7 5.0 1.5 5.6 5.7 0.0 45.3 4.7 5.1 6.7 12.1 FCN2 "EBP-37, FCNL, ficolin-2, P35" ENSG00000160339 "Ficolin 2" Q15485 9 134880810-134887523 "Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 100.5" "Cell type enriched" "Detected in some" 18 "Hepatic stellate cells: 1192.6" "Group enriched" "Detected in some" 8 "breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 5.5;intermediate monocyte: 4.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in some" 23 "spinal cord: 38.6" "Secreted to blood" NA NA 8100000000 1400000000 "unprognostic (1.91e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-4)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.81e-1)" "unprognostic (2.82e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" "unprognostic (1.05e-1)" "unprognostic (3.07e-1)" 4.7 24.8 0.3 0.0 0.3 0.1 7.7 0.2 0.5 0.3 0.4 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.2 0.5 0.3 6.2 100.5 0.1 0.1 0.3 0.5 0.2 0.5 0.5 0.2 3.1 0.0 0.3 3.2 0.0 0.0 3.2 0.4 0.1 0.2 0.1 0.0 0.2 3.1 0.2 0.2 0.3 0.0 2.1 0.1 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 9.0 0.3 0.3 0.2 0.5 0.5 0.3 0.3 0.5 0.2 0.3 0.2 0.3 0.3 0.1 0.0 0.0 0.7 3.8 0.0 0.1 0.0 0.0 0.0 3.8 0.4 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 34.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1192.6 12.6 0.0 0.0 0.1 0.0 0.0 64.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 98.1;testis: 62.9" "Group enriched" "Detected in many" 4 "Early spermatids: 520.9;Endometrial ciliated cells: 442.5;Late spermatids: 579.4;Respiratory ciliated cells: 610.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 13.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 41.3;T-47d: 41.9;U-2197: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: AB_2732732" "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favorable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 2.6 16.4 14.6 0.8 12.1 0.9 3.1 11.8 13.1 5.5 20.9 1.8 1.0 4.2 26.0 1.9 98.1 2.8 1.9 12.6 16.7 9.6 3.5 9.3 0.7 14.5 14.3 10.2 2.9 6.5 6.9 17.0 1.6 14.5 4.3 1.3 10.1 3.4 6.4 1.5 1.8 1.4 1.2 15.9 1.9 3.1 62.9 11.7 0.6 8.2 0.9 1.2 2.8 1.5 12.2 11.0 18.7 8.1 12.7 3.5 7.4 1.6 7.3 5.1 8.7 5.9 7.1 10.9 1.9 9.5 4.9 4.7 7.4 9.1 4.1 7.4 0.5 8.0 0.0 21.0 22.1 9.7 1.5 5.0 5.2 3.2 4.4 1.4 7.1 4.2 8.6 10.3 1.4 4.2 41.3 5.7 1.9 17.1 17.2 21.5 8.7 3.9 6.9 21.0 7.7 7.9 8.3 10.3 4.4 1.2 3.7 41.9 1.8 2.1 5.0 6.5 42.9 2.9 4.7 12.6 1.8 14.7 0.7 1.5 0.0 0.8 0.0 0.5 0.5 1.2 0.2 0.4 0.4 0.3 0.4 0.7 0.5 0.0 0.6 0.1 0.1 0.5 0.3 14.6 12.1 11.8 13.1 12.6 16.7 14.5 14.3 10.2 14.5 15.9 11.7 12.2 1.2 9.6 7.8 2.3 1.9 0.9 1.8 39.7 2.2 5.0 11.7 9.8 1.7 15.7 46.3 14.7 14.6 11.5 0.7 0.5 11.7 26.0 520.9 442.5 6.6 2.1 1.2 1.3 2.1 7.8 3.4 5.2 4.6 23.9 1.3 12.0 0.7 1.6 3.6 3.3 2.2 1.0 38.7 1.2 1.4 579.4 8.1 1.3 0.0 0.0 2.0 13.2 0.0 1.0 0.2 6.9 1.7 7.5 3.6 2.4 1.3 58.8 610.3 19.9 0.0 1.4 15.0 133.8 20.0 1.3 0.3 4.5 1.6 41.4 1.7 3.1 LCN1 "MGC71975, PMFA, TLC, TP, VEGP" ENSG00000160349 "Lipocalin 1" P31025 9 135521438-135526540 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Sensory transduction, Taste, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 12.9;seminal vesicle: 8.0" "Cell type enriched" "Detected in some" 8 "Basal prostatic cells: 8.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 3800000 "unprognostic (5.50e-3)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (3.99e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-4)" "unprognostic (1.22e-1)" "unprognostic (7.84e-2)" "unprognostic (9.47e-2)" "unprognostic (3.94e-8)" "unprognostic (2.07e-3)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 12.9 1.9 0.0 0.5 0.9 0.3 0.0 0.0 0.1 0.0 0.3 0.3 0.3 0.0 0.1 0.0 1.9 0.2 0.3 0.0 0.0 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.9 0.9 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZNF714 ENSG00000160352 "Zinc finger protein 714" 19 21082159-21125270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 17.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Granulosa cells: 49.8;Oligodendrocyte precursor cells: 40.2;Theca cells: 40.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 49.5" NA NA "unprognostic (2.72e-1)" "unprognostic (3.04e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (5.47e-4)" "unprognostic (4.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (1.02e-1)" "unprognostic (2.20e-2)" "prognostic favorable (4.27e-5)" "unprognostic (1.21e-1)" "unprognostic (6.88e-3)" "unprognostic (6.32e-2)" "unprognostic (3.15e-2)" "unprognostic (2.73e-1)" "unprognostic (5.40e-3)" "unprognostic (7.86e-2)" 1.5 4.5 3.0 3.2 4.4 7.0 3.3 7.4 3.3 2.1 0.1 2.2 2.6 3.2 3.4 5.3 2.6 1.6 1.4 2.8 2.9 1.7 0.6 2.1 4.9 3.3 3.2 2.6 17.5 3.9 1.6 1.2 2.9 4.5 2.4 3.7 3.2 2.1 1.6 2.9 6.8 3.3 1.7 2.0 2.4 2.8 4.0 3.4 5.8 14.6 1.8 4.4 1.7 2.2 4.6 18.3 3.5 26.9 12.5 1.3 3.8 21.2 10.2 6.0 21.8 20.3 8.2 14.1 7.6 14.8 5.5 7.9 4.6 0.1 8.9 32.4 6.1 18.6 1.3 12.9 8.2 2.1 10.3 8.2 2.2 1.6 15.0 6.1 5.5 7.3 39.3 20.0 9.4 13.0 4.3 49.5 7.0 25.8 3.9 5.8 17.1 1.8 7.3 5.9 10.7 23.6 13.9 16.1 0.2 4.8 20.8 0.5 1.0 3.4 9.7 0.3 8.9 6.7 7.6 22.6 1.4 0.4 2.9 3.4 5.4 2.0 4.9 2.3 2.4 2.3 1.9 2.4 3.3 3.1 2.9 4.4 3.9 1.4 2.7 1.8 7.8 3.6 1.3 3.0 4.4 7.4 3.3 2.8 2.9 3.3 3.2 2.6 4.5 2.0 3.4 4.6 3.9 44.8 9.1 27.4 8.0 4.1 4.3 4.6 13.1 22.3 4.6 5.5 4.9 5.7 6.3 5.5 16.7 7.7 7.3 6.6 1.9 4.2 1.6 4.7 8.7 4.9 6.7 9.7 28.8 3.8 13.6 7.4 6.6 7.0 1.3 49.8 5.3 0.1 4.9 16.8 37.0 3.3 4.1 6.0 8.2 1.5 5.3 5.2 3.6 13.1 2.6 6.2 6.2 40.2 19.6 3.3 2.2 3.8 11.5 6.3 4.1 1.1 3.0 14.5 6.6 4.9 6.9 36.3 15.6 7.5 4.0 4.7 6.7 40.0 5.5 7.7 GPSM1 "AGS3, DKFZP727I051" ENSG00000160360 "G protein signaling modulator 1" Q86YR5 9 136327476-136359605 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042199, HPA060736" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA042199: AB_10959329, HPA060736: " "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.07e-3)" "unprognostic (3.44e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-2)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (5.96e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (4.66e-2)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.48e-2)" 11.8 21.8 30.5 4.2 27.9 4.5 12.5 43.8 44.8 37.0 10.9 15.1 3.3 23.5 7.3 6.0 20.4 4.7 72.4 28.2 24.0 19.6 4.7 35.7 2.2 32.3 27.8 29.2 38.4 42.7 3.8 19.8 6.6 34.2 30.9 1.2 18.9 8.7 5.9 2.8 16.0 9.4 4.0 23.0 20.0 17.3 29.6 25.4 2.0 12.5 0.7 1.1 15.3 24.6 25.9 3.9 6.2 14.5 25.4 8.1 14.1 12.1 43.0 17.6 11.8 6.4 12.5 4.1 0.0 17.8 26.0 9.9 2.9 2.3 8.8 2.6 35.1 25.5 5.0 23.4 2.3 34.7 0.3 6.1 23.0 5.8 10.8 6.2 14.5 12.0 5.9 13.5 0.2 7.9 14.2 2.4 4.9 15.5 1.4 22.5 82.3 26.2 12.7 3.2 2.8 35.6 44.4 8.0 1.0 13.7 5.6 17.7 8.6 20.0 21.7 17.5 25.7 8.9 7.6 0.3 0.1 13.0 0.0 21.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 30.5 27.9 43.8 44.8 28.2 24.0 32.3 27.8 29.2 34.2 23.0 25.4 25.9 4.7 3.2 3.3 26.1 0.6 4.2 2.3 0.8 0.0 37.2 2.5 5.8 12.4 0.0 0.8 0.0 22.9 0.6 1.6 0.0 11.7 3.3 0.6 2.7 18.1 3.9 1.8 2.5 9.0 1.9 0.8 9.1 0.5 5.5 5.7 14.2 3.6 0.0 1.1 10.1 11.6 0.0 0.0 0.3 2.8 1.3 10.5 1.5 8.8 6.5 0.5 36.0 0.0 9.5 10.4 7.3 0.0 9.4 0.3 10.6 0.0 0.1 0.6 43.0 0.0 5.8 6.0 0.4 3.7 0.1 3.3 0.3 1.1 3.3 0.0 4.0 C19orf47 FLJ36888 ENSG00000160392 "Chromosome 19 open reading frame 47" Q8N9M1 19 40319536-40348527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "heart muscle: 73.0;skeletal muscle: 261.9;tongue: 140.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 45.2;Late spermatids: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 29.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 29.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041843, HPA046309" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA041843: AB_10959886, HPA046309: AB_10960266" "prognostic favorable (6.50e-4)" "unprognostic (1.35e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (2.75e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.26e-1)" "unprognostic (1.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.47e-2)" "unprognostic (3.25e-2)" "unprognostic (6.23e-2)" "unprognostic (1.62e-2)" "unprognostic (5.28e-2)" "unprognostic (2.77e-1)" "unprognostic (3.28e-2)" 6.4 5.9 17.0 6.6 14.6 8.4 8.4 10.7 14.3 8.0 1.2 7.0 5.7 7.7 4.0 12.7 6.1 3.5 73.0 11.5 10.9 5.8 7.8 6.5 7.6 14.9 14.2 9.6 6.8 5.2 6.7 7.5 6.6 17.4 8.8 2.9 2.6 10.6 6.4 261.9 12.0 6.0 3.9 13.2 7.4 6.3 26.7 13.4 7.4 6.9 140.3 4.4 8.6 8.7 14.5 20.3 30.5 12.7 13.8 7.4 6.6 17.4 20.6 9.3 19.1 22.9 25.5 8.3 23.5 11.1 9.7 10.0 9.9 15.5 18.9 7.9 29.1 19.1 19.3 18.2 19.6 5.5 19.5 11.9 6.6 11.0 25.6 9.0 5.1 11.7 21.5 24.0 13.4 15.9 19.9 29.4 11.0 8.2 16.2 11.5 28.8 20.7 11.8 6.1 17.6 16.2 13.2 22.1 20.5 8.1 7.4 12.2 15.9 15.7 23.7 16.6 16.2 28.4 16.0 24.2 24.1 10.1 18.6 16.7 29.0 2.2 6.6 1.6 2.0 2.0 2.0 3.0 2.7 2.1 2.5 2.0 1.4 7.3 2.5 2.3 2.1 2.3 2.1 17.0 14.6 10.7 14.3 11.5 10.9 14.9 14.2 9.6 17.4 13.2 13.4 14.5 2.6 3.2 2.8 9.1 2.6 4.8 3.2 2.6 4.0 3.1 4.9 5.0 45.2 2.8 2.3 0.0 2.1 11.0 1.5 3.6 0.0 3.5 12.5 2.5 2.3 4.3 3.6 1.7 19.2 4.7 13.8 6.2 2.6 2.7 4.5 3.6 5.7 5.0 6.6 3.3 15.4 3.4 0.0 6.2 4.1 27.4 1.8 2.8 5.4 8.4 3.3 2.9 3.1 9.5 11.2 4.4 1.4 6.8 6.5 2.0 2.8 2.8 1.3 2.0 6.6 7.1 3.8 18.2 6.3 4.1 7.0 15.9 3.3 1.4 2.4 1.8 HIPK4 FLJ32818 ENSG00000160396 "Homeodomain interacting protein kinase 4" Q8NE63 19 40379271-40390181 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 6.0;testis: 18.3" "Group enriched" "Detected in some" 6 "Early spermatids: 101.4;Late spermatids: 32.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.07e-2)" "unprognostic (6.25e-2)" "unprognostic (2.58e-2)" "unprognostic (5.53e-3)" "unprognostic (4.00e-2)" "unprognostic (1.36e-1)" "unprognostic (3.69e-2)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (7.48e-3)" "unprognostic (8.85e-2)" "unprognostic (9.09e-2)" "unprognostic (3.06e-2)" "unprognostic (8.71e-3)" "unprognostic (3.64e-2)" "unprognostic (2.03e-2)" "unprognostic (4.63e-2)" 0.2 0.1 1.6 0.0 6.0 0.1 0.2 0.9 3.5 0.2 0.0 0.4 0.0 0.4 0.0 0.2 0.2 0.0 0.4 5.0 0.4 0.1 0.1 0.2 0.0 2.1 0.0 0.5 0.1 0.1 0.0 0.1 0.0 3.0 0.2 0.0 0.1 0.1 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.1 18.3 0.6 0.0 0.1 0.0 0.0 0.3 0.1 0.6 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 6.0 0.9 3.5 5.0 0.4 2.1 0.0 0.5 3.0 0.0 0.6 0.6 1.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.6 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 101.4 0.1 0.3 0.6 0.0 0.0 8.4 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.7 32.9 1.5 0.3 0.0 1.9 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 4.2 0.7 10.3 0.5 1.1 0.3 0.0 0.1 0.2 0.0 0.1 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706988-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 29.2;fallopian tube: 60.0" "Group enriched" "Detected in some" 4 "Early spermatids: 56.8;Endometrial ciliated cells: 153.5;Late spermatids: 85.0;Respiratory ciliated cells: 189.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 7.3;HeLa: 6.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favorable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.2 0.3 8.5 0.1 3.2 0.1 0.2 3.5 2.0 5.0 29.2 0.1 0.0 1.2 1.8 0.9 60.0 0.6 0.3 2.1 9.0 0.5 0.1 11.3 0.4 9.9 13.9 0.0 0.4 1.1 0.2 4.7 0.2 7.0 0.3 0.0 0.1 0.6 0.2 0.3 0.6 0.1 0.1 10.6 0.3 0.2 10.2 4.4 0.1 0.4 0.0 0.0 0.4 0.1 2.0 1.4 7.3 0.9 1.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.8 0.8 1.4 1.0 0.0 1.6 3.6 0.0 0.0 0.0 2.8 1.2 0.8 6.2 1.7 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.5 0.0 2.1 2.9 0.4 0.0 5.0 1.1 0.4 0.7 1.5 3.6 2.0 1.1 1.2 0.0 0.3 5.1 1.0 1.7 2.9 0.4 0.1 2.4 0.4 1.5 1.6 1.4 4.1 0.8 0.7 2.3 0.9 0.7 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 3.2 3.5 2.0 2.1 9.0 9.9 13.9 0.0 7.0 10.6 4.4 2.0 0.2 9.6 10.5 0.0 0.0 0.0 0.3 0.0 0.0 0.7 1.3 0.6 0.0 0.0 27.9 0.0 0.0 0.1 0.1 0.2 1.9 0.3 56.8 153.5 1.9 0.8 0.0 0.0 0.0 0.0 0.1 1.0 0.0 4.8 2.5 0.1 0.4 0.2 0.2 0.0 0.0 0.6 0.0 0.6 0.0 85.0 0.3 0.5 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.1 0.7 0.1 0.4 0.5 0.4 189.5 0.4 0.0 0.4 0.3 14.3 0.9 0.0 0.0 0.0 0.3 1.4 0.3 0.2 TOR2A "FLJ14771, TORP1" ENSG00000160404 "Torsin family 2 member A" "Q5JU69, Q8N2E6" 9 127731524-127735313 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 69.1;Theca cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071229 Approved Uncertain "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA071229: AB_2732175" "unprognostic (1.67e-1)" "unprognostic (9.19e-3)" "unprognostic (1.47e-1)" "unprognostic (1.27e-3)" "unprognostic (3.04e-2)" "unprognostic (6.97e-2)" "unprognostic (2.43e-3)" "unprognostic (4.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.33e-1)" "unprognostic (6.51e-3)" "unprognostic (1.05e-2)" "unprognostic (6.98e-2)" "prognostic favorable (7.51e-4)" "unprognostic (1.72e-1)" "unprognostic (3.27e-1)" "unprognostic (2.82e-2)" 6.6 10.8 8.6 6.8 8.3 27.1 6.7 8.4 13.4 7.2 8.2 9.4 11.3 6.7 3.4 11.4 7.1 4.9 4.8 8.2 8.1 10.2 14.1 8.8 7.7 8.4 8.2 8.0 8.3 13.7 3.1 10.1 8.0 8.2 8.2 5.5 2.9 8.8 3.7 3.4 9.2 12.9 2.8 7.6 20.9 11.9 20.6 8.4 8.5 8.8 2.2 4.5 7.2 7.2 7.9 7.4 11.5 9.7 12.2 4.7 4.6 13.0 5.1 6.3 8.0 6.3 7.9 12.6 13.6 7.5 4.4 6.0 23.2 3.0 6.4 2.2 21.1 11.0 5.2 10.6 9.7 7.7 11.0 27.0 7.4 11.8 7.4 3.9 4.0 11.5 16.2 16.2 37.3 4.7 43.4 14.3 34.7 8.7 24.0 9.9 23.4 4.5 30.9 8.3 6.9 21.0 8.3 4.7 16.6 5.3 5.3 37.0 21.4 7.2 5.2 6.0 9.1 6.0 23.4 21.8 5.6 6.4 17.8 5.0 26.5 68.5 96.5 32.8 80.2 26.1 12.1 18.9 32.5 71.6 18.0 14.0 25.2 44.0 26.9 78.3 16.2 32.2 41.5 8.6 8.3 8.4 13.4 8.2 8.1 8.4 8.2 8.0 8.2 7.6 8.4 7.9 5.3 3.2 5.1 6.2 12.4 1.5 4.4 16.6 1.2 13.7 8.7 5.8 0.6 15.7 9.6 3.7 0.0 37.9 16.0 26.4 1.9 19.1 69.1 7.0 5.7 8.5 22.8 34.1 5.5 27.4 38.9 10.1 8.2 10.8 5.7 11.7 15.0 7.5 56.9 8.4 4.6 20.4 20.3 33.9 8.3 10.7 11.5 26.2 3.6 2.8 25.2 11.7 30.9 6.0 3.7 15.5 28.7 11.3 21.1 6.0 33.9 8.7 7.7 14.6 0.0 2.5 4.2 30.6 10.9 7.5 1.4 51.9 15.0 114.6 18.3 4.9 ST6GALNAC6 "SIAT7F, ST6GALNACVI" ENSG00000160408 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6" Q969X2 9 127885321-127905408 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 258.8;Intestinal goblet cells: 100.6;Paneth cells: 178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "NK-cells: 23.7;T-cells: 25.6" "Cell line enhanced" "Detected in all" "ASC diff: 157.1" "Low region specificity" "Detected in all" HPA018890 Approved "Intracellular and membrane" NA NA "HPA018890: AB_1857531" "unprognostic (2.27e-1)" "unprognostic (5.23e-2)" "unprognostic (2.81e-1)" "unprognostic (4.54e-2)" "unprognostic (1.81e-2)" "unprognostic (5.71e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.24e-3)" "unprognostic (3.31e-2)" "unprognostic (3.29e-1)" "unprognostic (1.10e-2)" "unprognostic (9.85e-2)" "unprognostic (3.46e-2)" "unprognostic (2.67e-2)" 91.6 37.7 146.1 21.6 143.7 17.9 69.3 120.3 179.2 47.0 115.4 76.1 9.6 49.0 50.4 35.3 67.8 28.6 57.6 155.8 125.2 50.3 64.0 67.3 27.7 131.5 128.1 138.5 83.7 53.2 32.6 26.2 22.2 126.6 40.5 127.6 16.2 28.6 41.9 46.4 34.9 35.5 38.3 117.3 64.6 44.2 17.8 133.3 15.1 32.8 40.5 23.3 57.0 42.9 130.8 12.0 9.2 18.9 36.9 157.1 91.9 7.4 29.7 69.6 43.7 35.9 16.3 10.0 13.8 13.4 68.1 28.4 21.9 25.6 23.7 19.0 50.9 14.0 13.4 19.0 16.7 48.1 3.3 18.9 94.9 27.5 34.0 15.1 61.6 40.9 11.9 12.2 14.6 54.9 9.9 8.4 19.3 9.1 12.3 17.5 24.6 27.0 14.3 32.2 2.4 13.1 21.3 21.4 8.8 7.6 12.3 9.3 29.0 26.7 27.6 16.3 30.5 15.8 18.4 9.8 21.5 24.5 4.1 8.7 3.3 1.2 0.1 25.3 1.9 18.5 5.3 16.5 18.8 1.8 3.9 10.0 13.7 0.6 23.7 5.0 2.1 25.6 12.4 146.1 143.7 120.3 179.2 155.8 125.2 131.5 128.1 138.5 126.6 117.3 133.3 130.8 1.3 3.2 4.3 13.1 10.5 23.2 17.2 15.7 9.1 22.0 0.9 0.6 8.7 8.6 9.5 0.0 6.2 4.3 11.7 258.8 0.0 0.3 2.5 0.8 1.7 20.6 38.5 26.1 11.5 0.4 7.7 26.6 3.6 1.4 7.0 0.2 46.8 28.5 11.6 25.2 10.7 100.6 18.3 10.0 35.6 9.4 66.5 4.1 24.9 8.4 3.2 58.7 46.4 5.5 3.8 0.3 178.3 60.9 8.9 20.5 0.3 0.0 16.1 8.5 85.5 41.2 31.9 1.4 4.8 10.3 26.9 3.6 17.7 0.5 84.7 18.6 SHKBP1 "PP203, Sb1" ENSG00000160410 "SH3KBP1 binding protein 1" Q8TBC3 19 40576853-40591399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 128.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041887 Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA041887: AB_10794639" "unprognostic (1.26e-1)" "unprognostic (7.55e-2)" "unprognostic (1.38e-1)" "unprognostic (4.52e-2)" "unprognostic (8.24e-2)" "unprognostic (9.14e-2)" "unprognostic (1.66e-3)" "unprognostic (3.53e-2)" "unprognostic (6.98e-2)" "unprognostic (6.69e-3)" "unprognostic (1.42e-1)" "unprognostic (6.87e-2)" "unprognostic (5.29e-2)" "unprognostic (6.15e-2)" "unprognostic (2.67e-1)" "unprognostic (1.65e-1)" "unprognostic (8.64e-2)" 32.1 32.4 14.4 39.8 14.1 67.4 29.4 13.5 19.5 34.4 14.2 31.3 18.6 34.7 7.8 47.3 33.5 14.5 26.4 12.3 16.0 42.3 30.2 52.8 41.2 16.9 14.6 10.5 25.4 38.0 15.9 22.0 14.4 17.4 35.4 10.5 1.3 32.0 13.6 15.9 32.7 45.8 16.0 13.9 128.2 41.5 17.4 15.5 29.8 35.3 6.8 25.2 36.9 35.9 22.8 70.9 107.1 21.1 30.2 18.0 20.0 39.7 26.8 39.9 41.1 56.2 46.9 47.5 73.9 52.1 42.3 35.0 30.2 27.3 50.8 19.4 114.6 65.1 53.9 29.4 32.1 38.8 50.6 147.9 32.4 36.2 37.4 23.3 30.0 60.8 81.7 30.7 60.2 32.0 61.6 52.1 70.5 15.3 63.5 39.2 92.9 27.4 55.7 34.0 57.0 17.4 40.2 41.4 22.3 25.1 20.2 35.5 82.7 46.4 41.2 54.0 65.1 54.1 56.4 28.4 50.6 66.2 59.5 37.4 223.9 217.9 216.7 74.2 202.2 60.1 77.5 71.4 76.5 157.3 69.0 41.1 48.2 453.9 72.3 246.4 46.4 109.8 213.1 14.4 14.1 13.5 19.5 12.3 16.0 16.9 14.6 10.5 17.4 13.9 15.5 22.8 28.8 12.8 19.9 1.3 53.1 8.5 20.5 41.7 10.2 2.1 9.5 7.2 4.3 17.2 30.8 29.5 6.2 24.5 40.8 35.2 29.4 42.5 8.6 5.4 9.3 25.0 22.8 25.0 2.1 38.6 53.1 13.5 37.2 13.3 51.5 18.2 26.7 13.2 76.5 3.3 1.8 17.9 48.8 82.0 36.3 18.4 14.6 66.8 23.2 3.7 93.3 6.3 56.7 1.5 6.4 39.0 35.9 12.4 33.9 11.5 28.1 31.7 14.2 1.8 0.0 7.0 15.2 3.5 26.8 19.3 9.8 29.6 45.0 14.4 22.0 20.7 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 209.7;Urothelial cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favorable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 3.8 4.8 2.3 3.5 2.3 2.2 4.5 3.4 3.5 6.8 3.3 6.6 6.8 4.2 0.7 20.0 4.9 3.0 11.9 2.2 3.1 9.2 8.3 4.5 3.5 3.4 3.0 2.3 3.7 8.7 12.5 6.5 10.2 3.4 6.3 3.8 2.1 9.7 3.8 9.8 20.4 6.1 2.0 1.2 6.2 10.6 5.3 3.8 2.2 7.6 4.9 2.8 5.1 12.3 4.3 10.9 12.3 2.9 10.3 1.5 3.0 17.9 3.4 2.1 3.7 6.4 23.3 15.7 9.4 5.3 1.2 2.7 14.1 7.8 7.2 1.7 7.3 60.0 12.2 9.8 14.6 2.9 12.4 8.0 2.6 6.3 3.0 2.9 3.7 3.0 5.2 27.2 2.9 2.3 13.4 6.1 9.6 2.5 17.7 25.7 15.7 6.7 27.6 8.2 37.3 8.8 6.2 8.9 31.3 7.0 2.7 12.0 9.3 3.0 0.3 3.7 0.1 8.2 7.8 11.0 9.6 9.1 10.6 6.6 3.8 4.1 4.1 8.2 6.3 7.7 5.4 6.3 7.6 4.2 5.8 8.4 6.1 1.9 7.8 5.0 6.4 5.5 3.0 2.3 2.3 3.4 3.5 2.2 3.1 3.4 3.0 2.3 3.4 1.2 3.8 4.3 8.9 16.0 13.1 3.9 6.6 10.7 31.7 11.1 7.4 21.0 12.2 9.9 27.5 20.0 19.3 14.7 41.7 41.3 9.4 47.2 11.7 13.5 24.3 18.3 8.8 9.1 12.0 4.2 9.4 6.5 29.0 7.1 46.4 31.8 8.2 24.4 18.5 7.3 11.5 25.2 10.0 27.5 12.2 4.9 5.0 13.2 3.7 4.2 7.2 4.7 5.0 9.0 6.2 5.0 2.9 14.5 35.7 3.4 8.7 30.6 20.3 4.8 12.8 25.3 6.6 5.1 6.5 3.2 8.9 11.1 17.5 209.7 9.2 11.1 28.1 110.1 ZER1 "C9orf60, Hzyg, ZYG, ZYG11BL" ENSG00000160445 "Zyg-11 related cell cycle regulator" Q7Z7L7 9 128729786-128772414 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 67.7;Inhibitory neurons: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048464 Approved Cytosol NA NA Cytosol "HPA048464: AB_2756306" "unprognostic (1.37e-1)" "prognostic favorable (1.18e-6)" "unprognostic (9.11e-3)" "unprognostic (2.36e-2)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (2.18e-1)" "unprognostic (4.81e-3)" "unprognostic (3.65e-1)" "unprognostic (4.90e-3)" "unprognostic (6.65e-3)" "unprognostic (1.69e-1)" "prognostic favorable (5.15e-11)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.14e-1)" 22.1 31.2 46.0 12.5 52.0 17.2 24.0 23.8 73.4 26.9 18.1 33.8 33.6 30.1 13.2 28.8 26.1 17.6 38.5 52.4 40.2 26.4 23.1 20.1 14.0 40.6 37.5 57.0 28.3 26.8 32.1 33.8 16.0 42.5 31.9 13.1 17.5 27.6 24.9 72.6 32.0 31.8 16.6 22.8 19.7 27.2 36.9 35.5 19.4 26.7 44.0 11.4 31.3 24.9 45.6 17.3 19.1 12.4 17.0 36.4 24.9 34.3 16.7 28.4 22.6 18.1 17.3 19.6 10.6 18.1 29.3 16.9 37.1 13.8 24.8 9.5 21.2 17.7 7.0 34.2 12.4 28.3 11.1 20.1 31.1 36.6 22.9 16.1 30.6 19.5 21.2 13.7 22.9 15.5 65.9 20.9 12.5 12.3 24.6 24.4 18.6 15.6 41.4 16.8 23.4 23.7 17.9 26.7 35.4 18.9 14.4 52.0 12.7 22.2 18.4 7.8 23.5 10.2 28.7 29.3 8.6 27.2 6.6 13.5 11.5 3.2 8.8 4.4 4.7 6.0 3.0 4.7 5.7 3.3 3.8 4.9 4.7 13.6 5.1 5.2 4.9 4.7 5.0 46.0 52.0 23.8 73.4 52.4 40.2 40.6 37.5 57.0 42.5 22.8 35.5 45.6 10.7 12.8 16.8 33.0 8.0 2.8 2.9 5.2 6.2 20.2 13.0 12.6 22.6 4.3 4.7 5.5 14.6 4.8 4.8 41.7 1.9 5.8 7.1 15.2 8.6 9.0 7.2 17.9 67.7 9.6 2.5 8.6 13.7 11.8 10.2 12.0 7.1 13.0 6.2 21.9 61.2 15.0 2.0 4.4 1.0 2.4 11.1 5.7 8.8 16.9 9.5 9.8 6.2 23.1 48.9 7.1 23.2 10.5 8.7 6.4 25.4 13.8 13.5 13.4 13.1 9.2 9.1 10.6 3.5 8.0 5.8 8.5 7.1 16.0 9.6 3.4 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type palmitoyltransferase 12" Q96GR4 9 128720870-128724127 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 18.6 24.1 6.4 15.6 6.4 41.6 19.5 6.1 10.0 13.5 7.2 29.3 26.5 13.0 7.2 68.3 12.1 14.3 13.0 6.0 8.8 30.6 52.7 23.5 20.2 8.2 6.4 5.2 7.4 67.6 9.9 11.4 16.4 6.9 26.8 13.8 0.5 43.6 12.6 15.7 42.2 37.1 6.4 6.7 32.0 49.6 24.9 8.1 12.5 16.3 4.2 13.9 18.8 30.7 8.0 53.5 127.6 6.0 31.3 17.6 12.1 59.4 32.8 28.8 34.5 22.9 109.6 61.5 37.3 29.6 25.5 62.9 139.8 13.0 65.0 3.8 65.0 31.7 20.1 92.7 49.1 34.7 33.1 87.1 19.9 44.7 29.6 11.0 17.7 25.6 65.6 18.8 93.6 7.1 187.3 45.9 66.2 26.8 118.8 107.6 21.0 21.0 108.4 28.7 43.4 42.1 30.4 46.2 64.1 18.3 9.6 98.9 35.6 27.5 0.1 36.9 25.9 45.8 58.1 106.8 17.3 61.3 38.4 41.4 231.1 122.3 385.6 105.1 123.9 91.2 94.6 95.9 101.5 100.1 111.0 99.2 91.4 269.5 90.5 150.0 244.7 130.9 101.0 6.4 6.4 6.1 10.0 6.0 8.8 8.2 6.4 5.2 6.9 6.7 8.1 8.0 10.0 16.0 12.0 1.3 31.8 16.2 43.3 94.0 10.8 1.2 55.5 30.4 14.8 77.2 59.0 46.0 0.0 183.9 39.1 171.0 13.7 106.8 73.2 20.7 11.5 21.1 51.2 51.1 0.6 200.0 224.0 14.2 38.7 52.5 18.4 13.7 35.7 55.3 137.0 0.0 0.5 108.5 67.1 62.2 20.9 30.0 9.6 46.5 42.7 6.5 115.3 18.4 81.4 0.5 2.0 133.8 167.7 7.2 43.3 56.5 186.0 48.5 20.1 2.0 6.6 5.4 16.3 36.0 18.6 55.2 28.1 134.1 34.1 22.0 110.0 77.5 PKN3 "PKNbeta, UTDP4-1" ENSG00000160447 "Protein kinase N3" Q6P5Z2 9 128702503-128720916 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 27.1;Breast glandular cells: 15.3;Endothelial cells: 17.9;Microglial cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 78.0;REH: 42.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045390, HPA058305" Uncertain Approved Vesicles NA NA Vesicles "HPA045390: AB_2679308, HPA058305: AB_2683674" "unprognostic (4.36e-2)" "unprognostic (5.70e-2)" "unprognostic (2.68e-2)" "unprognostic (7.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.65e-2)" "unprognostic (6.10e-2)" "unprognostic (8.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.68e-1)" "unprognostic (1.48e-1)" "unprognostic (7.91e-2)" "unprognostic (8.73e-3)" "unprognostic (6.18e-3)" "unprognostic (9.99e-2)" "unprognostic (7.23e-2)" "unprognostic (2.36e-1)" 12.7 2.7 5.8 2.7 4.4 2.6 13.3 6.0 6.8 6.2 4.6 4.7 4.8 7.7 0.6 5.3 7.0 2.3 11.7 4.0 4.1 6.1 4.1 11.2 2.1 5.0 4.8 3.2 2.9 5.3 2.2 1.8 3.4 5.4 5.5 0.9 0.1 11.6 2.0 3.7 5.3 6.2 2.9 4.1 9.6 7.1 2.7 6.1 2.9 7.0 3.4 1.1 7.0 6.4 5.4 2.9 14.1 11.3 17.2 0.1 0.3 27.7 8.7 2.7 12.6 13.0 0.1 10.1 0.1 8.4 4.7 2.6 19.0 13.8 2.1 2.9 9.0 26.0 17.1 78.0 20.5 2.1 2.1 3.0 0.6 0.7 6.8 1.9 2.7 25.1 5.0 39.6 1.9 2.3 26.9 2.6 9.2 10.5 13.1 4.1 42.4 21.3 3.8 5.3 1.7 1.9 8.5 6.6 3.5 6.5 6.1 12.3 13.6 21.9 0.1 10.3 20.0 6.7 6.2 2.9 5.7 1.6 2.2 8.0 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 5.8 4.4 6.0 6.8 4.0 4.1 5.0 4.8 3.2 5.4 4.1 6.1 5.4 27.1 0.0 2.0 0.3 1.2 1.0 1.7 1.7 3.4 0.2 15.3 3.6 1.8 4.3 2.1 0.0 0.0 2.2 2.0 1.5 0.0 1.9 0.2 2.2 1.1 17.9 0.0 5.0 0.3 2.6 6.1 1.8 5.1 4.9 0.0 5.0 9.3 0.4 1.9 0.0 0.2 1.7 0.0 0.8 2.3 0.9 1.5 0.8 0.0 13.1 1.2 0.3 4.1 0.0 0.1 3.3 1.5 0.7 1.6 1.1 2.6 0.6 0.5 0.2 0.0 0.7 1.3 2.8 6.6 2.8 1.0 1.4 1.9 1.4 2.5 1.7 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.1;pituitary gland: 7.9" "Cell type enhanced" "Detected in some" "Astrocytes: 48.6;Bipolar cells: 65.2;Cone photoreceptor cells: 56.3;Excitatory neurons: 209.5;Horizontal cells: 74.0;Inhibitory neurons: 194.8;Oligodendrocyte precursor cells: 46.3;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 21.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.8;Karpas-707: 2.5;SCLC-21H: 3.9;SH-SY5Y: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054481: AB_2682502" "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 1.0 2.1 4.5 0.1 5.9 0.1 0.7 5.6 21.1 1.1 0.0 1.2 0.3 1.5 0.1 0.4 1.3 0.4 2.0 4.9 1.1 0.8 0.3 0.3 0.0 4.6 0.2 6.5 2.6 0.9 1.4 7.9 0.0 3.7 1.5 0.0 3.4 0.6 0.4 2.1 0.5 0.5 0.3 0.0 0.2 1.2 2.0 1.2 0.1 0.7 0.9 0.0 1.2 0.7 6.6 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.8 2.5 0.0 0.6 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.5 0.0 0.0 3.9 2.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.9 5.6 21.1 4.9 1.1 4.6 0.2 6.5 3.7 0.0 1.2 6.6 0.2 0.0 0.0 48.6 0.1 0.1 0.2 0.1 0.6 65.2 0.7 0.6 4.9 0.0 0.2 0.0 56.3 0.0 2.7 0.1 0.0 0.2 3.4 0.3 0.8 0.5 16.3 0.0 209.5 0.0 0.0 1.0 0.0 0.8 0.0 0.7 0.4 0.8 0.2 74.0 194.8 0.5 0.0 0.6 0.2 1.3 8.1 0.6 1.8 10.3 0.6 6.1 0.0 46.3 13.4 0.1 0.0 7.2 0.1 0.4 0.3 1.7 0.2 64.2 0.0 1.6 0.7 3.5 6.0 0.3 0.4 0.0 0.4 0.4 0.3 0.2 BRSK1 KIAA1811 ENSG00000160469 "BR serine/threonine kinase 1" Q8TDC3 19 55282072-55312562 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 136.5;pituitary gland: 53.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6" "Cancer enhanced" "Detected in all" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021212, HPA061719" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA021212: AB_1845455, HPA061719: AB_2684593" "unprognostic (1.42e-3)" "unprognostic (2.92e-2)" "unprognostic (1.20e-1)" "unprognostic (6.69e-3)" "unprognostic (2.71e-1)" "unprognostic (4.21e-2)" "unprognostic (3.06e-6)" "unprognostic (4.24e-1)" "unprognostic (2.06e-2)" "unprognostic (3.04e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (7.98e-6)" "unprognostic (1.16e-1)" "unprognostic (6.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" 1.4 12.1 68.1 3.7 85.0 0.5 2.7 41.0 136.5 4.8 1.3 9.1 3.9 8.4 4.0 3.2 5.4 4.4 8.8 98.8 56.3 2.4 0.7 1.9 2.8 67.4 52.6 79.7 5.5 2.8 17.1 53.4 1.1 78.1 8.3 1.6 20.5 2.3 5.0 0.7 1.4 4.8 5.7 25.7 1.8 4.9 11.5 68.7 2.3 3.2 1.4 1.4 6.4 4.6 100.4 0.8 2.8 33.2 17.6 0.1 1.4 0.3 5.9 7.7 7.1 10.3 13.1 5.9 7.0 3.7 6.2 6.6 0.3 7.0 0.3 6.6 33.3 28.0 4.6 4.0 1.4 7.0 1.5 12.8 4.6 0.6 7.3 0.0 27.4 0.3 17.9 6.6 40.8 6.5 1.9 9.0 1.7 24.9 0.7 2.3 20.4 8.5 1.1 0.5 0.0 56.4 51.8 0.1 1.0 12.8 9.2 2.9 3.8 0.0 13.7 15.2 7.7 10.8 37.9 28.0 16.6 13.8 3.1 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.1 85.0 41.0 136.5 98.8 56.3 67.4 52.6 79.7 78.1 25.7 68.7 100.4 0.3 0.0 1.3 9.4 5.2 0.1 1.0 0.1 1.2 34.8 0.9 2.2 1.2 0.0 0.6 1.8 2.1 0.0 1.2 10.4 0.0 0.4 1.2 0.3 3.8 0.9 3.5 0.0 30.1 0.0 0.0 1.2 0.5 0.3 0.0 2.3 0.0 0.0 1.6 38.7 27.6 1.6 0.0 6.6 0.4 0.3 0.6 1.0 0.0 1.0 2.3 4.1 3.1 17.1 29.4 0.5 0.1 4.9 9.8 1.0 23.6 0.9 0.2 10.1 0.0 0.6 2.1 3.9 7.0 0.0 0.0 0.0 1.1 2.8 1.9 0.2 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354719 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 91.2" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "CAPAN-2: 24.9;SCLC-21H: 10.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.4 0.1 0.4 1.1 0.3 1.1 0.9 0.9 0.5 0.3 0.4 4.7 0.2 0.2 1.2 1.2 0.7 0.2 0.1 0.3 0.3 0.8 0.1 0.3 0.2 0.3 0.6 0.3 0.5 0.2 0.0 0.9 0.2 0.5 0.7 4.9 0.4 1.4 0.2 0.3 2.5 0.3 0.2 0.1 0.4 0.2 91.2 0.5 3.3 0.1 0.0 1.9 0.5 1.0 0.6 3.1 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.2 24.9 0.1 0.2 0.3 0.3 1.8 0.7 0.2 0.2 0.9 0.7 0.0 2.0 0.1 0.3 0.2 1.8 0.2 2.7 0.5 0.6 1.7 0.0 0.1 0.4 0.2 0.0 0.6 0.1 0.2 0.6 2.6 0.5 0.1 0.0 0.2 0.1 0.4 10.1 0.3 0.4 0.1 0.0 0.6 0.4 0.0 0.5 0.2 0.5 0.1 0.3 1.6 1.4 0.1 0.1 0.3 0.1 0.8 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.2 0.2 1.5 0.5 0.2 0.4 0.2 0.3 0.4 0.3 0.9 0.5 0.3 0.3 0.3 0.6 0.3 0.5 0.1 0.5 0.6 0.2 0.0 0.5 0.0 0.0 0.5 0.7 3.5 1.2 2.4 0.9 1.3 0.6 0.0 2.1 0.0 4.2 0.5 1.8 8.0 0.0 0.5 36.0 1.3 0.5 0.2 1.2 0.0 0.0 0.6 0.3 0.6 0.0 0.8 0.0 0.2 0.0 0.0 0.1 3.3 0.1 1.3 4.1 0.0 0.0 27.4 0.6 0.3 0.0 0.0 0.0 1.4 2.1 0.0 0.1 9.6 4.1 0.0 0.3 0.7 3.4 0.1 12.6 5.4 0.0 0.4 0.5 61.1 1.7 0.3 0.4 0.4 0.6 0.1 6.5 2.3 TMEM190 MDAC1 ENSG00000160472 "Transmembrane protein 190" Q8WZ59 19 55376826-55378246 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 139.3;testis: 58.1" "Cell type enhanced" "Detected in some" "Early spermatids: 556.2;Endometrial ciliated cells: 307.5;Late spermatids: 179.0;Respiratory ciliated cells: 1386.5" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 11.5" "Region enhanced" "Detected in many" "cerebellum: 6.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 10.6;SCLC-21H: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.00e-2)" "unprognostic (6.58e-2)" "unprognostic (6.24e-3)" "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (5.02e-1)" "unprognostic (2.08e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (5.38e-5)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.93e-1)" 0.1 1.6 0.4 0.2 0.7 0.2 0.0 6.6 0.9 4.1 0.0 0.2 0.2 0.4 0.0 0.1 139.3 0.2 0.0 0.5 0.1 0.8 0.0 18.3 0.1 1.2 1.0 0.0 0.2 0.1 0.0 7.5 0.6 2.6 0.5 0.0 0.2 0.1 0.5 0.0 1.3 0.1 0.1 0.1 0.1 1.0 58.1 2.4 0.1 0.0 0.0 0.0 0.1 0.0 0.8 1.0 1.8 0.0 0.4 0.0 0.0 0.2 0.5 0.2 0.4 0.1 1.3 1.1 1.8 0.1 0.5 0.2 3.3 0.0 0.0 0.0 3.2 0.1 0.0 2.2 10.6 0.6 0.0 0.0 0.2 0.0 0.1 0.0 3.4 0.0 0.1 0.0 2.5 0.0 1.5 0.2 0.0 0.4 1.3 0.5 0.1 1.2 1.1 0.0 0.9 5.0 0.9 1.0 1.3 0.4 0.9 0.5 0.0 0.0 0.1 0.8 0.1 0.5 0.3 2.5 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 6.6 0.9 0.5 0.1 1.2 1.0 0.0 2.6 0.1 2.4 0.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 63.5 0.0 0.6 0.0 0.0 0.0 0.0 66.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 556.2 307.5 1.8 0.4 8.9 0.0 0.0 0.0 0.1 1.8 0.0 3.7 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 91.6 0.0 0.0 179.0 5.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.2 0.0 0.0 1386.5 0.1 0.0 0.0 28.6 3.4 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.3 NLRP4 "CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2" ENSG00000160505 "NLR family pyrin domain containing 4" Q96MN2 19 55836540-55881855 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 5.1;testis: 7.1" "Cell type enhanced" "Detected in some" "Early spermatids: 17.6;Late spermatids: 5.1;Spermatogonia: 3.3" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Daudi: 82.3" "Not detected" "Not detected" HPA062128 Approved Mitochondria NA NA Mitochondria "HPA062128: " "unprognostic (2.48e-1)" "unprognostic (7.01e-2)" "unprognostic (4.21e-2)" "unprognostic (1.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.81e-1)" "unprognostic (2.36e-3)" "unprognostic (3.72e-2)" "unprognostic (2.36e-1)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" 0.1 0.0 0.6 0.6 0.6 0.0 0.0 0.6 1.3 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 1.6 0.7 0.5 0.4 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 7.1 0.6 0.1 0.0 0.0 5.1 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 82.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.6 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 1.3 1.2 0.5 0.7 0.5 0.4 1.0 0.5 0.6 1.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 5.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "heart muscle: 83.6;skeletal muscle: 212.1;tongue: 75.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 18.8;Horizontal cells: 8.4;Leydig cells: 5.0;Skeletal myocytes: 7.0" "Cancer enhanced" "Detected in many" "glioma: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.1;ASC diff: 11.4;ASC TERT1: 8.6;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 4.8 9.8 9.6 1.1 10.2 0.4 4.9 14.1 13.7 6.3 1.3 7.1 0.7 6.4 0.6 2.6 5.2 2.1 83.6 9.6 8.5 4.2 0.4 2.1 0.5 10.2 10.3 10.4 8.8 2.3 1.2 4.7 0.6 10.9 5.0 0.5 4.0 3.4 2.5 212.1 1.4 3.1 2.7 8.2 2.4 3.2 5.1 11.4 0.4 1.8 75.1 0.3 6.8 4.1 10.5 0.0 0.0 2.2 11.1 11.4 8.6 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.5 2.4 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.6 2.8 0.0 0.0 2.9 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.8 0.1 0.1 0.7 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.8 0.0 2.6 0.0 0.0 1.7 0.0 0.4 0.0 0.0 2.3 0.5 0.2 0.2 0.0 1.3 1.5 1.0 0.0 0.9 9.6 10.2 14.1 13.7 9.6 8.5 10.2 10.3 10.4 10.9 8.2 11.4 10.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.8 0.1 0.0 0.0 0.0 0.0 1.8 2.1 0.1 0.1 0.0 1.9 0.0 1.4 0.1 1.7 1.4 0.0 1.3 0.0 0.6 0.7 4.1 0.0 0.1 0.0 0.8 1.1 0.0 0.5 8.4 0.0 0.0 0.0 0.3 0.0 1.7 5.0 2.2 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 2.3 0.0 3.7 0.0 7.0 3.0 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 TAOK1 "FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1" ENSG00000160551 "TAO kinase 1" Q7L7X3 17 29390363-29551903 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007669 Approved Uncertain Vesicles NA NA 1600000 Vesicles "HPA007669: AB_1080201" "unprognostic (1.46e-1)" "unprognostic (7.15e-3)" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.81e-2)" "unprognostic (4.85e-2)" "unprognostic (1.28e-2)" "unprognostic (4.31e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (2.85e-2)" "unprognostic (5.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" 13.8 9.1 12.9 9.9 16.5 10.6 10.4 13.8 13.9 11.9 2.7 8.6 5.3 10.9 8.6 10.4 7.9 9.6 13.3 14.4 13.0 10.3 8.7 9.9 10.0 16.9 14.9 10.0 10.4 7.9 19.5 8.1 11.8 17.1 9.1 8.6 21.1 7.8 10.1 11.5 10.0 7.4 11.8 14.9 10.5 8.2 11.8 14.4 13.4 14.6 15.4 9.6 12.2 8.8 21.0 19.3 35.0 32.1 13.4 24.1 29.8 11.3 20.0 23.9 20.3 21.1 20.7 7.9 13.8 15.8 35.9 20.7 16.3 30.4 15.7 36.4 20.7 18.2 21.0 21.3 12.2 16.6 26.5 16.7 19.4 19.6 29.0 30.6 21.3 27.3 14.0 20.7 12.0 26.7 14.2 18.5 9.5 12.0 12.9 8.6 15.1 41.2 8.8 19.1 31.5 16.1 18.7 34.6 34.4 21.1 32.6 23.6 21.6 33.6 28.0 19.7 23.7 27.5 9.3 18.6 14.0 20.3 14.8 24.3 0.6 0.5 0.5 0.6 0.6 0.5 0.5 0.6 0.7 0.5 0.6 0.7 0.7 1.7 0.5 0.6 1.4 0.4 0.3 12.9 16.5 13.8 13.9 14.4 13.0 16.9 14.9 10.0 17.1 14.9 14.4 21.0 96.9 48.1 45.8 105.8 35.9 44.5 27.4 27.0 52.9 56.6 35.5 23.2 90.2 30.0 37.7 46.0 98.0 18.7 40.5 29.3 15.6 27.3 11.8 45.0 72.0 55.4 37.7 18.7 162.3 24.3 16.0 58.0 31.6 80.1 28.5 44.3 52.1 29.5 30.1 52.2 160.5 23.7 24.4 65.6 60.4 19.8 39.7 67.3 40.9 92.8 55.8 37.1 29.9 142.2 220.8 38.9 24.0 54.2 34.2 40.4 17.6 22.1 31.0 54.7 26.3 66.1 52.1 59.1 33.2 49.5 45.9 37.6 43.1 43.0 21.1 41.6 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131852928-132079867 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 87.7;Oligodendrocytes: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 14.0 14.8 20.0 10.2 21.0 18.5 14.9 18.8 22.2 14.0 16.9 14.7 8.4 19.1 23.7 17.2 15.3 9.7 18.7 22.2 18.8 13.7 10.0 14.1 15.6 19.8 18.9 20.6 12.9 9.0 15.9 17.2 13.2 19.2 15.6 11.2 13.9 11.4 13.9 21.1 20.1 11.8 16.9 18.3 14.4 13.0 18.3 18.5 28.5 13.4 14.5 14.2 17.5 13.8 21.3 33.1 29.8 40.9 32.0 28.4 24.7 33.3 34.7 48.8 73.9 58.8 53.0 29.4 31.7 21.5 39.3 48.1 60.9 54.5 51.8 46.8 34.6 36.1 24.5 31.1 31.3 42.7 43.2 33.4 28.9 37.9 57.9 61.4 22.9 41.4 52.1 36.7 29.0 57.2 57.8 52.4 30.8 40.6 36.5 62.6 44.7 51.0 43.6 31.0 17.8 72.5 28.9 44.4 22.7 26.5 25.7 37.6 22.1 29.5 71.8 31.4 52.6 51.5 10.8 32.0 57.2 40.3 33.9 50.6 5.7 18.1 21.2 26.5 28.6 21.5 16.7 20.2 26.3 28.3 19.3 16.5 21.8 7.0 27.8 24.9 29.2 30.0 18.7 20.0 21.0 18.8 22.2 22.2 18.8 19.8 18.9 20.6 19.2 18.3 18.5 21.3 10.4 16.0 7.8 55.8 12.0 6.0 14.4 28.2 18.8 24.6 3.8 6.7 6.2 2.8 17.2 12.9 18.8 33.1 14.5 4.7 13.7 15.0 14.3 8.6 10.3 12.4 5.3 6.3 87.7 16.7 20.4 12.0 10.2 8.3 10.8 12.6 6.8 5.2 17.5 21.9 63.3 5.5 18.3 3.1 5.0 8.4 14.3 9.1 7.2 33.7 10.1 25.0 3.1 69.4 130.0 16.1 2.0 17.0 13.9 7.0 2.3 7.8 9.2 20.0 6.6 16.7 17.0 24.2 28.7 10.9 5.1 54.7 15.5 18.8 4.8 10.1 DEDD2 FLAME-3 ENSG00000160570 "Death effector domain containing 2" Q8WXF8 19 42198598-42220140 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Paneth cells: 178.2;Syncytiotrophoblasts: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043419 Approved Nucleoplasm NA NA Nucleoplasm "HPA043419: AB_10960747" "unprognostic (1.59e-1)" "unprognostic (5.90e-2)" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (5.57e-2)" "unprognostic (6.48e-2)" "unprognostic (1.03e-1)" "unprognostic (7.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (6.39e-2)" "unprognostic (2.46e-1)" "unprognostic (3.59e-2)" "unprognostic (1.24e-1)" "unprognostic (5.80e-2)" "unprognostic (3.70e-2)" "prognostic favorable (3.26e-6)" 5.9 11.5 20.0 6.7 16.2 12.9 5.9 16.7 40.8 9.1 19.6 8.0 6.8 7.4 3.1 12.4 10.2 2.1 8.3 25.4 21.4 10.7 13.0 13.9 5.4 18.5 17.0 16.2 11.3 9.6 4.2 19.5 3.6 18.5 10.7 2.2 3.4 10.1 3.4 9.9 13.0 10.0 1.3 16.0 17.9 9.6 11.8 21.3 7.1 9.9 3.4 4.2 8.9 11.1 23.2 17.1 32.4 2.3 2.8 5.7 1.3 10.5 6.5 5.6 5.2 3.3 9.3 12.2 10.5 12.8 1.9 6.1 7.0 11.1 2.4 2.3 9.0 28.5 5.2 8.7 15.9 6.9 5.8 10.6 0.8 6.3 3.8 5.2 9.5 2.9 4.5 26.7 12.3 1.5 7.2 6.5 21.1 6.0 15.8 22.3 6.8 4.4 9.8 4.1 5.6 19.0 7.1 6.0 18.1 3.6 3.4 3.1 7.2 5.7 3.9 12.6 1.6 12.3 21.4 10.3 3.3 5.8 9.3 4.0 81.7 56.4 94.7 47.9 73.1 51.7 40.6 44.2 46.7 34.6 39.0 39.9 41.2 126.2 40.9 83.1 48.6 46.4 71.9 20.0 16.2 16.7 40.8 25.4 21.4 18.5 17.0 16.2 18.5 16.0 21.3 23.2 13.4 6.4 7.5 2.9 47.6 46.4 67.0 30.2 18.2 26.0 33.5 24.5 7.6 21.5 14.4 14.7 12.5 29.1 57.6 101.8 11.7 26.0 32.4 38.4 8.6 19.1 92.2 53.2 5.6 24.2 47.8 15.5 20.4 36.0 70.6 10.0 9.3 8.2 36.6 15.2 5.5 67.0 20.3 31.7 73.6 5.9 13.4 47.4 39.2 2.8 44.5 20.9 75.2 2.5 5.5 45.9 178.2 12.8 34.1 60.7 52.9 20.7 21.4 22.9 6.6 10.3 19.9 18.1 21.1 21.9 53.6 162.0 70.8 17.7 48.7 90.2 SIK3 "FLJ12240, KIAA0999, L19, QSK" ENSG00000160584 "SIK family kinase 3" Q9Y2K2 11 116843402-117098437 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045245, HPA048161" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045245: AB_2679270, HPA048161: AB_2680293" "unprognostic (3.19e-2)" "unprognostic (3.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (2.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.46e-2)" "unprognostic (1.28e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.82e-1)" "unprognostic (6.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" 10.2 7.3 15.4 11.5 33.6 12.8 9.3 10.7 25.7 9.7 0.0 10.0 8.6 12.7 7.2 10.5 12.5 9.9 12.9 16.0 17.8 10.4 14.0 9.8 10.0 23.2 21.9 13.5 16.7 15.5 17.8 10.1 12.2 29.7 8.3 8.9 19.2 9.9 11.4 19.7 7.6 8.8 14.3 6.4 11.9 9.8 21.6 19.1 12.5 17.2 14.5 10.5 10.2 7.5 38.7 11.8 8.9 13.9 14.7 11.7 12.6 22.2 8.8 15.7 6.8 7.6 21.8 13.3 13.9 14.0 16.3 15.0 18.1 11.6 12.7 9.4 38.5 7.4 31.2 9.7 13.6 10.9 11.2 11.8 13.9 7.2 14.5 23.3 8.7 9.2 9.0 15.2 10.1 9.4 4.0 10.2 12.1 7.7 8.0 6.6 12.9 8.0 11.1 9.3 2.2 13.5 10.8 23.7 10.3 4.4 10.5 6.8 11.8 10.6 8.3 10.4 14.0 8.9 7.1 5.6 17.5 7.7 18.2 11.4 2.0 0.4 0.0 0.3 0.5 0.5 0.1 0.3 0.1 0.6 1.0 0.0 0.0 0.9 0.6 1.5 0.0 0.0 0.2 15.4 33.6 10.7 25.7 16.0 17.8 23.2 21.9 13.5 29.7 6.4 19.1 38.7 25.8 9.6 22.1 375.5 34.9 26.5 26.0 6.8 7.4 42.6 26.1 21.5 22.2 10.0 12.4 5.5 112.6 8.7 47.3 12.5 5.9 7.6 89.2 64.4 27.9 20.4 17.3 12.4 384.4 7.3 2.8 22.1 12.8 71.5 17.2 37.4 17.2 26.3 7.7 47.1 399.6 11.1 6.1 21.7 45.1 214.9 10.2 31.4 16.0 161.1 25.6 36.3 12.3 457.9 1679.9 9.2 8.2 14.3 28.1 22.0 9.7 6.9 20.5 63.9 0.0 35.0 23.2 18.0 14.8 7.4 24.3 29.7 44.2 14.8 11.4 30.0 MPZL3 ENSG00000160588 "Myelin protein zero like 3" Q6UWV2 11 118226690-118252365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.6;skin 1: 29.4" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 6 "basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8" "Group enriched" "Detected in all" 8 "granulocytes: 99.4;T-cells: 28.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029116 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA029116: AB_10610142" "unprognostic (2.54e-2)" "unprognostic (1.24e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (8.74e-3)" "unprognostic (2.86e-2)" "unprognostic (9.82e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.86e-2)" "unprognostic (1.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.90e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.20e-1)" 2.6 0.5 0.7 4.8 0.9 7.4 8.3 2.4 0.8 6.6 1.7 5.7 5.5 1.5 5.0 33.6 5.5 7.7 1.3 0.7 0.9 2.5 7.5 8.0 4.8 0.9 0.9 0.6 0.5 7.2 6.8 3.8 0.8 1.4 5.6 6.2 1.3 11.8 2.7 1.8 29.4 5.3 1.6 0.6 6.0 6.9 1.1 0.8 2.8 6.2 0.9 12.7 4.4 16.9 1.1 5.0 0.6 0.0 0.7 0.0 0.0 0.7 0.6 0.1 0.1 0.1 16.7 26.3 4.9 12.5 0.0 1.9 6.8 1.2 5.6 0.1 0.3 2.0 3.0 1.4 8.1 0.2 4.1 29.0 0.3 13.6 0.0 5.4 0.0 8.8 3.3 3.8 2.7 0.1 17.1 1.9 2.2 2.4 16.5 1.2 0.0 0.0 7.4 10.0 6.2 3.4 0.3 6.6 8.6 0.5 1.3 15.4 2.2 4.3 0.1 1.3 0.1 0.1 0.4 5.1 3.1 0.1 0.1 0.3 44.3 6.0 99.4 7.0 3.7 28.9 1.7 11.3 9.6 8.1 1.9 8.4 6.9 87.8 8.2 2.6 1.1 8.4 5.3 0.7 0.9 2.4 0.8 0.7 0.9 0.9 0.9 0.6 1.4 0.6 0.8 1.1 2.4 16.0 26.9 0.0 4.9 35.6 21.7 11.8 9.6 0.3 28.2 14.7 1.7 5.7 15.9 9.2 2.1 0.6 9.6 19.6 0.0 10.5 7.4 32.7 4.1 4.9 12.0 0.4 2.2 8.8 0.7 1.6 18.3 34.0 1.3 0.1 2.2 8.2 1.3 0.0 2.3 5.1 14.2 5.1 18.7 7.7 0.0 5.5 10.6 1.9 3.8 0.3 4.1 0.5 0.3 16.7 9.1 0.4 6.6 30.6 9.3 1.1 43.8 1.7 0.0 0.4 2.3 1.7 0.8 14.3 63.9 1.6 44.3 0.2 8.1 46.4 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193725-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 43.6;lymphoid tissue: 69.4" "Group enriched" "Detected in many" 4 "dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 3529.6" "Group enriched" "Detected in all" 5 "dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8" "Cell line enriched" "Detected in some" 5 "HMC-1: 28.0" "Region enriched" "Detected in many" 11 "cerebellum: 58.0" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 14.0 4.5 0.8 69.4 0.9 21.1 5.6 2.3 2.1 5.6 2.9 17.0 17.9 3.5 1.5 8.6 4.3 20.5 3.3 0.7 1.0 3.4 9.9 43.6 31.4 1.2 1.0 0.6 1.9 2.9 1.0 1.7 7.9 1.4 4.4 22.9 0.3 3.0 3.7 1.2 4.7 32.3 15.4 1.0 60.4 9.5 1.5 0.9 24.5 2.9 7.9 31.9 25.1 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.9 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.3 3.1 0.4 3.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 137.4 1023.8 3529.6 60.1 616.5 386.5 7.1 107.4 113.7 1017.6 2.9 124.7 103.1 2121.1 24.3 310.3 765.1 191.3 844.1 0.8 0.9 2.3 2.1 0.7 1.0 1.2 1.0 0.6 1.4 1.0 0.9 1.1 1.2 6.4 34.2 0.0 6.9 0.0 0.2 0.0 0.0 0.3 0.9 1.3 0.0 2.8 5.6 1.8 0.0 0.3 136.9 0.9 0.0 0.1 1.0 0.4 0.2 1.3 0.0 5.0 0.0 0.4 0.4 1.8 2.6 0.6 15.2 0.0 5.7 2.8 31.0 0.0 0.0 0.2 0.0 125.8 0.0 1.1 0.0 166.6 0.0 0.0 204.7 0.0 9.2 0.0 0.0 0.1 0.1 0.0 6.3 0.1 0.6 0.8 2.2 0.2 0.0 0.4 0.5 2.2 5.9 0.2 0.0 0.4 56.0 0.0 0.1 0.2 NEK8 NPHP9 ENSG00000160602 "NIMA related kinase 8" Q86SG6 17 28725897-28743455 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040661, HPA040679" Approved Approved "Nuclear speckles,Microtubules,Mitotic spindle" Yes NA Microtubules "Nuclear speckles, Mitotic spindle" "HPA040661: AB_10794065, HPA040679: AB_10796226" "unprognostic (2.63e-1)" "unprognostic (4.57e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (6.25e-2)" "unprognostic (2.23e-2)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "prognostic favorable (4.52e-4)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (1.51e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-3)" "unprognostic (4.61e-2)" "unprognostic (3.58e-1)" "unprognostic (1.75e-1)" "unprognostic (4.67e-3)" 1.5 3.1 1.5 3.3 1.7 1.7 2.5 1.3 1.7 2.4 3.2 1.9 3.0 1.5 3.3 2.5 4.0 2.0 1.0 1.3 1.4 6.7 5.3 3.4 5.8 2.0 1.6 1.2 2.0 4.5 2.9 4.5 2.6 1.9 4.0 2.3 0.6 3.7 2.6 0.5 3.2 4.2 1.2 1.5 5.8 3.4 3.8 1.6 2.7 7.3 0.4 5.1 2.6 2.2 2.2 2.1 3.4 3.5 2.8 1.9 2.1 10.9 0.9 2.1 1.3 1.7 5.4 5.0 13.1 3.5 2.8 2.5 3.8 5.2 4.8 1.3 3.5 6.4 2.9 5.8 10.1 3.3 1.8 3.7 4.8 1.8 2.5 5.8 1.8 0.9 1.9 4.3 1.3 1.5 4.7 1.9 3.4 3.3 3.7 1.0 4.9 2.3 5.9 7.0 5.7 6.4 1.5 3.0 6.3 1.6 4.7 9.3 2.4 0.8 1.3 2.2 1.6 1.0 1.5 1.8 8.9 2.0 1.6 3.1 3.3 0.9 1.2 0.7 0.5 0.8 2.8 0.6 0.7 0.1 4.2 0.7 1.0 0.4 1.3 1.1 14.8 0.5 0.8 1.5 1.7 1.3 1.7 1.3 1.4 2.0 1.6 1.2 1.9 1.5 1.6 2.2 2.7 9.6 19.3 3.9 22.9 2.8 9.2 8.3 7.4 2.8 10.1 14.1 1.7 12.8 11.6 25.8 8.4 17.6 19.1 14.9 7.9 5.8 9.5 12.8 6.0 2.9 10.3 7.0 0.7 6.0 9.2 3.9 6.1 15.2 26.6 3.2 3.3 9.4 3.9 1.7 0.5 14.4 10.2 5.0 2.7 2.0 3.4 4.4 3.6 2.8 4.0 2.6 3.1 1.5 1.6 3.9 17.2 2.6 7.2 8.6 13.4 4.3 14.3 1.8 0.0 11.7 3.0 19.9 11.4 8.8 1.6 11.1 4.9 7.8 15.9 4.2 TLCD1 ENSG00000160606 "TLC domain containing 1" Q96CP7 17 28724348-28727935 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 36.4;Syncytiotrophoblasts: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "plasmacytoid DC: 21.7" "Lineage enriched" "Detected in many" 11 "dendritic cells: 21.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042366 Enhanced NA NA "HPA042366: AB_10794419" "unprognostic (1.23e-1)" "unprognostic (3.78e-2)" "unprognostic (8.52e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.47e-3)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.05e-5)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (1.86e-2)" "unprognostic (3.93e-2)" 2.5 5.5 12.8 3.2 12.8 1.4 5.2 14.7 21.7 4.5 11.1 8.1 8.2 1.8 13.9 13.2 14.6 2.3 2.3 13.0 13.1 18.9 15.1 7.4 3.3 12.8 13.3 12.1 1.1 12.0 3.4 4.0 4.6 14.5 6.6 8.3 1.7 13.0 3.7 0.8 20.3 4.0 1.0 12.6 1.4 8.9 13.2 13.3 4.6 5.3 0.1 9.9 13.9 5.7 12.4 12.4 55.8 14.9 12.7 10.2 18.5 34.6 10.1 17.8 4.7 6.7 31.1 21.3 3.9 15.3 12.1 21.4 19.4 16.6 31.6 7.2 3.1 15.8 6.6 33.4 38.2 10.9 14.0 1.0 12.5 25.4 17.1 30.0 7.3 4.1 1.2 24.3 0.6 8.1 43.5 1.6 5.9 17.0 42.4 10.0 4.6 6.3 23.7 38.9 22.2 28.1 5.6 20.6 116.2 11.3 22.1 57.1 4.9 4.2 4.8 16.2 8.9 16.4 4.0 4.9 9.0 9.1 8.0 16.2 1.9 0.9 0.2 0.2 1.1 0.5 1.4 0.5 0.3 0.9 0.6 0.2 0.3 0.6 0.4 0.7 21.7 0.4 0.4 12.8 12.8 14.7 21.7 13.0 13.1 12.8 13.3 12.1 14.5 12.6 13.3 12.4 2.1 0.0 8.4 4.2 2.5 2.4 11.8 23.9 2.2 0.2 19.0 17.1 0.9 7.2 16.6 12.9 0.0 18.3 1.0 7.8 0.0 9.0 17.0 24.1 4.6 1.7 4.8 1.3 0.0 8.3 36.4 4.2 7.1 23.6 0.0 0.9 1.1 18.6 3.5 1.7 0.0 8.8 14.2 0.8 3.7 15.6 1.2 1.5 3.6 0.0 2.1 5.3 0.0 1.0 0.0 10.5 4.5 0.4 1.8 23.7 8.5 6.9 31.0 0.7 0.0 2.0 8.8 20.2 7.2 8.4 2.0 32.3 2.2 3.0 8.0 23.1 PCSK7 "LPC, PC7, PC8, SPC7" ENSG00000160613 "Proprotein convertase subtilisin/kexin type 7" Q16549 11 117204337-117232525 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 8400 "unprognostic (7.11e-2)" "unprognostic (2.90e-2)" "unprognostic (8.33e-3)" "unprognostic (4.24e-2)" "unprognostic (1.32e-1)" "unprognostic (2.77e-2)" "unprognostic (1.56e-1)" "unprognostic (2.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.41e-1)" "unprognostic (8.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" 28.5 16.5 16.8 28.1 17.4 25.9 24.2 16.4 21.1 27.0 16.6 62.1 29.5 73.1 7.7 24.2 36.0 13.1 19.0 20.2 16.3 15.8 19.7 25.8 31.9 18.3 17.6 15.8 17.7 29.9 11.9 16.7 13.6 19.5 35.7 37.9 10.0 16.0 11.3 15.8 20.8 35.7 13.6 16.3 30.9 45.5 12.6 19.4 25.2 18.2 10.8 29.4 39.8 22.4 20.6 14.6 27.5 19.1 21.4 23.3 19.0 15.0 48.5 22.2 24.1 23.9 38.3 82.6 24.8 33.5 38.6 31.1 48.0 25.2 34.7 15.5 34.2 24.2 36.7 40.7 17.5 26.1 23.2 49.4 32.9 22.5 33.0 26.4 12.4 41.2 28.0 22.5 22.0 34.8 19.0 31.5 24.3 17.6 63.4 28.1 19.1 16.9 29.5 30.1 33.7 24.9 32.3 39.6 51.1 7.5 14.8 32.3 18.6 36.4 36.4 16.4 31.5 34.3 13.4 8.7 14.0 18.6 33.1 33.3 7.9 7.1 9.0 38.1 9.8 33.0 23.5 29.7 35.6 7.6 18.5 20.8 24.7 5.3 41.0 11.5 8.8 42.8 20.6 16.8 17.4 16.4 21.1 20.2 16.3 18.3 17.6 15.8 19.5 16.3 19.4 20.6 47.4 48.1 36.2 44.4 93.3 70.1 50.0 35.2 19.4 124.1 31.2 23.5 8.1 35.8 42.5 47.8 246.0 50.7 97.4 204.9 5.9 27.4 6.4 21.0 40.3 47.5 62.4 27.4 47.2 54.5 39.0 38.5 110.6 36.5 34.1 30.2 77.4 27.8 32.4 87.5 41.4 91.2 24.4 60.6 83.9 7.5 33.5 39.2 53.4 25.3 54.6 21.8 310.0 48.2 62.0 73.7 132.2 39.9 58.7 39.0 98.2 9.2 22.9 178.8 72.3 87.5 107.7 64.4 24.5 27.4 94.3 62.5 127.3 42.7 110.3 53.3 SAFB "HET, SAFB1" ENSG00000160633 "Scaffold attachment factor B" Q15424 19 5623035-5668478 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001969, HPA016832, HPA020076" Supported Enhanced Nucleoplasm,Midbody Yes NA 67000 Nucleoplasm Midbody "CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624" "unprognostic (2.41e-2)" "unprognostic (8.18e-3)" "unprognostic (6.66e-2)" "unprognostic (3.81e-3)" "unprognostic (6.50e-2)" "unprognostic (7.82e-2)" "unprognostic (1.62e-3)" "unprognostic (9.31e-2)" "unprognostic (5.76e-2)" "unprognostic (4.85e-2)" "prognostic favorable (9.75e-5)" "unprognostic (3.25e-2)" "unprognostic (3.53e-3)" "unprognostic (3.14e-2)" "unprognostic (2.67e-2)" "unprognostic (4.07e-1)" "prognostic favorable (1.70e-4)" 43.2 40.4 27.2 34.8 29.1 56.0 44.6 34.2 32.2 51.9 23.6 48.8 29.0 50.1 14.1 45.5 45.6 17.4 45.4 26.6 26.6 39.3 43.0 46.2 39.4 30.9 27.8 23.6 54.9 44.7 22.9 43.7 27.9 32.7 46.8 17.9 32.3 43.1 19.8 86.0 60.8 48.8 20.8 24.3 59.3 43.6 43.8 31.1 43.8 43.0 30.5 29.6 43.7 48.0 43.7 94.1 81.8 95.3 62.0 41.6 36.4 111.5 68.0 43.7 56.8 47.4 124.2 52.0 149.7 52.9 33.8 48.3 86.4 92.7 55.7 58.1 101.6 94.6 109.9 75.1 118.0 39.4 136.7 93.6 33.6 50.9 50.8 53.2 40.4 45.5 65.9 156.7 75.0 43.5 84.7 146.2 109.9 128.3 63.7 81.1 144.4 105.1 104.8 44.4 76.6 88.2 76.4 76.3 61.2 76.2 54.3 56.3 74.4 71.4 57.6 71.6 72.2 106.2 121.5 112.0 133.3 55.4 112.6 77.7 65.4 47.4 84.1 55.9 47.8 57.1 53.1 55.1 54.9 53.2 47.6 56.8 55.1 53.1 54.6 79.8 44.6 58.6 55.4 27.2 29.1 34.2 32.2 26.6 26.6 30.9 27.8 23.6 32.7 24.3 31.1 43.7 34.8 32.1 21.0 33.3 59.1 65.6 50.2 41.0 51.2 41.3 28.9 30.2 43.4 17.2 47.6 16.5 35.5 53.6 47.7 41.0 25.4 44.0 10.0 56.6 55.6 38.9 29.8 29.6 28.6 35.0 55.2 42.6 33.1 46.4 50.6 52.6 23.2 28.1 38.0 50.5 29.8 43.4 32.6 23.0 52.6 8.2 35.8 37.0 30.2 30.9 55.6 30.0 50.4 34.2 41.5 32.3 29.9 25.9 50.9 44.8 33.7 28.1 72.9 47.2 19.7 44.5 45.1 89.7 94.3 37.2 65.4 62.5 52.2 44.0 40.5 38.9 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 95.6" "Group enriched" "Detected in many" 11 "dendritic cells: 139.6;T-cells: 294.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 21 "gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0" "Lineage enriched" "Detected in many" 26 "T-cells: 241.7" "Group enriched" "Detected in some" 52 "JURKAT: 70.9;MOLT-4: 193.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 0.7 0.8 0.6 10.6 0.7 1.3 1.0 0.9 0.8 0.7 1.0 2.3 3.3 0.5 0.6 1.5 0.9 2.5 0.5 0.4 0.3 0.6 1.6 2.8 28.1 0.9 0.5 0.4 0.4 0.5 0.2 0.0 0.3 1.0 0.9 2.7 0.4 1.6 0.3 10.6 0.9 4.6 0.6 0.4 11.6 4.2 0.5 0.5 95.6 0.6 0.3 20.6 3.0 0.4 1.6 0.2 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 70.9 2.5 0.3 0.0 0.6 193.8 1.3 0.2 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.5 0.2 0.0 1.1 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.7 0.3 0.2 0.2 0.1 9.2 1.2 1.2 229.0 0.6 135.6 0.8 187.3 197.3 0.6 0.9 192.6 241.7 6.4 1.4 1.2 1.5 200.0 90.4 0.6 0.7 0.9 0.8 0.4 0.3 0.9 0.5 0.4 1.0 0.4 0.5 1.6 3.2 3.2 6.9 0.0 7.8 2.3 0.1 0.0 1.8 0.2 2.0 2.9 0.8 1.5 1.9 0.0 0.0 0.1 139.6 0.4 0.0 0.3 1.0 0.4 0.4 1.4 0.0 3.4 0.1 0.0 0.0 2.3 13.7 0.4 6.3 0.0 4.2 1.7 0.1 0.0 0.1 0.2 0.0 3.8 5.8 1.4 0.0 7.7 5.4 1.0 8.1 0.0 14.4 0.0 0.3 0.0 0.1 0.0 18.5 0.0 0.0 0.6 0.7 0.8 0.0 1.3 1.6 0.2 0.4 0.6 2.4 0.3 294.0 0.1 0.3 0.0 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 3105.8;skeletal muscle: 3089.2;tongue: 4955.1" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 1848.3" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "Hep G2: 325.8;SK-MEL-30: 1130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 290000 Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 181.3 8.3 724.3 6.5 774.6 2.3 78.0 766.5 960.2 2.4 564.9 11.2 11.2 4.2 1.0 81.7 42.1 4.9 3105.8 695.3 710.4 192.2 4.5 4.0 5.1 844.2 800.4 660.0 2.0 16.9 162.4 55.1 18.2 802.7 29.2 1.2 36.8 627.5 9.4 3089.2 22.5 7.0 1.7 813.2 4.3 23.3 6.0 811.0 9.5 169.4 4955.1 4.0 4.4 3.0 920.4 6.0 3.4 3.9 33.7 0.5 0.2 2.9 7.7 0.2 0.6 0.2 6.6 3.4 3.7 137.7 0.6 2.7 10.3 0.3 0.4 0.0 4.2 3.3 8.2 5.4 325.8 0.4 3.0 2.3 0.7 0.0 0.0 0.1 7.9 0.0 1.5 27.2 3.7 0.1 10.6 1.2 4.9 1.8 4.3 2.6 22.5 3.3 8.0 6.0 12.1 6.1 1.9 3.5 10.6 1130.2 11.1 32.8 16.2 2.7 3.3 2.8 3.0 3.8 6.1 5.7 6.2 2.5 6.2 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 724.3 774.6 766.5 960.2 695.3 710.4 844.2 800.4 660.0 802.7 813.2 811.0 920.4 4.3 0.0 0.0 59.4 9.5 9.7 1.2 0.4 1.8 1.1 369.9 354.1 74.4 8.6 0.2 154.5 2.1 1.1 5.9 1.1 162.4 0.9 0.6 90.5 17.3 5.3 1.8 0.0 0.3 3.7 1.9 6.0 0.0 193.3 0.0 0.0 7.9 4.7 199.1 0.0 0.3 3.7 0.0 0.6 3.5 2.2 6.5 15.6 341.5 2.8 0.0 163.5 0.0 2.0 45.8 1.9 0.6 9.1 0.0 1.8 0.9 1848.3 0.2 2.7 0.0 67.0 4.2 3.8 2.8 1.0 2.3 3.4 8.2 2.3 1.8 0.7 CHTOP "C1orf77, DKFZP547E1010, FOP, SRAG" ENSG00000160679 "Chromatin target of PRMT1" Q9Y3Y2 1 153633982-153646306 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028647, HPA030540" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA028647: AB_10602699, HPA030540: AB_2673516" "unprognostic (2.72e-1)" "unprognostic (2.41e-1)" "unprognostic (3.41e-2)" "unprognostic (6.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (8.65e-2)" "prognostic unfavorable (4.08e-4)" "unprognostic (9.16e-2)" "unprognostic (2.20e-1)" "unprognostic (7.30e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.58e-2)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.69e-4)" 42.1 45.2 50.5 36.8 56.5 63.1 44.6 57.4 56.4 52.8 50.4 44.4 30.6 45.6 36.5 50.7 47.9 22.1 57.1 50.2 53.3 47.9 55.2 39.6 47.0 53.2 53.4 49.2 55.7 63.9 36.2 49.1 33.7 54.9 48.8 33.0 60.4 44.7 29.9 125.6 51.6 47.2 30.7 52.9 66.0 48.3 37.9 52.1 66.3 56.2 69.0 44.8 45.5 48.3 66.0 74.3 63.9 106.2 65.0 45.2 33.1 84.3 51.2 47.0 71.3 61.2 71.6 72.9 83.5 75.6 48.0 46.6 66.8 103.4 74.7 46.9 97.8 95.7 65.5 102.2 60.0 56.1 101.8 78.8 38.5 84.8 69.0 97.5 59.2 57.7 89.4 82.1 62.2 54.1 94.3 109.8 102.6 123.6 106.9 79.1 67.5 65.0 92.5 69.8 100.5 64.3 74.5 54.6 77.8 91.6 69.9 83.7 138.6 50.0 47.7 70.4 60.7 83.8 86.2 77.8 95.5 50.1 81.9 56.8 84.9 42.9 40.9 46.0 44.8 46.2 46.2 45.3 45.3 54.4 43.3 45.2 41.0 30.8 35.1 43.0 41.7 51.9 46.4 50.5 56.5 57.4 56.4 50.2 53.3 53.2 53.4 49.2 54.9 52.9 52.1 66.0 46.4 32.1 37.3 32.3 50.1 63.0 103.6 59.7 37.5 40.8 45.6 33.5 74.1 57.2 43.5 53.3 33.3 91.7 47.7 49.2 50.9 69.5 34.9 50.6 42.6 54.2 60.3 81.9 16.1 64.8 121.9 47.1 42.3 63.4 46.3 59.7 43.9 41.2 69.7 43.7 17.6 56.4 42.7 48.9 38.2 18.0 44.7 40.9 35.6 14.0 69.3 44.0 52.5 16.6 40.1 61.3 58.1 42.2 48.2 101.8 48.4 49.0 33.2 57.5 19.7 34.9 59.7 125.2 115.2 46.5 61.7 128.6 45.7 57.9 52.3 110.2 CXCR5 "BLR1, CD185, MDR15" ENSG00000160683 "C-X-C motif chemokine receptor 5" P32302 11 118883892-118897787 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "B-cell activation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 10.7;intestine: 10.3;lymphoid tissue: 29.1" "Cell type enriched" "Detected in some" 13 "B-cells: 83.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "memory B-cell: 67.7;naive B-cell: 92.4" "Lineage enriched" "Detected in many" 8 "B-cells: 92.4" "Group enriched" "Detected in some" 11 "Daudi: 18.9;U-698: 65.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026149, HPA042432" Enhanced NA NA "CAB026149: , HPA042432: AB_2677995" "unprognostic (8.51e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-1)" "unprognostic (4.02e-5)" "unprognostic (2.08e-2)" "unprognostic (3.23e-3)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-5)" "unprognostic (4.21e-1)" "unprognostic (2.03e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" 0.3 1.9 0.3 11.4 0.4 10.7 0.2 0.6 0.3 2.5 0.1 2.8 0.5 0.3 0.1 2.6 0.1 1.0 0.6 0.4 0.2 0.5 1.5 1.4 29.1 0.3 0.5 0.1 0.7 0.9 0.0 1.0 0.2 0.3 3.7 0.5 0.6 1.3 0.0 2.1 1.9 10.3 0.0 0.1 21.3 2.0 0.3 0.4 1.9 0.8 0.0 16.1 2.3 1.4 0.3 0.1 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 18.9 0.5 0.0 0.7 2.1 0.0 0.0 0.0 0.4 0.3 3.9 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.6 0.0 1.1 0.8 1.6 0.0 0.7 0.0 0.8 0.1 0.3 0.0 0.0 0.6 0.5 0.0 0.1 0.9 0.2 0.4 0.8 0.0 0.6 0.9 0.0 0.2 0.3 0.0 65.2 0.1 0.7 0.0 0.1 0.1 0.0 1.0 0.0 0.9 67.7 10.9 3.0 0.1 92.4 1.1 1.0 0.1 0.2 0.1 0.1 1.7 6.2 0.3 0.4 0.6 0.3 0.4 0.2 0.3 0.5 0.1 0.3 0.1 0.4 0.3 0.1 0.0 1.8 0.0 83.0 0.1 0.0 0.0 1.2 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.2 1.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.9 0.6 0.3 6.1 0.1 0.1 0.1 ZBTB7B "c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B" ENSG00000160685 "Zinc finger and BTB domain containing 7B" O15156 1 155002630-155018522 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 135.2;Proximal enterocytes: 158.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006811, HPA025820" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006811: AB_1859046, HPA025820: AB_1859045" "unprognostic (5.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-2)" "unprognostic (2.43e-1)" "unprognostic (4.95e-3)" "unprognostic (9.55e-2)" "unprognostic (1.41e-1)" "unprognostic (3.72e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.46e-2)" "unprognostic (5.35e-2)" "unprognostic (1.11e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" "unprognostic (1.53e-2)" 24.5 35.6 12.1 18.3 13.8 30.2 28.1 14.1 12.4 19.2 10.6 40.3 62.5 16.2 6.5 96.2 18.0 11.1 23.1 9.3 11.6 19.9 48.8 25.2 16.3 17.0 16.2 6.9 12.8 30.1 15.8 20.2 9.1 18.4 30.8 18.7 6.6 40.5 12.9 40.9 111.2 71.8 10.0 14.8 31.8 38.0 6.2 15.9 9.1 25.7 17.8 15.4 20.5 44.7 15.3 16.5 29.0 2.5 8.8 12.7 7.2 34.7 11.1 13.1 11.4 13.2 19.5 23.4 7.2 19.5 12.6 9.1 24.5 8.1 15.7 2.4 39.4 9.1 12.0 51.4 13.1 18.6 9.2 31.7 9.4 54.8 15.6 19.3 15.3 9.1 1.1 17.3 32.2 6.7 31.2 0.2 20.7 8.7 26.4 23.8 6.8 1.9 45.6 17.2 16.9 16.1 16.5 21.4 56.5 8.9 10.6 35.2 30.7 7.7 7.4 12.9 14.8 9.5 38.1 25.1 7.6 17.3 30.3 8.6 0.4 1.5 1.3 0.6 1.4 0.2 0.6 0.7 0.3 0.9 0.7 0.6 0.2 2.3 0.7 1.2 0.0 1.0 2.5 12.1 13.8 14.1 12.4 9.3 11.6 17.0 16.2 6.9 18.4 14.8 15.9 15.3 6.5 9.6 0.0 11.1 8.5 35.2 9.3 8.8 29.6 13.6 35.2 15.6 2.6 18.6 7.1 5.5 2.1 11.9 6.9 135.2 11.7 13.3 4.3 15.4 6.7 5.6 6.7 6.1 1.0 15.1 14.6 4.9 27.5 21.3 5.7 2.8 6.1 29.9 14.8 16.8 1.1 32.7 14.2 28.7 40.3 8.3 9.0 20.7 16.0 4.7 25.8 5.4 11.3 0.0 8.6 16.8 57.7 7.2 6.8 24.9 158.5 10.0 4.2 10.3 0.0 3.2 5.7 0.5 1.2 51.7 53.6 27.5 11.3 4.4 38.5 24.4 FLAD1 "FAD1, PP591" ENSG00000160688 "Flavin adenine dinucleotide synthetase 1" Q8NFF5 1 154983338-154993111 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028476, HPA028486, HPA028563" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286" "unprognostic (2.64e-1)" "unprognostic (2.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.84e-2)" "unprognostic (7.34e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.31e-1)" "unprognostic (2.32e-1)" "unprognostic (8.08e-2)" "unprognostic (6.51e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.67e-2)" "unprognostic (5.06e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-2)" 21.8 21.3 18.9 17.2 19.8 14.4 23.7 19.6 20.7 20.5 18.6 22.4 20.3 19.9 20.6 26.3 19.3 11.9 24.9 19.5 18.9 21.8 33.1 17.9 23.0 19.8 19.6 18.6 15.6 19.1 18.1 15.3 14.4 20.4 24.6 19.1 9.9 21.2 13.9 34.4 32.3 25.1 17.9 19.1 30.3 22.2 19.2 19.6 16.1 22.7 32.3 23.2 22.8 21.3 20.5 33.4 52.4 32.8 56.1 27.9 20.5 62.1 24.7 20.5 35.2 30.2 46.9 40.1 38.5 48.8 23.0 18.3 42.6 63.4 51.3 23.0 40.6 47.5 31.4 42.8 33.7 38.1 46.0 39.1 29.5 65.9 40.2 42.8 17.0 41.5 40.4 51.4 30.3 30.2 71.8 31.9 32.0 71.7 72.2 53.8 52.8 16.2 88.7 33.9 45.8 54.9 75.6 38.7 86.2 50.0 63.0 74.0 68.6 26.4 21.9 30.1 28.6 39.6 47.5 63.7 66.9 26.4 36.8 36.1 29.8 35.3 23.7 34.5 33.0 38.9 39.0 31.9 33.8 37.7 34.2 29.1 28.9 7.8 26.1 41.4 38.3 37.9 37.6 18.9 19.8 19.6 20.7 19.5 18.9 19.8 19.6 18.6 20.4 19.1 19.6 20.5 12.2 9.6 10.6 9.8 19.3 26.5 18.1 37.1 23.3 15.7 16.4 15.9 39.4 20.0 22.6 25.8 6.2 42.5 16.9 22.1 31.3 24.4 25.3 15.4 12.0 14.1 12.0 19.0 8.2 28.2 42.6 12.1 25.0 12.6 8.8 21.2 11.7 27.0 27.6 15.2 6.3 20.8 28.5 18.1 11.1 77.6 10.2 14.8 14.2 5.6 34.7 23.3 32.0 4.5 8.2 25.4 14.9 9.8 18.3 26.1 30.3 32.9 19.3 17.2 6.6 9.7 18.3 22.9 20.6 25.7 27.6 36.0 20.2 23.1 25.4 20.0 SHC1 "p66, SHC, ShcA" ENSG00000160691 "SHC adaptor protein 1" P29353 1 154962298-154974395 "Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001844, CAB005374, CAB016305" Supported Enhanced Cytosol NA NA Cytosol "CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826" "unprognostic (4.12e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.10e-2)" "unprognostic (3.77e-2)" "unprognostic (6.40e-2)" "unprognostic (4.08e-3)" "unprognostic (2.94e-3)" "prognostic unfavorable (1.92e-4)" "unprognostic (9.13e-2)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-16)" "unprognostic (7.19e-2)" "unprognostic (1.40e-1)" "unprognostic (9.21e-2)" "unprognostic (1.31e-1)" 137.9 104.7 31.5 91.2 28.0 73.4 127.8 27.6 32.7 91.7 33.4 70.3 72.8 86.7 54.2 74.1 88.2 89.6 64.8 27.8 49.5 63.9 95.2 107.3 51.0 35.6 30.7 25.6 71.3 58.2 62.3 121.5 77.7 35.9 85.7 71.6 16.6 59.1 70.9 63.8 59.7 73.6 108.5 31.1 73.4 70.3 23.6 36.3 47.8 87.1 56.7 53.3 97.5 83.9 41.1 110.8 223.7 168.9 272.3 180.6 359.3 88.6 393.5 355.3 223.6 168.7 80.2 258.5 59.3 314.0 476.4 64.1 92.9 45.5 389.6 200.2 72.7 25.0 152.0 185.7 143.9 471.1 49.3 164.8 538.3 452.4 279.4 344.0 605.8 497.7 25.0 68.2 461.3 473.8 90.0 56.8 29.8 147.9 89.7 94.2 51.1 56.1 122.6 107.1 82.5 21.6 582.1 234.8 130.2 126.3 293.3 189.8 102.9 595.6 349.6 217.5 75.1 209.0 206.6 146.2 101.7 341.4 65.9 463.5 32.4 36.7 58.0 39.0 47.7 38.7 22.4 30.7 34.6 38.0 20.8 24.6 22.4 29.2 23.2 48.2 17.5 24.6 39.1 31.5 28.0 27.6 32.7 27.8 49.5 35.6 30.7 25.6 35.9 31.1 36.3 41.1 86.0 28.9 23.6 7.5 14.1 35.7 54.5 76.5 40.9 5.1 24.0 30.6 2.2 20.0 19.1 5.5 6.2 25.7 13.1 44.1 7.9 29.0 0.7 14.7 58.8 88.0 12.6 16.0 5.4 28.0 58.0 36.3 26.0 26.9 17.7 16.8 77.8 44.5 23.3 25.2 3.7 24.5 34.6 22.3 25.1 2.7 23.0 19.5 17.8 2.8 14.5 8.7 11.3 4.5 2.1 34.0 27.6 34.6 29.1 53.5 34.4 9.6 13.0 7.4 19.7 22.7 35.7 3.8 4.9 26.9 36.4 60.9 16.2 24.5 22.4 50.0 VPS11 "PEP5, RNF108" ENSG00000160695 "VPS11 core subunit of CORVET and HOPS complexes" Q9H270 11 119067818-119081972 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039020 Approved Approved Cytosol NA NA Cytosol "HPA039020: AB_10674847" "unprognostic (6.97e-2)" "unprognostic (3.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-2)" "unprognostic (1.43e-2)" "unprognostic (1.28e-1)" "unprognostic (2.59e-3)" "unprognostic (1.11e-1)" "unprognostic (3.21e-1)" "unprognostic (9.17e-2)" "unprognostic (6.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.44e-4)" "unprognostic (4.07e-2)" "unprognostic (4.05e-2)" "unprognostic (2.71e-2)" "unprognostic (2.25e-1)" 19.6 25.3 16.5 14.8 16.1 17.8 19.6 16.0 18.7 20.7 14.4 18.4 13.5 23.7 19.1 14.7 20.3 12.9 16.8 16.7 16.9 16.9 11.6 17.0 18.2 16.4 17.3 16.1 22.7 18.2 22.5 23.0 17.5 16.7 18.6 13.5 17.8 18.4 16.7 21.9 20.7 18.0 19.7 14.8 21.9 18.7 13.4 16.8 20.2 21.3 21.3 17.4 21.2 17.6 17.6 11.6 11.8 12.8 9.8 27.5 24.2 14.0 15.4 18.4 15.3 16.5 19.9 24.2 16.6 21.5 30.2 27.1 21.0 16.1 20.7 15.1 17.1 8.0 36.6 12.0 19.5 30.8 22.9 21.5 29.6 21.3 23.2 15.9 27.2 24.4 13.9 29.5 28.8 20.2 30.5 19.3 21.6 6.4 21.2 22.5 21.7 21.1 12.6 18.2 24.1 10.2 17.5 19.2 25.3 16.8 13.7 38.3 20.1 24.5 19.1 7.1 6.9 11.5 11.3 11.0 15.6 14.0 27.2 17.0 24.8 16.8 12.8 16.4 13.9 16.8 11.3 13.7 15.2 20.7 11.9 12.9 16.6 3.8 16.5 19.0 8.7 16.5 13.9 16.5 16.1 16.0 18.7 16.7 16.9 16.4 17.3 16.1 16.7 14.8 16.8 17.6 9.9 6.4 10.5 8.1 10.2 2.9 4.4 7.0 8.6 10.2 8.1 9.8 7.6 8.6 12.1 9.2 12.5 11.2 16.2 9.7 9.8 8.2 7.8 9.9 10.0 10.7 9.6 6.3 9.6 10.1 7.0 9.7 11.2 9.9 15.2 10.2 13.2 6.0 17.0 5.0 9.9 10.1 6.1 14.8 8.9 3.0 17.1 12.6 7.2 7.5 11.6 9.2 5.2 6.6 14.4 7.2 6.8 15.4 11.5 3.6 9.2 11.0 10.5 15.5 13.1 6.2 10.2 11.3 7.3 6.5 4.8 14.1 12.2 9.4 9.5 3.8 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 15.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 15.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 8.2 10.8 4.4 4.7 4.8 6.6 7.1 4.5 5.6 8.1 5.6 9.3 4.8 10.2 3.4 43.5 9.9 5.3 14.1 4.1 5.0 8.0 9.1 5.6 5.1 4.9 4.5 3.8 4.0 9.7 6.1 4.9 4.2 5.1 8.4 3.5 2.7 10.4 6.9 24.3 20.6 6.5 5.9 4.7 8.2 7.4 3.5 4.5 4.7 8.0 13.9 10.5 9.7 16.7 5.0 5.3 15.6 1.6 12.2 5.1 5.9 2.4 7.0 8.0 3.4 5.9 0.9 13.0 9.5 21.0 8.9 5.1 13.1 4.7 4.0 1.1 12.5 5.0 12.6 5.5 8.6 7.7 4.4 7.0 6.6 16.4 4.5 8.7 6.9 7.0 12.5 0.1 6.2 3.6 14.2 7.5 10.7 7.5 6.9 8.6 14.6 2.1 3.1 8.2 6.8 2.3 7.9 10.4 5.5 4.5 2.4 17.7 13.0 8.2 6.8 6.0 6.1 3.6 2.2 2.6 3.3 1.0 13.4 4.9 2.8 3.5 15.4 0.8 1.5 1.0 0.5 0.8 1.2 2.1 0.4 0.9 1.0 8.1 1.4 1.4 0.9 1.4 2.3 4.4 4.8 4.5 5.6 4.1 5.0 4.9 4.5 3.8 5.1 4.7 4.5 5.0 3.0 0.0 7.9 5.9 3.2 2.5 1.7 4.5 2.8 1.3 4.1 4.2 12.8 2.8 4.2 7.3 2.1 3.6 1.4 7.3 1.9 7.1 2.0 8.7 2.8 3.8 2.4 3.8 5.9 3.8 2.2 3.5 8.2 4.1 0.0 5.7 5.3 10.2 6.5 0.0 4.0 3.7 2.0 6.0 1.8 4.7 1.2 4.0 1.8 2.8 6.2 6.1 5.2 5.5 2.8 5.5 7.6 1.2 1.8 1.6 3.9 5.3 7.2 3.2 0.0 2.9 2.7 1.9 2.0 10.8 4.7 0.5 2.8 2.1 5.5 1.2 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase RNA specific" P55265 1 154581695-154628013 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 41.6 45.1 26.2 57.8 27.2 47.6 41.5 15.3 32.6 49.2 14.8 42.7 46.8 50.6 26.6 38.2 50.7 46.0 34.2 26.5 33.1 52.2 56.6 55.1 66.6 29.2 31.8 22.3 55.4 40.9 63.2 54.3 46.9 28.6 43.1 44.9 48.3 59.9 43.4 18.9 40.1 53.2 57.1 20.2 74.1 40.6 34.7 31.6 86.0 47.6 27.9 65.5 50.9 40.3 34.6 93.2 103.1 84.4 104.8 87.4 88.5 97.8 59.5 132.7 209.8 183.4 87.8 85.3 162.6 97.7 98.7 112.4 85.4 111.9 115.5 109.8 159.1 52.3 84.9 66.2 48.4 96.7 122.8 83.8 86.2 84.7 100.4 104.1 81.2 104.5 112.4 82.4 111.6 72.0 107.8 165.0 43.3 139.7 125.5 74.6 140.1 74.2 131.2 67.6 106.1 84.8 100.2 104.4 167.9 126.2 128.1 113.4 148.2 94.3 67.5 68.5 58.8 71.5 132.9 179.0 177.6 70.2 78.4 81.0 7.8 8.1 15.0 10.8 9.9 10.2 9.0 10.6 11.2 7.8 5.8 9.8 10.0 29.1 8.6 9.4 6.3 9.1 7.4 26.2 27.2 15.3 32.6 26.5 33.1 29.2 31.8 22.3 28.6 20.2 31.6 34.6 73.3 83.3 51.2 37.5 80.5 33.3 39.4 39.9 32.5 94.5 43.6 36.6 22.1 45.8 44.0 47.8 95.9 41.2 103.0 73.3 9.8 49.2 4.2 48.9 61.0 86.7 63.1 45.2 44.8 66.9 57.8 49.1 56.6 52.4 62.1 88.6 84.9 93.8 53.5 168.2 53.2 53.9 34.6 104.1 43.9 13.1 73.7 78.0 19.6 32.8 110.2 37.9 126.7 38.2 39.7 69.6 62.7 59.0 87.5 61.1 86.7 42.5 50.0 80.2 52.6 40.1 45.2 11.4 35.0 37.9 40.3 31.5 85.6 66.5 56.2 53.8 IL6R CD126 ENSG00000160712 "Interleukin 6 receptor" P08887 1 154405193-154469450 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.8;skeletal muscle: 95.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 115.4;Hepatocytes: 108.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 88.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 224.4;U-266/84: 274.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 24800000 35000000 "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (1.19e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-2)" "unprognostic (3.27e-1)" "unprognostic (6.42e-2)" "prognostic favorable (1.65e-4)" "unprognostic (7.94e-2)" "unprognostic (1.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" 11.1 5.8 8.3 25.7 7.2 16.7 6.0 7.3 10.1 7.2 5.7 14.8 15.8 8.4 2.6 7.5 12.5 9.1 6.4 5.9 9.6 14.4 58.8 16.5 27.5 10.1 9.3 3.6 9.0 8.8 1.2 8.9 6.6 10.7 6.1 9.9 1.4 3.4 2.9 95.0 6.3 20.0 8.8 9.2 19.9 10.3 3.4 10.3 9.4 2.8 26.7 22.5 9.4 5.4 17.0 3.3 5.8 0.4 0.4 3.4 5.1 0.4 3.3 2.5 2.0 1.0 0.6 3.9 0.2 7.4 4.1 12.0 1.7 1.1 17.8 1.6 62.6 1.9 0.8 2.2 13.9 0.5 9.6 5.0 3.0 10.5 1.7 26.1 0.6 2.6 0.1 0.7 24.0 0.6 1.4 0.2 16.0 1.8 1.1 13.5 0.3 0.3 53.6 10.9 4.5 0.5 0.3 1.1 36.2 59.5 4.5 3.3 224.4 2.5 3.5 3.4 3.3 2.2 43.1 274.1 0.4 4.4 61.0 5.7 7.5 29.4 28.1 0.6 18.0 1.5 1.5 15.2 1.6 36.1 0.6 14.9 5.4 88.2 1.3 8.0 13.1 21.2 15.8 8.3 7.2 7.3 10.1 5.9 9.6 10.1 9.3 3.6 10.7 9.2 10.3 17.0 3.4 115.4 82.7 18.6 11.0 37.9 72.9 8.3 13.1 0.1 7.5 7.4 9.9 25.8 33.9 1.8 0.0 0.5 16.9 38.5 0.0 4.3 35.1 34.1 5.7 10.9 7.7 3.8 5.7 1.2 1.2 26.3 25.5 48.7 61.3 1.3 3.9 108.6 42.9 0.0 5.9 6.5 14.2 41.8 79.3 14.5 0.3 63.7 24.9 44.0 76.8 3.8 4.1 3.0 3.3 7.5 8.7 0.4 41.9 58.9 60.1 15.5 29.0 0.2 0.0 28.3 19.2 0.4 1.1 7.2 29.7 1.0 17.1 0.1 15.4 17.0 UBE2Q1 "NICE-5, PRO3094, UBE2Q" ENSG00000160714 "Ubiquitin conjugating enzyme E2 Q1" Q7Z7E8 1 154548577-154559028 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063368 Approved Approved Nucleoplasm,Centrosome,Cytosol No No Nucleoplasm "Centrosome, Cytosol" "HPA063368: AB_2684996" "unprognostic (3.88e-1)" "unprognostic (2.13e-1)" "unprognostic (4.44e-3)" "unprognostic (3.64e-3)" "unprognostic (5.32e-3)" "unprognostic (6.10e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (2.92e-1)" "unprognostic (2.07e-1)" "unprognostic (9.92e-3)" "unprognostic (3.79e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.84e-7)" "unprognostic (2.20e-1)" "unprognostic (4.46e-1)" "prognostic favorable (1.86e-5)" "unprognostic (1.04e-2)" 24.2 23.3 36.8 19.2 37.8 32.5 22.6 35.2 43.6 21.0 35.6 24.5 18.8 22.0 27.4 27.6 24.0 20.1 24.1 37.6 38.0 29.1 31.9 25.2 29.8 36.8 36.7 36.3 23.3 32.0 28.5 31.6 24.1 37.5 21.4 28.5 26.1 22.7 21.1 26.5 26.9 25.7 24.6 36.3 32.6 27.0 34.8 38.0 30.1 23.1 26.1 35.5 25.9 22.4 39.0 39.0 33.0 45.6 35.0 45.8 46.9 39.4 38.0 57.0 47.3 38.0 37.3 40.4 47.5 53.3 52.8 39.5 33.0 54.3 43.6 40.5 48.7 34.3 37.8 29.6 36.4 57.5 62.1 58.3 45.5 56.7 38.5 44.1 51.3 61.8 43.3 32.4 57.1 61.3 60.4 38.1 45.6 62.5 92.3 55.5 43.4 31.8 50.3 52.4 40.6 46.2 64.6 38.1 70.6 64.5 77.5 43.3 93.2 43.3 30.5 34.1 36.5 41.2 69.3 55.2 62.1 34.2 43.2 47.1 3.9 1.3 2.9 2.1 1.6 2.0 1.4 2.0 2.7 1.2 1.5 2.2 2.5 2.0 2.3 1.3 2.4 3.1 0.8 36.8 37.8 35.2 43.6 37.6 38.0 36.8 36.7 36.3 37.5 36.3 38.0 39.0 40.8 32.1 26.5 9.8 24.7 16.2 18.0 15.9 15.4 41.2 27.3 32.5 29.4 27.1 18.4 16.5 4.2 19.8 45.2 33.4 11.7 14.5 4.5 24.8 20.9 32.8 33.6 12.0 12.2 21.0 18.2 23.3 14.3 24.9 10.8 31.9 35.3 38.3 27.5 60.6 11.7 29.2 22.4 48.0 19.7 7.3 17.7 27.9 14.2 10.3 30.9 42.8 39.1 7.1 11.7 26.2 18.5 19.2 22.1 29.5 29.6 19.7 29.0 23.1 13.1 20.1 21.2 34.1 29.2 18.1 19.0 19.6 26.5 36.3 25.7 31.4 CHRNB2 ENSG00000160716 "Cholinergic receptor nicotinic beta 2 subunit" P17787 1 154567778-154580013 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;retina: 8.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.7;Cone photoreceptor cells: 14.6;Horizontal cells: 42.1;Inhibitory neurons: 7.8;Late spermatids: 11.8;Rod photoreceptor cells: 7.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 25.7;SH-SY5Y: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-1)" "unprognostic (6.33e-2)" "unprognostic (8.15e-3)" "unprognostic (3.32e-1)" "unprognostic (4.37e-3)" "unprognostic (2.25e-1)" "unprognostic (3.51e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (4.36e-1)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (5.65e-2)" "unprognostic (1.84e-1)" 0.0 1.0 5.9 0.1 7.8 0.0 0.4 2.6 17.9 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.5 5.6 0.0 0.0 0.0 0.0 3.9 6.0 9.5 0.0 0.6 0.1 3.7 0.0 6.9 0.0 0.1 8.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.7 15.2 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 25.7 25.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.8 2.6 17.9 8.5 5.6 3.9 6.0 9.5 6.9 0.0 15.2 10.6 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 12.7 0.1 0.3 1.5 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.2 3.6 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 7.8 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 1.0 0.0 1.3 0.0 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 1.5 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 CRTC2 TORC2 ENSG00000160741 "CREB regulated transcription coactivator 2" Q53ET0 1 153947669-153958615 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028454, HPA028465" Supported Enhanced Nucleoplasm NA NA 13000 Nucleoplasm "HPA028454: AB_10599617, HPA028465: AB_10601991" "unprognostic (4.91e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (4.32e-3)" "unprognostic (2.86e-1)" "unprognostic (4.63e-3)" "unprognostic (1.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.35e-7)" "unprognostic (7.90e-2)" "unprognostic (2.59e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.12e-5)" 31.1 28.9 26.1 20.6 27.1 28.2 29.9 26.0 30.4 33.8 24.1 27.9 11.2 27.4 15.8 25.9 29.4 13.8 25.6 24.6 25.0 31.4 35.4 39.1 29.1 28.2 27.4 23.2 40.9 26.6 21.2 25.1 16.0 27.8 29.2 12.8 10.1 27.3 16.9 36.9 34.4 35.0 17.3 25.4 56.3 28.1 21.6 26.7 23.8 32.5 18.7 25.5 28.7 29.5 27.9 24.2 17.9 17.1 19.6 27.2 19.8 25.2 12.8 27.2 24.9 20.3 18.5 24.0 22.8 20.4 23.2 16.8 27.0 20.5 26.8 13.9 29.5 25.7 11.2 18.8 14.4 27.4 19.0 18.7 26.1 25.5 27.6 22.3 19.7 23.3 12.8 19.2 27.1 18.0 38.4 20.6 29.9 12.8 26.1 19.5 15.5 11.7 19.6 26.3 19.4 14.2 23.2 21.5 43.3 32.7 16.5 20.9 37.3 17.7 20.0 17.9 21.7 22.9 43.6 30.7 15.7 18.4 15.9 15.1 3.2 2.2 5.0 2.3 3.5 2.0 2.5 2.5 2.6 1.9 3.2 1.6 2.0 5.7 2.9 2.7 2.6 1.9 1.0 26.1 27.1 26.0 30.4 24.6 25.0 28.2 27.4 23.2 27.8 25.4 26.7 27.9 17.8 6.4 10.0 10.4 22.3 24.6 6.9 11.1 13.6 6.3 14.6 12.8 6.0 11.5 8.7 12.9 4.2 9.7 23.0 15.9 1.9 9.0 1.4 13.4 15.0 13.7 16.1 9.7 7.4 10.2 9.4 11.1 14.3 27.7 8.2 6.1 12.5 12.8 10.9 1.7 6.9 13.8 6.1 14.6 23.6 1.2 12.2 17.4 3.6 6.5 11.8 4.8 19.6 6.0 11.1 15.0 5.0 15.1 20.6 12.6 9.8 4.0 7.3 6.9 6.6 9.3 12.1 17.0 12.0 12.7 22.6 12.2 19.6 6.1 7.9 13.0 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA016624: , HPA051569: AB_2681537" "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favorable (6.70e-4)" "prognostic favorable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 26.9 14.2 17.7 15.2 18.4 33.3 22.0 23.8 21.0 22.5 18.6 39.8 61.6 21.8 13.8 25.5 14.0 19.5 12.6 17.6 21.3 30.2 14.2 17.0 7.6 22.7 22.8 17.8 14.1 15.3 23.9 14.1 18.2 23.2 14.3 34.0 10.2 28.9 20.4 15.6 31.0 55.2 28.3 20.0 9.2 13.6 13.1 19.7 7.1 24.8 11.7 9.7 18.3 21.7 24.5 30.6 23.6 26.1 27.4 101.1 53.5 31.2 87.7 141.1 42.0 54.4 16.2 27.5 3.1 27.4 114.8 43.1 16.3 20.6 47.0 52.6 33.6 14.2 39.4 28.7 17.7 43.9 7.2 31.1 50.5 36.3 53.6 71.8 79.4 100.3 18.7 30.8 24.9 95.2 20.8 7.8 5.2 31.3 23.7 28.6 6.3 18.7 10.2 85.5 31.4 6.4 19.4 34.4 27.0 19.8 45.3 59.5 14.5 84.7 66.2 24.4 70.2 40.7 15.7 22.9 1.1 60.2 14.6 44.2 7.4 19.0 1.4 6.7 11.1 3.8 2.7 4.6 4.5 13.1 2.5 3.9 6.0 32.8 9.7 12.7 2.3 5.4 7.0 17.7 18.4 23.8 21.0 17.6 21.3 22.7 22.8 17.8 23.2 20.0 19.7 24.5 24.3 6.4 3.2 70.2 4.1 5.6 5.8 6.9 8.0 8.0 18.2 8.4 5.2 8.6 13.2 14.7 0.0 14.4 3.7 38.5 123.3 21.6 2.9 11.8 23.6 17.8 9.6 11.8 77.4 17.8 19.5 10.6 10.2 31.2 2.5 6.8 23.6 10.7 11.6 10.1 97.9 23.8 10.2 9.6 5.3 5.2 5.6 9.1 14.2 69.3 9.2 17.1 5.2 71.4 46.4 11.7 22.1 10.1 2.6 4.4 58.4 19.0 4.0 3.6 6.6 19.1 15.7 17.1 23.6 8.7 6.1 17.1 5.8 6.2 26.9 4.8 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 358.6" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 927.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 1187.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol NA NA 1500000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 71.0 189.8 47.8 67.1 50.2 70.0 69.5 58.7 59.2 63.8 48.8 89.6 168.7 57.9 73.6 143.6 57.9 40.2 72.9 48.3 57.0 78.7 358.6 86.8 76.7 66.2 61.9 47.1 45.4 76.3 68.4 40.7 73.1 73.2 56.6 103.9 46.3 83.2 43.1 61.4 99.8 81.8 66.6 55.2 59.8 82.1 42.3 55.5 73.2 47.1 67.3 103.1 47.4 77.5 72.0 293.9 156.2 561.5 204.4 128.7 467.7 199.6 136.8 268.1 213.6 344.2 255.4 677.7 222.3 323.6 120.6 506.9 319.1 338.9 1187.5 198.9 122.4 242.5 129.4 260.1 311.5 210.8 212.1 142.0 335.5 184.6 339.6 168.8 96.4 377.6 322.3 235.1 579.9 225.3 315.1 273.6 205.0 338.9 216.4 225.5 231.6 243.2 620.0 567.7 193.0 217.4 185.6 140.7 253.0 243.0 317.3 182.6 567.6 277.1 118.4 144.3 74.3 254.9 244.3 202.3 401.1 115.3 221.7 191.1 90.6 85.5 124.1 89.2 92.9 79.7 102.8 77.8 91.1 95.6 95.1 69.9 87.1 38.9 115.2 70.0 76.2 113.7 134.7 47.8 50.2 58.7 59.2 48.3 57.0 66.2 61.9 47.1 73.2 55.2 55.5 72.0 154.2 73.7 181.6 38.5 68.4 36.8 83.3 927.7 42.1 69.4 84.6 56.9 1.8 97.2 431.5 53.3 62.6 207.8 74.9 343.0 137.0 180.9 216.6 56.7 38.2 161.9 71.4 133.4 30.8 329.9 198.7 59.8 52.0 77.8 62.8 116.6 168.1 361.9 112.0 55.5 28.1 135.7 299.1 54.8 44.4 67.9 60.9 52.8 96.0 15.0 144.7 81.1 87.6 22.6 39.7 256.7 324.3 70.3 91.3 206.1 194.1 145.0 129.6 90.8 72.3 47.0 177.5 42.0 14.2 49.7 59.8 143.5 68.3 230.6 165.4 148.2 RUSC1 NESCA ENSG00000160753 "RUN and SH3 domain containing 1" Q9BVN2 1 155320894-155331114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028510, HPA029922, HPA029923" Approved Enhanced Cytosol NA Yes Cytosol "HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288" "unprognostic (1.98e-1)" "unprognostic (2.82e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-1)" "unprognostic (5.25e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.78e-6)" "unprognostic (1.42e-1)" "unprognostic (1.38e-1)" "unprognostic (1.73e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (9.24e-6)" "unprognostic (7.59e-2)" "unprognostic (4.25e-2)" "unprognostic (2.05e-2)" "unprognostic (1.40e-1)" 25.4 26.8 39.5 11.7 41.1 12.9 23.4 40.2 66.5 35.4 13.4 35.2 21.8 29.1 8.7 49.9 25.0 17.0 28.9 37.8 40.4 32.3 12.7 23.9 10.8 51.5 35.4 43.9 27.7 22.7 11.8 45.4 18.4 54.3 32.3 23.2 12.0 32.2 20.5 14.2 37.1 30.1 18.7 27.4 18.2 27.5 6.6 46.2 18.8 19.5 13.4 11.4 26.9 39.5 66.8 70.4 43.5 24.5 36.4 29.6 32.1 47.2 32.7 20.8 42.2 47.1 50.1 45.2 13.7 24.4 33.2 24.2 95.1 38.3 47.4 18.2 18.8 48.8 19.8 44.7 26.6 24.5 19.9 32.9 33.0 29.3 42.5 14.6 20.4 43.9 29.7 30.5 9.4 36.9 133.4 25.0 25.3 48.4 128.4 68.3 33.6 17.1 24.3 40.3 52.7 25.2 40.5 27.6 76.9 16.8 39.8 114.8 33.6 20.2 54.0 44.4 51.4 65.8 7.4 18.0 8.6 38.2 26.5 15.0 5.8 8.0 4.0 6.3 9.8 7.2 3.6 5.1 6.4 8.8 1.5 2.8 6.0 1.1 3.3 25.2 8.4 5.5 5.4 39.5 41.1 40.2 66.5 37.8 40.4 51.5 35.4 43.9 54.3 27.4 46.2 66.8 18.2 9.6 12.7 4.9 8.0 28.0 20.1 29.5 22.8 16.9 21.3 19.3 10.2 15.7 27.9 18.4 6.2 30.8 14.8 82.2 23.5 22.4 0.4 9.9 14.7 20.0 15.6 14.5 23.8 17.7 76.6 19.1 25.5 23.6 8.2 9.8 16.4 7.8 21.0 37.0 30.5 51.7 18.3 12.8 20.3 0.5 18.3 11.9 19.6 6.5 11.7 13.4 15.5 7.1 8.2 25.6 43.7 18.0 8.4 29.4 51.8 27.9 10.4 7.0 19.7 12.7 22.2 2.3 8.9 41.4 34.9 38.0 15.2 6.7 40.1 26.0 FAM189B "C1orf2, cote1" ENSG00000160767 "Family with sequence similarity 189 member B" P81408 1 155247205-155255483 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006659, HPA050674" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA006659: AB_1078339, HPA050674: AB_2681213" "unprognostic (1.56e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.59e-5)" "unprognostic (1.46e-2)" "unprognostic (4.86e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.70e-2)" "unprognostic (3.49e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.43e-7)" "unprognostic (4.16e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-3)" "unprognostic (3.25e-2)" 12.2 14.7 7.1 3.7 4.5 1.7 11.2 5.8 13.7 13.5 0.0 18.2 5.3 17.3 0.6 17.7 12.4 1.9 10.6 5.3 2.6 11.4 8.7 10.7 2.2 10.5 3.9 3.6 12.1 9.2 4.5 14.1 3.2 13.3 14.0 1.3 1.5 11.2 4.1 28.6 13.5 11.5 3.3 4.6 9.0 15.8 13.2 13.1 1.5 9.9 5.7 1.4 21.3 14.2 8.2 22.4 18.9 9.2 31.1 9.6 14.8 4.2 20.9 10.5 10.9 9.8 21.5 13.6 21.9 27.0 11.2 7.8 21.2 12.1 16.7 2.4 27.5 39.6 17.3 12.3 11.0 16.4 4.7 18.4 16.5 10.3 10.5 6.4 11.4 15.3 14.7 13.3 7.2 8.8 14.0 19.9 8.3 20.6 13.0 39.2 21.3 14.5 24.7 7.2 8.9 19.9 30.1 8.9 25.5 23.8 4.9 27.5 16.7 17.4 14.5 18.3 15.4 21.7 16.1 17.4 10.5 17.1 9.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 4.5 5.8 13.7 5.3 2.6 10.5 3.9 3.6 13.3 4.6 13.1 8.2 10.1 3.2 2.2 7.5 6.1 6.0 12.8 10.0 17.6 18.0 10.8 9.7 12.2 8.6 5.3 12.9 18.8 12.9 3.9 8.0 1.9 13.7 3.7 4.8 9.2 13.3 6.7 9.2 14.8 10.5 15.1 9.2 8.2 8.0 5.7 13.9 13.6 7.5 8.0 40.4 14.5 10.2 12.2 11.2 4.7 8.0 9.6 6.0 7.2 4.7 6.0 7.5 8.2 8.0 8.5 11.9 5.2 9.1 4.3 19.2 12.3 5.9 6.0 19.3 0.0 8.5 9.6 23.2 13.6 13.3 8.2 14.4 4.3 12.6 9.6 12.6 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243320-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 35 "brain: 542.8;choroid plexus: 288.0" "Group enriched" "Detected in many" 5 "Astrocytes: 44.1;Muller glia cells: 70.9;Oligodendrocytes: 65.1" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "NK-cell: 5.7" "Lineage enriched" "Detected in single" 7 "NK-cells: 5.7" "Cell line enhanced" "Detected in many" "RT4: 14.8;T-47d: 17.8;U-266/70: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.99e-4)" "prognostic unfavorable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.86e-4)" 1.9 1.8 380.6 0.8 399.6 6.1 2.7 405.7 542.8 2.8 288.0 6.3 1.3 0.9 0.4 4.9 3.4 1.3 2.1 331.4 364.6 6.3 7.3 2.6 0.4 501.9 411.1 311.5 1.8 1.9 0.4 11.9 0.7 456.0 7.0 0.8 6.8 3.1 1.0 1.5 11.1 3.7 0.5 489.9 4.7 3.4 4.2 401.2 0.6 3.8 0.3 0.7 1.9 4.2 491.0 1.7 1.5 3.8 3.1 0.8 0.5 9.9 0.3 0.6 0.2 0.2 1.3 6.7 3.7 2.0 0.7 0.4 7.5 0.0 1.6 0.5 2.2 2.6 2.4 2.6 1.5 0.5 1.2 7.5 1.6 4.3 2.8 3.0 3.7 0.2 8.6 2.4 9.4 0.5 7.4 0.5 1.1 5.3 1.1 1.3 1.8 0.9 2.4 3.0 14.8 3.3 6.8 0.5 1.3 5.0 6.9 17.8 1.7 0.6 1.2 6.2 2.0 0.8 27.4 7.7 2.4 0.5 10.5 1.2 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.6 0.0 0.1 380.6 399.6 405.7 542.8 331.4 364.6 501.9 411.1 311.5 456.0 489.9 401.2 491.0 0.6 0.0 0.5 44.1 1.7 1.3 0.5 1.8 0.0 3.9 1.8 2.0 3.5 1.5 1.3 0.0 0.0 0.1 1.0 0.9 0.0 0.7 0.4 1.3 0.6 0.7 4.2 3.2 1.5 3.4 0.2 1.3 4.6 1.7 1.3 1.1 0.7 0.9 0.6 6.7 1.4 0.5 2.0 1.3 0.4 0.8 0.3 0.9 0.0 3.7 0.6 70.9 0.0 6.0 65.1 1.8 0.0 2.2 3.5 0.7 0.8 0.4 2.3 11.2 0.0 0.6 0.5 1.3 0.5 0.6 1.4 0.3 2.3 0.5 1.1 0.5 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 39.2 39.9 34.8 29.9 36.8 74.3 43.1 36.3 38.3 44.4 33.6 38.2 30.9 43.0 24.6 50.4 35.1 26.2 63.7 34.7 35.4 57.0 62.9 39.1 47.2 39.9 36.4 33.1 43.3 39.8 56.8 35.2 30.1 38.1 47.6 27.0 16.9 43.3 27.4 114.4 54.6 37.0 28.8 36.2 52.9 44.0 15.2 35.9 46.0 51.1 90.5 40.0 39.7 42.1 40.2 68.2 82.5 86.8 66.1 16.1 33.5 67.3 34.6 48.7 91.4 75.4 101.6 95.3 62.2 73.3 44.5 31.6 44.4 88.1 57.7 47.0 44.6 104.6 46.3 59.3 91.8 33.3 65.8 61.3 30.2 57.2 41.2 43.0 36.3 69.9 44.7 69.9 70.1 45.0 138.2 69.2 84.7 151.5 99.6 72.2 75.2 46.3 123.6 97.2 50.5 79.0 99.5 57.4 65.4 45.6 63.2 106.1 79.7 40.7 39.4 50.5 44.4 69.4 52.0 58.1 123.7 31.9 63.1 55.7 18.4 85.7 40.5 43.9 60.6 39.6 54.0 43.0 41.4 70.0 45.6 41.5 42.0 59.9 49.5 55.2 95.9 75.5 77.7 34.8 36.8 36.3 38.3 34.7 35.4 39.9 36.4 33.1 38.1 36.2 35.9 40.2 25.5 19.2 25.1 0.0 38.2 49.8 87.2 108.6 3.4 12.3 39.5 33.4 11.9 51.5 57.4 75.4 12.5 136.3 63.4 21.5 176.1 98.0 5.3 22.1 26.3 41.5 49.1 13.2 0.0 99.0 115.7 34.7 8.6 36.5 45.0 50.3 47.2 56.7 80.5 8.4 0.0 46.6 61.1 40.3 43.9 6.0 39.1 34.2 85.4 0.0 59.6 71.2 43.3 0.0 0.0 81.6 52.1 28.2 11.7 51.5 44.7 120.1 15.6 28.8 26.3 36.6 35.7 14.7 33.4 7.6 51.0 157.5 47.3 66.1 52.5 83.8 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 114.1;Late spermatids: 95.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 70.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA065411: AB_2685486" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favorable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 15.2 11.7 17.3 10.5 19.6 12.9 9.6 15.2 24.0 8.9 9.9 11.3 18.4 9.6 11.3 12.0 9.3 11.3 12.3 19.6 17.9 28.0 35.6 11.5 10.5 16.8 18.8 19.5 6.9 8.9 17.3 13.5 8.3 20.1 9.5 11.6 18.4 8.8 9.4 17.8 11.0 13.1 11.6 14.5 16.7 11.5 12.5 19.1 14.7 10.4 21.4 12.5 15.0 8.4 19.4 18.3 30.5 14.6 19.5 31.0 16.7 11.6 19.2 27.9 33.8 27.5 30.1 16.4 14.4 16.3 28.6 18.3 26.6 53.9 22.5 29.8 16.6 18.0 13.1 18.8 18.4 23.8 17.2 23.2 23.6 19.3 34.3 20.6 16.3 27.8 17.5 14.0 23.0 23.6 32.7 18.1 12.2 34.6 34.6 31.2 11.5 14.8 24.6 44.2 21.2 22.8 30.7 22.3 40.0 26.1 25.6 30.1 27.8 22.7 19.6 16.4 22.0 23.1 23.4 19.2 21.5 21.6 17.8 19.8 14.2 18.2 19.3 9.3 19.1 9.6 8.2 7.4 8.9 13.4 5.4 6.0 7.3 70.5 9.4 16.1 5.8 7.3 13.5 17.3 19.6 15.2 24.0 19.6 17.9 16.8 18.8 19.5 20.1 14.5 19.1 19.4 16.4 12.8 22.4 7.5 11.1 27.8 6.2 5.5 10.8 14.4 33.0 25.4 41.1 11.5 11.5 9.2 20.9 5.2 12.0 10.4 5.9 6.0 114.1 17.9 12.3 16.6 6.0 9.5 12.0 5.6 4.0 15.6 12.2 35.4 5.1 5.3 11.7 34.0 7.5 20.2 12.4 11.7 8.2 11.3 34.4 95.6 7.2 19.1 12.4 6.5 10.1 8.2 22.6 5.5 11.6 6.2 6.1 5.7 10.2 6.6 13.8 17.1 5.2 9.0 19.7 40.7 10.8 9.6 10.3 17.6 34.1 8.2 12.8 7.3 8.5 6.9 LMNA "CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1" ENSG00000160789 "Lamin A/C" P02545 1 156082573-156140081 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease variant, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 1533.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 85.1;T-reg: 83.2" "Group enriched" "Detected in all" 8 "dendritic cells: 85.1;granulocytes: 23.9;T-cells: 83.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004022, HPA006523, HPA006660" Supported Supported "Nuclear speckles" NA NA 5700000 "Nuclear speckles" "CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231" "unprognostic (2.22e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-2)" "unprognostic (5.75e-2)" "unprognostic (7.43e-3)" "unprognostic (1.47e-1)" "unprognostic (5.23e-3)" "unprognostic (3.27e-2)" "unprognostic (8.33e-2)" "unprognostic (5.90e-2)" "unprognostic (5.10e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "unprognostic (2.89e-1)" "unprognostic (3.08e-2)" "unprognostic (1.44e-2)" 276.1 176.3 18.3 65.5 24.4 58.6 233.5 24.0 20.1 197.8 35.1 180.3 73.5 273.6 14.6 258.3 175.4 92.9 212.4 15.1 83.9 110.9 94.0 190.2 18.3 28.5 24.7 11.6 179.7 82.5 21.5 77.5 53.4 26.6 126.4 38.6 4.7 177.5 43.2 191.6 353.1 138.0 79.5 21.8 84.8 162.0 62.4 27.1 15.4 148.6 24.0 23.1 170.1 219.4 43.2 518.8 269.7 26.2 72.4 119.5 238.7 169.4 607.3 379.6 221.3 146.8 68.3 311.9 2.8 338.7 417.9 94.6 515.4 31.4 227.8 70.3 188.6 50.8 175.4 168.4 130.8 124.0 25.7 412.9 133.0 92.0 154.8 134.7 120.2 207.5 0.7 82.8 21.9 205.8 193.1 1.0 67.8 32.1 202.9 706.0 1.6 195.9 137.7 128.9 105.6 33.8 114.9 414.3 154.2 427.4 56.2 230.1 74.2 727.9 241.6 233.0 389.1 393.3 39.5 10.5 4.9 449.2 24.8 760.4 23.9 8.3 0.4 2.8 2.1 2.5 2.4 17.8 7.3 85.1 0.2 0.2 0.7 2.1 3.7 0.2 0.3 83.2 14.6 18.3 24.4 24.0 20.1 15.1 83.9 28.5 24.7 11.6 26.6 21.8 27.1 43.2 353.5 262.8 350.0 16.0 179.1 610.5 1235.3 446.2 531.6 7.2 542.5 374.9 94.1 191.6 320.3 161.8 47.9 478.8 239.8 614.1 109.5 429.3 38.6 215.4 209.4 386.0 431.5 70.4 9.9 360.2 387.8 622.1 505.1 270.5 1181.8 145.5 277.7 103.1 343.0 13.5 15.1 601.2 177.0 60.6 1533.4 45.4 288.6 409.0 859.2 10.3 20.4 37.2 3.1 17.1 20.1 513.0 384.1 287.3 331.3 340.6 262.6 125.0 170.5 17.8 203.8 1028.4 766.8 107.4 42.2 404.1 602.4 680.9 472.3 111.6 513.8 942.6 CCR5 "CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22" ENSG00000160791 "C-C motif chemokine receptor 5" P51681 3 46370854-46376206 "CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.1" "Cell type enhanced" "Detected in some" "Kupffer cells: 5.5;Langerhans cells: 32.6;Macrophages: 12.8;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 39.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;Karpas-707: 6.8;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.32e-3)" "unprognostic (1.94e-3)" "unprognostic (1.89e-3)" "prognostic favorable (7.42e-5)" "unprognostic (1.80e-2)" "prognostic favorable (9.33e-5)" "unprognostic (3.38e-3)" "unprognostic (9.90e-3)" "unprognostic (7.65e-2)" "unprognostic (6.22e-2)" "unprognostic (1.36e-1)" "unprognostic (5.34e-2)" "unprognostic (1.14e-3)" "unprognostic (8.34e-2)" "unprognostic (4.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.42e-2)" 1.8 2.0 0.4 15.1 0.7 1.3 2.5 0.6 0.7 2.1 1.0 3.3 4.2 1.4 1.0 1.4 1.7 5.0 1.1 0.4 1.9 1.0 3.4 7.4 14.5 1.3 0.8 0.4 1.7 0.6 0.6 0.4 0.7 1.2 1.9 4.0 0.1 2.9 1.0 0.3 1.1 5.9 3.2 1.6 9.5 6.8 0.8 1.1 4.2 0.8 0.2 9.5 4.9 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.1 0.0 12.0 2.2 0.0 11.0 3.8 39.7 0.5 4.7 16.1 9.5 0.0 0.4 4.1 0.5 6.3 0.0 9.0 8.0 3.2 0.4 0.7 0.6 0.7 0.4 1.9 1.3 0.8 0.4 1.2 1.6 1.1 1.6 0.3 0.0 1.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.3 1.5 0.0 1.3 0.0 1.4 0.3 4.7 0.0 0.0 0.0 0.0 5.5 32.6 0.0 0.0 12.8 3.6 1.9 1.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 13.1 0.1 0.0 0.1 NBEAL2 KIAA0540 ENSG00000160796 "Neurobeachin like 2" Q6ZNJ1 3 46979666-47009704 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 104.0" "Cell type enriched" "Detected in many" 4 "Gastric mucus-secreting cells: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HEL: 69.1;SK-BR-3: 64.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051969 Approved NA NA 31000 "HPA051969: " "unprognostic (3.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-1)" "unprognostic (3.37e-2)" "unprognostic (5.99e-3)" "prognostic favorable (4.60e-4)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (6.27e-2)" "unprognostic (5.29e-2)" "unprognostic (1.06e-3)" "unprognostic (3.75e-1)" "unprognostic (6.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.34e-2)" 15.6 16.2 3.7 23.5 3.1 93.0 19.4 2.8 5.0 22.9 5.1 17.1 13.0 10.6 4.7 104.0 14.8 11.1 13.0 2.7 3.4 32.1 11.3 54.5 21.0 3.6 2.8 2.4 7.9 41.0 6.7 11.4 4.8 4.0 21.7 8.4 0.8 35.9 8.4 6.6 82.0 31.3 5.6 3.0 70.5 42.8 6.4 4.2 11.3 14.8 2.9 15.9 16.8 57.3 4.3 20.2 22.1 4.0 11.3 2.3 0.8 12.9 2.8 1.7 3.8 2.5 19.4 14.2 17.4 7.7 2.4 3.7 13.0 8.3 9.0 1.9 15.4 12.4 69.1 27.8 12.2 2.2 11.9 48.5 1.9 14.8 3.9 6.0 4.6 34.2 36.2 14.6 26.3 1.9 31.2 20.5 32.7 10.6 31.9 10.0 21.6 0.5 23.0 9.1 41.1 6.1 9.9 2.4 64.4 5.7 4.9 31.5 19.9 25.3 0.3 11.7 5.1 8.9 20.1 20.7 16.3 5.1 55.0 2.9 0.2 0.6 0.4 0.5 0.6 0.1 0.0 0.2 0.5 0.1 0.0 0.1 0.1 4.4 0.4 0.4 0.1 0.2 0.3 3.7 3.1 2.8 5.0 2.7 3.4 3.6 2.8 2.4 4.0 3.0 4.2 4.3 15.0 12.8 9.4 7.8 10.0 3.3 5.5 2.4 5.7 1.3 16.3 18.2 4.3 8.6 9.3 33.1 18.8 2.2 30.8 15.1 1.9 22.9 1.4 20.0 4.1 9.8 7.2 10.3 4.0 23.1 1.1 3.0 144.3 23.9 6.3 5.1 11.7 1.2 11.1 0.0 1.5 11.5 4.1 12.9 8.3 1.0 1.2 27.9 0.0 6.5 14.6 1.5 26.8 1.0 1.4 31.4 5.6 0.0 14.2 6.2 3.4 1.3 6.6 1.9 13.1 3.4 3.5 0.5 2.4 33.6 8.0 1.9 26.3 4.5 15.1 21.0 CCDC12 MGC23918 ENSG00000160799 "Coiled-coil domain containing 12" Q8WUD4 3 46921726-46982010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056814, HPA060530" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA056814: AB_2683241, HPA060530: AB_2684309" "unprognostic (1.47e-2)" "unprognostic (1.79e-3)" "unprognostic (2.27e-1)" "unprognostic (1.32e-3)" "unprognostic (1.65e-1)" "unprognostic (4.24e-2)" "unprognostic (6.15e-2)" "unprognostic (4.27e-3)" "unprognostic (1.88e-1)" "unprognostic (4.35e-2)" "unprognostic (1.50e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.15e-4)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.86e-3)" "unprognostic (4.65e-2)" 39.4 55.9 39.5 38.7 39.7 58.4 40.5 40.9 45.6 43.4 38.3 44.8 40.0 45.6 22.3 75.8 33.7 22.3 48.5 38.9 39.1 46.6 46.5 39.7 51.5 39.8 39.4 38.2 40.8 41.2 34.0 35.5 26.9 39.7 38.8 21.5 19.3 42.6 23.1 81.4 70.4 43.2 21.3 40.1 49.3 47.3 30.3 40.3 41.8 43.5 30.4 33.7 39.5 56.1 40.7 63.7 52.5 60.4 31.7 33.4 27.1 46.5 63.1 32.1 46.6 34.0 68.5 53.5 123.9 56.1 38.2 66.3 35.1 51.6 58.6 19.6 122.3 39.3 136.0 77.8 104.6 45.5 147.1 93.1 37.2 54.6 59.2 52.2 36.9 45.7 78.0 148.3 59.6 23.1 77.0 114.6 139.0 78.7 62.5 42.9 48.0 46.9 79.6 49.2 65.5 32.0 62.1 77.0 62.8 62.7 26.7 47.8 143.9 94.6 31.1 61.4 63.5 101.4 77.5 185.8 155.1 43.5 102.2 45.6 50.0 132.0 122.0 139.3 142.8 109.8 209.7 106.6 122.8 126.9 222.4 90.8 107.3 40.4 123.7 155.8 202.1 148.8 118.9 39.5 39.7 40.9 45.6 38.9 39.1 39.8 39.4 38.2 39.7 40.1 40.3 40.7 58.0 80.1 54.7 15.0 119.1 79.2 146.0 146.6 73.4 53.4 55.9 47.1 53.3 82.9 97.4 80.9 54.2 137.0 132.2 137.2 111.6 103.7 4.3 64.4 54.8 66.1 79.1 38.7 15.9 124.8 112.5 53.5 85.6 89.4 82.4 52.4 55.6 54.1 100.0 58.9 14.6 104.4 87.5 70.8 75.6 9.8 58.4 58.6 46.2 16.9 112.7 68.8 213.1 15.1 21.0 103.5 132.4 48.2 73.9 124.1 147.7 90.5 71.1 90.7 39.5 82.8 55.6 21.7 57.5 97.1 108.8 166.9 98.6 82.0 112.6 209.0 PTH1R "PTHR, PTHR1" ENSG00000160801 "Parathyroid hormone 1 receptor" Q03431 3 46877721-46903799 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 573.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1" "Group enriched" "Detected in many" 4 "renal cancer: 18.8;testis cancer: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 116.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075879 Enhanced NA NA "HPA075879: " "unprognostic (1.26e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-5)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (5.02e-2)" "unprognostic (3.84e-3)" "unprognostic (5.47e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (7.51e-2)" "unprognostic (8.44e-2)" "prognostic favorable (6.79e-6)" "unprognostic (4.22e-3)" "unprognostic (1.50e-1)" "unprognostic (1.35e-4)" "unprognostic (6.62e-3)" 28.3 72.8 39.4 1.1 39.8 0.0 20.4 40.8 61.3 41.2 33.6 9.8 1.2 19.3 2.7 3.8 20.4 3.6 27.2 37.7 38.3 573.4 85.3 25.8 2.4 41.0 39.9 35.5 22.4 7.6 1.3 6.0 16.2 43.0 12.5 0.6 0.7 2.7 3.5 7.7 9.6 9.7 2.6 39.3 54.8 7.6 10.4 40.5 0.4 6.5 2.2 0.4 12.4 20.5 38.4 0.0 0.2 0.2 0.2 15.9 1.9 0.2 0.4 0.2 0.3 0.2 0.4 0.0 0.0 1.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 15.5 0.0 0.1 0.0 0.2 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.3 2.1 0.0 0.1 0.1 5.3 0.0 116.9 0.0 0.2 0.7 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 39.8 40.8 61.3 37.7 38.3 41.0 39.9 35.5 43.0 39.3 40.5 38.4 4.6 0.0 0.0 17.3 2.5 1.3 0.1 0.0 0.6 1.5 2.9 0.4 5.0 2.8 0.0 33.1 0.0 0.6 0.1 0.0 95.9 0.0 11.6 0.6 20.5 4.1 0.0 8.0 1.6 0.5 60.8 9.6 0.0 0.6 0.0 0.1 17.2 0.7 2.0 1.7 2.8 0.0 0.0 1.3 2.8 32.5 5.9 2.1 0.0 1.9 0.0 3.2 0.0 1.0 0.3 0.3 0.0 2.2 0.0 0.0 0.0 324.8 0.0 1.7 138.1 6.5 21.7 0.9 2.7 0.0 0.9 0.8 2.0 0.3 0.0 0.1 UBQLN4 "A1U, C1orf6, UBIN" ENSG00000160803 "Ubiquilin 4" Q9NRR5 1 156035299-156053798 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 9.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061797 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061797: AB_2684613" "unprognostic (3.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-3)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-2)" "unprognostic (1.91e-2)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "unprognostic (7.25e-3)" "unprognostic (7.65e-2)" "unprognostic (4.73e-1)" "unprognostic (1.57e-1)" 18.9 19.6 41.0 14.8 46.1 9.2 19.3 35.4 52.9 31.7 28.4 23.0 13.7 24.5 15.4 34.0 26.9 11.6 25.7 41.4 39.6 23.0 31.9 21.0 15.1 39.3 39.4 39.4 21.3 32.4 25.8 11.4 15.6 40.3 25.6 15.7 18.5 23.5 19.8 60.2 27.2 19.0 23.1 37.3 20.4 28.5 19.9 38.9 14.3 17.9 39.8 17.1 26.3 26.2 40.8 45.9 54.1 50.8 50.1 34.1 21.0 50.0 37.8 20.7 37.2 27.8 49.0 40.5 77.7 33.9 34.7 20.1 50.2 51.8 40.8 35.2 65.9 54.9 42.8 31.5 47.7 21.9 46.4 77.3 15.9 51.6 51.3 41.5 32.6 44.8 24.4 81.4 42.1 34.0 56.3 51.4 46.5 69.8 117.2 49.8 64.8 37.4 76.9 30.2 45.7 37.3 108.0 38.0 93.2 38.7 49.0 90.1 50.4 43.7 34.3 44.9 35.3 41.4 92.7 79.4 83.2 21.0 45.9 49.1 9.7 0.7 0.4 1.5 0.7 1.9 1.1 1.1 1.6 0.5 0.8 0.8 1.2 0.0 1.2 0.1 1.2 1.0 0.7 41.0 46.1 35.4 52.9 41.4 39.6 39.3 39.4 39.4 40.3 37.3 38.9 40.8 8.6 6.4 5.3 9.8 8.4 13.4 9.4 9.1 18.2 6.8 17.2 9.9 4.3 17.2 8.5 23.9 6.2 8.1 8.1 9.6 3.9 11.6 0.8 5.0 10.2 9.3 10.7 6.3 5.9 10.9 9.1 7.4 7.1 8.9 1.3 13.4 11.7 22.7 9.9 6.7 6.6 10.8 8.2 8.4 7.2 4.9 6.5 8.3 17.8 9.4 15.6 7.3 5.2 4.5 9.2 13.1 6.9 9.1 13.0 25.3 8.2 12.1 5.4 6.0 0.0 10.7 7.8 4.9 5.6 21.0 14.6 8.2 7.7 4.8 15.0 14.3 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46835111-46882172 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 26 "heart muscle: 4888.7;skeletal muscle: 5183.9;tongue: 2092.6" "Cell type enriched" "Detected in some" 53 "Cardiomyocytes: 3626.2" "Group enriched" "Detected in many" 4 "head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria NA NA 7300000 "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favorable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 5.8 4.2 9.8 1.0 9.6 1.5 9.0 10.2 14.9 6.7 7.2 2.3 1.6 3.4 3.4 158.4 4.2 3.6 4888.7 9.8 11.1 49.4 4.1 5.8 3.3 13.9 11.0 8.7 5.2 2.7 1.3 1.7 4.7 11.2 25.3 0.8 1.9 19.8 1.5 5183.9 3.5 2.3 2.0 11.9 8.0 2.1 2.3 11.9 0.7 2.4 2092.6 0.6 2.4 4.8 12.1 0.5 0.7 0.4 0.3 4.4 1.5 3.6 0.7 0.4 0.4 0.6 8.6 0.8 1.6 1.4 0.1 0.2 0.5 0.4 0.1 0.7 0.3 0.1 0.8 2.6 0.3 0.7 0.9 0.8 8.7 0.2 0.3 0.1 0.2 0.1 0.5 0.4 1.2 0.2 1.2 0.3 0.5 1.0 0.4 0.4 0.9 0.3 0.1 34.2 1.3 0.6 0.4 0.3 0.7 0.1 0.7 0.3 0.5 0.2 1.0 0.8 0.6 0.3 0.5 0.4 0.7 0.3 0.8 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 9.8 9.6 10.2 14.9 9.8 11.1 13.9 11.0 8.7 11.2 11.9 11.9 12.1 0.7 0.0 0.0 1.0 0.0 0.8 0.2 0.0 0.0 0.2 2.3 0.1 3626.2 0.0 0.0 1.8 0.0 0.4 0.0 0.0 54.8 0.0 2.4 0.1 2.2 32.8 0.0 0.0 0.1 0.0 16.4 23.7 0.0 0.0 0.0 0.0 1.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 12.8 1.2 0.7 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 68.1 0.0 0.4 6.6 27.9 20.4 0.2 0.5 0.0 0.4 0.8 0.4 0.1 0.0 0.0 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436497 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Cell type enhanced" "Detected in all" "Spermatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021604: AB_2670774, HPA051607: AB_2681548" "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.97e-4)" 8.6 16.8 7.4 12.0 6.8 8.8 9.7 9.0 13.9 12.2 7.8 10.7 11.6 11.0 2.2 11.2 11.1 3.1 8.7 7.1 8.2 12.2 13.0 9.5 14.6 7.6 7.1 6.6 13.6 10.6 7.8 12.0 6.8 7.2 11.3 2.4 2.4 10.0 5.5 6.4 7.4 12.1 2.8 7.6 22.3 11.0 49.1 7.3 15.4 12.1 3.5 5.5 10.4 10.4 7.0 41.0 14.7 11.1 19.4 3.3 4.9 14.5 11.6 10.5 8.2 9.4 6.8 36.2 14.0 22.2 6.4 39.3 17.4 5.9 9.4 1.8 30.9 18.3 11.6 11.8 14.1 14.5 12.2 16.4 6.8 17.0 7.3 12.0 14.1 17.2 38.8 21.1 24.1 9.9 34.1 36.2 64.6 23.0 17.1 20.1 14.6 4.7 37.9 11.4 9.5 11.8 35.0 8.9 62.5 35.0 6.9 18.0 28.8 13.9 12.2 18.4 16.4 28.9 37.9 23.1 20.2 13.3 19.6 25.0 17.1 2.3 5.7 5.8 1.0 6.2 4.3 5.9 6.6 1.7 5.4 3.3 3.2 10.5 3.8 0.7 7.6 7.6 2.7 7.4 6.8 9.0 13.9 7.1 8.2 7.6 7.1 6.6 7.2 7.6 7.3 7.0 47.7 16.0 9.6 13.1 30.8 21.0 39.9 13.9 28.5 35.7 51.3 60.6 2.0 27.1 7.8 47.8 8.4 66.5 47.8 23.6 52.8 9.1 17.3 34.6 22.7 22.1 18.6 17.2 10.2 10.0 40.2 16.5 20.4 24.9 8.2 28.3 15.4 16.1 16.8 48.8 11.8 32.0 18.3 12.0 15.4 8.7 18.0 17.4 17.8 12.2 11.6 26.8 27.8 12.1 12.5 10.7 30.2 9.4 24.2 55.2 26.2 39.5 16.5 37.7 13.1 12.4 17.8 106.1 29.8 36.7 33.4 33.9 37.6 35.2 28.1 43.9 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594301-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: AB_2682447" "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 21.6 19.7 13.0 16.8 12.7 10.7 19.1 9.5 18.4 14.8 8.8 18.8 9.0 20.0 9.1 21.9 16.7 6.9 20.1 12.4 11.8 16.0 21.6 15.1 16.9 12.8 12.6 11.6 15.1 19.8 15.8 10.2 9.7 14.4 19.3 13.1 2.9 16.4 10.7 79.6 17.1 16.4 14.4 10.5 18.7 19.5 13.2 12.7 11.9 14.6 32.2 19.1 23.0 16.3 15.7 54.6 67.6 31.2 46.3 28.1 20.4 44.0 66.0 27.8 53.3 30.7 74.9 44.8 131.6 55.0 47.8 34.3 38.7 68.9 59.4 54.5 38.2 65.2 82.1 65.2 57.3 26.2 174.9 48.3 25.0 51.1 96.9 79.3 13.1 36.6 44.0 135.5 31.8 40.7 96.2 82.0 39.8 138.9 92.5 71.4 72.9 52.1 96.3 35.0 58.4 50.4 75.8 59.6 146.7 41.6 31.9 46.2 89.3 52.8 50.7 66.0 53.4 121.1 57.8 69.5 169.9 45.7 89.7 79.7 0.1 9.4 0.1 20.9 17.9 20.4 29.1 21.2 24.0 17.5 30.7 24.1 25.1 0.4 19.0 22.0 11.1 15.7 12.6 13.0 12.7 9.5 18.4 12.4 11.8 12.8 12.6 11.6 14.4 10.5 12.7 15.7 17.0 32.1 38.3 5.2 36.0 73.7 65.9 32.5 26.2 7.7 23.8 25.4 27.2 25.8 33.4 16.5 8.4 35.6 19.5 26.5 25.4 51.9 12.9 19.1 53.7 32.5 37.0 42.9 6.4 57.1 53.0 29.0 23.0 20.1 57.7 24.3 18.5 46.9 37.4 8.4 4.6 26.1 10.2 13.6 21.3 11.4 26.8 19.0 23.2 2.8 18.8 6.9 23.7 1.5 3.3 53.0 17.5 26.7 23.8 92.5 7.8 34.3 14.9 6.4 32.9 66.0 45.4 47.4 44.3 33.5 62.7 15.5 26.3 38.6 43.6 51.5 LRRC71 "C1orf92, FLJ32884" ENSG00000160838 "Leucine rich repeat containing 71" Q8N4P6 1 156920632-156933094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 7.2;fallopian tube: 12.5;testis: 25.6" "Group enriched" "Detected in some" 4 "Early spermatids: 236.9;Late spermatids: 605.3" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.5;PC-3: 1.6;TIME: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.91e-2)" "unprognostic (4.21e-2)" "unprognostic (6.13e-2)" "unprognostic (1.95e-3)" "unprognostic (5.43e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (8.02e-2)" "unprognostic (5.07e-3)" "unprognostic (5.18e-1)" "unprognostic (1.68e-7)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" 0.1 0.5 3.0 0.0 1.0 0.0 0.1 1.3 0.7 0.6 7.2 0.0 0.0 0.2 0.0 0.0 12.5 0.0 0.1 0.7 1.5 0.1 0.0 2.4 0.0 3.0 3.9 0.0 0.1 0.0 0.0 0.2 0.1 2.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 25.6 1.3 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.0 1.3 0.7 0.7 1.5 3.0 3.9 0.0 2.4 4.4 1.3 1.0 0.2 0.0 1.8 0.7 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.0 0.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 236.9 37.8 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 605.3 4.4 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 3.4 0.0 0.1 0.0 0.0 89.6 0.6 0.0 0.0 1.1 54.2 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FCRL3 "CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e" ENSG00000160856 "Fc receptor like 3" Q96P31 1 157674321-157700769 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 49.9" "Cell type enhanced" "Detected in some" "B-cells: 54.3;dendritic cells: 21.2;Early spermatids: 8.0;Late spermatids: 9.1;NK-cells: 30.9;T-cells: 12.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive B-cell: 35.3" "Group enriched" "Detected in many" 54 "B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0" "Cell line enriched" "Detected in some" 7 "Daudi: 9.9" "Low region specificity" "Detected in some" HPA048022 Enhanced NA NA "HPA048022: AB_2732541" "unprognostic (6.73e-3)" "unprognostic (5.06e-4)" "unprognostic (1.13e-2)" "unprognostic (2.08e-4)" "unprognostic (3.86e-1)" "unprognostic (1.74e-5)" "unprognostic (1.09e-2)" "unprognostic (4.29e-3)" "unprognostic (3.69e-3)" "unprognostic (2.46e-4)" "unprognostic (1.13e-1)" "unprognostic (2.55e-2)" "unprognostic (2.01e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (2.21e-1)" "unprognostic (6.69e-2)" 0.4 0.0 0.0 14.2 0.0 1.1 0.1 0.0 0.0 0.1 0.1 1.1 0.3 0.2 0.1 0.1 0.1 1.0 0.2 0.0 0.0 0.2 0.8 0.9 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.3 0.0 0.8 0.0 0.1 0.0 8.7 0.1 0.0 27.8 1.5 0.2 0.0 4.6 0.4 0.1 36.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 19.0 0.0 1.8 30.3 2.6 13.2 0.0 35.3 0.2 8.3 0.4 20.4 0.0 0.0 11.3 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 54.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 8.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.0 1.2 0.0 9.1 0.0 0.4 0.0 1.0 0.9 0.0 30.9 0.5 0.0 0.0 1.1 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 12.4 0.0 0.0 0.0 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976042 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 2832.6;salivary gland: 3880.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 74000000000 Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 129.8 3.9 17.4 2.8 28.0 0.4 1072.2 23.6 22.9 2.5 16.4 6.8 31.1 1.5 2.5 22.2 3.0 39.1 67.4 15.6 23.4 329.8 2832.6 14.9 0.4 22.9 23.6 14.9 6.1 758.5 0.1 1.3 0.5 29.9 1060.6 4.3 3.6 3880.0 40.6 1.7 188.9 28.9 0.3 14.8 1.4 317.7 26.1 23.1 0.8 1.9 2.3 1.5 5.8 7.6 26.1 0.2 0.0 0.0 0.0 11.3 0.0 5.5 0.0 0.0 0.0 0.0 0.1 4.0 14.2 0.7 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.3 0.1 56.6 4.9 1.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.3 29.9 0.0 0.0 0.0 5.1 0.2 158.9 0.0 0.0 1.7 130.4 0.0 0.0 0.0 2.0 1.0 25.4 13.0 0.0 41.8 0.0 0.0 0.5 0.1 1.8 0.9 1.9 0.8 0.4 0.0 0.5 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 28.0 23.6 22.9 15.6 23.4 22.9 23.6 14.9 29.9 14.8 23.1 26.1 9.9 22.4 276.8 0.0 14.7 4.2 422.1 25.3 0.0 0.0 1315.5 704.8 115.9 451.8 63.0 5.5 2.1 0.0 10.4 5.5 46.9 11.7 1.9 1.4 1.2 14.2 12.4 85.5 0.1 254.2 0.0 7.7 94.8 5.5 3.8 1.2 65.3 4270.8 0.0 0.0 0.1 13.1 901.3 93.1 0.7 4.2 0.9 14.8 62.2 1.0 2.0 23.7 0.0 7.5 7.3 221.5 6.4 0.0 0.3 1691.9 15.3 596.1 6.3 0.3 0.0 0.0 11.9 7.4 0.4 9.9 9.7 0.0 12.3 0.1 12.6 674.2 FGFR4 "CD334, JTK2" ENSG00000160867 "Fibroblast growth factor receptor 4" P22455 5 177086905-177098144 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 83.2;lung: 66.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6" "Cancer enhanced" "Detected in many" "liver cancer: 42.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005196, HPA027273, HPA027369, HPA028251" Approved "Intracellular and membrane" NA NA 7400000 "CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221" "unprognostic (1.96e-1)" "unprognostic (2.10e-2)" "unprognostic (1.12e-1)" "unprognostic (9.06e-3)" "unprognostic (2.87e-1)" "unprognostic (1.95e-2)" "unprognostic (7.85e-3)" "unprognostic (9.19e-2)" "unprognostic (4.25e-1)" "unprognostic (4.46e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.71e-3)" "unprognostic (2.41e-1)" "unprognostic (5.75e-2)" "unprognostic (4.68e-2)" 0.8 14.1 1.3 4.1 1.1 0.5 4.6 2.6 2.2 2.8 1.0 13.1 21.5 2.4 0.2 3.2 4.2 10.3 2.0 1.4 1.0 39.7 83.2 66.0 0.8 1.1 0.9 1.0 27.7 29.7 0.2 2.0 2.1 1.3 5.3 6.1 1.5 1.1 0.7 6.6 1.6 20.1 1.1 0.7 22.9 8.9 6.0 0.9 0.2 0.9 1.9 0.2 6.4 3.3 1.3 3.2 48.8 1.0 11.7 0.1 0.1 24.5 0.2 0.1 0.2 0.3 173.9 6.5 5.3 23.0 0.1 2.4 2.8 9.5 1.8 0.1 3.2 13.8 0.5 2.8 176.4 5.2 0.6 4.7 1.1 0.2 8.4 0.2 0.3 0.2 3.5 18.1 0.7 3.9 40.3 0.1 3.6 29.2 30.9 4.5 8.2 274.3 30.9 22.9 0.4 1.8 2.9 1.8 12.4 5.9 5.9 11.7 2.5 1.1 0.0 23.4 0.3 0.7 1.6 1.9 3.7 0.1 1.1 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.3 1.1 2.6 2.2 1.4 1.0 1.1 0.9 1.0 1.3 0.7 0.9 1.3 0.3 0.0 0.0 0.3 0.3 0.6 0.7 0.4 0.0 0.9 2.9 2.0 0.9 78.6 0.1 3.7 0.0 1.3 0.1 12.9 3.9 10.9 0.1 1.6 0.3 0.7 4.2 0.0 0.5 4.9 3.8 9.6 9.7 2.9 0.0 0.7 3.9 31.2 0.3 0.0 0.5 10.1 0.0 0.9 0.5 0.0 0.6 0.7 0.0 1.9 0.6 0.6 0.0 0.5 0.1 3.0 4.4 1.5 0.1 1.7 15.9 21.6 0.1 0.4 19.7 141.2 0.7 3.0 9.9 0.8 0.4 8.8 0.4 36.7 38.6 0.5 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784248 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 3827.5" "Group enriched" "Detected in some" 40 "Hepatocytes: 2612.9;Proximal enterocytes: 1685.2" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0" "Low region specificity" "Detected in all" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.3 3.9 0.0 1.1 0.3 0.0 0.3 0.0 0.8 0.1 0.0 3.5 804.8 0.6 0.2 0.4 0.1 0.6 0.1 0.1 0.0 4.9 3827.5 0.1 0.9 0.0 0.0 0.0 0.1 43.7 0.0 1.1 0.0 0.0 0.2 2.2 0.5 0.3 0.0 2.4 1.9 860.3 0.0 0.0 0.1 1.2 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.8 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.0 0.0 0.8 3.4 0.0 0.1 1.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.2 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.4 32.9 0.0 0.0 0.0 0.3 0.0 5.6 0.0 0.1 0.4 0.0 0.0 1.4 0.0 26.7 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 30.0 2612.9 0.0 0.0 0.6 29.6 2.0 52.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 38.9 0.0 0.0 0.6 1685.2 3.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.9 0.1 2.3 0.5 16.1 1.1 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99705036-99735196 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "liver: 307.5" "Group enriched" "Detected in some" 17 "Cholangiocytes: 85.8;Hepatocytes: 60.5" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.3;Hep G2: 2.5;HHSteC: 1.4" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.9 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.2 0.5 0.3 0.3 0.1 0.0 6.6 0.0 0.0 0.1 8.6 307.5 2.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 85.8 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.3 60.5 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.8 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 1.3 0.0 0.2 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13116862-13141147 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 11.2 19.6 28.2 14.8 14.9 8.9 10.4 4.9 26.8 9.6 0.0 16.5 13.4 18.5 8.0 27.9 12.0 6.5 17.8 21.5 6.4 14.8 20.7 16.8 12.2 15.1 13.9 13.2 7.8 12.3 10.8 14.9 12.5 15.6 14.7 6.7 3.7 15.9 11.3 24.4 17.2 16.1 7.8 6.0 16.0 16.2 17.2 15.4 11.4 14.1 8.0 8.9 15.1 12.7 13.8 98.8 110.0 28.0 59.6 15.0 17.7 74.9 47.4 34.2 42.4 32.4 114.8 40.4 50.9 104.1 39.8 37.3 49.0 34.8 80.7 16.2 89.1 52.5 32.4 87.9 84.7 35.5 52.0 82.3 28.8 28.0 46.1 24.7 36.5 50.2 46.4 72.5 19.8 22.9 206.1 82.9 39.6 123.6 28.9 101.7 47.8 32.9 49.5 28.2 101.1 58.2 37.7 49.6 64.9 39.1 29.8 59.3 46.4 76.7 94.6 58.8 67.2 87.0 53.4 88.1 42.4 99.7 52.8 58.9 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 28.2 14.9 4.9 26.8 21.5 6.4 15.1 13.9 13.2 15.6 6.0 15.4 13.8 4.9 0.0 1.7 6.2 5.6 12.1 7.5 11.8 2.8 16.6 11.5 7.5 2.1 12.8 8.5 16.5 2.1 19.0 12.9 22.7 7.9 12.3 2.3 10.9 8.9 8.1 4.9 12.2 7.2 8.8 20.0 5.2 10.7 17.6 10.2 13.3 8.6 18.0 21.1 26.9 5.9 16.2 14.2 9.6 9.6 2.0 4.4 8.8 5.4 3.7 10.5 12.0 10.3 5.5 5.4 21.7 11.1 9.4 5.6 16.5 14.0 15.0 5.9 7.7 6.6 7.5 7.0 11.1 15.6 8.4 13.9 27.1 7.9 15.2 15.4 17.2 CYP11B1 "CPN1, CYP11B, FHI, P450C11" ENSG00000160882 "Cytochrome P450 family 11 subfamily B member 1" P15538 8 142872356-142879846 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 877 "adrenal gland: 3716.6" "Group enriched" "Detected in some" 113 "Early spermatids: 53.3;Late spermatids: 83.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049171, HPA049565, HPA056348, HPA057752" Supported Approved Mitochondria NA NA Mitochondria "HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516" 0.2 3716.6 0.1 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.3 0.0 0.8 0.5 0.3 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 0.2 0.2 0.0 0.1 0.3 0.4 4.2 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HK3 ENSG00000160883 "Hexokinase 3" P52790 5 176880869-176899346 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 130.5;lymphoid tissue: 77.2" "Group enriched" "Detected in some" 13 "Early spermatids: 11.1;Hofbauer cells: 34.5;Kupffer cells: 43.9;Macrophages: 38.8;monocytes: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 569.7" "Group enriched" "Detected in many" 13 "granulocytes: 569.7;monocytes: 200.9" "Cell line enriched" "Detected in some" 5 "U-937: 20.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA056743 Enhanced NA NA 2000000 "HPA056743: AB_2683222" "unprognostic (4.22e-2)" "unprognostic (4.07e-2)" "unprognostic (1.23e-1)" "unprognostic (8.63e-2)" "unprognostic (2.02e-2)" "unprognostic (1.39e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-1)" "unprognostic (5.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (3.82e-1)" "prognostic unfavorable (3.84e-8)" "unprognostic (7.02e-2)" "unprognostic (6.01e-3)" "unprognostic (1.46e-1)" "unprognostic (5.42e-2)" 8.0 4.5 0.0 19.1 0.3 130.5 2.6 1.1 1.6 0.7 0.2 2.4 2.0 1.0 0.1 0.9 5.2 2.1 3.3 0.2 0.7 1.8 5.3 25.3 4.2 0.0 0.0 0.0 1.0 1.6 0.1 0.7 2.9 1.1 1.1 1.4 0.1 1.5 0.3 0.9 0.4 3.1 8.0 0.0 77.2 2.1 1.3 2.0 1.4 1.3 0.5 0.7 4.5 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.5 0.1 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.6 0.0 569.7 92.5 204.8 0.3 179.4 0.2 0.4 0.2 0.1 30.2 0.2 0.1 0.1 32.2 0.2 200.9 1.4 0.2 43.6 0.0 0.3 1.1 1.6 0.2 0.7 0.0 0.0 0.0 1.1 0.0 2.0 0.5 0.0 0.0 1.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 11.1 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.4 1.3 0.0 0.4 0.2 34.5 0.0 0.4 0.0 0.0 43.9 0.9 1.8 0.0 38.8 0.0 1.0 14.6 0.0 2.1 0.0 0.1 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.2 0.1 0.3 0.3 0.1 0.0 0.0 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 12.6;testis: 36.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4" "Cancer enhanced" "Detected in many" "cervical cancer: 11.0" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.8" "Cell line enhanced" "Detected in many" "A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017770, CAB075742, CAB075743, CAB079929" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 5.5 0.2 0.4 0.2 0.5 0.3 4.5 0.8 1.6 2.3 0.0 0.4 0.3 0.5 0.2 12.6 1.2 0.5 1.3 0.6 0.8 1.6 0.2 0.8 0.2 1.4 0.9 0.5 0.7 0.3 0.0 0.4 2.4 1.9 1.1 0.0 2.4 1.7 0.8 5.4 6.0 0.3 0.1 0.9 0.2 1.1 36.3 0.8 0.6 1.0 1.3 0.6 1.0 5.1 1.0 125.2 2.0 0.0 6.3 2.4 7.9 1.5 131.9 15.3 39.9 24.0 0.2 0.5 0.0 10.9 15.0 14.3 10.8 0.0 7.5 33.5 1.2 0.2 0.1 142.4 0.3 1.9 0.0 0.0 11.7 21.1 29.7 38.0 0.1 3.7 0.0 0.0 0.6 76.2 1.0 0.2 0.3 4.2 4.1 2.0 0.3 0.5 0.2 6.7 1.7 3.7 0.5 206.3 2.7 41.3 6.6 0.5 0.2 5.4 1.9 11.8 273.2 0.2 0.2 0.1 0.3 0.6 0.1 13.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.4 0.5 0.8 1.6 0.6 0.8 1.4 0.9 0.5 1.9 0.9 0.8 1.0 25.6 3.2 0.5 0.0 0.4 38.9 54.2 4.3 21.6 0.6 15.1 49.8 0.2 5.7 9.8 25.8 0.0 13.5 0.3 0.0 0.0 0.8 7.7 3.1 8.5 9.2 0.0 0.0 0.0 0.0 186.7 8.0 0.0 9.0 0.0 0.0 3.3 0.1 6.0 0.0 0.0 0.0 6.1 0.3 28.7 14.8 4.1 4.6 12.4 0.0 0.0 0.5 0.0 0.0 0.1 6.7 1.1 3.0 0.0 105.2 0.0 0.2 3.6 0.6 0.0 17.8 13.1 404.4 105.8 32.2 44.9 25.3 0.7 0.1 0.0 131.4 IER2 ETR101 ENSG00000160888 "Immediate early response 2" Q9BTL4 19 13150411-13154911 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 255.5;U-266/84: 338.3" "Low region specificity" "Detected in all" "HPA055387, HPA060574" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055387: AB_2682802, HPA060574: AB_2684324" "unprognostic (3.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.99e-1)" "unprognostic (4.86e-2)" "unprognostic (3.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.10e-1)" "unprognostic (3.31e-1)" "unprognostic (2.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (2.86e-1)" "unprognostic (1.01e-1)" 132.3 75.4 26.7 44.6 20.2 241.9 104.7 41.0 27.0 49.1 21.5 112.2 40.0 65.6 7.3 129.7 301.0 37.1 90.1 18.4 48.4 92.0 119.4 137.6 47.7 27.5 25.4 15.5 108.4 120.3 31.2 88.5 34.2 25.3 84.5 30.1 16.9 105.7 28.1 26.6 222.5 79.0 45.8 24.1 96.1 140.8 13.8 29.1 45.6 108.6 49.9 21.0 91.5 79.0 27.5 62.4 36.3 28.2 43.0 18.3 24.5 62.2 47.4 25.6 32.0 18.8 31.4 36.9 36.7 46.7 34.5 53.8 41.4 13.1 27.4 15.9 22.2 24.6 48.2 67.9 26.5 22.4 61.2 51.9 12.7 66.3 34.5 21.4 38.9 37.9 37.4 123.6 48.1 12.5 102.4 37.1 255.5 53.5 66.9 155.8 71.8 28.4 45.0 29.5 36.2 34.7 49.7 53.0 160.0 114.5 22.1 19.1 36.6 68.8 67.0 46.2 56.1 138.6 139.9 338.3 37.9 36.3 120.4 53.0 363.9 167.4 273.7 249.7 191.3 214.5 139.9 175.1 202.5 100.5 155.3 114.7 146.8 833.3 215.0 183.7 45.1 178.2 275.5 26.7 20.2 41.0 27.0 18.4 48.4 27.5 25.4 15.5 25.3 24.1 29.1 27.5 1678.3 176.3 492.4 31.3 636.9 319.0 1201.7 587.9 659.0 82.2 977.1 1651.1 61.3 571.9 330.0 95.6 35.5 539.9 974.9 807.5 52.8 873.6 14.0 714.9 1302.8 718.1 977.5 75.6 6.7 380.3 541.6 721.1 1071.4 1261.4 489.2 279.8 427.3 83.5 593.9 15.2 7.5 973.4 553.4 316.8 366.4 11.9 137.9 714.3 236.5 48.7 144.7 453.1 185.3 7.5 6.7 494.4 691.5 38.7 484.3 779.5 680.9 44.5 221.7 141.9 644.2 591.4 730.3 6.6 10.1 720.1 441.6 915.6 671.4 313.4 652.7 418.5 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99473877-99504857 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 97.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Approved Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 12.7 9.6 9.3 10.4 9.4 97.8 12.6 15.8 8.9 11.3 9.0 12.5 10.4 10.4 7.0 12.7 12.6 7.4 11.5 7.8 8.8 10.0 10.2 13.4 13.7 9.4 9.2 7.1 14.0 9.7 7.7 9.4 8.1 10.0 13.7 8.7 5.5 10.3 7.8 12.3 14.5 14.5 7.8 8.8 19.4 11.6 10.6 9.6 12.9 10.3 9.7 11.4 12.0 12.3 10.7 10.3 10.2 6.6 14.0 10.4 7.1 13.1 8.5 11.6 9.9 9.7 11.0 11.0 12.4 12.2 9.2 13.5 9.6 9.2 11.2 9.8 9.1 12.0 12.2 12.0 12.1 8.3 17.4 20.0 9.4 9.6 9.6 10.2 7.3 11.6 10.5 17.6 24.0 9.3 19.6 18.3 28.8 15.0 12.9 12.0 10.2 7.3 22.1 11.0 14.7 7.8 16.5 10.2 24.6 16.9 16.5 6.4 21.8 11.9 11.7 12.0 17.4 10.9 19.7 22.1 20.0 8.5 17.4 12.9 56.8 20.6 36.6 31.7 25.5 33.2 24.5 31.8 34.3 22.6 23.6 38.5 30.8 37.8 36.8 26.8 32.8 37.7 24.6 9.3 9.4 15.8 8.9 7.8 8.8 9.4 9.2 7.1 10.0 8.8 9.6 10.7 29.3 16.0 19.7 5.2 37.1 35.6 36.1 16.4 16.5 9.7 20.6 14.6 11.4 8.6 16.6 11.0 12.5 15.8 56.7 26.3 17.6 15.7 10.4 17.3 12.9 22.2 20.8 31.5 4.6 14.1 18.2 17.5 25.0 24.4 58.9 17.1 17.5 12.3 18.9 15.2 5.0 16.9 8.2 25.5 29.6 2.9 15.5 29.3 28.4 1.9 19.3 13.6 45.3 7.1 5.6 16.4 20.8 13.5 31.8 29.2 29.7 11.7 19.4 11.7 13.1 22.6 19.7 41.9 30.6 21.5 35.5 29.7 54.3 24.6 18.6 65.6 CPSF4 "CPSF30, NAR" ENSG00000160917 "Cleavage and polyadenylation specific factor 4" O95639 7 99438922-99457373 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049094, HPA066470" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049094: AB_2680626, HPA066470: AB_2685672" "unprognostic (4.03e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.84e-2)" "unprognostic (2.28e-2)" "unprognostic (3.15e-1)" "unprognostic (3.73e-3)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (4.23e-2)" 19.9 19.2 32.3 14.0 30.7 20.3 19.3 29.9 35.4 18.3 24.5 16.1 14.1 16.9 11.8 20.5 15.9 11.4 15.2 31.0 30.9 17.4 20.4 15.5 23.9 36.5 31.1 29.9 18.9 30.2 8.4 18.5 16.8 32.1 19.3 10.8 7.3 19.9 12.4 36.4 20.6 16.3 11.2 31.4 22.2 20.2 32.3 35.2 16.3 14.0 18.2 20.1 16.2 17.5 31.4 40.0 33.9 55.4 44.9 22.4 25.5 66.8 25.8 31.5 38.8 50.5 56.0 52.0 56.4 34.2 25.2 48.2 34.0 39.1 40.5 35.4 41.9 41.6 27.0 41.4 54.4 117.2 49.4 33.3 46.8 34.0 40.7 60.4 28.1 35.8 40.1 70.8 64.8 36.2 95.6 99.6 88.9 51.3 53.0 47.7 40.8 37.0 66.8 24.2 36.1 43.3 50.6 29.4 60.9 61.6 58.2 25.3 51.8 20.0 36.5 50.1 64.3 50.0 59.9 68.6 83.3 28.1 48.1 44.1 1.2 3.4 2.6 3.3 3.0 4.4 8.2 5.0 6.1 4.1 8.4 6.3 5.6 1.3 4.4 2.1 5.4 8.2 3.0 32.3 30.7 29.9 35.4 31.0 30.9 36.5 31.1 29.9 32.1 31.4 35.2 31.4 11.6 6.4 8.9 6.2 11.2 8.8 16.4 10.6 9.6 4.6 11.9 10.3 10.4 14.3 8.6 1.8 10.4 55.9 17.7 8.7 15.6 15.6 3.0 4.9 9.3 11.0 7.7 15.6 10.7 17.1 33.1 12.7 5.1 5.3 12.7 27.0 8.2 8.2 21.5 6.7 14.7 10.6 14.2 10.1 13.5 7.8 27.4 8.7 8.8 5.6 18.5 10.7 14.4 6.0 8.1 13.9 6.0 17.3 14.7 28.6 10.1 20.2 4.3 6.9 19.7 23.7 16.4 20.9 19.8 9.3 9.2 45.4 10.7 25.1 12.6 14.9 LY6E "RIG-E, SCA-2, TSA-1" ENSG00000160932 "Lymphocyte antigen 6 family member E" Q16553 8 143017982-143023832 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 619.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1386.5;Extravillous trophoblasts: 4724.2;Granulosa cells: 998.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 753.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 627.1;BJ hTERT+ SV40 Large T+ RasG12V: 888.7;MCF7: 878.7" "Intracellular and membrane" NA NA 44000 "unprognostic (1.05e-1)" "unprognostic (8.80e-2)" "unprognostic (3.88e-2)" "unprognostic (3.70e-3)" "unprognostic (9.08e-3)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" "unprognostic (6.64e-2)" "unprognostic (4.94e-1)" "unprognostic (7.34e-2)" "unprognostic (1.74e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (6.74e-8)" "unprognostic (2.68e-1)" "unprognostic (2.28e-3)" "unprognostic (1.84e-3)" "unprognostic (2.12e-2)" 184.0 250.2 88.3 48.4 90.9 121.8 207.4 84.6 134.8 202.7 81.5 73.9 25.0 144.7 37.2 188.7 158.4 86.7 125.3 105.0 80.1 211.9 619.1 234.2 40.9 88.3 81.2 82.2 200.9 58.9 23.3 93.2 89.5 82.8 144.3 15.4 4.8 141.6 47.8 38.7 130.0 79.7 50.6 78.6 220.1 73.3 52.8 85.6 57.0 95.5 37.9 30.5 108.5 160.6 92.2 75.8 114.5 2.4 98.9 147.9 267.8 161.4 174.7 504.5 627.1 888.7 1.8 204.3 19.2 122.0 214.8 75.1 216.2 60.2 102.7 72.5 13.4 17.9 76.0 54.1 75.5 106.3 7.0 45.0 230.3 37.4 96.1 42.3 68.5 37.9 32.2 17.9 248.8 45.1 878.7 49.0 56.9 41.0 439.2 34.5 32.2 0.8 98.4 153.8 82.3 94.8 12.8 142.3 216.1 231.9 96.3 236.8 44.7 7.2 26.9 66.4 73.9 0.9 1.0 4.7 1.9 56.6 27.4 96.7 14.0 124.4 15.4 186.5 565.5 71.2 129.5 137.1 123.6 72.8 160.1 75.8 125.7 34.8 272.7 753.3 7.6 121.3 241.1 88.3 90.9 84.6 134.8 105.0 80.1 88.3 81.2 82.2 82.8 78.6 85.6 92.2 318.1 22.4 13.4 3.3 141.6 175.5 427.7 528.1 255.6 8.7 301.7 492.0 4.5 255.9 440.5 46.0 0.0 1386.5 149.6 2.4 23.5 298.8 3.8 13.5 233.3 312.0 29.3 76.6 21.4 22.7 4724.2 295.8 43.3 18.9 53.3 998.5 151.0 314.0 365.9 47.1 13.1 20.1 130.2 104.3 225.3 10.0 289.8 176.4 158.3 26.2 111.5 18.7 436.7 5.5 3.6 196.8 0.6 222.3 121.6 240.5 2.0 212.3 112.8 3.6 144.7 34.9 151.6 1.5 45.1 238.6 117.3 534.3 229.6 99.8 14.4 593.7 VPS28 ENSG00000160948 "VPS28 subunit of ESCRT-I" Q9UK41 8 144423601-144428563 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "pons: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024688, HPA024745" Supported NA NA 63000 "HPA024688: AB_1858766, HPA024745: AB_1858765" "unprognostic (2.87e-2)" "unprognostic (1.87e-1)" "unprognostic (1.27e-1)" "prognostic favorable (9.93e-4)" "unprognostic (3.18e-1)" "unprognostic (2.03e-1)" "unprognostic (9.29e-2)" "unprognostic (7.94e-3)" "unprognostic (1.54e-2)" "unprognostic (2.00e-2)" "unprognostic (7.92e-2)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.27e-1)" "unprognostic (2.37e-2)" 131.6 138.7 0.2 0.0 0.1 0.0 134.0 0.0 0.3 143.3 0.1 146.6 0.0 134.8 0.0 139.1 128.4 0.1 161.3 0.1 0.2 173.9 164.0 124.2 0.1 0.1 0.2 0.0 161.0 147.7 0.0 130.3 0.1 1.1 137.4 0.0 0.7 120.7 0.2 199.3 151.4 141.1 0.0 0.1 146.1 155.3 153.0 0.1 0.0 145.7 1.1 0.0 129.8 136.6 0.2 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.0 1.1 0.1 0.1 0.2 189.6 112.2 128.6 32.3 126.9 103.2 138.6 180.0 105.9 91.9 139.0 171.2 70.1 131.5 133.9 169.2 60.5 166.4 126.6 387.2 273.9 264.5 208.6 130.4 131.5 149.7 172.7 139.3 20.1 251.1 160.9 142.9 154.9 164.9 185.5 191.5 142.1 141.4 250.7 57.2 25.9 256.8 128.1 178.9 155.9 183.1 198.8 172.1 188.5 22.5 285.8 168.6 144.1 20.1 32.3 287.3 462.2 156.1 112.8 128.9 561.9 526.5 134.6 121.8 157.8 140.0 206.5 232.1 127.2 142.7 133.5 112.7 160.9 275.7 206.0 168.8 TONSL "IKBR, NFKBIL2" ENSG00000160949 "Tonsoku like, DNA repair protein" Q96HA7 8 144428775-144444440 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.6" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024679, HPA046494" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA024679: AB_1854441, HPA046494: AB_2679673" "unprognostic (6.68e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.88e-2)" "unprognostic (7.35e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.04e-3)" "unprognostic (7.81e-2)" "unprognostic (4.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.62e-7)" "unprognostic (3.24e-2)" "unprognostic (1.78e-1)" "unprognostic (9.11e-3)" "unprognostic (7.96e-2)" 0.9 2.1 0.5 2.6 0.3 8.6 1.3 0.3 1.2 1.6 0.0 2.7 3.5 1.6 0.2 3.9 1.4 0.6 1.3 0.2 0.3 1.4 1.8 1.3 2.4 1.0 0.5 0.3 1.7 1.5 0.4 0.9 1.5 1.0 1.6 0.8 0.1 1.5 0.8 0.5 3.1 4.5 0.6 0.1 4.0 2.3 3.8 0.6 2.3 2.4 0.1 1.4 2.3 2.1 1.1 21.2 18.6 13.7 21.7 1.0 1.7 33.0 17.6 3.4 10.4 8.1 15.0 17.9 19.6 17.5 2.7 4.9 14.2 13.4 10.7 2.3 20.2 26.6 46.5 26.1 15.9 0.6 14.3 28.1 1.7 1.5 10.9 2.1 2.6 5.0 26.5 53.0 14.3 4.2 43.4 35.5 24.5 19.4 20.4 26.7 42.6 8.9 20.3 5.9 22.6 22.9 13.0 18.4 12.3 7.8 5.2 17.6 13.2 5.9 12.7 52.3 14.5 21.7 5.0 9.9 12.0 12.3 30.2 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.3 0.3 1.2 0.2 0.3 1.0 0.5 0.3 1.0 0.1 0.6 1.1 2.5 6.4 22.4 1.6 2.9 8.9 5.2 1.0 1.2 3.1 3.5 2.9 2.3 8.6 3.7 1.8 2.1 4.1 1.3 20.2 0.0 0.9 0.4 4.3 2.7 4.3 2.4 7.2 2.4 1.0 5.3 3.8 11.7 6.1 2.5 8.5 2.9 11.4 4.5 1.7 1.0 14.6 0.0 0.9 16.7 0.7 0.3 3.0 14.2 1.9 1.2 1.1 1.0 0.5 0.8 1.2 7.1 1.2 4.0 3.9 76.5 7.7 4.1 3.0 6.6 6.4 2.8 4.6 7.8 3.4 11.2 1.2 3.1 3.3 15.9 3.9 PTGER1 EP1 ENSG00000160951 "Prostaglandin E receptor 1" P34995 19 14472466-14475354 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 11.6;lymphoid tissue: 6.6" "Cell type enriched" "Detected in some" 70 "Collecting duct cells: 198.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (3.31e-1)" "unprognostic (2.68e-1)" "unprognostic (3.50e-4)" "unprognostic (8.69e-2)" "unprognostic (5.58e-2)" "unprognostic (2.39e-2)" "unprognostic (3.19e-2)" "unprognostic (2.05e-1)" "unprognostic (3.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (7.74e-8)" "unprognostic (1.19e-1)" "unprognostic (4.41e-2)" "unprognostic (4.27e-3)" "unprognostic (4.88e-2)" 0.6 1.4 0.6 0.5 0.6 0.0 0.4 0.3 2.0 0.8 0.7 0.4 0.3 0.5 0.0 0.8 1.0 0.0 0.1 0.3 0.8 11.6 0.3 2.4 0.0 0.7 0.3 0.2 0.1 0.3 0.1 1.4 0.0 0.8 0.7 0.0 0.0 0.3 0.0 0.1 0.1 1.4 0.4 0.2 6.6 3.0 0.2 0.4 0.0 0.5 0.0 0.0 1.1 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.0 3.2 0.3 0.0 0.1 0.0 0.0 0.2 1.8 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.6 0.3 2.0 0.3 0.8 0.7 0.3 0.2 0.8 0.2 0.4 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.3 0.9 2.8 0.0 198.6 0.0 0.1 1.3 0.3 0.0 0.1 0.1 1.5 0.4 0.2 0.0 0.0 0.0 0.0 0.2 2.5 1.1 1.4 0.0 0.4 0.4 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.8 0.0 0.8 0.1 0.1 0.0 0.4 2.5 0.3 0.9 0.3 0.0 0.0 0.6 0.8 0.2 0.4 PWWP3A "EXPAND1, MUM-1, MUM1" ENSG00000160953 "PWWP domain containing 3A, DNA repair factor" Q2TAK8 19 1354711-1378431 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 20.7;Cardiomyocytes: 31.4;Cytotrophoblasts: 18.8;Extravillous trophoblasts: 24.5;Fibroblasts: 14.5;Hofbauer cells: 16.9;Smooth muscle cells: 13.0;Syncytiotrophoblasts: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048063, HPA054491" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA048063: AB_2680243, HPA054491: " "unprognostic (2.50e-2)" "unprognostic (4.67e-1)" "unprognostic (1.72e-1)" "prognostic favorable (4.82e-4)" "unprognostic (1.14e-1)" "unprognostic (4.21e-3)" "unprognostic (4.84e-2)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.25e-6)" "unprognostic (1.60e-1)" "unprognostic (6.05e-3)" "unprognostic (5.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (7.29e-3)" 16.3 13.9 27.0 5.3 24.0 3.1 16.4 19.9 26.8 19.7 13.9 16.8 5.0 23.3 5.9 10.0 22.8 5.5 12.6 23.4 26.0 14.1 22.8 12.3 5.2 29.7 28.0 22.1 29.6 11.9 6.3 30.6 6.7 24.7 15.9 4.9 8.1 13.3 9.2 13.2 12.6 14.7 10.2 21.8 16.7 13.4 36.7 28.3 4.9 15.7 5.9 4.5 16.5 13.9 24.3 7.9 12.3 11.4 15.8 7.7 10.2 18.5 11.1 6.9 8.8 7.7 8.2 5.5 14.9 5.3 13.4 3.1 9.1 9.4 7.2 7.5 17.2 10.3 6.9 12.9 12.4 9.1 5.8 20.5 7.8 5.0 5.2 2.9 12.6 9.3 9.7 14.4 7.5 8.9 9.6 10.1 8.7 16.4 6.7 5.9 18.4 11.6 6.6 6.9 12.3 9.9 24.6 8.7 14.8 8.7 10.0 7.7 16.8 11.4 12.2 16.2 9.5 13.0 15.8 11.5 5.2 14.8 10.6 17.2 9.6 0.8 4.8 2.9 1.8 2.5 2.8 1.7 2.1 1.4 2.5 2.3 2.4 1.4 3.1 1.6 2.6 0.8 0.9 27.0 24.0 19.9 26.8 23.4 26.0 29.7 28.0 22.1 24.7 21.8 28.3 24.3 20.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 18.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 24.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 14.2 0.8 0.0 0.0 0.0 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" O94761 8 144511288-144517845 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase" "Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.6;testis: 22.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.5;Spermatogonia: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 1.7 1.8 3.6 5.9 3.1 25.6 2.0 6.2 6.8 2.8 0.0 3.6 6.1 2.5 0.4 13.4 2.1 2.1 1.7 2.4 1.6 2.3 2.7 2.3 6.8 5.9 3.3 2.2 2.8 3.1 0.7 3.1 2.5 7.0 8.7 1.6 1.6 5.8 0.8 2.5 10.2 5.3 1.0 1.9 6.5 3.3 22.6 3.9 7.5 3.4 0.5 2.5 2.5 3.1 3.8 33.7 58.8 27.0 57.1 1.6 2.6 47.1 33.2 5.9 24.2 20.2 58.4 48.4 22.8 21.5 5.6 14.2 40.1 18.0 14.2 6.6 40.3 68.6 82.4 118.5 44.3 0.5 21.2 65.7 3.3 2.1 27.1 5.5 3.4 6.8 45.4 83.3 28.9 8.5 104.1 77.3 56.9 18.8 27.8 69.5 80.0 21.2 37.9 6.7 35.8 52.9 32.0 45.2 37.3 12.1 7.4 45.5 45.7 9.2 38.9 117.4 47.3 62.6 16.0 18.1 39.3 22.4 64.6 39.9 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.1 6.2 6.8 2.4 1.6 5.9 3.3 2.2 7.0 1.9 3.9 3.8 0.7 0.0 0.0 2.0 2.2 1.5 0.7 0.9 1.2 2.7 3.7 2.7 1.8 1.5 0.5 0.0 4.2 3.9 1.0 5.9 0.0 0.5 3.9 2.1 0.9 0.7 0.0 6.1 2.0 0.4 8.1 1.8 4.6 2.0 0.0 8.8 0.0 0.7 3.6 0.0 1.6 4.1 0.0 0.6 1.1 7.4 1.2 1.0 0.0 0.0 0.3 0.3 1.0 0.0 0.8 0.3 0.2 1.5 9.1 0.7 0.7 0.5 0.7 1.7 0.0 1.4 1.2 23.5 20.6 6.6 1.0 1.5 1.2 0.5 7.0 0.7 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favorable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 8.5 13.2 10.6 6.5 9.5 7.5 9.8 14.0 12.0 14.7 3.4 15.0 7.6 16.3 5.8 14.3 13.2 5.8 10.1 11.6 7.3 11.6 12.0 9.9 9.4 9.8 9.2 10.2 13.0 16.3 8.3 16.2 5.0 10.5 19.6 5.3 3.3 12.1 8.2 11.5 12.9 13.4 5.7 9.2 14.6 14.4 11.7 8.9 7.2 16.9 5.1 6.6 14.7 12.3 10.9 18.2 36.2 9.7 15.8 10.2 8.3 13.8 15.9 6.8 12.6 10.8 15.9 21.6 14.5 16.5 11.9 7.7 19.4 15.3 15.8 5.7 19.7 34.8 21.9 42.7 6.9 9.5 9.3 17.3 10.1 13.3 12.7 6.2 10.4 10.9 16.6 29.2 17.1 12.4 22.3 34.9 12.2 7.9 15.8 51.8 29.6 8.0 20.9 7.6 15.6 26.4 14.7 24.2 19.3 11.2 5.7 29.8 10.3 11.8 21.4 37.6 19.0 23.7 9.5 6.0 18.2 20.1 21.4 13.4 1.6 7.2 1.6 8.3 6.8 8.0 7.8 6.2 7.8 7.2 7.9 6.7 5.6 3.8 11.4 6.0 8.4 6.7 8.0 10.6 9.5 14.0 12.0 11.6 7.3 9.8 9.2 10.2 10.5 9.2 8.9 10.9 6.3 6.4 3.1 6.5 10.9 6.4 5.0 3.4 9.1 11.5 9.8 9.5 4.6 14.3 6.0 9.2 2.1 6.9 6.9 10.3 5.9 5.4 2.8 6.3 6.8 7.3 5.4 8.4 3.8 8.2 6.6 5.8 10.2 6.4 7.0 11.2 8.9 9.8 7.7 11.8 2.8 8.1 2.0 6.0 4.0 3.9 7.5 4.4 1.8 8.4 7.4 9.5 9.2 6.6 3.3 7.3 4.9 7.9 11.1 8.3 6.0 7.4 7.5 7.4 6.6 5.0 6.7 29.3 22.0 6.6 5.8 5.5 9.4 16.8 11.9 3.9 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA043973: AB_10961277, HPA054680: AB_2682571" "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 5.6 3.8 4.8 3.8 5.3 6.3 5.2 6.1 5.6 6.6 3.8 5.0 1.9 6.5 4.7 2.3 6.7 2.9 3.5 4.8 4.5 2.8 2.2 4.2 3.5 5.1 5.0 4.4 7.4 4.3 3.1 3.1 3.5 5.3 4.3 2.5 5.7 3.0 3.6 7.8 3.4 3.7 5.2 4.8 6.9 3.7 3.8 5.1 3.6 3.4 4.1 3.1 5.8 4.8 6.9 1.2 0.8 4.6 6.1 6.6 6.2 1.8 2.7 4.0 2.5 3.6 0.1 0.9 1.8 3.3 3.5 0.6 1.0 1.2 0.9 3.6 4.9 1.3 8.5 1.9 1.8 5.5 3.2 4.6 5.4 3.2 2.1 6.6 3.3 3.6 2.2 1.5 3.9 3.2 0.5 1.7 8.1 1.7 2.8 1.5 3.1 2.6 1.9 2.4 1.4 2.5 5.1 2.6 0.3 4.9 1.8 1.1 5.5 5.8 4.1 1.9 6.9 3.0 1.7 0.9 1.7 4.3 5.8 5.0 8.6 3.4 5.3 3.5 4.5 4.6 2.3 3.0 2.9 4.3 2.2 3.5 3.3 6.4 13.8 4.6 2.7 3.2 2.2 4.8 5.3 6.1 5.6 4.8 4.5 5.1 5.0 4.4 5.3 4.8 5.1 6.9 8.8 6.4 8.7 9.1 6.6 3.1 5.4 1.6 6.2 12.7 4.5 5.6 3.7 0.0 2.7 3.7 4.2 3.0 4.7 2.2 1.9 2.7 5.8 2.3 9.0 7.5 2.4 3.4 12.6 3.0 3.0 9.1 3.1 3.1 16.5 12.0 5.0 2.2 5.1 8.4 15.7 1.0 4.1 9.1 6.0 3.7 9.9 8.0 1.8 11.2 9.5 5.5 12.3 13.6 22.9 2.3 2.1 9.1 4.1 4.1 2.0 2.1 3.5 17.4 13.1 10.8 9.8 11.9 7.3 2.6 2.7 1.4 5.5 4.3 2.3 3.5 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362875-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.3;liver: 5.6" "Group enriched" "Detected in some" 7 "Excitatory neurons: 68.4;Inhibitory neurons: 18.5" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 45 "plasmacytoid DC: 9.2" "Lineage enriched" "Detected in single" 45 "dendritic cells: 9.2" "Cell line enhanced" "Detected in some" "AF22: 30.0;BEWO: 23.9;HAP1: 10.7;NTERA-2: 25.4;SuSa: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favorable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.5 5.4 0.1 8.1 0.2 0.1 0.5 13.3 0.2 0.6 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.0 9.9 3.8 2.1 5.6 0.4 0.5 1.5 1.3 7.3 0.5 2.2 3.9 0.9 0.3 4.5 2.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.3 0.2 0.3 1.0 1.9 1.2 0.1 0.0 0.1 0.2 0.1 5.8 0.0 0.8 30.0 1.9 0.0 0.0 23.9 0.0 0.0 0.0 0.0 1.3 0.0 0.1 4.7 0.0 0.1 0.0 10.7 0.0 0.0 1.0 1.3 0.0 0.0 7.9 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 25.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.2 19.2 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 5.4 8.1 0.5 13.3 9.9 3.8 1.5 1.3 7.3 4.5 0.3 1.9 5.8 0.0 0.0 0.0 3.3 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 5.5 0.0 0.3 0.0 0.0 0.0 0.2 1.5 0.1 1.7 0.1 0.0 0.0 68.4 0.6 0.4 0.5 0.0 0.2 0.0 1.0 0.0 3.6 0.1 0.0 18.5 0.0 0.0 0.0 0.0 3.5 0.0 0.5 0.0 5.6 0.0 0.0 0.0 3.5 2.1 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.4 0.0 0.9 0.0 0.4 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 208.9;Proximal enterocytes: 440.8;Proximal tubular cells: 404.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 49.9" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 6.1 15.2 9.1 4.7 7.6 3.9 8.2 4.4 15.2 8.7 12.9 19.4 27.3 10.5 1.6 9.9 19.1 3.1 8.8 12.0 7.7 26.7 23.7 10.9 2.9 7.7 9.9 7.3 8.0 17.8 7.4 37.2 1.7 6.3 15.7 2.4 3.0 11.7 5.6 6.4 8.6 24.8 1.6 6.7 8.1 14.2 33.5 9.8 2.4 27.2 1.0 1.0 9.2 6.8 5.3 30.4 24.3 3.9 15.1 1.6 2.7 19.3 8.2 5.1 6.3 5.1 6.4 21.2 5.0 21.1 3.0 5.6 19.8 2.0 6.7 1.0 10.3 11.9 6.0 26.4 6.8 4.7 4.3 7.9 2.7 8.9 7.3 2.1 4.1 4.5 8.2 24.0 6.1 2.3 49.9 15.3 19.9 7.4 15.6 30.3 15.9 1.9 10.1 5.7 10.0 12.5 23.9 14.9 13.7 13.0 1.0 32.3 9.1 7.7 7.1 33.2 19.8 15.8 4.0 4.3 1.8 22.8 8.3 6.5 0.0 0.8 0.0 1.0 1.2 0.9 0.8 0.8 1.0 1.2 0.1 0.5 1.1 0.2 0.2 1.7 0.7 0.6 0.8 9.1 7.6 4.4 15.2 12.0 7.7 7.7 9.9 7.3 6.3 6.7 9.8 5.3 7.9 3.2 15.4 28.1 6.2 43.2 36.2 47.6 54.1 25.0 78.3 82.0 85.8 157.3 24.6 40.5 14.6 7.2 6.0 135.9 121.3 33.7 12.6 43.8 15.6 13.3 51.6 6.1 7.8 41.6 24.3 13.3 70.3 24.2 3.8 16.4 12.8 208.9 6.1 30.3 7.6 98.1 26.4 7.0 27.1 14.4 22.7 9.8 8.8 5.6 3.8 102.8 5.2 6.6 2.8 29.3 109.8 15.4 5.9 40.0 440.8 404.2 59.8 50.9 6.6 17.2 17.3 52.9 28.7 77.8 61.8 6.7 7.1 69.2 116.0 28.3 FOXH1 FAST1 ENSG00000160973 "Forkhead box H1" O75593 8 144473412-144475849 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 2.1;skin 1: 1.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 3.4;Spermatogonia: 1.7" "Cancer enriched" "Detected in some" 26 "testis cancer: 23.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NTERA-2: 26.6;SuSa: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.62e-1)" "unprognostic (8.26e-2)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (2.10e-1)" "unprognostic (1.65e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (6.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.52e-1)" "unprognostic (2.65e-8)" "unprognostic (1.03e-1)" "unprognostic (3.39e-2)" "unprognostic (3.99e-1)" "unprognostic (9.35e-3)" 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.4 0.2 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.1 0.5 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.1 0.4 0.2 2.1 0.2 0.0 0.0 1.4 0.8 0.0 0.0 0.2 0.5 1.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.1 0.1 1.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.0 0.7 0.0 0.3 26.6 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 6.9 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.7 0.0 0.1 0.0 0.1 0.4 0.7 0.1 ORAI2 "C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B" ENSG00000160991 "ORAI calcium release-activated calcium modulator 2" Q96SN7 7 102433106-102456825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 140.4;Endometrial ciliated cells: 77.2;Glandular and luminal cells: 76.9;Plasma cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 75.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 149.0;RPMI-8226: 160.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055137, HPA065937" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055137: AB_2682712, HPA065937: AB_2685581" "unprognostic (5.09e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (5.07e-3)" "unprognostic (8.56e-2)" "unprognostic (3.82e-2)" "unprognostic (7.07e-2)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "prognostic favorable (8.49e-5)" "unprognostic (7.16e-2)" "unprognostic (1.57e-3)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.46e-1)" 8.1 10.8 17.5 31.2 14.3 39.8 7.2 14.4 20.5 6.9 19.7 7.2 8.0 12.0 6.9 3.3 10.7 9.5 4.3 23.4 20.1 9.2 2.1 10.0 31.2 19.3 18.6 15.4 6.1 7.1 39.9 39.3 5.6 17.3 6.9 4.0 3.3 7.4 9.5 1.4 2.3 18.0 6.4 11.1 27.9 11.4 3.1 21.6 12.1 16.2 1.6 22.3 10.8 3.8 17.3 22.1 52.2 20.0 38.3 17.2 17.2 1.3 21.4 24.3 24.6 20.7 28.9 24.1 149.0 59.7 38.9 47.9 8.8 7.6 6.2 8.6 17.1 11.7 23.0 24.2 9.1 26.1 56.6 29.2 16.2 3.6 39.4 5.8 24.4 39.6 21.3 27.8 130.7 18.1 44.9 77.4 25.1 23.8 8.1 18.6 33.0 15.3 160.8 14.4 18.0 32.1 78.5 20.5 9.4 11.8 10.2 13.3 22.7 36.3 57.0 55.5 39.3 29.9 115.9 94.8 116.4 40.6 30.8 28.5 13.2 6.8 75.9 4.9 5.8 5.1 29.2 4.1 3.6 3.9 29.4 2.6 3.2 58.9 18.3 3.3 6.4 2.4 7.0 17.5 14.3 14.4 20.5 23.4 20.1 19.3 18.6 15.4 17.3 11.1 21.6 17.3 29.0 3.2 9.6 5.2 140.4 4.0 9.7 5.3 5.2 33.5 10.0 6.7 4.2 8.6 11.1 16.5 66.7 1.3 55.4 1.0 5.9 20.9 3.6 77.2 39.8 27.0 17.3 27.1 13.2 11.6 1.6 13.9 1.5 76.9 26.0 14.9 23.9 0.7 14.9 43.7 14.7 2.4 2.0 19.1 12.5 7.4 8.1 33.0 10.6 7.5 37.6 12.1 39.1 7.1 1.2 10.7 0.3 10.1 76.3 10.3 0.2 8.9 31.2 19.1 0.0 17.9 15.2 5.3 9.1 1.2 3.1 3.0 28.8 12.8 2.0 7.0 ALKBH4 FLJ20013 ENSG00000160993 "AlkB homolog 4, lysine demethylase" Q9NXW9 7 102456238-102464863 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051422 Approved NA NA "HPA051422: AB_2681480" "unprognostic (1.18e-2)" "unprognostic (7.35e-2)" "unprognostic (3.50e-2)" "unprognostic (1.75e-2)" "unprognostic (4.14e-3)" "unprognostic (3.83e-2)" "unprognostic (2.71e-3)" "unprognostic (6.04e-3)" "unprognostic (1.34e-1)" "unprognostic (7.25e-3)" "unprognostic (3.20e-3)" "unprognostic (1.10e-1)" "prognostic favorable (3.09e-4)" "unprognostic (1.44e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.44e-2)" 3.2 5.3 8.2 2.9 8.9 5.1 3.7 10.0 9.5 4.0 7.4 3.9 3.9 4.6 3.5 4.2 3.9 2.3 4.1 8.6 9.0 5.0 4.9 2.8 4.3 8.5 8.6 8.4 4.0 5.1 7.0 5.2 2.9 8.9 4.2 2.6 2.3 5.1 3.2 4.3 4.8 5.1 2.9 8.4 7.1 4.3 2.7 8.7 4.5 5.9 4.3 3.3 3.8 3.9 9.4 5.4 7.2 5.9 13.9 4.0 4.5 6.5 4.0 6.9 8.4 7.9 8.2 7.1 6.3 6.6 5.7 7.4 4.3 7.6 5.6 6.2 6.3 15.9 6.3 3.3 6.0 6.2 5.6 5.9 6.8 7.6 6.5 2.9 7.2 5.5 10.1 11.2 7.5 5.2 19.6 15.7 17.5 9.0 10.2 10.9 9.3 6.2 11.2 7.0 5.8 7.3 10.9 5.0 15.1 5.6 7.4 6.3 6.6 1.8 8.9 10.2 13.8 8.8 10.2 8.4 11.7 5.2 7.6 9.4 3.7 5.4 3.0 6.1 4.8 6.4 5.2 4.7 8.0 5.4 4.6 4.7 6.1 1.6 9.2 9.8 6.9 4.9 3.4 8.2 8.9 10.0 9.5 8.6 9.0 8.5 8.6 8.4 8.9 8.4 8.7 9.4 10.2 6.4 5.8 2.3 7.0 8.3 4.3 12.9 5.2 16.6 8.1 11.7 2.2 11.5 5.9 9.2 4.2 25.6 9.2 7.3 25.4 16.3 1.3 6.8 12.2 10.5 6.1 19.6 5.2 14.9 15.4 10.8 7.7 10.0 3.8 11.7 10.4 9.1 15.3 28.6 6.2 8.1 10.2 12.0 5.8 1.9 14.0 7.2 3.6 2.8 14.6 13.4 25.7 2.0 4.5 11.8 10.6 21.4 8.3 6.3 12.0 18.8 4.6 10.2 0.0 7.6 9.5 11.9 16.9 9.5 7.4 11.1 8.7 17.7 10.1 1.8 CCDC105 FLJ40365 ENSG00000160994 "Coiled-coil domain containing 105" Q8IYK2 19 15010726-15023276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 15.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 201.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA058585 Approved NA NA "HPA058585: AB_2683763" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 33.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SH2B2 APS ENSG00000160999 "SH2B adaptor protein 2" 7 102285091-102321711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 37.7" "Cell type enhanced" "Detected in many" "B-cells: 31.4;Extravillous trophoblasts: 67.0;Plasma cells: 30.0;Syncytiotrophoblasts: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.4" "Group enriched" "Detected in many" 6 "B-cells: 3.4;granulocytes: 1.8;monocytes: 1.6" "Cell line enhanced" "Detected in many" "Daudi: 64.2;Karpas-707: 60.7;RPMI-8226: 46.7;U-266/70: 56.1;U-266/84: 106.7;U-698: 88.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051131 Uncertain Approved Cytosol NA NA Cytosol "HPA051131: AB_2681354" "unprognostic (2.01e-2)" "unprognostic (4.00e-1)" "unprognostic (2.43e-2)" "unprognostic (7.32e-3)" "unprognostic (4.65e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-3)" "unprognostic (2.42e-1)" "unprognostic (3.65e-1)" "unprognostic (1.29e-1)" "unprognostic (8.29e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.99e-7)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (2.02e-3)" "unprognostic (3.42e-2)" 4.3 1.8 5.9 5.8 5.1 3.7 3.6 4.0 5.3 4.4 1.3 2.5 2.3 4.6 0.3 2.0 4.6 1.5 2.1 3.8 8.8 5.9 1.8 5.7 10.8 10.4 10.1 4.5 2.0 2.0 1.0 3.0 1.8 6.2 4.4 0.5 0.8 2.8 0.7 37.7 3.5 5.6 0.9 5.2 14.6 2.4 3.4 8.1 0.8 4.5 13.9 5.5 4.0 3.4 6.3 3.7 2.8 3.0 6.6 0.7 0.3 27.6 1.3 0.5 0.8 0.6 0.8 0.6 64.2 6.4 0.5 2.8 3.7 0.7 0.9 0.3 8.1 2.8 0.0 1.7 0.6 0.6 0.5 2.2 0.6 0.9 0.5 0.2 1.1 0.2 1.6 0.4 60.7 1.3 6.9 0.3 11.5 7.0 2.3 11.5 8.1 3.3 46.7 2.1 1.0 3.2 11.4 2.3 5.6 1.6 2.3 1.0 8.4 0.2 1.0 6.2 11.0 1.3 56.1 106.7 88.3 3.9 2.3 1.5 0.0 0.3 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.3 3.4 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 5.9 5.1 4.0 5.3 3.8 8.8 10.4 10.1 4.5 6.2 5.2 8.1 6.3 5.6 0.0 0.0 6.2 31.4 2.5 2.5 0.0 1.8 6.8 3.4 2.9 1.1 1.5 0.0 0.0 0.0 9.3 2.9 0.8 0.0 0.2 0.4 3.8 2.4 7.3 1.8 0.4 2.2 0.0 67.0 2.0 1.1 5.4 0.0 1.0 2.2 0.8 7.8 5.0 4.8 0.6 0.0 14.1 17.6 2.0 0.6 15.1 7.2 2.8 6.0 9.2 1.0 1.0 0.5 0.1 0.5 0.4 30.0 5.7 0.1 13.0 0.0 1.4 0.0 6.6 2.0 1.1 15.8 0.6 1.6 58.1 1.3 0.4 1.3 2.2 MRNIP "C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537" ENSG00000161010 "MRN complex interacting protein" Q6NTE8 5 179835133-179862173 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 46.9;Endometrial ciliated cells: 49.7;Glandular and luminal cells: 31.3;Respiratory ciliated cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043975 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043975: AB_2678754" "unprognostic (4.97e-2)" "unprognostic (2.79e-1)" "unprognostic (7.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (5.15e-3)" "unprognostic (1.68e-3)" "unprognostic (2.51e-2)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.63e-3)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (7.00e-2)" "unprognostic (1.43e-3)" 7.4 7.2 10.0 3.5 10.0 1.5 9.6 12.3 13.0 21.9 10.5 11.4 2.5 11.5 6.0 6.5 16.9 2.2 7.1 9.9 9.7 11.2 10.1 8.9 5.6 10.1 9.8 9.9 21.2 10.4 5.2 19.3 1.5 11.2 15.5 2.9 3.0 10.0 7.2 5.4 7.7 17.3 3.9 9.4 19.1 8.9 10.2 10.0 2.7 15.7 2.8 5.4 12.8 13.9 11.2 1.0 1.9 3.5 8.4 7.4 6.6 4.0 2.5 2.3 3.2 4.8 2.5 3.2 4.1 2.9 1.3 1.4 2.6 4.4 8.3 2.6 3.7 3.5 1.3 4.3 2.1 4.6 1.7 1.6 4.9 7.0 3.7 3.0 2.4 3.6 4.1 2.0 1.8 3.5 3.9 2.8 1.7 1.7 1.3 1.9 3.3 1.4 3.2 5.7 0.8 6.6 2.1 1.2 3.3 3.1 2.6 4.1 1.4 0.7 1.8 1.4 1.4 1.5 2.2 1.4 2.9 1.7 2.7 1.3 1.5 0.6 2.9 2.7 0.7 3.8 8.0 4.0 3.2 0.8 10.2 6.4 4.5 0.9 3.5 0.9 4.9 2.6 1.9 10.0 10.0 12.3 13.0 9.9 9.7 10.1 9.8 9.9 11.2 9.4 10.0 11.2 22.4 16.0 15.6 0.0 6.2 0.0 0.0 0.0 0.0 0.0 13.7 21.1 0.0 0.0 11.8 18.4 0.0 10.5 11.6 0.0 46.9 5.1 0.0 49.7 19.0 5.8 0.0 0.0 0.0 2.2 6.8 9.7 0.0 31.3 11.4 20.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.0 0.0 0.0 14.5 29.9 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 9.3 7.6 18.4 0.0 0.0 SQSTM1 "A170, OSIL, p60, p62, p62B, PDB3" ENSG00000161011 "Sequestosome 1" Q13501 5 179806398-179838078 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Autophagy, Differentiation, Immunity" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1193.1" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 2045.0;Urothelial cells: 2233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 1923.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004587, HPA064165, HPA068843" Supported Enhanced Vesicles,Cytosol No No 81000 "Vesicles, Cytosol" "CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.45e-2)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.31e-5)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (5.65e-2)" "unprognostic (1.66e-1)" "unprognostic (1.70e-1)" "unprognostic (9.52e-2)" "unprognostic (3.21e-1)" "unprognostic (8.68e-3)" "unprognostic (4.41e-2)" "unprognostic (2.01e-1)" 314.0 476.5 184.2 86.8 193.6 137.0 271.8 190.4 194.2 243.3 211.2 239.0 113.1 281.1 92.5 193.9 209.3 189.9 301.9 166.7 247.7 223.0 395.3 265.7 82.1 208.1 172.9 149.0 237.5 233.2 122.4 182.9 119.7 176.2 208.0 83.1 46.8 292.0 175.8 1193.1 188.7 189.0 133.9 191.2 180.5 265.8 66.2 198.0 90.2 319.0 289.7 97.2 350.2 212.8 241.3 130.1 740.6 36.9 114.3 547.8 384.8 546.3 187.9 596.3 164.1 201.2 154.6 532.9 16.0 522.7 298.9 898.3 170.8 79.9 181.9 76.9 1923.9 97.6 58.5 303.9 223.4 1167.2 59.9 365.0 337.1 181.2 273.0 441.5 390.8 152.6 17.3 68.0 472.1 327.0 111.6 26.4 62.0 93.8 410.0 195.1 54.8 78.8 213.7 243.6 609.6 79.0 74.5 253.2 274.3 662.2 62.3 143.8 120.4 286.2 243.1 103.4 252.3 271.6 723.7 819.3 73.5 521.1 111.6 338.4 807.6 412.3 422.2 194.7 268.3 231.3 156.5 170.1 174.6 227.5 168.2 131.8 139.1 672.6 196.3 260.3 89.6 262.1 439.8 184.2 193.6 190.4 194.2 166.7 247.7 208.1 172.9 149.0 176.2 191.2 198.0 241.3 411.1 185.9 248.8 36.9 280.0 297.5 1289.0 320.4 799.6 81.7 280.7 253.0 38.5 314.5 247.8 121.4 54.2 266.8 276.4 572.9 234.8 906.0 34.2 408.7 255.4 415.8 340.4 89.0 35.2 686.7 133.2 516.0 1270.6 589.7 386.3 73.8 142.5 297.8 288.3 90.9 37.2 337.2 236.0 149.8 556.3 72.2 325.3 388.3 231.3 28.1 611.3 143.3 125.7 16.6 62.2 639.4 618.9 259.2 606.5 1281.6 311.3 327.1 190.1 73.5 164.3 356.4 316.1 45.5 48.0 595.4 259.1 2045.0 259.9 133.4 242.3 2233.9 MGAT4B GnT-Ivb ENSG00000161013 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B" Q9UQ53 5 179797597-179806952 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 279.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 224.7;Proximal enterocytes: 224.5;Undifferentiated cells: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012804, HPA052134" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA 19000 Nucleoplasm "Golgi apparatus, Vesicles, Cytosol" "HPA012804: , HPA052134: AB_2681741" "unprognostic (2.01e-2)" "unprognostic (8.68e-3)" "unprognostic (1.40e-1)" "unprognostic (3.83e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (3.61e-3)" "unprognostic (7.57e-3)" "unprognostic (1.22e-2)" "unprognostic (2.02e-1)" "unprognostic (5.13e-2)" "unprognostic (2.26e-2)" "unprognostic (2.27e-2)" "prognostic favorable (5.78e-4)" "unprognostic (1.52e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.42e-1)" 43.9 105.8 17.0 19.2 16.5 24.8 40.3 16.2 19.4 36.3 17.5 98.6 135.4 37.2 13.5 75.7 37.5 23.8 85.3 18.7 15.5 124.1 279.4 61.7 15.7 15.9 15.0 16.6 41.5 63.9 23.1 38.0 18.0 16.3 42.7 65.6 4.5 58.4 12.0 44.1 53.2 169.7 15.0 14.6 53.2 97.1 30.9 17.1 10.6 60.6 15.1 16.1 39.0 42.5 15.8 84.2 85.3 40.8 93.7 117.4 65.1 71.1 48.3 98.3 44.4 34.8 91.7 226.4 14.4 122.3 108.2 193.1 61.6 57.9 110.1 32.2 121.0 33.0 43.5 75.1 78.4 85.9 53.7 13.4 70.5 76.6 44.1 53.0 165.2 89.1 16.9 28.7 38.5 73.6 92.6 8.4 47.4 24.7 123.7 35.1 21.6 31.4 40.4 132.3 158.5 67.5 39.7 73.7 75.2 139.1 33.8 51.3 56.3 109.2 106.6 48.6 61.2 80.2 32.5 39.5 35.4 125.0 68.2 78.7 0.0 0.4 5.5 0.1 0.1 0.0 0.0 0.3 0.1 0.3 0.9 0.2 0.3 0.1 0.0 0.3 0.3 0.0 0.2 17.0 16.5 16.2 19.4 18.7 15.5 15.9 15.0 16.6 16.3 14.6 17.1 15.8 35.7 12.8 9.2 9.4 7.7 12.5 17.8 12.5 5.2 15.5 29.6 30.7 24.1 37.1 11.1 27.6 4.2 8.1 22.1 224.7 3.9 66.7 0.7 27.2 17.8 24.3 22.9 5.5 11.4 54.0 11.1 15.3 78.5 50.5 5.1 39.5 26.7 89.9 17.7 30.3 10.0 72.2 14.2 20.7 11.7 2.6 15.2 24.5 10.6 9.4 16.8 25.7 6.2 4.5 6.3 89.9 114.6 17.0 7.0 49.0 224.5 22.4 7.7 11.1 13.1 16.2 24.7 1.5 6.5 21.1 11.9 14.0 12.5 24.9 131.8 64.8 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 6599.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 1079.7 871.5 156.3 401.2 147.1 1029.2 1172.7 152.8 364.6 1367.3 168.5 1088.0 695.0 1051.1 64.3 1417.9 1128.3 147.8 923.6 128.7 176.9 896.5 715.5 803.0 428.0 170.6 157.7 121.0 2211.1 2038.0 151.6 790.3 266.6 165.2 983.2 111.0 23.1 1331.4 203.6 1667.2 1759.4 893.1 116.7 185.4 926.0 1011.7 307.1 192.0 151.4 746.0 195.7 198.1 1109.1 1250.7 166.6 2486.1 2860.3 200.1 874.6 220.0 496.0 1913.2 1747.7 325.3 522.4 369.7 2518.8 1299.5 3296.6 2461.9 208.4 174.3 1470.7 263.8 609.1 95.7 1446.1 3218.7 1962.1 2166.5 1805.2 546.9 1299.9 1027.5 537.1 680.7 235.9 400.8 246.5 387.8 703.1 2695.3 742.2 226.0 6599.2 1862.9 1754.6 1865.3 674.7 3196.8 1806.5 1154.4 3160.7 280.1 1842.0 1215.9 2028.4 1677.7 899.2 2541.5 81.0 2093.2 1233.3 1573.7 689.8 2622.6 1454.9 2127.3 1344.2 1235.8 2856.3 1372.4 2117.5 968.7 534.8 1464.1 574.8 1160.0 1504.9 1934.6 2970.9 1937.9 1430.4 2051.1 2991.2 2181.6 1718.2 166.1 1469.4 1479.6 1129.7 2070.5 5473.9 156.3 147.1 152.8 364.6 128.7 176.9 170.6 157.7 121.0 165.2 185.4 192.0 166.6 2510.5 852.5 1309.5 28.7 4225.5 6439.6 7085.5 5724.6 4563.8 424.0 6122.9 9469.1 1049.0 1988.8 2513.8 1028.1 268.9 4313.8 1790.8 1780.8 4433.5 2429.1 891.2 1083.4 2465.0 2455.7 1698.3 2407.7 24.0 5851.2 6733.6 2161.3 1804.3 1452.8 1044.4 2390.5 2116.1 1309.7 3031.0 166.5 28.5 3563.5 1698.8 2811.4 5097.7 2782.3 3122.7 2281.9 3520.0 30.9 2951.5 1300.3 1607.7 16.1 32.8 3402.4 3311.1 1432.3 3168.7 6500.7 3930.7 4195.9 961.7 689.1 1078.1 2701.0 3865.8 591.8 583.4 5817.5 8224.4 4365.8 2704.6 3472.7 4291.2 7522.7 MAML1 "KIAA0200, Mam-1" ENSG00000161021 "Mastermind like transcriptional coactivator 1" Q92585 5 179732822-179777283 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 11.2;hTCEpi: 11.3;SK-MEL-30: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037687, HPA057531" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA037687: AB_10672604, HPA057531: AB_2683458" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (3.01e-2)" "unprognostic (5.41e-3)" "unprognostic (5.79e-2)" "unprognostic (2.45e-1)" "unprognostic (1.75e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (3.44e-1)" "unprognostic (6.05e-2)" "unprognostic (1.06e-1)" "unprognostic (6.69e-2)" 14.0 15.9 0.4 2.5 0.5 5.0 14.1 0.7 2.4 17.2 0.5 16.2 3.3 17.9 5.1 15.4 17.0 0.0 11.8 0.3 0.7 11.2 11.1 14.1 1.6 0.4 1.9 0.2 20.4 15.3 0.0 12.8 3.1 2.0 15.8 2.6 1.5 13.5 0.0 12.6 16.1 14.8 3.8 1.8 16.4 14.0 9.8 0.4 0.0 14.5 3.7 0.0 16.0 15.5 0.5 0.0 0.0 0.0 0.0 9.3 9.1 0.0 5.9 10.8 11.2 8.1 0.0 0.0 7.1 8.2 0.0 0.0 0.3 0.0 0.0 7.1 0.0 0.0 0.0 8.7 0.0 8.2 0.0 0.1 0.0 11.3 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.7 0.2 0.1 0.0 0.0 0.2 19.8 10.1 8.9 0.0 9.0 0.1 1.4 0.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.4 0.2 0.1 0.7 0.2 0.3 0.1 0.5 0.2 0.2 0.7 0.2 0.5 0.2 0.1 0.3 0.4 0.5 0.7 2.4 0.3 0.7 0.4 1.9 0.2 2.0 1.8 0.4 0.5 15.0 16.0 9.3 11.8 14.0 25.0 12.1 12.1 20.5 12.5 13.9 15.2 7.2 15.7 7.5 9.2 18.8 10.1 20.8 12.0 1.9 6.4 2.4 10.1 15.6 26.4 9.0 16.2 18.1 6.5 12.0 11.6 13.7 13.9 56.0 14.4 33.5 9.9 13.0 21.9 18.2 11.6 12.2 24.2 26.7 2.3 17.4 16.6 5.4 9.4 19.6 7.9 13.4 18.6 14.8 6.7 6.4 25.2 14.0 12.6 7.7 3.9 6.1 9.4 13.1 11.6 14.1 6.1 10.0 19.7 29.8 9.3 17.1 9.7 12.3 16.0 PGLYRP2 "PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like" ENSG00000161031 "Peptidoglycan recognition protein 2" Q96PD5 19 15468645-15498956 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "liver: 260.9" "Cell type enriched" "Detected in some" 11 "Hepatocytes: 168.7" "Cancer enriched" "Detected in some" 16 "liver cancer: 42.9" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3" "Group enriched" "Detected in some" 5 "MCF7: 8.1;T-47d: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033468, HPA046311, HPA075237" Supported Approved "Cell Junctions" "Secreted to blood" NA NA 87000000000 "Cell Junctions" "CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739" "unprognostic (7.39e-3)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (8.79e-2)" "unprognostic (3.97e-1)" "unprognostic (4.88e-4)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.40e-1)" "unprognostic (6.66e-16)" "unprognostic (6.35e-3)" "unprognostic (2.80e-1)" "unprognostic (2.45e-2)" "unprognostic (2.81e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 260.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 5.7 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.4 0.4 0.2 1.6 1.7 1.6 0.2 0.9 0.8 0.1 0.0 2.2 2.3 1.6 0.5 5.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.3 0.0 0.2 0.5 0.0 0.0 4.1 1.5 0.2 4.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.4 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.9 168.7 0.3 0.0 0.4 0.0 0.0 2.2 0.0 3.1 0.3 1.9 8.8 0.0 1.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 14.1 0.8 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.4 0.7 0.1 0.1 0.0 7.6 0.0 0.0 0.1 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464956-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "testis: 277.4" "Group enriched" "Detected in many" 4 "Early spermatids: 1002.6;Spermatocytes: 677.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 7.9 16.9 11.0 6.9 9.4 15.1 8.0 10.8 13.2 9.6 8.7 8.7 5.4 10.1 2.3 7.7 13.9 4.0 9.2 11.2 10.1 10.4 15.1 10.2 8.2 10.9 10.5 9.9 9.4 9.4 8.8 17.8 3.1 10.6 8.6 2.3 3.4 7.6 6.1 13.3 6.7 17.2 4.3 9.7 24.5 9.1 277.4 10.8 8.8 10.1 5.3 7.4 9.0 7.4 9.5 18.6 24.6 13.0 36.8 9.4 7.2 21.0 19.6 11.9 30.5 20.9 23.7 10.3 44.8 27.5 13.9 36.3 19.2 18.7 16.4 9.0 16.6 39.2 10.0 11.1 14.8 12.7 17.6 17.4 6.7 9.9 35.4 7.5 10.2 16.2 33.9 44.5 13.3 16.8 54.3 53.4 42.1 28.7 22.0 37.8 28.2 12.2 48.5 9.2 11.3 17.7 50.7 21.0 20.1 19.3 14.6 11.2 14.4 11.1 17.3 37.7 54.8 30.8 50.5 94.3 43.6 19.3 17.1 31.4 10.6 2.6 9.9 9.7 4.0 9.0 10.0 8.4 8.4 2.7 11.8 5.2 6.9 5.5 10.5 3.8 9.7 9.3 6.0 11.0 9.4 10.8 13.2 11.2 10.1 10.9 10.5 9.9 10.6 9.7 10.8 9.5 9.1 0.0 1.1 5.5 10.6 10.5 6.4 16.5 3.4 11.7 5.5 5.0 0.8 2.8 12.8 12.9 2.1 9.2 10.8 8.6 7.9 12.3 1002.6 54.4 7.3 6.5 7.8 13.7 4.7 10.5 12.4 7.0 10.7 13.7 0.0 14.8 5.7 7.2 8.8 5.0 5.0 9.8 18.3 3.4 4.0 172.3 19.0 5.0 5.4 2.8 7.2 7.9 10.3 4.5 2.8 12.4 11.2 15.8 20.2 3.9 8.6 15.9 65.3 11.4 0.0 5.4 13.6 677.0 38.3 4.5 9.8 6.2 9.3 22.2 7.5 3.4 FBXL13 "CFAP169, DRC6, Fbl13, MGC21636" ENSG00000161040 "F-box and leucine rich repeat protein 13" Q8NEE6 7 102813230-103074843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 20.8" "Cell type enhanced" "Detected in many" "Early spermatids: 179.3;Late spermatids: 431.8;Oligodendrocyte precursor cells: 107.5;Oligodendrocytes: 88.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "eosinophil: 10.8;neutrophil: 38.4" "Lineage enriched" "Detected in single" 55 "granulocytes: 38.4" "Cell line enhanced" "Detected in some" "HEL: 7.6;HUVEC TERT2: 13.9;U-266/84: 18.1;U-87 MG: 9.5;U-937: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA057232 Uncertain NA NA "HPA057232: AB_2683375" "unprognostic (1.46e-2)" "unprognostic (1.91e-1)" "unprognostic (6.73e-4)" "unprognostic (1.97e-2)" "unprognostic (1.69e-3)" "unprognostic (4.41e-2)" "unprognostic (2.31e-2)" "unprognostic (6.64e-2)" "unprognostic (7.81e-2)" "unprognostic (1.49e-1)" "unprognostic (7.72e-2)" "unprognostic (2.62e-1)" "unprognostic (1.33e-3)" "unprognostic (4.54e-2)" "unprognostic (1.25e-1)" "unprognostic (1.93e-2)" "unprognostic (1.47e-1)" 0.2 0.8 2.3 0.3 0.8 0.3 0.2 0.5 0.8 0.5 3.7 0.1 0.2 0.6 0.7 0.2 5.0 0.3 0.1 0.2 1.6 0.4 0.1 0.6 0.2 2.2 2.1 0.4 0.8 0.4 0.5 0.6 0.2 1.1 0.5 0.3 2.4 0.2 0.4 0.0 0.4 0.2 0.3 1.8 0.2 5.0 20.8 0.7 0.6 0.6 0.0 0.1 0.2 0.1 1.6 0.6 0.1 0.2 1.2 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.5 0.5 1.0 0.5 0.3 0.8 0.4 0.0 0.0 0.5 0.5 0.2 7.6 1.2 0.2 2.4 7.0 0.3 0.0 0.1 3.9 0.1 1.2 13.9 0.8 2.3 0.3 1.0 0.5 0.5 6.4 1.0 0.1 0.4 0.3 0.1 0.5 1.7 0.4 0.5 0.5 0.3 0.0 0.1 0.3 0.1 0.2 0.4 2.0 3.9 1.6 0.2 0.9 18.1 1.8 9.5 12.3 5.9 0.0 0.0 10.8 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.2 38.4 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.5 0.8 0.2 1.6 2.2 2.1 0.4 1.1 1.8 0.7 1.6 1.7 0.0 1.1 49.0 0.4 1.8 1.0 0.9 1.2 1.0 0.8 1.8 0.7 1.5 1.7 0.0 12.5 0.2 0.2 0.5 3.9 1.3 179.3 12.2 1.5 1.4 1.8 0.4 61.8 1.1 0.1 1.1 13.3 1.3 0.0 2.1 1.1 0.0 0.1 0.0 53.9 0.1 0.0 0.0 0.9 431.8 0.6 0.5 0.0 48.7 0.1 2.5 1.0 107.5 88.0 1.6 0.1 3.4 0.1 0.8 0.0 1.5 25.8 9.6 13.1 1.6 21.9 23.3 6.5 0.2 0.9 0.1 0.4 1.1 0.3 0.8 NAPEPLD "C7orf18, FMP30, NAPE-PLD" ENSG00000161048 "N-acyl phosphatidylethanolamine phospholipase D" Q6IQ20 7 103099776-103149560 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 128.0;Excitatory neurons: 99.2;Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 193.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "white matter: 8.2" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019832, HPA024338" Approved Approved Cytosol NA NA Cytosol "HPA019832: AB_1844422, HPA024338: AB_2671533" "unprognostic (3.62e-1)" "unprognostic (1.86e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.58e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" "unprognostic (6.39e-3)" "unprognostic (2.70e-2)" "unprognostic (1.20e-1)" "unprognostic (2.81e-2)" "unprognostic (3.21e-1)" "prognostic favorable (7.32e-6)" "unprognostic (8.83e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" "unprognostic (2.41e-2)" 2.0 4.7 1.3 3.7 2.5 2.0 1.7 1.2 3.8 3.6 0.0 7.8 14.6 3.6 2.2 1.9 5.3 5.9 4.0 0.9 0.2 15.0 7.5 3.0 3.3 1.1 1.4 0.0 8.7 3.5 6.0 1.5 2.2 1.2 4.5 7.6 4.9 1.8 3.4 2.4 3.1 9.8 3.0 0.3 6.5 9.9 6.8 2.2 3.1 8.3 2.4 2.7 3.5 1.9 8.2 6.9 7.4 5.1 4.3 4.9 4.9 0.9 5.4 3.1 1.6 3.3 2.7 6.3 5.2 7.7 1.7 6.3 5.6 3.3 0.5 3.8 6.9 6.0 1.9 4.1 1.5 1.1 3.3 2.2 2.8 0.9 1.6 0.0 12.5 3.5 3.5 2.0 4.8 5.0 2.2 5.1 2.4 4.7 9.4 9.7 3.6 2.8 1.9 10.5 2.9 3.8 4.6 10.7 3.7 2.7 3.1 2.4 4.4 4.6 7.7 4.0 17.8 4.9 6.8 8.6 3.7 7.6 2.9 14.8 0.1 1.9 3.7 2.7 2.9 2.3 4.6 3.1 3.4 2.1 4.5 4.4 3.2 0.2 1.5 1.9 1.7 2.9 1.4 1.3 2.5 1.2 3.8 0.9 0.2 1.1 1.4 0.0 1.2 0.3 2.2 8.2 4.6 19.2 10.0 38.8 13.2 6.6 5.5 5.3 9.6 78.1 5.7 5.0 12.3 17.2 6.8 53.3 52.1 8.1 5.6 37.5 9.8 5.3 128.0 27.5 10.7 5.2 13.8 36.6 99.2 2.6 4.0 7.3 41.3 42.9 4.5 12.0 4.6 19.1 3.9 50.5 56.7 27.0 4.1 5.5 1.8 43.8 31.7 4.4 14.2 21.5 7.2 16.1 18.6 126.7 193.3 5.0 28.7 33.4 10.6 6.5 46.5 32.6 3.0 35.4 6.6 7.8 6.3 21.1 12.2 3.1 2.8 2.9 8.1 18.9 26.8 7.8 SCGB3A1 "HIN-1, HIN1, LU105, PnSP-2, UGRP2" ENSG00000161055 "Secretoglobin family 3A member 1" Q96QR1 5 180590105-180591499 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 272.2;lung: 512.5;salivary gland: 752.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2883.9;Breast myoepithelial cells: 4199.8;Club cells: 13674.8;Respiratory ciliated cells: 3325.6;Urothelial cells: 3139.7" "Group enriched" "Detected in many" 7 "endometrial cancer: 114.2;lung cancer: 288.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 51.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 2.3;T-47d: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 10000000 "unprognostic (7.70e-3)" "unprognostic (4.90e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-2)" "unprognostic (3.03e-1)" "unprognostic (1.36e-2)" "unprognostic (7.87e-3)" "unprognostic (2.00e-2)" "unprognostic (3.20e-1)" "unprognostic (4.88e-2)" "unprognostic (3.55e-2)" "unprognostic (7.19e-2)" "unprognostic (8.74e-3)" "unprognostic (5.43e-2)" "unprognostic (4.62e-1)" "unprognostic (4.50e-1)" "unprognostic (1.50e-2)" 1.4 1.6 0.9 0.2 1.0 0.5 123.6 0.5 1.0 272.2 9.4 0.5 0.6 1.5 1.3 75.4 30.2 3.0 0.7 0.9 4.3 1.4 7.1 512.5 0.4 1.2 0.9 0.9 2.0 18.3 0.0 12.7 0.1 0.7 38.2 0.0 0.0 752.6 2.4 0.3 4.6 1.0 0.0 0.9 9.5 51.2 3.0 2.1 0.8 3.1 0.0 0.8 14.6 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 20.3 2.4 17.2 13.3 1.8 3.3 4.5 10.1 0.0 5.9 5.0 0.0 0.0 51.8 0.2 4.3 2.6 0.9 1.0 0.5 1.0 0.9 4.3 1.2 0.9 0.9 0.7 0.9 2.1 1.3 36.4 173.1 1441.5 0.0 5.9 0.5 51.2 2883.9 0.6 0.0 1831.7 4199.8 0.4 1554.2 13674.8 0.0 0.0 0.0 30.4 0.1 0.0 20.5 0.1 1.6 0.1 40.5 0.0 10.7 0.2 1.6 0.3 15.2 3.6 1.7 35.3 1.0 68.9 1.1 0.4 0.0 0.0 0.1 1566.5 1.2 0.6 0.2 0.6 14.8 5.4 0.0 0.6 0.0 0.0 0.0 0.1 146.1 0.5 0.0 0.0 214.9 0.0 0.0 3325.6 0.0 0.0 1.6 305.2 0.3 4.4 140.8 0.4 0.0 20.2 0.1 0.2 3139.7 PSMC2 "MSS1, Nbla10058, S7" ENSG00000161057 "Proteasome 26S subunit, ATPase 2" P35998 7 103328570-103370346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 231.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019238, HPA049621" Supported Supported "Cytosol,Cytoplasmic bodies" NA NA 190000 "Cytosol, Cytoplasmic bodies" "HPA019238: AB_1855834, HPA049621: AB_2680833" "unprognostic (4.00e-2)" "unprognostic (6.66e-2)" "unprognostic (2.55e-1)" "unprognostic (3.58e-1)" "unprognostic (1.57e-3)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (6.08e-2)" "unprognostic (7.73e-2)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" "unprognostic (4.71e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (9.76e-2)" "unprognostic (1.41e-1)" 34.4 33.9 21.0 31.9 23.3 32.2 25.8 24.4 29.8 26.5 24.6 26.5 25.4 23.6 28.0 27.4 23.3 22.2 36.2 21.5 27.3 40.3 54.7 23.7 29.8 23.4 22.7 19.5 21.4 16.7 41.7 16.2 31.2 23.3 27.4 23.1 22.5 24.0 26.7 88.0 27.8 24.7 29.9 24.1 22.6 29.8 26.0 22.3 42.8 29.5 77.8 33.8 34.6 17.9 26.4 133.5 78.3 84.4 98.2 93.0 69.7 58.5 102.5 97.9 123.7 122.7 92.7 97.3 100.1 199.2 94.7 168.1 71.0 109.2 76.6 128.7 153.3 68.0 90.5 57.9 57.8 65.2 149.0 84.9 55.3 50.2 122.5 38.9 60.9 89.8 70.4 190.1 98.2 104.2 135.8 165.0 74.2 98.7 109.6 95.2 73.8 108.4 93.8 80.6 64.2 65.3 64.9 97.6 123.9 89.6 92.9 56.6 73.3 91.5 80.9 106.6 174.6 153.8 98.9 274.8 191.3 118.1 143.7 138.5 140.0 53.4 52.7 44.7 81.6 51.5 47.5 51.1 47.9 75.3 40.6 46.3 47.3 7.3 58.4 98.2 42.3 93.3 74.2 21.0 23.3 24.4 29.8 21.5 27.3 23.4 22.7 19.5 23.3 24.1 22.3 26.4 36.2 48.1 29.5 18.3 33.8 39.8 41.4 131.8 24.5 36.0 23.5 27.2 61.8 40.0 73.9 27.6 14.6 172.2 34.4 22.5 66.5 113.9 118.9 32.3 33.9 48.5 8.4 64.6 27.9 96.4 110.6 49.7 27.5 24.9 56.4 35.5 34.2 48.5 134.6 26.9 25.1 36.9 93.6 48.5 40.4 33.2 58.4 46.1 32.0 15.9 62.4 69.5 40.2 21.1 32.8 87.3 38.5 64.3 45.0 34.7 36.9 88.8 52.5 49.1 59.2 43.7 105.2 96.3 47.2 23.6 42.9 231.8 39.5 49.1 32.0 42.9 CELF5 BRUNOL5 ENSG00000161082 "CUGBP Elav-like family member 5" Q8N6W0 19 3224661-3297076 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 93.1;Excitatory neurons: 88.7;Inhibitory neurons: 72.8;Oligodendrocyte precursor cells: 22.1" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.4;REH: 4.3;SCLC-21H: 4.3;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042012, HPA060336" Enhanced Supported NA NA "HPA042012: AB_10796896, HPA060336: AB_2684256" "unprognostic (1.09e-1)" "unprognostic (9.24e-2)" "unprognostic (9.25e-3)" "unprognostic (3.48e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (1.35e-1)" "unprognostic (4.70e-3)" "unprognostic (1.11e-2)" "unprognostic (1.74e-3)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-1)" "unprognostic (8.07e-2)" 0.0 0.2 11.0 0.0 17.7 0.0 0.5 0.0 14.4 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.5 0.0 0.0 14.7 11.0 0.1 0.2 0.0 0.0 3.0 1.2 22.4 4.2 0.5 1.3 0.9 0.0 5.0 0.2 0.2 4.5 0.8 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.3 2.2 5.6 0.7 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.7 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.6 0.0 0.0 3.4 1.4 0.0 4.3 0.0 0.0 0.0 0.0 4.3 2.6 0.2 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 17.7 0.0 14.4 14.7 11.0 3.0 1.2 22.4 5.0 0.0 5.6 4.9 0.1 0.0 0.0 3.3 0.2 0.4 2.1 0.0 0.0 93.1 3.9 6.6 2.2 2.8 0.0 0.0 0.0 0.4 0.2 1.6 0.0 0.6 19.3 0.2 0.2 0.4 1.2 0.0 88.7 0.2 0.1 0.4 0.0 0.6 0.0 12.1 0.0 0.8 0.1 8.4 72.8 1.4 0.0 0.3 0.3 15.5 0.3 0.3 0.0 8.4 0.0 3.4 0.0 22.1 3.2 0.4 0.1 2.2 0.0 2.3 0.1 0.4 0.0 3.7 0.0 1.1 0.8 2.5 7.7 0.0 0.3 0.0 0.3 1.4 1.6 0.9 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Melanin biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.7;Extravillous trophoblasts: 142.4;Melanocytes: 195.7;Syncytiotrophoblasts: 92.6" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HeLa: 261.4;SK-MEL-30: 339.8;WM-115: 628.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain NA NA "HPA042149: AB_2677875, HPA043088: AB_2678308" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favorable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavorable (6.61e-4)" "prognostic unfavorable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 22.5 26.6 29.5 24.3 23.6 30.7 19.4 19.5 33.3 18.4 6.4 17.2 15.2 18.1 13.0 22.9 22.0 9.6 16.9 39.0 19.9 54.5 36.1 29.5 20.5 26.5 21.9 19.1 14.8 38.9 14.1 26.1 17.7 28.2 21.6 6.2 10.9 30.0 11.3 16.5 54.1 27.4 11.8 19.2 38.2 22.9 13.7 31.1 24.9 19.2 4.1 10.9 19.6 17.1 56.6 97.6 76.4 18.6 48.9 37.9 29.2 66.9 58.3 31.2 66.6 72.7 33.1 32.4 27.3 43.2 31.2 106.4 60.1 24.3 30.2 23.8 60.0 69.0 15.9 261.4 34.9 47.4 34.9 51.1 26.2 44.9 68.6 15.9 25.5 18.1 40.2 77.1 38.2 17.3 58.0 35.0 61.8 34.9 42.9 62.1 24.3 26.2 115.1 27.9 41.0 70.0 35.5 115.0 53.4 339.8 23.1 18.2 71.6 75.8 30.1 44.4 123.8 67.1 43.8 26.9 25.1 132.4 88.2 628.4 0.1 3.7 2.6 1.8 7.7 1.8 2.3 2.8 1.4 2.7 1.4 2.4 1.9 1.2 0.5 7.7 12.1 0.5 1.7 29.5 23.6 19.5 33.3 39.0 19.9 26.5 21.9 19.1 28.2 19.2 31.1 56.6 15.4 6.4 2.8 5.5 12.9 26.5 6.8 4.9 1.8 15.6 19.9 14.0 1.9 8.6 6.1 20.2 6.2 16.8 21.5 11.6 0.0 23.1 120.7 26.9 20.9 13.1 28.1 3.8 10.2 31.4 142.4 10.9 14.8 42.5 0.0 57.3 6.4 22.3 76.9 37.0 8.0 18.4 2.0 24.8 54.4 30.4 2.5 47.7 195.7 13.1 20.7 9.3 5.2 7.5 25.5 34.2 16.2 3.4 12.6 16.7 18.7 34.0 8.1 12.7 13.1 5.4 12.0 4.0 9.0 8.4 25.4 92.6 10.9 11.1 13.2 13.8 USP41 ENSG00000161133 "Ubiquitin specific peptidase 41" 22 20350578-20377251 "Metabolic proteins, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 1.2;SCLC-21H: 1.5" NA NA "unprognostic (4.01e-6)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (4.63e-3)" "unprognostic (7.44e-2)" "unprognostic (1.75e-1)" "unprognostic (5.28e-2)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (9.91e-5)" "unprognostic (3.43e-2)" "unprognostic (3.51e-2)" "unprognostic (2.54e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-1)" "unprognostic (4.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.1 0.0 1.2 0.0 0.0 0.5 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YDJC ENSG00000161179 "YdjC chitooligosaccharide deacetylase homolog" A8MPS7 22 21628089-21630064 "Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA061005 Approved Nucleoplasm NA NA Nucleoplasm "HPA061005: AB_2684412" "unprognostic (5.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.96e-1)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (9.35e-2)" "unprognostic (7.08e-2)" "unprognostic (8.09e-3)" "unprognostic (1.24e-1)" "unprognostic (9.86e-2)" "unprognostic (4.90e-3)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (9.60e-2)" "prognostic favorable (8.98e-5)" 2.0 4.2 4.0 1.2 4.0 0.7 2.8 3.6 7.5 3.3 3.3 3.4 1.9 4.0 1.7 7.2 4.5 0.3 2.7 4.4 4.0 8.0 6.7 2.8 0.5 4.4 3.9 3.7 3.9 9.8 1.4 3.3 0.5 4.2 5.0 1.2 0.4 4.6 1.5 2.1 5.4 4.9 0.8 3.9 5.0 5.7 3.2 3.9 0.6 6.2 0.0 2.6 4.6 4.3 4.5 8.3 1.5 0.1 1.2 2.4 1.8 8.8 3.5 2.5 2.7 3.7 0.7 3.5 7.4 12.6 0.9 1.9 6.8 5.0 8.3 4.5 6.5 23.8 9.7 1.5 12.3 4.2 18.7 8.5 3.5 13.1 2.4 21.1 2.6 5.9 10.0 82.4 1.5 2.3 10.5 6.7 30.5 3.0 23.8 13.8 4.7 0.0 8.2 15.4 4.5 11.0 6.1 3.1 6.3 6.3 1.6 6.7 10.3 4.9 0.9 8.9 1.9 4.3 12.8 7.4 5.7 1.0 6.0 1.6 8.1 14.4 12.4 9.4 14.5 9.9 18.3 13.6 10.1 18.0 18.4 11.4 10.4 5.3 22.3 9.4 11.2 15.3 11.1 4.0 4.0 3.6 7.5 4.4 4.0 4.4 3.9 3.7 4.2 3.9 3.9 4.5 11.8 6.4 8.2 1.0 39.4 25.0 54.1 35.0 22.2 5.8 27.1 28.2 3.6 18.6 15.3 44.1 0.0 43.1 30.3 24.9 39.2 57.7 25.3 15.2 10.1 13.0 16.2 19.1 5.4 42.8 69.1 11.6 15.8 15.8 12.0 27.9 5.0 15.0 30.2 3.3 4.6 33.5 22.4 15.7 22.9 4.8 10.5 16.3 14.2 1.9 53.9 8.6 27.8 1.5 5.3 51.4 44.5 6.8 21.1 88.9 52.0 68.3 11.3 5.6 19.7 3.7 10.7 27.7 26.3 26.6 22.7 23.1 28.9 32.6 38.9 45.7 CCDC116 FLJ36046 ENSG00000161180 "Coiled-coil domain containing 116" Q8IYX3 22 21632716-21637329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 29.9" "Group enriched" "Detected in some" 40 "Early spermatids: 224.6;Late spermatids: 169.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.1;JURKAT: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (7.01e-2)" "unprognostic (6.01e-4)" "unprognostic (1.04e-1)" "unprognostic (6.85e-3)" "unprognostic (1.34e-2)" "unprognostic (1.15e-1)" "unprognostic (1.67e-2)" "unprognostic (5.13e-2)" "unprognostic (2.01e-1)" "unprognostic (4.75e-2)" "unprognostic (1.37e-3)" "unprognostic (4.14e-1)" "unprognostic (5.79e-4)" "unprognostic (1.82e-1)" "unprognostic (3.13e-2)" "unprognostic (2.47e-2)" "unprognostic (8.64e-2)" 0.7 0.2 0.4 0.2 0.3 0.2 0.8 0.4 0.7 1.2 0.0 0.9 0.1 1.3 0.2 0.3 0.8 0.2 0.6 0.3 0.1 0.5 0.3 0.6 0.3 0.3 0.3 0.2 1.1 0.4 0.1 0.4 0.5 0.3 1.0 0.2 0.1 0.4 0.4 0.3 0.5 0.6 0.1 0.0 0.7 0.5 29.9 0.3 0.1 0.8 0.0 0.1 0.8 0.8 0.4 0.1 0.0 0.2 0.5 0.3 0.0 0.6 0.7 0.0 0.3 0.1 0.0 0.2 0.4 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.3 0.1 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 5.3 1.3 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.0 1.0 1.1 0.3 0.1 1.3 0.8 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.7 0.3 0.1 0.3 0.3 0.2 0.3 0.0 0.3 0.4 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.1 224.6 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 169.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 4.9 1.3 0.0 0.0 0.3 0.1 0.0 0.1 0.1 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155377-184173614 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" Yes No "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: AB_2683658" "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.77e-5)" "prognostic unfavorable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 33.0 28.3 16.0 18.9 16.4 18.8 30.0 17.0 19.1 38.9 15.2 38.9 17.4 45.1 16.2 30.6 34.8 22.8 35.0 16.1 16.3 23.3 20.2 32.0 14.0 18.5 16.9 14.6 42.4 25.8 18.0 24.6 38.6 17.0 29.3 16.3 23.0 25.9 26.0 35.2 33.5 27.3 32.0 16.3 25.8 28.2 15.2 16.5 12.5 30.3 22.5 16.1 36.9 31.8 17.9 47.9 13.6 36.4 41.4 37.5 37.8 95.0 28.4 28.9 32.7 27.6 43.6 18.3 33.6 73.3 37.0 32.4 40.8 29.6 22.2 23.4 54.0 32.2 38.1 21.3 28.2 56.6 21.2 27.8 38.4 39.9 23.4 27.3 55.9 24.6 21.6 38.9 44.2 35.5 46.5 28.3 25.2 32.8 34.6 22.1 49.9 42.7 30.0 31.7 36.2 36.3 51.0 34.9 39.8 67.4 35.8 98.7 26.8 25.0 29.5 28.5 31.0 43.8 48.3 38.8 37.0 30.0 22.4 23.6 0.1 0.6 1.3 0.6 1.0 0.8 0.7 0.4 0.7 0.6 0.5 0.5 0.3 0.9 0.4 0.3 0.8 0.2 0.4 16.0 16.4 17.0 19.1 16.1 16.3 18.5 16.9 14.6 17.0 16.3 16.5 17.9 15.9 25.6 14.1 16.6 10.8 18.7 15.7 12.9 15.9 20.1 23.5 16.5 26.9 12.8 17.2 22.0 27.1 34.4 14.6 40.8 23.5 13.3 12.8 23.2 30.9 15.9 34.3 6.9 11.4 16.6 21.6 22.6 32.6 27.7 17.1 29.7 19.2 20.5 20.3 62.2 11.8 22.3 12.2 16.2 14.4 47.5 33.5 17.4 12.4 14.0 10.8 19.7 14.4 9.0 11.5 20.7 18.9 37.2 13.9 20.8 25.2 18.3 13.4 18.5 19.7 23.6 27.1 10.6 12.4 20.4 21.7 52.1 10.3 21.9 21.5 25.7 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 subunit mu 1" Q96CW1 3 184174689-184184091 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" NA NA 7500 "Plasma membrane" "HPA036849: AB_10672101, HPA069870: AB_2686217" "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 192.2 367.2 225.0 166.2 260.7 233.3 166.0 219.0 260.8 221.3 204.5 208.6 169.0 218.3 105.1 220.1 180.2 167.9 369.6 259.4 262.2 196.5 142.1 181.6 149.5 238.4 224.3 243.5 200.3 107.3 226.6 226.6 245.3 256.4 184.8 142.4 232.5 168.6 234.0 182.7 158.5 157.5 245.8 208.2 163.8 157.6 107.4 237.7 159.8 149.3 195.8 158.9 225.6 194.0 285.3 436.3 327.5 275.7 311.8 432.1 450.8 284.3 714.3 412.5 788.5 550.5 355.1 309.9 198.2 851.3 1076.1 516.1 480.0 376.3 482.9 647.1 409.8 470.4 512.2 365.8 317.9 508.9 254.8 311.5 577.0 269.4 501.1 318.5 711.0 595.3 258.3 250.0 377.1 750.1 993.6 330.1 151.2 674.1 388.1 484.7 302.7 351.5 393.7 489.7 389.3 292.0 212.6 561.3 696.4 335.1 427.5 934.4 305.7 645.0 497.1 400.1 492.4 960.2 336.9 318.7 441.6 937.1 369.9 331.7 194.4 294.8 244.9 137.5 238.8 136.2 114.3 127.6 134.0 268.7 112.7 107.7 111.8 127.7 170.2 206.8 134.1 185.4 441.0 225.0 260.7 219.0 260.8 259.4 262.2 238.4 224.3 243.5 256.4 208.2 237.7 285.3 146.8 54.5 50.7 41.4 84.8 124.9 177.2 275.1 97.9 174.2 108.0 98.2 195.9 112.9 133.5 114.0 70.9 400.9 117.3 155.9 375.6 243.7 326.6 69.3 131.2 172.2 140.8 277.8 62.0 161.3 327.1 161.5 71.4 78.5 149.1 173.6 182.4 78.0 576.9 277.6 63.4 119.0 201.4 137.1 162.9 347.8 164.7 185.1 199.3 34.7 369.4 199.4 130.7 26.2 46.1 232.1 153.1 214.8 100.2 138.8 253.8 290.7 58.3 125.9 197.2 106.9 278.0 83.3 101.7 128.5 126.6 513.6 102.6 278.1 154.1 185.1 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins, Transporters" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 16.1 56.6 10.3 13.5 10.6 17.0 15.9 11.3 13.1 17.5 8.8 14.5 15.9 15.7 12.4 20.1 17.1 12.8 28.7 10.9 11.4 19.4 22.9 14.6 17.1 12.9 11.8 9.6 20.1 23.8 43.8 21.2 16.5 12.7 16.4 13.7 14.3 27.1 19.8 47.2 19.1 16.4 12.5 8.7 17.9 17.6 16.7 11.7 14.7 18.1 41.7 16.3 17.3 17.7 13.9 49.9 30.2 16.9 32.8 48.1 26.9 33.3 35.2 39.1 46.7 36.5 52.0 19.3 29.8 69.5 38.1 54.9 46.4 26.5 37.1 24.1 38.4 25.5 25.7 26.6 30.8 40.4 29.2 25.2 39.7 33.5 33.1 32.7 27.4 33.8 25.7 24.1 34.9 33.5 60.0 28.7 18.8 25.7 51.1 41.2 28.5 28.1 50.4 25.4 29.6 29.1 16.9 36.5 69.1 33.8 18.3 93.7 25.3 33.5 24.9 27.1 39.5 53.1 39.2 40.5 38.2 38.8 28.7 31.3 8.1 29.1 22.7 32.9 30.4 34.7 23.6 29.0 27.5 25.6 23.8 36.0 29.5 14.6 24.0 32.4 15.8 27.2 37.2 10.3 10.6 11.3 13.1 10.9 11.4 12.9 11.8 9.6 12.7 8.7 11.7 13.9 10.2 9.6 2.0 6.2 17.4 14.5 10.0 29.8 9.6 16.7 10.8 6.7 11.6 17.2 19.7 14.7 14.6 36.9 16.2 19.8 29.4 22.5 9.5 11.2 12.0 11.6 11.4 8.6 7.1 22.4 25.5 12.5 13.3 12.0 9.5 16.0 16.8 20.0 21.6 20.2 9.9 13.4 30.5 9.4 6.9 10.2 12.5 12.9 16.0 3.7 22.8 14.7 17.5 6.6 7.3 20.5 9.8 11.7 19.4 9.0 28.6 37.3 14.4 22.3 6.6 11.9 9.5 12.8 17.1 14.5 10.2 43.8 16.6 18.1 14.7 11.7 PCYT1A "CT, CTPCT, PCYT1" ENSG00000161217 "Phosphate cytidylyltransferase 1, choline, alpha" P49585 3 196214222-196287957 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Cone-rod dystrophy, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 215.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035428 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035428: AB_10602045" "unprognostic (8.58e-3)" "unprognostic (2.63e-1)" "unprognostic (8.45e-2)" "unprognostic (8.61e-3)" "unprognostic (2.87e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (8.52e-2)" "unprognostic (5.99e-2)" "unprognostic (1.65e-2)" "unprognostic (6.72e-3)" "unprognostic (1.74e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.47e-2)" "unprognostic (7.16e-3)" "unprognostic (2.41e-2)" 31.7 24.6 16.4 30.3 16.8 45.8 21.2 18.3 16.6 15.8 18.0 25.9 60.9 19.2 14.0 31.3 15.7 20.9 46.9 16.7 18.8 18.5 20.9 22.7 23.0 19.7 18.7 13.4 15.9 17.0 22.9 13.0 20.3 19.6 16.8 23.2 14.5 19.4 18.8 74.5 43.3 49.6 23.2 18.5 26.2 24.4 22.6 18.9 18.2 17.3 42.5 27.1 21.2 19.9 18.4 92.6 36.6 25.8 37.2 52.2 53.9 37.0 68.2 47.1 59.2 51.8 92.3 32.8 23.9 215.2 78.1 60.2 71.4 40.5 52.1 50.4 42.1 28.6 68.6 40.6 39.5 45.2 34.3 56.7 47.4 40.0 55.9 39.6 35.4 63.0 21.0 38.3 53.3 58.1 79.6 19.9 17.3 21.4 55.7 53.0 34.5 31.0 37.5 35.7 53.6 25.4 18.3 44.5 79.5 44.2 32.8 114.1 37.2 88.5 45.5 25.2 61.8 92.7 45.8 101.1 44.1 69.6 43.8 56.9 9.6 9.2 10.4 8.8 9.3 7.5 7.2 6.5 9.7 9.1 6.3 4.2 6.3 21.0 9.4 11.0 5.9 14.9 5.2 16.4 16.8 18.3 16.6 16.7 18.8 19.7 18.7 13.4 19.6 18.5 18.9 18.4 24.7 16.0 25.7 15.3 19.9 14.5 9.4 19.7 14.2 15.9 14.1 9.4 70.1 20.0 17.5 14.7 25.0 11.9 27.3 36.4 13.7 24.8 76.3 17.8 22.9 23.2 22.1 12.2 20.4 22.9 17.7 17.0 23.4 15.6 20.8 16.1 26.7 35.6 37.4 8.4 22.7 24.2 6.1 34.6 27.1 67.6 19.9 33.9 19.6 20.6 39.4 13.1 39.1 16.1 17.6 24.6 21.1 28.2 27.2 12.0 67.2 23.2 33.9 12.8 26.3 15.0 19.0 46.0 13.2 30.0 21.5 18.6 25.6 25.5 23.8 12.2 FBXO27 "Fbg5, Fbx27" ENSG00000161243 "F-box protein 27" Q8NI29 19 38990714-39032785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 37.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 35.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA046800, HPA062242" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046800: AB_2679813, HPA062242: AB_2684723" "prognostic favorable (2.15e-4)" "unprognostic (7.32e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (1.48e-3)" "unprognostic (4.38e-3)" "unprognostic (1.02e-1)" "unprognostic (8.95e-2)" "unprognostic (1.67e-1)" "unprognostic (7.31e-3)" "unprognostic (6.80e-2)" "unprognostic (9.31e-2)" "unprognostic (2.25e-2)" "unprognostic (8.72e-3)" "unprognostic (6.04e-2)" "unprognostic (7.51e-2)" "unprognostic (3.21e-2)" 13.4 3.7 16.9 2.2 15.2 2.8 6.3 19.6 17.8 5.5 4.7 6.8 2.2 4.7 2.4 15.5 5.3 5.6 19.8 13.8 6.8 6.4 7.6 3.2 3.7 10.8 6.8 15.9 10.3 4.8 2.5 4.1 3.8 13.4 9.0 8.8 4.9 7.5 7.9 1.6 37.8 4.9 7.5 3.9 3.1 3.8 4.7 10.0 4.0 4.6 2.5 4.0 7.8 9.8 14.9 9.1 11.4 0.3 7.2 15.3 0.8 3.3 1.2 6.7 5.2 4.9 3.8 3.4 0.9 17.5 10.3 9.0 15.5 0.6 6.6 3.4 0.8 0.4 0.3 3.0 0.6 2.7 0.9 2.5 5.5 10.2 5.4 0.4 8.2 3.3 0.4 5.4 1.2 7.2 8.1 0.6 1.4 8.1 3.0 20.4 0.2 0.1 1.1 3.4 35.3 0.4 10.8 17.7 2.2 0.1 4.8 9.2 1.7 4.0 0.5 0.4 0.3 0.9 3.5 8.9 1.9 9.0 0.2 0.3 1.1 0.3 0.2 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.6 0.4 0.3 1.7 1.7 0.2 0.5 0.3 0.2 16.9 15.2 19.6 17.8 13.8 6.8 10.8 6.8 15.9 13.4 3.9 10.0 14.9 0.2 3.2 15.0 2.3 0.1 5.9 4.1 1.4 9.1 7.5 3.8 4.2 9.5 7.2 6.4 1.8 0.0 36.1 0.5 0.2 1.9 1.5 3.7 1.9 3.6 3.2 0.0 0.0 4.8 0.8 4.8 2.7 6.1 1.6 7.6 2.3 1.4 3.2 4.9 8.4 4.6 0.2 8.2 0.3 4.9 2.5 2.8 2.1 0.0 1.0 1.1 5.6 0.0 3.0 4.1 0.3 0.0 4.1 1.9 2.3 6.9 7.3 4.7 3.0 0.0 1.8 1.5 6.4 2.0 13.5 17.8 27.0 1.3 0.4 0.2 5.3 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "skin 1: 4714.4" "Cell type enriched" "Detected in many" 5 "Suprabasal keratinocytes: 8514.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 11.7" "Group enriched" "Detected in many" 5 "NK-cells: 11.7;T-cells: 6.4" "Cell line enhanced" "Detected in many" "A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2" "Region enhanced" "Detected in all" "basal ganglia: 51.9" "Low region specificity" "Detected in all" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA 47000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 11.7 9.4 6.2 1.1 9.7 1.7 197.6 6.9 7.6 134.9 13.5 9.6 5.6 16.3 14.6 223.3 74.6 1.8 11.3 5.3 8.0 37.7 4.7 22.5 1.2 16.2 9.2 4.8 35.3 60.2 87.9 58.5 2.2 18.3 19.4 5.0 1.9 70.0 14.7 20.3 4714.4 8.4 4.2 5.7 2.9 20.0 4.1 6.4 12.3 60.5 0.2 51.1 14.2 381.6 14.7 150.1 24.0 0.0 0.1 5.7 8.7 40.5 0.5 19.6 1.0 1.4 182.0 153.9 0.0 57.5 1.4 7.3 81.8 44.5 236.4 1.9 0.7 43.0 0.0 0.0 41.3 6.8 0.0 0.5 77.6 62.3 4.2 133.2 13.4 0.0 0.0 0.8 0.2 0.5 130.2 0.1 0.0 129.2 107.9 9.7 0.2 0.0 6.2 232.2 97.4 0.4 0.0 35.6 0.1 14.9 36.7 58.5 0.0 0.3 22.3 67.1 0.8 0.6 0.9 0.3 1.1 18.8 0.3 1.4 0.0 0.0 0.0 6.4 0.0 5.5 1.7 0.5 3.1 0.0 0.1 0.1 2.0 0.0 11.7 0.0 0.2 0.0 1.3 6.2 9.7 6.9 7.6 5.3 8.0 16.2 9.2 4.8 18.3 5.7 6.4 14.7 13.9 105.8 115.3 1.0 5.9 1623.7 143.2 169.9 39.3 1.7 71.8 164.3 20.4 100.1 107.6 204.1 0.0 1.0 6.7 6.0 230.9 138.0 15.9 181.5 9.0 27.7 49.3 2.7 6.9 140.2 1.5 47.1 27.0 107.8 7.6 2.4 12.1 4.0 1.0 0.0 5.3 8.0 46.8 0.3 287.0 98.0 13.1 2.8 305.9 0.0 2.6 15.1 28.8 0.0 0.4 146.1 9.3 15.8 3.4 94.0 0.2 7.6 270.2 0.8 0.0 0.9 22.9 7.6 31.4 34.0 8514.1 2.3 15.0 0.2 14.2 77.4 U2AF1L4 "MGC33901, U2AF1L3, U2af26" ENSG00000161265 "U2 small nuclear RNA auxiliary factor 1 like 4" Q8WU68 19 35742464-35745445 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052083, HPA061644" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA052083: AB_2681720, HPA061644: AB_2684574" "prognostic favorable (2.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" "unprognostic (1.31e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.58e-5)" "unprognostic (3.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.67e-2)" "prognostic favorable (8.58e-5)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (1.06e-1)" "unprognostic (7.21e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.05e-4)" 2.2 3.7 8.3 1.6 9.1 1.7 2.2 7.7 12.7 3.3 6.4 4.4 1.6 3.6 0.0 2.3 4.0 0.5 11.1 8.6 8.7 3.1 2.4 2.4 0.4 8.9 8.4 8.2 4.5 2.2 5.5 5.5 1.8 8.8 3.8 0.6 4.6 1.9 3.1 9.2 1.4 2.6 2.1 7.7 2.6 3.5 8.6 8.7 2.6 2.8 7.0 1.0 4.2 2.5 9.2 4.1 13.7 2.2 3.3 0.4 1.6 3.0 3.3 3.4 8.3 8.2 5.1 3.3 1.7 6.6 7.7 7.7 1.9 6.7 5.4 5.1 10.7 1.5 2.3 3.4 5.9 10.2 2.6 5.5 2.0 2.1 3.4 2.0 3.0 1.6 5.2 4.4 4.6 5.5 8.5 8.0 2.5 3.1 8.9 2.7 2.2 3.0 0.0 1.9 0.6 4.5 4.1 5.0 3.7 1.2 4.4 3.7 4.9 2.9 5.3 2.2 1.4 5.5 5.4 7.0 3.5 4.1 5.9 6.6 0.0 2.0 1.7 2.9 4.0 2.9 8.4 5.7 5.5 2.4 6.8 8.1 7.8 2.3 0.9 2.7 9.0 10.2 3.3 8.3 9.1 7.7 12.7 8.6 8.7 8.9 8.4 8.2 8.8 7.7 8.7 9.2 12.0 19.2 25.4 7.8 40.9 10.3 14.3 34.7 10.2 26.9 19.8 18.9 4.7 8.6 16.5 9.2 14.6 14.9 35.2 20.1 27.4 11.1 13.9 6.5 8.9 11.9 12.6 7.8 6.5 12.6 9.4 13.6 12.2 7.8 36.6 10.3 10.4 18.3 19.2 20.2 7.1 13.4 48.8 18.5 36.3 15.6 15.5 18.4 30.2 1.9 27.9 12.3 30.9 4.5 7.7 9.5 22.5 12.4 38.4 12.0 23.6 26.6 12.7 29.3 13.1 15.2 16.7 36.7 16.0 9.3 8.8 29.6 39.1 12.6 10.7 12.7 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 326.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 44.2;U-937: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030947, HPA058709" Enhanced Approved Mitochondria NA NA Mitochondria "HPA030947: AB_10669548, HPA058709: AB_2683797" "unprognostic (2.72e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favorable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 8.0 6.8 12.9 4.1 16.5 7.4 9.8 17.0 19.6 6.1 25.1 27.5 17.5 6.3 3.9 48.4 9.8 3.8 35.2 15.3 13.2 19.3 326.6 5.2 4.0 13.2 12.8 14.9 8.3 7.1 15.7 12.7 0.3 14.3 16.4 20.0 9.4 25.5 4.1 21.7 29.0 28.4 2.3 11.0 8.0 16.8 4.5 14.8 6.1 17.9 23.0 7.2 10.0 14.8 13.1 23.7 2.9 1.2 11.3 1.9 0.1 0.0 2.8 2.2 11.4 6.3 20.5 7.5 0.2 33.0 0.7 0.9 10.3 10.0 5.4 4.2 0.3 0.0 12.0 8.3 7.0 8.3 27.0 12.3 3.4 6.0 4.4 9.4 1.2 2.8 13.7 0.0 8.4 0.2 40.9 20.5 18.8 8.2 44.2 4.2 19.6 4.1 31.5 12.3 9.9 20.1 8.8 8.2 1.1 4.5 0.5 26.3 22.7 0.3 0.7 3.9 0.1 21.6 10.4 20.5 0.3 0.7 75.8 1.5 2.9 1.3 0.6 4.6 0.2 6.4 5.1 5.1 4.2 3.5 4.6 7.6 4.7 0.0 4.5 0.2 3.8 3.7 3.4 12.9 16.5 17.0 19.6 15.3 13.2 13.2 12.8 14.9 14.3 11.0 14.8 13.1 0.4 3.2 9.4 27.7 7.0 9.3 8.5 10.0 16.5 21.3 20.3 14.7 36.7 17.2 13.8 12.9 20.9 2.0 7.1 68.9 52.8 6.6 9.5 34.1 3.6 2.2 27.2 6.7 60.5 5.6 5.1 2.8 17.3 16.5 1.3 6.6 5.0 112.3 8.9 18.5 58.0 43.2 10.2 5.4 8.5 13.9 5.6 3.5 16.0 8.4 1.0 17.5 11.3 27.2 12.5 3.0 36.4 4.1 5.4 6.5 62.8 30.2 48.0 33.6 0.0 2.4 3.7 16.8 4.9 36.3 10.9 1.9 8.5 10.0 68.7 13.1 NPHS1 "CNF, NPHN" ENSG00000161270 "NPHS1 adhesion molecule, nephrin" O60500 19 35825372-35869287 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Myogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 40.3;pancreas: 23.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;JURKAT: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB035555 Enhanced NA NA "CAB035555: " "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" "unprognostic (1.65e-1)" "unprognostic (2.39e-2)" "unprognostic (6.47e-3)" "unprognostic (2.25e-2)" "unprognostic (1.58e-1)" "unprognostic (1.69e-1)" "unprognostic (3.32e-2)" "unprognostic (3.17e-1)" "unprognostic (3.83e-5)" "unprognostic (4.30e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" 0.1 0.0 0.3 0.6 0.8 0.2 0.0 0.7 0.4 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 40.3 0.1 0.0 4.0 0.4 0.3 0.4 0.0 23.0 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.7 0.4 0.7 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.7 0.4 0.4 0.3 0.4 0.3 0.4 0.5 0.1 0.4 0.6 0.3 0.0 0.5 0.0 0.2 0.8 0.8 0.0 0.6 5.0 0.3 0.3 1.0 0.0 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.3 13.5 4.5 0.4 0.7 0.0 0.0 0.7 2.4 0.0 5.1 0.0 12.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 2.1 6.9 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.4 0.5 0.8 0.4 0.1 0.4 0.0 0.3 0.0 0.1 0.3 THAP8 FLJ32891 ENSG00000161277 "THAP domain containing 8" Q8NA92 19 36034984-36054739 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.8;Spermatogonia: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064056, HPA070139" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064056: AB_2685184, HPA070139: AB_2686230" "unprognostic (1.33e-3)" "unprognostic (2.24e-1)" "unprognostic (8.03e-2)" "unprognostic (1.08e-2)" "unprognostic (3.10e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (9.01e-3)" "unprognostic (3.94e-1)" "unprognostic (1.27e-1)" "prognostic favorable (3.19e-4)" "unprognostic (2.50e-1)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.48e-2)" "unprognostic (2.48e-1)" 3.2 3.2 9.1 2.5 9.2 0.9 2.7 9.3 9.7 4.8 6.3 7.2 3.7 4.7 3.4 3.7 3.8 3.5 3.5 8.1 9.0 4.1 4.7 2.8 3.1 9.9 9.5 7.4 3.6 2.8 3.7 3.4 2.8 9.8 3.6 2.4 4.6 3.0 4.3 10.3 5.3 3.5 4.4 9.0 3.5 3.6 9.8 9.4 4.1 3.2 3.3 2.2 6.7 4.0 11.0 3.3 8.2 4.4 3.7 11.6 8.0 2.8 2.7 4.8 5.5 7.8 3.6 2.3 4.5 9.7 4.5 5.7 1.5 2.5 3.3 2.1 3.2 1.6 2.8 3.0 4.3 12.7 1.6 2.7 6.2 5.0 3.8 2.6 6.2 2.6 8.2 2.4 5.3 5.8 5.5 4.1 3.4 3.9 5.6 3.1 3.9 1.4 4.2 4.5 2.9 8.1 6.1 4.6 3.9 3.3 5.7 4.1 2.2 2.3 7.3 4.5 4.5 2.2 5.2 4.5 3.3 8.0 2.6 4.7 7.1 6.5 7.9 5.2 7.6 5.9 4.1 5.5 5.4 4.7 3.0 4.1 6.1 2.7 6.2 6.6 4.5 5.8 4.1 9.1 9.2 9.3 9.7 8.1 9.0 9.9 9.5 7.4 9.8 9.0 9.4 11.0 1.4 3.2 3.7 3.6 3.4 1.1 1.2 3.2 2.8 2.2 3.0 2.4 3.7 5.7 2.9 7.3 2.1 10.2 3.5 2.1 1.9 5.7 3.0 1.5 3.9 2.5 6.6 1.3 2.7 0.5 5.5 3.8 4.1 2.7 5.7 8.8 3.9 3.5 15.8 3.3 3.3 1.3 12.2 4.4 0.8 6.1 1.8 3.2 1.8 1.9 4.4 5.2 8.2 4.5 5.5 2.6 2.7 4.1 2.5 1.2 5.3 11.7 1.2 3.0 0.0 1.7 2.9 18.8 21.5 2.3 2.3 10.5 2.5 5.8 2.2 1.0 COX7A1 "COX7A, COX7AH" ENSG00000161281 "Cytochrome c oxidase subunit 7A1" P24310 19 36150922-36152449 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 17 "heart muscle: 1859.2;skeletal muscle: 7012.9;tongue: 5004.0" "Cell type enriched" "Detected in many" 26 "Cardiomyocytes: 21879.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 162.5;ASC TERT1: 122.3;BJ: 84.7;BJ hTERT+: 102.7;fHDF/TERT166: 178.6;HHSteC: 91.4;HSkMC: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.48e-2)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "unprognostic (6.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (9.93e-2)" "unprognostic (1.92e-1)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (7.84e-3)" "unprognostic (7.27e-3)" "unprognostic (9.44e-2)" "unprognostic (6.23e-2)" "unprognostic (1.54e-2)" 271.6 92.3 190.5 20.6 190.6 2.2 106.8 188.8 258.6 64.4 193.4 93.3 15.0 55.0 39.6 83.0 58.3 32.2 1859.2 199.0 209.6 71.1 12.0 63.9 12.1 191.3 183.4 189.1 46.4 41.0 149.1 106.4 27.6 193.9 87.3 23.9 50.1 88.8 120.2 7012.9 30.2 37.0 85.8 184.1 34.7 47.1 9.8 191.1 86.6 55.2 5004.0 7.4 89.3 50.5 210.6 0.5 5.9 0.6 0.1 162.5 122.3 0.0 84.7 102.7 3.4 0.0 0.0 1.8 1.4 13.0 178.6 0.0 0.7 0.0 0.0 0.8 0.2 1.8 0.4 2.1 0.3 91.4 0.0 0.8 109.0 0.0 0.0 0.0 0.0 11.3 0.0 0.6 0.7 0.0 0.8 0.0 0.7 1.0 0.6 1.2 0.2 0.0 0.4 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.1 20.7 0.0 1.3 0.5 0.4 0.8 1.9 0.7 0.2 0.8 1.2 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 190.5 190.6 188.8 258.6 199.0 209.6 191.3 183.4 189.1 193.9 184.1 191.1 210.6 309.7 0.0 5.1 2.3 2.2 26.4 1.0 28.2 2.8 80.6 25.0 89.4 21879.1 18.6 11.0 22.0 45.9 1.0 1.5 0.0 817.8 13.7 17.0 6.0 124.6 360.4 0.0 5.3 5.9 14.1 0.7 602.1 0.5 3.7 45.0 5.5 259.5 7.3 24.0 67.3 4.3 0.0 26.4 10.7 30.5 90.8 224.6 5.2 284.6 3.7 0.0 31.5 0.0 2.0 2.3 6.2 0.0 281.3 1.5 3.5 0.0 183.1 10.7 84.7 184.1 328.4 463.4 2.0 3.8 4.3 19.0 1.9 4.8 17.3 0.1 0.8 ZNF382 "FLJ14686, KS1" ENSG00000161298 "Zinc finger protein 382" Q96SR6 19 36604817-36634114 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;retina: 18.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.8;Early spermatids: 23.3;Excitatory neurons: 19.1;Horizontal cells: 50.5;Late spermatids: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049259 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049259: AB_2680694" "unprognostic (5.43e-3)" "unprognostic (5.16e-2)" "unprognostic (1.17e-1)" "unprognostic (2.68e-3)" "unprognostic (6.13e-2)" "unprognostic (1.85e-3)" "unprognostic (5.63e-2)" "unprognostic (6.64e-2)" "unprognostic (1.12e-2)" "unprognostic (5.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.07e-3)" "unprognostic (1.76e-5)" "unprognostic (8.71e-2)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" "unprognostic (6.22e-2)" 1.7 2.8 1.7 1.9 4.5 1.0 1.6 11.7 4.6 1.9 0.3 2.1 0.6 2.3 2.0 1.5 2.8 1.5 4.0 3.4 2.8 1.8 0.7 1.3 2.8 0.9 0.5 3.2 2.1 1.3 2.2 5.4 2.3 4.9 1.7 0.8 18.1 1.6 1.4 0.9 0.6 1.7 2.1 0.0 2.9 1.1 3.9 3.2 3.2 2.8 2.7 3.3 1.8 1.0 4.2 0.2 0.1 4.5 6.4 1.8 2.5 1.5 2.0 0.6 5.9 6.0 0.1 0.3 4.0 4.2 2.5 2.5 0.1 5.8 0.1 3.7 11.3 2.6 6.6 0.3 1.6 5.0 0.9 7.6 3.4 0.2 3.3 0.1 5.9 0.7 7.8 0.1 0.2 3.9 0.6 9.3 2.1 2.9 0.0 2.2 0.4 1.9 1.8 1.6 0.1 0.5 8.6 0.3 0.3 3.7 6.5 2.7 0.7 0.1 1.4 0.3 0.3 5.9 9.9 0.8 0.4 0.0 0.1 3.5 2.4 0.5 3.3 5.2 0.6 7.7 9.0 7.7 5.4 2.1 5.3 6.3 7.3 0.9 4.4 0.6 2.2 4.9 2.6 1.7 4.5 11.7 4.6 3.4 2.8 0.9 0.5 3.2 4.9 0.0 3.2 4.2 2.4 3.2 0.0 7.5 3.5 0.1 0.9 0.5 2.2 23.8 1.7 2.0 13.2 1.5 1.0 3.7 10.4 2.0 1.3 0.1 5.9 3.2 23.3 3.5 2.3 2.4 0.0 4.8 19.1 0.4 1.0 1.7 0.5 1.9 0.0 6.8 2.5 0.3 2.9 50.5 16.0 0.1 0.0 0.8 0.8 20.5 0.6 1.2 1.8 1.9 0.7 4.3 0.0 8.0 8.5 0.2 0.3 1.2 0.3 0.4 0.0 1.8 2.6 13.7 0.0 2.6 2.7 6.5 3.0 0.5 0.0 0.1 3.5 2.9 0.0 0.3 LRRC56 "DKFZp761L1518, FLJ00101" ENSG00000161328 "Leucine rich repeat containing 56" Q8IYG6 11 537527-554912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.4;testis: 22.5" "Group enriched" "Detected in many" 6 "Early spermatids: 68.0;Late spermatids: 141.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;Daudi: 1.3;Karpas-707: 2.4;SK-BR-3: 1.6;T-47d: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038728 Approved NA NA "HPA038728: AB_10671864" "unprognostic (2.77e-2)" "unprognostic (9.54e-3)" "unprognostic (1.28e-2)" "prognostic favorable (7.39e-4)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (2.29e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.32e-4)" "unprognostic (1.17e-1)" "unprognostic (7.89e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-3)" 0.7 0.8 0.6 0.1 1.5 0.2 1.6 0.3 0.5 2.0 0.4 1.1 0.1 0.9 1.3 2.7 6.5 0.0 0.4 0.8 0.4 2.6 1.6 2.9 0.0 0.3 0.5 0.4 1.8 2.4 0.0 12.4 0.0 1.1 3.7 0.0 0.1 2.0 0.3 1.2 2.5 2.2 0.0 0.6 2.2 2.1 22.5 0.5 0.1 2.7 0.0 0.2 1.2 2.1 1.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.4 1.1 0.4 0.8 0.0 0.2 0.0 0.0 0.5 0.0 2.4 0.0 0.0 0.1 0.7 0.0 0.7 0.7 0.0 0.0 0.5 0.2 0.0 0.3 0.2 0.0 1.6 0.0 0.0 2.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 1.5 0.3 0.5 0.8 0.4 0.3 0.5 0.4 1.1 0.6 0.5 1.0 0.5 0.0 3.4 3.3 3.0 1.7 1.5 1.5 0.0 1.1 2.1 0.9 0.6 1.5 2.4 3.7 16.7 0.3 0.6 4.9 0.0 1.1 68.0 11.6 0.6 0.5 12.5 0.4 5.2 0.4 0.2 1.1 1.5 1.3 0.0 0.5 1.1 0.3 0.3 6.7 3.8 2.1 6.1 0.6 0.3 141.2 1.2 0.3 1.8 1.0 0.0 2.7 1.0 1.5 2.8 0.5 1.4 1.2 0.1 1.2 0.2 0.8 14.4 7.0 0.0 0.2 0.6 6.6 2.2 0.6 0.9 0.5 1.4 0.7 0.6 0.8 PLXDC1 "TEM3, TEM7" ENSG00000161381 "Plexin domain containing 1" Q8IUK5 17 39063313-39154394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 48.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 299.3;Fibroblasts: 63.8;Sertoli cells: 46.0;Skeletal myocytes: 96.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;MOLT-4: 3.0;U-87 MG: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012805 Approved "Intracellular and membrane" NA NA 17000000 "HPA012805: AB_1857893" "unprognostic (4.28e-1)" "unprognostic (3.55e-1)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "unprognostic (9.50e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-2)" "unprognostic (4.07e-3)" "unprognostic (6.07e-3)" "unprognostic (4.62e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (9.15e-8)" "unprognostic (9.37e-3)" "unprognostic (1.72e-2)" "unprognostic (2.42e-1)" "unprognostic (2.33e-2)" 5.0 2.8 7.4 3.3 7.8 1.1 8.4 10.4 11.7 5.2 5.3 4.7 1.8 12.7 3.8 12.3 11.6 14.4 17.2 6.4 6.5 2.8 0.6 4.2 5.5 7.1 10.5 5.7 15.1 3.5 6.8 2.8 2.2 8.2 5.4 2.9 48.8 4.1 5.2 8.2 4.2 5.3 10.9 5.3 1.9 4.5 5.8 8.7 23.4 3.1 18.6 5.4 4.0 4.6 8.2 0.1 0.0 0.1 1.4 0.2 0.0 0.2 0.1 9.2 0.6 0.4 0.1 2.2 0.1 0.2 0.3 0.0 0.2 0.2 0.1 0.5 0.0 0.7 0.2 0.6 0.1 0.2 0.3 0.1 0.3 0.1 0.4 0.1 0.1 0.0 0.9 0.0 0.6 0.0 1.1 3.0 0.3 0.3 0.1 0.0 0.3 0.4 0.4 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.1 0.2 0.2 0.0 1.1 0.6 0.4 0.2 0.1 0.0 0.1 5.9 0.4 0.1 0.3 0.1 0.1 1.8 0.0 1.5 0.1 0.5 0.6 0.0 0.1 2.1 2.2 0.4 1.1 0.0 0.9 0.0 0.8 7.4 7.8 10.4 11.7 6.4 6.5 7.1 10.5 5.7 8.2 5.3 8.7 8.2 3.4 0.0 14.9 2.9 0.7 5.2 0.9 0.2 2.8 299.3 1.6 1.8 6.9 0.0 1.9 0.0 20.9 0.1 5.4 0.1 0.0 0.0 2.2 0.2 2.4 14.4 0.0 2.7 16.6 0.2 0.1 63.8 2.0 0.3 1.3 0.2 0.4 0.2 0.1 6.7 16.3 0.0 2.0 1.3 6.9 9.1 0.6 7.9 7.2 35.6 5.2 12.2 18.6 3.0 1.4 0.1 0.0 1.2 2.0 0.9 0.0 0.1 1.5 24.2 46.0 96.1 29.3 0.7 0.7 1.2 4.4 0.0 12.1 0.4 0.0 0.5 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins phospholipase 3" Q96FM1 17 39671122-39696797 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "OE19: 800.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 9.7 12.0 17.0 5.6 16.5 5.1 13.0 13.9 19.8 14.5 15.8 17.2 15.1 11.4 18.4 26.0 16.0 13.5 13.8 17.3 16.2 20.8 35.9 12.2 7.5 15.8 15.3 17.2 13.7 27.3 22.8 15.1 11.9 15.3 18.6 13.8 7.2 25.3 11.8 8.4 20.6 17.3 6.1 14.1 12.4 16.7 9.2 15.6 4.8 27.3 4.6 7.6 12.3 13.8 15.9 3.7 9.6 7.7 7.0 7.9 8.1 7.9 4.3 10.1 6.7 6.1 5.4 23.8 4.2 19.7 8.3 2.2 12.6 2.4 2.9 3.1 8.6 7.7 5.2 6.0 9.3 10.6 12.9 12.8 14.9 15.0 3.1 6.8 7.6 2.2 1.9 4.9 9.6 6.1 8.7 2.9 11.7 7.6 800.4 2.1 3.2 4.7 12.1 10.7 12.0 7.1 4.7 11.9 134.0 6.9 0.8 11.4 12.4 3.4 7.2 7.6 3.5 3.3 8.5 2.0 1.4 8.1 4.9 8.1 2.6 7.2 4.6 15.2 11.6 8.3 8.1 10.6 12.5 5.7 7.7 10.1 10.1 2.0 10.4 4.3 3.9 5.4 7.3 17.0 16.5 13.9 19.8 17.3 16.2 15.8 15.3 17.2 15.3 14.1 15.6 15.9 6.5 3.2 14.9 7.8 3.7 3.8 3.3 5.6 3.4 12.6 9.1 7.0 7.7 14.3 10.1 14.7 8.4 8.1 5.3 20.3 1.9 7.6 0.1 3.5 4.5 5.0 8.4 3.0 9.0 11.1 6.5 5.1 9.2 5.7 8.9 6.8 4.6 9.0 4.4 13.5 6.3 15.3 8.2 5.1 2.8 0.1 3.1 3.7 1.8 2.8 1.9 7.5 4.1 9.0 6.1 6.3 13.9 1.5 2.8 3.7 22.9 3.4 4.9 22.1 0.0 5.0 3.3 0.7 2.4 8.1 2.8 10.4 4.9 5.8 13.3 3.1 IKZF3 "Aiolos, ZNFN1A3" ENSG00000161405 "IKAROS family zinc finger 3" Q9UKT9 17 39757718-39864312 "Predicted intracellular proteins, Transcription factors" "B-cell activation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 12.2;lymphoid tissue: 41.3" "Group enriched" "Detected in many" 4 "B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.2;T-cells: 28.8" "Cell line enhanced" "Detected in some" "Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA024377, HPA073266" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024377: AB_1859477, HPA073266: " "unprognostic (5.43e-3)" "prognostic favorable (6.85e-6)" "unprognostic (6.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.36e-2)" "unprognostic (3.14e-3)" "prognostic favorable (5.42e-4)" "unprognostic (8.03e-3)" "unprognostic (1.65e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (9.13e-2)" "unprognostic (2.20e-1)" "unprognostic (5.51e-2)" "unprognostic (1.05e-3)" 1.0 0.8 0.2 19.0 0.3 6.0 1.9 0.6 0.8 1.5 0.9 3.3 3.5 1.0 0.7 1.6 0.7 3.0 0.5 0.7 0.1 0.6 2.0 3.1 36.8 0.5 0.1 0.3 0.7 0.4 0.1 0.2 0.3 0.5 1.0 3.1 0.3 2.2 0.4 0.5 0.9 12.2 0.8 0.1 22.5 6.3 1.6 0.4 23.2 1.0 0.3 41.3 4.5 0.7 0.9 0.2 0.2 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.3 69.0 0.1 0.0 0.1 0.3 0.1 0.2 0.0 15.6 0.3 4.2 0.4 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.1 1.8 35.6 0.0 0.2 6.2 2.4 0.2 3.9 0.1 0.3 0.2 12.7 0.0 4.2 0.4 0.2 1.2 0.5 0.1 0.1 0.2 0.8 0.3 0.3 0.5 0.2 0.1 41.7 50.0 108.1 0.1 0.2 0.1 1.0 0.2 0.8 26.3 0.1 28.8 13.2 11.0 20.3 0.1 11.9 4.5 12.2 1.1 4.5 0.3 0.6 18.9 8.7 0.2 0.3 0.6 0.8 0.7 0.1 0.5 0.1 0.3 0.5 0.1 0.4 0.9 1.1 9.6 21.8 0.3 108.1 0.1 2.2 0.0 0.0 1.7 1.2 0.9 4.0 1.5 5.6 1.8 0.0 0.1 76.5 0.2 0.0 0.1 12.8 1.9 0.9 2.4 0.0 4.0 0.6 0.0 0.4 2.3 3.1 3.9 47.9 0.4 4.2 1.2 0.1 0.0 0.4 0.1 0.0 6.3 0.0 11.8 0.0 4.4 0.0 2.8 3.3 0.2 121.5 0.0 0.1 1.2 0.1 0.0 80.2 1.8 0.0 0.3 0.7 1.7 0.0 4.0 1.2 6.3 2.3 0.6 0.1 0.3 99.9 0.1 0.0 1.6 GRIN2C "GluN2C, NMDAR2C" ENSG00000161509 "Glutamate ionotropic receptor NMDA type subunit 2C" Q14957 17 74842023-74861504 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 53.6;thyroid gland: 16.8" "Cell type enriched" "Detected in some" 6 "Astrocytes: 138.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 14 "cerebellum: 43.2" NA NA "unprognostic (7.21e-3)" "unprognostic (4.68e-2)" "unprognostic (9.38e-3)" "unprognostic (2.24e-5)" "unprognostic (3.42e-1)" "unprognostic (1.53e-2)" "unprognostic (1.84e-1)" "unprognostic (1.82e-2)" "unprognostic (1.78e-1)" "unprognostic (2.95e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-3)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (1.51e-2)" "unprognostic (1.14e-1)" 0.6 2.4 24.4 0.2 23.5 0.6 0.2 53.6 27.2 0.4 7.8 0.5 0.2 0.2 0.2 0.2 0.2 0.2 9.7 21.5 15.2 0.1 0.2 0.1 0.1 29.0 20.6 17.5 0.3 0.2 0.1 0.7 1.8 34.4 0.2 0.1 3.3 10.6 0.2 0.4 0.2 0.4 0.2 12.3 0.2 0.3 3.8 24.6 0.0 16.8 0.2 0.0 0.3 0.3 25.0 0.0 0.2 0.2 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.2 0.0 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 2.3 0.0 0.1 2.8 0.2 1.2 0.1 0.4 0.4 0.4 0.0 0.1 0.2 1.1 0.2 0.1 0.6 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.4 23.5 53.6 27.2 21.5 15.2 29.0 20.6 17.5 34.4 12.3 24.6 25.0 0.5 0.0 0.0 138.7 0.0 0.1 0.1 0.0 0.0 6.9 0.2 0.0 16.6 1.5 0.2 1.8 0.0 0.2 0.7 0.0 0.0 0.1 1.1 0.7 0.4 0.4 0.0 0.0 0.4 0.2 0.2 0.9 0.0 3.4 0.0 21.5 0.7 0.1 12.5 1.7 1.3 0.4 0.0 0.6 0.3 6.5 0.0 0.5 1.8 11.2 0.1 20.7 2.1 4.5 0.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 2.4 0.0 0.9 2.8 5.8 3.4 0.0 0.0 0.7 0.6 8.5 0.1 0.1 FDXR "ADR, ADXR" ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 345.9" "Group enriched" "Detected in many" 7 "Granulosa cells: 329.3;Theca cells: 794.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 89.5;Hep G2: 173.5" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favorable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 3.8 345.9 5.6 2.5 6.4 2.3 3.8 6.5 8.2 6.3 6.7 9.8 4.6 6.8 5.1 26.3 13.0 4.2 5.5 5.3 5.7 6.5 15.1 5.3 2.9 6.0 5.9 5.1 20.6 13.0 6.0 4.1 3.0 6.7 6.7 3.2 0.5 7.2 4.4 7.7 16.1 5.7 2.3 5.9 34.2 7.7 46.0 5.8 4.7 6.0 1.7 2.5 6.3 10.6 6.7 12.5 65.6 9.6 10.8 6.8 9.1 89.5 14.8 15.9 8.6 17.1 18.3 10.8 29.6 2.6 6.2 4.8 24.9 6.9 18.4 2.5 27.9 15.2 22.6 10.6 173.5 19.0 5.0 75.1 29.2 20.3 9.1 3.1 7.0 43.9 10.9 36.1 4.8 13.4 53.4 19.7 10.6 5.5 11.8 14.5 10.6 16.4 16.2 7.1 21.0 5.2 12.1 10.0 21.7 11.2 10.9 47.4 4.7 20.5 5.9 51.9 9.4 7.4 12.7 2.3 6.5 16.1 7.7 20.6 1.7 6.0 5.0 5.6 4.5 5.0 4.8 5.1 6.8 7.3 2.4 4.4 5.4 2.0 10.3 3.4 1.4 15.4 5.2 5.6 6.4 6.5 8.2 5.3 5.7 6.0 5.9 5.1 6.7 5.9 5.8 6.7 4.0 3.2 3.9 7.5 8.2 9.7 17.8 42.6 17.1 4.9 6.6 8.4 3.8 5.7 23.3 9.2 4.2 53.2 2.8 18.6 5.9 11.1 6.5 28.2 4.3 4.6 7.1 4.0 1.4 7.9 18.9 12.9 13.7 3.5 5.7 329.3 12.5 13.9 23.1 3.3 2.2 13.1 36.7 6.2 2.7 14.9 5.9 4.6 5.4 1.0 3.9 11.4 8.2 3.0 1.3 9.0 16.9 4.5 7.1 5.2 24.9 21.7 73.6 5.1 0.0 6.2 18.3 6.3 6.1 33.7 18.2 46.1 8.6 794.1 20.3 17.4 SAP30BP "HCNGP, HTRG, HTRP" ENSG00000161526 "SAP30 binding protein" Q9UHR5 17 75667251-75708062 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042382, HPA052943" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042382: AB_10793881, HPA052943: AB_2681995" "unprognostic (6.92e-2)" "unprognostic (8.56e-3)" "unprognostic (1.20e-1)" "unprognostic (5.34e-3)" "unprognostic (2.95e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.53e-2)" "unprognostic (2.15e-1)" "unprognostic (8.32e-3)" "unprognostic (1.03e-2)" "unprognostic (3.31e-3)" "prognostic unfavorable (1.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.88e-1)" "unprognostic (6.06e-2)" "unprognostic (6.58e-2)" 17.1 13.2 32.8 14.7 32.1 23.4 17.4 31.9 33.8 20.5 36.6 20.2 12.0 17.1 17.3 20.1 17.1 15.4 18.0 31.1 35.0 17.5 19.2 15.3 19.7 34.9 32.5 30.8 17.4 16.3 18.7 17.9 18.1 31.7 20.0 15.3 14.8 23.2 17.3 18.0 17.9 16.2 17.1 32.2 21.3 18.4 14.8 32.5 22.9 16.0 22.4 23.1 19.7 19.2 37.0 28.2 36.9 27.8 26.7 25.6 26.9 31.5 29.2 31.4 53.2 54.8 31.8 23.2 30.2 15.1 27.8 48.8 23.5 33.5 32.0 53.1 10.7 40.1 23.7 26.2 33.2 25.4 25.4 21.5 25.5 28.7 39.9 43.2 30.6 73.5 30.8 29.2 23.0 41.9 29.9 42.0 24.4 23.7 41.7 41.0 27.4 40.4 22.7 44.7 24.7 19.3 31.8 26.4 28.2 33.7 40.7 42.8 22.9 28.7 47.0 30.9 20.9 40.5 17.1 7.1 35.9 31.4 18.8 38.4 18.0 23.1 24.6 24.3 19.8 26.8 21.6 22.0 25.2 19.4 21.7 22.0 22.7 22.8 27.7 23.7 32.0 25.6 22.9 32.8 32.1 31.9 33.8 31.1 35.0 34.9 32.5 30.8 31.7 32.2 32.5 37.0 72.4 54.5 62.7 25.5 54.1 49.5 117.7 65.5 34.1 19.6 34.0 43.2 53.5 30.0 71.1 22.0 12.5 59.5 68.3 71.2 68.4 71.3 47.5 32.8 48.4 63.5 35.9 26.9 15.9 73.2 67.0 55.9 45.9 56.3 77.2 38.9 52.8 34.2 57.5 10.1 14.2 43.8 59.0 35.5 48.1 93.6 44.4 48.0 56.9 10.3 59.7 72.6 55.6 22.6 30.5 103.3 109.2 34.6 57.4 52.0 43.3 47.2 58.0 17.3 65.7 50.9 64.3 34.8 34.3 36.1 45.5 96.0 59.8 31.7 37.2 94.0 ACOX1 PALMCOX ENSG00000161533 "Acyl-CoA oxidase 1" Q15067 17 75941507-75979177 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 193.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 199.8;Hepatocytes: 287.4;Proximal enterocytes: 238.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 77.2;neutrophil: 113.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 113.7" "Cell line enhanced" "Detected in all" "BEWO: 96.9;RT4: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021094, HPA021192, HPA021195, HPA028759" Approved Approved Nucleoli,Peroxisomes NA NA 96000 Peroxisomes Nucleoli "CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352" "unprognostic (7.47e-2)" "unprognostic (3.69e-1)" "unprognostic (1.25e-3)" "unprognostic (1.36e-1)" "unprognostic (7.49e-2)" "unprognostic (8.14e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "prognostic favorable (5.25e-7)" "unprognostic (3.39e-1)" "unprognostic (2.41e-2)" "unprognostic (1.72e-1)" "unprognostic (4.46e-2)" 38.1 18.2 15.8 10.7 17.4 8.9 17.2 16.9 15.6 11.1 19.3 41.2 63.0 9.4 9.8 30.6 10.0 15.1 22.8 13.7 19.2 40.7 193.1 13.7 6.3 15.9 17.5 12.4 9.6 40.1 19.0 12.7 17.4 15.4 18.6 27.4 16.3 15.5 11.9 30.4 25.0 51.9 11.2 16.8 10.5 27.7 9.4 17.6 8.4 17.1 29.4 12.2 19.6 12.9 18.4 16.3 24.5 7.2 9.9 34.0 14.4 96.9 11.8 11.3 12.9 14.8 16.4 24.0 9.1 14.0 17.9 12.5 9.9 28.7 12.4 19.2 10.0 9.5 10.9 13.1 47.2 19.4 9.7 7.8 24.0 9.4 15.7 9.2 13.1 32.3 13.6 12.3 8.9 14.0 45.3 26.3 7.0 4.9 36.8 19.8 13.4 21.3 10.2 20.7 129.1 8.7 12.6 30.6 46.5 11.4 21.2 32.6 11.3 20.9 18.2 13.4 15.2 11.5 14.4 11.0 4.0 10.0 9.7 11.4 77.2 18.3 5.2 6.9 14.2 8.2 5.4 6.6 8.8 10.3 4.5 7.2 7.1 113.7 7.2 9.4 9.4 9.3 8.0 15.8 17.4 16.9 15.6 13.7 19.2 15.9 17.5 12.4 15.4 16.8 17.6 18.4 28.0 28.9 25.0 25.1 10.8 13.5 15.9 26.1 21.1 27.4 19.4 13.5 47.4 51.5 23.4 23.9 22.9 37.7 12.1 199.8 21.5 22.9 11.6 18.1 16.7 18.8 34.4 21.5 17.8 40.6 46.5 19.8 88.7 24.1 17.1 21.4 21.8 287.4 25.4 18.5 18.8 44.5 24.4 35.4 14.1 7.1 29.8 23.7 14.2 15.0 36.3 61.9 9.2 22.1 18.2 34.2 100.0 47.0 18.3 24.0 238.7 107.8 17.4 28.4 0.0 18.4 17.2 5.5 11.0 28.5 30.3 43.2 13.2 17.1 41.9 31.7 PRPSAP1 PAP39 ENSG00000161542 "Phosphoribosyl pyrophosphate synthetase associated protein 1" Q14558 17 76309478-76384521 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062396 Approved Cytosol NA NA 24000 Cytosol "HPA062396: AB_2684750" "unprognostic (1.12e-1)" "unprognostic (3.37e-2)" "prognostic favorable (1.39e-5)" "unprognostic (3.31e-2)" "unprognostic (3.11e-2)" "unprognostic (8.45e-3)" "unprognostic (1.09e-1)" "unprognostic (7.19e-2)" "unprognostic (2.66e-2)" "unprognostic (2.37e-2)" "unprognostic (6.51e-2)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (8.20e-2)" "unprognostic (5.37e-2)" 24.6 26.4 26.0 13.8 26.1 22.4 27.8 27.7 29.5 26.9 25.3 22.9 16.7 22.8 28.3 35.2 22.0 19.0 21.2 24.2 28.1 26.6 70.5 27.7 18.6 30.3 27.9 24.0 21.3 25.3 44.3 22.1 21.1 32.2 20.9 25.8 29.6 66.4 19.1 16.8 24.6 19.6 23.3 26.8 16.1 23.4 35.9 28.3 18.3 49.7 14.0 26.3 19.2 27.4 28.0 38.6 46.4 54.7 26.9 36.3 32.2 21.5 33.9 46.9 55.7 45.9 33.8 32.4 44.2 18.2 50.9 44.4 22.3 49.8 40.5 55.3 17.4 44.7 32.6 36.0 149.2 45.0 28.0 24.8 35.3 32.4 40.1 34.9 54.1 110.4 44.2 40.1 40.3 37.2 41.2 50.9 25.8 13.8 65.7 41.2 41.0 70.9 32.8 42.7 43.8 31.1 51.0 37.4 37.4 77.8 60.9 61.3 32.5 42.3 63.9 46.8 38.2 42.4 27.0 18.2 31.2 28.4 25.5 27.7 18.3 16.4 22.1 16.4 14.5 17.3 17.2 16.4 15.7 14.2 13.6 13.8 13.4 5.3 19.1 14.1 14.1 24.6 13.4 26.0 26.1 27.7 29.5 24.2 28.1 30.3 27.9 24.0 32.2 26.8 28.3 28.0 37.7 0.0 14.2 25.5 18.2 13.0 33.3 42.6 16.5 33.9 34.7 40.6 17.3 38.6 25.0 14.7 35.5 49.4 23.5 21.2 49.0 60.6 32.3 26.2 25.8 43.6 15.7 13.2 29.5 29.6 65.0 21.3 23.9 40.9 20.3 70.3 20.7 38.5 29.9 60.6 52.9 26.0 44.7 18.9 21.3 27.5 29.2 21.9 32.0 15.9 64.2 129.4 18.6 24.6 27.7 38.8 18.7 46.3 16.8 25.1 26.3 27.9 32.5 40.4 59.2 25.7 30.8 118.0 97.7 24.8 14.6 30.6 24.2 19.2 34.3 22.3 CYGB "HGB, STAP" ENSG00000161544 Cytoglobin Q8WWM9 17 76527356-76551175 "Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017757, HPA061642" Approved Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA017757: AB_1847410, HPA061642: AB_2684573" "unprognostic (6.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.97e-2)" "prognostic favorable (2.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.36e-2)" "unprognostic (3.31e-3)" "unprognostic (2.01e-1)" "unprognostic (7.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.34e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (7.76e-2)" 73.8 21.0 8.5 12.1 9.0 1.7 55.6 18.9 21.3 27.4 10.6 26.6 21.3 19.7 4.6 12.9 20.6 13.3 85.6 7.3 12.8 12.5 19.1 28.0 7.2 15.4 23.7 9.2 13.9 12.9 11.8 11.0 8.9 26.0 30.1 9.4 78.3 14.3 11.1 19.5 17.0 26.8 6.0 8.2 12.3 23.1 5.3 12.7 5.4 50.5 9.7 2.6 51.2 25.8 24.3 0.2 1.1 1.8 0.4 79.6 23.1 26.1 0.7 2.0 0.3 0.9 0.0 0.3 0.2 24.1 2.4 0.3 0.7 0.1 33.7 0.1 0.1 0.2 0.4 0.4 61.7 120.7 0.0 0.0 95.4 7.2 2.5 2.5 0.4 0.3 0.8 0.3 0.1 1.2 0.8 0.2 0.4 0.3 0.0 1.4 0.5 0.3 0.2 0.4 0.1 0.6 129.8 0.1 0.0 2.7 5.9 0.2 0.6 0.2 3.1 1.6 0.3 0.0 1.2 0.3 0.3 0.2 0.3 9.9 0.0 0.1 0.1 0.2 0.1 0.1 1.6 0.1 0.0 0.1 2.2 0.2 0.5 0.9 1.0 0.0 0.0 0.2 0.2 8.5 9.0 18.9 21.3 7.3 12.8 15.4 23.7 9.2 26.0 8.2 12.7 24.3 94.3 3.2 2.0 2.0 3.5 10.8 1.3 17.3 3.4 38.5 1.4 5.7 6.1 0.0 6.7 0.0 0.0 1.4 1.9 0.1 0.0 0.8 0.7 2.9 4.2 23.1 0.0 0.0 2.4 0.2 0.6 87.6 1.5 0.7 0.0 0.2 2.2 1.2 0.4 8.4 12.3 0.0 0.0 0.0 13.3 2.5 95.7 2.6 78.2 3.7 0.0 22.1 0.0 1.0 1.0 0.1 0.0 23.3 0.6 0.8 0.0 0.2 21.1 12.9 92.1 21.8 95.6 1.6 1.4 0.7 6.7 2.9 2.6 9.2 0.0 1.0 SRSF2 "PR264, SC-35, SC35, SFRS2, SFRS2A" ENSG00000161547 "Serine and arginine rich splicing factor 2" Q01130 17 76734115-76737333 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049905 Supported Approved Nucleoplasm,Cytosol NA NA 180000 Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.50e-1)" "unprognostic (2.16e-3)" "unprognostic (2.73e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.53e-8)" "unprognostic (1.19e-1)" "unprognostic (7.79e-3)" "unprognostic (7.03e-3)" "unprognostic (1.92e-1)" "unprognostic (1.07e-3)" "prognostic unfavorable (1.05e-7)" "unprognostic (3.85e-2)" "unprognostic (8.05e-2)" "unprognostic (1.95e-1)" "prognostic favorable (9.87e-4)" 96.3 107.7 28.0 96.4 29.2 186.2 92.9 29.6 33.3 83.7 33.9 92.4 87.0 89.6 64.5 130.6 90.3 42.4 77.2 28.6 36.8 83.5 116.1 96.2 112.5 31.0 30.1 26.0 86.3 89.0 48.8 82.6 66.5 29.5 78.7 72.3 53.8 91.3 52.8 92.5 87.0 114.2 49.4 30.7 122.6 95.2 49.9 30.5 95.1 102.9 36.3 101.0 80.8 95.1 34.4 318.7 239.8 289.5 207.5 70.9 58.5 300.5 197.3 146.8 225.4 207.0 257.2 216.8 478.0 143.3 188.7 164.3 279.9 293.3 229.0 230.2 202.3 489.3 357.9 246.6 311.9 79.3 404.4 210.6 65.2 51.1 186.2 54.0 91.1 179.9 212.0 373.4 209.6 183.7 251.0 460.0 440.9 339.5 186.4 340.2 455.0 310.6 360.5 156.5 225.2 247.7 350.8 227.1 196.3 120.4 154.0 238.8 301.6 187.9 206.9 271.3 139.4 330.0 278.2 219.2 552.9 187.3 318.9 177.1 2.5 40.9 10.0 26.0 53.3 26.0 23.5 17.7 26.7 67.0 19.6 20.1 19.4 4.4 35.6 33.6 49.2 24.0 33.0 28.0 29.2 29.6 33.3 28.6 36.8 31.0 30.1 26.0 29.5 30.7 30.5 34.4 271.3 118.6 105.6 57.5 396.7 460.8 439.7 205.9 540.1 151.9 291.7 277.9 86.2 148.7 141.5 88.3 91.8 339.4 548.0 233.1 156.5 199.1 203.6 176.8 181.9 204.3 266.3 366.6 51.1 157.3 579.7 233.9 196.7 257.4 218.4 241.7 116.7 125.1 251.3 99.3 55.4 246.9 132.2 143.7 480.4 162.0 159.1 273.5 282.8 63.7 226.9 153.3 196.7 55.8 87.9 189.0 288.7 127.5 492.0 384.8 250.5 128.7 97.4 188.9 118.3 286.8 242.1 272.3 296.8 489.5 443.4 316.0 469.1 185.4 329.4 459.4 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041499: AB_2677516, HPA046761: AB_2679791" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favorable (2.03e-4)" 9.2 7.3 11.2 5.5 14.0 4.2 12.3 13.5 13.3 12.6 7.0 12.3 4.6 11.8 7.2 6.8 12.9 8.1 11.1 10.6 11.5 13.7 6.8 8.0 5.5 12.6 11.6 8.5 27.3 8.9 15.0 8.5 9.4 14.2 18.5 6.6 17.0 12.1 11.4 7.2 20.8 9.1 7.2 10.2 12.8 9.0 18.9 12.8 7.8 18.8 9.1 5.7 11.2 9.4 20.5 1.6 0.1 7.8 9.5 13.1 14.1 0.0 9.3 3.4 3.5 7.1 1.0 1.3 1.6 0.9 4.3 5.2 2.5 3.1 1.9 1.9 0.0 9.0 15.6 0.2 1.4 10.2 3.4 5.1 11.1 5.8 5.2 1.5 10.9 1.8 0.0 3.5 0.1 4.5 0.0 9.7 4.4 9.0 0.0 0.2 4.2 3.9 2.9 5.8 3.4 3.2 1.6 2.3 1.1 8.0 7.9 1.6 3.7 1.2 6.4 8.8 1.8 3.4 6.3 0.0 2.0 1.7 0.6 10.6 4.4 1.6 3.7 0.9 2.5 2.7 7.2 1.8 2.2 1.8 3.5 2.2 1.4 0.6 3.3 2.0 2.0 0.9 1.1 11.2 14.0 13.5 13.3 10.6 11.5 12.6 11.6 8.5 14.2 10.2 12.8 20.5 8.8 0.0 2.6 14.4 4.0 4.5 3.7 4.0 2.2 12.2 8.1 7.9 8.5 4.3 3.0 18.4 10.4 7.2 4.8 2.7 39.2 4.3 56.3 7.2 7.4 6.6 3.0 2.1 20.1 1.1 5.4 6.3 4.1 5.6 5.1 9.8 7.1 1.8 5.7 6.7 19.3 4.7 2.0 2.2 3.7 60.6 8.1 6.7 0.0 9.4 4.0 15.2 1.0 26.2 50.1 1.2 1.9 12.8 0.9 5.9 5.1 4.9 3.0 9.9 0.0 6.9 7.6 12.3 14.0 4.2 5.3 4.5 2.5 4.2 4.4 3.0 TMEM143 FLJ10922 ENSG00000161558 "Transmembrane protein 143" Q96AN5 19 48332356-48364059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4;tongue: 61.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014476, HPA058645" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA014476: AB_1858092, HPA058645: " "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (5.23e-2)" "unprognostic (2.50e-1)" "unprognostic (5.94e-2)" "unprognostic (2.11e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (4.08e-1)" "unprognostic (2.25e-1)" "unprognostic (7.29e-2)" "unprognostic (9.82e-2)" "prognostic favorable (1.53e-7)" "unprognostic (5.46e-2)" "unprognostic (1.24e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-1)" 6.5 9.1 5.2 2.6 5.8 2.7 5.2 5.5 6.8 4.7 4.2 6.7 4.5 4.3 2.6 4.6 4.6 3.2 33.7 5.3 5.4 10.4 18.2 4.4 3.8 5.6 5.6 5.5 4.7 5.8 3.8 5.1 2.7 6.1 5.3 2.7 3.3 5.7 2.6 96.4 5.8 6.8 2.2 4.7 7.8 6.8 4.2 5.8 6.3 6.4 61.8 2.4 6.2 4.4 5.9 4.6 7.4 2.3 4.2 4.5 6.3 4.7 4.2 2.5 2.9 3.7 6.3 5.9 8.6 7.5 2.8 1.4 5.2 2.3 3.0 1.6 10.6 5.2 5.2 6.3 10.1 3.6 4.1 4.8 5.8 3.7 1.5 3.7 3.3 2.4 12.9 3.8 12.5 3.1 2.6 5.9 14.8 2.9 8.7 2.5 8.6 1.4 14.2 3.9 3.4 8.6 8.5 2.5 3.1 2.1 2.6 4.4 2.9 2.9 3.5 3.9 2.6 1.6 24.3 8.2 6.5 2.9 5.4 2.8 1.9 1.2 1.4 2.2 0.7 2.7 2.1 1.7 2.1 1.5 1.5 2.6 1.5 1.0 3.4 1.2 0.6 1.3 1.3 5.2 5.8 5.5 6.8 5.3 5.4 5.6 5.6 5.5 6.1 4.7 5.8 5.9 2.3 3.2 1.1 8.1 3.7 0.3 3.0 3.4 2.8 3.3 3.2 1.8 27.0 0.0 2.0 1.8 8.4 9.5 2.8 3.7 13.7 3.5 0.7 2.0 1.4 2.2 3.0 4.8 9.8 2.4 6.1 3.3 5.6 1.3 1.3 4.6 1.4 7.5 5.5 0.0 8.7 4.4 4.1 2.1 1.0 1.3 2.5 2.6 8.8 6.5 2.5 3.9 2.1 5.5 9.9 1.2 7.1 1.2 7.6 0.9 8.5 14.6 5.3 6.7 0.0 2.5 3.1 8.7 5.5 3.1 1.0 3.7 3.6 3.4 4.3 1.2 KLHL10 FLJ32662 ENSG00000161594 "Kelch like family member 10" Q6JEL2 17 41835685-41848384 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 57.8" "Group enriched" "Detected in some" 21 "Early spermatids: 363.3;Late spermatids: 532.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067538 Enhanced NA NA "HPA067538: AB_2685859" "unprognostic (3.46e-4)" "unprognostic (1.95e-1)" "unprognostic (3.23e-1)" "unprognostic (1.52e-1)" "unprognostic (5.18e-3)" "unprognostic (1.22e-2)" "unprognostic (3.20e-1)" "unprognostic (5.08e-3)" "unprognostic (1.90e-1)" "unprognostic (3.82e-2)" "unprognostic (4.07e-2)" "unprognostic (8.58e-2)" "unprognostic (1.35e-3)" "unprognostic (1.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.96e-1)" "unprognostic (5.17e-2)" 0.5 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.5 0.2 0.0 0.6 0.1 0.4 1.5 0.5 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.1 0.3 0.7 0.0 0.1 0.4 57.8 0.1 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 363.3 0.1 0.4 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 532.8 3.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 6.0 0.1 0.1 0.0 0.1 0.0 2.6 0.0 0.2 0.2 21.1 2.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 KASH5 "CCDC155, FLJ32658" ENSG00000161609 "KASH domain containing 5" Q8N6L0 19 49388219-49417990 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 54.9" "Cell type enriched" "Detected in single" 18 "Cardiomyocytes: 1.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 7 "cerebellum: 3.8;pons: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.3;U-266/70: 3.6;U-698: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA019937, HPA019940" Enhanced NA NA "HPA019937: AB_1848877, HPA019940: AB_1848879" "unprognostic (1.31e-1)" "unprognostic (4.23e-2)" "unprognostic (2.28e-2)" "unprognostic (1.09e-2)" "unprognostic (3.99e-1)" "unprognostic (1.79e-1)" "unprognostic (6.41e-2)" "unprognostic (5.31e-2)" "unprognostic (8.96e-2)" "unprognostic (1.84e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-1)" "unprognostic (7.11e-9)" "unprognostic (6.50e-2)" "unprognostic (4.18e-1)" "unprognostic (3.08e-3)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.7 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.6 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.1 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HCRT "OX, PPOX" ENSG00000161610 "Hypocretin neuropeptide precursor" O43612 17 42184060-42185452 "Disease related genes, Human disease related genes, Predicted secreted proteins" Neuropeptide "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1460 "brain: 352.2" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Enteroendocrine cells: 3.0;Kupffer cells: 1.6;Oligodendrocyte precursor cells: 2.0;Proximal enterocytes: 1.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in many" 6 "amygdala: 104.6;hypothalamus: 352.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "hypothalamus: 93.5" "Region enriched" "Detected in some" 21 "hypothalamus: 25.3" "HPA064801, CAB079778" Enhanced Supported "Secreted to blood" NA NA "CAB079778: , HPA064801: " "unprognostic (3.34e-2)" "unprognostic (7.76e-5)" "unprognostic (3.21e-2)" "unprognostic (3.01e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 0.1 0.0 104.6 0.1 1.2 0.1 0.0 0.5 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 352.2 0.0 0.0 0.0 0.0 0.5 2.8 0.3 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.1 0.5 0.3 0.2 0.3 0.1 0.6 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.0 104.6 1.2 0.5 1.2 0.3 352.2 0.5 2.8 0.3 2.7 0.1 40.2 0.6 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 1.8 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.5 0.1 0.1 3.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.7 0.2 0.6 0.0 0.4 0.8 0.0 1.6 1.0 0.2 0.0 0.3 0.0 1.0 0.8 0.1 0.0 2.0 0.3 0.4 0.1 0.0 0.4 0.0 1.6 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.9 0.1 0.9 0.1 ALDH16A1 MGC10204 ENSG00000161618 "Aldehyde dehydrogenase 16 family member A1" Q8IZ83 19 49453225-49471050 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059488 Approved NA NA 600000 "HPA059488: AB_2684037" "unprognostic (2.39e-1)" "unprognostic (3.95e-3)" "unprognostic (7.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-3)" "unprognostic (5.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.92e-2)" "unprognostic (4.90e-1)" "unprognostic (1.19e-3)" "unprognostic (4.28e-2)" "unprognostic (1.91e-3)" "unprognostic (2.94e-2)" "unprognostic (4.19e-1)" "unprognostic (1.27e-1)" "unprognostic (5.23e-3)" 16.3 14.2 2.7 9.7 3.3 10.0 14.6 3.4 3.8 17.3 3.9 12.4 14.0 16.0 0.8 15.6 13.1 3.5 7.9 2.7 3.7 13.6 17.2 11.8 10.5 4.3 3.7 2.6 11.4 18.8 3.9 7.6 5.0 3.6 10.4 2.3 1.0 10.8 4.9 7.0 15.9 19.3 3.2 3.7 28.5 14.2 5.3 3.7 5.0 12.5 1.8 4.9 13.0 13.9 3.9 24.6 32.7 7.8 18.4 3.5 2.3 26.3 15.5 4.9 11.8 12.1 17.1 9.3 36.8 24.9 2.1 2.8 16.7 3.1 8.9 1.5 23.3 19.0 28.7 13.1 24.6 5.1 17.6 61.3 4.3 5.0 5.7 4.6 2.4 7.7 12.5 20.7 37.3 3.1 24.8 12.8 51.9 17.1 10.6 0.0 21.8 11.1 28.1 5.7 28.7 14.1 16.1 13.9 15.4 13.4 1.9 14.0 20.3 17.4 17.4 11.3 8.0 17.4 31.4 38.2 10.7 4.3 24.9 12.6 11.2 10.9 18.6 9.3 26.0 9.8 17.1 9.1 10.1 16.4 17.1 8.4 8.8 1.8 8.6 29.8 17.4 7.9 8.1 2.7 3.3 3.4 3.8 2.7 3.7 4.3 3.7 2.6 3.6 3.7 3.7 3.9 22.3 6.4 11.5 1.0 27.2 9.9 28.6 19.2 21.1 9.2 10.8 8.6 4.0 12.8 15.5 11.0 8.4 33.7 19.5 27.6 5.9 22.0 1.5 6.3 6.3 16.9 13.1 20.0 1.3 24.5 28.7 16.3 21.4 8.0 17.2 12.9 15.4 17.4 46.2 1.7 1.2 16.6 20.3 29.9 14.7 2.9 28.0 20.2 16.0 3.7 31.4 6.4 15.5 1.5 4.2 14.0 26.0 8.2 17.6 9.1 43.8 22.9 24.3 7.0 19.7 7.2 15.8 3.6 13.1 19.7 10.5 40.4 13.8 27.6 23.7 28.3 DCD "AIDD, DCD-1, DSEP, HCAP, PIF" ENSG00000161634 Dermcidin P81605 12 54644589-54648493 "Plasma proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 2047.6" "Cell type enriched" "Detected in some" 355 "Melanocytes: 8167.8" "Cancer enriched" "Detected in some" 9 "breast cancer: 91.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" HPA063967 Enhanced "Secreted in other tissues" NA NA 410000000 "HPA063967: AB_2685163" "unprognostic (3.55e-2)" "unprognostic (1.61e-1)" 56.1 0.4 3.3 0.3 3.1 1.1 358.3 3.2 5.4 0.3 3.6 0.7 0.2 0.7 0.9 0.5 0.2 0.8 1.2 3.3 3.0 0.2 1.0 0.6 0.2 3.0 3.3 3.1 0.4 1.1 0.0 0.5 0.1 3.3 0.4 0.2 0.5 0.5 0.1 14.1 2047.6 0.7 0.1 2.9 0.4 0.7 1.1 2.9 0.3 0.5 0.0 0.2 0.2 0.7 3.9 0.2 0.3 0.4 0.4 0.3 0.4 0.4 0.5 0.1 0.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.4 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.2 0.1 0.3 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 1.9 0.4 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.2 0.4 0.5 0.5 1.1 0.9 0.7 0.5 0.6 0.2 3.3 3.1 3.2 5.4 3.3 3.0 3.0 3.3 3.1 3.3 2.9 2.9 3.9 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.0 8167.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.4 0.2 0.0 23.0 0.0 1.0 0.0 0.0 0.0 ITGA5 "CD49e, FNRA" ENSG00000161638 "Integrin subunit alpha 5" P08648 12 54395261-54419266 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 365.4;urinary bladder: 389.8" "Cell type enhanced" "Detected in many" "Endothelial cells: 101.5;Extravillous trophoblasts: 391.9;Hepatic stellate cells: 88.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 89.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 615.4;HUVEC TERT2: 1360.8;TIME: 1277.7;U-87 MG: 623.6" "Region enriched" "Detected in many" 5 "basal ganglia: 10.4" "Low region specificity" "Detected in many" "HPA002642, CAB009008" Enhanced NA NA 26000000 "CAB009008: AB_647474, HPA002642: AB_1078469" "unprognostic (7.51e-3)" "prognostic unfavorable (4.07e-6)" "prognostic unfavorable (8.43e-4)" "unprognostic (1.58e-1)" "unprognostic (8.51e-3)" "prognostic unfavorable (2.91e-4)" "prognostic unfavorable (2.23e-5)" "prognostic unfavorable (2.44e-4)" "unprognostic (2.76e-2)" "unprognostic (6.19e-2)" "unprognostic (8.99e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.11e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (8.89e-4)" "unprognostic (2.18e-3)" 104.4 47.5 9.3 137.4 9.1 46.8 69.7 9.0 12.9 64.3 13.1 280.6 15.5 107.0 5.0 73.0 71.8 51.3 107.8 8.2 13.9 23.5 49.0 122.7 17.6 11.0 9.5 6.5 39.6 21.1 15.0 10.5 92.3 9.9 143.1 41.0 1.3 24.7 116.0 29.3 43.3 88.4 365.4 10.1 16.5 91.6 4.1 14.3 13.3 40.8 25.9 12.6 389.8 77.6 12.4 65.4 23.9 43.6 0.6 130.8 278.7 113.5 286.0 308.2 300.9 220.6 17.1 15.3 0.5 206.9 308.5 149.1 10.1 12.5 81.4 197.4 0.4 12.2 28.1 31.3 1.1 179.5 88.7 44.4 206.8 39.2 351.9 258.3 615.4 1360.8 15.6 25.6 0.8 165.4 6.4 13.7 99.2 18.1 4.2 19.1 13.7 29.2 6.2 46.9 1.1 0.1 0.6 57.7 4.3 2.2 93.8 7.1 79.9 1277.7 353.0 62.3 85.9 121.5 0.3 3.6 0.7 623.6 83.0 118.5 16.4 64.9 0.5 14.2 27.3 11.2 0.1 10.9 10.9 62.6 0.3 7.7 6.6 89.1 26.4 24.0 3.4 4.9 42.9 9.3 9.1 9.0 12.9 8.2 13.9 11.0 9.5 6.5 9.9 10.1 14.3 12.4 58.3 3.2 4.4 1.6 2.7 14.3 3.4 11.3 4.0 1.1 6.1 2.8 16.3 14.3 4.9 0.0 0.0 5.4 19.6 0.0 0.0 34.0 0.3 1.7 32.1 101.5 0.0 3.4 1.4 3.4 391.9 45.0 0.5 3.0 19.7 5.1 88.9 27.1 28.4 0.0 1.2 0.0 2.0 22.8 58.5 0.5 6.5 38.5 10.6 14.0 24.6 0.0 21.6 0.0 0.2 8.8 0.0 4.5 8.7 3.6 0.0 0.2 1.8 1.1 13.1 11.1 30.7 0.2 0.7 1.3 10.7 34.6 14.3 2.4 0.0 2.0 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 23.3;ovary: 66.1" "Group enriched" "Detected in some" 7 "Granulosa cells: 196.9;Theca cells: 192.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "eosinophil: 1.4;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 6 "granulocytes: 1.4;monocytes: 1.3" "Cell line enriched" "Detected in single" 16 "HEL: 10.1" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 1.1 7.4 0.6 1.8 0.6 0.4 0.4 0.4 0.6 0.3 0.6 0.5 0.8 0.3 0.2 0.2 0.9 0.3 0.4 0.4 0.8 0.3 1.8 1.8 0.6 1.0 0.8 0.1 66.1 2.7 0.1 0.2 1.8 1.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 1.0 1.2 1.2 23.3 4.7 1.6 0.9 0.1 0.2 0.1 0.0 0.6 0.2 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 10.1 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.3 1.4 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 1.3 0.1 0.0 0.1 0.6 0.6 0.4 0.6 0.4 0.8 1.0 0.8 0.1 1.3 1.2 0.9 1.2 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 19.6 0.0 0.6 0.2 0.3 1.0 0.0 0.0 0.0 1.1 0.1 4.3 0.0 0.3 0.0 196.9 5.3 0.6 7.9 0.0 0.0 0.0 0.0 26.8 0.2 0.1 0.0 6.1 0.0 5.6 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.2 7.5 1.7 0.7 0.0 0.1 0.1 0.2 192.3 0.0 0.0 ZNF385A "DKFZp586G1122, Hzf, ZFP385, ZNF385" ENSG00000161642 "Zinc finger protein 385A" Q96PM9 12 54369133-54391298 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation, Translation regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 252.8;skin 1: 155.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 212.8;Cone photoreceptor cells: 171.0;Horizontal cells: 144.7;Muller glia cells: 142.6;Rod photoreceptor cells: 209.7;Syncytiotrophoblasts: 108.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "classical monocyte: 29.2;intermediate monocyte: 32.8;myeloid DC: 31.9;non-classical monocyte: 25.7" "Group enriched" "Detected in many" 11 "dendritic cells: 31.9;monocytes: 32.8" "Cell line enhanced" "Detected in many" "HaCaT: 89.5;HBEC3-KT: 85.7;HEL: 109.5;hTCEpi: 94.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039799 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039799: AB_10795117" "unprognostic (8.56e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (6.70e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-3)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.75e-5)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (2.43e-1)" "unprognostic (6.07e-3)" 43.7 10.2 69.8 28.9 70.8 33.1 22.4 91.4 87.0 19.7 44.3 13.7 7.2 7.6 16.8 100.3 9.8 14.3 13.3 51.5 75.8 7.1 6.5 19.3 15.5 96.6 91.1 39.5 5.4 3.3 26.9 26.9 19.5 94.7 35.2 8.1 252.8 28.3 15.2 22.1 155.9 15.9 14.4 76.5 25.0 10.5 2.5 139.5 12.2 41.1 23.5 20.5 39.1 56.2 75.1 2.5 10.7 15.9 20.0 17.9 12.0 43.6 2.1 8.1 8.3 7.1 21.8 7.8 5.9 7.2 4.4 6.7 89.5 6.1 85.7 2.8 5.8 8.5 109.5 6.6 4.3 8.0 1.6 73.4 10.7 94.8 9.3 23.5 20.3 5.2 15.0 53.6 0.5 3.8 49.9 5.4 15.9 9.2 10.1 8.3 19.5 1.3 21.7 6.5 71.0 7.0 31.6 0.8 59.7 4.5 18.3 71.0 45.5 5.3 4.4 10.2 5.4 5.6 1.7 0.5 5.3 18.6 5.0 11.8 3.0 29.2 0.0 0.0 32.8 0.0 1.3 0.0 0.0 31.9 1.3 0.0 0.4 2.2 0.1 25.7 3.0 0.1 16.5 69.8 70.8 91.4 87.0 51.5 75.8 96.6 91.1 39.5 94.7 76.5 139.5 75.1 8.3 0.0 0.0 12.1 7.3 36.2 21.3 76.5 49.5 212.8 16.7 13.8 3.2 1.5 20.4 9.2 171.0 63.9 2.5 0.2 9.8 3.4 0.5 13.3 9.8 8.8 4.8 9.2 5.4 0.6 9.4 29.6 3.6 2.2 1.3 4.8 4.6 1.3 56.4 144.7 13.5 0.1 12.2 71.6 54.7 0.5 14.9 78.0 8.8 6.5 49.4 142.6 3.1 3.5 0.9 1.8 0.1 9.1 2.0 13.1 0.0 2.8 12.1 209.7 0.0 4.0 12.3 2.6 3.6 68.3 66.1 108.9 2.2 0.2 0.1 29.7 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 10.0;heart muscle: 10.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.2;Early spermatids: 38.4;Late spermatids: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 1.4 0.6 2.6 0.3 1.7 0.0 1.4 10.0 2.2 1.2 2.6 0.8 0.4 0.7 1.8 1.1 1.1 0.7 10.9 2.1 3.2 1.0 0.3 2.2 0.2 4.1 2.4 1.8 0.6 2.2 0.3 1.8 0.4 4.5 1.6 0.3 0.9 0.5 0.9 0.2 1.0 0.5 0.6 1.7 1.2 1.0 0.8 3.1 0.0 0.7 0.1 0.2 0.8 1.1 3.6 0.5 1.4 0.5 0.6 0.9 1.2 0.0 1.1 0.4 1.1 0.4 0.9 0.8 0.0 0.3 0.8 0.7 0.5 1.1 1.1 1.6 0.0 1.3 0.2 3.3 0.7 0.1 0.0 0.0 0.7 2.3 1.5 2.1 1.4 0.3 0.0 0.5 0.0 0.6 1.1 0.0 0.0 0.6 0.5 1.1 0.0 0.9 0.0 1.8 0.0 4.8 1.1 0.7 1.5 0.3 0.8 2.6 1.1 1.0 1.2 1.9 0.5 1.4 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.7 10.0 2.2 2.1 3.2 4.1 2.4 1.8 4.5 1.7 3.1 3.6 12.1 12.8 4.1 3.9 0.0 4.0 8.3 2.7 5.7 2.7 3.2 4.8 29.2 7.2 5.4 1.8 0.0 0.1 0.0 1.2 0.0 3.9 38.4 0.8 1.9 5.3 1.2 0.8 3.6 1.4 0.6 3.3 12.8 1.9 1.3 1.1 3.6 0.7 1.1 10.1 5.4 1.2 0.0 0.0 3.9 76.0 3.7 1.1 1.8 1.0 1.9 0.8 0.0 3.5 10.0 2.9 3.4 2.6 0.0 8.1 0.4 0.3 0.8 1.7 6.6 0.8 2.9 0.8 2.6 4.7 2.7 0.1 0.5 0.3 2.3 3.2 CD300LG "CLM9, Trem4" ENSG00000161649 "CD300 molecule like family member g" Q6UXG3 17 43847148-43863639 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 134.8;breast: 112.8;placenta: 59.1" "Cell type enriched" "Detected in some" 11 "Adipocytes: 567.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 1400000 "unprognostic (2.38e-2)" "unprognostic (2.06e-3)" "unprognostic (2.63e-1)" "unprognostic (2.72e-1)" "unprognostic (3.18e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (2.01e-2)" "unprognostic (4.08e-3)" "unprognostic (8.69e-4)" "unprognostic (2.12e-5)" "unprognostic (1.30e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-2)" "unprognostic (1.57e-1)" 134.8 2.5 0.2 1.5 0.2 0.2 112.8 0.2 0.2 3.6 0.0 2.4 0.1 4.2 12.8 1.9 4.4 4.6 27.4 0.1 0.1 2.1 1.2 11.4 1.8 0.3 0.2 0.0 1.9 2.1 1.1 0.2 59.1 0.3 1.7 0.5 0.0 1.9 2.1 22.3 7.5 2.3 1.1 0.1 2.8 3.1 20.1 0.1 3.5 3.1 47.6 0.2 2.6 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.1 0.1 567.9 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.6 0.0 1.8 2.3 3.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 50.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.3 1.6 13.1 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.9 0.3 0.0 0.0 0.0 0.7 0.0 13.1 2.3 2.9 0.3 0.7 0.1 0.4 0.0 0.3 0.2 0.0 0.0 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 242 "testis: 65.1" "Group enriched" "Detected in some" 41 "Early spermatids: 730.7;Late spermatids: 355.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain NA NA "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 65.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.2 0.3 0.8 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 730.7 0.1 0.1 0.4 3.6 0.0 1.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.4 0.0 0.1 0.0 0.5 1.0 0.0 0.0 0.3 355.2 4.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 3.4 0.0 0.8 0.0 0.1 0.1 0.3 13.1 1.3 0.3 7.0 5.5 0.0 0.4 0.0 0.2 0.0 0.4 1.4 NAGS "AGAS, ARGA, NAT7" ENSG00000161653 "N-acetylglutamate synthase" Q8N159 17 44004622-44009068 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Urea cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 16.0;liver: 48.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 21.7;Proximal enterocytes: 44.2;Proximal tubular cells: 20.7;Spermatocytes: 16.0" "Cancer enhanced" "Detected in all" "liver cancer: 12.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;HHSteC: 5.2;TIME: 7.1;U-87 MG: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA027300 Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA027300: AB_2672207" "unprognostic (1.51e-3)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (8.67e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.38e-2)" "unprognostic (1.98e-1)" "unprognostic (3.14e-2)" "unprognostic (2.73e-2)" "unprognostic (2.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.19e-2)" "unprognostic (6.99e-2)" "unprognostic (1.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" 0.7 0.7 1.9 0.5 1.2 0.0 1.4 0.9 2.0 0.7 0.0 1.4 16.0 0.8 1.8 1.5 0.7 0.4 0.7 0.9 2.6 4.8 48.6 1.9 0.3 2.0 1.2 0.6 0.6 0.3 3.3 0.5 0.1 1.8 1.2 0.5 0.0 1.0 1.4 0.2 0.9 13.7 0.1 1.0 0.4 0.4 0.6 2.8 0.1 4.5 0.2 0.1 0.4 1.0 1.7 2.9 0.1 0.0 0.4 0.0 5.5 0.1 0.5 0.1 0.1 0.2 1.7 0.7 0.0 1.1 0.0 0.1 1.3 0.1 1.5 0.3 0.2 0.7 0.1 0.2 2.2 5.2 0.0 0.0 3.2 0.0 0.7 0.0 0.6 1.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.7 0.0 0.3 0.0 0.1 0.0 2.1 0.0 0.9 0.0 0.0 0.2 0.2 0.0 7.1 2.5 0.7 0.2 0.6 0.1 0.1 0.1 10.0 0.0 0.3 0.8 0.5 0.7 0.9 0.4 0.7 0.3 0.6 0.8 0.5 0.3 0.3 0.4 0.3 0.2 0.8 0.1 0.5 0.3 1.9 1.2 0.9 2.0 0.9 2.6 2.0 1.2 0.6 1.8 1.0 2.8 1.7 1.8 3.2 4.2 0.0 0.9 1.5 0.9 1.9 6.8 0.4 3.5 4.8 2.6 2.8 2.9 12.9 0.0 0.9 1.1 10.5 7.9 1.9 5.8 0.5 0.2 2.3 7.2 0.0 0.0 4.2 1.9 0.9 2.0 0.2 0.0 0.3 0.7 21.7 1.1 0.0 0.3 3.8 4.1 1.9 5.3 5.3 1.5 2.1 0.0 1.0 6.1 1.0 3.1 0.0 0.0 5.1 11.1 0.7 0.0 0.6 44.2 20.7 1.1 0.5 0.0 0.2 0.9 16.0 2.5 1.0 0.9 0.4 1.4 0.7 6.6 0.6 LSM12 FLJ30656 ENSG00000161654 "LSM12 homolog" Q3MHD2 17 44034328-44067619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 267.0;Late spermatids: 568.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051934 Approved Approved Cytosol NA NA Cytosol "HPA051934: AB_2681666" "unprognostic (3.42e-2)" "unprognostic (1.01e-2)" "unprognostic (1.64e-1)" "unprognostic (5.98e-2)" "unprognostic (8.04e-2)" "unprognostic (3.87e-3)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.79e-2)" "unprognostic (1.17e-1)" "unprognostic (4.30e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.18e-7)" "unprognostic (8.91e-3)" "unprognostic (2.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.18e-2)" 20.2 22.1 20.5 17.1 21.0 29.9 18.8 20.6 24.9 15.0 19.2 19.9 17.4 17.7 25.2 28.3 15.2 15.6 21.9 21.5 22.3 20.4 29.6 17.0 20.9 21.4 20.9 20.6 15.5 24.1 21.7 14.3 23.2 21.3 17.0 23.9 31.5 18.2 15.5 37.4 16.6 17.0 20.5 21.2 17.3 20.1 24.2 21.7 20.1 18.4 23.9 25.0 23.0 17.5 23.0 47.4 51.3 35.7 56.3 45.9 49.4 65.2 52.3 51.6 65.5 65.3 59.2 50.5 78.6 36.8 59.8 51.9 37.9 75.7 67.7 97.7 59.5 78.5 54.5 38.7 72.6 42.4 95.6 55.9 44.4 53.8 61.3 88.0 42.7 57.1 50.2 81.0 56.6 44.8 46.5 91.4 53.1 52.8 46.7 72.5 57.3 69.8 76.2 61.4 68.5 49.6 32.9 42.4 45.3 55.9 74.0 94.5 62.5 51.8 82.7 49.0 45.1 86.5 44.4 48.3 83.6 70.2 66.9 64.0 43.8 61.7 28.3 48.3 80.3 54.0 46.7 53.5 51.8 70.7 41.0 46.9 46.6 32.6 47.1 78.4 71.9 58.2 61.2 20.5 21.0 20.6 24.9 21.5 22.3 21.4 20.9 20.6 21.3 21.2 21.7 23.0 37.9 16.0 17.5 4.6 32.0 50.3 44.0 36.7 42.1 41.4 58.4 44.6 19.3 27.1 27.4 16.5 87.6 48.0 50.4 43.9 43.0 62.7 267.0 57.2 51.2 35.5 39.9 45.8 13.3 101.6 94.0 37.2 28.5 52.3 7.6 39.6 28.9 48.6 43.8 35.3 14.3 46.5 26.4 38.0 64.4 568.8 35.1 44.6 33.8 14.0 50.1 35.4 39.1 8.0 14.8 85.2 38.5 31.6 48.0 76.7 30.3 58.4 22.7 63.1 26.3 35.5 57.9 59.7 70.0 50.5 48.9 83.7 37.8 63.7 48.5 78.6 ASB16 FLJ30165 ENSG00000161664 "Ankyrin repeat and SOCS box containing 16" Q96NS5 17 44170447-44179084 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 68.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.4;Horizontal cells: 1.7;Inhibitory neurons: 1.6;NK-cells: 2.1;Oligodendrocyte precursor cells: 1.5;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066834 Approved Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA066834: AB_2685732" "unprognostic (2.72e-2)" "unprognostic (8.47e-3)" "unprognostic (4.24e-2)" "unprognostic (1.46e-1)" "unprognostic (1.12e-1)" "unprognostic (5.95e-2)" "unprognostic (2.45e-2)" "unprognostic (2.31e-3)" "unprognostic (1.03e-2)" "unprognostic (6.13e-2)" "unprognostic (7.23e-4)" "unprognostic (5.84e-2)" "unprognostic (3.97e-2)" "unprognostic (8.53e-3)" "unprognostic (7.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.07e-3)" 0.8 1.0 1.0 2.3 0.9 2.2 0.6 8.7 0.9 1.0 0.0 1.3 2.2 1.9 0.0 1.0 1.4 1.1 3.8 0.6 0.4 1.1 0.6 1.1 3.3 1.6 1.8 0.2 1.7 3.7 1.6 1.9 0.6 3.3 1.6 0.0 2.3 2.0 0.2 68.3 3.2 2.1 0.6 0.3 3.1 2.0 1.0 0.9 0.0 1.3 13.2 0.0 1.2 0.8 1.7 2.1 3.9 4.6 4.2 0.0 0.0 3.7 4.2 0.0 0.0 0.0 3.0 2.3 3.2 2.5 0.0 1.0 4.9 0.0 0.0 0.0 5.0 6.8 2.0 8.0 3.4 0.0 2.1 6.2 0.0 0.0 0.0 0.0 1.2 0.0 4.7 3.7 7.6 0.0 3.5 2.6 4.0 1.3 0.7 4.5 8.0 4.4 4.8 0.0 3.1 4.6 2.6 2.0 0.6 0.7 1.3 6.0 2.0 2.1 5.7 5.1 3.5 2.7 11.8 6.2 2.9 1.3 3.0 3.8 2.3 1.3 5.8 1.7 1.2 2.0 2.5 1.8 1.6 0.7 1.9 2.3 1.5 4.1 2.6 1.1 1.6 1.9 1.6 1.0 0.9 8.7 0.9 0.6 0.4 1.6 1.8 0.2 3.3 0.3 0.9 1.7 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 1.4 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.7 0.0 0.1 1.7 1.6 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 1.0 0.0 0.7 2.1 1.5 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.6 0.2 0.3 0.4 0.3 0.0 0.0 0.2 0.3 0.1 0.1 EMC10 "C19orf63, HSM1, HSS1, INM02" ENSG00000161671 "ER membrane protein complex subunit 10" Q5UCC4 19 50476400-50490871 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 187.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 193.0;PC-3: 137.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053905, HPA062723" Approved "Secreted to blood" NA NA "HPA053905: AB_2682303, HPA062723: " "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (9.86e-3)" "unprognostic (1.65e-1)" "unprognostic (6.94e-2)" "unprognostic (8.38e-3)" "unprognostic (3.23e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-1)" "unprognostic (2.99e-1)" "prognostic favorable (4.39e-4)" "unprognostic (5.01e-2)" "prognostic favorable (6.64e-6)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" 23.0 64.5 25.0 11.5 34.3 19.9 27.8 34.6 38.5 31.4 37.9 30.6 24.0 39.2 15.4 36.3 32.2 13.6 47.0 23.4 36.5 76.1 63.5 32.4 9.8 34.9 31.4 19.9 50.0 55.6 44.7 107.2 9.6 29.8 38.6 7.2 8.8 56.1 17.1 187.5 31.9 36.3 6.7 31.4 28.0 48.1 46.0 29.9 7.0 83.0 9.1 6.9 31.3 27.5 45.6 66.2 80.1 3.0 30.8 8.8 10.8 0.8 62.9 11.4 5.4 5.9 0.7 44.4 21.6 0.8 11.3 9.9 55.1 3.7 10.3 2.0 84.2 193.0 4.6 33.9 0.0 14.7 19.1 123.2 13.3 11.3 5.6 4.3 5.2 13.5 18.5 42.7 44.9 11.3 46.0 30.3 0.6 0.3 26.0 137.6 51.7 9.7 71.7 25.0 59.2 48.5 107.9 92.5 29.6 36.1 3.6 31.0 34.8 26.2 3.8 83.1 23.0 34.4 49.5 132.7 17.9 24.8 13.2 30.8 6.2 6.9 8.1 5.0 5.6 4.3 6.4 5.3 5.3 5.3 8.5 6.2 6.0 3.0 3.1 4.3 7.0 4.7 5.2 25.0 34.3 34.6 38.5 23.4 36.5 34.9 31.4 19.9 29.8 31.4 29.9 45.6 30.3 64.1 111.1 15.7 65.6 29.7 53.4 60.9 31.3 82.3 72.5 53.8 11.3 81.5 64.0 69.9 81.3 129.5 71.0 103.6 23.5 181.8 177.7 52.1 49.4 46.0 212.2 21.7 7.9 112.3 155.0 46.6 71.9 79.8 53.2 80.3 55.6 79.4 133.8 37.0 11.8 117.7 59.0 109.2 36.7 39.1 69.0 67.7 83.6 9.4 103.1 101.2 90.6 44.2 78.3 114.4 144.9 115.1 80.2 66.4 158.2 66.8 28.6 71.7 6.6 93.3 43.7 18.0 56.2 50.3 31.3 151.0 67.4 78.5 130.5 66.5 JOSD2 SBBI54 ENSG00000161677 "Josephin domain containing 2" Q8TAC2 19 50505998-50511220 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.77e-2)" "unprognostic (3.09e-2)" "unprognostic (2.59e-1)" "unprognostic (1.57e-2)" "unprognostic (7.25e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (3.63e-2)" "unprognostic (2.41e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-2)" "unprognostic (6.49e-2)" "unprognostic (2.42e-3)" "unprognostic (8.05e-2)" "unprognostic (2.04e-1)" "unprognostic (6.05e-2)" "unprognostic (9.34e-2)" 37.5 33.7 27.3 10.7 30.2 13.3 34.4 32.0 48.5 37.4 15.2 36.7 16.9 38.2 2.5 49.5 32.0 5.9 44.3 22.2 25.8 37.6 48.5 29.3 6.8 35.3 29.5 19.0 29.9 27.0 11.4 28.4 8.1 33.0 32.8 2.9 1.5 26.7 8.3 50.6 35.8 29.7 5.8 33.4 33.1 37.7 18.8 28.5 5.6 40.8 8.0 4.0 38.3 39.3 41.8 38.5 65.7 0.3 18.2 20.4 23.6 12.5 46.8 15.9 12.1 12.9 11.4 26.8 12.2 26.7 16.6 14.6 24.8 1.9 20.2 3.2 54.0 31.3 11.7 12.2 5.8 25.5 3.2 39.1 26.1 17.7 7.8 6.2 15.5 11.4 12.8 15.7 27.2 12.6 27.9 13.3 15.6 4.6 23.9 67.4 3.7 31.1 21.6 11.8 36.8 11.0 29.4 14.0 32.8 40.8 1.5 27.1 19.7 27.5 21.0 25.9 27.6 27.0 30.2 26.1 4.2 59.5 15.7 41.4 55.4 95.3 95.0 45.0 93.8 38.6 24.1 41.9 46.1 70.1 25.1 29.9 33.3 16.2 31.9 70.0 50.6 51.6 48.9 27.3 30.2 32.0 48.5 22.2 25.8 35.3 29.5 19.0 33.0 33.4 28.5 41.8 42.8 6.4 1.7 6.2 18.4 31.0 45.4 83.2 38.1 11.1 45.3 48.0 3.1 47.1 30.1 33.1 0.0 39.5 30.0 153.4 66.5 88.3 12.3 25.4 61.4 30.7 16.8 21.0 3.1 86.3 92.8 47.3 57.6 36.2 5.7 52.5 47.5 56.3 93.5 16.8 2.8 67.8 50.8 70.6 48.8 34.6 89.2 59.4 78.2 3.7 94.1 32.9 30.9 3.0 21.7 120.8 103.2 97.8 21.4 26.3 157.8 106.6 63.0 10.0 52.6 26.2 52.7 32.0 18.4 58.5 45.9 41.3 33.6 48.9 51.8 57.0 SHANK1 "SPANK-1, SSTRIP, synamon" ENSG00000161681 "SH3 and multiple ankyrin repeat domains 1" Q9Y566 19 50659255-50719802 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 81.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.7;Excitatory neurons: 29.6;Horizontal cells: 8.4;Inhibitory neurons: 32.9;Oligodendrocyte precursor cells: 7.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Region enhanced" "Detected in many" "cerebral cortex: 81.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 5.2;THP-1: 2.4;U-138 MG: 2.7;U-2 OS: 7.3;U-87 MG: 2.9;U-937: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032129, HPA032130" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA032129: AB_10602796, HPA032130: AB_2674169" "unprognostic (1.62e-1)" "unprognostic (4.40e-2)" "unprognostic (7.83e-3)" "unprognostic (4.62e-2)" "unprognostic (1.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.35e-2)" "unprognostic (5.02e-2)" "unprognostic (1.61e-1)" "unprognostic (7.51e-2)" "unprognostic (3.27e-1)" "unprognostic (3.65e-2)" "unprognostic (1.61e-2)" "unprognostic (5.14e-2)" "unprognostic (4.66e-3)" "unprognostic (1.29e-3)" 0.0 1.2 22.8 0.0 30.9 0.3 0.1 2.8 81.4 0.4 0.0 0.1 0.0 0.4 0.1 0.0 2.4 0.2 0.1 41.7 4.7 0.0 0.0 0.0 0.0 0.9 0.3 41.3 0.2 0.0 1.6 1.1 0.1 8.5 0.1 0.0 5.3 0.1 0.1 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.5 7.4 0.3 0.1 0.0 0.0 0.1 0.1 12.6 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.8 0.0 0.1 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.5 0.1 0.1 0.5 0.8 0.0 0.0 5.2 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 2.4 1.6 2.7 7.3 0.0 0.0 0.0 0.0 0.0 2.9 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 30.9 2.8 81.4 41.7 4.7 0.9 0.3 41.3 8.5 0.0 7.4 12.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 4.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 29.6 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 8.4 32.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.1 0.0 7.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM171A2 MGC34829 ENSG00000161682 "Family with sequence similarity 171 member A2" A8MVW0 17 44353215-44363853 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.6;pituitary gland: 7.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 40.1;Horizontal cells: 43.7;Muller glia cells: 131.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 14.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 12.9;REH: 23.2;SCLC-21H: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019770 Uncertain NA NA "HPA019770: AB_1848383" "unprognostic (1.28e-2)" "unprognostic (2.07e-2)" "unprognostic (4.14e-3)" "unprognostic (8.47e-2)" "unprognostic (9.98e-2)" "unprognostic (1.92e-1)" "unprognostic (1.62e-4)" "unprognostic (5.76e-2)" "unprognostic (1.98e-2)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (3.00e-1)" "unprognostic (2.43e-3)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.36e-2)" "unprognostic (4.76e-2)" 1.1 1.0 6.9 0.1 10.9 0.1 0.4 0.2 11.4 3.8 0.0 0.5 0.1 2.5 2.8 2.2 1.8 0.7 0.6 10.3 3.0 0.7 0.1 0.5 0.2 3.7 1.7 15.6 3.4 0.2 2.9 7.9 0.4 5.9 1.0 0.0 1.6 0.6 0.9 0.1 0.6 0.4 0.3 0.0 0.2 0.3 0.4 0.8 0.1 1.5 0.0 0.1 0.2 2.0 6.8 1.5 2.2 6.7 9.4 1.1 1.3 4.7 2.6 0.3 2.1 2.6 0.2 0.2 3.1 5.8 0.7 1.2 0.1 2.4 0.6 0.2 2.6 12.9 0.9 0.2 1.3 0.7 0.2 0.5 1.6 0.2 0.8 0.0 3.8 3.3 6.9 2.1 0.1 0.7 8.0 7.3 1.2 10.0 0.1 4.9 23.2 4.4 1.9 0.4 0.5 15.9 11.9 0.9 0.1 1.2 1.6 2.6 1.6 2.1 3.1 5.8 5.2 0.8 1.0 0.3 1.1 0.2 1.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 10.9 0.2 11.4 10.3 3.0 3.7 1.7 15.6 5.9 0.0 0.8 6.8 1.7 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.2 40.1 0.3 1.7 1.4 0.0 0.0 3.7 12.5 0.0 0.7 0.0 0.0 0.2 0.0 2.8 7.4 2.0 0.0 0.0 1.6 0.0 0.2 1.4 0.0 11.3 0.0 2.7 2.5 0.0 0.2 43.7 0.7 0.0 0.0 0.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 131.2 0.0 0.0 0.1 0.3 0.0 0.7 0.1 0.1 0.0 0.0 0.0 7.8 0.0 0.2 1.6 0.1 1.2 0.5 0.1 0.0 0.7 0.5 0.1 0.1 DBF4B "ASKL1, chifb, DRF1, FLJ13087, ZDBF1B" ENSG00000161692 "DBF4 zinc finger B" Q8NFT6 17 44708608-44752264 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.0;Horizontal cells: 30.3;Oligodendrocytes: 30.9;Spermatocytes: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048465, HPA077959" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "HPA048465: AB_2680405, HPA077959: " "unprognostic (2.44e-1)" "unprognostic (1.26e-1)" "unprognostic (6.37e-2)" "unprognostic (2.15e-3)" "unprognostic (1.62e-1)" "unprognostic (6.13e-2)" "unprognostic (1.53e-4)" "unprognostic (7.61e-2)" "unprognostic (1.54e-2)" "unprognostic (4.08e-2)" "unprognostic (8.43e-3)" "unprognostic (1.83e-1)" "unprognostic (4.23e-6)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.39e-1)" 0.9 0.8 1.2 1.3 1.2 2.0 1.3 1.3 1.8 1.5 0.7 1.6 0.6 1.9 3.5 1.4 1.9 0.7 0.7 1.2 1.0 1.2 0.6 0.8 1.5 1.3 1.2 1.1 1.7 0.9 0.8 1.7 1.0 1.4 2.3 1.2 2.9 1.1 1.3 0.6 2.0 1.6 1.5 0.9 1.7 1.3 5.2 1.3 1.9 2.7 0.4 1.3 1.6 1.3 1.4 3.7 7.7 5.7 4.2 0.5 1.1 4.9 3.9 1.7 8.1 7.9 3.3 3.1 5.5 2.1 1.3 7.2 3.6 5.0 1.7 9.3 9.2 8.2 7.0 6.2 4.3 0.2 4.8 5.9 0.5 0.6 4.4 1.4 1.8 4.1 9.3 8.9 5.6 4.4 4.0 7.1 2.9 2.5 7.7 4.0 6.2 6.6 2.3 1.8 2.2 3.1 3.4 3.8 1.2 2.9 6.1 3.9 3.1 1.8 2.8 5.2 3.6 7.2 2.6 3.5 7.2 2.1 4.1 4.3 0.0 0.1 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.1 1.2 1.2 1.3 1.8 1.2 1.0 1.3 1.2 1.1 1.4 0.9 1.3 1.4 2.1 0.0 1.1 15.0 4.0 0.6 2.6 1.2 1.2 30.0 1.5 1.3 1.1 0.0 2.1 5.5 12.5 4.2 5.8 0.6 0.0 0.3 8.1 2.0 2.2 2.8 4.2 5.5 11.4 0.8 1.4 2.3 1.5 1.1 3.8 9.6 3.3 0.3 1.4 30.3 11.0 0.3 0.0 1.3 3.1 7.4 1.2 2.5 5.4 5.6 1.4 7.2 2.1 7.5 30.9 0.2 0.2 3.0 3.4 2.0 0.7 0.5 1.9 15.7 0.0 4.5 2.0 35.7 16.5 1.9 0.1 1.4 1.4 5.3 1.1 2.3 PLCD3 ENSG00000161714 "Phospholipase C delta 3" Q8N3E9 17 45108959-45133354 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 86.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025711, HPA053665" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025711: AB_1855320, HPA053665: AB_2732580" "unprognostic (3.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.77e-2)" "unprognostic (1.27e-2)" "unprognostic (2.66e-1)" "unprognostic (4.14e-3)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.96e-1)" "unprognostic (9.53e-2)" "unprognostic (1.34e-3)" "unprognostic (6.21e-2)" "unprognostic (3.18e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "prognostic favorable (4.28e-4)" "unprognostic (3.34e-3)" 12.9 34.5 37.6 5.1 40.7 2.0 11.8 48.1 36.3 12.3 22.7 30.4 2.5 13.3 1.5 14.8 10.2 6.4 28.2 29.2 40.8 8.4 1.4 7.8 1.0 66.0 47.2 22.3 19.0 2.7 1.3 7.7 5.9 40.8 13.1 15.5 14.5 10.9 5.4 86.6 17.9 6.5 5.1 58.0 2.0 21.2 10.9 51.2 0.9 5.4 57.0 1.5 30.7 12.0 53.1 23.1 56.2 4.1 8.1 5.9 12.8 28.0 12.3 27.3 11.2 10.5 13.7 40.9 0.8 43.5 29.0 9.2 51.9 6.3 53.1 4.4 11.6 21.0 0.9 62.6 18.1 30.3 1.3 3.2 13.7 21.0 10.4 13.7 28.5 7.0 2.5 5.0 1.7 12.1 36.2 3.7 5.4 4.9 109.9 55.0 8.1 9.2 1.5 35.8 45.1 1.1 7.2 13.3 22.1 12.5 8.5 47.0 2.5 14.3 6.9 37.9 9.3 14.8 2.1 2.6 1.8 11.4 1.5 5.7 0.7 0.3 0.5 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.2 0.0 0.1 0.1 0.1 37.6 40.7 48.1 36.3 29.2 40.8 66.0 47.2 22.3 40.8 58.0 51.2 53.1 8.7 12.8 1.3 22.9 1.0 7.6 16.3 12.2 21.1 29.8 6.8 9.3 26.9 14.3 4.9 7.3 25.0 3.9 0.9 195.8 1.9 6.7 15.8 3.3 12.7 9.0 4.9 0.0 1.3 3.5 13.1 10.6 29.6 9.6 1.3 6.5 10.4 0.7 1.6 6.7 3.7 15.1 4.1 1.4 1.9 5.5 19.9 1.6 3.6 1.0 1.2 8.9 0.0 0.0 0.1 30.0 104.7 33.1 1.1 28.7 4.2 2.0 2.7 40.0 6.6 16.8 4.9 2.3 7.6 3.8 5.7 7.3 1.1 7.0 46.2 88.6 FMNL3 "DKFZp762B245, MGC45819, WBP3" ENSG00000161791 "Formin like 3" Q8IVF7 12 49636499-49708165 "Predicted intracellular proteins" Angiogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 35.8;Cone photoreceptor cells: 39.6;dendritic cells: 48.6;Microglial cells: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002552, HPA023201" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Vesicles, Plasma membrane" Cytosol "HPA002552: AB_1078862, HPA023201: AB_1848575" "unprognostic (2.97e-1)" "unprognostic (2.77e-3)" "unprognostic (4.97e-3)" "unprognostic (7.19e-2)" "unprognostic (5.42e-2)" "unprognostic (2.33e-3)" "unprognostic (5.37e-3)" "unprognostic (1.52e-2)" "unprognostic (2.83e-1)" "unprognostic (1.54e-1)" "unprognostic (6.67e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (1.04e-1)" "unprognostic (2.31e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" 12.2 5.7 12.0 20.6 11.5 5.2 10.7 12.1 10.8 9.2 4.9 7.0 5.8 11.3 19.3 4.6 7.0 11.2 12.3 9.4 10.5 8.7 2.8 17.5 23.7 15.6 12.1 5.8 16.3 3.3 3.6 4.2 14.1 19.6 6.1 5.6 2.7 4.6 4.5 5.7 4.3 10.3 11.6 15.9 13.5 6.7 10.2 16.4 20.3 13.5 6.7 28.5 8.7 6.4 17.2 8.6 2.5 18.4 6.1 5.0 20.1 0.2 10.4 21.0 13.8 12.1 9.7 2.3 18.2 19.5 12.4 15.2 0.4 9.5 4.3 12.6 16.2 3.6 20.1 2.9 0.5 8.8 4.0 25.1 12.7 0.7 21.7 9.1 41.2 37.1 9.0 4.6 13.0 20.5 6.3 16.6 6.0 6.0 0.9 5.5 7.9 23.0 2.8 13.1 1.3 3.0 8.6 6.0 0.8 11.8 9.3 1.5 5.9 47.2 34.2 11.8 0.6 18.2 6.7 0.4 9.8 21.3 12.4 14.7 3.0 0.1 0.8 0.8 0.4 0.4 0.2 0.3 0.5 0.2 1.1 0.4 0.5 0.0 0.6 0.3 5.1 0.1 0.5 12.0 11.5 12.1 10.8 9.4 10.5 15.6 12.1 5.8 19.6 15.9 16.4 17.2 35.8 3.2 3.4 6.8 17.5 1.7 0.7 0.4 2.2 11.3 1.3 2.3 3.3 0.0 1.4 1.8 39.6 2.1 48.6 0.1 0.0 0.3 2.0 0.7 2.6 29.7 0.0 1.7 16.0 0.6 0.8 7.1 1.5 2.0 27.8 5.4 15.7 0.8 11.1 3.3 6.5 0.8 0.0 6.9 9.0 4.6 3.7 17.7 5.4 119.0 22.9 0.5 16.5 27.6 5.5 0.8 0.1 6.4 1.8 0.8 0.0 0.2 0.2 2.0 13.1 15.5 10.3 5.9 7.5 0.4 1.4 2.5 13.6 2.6 0.1 0.4 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961872-49965682 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 628.0;testis: 223.8" "Group enriched" "Detected in many" 7 "Early spermatids: 1542.9;Late spermatids: 4265.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 223.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065008 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA065008: AB_2685401" "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favorable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 1.8 0.8 2.5 0.1 3.3 0.2 17.3 3.2 2.7 13.0 1.3 0.3 15.5 2.7 0.2 16.6 0.7 2.9 2.3 2.2 2.7 1.2 0.1 7.7 0.0 3.1 3.6 1.9 0.2 2.0 3.1 1.2 0.0 3.1 1.3 0.0 1.0 628.0 1.0 0.2 97.3 0.1 0.3 2.3 0.4 52.8 223.8 3.3 0.0 1.7 0.0 0.1 0.3 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.7 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.7 223.2 0.0 10.1 0.0 0.0 0.3 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.3 3.2 2.7 2.2 2.7 3.1 3.6 1.9 3.1 2.3 3.3 2.4 0.5 57.7 3.1 0.0 0.1 1.3 0.5 18.3 0.0 0.8 53.9 48.0 0.3 0.0 56.4 7.3 0.0 0.0 0.1 0.0 0.0 0.1 1542.9 1.5 0.1 1.8 0.0 0.0 0.0 0.2 0.0 1.4 34.7 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 26.4 0.0 1.6 4265.6 28.6 1.7 295.3 0.0 0.0 53.7 0.0 3.0 0.1 7.2 0.0 19.2 0.3 1.6 0.0 0.0 9.7 1.7 19.7 0.0 1.8 403.9 15.9 1.3 0.9 0.0 0.6 18.7 0.0 0.6 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.3;lymphoid tissue: 43.4;testis: 45.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 5.0 2.5 5.8 13.8 8.3 39.3 7.2 7.2 6.7 4.8 4.1 16.8 10.6 5.4 1.5 21.5 4.4 6.5 2.8 5.6 6.6 9.3 4.7 6.3 24.1 7.1 7.6 5.3 2.4 2.7 5.9 1.4 14.1 7.4 3.4 18.9 5.4 4.8 3.4 4.9 14.5 11.7 12.7 6.3 6.6 9.9 45.9 7.3 43.4 3.4 4.8 30.4 7.8 8.0 7.4 193.0 174.5 135.8 86.8 24.8 29.7 113.0 195.0 97.0 207.3 140.3 174.6 144.7 107.5 86.0 108.3 99.9 127.1 137.7 93.6 219.9 203.0 85.4 137.9 165.8 58.1 8.4 146.1 109.0 16.2 17.2 140.7 111.4 60.3 71.7 96.4 101.6 159.6 197.0 136.8 122.5 72.6 96.2 108.9 112.9 113.9 163.5 78.3 54.9 95.7 113.9 97.5 161.7 102.7 53.0 68.8 199.7 64.8 64.9 136.2 119.1 86.8 144.7 83.3 225.2 126.6 67.7 97.0 81.1 24.1 3.2 4.7 6.5 4.1 5.7 8.2 7.9 9.2 2.8 4.3 4.6 6.1 0.7 11.0 2.6 1.8 19.1 5.8 5.8 8.3 7.2 6.7 5.6 6.6 7.1 7.6 5.3 7.4 6.3 7.3 7.4 2.0 6.4 6.4 2.9 4.2 12.9 2.5 4.9 6.2 1.5 4.8 5.1 1.5 2.8 3.3 5.5 4.2 21.8 4.4 3.1 19.6 1.9 15.2 2.2 3.1 2.7 0.0 55.7 7.5 2.2 49.4 5.9 7.7 4.0 2.5 14.2 5.3 2.7 13.1 1.7 8.0 5.7 20.3 11.3 8.0 17.7 1.5 7.1 1.8 1.0 4.5 2.7 6.2 6.0 12.3 2.0 1.0 3.8 10.9 2.8 1.1 2.1 2.3 0.8 13.1 3.1 5.5 79.6 32.2 19.5 12.9 8.6 6.9 2.2 11.6 2.9 OR7G1 "OR19-15, OR7G1P" ENSG00000161807 "Olfactory receptor family 7 subfamily G member 1" Q8NGA0 19 9114828-9115763 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LARP4 PP13296 ENSG00000161813 "La ribonucleoprotein 4" Q71RC2 12 50392383-50480004 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039306, HPA039673" Approved Enhanced "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA039306: AB_10805362, HPA039673: AB_10795110" "unprognostic (4.41e-3)" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (8.50e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (9.93e-3)" "unprognostic (9.08e-2)" "unprognostic (8.94e-2)" "unprognostic (8.51e-3)" "unprognostic (1.91e-2)" "unprognostic (3.14e-1)" "unprognostic (9.06e-2)" "unprognostic (3.99e-3)" 17.6 28.0 11.0 16.3 12.7 14.1 14.8 17.0 14.5 14.2 23.8 15.5 16.9 10.6 11.8 19.1 9.4 13.0 16.4 10.2 30.5 29.3 62.6 13.6 15.8 14.0 14.2 6.9 9.5 16.6 21.9 8.9 18.5 14.6 14.0 14.6 20.5 16.1 11.4 26.6 11.2 13.3 11.8 13.7 12.6 17.3 15.0 13.5 16.1 20.2 37.3 15.6 21.7 9.1 18.0 43.9 61.0 40.1 29.6 36.6 30.2 67.9 52.9 31.5 51.3 40.8 120.5 50.2 102.9 63.9 33.2 47.5 41.1 88.2 36.1 67.3 64.3 35.9 83.9 56.1 43.6 34.0 93.9 47.5 27.6 33.9 60.9 65.1 33.9 45.9 37.2 122.8 47.4 48.0 39.3 77.7 31.6 58.2 28.5 52.9 56.6 63.6 61.0 27.8 65.1 47.2 27.7 94.0 48.3 54.9 37.0 42.1 37.4 66.9 34.0 50.2 39.7 50.4 45.9 134.7 90.3 47.0 37.9 28.9 8.2 8.7 6.0 8.1 9.6 7.5 8.6 7.0 4.5 11.7 8.6 8.2 6.7 4.4 8.2 12.1 10.0 7.6 7.7 11.0 12.7 17.0 14.5 10.2 30.5 14.0 14.2 6.9 14.6 13.7 13.5 18.0 35.9 48.1 44.7 31.0 26.8 71.0 33.8 23.1 59.7 41.0 34.0 25.1 47.8 22.8 27.7 29.5 87.6 27.4 22.0 29.1 9.8 19.7 8.6 52.9 50.4 28.6 24.0 33.0 38.9 24.0 17.3 31.0 38.7 57.5 19.7 27.9 21.0 129.0 27.3 18.5 45.5 25.8 20.3 33.0 26.6 25.4 14.9 23.0 26.6 24.4 27.6 18.4 13.4 26.7 40.4 27.0 16.1 19.2 56.4 44.3 20.3 54.7 33.0 54.0 6.6 42.2 36.8 37.4 42.5 52.2 74.3 34.2 22.0 34.4 27.5 33.2 TAMALIN GRASP ENSG00000161835 "Trafficking regulator and scaffold protein tamalin" Q7Z6J2 12 52006946-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" No NA Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: AB_2684664" "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 32.1 6.3 8.2 4.2 10.9 24.0 27.1 2.5 20.7 17.7 2.6 9.3 2.3 22.2 1.6 7.1 22.4 9.7 20.5 8.7 6.6 12.2 4.3 47.2 3.8 5.1 4.2 7.9 15.0 5.7 2.8 6.2 9.0 5.2 13.1 1.9 0.1 6.5 3.1 10.7 10.2 9.9 6.1 2.7 18.3 8.7 2.6 5.5 3.7 16.4 8.5 2.3 12.6 17.2 6.3 0.0 0.0 4.4 0.2 1.9 3.6 1.0 0.2 1.1 0.0 1.1 0.0 0.0 0.0 10.0 0.0 0.4 0.1 1.3 0.0 0.4 0.2 1.3 0.3 0.0 6.2 7.4 0.3 3.3 7.2 0.0 0.3 0.0 0.0 37.4 1.0 1.6 0.0 0.9 0.2 3.1 10.5 4.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 1.1 1.6 0.0 0.2 7.5 2.7 0.0 0.3 27.4 0.0 2.5 0.2 0.0 0.2 0.0 0.1 0.6 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 8.2 10.9 2.5 20.7 8.7 6.6 5.1 4.2 7.9 5.2 2.7 5.5 6.3 243.8 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.2 114.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 RAVER1 KIAA1978 ENSG00000161847 "Ribonucleoprotein, PTB binding 1" Q8IY67 19 10316212-10333638 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 255.5" "Low region specificity" "Detected in all" "HPA043575, HPA049457" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA043575: AB_2678562, HPA049457: AB_2680774" "unprognostic (2.04e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.80e-2)" "unprognostic (1.59e-1)" "unprognostic (4.22e-2)" "unprognostic (2.01e-2)" "unprognostic (7.20e-2)" "unprognostic (2.64e-2)" "unprognostic (3.22e-2)" "unprognostic (3.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (2.97e-1)" 12.0 13.0 2.9 11.9 3.5 19.1 12.7 3.4 5.6 17.5 4.6 17.6 17.9 23.0 0.7 15.2 19.9 3.3 9.6 2.7 6.3 12.0 8.3 13.2 11.2 5.4 3.1 0.7 19.5 11.8 4.5 17.6 6.1 3.3 15.3 3.2 1.2 13.2 7.6 8.6 11.8 22.8 4.0 2.8 21.8 14.0 11.6 3.8 11.5 14.4 2.2 5.3 16.9 14.1 3.6 62.0 38.9 14.1 21.6 5.6 7.0 31.0 31.9 14.0 24.7 21.8 42.7 17.3 65.0 43.7 10.4 19.9 31.5 15.8 21.1 4.9 55.2 93.5 100.3 25.7 48.6 12.6 63.5 62.4 8.2 7.2 16.6 6.2 8.2 16.2 48.6 80.9 56.2 7.6 57.8 85.6 255.5 55.1 13.1 73.9 78.3 20.5 57.2 6.9 24.4 40.3 46.7 34.7 22.3 18.3 4.8 32.0 30.5 22.5 63.7 32.4 56.7 54.5 122.1 109.0 54.9 42.1 44.2 42.5 0.2 1.3 1.8 3.3 1.5 1.7 1.4 2.8 4.6 2.1 2.0 1.9 1.7 1.2 1.9 3.3 0.9 1.1 2.2 2.9 3.5 3.4 5.6 2.7 6.3 5.4 3.1 0.7 3.3 2.8 3.8 3.6 1.2 0.0 1.1 6.5 7.8 0.8 0.3 0.5 10.2 0.8 2.0 1.1 0.7 0.0 0.4 0.0 0.0 2.0 2.3 15.2 0.0 4.5 0.4 1.6 2.2 1.1 16.3 12.0 4.8 4.3 1.9 1.6 6.1 1.2 4.5 0.6 0.4 0.3 1.3 0.0 4.5 9.3 0.0 0.0 0.8 0.0 0.0 2.0 0.0 6.5 6.8 0.3 0.0 4.0 4.2 5.4 10.2 0.7 15.3 0.3 14.0 0.6 1.1 1.0 0.0 0.8 2.4 0.7 0.3 6.1 0.1 1.5 5.5 0.6 14.3 0.2 KRT84 "Hb-4, KRTHB4" ENSG00000161849 "Keratin 84" Q9NSB2 12 52377812-52385652 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 1.5;skin 1: 1.1" "Cell type enriched" "Detected in single" 22 "Cardiomyocytes: 2.2" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039714 Supported NA NA 67000000 "HPA039714: AB_2676641" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT82 "Hb-2, KRTHB2" ENSG00000161850 "Keratin 82" Q9NSB4 12 52393931-52406335 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "skin 1: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058715, HPA067230" Enhanced NA NA 29000000 "HPA058715: AB_2683798, HPA067230: AB_2685807" "unprognostic (3.04e-1)" "unprognostic (3.59e-3)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SYCE2 CESC1 ENSG00000161860 "Synaptonemal complex central element protein 2" Q6PIF2 19 12898786-12919293 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 26.9" "Group enriched" "Detected in some" 4 "Spermatocytes: 214.8;Spermatogonia: 72.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "NK-cell: 2.7" "Lineage enhanced" "Detected in single" "NK-cells: 2.7" "Cell line enhanced" "Detected in many" "EFO-21: 11.6;JURKAT: 10.4;MOLT-4: 11.1;SiHa: 11.7;U-266/70: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042080, HPA062919" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA042080: AB_10794411, HPA062919: AB_2684905" "unprognostic (3.00e-1)" "prognostic favorable (3.85e-5)" "unprognostic (9.99e-3)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.75e-1)" "unprognostic (3.48e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "unprognostic (1.78e-1)" "unprognostic (8.28e-3)" "unprognostic (1.30e-2)" "unprognostic (8.39e-4)" "unprognostic (1.79e-10)" "unprognostic (7.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.09e-1)" "unprognostic (7.87e-5)" 0.5 0.5 0.4 0.5 0.7 3.3 0.7 1.4 0.9 0.8 0.1 0.7 0.3 0.5 0.5 0.7 0.9 0.3 0.5 0.4 0.3 0.6 1.8 0.5 1.1 0.5 0.5 0.3 1.2 0.6 0.1 0.8 0.4 0.6 1.1 0.2 1.4 0.6 0.1 0.4 1.2 0.6 0.1 0.3 0.8 0.7 26.9 0.4 1.8 0.7 0.0 0.7 0.8 0.7 1.6 5.9 1.1 3.0 1.8 0.3 0.8 3.2 1.4 0.6 0.8 0.9 0.2 0.8 4.5 11.6 0.8 1.0 1.2 1.0 0.3 0.9 1.7 0.7 1.3 2.7 0.6 0.1 3.0 4.0 0.8 0.2 0.3 0.6 1.4 0.2 10.4 1.1 1.3 0.5 2.4 11.1 2.0 1.9 0.2 3.3 3.3 1.4 1.1 0.5 0.9 2.1 1.4 11.7 0.6 0.7 0.8 2.3 3.2 0.8 0.8 1.5 4.3 0.4 12.1 1.7 5.1 1.0 4.0 5.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.2 0.0 0.4 0.7 1.4 0.9 0.4 0.3 0.5 0.5 0.3 0.6 0.3 0.4 1.6 0.3 0.0 0.0 4.9 0.6 1.3 0.3 0.9 0.0 0.7 0.4 0.6 0.1 0.0 0.2 0.0 0.0 1.3 0.1 0.1 0.0 0.2 34.3 0.4 0.2 0.5 0.0 0.0 1.7 0.4 1.9 0.3 0.0 0.5 0.0 1.8 0.0 0.2 1.0 0.0 1.7 0.0 0.0 0.6 0.8 23.5 3.1 0.3 0.0 0.0 0.0 0.5 0.0 1.5 2.7 0.1 0.1 1.2 0.1 0.3 0.1 0.2 0.2 0.2 26.3 0.4 0.4 214.8 72.2 0.0 0.4 0.3 0.2 0.1 0.3 0.2 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24 component of NDC80 kinetochore complex" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.2;lymphoid tissue: 14.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 1.9 1.7 1.5 4.9 1.7 26.2 1.2 3.4 2.1 2.1 1.8 4.8 4.6 2.7 0.8 5.0 1.3 2.3 2.2 1.7 1.6 0.8 1.6 1.6 6.4 1.2 1.1 1.7 1.3 1.1 0.4 0.4 3.2 1.7 1.6 4.3 1.3 1.3 2.0 4.1 4.0 4.1 8.2 0.7 3.2 3.0 4.3 1.6 14.8 0.9 1.1 6.6 2.6 2.0 2.6 73.6 26.9 36.9 30.1 5.0 9.7 16.6 42.3 15.7 38.6 43.6 28.4 24.6 58.2 46.0 18.5 22.8 38.8 29.0 30.3 28.7 30.9 24.9 78.5 68.9 43.2 1.1 55.5 33.7 1.9 1.1 27.8 12.8 10.0 34.7 62.3 42.8 118.3 27.6 48.7 76.4 32.9 25.5 19.8 43.9 59.8 56.7 18.6 11.2 23.8 38.4 27.2 37.0 22.4 9.6 17.5 22.0 19.8 33.2 36.8 38.3 49.6 51.2 70.5 39.8 55.6 26.9 53.9 30.5 1.9 0.4 0.4 0.5 0.5 0.4 0.8 0.9 1.5 0.2 0.7 0.9 0.6 2.2 2.0 0.5 0.5 1.7 0.3 1.5 1.7 3.4 2.1 1.7 1.6 1.2 1.1 1.7 1.7 0.7 1.6 2.6 0.2 0.0 0.5 0.3 1.5 1.1 1.2 1.3 0.0 0.0 1.0 0.4 9.0 1.5 0.8 5.5 6.2 10.0 0.9 2.8 0.0 0.2 0.3 1.0 2.2 2.2 2.4 35.0 0.3 0.0 15.5 3.5 3.6 1.8 5.7 6.5 4.6 0.7 14.0 0.0 0.3 2.6 0.0 3.0 2.5 3.0 0.6 1.0 0.0 1.0 0.0 2.1 2.1 0.5 0.3 0.3 0.0 0.4 6.3 0.3 0.7 0.6 0.2 0.6 0.0 1.3 2.4 6.9 10.8 2.1 0.3 2.1 2.2 0.5 6.6 1.2 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721662-33746905 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 310.6;tongue: 84.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA053644, HPA062531" Enhanced Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA053644: AB_2682214, HPA062531: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 1.4 0.7 4.5 0.4 13.8 0.0 1.3 11.3 8.9 1.9 4.8 5.1 0.4 3.8 0.1 6.6 1.2 0.1 22.2 5.1 9.7 6.1 19.0 5.2 0.1 12.4 12.9 2.6 0.5 0.6 0.0 0.5 4.7 13.8 5.3 0.6 0.9 2.7 1.7 310.6 0.5 2.4 1.8 8.7 3.3 1.6 0.2 12.1 0.5 13.0 84.1 0.0 2.4 2.0 26.6 0.1 0.0 0.5 0.0 0.0 0.1 3.6 0.1 0.4 0.3 2.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 21.9 0.0 0.1 7.9 1.2 0.1 0.6 0.1 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.4 0.1 0.0 0.7 0.5 5.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 13.8 11.3 8.9 5.1 9.7 12.4 12.9 2.6 13.8 8.7 12.1 26.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 8.5 0.4 0.4 11.2 0.0 1.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 5.0 0.2 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.0 8.9 0.3 10.1 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.0 1.1 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 1.0 0.4 6.6 51.7 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 LEMD2 "dJ482C21.1, LEM2, NET25" ENSG00000161904 "LEM domain nuclear envelope protein 2" Q8NC56 6 33771202-33789130 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017340 Supported Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA017340: AB_2296925" "unprognostic (9.01e-2)" "unprognostic (7.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.12e-2)" "unprognostic (2.98e-1)" "unprognostic (8.29e-3)" "unprognostic (6.53e-2)" "unprognostic (5.98e-2)" "unprognostic (4.42e-2)" "unprognostic (7.03e-2)" "unprognostic (1.67e-3)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.82e-2)" "unprognostic (7.12e-2)" 39.4 46.2 44.6 35.3 46.6 63.9 39.9 51.7 51.2 51.2 43.7 44.9 32.2 44.5 29.9 50.6 46.3 30.2 43.4 43.2 46.0 49.3 50.3 51.6 45.7 51.2 46.4 43.7 54.2 55.0 39.6 56.9 38.9 49.4 52.3 30.3 30.0 43.6 31.6 37.7 51.8 50.5 30.7 46.3 70.6 45.3 45.8 46.4 46.5 53.4 28.3 41.9 44.2 45.3 53.9 36.6 40.5 67.3 66.1 37.6 40.3 50.9 39.1 59.7 48.5 50.9 30.6 37.8 33.8 53.5 55.6 136.7 62.0 39.4 52.1 34.0 35.9 36.6 12.7 45.8 40.3 78.4 26.1 42.6 44.3 96.5 51.6 88.1 80.0 52.8 43.9 36.3 38.3 42.8 30.8 48.6 64.1 39.2 53.5 23.2 31.8 27.8 28.3 52.0 50.5 47.8 37.8 23.4 74.0 52.6 68.0 49.5 70.7 24.6 67.8 26.3 36.6 46.5 49.8 43.0 24.0 26.7 40.3 83.0 1.6 1.7 3.2 2.3 1.5 2.9 2.2 2.5 2.3 1.7 2.3 2.0 2.3 1.4 1.5 2.1 2.9 2.8 1.2 44.6 46.6 51.7 51.2 43.2 46.0 51.2 46.4 43.7 49.4 46.3 46.4 53.9 19.8 3.2 9.0 16.0 17.4 10.8 13.4 7.9 14.2 18.6 10.0 7.1 10.0 8.6 5.2 9.2 18.8 24.9 18.6 24.3 1.9 9.4 24.9 7.5 10.1 18.5 5.4 8.6 14.5 6.8 36.6 12.2 15.3 10.6 12.7 16.6 12.5 7.7 17.5 43.7 17.4 17.7 6.1 14.5 12.4 44.2 10.5 13.5 12.4 14.0 9.4 14.0 13.4 14.6 18.2 13.2 20.1 16.1 11.9 14.6 14.8 6.6 7.2 13.1 19.7 12.7 15.2 24.6 7.4 8.9 10.2 29.8 15.2 12.5 15.9 13.2 ALOX15 15-LOX-1 ENSG00000161905 "Arachidonate 15-lipoxygenase" P16050 17 4630919-4642294 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 16.9;fallopian tube: 12.8" "Group enriched" "Detected in some" 5 "Club cells: 60.3;Langerhans cells: 72.2;Respiratory ciliated cells: 191.8" "Cancer enhanced" "Detected in many" "cervical cancer: 6.6" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 193 "eosinophil: 602.9" "Lineage enriched" "Detected in many" 193 "granulocytes: 602.9" "Group enriched" "Detected in some" 7 "HMC-1: 15.9;MCF7: 14.7;T-47d: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004962, CAB004963, HPA013859" Approved NA NA "CAB004962: , CAB004963: , HPA013859: AB_1844758" "unprognostic (5.31e-4)" "unprognostic (1.43e-2)" "unprognostic (2.81e-2)" "unprognostic (8.36e-3)" "unprognostic (2.22e-1)" "unprognostic (8.60e-2)" "unprognostic (2.36e-1)" "unprognostic (2.66e-2)" "unprognostic (1.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.31e-3)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "unprognostic (2.78e-1)" "unprognostic (1.59e-1)" 16.9 0.0 0.5 1.7 1.6 0.5 3.2 0.0 1.3 0.5 0.0 1.1 1.9 0.0 0.4 0.8 12.8 0.6 1.6 0.5 0.6 0.0 0.1 6.7 1.9 1.1 0.2 0.6 0.1 0.0 0.0 3.0 0.1 0.7 0.2 1.0 0.0 0.2 0.3 0.0 2.3 3.4 0.6 0.2 1.4 1.1 1.9 0.4 0.8 0.0 0.0 0.6 1.1 0.1 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 14.7 0.0 0.3 1.1 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 602.9 0.0 0.2 0.2 0.1 0.0 0.1 3.1 0.2 0.0 0.1 0.9 0.0 0.1 2.7 0.1 0.4 0.5 1.6 0.0 1.3 0.5 0.6 1.1 0.2 0.6 0.7 0.2 0.4 0.6 0.0 0.0 1.1 0.0 0.2 1.5 0.0 13.0 0.0 0.0 1.1 0.1 0.9 11.5 60.3 0.0 0.0 1.8 1.3 0.0 0.0 0.0 19.2 3.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 3.6 0.0 0.1 1.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 72.2 2.5 0.0 0.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 191.8 0.0 0.0 0.1 3.9 1.2 1.2 0.0 0.9 7.4 0.3 0.0 0.0 0.3 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.8;brain: 5.8;lymphoid tissue: 7.3" "Group enriched" "Detected in some" 7 "Macrophages: 75.6;monocytes: 28.3" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "basophil: 92.4" "Lineage enriched" "Detected in many" 49 "granulocytes: 92.4" "Cell line enriched" "Detected in single" 170 "HEL: 66.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced Uncertain "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA 43000000 "Nuclear speckles, Cytosol" "Golgi apparatus, Plasma membrane" "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 0.7 1.0 2.9 2.7 3.2 8.8 0.5 3.4 4.5 0.2 2.5 0.3 0.0 0.1 0.4 0.1 0.4 0.9 0.3 3.0 3.4 0.2 0.3 2.1 5.4 4.6 3.5 2.6 0.1 0.4 0.2 0.4 0.5 5.8 0.2 0.9 0.2 0.4 0.3 0.1 0.3 0.4 0.2 4.1 7.3 0.3 0.1 3.9 4.2 0.3 0.5 4.8 0.4 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 1.7 2.8 0.2 1.8 0.4 0.2 0.1 0.0 0.7 0.3 0.5 0.0 10.7 0.0 0.3 0.9 0.0 110.6 2.9 3.2 3.4 4.5 3.0 3.4 4.6 3.5 2.6 5.8 4.1 3.9 3.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 3.9 0.0 0.0 0.0 0.0 1.6 2.7 0.0 0.0 75.6 0.0 6.5 28.3 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 ZNF653 Zip67 ENSG00000161914 "Zinc finger protein 653" Q96CK0 19 11483427-11505839 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 15.1;Late spermatids: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023631, HPA023635" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA023631: AB_2671269, HPA023635: AB_10603940" "unprognostic (1.21e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (8.37e-4)" "prognostic favorable (4.15e-4)" "unprognostic (9.75e-2)" "unprognostic (1.67e-3)" "unprognostic (1.11e-1)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-3)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (7.91e-3)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (3.15e-1)" "prognostic favorable (8.74e-4)" 4.5 8.1 11.5 4.4 12.4 3.8 5.3 18.0 17.1 5.9 10.0 6.7 3.3 5.9 1.7 5.5 6.4 4.1 5.3 13.8 11.3 9.5 8.5 4.8 4.3 11.4 11.4 11.2 6.5 8.3 5.4 8.8 3.4 13.4 8.6 2.1 3.6 5.6 3.1 7.6 7.7 6.5 3.8 9.5 5.8 7.6 25.5 11.1 6.3 8.9 3.7 2.7 6.3 5.9 12.5 11.7 9.5 7.1 6.4 1.9 1.4 5.2 4.3 3.7 6.2 5.6 6.5 5.0 8.0 5.4 4.8 6.5 5.2 5.5 4.3 3.1 8.6 7.2 5.2 6.4 7.7 2.0 6.9 8.8 4.2 5.5 5.8 4.7 5.9 4.7 7.0 7.5 11.8 3.5 16.3 9.5 15.6 7.8 6.5 7.7 8.3 4.7 10.5 6.8 9.6 8.3 12.2 2.9 5.0 5.8 3.1 4.8 4.4 6.0 8.8 5.9 10.1 10.6 15.6 24.9 6.1 7.8 9.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 11.5 12.4 18.0 17.1 13.8 11.3 11.4 11.4 11.2 13.4 9.5 11.1 12.5 2.5 0.0 0.0 2.6 2.7 3.2 4.0 0.8 1.2 4.4 3.1 3.0 1.8 1.5 0.5 1.8 6.2 1.4 2.5 5.2 0.0 4.5 15.1 4.9 1.7 1.9 4.8 6.1 3.8 5.2 1.3 1.6 2.6 3.1 4.5 3.0 3.6 3.6 0.9 1.7 3.5 4.1 0.0 1.6 0.5 26.7 1.8 1.1 0.0 2.8 3.9 4.9 0.0 2.0 1.5 4.5 0.8 2.2 1.0 2.5 2.0 2.7 1.1 4.1 0.0 2.6 3.1 9.1 4.7 1.3 2.7 1.6 1.5 2.6 3.3 2.2 MED11 "HSPC296, MGC88387" ENSG00000161920 "Mediator complex subunit 11" Q9P086 17 4731428-4733608 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056669 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA056669: AB_2683204" "unprognostic (4.01e-2)" "unprognostic (2.34e-2)" "unprognostic (7.91e-2)" "prognostic favorable (1.86e-5)" "unprognostic (8.24e-2)" "unprognostic (5.47e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.82e-2)" "unprognostic (3.86e-2)" "unprognostic (2.10e-3)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (4.84e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" 19.1 41.7 29.7 22.7 32.9 11.3 20.5 33.6 34.1 20.6 29.6 25.2 27.4 19.1 25.5 29.5 24.6 19.2 29.8 29.4 31.4 32.8 39.0 23.1 28.7 33.1 32.5 27.4 17.0 29.2 35.9 19.2 16.5 32.6 23.4 23.6 17.3 26.9 19.7 39.4 27.4 26.7 17.1 31.9 34.8 30.9 16.3 32.0 25.6 22.6 33.2 26.8 22.5 21.5 36.7 26.2 73.5 26.9 27.8 28.6 34.6 20.7 18.4 30.8 26.4 33.0 25.6 19.7 35.7 18.9 22.3 17.2 38.8 27.1 51.9 20.5 42.5 63.1 17.8 42.6 40.6 17.7 12.9 20.7 30.1 35.6 28.3 17.3 28.2 30.3 36.4 18.1 26.5 23.4 37.6 24.8 16.8 16.0 39.3 23.6 24.5 19.7 23.3 54.3 27.5 10.9 18.1 23.7 31.5 18.5 22.0 28.4 15.1 18.1 14.1 14.1 27.4 29.3 12.5 11.8 14.2 24.4 22.0 18.8 49.1 31.0 79.3 41.6 45.6 45.4 62.8 40.8 41.8 31.0 61.9 48.3 53.1 136.3 40.9 68.0 49.8 33.7 38.5 29.7 32.9 33.6 34.1 29.4 31.4 33.1 32.5 27.4 32.6 31.9 32.0 36.7 12.5 6.4 23.5 7.8 31.5 12.2 28.8 42.6 19.4 22.1 20.0 17.8 15.1 32.9 32.3 14.7 10.4 45.4 34.3 32.8 64.6 37.0 1.2 35.1 24.8 15.8 10.8 13.5 5.5 35.3 34.2 17.3 28.5 25.0 29.1 9.3 22.5 29.4 33.8 30.3 7.2 30.9 48.8 31.5 21.1 3.8 17.4 25.5 10.6 5.6 44.6 20.9 50.4 5.0 14.6 22.4 51.1 13.9 18.8 22.9 66.4 99.5 36.9 26.6 19.7 16.5 18.2 56.6 49.9 31.3 18.8 25.0 27.3 33.8 29.7 28.6 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733533-4739928 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 4051.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6" "Group enriched" "Detected in many" 7 "dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6" "Cell line enhanced" "Detected in many" "A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1100000 6800000 "Golgi apparatus" Vesicles "HPA053253: AB_2682091, HPA066315: AB_2685657" "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 27.8 18.2 18.0 56.5 19.7 71.0 29.6 20.9 31.0 19.9 22.0 22.1 46.1 11.8 15.5 24.8 24.2 54.5 7.9 17.4 28.1 19.7 53.1 106.9 23.9 28.0 20.5 13.5 10.6 21.0 62.2 14.6 31.4 26.8 16.4 26.1 10.3 47.5 14.5 2.6 22.0 39.6 17.8 25.1 44.2 41.5 113.4 23.8 12.7 10.6 3.3 18.0 61.2 14.4 30.8 86.5 12.4 0.4 44.7 0.7 3.1 11.5 1.1 8.9 11.2 15.6 63.5 58.4 0.1 10.0 1.5 8.6 97.9 20.0 14.1 5.3 8.9 14.8 0.4 1.7 29.5 8.5 0.1 15.8 0.7 26.6 5.9 1.3 7.4 3.1 0.9 0.4 0.7 0.8 20.9 0.3 1.8 0.4 42.1 7.2 1.2 0.0 13.2 30.4 15.8 0.4 1.4 17.6 11.3 5.5 2.3 57.4 1.4 0.4 1.5 6.8 2.2 5.3 3.0 3.9 0.1 0.5 2.9 2.4 0.6 63.3 16.7 0.5 107.5 0.7 9.5 1.1 0.8 38.2 13.0 0.8 1.2 103.2 0.6 141.6 16.0 0.1 29.2 18.0 19.7 20.9 31.0 17.4 28.1 28.0 20.5 13.5 26.8 25.1 23.8 30.8 9.7 73.7 46.6 1.6 17.4 70.1 130.4 133.4 40.5 2.6 64.8 50.3 0.8 58.6 132.4 40.5 2.1 3.4 11.1 28.1 3.9 151.0 795.4 22.1 4.1 25.4 30.9 2.7 0.1 145.9 2.5 14.2 36.7 32.7 74.1 2.3 132.1 9.0 196.4 3.3 0.3 32.2 44.7 231.6 406.3 4051.5 24.5 270.6 26.6 15.0 556.1 13.2 1.0 5.0 1.2 188.1 44.5 30.1 2.2 277.2 51.3 17.4 62.4 1.3 19.7 3.4 14.4 22.7 11.5 33.7 76.4 2.9 11.7 1.6 23.7 272.7 SCIMP "C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783" ENSG00000161929 "SLP adaptor and CSK interacting membrane protein" Q6UWF3 17 5208920-5234860 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.6" "Cell type enhanced" "Detected in many" "B-cells: 66.4;Hofbauer cells: 26.2;Kupffer cells: 120.3;Macrophages: 66.3;monocytes: 60.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 8 "classical monocyte: 110.6;intermediate monocyte: 239.0;memory B-cell: 145.8;myeloid DC: 84.2;naive B-cell: 124.5;non-classical monocyte: 265.5" "Group enriched" "Detected in all" 9 "B-cells: 145.8;dendritic cells: 84.2;monocytes: 265.5" "Cell line enhanced" "Detected in many" "HeLa: 6.8;U-698: 10.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006117 Enhanced NA NA "HPA006117: AB_1858633" "unprognostic (2.53e-2)" "unprognostic (7.88e-3)" "unprognostic (1.26e-2)" "unprognostic (5.79e-3)" "unprognostic (1.10e-1)" "unprognostic (3.87e-2)" "unprognostic (7.96e-2)" "unprognostic (1.73e-2)" "unprognostic (4.93e-2)" "unprognostic (2.99e-1)" "unprognostic (1.35e-1)" "unprognostic (8.05e-2)" "unprognostic (3.33e-2)" "unprognostic (2.07e-1)" "unprognostic (4.42e-2)" "unprognostic (1.77e-1)" "unprognostic (9.95e-2)" 6.0 4.1 0.7 30.7 0.1 5.2 1.4 2.0 1.3 1.5 2.9 4.5 5.4 2.9 1.1 1.9 3.1 7.4 1.7 0.4 0.1 2.3 10.6 16.3 39.7 0.1 0.3 0.0 3.6 3.9 0.8 0.7 3.9 0.7 3.2 4.7 7.5 4.0 1.4 4.3 3.2 10.3 6.2 0.0 49.6 5.0 2.8 0.1 5.2 3.4 0.8 45.3 6.1 0.6 0.4 1.0 1.5 2.5 3.3 0.0 0.0 2.5 1.1 0.0 0.0 0.0 0.7 2.1 4.8 0.9 0.0 1.8 1.0 0.0 0.0 0.0 0.8 2.1 2.0 6.8 0.7 0.0 0.2 0.7 0.0 0.1 0.0 0.2 1.2 0.0 4.2 0.1 1.2 0.0 1.6 2.4 0.7 1.1 0.3 1.4 2.2 0.5 0.5 0.0 0.6 1.8 0.8 1.8 0.6 1.3 0.7 2.6 2.4 0.3 0.3 1.1 1.4 0.6 0.7 0.3 10.8 1.2 0.3 0.7 16.8 110.6 3.0 1.3 239.0 1.5 145.8 0.8 1.2 84.2 124.5 1.7 1.2 19.0 5.3 265.5 3.2 1.4 68.0 0.7 0.1 2.0 1.3 0.4 0.1 0.1 0.3 0.0 0.7 0.0 0.1 0.4 0.5 0.0 4.4 2.6 66.4 0.4 0.4 0.0 0.0 2.5 0.4 0.5 0.4 1.5 0.6 0.0 12.5 0.3 1.5 0.0 0.0 0.7 1.4 0.4 0.3 2.0 0.0 0.4 6.5 0.9 0.3 0.6 0.0 0.1 1.3 0.4 3.3 1.9 26.2 1.7 4.9 0.0 0.0 120.3 4.2 0.7 0.3 66.3 0.0 8.4 60.3 0.4 10.3 4.0 2.3 0.4 0.0 0.4 1.7 0.3 0.0 1.0 1.6 4.1 0.0 0.7 0.3 0.5 0.8 0.0 0.4 0.1 3.2 0.2 0.0 0.4 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 64.1;Alveolar cells type 2: 59.4;Club cells: 31.1;granulocytes: 60.5;Respiratory ciliated cells: 56.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.9;THP-1: 3.7;U-87 MG: 3.7" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 1.8 4.1 0.0 0.2 0.0 0.6 1.6 0.1 0.2 1.8 0.0 1.6 0.0 1.4 0.0 2.1 1.4 0.0 2.3 0.2 0.0 3.6 2.1 2.5 0.0 0.0 0.0 0.0 1.6 1.5 0.1 3.6 0.0 0.0 1.5 0.0 0.0 1.8 0.1 2.3 1.8 1.7 0.1 0.0 2.7 1.9 1.7 0.1 0.0 1.8 0.0 0.1 1.2 1.6 0.0 0.7 2.0 0.2 0.3 0.0 0.0 0.6 1.3 1.0 1.5 1.1 1.3 0.6 1.0 0.1 0.0 0.1 0.3 0.4 2.9 0.4 0.0 2.4 0.0 1.3 0.5 1.4 0.0 0.3 0.0 0.0 0.9 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.7 1.1 1.3 1.2 0.3 0.6 0.8 0.0 0.0 0.4 0.4 0.2 1.0 0.0 0.0 0.2 0.1 0.3 3.7 0.0 0.0 0.1 1.9 0.5 0.0 0.4 0.2 3.7 0.3 0.0 2.4 2.3 1.9 0.5 1.6 0.8 1.0 0.7 0.4 2.0 0.9 0.6 0.6 3.8 0.5 1.8 2.1 0.5 1.7 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 64.1 59.4 0.0 2.6 0.4 0.0 0.3 0.6 0.0 0.9 0.3 0.0 0.0 31.1 0.0 0.0 0.3 0.7 3.2 3.9 8.3 0.0 0.3 0.2 6.5 5.4 1.3 0.0 8.2 0.2 5.3 0.0 0.3 60.5 0.0 0.7 0.1 0.6 0.0 0.0 3.2 0.0 1.2 0.8 0.0 0.3 14.8 0.0 0.0 4.8 0.0 0.0 0.0 0.0 7.7 6.1 0.4 2.8 0.1 3.9 0.5 56.2 0.0 0.0 0.1 1.3 0.2 0.1 2.0 1.0 0.8 5.9 0.1 2.6 0.1 BCL6B "BAZF, ZBTB28, ZNF62" ENSG00000161940 "BCL6B transcription repressor" Q8N143 17 7023050-7030290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA059147, HPA075112" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA059147: AB_2683928, HPA075112: AB_2732279" "unprognostic (5.61e-2)" "unprognostic (9.43e-3)" "unprognostic (2.33e-2)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (8.56e-5)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-1)" "unprognostic (6.10e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (7.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "unprognostic (4.26e-2)" 30.1 5.7 9.9 5.8 6.1 0.1 15.6 5.9 8.8 5.8 5.0 4.2 3.2 7.7 0.7 3.8 5.1 13.5 16.3 7.1 6.3 8.1 4.0 29.1 5.5 7.3 6.6 4.6 3.0 3.9 3.1 5.6 20.1 7.2 4.5 2.2 0.6 4.0 3.5 11.6 4.0 4.9 7.8 5.9 13.1 4.3 2.0 10.4 2.1 12.1 14.9 2.1 8.0 4.8 10.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 18.2 0.0 0.0 0.5 0.0 53.2 0.0 0.0 0.0 0.1 0.0 96.2 0.2 3.4 0.4 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 38.2 0.8 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 6.1 5.9 8.8 7.1 6.3 7.3 6.6 4.6 7.2 5.9 10.4 10.1 37.8 3.2 4.2 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 45.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.1 23.6 0.2 0.1 0.0 0.0 0.2 0.0 1.9 2.3 0.0 0.0 0.3 3.6 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.4 0.0 0.1 0.0 0.2 0.0 0.9 0.8 0.6 1.5 0.4 1.3 0.1 0.2 0.9 0.0 0.5 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "liver: 847.6" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 878.6" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 110.0;myeloid DC: 64.1" "Group enriched" "Detected in many" 51 "dendritic cells: 64.1;monocytes: 110.0" "Cell line enriched" "Detected in some" 9 "Hep G2: 528.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA 14000000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 1.2 0.3 0.8 8.0 0.9 7.0 0.5 0.8 1.5 0.4 1.5 0.5 0.3 0.3 0.1 0.5 0.6 17.8 0.4 1.1 1.2 1.2 847.6 2.5 0.9 1.1 0.9 0.7 0.2 0.5 0.1 0.2 0.5 0.9 0.4 0.4 0.0 0.5 0.2 0.2 5.3 0.6 1.3 1.0 6.9 0.5 0.5 1.2 0.5 0.3 0.1 1.1 2.0 0.4 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 528.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.3 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 1.0 110.0 0.8 0.1 11.2 0.2 0.0 0.0 0.0 64.1 0.0 0.1 0.0 1.7 0.1 0.1 1.6 0.3 31.8 0.8 0.9 0.8 1.5 1.1 1.2 1.1 0.9 0.7 0.9 1.0 1.2 1.5 0.0 0.0 5.1 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 150.2 0.0 0.0 0.0 0.1 0.0 0.1 1.9 0.0 0.4 0.0 0.0 1.3 7.1 19.6 1.9 0.0 0.2 0.1 0.0 0.1 2.5 0.0 16.1 878.6 8.4 0.0 0.1 0.1 0.0 41.1 7.7 0.7 0.0 19.6 0.0 0.0 15.3 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 6.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.3 0.4 1.4 0.0 0.0 0.1 TNFSF13 "APRIL, CD256" ENSG00000161955 "TNF superfamily member 13" O75888 17 7558292-7561608 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 143.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 10.4;Basal squamous epithelial cells: 8.0;Erythroid cells: 5.9;Gastric mucus-secreting cells: 11.2;Macrophages: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 438.1;intermediate monocyte: 420.9" "Group enriched" "Detected in all" 12 "dendritic cells: 283.5;granulocytes: 158.9;monocytes: 438.1" "Cell line enhanced" "Detected in many" "EFO-21: 43.6;RPMI-8226: 39.9;RPTEC TERT1: 110.6;U-937: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004863 Uncertain "Secreted to blood" NA NA 6770000 35000 "HPA004863: AB_1078187" "unprognostic (2.46e-2)" "unprognostic (2.20e-1)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (3.57e-1)" "unprognostic (3.32e-2)" "unprognostic (3.70e-2)" "unprognostic (3.75e-1)" "unprognostic (1.15e-1)" "unprognostic (6.95e-2)" "unprognostic (2.65e-1)" "prognostic favorable (1.30e-9)" "unprognostic (4.69e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.38e-2)" 27.9 31.9 36.4 38.1 38.9 48.8 29.8 38.0 47.7 33.8 58.4 46.4 75.4 13.5 19.3 12.6 32.1 54.6 13.8 32.8 43.3 53.7 16.3 101.6 33.4 42.6 38.3 30.2 25.0 41.4 18.1 19.8 14.8 41.2 22.8 42.3 13.1 143.1 32.4 5.4 10.3 39.8 25.0 35.9 30.8 54.5 4.6 41.5 14.2 27.2 10.2 24.8 26.3 15.6 37.4 20.8 8.3 2.8 5.5 3.2 1.7 3.4 3.7 2.7 1.5 1.3 4.6 12.8 9.1 43.6 3.8 5.2 13.1 0.1 3.6 1.6 16.2 7.0 5.9 18.2 9.7 6.7 5.1 5.9 3.6 3.6 1.0 5.7 8.8 4.7 6.5 4.6 3.5 1.3 3.1 2.3 16.6 2.7 20.3 6.0 16.5 3.4 39.9 110.6 13.5 5.1 4.9 7.2 18.8 2.5 4.1 25.2 12.4 2.4 4.8 5.8 2.1 8.1 0.8 2.8 2.4 1.9 44.1 9.5 75.2 438.1 158.9 0.9 420.9 0.8 13.7 0.5 0.7 283.5 25.0 2.4 1.5 56.9 7.9 265.4 130.8 0.9 257.1 36.4 38.9 38.0 47.7 32.8 43.3 42.6 38.3 30.2 41.2 35.9 41.5 37.4 0.2 6.4 10.4 0.0 2.1 0.0 0.2 0.2 8.0 0.1 0.4 0.1 0.0 0.0 2.0 1.8 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.2 0.1 0.0 1.2 5.9 0.0 0.2 0.0 2.9 11.2 0.4 2.5 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 19.5 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.7 0.3 1.5 0.2 0.0 0.1 0.2 0.0 0.0 2.6 0.0 0.0 0.8 0.1 0.6 0.2 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO specific peptidase 3" Q9H4L4 17 7561919-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" HPA060290 Supported Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA060290: AB_2684244" "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 23.9 24.2 44.6 21.2 44.0 25.6 23.9 40.2 48.3 23.5 39.0 30.1 21.4 26.9 27.6 25.6 26.1 19.5 23.8 44.0 41.6 26.9 20.7 28.9 26.7 43.1 43.6 44.1 27.0 26.6 38.4 26.6 22.7 43.8 23.2 25.6 24.9 25.0 26.3 33.8 28.7 25.4 29.1 40.8 28.5 27.2 29.3 43.9 34.1 24.1 31.2 31.4 30.0 22.0 43.7 76.4 90.8 52.7 82.5 58.6 42.8 54.8 54.8 56.0 93.4 87.2 54.9 32.5 90.3 52.6 72.7 62.3 72.0 114.4 85.8 78.0 63.7 105.0 46.7 74.8 56.9 79.1 44.0 57.9 55.1 86.5 107.1 103.5 53.3 76.0 102.1 61.5 24.7 73.0 51.4 107.9 33.6 64.2 70.9 54.5 97.1 48.8 52.4 62.9 44.0 52.5 67.6 55.3 52.7 60.0 66.6 44.1 28.5 40.5 53.0 45.9 51.3 119.0 36.3 40.4 57.3 53.9 45.7 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 44.6 44.0 40.2 48.3 44.0 41.6 43.1 43.6 44.1 43.8 40.8 43.9 43.7 4.5 3.2 5.4 0.0 4.9 8.5 6.4 1.6 10.2 6.1 6.7 11.0 7.1 7.2 3.6 1.8 22.9 3.0 4.8 2.6 0.0 2.3 1.4 4.0 4.2 4.7 6.6 1.3 0.0 2.4 2.3 3.8 3.6 4.7 1.3 5.2 8.2 2.7 1.5 6.7 0.0 3.0 2.0 6.0 6.4 0.7 4.1 4.9 3.6 0.0 4.7 5.5 4.1 0.0 0.0 2.1 0.8 2.2 6.4 6.1 4.0 1.1 2.1 7.3 0.0 5.2 4.4 3.7 4.0 7.4 11.6 4.1 4.9 3.0 3.7 6.4 FGF11 "FHF3, FLJ16061, MGC102953, MGC45269" ENSG00000161958 "Fibroblast growth factor 11" Q92914 17 7438273-7444937 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 31.4" "Cell type enhanced" "Detected in many" "Astrocytes: 10.4;Basal respiratory cells: 10.2;Horizontal cells: 18.5;Muller glia cells: 15.2;Suprabasal keratinocytes: 9.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 10.4;HaCaT: 18.4;LHCN-M2: 12.1" "Low region specificity" "Detected in all" "HPA066605, HPA075188" Enhanced Approved Centrosome NA NA Centrosome "HPA066605: AB_2685693, HPA075188: AB_2732283" "unprognostic (7.35e-2)" "unprognostic (1.14e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-4)" "unprognostic (9.15e-2)" "unprognostic (3.28e-2)" "unprognostic (7.31e-2)" "unprognostic (3.11e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.69e-2)" "unprognostic (2.89e-3)" "unprognostic (2.00e-6)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.90e-3)" "unprognostic (4.97e-3)" 3.6 31.4 7.5 1.5 8.1 0.9 3.5 12.3 6.7 6.5 3.8 0.9 0.6 2.1 0.6 20.0 1.6 1.5 11.4 7.2 6.9 4.3 0.8 1.1 3.6 9.8 9.0 5.2 1.7 0.9 0.7 1.5 0.7 12.4 1.6 0.4 14.9 5.8 0.5 7.6 18.5 1.6 1.2 6.2 2.4 1.0 2.4 12.2 2.0 7.0 8.7 5.2 1.4 15.6 8.8 10.4 0.6 5.5 0.1 3.2 0.1 2.7 0.3 3.4 0.4 0.7 0.2 1.1 3.1 0.7 0.2 0.1 18.4 2.1 5.8 1.3 6.4 4.5 5.6 0.7 1.4 0.5 0.2 6.0 0.6 1.6 0.4 0.2 0.6 0.2 2.3 2.2 0.2 12.1 2.4 1.9 2.5 2.0 0.4 0.2 4.9 5.1 1.3 0.7 0.8 1.2 5.7 0.7 0.7 0.5 3.1 0.3 0.4 0.2 0.3 5.7 0.0 0.3 0.4 1.5 0.9 1.4 3.5 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 8.1 12.3 6.7 7.2 6.9 9.8 9.0 5.2 12.4 6.2 12.2 8.8 1.8 0.0 0.0 10.4 0.3 5.5 0.4 10.2 7.4 4.7 1.5 1.5 0.4 1.5 4.5 1.8 6.2 0.4 0.5 1.0 3.9 0.6 3.3 1.5 0.9 2.4 0.0 0.0 0.1 0.2 0.4 0.9 0.0 3.9 0.0 2.0 1.4 0.2 0.4 18.5 0.8 0.5 0.0 0.6 2.6 4.6 1.8 0.9 1.8 2.8 0.0 15.2 0.0 5.5 0.3 1.1 0.2 2.2 0.2 0.5 0.8 0.2 7.0 2.8 0.0 2.3 1.6 3.4 2.7 6.3 9.7 0.7 0.5 0.1 0.6 1.2 EIF4A1 "DDX2A, EIF-4A, EIF4A" ENSG00000161960 "Eukaryotic translation initiation factor 4A1" P60842 17 7572824-7579006 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011689, HPA068286" Uncertain Approved Cytosol NA NA 4100000 Cytosol "CAB011689: AB_732122, HPA068286: AB_2685968" "unprognostic (1.49e-2)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.17e-1)" "unprognostic (2.49e-1)" "unprognostic (2.12e-3)" "unprognostic (7.25e-2)" "unprognostic (2.89e-2)" "unprognostic (2.72e-2)" "unprognostic (2.11e-2)" "unprognostic (2.65e-2)" "unprognostic (5.19e-3)" "prognostic unfavorable (1.76e-8)" "unprognostic (1.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.16e-1)" "unprognostic (1.13e-2)" 429.8 376.4 111.9 299.2 118.7 419.7 357.2 119.0 130.6 272.9 120.9 254.7 201.5 292.8 198.4 570.8 310.6 231.5 226.5 113.6 159.0 222.7 331.0 341.9 288.7 129.8 117.3 111.1 305.4 363.5 151.6 191.7 304.4 125.0 221.0 292.4 119.6 270.8 170.3 283.5 374.3 230.9 319.4 125.8 293.8 315.8 161.1 126.8 312.1 172.8 123.5 388.3 511.8 324.3 129.4 1048.3 1396.3 914.1 833.9 802.7 931.9 852.4 977.9 1104.0 1770.4 1356.8 1420.1 457.7 1428.7 735.7 1032.2 774.7 907.6 1962.5 1505.4 1890.2 468.1 1454.0 799.3 854.7 1597.9 1226.2 826.4 771.9 1244.8 763.3 1491.8 1510.3 1055.1 1351.6 784.4 831.1 284.9 1294.2 1092.6 865.0 704.8 789.1 1068.6 952.6 802.1 691.1 682.2 1249.8 939.1 481.2 934.2 883.0 585.6 1273.8 679.4 651.5 625.1 976.1 930.2 649.9 603.8 2010.9 276.0 425.7 921.2 1000.8 999.3 1045.7 318.5 1639.1 408.1 463.4 1377.5 755.2 469.1 493.1 497.9 1905.9 412.2 477.7 488.1 157.1 658.5 1076.3 727.7 682.0 2945.6 111.9 118.7 119.0 130.6 113.6 159.0 129.8 117.3 111.1 125.0 125.8 126.8 129.4 212.3 115.4 239.6 0.0 139.7 1342.5 678.5 1913.6 173.0 113.5 191.0 183.4 6.8 104.4 799.6 73.5 116.7 345.6 185.8 100.5 152.6 295.4 32.4 120.7 171.6 286.1 116.1 139.6 0.0 231.4 370.5 299.2 129.5 165.0 149.1 237.5 154.2 63.8 212.1 106.0 0.0 117.3 767.0 160.4 1330.1 42.0 160.9 206.7 725.7 0.0 133.3 120.7 119.4 0.0 0.0 313.9 123.3 109.1 134.7 342.8 151.8 174.0 446.1 119.4 151.2 374.4 871.4 71.5 102.8 154.0 1233.4 636.9 224.2 197.1 135.9 474.6 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383213 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 2568.2 1849.8 1460.9 1236.3 1491.2 3895.9 4244.7 1460.3 2321.7 2834.7 1444.3 2121.2 1297.9 1927.0 2248.6 2586.4 2273.7 1408.8 1736.2 1421.1 1525.5 2017.2 1841.0 1629.7 3072.5 1498.8 1458.3 1394.8 4771.8 3646.9 1261.1 1075.3 1549.1 1519.3 2043.8 2063.7 823.0 2090.1 1284.8 2647.5 2893.6 1937.9 1391.6 1551.8 2076.9 2155.6 553.1 1499.4 2261.8 1943.3 1928.4 2863.7 2198.5 2582.1 1560.9 2791.7 2553.3 2428.3 2899.9 4595.7 7595.7 2377.2 2357.4 3627.6 3234.3 2430.6 2732.4 1406.4 4875.0 2641.6 2899.3 1278.3 3012.9 3173.2 4954.7 3806.7 1824.4 5711.8 1893.9 2682.1 3218.0 5344.6 2835.2 2347.9 6463.5 9908.8 2638.4 7949.9 4443.9 4106.5 2739.0 2210.9 1423.8 3478.6 1967.6 3153.9 3903.4 2275.5 2924.4 1691.8 3097.3 2453.7 3094.4 4394.8 2116.9 1014.7 2144.2 1268.6 2353.7 5882.6 2142.4 2417.5 3740.1 2492.5 1270.3 1564.9 1765.2 4201.2 1119.0 1485.1 2188.6 2074.1 4071.7 1920.7 490.8 1528.6 300.6 1323.8 1277.1 1928.7 2409.5 1960.7 1734.1 1901.2 2152.5 2270.0 2008.9 167.6 1562.4 1173.0 1634.7 1803.3 3235.4 1460.9 1491.2 1460.3 2321.7 1421.1 1525.5 1498.8 1458.3 1394.8 1519.3 1551.8 1499.4 1560.9 2207.3 897.4 1239.5 29.0 4966.6 5577.5 3390.4 3434.2 4618.4 256.5 5263.8 5691.4 292.0 3039.7 1994.1 1004.2 133.5 4514.0 3481.7 1395.1 3946.3 2664.5 884.0 1146.1 2485.1 2507.8 2284.5 2894.1 39.3 4897.5 7026.7 2100.3 1725.3 1470.3 1868.6 1738.7 3416.5 2960.2 3431.5 136.3 33.9 4440.7 1062.0 5356.7 6335.6 1657.9 4777.0 3085.5 3198.1 45.9 6036.5 747.5 3887.8 22.1 39.7 3561.4 3590.4 2157.9 2546.9 3577.0 3412.0 5475.1 856.5 477.7 1512.0 4011.2 2218.8 568.4 716.4 6164.5 7093.8 4568.3 3804.2 2012.8 4955.7 3367.7 CCDC42 "CCDC42A, FLJ32734" ENSG00000161973 "Coiled-coil domain containing 42" Q96M95 17 8729935-8745219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 292 "testis: 95.8" "Cell type enhanced" "Detected in some" "Early spermatids: 103.6;Late spermatids: 52.2;Spermatocytes: 284.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (1.66e-1)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (3.60e-2)" "unprognostic (9.24e-2)" "unprognostic (1.13e-4)" "unprognostic (8.35e-2)" "unprognostic (9.71e-2)" "unprognostic (3.06e-2)" "unprognostic (4.36e-3)" "unprognostic (6.08e-2)" "unprognostic (1.04e-5)" "unprognostic (5.74e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 95.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 103.6 0.0 0.0 0.2 0.0 2.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.2 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 284.7 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 POLR3K "C11, RPC11" ENSG00000161980 "RNA polymerase III subunit K" Q9Y2Y1 16 46407-53608 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 183.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005891 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005891: AB_1079653" "unprognostic (3.00e-1)" "unprognostic (1.50e-3)" "unprognostic (1.53e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-1)" "unprognostic (1.40e-1)" "unprognostic (8.03e-3)" "unprognostic (9.06e-2)" "unprognostic (7.40e-2)" "unprognostic (5.72e-2)" "unprognostic (9.96e-2)" "unprognostic (1.84e-1)" "unprognostic (7.36e-3)" "unprognostic (2.68e-2)" "unprognostic (3.63e-2)" "unprognostic (3.53e-2)" "unprognostic (9.63e-2)" 6.3 10.5 12.4 13.2 13.2 11.7 7.0 12.5 13.1 6.4 11.3 7.9 8.4 6.9 7.4 8.8 7.5 5.3 10.4 12.7 12.9 8.1 9.0 6.6 18.6 12.2 12.6 12.9 7.1 7.0 12.4 6.1 6.8 12.7 8.1 7.7 5.1 8.4 6.9 20.7 5.1 8.6 6.8 12.0 12.0 8.5 2.6 13.3 13.3 9.6 12.7 16.4 8.9 5.8 13.8 36.1 60.9 37.7 39.4 15.2 9.4 30.3 50.2 16.0 43.4 28.7 79.4 38.2 93.1 37.1 17.7 17.3 35.0 88.5 23.0 31.0 56.5 82.1 68.2 44.5 56.6 11.6 62.1 64.3 9.2 20.4 48.3 24.3 9.9 21.7 40.9 99.0 29.0 28.4 89.9 75.1 41.2 62.3 44.8 57.4 89.9 43.7 96.7 25.0 25.7 55.1 32.5 34.7 63.2 30.8 15.9 37.2 55.2 20.9 28.1 34.5 37.8 61.6 18.5 47.5 183.8 12.1 45.1 42.5 30.5 36.3 93.2 40.4 54.7 42.1 114.6 51.3 46.5 34.4 109.9 45.8 42.6 27.7 41.2 51.8 70.2 87.6 53.1 12.4 13.2 12.5 13.1 12.7 12.9 12.2 12.6 12.9 12.7 12.0 13.3 13.8 23.3 3.2 11.3 2.0 31.8 33.3 19.9 34.4 17.6 16.4 29.7 33.8 28.9 18.6 30.3 18.4 4.2 42.5 28.2 17.6 49.0 34.0 0.7 21.6 15.6 20.0 18.0 38.3 5.1 35.0 51.1 16.9 9.2 14.9 22.2 29.7 20.7 27.5 43.7 10.1 4.6 21.8 71.2 15.1 24.3 1.8 21.1 23.2 23.2 3.7 44.1 23.5 34.0 1.0 3.4 37.0 16.2 16.6 28.1 29.6 17.1 43.4 30.6 10.8 13.1 12.0 25.2 4.5 18.9 23.4 44.2 12.9 23.1 58.8 29.3 22.1 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53828-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 156.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 219.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: AB_2677353, HPA044248: AB_2678873" "unprognostic (7.87e-2)" "prognostic favorable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 15.3 29.6 82.2 20.8 81.7 33.0 16.3 96.2 99.1 13.5 74.7 25.0 13.0 16.0 16.4 20.2 16.1 10.5 73.6 82.0 81.4 25.1 39.5 10.9 32.9 86.0 83.7 79.9 20.0 19.8 24.9 30.9 8.8 88.0 20.0 17.7 12.5 23.1 13.9 132.9 10.7 16.6 15.3 82.6 19.2 27.8 11.1 87.6 22.7 17.9 85.2 31.5 17.4 12.0 84.0 50.1 111.2 60.7 70.8 21.2 24.9 29.5 41.4 26.5 90.7 76.1 150.4 47.5 157.3 48.3 34.2 48.6 50.4 111.8 76.2 69.2 57.3 87.8 91.6 155.3 152.9 22.4 168.9 103.9 32.1 27.0 80.8 22.4 19.6 49.6 93.5 139.2 36.5 52.2 236.5 89.5 70.0 72.8 88.4 54.5 141.9 64.6 186.9 48.6 34.7 66.2 42.9 93.4 119.8 20.7 59.0 77.5 80.8 39.3 40.0 49.6 51.8 67.2 37.6 96.9 248.2 21.3 89.5 62.3 15.1 25.5 93.3 14.9 40.3 17.9 74.3 15.1 17.9 49.6 75.1 15.9 16.3 17.2 22.5 35.9 219.7 26.1 23.2 82.2 81.7 96.2 99.1 82.0 81.4 86.0 83.7 79.9 88.0 82.6 87.6 84.0 16.5 12.8 14.3 6.8 53.4 18.6 27.2 39.5 14.8 17.9 48.1 51.9 113.0 18.6 29.3 33.1 4.2 54.6 62.3 30.9 156.5 41.6 3.0 27.3 23.8 18.9 44.0 58.5 9.9 51.4 63.3 29.3 30.1 36.9 4.5 62.3 16.4 67.5 114.5 11.8 9.8 34.5 69.2 26.4 59.8 6.5 21.5 36.2 62.2 5.6 94.3 89.0 32.0 4.5 6.5 31.0 44.8 29.7 65.9 31.5 24.0 87.6 53.2 14.5 6.6 29.4 35.7 33.7 44.8 35.8 21.9 26.1 22.4 105.0 53.5 27.7 PRR35 C16orf11 ENSG00000161992 "Proline rich 35" P0CG20 16 560394-565529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 44.7" "Cell type enriched" "Detected in some" 9 "Collecting duct cells: 36.8" "Not detected" "Not detected" "Group enriched" "Detected in many" 12 "cerebellum: 44.7;pons: 17.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.5" "Not detected" "Not detected" HPA069297 Uncertain Approved "Nucleoli,Cytokinetic bridge,Cytosol" Yes NA Nucleoli "Cytokinetic bridge, Cytosol" "HPA069297: AB_2686113" "unprognostic (6.96e-2)" "unprognostic (3.08e-2)" "unprognostic (5.25e-1)" "unprognostic (8.11e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 44.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 10.5 0.0 0.0 0.0 0.2 2.6 0.0 0.0 1.1 0.0 0.0 0.0 17.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.7 1.4 0.2 0.2 0.2 2.6 0.0 17.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.1 0.0 1.3 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WDR90 "C16orf15, C16orf16, C16orf17, C16orf18, C16orf19, FLJ36483, KIAA1924, POC16" ENSG00000161996 "WD repeat domain 90" Q96KV7 16 649311-667833 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 32.3;Respiratory ciliated cells: 57.6;Rod photoreceptor cells: 34.7;Spermatocytes: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA049362, HPA061785" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049362: AB_2680728, HPA061785: AB_2684606" "unprognostic (1.97e-2)" "unprognostic (1.50e-2)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.89e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.67e-2)" "unprognostic (8.28e-2)" "unprognostic (5.23e-2)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (9.96e-3)" "unprognostic (2.84e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-1)" "unprognostic (4.25e-2)" "unprognostic (4.48e-2)" 8.2 16.4 8.8 3.4 8.6 11.6 11.0 9.3 12.4 16.1 9.3 11.1 6.0 13.4 3.2 10.6 22.3 3.7 8.7 8.6 8.8 16.5 11.0 10.1 4.0 8.8 9.0 8.3 21.7 15.8 4.5 26.1 2.5 8.8 15.3 2.2 4.7 9.6 5.5 4.7 9.8 9.4 2.3 8.3 7.5 11.8 61.7 8.6 5.1 22.4 1.4 2.0 10.1 10.6 9.2 10.2 14.1 7.8 18.8 2.9 1.9 0.5 7.4 2.8 5.4 6.3 18.2 14.0 8.8 5.7 2.3 0.1 22.0 3.8 6.0 1.2 15.0 13.7 2.9 57.2 16.9 0.8 15.7 13.4 3.8 4.7 10.8 2.5 2.0 4.0 13.7 1.0 21.9 2.4 7.4 12.5 15.0 7.6 8.4 4.4 34.7 3.1 14.6 6.0 9.4 14.6 15.3 6.8 13.9 1.6 0.5 28.7 12.9 4.3 13.0 13.1 14.3 9.8 22.0 10.4 9.7 3.8 8.5 8.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 8.8 8.6 9.3 12.4 8.6 8.8 8.8 9.0 8.3 8.8 8.3 8.6 9.2 4.5 0.0 9.1 10.4 1.1 3.4 2.8 4.5 3.4 9.4 9.7 10.4 4.9 14.3 6.9 9.2 14.6 2.8 0.7 10.1 0.0 5.4 5.6 32.3 6.5 4.3 1.2 2.5 5.0 3.8 2.6 5.9 12.2 9.9 0.0 15.1 1.8 4.5 2.7 11.8 5.5 6.9 0.0 0.8 2.5 4.0 6.2 2.2 3.6 5.6 0.3 5.6 0.0 1.5 2.6 4.5 3.1 4.5 1.3 2.7 3.0 2.1 57.6 34.7 6.6 8.3 5.1 34.2 20.7 3.0 2.3 2.5 1.5 8.3 10.8 2.0 JMJD8 C16orf20 ENSG00000161999 "Jumonji domain containing 8" Q96S16 16 681670-684528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.32e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-2)" "unprognostic (1.63e-2)" "unprognostic (4.96e-3)" "unprognostic (5.53e-2)" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "unprognostic (7.04e-2)" 24.7 26.1 16.9 14.6 16.8 17.5 17.4 16.3 23.9 26.1 27.2 18.6 17.7 25.1 30.8 24.9 29.8 21.5 37.5 17.3 21.9 23.2 23.3 19.4 15.7 19.3 17.3 15.0 23.9 41.4 31.7 14.1 15.5 16.9 24.0 11.0 7.5 40.9 32.9 13.2 22.6 15.5 22.1 17.0 15.8 19.5 15.8 18.0 15.2 32.5 14.7 10.9 22.5 15.6 16.6 21.5 59.5 14.6 63.0 59.8 22.9 8.5 26.3 49.0 26.9 30.6 33.7 49.8 7.4 28.2 38.1 0.3 36.8 17.4 34.2 10.2 28.6 27.5 15.5 32.5 4.3 26.4 35.7 27.3 27.3 22.8 18.0 20.9 20.1 41.4 14.9 20.0 40.8 16.1 52.8 18.8 28.1 34.9 35.5 25.3 22.6 3.8 76.3 54.0 13.4 26.1 28.3 38.1 43.0 9.3 8.4 44.3 33.3 21.8 1.9 21.5 12.8 15.6 23.7 14.5 9.5 7.1 16.6 22.5 0.2 6.3 0.1 5.0 5.2 6.5 3.9 5.7 5.0 7.3 4.6 4.8 4.8 0.2 3.4 4.8 4.9 6.7 3.0 16.9 16.8 16.3 23.9 17.3 21.9 19.3 17.3 15.0 16.9 17.0 18.0 16.6 33.8 9.6 21.3 5.5 14.0 13.8 21.1 7.2 14.2 15.2 34.5 37.6 11.5 21.5 11.3 23.9 14.6 35.8 19.8 26.2 29.4 46.4 21.2 22.5 23.9 19.8 21.6 9.2 4.3 42.0 40.7 29.1 15.8 18.8 2.5 29.9 15.4 26.8 20.5 16.8 5.0 17.0 8.2 16.1 17.3 50.1 23.3 13.9 17.8 1.9 15.5 31.8 17.5 3.5 4.4 31.0 10.7 29.3 19.9 23.3 15.4 30.6 11.0 21.2 0.0 16.3 32.0 22.4 13.0 18.8 19.5 30.4 14.2 39.2 23.5 18.3 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "fallopian tube: 50.7" "Group enriched" "Detected in some" 11 "Endometrial ciliated cells: 179.7;Respiratory ciliated cells: 240.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.2;U-266/70: 9.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.3 1.1 3.2 1.7 3.4 1.5 0.4 4.7 4.4 1.9 3.1 0.2 0.3 1.7 0.1 0.5 50.7 0.9 0.6 4.1 5.1 0.9 0.1 10.1 2.2 6.3 5.2 2.1 0.5 1.0 0.7 5.0 0.5 4.4 0.6 0.3 0.8 1.2 0.7 0.5 0.7 1.9 0.1 5.3 2.2 1.1 0.6 4.0 0.9 0.6 0.2 0.8 0.9 0.3 5.9 1.8 3.1 1.1 5.4 1.1 1.2 2.8 1.1 2.2 0.5 0.1 0.8 2.8 2.0 0.4 0.3 1.0 1.7 2.8 1.1 0.1 9.0 2.1 2.3 4.8 1.4 0.8 1.5 1.5 2.5 0.4 0.1 3.3 2.4 0.2 3.7 1.4 2.4 0.8 8.6 0.0 4.5 1.5 1.3 0.8 2.1 0.9 6.6 2.5 1.7 12.2 2.1 0.9 3.6 0.9 0.9 4.5 1.7 0.9 1.5 0.5 0.4 0.3 9.9 4.7 1.9 0.8 3.2 2.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 3.2 3.4 4.7 4.4 4.1 5.1 6.3 5.2 2.1 4.4 5.3 4.0 5.9 0.1 0.0 0.0 2.6 1.9 0.0 0.1 17.9 0.0 3.5 0.7 0.6 0.5 0.0 17.7 0.0 0.0 0.0 3.4 0.2 1.9 0.0 0.0 179.7 2.1 0.1 0.0 0.4 1.4 0.2 0.1 0.2 1.1 2.4 0.0 0.0 0.0 0.0 0.9 3.3 1.0 0.0 18.3 0.6 0.0 0.1 0.3 0.5 0.0 1.0 0.1 0.7 2.1 1.0 2.0 0.3 0.0 0.0 0.2 0.6 0.0 0.2 240.7 0.2 0.0 0.0 7.6 0.8 0.9 0.0 0.1 0.0 1.4 0.1 0.1 0.2 MSLNL "C16orf37, MPFL" ENSG00000162006 "Mesothelin like" Q96KJ4 16 769428-783370 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CAPAN-2: 11.2;HeLa: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (5.26e-4)" "unprognostic (3.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.38e-2)" "unprognostic (1.54e-1)" "unprognostic (3.73e-3)" "unprognostic (6.50e-2)" "unprognostic (2.09e-1)" "unprognostic (5.36e-2)" "unprognostic (2.16e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSTR5 ENSG00000162009 "Somatostatin receptor 5" P35346 16 1078781-1080142 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.5;heart muscle: 6.4;pituitary gland: 7.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "Hep G2: 15.4;PC-3: 54.7" "Group enriched" "Detected in some" 5 "basal ganglia: 4.1;hypothalamus: 2.3" "Low region specificity" "Detected in many" HPA066503 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA066503: AB_2685679" "unprognostic (2.16e-2)" "unprognostic (7.31e-2)" "unprognostic (3.69e-2)" "unprognostic (2.39e-2)" "unprognostic (2.14e-1)" "unprognostic (9.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.72e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (4.09e-2)" 0.0 2.5 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 6.4 0.3 1.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 7.4 0.0 0.1 0.7 0.0 0.2 1.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 54.7 0.0 2.1 0.6 0.0 2.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.3 1.0 0.2 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPSB3 "C16orf31, SSB-3" ENSG00000162032 "SplA/ryanodine receptor domain and SOCS box containing 3" Q6PJ21 16 1776712-1793700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046602 Uncertain Approved Mitochondria NA NA Mitochondria "HPA046602: AB_2679717" "unprognostic (1.18e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-3)" "unprognostic (1.82e-1)" "unprognostic (8.91e-4)" "unprognostic (1.07e-2)" "unprognostic (8.31e-2)" "unprognostic (5.65e-2)" "unprognostic (8.43e-2)" "unprognostic (3.41e-2)" "unprognostic (4.83e-2)" "unprognostic (5.25e-7)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-1)" "unprognostic (4.72e-4)" 25.2 45.1 24.1 7.8 24.1 21.4 26.1 33.0 40.5 25.8 20.3 25.6 14.8 21.4 3.3 36.4 23.9 10.1 26.0 23.4 23.1 24.3 42.2 20.8 12.5 25.0 24.9 21.6 37.4 44.4 11.5 15.5 10.4 25.7 23.5 5.2 9.7 26.6 15.6 89.2 46.8 19.0 5.7 25.1 23.5 28.1 17.4 25.1 26.3 19.9 31.3 7.9 23.4 29.0 28.1 7.3 9.1 9.7 13.4 13.6 12.5 19.8 10.6 11.0 11.5 12.6 8.4 20.0 3.2 17.4 6.0 4.5 13.9 4.8 10.9 1.8 14.7 15.0 5.2 13.9 10.4 20.2 4.5 12.0 11.3 26.8 7.2 8.4 17.1 17.5 22.1 7.8 15.4 5.4 24.0 16.3 16.0 8.1 10.8 7.1 29.7 5.9 26.7 10.6 1.3 12.9 16.6 12.6 27.8 29.4 6.9 16.1 18.0 16.1 5.6 10.6 10.5 5.5 26.1 28.2 8.9 5.4 8.9 5.9 112.3 44.8 83.4 67.9 41.8 81.2 46.8 63.1 61.7 42.3 44.2 43.6 46.6 91.5 45.7 37.2 42.8 100.7 48.4 24.1 24.1 33.0 40.5 23.4 23.1 25.0 24.9 21.6 25.7 25.1 25.1 28.1 74.2 38.5 32.1 29.7 56.1 98.4 53.3 72.7 60.3 74.1 64.1 83.7 0.2 40.0 54.9 55.2 39.6 63.0 104.2 68.6 52.8 50.8 46.7 29.4 32.3 46.1 48.7 50.5 18.2 47.6 74.8 42.8 65.2 37.8 35.4 76.2 57.1 62.5 31.8 90.9 19.4 57.8 38.7 42.7 72.2 91.6 77.0 44.8 76.5 24.4 61.6 76.0 99.9 24.6 30.7 45.3 83.2 74.9 61.2 50.5 96.3 50.6 37.2 89.8 39.5 34.0 45.3 23.8 39.7 37.0 128.3 64.4 87.8 33.2 52.7 54.3 MEIOB "C16orf73, MGC35212" ENSG00000162039 "Meiosis specific with OB-fold" Q8N635 16 1833986-1884294 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 37.4" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 499.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 27.6;K-562: 92.7;THP-1: 76.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (7.18e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-2)" "unprognostic (9.73e-2)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (2.00e-2)" "unprognostic (2.68e-2)" "unprognostic (7.30e-3)" "unprognostic (1.34e-1)" "unprognostic (3.80e-1)" "unprognostic (2.18e-3)" 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 1.0 0.3 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.9 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.1 37.4 0.1 0.9 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.7 0.1 0.0 1.5 0.0 0.0 4.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.6 9.4 0.8 0.0 0.4 1.1 76.2 1.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.5 58.0 0.1 0.3 0.2 0.0 0.0 2.6 0.0 0.2 0.2 0.0 0.2 4.5 2.3 0.0 0.0 0.1 3.3 4.1 0.0 0.0 0.0 0.0 15.9 1.8 0.2 0.0 0.0 0.0 0.1 0.0 1.0 2.1 0.1 0.0 1.5 0.0 0.3 0.0 3.4 0.0 0.3 6.6 0.0 0.3 499.7 75.2 0.6 0.4 0.0 0.0 0.8 0.0 0.4 HS3ST6 HS3ST5 ENSG00000162040 "Heparan sulfate-glucosamine 3-sulfotransferase 6" Q96QI5 16 1911475-1918415 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 74.8" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 10.7;Horizontal cells: 21.9;Suprabasal keratinocytes: 9.1;Urothelial cells: 24.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.72e-2)" "prognostic favorable (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-1)" "unprognostic (4.99e-3)" "unprognostic (2.10e-2)" "unprognostic (6.55e-3)" "unprognostic (2.42e-1)" "unprognostic (3.61e-1)" "unprognostic (2.26e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.4 0.0 0.0 0.0 14.5 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 1.4 0.0 0.0 1.9 0.0 0.3 74.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 4.1 10.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 3.4 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.7 1.8 0.0 0.2 0.0 6.3 0.0 0.0 4.5 10.7 0.5 0.1 0.0 0.0 0.1 0.0 0.4 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 21.9 0.1 0.9 4.1 0.0 1.5 1.4 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 0.0 2.7 0.2 0.2 5.0 0.2 0.0 0.0 0.3 0.0 0.0 4.5 9.1 0.1 0.1 0.0 1.7 24.9 TEDC2 "C16orf59, FLJ13909" ENSG00000162062 "Tubulin epsilon and delta complex 2" Q7L2K0 16 2460086-2464963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.1;testis: 5.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 12.8;Extravillous trophoblasts: 12.5;Granulosa cells: 6.7;Hofbauer cells: 4.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051394, HPA055389" Approved Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA051394: AB_2681465, HPA055389: AB_2732595" "unprognostic (3.23e-1)" "unprognostic (1.03e-2)" "unprognostic (2.14e-2)" "unprognostic (7.46e-3)" "unprognostic (1.27e-1)" "unprognostic (1.38e-3)" "prognostic unfavorable (2.43e-5)" "prognostic unfavorable (7.58e-4)" "unprognostic (4.04e-3)" "unprognostic (8.85e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (1.16e-4)" "unprognostic (1.28e-3)" "unprognostic (1.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.03e-1)" 0.3 0.8 0.8 1.7 0.8 4.1 0.4 0.4 1.4 0.5 0.1 0.9 1.5 0.5 0.0 2.3 0.3 0.1 0.7 0.9 1.0 0.6 0.8 0.5 2.2 0.7 0.6 0.7 0.4 0.6 0.2 0.9 0.9 0.8 0.6 0.7 0.2 0.7 0.2 0.4 0.9 1.4 0.3 0.3 1.3 0.8 5.0 0.8 2.2 0.4 0.0 1.4 0.4 0.8 0.8 10.2 31.3 17.7 20.8 0.3 1.2 17.7 7.9 4.7 12.5 12.1 21.9 8.2 14.0 12.6 3.4 6.8 15.3 12.9 8.0 3.0 15.6 17.4 12.7 23.2 22.9 0.4 12.3 16.3 1.1 1.0 11.0 3.0 1.0 5.8 22.8 21.9 5.2 4.4 19.7 21.6 23.2 39.2 9.7 11.5 52.0 15.1 31.3 2.7 4.4 16.6 27.2 9.1 9.5 7.1 4.7 14.0 14.2 2.2 13.2 19.2 12.8 18.2 11.4 20.1 28.3 6.7 12.3 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.4 0.1 0.8 0.8 0.4 1.4 0.9 1.0 0.7 0.6 0.7 0.8 0.3 0.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 0.0 0.0 0.0 0.0 0.0 12.8 0.5 0.0 1.9 2.9 0.0 1.2 1.1 0.6 0.0 0.0 0.0 1.3 12.5 1.7 0.0 1.0 0.0 6.7 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.9 0.4 2.7 0.0 0.0 CCNF "FBX1, FBXO1" ENSG00000162063 "Cyclin F" P41002 16 2429394-2458854 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060596, HPA070495, HPA071600" Enhanced Supported Centrosome NA Yes Centrosome "HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424" "unprognostic (3.87e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-3)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.46e-7)" "unprognostic (2.45e-2)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-1)" 1.4 1.0 2.3 3.9 2.2 7.4 1.9 3.1 2.6 1.0 0.0 2.0 2.9 0.8 2.0 4.0 0.9 0.8 0.6 2.5 1.9 0.6 0.7 1.0 7.5 1.6 2.1 2.6 1.0 0.8 0.5 0.8 2.5 2.0 1.6 2.0 0.9 2.1 1.1 1.3 4.8 2.1 1.1 0.9 2.2 1.6 2.8 2.3 15.3 0.7 1.3 9.7 1.7 1.6 2.3 21.0 32.4 31.3 28.9 2.2 2.9 23.8 24.1 12.2 34.2 26.1 64.6 25.6 42.3 8.0 14.1 10.2 33.1 52.2 19.6 16.4 30.9 23.4 46.1 35.3 20.4 2.3 30.4 30.7 2.0 2.5 24.1 11.7 4.4 25.5 36.5 52.0 28.5 17.6 45.6 46.1 25.0 31.2 22.6 13.2 76.2 35.1 39.5 9.5 9.3 29.8 17.0 36.0 32.8 6.4 15.6 34.3 16.6 18.1 19.1 46.7 13.5 27.1 16.4 20.9 74.5 5.6 31.8 26.9 0.0 0.3 0.0 0.7 0.1 0.4 0.6 0.4 0.9 0.1 0.4 0.3 0.4 0.0 1.3 0.3 0.5 0.5 0.6 2.3 2.2 3.1 2.6 2.5 1.9 1.6 2.1 2.6 2.0 0.9 2.3 2.3 0.9 0.0 3.9 3.3 2.7 2.8 2.7 1.4 6.2 5.3 2.4 2.0 1.9 0.0 1.6 1.8 12.5 7.0 3.7 2.4 0.0 1.2 0.9 1.0 2.7 2.2 1.2 37.5 5.7 0.6 12.2 2.2 5.6 1.0 1.3 8.9 2.5 0.9 6.1 8.4 5.6 2.6 4.1 2.4 1.6 0.0 1.8 1.5 5.4 0.0 0.8 0.9 2.1 1.0 1.0 1.1 0.3 2.6 7.2 1.9 0.9 0.2 0.3 1.6 0.0 0.8 2.7 3.9 5.7 3.5 1.1 1.9 3.4 1.7 4.7 1.6 TBC1D24 "DFNA65, DFNB86, KIAA1171, TLDC6" ENSG00000162065 "TBC1 domain family member 24" Q9ULP9 16 2475051-2509560 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Deafness, Disease variant, Epilepsy, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 16.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 43.8;Inhibitory neurons: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SCLC-21H: 34.7" "HPA044712, HPA068080" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA044712: AB_10795619, HPA068080: AB_2685948" "prognostic unfavorable (3.22e-4)" "unprognostic (5.23e-2)" "unprognostic (4.02e-2)" "unprognostic (6.41e-2)" "unprognostic (3.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.40e-1)" "unprognostic (2.03e-2)" "unprognostic (1.68e-1)" "unprognostic (7.37e-2)" "unprognostic (4.37e-2)" "unprognostic (1.28e-1)" "unprognostic (4.66e-3)" "unprognostic (2.02e-2)" "unprognostic (8.19e-2)" "unprognostic (7.78e-3)" "unprognostic (1.61e-1)" 3.9 3.3 4.9 1.8 8.1 2.5 2.8 3.6 6.6 2.0 0.0 1.7 2.2 1.4 2.8 1.1 2.3 1.9 3.0 7.2 5.5 4.4 3.7 3.9 1.9 3.1 3.3 9.2 1.0 10.7 2.0 2.6 2.1 2.5 2.5 0.9 4.2 16.6 3.6 3.4 1.2 1.6 1.7 1.2 2.0 2.2 1.2 3.4 0.9 3.1 1.7 1.2 1.8 0.9 6.0 3.4 6.7 4.5 9.2 5.1 5.1 3.8 6.2 3.3 4.0 3.5 6.2 2.9 8.6 5.2 4.9 1.9 6.3 7.1 2.0 2.9 9.3 8.0 8.0 9.5 5.5 3.1 5.9 3.2 1.9 2.8 3.5 1.4 2.8 5.1 3.3 9.9 4.8 3.8 6.4 4.1 11.9 4.0 3.2 4.3 20.9 8.5 6.1 2.9 2.3 34.7 8.5 3.8 15.3 2.6 1.6 4.8 5.2 5.4 7.8 8.4 7.9 6.2 3.2 3.0 11.0 3.4 8.5 7.2 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 4.9 8.1 3.6 6.6 7.2 5.5 3.1 3.3 9.2 2.5 1.2 3.4 6.0 4.7 28.9 26.7 15.7 1.9 0.5 3.0 1.4 1.8 19.0 17.8 10.8 6.9 10.0 6.9 5.5 43.8 1.5 5.6 2.4 33.2 5.0 0.2 2.8 10.0 5.4 11.4 6.5 29.6 6.1 1.0 5.8 5.6 4.0 3.8 6.0 10.4 17.3 3.5 26.9 34.0 2.6 6.1 5.1 3.3 1.0 9.0 3.0 1.8 6.5 3.6 13.8 6.2 25.1 9.7 5.0 2.8 6.0 1.7 3.1 1.8 3.9 3.6 25.5 0.0 11.2 3.7 8.8 5.9 1.4 1.4 0.3 2.9 3.4 4.7 1.6 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 64.1;Hofbauer cells: 127.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol No No 110000 "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favorable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 14.0 20.3 1.9 5.6 2.3 5.6 13.8 1.7 4.8 12.1 1.9 12.4 9.1 12.3 0.7 10.7 10.9 4.4 6.7 2.5 1.5 18.5 14.0 12.3 7.9 2.6 2.3 2.1 9.3 8.3 3.1 8.6 4.6 3.8 10.9 0.8 0.4 13.9 3.2 8.9 15.1 17.4 1.4 1.9 26.3 10.0 37.3 2.3 3.8 12.2 1.3 1.9 11.0 9.9 3.3 9.6 11.7 3.1 6.7 3.5 2.5 15.4 9.0 3.4 7.4 9.0 8.7 16.9 4.4 4.4 1.7 14.0 9.3 1.7 2.5 0.2 6.0 7.8 6.6 13.8 12.7 12.9 4.6 16.8 6.6 2.5 4.9 0.8 1.8 4.0 12.5 14.3 9.3 3.1 19.0 7.8 11.7 6.7 0.8 10.1 29.6 4.4 14.0 2.4 5.4 10.3 9.9 5.7 13.1 21.4 0.5 13.1 1.5 6.9 7.4 11.3 14.3 4.7 15.7 14.1 8.9 8.1 9.5 7.4 9.5 3.3 9.6 4.8 7.5 3.8 6.4 3.5 2.9 1.2 4.1 2.7 2.4 8.4 3.1 9.9 9.9 3.8 2.9 1.9 2.3 1.7 4.8 2.5 1.5 2.6 2.3 2.1 3.8 1.9 2.3 3.3 8.0 3.2 11.6 1.3 16.7 8.9 5.2 3.2 4.0 10.3 13.6 11.6 2.5 10.0 5.2 5.5 6.2 16.7 16.4 16.2 5.9 30.3 64.1 6.0 4.1 8.3 12.6 11.0 1.6 17.0 27.1 9.9 7.1 5.2 7.0 13.1 18.2 11.9 127.0 23.5 1.1 12.8 6.1 47.6 12.1 27.4 10.5 28.9 19.6 1.9 26.9 11.0 20.6 0.5 0.8 14.5 26.4 6.4 11.5 4.1 59.4 48.9 9.1 13.0 0.0 7.8 8.4 52.9 16.3 5.1 8.9 27.9 13.2 7.6 10.4 4.2 NTN3 NTN2L ENSG00000162068 "Netrin 3" O00634 16 2471297-2474145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 3.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 1.7;REH: 5.0;SCLC-21H: 5.8;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050817 Uncertain "Secreted in brain" NA NA "HPA050817: AB_2681247" "unprognostic (2.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.79e-1)" "unprognostic (9.17e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-2)" "unprognostic (9.62e-3)" "unprognostic (2.11e-1)" "unprognostic (4.55e-2)" "unprognostic (6.95e-2)" "unprognostic (5.58e-2)" "unprognostic (2.34e-1)" "unprognostic (1.35e-2)" "unprognostic (3.26e-2)" "unprognostic (6.68e-2)" "unprognostic (2.39e-2)" "unprognostic (6.61e-2)" 0.1 0.0 2.4 0.0 1.3 0.0 0.0 0.9 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 2.3 0.0 0.2 0.0 0.0 3.2 2.3 1.4 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.0 5.0 0.1 0.1 0.0 0.0 5.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.9 2.0 1.5 2.3 3.2 2.3 1.4 1.3 1.7 2.1 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.7;pancreas: 128.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 52.2;Breast myoepithelial cells: 22.1;Ductal cells: 34.3;Endometrial ciliated cells: 28.9;Exocrine glandular cells: 49.8;Glandular and luminal cells: 28.3;Pancreatic endocrine cells: 35.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.0;BEWO: 15.4;CAPAN-2: 14.4;HaCaT: 22.5;MCF7: 22.8;RT4: 10.8;SK-BR-3: 11.0;T-47d: 14.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 2.7" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favorable (9.04e-4)" 0.4 0.0 0.2 2.0 0.1 0.0 8.6 0.4 0.4 13.4 0.1 14.5 10.5 0.7 2.6 105.7 6.0 3.4 0.0 0.2 0.1 3.7 0.9 5.9 0.0 0.5 0.2 0.1 0.1 128.3 4.1 1.5 0.3 0.8 16.9 6.5 0.0 44.8 3.2 0.6 41.2 13.6 0.2 0.2 0.2 21.7 0.1 0.3 0.2 6.1 0.0 3.1 11.5 44.7 0.6 9.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 2.6 14.4 0.0 0.0 0.0 0.0 22.5 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.0 6.4 0.0 0.1 0.0 0.2 0.0 10.8 0.2 0.1 0.0 11.0 0.0 0.3 14.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.4 0.2 0.1 0.5 0.2 0.1 0.8 0.2 0.3 0.6 0.3 12.8 18.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 52.2 22.1 0.0 0.0 12.4 16.5 0.0 4.5 1.3 0.0 3.9 34.3 0.0 28.9 2.8 0.5 0.0 0.0 0.0 49.8 6.1 0.6 0.0 28.3 2.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.1 0.0 0.0 0.2 12.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.5 0.6 0.3 0.0 0.0 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969270-2973484 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 125.8;retina: 64.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 58.4;Oligodendrocytes: 62.0;Rod photoreceptor cells: 153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "non-classical monocyte: 3.6" "Lineage enriched" "Detected in single" 9 "monocytes: 3.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles NA Yes Vesicles "HPA068394: AB_2685980" "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.01e-6)" "prognostic favorable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 4.0 8.2 58.0 7.0 77.8 15.8 4.3 79.6 67.5 2.9 34.7 6.2 6.3 2.3 0.5 11.4 3.7 7.0 7.7 54.9 60.2 3.9 3.4 7.9 8.8 84.7 79.5 46.8 0.7 12.0 38.7 2.1 2.6 82.6 11.9 5.6 64.2 22.9 1.4 17.8 16.3 6.4 3.5 78.4 7.9 10.6 3.2 69.4 11.1 3.3 28.2 10.4 2.5 4.7 125.8 36.9 30.9 34.4 49.5 5.6 10.0 11.3 13.9 16.6 24.9 23.5 18.8 38.3 36.8 18.3 16.1 17.5 50.8 36.1 21.7 10.4 38.8 16.3 11.5 63.6 25.4 0.6 24.1 39.2 2.4 11.3 13.5 3.5 12.6 16.7 30.7 22.5 95.6 21.7 73.8 35.1 25.8 29.1 55.3 21.6 69.5 45.0 117.6 17.5 12.4 77.3 36.0 51.2 48.5 37.3 4.6 51.6 37.2 10.3 43.0 26.3 20.0 19.8 42.2 30.7 49.3 19.1 32.4 48.4 0.0 0.4 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 3.6 0.2 0.0 0.3 58.0 77.8 79.6 67.5 54.9 60.2 84.7 79.5 46.8 82.6 78.4 69.4 125.8 4.8 0.0 0.0 13.4 2.0 3.1 1.6 2.6 2.2 14.9 5.2 5.2 1.1 12.8 7.8 0.0 58.4 2.2 2.0 5.1 0.0 5.2 0.8 3.0 1.5 4.5 4.2 12.6 8.9 11.3 8.9 2.0 2.6 5.2 2.5 4.6 3.9 0.3 13.3 6.7 4.5 5.5 6.1 7.6 4.6 3.6 0.6 7.2 5.4 2.8 2.2 27.8 2.1 4.5 62.0 9.5 2.5 0.0 5.5 5.0 2.2 1.0 11.0 153.4 0.0 0.3 3.5 1.5 6.3 4.1 5.1 0.5 1.8 1.0 10.9 1.0 FLYWCH2 ENSG00000162076 "FLYWCH family member 2" Q96CP2 16 2883213-2899382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041354 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041354: AB_10795007" "unprognostic (3.57e-2)" "prognostic favorable (9.38e-4)" "unprognostic (7.33e-2)" "unprognostic (8.53e-3)" "unprognostic (4.40e-1)" "unprognostic (3.81e-2)" "unprognostic (4.83e-3)" "unprognostic (8.35e-3)" "unprognostic (8.92e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.87e-5)" "unprognostic (5.50e-2)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" 25.1 45.1 22.9 10.3 20.1 7.6 26.7 26.1 33.4 21.7 16.0 22.8 15.8 27.4 5.7 24.3 22.0 11.1 34.8 23.8 26.2 27.6 11.8 21.7 10.8 32.9 25.0 19.0 27.5 14.3 17.8 35.1 7.7 26.9 30.6 5.4 5.8 26.3 14.1 31.8 18.9 17.5 10.2 22.1 35.5 20.3 24.4 27.2 11.7 30.8 17.8 6.9 19.5 22.1 29.2 23.0 44.7 18.9 45.0 17.4 26.2 27.8 18.0 13.7 19.0 13.2 20.9 28.7 23.1 67.0 16.0 17.7 15.0 10.8 25.5 3.4 38.7 28.5 24.9 45.3 17.1 53.3 14.7 23.9 36.5 18.8 15.1 7.4 23.5 15.1 40.5 17.7 24.1 12.9 110.1 37.4 63.8 20.9 22.1 47.3 72.4 20.8 50.7 13.7 6.7 29.2 38.1 50.5 53.2 38.4 7.1 63.2 45.5 20.7 31.7 26.0 50.0 18.6 39.9 38.1 32.6 18.9 21.8 22.9 8.5 19.2 16.2 21.7 28.2 23.1 22.9 24.7 20.7 27.7 22.0 26.7 23.4 7.9 16.2 28.7 38.0 25.3 20.2 22.9 20.1 26.1 33.4 23.8 26.2 32.9 25.0 19.0 26.9 22.1 27.2 29.2 62.3 12.8 11.2 7.5 21.9 20.4 40.4 60.0 29.6 19.9 45.5 50.5 15.0 14.3 31.8 44.1 8.4 21.5 25.9 32.8 84.1 45.5 12.6 34.1 46.0 45.0 33.6 11.1 10.5 55.6 46.2 38.3 15.8 31.6 14.5 31.3 18.2 5.5 34.5 15.2 14.0 42.2 61.1 9.2 25.3 12.2 21.1 25.1 42.7 5.6 27.2 54.1 32.0 7.5 7.2 43.8 34.4 25.2 12.8 30.5 29.3 60.2 24.5 19.3 32.9 25.9 46.3 84.8 69.3 34.1 28.4 12.0 22.0 60.5 35.2 34.7 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 717 "salivary gland: 64448.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "Cell line enhanced" "Detected in some" "MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2" "Not detected" "Not detected" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 690000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favorable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 2.0 13.3 0.0 3.9 0.0 4.6 33.5 0.0 0.1 33.2 0.0 13.7 11.6 0.6 1.5 25.5 4.4 34.7 9.1 0.0 0.0 2.6 8.3 3.4 0.3 0.0 0.3 0.0 10.4 47.0 30.6 6.1 4.8 0.0 89.9 18.0 0.0 64448.9 7.1 6.1 40.5 9.6 0.4 0.0 4.2 33.5 4.4 0.1 0.2 2.9 0.1 5.9 11.3 16.4 0.1 0.0 1.1 0.0 0.0 0.3 1.9 0.2 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.3 0.0 0.2 2.1 0.0 4.4 0.0 0.0 0.0 9.0 2.8 2.4 1.6 0.0 0.0 0.1 0.2 0.0 1.2 0.1 0.0 0.0 0.2 3.6 0.2 27.1 0.0 0.4 0.1 57.5 5.0 0.0 0.0 8.6 0.2 6.3 0.0 0.0 0.1 24.1 0.0 0.1 22.2 0.0 3.1 0.1 0.5 1.9 0.1 0.0 0.5 0.3 0.3 6.5 0.3 1.7 6.3 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.4 1.2 7.4 0.0 0.5 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.5 9.1 194.0 181.6 0.0 0.0 154.9 82.5 0.0 70.1 343.9 1.8 0.0 0.1 2.0 107.1 0.0 5.9 7.7 3.5 1.6 2.8 58.2 0.4 0.0 28.1 3.2 1.8 21.9 13.0 5.7 1.7 0.7 0.1 14.6 0.0 0.0 232.2 140.4 4.6 0.5 5.7 0.0 4.4 83.6 0.0 5.6 0.0 0.0 0.0 0.0 46.4 65.3 0.0 0.0 398.1 12.5 0.0 74.7 0.0 0.0 0.0 19.2 1.4 0.6 9.5 24.0 0.3 2.5 21.3 76.7 357.4 ZNF75A FLJ31529 ENSG00000162086 "Zinc finger protein 75a" Q96N20 16 3305406-3318852 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001665 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA001665: AB_1080751" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (1.64e-1)" "unprognostic (7.79e-3)" "unprognostic (6.32e-2)" "unprognostic (4.45e-1)" "unprognostic (2.67e-2)" "unprognostic (5.93e-2)" "unprognostic (4.66e-3)" "unprognostic (2.75e-3)" "unprognostic (6.79e-3)" "unprognostic (4.71e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "unprognostic (8.97e-3)" 5.4 7.3 9.0 8.6 9.3 7.8 10.2 11.9 11.7 8.3 9.7 7.0 6.8 8.7 16.9 5.5 11.6 5.6 8.3 9.2 9.0 9.2 9.1 7.8 13.5 9.7 9.3 8.6 14.6 7.9 15.5 8.1 8.2 9.6 11.4 10.1 17.1 7.0 7.8 7.9 10.0 7.8 7.2 8.6 11.1 7.9 11.1 9.4 12.5 10.8 7.5 12.4 5.6 5.0 10.4 7.4 8.8 18.5 8.4 9.3 9.6 17.6 10.6 5.4 9.6 11.4 0.0 10.0 12.3 7.9 8.2 13.0 5.0 10.2 6.1 15.8 4.8 12.6 23.5 10.4 0.9 6.2 16.4 21.3 9.7 8.7 9.0 8.9 10.4 8.1 9.9 15.0 18.8 14.3 9.9 26.3 9.5 30.1 7.4 8.1 49.4 10.0 14.5 10.9 11.7 16.5 11.8 16.3 6.9 9.0 23.1 22.5 19.2 9.9 6.3 17.8 7.0 10.0 13.2 10.9 31.1 2.4 17.2 11.9 29.5 11.7 29.3 22.2 11.9 27.4 33.7 26.1 23.8 9.5 44.1 39.4 29.0 8.8 34.5 17.3 25.8 23.5 6.4 9.0 9.3 11.9 11.7 9.2 9.0 9.7 9.3 8.6 9.6 8.6 9.4 10.4 14.5 22.4 14.0 22.5 40.5 4.1 30.6 17.5 6.8 40.4 12.0 9.1 13.3 14.3 15.9 16.5 33.3 19.4 23.8 10.7 5.9 22.0 3.5 8.6 16.7 15.7 6.0 12.4 20.4 10.2 9.4 12.4 13.3 8.4 13.9 27.0 16.8 11.5 10.7 48.8 18.0 10.8 12.2 11.7 5.4 3.6 23.3 12.5 8.8 14.0 19.8 26.8 58.7 27.6 28.7 13.7 8.5 26.7 12.7 24.1 28.6 7.8 12.9 66.5 26.3 19.7 15.4 53.0 48.3 8.3 3.4 15.7 27.1 16.0 13.5 14.5 ADCY9 AC9 ENSG00000162104 "Adenylate cyclase 9" O60503 16 3953387-4116442 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 95.3;Inhibitory neurons: 72.7;Oligodendrocyte precursor cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041328, HPA044225" Approved Approved Cytosol NA NA Cytosol "HPA041328: AB_2677414, HPA044225: AB_2678863" "unprognostic (1.78e-1)" "unprognostic (5.54e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (6.62e-2)" "unprognostic (1.30e-2)" "unprognostic (2.52e-1)" "unprognostic (3.61e-2)" "unprognostic (6.93e-2)" "unprognostic (4.76e-3)" "unprognostic (5.40e-2)" "unprognostic (1.37e-1)" "prognostic favorable (5.24e-8)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (1.55e-2)" 6.3 5.6 5.0 4.4 5.8 1.5 6.2 3.5 7.4 8.0 35.7 8.1 8.2 8.0 2.4 8.5 9.3 7.0 13.0 10.8 1.0 9.5 12.0 14.2 2.0 3.3 1.2 2.7 11.3 15.9 9.2 5.1 10.0 3.1 4.4 6.8 3.0 12.0 5.9 53.3 5.5 9.6 8.0 0.0 4.4 6.4 4.0 0.7 2.1 19.0 28.9 2.6 9.8 6.1 5.1 8.5 12.9 3.8 7.0 13.3 16.0 5.6 14.5 15.1 8.0 6.3 10.6 7.2 0.0 21.8 40.1 4.8 8.0 14.9 9.1 5.4 10.4 14.3 0.3 29.4 20.3 14.2 1.1 6.4 17.1 13.6 9.3 4.9 6.6 5.4 2.7 4.7 0.0 8.3 15.3 0.1 4.4 6.9 3.6 6.9 13.3 18.0 0.4 2.9 2.3 8.7 3.8 11.3 13.2 9.6 4.2 33.5 15.0 4.9 15.8 4.3 15.6 6.4 3.2 2.1 1.7 3.4 4.4 6.3 0.8 0.3 0.2 0.4 0.3 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.3 5.0 5.8 3.5 7.4 10.8 1.0 3.3 1.2 2.7 3.1 0.0 0.7 5.1 7.0 12.8 12.8 33.3 1.0 6.4 1.1 3.9 5.2 10.6 4.2 3.7 17.3 22.8 7.1 12.9 12.5 1.8 5.8 19.5 0.0 4.5 0.8 6.1 10.5 6.3 1.2 0.4 95.3 5.3 1.8 8.1 1.5 5.7 0.0 15.3 8.2 19.9 1.5 1.7 72.7 7.6 2.0 4.7 2.0 2.2 8.4 3.3 7.2 31.9 2.6 5.5 4.1 42.3 12.5 3.5 4.3 7.5 2.5 1.1 15.0 5.6 9.5 14.9 0.0 9.4 12.5 1.1 5.0 0.9 3.8 1.0 3.4 4.8 7.2 1.3 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467854-71252577 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 27.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.5;Horizontal cells: 136.3;Inhibitory neurons: 167.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 11.5;Karpas-707: 17.5;RT4: 15.9;T-47d: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nuclear speckles,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nuclear speckles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favorable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 1.3 1.2 9.6 0.5 9.3 0.0 4.5 0.7 11.7 1.4 27.7 2.2 1.5 1.0 2.2 3.4 5.2 0.8 0.0 11.5 3.7 5.0 3.8 3.7 0.1 1.1 0.8 8.8 0.1 7.5 0.1 2.3 1.9 2.6 3.3 2.0 5.5 9.9 1.8 0.0 0.8 1.3 0.4 0.0 1.1 3.0 0.9 1.6 0.0 6.0 0.1 0.4 1.1 0.3 4.8 0.5 7.4 4.1 0.0 0.6 0.4 4.5 0.7 0.3 0.0 0.0 6.6 3.1 6.2 2.2 0.0 0.1 1.1 0.0 4.8 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 1.9 0.1 1.8 0.0 0.0 1.6 0.0 0.1 0.0 17.5 1.7 10.5 0.0 0.1 3.5 10.2 0.3 0.0 9.9 8.2 5.2 15.9 3.5 1.1 0.0 8.4 0.0 5.2 16.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 9.3 0.7 11.7 11.5 3.7 1.1 0.8 8.8 2.6 0.0 1.6 4.8 8.0 41.7 17.0 21.5 0.2 0.0 3.2 3.2 0.6 17.9 26.9 13.0 3.7 11.5 5.4 7.3 0.0 12.8 0.4 3.2 3.9 8.4 1.7 30.0 3.2 1.3 0.0 0.0 153.5 2.2 2.9 1.8 10.2 13.0 2.5 1.2 0.4 21.9 1.2 136.3 167.5 7.9 8.2 0.0 0.3 2.1 0.0 0.4 5.4 14.0 0.0 4.6 0.0 41.7 5.3 10.7 2.7 0.7 0.4 10.9 0.6 10.8 23.3 1.0 0.0 0.3 1.3 0.7 0.9 1.3 0.6 14.6 0.3 0.1 5.5 4.0 CLPB "ANKCLB, FLJ13152, HSP78, SKD3" ENSG00000162129 "Caseinolytic mitochondrial matrix peptidase chaperone subunit B" Q9H078 11 72285495-72434680 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cataract, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 145.8" "Cell type enriched" "Detected in many" 4 "Late spermatids: 5136.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 25.5" "Group enriched" "Detected in all" 5 "dendritic cells: 25.5;granulocytes: 7.7;monocytes: 15.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039005, HPA039006, HPA064571" Enhanced NA NA "HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290" "unprognostic (9.36e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-1)" "unprognostic (1.23e-1)" "unprognostic (2.99e-1)" "unprognostic (2.05e-2)" "unprognostic (8.22e-2)" "unprognostic (8.37e-2)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "prognostic favorable (8.36e-8)" "unprognostic (9.29e-2)" "unprognostic (1.25e-1)" "unprognostic (5.83e-2)" "unprognostic (3.28e-2)" 6.0 7.2 3.7 6.7 4.1 11.8 3.5 6.2 7.7 2.7 0.2 3.8 3.9 3.4 2.0 4.0 3.2 3.1 6.2 3.9 6.0 9.1 11.3 3.5 3.8 6.9 5.2 3.8 3.0 6.0 9.4 2.2 6.1 8.0 2.3 3.4 6.8 5.9 3.8 8.9 2.3 2.7 6.4 4.5 3.9 3.9 145.8 6.6 4.1 5.8 7.3 3.4 3.8 2.6 6.4 12.7 39.4 9.5 20.5 12.2 9.8 28.8 12.9 8.9 21.8 15.5 55.5 19.1 28.6 30.5 13.0 35.0 26.5 30.6 31.0 23.0 26.3 24.0 23.5 38.3 28.4 10.1 28.0 45.3 14.6 7.7 37.7 33.2 6.4 23.3 26.9 39.7 20.3 12.7 33.0 26.7 23.3 10.5 40.4 35.4 22.2 16.6 14.3 9.9 22.6 27.7 16.9 16.8 39.9 30.8 11.5 22.4 22.0 16.9 29.0 18.0 27.4 25.9 9.9 16.6 18.4 14.6 22.2 19.5 7.7 15.7 0.8 3.0 13.5 3.1 1.9 1.6 2.8 25.5 1.8 2.1 1.8 1.1 2.6 7.8 4.3 1.1 7.8 3.7 4.1 6.2 7.7 3.9 6.0 6.9 5.2 3.8 8.0 4.5 6.6 6.4 9.0 16.0 9.7 4.6 6.1 0.4 5.3 5.9 2.2 4.1 7.7 5.0 3.7 2.8 8.6 9.2 4.2 13.0 3.2 3.9 5.9 13.7 1135.5 7.2 13.4 8.0 0.0 11.4 9.8 16.3 17.1 5.5 7.1 9.7 3.8 9.2 1.4 10.7 21.6 3.3 9.8 1.8 10.2 5.9 4.2 5136.8 25.1 13.2 1.8 14.0 8.8 1.9 2.1 11.1 10.4 10.4 1.4 18.4 14.2 6.3 4.3 24.3 5.3 5.5 13.1 3.5 8.1 40.9 22.9 6.0 1.1 33.1 3.6 16.7 2.6 6.6 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988279-75018893 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA038729: AB_2676179, HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 3.2 12.8 5.3 6.4 7.7 23.9 6.5 4.0 10.5 3.7 2.2 4.2 4.4 5.0 5.3 2.6 4.2 4.5 5.6 5.3 4.6 5.1 8.3 5.1 8.4 4.5 3.9 7.1 8.1 6.1 10.5 5.8 3.9 5.2 11.6 6.5 10.5 4.2 3.2 26.6 8.1 4.3 4.8 1.0 6.2 4.9 14.0 4.2 12.4 8.1 22.8 7.9 3.5 2.5 11.1 9.1 8.2 6.7 11.7 5.2 4.4 7.1 8.7 5.7 9.4 7.7 24.3 7.2 25.7 8.5 7.2 12.9 8.1 16.1 11.4 14.7 13.2 7.9 21.8 14.4 10.8 5.6 34.7 19.3 5.5 9.4 9.9 15.0 6.5 7.2 37.3 35.1 17.5 11.2 9.7 33.1 16.8 8.0 18.5 10.3 27.0 17.5 22.2 12.8 9.3 12.0 7.2 13.7 8.4 37.0 8.0 18.9 8.2 10.4 11.6 11.7 8.0 9.1 15.5 15.8 51.8 3.6 17.2 9.8 1.2 2.6 2.4 1.5 1.4 1.1 1.0 1.2 1.5 1.5 1.2 1.2 1.5 1.5 0.5 1.8 1.1 0.9 0.9 5.3 7.7 4.0 10.5 5.3 4.6 4.5 3.9 7.1 5.2 1.0 4.2 11.1 1.4 3.2 4.6 4.6 5.3 0.5 2.0 0.4 0.6 8.6 3.5 3.9 7.7 2.8 2.7 1.8 62.6 2.1 4.1 1.0 0.0 1.2 9.2 2.2 2.3 2.3 7.2 5.0 12.5 3.1 1.4 2.1 3.1 2.7 1.3 3.7 3.6 6.9 5.4 11.8 10.3 2.9 2.0 10.1 1.1 7.6 1.5 6.2 0.0 8.4 6.8 3.4 3.1 9.5 9.9 2.6 1.0 1.9 5.8 3.0 1.6 3.7 1.6 6.4 0.0 5.8 1.8 32.0 2.2 1.6 0.6 1.4 3.9 3.8 2.8 0.6 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348754-61362283 "Predicted membrane proteins" "Electron transport, Transport" "Oxidoreductase, Translocase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 253.5" "Cell type enhanced" "Detected in all" "dendritic cells: 145.1;Melanocytes: 320.2;Theca cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 314.5;naive B-cell: 386.6;plasmacytoid DC: 841.4" "Group enriched" "Detected in all" 9 "B-cells: 386.6;dendritic cells: 841.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 19.7 253.5 10.2 32.9 10.4 26.2 17.4 10.4 10.0 16.8 15.7 33.6 19.4 24.3 18.9 19.7 30.7 27.7 11.4 9.8 13.6 15.4 31.3 21.5 70.8 11.9 11.9 9.0 27.4 24.6 21.7 13.9 17.4 11.5 21.1 28.1 11.5 22.0 19.9 26.3 76.6 28.0 19.0 13.0 50.1 21.0 13.7 10.7 28.4 18.6 17.9 70.9 23.1 16.4 13.0 50.2 80.6 13.4 40.6 67.8 41.9 11.3 26.0 37.3 29.8 28.9 22.6 54.3 98.1 42.1 46.2 24.0 67.5 13.6 72.2 20.1 64.5 28.5 18.3 53.6 16.5 32.0 24.9 42.3 63.4 95.7 65.3 30.0 25.0 44.1 46.1 55.5 57.3 51.2 53.3 45.7 11.4 24.5 44.7 51.9 52.2 14.0 72.6 35.2 48.1 16.2 26.1 54.7 71.5 60.5 9.6 58.6 29.3 31.7 34.2 17.8 34.2 35.6 34.3 49.9 56.8 50.6 44.2 46.4 19.4 66.4 35.5 31.0 53.8 28.6 314.5 22.1 29.2 63.5 386.6 23.5 24.6 21.8 31.5 64.0 841.4 23.6 84.8 10.2 10.4 10.4 10.0 9.8 13.6 11.9 11.9 9.0 11.5 13.0 10.7 13.0 13.0 6.4 22.8 6.8 96.2 28.3 18.3 86.6 19.9 15.9 19.6 18.7 1.9 10.0 30.0 12.9 31.3 49.9 145.1 53.6 11.7 26.2 53.6 15.4 12.0 13.5 19.2 14.1 4.3 38.8 39.5 16.4 21.4 7.5 8.8 13.0 15.4 21.0 51.4 18.5 4.1 28.9 22.4 23.8 21.2 14.2 20.8 47.9 320.2 8.4 57.1 23.7 28.8 5.5 7.2 26.6 48.9 20.7 10.5 15.9 55.6 13.7 72.0 56.2 13.1 14.8 15.8 7.2 11.5 18.4 24.0 39.5 18.7 128.9 30.7 16.2 PPP1R32 "C11orf66, FLJ32771, IIIG9" ENSG00000162148 "Protein phosphatase 1 regulatory subunit 32" Q7Z5V6 11 61481120-61490931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 94.6" "Group enriched" "Detected in many" 4 "Early spermatids: 253.2;Late spermatids: 363.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039068 Enhanced NA NA "HPA039068: AB_10672840" "unprognostic (1.70e-1)" "unprognostic (3.18e-3)" "unprognostic (4.48e-4)" "prognostic favorable (4.13e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (1.50e-3)" "unprognostic (4.52e-2)" "unprognostic (2.81e-1)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (3.03e-2)" "unprognostic (9.44e-9)" "unprognostic (2.64e-1)" "unprognostic (2.71e-1)" "unprognostic (2.32e-1)" "unprognostic (1.75e-2)" 5.0 3.4 40.1 3.8 18.2 5.5 5.8 17.1 20.6 8.5 28.0 5.7 3.7 6.3 12.8 2.9 40.9 3.7 4.2 18.1 23.0 6.5 7.8 11.0 7.4 25.1 28.3 14.8 6.6 3.6 1.9 14.1 4.2 23.9 6.0 2.8 2.6 4.1 4.6 4.6 11.6 5.0 4.8 25.7 7.4 4.2 94.6 21.9 6.5 4.5 2.0 4.3 4.4 5.7 21.2 0.7 1.4 8.4 3.5 3.7 5.5 1.1 1.7 1.3 1.1 0.9 0.4 7.4 1.6 2.3 0.8 0.4 0.9 1.2 0.6 2.1 2.7 1.7 2.1 0.4 0.2 3.6 1.4 1.6 5.8 2.1 0.4 6.2 6.7 0.8 6.0 0.8 5.0 0.5 1.9 2.1 3.0 0.6 1.4 0.8 4.1 0.2 0.5 1.1 0.3 0.9 2.0 0.3 3.7 0.6 0.7 4.3 4.6 3.1 0.4 1.7 1.3 0.3 8.0 2.3 1.0 0.9 6.0 0.7 1.5 1.1 0.7 1.0 1.3 1.0 0.4 0.6 0.2 0.5 0.4 0.4 1.3 2.0 0.8 0.4 0.4 0.8 0.9 40.1 18.2 17.1 20.6 18.1 23.0 25.1 28.3 14.8 23.9 25.7 21.9 21.2 1.5 3.2 1.1 6.8 0.5 0.1 0.8 2.5 0.0 0.5 4.2 4.1 1.3 0.0 6.1 5.5 0.0 1.0 2.2 0.7 31.3 0.5 253.2 27.9 0.9 1.5 3.5 0.0 2.2 1.6 0.3 1.1 0.0 0.8 0.0 1.7 0.4 10.8 0.8 0.0 1.1 1.0 4.1 1.8 1.2 363.8 3.7 0.8 0.0 1.9 1.3 3.0 2.1 1.5 2.7 0.6 1.1 4.1 0.9 1.8 2.1 20.3 72.1 0.2 0.0 0.7 2.6 8.1 1.9 0.1 0.3 0.4 0.7 0.6 0.9 0.8 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase and isoaspartyl peptidase 1" Q7L266 11 62337448-62393412 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 104.3;cervix: 122.7;testis: 101.2" "Cell type enhanced" "Detected in many" "Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 277.9;eosinophil: 269.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 277.9" "Cell line enhanced" "Detected in many" "EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA Microtubules "Nucleoplasm, Cytokinetic bridge" "CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favorable (6.14e-4)" "prognostic favorable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favorable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 14.0 3.7 89.3 6.6 89.9 14.5 12.1 89.9 104.3 122.7 67.3 14.3 6.9 26.7 3.1 2.1 68.7 11.3 5.8 83.1 88.0 42.8 10.3 26.0 5.6 93.2 96.5 79.1 1.9 13.5 2.3 21.4 3.3 96.8 24.0 17.3 18.0 13.4 7.2 7.4 2.5 9.6 4.5 76.5 4.8 15.2 101.2 101.0 10.4 6.7 3.0 4.8 4.3 2.0 86.9 2.4 19.5 20.9 27.2 0.1 0.0 16.4 2.3 0.8 3.6 3.5 32.0 8.5 1.9 85.2 0.3 9.3 1.8 83.9 0.7 4.2 2.6 34.4 1.2 28.1 23.5 0.6 24.0 30.8 0.8 0.2 1.6 0.4 1.3 39.4 47.8 24.5 21.5 0.9 37.5 65.3 15.9 28.5 13.6 15.2 26.1 12.5 11.8 73.3 5.9 112.3 16.1 16.4 28.2 14.4 21.2 15.0 12.1 2.0 0.4 15.4 1.2 9.5 32.8 33.6 3.0 0.8 12.3 9.7 277.9 68.6 269.5 2.8 50.8 1.9 2.4 1.0 3.3 39.7 1.5 2.3 3.4 16.3 11.5 38.5 7.2 0.8 24.2 89.3 89.9 89.9 104.3 83.1 88.0 93.2 96.5 79.1 96.8 76.5 101.0 86.9 29.2 6.4 27.8 56.8 5.2 3.4 2.5 2.2 0.6 24.4 13.8 6.6 2.4 42.9 4.1 22.0 33.3 2.3 3.2 14.0 133.1 30.3 372.5 414.6 39.9 31.2 47.2 14.1 13.9 22.3 2.4 4.0 19.9 437.1 80.9 16.6 49.2 3.7 25.0 16.8 18.6 67.4 6.1 11.4 6.4 597.6 8.7 26.9 1.8 9.4 10.5 80.8 4.1 15.1 22.0 7.8 7.5 7.2 13.9 35.4 2.9 214.1 5.4 37.1 13.1 7.7 6.1 534.3 48.6 0.1 1.3 0.8 7.8 10.8 36.0 15.9 GNG3 ENSG00000162188 "G protein subunit gamma 3" P63215 11 62707676-62709201 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 318.7;choroid plexus: 84.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 39.8;Early spermatids: 27.6;Excitatory neurons: 23.3;Inhibitory neurons: 20.7;Late spermatids: 123.0" "Cancer enriched" "Detected in some" 14 "glioma: 12.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 16.9;naive B-cell: 17.1" "Lineage enriched" "Detected in single" 31 "B-cells: 17.1" "Group enriched" "Detected in many" 7 "Karpas-707: 149.4;SCLC-21H: 292.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.43e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-1)" "unprognostic (4.68e-4)" "unprognostic (2.73e-2)" "unprognostic (7.60e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-1)" "unprognostic (6.03e-3)" "unprognostic (3.04e-1)" "unprognostic (2.33e-3)" "unprognostic (1.50e-1)" "unprognostic (5.37e-5)" "unprognostic (3.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (1.00e-1)" 0.3 15.0 164.3 1.9 207.4 1.1 0.3 154.5 318.7 0.3 84.6 6.8 1.3 0.2 1.0 0.4 0.3 0.3 0.6 211.3 205.3 0.5 0.8 0.4 0.4 165.5 197.6 215.4 0.6 0.7 0.9 48.7 0.1 195.2 0.7 2.7 35.6 0.6 0.7 0.6 0.5 3.2 1.2 119.7 0.3 1.5 11.4 185.4 0.0 0.4 0.1 0.2 0.3 1.2 267.4 0.5 1.0 7.3 0.5 0.0 0.0 3.2 0.6 0.0 0.5 0.0 2.4 1.4 0.4 0.8 0.0 0.3 1.0 0.0 0.0 0.0 2.2 0.5 0.8 0.9 2.1 0.2 1.3 0.6 0.3 0.0 0.1 0.0 1.3 0.0 1.1 1.7 149.4 0.0 1.3 0.3 3.9 33.2 0.7 0.1 2.0 1.3 0.8 0.5 2.4 292.9 2.5 0.8 1.0 0.2 1.5 1.7 0.7 0.4 1.7 2.9 0.9 0.5 0.9 2.4 0.8 1.5 1.1 0.4 0.0 0.1 0.5 0.0 0.0 0.0 16.9 0.1 0.1 0.1 17.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 164.3 207.4 154.5 318.7 211.3 205.3 165.5 197.6 215.4 195.2 119.7 185.4 267.4 0.1 0.0 0.0 5.9 1.2 0.0 0.4 0.0 0.0 39.8 0.4 0.9 0.1 0.0 0.0 0.0 4.2 0.2 0.0 0.2 0.0 0.1 27.6 0.5 0.0 0.1 0.0 0.0 23.3 0.4 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.3 5.0 20.7 0.2 0.0 0.0 0.4 123.0 0.9 0.1 0.0 2.8 0.6 5.3 0.0 8.0 7.4 0.0 1.2 0.0 0.0 0.0 0.1 0.3 0.0 14.1 0.0 0.0 0.1 4.4 3.0 0.0 0.3 0.0 0.1 0.4 0.1 0.2 UBXN1 "2B28, LOC51035, SAKS1, UBXD10" ENSG00000162191 "UBX domain protein 1" Q04323 11 62676498-62679117 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012669, HPA076932" Approved Supported Nucleoplasm,Cytosol NA NA 45000 Cytosol Nucleoplasm "HPA012669: AB_1853149, HPA076932: " "unprognostic (1.76e-3)" "unprognostic (8.72e-3)" "unprognostic (3.67e-3)" "unprognostic (2.94e-2)" "unprognostic (9.39e-2)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (3.52e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-3)" "unprognostic (2.42e-1)" 127.5 103.8 85.5 67.7 89.6 64.2 122.3 88.0 103.7 134.5 84.4 114.7 72.6 114.2 44.7 100.4 113.3 54.9 98.0 82.6 85.4 95.2 73.4 82.6 108.9 90.8 86.9 79.2 149.1 121.3 59.4 76.4 52.6 90.2 90.1 38.2 28.3 79.7 56.6 286.6 126.4 94.1 48.8 88.9 112.6 117.6 114.4 89.7 108.5 97.6 106.3 82.9 114.2 104.7 91.5 86.2 137.7 101.3 142.5 137.7 147.0 87.7 73.4 136.6 139.4 94.6 99.0 109.7 135.7 131.3 100.1 123.7 119.2 81.6 128.3 64.5 124.3 99.5 95.6 118.9 136.4 269.1 150.7 102.6 191.7 195.1 123.5 188.5 149.4 132.1 170.3 148.0 86.4 88.5 196.6 117.8 280.3 5.2 67.4 88.9 86.6 107.9 135.3 114.1 85.8 98.6 165.5 68.8 108.3 330.0 43.2 150.5 188.0 128.6 111.8 84.0 113.4 84.6 109.0 89.3 123.8 129.7 64.9 103.7 158.0 320.2 160.7 273.9 346.7 350.2 534.6 415.2 323.7 346.2 533.5 494.7 365.8 173.5 303.8 440.6 276.8 562.3 559.0 85.5 89.6 88.0 103.7 82.6 85.4 90.8 86.9 79.2 90.2 88.9 89.7 91.5 183.1 93.0 116.4 16.6 222.8 264.0 176.5 240.7 142.3 61.7 202.9 190.2 86.4 137.2 160.7 75.4 45.9 172.9 194.1 162.0 156.5 191.1 184.1 91.2 119.0 194.9 126.2 144.9 9.2 184.7 195.2 124.1 78.0 81.4 162.7 146.6 180.2 77.0 216.3 30.3 9.1 156.5 187.2 325.2 352.2 245.8 208.8 196.2 183.2 8.4 307.5 153.5 244.1 7.5 17.8 203.8 235.9 143.3 93.0 192.7 335.9 259.7 132.7 57.4 197.2 171.3 300.3 257.6 220.6 130.2 302.8 324.7 226.9 147.0 161.4 235.0 LBHD1 "C11orf48, MGC2477" ENSG00000162194 "LBH domain containing 1" Q9BQE6 11 62662817-62672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 66.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Respiratory ciliated cells: 8.7;Rod photoreceptor cells: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.8;JURKAT: 53.8" "Low region specificity" "Detected in all" "HPA012127, HPA023592" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012127: AB_1845527, HPA023592: AB_1845528" "unprognostic (4.34e-4)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (7.90e-3)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.18e-8)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-2)" "unprognostic (2.81e-1)" "unprognostic (6.79e-2)" "unprognostic (2.78e-8)" "unprognostic (3.69e-2)" "unprognostic (1.62e-1)" "unprognostic (5.79e-2)" "unprognostic (4.72e-3)" 4.4 13.3 2.0 5.5 2.1 6.4 3.8 2.9 2.8 3.2 2.8 3.6 3.5 2.0 4.2 3.4 3.4 2.6 3.3 2.0 2.2 3.8 8.7 3.5 7.5 2.1 2.1 1.9 2.0 3.9 4.1 4.0 1.9 2.3 4.4 3.4 66.5 3.7 3.5 1.8 2.5 6.0 2.3 1.9 9.6 4.6 7.3 2.3 6.0 4.2 1.0 4.8 3.6 2.6 2.5 2.7 4.7 2.8 2.1 4.2 7.9 6.2 3.6 5.3 5.8 4.6 3.7 30.8 9.4 7.7 4.5 6.0 11.8 3.0 8.4 4.5 12.8 9.5 7.9 14.6 2.7 6.2 7.4 9.9 10.9 0.9 10.4 3.2 6.5 3.2 53.8 8.3 8.3 3.7 4.8 4.6 11.0 3.6 6.4 4.0 11.2 6.9 17.4 7.7 5.4 3.2 4.7 4.0 5.4 12.1 3.8 10.1 11.1 2.5 3.6 2.3 3.7 4.0 13.7 12.8 9.1 3.3 7.4 3.8 1.5 3.5 3.4 3.2 2.4 2.9 2.4 1.9 3.5 3.1 2.5 2.6 2.1 0.8 4.8 2.1 3.9 1.2 2.6 2.0 2.1 2.9 2.8 2.0 2.2 2.1 2.1 1.9 2.3 1.9 2.3 2.5 0.8 3.2 2.7 0.0 2.0 0.0 0.2 0.0 1.2 2.3 0.6 0.5 0.8 0.0 2.5 0.0 4.2 0.2 2.0 0.2 0.0 0.2 0.0 2.7 1.1 0.5 0.0 0.4 0.3 0.0 0.3 1.0 2.0 0.7 2.5 1.2 0.0 0.6 0.2 1.7 0.3 0.1 0.0 0.3 0.0 0.3 0.3 1.6 0.0 1.0 0.1 1.5 2.1 0.0 0.1 0.2 0.0 0.4 3.9 0.4 0.4 0.3 8.7 7.6 0.0 1.1 0.3 0.7 0.6 0.9 0.0 0.3 1.8 3.6 0.1 0.3 TTC9C MGC29649 ENSG00000162222 "Tetratricopeptide repeat domain 9C" Q8N5M4 11 62728069-62740293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055169 Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA055169: AB_2682724" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (2.71e-2)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (6.56e-3)" "unprognostic (1.86e-3)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" "unprognostic (6.90e-3)" "unprognostic (1.33e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.67e-7)" "prognostic favorable (4.15e-5)" "unprognostic (7.49e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-2)" 13.1 14.2 16.6 18.4 17.4 5.7 14.9 18.9 21.0 13.9 16.2 16.2 20.6 15.4 17.4 14.5 18.6 15.2 11.4 17.7 17.4 15.2 13.5 12.5 26.1 18.2 17.5 17.3 26.5 13.4 9.5 12.0 19.5 18.9 12.2 15.6 10.0 15.1 14.4 16.3 20.1 15.6 15.8 16.9 19.9 15.5 14.2 17.3 25.4 19.4 13.8 24.1 16.0 11.6 20.4 47.4 39.4 32.8 31.5 46.6 54.3 24.4 48.7 49.7 57.1 47.6 35.0 45.0 35.7 88.1 33.5 50.7 41.2 49.8 14.8 44.9 93.0 24.8 39.3 57.1 43.0 51.1 26.9 41.1 35.8 31.4 46.3 47.1 42.5 43.3 42.0 29.3 34.3 54.2 33.9 42.5 55.2 27.4 38.5 31.5 32.5 42.3 54.0 36.6 18.0 28.3 23.3 41.3 35.3 57.1 29.1 46.5 24.8 36.9 56.5 33.3 64.0 34.1 36.4 58.6 40.1 31.3 20.2 30.5 70.1 39.1 40.5 22.4 36.4 17.6 42.3 24.1 22.9 33.9 37.9 23.6 21.7 25.1 29.9 24.3 33.9 39.5 24.7 16.6 17.4 18.9 21.0 17.7 17.4 18.2 17.5 17.3 18.9 16.9 17.3 20.4 14.5 16.0 10.9 7.8 27.0 29.6 13.3 14.2 25.0 17.5 13.8 13.8 9.3 10.0 17.3 18.4 8.4 35.0 21.8 17.0 27.4 24.0 23.3 14.0 14.4 19.6 6.0 14.1 18.0 14.9 41.9 18.5 7.7 10.9 8.2 22.6 13.6 9.9 38.5 28.6 13.5 15.8 18.3 27.1 20.6 20.4 28.3 18.8 16.0 4.7 40.5 13.5 35.0 7.5 9.8 19.7 15.3 27.4 22.4 21.3 25.9 27.0 18.2 16.0 32.9 10.2 17.0 32.4 31.8 21.2 33.2 23.8 21.5 19.6 17.7 19.6 TAF6L PAF65A ENSG00000162227 "TATA-box binding protein associated factor 6 like" Q9Y6J9 11 62771357-62787342 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067239 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA067239: AB_2685809" "unprognostic (5.41e-2)" "unprognostic (1.37e-1)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "prognostic favorable (8.98e-5)" "unprognostic (1.03e-1)" "unprognostic (2.47e-1)" "unprognostic (9.37e-2)" "unprognostic (2.83e-3)" "unprognostic (5.45e-3)" "unprognostic (9.65e-2)" "unprognostic (4.38e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.66e-1)" "unprognostic (2.61e-3)" 8.2 12.1 5.4 4.4 5.4 5.8 9.2 5.8 8.9 10.9 3.1 9.0 6.7 13.1 6.3 10.0 10.3 3.9 7.4 4.6 5.0 11.9 21.3 7.5 5.3 6.9 5.7 5.3 11.1 13.1 5.2 15.0 3.5 6.8 11.2 3.3 4.0 8.6 5.2 17.6 11.7 9.9 4.9 4.5 11.9 9.4 6.7 5.0 5.3 12.8 5.1 3.9 9.7 8.7 5.7 12.6 12.3 15.8 12.6 7.0 5.8 13.1 10.5 7.1 11.6 9.0 6.9 14.3 16.9 21.0 7.5 10.7 16.7 11.2 10.5 3.6 23.3 24.4 8.9 14.4 11.8 10.0 11.4 15.6 7.7 7.6 9.3 6.1 6.0 10.0 17.2 18.9 12.2 7.4 24.5 16.7 31.8 17.1 6.4 15.8 20.4 11.2 21.4 7.9 8.9 16.8 16.7 9.9 10.5 16.2 6.6 18.5 7.9 9.3 11.7 14.6 19.2 11.9 13.3 23.1 19.7 10.4 8.6 10.9 0.7 0.7 0.9 0.6 0.8 0.7 0.8 0.4 0.4 0.9 0.7 0.9 0.6 0.2 1.1 0.3 0.9 0.3 0.2 5.4 5.4 5.8 8.9 4.6 5.0 6.9 5.7 5.3 6.8 4.5 5.0 5.7 6.1 3.2 3.0 8.8 9.3 6.1 4.7 1.5 11.4 8.7 6.8 6.0 2.8 12.8 1.8 1.8 0.0 15.0 5.0 9.8 15.6 4.8 6.0 5.3 5.0 5.6 5.3 11.6 3.5 3.1 8.9 5.0 10.2 7.2 0.0 6.9 5.7 12.1 9.8 3.3 5.2 6.9 0.0 10.9 5.5 5.0 5.3 8.0 8.8 2.8 8.9 9.9 13.4 6.0 5.1 3.4 8.5 4.9 11.8 4.6 8.5 18.1 3.2 5.5 0.0 6.8 7.0 3.2 9.6 10.7 6.3 19.4 5.7 9.9 9.4 4.3 NXF1 "DKFZp667O0311, Mex67, TAP" ENSG00000162231 "Nuclear RNA export factor 1" Q9UBU9 11 62792123-62806302 "Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016327, HPA061593" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016327: AB_627608, HPA061593: AB_2684565" "unprognostic (2.45e-2)" "unprognostic (1.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.68e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (5.40e-3)" "unprognostic (7.21e-3)" "unprognostic (2.54e-2)" "unprognostic (2.64e-1)" "prognostic favorable (4.08e-4)" "unprognostic (4.33e-3)" "unprognostic (8.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.38e-1)" "unprognostic (3.66e-3)" "unprognostic (1.25e-2)" 89.7 104.3 57.0 48.4 56.3 206.4 82.5 60.8 72.5 97.4 65.0 96.1 39.7 95.4 55.7 80.9 87.5 52.3 73.5 56.1 62.5 101.0 131.1 82.7 70.5 56.4 55.3 56.2 98.1 99.1 64.3 137.8 59.4 56.6 108.1 46.0 50.3 78.0 58.3 76.3 104.9 96.9 67.1 56.3 145.0 97.9 59.9 56.7 76.2 124.1 41.9 56.6 83.8 79.5 59.0 44.6 48.5 82.8 56.5 69.6 50.2 50.2 67.5 60.5 89.0 52.6 66.8 35.1 70.0 39.1 54.4 35.7 54.1 89.9 42.3 80.2 55.5 61.3 52.9 82.1 56.4 52.8 66.3 73.6 74.5 59.9 65.6 31.5 66.5 58.9 60.7 69.3 50.7 64.4 61.1 81.3 85.1 50.4 54.8 41.6 77.5 46.0 74.6 61.7 51.7 43.6 36.5 66.4 52.8 49.8 59.9 60.3 57.9 60.3 51.2 41.5 64.6 61.3 61.4 56.8 70.2 39.6 55.2 52.1 7.6 21.3 23.5 18.9 26.0 20.5 16.0 18.4 18.5 23.6 12.8 19.6 18.4 16.1 20.2 23.6 18.3 24.0 17.1 57.0 56.3 60.8 72.5 56.1 62.5 56.4 55.3 56.2 56.6 56.3 56.7 59.0 53.2 38.5 45.3 14.7 40.2 83.4 27.0 29.4 42.7 13.2 45.9 74.7 24.6 21.5 23.4 22.0 31.3 50.4 44.1 42.2 9.8 17.6 32.6 30.4 36.8 36.8 31.6 17.7 11.0 12.3 25.9 35.1 43.3 51.7 49.9 19.8 26.0 18.6 28.6 5.0 13.0 35.9 22.4 33.8 43.2 12.3 36.7 62.5 32.0 11.2 21.8 12.7 21.6 7.1 10.1 14.7 28.6 25.9 29.7 22.0 24.0 10.2 18.6 17.2 26.3 48.6 40.4 28.2 19.9 53.4 70.0 99.2 42.3 15.4 30.4 15.2 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806860-62832051 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 33.5 32.1 30.3 22.4 31.2 42.3 34.7 34.3 39.3 40.7 32.9 27.6 22.9 30.9 43.0 35.2 33.4 25.2 27.3 30.4 35.3 35.2 51.4 33.0 25.4 33.6 31.4 29.7 42.5 51.6 27.2 29.8 27.6 31.1 43.9 22.6 19.0 52.3 27.2 27.9 40.7 28.6 24.1 30.9 35.8 36.3 29.3 31.7 30.7 38.2 20.4 31.9 28.7 34.5 32.6 40.9 25.4 34.5 29.9 44.6 50.2 31.0 39.2 54.9 64.7 52.0 18.8 39.0 26.0 35.9 55.9 37.8 41.7 29.7 37.2 47.8 60.4 28.3 23.0 33.0 39.2 55.3 26.9 33.5 40.7 41.6 58.6 70.3 50.5 31.9 37.0 21.0 71.7 34.5 48.4 36.5 43.8 11.3 36.2 36.8 37.1 32.3 70.2 28.8 20.7 26.3 21.6 31.4 49.4 63.6 25.7 54.4 35.9 36.8 46.8 24.6 54.6 25.1 64.2 38.1 27.4 38.0 18.7 29.6 11.7 11.4 36.2 10.4 14.1 9.3 11.0 8.1 10.1 10.4 11.3 7.5 7.6 17.8 13.1 12.7 12.9 13.0 6.6 30.3 31.2 34.3 39.3 30.4 35.3 33.6 31.4 29.7 31.1 30.9 31.7 32.6 30.3 22.4 29.3 12.7 64.1 67.2 79.5 37.9 13.6 21.0 38.0 27.9 5.6 20.0 27.6 11.0 27.1 55.3 57.6 29.8 29.4 45.7 113.1 28.2 28.6 33.1 32.9 23.5 16.0 59.6 75.1 39.5 23.9 34.0 52.7 25.2 30.0 24.4 46.5 18.5 15.4 54.8 22.4 39.5 53.5 143.7 39.1 33.2 46.2 12.2 51.6 30.3 44.3 10.1 16.6 44.1 36.0 25.2 47.2 61.2 44.8 32.6 20.7 18.6 32.9 34.1 33.6 32.2 30.1 19.8 64.2 177.6 40.4 28.0 26.2 75.5 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.5" "Cell type enhanced" "Detected in many" "dendritic cells: 46.7;NK-cells: 103.0;Proximal enterocytes: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.5;Karpas-707: 22.8;RPMI-8226: 17.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA042495, HPA050821" Uncertain Approved Cytosol NA NA Cytosol "HPA042495: , HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 3.8 3.3 2.7 5.9 3.1 4.9 4.8 2.5 4.2 1.9 2.4 2.9 5.7 1.8 2.5 2.5 2.0 2.0 3.8 2.8 3.2 6.5 12.2 3.9 10.2 3.1 2.9 2.7 1.9 34.5 3.0 6.7 1.9 3.4 3.8 1.8 0.3 6.3 1.9 7.2 2.9 7.6 1.3 3.0 13.4 2.9 1.9 2.8 8.0 12.2 3.8 6.7 2.0 1.9 3.6 0.4 5.8 0.2 8.5 1.5 0.7 4.2 1.0 2.6 0.5 0.5 1.4 2.7 5.2 4.7 2.4 2.1 0.8 0.6 0.4 0.0 17.5 1.2 5.7 3.2 0.4 0.9 1.8 5.7 1.9 0.1 0.7 0.5 0.4 0.9 9.9 0.8 22.8 0.9 1.9 4.2 0.1 0.3 0.3 2.6 7.7 1.1 17.1 0.9 0.1 2.8 3.7 1.8 4.5 1.0 0.5 2.4 0.9 1.7 0.6 2.0 5.5 0.4 9.5 6.4 1.5 1.7 1.3 3.3 10.5 6.3 4.8 8.8 11.2 9.3 10.6 7.8 8.5 6.9 11.9 12.4 9.3 3.9 17.1 13.3 23.0 7.7 3.1 2.7 3.1 2.5 4.2 2.8 3.2 3.1 2.9 2.7 3.4 3.0 2.8 3.6 5.0 0.0 5.6 0.3 40.0 2.8 5.9 4.2 3.4 12.3 10.7 7.7 5.6 8.6 4.7 12.9 0.0 2.1 46.7 14.4 0.0 5.9 5.1 6.2 3.1 6.0 6.7 3.0 5.2 5.4 1.7 7.7 5.6 7.9 4.5 21.8 6.8 14.0 7.3 6.7 0.6 16.7 4.1 9.7 14.4 3.9 6.8 11.7 5.4 4.7 18.4 5.5 103.0 1.5 3.9 5.2 12.5 3.8 15.3 7.0 90.9 6.9 12.3 0.4 6.6 12.6 3.6 2.2 0.4 2.2 2.0 1.5 31.6 11.8 13.3 4.6 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993522-51995895 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 190000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 1637.7 1412.2 631.9 726.5 630.4 2129.1 1673.5 624.5 822.8 1749.0 627.0 1304.1 874.2 1218.8 663.6 1786.9 1483.0 651.6 1038.3 600.4 654.0 1113.0 1165.1 980.8 1359.0 658.3 622.8 590.0 2763.8 2763.4 542.1 714.3 539.2 647.9 1318.2 630.8 231.3 1491.2 555.4 2711.6 2392.1 1165.4 572.4 690.7 1249.3 1352.7 443.6 662.5 1085.4 990.8 1298.7 999.8 1351.0 1657.4 670.1 1208.7 1467.7 1123.3 1808.9 1933.5 3007.1 1603.5 1299.2 1540.3 1693.7 1396.9 1757.3 1831.7 3226.6 553.5 1292.3 1044.1 1084.1 1622.7 2689.1 802.7 1335.2 2202.3 1689.2 1892.1 3037.1 2287.6 2548.8 1630.1 3714.1 3735.4 1254.5 2210.9 1936.9 1920.9 1420.6 1338.0 2536.8 1264.3 2629.0 2238.9 3210.8 1965.5 1755.6 2463.0 1038.1 1267.3 3258.5 2211.8 2509.3 948.0 1820.6 969.6 2279.1 2378.1 706.9 1710.1 4227.3 1745.3 1001.3 1324.5 1559.7 2006.9 1615.8 2498.1 2399.9 1326.2 2953.0 1357.6 556.4 1184.0 333.4 895.8 882.9 1488.2 1886.9 1446.6 1149.2 1356.0 1749.9 1662.7 1421.4 145.3 1115.6 724.8 1154.7 1444.1 3507.7 631.9 630.4 624.5 822.8 600.4 654.0 658.3 622.8 590.0 647.9 690.7 662.5 670.1 2092.1 189.1 415.6 35.3 3749.3 3975.7 5198.9 3485.6 4465.8 234.8 4763.1 7627.1 82.4 1611.4 1245.9 711.7 102.2 2537.2 2453.7 1497.3 2181.5 1773.3 1117.1 1158.9 3170.1 1957.3 1430.9 2176.2 28.2 4573.5 5119.4 1862.6 1826.2 1529.2 694.4 3951.5 2026.4 1661.0 2373.7 107.7 33.6 3051.9 1043.6 2693.9 3423.6 4294.3 3611.5 2216.3 2218.0 37.5 2893.8 989.3 2520.1 18.1 49.2 3180.2 2816.5 1583.5 2556.8 5203.2 3720.1 3760.6 507.1 405.3 1143.9 2535.7 2110.2 564.9 465.2 5714.8 5075.9 2455.2 2765.1 5917.8 3455.9 5933.8 ITIH3 H3P ENSG00000162267 "Inter-alpha-trypsin inhibitor heavy chain 3" Q06033 3 52794768-52809009 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 97 "liver: 799.2" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1183.8" "Cancer enriched" "Detected in some" 247 "liver cancer: 273.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "Hep G2: 17.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA017373 Approved "Secreted to blood" NA NA 9100000000 "HPA017373: AB_1851954" "unprognostic (2.07e-2)" "unprognostic (5.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-4)" "unprognostic (4.28e-2)" "unprognostic (3.26e-2)" "unprognostic (5.97e-2)" "unprognostic (6.07e-2)" "unprognostic (1.49e-1)" "unprognostic (7.05e-2)" "unprognostic (1.04e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.49e-8)" "unprognostic (2.09e-4)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (9.31e-2)" 4.3 0.7 0.4 0.9 0.5 0.0 2.2 0.4 0.8 4.5 0.7 1.0 0.3 3.6 1.7 1.3 3.5 1.3 0.7 0.4 0.3 0.7 799.2 3.0 2.5 0.4 0.4 0.4 2.8 0.3 0.1 0.4 1.7 0.4 1.1 1.0 0.1 0.4 2.4 0.6 0.9 1.3 1.2 0.3 8.2 1.2 3.5 0.4 0.2 1.2 0.4 1.8 1.4 2.3 0.5 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.8 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.4 0.5 0.1 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.0 0.5 0.1 1.4 0.8 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.1 0.1 3.5 0.0 90.9 0.0 0.0 0.1 2.1 0.0 0.0 0.0 12.3 66.4 1183.8 0.0 0.0 0.0 0.0 0.0 85.1 0.3 132.0 1.2 0.1 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 9.1 0.4 0.3 0.0 0.1 0.3 3.6 19.2 0.0 0.1 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134532 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 72.9;Plasma cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 205.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 28.6 40.6 18.8 37.5 23.0 31.2 27.9 21.6 21.4 29.7 22.9 28.3 26.3 29.3 39.1 28.6 30.9 19.9 25.0 17.1 18.3 24.6 118.5 27.2 61.4 27.0 24.1 15.0 31.2 91.7 35.2 38.5 26.4 24.6 28.8 29.3 18.8 56.4 30.6 34.5 28.8 39.7 26.2 22.2 51.6 39.7 24.4 21.5 18.5 43.8 19.2 81.7 26.0 25.1 24.5 32.4 40.6 24.0 32.5 59.8 33.8 23.8 32.8 33.5 40.9 28.8 22.2 55.0 181.0 43.8 42.4 53.8 48.8 26.4 33.3 33.6 28.4 20.0 28.6 46.8 50.2 72.3 43.3 49.6 43.3 59.0 36.1 81.0 36.4 27.0 19.0 36.4 90.1 24.3 47.9 19.1 31.2 26.1 33.6 28.0 31.9 20.3 74.0 25.7 31.5 15.6 32.0 30.4 74.1 53.3 21.0 55.4 28.2 25.9 28.3 18.6 51.2 22.4 178.1 134.2 205.9 38.1 21.8 32.3 16.8 7.4 14.0 7.4 4.7 6.5 21.9 5.2 6.9 4.4 22.6 3.7 3.9 7.0 3.5 4.7 18.4 5.3 6.6 18.8 23.0 21.6 21.4 17.1 18.3 27.0 24.1 15.0 24.6 22.2 21.5 24.5 11.5 16.0 21.4 11.1 43.5 17.6 6.9 13.8 12.0 10.7 21.0 15.5 4.0 22.8 20.8 11.0 33.3 14.5 16.4 23.1 1.9 13.6 6.6 14.2 16.2 11.3 8.4 13.2 9.6 18.9 16.5 14.2 17.9 22.1 1.3 10.1 15.0 72.9 15.1 13.5 9.5 33.6 16.2 15.3 13.2 4.1 20.5 10.8 12.4 9.4 10.5 11.0 13.4 13.0 15.8 18.2 11.7 13.2 90.5 14.9 14.0 7.7 15.1 18.7 13.1 11.9 10.7 19.3 13.2 9.7 16.1 42.8 11.7 13.6 18.6 13.8 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084210-65088398 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favorable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 27.7 32.8 19.9 11.6 22.0 29.5 29.5 21.6 30.0 29.4 19.1 30.4 18.0 31.6 18.9 30.2 28.1 10.1 29.5 19.3 20.3 28.0 32.9 21.6 12.0 22.3 21.4 18.8 29.5 32.3 15.8 40.9 12.9 21.3 31.8 9.2 7.6 31.1 16.9 38.1 34.4 28.3 12.8 20.2 25.6 30.7 27.7 21.1 11.1 27.3 20.6 8.3 31.4 26.8 23.1 60.3 41.1 25.4 26.5 22.3 31.5 40.5 26.0 33.8 31.8 25.2 27.5 40.9 19.5 51.2 39.5 31.0 30.8 15.0 34.4 11.1 27.7 25.0 20.0 29.3 54.3 48.0 14.8 27.0 29.7 45.2 24.0 40.6 20.2 31.2 30.4 24.3 29.4 23.9 83.1 25.6 35.8 17.2 19.9 35.7 23.3 14.5 53.7 25.0 27.9 27.6 22.3 21.5 41.8 63.5 12.1 61.7 25.4 30.1 21.2 35.0 47.2 21.4 19.4 21.0 24.0 33.2 14.6 41.2 77.1 19.7 42.2 15.1 21.4 16.3 18.0 14.0 15.9 20.0 20.1 15.3 13.8 27.3 23.8 21.2 19.6 26.1 12.0 19.9 22.0 21.6 30.0 19.3 20.3 22.3 21.4 18.8 21.3 20.2 21.1 23.1 22.6 12.8 18.4 6.8 16.1 11.0 29.6 45.0 19.4 20.4 27.4 27.1 4.4 21.5 35.3 12.9 4.2 49.9 19.0 49.6 58.7 39.4 18.6 24.1 17.9 17.9 22.8 14.5 6.4 47.9 47.1 19.4 25.0 29.6 9.5 30.0 16.4 20.7 32.1 23.5 6.1 40.1 32.6 15.7 11.9 47.0 20.5 12.8 17.8 3.7 25.0 39.2 18.6 5.0 23.7 44.0 44.4 20.3 29.5 29.8 55.0 32.6 25.8 19.5 19.7 17.5 27.5 35.7 18.3 24.4 12.5 68.3 13.6 17.0 37.5 36.1 RPS6KA4 "MSK2, RSK-B" ENSG00000162302 "Ribosomal protein S6 kinase A4" O75676 11 64359148-64372215 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 10.5;monocytes: 2.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008649, HPA023225" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "CAB008649: AB_1619460, HPA023225: AB_1854144" "unprognostic (2.30e-1)" "unprognostic (7.05e-2)" "unprognostic (2.03e-1)" "unprognostic (4.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.45e-1)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-3)" "unprognostic (1.98e-2)" "unprognostic (3.93e-3)" "unprognostic (5.25e-2)" "unprognostic (1.09e-1)" "unprognostic (2.85e-1)" 14.5 13.2 14.3 11.9 15.4 11.0 12.6 17.0 18.1 13.8 11.1 15.5 9.9 16.6 2.9 31.3 12.1 4.7 14.1 15.1 14.0 13.5 12.1 16.5 12.1 14.6 14.8 14.7 8.6 12.3 3.3 6.9 11.8 15.8 13.2 5.6 2.1 12.6 5.6 16.1 22.7 17.3 6.8 13.8 25.2 15.9 3.5 14.9 5.7 10.3 5.0 9.6 16.7 14.8 14.4 76.1 41.5 5.9 15.0 12.8 11.9 84.0 39.4 20.6 30.2 14.9 41.7 38.8 7.9 44.9 22.9 38.6 69.1 7.1 32.1 14.7 24.1 14.0 17.8 36.8 21.6 12.8 18.0 32.0 12.0 29.7 25.7 20.9 10.9 18.4 14.2 7.4 10.6 15.6 69.2 16.6 28.4 6.5 29.2 88.1 31.8 24.4 25.3 21.1 34.4 8.7 6.9 40.7 24.8 35.6 8.5 28.6 22.3 37.0 41.0 51.7 74.7 35.9 12.5 10.4 7.8 27.0 20.6 21.2 1.3 2.7 1.4 0.7 2.1 0.7 0.4 0.5 0.6 2.2 0.2 0.3 0.3 0.2 0.2 1.3 10.5 0.5 2.6 14.3 15.4 17.0 18.1 15.1 14.0 14.6 14.8 14.7 15.8 13.8 14.9 14.4 11.8 3.2 3.0 8.5 6.4 12.1 6.8 8.6 8.6 7.3 5.4 4.8 15.2 7.2 5.4 3.7 4.2 70.0 75.0 25.2 5.9 20.1 0.8 3.5 8.7 9.9 8.4 9.9 6.6 25.2 38.2 9.3 26.0 7.6 19.1 5.7 10.8 7.8 29.6 8.4 5.3 14.3 2.0 30.5 13.2 1.5 11.1 25.8 8.8 11.2 26.6 3.6 10.3 4.5 5.4 65.1 12.8 6.8 5.7 10.2 16.2 8.4 3.1 2.1 0.0 6.0 10.2 0.7 6.5 13.9 10.7 46.7 11.3 7.5 19.9 9.6 LRP5 "BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2" ENSG00000162337 "LDL receptor related protein 5" O75197 11 68312591-68449275 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Disease variant, Osteogenesis imperfecta, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 130.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 84.7;Proximal enterocytes: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013001, HPA030505" Approved NA NA 1500000 "CAB013001: AB_2533267, HPA030505: AB_2673505" "unprognostic (3.67e-1)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.13e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.94e-2)" "unprognostic (9.63e-2)" "unprognostic (2.54e-1)" "unprognostic (2.78e-1)" "unprognostic (6.82e-2)" "prognostic favorable (3.55e-10)" "unprognostic (2.28e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.42e-2)" 35.9 37.9 8.7 7.0 9.2 3.3 37.3 9.7 11.3 25.8 36.7 30.4 43.5 30.8 4.2 18.6 26.7 21.2 35.2 6.9 12.5 30.1 130.8 23.5 4.4 12.8 9.4 5.4 28.1 35.2 11.7 16.1 23.4 9.5 25.4 11.3 1.7 73.9 20.2 10.5 19.4 45.2 11.2 8.9 9.0 32.1 5.6 9.2 9.6 33.7 7.4 2.6 24.7 19.5 9.2 30.9 103.6 11.0 25.4 20.6 11.4 47.0 14.0 12.1 8.3 7.5 58.7 104.2 0.0 87.5 18.2 35.1 38.9 9.9 37.3 1.2 5.0 22.6 21.6 52.8 77.2 20.8 15.8 2.0 16.4 12.5 0.4 13.6 22.3 23.7 18.8 38.5 1.6 6.0 69.5 23.7 62.7 19.6 161.2 41.7 29.6 30.1 49.7 14.2 82.1 10.6 21.6 37.0 49.4 41.0 5.3 34.6 36.2 31.5 0.2 9.0 11.6 15.8 6.3 0.8 6.3 0.0 9.7 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 8.7 9.2 9.7 11.3 6.9 12.5 12.8 9.4 5.4 9.5 8.9 9.2 9.2 37.4 6.4 5.4 17.0 1.1 9.2 8.5 11.3 10.8 0.2 24.4 23.2 5.6 21.5 9.6 7.3 0.0 49.0 0.0 42.7 0.0 11.7 1.1 19.2 6.5 20.4 17.5 10.7 1.1 9.8 6.7 10.6 30.5 12.5 1.3 84.7 31.8 52.5 8.4 0.0 5.7 43.0 18.3 3.2 4.6 1.0 3.1 1.7 1.8 11.2 1.3 8.8 0.0 13.0 5.2 12.5 32.4 9.8 5.7 13.0 54.9 8.5 4.8 0.1 6.6 18.5 10.9 0.8 7.3 7.6 5.3 24.8 1.0 1.3 25.1 13.8 TPCN2 TPC2 ENSG00000162341 "Two pore segment channel 2" Q8NHX9 11 69048932-69136316 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 30.5;Melanocytes: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA016561, HPA027080" Supported Approved Nucleoli NA NA Nucleoli "HPA016561: AB_1858207, HPA027080: AB_10600917" "unprognostic (1.29e-1)" "unprognostic (1.53e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (7.60e-2)" "unprognostic (7.04e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.15e-2)" "unprognostic (1.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-3)" "unprognostic (5.01e-2)" "unprognostic (4.88e-2)" 5.6 3.8 1.6 4.8 2.7 4.4 5.2 4.6 2.8 8.1 0.1 9.5 7.7 9.0 3.2 4.6 8.6 3.8 3.6 2.0 1.0 7.4 11.2 4.6 5.8 1.1 0.8 2.0 5.9 3.6 2.7 4.2 3.0 2.2 7.3 3.9 4.4 4.1 5.8 4.3 10.1 7.3 4.8 0.1 6.3 4.7 3.2 1.0 3.1 4.3 1.4 4.2 6.4 6.0 3.2 4.6 8.8 3.5 4.9 2.7 3.0 10.5 3.6 3.9 4.7 2.4 8.5 12.4 3.5 5.0 6.9 3.2 9.6 3.2 5.8 2.0 2.7 3.3 7.7 13.7 1.9 3.2 6.5 8.5 4.0 3.2 2.2 2.8 2.4 4.9 8.4 4.7 16.7 2.7 6.9 4.4 9.4 2.4 11.5 3.1 4.6 3.3 6.8 5.1 8.0 2.8 3.6 5.9 11.4 17.0 4.3 7.0 9.1 5.2 3.5 4.5 6.4 4.0 6.8 2.9 4.0 7.7 5.5 8.3 2.9 10.2 2.6 0.9 9.9 0.8 2.4 1.8 2.1 7.7 1.8 1.8 1.9 7.0 6.2 11.7 3.1 2.7 4.4 1.6 2.7 4.6 2.8 2.0 1.0 1.1 0.8 2.0 2.2 0.1 1.0 3.2 4.5 9.6 1.5 10.1 6.7 4.0 2.7 3.0 2.2 1.8 2.8 2.5 3.1 5.7 2.3 12.9 2.1 2.6 6.1 4.4 17.6 7.2 17.7 2.1 5.6 4.2 0.0 8.2 30.5 8.6 4.8 4.0 8.6 3.4 2.5 7.3 5.3 18.4 11.9 0.0 22.4 2.6 2.0 12.6 5.5 2.7 6.2 10.2 35.6 4.7 7.7 2.5 3.1 26.2 4.5 4.8 2.6 6.8 8.3 1.5 8.8 9.1 0.8 4.9 6.6 5.1 5.7 2.2 4.4 1.9 3.4 1.9 3.6 3.2 3.6 2.1 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698238-69704022 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "gallbladder: 239.3" "Group enriched" "Detected in some" 4 "Cholangiocytes: 24.3;Ductal cells: 15.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CAPAN-2: 138.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036082 Approved "Secreted to blood" NA NA 133000 "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.4 0.1 0.0 239.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.2 0.0 0.1 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 1.4 0.6 24.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.1 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 1.3 0.0 0.0 0.0 0.3 1.8 CYP4A22 ENSG00000162365 "Cytochrome P450 family 4 subfamily A member 22" Q5TCH4 1 47137435-47149735 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 216.0" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 143.0" "Cancer enriched" "Detected in some" 13 "liver cancer: 20.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.2" NA NA "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-2)" "unprognostic (2.88e-3)" "unprognostic (2.76e-3)" "unprognostic (1.50e-3)" "unprognostic (2.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-2)" "unprognostic (5.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.71e-1)" "unprognostic (8.59e-4)" 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.1 0.2 0.0 33.2 216.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 143.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183582-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 1056.7" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 5516.6" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 6.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 148.8;RPTEC TERT1: 501.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 10.2 8.3 0.6 24.8 0.9 43.5 36.8 0.4 1.6 17.9 1.5 42.8 21.8 10.8 2.9 207.5 26.0 199.4 1.0 0.5 1.1 1056.7 6.9 29.7 0.4 0.5 0.6 0.3 0.7 100.8 0.0 1.1 3.9 0.6 12.2 31.2 0.0 205.1 8.7 1.6 144.1 66.9 3.1 0.4 3.7 64.0 1.4 0.7 1.9 1.5 0.6 60.7 20.1 67.2 0.9 54.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 41.5 0.0 148.8 0.0 0.0 0.7 0.0 0.5 0.0 0.6 0.0 0.6 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 2.6 501.3 0.0 0.0 0.0 0.5 4.3 0.0 0.0 1.4 0.0 0.0 0.1 1.2 0.1 0.4 0.3 0.6 0.3 0.1 0.1 0.0 0.0 3.4 0.3 0.6 1.1 0.2 0.0 0.0 0.0 1.7 0.4 0.2 0.0 6.6 0.7 0.1 1.5 1.1 144.5 0.6 0.9 0.4 1.6 0.5 1.1 0.5 0.6 0.3 0.6 0.4 0.7 0.9 1.6 76.9 47.4 0.0 31.2 14.1 13.3 489.8 7.4 0.0 152.9 105.5 0.1 303.1 413.3 233.6 0.0 0.1 1.7 118.8 414.8 1175.8 0.0 6.1 3.3 4.5 39.6 148.4 0.0 760.0 0.0 6.6 36.7 38.1 10.8 0.2 5.0 1.7 0.3 0.0 0.0 143.3 52.9 0.3 2.1 0.0 3.4 59.3 8.8 0.0 13.6 0.6 2.1 0.0 0.0 1115.2 91.0 0.0 0.1 38.9 106.2 5516.6 147.6 0.0 0.0 0.1 28.7 0.0 0.1 30.7 54.0 0.8 22.0 0.0 150.5 68.5 TAL1 "bHLHa17, SCL, TCL5" ENSG00000162367 "TAL bHLH transcription factor 1, erythroid differentiation factor" P17542 1 47216290-47232220 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.6" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 151.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4" "Region enriched" "Detected in many" 5 "midbrain: 14.3" "Low region specificity" "Detected in many" "CAB017805, HPA047866, HPA073983" Approved Enhanced Nucleoplasm Yes NA Nucleoplasm "CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246" "unprognostic (2.63e-1)" "unprognostic (2.62e-2)" "unprognostic (1.22e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-3)" "unprognostic (3.95e-3)" "unprognostic (1.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.99e-2)" "unprognostic (5.42e-3)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (2.76e-2)" "unprognostic (2.19e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-2)" 7.0 2.6 5.0 1.0 4.3 29.6 6.4 4.6 4.9 2.8 4.0 2.1 0.8 2.9 0.6 1.8 3.6 2.4 4.7 4.3 4.7 4.4 1.5 13.1 1.4 6.2 6.3 3.2 1.2 0.9 0.9 1.7 7.0 6.4 2.1 1.3 0.2 1.1 0.9 2.1 1.6 3.1 2.7 7.2 7.2 1.8 0.9 7.0 0.4 5.4 2.6 0.7 2.5 2.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.2 0.1 153.7 0.0 0.0 0.0 0.0 70.6 0.0 0.0 0.0 0.0 0.0 31.2 60.0 48.9 0.1 0.0 0.0 26.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.1 34.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.5 5.0 4.3 4.6 4.9 4.3 4.7 6.2 6.3 3.2 6.4 7.2 7.0 6.9 23.9 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.1 0.1 3.7 1.5 1.3 1.8 0.0 0.1 0.0 0.0 0.0 0.1 5.3 0.0 0.1 18.1 0.0 151.5 0.0 0.0 0.3 0.6 0.0 0.0 36.8 0.0 26.7 0.1 10.6 0.0 0.1 0.0 0.0 1.6 1.5 18.2 0.0 4.8 1.8 29.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.4 1.3 0.4 0.1 1.0 0.0 2.0 0.0 0.0 0.0 CMPK1 "CMPK, UMP-CMPK" ENSG00000162368 "Cytidine/uridine monophosphate kinase 1" P30085 1 47333797-47378839 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053730, HPA058604" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 1400000 Nucleoplasm "HPA053730: AB_2682244, HPA058604: AB_2683773" "unprognostic (2.16e-2)" "unprognostic (1.16e-1)" "unprognostic (9.39e-3)" "unprognostic (1.18e-1)" "unprognostic (1.09e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-2)" "unprognostic (9.88e-2)" "unprognostic (5.80e-2)" "unprognostic (2.90e-2)" "unprognostic (1.71e-2)" "unprognostic (2.61e-1)" "unprognostic (1.28e-2)" "unprognostic (2.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-3)" "unprognostic (7.36e-2)" 89.0 45.7 56.5 64.8 59.4 53.6 103.3 61.3 67.1 75.4 60.3 135.4 165.3 44.6 42.6 109.2 35.5 89.3 63.8 54.2 67.8 79.5 219.0 64.4 72.4 61.9 61.7 48.7 38.5 91.7 58.1 33.2 49.2 64.3 95.8 142.4 29.5 158.7 51.2 71.7 65.6 153.7 56.5 62.2 58.5 110.0 17.6 62.2 62.3 92.8 74.5 88.6 81.4 64.3 65.7 124.9 68.4 86.6 77.9 154.6 179.3 122.5 216.4 129.8 128.6 129.9 61.3 84.1 183.4 108.6 147.9 120.5 82.7 64.8 112.1 174.9 279.5 52.7 142.9 91.0 106.7 100.8 206.2 100.2 101.2 132.7 107.5 119.7 121.1 135.2 67.4 137.3 143.5 169.8 45.9 168.2 96.8 55.1 162.9 93.6 103.4 149.8 138.5 126.5 134.9 78.3 41.3 155.0 177.7 128.9 113.7 44.2 121.0 127.7 159.6 92.7 154.5 180.8 103.8 154.3 124.4 126.3 125.3 111.7 43.3 12.8 24.2 16.1 14.0 20.7 13.6 18.0 20.0 13.5 14.3 16.9 16.4 5.3 19.4 17.0 11.4 20.9 15.6 56.5 59.4 61.3 67.1 54.2 67.8 61.9 61.7 48.7 64.3 62.2 62.2 65.7 101.7 70.5 54.4 14.4 148.1 175.5 125.3 88.9 102.4 34.2 167.8 67.7 48.9 147.3 87.0 75.4 16.7 82.3 117.9 280.0 174.1 186.8 1.6 56.2 63.3 83.8 117.5 126.0 28.5 181.6 133.0 91.2 125.4 98.2 94.0 39.7 88.5 235.9 75.9 43.7 30.2 326.6 91.6 122.0 265.0 5.0 59.4 107.1 254.3 31.9 100.5 66.9 124.6 20.6 25.0 146.8 168.6 70.0 119.8 203.5 234.6 254.5 112.3 31.1 85.5 75.9 95.8 14.0 29.8 167.0 195.1 118.3 160.5 49.0 240.2 250.8 BEND5 "C1orf165, FLJ11588" ENSG00000162373 "BEN domain containing 5" Q7L4P6 1 48727519-48776969 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8;Proximal tubular cells: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 6.5;naive B-cell: 8.0" "Lineage enriched" "Detected in many" 5 "B-cells: 8.0" "Cell line enhanced" "Detected in some" "AF22: 3.4;HDLM-2: 11.7;JURKAT: 4.5;MOLT-4: 4.8;REH: 6.5;SH-SY5Y: 2.9" "Low region specificity" "Detected in many" "HPA054347, HPA058007" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA054347: AB_2682456, HPA058007: AB_2683577" "prognostic favorable (2.50e-5)" "unprognostic (1.36e-2)" "unprognostic (7.19e-3)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (4.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.32e-2)" "unprognostic (4.28e-2)" "unprognostic (2.37e-3)" "unprognostic (3.35e-2)" "unprognostic (9.68e-2)" "prognostic favorable (8.30e-6)" 1.4 2.0 4.6 0.7 4.9 1.0 1.8 4.0 7.3 2.7 3.8 2.5 0.4 2.0 1.5 0.6 2.5 2.1 1.5 4.9 4.1 3.4 0.1 0.9 2.2 6.0 4.6 4.9 4.4 1.7 1.8 3.4 0.3 6.4 1.5 0.4 3.8 1.0 1.2 2.6 0.8 1.6 0.7 3.8 2.7 1.7 1.0 4.6 4.8 1.8 1.7 1.4 2.2 1.7 6.0 0.0 0.0 3.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 4.8 0.2 2.6 0.0 0.0 6.5 1.1 0.0 0.0 1.2 1.1 2.9 0.0 0.0 0.2 1.2 0.0 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 1.7 8.0 1.6 1.0 0.2 1.2 0.0 1.7 0.0 0.4 4.6 4.9 4.0 7.3 4.9 4.1 6.0 4.6 4.9 6.4 3.8 4.6 6.0 8.7 6.4 3.1 0.0 17.2 1.9 4.6 4.6 1.8 13.3 4.0 16.9 8.6 8.6 6.1 5.5 16.7 0.3 0.6 0.5 54.8 6.4 8.9 2.7 1.9 6.9 12.1 0.8 0.0 1.8 0.5 8.4 2.6 1.3 1.3 10.2 4.6 0.2 0.3 8.4 0.0 0.8 2.0 0.6 4.4 7.1 13.1 1.5 3.6 0.0 0.5 22.7 0.0 0.0 0.0 2.6 4.5 21.4 7.6 1.1 0.2 30.2 6.4 17.8 6.6 6.8 5.6 3.7 9.1 0.3 2.3 0.1 2.8 11.4 1.6 1.9 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50024029-50203772 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 64.8" "Group enriched" "Detected in some" 4 "Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4" "Cancer enriched" "Detected in some" 4 "glioma: 2.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Cell line enriched" "Detected in some" 17 "SH-SY5Y: 157.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: AB_2732502" "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.1 11.3 11.5 2.5 20.2 0.0 0.2 9.4 52.1 0.0 0.0 2.2 1.4 0.0 0.0 0.2 0.1 0.2 0.2 19.6 19.5 0.1 0.1 0.3 0.2 35.3 20.7 15.6 0.0 2.3 0.0 3.4 0.2 36.4 0.1 2.8 3.9 0.2 0.1 0.0 0.4 2.2 1.1 2.8 0.2 1.0 8.6 21.9 0.9 0.0 0.0 0.2 0.1 0.2 64.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.2 157.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 11.5 20.2 9.4 52.1 19.6 19.5 35.3 20.7 15.6 36.4 2.8 21.9 64.8 0.1 0.0 0.0 7.2 0.1 0.8 0.0 0.0 0.0 3.9 0.1 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 155.5 0.0 0.0 0.3 32.9 0.0 158.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 109.7 0.1 4.1 4.0 5.0 159.4 1.5 3.1 1.8 22.5 0.0 1.5 0.0 75.4 5.9 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.1 8.9 11.8 0.0 0.9 0.1 0.2 0.0 0.1 0.1 COA7 "C1orf163, FLJ12439, RESA1, SELRC1" ENSG00000162377 "Cytochrome c oxidase assembly factor 7 (putative)" Q96BR5 1 52684449-52698347 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028154, HPA029926" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA028154: AB_10600656, HPA029926: AB_10602173" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.30e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (1.14e-1)" "unprognostic (2.27e-2)" "unprognostic (1.24e-1)" "unprognostic (4.07e-2)" "unprognostic (7.42e-2)" "unprognostic (2.49e-1)" "prognostic favorable (4.35e-4)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 6.9 4.9 5.2 5.4 6.0 4.0 7.4 5.5 6.7 4.6 2.8 8.0 7.8 5.5 4.3 6.4 4.7 3.6 5.6 5.3 5.2 9.7 12.2 3.9 4.0 5.1 4.9 6.0 3.7 10.8 5.2 2.5 5.3 5.6 3.6 7.6 4.4 3.3 3.7 16.1 6.5 5.7 6.0 4.3 3.9 5.1 3.2 5.2 2.7 7.2 20.6 4.5 5.6 3.5 6.1 26.0 14.5 13.0 21.1 20.7 17.9 28.6 19.1 15.9 23.4 19.5 18.2 9.0 59.4 12.7 11.4 29.6 19.5 31.9 27.1 30.4 18.4 31.9 49.9 22.5 20.9 25.5 49.7 16.4 19.8 23.5 26.6 33.0 10.3 16.3 16.6 46.5 10.0 17.9 17.3 17.0 25.3 57.7 27.7 40.8 32.9 44.6 43.2 20.7 25.9 29.2 15.4 27.9 35.0 36.3 18.3 20.5 33.4 18.2 18.3 24.0 25.5 26.7 21.2 57.0 27.2 8.5 35.4 15.2 1.6 2.9 0.4 1.1 4.3 1.5 1.8 1.2 1.1 3.0 0.7 1.0 1.1 0.6 1.1 2.2 1.1 0.7 1.6 5.2 6.0 5.5 6.7 5.3 5.2 5.1 4.9 6.0 5.6 4.3 5.2 6.1 6.0 6.4 12.4 0.7 4.5 11.5 31.2 7.1 9.6 8.8 6.1 5.2 13.2 10.0 7.1 3.7 4.2 17.1 1.7 11.4 27.4 11.9 0.5 3.2 12.3 8.8 2.4 5.5 1.6 13.3 17.0 7.8 5.1 3.4 0.0 8.0 3.6 13.7 13.7 16.8 2.1 7.0 6.1 4.7 3.5 0.8 7.5 7.0 1.8 1.9 8.7 6.8 4.1 3.5 1.5 11.0 7.0 7.5 9.9 19.3 5.0 20.1 2.6 10.2 6.6 11.4 14.0 4.6 13.0 9.7 12.9 16.6 4.2 10.5 10.5 17.8 ZYG11B "FLJ13456, ZYG11" ENSG00000162378 "Zyg-11 family member B, cell cycle regulator" Q9C0D3 1 52726453-52827336 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6;tongue: 62.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028156 Uncertain Approved "Golgi apparatus,Intermediate filaments" NA NA "Golgi apparatus, Intermediate filaments" "HPA028156: AB_10602360" "unprognostic (2.54e-1)" "unprognostic (2.02e-1)" "prognostic favorable (5.42e-6)" "unprognostic (1.58e-2)" "unprognostic (4.44e-2)" "unprognostic (3.04e-3)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (4.84e-3)" "unprognostic (5.06e-2)" "unprognostic (2.76e-1)" "unprognostic (6.08e-2)" "prognostic favorable (9.80e-7)" "unprognostic (2.22e-1)" "unprognostic (3.37e-1)" "unprognostic (1.13e-1)" "unprognostic (9.57e-2)" 9.5 8.5 11.5 5.5 15.3 7.7 7.2 16.7 13.5 9.2 3.8 8.3 4.4 10.9 6.0 9.6 6.8 6.6 17.3 13.0 16.0 13.0 18.8 7.7 5.1 8.8 11.3 13.1 10.9 5.2 10.1 4.7 7.1 10.6 9.5 7.6 13.5 6.4 8.7 79.6 6.3 4.7 12.6 7.6 5.7 5.0 8.6 14.3 6.9 12.9 62.6 5.5 7.7 5.8 15.3 10.8 9.9 12.1 15.1 21.7 18.5 10.0 11.7 15.3 9.4 8.7 8.4 3.5 10.2 11.1 23.6 12.6 5.5 14.1 10.6 14.9 7.9 8.6 13.1 10.4 5.3 11.5 9.9 7.7 13.5 11.2 13.4 9.4 13.1 16.6 2.3 12.0 2.1 17.2 4.4 3.9 6.4 12.3 5.4 10.0 6.7 22.4 9.3 9.6 17.2 5.5 10.9 20.6 12.8 10.6 15.2 7.7 7.8 19.1 14.4 8.2 14.3 7.4 8.6 10.8 7.4 9.8 6.6 9.5 0.3 0.7 0.9 0.5 0.3 0.6 0.6 0.7 0.4 0.7 0.5 1.1 0.8 1.7 0.6 0.6 0.4 1.0 0.3 11.5 15.3 16.7 13.5 13.0 16.0 8.8 11.3 13.1 10.6 7.6 14.3 15.3 26.8 25.6 28.8 29.0 13.4 11.3 10.5 12.1 10.2 49.5 13.6 11.9 88.3 20.0 14.0 14.7 20.9 24.6 6.9 37.2 7.9 12.2 5.7 13.2 40.9 22.1 10.2 9.0 72.4 11.1 12.0 26.3 12.2 18.6 8.2 32.0 32.5 107.7 20.6 97.6 82.6 11.4 14.2 37.5 11.8 7.9 24.5 21.5 21.4 36.5 21.9 21.6 4.1 46.3 52.0 16.3 17.9 30.9 11.6 26.0 14.0 30.0 11.1 24.4 26.3 35.7 25.9 11.4 23.7 17.3 14.6 34.8 9.7 19.5 15.5 19.0 SLC1A7 EAAT5 ENSG00000162383 "Solute carrier family 1 member 7" O00341 1 53087179-53142638 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 40.5" "Group enriched" "Detected in some" 6 "Bipolar cells: 207.7;Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 72.3" "Cancer enhanced" "Detected in many" "lung cancer: 3.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "gdT-cell: 2.2" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Cell line enriched" "Detected in some" 8 "HHSteC: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA049124 Enhanced NA NA "HPA049124: AB_2680643" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (9.48e-4)" "unprognostic (2.31e-1)" "unprognostic (8.73e-2)" "unprognostic (1.52e-2)" "unprognostic (6.26e-3)" "unprognostic (4.35e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-1)" "unprognostic (7.65e-2)" "unprognostic (1.19e-3)" "unprognostic (2.58e-3)" "unprognostic (5.43e-2)" "unprognostic (8.12e-2)" "unprognostic (4.70e-3)" 1.4 0.2 1.6 0.2 0.9 0.0 1.1 0.9 1.4 1.4 0.7 0.8 2.3 1.4 0.0 1.2 1.8 5.2 1.6 1.1 1.0 0.4 1.0 0.6 0.1 1.5 1.8 0.6 2.4 0.2 0.4 0.1 0.2 1.5 0.8 0.0 40.5 0.5 0.0 1.4 0.8 3.1 0.0 1.3 0.0 0.8 0.5 2.1 0.0 0.6 3.1 0.0 1.0 1.1 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.9 0.9 1.4 1.1 1.0 1.5 1.8 0.6 1.5 1.3 2.1 3.1 1.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 207.7 0.0 0.0 0.6 0.0 0.0 0.0 70.9 0.1 3.0 2.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.5 0.2 5.9 4.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.3 0.0 0.0 1.2 0.5 0.0 7.5 0.0 8.5 16.5 0.0 0.1 0.0 4.0 1.2 0.7 0.0 17.7 0.7 0.0 72.3 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 1.7 0.1 0.3 0.0 CZIB "C1orf123, FLJ20580" ENSG00000162384 "CXXC motif containing zinc binding protein" Q9NWV4 1 53214099-53220634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Adipocytes: 29.2;Cardiomyocytes: 45.8;Cytotrophoblasts: 60.7;Extravillous trophoblasts: 76.7;Fibroblasts: 22.2;Hofbauer cells: 66.5;Syncytiotrophoblasts: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043835 Uncertain Approved "Vesicles,Mitotic spindle,Cytosol" Yes No 320000 Cytosol "Vesicles, Mitotic spindle" "HPA043835: AB_10796797" "unprognostic (1.09e-2)" "unprognostic (5.91e-2)" "unprognostic (2.03e-2)" "unprognostic (4.55e-2)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (9.20e-3)" "unprognostic (2.27e-1)" "unprognostic (5.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.46e-1)" "unprognostic (3.05e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (6.31e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (2.43e-1)" 53.7 35.8 57.1 22.5 58.2 22.0 49.8 57.5 75.2 54.0 58.8 54.9 22.7 57.5 40.2 32.6 52.8 30.5 47.6 57.6 58.9 39.8 43.9 33.4 30.3 58.0 57.7 56.3 47.6 25.3 34.8 28.7 30.8 57.5 41.3 35.1 21.8 25.0 45.9 77.1 26.0 31.9 59.7 57.4 32.8 40.6 31.3 57.2 36.7 35.4 65.9 29.9 58.2 38.0 59.7 32.6 34.7 44.7 41.0 101.6 129.1 39.4 47.8 50.4 47.3 50.8 29.6 27.5 50.1 39.0 58.1 45.8 12.6 27.9 46.9 57.0 65.0 47.5 51.0 24.9 45.0 100.0 59.5 32.1 84.6 50.3 50.6 53.3 71.5 78.5 61.0 53.7 13.7 60.1 54.6 73.5 55.6 74.8 39.7 54.3 52.8 56.8 39.7 55.8 32.6 37.6 36.1 45.1 40.9 47.7 72.2 29.2 59.8 49.3 54.5 31.9 38.2 47.2 19.5 30.7 57.3 43.9 58.5 42.8 60.7 56.6 58.6 50.9 72.3 46.9 46.9 49.8 53.6 68.8 45.1 55.0 54.9 22.8 59.0 60.3 46.3 68.2 51.1 57.1 58.2 57.5 75.2 57.6 58.9 58.0 57.7 56.3 57.5 57.4 57.2 59.7 29.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 60.7 8.2 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 76.7 22.2 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 46.7 1.3 0.0 0.0 0.0 MAGOH "MAGOH1, MAGOHA" ENSG00000162385 "Mago homolog, exon junction complex subunit" P61326 1 53226900-53238518 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015425, HPA043036, HPA047754" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148" "prognostic favorable (1.85e-4)" "unprognostic (2.61e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-1)" "unprognostic (3.59e-1)" "unprognostic (6.34e-3)" "unprognostic (3.07e-3)" "unprognostic (2.18e-1)" "unprognostic (5.17e-2)" "unprognostic (1.46e-2)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (2.01e-2)" "unprognostic (1.63e-1)" "unprognostic (3.60e-2)" "unprognostic (6.75e-3)" 51.9 49.0 38.3 59.5 38.2 142.3 52.3 39.5 47.5 41.3 40.1 61.8 53.5 57.7 59.5 48.5 56.4 38.2 43.7 38.3 41.8 54.1 77.0 45.2 85.7 39.2 39.5 37.6 49.6 44.2 50.9 35.2 68.5 39.4 40.3 56.0 34.7 44.9 37.8 44.2 43.2 55.6 51.1 39.2 55.6 47.2 32.6 38.6 102.6 52.2 42.9 87.0 62.7 39.2 39.7 207.8 101.0 169.4 150.2 88.1 56.9 197.6 152.3 92.0 202.4 204.5 233.2 97.1 293.5 168.8 93.1 248.4 125.9 228.3 136.7 242.3 197.1 249.6 266.1 127.4 253.3 141.4 459.3 143.3 62.7 95.3 184.4 150.6 77.7 136.8 260.8 279.6 63.8 109.9 169.3 377.2 316.0 310.0 171.1 218.4 256.1 323.2 154.5 109.1 208.3 142.7 115.7 202.0 161.2 250.1 206.8 85.1 330.2 122.0 122.6 167.7 170.7 354.9 93.6 184.8 453.4 109.4 289.5 127.0 31.5 34.8 53.9 49.3 51.9 48.1 47.4 46.9 51.5 50.0 42.9 42.6 44.9 41.9 52.9 50.2 58.6 54.2 32.7 38.3 38.2 39.5 47.5 38.3 41.8 39.2 39.5 37.6 39.4 39.2 38.6 39.7 134.5 51.3 47.6 10.1 93.5 144.4 121.3 231.6 99.0 31.0 62.1 85.9 50.6 60.1 106.9 57.0 14.6 206.9 123.5 47.0 178.1 96.2 44.9 123.9 83.7 89.6 54.4 90.9 13.0 84.9 195.4 83.5 46.9 102.2 83.6 78.4 57.8 44.2 116.0 23.5 12.4 89.2 130.2 47.8 103.2 16.1 75.5 80.0 81.8 7.5 102.5 67.2 84.5 10.6 15.1 87.4 70.9 68.1 62.6 92.3 69.0 152.0 100.4 36.4 59.2 93.9 148.1 90.0 67.9 82.7 120.8 241.9 107.6 89.5 87.1 92.1 ACOT11 "BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1" ENSG00000162390 "Acyl-CoA thioesterase 11" Q8WXI4 1 54542257-54639192 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 36.7;intestine: 36.3" "Cell type enhanced" "Detected in many" "Astrocytes: 134.8;Distal enterocytes: 71.3;Late spermatids: 150.6;Proximal enterocytes: 106.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 4.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "HaCaT: 18.9;OE19: 27.3;RT4: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041047 Enhanced Supported Cytosol NA NA Cytosol "HPA041047: AB_2677273" "unprognostic (9.73e-2)" "unprognostic (1.28e-1)" "prognostic favorable (9.37e-4)" "unprognostic (3.61e-4)" "unprognostic (5.42e-2)" "unprognostic (1.94e-1)" "unprognostic (2.20e-3)" "unprognostic (5.12e-4)" "unprognostic (1.05e-1)" "unprognostic (2.84e-2)" "unprognostic (9.60e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.07e-8)" "unprognostic (5.89e-2)" "unprognostic (1.08e-1)" "unprognostic (3.83e-2)" "unprognostic (8.49e-3)" 1.4 3.4 7.6 2.4 5.0 3.7 1.1 8.1 6.0 2.6 36.7 13.9 36.3 2.6 3.2 16.0 3.1 2.4 23.6 5.4 4.0 16.4 1.2 1.9 1.7 6.2 7.6 1.3 5.3 3.1 21.4 8.1 1.5 7.6 3.6 11.8 8.0 9.5 3.5 9.3 2.9 29.5 2.5 3.4 1.5 11.2 2.5 6.4 0.6 10.2 10.7 3.3 6.6 6.3 3.4 6.7 4.2 2.0 1.2 0.8 1.9 3.4 3.7 0.2 1.1 0.8 6.4 16.9 1.4 5.6 3.0 4.0 18.9 0.8 3.3 0.6 3.9 1.4 16.0 6.2 2.7 0.3 1.8 2.1 2.0 3.7 0.4 1.6 1.7 3.4 1.1 0.9 1.9 4.0 2.0 0.7 2.4 3.3 27.3 0.9 1.2 11.1 1.5 0.7 40.1 4.2 4.2 1.8 1.2 0.8 6.8 1.6 5.1 3.5 2.5 2.4 1.7 1.4 1.9 1.0 1.5 1.2 11.7 1.3 1.1 0.6 4.6 0.3 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.4 1.3 0.4 0.5 0.4 0.3 0.3 7.6 5.0 8.1 6.0 5.4 4.0 6.2 7.6 1.3 7.6 3.4 6.4 3.4 0.5 0.0 7.8 134.8 1.4 4.8 16.6 7.3 2.8 46.4 3.4 0.9 24.7 10.0 7.2 25.8 0.0 2.0 0.2 71.3 11.7 4.4 22.6 11.4 1.7 2.1 47.5 3.0 11.7 2.6 6.2 3.5 33.6 14.1 15.2 3.3 3.9 0.4 8.3 15.2 6.0 38.8 10.2 8.0 7.4 150.6 13.7 6.1 8.8 10.3 2.9 46.4 0.0 19.6 3.9 4.7 37.0 17.7 0.5 6.6 106.1 48.0 8.5 5.3 0.0 19.1 2.5 0.6 1.0 5.3 2.8 2.5 1.2 16.4 44.8 26.3 FAM151A "C1orf179, MGC27169" ENSG00000162391 "Family with sequence similarity 151 member A" Q8WW52 1 54609181-54623556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 66.8;kidney: 176.1" "Group enriched" "Detected in some" 15 "Proximal enterocytes: 478.5;Proximal tubular cells: 294.8" "Group enriched" "Detected in many" 5 "liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "CACO-2: 78.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA016840 Approved NA NA 10000 "HPA016840: AB_2669461" "unprognostic (1.89e-1)" "unprognostic (6.90e-3)" "unprognostic (3.73e-2)" "unprognostic (1.97e-6)" "unprognostic (1.71e-2)" "unprognostic (4.84e-3)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.05e-2)" "unprognostic (4.91e-3)" "unprognostic (9.99e-2)" "prognostic favorable (4.09e-5)" "unprognostic (5.85e-2)" "unprognostic (8.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-3)" 0.6 0.3 1.7 0.7 1.2 0.2 0.1 1.8 1.2 0.0 5.0 2.1 2.4 0.1 0.0 0.3 0.0 0.1 3.1 0.7 0.3 176.1 16.9 0.0 5.4 2.7 2.3 0.0 0.3 0.6 0.0 0.1 0.0 1.5 0.1 1.3 0.3 0.5 0.0 1.0 0.1 66.8 0.0 0.5 0.8 0.7 0.6 2.8 0.2 0.4 0.0 1.9 0.1 0.0 0.8 0.7 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 78.9 0.9 0.0 0.3 0.0 0.2 1.1 0.0 0.0 0.0 0.5 0.0 1.7 0.4 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.5 0.0 0.0 0.8 0.0 0.0 1.6 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.2 1.8 1.2 0.7 0.3 2.7 2.3 0.0 1.5 0.5 2.8 0.8 0.0 0.0 0.0 3.6 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 7.3 0.0 0.0 0.0 9.3 13.7 0.0 5.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.4 16.8 0.0 0.3 0.0 14.3 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 25.0 0.0 0.0 0.0 478.5 294.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.1 18.1 0.0 PARS2 DKFZp727A071 ENSG00000162396 "Prolyl-tRNA synthetase 2, mitochondrial" Q7L3T8 1 54756898-54764523 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028308, HPA028314, HPA028518" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" No No "Nucleoli fibrillar center, Mitochondria" "HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653" "unprognostic (1.95e-1)" "unprognostic (1.10e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.93e-2)" "unprognostic (1.19e-2)" "unprognostic (1.79e-3)" "prognostic unfavorable (2.34e-4)" "unprognostic (6.48e-2)" "unprognostic (2.72e-1)" "unprognostic (1.14e-1)" "unprognostic (9.42e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.24e-6)" "unprognostic (2.72e-2)" "unprognostic (9.77e-2)" "unprognostic (1.73e-2)" "unprognostic (9.64e-2)" 1.3 2.9 2.5 1.9 2.9 0.2 2.7 2.7 3.2 2.7 2.7 4.1 2.7 2.5 3.2 2.7 4.5 1.6 3.0 2.5 2.6 4.2 3.4 1.4 2.0 2.6 2.6 2.5 4.9 2.3 4.8 2.1 2.5 2.7 2.3 3.7 2.0 3.3 2.8 4.4 3.0 2.1 2.1 2.6 1.8 2.5 4.9 2.6 2.6 2.9 5.5 2.4 2.1 2.0 3.0 4.4 7.2 4.6 6.0 5.5 4.6 10.3 3.7 4.5 6.4 4.6 8.3 2.8 7.7 5.6 3.3 9.3 6.9 8.3 5.8 4.7 5.0 7.5 7.4 4.0 6.2 8.5 4.3 2.5 5.0 8.8 8.3 7.4 5.5 4.8 8.4 13.2 1.0 4.9 4.6 6.1 5.7 10.6 8.3 9.1 4.6 9.0 9.0 5.4 3.2 4.7 4.8 5.3 6.9 9.7 8.7 3.9 5.5 2.6 4.8 4.9 6.8 4.7 7.3 6.6 3.0 3.6 5.1 2.8 1.2 5.3 4.5 4.8 7.7 5.9 4.9 5.3 5.3 7.3 5.5 7.8 5.3 0.5 7.4 10.7 5.9 8.2 5.0 2.5 2.9 2.7 3.2 2.5 2.6 2.6 2.6 2.5 2.7 2.6 2.6 3.0 0.6 0.0 1.1 0.3 1.0 0.6 0.9 2.0 1.8 2.6 1.3 1.9 1.5 2.8 1.8 0.0 0.0 7.0 0.2 2.4 9.8 4.5 11.0 1.1 1.4 0.8 0.0 0.0 0.9 2.8 3.9 1.3 1.5 0.6 0.0 2.9 0.0 2.3 3.1 5.0 1.1 2.8 0.0 1.2 0.3 6.8 3.7 0.8 0.0 2.8 1.1 3.2 0.0 0.5 1.6 1.9 1.5 3.0 0.3 1.8 1.5 6.5 1.0 1.9 0.0 1.3 1.1 10.5 11.5 2.0 1.0 3.3 0.7 5.1 3.5 0.8 LEXM "C1orf177, FLJ40201, LEM" ENSG00000162398 "Lymphocyte expansion molecule" Q3ZCV2 1 54806063-54842252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 12.8;testis: 4.8;vagina: 4.1" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 46.0" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 1.5" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035889, HPA035890" Uncertain NA NA "HPA035889: AB_2674844, HPA035890: AB_10669535" "unprognostic (1.61e-1)" "unprognostic (2.18e-2)" "unprognostic (5.01e-2)" "unprognostic (3.69e-2)" "unprognostic (1.50e-2)" "unprognostic (8.32e-2)" "unprognostic (7.28e-2)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (5.13e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.64e-1)" "unprognostic (1.81e-1)" 0.0 0.1 0.0 0.0 1.5 0.1 0.1 0.1 0.6 0.7 0.0 0.4 1.6 0.0 0.1 12.8 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.4 0.0 0.7 0.0 0.0 1.0 1.3 0.0 0.0 0.1 0.2 4.8 0.1 0.0 0.0 0.0 0.5 0.0 4.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.8 0.0 0.2 0.0 0.8 2.0 0.0 0.0 0.1 2.5 0.0 2.0 0.0 0.1 0.2 1.0 0.0 1.5 0.1 0.6 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 37.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 46.0 0.3 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 0.0 0.7 0.3 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.6 0.0 0.0 1.0 0.0 0.6 0.2 BSND "BART, DFNB73" ENSG00000162399 "Barttin CLCNK type accessory subunit beta" Q8WZ55 1 54998933-55017172 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Bartter syndrome, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 9.5" "Group enriched" "Detected in some" 6 "Distal tubular cells: 25.4;Ionocytes: 87.5" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 25 "RPMI-8226: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053836, HPA060617" Enhanced NA NA "HPA053836: AB_2682277, HPA060617: AB_2732651" "unprognostic (3.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.97e-3)" "unprognostic (3.35e-1)" "unprognostic (8.97e-3)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.93e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-2)" "unprognostic (1.68e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 1.2 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.2 0.1 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.2 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 USP24 KIAA1057 ENSG00000162402 "Ubiquitin specific peptidase 24" Q9UPU5 1 55066359-55215364 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 552.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026723, HPA028428, HPA067124" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785" "unprognostic (2.28e-1)" "unprognostic (9.81e-3)" "unprognostic (4.70e-3)" "unprognostic (4.86e-3)" "unprognostic (9.31e-3)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (2.04e-1)" "unprognostic (6.93e-2)" "unprognostic (2.98e-1)" "unprognostic (5.08e-2)" "unprognostic (1.86e-1)" "unprognostic (8.12e-2)" "unprognostic (1.79e-1)" "unprognostic (6.42e-2)" "unprognostic (4.12e-2)" "unprognostic (1.64e-1)" 16.7 8.2 13.4 14.3 13.4 57.2 13.6 25.4 13.7 9.4 13.4 11.3 8.4 10.8 9.3 9.4 10.0 9.1 12.4 12.8 13.6 15.9 15.5 10.7 22.3 13.5 13.5 12.0 16.7 11.5 20.4 12.9 9.7 14.5 10.2 13.5 17.3 12.9 9.7 48.4 13.7 12.7 9.8 11.7 18.8 12.5 8.5 13.6 22.1 9.3 37.0 21.0 10.5 9.3 14.1 32.5 17.4 21.3 11.6 27.2 23.5 24.6 14.0 17.5 19.6 20.3 25.0 11.1 25.9 15.1 26.1 40.1 25.6 28.5 23.6 30.5 27.2 17.4 51.5 40.2 29.6 16.1 36.0 38.6 21.0 20.6 30.0 33.7 19.0 18.2 25.7 48.5 10.6 26.6 7.6 21.9 19.1 31.4 15.5 21.0 22.3 27.1 11.3 34.6 21.4 18.7 13.1 23.8 16.8 21.1 32.3 11.7 17.5 24.7 17.9 17.3 21.7 22.6 13.2 10.6 33.2 16.9 29.4 16.3 5.4 1.3 1.7 2.8 1.1 1.7 3.0 2.2 2.2 1.2 3.4 1.9 2.5 1.4 2.3 1.5 6.9 1.3 0.7 13.4 13.4 25.4 13.7 12.8 13.6 13.5 13.5 12.0 14.5 11.7 13.6 14.1 20.4 16.0 20.0 92.4 27.7 14.9 8.4 5.6 9.1 14.0 13.4 10.2 37.7 10.0 13.0 12.9 73.0 4.2 42.6 11.1 0.0 10.3 0.7 11.9 15.1 16.1 17.3 37.4 84.5 10.2 7.8 11.9 21.4 15.0 12.7 18.2 12.1 11.9 9.7 38.7 100.4 16.2 8.2 19.2 18.8 2.5 11.8 18.6 10.6 87.1 19.6 7.0 15.5 552.4 115.2 11.8 11.4 7.9 18.1 12.7 8.3 5.9 10.0 16.9 6.6 18.0 13.5 7.7 7.1 13.9 17.2 1.5 21.8 9.8 16.0 12.1 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494761-56645301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.4;naive B-cell: 2.3" "Lineage enriched" "Detected in single" 6 "B-cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4" "Low region specificity" "Detected in all" HPA072751 Approved Supported "Golgi apparatus" NA Yes "Golgi apparatus" "HPA072751: AB_2686555" "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 156.2 53.4 90.6 33.9 85.3 13.2 141.0 86.4 106.9 297.1 47.8 56.4 24.2 108.1 56.7 51.8 123.6 66.9 79.7 86.1 86.1 92.2 183.5 87.7 22.6 98.8 95.4 72.2 82.6 37.1 131.3 23.3 227.4 103.3 103.7 42.2 19.2 76.8 171.3 51.3 76.2 46.2 66.1 77.3 23.5 66.6 37.6 107.9 30.1 330.7 63.5 20.1 140.4 144.0 83.3 3.3 10.8 14.1 1.5 710.0 351.8 34.5 39.3 39.7 35.5 17.4 31.8 6.2 5.2 4.6 59.3 39.4 5.9 2.1 0.8 7.4 0.0 9.4 1.3 4.4 44.5 17.3 0.1 0.0 438.1 3.0 34.2 28.6 25.1 34.1 0.4 2.9 0.1 39.0 3.2 0.1 0.5 43.3 9.2 42.6 0.1 0.1 1.7 6.1 32.6 0.4 28.1 12.4 16.1 4.2 42.6 5.2 0.0 21.6 176.2 14.4 660.4 1.8 0.0 0.0 0.0 31.0 1.7 12.7 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 90.6 85.3 86.4 106.9 86.1 86.1 98.8 95.4 72.2 103.3 77.3 107.9 83.3 148.5 25.6 18.9 0.0 7.2 0.0 19.8 0.0 35.3 3.9 12.2 31.2 0.0 44.3 13.0 22.0 0.0 127.0 1.1 8.1 21.5 21.5 7.9 13.9 139.4 148.3 2.4 8.0 0.0 9.2 9.8 392.7 5.6 16.3 3.8 8.1 779.6 132.6 38.8 0.0 0.0 8.5 0.0 35.2 0.0 28.3 1092.6 14.9 0.0 0.0 0.9 136.0 0.0 0.0 0.0 7.9 5.9 398.7 7.1 20.8 15.5 21.3 4.4 4.1 138.1 179.7 107.2 4.5 3.4 16.4 0.0 214.9 5.0 22.4 7.2 20.1 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554513 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" NA NA Nucleoli "Intermediate filaments" "HPA036347: AB_2675076" "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 3.8 4.7 4.5 3.6 5.1 7.6 3.7 5.0 5.8 4.5 2.0 4.7 2.4 5.1 3.6 4.8 4.4 2.3 3.9 6.2 4.1 3.3 5.3 3.2 5.3 3.7 4.1 5.0 4.9 6.0 3.4 4.0 3.0 4.4 4.1 3.1 4.3 3.6 3.1 7.1 6.1 4.8 4.0 2.8 8.9 4.6 3.7 4.3 3.8 3.5 4.5 5.1 4.5 3.8 4.7 6.4 9.1 5.0 15.2 6.6 4.0 5.4 6.3 4.1 6.4 6.8 12.6 8.6 17.9 7.3 7.1 5.5 8.3 10.2 8.6 10.9 7.3 5.5 12.2 14.7 9.9 6.6 10.4 6.4 5.8 2.6 13.6 11.8 3.7 7.6 7.8 14.3 7.3 6.6 11.2 10.2 9.2 6.9 5.0 8.7 12.7 11.7 8.3 5.1 5.8 9.7 4.4 9.7 12.1 8.1 5.1 7.9 4.8 10.0 10.1 8.1 7.2 10.6 6.1 6.2 31.9 9.4 11.4 4.9 3.5 1.9 1.6 3.1 1.9 3.2 2.9 4.5 2.9 1.3 3.7 4.6 3.8 1.2 1.7 3.2 3.5 3.2 1.2 4.5 5.1 5.0 5.8 6.2 4.1 3.7 4.1 5.0 4.4 2.8 4.3 4.7 15.0 19.2 19.5 9.4 16.2 15.4 6.9 6.9 10.8 17.1 9.8 13.2 15.0 11.5 7.4 7.3 14.6 14.8 17.3 6.7 15.6 8.9 6.0 13.7 19.7 15.2 6.7 11.6 18.9 8.6 12.6 15.3 11.7 15.6 5.1 18.3 14.3 13.2 9.1 10.1 18.5 10.9 4.1 13.8 7.3 17.0 9.6 8.6 1.8 10.3 13.4 8.1 12.3 13.0 20.1 9.0 6.2 12.8 17.9 7.3 7.6 10.7 9.0 18.2 0.0 22.6 12.7 11.7 21.5 16.0 14.8 12.7 17.3 19.1 13.2 7.3 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645314-56715335 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.2;skeletal muscle: 39.1;tongue: 36.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5" "Cancer enhanced" "Detected in many" "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA044540: AB_2678977" "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavorable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favorable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 1.3 1.4 1.5 0.5 4.0 0.0 3.3 3.5 3.9 1.4 3.7 3.7 0.5 1.8 1.1 4.7 2.7 1.9 41.2 3.7 3.3 13.7 0.7 1.4 0.1 1.3 1.7 3.0 1.5 1.8 8.4 1.3 0.5 1.7 3.8 1.4 13.6 4.3 2.6 39.1 0.6 1.3 3.2 0.4 1.3 2.3 1.1 1.4 0.4 3.4 36.7 0.1 1.8 1.3 1.9 0.0 3.8 2.1 0.0 0.7 0.5 2.3 1.9 1.5 2.5 4.3 3.9 4.9 0.0 0.6 0.6 7.5 0.1 8.0 0.0 7.1 0.0 8.8 0.0 7.0 5.5 0.0 0.0 0.1 0.6 0.0 3.5 0.3 5.8 0.8 2.0 0.0 0.0 1.1 0.1 0.0 0.0 5.6 0.0 5.5 0.0 0.0 0.0 14.1 1.3 2.0 5.5 6.0 0.1 0.0 6.0 3.3 0.0 0.0 1.5 2.3 2.8 6.6 0.0 0.0 0.0 4.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 4.0 3.5 3.9 3.7 3.3 1.3 1.7 3.0 1.7 0.4 1.4 1.9 1.1 9.6 4.8 30.7 2.0 0.9 8.0 6.7 2.2 42.0 19.4 9.5 328.5 24.3 14.3 49.7 50.1 1.0 0.2 6.1 54.8 9.5 3.9 14.4 2.9 10.3 14.4 0.0 109.4 4.8 0.4 15.3 5.1 17.4 2.5 11.7 9.7 8.1 0.1 26.9 119.0 6.3 8.2 0.0 1.6 4.8 6.8 1.4 5.4 18.7 0.0 18.6 0.0 84.9 20.4 6.2 3.0 29.3 0.0 21.2 0.2 82.4 10.7 115.5 6.6 24.5 17.2 7.2 3.7 17.7 0.4 0.4 1.2 5.3 6.1 13.4 KLHL21 KIAA0469 ENSG00000162413 "Kelch like family member 21" Q9UJP4 1 6590724-6614607 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 171.2" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 104.8;Suprabasal keratinocytes: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 21.4;neutrophil: 63.0" "Lineage enriched" "Detected in all" 8 "granulocytes: 63.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051364, HPA059307" Uncertain Supported Centrosome NA NA Centrosome "HPA051364: AB_2681455, HPA059307: " "unprognostic (6.13e-3)" "unprognostic (5.26e-2)" "unprognostic (2.30e-2)" "unprognostic (9.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.39e-2)" "unprognostic (5.77e-3)" "unprognostic (2.28e-1)" "unprognostic (8.52e-2)" "unprognostic (4.85e-2)" "unprognostic (4.02e-1)" "unprognostic (6.33e-3)" "prognostic favorable (1.71e-4)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (9.74e-2)" "unprognostic (4.19e-2)" 30.7 29.7 33.7 12.7 35.5 25.7 24.8 33.9 33.3 26.5 60.5 33.7 7.0 35.6 8.8 36.7 24.4 14.5 53.3 30.8 40.2 21.6 22.3 16.6 9.3 39.4 33.8 26.2 28.9 33.6 21.7 30.3 6.9 37.7 32.0 5.0 7.7 33.5 28.5 171.2 36.9 16.1 16.5 33.6 17.4 30.3 15.3 34.7 9.8 18.9 102.2 7.7 46.9 25.2 43.1 25.8 15.1 7.5 24.3 41.5 25.8 19.5 35.5 28.1 23.0 13.7 44.1 16.1 0.9 30.8 21.9 20.7 41.7 16.6 39.2 12.8 54.8 26.8 29.7 27.8 40.3 34.4 17.8 17.5 28.9 13.0 52.3 17.6 21.6 9.9 14.8 33.3 23.1 19.0 8.9 18.4 15.7 13.8 13.1 55.5 28.0 31.3 32.3 13.5 7.8 30.2 7.5 27.8 22.0 62.8 6.5 14.5 21.0 33.3 74.4 9.1 68.9 86.1 26.2 35.2 18.0 72.2 33.1 28.4 8.4 6.2 21.4 7.1 2.6 6.2 4.5 6.6 7.0 3.8 2.6 5.3 5.3 63.0 2.9 2.3 3.4 8.2 6.1 33.7 35.5 33.9 33.3 30.8 40.2 39.4 33.8 26.2 37.7 33.6 34.7 43.1 11.6 3.2 5.1 19.6 8.9 71.2 46.9 22.3 63.2 4.1 47.1 44.4 68.3 7.2 10.7 9.2 4.2 5.1 15.6 10.1 7.9 12.0 2.7 19.6 14.9 15.6 3.0 2.1 8.2 12.9 7.0 24.7 31.1 35.3 0.0 6.4 7.1 23.6 5.6 5.0 8.9 5.6 14.2 10.4 30.1 7.6 10.8 17.1 26.6 8.4 7.6 12.2 4.1 6.6 14.1 20.0 7.3 15.1 12.6 43.1 5.3 7.6 14.0 5.9 13.1 32.2 25.2 2.0 10.9 104.8 72.0 6.4 15.3 9.2 5.5 31.3 ZSWIM5 KIAA1511 ENSG00000162415 "Zinc finger SWIM-type containing 5" Q9P217 1 45016399-45306209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Astrocytes: 96.9;Excitatory neurons: 84.3;Granulosa cells: 36.3;Inhibitory neurons: 133.8;Microglial cells: 54.4;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 5.2;Hep G2: 6.1;SCLC-21H: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018211 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA018211: AB_1859502" "unprognostic (1.86e-1)" "unprognostic (2.58e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-3)" "unprognostic (3.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (2.65e-2)" "unprognostic (1.57e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-3)" "unprognostic (2.55e-1)" "unprognostic (4.12e-3)" "unprognostic (7.12e-2)" "unprognostic (3.09e-2)" "unprognostic (2.88e-2)" "unprognostic (1.16e-1)" 0.9 12.2 2.7 0.9 3.1 0.2 1.7 5.4 3.1 2.0 1.0 4.1 4.5 3.0 2.4 1.3 2.4 1.1 1.2 2.6 3.1 2.9 0.6 2.1 1.1 3.0 2.8 2.7 8.1 2.9 6.0 6.0 0.9 3.5 3.1 5.0 8.6 3.0 2.3 1.2 1.5 6.8 3.0 2.2 1.6 1.9 3.0 3.3 0.7 4.1 1.1 0.9 2.7 1.3 2.5 0.4 1.3 3.1 5.2 0.4 0.1 0.7 0.1 4.2 0.8 0.6 0.4 0.5 0.3 0.1 0.1 2.3 0.1 2.2 0.0 0.9 2.2 3.9 0.2 4.6 6.1 0.0 0.6 0.6 0.1 0.1 0.2 0.0 0.4 0.9 1.0 0.2 0.2 0.1 1.8 0.4 0.2 2.8 3.7 1.5 1.4 0.1 0.2 0.0 1.0 7.2 3.7 2.0 0.7 0.3 0.9 1.5 0.1 0.2 0.7 0.4 0.2 0.8 1.4 0.2 0.1 2.8 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 3.1 5.4 3.1 2.6 3.1 3.0 2.8 2.7 3.5 2.2 3.3 2.5 0.3 0.0 3.1 96.9 0.4 0.5 0.5 0.1 1.2 9.3 1.5 1.4 1.4 2.8 1.3 0.0 10.4 0.1 0.2 5.7 1.9 0.3 1.2 0.4 0.7 1.9 6.7 0.0 84.3 1.3 0.0 1.0 1.5 0.7 0.0 36.3 1.8 0.3 0.1 8.4 133.8 3.9 0.0 0.0 0.3 1.5 0.3 0.2 0.0 54.4 0.6 1.8 0.0 144.8 106.1 0.8 3.7 1.5 0.2 0.5 6.1 1.8 0.7 4.9 0.0 1.1 1.1 1.3 2.3 0.5 0.9 0.1 0.9 0.7 4.4 0.3 GMEB1 "P96PIF, PIF96" ENSG00000162419 "Glucocorticoid modulatory element binding protein 1" Q9Y692 1 28668778-28719353 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044811, HPA052975" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044811: AB_10959666, HPA052975: AB_2682003" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" "unprognostic (2.49e-2)" "prognostic favorable (1.94e-4)" "unprognostic (2.71e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.91e-7)" "unprognostic (1.42e-2)" "unprognostic (1.41e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (3.38e-2)" "unprognostic (8.41e-2)" "unprognostic (4.79e-3)" "unprognostic (3.44e-1)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" 4.5 3.1 2.3 5.8 2.2 13.7 4.3 5.8 3.1 4.9 3.1 4.4 3.0 4.9 3.0 5.2 4.5 4.3 3.1 2.5 2.1 3.1 3.4 4.3 6.8 2.6 2.3 1.9 5.6 4.1 3.4 3.8 5.7 3.1 3.5 4.5 5.6 3.4 3.1 5.3 4.9 4.4 4.8 2.2 5.5 4.1 6.0 2.5 10.7 3.5 4.4 8.1 4.3 4.4 3.1 12.1 8.5 14.1 12.9 4.6 8.5 10.0 12.5 9.0 7.9 11.7 2.7 9.4 22.1 6.5 11.7 4.7 4.6 12.7 9.7 10.2 25.4 7.9 20.4 8.9 5.2 6.9 17.1 10.2 6.8 6.8 19.2 12.3 6.9 11.1 10.8 12.6 17.1 9.6 10.5 10.7 5.7 18.9 8.0 5.7 7.2 9.7 10.3 6.0 9.6 10.4 8.6 12.1 8.0 8.1 9.4 6.1 8.7 11.2 5.4 13.1 9.3 17.0 7.6 13.8 12.1 6.6 15.8 8.7 8.1 5.4 9.9 6.7 7.0 5.1 4.0 6.5 7.9 6.3 6.0 5.3 5.5 7.6 7.5 9.0 4.6 6.0 4.6 2.3 2.2 5.8 3.1 2.5 2.1 2.6 2.3 1.9 3.1 2.2 2.5 3.1 12.9 6.4 20.0 3.9 20.5 17.0 19.9 8.6 8.6 23.6 9.0 10.2 4.0 10.0 11.0 14.7 12.5 14.1 17.7 12.7 5.9 10.9 13.3 10.1 12.5 13.2 7.8 26.7 7.0 11.1 16.6 10.0 9.2 16.3 28.5 12.8 16.8 6.1 10.7 25.2 5.9 13.1 10.2 13.4 7.9 2.8 9.6 12.2 1.8 4.7 14.8 17.5 29.9 5.0 9.2 11.5 14.1 7.9 11.5 12.4 8.5 5.7 7.1 24.7 19.7 18.3 13.0 34.8 28.6 8.3 16.8 32.3 19.5 13.2 11.0 19.6 SLC45A1 DNB5 ENSG00000162426 "Solute carrier family 45 member 1" Q9Y2W3 1 8318114-8344167 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Symport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 10.0;Horizontal cells: 10.1;Inhibitory neurons: 11.1" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 3.9" "Lineage enriched" "Detected in single" 5 "monocytes: 3.9" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;GAMG: 2.7;HHSteC: 4.9;U-87 MG: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078818 Enhanced NA NA "HPA078818: " "unprognostic (1.77e-3)" "unprognostic (1.37e-2)" "unprognostic (4.32e-3)" "unprognostic (8.32e-2)" "unprognostic (3.22e-3)" "unprognostic (1.56e-1)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (1.20e-1)" "unprognostic (1.43e-1)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (5.67e-2)" "unprognostic (8.53e-3)" "unprognostic (2.16e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-3)" 2.2 1.8 2.3 0.5 3.1 0.0 2.1 2.4 5.4 3.4 1.5 3.0 0.5 5.2 0.8 0.9 4.3 1.1 1.8 2.9 3.0 4.1 0.2 0.9 0.4 4.1 3.0 4.3 3.0 1.0 1.1 6.7 0.3 4.6 3.0 0.3 1.6 1.0 2.1 1.3 0.8 1.9 1.1 0.7 1.5 1.7 1.4 4.7 0.1 1.4 1.3 0.1 3.0 2.6 6.9 0.0 1.8 0.3 0.8 3.7 2.6 0.0 0.1 0.8 0.2 0.5 0.0 0.2 0.0 0.2 0.5 2.7 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.1 0.0 4.9 0.0 1.4 1.2 0.1 0.6 0.0 0.9 0.4 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.9 0.0 1.2 0.0 0.8 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.3 1.5 0.2 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.1 0.0 0.6 0.6 0.8 0.3 0.4 0.4 0.1 0.0 0.2 0.3 0.0 0.0 3.9 0.0 0.3 0.4 2.3 3.1 2.4 5.4 2.9 3.0 4.1 3.0 4.3 4.6 0.7 4.7 6.9 6.3 0.0 0.0 5.2 0.6 0.4 1.8 0.8 0.6 7.0 0.3 0.0 1.4 0.0 0.1 1.8 4.2 0.1 0.2 0.0 0.0 0.6 2.5 0.6 2.4 2.9 0.0 0.0 10.0 0.2 0.0 3.1 0.0 0.9 0.0 1.6 1.1 0.0 0.1 10.1 11.1 0.2 0.0 0.3 1.5 5.4 3.4 0.7 0.0 0.0 0.0 6.1 0.0 5.0 4.4 0.1 0.0 5.7 0.3 0.9 0.0 0.5 0.1 5.0 6.6 2.7 2.5 0.6 0.5 0.0 0.3 0.0 1.0 1.4 0.1 0.4 SELENON "MDRS1, RSMD1, RSS, SELN, SEPN1" ENSG00000162430 "Selenoprotein N" Q9NZV5 1 25800176-25818221 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Desmin-related myopathy, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 99.2;Exocrine glandular cells: 42.3;Granulosa cells: 31.2;Hofbauer cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058076 Approved Uncertain Cytosol "Intracellular and membrane" NA NA Cytosol "HPA058076: AB_2683598" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-1)" "prognostic favorable (2.23e-4)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (3.32e-3)" "unprognostic (6.01e-2)" "unprognostic (3.07e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (5.56e-3)" "unprognostic (5.89e-2)" 60.7 48.4 46.1 34.3 45.7 17.2 61.4 42.0 53.7 44.0 63.6 38.0 17.5 49.2 19.7 36.8 40.5 30.3 50.2 44.3 62.2 52.6 20.4 52.3 20.7 68.0 49.2 38.5 52.1 60.6 37.3 40.5 39.2 45.0 58.7 21.0 11.8 46.1 39.9 56.8 29.0 31.3 56.7 48.7 43.7 43.8 12.0 53.3 13.8 54.3 40.1 16.5 47.3 35.9 50.6 52.6 49.5 160.9 138.4 102.5 178.8 54.4 62.2 93.4 67.7 53.9 12.9 54.2 0.1 40.4 94.6 74.8 49.9 42.4 66.2 51.1 55.8 32.6 51.4 18.2 16.0 73.8 11.0 116.6 191.7 43.8 71.0 35.5 79.9 214.4 17.4 18.5 7.2 64.7 26.8 2.3 15.7 61.0 40.9 33.7 45.4 70.3 6.4 27.7 14.8 33.5 56.9 39.4 35.3 52.7 43.0 35.6 36.1 180.5 68.4 46.2 126.6 37.1 5.8 0.2 1.4 94.8 15.9 84.4 2.7 1.2 1.6 0.7 1.0 0.4 0.7 0.6 0.5 0.8 0.4 0.9 0.6 0.2 0.3 1.1 0.1 0.7 0.4 46.1 45.7 42.0 53.7 44.3 62.2 68.0 49.2 38.5 45.0 48.7 53.3 50.6 99.2 9.6 10.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 23.0 19.3 0.0 0.0 3.7 20.2 0.0 16.4 3.8 0.0 0.0 18.6 0.0 6.5 22.4 21.5 0.0 0.0 0.0 42.3 11.4 12.5 0.0 13.5 2.5 31.2 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.9 0.0 0.0 14.9 3.6 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 13.0 2.2 8.6 0.0 0.0 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 185.2;liver: 104.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 242.6;Proximal tubular cells: 595.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.1;myeloid DC: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 208.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" NA Yes 39000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavorable (4.36e-4)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 24.9 1.9 19.4 6.7 21.0 5.0 26.9 17.1 21.1 6.1 16.5 15.9 4.3 7.0 4.2 23.6 7.6 13.8 52.1 20.5 19.3 185.2 104.8 2.8 1.6 18.8 20.4 18.9 4.7 1.2 18.4 4.7 8.4 19.3 16.4 14.2 22.0 9.6 12.9 1.7 27.6 6.6 21.6 18.4 1.2 15.1 11.4 22.9 5.8 2.5 39.1 3.3 19.2 11.9 20.9 73.2 5.0 5.6 23.9 51.6 48.7 12.0 12.1 15.0 25.6 70.8 108.1 8.6 39.1 31.0 19.0 32.1 46.1 18.8 89.9 101.9 33.0 21.5 37.9 21.9 208.6 2.5 29.9 4.6 27.2 49.6 25.1 73.0 42.2 0.9 12.2 48.0 0.6 39.6 31.2 1.1 1.3 24.6 1.0 42.5 0.2 41.0 7.1 37.8 3.2 20.5 15.4 21.6 1.5 16.7 25.8 29.7 12.9 4.2 42.4 36.2 3.3 20.9 39.5 18.8 2.1 68.7 10.9 2.5 0.9 3.1 0.0 0.1 0.6 0.2 0.2 0.1 0.2 2.7 0.1 0.1 0.1 0.4 0.3 0.1 0.4 0.0 0.8 19.4 21.0 17.1 21.1 20.5 19.3 18.8 20.4 18.9 19.3 18.4 22.9 20.9 11.2 0.0 0.5 51.2 4.7 49.7 23.6 44.2 63.7 24.5 48.9 44.7 105.7 52.9 14.3 31.3 2.1 2.2 0.6 15.8 56.7 18.6 3.4 30.1 8.2 19.6 5.4 13.9 17.1 12.1 21.1 11.4 27.5 52.2 0.0 36.4 11.7 242.6 3.3 16.8 7.7 8.7 24.4 7.8 9.2 5.8 4.1 6.9 24.9 3.7 5.7 32.7 0.0 9.5 2.5 31.9 4.3 9.4 0.4 38.7 18.8 595.5 12.3 6.5 6.6 5.6 18.8 1.8 9.5 43.1 74.3 4.9 3.6 0.7 23.1 20.4 JAK1 "JAK1A, JAK1B, JTK3" ENSG00000162434 "Janus kinase 1" P23458 1 64833229-65067754 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 700.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 336.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013088 Approved NA NA "CAB013088: " "prognostic favorable (9.63e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.81e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (4.21e-2)" "unprognostic (1.53e-1)" "unprognostic (7.00e-3)" "unprognostic (8.40e-2)" "unprognostic (7.88e-3)" "unprognostic (1.66e-2)" "unprognostic (8.84e-2)" "prognostic favorable (2.67e-4)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (7.30e-2)" "unprognostic (3.51e-1)" 100.4 38.5 45.1 74.5 45.5 51.8 61.4 47.2 45.8 58.7 61.2 50.9 34.2 57.3 61.3 39.0 41.0 64.8 48.7 45.4 52.5 56.0 87.3 62.7 110.9 52.2 47.6 37.6 77.8 47.1 55.4 35.9 57.5 49.6 42.6 55.0 42.0 34.5 55.7 84.1 79.9 51.3 64.7 45.2 89.0 49.9 47.2 61.0 104.8 45.4 119.7 102.5 82.0 39.7 48.2 50.4 66.2 27.7 3.0 336.8 177.2 35.1 76.3 116.1 64.6 75.7 21.4 27.7 76.5 59.1 142.8 118.7 27.8 19.4 63.6 93.8 102.7 29.5 104.0 32.1 56.2 126.6 40.2 68.4 159.9 92.6 97.2 103.0 78.4 208.7 37.0 37.9 78.9 80.1 31.2 22.3 39.6 18.6 65.3 37.4 30.5 77.8 28.5 213.8 84.9 19.8 57.9 107.4 51.6 52.9 56.6 104.3 28.6 180.8 74.7 34.1 174.2 42.0 47.7 23.6 60.4 70.5 57.9 34.1 162.4 52.1 146.8 94.0 66.3 105.7 89.1 90.2 100.7 69.4 73.1 97.0 80.6 177.9 305.4 76.2 55.0 117.1 130.8 45.1 45.5 47.2 45.8 45.4 52.5 52.2 47.6 37.6 49.6 45.2 61.0 48.2 211.2 51.3 94.9 62.3 219.8 116.6 150.7 91.3 78.0 37.0 66.2 71.6 112.8 87.2 84.2 112.2 22.9 9.0 345.0 89.2 43.0 171.3 125.2 90.1 167.0 183.0 66.4 52.8 59.6 213.8 105.2 131.9 91.3 151.2 57.0 48.7 174.2 91.4 58.5 21.9 85.3 62.0 69.2 160.2 148.9 101.7 96.0 177.9 49.8 80.6 234.8 53.5 700.3 61.3 42.7 217.5 58.6 84.7 175.2 183.8 53.7 79.0 61.9 38.6 164.3 70.6 191.8 40.8 53.1 71.2 166.1 12.2 256.0 95.7 47.6 200.1 RAVER2 "FLJ10770, KIAA1579" ENSG00000162437 "Ribonucleoprotein, PTB binding 2" Q9HCJ3 1 64745095-64833232 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 72.8;Distal enterocytes: 60.1;Inhibitory neurons: 40.4;Oligodendrocyte precursor cells: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "basophil: 6.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045785 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045785: AB_10964058" "unprognostic (8.02e-2)" "unprognostic (5.23e-2)" "unprognostic (4.23e-3)" "unprognostic (2.73e-1)" "unprognostic (2.32e-1)" "unprognostic (2.89e-2)" "unprognostic (2.22e-3)" "unprognostic (1.23e-2)" "unprognostic (3.14e-1)" "unprognostic (1.47e-1)" "unprognostic (6.56e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.14e-6)" "unprognostic (1.74e-1)" "unprognostic (3.50e-2)" "unprognostic (1.41e-1)" "unprognostic (5.09e-2)" 4.8 8.2 12.7 4.2 11.0 9.6 8.3 15.0 12.5 7.7 12.1 23.8 24.4 7.8 5.8 9.5 7.5 11.4 12.8 13.4 11.8 7.7 1.6 8.4 2.0 10.2 11.9 10.3 6.5 7.4 16.4 12.4 7.4 11.2 12.1 27.1 15.3 15.6 10.4 22.4 6.7 26.3 9.4 9.9 4.3 12.6 2.7 13.4 8.4 6.1 17.9 4.1 6.5 7.5 9.8 16.7 5.1 15.2 16.7 2.7 2.3 4.1 3.6 6.5 7.3 8.2 13.6 7.3 0.1 8.2 3.8 16.6 12.4 15.7 10.9 8.9 0.1 17.3 20.2 13.7 12.2 5.1 27.5 0.2 6.8 9.8 0.5 7.5 16.9 12.2 16.6 4.5 16.3 0.6 6.2 9.2 5.6 18.8 13.1 13.3 31.1 23.9 6.7 8.0 12.3 11.5 25.6 16.4 0.0 16.0 14.3 12.6 4.3 4.6 6.8 10.9 6.8 13.1 12.3 14.9 7.0 4.1 0.1 6.4 6.2 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 12.7 11.0 15.0 12.5 13.4 11.8 10.2 11.9 10.3 11.2 9.9 13.4 9.8 9.2 6.4 13.5 72.8 0.6 8.0 7.0 3.9 8.0 7.1 7.2 6.0 24.4 11.5 8.3 1.8 14.6 0.2 1.1 60.1 0.0 3.4 9.8 5.7 2.5 10.6 18.0 4.2 29.0 5.2 0.3 6.3 11.2 6.5 1.3 7.1 6.8 0.3 0.6 0.0 40.4 30.7 4.1 4.8 3.3 16.8 6.5 2.0 3.6 22.5 0.3 26.1 0.0 40.2 1.8 2.7 20.5 8.2 2.3 6.6 26.9 2.1 6.1 3.7 0.0 6.2 5.5 3.1 3.2 8.5 5.8 0.3 1.5 1.7 27.8 7.3 CTRC "CLCR, ELA4" ENSG00000162438 "Chymotrypsin C" Q99895 1 15438442-15449242 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4560 "pancreas: 25923.7" "Cell type enriched" "Detected in some" 9 "Exocrine glandular cells: 6566.4" "Cancer enriched" "Detected in some" 168 "pancreatic cancer: 236.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046920 Enhanced "Secreted to digestive system" NA NA "HPA046920: AB_2679865" "unprognostic (2.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (8.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (2.94e-2)" "unprognostic (7.60e-2)" "unprognostic (3.34e-1)" "unprognostic (2.00e-1)" "unprognostic (9.55e-11)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.50e-1)" "unprognostic (5.99e-3)" 5.6 1.2 0.3 0.2 0.3 0.7 2.9 0.7 0.5 1.6 0.2 1.1 1.2 1.4 0.1 1.9 0.9 0.0 2.2 0.4 0.1 1.2 3.5 1.0 0.3 0.2 0.2 0.2 5.6 25923.7 0.0 1.5 0.7 0.3 1.8 0.0 0.1 2.1 0.0 1.0 1.7 1.7 0.0 0.2 2.0 2.3 1.0 0.2 0.0 1.1 0.0 0.0 0.6 1.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.3 0.3 0.7 0.5 0.4 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.5 0.2 0.0 0.5 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 17.3 0.0 0.6 1.0 0.7 0.0 0.0 0.2 6566.4 0.1 0.2 0.0 2.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.0 1.1 1.8 0.0 24.3 0.0 1.0 0.0 0.0 673.8 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 1.3 3.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.3 LZIC MGC15436 ENSG00000162441 "Leucine zipper and CTNNBIP1 domain containing" Q8WZA0 1 9922113-9943407 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 304.7;Spermatocytes: 191.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028184, HPA058614" Approved Approved Nucleoplasm,Cytosol NA NA 160000 Nucleoplasm Cytosol "HPA028184: AB_10602706, HPA058614: AB_2683779" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (1.76e-2)" "unprognostic (1.62e-1)" "unprognostic (6.26e-2)" "unprognostic (8.37e-2)" "prognostic unfavorable (2.47e-5)" "unprognostic (2.89e-1)" "unprognostic (3.79e-3)" "unprognostic (7.84e-2)" "unprognostic (1.70e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.56e-5)" "unprognostic (1.19e-1)" "unprognostic (3.76e-3)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 20.7 18.3 21.6 19.0 24.6 19.5 25.8 25.8 23.6 24.5 17.7 28.8 29.2 26.1 16.3 23.2 23.9 18.3 29.9 20.7 22.4 29.1 30.6 17.2 22.1 25.7 25.1 18.9 35.3 13.5 29.4 12.4 22.4 25.2 22.1 27.9 26.2 21.1 20.0 27.6 20.3 27.4 25.0 26.5 15.9 16.9 67.5 23.0 30.2 24.9 27.7 24.0 18.3 15.4 29.6 43.0 27.8 52.5 37.2 32.0 51.9 23.3 38.1 32.1 52.8 50.9 34.6 73.4 51.6 42.3 48.1 33.3 31.9 49.7 55.1 78.7 48.5 33.5 75.7 34.9 57.9 30.7 69.7 37.5 34.3 77.0 74.1 69.2 37.6 41.8 67.4 95.6 28.7 49.1 30.5 57.3 33.8 26.6 53.7 44.5 60.7 69.4 41.9 28.5 19.2 26.1 41.2 46.6 20.2 91.2 49.9 33.5 35.1 38.6 36.5 49.6 52.4 40.8 23.2 57.5 87.4 37.3 101.7 49.6 34.9 25.1 40.3 20.5 29.5 17.8 18.4 20.6 20.1 24.8 20.4 20.1 21.2 25.6 23.2 33.2 38.0 29.3 17.5 21.6 24.6 25.8 23.6 20.7 22.4 25.7 25.1 18.9 25.2 26.5 23.0 29.6 34.3 6.4 17.3 6.8 20.7 12.7 21.9 24.1 17.6 12.0 22.6 27.3 57.4 10.0 15.9 7.3 6.2 26.9 26.9 25.9 49.0 27.0 304.7 34.7 36.4 19.9 9.1 24.0 11.1 21.2 45.7 27.8 13.3 27.0 30.4 27.2 14.3 23.9 42.7 42.1 14.8 18.1 10.2 22.6 15.7 91.6 26.4 34.9 14.2 14.0 36.8 45.6 20.6 13.6 23.8 22.6 27.8 27.4 22.4 27.6 41.7 53.0 27.4 18.0 19.7 26.6 31.1 191.3 86.2 29.2 16.8 34.5 26.8 21.4 22.5 21.6 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016021 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 349.2;breast: 398.0;lymphoid tissue: 113.0" "Cell type enriched" "Detected in many" 7 "Adipocytes: 3631.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 311.5;neutrophil: 344.7" "Group enriched" "Detected in many" 31 "granulocytes: 344.7;monocytes: 311.5" "Group enriched" "Detected in some" 4 "EFO-21: 13.0;SK-MEL-30: 9.8;T-47d: 34.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 349.2 15.1 26.1 8.9 31.2 28.9 398.0 28.8 33.5 21.0 28.2 13.9 2.7 20.5 4.2 34.7 14.8 52.1 71.4 25.4 27.9 33.0 9.7 8.9 8.4 28.3 29.5 24.2 12.8 12.0 69.4 16.8 16.0 30.2 18.8 4.4 5.0 22.5 8.2 16.1 33.9 11.6 15.0 28.5 113.0 17.4 9.3 28.9 12.7 36.5 25.2 5.7 23.8 28.1 42.2 0.0 0.6 0.3 0.0 0.0 0.5 0.0 0.0 0.0 2.5 0.9 2.5 3.2 0.0 13.0 1.3 0.0 0.0 0.1 1.0 4.4 0.0 2.8 0.0 0.1 1.3 1.6 0.0 0.0 0.0 2.0 2.1 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 3.4 0.0 0.0 0.0 0.7 0.0 0.2 0.5 2.6 0.2 9.8 3.5 34.8 2.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 311.5 2.8 0.4 138.4 0.2 0.1 0.0 0.1 10.6 0.2 0.2 0.1 344.7 0.0 68.3 2.0 0.7 96.8 26.1 31.2 28.8 33.5 25.4 27.9 28.3 29.5 24.2 30.2 28.5 28.9 42.2 3631.8 0.0 1.3 0.7 9.5 20.6 9.5 2.6 9.1 0.2 43.0 73.9 22.9 10.0 1.2 1.8 0.0 5.0 16.2 0.1 23.5 2.0 3.2 2.5 15.8 349.2 0.0 5.7 0.4 2.8 1.9 36.1 0.0 4.8 3.8 7.1 69.7 3.7 63.7 0.0 0.4 0.4 2.0 502.5 14.1 6.1 6.2 42.5 21.4 1.0 149.7 2.1 3.1 0.0 13.4 2.7 0.1 0.7 2.7 20.7 0.0 1.4 0.9 1.5 0.0 3.9 20.5 1.8 2.8 26.2 17.6 6.2 3.8 3.6 0.6 6.3 KNCN "FLJ32011, KINO, L5" ENSG00000162456 Kinocilin A6PVL3 1 46545641-46551647 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "brain: 3.5" "Group enriched" "Detected in some" 46 "Early spermatids: 15.1;Late spermatids: 31.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.99e-3)" "unprognostic (2.28e-2)" "unprognostic (2.80e-2)" 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.5 0.0 0.0 0.0 0.0 1.9 1.6 0.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.5 3.5 1.9 1.6 0.1 1.1 0.3 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBLIM1 "CAL, FBLP-1, migfilin" ENSG00000162458 "Filamin binding LIM protein 1" Q8WUP2 1 15756607-15786594 "Predicted intracellular proteins" "Cell adhesion, Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 207.3;Paneth cells: 153.6;Peritubular cells: 191.5;Proximal enterocytes: 145.9;Sertoli cells: 144.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 255.9;TIME: 420.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025287, HPA072750" Approved Enhanced "Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "Nucleoli fibrillar center" "HPA025287: AB_1848443, HPA072750: AB_2686554" "unprognostic (4.10e-2)" "prognostic unfavorable (4.07e-4)" "unprognostic (2.26e-1)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.33e-2)" "unprognostic (8.77e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (2.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.33e-2)" "unprognostic (3.01e-1)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 31.3 18.1 2.7 21.7 3.1 0.8 28.3 3.3 8.2 38.3 11.7 76.3 82.9 76.4 15.7 24.3 43.9 70.4 45.7 2.6 3.0 26.9 7.2 39.7 9.7 2.9 3.1 2.6 39.4 27.7 36.5 11.0 29.6 2.9 47.4 53.7 1.8 31.9 63.7 5.5 15.7 86.9 47.6 2.4 27.8 64.6 12.9 3.4 2.8 17.7 5.6 6.8 45.0 29.6 3.0 34.2 17.2 15.9 0.6 3.7 8.1 21.6 55.2 84.3 38.4 30.4 6.0 48.8 0.3 114.5 87.8 67.3 62.5 11.3 121.0 19.2 0.3 6.6 0.2 4.7 31.7 98.5 0.2 0.6 39.7 81.7 31.9 75.1 82.7 255.9 2.0 1.2 7.6 13.2 0.8 0.6 1.1 16.5 50.9 25.0 0.1 0.4 1.0 51.4 22.1 0.2 38.9 29.0 3.4 6.0 33.9 6.8 0.6 420.4 50.7 7.1 0.8 25.7 0.4 1.0 0.5 8.0 0.2 0.5 1.7 0.3 0.3 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.5 0.3 0.3 0.8 0.4 0.2 0.4 0.1 0.1 2.7 3.1 3.3 8.2 2.6 3.0 2.9 3.1 2.6 2.9 2.4 3.4 3.0 10.8 12.8 18.1 0.0 3.1 86.3 82.7 41.4 20.5 3.7 28.6 23.9 37.1 47.1 30.6 16.5 6.2 8.9 4.8 207.3 0.0 99.1 3.4 13.6 75.9 19.2 46.0 0.0 0.7 53.5 114.2 29.3 133.5 20.5 18.9 9.4 55.0 2.5 5.6 1.7 5.5 54.8 26.4 1.9 23.5 4.0 80.2 5.8 14.2 2.8 2.7 9.1 1.0 1.0 1.2 113.0 153.6 191.5 1.2 29.8 145.9 2.5 11.6 6.4 144.7 11.9 64.8 2.8 1.9 17.4 62.8 19.4 6.0 6.6 53.8 62.6 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742499-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.6;kidney: 11.2;liver: 53.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3" "Cancer enhanced" "Detected in some" "liver cancer: 10.2;renal cancer: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "CACO-2: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 24.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.2 53.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 1.6 0.0 42.8 7.9 0.0 0.0 0.0 0.0 0.0 2.4 2.7 0.0 0.2 2.9 0.0 1.5 0.1 0.0 0.0 0.4 49.3 0.1 0.0 0.0 9.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 60.2 0.0 0.0 0.0 173.6 53.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 12.5 0.0 SLC25A34 DKFZp781A10161 ENSG00000162461 "Solute carrier family 25 member 34" Q6PIV7 1 15736258-15741392 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.1;tongue: 47.7" "Cell type enriched" "Detected in many" 5 "Proximal enterocytes: 44.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069806 Approved Mitochondria NA NA Mitochondria "HPA069806: AB_2686202" "unprognostic (2.06e-1)" "unprognostic (4.72e-1)" "unprognostic (1.15e-1)" "unprognostic (2.43e-1)" "unprognostic (2.58e-1)" "unprognostic (8.08e-3)" "unprognostic (1.98e-2)" "unprognostic (9.92e-2)" "unprognostic (1.55e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-4)" "unprognostic (5.74e-2)" "unprognostic (6.10e-2)" "unprognostic (4.02e-1)" "unprognostic (1.82e-1)" "unprognostic (4.04e-2)" "unprognostic (2.40e-4)" 2.3 4.4 3.3 1.0 3.3 3.4 1.8 6.0 4.8 3.5 2.1 4.4 14.1 3.2 0.8 1.8 3.0 1.5 8.9 3.1 2.9 4.8 5.6 2.5 1.3 2.9 2.7 3.2 4.2 4.9 0.6 3.8 1.3 3.6 2.4 2.0 1.9 4.8 0.8 38.1 1.6 13.8 1.1 2.0 3.7 2.2 2.6 3.1 0.5 3.5 47.7 0.5 2.8 2.3 3.6 0.3 0.2 1.5 0.6 0.7 0.3 0.6 0.2 0.1 0.3 0.2 0.6 0.8 0.4 0.3 0.3 0.8 0.3 0.2 0.2 0.3 0.5 0.3 0.7 0.5 0.2 0.2 0.2 0.9 0.3 1.1 0.4 0.1 0.9 0.2 2.0 0.3 1.3 0.2 0.7 1.7 0.9 1.3 0.2 0.4 0.9 1.3 0.4 0.1 0.0 0.3 1.2 0.3 0.4 3.4 1.4 0.7 1.0 0.8 0.7 1.0 1.0 0.2 1.7 1.6 0.3 0.2 0.9 0.6 0.5 0.1 0.1 0.4 0.0 0.9 0.1 0.9 0.6 0.0 0.2 1.2 0.7 0.6 0.6 0.0 0.1 0.4 0.3 3.3 3.3 6.0 4.8 3.1 2.9 2.9 2.7 3.2 3.6 2.0 3.1 3.6 0.9 0.0 0.0 6.2 0.4 0.3 0.3 0.6 0.0 2.6 0.5 0.5 2.7 1.5 0.2 0.0 0.0 0.3 0.3 8.8 0.0 0.2 0.3 0.4 1.3 1.2 3.5 0.0 5.1 0.2 0.4 0.8 2.0 1.7 0.0 1.3 2.2 2.3 1.5 3.3 4.6 3.1 0.0 1.9 0.3 1.0 0.9 1.5 0.0 2.8 1.1 1.8 0.0 2.5 1.7 0.3 8.0 0.4 0.0 0.6 44.6 3.7 0.0 1.8 0.0 2.7 0.9 0.6 0.6 1.1 0.1 1.4 0.6 0.4 5.5 0.7 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282573-19288770 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 251.2;liver: 155.9;pancreas: 290.9;stomach 1: 226.2" "Group enriched" "Detected in many" 5 "Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 15.9;SK-BR-3: 25.0" HPA064638 Supported "Golgi apparatus,Cytosol" NA NA 1900000 Cytosol "Golgi apparatus" "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 1.5 4.0 2.2 2.6 2.0 0.3 4.2 2.5 3.3 2.3 13.5 24.5 251.2 1.4 0.4 1.8 1.8 38.4 0.6 3.1 2.1 71.8 155.9 1.0 0.4 2.5 2.6 1.7 2.6 290.9 0.3 2.3 0.2 2.4 1.9 17.5 1.5 3.5 0.3 0.4 2.5 146.0 1.5 2.2 1.3 226.2 2.1 2.5 0.1 1.8 0.1 0.2 1.0 1.6 2.3 0.5 0.0 0.5 0.3 0.5 0.2 1.8 0.1 0.1 0.2 0.1 0.5 1.9 0.2 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.5 0.2 0.7 0.8 0.2 0.2 0.2 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.7 0.5 1.7 0.3 15.9 0.6 0.7 0.1 1.6 0.0 0.1 0.9 1.4 0.3 25.0 0.6 0.1 4.1 0.5 0.4 0.3 0.2 0.9 0.3 1.2 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 2.0 2.5 3.3 3.1 2.1 2.5 2.6 1.7 2.4 2.2 2.5 2.3 0.4 0.0 0.0 7.5 3.3 0.8 0.7 0.2 0.6 1.0 13.8 9.5 0.8 140.2 0.3 29.5 0.0 0.5 0.5 133.3 119.3 3.9 3.5 0.5 0.4 0.8 20.8 11.2 4.1 31.8 0.3 0.5 348.1 0.4 4.5 0.9 4.2 119.0 0.3 0.0 3.6 87.6 4.1 3.5 0.0 4.7 0.3 4.4 0.0 1.9 0.1 3.6 0.0 2.5 1.9 18.3 125.0 0.4 0.8 1.2 1132.3 766.6 3.2 1.1 0.0 0.7 0.4 1.8 1.1 1.1 0.6 0.5 3.0 0.7 130.2 0.4 DRAXIN "C1orf187, FLJ34999, Neucrin" ENSG00000162490 "Dorsal inhibitory axon guidance protein" Q8NBI3 1 11691710-11725857 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 4.0" "Cell type enhanced" "Detected in some" "dendritic cells: 5.5;NK-cells: 3.1;T-cells: 4.6" "Group enriched" "Detected in some" 6 "glioma: 5.1;testis cancer: 2.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 2.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.5" "Cell line enriched" "Detected in some" 4 "NTERA-2: 27.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA014302 Uncertain "Secreted in brain" NA NA "HPA014302: AB_1853084" "unprognostic (5.28e-2)" "unprognostic (2.73e-1)" "unprognostic (6.58e-2)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.37e-2)" "unprognostic (1.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-2)" "unprognostic (7.47e-2)" "unprognostic (5.16e-6)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (8.52e-2)" "unprognostic (5.08e-1)" 0.0 0.0 1.7 0.2 1.5 0.5 0.0 1.1 1.3 0.0 0.6 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 1.3 4.0 0.0 0.0 0.1 0.2 2.7 0.7 1.5 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.7 0.0 0.1 0.2 0.1 0.0 0.6 0.1 0.0 0.3 3.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.6 0.0 0.9 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 5.7 0.0 0.2 0.0 0.1 0.0 0.2 2.1 0.3 27.9 0.0 0.1 6.4 0.2 0.0 0.0 0.0 1.8 0.7 0.1 0.0 0.1 4.6 0.0 0.2 0.2 0.1 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.4 2.5 0.3 0.1 0.5 0.1 0.2 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.8 0.2 0.2 0.1 0.2 0.1 1.7 1.5 1.1 1.3 1.3 4.0 2.7 0.7 1.5 0.8 0.6 3.0 1.2 0.1 0.0 0.5 0.0 1.2 0.5 2.9 0.6 0.0 0.7 0.4 0.4 1.1 1.5 0.1 0.0 2.1 0.1 5.5 0.1 0.0 0.1 0.7 0.4 0.4 0.6 0.0 0.0 0.4 0.2 0.2 0.6 0.0 0.4 1.3 0.1 1.1 0.2 0.4 0.0 0.5 0.7 0.0 0.8 1.9 2.1 0.6 1.2 1.8 0.0 0.3 0.2 3.1 1.5 0.4 0.2 0.2 0.0 1.5 2.1 0.0 0.1 0.0 0.7 0.0 2.3 0.7 0.6 1.7 0.0 0.3 0.0 4.6 0.1 0.1 2.2 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 136.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8" "Group enriched" "Detected in many" 4 "glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 38.7 3.3 8.9 56.4 9.1 0.0 21.1 14.3 9.8 36.2 21.0 16.1 3.9 26.2 11.4 16.0 33.7 42.5 17.1 6.9 43.2 3.4 0.6 32.7 9.9 25.5 14.2 5.4 29.6 6.4 1.1 3.4 136.7 17.0 14.1 10.7 22.9 9.2 14.2 30.2 19.4 16.0 34.8 18.5 0.3 24.9 4.6 18.9 10.4 6.2 11.4 18.6 97.1 25.4 28.6 0.1 0.0 149.5 0.1 0.5 0.0 0.1 2.4 0.1 0.0 0.0 0.0 0.1 0.2 356.4 9.0 0.1 0.7 253.3 44.7 0.0 1.0 46.1 0.1 0.0 0.0 216.0 0.0 0.2 29.5 82.9 18.6 21.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 116.0 0.0 0.6 0.3 0.2 0.1 0.0 4.0 0.1 0.1 0.2 0.0 0.3 119.0 0.1 0.6 242.2 41.8 34.6 0.6 0.1 0.1 0.3 1.0 88.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.9 9.1 14.3 9.8 6.9 43.2 25.5 14.2 5.4 17.0 18.5 18.9 28.6 2.4 105.8 11.2 3.9 0.2 14.5 30.4 98.5 14.8 1.4 0.5 19.9 8.4 2.8 18.8 0.0 4.2 2.0 0.1 0.0 0.0 0.5 0.7 1.6 37.6 22.4 0.0 0.0 2.6 0.0 2.1 123.1 0.0 2.8 1.3 3.4 6.4 0.0 6.5 0.0 3.5 0.0 8.2 0.0 14.0 1.8 20.2 5.3 7.2 5.6 116.3 97.7 0.0 19.6 0.2 0.4 0.0 62.8 0.0 15.8 0.0 0.0 5.4 3.4 0.0 17.0 8.4 1.0 8.2 3.9 7.0 2.9 1.3 0.9 0.0 3.4 LRRC38 ENSG00000162494 "Leucine rich repeat containing 38" Q5VT99 1 13474973-13514003 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 19.7;skeletal muscle: 44.9;tongue: 14.8" "Group enriched" "Detected in some" 6 "Bipolar cells: 19.3;Inhibitory neurons: 10.6" "Group enriched" "Detected in some" 4 "head and neck cancer: 0.5;lung cancer: 0.8;testis cancer: 0.6;urothelial cancer: 0.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.2;MOLT-4: 16.7;PC-3: 11.5;U-138 MG: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA038778 Approved NA NA "HPA038778: AB_10673294" "unprognostic (5.13e-2)" "unprognostic (3.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.88e-1)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (1.72e-1)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (4.23e-1)" "unprognostic (7.81e-2)" "unprognostic (4.47e-2)" "unprognostic (1.05e-1)" 0.2 19.7 0.4 0.0 0.4 0.1 0.6 2.9 1.2 0.1 0.7 0.0 0.0 0.1 0.2 0.3 0.1 0.1 1.2 0.4 0.6 0.1 0.0 0.0 0.0 1.0 2.9 0.4 0.1 0.0 0.0 0.0 0.5 0.8 0.2 0.0 3.0 0.6 0.0 44.9 1.0 0.0 0.0 0.6 0.0 0.1 0.4 0.4 1.3 0.0 14.8 0.0 0.3 0.7 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 11.5 0.1 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 18.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 2.9 1.2 0.4 0.6 1.0 2.9 0.4 0.8 0.6 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.3 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.5 0.1 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12618210 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 326.3" "Cell type enhanced" "Detected in many" "Late spermatids: 409.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 86.8;MAIT T-cell: 63.1;memory CD4 T-cell: 46.9;memory CD8 T-cell: 41.0;myeloid DC: 24.0;naive CD4 T-cell: 79.2;naive CD8 T-cell: 50.1;NK-cell: 41.1" "Group enriched" "Detected in many" 5 "dendritic cells: 24.0;NK-cells: 41.1;T-cells: 86.8" "Cell line enhanced" "Detected in many" "A549: 107.4;CAPAN-2: 206.9;hTERT-RPE1: 196.7;SK-BR-3: 104.6;WM-115: 192.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favorable (2.65e-4)" "unprognostic (5.48e-2)" 140.5 21.8 36.4 18.8 36.3 13.9 116.7 35.0 41.4 89.2 85.6 57.1 50.7 34.9 25.5 118.0 54.4 33.8 70.4 36.2 45.6 86.2 326.3 56.9 18.2 55.9 35.3 29.9 39.2 109.3 31.6 49.2 19.7 37.1 171.0 21.4 8.6 67.6 48.7 76.8 69.9 53.0 16.9 38.8 27.2 87.8 20.3 39.5 10.5 122.2 25.0 8.9 73.6 107.9 43.8 18.1 107.4 0.1 42.7 54.9 5.0 11.9 6.2 0.3 0.2 0.4 11.8 206.9 0.1 5.2 57.7 17.6 79.9 21.4 10.6 0.2 0.1 36.3 16.5 11.3 57.3 8.5 0.3 0.3 27.9 13.5 0.3 0.5 196.7 18.0 0.7 24.3 0.3 0.3 3.0 4.4 1.0 6.8 18.5 40.3 0.5 0.1 20.2 0.1 36.6 1.3 2.0 35.0 104.6 6.6 13.2 10.3 4.8 13.5 0.5 2.2 30.3 0.4 3.3 0.2 0.2 23.9 1.4 192.8 9.2 0.8 0.1 86.8 0.5 63.1 0.6 46.9 41.0 24.0 0.7 79.2 50.1 4.7 41.1 1.1 3.0 1.4 48.2 36.4 36.3 35.0 41.4 36.2 45.6 55.9 35.3 29.9 37.1 38.8 39.5 43.8 139.5 96.1 55.9 26.8 3.4 25.6 136.0 114.8 59.2 2.0 17.5 22.6 42.3 45.8 93.4 20.2 18.8 34.4 35.5 83.8 23.5 99.3 99.6 69.8 50.2 54.1 25.1 23.6 3.7 163.1 45.0 56.4 32.1 83.7 15.8 2.6 73.5 181.3 67.1 0.0 3.3 33.0 42.7 69.6 8.4 409.5 22.7 43.6 7.2 17.8 11.5 15.3 38.1 1.0 0.6 129.6 69.5 9.8 3.5 76.2 112.6 52.9 82.8 2.4 0.0 10.5 30.8 1.9 1.4 51.7 27.0 26.3 28.3 7.9 33.0 156.8 MATN1 "CMP, CRTM" ENSG00000162510 "Matrilin 1" P21941 1 30711277-30723585 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 5.2" "Cell type enhanced" "Detected in some" "B-cells: 4.1;Paneth cells: 1.1" "Cancer enriched" "Detected in single" 4 "thyroid cancer: 1.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028580 Supported "Secreted to extracellular matrix" NA NA "HPA028580: AB_10601913" "unprognostic (4.71e-2)" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (3.75e-6)" "unprognostic (9.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.31e-3)" "unprognostic (2.63e-1)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (7.31e-2)" "unprognostic (5.22e-2)" "unprognostic (4.01e-13)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (3.42e-2)" 0.0 0.1 0.3 0.3 0.4 0.7 0.0 0.3 0.3 0.5 0.0 0.0 0.1 0.4 0.1 0.1 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.6 0.4 0.1 0.7 0.2 0.0 0.2 0.3 0.7 0.1 0.0 5.2 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.1 0.2 1.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.7 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.3 0.3 0.2 0.2 0.6 0.4 0.1 0.7 0.2 0.3 1.1 0.3 0.0 0.5 0.0 4.1 0.1 0.6 0.1 0.0 0.0 0.4 1.0 0.5 0.0 0.6 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.1 0.4 0.3 0.2 0.0 0.1 0.0 0.3 0.0 0.5 0.2 0.8 0.5 0.5 0.1 0.3 0.5 0.3 0.0 0.1 LAPTM5 ENSG00000162511 "Lysosomal protein transmembrane 5" Q13571 1 30732469-30757774 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1297.4;lymphoid tissue: 677.6" "Group enriched" "Detected in many" 4 "B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051293 Approved Approved Cytosol NA NA Cytosol "HPA051293: AB_2681424" "unprognostic (3.12e-2)" "prognostic favorable (3.40e-4)" "unprognostic (6.86e-2)" "unprognostic (4.05e-3)" "unprognostic (1.63e-1)" "unprognostic (8.45e-2)" "unprognostic (1.43e-1)" "unprognostic (3.76e-1)" "unprognostic (1.22e-3)" "unprognostic (2.30e-1)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (9.47e-2)" "unprognostic (8.18e-3)" "unprognostic (5.98e-2)" "unprognostic (3.94e-2)" 146.0 82.9 49.4 447.0 56.6 1297.4 60.9 54.6 91.1 53.5 67.9 83.0 68.7 27.5 16.9 50.0 47.2 139.1 26.2 47.8 106.3 30.5 99.4 287.4 677.6 86.1 59.2 41.9 16.6 30.5 22.0 22.7 146.4 76.2 31.7 91.5 5.9 38.9 31.2 9.3 24.1 157.2 94.4 82.8 495.0 73.5 11.0 73.9 301.1 38.8 21.0 641.7 162.6 23.0 87.2 1.2 0.0 1.7 0.0 0.1 0.1 0.6 0.9 0.3 0.5 0.1 0.7 1.2 554.0 56.0 1.7 1.9 2.2 0.0 0.8 0.5 62.3 0.0 1053.2 0.0 1.6 0.9 676.4 2382.4 0.6 1.2 0.6 4.1 0.3 124.2 70.7 13.8 34.0 8.8 0.0 117.5 142.2 0.7 0.0 0.0 785.2 99.6 391.6 0.8 0.1 0.6 0.4 1.3 1.3 1.1 1.0 0.5 422.2 145.3 0.6 3.0 0.6 3.4 2.7 0.7 898.1 3.1 542.8 1.8 1094.2 1522.8 1446.7 538.5 1046.1 616.3 823.6 485.5 502.8 825.7 1089.4 481.2 481.2 1709.5 327.0 1075.7 392.7 656.9 2740.4 49.4 56.6 54.6 91.1 47.8 106.3 86.1 59.2 41.9 76.2 82.8 73.9 87.2 62.9 25.6 100.4 0.0 872.9 23.8 1.1 1.3 4.0 0.0 6.2 10.4 5.5 14.3 13.9 3.7 0.0 5.8 340.2 0.8 0.0 1.2 2.0 1.4 0.9 60.2 1.2 78.2 0.2 0.7 8.4 12.3 10.2 1.1 639.8 0.2 47.2 9.4 1150.4 0.0 0.8 0.9 0.0 942.2 489.6 4.9 1.5 925.0 49.8 43.1 446.1 0.3 562.3 0.5 0.5 1.4 0.2 0.4 144.8 0.9 0.5 3.0 11.4 1.3 0.0 4.1 5.6 0.3 1.1 1.8 20.0 8.9 432.7 18.2 2.4 1.9 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869466-30908758 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 133.8" "Cell type enhanced" "Detected in many" "Astrocytes: 64.6;Endometrial stromal cells: 59.8;Kupffer cells: 174.8;Late spermatids: 82.4;Oligodendrocyte precursor cells: 108.6" "Group enriched" "Detected in all" 5 "glioma: 115.2;melanoma: 102.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 249.5;WM-115: 342.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256" "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favorable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 34.2 99.9 101.6 23.1 104.0 3.0 18.0 95.8 106.2 36.9 35.5 42.5 12.4 62.8 12.4 17.8 30.0 30.3 21.6 88.8 94.1 10.2 22.5 22.7 36.7 133.8 110.9 76.8 9.4 7.6 13.4 11.8 18.2 122.3 27.2 14.7 27.4 16.0 53.2 27.4 10.2 16.6 66.8 100.5 91.8 19.9 3.3 115.2 6.5 9.9 9.2 7.7 33.0 13.5 88.4 12.9 10.4 80.4 36.5 60.6 14.8 13.8 31.4 48.0 15.0 9.5 2.0 12.3 0.9 68.6 95.3 21.8 16.3 8.7 7.6 10.0 5.7 6.3 0.0 4.1 1.8 56.9 0.3 8.2 35.4 35.9 1.0 15.4 86.6 20.1 3.6 6.2 0.5 30.6 15.0 0.3 0.2 36.4 10.2 9.4 0.8 75.2 2.8 19.7 14.9 28.9 17.5 40.3 5.7 249.5 50.8 5.7 6.1 19.3 18.6 28.2 2.0 7.5 0.1 0.5 0.9 1.9 0.2 342.9 1.1 0.3 0.2 0.1 0.6 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.5 0.4 0.4 0.2 0.2 0.2 101.6 104.0 95.8 106.2 88.8 94.1 133.8 110.9 76.8 122.3 100.5 115.2 88.4 37.3 0.0 2.2 64.6 0.5 2.5 3.4 4.7 4.0 9.6 14.9 25.5 4.9 14.3 2.6 47.8 0.0 2.1 0.2 0.8 0.0 10.7 17.7 14.1 59.8 17.9 3.0 0.0 14.7 3.1 3.4 16.6 3.1 28.6 0.0 17.5 20.3 1.0 14.3 0.0 13.9 1.1 6.1 174.8 3.1 82.4 2.1 24.4 19.6 18.7 4.0 2.5 1.0 108.6 6.8 6.0 1.3 7.9 1.5 8.5 0.0 0.6 0.4 27.8 0.0 1.1 9.1 0.7 0.4 1.3 2.3 3.6 2.3 15.4 1.6 5.7 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629866-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Supported Nucleoplasm,Vesicles,Cytosol NA NA 570000 "Nucleoplasm, Vesicles, Cytosol" "HPA061608: AB_2684567" "unprognostic (2.92e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 56.8 67.7 79.1 28.8 78.8 38.2 56.9 80.3 82.0 56.1 77.3 54.8 31.6 63.9 85.2 62.6 55.1 39.0 57.0 77.6 79.7 63.1 71.9 61.9 38.8 82.0 80.6 76.9 50.6 41.3 69.7 52.5 61.9 83.9 59.9 45.5 26.8 40.2 59.7 42.9 85.9 44.4 60.6 81.4 56.3 51.7 40.4 80.5 57.1 111.9 39.7 62.1 62.4 52.6 86.1 56.9 65.0 53.1 41.3 61.2 63.8 51.0 52.8 89.8 124.4 109.0 38.7 83.2 60.2 71.9 118.3 63.9 58.1 103.9 134.5 100.1 76.0 112.6 49.9 49.4 78.6 107.9 49.0 45.3 66.3 152.6 122.0 113.2 79.2 122.2 72.6 52.4 60.6 90.4 67.1 75.6 47.5 74.3 69.7 72.9 72.5 51.7 66.2 98.6 60.8 75.8 43.9 60.2 56.1 81.0 82.9 50.0 35.5 65.7 54.0 46.0 92.7 71.3 38.7 42.2 65.4 67.7 71.8 65.9 147.3 75.6 93.0 90.2 69.4 86.8 70.9 75.5 81.4 77.5 76.4 70.2 70.6 76.2 87.4 67.2 71.4 84.0 104.8 79.1 78.8 80.3 82.0 77.6 79.7 82.0 80.6 76.9 83.9 81.4 80.5 86.1 58.2 41.7 37.7 5.9 31.6 36.2 66.6 70.8 29.6 41.2 34.7 36.2 20.4 21.5 35.3 69.9 12.5 160.0 33.9 36.6 113.5 72.0 81.3 17.4 20.0 60.3 44.3 40.0 8.0 61.9 106.1 34.0 21.9 19.8 72.9 34.3 35.3 24.4 61.9 53.8 7.4 49.8 50.8 18.5 21.8 87.5 45.1 27.8 49.8 7.5 81.6 59.6 46.4 6.0 13.8 59.1 44.0 58.6 23.6 65.4 48.9 57.8 23.5 26.5 19.7 25.8 38.8 44.1 44.2 24.6 51.4 182.8 33.6 50.9 39.5 58.3 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32679906-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 107.8;smooth muscle: 54.6;tongue: 74.1" "Cell type enhanced" "Detected in many" "Horizontal cells: 74.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 121.0;U-138 MG: 113.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028311, HPA063549" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: AB_2672554, HPA063549: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 10.6 8.6 7.0 15.7 6.0 0.7 5.5 7.9 6.7 9.8 6.1 11.6 6.5 11.0 4.9 18.1 7.5 9.6 17.4 6.0 11.9 2.4 2.3 10.6 6.4 8.8 7.8 5.8 3.8 2.6 4.7 0.7 2.5 7.7 13.2 8.8 0.4 9.7 14.7 107.8 2.6 7.4 54.6 9.6 6.3 9.1 9.8 7.9 1.1 4.5 74.1 1.7 12.5 2.9 8.8 8.7 7.0 11.2 19.3 19.4 30.5 6.6 41.9 81.5 28.7 19.6 1.2 24.8 23.9 13.0 121.0 43.4 5.8 1.0 0.7 16.2 12.4 0.8 26.1 22.6 18.0 16.4 33.0 12.0 46.6 2.9 31.6 1.1 86.1 9.0 17.2 19.6 26.2 24.3 4.2 32.0 8.9 5.9 11.2 9.6 34.5 36.5 12.7 32.6 14.2 18.1 1.7 57.1 17.6 21.7 22.2 16.0 10.4 14.4 113.0 19.4 69.4 18.8 11.4 21.1 30.2 39.0 10.4 98.3 5.9 7.7 6.1 6.1 9.6 8.1 6.9 6.9 6.4 9.7 5.2 6.2 7.0 0.9 9.1 9.5 12.3 7.9 12.0 7.0 6.0 7.9 6.7 6.0 11.9 8.8 7.8 5.8 7.7 9.6 7.9 8.8 10.6 9.6 9.8 15.7 15.1 22.0 14.2 14.5 8.0 50.2 20.6 7.0 1.0 20.0 14.1 9.2 39.6 9.4 20.7 8.3 5.9 11.7 11.2 12.9 25.0 13.1 7.3 16.0 12.2 5.4 9.3 17.1 0.5 16.3 22.2 12.4 22.9 19.1 5.4 74.0 13.2 8.4 8.2 17.7 23.2 14.8 41.7 7.3 33.8 7.5 11.4 20.0 34.0 15.1 11.6 7.9 7.9 64.3 5.7 16.0 10.7 10.1 6.0 53.9 19.7 16.6 12.8 32.8 36.0 7.2 22.3 5.1 15.3 9.4 12.6 9.4 RBBP4 "lin-53, NURF55, RbAp48" ENSG00000162521 "RB binding protein 4, chromatin remodeling factor" Q09028 1 32651142-32686211 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006264, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 150000 Nucleoplasm "CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (1.18e-3)" "unprognostic (1.79e-3)" "unprognostic (2.96e-3)" "unprognostic (1.82e-2)" "prognostic favorable (9.23e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (1.24e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (1.57e-2)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (1.36e-3)" "unprognostic (3.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-2)" 31.1 39.1 20.6 33.8 22.5 35.1 38.9 25.8 23.3 39.7 21.3 33.0 27.2 42.8 35.4 32.4 45.9 25.5 32.0 19.5 29.7 32.2 30.8 29.0 63.4 22.2 21.8 19.4 47.3 38.8 34.3 31.4 34.9 22.8 30.3 46.3 56.7 38.7 31.0 43.3 33.0 36.0 42.4 22.6 33.0 37.4 76.1 22.0 58.6 46.2 21.3 92.3 35.5 31.5 30.7 68.8 59.1 166.2 120.1 49.9 47.4 66.7 55.3 44.9 103.0 99.7 85.5 135.6 206.9 54.8 61.4 62.7 42.9 184.7 53.6 110.0 80.9 88.3 194.3 112.0 111.9 72.3 183.9 79.9 52.2 66.8 78.1 50.3 83.6 77.2 139.8 138.0 142.1 89.0 48.0 239.4 57.6 185.4 67.0 67.8 228.3 173.8 181.0 72.4 143.4 156.7 94.7 122.1 41.9 83.8 161.3 71.9 83.3 64.3 63.8 61.6 80.4 70.2 113.4 128.0 229.5 75.2 146.9 99.3 79.1 99.9 68.5 74.4 99.8 77.4 79.6 69.8 75.2 115.0 60.1 61.2 67.3 24.8 87.7 95.4 95.7 77.9 151.8 20.6 22.5 25.8 23.3 19.5 29.7 22.2 21.8 19.4 22.8 22.6 22.0 30.7 61.6 41.7 53.7 32.3 115.8 71.5 68.3 76.8 120.1 106.1 105.2 57.3 22.2 77.2 59.1 73.5 143.9 129.2 132.0 55.4 84.1 84.7 26.3 51.2 89.0 65.7 97.1 201.4 38.0 58.3 87.6 81.3 70.3 71.6 49.4 93.3 64.6 76.5 80.6 106.0 41.5 83.9 79.3 78.8 74.3 17.5 79.6 80.8 49.8 22.5 90.7 77.4 91.6 44.2 49.7 76.1 42.1 88.4 201.8 59.5 44.3 65.9 50.5 109.2 98.6 47.6 76.9 154.2 88.8 132.5 77.4 85.5 95.4 79.5 86.9 58.7 KIAA1522 ENSG00000162522 KIAA1522 Q9P206 1 32741830-32774970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 154.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 125.7;hTCEpi: 103.0;RT4: 117.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032050, HPA032051, HPA064839" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.29e-7)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (4.55e-2)" "prognostic favorable (1.29e-5)" "unprognostic (1.35e-2)" "unprognostic (1.35e-1)" "unprognostic (3.98e-1)" "unprognostic (2.12e-1)" 6.7 93.7 14.7 7.1 10.8 1.2 24.6 2.5 15.7 14.6 22.7 37.4 52.1 10.2 12.3 77.3 23.7 16.2 4.6 11.9 6.8 39.0 12.1 18.4 1.3 6.8 6.0 12.4 22.5 71.2 38.1 9.1 8.5 8.7 41.2 31.2 1.2 68.9 20.4 3.1 73.1 46.3 6.8 4.2 1.4 62.3 5.1 8.0 8.2 39.7 3.2 12.2 22.4 28.4 8.9 65.7 33.6 5.4 9.3 2.4 4.6 24.6 7.9 15.3 8.9 8.7 37.0 125.7 0.2 32.3 11.6 26.5 95.1 10.3 67.8 4.6 0.2 13.4 13.6 49.4 30.4 4.0 0.2 33.3 1.7 103.0 23.6 28.2 40.1 18.6 2.7 20.1 0.4 4.3 54.3 0.3 0.6 11.0 56.3 20.9 8.7 6.7 16.7 85.8 117.5 4.6 4.7 49.5 70.1 9.7 33.7 74.7 4.3 17.6 14.9 39.3 13.7 17.3 0.8 0.3 0.3 15.2 2.3 17.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 10.8 2.5 15.7 11.9 6.8 6.8 6.0 12.4 8.7 4.2 8.0 8.9 5.7 12.8 56.9 5.5 0.6 73.9 37.0 52.7 59.2 0.6 69.8 42.3 3.8 72.9 52.0 27.6 2.1 15.6 1.5 154.4 9.8 47.3 4.2 54.7 5.6 8.7 28.9 1.3 10.2 66.7 5.2 6.7 51.0 50.2 27.8 10.2 4.6 10.6 2.9 0.0 5.2 54.0 48.8 0.8 6.5 5.1 8.7 2.2 7.2 3.7 2.4 0.8 0.0 2.0 0.4 60.7 64.6 4.9 0.3 80.9 84.7 14.8 60.7 0.1 6.6 3.1 7.5 3.8 2.7 59.7 83.1 7.9 2.1 59.9 65.4 99.6 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 12.8;testis: 34.3" "Group enriched" "Detected in some" 67 "Early spermatids: 335.4;Late spermatids: 1251.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 2.0 2.7 0.1 2.5 0.2 12.8 2.1 2.2 0.4 2.9 0.3 2.1 3.4 2.3 0.0 1.3 2.7 1.8 1.5 0.1 0.0 1.9 2.7 2.7 3.9 0.4 0.1 0.0 3.0 2.1 0.0 1.7 0.7 0.8 2.1 0.0 4.3 2.4 0.0 3.0 4.8 4.1 0.1 0.0 4.3 2.2 34.3 0.1 0.0 2.3 0.0 0.0 1.8 2.3 0.4 2.4 2.8 6.0 3.6 0.0 0.8 5.2 0.6 0.9 0.0 0.0 0.5 1.3 1.4 0.8 0.0 1.0 3.5 0.0 0.0 0.0 3.6 6.8 2.8 14.1 4.3 3.3 1.3 3.2 0.1 0.7 0.0 1.0 6.7 0.0 4.5 3.5 5.5 0.0 0.7 1.5 1.5 1.1 0.5 1.6 2.1 1.6 4.7 0.0 2.4 1.7 3.8 0.8 3.0 3.9 4.5 1.8 2.4 2.4 2.1 2.9 3.0 2.4 7.6 3.3 1.9 3.5 4.3 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.8 0.0 0.1 0.4 0.4 0.0 0.5 0.7 0.3 0.1 0.4 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.3 335.4 0.4 0.6 0.5 0.0 0.0 0.0 0.7 0.1 0.3 0.0 0.5 0.0 1.4 0.7 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 1251.0 9.3 0.3 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.3 0.1 9.4 0.0 0.2 0.7 0.8 0.8 1.2 6.6 0.2 0.2 11.7 3.7 0.0 0.0 0.3 0.2 0.5 0.3 0.3 TMCO4 DKFZp686C23231 ENSG00000162542 "Transmembrane and coiled-coil domains 4" Q5TGY1 1 19682240-19799945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA014601, HPA014620" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA014601: AB_2204302, HPA014620: AB_2669051" "unprognostic (3.31e-3)" "unprognostic (8.94e-2)" "unprognostic (9.71e-2)" "prognostic favorable (3.71e-4)" "unprognostic (6.99e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (9.21e-2)" "unprognostic (2.60e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (2.71e-2)" "prognostic favorable (4.12e-11)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" "unprognostic (9.81e-2)" "prognostic favorable (3.64e-4)" 7.1 8.9 1.4 5.4 2.4 4.7 9.6 1.3 1.5 8.7 5.7 8.0 17.5 9.9 21.1 8.5 10.4 6.5 4.8 1.5 2.6 9.2 5.4 6.1 6.9 1.7 1.6 1.0 7.3 10.9 34.9 3.6 3.1 1.6 13.3 6.1 0.3 17.1 10.7 2.3 5.4 9.7 5.6 1.7 9.6 11.8 1.7 1.5 3.8 11.6 2.4 5.1 9.5 7.9 1.5 9.3 5.6 0.0 0.3 7.5 5.2 6.2 6.8 20.9 13.1 7.3 4.6 42.5 16.2 9.9 19.7 5.8 6.9 1.7 6.8 2.7 13.8 1.7 6.1 6.6 2.3 6.1 0.0 8.1 5.4 7.6 4.4 2.5 4.8 6.3 0.3 1.2 10.7 5.8 7.9 0.0 3.6 0.6 12.6 7.9 3.1 17.5 10.0 11.2 7.2 0.0 0.7 9.0 12.3 13.9 0.9 10.6 10.4 4.0 10.0 4.6 7.2 4.7 1.2 0.6 4.6 11.4 13.8 6.5 0.1 3.8 2.1 4.7 6.7 4.7 4.2 5.0 5.0 7.4 4.9 3.7 3.2 0.3 4.2 4.1 0.2 3.9 3.6 1.4 2.4 1.3 1.5 1.5 2.6 1.7 1.6 1.0 1.6 1.7 1.5 1.5 5.8 12.8 11.0 8.8 9.9 2.8 9.6 6.3 4.6 0.2 17.0 15.4 8.0 2.8 12.0 11.0 0.0 9.3 6.0 12.3 9.8 13.2 0.3 10.6 8.1 5.2 6.0 6.5 2.4 16.9 18.6 7.7 15.8 16.5 3.8 7.7 5.3 5.1 9.1 0.0 5.0 15.9 12.2 7.1 3.3 0.5 6.2 6.7 10.6 11.2 9.5 3.0 5.2 3.0 0.4 11.0 7.5 5.7 6.9 11.4 4.5 7.9 18.8 0.5 0.0 6.1 7.7 0.3 2.1 7.9 2.6 7.3 8.2 5.7 14.2 7.9 UBXN10 "FLJ25429, UBXD3" ENSG00000162543 "UBX domain protein 10" Q96LJ8 1 20186096-20196050 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 50.1" "Group enriched" "Detected in many" 7 "Early spermatids: 117.5;Endometrial ciliated cells: 72.6;Late spermatids: 146.8;Respiratory ciliated cells: 117.8;Spermatocytes: 48.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 2.9;HMC-1: 7.1;K-562: 8.5;SCLC-21H: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028555, HPA028564" Uncertain NA NA "HPA028555: AB_10600417, HPA028564: AB_10601897" "unprognostic (3.00e-3)" "unprognostic (3.30e-2)" "unprognostic (4.31e-2)" "prognostic favorable (2.02e-4)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-2)" "unprognostic (2.37e-1)" "unprognostic (6.76e-2)" "unprognostic (4.60e-1)" "unprognostic (8.79e-2)" "unprognostic (5.78e-2)" "unprognostic (1.65e-3)" "unprognostic (7.11e-2)" "unprognostic (4.47e-2)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" 0.4 1.4 5.1 0.5 2.8 2.0 3.0 2.9 2.9 7.2 12.5 7.2 0.8 6.3 4.7 4.1 50.1 2.0 3.6 3.3 5.8 2.1 6.0 5.3 0.3 4.4 4.6 1.3 0.4 1.6 4.9 3.0 1.0 4.1 2.4 4.8 2.2 0.9 2.7 0.2 0.5 2.0 3.4 6.1 0.1 2.3 14.2 3.0 0.3 5.5 0.2 0.5 2.6 0.3 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 1.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 8.5 0.0 0.0 0.0 0.3 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.6 0.4 5.6 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.0 2.7 0.4 0.7 0.9 0.8 0.1 0.5 0.8 0.4 4.1 0.0 0.0 0.4 0.5 5.1 2.8 2.9 2.9 3.3 5.8 4.4 4.6 1.3 4.1 6.1 3.0 4.3 0.1 0.0 6.1 0.7 0.2 0.1 0.0 5.5 0.0 0.5 1.2 1.5 5.3 1.5 13.0 3.7 0.0 0.1 0.4 5.1 5.9 3.7 117.5 72.6 2.0 0.8 1.2 2.1 1.8 1.7 0.6 2.0 0.0 7.4 13.9 0.4 1.1 4.2 0.9 0.0 1.6 10.6 10.2 1.2 0.0 146.8 2.8 0.8 0.0 0.0 0.6 1.9 0.0 0.0 0.1 1.4 1.4 1.2 0.0 0.1 0.6 2.9 117.8 3.1 0.0 0.4 4.1 48.9 2.2 0.0 0.0 0.3 1.2 0.0 3.2 0.3 CAMK2N1 CaMKIINalpha ENSG00000162545 "Calcium/calmodulin dependent protein kinase II inhibitor 1" Q7Z7J9 1 20482391-20486210 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 455.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 640.5;Intestinal goblet cells: 431.4;Paneth cells: 367.7;Proximal tubular cells: 519.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.6;MAIT T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enhanced" "Detected in many" "AN3-CA: 212.1;CAPAN-2: 199.1;Hep G2: 165.6;SK-BR-3: 159.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075200 Approved NA NA "HPA075200: " "unprognostic (1.67e-1)" "unprognostic (2.70e-3)" "unprognostic (9.71e-3)" "unprognostic (3.13e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (1.37e-7)" "prognostic unfavorable (5.49e-4)" "prognostic unfavorable (1.66e-4)" "unprognostic (4.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.48e-3)" "unprognostic (1.93e-2)" "unprognostic (1.40e-3)" "unprognostic (4.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.96e-2)" "unprognostic (1.31e-2)" 16.7 62.2 376.8 9.4 367.4 0.5 20.0 206.4 455.7 30.9 168.0 85.8 81.1 28.1 38.4 28.0 22.5 27.6 21.5 372.9 265.9 86.2 54.2 68.5 2.0 268.8 268.0 401.5 30.5 8.8 42.7 38.0 11.7 321.3 36.1 77.7 32.9 30.7 41.2 7.2 12.1 87.6 22.8 246.4 12.3 19.7 4.7 293.8 2.0 10.9 10.0 7.1 27.5 24.6 386.1 63.1 17.5 15.0 212.1 28.4 52.6 2.2 52.6 119.0 9.5 4.8 20.1 199.1 6.3 14.7 21.7 7.7 103.2 4.6 90.0 5.9 11.7 3.8 1.3 0.9 165.6 31.4 0.1 6.2 8.4 41.2 5.6 21.2 19.6 16.4 4.3 6.3 0.5 105.8 17.4 0.2 0.5 2.8 109.7 3.9 5.6 9.4 0.4 59.3 93.5 57.6 16.2 28.5 159.6 16.3 10.2 30.6 0.6 5.0 34.9 46.1 48.5 21.1 0.1 0.1 2.5 119.5 13.5 22.0 0.0 0.0 0.0 1.6 0.0 1.1 0.5 0.5 0.4 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 376.8 367.4 206.4 455.7 372.9 265.9 268.8 268.0 401.5 321.3 246.4 293.8 386.1 28.3 3.2 1.1 35.6 7.6 9.3 11.7 2.3 0.6 248.6 96.5 104.5 20.8 178.7 2.5 248.3 6.2 0.5 10.1 640.5 229.0 20.1 0.8 6.2 45.6 20.0 299.2 8.0 132.5 40.8 2.9 65.1 9.2 12.0 1.3 4.6 9.3 201.6 0.3 85.8 108.7 431.4 14.2 1.9 12.1 3.9 62.7 5.6 39.2 26.2 0.6 81.1 0.0 27.6 249.1 141.5 367.7 94.0 3.5 37.7 183.2 519.2 1.2 35.6 131.5 86.2 96.4 0.8 2.8 1.0 7.5 2.1 14.7 0.8 223.5 50.3 ALPL "HOPS, TNALP, TNAP, TNSALP" ENSG00000162551 "Alkaline phosphatase, biomineralization associated" P05186 1 21509397-21578410 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Biomineralization Hydrolase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 61.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2" "Cancer enhanced" "Detected in all" "testis cancer: 199.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 90 "neutrophil: 379.1" "Lineage enriched" "Detected in many" 139 "granulocytes: 379.1" "Cell line enhanced" "Detected in many" "HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007105, HPA008765, CAB020829" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 13000000 Cytosol "CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138" "unprognostic (3.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.05e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.17e-2)" "unprognostic (2.48e-3)" "unprognostic (1.74e-1)" "unprognostic (7.28e-2)" "unprognostic (1.73e-2)" "unprognostic (2.27e-1)" "unprognostic (9.70e-3)" "unprognostic (2.58e-1)" 23.7 61.2 19.8 28.1 14.6 4.3 23.1 16.2 26.0 2.9 23.6 3.7 2.6 5.9 1.3 4.2 10.4 3.9 16.0 15.7 16.5 46.1 56.7 55.3 6.4 20.7 16.0 14.1 2.8 3.9 3.3 9.4 3.1 19.9 7.1 1.6 18.9 6.5 9.3 1.1 4.1 7.6 3.5 16.1 45.8 4.7 4.2 19.8 1.6 8.7 5.7 5.9 9.8 3.4 18.4 0.0 0.2 5.2 0.2 0.8 6.6 11.4 0.4 2.4 0.9 1.5 1.0 0.0 2.4 7.7 0.0 0.1 0.1 31.3 0.2 0.6 0.0 2.1 0.0 3.5 3.9 1.8 0.0 0.7 176.9 0.0 141.2 0.5 0.0 0.0 0.0 0.2 0.0 103.7 0.0 0.1 0.0 41.2 0.2 0.0 0.0 3.8 0.2 0.1 0.0 88.2 1.2 0.0 0.1 0.3 48.1 0.2 0.0 0.0 5.2 4.3 0.1 0.0 0.3 0.0 0.1 0.9 0.0 0.8 0.0 0.0 4.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 379.1 0.0 0.0 0.0 0.0 0.1 19.8 14.6 16.2 26.0 15.7 16.5 20.7 16.0 14.1 19.9 16.1 19.8 18.4 25.9 3.2 92.0 0.3 3.8 0.1 0.6 8.2 0.6 2.5 6.6 32.4 2.1 2.8 17.6 0.0 0.0 0.1 0.1 0.0 7.9 0.0 1.4 15.0 2.2 26.5 0.0 5.7 0.9 0.0 0.3 6.8 0.0 43.3 7.6 10.6 40.7 30.1 0.1 1.7 0.3 0.0 12.2 1.6 0.3 8.5 0.3 1.0 0.0 18.7 0.0 6.0 0.0 6.0 0.2 0.0 0.0 0.0 0.3 1.7 0.0 43.9 3.6 34.2 0.0 0.3 5.1 0.4 14.0 0.2 0.4 1.5 1.0 8.0 0.0 0.3 WNT4 WNT-4 ENSG00000162552 "Wnt family member 4" P56705 1 22117313-22143969 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 41.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 42.1;Breast glandular cells: 19.9;Breast myoepithelial cells: 24.3;Endometrial stromal cells: 71.4;Enteroendocrine cells: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.5;SCLC-21H: 10.2;SK-BR-3: 8.6;T-47d: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA011397 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA011397: AB_1858854" "unprognostic (1.85e-1)" "unprognostic (9.08e-2)" "unprognostic (6.67e-3)" "unprognostic (1.75e-2)" "unprognostic (7.17e-2)" "unprognostic (4.30e-3)" "unprognostic (2.77e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.34e-4)" "unprognostic (2.14e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.01e-1)" "unprognostic (2.95e-2)" "unprognostic (4.21e-1)" "unprognostic (2.32e-1)" "unprognostic (4.74e-2)" "unprognostic (9.49e-2)" 0.5 9.1 2.2 0.4 1.7 0.3 2.2 0.4 3.7 6.0 1.5 2.3 3.2 4.5 9.0 12.2 8.4 2.6 0.1 2.2 2.2 1.1 1.4 1.3 0.1 1.8 1.5 1.3 16.9 3.0 0.1 5.6 1.6 1.2 5.5 1.7 0.2 4.1 2.7 3.1 41.1 3.1 1.9 1.2 0.3 4.3 0.6 3.0 1.1 3.4 0.6 1.5 3.2 6.4 1.5 1.3 0.1 2.5 0.1 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.3 8.5 0.0 0.6 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 1.1 0.2 0.3 0.0 0.0 0.0 1.6 10.2 0.0 0.1 8.6 0.6 0.6 3.4 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 0.4 3.7 2.2 2.2 1.8 1.5 1.3 1.2 1.2 3.0 1.5 0.9 3.2 8.6 0.3 0.7 16.7 4.3 42.1 6.8 0.0 19.9 24.3 0.6 0.0 15.2 0.0 0.0 0.7 0.1 0.9 0.0 2.7 0.1 4.1 71.4 0.6 29.4 0.0 0.2 0.6 0.1 3.1 0.5 1.6 0.0 0.2 0.7 0.5 0.1 0.0 1.9 16.0 4.1 0.0 0.2 0.9 0.0 0.4 5.4 6.5 0.1 0.0 0.0 0.0 0.3 0.9 0.1 3.8 0.6 5.7 0.3 0.0 12.0 0.0 0.0 0.4 2.2 0.0 0.3 2.5 10.4 0.3 0.6 0.0 0.6 4.2 TTLL10 "FLJ36119, TTLL5" ENSG00000162571 "Tubulin tyrosine ligase like 10" Q6ZVT0 1 1173880-1197936 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 10.7;fallopian tube: 10.8;testis: 42.2" "Group enriched" "Detected in many" 6 "Early spermatids: 244.1;Late spermatids: 768.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.5;endometrial cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 32 "SCLC-21H: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA042712 Uncertain NA NA "HPA042712: AB_10797019" "unprognostic (1.74e-1)" "unprognostic (7.95e-2)" "unprognostic (2.66e-3)" "prognostic favorable (1.61e-5)" "unprognostic (5.33e-2)" "unprognostic (2.68e-3)" "unprognostic (4.93e-3)" "unprognostic (2.14e-3)" "unprognostic (4.50e-1)" "unprognostic (3.69e-2)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "unprognostic (6.00e-4)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (1.12e-1)" "unprognostic (4.39e-2)" 1.3 0.0 2.5 0.1 0.7 0.0 1.1 0.7 0.5 0.9 10.7 0.1 0.1 0.2 0.4 0.3 10.8 0.3 0.1 0.9 1.4 0.3 0.0 2.9 0.1 1.9 2.1 0.0 0.0 0.3 0.0 2.1 1.5 1.7 0.3 0.1 0.0 0.3 0.1 0.4 0.2 0.2 0.0 2.5 0.1 0.5 42.2 0.9 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 0.7 0.7 0.5 0.9 1.4 1.9 2.1 0.0 1.7 2.5 0.9 0.6 14.4 0.0 0.5 0.0 0.3 1.8 0.7 3.0 0.0 0.1 1.4 1.0 0.8 1.5 3.4 0.0 2.1 0.0 0.9 0.9 0.0 0.5 244.1 52.2 0.6 2.1 0.0 0.0 0.2 1.3 1.0 0.3 3.6 6.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 3.1 0.0 0.0 1.1 768.4 5.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.5 1.0 4.5 0.0 1.5 0.4 0.1 72.5 0.1 6.6 0.9 1.0 9.3 2.1 1.0 2.0 0.1 0.9 0.0 3.6 1.3 SCNN1D "dNaCh, ENaCdelta" ENSG00000162572 "Sodium channel epithelial 1 subunit delta" P51172 1 1280436-1292029 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.8" "Cell type enhanced" "Detected in many" "Astrocytes: 10.7;Early spermatids: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 9.3" "Low region specificity" "Detected in all" HPA026884 Enhanced Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA026884: AB_10601501" "unprognostic (2.08e-2)" "unprognostic (2.08e-1)" "unprognostic (7.39e-4)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.60e-4)" "unprognostic (1.44e-2)" "unprognostic (1.81e-1)" "unprognostic (2.08e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.32e-4)" "unprognostic (5.27e-2)" "prognostic unfavorable (6.67e-5)" "unprognostic (3.13e-1)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (7.06e-2)" 5.0 7.1 8.4 1.7 8.3 3.2 6.0 9.4 18.2 10.9 3.7 7.4 5.2 8.0 0.9 4.0 14.1 1.3 5.8 7.8 5.4 7.8 13.8 3.8 2.3 8.9 7.2 7.8 14.8 4.9 0.7 18.6 1.1 10.5 9.8 0.3 1.7 5.9 1.7 3.4 4.3 7.7 0.9 5.3 8.0 6.3 35.8 6.9 1.0 6.4 1.4 0.7 5.1 7.6 9.9 0.5 4.2 1.6 4.3 1.1 0.6 0.7 2.8 0.8 1.3 1.5 0.8 2.4 3.0 1.5 1.2 2.2 0.7 0.7 0.6 0.2 5.8 2.5 0.4 5.9 1.1 1.1 0.1 2.9 1.8 0.9 2.3 0.0 1.8 0.4 5.5 2.1 7.0 0.3 1.5 1.2 2.0 0.8 0.5 3.0 8.1 0.3 0.7 0.6 0.2 2.2 3.1 1.2 1.2 1.9 0.6 5.4 1.6 1.2 2.6 2.1 4.1 0.9 9.3 0.6 2.5 2.3 5.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 8.3 9.4 18.2 7.8 5.4 8.9 7.2 7.8 10.5 5.3 6.9 9.9 1.7 3.2 2.3 10.7 1.0 0.8 0.2 1.2 1.2 3.7 2.2 3.4 4.0 0.0 1.7 0.0 4.2 0.1 0.6 1.0 0.0 0.5 10.5 0.6 2.1 0.6 1.2 2.7 5.2 0.5 0.4 1.7 4.1 1.3 2.5 3.2 0.7 3.5 0.4 5.0 6.0 0.4 0.0 0.8 0.5 4.0 0.9 1.1 0.0 1.0 0.1 1.4 0.0 4.5 5.4 2.0 3.8 1.9 0.7 0.1 3.9 0.7 1.9 2.8 0.0 1.8 1.5 2.8 2.2 0.8 1.6 0.0 1.0 0.5 0.9 0.3 MXRA8 DKFZp586E2023 ENSG00000162576 "Matrix remodeling associated 8" Q9BRK3 1 1352689-1361777 "Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "naive CD8 T-cell: 6.4" "Lineage enriched" "Detected in single" 64 "T-cells: 6.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053958, HPA055780" Uncertain Approved Nucleoli NA NA 760000 Nucleoli "HPA053958: AB_2682322, HPA055780: AB_2682918" "unprognostic (1.39e-1)" "unprognostic (2.85e-1)" "unprognostic (7.31e-3)" "unprognostic (1.26e-2)" "unprognostic (1.94e-3)" "unprognostic (2.61e-1)" "unprognostic (6.75e-2)" "unprognostic (2.03e-1)" "unprognostic (4.22e-2)" "unprognostic (5.38e-2)" "unprognostic (2.97e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.43e-6)" "prognostic unfavorable (9.93e-4)" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.87e-4)" 83.0 11.8 3.0 8.3 2.7 0.6 70.6 1.3 5.4 92.4 4.7 48.5 6.4 118.2 2.6 17.7 57.9 19.6 34.6 4.0 7.0 26.0 7.4 54.4 2.5 5.4 4.2 2.1 82.6 8.7 1.1 21.9 11.7 4.2 39.3 1.7 0.8 32.7 11.5 16.7 35.8 29.7 6.4 1.9 26.6 29.2 14.8 3.4 0.6 47.0 5.0 0.8 53.3 59.8 2.9 4.1 0.8 1.2 1.0 16.5 46.0 42.3 143.6 66.9 16.6 19.9 8.0 3.3 1.7 0.6 71.9 0.1 3.0 1.0 0.0 3.2 3.2 1.3 1.2 3.1 12.8 43.4 0.2 1.6 54.8 0.0 6.2 0.0 32.4 0.0 0.9 17.3 1.4 21.5 0.4 0.4 0.5 14.0 0.3 4.7 0.6 0.3 0.4 0.0 0.7 3.2 8.9 0.5 1.4 0.1 10.4 11.1 0.7 1.3 0.7 23.1 21.8 0.6 3.3 0.3 0.2 5.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 6.4 0.0 0.0 0.0 0.0 0.0 0.2 3.0 2.7 1.3 5.4 4.0 7.0 5.4 4.2 2.1 4.2 1.9 3.4 2.9 22.2 3.2 0.0 7.5 0.5 10.7 1.1 0.7 2.2 0.7 7.0 47.9 3.5 0.0 0.0 9.2 0.0 9.5 1.1 0.0 0.0 5.7 1.7 4.3 149.5 5.1 0.0 0.0 0.3 0.0 259.9 183.3 2.6 3.7 0.0 0.5 6.4 0.1 9.3 0.0 0.4 0.0 0.0 0.0 19.7 11.4 176.1 1.7 10.6 6.5 0.7 50.7 0.0 0.0 0.1 1.1 0.0 183.6 1.4 0.6 0.0 1.4 0.0 1.5 13.1 65.8 74.7 0.7 5.4 1.3 10.5 29.4 2.2 0.8 0.0 0.3 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "FA core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 337.5;Proximal tubular cells: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 39.1 58.0 15.5 3.2 14.2 5.6 41.5 17.8 28.2 50.1 16.2 41.1 4.7 50.4 1.3 39.2 38.1 1.5 48.9 11.8 19.6 64.4 52.6 38.2 3.6 21.9 17.7 6.7 45.7 39.0 5.1 76.1 3.3 17.7 61.6 1.8 3.8 31.0 7.2 26.6 41.9 32.0 1.8 17.4 45.3 47.7 55.2 21.3 2.9 53.3 4.0 3.1 44.1 41.1 17.0 27.7 4.4 5.8 7.3 3.6 4.7 34.8 30.4 11.0 9.6 12.9 6.7 18.0 31.7 43.7 4.8 9.0 13.5 4.2 4.6 4.9 68.3 61.0 26.5 6.8 14.4 13.5 18.7 24.8 8.1 9.8 5.8 6.3 5.9 11.9 24.6 37.1 7.6 6.7 11.6 27.0 57.6 20.8 5.4 55.6 36.0 18.1 30.7 4.6 4.5 47.4 63.5 19.8 8.6 58.5 5.3 8.5 7.5 25.6 15.1 35.8 18.7 17.4 68.9 39.9 48.2 28.0 11.4 6.4 9.8 16.4 63.4 18.4 16.9 18.1 28.3 16.5 19.8 17.0 25.7 22.2 18.6 20.6 10.8 15.6 42.4 16.2 10.6 15.5 14.2 17.8 28.2 11.8 19.6 21.9 17.7 6.7 17.7 17.4 21.3 17.0 71.7 6.4 11.9 0.0 82.3 0.0 97.7 0.0 79.6 29.1 120.9 138.2 22.1 62.9 6.8 97.5 4.2 119.7 83.6 14.5 170.2 128.5 102.7 44.3 77.2 62.1 43.7 36.8 0.0 110.8 144.1 65.3 64.7 49.9 7.6 74.8 84.6 94.5 134.0 15.2 0.0 56.0 0.0 110.8 0.0 337.5 86.0 82.3 0.0 0.0 178.9 84.7 91.6 0.0 0.0 141.1 40.8 82.8 60.9 152.8 56.2 290.1 8.0 29.5 65.7 63.3 68.8 101.5 38.3 88.4 0.0 89.8 62.4 102.5 42.2 113.2 MEGF6 EGFL3 ENSG00000162591 "Multiple EGF like domains 6" O75095 1 3487951-3611508 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 20.6;Basal keratinocytes: 18.4;Basal squamous epithelial cells: 23.3;Melanocytes: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 51.1;HeLa: 56.3;hTERT-RPE1: 69.7;U-2197: 55.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052129 Uncertain Approved "Microtubules,Cytokinetic bridge" "Secreted to blood" Yes No 1700000 Microtubules "Cytokinetic bridge" "HPA052129: AB_2681739" "unprognostic (1.95e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.19e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (3.09e-3)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (9.51e-2)" "unprognostic (3.43e-2)" 22.7 4.4 2.7 3.9 2.3 10.9 20.2 2.9 2.8 11.8 1.8 11.0 2.2 9.7 1.4 13.3 29.2 11.3 9.5 1.7 3.6 5.8 5.0 22.3 5.6 3.5 4.7 1.5 18.1 6.6 0.4 4.1 2.8 3.6 26.7 1.1 1.8 19.4 4.7 4.9 41.6 10.1 1.4 1.8 10.8 10.1 3.3 3.0 3.4 11.7 1.9 3.4 11.1 23.0 2.7 11.6 14.1 4.3 6.6 0.4 0.3 1.0 51.1 14.1 5.2 1.6 3.3 10.4 0.0 13.8 24.6 4.4 6.7 0.0 0.5 1.7 0.0 0.4 0.0 56.3 3.3 0.0 0.2 0.9 0.1 0.6 0.4 0.8 69.7 5.6 0.1 0.0 0.0 0.1 6.0 0.0 10.9 2.7 3.3 0.9 2.2 3.0 6.2 1.1 3.8 3.8 3.1 18.8 1.1 6.4 11.4 4.9 1.5 2.2 19.6 1.7 55.6 3.9 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.0 0.8 0.1 2.7 2.3 2.9 2.8 1.7 3.6 3.5 4.7 1.5 3.6 1.8 3.0 2.7 5.0 22.4 20.6 8.8 2.7 18.4 7.1 3.9 23.3 0.8 3.6 3.0 3.3 5.7 4.4 1.8 0.0 0.2 0.4 0.6 0.0 3.6 0.2 1.4 0.6 7.0 0.0 4.8 6.5 1.4 1.3 9.4 6.6 5.0 1.3 9.8 16.8 0.9 1.0 0.0 7.2 1.4 0.0 0.3 7.5 0.5 11.5 2.8 19.6 5.6 0.7 14.7 1.0 4.5 5.2 4.5 0.1 3.4 0.4 4.0 0.5 1.2 0.3 1.2 0.0 0.5 2.7 0.3 1.1 7.6 11.4 0.4 3.6 0.1 1.1 2.7 CCDC27 FLJ32825 ENSG00000162592 "Coiled-coil domain containing 27" Q2M243 1 3746460-3771645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 17.1" "Group enriched" "Detected in some" 63 "Early spermatids: 87.6;Late spermatids: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "basal ganglia: 1.1" HPA044395 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044395: AB_10962987" "unprognostic (1.36e-1)" "unprognostic (6.67e-3)" "unprognostic (3.23e-4)" "unprognostic (3.13e-2)" "unprognostic (3.42e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (7.18e-2)" "unprognostic (1.20e-1)" "unprognostic (2.17e-2)" "unprognostic (2.54e-3)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "unprognostic (2.28e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 27.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL23R IL-23R ENSG00000162594 "Interleukin 23 receptor" Q5VWK5 1 67138907-67259979 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.6;testis: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 11.1;Enteroendocrine cells: 3.0;Late spermatids: 6.0;T-cells: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "MAIT T-cell: 21.7" "Lineage enriched" "Detected in single" 29 "T-cells: 21.7" "Cell line enhanced" "Detected in some" "HL-60: 2.4;HMC-1: 9.1;K-562: 3.6;U-2197: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056427 Uncertain NA NA "HPA056427: AB_2683129" "unprognostic (4.01e-3)" "unprognostic (8.04e-2)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.16e-3)" "unprognostic (1.57e-1)" "unprognostic (2.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (8.64e-5)" "unprognostic (1.43e-1)" "unprognostic (3.02e-1)" "unprognostic (2.73e-2)" "unprognostic (6.41e-3)" 0.0 1.6 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.4 1.5 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 2.4 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 13.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 21.7 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.6 1.6 0.0 0.0 11.1 0.2 0.1 0.1 3.0 0.0 0.3 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.2 6.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.2 0.0 0.2 0.7 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.3 0.0 4.2 0.0 0.4 0.2 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045886-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.5;ovary: 60.7;pituitary gland: 53.0" "Group enriched" "Detected in many" 5 "Distal tubular cells: 64.6;Theca cells: 206.2" "Group enriched" "Detected in many" 4 "endometrial cancer: 4.3;glioma: 16.3;pancreatic cancer: 5.6;thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 8.2;HSkMC: 17.2;TIME: 11.2;U-251 MG: 9.1;U-87 MG: 16.9" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favorable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.3 20.3 30.5 0.5 19.1 0.1 5.1 2.6 10.3 4.7 3.0 2.6 7.5 2.6 10.7 1.7 3.4 10.3 11.4 7.1 97.5 7.0 9.6 5.2 0.2 36.5 47.1 6.1 60.7 20.1 7.6 53.0 0.6 17.2 3.0 0.8 4.0 2.4 2.6 1.1 2.1 1.4 1.2 8.0 2.6 4.3 5.5 69.1 1.6 3.8 1.9 0.3 3.1 6.5 11.2 0.0 1.5 1.6 0.0 5.2 3.9 0.6 4.6 1.6 0.3 1.2 0.0 0.8 0.0 0.2 4.8 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.6 0.0 8.2 0.0 0.0 17.2 0.1 0.7 0.0 0.0 1.0 0.2 0.3 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.1 0.5 0.1 0.0 11.2 0.0 0.5 0.2 9.1 2.7 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 30.5 19.1 2.6 10.3 7.1 97.5 36.5 47.1 6.1 17.2 8.0 69.1 11.2 0.3 0.0 1.8 5.2 0.0 3.2 25.0 0.6 0.6 1.1 5.4 6.5 5.9 7.2 2.5 3.7 10.4 1.1 0.0 0.4 64.6 3.7 0.1 0.7 0.7 1.7 16.2 0.0 2.2 18.7 0.1 10.3 4.1 1.8 0.0 0.8 3.3 3.9 0.1 0.0 8.8 2.3 0.0 0.0 4.8 0.8 6.8 0.3 5.4 0.0 0.0 0.7 1.0 5.0 0.2 2.9 0.1 1.5 0.0 5.3 0.1 11.1 0.9 6.1 0.0 16.9 1.7 0.0 1.4 1.7 2.8 0.4 0.7 206.2 0.7 2.4 C1orf87 "CREF, MGC34837" ENSG00000162598 "Chromosome 1 open reading frame 87" Q8N0U7 1 59987269-60073770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 8.2;fallopian tube: 30.2" "Cell type enhanced" "Detected in some" "Early spermatids: 113.0;Endometrial ciliated cells: 63.0;Late spermatids: 25.4;Respiratory ciliated cells: 101.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031366, HPA031368" Enhanced NA NA "HPA031366: AB_2673847, HPA031368: AB_10600795" "unprognostic (1.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.83e-2)" "unprognostic (1.92e-2)" "unprognostic (6.69e-2)" "unprognostic (7.11e-2)" "unprognostic (8.95e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" 0.0 0.0 6.2 0.0 1.8 0.0 0.0 1.8 1.1 0.7 2.9 0.0 0.0 0.5 0.0 0.0 30.2 0.0 0.0 1.1 5.2 0.1 0.0 3.2 0.0 8.2 5.2 0.6 0.0 0.0 0.6 0.3 0.0 5.6 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.9 2.9 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.2 1.8 1.8 1.1 1.1 5.2 8.2 5.2 0.6 5.6 7.4 2.9 2.8 0.0 0.0 1.5 4.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 11.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 113.0 63.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 0.0 25.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.7 0.0 0.0 0.0 0.7 11.4 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 NFIA "KIAA1439, NFI-L" ENSG00000162599 "Nuclear factor I A" Q12857 1 60865259-61462788 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.4" "Cell type enhanced" "Detected in all" "Astrocytes: 777.3;Oligodendrocyte precursor cells: 606.7;Peritubular cells: 438.5;Skeletal myocytes: 513.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006111, HPA008884" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006111: AB_1854422, HPA008884: AB_1854421" "unprognostic (1.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" "unprognostic (3.44e-2)" "prognostic favorable (7.30e-4)" "unprognostic (2.55e-1)" "unprognostic (1.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.38e-2)" "unprognostic (2.85e-2)" "unprognostic (5.20e-2)" "prognostic favorable (7.01e-4)" "unprognostic (2.11e-1)" "unprognostic (1.20e-1)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.03e-4)" 23.2 12.5 30.0 5.3 34.8 10.1 15.2 73.4 25.9 18.5 30.4 11.5 7.3 9.0 11.8 19.0 15.7 14.4 17.0 30.0 27.4 10.9 40.8 8.5 5.1 56.7 31.9 15.3 15.8 13.6 11.0 5.4 4.3 34.5 15.1 9.2 4.2 17.6 11.7 14.0 8.7 6.4 13.4 35.1 9.5 9.8 5.8 32.7 8.7 27.7 16.0 6.8 13.9 10.4 28.7 5.0 6.8 1.0 74.2 31.8 20.2 0.2 1.6 5.1 1.6 2.4 0.4 4.8 10.9 4.8 2.7 0.7 7.2 3.1 15.4 0.9 23.4 6.6 0.4 15.2 4.8 7.3 1.2 1.8 25.7 14.9 6.8 27.6 5.5 19.1 3.0 5.1 16.9 1.5 3.6 0.3 0.3 2.9 6.9 6.6 1.1 6.9 18.2 4.3 13.1 4.8 5.7 4.1 28.2 10.3 0.8 30.2 0.5 15.5 1.3 8.5 15.2 3.1 1.2 3.1 0.1 1.7 0.2 1.7 3.2 2.7 1.5 1.9 1.9 2.9 0.6 2.3 3.0 1.3 0.3 2.2 2.7 0.1 0.5 2.5 1.0 0.1 1.8 30.0 34.8 73.4 25.9 30.0 27.4 56.7 31.9 15.3 34.5 35.1 32.7 28.7 232.1 35.3 44.7 777.3 4.4 85.0 68.8 72.1 220.9 42.6 140.7 107.4 192.9 148.7 68.1 47.8 2.1 5.7 8.1 28.4 27.4 38.0 28.9 85.8 69.8 132.7 25.2 163.7 142.3 47.8 1.1 265.6 30.5 68.2 27.3 11.6 197.0 304.5 14.8 42.1 125.7 46.8 36.7 60.8 42.6 26.4 408.8 19.2 46.2 259.5 14.9 150.2 5.2 606.7 431.3 20.8 37.6 438.5 8.0 53.0 19.1 109.9 82.6 6.9 144.7 513.1 133.7 5.0 13.5 148.4 76.3 1.6 15.0 34.9 69.7 57.1 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA055120: AB_2682702" "prognostic favorable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favorable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 11.5 18.9 17.1 14.1 22.0 12.9 19.9 22.7 15.0 16.9 15.0 21.0 15.0 13.6 18.0 13.4 19.6 15.2 20.0 13.1 19.1 28.7 31.4 12.0 23.6 19.0 17.8 11.9 13.6 18.1 18.2 10.5 11.6 21.2 21.0 20.2 20.7 19.7 16.8 28.5 13.0 14.3 12.5 16.6 20.4 17.5 8.3 18.3 20.4 20.3 30.2 21.6 14.9 10.6 27.7 31.2 13.0 8.3 7.9 41.7 39.0 24.6 12.7 13.9 10.9 13.7 4.0 18.7 69.8 26.3 13.1 37.8 31.2 31.1 31.3 13.3 55.1 17.9 22.0 10.4 16.1 20.3 54.3 14.7 37.3 33.6 10.4 22.4 24.1 9.3 34.3 42.7 20.1 29.2 19.5 18.0 19.4 12.4 47.4 28.5 22.1 27.7 29.1 23.6 20.5 8.7 4.3 26.0 41.9 37.6 38.4 19.5 20.1 5.4 5.6 10.8 27.8 13.5 16.3 23.4 46.2 16.8 42.2 14.1 20.1 14.4 32.1 19.4 24.1 25.6 35.6 23.7 23.1 15.4 35.0 33.9 31.5 17.2 30.9 35.1 8.2 23.6 15.9 17.1 22.0 22.7 15.0 13.1 19.1 19.0 17.8 11.9 21.2 16.6 18.3 27.7 8.4 19.2 11.5 37.9 25.7 6.0 18.2 35.6 13.6 7.8 15.0 12.3 27.2 8.6 33.0 25.8 12.5 22.9 14.4 8.4 25.4 11.2 5.8 31.6 10.8 6.3 6.0 15.6 18.3 5.5 10.0 12.0 5.6 18.4 6.3 10.9 6.4 18.7 15.8 1.7 31.7 17.7 36.7 10.1 9.7 12.7 9.9 12.9 7.2 29.0 11.3 10.9 15.5 52.8 106.5 3.8 10.9 8.6 16.8 12.3 8.5 32.4 63.1 20.5 6.6 12.0 8.6 14.3 13.6 17.3 6.8 18.3 20.7 17.1 14.6 17.1 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58643440-58700077 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA057306" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA054291: AB_2682438, HPA057306: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 10.5 7.6 4.9 4.5 4.9 12.6 12.1 5.2 5.9 11.8 5.1 11.3 5.4 10.7 6.3 10.1 10.3 3.2 9.8 5.1 4.7 7.1 8.1 10.2 6.3 4.9 4.8 4.8 13.3 12.2 6.0 8.8 4.4 4.9 9.7 4.4 8.5 11.9 4.1 10.1 10.4 12.7 3.6 4.7 11.5 9.9 4.4 4.9 5.3 11.6 3.2 5.0 9.4 11.2 5.3 10.1 2.6 5.0 6.7 6.0 7.2 10.5 5.9 5.6 5.1 3.9 5.3 4.2 10.3 1.8 3.8 4.8 7.4 7.7 2.1 11.0 6.2 4.3 11.3 2.1 5.1 7.4 19.6 9.7 5.4 5.9 7.5 3.8 6.1 1.2 4.2 12.6 6.3 6.8 2.6 7.8 16.3 11.4 3.5 3.5 7.3 16.4 6.1 4.6 3.8 5.8 6.6 4.4 9.4 13.9 9.0 3.1 10.6 4.9 9.3 4.6 6.4 11.3 10.8 5.8 13.9 5.8 13.7 11.6 0.9 0.3 0.1 0.3 0.4 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.4 1.0 0.1 0.5 0.4 0.4 0.1 4.9 4.9 5.2 5.9 5.1 4.7 4.9 4.8 4.8 4.9 4.7 4.9 5.3 36.5 22.4 33.7 47.7 26.0 19.1 22.8 13.5 30.7 19.5 25.6 21.0 28.2 10.0 35.1 11.0 25.0 8.4 36.6 22.1 15.6 8.8 3.9 22.1 34.8 25.4 16.2 14.1 87.4 9.4 5.7 20.8 19.9 36.9 56.3 30.1 23.9 16.3 11.3 18.5 58.2 17.0 24.4 13.9 14.2 6.3 12.8 22.2 8.8 35.6 21.3 12.7 22.6 58.3 106.9 12.7 13.1 17.3 29.5 19.3 19.2 8.8 21.2 27.8 26.3 28.8 21.5 15.5 20.6 25.0 18.5 11.4 30.8 22.0 18.5 26.4 TM2D1 BBP ENSG00000162604 "TM2 domain containing 1" Q9BX74 1 61681046-61725423 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046058, HPA055621" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046058: AB_2679519, HPA055621: AB_2682865" "unprognostic (1.80e-1)" "unprognostic (1.99e-3)" "unprognostic (1.68e-1)" "unprognostic (2.20e-2)" "unprognostic (5.79e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.00e-1)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" 31.2 36.7 29.1 16.6 29.8 23.4 36.2 30.9 36.8 29.7 30.6 27.9 20.7 30.6 45.7 21.6 30.1 26.2 45.8 29.0 30.6 39.2 29.6 27.6 26.7 30.5 30.5 28.5 36.7 22.0 41.9 20.6 36.0 30.8 33.5 28.7 26.5 30.4 22.7 41.3 20.0 25.2 29.5 30.8 24.1 24.6 35.3 29.7 25.3 40.9 35.6 20.5 30.4 20.9 32.3 31.3 15.0 22.8 18.2 68.1 66.2 29.2 54.5 55.2 26.4 35.0 9.7 39.0 25.3 70.9 45.9 52.7 34.8 29.2 39.7 40.5 41.3 34.4 28.2 23.0 21.8 66.7 40.9 48.0 74.2 67.0 30.5 38.0 64.4 50.5 33.6 32.7 47.7 64.7 10.1 20.9 32.0 24.9 27.5 21.4 17.9 43.1 31.5 78.4 24.3 25.4 30.9 32.5 64.1 102.6 30.5 35.1 43.2 45.3 35.3 17.8 19.8 41.9 40.0 39.4 30.8 61.3 39.4 31.8 52.8 18.7 44.9 16.1 23.7 16.6 24.2 18.6 19.7 18.6 20.1 17.2 19.9 12.2 23.3 26.8 36.4 24.3 19.4 29.1 29.8 30.9 36.8 29.0 30.6 30.5 30.5 28.5 30.8 30.8 29.7 32.3 49.5 41.7 40.2 32.3 49.0 78.3 91.9 205.2 59.2 60.3 67.7 56.6 40.5 48.6 99.9 79.1 60.5 51.2 47.4 46.5 39.2 50.3 6.5 43.3 34.7 59.2 43.9 42.1 42.3 45.3 60.0 84.3 29.0 42.2 61.5 37.6 80.7 54.2 50.3 69.0 46.9 41.3 158.7 58.7 53.8 9.9 79.9 48.1 90.7 43.1 54.1 99.2 63.8 50.3 63.4 54.2 60.4 53.0 51.4 110.0 45.9 67.6 100.0 70.1 39.5 75.3 60.0 172.1 72.5 58.6 76.4 53.5 47.3 42.0 43.0 110.1 USP1 ENSG00000162607 "Ubiquitin specific peptidase 1" O94782 1 62436297-62451804 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 302.7;Spermatogonia: 206.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028387, HPA028440" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028387: AB_2672578, HPA028440: AB_10603000" "unprognostic (1.22e-1)" "unprognostic (5.36e-2)" "unprognostic (1.78e-3)" "unprognostic (4.05e-3)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (6.72e-2)" "unprognostic (1.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.33e-3)" "unprognostic (3.99e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-3)" "unprognostic (5.70e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" 14.0 10.7 13.5 21.2 15.7 53.6 24.2 21.6 15.3 16.3 13.0 19.1 17.3 20.9 16.9 18.1 16.9 12.0 12.4 12.8 15.7 14.2 13.6 16.1 32.5 14.0 14.4 12.1 26.3 16.2 18.4 10.1 14.5 14.6 16.9 20.9 34.8 14.9 16.0 12.0 19.4 17.3 17.1 15.3 19.5 17.1 52.0 14.0 48.6 20.4 16.1 32.0 14.0 12.0 18.6 85.6 25.5 96.8 53.2 21.3 25.5 57.0 79.7 52.1 93.3 101.2 41.4 39.3 151.3 57.0 43.1 83.6 48.0 80.3 53.0 128.5 79.5 63.5 124.5 82.1 42.7 23.2 132.5 60.9 13.7 33.8 84.1 62.8 25.1 44.9 100.1 92.7 125.3 66.2 38.0 136.9 50.9 88.2 48.5 52.4 131.9 166.3 93.9 34.9 60.1 103.4 58.6 89.3 70.1 86.8 64.2 41.3 79.7 32.1 72.7 80.7 109.3 112.9 52.2 78.1 171.1 49.5 104.0 67.0 22.6 9.9 26.0 12.7 10.5 16.9 15.6 15.3 13.5 12.3 11.2 14.4 12.2 17.4 17.9 14.9 12.4 15.3 10.3 13.5 15.7 21.6 15.3 12.8 15.7 14.0 14.4 12.1 14.6 15.3 14.0 18.6 35.8 48.1 31.8 6.2 58.7 62.2 34.7 32.9 75.7 49.6 41.5 46.2 34.9 24.3 34.9 16.5 22.9 43.7 52.4 22.7 19.6 34.1 173.9 37.2 32.3 39.7 8.4 85.2 10.3 34.1 59.2 43.9 15.8 33.2 27.8 41.4 30.0 18.4 31.0 35.3 11.2 33.3 30.5 27.2 38.8 81.1 50.1 34.7 26.6 7.5 56.0 49.5 62.8 10.6 17.2 27.5 12.7 41.0 63.7 56.8 22.7 17.3 41.9 86.6 52.6 59.7 42.0 302.7 206.7 73.8 64.4 33.0 59.7 21.2 39.5 35.8 FUBP1 "FBP, FUBP" ENSG00000162613 "Far upstream element binding protein 1" Q96AE4 1 77944055-77979110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006149 Supported Enhanced Nucleoplasm NA NA 300000 Nucleoplasm "HPA006149: AB_1849172" "unprognostic (4.17e-2)" "unprognostic (2.83e-2)" "unprognostic (3.35e-3)" "unprognostic (3.89e-2)" "unprognostic (3.77e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.83e-9)" "unprognostic (2.32e-2)" "unprognostic (2.16e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-3)" "unprognostic (9.80e-3)" "unprognostic (9.02e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (6.24e-2)" "unprognostic (9.46e-2)" 29.7 38.1 14.5 35.8 16.3 80.4 31.2 24.5 18.0 27.3 18.8 23.9 25.2 36.8 37.1 25.0 28.8 17.0 29.7 14.3 19.1 27.9 17.2 31.9 43.2 15.4 16.6 13.5 47.3 34.0 23.2 42.0 23.2 17.2 24.3 27.8 57.7 30.7 13.4 34.1 27.7 27.7 19.1 14.9 35.5 26.3 17.1 15.4 36.0 37.2 15.3 38.9 25.5 27.6 24.9 49.4 36.5 106.9 40.0 11.9 19.0 77.6 53.5 23.4 35.8 29.2 34.7 49.1 91.3 22.1 31.9 49.1 51.4 54.8 45.4 48.1 91.6 38.5 58.8 87.4 56.9 25.8 104.9 22.8 25.2 35.5 39.7 36.4 39.6 29.2 59.1 65.8 45.1 31.0 39.0 74.0 60.4 75.7 38.0 26.2 94.6 78.7 30.9 35.2 49.0 54.2 61.1 41.5 42.8 44.2 44.7 52.9 38.7 50.7 50.7 66.0 14.7 62.5 44.8 39.4 106.1 21.1 45.3 44.5 6.5 10.5 12.3 20.5 17.0 23.3 19.0 19.6 20.8 9.3 14.7 19.4 23.6 5.3 29.4 19.1 15.4 24.5 15.3 14.5 16.3 24.5 18.0 14.3 19.1 15.4 16.6 13.5 17.2 14.9 15.4 24.9 38.6 73.7 57.5 48.0 70.7 84.8 107.0 49.5 39.3 44.7 48.7 31.2 76.4 24.3 71.0 33.1 41.7 46.8 68.2 27.1 43.0 59.5 33.3 54.8 50.7 52.0 55.1 43.1 48.8 72.1 66.2 49.0 28.5 60.5 77.8 59.4 30.4 23.4 33.4 18.5 53.6 35.9 36.7 32.1 37.0 19.8 48.1 41.8 39.2 61.8 61.5 32.5 52.5 56.3 88.3 69.2 33.5 30.1 68.9 54.2 23.6 28.9 73.2 40.5 32.9 70.3 65.7 33.2 41.3 40.9 63.1 35.7 72.1 38.0 37.8 72.7 NEXN "NELIN, nexilin" ENSG00000162614 "Nexilin F-actin binding protein" Q0ZGT2 1 77888513-77943895 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 408.5;skeletal muscle: 683.2;tongue: 553.8" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2329.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5" "Region enhanced" "Detected in all" "basal ganglia: 40.4" "Group enriched" "Detected in all" 4 "basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2" "HPA011185, HPA011904" Approved Supported "Plasma membrane,Actin filaments" NA NA 2900000 "Plasma membrane, Actin filaments" "HPA011185: AB_1854409, HPA011904: " "unprognostic (9.73e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.46e-1)" "unprognostic (3.25e-1)" "unprognostic (5.41e-2)" "unprognostic (5.60e-2)" "unprognostic (2.48e-1)" "unprognostic (9.65e-3)" "unprognostic (3.68e-2)" 43.2 22.6 2.2 24.8 2.6 0.6 16.3 1.8 1.9 21.7 3.8 67.4 10.3 79.7 10.8 49.8 47.9 29.0 408.5 1.4 2.1 8.1 5.7 25.4 5.6 1.6 3.3 0.9 15.3 10.0 1.5 1.5 10.7 1.9 63.0 15.8 0.6 11.6 70.4 683.2 5.5 26.9 71.2 1.1 8.6 44.5 5.8 5.1 2.1 10.4 553.8 1.8 50.1 19.7 2.0 26.0 1.5 4.5 0.2 79.5 75.3 12.3 152.2 65.5 29.8 20.2 4.6 0.2 0.0 8.6 54.7 34.4 3.4 3.3 14.3 53.3 0.7 3.4 6.2 7.5 1.5 59.3 1.3 0.2 56.6 3.3 40.7 23.8 65.2 22.8 6.0 0.3 0.0 135.1 0.0 29.9 1.8 23.8 0.0 18.6 24.3 108.5 0.2 35.5 1.2 0.1 1.1 13.3 0.0 1.0 29.9 0.0 3.5 23.4 71.7 53.6 31.2 76.1 0.2 0.2 0.1 4.0 2.8 0.2 0.0 1.7 0.0 0.2 1.0 0.0 0.7 0.1 0.2 0.9 0.5 0.3 0.1 1.4 0.3 0.8 0.6 0.0 3.6 2.2 2.6 1.8 1.9 1.4 2.1 1.6 3.3 0.9 1.9 1.1 5.1 2.0 8.3 105.8 4.9 11.4 2.1 1.8 0.9 4.6 1.2 2.7 1.4 33.1 2329.6 0.0 5.4 0.0 4.2 0.8 4.1 0.4 1.9 15.3 24.0 2.6 24.2 17.4 0.0 1.7 26.6 32.4 4.0 93.2 1.1 3.2 1.3 29.7 38.6 1.5 1.2 1.7 27.6 0.5 0.0 4.4 2.2 9.0 73.3 44.9 0.0 16.9 5.8 0.7 0.0 24.6 27.3 21.8 0.1 346.1 0.3 1.3 5.3 0.7 0.4 3.8 216.9 70.4 177.2 0.7 3.6 0.8 0.9 0.3 2.3 13.0 2.1 0.4 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 119.0;HUVEC TERT2: 182.3;LHCN-M2: 312.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 9500 Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 31.9 50.2 30.7 11.2 28.9 6.8 15.6 29.6 56.5 24.2 29.6 12.8 6.5 21.5 10.9 26.6 14.0 32.5 50.9 34.6 31.5 20.8 20.2 17.2 9.8 30.8 30.3 24.0 16.2 23.0 14.2 11.7 26.2 31.6 23.5 11.3 15.2 7.7 14.2 44.5 9.6 9.6 30.2 31.3 42.6 12.4 8.0 34.7 10.6 44.9 72.0 6.2 23.8 12.9 42.9 6.2 11.8 14.5 8.6 61.8 115.0 6.7 119.0 28.8 50.8 56.8 3.9 8.0 8.9 19.4 55.5 20.7 9.2 18.7 10.1 86.1 10.1 5.3 4.5 32.9 28.7 84.1 2.5 2.4 47.9 27.9 66.5 18.9 28.4 182.3 2.9 19.6 6.1 312.1 0.7 3.0 6.6 9.4 1.8 5.6 5.0 25.2 5.9 12.0 3.1 10.8 3.4 13.3 10.0 11.7 15.0 3.9 3.7 88.7 72.5 17.8 51.2 15.9 5.5 1.8 7.9 9.9 5.3 12.9 3.3 0.7 1.2 1.1 0.8 1.8 1.6 1.3 1.3 0.7 1.3 3.0 2.1 0.2 1.6 0.9 2.3 1.9 0.9 30.7 28.9 29.6 56.5 34.6 31.5 30.8 30.3 24.0 31.6 31.3 34.7 42.9 81.5 60.9 6.3 35.9 23.9 41.7 112.5 16.3 48.3 29.3 90.9 57.1 98.7 18.6 20.0 18.4 68.8 51.2 15.3 40.9 37.2 11.2 144.7 55.1 37.3 84.4 21.4 42.1 41.6 14.7 23.2 87.3 45.9 51.9 56.6 16.7 42.8 22.3 19.4 30.3 39.0 37.9 12.2 18.3 70.1 62.6 24.5 33.7 65.8 21.5 5.1 40.5 8.2 28.6 53.8 11.4 27.3 35.0 70.6 33.9 16.8 31.0 34.7 56.5 26.3 82.8 120.3 23.1 12.0 55.5 39.2 181.0 52.7 32.1 30.9 43.2 ADGRL4 "ELTD1, ETL" ENSG00000162618 "Adhesion G protein-coupled receptor L4" Q9HBW9 1 78889764-79282124 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 72.1" "Group enriched" "Detected in many" 5 "Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025229 Supported NA NA 3800000 "HPA025229: AB_10602493" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.05e-2)" "unprognostic (2.58e-1)" "unprognostic (5.32e-2)" "unprognostic (8.11e-3)" "unprognostic (2.01e-1)" "unprognostic (1.23e-1)" "unprognostic (7.52e-2)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.32e-3)" "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (3.85e-3)" 72.1 8.3 8.0 9.8 7.8 0.7 64.6 8.1 14.0 22.3 7.8 9.2 4.8 16.5 6.3 9.1 12.2 22.6 20.2 7.6 7.5 12.9 14.4 18.2 10.0 8.2 7.7 6.0 4.9 4.7 9.7 5.2 22.7 8.7 9.5 6.4 3.0 7.9 9.0 14.3 8.3 8.6 27.8 7.0 40.2 8.0 6.8 9.1 4.7 21.0 23.8 7.1 24.2 10.5 8.3 0.0 0.0 25.7 0.2 7.3 24.7 0.0 7.8 7.7 0.5 0.3 0.8 0.2 0.2 0.6 22.5 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.5 0.7 0.1 25.3 0.0 0.3 17.8 0.4 55.7 0.3 101.2 330.0 0.2 0.4 2.5 7.0 0.0 0.0 1.0 0.4 0.2 0.4 0.2 0.0 0.0 61.1 3.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 379.3 0.2 5.8 2.0 0.0 0.8 0.5 0.1 0.3 0.5 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 8.0 7.8 8.1 14.0 7.6 7.5 8.2 7.7 6.0 8.7 7.0 9.1 8.3 559.9 0.0 6.0 0.3 1.2 0.0 0.4 0.0 4.6 0.0 1.8 2.5 7.6 5.7 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 45.3 0.8 1.5 276.0 0.0 2.7 1.5 0.2 0.0 10.2 0.0 3.8 0.0 0.0 287.7 3.5 0.6 1.7 1.0 0.0 0.0 19.2 0.0 57.9 0.6 1.5 0.0 72.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.4 1.2 1.3 0.0 0.0 0.0 0.4 0.0 5.1 5.7 7.2 1.8 1.0 0.0 0.0 1.1 5.4 0.0 0.7 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 20.6" "Group enriched" "Detected in many" 5 "Early spermatids: 258.5;Late spermatids: 103.6;Spermatocytes: 204.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 7.9;JURKAT: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.6 0.7 0.7 0.7 0.6 0.1 0.7 0.7 0.7 0.1 1.1 0.3 0.2 0.2 0.3 0.1 2.2 0.4 0.3 0.5 0.7 2.0 0.9 0.3 0.7 0.7 0.9 0.4 0.3 0.2 1.2 0.5 0.2 0.8 0.4 0.2 0.5 0.7 0.4 0.1 0.1 0.2 0.0 0.7 0.4 0.3 20.6 0.8 1.0 1.5 0.5 0.6 0.2 0.1 1.6 0.2 1.0 0.1 0.4 1.0 0.4 0.6 0.6 0.4 0.8 0.9 0.1 1.4 1.4 1.2 0.1 7.9 0.1 2.1 2.0 1.0 3.5 0.0 1.3 0.3 0.7 0.1 2.3 0.7 0.7 1.0 1.4 0.5 0.3 0.4 4.8 1.1 1.9 1.4 0.0 0.9 0.3 1.1 2.5 0.6 1.1 0.8 1.4 1.2 0.1 1.0 0.7 0.1 0.1 3.1 0.2 0.9 1.3 0.1 0.1 0.7 0.5 1.2 2.0 0.7 1.1 1.5 0.2 1.1 0.0 0.0 0.8 0.9 0.5 1.1 1.6 1.0 1.1 0.1 0.7 0.9 1.3 0.0 0.4 0.1 0.4 1.6 0.3 0.7 0.6 0.7 0.7 0.5 0.7 0.7 0.9 0.4 0.8 0.7 0.8 1.6 1.0 0.0 1.5 2.0 2.8 1.1 1.2 4.0 0.0 1.0 2.0 2.8 1.2 2.8 2.6 0.0 4.2 1.7 0.5 0.3 13.7 1.5 258.5 21.6 0.8 0.8 3.0 0.4 4.1 1.7 1.5 0.3 0.0 1.5 0.0 3.2 0.7 1.8 1.3 0.0 3.9 0.6 0.0 0.6 0.2 103.6 1.8 0.5 0.0 1.9 0.8 1.2 2.1 2.0 4.0 0.9 0.1 1.5 0.6 0.9 0.1 6.3 36.0 0.7 0.0 0.2 1.5 204.8 31.3 0.0 0.1 0.3 1.5 3.6 0.7 1.2 LRRC53 ENSG00000162621 "Leucine rich repeat containing 53" A6NM62 1 74469376-74512611 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "brain: 1.1" "Cell type enriched" "Detected in single" 8 "Enteroendocrine cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054062 Uncertain NA NA "HPA054062: AB_2682364" "unprognostic (3.67e-1)" 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.5 0.2 0.2 0.2 0.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TYW3 "C1orf171, FLJ40918" ENSG00000162623 "TRNA-yW synthesizing protein 3 homolog" Q6IPR3 1 74733152-74766678 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029641 Approved Approved "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA029641: AB_2272535" "unprognostic (6.89e-3)" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (1.49e-7)" "unprognostic (3.79e-1)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-2)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (2.05e-1)" "unprognostic (8.90e-2)" "unprognostic (2.98e-3)" 13.1 15.5 11.0 11.9 11.8 13.2 17.1 11.5 12.8 13.2 11.0 12.9 9.0 16.1 12.3 11.7 14.9 9.3 20.5 10.9 12.4 17.5 13.9 10.7 14.7 11.6 12.3 9.8 26.8 11.8 21.6 11.8 12.8 11.9 15.2 11.2 14.7 14.1 13.7 10.7 10.0 9.0 18.0 11.6 11.1 11.6 12.0 12.9 12.8 19.4 14.6 16.6 15.3 11.2 13.4 19.6 16.1 27.3 19.5 30.3 32.9 41.4 32.9 30.0 30.7 26.9 34.3 16.2 51.0 29.4 28.6 45.1 15.6 31.5 37.9 38.3 31.9 27.1 40.2 49.4 67.0 19.9 81.2 24.9 25.1 37.7 39.2 37.6 24.7 27.7 34.8 70.8 38.0 39.9 16.6 39.8 27.1 72.8 29.2 37.2 37.2 56.8 23.0 26.6 25.2 21.1 18.0 15.7 42.4 53.7 29.5 23.2 29.3 18.2 13.6 37.0 37.0 40.2 21.9 42.7 35.4 30.3 29.0 39.9 9.1 6.4 1.8 10.6 8.8 10.0 10.7 9.2 9.7 9.9 9.8 13.2 14.2 0.5 15.4 6.9 9.6 9.4 5.8 11.0 11.8 11.5 12.8 10.9 12.4 11.6 12.3 9.8 11.9 11.6 12.9 13.4 30.6 16.0 23.9 17.6 34.1 25.6 40.5 32.7 58.1 34.5 32.4 42.3 29.9 20.0 28.6 16.5 4.2 44.5 21.2 7.4 78.2 36.2 19.8 28.9 38.8 31.7 13.8 18.5 28.0 59.4 51.1 34.7 15.8 29.0 21.0 32.8 21.8 29.2 33.1 50.5 22.7 19.5 22.4 30.9 22.6 19.6 43.5 26.2 21.4 14.0 39.5 27.6 37.0 30.2 24.5 32.5 8.4 61.3 35.6 45.7 12.2 64.4 18.4 22.5 13.1 44.2 36.0 34.3 45.3 44.1 22.7 22.3 29.2 55.7 25.9 31.2 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.8;lymphoid tissue: 1.7;salivary gland: 2.7" "Group enriched" "Detected in some" 8 "Early spermatids: 1.2;Late spermatids: 1.4;Spermatocytes: 3.3;Spermatogonia: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebral cortex: 4.8;hypothalamus: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 25.6;U-266/70: 8.6" "Region enhanced" "Detected in many" "basal ganglia: 9.9" "Region enriched" "Detected in some" 5 "basal ganglia: 9.7" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.6 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 1.3 1.7 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.3 0.0 0.0 8.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 4.8 0.0 4.7 0.3 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNX7 ENSG00000162627 "Sorting nexin 7" Q9UNH6 1 98661701-98760500 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037419 Enhanced Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA037419: AB_10671754" "unprognostic (3.19e-1)" "unprognostic (2.18e-1)" "prognostic favorable (5.10e-5)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (9.59e-7)" "unprognostic (1.53e-2)" "unprognostic (2.64e-1)" "unprognostic (1.41e-2)" "unprognostic (1.19e-3)" "unprognostic (1.88e-1)" "unprognostic (7.95e-3)" "unprognostic (1.68e-1)" "unprognostic (1.45e-1)" "unprognostic (8.65e-2)" "unprognostic (1.77e-1)" 15.9 13.9 10.7 7.6 9.8 0.1 17.3 9.5 10.0 20.7 8.3 30.4 23.7 19.6 12.7 16.7 15.7 16.3 22.3 10.6 12.5 25.1 13.0 11.4 3.5 11.5 12.8 9.2 11.4 13.8 15.2 8.4 16.9 11.0 14.4 30.2 3.2 14.2 16.6 5.4 10.5 23.1 26.0 10.4 5.5 17.1 15.8 14.0 3.6 12.3 11.0 4.7 20.5 14.4 11.4 50.4 26.7 15.8 21.6 54.9 86.3 8.9 31.3 56.6 45.9 59.2 15.6 18.4 0.0 39.7 77.1 37.7 14.2 16.8 44.4 45.5 0.2 32.3 0.0 41.2 27.1 32.4 0.0 0.0 43.5 46.8 37.8 16.5 51.7 64.9 0.7 0.0 0.1 73.3 10.3 0.4 0.0 15.2 20.0 38.0 0.0 35.4 0.1 45.3 39.8 7.8 93.5 41.6 39.0 23.7 26.2 0.0 1.8 44.9 44.7 24.8 35.0 64.2 0.0 0.1 0.1 63.3 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 9.8 9.5 10.0 10.6 12.5 11.5 12.8 9.2 11.0 10.4 14.0 11.4 14.1 19.2 6.7 23.2 0.5 14.7 44.7 60.0 9.6 0.7 16.3 23.0 49.1 27.1 22.0 23.9 0.0 34.1 0.1 37.4 37.2 47.0 19.3 29.4 33.0 17.8 21.0 0.0 18.3 80.7 33.8 37.9 20.9 19.6 1.3 22.4 17.9 12.0 12.9 3.3 25.7 26.6 48.8 2.1 13.7 23.9 34.2 5.0 35.6 12.2 37.2 12.8 0.0 58.8 8.2 56.8 25.7 52.6 0.1 28.5 34.1 69.0 27.2 0.8 32.9 23.1 36.2 15.5 10.5 27.1 16.3 14.1 1.6 30.2 49.1 57.3 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193178730-193186613 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;gallbladder: 15.2;heart muscle: 21.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 46.6;Cardiomyocytes: 34.4;Excitatory neurons: 27.6;Inhibitory neurons: 28.3;Leydig cells: 31.7;Peritubular cells: 21.1" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 8.4" "Lineage enriched" "Detected in single" 53 "T-cells: 8.4" "Group enriched" "Detected in some" 4 "AF22: 18.3;ASC TERT1: 8.1;LHCN-M2: 12.6;WM-115: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.2 1.2 10.4 0.7 16.0 0.2 0.3 5.5 15.5 0.2 3.3 1.0 0.9 0.1 1.0 0.6 0.2 15.2 21.2 18.1 10.0 0.9 0.2 1.8 0.2 6.7 8.4 12.1 10.5 0.2 0.0 0.5 0.3 8.1 4.7 1.2 6.7 0.1 5.2 0.1 0.2 3.1 0.1 6.7 0.8 1.3 0.7 9.4 0.0 1.0 0.3 0.9 1.4 0.3 16.5 0.0 0.0 18.3 0.0 0.5 8.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.2 0.0 8.4 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 10.4 16.0 5.5 15.5 18.1 10.0 6.7 8.4 12.1 8.1 6.7 9.4 16.5 0.6 0.0 0.5 1.6 0.9 0.3 0.1 0.0 0.6 46.6 0.0 0.1 34.4 11.5 0.0 1.8 4.2 0.0 0.2 0.1 0.0 0.1 0.0 0.3 1.3 1.1 3.0 0.8 27.6 0.0 0.0 2.0 0.0 0.9 2.5 0.4 0.7 0.1 0.3 8.4 28.3 0.7 0.0 0.6 0.3 0.7 31.7 0.7 0.0 4.7 0.0 2.4 0.0 12.1 9.3 0.5 0.1 21.1 0.4 0.1 3.4 0.1 2.2 6.2 0.0 0.3 1.2 0.0 0.0 0.3 0.3 0.0 4.9 0.3 0.5 0.0 NTNG1 "KIAA0976, Lmnt1" ENSG00000162631 "Netrin G1" Q9Y2I2 1 107140007-107484923 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 65.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 59.7;Excitatory neurons: 122.1;Inhibitory neurons: 162.5;Oligodendrocyte precursor cells: 425.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "thalamus: 65.3" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 48.7;fHDF/TERT166: 25.0;RPTEC TERT1: 27.4;U-138 MG: 21.8;U-251 MG: 16.9;U-87 MG: 24.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "hippocampal formation: 19.7;midbrain: 61.3;pons: 56.0;thalamus: 76.4" HPA065954 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA065954: AB_2685585" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.67e-2)" "unprognostic (9.38e-5)" "unprognostic (1.93e-3)" "unprognostic (9.87e-3)" "unprognostic (3.34e-1)" "unprognostic (8.38e-3)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "unprognostic (2.05e-2)" "unprognostic (3.10e-4)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (1.93e-5)" 1.7 4.4 16.0 0.2 3.9 0.0 0.2 6.2 6.2 2.6 0.0 1.4 0.0 0.6 0.0 0.1 0.4 0.6 0.1 7.2 13.8 8.5 0.0 3.8 0.4 5.0 28.2 4.3 0.4 0.1 0.1 2.5 1.1 5.5 3.4 0.4 10.4 0.2 4.8 0.0 0.9 0.4 0.1 3.0 0.3 0.2 0.4 65.3 0.5 0.1 0.2 0.6 4.0 1.8 5.0 0.0 0.0 2.8 0.0 5.0 48.7 0.0 13.9 2.1 1.2 1.1 0.0 0.0 0.0 0.6 25.0 0.0 0.0 0.0 1.5 2.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 13.9 0.3 3.5 1.8 14.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.0 6.1 0.0 3.1 0.0 27.4 0.0 0.3 0.4 0.0 0.0 0.0 0.8 0.0 0.1 0.2 21.8 4.3 8.1 16.9 0.1 0.0 0.0 24.8 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 16.0 3.9 6.2 6.2 7.2 13.8 5.0 28.2 4.3 5.5 3.0 65.3 5.0 0.2 0.0 0.0 46.4 3.1 0.5 6.5 0.4 0.0 59.7 0.1 0.0 0.9 0.0 0.2 7.3 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.1 0.8 0.9 0.0 0.0 122.1 0.0 0.0 2.8 0.0 0.4 0.0 6.1 0.4 0.0 0.0 0.0 162.5 0.0 6.1 0.0 1.3 1.8 8.1 0.0 1.8 18.7 0.0 1.0 0.0 425.3 2.5 0.3 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.9 6.6 0.2 2.7 0.2 1.1 0.1 0.6 0.0 0.1 7.2 0.0 4.3 FAM102B "DKFZp779B126, SYM-3B" ENSG00000162636 "Family with sequence similarity 102 member B" Q5T8I3 1 108560089-108644900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028451 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028451: AB_10602497" "unprognostic (1.30e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (3.87e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-3)" "unprognostic (3.10e-1)" "unprognostic (2.62e-2)" "unprognostic (1.32e-2)" "unprognostic (2.17e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.47e-6)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" 9.2 4.0 5.6 10.6 9.1 21.4 10.8 5.6 7.6 7.4 1.1 13.5 11.1 6.5 4.2 6.1 5.1 14.8 6.6 8.8 8.9 3.2 5.0 7.9 9.1 5.3 6.7 8.7 5.3 3.8 7.6 3.8 5.9 6.0 6.4 14.8 3.7 13.8 7.9 1.4 3.8 11.3 8.9 4.0 8.8 7.6 8.7 5.5 8.8 3.5 6.1 8.3 16.5 4.4 8.0 6.9 4.9 9.7 5.2 17.0 10.2 6.4 4.0 5.4 6.1 10.3 1.8 6.8 7.6 3.6 10.4 6.3 13.1 33.2 1.4 7.8 5.1 4.8 10.6 35.8 0.8 4.3 14.0 19.8 5.5 1.4 9.0 0.5 12.3 4.0 12.5 26.3 41.2 14.4 28.4 9.0 10.0 7.6 16.2 24.6 20.8 24.5 1.6 1.7 7.9 31.4 9.3 15.9 27.4 8.3 6.8 5.8 22.5 0.7 9.8 18.4 8.6 15.5 7.6 1.9 7.1 14.4 10.8 5.3 2.9 0.4 0.4 0.3 0.9 0.2 0.3 0.3 0.4 1.0 0.3 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.1 5.6 9.1 5.6 7.6 8.8 8.9 5.3 6.7 8.7 6.0 4.0 5.5 8.0 5.9 0.0 2.2 12.1 6.1 6.1 2.3 1.0 4.6 3.9 10.1 7.2 1.9 10.0 2.2 1.8 0.0 2.4 17.2 15.6 1.9 2.7 15.3 2.1 7.8 5.5 7.2 3.8 54.9 6.1 2.7 16.3 6.6 5.2 7.6 3.6 8.2 1.2 9.7 0.0 27.9 8.1 0.0 25.1 43.2 6.9 14.3 27.5 5.4 52.5 15.2 1.2 11.3 25.1 7.2 4.5 10.5 20.7 11.9 1.9 4.5 1.0 1.8 1.1 0.0 3.2 6.5 4.4 6.4 6.5 3.7 3.4 16.4 36.2 13.8 4.6 HENMT1 "C1orf59, FLJ30525, HEN1" ENSG00000162639 "HEN methyltransferase 1" Q5T8I9 1 108648290-108661526 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 72.6" "Group enriched" "Detected in many" 4 "NK-cells: 58.7;Spermatocytes: 178.5;Spermatogonia: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 71.4;MOLT-4: 68.2;NB-4: 75.3;U-937: 98.6" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 19 "cerebellum: 9.1" "HPA028464, HPA028497" Uncertain Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA028464: AB_10600103, HPA028497: AB_10601552" "unprognostic (1.82e-1)" "prognostic favorable (2.56e-4)" "prognostic favorable (9.95e-4)" "unprognostic (2.92e-3)" "unprognostic (1.91e-1)" "unprognostic (3.88e-3)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.95e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.53e-1)" "unprognostic (2.43e-1)" "unprognostic (2.18e-1)" "unprognostic (1.65e-1)" 5.4 3.0 8.5 8.1 9.6 13.4 8.1 7.4 9.2 8.6 6.1 6.6 5.0 4.0 4.8 2.7 2.3 6.6 1.7 9.3 10.3 2.3 2.0 4.8 13.6 8.7 8.8 8.6 5.3 2.1 0.9 5.3 5.7 9.3 3.7 9.6 3.0 3.1 3.4 3.2 3.9 7.7 3.6 8.3 11.1 4.7 72.6 10.6 18.8 2.2 6.2 11.4 6.3 2.0 10.3 16.9 8.5 0.7 0.0 0.7 0.5 0.1 4.0 1.5 9.4 1.5 24.7 26.0 0.0 8.9 7.5 0.0 0.1 0.0 0.2 5.9 5.5 0.0 42.4 31.7 0.0 8.1 25.4 36.4 7.8 0.5 2.1 0.0 0.0 1.9 71.4 0.0 18.5 0.4 42.8 68.2 75.3 24.0 13.5 3.7 29.3 0.0 1.5 0.0 18.0 40.1 0.0 35.3 9.8 0.1 2.4 0.0 55.7 0.5 0.0 31.4 17.5 0.1 11.2 15.0 0.1 0.0 98.6 0.3 43.3 19.7 43.2 61.8 24.0 55.6 12.6 30.0 56.4 24.6 7.1 24.7 45.1 19.6 55.6 29.8 19.5 31.2 39.9 8.5 9.6 7.4 9.2 9.3 10.3 8.7 8.8 8.6 9.3 8.3 10.6 10.3 2.4 0.0 1.1 2.3 5.4 1.7 1.4 6.6 1.2 5.2 8.1 7.1 1.8 14.3 4.0 5.5 0.0 12.8 28.0 4.0 3.9 3.0 12.2 2.2 3.6 3.0 4.9 13.9 5.2 1.3 21.5 5.2 2.6 2.4 7.0 2.9 6.1 0.5 15.8 0.0 3.7 4.0 4.1 11.7 3.3 20.1 5.0 7.5 1.8 3.7 11.2 3.6 58.7 4.0 2.7 2.8 7.4 3.0 8.0 1.2 5.5 0.8 2.8 2.4 6.6 3.0 3.5 178.5 107.7 2.9 1.6 5.2 23.0 8.5 6.1 3.3 AKNAD1 "C1orf62, MGC26989" ENSG00000162641 "AKNA domain containing 1" Q5T1N1 1 108815898-108963484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 4.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 80.6" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.1;hTCEpi: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030270, HPA030271, HPA030272" Uncertain Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Microtubules, Cytokinetic bridge" "HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342" "unprognostic (4.93e-2)" "unprognostic (1.72e-1)" "unprognostic (5.52e-2)" "unprognostic (2.00e-3)" "unprognostic (7.22e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-5)" "unprognostic (8.15e-2)" "unprognostic (5.95e-2)" "unprognostic (2.83e-2)" "unprognostic (1.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.00e-8)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "unprognostic (5.75e-2)" "unprognostic (8.22e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.0 0.0 1.6 0.0 1.5 0.1 0.0 1.8 2.5 0.5 0.9 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 80.6 0.3 5.1 1.4 0.0 0.0 1.0 0.2 0.8 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.7 0.0 0.0 0.3 17.8 2.5 0.1 1.8 0.0 0.0 0.4 0.0 3.5 3.1 0.2 0.0 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.9 0.6 1.4 0.1 0.1 0.7 0.1 0.7 0.5 0.0 C1orf52 "FLJ44982, gm117" ENSG00000162642 "Chromosome 1 open reading frame 52" Q8N6N3 1 85249953-85259672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036072, HPA061790" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036072: AB_10602696, HPA061790: AB_2684610" "unprognostic (1.59e-1)" "unprognostic (2.30e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.37e-5)" "unprognostic (6.67e-3)" "unprognostic (2.95e-2)" "unprognostic (3.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.93e-4)" "prognostic unfavorable (1.17e-7)" "unprognostic (8.01e-2)" "unprognostic (2.54e-1)" "unprognostic (4.14e-1)" "unprognostic (2.05e-2)" 14.3 11.1 11.9 10.3 14.9 23.2 13.5 9.9 16.5 13.6 7.0 12.9 6.3 11.8 7.6 13.2 12.7 6.8 13.7 17.3 10.9 10.5 15.3 14.1 15.4 12.3 12.3 13.7 13.1 13.1 5.3 13.4 12.3 12.3 12.6 6.5 10.8 9.3 7.3 16.4 11.7 11.5 5.2 10.0 14.9 12.1 16.0 12.7 9.8 11.6 10.0 8.6 13.0 13.2 16.0 25.6 12.1 17.3 15.6 18.6 14.4 21.4 20.4 10.6 26.2 23.2 17.2 13.1 20.0 17.2 22.5 14.7 16.1 42.4 12.3 13.0 26.1 25.4 32.2 19.5 15.5 11.3 28.0 14.2 9.4 17.8 24.1 11.9 13.0 9.7 35.2 35.9 23.6 13.0 7.3 27.3 13.8 63.7 12.0 9.8 28.3 18.5 10.8 14.2 7.0 7.3 16.4 5.0 16.3 20.7 17.4 8.8 57.7 16.6 10.6 19.5 27.2 32.8 22.6 46.2 28.3 8.9 21.7 12.9 17.6 18.4 30.0 19.5 28.6 21.1 35.5 18.1 17.2 24.7 19.6 27.5 26.4 30.1 19.7 24.0 26.8 17.3 22.3 11.9 14.9 9.9 16.5 17.3 10.9 12.3 12.3 13.7 12.3 10.0 12.7 16.0 46.7 44.8 34.3 31.3 48.4 145.4 55.0 60.0 56.9 23.5 51.9 50.3 24.3 21.5 46.0 16.5 22.9 61.3 56.3 23.4 19.6 33.3 69.0 36.3 36.1 40.7 38.8 29.0 37.4 27.5 61.1 46.9 23.4 40.9 51.3 25.4 29.6 16.6 37.1 15.2 21.7 25.1 77.3 28.9 81.6 16.8 36.7 32.5 32.0 21.5 25.4 30.8 38.1 23.1 58.6 37.9 24.6 24.5 42.7 53.0 25.9 19.7 34.0 27.1 39.5 27.7 45.6 92.5 67.3 63.9 128.9 67.9 53.4 27.5 24.7 71.5 DNAI3 "DIC3, FLJ30067, NYD-SP29, WDR63" ENSG00000162643 "Dynein axonemal intermediate chain 3" Q8IWG1 1 84999147-85133138 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 22.1;choroid plexus: 20.3;fallopian tube: 14.6;testis: 19.0" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.2" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.3;melanoma: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.4;HBEC3-KT: 4.4;HSkMC: 5.6;hTCEpi: 6.9;LHCN-M2: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038526 Enhanced NA NA "HPA038526: AB_2676063" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.61e-2)" "unprognostic (1.09e-4)" "unprognostic (1.10e-3)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.56e-1)" "unprognostic (2.53e-1)" "unprognostic (1.82e-3)" "unprognostic (2.31e-1)" "unprognostic (1.14e-5)" "unprognostic (8.57e-3)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" 0.2 22.1 6.0 0.4 1.9 0.0 0.2 3.3 1.2 0.9 20.3 0.7 0.2 0.7 4.2 0.3 14.6 0.4 0.5 1.8 6.1 0.7 0.1 1.8 0.4 6.6 7.0 0.0 0.1 0.5 5.7 3.0 0.5 5.6 0.3 0.5 0.7 0.8 0.2 0.1 2.1 0.1 0.4 10.3 0.2 0.2 19.0 3.1 0.8 1.1 2.2 0.2 0.5 0.1 4.4 0.1 0.4 0.1 0.3 3.0 8.4 1.6 1.7 3.4 0.5 0.9 0.0 0.5 0.4 0.0 0.3 2.0 0.0 0.3 4.4 0.7 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 5.6 6.9 2.9 0.2 0.3 0.1 0.5 0.0 0.0 6.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.2 0.1 0.0 0.0 0.2 1.1 1.6 0.0 2.9 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.3 3.3 0.1 1.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 6.0 1.9 3.3 1.2 1.8 6.1 6.6 7.0 0.0 5.6 10.3 3.1 4.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042682, CAB045975" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB045975: AB_10584474, HPA042682: AB_2678113" "prognostic favorable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavorable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favorable (1.10e-5)" 62.1 90.0 3.0 32.1 3.2 8.1 65.2 2.8 4.7 78.4 3.1 81.7 15.2 63.9 11.8 41.5 64.9 22.9 19.3 2.4 8.7 27.3 27.9 90.5 26.4 8.8 3.7 2.2 61.0 7.5 28.1 13.9 8.2 5.8 55.0 18.6 0.5 34.9 20.8 54.3 53.2 62.5 32.1 3.6 51.5 46.3 9.1 5.5 9.4 21.3 16.6 16.0 84.5 65.9 6.4 5.4 0.1 0.0 0.0 19.1 12.5 1.9 2.1 17.0 2.1 6.8 0.0 5.0 0.0 20.3 14.0 14.8 0.7 0.0 0.1 1.3 25.9 0.0 0.1 3.1 1.3 2.6 0.5 0.9 14.1 0.0 5.1 0.0 9.3 18.1 0.0 0.3 0.4 7.4 0.0 0.0 4.3 0.0 4.6 0.1 0.0 7.5 0.0 3.7 21.6 0.0 0.2 7.4 1.5 0.1 0.5 0.1 1.0 13.9 2.7 0.1 3.1 1.5 14.0 0.0 0.0 6.9 0.1 0.1 19.1 31.4 10.9 34.4 42.8 43.3 4.7 32.4 32.9 11.6 3.4 24.3 25.4 139.4 26.7 77.8 0.6 79.1 32.5 3.0 3.2 2.8 4.7 2.4 8.7 8.8 3.7 2.2 5.8 3.6 5.5 6.4 35.4 25.6 34.3 0.7 21.5 46.5 123.5 24.9 18.2 0.2 56.1 30.4 4.1 27.1 27.1 18.4 0.0 40.2 47.7 41.9 0.0 113.9 35.7 59.6 39.7 60.5 10.2 8.2 0.6 73.2 51.2 41.2 18.3 152.4 47.4 2.5 28.2 30.5 33.2 0.0 1.1 15.7 8.2 84.5 29.4 33.3 4.7 81.1 8.8 14.0 60.6 0.5 110.2 1.5 0.1 73.2 25.9 8.6 17.3 80.3 128.3 12.2 27.5 0.2 19.7 81.9 45.2 1.8 4.6 24.9 61.8 57.7 81.8 33.3 15.3 87.0 ATXN7L2 "FLJ00381, MGC46534" ENSG00000162650 "Ataxin 7 like 2" Q5T6C5 1 109483479-109492804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029827, HPA054952" Uncertain Approved "Nucleoli rim,Vesicles,Cytosol" NA NA "Nucleoli rim" "Vesicles, Cytosol" "HPA029827: AB_10602390, HPA054952: AB_2682647" "unprognostic (4.53e-2)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (3.90e-2)" "unprognostic (4.61e-5)" "unprognostic (2.40e-4)" "unprognostic (1.75e-1)" "unprognostic (3.53e-2)" "unprognostic (8.07e-2)" "unprognostic (2.77e-4)" "unprognostic (2.85e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" "unprognostic (8.27e-2)" "unprognostic (3.94e-3)" 1.1 2.7 1.0 0.7 1.1 3.1 1.1 1.0 2.7 1.8 0.3 1.1 0.5 2.0 0.1 1.3 1.4 0.8 1.1 2.2 0.8 2.0 1.8 1.0 0.9 0.9 0.8 1.3 1.9 1.0 0.3 2.1 0.4 1.0 1.2 0.1 0.1 0.9 0.4 7.9 1.6 1.4 0.3 0.5 2.2 1.0 5.3 0.9 1.5 2.2 1.7 0.5 1.3 1.2 1.3 1.8 1.4 0.9 3.6 1.2 2.2 2.5 1.3 1.6 2.6 1.8 3.0 1.2 4.8 2.0 1.6 0.7 2.1 1.9 1.8 0.3 4.4 2.7 2.6 3.0 1.3 0.8 4.0 6.0 2.4 0.9 2.8 0.0 1.1 0.6 5.1 4.5 2.6 0.5 5.8 7.1 5.2 5.6 1.9 2.0 4.9 2.3 3.4 0.9 1.9 8.4 3.4 1.4 4.5 2.2 0.2 0.8 4.1 0.3 1.9 5.5 1.8 5.3 1.7 1.2 4.6 2.2 3.3 4.8 0.0 0.8 1.1 2.3 1.1 2.2 1.0 1.9 2.5 0.6 1.3 1.7 1.6 0.9 1.4 0.8 0.4 1.8 1.0 1.0 1.1 1.0 2.7 2.2 0.8 0.9 0.8 1.3 1.0 0.5 0.9 1.3 1.0 0.0 0.5 5.5 2.4 0.6 1.4 1.3 1.8 3.5 1.4 0.9 1.9 1.5 2.1 1.8 2.1 1.4 1.6 1.4 0.0 1.4 3.5 0.8 2.4 1.3 1.8 0.8 4.7 1.8 1.5 1.7 1.1 1.0 4.5 2.3 1.8 1.1 0.6 3.3 3.9 1.1 2.0 1.2 1.0 1.0 1.2 0.6 0.0 1.0 0.4 0.9 1.0 3.0 1.8 1.5 1.4 1.5 2.9 0.7 0.7 0.6 0.3 2.0 0.0 2.5 4.8 4.2 4.9 1.3 0.9 3.1 2.6 3.5 0.9 0.9 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181144-89198942 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 11.4 5.3 4.1 29.8 4.5 6.6 6.7 4.5 4.8 4.2 2.9 6.6 12.5 8.9 4.6 7.3 9.2 8.8 11.1 3.8 3.3 9.9 14.2 31.5 34.6 6.5 3.6 2.8 16.5 1.7 6.5 2.7 12.0 7.8 5.8 7.3 3.4 7.2 6.8 7.2 2.1 11.9 7.8 3.4 29.2 12.0 2.9 4.8 10.1 7.9 9.5 11.0 13.2 4.6 5.2 0.8 0.0 0.1 0.3 0.1 0.1 0.6 1.8 7.6 8.0 7.2 0.1 12.1 0.6 1.0 2.3 0.6 0.9 0.0 0.3 0.4 9.9 0.1 13.0 0.4 0.3 1.0 0.2 0.3 0.4 0.0 0.1 0.0 1.2 1.9 0.3 0.4 2.3 0.0 0.2 6.6 0.3 0.4 0.1 0.1 11.1 0.2 0.4 0.1 18.3 0.2 0.5 0.3 0.7 0.3 0.6 0.5 1.4 0.4 0.3 1.6 0.2 0.2 16.0 0.3 0.3 0.3 0.1 2.3 0.6 4.1 0.4 7.1 14.1 6.1 2.5 7.6 7.9 2.2 3.3 5.6 5.2 5.6 13.8 14.5 0.9 9.0 5.5 4.1 4.5 4.5 4.8 3.8 3.3 6.5 3.6 2.8 7.8 3.4 4.8 5.2 84.4 32.1 39.3 0.0 28.3 4.6 9.1 20.7 1.8 2.8 3.5 2.4 3.6 8.6 25.3 5.5 8.4 0.9 29.0 5.1 0.0 2.2 1.9 4.8 8.4 81.2 0.0 11.2 0.5 3.3 1.6 22.2 9.2 7.4 21.5 17.9 92.4 6.5 8.3 0.0 2.5 4.3 4.1 29.2 10.9 1.2 3.7 33.7 5.4 15.9 33.8 15.5 36.0 1.0 0.6 36.3 1.9 1.9 7.2 24.4 4.4 1.5 43.3 12.2 0.0 5.3 11.3 2.4 3.4 2.9 3.0 1.5 34.2 122.6 2.4 13.6 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995110-90035533 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 53.1" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favorable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favorable (2.84e-4)" 10.7 9.6 6.3 5.5 7.5 21.2 11.2 9.6 6.4 13.0 6.9 11.4 8.9 12.6 7.5 15.5 11.1 5.4 9.7 7.4 8.1 8.5 12.9 8.5 6.9 7.3 7.0 5.3 17.3 17.2 4.6 10.4 6.3 7.3 9.4 8.6 53.1 13.5 3.9 9.9 10.2 12.7 5.1 7.7 8.1 10.4 6.9 6.6 5.3 11.0 2.4 6.0 9.7 12.5 10.6 9.2 6.9 17.9 7.1 6.1 4.3 16.4 11.1 4.5 6.6 5.0 7.2 8.1 13.3 5.7 5.6 6.3 9.5 10.8 7.2 8.8 5.9 7.2 10.6 14.3 7.0 2.4 12.6 6.1 4.3 4.3 6.8 5.7 8.5 4.6 7.8 11.7 5.8 7.1 4.0 13.3 9.6 11.2 6.1 8.0 11.1 11.1 3.0 6.2 15.5 11.3 10.9 10.1 10.6 5.0 10.2 7.8 4.2 8.0 9.3 7.7 8.3 8.4 7.2 3.8 8.8 2.7 10.1 5.3 1.0 1.1 1.2 0.9 1.4 0.8 0.9 0.8 0.9 0.7 1.5 0.8 1.0 0.8 2.0 1.5 1.7 0.6 0.4 6.3 7.5 9.6 6.4 7.4 8.1 7.3 7.0 5.3 7.3 7.7 6.6 10.6 43.0 22.4 50.9 48.0 40.5 65.1 61.5 43.3 37.0 140.8 35.3 39.0 39.2 28.6 43.4 23.9 373.2 46.4 46.7 81.6 19.6 54.2 5.1 45.0 50.3 43.5 70.3 66.9 29.1 54.8 85.3 35.6 35.2 48.9 51.8 68.4 29.6 35.1 26.1 69.0 35.1 47.8 38.7 19.4 38.2 7.3 43.2 34.0 39.2 28.1 40.9 57.0 28.8 58.8 61.3 47.7 70.6 33.8 33.0 53.8 61.0 19.6 44.6 458.4 26.3 45.0 53.6 58.5 35.8 53.2 45.3 49.4 31.6 71.0 50.0 82.0 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "Helicase for meiosis 1" A2PYH4 1 91260766-91404856 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 9.3;testis: 13.9" "Cell type enhanced" "Detected in some" "Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA035036: AB_2797224, HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.4 0.4 1.3 0.1 0.9 0.2 0.4 4.9 1.1 0.9 0.0 0.4 0.3 2.4 1.1 0.1 0.8 0.2 0.6 0.6 1.8 0.7 0.1 0.2 0.1 1.7 1.4 0.4 3.9 0.7 0.1 9.3 0.5 2.5 0.6 0.3 4.6 0.5 1.2 1.5 0.1 0.2 0.9 1.0 0.4 0.2 13.9 1.1 0.1 1.7 1.1 0.2 0.4 0.3 1.3 0.0 0.1 5.2 2.8 0.0 0.1 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.3 0.1 1.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 2.1 0.0 0.0 0.7 1.4 0.0 0.5 0.0 0.0 0.5 0.5 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 4.9 1.1 0.6 1.8 1.7 1.4 0.4 2.5 1.0 1.1 1.3 0.2 0.0 1.1 50.9 0.0 0.0 0.0 0.0 0.6 3.9 0.1 0.3 3.1 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 0.4 17.8 0.2 1.9 0.4 0.0 2.5 17.6 0.2 0.2 0.6 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 38.4 0.0 0.0 0.0 0.0 5.0 4.1 0.0 0.0 10.3 0.0 2.4 0.0 90.5 9.5 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 6.2 0.0 2.0 1.4 58.9 15.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 BRINP3 "DBCCR1L, DBCCR1L1, FAM5C" ENSG00000162670 "BMP/retinoic acid inducible neural specific 3" Q76B58 1 190097658-190478404 "Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;intestine: 18.0" "Cell type enhanced" "Detected in some" "Astrocytes: 266.7;Excitatory neurons: 333.7;Inhibitory neurons: 129.7;Oligodendrocyte precursor cells: 1079.2" "Group enriched" "Detected in some" 14 "breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054693 Uncertain "Secreted in other tissues" NA NA "HPA054693: AB_2682575" "unprognostic (3.18e-2)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" "unprognostic (8.25e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (9.84e-2)" "unprognostic (4.58e-3)" 0.3 1.8 16.7 0.6 16.6 0.0 1.4 18.6 17.3 0.2 0.0 6.7 4.6 0.3 3.0 1.7 0.4 1.6 5.3 27.0 22.5 2.3 0.0 1.2 0.0 12.1 15.9 13.8 0.0 0.0 0.0 0.2 0.0 13.3 6.8 6.8 0.7 1.6 5.1 0.1 0.1 18.0 0.6 9.8 0.0 0.2 3.4 20.2 0.1 2.2 0.0 0.1 0.5 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 16.6 18.6 17.3 27.0 22.5 12.1 15.9 13.8 13.3 9.8 20.2 14.9 0.0 0.0 0.0 266.7 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.4 2.3 0.0 0.0 3.7 0.0 0.0 0.0 2.0 3.9 0.0 63.3 0.0 0.0 0.1 1.2 0.0 333.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 129.7 2.8 0.0 0.0 0.0 10.5 0.0 0.1 0.0 8.4 0.0 0.0 0.0 1079.2 4.3 0.0 10.8 0.0 0.0 1.0 8.1 0.3 0.0 0.1 0.0 0.0 5.8 2.0 0.7 0.1 0.0 0.0 0.0 0.0 5.2 0.1 GFI1 "GFI-1, GFI1A, ZNF163" ENSG00000162676 "Growth factor independent 1 transcriptional repressor" Q99684 1 92473043-92486925 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 54.2;lymphoid tissue: 31.5" "Cell type enhanced" "Detected in some" "dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB011197 Uncertain NA NA "CAB011197: AB_532302" "unprognostic (5.67e-4)" "unprognostic (8.67e-3)" "prognostic favorable (5.68e-5)" "unprognostic (4.88e-3)" "unprognostic (3.57e-2)" "unprognostic (5.86e-3)" "unprognostic (2.06e-1)" "unprognostic (3.87e-3)" "unprognostic (1.26e-3)" "unprognostic (4.47e-3)" "unprognostic (5.20e-2)" "unprognostic (1.72e-1)" "unprognostic (6.80e-6)" "unprognostic (2.63e-1)" "unprognostic (8.27e-2)" "unprognostic (3.97e-1)" "unprognostic (4.37e-2)" 0.7 0.5 0.1 5.1 0.1 54.2 0.9 0.1 0.2 0.6 0.4 3.6 4.8 0.6 0.5 0.5 0.8 1.9 0.3 0.1 0.1 0.5 1.0 2.8 7.0 0.3 0.2 0.1 0.5 9.5 0.2 0.5 0.2 0.2 0.8 4.6 0.0 1.0 0.3 0.2 0.3 5.8 0.4 0.2 7.1 3.2 0.9 0.2 31.5 0.9 0.0 4.5 1.7 0.6 0.2 1.4 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.1 0.1 1.0 10.3 0.1 0.7 0.0 0.5 0.4 1.2 0.0 0.2 0.0 2.5 1.6 0.2 5.3 0.1 61.9 47.5 0.0 0.0 0.1 0.1 0.3 0.1 17.1 0.4 15.3 0.1 2.1 39.5 64.7 0.0 0.1 0.2 7.8 2.7 3.4 0.0 0.7 0.1 0.1 0.3 0.1 0.3 0.1 0.0 127.7 0.0 0.0 1.5 0.1 0.2 22.2 1.6 4.0 0.0 261.3 0.0 0.0 0.0 0.4 2.1 0.0 1.0 0.0 0.9 1.4 0.0 0.0 0.3 1.9 0.0 0.1 0.0 0.8 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.2 0.2 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.9 0.0 0.1 1.1 0.2 0.0 0.1 1.4 0.0 0.1 0.0 0.1 12.4 0.0 0.8 0.2 0.2 0.0 0.8 0.0 0.0 0.1 0.0 11.3 0.0 0.1 0.4 0.0 0.0 8.6 0.0 0.7 0.1 0.1 0.0 0.0 0.1 0.2 0.5 3.9 0.0 0.0 0.0 16.4 0.1 0.4 0.0 KCNT2 "KCa4.2, SLICK, SLO2.1" ENSG00000162687 "Potassium sodium-activated channel subfamily T member 2" Q6UVM3 1 196225779-196609225 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 3.8" "Group enriched" "Detected in some" 4 "Excitatory neurons: 220.2;Inhibitory neurons: 240.5;Oligodendrocyte precursor cells: 310.7" "Cancer enhanced" "Detected in some" "renal cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 3.2;hTERT-RPE1: 9.0;SCLC-21H: 7.5;SH-SY5Y: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051218 Uncertain Approved Vesicles NA NA Vesicles "HPA051218: AB_2681392" "unprognostic (5.06e-2)" "unprognostic (2.94e-2)" "unprognostic (8.01e-2)" "unprognostic (5.10e-6)" "unprognostic (1.22e-3)" "unprognostic (1.30e-2)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (5.90e-2)" "unprognostic (2.18e-1)" "unprognostic (9.56e-3)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.67e-5)" "unprognostic (3.30e-4)" "unprognostic (2.95e-2)" "unprognostic (4.75e-1)" "unprognostic (1.72e-3)" 0.9 0.6 0.6 0.1 2.2 0.0 0.4 0.0 2.1 0.3 0.8 0.4 0.2 0.3 0.4 1.0 0.5 1.4 1.0 2.6 2.5 0.3 2.8 1.8 0.1 0.2 0.2 1.2 3.8 0.1 0.0 0.9 0.2 0.7 1.0 0.5 0.1 0.5 0.6 0.1 0.2 0.4 0.5 0.3 0.2 0.5 1.1 0.6 0.1 1.1 0.8 0.1 0.8 0.4 0.7 0.0 0.1 1.8 0.0 0.2 0.2 0.0 0.0 1.0 0.1 1.8 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.0 3.2 0.0 0.0 1.2 0.0 0.4 0.1 9.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 2.4 0.0 0.1 0.0 0.1 0.0 0.0 0.5 7.5 5.6 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 0.0 2.1 2.6 2.5 0.2 0.2 1.2 0.7 0.3 0.6 0.7 0.8 41.7 1.1 6.8 0.0 0.4 0.2 0.0 0.6 0.0 0.0 0.1 1.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.2 0.8 0.0 0.0 220.2 0.0 0.0 9.3 0.0 0.0 0.0 6.1 2.5 6.2 0.0 0.0 240.5 0.0 0.0 0.0 0.7 3.3 6.5 0.0 1.8 58.1 0.0 0.0 0.0 310.7 6.1 0.0 0.0 4.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.4 4.0 0.6 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.2 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850361-99924023 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 260.0;tongue: 213.9" "Cell type enhanced" "Detected in all" "Muller glia cells: 160.5;Theca cells: 159.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 450000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: AB_2682455" "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favorable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 12.0 6.8 4.7 7.2 5.5 6.2 9.2 7.5 5.8 6.1 6.0 10.1 8.8 7.4 7.7 16.5 5.5 5.3 23.1 4.3 5.5 13.4 43.2 6.0 7.4 7.1 6.4 3.9 5.9 4.3 17.8 4.6 11.8 5.9 13.9 10.7 23.5 7.8 9.7 260.0 5.3 7.1 9.8 5.4 8.1 7.7 4.7 5.5 7.9 10.6 213.9 8.5 8.9 5.0 6.4 20.4 5.9 7.0 11.4 11.0 10.4 23.4 6.3 9.2 5.5 9.8 22.3 6.8 26.4 11.7 10.8 4.9 11.3 40.5 12.4 10.2 14.2 12.9 15.5 18.9 12.4 7.3 13.7 8.9 12.8 7.9 7.5 6.2 7.5 8.5 9.2 26.3 2.0 5.5 6.2 16.3 4.3 10.9 8.9 7.7 0.0 2.3 1.3 16.3 26.7 17.2 12.1 18.2 17.3 9.9 12.8 12.6 9.0 9.4 6.6 9.3 8.9 6.3 7.3 6.1 30.5 11.7 3.6 3.5 0.0 0.4 1.4 1.5 0.6 1.4 1.0 1.1 1.0 0.9 1.0 1.1 1.1 0.5 2.4 0.3 0.8 1.3 0.8 4.7 5.5 7.5 5.8 4.3 5.5 7.1 6.4 3.9 5.9 5.4 5.5 6.4 12.8 22.4 26.8 96.6 28.5 10.6 18.1 24.6 18.2 34.6 18.8 18.0 119.6 18.6 25.8 16.5 54.2 107.9 18.8 23.2 23.5 13.7 1.2 18.8 23.6 13.9 16.8 15.6 45.6 12.9 20.3 28.5 31.1 18.6 10.8 45.0 14.6 111.0 17.9 52.2 56.0 15.8 12.2 19.1 8.8 2.5 10.2 13.5 16.0 23.4 14.1 160.5 21.6 36.2 34.4 17.7 14.3 21.4 20.4 13.0 15.2 19.2 26.0 46.9 6.6 41.4 18.4 8.7 11.9 40.0 9.2 29.1 25.7 159.1 23.5 20.1 VCAM1 CD106 ENSG00000162692 "Vascular cell adhesion molecule 1" P19320 1 100719742-100739045 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 392.7" "Cell type enhanced" "Detected in many" "Ductal cells: 142.6;Hepatic stellate cells: 94.9;Kupffer cells: 561.9;Proximal tubular cells: 188.4;Theca cells: 186.8" "Cancer enriched" "Detected in all" 8 "renal cancer: 89.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 164.7;HSkMC: 111.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000154, HPA034796, HPA069867" Enhanced Approved "Cell Junctions" NA NA 624000000 1300000000 "Cell Junctions" "CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215" "unprognostic (2.96e-1)" "prognostic favorable (3.82e-4)" "unprognostic (1.31e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.19e-5)" "unprognostic (1.60e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (3.95e-2)" "unprognostic (8.23e-2)" "unprognostic (1.80e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.55e-2)" 22.3 43.6 4.4 35.1 3.3 8.4 15.2 5.5 4.9 6.7 9.1 15.1 15.6 9.5 2.5 7.7 9.9 29.8 7.4 2.8 8.4 63.9 44.1 18.2 97.1 6.5 6.8 1.8 39.8 13.4 18.5 7.1 43.6 7.0 9.8 23.7 1.6 8.8 5.6 3.1 3.6 14.5 11.1 5.7 392.7 14.5 5.4 9.0 24.8 7.4 6.4 76.6 73.4 5.5 7.2 0.0 0.0 0.8 0.3 0.6 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.1 25.7 0.0 0.0 0.0 0.0 164.7 0.2 0.0 111.0 0.0 29.3 0.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.3 5.5 4.9 2.8 8.4 6.5 6.8 1.8 7.0 5.7 9.0 7.2 9.6 0.0 5.6 0.0 1.7 9.9 0.5 0.4 0.0 0.1 0.9 0.6 1.9 0.0 0.2 3.7 0.0 1.3 1.1 0.0 9.8 142.6 0.3 0.7 14.0 40.3 0.0 2.7 0.0 3.2 1.2 60.1 0.0 0.8 1.3 7.5 94.9 3.2 3.6 0.0 0.0 0.0 0.0 561.9 15.9 0.0 17.1 7.9 1.8 6.5 0.0 4.0 0.0 0.0 0.1 2.3 1.1 7.5 0.9 1.3 0.0 188.4 1.5 0.0 0.0 5.5 19.2 0.1 2.3 0.4 7.4 2.7 10.0 186.8 0.1 0.4 EXTL2 ENSG00000162694 "Exostosin like glycosyltransferase 2" Q9UBQ6 1 100872372-100895179 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 214.1;Theca cells: 328.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020716, HPA068921" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 80000000 Nucleoplasm Cytosol "CAB020716: , HPA068921: AB_2686058" "unprognostic (3.14e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-2)" "unprognostic (8.20e-2)" "unprognostic (9.07e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (6.84e-2)" "unprognostic (7.83e-2)" "unprognostic (1.24e-2)" "unprognostic (4.34e-2)" 8.9 24.8 12.6 5.0 14.2 2.2 11.6 13.4 17.1 14.0 18.0 9.2 4.8 18.3 13.8 6.6 11.0 11.5 9.3 11.6 15.7 12.2 12.7 8.5 4.2 13.7 15.6 10.5 19.8 9.0 14.8 13.0 25.1 13.9 13.5 7.7 14.0 7.2 12.0 6.9 6.6 5.4 17.2 12.1 6.5 7.4 10.8 18.3 8.3 10.2 7.2 3.8 9.3 6.9 17.1 13.0 6.9 50.2 50.7 53.2 39.3 31.4 23.2 37.5 17.5 39.4 6.1 9.9 15.2 21.8 20.9 13.5 12.7 18.3 19.6 35.4 31.8 13.4 19.0 23.6 18.3 17.5 28.9 9.3 47.3 6.8 35.9 6.6 36.5 65.0 19.2 23.9 2.0 45.1 6.9 15.5 15.5 62.2 12.2 15.5 11.2 51.5 12.1 18.4 9.7 20.6 57.5 17.4 4.6 42.0 35.8 10.9 12.7 27.7 44.0 25.8 27.8 24.4 15.5 15.0 9.8 69.2 29.3 14.4 2.0 0.5 0.0 3.4 0.7 1.5 1.2 1.1 2.3 1.7 1.7 1.2 2.7 0.1 3.9 0.5 4.6 0.0 1.2 12.6 14.2 13.4 17.1 11.6 15.7 13.7 15.6 10.5 13.9 12.1 18.3 17.1 12.3 12.8 8.4 39.8 4.9 8.5 10.2 13.8 21.1 20.7 13.2 13.5 12.7 10.0 11.0 14.7 35.5 214.1 5.0 3.3 11.7 5.8 45.3 20.3 28.7 13.1 9.5 16.2 47.1 2.1 36.9 36.0 15.3 11.0 17.7 35.3 13.6 16.4 24.3 3.3 49.9 5.6 12.2 7.3 5.7 34.9 25.1 5.8 23.2 12.2 7.4 18.8 8.2 40.7 32.9 2.4 2.6 34.6 5.9 6.2 2.9 11.9 25.3 19.7 13.1 25.4 22.4 37.1 12.3 8.5 8.1 74.3 6.1 328.5 7.1 4.9 SLC30A7 "ZNT7, ZnTL2" ENSG00000162695 "Solute carrier family 30 member 7" Q8NEW0 1 100896076-100981757 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018034 Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA018034: AB_1857089" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (8.05e-3)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "unprognostic (3.18e-1)" "unprognostic (2.89e-3)" "unprognostic (1.24e-1)" "unprognostic (1.61e-1)" "unprognostic (1.11e-3)" "unprognostic (2.78e-2)" "unprognostic (1.95e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (3.37e-1)" 6.5 6.8 2.9 7.3 3.2 6.8 6.6 3.9 3.6 7.3 6.5 5.9 6.6 4.7 7.8 5.0 4.6 6.7 3.8 2.9 4.6 5.4 10.3 9.4 7.5 3.1 3.3 2.8 4.6 8.0 6.8 5.7 8.8 3.2 6.0 7.1 4.8 8.7 3.6 2.6 6.2 6.1 4.4 3.2 7.2 7.7 3.0 3.3 7.1 6.9 2.1 7.0 7.9 5.4 4.1 11.3 5.2 6.1 12.5 16.5 14.9 16.2 8.5 17.0 7.3 9.4 5.3 7.7 5.0 17.2 14.1 4.9 10.7 6.5 11.1 12.7 6.4 4.7 8.5 8.4 11.4 19.5 11.7 7.6 17.3 8.4 12.9 18.9 10.9 15.3 8.4 4.9 15.9 12.5 4.4 9.4 8.1 7.7 5.6 5.5 4.2 10.8 5.8 10.6 10.0 3.3 7.4 11.4 15.8 12.2 5.3 6.7 8.1 17.9 18.2 6.3 19.9 13.7 14.0 5.7 4.6 23.1 11.1 5.7 8.3 5.8 4.2 5.2 6.6 4.9 2.7 5.3 4.8 3.9 2.5 5.5 5.7 2.7 3.5 8.7 3.9 4.3 3.1 2.9 3.2 3.9 3.6 2.9 4.6 3.1 3.3 2.8 3.2 3.2 3.3 4.1 28.3 32.1 21.6 32.3 26.3 57.4 19.7 22.8 21.1 10.1 25.8 13.2 6.1 20.0 22.1 23.9 6.2 32.6 24.5 24.1 1.9 24.1 0.9 14.9 27.0 34.5 22.8 11.6 44.8 26.4 24.3 29.1 29.0 29.4 37.4 16.3 33.5 44.6 22.1 5.0 39.6 38.3 14.2 37.0 39.1 1.1 17.1 28.5 32.0 34.7 29.6 6.5 28.8 52.8 59.2 36.0 27.9 16.6 48.1 46.0 20.7 15.7 23.5 13.7 6.6 30.2 20.9 11.4 9.2 19.3 63.9 41.7 28.8 34.8 24.3 32.7 ZNF281 ZBP-99 ENSG00000162702 "Zinc finger protein 281" Q9Y2X9 1 200404940-200410056 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051228 Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051228: AB_2681396" "unprognostic (3.13e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.50e-1)" "unprognostic (8.99e-3)" "unprognostic (1.23e-1)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" "unprognostic (3.71e-3)" "unprognostic (8.30e-2)" "unprognostic (3.69e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.26e-2)" "unprognostic (4.86e-1)" "unprognostic (6.19e-2)" "unprognostic (1.83e-1)" 7.7 3.4 7.0 10.8 11.7 33.9 8.0 11.1 10.7 7.0 4.6 4.5 5.5 7.0 3.9 3.3 4.3 10.2 4.3 7.5 8.5 7.1 21.8 7.5 11.4 8.9 9.4 5.9 5.8 5.7 5.7 2.7 9.0 10.1 4.8 4.3 10.8 5.6 4.3 5.8 2.7 4.1 9.0 7.8 9.8 5.1 9.7 8.9 12.8 5.1 8.0 11.8 7.9 2.0 21.1 19.9 19.8 27.2 12.5 10.8 14.5 22.2 21.0 33.3 21.0 19.6 19.7 15.7 29.0 11.6 24.2 24.4 13.4 29.6 19.7 24.9 30.6 17.5 23.6 15.6 20.4 11.6 21.3 12.9 14.1 21.9 22.6 24.5 26.2 19.1 15.6 33.9 4.6 21.5 9.8 22.5 13.8 61.1 6.3 17.1 20.6 18.8 17.2 21.7 10.3 9.2 24.4 21.1 13.8 18.6 42.4 27.0 15.4 25.7 38.1 28.2 8.7 22.3 16.8 17.8 37.0 20.2 16.8 20.5 15.2 8.1 30.3 9.9 8.5 9.7 10.7 8.3 10.4 8.0 9.1 13.6 11.9 38.1 8.1 8.3 8.3 10.9 3.4 7.0 11.7 11.1 10.7 7.5 8.5 8.9 9.4 5.9 10.1 7.8 8.9 21.1 30.2 64.1 40.3 7.2 35.1 48.2 26.2 24.0 37.5 55.1 46.3 26.9 14.5 28.6 25.9 27.6 29.2 15.4 24.6 13.8 13.7 22.1 2.6 21.6 37.1 38.9 26.8 22.9 16.0 10.5 31.0 21.2 11.2 41.4 6.3 16.3 30.0 76.9 19.6 18.5 19.6 11.4 8.2 52.1 25.8 3.6 9.9 43.5 23.2 15.0 30.6 15.5 26.8 22.6 59.4 17.8 13.3 7.9 31.7 25.4 10.9 20.3 20.5 37.0 13.1 21.1 32.9 50.1 42.4 18.9 22.7 12.3 29.5 14.2 12.9 20.4 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635783 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA 3300000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 86.9 49.7 13.6 149.6 18.2 69.7 49.2 19.7 24.0 46.9 16.8 105.7 100.4 70.1 15.8 78.5 52.4 53.4 36.0 19.0 23.5 39.3 64.8 104.0 160.2 32.0 19.4 11.1 30.8 52.1 30.1 19.9 109.1 25.1 46.4 69.6 8.1 46.3 36.2 18.8 42.5 118.4 79.6 23.4 121.9 89.4 38.8 20.5 131.7 46.4 22.7 132.3 76.6 52.3 31.5 313.4 167.7 141.0 98.1 114.0 161.5 338.7 419.7 317.9 176.3 143.0 150.9 215.9 284.9 463.9 241.7 114.6 211.2 101.1 141.6 93.9 413.6 87.1 172.9 212.6 132.6 185.2 254.8 325.0 197.6 148.2 215.7 170.3 201.2 213.7 196.1 133.3 229.1 233.9 125.6 238.5 67.9 133.7 238.5 63.0 219.2 126.3 278.6 97.3 158.7 61.1 164.7 435.8 186.1 167.3 147.1 185.2 222.5 480.9 259.0 134.5 293.8 410.1 270.1 321.8 196.2 204.5 179.6 204.6 1221.0 987.7 1563.7 395.7 1110.1 315.7 338.3 382.3 407.1 838.9 339.7 409.4 415.4 1852.1 392.6 1267.7 394.3 512.4 1913.3 13.6 18.2 19.7 24.0 19.0 23.5 32.0 19.4 11.1 25.1 23.4 20.5 31.5 148.7 375.0 188.9 8.1 163.3 249.1 178.3 275.9 91.0 34.2 79.9 118.9 30.2 150.2 197.6 82.8 14.6 475.1 227.4 283.5 166.3 344.3 35.5 78.8 211.4 186.7 202.0 90.0 21.6 280.2 734.2 166.2 87.1 119.8 258.8 147.7 181.7 87.4 608.5 38.7 13.8 146.6 238.0 556.3 740.8 24.2 125.9 558.5 254.3 20.6 635.1 56.7 423.3 7.5 51.5 381.6 234.5 183.6 132.1 182.6 213.6 152.0 95.2 25.4 243.3 83.9 286.8 151.9 137.3 161.5 244.9 199.5 234.4 144.4 155.4 234.6 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 155.6;placenta: 81.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 146.4;Excitatory neurons: 35.5;Fibroblasts: 39.5;Horizontal cells: 35.3;Inhibitory neurons: 40.5;Muller glia cells: 39.4" "Cancer enriched" "Detected in many" 4 "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 65.0;HSkMC: 218.8;hTERT-HME1: 118.5;WM-115: 60.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Supported "Intracellular and membrane" NA NA 800000 "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (5.75e-4)" 15.1 8.0 101.0 15.2 121.1 0.1 9.2 155.6 132.6 27.8 3.4 23.3 4.4 3.9 1.4 11.7 9.3 6.2 11.7 131.8 94.5 2.1 0.6 5.1 14.5 87.1 90.4 135.7 1.5 2.3 0.2 31.3 81.3 91.6 5.2 14.6 67.4 6.0 4.7 2.4 13.1 15.9 6.2 62.5 13.4 11.2 3.0 91.0 1.2 7.3 6.6 9.9 16.3 31.2 83.6 0.0 0.0 0.6 0.0 4.2 1.2 0.0 0.0 0.0 9.4 1.8 0.0 0.0 0.1 0.5 0.0 0.1 0.1 0.0 0.0 3.8 0.0 0.0 3.7 0.0 0.0 65.0 0.0 0.2 218.8 0.0 0.1 118.5 0.0 5.3 0.0 0.0 0.2 2.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.1 4.1 0.0 0.0 5.0 0.0 0.1 9.1 0.0 32.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.0 121.1 155.6 132.6 131.8 94.5 87.1 90.4 135.7 91.6 62.5 91.0 83.6 4.2 0.0 0.5 11.4 0.0 6.6 0.1 0.0 0.6 146.4 0.1 0.8 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.0 0.0 0.2 8.0 0.0 0.0 35.5 0.0 0.8 39.5 0.5 0.0 0.0 0.0 3.6 0.0 1.2 35.3 40.5 0.0 0.0 0.0 10.7 8.3 0.6 0.3 24.9 1.9 0.0 39.4 0.0 18.6 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.6 0.0 16.3 3.6 3.1 2.6 0.3 4.3 0.7 0.6 0.0 0.0 0.1 NLRP3 "AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS, FCU, MWS, NALP3, PYPAF1" ENSG00000162711 "NLR family pyrin domain containing 3" Q96P20 1 247416156-247449108 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" Activator "Amyloidosis, Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 54.3" "Cell type enriched" "Detected in many" 6 "Macrophages: 254.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 129.4" "Group enriched" "Detected in many" 23 "dendritic cells: 37.3;granulocytes: 129.4;monocytes: 35.6" "Cell line enriched" "Detected in some" 4 "THP-1: 78.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012878 Uncertain "Intracellular and membrane" NA NA "HPA012878: AB_1846752" "unprognostic (3.56e-2)" "unprognostic (1.33e-1)" "unprognostic (6.23e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (7.86e-2)" "unprognostic (4.46e-2)" "unprognostic (3.84e-1)" "unprognostic (7.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" "unprognostic (4.88e-3)" "unprognostic (2.17e-4)" "unprognostic (1.10e-1)" "unprognostic (6.10e-2)" 8.4 1.4 1.0 10.1 0.7 54.3 3.5 0.9 0.8 1.8 1.1 1.5 0.8 0.9 0.4 2.7 1.4 6.5 0.8 0.8 1.6 0.6 2.1 4.6 2.5 1.8 1.1 0.3 0.7 1.6 0.9 0.5 3.4 1.8 0.8 1.8 0.3 0.8 0.7 0.5 0.4 2.4 4.8 2.2 4.6 1.4 0.3 1.2 1.7 1.0 0.5 1.7 6.4 0.4 2.5 7.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.2 0.4 0.0 0.3 0.0 0.3 0.0 0.5 0.0 0.0 2.2 2.9 0.5 0.0 1.3 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 13.8 0.0 0.0 0.4 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 78.4 0.1 3.2 2.5 0.0 0.2 0.0 0.0 0.0 7.2 18.9 2.4 129.4 35.6 0.2 0.6 21.7 1.7 0.0 2.9 1.2 37.3 0.1 1.1 0.7 8.6 0.0 11.5 1.8 0.1 12.2 1.0 0.7 0.9 0.8 0.8 1.6 1.8 1.1 0.3 1.8 2.2 1.2 2.5 2.2 0.0 0.5 0.3 2.6 1.0 0.1 0.0 0.6 0.3 0.6 1.1 0.6 0.0 0.0 0.0 0.0 0.7 6.0 0.0 0.0 0.0 0.3 0.1 0.5 2.3 0.0 1.7 2.6 0.0 0.4 1.2 1.5 0.1 2.5 0.2 0.4 0.3 16.2 0.0 1.2 0.2 0.0 35.4 41.4 0.2 0.0 254.2 0.0 17.8 14.5 0.7 1.0 1.0 0.4 0.1 0.0 0.4 4.0 0.0 0.0 0.2 0.0 0.4 0.0 1.0 1.1 0.4 0.4 1.3 0.6 1.4 10.2 0.1 0.0 0.0 ZNF496 "MGC15548, ZKSCAN17, ZSCAN49" ENSG00000162714 "Zinc finger protein 496" Q96IT1 1 247297412-247331846 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025824 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025824: " "unprognostic (1.88e-3)" "unprognostic (3.31e-2)" "unprognostic (2.48e-2)" "unprognostic (1.23e-1)" "unprognostic (5.87e-2)" "unprognostic (6.88e-2)" "unprognostic (3.72e-3)" "unprognostic (3.31e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (6.41e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-3)" "unprognostic (8.24e-2)" "unprognostic (1.86e-1)" "unprognostic (2.25e-2)" "unprognostic (2.55e-1)" 8.4 6.1 7.2 5.4 7.5 6.9 8.2 6.6 8.1 12.8 6.5 9.8 3.8 14.4 5.5 5.6 14.9 7.9 9.1 6.8 7.1 8.1 3.7 8.6 7.0 7.2 7.2 6.4 18.9 15.5 11.4 6.4 9.9 7.2 9.4 5.7 5.8 7.8 8.5 15.7 5.5 6.9 11.6 6.7 9.3 9.1 10.9 7.4 24.0 12.4 13.8 5.5 9.3 8.1 7.9 20.8 18.7 19.4 23.7 7.5 19.1 24.2 9.5 23.5 20.9 18.8 10.3 18.9 5.9 16.1 15.6 7.8 17.4 20.1 18.3 20.8 16.0 4.8 19.2 13.1 11.8 20.3 23.5 9.5 20.4 19.0 16.2 38.9 23.2 25.1 27.3 34.6 14.5 13.1 13.3 23.4 16.2 39.0 9.2 27.5 22.0 21.2 8.1 12.8 24.8 16.5 36.4 12.7 14.3 19.0 17.6 14.9 28.7 17.4 15.1 21.4 6.9 30.2 16.1 13.8 16.8 6.3 1.6 16.8 0.0 0.4 0.1 0.8 0.3 1.2 0.3 0.3 0.9 1.1 0.4 0.7 2.1 0.1 1.1 0.4 0.7 0.1 0.8 7.2 7.5 6.6 8.1 6.8 7.1 7.2 7.2 6.4 7.2 6.7 7.4 7.9 9.2 0.0 3.2 16.3 3.3 3.7 4.4 5.0 8.0 7.4 7.0 7.5 8.3 5.7 4.7 1.8 2.1 4.8 2.4 1.2 1.9 4.4 11.2 4.9 7.5 7.5 4.9 3.0 13.0 6.0 5.8 6.8 7.1 6.5 3.8 13.7 7.1 2.3 6.0 3.3 16.9 2.5 2.0 5.1 3.6 40.0 5.6 4.0 3.6 9.4 3.4 1.7 5.2 18.6 10.8 4.9 2.6 7.2 7.5 7.5 0.8 3.0 3.9 7.3 6.6 9.7 6.2 15.9 10.8 2.4 3.4 4.2 4.7 7.5 4.3 4.3 TRIM58 BIA2 ENSG00000162722 "Tripartite motif containing 58" Q8NG06 1 247857187-247880138 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 32.5;thyroid gland: 15.3" "Cell type enriched" "Detected in many" 23 "Erythroid cells: 456.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 18.3;HEL: 40.7;K-562: 21.8;PC-3: 37.0;U-2 OS: 29.0;WM-115: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023637 Uncertain NA NA "HPA023637: AB_1858309" "unprognostic (3.85e-1)" "unprognostic (5.24e-3)" "unprognostic (7.00e-2)" "unprognostic (6.52e-4)" "unprognostic (1.46e-1)" "unprognostic (3.47e-2)" "unprognostic (1.10e-1)" "unprognostic (4.14e-5)" "unprognostic (3.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (3.31e-1)" "unprognostic (1.08e-2)" "unprognostic (3.34e-1)" "unprognostic (1.00e-2)" "unprognostic (2.57e-2)" 0.5 0.6 1.4 0.6 0.8 32.5 0.5 0.2 1.4 0.4 1.3 1.2 0.1 0.2 0.1 0.1 1.3 0.3 0.2 0.6 2.8 0.2 0.2 1.3 0.2 3.0 3.2 0.7 0.0 0.2 0.1 0.2 5.8 3.6 1.5 0.9 0.6 0.3 0.2 0.2 0.9 0.3 0.6 1.1 2.4 0.4 2.7 2.7 0.3 15.3 1.6 0.1 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.7 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.4 1.7 18.3 0.0 0.0 0.0 1.3 40.7 0.0 0.0 0.0 5.5 2.4 0.0 0.0 0.2 0.0 0.0 0.0 1.4 21.8 0.1 0.0 0.0 0.2 0.3 2.7 0.0 37.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.2 4.7 0.0 0.0 29.0 0.0 0.0 6.3 0.0 0.0 0.0 13.0 42.1 0.7 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.6 1.4 0.8 0.2 1.4 0.6 2.8 3.0 3.2 0.7 3.6 1.1 2.7 3.3 0.6 3.2 3.0 0.3 1.7 1.0 1.4 0.0 0.6 3.4 1.1 0.3 0.5 0.0 5.6 1.8 12.5 3.3 0.4 0.8 0.0 0.1 4.3 2.5 0.7 1.7 1.2 456.4 3.7 0.0 4.6 3.0 0.0 2.1 8.2 0.4 1.8 0.1 2.4 0.0 1.8 0.4 0.0 3.2 1.4 1.2 0.9 19.4 1.8 0.0 1.0 2.7 2.1 0.5 0.3 0.2 0.7 0.7 0.3 4.0 0.0 0.2 3.7 3.7 0.0 0.9 0.7 2.8 9.7 0.1 0.9 4.9 1.7 0.3 0.8 0.8 SLAMF9 "CD2F-10, CD84-H1, SF2001" ENSG00000162723 "SLAM family member 9" Q96A28 1 159951492-159954237 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Langerhans cells: 53.9;Late spermatids: 38.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 2.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.7;HEL: 5.1;PC-3: 2.0;SK-MEL-30: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035153 Uncertain NA NA "HPA035153: AB_10670586" "unprognostic (1.05e-1)" "unprognostic (1.54e-5)" "unprognostic (6.12e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (7.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" "unprognostic (2.46e-1)" "unprognostic (3.54e-4)" "unprognostic (5.27e-4)" "unprognostic (5.47e-2)" "unprognostic (6.17e-5)" "unprognostic (8.97e-3)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" 0.3 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 2.0 0.5 0.4 0.8 0.0 0.7 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 1.5 0.4 9.4 0.0 0.0 1.0 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.7 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 2.8 6.8 0.0 0.0 0.0 0.0 1.3 53.9 38.5 0.3 7.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.9 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.7 OR2M5 OR2M5P ENSG00000162727 "Olfactory receptor family 2 subfamily M member 5" A3KFT3 1 248145148-248146086 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ9 "GIRK3, Kir3.3" ENSG00000162728 "Potassium inwardly rectifying channel subfamily J member 9" Q92806 1 160081538-160090563 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 69.9;choroid plexus: 27.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.9;Excitatory neurons: 23.5;Horizontal cells: 8.4;Inhibitory neurons: 12.6;Oligodendrocytes: 8.3" "Cancer enriched" "Detected in single" 35 "glioma: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070478 Enhanced NA NA "HPA070478: AB_2686270" "unprognostic (2.35e-1)" "unprognostic (6.53e-2)" "unprognostic (2.17e-2)" "unprognostic (4.73e-1)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (1.66e-1)" "unprognostic (3.33e-2)" "unprognostic (2.64e-1)" "unprognostic (3.29e-1)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-2)" "unprognostic (2.66e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (5.24e-2)" 0.0 0.3 58.6 0.0 57.2 0.0 0.0 69.9 65.0 0.0 27.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 45.3 0.0 0.0 0.0 0.0 47.4 58.3 57.0 0.0 0.0 0.0 2.1 0.0 53.9 0.0 0.0 7.5 0.0 0.0 0.0 0.1 0.0 0.0 41.8 0.0 0.1 0.4 66.6 0.0 0.0 0.0 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.6 57.2 69.9 65.0 62.0 45.3 47.4 58.3 57.0 53.9 41.8 66.6 66.6 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.9 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.0 8.4 12.6 0.0 0.0 0.3 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.7 0.0 1.5 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.1 0.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.6" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 219.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 177.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles NA NA 280000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 20.8 19.2 85.5 14.2 101.4 3.8 26.9 86.3 131.7 25.8 35.2 27.3 26.8 20.0 22.9 22.5 28.4 12.4 28.7 99.9 89.2 35.7 54.3 23.8 16.9 103.9 93.9 99.8 37.8 32.1 15.9 30.9 11.3 100.4 26.6 10.5 14.4 30.3 18.3 12.5 50.7 28.7 7.0 87.7 24.4 27.7 33.6 88.1 13.7 28.8 7.1 8.9 20.5 25.2 149.6 26.8 15.7 20.1 51.3 11.6 7.3 42.9 12.9 16.8 26.9 25.0 17.9 17.9 39.0 47.1 18.8 23.4 50.3 8.2 18.9 3.8 47.3 15.0 5.1 17.3 31.2 19.2 13.5 41.7 9.0 37.7 17.5 5.6 19.0 5.6 42.0 7.0 21.8 6.3 25.4 33.8 31.3 42.4 55.6 24.8 19.1 10.3 28.7 24.7 27.4 8.5 36.6 14.8 47.4 177.6 17.5 33.7 17.3 5.8 11.8 25.4 21.5 10.6 59.6 71.2 17.7 41.6 5.3 31.6 0.1 5.2 2.4 22.0 7.2 19.5 19.6 18.0 25.6 5.8 22.7 23.4 25.7 1.4 9.2 4.7 9.9 26.9 11.3 85.5 101.4 86.3 131.7 99.9 89.2 103.9 93.9 99.8 100.4 87.7 88.1 149.6 12.2 9.6 3.3 18.3 21.1 43.7 30.2 43.1 26.2 55.6 28.0 29.2 3.3 17.2 16.7 38.6 10.4 32.8 15.1 36.1 5.9 34.2 3.8 12.0 7.2 7.8 19.9 7.4 65.3 12.4 219.7 22.4 6.6 26.4 10.2 12.2 13.2 28.8 14.9 65.6 43.8 24.7 44.7 4.3 16.2 1.1 16.8 8.5 42.7 9.4 51.5 75.7 10.3 9.0 107.2 20.6 39.5 15.8 20.0 22.0 47.6 15.8 6.0 11.8 6.6 39.8 15.3 4.0 6.6 21.0 62.4 69.4 19.5 13.6 32.6 26.0 DDR2 "NTRKR3, TKT, TYRO10" ENSG00000162733 "Discoidin domain receptor tyrosine kinase 2" Q16832 1 162631373-162787405 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Osteogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 89.8;Fibroblasts: 116.5;Leydig cells: 63.0;Peritubular cells: 88.4;Skeletal myocytes: 98.2;Smooth muscle cells: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 233.3;ASC TERT1: 214.4;BJ hTERT+: 163.4;fHDF/TERT166: 137.6;HSkMC: 157.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070112 Approved "Plasma membrane,Actin filaments" Yes No 770000 "Plasma membrane, Actin filaments" "HPA070112: AB_2686229" "unprognostic (4.12e-2)" "unprognostic (2.73e-1)" "unprognostic (6.97e-3)" "unprognostic (4.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.16e-2)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (6.62e-2)" "unprognostic (2.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.73e-7)" "unprognostic (1.56e-3)" "unprognostic (8.26e-3)" "unprognostic (7.57e-2)" "unprognostic (4.10e-3)" 60.3 64.8 12.7 15.9 11.3 0.3 25.5 12.1 10.0 34.0 45.1 42.8 5.9 26.4 13.3 18.2 22.5 24.0 18.1 12.4 25.0 6.5 5.4 14.6 9.1 37.8 16.7 6.6 37.7 3.7 2.6 5.4 10.7 27.9 17.5 14.2 5.1 9.9 29.4 4.9 8.8 17.7 43.2 18.8 5.9 20.6 4.0 21.4 3.4 13.0 19.5 6.9 23.4 23.8 27.2 0.3 0.0 0.2 63.2 233.3 214.4 1.0 92.2 163.4 41.5 56.8 0.0 0.2 0.0 0.1 137.6 8.9 0.1 0.3 0.4 54.0 42.9 0.3 0.0 0.4 0.1 103.9 0.2 0.2 157.0 0.4 73.1 2.2 65.8 46.0 0.4 0.6 16.8 36.9 0.1 0.0 0.3 0.4 0.1 0.3 0.1 24.1 0.7 0.2 0.2 0.3 35.4 0.2 0.1 2.9 3.6 0.2 0.3 2.1 58.5 13.8 29.1 12.6 2.6 4.0 0.1 56.3 0.1 62.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 11.3 12.1 10.0 12.4 25.0 37.8 16.7 6.6 27.9 18.8 21.4 27.2 23.4 3.2 2.3 53.2 2.5 12.6 3.9 0.8 1.2 3.0 6.0 15.6 31.3 1.5 1.1 0.0 0.0 0.5 1.7 3.2 0.0 0.4 8.9 5.0 89.8 22.3 1.2 0.0 13.1 1.8 0.5 116.5 2.6 8.2 1.3 16.7 30.0 3.5 1.2 0.0 26.2 1.0 0.0 1.9 19.3 7.1 63.0 3.1 23.2 29.0 0.0 16.5 2.1 6.0 5.6 1.8 4.4 88.4 5.6 5.9 1.2 2.1 2.4 3.0 39.5 98.2 78.3 1.0 0.9 2.0 8.7 1.0 2.5 34.2 0.8 4.2 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205380-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1174.0;choroid plexus: 647.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8" "Cancer enhanced" "Detected in all" "glioma: 466.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 78.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Supported Nucleoplasm,Cytosol NA NA 300000 Cytosol Nucleoplasm "HPA028356: AB_10602814, HPA070820: AB_2732166" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 191.9 82.9 881.7 122.8 921.0 16.8 143.9 927.8 957.2 108.7 647.6 118.0 32.0 125.5 84.1 120.2 105.1 89.0 225.7 883.4 920.8 101.9 41.6 149.2 76.1 1024.2 966.2 843.0 81.1 39.9 86.1 80.6 103.1 990.3 113.2 59.1 465.5 81.4 120.5 61.6 102.2 65.3 196.3 1012.8 104.1 76.4 81.1 932.4 41.1 84.2 85.2 97.7 134.6 111.1 1174.0 139.2 46.8 190.5 82.5 344.5 191.5 63.6 593.2 503.3 471.6 328.5 103.7 72.3 63.4 210.9 729.4 226.6 146.4 71.5 181.7 365.3 34.4 40.2 52.4 32.5 26.7 423.9 17.8 62.0 161.8 100.7 260.2 328.5 259.6 360.7 45.7 55.1 111.8 640.6 68.3 21.0 41.1 127.0 160.9 134.3 34.4 200.6 43.8 173.0 71.0 38.0 100.0 310.4 207.6 179.9 409.4 128.1 122.6 487.7 311.3 246.4 234.4 254.5 88.1 59.5 118.7 287.1 33.2 450.8 1.3 39.3 5.2 8.4 78.2 6.5 18.9 6.2 6.9 56.7 13.5 3.8 4.2 1.8 7.9 38.7 25.0 7.9 14.9 881.7 921.0 927.8 957.2 883.4 920.8 1024.2 966.2 843.0 990.3 1012.8 932.4 1174.0 137.8 16.0 29.9 40.5 38.6 80.2 124.2 21.8 33.6 172.1 76.9 60.2 246.3 11.5 24.7 5.5 73.0 21.8 13.7 12.7 29.4 74.7 65.4 36.4 33.7 125.1 12.0 7.4 24.8 46.3 61.1 81.5 17.9 85.9 31.1 17.2 89.3 6.5 63.3 92.5 19.1 12.0 8.2 42.6 234.6 55.4 66.8 68.9 74.7 14.0 267.6 315.8 8.2 12.1 48.3 102.5 4.7 109.9 14.8 119.4 5.4 18.3 13.8 129.2 46.0 69.4 78.3 16.5 4.1 42.7 73.3 45.3 19.4 18.5 12.8 178.8 PEX19 "D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1" ENSG00000162735 "Peroxisomal biogenesis factor 19" P40855 1 160276807-160286348 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044837, HPA051966" Supported Supported Peroxisomes NA NA 7900 Peroxisomes "HPA044837: AB_10962496, HPA051966: AB_2681677" "unprognostic (1.49e-2)" "unprognostic (2.26e-1)" "unprognostic (3.42e-1)" "unprognostic (4.80e-3)" "unprognostic (3.89e-2)" "unprognostic (3.88e-2)" "unprognostic (3.79e-1)" "unprognostic (1.51e-1)" "unprognostic (2.32e-1)" "unprognostic (1.53e-2)" "unprognostic (8.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (2.92e-5)" "unprognostic (3.46e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-2)" "unprognostic (1.24e-2)" 80.0 25.9 20.4 14.6 21.5 12.4 36.8 20.9 23.7 20.5 14.3 22.8 19.6 18.4 25.3 25.1 23.1 19.8 39.7 20.4 21.3 33.4 110.0 21.8 16.7 24.3 21.5 20.6 23.8 17.3 40.8 15.1 22.1 22.1 28.3 23.5 31.1 21.5 26.8 66.8 18.1 19.0 16.8 20.1 16.9 20.2 16.9 21.9 21.2 34.6 85.6 20.6 24.1 15.4 25.3 31.2 18.9 69.8 22.4 59.8 57.8 53.0 25.3 51.3 44.6 35.3 35.1 37.2 37.8 40.9 37.3 26.3 29.7 34.2 44.0 35.3 32.3 17.3 26.6 26.5 36.3 46.9 48.6 32.6 84.7 51.0 60.0 38.6 35.8 32.2 51.4 40.8 27.9 50.0 17.8 37.0 15.8 50.3 38.6 48.2 45.7 34.4 45.5 45.8 61.8 23.2 38.3 98.3 49.5 37.4 71.3 48.1 48.2 24.8 26.5 31.1 29.9 30.1 42.5 57.9 68.6 43.1 20.9 38.9 9.1 5.5 5.0 5.8 8.9 4.2 5.0 2.8 3.5 5.5 1.9 4.0 3.7 2.2 4.7 6.6 3.4 4.2 2.3 20.4 21.5 20.9 23.7 20.4 21.3 24.3 21.5 20.6 22.1 20.1 21.9 25.3 16.4 9.6 20.6 9.1 12.7 9.9 21.0 15.4 13.1 18.8 18.9 16.4 45.6 20.0 11.3 16.5 10.4 30.0 6.9 25.4 49.0 22.6 6.6 12.0 13.7 13.6 11.4 15.6 8.6 14.8 51.2 18.4 13.3 12.0 16.5 15.6 20.0 60.1 30.1 25.2 9.0 11.5 0.0 15.7 7.0 3.1 21.8 15.0 21.4 6.5 24.9 39.0 12.3 6.0 11.5 20.2 17.2 29.3 9.5 18.5 29.8 40.7 11.8 12.7 32.9 14.6 16.2 17.8 25.3 15.0 9.9 38.7 12.5 18.2 15.7 25.2 NCSTN "APH2, KIAA0253" ENSG00000162736 Nicastrin Q92542 1 160343316-160358952 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021982, HPA054846, HPA070642" Approved Approved Cytosol NA NA 130000 Cytosol "CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289" "unprognostic (1.08e-1)" "unprognostic (5.22e-3)" "unprognostic (1.51e-1)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-3)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (3.62e-2)" "unprognostic (8.21e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.75e-9)" "unprognostic (1.36e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-2)" "unprognostic (4.89e-2)" 51.5 36.9 30.4 42.4 35.2 38.5 44.3 38.7 32.8 52.9 41.1 59.0 81.1 40.6 56.9 35.3 50.1 43.3 51.0 29.4 37.8 60.3 59.8 56.5 38.6 40.1 34.9 27.4 52.2 64.4 86.7 30.4 99.5 41.1 45.6 61.5 48.5 61.0 47.8 37.9 39.2 64.0 52.5 36.7 46.6 46.1 42.2 34.4 40.4 64.4 38.7 43.4 46.1 31.8 48.9 52.1 57.4 100.4 82.8 301.0 153.4 108.3 104.0 177.0 95.4 109.9 47.9 140.0 36.6 208.6 209.3 67.1 81.5 47.3 95.9 82.4 56.5 42.3 36.6 70.9 70.0 118.6 82.8 152.0 155.7 92.3 94.3 93.6 207.2 139.9 54.3 66.9 100.2 142.2 34.3 26.8 39.8 82.2 130.6 33.8 35.1 59.9 103.6 130.5 69.9 34.2 75.6 109.1 118.5 70.9 158.0 108.2 186.3 125.5 70.3 46.4 48.8 79.9 130.8 194.4 38.6 106.6 49.8 129.4 71.4 79.0 67.8 27.4 79.0 26.2 31.1 23.5 24.0 75.1 27.8 23.9 23.3 69.2 36.6 79.6 45.1 26.5 52.2 30.4 35.2 38.7 32.8 29.4 37.8 40.1 34.9 27.4 41.1 36.7 34.4 48.9 28.0 6.4 9.3 0.0 23.0 10.5 23.8 59.5 15.9 20.0 27.9 23.1 14.6 45.8 42.6 53.3 52.1 107.7 27.8 53.3 7.9 38.9 2.6 19.2 19.7 23.9 20.3 17.2 0.0 27.0 95.7 33.7 17.9 30.2 13.3 25.8 29.6 31.4 58.0 18.5 0.0 31.8 46.8 47.1 18.8 4.7 27.1 33.4 17.8 0.0 31.7 35.0 20.6 0.0 0.0 34.8 33.4 21.1 33.2 15.6 66.1 24.7 28.7 26.3 26.3 23.8 19.6 44.6 35.9 15.5 11.4 147.4 16.5 32.5 29.6 20.5 VANGL2 "KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1" ENSG00000162738 "VANGL planar cell polarity protein 2" Q9ULK5 1 160400564-160428670 "Disease related genes, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Intestinal goblet cells: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 106.3;AN3-CA: 26.4;NTERA-2: 43.1;SH-SY5Y: 28.9;SuSa: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027043 Uncertain NA NA "HPA027043: AB_10601709" "unprognostic (4.32e-3)" "unprognostic (1.86e-1)" "unprognostic (1.59e-2)" "unprognostic (1.07e-3)" "unprognostic (3.05e-1)" "unprognostic (2.55e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (1.84e-3)" "unprognostic (9.83e-2)" "unprognostic (3.84e-1)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-2)" 1.5 1.5 9.8 2.6 7.7 0.2 5.7 8.9 6.2 10.2 4.8 6.1 5.2 7.1 6.4 13.2 6.1 3.1 3.9 8.4 10.7 3.9 0.4 5.8 4.9 13.0 13.5 5.7 8.4 6.1 5.5 4.5 6.1 10.0 10.8 5.6 4.4 13.4 8.3 1.9 37.9 5.4 3.8 12.7 2.1 5.0 1.9 11.3 8.4 8.2 1.3 7.0 6.1 14.1 10.8 1.2 1.6 106.3 26.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 10.0 0.1 13.5 0.0 0.2 6.2 17.8 0.9 0.0 0.0 1.3 5.4 0.0 0.0 0.1 0.0 0.0 0.2 3.7 0.0 0.0 0.3 0.0 4.1 8.4 0.0 0.7 0.0 7.2 0.3 43.1 0.5 0.0 14.5 5.6 0.1 0.0 0.2 9.8 28.9 0.0 0.0 9.6 36.7 0.0 1.4 0.0 0.0 16.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 7.7 8.9 6.2 8.4 10.7 13.0 13.5 5.7 10.0 12.7 11.3 10.8 1.3 0.0 0.5 14.0 0.0 15.8 2.8 7.1 6.2 4.3 11.0 9.5 3.8 4.3 4.3 0.0 33.3 0.0 1.3 1.9 0.0 3.9 1.2 1.9 7.8 2.6 16.8 0.0 0.8 1.6 0.0 5.0 3.1 4.1 0.0 5.0 2.5 0.0 0.1 10.1 2.5 18.4 8.2 0.0 0.4 1.4 3.7 0.2 7.2 0.0 0.0 4.3 0.0 13.0 3.5 4.3 2.2 7.2 0.1 7.1 1.3 0.4 3.9 0.4 0.0 3.5 3.7 0.5 3.0 13.1 17.0 0.0 0.2 1.5 6.4 5.6 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 62.2" "Cell type enhanced" "Detected in some" "B-cells: 23.6;dendritic cells: 19.7;Late spermatids: 22.1;NK-cells: 45.3;Plasma cells: 21.4;T-cells: 26.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Daudi: 88.2;U-698: 127.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051363: AB_2681454, HPA051903: AB_2681658" "prognostic favorable (9.42e-4)" "prognostic favorable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favorable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favorable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 1.7 1.2 0.1 20.8 0.2 3.2 2.2 0.8 0.4 2.1 0.4 3.8 2.7 1.3 1.5 2.1 1.3 4.7 1.0 0.2 0.2 0.9 4.1 4.4 62.2 0.3 0.1 0.2 1.2 0.9 0.2 0.2 1.8 0.4 1.3 3.5 0.1 2.2 0.5 0.4 0.6 13.9 1.4 0.1 32.5 5.5 1.2 0.2 19.5 1.7 0.5 49.0 5.8 1.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 6.7 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.8 0.1 0.0 0.0 21.8 1.3 0.1 0.7 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.1 14.2 127.4 0.0 0.6 0.0 11.2 0.3 23.1 56.1 1.0 38.9 36.2 35.6 71.4 0.3 35.4 19.5 39.5 2.5 41.3 3.1 1.0 45.6 22.2 0.1 0.2 0.8 0.4 0.2 0.2 0.3 0.1 0.2 0.4 0.1 0.2 0.4 0.1 0.0 1.3 0.0 23.6 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.1 9.4 0.1 0.1 0.3 0.0 3.2 0.0 0.2 0.0 0.4 0.5 0.1 1.3 0.0 3.3 1.1 1.1 0.0 0.0 0.0 0.0 4.3 0.8 22.1 0.0 1.1 0.0 0.0 1.6 0.0 45.3 0.0 0.0 0.1 0.1 0.0 21.4 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.3 0.0 26.1 0.0 0.0 0.0 OLFML2B DKFZP586L151 ENSG00000162745 "Olfactomedin like 2B" Q68BL8 1 161983192-162023869 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.7" "Cell type enhanced" "Detected in many" "Early spermatids: 122.5;Hofbauer cells: 38.4;Skeletal myocytes: 175.5;Smooth muscle cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 6.7;non-classical monocyte: 5.5" "Lineage enriched" "Detected in single" 11 "monocytes: 6.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 39.7;HSkMC: 113.3;RH-30: 88.5" "Group enriched" "Detected in all" 4 "hippocampal formation: 41.0;white matter: 11.9" "Low region specificity" "Detected in all" "HPA054136, HPA062739" Approved Approved Cytosol "Secreted - unknown location" NA NA 12000 Cytosol "HPA054136: AB_2682397, HPA062739: AB_2684858" "unprognostic (2.97e-2)" "unprognostic (1.79e-1)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (6.01e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (5.97e-3)" "unprognostic (7.32e-2)" "unprognostic (7.68e-3)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.01e-12)" "unprognostic (1.64e-3)" "unprognostic (2.11e-2)" "unprognostic (4.53e-3)" "unprognostic (1.97e-2)" 22.5 6.9 3.5 19.4 6.8 0.4 14.9 2.4 5.2 17.0 6.7 13.2 2.1 16.4 5.1 4.0 11.5 48.7 5.5 5.7 8.5 3.0 0.8 15.4 14.1 4.3 3.7 3.9 4.2 1.4 3.6 2.8 41.0 3.4 5.3 2.9 0.2 10.5 6.9 10.3 8.3 5.6 22.2 2.9 10.3 3.3 16.0 8.3 3.8 21.0 6.5 11.3 17.0 7.4 7.0 0.1 0.4 6.6 2.2 21.0 39.7 0.0 2.3 10.6 4.3 11.8 0.0 0.2 0.0 0.3 25.7 4.3 0.0 0.6 0.1 2.5 0.0 0.8 0.5 0.2 0.0 0.3 0.1 0.8 113.3 0.0 5.3 0.0 2.1 0.7 0.0 0.0 1.0 19.3 0.1 0.1 0.2 2.1 0.0 1.0 0.2 88.5 8.9 1.6 0.1 0.8 0.3 9.1 0.0 0.6 19.6 0.0 0.1 0.1 2.7 0.7 4.0 3.6 0.0 0.1 0.0 25.1 2.7 1.3 0.0 0.4 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.2 3.5 6.8 2.4 5.2 5.7 8.5 4.3 3.7 3.9 3.4 2.9 8.3 7.0 4.1 0.0 0.6 0.0 0.2 3.3 0.1 0.1 0.0 0.1 0.4 1.0 3.0 1.5 0.7 1.8 0.0 0.3 0.1 0.0 0.0 0.0 122.5 1.2 24.9 1.7 0.0 0.4 2.8 0.0 0.3 21.9 0.0 0.7 1.3 1.1 1.1 0.2 38.4 0.0 0.9 0.1 0.0 31.1 9.0 12.9 20.8 16.6 1.8 8.4 0.9 0.8 0.0 0.0 2.9 0.0 0.0 29.3 0.1 0.1 0.0 0.1 0.1 0.1 6.6 175.5 57.2 8.8 1.7 0.1 2.3 0.3 0.6 16.4 0.0 0.0 FCRLB "FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2" ENSG00000162746 "Fc receptor like B" Q6BAA4 1 161721563-161728143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.8" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 7.5;NK-cells: 11.3;Proximal tubular cells: 14.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 7.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.8;Daudi: 6.0;fHDF/TERT166: 8.8;HMC-1: 7.4;PC-3: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB026139 Uncertain Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB026139: " "unprognostic (1.87e-1)" "unprognostic (1.20e-4)" "unprognostic (5.77e-3)" "unprognostic (7.49e-3)" "unprognostic (1.73e-3)" "unprognostic (2.95e-1)" "unprognostic (2.98e-2)" "unprognostic (1.18e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.27e-1)" "unprognostic (9.92e-3)" "unprognostic (3.14e-2)" 0.2 0.1 0.3 0.7 0.3 0.0 0.1 0.4 0.7 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.4 0.6 0.3 0.1 0.9 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.3 0.9 0.0 0.2 0.1 0.0 0.4 0.3 0.1 0.1 0.4 0.0 0.1 0.0 1.8 0.2 0.1 0.5 0.6 0.1 0.0 0.3 0.4 0.6 0.0 3.7 4.8 1.2 1.2 0.1 0.1 6.0 0.2 8.8 0.2 0.0 0.2 0.3 3.1 0.1 0.3 0.2 0.1 0.1 0.2 0.0 7.4 1.1 0.0 2.1 0.1 0.3 1.1 0.0 0.3 0.3 0.1 0.3 0.0 2.1 0.1 0.0 4.4 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.1 1.9 0.2 0.0 0.0 0.6 1.3 0.6 1.3 0.7 0.0 0.0 2.3 2.5 0.4 0.6 6.4 0.1 1.8 1.8 0.0 0.6 3.4 1.1 1.0 0.4 4.7 0.5 0.8 1.0 3.7 0.2 0.0 0.0 0.5 0.3 0.3 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.5 2.8 0.0 0.0 0.3 2.9 1.1 1.1 1.0 0.6 0.2 1.5 1.5 1.5 0.0 1.2 3.7 0.0 2.1 3.9 0.1 5.9 1.3 0.1 0.3 1.3 2.3 1.2 5.3 0.9 1.1 5.6 1.1 0.0 0.4 0.0 1.2 7.5 1.2 1.4 0.0 1.2 0.0 0.0 1.9 1.2 0.2 0.0 3.4 1.8 0.0 0.7 3.4 11.3 0.0 0.3 1.0 0.1 0.4 3.0 0.6 0.0 14.7 0.7 0.7 0.0 0.2 1.6 2.7 1.4 1.3 0.4 0.8 2.4 2.2 0.0 1.1 FCGR3B "CD16, CD16b, FCG3, FCGR3" ENSG00000162747 "Fc fragment of IgG receptor IIIb" O75015 1 161623196-161631963 "CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.9;lymphoid tissue: 82.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Club cells: 3.1;dendritic cells: 2.2;Fibroblasts: 2.2;Kupffer cells: 2.2;Macrophages: 4.3;NK-cells: 2.1;Respiratory ciliated cells: 2.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 6.2" "Immune cell enriched" "Detected in many" 79 "neutrophil: 7208.7" "Lineage enriched" "Detected in many" 79 "granulocytes: 7208.7" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (1.60e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (4.16e-2)" "unprognostic (1.15e-1)" "unprognostic (6.52e-2)" "unprognostic (3.97e-2)" "unprognostic (6.96e-3)" "unprognostic (2.53e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (8.67e-2)" "unprognostic (5.16e-2)" "unprognostic (1.35e-1)" "unprognostic (8.37e-3)" "unprognostic (2.28e-1)" "unprognostic (9.24e-2)" 23.2 2.8 0.9 77.0 1.0 36.9 1.3 0.8 6.2 2.8 3.9 2.1 0.5 0.9 0.0 5.0 5.3 16.6 3.3 0.6 1.0 1.9 8.0 22.2 1.3 1.1 0.8 0.4 0.4 4.0 1.4 0.7 9.2 2.9 0.8 0.9 0.0 1.3 0.4 0.8 4.0 2.5 5.6 0.6 82.7 1.9 0.2 0.9 6.1 1.3 23.2 1.5 18.4 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.1 12.5 17.2 30.4 0.6 0.3 0.9 6.9 3.0 0.6 0.5 6.2 7208.7 3.6 90.8 0.4 0.6 18.5 0.9 1.0 0.8 6.2 0.6 1.0 1.1 0.8 0.4 2.9 0.6 0.9 2.2 0.0 3.2 7.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 1.5 3.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.3 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.9 0.0 4.3 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500460-173603072 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;choroid plexus: 1.6;testis: 6.0" "Cell type enriched" "Detected in some" 4 "Astrocytes: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.5 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 1.2 0.8 0.1 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 6.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.5 0.5 0.4 0.5 1.3 1.2 0.8 0.1 0.7 1.0 0.5 0.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 1.3 0.0 6.2 0.1 1.3 0.1 0.0 0.1 6.2 1.7 0.1 0.4 0.0 0.0 5.0 0.0 0.5 0.3 0.0 0.1 0.0 0.5 0.4 1.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 4.7 0.0 0.7 0.0 1.5 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.1 0.1 5.4 0.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 29.2" "Group enriched" "Detected in many" 4 "Early spermatids: 424.7;Late spermatids: 448.2;Spermatocytes: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;HDLM-2: 1.5;HEK 293: 1.8;MCF7: 1.4;T-47d: 1.4;U-266/70: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043197 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favorable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 0.3 3.1 1.6 0.1 1.7 0.0 0.7 1.2 2.9 1.0 1.7 1.3 0.2 1.4 0.5 0.5 2.2 0.0 0.8 1.5 2.0 3.9 1.9 0.8 0.0 1.6 1.8 1.5 1.0 2.4 1.2 4.7 0.0 1.8 1.7 0.2 0.4 1.0 0.4 0.7 0.3 0.8 0.0 1.2 0.3 1.3 29.2 1.7 0.0 2.4 0.1 0.1 1.1 0.5 1.3 0.1 1.1 0.4 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 1.5 1.8 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.2 0.9 1.0 0.0 0.7 0.2 0.0 1.0 0.4 0.0 0.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.7 1.2 2.9 1.5 2.0 1.6 1.8 1.5 1.8 1.2 1.7 1.3 2.4 0.0 6.7 8.8 1.5 0.9 11.7 11.5 0.6 13.7 15.3 16.3 9.3 14.3 11.7 29.5 2.1 2.3 0.4 7.6 56.7 10.2 424.7 57.5 2.8 3.4 5.4 0.0 8.9 5.5 3.6 3.2 3.1 10.3 1.3 1.6 3.9 9.5 0.6 3.3 6.8 10.6 16.2 0.6 0.7 448.2 8.1 0.9 7.2 2.8 0.6 35.1 1.0 6.0 1.7 3.9 8.2 8.2 2.1 6.4 2.5 47.8 77.8 20.0 13.1 2.8 4.4 198.1 15.6 2.6 0.9 0.8 1.2 1.7 8.7 8.2 C1orf74 "FLJ25078, URLC4" ENSG00000162757 "Chromosome 1 open reading frame 74" Q96LT6 1 209779208-209784559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 14.9;Glandular and luminal cells: 28.4;Squamous epithelial cells: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028496 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028496: AB_10602698" "unprognostic (3.25e-1)" "prognostic unfavorable (8.52e-6)" "unprognostic (8.41e-3)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-2)" "unprognostic (9.98e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.95e-1)" "unprognostic (2.81e-1)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (1.07e-1)" "unprognostic (5.40e-2)" 0.6 0.9 0.7 2.5 0.7 1.1 2.3 1.8 0.7 1.0 0.3 1.6 1.3 0.8 2.0 4.0 1.1 0.9 1.5 0.7 0.8 2.0 1.7 0.9 4.4 0.7 0.7 0.7 0.9 0.8 1.2 0.8 1.1 1.0 1.7 2.1 0.9 1.9 0.9 1.0 5.0 2.8 0.6 0.7 4.2 1.7 1.3 1.0 2.1 1.2 1.0 2.4 1.9 1.7 0.8 4.7 2.4 1.5 0.8 2.0 2.3 3.5 2.6 3.4 3.1 3.2 4.9 3.5 4.9 1.5 1.7 1.9 9.3 0.9 7.6 3.6 4.9 3.1 3.2 1.7 0.4 2.8 4.6 1.4 1.4 6.6 3.9 6.3 2.6 1.8 6.6 6.5 3.5 2.7 2.4 3.9 4.7 6.4 3.2 4.1 4.0 7.2 6.9 2.7 4.0 6.0 6.5 3.5 2.7 4.0 3.4 4.2 2.4 1.7 2.6 3.1 2.7 4.2 3.2 3.4 5.4 2.3 3.7 3.8 4.7 0.8 0.7 1.3 0.9 0.9 1.8 0.6 1.0 1.6 3.7 1.1 1.2 0.5 1.5 0.5 2.7 0.6 0.9 0.7 0.7 1.8 0.7 0.7 0.8 0.7 0.7 0.7 1.0 0.7 1.0 0.8 0.6 3.2 2.2 0.0 1.1 2.2 6.1 4.6 6.8 1.6 3.7 2.8 2.0 0.0 1.8 0.0 0.0 3.9 1.5 3.5 7.9 1.9 0.1 14.9 1.8 0.8 3.6 2.1 0.5 2.0 5.0 0.9 2.6 28.4 1.3 2.2 1.4 2.3 2.8 1.7 0.6 5.9 0.0 1.3 0.3 0.6 2.5 1.6 0.0 1.0 1.3 2.2 0.0 0.0 0.3 4.1 3.5 0.0 0.6 5.1 2.4 7.4 1.8 1.3 0.0 0.4 1.0 3.6 4.7 25.0 4.8 4.0 1.1 2.8 3.4 12.1 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "choroid plexus: 17.3" "Group enriched" "Detected in some" 16 "Early spermatids: 30.6;Enteroendocrine cells: 41.9;Late spermatids: 23.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.1 0.2 17.3 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.7 1.5 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.1 1.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.7 1.5 0.9 1.4 0.0 0.4 0.0 1.8 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.6 0.2 0.0 0.1 41.9 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 23.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 LRRC52 FLJ25811 ENSG00000162763 "Leucine rich repeat containing 52" Q8N7C0 1 165544000-165563957 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 16.8" "Cell type enriched" "Detected in some" 4 "Early spermatids: 185.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.09e-2)" "unprognostic (1.76e-2)" "unprognostic (6.48e-2)" "unprognostic (3.79e-2)" "unprognostic (8.45e-2)" "unprognostic (6.70e-4)" "unprognostic (6.05e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLVCR1 "AXPC1, FLVCR, MFSD7B, PCA, SLC49A1" ENSG00000162769 "FLVCR heme transporter 1" Q9Y5Y0 1 212858275-212899363 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Erythrocyte maturation, Transport" Receptor "Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.6" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "NTERA-2: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046646 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA046646: AB_2679735" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.01e-1)" "unprognostic (2.83e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.03e-1)" "unprognostic (1.21e-1)" "unprognostic (3.88e-2)" "prognostic favorable (3.50e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (7.15e-2)" "unprognostic (2.25e-1)" "unprognostic (3.91e-2)" "unprognostic (7.29e-3)" 2.0 2.4 3.8 3.2 3.3 6.3 3.1 5.1 3.8 2.9 2.9 3.4 9.8 2.6 5.0 2.1 2.4 2.0 1.5 3.6 4.3 2.1 1.8 2.5 2.9 4.7 4.2 3.5 2.4 2.6 3.6 7.0 2.4 5.1 3.4 2.9 7.1 1.9 1.8 1.1 2.9 19.6 1.8 3.0 2.7 4.8 2.8 4.5 2.7 2.2 0.7 2.2 2.3 2.3 6.3 8.4 11.0 16.8 5.1 2.8 3.4 31.3 2.4 1.8 4.8 2.9 16.1 15.2 9.1 4.4 1.7 10.2 12.5 18.2 5.4 4.7 5.4 8.0 5.4 10.4 14.9 3.2 14.5 8.4 2.7 3.5 5.2 6.6 2.5 3.8 6.4 14.7 7.4 3.2 3.2 4.1 7.2 55.3 11.1 7.7 9.0 15.4 10.6 6.0 8.0 18.1 12.7 11.2 11.1 10.4 13.8 18.2 6.7 2.2 2.3 5.6 7.7 11.2 4.6 9.9 10.8 3.5 8.3 2.9 0.5 0.2 1.5 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.3 0.3 0.3 0.7 0.2 0.2 0.4 0.4 0.0 3.8 3.3 5.1 3.8 3.6 4.3 4.7 4.2 3.5 5.1 3.0 4.5 6.3 6.7 12.8 16.0 12.4 8.3 14.3 8.8 6.9 9.6 24.0 10.3 9.5 4.1 14.3 12.1 20.2 35.5 3.9 6.8 13.7 1.9 5.5 4.7 7.0 7.8 9.3 32.4 9.5 28.8 13.4 6.7 8.8 17.3 7.6 7.0 20.1 10.0 9.2 6.5 16.8 39.4 10.6 10.2 10.1 9.6 6.8 6.2 9.0 5.4 9.4 10.5 5.8 4.1 24.1 28.7 8.9 12.0 2.6 6.5 11.9 73.7 4.6 10.1 31.8 6.6 18.0 7.2 10.4 6.8 7.0 9.2 2.5 8.3 5.1 8.2 4.3 FAM71A FLJ32796 ENSG00000162771 "Family with sequence similarity 71 member A" Q8IYT1 1 212624474-212626775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 147 "testis: 79.3" "Group enriched" "Detected in many" 50 "Early spermatids: 1174.2;Late spermatids: 453.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028462, HPA060344" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA028462: AB_10601904, HPA060344: " 0.2 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 79.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 3.7 0.0 0.1 0.5 1.7 4.4 0.6 0.1 3.5 6.7 0.0 4.3 3.3 0.0 0.0 2.6 0.3 1.9 0.0 0.7 1174.2 7.2 2.8 1.6 1.2 0.0 0.0 1.2 1.5 1.8 9.7 16.0 1.3 0.0 1.8 0.4 1.2 0.0 0.0 2.8 0.0 0.0 0.3 453.8 5.3 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 2.8 2.6 0.6 2.5 0.4 0.0 1.5 0.0 0.0 3.2 2.7 3.9 2.4 0.8 0.1 2.9 0.8 0.1 2.0 0.5 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 15 "dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 9.3" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 123.6 83.6 17.9 63.9 19.5 45.7 98.4 16.5 21.5 107.2 18.3 61.5 21.2 109.6 9.4 129.5 123.8 136.1 101.7 14.6 86.0 86.1 141.1 117.0 21.0 21.7 16.6 12.9 40.6 67.8 49.2 45.3 66.9 18.7 117.4 60.5 16.3 33.4 24.3 31.0 105.9 45.9 315.4 17.2 24.6 105.7 3.9 18.7 85.3 182.8 30.3 3.1 284.0 55.7 29.9 21.1 1.2 40.7 8.7 3.9 10.4 131.5 14.7 11.9 12.5 29.8 27.7 15.5 0.4 6.5 0.9 68.0 11.6 24.6 4.0 20.5 100.4 24.6 1.6 11.6 10.0 72.9 9.0 22.7 18.3 65.3 34.9 80.4 2.4 2.6 23.9 10.0 77.0 1.9 2.8 27.5 5.9 29.2 11.5 9.2 8.1 27.1 18.4 1.8 3.0 18.3 18.4 19.1 34.2 59.0 155.0 19.9 6.5 2.4 3.6 19.5 12.3 6.7 60.4 27.9 7.4 11.9 4.8 10.8 6.4 0.7 0.0 0.3 4.0 0.3 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.2 0.0 6.3 0.8 0.0 0.7 17.9 19.5 16.5 21.5 14.6 86.0 21.7 16.6 12.9 18.7 17.2 18.7 29.9 568.2 423.1 146.5 1.6 55.3 202.8 866.2 236.1 1462.0 4.4 753.9 510.9 689.3 92.9 136.0 55.2 0.0 178.9 100.3 611.7 1.9 186.2 3.7 1049.4 318.2 176.2 889.6 2.7 2.6 122.7 330.8 452.6 966.9 1429.3 78.6 5.6 30.7 25.8 103.7 1.7 2.4 758.4 114.0 29.8 282.8 2.8 17.4 351.8 174.3 3.7 32.3 39.9 0.0 1.5 10.8 185.7 484.8 1.2 161.0 457.5 421.3 3.3 133.2 5.3 98.6 279.4 573.7 2.2 3.1 474.6 202.7 420.6 97.1 5.8 349.6 263.6 RBM15 "OTT, OTT1" ENSG00000162775 "RNA binding motif protein 15" Q96T37 1 110338506-110346681 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015201, HPA019824, HPA049642" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (9.39e-2)" "unprognostic (7.57e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.13e-1)" "unprognostic (1.84e-2)" "unprognostic (4.91e-2)" "unprognostic (9.67e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.37e-4)" "prognostic favorable (7.97e-4)" "unprognostic (2.88e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" 4.7 4.0 3.6 7.1 3.9 45.1 4.2 11.0 4.5 3.2 4.7 4.3 5.3 3.4 3.5 3.3 3.8 4.3 4.6 4.7 3.3 3.2 7.3 4.2 11.4 3.4 3.3 3.5 5.9 4.3 3.8 1.6 5.1 5.2 3.7 3.8 4.9 4.6 2.6 7.1 2.9 4.9 3.7 3.5 7.3 5.5 8.7 3.5 8.7 4.6 6.7 9.7 4.5 2.2 5.8 11.8 12.7 11.2 11.6 7.0 7.2 17.6 6.2 8.1 9.5 12.4 15.7 10.6 22.4 9.7 7.0 7.8 16.4 17.6 15.5 13.9 23.4 16.3 18.1 21.0 11.4 9.6 19.9 18.4 6.6 10.5 13.2 12.3 5.0 10.2 16.6 26.1 38.0 9.6 12.1 18.0 15.4 24.0 10.4 7.1 21.1 17.0 15.3 7.8 11.8 13.4 6.8 13.5 16.7 13.1 11.9 11.6 23.5 7.2 9.1 16.2 9.9 11.4 28.8 15.9 48.0 13.6 19.7 11.4 6.3 3.9 5.6 3.7 3.4 5.3 6.1 4.2 3.3 2.8 5.1 3.5 4.3 5.4 3.1 3.9 2.7 4.5 3.3 3.6 3.9 11.0 4.5 4.7 3.3 3.4 3.3 3.5 5.2 3.5 3.5 5.8 9.1 6.4 3.7 21.5 18.3 33.1 9.3 7.3 6.2 5.7 10.8 5.0 12.3 5.7 4.8 3.7 14.6 8.7 12.8 9.1 0.0 4.1 9.6 15.9 14.5 8.4 9.6 10.7 30.0 3.5 7.9 8.1 10.2 18.8 28.6 10.6 11.0 18.5 6.5 0.0 26.2 8.4 0.0 6.8 11.4 6.7 4.1 7.7 8.8 39.4 6.1 3.9 7.2 29.1 31.2 4.3 3.9 5.3 15.5 9.6 8.8 4.5 10.6 7.3 0.0 11.2 12.4 30.6 13.9 9.4 33.8 4.7 14.3 6.5 9.9 8.6 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111185969-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 94.6" "Cell type enhanced" "Detected in many" "dendritic cells: 71.2;NK-cells: 232.8;T-cells: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 5 "gdT-cell: 236.8;MAIT T-cell: 204.4;memory CD4 T-cell: 172.0;memory CD8 T-cell: 243.8;naive CD4 T-cell: 265.5;naive CD8 T-cell: 256.8;NK-cell: 278.3;T-reg: 79.5" "Group enriched" "Detected in all" 6 "NK-cells: 278.3;T-cells: 265.5" "Cell line enhanced" "Detected in many" "HDLM-2: 61.2;MOLT-4: 154.0;SK-BR-3: 96.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043630: AB_2678589, HPA048642: AB_2680474" "unprognostic (1.72e-3)" "prognostic favorable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favorable (8.66e-5)" 9.2 13.2 0.7 39.7 0.9 11.9 12.1 0.6 2.5 11.0 3.7 19.4 19.4 3.6 9.7 25.4 18.8 10.9 1.8 0.4 2.3 13.8 12.2 16.6 94.6 1.7 1.1 0.2 6.6 7.9 33.7 9.8 9.1 1.2 7.7 19.9 0.3 19.2 7.7 0.6 14.3 22.7 3.3 1.5 40.4 27.0 9.8 2.1 42.0 11.5 2.2 80.1 29.5 11.7 2.1 32.6 1.4 0.1 0.0 7.3 3.0 0.3 1.9 0.1 3.4 0.8 9.9 14.8 34.4 11.0 4.9 0.2 10.2 0.1 1.7 3.3 61.2 0.0 10.1 2.4 0.0 11.3 0.1 10.1 8.9 7.0 1.0 0.0 10.2 0.3 11.1 0.2 10.3 1.0 27.8 154.0 0.9 0.0 40.8 4.4 4.0 0.0 46.0 10.9 33.6 11.2 0.0 11.4 96.5 3.6 0.2 30.3 32.0 0.0 0.0 0.1 0.0 0.2 9.5 4.1 25.8 0.0 27.1 0.2 5.3 21.0 15.0 236.8 15.5 204.4 42.6 172.0 243.8 19.7 46.3 265.5 256.8 20.7 278.3 11.9 15.1 79.5 197.5 0.7 0.9 0.6 2.5 0.4 2.3 1.7 1.1 0.2 1.2 1.5 2.1 2.1 2.1 6.4 16.8 0.3 24.7 5.0 17.9 24.1 9.6 0.1 14.9 8.6 1.2 8.6 23.8 20.2 0.0 1.7 71.2 22.8 19.6 38.0 35.4 8.9 1.4 3.7 6.0 8.2 0.2 15.9 3.1 3.7 25.5 11.3 17.7 4.6 7.5 5.3 57.1 0.0 0.2 34.6 14.2 32.4 2.5 49.2 1.2 17.2 7.2 1.9 11.9 0.0 232.8 0.0 0.1 12.7 18.2 0.4 12.3 35.4 20.4 28.7 20.7 0.4 0.0 1.2 1.8 25.4 0.7 17.7 4.0 11.5 83.2 10.2 21.0 31.3 AXDND1 "C1orf125, FLJ32940" ENSG00000162779 "Axonemal dynein light chain domain containing 1" Q5T1B0 1 179365720-179554735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 15.9" "Group enriched" "Detected in some" 4 "Early spermatids: 226.5;Late spermatids: 247.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA071114 Enhanced NA NA "HPA071114: AB_2686345" "unprognostic (1.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.81e-2)" "unprognostic (1.05e-1)" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (3.78e-4)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-3)" "unprognostic (2.09e-2)" "unprognostic (1.31e-1)" "unprognostic (5.17e-3)" "unprognostic (1.92e-1)" "unprognostic (5.48e-2)" "unprognostic (5.04e-2)" "unprognostic (2.25e-1)" 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.2 15.9 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.3 0.0 0.2 0.4 0.2 0.2 0.1 0.0 0.5 8.8 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.3 0.8 0.0 0.8 0.0 2.1 0.1 0.1 16.3 0.0 0.2 226.5 3.1 0.3 0.2 0.0 0.0 3.1 0.2 0.3 0.1 31.6 0.3 0.0 0.2 0.0 0.0 0.1 0.0 3.2 1.5 0.0 0.0 0.0 247.2 1.5 0.5 0.0 1.0 0.0 0.6 0.0 2.0 2.5 0.6 3.8 1.9 0.1 0.1 2.0 0.1 3.2 0.7 0.0 0.0 0.2 50.2 4.3 0.0 0.0 0.1 0.2 0.6 6.1 0.2 TDRD5 "FLJ34823, TUDOR3" ENSG00000162782 "Tudor domain containing 5" Q8NAT2 1 179591613-179691272 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 6.6;testis: 22.1" "Group enriched" "Detected in some" 4 "Early spermatids: 36.1;Late spermatids: 12.1;Spermatocytes: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.7;SK-BR-3: 5.8;T-47d: 10.3;U-266/70: 14.3;U-266/84: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA029418 Enhanced NA NA "HPA029418: AB_10603035" "unprognostic (1.87e-1)" "unprognostic (1.43e-1)" "unprognostic (2.08e-1)" "unprognostic (2.15e-4)" "unprognostic (3.96e-1)" "unprognostic (4.39e-3)" "unprognostic (4.41e-4)" "unprognostic (3.18e-1)" "unprognostic (4.30e-1)" "unprognostic (3.75e-2)" "unprognostic (1.18e-1)" "unprognostic (3.37e-1)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (6.89e-2)" "unprognostic (2.31e-1)" 0.2 0.3 0.8 0.1 1.4 0.4 3.6 0.0 0.7 0.1 0.0 0.6 0.5 0.0 6.6 0.5 0.9 0.2 0.0 0.8 0.6 1.1 0.0 0.1 0.0 0.8 0.7 0.8 0.0 0.2 0.3 2.3 0.2 1.1 0.6 0.7 0.3 0.8 0.3 0.0 0.3 0.4 0.0 0.4 0.0 0.3 22.1 0.9 0.1 0.8 0.0 0.4 0.3 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.8 0.0 0.7 10.3 0.2 0.0 0.0 1.5 0.0 0.0 14.3 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.7 0.8 0.6 0.8 0.7 0.8 1.1 0.4 0.9 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 3.5 1.8 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 36.1 1.0 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.9 0.0 0.0 0.0 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 5.7 0.0 0.3 0.0 0.0 0.0 0.3 0.1 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088700-181092900 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 282.8;Macrophages: 276.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favorable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 9.5 6.3 12.4 11.3 11.0 50.0 8.5 10.9 40.7 7.6 15.6 9.4 5.7 14.9 2.5 26.7 15.3 6.2 25.0 16.6 15.3 4.4 6.8 23.4 9.5 11.4 9.8 9.6 3.3 5.2 1.8 5.3 11.1 10.2 5.6 5.7 1.1 6.9 3.7 33.7 21.5 13.4 8.4 11.4 32.9 9.1 5.4 10.7 8.7 5.0 16.6 10.9 11.0 13.4 17.8 25.3 21.8 11.7 10.3 15.9 21.9 31.3 43.6 45.9 24.1 21.4 6.1 13.8 8.3 18.9 16.9 16.9 45.5 3.8 29.7 15.6 47.6 18.7 7.4 11.5 4.1 24.9 8.6 23.1 15.7 29.5 28.0 18.7 18.3 16.6 6.9 31.0 36.5 43.3 11.5 8.6 13.8 12.2 9.5 10.8 9.8 20.4 31.6 8.8 13.7 16.9 18.2 22.1 21.3 51.7 14.2 17.0 7.5 25.3 17.3 30.5 19.9 26.8 23.9 9.1 6.5 13.5 9.0 4.9 3.6 1.4 2.7 1.0 5.5 1.2 4.0 0.8 1.4 1.1 3.0 0.1 0.5 1.2 1.1 5.3 0.2 1.3 0.7 12.4 11.0 10.9 40.7 16.6 15.3 11.4 9.8 9.6 10.2 11.4 10.7 17.8 156.4 22.4 66.7 3.6 124.8 69.8 163.7 24.2 53.5 24.2 198.1 197.7 110.9 21.5 25.9 9.2 37.5 10.9 131.1 94.2 0.0 10.6 5.1 66.7 83.0 87.2 56.4 32.0 8.7 6.9 56.4 74.7 50.0 67.3 36.1 35.0 41.4 5.6 50.9 8.4 2.8 110.6 6.1 149.5 282.8 11.9 12.2 276.4 46.2 11.2 56.1 17.8 17.5 0.5 1.3 21.9 54.8 9.4 61.5 94.9 35.0 1.5 27.4 21.3 0.0 177.9 102.8 3.6 5.4 115.9 59.7 34.2 151.3 15.5 62.0 146.8 SNED1 "FLJ00133, Snep, SST3" ENSG00000162804 "Sushi, nidogen and EGF like domains 1" Q8TER0 2 240998618-241095568 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 95.0;Excitatory neurons: 86.0;Leydig cells: 95.1;Microglial cells: 77.8;Peritubular cells: 71.1;Skeletal myocytes: 53.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "ASC TERT1: 410.4;HSkMC: 211.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036414, HPA036415" Uncertain "Secreted to blood" NA NA 27000000 "HPA036414: AB_10960852, HPA036415: AB_10964128" "unprognostic (1.41e-1)" "unprognostic (3.92e-2)" "unprognostic (1.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.57e-3)" "unprognostic (4.62e-2)" "unprognostic (7.77e-4)" "unprognostic (3.49e-2)" "unprognostic (4.96e-1)" "unprognostic (7.85e-3)" "unprognostic (3.42e-2)" "unprognostic (2.06e-2)" "unprognostic (2.80e-2)" "unprognostic (1.16e-1)" "unprognostic (3.72e-1)" "unprognostic (5.51e-3)" "unprognostic (4.95e-3)" 22.7 9.4 4.9 6.4 6.4 1.2 15.9 12.9 7.0 27.6 27.5 6.6 4.6 18.2 11.9 6.2 21.8 18.9 8.9 10.3 23.1 6.9 8.1 13.5 4.7 8.0 4.2 3.7 22.1 7.3 3.1 7.2 1.9 6.6 12.6 3.4 2.5 14.7 7.6 19.9 11.4 10.5 6.3 0.5 14.2 5.7 9.3 1.8 3.3 30.5 9.2 2.9 11.6 10.8 5.4 0.1 0.6 0.4 4.8 61.1 410.4 0.3 2.4 1.5 0.5 0.2 0.2 0.2 0.1 1.0 4.4 0.5 0.2 0.4 0.0 0.3 2.7 1.0 0.2 4.5 0.4 2.6 0.2 0.5 211.6 0.1 0.5 0.3 28.4 9.5 0.2 0.1 2.7 11.5 2.4 1.6 0.2 0.7 0.1 0.3 0.2 8.1 0.1 5.6 0.5 0.8 0.3 1.9 8.3 4.2 0.6 1.8 0.8 23.7 8.7 0.6 50.9 1.5 0.8 0.4 1.5 11.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.3 1.9 0.4 0.2 0.0 0.6 0.2 0.2 0.0 0.0 0.7 0.0 0.4 0.0 4.9 6.4 12.9 7.0 10.3 23.1 8.0 4.2 3.7 6.6 0.5 1.8 5.4 8.0 6.4 11.0 95.0 8.4 3.6 0.9 0.4 2.8 2.8 1.1 1.8 2.4 1.5 8.5 5.5 0.0 0.1 0.3 0.3 0.0 1.2 1.3 10.6 16.8 10.9 2.4 3.2 86.0 1.2 0.1 22.1 2.6 10.7 0.0 5.0 22.9 5.8 0.2 1.7 32.5 0.2 0.0 2.9 5.9 5.9 95.1 2.7 1.8 77.8 0.6 7.4 0.0 11.6 7.0 0.7 0.1 71.1 0.9 3.0 0.0 0.5 4.2 1.2 26.3 53.7 4.9 0.6 1.5 0.7 2.6 0.4 1.8 36.4 0.5 0.6 BPNT1 ENSG00000162813 "3'(2'), 5'-bisphosphate nucleotidase 1" O95861 1 220057482-220090462 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 55.5;Proximal enterocytes: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 183.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048461 Approved Approved "Nuclear speckles" NA NA 420000 "Nuclear speckles" "HPA048461: AB_2680404" "unprognostic (6.42e-2)" "unprognostic (4.69e-2)" "unprognostic (2.78e-2)" "unprognostic (1.02e-1)" "unprognostic (5.19e-3)" "unprognostic (7.65e-2)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (6.69e-2)" "unprognostic (2.87e-1)" "prognostic favorable (6.38e-4)" "unprognostic (1.82e-2)" "unprognostic (6.58e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-1)" 16.3 21.0 6.4 18.4 7.8 4.6 20.5 7.1 9.2 18.3 7.1 38.1 44.2 14.1 13.1 14.9 17.8 21.4 17.9 6.9 7.0 31.8 25.2 17.8 34.5 7.0 6.9 6.8 18.1 7.8 21.7 11.0 13.3 7.3 13.9 32.6 15.6 17.5 12.0 9.4 10.4 46.1 18.4 6.9 14.7 19.9 14.9 6.9 17.8 21.0 11.4 44.6 16.0 10.0 9.8 37.5 30.3 22.1 17.5 40.6 33.3 35.4 48.0 25.0 42.9 38.3 40.1 70.7 183.9 64.8 33.2 19.1 26.1 45.8 42.3 34.5 68.8 51.2 33.3 34.6 48.3 23.8 90.4 29.9 31.8 20.7 61.0 25.3 28.0 35.9 54.1 62.3 18.4 43.4 21.2 51.9 24.3 18.9 32.0 37.1 36.5 62.9 54.0 55.5 49.2 40.2 33.6 60.1 71.5 43.0 22.1 56.5 31.7 54.2 25.4 19.5 36.7 60.8 31.3 81.6 85.0 22.0 33.6 56.8 20.6 9.2 6.1 12.3 10.0 9.4 20.8 12.8 12.7 10.9 16.5 15.0 11.2 1.1 14.0 9.9 13.3 14.6 9.7 6.4 7.8 7.1 9.2 6.9 7.0 7.0 6.9 6.8 7.3 6.9 6.9 9.8 9.3 28.9 23.9 3.6 12.7 3.3 12.5 22.0 3.4 13.7 9.1 6.2 10.5 11.5 23.4 14.7 10.4 13.1 11.6 55.5 13.7 18.7 2.5 10.3 7.7 7.7 19.2 5.5 8.4 15.6 14.1 7.8 7.7 9.7 3.8 12.1 7.9 12.6 9.8 6.7 10.8 14.5 32.6 7.5 3.6 3.1 9.6 7.2 10.6 1.9 8.0 10.8 15.5 10.1 13.0 18.9 28.5 13.5 10.3 6.3 56.9 29.5 14.5 12.0 13.1 5.6 8.7 15.5 11.8 8.2 5.1 25.2 9.6 25.0 17.2 12.7 SPATA17 "CFAP305, FAP305, IQCH, MOT17" ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 10.3" "Cell type enhanced" "Detected in many" "Early spermatids: 770.1;Endometrial ciliated cells: 117.8;Late spermatids: 518.2;Respiratory ciliated cells: 150.1;Spermatocytes: 284.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.1 0.2 1.3 0.2 0.6 1.6 0.5 1.0 0.8 0.4 1.7 0.2 0.4 0.4 3.4 0.3 4.2 0.3 0.2 0.6 0.8 0.8 0.1 0.5 0.2 1.4 1.0 0.4 0.3 0.3 2.6 0.4 0.2 1.6 0.3 0.2 1.7 0.3 0.3 2.1 0.6 0.4 0.1 1.1 0.2 0.3 10.3 0.6 0.1 0.8 0.1 0.1 0.1 0.0 1.2 0.1 0.3 0.4 0.3 0.1 0.5 0.3 0.1 0.2 0.1 0.0 0.2 0.9 0.1 0.3 0.1 0.1 0.8 0.2 0.3 0.1 0.1 0.3 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.6 0.3 0.3 0.4 0.0 0.2 0.2 0.3 0.1 0.7 0.1 0.3 0.6 0.4 0.3 0.1 0.1 0.1 0.6 0.3 1.4 0.6 0.2 0.2 0.2 0.5 0.4 0.1 0.1 0.2 0.2 0.3 0.1 0.3 0.2 0.1 0.6 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 1.3 0.6 1.0 0.8 0.6 0.8 1.4 1.0 0.4 1.6 1.1 0.6 1.2 0.2 3.2 0.0 10.7 0.1 0.6 0.9 6.6 0.0 0.4 2.1 1.9 2.1 0.0 18.4 3.7 20.9 0.9 0.0 0.4 5.9 2.4 770.1 117.8 3.4 0.6 1.8 0.0 5.1 0.7 0.6 1.6 0.5 3.2 0.0 2.0 0.0 0.0 0.2 0.0 3.3 1.3 12.2 0.0 0.3 518.2 8.7 0.5 1.8 2.8 0.0 4.4 0.0 5.0 1.3 0.3 0.2 6.8 0.3 1.0 0.2 10.6 150.1 18.5 0.0 2.0 2.3 284.7 8.4 0.4 1.0 0.3 0.3 2.8 0.9 0.4 C1orf115 "FLJ14146, RDD1" ENSG00000162817 "Chromosome 1 open reading frame 115" Q9H7X2 1 220690363-220699153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 109.8;Hepatocytes: 121.3;Proximal enterocytes: 255.7;Syncytiotrophoblasts: 183.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 62.4;HUVEC TERT2: 49.7;TIME: 93.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (5.16e-2)" "prognostic favorable (6.52e-4)" "unprognostic (1.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.03e-1)" "unprognostic (5.69e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.12e-5)" "unprognostic (3.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.74e-2)" "unprognostic (4.24e-1)" "unprognostic (4.54e-2)" "unprognostic (9.21e-3)" "unprognostic (1.07e-1)" 50.5 6.9 29.9 6.9 47.0 0.3 28.6 12.8 45.0 14.9 18.8 31.2 113.5 12.6 21.5 5.8 14.5 10.4 19.0 44.5 22.5 53.3 102.2 23.6 8.6 18.2 14.2 43.0 18.1 12.2 20.7 17.7 70.7 22.5 31.4 23.5 8.9 74.8 10.7 14.7 8.9 121.9 11.9 11.2 50.5 22.7 7.3 16.0 3.9 16.6 19.5 9.6 6.9 7.3 30.1 1.6 7.3 0.5 10.1 0.0 0.0 29.0 2.0 8.1 4.2 18.3 7.3 7.6 0.0 3.1 0.6 8.5 0.2 16.9 3.4 3.8 0.0 16.9 0.2 1.5 62.4 9.4 0.0 0.2 1.3 5.7 0.3 2.1 0.0 49.7 0.0 4.7 0.0 0.3 6.7 0.0 0.5 12.3 20.4 5.2 0.0 0.1 0.6 9.0 9.8 5.3 7.4 0.0 12.3 30.9 17.5 20.0 0.4 93.6 0.0 0.1 0.3 1.7 1.1 0.0 0.0 0.2 0.0 1.5 0.0 0.2 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.9 47.0 12.8 45.0 44.5 22.5 18.2 14.2 43.0 22.5 11.2 16.0 30.1 76.7 3.2 6.7 1.6 5.8 3.4 4.2 1.4 1.8 17.3 29.8 20.4 19.5 17.2 5.1 31.3 6.2 74.4 0.9 109.8 39.2 9.7 1.5 7.6 1.3 51.5 8.4 8.0 20.7 16.6 68.2 5.6 2.0 11.7 0.0 59.0 18.9 121.3 6.4 0.0 2.0 25.6 6.1 4.7 2.7 2.8 3.1 1.4 8.8 5.6 4.8 10.4 0.0 0.0 1.4 13.9 55.5 19.2 0.0 11.0 255.7 58.2 1.9 3.9 0.0 2.1 4.6 0.5 5.5 0.8 1.7 183.9 1.2 54.9 25.1 2.6 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 270000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 17.5 14.7 20.6 18.2 23.6 41.1 23.6 23.3 21.6 17.7 17.1 26.2 21.8 17.4 15.4 28.0 18.7 19.4 16.7 18.4 26.6 22.5 17.0 20.2 19.2 25.2 21.7 15.3 21.8 14.9 26.4 8.9 20.6 24.5 17.5 25.1 16.4 16.8 17.9 27.0 23.4 27.8 17.8 23.1 21.1 25.1 12.9 21.2 14.5 26.7 20.6 22.3 16.5 13.7 35.8 56.6 34.2 20.1 17.5 28.6 30.2 38.8 38.2 47.6 30.6 34.8 19.0 71.6 18.7 44.1 47.2 16.5 48.2 22.9 36.5 46.1 23.2 20.4 28.2 34.8 19.2 32.2 32.2 25.4 26.8 34.8 38.4 44.8 34.5 28.3 11.9 43.0 24.8 38.0 17.4 13.7 16.7 25.3 46.0 39.8 14.4 61.2 42.3 36.3 55.6 22.5 35.3 41.7 46.3 28.8 18.9 57.1 32.5 40.7 42.1 23.9 43.6 43.5 18.4 33.8 16.7 34.0 26.8 39.0 75.4 28.0 36.6 21.3 42.1 24.1 15.9 27.0 21.8 26.1 14.4 17.8 22.6 52.7 28.4 44.1 14.4 27.2 18.6 20.6 23.6 23.3 21.6 18.4 26.6 25.2 21.7 15.3 24.5 23.1 21.2 35.8 35.7 73.7 46.5 15.7 30.4 48.6 32.3 32.2 27.3 16.3 42.1 23.9 35.9 30.0 38.3 51.5 8.4 29.7 49.1 56.2 56.7 40.0 20.8 43.2 30.9 29.0 31.8 73.0 17.1 32.5 32.6 29.7 35.7 54.2 16.4 26.3 31.8 28.4 36.6 35.3 20.1 50.1 32.6 65.5 33.1 23.7 24.2 50.8 49.8 12.2 52.4 31.0 42.2 25.1 27.3 54.5 44.6 32.0 23.2 47.8 48.4 58.8 67.8 20.8 52.6 27.4 26.8 29.9 27.4 40.4 46.7 51.6 40.5 35.1 41.0 56.4 NBPF20 ENSG00000162825 "NBPF member 20" P0DPF2 1 145289900-145405778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "brain: 46.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 30.6;Early spermatids: 25.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (6.25e-3)" "unprognostic (4.74e-2)" "unprognostic (1.23e-1)" "unprognostic (8.05e-2)" "unprognostic (1.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.25e-2)" "unprognostic (5.37e-2)" "unprognostic (3.22e-3)" "unprognostic (3.54e-1)" "unprognostic (4.26e-4)" "unprognostic (1.69e-1)" "unprognostic (1.45e-4)" "unprognostic (9.74e-2)" "unprognostic (5.21e-2)" "unprognostic (1.00e-1)" "unprognostic (1.70e-1)" 3.8 3.7 6.3 4.3 5.1 4.0 4.2 46.2 7.7 3.7 1.2 3.2 1.8 4.0 4.6 2.3 2.8 3.0 2.1 4.3 5.8 2.7 6.1 3.3 4.3 10.8 38.9 4.3 5.1 3.5 7.0 1.9 2.0 25.0 4.2 3.6 9.1 4.7 4.9 3.1 5.9 3.2 4.5 4.6 4.0 2.8 8.0 17.8 5.4 2.8 3.6 4.5 3.2 1.2 12.1 25.7 12.0 3.4 9.8 20.4 35.6 8.5 12.3 2.9 4.1 4.4 13.4 3.0 5.8 4.7 12.0 7.0 7.5 11.9 14.0 11.7 11.9 14.4 3.9 17.6 9.7 4.2 7.1 6.4 10.6 10.4 22.8 18.9 7.7 10.9 3.2 15.5 9.0 17.0 16.0 1.0 3.2 3.2 5.4 19.3 5.8 9.7 3.7 5.9 4.5 6.0 10.6 23.8 12.6 6.6 8.6 9.3 9.2 20.5 20.0 25.5 11.3 27.3 5.2 4.5 13.0 11.3 2.9 3.0 0.5 1.5 0.5 0.9 0.7 0.7 1.3 0.6 0.8 0.4 3.3 0.9 0.7 0.8 2.4 2.0 11.5 0.9 0.4 6.3 5.1 46.2 7.7 4.3 5.8 10.8 38.9 4.3 25.0 4.6 17.8 12.1 2.1 22.4 30.6 3.6 3.1 2.9 1.9 2.1 1.2 4.7 3.4 1.8 3.9 1.5 3.0 0.0 18.8 1.3 10.9 1.2 0.0 8.0 25.9 2.4 3.4 4.7 6.1 2.1 6.6 11.2 5.1 7.1 0.5 3.5 7.6 1.6 2.9 16.5 1.8 1.7 3.3 2.4 0.0 4.6 5.8 2.9 5.6 3.3 3.6 1.9 7.5 1.8 2.1 2.0 2.5 11.3 9.8 3.8 3.3 1.5 2.1 0.4 5.4 8.6 0.0 2.6 3.4 11.8 8.1 2.2 3.1 0.7 3.7 1.8 3.3 0.8 ACP6 "ACPL1, LPAP" ENSG00000162836 "Acid phosphatase 6, lysophosphatidic" Q9NPH0 1 147629652-147670524 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 108.9;RPTEC TERT1: 119.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028560 Uncertain "Intracellular and membrane" NA NA 64000 "HPA028560: AB_10602427" "unprognostic (3.17e-2)" "unprognostic (3.01e-2)" "unprognostic (3.50e-1)" "unprognostic (1.87e-2)" "unprognostic (3.85e-1)" "unprognostic (8.50e-3)" "unprognostic (3.36e-3)" "unprognostic (1.00e-1)" "unprognostic (6.32e-2)" "unprognostic (1.30e-2)" "unprognostic (3.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.52e-2)" "unprognostic (3.94e-1)" "unprognostic (8.07e-2)" "unprognostic (1.26e-1)" "prognostic favorable (6.44e-4)" 6.4 13.7 6.3 4.2 6.2 5.1 18.0 5.4 6.7 11.9 7.0 11.0 7.5 8.4 16.3 7.9 12.8 6.8 8.4 5.7 7.7 15.8 13.3 7.4 3.9 6.4 6.0 5.2 9.3 11.1 22.1 15.4 4.2 5.9 12.7 9.8 3.6 10.5 11.3 6.7 9.3 8.9 6.1 6.0 6.1 12.5 5.8 5.8 8.0 15.4 6.1 6.9 11.3 6.8 5.9 21.1 8.5 7.1 12.7 4.5 4.3 20.2 4.8 14.8 14.8 17.5 10.2 31.9 6.1 17.4 10.4 11.4 35.6 9.6 32.0 15.4 8.2 16.1 21.9 11.8 19.4 13.2 3.9 0.8 6.3 23.3 7.7 15.4 17.6 15.2 30.2 10.5 3.4 17.0 15.8 16.5 10.0 17.0 108.9 62.9 11.7 6.1 70.9 119.7 41.3 5.8 7.1 17.5 12.5 36.5 15.9 20.3 6.0 10.7 4.6 8.6 0.9 15.1 13.4 21.3 2.8 8.7 0.3 25.8 0.1 2.3 13.4 4.6 0.8 7.9 2.6 7.5 6.1 5.4 2.8 8.2 7.0 3.5 0.3 0.3 3.4 14.8 2.7 6.3 6.2 5.4 6.7 5.7 7.7 6.4 6.0 5.2 5.9 6.0 5.8 5.9 2.1 19.2 13.9 74.4 2.9 1.1 6.1 7.4 7.4 3.1 6.3 6.3 7.0 10.0 6.7 16.5 0.0 19.7 7.0 3.7 17.6 7.5 6.0 9.1 2.3 2.4 9.1 4.2 14.2 15.3 7.2 2.4 10.7 9.4 1.3 15.2 5.3 10.9 4.6 0.0 20.6 8.5 8.2 4.8 6.7 1.5 5.9 2.9 3.6 15.0 3.4 8.8 4.1 18.1 10.4 18.7 5.4 4.1 3.8 4.9 6.3 14.4 11.9 1.1 13.1 5.7 7.7 7.5 4.7 9.1 1.3 8.1 9.6 7.3 8.5 5.8 WDR64 FLJ32978 ENSG00000162843 "WD repeat domain 64" B1ANS9 1 241652278-241802133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 3.1" "Group enriched" "Detected in some" 18 "Early spermatids: 158.3;Late spermatids: 149.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046186 Uncertain NA NA "HPA046186: AB_10960064" "unprognostic (6.44e-2)" "unprognostic (1.13e-1)" "unprognostic (2.34e-1)" "unprognostic (2.78e-1)" "unprognostic (1.87e-3)" "unprognostic (1.52e-1)" "unprognostic (9.26e-2)" "unprognostic (2.35e-1)" "unprognostic (1.40e-2)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (4.49e-2)" "unprognostic (4.56e-4)" "unprognostic (2.43e-1)" "unprognostic (1.93e-1)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 158.3 0.0 0.0 0.2 0.0 0.0 8.3 0.0 1.2 0.1 0.0 0.1 0.0 2.7 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.0 0.0 149.8 1.8 0.2 0.0 2.8 0.0 0.0 0.0 1.5 1.3 0.0 0.0 0.4 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.9 0.7 0.0 0.0 0.8 0.3 0.5 0.0 0.0 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709432 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7" "Group enriched" "Detected in many" 4 "Inhibitory neurons: 282.0;Oligodendrocyte precursor cells: 378.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "HSkMC: 16.5;REH: 15.2;SH-SY5Y: 14.4;U-937: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.1 0.7 2.7 0.3 2.2 0.0 0.4 4.1 3.5 1.1 0.0 0.5 0.1 0.7 0.2 0.2 0.4 0.8 0.3 2.2 3.3 1.0 0.2 1.1 0.2 2.9 5.7 1.7 0.1 0.2 0.4 0.4 1.7 2.9 0.8 0.0 0.2 0.4 0.8 0.1 1.1 0.3 0.5 2.9 0.3 0.5 0.6 2.3 0.3 1.0 0.0 0.2 0.5 0.2 2.8 0.0 0.0 2.2 3.9 1.1 1.3 1.5 1.9 2.4 0.1 0.0 2.2 0.0 0.0 3.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.1 0.3 16.5 0.7 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 15.2 0.2 0.0 2.0 0.0 4.0 14.4 0.0 0.0 0.0 2.8 0.0 0.9 0.2 3.3 0.0 0.0 1.1 0.0 0.0 0.0 0.7 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.7 2.2 4.1 3.5 2.2 3.3 2.9 5.7 1.7 2.9 2.9 2.3 2.8 0.1 0.0 0.5 9.8 0.0 0.9 0.1 0.8 0.6 1.0 0.8 1.7 2.3 0.0 1.1 7.3 4.2 2.4 2.8 0.0 0.0 2.0 2.1 4.3 17.7 0.6 0.0 0.0 34.6 4.8 2.8 2.1 1.5 1.1 0.0 1.4 0.0 0.0 0.8 0.0 282.0 0.0 0.0 0.0 0.4 5.6 0.6 0.6 3.6 66.5 0.8 0.5 0.0 378.0 9.8 9.2 0.0 0.0 0.0 0.2 0.2 0.5 2.0 0.4 0.0 0.8 1.5 1.1 2.0 0.5 1.3 2.5 0.3 0.1 0.5 0.0 TFB2M "FLJ22661, FLJ23182, Hkp1" ENSG00000162851 "Transcription factor B2, mitochondrial" Q9H5Q4 1 246540561-246566261 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028482, HPA028554, HPA030265" Approved Enhanced Mitochondria NA NA Mitochondria "HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209" "unprognostic (4.38e-2)" "unprognostic (2.45e-2)" "unprognostic (3.79e-3)" "unprognostic (5.63e-2)" "unprognostic (1.10e-1)" "unprognostic (8.13e-2)" "unprognostic (8.76e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-2)" "unprognostic (1.68e-2)" "unprognostic (2.46e-1)" "unprognostic (6.81e-2)" "unprognostic (5.26e-2)" "unprognostic (2.27e-1)" "unprognostic (9.44e-2)" "unprognostic (6.41e-2)" "unprognostic (3.53e-2)" 11.7 23.7 3.7 9.5 4.0 24.4 12.2 6.5 5.0 8.6 5.9 12.7 11.5 7.3 9.6 11.0 8.6 7.2 14.1 3.7 4.1 21.4 38.1 6.4 13.4 3.9 4.1 3.5 6.9 15.8 10.9 6.4 9.1 4.0 8.9 13.0 5.0 11.4 7.5 22.9 9.4 9.2 8.1 4.0 7.1 10.2 8.8 4.1 9.4 13.7 24.6 13.3 13.4 6.1 4.3 33.9 31.9 12.1 21.5 14.8 21.1 42.2 24.2 24.8 26.9 24.6 39.0 31.6 59.8 36.9 24.7 17.4 28.5 29.3 25.7 36.8 23.4 11.3 30.3 18.1 34.5 24.2 54.1 26.3 21.0 30.2 23.1 25.8 14.8 21.2 20.9 89.2 19.8 23.4 15.7 27.5 24.1 53.8 58.6 32.1 27.2 23.9 72.9 24.5 36.7 26.7 53.8 23.4 41.9 82.2 13.3 30.6 51.3 15.6 18.7 22.7 26.6 63.8 57.1 102.9 47.6 23.0 52.6 23.9 0.3 5.4 1.5 9.1 5.7 11.5 11.9 8.0 9.7 12.9 12.0 10.3 8.9 1.2 14.8 9.8 11.1 12.3 5.3 3.7 4.0 6.5 5.0 3.7 4.1 3.9 4.1 3.5 4.0 4.0 4.1 4.3 11.9 6.4 9.4 4.2 17.2 53.3 13.7 27.9 31.9 3.2 12.4 11.9 16.5 14.3 18.4 16.5 10.4 24.4 13.1 7.6 29.4 13.8 1.5 17.6 12.9 13.2 11.4 8.6 8.1 15.5 28.1 10.2 18.8 22.4 14.0 7.5 5.7 33.9 11.9 0.0 7.2 14.3 6.1 9.3 7.7 3.4 6.5 7.3 5.4 1.9 6.9 6.6 7.2 6.0 5.5 11.0 10.3 4.5 12.7 17.2 7.8 39.2 15.4 3.4 13.1 14.4 12.2 13.2 21.6 21.3 44.9 21.1 10.9 17.7 19.8 10.4 CNST "C1orf71, FLJ32001, PPP1R64" ENSG00000162852 "Consortin, connexin sorting protein" Q6PJW8 1 246566444-246668595 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007225, HPA007226" Approved Supported Vesicles NA NA 480000 Vesicles "HPA007225: AB_1848869, HPA007226: AB_2667782" "unprognostic (1.55e-2)" "unprognostic (9.75e-2)" "unprognostic (3.33e-2)" "unprognostic (9.76e-2)" "unprognostic (2.78e-1)" "unprognostic (4.28e-2)" "unprognostic (3.72e-2)" "unprognostic (7.28e-3)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.52e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-3)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" "unprognostic (8.77e-3)" "unprognostic (2.26e-1)" 13.2 19.4 8.6 10.6 10.8 23.7 11.0 15.8 14.5 9.1 16.5 13.9 10.3 9.1 8.2 16.8 8.9 8.8 8.9 10.8 11.0 8.7 23.7 10.0 16.8 8.1 9.7 9.0 10.6 10.3 11.4 7.6 9.4 9.0 8.1 12.1 16.9 7.3 7.3 32.1 10.2 13.3 10.2 6.9 10.5 8.5 13.0 8.9 14.4 14.0 39.3 13.5 11.4 8.9 10.6 8.4 11.0 7.9 7.0 12.8 14.7 16.0 26.9 26.5 26.7 20.2 10.5 10.9 24.6 11.7 26.9 7.9 8.6 12.3 9.2 36.2 13.8 4.2 28.9 10.4 8.0 18.4 14.5 53.5 14.0 8.7 25.9 27.4 13.2 8.4 13.0 37.3 10.5 15.3 6.1 15.9 6.7 25.9 11.7 9.5 15.5 14.2 20.1 10.1 24.4 18.0 21.6 11.5 6.7 34.0 9.2 12.3 12.6 12.0 33.0 7.9 13.8 18.5 31.8 43.8 25.0 8.1 21.2 32.5 47.1 8.1 23.9 14.4 8.8 16.1 35.6 24.8 13.6 8.1 35.7 31.1 16.9 10.7 15.1 22.2 11.7 33.2 15.9 8.6 10.8 15.8 14.5 10.8 11.0 8.1 9.7 9.0 9.0 6.9 8.9 10.6 41.3 12.8 17.2 21.2 46.0 24.9 21.5 6.7 27.3 31.5 10.2 7.5 14.3 12.8 17.7 3.7 14.6 4.0 18.2 46.9 7.9 6.9 44.7 43.7 17.2 29.0 15.0 25.2 58.5 6.0 6.2 22.5 16.3 68.3 40.4 8.1 30.0 22.1 10.0 16.8 54.1 19.3 10.2 12.5 12.2 41.6 9.6 32.9 14.2 22.5 10.1 14.9 18.6 43.2 35.7 8.8 31.4 7.9 26.4 16.4 42.7 5.9 23.4 24.4 13.1 20.6 29.2 16.7 13.1 20.6 26.9 9.3 31.7 8.3 14.3 23.3 PPP1R21 "CCDC128, FLJ16566, KLRAQ1" ENSG00000162869 "Protein phosphatase 1 regulatory subunit 21" Q6ZMI0 2 48440598-48515391 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 99.6;Oligodendrocytes: 190.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036791, HPA036792" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA036791: AB_10671713, HPA036792: AB_2675317" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.78e-3)" "unprognostic (1.44e-2)" "unprognostic (7.46e-2)" "unprognostic (3.00e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.13e-1)" "prognostic favorable (4.59e-6)" "unprognostic (9.23e-2)" "unprognostic (1.93e-1)" "prognostic favorable (9.87e-4)" "unprognostic (6.60e-2)" 9.4 10.7 10.1 10.6 14.0 10.0 8.6 8.7 13.5 8.6 11.1 8.9 7.9 12.8 19.8 12.2 14.6 10.9 10.2 10.2 10.9 28.3 11.7 11.3 13.4 11.7 11.3 10.3 13.5 8.2 33.7 9.7 12.9 13.3 11.5 10.7 12.1 5.7 10.7 5.8 10.6 9.9 13.1 9.5 13.1 9.1 9.4 11.7 14.0 21.6 4.9 12.3 9.6 7.7 18.8 17.3 8.2 6.8 8.5 17.1 12.5 18.3 10.0 11.0 6.1 7.2 4.5 10.6 11.8 16.4 14.2 11.7 9.3 5.8 9.1 12.4 15.1 4.8 12.6 7.2 10.8 11.6 5.5 9.8 15.9 8.1 11.0 13.2 15.1 15.3 5.9 5.2 19.2 16.7 9.5 10.9 9.5 17.7 12.3 8.4 9.1 18.8 13.1 11.9 10.8 9.2 5.7 19.0 4.8 18.1 18.2 8.6 9.0 13.9 6.4 7.8 5.6 8.0 14.3 4.1 10.5 10.2 12.5 8.6 18.6 4.7 8.1 3.7 5.4 2.9 5.4 4.3 4.4 5.0 6.8 6.4 5.5 11.6 3.8 4.8 3.1 4.6 2.3 10.1 14.0 8.7 13.5 10.2 10.9 11.7 11.3 10.3 13.3 9.5 11.7 18.8 14.5 22.4 16.5 37.5 23.6 10.5 32.9 8.6 13.6 9.1 6.9 6.7 11.0 14.3 9.2 25.8 2.1 21.7 8.5 11.7 5.9 11.0 3.9 10.2 11.5 10.9 18.7 10.3 99.6 8.4 16.3 15.0 25.5 12.3 12.0 12.4 10.8 13.6 35.2 28.6 49.6 10.7 10.2 26.1 12.2 5.7 12.2 19.3 12.4 44.0 24.3 21.2 19.6 69.9 190.3 12.2 9.3 20.7 19.4 17.0 10.7 59.3 20.0 6.8 13.1 9.6 14.2 9.8 10.8 17.4 14.1 27.1 20.5 12.1 8.4 27.2 KLHDC8A FLJ10748 ENSG00000162873 "Kelch domain containing 8A" Q8IYD2 1 205336061-205357090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "ovary: 286.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 50.8;Granulosa cells: 97.0;Muller glia cells: 19.8;Peritubular cells: 21.1;Theca cells: 44.6" "Group enriched" "Detected in many" 5 "glioma: 45.7;thyroid cancer: 14.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.2;HAP1: 8.7;NTERA-2: 2.1;SCLC-21H: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (4.18e-2)" "unprognostic (4.80e-2)" "unprognostic (3.43e-2)" "unprognostic (3.21e-1)" "unprognostic (2.63e-2)" "unprognostic (2.97e-1)" "unprognostic (4.92e-1)" "unprognostic (8.37e-3)" "unprognostic (7.39e-3)" "unprognostic (4.03e-2)" "unprognostic (1.84e-7)" "unprognostic (4.53e-3)" "unprognostic (5.83e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.20e-2)" 0.1 26.7 9.5 0.4 7.3 6.5 0.5 15.3 15.2 1.8 3.9 2.1 0.8 1.6 0.7 4.6 14.0 0.6 0.4 12.9 44.0 0.2 0.2 0.2 0.2 14.9 11.2 7.0 286.3 2.1 0.6 18.1 0.0 17.9 0.4 0.6 26.7 1.4 0.2 0.1 0.5 0.8 2.5 11.6 0.3 6.9 6.4 15.0 0.3 3.4 0.0 1.2 0.4 2.5 16.1 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 7.3 15.3 15.2 12.9 44.0 14.9 11.2 7.0 17.9 11.6 15.0 16.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 50.8 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 2.1 7.1 11.6 1.2 0.0 0.0 7.6 0.0 0.2 0.0 97.0 0.4 0.0 0.0 5.0 8.9 0.0 0.0 0.0 0.0 0.2 5.3 0.2 0.0 0.0 0.0 19.8 0.0 3.0 0.2 0.3 0.0 21.1 0.5 0.0 0.0 0.2 0.1 4.8 0.0 0.0 8.1 0.8 5.0 0.0 0.0 0.0 0.0 44.6 0.0 0.0 PM20D1 "Cps1, FLJ32569" ENSG00000162877 "Peptidase M20 domain containing 1" Q6GTS8 1 205828025-205850132 "Enzymes, Predicted secreted proteins" "Hydrolase, Lyase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 78.7" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 20.9;Gastric mucus-secreting cells: 7.1;Proximal tubular cells: 7.1" "Cancer enriched" "Detected in some" 32 "urothelial cancer: 30.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 2.2" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enriched" "Detected in single" 9 "Karpas-707: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to digestive system" NA NA 3300000 "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (4.83e-1)" "unprognostic (4.08e-3)" "unprognostic (1.17e-3)" "unprognostic (3.11e-1)" "unprognostic (1.20e-1)" "unprognostic (5.50e-2)" "unprognostic (5.81e-2)" "unprognostic (4.57e-2)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (1.68e-2)" 0.8 0.0 0.4 0.1 0.3 0.0 1.2 0.1 0.9 0.1 1.2 0.1 0.1 0.1 0.6 0.0 0.4 0.0 0.3 0.3 0.5 6.4 0.2 0.2 1.1 0.8 0.7 0.2 0.3 78.7 0.0 0.0 0.1 0.9 0.0 0.1 0.3 0.0 0.0 0.0 19.2 0.1 0.0 0.3 1.0 3.0 0.0 0.6 0.1 0.1 0.0 0.4 2.2 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.5 0.1 0.4 1.3 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 2.2 0.3 0.4 0.3 0.1 0.9 0.3 0.5 0.8 0.7 0.2 0.9 0.3 0.6 0.4 0.8 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.6 0.5 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.0 0.9 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.4 3.2 20.9 0.3 0.5 7.1 0.0 0.0 0.0 0.7 0.3 0.1 0.0 3.5 0.2 0.0 1.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.0 1.5 1.5 0.6 0.0 0.0 1.8 0.2 0.0 7.1 0.0 0.8 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.9 2.4 0.0 0.1 PKDCC "SgK493, Vlk" ENSG00000162878 "Protein kinase domain containing, cytoplasmic" Q504Y2 2 42048021-42058517 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Differentiation, Osteogenesis, Protein transport, Transport" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 86.2" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 71.9;Fibroblasts: 55.4;Leydig cells: 137.6;Peritubular cells: 112.1;Rod photoreceptor cells: 95.9;Theca cells: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 85.9;ASC diff: 61.7;CACO-2: 101.0;HHSteC: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026427, HPA026442, HPA026526" Approved "Secreted to blood" NA NA 80000 "HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416" "unprognostic (6.77e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (3.59e-3)" "unprognostic (8.31e-2)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (5.79e-3)" "unprognostic (1.04e-2)" "unprognostic (1.32e-1)" "unprognostic (3.20e-1)" "unprognostic (6.09e-2)" "unprognostic (2.14e-2)" "unprognostic (9.08e-2)" "unprognostic (2.62e-1)" "unprognostic (4.73e-3)" "unprognostic (2.58e-3)" 25.6 11.4 2.7 5.0 3.8 0.8 16.3 1.1 6.2 32.0 6.4 19.1 10.8 25.9 2.1 2.2 24.4 3.4 31.2 4.8 1.5 10.6 6.9 16.6 2.1 1.7 1.7 4.8 50.6 7.0 1.2 6.8 3.6 3.0 12.3 5.8 5.3 20.9 5.9 86.2 3.5 13.8 9.9 2.0 9.7 9.6 14.9 2.2 6.5 5.1 28.0 1.4 32.7 17.5 4.7 0.0 5.5 14.0 85.9 61.7 0.7 5.3 0.2 0.0 1.2 1.5 101.0 0.2 0.0 0.3 1.7 1.8 0.0 1.3 0.0 0.0 8.1 3.5 0.2 3.3 27.0 53.7 0.0 1.2 5.7 0.3 0.2 0.0 0.6 0.7 0.0 1.2 0.0 0.3 0.3 0.0 0.3 23.8 6.8 1.7 0.0 27.3 0.0 0.0 0.0 2.8 5.1 1.3 0.0 0.2 16.3 0.1 0.7 0.0 0.6 2.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.8 1.1 6.2 4.8 1.5 1.7 1.7 4.8 3.0 2.0 2.2 4.7 28.8 19.2 0.5 4.2 0.3 3.2 0.2 0.0 0.0 4.7 1.3 2.0 9.2 1.5 0.0 1.8 16.7 0.5 0.6 22.8 0.0 2.1 1.1 6.0 31.4 3.1 71.9 0.0 22.8 1.3 1.3 55.4 2.6 26.3 0.0 4.5 2.9 2.7 0.6 0.0 3.3 18.6 0.0 0.6 3.1 5.4 137.6 0.6 1.8 3.7 0.0 21.3 0.0 10.1 1.8 1.9 16.0 112.1 0.0 0.8 15.2 3.9 0.0 95.9 13.1 14.2 15.1 0.7 1.7 0.0 1.8 0.3 0.8 135.4 35.9 0.1 OXER1 "GPCR, GPR170, TG1019" ENSG00000162881 "Oxoeicosanoid receptor 1" Q8TDS5 2 42762481-42764261 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 56.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 8.3;Proximal enterocytes: 16.1;Skeletal myocytes: 12.9" "Cancer enhanced" "Detected in all" "liver cancer: 12.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 67.0;eosinophil: 144.5" "Lineage enriched" "Detected in many" 79 "granulocytes: 144.5" "Cell line enhanced" "Detected in some" "CACO-2: 6.6;Hep G2: 7.6;HMC-1: 6.1;REH: 3.2;THP-1: 2.8" HPA051433 Approved NA NA "HPA051433: AB_2681485" "unprognostic (6.77e-2)" "unprognostic (4.20e-2)" "unprognostic (3.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.09e-3)" "unprognostic (4.45e-3)" "unprognostic (7.80e-2)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-3)" "unprognostic (5.39e-2)" "unprognostic (1.82e-3)" "unprognostic (5.83e-2)" "unprognostic (1.66e-1)" "unprognostic (4.89e-2)" "unprognostic (5.46e-2)" 1.9 1.8 1.3 1.6 1.3 2.4 1.9 0.4 1.8 6.2 1.3 2.9 5.1 3.1 2.4 2.4 3.6 1.4 2.3 1.4 0.7 8.2 56.8 1.9 1.2 1.1 0.8 0.8 9.2 7.2 0.3 3.8 1.7 1.1 6.7 1.8 0.3 1.5 1.7 0.9 3.1 8.6 0.8 0.6 4.9 2.3 1.2 0.7 1.0 2.2 0.4 1.1 6.1 4.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 6.6 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.3 2.2 0.0 7.6 0.0 0.1 6.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.4 0.0 0.0 3.2 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 67.0 1.8 144.5 0.1 0.6 0.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 16.9 0.0 0.1 0.2 0.0 0.8 1.3 1.3 0.4 1.8 1.4 0.7 1.1 0.8 0.8 1.1 0.6 0.7 1.4 0.1 0.0 0.5 0.7 0.1 0.5 0.6 0.2 0.6 1.6 0.4 0.6 0.4 2.8 0.2 1.8 0.0 0.1 0.0 1.9 1.9 0.6 0.0 0.1 2.0 0.1 1.2 0.0 0.0 2.0 0.1 2.0 0.0 0.1 2.5 0.4 0.4 8.3 1.0 0.0 0.0 3.4 0.0 1.3 1.2 0.3 3.4 1.5 3.6 1.0 3.0 0.9 0.0 0.0 0.0 0.6 5.3 1.9 0.0 0.5 16.1 4.9 0.2 0.0 0.0 12.9 1.1 0.3 0.2 0.3 0.1 0.3 1.1 0.3 5.1 0.3 HAAO ENSG00000162882 "3-hydroxyanthranilate 3,4-dioxygenase" P46952 2 42767089-42792593 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 298.2" "Group enriched" "Detected in many" 5 "Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7" "Group enriched" "Detected in all" 5 "liver cancer: 46.5;renal cancer: 13.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 23.2" "Group enriched" "Detected in many" 5 "dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036394, HPA042024" Enhanced NA NA 580000 "HPA036394: AB_10673131, HPA042024: AB_2677803" "unprognostic (6.97e-3)" "unprognostic (1.86e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-2)" "unprognostic (1.78e-1)" "unprognostic (7.23e-3)" "prognostic favorable (5.77e-4)" "unprognostic (6.20e-2)" "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.03e-1)" 8.8 5.4 1.7 5.9 1.9 4.1 13.0 2.0 2.5 15.1 3.2 13.3 23.3 10.6 14.6 6.0 10.7 6.2 6.3 1.7 3.8 42.2 298.2 5.8 6.2 2.0 2.3 1.5 14.2 26.5 2.9 4.5 8.6 2.1 10.2 11.7 0.3 3.8 11.4 2.4 4.7 41.1 4.8 2.0 5.4 9.7 1.8 2.1 4.1 5.8 3.2 4.6 15.9 9.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 4.6 14.0 0.1 0.0 0.1 0.6 0.0 0.0 4.7 0.0 0.8 0.0 1.4 5.6 0.0 49.4 0.4 1.9 0.1 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.6 0.2 0.0 9.9 1.1 0.3 0.0 0.0 0.1 0.0 0.6 1.0 0.0 1.3 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 7.9 17.4 19.2 0.0 10.5 0.0 3.5 0.0 0.0 23.2 3.9 0.0 0.1 5.5 0.7 2.9 7.7 0.0 5.6 1.7 1.9 2.0 2.5 1.7 3.8 2.0 2.3 1.5 2.1 2.0 2.1 2.3 2.5 0.0 1.1 3.6 3.5 4.0 6.3 2.3 14.8 0.1 2.9 7.6 0.6 14.3 1.6 1.8 0.0 1.1 2.9 18.3 17.6 7.4 0.0 0.6 8.1 1.9 6.7 12.0 3.4 13.3 0.5 18.0 1.5 0.3 30.4 1.2 4.6 209.8 21.3 0.0 2.2 14.9 0.0 13.5 4.9 0.2 12.5 8.7 5.4 8.4 8.4 3.6 1.0 5.5 1.0 4.8 28.7 10.5 0.5 2.1 236.8 162.7 0.5 0.3 13.1 37.7 13.8 0.4 0.7 6.0 4.8 1.2 1.2 2.2 25.5 2.7 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235447190-235504452 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 252.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007846, HPA050662" Approved Uncertain "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA007846: , HPA050662: AB_2681209" "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 4.8 5.4 2.5 2.8 2.4 1.6 4.1 2.7 2.5 5.1 5.2 7.2 3.2 7.3 4.8 9.0 5.6 5.3 6.1 2.5 4.6 3.3 3.2 3.4 2.2 2.5 2.8 2.3 5.2 22.5 6.8 3.8 4.4 2.5 7.4 5.4 3.9 6.1 6.6 23.5 6.2 5.2 10.6 2.6 2.7 9.0 5.9 2.7 3.6 7.3 16.8 3.4 7.9 5.4 2.5 15.0 10.4 11.1 16.2 14.2 15.7 21.6 14.1 11.8 9.8 10.0 7.7 13.1 8.2 15.3 15.5 7.0 17.3 21.3 14.8 12.5 14.5 11.7 5.8 12.7 9.3 10.0 17.9 4.3 9.9 9.5 10.4 21.5 7.0 14.1 19.2 10.9 10.9 9.2 7.3 10.0 8.8 15.7 7.9 3.1 10.6 19.9 18.8 6.4 21.1 14.2 16.8 23.7 7.8 12.2 3.9 18.5 15.6 13.1 9.7 13.3 16.6 18.1 11.3 14.8 5.0 6.7 12.1 21.7 1.1 1.1 0.5 0.6 1.6 0.8 0.6 0.6 0.7 2.3 0.5 0.5 0.9 0.2 1.2 1.4 1.9 0.3 0.4 2.5 2.4 2.7 2.5 2.5 4.6 2.5 2.8 2.3 2.5 2.6 2.7 2.5 9.6 9.6 5.0 38.8 7.8 31.2 39.0 15.1 36.5 33.1 8.9 6.7 6.7 1.5 9.5 5.5 252.3 20.3 14.6 5.2 0.0 6.9 26.7 20.2 14.8 7.0 9.0 5.0 38.4 7.2 7.0 11.5 10.7 19.9 5.7 11.9 4.6 4.7 3.9 28.6 56.2 6.2 4.1 3.0 16.3 7.3 10.5 6.9 1.8 23.4 11.5 11.2 7.2 29.1 21.7 9.2 5.4 16.1 14.0 27.6 9.7 2.3 8.1 18.4 0.0 21.0 20.5 35.8 40.3 28.5 29.7 22.4 9.0 17.6 7.0 33.1 MAPKAPK2 MK2 ENSG00000162889 "MAPK activated protein kinase 2" P49137 1 206684905-206734281 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 21.9" "Lineage enriched" "Detected in all" 6 "dendritic cells: 21.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263" "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 54.7 81.1 35.1 56.7 36.5 176.1 51.0 36.6 34.2 45.6 37.3 50.5 66.0 53.7 24.3 56.3 51.3 53.0 169.7 29.6 42.6 75.9 67.4 80.0 58.3 52.2 41.0 25.8 45.1 54.3 38.4 63.8 25.9 39.8 43.2 35.6 17.7 55.3 33.4 198.3 52.9 62.2 45.8 39.7 78.9 68.8 47.3 41.1 46.0 48.1 95.2 54.9 64.1 47.0 42.1 85.4 33.1 44.8 50.6 128.4 75.0 55.1 57.3 130.0 86.0 80.7 63.8 40.4 40.6 38.8 116.9 54.1 63.0 33.8 61.7 61.4 46.5 25.4 69.1 41.7 41.3 99.0 102.3 219.5 104.1 77.3 82.8 91.3 71.8 71.7 54.1 79.7 180.2 70.5 105.2 41.2 73.3 51.5 29.9 45.1 103.7 94.0 13.5 64.9 51.5 35.7 45.7 68.0 114.2 83.1 83.0 55.4 97.2 68.7 77.6 64.7 91.0 79.7 232.0 220.6 33.2 87.8 60.9 26.0 1.6 0.8 1.8 1.8 1.4 1.6 1.1 1.3 1.7 0.7 1.2 0.6 1.2 3.7 2.6 1.3 21.9 1.8 0.7 35.1 36.5 36.6 34.2 29.6 42.6 52.2 41.0 25.8 39.8 39.7 41.1 42.1 49.2 54.5 49.9 15.7 27.9 85.4 52.3 18.3 20.5 12.4 61.4 37.8 102.5 37.1 26.8 31.3 20.9 6.4 185.9 51.9 15.6 30.6 76.2 32.2 40.9 43.7 61.7 15.4 4.7 58.5 9.2 33.4 32.1 46.6 34.9 24.8 19.2 40.0 24.8 0.0 10.6 38.1 16.2 34.6 82.7 36.1 22.7 60.9 33.8 13.1 23.7 21.7 74.2 8.5 17.4 61.6 34.4 17.3 69.6 67.3 22.2 25.0 14.4 16.0 26.3 36.9 48.5 13.7 10.3 31.5 72.0 16.6 46.0 19.2 30.5 75.0 IL20 "IL-20, IL10D, ZCYTO10" ENSG00000162891 "Interleukin 20" Q9NYY1 1 206865623-206869223 "Predicted secreted proteins" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "Basal keratinocytes: 69.6" "Cancer enhanced" "Detected in some" "breast cancer: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SiHa: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" CAB025802 Uncertain "Secreted to blood" NA NA 109000 "CAB025802: " "unprognostic (3.08e-2)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-2)" "unprognostic (6.45e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.46e-1)" "unprognostic (1.60e-1)" "unprognostic (3.38e-2)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.6 6.6 15.1 0.0 0.0 9.4 3.7 0.1 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.3 0.0 9.9 0.0 0.1 0.0 0.1 7.3 IL24 "C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16" ENSG00000162892 "Interleukin 24" Q13007 1 206897443-206904139 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 15.3;lymphoid tissue: 25.7;urinary bladder: 14.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.8;Basal prostatic cells: 2.9;Fibroblasts: 11.6;Smooth muscle cells: 7.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 9.9" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 5.4;T-cells: 3.6" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 172.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB025972 Uncertain "Secreted to blood" NA NA 140000 "CAB025972: " "prognostic favorable (5.09e-4)" "unprognostic (3.79e-1)" "unprognostic (2.89e-2)" "unprognostic (4.09e-3)" "unprognostic (3.98e-1)" "unprognostic (2.68e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (3.35e-2)" "unprognostic (8.04e-2)" "unprognostic (7.63e-2)" "unprognostic (3.43e-4)" "unprognostic (5.41e-2)" "unprognostic (1.29e-1)" "unprognostic (7.91e-2)" "unprognostic (3.33e-2)" 1.9 0.1 0.1 3.6 0.1 1.5 0.7 0.0 0.4 0.3 0.7 0.9 0.0 1.0 0.0 0.9 1.0 1.3 0.7 0.1 0.2 0.8 1.2 1.8 5.9 0.2 0.3 0.0 0.2 0.2 0.0 0.5 1.0 0.2 1.0 0.0 0.0 1.1 0.0 3.8 0.2 15.3 0.1 0.2 25.7 0.6 0.1 0.2 0.0 1.0 0.0 0.2 14.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.7 0.0 0.4 0.0 0.5 0.2 0.1 0.0 3.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.2 2.5 18.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 16.7 0.7 0.0 0.0 0.0 2.3 1.2 7.4 0.5 2.5 0.8 0.3 1.4 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.9 5.4 1.7 2.7 0.0 5.0 3.6 2.9 0.4 0.4 0.0 0.0 1.9 0.8 0.1 0.1 0.0 0.4 0.1 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.0 1.3 0.0 1.8 6.8 2.9 0.5 0.0 0.0 0.4 0.3 1.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 7.9 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.1 0.7 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206903317-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 66.0;lymphoid tissue: 182.2" "Cell type enhanced" "Detected in many" "B-cells: 262.3;dendritic cells: 43.5;NK-cells: 108.1;T-cells: 74.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "RPMI-8226: 171.4;U-266/70: 73.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 5500000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favorable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 4.9 1.5 0.2 75.5 0.3 12.7 2.4 0.4 0.8 1.5 0.9 8.1 6.1 2.4 2.6 3.0 2.0 11.4 2.6 0.1 0.3 2.3 5.9 6.0 153.4 0.3 0.2 0.1 0.8 1.1 0.5 1.0 1.8 0.3 3.5 10.0 0.2 3.6 1.2 3.6 0.4 66.0 2.3 0.2 116.0 14.3 0.5 0.3 77.9 3.3 1.4 182.2 19.3 1.6 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.3 0.3 0.0 0.0 11.6 0.0 0.4 0.7 0.3 0.0 0.6 0.5 0.0 0.2 0.2 0.9 0.0 1.6 0.1 0.0 0.1 0.7 0.3 1.2 0.0 0.0 7.0 0.2 23.5 0.0 0.2 3.5 0.3 0.1 0.0 0.2 4.9 0.6 171.4 0.1 0.3 0.1 0.0 2.8 0.6 13.0 0.0 0.3 0.0 0.5 0.0 0.5 0.2 0.1 73.8 5.9 23.2 0.8 0.1 0.6 7.9 2.8 3.6 209.3 4.3 276.9 882.3 280.1 266.3 3.2 1057.5 483.2 336.0 56.0 218.8 4.3 13.7 687.7 416.6 0.2 0.3 0.4 0.8 0.1 0.3 0.3 0.2 0.1 0.3 0.2 0.3 0.4 1.3 0.0 3.9 0.0 262.3 0.0 4.9 0.0 1.2 0.0 3.5 3.0 3.6 5.7 1.3 0.0 0.0 0.1 43.5 0.9 0.0 1.7 0.2 0.8 0.7 1.7 0.0 8.4 0.0 2.9 0.1 3.4 4.1 0.9 0.0 0.6 4.6 1.4 4.4 0.0 0.0 0.6 0.0 5.7 0.0 0.4 0.3 8.1 0.0 0.0 3.6 0.0 108.1 0.0 0.0 1.2 0.3 0.0 30.5 2.9 0.1 1.0 0.7 0.0 0.0 0.2 2.9 0.1 2.3 1.7 0.0 0.0 74.9 0.0 1.9 6.8 PIGR ENSG00000162896 "Polymeric immunoglobulin receptor" P01833 1 206928522-206946466 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2664.9;salivary gland: 1659.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 7090.1;Intestinal goblet cells: 2361.1;Paneth cells: 3208.3;Proximal enterocytes: 1558.6;Undifferentiated cells: 4954.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 731.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "EFO-21: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006154, CAB009454, HPA012012" Enhanced "Secreted to digestive system" NA NA 1300000000 "CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371" "prognostic favorable (1.22e-5)" "unprognostic (7.42e-2)" "unprognostic (4.78e-3)" "prognostic favorable (2.57e-4)" "unprognostic (2.31e-2)" "unprognostic (6.71e-2)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (2.13e-1)" "prognostic favorable (5.08e-5)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (6.92e-3)" "unprognostic (3.39e-2)" 2.4 0.5 0.4 189.0 0.3 0.3 132.4 0.4 0.5 551.6 0.3 1709.1 2664.9 20.7 0.2 12.5 3.7 459.2 0.5 0.4 0.1 107.2 34.8 102.6 1.7 0.3 0.2 0.5 0.6 13.4 0.1 1.3 0.3 0.4 13.7 1234.5 0.1 1659.4 5.4 0.3 0.5 816.5 39.5 0.3 0.8 418.1 0.3 0.2 0.4 0.2 0.0 0.6 81.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 36.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.9 0.3 0.0 0.0 0.2 0.0 6.9 0.2 1.7 0.8 2.5 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.3 0.6 0.3 0.4 1.3 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.4 0.3 0.4 0.5 0.4 0.1 0.3 0.2 0.5 0.4 0.3 0.2 0.4 2.1 93.0 604.3 0.0 22.1 0.3 4.0 106.6 0.0 0.0 392.4 192.0 1.4 876.4 638.4 108.5 0.0 0.1 2.5 7090.1 17.6 92.5 0.0 65.9 14.6 5.4 426.4 2.7 0.0 64.5 0.0 4.7 482.1 120.1 52.0 0.0 1.8 28.0 0.4 0.0 0.0 2361.1 59.0 2.2 1.1 0.0 0.0 5.7 1.8 0.0 0.6 0.0 0.0 0.0 0.0 221.5 3208.3 0.0 0.7 53.9 1558.6 328.4 415.4 0.0 0.0 0.0 21.0 0.0 0.0 6.9 0.0 0.0 15.6 0.1 4954.6 761.3 FCAMR "CD351, FCA/MR, FKSG87" ENSG00000162897 "Fc fragment of IgA and IgM receptor" Q8WWV6 1 206957965-206970625 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 38.4;lymphoid tissue: 26.4" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 32.9" "Group enriched" "Detected in some" 5 "liver cancer: 2.4;renal cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056505 Enhanced NA NA 5300000 "HPA056505: AB_2732604" "unprognostic (2.94e-1)" "unprognostic (1.06e-1)" "unprognostic (8.53e-2)" "unprognostic (2.92e-1)" "unprognostic (7.44e-2)" "unprognostic (4.55e-3)" "unprognostic (2.69e-3)" "unprognostic (1.08e-4)" "unprognostic (3.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.08e-1)" "unprognostic (1.26e-1)" 0.2 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 38.4 8.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 2.4 0.6 0.0 0.0 1.0 0.0 0.0 26.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 CAPN2 "CANPL2, CANPml, mCANP" ENSG00000162909 "Calpain 2" P17655 1 223701593-223776018 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 858.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024470 Approved Approved Supported Cytosol NA NA 2800000 Cytosol "HPA024470: AB_1845925" "unprognostic (2.77e-2)" "unprognostic (1.27e-3)" "unprognostic (2.03e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.85e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.21e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.61e-1)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (6.21e-4)" 119.8 94.7 38.7 65.5 45.2 41.3 93.2 44.4 39.9 111.3 29.6 141.4 46.6 68.3 58.6 135.5 121.6 120.8 72.4 34.4 47.5 116.3 31.5 184.1 35.8 49.4 44.4 31.4 84.0 55.5 137.4 28.2 68.9 45.7 47.9 132.7 19.4 152.4 92.0 82.8 37.8 58.9 88.1 43.3 42.9 131.6 26.5 45.7 27.3 81.6 82.3 54.8 86.4 90.0 48.3 419.9 263.7 79.2 54.9 257.6 356.6 79.4 383.9 541.3 267.2 151.1 209.2 323.6 0.4 125.0 417.1 209.1 255.1 86.3 593.1 243.4 109.8 95.2 7.8 124.9 25.6 232.3 21.5 13.9 193.3 187.3 416.6 217.8 472.3 537.1 0.1 123.2 106.8 789.3 8.6 1.0 19.4 45.5 49.7 346.3 35.4 262.4 7.3 454.9 24.3 17.7 94.7 198.1 524.2 122.8 189.7 80.9 98.7 858.1 252.7 212.0 220.6 498.4 32.5 66.8 1.4 625.3 46.2 284.7 7.9 118.6 7.2 106.8 77.9 89.8 34.4 72.6 103.2 163.9 16.6 22.9 62.2 6.1 24.5 73.7 7.4 81.7 136.6 38.7 45.2 44.4 39.9 34.4 47.5 49.4 44.4 31.4 45.7 43.3 45.7 48.3 240.0 394.2 134.9 82.9 42.3 47.3 136.6 197.5 38.7 12.0 35.7 32.8 38.4 115.8 264.4 53.3 33.3 24.4 72.4 356.0 181.9 271.4 94.5 70.0 52.7 125.3 24.6 6.9 13.3 195.9 92.0 105.0 103.5 93.3 27.8 47.8 35.7 9.7 38.9 13.5 23.1 104.4 242.1 50.0 239.3 232.8 77.3 86.4 112.1 22.5 66.0 22.6 78.2 48.7 21.6 373.0 191.5 68.8 83.3 237.7 104.1 23.6 288.8 18.0 39.5 85.0 107.9 3.4 3.3 67.5 27.6 8.2 83.5 63.5 98.2 268.2 MRPL55 ENSG00000162910 "Mitochondrial ribosomal protein L55" Q7Z7F7 1 228106679-228109312 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 249.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027641 Supported "Intracellular and membrane" NA NA "HPA027641: AB_10600825" "unprognostic (4.84e-2)" "unprognostic (3.63e-2)" "unprognostic (6.10e-3)" "unprognostic (3.03e-2)" "unprognostic (7.49e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.22e-2)" "unprognostic (4.15e-1)" "prognostic favorable (6.76e-4)" "unprognostic (6.09e-3)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (5.54e-2)" "unprognostic (8.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" 42.4 60.2 46.3 15.0 46.3 50.3 43.9 49.6 67.7 39.0 39.3 42.9 24.7 38.6 16.9 41.9 38.9 16.6 68.5 46.7 47.8 57.7 94.0 34.0 21.9 51.7 46.8 48.3 39.1 47.6 28.5 52.7 14.4 49.0 48.6 7.8 8.1 43.9 23.9 76.7 42.3 35.9 12.2 47.4 40.7 49.2 41.6 49.8 16.0 43.7 20.8 11.0 40.9 34.9 50.9 59.8 89.3 18.7 34.2 21.5 23.6 75.7 40.0 21.4 43.5 36.6 90.3 56.1 46.2 82.4 27.6 22.5 50.1 18.5 43.6 10.4 39.7 202.3 21.3 68.9 100.9 36.1 56.1 23.3 26.5 35.3 39.1 21.5 17.8 35.5 70.7 54.7 48.6 20.5 69.2 66.5 84.6 63.1 58.6 249.7 58.4 36.7 124.1 27.0 31.4 49.2 49.2 33.1 100.4 75.1 6.4 84.4 50.4 30.7 36.3 41.0 69.7 78.0 42.9 58.3 57.9 60.5 47.9 73.5 62.5 107.6 83.6 86.8 113.5 104.3 121.0 99.2 95.8 107.3 152.1 101.9 108.1 67.9 94.1 96.3 147.8 128.7 104.3 46.3 46.3 49.6 67.7 46.7 47.8 51.7 46.8 48.3 49.0 47.4 49.8 50.9 41.6 44.8 59.4 9.1 58.9 76.3 71.5 131.8 44.3 35.9 108.1 112.3 93.1 87.2 82.0 93.8 8.4 142.0 50.4 80.7 236.7 70.2 121.0 44.6 43.2 55.7 78.2 57.4 12.0 94.5 127.2 59.3 37.2 46.1 48.1 53.5 73.2 262.4 124.3 23.5 10.4 105.1 105.8 64.5 128.9 216.3 77.6 54.9 72.9 3.7 98.6 68.7 70.0 4.5 8.3 87.0 69.8 70.0 79.3 74.7 190.3 270.1 73.6 40.7 78.9 46.5 69.8 77.4 80.9 59.4 97.0 110.5 50.6 57.4 94.1 76.1 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385146-224437033 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 243.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 34.0 28.6 24.2 32.4 23.0 89.7 26.9 22.6 23.8 27.9 29.6 27.4 21.4 26.8 21.0 52.6 22.9 27.4 27.4 25.5 25.7 23.9 35.7 35.4 34.1 24.7 23.7 20.4 24.5 24.6 26.7 20.8 35.9 24.4 26.3 25.6 31.8 29.0 25.2 57.6 40.0 26.7 28.9 23.6 38.5 26.9 37.7 23.2 36.3 26.2 45.4 33.5 32.9 31.8 23.9 49.7 28.0 54.6 29.7 76.8 74.6 47.6 58.4 86.4 51.7 48.0 39.0 46.8 51.9 74.4 86.3 21.7 40.6 40.2 47.2 76.1 55.3 53.6 36.2 31.5 31.0 74.7 40.3 68.6 70.8 58.4 55.0 52.1 72.6 80.8 31.7 52.7 51.4 62.4 24.8 42.4 34.7 65.7 41.5 32.0 42.6 66.1 44.2 55.1 48.3 29.5 56.0 64.8 94.9 74.9 55.5 117.5 67.0 88.7 47.7 28.7 41.5 71.3 66.8 33.6 35.2 53.3 26.1 66.8 2.1 1.0 2.1 1.4 1.4 0.8 0.8 0.8 1.0 0.9 0.6 0.7 1.0 4.8 1.5 2.4 1.0 1.1 0.8 24.2 23.0 22.6 23.8 25.5 25.7 24.7 23.7 20.4 24.4 23.6 23.2 23.9 32.6 105.8 54.2 55.2 34.4 111.4 29.6 30.9 43.3 24.6 54.1 30.5 49.2 40.0 48.2 35.0 31.3 30.4 54.3 34.8 5.9 22.2 243.3 60.6 35.2 44.2 35.4 53.7 63.4 23.8 15.7 37.9 26.5 71.0 48.1 34.1 41.4 44.2 53.4 38.7 61.3 44.4 40.7 133.4 96.4 102.1 37.0 74.5 46.2 67.5 45.7 16.3 32.0 63.3 70.0 34.2 26.2 28.2 33.0 49.0 19.2 22.8 55.4 24.2 19.7 35.2 41.4 37.1 25.8 63.9 122.3 68.3 45.1 37.9 25.0 63.7 REL "c-Rel, I-Rel" ENSG00000162924 "REL proto-oncogene, NF-kB subunit" Q04864 2 60881521-60931612 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.7" "Cell type enhanced" "Detected in all" "Langerhans cells: 2061.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 61.2;U-698: 109.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB004404 Uncertain NA NA "CAB004404: AB_670194" "unprognostic (2.77e-1)" "unprognostic (2.05e-2)" "unprognostic (8.26e-2)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (4.41e-2)" "unprognostic (1.11e-1)" "unprognostic (7.15e-2)" "unprognostic (2.15e-1)" "unprognostic (5.87e-2)" "unprognostic (4.38e-2)" "unprognostic (4.37e-1)" "unprognostic (2.82e-2)" "unprognostic (2.91e-2)" "unprognostic (3.53e-1)" "unprognostic (3.85e-1)" "unprognostic (3.66e-2)" 4.8 4.6 1.9 14.2 2.0 37.7 5.5 8.1 4.4 4.7 0.9 4.6 4.8 5.7 2.8 6.1 3.3 8.2 2.2 2.3 1.8 3.4 7.3 6.7 15.9 2.3 1.6 1.8 5.0 5.0 6.3 1.9 5.5 3.7 4.1 5.0 9.9 4.7 2.8 2.4 8.4 5.3 3.5 0.9 11.2 5.8 3.5 1.7 9.3 4.1 2.5 16.5 13.2 3.3 4.1 7.2 3.8 3.4 4.5 2.7 2.6 7.3 2.5 3.2 1.8 2.1 3.2 6.0 61.2 6.4 2.2 4.6 7.7 5.3 3.9 4.0 7.0 5.0 6.3 6.5 3.5 1.5 13.3 7.1 2.3 10.1 4.6 7.0 3.0 4.8 6.6 7.6 4.3 1.7 4.0 9.1 5.6 4.2 5.0 1.8 12.0 8.8 2.7 2.8 24.5 3.3 3.5 6.4 7.9 2.3 5.0 4.6 5.5 5.6 5.0 6.0 3.5 3.8 5.4 2.8 109.7 3.0 10.9 2.7 3.4 4.1 2.6 2.8 4.5 2.0 5.9 1.5 2.2 3.5 7.9 1.0 2.1 5.0 2.9 5.7 3.1 1.9 2.3 1.9 2.0 8.1 4.4 2.3 1.8 2.3 1.6 1.8 3.7 0.9 1.7 4.1 67.5 320.5 325.8 8.1 430.2 517.6 123.3 69.4 194.6 82.0 95.3 58.5 5.0 48.6 165.0 51.5 85.5 29.0 469.7 59.0 3.9 31.7 4.2 150.5 79.5 103.5 42.5 37.0 16.3 29.4 58.5 97.3 96.4 300.1 412.1 82.4 30.0 19.1 51.7 58.9 16.7 49.1 46.8 141.5 2061.4 3.4 15.5 463.9 135.2 42.2 451.1 21.3 145.2 8.5 9.2 35.1 46.6 23.7 119.5 99.7 34.3 7.7 153.1 56.2 13.1 65.9 73.9 51.5 38.4 158.0 463.1 77.6 303.7 21.3 50.1 260.6 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridine synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: AB_2680824" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 3.7 3.7 3.1 4.1 3.0 5.1 5.4 3.2 3.4 3.0 3.5 3.6 7.6 3.4 6.5 2.7 3.7 4.1 3.8 3.0 3.0 4.8 15.1 4.9 6.8 3.1 2.9 3.1 4.9 4.0 3.9 2.9 3.2 3.1 4.9 4.4 3.9 3.9 2.6 3.2 4.9 9.4 2.7 3.3 4.9 3.4 4.5 3.0 4.6 7.0 1.9 6.9 2.6 1.6 3.9 3.2 1.7 4.9 8.4 4.1 4.6 5.3 6.1 5.5 6.0 5.6 4.8 4.4 12.8 6.3 3.4 5.4 4.2 5.7 4.9 7.4 10.0 2.9 9.0 2.5 15.9 7.6 10.6 5.8 5.3 6.0 4.2 9.4 7.7 7.9 9.1 9.2 6.4 4.6 2.7 8.0 8.7 4.4 3.0 3.5 7.7 6.6 4.7 4.3 6.3 2.8 3.9 5.0 9.7 9.9 3.5 3.4 6.3 5.9 5.7 4.6 3.9 4.7 8.1 3.8 23.6 5.0 6.8 6.5 9.1 1.2 1.1 2.3 1.3 2.5 3.0 1.4 1.6 0.9 1.7 1.7 1.9 2.3 3.1 4.8 3.0 1.0 1.1 3.1 3.0 3.2 3.4 3.0 3.0 3.1 2.9 3.1 3.1 3.3 3.0 3.9 6.6 0.0 14.3 20.5 6.8 2.4 3.5 3.3 1.8 6.6 5.9 2.8 5.1 1.5 4.3 3.7 0.0 7.0 8.1 11.9 7.9 3.7 1.6 6.2 4.3 5.8 1.2 5.9 28.3 5.1 4.7 3.1 5.1 8.5 0.0 9.9 4.6 16.3 5.8 1.7 21.7 2.5 4.1 5.7 2.1 1.8 3.1 4.6 1.8 14.0 9.0 7.0 7.2 19.1 24.4 3.5 3.0 1.5 4.6 3.8 26.7 6.3 7.7 7.1 6.6 3.1 3.0 13.9 13.4 3.9 2.3 12.4 6.6 8.2 4.5 10.6 PEX13 ENSG00000162928 "Peroxisomal biogenesis factor 13" Q92968 2 61017225-61051990 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 125.8;Urothelial cells: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032141, HPA032142, CAB032689" Enhanced Supported Peroxisomes NA NA Peroxisomes "CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676" "unprognostic (2.44e-3)" "unprognostic (4.10e-2)" "unprognostic (7.84e-3)" "unprognostic (2.73e-2)" "unprognostic (1.28e-1)" "unprognostic (5.08e-2)" "unprognostic (2.05e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "prognostic unfavorable (8.07e-5)" "unprognostic (5.42e-2)" "unprognostic (4.44e-2)" "unprognostic (1.93e-1)" "unprognostic (2.84e-1)" "unprognostic (1.41e-1)" "unprognostic (2.63e-2)" 9.6 8.1 7.1 6.8 7.7 7.5 11.2 10.2 9.3 10.3 10.1 10.3 10.3 9.3 7.5 10.3 6.6 8.9 12.0 7.2 8.9 13.7 25.2 9.3 6.9 7.2 7.9 7.3 11.1 11.9 9.6 7.5 9.3 7.8 14.7 10.8 8.8 8.7 5.8 14.7 7.3 9.9 8.1 7.5 6.7 10.2 15.1 7.5 7.4 13.8 13.8 6.8 13.9 9.2 8.2 15.5 11.3 15.7 20.3 14.8 11.5 24.2 15.9 12.3 10.6 10.8 16.9 22.9 10.0 16.7 15.6 19.9 22.8 14.1 19.2 20.0 9.9 9.7 9.2 15.1 28.0 17.5 13.9 10.8 14.2 28.9 14.5 22.3 16.2 19.4 11.3 22.8 8.7 16.3 14.1 10.4 16.6 17.2 28.6 11.2 11.1 17.4 12.7 20.3 38.2 17.7 12.2 17.7 23.7 14.9 18.5 15.8 7.1 15.3 20.2 27.0 11.8 13.6 14.2 11.6 25.0 12.7 14.0 14.5 12.4 3.9 5.9 5.0 3.9 4.7 5.4 5.8 5.5 5.1 4.1 6.1 4.6 3.7 5.5 5.0 4.5 5.4 3.9 7.1 7.7 10.2 9.3 7.2 8.9 7.2 7.9 7.3 7.8 7.5 7.5 8.2 12.9 19.2 19.1 14.0 13.8 51.2 35.1 61.9 25.6 11.9 23.0 13.2 21.9 28.6 53.0 22.0 8.4 36.9 13.4 27.6 25.4 28.8 125.8 24.5 16.1 15.1 2.4 9.9 18.8 28.5 43.1 14.5 12.8 28.8 8.2 15.6 13.6 49.3 20.9 16.8 16.8 14.5 36.7 14.6 25.9 28.7 9.6 14.8 16.0 25.3 19.3 12.6 18.6 14.1 19.4 23.2 13.2 11.7 9.9 43.9 28.8 33.2 38.7 15.0 6.6 11.6 18.8 66.8 26.4 21.8 50.3 68.7 15.0 11.4 18.1 112.0 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 11.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 91.2;Inhibitory neurons: 78.5;Oligodendrocytes: 63.8;Respiratory ciliated cells: 58.0;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051240: AB_2681401" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 2.5 1.6 4.0 1.8 4.4 1.1 1.8 4.7 7.0 4.3 2.0 3.2 2.6 1.8 2.2 1.6 3.4 1.3 2.3 4.1 4.2 1.2 1.0 3.6 1.6 5.1 4.0 3.1 1.1 1.6 1.3 3.4 1.6 6.5 4.2 3.7 11.3 1.5 1.3 1.8 3.9 2.8 2.4 2.9 1.4 2.5 3.7 4.7 2.5 1.8 2.3 1.6 1.5 1.8 6.9 5.1 10.9 12.5 5.3 6.5 7.7 4.3 10.1 2.2 4.8 4.4 3.4 3.2 2.1 2.6 7.5 9.8 6.3 8.2 3.3 6.7 10.0 3.0 2.2 6.9 8.8 3.5 2.5 2.0 3.7 4.9 8.8 3.1 5.3 7.1 3.0 2.1 1.7 13.5 0.4 2.1 1.7 3.9 5.9 2.5 6.7 10.5 0.5 5.4 10.6 7.5 4.7 11.8 2.6 3.4 9.1 1.8 2.7 9.4 7.8 3.1 6.5 6.8 1.0 3.1 3.0 5.6 1.8 5.5 0.4 0.5 1.8 0.4 0.7 0.4 0.5 0.4 0.2 0.5 0.1 0.0 0.3 1.3 0.5 1.0 0.3 1.5 0.2 4.0 4.4 4.7 7.0 4.1 4.2 5.1 4.0 3.1 6.5 2.9 4.7 6.9 12.9 6.4 5.8 26.1 1.5 2.5 3.2 4.4 1.8 14.5 3.5 2.8 7.0 2.8 11.6 3.7 56.3 1.1 4.5 7.5 0.0 3.8 4.0 22.4 8.3 8.0 7.7 5.5 91.2 6.2 2.7 8.0 14.8 4.5 1.3 18.6 7.1 0.9 5.8 8.4 78.5 5.3 4.1 5.9 5.3 2.6 3.7 5.2 3.6 22.5 9.1 5.1 7.2 19.1 63.8 9.2 8.4 1.9 2.0 4.0 4.7 0.8 58.0 45.4 0.0 4.4 7.5 10.5 20.7 4.8 3.3 0.4 4.0 0.9 4.7 2.7 TRIM17 "RBCC, RNF16, terf" ENSG00000162931 "Tripartite motif containing 17" Q9Y577 1 228407935-228416861 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 42.3" "Group enriched" "Detected in some" 27 "Early spermatids: 291.1;Late spermatids: 87.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.4;HEL: 2.1;NTERA-2: 1.9;SH-SY5Y: 2.3;T-47d: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA054908 Approved Approved Vesicles NA NA Vesicles "HPA054908: AB_2682638" "prognostic favorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (3.06e-2)" "unprognostic (5.45e-2)" "unprognostic (1.25e-1)" "unprognostic (7.74e-3)" "unprognostic (7.42e-3)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (8.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.04e-1)" "unprognostic (5.96e-4)" "unprognostic (3.88e-1)" "unprognostic (4.88e-2)" "unprognostic (6.33e-2)" "unprognostic (3.64e-1)" 1.1 1.2 3.7 0.3 5.6 0.2 2.9 10.2 5.0 2.9 1.1 0.5 0.3 2.0 0.4 1.9 3.9 0.4 1.2 5.4 2.2 3.0 0.2 1.5 0.6 2.2 1.6 3.7 3.2 0.7 1.6 2.2 0.3 5.1 4.1 0.0 0.2 4.7 0.7 0.1 1.8 1.0 0.2 0.0 6.5 1.0 42.3 2.3 0.0 3.2 0.0 0.2 1.7 3.2 1.6 0.1 0.4 0.2 0.2 0.0 0.0 4.4 0.3 0.0 0.0 0.0 1.0 0.5 0.0 1.0 0.0 0.1 1.1 0.0 0.0 0.1 0.1 0.4 2.1 0.7 0.1 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.3 0.0 0.1 0.2 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.3 2.3 0.0 0.2 0.0 0.4 5.6 0.1 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 5.6 10.2 5.0 5.4 2.2 2.2 1.6 3.7 5.1 0.0 2.3 1.6 0.0 0.0 0.5 0.3 0.1 0.3 1.7 0.1 2.8 1.0 0.6 0.9 1.5 0.0 1.5 1.8 0.0 0.0 0.9 0.1 0.0 0.7 291.1 1.2 1.3 0.3 0.0 0.0 7.0 0.0 0.0 1.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 87.9 1.2 0.1 0.0 1.0 0.0 0.5 1.0 0.5 0.9 0.6 0.0 0.4 0.1 0.7 0.0 0.0 2.4 0.0 0.0 0.1 0.3 2.5 1.8 0.2 0.3 0.8 0.9 0.0 0.0 0.6 RFTN2 "C2orf11, FLJ30574, Raftlin-2" ENSG00000162944 "Raftlin family member 2" Q52LD8 2 197568224-197676045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.1" "Group enriched" "Detected in many" 7 "Astrocytes: 152.8;Early spermatids: 125.0;Late spermatids: 351.7;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 320.6" "Cancer enriched" "Detected in many" 5 "glioma: 10.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 19.8;ASC diff: 15.5;ASC TERT1: 8.7;HSkMC: 10.7;TIME: 6.4;WM-115: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035232, HPA043190" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA035232: AB_10601495, HPA043190: " "unprognostic (1.15e-1)" "unprognostic (3.52e-1)" "unprognostic (2.07e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.89e-2)" "unprognostic (1.81e-1)" "unprognostic (3.09e-2)" "unprognostic (2.16e-2)" "unprognostic (6.04e-2)" "unprognostic (1.39e-1)" "unprognostic (1.05e-1)" "unprognostic (8.44e-3)" "unprognostic (2.56e-2)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.77e-2)" 10.9 4.7 29.2 2.0 47.5 0.3 3.2 40.7 32.5 4.4 8.6 1.8 0.7 4.6 1.2 2.5 2.2 4.5 3.4 27.7 29.4 2.0 1.0 2.4 2.5 47.1 37.4 21.6 10.0 2.0 0.6 0.7 6.2 47.9 1.7 1.9 4.3 3.3 1.6 1.5 2.3 1.3 3.4 40.7 2.0 1.5 3.1 37.4 0.9 1.9 5.8 1.5 2.8 2.4 73.1 0.2 0.0 19.8 0.4 15.5 8.7 0.7 0.2 1.3 0.0 1.1 0.3 0.4 0.4 0.5 1.8 0.4 0.6 0.0 0.0 0.0 0.8 0.1 0.1 1.0 0.0 2.2 0.3 0.3 10.7 0.4 0.1 0.0 0.1 2.3 0.6 0.0 0.2 0.4 0.9 0.1 0.1 0.8 0.8 0.6 0.1 0.5 0.2 0.0 0.2 0.5 0.2 0.0 0.0 3.0 3.4 0.1 0.0 6.4 1.7 0.3 0.1 0.3 0.5 1.1 0.2 1.6 0.0 9.6 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.1 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.1 0.1 0.0 29.2 47.5 40.7 32.5 27.7 29.4 47.1 37.4 21.6 47.9 40.7 37.4 73.1 14.8 0.0 0.6 152.8 0.2 2.4 0.2 0.1 0.0 1.3 1.3 1.4 2.2 2.8 0.1 0.0 0.0 0.2 0.5 0.1 0.0 1.0 125.0 0.9 9.7 13.0 0.0 0.0 1.2 0.0 0.1 16.3 0.0 0.4 0.0 8.6 19.6 0.3 0.4 3.3 1.5 0.0 0.0 0.6 3.3 351.7 15.8 0.7 16.0 32.8 0.0 23.5 0.0 198.5 320.6 0.1 0.0 22.2 1.6 0.3 0.0 0.1 0.2 1.5 6.6 16.2 8.3 4.5 2.8 0.5 2.3 0.0 0.6 3.3 0.0 0.1 DISC1 ENSG00000162946 "DISC1 scaffold protein" Q9NRI5 1 231626790-232041272 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 21.9" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 113.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "THP-1: 11.4;TIME: 8.7;WM-115: 8.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048911 Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA048911: AB_2732549" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-2)" "unprognostic (3.36e-2)" "unprognostic (6.69e-3)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.71e-1)" "unprognostic (8.89e-2)" "unprognostic (9.53e-2)" "unprognostic (1.31e-4)" "unprognostic (1.74e-2)" "unprognostic (2.02e-1)" "unprognostic (5.94e-2)" "unprognostic (1.94e-1)" 2.3 1.4 5.3 3.2 5.1 2.6 1.9 4.0 5.4 2.1 4.5 1.5 1.1 1.5 0.5 1.3 1.2 2.6 9.1 4.4 7.1 1.1 1.4 1.8 2.4 6.9 5.3 2.9 4.5 0.8 1.1 1.0 7.3 6.9 1.2 1.2 21.9 2.0 0.9 1.4 1.1 1.4 1.5 6.1 2.9 1.0 0.9 6.1 3.1 1.8 1.1 1.7 1.6 1.3 9.3 0.0 0.4 4.0 0.1 0.1 0.3 2.8 1.6 3.6 4.1 3.5 1.4 0.8 0.1 4.8 1.3 1.0 0.0 0.3 0.1 3.7 2.6 1.7 2.2 0.3 4.0 0.5 3.7 5.1 2.2 0.7 1.4 1.2 2.8 3.8 2.7 0.0 1.4 4.6 0.4 1.1 5.6 2.0 0.0 1.5 2.7 1.1 0.4 0.1 0.0 0.7 2.2 1.4 0.0 2.4 1.0 0.0 11.4 8.7 2.1 2.3 1.0 0.9 0.9 0.7 0.0 1.7 5.6 8.8 0.1 0.8 0.0 0.2 0.8 0.1 0.0 0.4 0.0 1.0 0.1 0.4 0.1 0.7 0.2 0.4 0.6 0.1 0.2 5.3 5.1 4.0 5.4 4.4 7.1 6.9 5.3 2.9 6.9 6.1 6.1 9.3 6.7 0.0 1.1 0.0 2.1 0.9 0.5 0.7 3.4 23.3 2.0 1.8 7.2 0.0 1.2 3.7 8.4 8.0 2.0 0.5 0.0 0.6 16.6 3.4 2.1 6.7 0.0 2.1 0.0 1.1 0.8 3.0 0.0 4.5 7.0 8.0 10.0 0.0 11.3 0.0 0.0 0.1 0.0 13.0 12.6 23.2 0.9 13.7 3.6 0.0 5.6 2.4 2.1 0.0 0.0 2.0 0.3 1.5 2.1 0.7 0.0 0.2 2.5 113.1 0.0 4.6 2.7 1.4 1.6 0.5 1.1 2.5 5.8 8.1 0.7 0.6 CAPN13 FLJ23523 ENSG00000162949 "Calpain 13" Q6MZZ7 2 30722771-30820542 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.4;stomach 1: 28.8" "Cell type enhanced" "Detected in many" "Club cells: 76.6;Gastric mucus-secreting cells: 50.0;Proximal enterocytes: 35.2;Undifferentiated cells: 18.1;Urothelial cells: 19.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RT4: 9.3;SK-BR-3: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029496, HPA029497, HPA030034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281" "unprognostic (7.42e-2)" "unprognostic (1.19e-1)" "unprognostic (7.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.56e-2)" "unprognostic (1.51e-1)" "unprognostic (1.68e-1)" "unprognostic (1.32e-3)" "unprognostic (2.17e-1)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.96e-2)" "unprognostic (3.64e-1)" "unprognostic (3.32e-2)" "unprognostic (5.03e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 0.0 1.3 0.0 7.2 0.9 1.2 9.8 0.9 11.5 21.0 0.2 0.3 0.9 1.1 2.9 0.0 0.7 0.8 2.5 0.2 7.3 0.0 1.2 1.2 0.6 0.0 3.6 0.4 0.2 0.0 1.2 3.9 24.8 0.0 1.2 0.2 0.0 0.1 29.4 0.2 0.8 0.1 28.8 0.1 1.1 0.0 0.0 0.0 0.6 4.2 0.5 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 9.3 0.1 0.4 0.0 21.9 0.0 0.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.9 1.2 0.7 0.8 1.2 1.2 0.6 1.2 0.8 1.1 2.4 0.0 6.4 3.1 0.3 0.0 0.0 10.2 3.5 4.0 0.0 4.2 1.8 1.3 0.0 76.6 1.8 0.0 0.0 0.0 16.9 0.0 1.3 0.8 2.0 0.0 0.1 15.0 0.0 0.3 5.3 0.0 0.6 50.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 1.5 12.0 6.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.4 1.9 6.2 0.0 0.0 2.7 35.2 0.2 12.4 0.0 0.0 0.0 6.1 0.0 0.1 1.4 0.0 0.0 0.1 0.0 18.1 19.4 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304752 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 20.0;salivary gland: 12.9" "Group enriched" "Detected in some" 4 "Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046607, HPA062660" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA046607: , HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.3 0.9 6.9 0.3 13.9 0.0 0.1 0.1 9.1 1.6 0.0 2.7 0.7 0.6 0.3 0.3 1.2 0.2 0.9 15.4 5.2 0.3 0.4 0.1 0.0 5.3 9.9 9.5 0.3 0.1 0.0 1.9 0.0 4.3 1.0 0.3 0.4 12.9 1.2 0.0 0.1 1.3 0.3 0.0 0.0 0.8 0.2 20.0 0.0 1.6 0.1 0.0 0.6 0.8 5.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 13.9 0.1 9.1 15.4 5.2 5.3 9.9 9.5 4.3 0.0 20.0 5.2 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 1.0 4.8 0.3 0.0 0.0 7.2 0.7 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 6.6 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MEMO1 "C2orf4, CGI-27, MEMO" ENSG00000162959 "Mediator of cell motility 1" Q9Y316 2 31865060-32011230 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 115.0;Inhibitory neurons: 111.2;Microglial cells: 100.2;Oligodendrocyte precursor cells: 106.1;Oligodendrocytes: 134.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042603, HPA057952" Approved Approved Vesicles NA NA 9100 Vesicles "HPA042603: AB_10806243, HPA057952: AB_2683562" "unprognostic (1.33e-1)" "unprognostic (1.28e-3)" "unprognostic (1.81e-1)" "unprognostic (2.94e-5)" "unprognostic (1.02e-2)" "unprognostic (3.96e-2)" "unprognostic (2.24e-4)" "unprognostic (1.70e-2)" "unprognostic (6.73e-2)" "unprognostic (8.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (5.95e-9)" "unprognostic (6.57e-2)" "unprognostic (2.26e-1)" "unprognostic (3.77e-2)" "unprognostic (4.23e-2)" 17.4 23.9 14.7 23.5 13.5 46.1 14.8 13.7 14.2 14.0 9.6 17.7 16.9 14.5 16.8 33.9 13.3 13.5 36.7 13.3 13.6 16.5 36.2 14.1 32.2 15.1 14.3 11.3 10.8 17.4 14.7 12.0 20.8 14.8 14.3 20.9 11.8 17.0 13.7 59.3 19.4 16.9 19.7 13.1 20.5 17.5 62.8 14.7 31.8 12.6 36.8 34.5 26.5 19.5 13.9 87.7 37.4 40.5 37.8 34.8 49.4 73.0 73.6 45.7 41.1 31.5 51.0 48.2 92.4 23.2 50.6 54.2 43.4 48.4 63.9 54.0 61.8 26.4 67.0 22.8 62.7 48.6 67.7 53.7 37.2 40.7 40.6 40.7 46.7 65.1 21.8 49.0 41.4 72.2 38.3 81.5 137.8 60.0 74.9 46.2 54.4 46.0 71.4 81.8 83.6 34.2 63.3 38.0 90.7 59.2 33.9 38.2 80.4 61.0 57.0 63.4 45.8 82.1 42.8 69.8 79.7 51.7 96.1 45.7 1.8 16.6 17.1 7.5 23.4 5.7 9.6 9.2 9.0 24.4 7.5 6.6 6.5 13.4 12.6 27.9 9.1 17.1 10.1 14.7 13.5 13.7 14.2 13.3 13.6 15.1 14.3 11.3 14.8 13.1 14.7 13.9 6.7 6.4 13.3 70.8 19.1 27.8 17.2 10.3 17.6 15.3 10.6 6.3 4.7 12.8 9.3 11.0 16.7 13.3 9.0 8.3 1.9 4.9 3.6 5.2 9.1 11.3 13.1 18.3 115.0 2.6 10.5 9.6 11.2 8.7 10.1 10.2 14.3 14.0 10.1 11.8 111.2 7.0 8.2 19.2 18.4 3.0 13.1 15.2 12.4 100.2 21.8 4.6 14.4 106.1 134.4 7.5 8.3 8.6 11.2 19.7 8.5 2.4 8.8 10.5 6.6 12.5 6.0 12.2 6.4 26.9 16.6 16.6 12.8 7.9 10.4 16.8 DPY30 "Cps25, HDPY-30, Saf19" ENSG00000162961 "Dpy-30 histone methyltransferase complex regulatory subunit" Q9C005 2 31867809-32039805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043761 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA 29000 Nucleoplasm "Golgi apparatus" "HPA043761: AB_10960501" "unprognostic (2.76e-2)" "unprognostic (1.48e-1)" "unprognostic (2.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (7.87e-2)" "unprognostic (1.01e-3)" "unprognostic (1.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.79e-2)" "unprognostic (1.49e-1)" 39.1 75.8 71.9 34.6 72.5 31.7 61.9 76.3 85.1 53.7 75.9 49.4 43.7 38.7 79.0 60.7 91.3 42.8 47.1 72.0 77.1 79.8 85.4 44.5 52.2 76.0 77.3 70.9 43.1 48.5 58.8 51.3 44.3 77.6 57.8 46.9 33.6 65.2 47.4 49.2 50.1 44.7 37.7 77.4 36.4 47.2 22.8 74.6 52.8 82.4 45.8 49.7 52.3 50.4 81.6 201.8 136.8 100.8 78.1 86.7 128.8 134.9 102.1 90.8 81.2 79.5 197.2 158.3 123.2 102.2 90.8 148.3 79.9 93.1 118.6 88.1 146.4 149.5 110.8 89.7 225.5 76.5 114.3 66.8 87.4 135.6 87.4 76.9 109.1 130.4 55.1 132.5 85.3 125.6 219.4 128.8 228.9 139.2 184.3 140.5 104.0 118.9 155.7 144.2 137.1 162.5 115.9 101.2 141.1 143.6 118.2 98.3 82.1 100.5 73.9 119.1 69.2 125.4 99.9 161.3 166.2 77.6 123.2 91.7 177.6 101.0 150.8 95.5 99.9 116.5 165.9 133.5 119.4 100.5 135.6 118.1 112.0 117.3 105.8 112.8 91.5 200.3 130.6 71.9 72.5 76.3 85.1 72.0 77.1 76.0 77.3 70.9 77.6 77.4 74.6 81.6 65.7 51.3 61.5 10.1 61.7 98.0 107.7 233.5 53.5 17.9 110.5 135.1 71.3 80.1 140.8 103.0 0.0 190.2 41.0 84.2 283.7 114.3 64.5 388.8 59.7 62.9 92.1 55.5 16.0 117.2 252.4 63.1 44.4 107.3 46.9 65.1 63.1 102.7 123.5 21.9 17.7 107.6 175.0 65.4 67.2 18.5 72.4 58.7 65.8 13.1 106.8 50.8 55.6 13.6 26.7 125.7 117.8 88.0 40.6 130.5 138.4 296.7 396.4 26.8 85.5 52.4 108.4 65.7 57.4 72.0 122.6 138.7 67.3 67.7 109.0 127.5 TYW5 "C2orf60, FLJ37953" ENSG00000162971 "TRNA-yW synthesizing protein 5" A2RUC4 2 199928913-199955736 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028294, HPA045803" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA028294: AB_2672549, HPA045803: AB_10964878" "unprognostic (3.44e-3)" "unprognostic (3.74e-1)" "unprognostic (2.11e-1)" "unprognostic (3.03e-2)" "unprognostic (9.22e-3)" "unprognostic (4.95e-2)" "unprognostic (1.47e-3)" "unprognostic (9.72e-2)" "unprognostic (6.55e-3)" "unprognostic (6.30e-3)" "unprognostic (9.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.87e-3)" "unprognostic (8.67e-2)" "unprognostic (4.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.42e-3)" 1.0 2.1 2.8 1.4 3.2 3.6 2.1 4.5 4.0 1.0 2.7 1.3 1.8 1.5 1.9 0.9 1.2 1.0 0.9 3.0 2.7 1.6 2.6 1.5 2.3 2.8 2.8 2.8 1.7 1.0 1.6 0.5 1.1 3.1 1.4 1.5 7.1 1.7 1.1 1.8 3.7 2.1 1.1 2.4 2.5 1.6 1.2 2.8 1.2 1.7 0.9 1.5 1.0 0.5 4.3 1.3 1.6 2.0 1.7 1.5 1.8 2.3 1.9 1.2 1.5 1.3 1.8 1.6 1.1 1.2 1.3 1.7 1.7 3.1 1.5 2.2 2.0 1.3 2.1 2.7 2.3 3.6 2.4 1.5 1.9 3.5 0.9 3.1 3.5 1.3 1.5 1.7 1.4 0.9 1.9 1.7 3.9 2.4 1.5 2.6 1.5 1.7 1.3 2.8 1.7 1.7 1.3 1.4 2.8 4.2 3.7 1.4 2.7 1.5 1.4 1.2 1.6 1.5 2.4 2.2 1.0 2.3 2.2 1.6 0.5 0.3 0.6 0.3 0.3 0.3 0.3 0.4 0.4 0.2 0.4 0.5 0.4 0.3 0.3 0.3 0.2 0.4 0.1 2.8 3.2 4.5 4.0 3.0 2.7 2.8 2.8 2.8 3.1 2.4 2.8 4.3 6.4 6.4 15.5 17.6 8.4 8.3 14.7 9.7 3.4 24.4 4.5 3.7 5.6 4.3 9.6 12.9 123.0 10.4 8.2 6.0 3.9 8.5 2.6 5.4 5.7 7.8 2.4 7.8 17.7 6.2 9.3 8.7 6.6 5.2 6.3 17.1 10.0 8.9 6.0 8.4 15.8 6.7 12.2 8.5 13.9 1.1 6.2 5.7 7.2 14.0 12.1 39.0 14.4 13.0 27.0 10.0 6.7 5.7 5.5 16.5 20.1 10.6 8.5 33.7 6.6 9.7 10.5 10.5 12.4 5.2 6.0 8.3 9.4 12.3 10.3 17.0 MAIP1 "C2orf47, DKFZp666A212, FLJ22555" ENSG00000162972 "Matrix AAA peptidase interacting protein 1" Q8WWC4 2 199955317-200008540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 30.0;Distal tubular cells: 37.2;Ductal cells: 31.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 33.8;Proximal tubular cells: 84.2;Syncytiotrophoblasts: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064013, HPA072231" Approved Approved Mitochondria NA NA Mitochondria "HPA064013: AB_2685175, HPA072231: AB_2732196" "unprognostic (4.89e-2)" "unprognostic (7.36e-2)" "unprognostic (7.40e-3)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.81e-4)" "unprognostic (4.86e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.02e-3)" "unprognostic (7.03e-2)" "unprognostic (2.00e-2)" "unprognostic (5.21e-3)" "unprognostic (1.45e-1)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (2.70e-2)" 11.2 16.2 6.9 8.4 7.2 18.8 11.4 10.3 8.5 7.3 6.3 14.6 21.3 7.9 7.5 11.8 9.1 8.1 13.7 7.6 6.9 31.3 46.6 7.5 8.8 7.0 7.3 7.5 7.6 10.4 12.3 5.8 9.4 8.1 9.2 13.2 7.3 9.7 9.0 22.4 9.7 17.0 7.6 7.6 8.6 12.7 5.0 7.2 9.4 9.8 16.9 10.5 9.3 8.2 8.6 23.9 21.8 19.3 15.2 16.8 16.9 44.5 21.1 20.2 30.7 29.3 59.5 21.0 15.7 29.6 14.6 25.4 25.8 28.7 22.7 28.8 24.7 32.9 26.4 18.5 54.7 22.6 36.7 18.0 18.1 18.3 20.3 21.9 17.6 19.7 29.9 35.2 19.8 20.2 31.4 27.8 34.0 24.7 25.2 51.6 26.4 22.9 31.6 36.6 30.5 21.8 15.1 21.7 24.4 40.1 24.3 21.6 22.1 17.6 17.9 25.6 15.6 23.7 18.8 23.6 33.7 27.0 21.1 18.7 9.9 12.9 9.4 10.8 12.8 13.3 13.8 10.6 7.7 16.8 14.1 10.0 8.6 2.0 8.9 12.6 13.5 13.9 8.2 6.9 7.2 10.3 8.5 7.6 6.9 7.0 7.3 7.5 8.1 7.6 7.2 8.6 11.7 9.6 14.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 10.8 14.1 0.0 0.0 5.0 3.7 0.0 30.0 7.0 0.0 37.2 31.4 0.0 10.0 10.2 6.1 0.0 0.0 0.0 28.0 33.8 6.2 0.0 11.9 3.8 12.2 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 21.2 0.0 0.0 1.3 0.0 0.0 84.2 5.8 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 32.0 4.0 18.3 0.0 0.0 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911934-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "brain: 27.5;choroid plexus: 25.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.3;MCF7: 5.1;T-47d: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.0 0.0 12.7 0.1 21.6 0.0 0.2 0.0 20.5 0.0 25.0 0.9 0.2 0.6 0.0 0.2 0.1 0.1 0.5 27.5 13.5 0.4 0.0 0.3 0.1 9.7 5.8 20.2 0.0 0.9 0.3 0.8 0.0 8.2 0.7 0.2 0.2 0.1 0.3 0.0 0.0 0.6 0.0 0.7 0.5 0.3 0.5 10.5 0.3 0.0 0.0 0.0 0.6 0.0 17.6 0.1 14.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 2.1 0.1 1.5 0.0 0.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 6.1 0.7 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 21.6 0.0 20.5 27.5 13.5 9.7 5.8 20.2 8.2 0.7 10.5 17.6 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 2.0 0.8 1.4 1.4 0.0 0.0 0.0 2.1 0.0 0.1 1.6 0.0 0.0 2.2 0.8 0.3 0.9 1.2 0.0 9.3 0.0 14.4 0.7 0.0 2.0 0.0 0.2 0.0 0.0 0.2 0.0 8.8 0.2 0.0 0.0 0.0 3.4 0.3 0.1 0.0 1.9 0.0 0.3 0.0 18.1 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 7.7 0.0 0.4 0.3 0.1 SLC66A3 "C2orf22, MGC33602, PQLC3" ENSG00000162976 "Solute carrier family 66 member 3" Q8N755 2 11155198-11178870 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 15.5;Cytotrophoblasts: 17.5;Extravillous trophoblasts: 82.4;Fibroblasts: 16.1;Hofbauer cells: 56.3" "Cancer enhanced" "Detected in all" "testis cancer: 72.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 64.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061607 Approved Cytosol NA NA Cytosol "HPA061607: AB_2797264" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.19e-1)" "unprognostic (5.55e-2)" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.09e-3)" "unprognostic (9.11e-2)" "unprognostic (3.14e-1)" "unprognostic (2.24e-1)" "unprognostic (4.93e-3)" "unprognostic (2.93e-1)" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.34e-1)" "unprognostic (4.00e-2)" 30.4 26.6 10.5 17.5 10.9 10.0 29.5 11.0 14.1 38.8 17.0 17.7 10.9 24.0 47.7 14.5 19.9 28.0 14.4 10.4 13.2 26.1 17.6 27.3 22.7 12.7 11.2 10.0 30.2 29.3 13.3 5.8 14.5 12.2 22.8 19.5 2.5 17.2 20.0 8.6 14.8 15.6 21.6 11.7 40.1 20.2 11.7 10.7 14.4 17.5 17.2 17.0 22.7 17.4 14.8 7.1 23.3 4.3 13.4 64.6 43.9 15.5 14.8 19.3 6.8 8.0 4.3 27.3 2.5 10.5 28.5 29.3 9.1 6.9 7.3 6.8 43.8 3.2 6.5 2.7 3.0 26.1 3.3 19.5 31.7 24.5 4.3 9.7 14.5 15.5 15.3 6.2 14.8 18.8 31.6 4.8 6.6 9.1 25.2 7.6 6.2 7.2 7.7 25.8 11.6 1.6 7.2 12.4 37.9 27.9 19.1 33.9 12.2 22.0 9.6 3.8 10.2 4.1 25.2 19.6 1.2 24.9 15.5 19.4 79.4 153.7 150.3 68.8 194.9 60.7 42.4 65.6 66.7 153.6 31.9 35.9 49.5 9.5 59.9 207.4 28.7 73.2 166.2 10.5 10.9 11.0 14.1 10.4 13.2 12.7 11.2 10.0 12.2 11.7 10.7 14.8 15.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 17.5 11.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 82.4 16.1 0.0 0.0 0.0 0.0 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 11.2 2.2 0.0 0.0 0.0 ARL5A ARL5 ENSG00000162980 "ADP ribosylation factor like GTPase 5A" Q9Y689 2 151788984-151828492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "basophil: 88.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 88.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027002 Approved NA NA "HPA027002: AB_10601685" "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (9.36e-2)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-2)" "unprognostic (6.04e-2)" "unprognostic (4.59e-2)" "unprognostic (4.61e-3)" "unprognostic (2.47e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-3)" "unprognostic (2.97e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (2.55e-1)" 20.6 21.1 12.4 13.2 15.8 11.9 19.9 17.4 12.8 14.8 13.6 17.8 22.3 14.2 7.4 24.1 14.7 17.4 36.1 11.8 20.8 25.4 22.6 20.1 20.5 18.7 14.8 8.1 15.4 16.1 18.1 7.6 23.8 17.3 17.3 16.8 17.8 15.6 13.7 32.8 29.0 20.7 18.2 19.1 14.7 17.9 6.4 16.1 17.6 29.9 36.9 24.8 18.4 11.3 19.4 20.2 20.2 29.0 25.7 20.9 35.6 39.1 34.7 26.8 24.8 30.0 59.5 24.7 66.9 36.4 37.2 18.6 12.8 34.6 26.7 40.0 40.4 31.6 73.6 21.9 77.8 28.8 74.0 39.5 27.9 39.3 34.0 36.4 33.3 34.7 41.1 55.7 78.0 26.5 23.4 63.1 29.3 36.8 24.7 21.5 28.5 40.1 27.6 35.7 33.6 13.0 27.0 21.1 21.8 29.5 34.3 17.0 44.0 28.5 19.6 24.1 18.8 37.7 39.3 47.6 64.6 34.7 50.4 34.7 88.3 7.9 8.9 6.9 6.1 6.5 11.0 6.1 8.6 11.2 15.2 6.6 5.1 3.8 7.4 4.7 6.7 7.9 4.5 12.4 15.8 17.4 12.8 11.8 20.8 18.7 14.8 8.1 17.3 19.1 16.1 19.4 18.1 57.7 38.6 28.7 104.3 138.7 122.6 120.7 64.3 62.6 24.4 12.6 109.8 91.5 60.6 14.7 14.6 84.3 46.2 44.3 45.0 55.3 11.9 15.3 17.2 62.9 75.6 66.3 29.8 59.9 153.1 79.6 51.5 12.1 48.2 17.9 77.8 76.6 128.0 116.1 31.9 64.3 126.1 135.8 154.7 13.8 74.6 82.9 81.8 51.5 97.5 64.1 132.8 34.7 23.8 52.6 44.1 82.4 160.7 167.4 166.8 42.9 60.3 61.9 72.3 85.9 60.4 72.6 65.0 103.9 163.7 143.0 63.6 9.2 72.7 135.9 LRATD1 "FAM84A, FLJ35392, NSE1" ENSG00000162981 "LRAT domain containing 1" Q96KN4 2 14632700-14650814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.4;intestine: 41.3" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 162.2;Syncytiotrophoblasts: 207.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 35.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 9.4;hTCEpi: 18.0;RT4: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047703 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047703: AB_2680123" "unprognostic (1.05e-2)" "unprognostic (9.22e-2)" "unprognostic (2.24e-3)" "unprognostic (1.13e-1)" "unprognostic (4.28e-2)" "unprognostic (7.38e-2)" "unprognostic (2.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-1)" "unprognostic (4.44e-2)" "unprognostic (1.20e-1)" "unprognostic (9.27e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-1)" "unprognostic (1.58e-1)" "unprognostic (5.57e-3)" "unprognostic (1.36e-1)" 0.5 1.4 19.8 4.9 12.6 0.0 2.4 0.2 16.7 10.6 0.0 41.3 26.6 2.7 32.4 28.8 2.9 3.4 1.2 11.8 6.6 4.0 1.5 3.1 0.2 2.4 1.1 12.8 8.2 3.3 5.3 3.3 5.3 4.7 13.7 36.5 1.0 14.0 2.1 0.9 17.0 25.5 2.8 0.0 0.2 3.0 12.4 1.7 1.3 2.2 0.1 1.4 15.0 16.7 6.6 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.2 2.5 0.6 0.5 0.0 0.3 0.0 0.0 0.3 0.0 9.4 1.0 4.2 1.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 18.0 0.0 5.9 0.2 0.0 0.0 0.0 0.0 1.3 7.8 0.0 0.2 0.8 0.0 4.0 0.0 0.0 0.1 6.9 49.3 4.3 2.0 0.0 1.8 0.0 0.3 0.0 0.0 2.9 8.2 0.7 0.0 3.2 0.0 0.0 0.0 2.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 12.6 0.2 16.7 11.8 6.6 2.4 1.1 12.8 4.7 0.0 1.7 6.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 162.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 22.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 207.8 0.0 0.0 0.0 0.0 KCNJ3 "GIRK1, KGA, Kir3.1" ENSG00000162989 "Potassium inwardly rectifying channel subfamily J member 3" P48549 2 154697855-154858354 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.6;heart muscle: 15.2" "Group enriched" "Detected in many" 5 "Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3" "Group enriched" "Detected in many" 5 "breast cancer: 12.2;renal cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.5;SH-SY5Y: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024231, HPA064138" Uncertain Approved "Plasma membrane,Mitochondria" NA NA Mitochondria "Plasma membrane" "HPA024231: AB_1855558, HPA064138: " "unprognostic (1.45e-1)" "unprognostic (9.42e-2)" "unprognostic (2.66e-2)" "unprognostic (4.49e-4)" "unprognostic (8.89e-2)" "unprognostic (6.81e-2)" "unprognostic (7.24e-3)" "unprognostic (1.15e-2)" "unprognostic (4.25e-3)" "unprognostic (3.72e-3)" "unprognostic (3.33e-1)" "unprognostic (8.90e-3)" "unprognostic (3.75e-2)" "unprognostic (5.59e-1)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" 0.5 1.4 5.2 0.1 9.1 0.1 0.3 33.6 17.7 1.6 3.9 0.8 10.8 0.1 1.1 0.1 0.4 1.3 15.2 15.6 6.4 10.6 3.2 0.2 0.0 2.7 7.2 9.0 0.1 2.1 10.4 6.9 0.0 10.3 6.6 0.8 5.1 0.0 11.4 5.3 0.1 9.6 0.2 0.6 0.4 0.7 0.4 4.6 0.0 0.1 0.2 0.0 0.4 0.6 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 0.1 0.1 5.2 9.1 33.6 17.7 15.6 6.4 2.7 7.2 9.0 10.3 0.6 4.6 8.6 0.3 0.0 0.0 38.8 0.0 0.8 5.3 0.0 0.0 10.9 3.7 1.7 49.0 5.7 0.0 20.2 14.6 0.0 0.0 0.1 5.9 0.1 0.3 0.0 0.0 1.3 31.1 0.0 309.6 3.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 1.3 0.1 124.5 431.3 7.0 0.0 0.0 2.1 0.0 6.2 0.6 1.8 5.6 0.0 0.7 0.0 32.6 6.8 0.0 1.2 4.1 0.0 6.1 16.2 8.7 0.0 3.9 0.0 8.0 1.6 0.4 0.3 0.0 1.8 0.0 0.8 1.9 8.4 4.7 NEUROD1 "BETA2, BHF-1, bHLHa3, MODY6, NEUROD" ENSG00000162992 "Neuronal differentiation 1" Q13562 2 181673088-181680547 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 60.4;retina: 126.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 77.5;Cone photoreceptor cells: 150.1;Enteroendocrine cells: 424.2;Rod photoreceptor cells: 203.7" "Group enriched" "Detected in some" 4 "glioma: 1.9;pancreatic cancer: 4.3" "Group enriched" "Detected in all" 4 "cerebellum: 60.4;pons: 16.6" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 74 "SCLC-21H: 321.5" "Region enriched" "Detected in all" 14 "cerebellum: 216.2" "Region enriched" "Detected in many" 19 "cerebellum: 217.0" "HPA003278, CAB022450" Approved NA NA "CAB022450: , HPA003278: AB_1845331" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" "unprognostic (6.92e-3)" "unprognostic (1.27e-1)" 0.0 0.1 3.5 0.1 2.7 0.1 0.0 60.4 7.5 0.0 1.4 1.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 9.2 2.2 0.0 0.0 0.0 0.0 1.6 5.0 3.4 0.0 10.2 0.0 0.7 0.0 16.6 0.0 1.4 126.8 0.0 0.0 0.1 0.0 4.7 0.0 1.4 0.0 5.5 0.3 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 321.5 4.3 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.4 0.2 0.2 0.1 3.5 2.7 60.4 7.5 9.2 2.2 1.6 5.0 3.4 16.6 1.4 1.4 2.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 77.5 0.0 0.0 0.5 0.0 0.0 0.0 150.1 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.9 424.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.1 23.8 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 25.9 0.0 0.0 0.1 1.7 12.6 0.0 0.0 0.2 0.7 0.1 0.0 203.7 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.2 CLHC1 "C2orf63, FLJ31438" ENSG00000162994 "Clathrin heavy chain linker domain containing 1" Q8NHS4 2 55172547-55232563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 35.6;Early spermatids: 52.6;Late spermatids: 40.1;Oligodendrocyte precursor cells: 48.2;Oligodendrocytes: 40.2;Respiratory ciliated cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045418, HPA053557" Uncertain Approved "Nucleoli fibrillar center,Centrosome" NA NA "Nucleoli fibrillar center, Centrosome" "HPA045418: AB_10962144, HPA053557: AB_2682188" "unprognostic (1.60e-1)" "unprognostic (2.86e-1)" "unprognostic (3.43e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.91e-2)" "unprognostic (6.41e-3)" "unprognostic (1.03e-3)" "unprognostic (1.39e-1)" "unprognostic (3.54e-4)" "unprognostic (6.36e-2)" "unprognostic (1.05e-4)" "unprognostic (1.84e-1)" "unprognostic (1.47e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.15e-4)" 2.3 2.8 5.6 1.8 3.6 2.1 3.4 7.3 4.2 3.1 9.8 2.6 2.1 4.2 5.0 2.6 4.4 3.1 2.4 3.4 4.3 2.7 1.7 2.5 2.9 4.9 5.1 2.6 3.2 2.6 5.5 5.9 3.7 4.1 4.6 3.2 7.8 2.8 3.5 1.7 4.9 2.8 3.5 4.7 3.5 2.4 15.2 3.5 4.1 3.9 1.0 2.1 2.9 3.0 4.8 3.4 2.2 6.6 3.4 2.4 3.3 5.1 4.2 3.9 2.1 1.9 4.5 2.8 4.7 2.6 1.9 2.7 5.3 2.8 3.7 4.3 4.3 3.6 7.1 7.9 4.5 2.8 4.4 3.5 4.3 3.0 2.8 6.0 6.6 2.2 4.3 3.8 2.9 2.4 2.5 3.9 4.6 2.3 1.2 1.0 3.8 3.3 3.0 3.5 4.2 6.4 4.4 2.8 4.0 4.7 4.7 2.8 2.4 5.8 5.2 3.4 2.7 3.5 5.4 1.5 2.6 4.3 4.4 1.4 0.5 0.2 1.3 0.3 0.6 0.0 0.4 0.5 0.3 0.4 0.4 0.6 0.3 0.1 0.9 0.5 0.9 0.4 0.3 5.6 3.6 7.3 4.2 3.4 4.3 4.9 5.1 2.6 4.1 4.7 3.5 4.8 3.0 0.0 4.1 35.6 2.7 1.9 5.2 7.0 4.0 12.3 3.9 3.8 4.7 1.5 9.8 3.7 16.7 3.4 1.0 2.1 5.9 3.8 52.6 19.3 7.1 3.0 7.3 2.1 18.8 1.4 1.7 5.1 3.6 4.3 0.0 13.5 5.0 0.3 2.3 10.1 27.0 1.7 4.1 4.6 0.7 40.1 4.1 3.1 1.8 15.0 2.0 9.6 2.1 48.2 40.2 1.0 1.2 5.7 1.6 3.9 1.8 3.0 44.9 19.7 0.0 3.8 3.7 29.9 2.3 3.5 2.3 3.4 2.2 7.6 2.9 4.1 FRZB "FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3" ENSG00000162998 "Frizzled related protein" Q92765 2 182833275-182866637 "Disease related genes, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 339.8" "Cell type enriched" "Detected in many" 13 "Muller glia cells: 3633.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "hypothalamus: 73.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 19.2;ASC diff: 9.4;NTERA-2: 7.4;SH-SY5Y: 6.5" "Region enhanced" "Detected in all" "olfactory bulb: 56.9" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 44000 "unprognostic (5.39e-2)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" "unprognostic (1.79e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.64e-2)" "unprognostic (2.38e-2)" "unprognostic (4.67e-2)" "unprognostic (8.58e-2)" "unprognostic (5.41e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (8.97e-6)" "unprognostic (3.53e-2)" "unprognostic (1.05e-2)" "unprognostic (6.04e-2)" "unprognostic (3.21e-1)" 10.0 5.8 12.3 6.2 11.9 0.7 12.8 11.0 16.9 19.1 51.8 16.3 14.5 17.3 11.5 12.5 7.2 39.3 20.1 10.3 73.7 16.4 3.4 9.2 18.9 14.3 10.9 9.5 13.6 7.2 6.8 18.7 30.8 15.6 13.0 20.0 339.8 4.8 16.8 26.8 8.7 14.6 31.4 11.8 89.7 22.1 14.4 11.8 4.9 10.9 117.3 12.0 10.4 12.4 11.5 0.0 0.0 19.2 0.2 9.4 0.2 0.2 0.0 0.9 3.2 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 7.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 1.0 6.5 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 11.9 11.0 16.9 10.3 73.7 14.3 10.9 9.5 15.6 11.8 11.8 11.5 13.8 0.0 0.5 1.0 0.8 8.2 0.4 0.2 0.6 39.8 7.8 18.7 2.9 0.0 1.4 0.0 33.3 5.3 0.5 2.1 0.0 0.1 0.3 0.5 1.4 18.5 1.2 0.0 2.7 8.2 3.8 97.8 9.7 0.9 0.0 0.5 3.6 1.0 7.8 26.9 7.7 137.4 0.0 0.8 3.7 2.8 3.7 0.5 245.5 25.3 0.0 3633.8 0.0 8.5 1.7 0.2 0.8 14.7 5.8 1.8 1.3 0.2 0.2 124.4 276.1 41.9 157.1 0.2 0.1 0.6 3.1 12.4 1.5 22.9 3.4 0.6 DUSP19 "DUSP17, SKRP1" ENSG00000162999 "Dual specificity phosphatase 19" Q8WTR2 2 183078559-183100008 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021501 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA021501: AB_1847892" "unprognostic (1.24e-1)" "unprognostic (2.13e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (5.18e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (8.30e-2)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (6.53e-2)" "unprognostic (5.80e-3)" "unprognostic (6.97e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.75e-2)" 1.1 1.4 1.5 0.8 2.4 0.3 1.1 0.0 2.9 1.2 0.2 1.1 1.4 1.4 3.5 1.4 3.3 1.3 3.1 3.6 0.6 1.8 1.1 1.3 1.0 0.6 0.1 1.7 1.6 0.9 1.6 1.2 1.0 0.8 1.5 1.0 1.2 0.9 2.0 1.6 1.3 1.1 1.9 0.0 1.6 4.0 3.7 0.2 1.3 1.7 1.7 0.7 1.1 0.6 1.1 0.1 1.6 1.8 0.9 2.5 1.4 0.0 0.7 1.1 2.9 1.0 1.5 1.9 0.6 3.8 0.8 2.1 0.2 3.8 0.5 2.3 3.9 1.8 7.1 1.1 1.0 1.0 1.8 4.2 1.1 0.3 1.3 0.7 1.8 1.5 0.0 2.2 1.0 1.8 0.6 3.4 1.6 1.5 0.6 1.2 3.3 2.9 0.2 0.6 0.7 2.3 0.9 2.6 1.1 2.0 0.1 0.5 0.6 1.3 1.6 1.3 1.1 0.6 1.3 1.6 0.0 2.0 0.3 2.4 0.7 0.1 0.6 0.6 0.2 0.6 1.1 0.5 0.8 0.1 0.5 0.7 0.7 0.3 0.7 0.1 0.4 1.0 0.3 1.5 2.4 0.0 2.9 3.6 0.6 0.6 0.1 1.7 0.8 0.0 0.2 1.1 2.5 0.0 3.2 0.7 1.6 1.0 1.3 1.1 3.4 1.8 2.1 2.7 8.3 1.5 1.8 1.8 2.1 2.0 0.8 1.5 5.9 0.9 15.2 17.7 2.3 3.3 2.4 0.0 9.9 0.7 1.5 1.7 3.6 1.5 1.3 3.0 2.9 1.9 0.6 1.7 7.8 1.9 0.0 0.8 0.3 6.0 1.8 2.2 0.0 1.0 1.1 4.8 2.1 4.0 3.1 0.6 3.4 2.6 0.3 0.7 2.2 2.9 15.7 1.5 0.0 1.9 4.4 15.5 3.8 2.3 1.6 0.7 1.2 3.6 1.8 1.1 CFAP36 "BARTL1, CCDC104, MGC15407" ENSG00000163001 "Cilia and flagella associated protein 36" Q96G28 2 55519604-55545079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 1342.4;Late spermatids: 262.5;Spermatocytes: 346.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008994, HPA017061" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies" Cytosol "HPA008994: AB_2275429, HPA017061: AB_1846129" "unprognostic (8.11e-2)" "unprognostic (3.21e-3)" "unprognostic (1.24e-1)" "unprognostic (3.36e-2)" "unprognostic (7.98e-2)" "unprognostic (3.68e-1)" "unprognostic (4.65e-3)" "unprognostic (7.79e-2)" "unprognostic (1.51e-2)" "unprognostic (1.58e-2)" "unprognostic (3.66e-3)" "unprognostic (7.63e-2)" "unprognostic (8.57e-3)" "unprognostic (4.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.56e-3)" "unprognostic (2.96e-1)" 38.2 43.1 75.8 20.4 79.0 16.6 49.4 66.2 99.6 47.7 85.3 42.2 15.2 47.6 77.7 22.1 62.9 41.3 34.3 77.3 80.2 63.8 17.8 34.2 21.9 75.2 71.4 75.6 59.4 33.9 78.6 107.5 20.8 78.5 42.0 23.4 125.4 29.0 45.4 19.4 18.7 25.4 37.7 69.9 18.3 42.5 146.5 74.9 23.0 78.7 27.4 19.9 41.1 33.8 82.6 59.5 47.3 50.2 66.3 64.4 119.4 30.4 36.6 73.4 54.9 46.6 34.6 21.2 21.3 82.3 48.9 81.9 38.4 39.3 51.4 67.7 51.9 76.2 31.0 43.9 38.1 70.0 59.4 38.4 58.1 82.7 74.0 92.1 146.8 58.9 42.5 40.1 18.2 66.1 44.4 35.7 67.5 25.2 38.7 44.8 27.2 59.7 21.7 112.1 33.7 74.1 36.6 49.4 25.6 68.5 26.2 42.1 19.7 32.5 57.6 33.7 58.5 50.8 29.9 14.2 7.3 94.0 26.7 26.8 15.5 4.3 13.6 18.3 5.0 35.4 16.9 50.6 29.6 5.8 11.7 41.1 26.0 5.2 12.3 6.4 13.5 30.5 15.9 75.8 79.0 66.2 99.6 77.3 80.2 75.2 71.4 75.6 78.5 69.9 74.9 82.6 51.3 48.1 30.6 15.7 14.5 0.0 52.6 0.0 22.2 39.6 48.7 77.2 37.9 38.6 27.2 35.0 8.4 14.3 14.8 6.4 92.0 61.9 1342.4 184.4 51.8 42.9 17.0 21.0 51.6 60.7 27.0 44.7 21.9 36.3 39.1 27.1 42.1 10.7 23.6 23.5 41.1 12.2 0.0 8.7 0.0 262.5 75.2 12.8 0.0 14.0 16.9 145.0 16.5 21.6 13.3 37.0 11.5 67.7 11.4 41.3 7.6 146.9 99.1 92.4 59.2 43.0 43.4 346.0 29.8 16.1 0.0 7.8 24.7 36.0 9.9 35.6 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 151.6;Late spermatids: 424.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" No No "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favorable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 7.3 9.0 5.9 7.0 7.1 4.6 13.3 9.2 7.8 7.8 5.3 7.6 6.4 8.2 7.7 8.8 9.0 6.9 6.0 6.3 6.7 10.3 14.5 6.0 9.1 5.9 6.2 6.2 10.5 10.3 9.0 6.4 7.9 6.8 7.9 9.2 9.1 8.5 7.1 7.4 9.1 6.5 9.0 6.2 5.7 7.2 24.5 6.1 10.5 8.2 8.8 11.1 9.3 8.0 6.7 19.7 19.7 32.5 20.5 11.8 11.5 23.2 23.0 18.8 35.3 33.5 37.6 24.7 34.6 22.0 12.4 40.9 17.4 45.4 26.7 57.8 29.6 27.8 32.6 16.4 43.9 8.2 23.6 21.8 8.2 13.8 29.9 28.9 7.9 20.8 20.5 28.7 25.3 27.8 23.7 28.7 29.1 57.9 31.6 61.9 34.3 25.2 25.0 34.0 24.7 29.4 20.3 21.6 26.6 26.0 24.4 17.0 16.2 10.6 28.6 19.7 23.3 26.5 16.4 38.3 37.9 19.3 16.8 39.2 0.0 4.1 1.4 4.9 5.5 8.6 7.2 6.3 6.0 3.2 6.5 7.5 6.7 0.2 5.6 6.6 3.1 6.7 4.1 5.9 7.1 9.2 7.8 6.3 6.7 5.9 6.2 6.2 6.8 6.2 6.1 6.7 9.6 9.6 6.8 6.5 10.3 26.0 20.7 17.5 12.5 10.8 9.3 8.9 4.7 14.3 13.8 16.5 18.8 23.6 8.5 3.3 11.7 15.5 151.6 5.3 8.1 10.2 3.6 12.6 11.5 12.7 20.2 10.8 5.1 6.4 8.2 8.1 12.8 12.6 8.4 6.7 12.0 7.5 16.2 4.4 9.9 424.7 9.6 3.6 21.4 2.8 5.0 11.4 7.2 17.1 12.8 11.1 5.1 8.2 7.5 12.8 4.2 14.5 6.9 19.1 13.1 18.7 11.6 39.8 21.1 11.3 27.4 9.4 11.5 9.0 9.6 11.2 CCDC138 FLJ32745 ENSG00000163006 "Coiled-coil domain containing 138" Q96M89 2 108786757-108885477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.0" "Cell type enhanced" "Detected in many" "Early spermatids: 154.1;Excitatory neurons: 56.5;Inhibitory neurons: 58.9;Oligodendrocytes: 48.7;Respiratory ciliated cells: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049899, HPA054223" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049899: AB_2680941, HPA054223: AB_2682420" "unprognostic (2.34e-1)" "unprognostic (3.74e-2)" "unprognostic (3.22e-2)" "unprognostic (3.04e-1)" "unprognostic (2.83e-2)" "unprognostic (1.64e-2)" "unprognostic (2.24e-5)" "unprognostic (2.89e-1)" "unprognostic (1.01e-4)" "unprognostic (2.56e-1)" "unprognostic (1.64e-1)" "unprognostic (5.77e-2)" "unprognostic (7.06e-4)" "unprognostic (7.88e-2)" "unprognostic (4.73e-2)" "unprognostic (2.69e-1)" "unprognostic (8.93e-2)" 1.0 0.9 2.2 2.0 2.1 3.5 2.4 5.2 3.2 1.3 2.2 1.9 1.0 2.1 1.3 2.1 4.3 1.8 0.6 2.7 2.2 1.7 2.8 1.3 4.5 3.0 2.6 1.9 1.7 1.7 0.7 0.8 1.3 2.7 1.4 2.3 2.3 1.3 0.7 1.0 2.4 1.7 1.5 2.5 1.2 1.8 11.0 2.3 6.5 0.8 0.7 3.9 1.6 1.3 3.3 14.7 6.7 22.4 11.6 1.8 2.0 14.2 6.3 2.0 14.6 10.6 21.8 8.4 35.2 9.2 2.0 7.3 12.2 16.3 8.5 13.0 8.2 21.0 16.3 11.6 18.2 2.2 22.4 2.3 1.4 2.5 17.2 5.1 2.2 7.7 15.0 31.4 15.8 7.5 8.2 32.2 15.3 33.3 8.0 6.9 21.1 21.2 21.3 8.1 11.5 15.7 15.3 13.6 7.3 11.1 13.6 7.8 10.7 4.9 9.2 16.2 6.0 13.5 4.9 12.2 36.4 3.8 17.2 9.3 2.6 0.5 0.8 1.1 1.2 2.2 3.0 1.5 2.3 0.5 3.2 2.2 2.6 0.3 2.0 0.4 4.8 2.4 1.2 2.2 2.1 5.2 3.2 2.7 2.2 3.0 2.6 1.9 2.7 2.5 2.3 3.3 2.4 0.0 3.3 14.7 7.9 2.4 3.5 4.5 6.8 7.3 3.6 3.9 1.4 2.8 9.6 1.8 8.4 5.2 13.6 0.9 1.9 3.7 154.1 38.9 7.0 2.7 5.4 5.9 56.5 1.4 5.5 6.3 8.6 7.3 4.5 6.7 1.1 2.4 2.2 6.7 58.9 2.5 2.0 1.6 1.5 34.0 3.7 3.9 1.8 10.3 1.3 1.8 6.2 19.1 48.7 3.3 0.5 1.9 14.4 1.1 0.7 1.7 43.8 7.0 0.0 5.0 3.5 29.5 20.1 7.0 2.8 1.4 5.9 5.5 2.9 2.3 ZSWIM2 "MEX, MGC33890, ZZZ2" ENSG00000163012 "Zinc finger SWIM-type containing 2" Q8NEG5 2 186827475-186849208 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 9.3" "Cell type enhanced" "Detected in some" "Early spermatids: 61.1;Late spermatids: 18.6;Spermatocytes: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 61.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 18.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284478 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.9;Enteroendocrine cells: 12.0;Excitatory neurons: 28.8;Inhibitory neurons: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.1 3.0 21.8 4.7 30.9 3.4 1.5 7.6 43.2 1.5 0.0 1.7 1.4 1.6 2.4 1.4 1.7 1.8 0.8 30.3 11.8 1.0 0.5 1.6 7.7 6.0 5.6 32.2 2.5 3.7 5.5 14.0 0.5 14.7 2.6 1.5 3.1 2.6 2.0 0.1 2.3 5.4 1.2 0.2 9.2 1.8 2.3 6.1 5.6 1.2 0.1 7.0 1.5 1.4 25.5 6.4 3.1 1.0 0.0 0.3 0.2 1.4 1.2 1.0 2.0 2.5 7.2 3.6 46.6 0.2 0.2 4.5 5.1 6.5 4.1 2.0 19.4 0.6 14.5 8.0 3.0 1.5 22.2 10.4 2.5 1.6 0.1 1.6 5.6 0.3 12.7 2.9 7.6 2.1 1.7 7.7 20.4 4.7 2.4 2.7 25.4 11.7 23.2 1.3 2.2 15.7 5.8 8.0 3.3 5.0 0.3 4.5 9.2 0.4 7.0 5.9 6.4 1.2 8.5 3.9 22.1 1.8 23.7 3.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 21.8 30.9 7.6 43.2 30.3 11.8 6.0 5.6 32.2 14.7 0.2 6.1 25.5 0.3 0.0 0.6 2.6 5.1 0.3 0.3 1.0 1.2 13.9 1.8 1.4 2.1 1.5 0.3 1.8 0.0 0.0 3.4 0.5 0.0 0.5 0.2 0.3 2.5 0.4 12.0 0.0 28.8 2.5 0.1 2.1 0.0 1.1 2.5 2.1 0.7 0.0 1.9 6.7 22.4 0.4 2.0 4.7 1.1 1.5 0.3 3.2 1.8 7.5 2.6 0.9 2.1 5.5 0.9 1.1 0.3 0.7 3.6 0.8 0.1 0.3 1.1 2.3 0.0 0.3 0.7 1.3 2.4 0.5 0.3 0.0 3.1 5.4 0.8 0.2 ACTG2 "ACTA3, ACTL3, ACTSG" ENSG00000163017 "Actin gamma 2, smooth muscle" P63267 2 73892314-73919865 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 6240.2;seminal vesicle: 6298.2;smooth muscle: 8688.4" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 394.2;Smooth muscle cells: 287.8" "Cancer enhanced" "Detected in all" "prostate cancer: 255.0;stomach cancer: 237.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "T-reg: 8.6" "Lineage enriched" "Detected in single" 17 "T-cells: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 63.8;BJ hTERT+: 53.5;BJ hTERT+ SV40 Large T+: 214.8;HHSteC: 55.1;SuSa: 52.5;U-251 MG: 229.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "midbrain: 11.8;spinal cord: 4.7" "HPA041264, HPA041271" Supported NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (5.79e-3)" "unprognostic (2.25e-1)" "unprognostic (2.36e-2)" "unprognostic (2.91e-1)" "unprognostic (4.56e-3)" "unprognostic (2.50e-1)" "unprognostic (8.05e-2)" "unprognostic (6.53e-2)" "unprognostic (4.48e-2)" "unprognostic (2.93e-1)" "unprognostic (7.23e-2)" "unprognostic (4.75e-2)" "prognostic unfavorable (3.95e-7)" "unprognostic (9.30e-3)" "unprognostic (6.84e-2)" "unprognostic (2.29e-2)" "unprognostic (7.57e-3)" 191.4 37.5 2.5 731.4 3.1 0.0 139.7 2.4 8.9 448.4 12.1 6240.2 395.6 3653.5 125.6 1973.1 864.9 333.3 24.2 2.5 2.6 6.8 10.9 138.8 6.8 4.1 2.9 2.5 89.3 8.2 0.9 6.2 97.2 2.7 2269.1 1189.8 0.0 75.8 6298.2 16.5 78.7 1365.4 8688.4 2.5 16.7 2117.5 4.9 2.6 2.8 34.0 7.0 1.2 2939.0 673.0 2.8 0.7 0.3 20.5 0.3 0.0 0.0 63.8 13.5 53.5 214.8 38.6 6.7 0.0 0.3 0.9 0.0 0.4 0.1 36.9 0.0 28.3 0.1 0.0 0.0 2.9 0.5 55.1 0.2 0.6 0.5 0.3 29.0 0.0 1.5 0.0 0.2 0.0 0.0 0.5 0.0 2.9 7.9 0.2 0.0 0.1 0.2 0.4 3.1 0.5 13.6 0.6 2.3 0.3 2.8 1.2 52.5 0.0 0.3 0.0 1.1 2.3 2.5 229.9 0.1 0.3 0.8 0.7 1.0 0.9 0.2 0.5 0.3 0.2 0.3 0.1 0.1 0.8 0.3 0.4 0.1 0.4 0.5 0.1 0.2 0.4 0.1 8.6 2.4 2.5 3.1 2.4 8.9 2.5 2.6 4.1 2.9 2.5 2.7 2.5 2.6 2.8 3.5 0.0 0.5 0.0 0.4 4.5 2.7 0.5 0.6 0.0 9.8 394.2 14.6 0.0 0.1 0.0 0.0 7.4 0.7 0.0 0.0 0.0 5.8 2.8 1.5 3.1 0.0 0.0 0.1 0.0 36.8 74.1 0.0 4.8 0.0 1.0 22.9 0.3 5.4 0.0 0.1 0.0 0.0 0.0 10.4 26.6 0.3 1.0 7.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 10.8 0.0 0.4 0.8 0.0 6.6 1.8 287.8 0.2 3.2 0.4 7.7 6.4 1.7 8.4 0.0 3.7 WDCP "C2orf44, FLJ21945, MMAP" ENSG00000163026 "WD repeat and coiled coil containing" Q9H6R7 2 24029347-24049575 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 9.2;Distal tubular cells: 7.9;Granulosa cells: 4.3;Theca cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041054 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041054: AB_10796566" "unprognostic (1.07e-1)" "unprognostic (3.19e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.32e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (5.14e-8)" "unprognostic (7.69e-2)" "unprognostic (9.01e-3)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (5.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (7.76e-2)" "unprognostic (3.00e-1)" 2.7 3.7 3.9 3.9 4.1 1.4 4.5 4.8 4.4 3.5 4.8 3.6 2.5 4.2 3.7 3.2 3.3 2.7 3.4 4.0 4.5 3.6 4.1 2.7 6.7 4.1 4.1 3.9 5.4 2.6 5.0 2.4 4.2 4.1 3.7 2.9 6.3 2.9 4.5 6.2 2.9 3.3 3.5 3.8 4.2 3.0 4.9 4.2 7.7 3.1 8.7 7.0 3.6 2.7 4.7 12.3 18.8 20.1 14.0 13.6 10.7 7.2 14.6 7.8 15.1 14.1 17.2 5.6 32.0 6.2 7.5 12.6 8.8 28.7 10.0 15.6 19.4 16.4 19.7 8.5 17.8 9.3 18.0 13.0 6.5 7.6 15.6 7.7 7.8 14.3 18.4 27.5 8.7 15.9 5.6 23.8 10.8 24.3 12.2 14.3 25.7 33.8 12.9 7.1 6.1 15.4 21.3 7.2 7.0 9.1 14.0 5.4 7.9 13.9 12.0 13.1 7.2 13.6 14.4 19.2 45.2 7.7 19.0 9.5 0.0 1.8 1.1 5.2 2.7 5.3 3.3 3.3 3.8 3.1 2.9 4.6 5.0 0.4 3.9 2.0 1.1 5.4 3.3 3.9 4.1 4.8 4.4 4.0 4.5 4.1 4.1 3.9 4.1 3.8 4.2 4.7 3.1 3.2 3.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.7 2.7 0.0 0.0 0.6 9.2 0.0 2.9 1.8 0.0 7.9 2.3 0.0 1.5 3.2 1.6 0.0 0.0 0.0 2.0 2.5 1.4 0.0 1.0 0.0 4.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 1.4 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 1.0 4.5 0.0 0.0 SMC6 "FLJ22116, SMC6L1" ENSG00000163029 "Structural maintenance of chromosomes 6" Q96SB8 2 17663812-17800242 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 153.4;Spermatocytes: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035057, CAB037186, HPA042733" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "CAB037186: AB_1080031, HPA035057: AB_2674435, HPA042733: AB_2678134" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-2)" "unprognostic (1.33e-3)" "unprognostic (1.70e-2)" "unprognostic (6.57e-2)" "unprognostic (1.38e-2)" "unprognostic (3.91e-2)" "unprognostic (2.03e-2)" "unprognostic (2.94e-3)" "unprognostic (9.33e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.15e-4)" "unprognostic (7.02e-2)" "unprognostic (1.57e-1)" "unprognostic (1.25e-1)" "unprognostic (5.25e-2)" 8.3 5.3 7.1 14.8 8.1 13.4 8.6 11.8 7.8 8.9 27.5 12.0 9.0 9.5 17.5 13.3 8.8 9.4 8.7 8.4 7.8 8.9 17.4 9.1 21.8 7.3 7.1 6.4 7.0 6.2 6.1 11.7 14.3 7.7 6.8 13.4 6.9 12.6 10.9 9.5 14.8 11.5 8.7 5.7 15.0 9.9 35.5 8.0 14.4 7.8 8.8 22.7 8.7 11.5 11.0 50.6 24.8 31.9 26.6 33.6 32.2 32.2 26.4 18.6 16.7 16.2 27.9 19.4 43.9 16.6 24.2 27.9 34.4 38.5 31.0 25.7 52.3 25.2 60.3 16.2 42.1 31.3 42.3 31.2 24.3 21.4 27.0 35.1 20.5 38.9 26.4 67.5 35.4 31.9 20.8 32.8 21.7 43.3 25.3 19.7 38.7 90.0 29.9 16.2 27.7 28.0 29.9 38.4 20.0 30.0 35.1 12.7 18.7 42.7 41.3 16.5 32.5 47.2 25.0 43.5 87.9 21.0 45.7 30.0 2.2 3.8 8.2 7.8 4.2 6.6 24.8 6.0 7.1 5.1 26.4 4.3 6.0 3.1 7.5 6.7 27.7 14.4 4.1 7.1 8.1 11.8 7.8 8.4 7.8 7.3 7.1 6.4 7.7 5.7 8.0 11.0 25.6 48.1 12.5 34.9 63.7 18.2 21.6 41.5 68.3 15.2 8.4 9.3 36.5 14.3 30.8 5.5 12.5 15.2 51.5 18.9 11.7 17.0 153.4 33.0 26.3 21.9 11.3 36.6 51.1 11.7 27.5 21.0 32.1 18.2 20.8 38.6 15.7 19.3 17.6 6.7 47.9 15.7 16.2 10.0 9.1 123.7 22.4 20.1 26.6 30.0 22.0 12.5 25.7 56.3 60.5 19.7 17.2 27.4 25.3 25.1 16.0 14.5 27.2 17.4 46.0 41.2 67.8 150.0 87.9 37.4 14.2 12.4 22.2 28.9 21.2 14.9 VSNL1 "HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1" ENSG00000163032 "Visinin like 1" P62760 2 17539126-17657018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 702.2" "Group enriched" "Detected in many" 4 "Excitatory neurons: 442.7;Inhibitory neurons: 243.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 702.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 125.9;Hep G2: 124.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (1.04e-1)" "unprognostic (7.90e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (4.90e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (4.66e-2)" "unprognostic (2.99e-1)" "unprognostic (1.65e-1)" "unprognostic (2.18e-1)" "unprognostic (5.14e-4)" "unprognostic (3.26e-2)" "unprognostic (1.23e-1)" "unprognostic (6.19e-3)" "unprognostic (1.51e-2)" 0.5 27.8 71.7 1.4 179.5 0.1 6.3 23.9 702.2 6.8 0.0 4.6 0.2 1.2 0.0 48.3 2.0 0.2 40.0 127.3 93.7 1.9 21.0 2.9 0.1 46.1 10.6 162.7 3.6 1.3 0.2 2.7 5.4 73.2 3.9 5.4 18.7 9.8 0.8 1.3 11.9 0.3 1.1 0.0 0.3 1.4 0.8 32.3 1.2 0.8 3.0 7.4 1.5 26.5 229.4 0.7 0.1 1.4 21.2 2.4 3.0 0.1 0.0 0.0 0.0 0.6 0.3 13.6 0.0 0.0 0.0 0.0 125.9 0.8 4.0 0.0 0.0 0.5 0.0 0.1 124.4 0.0 0.0 0.3 0.9 6.0 0.0 2.9 0.1 0.0 0.0 0.1 0.6 1.6 0.0 0.0 0.1 21.0 6.7 0.0 0.1 0.1 0.0 0.0 0.4 9.3 8.5 0.0 0.0 0.0 4.9 0.0 0.1 0.0 4.2 0.0 0.0 2.4 0.1 0.0 0.0 3.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.7 179.5 23.9 702.2 127.3 93.7 46.1 10.6 162.7 73.2 0.0 32.3 229.4 0.1 0.0 0.5 41.1 0.0 18.2 29.8 54.3 59.2 8.8 4.9 19.7 30.8 4.3 18.0 0.0 0.0 0.3 0.1 2.2 1.9 0.1 5.1 0.0 0.1 1.1 1.2 0.0 442.7 0.2 0.2 5.9 0.0 0.1 0.0 0.1 0.0 17.8 0.6 3.3 243.2 7.1 18.3 0.3 0.8 6.5 0.6 0.5 3.6 54.4 0.6 3.7 0.0 36.7 42.9 0.2 1.0 0.0 0.0 15.0 0.0 4.0 0.8 14.7 0.0 0.2 1.3 1.7 0.9 85.5 20.2 0.4 0.8 1.8 5.6 14.2 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 74.1" "Cell type enhanced" "Detected in many" "Early spermatids: 424.4;Late spermatids: 274.9;Respiratory ciliated cells: 166.1;Spermatocytes: 154.2;Theca cells: 211.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 28.6;SCLC-21H: 23.2" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favorable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 3.1 32.9 11.3 1.2 8.7 0.1 9.6 7.7 11.3 15.1 24.7 5.3 1.2 12.9 9.0 3.0 34.8 7.1 3.3 10.7 10.5 8.0 1.3 6.3 1.4 10.4 10.6 8.3 14.9 2.6 20.6 35.0 1.1 9.5 15.9 1.7 2.0 3.1 6.3 0.5 4.8 2.6 3.0 10.4 1.2 3.2 74.1 11.3 5.3 7.4 0.8 0.8 14.6 8.0 7.5 0.0 5.9 6.0 0.3 8.4 20.2 0.5 5.1 8.4 4.6 3.4 0.2 8.9 2.3 3.1 7.9 7.7 4.6 2.6 1.5 1.9 6.1 11.1 0.0 6.2 0.2 1.0 0.2 0.5 6.6 0.6 4.5 0.0 9.0 1.8 12.7 3.4 6.5 4.2 3.8 13.3 3.6 28.6 2.3 3.8 6.4 0.0 2.7 11.8 0.1 23.2 16.9 0.6 0.8 0.9 2.3 8.2 1.3 1.9 1.4 4.3 18.0 3.9 1.3 1.2 0.8 19.0 0.6 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 8.7 7.7 11.3 10.7 10.5 10.4 10.6 8.3 9.5 10.4 11.3 7.5 0.8 0.0 0.5 1.6 0.3 5.1 12.2 21.6 14.2 1.0 34.8 28.4 0.5 4.3 15.8 7.3 0.0 0.5 1.1 0.8 7.9 9.4 424.4 88.2 7.6 1.4 7.7 0.0 3.7 0.7 0.4 11.1 1.1 4.7 0.0 30.4 1.4 0.1 0.3 0.0 2.4 0.6 16.2 0.0 5.9 274.9 37.0 0.8 1.8 1.0 0.0 14.2 0.0 1.0 0.5 2.7 0.5 68.4 0.9 7.4 0.1 2.6 166.1 1.1 0.0 2.5 14.2 154.2 18.8 7.2 6.0 0.3 1.2 211.1 2.4 7.2 H3-3A "H3.3A, H3F3, H3F3A" ENSG00000163041 "H3.3 histone A" P84243 1 226061851-226072019 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 600.6;Cytotrophoblasts: 1411.0;Extravillous trophoblasts: 2181.9;Hofbauer cells: 1487.3;Syncytiotrophoblasts: 1616.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4487.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 4487.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011481, CAB037178, HPA042570" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.19e-3)" "unprognostic (2.83e-2)" "unprognostic (3.74e-1)" "unprognostic (9.83e-3)" "unprognostic (4.71e-2)" "unprognostic (1.77e-3)" "unprognostic (3.69e-2)" "unprognostic (1.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (3.66e-2)" "unprognostic (8.03e-3)" "unprognostic (2.21e-3)" "unprognostic (6.03e-2)" 413.3 444.6 279.8 668.2 291.0 2052.0 600.9 301.0 346.5 548.7 297.6 715.0 661.1 496.8 727.6 601.2 570.2 492.0 504.8 267.9 331.3 462.1 542.3 442.7 800.0 314.2 300.6 263.4 457.0 439.1 503.8 272.1 494.0 307.6 479.0 797.6 274.0 592.1 385.5 340.3 622.2 678.2 472.7 314.4 543.7 552.2 258.2 293.1 1251.0 484.9 439.4 901.9 603.1 412.4 334.5 751.2 417.0 1589.6 910.2 432.9 498.9 1186.2 337.3 416.2 547.8 429.0 446.2 1214.5 715.3 731.0 427.9 273.5 684.4 802.4 631.9 535.0 445.9 1371.0 889.5 569.9 595.2 427.8 901.4 1026.6 465.6 715.8 385.3 502.1 743.0 826.8 915.7 1271.3 1125.2 626.2 433.8 1791.8 1504.6 2163.0 1881.1 815.7 1286.9 1110.4 1871.4 1159.6 784.3 1542.1 2279.8 991.0 1227.4 842.4 882.3 1399.1 2103.7 471.4 397.1 527.2 532.6 1024.0 523.6 643.4 1178.4 380.2 853.2 874.1 869.5 1043.6 1486.1 378.9 830.2 385.9 722.1 405.2 415.8 791.8 661.7 375.0 423.1 4487.2 442.5 945.8 635.2 636.8 1364.8 279.8 291.0 301.0 346.5 267.9 331.3 314.2 300.6 263.4 307.6 314.4 293.1 334.5 600.6 0.0 0.0 0.0 202.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 1411.0 449.2 0.0 0.0 0.0 0.0 0.0 0.0 109.5 0.0 0.0 0.0 0.0 2181.9 188.0 0.0 0.0 0.0 0.0 0.0 0.0 1487.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 1616.9 75.3 0.0 0.0 0.0 ANKRD30BL "ANKRD30BP3, NCRNA00164" ENSG00000163046 "Ankyrin repeat domain 30B like" A7E2S9 2 132147591-132257969 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 3.4" "Group enriched" "Detected in some" 4 "Excitatory neurons: 239.7;Inhibitory neurons: 229.8;Oligodendrocyte precursor cells: 73.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "REH: 2.0" NA NA "unprognostic (1.67e-1)" "unprognostic (1.42e-1)" "unprognostic (5.57e-2)" "unprognostic (2.15e-1)" "unprognostic (2.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 20.2 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.1 0.0 0.0 0.0 239.7 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 229.8 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 3.7 0.0 0.2 0.0 73.9 6.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 42.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226940286-226987544 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease variant, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 1176.3;tongue: 489.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 21.9;Collecting duct cells: 33.1;Ductal cells: 21.2;Exocrine glandular cells: 32.7;Proximal tubular cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 82.0;RPMI-8226: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria NA NA Mitochondria "HPA061662: AB_2684578" "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 64.5 124.8 4.8 10.4 6.1 26.3 36.1 15.8 8.2 15.2 11.7 28.3 30.1 16.0 0.5 32.5 24.8 19.9 95.3 5.4 4.6 14.5 36.0 9.7 12.8 7.7 5.2 6.0 34.4 94.6 6.4 5.4 6.6 8.4 18.7 6.5 1.4 33.0 11.8 1176.3 23.8 18.7 7.3 5.1 14.5 53.3 6.7 4.4 8.7 9.5 489.0 4.3 41.1 13.6 10.1 8.0 14.4 3.3 10.3 11.4 7.3 57.7 3.6 2.9 5.2 6.9 23.0 12.8 24.5 17.9 2.4 2.6 9.2 6.9 8.2 0.8 25.5 82.0 16.7 11.2 38.8 2.5 25.8 9.3 14.2 12.2 4.0 5.4 4.9 2.5 24.7 29.4 19.4 0.7 11.0 15.2 37.3 15.5 62.8 29.5 14.9 17.1 78.6 1.6 5.9 59.9 24.2 7.3 28.7 20.6 3.4 15.1 34.8 2.5 5.9 5.3 8.2 13.3 43.0 40.5 13.1 5.3 29.3 6.0 47.7 23.5 68.4 15.8 17.1 15.3 22.2 15.8 14.6 18.6 26.8 21.5 17.0 43.1 21.2 13.6 8.1 21.5 26.0 4.8 6.1 15.8 8.2 5.4 4.6 7.7 5.2 6.0 8.4 5.1 4.4 10.1 11.4 3.2 21.9 0.0 5.8 0.0 0.0 0.0 0.0 0.0 18.1 17.1 0.0 0.0 4.3 33.1 0.0 12.2 10.2 0.0 15.6 21.2 0.0 12.3 8.9 5.4 0.0 0.0 0.0 32.7 10.0 6.3 0.0 9.6 13.9 9.8 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 3.2 0.0 0.0 24.8 2.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 7.7 5.2 16.0 0.0 0.0 SLC16A14 "FLJ30794, MCT14" ENSG00000163053 "Solute carrier family 16 member 14" Q7RTX9 2 230034982-230068993 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 18.7" "Cell type enhanced" "Detected in many" "Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 24 "eosinophil: 11.3" "Lineage enriched" "Detected in single" 24 "granulocytes: 11.3" "Cell line enhanced" "Detected in many" "HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040518 Uncertain Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA040518: AB_10794877" "unprognostic (2.99e-1)" "unprognostic (1.74e-1)" "unprognostic (2.63e-1)" "unprognostic (1.74e-3)" "unprognostic (2.20e-3)" "unprognostic (2.01e-1)" "unprognostic (4.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.15e-1)" "unprognostic (5.70e-3)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.03e-3)" "unprognostic (3.51e-1)" "unprognostic (2.39e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" 4.6 3.9 7.9 1.7 7.5 5.7 3.2 9.3 7.7 5.0 3.0 3.7 1.0 3.9 2.3 4.1 3.1 2.8 2.4 6.9 8.0 1.1 2.0 1.9 1.3 5.4 6.8 6.6 7.4 0.8 7.1 1.4 1.2 5.9 4.5 4.0 2.6 18.7 3.6 1.1 11.1 1.3 3.8 3.2 5.9 1.4 1.2 8.9 2.3 1.5 2.1 1.5 2.0 2.7 4.8 2.9 1.6 1.3 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.4 0.0 0.5 0.0 0.3 0.1 0.0 0.5 5.1 1.4 0.1 0.0 9.7 0.2 3.1 0.0 0.3 24.2 0.0 0.5 3.6 0.0 0.0 3.9 0.2 4.7 0.0 15.2 0.3 0.0 2.4 2.7 1.0 0.3 2.7 19.5 0.0 17.3 5.6 2.6 6.3 2.3 4.9 0.0 0.1 0.1 7.7 1.9 0.0 0.0 1.3 3.3 2.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 11.3 0.4 0.0 0.3 0.3 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.9 7.5 9.3 7.7 6.9 8.0 5.4 6.8 6.6 5.9 3.2 8.9 4.8 17.0 0.0 0.0 2.3 1.5 2.5 0.5 1.9 3.4 3.3 1.2 0.8 3.9 0.0 3.5 0.0 2.1 0.0 0.1 1.8 0.0 0.8 0.0 0.5 2.6 10.8 3.6 0.0 18.5 0.6 0.0 2.3 0.0 0.3 0.0 0.2 4.2 2.1 0.1 3.3 21.1 0.3 4.1 0.3 0.6 0.0 1.2 0.1 1.8 45.0 0.0 1.9 0.0 13.6 1.8 0.8 1.0 3.0 8.4 0.9 0.0 0.3 1.6 1.6 0.0 0.5 1.4 0.2 0.2 6.8 4.7 0.3 1.4 8.4 1.3 0.3 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871430-94876823 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Group enriched" "Detected in many" 7 "Early spermatids: 137.1;Endometrial ciliated cells: 49.0;Late spermatids: 129.3;Respiratory ciliated cells: 51.6" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 2.9" "HPA048600, HPA053929, HPA069872" Enhanced Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favorable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.4 0.1 0.0 0.6 0.5 0.8 0.0 0.5 0.5 0.4 0.3 3.6 0.0 1.5 2.9 0.4 1.5 0.1 1.9 0.0 0.0 0.7 0.6 0.5 7.2 4.7 1.8 0.0 0.5 0.1 0.3 1.9 1.9 137.1 49.0 1.3 1.3 0.0 0.0 1.3 0.4 0.5 1.1 0.0 0.9 1.3 0.1 1.8 1.5 0.2 0.0 0.9 0.2 0.0 1.6 0.5 129.3 2.8 0.8 0.0 1.0 2.6 0.0 0.0 2.0 2.3 0.8 0.0 1.2 0.0 0.4 0.0 8.3 51.6 0.0 6.6 0.6 0.9 12.4 2.4 0.0 1.3 0.5 0.5 0.0 0.2 0.4 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847648 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.0;skeletal muscle: 14.1;skin 1: 9.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Region enriched" "Detected in many" 5 "midbrain: 15.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2" "Region enriched" "Detected in single" 5 "midbrain: 4.9" "Region enriched" "Detected in some" 6 "midbrain: 23.6" "CAB014884, HPA073141" Enhanced Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "CAB014884: , HPA073141: AB_2686573" "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 2.2 0.2 0.2 0.0 0.1 0.0 1.7 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.8 1.4 15.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 14.1 9.0 0.0 0.0 0.6 0.0 0.0 0.1 2.8 0.0 0.0 0.6 0.0 0.0 0.0 0.8 4.0 0.2 0.6 0.2 16.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 4.7 0.5 0.6 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.1 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.3 0.0 0.0 0.0 9.9 1.0 11.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.2 0.0 0.4 1.4 15.0 0.0 2.1 0.6 2.8 0.8 1.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 5.6 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 12.4 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 5.4 0.1 0.4 0.0 2.6 0.0 0.2 0.0 0.0 0.0 SGCB "A3b, LGMD2E, SGC" ENSG00000163069 "Sarcoglycan beta" Q16585 4 52020706-52038299 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 106.7" "Cell type enhanced" "Detected in many" "Late spermatids: 203.7" "Cancer enhanced" "Detected in all" "glioma: 56.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 104.7" "Low region specificity" "Detected in all" "HPA011422, HPA058656" Enhanced Approved Cytosol NA NA Cytosol "HPA011422: AB_1856795, HPA058656: AB_2683790" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (1.03e-1)" "unprognostic (1.60e-3)" "unprognostic (9.80e-2)" "unprognostic (3.42e-2)" "unprognostic (3.57e-3)" "unprognostic (1.86e-2)" "unprognostic (2.84e-2)" "unprognostic (6.04e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.53e-6)" "unprognostic (3.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (7.61e-4)" 33.0 21.8 29.0 9.6 32.1 0.5 14.8 29.5 32.5 23.6 23.5 26.3 13.2 28.4 11.2 22.1 20.7 19.7 57.7 26.8 36.7 35.3 10.9 15.3 6.1 31.4 30.4 26.2 20.3 6.5 47.4 14.0 24.4 31.3 25.2 16.4 16.8 13.6 27.4 106.7 7.2 15.0 37.7 30.8 11.1 14.1 16.2 30.7 5.6 9.3 82.0 4.5 20.5 15.9 35.3 11.4 13.7 27.8 10.6 104.7 78.5 10.1 62.8 79.9 34.5 36.2 3.7 14.9 3.0 11.8 82.9 53.5 5.5 20.9 23.1 36.7 18.8 7.8 0.2 11.8 6.8 42.8 6.8 3.6 86.8 15.9 29.9 17.3 89.8 46.1 10.7 0.1 0.1 74.5 4.4 15.1 0.1 10.0 4.6 20.4 0.0 14.8 0.2 29.2 3.8 16.2 28.4 39.9 1.9 14.1 31.0 5.2 4.1 47.0 50.8 17.0 24.1 56.6 14.9 20.4 5.5 37.5 2.4 59.7 0.3 1.0 0.0 2.1 0.5 2.1 2.6 2.5 2.3 0.5 2.3 1.7 2.2 0.5 0.3 0.4 1.0 4.2 1.0 29.0 32.1 29.5 32.5 26.8 36.7 31.4 30.4 26.2 31.3 30.8 30.7 35.3 38.9 32.1 13.1 15.3 6.6 13.4 25.8 70.2 9.6 22.0 8.6 19.7 88.8 25.8 19.6 12.9 6.2 5.7 2.8 15.6 1.9 28.7 61.1 32.6 48.1 27.2 16.3 0.0 17.3 51.8 49.8 64.6 12.8 29.7 2.5 16.7 36.0 15.7 2.8 28.6 21.2 4.2 8.2 2.1 8.7 203.7 38.8 2.7 26.6 24.4 1.9 23.6 1.0 38.7 38.1 53.8 6.0 91.4 4.6 11.7 32.6 64.6 20.4 16.5 46.0 102.8 59.8 12.2 17.4 8.0 10.5 6.3 7.3 14.2 15.1 13.5 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051304-52097299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 68.9;testis: 29.0" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2341.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036854, HPA036855" Enhanced Supported Mitochondria NA NA Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favorable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 5.0 5.4 0.7 2.2 0.0 6.3 2.6 1.5 10.8 13.2 4.2 2.1 4.2 2.0 4.7 68.9 6.7 1.6 1.9 16.3 5.4 5.5 8.0 0.3 6.0 5.5 0.8 1.8 2.0 4.5 4.9 1.9 5.3 4.2 5.6 0.1 10.2 5.6 0.8 6.6 2.2 3.1 8.3 0.6 5.0 29.0 2.6 3.2 1.2 1.3 0.9 2.8 3.4 3.9 0.0 3.8 1.8 0.0 12.7 31.5 24.4 9.3 15.9 0.6 0.7 0.0 1.5 0.0 0.0 12.3 0.2 0.3 0.1 7.1 0.3 0.0 1.1 0.0 0.0 8.0 11.2 0.0 0.0 29.3 28.7 1.0 4.5 5.1 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.9 2.0 1.0 0.0 0.0 9.7 0.0 0.2 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 2.2 2.6 1.5 1.9 16.3 6.0 5.5 0.8 5.3 8.3 2.6 3.9 0.3 9.6 3.0 0.3 0.0 5.2 8.5 9.4 8.6 0.0 6.0 6.7 2.2 8.6 15.1 0.0 0.0 1.7 0.3 1.8 1.9 1.2 561.1 124.6 1.8 1.2 1.8 0.0 1.7 2.6 1.8 4.3 11.2 4.7 2.5 1.9 1.4 3.4 0.3 0.0 0.5 1.6 6.1 0.6 1.6 2341.5 10.8 1.1 0.0 2.8 0.1 0.0 0.0 0.5 0.1 2.0 2.7 10.9 0.0 5.1 1.9 7.4 141.4 0.0 0.0 1.8 3.9 13.9 7.1 7.1 7.5 0.8 0.2 2.5 4.3 6.8 NOSTRIN MGC20702 ENSG00000163072 "Nitric oxide synthase trafficking" Q8IVI9 2 168786539-168865514 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044384, HPA076885" Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA044384: AB_2678922, HPA076885: " "unprognostic (4.74e-2)" "unprognostic (2.42e-1)" "unprognostic (8.73e-2)" "unprognostic (2.27e-1)" "unprognostic (3.15e-3)" "unprognostic (3.02e-6)" "unprognostic (4.89e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-4)" "unprognostic (5.47e-3)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.63e-1)" "unprognostic (1.75e-1)" "unprognostic (2.33e-1)" "unprognostic (6.47e-2)" "unprognostic (4.98e-2)" 31.5 20.6 7.0 4.7 5.9 0.3 31.7 5.3 7.6 17.4 4.6 15.5 14.1 15.1 4.4 5.2 16.6 14.1 15.8 5.3 5.8 24.6 7.4 31.1 4.6 6.9 6.3 4.0 10.7 22.8 3.9 3.8 25.6 6.9 13.5 16.5 0.8 49.3 6.9 5.2 6.9 14.4 12.9 5.5 5.5 23.2 14.6 6.6 1.9 13.6 3.7 3.1 8.2 11.4 6.2 0.0 3.6 1.1 0.0 0.0 0.0 10.1 0.4 0.0 0.0 0.0 6.3 6.5 0.1 4.3 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 41.9 1.8 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 31.8 0.0 0.0 0.1 0.1 0.1 0.1 20.5 0.3 0.4 1.9 0.0 3.4 1.6 0.0 0.1 0.2 1.9 0.0 0.2 0.5 0.0 0.0 0.0 0.7 0.2 0.6 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 5.9 5.3 7.6 5.3 5.8 6.9 6.3 4.0 6.9 5.5 6.6 6.2 167.0 9.6 10.3 2.0 1.6 1.0 0.6 0.3 0.6 0.1 20.0 11.0 7.1 15.7 3.3 3.7 0.0 18.9 0.4 57.3 13.7 8.0 26.6 16.3 3.3 129.6 11.4 2.7 0.4 21.8 7.0 6.1 41.3 23.2 0.0 72.4 172.5 1.0 1.6 0.0 0.5 35.9 0.0 6.3 0.9 60.9 8.7 1.2 24.9 55.3 0.7 1.6 0.0 2.0 0.0 17.7 53.4 5.7 0.2 3.3 43.1 59.0 1.5 0.3 72.3 1.3 11.3 13.7 1.8 0.4 0.4 26.3 0.9 71.9 20.7 1.2 CFAP221 "FAP221, PCDP1" ENSG00000163075 "Cilia and flagella associated protein 221" Q4G0U5 2 119544432-119662251 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.8;testis: 25.6" "Cell type enhanced" "Detected in many" "Early spermatids: 182.9;Endometrial ciliated cells: 96.5;Excitatory neurons: 93.3;Late spermatids: 292.7;Respiratory ciliated cells: 97.7;Spermatocytes: 64.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;HeLa: 2.3;RPTEC TERT1: 5.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.98e-1)" "unprognostic (1.70e-1)" "unprognostic (5.27e-2)" "unprognostic (7.62e-3)" "unprognostic (6.26e-4)" "unprognostic (3.52e-2)" "unprognostic (2.58e-1)" "unprognostic (7.71e-3)" "unprognostic (1.72e-1)" "unprognostic (3.75e-2)" "unprognostic (1.16e-1)" "unprognostic (2.90e-3)" "unprognostic (2.21e-3)" "unprognostic (8.96e-3)" "unprognostic (3.06e-2)" "unprognostic (7.03e-3)" "unprognostic (2.19e-1)" 0.3 1.6 6.5 0.2 1.4 1.0 0.1 1.8 6.3 0.9 10.2 0.2 8.7 1.1 1.8 0.2 29.8 2.0 0.6 2.3 0.8 8.6 1.3 7.8 0.4 5.2 4.8 1.3 0.5 10.0 1.8 3.2 0.6 2.9 0.5 0.2 5.3 0.2 0.6 0.2 1.0 1.1 0.2 4.8 0.4 2.2 25.6 1.4 0.1 2.5 0.2 0.3 0.2 0.2 1.8 0.1 0.3 1.1 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.8 0.2 0.2 1.1 0.0 0.7 0.1 0.0 0.1 0.1 0.2 1.0 0.1 2.3 0.3 0.3 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.6 0.0 0.3 0.4 0.7 0.2 0.2 0.1 0.4 0.0 0.1 5.4 0.5 0.6 0.7 0.1 0.1 0.0 0.4 1.4 0.4 0.3 0.2 0.5 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 0.7 0.3 0.2 0.2 0.1 0.0 6.5 1.4 1.8 6.3 2.3 0.8 5.2 4.8 1.3 2.9 4.8 1.4 1.8 0.0 0.0 35.3 24.8 0.0 0.0 0.1 0.0 0.0 3.4 0.4 0.0 2.4 10.0 13.0 7.3 29.2 0.1 0.0 0.0 27.4 19.6 182.9 96.5 1.7 0.4 0.0 0.0 93.3 18.6 0.0 0.9 0.0 3.0 0.0 0.5 0.0 2.4 0.1 0.0 36.7 0.1 0.0 0.0 0.0 292.7 2.8 0.7 0.0 1.0 0.6 3.7 0.0 1.0 2.5 8.4 0.0 2.2 0.0 0.2 0.1 8.7 97.7 31.0 0.0 1.2 1.0 64.7 15.2 0.0 0.0 0.0 0.4 1.4 0.4 0.0 SGPP2 "FLJ39004, SPP2" ENSG00000163082 "Sphingosine-1-phosphate phosphatase 2" Q8IWX5 2 222424543-222562621 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 33.0;Excitatory neurons: 43.5;Glandular and luminal cells: 54.2;Microglial cells: 48.7;Urothelial cells: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.2;EFO-21: 13.0;hTCEpi: 52.6;RPTEC TERT1: 59.0;SCLC-21H: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.56e-3)" "unprognostic (1.79e-1)" "unprognostic (8.50e-2)" "unprognostic (2.97e-2)" "unprognostic (1.24e-3)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.31e-2)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (2.69e-2)" 1.4 6.2 13.1 4.1 11.1 1.4 5.4 14.5 14.7 13.4 2.6 17.5 17.5 2.7 3.8 21.5 13.3 11.6 3.7 10.7 12.6 16.5 0.4 8.1 3.9 15.7 10.7 8.2 0.5 3.1 27.0 5.9 0.1 17.4 1.6 18.3 3.7 8.0 7.7 0.9 22.6 18.3 1.4 8.6 1.0 25.3 1.6 15.1 5.3 21.4 0.0 15.3 22.5 10.1 17.6 1.4 1.1 0.4 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 16.2 0.6 13.0 0.0 0.2 0.3 0.2 0.1 0.0 0.3 4.6 1.0 0.4 0.0 0.0 1.7 0.8 0.0 52.6 0.0 0.2 0.0 0.0 0.7 0.3 0.6 0.0 0.8 0.4 1.2 0.5 10.6 0.4 0.7 0.4 0.6 59.0 3.7 16.5 0.6 0.0 1.9 0.1 0.8 0.2 0.1 0.0 0.2 0.5 0.6 0.5 0.5 0.4 1.0 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 13.1 11.1 14.5 14.7 10.7 12.6 15.7 10.7 8.2 17.4 8.6 15.1 17.6 0.1 3.2 11.5 1.3 2.2 3.7 4.4 29.1 4.6 5.3 1.6 1.5 6.9 7.2 26.2 12.9 6.2 0.1 0.6 20.2 1.9 14.5 9.7 33.0 4.8 1.5 1.2 0.0 43.5 1.8 0.3 1.4 25.5 54.2 0.0 0.4 0.0 0.1 0.2 1.7 15.8 5.5 14.2 0.0 1.1 3.7 0.6 0.8 0.0 48.7 0.1 0.7 1.0 2.5 1.1 9.3 16.3 0.4 2.3 7.5 13.1 0.5 20.4 5.9 0.0 2.1 1.7 3.1 1.0 26.3 14.3 2.5 2.5 0.3 9.9 39.4 INHBB ENSG00000163083 "Inhibin subunit beta B" P09529 2 120346136-120351803 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 45.2;breast: 43.7" "Group enriched" "Detected in many" 7 "Adipocytes: 200.5;Granulosa cells: 653.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 44.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 47.6;ASC diff: 63.1;BJ hTERT+ SV40 Large T+ RasG12V: 38.5;MCF7: 58.4;PC-3: 91.7;SK-BR-3: 163.4;T-47d: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 130000 "unprognostic (7.80e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.26e-2)" "unprognostic (4.26e-2)" "unprognostic (3.61e-3)" "unprognostic (2.13e-2)" "unprognostic (5.52e-2)" "unprognostic (6.99e-2)" "unprognostic (3.59e-1)" "unprognostic (1.59e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.57e-3)" "unprognostic (4.14e-1)" "prognostic favorable (1.02e-4)" "unprognostic (1.76e-2)" 45.2 3.8 5.3 1.0 5.1 0.2 43.7 8.3 4.2 6.7 3.1 3.1 1.3 7.5 2.6 2.5 6.3 2.6 5.4 3.5 4.3 3.9 20.4 4.4 1.2 9.8 7.1 3.2 2.5 4.2 6.4 8.1 1.3 5.9 8.3 0.3 1.1 16.5 0.8 10.5 15.6 2.4 2.2 5.8 0.5 3.7 17.3 7.8 0.4 21.1 2.4 0.7 8.3 6.5 5.3 24.5 47.6 0.2 0.0 63.1 4.9 0.0 3.3 3.8 20.7 38.5 1.0 0.0 0.0 8.3 1.2 0.1 0.1 3.7 0.0 28.9 0.1 0.8 0.0 0.0 1.2 1.0 0.0 0.1 2.6 3.5 0.7 0.0 0.3 0.4 0.0 0.0 0.0 0.1 58.4 0.0 0.1 0.0 4.7 91.7 0.0 0.0 1.2 5.6 0.0 5.4 0.0 0.2 163.4 0.0 0.0 39.2 0.5 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 5.1 8.3 4.2 3.5 4.3 9.8 7.1 3.2 5.9 5.8 7.8 5.3 200.5 3.2 2.2 8.1 0.2 4.0 2.2 5.5 0.0 0.1 53.7 24.4 0.7 8.6 9.2 1.8 25.0 0.1 0.7 0.1 0.0 0.4 0.6 9.2 1.6 24.3 0.0 2.7 0.1 0.0 0.2 9.8 0.0 12.5 0.0 653.3 24.7 19.4 0.1 0.0 1.3 0.0 8.2 1.3 6.6 3.6 11.8 1.3 1.8 1.0 0.0 0.2 0.0 2.5 0.0 0.2 0.0 6.8 0.3 8.9 0.0 0.0 30.0 0.6 0.0 37.3 3.1 0.8 6.0 0.6 3.0 0.1 0.6 0.2 0.0 3.2 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888480-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 1042.6;tongue: 548.0" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 1907.2" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 140.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 6.0 0.0 0.0 8.0 0.0 1042.6 0.7 0.1 0.0 0.0 0.5 0.1 3.1 0.0 0.1 0.3 548.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1907.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 10.1 0.0 0.0 1.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 23.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.5 1.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.4 5.8 1.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 BBS5 DKFZp762I194 ENSG00000163093 "Bardet-Biedl syndrome 5" Q8N3I7 2 169479480-169506655 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 70.9;Early spermatids: 213.4;Endometrial ciliated cells: 49.1;Rod photoreceptor cells: 63.4;Spermatocytes: 62.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 17.3" "Low region specificity" "Detected in all" HPA046125 Uncertain NA NA "HPA046125: AB_2679549" "unprognostic (4.37e-2)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" "unprognostic (1.89e-2)" "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.81e-1)" "unprognostic (5.83e-2)" "unprognostic (2.35e-1)" "unprognostic (2.78e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.55e-1)" "unprognostic (2.62e-2)" "unprognostic (1.25e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (1.67e-1)" 4.2 5.5 5.6 2.8 6.1 1.4 3.5 5.1 5.9 4.1 8.0 3.6 2.6 4.4 3.8 2.7 7.9 3.1 5.2 6.3 8.2 4.2 2.1 2.9 2.1 6.0 6.9 5.5 4.8 3.2 7.2 8.0 2.2 6.1 4.2 1.3 11.4 2.7 4.2 7.2 4.0 2.0 3.0 5.9 2.6 3.3 8.7 6.4 1.6 6.1 3.2 1.0 4.5 2.9 5.7 1.0 2.8 3.2 5.2 8.0 6.4 3.2 7.2 2.3 8.4 3.6 2.0 2.0 0.1 3.3 3.5 5.6 3.1 2.4 1.2 3.2 4.9 0.9 1.8 1.2 4.0 8.0 3.9 4.3 7.1 7.3 5.9 1.5 3.9 2.9 5.0 6.7 0.0 2.5 4.0 6.5 4.0 2.7 0.7 3.6 0.0 0.7 0.0 4.6 3.0 3.0 5.4 4.9 3.7 17.3 1.1 3.7 4.3 2.9 11.8 5.6 9.5 6.6 4.5 6.8 0.1 7.0 2.5 7.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 6.1 5.1 5.9 6.3 8.2 6.0 6.9 5.5 6.1 5.9 6.4 5.7 3.7 0.0 5.1 18.9 0.7 1.3 1.2 1.2 2.8 17.1 3.4 4.2 5.1 1.5 3.5 11.0 70.9 0.8 0.3 0.3 0.0 2.1 213.4 49.1 10.7 2.5 2.4 0.4 38.0 1.5 0.5 4.9 0.5 5.8 0.0 3.2 1.1 0.7 1.4 10.1 34.1 1.7 4.1 4.5 0.4 38.4 5.0 2.0 7.2 14.0 0.1 12.2 0.0 17.6 19.0 1.1 0.5 6.0 1.7 0.7 0.4 2.1 15.1 63.4 0.0 5.5 4.2 62.3 7.8 0.9 1.7 0.3 1.1 7.8 1.0 0.4 SMARCAD1 "DKFZP762K2015, ETL1, KIAA1122" ENSG00000163104 "SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1" Q9H4L7 4 94207611-94291292 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016737 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016737: AB_1857271" "unprognostic (5.01e-2)" "unprognostic (5.83e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (8.41e-3)" "unprognostic (9.08e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.45e-1)" "unprognostic (3.49e-3)" "unprognostic (3.55e-1)" "unprognostic (2.57e-2)" "unprognostic (7.72e-2)" "unprognostic (2.99e-2)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (3.20e-3)" 10.1 9.5 8.1 11.3 8.4 7.6 15.4 12.6 9.1 10.7 7.6 9.5 9.8 14.6 12.7 10.6 10.8 10.4 7.7 7.7 8.7 11.9 9.8 9.8 16.1 8.3 7.9 7.3 14.4 8.8 11.8 11.1 14.2 8.3 11.2 12.4 14.7 9.0 10.1 7.4 21.0 9.6 11.9 8.0 12.0 10.9 12.3 8.4 18.8 15.1 6.8 14.3 11.3 9.7 10.5 15.0 18.6 59.1 38.1 16.5 26.6 30.1 26.8 24.3 21.8 20.3 18.2 23.7 37.8 17.7 23.1 19.8 12.9 42.3 22.4 30.7 29.8 18.7 27.5 20.5 27.2 24.4 41.2 28.9 27.8 17.8 27.3 34.9 27.0 33.7 33.3 46.7 15.5 32.4 12.3 69.1 21.3 40.1 19.1 9.4 40.1 33.6 19.6 24.6 18.4 33.8 49.9 20.1 32.8 28.6 36.7 17.1 26.9 32.3 27.6 29.9 17.1 20.3 21.8 34.8 45.1 25.7 21.2 34.8 2.7 1.3 0.2 2.3 1.7 2.5 2.9 2.6 2.6 2.4 2.4 2.8 3.3 0.0 4.5 1.7 2.1 2.3 1.3 8.1 8.4 12.6 9.1 7.7 8.7 8.3 7.9 7.3 8.3 8.0 8.4 10.5 19.0 12.8 11.3 56.2 16.7 11.7 6.5 12.8 25.6 20.9 15.5 13.2 12.7 4.3 24.7 9.2 16.7 13.5 20.1 7.1 1.9 12.4 2.1 27.6 32.3 17.8 9.0 25.5 86.5 10.0 11.8 19.9 17.9 17.9 24.0 29.5 13.2 13.5 10.8 18.5 82.5 12.9 14.2 14.6 5.4 3.1 14.3 13.7 3.6 47.8 12.6 8.1 17.5 86.5 99.5 15.0 6.3 18.4 16.4 7.7 4.4 15.5 26.8 18.8 6.6 21.1 16.2 25.9 34.8 18.7 9.7 9.6 17.3 26.2 12.6 5.8 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.9" "Group enriched" "Detected in many" 18 "granulocytes: 1056.2;Hofbauer cells: 631.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 28 "basophil: 18.1" "Lineage enriched" "Detected in single" 28 "granulocytes: 18.1" "Group enriched" "Detected in some" 8 "HEL: 46.2;HMC-1: 13.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 250000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 3.2 1.9 2.1 1.1 2.2 1.1 4.0 2.3 3.2 3.6 2.2 5.1 5.9 2.4 2.3 2.9 1.4 6.9 1.8 2.2 2.6 0.7 0.8 9.5 0.6 2.4 2.3 1.8 0.5 0.5 0.8 0.4 18.9 2.8 2.6 5.4 0.1 1.5 1.3 0.5 3.4 5.6 3.3 3.1 0.3 2.8 0.7 2.6 2.0 0.3 1.7 0.9 4.9 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 3.5 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.1 2.2 2.3 3.2 2.2 2.6 2.4 2.3 1.8 2.8 3.1 2.6 3.0 0.3 12.8 44.7 1.0 0.2 4.1 0.8 0.0 0.6 0.0 0.2 0.8 0.3 0.0 3.7 0.0 0.0 3.6 0.7 0.5 0.0 0.5 0.1 0.2 0.0 2.0 7.1 12.2 0.8 0.0 3.0 3.0 3.6 0.0 1056.2 0.0 0.0 0.0 631.9 0.0 0.6 0.0 0.0 11.4 13.1 0.0 0.3 16.3 3.6 32.8 0.1 0.0 0.0 0.0 0.5 0.1 1.2 0.4 2.1 3.9 0.0 0.0 1.5 0.1 0.0 0.6 0.4 0.0 0.1 0.0 5.4 5.5 20.5 0.3 0.9 0.2 PDLIM5 "Enh, LIM" ENSG00000163110 "PDZ and LIM domain 5" Q96HC4 4 94451857-94668227 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "heart muscle: 635.2;skeletal muscle: 1174.5;tongue: 581.1" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 1844.2" "Cancer enriched" "Detected in all" 8 "prostate cancer: 132.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 219.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 219.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013511, HPA016740, HPA020026" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 1200000 "Plasma membrane" "Nucleoplasm, Focal adhesion sites" "CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.08e-2)" "unprognostic (6.61e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.46e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.11e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" 42.1 26.3 21.2 25.8 24.1 60.2 39.9 23.9 22.6 27.5 79.3 34.4 33.6 95.6 11.4 73.0 40.9 47.9 635.2 21.6 94.7 35.2 83.4 22.2 16.4 31.7 27.7 16.1 27.4 30.4 12.3 17.7 68.3 24.6 89.3 31.0 18.3 40.5 69.5 1174.5 20.8 34.7 106.8 22.6 24.3 31.3 12.8 23.8 11.0 25.7 581.1 21.3 46.3 27.8 22.1 31.4 87.2 33.6 13.0 71.7 51.3 13.0 71.6 59.9 40.1 32.6 80.8 66.3 12.0 72.0 72.3 21.0 31.8 46.5 68.2 65.9 24.1 19.3 43.7 53.8 32.2 103.7 14.6 38.3 66.4 58.4 96.1 74.0 177.9 93.5 13.2 19.2 12.5 86.2 29.8 15.0 4.8 11.4 66.7 36.6 7.2 24.7 11.1 45.0 94.6 16.5 21.8 38.9 88.7 20.3 26.7 10.3 5.2 113.7 103.7 17.3 46.1 44.1 9.5 13.0 12.7 56.5 10.3 24.9 219.7 23.4 21.0 12.1 40.6 9.7 10.5 12.0 12.8 19.5 7.6 7.9 10.4 22.6 9.2 44.6 6.6 11.8 15.2 21.2 24.1 23.9 22.6 21.6 94.7 31.7 27.7 16.1 24.6 22.6 23.8 22.1 107.4 44.8 23.6 184.1 22.1 194.4 380.3 92.1 63.7 4.7 90.2 67.4 1844.2 62.9 82.9 49.7 31.3 13.7 18.5 180.0 13.7 95.0 19.2 68.7 11.8 117.2 109.4 27.6 4.9 95.1 96.5 97.8 84.6 108.7 52.0 29.1 137.8 207.0 38.8 1.7 20.7 107.4 36.7 60.6 75.3 9.1 41.3 59.8 62.2 104.0 41.6 86.2 12.3 181.5 43.1 139.2 166.8 66.5 23.2 300.7 117.5 73.6 70.0 35.8 78.9 96.7 134.7 23.8 34.4 107.3 157.0 23.8 31.1 6.8 74.0 217.5 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 subunit alpha 2" P29803 4 95840093-95841464 "Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 607 "testis: 60.7" "Group enriched" "Detected in some" 71 "Early spermatids: 426.6;Late spermatids: 288.3;Spermatocytes: 229.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria NA NA Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 426.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 288.3 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 229.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STPG2 "C4orf37, MGC46496" ENSG00000163116 "Sperm tail PG-rich repeat containing 2" Q8N412 4 97184093-98143476 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;testis: 1.9" "Cell type enhanced" "Detected in some" "Astrocytes: 81.6;Excitatory neurons: 34.7;Inhibitory neurons: 38.2;Microglial cells: 36.5;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 150.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059473 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA059473: " "unprognostic (3.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.12e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-2)" "unprognostic (6.59e-3)" "unprognostic (8.87e-3)" "unprognostic (2.18e-1)" "unprognostic (2.05e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-3)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" "unprognostic (7.55e-3)" "unprognostic (5.78e-2)" 0.0 0.1 0.7 0.0 1.2 0.0 0.2 0.8 0.6 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.3 0.9 0.6 0.2 0.1 0.1 1.0 1.1 0.2 0.1 0.2 0.2 0.4 0.2 1.3 0.1 0.1 0.9 0.1 0.1 0.0 0.2 0.1 0.0 1.0 0.1 0.1 1.9 1.0 0.1 0.4 0.0 0.1 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 1.2 0.8 0.6 0.3 0.9 1.0 1.1 0.2 1.3 1.0 1.0 2.0 0.2 0.0 0.0 81.6 0.7 0.0 0.4 0.0 0.0 0.9 0.4 0.1 0.4 0.0 0.1 0.0 6.2 0.1 0.0 0.0 3.9 0.0 1.8 0.6 0.1 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.7 0.1 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 36.5 0.0 0.8 0.0 21.1 150.4 0.2 0.0 0.0 0.1 0.1 0.3 0.8 0.0 1.8 0.0 0.0 0.0 3.2 1.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 NEURL3 "Lincr, LOC93082, RNF132" ENSG00000163121 "Neuralized E3 ubiquitin protein ligase 3" Q96EH8 2 96497646-96508109 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 9.0;pancreas: 25.3;salivary gland: 30.6" "Group enriched" "Detected in many" 4 "Ductal cells: 114.6;Exocrine glandular cells: 36.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.8;CAPAN-2: 15.6;GAMG: 5.5;RPMI-8226: 10.1;RT4: 4.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (4.97e-2)" "unprognostic (6.07e-2)" "unprognostic (7.22e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.29e-1)" "unprognostic (9.55e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (8.14e-3)" "unprognostic (1.23e-2)" "unprognostic (5.83e-2)" "unprognostic (6.57e-2)" "unprognostic (2.44e-1)" "unprognostic (6.57e-4)" 0.1 0.0 0.7 0.4 0.8 0.3 1.9 0.6 0.8 0.1 0.5 0.5 1.6 0.1 0.1 0.1 0.2 2.2 0.2 0.8 0.6 9.0 2.6 2.5 0.2 0.8 0.7 0.7 0.0 25.3 0.0 0.3 0.0 0.9 3.9 0.5 0.1 30.6 2.5 0.1 0.6 2.1 0.0 0.7 0.6 0.5 0.4 0.7 4.8 0.0 0.0 0.3 0.4 0.0 0.8 1.0 0.5 0.0 0.3 0.0 0.0 3.8 0.0 0.4 0.3 0.2 2.3 15.6 0.0 1.2 0.0 5.5 2.3 0.2 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 10.1 2.1 4.7 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.8 0.6 0.8 0.8 0.6 0.8 0.7 0.7 0.9 0.7 0.7 0.8 0.4 0.0 1.5 0.7 0.9 0.0 10.2 0.0 0.0 0.0 7.6 8.3 0.4 11.5 0.6 9.2 0.0 0.3 0.3 6.9 3.9 114.6 0.0 4.9 0.2 1.0 2.4 3.2 0.4 36.5 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.2 1.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 12.2 0.8 0.0 0.0 0.1 17.8 5.2 0.0 0.0 13.2 10.6 5.8 0.0 0.0 0.0 0.0 0.4 0.7 1.9 0.0 0.0 0.0 0.2 1.4 1.2 5.9 RPRD2 "FLJ32145, HSPC099, KIAA0460" ENSG00000163125 "Regulation of nuclear pre-mRNA domain containing 2" Q5VT52 1 150363091-150476566 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 132.9;Inhibitory neurons: 133.8;Oligodendrocyte precursor cells: 136.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061693 Approved Approved Nucleoplasm,Vesicles NA NA 66000 "Nucleoplasm, Vesicles" "HPA061693: AB_2684587" "unprognostic (1.68e-1)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (7.25e-2)" "unprognostic (5.67e-3)" "unprognostic (3.79e-2)" "unprognostic (1.75e-2)" "unprognostic (9.03e-2)" "unprognostic (1.50e-1)" "unprognostic (3.93e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-1)" "unprognostic (1.10e-3)" "unprognostic (1.11e-1)" "unprognostic (1.71e-1)" "unprognostic (7.92e-2)" "unprognostic (1.38e-1)" 10.9 11.5 5.5 10.9 7.1 13.8 12.1 16.4 11.1 16.1 3.0 12.0 10.7 19.1 14.4 14.1 21.3 10.8 13.3 6.5 6.0 16.2 11.5 13.0 13.7 4.6 5.0 5.2 30.0 14.6 19.4 10.8 9.9 7.4 14.4 14.7 17.6 14.2 16.4 24.8 12.9 12.2 17.9 2.4 14.1 12.0 14.2 6.2 19.7 23.2 23.0 15.9 12.8 11.4 7.6 24.6 18.4 23.9 24.3 24.3 20.5 22.6 17.4 20.7 18.8 18.4 16.1 29.4 38.8 19.5 21.4 10.4 26.6 34.0 25.9 20.4 17.9 14.2 22.3 21.2 19.5 17.4 33.8 26.3 21.8 19.3 26.2 34.4 20.9 23.5 23.2 22.1 40.9 19.3 35.4 29.8 10.9 30.0 30.9 20.6 27.0 17.7 39.4 27.7 22.4 25.4 25.6 35.6 30.0 22.6 21.2 23.7 29.5 21.7 17.3 17.8 14.6 24.9 24.9 29.5 28.7 17.2 24.8 17.4 5.8 2.9 3.5 5.6 1.8 5.1 5.4 5.3 4.5 2.6 5.2 6.1 6.2 1.4 3.9 7.3 3.1 7.0 2.4 5.5 7.1 16.4 11.1 6.5 6.0 4.6 5.0 5.2 7.4 2.4 6.2 7.6 18.7 19.2 25.9 97.3 30.8 15.4 10.5 17.1 25.0 35.0 22.0 19.8 27.6 17.2 24.5 33.1 16.7 14.0 27.2 20.6 7.9 14.6 11.0 31.8 30.1 21.6 25.8 16.8 132.9 12.9 9.1 23.4 16.8 33.5 17.7 28.5 26.0 27.1 14.7 11.8 133.8 22.1 18.3 22.6 10.5 6.6 37.9 16.6 10.6 56.2 18.6 22.9 27.8 136.2 112.2 14.1 17.7 39.9 29.6 16.4 21.6 30.8 29.9 29.8 32.9 37.1 20.6 21.1 21.3 26.4 14.6 10.0 27.6 27.3 22.3 16.9 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 51 "skeletal muscle: 1452.2;tongue: 452.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 5.0;Respiratory ciliated cells: 7.4;Rod photoreceptor cells: 5.2;Skeletal myocytes: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Karpas-707: 38.5" "Low region specificity" "Detected in many" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.7 0.9 1.5 0.4 1.8 0.7 1.3 2.1 2.1 1.2 0.6 1.1 0.8 1.8 0.0 6.1 2.5 0.2 17.2 1.4 1.3 0.7 2.2 1.0 0.6 2.4 1.7 1.3 1.7 1.6 0.3 10.4 0.2 2.5 5.3 0.1 0.1 18.6 0.3 1452.2 2.3 1.4 0.2 1.5 2.3 0.7 0.7 1.8 0.6 1.1 452.6 0.4 1.2 1.1 1.9 0.5 0.7 0.4 0.8 0.0 0.2 1.1 0.3 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.3 0.3 0.3 0.2 1.1 1.0 0.5 0.8 0.2 0.1 0.8 1.8 0.3 0.3 0.6 0.0 0.2 0.1 1.5 0.9 38.5 0.3 0.9 0.5 0.8 0.4 0.1 0.3 1.4 0.0 5.0 0.2 0.9 1.4 0.2 0.3 0.7 0.0 0.2 1.1 0.0 0.3 0.5 0.6 0.7 0.1 1.7 0.7 0.3 0.4 1.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.8 2.1 2.1 1.4 1.3 2.4 1.7 1.3 2.5 1.5 1.8 1.9 1.1 0.0 1.1 2.0 0.5 0.8 0.5 0.4 0.6 2.6 0.8 2.3 5.0 0.0 1.5 0.0 2.1 0.4 2.1 0.9 0.0 0.3 3.3 1.3 1.9 0.8 0.0 0.4 2.8 1.1 0.2 1.3 0.5 0.7 1.3 1.1 1.4 1.2 0.2 1.7 2.7 1.0 0.0 0.6 0.3 1.8 1.5 0.6 0.0 1.0 0.2 1.1 1.0 0.5 2.9 0.1 0.3 3.0 0.4 0.3 0.6 0.2 7.4 5.2 0.0 6.1 1.6 1.3 0.4 0.4 1.3 0.3 1.1 0.7 0.9 0.2 CTSS ENSG00000163131 "Cathepsin S" P25774 1 150730079-150765957 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 138.2;lymphoid tissue: 166.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 698.6;Kupffer cells: 2230.8;Macrophages: 1316.2;monocytes: 2312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 2483.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 81.6;HMC-1: 187.5;U-698: 387.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000460, HPA002988" Supported Approved Vesicles "Intracellular and membrane" NA NA 23000000 Vesicles "CAB000460: , HPA002988: AB_1078409" "unprognostic (7.81e-2)" "unprognostic (9.04e-2)" "unprognostic (3.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (6.00e-3)" "unprognostic (1.46e-1)" "unprognostic (3.89e-1)" "unprognostic (6.24e-2)" "unprognostic (7.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.13e-1)" "unprognostic (2.47e-3)" 37.8 16.8 3.8 88.6 6.2 138.2 20.5 5.2 8.8 9.5 11.7 84.4 60.7 7.8 5.8 16.6 18.0 29.4 8.9 4.0 13.6 9.4 40.8 89.1 72.3 9.7 5.5 2.9 4.9 11.4 2.4 4.7 23.8 9.4 9.2 59.9 3.4 24.1 7.3 4.1 7.1 65.1 16.5 8.9 166.1 43.0 3.9 9.1 20.2 11.6 9.1 38.8 43.3 10.1 13.1 3.7 10.9 0.2 0.3 1.2 1.4 0.7 0.4 8.6 0.9 1.3 1.2 81.6 44.3 5.7 1.2 15.3 2.1 0.2 0.7 0.5 26.9 0.2 29.0 1.1 0.8 0.2 33.6 187.5 2.6 0.1 6.6 1.5 0.5 6.3 0.6 3.4 45.0 2.4 0.3 0.4 22.5 0.2 0.1 0.3 14.9 4.6 49.8 10.7 8.7 0.3 0.4 1.1 2.3 0.8 0.3 0.4 49.8 9.1 6.2 1.3 0.8 1.2 27.8 2.2 387.3 28.5 35.2 2.3 20.9 2483.4 218.0 41.3 1735.3 51.1 139.5 46.6 50.9 571.0 138.8 45.0 40.8 1022.2 41.8 1655.1 106.8 77.4 2577.6 3.8 6.2 5.2 8.8 4.0 13.6 9.7 5.5 2.9 9.4 8.9 9.1 13.1 37.6 109.0 158.7 1.6 255.3 17.0 31.3 72.0 4.6 2.3 21.0 8.9 5.3 74.4 143.4 42.3 12.5 3.7 198.0 549.2 0.0 183.6 6.6 126.9 8.6 44.1 42.4 22.5 10.3 177.0 5.7 34.4 71.9 39.0 106.8 9.5 60.3 30.6 698.6 0.0 9.5 205.7 73.2 2230.8 316.4 3.0 5.3 1316.2 56.9 27.2 2312.9 0.5 137.0 0.5 0.9 200.9 466.5 2.2 121.4 20.6 210.8 4.7 488.9 4.9 19.7 5.6 13.3 0.2 0.5 12.4 15.5 6.2 108.9 66.0 237.8 113.3 MSX1 "HOX7, HYD1, OFC5" ENSG00000163132 "Msh homeobox 1" P28360 4 4859665-4863936 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 47.8;choroid plexus: 78.9" "Group enriched" "Detected in many" 6 "Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0" "Cancer enriched" "Detected in all" 17 "endometrial cancer: 246.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 47.9;EFO-21: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB026198, HPA063895, HPA073604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617" "unprognostic (1.12e-1)" "unprognostic (1.93e-2)" "unprognostic (3.39e-2)" "prognostic favorable (1.64e-7)" "unprognostic (9.13e-2)" "unprognostic (1.16e-3)" "unprognostic (4.07e-3)" "unprognostic (3.81e-2)" "unprognostic (1.48e-2)" "unprognostic (2.21e-3)" "unprognostic (4.78e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (4.35e-2)" "unprognostic (2.06e-1)" "unprognostic (2.34e-3)" "unprognostic (1.33e-2)" 18.2 6.0 10.5 0.7 9.5 0.2 12.9 10.2 17.0 47.8 78.9 1.5 0.5 17.7 0.3 0.9 9.6 1.3 7.2 16.3 15.6 2.0 0.5 4.3 0.6 15.1 10.6 8.8 3.5 2.3 0.4 21.3 4.1 11.3 5.6 0.1 0.6 8.9 3.6 20.3 5.1 1.1 3.2 13.4 4.5 2.0 0.7 11.8 0.2 9.2 2.0 0.4 11.3 14.6 10.8 2.5 1.5 0.5 2.8 8.0 5.1 8.9 6.1 2.8 3.5 1.7 47.9 15.3 0.3 21.4 4.4 17.0 0.1 10.6 0.0 1.2 2.0 12.2 0.1 8.0 17.4 0.6 0.1 1.4 1.0 0.8 2.6 0.9 1.1 0.8 4.1 7.9 0.3 1.9 1.2 1.3 2.4 0.2 0.7 11.1 6.4 6.4 0.6 0.2 1.5 0.4 0.3 5.4 0.3 4.0 0.8 0.9 2.1 2.0 4.1 9.1 13.0 9.9 1.0 0.9 5.7 2.6 3.1 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 10.5 9.5 10.2 17.0 16.3 15.6 15.1 10.6 8.8 11.3 13.4 11.8 10.8 118.4 0.0 0.0 17.3 0.5 7.1 2.4 0.3 4.6 0.8 8.6 24.3 5.5 0.0 0.0 0.0 4.2 0.3 1.6 3.9 0.0 0.2 0.4 364.0 35.7 48.1 0.0 0.0 1.1 0.9 0.1 34.8 1.1 462.0 0.0 1.1 5.7 0.2 0.5 0.0 1.2 2.5 0.0 0.6 8.8 0.0 1.2 4.4 16.0 3.7 0.0 0.7 0.0 1.0 0.3 0.3 0.1 0.4 1.6 3.3 0.6 0.5 0.0 0.7 0.0 13.6 18.2 0.8 1.5 2.6 4.7 0.3 4.8 14.6 2.6 2.0 PACRGL "C4orf28, MGC29898" ENSG00000163138 "Parkin coregulated like" Q8N7B6 4 20696282-20752907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 211.7;Late spermatids: 88.4;Oligodendrocytes: 66.9;Spermatocytes: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054666 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA054666: AB_2682564" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.90e-3)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-1)" "unprognostic (4.55e-2)" "unprognostic (2.20e-2)" "unprognostic (5.08e-2)" "unprognostic (3.35e-2)" "unprognostic (1.25e-2)" "unprognostic (6.74e-3)" "unprognostic (3.63e-2)" "unprognostic (1.07e-2)" "prognostic favorable (4.85e-4)" 7.6 8.6 8.9 5.8 10.5 4.0 16.2 3.8 11.8 7.9 13.5 8.6 6.7 13.0 14.4 9.3 13.6 9.7 9.3 11.2 9.7 8.3 4.6 7.4 8.0 8.0 6.6 9.0 13.6 7.1 11.2 8.0 7.5 6.3 10.6 8.7 15.1 7.0 10.2 7.3 14.9 7.9 10.2 5.0 7.1 7.7 28.3 9.0 5.5 15.2 8.1 6.4 9.3 7.7 11.8 12.5 8.9 16.8 12.1 23.7 21.9 8.0 15.9 11.9 13.4 17.5 8.9 28.2 11.9 11.5 8.7 24.1 6.4 9.3 10.9 24.3 4.3 8.6 8.4 16.1 13.7 11.8 17.6 8.9 14.4 18.8 17.9 17.4 14.5 14.9 12.2 13.9 7.6 12.7 9.1 18.1 17.0 20.3 11.0 12.3 9.4 18.4 7.4 12.9 7.8 25.4 17.9 12.5 5.6 12.2 9.4 11.5 10.0 12.0 14.4 13.5 20.0 22.6 8.0 2.5 11.3 21.7 10.9 25.5 0.0 1.5 0.7 1.3 2.4 2.9 2.0 1.4 1.3 2.7 1.8 2.2 1.5 0.6 2.3 2.0 3.5 1.9 1.4 8.9 10.5 3.8 11.8 11.2 9.7 8.0 6.6 9.0 6.3 5.0 9.0 11.8 6.7 9.6 6.4 37.9 4.9 13.6 10.6 6.8 13.1 5.8 8.2 7.0 5.4 8.6 8.6 7.3 4.2 5.5 4.9 5.5 7.9 9.7 211.7 15.8 8.6 7.4 9.0 5.7 48.0 9.1 6.9 9.7 6.6 4.8 2.5 7.9 7.5 3.1 4.2 5.0 44.9 5.9 6.1 4.9 4.0 88.4 13.1 4.6 5.4 31.9 3.3 9.7 3.1 35.7 66.9 8.7 9.1 12.4 2.1 9.7 5.5 6.2 27.1 12.1 13.1 9.2 7.3 90.6 30.3 9.0 10.5 5.9 3.6 9.3 6.7 8.0 BNIPL "BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753" ENSG00000163141 "BCL2 interacting protein like" Q7Z465 1 151036321-151047720 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "esophagus: 129.5;skin 1: 182.9;vagina: 70.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 17.2;Squamous epithelial cells: 42.7;Suprabasal keratinocytes: 57.1;Urothelial cells: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "T-47d: 46.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.6;cerebellum: 2.4" "Not detected" "Not detected" HPA019946 Uncertain Cytosol NA NA Cytosol "HPA019946: AB_2732424" "unprognostic (2.62e-1)" "unprognostic (7.59e-3)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.50e-4)" "unprognostic (6.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.32e-3)" "unprognostic (3.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.88e-4)" "unprognostic (1.91e-1)" "unprognostic (8.43e-11)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" "prognostic favorable (4.32e-4)" "unprognostic (6.81e-2)" 0.3 0.3 1.2 0.4 1.0 0.6 15.8 2.9 1.3 12.3 0.9 0.3 0.3 0.3 0.2 129.5 2.7 0.3 0.6 1.1 1.2 1.7 1.2 9.5 0.6 1.5 1.0 1.0 0.6 0.4 1.1 0.6 0.5 1.6 12.6 0.2 0.8 23.1 4.8 1.7 182.9 0.5 0.1 1.0 1.1 1.5 4.4 1.0 0.7 7.4 0.1 10.1 9.8 70.3 1.5 0.4 0.4 0.6 0.6 0.4 0.4 0.7 0.3 0.0 0.3 0.2 1.5 0.4 0.7 0.7 0.0 0.1 1.5 0.9 0.2 0.6 1.1 1.0 1.2 0.8 0.2 0.1 0.6 0.6 0.0 3.1 0.2 0.3 1.0 0.0 1.1 0.6 0.5 0.3 2.0 0.7 1.2 0.5 1.0 0.4 0.3 0.3 0.4 0.6 0.4 1.3 0.6 0.5 0.9 0.3 2.2 46.1 0.4 1.1 0.7 0.5 0.2 0.1 1.7 1.3 3.9 0.1 0.3 0.8 0.5 0.1 0.1 0.3 0.1 0.2 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 1.2 1.0 2.9 1.3 1.1 1.2 1.5 1.0 1.0 1.6 1.0 1.0 1.5 0.4 16.0 17.2 0.0 0.3 15.3 6.1 3.9 12.5 0.4 14.2 6.1 0.3 0.0 11.0 11.0 0.0 1.6 1.2 0.3 0.0 0.0 7.6 1.1 1.3 0.8 0.0 0.0 1.1 0.0 0.4 0.9 0.0 1.1 0.0 0.4 2.5 0.1 0.3 0.0 1.2 0.3 2.0 0.6 5.5 1.3 0.9 1.9 3.6 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.6 5.5 0.8 0.3 12.8 1.5 0.0 0.9 1.2 0.9 0.3 42.7 57.1 2.6 1.3 0.2 0.4 24.4 C1QTNF7 CTRP7 ENSG00000163145 "C1q and TNF related 7" Q9BXJ2 4 15339818-15446167 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.8;Fibroblasts: 32.3;Leydig cells: 22.7;Peritubular cells: 31.6;Skeletal myocytes: 15.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 4.2;ASC TERT1: 2.8;HSkMC: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB007055, HPA051797, HPA055392" Uncertain Approved Vesicles "Secreted to blood" NA NA 238000000 Vesicles "CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596" "unprognostic (6.61e-2)" "unprognostic (4.50e-2)" "unprognostic (6.16e-2)" "unprognostic (6.50e-4)" "unprognostic (1.24e-1)" "unprognostic (4.98e-3)" "unprognostic (2.31e-2)" "unprognostic (7.69e-3)" "unprognostic (7.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.97e-4)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (7.56e-3)" "unprognostic (7.28e-3)" 7.8 1.4 1.3 1.6 1.5 0.0 4.7 1.3 2.5 23.3 0.6 7.1 1.2 16.7 10.3 6.1 6.4 14.1 7.1 1.3 1.4 5.6 1.2 10.9 1.2 1.3 1.1 1.0 21.1 0.8 0.1 1.1 7.3 1.5 9.6 4.2 0.1 2.5 3.2 0.6 3.1 3.8 12.1 0.8 9.8 9.1 1.7 1.5 0.4 3.8 6.6 0.5 10.4 10.3 1.7 0.0 0.0 0.0 0.0 4.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.5 1.3 2.5 1.3 1.4 1.3 1.1 1.0 1.5 0.8 1.5 1.7 1.2 0.0 0.0 1.0 0.0 3.6 0.0 0.0 0.0 15.8 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.1 0.2 6.5 0.5 0.0 0.0 1.0 0.0 0.3 32.3 0.0 0.6 0.0 2.0 0.0 0.0 0.1 1.7 4.4 0.0 0.0 0.0 3.2 0.5 22.7 0.3 5.4 6.5 0.0 0.3 0.0 2.5 0.7 0.0 0.0 31.6 0.2 0.1 0.0 2.8 0.0 1.2 6.6 15.2 9.9 0.0 0.1 0.6 3.0 0.0 0.7 5.7 0.0 0.1 TNFAIP8L2 FLJ23467 ENSG00000163154 "TNF alpha induced protein 8 like 2" Q6P589 1 151156649-151159749 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.5" "Cell type enhanced" "Detected in some" "Hofbauer cells: 70.4;Kupffer cells: 65.4;Macrophages: 35.8;monocytes: 34.7;NK-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 29.8;HL-60: 17.6;HMC-1: 44.1;NB-4: 25.2;THP-1: 95.2;U-937: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062742 Approved Vesicles NA NA Vesicles "HPA062742: " "unprognostic (3.19e-3)" "unprognostic (1.02e-2)" "unprognostic (6.63e-3)" "unprognostic (2.27e-2)" "unprognostic (1.29e-1)" "unprognostic (6.49e-3)" "unprognostic (1.05e-1)" "unprognostic (9.15e-3)" "prognostic favorable (3.64e-4)" "unprognostic (9.54e-2)" "unprognostic (3.32e-2)" "unprognostic (9.03e-2)" "prognostic unfavorable (3.53e-7)" "unprognostic (1.78e-1)" "unprognostic (3.91e-2)" "unprognostic (4.87e-2)" "unprognostic (2.23e-1)" 4.7 4.4 4.9 19.8 5.4 6.2 3.4 5.5 7.5 2.4 6.0 4.5 5.4 1.5 1.5 2.5 2.2 5.6 2.3 5.1 7.3 1.6 5.7 10.9 32.2 6.6 5.6 4.7 1.0 1.4 1.2 1.2 7.0 6.9 2.1 6.1 0.9 2.6 1.8 0.8 3.8 7.6 5.5 7.1 39.5 3.5 0.8 6.5 19.4 1.3 2.2 17.9 7.9 1.4 7.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 29.8 0.4 0.0 0.0 17.6 44.1 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.1 0.1 0.0 0.1 0.4 25.2 0.0 0.0 0.1 5.3 0.1 4.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 95.2 2.5 0.2 0.1 0.1 0.2 0.3 0.0 1.9 0.1 37.8 0.1 317.0 238.8 246.7 103.2 220.2 101.9 78.3 125.7 105.2 265.4 83.2 189.5 137.3 292.3 232.9 210.6 63.0 155.7 249.5 4.9 5.4 5.5 7.5 5.1 7.3 6.6 5.6 4.7 6.9 7.1 6.5 7.2 0.3 0.0 1.7 0.0 6.9 0.3 0.0 0.0 0.0 0.8 0.8 0.3 0.1 2.8 1.3 0.0 0.0 0.3 11.1 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 8.8 0.0 0.0 0.5 0.2 0.0 0.0 5.1 0.0 0.7 0.3 70.4 0.0 0.0 0.0 0.0 65.4 12.8 0.4 0.3 35.8 0.0 0.0 34.7 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.4 10.6 0.0 0.0 0.0 LYSMD1 "MGC35223, RP11-68I18.5, SB145" ENSG00000163155 "LysM domain containing 1" Q96S90 1 151159748-151165948 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028055, HPA064537" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028055: AB_10601912, HPA064537: AB_2685281" "unprognostic (1.71e-1)" "unprognostic (1.45e-2)" "unprognostic (1.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.59e-3)" "unprognostic (8.26e-2)" "unprognostic (7.24e-3)" "unprognostic (7.31e-3)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (8.72e-3)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (8.47e-3)" "unprognostic (6.33e-2)" 4.9 7.1 7.4 2.7 7.5 1.1 5.6 9.6 10.1 7.2 6.8 6.0 6.2 6.2 4.3 5.1 7.1 3.5 8.1 7.4 7.4 5.4 6.6 3.3 3.2 7.7 7.1 7.1 11.0 5.0 9.8 5.6 7.4 7.7 5.6 5.5 9.7 4.9 6.4 13.9 6.3 4.3 6.0 6.6 4.3 5.8 4.3 7.3 6.3 6.3 13.6 3.3 7.3 6.1 7.8 5.0 5.3 11.4 8.9 6.5 7.2 8.9 7.2 6.2 8.4 7.5 3.4 5.9 6.6 8.6 4.6 4.3 8.6 8.9 5.1 6.2 12.8 9.8 3.8 8.7 3.6 10.2 4.0 6.0 10.1 10.9 7.9 11.2 11.3 3.5 14.9 7.7 6.2 5.8 7.9 10.3 5.0 7.2 5.0 6.8 7.2 8.3 3.9 6.1 2.3 13.6 16.6 5.4 16.4 9.5 14.3 10.0 13.4 3.6 6.4 3.5 4.1 9.6 19.6 16.0 3.1 5.5 1.6 6.2 1.6 0.8 1.4 0.8 0.5 0.9 0.7 1.0 0.5 0.7 1.7 1.3 1.4 3.1 1.3 0.8 1.4 1.5 0.3 7.4 7.5 9.6 10.1 7.4 7.4 7.7 7.1 7.1 7.7 6.6 7.3 7.8 2.2 0.0 0.5 3.3 0.3 0.9 0.9 0.8 1.8 4.0 4.1 2.0 8.8 0.0 2.8 5.5 6.2 4.6 0.1 3.4 3.9 1.8 0.3 2.9 5.1 2.0 4.2 3.2 3.1 0.6 3.1 3.0 0.0 2.1 0.0 5.0 3.9 4.2 0.6 1.7 3.4 1.7 2.0 0.0 0.8 0.4 4.4 0.2 1.8 1.0 0.1 3.7 0.0 2.5 4.3 2.2 1.1 6.0 0.3 1.1 3.8 8.2 2.4 8.0 0.0 2.5 3.9 2.0 2.7 1.3 1.1 2.9 0.5 3.0 2.7 1.0 SCNM1 MGC3180 ENSG00000163156 "Sodium channel modifier 1" Q9BWG6 1 151156664-151170296 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 269.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052439, HPA054324" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052439: AB_2681834, HPA054324: AB_2682451" "unprognostic (1.20e-1)" "unprognostic (4.42e-2)" "unprognostic (6.13e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-3)" "unprognostic (1.77e-1)" "unprognostic (4.25e-3)" "unprognostic (1.25e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.23e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (2.17e-13)" "unprognostic (8.74e-2)" "unprognostic (1.13e-1)" "unprognostic (8.48e-2)" "unprognostic (9.71e-2)" 26.3 20.1 36.4 27.7 36.5 46.5 24.6 37.4 40.9 24.3 34.6 24.2 20.3 25.4 17.5 26.0 22.0 18.9 21.8 35.4 36.5 23.0 17.0 21.8 40.2 37.2 36.2 34.1 20.9 15.1 17.8 16.6 21.3 37.3 23.9 17.5 13.8 20.3 17.4 65.6 28.3 23.5 21.8 37.4 34.3 21.4 18.5 37.0 35.3 18.2 34.6 35.0 30.0 23.2 39.1 46.5 32.0 35.0 41.4 47.9 35.9 58.3 35.9 41.5 85.7 66.5 69.9 44.2 73.3 57.1 39.0 22.4 61.5 41.3 33.1 41.4 46.6 45.7 63.5 44.5 45.5 69.2 85.2 60.0 37.8 63.3 60.3 53.4 40.2 52.4 50.5 51.7 54.7 42.6 114.0 61.2 132.0 89.0 72.1 49.2 82.3 41.7 91.7 46.7 30.6 43.0 69.0 40.5 65.4 83.5 43.2 60.5 269.9 38.7 40.8 38.3 42.5 78.1 70.7 104.3 117.4 42.5 89.5 53.6 286.7 189.1 203.3 80.4 146.0 77.6 125.9 97.4 92.0 254.9 112.7 89.0 76.9 190.5 131.6 95.1 260.8 131.4 182.3 36.4 36.5 37.4 40.9 35.4 36.5 37.2 36.2 34.1 37.3 37.4 37.0 39.1 21.0 3.2 15.2 0.0 33.7 26.6 17.8 47.8 33.0 19.9 20.2 26.3 32.9 17.2 34.1 29.5 18.8 36.6 52.3 21.4 54.8 34.0 33.5 24.0 23.1 26.9 14.4 34.7 0.0 31.9 33.6 26.5 26.0 15.2 40.5 15.8 27.5 11.9 74.1 8.4 0.0 20.4 54.9 57.2 62.0 25.3 31.1 55.1 21.4 0.0 67.6 25.7 64.9 0.0 0.0 41.9 31.2 21.4 23.2 16.6 36.3 37.1 38.5 16.9 32.9 14.2 43.9 27.9 15.1 33.6 18.3 27.5 37.8 14.7 16.8 22.0 TMOD4 Sk-Tmod ENSG00000163157 "Tropomodulin 4" Q9NZQ9 1 151169986-151176284 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 68 "skeletal muscle: 1236.6;tongue: 538.8" "Cell type enhanced" "Detected in single" "Astrocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 8.6;U-266/84: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA028203 Enhanced NA NA "HPA028203: AB_10600830" 0.9 1.0 1.6 2.9 1.4 2.3 1.6 1.3 2.5 0.8 1.9 2.0 1.0 2.0 2.6 13.0 1.8 2.2 0.7 1.5 1.3 0.8 0.2 2.4 5.9 1.4 1.4 1.1 1.7 0.4 0.6 0.1 1.3 1.3 10.1 2.5 1.0 8.2 1.8 1236.6 4.2 2.1 1.5 1.6 3.5 1.7 1.4 1.4 2.7 0.5 538.8 7.1 1.2 0.2 1.9 0.9 1.5 2.1 0.5 1.3 0.2 1.8 0.8 0.3 0.8 0.1 0.7 0.8 1.2 0.9 1.2 0.4 0.7 1.5 0.4 0.3 2.9 4.4 2.1 3.4 0.0 0.6 1.9 5.0 0.2 0.6 0.9 2.5 2.4 0.6 4.5 1.2 2.8 0.4 2.4 0.8 8.6 1.3 0.6 2.3 3.6 0.8 0.4 0.3 1.2 1.7 1.4 0.4 0.0 0.2 0.5 0.7 4.0 0.5 0.1 1.0 1.7 1.0 3.4 6.4 1.0 0.6 4.3 0.6 0.0 0.1 0.1 0.5 0.0 0.2 0.4 0.5 0.1 0.0 0.4 0.4 0.9 0.0 0.0 0.1 0.3 0.4 0.2 1.6 1.4 1.3 2.5 1.5 1.3 1.4 1.4 1.1 1.3 1.6 1.4 1.9 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 VPS72 "Swc2, TCFL1, YL-1, YL1" ENSG00000163159 "Vacuolar protein sorting 72 homolog" Q15906 1 151176304-151195321 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065709 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA065709: AB_2685540" "unprognostic (2.55e-1)" "unprognostic (3.79e-1)" "unprognostic (3.10e-1)" "unprognostic (4.50e-2)" "unprognostic (2.16e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (4.41e-6)" "unprognostic (4.10e-2)" "unprognostic (2.25e-1)" "unprognostic (1.10e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (7.92e-2)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (4.49e-2)" "unprognostic (1.30e-1)" 23.0 21.1 31.7 17.1 32.0 13.0 22.9 33.6 40.0 27.5 28.3 24.7 16.9 28.4 19.2 25.2 23.7 15.1 23.7 31.0 32.5 22.5 18.0 18.8 21.3 32.8 31.8 30.6 26.0 21.7 21.4 19.3 22.5 32.2 26.0 16.3 18.4 23.7 18.3 56.7 24.4 20.7 24.4 31.4 23.7 24.0 18.8 32.5 28.2 20.1 32.6 26.5 32.5 23.8 34.5 60.7 41.0 92.8 66.9 40.1 35.0 79.5 64.2 33.8 50.4 36.4 43.7 49.4 60.6 77.3 48.7 35.0 56.0 69.1 41.4 38.0 72.2 75.4 52.3 31.0 30.2 55.7 77.8 46.0 28.5 56.8 57.4 47.5 52.8 66.7 74.3 100.2 44.5 40.3 103.3 67.0 54.8 108.5 107.5 69.2 73.2 52.9 95.3 47.1 30.5 65.5 116.8 44.1 67.6 78.9 86.6 76.5 114.4 63.2 26.5 44.9 42.7 82.3 82.5 124.9 96.4 43.4 52.9 49.9 63.3 48.8 82.4 57.2 47.5 55.4 65.8 50.9 49.3 55.3 53.9 50.3 45.6 35.7 75.3 40.6 35.2 67.5 58.3 31.7 32.0 33.6 40.0 31.0 32.5 32.8 31.8 30.6 32.2 31.4 32.5 34.5 23.3 6.4 9.1 7.5 21.9 28.4 28.6 40.0 28.5 13.7 24.8 32.1 15.1 24.3 26.8 23.9 4.2 57.6 19.1 24.6 64.6 49.9 12.2 15.2 18.1 25.2 20.3 30.9 6.3 46.4 53.5 24.3 20.9 17.4 31.7 25.4 25.0 18.1 32.0 15.2 6.9 30.6 63.1 22.9 18.8 9.7 25.1 17.7 42.7 2.8 33.8 32.8 29.9 4.5 9.1 59.8 30.5 24.8 13.5 31.4 28.6 35.4 15.7 12.9 52.6 23.3 40.7 39.5 30.4 23.5 31.7 63.1 24.8 16.1 27.1 35.5 ERCC3 "BTF2, RAD25, XPB" ENSG00000163161 "ERCC excision repair 3, TFIIH core complex helicase subunit" P19447 2 127257290-127294166 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037153, HPA046077" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037153: AB_796181, HPA046077: AB_2679527" "unprognostic (2.31e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-3)" "unprognostic (1.05e-1)" "unprognostic (8.85e-2)" "prognostic unfavorable (1.62e-7)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (9.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.30e-6)" "unprognostic (3.71e-1)" "unprognostic (8.50e-2)" "unprognostic (5.73e-2)" "unprognostic (3.92e-2)" 23.8 26.2 15.4 14.7 15.8 19.9 24.6 14.9 16.2 31.3 18.5 26.0 9.7 27.2 11.7 22.9 29.2 14.4 22.6 16.0 14.8 23.0 22.4 22.3 21.7 15.1 14.9 14.4 29.7 24.0 26.5 34.1 13.8 15.5 27.6 13.9 4.4 23.4 16.9 35.6 27.7 24.5 21.7 14.7 32.9 23.9 30.0 15.5 26.8 25.2 25.9 22.6 27.4 26.6 15.8 45.9 30.8 37.8 40.6 40.6 27.8 46.4 41.3 52.9 65.1 62.5 48.1 32.9 34.5 33.2 37.8 41.7 40.2 57.7 43.3 56.1 54.4 51.4 43.6 35.8 51.0 30.5 38.1 45.4 28.9 39.8 75.7 32.4 41.5 42.4 44.3 43.0 22.1 41.7 45.1 54.8 42.2 55.0 29.2 47.3 44.5 42.7 28.8 36.4 42.2 45.2 49.2 35.3 52.6 55.0 42.4 28.7 43.0 34.1 39.2 45.2 35.8 49.7 39.2 81.5 54.0 34.3 18.0 42.8 8.0 11.5 8.8 18.2 12.0 18.4 13.7 13.1 15.7 16.9 12.7 17.7 12.2 3.5 25.0 9.9 13.6 20.5 15.5 15.4 15.8 14.9 16.2 16.0 14.8 15.1 14.9 14.4 15.5 14.7 15.5 15.8 12.2 22.4 14.6 24.8 17.7 7.6 9.5 20.6 21.1 0.0 13.0 11.6 13.0 5.7 25.4 7.3 0.0 18.6 18.9 6.1 1.9 13.7 9.0 22.9 13.9 12.2 6.1 3.8 22.3 14.9 12.2 16.6 18.8 13.1 10.1 17.1 15.4 8.6 14.6 0.0 23.5 10.0 14.2 12.5 7.6 5.1 16.4 10.7 8.8 10.3 12.3 0.0 14.4 18.1 22.4 15.5 7.3 12.8 16.4 7.4 6.3 8.5 45.2 0.0 13.1 17.6 13.3 41.1 31.0 11.3 9.5 14.6 15.7 12.3 10.6 8.5 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 278.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 619.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 619.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 26.9 15.3 9.0 40.6 9.1 52.8 16.4 9.2 10.3 15.1 13.1 15.9 17.0 12.5 16.4 35.7 17.0 19.0 11.7 9.1 13.5 14.3 26.9 30.8 18.4 11.4 9.9 8.8 16.1 22.4 18.0 10.5 22.0 10.3 12.7 15.9 7.9 18.4 10.2 8.6 25.8 18.4 13.0 10.1 53.5 19.3 16.0 10.4 15.3 12.3 9.5 19.8 29.3 22.9 11.9 19.9 11.4 8.8 11.3 31.6 31.3 49.7 24.0 31.8 32.1 35.8 29.0 51.6 6.1 28.3 23.9 42.9 39.0 12.5 24.6 29.7 16.9 16.6 12.4 9.9 50.0 42.1 13.4 19.2 28.9 40.0 37.9 25.1 24.7 58.9 13.0 10.7 18.0 32.4 16.9 18.8 14.0 6.1 27.1 20.0 11.5 14.2 23.4 38.0 48.0 11.5 8.5 14.4 36.0 37.2 9.5 9.7 17.8 39.6 16.2 9.1 24.5 5.3 35.5 22.5 0.2 5.2 18.6 12.2 44.0 73.6 90.3 43.8 118.1 41.8 13.2 40.0 45.3 27.9 8.5 28.2 30.2 619.9 15.3 134.1 52.5 53.8 69.8 9.0 9.1 9.2 10.3 9.1 13.5 11.4 9.9 8.8 10.3 10.1 10.4 11.9 19.9 48.1 48.1 44.7 55.2 76.9 78.1 63.5 54.7 20.4 29.7 15.9 13.0 41.5 48.4 55.2 56.3 65.2 112.4 53.1 1.9 59.1 97.9 41.8 31.9 30.0 8.5 22.7 82.8 42.2 73.0 53.5 37.2 63.1 39.2 17.3 27.1 46.2 85.9 8.4 71.6 31.7 12.2 278.6 144.2 37.2 30.7 209.0 40.9 50.6 116.5 11.6 61.8 34.7 59.6 54.3 52.3 19.5 125.5 73.5 45.9 25.8 44.8 20.7 59.2 40.5 30.1 36.6 40.3 128.3 91.6 128.1 115.7 23.8 32.8 154.1 IWS1 "DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319" ENSG00000163166 "Interacts with SUPT6H, CTD assembly factor 1" Q96ST2 2 127436207-127526886 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035719, HPA061866" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035719: AB_10669527, HPA061866: AB_2684628" "unprognostic (3.11e-2)" "unprognostic (1.31e-1)" "unprognostic (1.80e-2)" "unprognostic (3.07e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (8.49e-2)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (2.25e-1)" "unprognostic (4.32e-2)" "unprognostic (9.96e-2)" "unprognostic (1.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.10e-2)" "unprognostic (9.01e-2)" "unprognostic (9.81e-2)" 22.9 18.7 31.5 23.4 36.2 31.8 22.4 34.0 35.1 22.2 33.6 24.4 23.6 23.0 24.0 23.0 21.5 19.0 46.2 30.8 34.0 25.1 40.6 22.7 29.1 34.2 36.2 28.2 18.1 21.8 24.0 25.0 26.7 38.2 23.5 24.0 26.8 22.8 19.5 76.6 21.1 24.6 22.1 32.3 27.8 23.3 23.5 35.7 31.5 20.9 62.6 28.7 26.1 23.6 45.0 52.0 34.5 68.4 45.0 51.0 42.4 71.4 73.9 50.0 67.2 55.9 81.6 38.8 48.7 38.2 59.3 51.4 41.9 66.7 58.2 79.4 50.7 45.4 68.1 50.6 92.9 60.2 78.2 54.5 42.0 43.6 71.5 64.0 35.7 58.0 60.3 72.8 37.0 64.3 48.3 77.7 63.4 92.2 43.0 46.8 68.9 53.5 44.9 67.6 62.0 53.4 34.7 52.9 65.9 60.3 73.4 29.6 53.5 66.4 66.3 50.4 40.4 43.8 28.6 33.6 64.5 36.6 54.2 45.0 3.6 13.2 18.5 9.7 14.8 11.8 11.4 11.1 11.8 13.0 15.1 10.5 11.0 13.9 15.0 17.3 11.8 11.0 9.5 31.5 36.2 34.0 35.1 30.8 34.0 34.2 36.2 28.2 38.2 32.3 35.7 45.0 23.1 112.2 74.3 35.3 36.6 15.7 55.3 22.8 23.9 27.9 16.9 15.7 77.4 21.5 53.5 16.5 27.1 40.0 33.5 35.1 19.6 38.6 13.2 38.5 39.8 28.9 28.1 30.7 21.9 25.5 56.3 41.9 32.1 36.8 42.3 42.3 20.7 25.7 27.1 21.9 27.8 25.7 30.5 16.4 25.4 8.5 39.1 29.2 10.6 25.3 40.1 26.4 46.4 25.6 105.0 41.9 28.0 31.6 37.5 53.8 25.1 19.1 44.6 44.7 32.9 29.3 35.6 69.8 52.0 24.1 17.0 92.8 37.4 34.6 26.9 77.2 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135400-74147912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 175.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 313.2;Distal tubular cells: 352.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: AB_2682063" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 35.9 39.7 52.3 22.8 53.5 41.1 31.7 58.4 66.6 19.4 54.2 47.0 34.1 24.7 25.3 32.0 21.0 12.0 99.7 52.0 55.9 60.1 34.0 23.7 22.4 56.5 53.1 51.3 16.7 45.1 56.7 29.8 14.3 56.1 25.6 38.0 36.1 40.1 23.9 118.9 15.7 29.1 22.8 53.9 22.1 41.4 16.0 53.7 25.1 29.1 175.5 21.8 27.3 24.6 54.8 102.8 134.0 44.8 46.2 81.5 78.3 113.9 92.5 54.5 104.0 72.0 176.6 45.4 67.2 79.7 82.4 99.3 53.2 107.9 135.4 95.8 126.5 172.8 85.4 88.3 269.8 76.1 167.3 39.0 62.2 96.6 100.9 124.2 45.9 79.4 144.3 183.2 73.7 116.0 163.6 136.4 123.1 66.9 196.8 198.6 88.5 120.1 132.0 138.8 106.2 70.4 40.7 68.3 106.8 123.3 62.0 62.6 102.8 42.6 83.9 142.9 93.8 185.4 67.5 135.3 92.7 87.6 131.8 73.8 14.7 14.2 3.9 68.3 29.9 75.7 45.4 92.7 72.6 37.8 44.5 79.3 68.7 3.0 51.7 33.5 65.1 91.2 40.6 52.3 53.5 58.4 66.6 52.0 55.9 56.5 53.1 51.3 56.1 53.9 53.7 54.8 54.7 9.6 29.8 8.5 33.2 22.7 44.5 111.8 43.3 29.9 82.0 109.5 313.2 44.3 50.1 84.6 16.7 54.9 42.8 125.4 352.1 93.2 20.0 67.0 46.2 45.5 76.1 138.2 14.3 111.4 167.5 48.6 58.1 61.5 25.4 31.9 36.4 113.3 113.9 26.9 15.0 128.3 83.4 32.1 28.9 10.2 32.9 32.2 99.6 3.7 59.4 61.8 62.8 7.5 7.7 95.0 70.9 46.3 76.1 50.9 85.6 266.4 51.2 52.6 19.7 39.6 64.4 66.8 80.5 101.0 16.9 22.3 45.1 83.0 176.2 52.0 CDC42EP3 "BORG2, CEP3, UB1" ENSG00000163171 "CDC42 effector protein 3" Q9UKI2 2 37641882-37738468 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 233.5;Langerhans cells: 259.6;Melanocytes: 200.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 23.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 607.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034986, HPA061792" Approved Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA034986: AB_10602207, HPA061792: AB_2732670" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-2)" "unprognostic (4.11e-3)" "unprognostic (2.38e-2)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (1.72e-1)" "unprognostic (1.84e-1)" "unprognostic (3.81e-1)" "unprognostic (3.14e-3)" "unprognostic (7.30e-3)" "unprognostic (1.97e-1)" "unprognostic (2.97e-1)" "unprognostic (4.53e-2)" 48.1 10.4 4.4 22.1 5.6 87.4 39.2 0.4 23.4 50.9 23.5 32.8 6.2 93.6 10.8 21.3 24.5 21.4 60.2 7.1 4.6 24.0 9.0 29.6 25.8 2.5 3.4 4.5 24.0 27.4 8.3 6.9 26.5 6.3 94.2 20.8 15.5 14.7 108.0 58.2 13.3 17.4 97.2 2.5 27.0 14.5 42.3 4.4 36.5 16.0 22.2 23.6 45.9 20.5 4.7 100.2 38.0 21.6 1.2 80.6 42.2 33.8 84.2 221.1 127.5 92.2 69.8 39.3 17.6 66.5 198.9 39.2 47.1 27.1 99.6 129.4 68.2 9.5 31.6 37.5 0.0 156.1 7.1 1.8 129.6 91.7 110.1 243.2 206.6 75.6 7.0 5.0 13.8 607.0 0.8 3.4 59.3 44.1 1.2 23.5 2.8 163.8 9.3 93.1 47.4 23.7 69.9 41.6 29.7 50.2 37.7 9.9 58.8 57.5 152.3 40.0 40.2 86.9 27.0 37.9 5.9 63.1 48.4 215.4 54.6 88.2 6.9 69.4 56.7 74.6 24.9 44.5 60.2 30.9 11.0 14.3 37.3 189.4 38.3 119.5 0.9 35.8 61.5 4.4 5.6 0.4 23.4 7.1 4.6 2.5 3.4 4.5 6.3 2.5 4.4 4.7 233.5 6.4 50.4 1.6 50.3 37.1 137.3 81.4 5.7 12.3 31.9 40.1 97.5 12.8 28.9 31.3 35.5 30.8 63.8 7.8 9.8 20.8 51.7 49.6 24.4 113.9 41.2 14.5 15.6 15.9 68.2 29.7 14.3 33.6 129.6 9.2 83.2 1.5 12.2 101.0 34.9 59.6 32.6 44.1 259.6 158.0 15.2 86.0 200.9 9.4 78.6 27.5 106.1 4.0 0.5 24.9 3.0 126.7 43.4 32.7 1.1 5.0 73.3 13.2 0.0 29.2 29.4 67.2 13.6 3.1 13.5 12.0 97.7 1.4 6.0 38.5 S100A11 S100C ENSG00000163191 "S100 calcium binding protein A11" P31949 1 152032506-152047907 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 4789.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 17820.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034320, HPA042745" Enhanced Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA 7900000 "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB034320: AB_2183487, HPA042745: AB_2678142" "unprognostic (1.85e-2)" "unprognostic (9.20e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-1)" "unprognostic (3.12e-2)" "unprognostic (7.61e-2)" "prognostic unfavorable (3.64e-5)" "unprognostic (3.34e-2)" "unprognostic (8.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.28e-3)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.24e-6)" "unprognostic (2.91e-1)" "unprognostic (2.75e-1)" "unprognostic (2.43e-3)" "unprognostic (8.86e-2)" 651.6 216.0 91.0 491.5 96.6 419.0 579.6 96.9 224.2 749.2 116.5 305.9 183.3 300.2 681.3 4789.6 616.4 441.7 335.5 88.5 126.7 689.1 128.7 782.7 208.4 110.8 97.1 83.9 153.3 266.3 912.2 212.3 729.2 108.8 541.0 331.9 8.5 1257.2 549.1 91.8 901.9 241.5 472.5 111.0 719.5 486.9 69.4 111.8 306.3 328.0 152.2 968.0 1542.4 1785.8 125.0 1889.0 1483.7 70.5 542.1 1960.9 2451.3 1172.4 1796.3 2626.0 1439.7 1464.8 697.6 2066.0 2.5 1571.4 2355.4 1142.4 2595.4 73.7 3254.0 814.0 913.6 149.2 162.6 830.1 409.1 1511.3 149.6 1098.4 1867.2 3255.1 1577.8 1974.9 826.9 1116.1 0.3 340.9 352.1 2137.7 3058.8 19.8 694.0 513.9 4043.1 1491.9 2.5 757.1 1426.0 4361.1 3196.5 2.5 115.8 1367.7 1797.9 1255.3 1727.2 1378.9 1612.5 1584.8 757.0 533.1 1188.8 975.7 2.5 17.0 8.2 1713.0 490.9 915.2 7956.3 4682.6 7210.4 713.6 4560.1 939.4 354.9 1346.4 845.1 3020.5 252.7 391.5 437.0 17820.3 740.5 4871.8 1042.8 1269.9 5289.9 91.0 96.6 96.9 224.2 88.5 126.7 110.8 97.1 83.9 108.8 111.0 111.8 125.0 718.5 137.8 189.4 1.3 136.6 2210.3 3924.9 5473.4 1027.8 0.7 686.8 823.8 30.8 546.2 2673.9 2284.2 0.0 3257.0 384.0 421.7 1019.3 4344.5 277.6 1738.8 561.2 617.8 277.7 52.6 0.0 4330.2 6093.0 890.7 676.4 1503.0 437.6 251.1 372.6 11.6 3806.0 0.0 0.0 479.6 1485.2 1216.7 2054.0 634.0 320.9 1971.8 1243.3 15.9 2265.2 0.8 371.8 0.0 0.0 6926.5 690.2 258.4 153.8 4365.0 343.9 925.4 2674.2 2.4 210.4 536.2 1054.9 14.5 34.8 4207.9 2822.4 3753.1 470.4 334.8 500.2 6250.2 LCE3D "LEP16, SPRL6A, SPRL6B" ENSG00000163202 "Late cornified envelope 3D" Q9BYE3 1 152579381-152580516 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 130.1;lymphoid tissue: 85.5;vagina: 231.6" "Cell type enriched" "Detected in some" 5 "Pancreatic endocrine cells: 8.2" "Group enriched" "Detected in many" 9 "head and neck cancer: 126.9;melanoma: 47.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTCEpi: 4.3;hTERT-HME1: 3.9" NA NA "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 130.1 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 64.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 85.5 0.0 231.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMCP MCSP ENSG00000163206 "Sperm mitochondria associated cysteine rich protein" P49901 1 152878322-152885047 "Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 957 "testis: 754.0" "Group enriched" "Detected in some" 80 "Early spermatids: 3632.3;Late spermatids: 13748.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.2;hTERT-HME1: 1.1" "Not detected" "Not detected" "HPA035105, HPA077113" Enhanced NA NA "HPA035105: AB_10601590, HPA077113: " "unprognostic (5.51e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 754.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3632.3 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13748.1 84.5 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 107.5 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IVL ENSG00000163207 Involucrin P07476 1 152908546-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 77.5;esophagus: 300.7;salivary gland: 95.3;skin 1: 145.7;vagina: 237.1" "Cell type enhanced" "Detected in some" "Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3" "Not detected" "Not detected" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" NA NA 4700000 Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: AB_2682739" "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 77.5 0.0 0.0 0.0 0.0 18.4 300.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 95.3 0.1 0.4 145.7 0.1 0.0 0.0 0.1 0.2 0.1 0.0 3.6 0.1 0.0 37.2 17.6 237.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 6.0 0.0 0.0 0.2 0.0 292.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.9 0.0 0.0 0.0 86.3 0.0 0.2 3.6 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 3.1 3.5 0.0 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.6 0.0 0.0 30.8 71.0 0.0 0.1 0.0 0.0 13.3 SPRR3 ENSG00000163209 "Small proline rich protein 3" Q9UBC9 1 153001747-153003856 "Cancer-related genes, Predicted intracellular proteins" Keratinization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 19659.3;vagina: 6111.4" "Cell type enriched" "Detected in some" 11 "Squamous epithelial cells: 987.1" "Group enriched" "Detected in many" 4 "cervical cancer: 206.3;head and neck cancer: 423.4;stomach cancer: 113.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.5;CAPAN-2: 5.8;hTCEpi: 9.7;OE19: 4.4;RT4: 12.6;TIME: 3.4" "Not detected" "Not detected" HPA044467 Enhanced NA NA 5200 "HPA044467: AB_2678952" "unprognostic (2.78e-2)" "unprognostic (3.54e-1)" "unprognostic (8.77e-2)" "unprognostic (7.50e-3)" "unprognostic (9.67e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (9.70e-2)" "unprognostic (4.66e-2)" "unprognostic (1.58e-2)" 3.7 3.5 0.0 0.1 0.0 0.0 3.0 0.0 0.0 2034.4 0.0 2.4 0.1 3.5 0.0 19659.3 3.4 38.5 7.4 0.0 0.0 2.5 5.8 1.7 0.0 0.0 0.1 0.0 4.4 8.8 0.0 11.1 0.7 0.0 3.4 0.1 0.0 3182.9 0.0 5.0 5.2 4.3 1.7 0.0 3.4 15.3 2.1 0.0 1.4 2.3 0.0 2420.4 65.8 6111.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 5.8 3.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.1 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 0.0 1.1 0.0 0.0 12.6 0.0 0.0 0.3 2.7 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.0 7.4 0.0 0.0 0.0 0.1 0.0 41.3 0.0 0.0 5.9 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 4.2 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.4 0.0 0.1 2.1 0.0 0.0 0.0 1.0 0.0 0.0 987.1 0.0 7.5 0.4 0.1 0.0 89.6 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 136.3;Late spermatids: 352.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 6.1 9.3 6.7 5.2 7.3 4.8 6.5 6.8 8.9 8.2 6.9 6.4 2.2 7.8 10.4 5.5 6.7 4.2 5.2 7.3 7.1 6.8 5.4 4.9 6.2 6.4 6.8 6.7 7.9 7.0 9.8 10.1 5.9 6.3 6.3 5.6 8.6 5.6 6.3 9.1 7.1 5.2 7.3 5.7 6.0 5.7 23.6 6.7 6.8 7.3 5.5 6.3 7.5 6.2 6.9 23.4 19.3 21.0 15.8 13.5 16.6 16.2 15.5 15.9 15.2 14.7 15.7 7.2 7.1 15.6 16.9 17.1 11.8 23.6 18.2 24.9 28.0 18.4 13.3 11.5 21.3 12.2 14.5 7.3 16.0 10.8 20.0 12.5 10.8 20.7 5.2 17.8 9.5 16.7 17.7 14.7 12.9 25.1 10.1 11.4 7.0 27.7 13.9 14.2 8.6 16.8 24.8 15.8 16.4 17.4 14.7 11.7 8.0 15.4 15.1 16.5 10.9 17.7 9.3 12.2 2.8 11.4 10.1 10.2 1.6 6.3 1.2 2.8 4.5 3.6 3.8 2.3 2.1 3.2 4.6 2.9 1.7 0.4 2.3 5.6 1.2 2.5 2.9 6.7 7.3 6.8 8.9 7.3 7.1 6.4 6.8 6.7 6.3 5.7 6.7 6.9 6.2 3.2 10.9 24.2 8.8 2.7 2.7 5.9 6.2 24.7 5.2 7.6 6.2 10.0 10.9 23.9 56.3 7.2 4.7 2.5 0.0 7.7 136.3 18.0 13.4 6.3 11.9 8.2 36.7 7.6 6.7 9.3 7.1 6.2 10.8 19.4 9.7 6.2 7.0 18.5 38.0 5.7 4.1 11.7 3.8 352.8 15.8 8.5 1.8 25.3 23.9 9.5 8.2 33.2 20.9 8.5 3.1 13.9 8.1 2.0 2.1 6.0 27.3 27.7 0.0 8.8 6.0 19.3 9.8 5.3 2.6 2.9 7.9 14.7 5.0 2.2 SPRR2D ENSG00000163216 "Small proline rich protein 2D" P22532 1 153039732-153041931 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "esophagus: 2105.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 58.6;Club cells: 20.7;Squamous epithelial cells: 14.4;Suprabasal keratinocytes: 15.6" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 353.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTCEpi: 41.1;hTERT-HME1: 35.8;SK-MEL-30: 18.2" NA NA "unprognostic (7.50e-2)" "unprognostic (1.84e-1)" "unprognostic (5.17e-2)" "unprognostic (5.14e-2)" "unprognostic (1.49e-3)" "unprognostic (3.58e-1)" "unprognostic (1.37e-3)" "unprognostic (6.85e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.62e-4)" 0.7 0.3 0.0 0.0 0.0 0.0 4.1 0.0 0.0 165.8 0.0 0.2 0.0 0.3 0.0 2105.1 0.3 0.5 0.8 0.0 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.4 0.0 0.0 0.2 0.0 0.0 315.5 0.0 0.8 175.4 0.3 0.3 0.0 0.2 1.1 0.3 0.1 2.8 0.2 0.0 386.5 0.4 477.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 41.1 0.0 35.8 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.2 0.2 0.0 0.0 1.2 0.0 0.8 0.0 0.0 1.1 0.1 0.3 6.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 58.6 0.0 0.0 0.0 0.0 0.1 0.0 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.2 0.0 0.0 14.4 15.6 0.3 0.0 0.1 0.0 0.8 BMP10 ENSG00000163217 "Bone morphogenetic protein 10" O95393 2 68860909-68871397 "Predicted secreted proteins" "Cell adhesion" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 451.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 230000 "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 451.9 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348841 "Metabolic proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix: 4.1;esophagus: 8.2;skin 1: 15.0;vagina: 10.3" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 30.1;Club cells: 9.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;HDLM-2: 2.2;Karpas-707: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB025879 Approved "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 15.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 30.1 0.6 0.0 0.0 0.1 0.3 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.0 1.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 2.0 0.0 0.3 0.3 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 4.0 3.4 0.3 0.0 0.0 0.2 0.2 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 73.4" "Cell type enhanced" "Detected in many" "B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 657.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favorable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 11.2 5.2 5.2 39.2 5.5 37.8 8.1 5.5 8.0 6.0 5.5 7.3 6.3 6.7 22.9 4.4 4.7 11.8 6.8 5.1 6.6 7.0 10.2 21.5 72.0 6.1 5.7 4.3 16.8 2.1 2.3 3.6 10.8 6.3 5.0 9.7 0.6 5.2 3.8 3.2 6.2 23.5 8.4 6.9 73.4 8.9 2.5 7.0 27.6 5.2 8.5 67.9 12.0 4.8 7.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 20.8 0.5 0.0 0.1 2.5 0.0 20.5 0.0 2.3 0.0 66.7 0.0 0.0 1.0 14.8 256.1 0.2 2.4 0.4 8.1 0.0 0.0 22.2 0.4 23.6 0.0 0.0 17.2 47.3 1.2 0.2 0.0 18.7 4.3 0.8 0.0 5.4 4.1 0.6 0.2 0.0 1.4 1.4 0.0 12.3 3.5 0.1 0.9 0.1 0.5 50.8 29.0 16.8 0.2 33.3 0.3 234.8 60.8 528.7 171.3 75.9 107.0 156.4 76.2 150.0 37.4 100.8 54.2 95.2 657.3 170.6 94.8 52.3 102.0 132.0 5.2 5.5 5.5 8.0 5.1 6.6 6.1 5.7 4.3 6.3 6.9 7.0 7.4 14.1 3.2 15.0 0.3 88.7 5.6 12.4 2.9 5.7 0.8 0.7 6.1 1.4 1.5 2.0 0.0 0.0 0.5 35.1 0.1 1.9 0.1 1.8 0.7 0.6 16.6 3.0 11.6 15.5 0.2 0.4 3.5 2.0 0.4 210.8 0.1 15.4 1.0 48.6 0.0 0.9 0.5 2.0 27.3 12.8 3.6 1.5 22.6 1.8 88.1 40.9 0.5 103.0 0.5 0.9 0.0 0.1 2.6 34.7 1.2 0.0 0.2 5.2 0.2 6.6 0.8 2.1 0.6 1.3 2.5 1.4 0.3 53.7 1.8 0.2 2.5 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361023 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 32501.4;esophagus: 30826.8;vagina: 14142.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 24579.6;neutrophil: 33654.0" "Group enriched" "Detected in all" 6 "granulocytes: 33654.0;monocytes: 24579.6" "Cell line enriched" "Detected in many" 6 "SK-BR-3: 2398.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1200000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 626.6 127.1 17.6 1519.1 24.3 32501.4 191.4 19.5 56.9 3782.1 47.1 123.8 24.3 50.4 2.0 30826.8 490.5 148.7 206.8 17.1 36.4 169.1 286.3 1643.5 69.9 26.7 22.1 16.8 52.0 74.6 11.6 65.9 373.2 26.5 92.1 20.4 3.6 5836.0 9.7 92.9 407.2 121.6 485.4 19.5 5424.7 189.2 16.8 24.8 199.6 91.2 151.7 4416.4 963.6 14142.7 30.9 24.6 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.5 0.0 9.2 372.2 0.0 0.4 23.0 0.0 157.3 0.0 0.4 0.0 6.2 0.0 0.1 0.0 7.8 0.0 0.0 130.2 0.0 8.4 0.0 0.0 0.1 7.6 3.5 0.0 31.4 0.8 3.3 0.1 3.1 0.2 0.8 5.1 82.2 0.3 100.4 1.3 0.6 4.0 2398.2 1.7 1.2 38.1 312.3 6.8 0.0 3.3 0.4 0.4 0.7 1.6 3.3 0.5 71.7 0.0 373.8 24579.6 2626.3 30.5 1754.8 52.6 29.7 25.3 17.2 4664.8 24.8 17.7 15.4 33654.0 18.8 860.2 153.3 29.2 24461.7 17.6 24.3 19.5 56.9 17.1 36.4 26.7 22.1 16.8 26.5 19.5 24.8 30.9 1.8 230.8 392.4 0.0 92.1 20.0 123.1 5771.3 28.5 0.0 55.6 6.7 8.0 57.2 1685.0 36.8 0.0 126.1 115.1 7.7 5.9 102.6 1.7 1.2 1.9 26.9 0.0 92.8 0.0 39.4 52.9 50.9 3.6 9.4 164.0 0.2 70.6 54.5 1926.0 0.0 0.0 3.7 309.3 7537.0 13.4 4.0 5.9 3678.1 0.0 0.0 11103.1 0.0 483.0 0.0 0.0 15.3 1.4 0.0 13.1 55.6 0.8 25.2 262.8 0.3 0.0 13.3 60.4 0.3 1.2 3263.1 33.2 1236.0 79.9 0.0 12.5 551.3 S100A12 "CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6" ENSG00000163221 "S100 calcium binding protein A12" P80511 1 153373711-153375621 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3523.6" "Group enriched" "Detected in many" 20 "Kupffer cells: 711.7;Macrophages: 475.0;monocytes: 998.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 51.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "classical monocyte: 1321.1;neutrophil: 1781.4" "Group enriched" "Detected in many" 13 "granulocytes: 1781.4;monocytes: 1321.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.6;THP-1: 1.6" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "HPA002881, CAB025872" Enhanced "Secreted to blood" NA NA 28500000 8300000 "CAB025872: , HPA002881: AB_1848175" "unprognostic (1.33e-1)" "unprognostic (4.51e-2)" "unprognostic (7.49e-2)" "unprognostic (1.36e-1)" "unprognostic (7.30e-2)" "unprognostic (4.36e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-3)" "unprognostic (9.04e-2)" "unprognostic (3.14e-2)" "unprognostic (1.58e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (5.03e-4)" "unprognostic (3.68e-3)" "unprognostic (1.05e-1)" "unprognostic (1.31e-2)" "unprognostic (7.70e-2)" 55.4 3.3 2.4 82.7 3.2 3523.6 7.0 2.8 7.8 11.7 4.6 4.6 1.7 2.2 0.0 52.8 19.4 6.8 15.3 2.6 2.6 14.7 25.9 149.7 2.0 3.4 3.0 2.4 2.2 3.6 1.3 4.3 19.9 3.6 3.5 0.4 0.3 11.5 0.2 4.0 3.8 4.4 40.8 2.8 527.4 8.9 0.9 2.9 30.4 6.0 14.9 46.9 42.3 33.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 1321.1 5.2 1.9 44.9 1.0 3.2 0.8 1.5 122.7 1.0 1.1 0.5 1781.4 0.4 9.6 8.3 2.0 1031.8 2.4 3.2 2.8 7.8 2.6 2.6 3.4 3.0 2.4 3.6 2.8 2.9 3.6 0.0 19.2 24.4 0.0 6.1 0.1 0.3 9.8 0.0 0.0 0.1 0.0 1.1 8.6 9.2 1.8 0.0 0.5 2.9 0.0 0.0 0.1 1.4 0.0 0.0 2.1 0.0 14.1 0.1 0.2 0.9 4.1 1.1 0.0 13.9 0.0 6.8 3.8 8.6 0.0 0.1 0.0 0.0 711.7 0.8 1.8 0.0 475.0 0.0 1.0 998.3 0.0 36.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 7.8 0.0 0.0 0.8 0.4 0.0 0.2 5.7 0.0 0.5 6.9 0.0 0.1 0.2 TGFA ENSG00000163235 "Transforming growth factor alpha" P01135 2 70447284-70554193 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 59.3;Pancreatic endocrine cells: 74.5;Urothelial cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 11.3;eosinophil: 23.8;neutrophil: 23.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 23.8" "Cell line enhanced" "Detected in many" "A-431: 72.5;CAPAN-2: 82.5;HBEC3-KT: 72.3;OE19: 54.6;RPTEC TERT1: 72.6;U-87 MG: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042297 Approved Approved Vesicles "Secreted to blood" No No 57900 Vesicles "HPA042297: AB_10793878" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (3.57e-3)" "unprognostic (6.39e-2)" "unprognostic (1.41e-1)" "unprognostic (8.49e-3)" "unprognostic (1.52e-1)" "unprognostic (3.00e-3)" "unprognostic (6.69e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (7.74e-2)" "unprognostic (3.70e-2)" "unprognostic (1.60e-1)" "unprognostic (9.21e-2)" "prognostic favorable (1.52e-4)" "unprognostic (9.19e-2)" 2.2 0.5 9.9 5.0 16.5 1.6 7.0 15.0 12.1 5.7 7.6 10.8 8.6 1.3 3.0 25.7 6.1 14.2 0.7 11.3 13.2 13.5 4.5 4.0 4.1 18.8 16.7 8.0 0.1 7.6 3.0 0.5 1.9 17.9 2.4 8.0 7.5 6.5 1.2 0.1 12.0 10.1 1.4 18.1 5.8 8.6 2.5 13.8 1.1 8.2 0.3 9.1 10.1 12.9 28.2 72.5 11.3 0.1 0.2 0.0 0.0 0.0 11.0 0.0 0.3 0.1 0.2 82.5 0.0 43.2 0.4 11.2 37.1 0.6 72.3 0.1 0.1 1.6 0.0 1.8 6.0 0.0 0.9 0.1 0.0 29.1 0.1 27.8 3.4 0.0 5.6 0.0 0.4 0.0 2.6 0.1 1.4 1.1 54.6 22.9 0.0 0.5 19.8 72.6 27.2 0.6 0.1 5.8 0.0 0.1 0.2 9.8 0.7 0.6 0.3 4.9 0.1 15.7 0.4 0.6 0.1 69.0 2.4 25.6 11.3 0.8 23.8 1.7 0.2 4.4 0.0 1.0 1.0 1.0 0.0 0.5 0.4 23.8 0.3 0.0 0.0 0.0 0.7 9.9 16.5 15.0 12.1 11.3 13.2 18.8 16.7 8.0 17.9 18.1 13.8 28.2 0.4 6.4 2.7 0.3 0.2 16.2 12.3 16.9 10.8 1.4 9.8 12.1 2.3 24.3 21.8 25.8 0.0 0.0 2.2 19.8 1.9 37.3 21.3 8.1 0.7 1.7 1.2 0.0 0.8 10.0 0.0 0.6 13.7 10.5 5.7 0.0 0.0 3.0 3.9 0.0 3.6 6.2 12.2 3.2 2.4 1.9 0.3 4.1 0.0 6.5 18.2 7.9 2.1 59.3 36.1 74.5 9.0 0.0 0.7 16.8 21.1 6.6 20.4 0.7 0.0 0.1 1.1 0.6 0.2 12.2 24.9 0.0 1.9 0.0 5.6 63.6 TDRD10 DKFZp434M202 ENSG00000163239 "Tudor domain containing 10" Q5VZ19 1 154502219-154548147 "Cancer-related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 56.0" "Group enriched" "Detected in some" 5 "Early spermatids: 61.8;Late spermatids: 89.0;Spermatocytes: 103.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 3.0;TIME: 1.4" "Not detected" "Not detected" HPA054327 Approved Vesicles NA NA Vesicles "HPA054327: AB_2682452" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.33e-3)" "unprognostic (9.69e-3)" "unprognostic (5.80e-3)" "unprognostic (2.99e-1)" "unprognostic (5.97e-3)" "unprognostic (2.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.00e-3)" "unprognostic (1.61e-1)" "unprognostic (1.34e-3)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (8.04e-5)" "unprognostic (1.62e-1)" 9.1 4.5 3.3 0.5 3.2 0.1 6.9 2.7 3.8 4.7 3.5 2.8 0.7 4.2 2.3 2.5 6.6 1.6 7.1 3.0 3.0 3.4 4.5 8.1 0.8 3.0 3.1 2.7 10.2 0.9 0.9 2.6 1.7 2.9 3.9 1.3 0.1 1.8 1.2 1.9 2.3 3.5 1.8 2.7 9.0 1.9 56.0 3.3 0.5 11.1 1.4 0.4 3.9 3.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.2 2.7 3.8 3.0 3.0 3.0 3.1 2.7 2.9 2.7 3.3 3.0 10.0 3.2 6.7 4.9 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.5 1.3 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.8 0.0 0.1 8.2 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 1.3 0.7 6.1 0.4 0.4 0.0 0.5 0.0 0.0 4.0 2.1 89.0 2.5 1.0 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.4 103.7 16.5 0.1 0.3 0.0 0.0 0.1 0.0 0.0 CCNYL1 FLJ40432 ENSG00000163249 "Cyclin Y like 1" Q8N7R7 2 207711540-207761839 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 62.7;Paneth cells: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 83.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046825 Approved Approved "Plasma membrane" Yes No "Plasma membrane" "HPA046825: AB_10963934" "unprognostic (2.59e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (1.20e-3)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-3)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-2)" "unprognostic (7.12e-3)" "unprognostic (7.99e-2)" "unprognostic (3.92e-2)" "unprognostic (8.08e-2)" "unprognostic (7.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.96e-3)" 12.8 4.7 4.2 10.7 5.5 10.0 7.1 3.2 6.2 5.9 4.1 15.5 11.8 5.0 5.3 18.0 4.2 8.0 6.2 5.4 9.1 11.0 12.5 11.9 8.7 5.2 4.7 4.9 3.5 13.9 4.2 4.5 13.7 5.1 4.9 13.5 9.1 7.0 4.8 7.9 3.9 11.4 8.8 4.5 8.2 11.1 16.4 4.8 6.2 11.5 4.5 9.4 10.5 9.6 7.3 25.7 11.0 14.5 20.4 18.6 21.2 83.3 15.6 25.8 15.7 17.7 51.1 23.7 9.9 14.2 28.6 38.5 17.4 17.7 29.4 15.2 3.7 13.5 13.3 12.8 41.6 18.7 11.9 15.2 10.7 12.0 20.0 20.9 13.8 52.5 11.5 6.8 9.4 21.9 13.6 10.5 11.2 28.1 10.3 12.2 9.4 12.4 8.0 16.2 19.5 3.5 10.8 18.5 8.0 23.5 33.6 7.2 31.5 27.3 17.7 16.6 23.2 10.5 5.6 8.4 13.4 18.5 13.5 15.4 0.7 1.1 0.5 0.3 0.6 0.4 0.3 0.5 0.5 0.5 1.1 0.4 0.8 1.3 0.6 0.5 0.5 0.4 0.3 4.2 5.5 3.2 6.2 5.4 9.1 5.2 4.7 4.9 5.1 4.5 4.8 7.3 31.8 3.2 19.1 10.1 14.1 12.2 13.8 7.6 5.7 6.2 10.0 10.0 9.0 2.8 8.5 23.9 10.4 12.6 13.2 62.7 1.9 5.8 13.7 13.6 7.7 17.0 9.6 6.5 34.1 14.7 42.9 11.4 25.0 20.4 5.7 5.8 23.9 12.5 16.2 5.0 11.6 13.1 8.2 17.5 29.9 10.9 2.8 18.7 8.8 7.5 20.8 10.2 7.2 14.6 28.7 13.9 121.3 3.8 7.7 16.1 10.1 12.6 6.3 12.3 0.0 16.0 10.4 23.9 9.5 7.6 10.5 7.7 10.9 4.3 17.0 18.0 FZD5 "C2orf31, DKFZP434E2135, HFZ5" ENSG00000163251 "Frizzled class receptor 5" Q13467 2 207762598-207769906 "G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 117.4;Hepatocytes: 59.8;Intestinal goblet cells: 50.1;Muller glia cells: 50.7;Undifferentiated cells: 57.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 104.7;CACO-2: 26.2;Hep G2: 36.5;NTERA-2: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052361 Approved NA NA "HPA052361: AB_2681799" "unprognostic (4.97e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" "unprognostic (1.53e-1)" "unprognostic (2.82e-1)" "unprognostic (4.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.48e-3)" "unprognostic (1.29e-1)" "unprognostic (8.00e-2)" "unprognostic (7.72e-2)" "unprognostic (2.51e-1)" "unprognostic (9.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.15e-3)" 6.1 5.0 2.1 2.6 3.2 4.3 2.4 1.6 2.8 2.7 3.1 18.5 18.7 2.3 0.6 3.3 1.3 1.5 1.5 1.4 10.7 5.2 23.7 6.8 1.1 2.7 4.4 1.3 4.3 10.5 1.0 4.7 4.4 3.5 6.4 14.9 11.0 3.1 2.7 2.7 1.0 15.4 2.6 1.9 2.0 11.3 0.4 2.7 1.5 8.8 2.0 1.4 1.7 2.3 6.2 3.3 5.8 0.3 3.1 2.6 0.1 104.7 0.5 0.7 0.8 0.7 26.2 6.0 0.6 7.0 0.3 2.0 4.8 9.0 3.9 0.7 0.4 6.9 7.6 2.8 36.5 2.0 1.5 2.0 0.2 3.7 1.2 3.0 2.0 1.0 1.1 15.5 1.2 0.7 2.3 0.8 1.9 31.0 14.2 2.0 1.9 3.3 1.4 7.3 11.4 5.0 0.7 1.4 0.6 1.5 14.1 1.7 1.5 0.4 1.6 3.0 3.2 2.5 1.7 4.1 1.3 2.1 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.2 1.6 2.8 1.4 10.7 2.7 4.4 1.3 3.5 1.9 2.7 6.2 6.5 32.1 32.6 4.6 2.0 5.1 5.4 5.4 6.2 2.2 8.7 3.7 7.8 25.8 4.8 1.8 33.3 18.9 1.6 117.4 0.0 14.9 0.7 9.0 2.2 4.1 12.6 15.1 0.5 24.7 6.0 3.2 17.3 18.8 0.0 16.8 2.9 59.8 10.5 6.7 0.9 50.1 6.1 8.4 9.8 0.1 1.8 3.3 1.8 1.0 0.7 50.7 0.0 0.0 6.0 18.2 38.6 0.4 0.5 12.5 43.2 12.2 3.4 7.0 0.0 8.1 4.5 1.5 2.1 4.0 4.1 4.0 1.4 8.1 57.6 5.9 CRYGC CRYG3 ENSG00000163254 "Crystallin gamma C" P07315 2 208128137-208129828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.7" "Group enriched" "Detected in some" 13 "Early spermatids: 1.9;Granulosa cells: 3.7;Late spermatids: 3.2;Spermatocytes: 2.1;Spermatogonia: 2.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8;ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "hippocampal formation: 3.2;hypothalamus: 1.5;thalamus: 1.2" "Group enriched" "Detected in some" 14 "cerebral cortex: 1.2;hippocampal formation: 1.5" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.89e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.40e-4)" "prognostic favorable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favorable (7.67e-4)" 9.0 8.3 4.8 8.1 7.4 18.3 13.1 7.1 6.4 12.9 3.3 10.3 8.0 14.0 10.2 8.0 12.0 6.6 8.2 4.8 7.2 8.0 4.8 9.2 12.0 7.3 5.8 4.9 19.5 11.3 12.4 13.4 9.9 7.6 10.7 9.5 13.4 11.0 8.0 8.3 15.1 10.3 9.0 5.0 9.0 8.9 11.0 8.0 12.1 10.2 4.4 11.5 10.1 10.3 10.0 21.7 4.6 24.3 25.5 6.8 11.9 13.2 13.9 16.3 16.2 19.1 13.1 17.2 24.2 10.8 12.9 13.1 10.7 14.4 14.7 23.9 8.3 13.2 34.2 16.0 21.5 16.3 30.4 13.4 15.5 11.8 20.6 20.3 10.8 11.3 23.6 37.4 39.3 9.4 8.2 33.4 29.0 20.0 6.3 13.1 35.0 27.8 15.7 7.1 16.9 36.0 28.9 14.8 3.9 16.9 12.2 14.3 8.1 14.5 18.7 14.7 20.8 17.8 17.3 7.4 29.4 15.4 20.6 12.8 7.8 1.4 2.1 2.5 1.6 3.3 2.0 2.7 2.8 0.9 2.9 3.4 3.2 1.0 2.1 1.1 1.8 2.1 1.3 4.8 7.4 7.1 6.4 4.8 7.2 7.3 5.8 4.9 7.6 5.0 8.0 10.0 11.6 19.2 24.8 13.1 17.6 25.4 24.3 9.4 25.6 12.2 16.3 16.9 21.9 12.8 14.4 9.2 6.2 17.6 27.0 8.6 13.7 9.9 19.6 12.9 18.4 13.0 17.5 21.7 20.2 7.7 10.0 15.9 14.3 13.3 17.1 24.8 11.4 6.4 7.7 15.2 20.2 12.5 14.2 11.9 11.3 11.5 21.1 9.4 10.6 15.0 10.2 27.5 7.2 29.1 36.7 11.8 7.6 22.2 27.6 14.6 9.2 5.1 17.1 14.6 13.1 21.7 16.2 28.8 17.3 19.5 21.2 12.3 20.3 19.0 13.9 19.2 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199085-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "fallopian tube: 30.8;testis: 19.8" "Cell type enhanced" "Detected in some" "Early spermatids: 88.7;Endometrial ciliated cells: 30.7;Late spermatids: 19.6;Respiratory ciliated cells: 25.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.9 0.1 0.4 0.5 0.1 0.6 0.4 1.7 0.5 0.0 0.0 0.5 0.3 0.1 30.8 0.0 0.1 0.2 0.3 0.1 0.3 1.8 0.1 1.6 0.8 0.0 0.1 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.0 1.1 0.0 0.1 19.8 1.2 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.4 0.2 0.4 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.5 0.1 0.1 0.5 0.2 0.5 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.3 0.0 0.4 0.2 0.2 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.9 0.4 0.6 0.4 0.2 0.3 1.6 0.8 0.0 1.3 1.1 1.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 30.7 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 25.1 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NPPC CNP ENSG00000163273 "Natriuretic peptide C" P23582 2 231921809-231926396 "Predicted secreted proteins, Transporters" Osteogenesis "Hormone, Vasoactive" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 36.1" "Group enriched" "Detected in many" 8 "Basal squamous epithelial cells: 190.1;Skeletal myocytes: 264.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "hypothalamus: 36.1;medulla oblongata: 34.1;spinal cord: 17.7;white matter: 15.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.4;NTERA-2: 3.9;SCLC-21H: 5.5;SK-MEL-30: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "medulla oblongata: 15.5;spinal cord: 12.5" HPA035362 Uncertain "Secreted to blood" NA NA 6140 "HPA035362: AB_10671103" "unprognostic (9.70e-2)" "unprognostic (4.45e-2)" "unprognostic (1.99e-1)" "unprognostic (1.06e-2)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.83e-1)" "unprognostic (3.22e-3)" "unprognostic (9.81e-3)" "unprognostic (9.16e-2)" "unprognostic (2.10e-2)" "unprognostic (4.06e-2)" "unprognostic (1.17e-1)" "unprognostic (6.58e-2)" "unprognostic (1.18e-1)" "unprognostic (3.72e-1)" "unprognostic (1.91e-1)" 0.2 0.1 0.9 2.1 5.1 1.4 0.7 2.4 3.6 1.0 0.0 2.6 0.1 0.6 0.0 3.2 2.6 0.0 3.7 1.9 36.1 0.2 0.0 0.0 1.5 34.1 3.7 0.5 1.3 0.1 0.0 2.7 0.2 4.3 4.3 0.2 2.4 1.1 0.4 0.7 0.4 0.9 0.5 17.7 0.4 2.5 0.2 4.9 2.9 0.5 0.1 2.0 0.2 0.4 15.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 1.0 0.0 3.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.5 0.3 0.2 0.2 26.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 5.1 2.4 3.6 1.9 36.1 34.1 3.7 0.5 4.3 17.7 4.9 15.0 2.1 0.0 0.0 0.7 1.3 3.4 27.1 5.9 190.1 1.1 6.5 18.3 1.9 0.0 0.1 11.0 10.4 0.2 0.6 4.2 0.0 1.1 0.3 3.6 1.3 1.6 3.5 0.0 0.0 0.0 0.0 10.9 5.6 4.8 0.0 0.3 0.0 0.0 0.1 0.0 1.5 3.2 0.0 0.0 1.7 0.0 0.3 1.6 1.8 0.0 2.5 15.2 0.0 0.0 1.3 0.8 3.1 0.0 5.8 11.5 0.0 0.0 0.0 4.1 0.0 264.2 2.0 1.2 7.0 13.2 1.1 0.3 1.7 0.0 2.9 3.1 GNPDA2 SB52 ENSG00000163281 "Glucosamine-6-phosphate deaminase 2" Q8TDQ7 4 44682200-44726588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 820000 Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (3.29e-1)" "unprognostic (1.55e-3)" "unprognostic (1.02e-1)" "unprognostic (1.33e-1)" "unprognostic (9.57e-2)" "unprognostic (9.75e-3)" "unprognostic (1.03e-1)" "unprognostic (1.28e-3)" "unprognostic (4.18e-2)" "unprognostic (6.86e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" 13.2 12.7 10.3 9.9 11.8 8.5 14.6 23.0 14.1 14.0 8.3 10.4 8.0 16.7 14.1 10.2 12.7 10.6 17.7 11.3 11.2 14.0 4.1 10.0 12.7 10.7 11.8 10.7 22.8 8.3 13.1 12.9 6.8 12.0 14.8 8.3 18.6 9.3 15.4 11.4 9.7 8.5 16.6 10.7 12.0 9.1 11.7 11.0 13.3 18.3 10.1 10.6 12.1 10.1 13.6 15.7 10.9 11.4 9.7 17.8 24.7 3.9 27.1 30.3 17.9 16.7 5.6 19.1 13.6 15.5 23.4 29.8 5.3 10.6 26.3 19.7 18.4 11.9 19.3 16.6 9.2 18.8 20.8 17.7 28.5 18.1 17.9 13.1 22.6 26.5 18.1 12.2 17.9 33.6 0.7 25.2 11.6 5.5 10.4 19.5 16.3 24.3 8.0 17.3 9.5 19.5 15.8 12.1 7.0 27.2 5.4 14.9 12.1 25.9 23.7 22.6 38.5 31.6 23.0 38.7 19.7 38.6 14.3 21.3 9.3 2.4 5.0 9.7 3.6 11.2 12.2 9.0 9.3 3.7 10.5 11.2 10.8 1.1 9.8 4.9 2.8 10.7 4.7 10.3 11.8 23.0 14.1 11.3 11.2 10.7 11.8 10.7 12.0 10.7 11.0 13.6 18.4 9.6 4.6 17.0 19.8 12.5 8.9 18.6 8.0 15.6 9.2 8.1 14.1 2.8 9.4 14.7 8.4 1.2 15.7 3.0 15.6 13.3 30.3 7.9 21.9 14.4 6.7 6.5 29.1 15.1 1.1 22.0 7.1 8.5 15.8 8.5 11.4 1.6 4.8 13.5 29.2 4.4 18.3 3.7 8.7 5.0 16.1 4.2 8.8 8.4 4.3 19.8 13.4 31.2 20.4 14.2 2.9 23.7 6.3 5.2 2.9 13.2 8.0 18.2 13.1 14.3 20.0 34.4 29.9 5.7 10.7 0.5 13.7 20.0 4.4 5.2 ALPP "PALP, PLAP" ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378724-232382889 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "cervix: 18.0;placenta: 34.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 12.8;Glandular and luminal cells: 5.0;Syncytiotrophoblasts: 6.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 381.0;SiHa: 103.6" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 18.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.5 42.9 0.0 0.1 0.0 0.1 381.0 0.0 0.0 0.0 0.0 0.2 0.0 7.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 103.6 35.3 0.0 3.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 6.7 0.1 0.2 0.0 0.0 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor subunit gamma1" Q8N1C3 4 46035769-46124054 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 37.3;choroid plexus: 9.6" "Cell type enriched" "Detected in some" 8 "Astrocytes: 135.5" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035622, HPA058102" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA035622: AB_10603669, HPA058102: " "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 0.1 0.1 26.3 0.0 20.4 0.0 0.0 21.0 27.5 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.0 28.3 0.0 0.0 0.0 0.0 26.4 37.3 16.6 1.2 0.0 0.0 0.6 0.0 23.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.1 0.0 0.2 32.2 0.0 0.1 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 20.4 21.0 27.5 20.0 28.3 26.4 37.3 16.6 23.4 22.6 32.2 23.7 0.3 0.0 0.0 135.5 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 11.2 0.0 15.4 0.0 2.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.6 0.0 1.8 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ALPG "ALPPL2, GCAP" ENSG00000163286 "Alkaline phosphatase, germ cell" P10696 2 232406844-232410714 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3" "CAB020698, HPA038764, HPA038765, HPA051699" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.7 33.9 0.0 0.0 0.0 0.0 24.9 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GABRB1 ENSG00000163288 "Gamma-aminobutyric acid type A receptor subunit beta1" P18505 4 46993723-47426447 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 27.8" "Group enriched" "Detected in some" 15 "Astrocytes: 926.2;Excitatory neurons: 440.3;Inhibitory neurons: 507.4;Oligodendrocyte precursor cells: 266.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 7.1;U-87 MG: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.56e-3)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-3)" "unprognostic (8.16e-3)" "unprognostic (6.22e-2)" "unprognostic (2.72e-2)" "unprognostic (2.34e-1)" 0.0 0.2 21.5 0.0 27.2 0.0 0.0 0.6 27.8 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 3.6 27.2 19.9 0.3 0.0 0.0 0.0 8.2 3.6 23.3 0.0 0.0 0.3 1.5 0.1 5.6 0.0 0.1 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 17.3 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 27.2 0.6 27.8 27.2 19.9 8.2 3.6 23.3 5.6 0.8 17.3 11.3 0.0 0.0 0.0 926.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.1 1.2 0.0 440.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 507.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.1 32.9 0.0 266.9 16.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.3 1.9 0.0 0.0 0.1 0.0 0.0 0.3 0.0 PAQR3 ENSG00000163291 "Progestin and adipoQ receptor family member 3" Q6TCH7 4 78887127-78939438 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Early spermatids: 81.4;Excitatory neurons: 58.1;Late spermatids: 139.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.41e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (2.33e-1)" "unprognostic (7.12e-3)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.74e-1)" "unprognostic (4.39e-2)" "unprognostic (7.65e-2)" "unprognostic (6.45e-2)" "unprognostic (5.93e-2)" "unprognostic (2.75e-1)" "unprognostic (1.34e-3)" "unprognostic (1.27e-1)" 0.5 1.1 0.1 0.1 0.1 0.1 0.5 0.6 0.3 0.2 0.0 0.7 0.2 0.4 0.0 1.1 0.5 0.1 1.5 0.1 0.1 0.9 1.3 0.3 0.2 0.2 0.2 0.0 0.2 1.0 0.0 0.4 0.0 0.3 0.2 0.0 0.2 0.5 0.0 0.3 0.5 1.3 0.0 0.3 1.4 0.9 0.6 0.2 0.0 0.4 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.2 0.2 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.8 0.3 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.4 0.1 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.4 5.6 3.2 8.3 19.2 7.9 17.6 5.2 3.0 6.2 20.0 4.9 4.6 9.6 2.8 5.1 11.0 4.2 9.5 9.9 7.5 0.0 2.9 81.4 17.9 10.2 6.4 8.4 7.8 58.1 3.8 12.3 12.7 1.5 11.8 24.1 5.6 5.0 10.8 4.4 5.0 36.2 12.8 0.0 5.2 8.6 139.2 7.5 6.2 7.2 12.2 4.0 12.8 6.2 15.6 24.2 3.2 8.2 10.5 7.1 5.4 16.7 2.6 6.6 10.7 13.1 11.4 9.3 17.6 17.1 8.6 23.3 13.0 9.8 2.9 5.9 3.2 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.0;liver: 16.3;skin 1: 25.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 42.0;Collecting duct cells: 42.3;Distal enterocytes: 56.2;Squamous epithelial cells: 44.4;Undifferentiated cells: 38.6;Urothelial cells: 55.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.3;CAPAN-2: 11.6;HaCaT: 15.3;HBEC3-KT: 11.1;RT4: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.3 0.1 0.2 1.7 0.3 0.2 3.6 0.3 0.3 1.0 0.2 14.2 5.5 0.3 7.4 22.0 2.1 1.4 0.1 0.1 0.4 3.4 16.3 0.5 0.1 0.2 0.2 0.2 0.0 2.0 3.8 0.6 1.8 0.2 2.2 13.4 1.8 5.1 1.2 1.7 25.9 7.2 0.5 0.1 0.2 7.1 0.6 0.8 0.4 1.7 0.1 3.1 7.8 4.8 0.2 13.3 0.2 0.0 0.0 0.0 0.0 2.1 2.4 2.3 1.8 3.2 7.8 11.6 0.0 1.7 0.0 3.3 15.3 2.2 11.1 4.7 0.1 2.8 0.0 0.1 0.5 0.0 0.1 0.1 0.1 4.0 0.2 2.6 3.1 0.6 0.8 0.1 0.0 2.6 5.1 0.1 0.1 1.9 9.1 3.4 0.0 0.0 0.0 6.4 17.9 1.1 0.3 1.2 4.3 1.9 1.0 2.7 0.0 5.0 0.1 4.5 0.0 0.3 0.1 0.2 0.0 0.2 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.8 0.2 0.3 9.6 6.1 0.0 0.4 14.4 42.0 6.4 4.6 0.2 9.9 5.0 2.8 4.3 12.6 42.3 0.0 2.1 0.2 56.2 0.0 15.7 0.7 7.3 1.1 1.1 11.5 0.0 0.9 6.7 1.4 1.5 11.2 14.2 0.0 0.3 0.4 18.5 0.4 0.0 1.0 27.5 4.1 1.2 2.1 0.3 0.0 0.6 1.8 1.0 0.6 0.7 0.0 0.5 0.1 16.1 31.2 0.0 1.4 27.4 31.8 1.0 3.2 5.1 0.0 1.9 2.8 1.3 2.8 44.4 33.0 3.6 1.0 0.1 38.6 55.2 ALPI IAP ENSG00000163295 "Alkaline phosphatase, intestinal" P09923 2 232456125-232460753 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 138 "intestine: 142.5" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 290.1" "Cancer enhanced" "Detected in many" "liver cancer: 4.7;renal cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "CACO-2: 4.8" "HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" NA NA 130000 "Plasma membrane" "HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.01e-1)" "unprognostic (7.71e-2)" "unprognostic (4.14e-2)" "unprognostic (1.47e-1)" "unprognostic (9.57e-4)" "unprognostic (8.07e-2)" "unprognostic (1.71e-1)" "unprognostic (9.99e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 142.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 129.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 290.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 ANTXR2 "CMG-2, CMG2, FLJ31074" ENSG00000163297 "ANTXR cell adhesion molecule 2" P58335 4 79901146-80125454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 215.4;HHSteC: 197.9;LHCN-M2: 221.0;U-2197: 176.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 13000000 "unprognostic (3.01e-1)" "unprognostic (1.79e-2)" "unprognostic (1.95e-2)" "unprognostic (4.87e-2)" "unprognostic (5.63e-2)" "unprognostic (2.30e-2)" "unprognostic (6.75e-2)" "unprognostic (3.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (3.34e-6)" "unprognostic (1.03e-3)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-1)" 61.4 30.3 4.4 35.7 3.4 18.9 18.9 3.8 5.8 52.6 5.5 40.3 23.2 96.3 22.1 24.7 31.4 55.4 32.1 3.4 7.5 17.3 34.7 24.9 16.4 4.7 4.1 2.1 75.7 4.6 28.0 1.6 90.7 3.9 111.2 43.1 1.6 10.2 91.1 6.2 5.5 29.8 109.3 5.7 18.5 23.4 8.5 3.5 10.8 5.0 21.9 16.2 53.6 12.1 4.3 15.5 1.9 34.6 6.6 215.4 118.0 3.1 48.3 124.6 17.5 19.9 0.6 11.8 0.0 0.8 76.8 11.4 4.5 4.4 49.7 66.9 2.2 4.2 12.2 1.3 4.8 197.9 51.6 29.5 145.3 15.2 132.7 68.3 150.2 52.6 1.6 27.1 35.8 221.0 0.0 1.1 57.1 5.7 21.7 70.3 2.4 19.8 9.0 12.0 14.4 30.6 41.2 4.9 0.6 8.2 16.3 0.7 11.0 69.8 155.7 9.7 176.7 103.4 3.1 0.0 0.1 78.6 39.4 49.0 72.7 17.5 61.6 12.8 9.5 13.8 23.5 21.4 13.1 32.2 9.4 11.3 5.9 54.4 4.3 18.0 32.2 40.4 14.0 4.4 3.4 3.8 5.8 3.4 7.5 4.7 4.1 2.1 3.9 5.7 3.5 4.3 6.4 12.8 10.0 23.5 25.7 7.0 15.5 6.5 4.0 6.9 4.0 2.2 24.9 4.3 10.2 0.0 29.2 18.3 24.9 42.4 3.9 4.2 2.3 7.7 69.3 15.5 18.6 6.3 25.4 6.7 29.0 58.7 4.1 6.1 60.1 8.9 15.0 24.9 17.7 0.0 2.1 15.1 4.1 13.4 28.9 5.3 39.1 28.3 1.8 45.9 53.7 6.9 4.1 19.1 0.8 45.5 28.9 63.9 14.1 13.9 16.9 2.5 4.9 21.4 39.5 32.5 28.5 0.6 2.1 0.9 4.3 6.6 24.4 18.3 13.3 1.6 HELQ Hel308 ENSG00000163312 "Helicase, POLQ like" Q8TDG4 4 83407343-83455855 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036852, HPA036853" Approved Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA036852: AB_2675349, HPA036853: AB_10672102" "unprognostic (4.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" "unprognostic (4.80e-2)" "unprognostic (5.56e-2)" "unprognostic (1.14e-1)" "unprognostic (5.13e-3)" "unprognostic (7.14e-2)" "unprognostic (8.62e-2)" "prognostic favorable (9.07e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.76e-4)" "unprognostic (3.54e-2)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.37e-1)" 4.5 9.1 2.2 5.1 2.6 4.6 5.6 4.1 2.8 5.4 4.5 3.7 3.2 4.9 4.5 3.4 4.7 3.8 5.1 2.2 2.5 5.4 5.5 4.0 9.4 2.5 2.6 1.9 8.1 3.8 5.6 4.4 3.3 2.6 4.0 3.9 5.5 4.6 4.0 7.2 3.8 4.5 4.4 2.4 6.3 3.7 6.0 2.4 8.1 5.8 8.1 7.6 4.4 4.1 3.0 4.0 2.9 6.0 4.0 7.5 7.2 3.1 5.5 7.9 7.2 6.9 2.9 4.1 11.2 4.3 5.1 4.9 4.0 6.9 3.9 7.7 6.5 3.3 6.3 4.8 3.9 4.5 8.4 15.9 6.1 5.5 5.9 5.8 6.1 5.3 7.2 8.8 9.4 7.0 4.3 7.5 5.9 2.7 6.0 2.2 5.9 7.1 3.9 6.2 2.3 4.7 4.2 5.6 6.2 6.6 5.9 3.8 8.3 4.6 5.4 4.8 6.7 4.4 8.7 3.8 9.2 4.7 6.1 6.1 3.4 1.7 3.6 3.1 2.2 3.2 3.4 3.3 3.2 2.6 5.1 5.6 4.7 1.3 3.6 3.1 2.5 4.5 1.6 2.2 2.6 4.1 2.8 2.2 2.5 2.5 2.6 1.9 2.6 2.4 2.4 3.0 14.1 3.2 14.0 14.4 23.1 4.2 8.6 6.6 12.0 10.2 6.7 9.0 12.3 5.7 7.7 5.5 8.4 10.9 11.4 4.5 11.7 6.7 28.3 7.3 10.2 10.2 0.0 7.8 17.0 5.4 10.3 11.1 4.1 7.7 7.6 9.8 10.0 4.1 10.2 6.7 21.3 5.5 4.1 7.2 5.4 8.9 13.1 9.9 7.2 20.6 10.7 7.8 17.5 10.6 15.7 4.4 8.3 7.9 15.8 5.4 7.6 11.8 15.9 13.8 0.0 11.2 11.9 24.3 12.7 7.0 3.8 11.5 18.2 17.4 5.5 6.1 MRPS18C "CGI-134, FLJ11146, FLJ22967, MRPS18-1" ENSG00000163319 "Mitochondrial ribosomal protein S18C" Q9Y3D5 4 83455932-83469735 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050404 Approved NA NA "HPA050404: AB_2681115" "unprognostic (4.53e-3)" "unprognostic (7.58e-3)" "unprognostic (5.70e-3)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (7.81e-3)" "unprognostic (1.43e-1)" "unprognostic (3.86e-2)" "unprognostic (8.19e-2)" "unprognostic (1.53e-2)" "unprognostic (5.25e-2)" "unprognostic (8.26e-3)" "prognostic favorable (2.90e-5)" "unprognostic (1.52e-2)" "unprognostic (9.86e-2)" "unprognostic (2.24e-2)" "unprognostic (8.31e-3)" 26.1 33.8 26.7 24.2 27.4 26.9 25.3 29.2 43.1 23.0 27.0 26.4 25.0 24.7 17.9 33.9 25.5 14.5 39.6 26.9 28.8 34.9 44.7 21.7 24.8 28.0 27.8 26.8 22.5 22.2 20.1 20.3 20.9 28.4 16.9 26.1 19.8 21.3 15.0 86.0 24.2 25.6 21.2 27.8 25.2 24.9 19.6 27.5 25.3 19.6 53.9 32.8 22.9 23.5 29.1 74.4 76.2 58.9 45.3 36.3 24.1 56.9 78.1 39.6 60.5 51.6 136.2 66.8 69.8 86.8 38.5 68.9 39.4 61.0 47.3 71.2 62.7 48.8 59.6 105.6 136.5 49.3 143.2 74.5 25.3 41.0 49.4 58.4 34.9 39.8 86.1 86.5 55.7 39.8 142.9 95.3 87.6 35.4 109.7 53.3 53.6 51.0 55.8 46.4 66.8 61.7 33.2 41.9 82.9 68.0 57.4 36.1 85.7 47.8 53.5 82.5 53.3 104.7 50.7 70.3 158.5 51.1 73.2 67.4 126.2 122.9 196.1 105.9 139.5 108.6 174.7 126.3 117.2 142.5 164.4 130.8 116.5 56.0 117.2 117.3 164.7 195.5 113.5 26.7 27.4 29.2 43.1 26.9 28.8 28.0 27.8 26.8 28.4 27.8 27.5 29.1 102.2 51.3 61.3 4.6 67.8 68.1 73.7 169.1 47.8 33.3 54.3 87.2 81.3 90.1 93.3 77.3 37.5 132.4 62.7 57.1 229.0 139.1 117.0 75.9 59.6 77.3 33.6 117.0 8.7 187.8 119.7 57.2 33.1 54.5 109.5 57.1 77.1 180.6 112.6 32.0 8.0 59.3 91.6 65.4 46.8 25.2 82.0 58.1 62.2 6.5 72.9 80.7 96.8 8.0 9.7 134.6 84.1 77.5 63.6 62.7 101.8 211.0 124.7 47.7 59.2 71.2 93.7 109.0 71.6 70.4 64.1 96.2 55.7 70.3 79.9 61.9 CGGBP1 "CGGBP, p20-CGGBP" ENSG00000163320 "CGG triplet repeat binding protein 1" Q9UFW8 3 88051944-88149885 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 528.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035568, HPA037017" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035568: AB_10670022, HPA037017: AB_2675433" "unprognostic (2.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.43e-2)" "unprognostic (4.89e-2)" "unprognostic (1.30e-2)" "unprognostic (2.96e-2)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" "unprognostic (8.30e-2)" "unprognostic (3.63e-1)" "unprognostic (1.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (3.35e-2)" "unprognostic (3.00e-1)" "prognostic favorable (7.79e-4)" 40.6 31.2 24.1 46.2 27.5 76.4 37.3 28.3 30.0 40.2 30.6 33.1 36.0 45.7 33.0 36.0 33.8 37.7 36.2 24.7 27.4 40.6 41.6 39.9 65.7 25.6 25.9 22.4 56.7 38.3 44.8 23.3 42.3 25.0 35.9 40.0 49.2 35.5 35.6 37.9 28.4 38.0 44.7 26.7 53.1 34.0 32.7 25.3 86.1 47.4 47.8 62.4 36.0 28.0 36.7 37.4 64.1 109.3 77.4 92.8 78.1 34.5 81.9 71.4 82.0 97.9 46.7 56.4 81.9 52.7 74.7 63.0 30.2 91.4 63.2 103.2 126.0 46.5 132.3 66.0 47.4 79.7 86.3 93.8 74.4 53.8 95.0 118.7 99.2 85.1 99.0 58.2 87.5 89.5 62.9 136.5 59.5 58.1 62.5 59.0 83.6 106.9 58.0 56.0 66.3 22.0 66.6 66.9 35.6 179.1 79.6 57.5 95.6 81.5 98.8 72.5 528.4 81.8 64.0 83.2 90.5 73.1 81.5 84.9 107.9 42.7 81.2 44.2 45.7 43.8 45.0 39.6 46.4 40.6 47.6 46.6 39.6 77.0 47.4 51.6 34.0 48.9 44.7 24.1 27.5 28.3 30.0 24.7 27.4 25.6 25.9 22.4 25.0 26.7 25.3 36.7 65.1 51.3 48.0 32.3 75.1 53.2 65.7 45.6 60.9 35.8 59.8 45.3 45.9 42.9 47.8 40.5 16.7 55.0 66.0 49.0 66.5 39.0 21.0 37.8 64.5 63.0 41.9 107.5 40.6 42.0 63.6 57.5 50.4 46.8 46.9 61.1 74.6 55.1 41.2 67.3 35.6 38.3 38.7 56.2 72.8 36.3 69.6 58.7 40.9 42.2 52.4 70.6 53.5 62.8 91.1 52.8 43.9 50.0 63.7 63.0 41.1 65.1 25.3 32.9 65.7 63.3 79.0 94.1 47.9 52.5 50.0 83.9 80.5 31.8 36.0 72.7 ABRAXAS1 "ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614" ENSG00000163322 "Abraxas 1, BRCA1 A complex subunit" Q6UWZ7 4 83459517-83523348 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037654 Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA037654: AB_2675588" "unprognostic (1.44e-1)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.81e-1)" "unprognostic (8.57e-3)" "unprognostic (6.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-1)" "unprognostic (2.35e-1)" "unprognostic (6.98e-2)" "prognostic favorable (1.53e-4)" "unprognostic (2.24e-3)" "unprognostic (9.34e-3)" "unprognostic (5.58e-2)" "unprognostic (6.57e-2)" 3.9 4.0 3.0 3.9 2.4 8.0 3.8 6.7 3.1 4.9 10.3 3.0 3.7 6.5 2.1 5.2 4.9 5.7 3.8 2.6 1.7 4.1 2.2 3.8 8.1 2.4 2.3 2.5 14.9 3.4 2.2 1.1 3.0 3.7 2.7 2.8 3.6 3.5 2.2 6.5 5.8 3.1 2.9 0.8 4.1 3.7 10.9 2.5 4.8 7.5 2.1 3.8 3.9 3.6 5.5 5.6 3.4 6.8 8.2 6.1 25.2 3.6 4.1 5.1 1.9 2.9 7.6 9.0 22.1 3.3 4.3 4.2 2.9 3.7 2.9 3.5 8.8 2.4 12.9 4.6 9.1 4.9 15.3 11.1 10.9 2.5 2.7 2.4 10.2 8.7 12.9 36.7 13.2 4.7 3.7 17.2 5.6 11.5 6.3 5.0 9.3 7.6 5.5 4.2 4.6 6.3 5.1 5.3 2.2 9.6 5.5 6.3 6.3 11.5 7.4 7.6 7.4 6.0 11.5 8.4 16.1 6.7 12.8 5.3 4.0 2.5 2.1 2.0 2.3 2.6 2.1 3.5 2.4 1.9 3.3 5.4 4.2 3.2 5.0 2.3 1.5 3.2 1.9 3.0 2.4 6.7 3.1 2.6 1.7 2.4 2.3 2.5 3.7 0.8 2.5 5.5 14.3 16.0 12.4 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.4 13.0 0.0 0.0 8.6 12.9 0.0 5.2 8.8 0.0 43.0 9.2 0.0 11.9 20.7 5.7 0.0 0.0 0.0 6.5 6.9 9.1 0.0 5.9 6.3 12.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 7.4 0.0 0.0 1.7 0.0 0.0 30.1 21.9 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 2.9 6.2 26.8 0.0 0.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 67.1;stomach 1: 53.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.3 9.8 5.9 5.9 13.1 2.3 2.5 6.6 12.2 2.4 67.1 7.7 3.9 1.9 12.4 5.9 1.6 5.8 7.1 12.7 7.2 20.3 7.3 3.0 6.3 5.5 6.1 8.6 2.5 18.3 8.9 2.3 4.5 6.2 7.6 3.8 10.1 3.6 8.5 4.8 13.3 4.1 6.2 3.2 5.4 53.1 2.2 6.4 3.0 8.4 4.4 3.7 4.1 2.7 9.2 0.7 0.3 0.8 2.0 4.9 2.7 0.5 3.8 1.3 0.6 2.1 0.3 0.2 2.2 1.2 2.8 1.3 0.2 1.3 1.1 2.1 0.8 1.5 2.3 1.1 0.2 0.9 0.7 1.1 3.9 3.1 1.9 0.6 4.0 1.0 3.0 0.3 5.5 4.2 0.6 1.6 0.8 0.4 2.3 1.5 1.9 5.6 1.0 2.0 1.3 5.9 5.0 1.2 0.8 2.0 2.5 0.3 0.3 2.6 2.7 1.0 3.9 0.5 14.6 2.2 0.3 3.0 0.6 9.9 1.3 2.2 0.1 1.8 4.0 1.6 1.1 3.1 2.9 0.6 1.0 2.5 3.9 7.3 3.6 5.7 0.3 5.5 1.4 5.9 13.1 6.6 12.2 12.7 7.2 5.5 6.1 8.6 6.2 3.2 6.4 9.2 18.5 12.8 3.6 31.3 9.8 42.7 4.0 4.0 29.0 34.9 5.8 6.1 26.0 2.8 6.8 11.0 125.1 1.5 12.2 0.6 1.9 1.9 0.7 1.4 24.1 9.8 12.7 15.2 99.4 6.0 1.2 9.7 9.7 0.6 1.3 4.0 16.1 16.1 6.1 50.5 131.1 0.8 2.0 50.4 23.0 1.8 14.9 27.0 152.9 8.4 34.3 16.7 11.3 130.2 21.2 3.5 0.1 32.0 14.3 3.1 0.4 41.7 0.5 25.8 0.0 16.9 9.5 3.3 3.2 7.5 28.6 0.8 25.7 52.4 1.0 1.8 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 198.7;esophagus: 243.9;skin 1: 280.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 1.4 56.6 2.0 0.1 2.1 0.8 29.0 1.8 5.8 23.6 3.6 2.2 0.5 0.6 198.7 243.9 81.2 0.6 0.5 1.6 6.5 3.5 0.2 1.6 0.6 1.7 5.4 1.9 1.0 23.0 0.0 24.6 0.1 2.2 9.3 0.7 116.6 30.4 1.1 1.0 280.9 1.1 0.5 1.6 0.3 1.5 1.6 3.6 4.8 34.6 0.0 25.2 8.7 108.9 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.1 0.2 23.2 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.4 5.9 0.0 0.0 0.0 0.6 0.0 0.7 1.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.0 1.2 0.8 0.5 0.1 0.6 0.2 0.4 0.2 0.1 0.3 0.4 0.1 0.1 0.5 0.7 0.1 1.2 0.4 0.1 2.0 2.1 1.8 5.8 1.6 6.5 1.7 5.4 1.9 2.2 1.6 3.6 1.6 0.6 0.0 0.0 0.0 4.1 106.9 51.8 74.8 212.9 7.2 15.0 19.6 0.1 2.8 29.8 9.2 6.2 6.0 4.9 2.0 3.9 7.6 13.8 5.6 2.2 2.0 3.0 0.0 0.2 6.0 12.8 2.4 0.0 5.4 4.5 148.1 0.7 14.3 14.7 3.3 0.4 2.0 14.2 9.1 9.3 56.1 4.1 5.0 12.4 0.0 5.4 913.0 2.1 1.0 0.1 5.8 7.1 2.2 3.4 11.8 5.9 13.3 4.8 23.8 0.0 1.9 10.9 10.8 4.2 736.5 126.6 4.5 3.1 1.7 2.3 67.4 PMVK "HUMPMKI, PMK, PMKA" ENSG00000163344 "Phosphomevalonate kinase" Q15126 1 154924740-154936719 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 266.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029900 Approved NA NA 15000 "HPA029900: AB_10601390" "unprognostic (2.52e-1)" "unprognostic (3.68e-2)" "unprognostic (1.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.31e-1)" "unprognostic (1.81e-2)" "unprognostic (8.13e-2)" "unprognostic (5.47e-2)" "unprognostic (8.22e-2)" "prognostic favorable (9.70e-4)" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "prognostic favorable (4.96e-4)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.10e-1)" 40.2 56.9 91.4 30.1 92.3 15.4 35.3 91.3 109.8 30.2 88.7 37.0 46.4 26.1 17.8 78.4 37.6 17.4 61.4 87.2 88.3 54.2 92.6 30.4 34.8 90.5 91.2 86.2 36.1 42.0 58.7 60.7 23.9 88.7 32.7 22.4 19.9 34.3 27.4 79.8 65.6 44.6 28.0 91.6 46.1 40.8 26.8 95.5 28.1 31.7 47.8 37.1 32.2 38.3 94.6 51.8 72.9 46.7 72.5 43.6 30.9 48.5 40.5 29.3 38.9 37.0 30.6 101.0 75.1 75.9 49.3 40.5 49.4 65.3 63.9 17.8 103.3 28.9 34.1 104.1 29.0 40.0 51.4 29.3 36.3 58.7 70.2 49.6 19.5 40.0 65.9 36.8 221.7 41.3 108.3 40.8 51.0 41.0 121.7 95.0 60.3 29.8 171.1 66.1 38.4 37.7 91.1 44.1 75.7 51.9 35.0 146.7 91.1 32.7 35.8 29.2 84.4 62.1 174.0 153.2 131.8 58.9 83.9 46.7 28.0 80.9 91.8 68.2 205.6 110.1 114.8 93.1 70.6 93.6 111.1 59.1 59.1 6.9 59.7 219.4 96.5 134.3 80.0 91.4 92.3 91.3 109.8 87.2 88.3 90.5 91.2 86.2 88.7 91.6 95.5 94.6 22.7 57.7 37.5 9.4 42.2 69.8 105.9 95.8 51.8 38.5 67.1 68.3 57.3 78.6 42.2 53.3 8.4 235.7 31.5 65.0 266.1 69.6 9.0 45.0 28.5 29.8 66.4 35.6 5.1 71.3 108.1 45.1 46.9 44.2 22.2 49.8 39.3 146.9 141.0 37.0 7.0 78.9 67.1 67.9 49.5 13.5 42.6 47.8 65.8 3.7 49.5 119.1 41.2 8.0 11.8 61.7 61.7 47.8 58.8 53.7 219.3 246.1 22.1 27.4 32.9 46.0 48.4 51.3 51.3 81.0 90.5 227.7 45.1 162.6 79.9 76.2 PBXIP1 HPIP ENSG00000163346 "PBX homeobox interacting protein 1" Q96AQ6 1 154944076-154956123 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 176.0;Muller glia cells: 221.4;Theca cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "granulocytes: 183.9;NK-cells: 56.9;T-cells: 197.4" "Cell line enriched" "Detected in all" 7 "Karpas-707: 1100.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006949 Approved Approved Vesicles,Cytosol NA NA 26000 Vesicles Cytosol "HPA006949: AB_1079572" "unprognostic (6.17e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (8.94e-2)" "unprognostic (2.16e-1)" "prognostic favorable (7.19e-4)" "unprognostic (1.62e-1)" "prognostic favorable (8.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.46e-1)" "prognostic favorable (2.64e-4)" "unprognostic (1.20e-2)" "prognostic favorable (9.22e-6)" "unprognostic (3.89e-1)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.26e-3)" 58.2 123.5 154.2 58.9 156.6 35.4 46.3 153.1 160.0 73.0 259.3 101.0 55.9 82.3 39.4 46.5 69.4 53.3 58.1 133.4 195.1 56.9 30.0 49.4 70.0 191.9 167.4 116.4 116.3 34.3 103.2 170.2 33.6 160.7 64.1 29.9 39.3 53.4 96.1 141.0 37.1 91.5 52.9 157.1 82.8 83.3 58.5 184.7 81.6 86.7 101.4 59.6 79.9 51.0 146.7 7.3 19.1 29.9 20.0 101.3 31.5 22.0 25.1 55.3 11.9 23.5 5.6 24.9 31.3 79.1 30.5 17.0 26.8 7.3 16.1 8.3 16.9 11.7 7.1 26.2 20.1 46.9 8.6 83.6 48.0 26.2 15.1 3.0 137.7 45.4 23.6 4.2 1100.7 29.8 11.1 17.6 27.5 11.4 19.3 14.4 20.2 43.1 69.7 32.9 14.1 4.9 37.6 32.5 10.2 26.7 56.1 31.0 36.6 42.9 11.8 8.6 7.6 7.8 149.4 133.9 7.7 42.2 12.4 9.6 129.4 10.3 183.9 41.9 14.8 116.3 36.0 112.4 66.9 9.1 23.6 72.9 46.2 95.2 56.9 29.7 16.2 197.4 61.5 154.2 156.6 153.1 160.0 133.4 195.1 191.9 167.4 116.4 160.7 157.1 184.7 146.7 24.5 67.3 77.9 56.8 43.0 10.1 24.0 22.4 13.1 23.8 17.6 19.7 38.5 38.6 31.1 42.3 16.7 19.5 48.2 21.0 0.0 46.0 142.1 12.9 25.9 23.8 83.7 22.3 1.5 18.5 24.0 35.9 19.9 10.5 51.9 30.3 28.9 19.4 14.7 1.7 1.2 20.9 69.2 20.2 13.8 176.0 64.3 16.8 26.6 7.5 25.5 221.4 39.1 3.5 1.6 22.4 29.3 129.1 49.0 10.5 56.0 9.9 23.9 8.8 52.6 83.9 50.6 8.8 13.9 6.3 11.5 27.1 116.2 153.3 15.9 13.9 CLDN1 "ILVASC, SEMP1" ENSG00000163347 "Claudin 1" O95832 3 190305707-190322446 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 312.4;skin 1: 274.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 12 "spinal cord: 25.4" "CAB002602, HPA048319" Enhanced NA NA "CAB002602: , HPA048319: AB_2680355" "unprognostic (5.89e-2)" "unprognostic (4.58e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (7.92e-3)" "unprognostic (2.43e-1)" "unprognostic (3.54e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (3.06e-1)" "unprognostic (1.13e-1)" "unprognostic (4.43e-2)" "unprognostic (9.20e-2)" "unprognostic (1.09e-3)" "unprognostic (1.22e-1)" 20.2 48.3 1.6 1.3 1.1 0.2 22.9 0.9 1.4 12.1 17.5 1.7 1.1 64.8 32.2 41.2 57.1 15.6 1.5 1.7 1.1 10.5 312.4 9.2 0.5 1.2 2.7 0.9 6.4 34.6 0.4 2.5 5.3 1.8 13.7 1.6 0.9 34.3 46.5 1.1 274.8 0.7 127.6 0.8 1.6 1.0 4.3 1.1 9.5 36.5 5.0 44.6 40.8 36.2 1.1 34.0 29.7 0.2 0.1 0.0 0.1 0.0 2.5 52.7 1.1 2.1 17.7 69.1 0.0 658.6 0.3 58.5 236.5 1.5 77.7 6.2 0.9 1.4 0.1 9.3 41.5 49.6 0.4 0.2 0.5 288.6 6.0 87.0 2.4 0.6 0.0 0.1 0.1 0.1 6.5 0.1 0.1 1.5 2.3 5.5 0.0 0.6 0.2 414.9 267.0 0.2 0.0 31.0 5.7 18.4 3.5 53.5 0.5 12.9 0.6 9.9 0.2 1.4 0.7 0.6 1.2 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.9 1.4 1.7 1.1 1.2 2.7 0.9 1.8 0.8 1.1 1.1 0.4 12.8 34.7 0.0 0.5 440.1 291.1 217.3 84.2 0.0 35.6 2.0 1.0 170.1 143.2 31.3 0.0 2.4 0.6 0.6 0.0 203.3 0.1 44.4 10.0 7.0 1.8 0.0 0.7 56.3 0.3 29.2 2.0 100.0 1.3 0.4 1.4 188.2 1.0 0.0 1.6 0.3 54.9 3.8 66.5 1.7 15.5 8.5 32.0 0.0 5.7 0.0 0.0 24.6 0.0 139.9 0.0 35.3 0.0 501.6 0.1 4.1 144.6 0.0 0.0 0.3 11.2 0.3 0.8 298.2 836.1 33.8 2.6 5.0 1.0 562.9 PYGO2 ENSG00000163348 "Pygopus family PHD finger 2" Q9BRQ0 1 154957026-154963853 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023689, HPA074813" Supported Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA023689: AB_1855974, HPA074813: " "unprognostic (1.49e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-3)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "unprognostic (4.32e-3)" "prognostic unfavorable (3.88e-6)" "unprognostic (2.45e-1)" "unprognostic (2.07e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-1)" "unprognostic (7.40e-3)" "unprognostic (1.63e-2)" "unprognostic (2.81e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.76e-4)" 14.3 30.9 30.5 16.9 29.6 6.5 15.5 29.2 30.1 21.1 21.2 22.2 19.2 19.2 23.7 24.4 20.5 12.8 14.6 29.7 31.8 21.4 20.2 15.8 26.7 30.4 30.5 28.1 27.4 18.2 27.7 32.6 16.5 29.3 23.7 15.5 12.8 23.4 23.5 19.1 22.6 24.6 15.9 30.0 28.4 21.8 16.3 32.9 22.7 26.4 16.0 28.0 21.4 20.1 32.4 28.1 19.4 40.4 36.0 39.8 19.5 37.0 17.1 23.0 26.5 22.7 26.1 34.2 34.9 26.4 19.9 28.7 37.2 35.6 23.7 17.4 34.7 25.1 27.9 32.7 23.6 18.5 25.8 23.9 16.2 33.8 23.9 20.0 30.0 16.5 52.5 37.1 57.6 25.2 42.8 36.0 30.0 43.3 55.7 34.2 40.2 25.7 55.6 27.1 26.1 48.4 71.8 27.0 48.5 34.9 39.1 59.7 45.9 14.1 23.5 35.1 25.6 25.1 56.8 54.3 37.1 19.6 32.4 31.8 2.3 3.9 10.9 8.0 6.5 10.0 6.9 10.3 10.7 4.1 7.5 11.0 8.7 3.8 6.3 8.4 3.9 5.8 6.2 30.5 29.6 29.2 30.1 29.7 31.8 30.4 30.5 28.1 29.3 30.0 32.9 32.4 7.0 9.6 4.9 5.5 12.6 5.5 3.8 5.8 7.4 11.8 14.3 10.0 5.3 5.7 7.4 12.9 2.1 15.5 14.1 10.3 19.6 6.2 3.4 5.7 7.5 6.8 5.4 12.4 6.3 5.9 12.6 5.8 9.7 7.4 0.0 9.3 7.1 9.4 6.5 21.9 4.3 10.6 6.1 6.6 3.5 2.2 9.0 5.6 5.4 6.5 6.4 10.6 8.2 5.5 4.7 9.7 9.1 9.1 11.5 4.9 12.0 9.8 4.0 6.0 6.6 5.4 6.9 5.9 12.2 9.8 5.3 11.6 11.7 9.3 8.4 3.7 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929324-113977869 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 143.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 176.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 20.0 20.2 30.2 20.3 24.6 143.3 17.0 46.2 21.5 24.6 39.8 18.4 12.8 18.2 17.4 23.3 35.3 22.4 18.1 22.3 57.3 18.4 18.0 23.6 21.1 42.0 39.2 15.5 23.0 21.9 21.5 20.7 17.8 30.0 15.6 19.1 57.0 15.3 17.9 26.0 23.6 16.9 18.4 40.8 20.9 17.9 47.5 32.5 57.9 30.1 27.3 20.8 19.9 18.9 27.8 23.4 18.8 25.4 19.5 29.2 15.2 17.1 15.8 19.0 22.2 20.9 21.8 8.8 31.4 21.2 25.3 8.2 15.5 33.1 18.6 31.7 23.0 16.7 45.8 23.7 23.0 24.3 36.7 54.2 16.5 26.5 28.3 28.7 20.8 33.2 54.2 31.8 32.8 32.1 176.4 48.8 21.0 26.2 17.1 15.8 29.1 74.4 10.9 19.8 19.9 11.2 15.0 28.9 30.6 20.5 27.9 17.7 52.3 32.6 21.5 29.0 35.3 24.3 20.1 17.2 26.7 23.7 29.3 50.3 2.1 2.5 5.0 3.0 2.1 3.0 0.9 2.7 2.8 1.7 1.1 2.6 3.3 5.8 2.7 1.6 3.7 2.0 1.5 30.2 24.6 46.2 21.5 22.3 57.3 42.0 39.2 15.5 30.0 40.8 32.5 27.8 30.1 54.5 37.2 14.4 26.0 61.4 16.2 16.7 15.4 57.7 29.8 20.2 34.6 22.8 24.5 27.6 70.9 10.7 125.8 38.9 5.9 14.6 95.2 147.9 33.4 28.9 37.2 64.4 27.4 21.0 10.3 24.3 20.9 47.0 46.9 26.3 21.8 37.4 22.2 74.0 33.9 25.4 12.2 49.5 77.7 101.4 22.1 50.2 21.4 31.9 43.1 30.6 36.0 21.1 26.5 18.8 22.4 37.2 43.5 33.7 17.8 16.4 116.4 64.8 26.3 36.5 44.3 49.7 31.5 25.6 80.6 14.2 69.7 21.9 28.3 32.7 LENEP LEP503 ENSG00000163352 "Lens epithelial protein" Q9Y5L5 1 154993586-154994315 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Muller glia cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.03e-1)" "unprognostic (3.60e-2)" "unprognostic (4.71e-2)" "unprognostic (1.16e-1)" "unprognostic (2.04e-2)" "unprognostic (9.50e-3)" "unprognostic (2.72e-2)" "unprognostic (4.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.79e-1)" "unprognostic (9.51e-2)" "unprognostic (8.04e-2)" "unprognostic (1.32e-5)" "unprognostic (5.26e-2)" "unprognostic (4.50e-3)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.7 0.2 0.2 0.3 0.3 0.0 0.3 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCST2 FLJ32934 ENSG00000163354 "DC-STAMP domain containing 2" Q5T1A1 1 155018520-155033781 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 8.6;skin 1: 4.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 16.7;Early spermatids: 53.7;Extravillous trophoblasts: 13.0;Late spermatids: 31.5;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;Karpas-707: 1.1;U-266/70: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.08e-2)" "unprognostic (5.67e-2)" "unprognostic (6.04e-4)" "unprognostic (1.63e-2)" "unprognostic (3.34e-2)" "unprognostic (1.88e-3)" "unprognostic (8.25e-2)" "unprognostic (2.65e-2)" "unprognostic (2.94e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (8.92e-2)" "unprognostic (2.78e-10)" "unprognostic (6.95e-3)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-3)" 0.5 0.3 0.2 0.1 0.2 0.2 1.2 0.2 0.4 1.1 0.2 0.5 1.3 0.5 0.7 0.8 0.9 0.1 0.3 0.2 0.4 0.3 0.6 0.3 0.3 0.3 0.3 0.2 0.5 0.3 0.0 0.2 0.2 0.3 1.3 0.4 8.6 1.4 0.6 0.2 4.6 0.9 0.2 0.2 0.2 0.5 3.8 0.2 0.3 0.5 0.0 0.2 0.3 1.5 0.3 0.1 0.1 0.5 0.5 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.4 0.6 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.4 0.3 0.3 0.2 0.3 0.2 0.2 0.3 1.0 0.0 0.0 2.6 0.1 0.9 0.8 0.9 0.0 1.2 1.2 1.9 0.3 1.5 0.4 0.0 16.7 0.5 0.0 0.9 0.0 0.1 53.7 2.1 0.2 0.6 0.0 0.0 0.5 0.2 13.0 0.5 0.0 1.1 0.0 0.2 0.4 0.1 0.5 1.7 0.5 1.4 0.0 0.3 0.3 31.5 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.5 0.5 0.2 0.4 0.7 0.1 0.4 1.9 0.4 3.1 16.6 0.0 0.0 0.5 2.2 1.9 0.6 1.3 0.8 0.1 0.1 0.9 0.5 DCST1 FLJ32785 ENSG00000163357 "DC-STAMP domain containing 1" Q5T197 1 155033824-155050930 "Enzymes, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 2.6;skin 1: 3.1;testis: 6.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 12.5;Early spermatids: 37.0;Late spermatids: 18.8;Rod photoreceptor cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;HeLa: 2.2;RPMI-8226: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060314 Uncertain NA NA "HPA060314: AB_2684250" "unprognostic (1.44e-1)" "unprognostic (7.66e-2)" "unprognostic (3.77e-2)" "unprognostic (1.05e-4)" "unprognostic (3.58e-2)" "unprognostic (8.75e-4)" "unprognostic (1.46e-2)" "unprognostic (2.66e-1)" "unprognostic (6.01e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.89e-2)" "unprognostic (8.33e-15)" "unprognostic (7.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.3 0.0 0.0 3.1 0.8 0.0 0.0 0.1 0.2 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.3 1.1 0.6 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 1.4 0.7 0.2 0.0 0.3 2.1 0.0 0.0 0.0 0.5 0.1 0.1 2.2 0.1 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.4 0.0 0.1 0.1 0.1 0.9 0.0 0.4 2.4 0.0 0.3 0.3 0.7 0.2 0.8 0.1 0.4 1.5 0.0 0.0 0.1 0.1 0.3 0.1 0.4 0.4 0.1 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 1.0 0.2 0.0 0.7 0.0 1.3 0.0 12.5 0.0 0.0 0.0 0.0 0.0 37.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 18.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 6.6 0.0 0.0 0.1 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 COL6A3 ENSG00000163359 "Collagen type VI alpha 3 chain" P12111 2 237324003-237414207 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 394.7" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 355.2;Fibroblasts: 567.9;Leydig cells: 315.1;Smooth muscle cells: 197.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebral cortex: 12.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 3311.7;ASC TERT1: 4227.5;BJ hTERT+: 1279.6;HSkMC: 2705.3" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Region enriched" "Detected in many" 4 "spinal cord: 12.0" "HPA010007, HPA010080" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 1000000000 "Endoplasmic reticulum" Vesicles "HPA010007: , HPA010080: AB_1078550" "unprognostic (8.94e-2)" "unprognostic (7.24e-2)" "unprognostic (6.60e-2)" "unprognostic (3.82e-1)" "unprognostic (3.90e-2)" "unprognostic (2.37e-1)" "unprognostic (5.34e-2)" "unprognostic (2.87e-2)" "unprognostic (8.20e-3)" "unprognostic (2.55e-2)" "unprognostic (1.33e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (5.57e-11)" "unprognostic (1.54e-2)" "unprognostic (2.50e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-3)" 152.2 8.4 0.5 127.7 0.6 0.4 75.2 0.2 12.7 214.4 7.8 74.1 23.1 157.6 10.3 44.5 92.6 238.5 50.7 2.2 1.1 5.8 10.4 66.4 31.0 0.6 0.3 0.0 124.9 21.3 17.5 2.8 134.0 1.2 48.2 52.3 0.0 45.5 55.9 32.8 36.0 47.0 394.7 0.8 19.2 41.9 15.7 1.4 25.0 38.4 62.8 16.3 190.2 63.3 0.8 0.2 0.5 0.6 0.0 3311.7 4227.5 60.9 815.6 1279.6 167.0 188.2 0.0 0.1 4.5 0.1 818.7 67.4 0.6 0.7 0.9 98.8 2.0 0.1 0.0 0.0 0.0 669.9 0.0 0.4 2705.3 0.0 596.3 1.8 7.8 0.2 0.0 0.1 0.6 6.2 0.0 0.1 0.2 0.5 0.0 7.4 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 17.3 0.0 0.4 2.9 19.0 45.1 27.6 142.4 1.0 0.0 0.1 859.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 12.7 2.2 1.1 0.6 0.3 0.0 1.2 0.8 1.4 0.8 48.2 0.0 10.5 0.3 0.6 61.1 0.5 0.5 1.8 1.0 2.5 2.9 10.6 1.5 3.8 0.0 0.0 4.5 1.2 0.0 0.0 0.9 5.4 11.0 355.2 17.6 0.0 0.0 0.8 0.0 6.2 567.9 6.6 8.7 1.3 1.8 25.4 1.8 8.1 0.0 0.4 0.0 0.0 1.3 85.4 9.6 315.1 5.5 72.9 29.0 2.2 1.1 1.0 0.0 0.3 2.4 0.0 103.4 2.0 0.9 0.0 0.2 1.0 2.3 32.9 19.2 197.7 1.5 1.3 3.3 61.5 5.7 9.3 48.7 0.0 1.0 INAVA "C1orf106, FLJ10901" ENSG00000163362 "Innate immunity activator" Q3KP66 1 200891048-200915742 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.5;intestine: 55.9;skin 1: 46.4" "Cell type enhanced" "Detected in some" "Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027499, HPA027511, HPA079622" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: " "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.78e-5)" "unprognostic (4.56e-2)" "unprognostic (2.18e-1)" "unprognostic (2.74e-2)" "unprognostic (6.62e-3)" "unprognostic (2.84e-2)" "unprognostic (9.38e-2)" "unprognostic (2.52e-2)" "unprognostic (2.81e-1)" "unprognostic (3.23e-3)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.73e-2)" 0.1 0.0 1.3 4.0 1.3 4.6 1.8 0.8 1.4 5.0 1.5 34.1 47.7 1.1 0.5 44.5 4.2 16.4 0.1 1.3 1.2 15.4 0.5 3.5 0.4 1.0 1.2 1.0 0.1 13.3 0.1 0.3 1.9 1.0 7.1 30.3 0.4 12.4 2.6 0.2 46.4 55.9 1.1 0.9 0.3 27.6 1.1 1.4 1.0 0.1 0.0 5.8 17.3 20.5 1.0 27.5 40.8 23.3 0.0 0.0 0.0 60.3 0.0 0.0 0.7 0.5 43.4 49.6 0.0 13.3 0.0 1.1 66.0 0.0 17.4 0.5 0.0 5.0 3.8 1.8 17.2 0.1 8.5 0.8 0.0 26.1 0.4 1.1 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.1 1.4 45.2 57.8 9.2 0.2 9.7 54.0 24.4 34.9 0.1 2.8 2.6 41.5 0.0 27.3 17.1 7.9 0.0 0.1 10.1 0.1 2.9 46.2 20.6 0.0 0.1 8.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 1.3 0.8 1.4 1.3 1.2 1.0 1.2 1.0 1.0 0.9 1.4 1.0 0.6 12.8 7.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 3.3 0.0 0.0 5.0 14.7 0.0 7.6 0.1 0.0 5.9 33.3 0.0 26.8 2.2 0.7 0.0 0.0 0.0 45.5 13.2 0.4 0.0 25.1 1.3 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.6 0.0 0.0 0.0 0.0 0.0 26.0 4.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.5 0.3 0.0 0.0 YY1AP1 "HCCA2, YAP, YY1AP" ENSG00000163374 "YY1 associated protein 1" Q9H869 1 155659443-155689000 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006986, HPA064249" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA006986: AB_1080620, HPA064249: AB_2685226" "unprognostic (1.96e-2)" "unprognostic (2.80e-1)" "unprognostic (1.09e-2)" "unprognostic (5.67e-2)" "unprognostic (3.91e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-3)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (8.13e-2)" "unprognostic (6.87e-2)" "unprognostic (8.65e-2)" "prognostic unfavorable (2.01e-6)" "unprognostic (6.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.39e-1)" "unprognostic (5.84e-2)" 41.3 36.4 36.4 28.4 39.0 77.9 43.1 53.1 42.0 46.2 24.2 50.5 23.7 41.8 39.0 53.5 44.6 26.9 46.0 35.1 35.4 38.0 38.7 49.7 38.9 35.0 36.8 32.0 47.9 37.9 35.7 47.5 32.3 35.6 46.7 36.0 41.7 41.3 37.9 114.8 54.0 40.0 43.0 34.4 48.3 42.2 75.2 38.3 50.8 40.3 73.8 50.3 46.2 46.1 39.0 63.5 32.0 40.3 45.9 44.9 40.4 86.5 39.9 58.0 70.4 59.9 49.3 65.7 50.1 38.4 58.6 35.8 60.5 61.3 55.7 66.2 46.7 30.5 41.6 36.2 31.2 47.5 66.7 54.2 43.0 56.1 53.7 68.5 48.8 44.3 47.5 55.8 69.9 52.2 56.0 68.5 32.4 63.7 86.5 46.4 53.7 34.9 80.4 42.7 45.5 40.3 47.8 52.6 75.0 51.5 72.5 82.3 108.7 36.0 39.4 34.6 41.4 53.5 87.7 62.8 123.2 38.9 43.0 46.4 40.3 27.6 50.3 34.7 27.5 36.8 26.7 29.6 36.4 34.0 20.9 25.5 25.5 29.5 45.0 27.7 15.9 40.1 35.1 36.4 39.0 53.1 42.0 35.1 35.4 35.0 36.8 32.0 35.6 34.4 38.3 39.0 18.3 19.2 26.7 28.7 26.0 34.7 30.5 20.2 38.7 24.5 27.4 21.3 23.2 22.8 22.9 12.9 43.8 23.6 24.5 25.7 13.7 17.3 68.0 20.0 21.8 24.5 34.9 42.9 33.8 19.1 27.9 24.7 25.0 25.5 25.3 16.6 15.7 23.1 21.5 16.8 34.8 23.8 12.2 20.8 36.3 81.0 28.0 28.5 19.6 37.5 27.4 20.8 15.5 38.7 48.3 18.4 16.2 25.6 36.9 29.2 22.5 11.7 17.3 24.9 6.6 24.9 22.3 77.6 25.5 38.8 35.7 45.0 26.7 26.6 24.4 33.8 KBTBD8 "KIAA1842, TA-KRP" ENSG00000163376 "Kelch repeat and BTB domain containing 8" Q8NFY9 3 66998307-67011210 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.0;lymphoid tissue: 20.8" "Cell type enhanced" "Detected in many" "B-cells: 31.9;Langerhans cells: 35.2;Macrophages: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 62.6;Karpas-707: 28.4;U-698: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041285, HPA069190" Approved NA NA "HPA041285: AB_10796341, HPA069190: AB_2686101" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.70e-4)" "unprognostic (1.99e-2)" "unprognostic (6.63e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-2)" "unprognostic (5.94e-3)" "unprognostic (1.93e-1)" "unprognostic (8.14e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (7.43e-2)" "unprognostic (2.96e-1)" "unprognostic (1.54e-1)" 1.4 1.1 1.1 6.9 2.1 14.0 1.0 1.9 3.3 0.7 3.5 2.4 1.8 0.4 0.2 1.3 0.4 1.8 3.9 1.6 1.4 0.6 1.3 2.2 20.5 0.8 1.1 1.5 0.4 0.9 0.3 0.5 3.2 1.0 1.0 2.0 1.3 0.9 0.4 1.6 0.5 2.8 1.2 1.0 5.8 2.2 7.9 1.1 3.6 0.8 2.2 20.8 1.9 0.3 1.7 1.2 1.4 2.5 2.9 1.7 1.1 5.3 3.1 1.1 2.3 1.6 5.7 0.6 62.6 0.8 0.9 1.3 1.7 14.5 3.4 3.6 10.7 4.7 23.0 0.7 2.9 2.2 14.8 23.9 1.9 1.5 4.6 4.0 0.7 1.7 12.4 5.7 28.4 1.6 2.4 11.9 2.5 10.5 2.3 1.1 6.8 2.5 8.5 0.7 1.9 8.6 3.1 1.2 1.0 2.1 3.1 0.6 4.2 4.8 7.7 1.8 16.8 6.0 16.4 27.6 43.3 2.1 11.7 2.6 0.0 1.1 0.4 1.1 3.0 0.6 6.2 1.3 1.2 2.4 6.7 1.2 0.8 0.0 1.1 2.6 0.3 2.4 1.2 1.1 2.1 1.9 3.3 1.6 1.4 0.8 1.1 1.5 1.0 1.0 1.1 1.7 2.3 0.0 1.8 0.3 31.9 5.2 0.4 0.1 5.7 1.3 1.9 2.5 11.6 1.5 0.7 0.0 2.1 4.0 7.5 2.1 0.0 0.5 1.4 0.3 0.3 1.6 1.2 3.0 4.5 0.9 1.4 1.3 1.1 0.4 4.5 0.1 2.2 0.5 3.8 3.3 2.7 1.2 2.0 1.9 35.2 1.3 0.0 20.9 0.0 1.9 1.3 1.7 0.0 2.0 1.8 1.2 1.5 0.4 11.0 0.3 0.9 0.5 0.2 0.7 0.0 3.5 2.5 9.9 5.3 5.1 5.5 2.5 9.1 0.8 1.4 0.5 TAFA4 "FAM19A4, TAFA-4" ENSG00000163377 "TAFA chemokine like family member 4" Q96LR4 3 68731766-68953297 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 15.0;brain: 13.2;retina: 11.2;stomach 1: 4.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.8;NTERA-2: 9.2;SCLC-21H: 1.0;SuSa: 2.5" "Region enriched" "Detected in many" 5 "thalamus: 13.5" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.92e-1)" "unprognostic (9.97e-3)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (8.78e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-2)" "unprognostic (1.22e-1)" "unprognostic (3.66e-2)" "unprognostic (8.06e-2)" "unprognostic (2.50e-1)" 0.0 15.0 4.6 0.2 4.9 0.0 0.0 3.9 3.1 0.0 0.7 0.3 0.0 0.0 0.0 0.3 0.0 1.2 0.0 1.8 6.8 0.1 0.0 0.1 0.0 4.5 9.8 1.5 0.4 0.0 0.0 0.7 0.3 4.5 0.9 0.0 11.2 0.0 0.1 0.0 0.0 0.2 0.2 3.7 0.0 4.9 1.0 13.2 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.9 3.9 3.1 1.8 6.8 4.5 9.8 1.5 4.5 3.7 13.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975217-69013684 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Peritubular cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 86.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 17.7 9.2 7.7 12.9 7.9 6.0 19.7 7.7 11.0 13.7 21.1 19.9 7.5 30.1 9.9 17.6 18.7 18.0 23.7 7.8 8.4 7.1 5.7 28.9 8.2 9.8 8.2 6.9 11.7 12.7 5.1 9.3 22.5 8.6 28.2 8.7 8.9 16.5 34.0 20.1 9.4 11.5 25.6 8.6 10.1 15.6 9.0 8.3 11.2 8.0 15.3 8.9 24.9 13.8 8.2 19.0 7.1 12.5 14.4 16.6 32.2 8.6 25.4 31.5 16.0 21.0 9.1 10.2 1.1 3.8 28.1 13.6 6.0 8.3 32.3 19.9 62.3 5.6 20.2 15.5 13.5 18.7 11.5 8.2 26.8 29.4 20.6 25.1 19.4 86.2 0.8 5.9 11.1 53.7 5.5 2.0 3.8 13.5 6.2 3.5 0.8 12.4 8.2 13.9 43.4 1.2 6.3 29.1 1.7 23.5 12.8 6.0 15.9 44.6 40.6 13.4 5.1 24.3 6.0 20.5 9.3 16.3 17.1 23.8 5.4 1.5 0.0 2.0 1.4 2.3 1.1 3.0 4.3 2.4 0.7 2.5 2.7 0.2 2.4 0.5 0.4 6.6 1.3 7.7 7.9 7.7 11.0 7.8 8.4 9.8 8.2 6.9 8.6 8.6 8.3 8.2 29.6 12.8 10.3 14.0 3.5 7.1 11.4 13.2 16.5 2.2 7.5 11.7 20.7 4.3 14.5 1.8 16.7 0.9 3.1 5.1 0.0 4.6 16.5 15.3 7.5 23.7 6.0 3.8 11.2 8.2 5.3 9.3 9.2 15.4 0.0 9.4 20.3 3.6 6.7 0.0 21.4 4.5 2.0 6.8 9.8 15.1 3.1 8.6 8.8 30.9 6.5 1.4 1.0 9.5 12.2 12.4 3.4 40.6 5.4 8.3 2.1 1.9 13.2 5.6 0.0 26.8 15.2 5.5 2.5 14.8 4.5 0.8 7.0 6.9 3.4 8.6 LMOD3 ENSG00000163380 "Leiomodin 3" Q0VAK6 3 69106065-69123032 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 112.2;skeletal muscle: 464.1;tongue: 230.2" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 278.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 1.6" "Region enhanced" "Detected in single" "midbrain: 2.1" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "HSkMC: 2.9" "Not detected" "Not detected" HPA036034 Uncertain NA NA "HPA036034: AB_10673494" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.93e-1)" "unprognostic (2.50e-3)" "unprognostic (1.96e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (6.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.33e-1)" "unprognostic (2.98e-4)" "unprognostic (3.67e-3)" "unprognostic (1.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.96e-1)" 0.2 0.1 0.3 0.2 0.4 0.2 0.1 0.4 0.5 0.1 0.3 0.1 0.2 0.0 0.2 6.5 0.0 0.3 112.2 0.3 0.3 0.1 0.1 0.5 0.2 0.3 2.1 0.3 0.0 0.4 0.0 0.9 0.5 0.4 3.9 0.1 1.3 9.1 0.4 464.1 0.1 0.2 0.1 0.2 0.7 0.4 0.1 0.3 0.1 0.1 230.2 0.0 0.8 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.3 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.2 1.6 0.2 0.4 0.2 0.2 0.2 0.3 0.4 0.3 0.1 0.3 0.3 0.4 0.4 0.2 0.4 0.2 0.4 0.1 0.3 0.4 0.4 0.5 0.3 0.3 0.3 2.1 0.3 0.4 0.2 0.3 0.4 0.5 0.0 0.0 0.3 6.2 2.3 1.5 2.1 0.0 5.0 2.4 1.8 278.1 5.7 1.3 0.0 39.6 0.8 10.0 2.4 0.0 1.0 1.6 3.4 1.2 2.4 0.0 0.0 0.1 0.0 2.1 8.2 0.0 10.0 17.8 0.5 0.7 1.2 0.7 6.7 2.0 1.9 6.1 2.2 28.1 0.5 0.3 2.2 12.4 0.0 3.9 1.0 13.4 0.0 0.3 1.1 0.2 1.2 0.9 2.6 6.1 0.4 0.3 18.1 0.0 33.1 3.4 0.6 0.1 0.8 1.4 0.4 8.2 0.9 1.1 2.5 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591756-156609507 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Lipid transport, Transport" Isomerase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3300000 Nucleoplasm "Vesicles, Cytosol" "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 46.0 75.4 58.4 21.1 59.7 22.4 48.3 63.8 70.2 54.5 65.1 61.9 45.9 69.4 89.5 58.5 60.0 26.7 99.5 57.1 62.8 84.3 87.2 44.0 27.3 59.9 61.5 56.6 46.9 70.3 105.6 70.5 23.9 59.2 63.0 42.0 17.5 54.3 48.8 72.4 55.1 48.7 40.0 61.6 43.6 68.0 41.2 60.6 30.9 60.3 68.8 34.6 55.4 48.2 67.4 114.2 155.4 43.9 84.4 64.0 43.8 55.5 29.5 62.3 69.5 72.6 130.6 76.8 62.4 113.4 52.5 55.9 111.1 49.4 99.0 47.5 81.2 98.5 58.1 76.2 86.1 75.1 60.0 60.9 44.2 123.7 87.9 81.9 53.4 95.4 104.7 54.7 70.1 71.6 209.6 83.3 98.0 43.1 158.1 118.2 87.7 40.2 212.6 93.0 93.6 114.7 102.9 90.4 172.4 141.6 66.4 178.3 117.5 51.1 45.1 64.8 64.6 70.6 180.1 110.3 53.0 63.1 37.0 70.4 25.4 96.3 52.9 121.2 111.3 121.3 236.2 109.4 124.3 89.1 186.5 122.8 114.9 11.4 141.3 89.1 225.7 110.1 186.6 58.4 59.7 63.8 70.2 57.1 62.8 59.9 61.5 56.6 59.2 61.6 60.6 67.4 29.5 41.7 32.9 0.0 14.8 0.0 0.0 0.0 0.0 0.0 87.5 96.0 0.0 0.0 23.5 68.0 0.0 136.7 28.7 0.0 201.5 112.8 0.0 27.3 29.9 18.4 0.0 0.0 0.0 100.1 43.1 27.2 0.0 32.0 5.1 53.5 0.0 0.0 92.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 40.8 0.0 0.0 0.0 0.0 91.0 0.0 0.0 6.2 0.0 0.0 219.6 11.7 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 81.3 13.4 48.1 0.0 0.0 POGLUT1 "9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi" ENSG00000163389 "Protein O-glucosyltransferase 1" Q8NBL1 3 119468963-119494708 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Gastrulation "Developmental protein, Glycosyltransferase, Transferase" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 81.2;monocytes: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037855, HPA037856" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA037855: AB_10672728, HPA037856: AB_2732477" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-1)" "unprognostic (2.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (6.52e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.02e-7)" "unprognostic (3.08e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-3)" "prognostic favorable (2.23e-4)" 6.5 7.3 6.6 7.8 6.7 3.2 7.7 6.6 8.3 7.0 7.5 6.9 4.3 9.1 7.8 5.7 6.1 4.7 5.5 6.7 7.6 5.7 6.6 5.6 10.9 7.4 7.0 6.5 5.6 7.9 9.5 4.9 8.2 7.3 5.5 7.3 4.2 4.7 11.7 3.2 10.1 7.8 10.5 6.8 9.0 5.4 2.6 7.7 9.8 5.6 3.4 10.9 8.6 6.4 8.2 10.8 7.1 11.7 13.1 29.5 16.8 8.6 16.7 16.7 12.3 18.4 11.5 6.9 16.5 22.2 21.4 10.6 11.9 15.9 16.8 20.4 14.4 10.6 19.3 11.1 12.9 19.1 21.3 21.7 17.5 9.6 13.3 18.0 15.7 15.5 11.2 10.5 19.7 13.9 10.9 12.5 20.7 12.4 18.6 13.8 12.2 12.2 24.0 11.6 13.9 12.7 20.0 8.1 4.9 13.4 11.7 13.2 17.8 19.7 13.1 8.0 3.8 8.9 27.1 25.2 21.7 11.1 20.6 18.8 2.9 16.4 13.9 16.2 15.7 18.7 13.9 18.2 17.0 20.7 10.1 21.1 20.0 1.2 29.5 10.8 11.5 22.3 15.0 6.6 6.7 6.6 8.3 6.7 7.6 7.4 7.0 6.5 7.3 6.8 7.7 8.2 19.1 0.0 6.2 11.4 15.7 16.8 7.3 17.4 16.5 13.6 9.7 8.5 5.2 14.3 10.1 20.2 6.2 10.6 17.1 5.2 0.0 6.9 0.7 5.5 19.3 16.1 9.5 8.4 32.7 5.3 14.7 14.5 9.2 7.0 17.7 11.3 13.6 12.5 8.4 5.0 31.6 11.7 22.4 11.9 81.2 0.2 8.7 16.6 12.4 6.5 151.4 10.3 21.6 23.6 25.8 5.0 8.3 17.0 14.1 8.0 8.5 6.0 6.5 13.0 13.1 16.7 13.4 1.5 1.5 13.9 14.9 6.6 15.5 17.4 13.9 5.9 SLC22A15 FLIPT1 ENSG00000163393 "Solute carrier family 22 member 15" Q8IZD6 1 115976513-116070054 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.9;brain: 32.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 1.3;non-classical monocyte: 1.2" "Group enriched" "Detected in many" 8 "granulocytes: 1.3;monocytes: 1.2" "Cell line enhanced" "Detected in many" "hTCEpi: 36.0;hTERT-HME1: 47.4;NB-4: 27.4;THP-1: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019785 Uncertain NA NA "HPA019785: AB_1857011" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.01e-3)" "unprognostic (5.62e-2)" "unprognostic (5.22e-2)" "unprognostic (5.85e-5)" "unprognostic (8.91e-3)" "unprognostic (1.81e-1)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (9.06e-2)" "unprognostic (7.29e-3)" "unprognostic (8.78e-3)" "unprognostic (3.44e-1)" "unprognostic (9.97e-4)" "unprognostic (1.30e-1)" 2.5 3.1 8.2 2.3 15.3 30.9 1.7 11.7 12.6 2.5 1.2 1.3 1.0 1.1 1.3 5.2 1.5 1.9 4.8 8.5 12.0 3.5 1.1 4.9 1.0 13.1 11.8 7.1 1.1 3.1 4.3 2.8 2.0 14.7 2.0 1.7 6.8 4.5 1.6 0.6 9.5 1.9 1.0 11.6 3.4 3.5 1.1 12.4 0.5 2.8 1.0 1.1 1.7 5.0 32.3 3.0 0.2 2.1 0.0 3.7 4.4 1.5 4.7 6.9 2.8 5.0 0.0 0.5 3.3 5.0 2.3 2.4 4.5 3.6 9.7 2.7 0.0 2.3 3.2 3.7 0.5 12.3 4.9 4.3 4.5 36.0 0.1 47.4 0.2 0.0 0.0 0.1 0.0 4.7 2.7 0.0 27.4 3.0 2.8 2.3 0.0 0.0 0.1 3.9 1.6 2.2 1.9 8.1 1.7 13.8 3.1 0.4 29.4 0.0 5.0 2.7 1.0 1.2 4.8 4.8 0.4 5.3 8.0 8.1 0.3 0.8 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 0.1 8.2 15.3 11.7 12.6 8.5 12.0 13.1 11.8 7.1 14.7 11.6 12.4 32.3 0.2 0.0 13.7 46.7 2.3 2.8 3.1 3.6 5.2 3.0 0.3 0.4 7.8 0.0 3.2 5.5 10.4 0.6 0.8 0.5 1.9 1.1 1.3 2.5 0.7 0.2 8.4 0.4 44.2 0.4 0.4 4.6 4.6 1.4 1.3 0.6 1.1 0.0 2.8 8.4 33.9 0.3 0.0 9.4 0.5 0.1 0.9 6.9 1.8 9.4 8.7 1.0 1.0 53.3 250.2 1.6 1.2 0.4 0.7 1.1 0.1 0.3 5.2 2.1 0.0 0.4 1.4 0.3 0.7 5.7 3.0 0.0 1.0 1.2 0.5 1.3 CCKAR ENSG00000163394 "Cholecystokinin A receptor" P32238 4 26481396-26490484 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 29.4;stomach 1: 16.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Group enriched" "Detected in some" 4 "amygdala: 1.4;hypothalamus: 2.6;midbrain: 5.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 7.2" "Region enhanced" "Detected in all" "midbrain: 12.6" HPA073900 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA073900: " "unprognostic (7.48e-2)" "unprognostic (3.70e-2)" "unprognostic (7.13e-2)" "unprognostic (3.08e-2)" "unprognostic (3.36e-1)" "unprognostic (3.79e-1)" 0.0 0.0 1.4 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 29.4 0.0 0.6 2.6 0.1 0.0 0.0 0.0 0.7 5.3 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.7 0.1 0.7 0.3 0.0 0.0 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.3 0.6 2.6 0.7 5.3 0.2 0.7 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGFN1 "DKFZp434B1231, EEF1A2BP1" ENSG00000163395 "Immunoglobulin like and fibronectin type III domain containing 1" Q86VF2 1 201190824-201228952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skeletal muscle: 188.1" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 103.8" "Cancer enriched" "Detected in some" 4 "thyroid cancer: 8.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "HeLa: 76.6" "Group enriched" "Detected in many" 7 "amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9" "Low region specificity" "Detected in some" HPA050415 Enhanced Approved "Midbody ring" Yes NA "Midbody ring" "HPA050415: AB_2681120" "unprognostic (2.09e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-2)" "unprognostic (3.25e-1)" "unprognostic (1.02e-2)" "unprognostic (2.00e-2)" "unprognostic (9.80e-3)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.27e-8)" "unprognostic (3.55e-4)" "unprognostic (6.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" 0.6 0.1 0.3 0.1 0.1 0.0 0.2 0.0 0.3 0.8 0.6 0.1 0.0 10.5 15.2 0.0 0.9 0.2 0.3 1.0 0.5 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.2 7.0 0.0 0.1 0.0 0.3 0.7 0.2 0.0 0.0 0.3 188.1 0.2 0.0 0.8 0.0 0.0 0.1 2.6 0.4 0.0 14.7 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 76.6 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 4.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.0 0.5 0.1 0.2 0.1 0.3 0.0 0.4 0.1 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.1 1.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 22.1 0.4 1.8 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 103.8 0.7 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ATP1A1 ENSG00000163399 "ATPase Na+/K+ transporting subunit alpha 1" P05023 1 116372668-116410261 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 1494.1" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 1879.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 2979.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018702, CAB069993" Enhanced NA NA 420000 "CAB018702: AB_626713, CAB069993: AB_2060979" "unprognostic (6.18e-2)" "unprognostic (2.18e-1)" "unprognostic (6.91e-2)" "unprognostic (1.42e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.80e-1)" "unprognostic (1.21e-2)" "unprognostic (6.32e-2)" "unprognostic (1.61e-2)" "unprognostic (1.65e-1)" "prognostic favorable (8.98e-8)" "unprognostic (4.75e-2)" "unprognostic (1.17e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.01e-4)" 137.9 208.5 126.0 145.4 164.3 105.3 222.4 207.4 278.3 138.7 213.0 586.0 792.6 93.2 307.3 257.9 144.9 364.5 212.6 207.4 159.5 1137.9 133.6 257.9 90.4 163.1 167.7 152.5 138.9 666.9 1494.1 161.9 121.0 190.7 178.0 547.9 303.9 728.3 296.8 148.5 314.6 820.6 147.4 143.8 78.7 203.2 141.3 138.4 93.7 751.2 118.7 133.5 151.2 189.0 251.1 399.8 144.8 147.2 74.5 288.8 277.5 750.8 232.9 462.9 281.6 396.6 583.9 278.5 314.2 321.3 279.0 284.4 505.1 293.8 493.7 406.2 116.1 324.2 183.5 249.2 498.4 220.1 465.2 246.1 311.6 808.0 328.4 429.0 395.5 350.8 187.4 306.9 294.2 253.0 793.7 189.6 167.7 346.0 630.5 285.6 179.7 343.4 278.6 1023.2 405.1 143.8 126.7 363.0 679.6 2979.2 358.2 179.1 265.9 311.9 159.4 221.4 415.4 479.5 140.7 118.1 238.0 488.2 263.1 956.1 19.2 36.6 17.2 59.7 56.6 62.8 26.4 66.9 64.2 59.6 15.2 76.5 55.5 4.5 30.8 86.0 30.4 57.6 53.6 126.0 164.3 207.4 278.3 207.4 159.5 163.1 167.7 152.5 190.7 143.8 138.4 251.1 199.2 275.7 295.3 26.8 84.6 276.8 336.8 220.5 390.9 101.0 189.2 145.2 74.1 579.0 238.4 770.6 398.2 83.7 89.1 789.9 373.7 625.6 31.2 205.4 54.3 201.6 176.4 89.2 130.5 315.6 160.6 141.6 134.6 372.1 43.8 212.6 144.2 71.2 129.8 102.6 123.9 353.4 463.9 98.8 254.2 19.3 117.8 145.5 208.1 36.5 56.9 556.8 64.9 77.9 60.9 187.6 307.8 100.8 73.2 271.6 1879.9 308.2 171.6 147.7 32.9 109.8 147.4 20.2 35.8 320.7 268.9 67.6 133.3 58.3 498.6 280.6 SLC15A2 PEPT2 ENSG00000163406 "Solute carrier family 15 member 2" Q16348 3 121894401-121944188 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 51.3;epididymis: 39.6;prostate: 40.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Astrocytes: 139.7;Club cells: 64.8;Microglial cells: 49.6;Muller glia cells: 51.4" "Cancer enhanced" "Detected in many" "prostate cancer: 12.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 5.7;U-937: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.72e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.50e-2)" "prognostic favorable (6.96e-4)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.74e-4)" "unprognostic (3.21e-1)" "unprognostic (1.28e-1)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-2)" "unprognostic (4.60e-2)" 1.0 1.4 14.3 3.0 15.2 5.9 4.8 11.9 16.2 51.3 4.6 2.6 2.2 2.0 39.6 3.4 11.4 6.3 1.8 13.5 11.3 11.1 0.9 20.2 6.0 10.7 11.5 12.7 0.8 5.5 1.7 3.4 2.3 15.1 40.0 2.9 21.1 24.8 22.2 0.8 0.9 2.1 1.2 9.1 6.1 1.6 4.2 13.1 1.6 6.7 0.4 6.0 4.9 2.3 10.4 1.3 0.6 0.7 0.2 0.8 0.4 0.9 0.1 0.1 0.3 0.4 1.2 2.1 2.4 0.1 0.1 0.4 1.4 0.5 1.2 0.4 2.0 0.5 3.3 1.0 0.6 0.1 3.6 3.2 0.7 3.6 0.4 0.2 0.4 0.2 0.7 0.5 1.0 0.4 1.0 0.7 5.7 3.7 1.4 0.3 0.8 0.3 0.7 0.8 0.8 0.3 0.3 0.3 0.2 0.1 1.1 0.2 3.1 0.1 0.3 0.2 0.2 0.3 1.2 0.4 3.3 0.4 4.8 0.3 0.9 0.4 0.1 0.0 0.1 0.1 1.3 0.1 0.0 0.1 1.3 0.1 0.1 0.2 0.0 1.0 0.6 0.0 0.1 14.3 15.2 11.9 16.2 13.5 11.3 10.7 11.5 12.7 15.1 9.1 13.1 10.4 0.4 99.3 22.8 139.7 5.9 0.5 2.8 22.5 1.2 1.0 5.0 2.0 2.6 4.3 64.8 11.0 0.0 2.5 3.2 1.4 3.9 0.6 0.4 8.9 2.0 1.0 0.0 1.7 15.4 8.3 0.6 1.3 0.5 21.3 3.8 1.0 1.4 0.0 2.7 0.0 22.6 1.4 14.2 13.5 3.8 0.6 6.5 5.3 0.0 49.6 3.1 51.4 1.0 16.6 5.0 2.0 1.0 5.3 7.7 14.4 0.2 1.6 28.8 2.9 0.0 0.9 2.4 0.4 0.5 10.4 0.6 1.4 1.2 0.3 1.6 12.7 EIF4E3 MGC39820 ENSG00000163412 "Eukaryotic translation initiation factor 4E family member 3" Q8N5X7 3 71675414-71754773 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 14.7" "Group enriched" "Detected in many" 7 "granulocytes: 14.7;monocytes: 4.2;T-cells: 5.7" "Cell line enhanced" "Detected in many" "HDLM-2: 28.0;Karpas-707: 36.3;U-937: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058649, HPA076465" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA058649: AB_2683785, HPA076465: " "unprognostic (3.16e-3)" "unprognostic (7.60e-3)" "unprognostic (4.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.31e-2)" "prognostic favorable (6.63e-4)" "unprognostic (3.10e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.16e-2)" "unprognostic (4.58e-2)" "prognostic favorable (6.99e-5)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.64e-2)" "unprognostic (1.83e-2)" 27.8 12.1 13.5 12.9 19.2 26.9 14.1 12.2 18.2 11.6 2.8 18.0 14.3 14.6 9.9 19.8 15.8 10.7 30.2 19.3 15.3 14.0 11.8 16.2 12.8 10.5 11.5 14.8 22.9 16.1 24.7 9.9 6.4 10.7 16.1 17.1 8.3 14.4 18.4 62.4 9.8 18.7 17.4 10.8 17.8 12.8 5.6 14.7 16.0 17.6 55.0 11.0 15.2 10.0 16.6 0.6 2.5 2.4 7.8 2.3 5.9 3.0 2.1 2.3 2.1 1.2 1.3 1.2 0.0 5.1 2.0 13.4 2.8 8.6 12.1 1.7 28.0 2.7 0.0 0.2 0.2 8.2 4.3 4.6 5.3 7.5 0.6 6.4 1.1 6.7 4.9 0.9 36.3 0.4 9.4 3.9 1.0 18.9 0.9 4.3 2.1 9.4 1.2 25.9 13.3 4.8 12.9 14.4 3.1 0.3 7.4 13.6 0.2 1.8 1.2 5.9 16.6 2.0 25.2 25.0 0.0 0.9 50.3 4.8 2.0 4.2 6.1 2.1 1.8 3.2 0.2 2.9 3.5 0.9 0.1 2.1 2.5 14.7 1.1 2.6 0.0 5.7 1.7 13.5 19.2 12.2 18.2 19.3 15.3 10.5 11.5 14.8 10.7 10.8 14.7 16.6 16.6 28.9 14.5 5.5 1.9 10.1 10.3 2.0 5.2 9.4 14.5 10.3 39.3 11.5 7.4 11.0 0.0 3.7 20.3 41.0 3.9 5.2 1.0 8.6 19.0 11.0 9.1 1.7 37.0 5.8 3.0 12.5 7.1 35.2 7.0 6.4 17.5 7.3 3.9 1.7 32.0 10.8 2.0 19.5 6.2 1.7 12.8 15.8 3.6 11.2 31.2 13.0 17.5 11.6 11.9 8.6 17.1 9.4 10.9 12.2 40.0 14.9 8.1 0.5 0.0 11.5 14.1 0.6 1.3 8.3 13.5 1.5 20.8 2.6 10.1 9.5 PROK2 "BV8, KAL4, MIT1, PK2" ENSG00000163421 "Prokineticin 2" Q9HC23 3 71771655-71785206 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Biological rhythms" Neuropeptide "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 65.0;lymphoid tissue: 22.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 5.9;Kupffer cells: 8.0;Macrophages: 11.3;monocytes: 6.9;Spermatocytes: 23.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.1" "Region enriched" "Detected in some" 6 "cerebral cortex: 11.4" "Immune cell enriched" "Detected in many" 50 "neutrophil: 414.4" "Lineage enriched" "Detected in many" 50 "granulocytes: 414.4" "Cell line enhanced" "Detected in some" "HL-60: 9.2;NB-4: 8.9;NTERA-2: 5.5;U-266/70: 12.0;U-266/84: 20.8;U-937: 8.3" "Group enriched" "Detected in some" 6 "basal ganglia: 2.7;hypothalamus: 1.1;olfactory bulb: 3.5" "Low region specificity" "Detected in all" HPA041408 Approved "Secreted to blood" NA NA "HPA041408: AB_10964057" "unprognostic (5.24e-2)" "unprognostic (3.13e-3)" "unprognostic (3.51e-3)" "unprognostic (3.59e-2)" "unprognostic (1.89e-1)" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (9.52e-2)" "unprognostic (4.29e-2)" "unprognostic (9.91e-3)" "unprognostic (6.89e-2)" "unprognostic (5.73e-1)" "unprognostic (1.59e-4)" "unprognostic (2.02e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" 7.3 0.3 0.6 17.8 0.6 65.0 0.3 0.2 11.4 0.4 1.1 0.4 0.3 0.2 0.0 0.4 2.7 1.2 1.0 0.2 1.3 0.6 2.6 13.2 0.2 0.5 0.9 0.3 0.2 1.1 0.0 0.4 3.1 1.3 0.2 0.2 0.1 0.3 0.0 0.5 0.1 0.5 1.5 0.3 22.6 0.6 11.5 2.0 1.1 0.5 4.3 0.5 6.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.6 0.0 0.0 0.0 0.3 8.9 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 20.8 0.0 0.0 8.3 0.0 0.0 8.2 3.5 3.4 0.7 0.0 0.0 2.7 2.9 0.7 0.0 0.9 5.0 414.4 0.0 0.2 0.3 1.7 3.1 0.6 0.6 0.2 11.4 0.2 1.3 0.5 0.9 0.3 1.3 0.3 2.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 1.8 0.0 0.0 2.5 0.0 0.0 0.0 1.6 0.1 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 8.0 0.3 2.8 0.3 11.3 1.8 0.0 6.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 23.8 2.9 0.0 0.0 0.0 3.5 0.1 0.0 0.0 TEX55 "C3orf30, FLJ32859, TSCPA" ENSG00000163424 "Testis expressed 55" Q96M34 3 119146151-119160042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 54.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA062468, HPA068480" Enhanced Approved Vesicles NA NA Vesicles "HPA062468: AB_2684772, HPA068480: " "unprognostic (4.06e-3)" "unprognostic (3.67e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA057574: AB_2683474" "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.06e-1)" 10.7 23.0 9.0 8.9 12.3 9.1 12.1 11.6 9.4 9.1 9.6 7.7 7.6 10.3 8.4 9.3 6.7 7.4 5.5 7.9 11.0 15.0 11.3 7.4 10.3 12.1 12.3 7.0 14.8 10.4 13.8 4.1 9.7 12.4 9.8 7.5 7.3 8.6 8.7 5.0 11.0 7.5 9.8 12.7 9.2 7.3 4.6 10.5 12.3 14.3 5.9 8.9 7.5 6.6 16.2 52.6 18.1 12.2 15.6 27.5 26.1 19.3 18.5 16.0 19.2 23.8 17.0 15.8 34.1 22.4 19.9 27.3 22.4 22.7 18.1 36.5 13.3 14.0 36.5 23.5 19.9 18.5 59.8 18.0 19.3 22.7 23.4 29.9 12.4 11.5 21.5 21.0 42.6 20.9 23.9 47.2 19.1 12.3 23.1 32.8 10.4 32.6 22.1 14.6 19.1 15.6 20.6 32.4 21.9 46.2 8.5 24.1 26.7 17.2 32.0 35.7 21.7 23.5 36.3 44.9 70.6 32.2 44.2 27.4 1.4 2.7 1.1 1.9 2.4 2.7 2.5 2.3 2.4 2.6 2.3 3.5 2.7 1.5 1.6 1.9 2.9 2.6 1.9 9.0 12.3 11.6 9.4 7.9 11.0 12.1 12.3 7.0 12.4 12.7 10.5 16.2 26.0 73.7 59.9 18.3 30.8 50.9 20.7 15.9 32.5 32.3 34.0 25.8 17.3 24.3 29.0 18.4 56.3 17.3 33.3 17.9 11.7 22.0 7.8 24.4 48.8 24.1 16.8 34.3 23.8 31.0 28.2 50.0 18.3 27.0 35.4 33.9 27.1 43.0 28.7 25.2 27.1 24.3 12.2 49.0 33.9 7.3 55.9 34.4 33.8 14.0 42.3 46.5 30.9 25.1 34.8 28.8 18.6 73.0 33.0 37.0 24.8 39.6 32.3 26.5 26.3 52.7 33.9 19.5 22.8 31.2 57.0 13.5 28.7 94.6 32.3 17.5 FSTL1 "FRP, FSL1, OCC-1, OCC1, tsc36" ENSG00000163430 "Follistatin like 1" Q12841 3 120392293-120450993 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "basophil: 12.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 12.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035251, HPA040815" Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 34000000 "Vesicles, Cytosol" "HPA035251: AB_10601906, HPA040815: AB_2732489" "unprognostic (2.60e-1)" "unprognostic (1.59e-3)" "unprognostic (8.84e-2)" "unprognostic (4.54e-3)" "unprognostic (4.10e-2)" "unprognostic (1.35e-1)" "unprognostic (9.88e-2)" "unprognostic (3.05e-2)" "unprognostic (1.19e-2)" "unprognostic (3.88e-2)" "unprognostic (3.54e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (4.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.05e-2)" "unprognostic (4.47e-3)" 436.4 135.5 20.5 117.3 17.4 2.2 167.5 25.1 26.8 282.3 85.3 128.6 37.4 158.9 51.3 127.3 151.9 259.3 244.8 20.4 45.0 45.8 36.0 121.8 50.7 28.3 35.8 14.4 91.2 37.6 35.7 25.9 445.7 22.9 190.0 91.2 30.0 59.8 186.2 32.1 58.9 69.7 413.4 22.5 63.7 69.2 33.8 24.0 24.5 79.5 90.6 39.1 262.9 105.1 21.5 81.0 21.2 222.9 91.8 1304.4 1782.4 1.3 2156.3 1208.9 1374.5 1211.0 0.1 178.5 0.8 178.8 2692.9 112.8 20.5 68.6 270.0 1741.5 1.1 32.5 0.4 159.8 0.3 286.0 1.2 0.9 1362.7 8.5 884.5 192.7 612.1 811.6 11.2 0.5 0.3 227.6 0.5 22.6 2.0 181.3 0.4 181.9 0.7 92.7 1.0 150.4 1.7 39.2 93.5 764.6 13.6 76.5 462.6 23.5 6.2 986.8 507.4 479.8 268.0 323.8 1.0 1.1 2.3 177.4 0.9 67.0 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 2.6 20.5 17.4 25.1 26.8 20.4 45.0 28.3 35.8 14.4 22.9 22.5 24.0 21.5 76.9 64.1 9.4 56.5 1.1 64.1 31.9 36.4 10.2 2.3 25.6 24.6 127.5 8.6 42.5 23.9 0.0 114.4 2.5 0.9 0.0 62.6 2.3 44.4 176.7 111.4 3.0 3.6 9.6 5.8 352.1 521.9 3.1 23.0 1.3 66.5 142.5 17.4 20.6 1.7 16.2 0.2 8.2 10.8 91.6 9.8 327.4 11.5 110.3 30.0 9.9 116.1 0.0 9.5 0.9 117.8 0.7 270.8 0.9 108.4 0.0 5.5 74.9 4.3 59.2 62.5 129.3 1.5 4.4 2.2 48.2 54.7 7.1 47.5 0.9 65.3 LMOD1 "1D, 64kD, D1" ENSG00000163431 "Leiomodin 1" P29536 1 201896456-201946588 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3" "Cancer enhanced" "Detected in all" "prostate cancer: 43.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028325, HPA028435, HPA030097" Enhanced Approved Cytosol No No Cytosol "HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223" "unprognostic (3.84e-2)" "unprognostic (5.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (5.64e-1)" "unprognostic (6.35e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.73e-2)" "unprognostic (3.51e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.30e-2)" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (1.15e-2)" 115.7 52.9 7.6 28.8 7.8 0.0 76.1 5.4 9.2 153.1 10.1 364.2 25.3 312.1 50.1 137.1 196.4 86.3 26.2 5.8 7.9 11.6 5.1 44.7 7.4 12.9 6.9 4.9 72.8 8.5 18.4 5.8 35.6 6.6 166.6 47.3 48.4 21.4 244.8 138.8 33.5 116.5 208.4 4.8 18.6 220.5 18.0 6.9 2.6 40.1 46.1 1.6 371.8 112.9 6.4 0.0 0.1 0.4 1.2 15.8 2.0 1.3 21.3 34.4 1.3 1.5 0.1 0.2 0.0 0.7 17.4 0.2 0.3 0.5 0.0 0.4 0.0 1.4 0.0 0.1 0.0 1.5 0.1 0.1 14.5 0.0 1.0 0.0 54.4 0.1 0.0 0.2 0.2 0.7 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.4 0.1 0.3 0.0 0.5 0.4 9.5 0.7 0.0 0.0 0.1 0.8 0.3 0.0 0.7 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.8 5.4 9.2 5.8 7.9 12.9 6.9 4.9 6.6 4.8 6.9 6.4 16.1 0.0 1.1 8.5 0.3 1.3 1.0 0.3 0.0 4.8 1.6 40.8 25.1 0.0 0.0 0.0 135.5 1.7 0.0 0.1 0.0 0.0 2.1 2.6 64.5 5.8 0.0 0.0 0.5 0.6 0.3 20.4 0.5 1.2 0.0 0.7 9.3 0.4 1.0 3.3 1.0 0.0 0.0 0.0 2.3 8.2 125.6 0.9 3.6 3.7 0.0 7.3 0.0 4.0 1.0 0.0 0.0 275.3 0.0 0.9 0.0 0.1 0.9 70.2 197.2 5.2 224.3 1.2 0.5 0.8 2.3 1.2 1.3 2.1 0.0 0.4 ELF3 "EPR-1, ERT, ESE-1, ESX" ENSG00000163435 "E74 like ETS transcription factor 3" P78545 1 202007945-202017183 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Inflammatory response, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 238.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003316, HPA003479" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003316: AB_1078757, HPA003479: AB_1078756" "unprognostic (9.90e-3)" "unprognostic (1.72e-1)" "unprognostic (7.50e-2)" "unprognostic (1.12e-1)" "unprognostic (2.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (1.69e-1)" "unprognostic (5.05e-3)" "unprognostic (7.67e-3)" "unprognostic (7.07e-2)" "unprognostic (9.92e-3)" "unprognostic (4.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-1)" "unprognostic (3.37e-3)" 1.6 0.2 0.2 12.8 0.2 0.8 79.9 0.9 0.4 33.5 0.1 162.8 144.2 13.0 4.6 238.9 35.8 78.3 3.2 0.1 0.1 66.2 79.9 60.4 0.3 0.1 0.0 0.1 1.2 121.8 8.5 3.9 6.1 0.3 59.2 128.7 1.0 148.3 15.0 0.2 14.4 146.8 7.4 0.0 0.5 123.8 0.2 0.1 1.6 6.7 0.0 16.1 166.8 94.4 0.2 56.1 209.6 0.0 0.4 0.0 0.0 63.5 0.0 7.9 0.0 0.1 47.3 296.0 0.3 24.0 0.0 1.7 53.8 0.0 0.2 0.0 6.7 0.2 0.0 38.3 9.2 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 40.7 0.3 0.7 3.3 196.3 17.6 0.1 0.1 3.0 78.3 215.3 0.3 0.4 2.4 405.7 0.2 9.2 28.8 0.0 0.1 0.0 0.7 0.4 0.5 1.2 3.9 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.2 2.7 294.9 422.9 0.0 12.2 5.1 691.3 879.7 113.8 1.5 470.3 180.3 1.5 586.2 1130.0 329.2 18.8 76.6 9.5 1599.6 41.1 792.7 0.0 812.3 90.8 16.4 452.2 2.7 0.4 641.0 122.2 15.9 1390.9 1127.5 40.6 0.2 0.4 38.6 9.3 0.0 0.2 1225.3 1102.7 2.5 2.7 0.0 0.0 18.6 8.8 0.0 15.4 2.6 1.0 0.5 0.1 512.5 1506.1 0.0 6.0 1014.2 1476.3 147.1 888.2 67.3 0.0 0.8 46.3 0.0 0.3 418.5 8.4 257.2 18.7 0.3 983.0 1628.9 PDCL2 GCPHLP ENSG00000163440 "Phosducin like 2" Q8N4E4 4 55556519-55592245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 197 "testis: 65.6" "Group enriched" "Detected in some" 19 "Early spermatids: 1285.9;Late spermatids: 634.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.0;testis cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;HaCaT: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048260, HPA072384" Enhanced Approved Microtubules,Centrosome NA NA Microtubules Centrosome "HPA048260: AB_2680333, HPA072384: " "unprognostic (5.93e-3)" "unprognostic (1.19e-7)" "unprognostic (1.04e-1)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1285.9 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 634.7 7.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 13.1 0.0 0.1 40.4 50.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007374-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: AB_2686539" "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 20.9 19.3 26.3 17.1 29.7 77.2 22.3 29.2 35.4 21.6 24.5 29.6 26.8 20.0 19.0 30.5 19.6 14.2 16.4 29.7 30.2 22.9 24.1 21.2 21.9 27.2 26.7 28.4 20.3 29.0 17.9 12.3 14.5 30.3 21.4 30.5 22.0 25.6 16.6 14.9 26.6 26.3 20.1 25.4 22.3 25.5 34.4 29.3 30.3 22.4 12.8 24.3 23.6 23.1 34.2 32.7 31.2 39.2 64.6 50.6 37.7 64.4 32.2 31.7 36.4 31.7 38.1 33.6 81.1 22.6 41.7 14.6 40.4 53.1 45.1 30.1 26.6 64.5 40.2 33.8 42.3 36.6 72.6 33.9 37.3 49.3 30.1 60.2 36.8 46.6 64.4 83.8 28.7 34.5 73.3 59.7 74.4 107.7 44.0 49.2 45.4 66.7 65.7 57.0 31.6 50.2 62.7 48.0 79.0 48.1 61.9 56.6 56.6 34.8 24.4 34.2 42.3 35.7 28.8 49.7 62.4 27.0 55.7 26.3 33.3 33.6 51.2 23.5 29.2 23.1 23.8 26.3 26.6 37.4 26.2 29.8 24.7 28.7 36.6 27.8 26.8 30.6 37.4 26.3 29.7 29.2 35.4 29.7 30.2 27.2 26.7 28.4 30.3 25.4 29.3 34.2 39.7 16.0 20.5 3.6 40.4 73.4 61.5 62.2 41.5 22.8 62.2 48.6 14.9 54.3 52.1 35.0 10.4 53.2 57.3 70.4 70.5 88.6 161.1 31.1 34.9 36.2 52.7 103.7 13.2 76.1 86.0 34.8 42.3 34.4 17.7 34.6 40.7 53.6 60.4 18.5 11.8 87.5 63.1 63.1 52.0 113.7 27.1 49.7 39.2 6.5 71.1 26.6 50.4 3.5 7.2 52.7 57.6 29.3 62.1 100.2 102.3 100.4 44.5 28.0 19.7 38.3 46.7 95.0 80.9 72.9 82.1 51.6 48.3 39.6 88.6 105.2 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;retina: 3.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.4;Cone photoreceptor cells: 22.9;Excitatory neurons: 13.1;Inhibitory neurons: 13.9;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 9.3;Rod photoreceptor cells: 11.6" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 7.3;RPTEC TERT1: 12.3;SCLC-21H: 9.9;SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 0.5 1.0 1.6 1.0 2.6 0.3 0.2 1.7 2.7 0.7 0.0 0.4 0.7 0.3 0.7 0.2 1.0 0.8 0.4 2.5 1.9 1.9 1.7 0.6 1.0 2.7 2.3 2.1 0.3 0.3 0.1 0.8 0.1 3.0 0.4 0.3 3.5 0.2 0.3 0.3 0.5 0.6 0.4 1.2 1.0 0.2 0.3 2.2 1.0 2.6 0.3 0.8 0.2 0.1 3.3 0.0 0.3 7.3 0.1 1.0 0.0 0.0 0.3 0.2 0.2 0.8 0.3 2.4 0.0 5.8 0.3 0.4 0.1 0.9 0.0 0.2 1.4 0.3 2.9 0.1 1.4 1.9 0.1 0.5 0.6 0.6 0.5 0.7 1.8 0.0 0.9 0.0 0.3 6.3 0.8 0.2 0.1 4.1 0.0 0.0 1.4 2.0 0.0 12.3 0.0 9.9 14.5 0.3 0.1 5.7 4.0 0.5 1.0 0.0 0.2 0.4 0.0 0.4 1.7 2.2 0.4 1.9 0.2 1.4 0.8 1.0 0.1 1.2 1.0 0.9 1.5 2.0 1.4 0.0 1.4 2.1 0.9 2.3 0.3 3.2 0.1 3.7 0.7 1.6 2.6 1.7 2.7 2.5 1.9 2.7 2.3 2.1 3.0 1.2 2.2 3.3 0.3 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 14.4 0.1 0.5 0.8 4.3 0.0 5.5 22.9 0.1 0.3 0.0 0.0 0.6 0.0 0.4 0.4 0.2 4.9 0.0 13.1 0.0 0.0 0.2 0.5 0.5 0.0 0.0 1.4 0.8 0.4 0.0 13.9 0.0 0.0 0.3 0.0 0.1 0.0 0.5 0.0 3.7 0.2 2.2 3.1 11.1 9.3 0.1 0.6 0.4 0.3 0.1 0.3 2.8 0.1 11.6 0.0 3.6 0.4 0.0 0.7 0.0 0.0 0.0 0.8 0.1 0.2 0.1 IGFBP7 "FSTL2, IGFBP-7, MAC25, PSF" ENSG00000163453 "Insulin like growth factor binding protein 7" Q16270 4 57030773-57110385 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 21.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002196, CAB020668" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 30300000 190000000 "Golgi apparatus" "CAB020668: , HPA002196: AB_1079107" "unprognostic (2.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.82e-2)" "unprognostic (5.97e-3)" "unprognostic (3.86e-1)" "unprognostic (3.18e-1)" "unprognostic (2.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.62e-1)" "unprognostic (1.01e-2)" "unprognostic (2.57e-1)" "unprognostic (6.65e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-3)" "unprognostic (1.78e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" 818.8 378.0 103.4 152.5 111.2 44.6 588.2 110.7 150.9 595.4 1147.0 401.1 106.6 658.7 262.7 116.2 623.4 409.4 923.2 123.0 245.0 1294.2 285.5 537.0 134.2 178.6 124.9 73.5 362.1 272.4 77.9 247.9 67.1 133.4 510.3 84.1 4.8 195.3 665.2 187.1 179.3 261.8 337.9 127.5 440.4 269.6 261.2 156.0 49.3 1003.5 92.6 82.6 551.1 498.2 165.9 1.3 4.8 1.1 0.0 134.8 50.4 4.7 693.6 643.1 59.2 19.0 2.8 0.1 0.3 433.7 33.5 35.3 70.2 0.7 111.1 15.7 1.3 5.4 2.5 78.7 0.5 207.7 17.1 17.9 234.7 55.8 96.8 26.2 1471.3 138.2 0.6 0.5 0.9 142.8 0.0 0.5 74.5 5.9 0.0 1.3 13.4 0.4 2.8 682.7 0.0 1.0 1.8 130.2 9.5 0.0 276.3 1.8 64.6 1009.4 60.5 46.4 7.8 114.8 41.1 0.4 1.4 159.2 58.3 1.8 2.0 3.9 21.7 0.1 4.1 0.1 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.3 10.8 4.5 0.4 0.1 1.7 103.4 111.2 110.7 150.9 123.0 245.0 178.6 124.9 73.5 133.4 127.5 156.0 165.9 2254.8 112.2 20.2 164.9 16.2 238.5 127.2 300.5 24.5 5.9 27.7 53.5 148.2 20.0 90.6 2087.4 22.9 6.6 76.9 1.4 516.5 2455.3 75.9 1235.5 702.2 2740.1 1.2 82.7 0.7 15.1 8.3 1435.9 29.0 381.3 15.8 1205.0 3079.4 16.4 26.5 0.0 3.7 1.0 61.1 101.9 375.7 335.4 11440.4 70.4 944.5 151.8 41.8 17.1 345.0 11.6 0.8 84.6 1.5 11731.6 11.0 113.3 0.0 692.2 731.0 12.5 8184.6 155.0 4434.0 36.6 38.6 9.9 179.1 5.7 51.3 759.1 2.5 64.0 TRIM46 "FLJ23229, TRIFIC" ENSG00000163462 "Tripartite motif containing 46" Q7Z4K8 1 155173787-155184971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.9;Early spermatids: 6.5;Excitatory neurons: 13.1;Inhibitory neurons: 9.7;Late spermatids: 7.5;Oligodendrocytes: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055583 Enhanced NA NA "HPA055583: AB_2732599" "unprognostic (1.06e-1)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "prognostic unfavorable (2.61e-7)" "unprognostic (1.75e-1)" "unprognostic (7.26e-2)" "unprognostic (1.59e-2)" "unprognostic (4.65e-2)" "unprognostic (4.09e-1)" "unprognostic (2.88e-2)" "unprognostic (2.18e-3)" "unprognostic (1.24e-1)" "unprognostic (2.29e-12)" "unprognostic (8.58e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.72e-2)" 0.5 0.4 7.0 0.5 8.7 0.4 0.5 7.9 10.2 1.0 3.5 0.7 0.3 3.1 3.3 0.4 2.3 0.4 0.2 8.8 6.9 0.5 0.1 0.5 0.5 6.5 6.1 9.2 0.3 0.5 0.1 5.0 0.1 7.2 1.1 0.2 1.1 0.4 0.8 0.1 0.3 0.7 0.9 5.4 1.0 1.0 1.9 7.0 1.1 0.3 0.0 0.2 0.5 0.9 8.5 1.7 2.2 1.5 0.1 0.3 1.3 0.1 1.6 1.7 1.9 2.2 0.0 0.8 0.7 1.1 2.0 0.4 1.8 0.0 0.7 0.6 3.9 0.7 1.3 2.6 0.1 0.8 0.4 4.1 1.4 0.4 2.0 0.7 4.5 2.5 4.1 0.0 3.2 1.0 1.1 2.4 0.2 5.7 0.2 2.3 4.1 0.1 0.8 0.3 0.0 3.9 9.3 0.7 0.5 1.2 0.6 2.8 3.4 3.7 3.8 1.2 0.2 0.8 3.2 1.2 0.7 4.0 0.6 1.1 0.4 0.0 0.0 0.2 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.7 0.1 7.0 8.7 7.9 10.2 8.8 6.9 6.5 6.1 9.2 7.2 5.4 7.0 8.5 0.2 0.0 0.0 1.0 0.3 0.4 0.8 0.2 0.0 6.9 2.9 1.8 1.1 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.7 6.5 2.9 0.4 0.7 1.8 0.8 13.1 0.2 0.0 0.8 1.5 3.9 0.0 0.1 0.4 0.0 0.8 0.0 9.7 0.0 0.0 0.0 1.0 7.5 0.3 0.2 0.0 0.0 2.6 0.6 2.1 3.0 9.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.6 0.0 1.4 0.9 1.3 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.8 KRTCAP2 KCP2 ENSG00000163463 "Keratinocyte associated protein 2" Q8N6L1 1 155169408-155173475 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.57e-2)" "unprognostic (5.93e-2)" "unprognostic (2.63e-2)" "unprognostic (2.67e-1)" "unprognostic (1.53e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-3)" "unprognostic (3.64e-1)" "unprognostic (3.38e-1)" "unprognostic (2.13e-2)" "unprognostic (7.81e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (9.70e-11)" "unprognostic (3.17e-1)" "unprognostic (8.95e-2)" "unprognostic (6.30e-2)" "unprognostic (4.94e-3)" 182.6 180.5 150.2 83.7 156.7 114.0 188.0 161.6 198.6 200.9 159.2 173.7 106.1 204.8 312.0 137.4 167.3 105.5 183.5 149.0 165.6 158.0 228.0 144.6 104.9 164.2 154.4 144.1 178.4 455.0 156.6 184.1 94.1 166.6 141.0 122.4 50.8 209.2 156.6 172.5 129.7 148.2 140.3 158.8 157.2 211.6 205.4 156.7 100.5 181.8 113.4 127.1 162.1 159.7 167.6 171.1 302.5 141.8 157.5 406.7 291.1 152.1 197.0 225.2 226.2 188.5 369.9 321.6 129.2 303.3 357.0 130.3 230.5 160.2 221.2 142.5 180.6 327.0 143.5 333.2 207.5 377.1 276.8 154.3 277.6 498.5 264.6 340.2 175.3 202.0 246.4 207.8 581.7 234.0 572.8 152.0 273.6 152.4 564.9 399.1 176.1 90.2 692.0 335.5 254.6 232.8 147.7 193.5 340.8 222.6 208.4 248.9 445.8 138.6 145.6 138.6 124.1 193.4 332.5 302.4 222.4 239.1 266.5 163.0 657.8 346.6 372.1 445.7 304.5 504.5 497.9 498.4 474.3 371.6 441.5 374.6 405.8 152.9 330.1 260.7 840.7 513.4 491.8 150.2 156.7 161.6 198.6 149.0 165.6 164.2 154.4 144.1 166.6 158.8 156.7 167.6 170.9 70.5 119.1 10.1 161.8 63.2 53.4 187.5 152.0 13.9 158.3 151.1 1.3 148.7 132.1 207.8 4.2 79.2 146.7 150.7 45.0 219.3 257.4 113.6 153.2 143.6 131.7 119.2 5.1 298.2 211.4 153.4 189.1 159.7 84.9 52.4 201.7 235.3 160.9 8.4 6.2 246.7 105.8 156.3 173.9 95.0 228.3 122.9 252.5 12.2 110.7 41.5 138.0 6.0 12.6 244.5 206.1 164.4 517.4 49.9 267.4 179.0 146.8 15.2 118.3 76.2 156.1 349.7 78.0 194.1 90.5 94.1 162.9 43.1 183.3 59.3 CXCR1 "CD181, CDw128a, CKR-1, CMKAR1, IL8RA" ENSG00000163464 "C-X-C motif chemokine receptor 1" P25024 2 218162841-218166962 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 5.1;dendritic cells: 5.2;granulocytes: 2.5;NK-cells: 11.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 14 "neutrophil: 1472.7" "Lineage enriched" "Detected in many" 62 "granulocytes: 1472.7" "Cell line enriched" "Detected in single" 26 "HMC-1: 5.8" "Not detected" "Not detected" HPA031991 Uncertain NA NA "HPA031991: AB_2674103" "unprognostic (2.80e-1)" "unprognostic (2.91e-2)" "unprognostic (3.53e-2)" "unprognostic (5.74e-2)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.14e-2)" "unprognostic (3.36e-2)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (8.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-1)" "unprognostic (8.85e-2)" 13.3 0.5 0.3 25.3 0.4 9.6 0.4 0.4 1.5 0.7 1.3 0.4 0.2 0.2 0.0 1.6 2.9 4.2 1.5 0.2 0.3 0.5 2.0 9.8 0.3 0.4 0.5 0.2 0.1 1.5 0.3 0.2 2.6 1.2 0.3 0.2 0.0 0.5 0.1 0.4 0.3 0.6 1.8 0.3 40.8 0.9 0.2 0.4 1.8 0.4 12.1 0.6 5.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 2.3 2.9 23.7 0.8 0.3 0.2 2.1 6.1 0.7 0.1 0.4 8.7 1472.7 1.5 3.2 0.9 0.3 8.3 0.3 0.4 0.4 1.5 0.2 0.3 0.4 0.5 0.2 1.2 0.3 0.4 0.4 0.0 0.0 5.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 ARPC2 "ARC34, p34-Arc" ENSG00000163466 "Actin related protein 2/3 complex subunit 2" O15144 2 218217141-218254356 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001994, HPA008352, HPA052703" Approved Supported Nucleoplasm NA NA 6600000 Nucleoplasm "CAB001994: , HPA008352: AB_1854887, HPA052703: " "unprognostic (7.42e-2)" "unprognostic (4.07e-1)" "unprognostic (1.50e-1)" "unprognostic (3.28e-3)" "unprognostic (2.77e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (3.95e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (1.07e-7)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (7.41e-2)" 206.5 122.8 114.4 364.7 124.0 548.9 164.9 110.6 130.1 150.2 124.6 255.2 202.1 154.6 163.2 464.2 147.6 213.1 168.9 132.2 126.8 150.0 154.0 262.0 509.3 116.5 114.5 114.5 122.4 123.1 116.4 95.4 297.4 116.7 133.2 277.4 78.1 165.0 177.7 389.0 295.8 228.4 293.8 125.7 297.2 253.8 151.0 117.9 301.0 116.4 253.0 631.1 405.8 233.6 122.6 438.3 188.3 264.1 198.0 346.6 463.6 489.4 680.5 640.7 551.2 549.5 588.6 452.0 358.6 347.6 764.7 396.8 492.3 362.6 985.4 645.4 284.2 296.5 362.1 279.0 325.8 386.8 764.2 968.9 310.2 784.1 552.0 454.6 515.1 731.3 294.1 179.5 681.4 858.6 304.3 416.8 888.6 310.8 500.8 201.1 307.2 235.0 488.7 556.8 787.8 156.3 278.8 246.7 265.8 590.0 544.4 192.7 689.2 642.1 709.5 268.1 321.9 507.8 359.8 418.8 624.7 515.1 472.9 548.2 1728.0 1318.5 1975.5 930.7 1773.7 626.1 785.9 720.7 913.6 1330.1 658.5 505.7 750.0 2200.3 698.9 2060.4 734.3 1039.0 2503.2 114.4 124.0 110.6 130.1 132.2 126.8 116.5 114.5 114.5 116.7 125.7 117.9 122.6 334.8 285.2 326.6 21.2 506.7 928.5 691.0 1140.2 425.2 89.8 150.3 189.7 145.3 200.1 465.4 172.9 56.3 944.5 902.3 595.0 342.4 585.8 604.0 220.6 288.5 363.5 319.7 144.9 48.5 658.7 1509.4 301.7 242.6 222.4 414.5 600.6 281.3 98.4 1094.0 58.9 33.1 329.4 364.2 779.9 1321.0 759.3 214.0 896.1 414.4 53.4 1721.9 175.3 1336.7 30.7 33.7 919.8 604.5 326.5 529.9 762.7 510.9 342.8 249.6 95.3 302.4 131.6 571.2 324.4 227.9 645.2 970.6 1045.8 694.1 285.6 337.6 1126.5 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 283 "testis: 932.1" "Group enriched" "Detected in many" 6 "Early spermatids: 6594.1;Late spermatids: 20555.9" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "basophil: 15.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA029897 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.4 1.5 1.6 0.9 1.5 0.6 1.0 2.0 2.1 0.4 1.5 0.4 0.8 0.3 2.4 0.6 0.4 0.6 0.4 2.2 1.3 1.0 1.8 0.2 1.0 1.6 1.6 1.0 0.3 0.6 0.7 0.5 0.5 2.2 1.3 0.4 2.3 0.5 0.9 0.9 0.4 0.8 0.1 1.2 0.4 0.5 932.1 1.8 0.2 1.0 0.4 0.5 0.3 0.3 3.2 2.7 3.7 1.6 1.8 1.1 2.1 2.9 1.3 0.7 1.7 1.9 3.4 1.9 4.0 2.1 0.8 1.9 3.1 3.1 0.3 1.6 2.3 6.7 2.8 6.3 3.7 0.8 2.5 2.3 0.8 5.1 1.7 2.3 1.0 0.5 3.8 7.6 2.5 0.3 4.8 2.5 1.5 5.0 6.7 4.4 2.8 0.6 4.0 4.6 1.7 2.4 1.3 1.8 5.0 2.2 6.9 2.7 2.7 1.3 1.1 1.8 0.9 1.9 4.5 7.8 6.1 0.7 1.4 1.0 15.2 0.4 0.1 1.1 0.3 0.5 1.2 0.8 1.0 0.2 1.4 1.5 1.3 0.1 1.9 0.4 1.7 1.0 0.3 1.6 1.5 2.0 2.1 2.2 1.3 1.6 1.6 1.0 2.2 1.2 1.8 3.2 0.1 0.0 0.0 0.7 1.2 0.3 0.3 1.4 0.6 0.6 1.3 1.9 0.6 0.0 1.8 3.7 0.0 4.8 0.1 0.2 1.9 0.9 6594.1 2.4 0.4 4.7 0.0 0.4 0.5 0.6 1.7 0.2 1.1 0.9 0.0 0.4 0.0 3.7 1.1 0.0 0.4 0.7 0.0 0.8 0.0 20555.9 111.6 7.6 0.0 0.0 0.0 0.4 0.0 0.5 0.9 1.0 0.1 85.7 1.2 0.3 0.6 7.9 4.5 0.8 52.6 0.1 0.3 2124.8 93.8 1.5 0.4 2.7 0.7 0.5 0.5 0.6 CCT3 "Cctg, TRIC5" ENSG00000163468 "Chaperonin containing TCP1 subunit 3" P49368 1 156308968-156367873 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006543 Approved Approved "Plasma membrane,Cytosol" NA NA 1300000 "Plasma membrane, Cytosol" "HPA006543: AB_1078426" "unprognostic (2.14e-2)" "unprognostic (3.20e-3)" "unprognostic (1.66e-1)" "unprognostic (6.00e-3)" "unprognostic (8.39e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (3.87e-7)" "unprognostic (4.43e-3)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (5.44e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (7.16e-2)" "unprognostic (5.76e-2)" "unprognostic (5.67e-2)" "unprognostic (1.10e-1)" 86.1 123.4 127.0 103.9 127.0 80.1 120.6 134.1 156.1 77.8 140.4 96.2 87.9 94.4 77.8 107.8 120.9 68.0 101.8 134.5 134.9 115.5 109.2 60.7 124.9 133.6 132.5 122.7 114.5 83.0 121.4 65.9 94.0 131.2 87.3 114.0 136.9 75.6 90.7 135.9 94.6 84.0 138.5 137.3 67.7 81.3 121.4 134.1 130.3 88.4 121.9 149.7 138.0 71.2 145.9 432.3 562.3 324.3 311.9 352.5 261.2 419.7 388.8 315.9 617.9 378.0 611.1 396.3 689.5 442.3 337.9 392.5 395.5 1045.2 519.9 519.1 384.3 660.6 437.6 438.6 579.2 261.9 547.7 357.2 333.7 312.4 556.6 514.7 303.3 531.6 425.3 795.2 250.1 375.5 603.5 688.2 372.1 656.4 859.5 702.1 587.3 314.5 771.1 496.9 349.9 434.9 448.1 347.0 635.0 388.7 531.0 560.2 707.3 366.1 249.0 373.0 263.3 717.1 457.5 808.2 975.7 288.1 349.1 408.1 75.1 107.1 49.0 129.0 137.0 171.2 142.1 144.3 138.8 171.7 156.8 177.0 156.7 14.9 145.8 146.8 120.8 164.3 222.3 127.0 127.0 134.1 156.1 134.5 134.9 133.6 132.5 122.7 131.2 137.3 134.1 145.9 82.8 54.5 62.5 18.3 104.8 144.9 241.1 247.4 119.5 124.5 133.2 118.5 121.1 98.7 132.3 90.1 106.3 226.7 100.5 71.7 113.5 208.6 111.9 118.4 137.4 122.4 125.3 134.0 29.7 183.2 217.8 113.9 70.8 86.6 73.0 180.1 74.6 88.4 162.6 74.0 34.6 93.8 193.3 83.0 96.5 226.7 83.6 78.1 112.1 22.5 153.6 158.1 105.0 37.2 41.9 199.1 78.8 88.0 95.8 169.0 115.9 212.3 137.6 244.3 118.3 110.3 145.4 410.0 232.4 123.1 159.8 184.6 112.1 347.9 149.8 157.9 TMEM79 "FLJ16057, FLJ32254, MATT, MGC13102" ENSG00000163472 "Transmembrane protein 79" Q9BSE2 1 156282935-156293185 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 133.5;skin 1: 89.6;vagina: 59.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 24.1;Squamous epithelial cells: 59.9;Suprabasal keratinocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 30.2;SK-BR-3: 26.7;T-47d: 28.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA055214 Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA055214: AB_2682741" "unprognostic (3.12e-1)" "unprognostic (2.96e-1)" "unprognostic (1.26e-1)" "unprognostic (8.17e-2)" "unprognostic (5.51e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (6.37e-2)" "unprognostic (2.44e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-3)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.72e-1)" "unprognostic (1.96e-1)" "unprognostic (3.98e-2)" "unprognostic (2.37e-1)" 2.0 2.9 6.6 1.5 6.1 2.9 4.5 5.9 6.5 17.9 4.9 2.3 2.6 2.5 2.6 133.5 2.5 1.8 1.8 6.0 5.4 2.1 3.6 2.0 2.9 6.5 5.9 4.6 2.4 2.1 6.1 3.7 1.6 6.9 28.6 1.3 1.7 23.7 2.7 3.0 89.6 2.7 1.2 6.0 3.8 3.0 2.0 6.4 3.6 2.2 0.7 11.0 7.0 59.9 7.7 12.5 7.2 2.4 4.7 1.8 1.8 5.9 3.5 1.4 6.2 2.4 8.5 3.4 2.2 7.6 0.9 2.2 10.8 2.8 5.1 2.7 8.3 3.9 2.3 3.3 2.5 3.3 2.6 3.3 1.7 30.2 4.6 4.7 4.4 1.4 8.2 10.5 14.8 2.9 14.1 7.3 4.0 3.6 9.0 5.7 8.5 2.3 5.0 1.3 3.0 4.3 4.7 4.3 26.7 7.0 2.9 28.3 7.4 3.4 11.5 3.8 4.2 9.5 11.3 13.0 5.2 8.0 6.0 8.8 0.0 2.0 3.0 1.7 0.7 1.8 1.7 1.5 1.8 1.6 2.2 2.0 2.4 3.7 1.7 1.3 2.0 2.1 1.7 6.6 6.1 5.9 6.5 6.0 5.4 6.5 5.9 4.6 6.9 6.0 6.4 7.7 1.8 3.2 1.5 8.8 3.9 13.3 1.4 24.1 9.1 3.0 10.0 6.5 1.2 2.8 14.3 1.8 2.1 7.7 3.6 2.4 1.9 2.5 0.1 3.7 2.4 2.0 3.0 0.8 1.8 3.3 1.8 2.1 1.5 6.7 0.0 3.1 2.2 2.4 3.4 8.4 2.2 2.9 10.2 2.5 1.8 0.3 1.5 1.4 5.4 3.7 4.4 1.5 1.0 2.5 5.8 4.5 2.1 0.7 1.6 10.7 4.3 1.6 4.2 2.2 0.0 1.0 1.9 1.3 2.1 59.9 33.1 7.4 3.2 2.9 3.1 6.4 SSR2 "TLAP, TRAPB" ENSG00000163479 "Signal sequence receptor subunit 2" P43308 1 156009048-156020951 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 62000 "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (9.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.05e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (7.35e-2)" "unprognostic (4.55e-2)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.28e-1)" "unprognostic (4.64e-1)" "unprognostic (4.55e-2)" "unprognostic (1.30e-1)" 177.4 293.0 103.2 158.4 106.0 247.9 279.5 103.9 120.2 283.8 111.8 189.4 142.1 203.3 461.4 135.6 185.9 181.6 129.4 100.9 106.1 166.7 235.1 194.1 222.0 103.3 103.3 98.7 328.6 517.4 169.4 137.6 195.7 103.0 159.6 248.7 56.2 296.0 156.9 93.1 162.5 160.1 210.0 105.5 208.2 219.1 108.9 104.7 232.2 154.1 106.4 279.7 224.2 155.2 106.1 249.4 197.1 330.9 576.6 531.9 593.1 239.0 384.6 664.6 514.5 526.3 231.8 418.9 219.7 348.8 733.2 195.9 274.0 230.8 302.2 494.9 206.0 234.7 150.0 207.0 296.4 409.3 394.5 275.2 474.1 372.4 369.6 514.0 468.2 670.1 245.6 145.8 611.3 525.8 368.9 200.7 303.7 462.0 590.8 298.0 170.2 204.7 751.5 344.0 189.5 256.3 640.6 275.8 630.1 432.5 373.1 391.0 732.4 324.4 219.8 216.5 210.2 377.2 753.1 390.4 267.4 304.9 317.5 374.0 674.9 403.3 326.5 408.0 301.4 471.0 385.6 436.2 422.1 344.8 327.5 442.1 390.1 336.4 412.8 282.5 404.0 393.8 1070.9 103.2 106.0 103.9 120.2 100.9 106.1 103.3 103.3 98.7 103.0 105.5 104.7 106.1 187.3 169.9 151.3 10.1 324.0 241.9 222.9 453.4 140.0 43.2 296.0 368.4 41.1 235.9 243.5 119.5 33.3 435.5 340.7 178.6 140.8 497.9 56.4 95.7 298.6 189.1 229.4 117.1 10.8 571.6 761.6 272.3 154.9 186.5 187.1 292.1 192.4 132.2 349.8 18.5 13.6 392.7 233.9 258.1 348.4 79.6 284.3 223.0 298.8 15.0 315.8 125.2 385.2 10.1 14.7 410.7 273.0 212.1 520.7 221.9 292.9 255.7 76.7 46.0 164.3 167.6 244.3 268.6 81.7 140.1 238.0 570.3 333.2 268.1 292.9 259.5 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663892-218672002 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Actin filaments" "HPA036420: AB_2675114, HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 11.0 11.6 17.9 8.9 18.1 7.3 11.1 17.9 21.1 12.3 16.5 10.4 6.2 12.8 16.0 11.8 12.5 10.9 14.0 18.0 18.8 9.3 11.2 10.5 14.6 17.9 18.0 17.5 14.6 11.6 15.3 11.5 11.5 18.1 11.9 8.3 7.1 11.1 14.1 15.1 14.7 8.0 13.8 18.0 10.4 9.5 14.4 18.4 15.3 14.3 17.3 12.0 14.1 9.8 18.5 18.8 20.4 22.1 24.6 27.6 17.5 20.4 27.3 43.5 58.0 53.6 32.4 13.2 11.6 17.6 42.3 35.2 19.5 22.1 33.9 31.0 16.4 27.3 22.7 21.3 34.6 33.6 19.3 20.6 33.9 30.9 55.5 44.7 21.4 31.0 40.9 27.4 24.3 41.1 45.3 20.6 20.4 32.9 16.2 23.4 23.2 15.5 15.9 36.3 21.8 19.5 23.8 18.1 17.2 28.4 21.9 20.6 25.6 26.6 40.2 20.5 19.2 31.1 23.7 13.7 23.5 33.4 19.1 25.7 58.6 21.5 32.6 26.0 21.3 24.8 25.7 25.7 27.2 17.1 30.4 29.0 23.2 17.1 30.5 25.2 15.0 25.9 24.8 17.9 18.1 17.9 21.1 18.0 18.8 17.9 18.0 17.5 18.1 18.0 18.4 18.5 4.2 0.0 0.5 5.2 7.8 6.2 4.8 16.3 6.8 7.7 3.4 3.7 4.0 10.0 8.9 1.8 8.4 12.3 4.5 7.4 15.6 12.3 16.8 6.3 8.1 7.6 1.2 2.1 6.2 12.9 9.7 7.5 9.7 4.8 7.0 5.9 8.9 7.1 13.2 5.0 5.8 5.5 8.2 5.0 4.0 5.3 7.2 5.5 8.8 2.8 8.9 7.9 9.2 3.5 4.9 12.7 9.6 12.8 8.5 3.8 7.2 14.8 8.2 5.0 26.3 5.6 9.2 19.3 12.8 5.9 6.8 10.0 8.0 8.5 6.1 3.6 STK36 "FU, KIAA1278" ENSG00000163482 "Serine/threonine kinase 36" Q9NRP7 2 218672069-218702716 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Respiratory ciliated cells: 38.2;Spermatocytes: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027409, HPA027453, HPA030058" Approved Supported Cytosol NA NA Cytosol "HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225" "unprognostic (8.11e-2)" "unprognostic (3.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (5.20e-4)" "unprognostic (1.55e-1)" "unprognostic (5.83e-3)" "unprognostic (9.04e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.52e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "unprognostic (1.77e-1)" "unprognostic (1.99e-3)" 5.4 9.9 3.3 5.5 1.4 2.5 6.7 0.8 2.6 12.9 12.1 7.9 4.5 11.5 13.5 5.1 14.5 10.6 3.3 2.1 0.3 7.4 4.6 7.3 4.5 0.8 1.1 1.0 13.6 10.8 9.5 14.9 4.3 0.9 9.7 6.6 11.7 7.4 8.3 3.7 5.1 6.5 8.1 0.6 5.1 8.9 32.3 0.8 3.2 11.9 2.3 4.1 8.3 7.7 0.4 3.7 8.2 17.6 15.0 18.7 14.5 10.9 9.8 7.8 12.2 11.4 10.7 6.0 4.8 13.3 10.3 8.2 7.2 12.2 10.3 10.7 2.8 10.2 4.7 27.1 15.0 9.1 6.7 7.6 15.7 7.5 12.0 8.4 32.3 9.3 6.2 11.1 6.0 10.3 8.5 4.0 8.5 10.7 4.6 5.2 7.3 7.6 5.1 14.9 18.2 14.2 12.3 7.6 12.2 5.0 18.2 12.4 5.3 8.9 16.8 6.1 6.5 6.8 7.5 6.3 2.5 10.4 3.1 7.1 0.0 0.4 0.7 0.3 0.2 0.1 0.4 0.2 0.2 0.3 0.1 0.2 0.3 0.0 0.5 0.3 0.3 0.2 0.4 3.3 1.4 0.8 2.6 2.1 0.3 0.8 1.1 1.0 0.9 0.6 0.8 0.4 2.1 9.6 6.3 18.3 1.6 1.1 0.9 3.6 2.8 7.4 7.4 5.5 4.0 5.7 3.7 3.7 37.5 1.8 2.9 2.9 0.0 3.7 16.9 17.5 9.0 3.3 2.4 0.8 22.0 2.5 1.5 4.5 10.7 6.3 1.3 12.2 3.3 5.9 2.7 1.7 18.0 4.4 6.1 2.5 1.2 6.0 5.9 2.0 0.0 2.8 2.5 4.9 1.0 8.5 6.2 2.2 5.0 4.9 0.6 1.6 2.5 4.4 38.2 9.1 6.6 3.1 4.0 28.0 8.9 3.7 1.0 0.8 1.5 11.0 4.9 0.9 ADORA1 RDC7 ENSG00000163485 "Adenosine A1 receptor" P30542 1 203090654-203167405 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.8;testis: 21.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 18.1;granulocytes: 22.3;Muller glia cells: 44.4;Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 31.5" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 40.3;MCF7: 24.4;RH-30: 65.4;RPTEC TERT1: 31.7;SK-BR-3: 35.2;U-138 MG: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044383 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044383: AB_2678921" "unprognostic (3.93e-3)" "unprognostic (8.16e-2)" "unprognostic (6.16e-2)" "unprognostic (2.38e-3)" "unprognostic (2.25e-2)" "unprognostic (2.34e-1)" "unprognostic (4.64e-2)" "unprognostic (4.17e-2)" "unprognostic (3.04e-1)" "unprognostic (4.80e-3)" "unprognostic (1.42e-1)" "unprognostic (2.98e-1)" "unprognostic (2.96e-3)" "unprognostic (1.54e-1)" "unprognostic (1.27e-1)" "unprognostic (4.13e-2)" "unprognostic (5.76e-4)" 3.4 0.2 30.8 1.7 32.0 0.0 4.6 25.8 36.9 0.8 0.0 0.7 1.0 1.2 0.6 1.1 1.2 0.9 11.1 28.6 19.4 9.1 0.4 1.7 0.6 32.6 35.8 20.0 0.3 13.3 8.1 2.0 6.9 38.8 1.1 0.6 4.9 6.4 0.4 1.8 4.2 1.2 0.4 19.7 6.4 1.0 21.6 49.8 0.4 2.2 2.5 0.5 1.6 0.7 39.9 0.3 3.0 0.6 0.2 0.2 1.6 0.2 2.0 3.0 0.7 0.4 40.3 0.7 0.0 8.9 7.3 4.8 0.1 0.7 0.0 0.2 0.0 1.1 0.0 0.4 0.0 0.6 0.0 0.1 0.9 0.0 0.9 0.0 6.4 0.0 6.4 0.0 0.1 6.2 24.4 0.1 0.0 10.2 0.0 0.0 0.0 65.4 2.3 31.7 0.0 0.8 0.7 4.4 35.2 0.5 3.6 2.0 1.0 0.0 20.9 10.6 0.0 11.7 0.0 0.2 0.0 10.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 32.0 25.8 36.9 28.6 19.4 32.6 35.8 20.0 38.8 19.7 49.8 39.9 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 1.1 9.4 6.9 3.1 7.2 0.0 3.7 0.0 0.1 0.1 0.1 0.0 11.7 0.1 0.0 0.4 0.3 0.0 0.0 18.1 3.3 1.3 1.1 0.0 0.1 22.3 0.8 0.0 0.0 0.9 0.0 2.9 0.0 0.0 1.0 1.0 0.5 0.0 0.6 1.8 1.9 0.2 44.4 0.0 35.2 31.5 0.5 0.0 0.7 0.0 0.0 0.0 3.0 0.0 1.6 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.9;tongue: 20.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.2 0.3 7.0 0.3 6.1 0.3 14.2 1.2 10.4 1.4 3.3 1.4 2.5 0.8 8.4 1.9 11.1 1.4 3.3 10.6 4.4 1.1 2.6 2.4 0.5 3.6 4.4 3.8 0.7 0.7 0.4 3.4 0.1 2.4 1.7 0.5 6.2 0.3 1.2 12.5 0.3 0.8 0.3 3.1 0.4 1.0 36.9 4.0 0.5 0.7 20.2 0.6 1.2 0.2 1.3 0.8 1.6 0.8 0.9 0.6 1.5 0.3 6.0 0.9 1.6 1.4 0.0 0.4 0.5 1.4 2.5 1.1 0.1 0.4 0.4 1.7 1.1 0.6 0.1 3.4 2.9 0.1 0.3 0.8 1.8 0.4 2.5 0.1 2.0 1.1 3.4 0.1 0.6 8.2 0.1 0.6 0.4 0.5 0.2 0.2 0.8 0.3 0.2 3.0 0.5 0.1 0.2 0.9 0.3 0.4 0.5 4.8 0.3 0.7 4.3 6.8 0.2 0.6 0.2 0.2 0.4 3.6 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 6.1 1.2 10.4 10.6 4.4 3.6 4.4 3.8 2.4 3.1 4.0 1.3 1.5 6.4 0.0 11.4 0.3 0.3 0.3 3.2 0.0 14.5 25.8 7.4 12.9 4.3 9.3 1.8 87.6 0.0 0.8 0.2 0.0 0.4 123.5 59.3 1.3 2.4 0.0 0.0 131.4 0.0 0.3 3.1 0.0 7.7 0.0 1.1 0.7 1.3 0.2 0.0 130.2 0.4 12.2 1.0 0.8 61.7 1.8 1.1 0.0 32.8 0.1 1.0 1.0 20.6 12.9 0.2 2.7 1.2 0.1 1.9 2.1 0.3 104.2 19.1 0.0 14.9 2.4 32.2 2.2 0.1 0.4 0.0 1.1 3.7 0.6 0.4 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" Q6ZP82 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 75.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 29.5;Bipolar cells: 28.1;Cardiomyocytes: 118.2;Cholangiocytes: 27.1;Early spermatids: 37.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 15.0" "Group enriched" "Detected in many" 9 "B-cells: 8.1;T-cells: 15.0" "Cell line enhanced" "Detected in some" "CACO-2: 4.6;Daudi: 3.0;HEL: 6.9;RH-30: 3.6;U-266/70: 4.3;U-698: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012718 Approved Nucleoplasm NA NA Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.5 0.4 0.8 0.5 0.5 1.3 0.7 0.9 0.7 0.6 1.4 0.2 0.1 0.6 0.2 0.4 0.4 1.7 75.3 0.2 0.6 0.1 0.3 2.0 1.5 1.2 1.2 0.1 1.0 5.9 0.1 0.0 1.2 1.5 0.3 0.2 1.1 0.1 0.2 17.3 0.5 0.2 0.2 1.7 0.7 0.2 1.5 0.8 1.5 0.3 3.5 1.2 0.3 0.1 1.9 0.1 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.1 4.6 0.3 3.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 2.6 0.1 6.9 0.2 0.0 0.0 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.1 0.2 2.4 0.4 0.5 0.1 3.6 1.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.7 0.2 0.3 0.0 0.2 0.1 0.2 0.0 4.3 0.1 6.1 0.2 0.3 0.4 0.4 0.0 0.2 0.3 0.0 0.2 7.3 2.2 1.5 0.0 8.1 6.5 5.1 0.3 1.2 0.0 0.0 15.0 0.4 0.8 0.5 0.9 0.7 0.2 0.6 1.2 1.2 0.1 1.5 1.7 0.8 1.9 4.5 6.4 29.5 5.5 11.0 0.1 0.0 0.0 0.6 28.1 0.2 0.3 118.2 27.1 0.6 0.0 0.0 0.0 2.8 0.1 0.0 4.6 37.3 0.2 1.1 6.7 0.0 0.4 3.6 1.3 0.2 2.9 0.0 1.1 6.3 0.0 0.4 0.3 0.0 6.7 3.1 0.1 0.0 1.0 1.0 16.8 1.2 3.9 1.8 8.4 0.1 5.5 1.0 0.5 0.8 0.2 0.0 1.9 2.6 0.0 0.2 0.1 1.5 0.6 6.6 2.8 5.4 0.1 1.1 0.0 0.1 0.0 10.3 1.1 0.2 0.2 FEV Pet-1 ENSG00000163497 "FEV transcription factor, ETS family member" Q99581 2 218981087-218985184 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 21.6" "Cell type enriched" "Detected in some" 32 "Enteroendocrine cells: 744.9" "Group enriched" "Detected in some" 10 "pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4" "Region enhanced" "Detected in many" "midbrain: 21.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HMC-1: 35.5;SH-SY5Y: 43.8" "Region enhanced" "Detected in single" "midbrain: 1.9" "Group enriched" "Detected in some" 5 "midbrain: 4.8;pons: 2.7" HPA067679 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA067679: AB_2685884" "unprognostic (4.58e-1)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "prognostic favorable (4.85e-4)" "unprognostic (2.87e-1)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" 0.1 2.3 0.3 0.0 1.4 0.0 0.0 0.1 0.8 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 6.2 21.6 0.0 0.0 1.3 0.0 2.6 0.0 10.4 2.2 1.8 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 3.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.1 0.8 0.5 0.2 6.2 21.6 0.0 10.4 0.1 5.6 5.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 744.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 6.0 0.0 0.0 3.4 1.2 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 CRYBA2 ENSG00000163499 "Crystallin beta A2" P53672 2 218990189-218993422 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 16.7;pituitary gland: 13.8" "Cell type enriched" "Detected in some" 34 "Enteroendocrine cells: 860.9" "Cancer enriched" "Detected in some" 15 "pancreatic cancer: 16.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "BEWO: 69.6" "Region enhanced" "Detected in some" "pons and medulla: 4.3" "Low region specificity" "Detected in some" HPA062293 Supported NA NA "HPA062293: AB_2732680" "unprognostic (5.29e-2)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (4.19e-1)" "unprognostic (6.19e-2)" "unprognostic (1.77e-1)" "unprognostic (2.72e-1)" "unprognostic (1.66e-2)" "unprognostic (3.75e-1)" "prognostic favorable (7.62e-4)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.19e-1)" 0.3 3.6 0.5 0.0 0.8 0.0 0.0 0.6 0.8 0.0 0.2 2.1 2.8 0.0 0.2 0.2 0.0 0.0 0.1 0.5 0.8 0.2 0.0 0.0 0.0 1.7 4.3 0.4 0.0 16.7 1.4 13.8 0.0 3.0 0.8 2.2 0.2 0.1 0.0 0.1 0.2 2.7 0.0 0.3 0.0 4.6 2.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 69.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 10.3 2.5 2.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.2 0.1 0.1 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.6 0.8 0.5 0.8 1.7 4.3 0.4 3.0 0.3 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.3 0.0 3.6 0.0 0.0 3.8 0.0 0.0 0.1 860.9 0.0 0.1 1.3 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 25.0 0.0 0.0 0.4 10.0 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 7.5 17.5 0.0 0.0 1.0 3.9 0.0 0.0 0.9 0.0 0.0 0.0 0.6 4.5 0.0 0.3 0.3 0.1 0.0 1.7 0.0 IHH "BDA1, HHG2" ENSG00000163501 "Indian hedgehog signaling molecule" Q14623 2 219054424-219060921 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 14.1;intestine: 17.9;stomach 1: 15.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 31.5;Enteroendocrine cells: 49.2;Granulosa cells: 122.4;Intestinal goblet cells: 34.7;Proximal enterocytes: 18.8;Undifferentiated cells: 23.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.8;endometrial cancer: 30.9" "Region enriched" "Detected in single" 6 "cerebral cortex: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 16.4;OE19: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 23000000 "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.63e-2)" "prognostic favorable (3.67e-6)" "unprognostic (4.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.28e-1)" "unprognostic (1.06e-1)" "unprognostic (5.86e-2)" "unprognostic (2.74e-1)" "unprognostic (6.31e-2)" "unprognostic (3.33e-3)" "unprognostic (1.81e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-1)" "unprognostic (1.51e-2)" "unprognostic (2.91e-2)" 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 1.7 4.9 0.0 17.9 12.3 14.1 0.0 0.3 0.9 0.7 0.0 0.0 0.0 2.4 3.5 1.3 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.5 0.1 0.2 2.4 12.5 0.0 0.0 0.7 0.0 0.0 13.0 0.7 0.2 0.0 15.1 0.1 0.1 0.0 1.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.8 0.0 1.8 0.0 0.0 0.4 31.5 0.0 0.1 0.0 6.0 0.5 0.1 49.2 0.0 0.0 3.3 0.0 0.1 12.2 8.9 0.0 122.4 0.0 0.6 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 14.0 0.0 0.0 1.8 18.8 3.2 0.9 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 23.6 0.3 CIP2A KIAA1524 ENSG00000163507 "Cellular inhibitor of PP2A" Q8TCG1 3 108549864-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.5;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 1.1 1.1 0.4 3.4 0.7 7.5 1.4 1.0 0.9 1.0 0.1 1.9 1.2 1.9 0.6 1.7 0.9 1.2 0.7 0.7 0.5 1.0 0.7 1.4 6.7 0.5 0.9 0.3 1.9 0.4 0.6 0.7 2.1 0.4 1.8 2.7 2.7 0.6 0.8 0.6 1.2 1.7 1.6 0.1 2.3 1.2 5.7 0.2 6.9 1.2 0.7 5.2 2.0 0.9 0.5 42.2 12.2 33.9 21.8 1.4 3.2 13.8 31.1 14.7 36.2 41.9 15.0 18.5 27.6 10.4 11.4 27.7 20.9 11.7 11.0 65.8 8.8 11.3 33.9 17.4 11.3 0.5 21.8 23.2 1.4 2.3 28.4 11.5 5.9 16.3 12.7 21.1 44.5 36.1 8.7 26.7 19.2 35.0 15.8 20.8 30.1 31.2 15.3 11.0 11.5 16.4 21.6 22.9 9.0 12.7 19.7 15.3 15.6 12.2 37.0 41.7 11.3 38.3 10.2 12.1 46.1 16.4 23.2 38.6 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.7 1.0 0.9 0.7 0.5 0.5 0.9 0.3 0.4 0.1 0.2 0.5 1.2 9.6 1.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 2.5 3.7 0.0 8.0 1.8 0.0 1.9 2.8 0.0 2.5 2.8 2.6 0.0 0.0 0.0 7.3 12.9 3.0 0.0 2.7 3.8 25.3 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.0 2.4 1.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.4 1.7 5.4 0.0 0.0 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.0;lymphoid tissue: 15.1" "Cell type enhanced" "Detected in some" "dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 5 "cerebellum: 8.0" "Group enriched" "Detected in many" 7 "gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0" "Group enriched" "Detected in many" 107 "NK-cells: 33.0;T-cells: 26.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9" "Region enriched" "Detected in many" 8 "olfactory bulb: 77.5" "Group enriched" "Detected in some" 27 "cerebellum: 30.2;olfactory bulb: 12.7" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 0.7 0.6 0.2 3.2 0.2 1.8 0.6 8.0 0.4 0.4 0.5 0.7 0.4 0.8 0.8 0.3 0.4 1.6 0.3 0.2 0.4 0.4 2.4 2.2 15.1 0.2 0.7 0.2 0.5 0.3 0.1 0.2 0.4 1.5 0.5 0.8 1.6 0.9 0.1 0.1 0.3 1.4 0.4 0.3 12.9 1.3 0.4 0.3 1.5 0.5 0.1 5.5 1.3 0.4 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.6 1.3 0.0 7.4 1.1 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.8 0.0 0.9 0.3 0.0 8.3 0.2 0.0 0.0 2.0 2.0 0.0 0.2 0.2 0.9 1.3 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 16.5 0.0 26.2 0.0 3.0 19.5 0.0 0.0 0.2 11.9 0.2 33.0 0.1 0.1 0.0 2.9 0.2 0.2 8.0 0.4 0.2 0.4 0.2 0.7 0.2 1.5 0.3 0.3 0.4 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.8 1.5 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 16.8 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 2.2 1.6 0.2 0.0 0.0 0.0 0.0 3.1 0.7 0.0 0.3 1.3 1.8 1.0 1.1 0.1 93.7 0.0 0.0 0.0 0.0 0.4 9.8 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 2.0 0.0 0.1 0.0 31.5 0.0 0.0 0.0 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007297 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 12.8 10.3 7.5 13.3 7.9 16.1 15.1 13.8 10.2 14.2 7.8 11.6 10.2 17.0 10.5 12.6 12.1 12.2 10.2 7.7 8.0 13.5 16.9 11.6 18.7 6.9 7.8 6.7 19.4 9.3 13.6 8.2 14.6 8.2 12.6 11.9 12.5 10.3 11.1 13.8 11.1 10.5 14.0 7.3 14.9 11.1 9.1 7.2 22.0 16.2 14.7 18.3 14.2 12.2 9.2 19.1 11.2 31.6 21.1 22.7 26.7 24.1 24.5 28.7 29.4 28.7 25.9 23.1 36.7 21.6 17.9 25.6 20.5 30.4 23.1 44.2 33.0 26.2 49.1 15.1 35.4 22.0 69.6 26.2 17.5 27.1 37.4 49.8 19.3 22.3 25.2 54.6 21.9 19.7 18.9 36.5 34.7 48.8 22.5 18.3 32.8 38.9 27.7 20.2 23.5 21.6 28.8 20.3 15.9 28.5 33.8 11.8 42.2 19.0 25.1 21.2 16.8 25.7 19.2 21.5 44.3 22.6 27.2 26.1 49.7 13.3 31.4 16.1 16.7 16.3 17.4 17.3 19.5 13.9 14.5 21.1 16.7 22.0 16.0 13.3 8.6 16.5 11.5 7.5 7.9 13.8 10.2 7.7 8.0 6.9 7.8 6.7 8.2 7.3 7.2 9.2 38.0 19.2 33.8 20.5 38.0 19.1 29.2 16.9 22.2 19.5 12.9 19.8 26.6 22.8 27.0 11.0 25.0 18.3 36.5 11.8 9.8 23.4 1.6 24.2 31.9 27.2 15.6 14.9 35.8 19.1 17.5 32.5 19.9 25.1 27.3 24.7 16.8 12.8 13.7 13.5 28.4 16.4 14.2 20.6 12.1 2.4 23.3 24.2 3.6 15.0 31.6 17.3 30.9 35.2 35.1 18.7 17.6 18.4 20.8 16.8 15.7 20.3 34.4 19.1 46.0 40.3 25.1 22.8 21.3 14.1 18.6 24.8 32.5 18.6 15.6 19.5 AZI2 "AZ2, FLJ21939, NAP1" ENSG00000163512 "5-azacytidine induced 2" Q9H6S1 3 28315003-28349050 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035258 Approved NA NA "HPA035258: AB_10602329" "unprognostic (1.86e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.05e-1)" "unprognostic (2.38e-1)" "unprognostic (3.60e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.76e-2)" "unprognostic (1.44e-1)" "unprognostic (7.48e-3)" "unprognostic (2.72e-1)" "unprognostic (1.17e-1)" "unprognostic (3.30e-3)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.77e-4)" 27.3 11.7 16.3 9.2 16.8 21.0 12.9 17.0 20.0 12.6 17.5 10.5 12.1 12.1 10.7 9.7 10.6 13.3 14.9 15.6 18.6 13.3 11.4 12.6 9.9 16.6 16.6 14.6 13.2 11.3 12.9 14.0 12.4 17.0 12.5 9.9 13.7 17.9 10.6 14.2 9.9 11.4 11.9 15.1 10.1 11.0 16.7 17.8 14.2 14.2 12.1 8.6 11.8 8.7 19.3 20.5 20.6 27.4 16.4 43.0 69.0 40.3 25.5 52.6 44.3 52.7 18.3 20.2 12.6 15.5 36.0 29.7 8.4 21.2 42.4 35.9 34.2 23.7 23.8 20.6 25.4 64.4 24.6 14.5 69.9 57.1 35.7 61.9 28.9 24.6 26.6 36.0 22.9 41.1 19.4 31.3 19.4 19.1 13.5 30.0 14.6 29.5 13.0 19.3 11.5 14.6 35.8 22.3 25.6 52.3 24.7 17.7 25.6 17.0 29.4 24.2 24.9 31.3 26.5 27.6 18.3 31.1 51.4 27.2 74.7 37.8 26.3 13.3 31.2 16.1 6.3 12.6 15.5 16.7 8.4 12.0 11.0 10.4 11.0 28.1 13.5 18.9 19.1 16.3 16.8 17.0 20.0 15.6 18.6 16.6 16.6 14.6 17.0 15.1 17.8 19.3 31.6 64.1 49.5 21.9 17.0 24.9 34.4 53.6 34.7 29.3 33.0 28.6 23.1 24.3 46.9 23.9 37.5 32.4 34.9 33.1 45.0 26.4 26.9 49.0 46.8 28.1 26.9 31.8 28.2 28.2 57.0 55.6 16.8 30.2 19.6 27.5 32.9 38.3 33.7 15.2 43.6 29.0 38.7 63.0 11.0 28.1 46.9 57.6 8.8 16.9 61.8 30.5 22.6 32.6 32.6 30.5 28.8 41.0 32.8 28.8 34.8 50.0 57.9 30.9 46.0 44.4 34.6 68.0 61.3 32.0 34.7 62.7 28.7 32.0 24.5 28.3 TGFBR2 "MFS2, TBR-ii, TBRII" ENSG00000163513 "Transforming growth factor beta receptor 2" P37173 3 30606601-30694142 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB073537 Supported "Plasma membrane" NA NA 810000 "Plasma membrane" "CAB073537: " "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (3.70e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (7.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.65e-2)" "unprognostic (4.72e-2)" "unprognostic (1.81e-2)" "unprognostic (8.81e-2)" "unprognostic (8.02e-2)" 232.1 56.6 16.1 74.5 12.6 29.6 146.9 13.5 19.5 90.8 29.9 86.2 44.6 69.7 18.3 45.3 70.2 92.7 92.6 10.6 17.4 68.6 59.6 149.3 70.7 16.1 14.8 7.9 26.8 52.4 59.5 17.0 82.3 15.9 44.5 54.6 2.1 49.6 61.4 31.4 37.4 78.3 108.2 15.9 112.1 64.0 7.9 21.9 50.2 92.6 62.8 61.2 98.9 55.6 19.1 16.6 100.2 5.3 0.1 313.6 472.3 15.9 83.9 116.1 28.5 27.7 22.9 86.6 2.2 298.2 117.2 32.2 33.3 4.0 125.4 42.0 7.0 8.9 10.1 10.7 104.5 128.5 14.9 76.6 430.0 93.6 126.3 114.4 117.0 296.0 10.9 1.8 0.0 381.7 1.3 16.2 10.5 2.2 75.7 39.8 14.1 36.4 2.1 113.5 40.5 0.1 5.6 24.9 6.1 22.0 6.6 0.0 14.0 418.6 134.7 33.2 61.4 32.0 2.8 0.3 12.5 80.1 16.1 55.8 9.0 3.0 11.5 3.4 3.1 3.3 4.5 4.8 3.3 2.6 6.4 16.6 7.3 13.1 1.9 8.0 6.6 0.7 3.8 16.1 12.6 13.5 19.5 10.6 17.4 16.1 14.8 7.9 15.9 15.9 21.9 19.1 391.5 144.2 99.7 0.7 77.0 37.3 18.9 23.5 39.9 5.1 23.7 24.1 84.5 50.1 39.5 27.6 0.0 6.8 85.3 10.5 3.9 13.1 2.5 28.3 57.5 236.4 8.4 20.4 0.4 15.8 5.1 129.2 39.3 30.8 29.8 0.7 478.0 55.5 30.4 0.0 1.0 12.4 22.4 147.0 58.0 3.8 32.9 67.9 30.2 170.5 47.5 0.2 56.7 6.0 2.4 37.6 12.1 47.4 37.5 8.6 13.6 7.2 14.7 1.2 32.9 60.8 53.4 0.3 1.2 8.0 30.5 3.7 68.2 1.7 14.5 10.8 RETNLB "FIZZ2, HXCP2, RELMb" ENSG00000163515 "Resistin like beta" Q9BQ08 3 108743424-108757384 "Predicted secreted proteins, Transporters" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "intestine: 248.0" "Cell type enriched" "Detected in some" 38 "Intestinal goblet cells: 210.1" "Cancer enriched" "Detected in some" 10 "colorectal cancer: 16.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049152 Enhanced "Secreted to blood" NA NA 123000 "HPA049152: AB_2680655" "prognostic favorable (6.86e-5)" "unprognostic (1.19e-3)" "unprognostic (3.37e-2)" "unprognostic (4.69e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-2)" "unprognostic (4.26e-1)" 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 76.4 16.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 248.0 0.0 0.0 0.1 0.0 0.0 34.8 0.8 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.5 0.0 ANKZF1 "FLJ10415, Vms1, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1" Q9H8Y5 2 219229783-219236679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 9.0 9.3 7.3 8.9 7.6 7.9 10.9 8.9 9.9 13.6 8.0 12.9 9.6 10.2 3.3 15.3 13.6 6.2 12.9 6.8 6.8 13.9 14.6 10.8 13.8 8.9 7.3 6.2 16.2 15.8 6.5 12.6 5.9 8.4 15.2 5.2 8.3 15.4 5.7 17.0 17.2 15.3 4.6 7.0 18.3 14.4 7.9 7.9 12.0 12.0 8.1 8.4 12.5 15.1 9.4 31.6 6.1 8.1 11.8 10.6 8.8 32.5 10.1 10.0 13.6 17.2 14.9 13.2 6.6 18.0 4.3 15.3 22.7 10.5 17.5 10.0 13.9 11.0 14.6 19.1 13.9 10.6 9.6 13.7 8.9 33.1 10.1 15.9 22.6 9.4 17.0 24.8 14.9 6.9 13.6 14.1 24.1 13.5 13.7 10.9 14.3 9.9 21.4 7.6 7.9 10.3 10.5 11.9 23.9 19.8 19.5 6.4 23.7 10.3 11.4 8.7 10.1 13.3 31.6 19.9 12.9 19.4 13.8 5.1 9.9 9.1 11.0 16.1 9.0 17.4 13.0 16.3 16.2 9.4 13.3 19.0 18.0 12.3 24.4 14.0 9.8 17.1 13.6 7.3 7.6 8.9 9.9 6.8 6.8 8.9 7.3 6.2 8.4 7.0 7.9 9.4 10.2 16.0 17.2 24.2 28.0 9.3 14.5 28.9 9.6 39.8 14.4 13.6 9.2 11.5 24.8 12.9 31.3 10.5 32.7 17.3 13.7 20.5 4.4 28.2 9.7 11.8 9.6 19.6 19.0 12.6 27.2 8.9 17.9 13.0 21.6 21.4 8.6 13.1 7.7 32.0 21.0 19.1 20.3 8.2 5.3 4.0 23.9 10.9 10.6 6.5 15.6 18.0 43.3 13.6 25.3 14.2 16.0 16.6 17.7 13.6 25.2 16.5 65.1 55.4 6.6 13.2 12.8 10.1 17.0 8.3 9.9 11.6 30.0 21.3 17.6 11.1 HDAC11 ENSG00000163517 "Histone deacetylase 11" Q96DB2 3 13479724-13506424 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 122.5" "Group enriched" "Detected in many" 6 "Early spermatids: 357.7;Late spermatids: 692.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 47.7;T-47d: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.22e-2)" "unprognostic (3.58e-2)" "unprognostic (1.83e-1)" "unprognostic (5.69e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (4.50e-2)" "unprognostic (5.67e-3)" "unprognostic (1.78e-2)" "unprognostic (9.87e-2)" "unprognostic (3.94e-1)" "prognostic favorable (7.88e-10)" "unprognostic (3.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-1)" "unprognostic (1.39e-3)" 7.7 10.2 91.4 3.9 108.4 0.8 9.5 85.7 91.4 16.6 59.5 16.7 12.4 11.9 6.6 17.8 13.4 9.2 30.9 80.7 87.7 20.9 6.7 9.1 2.8 93.7 98.0 74.0 16.9 38.4 23.4 22.9 4.6 98.8 16.0 7.0 6.2 17.6 12.3 52.0 18.9 13.5 7.3 80.9 5.3 13.0 84.8 92.3 4.9 16.6 15.7 4.1 14.9 14.5 122.5 12.0 8.0 8.0 6.6 11.9 10.4 6.5 7.5 5.4 7.8 5.1 4.0 10.4 1.0 9.3 11.6 12.3 8.9 4.7 14.6 5.0 5.1 4.4 2.4 3.7 11.3 12.6 0.2 4.1 9.0 26.6 8.7 6.8 14.2 5.8 7.6 5.0 2.1 7.7 12.2 1.5 1.7 2.1 8.1 20.9 1.7 11.8 3.4 16.6 9.0 1.3 6.2 12.1 47.7 21.8 6.6 42.6 2.8 5.3 6.7 13.0 13.0 4.7 1.5 4.5 0.2 2.1 1.8 4.1 0.1 2.6 5.8 3.3 1.6 2.3 1.1 3.1 2.6 1.8 0.4 3.0 2.1 1.0 9.6 0.6 1.7 2.6 1.9 91.4 108.4 85.7 91.4 80.7 87.7 93.7 98.0 74.0 98.8 80.9 92.3 122.5 5.2 9.6 5.0 11.4 0.9 11.5 7.7 11.0 8.6 8.5 10.6 8.0 84.6 8.6 8.9 11.0 0.0 18.9 2.8 23.1 19.6 14.6 357.7 8.6 5.2 6.3 8.9 0.8 6.9 11.4 3.1 9.7 9.7 7.8 1.3 5.0 7.1 2.8 6.0 10.1 7.1 14.4 18.3 3.5 3.8 692.3 16.1 3.6 8.8 1.0 4.6 21.8 2.1 12.5 46.9 11.1 13.6 15.4 0.7 5.1 36.1 24.9 12.0 5.6 0.0 5.6 9.5 15.3 7.3 10.1 10.5 5.7 3.3 3.1 20.0 6.8 FCRL4 "CD307d, FCRH4, IGFP2, IRTA1" ENSG00000163518 "Fc receptor like 4" Q96PJ5 1 157573747-157598085 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 10.5" "Cell type enhanced" "Detected in single" "B-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "U-266/70: 4.6" "Not detected" "Not detected" HPA054030 Approved NA NA "HPA054030: " "unprognostic (6.06e-2)" "unprognostic (3.41e-3)" "unprognostic (2.57e-1)" "unprognostic (5.08e-2)" "unprognostic (4.69e-4)" "unprognostic (2.06e-2)" "unprognostic (6.38e-2)" "unprognostic (1.99e-1)" "unprognostic (2.14e-1)" "unprognostic (3.37e-1)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.3 0.0 0.0 0.3 0.0 0.0 10.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822770-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "lymphoid tissue: 80.6" "Cell type enriched" "Detected in some" 10 "T-cells: 129.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 395.1" "Group enriched" "Detected in many" 155 "granulocytes: 395.1;T-cells: 313.1" "Group enriched" "Detected in some" 25 "JURKAT: 29.9;MOLT-4: 76.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130, HPA072760" Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes NA "Plasma membrane" "Mitotic spindle, Centriolar satellite" "CAB026130: , HPA002356: AB_1080375, HPA072760: " "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 0.8 0.6 0.0 11.1 0.0 2.8 0.8 0.0 0.1 0.4 0.2 1.3 1.4 0.4 0.4 1.0 0.3 2.5 0.4 0.1 0.1 0.3 1.3 2.1 24.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 1.5 0.0 0.6 0.1 0.1 0.6 3.0 0.5 0.0 8.6 2.4 0.4 0.1 80.6 0.4 0.4 12.5 2.9 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 2.1 0.0 0.0 76.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 395.1 0.6 0.2 57.0 0.2 116.4 1.0 229.5 119.6 0.3 0.4 313.1 77.7 3.5 2.2 0.7 0.8 111.1 139.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 3.2 0.0 3.3 8.4 0.1 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 1.8 0.0 0.0 8.9 0.1 0.0 0.0 2.3 0.1 0.1 1.1 0.0 2.7 0.1 0.0 0.0 1.7 7.7 0.1 2.5 0.0 1.8 0.6 0.2 0.0 0.2 0.0 0.0 1.0 12.2 2.2 0.0 1.8 3.6 0.0 3.2 0.0 3.1 0.0 0.2 0.0 0.0 0.0 5.1 0.2 0.0 0.5 0.0 0.0 0.0 0.3 0.8 0.0 0.1 0.0 8.0 0.1 129.3 0.6 0.0 0.2 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549125-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 187.7" "Cell type enhanced" "Detected in many" "Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 6.7;naive CD8 T-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2" "Group enriched" "Detected in many" 4 "olfactory bulb: 12.4;white matter: 3.1" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 35000000 "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 136.2 7.7 5.9 12.8 6.3 1.0 98.2 5.3 16.1 57.1 17.0 32.0 6.3 31.4 3.3 42.8 27.1 46.6 187.7 6.5 7.7 3.8 3.7 29.4 8.5 5.5 5.3 4.8 5.9 8.6 3.0 2.3 80.9 5.1 29.4 11.9 0.7 39.7 8.9 48.2 66.0 19.9 14.8 4.0 6.1 22.5 47.1 6.7 14.3 64.2 49.4 5.6 80.4 57.2 7.1 0.0 1.4 50.9 0.0 384.0 51.7 23.8 124.9 98.2 122.4 80.4 8.1 0.3 0.0 5.9 264.3 0.2 0.2 0.0 0.5 22.9 0.1 0.1 100.7 1.9 0.0 26.0 0.2 311.6 221.9 2.0 19.3 0.0 0.2 0.0 8.6 0.8 0.9 0.6 0.3 5.2 0.6 12.2 0.0 0.7 0.2 0.0 0.5 0.9 0.1 3.0 2.4 0.5 90.3 0.1 13.6 0.2 0.3 0.1 0.1 0.1 139.2 0.1 0.2 0.0 0.0 1.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.2 6.7 1.3 0.0 3.7 0.0 0.2 0.0 0.5 0.0 0.9 5.9 6.3 5.3 16.1 6.5 7.7 5.5 5.3 4.8 5.1 4.0 6.7 7.1 92.7 0.0 1.5 1.6 3.6 30.8 0.8 10.5 2.2 0.0 1.7 1.9 8.8 0.0 12.3 7.3 2.1 7.8 1.9 0.1 0.0 0.0 3.8 2.9 84.4 43.8 0.0 1.7 0.6 0.2 4.8 458.4 6.1 2.7 23.6 0.6 47.8 0.4 3.6 0.0 0.6 0.0 0.0 1.9 49.8 12.1 170.9 4.5 39.2 26.2 0.3 1.2 0.0 30.7 0.3 0.3 0.0 227.2 1.6 1.2 2.7 0.1 1.4 0.4 13.1 29.7 26.4 3.4 13.5 2.0 28.8 6.2 5.3 0.2 0.0 1.1 GLB1L MGC10771 ENSG00000163521 "Galactosidase beta 1 like" Q6UWU2 2 219236598-219245478 "Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 52.8" "Cell type enhanced" "Detected in many" "Early spermatids: 41.5;Spermatocytes: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 19.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043058 Enhanced "Secreted - unknown location" NA NA "HPA043058: AB_10806375" "unprognostic (4.30e-2)" "unprognostic (6.93e-2)" "unprognostic (2.68e-2)" "unprognostic (2.08e-3)" "unprognostic (4.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.67e-3)" "unprognostic (3.32e-2)" "unprognostic (4.77e-1)" "unprognostic (2.39e-1)" "unprognostic (8.48e-3)" "unprognostic (3.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.28e-1)" "unprognostic (9.23e-3)" "unprognostic (1.33e-1)" "unprognostic (8.50e-2)" 4.5 4.9 4.2 4.1 3.1 4.5 5.3 3.1 2.8 5.3 12.1 3.1 3.1 6.0 11.5 2.5 23.3 9.1 2.2 2.6 7.1 13.7 3.2 5.4 3.0 4.8 5.4 2.2 7.2 3.1 14.5 6.8 8.6 4.7 5.6 3.7 8.0 4.5 4.8 0.9 4.7 4.2 5.9 4.8 4.9 2.9 52.8 3.2 3.4 8.5 1.0 3.4 6.0 2.2 4.9 2.8 4.8 7.4 5.9 8.0 9.8 3.7 4.6 9.7 5.7 5.3 1.9 7.7 0.9 4.1 4.1 4.3 1.5 1.9 4.6 4.5 2.6 3.6 2.9 6.9 4.5 19.7 1.1 4.4 11.4 2.9 5.4 3.3 13.5 5.3 4.3 1.8 5.3 5.4 4.0 2.5 2.7 1.3 1.0 1.3 2.5 4.1 4.0 11.5 1.6 4.7 4.2 3.9 5.3 4.3 4.9 8.4 2.6 4.1 4.7 5.8 2.8 2.6 5.0 1.7 1.5 8.8 1.2 12.3 1.9 5.1 0.3 0.7 6.4 0.4 0.4 0.5 0.7 2.1 1.0 1.1 0.7 2.1 1.0 5.4 0.9 0.2 1.7 4.2 3.1 3.1 2.8 2.6 7.1 4.8 5.4 2.2 4.7 4.8 3.2 4.9 3.2 3.2 5.1 3.3 1.3 1.8 2.6 3.6 0.6 4.7 4.9 5.6 1.9 1.5 6.3 3.7 12.5 3.4 1.9 1.1 3.9 3.8 41.5 15.7 3.9 4.2 4.9 1.3 0.9 1.8 2.2 8.4 1.1 2.2 0.0 2.7 8.6 1.3 14.5 3.3 1.1 3.2 2.0 5.6 2.4 25.6 10.8 4.4 8.8 1.9 2.7 5.0 3.1 1.0 0.5 2.1 3.3 6.4 1.8 2.7 6.5 16.5 23.9 10.2 6.6 3.8 2.2 117.4 9.7 1.8 1.7 1.4 2.0 7.0 2.4 1.7 STT3B "FLJ90106, SIMP, STT3-B" ENSG00000163527 "STT3 oligosaccharyltransferase complex catalytic subunit B" Q8TCJ2 3 31532638-31637616 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 264.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036448, HPA036646" Approved Supported "Endoplasmic reticulum" NA NA 17000 "Endoplasmic reticulum" "HPA036448: AB_2675129, HPA036646: AB_10673472" "unprognostic (2.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (7.91e-5)" "unprognostic (1.60e-1)" "unprognostic (3.11e-1)" "unprognostic (2.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.04e-1)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (3.68e-2)" "unprognostic (3.86e-2)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (6.71e-3)" "unprognostic (1.02e-1)" 43.1 60.5 24.1 52.7 29.8 64.2 57.7 26.1 27.3 62.6 33.3 60.2 48.3 52.3 91.1 45.2 45.7 60.8 49.9 24.9 33.1 50.1 75.4 49.7 60.4 27.4 26.0 25.4 106.4 46.1 77.2 25.0 60.8 26.7 56.8 62.0 38.9 50.3 51.8 62.7 45.1 49.5 58.2 28.1 44.6 55.6 95.1 27.4 72.5 81.5 58.3 59.3 57.1 32.4 30.0 77.9 128.0 115.4 121.7 142.0 142.3 249.7 142.3 124.9 104.2 119.9 117.7 164.5 134.0 67.8 130.0 85.8 63.9 108.1 123.5 135.9 377.1 70.2 115.0 120.7 126.4 109.4 252.0 131.1 109.8 129.7 148.8 186.7 160.7 107.1 168.3 62.8 209.6 144.0 44.4 246.8 154.8 92.9 129.6 70.7 252.3 62.6 196.0 122.0 110.7 48.7 59.4 141.3 207.2 84.5 98.3 93.4 132.8 209.3 139.8 88.6 139.7 127.3 129.0 166.4 111.4 126.9 170.0 117.6 2.1 3.3 6.2 3.1 3.9 5.0 2.4 5.6 4.4 2.9 2.7 5.3 4.3 1.2 6.1 2.9 5.5 3.0 2.0 24.1 29.8 26.1 27.3 24.9 33.1 27.4 26.0 25.4 26.7 28.1 27.4 30.0 32.1 86.6 57.7 34.6 69.6 68.1 58.4 34.1 74.6 51.0 57.2 29.5 71.1 54.3 76.0 44.1 68.8 67.3 65.3 41.8 13.7 34.1 162.8 25.0 65.9 42.0 45.1 50.9 61.5 45.3 100.5 49.6 45.3 43.5 31.1 43.6 37.9 68.2 54.8 45.4 59.4 57.5 36.7 58.0 76.0 264.9 36.4 71.5 51.6 53.4 49.1 34.2 56.7 60.3 73.3 36.5 50.0 32.7 144.2 74.1 50.5 31.5 42.2 37.4 26.3 39.0 53.3 90.9 55.2 65.0 61.8 95.4 78.3 68.4 66.1 69.4 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 84.1;Proximal tubular cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria NA NA Mitochondria "HPA034688: AB_10696361, HPA063727: AB_2685103" "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 11.7 14.1 14.0 8.7 14.4 3.3 11.6 14.4 16.5 9.5 14.5 17.8 14.8 9.0 10.2 12.5 9.7 5.8 22.2 13.9 15.7 21.1 19.0 7.7 9.0 14.7 15.2 13.8 10.5 11.2 23.1 9.7 8.5 14.9 10.9 15.6 11.5 10.2 11.9 34.4 10.3 11.6 8.8 14.4 10.4 13.8 8.8 14.3 9.5 9.7 29.3 12.9 15.2 9.9 15.2 19.1 39.2 19.8 19.8 16.9 18.9 57.5 20.3 18.7 24.4 21.4 23.3 15.3 40.9 19.4 15.5 24.7 15.3 41.5 41.8 29.8 25.7 41.6 47.9 28.5 31.3 28.2 32.5 19.9 16.6 43.5 40.0 63.5 17.3 27.7 32.4 50.6 35.6 26.3 40.7 41.0 19.6 30.6 59.5 52.1 29.3 19.9 87.5 27.8 20.7 16.3 20.1 22.6 72.2 30.1 17.0 34.6 32.8 10.0 22.3 16.2 27.8 37.4 19.8 56.1 40.6 21.9 49.5 16.6 12.0 15.6 10.7 7.8 24.0 14.0 15.0 13.2 12.1 25.7 22.0 16.8 11.5 6.9 21.8 24.8 10.5 16.3 11.6 14.0 14.4 14.4 16.5 13.9 15.7 14.7 15.2 13.8 14.9 14.4 14.3 15.2 6.7 16.0 8.6 2.9 10.6 9.4 14.5 17.9 13.1 7.9 13.3 11.4 24.5 11.5 8.8 9.2 0.0 21.6 3.5 12.2 84.1 18.8 2.6 6.7 8.3 9.0 4.9 20.8 3.2 13.4 22.3 8.9 5.6 5.4 10.8 7.6 3.9 20.4 21.0 5.0 3.8 13.3 16.2 10.0 6.6 5.3 11.5 9.7 8.8 1.9 11.4 9.9 15.5 2.5 3.5 13.1 10.0 10.1 13.2 25.3 22.4 62.2 5.9 7.2 6.6 9.9 11.8 24.7 40.4 20.8 11.8 13.0 7.3 12.0 17.9 11.6 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 3.4" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 12.0;Spermatogonia: 14.5" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 6.0;EFO-21: 11.4;SuSa: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036134 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.4 0.0 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 1.6 0.0 0.1 0.0 0.0 NFASC "FLJ46866, KIAA0756, NF, NRCAML" ENSG00000163531 Neurofascin O94856 1 204828651-205022822 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 151.0;Excitatory neurons: 148.4;Horizontal cells: 220.4;Inhibitory neurons: 139.0;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 226.6;Rod photoreceptor cells: 195.5" "Cancer enriched" "Detected in many" 5 "glioma: 8.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 27.6;fHDF/TERT166: 50.3;hTERT-RPE1: 24.0;SCLC-21H: 22.8;U-138 MG: 62.7;U-87 MG: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008832 Enhanced NA NA 2200000 "HPA008832: AB_1854411" "unprognostic (1.71e-1)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (3.39e-2)" "unprognostic (6.65e-2)" "unprognostic (1.18e-2)" "unprognostic (3.71e-3)" "unprognostic (3.37e-1)" "unprognostic (6.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.21e-5)" "unprognostic (3.76e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (1.56e-3)" "unprognostic (1.91e-1)" "unprognostic (6.90e-2)" "unprognostic (5.26e-3)" 4.3 7.6 4.5 3.7 21.5 0.1 3.3 3.1 17.0 4.6 0.0 7.0 4.5 8.3 9.1 10.1 12.2 5.9 12.7 5.8 2.2 9.6 1.9 5.0 2.3 12.9 8.9 3.6 10.2 5.9 1.0 5.6 10.7 14.3 7.5 5.9 22.8 2.2 16.4 3.0 3.7 5.0 14.4 2.2 6.6 4.5 1.5 14.4 0.6 2.9 3.8 2.9 9.5 7.7 43.6 0.0 0.1 3.1 0.1 0.4 1.0 0.1 27.6 0.0 19.9 5.9 0.2 0.1 0.0 0.1 50.3 18.5 13.4 0.6 0.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 12.7 0.7 24.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 7.0 0.9 0.3 0.0 2.3 0.0 0.0 0.0 22.8 1.3 0.0 1.5 0.0 2.0 0.3 0.0 0.0 62.7 13.5 0.1 0.0 0.0 0.0 0.0 31.3 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 21.5 3.1 17.0 5.8 2.2 12.9 8.9 3.6 14.3 2.2 14.4 43.6 2.5 0.0 0.6 64.3 0.0 2.2 1.5 1.9 0.6 151.0 1.7 10.5 23.9 1.5 1.5 0.0 12.5 0.5 0.0 0.3 0.0 0.2 7.3 0.5 0.4 7.6 37.8 0.0 148.4 0.0 0.5 14.2 1.1 0.1 0.0 0.1 3.3 1.7 0.4 220.4 139.0 6.0 0.0 0.6 1.9 17.9 6.5 0.4 1.8 15.0 0.0 14.2 0.0 87.9 226.6 0.5 0.5 5.7 0.0 1.1 0.0 1.5 5.9 195.5 52.6 2.3 49.9 1.7 3.9 5.5 4.7 0.7 0.3 0.7 1.0 0.8 FCRL1 "CD307a, FCRH1, IFGP1, IRTA5" ENSG00000163534 "Fc receptor like 1" Q96LA6 1 157794403-157820120 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "bone marrow: 8.1;intestine: 8.7;lymphoid tissue: 27.5" "Cell type enriched" "Detected in some" 26 "B-cells: 88.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "memory B-cell: 39.3;naive B-cell: 68.1" "Lineage enriched" "Detected in many" 62 "B-cells: 68.1" "Group enriched" "Detected in some" 26 "Daudi: 5.4;U-698: 17.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013323 Enhanced NA NA 290000 "HPA013323: AB_1848480" "unprognostic (6.52e-4)" "unprognostic (3.49e-3)" "unprognostic (8.68e-3)" "unprognostic (8.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-5)" "unprognostic (1.47e-2)" "unprognostic (5.48e-3)" "unprognostic (1.40e-2)" "unprognostic (4.30e-2)" "unprognostic (1.81e-1)" "unprognostic (2.85e-2)" "unprognostic (1.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.65e-2)" "unprognostic (4.80e-2)" "unprognostic (6.74e-2)" 0.2 0.0 0.0 10.2 0.0 8.1 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.2 0.6 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.6 0.0 0.0 0.0 8.7 0.0 0.0 18.0 0.8 0.0 0.0 3.0 0.4 0.0 22.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 39.3 0.0 0.0 0.0 68.1 0.0 0.1 1.1 0.2 0.5 0.0 0.3 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200584096 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.0;testis: 32.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "basophil: 16.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: AB_2677149" "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 2.0 0.9 0.6 4.4 0.9 6.9 1.9 0.8 0.9 0.9 0.4 3.1 2.5 1.8 0.7 2.4 1.5 1.2 1.0 0.5 0.8 0.9 0.8 1.5 8.0 0.9 0.8 0.4 1.9 0.5 1.1 0.3 2.6 0.9 1.4 3.3 0.9 0.8 0.7 0.4 2.3 2.6 2.0 0.8 2.0 1.8 32.9 0.8 15.0 1.2 0.6 8.1 1.5 0.9 1.5 34.6 16.2 37.0 17.4 5.2 7.9 23.7 38.7 16.6 32.0 33.1 24.3 23.5 22.5 18.6 18.1 34.4 25.3 33.6 20.1 54.5 48.0 16.9 43.5 21.6 17.5 1.6 43.9 33.1 3.4 2.5 32.9 17.3 8.0 29.4 31.3 33.1 31.6 61.4 15.4 35.9 17.9 26.7 24.9 41.2 28.8 49.1 21.3 13.3 13.6 22.2 15.4 28.6 13.3 16.3 29.2 14.1 25.2 18.1 33.9 34.0 31.6 34.0 14.3 33.5 49.8 21.4 28.9 49.4 16.7 1.4 4.5 2.2 1.4 1.4 2.7 2.4 2.2 0.8 3.2 1.8 2.2 1.0 2.0 1.7 1.7 3.6 1.2 0.6 0.9 0.8 0.9 0.5 0.8 0.9 0.8 0.4 0.9 0.8 0.8 1.5 9.4 3.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.8 7.1 0.0 0.0 6.2 0.0 0.0 11.6 7.8 0.0 3.9 3.9 0.0 12.1 5.3 3.3 0.0 0.0 0.0 2.7 31.0 6.7 0.0 3.6 11.4 23.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.2 0.0 0.0 1.7 0.0 0.0 2.5 8.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.4 3.8 4.0 0.0 0.0 SERPINI1 PI12 ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825569 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 266.2;choroid plexus: 119.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 219.4;Excitatory neurons: 176.9;Inhibitory neurons: 228.8;Oligodendrocytes: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 29.2;Karpas-707: 29.1;U-266/84: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 750000 Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 13.2 16.0 156.5 4.1 195.5 2.4 11.8 150.5 266.2 8.5 119.9 5.1 2.3 8.7 8.3 5.6 8.0 6.4 14.1 187.8 175.6 32.4 4.1 6.4 4.6 157.8 196.9 184.3 7.0 39.9 7.0 43.1 6.7 159.9 11.9 4.5 85.1 23.2 7.5 3.3 3.1 4.4 6.2 171.0 8.8 10.9 15.9 169.4 4.5 11.3 8.1 8.3 4.9 6.0 197.1 0.8 3.5 5.5 0.4 10.3 2.2 0.3 1.9 2.7 1.3 2.2 1.5 5.9 29.2 9.5 1.3 4.5 1.3 3.9 3.8 1.5 7.7 6.5 8.9 22.5 10.7 0.7 1.4 1.1 3.8 1.4 0.8 1.3 2.9 0.4 10.5 18.9 29.1 1.2 2.7 0.8 1.9 3.3 4.2 4.5 2.7 0.4 3.2 11.2 1.0 2.2 13.4 3.6 6.8 8.3 12.4 10.6 4.4 1.0 5.5 0.5 0.5 10.3 23.0 28.4 18.8 4.2 7.7 3.2 1.5 0.3 0.8 9.3 0.7 6.9 22.1 9.7 10.2 0.5 25.2 6.9 8.1 0.9 9.5 0.5 7.2 27.2 5.2 156.5 195.5 150.5 266.2 187.8 175.6 157.8 196.9 184.3 159.9 171.0 169.4 197.1 49.8 6.4 1.5 43.1 10.7 3.7 13.2 6.4 14.2 219.4 3.6 14.1 8.2 1.5 6.7 5.5 14.6 6.1 6.2 0.7 7.9 1.8 0.4 2.0 1.0 16.0 4.8 7.4 176.9 18.0 6.0 8.9 2.6 1.7 2.5 2.3 3.9 0.6 2.3 5.0 228.8 0.3 73.2 0.6 3.2 2.4 4.1 0.9 7.2 25.3 1.2 78.0 2.1 31.2 174.7 3.0 0.0 2.6 14.6 6.7 0.0 39.9 13.6 35.4 26.3 5.2 54.7 3.0 27.4 0.5 1.7 5.1 6.2 1.1 0.3 2.3 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 175.0;retina: 127.5" "Cell type enhanced" "Detected in all" "Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA067071: AB_2685775" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favorable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 14.2 25.4 40.6 12.2 76.2 12.4 16.0 97.5 87.0 21.6 0.0 14.5 10.0 20.7 11.4 18.1 16.1 17.9 40.7 45.3 62.8 18.3 10.9 15.5 15.5 69.7 61.0 44.4 27.5 11.6 17.8 33.6 15.7 84.5 16.7 13.2 127.5 8.9 20.9 65.5 13.1 11.1 19.6 55.9 14.7 11.3 11.9 54.9 16.2 14.2 64.0 16.0 14.7 11.6 175.0 13.5 29.4 32.9 27.8 20.9 20.4 23.6 24.8 23.2 28.5 30.6 17.2 13.8 44.4 14.1 19.6 18.3 11.5 43.0 19.7 34.4 36.0 30.5 43.7 24.6 15.4 9.9 43.6 35.8 12.7 19.3 30.9 29.2 16.5 28.0 27.0 43.3 24.8 31.1 7.6 32.5 18.6 24.5 13.5 18.4 34.5 30.9 24.1 17.9 15.2 27.4 46.4 28.7 22.1 24.7 26.5 20.9 38.1 27.0 22.3 19.4 16.9 27.7 17.3 34.6 36.5 20.2 29.6 28.8 3.7 4.6 2.6 3.3 4.5 5.1 6.1 2.9 3.2 6.5 3.7 3.9 3.6 0.9 9.1 7.0 6.1 3.5 4.8 40.6 76.2 97.5 87.0 45.3 62.8 69.7 61.0 44.4 84.5 55.9 54.9 175.0 19.7 6.4 11.7 294.5 29.9 21.0 8.6 8.8 18.8 103.3 26.0 13.8 37.4 15.7 12.7 14.7 156.4 12.3 36.2 9.9 1.9 6.4 2.8 20.8 15.6 16.1 14.4 12.2 514.2 7.0 8.1 19.2 26.5 27.9 12.0 17.8 16.1 13.9 15.0 92.5 526.3 8.8 8.2 32.3 26.6 2.9 14.3 26.0 16.0 128.4 19.5 32.0 22.6 739.9 1315.9 8.0 5.6 13.5 28.8 12.3 6.1 12.2 13.8 120.6 6.6 34.2 22.9 11.1 14.4 19.3 30.7 12.9 25.6 15.5 11.2 8.8 SUCLG1 ENSG00000163541 "Succinate-CoA ligase GDP/ADP-forming subunit alpha" P53597 2 84423528-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 559.2" "Cell type enhanced" "Detected in all" "Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA 350000 Mitochondria "Plasma membrane, Cytosol" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavorable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 119.8 74.0 73.7 43.5 75.9 48.6 80.9 78.0 93.3 50.3 89.1 158.4 233.2 42.8 79.5 87.6 55.1 42.2 248.9 73.0 76.3 559.2 194.5 41.9 48.2 75.3 75.0 71.2 46.1 94.4 246.2 47.2 49.2 75.1 54.8 167.5 38.7 121.6 67.2 276.7 55.9 197.0 64.0 75.0 39.9 81.8 37.3 75.6 62.3 98.5 371.4 63.6 67.0 59.0 79.3 90.2 94.9 73.8 91.1 137.8 91.2 127.7 98.4 85.2 126.0 91.2 224.5 72.0 122.4 67.0 119.8 100.2 126.8 156.7 118.4 149.8 119.3 141.4 105.9 75.4 129.2 116.0 110.6 82.7 109.1 95.6 106.3 143.7 76.7 115.1 97.9 110.1 98.1 117.5 137.4 158.2 101.1 39.4 334.1 170.0 98.3 172.6 134.5 172.2 106.4 89.8 49.3 78.9 163.7 162.3 69.0 99.8 85.4 93.1 96.6 94.6 119.9 124.9 84.2 131.0 107.8 113.9 150.4 88.0 101.6 91.0 80.8 79.0 110.2 88.5 70.2 72.0 88.4 115.4 55.4 79.1 84.3 49.7 102.3 114.3 63.2 107.7 142.7 73.7 75.9 78.0 93.3 73.0 76.3 75.3 75.0 71.2 75.1 75.0 75.6 79.3 52.7 64.1 96.5 32.7 61.0 35.4 108.9 129.6 44.3 33.3 105.0 109.1 408.6 131.5 115.2 141.6 22.9 232.3 49.9 218.1 935.2 131.8 49.2 67.1 56.9 57.0 106.3 68.4 45.8 113.2 129.3 69.8 79.5 80.8 91.3 46.0 57.5 210.0 131.7 45.4 43.5 202.1 105.8 71.3 46.0 35.9 54.7 82.2 119.2 16.9 89.8 68.2 58.7 28.1 46.2 67.1 215.4 74.1 57.1 64.2 647.5 2949.2 83.7 36.1 52.6 61.1 98.3 138.9 54.4 111.3 41.3 188.4 64.4 90.7 388.7 111.0 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302063-205321745 "Enzymes, Metabolic proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 57.2;vagina: 45.6" "Cell type enhanced" "Detected in many" "Ductal cells: 46.9;Endometrial ciliated cells: 45.3;Glandular and luminal cells: 52.4;Intestinal goblet cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 120.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 44.1;RPMI-8226: 36.1;RPTEC TERT1: 40.9;SuSa: 45.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA008958 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favorable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.6 3.8 1.2 7.8 1.7 11.5 0.9 4.4 1.6 15.5 2.8 8.0 16.6 1.6 1.3 57.2 4.1 1.7 1.0 1.0 2.1 20.1 5.1 10.4 11.6 2.0 1.7 0.9 1.3 16.1 0.8 3.0 4.4 2.4 2.0 8.9 0.5 15.3 1.6 0.7 20.9 12.6 1.2 1.6 13.2 2.5 3.7 1.8 3.9 16.2 1.1 8.1 3.1 45.6 3.9 4.3 23.1 13.7 0.6 0.3 0.6 44.1 5.5 5.7 14.7 5.9 24.4 0.8 7.0 3.2 1.5 24.1 8.3 3.2 8.3 6.3 0.0 0.4 0.0 1.4 4.2 9.3 0.0 0.1 2.6 6.1 8.6 5.0 3.3 0.7 0.0 0.9 1.7 2.8 1.0 0.0 0.1 8.9 3.1 0.7 0.0 1.0 36.1 40.9 0.1 2.1 0.2 1.6 6.5 0.7 45.6 6.6 0.1 1.7 5.3 2.5 0.6 8.7 12.1 2.0 4.4 0.8 0.0 2.1 11.2 16.5 40.1 10.3 11.8 7.6 37.9 12.7 12.3 10.4 39.3 27.9 21.9 120.4 17.5 13.1 4.1 8.1 17.4 1.2 1.7 4.4 1.6 1.0 2.1 2.0 1.7 0.9 2.4 1.6 1.8 3.9 2.0 6.4 6.8 0.3 28.0 1.1 3.2 3.7 13.1 1.1 1.9 2.2 2.7 20.0 2.9 33.1 0.0 9.2 7.1 34.9 5.9 46.9 2.0 45.3 7.5 5.9 10.8 2.7 0.1 1.8 29.1 3.7 7.7 52.4 0.0 2.4 0.7 2.6 4.7 0.0 0.4 43.0 18.3 12.3 11.1 2.1 0.0 8.9 7.2 3.7 38.5 1.3 18.6 0.5 3.5 6.9 7.8 0.0 18.5 2.5 18.3 17.2 7.7 0.5 6.6 2.4 5.5 0.9 1.1 21.5 5.4 4.1 5.7 0.5 22.0 0.5 SPTA1 EL2 ENSG00000163554 "Spectrin alpha, erythrocytic 1" P02549 1 158610704-158686715 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin capping, Actin-binding" "Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "bone marrow: 76.3" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 255.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "K-562: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016193, HPA028048, HPA028253, CAB037246" Enhanced NA NA 11000000 "CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.99e-1)" "unprognostic (1.34e-1)" "unprognostic (3.65e-3)" "unprognostic (1.50e-3)" "unprognostic (9.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-1)" "unprognostic (9.09e-2)" "unprognostic (6.73e-8)" "unprognostic (6.08e-2)" "unprognostic (6.33e-2)" "unprognostic (1.76e-2)" "unprognostic (5.85e-3)" 0.1 0.0 0.0 0.0 0.0 76.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 8.7 0.0 0.0 0.3 0.0 255.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 PRKCI "DXS1179E, PKCI" ENSG00000163558 "Protein kinase C iota" P41743 3 170222424-170305977 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026574, HPA038635" Approved Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA026574: AB_1855428, HPA038635: AB_2676124" "unprognostic (2.26e-1)" "unprognostic (6.75e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (3.93e-6)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.52e-1)" "unprognostic (7.10e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (5.32e-3)" "prognostic favorable (3.10e-4)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" 6.8 5.0 1.3 7.0 2.6 2.7 10.6 2.2 3.3 12.8 0.2 12.5 11.7 11.1 8.3 15.3 16.1 11.5 7.0 3.0 1.9 13.6 7.4 16.8 4.7 0.5 0.4 2.5 13.8 7.1 13.1 3.1 11.0 0.9 17.5 13.3 6.2 17.7 12.8 6.3 6.9 10.9 11.1 0.1 5.3 34.8 12.6 0.9 11.0 24.7 9.9 10.5 16.2 6.2 1.8 81.6 20.2 20.0 21.6 17.3 23.9 32.2 20.4 29.9 26.4 28.3 29.7 38.6 24.7 65.3 28.8 36.4 37.3 37.9 40.0 44.8 18.2 23.5 22.9 24.3 16.6 27.9 20.9 10.0 21.8 27.5 22.6 35.1 42.8 20.9 13.3 25.8 19.8 27.4 28.0 30.5 8.5 42.3 86.4 22.1 21.8 30.7 41.2 42.3 24.4 31.5 25.8 44.1 57.7 20.0 29.5 63.0 14.5 22.4 27.5 21.1 26.0 34.3 33.9 34.9 35.2 19.8 16.4 11.0 0.0 0.6 0.4 1.1 0.6 1.7 0.9 1.5 2.0 0.8 1.2 1.6 0.9 0.3 2.6 0.5 0.8 1.1 0.7 1.3 2.6 2.2 3.3 3.0 1.9 0.5 0.4 2.5 0.9 0.1 0.9 1.8 17.6 73.7 82.1 23.2 5.8 57.1 49.5 39.8 30.7 16.4 29.0 19.7 16.2 24.3 45.3 49.7 14.6 30.2 15.0 29.0 25.4 16.5 8.4 42.0 29.7 20.5 29.3 10.5 77.2 22.0 26.6 32.2 59.7 72.3 8.8 20.4 17.5 17.7 10.0 15.2 55.2 28.3 50.8 18.6 26.8 6.8 23.3 11.6 17.8 22.5 12.7 8.8 6.2 33.2 33.5 55.2 18.6 28.6 29.4 99.4 18.7 20.4 31.9 9.4 19.7 23.7 18.7 15.8 20.6 38.5 63.6 20.7 14.8 14.3 28.5 80.1 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831351-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 295.6;lymphoid tissue: 108.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 6012.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 6012.8" "Group enriched" "Detected in some" 14 "NB-4: 151.8;THP-1: 282.7;U-937: 185.5" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 400000 Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 24.4 15.1 2.4 83.2 3.2 295.6 6.0 2.9 4.5 6.3 4.1 6.8 3.7 4.0 1.5 7.5 5.8 26.8 4.3 2.4 5.1 3.6 11.6 47.7 15.7 4.3 2.9 1.7 2.2 4.8 3.8 1.6 20.5 4.1 3.9 7.8 12.2 5.7 3.6 3.9 5.2 7.8 20.9 4.1 108.7 4.6 5.1 4.4 14.5 3.8 19.2 14.6 23.6 1.8 6.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 282.7 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 185.5 0.0 155.4 1354.4 243.8 2.6 534.3 3.7 33.5 1.6 1.9 616.5 15.3 1.6 1.4 6012.8 2.8 270.6 9.6 1.5 1099.5 2.4 3.2 2.9 4.5 2.4 5.1 4.3 2.9 1.7 4.1 4.1 4.4 6.5 2.6 35.3 56.0 0.0 34.7 2.4 0.0 0.0 0.0 1.2 1.1 3.4 0.9 5.7 9.3 0.0 0.0 0.9 5.9 0.0 0.0 0.0 0.4 0.1 0.1 5.0 0.0 22.3 0.0 0.4 1.3 6.5 0.5 0.1 44.1 0.0 3.9 2.2 219.1 0.0 0.1 0.0 0.0 408.5 241.7 3.3 1.2 412.0 1.8 33.7 1118.9 136.1 26.8 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.7 8.0 4.8 13.1 1.5 8.2 0.9 0.3 0.4 2.3 1.0 11.7 0.0 0.0 0.1 PYHIN1 "IFIX, MGC23885" ENSG00000163564 "Pyrin and HIN domain family member 1" Q6K0P9 1 158930796-158977059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 23.3" "Group enriched" "Detected in many" 5 "dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3" "Group enriched" "Detected in many" 5 "NK-cells: 36.8;T-cells: 97.3" "Cell line enriched" "Detected in some" 6 "U-698: 49.1" "HPA051224, HPA055373" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA051224: AB_2681394, HPA055373: " "unprognostic (1.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.93e-3)" "unprognostic (2.64e-3)" "unprognostic (3.99e-2)" "unprognostic (3.57e-3)" "unprognostic (2.44e-3)" "unprognostic (2.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.47e-3)" "unprognostic (3.94e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-6)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-2)" "unprognostic (4.45e-3)" 2.2 0.6 0.2 8.4 0.4 5.6 1.2 0.2 0.6 1.0 0.7 1.7 1.6 1.1 0.9 0.8 0.9 3.8 0.6 0.2 0.5 0.7 3.2 3.8 23.3 0.7 0.2 0.2 0.8 0.3 0.2 0.3 0.9 0.5 1.0 2.2 0.1 1.6 0.5 0.3 0.5 5.4 0.7 0.2 14.0 2.8 0.4 0.5 3.7 1.4 0.6 12.6 3.3 0.8 1.2 0.0 0.0 0.0 0.0 0.7 0.4 0.6 0.0 0.2 0.0 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.1 0.1 0.0 0.0 0.9 0.0 49.1 0.0 7.7 0.0 1.5 0.3 0.4 97.3 0.4 56.3 14.8 40.8 74.7 0.3 8.7 13.5 45.1 3.5 36.8 0.5 0.6 67.3 21.0 0.2 0.4 0.2 0.6 0.2 0.5 0.7 0.2 0.2 0.5 0.2 0.5 1.2 1.3 12.8 2.8 1.0 17.0 0.4 0.6 0.0 0.0 0.5 1.2 0.9 0.6 0.0 2.0 3.7 0.0 0.1 165.9 0.1 0.0 0.1 0.3 0.5 0.3 1.2 0.0 7.4 0.5 0.0 0.0 2.7 2.6 0.2 2.5 0.1 3.9 1.2 2.7 0.0 0.5 0.0 0.0 5.0 1.5 0.3 0.0 3.5 1.8 6.5 2.3 0.5 324.4 0.0 0.2 0.0 0.0 0.0 37.9 0.6 0.0 0.6 5.3 1.1 0.0 0.7 0.7 0.1 0.2 0.1 0.6 0.1 104.7 0.0 0.2 0.4 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 378.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002134, CAB016293, HPA073514" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: " "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 96.4 38.2 12.5 115.5 15.6 35.9 73.5 14.2 14.2 57.3 13.7 34.5 24.0 77.2 22.9 64.1 54.7 101.4 31.7 12.8 35.4 19.8 27.9 68.8 141.8 30.4 17.4 8.3 77.5 16.8 9.8 9.3 67.2 25.3 26.7 45.5 7.7 64.2 32.3 16.9 59.3 48.3 88.1 21.9 108.7 31.0 19.0 19.4 117.8 37.7 32.9 134.2 114.7 53.3 36.9 43.5 3.2 14.4 0.6 97.4 319.5 0.4 89.9 238.0 245.7 324.2 0.0 54.1 251.7 75.4 55.3 79.2 122.2 2.2 91.1 97.7 78.4 1.1 64.9 17.2 0.1 181.8 22.8 4.2 302.4 159.5 126.5 177.8 117.8 262.8 218.1 1.4 179.4 138.6 0.0 302.2 21.1 38.4 0.0 32.5 140.6 91.4 295.0 34.4 16.1 6.6 0.1 117.7 1.0 259.5 56.9 0.4 26.3 150.2 63.1 29.7 179.9 38.2 165.8 82.8 235.5 181.2 72.7 155.7 9.1 67.7 0.4 57.5 66.4 51.9 88.4 54.3 59.4 68.3 94.6 33.9 43.3 164.4 91.6 65.3 51.1 82.1 63.8 12.5 15.6 14.2 14.2 12.8 35.4 30.4 17.4 8.3 25.3 21.9 19.4 36.9 378.4 38.5 54.6 4.2 217.8 95.0 110.7 197.6 174.8 0.4 47.8 43.8 10.7 37.1 130.7 42.3 0.0 3.4 278.3 7.9 1.9 38.0 4.9 41.9 219.1 286.8 12.1 38.7 1.3 47.8 2.9 207.8 9.7 68.0 138.3 27.7 137.4 3.0 214.2 0.0 2.2 19.9 79.3 163.8 135.0 9.8 117.4 187.2 83.6 116.2 202.4 30.8 329.6 37.2 20.7 47.1 23.5 53.0 143.3 32.6 7.9 4.9 76.6 1.4 85.5 185.3 132.7 2.4 13.2 92.6 68.2 3.3 219.2 70.6 26.4 107.5 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.7;lymphoid tissue: 50.7;urinary bladder: 14.2" "Group enriched" "Detected in some" 4 "B-cells: 64.2;Early spermatids: 24.0;Late spermatids: 33.3;Plasma cells: 40.1" "Cancer enhanced" "Detected in many" "cervical cancer: 15.1" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "memory B-cell: 143.8;naive B-cell: 63.7" "Lineage enriched" "Detected in many" 7 "B-cells: 143.8" "Cell line enhanced" "Detected in some" "Daudi: 94.6;HDLM-2: 132.5;Karpas-707: 50.4;U-266/70: 41.7;U-266/84: 34.2;U-87 MG: 38.6" "Low region specificity" "Detected in many" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 1.2 0.6 0.8 21.8 0.5 1.2 0.9 0.8 0.7 0.6 6.9 2.4 1.9 0.4 0.3 1.6 0.4 2.4 0.3 0.8 0.7 0.4 1.7 1.7 50.7 1.2 1.0 0.4 0.2 0.4 0.0 9.9 0.9 1.0 0.9 2.3 0.4 1.3 0.1 0.3 0.6 15.7 0.8 0.7 25.1 3.2 2.5 0.9 4.2 0.7 1.0 49.9 14.2 0.5 0.6 15.8 0.0 0.9 0.0 0.0 12.5 0.0 0.0 1.6 1.1 1.0 0.0 0.0 94.6 0.1 0.0 0.1 0.1 0.0 0.0 1.0 132.5 0.0 3.3 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 50.4 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 0.0 8.9 0.0 8.3 8.6 0.0 0.2 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.1 17.9 0.3 41.7 34.2 0.8 38.6 3.4 6.7 20.7 8.2 0.0 2.0 7.0 5.4 143.8 5.3 3.5 4.2 63.7 0.5 1.3 16.3 0.0 8.2 0.0 11.9 5.0 0.8 0.5 0.8 0.7 0.8 0.7 1.2 1.0 0.4 1.0 0.7 0.9 0.6 0.4 0.0 0.0 0.0 64.2 0.0 0.1 0.2 0.0 0.7 0.1 0.3 0.3 0.0 0.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 24.0 0.0 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.4 0.0 0.0 3.2 1.9 33.3 0.3 3.2 3.6 0.0 4.0 0.3 0.0 0.5 0.0 0.1 0.1 0.7 40.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 1.7 0.4 1.4 0.0 0.0 10.0 0.0 0.0 0.4 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.9;fallopian tube: 17.2;testis: 15.6" "Group enriched" "Detected in many" 4 "Early spermatids: 77.2;Endometrial ciliated cells: 49.9;Late spermatids: 25.7;Respiratory ciliated cells: 93.6;Spermatocytes: 32.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "RPTEC TERT1: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA034835 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA034835: " "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 0.5 0.7 2.8 0.1 1.7 0.2 0.9 1.7 1.7 0.9 2.3 0.2 0.0 1.1 0.6 0.4 17.2 0.6 0.2 1.3 2.5 1.0 0.2 2.0 0.2 5.9 3.3 0.9 1.5 0.2 0.5 0.4 0.4 3.4 0.4 0.3 0.8 0.2 0.5 0.2 0.4 0.2 0.5 5.4 0.5 0.2 15.6 2.3 0.3 0.5 0.2 0.3 0.3 0.2 2.3 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 19.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 1.7 1.7 1.7 1.3 2.5 5.9 3.3 0.9 3.4 5.4 2.3 2.3 1.0 0.0 1.1 5.5 0.3 0.1 0.5 1.9 0.6 0.8 1.8 1.4 0.3 5.7 12.4 3.7 2.1 0.9 1.6 0.5 5.9 0.3 77.2 49.9 1.8 0.7 1.2 3.6 1.7 0.2 0.5 1.3 0.0 1.8 3.8 1.8 1.8 0.6 0.5 1.7 2.2 0.2 4.1 1.3 0.3 25.7 2.5 1.0 0.0 1.9 0.2 5.3 0.0 3.0 1.7 0.6 0.1 2.2 0.0 0.3 1.2 8.3 93.6 0.8 0.0 3.6 1.7 32.7 4.3 0.1 0.1 0.8 0.3 1.0 0.4 0.3 EIF5A2 ENSG00000163577 "Eukaryotic translation initiation factor 5A2" Q9GZV4 3 170888418-170908644 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Group enriched" "Detected in many" 12 "Early spermatids: 353.0;Late spermatids: 977.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029090 Approved Supported Vesicles NA NA Vesicles "HPA029090: AB_10671359" "unprognostic (2.41e-1)" "unprognostic (2.42e-1)" "unprognostic (4.05e-1)" "unprognostic (5.75e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (1.11e-3)" "unprognostic (1.47e-1)" "unprognostic (3.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (2.66e-2)" "unprognostic (3.45e-2)" "unprognostic (5.92e-2)" "unprognostic (1.64e-2)" "unprognostic (4.29e-3)" 4.0 2.7 3.1 3.1 3.4 4.2 3.0 6.2 6.4 3.2 2.0 2.7 1.8 4.5 1.3 2.9 2.4 3.5 4.1 2.7 5.3 5.0 1.6 2.3 2.8 7.2 4.8 1.8 4.4 3.4 3.7 1.9 1.8 8.5 2.7 2.6 2.9 1.9 3.0 1.3 1.9 1.6 7.2 4.6 2.4 9.2 28.6 5.5 4.3 2.2 3.1 3.2 3.5 2.0 7.6 22.7 11.6 4.2 5.9 21.7 14.2 10.0 17.1 22.3 17.4 25.1 23.6 14.4 14.2 30.9 23.4 38.9 7.4 13.4 6.0 21.9 15.8 5.8 6.9 4.6 7.5 14.6 18.2 19.9 16.6 8.7 26.3 21.4 24.2 9.1 3.7 5.8 0.1 28.7 7.6 8.1 7.9 8.1 17.5 7.8 0.0 12.0 0.0 7.3 4.0 3.4 6.4 17.7 4.6 14.4 6.5 10.0 11.9 12.0 21.2 15.0 44.8 38.9 21.6 0.3 33.3 7.2 6.2 15.4 14.9 1.4 1.5 12.4 1.5 8.7 2.2 8.4 11.9 1.0 3.5 5.0 8.3 0.7 8.8 1.4 1.0 11.3 5.0 3.1 3.4 6.2 6.4 2.7 5.3 7.2 4.8 1.8 8.5 4.6 5.5 7.6 16.6 0.0 0.5 4.9 4.4 17.1 8.5 7.8 10.8 2.5 2.1 2.7 9.5 0.0 1.8 1.8 0.0 1.2 18.1 1.6 1.9 6.4 353.0 0.9 7.7 12.8 4.9 2.1 7.1 7.5 1.9 11.7 8.6 0.6 2.5 2.6 3.3 2.5 8.9 0.0 8.8 0.8 2.0 3.8 7.2 977.9 12.8 4.5 10.6 3.7 7.9 8.0 28.8 4.0 10.1 19.6 6.1 11.3 3.7 8.2 1.7 21.1 3.4 2.7 46.0 9.6 11.6 54.3 10.0 2.3 21.6 0.7 15.7 2.2 1.8 5.7 SLC2A2 GLUT2 ENSG00000163581 "Solute carrier family 2 member 2" P11168 3 170996347-171026743 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 842.9" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 457.6" "Cancer enriched" "Detected in some" 12 "liver cancer: 105.2" "Region enhanced" "Detected in single" "white matter: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 55 "CACO-2: 7.7;Hep G2: 27.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010444, HPA028997" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB010444: AB_641068, HPA028997: AB_2672860" "unprognostic (9.56e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.63e-5)" "unprognostic (3.10e-1)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (6.31e-2)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.1 0.0 66.7 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.2 31.1 842.9 0.0 0.0 0.5 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 27.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.4 0.2 0.2 0.5 0.4 0.0 0.6 0.3 0.3 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 90.1 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.2 6.7 0.0 0.0 0.1 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 457.6 0.0 0.0 0.1 3.0 0.0 10.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 2.5 0.0 0.0 0.0 105.4 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.8 0.0 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870208 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 651.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 912.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 31.1 32.3 14.0 64.8 15.5 94.4 47.2 14.4 20.7 23.5 13.6 36.5 19.1 25.0 17.9 75.9 32.6 17.3 22.7 13.9 14.9 19.0 48.3 26.1 75.9 15.5 15.6 13.7 34.3 47.9 8.3 22.6 17.4 17.2 25.3 33.4 7.8 34.5 15.9 10.0 38.8 33.2 26.7 14.8 67.9 39.0 13.9 15.3 40.2 17.1 6.3 63.7 61.9 38.3 20.1 153.8 169.2 54.4 632.1 156.8 912.4 165.5 152.9 349.5 121.7 78.4 72.8 34.8 472.8 34.5 143.1 379.6 39.3 136.4 390.2 67.7 28.8 24.7 43.2 21.4 166.4 632.4 88.7 60.1 670.6 775.2 38.9 409.7 189.0 418.9 257.7 30.4 29.8 672.0 194.3 650.6 49.7 849.1 58.6 31.0 857.7 19.4 72.7 305.4 337.4 9.2 45.7 15.4 75.6 72.1 29.2 105.6 77.2 196.3 23.3 175.9 47.2 216.8 47.1 36.0 76.2 420.5 53.7 489.4 2.2 9.5 4.3 13.2 12.6 26.9 47.1 19.4 17.9 10.7 34.8 12.9 14.5 2.1 28.8 17.8 51.2 13.1 6.9 14.0 15.5 14.4 20.7 13.9 14.9 15.5 15.6 13.7 17.2 14.8 15.3 20.1 153.2 9.6 43.7 4.6 379.6 197.6 240.2 260.8 198.6 13.9 185.1 397.2 18.1 55.8 111.4 20.2 4.2 89.8 241.9 111.5 66.5 160.8 37.6 128.4 279.6 138.5 144.6 266.7 3.3 232.3 297.4 169.0 146.3 116.8 106.5 202.8 103.9 129.5 184.7 8.4 4.5 240.7 93.6 187.4 101.4 36.3 139.4 148.9 78.2 2.8 108.7 54.2 69.0 7.5 10.1 400.8 137.1 89.1 651.0 421.5 99.1 94.1 60.5 21.0 46.0 189.5 472.0 67.2 58.9 511.7 247.8 98.4 173.7 260.4 197.5 356.3 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128062 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "intestine: 5552.3;liver: 13171.3" "Cell type enhanced" "Detected in some" "Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 122.1;Hep G2: 393.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol NA NA 45000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 6.7 0.8 0.6 161.7 0.5 0.0 10.7 0.4 1.8 0.6 0.3 5552.3 4794.9 13.1 0.0 2.6 3.9 0.5 0.7 0.5 0.5 734.4 13171.3 0.9 3.8 0.5 0.5 0.4 0.9 1.1 0.3 0.8 0.7 0.5 2.6 3448.7 0.1 0.5 8.5 0.9 0.4 4767.4 232.6 0.4 2.8 15.9 1.1 0.5 0.1 0.5 0.4 0.1 0.6 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 122.1 0.0 1.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 393.9 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 33.0 0.5 0.0 0.0 0.3 6.4 37.4 0.0 0.5 3.6 24.7 2.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 11.8 0.7 0.4 0.1 2.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 1.8 0.5 0.5 0.5 0.5 0.4 0.5 0.4 0.5 0.6 0.0 0.0 0.0 0.3 42.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.3 120.1 0.0 60.7 0.0 0.2 0.0 12424.2 156.5 0.0 0.0 0.0 0.0 7.5 261.9 149.7 0.1 0.0 1.2 0.1 2.6 0.0 129.2 0.0 105.3 7459.2 1.5 0.0 0.1 1061.1 0.0 166.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3975.2 0.0 0.0 0.1 15929.5 2014.4 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.0 1.4 29.3 0.0 1708.4 0.0 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078902 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 4.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "HDLM-2: 79.8;U-266/70: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol NA NA 26000 Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavorable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 6.0 5.9 5.4 2.3 8.9 2.5 3.3 11.8 14.2 7.4 0.0 4.8 1.9 4.2 1.9 6.3 4.1 5.9 5.5 10.0 5.9 5.8 3.2 3.1 1.0 11.0 8.5 7.4 2.2 3.8 15.6 10.2 8.7 14.3 4.0 4.0 11.4 15.4 2.2 22.0 5.8 2.5 4.1 0.0 2.2 6.1 1.7 11.7 3.5 10.8 18.0 2.3 10.9 4.0 13.7 2.6 1.7 8.7 4.6 5.1 0.1 5.4 0.3 0.2 0.9 0.3 0.5 0.6 0.5 0.8 0.4 2.0 8.1 7.4 0.5 0.3 79.8 7.9 7.7 7.0 0.9 0.2 4.7 8.6 0.9 3.5 0.2 0.5 0.6 0.5 3.8 0.3 12.0 0.1 4.2 1.8 0.5 5.1 14.2 1.7 9.5 1.5 1.8 0.4 8.4 10.5 9.0 4.5 5.2 0.3 3.0 5.7 4.7 0.4 0.9 0.9 0.7 2.9 75.6 0.3 4.3 1.1 3.9 1.9 0.4 1.6 3.2 1.5 3.5 0.1 0.1 0.3 1.0 0.8 0.6 0.5 1.0 0.1 0.6 4.9 0.4 0.0 1.6 5.4 8.9 11.8 14.2 10.0 5.9 11.0 8.5 7.4 14.3 0.0 11.7 13.7 2.6 6.4 2.7 126.7 1.5 8.7 5.7 3.0 8.6 59.4 4.7 3.0 33.9 8.6 10.9 1.8 35.5 3.8 11.6 12.5 0.0 2.1 1.2 3.2 17.5 5.3 13.8 3.4 344.6 4.3 3.4 6.5 11.7 6.8 0.0 2.2 2.5 18.1 7.1 6.7 175.7 8.0 14.2 15.4 7.2 1.2 5.0 14.0 3.6 53.4 6.6 10.2 26.8 111.6 77.4 2.2 8.3 5.3 2.9 5.9 2.2 3.7 9.5 10.4 0.0 42.5 21.4 2.6 3.4 13.1 8.7 2.6 3.8 2.6 5.6 21.2 ICA1L "ALS2CR14, ALS2CR15" ENSG00000163596 "Islet cell autoantigen 1 like" Q8NDH6 2 202773150-202871766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 171.7;Inhibitory neurons: 114.3;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 84.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042507 Approved Approved Mitochondria NA NA Mitochondria "HPA042507: AB_10797016" "unprognostic (4.14e-3)" "unprognostic (3.60e-3)" "unprognostic (5.15e-2)" "unprognostic (5.63e-3)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (8.05e-4)" "unprognostic (1.66e-1)" "unprognostic (9.60e-2)" "unprognostic (4.50e-4)" "unprognostic (4.15e-1)" "unprognostic (8.15e-3)" "unprognostic (2.97e-2)" "unprognostic (1.74e-1)" "unprognostic (9.79e-2)" "unprognostic (1.58e-3)" 3.4 4.9 9.8 1.3 12.2 4.0 3.5 23.4 21.5 6.6 6.8 5.1 1.5 7.6 5.7 2.6 9.6 3.6 4.5 13.4 11.3 2.2 0.5 2.2 1.5 4.9 6.5 10.6 8.1 2.7 7.2 15.9 5.3 8.7 5.6 1.7 17.7 1.9 6.2 5.1 1.9 2.0 4.7 2.8 1.4 3.7 8.4 8.3 2.7 5.1 6.8 1.2 5.4 3.4 12.8 1.5 1.2 2.9 8.4 2.7 5.0 21.8 2.9 3.8 1.6 2.3 1.4 0.6 1.7 0.8 3.5 4.6 0.8 4.0 1.4 2.1 1.5 3.1 3.6 1.8 1.8 1.5 4.4 2.1 1.9 2.4 1.7 1.4 4.9 2.4 5.6 2.8 1.6 2.5 0.7 3.6 6.0 8.4 0.5 3.1 4.3 4.4 0.7 1.6 3.9 7.8 7.5 4.5 0.2 1.9 2.4 1.0 3.4 1.6 7.0 1.8 1.5 4.4 5.5 8.9 4.5 4.0 1.4 1.3 1.2 1.1 0.6 0.9 1.2 0.7 1.3 0.8 0.7 1.6 2.3 1.1 1.6 1.5 2.3 2.1 1.1 0.7 0.7 9.8 12.2 23.4 21.5 13.4 11.3 4.9 6.5 10.6 8.7 2.8 8.3 12.8 13.0 9.6 10.0 62.0 10.5 2.0 4.4 2.9 1.2 58.7 4.1 2.8 15.2 1.5 8.7 18.4 60.5 16.3 5.7 1.0 0.0 5.3 28.7 40.9 17.0 5.8 19.2 2.5 171.7 4.9 37.7 12.0 3.6 9.9 6.3 17.4 5.7 1.1 3.6 16.8 114.3 2.1 4.1 5.3 9.7 40.2 31.7 5.2 7.2 15.9 3.8 22.1 17.5 93.5 42.7 3.4 0.6 46.3 2.1 5.2 1.9 3.7 36.7 84.1 0.0 10.0 6.3 34.1 8.8 1.9 2.3 7.5 7.3 6.0 1.7 2.7 CTLA4 "CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12" ENSG00000163599 "Cytotoxic T-lymphocyte associated protein 4" P16410 2 203867771-203873965 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 37.7" "Cell type enriched" "Detected in some" 8 "T-cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 7 "T-reg: 44.5" "Lineage enriched" "Detected in single" 445 "T-cells: 44.5" "Cell line enhanced" "Detected in some" "Karpas-707: 1.5;SK-MEL-30: 3.0;U-266/70: 4.3;U-266/84: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.92e-2)" "unprognostic (9.13e-3)" "unprognostic (1.47e-3)" "unprognostic (9.89e-6)" "unprognostic (1.86e-1)" "prognostic favorable (4.48e-5)" "unprognostic (1.02e-1)" "unprognostic (1.75e-2)" "unprognostic (1.84e-3)" "unprognostic (2.65e-3)" "unprognostic (2.77e-1)" "unprognostic (3.76e-1)" "unprognostic (9.86e-10)" "unprognostic (4.13e-2)" "unprognostic (7.45e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-2)" 1.1 0.2 0.6 18.6 0.5 6.1 1.1 0.5 0.7 0.6 0.6 1.2 0.3 0.3 0.0 1.6 0.6 5.3 0.5 0.5 2.0 0.6 0.7 2.9 37.7 1.2 0.6 0.4 0.1 0.4 0.5 0.3 0.3 1.6 1.5 3.2 0.0 0.5 1.0 0.1 0.7 6.2 0.9 0.6 3.9 2.9 1.1 0.5 10.2 1.1 0.2 17.1 5.9 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 4.3 13.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 6.2 0.8 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 44.5 0.6 0.6 0.5 0.5 0.7 0.5 2.0 1.2 0.6 0.4 1.6 0.6 0.5 0.5 0.4 0.0 3.2 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 4.1 0.0 1.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 3.3 0.0 2.8 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 1.0 0.2 0.9 0.1 41.9 0.0 0.0 0.1 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936763-203961577 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 16.6;lymphoid tissue: 20.4" "Cell type enriched" "Detected in some" 12 "T-cells: 81.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 29.1" "Lineage enriched" "Detected in single" 54 "T-cells: 29.1" "Group enriched" "Detected in some" 8 "HEL: 4.6;MOLT-4: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favorable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 0.5 0.1 0.0 7.8 0.0 16.6 0.3 0.0 0.0 0.2 0.0 0.7 0.7 0.2 0.1 0.5 0.3 1.5 0.2 0.0 0.0 0.2 0.4 2.6 14.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 1.3 0.0 0.4 0.0 0.0 0.2 2.3 0.4 0.0 3.3 1.3 0.2 0.0 20.4 0.4 0.0 16.3 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 4.2 0.0 15.1 6.8 0.0 0.0 15.7 7.2 0.1 0.5 0.0 0.0 29.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.3 0.0 3.1 2.9 0.0 0.0 0.0 0.0 1.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.1 2.0 0.2 6.3 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.8 4.7 0.1 0.0 3.1 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.0 1.8 0.1 81.2 0.0 0.0 0.1 RYBP "AAP1, DEDAF, YEAF1" ENSG00000163602 "RING1 and YY1 binding protein" Q8N488 3 72371825-72446623 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 524.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053357 Approved Supported Nucleoplasm NA No Nucleoplasm "HPA053357: AB_2682124" "unprognostic (6.80e-2)" "unprognostic (2.81e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-1)" "unprognostic (1.65e-1)" "unprognostic (1.14e-2)" "unprognostic (2.40e-2)" "unprognostic (3.84e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.50e-5)" "unprognostic (1.89e-1)" "unprognostic (4.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.22e-1)" 8.2 5.4 1.9 0.9 2.0 2.7 7.8 1.5 2.4 9.3 1.0 9.2 0.8 10.1 0.6 7.2 8.6 1.2 5.3 1.9 1.9 6.8 8.7 11.6 0.8 1.7 1.6 1.8 11.0 4.7 0.8 5.9 2.2 1.5 8.8 1.1 2.1 6.7 1.2 4.4 7.9 7.4 1.5 1.4 8.7 7.1 8.2 1.9 1.6 5.9 0.8 1.0 8.9 7.9 2.1 0.9 0.9 1.7 1.6 1.5 1.5 1.1 0.9 2.0 1.7 2.1 1.6 1.2 1.0 0.9 1.5 2.0 0.4 1.9 1.4 2.1 6.0 1.0 4.7 1.2 0.7 1.1 0.9 1.1 2.3 1.7 2.2 3.5 2.2 0.5 1.1 1.4 3.1 1.4 1.4 1.3 0.9 3.1 2.7 1.1 1.4 1.5 0.6 1.3 1.0 1.3 5.2 2.4 2.3 1.2 2.7 0.7 1.1 1.3 2.2 1.6 1.3 0.8 2.5 2.7 0.9 1.1 1.6 2.4 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.8 0.1 0.2 0.2 0.1 0.1 1.9 2.0 1.5 2.4 1.9 1.9 1.7 1.6 1.8 1.5 1.4 1.9 2.1 67.4 57.7 27.6 29.4 39.1 107.2 67.8 19.2 46.1 74.7 75.5 51.4 39.2 32.9 28.9 42.3 16.7 26.9 63.1 58.7 33.2 21.1 27.3 67.5 103.7 70.9 81.2 42.7 49.5 24.0 51.7 61.5 13.7 87.5 69.0 27.1 55.0 40.5 16.5 38.7 64.2 50.5 26.4 37.6 77.3 13.4 25.7 71.3 35.6 60.9 31.9 22.4 27.8 42.7 524.1 32.8 49.0 43.6 49.0 65.0 16.8 24.7 32.3 40.8 32.9 74.9 42.1 57.9 37.0 51.7 97.0 186.9 44.3 98.5 34.9 65.1 PPP4R2 ENSG00000163605 "Protein phosphatase 4 regulatory subunit 2" Q9NY27 3 72996803-73069198 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034695, HPA039837, HPA073758" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632" "unprognostic (4.60e-2)" "unprognostic (2.75e-1)" "unprognostic (3.98e-3)" "unprognostic (5.62e-2)" "unprognostic (8.86e-2)" "unprognostic (4.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (2.13e-3)" "unprognostic (1.87e-2)" "unprognostic (2.86e-3)" "unprognostic (1.67e-2)" "unprognostic (4.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.23e-1)" "unprognostic (3.35e-1)" 27.5 23.4 19.7 27.1 26.9 102.2 23.0 26.5 25.5 28.1 25.6 27.2 24.9 24.9 19.2 23.2 27.9 23.5 26.0 20.7 22.1 23.8 54.0 18.1 26.5 23.3 23.2 20.2 23.1 23.2 25.6 11.1 28.8 23.1 18.5 24.0 24.7 20.9 15.8 26.0 16.8 22.5 19.0 23.4 21.8 21.6 27.4 22.4 36.6 25.0 25.1 26.0 24.2 15.4 42.1 33.6 38.5 80.9 48.2 41.7 35.9 48.8 66.2 46.7 59.0 61.3 56.1 39.8 63.3 37.3 39.7 56.0 23.6 63.6 36.8 76.0 96.6 23.8 71.1 43.6 67.8 45.8 105.7 70.6 40.9 53.6 71.3 58.3 40.9 41.4 62.9 63.6 70.6 49.5 49.3 88.3 45.8 74.8 50.0 31.8 82.0 45.9 58.9 50.0 89.4 18.1 47.7 77.3 49.9 62.1 57.9 45.9 58.7 47.0 52.4 62.4 61.3 57.3 43.1 97.4 125.5 36.9 79.9 60.4 7.9 5.9 14.8 12.5 3.4 13.8 6.9 12.9 13.1 5.1 7.8 11.1 10.0 21.3 11.3 5.7 18.0 17.6 4.3 19.7 26.9 26.5 25.5 20.7 22.1 23.3 23.2 20.2 23.1 23.4 22.4 42.1 56.8 57.7 32.4 19.2 58.5 117.1 110.1 115.8 69.4 50.1 53.2 55.5 54.7 47.1 74.0 27.6 14.6 74.8 62.8 72.4 19.6 63.4 58.1 86.3 76.0 61.9 53.8 61.0 45.6 53.1 72.0 61.6 38.2 142.7 30.9 49.1 40.4 76.4 43.1 50.5 34.8 55.5 77.3 39.2 78.1 12.7 53.4 61.6 56.9 41.2 52.6 53.9 54.6 42.3 101.8 71.4 58.3 48.5 69.7 115.7 44.3 45.8 64.0 39.0 39.5 73.9 60.4 100.6 77.1 54.6 109.1 138.3 69.4 59.1 54.5 128.1 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921205-112975103 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 14.8;granulocytes: 15.2;Hepatic stellate cells: 14.6;Hofbauer cells: 31.8;Langerhans cells: 19.9;T-cells: 12.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.7" "Immune cell enriched" "Detected in many" 4 "basophil: 234.9" "Lineage enriched" "Detected in all" 10 "granulocytes: 234.9" "Cell line enriched" "Detected in some" 8 "HEL: 25.5" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" NA NA 2000000 "Plasma membrane" "HPA068512: AB_2732784" "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 1.7 1.2 0.3 3.0 0.3 1.7 1.4 0.2 1.7 0.7 2.5 1.5 1.6 0.7 0.3 3.8 0.5 1.9 0.6 0.3 0.3 0.5 2.4 1.9 4.4 0.3 0.2 0.3 0.3 0.5 0.5 0.2 5.4 0.3 0.6 2.3 0.1 0.6 0.7 0.1 2.7 2.0 1.1 0.2 8.0 1.5 0.7 0.3 3.4 0.5 0.9 4.6 1.9 0.5 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 25.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 1.2 0.0 234.9 2.9 53.6 4.0 1.3 7.0 9.9 13.8 7.9 22.9 5.6 13.4 6.1 0.8 2.5 0.4 0.5 4.3 5.2 0.3 0.3 0.2 1.7 0.3 0.3 0.3 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 1.1 1.6 4.4 1.9 0.1 0.0 14.8 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.1 1.0 0.1 0.5 0.0 4.0 5.7 0.0 0.2 0.9 0.0 0.1 15.2 0.0 14.6 0.1 31.8 0.0 2.2 0.0 0.0 6.7 19.9 0.0 0.0 9.1 5.4 5.6 5.2 0.0 0.0 1.0 0.7 0.1 0.0 0.0 2.7 0.1 0.0 0.1 1.2 0.0 0.0 0.3 0.4 0.8 0.3 5.8 0.9 0.7 12.4 0.0 0.0 0.2 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990984-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 79.8;Spermatocytes: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria No No Mitochondria "HPA034831: AB_10671506, HPA058631: AB_2683783" "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favorable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 5.3 5.8 4.0 6.2 4.6 8.5 5.7 5.0 5.0 4.6 4.6 6.1 6.6 5.7 3.7 7.5 4.4 5.2 12.0 4.3 4.4 7.3 6.0 4.4 11.3 4.7 4.5 3.8 6.8 6.9 9.0 4.5 6.1 4.7 5.8 7.2 4.3 6.6 3.7 20.2 4.8 6.0 5.5 4.6 4.9 7.5 14.5 4.6 9.8 10.2 18.5 8.2 5.9 4.8 6.8 25.5 10.8 15.7 16.5 9.2 15.6 11.5 17.9 14.7 17.0 20.5 18.6 10.4 16.8 9.7 10.0 14.2 17.1 21.0 17.1 23.5 7.0 13.4 46.5 11.4 11.6 8.4 28.9 10.5 11.9 11.9 9.6 7.0 19.2 16.1 19.9 16.4 19.5 18.0 8.8 18.5 14.4 32.8 13.2 20.8 16.1 14.7 10.4 14.4 16.3 17.5 18.2 14.2 11.3 25.7 13.7 12.3 19.6 9.8 12.7 19.4 4.5 16.0 13.1 17.4 24.0 12.7 23.6 14.0 7.9 4.3 2.9 6.4 3.0 5.7 4.2 7.8 6.3 8.1 3.6 9.9 6.5 0.7 8.7 2.7 3.7 5.4 4.5 4.0 4.6 5.0 5.0 4.3 4.4 4.7 4.5 3.8 4.7 4.6 4.6 6.8 13.1 16.0 15.4 2.9 16.9 13.5 15.9 28.8 8.0 11.5 12.9 12.4 25.8 10.0 19.5 5.5 6.2 28.3 27.1 10.4 23.5 16.3 79.8 17.7 12.9 11.6 10.2 22.7 5.5 18.3 25.1 13.3 12.8 18.3 19.7 20.0 17.9 7.7 22.7 10.1 6.3 10.3 28.5 16.7 14.8 35.5 11.8 13.6 10.6 4.7 18.3 10.4 13.4 7.1 6.9 16.5 12.2 5.7 17.1 12.8 17.7 29.6 16.0 14.0 0.0 17.4 15.8 79.7 28.1 16.1 12.1 15.2 22.5 34.9 12.0 18.9 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002444-113019861 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 5.9 6.8 5.2 7.0 6.1 10.7 8.9 7.3 6.4 6.5 6.4 6.6 7.2 8.5 10.4 6.0 6.5 7.5 8.5 5.7 5.4 6.4 5.9 6.5 12.4 6.0 5.9 5.8 8.1 8.3 6.9 6.6 6.7 6.0 6.7 5.5 11.8 7.0 6.2 18.8 10.8 7.0 5.9 5.7 8.9 8.4 11.4 5.5 9.5 11.6 7.8 7.8 6.8 5.4 8.4 13.6 10.9 17.3 13.0 5.5 10.1 9.2 12.6 8.1 6.9 4.7 10.1 8.5 17.6 6.6 4.3 9.6 13.7 12.7 5.8 9.4 3.5 8.0 27.3 10.0 7.5 10.0 17.4 9.4 15.7 10.0 5.5 14.2 18.8 6.1 17.2 9.5 13.5 5.2 8.6 15.1 10.3 18.1 12.0 14.0 12.1 13.7 9.3 7.8 11.2 11.9 17.3 7.3 9.1 21.4 12.7 10.4 14.7 12.4 9.4 9.3 3.6 9.1 13.3 11.2 20.6 15.2 13.6 7.0 1.9 1.3 1.6 2.2 1.6 2.3 1.8 2.6 1.9 1.8 1.4 3.2 3.2 0.8 4.3 0.7 1.3 1.2 1.4 5.2 6.1 7.3 6.4 5.7 5.4 6.0 5.9 5.8 6.0 5.7 5.5 8.4 16.3 9.6 12.8 0.0 7.6 0.0 0.0 0.0 0.0 0.0 17.4 16.9 0.0 0.0 10.5 18.4 0.0 18.4 23.4 0.0 17.6 14.1 0.0 11.9 20.7 6.3 0.0 0.0 0.0 12.6 15.5 9.3 0.0 16.1 17.7 24.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 4.5 0.0 0.0 14.8 8.7 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 20.4 9.1 33.9 0.0 0.0 SPICE1 "CCDC52, SPICE" ENSG00000163611 "Spindle and centriole associated protein 1" Q8N0Z3 3 113442718-113515187 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA064843 Approved Supported Centrosome NA NA Centrosome "HPA064843: AB_2685367" "unprognostic (2.66e-1)" "unprognostic (1.27e-2)" "unprognostic (1.12e-1)" "unprognostic (4.95e-3)" "unprognostic (2.69e-1)" "unprognostic (1.01e-1)" "unprognostic (4.99e-3)" "unprognostic (1.17e-1)" "unprognostic (6.30e-2)" "unprognostic (2.24e-1)" "unprognostic (1.17e-3)" "unprognostic (1.89e-2)" "unprognostic (4.75e-3)" "unprognostic (6.53e-2)" "unprognostic (4.47e-1)" "unprognostic (3.64e-3)" "unprognostic (2.95e-2)" 4.4 3.8 2.4 4.6 2.5 4.2 7.5 3.4 3.1 8.3 3.6 6.7 4.2 8.6 4.9 7.0 8.0 7.8 3.8 2.7 3.1 4.6 4.1 4.7 4.2 2.3 1.9 1.2 7.9 6.4 6.4 8.9 5.5 2.0 6.5 6.6 7.8 8.6 5.0 2.7 5.7 5.4 6.8 2.0 4.2 6.9 7.2 2.0 8.4 6.9 2.3 5.5 6.2 7.3 3.5 17.0 10.4 12.1 10.6 7.5 9.2 7.6 8.2 6.3 10.9 13.6 9.2 9.4 9.9 11.6 7.2 10.7 16.0 6.3 8.0 14.7 5.9 2.8 9.0 9.3 6.1 4.5 18.0 6.8 7.5 7.9 11.3 4.6 9.6 8.0 18.0 5.8 8.2 3.8 17.7 15.6 7.0 13.0 13.4 11.5 10.8 10.3 8.8 4.0 10.7 6.2 10.8 8.7 10.3 4.8 13.4 10.2 7.2 8.0 5.5 8.8 5.1 7.5 7.9 5.8 16.7 11.0 10.5 8.2 3.6 4.1 1.5 3.2 3.0 5.2 5.6 5.0 4.0 3.1 6.1 7.0 5.2 2.1 2.7 2.9 9.7 2.6 2.0 2.4 2.5 3.4 3.1 2.7 3.1 2.3 1.9 1.2 2.0 2.0 2.0 3.5 6.7 0.0 4.2 14.4 12.0 6.8 7.9 5.4 9.1 6.4 9.4 5.8 2.5 5.7 5.6 5.5 8.4 4.7 3.5 8.0 0.0 5.4 6.5 22.8 11.9 4.7 3.6 9.9 20.2 4.5 5.9 7.4 16.3 12.7 1.3 10.1 3.3 5.2 4.4 3.3 6.8 10.6 6.1 2.5 3.9 3.5 9.9 4.1 0.0 15.9 2.3 7.9 1.0 16.1 14.4 5.6 3.6 3.4 13.9 4.1 3.9 4.2 15.3 25.0 6.6 6.2 5.4 20.9 16.9 7.7 7.7 3.4 7.5 6.2 7.4 8.5 CCDC191 KIAA1407 ENSG00000163617 "Coiled-coil domain containing 191" Q8NCU4 3 113964137-114056594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Endometrial ciliated cells: 68.0;Respiratory ciliated cells: 104.2;Rod photoreceptor cells: 40.4;Spermatocytes: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047833 Approved Approved Mitochondria NA NA Mitochondria "HPA047833: AB_10961639" "unprognostic (2.59e-2)" "unprognostic (3.93e-2)" "unprognostic (1.86e-1)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (1.42e-2)" "unprognostic (6.57e-2)" "unprognostic (5.91e-2)" "unprognostic (1.08e-1)" "unprognostic (2.90e-1)" "unprognostic (6.33e-2)" "unprognostic (3.64e-2)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.62e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.45e-4)" 2.6 3.3 5.4 3.2 4.7 2.9 4.8 4.0 4.5 4.1 10.8 3.2 1.8 5.4 7.9 2.5 12.2 3.5 1.6 4.5 5.8 6.0 1.9 4.7 4.4 5.9 5.9 3.6 4.8 5.1 8.0 11.0 2.1 5.0 5.1 3.2 14.1 3.6 4.9 0.9 7.7 4.0 2.7 5.7 5.6 3.1 9.8 4.8 2.8 8.4 0.8 4.1 3.5 3.4 4.7 3.7 1.9 3.0 2.5 0.8 4.3 0.9 0.8 1.5 1.1 1.8 0.4 4.1 1.0 1.4 1.5 1.0 4.6 0.9 1.6 2.6 0.7 0.7 0.8 0.7 0.3 1.2 1.1 0.5 1.8 4.2 1.5 2.2 2.0 2.2 2.8 0.3 2.1 0.7 1.6 2.3 0.4 0.5 2.4 1.4 1.4 0.6 2.0 4.2 1.8 1.8 2.9 1.5 0.3 1.5 1.5 7.2 0.4 2.4 2.1 0.5 0.9 0.5 3.0 2.6 3.5 2.7 0.6 1.0 0.1 0.8 1.6 0.9 0.8 1.0 8.9 1.8 1.5 0.9 8.3 0.9 1.5 4.4 0.8 0.5 3.7 1.4 0.9 5.4 4.7 4.0 4.5 4.5 5.8 5.9 5.9 3.6 5.0 5.7 4.8 4.7 5.2 12.8 14.4 0.0 20.0 0.0 4.0 0.0 4.6 8.9 5.7 7.0 0.0 0.0 16.1 12.9 37.5 1.8 7.9 1.5 13.7 5.4 27.1 68.0 9.5 3.7 4.9 2.1 0.0 3.6 0.5 4.0 9.7 10.6 1.3 9.1 4.6 1.3 3.0 20.2 0.0 2.3 0.0 3.2 0.0 13.1 4.1 3.0 0.0 0.0 2.0 21.6 4.1 0.0 0.0 2.6 1.0 5.3 3.0 1.7 2.4 5.0 104.2 40.4 0.0 6.3 3.5 68.3 13.3 4.3 0.0 0.3 4.5 8.1 2.7 2.8 CADPS "CAPS, CAPS1, KIAA1121, UNC-31" ENSG00000163618 "Calcium dependent secretion activator" Q9ULU8 3 62398346-62875416 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 139.8;retina: 186.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 772.6;Cone photoreceptor cells: 627.6;Excitatory neurons: 830.8;Inhibitory neurons: 1152.7;Oligodendrocyte precursor cells: 266.9" "Cancer enhanced" "Detected in many" "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 11.5;SCLC-21H: 19.7;SK-MEL-30: 9.0;U-698: 13.2;U-87 MG: 20.5" HPA059328 Enhanced Supported Approved Vesicles NA NA Vesicles "HPA059328: AB_2683982" "unprognostic (3.46e-3)" "unprognostic (1.40e-2)" "unprognostic (1.61e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (3.12e-2)" "unprognostic (9.27e-2)" "unprognostic (5.73e-2)" "unprognostic (2.08e-3)" "unprognostic (3.21e-1)" "unprognostic (4.20e-3)" "unprognostic (1.90e-2)" "unprognostic (2.04e-1)" "unprognostic (7.91e-3)" "unprognostic (5.35e-3)" 0.4 16.5 35.0 2.0 57.7 0.1 0.7 26.7 93.0 2.8 0.0 2.8 3.2 0.6 2.5 0.2 0.4 2.4 12.2 44.9 39.8 0.2 0.2 0.8 0.5 85.1 47.7 44.6 2.0 13.6 0.2 39.9 0.2 97.8 3.6 2.4 186.0 1.4 2.8 0.1 1.4 3.3 0.8 7.8 0.6 3.0 3.2 55.7 0.6 0.2 0.0 0.7 0.4 1.5 139.8 0.0 0.0 0.8 0.0 4.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 11.5 0.0 0.1 0.0 0.0 0.0 0.0 19.7 1.5 0.0 0.0 9.0 0.4 0.0 0.0 0.1 1.6 0.1 3.3 0.9 0.0 1.7 13.2 20.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 57.7 26.7 93.0 44.9 39.8 85.1 47.7 44.6 97.8 7.8 55.7 139.8 0.0 0.0 1.9 93.0 0.1 1.3 0.2 0.0 0.0 772.6 0.5 2.8 25.6 7.2 0.0 0.0 627.6 0.1 0.0 0.4 0.0 4.1 1.1 0.2 1.1 0.9 95.9 0.0 830.8 0.4 0.0 3.2 0.0 0.1 42.5 0.2 0.0 0.0 0.0 47.1 1152.7 5.0 0.0 0.0 1.6 2.1 15.2 0.0 8.8 30.0 0.0 21.3 0.0 266.9 27.0 0.9 1.3 2.6 0.0 0.3 0.7 0.1 0.0 64.7 0.0 3.2 1.2 0.2 0.7 0.0 0.1 0.0 0.4 36.9 1.8 0.2 NKX6-1 "Nkx6.1, NKX6A" ENSG00000163623 "NK6 homeobox 1" P78426 4 84491985-84499292 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.7;esophagus: 9.3;pancreas: 6.5" "Group enriched" "Detected in some" 5 "Ductal cells: 9.3;Early spermatids: 25.8;Spermatocytes: 16.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.4;HAP1: 6.2;HEK 293: 5.0;HMC-1: 4.1;PC-3: 3.0;U-2197: 6.8" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Group enriched" "Detected in many" 5 "hypothalamus: 2.5;medulla oblongata: 3.4;midbrain: 3.8;pons: 3.8;spinal cord: 7.9" "HPA036774, CAB070169" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB070169: AB_10011794, HPA036774: AB_10673664" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (9.13e-2)" "unprognostic (3.19e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.71e-2)" "unprognostic (2.46e-1)" "unprognostic (2.75e-2)" "unprognostic (3.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.85e-1)" "unprognostic (5.41e-2)" "unprognostic (7.13e-3)" "unprognostic (3.68e-1)" 0.0 0.0 1.7 0.0 1.0 0.0 0.2 0.7 1.0 0.0 0.8 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.1 0.0 4.3 13.7 0.3 0.1 6.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.7 2.2 1.7 0.0 3.2 0.0 0.0 0.0 0.0 2.0 0.2 0.1 4.4 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 2.0 0.0 6.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 3.0 0.0 2.0 0.0 0.0 0.3 1.1 0.0 0.7 0.0 0.0 1.3 0.0 0.5 0.0 0.0 1.8 6.8 2.0 0.0 0.0 0.0 1.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.7 1.0 0.5 2.7 4.3 13.7 0.3 3.2 5.3 1.7 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 25.8 0.2 1.0 0.1 0.0 0.0 0.0 0.4 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 16.7 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84583127-84651334 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 129.8;Respiratory ciliated cells: 210.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.1;hTCEpi: 56.9;OE19: 45.5;SK-BR-3: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced NA NA "HPA036187: AB_10601797, HPA064546: AB_2732714" "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favorable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favorable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.8 6.2 9.1 1.5 9.7 0.6 10.3 11.7 17.7 6.3 15.8 20.2 40.6 3.1 29.3 20.3 32.5 8.0 0.4 8.7 10.7 15.1 0.5 10.7 0.6 14.6 12.0 7.7 5.3 4.7 28.5 4.8 7.3 17.0 9.5 21.5 22.6 12.6 4.8 0.1 15.3 34.7 1.2 10.4 1.7 18.5 7.5 14.6 3.5 30.6 0.1 5.2 6.8 9.3 15.3 26.5 0.6 1.5 0.3 0.1 0.0 26.5 0.0 0.4 0.6 0.5 11.2 46.1 0.0 2.0 0.0 5.4 27.2 8.5 23.2 0.3 1.8 12.6 0.0 3.8 2.7 0.0 0.8 1.8 0.2 56.9 0.0 8.2 1.0 0.0 1.5 0.1 0.0 0.1 18.8 0.2 0.1 3.8 45.5 1.8 0.1 0.0 5.7 12.7 20.0 10.6 0.2 2.9 62.1 0.1 4.9 19.0 0.5 0.0 0.0 1.4 2.8 3.5 0.0 0.0 0.0 2.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 9.7 11.7 17.7 8.7 10.7 14.6 12.0 7.7 17.0 10.4 14.6 15.3 0.8 16.0 42.3 33.3 0.4 29.1 27.7 26.4 26.7 16.7 26.6 13.6 1.4 24.3 39.5 40.5 10.4 60.0 0.4 63.0 3.9 26.4 12.1 129.8 3.8 3.3 22.3 0.0 43.1 22.8 12.1 3.5 41.3 45.2 0.0 15.4 1.4 0.7 12.7 21.9 64.6 53.9 48.8 3.5 13.9 4.5 0.6 3.5 0.0 9.4 1.2 29.0 0.0 3.5 2.4 40.8 30.4 0.4 0.1 30.8 80.0 15.9 210.7 32.0 0.0 1.2 4.3 13.1 6.6 41.1 54.1 57.3 1.6 4.8 51.6 38.3 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669597-84966690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.6" "Group enriched" "Detected in many" 5 "Astrocytes: 241.0;Excitatory neurons: 231.0;Inhibitory neurons: 248.7;Microglial cells: 209.9;Oligodendrocyte precursor cells: 262.9;Oligodendrocytes: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "TIME: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "HPA042734: AB_2678135, HPA048572: AB_2680447" "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favorable (3.64e-5)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 8.7 8.7 15.5 7.6 29.4 14.5 8.8 26.4 21.0 8.6 7.4 5.7 3.6 8.2 6.5 7.5 8.2 8.8 5.7 17.0 21.3 20.3 5.6 7.4 2.6 30.8 30.9 14.5 13.7 9.1 16.5 6.5 11.9 26.4 8.7 5.7 26.5 7.2 7.5 5.9 10.9 4.8 8.5 23.3 7.9 5.6 8.2 23.0 3.5 11.8 13.4 2.4 8.7 5.8 45.6 11.9 7.8 14.3 7.9 24.8 19.3 9.0 11.2 11.8 11.5 10.3 9.1 9.6 0.0 11.3 18.8 12.3 5.9 15.4 12.3 14.6 7.9 4.9 7.5 9.0 5.5 9.4 5.9 13.7 14.2 10.9 15.0 15.1 13.9 37.1 6.0 7.5 35.3 21.4 8.5 5.7 1.4 7.4 11.4 4.0 8.4 11.4 1.8 19.6 15.6 16.8 7.8 13.8 15.1 7.5 13.5 7.9 14.4 57.0 15.1 14.9 8.5 14.1 0.1 0.0 0.0 10.2 5.0 16.9 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.1 15.5 29.4 26.4 21.0 17.0 21.3 30.8 30.9 14.5 26.4 23.3 23.0 45.6 28.5 19.2 12.9 241.0 1.0 14.7 9.1 12.4 11.4 46.6 13.8 11.3 18.2 20.0 14.7 16.5 35.5 11.8 0.5 6.5 1.9 8.6 6.7 27.1 27.8 20.1 9.1 1.3 231.0 7.3 6.9 19.5 15.3 43.4 0.0 31.0 17.9 8.1 20.5 28.6 248.7 7.8 20.3 43.1 14.1 10.1 18.3 29.9 7.2 209.9 19.7 28.7 0.0 262.9 440.4 10.7 6.5 24.5 0.2 13.6 4.8 18.4 15.5 41.9 26.3 30.0 22.8 11.4 7.3 14.1 16.1 14.5 1.8 15.0 6.7 13.6 COX18 FLJ38991 ENSG00000163626 "Cytochrome c oxidase assembly factor COX18" Q8N8Q8 4 73052362-73069755 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046772, HPA049489" Approved NA NA "HPA046772: AB_2679799, HPA049489: AB_2680791" "unprognostic (3.32e-3)" "unprognostic (2.01e-1)" "prognostic favorable (6.31e-4)" "unprognostic (9.01e-3)" "unprognostic (2.43e-1)" "unprognostic (2.17e-1)" "unprognostic (3.81e-2)" "unprognostic (6.97e-2)" "unprognostic (2.92e-1)" "unprognostic (5.29e-3)" "unprognostic (1.58e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.22e-7)" "unprognostic (1.28e-2)" "unprognostic (2.94e-1)" "unprognostic (5.80e-2)" "unprognostic (1.22e-3)" 1.4 3.9 0.7 0.5 0.8 0.5 1.4 1.3 1.0 1.2 0.9 1.4 0.6 1.5 0.9 1.4 1.2 0.4 2.5 0.8 0.7 1.7 2.4 1.2 0.7 0.5 0.5 0.7 1.6 2.0 0.7 1.3 0.6 0.7 0.9 0.6 1.3 1.9 0.6 2.7 1.3 1.4 0.4 0.2 1.3 1.7 1.3 0.7 0.4 1.1 1.2 0.5 1.2 1.2 0.7 0.6 1.0 1.0 1.0 0.9 0.9 0.8 1.0 0.9 0.4 0.5 0.8 1.1 1.8 0.7 0.6 0.7 0.6 1.0 0.7 0.4 1.4 0.7 0.9 1.3 1.3 0.7 1.5 1.2 1.1 0.7 0.4 0.8 1.1 0.8 1.6 1.4 1.7 0.8 0.5 1.8 1.0 1.5 1.1 1.1 1.0 1.6 2.6 0.8 0.6 1.5 1.0 1.1 0.9 0.4 0.8 0.8 0.8 1.1 1.0 0.8 1.3 0.5 1.7 0.8 1.1 1.2 1.1 0.8 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.1 0.2 0.2 0.3 0.1 0.1 0.7 0.8 1.3 1.0 0.8 0.7 0.5 0.5 0.7 0.7 0.2 0.7 0.7 5.6 3.2 6.3 7.2 10.1 2.5 3.7 4.5 1.2 11.7 7.1 4.2 13.9 5.7 7.3 9.2 22.9 8.0 9.0 5.5 13.7 6.5 4.0 6.7 8.4 6.7 5.4 7.8 10.5 8.0 8.3 7.0 5.6 7.1 0.0 17.4 11.4 16.7 8.8 20.2 10.6 7.7 4.1 13.9 3.0 2.0 9.0 8.4 5.4 6.5 12.5 6.6 11.3 10.1 13.4 9.3 5.2 9.4 18.1 6.6 6.6 13.0 8.1 14.3 13.1 7.5 6.0 10.2 7.3 5.5 1.4 3.0 8.6 12.7 9.6 3.4 PTPN13 "PTP-BAS, PTP-BL, PTP1E, PTPL1" ENSG00000163629 "Protein tyrosine phosphatase non-receptor type 13" Q12923 4 86594315-86815171 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 125.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 117.6;RT4: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002213, HPA063119" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "CAB002213: AB_564089, HPA063119: " "unprognostic (5.36e-2)" "unprognostic (4.46e-1)" "unprognostic (1.11e-1)" "unprognostic (2.54e-3)" "unprognostic (4.02e-1)" "unprognostic (9.03e-3)" "unprognostic (4.43e-2)" "unprognostic (4.38e-2)" "unprognostic (2.46e-1)" "unprognostic (7.05e-2)" "unprognostic (3.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-3)" "unprognostic (3.95e-3)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "unprognostic (2.85e-2)" 14.1 6.8 10.1 3.0 16.6 0.3 11.8 8.5 11.1 18.2 20.0 4.3 0.8 13.3 25.7 22.4 13.1 7.7 4.5 13.9 24.3 26.8 1.4 23.1 5.2 16.9 13.0 7.4 28.9 5.0 17.6 16.9 3.3 9.4 11.1 2.4 125.4 6.7 10.7 1.0 56.3 2.6 7.9 8.5 4.1 4.1 15.9 11.1 7.7 21.0 5.1 11.6 20.9 22.9 20.7 13.8 6.8 117.6 11.5 48.2 41.9 0.0 25.0 51.0 9.4 11.7 0.1 6.8 0.0 5.3 28.0 3.3 44.4 20.6 37.9 18.0 0.3 15.1 11.4 14.6 0.0 5.9 20.5 0.1 27.2 11.8 6.8 22.4 19.7 0.0 0.0 0.0 19.2 0.0 6.2 1.8 7.4 26.5 0.0 5.1 4.1 0.0 0.0 35.6 57.2 6.8 9.8 7.4 16.4 13.3 18.8 9.6 0.7 0.0 9.1 6.9 0.2 3.3 19.8 0.0 0.0 9.5 0.0 4.0 0.0 0.1 0.0 0.1 1.3 0.9 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 10.1 16.6 8.5 11.1 13.9 24.3 16.9 13.0 7.4 9.4 8.5 11.1 20.7 5.3 48.1 223.1 165.2 0.6 109.4 25.6 26.3 79.1 11.6 11.2 8.9 1.8 11.5 52.0 47.8 91.8 0.2 0.3 0.1 3.9 5.0 23.2 16.9 49.4 3.7 4.8 0.8 67.0 3.7 0.1 28.8 4.1 7.7 5.1 7.5 3.6 0.1 0.3 1.7 39.3 1.1 8.2 1.4 10.6 20.8 45.7 4.5 19.6 51.5 0.5 20.3 0.0 75.4 200.2 6.2 2.7 32.7 3.0 16.0 0.1 10.9 27.3 179.0 13.1 10.1 20.8 25.4 20.5 97.8 99.4 0.3 6.6 14.0 0.7 52.5 SYNPR "MGC26651, SPO" ENSG00000163630 Synaptoporin Q8TBG9 3 63228315-63616924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 101.6;retina: 39.1" "Cell type enriched" "Detected in some" 6 "Inhibitory neurons: 641.5" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Region enhanced" "Detected in all" "olfactory bulb: 743.6" "Low region specificity" "Detected in all" "HPA051368, HPA061671" Enhanced NA NA "HPA051368: AB_2681456, HPA061671: AB_2684582" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" "unprognostic (3.14e-3)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.50e-1)" "unprognostic (5.32e-2)" "unprognostic (1.82e-1)" "unprognostic (1.89e-1)" 0.0 0.3 36.1 0.1 101.6 0.0 0.0 61.9 61.3 0.0 12.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.6 52.3 37.6 0.0 0.0 0.0 0.0 44.5 33.4 70.1 0.0 0.1 0.0 1.2 0.0 26.9 0.0 0.1 39.1 0.6 0.0 0.0 0.0 0.1 0.0 20.2 0.0 0.5 0.0 49.2 0.0 0.2 0.0 0.0 0.0 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 101.6 61.9 61.3 52.3 37.6 44.5 33.4 70.1 26.9 20.2 49.2 47.7 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 5.3 0.0 72.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.0 641.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 45.0 0.0 8.0 7.6 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 ALB ENSG00000163631 Albumin P02768 4 73397114-73421482 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 135 "liver: 214254.8" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 65190.0" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 38 "Hep G2: 4500.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" NA NA 40000000000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 6.4 3.8 1.1 0.0 1.2 0.0 6.0 0.8 1.2 1.5 0.8 2.2 0.0 1.8 15.5 2.7 4.3 3.9 6.3 0.9 1.0 469.5 214254.8 6.7 1.3 0.9 0.9 0.9 2.5 1582.3 1.0 3.4 4.6 1.0 2.2 0.1 0.5 2.1 0.1 2.0 2.6 2.3 0.0 0.9 37.3 10.1 3.6 0.9 0.3 3.6 0.1 1.4 0.9 1.7 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.8 0.6 0.0 0.0 1.6 0.0 0.0 0.1 0.6 0.0 31.7 2.1 4500.0 0.0 117.1 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 17.0 0.2 0.0 0.1 2.0 0.0 4.0 0.0 0.1 2.1 95.1 0.0 0.0 3.2 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.4 0.1 0.1 7.0 0.6 32.9 0.1 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.8 1.2 0.9 1.0 0.9 0.9 0.9 1.0 0.9 0.9 1.0 0.1 0.0 0.0 1.0 187.5 0.0 0.0 0.0 0.0 0.0 43.4 18.9 0.1 13788.8 0.0 38.6 0.0 1.4 0.6 0.1 72.4 5.3 2.5 0.2 0.1 65.5 1.8 1133.8 0.2 273.8 11.1 0.5 4.6 0.0 0.0 0.1 1252.5 65190.0 8.5 0.0 0.2 0.0 0.0 1764.5 0.0 0.1 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.1 160.6 0.0 0.0 0.0 0.2 0.0 686.5 0.0 0.0 0.0 0.0 1.1 0.2 1.3 0.0 0.1 21.2 77.1 0.1 0.0 0.1 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819299-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8" "Group enriched" "Detected in some" 6 "Early spermatids: 19.5;Late spermatids: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.0;MCF7: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA053582 Uncertain Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "HPA053582: AB_2682199" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.0 0.2 0.0 0.2 0.4 0.6 0.0 1.1 1.8 0.0 0.0 0.1 0.6 0.3 0.0 0.7 0.1 0.2 0.3 0.5 0.1 0.1 0.3 0.3 0.3 0.0 0.1 0.3 0.5 0.6 0.0 0.0 0.1 0.7 0.1 0.0 1.4 0.3 0.0 1.1 0.9 0.3 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.8 0.2 0.7 0.4 0.4 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.7 0.3 1.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.6 0.8 2.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.4 0.0 1.8 0.4 0.4 0.5 0.4 0.1 0.6 0.4 0.9 0.0 0.4 0.4 0.3 0.1 0.9 0.1 0.1 0.2 0.3 0.5 0.3 0.4 0.6 0.7 0.2 0.9 0.1 0.9 1.4 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.4 1.1 1.8 0.5 0.1 0.0 0.1 0.3 0.7 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.2 0.1 0.5 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 19.5 0.2 0.2 0.1 0.0 0.0 3.9 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 34.4 0.3 0.0 0.0 1.0 0.1 0.2 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.3 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.3 C4orf36 MGC26744 ENSG00000163633 "Chromosome 4 open reading frame 36" Q96KX1 4 86876205-86892422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 10.8" "Group enriched" "Detected in many" 12 "Early spermatids: 129.5;Late spermatids: 349.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.8;CAPAN-2: 2.1;hTCEpi: 1.7;hTERT-HME1: 2.4" HPA057434 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites" Cytosol "HPA057434: AB_2683438" "unprognostic (2.01e-1)" "unprognostic (2.68e-1)" "unprognostic (7.78e-2)" "unprognostic (4.76e-2)" "unprognostic (7.31e-2)" "unprognostic (5.68e-2)" "unprognostic (5.93e-3)" "unprognostic (2.39e-2)" "unprognostic (5.20e-2)" "unprognostic (2.77e-1)" "unprognostic (2.76e-2)" "unprognostic (2.55e-1)" "prognostic favorable (7.69e-5)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (4.28e-2)" "unprognostic (7.75e-2)" 0.3 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.4 0.8 0.0 0.1 0.1 0.3 0.0 0.7 0.2 0.0 0.1 0.1 0.2 0.3 0.1 0.4 0.0 0.1 0.1 0.0 0.6 0.2 0.1 0.2 0.0 0.2 0.5 0.0 0.0 0.4 0.1 0.0 1.5 0.1 0.2 0.0 0.1 0.1 10.8 0.3 0.0 0.4 0.0 0.1 0.3 0.6 0.3 2.8 0.2 0.1 0.1 0.0 0.1 0.6 1.4 0.4 0.3 0.0 0.1 2.1 0.0 0.2 0.0 0.0 1.2 0.2 1.2 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.4 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.8 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.3 1.1 0.3 0.8 0.3 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.3 0.2 0.0 0.0 2.6 2.3 5.0 8.9 9.6 4.0 5.4 0.2 0.0 19.2 15.7 5.1 0.0 10.4 0.9 4.0 13.0 0.0 0.1 129.5 0.1 0.4 5.9 3.0 4.8 1.4 0.0 2.9 4.3 11.7 0.2 0.0 0.1 7.9 3.1 3.3 1.7 1.6 9.1 8.2 6.2 5.8 349.7 5.3 3.5 1.8 1.0 1.4 6.4 5.2 1.0 3.6 0.2 11.3 3.4 6.9 3.7 10.8 0.0 5.6 6.7 6.6 6.2 2.3 3.9 6.9 6.7 10.2 9.7 2.1 0.0 7.1 4.6 THOC7 "FLJ23445, fSAP24, NIF3L1BP1" ENSG00000163634 "THO complex 7" Q6I9Y2 3 63833870-63863868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 1032.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044143 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA044143: AB_10794892" "unprognostic (4.33e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-2)" "unprognostic (1.30e-1)" "unprognostic (2.26e-2)" "unprognostic (2.86e-1)" "unprognostic (1.20e-3)" "unprognostic (3.53e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-2)" "unprognostic (2.86e-2)" "unprognostic (9.90e-2)" "unprognostic (3.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.18e-2)" "unprognostic (4.25e-2)" "unprognostic (2.31e-1)" 55.2 64.1 61.4 43.6 64.0 80.8 75.8 62.0 85.8 54.8 56.4 66.0 64.8 51.0 53.7 73.8 43.4 49.0 88.8 64.6 64.7 68.5 74.1 41.3 68.6 62.4 63.0 61.0 44.8 62.8 52.5 33.8 54.0 61.7 44.2 69.8 65.1 50.9 50.0 104.4 64.7 54.2 60.1 61.0 38.5 49.6 48.0 62.3 73.0 44.8 105.0 68.6 61.4 50.8 64.8 141.2 83.5 95.6 23.9 125.1 172.5 89.6 120.2 126.9 139.2 140.1 101.6 151.5 168.3 49.1 155.1 139.2 79.3 107.5 190.4 194.1 169.6 75.5 150.2 102.8 117.2 130.1 212.6 69.6 123.9 157.2 118.4 213.1 137.6 155.1 110.0 116.8 158.6 170.2 1032.4 186.4 186.9 120.4 304.8 65.5 132.3 89.7 227.4 245.4 128.0 47.3 107.8 105.0 147.6 171.6 93.9 93.6 289.6 113.6 100.8 105.9 125.1 216.3 101.3 162.3 204.1 125.3 268.3 133.5 73.1 40.4 33.1 38.7 47.7 54.0 46.7 47.9 53.2 59.0 31.5 40.5 43.4 23.4 55.6 41.9 54.0 61.7 35.6 61.4 64.0 62.0 85.8 64.6 64.7 62.4 63.0 61.0 61.7 61.0 62.3 64.8 82.6 89.8 45.0 14.4 59.2 61.6 91.2 179.9 70.6 53.5 70.9 121.3 143.8 81.5 102.9 84.6 18.8 180.3 66.0 62.1 207.4 145.2 84.7 100.7 75.6 57.8 55.2 159.7 26.8 126.9 166.1 65.4 47.4 73.8 54.4 74.3 44.6 78.1 111.6 48.8 26.4 106.3 101.7 75.6 58.9 89.7 88.9 70.2 67.6 14.0 173.1 82.5 93.7 12.5 18.9 127.6 86.7 71.5 53.3 96.6 108.8 241.2 102.1 73.1 52.6 66.9 83.4 244.9 54.5 116.6 71.6 213.4 68.0 80.7 133.2 95.7 ATXN7 "ADCAII, OPCA3, SCA7, SGF73" ENSG00000163635 "Ataxin 7" O15265 3 63863155-64003462 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 102.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 15.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 7.6 6.3 4.9 11.5 4.0 24.6 7.2 4.4 4.4 7.4 0.7 7.0 8.0 8.7 4.8 8.8 6.4 9.7 5.9 3.6 2.7 7.1 8.5 9.1 12.8 4.3 1.9 1.9 8.1 21.2 10.9 2.3 8.4 3.3 6.8 8.9 16.4 7.8 5.2 7.2 9.4 9.3 7.9 0.7 10.7 8.5 15.1 2.6 16.6 7.6 8.8 11.8 7.4 4.4 3.5 8.4 5.7 8.1 7.2 8.5 11.3 9.5 6.5 9.0 11.1 10.5 8.9 8.7 12.5 3.1 9.0 12.5 6.5 9.6 9.1 11.9 22.8 4.9 16.1 10.7 4.2 6.4 8.5 17.7 7.9 9.0 15.7 17.7 9.0 8.4 13.3 6.3 26.2 7.7 25.8 12.7 6.8 5.5 5.7 3.0 9.1 7.1 10.1 6.1 11.0 3.1 5.6 13.2 9.4 10.8 6.4 5.1 12.2 11.9 11.4 12.0 12.7 12.9 12.9 13.2 10.3 10.3 11.6 9.4 15.8 1.1 2.1 3.7 1.0 3.3 1.0 6.2 4.0 0.8 2.4 6.2 4.1 4.5 3.5 0.7 1.5 6.2 1.3 4.9 4.0 4.4 4.4 3.6 2.7 4.3 1.9 1.9 3.3 0.7 2.6 3.5 2.4 9.6 9.1 34.6 17.0 43.6 24.9 17.6 29.6 73.2 3.4 1.7 10.5 35.8 17.9 5.5 102.2 14.1 21.5 38.3 0.0 2.8 17.1 3.3 1.5 16.1 26.4 29.5 81.2 4.2 13.6 16.6 18.8 3.5 14.7 1.2 26.7 22.8 14.2 25.2 67.0 19.7 24.4 34.6 30.3 9.5 12.8 20.1 12.4 64.6 33.5 24.5 54.6 60.3 46.7 2.5 28.5 13.2 14.8 26.1 28.1 0.7 27.4 70.8 0.0 39.2 15.6 14.8 15.6 25.6 46.2 61.2 41.5 1.6 20.1 38.6 PSMD6 "KIAA0107, p44S10, Rpn7, S10" ENSG00000163636 "Proteasome 26S subunit, non-ATPase 6" Q15008 3 64010550-64024010 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 288.2" "Cell type enhanced" "Detected in all" "Early spermatids: 513.3;Late spermatids: 717.7;Spermatocytes: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "MCF7: 1458.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036921, HPA036922" Uncertain NA NA 120000 "HPA036921: AB_2675383, HPA036922: AB_10670850" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (4.76e-3)" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.65e-2)" "unprognostic (1.38e-1)" "unprognostic (1.95e-3)" "unprognostic (6.69e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (4.20e-2)" "unprognostic (1.89e-1)" "unprognostic (9.55e-2)" "unprognostic (8.22e-3)" 47.7 68.4 46.6 43.7 47.9 116.0 50.0 49.3 63.7 37.4 46.6 42.9 34.3 43.4 60.7 61.9 35.5 28.5 69.1 48.5 49.8 63.5 75.5 38.2 50.6 49.9 49.6 46.8 33.1 288.2 73.5 31.0 54.7 50.9 42.5 43.8 48.8 44.0 46.0 162.1 54.3 35.1 49.9 49.8 39.1 46.4 121.3 47.2 55.3 40.7 91.7 64.5 52.8 40.8 51.9 98.4 102.5 141.1 99.5 97.6 87.0 125.9 136.3 128.8 221.5 162.4 193.0 79.8 136.9 57.6 132.4 154.7 66.1 166.4 144.7 207.3 141.1 104.6 183.6 76.3 128.2 142.9 204.9 112.2 93.7 100.8 184.2 80.3 107.4 141.5 117.7 187.3 86.1 157.8 1458.7 141.0 125.3 180.7 157.3 71.9 117.2 101.1 132.4 177.1 140.7 52.1 85.0 101.6 85.4 136.2 123.4 74.3 125.0 125.7 98.1 106.5 145.2 217.1 108.2 171.0 204.1 144.3 190.8 116.1 99.2 113.9 140.3 103.4 133.0 107.3 124.7 114.0 112.9 120.1 120.3 113.6 110.5 139.4 111.5 139.8 84.0 137.1 167.2 46.6 47.9 49.3 63.7 48.5 49.8 49.9 49.6 46.8 50.9 49.8 47.2 51.9 46.4 32.1 43.2 7.5 48.7 62.1 71.7 152.5 27.9 37.0 33.9 34.9 100.0 22.8 86.4 44.1 22.9 197.8 47.3 27.6 86.1 104.0 513.3 49.0 42.3 55.3 25.8 99.9 11.7 133.7 102.3 47.6 27.0 48.9 45.6 46.7 28.9 47.4 92.2 33.7 10.9 27.3 73.2 38.1 40.5 717.7 51.9 51.7 48.0 4.7 71.0 81.8 39.1 10.1 15.4 87.1 30.4 51.1 58.1 44.7 29.7 95.9 73.0 41.2 59.2 41.3 145.8 336.9 131.3 53.4 69.9 290.6 50.4 68.7 35.8 66.1 PRICKLE2 DKFZp686D143 ENSG00000163637 "Prickle planar cell polarity protein 2" Q7Z3G6 3 64092236-64445476 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Excitatory neurons: 185.5;Inhibitory neurons: 232.4;Microglial cells: 112.4;Oligodendrocyte precursor cells: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;ASC TERT1: 14.9;HSkMC: 22.1;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035493 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA035493: AB_10696504" "unprognostic (2.87e-1)" "unprognostic (4.31e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.92e-1)" "unprognostic (3.83e-2)" "unprognostic (3.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.32e-3)" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (9.04e-3)" "unprognostic (1.77e-1)" 21.0 3.0 11.4 3.9 15.4 0.3 8.1 4.5 15.9 16.5 8.2 13.9 2.3 17.5 6.8 7.8 11.8 8.9 5.6 25.1 11.3 3.9 3.1 10.7 0.8 6.5 8.3 12.3 8.5 3.9 5.5 5.7 5.7 7.1 7.3 4.6 10.2 5.0 13.9 1.9 4.2 6.0 16.7 5.4 1.4 8.2 1.8 11.1 1.0 6.9 3.9 1.0 12.5 8.9 9.5 0.0 4.7 1.3 0.1 24.1 14.9 0.0 3.5 4.5 2.8 4.2 8.3 0.1 0.0 0.5 3.4 7.6 0.1 0.0 3.2 2.8 3.3 0.1 0.0 0.5 0.1 6.7 0.0 0.0 22.1 4.0 8.2 3.5 8.4 1.7 0.0 0.0 1.8 3.9 4.6 0.0 0.1 3.0 0.0 0.1 0.0 0.2 0.1 4.5 11.7 1.2 0.2 0.0 0.9 0.1 7.7 1.6 0.1 0.1 11.9 5.4 2.9 6.9 3.7 0.0 0.7 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.4 15.4 4.5 15.9 25.1 11.3 6.5 8.3 12.3 7.1 5.4 11.1 9.5 12.4 0.0 10.9 114.3 1.5 6.2 4.1 7.3 7.4 25.6 4.3 8.4 6.2 1.5 7.3 3.7 64.6 1.4 0.3 1.6 0.0 2.7 15.1 24.7 47.5 9.5 0.0 0.0 185.5 0.4 0.4 20.3 0.0 8.7 0.0 5.2 33.5 1.7 4.1 16.8 232.4 0.6 4.1 1.2 1.8 3.5 9.9 0.6 5.4 112.4 0.0 7.5 1.0 103.5 26.4 0.7 0.3 23.0 0.2 0.9 0.0 6.2 7.6 4.4 13.1 14.6 14.3 2.0 1.0 6.2 3.0 4.9 0.6 6.6 1.1 2.7 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" No NA Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 27.3 4.8 6.9 12.3 4.2 0.1 19.2 5.9 5.3 12.2 7.3 6.4 1.2 13.3 1.1 5.3 10.3 7.9 14.6 4.2 30.4 9.6 2.7 13.7 1.9 11.5 6.0 1.8 7.4 9.9 6.4 2.2 32.0 8.2 7.9 2.7 1.4 3.2 3.7 7.5 2.5 3.7 12.2 8.3 4.2 4.7 0.8 7.2 1.0 7.4 7.3 1.1 22.7 9.1 20.4 0.0 1.2 13.9 0.0 0.6 0.1 1.3 0.2 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.0 8.8 2.6 0.0 0.0 0.5 0.0 23.6 0.0 0.5 0.0 0.3 0.1 0.0 0.0 7.5 1.1 0.0 0.0 2.4 0.1 27.1 0.3 0.1 128.3 0.0 0.0 0.0 40.5 0.0 0.7 5.4 0.8 0.4 0.0 0.8 0.0 0.0 0.0 0.5 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 4.2 5.9 5.3 4.2 30.4 11.5 6.0 1.8 8.2 8.3 7.2 20.4 166.3 3.2 4.8 84.2 0.0 17.5 87.2 0.0 4.6 0.0 6.9 15.9 6.6 2.8 2.6 38.6 2.1 1.0 0.2 1.1 0.0 69.7 0.9 13.2 179.1 221.0 1.2 0.0 4.2 3.3 0.6 31.4 1.5 33.8 0.0 8.4 27.1 0.3 7.5 0.0 14.3 1.1 0.0 0.3 20.1 0.4 2.5 2.7 26.6 21.5 0.0 0.2 0.0 26.7 0.6 45.5 1.0 2.2 0.0 115.7 0.0 10.8 0.1 0.1 0.0 20.7 94.8 0.3 0.7 1.3 13.5 1.6 3.2 12.1 0.9 36.7 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 93.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 512.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria No No Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 5.4 8.6 24.1 15.0 28.6 10.0 14.6 24.2 29.3 19.2 21.3 5.5 4.4 33.0 7.7 11.3 21.7 9.0 93.4 27.8 23.8 18.0 7.7 9.8 25.8 23.2 27.4 27.0 32.8 11.2 12.6 10.0 9.8 23.7 16.3 6.1 14.3 11.9 7.2 14.3 2.6 10.5 26.8 15.8 19.0 8.0 20.1 25.4 15.4 8.0 11.6 26.1 9.0 11.8 35.5 4.6 1.5 5.7 10.1 8.3 10.9 2.3 7.2 13.0 23.3 27.4 11.6 1.1 58.0 7.7 4.6 11.5 0.5 17.0 5.4 9.1 44.9 7.1 10.8 5.0 10.8 6.6 14.6 5.3 7.2 2.7 14.5 12.5 4.9 4.2 25.4 15.5 48.6 7.0 6.5 20.3 7.9 3.4 3.5 2.3 10.8 9.3 21.9 8.1 2.0 4.4 3.9 4.6 0.5 5.4 9.6 23.2 3.9 0.8 8.3 4.2 2.8 4.1 15.6 15.0 48.3 9.1 11.7 14.0 24.7 9.9 8.1 39.4 12.0 51.4 102.9 37.1 39.9 18.6 113.5 36.3 44.2 3.2 27.6 3.6 131.3 46.9 24.5 24.1 28.6 24.2 29.3 27.8 23.8 23.2 27.4 27.0 23.7 15.8 25.4 35.5 20.7 48.1 12.4 105.4 124.8 9.8 15.8 5.7 29.6 109.5 42.8 25.7 512.1 8.6 13.7 49.7 18.8 11.5 153.0 0.8 156.5 7.0 7.9 9.7 37.2 27.2 9.6 34.3 89.5 6.2 3.2 42.9 8.2 20.0 19.0 32.2 24.7 30.2 28.9 85.8 145.6 16.5 4.1 14.5 16.4 10.5 23.9 27.5 21.4 40.3 75.6 21.8 80.3 100.0 54.7 4.6 9.2 31.6 82.7 32.1 8.2 47.6 19.5 14.8 26.3 38.5 36.4 38.2 22.9 71.4 5.4 2.9 70.1 45.4 4.1 6.7 ERICH6 "C3orf44, ERICH6A, FAM194A, MGC39662" ENSG00000163645 "Glutamate rich 6" Q7L0X2 3 150659885-150703971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 30.0" "Group enriched" "Detected in some" 25 "Early spermatids: 96.1;Late spermatids: 56.0;Spermatocytes: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.5;SH-SY5Y: 1.6;U-266/70: 1.7;U-266/84: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA048373 Enhanced NA NA "HPA048373: AB_2680375" "unprognostic (7.38e-2)" "unprognostic (3.89e-3)" "unprognostic (7.02e-3)" "unprognostic (2.52e-2)" "unprognostic (7.38e-3)" "unprognostic (1.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (1.96e-1)" "unprognostic (8.44e-2)" "unprognostic (1.71e-2)" "unprognostic (1.80e-2)" "unprognostic (7.27e-2)" "unprognostic (2.21e-1)" "unprognostic (1.49e-2)" "unprognostic (3.16e-2)" 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.1 0.2 0.0 0.7 0.1 0.5 0.4 1.7 0.2 0.3 0.3 0.3 0.4 0.4 0.6 0.1 0.2 0.6 0.2 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.1 0.3 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.3 30.0 0.2 0.0 1.2 0.0 0.0 0.1 0.0 0.3 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.6 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.7 1.6 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.2 0.5 0.6 0.1 1.7 2.8 0.3 0.2 0.0 0.0 0.0 0.1 0.1 2.6 0.0 5.1 1.9 1.6 2.0 0.1 2.0 2.2 2.3 0.0 4.2 0.0 2.4 1.9 1.4 0.2 0.3 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 96.1 0.3 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 56.0 2.1 0.2 0.0 1.9 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 25.0 1.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 CLRN1 "RP61, USH3, USH3A" ENSG00000163646 "Clarin 1" P58418 3 150926163-150972727 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 5.0;retina: 12.9" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 165.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "NTERA-2: 3.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.00e-3)" "unprognostic (1.26e-1)" "unprognostic (5.54e-1)" "unprognostic (9.68e-2)" 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GMPS GATD7 ENSG00000163655 "Guanine monophosphate synthase" P49915 3 155870650-155944020 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" Ligase Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 101.2" "Cell type enhanced" "Detected in all" "Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046630 Approved Cytosol No No 50000 Cytosol "HPA046630: AB_2679727" "unprognostic (3.89e-2)" "unprognostic (2.02e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (8.73e-7)" "unprognostic (1.71e-2)" "unprognostic (3.52e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.58e-2)" "unprognostic (2.79e-2)" "unprognostic (2.89e-2)" "unprognostic (3.78e-1)" "unprognostic (3.55e-3)" "unprognostic (8.79e-2)" 18.7 20.9 6.8 20.2 7.9 45.0 24.3 23.4 11.1 19.8 7.9 19.9 15.9 20.8 16.2 22.3 17.2 14.2 18.1 6.8 8.7 16.0 22.8 18.4 27.2 8.1 8.3 6.3 17.2 26.6 23.3 11.6 21.0 8.9 17.6 22.7 10.2 21.1 17.7 20.2 25.1 16.8 23.6 6.4 19.4 18.1 101.2 8.0 32.6 20.5 16.9 29.7 23.5 20.1 9.5 241.0 93.1 123.0 101.1 49.0 77.0 118.9 99.8 91.6 128.2 128.8 170.5 156.2 171.7 116.1 77.1 98.1 114.6 105.7 104.2 175.0 101.1 81.8 183.2 63.7 92.8 55.9 188.5 68.7 57.3 62.9 99.4 150.5 68.2 79.9 91.3 131.7 63.8 96.8 160.1 153.9 99.4 118.5 130.4 68.3 149.2 145.8 207.5 66.3 103.5 73.3 68.0 111.0 156.0 101.8 83.9 163.6 122.3 56.9 84.4 68.5 121.0 204.3 88.8 58.5 288.5 84.8 137.4 77.0 23.7 16.1 11.5 24.7 20.2 29.1 16.0 23.6 22.3 26.1 11.6 23.3 22.3 2.2 29.3 29.5 14.2 27.1 17.5 6.8 7.9 23.4 11.1 6.8 8.7 8.1 8.3 6.3 8.9 6.4 8.0 9.5 23.8 19.2 20.2 19.6 21.5 39.9 47.4 43.9 22.8 22.0 19.5 18.5 16.4 15.7 28.4 7.3 2.1 44.1 21.6 8.3 25.4 33.8 272.7 14.3 37.5 29.9 7.2 68.5 40.9 29.5 56.2 32.4 19.9 18.4 28.6 34.0 22.1 11.6 29.9 21.9 41.6 19.7 26.4 18.5 27.1 193.6 23.0 25.2 23.2 22.5 31.7 17.8 30.9 30.2 31.6 21.3 11.9 24.8 21.9 50.6 17.8 22.8 17.3 8.7 19.7 28.6 65.2 171.2 65.5 29.0 38.2 30.8 30.4 63.2 26.8 42.4 TIPARP "ARTD14, DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1" ENSG00000163659 "TCDD inducible poly(ADP-ribose) polymerase" Q7Z3E1 3 156673235-156706770 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 302.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 53.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 53.5" "Cell line enhanced" "Detected in all" "HBEC3-KT: 168.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036796 Approved Microtubules NA NA Microtubules "HPA036796: AB_10672268" "prognostic favorable (2.00e-5)" "unprognostic (3.50e-1)" "unprognostic (7.62e-2)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (4.56e-2)" "unprognostic (9.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.43e-1)" "unprognostic (4.27e-3)" "unprognostic (2.01e-1)" "unprognostic (4.69e-2)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (6.16e-3)" "unprognostic (4.90e-3)" 68.1 57.1 17.2 16.1 19.5 74.7 40.1 18.3 22.8 30.0 16.7 15.3 13.6 30.9 14.8 55.6 39.9 28.2 26.5 16.6 73.8 28.4 44.7 27.7 13.8 33.5 20.0 15.5 40.6 29.8 99.9 15.2 12.6 24.5 26.1 14.6 18.4 10.4 28.0 17.7 34.6 23.3 44.0 21.0 11.0 22.1 50.7 27.3 21.9 17.2 9.7 18.3 65.6 24.2 22.7 42.8 29.6 9.8 8.4 35.7 25.9 8.0 70.0 56.4 34.9 48.2 17.2 86.9 12.7 22.2 79.9 46.5 42.1 25.1 168.0 51.4 27.3 18.5 21.0 29.0 11.7 15.2 7.4 38.1 21.3 103.0 35.6 84.9 93.8 32.3 9.4 16.9 49.9 122.5 8.2 6.4 9.8 11.2 53.5 24.5 10.5 22.5 43.6 36.7 20.1 29.5 7.5 55.2 16.9 11.9 22.5 26.2 12.5 70.2 15.1 4.9 28.5 25.1 53.9 10.6 11.3 25.7 11.3 51.4 53.5 5.0 7.5 6.1 3.3 8.6 2.9 5.9 8.2 3.6 5.4 3.6 4.9 15.9 11.6 9.2 5.0 7.4 3.3 17.2 19.5 18.3 22.8 16.6 73.8 33.5 20.0 15.5 24.5 21.0 27.3 22.7 112.8 86.6 98.3 27.7 43.9 196.0 117.3 51.7 185.5 5.0 62.0 57.7 29.9 31.5 66.5 7.3 39.6 5.1 97.0 38.3 21.5 35.2 302.3 114.6 118.7 45.6 54.5 7.0 3.6 23.5 10.3 109.0 57.6 169.4 115.0 12.2 20.3 18.9 19.2 21.9 8.7 32.4 18.3 18.5 97.5 28.0 19.6 101.7 37.4 12.2 17.3 10.1 16.5 22.1 20.4 36.9 40.1 19.2 60.5 83.9 40.4 16.2 43.5 10.4 13.1 138.0 87.7 58.0 33.4 100.1 121.5 7.5 105.4 7.3 18.2 187.8 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" "HPA057911: AB_2683553" "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favorable (6.96e-7)" 37.1 25.4 12.8 11.7 13.5 57.1 27.5 14.9 21.4 21.3 13.6 21.7 13.6 19.5 5.7 22.3 30.7 13.6 22.8 13.5 17.6 31.9 45.7 30.4 14.2 15.6 13.4 12.4 31.5 33.7 8.4 22.0 10.4 13.6 24.0 6.6 5.3 18.8 6.2 21.4 22.9 30.0 9.2 12.5 35.9 29.3 9.2 13.7 20.2 23.9 10.4 9.9 19.6 23.1 15.1 19.2 11.4 16.8 11.6 16.1 10.9 16.0 12.0 14.4 13.9 13.0 19.7 14.8 20.3 10.0 8.9 9.7 14.7 12.4 14.6 12.8 18.2 14.1 12.6 12.2 17.2 13.2 8.8 7.7 13.3 25.1 13.2 17.7 13.9 11.1 11.4 8.7 12.7 10.2 13.8 17.8 16.7 13.9 14.7 12.5 16.2 13.6 31.7 8.9 11.4 8.9 16.5 9.1 8.4 26.1 12.5 8.7 26.1 9.1 12.8 7.1 13.8 15.9 25.3 21.5 26.7 12.8 13.1 12.6 5.9 10.3 16.0 13.5 8.4 14.1 13.4 12.5 14.0 13.1 15.2 17.1 14.2 28.6 17.4 11.3 14.0 15.4 8.2 12.8 13.5 14.9 21.4 13.5 17.6 15.6 13.4 12.4 13.6 12.5 13.7 15.1 367.4 218.0 392.4 33.0 222.5 268.0 499.2 203.8 310.7 73.7 279.3 247.0 54.3 177.3 259.0 68.0 133.5 139.2 253.6 389.6 23.5 189.4 41.0 379.7 426.5 287.1 247.7 86.5 30.6 127.8 152.9 302.7 268.1 761.2 222.2 281.6 167.8 90.4 164.6 40.4 32.3 294.6 154.6 241.5 251.4 20.9 128.0 292.5 140.5 42.2 160.1 69.5 122.6 35.7 66.3 143.2 378.2 75.2 258.5 408.2 415.6 21.2 188.9 183.3 131.5 460.0 276.4 46.5 25.0 252.6 276.9 209.1 282.8 182.6 244.1 503.2 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436850-157443633 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 180.0;urinary bladder: 193.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 16.2;Fibroblasts: 44.7;Glandular and luminal cells: 24.0;Langerhans cells: 23.6;Macrophages: 27.0;Melanocytes: 14.2" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Region enhanced" "Detected in some" "hypothalamus: 5.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1219.3;ASC TERT1: 1751.7;BJ hTERT+: 1201.8;HHSteC: 2261.1;HSkMC: 2364.2;hTEC/SVTERT24-B: 1276.5;TIME: 1761.1;U-2197: 1605.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" NA NA 1090000 970000 "Plasma membrane" "HPA069320: AB_2686118" "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavorable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavorable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 180.0 11.2 0.4 39.1 0.5 89.8 58.4 0.6 1.6 2.7 1.0 11.8 0.8 2.5 0.5 3.0 21.6 7.8 38.7 0.7 5.0 6.9 2.7 84.0 0.9 0.6 0.7 0.4 1.4 42.0 1.2 4.5 11.5 0.7 6.9 2.4 0.4 5.4 0.5 5.2 20.2 9.8 5.8 0.4 23.8 25.1 0.7 3.2 1.6 5.8 0.5 0.3 193.5 3.1 0.8 1.2 0.0 752.4 0.2 1219.3 1751.7 0.3 132.3 1201.8 56.2 60.9 0.7 7.9 0.2 460.6 157.4 87.6 0.0 0.3 1.1 110.5 0.8 0.3 2.0 0.1 0.0 2261.1 2.5 0.0 2364.2 0.8 1276.5 429.8 110.2 266.4 0.1 0.3 0.0 380.1 0.0 0.3 2.9 11.2 0.0 4.6 0.2 0.0 0.2 5.3 53.1 6.0 0.8 7.6 1.0 0.9 0.1 0.6 2.4 1761.1 252.2 12.2 1605.1 23.0 0.2 0.5 0.9 52.8 6.4 74.2 0.0 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.6 1.6 0.7 5.0 0.6 0.7 0.4 0.7 0.4 3.2 0.8 2.3 0.0 1.7 0.0 0.1 1.7 1.7 0.3 0.0 1.8 3.6 0.6 0.6 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 7.2 2.4 16.2 10.3 5.1 0.0 0.0 0.5 0.0 0.1 44.7 0.0 24.0 0.0 0.7 3.3 0.0 2.6 0.0 1.0 0.0 0.0 10.0 23.6 1.2 0.3 27.0 14.2 0.0 2.3 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.3 1.0 0.0 0.2 0.0 0.8 0.0 4.0 7.2 0.0 0.4 0.4 1.0 0.3 0.4 0.0 0.0 0.4 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197838-57227606 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 36.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 6.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 73.5;U-266/84: 23.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.4 1.8 1.8 1.0 1.8 6.0 2.6 2.3 2.2 1.2 1.5 1.1 1.1 0.9 3.4 1.0 1.1 1.6 1.2 1.8 2.0 2.1 3.8 1.4 1.8 2.1 1.9 1.8 1.4 1.8 1.6 1.8 1.2 1.9 1.5 0.8 2.0 1.1 2.0 0.9 4.3 1.0 0.6 1.6 2.2 2.0 6.3 1.8 1.3 2.5 0.6 1.3 0.9 1.1 1.9 1.3 1.2 2.6 4.3 0.4 1.6 0.8 0.1 0.5 0.8 1.4 0.6 3.9 3.4 0.6 0.1 1.0 0.2 1.2 1.4 1.0 2.0 2.9 5.0 1.8 0.4 2.9 1.6 0.5 4.1 1.2 0.4 2.8 2.1 0.7 7.2 0.8 4.3 0.3 0.3 2.2 9.1 73.5 1.1 0.8 0.8 1.6 1.7 3.6 0.7 1.1 3.5 1.0 1.4 2.7 1.2 1.0 7.0 0.5 3.3 1.3 1.0 1.4 12.2 23.7 10.1 1.2 3.1 1.6 0.5 0.8 0.4 0.2 1.6 0.0 0.6 0.2 0.1 0.5 0.5 0.2 0.1 1.4 0.7 0.2 1.8 0.0 0.2 1.8 1.8 2.3 2.2 1.8 2.0 2.1 1.9 1.8 1.9 1.6 1.8 1.9 1.0 0.0 0.5 6.5 0.9 0.4 0.6 1.4 0.0 0.3 1.3 1.8 0.8 1.5 0.4 1.8 0.0 1.5 1.7 0.9 0.0 0.4 0.5 1.7 0.7 1.2 0.0 0.0 1.7 0.2 1.1 0.6 0.5 0.4 0.0 1.0 1.4 1.0 2.1 1.7 1.5 0.1 2.0 1.6 0.6 0.4 0.9 2.0 0.0 6.5 1.1 1.6 0.0 3.0 5.1 0.5 0.2 0.4 0.2 0.7 0.7 1.2 0.9 2.6 0.0 0.8 0.5 36.3 7.6 0.3 1.1 0.5 0.7 2.7 0.7 0.4 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;testis: 2.8" "Cell type enriched" "Detected in some" 6 "Early spermatids: 53.8" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040685, HPA053234" Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA040685: AB_2732487, HPA053234: " "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 0.4 0.1 1.0 0.4 3.9 0.1 0.2 0.2 1.5 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.8 1.5 0.0 0.0 0.0 0.0 0.7 0.2 0.9 0.0 0.1 0.2 1.0 0.3 0.7 0.0 0.1 1.5 0.1 0.0 0.9 0.1 0.1 0.3 0.7 0.0 0.0 2.8 0.5 1.3 0.3 0.9 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.2 1.5 0.8 1.5 0.7 0.2 0.9 0.7 0.7 0.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 53.8 0.1 0.1 0.5 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.4 8.9 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 3.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLMAP "KIAA1601, SLAP" ENSG00000163681 "Sarcolemma associated protein" Q14BN4 3 57755450-57930003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 295.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002357, HPA002358" Enhanced Approved "Endoplasmic reticulum" NA NA 9200 "Endoplasmic reticulum" "HPA002357: AB_1080023, HPA002358: AB_1080021" "unprognostic (3.70e-1)" "unprognostic (2.87e-2)" "unprognostic (1.82e-3)" "unprognostic (3.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.18e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.59e-3)" "unprognostic (1.06e-1)" "prognostic favorable (1.58e-6)" "unprognostic (8.18e-2)" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (6.08e-2)" 26.2 28.3 9.4 35.5 14.0 15.6 22.1 14.9 10.5 25.8 12.9 96.0 34.3 94.3 14.3 117.9 49.0 31.9 135.9 9.0 12.2 25.1 16.6 17.7 16.5 9.7 9.2 7.9 37.8 16.3 36.8 11.6 23.7 9.9 66.2 38.5 20.6 20.2 101.2 64.5 20.9 38.0 138.8 7.6 15.0 52.8 32.1 10.0 20.0 28.9 42.4 18.5 88.2 29.2 10.2 43.3 23.1 23.0 25.7 31.8 28.9 24.2 40.8 41.9 27.0 25.5 59.4 54.6 25.1 17.9 30.4 48.4 23.5 38.5 54.5 36.8 32.2 20.6 49.9 31.1 47.6 29.1 47.8 26.5 20.0 39.1 33.6 60.8 38.1 31.8 25.0 39.7 23.7 28.5 11.7 28.0 20.4 29.7 29.3 38.7 12.4 21.0 28.0 47.7 44.3 10.0 12.8 49.9 37.4 23.7 26.7 19.9 27.4 38.1 33.0 23.1 28.2 52.8 28.9 57.1 36.7 25.5 45.4 27.9 3.3 3.8 10.9 3.6 2.7 3.2 3.7 2.8 3.2 3.2 2.5 3.2 3.4 9.5 5.2 2.4 1.4 4.1 3.6 9.4 14.0 14.9 10.5 9.0 12.2 9.7 9.2 7.9 9.9 7.6 10.0 10.2 17.3 38.5 39.6 90.1 25.6 92.0 45.4 49.3 54.1 28.0 25.0 23.7 295.9 40.0 40.0 33.1 50.1 19.0 34.4 53.9 19.6 45.8 40.2 45.9 24.6 22.8 14.4 28.6 113.3 34.3 12.2 28.6 41.3 72.4 3.8 34.8 18.2 22.7 15.6 32.0 121.5 26.8 20.3 20.3 25.9 26.2 32.6 27.8 28.4 76.8 25.1 86.8 34.0 101.0 97.7 64.1 36.6 71.8 39.0 93.3 36.4 24.8 46.5 32.4 52.6 26.8 82.2 87.4 47.0 54.5 73.3 16.3 26.1 52.0 28.7 126.9 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452587-39458931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 180000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 1835.2 1190.6 718.4 816.7 655.5 2507.5 2153.8 638.0 1803.2 2247.7 649.0 1608.5 744.1 1430.2 2359.1 1581.3 1912.9 792.1 1161.4 656.4 687.8 1321.5 1065.0 1140.0 618.8 784.8 741.8 623.3 3637.7 2818.0 514.8 1068.3 422.3 800.2 1576.0 611.8 317.0 1399.0 687.5 1563.1 2036.6 1339.0 555.7 664.2 1411.4 1496.8 389.9 721.3 44.0 1081.1 1783.2 711.6 1689.9 1788.4 1116.6 52.4 41.7 2173.3 48.2 57.0 90.0 72.9 1109.3 1618.3 1306.1 981.0 131.1 1243.5 2771.5 93.8 1081.2 1040.1 1169.0 67.3 79.3 1422.3 964.2 2080.2 80.0 415.4 131.2 81.3 153.2 711.1 113.8 3249.4 56.1 1445.8 1907.5 69.6 70.4 2126.4 1196.8 60.9 69.4 1556.5 163.4 1954.7 1523.9 57.6 1417.2 2327.7 76.3 1656.7 63.7 74.3 915.0 31.6 899.8 115.5 1976.1 1864.0 98.7 63.2 51.1 72.1 1486.9 134.2 1806.3 2754.2 2483.9 1456.9 1717.2 56.6 447.2 556.1 171.7 664.4 585.3 1320.8 1566.4 1311.6 919.0 779.1 1361.8 1804.5 1436.1 94.8 927.3 456.8 1013.2 1101.2 2263.3 718.4 655.5 638.0 1803.2 656.4 687.8 784.8 741.8 623.3 800.2 664.2 721.3 1116.6 1634.0 663.4 908.4 2.3 3629.4 4132.6 5621.6 3089.9 1994.2 406.0 4149.6 3833.2 428.0 2051.8 1359.8 709.9 160.6 3011.2 2723.2 1300.0 2733.2 2184.8 1549.9 1126.9 2738.2 2121.2 1850.2 1755.0 3.0 4399.8 5910.8 1698.9 828.7 1534.0 913.2 2226.7 2439.5 1991.3 2775.3 198.5 3.2 3581.7 1053.8 3282.8 3322.0 1707.8 4819.6 2242.3 1851.6 2.8 4568.2 1398.0 3045.4 3.0 3.6 3145.0 2925.6 2394.1 1420.3 4718.4 2823.2 3698.3 656.7 581.0 1512.0 3760.1 2630.9 684.0 593.6 2325.1 4675.5 3400.0 2937.1 2567.2 3793.6 5564.6 SMIM14 "C4orf34, FLJ13289" ENSG00000163683 "Small integral membrane protein 14" Q96QK8 4 39546336-39638902 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 119.4" "Cell type enhanced" "Detected in all" "Hepatocytes: 553.9;Intestinal goblet cells: 408.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 269.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051299 Uncertain NA NA "HPA051299: AB_2681429" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.48e-2)" "prognostic favorable (3.00e-6)" "prognostic favorable (3.47e-4)" "unprognostic (2.67e-2)" "unprognostic (1.54e-1)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (7.18e-2)" "prognostic favorable (2.07e-4)" "unprognostic (6.66e-2)" "unprognostic (1.33e-1)" "unprognostic (9.50e-2)" "unprognostic (4.92e-3)" 21.9 45.9 14.3 22.6 16.5 4.7 33.5 15.6 14.5 36.5 16.7 41.8 17.9 19.4 38.7 20.2 27.7 19.9 10.3 13.9 17.5 23.1 119.4 22.6 39.2 17.2 16.5 12.5 23.4 24.5 25.6 17.6 8.5 17.2 35.9 37.1 12.4 41.1 20.0 6.7 14.4 21.3 14.6 17.9 27.5 47.0 14.3 16.7 15.7 28.1 9.4 45.6 19.6 14.6 20.6 12.4 20.9 9.9 9.6 64.4 71.8 17.7 16.9 21.5 7.4 10.8 6.8 44.2 269.3 15.8 19.2 11.8 4.6 2.0 3.6 6.1 7.1 2.2 0.3 8.9 12.2 22.0 1.8 2.8 27.4 13.1 7.6 4.9 26.4 11.3 11.8 2.9 8.6 12.5 38.4 2.9 4.8 4.7 54.2 14.4 11.9 0.5 3.0 15.5 10.8 7.5 9.4 19.0 25.1 6.8 3.9 25.1 4.0 37.8 17.0 3.8 22.1 2.9 28.0 6.4 1.1 27.9 3.4 6.7 53.5 52.7 28.0 20.7 46.0 22.6 103.9 14.5 18.4 55.9 107.1 11.0 16.2 37.3 40.4 49.1 100.1 9.1 44.5 14.3 16.5 15.6 14.5 13.9 17.5 17.2 16.5 12.5 17.2 17.9 16.7 20.6 55.3 57.7 124.4 29.4 228.9 49.3 76.5 83.4 42.7 80.6 150.3 96.6 17.0 65.8 143.4 104.8 35.5 38.3 74.9 242.2 84.1 86.9 238.5 115.3 65.6 45.8 106.1 25.3 34.0 144.8 49.6 108.6 85.1 73.4 45.7 19.2 57.1 553.9 43.6 92.5 52.4 408.8 126.1 79.8 85.1 31.5 113.1 62.6 46.2 36.5 108.0 109.7 36.0 29.1 85.5 226.2 132.4 124.5 19.8 199.0 75.0 117.9 225.3 48.5 59.2 56.5 58.8 66.2 25.0 95.0 59.8 104.1 28.8 65.7 118.3 124.0 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306245-58324695 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.2;tongue: 39.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favorable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (5.78e-2)" 5.0 5.8 2.9 4.7 3.4 4.8 5.0 5.8 4.1 4.6 2.1 6.8 6.9 5.5 3.7 6.0 4.9 4.2 9.4 3.4 3.0 9.1 11.6 4.1 4.1 3.1 2.6 3.3 5.5 6.2 7.8 5.9 4.0 3.4 4.8 6.5 5.1 5.0 4.5 41.2 5.3 6.9 7.2 2.2 5.8 5.4 5.1 3.0 6.5 5.6 39.3 6.0 5.3 5.0 3.8 12.3 10.4 11.5 8.2 6.6 9.0 12.3 9.9 11.7 14.5 17.1 15.9 8.0 13.8 2.4 14.4 13.7 7.2 17.6 15.8 14.8 10.6 8.5 12.0 11.9 8.4 7.8 24.4 10.7 8.4 12.1 18.6 16.3 5.2 12.1 18.2 12.0 7.8 14.3 6.5 16.2 7.9 11.9 10.5 17.9 6.8 8.4 14.0 9.6 18.9 6.9 11.8 10.2 9.8 11.9 7.3 11.0 8.6 11.1 10.4 11.7 10.5 20.4 13.0 28.3 22.3 11.2 17.1 6.7 2.1 3.4 2.6 2.1 2.8 3.0 2.1 2.7 3.2 3.9 3.0 3.2 3.5 4.0 5.5 6.0 3.9 1.8 2.1 2.9 3.4 5.8 4.1 3.4 3.0 3.1 2.6 3.3 3.4 2.2 3.0 3.8 9.0 9.6 11.9 6.2 8.2 31.2 8.1 21.1 17.1 26.3 8.2 7.6 28.4 7.2 11.8 3.7 25.0 8.4 9.4 14.9 11.7 5.7 0.8 8.2 12.4 10.6 9.6 7.6 18.4 6.2 5.9 11.5 13.3 8.2 3.8 11.5 11.4 21.3 6.2 18.5 18.2 11.8 16.2 11.0 20.0 1.7 12.5 9.7 23.2 13.1 9.2 13.2 7.2 10.6 11.2 7.8 7.6 9.8 14.2 8.1 16.2 11.4 9.7 28.3 0.0 14.1 13.7 11.9 15.3 20.4 43.0 10.3 9.2 15.0 13.7 6.5 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6, acylglycerol lipase" Q9BV23 3 58237532-58295693 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 65.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 12.3 13.0 25.8 6.4 32.6 0.9 9.0 33.4 33.3 4.5 19.0 11.9 39.8 6.2 14.8 6.4 9.2 5.8 5.7 32.7 27.6 35.9 65.4 8.6 8.1 31.0 34.1 25.0 5.1 2.8 9.0 16.7 6.4 33.2 5.6 11.2 9.3 4.0 14.5 4.7 25.7 52.7 9.3 30.8 35.3 13.0 3.9 32.8 5.6 9.2 5.5 7.6 5.8 5.9 50.5 3.5 12.0 1.8 8.5 23.2 4.2 21.2 8.9 8.1 9.2 12.5 6.9 4.8 6.6 0.8 4.7 28.5 9.9 8.3 3.9 8.4 11.3 4.2 5.7 8.1 9.7 7.8 1.7 28.1 3.9 18.4 8.8 3.8 10.6 5.0 10.6 6.8 15.0 7.2 2.6 11.7 0.7 6.1 28.5 27.3 4.2 3.8 14.8 14.5 4.8 10.8 4.4 9.9 5.1 19.0 3.7 3.6 4.5 5.8 6.6 7.0 16.6 10.8 4.2 13.5 0.3 17.1 16.9 9.3 0.0 2.2 1.7 1.6 7.4 1.5 3.6 0.9 1.9 3.7 2.5 0.9 1.1 0.0 0.7 5.2 5.4 1.2 1.0 25.8 32.6 33.4 33.3 32.7 27.6 31.0 34.1 25.0 33.2 30.8 32.8 50.5 27.1 0.0 1.8 11.4 13.6 8.7 3.0 2.7 6.2 13.3 2.1 1.5 5.6 5.7 4.9 3.7 4.2 2.0 7.7 11.2 1.9 3.0 1.0 9.8 7.9 14.1 0.0 5.7 33.6 1.9 0.9 2.9 7.7 1.5 11.4 10.1 21.4 60.6 8.9 15.2 34.3 4.0 0.0 16.7 20.0 0.7 6.8 12.1 3.6 11.2 11.5 11.2 6.2 37.7 88.6 1.9 1.4 8.2 2.0 1.8 55.1 17.4 13.8 3.3 0.0 2.9 3.9 0.5 2.2 6.9 24.6 0.5 5.1 16.0 5.8 2.0 DNASE1L3 "DNAS1L3, LSD" ENSG00000163687 "Deoxyribonuclease 1 like 3" Q13609 3 58192257-58214697 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Necrosis" "Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 273.6;lymphoid tissue: 265.7" "Cell type enriched" "Detected in many" 6 "Hepatic stellate cells: 1670.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 424.7" "Lineage enriched" "Detected in many" 20 "dendritic cells: 424.7" "Cell line enhanced" "Detected in some" "BEWO: 1.9;Karpas-707: 1.1;RPMI-8226: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA019955 Approved "Secreted to blood" NA NA "HPA019955: AB_1847805" "unprognostic (7.49e-3)" "unprognostic (3.08e-3)" "unprognostic (9.75e-3)" "unprognostic (3.92e-3)" "unprognostic (2.93e-3)" "unprognostic (1.01e-2)" "prognostic favorable (1.20e-6)" "unprognostic (4.74e-4)" "unprognostic (2.10e-1)" "unprognostic (9.71e-2)" "unprognostic (1.91e-3)" "unprognostic (6.95e-2)" "prognostic favorable (1.06e-7)" "unprognostic (7.57e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (5.64e-3)" 20.8 41.3 0.5 38.4 0.5 3.0 10.4 1.2 0.7 4.2 4.2 31.7 30.0 1.7 1.5 17.1 2.8 8.0 12.1 0.5 1.0 36.6 273.6 18.2 39.1 0.6 0.4 0.6 1.1 1.1 1.7 20.4 7.2 0.8 1.8 42.5 0.5 8.8 1.4 1.0 4.6 42.9 3.5 0.4 265.7 6.0 3.9 0.5 22.8 16.7 0.3 54.4 12.1 9.5 0.8 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.7 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 2.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.3 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 20.4 0.1 0.1 40.4 20.7 0.1 0.0 0.6 0.5 0.2 424.7 0.0 3.4 0.5 0.5 1.2 0.7 0.5 1.0 0.6 0.4 0.6 0.8 0.4 0.5 0.8 126.6 0.0 9.8 0.3 25.7 9.2 0.3 1.1 12.0 0.1 0.9 1.4 1.2 35.8 2.0 0.0 0.0 0.1 76.3 0.5 3.9 0.0 1.9 0.4 0.2 239.9 0.0 85.5 0.1 0.4 1.2 6.1 0.0 0.8 1.3 0.1 1670.9 27.1 0.5 1.7 0.1 0.2 0.0 127.1 144.3 3.2 4.1 18.6 3.6 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.2 0.3 0.1 3.3 0.0 0.2 0.0 0.3 1.3 0.3 0.2 59.3 16.3 0.3 3.8 2.6 0.0 1.0 CFAP20DC "C3orf67, FLJ42117, FLJ42930" ENSG00000163689 "CFAP20 domain containing" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 8.0;testis: 22.3" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 1.9;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.2 1.1 0.6 0.7 0.6 0.2 0.5 0.1 0.7 0.6 0.1 0.6 0.0 0.3 0.3 8.0 2.9 0.5 0.1 0.7 0.5 0.5 1.0 0.4 1.6 0.6 0.5 0.6 0.2 0.5 0.8 1.9 1.1 0.3 0.3 0.7 0.4 2.0 0.2 0.0 0.3 0.1 0.4 0.3 0.3 0.4 22.3 0.4 0.5 0.3 0.1 3.2 0.2 2.2 0.6 11.2 1.8 3.0 0.0 1.8 5.7 0.0 5.2 1.7 2.3 1.8 1.0 3.6 11.6 1.7 1.2 0.0 1.1 4.8 2.5 4.0 1.8 0.3 0.0 1.9 0.0 0.9 0.0 0.0 1.1 2.4 4.8 3.9 2.8 4.7 7.6 9.0 0.1 3.1 1.5 0.6 0.0 3.8 3.6 7.7 11.3 0.0 4.8 2.4 0.1 7.8 3.6 1.4 1.1 3.4 5.0 3.5 0.0 0.1 0.2 3.4 5.6 2.4 4.6 10.3 2.3 2.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.7 0.7 0.5 0.6 0.5 0.6 0.3 0.3 0.4 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 RBM47 "FLJ20273, NET18" ENSG00000163694 "RNA binding motif protein 47" A0AV96 4 40423267-40630875 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 442.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 136.2" "Group enriched" "Detected in many" 12 "dendritic cells: 34.4;granulocytes: 136.2;monocytes: 45.5" "Cell line enhanced" "Detected in many" "BEWO: 134.0;CAPAN-2: 63.5;OE19: 56.7;SK-BR-3: 58.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA006347 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA006347: AB_2181208" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.49e-3)" "unprognostic (2.38e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-2)" "unprognostic (7.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.33e-16)" "unprognostic (1.62e-2)" "unprognostic (9.81e-2)" "unprognostic (1.72e-1)" "unprognostic (5.77e-2)" 9.4 50.1 2.1 20.5 2.7 9.6 24.9 2.0 4.6 15.4 38.4 61.6 69.0 3.6 23.3 42.5 17.9 18.0 1.1 2.8 13.3 68.2 34.8 21.2 8.2 4.8 3.2 1.2 2.2 26.1 28.0 3.2 20.3 4.3 33.5 51.0 0.4 59.9 13.5 0.5 8.5 64.6 4.8 4.1 14.8 65.2 6.8 4.7 4.4 49.9 1.1 11.5 22.8 15.7 5.9 31.9 47.8 0.0 1.8 0.2 0.0 134.0 0.8 1.6 0.1 0.6 28.3 63.5 0.2 23.0 1.2 3.8 14.2 0.9 11.8 0.3 0.2 7.6 0.0 3.1 7.9 0.6 0.3 0.3 0.8 6.0 0.1 0.1 1.8 0.0 0.0 1.8 7.0 0.1 18.1 0.2 1.1 13.5 56.7 2.4 0.2 0.0 34.7 46.8 41.6 1.6 0.3 17.3 58.4 0.3 14.8 23.9 9.0 0.0 0.5 1.9 0.3 1.0 23.5 37.7 4.1 5.0 3.9 0.2 0.5 45.5 0.5 0.2 33.1 0.3 5.9 0.2 0.1 34.4 5.4 0.4 0.1 136.2 0.5 26.2 14.1 0.2 16.9 2.1 2.7 2.0 4.6 2.8 13.3 4.8 3.2 1.2 4.3 4.1 4.7 5.9 1.1 80.1 116.6 0.7 21.2 58.9 75.2 42.9 95.0 0.1 145.7 63.5 1.9 75.8 92.2 112.2 0.0 99.6 16.3 442.8 64.6 90.6 1.3 132.6 9.5 6.0 121.9 2.5 2.5 115.4 84.3 7.7 174.8 143.7 7.0 8.7 23.6 140.4 92.6 1.7 1.9 234.2 59.0 138.8 92.8 2.6 2.5 119.9 37.4 82.4 80.6 0.3 1.0 2.5 0.8 108.0 228.1 1.2 40.1 164.7 218.1 143.6 118.3 0.1 0.0 1.4 5.1 2.6 10.4 178.1 75.4 262.6 4.8 16.9 203.8 295.4 APBB2 "FE65L, FE65L1, MGC35575" ENSG00000163697 "Amyloid beta precursor protein binding family B member 2" Q92870 4 40810027-41216714 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 74.0" "Group enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 586.1;Oligodendrocytes: 803.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "naive B-cell: 5.6" "Lineage enriched" "Detected in single" 14 "B-cells: 5.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 138.7;TIME: 192.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023542 Approved Approved Mitochondria No No Mitochondria "HPA023542: AB_1844909" "unprognostic (4.43e-2)" "unprognostic (4.40e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (5.91e-3)" "unprognostic (8.13e-2)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (2.51e-1)" "unprognostic (1.21e-2)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (2.19e-3)" "unprognostic (9.35e-3)" "unprognostic (3.92e-2)" "unprognostic (2.29e-2)" "unprognostic (2.61e-1)" 41.9 9.2 27.3 5.5 39.9 8.7 25.3 36.3 29.7 15.6 8.7 11.9 8.3 14.1 5.9 9.0 13.2 16.3 21.6 20.0 30.0 16.6 14.8 18.7 7.5 38.9 40.1 14.5 32.3 10.9 8.6 8.6 17.7 45.2 8.8 7.8 15.8 8.7 9.9 29.0 12.1 7.0 15.0 31.9 14.9 11.4 8.5 35.8 13.3 33.9 21.9 5.6 10.8 13.2 74.0 19.4 9.4 20.6 28.8 64.9 50.7 45.2 38.5 45.8 14.0 24.5 34.1 40.2 33.9 20.7 16.5 44.5 5.6 36.5 49.4 25.0 1.1 7.3 0.4 23.5 21.1 65.0 19.2 1.1 76.7 24.6 42.5 43.0 58.2 138.7 19.0 1.1 0.7 86.1 16.3 6.3 3.6 17.1 9.8 17.9 50.9 58.6 38.4 19.9 8.9 27.2 15.4 11.7 6.6 6.9 23.7 17.2 2.2 192.3 20.1 59.5 13.8 61.1 8.1 18.5 41.2 20.7 30.8 24.6 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 5.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 27.3 39.9 36.3 29.7 20.0 30.0 38.9 40.1 14.5 45.2 31.9 35.8 74.0 58.8 80.1 14.5 46.7 5.0 10.7 3.8 10.4 7.4 7.6 25.5 13.6 22.5 12.8 6.3 9.2 6.2 14.4 0.5 5.2 7.9 3.8 14.5 5.6 32.8 39.4 3.0 5.3 121.3 6.4 2.8 25.2 12.8 7.5 1.3 13.5 47.2 13.8 3.2 62.2 171.3 4.0 16.2 4.0 6.7 23.1 35.8 2.5 7.2 164.9 0.1 9.3 0.0 586.1 803.4 6.2 6.7 37.2 0.2 2.7 5.5 6.3 4.0 7.6 59.2 43.2 51.4 3.8 10.8 7.3 11.9 6.0 1.2 24.0 7.4 3.6 IL17RE FLJ23658 ENSG00000163701 "Interleukin 17 receptor E" Q8NFR9 3 9902612-9916402 "Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.0;skin 1: 29.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 92.6;Gastric mucus-secreting cells: 58.1;Intestinal goblet cells: 52.1;Paneth cells: 37.7;Proximal enterocytes: 74.4;Undifferentiated cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.5;ASC TERT1: 38.5;hTCEpi: 16.5;T-47d: 19.4" "Region enhanced" "Detected in single" "cerebellum: 1.5" HPA019011 Uncertain "Intracellular and membrane" NA NA "HPA019011: AB_1851667" "unprognostic (1.08e-2)" "unprognostic (7.58e-2)" "unprognostic (2.06e-1)" "unprognostic (1.43e-3)" "unprognostic (1.09e-1)" "unprognostic (9.81e-2)" "unprognostic (1.50e-1)" "unprognostic (8.43e-2)" "unprognostic (6.69e-2)" "unprognostic (6.31e-2)" "unprognostic (3.55e-3)" "unprognostic (4.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-2)" 5.5 0.4 0.5 1.4 1.4 0.0 6.0 2.0 0.7 4.2 0.3 16.8 21.0 1.8 2.7 7.6 2.5 6.9 0.8 0.3 0.7 2.6 0.8 8.2 0.4 1.4 0.5 0.4 0.6 9.8 4.2 1.6 1.1 2.3 4.8 13.9 0.1 6.4 3.3 0.4 29.8 20.6 1.4 0.3 1.0 16.9 0.2 0.6 2.8 3.3 0.2 1.8 1.7 6.6 1.0 2.6 0.3 0.0 0.1 15.5 38.5 11.3 1.0 1.4 0.3 0.9 2.9 2.3 0.0 0.6 2.7 0.0 7.1 0.0 6.2 0.1 0.1 0.1 0.8 0.2 6.8 0.4 0.0 3.2 2.4 16.5 0.0 0.1 0.0 0.1 2.5 0.1 0.0 0.7 3.1 0.4 11.3 0.1 8.1 0.8 0.0 0.0 0.1 2.8 3.2 0.6 0.2 0.0 6.5 0.0 0.3 19.4 0.3 1.5 0.1 0.0 0.3 0.2 0.2 0.1 0.0 0.4 6.5 0.2 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 2.0 0.7 0.3 0.7 1.4 0.5 0.4 2.3 0.3 0.6 1.0 3.4 6.4 1.1 3.3 1.0 14.5 11.9 2.3 14.2 3.0 8.4 8.3 0.9 15.7 2.0 16.5 0.0 4.3 0.8 92.6 7.9 2.7 0.2 1.4 2.0 1.3 33.6 9.0 2.4 4.8 1.8 4.9 58.1 1.3 0.0 1.2 1.8 15.4 2.6 1.7 1.9 52.1 2.0 2.2 3.5 0.4 2.1 1.6 5.4 0.0 1.0 4.7 2.1 2.0 0.6 2.5 37.7 3.4 0.8 6.1 74.4 8.0 1.0 1.0 19.7 1.8 7.2 1.6 2.3 11.8 14.8 0.8 2.8 1.0 40.8 4.6 IL17RC IL17-RL ENSG00000163702 "Interleukin 17 receptor C" Q8NAC3 3 9917074-9933630 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.7;myeloid DC: 2.1" "Group enriched" "Detected in many" 18 "dendritic cells: 2.1;monocytes: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 71.2;ASC TERT1: 43.6;HSkMC: 40.7;T-47d: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019885, CAB026255" Approved "Intracellular and membrane" NA NA "CAB026255: , HPA019885: AB_1851664" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.38e-4)" "unprognostic (2.58e-2)" "unprognostic (1.45e-3)" "unprognostic (8.60e-2)" "unprognostic (7.11e-2)" "unprognostic (1.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.30e-2)" "unprognostic (5.98e-2)" "unprognostic (9.35e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.48e-1)" "unprognostic (2.83e-1)" 17.4 32.5 4.4 4.2 4.0 3.8 19.0 4.1 6.3 14.5 4.6 18.4 15.1 15.1 4.9 23.8 14.9 7.4 19.4 4.4 6.6 15.6 64.2 9.3 1.8 6.1 4.7 3.0 13.0 15.4 17.2 28.1 2.9 5.7 31.6 4.7 1.1 24.0 12.7 17.1 31.6 15.7 7.0 5.3 5.9 16.9 1.7 6.0 1.9 14.0 15.8 2.5 18.1 19.5 3.8 7.3 4.6 1.5 4.5 71.2 43.6 10.8 10.0 23.4 12.3 19.5 1.6 19.9 0.0 11.8 15.8 8.7 5.1 2.0 10.7 4.1 4.7 6.0 1.9 13.6 6.6 22.0 0.1 0.0 40.7 8.7 14.9 3.3 5.7 10.6 0.0 0.8 9.1 9.8 11.3 0.2 0.4 0.9 2.6 31.4 4.5 5.1 2.6 9.1 4.1 4.0 6.4 6.1 13.7 10.8 0.4 41.2 0.8 8.9 13.4 6.4 5.9 6.7 0.1 0.3 0.0 21.0 0.9 9.8 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 4.4 4.0 4.1 6.3 4.4 6.6 6.1 4.7 3.0 5.7 5.3 6.0 3.8 10.1 0.0 0.5 18.9 2.0 10.8 18.6 11.2 12.5 2.1 30.2 24.1 3.4 18.6 11.7 1.8 0.0 5.8 2.6 22.4 3.9 15.1 0.5 8.0 8.7 7.8 14.4 6.5 3.8 21.1 4.7 15.7 15.8 10.0 0.0 14.0 11.4 43.9 11.0 1.7 4.8 25.3 16.2 6.0 7.8 1.4 19.0 6.0 14.2 4.7 3.4 25.5 1.0 7.1 0.9 13.2 29.8 17.0 1.7 25.7 53.2 17.7 6.9 1.6 19.7 12.8 12.4 0.8 0.5 13.3 19.9 2.9 2.1 11.9 20.0 16.6 CRELD1 "AVSD2, CIRRIN" ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933816-9945406 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 110.3;hTERT-RPE1: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 19000000 Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 27.5 37.6 63.8 11.5 61.1 9.4 25.0 66.6 85.8 27.0 55.8 46.0 14.2 31.6 17.1 18.2 35.2 16.7 71.0 62.8 62.4 42.9 57.6 27.7 12.5 63.6 61.0 62.5 32.7 27.8 22.8 71.5 18.1 68.1 48.0 12.2 16.6 26.5 34.8 49.3 18.5 26.2 22.4 57.0 28.8 35.9 23.8 69.0 10.6 68.1 26.7 9.3 33.9 24.6 68.3 6.4 8.1 19.3 8.8 30.1 17.6 110.3 26.7 8.0 6.1 11.7 11.1 20.7 8.4 57.6 17.7 27.7 4.5 10.4 17.6 4.9 15.2 9.2 7.3 15.2 28.2 68.7 3.3 29.3 21.7 32.3 15.2 13.6 77.2 28.8 11.1 9.5 10.4 6.1 15.5 3.6 19.3 5.7 30.1 6.6 4.8 3.1 21.6 25.9 9.9 6.9 26.7 12.6 10.3 24.3 27.5 27.9 17.0 21.7 12.1 19.5 16.2 6.3 10.7 14.2 15.2 27.3 7.8 13.0 12.3 10.2 9.3 11.9 9.8 12.2 7.9 8.9 11.5 6.9 8.7 11.3 10.4 1.8 13.8 12.9 12.3 7.2 9.5 63.8 61.1 66.6 85.8 62.8 62.4 63.6 61.0 62.5 68.1 57.0 69.0 68.3 24.7 19.2 17.5 43.4 14.1 9.7 26.2 48.5 15.9 21.5 17.5 15.0 41.9 31.5 24.0 16.5 16.7 23.7 15.1 10.9 7.9 19.6 6.8 10.3 7.0 20.2 27.0 7.8 38.0 4.4 11.5 20.1 19.4 12.9 21.0 18.8 19.2 14.9 20.6 32.0 37.1 19.1 38.7 8.8 9.0 10.1 32.0 10.0 12.4 15.0 13.9 18.3 27.8 14.6 21.7 8.7 20.4 26.4 15.3 31.4 18.8 11.1 13.2 15.8 26.3 11.0 17.1 68.0 26.5 9.6 12.4 22.2 15.4 11.2 15.4 20.2 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.4;fallopian tube: 7.6;parathyroid gland: 15.4;pituitary gland: 11.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 83000 "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 0.9 1.9 3.9 1.1 4.3 1.5 1.2 9.3 11.4 1.4 0.3 1.1 0.4 1.2 1.2 1.2 7.6 1.1 0.9 4.4 1.0 1.1 0.4 0.9 1.2 4.7 2.2 3.8 1.3 1.9 15.4 11.1 0.3 5.4 2.5 0.3 2.3 2.3 1.7 1.4 2.0 1.0 0.9 0.0 0.9 1.1 2.1 4.3 1.3 2.3 0.2 1.3 1.8 1.1 5.4 0.4 1.0 3.6 4.7 17.2 2.3 1.2 1.8 3.4 2.0 4.5 0.3 3.4 2.0 0.4 4.2 2.1 0.3 1.3 4.5 0.9 9.8 2.0 0.7 1.9 0.2 1.7 0.4 1.7 4.4 0.3 1.7 0.7 9.7 0.8 6.0 1.0 4.7 2.5 23.1 4.4 0.4 8.5 0.1 2.1 2.8 0.4 1.9 1.0 0.4 6.6 4.4 1.8 33.6 0.7 1.4 9.1 0.4 0.7 0.4 4.6 0.9 1.3 6.1 6.6 0.6 10.9 0.3 1.3 0.5 0.2 0.2 1.2 0.1 1.4 0.5 1.3 1.2 0.0 0.6 1.4 1.3 0.3 0.7 0.1 0.6 0.2 0.4 3.9 4.3 9.3 11.4 4.4 1.0 4.7 2.2 3.8 5.4 0.0 4.3 5.4 3.3 0.0 2.0 3.9 2.9 2.7 3.8 3.7 3.4 22.8 7.4 6.2 3.0 7.2 3.4 11.0 14.6 0.7 4.4 4.5 3.9 2.9 4.3 5.0 5.4 3.3 11.3 2.1 14.7 5.0 0.5 5.2 5.6 4.9 1.3 7.9 2.2 2.9 3.8 15.2 10.8 5.4 2.0 2.5 2.6 3.5 5.6 2.2 1.8 2.8 11.3 8.6 11.3 5.5 3.7 3.1 1.0 2.6 2.2 4.2 6.4 8.0 12.4 21.6 0.0 7.2 5.3 10.4 6.4 3.4 2.3 0.4 5.6 7.8 4.7 3.0 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 39 "testis: 62.1" "Group enriched" "Detected in some" 59 "Early spermatids: 565.0;Late spermatids: 852.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "neutrophil: 5.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;MCF7: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA076166 Approved Vesicles NA NA Vesicles "HPA076166: " "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.3 0.0 0.2 1.0 0.0 1.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 62.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.5 0.4 0.3 0.2 0.4 0.3 0.3 0.4 0.2 0.1 0.8 0.3 0.3 5.4 0.2 1.0 0.3 0.1 0.1 0.3 0.2 1.6 0.3 0.2 0.2 0.3 0.3 0.2 0.5 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 565.0 0.4 0.0 0.3 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 852.8 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.0 4.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889206 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 88.4;heart muscle: 81.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3" "Low region specificity" "Detected in many" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 580000 "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavorable (1.08e-4)" 88.4 2.8 0.8 4.0 1.0 15.0 29.3 0.5 1.0 21.7 0.9 6.9 0.1 4.2 2.2 7.9 4.0 1.5 81.1 1.4 1.6 18.1 18.5 16.5 2.3 0.7 1.2 0.7 3.9 1.4 0.7 23.9 48.5 0.6 21.7 5.1 0.8 3.1 9.0 2.5 4.8 2.8 8.8 0.6 3.0 3.5 2.4 1.3 0.7 6.5 22.3 1.9 25.9 26.2 0.8 1.4 11.0 3.4 0.0 65.5 18.1 0.0 1.0 0.2 2.9 3.6 0.7 1.2 0.0 3.3 4.9 14.8 0.1 13.7 0.0 3.4 0.0 21.0 2.5 6.8 0.0 0.0 1.5 0.0 6.9 0.0 6.9 1.7 14.5 0.2 2.2 0.5 0.0 1.4 2.0 4.5 1.2 5.5 0.2 21.9 0.0 8.1 36.8 3.2 0.1 7.6 4.6 17.8 0.0 6.5 4.7 0.0 4.5 0.0 5.8 12.8 77.9 6.0 68.6 34.3 0.0 16.6 1.9 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.5 1.0 1.4 1.6 0.7 1.2 0.7 0.6 0.6 1.3 0.8 17.3 0.0 3.2 0.7 0.2 7.4 0.7 0.9 0.6 18.0 0.5 0.6 37.3 0.0 0.9 12.9 25.0 138.0 0.2 0.2 0.0 0.0 0.6 2.1 2.2 4.5 0.0 0.0 1.6 0.0 63.1 225.8 0.5 3.7 1.3 29.0 0.4 11.8 15.3 6.7 2.2 0.2 0.0 0.6 12.4 1.0 0.6 6.7 3.6 1.9 0.0 13.8 0.0 29.7 1.6 0.5 0.4 0.0 0.0 2.1 0.0 0.0 0.0 12.6 0.0 6.1 16.9 25.8 47.7 1.0 7.4 241.6 1.1 19.1 0.0 0.4 U2SURP "fSAPa, SR140" ENSG00000163714 "U2 snRNP associated SURP domain containing" O15042 3 142964497-143060725 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037545, HPA037546, HPA061407" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506" "unprognostic (2.01e-1)" "unprognostic (9.78e-2)" "unprognostic (8.09e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (3.11e-2)" "unprognostic (4.30e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.72e-2)" "unprognostic (1.98e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.85e-3)" "prognostic unfavorable (8.86e-7)" "unprognostic (6.71e-2)" "unprognostic (2.19e-1)" "unprognostic (3.12e-1)" "prognostic favorable (6.78e-4)" 22.2 18.4 18.9 19.5 20.0 58.1 23.7 24.5 24.4 25.0 18.1 21.4 13.0 22.8 20.9 21.7 24.1 12.4 17.9 18.8 18.8 18.0 24.5 19.0 30.1 18.6 19.3 18.1 32.0 25.4 22.7 21.6 17.9 19.8 19.9 20.3 52.3 18.6 14.7 27.6 22.1 22.2 17.6 17.4 25.9 20.1 20.6 18.5 31.6 22.7 17.9 26.3 21.1 22.1 23.4 165.4 54.2 59.7 40.1 30.9 28.3 103.9 72.8 46.4 82.2 61.2 72.7 49.7 189.2 76.0 47.5 157.0 58.2 124.0 66.1 93.2 51.8 88.0 205.1 49.9 58.3 31.7 202.1 75.3 34.4 32.0 64.3 81.9 36.4 45.4 118.5 129.5 59.1 39.0 46.3 100.4 86.8 96.7 52.8 50.4 101.9 116.2 79.0 40.8 102.8 76.5 44.5 146.1 48.2 87.1 61.2 85.3 84.8 49.5 44.1 52.2 35.1 118.0 69.4 97.5 319.8 34.9 72.1 63.1 40.2 32.7 33.3 40.9 31.7 35.1 60.1 37.1 37.0 27.0 60.7 42.4 36.6 33.3 35.5 48.2 53.9 40.5 21.6 18.9 20.0 24.5 24.4 18.8 18.8 18.6 19.3 18.1 19.8 17.4 18.5 23.4 124.4 118.6 129.4 116.2 94.8 60.8 85.7 140.5 68.9 124.2 64.4 90.3 123.8 52.9 115.6 62.5 66.7 78.9 109.9 50.0 52.8 77.2 35.1 91.5 129.4 96.4 55.2 126.0 71.7 79.8 83.7 103.8 58.1 99.1 98.1 165.5 62.8 58.5 61.3 92.5 80.7 74.7 85.5 60.2 54.6 22.0 108.7 78.4 51.6 63.7 115.9 98.1 110.2 104.5 145.8 89.6 55.7 79.7 108.7 81.9 48.0 60.6 100.2 125.4 78.9 122.8 139.4 243.6 235.6 76.9 64.8 79.1 98.6 111.6 80.7 78.4 MTMR14 "C3orf29, FLJ22405, FLJ90311, hEDTP, hJumpy" ENSG00000163719 "Myotubularin related protein 14" Q8NCE2 3 9649433-9702393 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054063 Approved "Intracellular and membrane" NA NA "HPA054063: AB_2682365" "unprognostic (9.50e-2)" "unprognostic (5.60e-3)" "unprognostic (9.28e-2)" "unprognostic (1.31e-1)" "unprognostic (8.81e-3)" "unprognostic (2.34e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (2.42e-1)" "unprognostic (2.00e-1)" "unprognostic (3.51e-3)" "unprognostic (7.04e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.74e-4)" "unprognostic (1.25e-2)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (1.01e-3)" 16.8 18.2 14.8 22.3 15.2 56.6 15.7 14.8 15.8 11.6 24.9 18.7 17.9 12.8 11.3 16.0 13.6 13.6 31.4 14.0 15.1 18.5 19.6 21.8 37.6 15.6 15.1 12.5 14.1 11.9 15.0 10.3 20.3 16.0 12.2 18.6 9.3 14.0 10.8 45.7 19.0 18.1 13.5 15.1 28.1 16.6 17.0 15.9 24.7 15.4 35.9 42.0 18.5 12.8 18.0 18.9 29.1 19.1 11.1 25.6 17.1 106.4 15.0 28.6 29.3 33.6 22.1 27.7 38.2 16.0 24.2 37.8 11.3 23.4 34.2 24.7 34.5 32.5 40.0 24.4 31.9 45.6 35.3 70.6 31.9 22.9 36.9 38.4 19.9 33.2 28.6 25.0 34.0 20.5 60.4 26.1 28.9 31.3 28.2 23.8 27.0 23.1 41.1 26.4 32.6 10.2 28.7 16.7 21.6 29.3 26.0 28.9 57.3 26.0 13.7 21.5 24.9 21.5 37.0 63.3 49.6 31.0 44.0 18.2 116.9 139.9 107.1 44.7 148.1 44.5 76.5 43.3 45.5 177.8 63.4 39.6 40.6 87.7 58.0 145.1 97.2 55.5 113.7 14.8 15.2 14.8 15.8 14.0 15.1 15.6 15.1 12.5 16.0 15.1 15.9 18.0 19.3 16.0 6.4 21.5 41.7 10.8 12.2 22.6 8.0 0.0 13.2 12.1 23.8 18.6 14.8 9.2 0.0 47.6 34.2 22.0 29.4 38.3 13.8 10.4 10.5 20.0 12.5 24.8 12.2 28.2 39.0 13.0 27.0 19.6 19.7 15.0 26.4 16.7 67.7 0.0 10.3 14.6 22.4 65.3 28.3 12.8 13.1 55.8 12.4 28.1 68.4 0.0 22.6 9.5 19.9 41.9 25.9 13.2 25.0 15.2 33.2 37.3 10.1 0.0 6.6 15.2 14.0 39.0 40.0 14.7 18.0 64.7 27.0 40.5 16.8 12.7 TTC14 "FLJ00166, KIAA1980" ENSG00000163728 "Tetratricopeptide repeat domain 14" Q96N46 3 180602163-180617828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009295 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009295: AB_1858425" "unprognostic (2.72e-1)" "unprognostic (4.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (3.63e-1)" "unprognostic (2.22e-3)" "unprognostic (2.27e-3)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-3)" 26.0 23.5 19.9 28.8 21.7 31.0 28.0 14.4 23.9 40.6 27.6 30.0 23.7 35.5 44.0 18.0 39.0 19.7 23.6 21.8 17.6 31.7 21.8 28.3 41.6 20.5 18.6 20.6 56.5 35.5 27.5 58.4 21.7 19.2 36.6 22.3 69.2 22.2 24.1 13.8 22.4 31.5 19.9 15.4 33.7 28.2 20.6 18.0 24.3 49.8 7.2 29.2 29.8 32.7 27.6 18.6 15.2 22.7 12.9 29.6 25.9 21.4 26.1 21.0 18.8 30.8 20.3 24.3 27.9 27.4 18.9 43.0 26.2 21.3 13.9 25.4 52.0 21.5 26.5 37.0 46.2 21.8 28.7 23.3 32.9 26.3 18.9 9.4 31.1 15.2 35.2 11.3 5.4 21.1 5.4 21.9 2.1 16.1 23.0 29.6 25.5 14.0 29.9 10.6 14.0 19.4 18.8 24.8 12.5 25.8 22.7 47.0 26.9 24.3 37.6 19.3 17.4 48.7 40.2 66.2 62.0 18.4 35.1 16.7 23.8 9.4 10.6 10.6 10.4 12.7 14.7 11.0 10.6 7.1 10.7 13.3 10.9 7.5 13.9 14.6 17.6 10.7 6.3 19.9 21.7 14.4 23.9 21.8 17.6 20.5 18.6 20.6 19.2 15.4 18.0 27.6 33.8 9.6 35.6 135.2 82.1 17.7 33.5 33.6 23.9 98.2 25.8 15.9 14.0 41.5 38.9 66.2 116.7 33.4 114.3 27.8 3.9 28.4 6.2 19.0 41.7 38.7 39.0 41.8 173.1 32.7 19.6 41.8 30.5 19.6 59.6 112.6 45.0 30.4 24.5 80.8 169.9 24.8 30.5 31.7 23.0 11.0 92.6 37.5 30.2 111.5 61.0 49.8 121.5 120.1 160.0 31.9 38.9 81.3 61.5 23.9 42.7 9.4 40.7 123.5 85.5 47.1 40.2 59.6 29.9 16.8 15.3 24.6 68.8 72.2 23.4 23.1 CXCL3 "CINC-2b, GRO3, GROg, MIP-2b, SCYB3" ENSG00000163734 "C-X-C motif chemokine ligand 3" P19876 4 74036589-74038807 "Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 21.0;cervix: 20.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2244.7;Club cells: 738.5;Ionocytes: 724.2;Langerhans cells: 2366.2;Macrophages: 718.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.4;stomach cancer: 18.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 48.5;hTEC/SVTERT24-B: 75.0;RPTEC TERT1: 43.8" "Secreted to blood" NA NA 28700 "unprognostic (2.12e-3)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.08e-3)" "unprognostic (6.97e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-4)" "unprognostic (2.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.81e-1)" "unprognostic (2.89e-6)" "unprognostic (2.61e-3)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (1.20e-1)" 21.0 1.0 0.6 14.6 0.4 15.9 1.6 0.3 2.0 20.9 1.0 4.1 0.7 0.8 0.0 1.0 1.3 7.0 4.5 0.4 1.5 1.4 3.9 15.9 0.7 0.6 0.5 0.3 1.0 1.8 0.1 0.5 0.6 0.5 1.7 9.3 0.1 5.9 0.3 0.5 0.5 2.6 1.6 0.4 2.0 9.0 0.3 2.2 2.1 0.7 1.1 0.7 16.1 0.6 0.6 0.5 3.7 1.5 0.0 0.8 1.4 0.0 5.3 48.5 1.3 2.9 0.1 5.9 0.0 5.2 0.0 17.6 0.2 0.3 1.7 10.5 0.0 0.0 4.1 0.6 0.0 5.7 0.5 0.0 1.1 1.2 75.0 7.3 1.2 1.1 0.8 0.9 0.0 2.1 0.0 1.1 0.2 0.7 7.0 1.5 0.1 1.7 0.0 43.8 1.3 0.0 0.0 0.5 0.0 1.1 0.7 0.2 0.0 2.0 10.5 0.6 5.3 13.7 0.0 0.0 0.0 11.9 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.6 0.4 0.3 2.0 0.4 1.5 0.6 0.5 0.3 0.5 0.4 2.2 0.6 34.2 99.3 244.9 1.6 10.1 228.4 205.6 2244.7 340.9 0.0 123.0 79.9 14.8 125.8 738.5 5.5 0.0 0.7 5.9 137.1 0.0 217.6 1.7 103.4 24.3 113.7 52.9 0.0 0.0 96.7 1.1 161.0 408.7 157.2 27.3 0.2 15.7 1.4 72.2 0.0 0.0 168.3 724.2 162.9 2366.2 5.6 14.0 718.0 188.5 1.0 28.1 0.0 0.0 0.0 0.0 186.1 33.5 0.4 5.1 225.9 95.7 0.2 144.2 0.0 39.5 78.5 92.6 1.7 8.3 50.3 148.6 8.1 14.0 0.1 197.5 79.7 CXCL5 "ENA-78, SCYB5" ENSG00000163735 "C-X-C motif chemokine ligand 5" P42830 4 73995642-73998677 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 36.2;salivary gland: 50.6" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 64.6;Ductal cells: 94.0;Macrophages: 222.6;Pancreatic endocrine cells: 245.4" "Group enriched" "Detected in many" 4 "pancreatic cancer: 56.2;stomach cancer: 74.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 191.9;EFO-21: 157.0;HSkMC: 111.4;hTEC/SVTERT24-B: 81.6;RPTEC TERT1: 603.6" HPA065474 Approved Approved Vesicles "Secreted to blood" NA NA 1110000 1600000 Vesicles "HPA065474: AB_2685494" "unprognostic (5.56e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.80e-2)" "unprognostic (1.43e-2)" "unprognostic (2.04e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.06e-2)" "unprognostic (3.04e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (7.99e-2)" "prognostic unfavorable (2.45e-5)" "unprognostic (3.72e-1)" "unprognostic (3.07e-1)" "unprognostic (2.72e-2)" "unprognostic (9.30e-2)" 2.1 0.2 1.4 36.2 0.9 1.2 3.2 0.8 7.9 7.8 0.5 0.7 0.8 0.2 0.0 0.1 0.2 4.8 0.5 0.8 2.3 0.1 1.3 10.1 6.4 1.3 2.0 0.6 0.0 0.5 0.0 0.1 0.2 3.2 1.3 0.3 0.0 50.6 0.6 0.1 0.0 2.1 0.2 1.1 2.2 8.6 0.4 4.9 0.6 0.0 0.2 0.6 8.4 0.0 1.3 0.1 191.9 0.7 0.0 0.3 6.9 0.0 3.5 2.9 1.5 3.0 0.6 1.6 0.0 157.0 0.1 34.0 0.4 0.0 0.0 17.6 0.2 0.0 0.0 0.0 0.0 15.1 0.0 0.0 111.4 0.0 81.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 603.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 1.0 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.0 1.4 0.9 0.8 7.9 0.8 2.3 1.3 2.0 0.6 3.2 1.1 4.9 1.3 0.2 3.2 0.0 0.0 0.0 0.9 0.7 64.6 0.0 0.0 8.0 4.4 1.2 15.7 33.2 0.0 0.0 0.0 0.1 1.3 0.0 94.0 0.7 0.7 0.1 1.8 0.0 0.0 0.3 1.4 0.1 3.6 15.3 1.2 0.0 0.0 0.7 0.0 0.5 0.0 0.3 0.7 4.1 0.3 30.4 0.3 0.0 222.6 0.0 1.0 2.1 0.0 0.0 0.0 0.1 245.4 0.0 0.0 0.3 3.1 0.0 0.1 4.3 0.0 0.0 0.6 4.0 0.1 0.6 0.0 0.3 0.0 0.3 0.0 1.1 2.0 PPBP "b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1" ENSG00000163736 "Pro-platelet basic protein" P02775 4 73986439-73988190 "Plasma proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 99.5;lymphoid tissue: 54.1" "Cell type enriched" "Detected in some" 18 "Macrophages: 1497.3" "Cancer enriched" "Detected in many" 7 "colorectal cancer: 86.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 13 "basophil: 394.2;neutrophil: 132.3" "Lineage enriched" "Detected in all" 20 "granulocytes: 394.2" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.0;HEL: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008354, CAB017624" Supported "Secreted to blood" NA NA 24500000 2900000000 "CAB017624: AB_1127132, HPA008354: AB_1847353" "unprognostic (2.13e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (7.69e-2)" "unprognostic (1.67e-1)" "unprognostic (4.37e-2)" "unprognostic (3.13e-1)" "unprognostic (2.79e-1)" "unprognostic (6.98e-3)" "unprognostic (2.58e-1)" "unprognostic (4.21e-2)" "unprognostic (1.81e-1)" "unprognostic (2.88e-1)" "unprognostic (2.38e-3)" "unprognostic (1.49e-1)" "unprognostic (2.90e-1)" "unprognostic (2.15e-3)" "unprognostic (2.59e-2)" 1.0 0.5 0.5 0.5 0.5 99.5 0.6 0.5 2.4 0.1 1.8 0.1 0.0 0.1 0.0 0.3 0.8 0.8 1.1 0.4 0.7 0.8 3.0 19.5 0.0 0.7 1.4 0.4 0.1 0.1 0.0 0.4 5.3 1.0 0.1 0.0 0.0 0.6 0.0 1.4 0.1 0.0 0.1 0.9 54.1 0.2 0.0 0.8 0.1 1.0 4.2 0.0 8.5 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 394.2 13.0 9.3 2.0 5.3 2.9 1.5 1.2 0.6 8.0 2.3 4.1 1.0 132.3 1.9 5.0 20.1 2.1 1791.5 0.5 0.5 0.5 2.4 0.4 0.7 0.7 1.4 0.4 1.0 0.9 0.8 0.6 0.3 3.2 1.1 0.0 10.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.5 4.0 1.8 0.0 0.0 9.3 0.1 0.0 4.7 0.0 0.0 0.0 12.3 0.0 2.7 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 36.8 1.1 0.1 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 1497.3 0.0 0.0 80.8 0.0 75.2 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.0 0.3 1.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.0 PF4 "CXCL4, SCYB4" ENSG00000163737 "Platelet factor 4" P02776 4 73980811-73982027 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 67.1;lymphoid tissue: 31.8" "Cell type enriched" "Detected in some" 23 "Macrophages: 1360.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Group enriched" "Detected in many" 12 "basophil: 85.2;neutrophil: 43.0" "Lineage enriched" "Detected in many" 16 "granulocytes: 85.2" "Cell line enriched" "Detected in some" 10 "HEL: 29.8" "CAB026008, HPA052485" Enhanced "Secreted to blood" NA NA 7700000 "CAB026008: , HPA052485: AB_2681847" "unprognostic (4.14e-4)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.96e-4)" "unprognostic (7.58e-2)" "unprognostic (1.42e-1)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (9.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (9.54e-5)" "unprognostic (2.55e-1)" "unprognostic (8.77e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" 0.6 0.2 0.1 0.7 0.2 67.1 0.3 0.1 2.3 0.1 1.1 1.0 0.0 0.1 0.0 0.1 0.3 0.7 0.8 0.1 0.2 0.6 2.2 10.6 0.3 0.4 0.6 0.1 0.1 0.3 0.0 0.3 3.0 0.3 0.1 0.8 0.0 0.4 0.1 1.0 0.0 0.2 0.1 0.4 31.8 0.9 0.1 0.2 0.0 0.6 2.6 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 29.8 0.0 0.0 1.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.2 3.8 1.4 0.8 1.2 0.8 0.0 0.2 0.0 1.5 0.7 0.7 0.3 43.0 0.1 3.9 5.4 0.6 148.4 0.1 0.2 0.1 2.3 0.1 0.2 0.4 0.6 0.1 0.3 0.4 0.2 0.3 0.7 0.0 0.0 0.0 10.8 0.0 0.2 0.4 0.0 0.0 0.1 0.3 0.0 2.8 1.5 1.8 0.0 0.0 4.1 5.3 0.0 6.0 0.0 0.0 0.0 7.1 13.3 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 24.7 0.2 0.3 0.0 0.0 1.8 0.0 9.5 0.0 0.1 0.0 1360.7 0.0 0.0 59.0 0.0 57.7 0.0 0.0 7.6 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.1 0.2 0.0 0.4 0.0 0.0 0.3 5.8 0.0 7.4 0.2 MTHFD2L MGC72244 ENSG00000163738 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like" Q9H903 4 74114174-74303099 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035434 Uncertain NA NA "HPA035434: AB_10601038" "unprognostic (2.01e-1)" "unprognostic (2.19e-1)" "unprognostic (2.03e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-2)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.42e-4)" "unprognostic (3.45e-3)" "unprognostic (4.23e-2)" "unprognostic (5.07e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-2)" "unprognostic (1.19e-1)" "unprognostic (3.00e-1)" "unprognostic (1.81e-3)" 1.6 3.7 6.0 1.2 5.9 1.7 3.4 3.9 7.0 1.3 1.8 1.3 1.6 1.7 3.4 1.9 1.5 1.1 6.1 4.5 8.6 1.9 7.0 1.3 1.2 5.4 5.4 3.2 1.7 1.6 2.5 1.5 1.8 5.5 1.5 1.1 2.7 1.4 1.7 2.7 1.2 1.0 1.2 6.0 1.4 1.4 0.9 5.8 3.4 2.1 3.9 1.1 1.4 1.2 8.0 2.8 2.8 4.0 3.6 1.4 2.1 0.9 3.3 2.6 2.2 2.4 2.2 2.6 3.0 4.5 1.5 1.6 1.7 3.2 2.2 3.3 3.1 2.0 3.7 1.9 2.6 2.4 5.8 0.7 1.5 5.1 3.3 7.9 4.1 4.7 6.7 6.6 3.6 2.7 2.7 10.9 8.3 1.2 4.5 3.1 10.9 2.7 5.1 14.2 1.4 3.7 8.0 1.8 2.8 3.5 4.3 1.5 4.0 4.9 2.5 3.8 4.8 5.6 3.6 5.0 8.8 15.5 1.3 3.8 0.3 0.9 0.4 0.3 0.9 0.3 1.8 0.2 0.4 1.5 0.6 0.8 0.9 0.6 1.1 3.5 1.6 1.4 1.0 6.0 5.9 3.9 7.0 4.5 8.6 5.4 5.4 3.2 5.5 6.0 5.8 8.0 23.3 22.4 19.6 57.5 18.9 16.6 63.5 31.1 30.1 0.0 90.5 53.6 24.5 30.0 27.6 49.7 0.0 17.9 17.1 23.3 84.1 24.0 85.7 67.1 11.0 19.9 37.2 44.2 41.2 19.1 8.8 13.5 35.7 50.4 10.2 35.5 25.0 104.7 24.5 0.0 41.0 34.7 69.2 27.3 23.0 23.2 12.8 30.4 16.0 20.6 17.3 0.0 12.3 74.9 73.1 15.6 19.4 8.6 20.9 69.2 18.3 51.3 30.1 0.0 26.3 19.4 21.1 8.1 12.3 44.0 22.6 12.3 11.1 36.8 36.4 71.9 CXCL1 "FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1" ENSG00000163739 "C-X-C motif chemokine ligand 1" P09341 4 73869393-73871308 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Inflammatory response" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 103.1;lymphoid tissue: 198.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 16674.3;Club cells: 7384.0;Ionocytes: 4146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 243 "neutrophil: 47.3" "Lineage enriched" "Detected in single" 243 "granulocytes: 47.3" "Group enriched" "Detected in many" 6 "BJ hTERT+: 748.4;EFO-21: 1906.7;RPTEC TERT1: 682.0" "Secreted to blood" NA NA 384000 "prognostic favorable (7.83e-4)" "prognostic unfavorable (7.23e-4)" "unprognostic (5.24e-3)" "unprognostic (1.27e-1)" "unprognostic (1.33e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (5.45e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.17e-1)" "unprognostic (5.30e-2)" "unprognostic (7.41e-2)" "unprognostic (9.41e-2)" 18.0 6.3 3.9 49.4 3.7 42.0 3.8 3.1 7.5 103.1 5.6 9.8 10.7 2.3 0.1 39.1 15.0 25.9 20.9 3.3 4.0 18.4 10.3 45.6 2.5 3.5 3.4 2.8 2.4 25.9 0.4 2.0 5.2 3.6 18.9 16.2 0.4 23.9 9.6 1.7 1.6 27.1 3.1 3.6 198.2 9.2 0.2 4.6 2.9 1.9 1.9 23.8 76.1 25.7 3.7 3.7 4.4 0.0 0.0 4.4 11.7 0.0 20.6 748.4 17.7 18.8 0.2 13.4 0.0 1906.7 1.3 72.5 38.6 0.0 3.5 94.2 2.8 0.0 0.0 1.3 0.0 4.4 0.0 0.0 9.7 1.3 133.2 10.6 1.4 144.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 7.7 5.4 0.0 0.0 0.0 682.0 16.7 0.1 0.0 1.5 0.3 40.4 2.0 0.5 1.9 173.9 0.0 6.6 37.8 1.5 0.0 1.6 3.7 1.9 0.1 26.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 3.9 3.7 3.1 7.5 3.3 4.0 3.5 3.4 2.8 3.6 3.6 4.6 3.7 7.9 44.8 273.3 0.0 2.9 126.6 991.1 16674.3 131.5 0.0 61.3 42.9 4.1 413.2 7384.0 5.5 0.0 0.3 1.4 40.3 0.0 1073.2 0.0 152.2 21.5 106.7 635.7 0.0 0.0 42.5 0.7 449.0 20.9 199.0 15.8 1.4 3.9 2.1 26.7 0.0 0.0 31.1 4146.2 10.4 467.3 0.0 0.0 110.8 124.5 0.0 56.9 0.0 0.0 0.0 0.0 232.8 7.6 0.0 0.1 2062.0 19.6 3.1 1219.7 0.0 0.0 152.9 217.7 0.4 0.2 48.7 105.1 0.4 27.8 0.1 66.0 1251.3 RCHY1 "ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363" ENSG00000163743 "Ring finger and CHY zinc finger domain containing 1" Q96PM5 4 75479037-75514764 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030338, HPA030339" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA030338: , HPA030339: AB_10603232" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.90e-1)" "unprognostic (3.45e-3)" "unprognostic (1.19e-2)" "unprognostic (7.87e-3)" "unprognostic (5.82e-2)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.60e-2)" "prognostic favorable (3.62e-5)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "prognostic favorable (7.89e-5)" 8.6 7.0 10.0 8.0 10.5 17.1 16.9 13.1 13.1 9.1 8.5 12.3 8.7 9.7 6.9 7.3 12.0 6.9 16.9 9.9 10.8 16.4 12.4 10.1 9.6 9.6 11.0 9.0 14.6 8.3 12.7 5.8 10.0 10.2 11.0 13.4 14.9 13.0 10.2 16.7 5.7 8.7 11.7 10.4 11.6 9.0 13.7 11.1 12.8 19.1 23.9 12.7 7.7 4.7 11.2 9.8 5.0 14.6 13.8 15.1 13.1 8.4 6.5 15.1 13.2 15.4 13.8 11.9 16.2 12.0 9.4 13.1 5.8 37.6 11.5 19.9 13.4 12.3 21.2 9.2 17.9 13.0 28.9 11.2 12.2 14.1 15.2 14.2 15.9 27.0 20.8 19.9 16.2 30.9 15.8 26.7 11.5 24.5 26.9 8.7 14.2 34.4 13.9 20.4 16.7 22.6 12.4 10.7 24.8 28.2 15.9 14.0 12.9 10.8 8.6 8.5 7.8 11.1 17.0 13.0 22.8 10.5 20.2 14.0 27.5 9.2 9.7 4.3 5.7 7.6 4.6 5.4 5.2 8.0 2.1 3.9 5.5 4.0 5.5 5.6 4.1 5.7 4.7 10.0 10.5 13.1 13.1 9.9 10.8 9.6 11.0 9.0 10.2 10.4 11.1 11.2 22.2 19.2 10.3 28.4 25.4 40.7 32.3 47.1 39.3 35.0 38.5 25.9 56.8 24.3 23.5 23.9 20.9 31.6 31.2 21.9 68.4 30.3 37.3 11.9 17.1 22.3 13.8 21.8 31.2 22.5 23.2 24.6 21.9 17.3 5.1 23.8 25.4 23.0 19.0 23.5 32.3 23.4 38.7 37.5 26.8 59.8 22.4 27.4 28.4 22.5 23.9 32.0 24.7 31.7 41.0 26.5 22.6 25.2 19.7 36.6 24.6 69.4 13.5 21.7 32.9 20.9 27.3 72.8 41.7 28.1 31.0 33.8 32.9 35.2 27.6 26.3 PLSCR2 ENSG00000163746 "Phospholipid scramblase 2" Q9NRY7 3 146391421-146495991 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.3" "Group enriched" "Detected in some" 30 "Early spermatids: 195.5;Late spermatids: 246.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051352 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA051352: " "unprognostic (1.11e-1)" "unprognostic (9.83e-2)" "unprognostic (8.94e-3)" "unprognostic (7.53e-3)" "unprognostic (3.81e-2)" "unprognostic (1.51e-2)" "unprognostic (3.67e-2)" "unprognostic (1.84e-2)" "unprognostic (4.11e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.16e-1)" "unprognostic (1.88e-4)" "unprognostic (4.06e-1)" "unprognostic (9.71e-2)" "unprognostic (3.02e-1)" "unprognostic (1.23e-2)" 0.2 0.1 0.7 0.3 0.4 1.1 0.3 0.3 0.7 0.1 0.5 0.3 0.2 0.1 1.8 0.2 0.7 0.5 0.0 0.2 2.6 0.6 0.2 0.2 0.1 1.1 0.5 0.1 0.1 0.9 0.2 0.1 0.2 0.7 0.3 0.4 0.5 0.3 0.5 0.0 0.0 0.3 0.2 0.6 0.1 0.4 13.3 0.9 0.2 0.5 0.0 0.1 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.7 0.4 0.3 0.7 0.2 2.6 1.1 0.5 0.1 0.7 0.6 0.9 1.3 0.4 0.0 0.0 0.3 0.2 0.3 0.1 0.1 0.6 0.0 1.3 0.6 0.0 1.5 0.2 7.3 0.0 0.2 1.5 0.7 1.9 1.6 195.5 1.4 0.1 0.4 1.8 0.0 1.0 0.6 0.1 0.5 1.5 0.7 0.0 0.4 0.4 0.1 0.1 0.0 1.1 0.3 2.0 0.0 1.1 246.0 1.8 0.6 0.0 1.0 0.0 1.2 0.0 0.0 0.2 0.5 1.0 1.5 0.0 0.3 0.1 1.5 1.4 0.3 0.0 0.7 0.3 5.4 2.6 0.1 0.1 0.0 0.2 0.2 0.9 0.3 CCDC158 FLJ25770 ENSG00000163749 "Coiled-coil domain containing 158" Q5M9N0 4 76312997-76421868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 33.8" "Group enriched" "Detected in some" 7 "Early spermatids: 88.5;Late spermatids: 81.7;Spermatocytes: 66.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.31e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-2)" "unprognostic (3.30e-2)" "unprognostic (3.29e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-3)" "unprognostic (6.99e-2)" "unprognostic (1.57e-1)" "unprognostic (9.70e-2)" "unprognostic (1.08e-3)" "unprognostic (2.18e-1)" "unprognostic (9.77e-3)" "unprognostic (6.22e-2)" "unprognostic (3.65e-2)" "unprognostic (9.29e-2)" "unprognostic (2.68e-1)" 0.5 0.1 0.2 0.0 0.1 0.0 1.1 0.3 0.4 0.1 0.0 0.1 0.0 0.2 0.9 0.1 0.2 0.2 0.4 0.1 0.6 0.5 1.6 0.1 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.5 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 33.8 0.3 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.1 0.6 0.3 0.4 0.0 0.4 0.5 0.3 0.4 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 0.7 1.0 2.4 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 88.5 2.3 0.1 0.1 0.0 0.0 10.9 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 1.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 81.7 0.6 0.3 0.0 0.0 0.0 1.1 0.0 3.0 3.0 0.1 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.3 0.2 66.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865296-148897203 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 113.0;lung: 87.1" "Cell type enriched" "Detected in some" 26 "granulocytes: 4422.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 1534 "basophil: 1115.4" "Lineage enriched" "Detected in single" 5518 "granulocytes: 1115.4" "Cell line enriched" "Detected in some" 45 "HEL: 303.3" "Not detected" "Not detected" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 16.2 2.7 0.0 20.0 0.3 25.9 21.2 0.0 0.0 59.9 0.2 39.6 27.6 26.3 19.5 41.5 6.6 113.0 6.3 0.0 0.0 3.3 2.8 87.1 11.3 0.0 0.0 0.0 0.9 21.2 2.8 0.9 1.7 0.0 18.7 57.2 0.0 12.2 15.2 1.6 16.8 46.3 25.9 0.0 1.1 45.7 3.8 0.0 15.0 1.0 10.3 15.3 54.5 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 303.3 0.0 0.0 0.2 0.2 6.7 0.2 0.0 0.1 0.3 0.5 3.8 0.0 0.1 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1115.4 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 163.9 0.0 0.5 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 16.0 0.0 1.6 0.0 3.5 0.5 0.0 4422.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 6.7 0.3 0.0 0.0 8.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.3 0.0 41.7 0.0 0.0 0.3 GYG1 GYG ENSG00000163754 "Glycogenin 1" P46976 3 148991408-149031775 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 564.6;tongue: 360.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 229.8;Early spermatids: 251.2;Late spermatids: 368.8;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030497, HPA073229" Supported Approved Vesicles NA NA 30000 Vesicles "HPA030497: AB_10602326, HPA073229: " "unprognostic (2.68e-2)" "unprognostic (6.31e-3)" "unprognostic (3.21e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (7.75e-3)" "unprognostic (1.29e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" 39.3 31.4 30.6 31.6 32.2 221.8 34.1 33.6 39.8 35.4 29.8 113.1 16.8 64.6 39.0 54.1 53.1 24.1 118.6 30.1 52.2 26.1 18.7 41.4 25.0 38.3 38.8 28.3 44.1 43.0 25.4 31.7 23.2 41.0 47.8 25.9 34.6 40.1 65.0 564.6 19.7 38.1 68.7 36.0 59.6 51.1 116.2 34.2 18.1 21.3 360.8 23.2 86.9 31.1 38.9 62.7 39.8 29.0 32.6 78.5 81.7 39.5 90.2 74.4 128.3 119.2 52.3 62.2 0.1 43.5 105.1 68.4 18.8 76.7 39.8 128.6 21.1 33.3 47.6 16.7 59.9 70.7 49.1 68.8 45.1 63.8 42.7 53.3 66.8 74.7 30.7 29.8 109.8 74.7 110.3 9.6 38.9 34.9 48.3 32.2 26.7 43.8 89.3 35.7 57.6 23.7 11.3 47.6 64.6 54.4 27.3 64.4 51.4 62.9 65.4 19.4 47.4 66.9 98.7 59.1 44.4 55.1 74.3 21.7 22.7 58.1 42.4 39.4 59.6 73.1 15.9 25.7 41.3 64.0 14.0 13.8 23.5 27.0 44.3 67.9 25.3 39.4 50.1 30.6 32.2 33.6 39.8 30.1 52.2 38.3 38.8 28.3 41.0 36.0 34.2 38.9 27.7 12.8 11.1 16.3 28.3 12.1 22.4 27.7 12.5 9.4 22.5 17.1 229.8 15.7 21.9 33.1 18.8 36.5 50.4 9.9 27.4 43.4 251.2 7.9 15.2 32.6 14.4 12.2 9.8 77.6 47.2 45.0 17.3 9.5 18.3 19.7 45.3 13.5 95.3 6.7 11.3 19.0 26.4 87.1 26.3 368.8 53.1 56.2 40.9 6.5 56.2 132.1 36.0 11.6 5.4 31.6 14.3 76.8 104.1 45.9 15.0 17.3 16.1 7.0 65.7 35.8 50.3 296.7 52.2 23.1 14.9 29.3 61.2 33.8 15.2 19.6 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3 biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129638-149173732 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 115.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 7.1 9.3 4.1 11.5 4.6 5.6 8.0 5.0 4.2 7.6 8.0 7.5 11.1 10.0 5.0 5.7 8.7 9.1 5.0 3.5 5.4 12.1 8.1 9.8 17.8 6.6 5.2 2.8 14.2 6.7 5.8 3.8 10.7 6.5 9.4 9.2 9.6 6.7 8.6 2.9 4.7 10.9 10.4 6.1 16.2 9.3 6.9 5.4 17.0 8.9 3.9 16.5 8.5 5.2 7.8 49.1 26.5 15.7 16.3 21.4 27.4 11.7 19.7 38.4 25.3 32.4 9.1 31.8 12.4 23.8 23.7 115.3 16.5 17.4 13.4 32.4 30.6 13.9 5.8 11.8 9.9 19.1 15.7 9.1 18.0 13.5 24.4 10.0 51.6 26.2 20.2 6.5 29.4 32.5 30.3 11.3 22.1 37.7 26.3 21.1 13.4 10.3 33.7 13.9 24.1 4.7 12.4 16.8 17.7 35.9 33.4 19.2 20.5 13.2 25.2 4.5 26.0 29.0 24.0 10.0 30.6 37.7 30.1 6.3 20.7 12.5 12.1 12.0 15.2 14.5 15.4 10.9 12.9 19.5 12.2 8.4 10.9 5.7 9.8 10.3 11.0 10.7 10.9 4.1 4.6 5.0 4.2 3.5 5.4 6.6 5.2 2.8 6.5 6.1 5.4 7.8 9.9 12.8 19.5 17.6 28.6 3.7 3.9 11.5 6.8 6.7 9.1 7.4 2.5 5.7 22.9 7.3 2.1 21.0 24.3 8.0 5.9 10.7 3.0 10.6 11.6 9.9 9.0 7.4 13.3 18.1 14.6 10.8 16.8 10.4 15.2 18.0 17.5 6.9 19.8 3.3 16.5 8.8 14.2 29.3 23.8 4.8 11.5 33.1 14.2 38.4 14.4 25.1 19.6 19.1 27.3 12.9 4.9 30.1 15.4 6.8 13.6 22.8 20.7 5.2 0.0 7.4 8.4 4.4 8.4 8.7 5.3 14.1 18.9 5.4 7.5 5.1 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.2" "Group enriched" "Detected in many" 4 "Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2" "Low region specificity" "Detected in many" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 21.4 5.2 10.4 5.0 8.4 0.1 16.4 8.1 11.6 8.4 8.8 3.3 3.9 7.6 4.7 3.4 6.5 10.7 8.5 8.7 9.0 19.3 7.9 9.2 6.6 11.4 10.0 6.7 3.2 9.9 6.9 3.1 17.5 10.7 4.1 3.4 1.1 4.1 6.6 6.0 2.1 3.7 15.0 8.9 34.2 3.4 2.0 10.5 2.1 12.8 5.7 5.1 6.7 2.5 9.6 0.1 94.8 3.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 1.2 0.0 194.9 0.0 38.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.3 0.1 0.7 0.0 0.0 0.0 24.7 65.9 0.0 0.0 0.0 6.2 0.7 0.0 0.2 47.2 0.0 0.0 0.1 2.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.5 1.5 0.1 0.1 8.4 0.1 1.2 0.0 0.5 0.1 0.1 0.5 0.0 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 10.4 8.4 8.1 11.6 8.7 9.0 11.4 10.0 6.7 10.7 8.9 10.5 9.6 226.1 0.0 4.4 0.3 1.6 3.2 0.2 0.0 0.6 0.2 41.4 23.9 2.8 4.3 0.0 1.8 0.0 0.0 1.0 0.0 9.8 35.2 0.4 0.7 1.1 188.9 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.9 1.3 0.3 151.0 1.1 0.1 0.0 0.1 0.0 0.0 9.1 3.0 1.8 2.1 1.2 1.8 33.7 0.6 0.4 0.0 0.5 0.6 0.9 0.0 6.8 2.5 1.3 0.0 35.8 0.7 0.0 0.0 1.5 2.5 0.2 0.5 0.2 2.8 0.0 1.1 5.2 0.0 0.6 TOPBP1 "Dpb11, KIAA0259, TOP2BP1" ENSG00000163781 "DNA topoisomerase II binding protein 1" Q92547 3 133598175-133662380 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 104.1;Spermatocytes: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022451, HPA036738, HPA036739" Approved Supported "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281" "unprognostic (7.72e-2)" "unprognostic (8.54e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.05e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (4.66e-5)" "unprognostic (8.03e-2)" "unprognostic (3.98e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (2.74e-3)" "unprognostic (8.65e-3)" "unprognostic (7.97e-2)" "unprognostic (2.52e-1)" "unprognostic (7.64e-2)" "unprognostic (1.60e-1)" 7.4 5.0 3.8 13.1 4.5 33.4 10.8 5.3 4.8 6.5 3.6 9.4 8.4 8.2 5.1 8.9 6.0 7.0 6.2 4.6 3.9 5.6 7.4 7.3 19.9 4.1 3.6 4.1 7.4 7.6 6.1 3.6 12.1 4.0 6.7 11.7 8.3 7.1 5.6 7.0 11.9 9.3 8.8 4.0 10.4 8.8 22.6 3.9 29.4 7.5 7.7 18.7 8.4 7.0 4.7 44.4 27.2 43.1 35.1 8.0 10.5 32.3 33.9 26.9 41.0 52.4 37.9 27.5 80.5 29.1 24.7 49.3 50.2 62.8 22.6 62.7 48.9 28.2 75.4 38.3 23.4 7.7 81.5 57.1 12.5 13.7 40.2 23.9 15.4 28.5 46.3 47.6 55.7 32.6 30.3 79.9 43.1 35.7 50.4 23.0 53.3 53.8 58.4 14.6 30.1 40.9 45.2 41.9 22.6 35.4 41.7 37.7 74.6 19.9 43.0 38.9 43.9 37.7 33.4 53.4 150.6 25.4 42.7 38.4 1.8 0.7 2.2 0.7 0.9 1.0 0.9 0.7 0.7 0.7 0.5 0.7 0.7 0.9 1.0 0.5 1.0 1.5 0.4 3.8 4.5 5.3 4.8 4.6 3.9 4.1 3.6 4.1 4.0 4.0 3.9 4.7 17.1 22.4 21.9 10.7 22.8 12.4 8.8 7.8 20.5 15.2 14.2 14.2 10.1 12.8 19.7 11.0 2.1 20.0 33.9 11.9 9.8 12.3 69.4 8.8 16.8 16.0 7.2 42.7 24.3 13.3 19.6 14.9 16.3 13.1 7.6 34.3 7.5 9.5 11.2 3.3 19.6 13.9 6.1 16.7 8.0 104.1 10.2 18.2 8.8 11.2 27.4 10.4 28.8 16.6 13.0 14.7 11.6 9.8 37.5 10.2 6.1 6.1 8.7 9.3 13.1 20.9 12.2 81.3 43.6 22.0 11.5 14.0 23.3 17.7 14.8 10.5 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor like tyrosine kinase" P34925 3 134065303-134250859 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293" "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 32.1 25.4 16.6 15.8 16.3 17.3 43.2 16.0 19.0 40.6 20.4 29.6 20.3 46.5 40.3 29.8 33.6 24.5 30.6 14.9 17.4 25.6 22.5 25.5 19.1 16.6 16.0 14.2 82.9 24.7 30.0 17.2 36.9 16.2 36.7 26.4 16.0 27.2 44.3 25.6 35.0 21.6 40.9 16.9 23.1 23.4 47.5 16.9 21.4 41.3 32.5 20.6 35.1 32.9 17.0 78.8 20.6 63.3 48.7 79.8 84.4 48.8 51.0 117.7 66.4 74.2 65.6 58.8 15.3 82.4 63.1 63.7 71.6 45.5 64.3 94.5 25.9 20.5 40.6 22.4 42.4 62.2 20.0 34.4 56.1 74.0 41.2 82.2 72.5 56.5 26.4 14.5 7.5 66.0 37.6 28.0 25.9 53.4 65.2 24.3 13.7 48.4 32.4 54.5 57.3 31.0 45.6 61.7 44.5 79.1 40.5 55.7 35.8 42.1 54.8 49.6 57.8 41.8 3.1 4.2 8.3 34.8 33.1 39.6 4.6 0.8 1.6 1.1 0.8 1.3 0.6 2.0 1.3 0.3 1.2 1.9 1.5 0.3 1.6 0.8 0.0 0.5 0.5 16.6 16.3 16.0 19.0 14.9 17.4 16.6 16.0 14.2 16.2 16.9 16.9 17.0 62.5 12.8 27.9 31.6 20.6 41.3 36.6 26.3 39.3 23.1 45.4 37.2 34.9 18.6 23.7 44.1 29.2 19.4 23.1 15.9 0.0 15.9 16.2 27.6 41.7 31.0 13.9 13.2 69.5 21.1 14.7 41.3 15.8 32.7 17.7 121.2 40.7 24.1 11.3 13.5 59.7 20.9 12.2 18.6 21.6 7.4 33.2 16.1 14.2 65.6 12.8 26.8 13.4 65.9 57.9 21.7 19.7 32.7 12.9 42.8 15.4 10.5 13.9 39.8 46.0 33.8 38.1 24.6 40.9 33.7 38.1 10.8 18.4 50.8 22.2 38.9 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 126.0;TIME: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favorable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favorable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 32.9 10.4 10.9 17.4 10.2 58.9 26.8 28.1 13.4 20.2 10.8 14.2 16.3 23.3 7.9 19.9 13.7 20.6 16.4 10.0 12.5 20.2 25.7 26.6 19.9 13.2 13.4 8.0 14.5 22.9 18.6 11.5 33.5 15.2 11.3 12.0 19.0 11.4 10.9 14.4 28.1 17.4 23.1 9.1 33.3 14.5 11.2 13.5 40.9 27.5 21.8 14.8 20.0 21.9 14.9 8.4 5.0 9.1 8.8 26.6 9.5 8.7 8.8 14.8 9.4 9.1 6.9 11.8 13.2 6.8 11.2 6.2 5.3 10.7 18.9 9.6 15.1 8.8 15.0 9.1 8.1 13.8 17.1 16.1 10.5 12.7 10.6 17.9 9.5 126.0 14.9 6.7 14.9 8.7 4.4 17.3 15.0 10.1 4.6 22.6 11.7 6.7 14.0 24.2 14.1 6.4 13.4 7.7 8.1 11.1 7.9 5.5 21.4 74.1 8.2 8.3 9.5 10.4 23.7 18.3 11.0 5.8 20.1 12.0 9.4 4.2 7.6 9.5 7.5 13.0 3.6 8.3 9.6 4.0 3.6 12.1 13.1 27.7 11.0 7.1 1.2 9.7 9.7 10.9 10.2 28.1 13.4 10.0 12.5 13.2 13.4 8.0 15.2 9.1 13.5 14.9 88.4 32.1 24.1 30.0 29.0 52.8 10.3 6.4 12.5 52.1 9.7 8.6 17.7 15.7 15.0 16.5 16.7 7.7 57.6 37.0 11.7 10.9 50.4 23.3 16.2 84.2 10.8 10.3 21.6 8.9 3.2 16.4 12.8 19.8 14.5 8.9 98.6 25.2 13.7 30.3 43.2 10.7 12.2 24.8 19.0 7.5 12.5 26.5 23.2 34.7 21.9 16.3 65.9 24.6 10.7 11.2 20.6 11.7 27.3 12.7 25.2 12.2 19.2 18.3 124.9 31.3 49.1 11.1 16.2 13.7 51.3 8.2 61.2 9.5 11.1 18.0 TCF23 "bHLHa24, OUT" ENSG00000163792 "Transcription factor 23" Q7RTU1 2 27149004-27156974 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "endometrium 1: 51.7;fallopian tube: 24.9;ovary: 18.7;smooth muscle: 20.5" "Cell type enhanced" "Detected in some" "Leydig cells: 10.5;Peritubular cells: 29.0;Sertoli cells: 52.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "THP-1: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044596 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044596: AB_10797258" "unprognostic (1.04e-1)" "unprognostic (2.47e-3)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (3.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-2)" "unprognostic (4.07e-2)" "unprognostic (3.21e-1)" "unprognostic (1.74e-2)" "unprognostic (4.08e-2)" "unprognostic (8.58e-2)" "unprognostic (2.41e-5)" "unprognostic (7.58e-3)" "unprognostic (3.01e-1)" "unprognostic (8.58e-4)" "unprognostic (2.64e-2)" 0.2 0.0 0.3 0.0 0.2 0.2 0.0 0.5 0.4 3.5 0.2 0.2 0.1 51.7 5.8 0.0 24.9 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.4 18.7 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.5 0.2 0.1 0.1 20.5 0.1 2.3 0.1 2.6 0.2 0.0 0.0 0.0 0.0 0.2 2.9 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.2 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.4 0.3 0.2 1.1 0.3 0.1 0.4 0.1 0.0 0.3 0.2 0.5 0.4 0.2 0.2 0.3 0.1 0.4 0.3 0.1 0.2 0.5 0.1 0.0 2.2 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.3 0.3 0.7 0.0 0.6 0.0 2.1 0.0 0.2 0.1 0.0 0.0 1.7 0.2 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 1.3 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 10.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.7 0.0 0.1 0.0 0.6 52.6 1.0 1.5 0.3 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.6 DNAJC5G "CSP-gamma, FLJ40417" ENSG00000163793 "DnaJ heat shock protein family (Hsp40) member C5 gamma" Q8N7S2 2 27275433-27281499 "Predicted membrane proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "epididymis: 47.3;testis: 23.0" "Group enriched" "Detected in some" 4 "Early spermatids: 69.1;Late spermatids: 83.6;Spermatocytes: 105.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041445 Approved NA NA "HPA041445: AB_2677485" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (2.26e-1)" "unprognostic (3.99e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.06e-1)" "unprognostic (1.75e-4)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (7.67e-2)" "unprognostic (1.97e-2)" 0.1 0.8 0.6 0.0 0.2 0.0 0.0 0.0 2.3 0.3 0.0 0.1 0.0 0.4 47.3 0.0 0.4 0.0 1.3 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.7 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.6 0.2 0.0 2.3 1.0 0.0 0.2 0.0 0.7 1.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.1 0.0 0.0 0.3 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 83.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 105.1 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 UCN "UI, UROC" ENSG00000163794 Urocortin P55089 2 27307400-27308445 "Predicted secreted proteins" Hearing Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell type enhanced" "Detected in many" "Astrocytes: 7.8;Excitatory neurons: 6.5;Inhibitory neurons: 5.5;Oligodendrocytes: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 19.4" "Low region specificity" "Detected in many" CAB010911 Approved Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 133000 "Endoplasmic reticulum" "CAB010911: AB_261834" "unprognostic (7.35e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.42e-2)" "unprognostic (5.08e-2)" "unprognostic (7.72e-2)" "unprognostic (5.69e-3)" "unprognostic (2.66e-1)" "unprognostic (2.48e-1)" "unprognostic (1.15e-1)" "unprognostic (3.80e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.84e-7)" "unprognostic (4.84e-2)" "unprognostic (3.87e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" 1.3 5.2 7.1 0.6 7.1 1.1 1.5 6.7 13.6 3.3 3.3 2.0 0.3 2.5 0.5 0.9 3.0 0.9 3.6 7.0 6.1 2.0 6.0 1.9 0.8 8.7 15.9 7.1 2.9 2.3 0.0 4.3 1.0 14.8 3.1 0.0 0.9 0.9 0.3 4.8 1.2 1.9 0.4 6.1 2.9 1.3 2.9 7.4 0.6 1.7 0.4 0.2 2.8 1.7 8.6 1.2 2.7 0.4 0.7 1.2 1.0 5.1 0.4 1.0 0.4 0.4 0.2 2.1 1.1 0.6 0.4 1.2 0.4 0.4 0.3 0.0 3.4 4.4 2.4 2.0 2.2 2.9 0.2 2.6 1.5 2.0 0.2 2.4 2.6 0.0 2.0 2.4 1.9 0.1 2.0 1.3 7.2 4.4 0.1 2.8 3.5 2.3 1.5 0.1 0.5 0.7 2.3 1.1 0.1 6.4 0.3 1.1 3.2 0.2 0.8 4.8 1.4 1.9 19.4 2.3 0.7 3.7 5.7 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 7.1 7.1 6.7 13.6 7.0 6.1 8.7 15.9 7.1 14.8 6.1 7.4 8.6 0.8 0.0 0.5 7.8 1.1 0.5 0.3 0.3 0.0 2.3 1.8 1.0 0.4 4.3 0.2 0.0 0.0 0.6 3.2 0.5 0.0 0.7 0.6 0.5 0.9 0.8 0.0 2.7 6.5 3.8 0.6 0.7 0.0 0.5 0.0 1.2 1.1 1.1 0.7 1.7 5.5 0.3 2.0 1.3 2.4 0.4 1.5 0.9 0.0 3.7 0.9 1.8 0.0 2.5 6.0 0.6 1.1 0.7 0.1 0.7 1.1 0.5 0.5 3.5 0.0 1.5 1.2 1.1 0.6 0.0 0.0 0.8 0.8 0.4 0.5 0.1 ZNF513 "FLJ32203, RP58, Zfp513" ENSG00000163795 "Zinc finger protein 513" Q8N8E2 2 27377235-27380790 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" DNA-binding "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SH-SY5Y: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051493 Uncertain NA NA "HPA051493: AB_2681505" "unprognostic (1.11e-1)" "unprognostic (1.68e-1)" "unprognostic (4.67e-3)" "unprognostic (1.16e-1)" "unprognostic (2.99e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (6.21e-5)" "unprognostic (2.86e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-1)" "unprognostic (9.48e-3)" "unprognostic (1.18e-1)" "unprognostic (5.18e-3)" "unprognostic (9.31e-2)" "unprognostic (1.79e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" 15.4 23.9 14.6 12.9 13.9 12.2 16.8 16.5 19.3 15.8 11.2 20.6 18.9 18.4 5.7 23.9 16.8 9.4 13.6 14.1 13.0 27.4 38.8 18.3 11.2 14.8 14.3 13.1 13.5 20.7 10.2 30.4 6.6 14.5 26.0 7.9 4.8 18.9 10.7 11.5 18.5 23.8 7.2 13.0 27.5 24.4 36.4 15.2 8.8 23.7 5.5 6.5 19.5 17.4 13.9 10.3 12.4 15.7 16.0 10.3 8.6 20.6 13.1 15.1 9.6 8.3 10.2 7.6 3.5 11.6 9.4 10.1 9.1 6.7 11.8 2.8 13.0 11.0 9.9 8.9 7.7 18.3 3.4 26.6 14.7 13.0 9.5 11.5 6.3 11.4 13.8 6.2 2.1 9.2 3.9 6.4 16.6 23.7 9.9 8.0 8.2 11.7 6.6 13.5 17.8 9.7 50.8 6.4 7.4 12.9 8.5 5.5 9.8 10.9 6.7 4.4 5.5 3.9 30.1 19.9 6.6 9.3 8.0 13.5 1.2 0.5 1.0 0.4 1.0 0.0 0.0 0.4 0.1 0.7 0.1 0.4 0.2 0.8 0.0 0.5 0.7 0.0 0.3 14.6 13.9 16.5 19.3 14.1 13.0 14.8 14.3 13.1 14.5 13.0 15.2 13.9 7.2 3.2 7.5 4.9 2.5 9.2 6.0 5.7 10.2 7.9 10.3 6.9 0.4 10.0 4.3 5.5 4.2 5.6 4.0 14.8 0.0 6.2 44.1 9.0 8.9 7.7 8.4 4.4 4.5 10.2 4.7 4.9 22.4 11.5 0.0 6.9 2.5 10.8 6.0 5.0 5.1 10.6 6.1 2.9 4.6 10.5 4.1 5.3 5.4 1.9 5.9 11.7 2.1 3.0 3.7 9.0 13.5 3.4 4.8 11.0 9.2 5.2 4.7 6.5 6.6 5.6 6.2 9.3 10.3 12.2 13.4 16.1 4.5 10.8 9.4 13.6 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA036679: AB_2675244" "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavorable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.79e-4)" 13.8 16.8 16.2 16.3 18.1 15.9 14.7 19.8 21.0 11.5 14.9 12.4 12.8 13.5 12.5 15.2 12.8 10.5 20.8 17.9 17.7 16.1 16.3 14.0 17.5 17.5 16.5 16.8 15.6 14.5 21.3 12.8 15.8 17.7 13.0 13.0 20.0 13.0 12.1 30.9 16.5 13.4 13.3 15.1 15.1 14.0 34.2 17.3 17.2 15.4 22.3 17.1 12.7 12.1 18.3 44.6 25.4 25.1 23.6 25.3 23.2 36.8 36.1 24.8 37.2 30.3 37.4 31.7 28.0 32.7 29.1 39.2 31.0 40.6 28.0 33.2 39.2 33.2 32.2 26.2 41.5 30.7 46.6 29.5 20.9 34.8 37.1 34.8 31.2 38.4 27.1 47.5 29.7 34.7 27.1 31.5 45.4 25.4 29.3 24.7 25.9 54.9 32.4 38.5 20.4 27.2 26.8 28.1 37.9 36.0 25.2 23.0 30.1 39.3 34.5 31.3 24.2 42.7 48.5 73.8 88.4 37.4 36.8 28.2 104.8 33.4 48.9 31.6 32.6 31.8 26.1 28.6 28.0 25.8 36.7 34.5 29.1 31.9 43.7 37.6 20.8 34.9 28.0 16.2 18.1 19.8 21.0 17.9 17.7 17.5 16.5 16.8 17.7 15.1 17.3 18.3 17.1 32.1 28.9 14.7 17.3 11.9 12.3 27.1 14.8 19.9 13.3 11.0 30.1 11.5 29.1 18.4 18.8 24.5 21.0 11.4 5.9 28.4 47.2 22.0 20.3 21.9 16.3 11.8 25.5 36.9 20.3 17.4 13.3 20.4 38.6 18.5 15.4 13.9 24.4 25.2 23.7 11.5 16.2 13.9 8.2 7.9 17.4 18.9 17.8 8.4 31.5 21.6 19.6 12.5 18.2 30.5 9.3 19.2 22.1 8.7 11.5 16.1 24.4 21.1 32.9 23.3 21.7 143.4 82.4 15.7 11.9 24.4 21.8 21.5 10.1 10.8 PLB1 "FLJ30866, PLB" ENSG00000163803 "Phospholipase B1" Q6P1J6 2 28457145-28644142 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 39.4" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 112.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0" "Group enriched" "Detected in many" 40 "dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;OE19: 7.8;RT4: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (2.18e-2)" "unprognostic (2.49e-1)" "unprognostic (6.58e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (4.91e-3)" "unprognostic (4.74e-2)" "unprognostic (4.48e-2)" "unprognostic (2.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (2.61e-9)" "unprognostic (2.48e-2)" "unprognostic (2.19e-2)" "unprognostic (4.99e-2)" "unprognostic (8.03e-2)" 1.6 5.8 3.4 1.8 3.1 5.0 1.8 1.1 3.0 1.8 2.7 1.5 0.7 1.7 1.7 1.0 1.3 1.5 1.0 2.7 2.5 0.5 0.5 1.6 0.4 2.2 2.0 2.6 0.9 0.6 0.3 1.6 2.2 1.8 2.1 1.8 0.1 1.4 1.5 2.0 8.0 39.4 2.8 1.7 4.1 0.9 2.6 2.3 0.6 2.0 0.6 0.3 1.8 1.3 2.1 0.4 0.0 2.4 0.0 0.5 0.3 3.6 0.1 1.0 0.2 0.2 2.5 0.2 0.2 0.2 0.4 1.0 0.5 0.0 1.9 0.2 0.1 0.0 0.2 0.4 0.4 0.8 0.4 0.1 0.4 1.1 0.4 0.5 0.4 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 7.8 0.5 0.0 0.4 0.0 1.1 2.7 1.0 0.2 0.1 0.1 0.2 0.2 0.0 1.3 0.2 0.2 0.7 0.1 0.1 0.5 0.1 0.0 0.8 1.8 0.0 0.0 3.0 3.0 0.0 4.4 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 8.8 0.0 5.0 0.3 0.1 1.1 3.4 3.1 1.1 3.0 2.7 2.5 2.2 2.0 2.6 1.8 1.7 2.3 2.1 0.6 0.0 0.6 0.7 0.3 0.4 1.0 0.6 0.6 0.1 1.6 1.5 1.6 0.0 1.5 0.0 0.0 0.5 2.1 6.5 1.9 1.6 27.0 2.4 1.0 1.5 1.2 0.0 3.2 0.9 23.2 0.6 0.0 1.1 5.7 0.1 1.1 0.0 12.5 0.0 3.4 5.4 0.0 17.4 10.1 18.3 1.2 12.5 0.0 15.0 4.8 0.3 0.0 1.5 0.4 1.0 2.6 0.7 0.5 0.4 112.6 0.0 1.5 0.0 0.0 1.1 0.3 1.0 0.9 0.3 0.4 8.2 1.5 0.6 2.5 1.6 SPDYA "Ringo3, SPDY1, SPY1" ENSG00000163806 "Speedy/RINGO cell cycle regulator family member A" Q5MJ70 2 28782517-28850611 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "testis: 32.8" "Group enriched" "Detected in many" 4 "Early spermatids: 58.8;Spermatocytes: 225.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.6;THP-1: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035162, HPA066214" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA035162: AB_2674501, HPA066214: AB_2685636" "unprognostic (3.41e-2)" "unprognostic (3.20e-3)" "unprognostic (2.45e-1)" "unprognostic (3.53e-2)" "unprognostic (4.21e-2)" "unprognostic (4.04e-3)" "unprognostic (1.10e-4)" "unprognostic (3.04e-3)" "unprognostic (1.95e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-2)" "unprognostic (1.66e-13)" "unprognostic (8.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (5.55e-5)" 0.7 0.9 0.2 0.2 0.3 0.6 0.7 0.3 0.4 1.6 0.0 0.8 0.5 0.7 0.0 0.9 1.0 0.5 0.8 0.3 0.0 1.2 1.4 0.7 0.5 0.1 0.0 0.2 1.5 0.8 0.0 1.4 0.2 0.3 1.7 0.0 1.0 0.7 0.0 0.3 1.6 0.9 0.0 0.1 1.8 0.8 32.8 0.1 0.0 1.2 0.0 0.0 0.8 1.0 0.2 0.4 0.2 0.7 1.6 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.4 0.3 0.3 0.5 0.0 0.4 1.0 0.1 0.0 0.1 0.2 0.4 0.3 1.0 1.3 0.0 0.5 0.7 0.1 0.0 0.1 0.2 0.3 0.0 0.3 0.2 0.6 0.3 0.2 0.1 2.6 0.2 0.1 0.1 0.3 1.2 0.4 0.5 0.3 0.5 0.3 0.8 1.0 0.3 0.7 0.3 2.5 0.1 1.2 1.0 0.6 0.6 0.3 0.7 0.7 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.4 0.3 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.2 4.5 3.2 0.5 6.5 2.6 0.3 1.0 0.4 0.6 0.8 3.7 3.8 0.6 0.0 1.4 1.8 6.2 0.1 2.1 2.1 0.0 0.7 58.8 9.9 2.7 1.4 0.0 0.4 9.0 0.5 0.2 1.9 4.1 12.2 2.5 0.8 1.8 0.1 0.4 0.0 6.0 0.0 0.0 0.3 3.1 29.1 2.5 6.7 0.0 1.9 0.8 0.1 0.0 9.0 6.0 0.8 0.3 2.2 2.9 1.2 0.5 0.1 1.6 1.4 6.6 9.0 1.7 225.0 9.6 1.8 0.1 0.5 3.8 0.5 0.5 2.1 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 245.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Enhanced "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favorable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favorable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 8.5 7.4 3.9 5.0 4.7 4.5 8.3 4.2 4.7 7.5 2.7 8.0 4.5 10.5 3.5 6.5 7.8 5.5 9.0 3.7 4.3 6.5 4.9 5.7 6.4 4.5 4.5 3.4 11.1 7.5 8.2 4.7 6.4 4.6 9.0 5.2 5.9 7.1 6.2 17.6 7.1 6.5 7.5 4.2 6.4 7.0 3.1 4.4 9.2 8.5 9.1 7.2 8.2 6.5 6.4 8.3 5.3 14.7 10.2 9.8 15.1 7.3 9.3 13.1 11.7 11.9 5.3 7.2 20.2 6.9 9.8 5.6 5.6 17.5 9.9 15.4 11.2 5.9 14.7 9.6 6.5 6.7 18.6 9.9 10.9 11.7 12.0 11.3 13.0 9.9 12.3 21.2 10.8 11.6 4.7 20.9 13.1 13.9 8.7 6.8 8.5 14.0 11.5 7.5 7.0 7.3 12.5 10.9 8.3 7.5 9.8 13.9 15.8 11.5 6.5 5.8 17.2 10.7 6.9 21.1 12.1 12.0 17.8 9.7 2.6 2.3 4.0 2.8 2.5 2.4 2.5 2.4 2.2 2.2 2.3 2.5 2.4 2.3 3.1 3.8 1.5 2.1 1.9 3.9 4.7 4.2 4.7 3.7 4.3 4.5 4.5 3.4 4.6 4.2 4.4 6.4 35.8 38.5 39.4 5.9 32.9 34.5 31.6 44.1 25.0 20.0 24.5 24.0 28.4 32.9 43.6 23.9 8.4 40.6 32.5 18.8 68.4 45.5 245.7 29.0 32.4 34.6 15.6 27.3 5.4 62.6 55.8 28.9 18.3 29.3 38.6 17.6 37.1 26.4 35.0 15.2 6.0 24.6 26.4 42.9 27.3 84.4 37.6 30.3 14.2 5.6 37.7 44.8 41.2 5.5 10.1 48.9 24.0 49.2 19.1 51.0 23.5 45.2 30.5 14.0 0.0 43.3 28.3 53.8 40.5 22.3 27.8 57.2 35.3 25.7 25.7 46.7 KIF15 "HKLP2, KNSL7, NY-BR-62" ENSG00000163808 "Kinesin family member 15" Q9NS87 3 44761721-44873376 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 5.1;lymphoid tissue: 9.3;testis: 7.4" "Group enriched" "Detected in many" 4 "Early spermatids: 177.5;Late spermatids: 78.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035516, HPA035517, HPA061469" Approved NA NA "HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: " "unprognostic (2.26e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.12e-4)" "unprognostic (3.49e-2)" "unprognostic (2.69e-1)" "unprognostic (5.17e-3)" "unprognostic (6.68e-7)" "unprognostic (1.35e-2)" "unprognostic (1.51e-2)" "unprognostic (6.94e-2)" "unprognostic (3.14e-4)" "unprognostic (2.72e-2)" "unprognostic (0.00e+0)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.58e-1)" 0.2 0.1 0.1 1.2 0.1 5.1 0.4 0.2 0.2 0.2 0.0 1.4 1.4 0.3 0.0 1.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 2.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 1.6 0.1 0.2 0.1 0.0 0.8 1.4 0.4 0.1 0.4 0.8 7.4 0.1 9.3 0.0 0.0 2.2 0.3 0.4 0.1 7.5 3.9 17.6 12.8 1.2 1.4 3.9 8.6 5.3 10.8 9.0 6.6 7.2 13.8 2.8 3.1 4.0 6.3 10.1 4.7 13.1 11.6 2.3 14.9 7.7 8.4 0.1 15.6 6.6 0.3 0.2 7.3 7.1 1.6 8.6 18.4 9.3 17.2 8.2 3.9 30.0 5.7 18.2 9.7 7.0 11.9 19.0 7.9 2.4 4.9 8.2 7.8 14.2 4.6 2.9 4.6 7.7 11.7 4.8 10.4 8.5 8.8 11.5 7.2 12.7 17.3 5.5 16.3 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.6 1.6 1.9 0.4 0.9 0.0 0.1 0.5 0.8 1.8 0.0 0.7 0.0 2.1 3.3 0.8 2.5 0.0 0.8 177.5 1.3 1.7 1.2 0.0 28.0 3.2 0.0 5.9 1.9 5.1 1.4 0.0 12.3 0.0 0.2 3.5 0.0 3.8 2.6 0.0 1.6 1.4 78.0 0.0 1.8 0.0 0.0 0.3 0.7 1.0 3.0 4.7 0.5 0.1 0.4 9.7 0.5 0.5 0.1 0.2 0.0 0.0 0.4 1.9 20.2 14.7 6.0 1.0 0.7 3.1 1.1 5.3 0.5 TGM4 TGP ENSG00000163810 "Transglutaminase 4" P49221 3 44874608-44914990 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 376 "prostate: 438.3" "Cell type enriched" "Detected in some" 20 "Prostatic glandular cells: 226.6" "Cancer enriched" "Detected in single" 312 "prostate cancer: 75.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;hTERT-HME1: 1.3;NB-4: 2.7;RPMI-8226: 2.0;SH-SY5Y: 1.4" "Not detected" "Not detected" "CAB033571, HPA073290" Enhanced NA NA "CAB033571: AB_2287329, HPA073290: " "unprognostic (4.40e-2)" "unprognostic (4.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.17e-3)" "unprognostic (2.84e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.41e-2)" "unprognostic (1.65e-1)" "unprognostic (8.56e-3)" "unprognostic (5.08e-2)" "unprognostic (1.44e-8)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.68e-1)" "unprognostic (6.41e-2)" 0.0 1.1 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 438.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.5 4.2 0.7 0.0 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 5.7 0.8 0.6 0.4 0.0 0.0 0.2 0.0 0.3 1.3 0.0 1.5 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 11.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.4 0.0 226.6 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.3 0.0 0.4 1.0 0.2 0.1 0.2 2.4 WDR43 "KIAA0007, NET12, UTP5" ENSG00000163811 "WD repeat domain 43" Q15061 2 28894667-28948219 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 383.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044733 Uncertain NA NA "HPA044733: AB_10959613" "unprognostic (3.39e-1)" "unprognostic (1.06e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (2.76e-2)" "unprognostic (3.52e-3)" "prognostic unfavorable (3.66e-5)" "unprognostic (7.00e-2)" "unprognostic (1.94e-2)" "unprognostic (1.60e-1)" "unprognostic (2.33e-3)" "unprognostic (2.66e-2)" "unprognostic (2.56e-3)" "unprognostic (6.20e-2)" "unprognostic (8.66e-2)" "unprognostic (6.30e-2)" "unprognostic (1.11e-1)" 22.3 11.5 7.4 17.7 8.4 42.7 23.8 11.7 8.7 16.7 8.6 16.7 12.2 15.7 9.1 18.3 14.7 12.2 9.7 7.5 13.0 12.4 23.2 11.2 20.5 8.0 7.9 6.4 17.2 23.0 15.8 7.4 17.6 8.9 12.2 16.7 13.4 11.6 12.1 56.2 16.9 11.6 19.3 8.8 14.5 12.9 20.0 8.7 18.7 14.6 15.8 24.4 24.4 12.0 10.6 108.5 90.7 42.9 57.0 37.7 47.4 127.1 69.1 44.7 61.4 44.8 92.6 48.6 138.2 50.1 57.9 77.1 54.4 116.6 103.4 98.1 57.9 81.8 122.4 65.5 135.6 57.1 160.9 56.3 49.3 60.5 97.0 164.0 29.3 58.9 52.5 130.2 52.5 54.4 63.7 127.0 89.6 111.0 74.7 59.3 96.3 130.1 95.1 43.4 111.8 61.6 63.8 40.9 67.6 75.1 40.5 30.4 40.5 53.5 63.5 73.1 50.8 118.8 64.2 95.0 383.1 44.2 101.3 60.8 0.4 11.5 8.7 12.5 13.6 22.7 17.3 15.5 14.0 14.8 16.5 19.5 15.0 2.5 22.0 15.5 12.6 14.0 11.7 7.4 8.4 11.7 8.7 7.5 13.0 8.0 7.9 6.4 8.9 8.8 8.7 10.6 40.8 51.3 50.7 17.6 54.1 167.7 93.1 41.2 82.0 29.8 53.1 49.7 36.5 37.1 71.5 25.8 22.9 39.0 35.3 21.8 15.6 55.7 88.7 46.1 75.6 40.5 20.9 36.6 28.6 46.2 44.4 56.5 34.7 82.7 45.5 27.5 20.3 49.6 24.3 21.9 29.0 32.1 26.4 21.6 29.6 125.8 37.6 30.3 33.8 30.9 31.8 17.7 27.8 34.2 26.5 55.2 15.7 29.3 42.8 50.8 15.0 19.6 29.7 42.3 6.6 82.7 46.4 33.6 38.6 67.8 148.0 40.4 38.6 41.4 53.8 58.5 ZDHHC3 "DHHC3, GODZ, ZNF373" ENSG00000163812 "Zinc finger DHHC-type palmitoyltransferase 3" Q9NYG2 3 44915257-44976185 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 570.7;Late spermatids: 1564.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012465, HPA016616" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB012465: , HPA016616: AB_1859004" "unprognostic (2.80e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.43e-4)" "unprognostic (3.10e-2)" "unprognostic (2.47e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.20e-2)" "unprognostic (1.04e-1)" "unprognostic (6.37e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "prognostic favorable (1.81e-8)" "unprognostic (2.64e-1)" "unprognostic (1.49e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-2)" 50.5 49.0 24.2 26.0 21.3 83.5 36.6 28.1 23.0 37.0 25.0 71.2 44.5 35.7 24.7 58.5 27.8 32.3 34.9 25.6 21.2 40.5 32.6 42.2 22.1 27.2 24.9 20.7 29.1 22.4 46.4 13.5 28.9 28.2 35.9 65.2 16.8 33.5 40.4 44.1 70.6 58.5 36.6 25.5 29.9 55.8 81.4 26.5 27.2 39.0 53.3 33.6 54.2 42.9 25.6 62.5 53.3 41.0 49.1 219.2 100.5 46.8 58.8 80.7 78.3 66.5 61.0 85.1 58.7 31.4 107.9 52.8 80.7 68.4 104.3 74.6 61.7 29.3 55.9 57.9 45.7 50.6 136.3 43.0 92.5 111.6 73.6 67.2 59.8 79.6 63.8 73.8 51.3 78.1 42.9 46.2 73.6 60.7 155.9 96.7 29.9 40.6 47.0 66.7 176.7 14.6 52.8 70.3 70.5 36.4 70.4 57.4 88.2 78.0 55.4 55.2 60.2 66.3 32.2 66.6 59.6 55.2 198.9 39.4 53.7 24.5 32.6 14.6 12.3 13.3 10.7 11.0 16.1 26.8 12.6 10.2 14.4 25.4 14.5 17.5 15.3 17.1 13.6 24.2 21.3 28.1 23.0 25.6 21.2 27.2 24.9 20.7 28.2 25.5 26.5 25.6 41.5 41.7 82.1 7.5 17.8 48.2 42.1 40.8 48.9 9.8 24.4 20.8 29.2 24.3 27.1 53.3 6.2 47.7 23.4 105.6 72.4 46.6 570.7 18.8 31.2 34.1 35.9 68.8 15.7 79.0 59.4 26.4 69.3 26.6 19.0 21.5 35.7 29.4 49.5 15.2 15.6 78.2 38.7 34.0 26.7 1564.3 51.9 37.4 24.9 18.7 35.6 25.1 34.0 15.1 11.2 115.8 73.1 44.8 26.2 73.7 112.9 30.1 20.9 10.6 19.7 15.6 31.9 104.5 45.3 70.5 60.2 101.7 25.0 26.1 72.8 128.9 CDCP1 "CD318, SIMA135" ENSG00000163814 "CUB domain containing protein 1" Q9H5V8 3 45082277-45146422 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 121.2;Basal respiratory cells: 92.6;Pancreatic endocrine cells: 137.1;Urothelial cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.3;NK-cell: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 94.9;HBEC3-KT: 109.0;hTEC/SVTERT24-B: 265.2;hTERT-HME1: 177.9;PC-3: 89.7;RPTEC TERT1: 81.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010978, HPA010979, CAB025637" Enhanced "Intracellular and membrane" NA NA "CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401" "unprognostic (9.31e-2)" "unprognostic (4.50e-2)" "unprognostic (1.67e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (2.15e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (9.98e-3)" "unprognostic (3.59e-2)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (1.34e-1)" 2.0 0.5 0.4 4.4 0.7 0.9 5.7 0.3 1.2 7.6 10.3 17.5 17.9 3.3 9.3 37.5 4.0 6.2 0.4 0.6 2.1 4.8 0.8 8.3 0.8 1.3 0.7 0.3 0.3 7.9 1.4 1.2 2.2 1.0 5.2 17.2 0.2 12.7 5.6 0.3 23.5 15.2 3.2 1.3 0.7 16.7 0.6 2.8 0.6 7.8 0.0 5.9 9.8 16.6 1.6 52.2 15.1 0.0 0.2 0.1 2.4 12.1 9.7 1.6 4.4 4.1 21.3 94.9 0.0 11.8 2.9 2.5 40.5 0.3 109.0 8.9 0.0 0.1 0.1 16.4 0.1 8.1 0.1 3.6 3.7 56.1 265.2 177.9 16.0 1.0 0.1 31.1 0.2 13.8 0.1 0.1 0.9 7.4 24.7 89.7 0.0 0.0 8.6 81.1 40.7 3.4 0.1 20.1 5.0 0.1 4.8 22.9 0.4 4.6 0.2 0.2 3.3 0.2 0.1 0.1 0.1 1.5 1.1 1.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.9 4.2 0.0 0.0 0.0 0.2 0.4 0.7 0.3 1.2 0.6 2.1 1.3 0.7 0.3 1.0 1.3 2.8 1.6 0.1 3.2 13.1 0.3 0.3 121.2 83.3 92.6 50.7 0.0 12.9 6.6 0.5 14.3 57.7 9.2 0.0 5.8 0.3 76.6 0.0 78.6 0.1 36.5 6.3 1.9 37.6 0.4 2.0 71.6 7.5 4.6 37.8 59.3 8.8 0.1 0.0 0.0 10.8 0.0 0.4 37.9 18.3 7.9 37.6 0.5 3.1 13.4 3.6 0.0 10.7 0.0 0.0 1.0 0.3 137.1 34.9 0.0 2.5 75.8 30.8 0.0 56.6 0.0 0.0 0.4 3.6 0.0 0.4 59.8 75.0 3.3 1.8 13.5 28.9 117.4 CLEC3B "TN, TNA" ENSG00000163815 "C-type lectin domain family 3 member B" P05452 3 45001548-45036071 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 76.3;Endothelial cells: 27.9;Fibroblasts: 126.4;Hepatic stellate cells: 57.5;Leydig cells: 30.1;Microglial cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 297.9;ASC TERT1: 591.9;U-2197: 120.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002582, HPA034794" Approved "Secreted to blood" NA NA 6540000000 25000000000 "CAB002582: AB_564027, HPA034794: AB_2674332" "unprognostic (2.04e-1)" "unprognostic (1.80e-3)" "unprognostic (2.58e-1)" "unprognostic (4.57e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.53e-4)" "prognostic favorable (9.99e-9)" "unprognostic (1.75e-2)" "unprognostic (2.25e-1)" "unprognostic (4.02e-1)" "prognostic favorable (5.68e-4)" "unprognostic (9.33e-2)" "unprognostic (2.39e-2)" "unprognostic (7.46e-2)" "unprognostic (1.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.21e-2)" 314.8 51.4 44.6 9.4 34.6 1.8 216.7 38.2 67.1 70.4 44.6 79.7 31.8 60.9 17.3 50.3 41.5 35.9 239.8 32.6 34.4 129.5 29.2 202.9 33.4 39.4 37.8 28.1 26.2 14.8 14.4 27.9 144.0 46.4 33.8 37.8 0.7 50.2 19.3 75.5 136.0 78.9 25.7 34.5 266.9 43.8 114.1 40.7 10.2 89.2 68.6 8.3 101.7 75.5 66.0 0.0 0.0 0.1 0.2 297.9 591.9 0.0 40.1 62.9 1.2 6.2 0.0 0.0 0.1 0.1 3.1 0.0 0.1 0.0 0.1 0.1 0.3 0.9 0.6 0.1 0.1 0.5 0.1 0.7 47.5 0.1 0.3 0.1 0.4 0.5 0.3 0.0 1.7 0.5 0.2 0.0 2.2 0.0 0.0 0.6 0.0 0.1 2.2 0.0 0.0 0.3 1.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 4.5 0.2 120.6 0.1 1.0 1.2 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.6 34.6 38.2 67.1 32.6 34.4 39.4 37.8 28.1 46.4 34.5 40.7 66.0 76.3 0.0 0.0 1.6 0.3 3.4 0.0 0.0 1.8 0.0 0.7 0.3 0.8 1.5 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.0 4.0 0.3 16.9 27.9 0.0 2.7 0.8 0.2 0.0 126.4 3.1 0.3 0.0 0.0 57.5 0.3 0.9 0.0 0.6 0.0 0.0 1.2 9.5 19.5 30.1 2.2 3.6 69.3 0.7 0.4 0.0 1.5 0.7 0.1 0.0 6.4 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.0 12.3 0.0 0.0 0.7 3.8 0.1 0.7 0.4 0.0 0.0 SLC6A20 "IMINO, SIT1, XT3, Xtrp3" ENSG00000163817 "Solute carrier family 6 member 20" Q9NP91 3 45755449-45796536 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 49.3;intestine: 24.5" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 74.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;OE19: 3.9;SuSa: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.57e-1)" "unprognostic (5.26e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "unprognostic (1.48e-1)" "unprognostic (9.43e-3)" "unprognostic (3.26e-2)" "unprognostic (4.33e-3)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (1.46e-1)" "prognostic favorable (1.55e-5)" "unprognostic (2.87e-1)" "unprognostic (1.23e-1)" "unprognostic (7.55e-2)" "unprognostic (2.09e-2)" 0.2 0.1 1.1 0.7 1.1 0.4 0.4 1.8 4.0 1.0 49.3 0.5 24.5 0.8 0.1 0.1 0.2 7.0 0.2 2.1 0.4 1.8 0.2 2.0 0.3 0.6 1.0 0.4 0.1 3.0 0.1 1.3 0.1 0.8 0.5 0.2 0.5 0.7 0.1 0.8 0.7 17.7 0.3 0.4 0.1 5.2 0.4 0.7 0.9 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.5 0.0 0.2 1.7 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.4 3.9 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.8 0.1 0.0 1.1 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.1 1.1 1.8 4.0 2.1 0.4 0.6 1.0 0.4 0.8 0.4 0.7 0.7 0.1 0.0 5.0 0.0 0.1 0.5 0.6 0.6 0.0 0.3 0.7 0.4 1.2 17.2 2.7 0.0 0.0 0.1 0.2 3.5 0.0 13.7 0.6 1.7 0.5 0.1 0.0 0.0 1.4 0.2 0.1 0.7 17.9 2.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 9.4 1.2 1.2 0.4 2.3 74.7 3.5 1.4 0.3 0.0 0.6 0.3 0.2 0.2 0.0 0.3 0.0 0.3 0.1 7.0 4.2 LZTFL1 BBS17 ENSG00000163818 "Leucine zipper transcription factor like 1" Q9NQ48 3 45823316-45916042 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 119.0;Endometrial ciliated cells: 56.7;Respiratory ciliated cells: 142.2;Spermatocytes: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043466, HPA048447" Enhanced Supported Cytosol NA NA Cytosol "HPA043466: AB_2678491, HPA048447: AB_2680398" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.65e-2)" "unprognostic (5.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.26e-2)" "unprognostic (4.20e-2)" "unprognostic (2.94e-2)" "unprognostic (7.83e-2)" "unprognostic (5.32e-2)" "unprognostic (1.30e-3)" "unprognostic (6.27e-3)" "unprognostic (8.31e-2)" "unprognostic (4.27e-3)" "unprognostic (4.19e-1)" 5.3 6.2 8.3 4.6 9.3 6.0 12.5 6.9 10.4 12.5 16.3 5.8 7.1 13.3 15.1 5.5 19.1 6.9 4.7 9.1 8.5 12.1 10.1 9.1 4.7 8.2 8.3 8.9 11.5 5.7 14.4 11.8 6.0 7.3 8.0 6.3 15.9 7.3 8.9 2.8 6.1 5.8 8.4 7.9 6.0 5.8 25.6 7.5 30.9 19.0 3.5 5.8 4.7 4.2 8.4 10.1 5.0 7.8 5.1 7.2 17.9 4.0 5.3 10.0 12.2 15.8 2.4 7.5 2.7 3.1 7.5 15.2 6.4 9.5 8.6 15.9 0.2 6.1 2.6 6.7 4.5 9.4 9.9 2.8 9.3 29.6 16.8 10.8 7.8 6.0 16.5 8.9 6.7 5.9 1.6 34.1 9.6 8.1 6.7 4.2 3.7 0.8 10.7 14.7 4.7 5.4 11.0 7.0 6.0 13.2 8.7 7.1 18.3 9.9 4.5 3.1 12.2 7.1 18.3 10.0 0.1 14.3 11.7 3.7 0.0 0.9 0.4 1.3 1.2 1.7 4.3 1.1 1.2 2.3 2.4 1.8 1.7 1.0 1.5 0.8 2.5 2.0 1.6 8.3 9.3 6.9 10.4 9.1 8.5 8.2 8.3 8.9 7.3 7.9 7.5 8.4 7.6 28.9 25.2 7.8 10.8 13.5 10.5 14.9 12.0 7.9 16.9 14.9 7.6 11.5 23.6 14.7 14.6 3.1 8.4 3.7 15.6 13.3 119.0 56.7 10.5 10.2 11.4 11.6 22.3 6.9 5.1 13.3 6.1 12.3 8.2 10.1 11.7 13.5 6.6 23.5 9.9 10.4 10.2 7.3 7.0 19.2 9.9 5.3 8.8 5.6 10.8 17.8 7.2 6.6 12.2 5.6 5.6 13.5 11.6 5.9 3.2 23.0 142.2 14.6 13.1 15.7 9.2 170.0 24.1 8.4 9.9 2.1 10.5 14.2 8.9 5.6 FYCO1 "FLJ13335, ZFYVE7" ENSG00000163820 "FYVE and coiled-coil domain autophagy adaptor 1" Q9BQS8 3 45917899-45995824 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 265.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035526, HPA057966" Uncertain Enhanced Vesicles NA NA Vesicles "HPA035526: AB_10672867, HPA057966: AB_2683567" "unprognostic (2.45e-1)" "unprognostic (6.62e-2)" "unprognostic (6.97e-3)" "unprognostic (1.14e-3)" "unprognostic (7.65e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-2)" "unprognostic (4.53e-3)" "unprognostic (5.85e-2)" "unprognostic (8.85e-2)" "unprognostic (2.36e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.33e-11)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (2.89e-2)" "unprognostic (6.99e-2)" 16.0 13.2 10.4 9.8 11.3 6.6 13.5 9.8 8.6 23.2 11.3 31.6 8.1 25.8 10.4 21.5 15.5 18.8 67.4 8.1 11.3 10.4 10.9 14.9 8.7 15.2 10.3 7.1 23.3 12.8 20.4 7.7 8.3 13.8 19.5 10.8 33.3 15.0 23.1 265.8 17.9 14.5 28.4 15.8 10.3 20.6 3.4 10.9 10.6 16.7 105.5 8.3 39.9 17.0 15.6 10.8 10.3 3.0 13.0 27.9 21.8 4.9 10.2 23.7 13.1 14.6 5.6 9.3 7.9 5.6 14.2 12.7 7.9 8.5 17.0 15.7 3.3 9.0 11.4 8.7 6.3 19.0 8.8 7.9 24.3 16.7 21.1 20.5 20.3 26.7 13.4 7.4 11.3 9.5 6.7 9.0 5.5 4.5 8.8 9.8 3.1 8.3 4.4 15.9 37.2 2.2 3.4 6.4 20.0 17.6 4.4 9.7 5.7 20.8 5.0 5.9 17.0 5.7 6.4 4.4 2.7 17.2 11.1 9.6 0.7 0.5 0.3 2.0 0.5 2.7 0.2 1.2 2.1 0.2 0.2 0.5 0.7 0.4 1.5 0.3 1.3 1.2 0.7 10.4 11.3 9.8 8.6 8.1 11.3 15.2 10.3 7.1 13.8 15.8 10.9 15.6 9.5 28.9 13.7 12.4 4.8 4.1 4.8 5.6 3.4 11.2 8.5 4.8 89.3 8.6 13.0 16.5 35.5 4.3 8.7 6.8 3.9 8.8 0.1 6.4 8.9 9.3 9.6 6.9 0.8 8.3 2.2 14.0 12.8 11.2 2.5 14.9 11.4 9.2 4.1 0.0 0.8 7.6 2.0 5.8 4.6 1.6 12.8 5.1 10.6 10.3 4.0 20.0 6.2 8.0 21.2 11.0 2.5 17.7 3.0 17.3 8.7 6.2 18.6 37.1 6.6 20.8 12.8 2.3 0.8 8.4 4.1 2.9 12.7 6.1 6.2 7.9 CCR1 "CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1" ENSG00000163823 "C-C motif chemokine receptor 1" P32246 3 46201711-46208313 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.9" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 81.2;Hofbauer cells: 117.4;Kupffer cells: 171.9;Macrophages: 74.2;monocytes: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 330.3;RPMI-8226: 158.5;U-266/70: 57.7;U-266/84: 183.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (3.95e-1)" "unprognostic (2.17e-1)" "unprognostic (1.20e-1)" "unprognostic (2.16e-1)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" "unprognostic (4.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.09e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.08e-1)" "unprognostic (5.52e-3)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" 21.1 4.7 1.9 42.9 2.8 25.0 4.0 2.4 3.2 2.5 3.0 5.7 7.4 2.6 1.6 3.4 2.8 11.8 2.4 1.8 6.0 5.0 17.4 18.9 11.0 3.8 2.8 1.4 2.1 3.1 1.9 0.9 26.7 4.2 1.7 7.4 0.3 2.1 2.6 1.4 0.6 6.7 15.7 5.2 31.1 4.9 1.7 4.0 5.8 1.0 3.3 10.3 16.8 0.7 6.4 0.3 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.2 0.0 0.3 0.7 1.5 0.1 0.4 0.0 3.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.1 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 330.3 0.0 0.2 0.2 13.0 0.0 0.0 0.0 0.1 0.0 158.5 0.0 5.6 0.0 0.0 0.0 0.4 1.3 0.9 0.2 35.5 0.0 0.8 0.0 0.0 0.2 57.7 183.7 0.1 29.1 26.5 0.4 82.5 125.1 25.8 10.5 76.2 50.1 2.9 0.1 8.5 53.9 0.2 0.1 1.4 113.4 84.5 51.3 18.9 0.1 50.6 1.9 2.8 2.4 3.2 1.8 6.0 3.8 2.8 1.4 4.2 5.2 4.0 6.4 0.3 3.2 3.0 0.0 2.0 0.9 0.0 0.0 0.6 0.0 0.1 0.5 0.6 0.0 1.3 0.0 0.0 1.3 15.9 0.0 1.9 0.0 0.4 0.1 0.6 1.6 0.0 1.7 0.0 0.0 81.2 2.4 0.0 0.0 3.8 0.0 1.4 1.2 117.4 0.0 0.0 0.0 0.0 171.9 23.5 0.1 0.0 74.2 5.4 9.4 51.5 0.2 7.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 3.2 1.5 0.2 0.0 0.4 0.5 0.0 0.2 0.2 1.7 2.9 6.0 0.0 0.0 0.0 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497976-46500950 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "liver: 120.5" "Cell type enriched" "Detected in some" 40 "Hepatocytes: 89.6" "Cancer enriched" "Detected in some" 5 "liver cancer: 22.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SiHa: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075932 Uncertain Mitochondria NA NA Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 89.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.4 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515385-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 45.7;skeletal muscle: 166.6;tongue: 94.9" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 198.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 2.4 0.7 1.2 0.7 4.0 0.8 2.0 1.2 2.8 3.4 0.3 1.6 0.7 4.8 2.4 1.5 2.4 3.0 45.7 2.7 1.5 4.5 5.6 1.2 0.6 0.7 0.6 2.7 5.2 1.1 0.9 1.3 1.0 0.8 2.1 1.6 0.3 2.2 0.3 166.6 1.8 0.8 4.1 0.8 2.8 1.8 0.8 0.3 3.2 22.3 94.9 0.7 2.3 2.1 1.6 0.1 0.0 0.1 0.1 0.6 1.4 0.1 0.5 1.0 0.3 0.5 0.0 0.1 0.2 0.1 7.2 0.0 0.1 2.5 0.0 0.9 0.3 0.0 4.2 0.3 0.0 0.1 0.1 0.0 0.1 0.0 2.8 0.0 2.3 0.1 0.5 0.0 0.2 4.1 0.0 0.5 0.1 1.0 0.3 0.1 0.1 0.0 0.2 0.0 0.2 0.3 0.8 0.5 0.1 1.0 0.7 0.1 0.5 3.2 0.1 0.3 1.6 1.1 0.2 0.2 1.9 0.1 0.1 0.9 0.6 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.1 0.5 0.1 1.2 4.0 1.2 2.8 2.7 1.5 0.7 0.6 2.7 0.8 0.8 0.3 1.6 1.6 9.6 1.1 2.0 0.2 1.9 1.1 0.6 0.6 0.1 0.8 1.3 198.4 7.2 0.0 1.8 0.0 0.1 0.0 0.2 9.8 0.6 2.3 0.3 1.6 4.0 3.0 0.0 12.5 1.0 0.0 11.9 3.1 0.4 10.2 2.5 5.0 10.2 2.0 0.0 11.2 1.8 0.0 0.8 5.7 2.9 0.6 0.6 10.6 3.7 0.0 0.4 0.0 3.5 0.7 1.0 0.4 0.0 3.0 0.6 0.0 0.8 0.7 0.2 0.0 32.7 2.6 0.6 0.7 0.0 2.4 0.1 2.1 7.9 1.9 0.4 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513712 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 13.6 27.2 20.3 14.4 21.6 11.6 16.0 22.4 23.8 13.7 22.3 15.5 15.4 17.3 23.3 15.6 17.1 14.9 19.8 20.4 20.2 17.4 21.5 12.2 22.1 21.6 21.1 20.1 21.9 14.9 21.2 15.2 14.5 21.5 19.6 14.1 8.7 16.6 17.8 35.9 16.7 13.5 18.1 21.3 15.8 15.9 21.2 21.6 24.8 19.4 29.3 20.7 16.2 13.4 22.2 37.6 36.4 45.3 46.8 34.9 32.0 26.5 43.4 29.7 54.2 48.6 35.1 38.4 68.7 27.1 37.6 51.3 22.1 43.6 62.5 33.0 39.9 34.4 62.6 55.5 40.4 38.5 49.1 38.5 34.9 33.2 61.4 38.3 31.5 47.3 58.8 67.1 21.7 54.1 44.0 59.8 56.7 55.1 35.4 57.9 29.2 22.3 42.2 38.4 33.9 40.3 40.9 36.9 29.8 25.8 36.0 40.8 41.1 32.8 57.3 41.9 28.9 56.9 44.8 63.5 64.9 28.4 58.8 58.4 19.7 20.4 15.1 31.8 18.9 25.2 33.4 29.4 32.9 25.9 35.2 28.3 28.9 2.8 35.3 13.7 33.9 38.5 25.6 20.3 21.6 22.4 23.8 20.4 20.2 21.6 21.1 20.1 21.5 21.3 21.6 22.2 19.3 6.4 12.3 8.8 24.9 8.4 15.2 35.7 19.4 21.7 20.3 22.4 23.0 24.3 20.0 33.1 14.6 44.0 27.8 16.0 60.7 28.1 8.3 15.3 19.4 22.6 17.4 30.3 9.4 23.6 39.6 23.4 17.9 14.0 22.2 56.3 30.0 28.5 28.6 38.7 11.9 15.0 40.7 14.5 8.3 14.5 23.0 17.4 16.0 9.4 21.7 43.7 48.4 5.5 11.7 21.3 12.7 30.5 23.1 10.9 22.9 51.1 15.7 26.0 6.6 14.2 22.6 47.2 22.4 15.6 8.4 26.8 23.9 58.4 21.7 10.4 FBXO40 "Fbx40, KIAA1195" ENSG00000163833 "F-box protein 40" Q9UH90 3 121593379-121630295 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 97 "heart muscle: 91.2;skeletal muscle: 163.8;tongue: 101.2" "Cell type enriched" "Detected in some" 33 "Cardiomyocytes: 416.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 1.7" "Low region specificity" "Detected in many" NA NA "unprognostic (1.67e-2)" "unprognostic (1.23e-4)" "unprognostic (9.17e-2)" "unprognostic (6.65e-2)" "unprognostic (2.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.22e-1)" "unprognostic (7.01e-2)" "unprognostic (2.91e-1)" "unprognostic (2.50e-1)" "unprognostic (3.48e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-1)" "unprognostic (4.30e-2)" 0.2 0.1 0.2 0.0 0.6 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 91.2 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.5 1.0 0.0 0.1 0.8 0.0 163.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 101.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.6 0.0 0.8 0.5 0.1 0.2 0.1 0.6 0.5 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 416.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.0 0.0 2.8 0.0 0.1 9.6 0.0 0.2 0.0 12.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 DTX3L "BBAP, RNF143" ENSG00000163840 "Deltex E3 ubiquitin ligase 3L" Q8TDB6 3 122564338-122575203 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 91.6;BJ hTERT+ SV40 Large T+ RasG12V: 112.3;GAMG: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010570 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA010570: AB_1847877" "unprognostic (8.15e-2)" "unprognostic (7.36e-3)" "unprognostic (5.04e-2)" "unprognostic (3.74e-3)" "unprognostic (9.51e-2)" "unprognostic (9.22e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (9.23e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.99e-4)" "unprognostic (2.76e-2)" "unprognostic (2.33e-2)" "unprognostic (7.77e-2)" "unprognostic (9.28e-2)" "unprognostic (3.33e-2)" "unprognostic (2.61e-2)" 11.2 9.3 6.4 24.6 6.8 12.9 10.9 5.0 6.4 10.2 5.7 15.7 20.7 12.5 6.6 11.5 11.5 15.5 6.6 4.4 8.7 8.4 32.4 20.9 22.0 8.9 5.9 3.5 9.5 17.9 11.2 5.3 16.4 7.3 12.4 16.3 2.6 20.5 8.6 7.9 8.2 18.9 14.9 6.7 26.8 16.0 3.6 8.2 17.6 12.0 9.2 21.1 18.4 8.3 12.5 31.2 9.4 2.6 7.9 12.0 27.6 10.2 7.9 29.3 91.6 112.3 9.2 31.2 3.6 15.1 13.2 87.8 30.5 9.2 12.8 20.1 26.3 3.4 27.1 7.2 9.8 23.7 14.0 20.2 23.8 14.8 13.7 7.8 17.4 17.6 16.9 3.5 18.8 6.9 9.6 34.3 9.9 1.7 9.7 17.2 37.5 21.0 6.0 23.4 19.8 3.8 4.1 16.6 7.4 59.5 1.8 8.5 17.5 21.6 10.4 14.5 1.0 10.2 6.8 4.0 16.4 17.9 17.9 10.9 21.4 11.3 12.0 11.6 18.1 12.5 7.5 9.5 12.4 8.7 7.9 8.4 9.3 28.2 10.5 19.4 0.9 9.9 9.9 6.4 6.8 5.0 6.4 4.4 8.7 8.9 5.9 3.5 7.3 6.7 8.2 12.5 31.3 32.1 28.1 3.9 19.7 8.9 10.2 10.4 9.1 0.3 12.9 8.1 5.1 15.7 15.0 7.3 0.0 4.1 15.3 46.3 0.0 23.1 2.5 17.2 26.7 24.1 18.5 16.2 0.0 32.5 15.2 13.3 30.5 27.5 15.8 17.5 25.4 56.7 28.4 0.0 0.3 26.6 10.2 38.6 5.8 1.1 8.4 26.1 5.4 13.1 38.2 5.1 40.2 0.5 1.1 32.4 15.0 9.1 11.8 20.1 24.2 15.1 17.0 0.4 32.9 10.0 10.7 1.8 0.5 12.4 6.0 1.8 19.2 8.3 20.6 20.1 ZNF148 "BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148" ENSG00000163848 "Zinc finger protein 148" Q9UQR1 3 125225669-125375325 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001656, CAB017486" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB017486: AB_794260, HPA001656: AB_1079995" "unprognostic (2.40e-1)" "unprognostic (1.12e-2)" "unprognostic (5.03e-2)" "unprognostic (3.94e-2)" "unprognostic (5.94e-3)" "unprognostic (5.66e-2)" "unprognostic (1.24e-2)" "unprognostic (2.36e-1)" "unprognostic (1.69e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (3.63e-2)" "unprognostic (2.72e-1)" 9.0 7.6 6.1 9.5 8.9 8.0 12.2 14.0 8.1 12.7 1.0 10.9 7.7 14.1 10.3 10.4 12.5 9.6 15.6 4.9 11.5 13.0 11.8 10.4 12.4 5.1 5.9 3.3 17.6 9.6 15.9 4.8 9.8 5.5 11.2 11.6 13.2 10.1 11.2 11.2 5.8 8.9 13.9 3.0 12.0 9.9 10.6 11.7 17.1 30.3 12.2 14.5 10.7 6.2 8.9 30.6 19.8 21.1 18.9 18.4 19.7 16.0 27.2 31.5 29.9 28.4 19.1 16.6 24.4 18.5 40.3 24.1 24.4 23.2 20.5 42.4 10.9 8.9 30.1 23.3 9.8 13.6 20.9 29.1 16.1 21.0 28.0 29.4 19.7 20.7 17.7 15.0 20.2 22.3 23.9 26.1 7.7 13.6 20.6 16.8 18.6 23.2 13.9 17.1 33.6 18.2 15.3 36.2 18.2 29.7 11.7 22.7 20.8 26.6 22.6 24.1 28.5 17.5 17.4 21.5 36.6 16.9 13.1 21.3 4.4 15.3 32.0 21.8 14.5 22.5 24.5 19.2 20.9 13.0 22.2 27.9 22.0 51.4 33.2 23.4 11.3 19.6 20.1 6.1 8.9 14.0 8.1 4.9 11.5 5.1 5.9 3.3 5.5 3.0 11.7 8.9 54.7 93.0 41.3 92.7 56.7 35.6 26.0 36.2 48.9 68.0 37.0 35.7 75.2 24.3 43.0 33.1 39.6 28.7 53.7 34.7 25.4 37.5 82.0 28.8 54.3 51.6 47.9 32.0 166.7 37.4 24.3 44.5 31.1 38.1 50.6 75.7 37.9 41.0 31.1 75.7 170.3 34.4 26.4 37.1 21.2 135.2 48.1 41.2 17.8 143.4 50.1 45.7 59.8 154.3 151.4 33.7 25.6 59.0 35.8 36.6 28.2 43.9 27.5 39.4 32.9 63.4 60.7 24.4 24.2 32.5 38.4 31.6 52.0 42.0 33.6 35.6 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 567.3;Alveolar cells type 2: 566.9;Club cells: 217.6;granulocytes: 278.8;Late spermatids: 223.3;Respiratory ciliated cells: 250.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039077, HPA057402" Approved Supported Mitochondria NA NA Mitochondria "HPA039077: AB_2676336, HPA057402: AB_2683427" "unprognostic (9.45e-3)" "prognostic favorable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 7.6 7.4 20.1 4.9 29.2 19.5 8.3 47.7 49.0 6.8 7.8 6.4 9.3 9.5 8.2 5.4 13.8 5.4 11.7 23.1 14.7 9.3 6.7 4.3 4.8 17.1 19.5 18.0 20.3 12.1 9.0 5.5 2.2 27.8 6.5 7.5 30.8 9.4 5.5 29.9 18.4 7.9 5.6 2.7 5.5 5.6 11.4 8.6 3.0 7.7 20.5 5.3 5.6 6.9 51.9 9.2 3.6 4.0 4.6 0.9 0.9 5.0 3.7 0.4 0.6 0.5 5.1 6.4 5.9 10.8 0.7 4.3 4.5 3.0 1.2 0.7 5.8 5.3 31.4 9.1 6.9 2.4 5.6 5.5 1.4 7.8 1.0 1.7 9.3 0.5 3.6 5.0 13.1 0.6 6.2 5.3 4.6 9.0 16.5 3.7 4.4 4.5 4.3 1.2 6.3 9.2 5.4 9.2 4.8 3.3 7.3 12.6 15.6 5.6 5.7 12.6 7.2 5.5 23.1 11.0 4.2 3.8 9.0 5.4 11.4 3.6 2.2 2.8 3.4 1.9 2.7 2.4 2.4 2.8 4.5 3.4 3.6 7.0 4.0 3.4 2.9 1.6 1.7 20.1 29.2 47.7 49.0 23.1 14.7 17.1 19.5 18.0 27.8 2.7 8.6 51.9 5.5 567.3 566.9 34.9 1.9 4.1 6.3 6.6 6.2 2.7 8.2 7.1 9.7 8.6 217.6 9.2 4.2 0.4 0.8 2.3 11.7 3.3 128.2 2.1 2.4 38.8 6.7 27.1 37.2 3.1 0.2 38.3 3.1 1.7 278.8 9.7 2.5 2.7 2.0 1.7 26.0 6.5 8.2 4.1 2.9 223.3 7.8 31.8 7.2 12.2 1.8 12.3 0.0 46.8 16.9 0.8 2.9 6.4 0.7 6.1 3.5 16.1 250.6 18.5 6.6 13.2 3.8 67.1 3.5 4.4 9.7 0.1 21.5 5.9 10.6 4.8 SMIM12 "C1orf212, FLJ90372" ENSG00000163866 "Small integral membrane protein 12" Q96EX1 1 34712737-34859755 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065331 Approved Approved Mitochondria NA NA Mitochondria "HPA065331: AB_2685470" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.64e-1)" "unprognostic (2.05e-1)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "prognostic favorable (1.15e-5)" "unprognostic (7.33e-2)" "unprognostic (6.70e-2)" "unprognostic (3.58e-2)" "unprognostic (2.52e-2)" 38.4 57.0 29.6 26.7 31.9 25.0 33.8 28.9 34.9 20.9 28.1 32.7 30.4 26.2 17.9 41.6 23.7 17.5 49.0 31.3 34.3 41.1 88.6 31.9 25.2 31.6 30.5 31.5 17.3 26.6 32.0 27.1 25.1 33.1 20.1 28.2 12.9 24.3 20.6 56.6 29.5 31.1 31.8 29.2 32.2 30.7 28.2 30.9 30.6 25.1 51.5 27.6 29.5 25.9 33.0 52.9 39.8 43.3 31.6 55.2 43.3 30.1 55.8 48.1 70.2 60.3 40.0 65.0 55.1 49.2 57.6 55.5 51.7 55.5 74.7 53.5 67.3 41.6 98.1 65.6 49.1 51.3 107.9 55.4 66.2 71.9 76.5 61.3 25.3 72.9 47.0 71.0 72.3 63.0 38.6 52.6 55.4 70.1 40.8 52.7 44.1 42.7 71.7 62.2 54.6 41.5 32.9 52.0 48.1 81.5 53.9 32.8 29.9 69.9 47.8 49.3 74.3 66.7 40.4 60.2 56.9 45.2 63.7 32.1 104.2 76.0 126.4 65.8 82.0 77.9 57.7 60.4 72.0 86.0 59.2 50.1 64.3 50.2 62.6 67.5 62.4 76.2 87.5 29.6 31.9 28.9 34.9 31.3 34.3 31.6 30.5 31.5 33.1 29.2 30.9 33.0 51.2 25.6 13.1 4.9 37.0 68.2 26.3 49.8 23.3 14.4 36.4 30.1 33.9 42.9 30.4 22.0 10.4 50.7 38.5 46.7 86.1 78.7 58.3 17.1 19.0 56.2 21.8 53.9 10.4 83.7 60.2 24.9 20.9 20.6 23.5 18.9 48.2 89.3 83.8 20.2 9.5 23.4 46.8 41.7 61.6 32.7 14.9 41.0 39.2 7.5 89.8 24.9 54.6 6.6 7.0 87.5 41.0 23.3 27.5 40.8 62.9 90.6 26.8 17.3 13.1 21.8 52.3 37.6 23.0 41.4 75.6 58.0 40.8 33.7 39.6 41.7 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031945 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011004: AB_1859075, HPA071865: AB_2686464" "prognostic favorable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 5.2 7.6 3.6 8.5 5.1 15.4 7.0 5.6 4.7 5.3 3.8 6.3 6.5 7.2 8.6 7.0 4.8 6.4 6.9 3.9 4.7 6.9 4.7 6.5 9.5 4.3 4.6 3.5 9.3 5.0 7.7 6.9 4.9 4.8 6.5 7.6 9.3 5.2 5.5 3.6 8.2 7.1 6.6 3.4 10.7 7.4 9.7 4.4 8.2 9.5 4.9 8.7 5.5 5.0 5.9 8.3 4.8 7.9 8.0 9.3 10.8 5.1 7.5 10.7 7.8 8.6 3.4 8.9 11.3 7.2 10.4 5.8 7.7 9.2 7.3 9.8 7.7 5.4 9.6 6.4 4.4 8.1 14.7 11.8 9.9 9.9 9.3 7.2 5.8 9.2 9.5 15.9 12.2 8.3 3.0 6.5 10.0 7.7 4.8 7.6 8.9 10.9 6.5 7.2 6.1 8.4 8.4 8.1 7.8 9.5 8.0 5.2 7.9 9.7 10.0 8.0 11.0 10.6 7.6 13.0 8.5 10.5 13.6 8.9 3.0 5.5 5.7 5.3 4.6 4.6 4.6 3.6 3.0 5.0 5.5 5.2 3.5 3.1 4.0 5.9 7.7 4.3 2.6 3.6 5.1 5.6 4.7 3.9 4.7 4.3 4.6 3.5 4.8 3.4 4.4 5.9 9.2 12.8 16.5 30.0 11.1 6.0 5.5 7.2 10.2 12.0 7.8 6.1 15.7 8.6 7.9 16.5 20.9 3.9 13.5 8.9 5.9 5.1 2.0 5.6 7.7 6.9 3.6 3.4 34.4 5.6 3.3 8.0 13.3 7.1 10.1 10.6 5.0 8.8 7.8 13.5 37.9 8.0 6.1 20.6 15.7 1.8 8.4 15.6 1.8 30.9 19.0 8.5 15.5 22.6 41.4 5.8 7.4 11.3 7.0 4.0 7.5 7.3 8.3 20.9 13.1 8.0 12.0 24.7 18.8 9.0 6.5 5.3 8.5 8.6 8.2 5.7 TPRA1 "FLJ32197, GPR175, TMEM227, TPRA40" ENSG00000163870 "Transmembrane protein adipocyte associated 1" Q86W33 3 127571232-127598267 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 179.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019784 Approved Approved Vesicles NA NA Vesicles "HPA019784: AB_2670266" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-3)" "unprognostic (1.66e-2)" "unprognostic (6.91e-3)" "unprognostic (9.74e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.91e-1)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (1.73e-2)" "unprognostic (4.42e-2)" "unprognostic (2.09e-1)" "unprognostic (4.28e-2)" 23.8 29.9 19.6 11.8 20.0 26.8 24.7 20.4 26.4 35.3 22.4 24.1 17.0 29.0 12.6 26.6 28.4 16.7 22.7 19.5 20.9 26.4 37.3 25.1 14.0 20.1 20.5 18.6 28.0 27.0 29.2 21.9 21.0 20.1 29.1 11.4 8.0 26.6 16.4 27.1 42.3 21.4 17.4 19.6 25.2 26.0 16.5 21.0 11.6 27.3 20.0 13.1 28.8 29.1 19.4 40.0 31.2 12.9 27.3 51.4 28.6 42.1 20.5 34.2 24.7 22.2 22.1 30.9 36.7 37.6 38.4 77.2 43.6 22.6 34.8 12.9 20.0 15.0 21.4 46.0 20.7 56.6 13.3 44.7 28.8 28.8 16.4 42.8 51.2 18.0 24.5 14.0 36.7 30.4 39.8 18.5 43.4 19.3 25.5 23.4 31.9 17.0 37.0 29.6 19.1 24.6 9.5 37.7 57.7 35.1 10.4 27.3 42.3 28.7 29.6 13.1 60.0 13.2 25.0 21.0 34.4 31.9 38.8 22.4 3.8 12.9 11.5 6.4 9.4 8.6 6.6 7.4 9.5 12.7 6.4 5.6 6.8 7.0 6.6 8.4 9.7 7.2 6.5 19.6 20.0 20.4 26.4 19.5 20.9 20.1 20.5 18.6 20.1 19.6 21.0 19.4 15.7 22.4 7.0 13.1 11.7 50.0 20.5 18.8 24.5 7.8 16.3 17.9 11.8 11.5 16.5 25.8 4.2 56.9 8.4 18.2 5.9 29.1 2.7 23.5 18.0 22.8 17.4 46.5 9.3 19.6 43.3 22.9 17.9 27.5 17.8 13.9 21.8 21.7 32.9 5.0 9.7 18.7 18.3 16.0 179.7 2.4 33.5 32.0 30.2 5.6 52.3 11.2 20.6 6.6 8.1 31.4 17.6 19.5 17.9 37.5 37.5 13.1 12.4 8.9 13.1 13.2 18.3 8.4 17.9 19.1 54.4 68.1 12.6 12.7 20.7 23.5 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697797-183812624 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 95.6;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 71.9;Oligodendrocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavorable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 7.5 4.8 4.4 9.0 6.3 14.6 7.9 7.1 8.9 8.2 0.0 8.0 5.5 9.1 4.8 8.2 10.4 6.5 6.4 6.1 4.3 6.1 3.4 10.0 13.0 4.0 3.5 5.4 15.2 5.4 10.0 8.7 11.3 3.5 8.3 6.8 15.8 8.1 7.4 5.5 8.5 7.1 12.0 0.5 9.0 5.9 8.1 3.9 17.1 9.8 4.8 11.9 8.8 8.5 6.7 38.1 11.3 32.4 14.5 15.5 22.8 35.8 22.1 17.0 32.1 37.5 27.8 13.3 34.7 39.8 19.5 49.9 23.9 31.8 21.2 32.7 28.5 18.8 35.0 12.2 13.7 23.9 26.3 19.4 15.6 16.3 23.1 27.8 32.1 33.1 35.2 14.0 28.3 24.5 10.2 38.3 20.2 29.3 13.8 22.0 53.5 30.5 42.0 12.9 16.6 31.3 22.3 16.4 55.4 29.2 27.1 27.5 17.8 28.2 29.5 21.3 15.1 25.0 26.9 22.6 57.6 22.9 25.8 21.3 0.1 4.6 1.2 1.9 2.0 1.3 1.9 1.7 1.4 1.6 1.3 1.3 1.5 8.5 1.3 7.1 2.1 0.7 1.8 4.4 6.3 7.1 8.9 6.1 4.3 4.0 3.5 5.4 3.5 0.5 3.9 6.7 13.8 35.3 2.3 41.4 7.0 2.0 3.3 7.0 8.6 19.5 5.6 7.5 10.1 5.7 5.9 5.5 10.4 4.8 7.4 4.4 0.0 5.7 2.4 10.5 18.3 15.3 8.5 6.3 95.6 4.0 9.7 9.2 7.1 9.8 7.0 42.1 7.5 3.0 7.1 13.5 62.1 6.0 6.1 8.7 6.7 3.3 9.9 10.1 1.8 40.3 6.6 5.8 5.2 71.9 80.0 7.1 3.1 9.4 9.5 5.3 4.7 1.0 11.2 15.8 0.0 10.1 10.4 3.1 12.3 8.7 3.4 2.1 8.8 9.7 4.8 2.8 GRIK3 "GluK3, GLUR7" ENSG00000163873 "Glutamate ionotropic receptor kainate type subunit 3" Q13003 1 36795527-37034515 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;pituitary gland: 9.3" "Group enriched" "Detected in some" 5 "Excitatory neurons: 39.1;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 72.9" "Cancer enriched" "Detected in some" 5 "glioma: 13.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.20e-2)" "unprognostic (1.90e-1)" "unprognostic (7.66e-2)" "unprognostic (9.26e-3)" "unprognostic (2.87e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-1)" "unprognostic (2.60e-3)" "unprognostic (9.06e-2)" "unprognostic (1.04e-1)" "unprognostic (3.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.28e-2)" "unprognostic (3.53e-3)" "unprognostic (2.06e-1)" "unprognostic (9.37e-2)" "unprognostic (2.08e-2)" 0.5 2.0 8.8 0.6 10.2 0.0 2.4 3.7 7.1 0.9 0.0 5.6 0.7 0.2 1.8 1.2 0.3 0.8 0.7 11.5 32.0 0.1 0.0 0.1 0.1 13.2 8.1 5.4 0.3 0.5 0.6 9.3 0.0 17.9 1.6 1.3 4.4 0.8 2.4 0.1 0.3 2.2 0.6 0.9 0.2 1.5 0.7 7.0 0.0 0.2 0.4 0.4 1.0 0.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.4 39.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 10.2 3.7 7.1 11.5 32.0 13.2 8.1 5.4 17.9 0.9 7.0 10.9 0.1 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.7 1.9 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 39.1 0.0 0.0 0.7 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 108.1 0.0 0.0 0.0 0.3 6.9 0.3 0.0 1.8 1.0 0.0 14.3 0.0 72.9 1.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZC3H12A "FLJ23231, MCPIP1, Regnase-1" ENSG00000163874 "Zinc finger CCCH-type containing 12A" Q5D1E8 1 37474580-37484377 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 137.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 300.7;Basal squamous epithelial cells: 242.4;Langerhans cells: 232.8;Squamous epithelial cells: 217.6;Suprabasal keratinocytes: 225.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "hypothalamus: 41.1" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 48.8;RT4: 61.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA032052, HPA032053" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" No No "Cytoplasmic bodies" Nucleoplasm "HPA032052: AB_10603241, HPA032053: AB_2674128" "unprognostic (2.35e-2)" "unprognostic (6.09e-3)" "unprognostic (1.51e-2)" "prognostic favorable (9.67e-4)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (9.03e-2)" "unprognostic (4.66e-3)" "unprognostic (1.05e-1)" "unprognostic (9.69e-3)" "unprognostic (9.01e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (5.17e-2)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.77e-2)" 17.3 28.2 3.5 17.5 2.1 137.6 15.3 3.0 6.9 9.2 3.2 13.1 14.2 6.7 4.6 45.7 14.4 36.4 10.2 3.1 41.1 15.4 23.5 40.3 13.7 3.9 2.6 1.1 6.1 12.5 2.5 9.2 3.8 3.2 29.7 7.9 0.3 23.1 5.2 10.9 42.3 20.2 5.8 2.6 15.6 23.6 5.3 3.5 5.8 6.5 3.2 15.6 39.4 21.6 4.4 7.8 5.5 0.6 3.5 2.7 4.0 6.2 5.5 48.8 3.5 4.5 6.1 17.2 8.7 22.8 5.3 37.8 16.8 2.2 35.4 2.0 17.8 3.2 2.3 20.9 9.7 3.9 4.6 3.5 8.6 17.8 30.0 5.3 7.9 3.9 4.4 4.3 14.1 3.1 9.4 3.5 8.3 4.2 10.4 4.8 5.2 2.2 5.1 8.8 61.2 1.6 1.1 11.0 17.4 1.3 5.3 6.0 5.1 4.1 10.3 5.7 7.7 8.5 11.2 4.5 6.6 23.5 9.7 2.0 1.2 1.4 4.0 3.1 1.4 3.3 3.1 1.3 1.9 1.7 3.9 0.7 1.5 5.6 3.5 1.2 1.5 2.0 1.7 3.5 2.1 3.0 6.9 3.1 41.1 3.9 2.6 1.1 3.2 2.6 3.5 4.4 19.1 16.0 36.2 1.6 56.9 195.9 149.8 300.7 242.4 0.4 93.6 69.8 4.2 61.5 117.6 11.0 0.0 3.7 78.1 71.5 0.0 79.5 16.9 67.6 20.8 32.2 63.9 0.4 0.1 73.9 10.0 41.0 66.3 102.2 42.6 5.0 5.3 11.4 9.7 0.0 0.1 77.3 69.2 10.5 232.8 2.7 0.9 71.2 48.0 1.0 14.0 0.9 9.2 0.5 0.9 55.4 73.2 1.2 52.1 127.9 59.5 0.6 58.4 4.5 6.6 52.7 36.1 1.6 1.3 217.6 225.2 11.8 76.6 9.5 62.2 81.9 MEAF6 "C1orf149, CENP-28, Eaf6, FLJ11730, NY-SAR-91" ENSG00000163875 "MYST/Esa1 associated factor 6" Q9HAF1 1 37489993-37514766 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029599 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA029599: AB_10599996" "unprognostic (4.95e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.41e-3)" "unprognostic (4.36e-2)" "unprognostic (3.16e-2)" "unprognostic (9.75e-3)" "unprognostic (2.87e-3)" "unprognostic (4.91e-2)" "unprognostic (2.68e-3)" "unprognostic (3.57e-2)" "unprognostic (4.77e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (3.93e-2)" "unprognostic (5.12e-3)" "unprognostic (2.19e-1)" 35.3 31.7 31.7 18.8 34.1 28.7 39.3 27.3 36.9 40.0 27.4 39.2 19.8 37.0 32.3 37.6 35.9 27.1 25.9 32.6 38.5 33.1 29.7 33.2 29.2 28.9 29.8 30.3 42.1 39.2 52.9 68.1 21.0 31.9 67.0 20.5 18.9 43.5 45.6 43.7 45.9 32.1 26.6 27.1 26.9 35.8 39.1 35.6 51.0 31.3 25.4 28.2 42.0 39.0 34.9 56.3 11.2 36.0 37.5 42.3 57.9 32.8 49.0 51.8 57.4 47.4 24.0 48.2 45.9 52.4 41.8 39.0 30.4 47.6 43.0 44.5 75.8 55.6 67.4 17.6 44.5 46.1 59.4 46.2 37.6 72.0 53.7 78.5 31.2 49.5 58.7 89.1 36.4 46.2 23.4 61.9 39.5 69.7 36.4 49.3 60.4 53.4 65.0 42.7 26.6 68.2 38.9 61.8 35.2 73.3 23.0 41.1 41.3 39.4 47.3 36.1 58.5 39.4 58.1 88.0 83.7 43.4 77.8 33.4 108.4 71.1 123.0 97.7 61.3 100.3 102.2 87.6 95.8 73.4 101.8 86.0 79.7 33.3 80.3 70.3 62.3 109.9 114.4 31.7 34.1 27.3 36.9 32.6 38.5 28.9 29.8 30.3 31.9 27.1 35.6 34.9 71.4 64.1 47.2 30.0 102.9 211.8 179.3 158.5 84.2 44.0 115.7 81.8 28.1 107.2 98.1 108.5 22.9 88.6 94.0 23.0 223.0 96.0 47.0 127.2 53.3 59.4 70.2 83.5 34.1 63.0 58.3 74.2 47.9 89.7 54.3 67.5 75.3 59.9 88.9 20.2 28.9 60.3 146.5 66.3 125.5 103.2 75.8 61.5 131.6 9.4 81.4 71.2 115.4 28.6 36.9 64.2 35.8 81.6 59.4 251.4 52.8 184.2 174.7 42.5 46.0 52.4 79.2 143.7 197.5 91.8 246.6 53.8 111.6 56.5 52.3 120.4 SNIP1 PML1 ENSG00000163877 "Smad nuclear interacting protein 1" Q8TAD8 1 37534449-37554293 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036896 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036896: AB_10670244" "unprognostic (1.37e-1)" "unprognostic (2.83e-1)" "unprognostic (1.65e-3)" "unprognostic (7.24e-2)" "unprognostic (5.83e-2)" "unprognostic (8.30e-3)" "unprognostic (3.26e-2)" "unprognostic (3.66e-2)" "unprognostic (7.74e-2)" "unprognostic (5.01e-2)" "unprognostic (9.30e-2)" "unprognostic (5.34e-3)" "unprognostic (3.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" 3.2 3.8 3.7 2.8 3.8 5.6 4.4 4.7 4.4 3.5 3.8 3.3 2.5 3.7 3.3 4.0 2.8 2.4 2.8 3.9 3.9 2.8 6.4 2.8 3.7 3.7 3.8 3.6 3.5 3.4 3.9 3.1 2.4 3.8 3.8 2.5 3.9 3.4 3.2 3.2 3.5 3.5 2.8 3.4 3.9 3.6 4.4 4.0 4.2 2.9 3.2 4.2 3.1 3.0 4.2 4.9 2.6 5.2 5.1 6.2 5.9 3.5 6.2 6.9 5.7 5.0 2.6 4.1 6.6 4.6 6.5 3.7 5.0 4.9 5.6 4.7 6.0 7.0 10.3 4.4 5.3 7.0 9.6 5.5 5.6 6.5 5.7 7.2 6.2 5.6 5.0 7.3 5.7 4.1 3.5 5.7 7.3 8.5 4.0 6.1 5.0 8.8 5.6 4.3 4.6 4.1 8.4 6.4 4.1 8.3 5.4 3.6 5.1 9.2 4.3 4.9 5.6 6.0 7.0 8.8 5.3 5.3 6.7 4.1 1.5 0.9 1.3 1.5 0.8 1.5 1.0 1.0 1.5 0.8 0.9 1.4 1.2 1.4 1.0 1.2 1.3 1.3 0.6 3.7 3.8 4.7 4.4 3.9 3.9 3.7 3.8 3.6 3.8 3.4 4.0 4.2 14.4 19.2 11.9 3.9 18.5 16.2 11.8 6.9 22.8 10.6 18.0 12.1 6.1 17.2 13.9 5.5 8.4 5.4 20.7 11.8 1.9 7.3 7.5 34.4 25.8 9.2 8.4 7.2 6.5 7.1 4.7 12.4 13.7 58.1 12.0 11.0 11.7 10.9 4.6 10.1 6.1 11.0 10.2 8.8 9.2 11.7 8.1 11.4 8.8 4.7 9.5 9.9 12.3 7.1 6.8 8.4 5.8 7.9 15.7 9.7 6.0 4.4 9.7 16.6 0.0 13.6 11.1 14.4 15.1 19.5 18.0 10.1 16.9 8.0 6.5 12.6 DNALI1 "dJ423B22.5, hp28, P28" ENSG00000163879 "Dynein axonemal light intermediate chain 1" O14645 1 37556919-37566857 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 54.9" "Group enriched" "Detected in many" 4 "Early spermatids: 664.5;Endometrial ciliated cells: 302.8;Late spermatids: 1051.9;Respiratory ciliated cells: 484.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.3;ASC TERT1: 12.1;hTERT-RPE1: 18.8;RPTEC TERT1: 16.9;SH-SY5Y: 11.7;T-47d: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028305, HPA031633" Enhanced NA NA "HPA028305: AB_10601807, HPA031633: " "unprognostic (1.21e-2)" "unprognostic (9.04e-2)" "unprognostic (2.58e-2)" "unprognostic (6.09e-3)" "unprognostic (2.33e-1)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "prognostic favorable (6.02e-4)" "unprognostic (1.52e-1)" "unprognostic (5.50e-3)" "unprognostic (8.00e-3)" "unprognostic (3.52e-2)" "unprognostic (1.74e-2)" "unprognostic (1.19e-1)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" "unprognostic (5.52e-2)" 2.2 6.1 17.5 0.7 14.1 0.0 7.5 15.5 15.5 9.2 24.3 4.3 1.3 8.6 14.5 2.7 54.9 9.2 2.7 13.2 26.6 12.3 12.1 10.6 0.9 17.3 18.7 11.7 14.1 9.2 9.2 12.7 1.6 17.9 6.8 2.3 11.9 4.6 7.3 1.2 0.6 2.3 4.2 18.5 1.1 6.4 29.6 15.6 0.7 10.8 1.3 0.6 3.9 2.0 18.0 0.0 0.0 14.3 1.3 2.9 12.1 0.2 1.8 3.9 0.1 0.5 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.3 9.3 0.0 0.1 5.5 0.0 9.3 0.0 18.8 1.5 0.0 1.0 0.0 7.5 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.9 0.0 16.9 0.0 1.6 11.7 0.0 0.0 0.0 2.2 30.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 14.1 15.5 15.5 13.2 26.6 17.3 18.7 11.7 17.9 18.5 15.6 18.0 1.9 19.2 32.4 6.8 1.0 0.9 22.6 42.3 1.2 2.7 19.6 15.9 5.6 21.5 48.5 20.2 8.4 2.7 0.3 0.8 29.4 34.0 664.5 302.8 12.2 4.7 20.9 0.0 2.6 10.2 8.5 15.7 20.4 16.7 2.5 38.9 8.6 9.4 2.8 3.3 2.8 11.5 46.8 0.6 0.6 1051.9 13.7 2.0 0.0 0.0 0.0 18.7 0.0 3.0 1.7 12.5 1.0 12.0 0.0 21.0 1.0 43.3 484.1 19.6 6.6 17.5 18.5 140.0 18.5 0.3 0.6 3.4 1.1 21.0 4.9 9.3 POLR2H RPB8 ENSG00000163882 "RNA polymerase II, I and III subunit H" P52434 3 184361718-184368596 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037745, HPA055813" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA037745: AB_10672914, HPA055813: AB_2797254" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (3.61e-3)" "unprognostic (7.15e-2)" "unprognostic (1.17e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.82e-3)" "unprognostic (2.84e-1)" "unprognostic (4.02e-3)" "unprognostic (4.24e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.34e-1)" "unprognostic (4.01e-1)" "unprognostic (1.71e-1)" "unprognostic (2.93e-3)" 38.7 61.1 51.0 32.8 51.3 31.4 42.7 53.9 60.6 49.2 51.9 54.9 58.2 36.6 40.0 52.5 40.2 30.3 32.7 51.2 51.6 70.2 64.3 38.0 41.5 51.4 51.0 50.6 40.6 52.5 35.8 33.1 35.2 51.8 43.2 58.3 14.7 44.6 26.5 37.6 37.9 55.9 35.3 50.8 42.3 51.6 32.6 52.8 40.1 48.7 30.3 41.1 43.8 41.8 53.5 225.2 77.3 81.7 121.4 89.0 62.8 101.2 82.8 86.3 110.8 141.6 199.6 104.6 126.0 201.7 65.0 168.4 88.8 147.4 148.7 98.1 124.4 194.7 121.4 89.8 126.2 80.1 129.3 67.9 81.6 83.3 72.6 129.8 99.4 116.3 124.6 95.3 81.0 89.0 265.6 128.7 172.3 89.0 279.0 159.3 74.3 74.9 171.2 133.9 100.3 122.8 87.3 69.7 214.0 126.9 78.6 267.9 102.4 61.5 52.5 82.9 70.9 224.3 161.7 181.3 237.3 83.4 136.2 71.5 8.3 17.6 15.9 26.8 30.7 32.9 32.9 31.6 29.1 34.0 33.9 45.8 34.8 1.3 29.8 19.2 34.7 36.7 21.6 51.0 51.3 53.9 60.6 51.2 51.6 51.4 51.0 50.6 51.8 50.8 52.8 53.5 45.1 38.5 43.8 23.8 39.4 113.4 74.1 113.7 61.5 22.0 70.1 77.0 17.4 47.1 70.2 44.1 16.7 103.2 45.8 132.8 140.8 73.0 21.0 62.3 62.3 57.9 55.7 53.8 12.9 91.2 146.0 52.8 53.5 83.7 31.1 50.4 43.2 58.5 61.4 25.2 15.8 80.2 93.6 21.4 57.5 14.3 46.0 29.9 51.6 9.4 29.0 26.7 32.0 8.5 11.5 97.6 90.9 27.8 52.1 139.7 94.5 150.5 55.1 24.9 39.5 48.0 69.6 92.9 111.0 66.0 74.2 122.3 38.0 71.6 83.1 92.5 KLF15 KKLF ENSG00000163884 "Kruppel like factor 15" Q9UIH9 3 126342635-126357408 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 93.2" "Cell type enhanced" "Detected in many" "Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1" "Cancer enhanced" "Detected in many" "liver cancer: 30.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003286, HPA028866" Uncertain Supported "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA003286: , HPA028866: AB_10600819" "unprognostic (3.77e-3)" "unprognostic (1.08e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.72e-3)" "unprognostic (2.11e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-1)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "prognostic favorable (3.27e-7)" "unprognostic (6.75e-2)" "unprognostic (7.65e-2)" "unprognostic (1.91e-2)" "unprognostic (5.58e-3)" 36.8 6.2 35.7 0.8 43.3 0.1 25.6 39.9 70.1 15.3 31.0 15.1 1.3 19.2 4.2 7.1 29.9 3.5 28.2 35.1 34.6 19.9 93.2 18.8 1.8 58.9 39.8 31.3 46.6 48.9 4.6 10.5 1.7 39.6 17.7 0.9 3.9 19.9 5.3 67.9 9.3 10.3 2.5 38.0 3.6 30.4 5.6 38.6 1.2 11.2 32.7 0.8 27.3 12.1 43.0 0.8 0.0 2.2 9.2 57.4 1.0 10.0 0.6 1.4 0.7 1.3 1.1 0.0 3.4 0.9 0.0 1.7 0.1 5.3 0.1 0.2 0.2 2.0 0.1 0.8 7.9 34.8 0.0 0.2 5.4 0.5 0.0 1.2 0.0 0.6 4.5 4.3 7.4 0.2 0.7 0.0 1.3 6.6 1.3 0.3 4.7 0.2 20.2 0.1 0.8 0.7 7.7 0.1 0.3 10.2 3.3 0.5 4.6 0.3 0.3 0.4 0.3 0.3 4.7 0.6 0.7 0.2 1.5 1.3 25.1 7.6 10.3 7.0 10.2 8.2 12.3 7.3 7.4 8.2 11.4 9.4 11.3 16.7 12.8 9.3 9.0 10.5 11.7 35.7 43.3 39.9 70.1 35.1 34.6 58.9 39.8 31.3 39.6 38.0 38.6 43.0 1.5 6.4 4.6 22.9 0.8 0.0 2.9 0.2 0.6 1.3 7.8 1.8 29.7 15.7 0.7 0.0 0.0 0.1 0.1 0.0 29.4 0.1 0.1 2.5 4.4 2.1 0.0 2.7 0.6 0.0 0.2 8.1 3.1 3.4 0.0 13.7 8.2 66.9 0.1 0.0 2.8 0.1 0.0 2.6 0.0 0.8 12.2 0.4 1.8 2.8 0.0 12.0 0.0 15.1 5.7 0.4 0.0 19.9 0.9 5.2 0.0 22.1 0.8 3.3 0.0 12.0 5.5 0.1 0.1 0.3 0.0 0.3 0.5 0.6 0.1 1.8 CFAP100 "CCDC37, FLJ40083, MIA1" ENSG00000163885 "Cilia and flagella associated protein 100" Q494V2 3 126394909-126436556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 21.6;choroid plexus: 25.7;fallopian tube: 27.3;testis: 32.6" "Group enriched" "Detected in some" 8 "Early spermatids: 316.1;Late spermatids: 703.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046354 Enhanced NA NA "HPA046354: AB_2679634" "unprognostic (1.79e-2)" "unprognostic (3.75e-3)" "unprognostic (7.17e-5)" "unprognostic (1.61e-3)" "unprognostic (6.75e-2)" "unprognostic (9.99e-3)" "unprognostic (1.47e-1)" "unprognostic (7.83e-2)" "unprognostic (1.61e-1)" "unprognostic (3.70e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.70e-5)" "unprognostic (3.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.96e-2)" "unprognostic (3.58e-4)" 0.0 0.0 21.6 0.0 5.1 0.0 0.0 6.0 2.8 1.7 25.7 0.0 0.0 1.0 0.0 0.0 27.3 0.0 0.0 4.2 11.0 0.1 0.0 6.3 0.1 12.5 19.1 1.2 0.1 0.0 0.0 0.3 0.0 9.8 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 17.8 0.0 0.0 32.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 5.1 6.0 2.8 4.2 11.0 12.5 19.1 1.2 9.8 17.8 8.0 7.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 316.1 60.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 703.3 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.8 48.1 0.0 6.6 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261553 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 109.0;pancreas: 33.9;pituitary gland: 39.9" "Group enriched" "Detected in some" 4 "Horizontal cells: 62.2;Inhibitory neurons: 45.3" "Cancer enhanced" "Detected in many" "glioma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 21.2;REH: 33.4;SCLC-21H: 33.2;U-138 MG: 32.1" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA050835: AB_2681253, HPA075200: " "unprognostic (7.28e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 0.1 14.7 60.6 0.2 30.2 0.0 0.1 45.9 50.4 0.1 1.6 0.5 0.2 0.2 0.0 0.1 0.1 0.1 0.1 36.7 59.2 0.2 0.7 0.1 0.0 94.5 74.4 35.5 0.1 33.9 0.8 39.9 0.1 80.5 0.3 0.0 5.6 0.2 0.1 0.0 0.2 0.2 0.2 45.9 0.1 0.5 0.2 109.0 0.0 0.1 0.0 0.0 0.1 0.2 101.4 21.2 0.5 3.2 1.7 0.5 0.5 2.2 0.5 6.2 4.0 4.1 1.2 1.1 2.0 5.4 0.3 13.0 2.8 1.1 0.7 2.2 16.1 1.4 0.7 0.5 0.9 0.1 1.4 3.0 0.5 1.0 0.6 2.8 1.4 0.0 0.9 0.3 7.5 0.6 14.5 0.4 1.1 13.3 1.5 8.4 33.4 9.4 3.2 0.9 5.0 33.2 7.3 3.9 1.7 0.3 0.3 13.3 0.2 0.2 32.1 15.0 4.3 6.7 4.1 8.1 6.8 8.1 3.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 30.2 45.9 50.4 36.7 59.2 94.5 74.4 35.5 80.5 45.9 109.0 101.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.2 0.3 0.5 0.4 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.1 0.3 0.1 0.4 0.2 3.6 0.0 7.8 4.3 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.8 0.0 62.2 45.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 2.8 0.0 2.0 0.0 7.5 2.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 7.2 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 LIPH "LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B" ENSG00000163898 "Lipase H" Q8WWY8 3 185506262-185552588 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.1;stomach 1: 48.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 144.2;Club cells: 135.5;Distal enterocytes: 312.3;Gastric mucus-secreting cells: 236.5;Intestinal goblet cells: 139.8;Proximal enterocytes: 226.1;Urothelial cells: 158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 74.1;OE19: 17.2;RPTEC TERT1: 36.7;T-47d: 17.6;U-266/84: 18.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049079 Approved "Secreted to blood" NA NA "HPA049079: AB_2680623" "unprognostic (4.50e-3)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (3.38e-1)" "unprognostic (1.01e-1)" "unprognostic (8.59e-2)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.88e-2)" "prognostic favorable (9.20e-5)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (4.21e-4)" "unprognostic (1.15e-1)" 0.3 0.3 0.4 2.8 0.5 0.1 3.8 0.1 0.6 1.4 5.7 36.6 11.2 0.2 7.2 14.8 1.1 12.4 0.4 0.4 1.4 5.7 0.4 18.5 0.1 0.2 0.2 0.2 0.5 5.6 0.0 0.3 0.1 0.2 6.8 38.1 0.2 13.3 2.0 0.5 6.7 11.9 0.6 0.0 0.4 48.6 2.7 0.3 0.3 0.2 0.1 3.0 12.3 4.4 0.3 10.3 13.5 0.1 0.1 0.0 0.2 2.9 0.3 0.0 0.3 0.3 1.3 74.1 0.0 7.5 0.2 2.9 3.6 5.6 0.1 0.4 0.1 1.6 1.8 1.8 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 5.4 0.1 0.0 1.3 0.5 0.1 0.7 17.2 1.1 0.0 0.0 1.0 36.7 9.2 0.0 0.0 1.1 12.2 0.3 0.6 17.6 0.3 0.0 0.1 1.1 0.1 0.2 1.2 18.9 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.4 0.5 0.1 0.6 0.4 1.4 0.2 0.2 0.2 0.2 0.0 0.3 0.3 0.1 144.2 38.5 2.0 0.8 0.8 16.3 76.5 0.6 0.7 55.6 12.7 0.4 94.4 135.5 68.0 0.0 0.2 1.0 312.3 1.9 57.8 0.2 7.0 0.5 1.8 22.2 0.0 1.7 24.9 0.1 1.1 236.5 5.7 7.0 36.0 1.1 0.3 0.0 0.0 0.9 139.8 38.7 0.3 0.3 0.1 0.0 2.4 16.0 0.0 0.8 0.3 2.1 2.5 0.4 60.4 102.7 0.0 0.3 72.8 226.1 1.6 105.6 0.9 0.0 0.1 5.5 1.1 0.3 6.9 2.0 0.3 0.8 12.0 102.1 158.0 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 9.0 27.4 9.9 5.5 9.7 11.1 10.3 10.0 11.1 9.0 9.4 7.9 26.6 8.8 11.3 23.8 9.2 7.7 9.4 9.4 9.6 14.8 20.7 10.7 7.5 9.7 11.9 9.1 14.2 9.8 8.7 5.7 8.5 9.6 10.3 8.9 7.5 12.1 8.4 9.8 18.6 24.3 7.5 10.1 12.6 10.4 9.4 12.9 7.9 7.1 16.5 12.7 10.9 14.8 11.2 43.6 15.4 10.1 12.5 15.6 16.8 29.6 16.3 14.3 20.2 14.6 40.5 16.7 13.4 30.5 15.3 28.5 29.4 28.1 17.5 20.4 22.6 25.8 23.3 8.6 41.2 17.5 25.3 12.5 15.7 25.6 18.3 20.9 12.7 15.6 16.8 42.1 32.4 13.0 16.8 15.6 14.5 16.8 34.1 24.1 15.5 15.6 24.6 17.4 31.4 10.1 13.1 14.1 35.8 25.7 14.4 42.8 19.6 11.4 11.9 15.0 25.2 34.5 47.2 78.0 26.5 18.2 15.1 14.6 14.0 8.2 7.2 16.3 9.4 21.0 17.5 16.7 18.1 9.3 15.6 18.2 19.8 2.8 12.2 12.2 21.7 15.3 9.2 9.9 9.7 10.0 11.1 9.4 9.6 9.7 11.9 9.1 9.6 10.1 12.9 11.2 12.1 9.6 30.5 7.2 16.7 53.0 42.8 29.5 50.7 22.4 38.2 20.6 12.6 24.3 24.9 20.2 18.8 27.5 18.3 23.3 7.9 33.4 0.7 17.7 14.5 19.8 18.6 16.4 8.1 56.0 23.5 18.0 36.2 38.0 8.8 50.2 17.2 40.9 19.6 16.8 9.8 28.3 16.2 14.2 17.3 2.8 14.3 12.5 8.8 2.8 65.9 11.4 11.3 20.1 7.6 50.3 17.0 13.5 20.9 64.2 200.8 23.2 9.6 28.6 19.7 16.8 16.5 22.1 14.3 113.0 84.7 46.0 18.5 82.6 45.6 93.4 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619969-128681075 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 424.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 730000 "Endoplasmic reticulum" Cytosol "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 92.9 89.1 58.1 95.4 64.8 97.9 106.5 70.3 63.8 143.2 91.7 125.1 98.0 92.8 355.5 77.2 125.9 91.3 82.5 55.7 79.1 120.6 228.1 113.6 77.4 74.0 65.2 55.2 81.6 119.8 145.0 84.4 141.0 69.9 101.1 135.6 47.3 121.4 114.9 90.0 64.0 95.3 112.5 69.1 85.9 116.0 91.8 66.2 86.8 179.3 78.4 103.2 118.3 64.5 78.6 358.5 190.9 156.2 289.8 412.7 273.1 351.3 300.0 393.2 391.4 452.1 399.4 328.2 221.9 274.8 437.3 363.2 349.7 255.4 268.2 374.7 158.8 160.3 392.7 127.9 332.3 454.3 322.5 198.2 229.5 307.3 258.4 377.5 260.9 308.6 164.2 164.2 289.6 260.4 327.8 179.7 353.0 198.1 476.6 170.2 193.6 209.4 540.6 272.7 212.0 238.6 137.4 246.3 253.6 313.6 199.0 271.0 329.0 203.2 200.9 154.7 297.0 226.9 306.1 259.9 234.4 329.4 235.9 296.9 178.0 171.6 137.6 129.3 147.0 154.7 91.5 104.7 117.7 159.5 60.7 63.8 99.3 233.2 90.3 159.3 192.4 114.2 250.8 58.1 64.8 70.3 63.8 55.7 79.1 74.0 65.2 55.2 69.9 69.1 66.2 78.6 82.9 60.9 74.1 13.1 72.4 49.5 83.6 102.8 55.2 13.0 53.7 26.9 42.4 51.5 91.6 112.2 8.4 113.7 59.1 126.0 15.6 111.5 19.1 85.3 73.9 72.4 43.3 63.5 11.7 93.3 199.1 91.7 113.2 126.8 43.7 40.2 96.0 180.0 135.7 20.2 16.3 158.4 73.2 154.1 70.8 29.5 94.1 87.6 58.7 11.2 77.0 30.3 39.1 18.1 21.3 104.0 83.1 64.3 424.1 93.3 109.1 90.7 110.2 13.2 46.0 43.9 53.7 65.9 62.6 67.0 53.4 156.7 65.8 54.0 130.2 78.9 SENP2 "AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2" ENSG00000163904 "SUMO specific peptidase 2" Q9HC62 3 185582496-185633551 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029247, HPA029248" Approved Supported Cytosol NA NA Cytosol "HPA029247: AB_10599305, HPA029248: AB_10601855" "unprognostic (4.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (7.98e-5)" "unprognostic (7.85e-2)" "unprognostic (2.90e-2)" "unprognostic (4.41e-3)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "unprognostic (8.41e-3)" "unprognostic (5.12e-2)" "unprognostic (6.92e-2)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (1.56e-1)" 7.3 7.3 14.4 4.4 16.3 10.8 7.5 14.4 16.1 6.0 12.8 7.2 6.1 6.1 9.8 6.6 7.3 4.5 7.5 14.8 14.8 7.4 9.6 6.5 6.2 14.0 14.8 14.8 10.1 7.5 9.6 10.6 9.0 13.7 6.6 6.2 12.9 7.6 6.4 19.0 9.3 6.7 4.8 13.3 6.7 8.1 15.3 14.8 8.2 7.3 13.1 6.1 7.1 6.3 15.7 24.4 4.6 11.6 13.4 20.6 13.8 15.1 10.9 12.6 13.8 14.6 18.3 7.5 13.2 20.3 10.2 23.6 12.6 24.3 9.0 20.3 9.7 11.6 8.9 9.8 11.0 10.9 13.2 5.6 8.6 13.3 7.8 9.5 10.2 9.6 12.5 10.8 18.1 12.0 12.0 11.4 14.7 42.4 12.3 8.1 13.1 15.8 22.1 7.7 7.9 11.9 13.4 9.3 20.4 18.3 23.0 27.8 17.5 6.1 9.0 9.8 16.4 17.7 20.9 26.8 23.8 14.9 13.9 12.5 5.1 1.3 2.6 1.6 1.3 1.6 1.3 1.3 1.3 1.0 1.9 1.5 1.5 3.4 2.3 1.6 2.0 1.3 0.9 14.4 16.3 14.4 16.1 14.8 14.8 14.0 14.8 14.8 13.7 13.3 14.8 15.7 12.3 28.9 27.4 17.9 21.2 10.8 23.7 12.6 6.2 22.8 21.6 15.4 24.2 11.5 26.2 9.2 31.3 25.0 22.6 15.7 5.9 12.9 249.6 26.3 12.0 12.8 5.4 11.1 42.9 15.2 19.9 16.1 15.3 25.2 10.8 21.3 17.2 20.5 13.2 11.8 43.0 15.1 14.2 12.5 9.1 43.0 22.7 11.1 17.8 26.2 13.6 17.8 21.6 41.2 41.3 17.9 6.6 17.7 25.7 17.0 24.2 18.2 28.8 38.1 19.7 23.2 16.3 84.2 31.8 13.4 12.5 39.7 18.2 33.7 15.8 22.5 HEYL "bHLHb33, HESR3, HEY3" ENSG00000163909 "Hes related family bHLH transcription factor with YRPW motif like" Q9NQ87 1 39623435-39639643 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 70.1" "Cell type enhanced" "Detected in many" "Late spermatids: 17.5;Leydig cells: 26.1;Peritubular cells: 56.8;Sertoli cells: 52.6;Skeletal myocytes: 33.4;Smooth muscle cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 8.0;LHCN-M2: 20.8;RH-30: 26.5;THP-1: 6.2;U-266/84: 7.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001438, HPA076960" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA001438: AB_1079052, HPA076960: AB_2732326" "unprognostic (1.98e-2)" "unprognostic (7.92e-2)" "unprognostic (4.19e-3)" "unprognostic (3.49e-1)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (7.20e-2)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (2.35e-1)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.26e-6)" "prognostic unfavorable (3.57e-4)" "unprognostic (2.67e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.63e-5)" 13.6 12.5 8.9 5.7 11.3 0.1 9.4 10.9 6.5 16.8 5.2 6.8 1.9 28.1 5.8 4.8 17.6 8.1 51.6 5.5 13.8 9.5 4.2 23.7 1.7 15.7 14.5 4.8 13.5 70.1 2.4 15.5 29.7 16.3 17.1 3.4 6.8 2.7 14.5 6.0 2.8 5.0 25.2 6.7 6.4 6.0 16.1 13.3 1.4 20.6 5.4 2.0 8.8 11.4 8.3 0.0 2.8 4.8 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 2.0 0.3 0.0 1.6 0.5 0.0 0.0 2.8 0.0 0.3 0.0 3.2 5.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 8.0 0.5 0.7 20.8 1.9 0.0 0.1 0.0 0.2 0.1 1.4 26.5 0.2 0.0 0.5 0.6 0.0 0.0 0.1 0.0 1.1 0.0 6.2 0.0 0.0 0.2 0.0 0.0 0.7 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 11.3 10.9 6.5 5.5 13.8 15.7 14.5 4.8 16.3 6.7 13.3 8.3 1.3 0.0 0.0 0.7 0.0 0.9 0.1 0.0 0.0 0.9 0.1 0.0 3.6 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 1.0 5.4 1.3 4.0 1.9 0.0 0.0 0.1 3.5 0.3 13.3 2.0 2.4 0.0 0.7 1.4 0.0 0.3 1.7 0.2 0.2 0.0 0.0 2.3 17.5 26.1 0.4 5.4 4.7 0.1 0.4 0.0 0.0 2.4 2.8 0.3 56.8 0.0 0.2 0.0 0.1 0.0 3.9 52.6 33.4 29.5 0.4 2.0 0.1 0.1 0.3 0.3 1.9 0.4 0.2 IFT122 "FAP80, SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.4" "Cell type enhanced" "Detected in many" "Early spermatids: 81.7;Late spermatids: 70.3;Spermatocytes: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Uncertain Cytosol NA NA Cytosol "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 9.3 7.5 6.1 5.3 7.3 10.2 12.6 6.4 9.3 13.2 12.7 7.0 4.7 12.7 12.8 7.2 24.9 6.7 11.3 6.9 6.1 11.8 9.3 8.8 6.7 4.5 5.7 5.4 25.6 13.4 14.0 14.5 10.8 4.6 7.5 7.0 11.3 8.0 8.6 3.9 14.0 5.3 9.0 4.3 4.5 9.1 73.4 5.9 9.0 13.2 3.0 5.8 6.7 8.5 6.2 16.5 24.6 21.0 13.5 29.7 21.0 10.5 8.5 12.9 14.8 14.1 11.9 10.7 10.6 10.0 11.3 14.5 10.4 8.2 7.7 13.3 5.8 8.8 8.2 21.8 10.3 8.1 22.2 7.2 24.7 5.7 11.4 8.8 12.9 20.3 21.8 8.4 22.1 12.1 18.2 18.2 11.6 14.1 12.3 7.0 16.3 8.0 7.7 15.7 3.0 25.9 10.6 24.8 8.2 7.5 7.9 22.6 17.9 9.0 10.1 8.7 13.6 10.2 15.0 11.4 9.3 9.2 11.3 8.1 4.5 3.1 3.7 0.9 2.2 1.6 1.9 1.6 2.3 3.2 2.1 1.8 2.2 1.4 1.5 0.9 0.8 3.0 2.1 6.1 7.3 6.4 9.3 6.9 6.1 4.5 5.7 5.4 4.6 4.3 5.9 6.2 7.5 9.6 8.2 28.1 4.3 2.7 5.8 4.5 2.8 9.7 18.0 13.3 6.4 15.7 5.6 25.8 37.5 6.7 4.5 6.2 7.9 5.2 81.7 43.4 11.0 9.7 3.0 7.4 35.1 8.9 5.2 9.8 19.9 10.2 5.1 8.7 20.7 6.0 9.3 5.0 23.1 10.2 4.1 7.2 2.2 70.3 18.6 4.1 3.6 15.0 3.8 11.8 3.1 12.1 15.9 3.4 4.2 13.9 3.4 3.6 6.2 8.2 37.3 21.4 0.0 12.8 7.7 120.4 38.0 5.4 2.8 2.6 4.1 10.6 8.7 3.4 RHO "CSNBAD1, OPN2, RP4" ENSG00000163914 Rhodopsin P08100 3 129528639-129535344 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Congenital stationary night blindness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6147 "retina: 4097.5" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 4509.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "hippocampal formation: 9.7" "Region enhanced" "Detected in single" "hippocampal formation: 1.1" "HPA013440, CAB022486, CAB034887, CAB034888" Enhanced NA NA "CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844" "unprognostic (4.32e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (2.87e-1)" "unprognostic (1.94e-1)" "unprognostic (9.19e-11)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4097.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 369.9 0.0 0.0 0.6 0.0 0.0 0.0 454.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 26.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 218.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 590.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4509.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RFC4 "A1, RFC37" ENSG00000163918 "Replication factor C subunit 4" P35249 3 186789880-186807058 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004557, HPA049123, HPA058507" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736" "unprognostic (2.45e-1)" "prognostic favorable (7.41e-5)" "unprognostic (2.84e-1)" "unprognostic (1.81e-3)" "unprognostic (1.03e-1)" "unprognostic (6.69e-3)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.29e-3)" "unprognostic (1.15e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.80e-2)" "unprognostic (4.98e-1)" "unprognostic (6.15e-2)" "unprognostic (2.16e-1)" 7.0 6.1 6.9 19.4 7.2 41.8 14.0 8.6 12.0 8.5 6.8 15.6 11.0 14.2 6.7 11.8 10.9 7.8 9.1 7.1 7.2 7.3 10.8 7.3 31.8 6.9 7.1 6.6 15.1 11.1 8.0 5.8 14.6 7.3 7.8 20.6 11.3 8.6 7.1 8.3 11.8 11.8 17.8 7.0 14.4 10.5 22.9 7.3 36.0 7.3 6.8 34.8 7.9 8.3 7.9 167.3 56.2 130.8 83.6 18.8 20.1 103.0 78.9 49.9 123.6 135.8 84.8 77.9 119.5 177.4 38.0 118.0 86.1 116.5 77.5 151.1 180.5 102.5 123.3 86.3 86.3 14.6 131.8 79.5 17.3 27.5 84.9 66.1 27.6 42.0 183.8 97.9 165.4 85.3 79.7 167.2 122.8 116.0 148.1 76.0 129.9 112.5 164.3 44.9 60.7 126.3 63.3 97.3 107.6 90.3 97.6 183.0 123.7 19.6 74.4 93.3 125.8 239.9 91.9 216.9 398.9 65.3 142.8 100.0 0.0 2.8 9.7 11.5 4.2 11.1 13.1 11.4 12.0 5.0 15.1 11.2 10.2 0.6 9.8 14.7 9.6 21.8 7.7 6.9 7.2 8.6 12.0 7.1 7.2 6.9 7.1 6.6 7.3 7.0 7.3 7.9 5.1 0.0 2.2 3.3 14.0 6.0 15.3 18.1 5.2 16.1 4.1 8.1 7.5 5.7 9.3 11.0 0.0 43.0 9.7 4.4 5.9 15.3 27.3 5.6 7.0 6.1 1.2 46.3 5.2 16.6 55.7 8.3 6.6 6.0 8.2 25.3 6.1 3.0 23.9 8.4 4.4 7.1 10.2 2.6 4.9 10.0 10.5 6.2 1.8 4.7 12.2 14.9 9.2 2.5 4.3 9.2 4.1 7.9 23.8 3.8 2.8 7.9 7.9 14.4 6.6 10.2 13.1 86.7 50.5 7.9 3.0 11.2 9.6 8.8 13.9 4.7 RPL39L RPL39L1 ENSG00000163923 "Ribosomal protein L39 like" Q96EH5 3 187120948-187180908 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 212.2" "Cell type enhanced" "Detected in many" "Early spermatids: 545.6;Late spermatids: 245.5;Spermatocytes: 785.0;Spermatogonia: 161.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047105 Approved NA NA "HPA047105: AB_2679933" "unprognostic (1.01e-1)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (6.05e-4)" "prognostic unfavorable (1.30e-6)" "unprognostic (6.94e-2)" "unprognostic (9.75e-3)" "unprognostic (1.66e-3)" "unprognostic (8.02e-2)" "prognostic favorable (1.94e-4)" "unprognostic (1.19e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-3)" "unprognostic (9.51e-2)" "unprognostic (1.61e-1)" "unprognostic (8.21e-3)" "unprognostic (2.60e-1)" 7.7 3.0 9.9 8.0 9.8 19.5 12.9 12.6 12.1 11.2 8.4 9.9 3.4 8.8 4.6 9.0 12.1 3.7 9.8 9.6 9.9 5.6 4.6 5.5 13.3 9.3 8.1 8.4 4.8 20.4 6.0 4.8 6.0 9.8 9.9 4.6 6.8 8.4 7.2 2.2 11.7 6.3 8.2 6.5 7.1 6.9 212.2 8.9 16.6 4.0 2.3 14.2 8.6 10.8 12.8 213.2 67.3 22.4 35.9 10.2 15.3 20.9 56.6 44.0 51.0 54.8 5.6 33.3 78.7 203.7 32.7 98.2 64.7 56.4 10.8 77.5 136.5 9.1 1.5 69.7 1.3 19.3 18.7 20.3 12.7 8.2 42.2 35.9 38.9 52.6 95.4 42.8 90.3 19.4 62.7 2.1 66.0 162.8 65.0 122.7 69.5 31.0 58.9 17.0 4.8 54.6 56.8 47.3 120.2 138.0 94.1 118.8 55.4 24.8 1.4 59.6 48.5 59.2 118.6 138.1 153.4 30.8 69.9 117.0 6.1 10.7 2.6 25.1 10.4 12.3 33.1 25.1 22.5 10.8 22.7 17.2 26.1 2.2 16.5 7.3 12.2 47.5 30.9 9.9 9.8 12.6 12.1 9.6 9.9 9.3 8.1 8.4 9.8 6.5 8.9 12.8 3.0 3.2 7.1 2.3 21.0 25.0 37.0 32.5 19.4 3.4 30.4 35.9 48.4 14.3 10.7 3.7 0.0 26.0 9.1 3.3 7.9 13.0 545.6 16.4 14.7 8.1 0.0 8.8 1.8 2.6 95.7 16.8 5.1 9.2 7.0 21.1 23.6 50.4 40.3 6.7 1.6 4.5 16.2 19.1 25.5 245.5 21.8 9.9 23.2 1.0 4.3 16.6 34.0 3.0 1.3 10.5 2.2 11.7 27.2 31.6 0.7 2.3 10.2 2.2 6.6 8.5 26.4 785.0 161.7 12.7 21.2 14.9 16.0 14.5 8.4 30.4 BAP1 "hucep-6, KIAA0272, UCHL2" ENSG00000163930 "BRCA1 associated protein 1" Q92560 3 52401008-52410008 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 103.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004322, HPA028814, HPA028815, HPA055560" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850" "unprognostic (1.52e-1)" "unprognostic (7.96e-2)" "unprognostic (1.96e-2)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-2)" "unprognostic (9.41e-3)" "unprognostic (8.53e-3)" "unprognostic (1.33e-1)" "unprognostic (3.15e-1)" "unprognostic (4.64e-3)" "unprognostic (3.30e-3)" "prognostic favorable (3.29e-7)" "unprognostic (6.37e-2)" "unprognostic (1.91e-1)" "unprognostic (5.54e-2)" "unprognostic (2.92e-1)" 43.4 64.0 99.8 25.2 101.2 74.6 43.3 82.0 136.6 39.0 75.1 47.7 21.8 40.8 23.3 59.8 36.3 25.9 50.6 114.3 84.8 57.7 65.8 46.4 29.7 84.6 88.6 101.0 44.3 53.1 40.5 37.2 24.8 87.6 50.5 24.3 20.3 43.4 22.7 75.3 71.8 43.8 24.0 80.2 54.6 48.5 141.1 90.6 33.4 49.5 43.9 28.1 45.0 42.1 93.7 39.1 43.1 52.2 44.8 50.1 31.4 59.3 37.8 50.1 62.4 48.0 52.5 35.8 55.7 18.3 54.7 69.3 31.4 55.7 63.0 37.9 55.1 51.4 68.6 94.4 53.2 45.7 65.6 58.5 48.0 80.1 68.5 36.1 33.3 50.3 107.7 59.9 48.3 44.5 33.7 79.1 89.5 58.0 31.0 52.8 33.7 41.7 55.8 37.4 61.2 19.8 63.6 46.1 13.7 56.9 29.2 37.7 90.6 52.5 54.1 49.3 66.0 70.9 71.7 101.6 81.2 58.5 68.2 66.1 2.9 3.2 5.4 5.4 2.8 2.6 3.2 4.3 4.4 2.2 4.1 3.1 4.0 7.4 2.2 2.2 5.6 4.2 2.7 99.8 101.2 82.0 136.6 114.3 84.8 84.6 88.6 101.0 87.6 80.2 90.6 93.7 13.5 0.0 16.0 8.1 12.2 31.6 10.5 13.2 23.3 16.6 16.4 12.6 23.6 11.5 10.2 25.8 0.0 14.0 17.7 23.2 11.7 13.5 103.4 9.2 12.4 14.7 10.8 8.2 7.5 16.7 15.8 13.6 14.8 13.6 21.0 18.1 14.6 29.2 12.6 10.1 7.7 16.6 6.1 17.4 10.7 48.0 10.2 12.0 12.4 5.6 15.2 16.1 16.5 7.1 6.7 15.8 16.5 11.7 16.2 11.7 13.3 18.5 8.2 12.3 19.7 14.7 14.2 37.8 13.9 23.0 23.4 12.0 12.2 15.9 19.8 9.6 TKT ENSG00000163931 Transketolase P29401 3 53224712-53256052 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 673.1" "Cell type enhanced" "Detected in all" "Kupffer cells: 696.7;monocytes: 624.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6" "Group enriched" "Detected in all" 9 "dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 150000000 Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 153.6 93.9 79.3 66.8 78.1 673.1 72.5 92.2 82.9 51.4 60.4 70.8 85.0 45.1 19.4 169.9 54.2 98.1 25.3 70.0 103.2 67.9 58.6 94.3 69.8 88.8 86.4 67.2 88.5 155.3 41.7 46.0 61.7 90.1 49.2 49.3 21.9 55.4 51.4 12.9 43.5 58.6 52.1 83.2 100.6 66.6 20.4 87.9 83.7 117.0 15.3 67.9 132.0 86.3 99.1 313.0 1542.9 216.0 241.5 470.8 570.8 439.5 206.2 353.8 348.8 330.8 430.1 779.3 388.5 96.8 302.9 673.3 438.3 377.9 775.8 102.4 131.0 210.3 259.6 1022.2 655.2 573.9 321.4 168.1 416.0 437.5 418.5 213.7 949.2 444.9 323.8 188.3 164.7 144.5 381.6 338.6 358.1 737.1 603.0 367.9 201.1 98.5 726.2 550.3 520.2 139.6 103.7 383.4 605.3 365.1 656.7 188.8 437.4 335.9 107.2 164.2 320.0 401.9 94.5 190.3 235.7 234.4 321.0 203.8 51.5 447.9 274.4 17.8 199.0 22.8 39.7 25.8 20.6 203.8 21.1 26.6 20.7 375.3 30.8 242.6 34.4 36.7 312.4 79.3 78.1 92.2 82.9 70.0 103.2 88.8 86.4 67.2 90.1 83.2 87.9 99.1 79.5 134.6 125.6 46.7 92.1 79.4 384.6 325.3 287.4 41.0 99.3 80.5 14.9 75.8 149.5 62.5 29.2 349.0 69.7 139.1 80.3 197.7 6.5 87.4 79.6 81.8 52.6 150.3 16.9 269.8 249.8 80.2 168.7 95.5 62.7 123.6 75.0 83.4 256.0 37.0 23.9 149.6 142.4 696.7 110.5 8.9 157.2 333.3 76.5 17.8 624.4 88.8 46.4 17.1 39.3 193.6 81.4 106.8 109.4 337.7 141.5 219.1 99.2 46.3 52.6 35.9 102.1 16.8 30.6 409.3 67.1 413.6 78.8 427.2 276.7 413.6 PRKCD ENSG00000163932 "Protein kinase C delta" Q05655 3 53156009-53192717 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 7 "dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 267.7;THP-1: 194.0" "Group enriched" "Detected in all" 5 "basal ganglia: 121.4;thalamus: 334.6" "Low region specificity" "Detected in all" "HPA001863, HPA001890, CAB010469, CAB013225" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 30000 Cytosol "Endoplasmic reticulum, Golgi apparatus" "CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628" "unprognostic (3.59e-1)" "unprognostic (4.85e-2)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.24e-4)" "prognostic favorable (9.01e-4)" "unprognostic (1.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.89e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (2.48e-2)" "unprognostic (2.06e-3)" "unprognostic (2.95e-3)" 46.5 60.3 10.4 45.8 11.3 91.2 29.1 4.8 10.5 26.1 10.0 43.9 55.3 9.2 39.5 32.9 42.7 33.1 16.6 12.4 9.7 25.9 8.9 44.7 47.2 9.0 8.0 11.0 13.7 33.5 20.9 8.2 20.7 8.7 39.7 41.9 2.2 26.1 32.2 6.8 32.8 56.1 16.4 11.3 54.6 65.6 21.0 6.9 16.5 42.1 9.3 62.6 44.6 23.4 9.1 33.5 14.4 5.2 8.7 35.9 21.6 46.2 20.4 25.7 24.5 23.7 34.4 31.9 86.5 8.3 45.6 42.9 14.5 34.1 49.8 20.6 75.2 23.6 50.1 18.3 32.0 23.6 64.8 103.4 17.1 35.8 25.6 23.2 21.8 22.4 9.3 9.7 11.8 36.1 85.0 7.0 81.0 13.0 51.5 23.0 7.6 13.6 20.6 25.5 72.8 8.3 6.5 15.4 267.7 39.6 24.0 22.6 194.0 31.5 11.7 14.4 15.4 19.2 18.1 33.6 45.9 27.6 116.4 22.6 51.8 73.7 50.1 3.6 71.3 2.2 6.2 2.1 2.5 57.0 8.2 2.2 2.0 52.9 6.9 47.7 16.3 2.6 24.1 10.4 11.3 4.8 10.5 12.4 9.7 9.0 8.0 11.0 8.7 11.3 6.9 9.1 4.3 3.2 23.5 2.0 25.7 29.2 26.3 8.0 23.9 0.3 11.8 4.3 6.4 14.3 16.1 14.7 0.0 3.1 24.7 61.8 3.9 8.9 34.5 18.5 4.4 2.7 26.5 5.2 3.4 10.7 16.0 6.7 54.0 17.8 5.7 8.9 3.3 2.3 44.8 1.7 4.2 37.1 4.1 47.4 43.0 75.6 9.0 41.5 10.6 20.6 44.9 2.0 8.2 1.0 0.5 13.2 55.4 6.8 25.8 19.7 64.5 13.1 16.5 0.2 6.6 6.5 12.1 23.1 3.7 23.9 27.8 8.8 10.0 10.4 23.0 34.6 RFT1 CDG1N ENSG00000163933 "RFT1 homolog" Q96AA3 3 53088483-53130453 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060327, HPA069022" Approved Approved Vesicles NA NA Vesicles "HPA060327: AB_2684253, HPA069022: AB_2732126" "unprognostic (5.74e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (5.16e-3)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.09e-1)" "unprognostic (1.22e-1)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.48e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (3.54e-2)" 11.9 12.6 5.4 14.6 6.2 8.4 12.6 5.6 6.7 8.9 5.1 11.9 10.4 9.2 13.1 12.2 12.5 10.5 9.1 6.1 6.2 8.8 14.1 9.3 16.9 5.6 5.4 6.3 12.6 22.5 15.7 6.2 13.9 6.0 9.3 13.4 4.4 18.2 10.5 5.2 9.8 10.6 11.3 5.6 10.0 10.5 13.7 5.5 14.4 14.7 6.8 16.0 12.7 8.8 8.1 39.1 36.3 24.3 39.0 27.9 29.5 50.6 34.8 32.3 59.2 53.7 35.9 74.6 51.0 21.3 33.5 55.6 40.7 55.4 56.8 51.9 48.4 24.5 50.6 24.8 36.0 48.8 46.7 28.4 31.4 46.8 79.6 57.1 26.2 37.9 52.7 27.1 45.2 39.4 39.6 44.2 27.3 48.8 67.5 47.3 18.1 23.5 77.5 32.8 26.1 13.8 18.7 43.0 30.9 31.2 26.2 23.3 65.5 25.5 54.3 35.2 37.7 69.1 28.6 37.1 38.4 38.9 58.8 58.3 50.2 40.2 18.4 22.2 40.5 22.5 21.2 20.6 22.9 42.9 35.5 23.7 23.7 13.4 23.1 29.4 48.9 20.1 25.7 5.4 6.2 5.6 6.7 6.1 6.2 5.6 5.4 6.3 6.0 5.6 5.5 8.1 6.0 3.2 3.7 8.8 8.7 5.0 10.8 18.3 5.2 4.6 7.6 5.5 7.4 11.5 12.6 9.2 4.2 39.4 6.0 5.1 1.9 17.4 1.9 5.6 9.5 8.1 2.4 17.7 9.4 21.1 33.1 9.2 4.1 5.7 2.5 17.8 10.4 10.7 22.0 5.0 8.9 6.4 10.2 9.9 5.0 2.3 8.7 9.8 7.2 9.4 11.7 5.8 3.1 7.5 11.3 12.2 8.8 6.0 19.3 9.1 5.7 5.6 8.3 6.4 0.0 7.0 8.7 10.1 8.9 8.0 4.3 24.2 7.7 22.0 11.7 8.1 SFMBT1 "DKFZp434L243, RU1, SFMBT" ENSG00000163935 "Scm like with four mbt domains 1" Q9UHJ3 3 52903572-53046750 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.0" "Cell type enhanced" "Detected in many" "Spermatocytes: 136.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036152, HPA064564" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036152: AB_2674972, HPA064564: AB_2685288" "unprognostic (2.78e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.69e-1)" "unprognostic (2.71e-2)" "unprognostic (1.28e-2)" "unprognostic (9.39e-2)" "unprognostic (6.79e-2)" "unprognostic (3.55e-2)" "unprognostic (2.36e-1)" "unprognostic (2.57e-2)" "unprognostic (3.57e-3)" "unprognostic (7.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (3.55e-2)" 3.2 2.5 2.6 5.6 3.2 6.9 5.8 5.4 3.3 3.6 3.7 7.4 4.8 2.4 5.1 6.6 5.4 3.6 7.3 2.9 3.8 6.4 7.9 4.2 7.6 3.0 3.0 2.0 1.4 9.1 12.0 5.3 4.7 3.1 3.7 7.7 6.4 7.5 2.8 13.1 5.2 5.3 3.5 2.7 4.0 6.4 46.0 3.0 5.2 5.9 8.8 8.6 5.1 3.1 3.4 25.6 6.8 10.9 19.8 2.3 1.7 22.3 5.5 5.2 16.3 20.1 14.1 21.5 13.2 6.3 3.4 17.8 2.1 11.0 7.0 19.7 23.8 6.9 11.0 14.9 6.4 3.7 17.4 10.9 1.6 10.1 11.2 7.5 1.8 3.0 14.8 3.8 18.9 5.4 8.0 11.1 7.0 5.7 9.7 7.2 9.8 10.2 7.3 2.2 27.1 12.8 8.1 23.6 9.6 11.8 1.2 6.3 16.0 1.9 7.2 16.2 12.5 17.2 9.0 34.1 27.3 6.6 7.1 12.4 1.3 1.5 9.1 2.5 0.7 3.3 6.2 3.9 2.3 0.6 5.2 3.6 4.0 2.4 2.9 0.7 0.7 1.9 1.9 2.6 3.2 5.4 3.3 2.9 3.8 3.0 3.0 2.0 3.1 2.7 3.0 3.4 2.5 9.6 9.4 42.7 22.7 11.6 8.6 5.1 9.6 15.4 11.7 6.2 17.0 10.0 6.0 1.8 45.9 10.0 7.3 11.0 7.9 8.2 56.2 5.1 3.5 4.1 6.0 16.0 37.1 13.4 8.7 6.2 10.7 5.1 8.9 8.2 3.6 16.8 6.5 8.4 47.3 8.3 0.0 6.7 7.9 58.5 2.1 6.9 0.0 46.9 3.6 6.2 17.5 60.3 41.8 9.4 6.9 7.5 11.5 9.1 6.0 7.6 11.1 23.2 6.6 5.2 4.2 136.6 27.0 9.8 8.7 5.3 14.4 8.4 12.2 5.3 GNL3 "C77032, E2IG3, MGC800, NS" ENSG00000163938 "G protein nucleolar 3" Q9BVP2 3 52681156-52694497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020770, HPA036742, HPA036743" Enhanced Enhanced "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No 13000 "Nucleoli rim" "Nuclear bodies, Mitotic chromosome" "CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283" "unprognostic (4.40e-1)" "unprognostic (9.30e-2)" "unprognostic (4.10e-3)" "unprognostic (2.21e-1)" "unprognostic (5.11e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.46e-1)" "unprognostic (3.29e-3)" "unprognostic (1.14e-2)" "unprognostic (1.67e-3)" "prognostic unfavorable (6.11e-4)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.33e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-3)" "unprognostic (1.06e-2)" 41.7 47.6 17.7 42.5 17.8 27.6 69.5 19.0 24.6 39.1 19.0 40.3 39.1 34.1 25.8 65.6 28.4 28.3 29.7 18.5 18.7 22.1 50.7 30.0 51.9 18.5 18.3 17.1 36.1 61.2 27.3 36.1 36.7 19.1 47.2 46.4 16.2 46.8 26.6 78.9 38.5 29.8 32.5 18.3 34.3 41.4 27.1 18.5 36.2 28.9 43.3 65.4 93.1 41.6 21.3 110.4 79.1 114.4 125.3 105.6 105.1 178.1 133.0 101.5 135.4 100.6 121.3 80.8 255.4 42.2 100.1 104.6 78.2 189.1 125.1 180.5 156.3 134.6 196.8 139.0 189.3 218.1 283.7 138.0 96.1 216.5 147.8 224.1 90.3 107.8 99.7 214.8 136.2 93.8 77.7 170.6 162.1 195.6 153.4 151.2 99.3 93.0 315.0 108.9 153.9 81.4 105.6 82.1 190.5 193.6 101.7 74.7 155.8 86.6 92.8 100.0 139.2 281.7 147.6 252.0 387.0 96.9 203.5 148.4 1.2 15.2 3.3 19.9 16.7 34.1 28.7 26.8 24.1 26.1 23.9 30.4 29.4 1.8 26.1 12.9 40.7 18.8 20.2 17.7 17.8 19.0 24.6 18.5 18.7 18.5 18.3 17.1 19.1 18.3 18.5 21.3 34.6 22.4 48.2 5.2 84.3 163.7 146.0 111.9 77.4 19.0 72.6 46.4 51.3 25.8 144.9 12.9 10.4 73.2 78.5 42.8 41.1 105.1 54.4 44.7 76.5 53.4 47.8 51.5 11.6 104.6 117.5 92.9 47.9 53.0 63.1 47.5 23.2 41.9 40.9 21.9 11.1 71.7 67.1 24.2 77.6 28.2 51.9 43.0 78.2 5.6 59.5 17.7 38.1 7.1 9.4 99.9 34.4 34.3 122.3 126.1 19.1 47.2 56.5 14.8 6.6 106.2 79.1 37.9 74.4 59.4 153.7 90.3 63.0 74.5 85.8 135.7 PBRM1 "BAF180, PB1" ENSG00000163939 "Polybromo 1" Q86U86 3 52545352-52685917 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015629, HPA059373" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015629: AB_1855012, HPA059373: AB_2683994" "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-2)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (1.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.89e-3)" "unprognostic (3.06e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-2)" "unprognostic (1.06e-1)" 21.6 13.0 8.4 21.0 10.6 24.8 16.7 17.8 8.3 21.3 12.0 18.1 15.5 22.4 16.5 22.7 19.6 17.0 18.7 5.2 10.5 11.3 18.4 17.8 22.3 9.8 8.9 4.1 29.7 12.1 14.4 8.7 21.1 11.2 18.8 18.7 20.4 13.3 17.6 15.6 17.4 14.4 25.6 7.9 19.1 16.1 14.2 9.1 42.4 26.9 23.0 22.2 20.2 12.1 19.2 32.5 20.5 71.9 35.4 34.7 35.0 50.4 44.5 29.9 49.5 43.0 23.3 21.5 78.7 6.2 51.8 40.8 21.8 63.1 33.1 59.6 85.5 34.6 74.6 38.1 18.1 49.6 62.7 54.6 33.2 37.3 55.4 35.4 38.9 48.4 60.6 43.7 41.7 50.3 11.0 103.9 18.8 43.8 22.0 34.4 53.8 45.1 40.1 20.4 62.5 48.7 53.8 52.7 12.4 41.6 43.4 23.4 35.7 56.5 46.1 34.8 40.1 54.4 30.0 51.3 73.6 28.5 49.8 46.9 9.0 4.0 9.9 3.6 2.6 3.8 2.9 3.6 4.0 4.0 5.3 5.7 3.6 2.3 3.6 8.0 8.7 3.9 1.6 8.4 10.6 17.8 8.3 5.2 10.5 9.8 8.9 4.1 11.2 7.9 9.1 19.2 49.1 41.7 61.3 95.3 44.0 40.5 35.8 28.3 43.9 45.6 40.7 30.4 61.7 30.0 39.8 23.9 47.9 36.0 67.7 36.8 19.6 37.7 39.1 61.4 54.5 47.7 35.2 82.9 76.4 46.2 36.9 39.8 42.8 46.8 29.1 61.9 33.5 47.9 53.0 30.3 84.5 35.3 28.5 61.7 47.7 17.1 34.2 65.6 48.0 80.6 67.6 29.1 49.4 87.9 135.5 49.7 29.2 58.3 76.9 37.5 18.7 18.4 58.2 44.3 26.3 54.3 69.2 48.6 35.8 43.7 51.6 50.9 50.4 45.8 39.8 37.0 UVSSA KIAA1530 ENSG00000163945 "UV stimulated scaffold protein A" Q2YD98 4 1345691-1395989 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050824, HPA053496" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050824: AB_2681251, HPA053496: AB_2682170" "unprognostic (6.40e-3)" "unprognostic (4.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-2)" "unprognostic (1.67e-1)" "unprognostic (3.85e-4)" "unprognostic (1.89e-1)" "unprognostic (4.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.88e-2)" "unprognostic (2.12e-3)" "unprognostic (3.92e-3)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.76e-3)" "unprognostic (5.19e-2)" "unprognostic (1.02e-2)" "prognostic favorable (6.87e-4)" 4.1 4.3 2.9 5.6 3.8 8.1 4.5 3.1 4.1 4.5 4.5 4.7 5.5 5.0 6.0 4.2 6.5 3.5 2.9 2.8 2.9 3.2 3.9 6.0 3.9 5.1 3.2 1.7 5.6 6.8 2.6 9.4 2.9 4.7 4.1 3.5 4.7 5.7 2.7 4.7 9.3 5.4 2.6 2.8 5.6 5.6 9.5 4.3 3.8 7.1 1.5 3.5 4.7 4.5 7.3 3.7 4.1 6.1 5.7 7.0 9.0 4.6 3.4 2.9 3.0 2.6 3.4 7.5 2.7 6.5 3.4 7.9 4.4 3.8 3.9 2.6 3.7 1.6 6.4 7.9 4.0 2.7 3.9 7.6 2.6 7.8 3.4 4.4 3.4 5.0 4.6 6.2 8.9 3.7 2.1 5.8 8.1 6.0 2.9 5.2 5.0 3.1 3.4 2.7 5.4 4.4 5.8 2.6 3.0 3.8 5.3 8.0 2.2 9.5 11.4 2.8 4.2 5.9 13.4 9.0 6.1 8.5 4.4 6.9 0.1 0.6 0.9 0.6 0.5 0.3 0.4 0.5 0.5 1.0 0.4 0.4 0.3 1.0 3.3 0.8 0.8 0.2 0.5 2.9 3.8 3.1 4.1 2.8 2.9 5.1 3.2 1.7 4.7 2.8 4.3 7.3 20.7 6.4 26.2 16.3 11.5 5.5 5.2 3.4 5.7 18.2 13.7 10.7 3.6 7.2 8.8 16.5 41.7 3.4 17.1 10.3 3.9 8.0 7.6 23.7 23.1 9.1 6.0 7.4 6.9 8.5 2.9 10.3 21.9 20.1 8.8 16.7 5.3 12.5 6.8 30.3 9.3 10.9 8.2 10.8 6.3 7.3 5.3 13.4 5.4 14.0 7.6 9.0 7.2 5.5 16.5 10.1 6.7 3.8 12.6 5.0 10.7 4.8 23.6 25.3 0.0 13.1 11.4 23.2 9.4 8.0 6.1 3.7 12.0 12.8 6.5 4.5 TASOR "C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1" ENSG00000163946 "Transcription activation suppressor" Q9UK61 3 56620133-56683237 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006735, HPA017142" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006735: AB_1852384, HPA017142: AB_1852382" "unprognostic (1.46e-1)" "unprognostic (7.97e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (2.30e-3)" "unprognostic (9.31e-2)" "unprognostic (3.91e-2)" "unprognostic (5.93e-2)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-1)" "unprognostic (2.74e-1)" 9.6 8.5 3.9 15.6 7.3 11.9 11.5 8.4 4.5 12.1 1.9 11.8 10.1 12.5 7.5 11.2 13.3 11.8 6.2 1.8 3.2 10.3 7.9 11.4 20.8 4.6 5.3 0.8 14.3 12.6 21.3 4.5 9.5 6.5 9.4 12.5 10.0 9.0 9.5 2.7 7.1 11.4 12.4 6.3 14.8 12.9 29.4 4.7 21.5 18.9 7.0 19.5 12.6 3.9 11.6 49.2 19.2 29.2 23.0 15.5 26.7 14.6 21.4 22.0 20.1 21.1 15.8 35.8 77.3 7.9 21.6 33.9 19.1 29.3 25.1 29.2 38.3 14.8 30.4 27.3 7.1 10.9 32.2 46.1 12.9 20.6 19.6 35.1 23.7 26.5 28.8 29.8 43.3 26.0 17.3 39.8 6.4 16.3 25.9 29.0 20.9 28.9 25.9 19.0 35.5 19.3 23.9 46.9 18.5 23.2 16.6 30.6 36.7 28.6 25.9 23.7 23.8 33.1 39.2 58.5 38.6 30.1 46.7 35.0 0.6 0.8 1.1 1.2 0.6 0.7 0.7 1.0 1.2 1.0 1.1 1.1 1.2 0.2 0.9 0.7 0.7 1.0 0.6 3.9 7.3 8.4 4.5 1.8 3.2 4.6 5.3 0.8 6.5 6.3 4.7 11.6 25.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 14.5 12.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 9.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 9.2 2.1 0.0 0.0 0.0 ARHGEF3 "DKFZP434F2429, GEF3, STA3, XPLN" ENSG00000163947 "Rho guanine nucleotide exchange factor 3" Q9NR81 3 56727418-57079329 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 157.8;NK-cells: 137.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 88.8;RPMI-8226: 92.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034715, HPA064945" Uncertain Approved Cytosol NA NA Cytosol "HPA034715: AB_10600780, HPA064945: AB_2685389" "unprognostic (1.84e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "prognostic favorable (2.17e-4)" "unprognostic (8.25e-2)" "prognostic favorable (2.61e-4)" "unprognostic (9.42e-2)" "unprognostic (3.83e-2)" "unprognostic (9.67e-2)" "unprognostic (7.44e-2)" "unprognostic (6.90e-2)" "unprognostic (4.99e-2)" "prognostic favorable (1.96e-7)" "unprognostic (8.24e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-2)" 16.2 43.6 10.7 20.8 15.1 9.9 13.9 14.6 17.8 16.1 26.3 11.8 6.5 38.3 12.6 19.1 23.4 22.5 12.8 24.8 34.4 25.5 5.2 25.1 29.5 12.4 10.5 12.1 20.8 29.4 52.7 21.7 21.5 12.3 14.9 13.6 8.3 21.7 15.5 8.1 12.7 9.7 34.8 8.9 21.7 16.0 14.4 11.8 36.4 14.4 8.6 28.9 17.3 11.7 13.4 24.2 8.4 1.2 7.7 2.7 2.2 16.5 2.6 2.2 2.6 3.4 4.1 22.3 12.6 2.5 4.7 25.3 12.1 7.2 30.8 3.0 18.4 3.5 10.3 5.2 88.8 6.6 0.0 10.9 9.7 19.9 2.3 3.5 23.6 25.5 13.3 2.9 27.2 5.9 3.7 34.8 1.3 2.3 19.5 12.9 0.2 9.2 92.2 19.8 13.2 1.4 3.8 15.3 11.2 6.9 8.5 2.9 10.6 11.8 1.3 6.0 5.4 4.0 35.0 14.2 45.1 21.7 12.2 10.9 20.6 23.0 3.7 96.1 25.5 72.5 26.0 73.6 85.0 13.9 16.9 59.3 73.5 8.3 39.7 32.2 5.9 67.4 76.0 10.7 15.1 14.6 17.8 24.8 34.4 12.4 10.5 12.1 12.3 8.9 11.8 13.4 22.7 16.0 22.4 30.0 24.2 11.1 8.6 16.3 32.5 9.5 7.6 9.9 9.8 2.8 12.6 23.9 4.2 11.4 57.5 4.8 11.7 11.0 22.6 10.1 7.0 40.3 9.6 14.1 157.8 10.2 7.9 13.5 36.2 16.5 13.9 4.8 22.9 0.1 7.6 0.0 70.8 1.3 2.0 38.1 8.2 14.1 17.7 18.7 10.6 63.7 19.9 9.0 137.0 68.3 80.0 7.5 1.4 24.0 22.1 11.2 0.2 7.3 9.5 1.2 0.0 8.0 4.4 3.3 2.6 37.9 14.9 11.9 64.3 3.2 3.2 13.4 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692731-1712344 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 263.6;Spermatogonia: 294.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 29.7 26.6 42.6 38.0 43.2 115.2 26.9 40.9 56.3 26.2 39.2 30.8 24.2 27.5 33.2 36.2 27.8 22.1 17.7 49.7 44.3 32.6 34.2 27.4 72.3 41.3 40.0 42.5 28.2 24.6 24.2 26.9 42.3 41.0 23.0 30.9 17.2 25.8 25.6 22.8 37.5 25.8 29.0 41.3 28.5 27.1 63.6 43.1 54.0 27.5 19.4 70.1 35.3 28.3 47.2 132.7 53.9 76.6 80.7 65.3 70.0 81.9 120.1 92.5 131.4 133.8 120.3 144.7 180.6 67.4 96.0 150.9 77.8 147.0 103.0 154.1 75.4 98.5 215.9 63.3 123.6 82.6 208.3 102.8 55.0 84.7 98.1 67.3 74.4 76.5 108.8 172.7 170.3 163.2 52.8 314.6 200.6 97.4 136.7 108.6 241.1 126.3 105.3 131.0 99.5 86.1 69.3 95.4 59.6 69.5 96.8 99.0 127.7 66.3 108.0 63.8 116.1 180.4 107.4 192.2 428.3 99.6 176.0 106.0 25.7 65.4 47.5 47.1 49.7 43.3 51.6 59.7 64.8 50.6 37.8 50.6 49.6 95.8 46.3 44.8 42.2 77.9 75.4 42.6 43.2 40.9 56.3 49.7 44.3 41.3 40.0 42.5 41.0 41.3 43.1 47.2 35.2 16.0 18.8 7.2 96.3 105.2 96.3 38.8 61.5 19.4 35.9 34.0 8.2 27.1 23.6 36.8 25.0 166.3 80.5 28.8 107.6 50.6 75.9 38.8 34.9 36.1 35.9 146.0 14.6 31.3 51.8 49.1 53.5 55.5 23.5 45.9 30.0 27.0 81.3 25.2 15.1 33.6 44.7 36.8 58.6 41.6 44.1 60.3 65.8 6.5 64.4 27.4 43.3 9.0 14.4 38.7 25.3 44.0 94.2 88.6 22.5 55.4 16.3 13.6 13.1 46.3 43.8 263.6 294.0 84.1 105.8 44.7 96.6 33.2 44.1 76.5 LRPAP1 "A2MRAP, HBP44, RAP" ENSG00000163956 "LDL receptor related protein associated protein 1" P30533 4 3503612-3532446 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 584.3;Syncytiotrophoblasts: 693.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008001, CAB025518" Enhanced Supported Supported "Endoplasmic reticulum" NA NA 810000 "Endoplasmic reticulum" "CAB025518: , HPA008001: AB_1853292" "unprognostic (3.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.30e-1)" "unprognostic (2.22e-2)" "unprognostic (1.37e-2)" "unprognostic (9.61e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (8.58e-2)" "unprognostic (6.12e-2)" "unprognostic (2.14e-3)" "unprognostic (2.19e-1)" "prognostic favorable (4.67e-11)" "unprognostic (6.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.58e-1)" "unprognostic (5.61e-2)" 6.3 9.1 6.1 2.6 9.0 6.1 6.4 8.0 7.6 8.4 8.9 7.5 3.4 8.7 3.2 5.9 7.6 2.0 18.3 5.3 7.0 12.7 9.7 8.5 2.1 7.5 6.6 5.6 9.6 14.5 7.8 14.5 6.3 7.0 8.3 1.8 2.8 10.2 4.2 9.0 6.4 6.7 2.0 4.8 8.7 9.3 9.2 6.8 1.7 9.0 2.4 1.4 7.3 6.4 7.1 3.7 7.4 5.7 8.2 5.5 2.9 12.5 5.9 4.8 4.3 3.1 14.9 7.0 2.1 6.0 4.2 7.0 6.2 3.4 5.8 2.4 1.6 7.9 2.9 7.8 10.4 4.2 4.7 12.5 4.0 4.3 3.9 1.9 4.7 5.2 3.9 5.1 7.0 3.6 5.9 3.1 18.4 4.9 5.1 7.8 4.3 4.2 7.1 4.8 8.6 5.6 4.6 7.4 3.0 8.1 3.4 6.7 8.6 5.6 5.1 4.7 4.1 8.2 4.2 2.9 2.8 5.9 13.3 7.2 21.9 23.2 60.1 9.3 19.7 8.1 9.9 8.6 8.8 13.3 10.0 9.4 8.6 20.5 11.7 19.1 10.2 11.5 27.3 6.1 9.0 8.0 7.6 5.3 7.0 7.5 6.6 5.6 7.0 4.8 6.8 7.1 95.0 109.0 90.9 21.2 78.0 67.8 174.6 267.7 52.9 70.6 75.3 84.2 165.9 108.7 158.7 195.0 45.9 584.3 75.8 147.7 50.9 159.3 40.4 85.5 229.6 88.2 82.6 35.7 22.5 107.9 184.0 152.5 79.0 71.2 81.1 102.3 62.4 92.6 243.1 38.7 20.6 121.6 164.8 100.5 80.2 60.0 126.2 154.2 147.7 16.9 107.1 140.0 91.6 28.1 16.7 95.4 153.4 151.6 205.2 124.5 204.6 273.7 144.8 86.2 78.9 82.8 108.1 272.5 161.4 40.7 61.4 693.5 86.0 99.9 109.9 140.5 ZDHHC19 MGC33345 ENSG00000163958 "Zinc finger DHHC-type palmitoyltransferase 19" Q8WVZ1 3 196197452-196211437 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 50.5" "Group enriched" "Detected in some" 17 "Early spermatids: 332.1;Late spermatids: 810.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "eosinophil: 1.2;memory B-cell: 2.5;naive B-cell: 2.4;neutrophil: 1.5" "Group enriched" "Detected in many" 20 "B-cells: 2.5;granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (7.50e-4)" "unprognostic (2.87e-3)" "unprognostic (6.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (3.66e-3)" "unprognostic (4.63e-2)" "unprognostic (6.52e-2)" "unprognostic (2.86e-2)" "unprognostic (3.46e-7)" "unprognostic (8.05e-4)" "unprognostic (4.71e-1)" "unprognostic (7.08e-3)" "unprognostic (4.28e-2)" 0.0 0.8 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.6 0.3 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 50.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 5.3 0.3 0.1 0.0 0.0 0.2 0.0 0.4 0.4 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 332.1 0.1 0.1 0.6 0.0 0.0 0.9 0.0 0.5 0.5 0.0 0.1 0.0 9.7 0.0 3.6 1.4 0.0 0.8 0.0 0.0 1.0 0.4 810.2 16.4 1.2 0.0 2.8 0.1 0.3 0.0 0.5 0.1 0.0 0.0 32.0 0.0 0.0 0.1 0.8 0.8 0.1 0.0 0.0 0.8 5.5 3.3 0.0 0.0 2.5 0.3 6.5 0.0 0.0 SLC51A OSTalpha ENSG00000163959 "Solute carrier family 51 subunit alpha" Q86UW1 3 196211487-196243178 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "intestine: 65.1;liver: 71.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7" "Cancer enriched" "Detected in many" 7 "liver cancer: 15.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.9;U-266/84: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045488 Enhanced NA NA "HPA045488: " "unprognostic (1.63e-2)" "unprognostic (1.27e-3)" "unprognostic (2.80e-1)" "unprognostic (7.66e-2)" "unprognostic (5.16e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.02e-2)" "unprognostic (1.07e-1)" "unprognostic (5.98e-3)" "unprognostic (5.41e-2)" "unprognostic (2.90e-2)" "unprognostic (2.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-5)" 1.3 5.2 0.3 1.3 0.3 6.0 1.2 0.1 0.7 1.5 0.0 10.4 30.7 0.8 0.8 1.5 1.6 0.6 1.1 0.3 0.4 5.5 71.9 2.0 0.6 0.3 0.1 0.1 1.4 0.9 2.7 1.2 0.2 0.3 1.1 0.7 0.7 1.2 0.0 1.6 2.4 65.1 0.2 0.1 1.8 0.9 4.1 0.6 0.1 1.5 0.0 0.5 1.0 1.8 0.5 0.5 0.7 0.6 0.7 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.5 0.0 0.4 0.0 0.0 0.0 0.3 1.3 0.5 0.4 0.8 0.1 0.6 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 1.5 0.0 0.3 0.0 0.6 0.0 0.1 0.9 3.9 0.0 0.2 0.0 0.4 0.1 0.2 0.2 1.4 0.1 0.1 1.1 0.2 0.2 0.7 0.3 0.6 0.4 1.5 2.0 0.2 0.5 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.7 0.3 0.4 0.3 0.1 0.1 0.3 0.1 0.6 0.5 1.1 0.0 0.5 0.3 1.0 3.3 2.5 10.9 0.0 0.5 0.6 0.3 4.1 1.5 18.2 0.0 4.2 0.7 3.0 43.5 3.9 0.2 20.7 2.7 1.6 1.6 0.0 2.7 1.0 0.2 0.4 2.4 0.0 1.6 0.0 2.3 3.9 49.1 0.6 1.7 0.7 8.4 22.4 4.4 7.3 12.9 61.5 1.3 3.6 1.0 0.8 0.4 1.0 0.5 0.2 0.1 12.1 101.5 0.8 1.5 271.8 11.5 18.0 1.1 144.7 2.3 2.6 2.4 1.3 0.0 2.6 1.0 3.0 13.6 11.8 2.8 UBXN7 "KIAA0794, UBXD7" ENSG00000163960 "UBX domain protein 7" O94888 3 196347662-196432430 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048441, HPA049442" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA048441: AB_2680394, HPA049442: AB_2680769" "unprognostic (8.36e-3)" "unprognostic (4.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-3)" "unprognostic (1.05e-1)" "unprognostic (6.64e-2)" "unprognostic (5.12e-3)" "unprognostic (1.49e-1)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (2.11e-2)" "unprognostic (2.91e-2)" "unprognostic (2.52e-2)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" 6.2 7.6 6.8 7.6 7.4 21.9 8.3 17.7 7.6 8.4 7.4 7.0 5.6 10.2 8.2 6.6 8.5 5.7 5.0 5.6 8.5 6.8 6.4 6.8 9.1 6.9 6.9 5.0 12.9 7.5 10.9 7.4 9.6 7.1 7.4 6.9 18.2 6.7 6.7 5.1 10.8 6.4 8.0 6.1 8.9 6.6 12.0 7.2 14.1 8.2 7.1 8.8 6.2 7.1 11.3 25.2 7.7 29.8 15.8 15.2 26.6 13.0 20.3 13.4 11.4 10.4 19.9 10.5 23.0 41.6 13.7 15.4 20.0 22.5 12.0 21.2 9.5 13.8 36.9 16.5 11.3 11.6 18.8 11.5 16.0 13.5 16.0 20.0 20.4 18.7 17.2 17.8 15.5 13.5 10.8 19.6 9.9 17.3 10.2 9.7 22.7 22.3 15.8 9.4 10.9 20.0 15.4 32.6 9.0 15.7 23.7 24.2 15.7 23.5 13.0 11.6 11.8 21.7 21.6 31.3 33.5 12.0 21.0 9.9 9.9 4.7 7.0 4.4 3.7 4.0 6.9 3.8 2.9 5.0 5.9 6.5 5.9 8.4 6.2 5.4 2.2 6.6 2.5 6.8 7.4 17.7 7.6 5.6 8.5 6.9 6.9 5.0 7.1 6.1 7.2 11.3 27.1 44.8 18.8 29.7 31.4 47.3 14.3 16.2 40.5 38.0 22.2 16.0 16.8 12.8 21.1 20.2 70.9 18.0 32.9 14.8 5.9 10.8 38.3 47.8 46.3 27.8 46.5 34.0 35.3 10.0 10.5 30.7 18.8 35.1 8.8 46.0 21.8 12.0 12.5 32.0 41.3 15.9 12.2 25.4 41.0 24.7 29.8 24.7 23.2 27.2 28.4 21.5 33.0 36.7 47.8 12.2 11.8 28.2 34.3 31.7 13.3 11.7 30.5 46.5 32.9 37.3 25.6 34.7 23.8 38.6 54.7 18.9 29.8 33.2 15.8 25.3 RNF168 FLJ35794 ENSG00000163961 "Ring finger protein 168" Q8IYW5 3 196468783-196503768 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 199.9;Late spermatids: 459.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046109 Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046109: AB_2679540" "unprognostic (6.15e-3)" "prognostic favorable (8.21e-4)" "unprognostic (3.11e-1)" "unprognostic (1.11e-2)" "unprognostic (4.22e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (6.81e-3)" "unprognostic (5.30e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (4.83e-3)" "unprognostic (2.80e-3)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.95e-2)" "unprognostic (6.65e-2)" 7.8 4.9 4.8 6.0 4.7 20.8 6.9 6.1 5.1 7.9 5.1 5.9 6.2 6.1 4.1 8.0 5.9 4.6 6.7 3.9 5.6 3.8 10.5 8.2 7.3 6.6 6.1 3.3 7.4 4.8 4.0 3.5 5.5 7.0 5.4 5.7 4.9 5.9 4.1 13.2 11.5 5.7 5.3 5.3 6.9 5.9 10.8 6.0 7.8 4.9 8.3 8.7 6.8 9.4 6.8 21.6 8.5 14.8 19.5 13.6 9.8 21.1 12.9 8.1 8.5 13.3 16.6 10.4 22.7 29.1 10.8 11.9 21.3 21.0 15.4 13.0 10.9 10.3 43.0 22.2 20.7 7.0 13.3 10.3 9.8 5.8 13.3 11.7 6.0 12.6 18.4 13.1 23.1 8.7 36.4 44.6 7.8 17.6 11.6 10.8 19.7 17.2 18.4 7.2 29.2 12.3 12.4 14.6 17.7 11.1 10.9 26.8 11.7 12.4 14.6 11.4 15.7 17.2 19.6 19.7 33.2 14.3 15.8 11.9 30.0 7.3 8.8 12.2 8.0 10.9 6.3 10.1 8.8 6.6 6.6 8.8 9.4 8.0 8.7 12.2 6.2 7.0 7.5 4.8 4.7 6.1 5.1 3.9 5.6 6.6 6.1 3.3 7.0 5.3 6.0 6.8 34.4 16.0 37.5 16.0 37.7 100.1 49.8 30.8 52.3 36.0 17.3 15.0 21.7 12.8 20.0 14.7 60.5 14.6 76.4 25.3 17.6 14.0 199.9 17.0 20.8 33.3 14.4 14.1 33.5 8.9 26.6 27.9 23.9 24.0 50.1 24.0 24.3 25.9 17.9 15.2 36.0 18.5 28.5 32.4 98.8 459.7 20.2 33.9 26.6 28.1 38.2 12.7 42.2 25.1 27.4 10.5 17.3 20.7 37.9 27.7 11.4 10.3 17.1 39.8 13.1 23.6 25.7 13.8 54.9 55.5 126.6 10.7 63.7 20.3 22.4 50.3 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 87.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 87.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 10.6 10.4 15.3 10.5 16.3 9.1 10.0 16.1 16.8 7.2 18.6 10.9 9.2 8.3 12.5 10.4 7.9 8.3 9.7 15.4 18.6 12.3 8.3 7.2 7.1 15.4 16.0 16.0 6.8 9.1 19.8 12.8 8.4 16.0 12.9 10.2 17.5 10.0 10.6 17.3 10.5 9.2 11.3 16.6 6.9 7.7 6.1 16.5 11.7 9.3 14.2 11.0 8.7 7.7 17.3 39.4 18.7 21.4 18.1 22.7 15.3 12.6 18.1 20.7 19.3 20.5 13.7 25.6 20.3 63.6 15.4 25.1 22.2 19.5 16.6 23.1 18.6 19.6 21.0 12.8 12.6 19.2 20.6 34.6 15.1 25.7 17.1 15.7 16.3 12.7 36.5 11.7 38.6 21.0 30.1 59.2 32.1 12.8 30.7 18.3 31.1 27.6 29.5 24.6 11.5 24.4 29.2 31.8 23.9 29.7 16.9 71.8 20.3 8.2 18.1 9.2 25.6 29.5 57.0 70.4 41.1 20.7 26.9 21.5 39.6 7.5 87.5 3.3 10.8 3.0 4.6 3.1 4.6 7.7 5.5 3.7 3.2 18.8 8.7 11.6 3.3 4.4 4.1 15.3 16.3 16.1 16.8 15.4 18.6 15.4 16.0 16.0 16.0 16.6 16.5 17.3 14.2 19.2 16.3 13.7 16.4 17.1 30.1 5.5 31.9 34.9 28.3 19.2 12.6 21.5 8.4 29.5 47.9 21.4 31.6 20.8 35.2 7.9 30.5 17.2 23.5 16.9 15.7 15.8 17.7 5.6 20.9 22.0 9.2 17.9 12.0 19.3 17.5 16.6 20.1 33.7 23.7 17.0 8.2 21.4 25.4 22.7 28.0 18.1 21.4 15.9 25.0 50.0 32.0 12.1 14.5 5.2 12.5 35.0 20.1 33.8 27.1 32.5 10.2 39.1 26.3 23.6 28.1 27.1 36.0 29.3 15.9 11.6 21.2 22.7 25.7 23.0 MELTF "CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1" ENSG00000163975 Melanotransferrin P08582 3 196988621-197029817 "CD markers, Plasma proteins, Predicted intracellular proteins" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 69.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4" "Cancer enhanced" "Detected in all" "melanoma: 32.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 162.1;SK-MEL-30: 201.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA004880 Approved "Intracellular and membrane" NA NA 41000000 "HPA004880: AB_1853844" "unprognostic (8.68e-3)" "unprognostic (3.68e-2)" "unprognostic (1.75e-2)" "unprognostic (7.68e-3)" "unprognostic (1.06e-2)" "unprognostic (1.08e-2)" "unprognostic (5.53e-2)" "unprognostic (1.64e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-1)" "unprognostic (3.68e-3)" "unprognostic (8.14e-2)" "prognostic unfavorable (6.99e-11)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.09e-2)" 6.8 1.7 2.5 3.8 2.9 2.3 7.5 2.3 11.2 7.3 21.8 3.8 2.5 6.9 0.7 2.9 8.7 1.6 6.0 2.6 2.1 6.6 1.6 1.9 1.9 1.3 3.0 1.8 1.2 4.6 10.4 3.0 1.5 2.9 4.1 2.1 0.3 69.3 5.5 1.1 15.9 9.9 1.2 1.0 1.1 1.7 3.4 5.9 3.0 3.1 1.0 1.6 3.3 7.4 2.1 162.1 34.6 0.4 1.2 4.8 6.0 4.0 2.8 1.5 5.2 6.3 9.8 23.6 4.5 33.3 5.6 4.5 49.6 1.8 0.1 2.3 7.4 10.8 5.6 7.9 4.1 30.5 0.8 30.8 33.0 4.3 4.3 0.4 0.2 0.8 8.9 4.3 30.5 3.1 9.8 9.3 0.0 3.6 6.9 22.5 13.4 5.3 2.0 0.8 1.5 3.1 11.3 32.5 2.8 201.4 3.8 9.5 4.8 1.2 1.2 26.8 5.5 19.9 5.3 46.0 4.5 3.9 9.5 0.2 0.0 0.1 0.0 0.2 0.2 0.8 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 2.5 2.9 2.3 11.2 2.6 2.1 1.3 3.0 1.8 2.9 1.0 5.9 2.1 0.8 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 21.1 20.6 0.0 0.0 1.8 14.7 0.0 0.2 1.0 0.0 0.0 28.3 0.0 3.2 6.1 0.6 0.0 0.0 0.0 5.7 0.3 3.7 0.0 4.4 0.0 3.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 66.4 0.0 0.0 1.7 0.0 0.0 0.5 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 OTOP1 ENSG00000163982 "Otopetrin 1" Q7RTM1 4 4188726-4226929 "Predicted membrane proteins, Transporters" "Biomineralization, Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035599 Uncertain NA NA "HPA035599: AB_10600924" "unprognostic (1.83e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100P ENSG00000163993 "S100 calcium binding protein P" P25815 4 6693878-6697170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 1423.9;stomach 1: 1757.5;urinary bladder: 1794.1" "Cell type enhanced" "Detected in many" "Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 564.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8" "Lineage enriched" "Detected in many" 73 "granulocytes: 2961.8" "Cell line enhanced" "Detected in many" "BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4" "HPA019502, HPA075251" Enhanced Supported Nucleoplasm NA NA 1600000 Nucleoplasm "HPA019502: AB_1856530, HPA075251: " "unprognostic (1.46e-1)" "unprognostic (1.50e-1)" "unprognostic (7.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.22e-1)" "unprognostic (7.34e-2)" "unprognostic (1.60e-3)" "unprognostic (3.92e-2)" "unprognostic (7.19e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.12e-2)" 14.2 1.7 1.1 42.8 1.2 1423.9 7.5 1.7 5.7 15.1 2.1 157.0 13.3 6.0 0.0 343.7 6.9 52.6 2.7 1.4 1.0 2.1 8.8 14.8 1.0 1.2 1.3 0.8 0.5 4.7 0.4 1.7 478.8 3.3 25.7 177.7 0.1 8.3 0.5 0.4 20.2 24.0 16.7 0.8 34.6 1757.5 1.4 1.0 10.7 0.6 12.3 97.7 1794.1 34.8 1.8 115.2 89.1 0.0 0.1 0.0 0.5 879.0 0.0 1.0 0.0 0.0 5.2 17.6 0.7 40.1 0.6 1.2 137.6 0.5 1.1 0.0 54.7 0.0 1.9 106.7 1283.2 0.0 53.4 3.2 0.6 1185.6 0.0 1.1 0.2 0.2 0.8 3.1 0.0 0.0 214.5 1.6 126.5 1.5 4335.4 149.6 0.9 0.5 0.5 0.0 2619.8 1.1 0.7 156.8 1057.4 2.4 39.9 31.0 169.6 0.5 0.0 1.4 0.2 0.9 1.2 0.7 0.8 0.1 479.1 0.2 1789.3 40.6 836.9 1.4 9.5 1.1 0.4 1.7 1.1 1.6 0.5 0.3 0.8 2961.8 0.1 5.7 0.4 1.1 16.7 1.1 1.2 1.7 5.7 1.4 1.0 1.2 1.3 0.8 3.3 0.8 1.0 1.8 0.9 9.6 48.6 0.0 6.2 1.1 318.3 568.6 4.0 0.0 3.4 3.6 1.2 27.1 1088.3 1.8 0.0 550.7 2.2 322.2 0.0 4.8 12.3 37.5 38.9 8.7 16.6 0.0 0.0 31.1 783.4 13.8 2306.9 202.5 31.6 0.0 1.4 7.4 69.2 0.0 0.0 443.7 152.5 11.8 1.0 7.4 0.0 11.0 8.8 0.0 5.6 0.0 2.1 0.0 0.1 828.1 580.9 0.0 5.9 288.4 2.2 0.5 301.5 0.0 0.0 0.1 32.1 0.5 0.6 18.6 6.3 2773.6 9.8 0.1 173.2 4448.3 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 206.5;tongue: 74.1" "Group enriched" "Detected in many" 4 "Excitatory neurons: 93.2;Inhibitory neurons: 67.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 13.8;SiHa: 5.9;U-2197: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 6.4 4.0 3.6 1.6 12.5 0.1 5.1 0.0 9.6 1.7 0.0 2.2 0.5 1.2 0.8 13.2 1.9 1.3 7.2 3.8 7.5 6.8 0.9 3.3 1.0 5.0 1.5 4.4 0.6 3.5 1.3 6.9 0.7 4.3 1.5 1.7 5.0 5.5 0.5 206.5 5.9 1.6 1.9 0.0 20.7 1.4 1.0 2.3 1.7 3.0 74.1 2.2 1.9 4.1 5.4 1.1 0.0 0.2 1.6 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.5 3.1 0.3 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.4 0.0 1.3 0.0 0.7 0.0 0.0 0.1 1.1 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.7 2.1 0.1 0.0 1.2 2.9 0.9 0.2 1.0 0.7 0.2 0.0 13.8 1.0 5.9 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.4 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.6 12.5 0.0 9.6 3.8 7.5 5.0 1.5 4.4 4.3 0.0 2.3 5.4 4.4 0.0 1.1 9.4 0.5 2.5 0.1 0.1 0.6 6.4 0.4 0.3 4.7 1.5 0.3 3.7 0.0 0.0 0.6 7.9 0.0 3.5 2.2 5.2 0.7 3.5 10.7 0.0 93.2 4.3 0.6 0.9 2.6 0.2 2.5 0.5 0.7 0.4 0.1 11.8 67.6 3.8 0.0 0.6 0.7 5.1 0.0 0.3 0.0 2.8 0.0 3.1 0.0 16.1 17.6 3.5 5.1 3.8 0.1 0.3 14.3 0.6 1.7 3.2 6.6 7.0 3.5 0.2 2.0 2.0 6.3 0.0 0.7 4.0 5.8 0.3 EXO5 "C1orf176, DEM1, FLJ21144" ENSG00000164002 "Exonuclease 5" Q9H790 1 40508741-40516556 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 150.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028429 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028429: AB_2092105" "unprognostic (9.44e-2)" "unprognostic (7.36e-2)" "unprognostic (3.69e-2)" "unprognostic (6.65e-2)" "unprognostic (1.66e-1)" "unprognostic (3.23e-2)" "prognostic unfavorable (9.16e-6)" "unprognostic (4.65e-2)" "unprognostic (2.24e-3)" "unprognostic (1.91e-3)" "unprognostic (4.78e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (9.95e-3)" "unprognostic (4.36e-2)" "unprognostic (4.13e-1)" "unprognostic (9.85e-3)" "unprognostic (2.53e-1)" 4.4 4.5 2.4 5.8 3.3 4.8 5.6 4.1 3.0 4.8 2.3 5.0 4.4 6.1 5.3 4.4 5.1 4.2 4.0 2.6 2.6 5.1 6.4 5.3 8.5 2.2 2.3 2.8 4.4 4.2 4.1 3.4 5.1 2.5 5.3 5.1 4.5 4.7 5.6 4.2 5.2 5.6 7.7 2.6 7.1 4.1 4.0 3.1 10.9 4.5 2.5 11.0 4.9 4.2 2.6 14.6 5.2 12.5 21.0 8.3 7.5 8.7 19.4 4.9 17.1 20.5 9.3 17.3 19.6 11.7 12.4 19.4 17.8 12.3 12.9 20.4 6.6 8.0 17.1 24.8 13.0 10.2 0.1 16.4 7.8 8.0 23.6 8.7 5.0 10.9 13.7 20.0 0.1 24.6 6.1 27.4 13.4 19.0 2.4 2.0 20.7 42.6 7.7 8.6 22.3 15.1 13.4 25.0 8.9 15.9 19.1 12.5 150.1 12.3 11.7 35.1 26.5 19.1 5.6 18.7 0.1 1.7 5.3 23.8 8.8 5.9 15.0 12.6 8.7 10.4 10.8 8.7 9.1 7.0 8.4 10.5 10.2 10.5 8.1 6.6 5.8 12.9 6.5 2.4 3.3 4.1 3.0 2.6 2.6 2.2 2.3 2.8 2.5 2.6 3.1 2.6 2.4 0.0 1.7 1.6 3.4 0.9 0.9 5.0 1.8 3.3 2.2 2.7 1.1 7.2 3.1 7.3 4.2 5.0 5.3 2.3 0.0 4.8 1.2 1.0 2.4 3.2 1.2 3.0 3.1 2.4 4.6 2.6 1.1 1.5 5.7 5.8 2.2 3.6 5.2 3.3 2.1 2.2 4.1 2.5 2.4 1.3 3.4 2.0 1.8 3.7 4.8 4.8 4.1 1.5 1.9 2.9 1.9 1.9 3.1 1.0 2.4 2.3 2.5 2.9 6.6 3.2 2.9 6.1 6.3 1.9 1.0 1.9 2.9 3.1 3.0 0.3 CLDN19 ENSG00000164007 "Claudin 19" Q8N6F1 1 42733093-42740254 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "Disease variant, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "choroid plexus: 15.7;kidney: 16.8;placenta: 9.8" "Cell type enriched" "Detected in some" 6 "Extravillous trophoblasts: 221.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5" "Region enhanced" "Detected in many" "olfactory bulb: 5.4" "Region enriched" "Detected in many" 6 "spinal cord: 41.8" NA NA "unprognostic (6.23e-4)" "unprognostic (1.80e-1)" "unprognostic (1.85e-6)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-1)" "unprognostic (9.45e-2)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (7.22e-2)" "unprognostic (8.76e-3)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.29e-3)" 0.4 0.1 0.1 0.0 0.1 0.1 1.2 0.5 0.5 0.0 15.7 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 1.3 0.1 16.8 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 9.8 0.5 0.3 0.0 0.0 0.8 0.8 0.2 0.4 0.1 0.0 0.1 0.0 0.3 0.0 0.1 1.6 0.0 0.9 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.5 1.3 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.2 8.3 0.3 0.0 0.6 12.9 0.0 12.5 0.0 0.0 33.2 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 221.6 0.7 0.0 0.2 0.0 0.0 0.7 0.0 5.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 12.4 0.1 0.2 0.1 0.0 C1orf50 MGC955 ENSG00000164008 "Chromosome 1 open reading frame 50" Q9BV19 1 42767249-42779491 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 67.8;Late spermatids: 201.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030236 Uncertain NA NA "HPA030236: AB_10602110" "unprognostic (1.86e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-1)" "unprognostic (6.35e-3)" "unprognostic (2.86e-1)" "unprognostic (1.29e-1)" "unprognostic (1.76e-3)" "unprognostic (9.15e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (5.63e-2)" "unprognostic (6.53e-3)" "unprognostic (1.72e-2)" "unprognostic (7.90e-3)" "unprognostic (3.64e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.53e-1)" 9.1 11.6 2.8 1.4 2.9 3.9 9.1 2.6 2.6 8.8 1.4 9.4 1.7 6.9 1.7 9.0 7.3 1.1 13.2 2.7 2.8 13.1 17.1 6.5 1.8 2.9 2.7 2.3 10.0 8.8 2.4 12.4 1.5 3.0 9.6 1.6 3.2 7.0 1.4 15.7 8.5 8.5 1.5 2.8 9.3 9.0 15.0 3.0 1.7 7.6 3.4 1.6 9.2 8.7 2.9 1.4 0.6 3.7 3.1 2.3 3.0 2.2 2.2 2.0 2.0 2.0 1.1 1.5 3.5 2.2 3.0 1.0 1.9 2.8 1.6 1.9 4.0 1.7 3.3 2.1 1.6 2.1 3.8 2.7 2.3 2.6 2.2 3.5 2.1 2.0 4.0 3.7 1.8 1.8 1.1 3.7 1.9 3.0 1.6 1.6 3.7 3.5 2.7 1.8 2.4 4.1 2.8 2.9 1.9 2.6 3.2 1.6 3.9 2.0 1.5 1.6 2.7 1.9 2.8 2.8 2.5 1.5 2.7 1.5 1.6 1.1 1.7 1.0 1.1 0.8 1.5 1.0 1.1 1.0 1.1 1.1 1.1 1.1 1.1 2.3 1.8 1.3 1.0 2.8 2.9 2.6 2.6 2.7 2.8 2.9 2.7 2.3 3.0 2.8 3.0 2.9 4.9 0.0 3.7 3.9 17.0 9.2 10.1 28.5 10.8 3.4 5.5 9.8 22.5 8.6 16.0 11.0 2.1 27.9 8.9 13.5 23.5 10.0 67.8 4.1 5.5 9.3 19.2 12.4 9.2 4.0 30.3 10.9 9.2 3.3 10.2 5.7 20.3 29.2 27.4 0.0 8.4 14.3 22.4 20.0 14.7 201.1 13.7 8.7 14.2 5.6 18.0 11.8 17.5 6.0 10.7 7.7 17.5 6.8 16.2 14.1 40.0 21.0 11.0 8.2 6.6 10.8 11.3 43.6 35.5 14.3 7.7 33.8 14.6 7.0 13.1 11.2 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817122-42844991 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 38.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 8.0 9.3 3.9 4.8 4.3 30.7 8.4 4.1 4.6 8.7 4.9 7.4 6.5 6.1 16.0 7.3 10.2 7.6 4.3 3.8 5.7 7.2 13.3 7.2 5.0 5.0 4.3 3.2 5.6 9.5 8.5 5.8 6.0 4.7 7.9 8.2 4.4 8.7 6.3 2.3 9.4 6.2 6.4 4.7 5.3 7.9 4.1 4.4 5.3 13.1 3.6 5.4 5.6 4.0 4.9 5.2 7.1 2.1 7.0 7.7 22.4 2.0 10.5 17.8 9.3 9.3 2.9 9.6 4.6 3.5 11.2 4.4 6.5 2.4 3.2 8.3 7.8 8.2 38.3 5.2 2.3 9.5 5.2 18.8 13.7 11.8 4.3 9.9 16.8 6.1 5.6 26.4 4.7 8.6 3.6 2.3 1.6 5.1 3.3 3.8 2.6 2.8 4.3 8.0 8.1 4.7 3.2 9.0 3.3 4.0 3.7 6.6 19.6 9.6 6.9 3.9 5.9 4.8 1.8 4.4 2.0 5.6 5.8 4.4 0.0 4.3 2.1 1.2 4.5 0.6 1.3 1.2 0.9 5.1 0.7 1.0 1.0 1.3 2.2 3.0 1.0 3.2 1.9 3.9 4.3 4.1 4.6 3.8 5.7 5.0 4.3 3.2 4.7 4.7 4.4 4.9 2.4 12.8 10.9 9.8 2.9 3.8 2.9 3.2 6.2 1.8 6.6 6.3 2.2 4.3 6.2 3.7 22.9 3.1 4.4 4.8 1.9 3.6 4.3 4.7 6.2 3.3 5.4 81.7 5.5 7.2 1.6 3.6 6.1 5.6 2.5 10.4 3.6 12.9 7.8 11.8 2.2 4.4 0.0 11.7 2.9 25.7 2.8 7.4 5.4 14.0 7.1 4.8 1.0 9.5 10.6 4.8 3.9 4.1 2.1 2.9 3.5 4.0 6.5 4.5 0.0 4.7 2.6 0.1 0.7 5.7 3.8 2.9 2.3 7.4 5.5 2.3 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA062527: AB_2684791" "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favorable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 5.8 9.9 11.5 8.8 12.3 2.3 11.3 11.9 14.6 10.2 12.1 8.6 6.5 10.0 15.2 6.2 10.0 6.2 8.8 11.1 12.4 10.7 18.3 7.3 13.1 12.4 11.9 11.0 13.1 9.0 13.7 9.3 9.4 12.4 10.6 7.2 11.4 9.9 11.1 8.1 9.5 7.5 9.6 11.9 12.2 7.8 6.8 12.4 15.6 12.2 10.0 12.8 9.0 7.0 13.1 6.6 9.1 18.1 15.0 16.0 12.2 2.3 7.7 9.3 12.4 12.3 6.5 9.5 16.2 11.8 7.3 6.2 11.5 17.6 10.3 10.6 29.3 17.8 17.0 27.2 11.7 11.9 6.6 3.5 10.6 12.3 15.6 12.7 15.1 12.8 15.8 16.8 6.9 12.3 5.3 19.8 8.7 27.1 7.2 6.8 13.2 22.8 11.2 11.6 6.2 13.0 12.9 7.9 14.2 13.3 26.9 7.8 22.2 6.7 12.3 12.8 7.0 8.6 16.5 14.0 4.7 8.6 7.8 10.6 24.5 12.7 19.2 12.9 11.5 17.0 17.2 17.4 17.8 12.7 23.4 16.8 16.6 6.9 21.3 12.4 14.1 23.1 14.8 11.5 12.3 11.9 14.6 11.1 12.4 12.4 11.9 11.0 12.4 11.9 12.4 13.1 3.6 6.4 2.7 2.6 4.1 1.8 2.7 4.1 2.8 2.5 4.5 5.6 6.5 10.0 2.7 5.5 4.2 6.5 1.4 1.4 7.9 5.5 6.8 1.2 3.3 5.1 3.0 3.0 2.0 3.8 5.3 4.3 3.1 1.2 5.1 5.3 5.0 7.6 6.8 1.7 2.3 2.8 6.1 4.1 1.2 3.2 7.2 3.0 1.8 3.7 3.1 6.4 5.2 5.0 4.1 2.3 3.2 7.2 2.3 3.2 3.5 9.6 3.2 4.2 0.0 2.3 3.2 10.4 7.4 3.1 0.9 3.3 3.3 5.3 2.4 1.2 AIMP1 "EMAP-2, EMAPII, p43, SCYE1" ENSG00000164022 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 1" Q12904 4 106315544-106349456 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis" "Cytokine, RNA-binding, tRNA-binding" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017618, HPA018476" Supported Enhanced Cytosol "Secreted to blood" NA NA 6500000 35000 Cytosol "CAB017618: AB_2285445, HPA018476: AB_1848137" "unprognostic (1.17e-3)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.36e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.29e-3)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" 32.8 33.8 25.7 31.7 28.7 60.7 44.8 28.7 33.2 32.4 28.3 42.5 40.3 34.8 35.4 38.0 32.3 32.4 34.7 25.7 28.1 40.7 36.1 29.3 38.9 27.9 28.1 23.9 42.6 32.6 38.1 25.8 30.3 28.7 33.4 42.0 36.3 35.3 35.5 65.9 29.1 38.2 32.6 26.8 33.8 35.1 23.8 27.3 35.8 39.3 50.8 39.6 41.3 31.0 30.6 66.7 46.1 47.3 60.3 51.0 78.0 68.1 80.8 69.7 73.9 87.7 81.9 97.8 109.4 61.6 79.6 50.5 61.4 69.6 86.6 98.8 62.1 47.4 64.2 63.8 134.0 101.3 147.4 75.4 62.9 100.2 74.5 117.5 56.3 64.3 68.2 120.8 58.0 82.4 58.5 99.2 78.2 51.4 94.6 46.5 81.1 86.3 101.5 94.7 60.5 72.9 56.9 52.7 158.1 86.4 61.7 75.2 107.8 50.5 87.9 73.1 66.1 105.9 71.5 98.9 110.0 74.6 112.7 97.0 60.6 54.7 55.0 42.9 61.8 51.7 57.4 54.0 43.9 58.5 55.8 55.8 51.0 7.7 51.9 73.4 74.7 72.2 34.9 25.7 28.7 28.7 33.2 25.7 28.1 27.9 28.1 23.9 28.7 26.8 27.3 30.6 87.4 70.5 55.2 18.6 72.7 50.2 147.0 166.1 50.7 49.7 71.3 87.8 95.4 82.9 130.2 66.2 35.5 124.5 58.1 83.3 156.5 121.1 79.0 75.4 83.8 60.8 73.8 66.7 17.3 126.6 144.8 66.0 48.9 130.8 79.3 64.2 61.4 109.8 109.6 25.2 20.4 144.4 116.0 90.1 53.3 19.4 99.1 68.8 32.0 16.9 117.2 56.0 74.2 24.6 38.3 118.3 93.7 85.4 40.9 141.8 146.8 166.1 105.6 45.5 59.2 77.5 128.4 127.2 74.3 66.4 50.2 150.9 68.9 74.3 142.2 173.1 SGMS2 "MGC26963, SMS2" ENSG00000164023 "Sphingomyelin synthase 2" Q8NHU3 4 107824563-107915047 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 126.6;Basal prostatic cells: 167.4;Endometrial ciliated cells: 172.1;Glandular and luminal cells: 147.8;Urothelial cells: 159.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 3.7;eosinophil: 2.4;intermediate monocyte: 1.5;myeloid DC: 4.2;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 35 "dendritic cells: 4.2;granulocytes: 2.4;monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015076 Supported NA NA "HPA015076: AB_1857298" "unprognostic (7.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.36e-2)" "unprognostic (1.87e-2)" "unprognostic (7.88e-3)" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (1.32e-1)" "unprognostic (4.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.82e-3)" "unprognostic (3.26e-1)" "prognostic favorable (1.37e-4)" "unprognostic (6.18e-2)" "unprognostic (5.63e-2)" "unprognostic (8.71e-2)" "unprognostic (5.22e-3)" 8.7 3.0 8.9 9.1 13.3 4.6 5.3 9.2 6.6 12.8 28.9 12.4 19.7 8.9 4.7 16.6 12.6 39.9 9.2 2.4 24.1 14.6 20.6 28.0 1.1 11.5 12.4 0.3 1.1 11.8 3.6 4.7 5.2 13.7 9.7 10.7 0.8 9.3 4.7 2.5 3.6 16.6 29.4 11.1 1.1 13.9 9.7 11.3 0.8 18.2 3.4 2.9 14.1 4.2 20.8 20.8 7.7 1.1 5.8 12.9 29.9 0.4 25.0 18.8 11.6 12.1 3.5 42.1 1.5 9.7 40.0 10.1 7.6 14.5 22.1 20.7 5.9 5.7 0.9 16.5 1.2 14.8 14.2 0.1 10.4 15.1 22.7 27.4 24.2 26.1 0.3 0.2 0.5 18.6 6.9 0.5 0.1 0.7 12.1 8.6 0.5 9.9 2.9 30.7 10.0 2.0 0.1 19.1 26.9 3.3 3.0 14.5 0.4 44.7 13.9 21.9 20.1 11.7 1.4 0.5 0.8 18.7 3.4 5.9 0.0 3.7 2.4 0.0 1.5 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 1.0 8.9 13.3 9.2 6.6 2.4 24.1 11.5 12.4 0.3 13.7 11.1 11.3 20.8 3.4 86.6 126.6 7.2 1.0 56.0 167.4 12.8 18.2 0.5 20.9 10.4 17.8 28.6 88.0 16.5 0.0 1.0 2.9 32.3 3.9 19.8 71.4 172.1 13.5 10.7 8.9 0.0 8.0 19.5 0.9 26.6 58.1 147.8 10.1 2.8 11.4 25.0 5.5 1.7 10.0 26.0 14.2 22.1 43.0 11.1 2.5 28.2 8.8 1.9 23.3 0.2 2.1 0.5 18.5 37.9 60.5 0.4 0.4 96.9 33.5 12.4 104.0 0.1 0.0 46.1 22.0 0.9 3.1 38.1 72.9 13.8 3.3 0.1 21.8 159.7 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995659-99062809 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 8900 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favorable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favorable (9.31e-4)" 14.9 9.6 11.0 20.7 12.9 25.3 29.0 11.8 14.0 19.4 10.2 32.1 24.3 26.0 44.1 52.8 24.5 15.2 41.5 12.0 11.6 25.0 24.2 15.7 25.1 10.8 11.4 11.1 14.1 19.7 14.1 11.7 17.0 11.2 29.4 33.9 11.4 23.3 29.9 34.1 28.9 23.6 25.9 10.6 17.7 19.8 52.0 11.7 42.3 19.0 28.9 31.5 34.8 31.1 11.5 57.6 55.9 47.7 51.7 37.2 59.1 52.9 80.3 51.5 67.1 63.7 62.9 83.3 84.1 31.3 65.5 40.3 56.1 84.8 80.5 92.9 59.2 39.9 75.6 37.8 68.2 40.2 103.6 60.8 42.8 57.5 57.0 60.4 52.4 56.3 46.9 60.0 49.7 73.2 44.0 90.9 49.3 58.7 97.7 44.3 58.9 74.5 45.4 109.2 73.6 64.7 38.5 27.0 82.5 32.8 53.1 31.6 39.3 46.1 53.9 68.0 49.9 70.9 35.5 53.5 66.2 46.5 51.9 54.8 19.1 11.6 5.7 17.7 14.6 23.1 16.0 18.0 17.6 14.9 11.4 17.4 15.8 2.9 17.7 14.7 7.2 17.7 14.1 11.0 12.9 11.8 14.0 12.0 11.6 10.8 11.4 11.1 11.2 10.6 11.7 11.5 16.1 41.7 14.6 20.2 19.8 42.4 47.5 26.2 51.2 5.2 21.0 24.9 57.0 17.2 19.5 14.7 2.1 24.4 17.4 36.7 13.7 28.4 330.3 45.4 30.0 17.3 7.8 24.2 22.6 29.4 70.5 15.3 22.4 60.9 3.8 16.9 12.8 21.4 17.2 3.3 15.0 23.3 24.4 20.2 16.2 1627.3 19.3 17.4 16.0 14.0 13.9 10.6 25.7 17.6 22.3 28.0 30.8 22.6 17.8 34.4 25.3 31.6 17.2 3.7 26.3 11.5 21.7 15.7 41.6 54.3 38.8 7.7 23.6 18.1 36.2 46.9 DNAJB14 FLJ14281 ENSG00000164031 "DnaJ heat shock protein family (Hsp40) member B14" Q8TBM8 4 99896248-99946618 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036016 Approved NA NA "HPA036016: AB_10670594" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (9.04e-3)" "unprognostic (5.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.35e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (2.75e-2)" "prognostic favorable (2.12e-6)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" 13.5 11.7 12.3 9.6 14.1 17.8 11.7 9.3 15.8 10.9 8.4 13.9 9.5 11.6 10.8 9.9 7.9 10.4 7.9 15.3 17.8 13.9 11.0 12.3 15.5 11.7 14.5 13.6 12.0 7.9 14.9 8.6 16.7 14.1 12.1 9.9 18.7 8.4 10.4 5.0 10.3 9.9 10.3 9.4 14.4 12.1 4.4 12.4 11.3 17.4 6.3 11.0 10.9 8.6 15.3 14.4 36.9 12.6 14.0 22.6 23.8 12.5 35.6 21.2 11.2 10.3 25.2 33.0 13.8 19.7 15.5 7.2 12.0 9.5 15.7 18.2 35.2 11.3 22.3 21.8 20.7 20.0 19.6 32.9 19.6 18.2 12.0 12.2 19.6 22.0 14.7 20.2 18.8 26.1 30.2 23.0 11.4 7.0 9.3 18.6 21.6 14.6 12.0 20.5 28.7 7.1 16.4 19.4 28.0 19.4 11.2 15.6 9.2 31.6 19.6 16.6 13.8 12.1 23.4 55.1 18.4 16.4 8.2 23.6 39.0 14.5 17.5 18.6 16.2 16.7 16.8 14.7 17.1 13.1 17.5 16.9 15.5 22.3 16.3 25.6 15.1 20.1 13.6 12.3 14.1 9.3 15.8 15.3 17.8 11.7 14.5 13.6 14.1 9.4 12.4 15.3 78.6 64.1 57.5 61.0 76.5 45.0 50.8 40.3 44.9 92.3 36.7 35.1 20.9 37.1 46.5 40.5 54.2 47.2 100.1 50.9 33.2 31.0 4.4 32.2 60.0 55.0 35.4 15.8 125.4 30.1 31.0 54.9 36.2 42.2 41.1 45.0 47.5 30.3 31.5 111.0 114.8 30.3 30.5 52.7 76.8 4.2 49.7 49.4 44.4 53.4 68.3 64.5 64.9 70.9 107.5 32.1 36.5 53.4 55.7 63.5 34.3 41.8 31.5 95.3 26.3 69.0 54.3 20.3 14.1 32.7 36.9 48.2 83.4 43.0 27.4 54.7 H2AZ1 "H2A.Z, H2AFZ, H2AZ" ENSG00000164032 "H2A.Z variant histone 1" P0C0S5 4 99948086-99950355 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 627.0" "Cell type enhanced" "Detected in some" "Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022549, HPA057236" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022549: , HPA057236: AB_2683377" "unprognostic (1.21e-2)" "unprognostic (2.97e-3)" "unprognostic (1.03e-3)" "unprognostic (7.60e-2)" "unprognostic (1.97e-1)" "unprognostic (8.74e-3)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.29e-3)" "unprognostic (1.98e-1)" "unprognostic (4.99e-3)" "unprognostic (9.70e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.02e-1)" "unprognostic (1.33e-1)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" 103.5 89.4 122.8 195.2 130.0 627.0 122.1 130.6 146.4 112.7 132.1 195.9 150.7 157.3 100.1 222.6 106.5 111.5 94.7 127.9 129.0 117.4 105.3 139.1 350.9 122.4 125.2 125.0 131.3 89.1 79.9 111.4 147.2 125.0 124.7 195.5 124.8 123.5 115.7 128.6 141.2 156.6 209.0 132.8 162.9 156.6 151.5 127.7 550.3 89.7 122.8 388.5 166.7 130.6 135.1 1249.7 864.3 1753.9 911.2 354.8 314.7 581.6 1287.6 930.7 1319.4 1229.9 897.5 1422.2 2205.2 451.5 666.0 862.3 442.9 1558.6 1268.1 1566.7 956.4 1088.7 1130.4 974.2 1029.1 212.4 2028.8 914.6 235.3 549.6 1004.5 561.1 369.3 1322.2 1313.0 1133.0 1293.1 1558.8 1751.0 1710.7 1697.0 1013.0 1402.9 822.1 1443.6 1279.6 928.0 741.0 750.1 1142.6 875.9 796.4 1507.4 1509.1 608.7 772.0 1550.7 686.7 841.6 1589.0 578.0 1674.1 736.1 1208.3 2671.0 939.8 1348.6 1342.7 780.2 689.8 1375.4 351.5 788.5 393.9 493.8 580.9 475.6 590.8 419.7 533.4 437.6 1482.5 453.8 1053.0 379.0 868.9 1555.4 122.8 130.0 130.6 146.4 127.9 129.0 122.4 125.2 125.0 125.0 132.8 127.7 135.1 211.4 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.2 0.0 0.0 0.0 0.0 625.4 147.1 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 1438.5 78.5 0.0 0.0 0.0 0.0 0.0 0.0 711.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.2 0.0 0.0 0.0 0.0 403.2 39.0 0.0 0.0 0.0 EMCN MUC14 ENSG00000164035 Endomucin Q9ULC0 4 100395341-100880126 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 11 "Adipocytes: 409.0;Endothelial cells: 261.7;Hepatic stellate cells: 175.3;Microglial cells: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005928 Approved "Intracellular and membrane" NA NA 470000 "HPA005928: AB_1078735" "unprognostic (8.01e-2)" "unprognostic (2.13e-4)" "unprognostic (1.36e-1)" "unprognostic (2.42e-1)" "unprognostic (2.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (1.03e-4)" "unprognostic (3.65e-1)" "unprognostic (5.94e-2)" "unprognostic (9.02e-2)" "unprognostic (2.39e-2)" "unprognostic (3.10e-2)" "prognostic favorable (2.25e-4)" "unprognostic (4.75e-3)" "unprognostic (2.36e-1)" "unprognostic (3.23e-1)" "unprognostic (9.75e-2)" 42.3 20.4 7.6 9.7 7.0 0.2 38.5 7.2 11.3 37.4 8.1 9.4 6.9 28.2 10.0 12.9 19.3 31.6 38.8 6.3 7.5 80.4 7.6 48.8 6.7 8.5 7.1 5.2 7.0 6.3 19.3 9.6 0.8 8.6 12.8 8.1 1.5 9.3 25.8 18.7 8.8 8.4 39.2 7.0 3.5 8.2 2.3 9.0 8.8 43.9 40.5 5.0 25.2 14.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.0 30.6 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.6 7.0 7.2 11.3 6.3 7.5 8.5 7.1 5.2 8.6 7.0 9.0 8.3 409.0 6.4 6.0 0.3 14.0 16.6 0.5 0.1 6.2 0.1 2.1 3.0 14.1 0.0 0.7 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.7 0.6 0.6 261.7 0.0 8.0 1.3 0.0 0.0 16.2 0.0 0.3 0.0 0.1 175.3 1.1 0.2 0.0 0.2 0.0 0.0 5.5 21.4 1.3 1.2 1.7 16.0 111.5 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.4 2.6 1.0 0.0 0.2 0.0 0.4 0.0 5.8 21.4 0.2 0.5 1.1 14.6 0.3 2.4 0.7 0.0 1.0 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019719 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 40.8" "Group enriched" "Detected in many" 4 "Early spermatids: 177.8;Late spermatids: 106.0;Spermatocytes: 224.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.0 0.8 2.1 0.6 2.7 0.6 0.5 2.3 2.4 0.4 0.1 0.4 0.7 1.3 2.2 0.3 0.6 1.5 0.8 1.5 2.0 0.6 0.2 0.5 1.0 2.7 2.6 1.1 1.4 1.2 0.7 0.5 0.8 3.2 0.9 0.7 1.8 0.2 0.7 0.2 1.9 0.5 0.6 3.2 0.9 0.4 40.8 2.5 1.1 1.0 0.0 1.1 0.8 0.2 4.4 0.1 0.0 0.9 1.5 1.9 1.4 0.3 0.3 0.4 0.0 0.1 0.0 0.1 0.7 0.2 0.8 0.3 0.0 0.7 0.4 0.6 1.5 0.9 1.2 1.0 0.0 0.0 0.4 0.2 0.2 0.4 0.0 0.8 0.4 0.5 2.0 0.5 0.8 0.7 0.6 0.4 1.0 0.4 0.2 0.0 1.3 0.8 0.2 0.4 0.2 0.9 2.3 0.2 0.3 1.1 0.6 0.2 0.8 0.3 0.4 0.1 0.5 0.5 2.5 1.9 0.7 0.5 0.4 1.0 0.2 0.2 0.0 0.4 0.1 0.5 0.5 0.3 0.6 0.2 0.5 1.5 0.9 0.1 0.1 0.1 0.6 0.6 0.2 2.1 2.7 2.3 2.4 1.5 2.0 2.7 2.6 1.1 3.2 3.2 2.5 4.4 1.3 3.2 1.5 26.1 3.4 1.3 0.5 1.8 1.8 1.8 1.0 0.6 0.9 1.5 0.4 0.0 16.7 0.6 1.1 0.2 1.9 0.3 177.8 0.8 1.1 1.7 0.0 0.4 6.0 0.4 0.4 2.3 0.0 0.6 0.0 1.9 1.4 0.2 1.3 3.3 8.3 0.1 6.1 3.9 3.1 106.0 5.3 1.3 1.8 4.7 1.5 2.5 1.0 24.1 40.5 1.1 0.0 3.0 1.8 0.9 0.4 0.9 0.2 5.0 0.0 6.4 1.8 224.8 9.5 0.7 0.6 0.5 2.9 2.0 0.3 0.6 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 39.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 57.9;Exocrine glandular cells: 68.5;Inhibitory neurons: 57.2;Pancreatic endocrine cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 11.8" "Group enriched" "Detected in many" 5 "B-cells: 5.1;NK-cells: 11.8;T-cells: 6.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA047008: AB_2679901" "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.1 6.1 10.5 5.2 12.7 4.6 5.7 11.5 13.4 6.0 4.2 4.9 1.2 6.9 2.4 3.5 5.7 7.7 4.8 11.8 14.2 1.6 39.1 3.6 6.0 11.7 10.0 11.1 6.7 2.4 0.4 8.5 3.9 13.8 4.1 2.7 12.9 2.4 5.1 3.0 2.8 3.8 7.7 8.2 3.6 4.9 3.6 10.4 3.6 2.9 3.5 5.6 6.6 4.9 15.8 4.9 2.1 5.2 10.5 26.0 20.7 0.0 22.0 7.8 3.2 3.0 2.5 3.0 29.3 3.7 24.3 5.1 1.4 12.2 9.3 4.8 24.7 7.5 30.2 7.5 21.8 13.5 22.5 8.8 18.7 10.8 7.7 27.3 11.1 15.3 8.3 10.1 22.1 10.7 1.7 15.3 10.8 4.4 0.1 6.4 0.0 6.0 12.2 9.0 2.4 17.5 14.9 10.0 2.3 6.0 1.4 2.6 13.4 17.6 7.5 4.3 11.6 6.9 16.8 14.2 21.7 8.7 17.5 3.0 0.0 0.1 0.0 4.9 0.0 6.4 5.1 5.1 4.1 0.9 3.0 3.1 3.8 0.0 11.8 0.1 1.6 2.4 1.8 10.5 12.7 11.5 13.4 11.8 14.2 11.7 10.0 11.1 13.8 8.2 10.4 15.8 13.9 0.0 0.5 15.0 15.6 4.8 3.4 2.0 6.2 9.7 3.1 2.8 2.5 8.6 1.1 0.0 27.1 0.5 6.5 0.2 0.0 14.1 12.1 1.1 8.6 17.8 3.0 17.2 57.9 68.5 2.3 13.2 22.4 0.9 1.3 10.3 6.1 39.5 1.4 8.4 57.2 1.1 4.1 1.3 5.3 6.9 5.6 3.4 10.6 5.6 3.9 0.7 0.0 32.6 17.6 94.7 0.3 5.3 12.0 4.9 0.0 1.4 1.1 2.3 6.6 16.5 11.5 5.8 4.2 5.6 3.8 0.3 7.9 4.8 0.3 1.3 BDH2 "DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308" ENSG00000164039 "3-hydroxybutyrate dehydrogenase 2" Q9BUT1 4 103077592-103099870 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 160.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 211.3;Proximal tubular cells: 795.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036028, HPA036029" Enhanced Supported Cytosol NA NA Cytosol "HPA036028: AB_10670674, HPA036029: AB_2674909" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (1.64e-1)" "prognostic favorable (5.21e-4)" "unprognostic (3.92e-1)" "unprognostic (2.28e-1)" "unprognostic (3.82e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.37e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.45e-13)" "unprognostic (2.54e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.75e-4)" "unprognostic (9.69e-3)" 40.4 97.4 23.0 4.3 25.1 3.5 40.0 27.2 27.5 45.7 26.4 30.9 39.7 31.4 16.7 27.4 43.8 15.0 39.3 20.5 26.1 160.9 71.1 36.3 6.7 27.0 26.9 19.4 55.3 23.4 31.1 29.4 7.8 26.7 32.2 10.4 8.5 33.1 14.3 24.8 26.0 39.9 9.7 25.0 21.4 39.2 14.9 28.0 17.6 63.4 16.9 7.4 37.4 37.6 26.4 3.1 5.3 26.5 10.0 30.4 29.4 3.4 6.7 17.8 6.9 10.6 3.4 11.8 12.4 11.1 10.2 2.1 1.5 17.3 10.1 8.2 8.2 8.5 1.5 6.4 8.1 15.0 7.4 2.1 24.8 9.1 10.6 2.6 23.0 20.7 14.3 8.0 5.5 24.1 1.0 37.2 6.3 9.6 2.0 2.1 24.5 30.7 7.9 46.4 3.6 4.5 12.0 12.8 6.7 7.9 9.6 5.7 5.3 9.9 10.7 3.4 5.5 3.7 8.1 7.9 12.5 11.8 8.9 5.4 2.6 2.5 0.2 7.6 1.4 8.8 4.8 6.6 6.0 3.2 6.7 9.8 10.4 0.4 6.5 0.2 5.0 10.2 4.0 23.0 25.1 27.2 27.5 20.5 26.1 27.0 26.9 19.4 26.7 25.0 28.0 26.4 37.7 32.1 57.8 33.6 10.2 30.3 47.1 59.4 36.5 2.5 31.9 36.1 9.6 64.3 46.9 108.5 0.0 7.9 19.0 18.0 211.3 58.2 1.9 60.6 45.5 30.3 22.9 16.4 1.2 21.3 18.5 75.2 41.8 27.9 19.6 39.1 27.8 71.6 20.4 3.3 3.8 24.4 46.8 10.9 16.9 4.8 69.9 12.5 23.2 14.0 14.9 50.4 14.4 3.5 21.8 23.0 18.6 77.8 8.0 18.9 162.3 795.7 48.7 3.8 13.1 40.9 36.5 0.9 4.0 25.9 26.7 3.4 18.2 52.6 37.6 37.5 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 274.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 76000 "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favorable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favorable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 108.2 52.3 26.3 38.4 27.8 42.0 77.2 28.1 30.0 58.9 35.7 68.8 128.5 52.8 51.7 58.1 44.6 53.9 51.2 26.4 34.9 96.9 175.3 43.1 30.9 28.2 30.5 25.3 58.4 74.8 81.2 49.4 86.0 29.5 53.4 65.8 55.6 55.8 73.9 54.9 99.0 122.9 68.0 28.9 32.8 96.7 39.8 30.0 28.2 66.2 44.4 41.1 56.8 51.4 31.9 123.3 44.4 80.3 64.9 339.8 177.6 80.5 164.6 182.7 119.4 158.3 46.4 123.6 86.3 187.8 213.4 138.8 70.1 74.3 81.6 149.3 49.7 42.7 58.0 111.3 88.3 429.1 84.7 41.7 140.9 161.3 100.3 123.3 277.0 109.1 55.0 98.2 105.6 173.7 38.2 78.9 39.2 63.1 148.5 39.7 62.5 64.2 59.8 176.8 42.9 63.3 59.7 92.4 103.1 97.3 131.2 79.7 38.0 203.5 100.0 81.4 103.8 77.3 121.0 106.0 91.3 109.9 74.4 70.1 2.2 1.0 2.0 1.5 0.9 0.7 1.2 1.8 1.5 0.6 0.9 1.6 1.5 0.9 1.1 0.7 2.4 2.0 0.6 26.3 27.8 28.1 30.0 26.4 34.9 28.2 30.5 25.3 29.5 28.9 30.0 31.9 95.9 54.5 41.0 16.6 27.0 100.1 49.7 27.8 54.1 22.4 49.2 32.8 60.7 58.6 35.9 44.1 10.4 85.4 41.2 68.2 29.4 57.3 80.9 42.2 59.1 50.0 35.5 104.2 20.4 74.2 146.6 69.9 53.0 64.2 12.0 31.0 47.2 125.1 35.3 11.8 19.1 67.8 40.7 15.7 39.5 49.5 46.3 22.1 67.6 13.1 19.0 98.6 21.6 13.6 25.0 69.7 50.6 37.6 48.9 58.0 177.3 111.0 27.4 41.1 13.1 63.3 53.1 33.3 27.3 51.9 111.8 274.9 32.4 39.4 58.8 34.4 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188417 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.5;lymphoid tissue: 8.9;testis: 13.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005855, HPA008803" Approved "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "HPA005855: AB_1846364, HPA008803: " "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.7 0.9 0.8 3.3 0.7 15.5 1.1 0.6 1.0 0.6 0.6 3.6 2.0 0.6 0.9 2.4 0.2 0.3 0.4 0.7 1.6 0.6 0.8 0.3 4.5 1.1 1.6 0.7 2.2 0.7 0.8 0.8 2.6 1.4 0.6 3.9 2.0 0.8 0.7 0.4 0.6 1.8 1.1 0.7 2.0 0.9 13.4 1.8 8.9 1.8 0.3 5.7 0.9 0.9 1.1 22.2 10.7 50.0 27.2 1.7 3.2 34.2 29.9 11.3 36.7 29.6 46.8 11.2 64.9 11.4 8.0 23.4 16.3 86.6 20.6 38.6 21.4 45.1 83.8 19.0 23.1 1.7 59.4 23.4 1.7 3.1 45.8 19.6 4.6 14.1 47.8 67.6 33.6 20.1 11.8 74.8 46.6 73.4 20.2 24.2 33.2 32.9 35.1 9.5 20.7 23.5 28.8 18.6 21.6 9.5 31.7 11.3 41.9 7.2 18.0 27.7 20.3 41.4 16.7 54.2 101.5 13.5 65.2 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.6 1.0 0.7 1.6 1.1 1.6 0.7 1.4 0.7 1.8 1.1 0.3 0.0 0.0 1.0 1.1 0.4 0.4 0.8 1.8 0.5 1.2 1.0 111.2 0.0 0.1 0.0 2.1 4.2 0.2 2.4 0.0 0.4 18.3 0.5 0.9 2.7 1.2 8.0 0.2 0.9 7.4 1.5 1.5 1.3 0.0 4.6 1.4 0.3 3.1 0.0 0.5 2.0 0.0 0.6 0.9 31.8 1.5 0.5 0.0 0.0 0.1 1.1 0.0 0.5 0.0 1.1 0.8 1.9 13.0 0.7 0.4 0.4 0.2 0.4 0.0 0.1 2.2 14.5 16.3 4.3 0.0 0.3 0.6 2.4 4.1 0.5 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" P49913 3 48223347-48225491 "Plasma proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 2941.9" "Cell type enhanced" "Detected in some" "Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 84.4;neutrophil: 335.4" "Lineage enriched" "Detected in many" 12 "granulocytes: 335.4" "Cell line enhanced" "Detected in some" "Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5" "Not detected" "Not detected" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 28000000 "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.6 0.1 0.1 1.6 0.1 2941.9 0.6 0.1 0.5 0.6 0.2 0.3 0.0 0.6 342.9 0.4 0.1 0.3 1.2 0.1 0.3 0.4 3.9 7.5 6.9 0.2 0.3 0.1 0.2 0.1 0.1 0.5 2.4 0.2 0.5 0.1 0.0 15.3 0.7 0.2 3.7 1.8 0.1 0.1 23.4 0.4 1.9 0.1 10.8 5.7 0.2 2.9 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 27.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 19.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 1.0 1.4 0.1 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 77.5 0.0 3.4 0.1 37.9 5.5 84.4 0.0 9.8 0.0 2.3 0.0 0.0 7.7 2.4 0.0 0.0 335.4 2.6 28.1 4.7 0.0 86.9 0.1 0.1 0.1 0.5 0.1 0.3 0.2 0.3 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.9 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.3 0.9 0.3 0.2 0.0 2.1 0.0 0.2 0.0 6.9 0.5 1.4 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 0.0 1.3 1.1 17.4 0.9 3.6 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.8 9.4 0.0 0.1 0.7 0.0 0.0 0.0 0.1 5.0 7.2 0.0 0.0 0.0 1.0 0.0 0.4 0.6 ZNF589 SZF1 ENSG00000164048 "Zinc finger protein 589" Q86UQ0 3 48241100-48299253 "Predicted intracellular proteins, Transcription factors" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9" "Cancer enhanced" "Detected in all" "testis cancer: 15.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HAP1: 44.1;NTERA-2: 71.1" HPA003145 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003145: AB_1080738" "unprognostic (2.49e-3)" "prognostic favorable (2.50e-4)" "unprognostic (9.14e-2)" "unprognostic (7.34e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.01e-5)" "prognostic favorable (6.45e-5)" "unprognostic (2.64e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.21e-4)" "unprognostic (8.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (3.45e-2)" "unprognostic (9.57e-3)" "unprognostic (2.19e-2)" 6.2 8.6 9.0 6.8 9.4 5.9 6.9 14.6 10.9 10.6 2.7 8.0 3.9 7.6 20.3 10.3 8.8 4.6 5.4 10.8 8.3 6.0 3.7 10.1 12.4 9.3 7.7 10.6 13.7 6.6 5.9 7.8 3.0 9.5 18.5 6.7 15.0 6.7 15.8 6.2 9.9 16.3 6.1 7.4 24.3 8.0 6.6 8.5 8.2 16.7 4.2 12.3 8.5 10.8 11.4 4.5 3.2 12.7 10.8 15.8 8.7 16.1 4.6 3.5 5.2 6.9 6.8 6.0 17.8 3.3 4.7 4.0 3.9 44.1 11.2 4.2 11.5 10.5 22.5 14.9 5.4 2.9 5.4 5.6 2.8 7.5 6.4 4.3 5.7 9.0 13.7 15.4 4.5 2.8 4.5 6.8 4.1 71.1 4.3 6.6 3.3 4.6 6.8 4.0 4.4 4.9 9.1 3.4 3.7 13.7 18.8 6.0 8.0 14.0 3.0 5.8 7.2 3.5 8.9 12.0 14.6 4.0 12.6 9.3 1.2 2.2 1.6 2.8 2.0 3.5 3.1 3.4 3.8 2.3 1.9 3.8 3.8 1.2 1.2 2.8 10.9 3.1 1.9 9.0 9.4 14.6 10.9 10.8 8.3 9.3 7.7 10.6 9.5 7.4 8.5 11.4 2.0 0.0 5.4 4.2 5.5 1.1 1.4 0.9 3.4 15.3 2.4 1.5 4.1 0.0 2.8 9.2 20.9 2.2 13.7 1.3 3.9 1.4 1.5 7.3 3.5 2.7 1.8 2.1 9.8 1.0 1.2 4.3 1.5 11.7 0.0 3.9 2.5 1.0 3.3 1.7 11.5 2.5 0.0 5.5 3.0 2.0 2.1 7.3 1.8 3.7 3.7 5.3 1.0 9.5 11.0 1.0 1.7 4.5 5.3 1.5 1.4 1.6 2.4 13.1 6.6 4.1 3.0 1.4 3.1 2.9 1.3 0.0 4.4 7.0 2.5 0.9 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "pancreas: 6.1" "Group enriched" "Detected in some" 4 "Early spermatids: 12.4;Late spermatids: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037491, HPA037492" Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA037491: AB_2675504, HPA037492: AB_2675505" "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 6.1 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.6 0.2 0.2 0.2 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.6 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 PLXNB1 "KIAA0407, PLXN5, SEP" ENSG00000164050 "Plexin B1" O43157 3 48403854-48430086 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 121.1;Oligodendrocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040586 Enhanced "Intracellular and membrane" NA NA 95000000 "HPA040586: AB_10794034" "unprognostic (1.31e-3)" "unprognostic (7.09e-2)" "unprognostic (9.63e-2)" "unprognostic (8.13e-2)" "unprognostic (3.65e-1)" "prognostic favorable (5.03e-4)" "unprognostic (1.06e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.01e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-2)" "prognostic favorable (2.77e-5)" "unprognostic (4.01e-2)" "unprognostic (1.61e-1)" "unprognostic (6.98e-2)" "prognostic favorable (7.60e-4)" 8.7 2.9 21.9 3.3 44.7 1.0 13.8 32.1 19.9 15.7 25.0 17.4 9.8 19.7 5.6 23.1 25.5 10.3 9.8 16.4 21.8 27.7 29.2 11.5 1.7 42.5 38.9 8.0 19.3 26.2 6.2 18.0 6.9 47.7 23.1 5.4 4.3 17.4 15.9 1.7 22.4 13.1 7.6 26.7 6.5 14.9 4.0 35.0 5.1 36.1 1.4 2.0 16.4 21.6 58.8 5.5 9.2 16.7 9.9 6.1 4.9 34.1 4.6 2.6 2.6 1.7 11.3 20.7 0.0 16.6 3.2 1.7 16.3 3.6 37.0 0.5 9.7 0.7 0.0 19.9 21.5 8.9 7.5 3.1 8.8 31.5 0.6 7.5 10.1 4.3 3.7 1.4 0.8 2.5 9.5 1.3 6.5 29.7 12.0 2.0 8.4 3.6 1.3 15.6 24.5 8.5 18.4 5.9 34.6 5.3 4.4 18.5 6.2 8.5 2.6 7.8 3.8 5.3 0.3 0.0 0.2 0.5 2.2 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 44.7 32.1 19.9 16.4 21.8 42.5 38.9 8.0 47.7 26.7 35.0 58.8 3.2 35.3 24.3 121.1 0.7 11.5 15.8 26.1 32.5 2.6 23.3 31.5 17.7 30.0 27.5 46.0 2.1 23.7 0.2 36.2 5.9 18.5 4.3 54.2 9.3 5.0 52.7 3.2 1.4 15.8 2.4 7.2 26.5 41.8 0.0 11.2 5.3 59.7 2.9 3.3 2.6 21.2 30.5 3.1 1.2 5.1 15.2 1.0 1.8 4.7 0.7 24.3 0.0 21.6 70.1 21.9 21.8 15.4 0.3 11.4 21.5 12.7 56.5 5.7 0.0 6.1 13.0 1.4 2.7 22.3 9.7 9.9 1.3 0.5 28.3 11.6 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.5 13.8 11.0 7.3 10.7 5.0 8.8 10.9 11.7 7.9 19.7 12.3 11.1 8.1 10.2 13.9 8.9 5.4 11.9 11.2 10.7 14.0 13.1 6.7 9.7 11.4 10.8 10.0 7.8 5.5 9.4 6.2 8.2 11.4 6.7 13.7 7.8 7.1 9.1 15.6 9.9 8.7 9.1 10.9 12.7 7.7 7.9 11.3 10.0 10.4 11.8 11.9 9.1 9.6 10.8 22.7 26.7 15.7 18.7 23.1 24.2 43.6 14.6 13.4 28.6 23.2 42.9 36.9 48.6 20.5 11.7 21.6 32.2 39.5 47.8 17.4 22.9 25.6 41.4 44.1 32.7 35.3 20.4 18.2 18.4 106.8 35.6 38.8 15.7 16.7 28.0 23.4 13.7 27.7 21.4 24.1 26.5 34.8 48.2 42.8 16.5 18.6 37.7 39.3 27.8 13.1 27.2 24.2 26.2 39.9 14.7 28.2 31.3 12.6 16.5 22.3 41.6 28.5 22.0 34.8 25.5 22.0 43.8 16.0 3.0 14.1 7.0 15.5 14.9 15.8 28.1 14.5 19.7 25.5 23.0 14.8 17.4 6.0 16.5 9.1 21.1 19.8 14.6 11.0 10.7 10.9 11.7 11.2 10.7 11.4 10.8 10.0 11.4 10.9 11.3 10.8 7.1 12.8 2.6 2.6 5.9 4.7 3.7 28.8 17.6 7.3 6.6 8.1 8.2 15.7 12.8 9.2 0.0 40.1 5.0 12.6 23.5 15.1 3.3 19.4 7.3 5.9 5.4 5.9 2.4 12.4 22.0 10.0 6.6 16.5 3.8 10.1 4.6 13.1 15.9 8.4 2.4 7.6 14.2 3.8 3.3 2.7 12.2 4.4 14.2 1.9 9.1 11.0 11.3 3.5 3.2 15.2 8.0 13.2 5.1 5.4 21.6 43.4 9.3 10.7 6.6 4.0 6.2 7.2 16.3 13.0 4.7 6.7 4.8 20.0 13.4 3.4 ATRIP "FLJ12343, MGC20625, MGC21482, MGC26740" ENSG00000164053 "ATR interacting protein" Q8WXE1 3 48446710-48467645 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 15.1" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033109, HPA047590" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB033109: AB_634993, HPA047590: AB_2680094" "unprognostic (5.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.85e-1)" "unprognostic (8.87e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "unprognostic (4.72e-2)" "unprognostic (8.88e-3)" "unprognostic (2.66e-1)" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (2.01e-1)" "unprognostic (8.89e-2)" "unprognostic (2.59e-1)" "unprognostic (1.40e-2)" "unprognostic (8.52e-2)" 3.5 2.6 1.7 3.7 1.7 5.0 3.8 3.5 2.3 3.9 1.8 2.9 2.4 3.4 1.4 3.7 3.1 2.1 2.4 1.7 1.4 3.1 2.5 3.6 3.7 1.7 1.6 1.6 3.6 2.7 4.1 1.8 3.2 2.2 3.0 3.5 2.8 2.5 3.6 4.8 4.3 2.6 3.0 1.3 3.1 2.8 15.1 1.6 4.9 5.5 3.0 4.9 3.4 3.5 1.9 8.7 3.7 9.7 7.4 5.6 9.5 10.2 13.1 6.0 15.7 12.8 5.1 6.3 19.3 5.9 5.4 7.3 9.2 10.9 10.2 15.1 11.5 5.6 14.9 19.1 3.7 3.2 15.0 9.7 3.8 3.1 8.5 4.0 3.5 7.0 7.1 12.0 9.6 14.7 4.9 12.6 5.4 7.5 4.4 10.5 8.5 8.7 13.7 5.3 4.3 4.7 6.9 10.4 10.5 3.9 8.5 8.8 5.7 8.1 10.7 7.0 13.0 15.3 11.6 20.0 13.6 5.7 11.2 6.0 0.2 0.7 0.0 1.1 0.3 0.1 0.3 0.9 0.5 0.5 0.2 0.7 1.0 0.5 0.5 0.6 1.1 1.2 0.7 1.7 1.7 3.5 2.3 1.7 1.4 1.7 1.6 1.6 2.2 1.3 1.6 1.9 4.3 0.0 1.5 2.0 0.9 2.9 0.0 0.9 0.0 1.0 4.1 4.7 1.6 0.0 2.0 0.0 2.1 0.2 4.4 2.4 0.0 3.6 0.0 3.8 6.4 2.3 0.0 0.4 3.2 3.9 0.1 2.2 1.5 5.8 0.0 5.5 0.0 0.0 0.1 1.7 3.2 1.7 2.0 0.0 0.5 0.0 0.0 2.5 0.0 1.9 1.6 0.5 3.1 2.0 3.3 4.1 1.1 0.0 0.7 0.0 0.0 2.1 3.6 2.1 0.0 0.0 4.5 0.0 0.0 0.0 3.8 0.1 2.2 4.2 1.3 0.0 SHISA5 "hShisa5, SCOTIN" ENSG00000164054 "Shisa family member 5" Q8N114 3 48467798-48504826 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 279.7;Extravillous trophoblasts: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042295 Approved NA NA "HPA042295: AB_10794794" "unprognostic (3.52e-3)" "unprognostic (4.79e-2)" "unprognostic (1.71e-1)" "unprognostic (3.98e-2)" "unprognostic (8.58e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.72e-6)" "unprognostic (3.82e-3)" "unprognostic (8.76e-3)" "unprognostic (1.21e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.64e-5)" "unprognostic (1.11e-1)" "unprognostic (6.08e-3)" "unprognostic (3.81e-3)" "unprognostic (1.74e-2)" 92.2 72.4 67.8 68.9 65.3 65.6 82.9 52.5 92.9 96.7 99.1 77.3 61.2 92.2 45.7 141.8 95.7 71.2 72.4 65.9 76.3 92.6 115.9 102.6 80.7 70.3 66.2 66.0 87.1 58.8 48.4 70.8 139.6 61.7 108.8 39.9 13.9 69.6 70.4 23.0 59.3 75.1 67.7 58.3 115.2 74.1 35.8 72.9 85.1 77.4 32.0 67.5 117.8 99.1 66.3 71.0 141.9 82.4 132.0 153.1 194.7 417.7 115.3 209.0 254.3 187.9 157.4 175.6 97.7 123.2 200.9 240.9 91.7 91.5 148.3 70.7 116.4 63.6 89.2 91.2 128.2 256.7 61.9 164.0 200.9 169.3 205.7 141.7 141.7 193.2 129.0 56.6 115.6 138.2 154.1 70.4 111.1 150.4 101.2 113.0 48.2 36.7 133.4 130.5 446.6 24.6 13.8 74.9 79.1 155.6 136.8 91.5 91.2 153.6 90.5 100.8 155.2 112.0 87.0 76.3 85.8 128.2 118.3 90.2 205.9 301.6 252.5 320.7 267.5 283.4 165.0 264.1 293.8 167.3 222.6 210.9 219.4 910.2 138.7 306.9 126.7 345.7 500.0 67.8 65.3 52.5 92.9 65.9 76.3 70.3 66.2 66.0 61.7 58.3 72.9 66.3 69.8 41.7 39.4 12.1 55.8 27.8 73.0 52.2 114.4 22.7 29.6 29.8 17.3 51.5 37.6 64.4 16.7 279.7 56.3 43.0 11.7 79.4 4.2 29.2 49.8 79.4 37.8 22.9 10.8 104.3 229.9 57.4 36.2 31.2 34.8 41.5 66.0 88.0 103.0 6.7 11.0 48.3 14.2 57.5 27.3 5.7 49.0 47.7 46.2 18.7 46.5 30.1 101.0 10.6 10.4 80.2 31.2 39.1 54.5 50.2 64.9 43.3 38.0 5.0 32.9 22.1 43.9 5.1 8.8 85.9 32.1 120.5 74.0 49.9 40.3 50.5 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 223.5" "Cell type enhanced" "Detected in many" "Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 61.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 223.5 38.8 5.8 22.5 8.0 22.9 155.6 7.7 8.8 72.5 22.5 40.3 15.9 41.3 24.3 42.9 81.9 84.6 70.7 7.5 17.9 35.7 21.7 58.8 13.1 5.4 5.3 6.8 30.3 32.0 37.7 27.5 50.0 5.7 52.4 27.7 19.1 45.6 24.9 50.3 70.9 25.4 58.2 5.6 17.1 35.4 10.2 7.2 29.5 93.5 50.4 10.2 75.1 71.6 6.3 6.3 1.8 95.4 194.1 76.5 51.6 6.4 0.4 4.9 0.3 2.0 5.8 10.3 0.0 42.4 2.9 0.4 1.2 2.6 4.6 0.7 0.1 10.0 2.2 0.0 31.0 21.7 14.2 0.1 21.1 2.5 0.7 2.1 10.5 8.1 2.2 1.7 1.9 4.7 0.7 16.4 34.8 22.8 22.6 32.0 7.1 10.3 0.2 13.2 14.5 14.5 12.3 0.1 19.4 19.6 10.1 1.9 0.0 20.2 1.2 0.2 0.4 2.9 1.0 0.1 0.2 1.4 2.6 3.2 0.1 0.4 6.5 1.1 0.2 33.1 29.8 4.0 9.2 0.1 61.2 5.7 6.4 0.4 14.2 0.1 1.7 0.0 2.0 5.8 8.0 7.7 8.8 7.5 17.9 5.4 5.3 6.8 5.7 5.6 7.2 6.3 771.3 28.9 28.3 14.4 16.2 49.6 17.3 37.3 68.9 86.2 22.8 69.6 16.9 32.9 20.6 27.6 33.3 12.7 21.6 10.4 80.3 5.0 2.5 45.9 41.9 352.8 26.5 5.7 5.0 10.9 1.7 222.3 8.2 67.4 9.5 0.2 166.3 5.9 10.1 6.7 2.2 15.0 14.2 15.3 37.9 10.5 448.0 17.1 46.2 5.6 0.7 158.3 0.0 7.5 0.3 7.0 6.3 57.9 6.1 16.8 8.1 38.7 11.7 84.5 151.2 245.0 81.6 6.2 9.6 37.0 43.3 3.1 57.3 1.8 17.9 13.5 BSN ZNF231 ENSG00000164061 "Bassoon presynaptic cytomatrix protein" Q9UPA5 3 49554477-49671549 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 33.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 76.6;Horizontal cells: 25.2;Inhibitory neurons: 50.1;Oligodendrocyte precursor cells: 22.6" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 2.0;SCLC-21H: 4.4;SH-SY5Y: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034757 Enhanced NA NA "HPA034757: AB_10671233" "unprognostic (8.57e-2)" "unprognostic (3.45e-1)" "unprognostic (7.31e-2)" "unprognostic (3.50e-4)" "unprognostic (7.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (5.46e-3)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (6.21e-5)" "unprognostic (2.50e-3)" "unprognostic (5.38e-5)" "unprognostic (9.33e-2)" "unprognostic (3.03e-1)" "unprognostic (2.30e-1)" "unprognostic (7.34e-2)" 0.1 1.4 8.1 0.1 14.5 0.0 0.1 0.5 33.1 0.1 0.0 0.2 0.1 0.3 3.0 0.0 0.1 0.0 0.2 14.0 4.3 0.2 0.5 0.1 0.0 5.2 0.0 20.5 0.3 0.6 0.3 5.4 0.1 7.9 0.2 0.0 3.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 3.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 4.7 0.1 0.2 1.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 1.2 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.4 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.0 0.2 0.0 0.4 0.2 0.1 0.8 0.1 0.5 0.0 0.1 0.2 0.0 0.2 4.4 2.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 14.5 0.5 33.1 14.0 4.3 5.2 0.0 20.5 7.9 0.0 0.0 4.7 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.0 15.0 0.2 0.5 2.5 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.0 7.8 0.4 0.3 0.5 0.0 0.0 76.6 0.5 0.1 0.3 0.0 0.3 0.0 0.6 0.7 0.4 0.1 25.2 50.1 0.1 0.0 0.3 0.0 11.7 1.2 0.1 1.8 9.4 0.0 3.9 2.1 22.6 6.3 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.0 8.8 0.0 1.0 1.3 6.7 8.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 APEH "D3F15S2, D3S48E, DNF15S2" ENSG00000164062 "Acylaminoacyl-peptide hydrolase" P13798 3 49674014-49683971 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029700, HPA029701, HPA029702, HPA029703" Enhanced Enhanced Cytosol No No 2300000 Cytosol "HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348" "unprognostic (4.93e-2)" "unprognostic (5.42e-2)" "unprognostic (6.04e-3)" "unprognostic (2.71e-1)" "unprognostic (9.32e-2)" "unprognostic (8.20e-2)" "unprognostic (3.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (8.03e-2)" "unprognostic (3.21e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.32e-10)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.34e-2)" "unprognostic (7.67e-2)" 21.9 44.0 17.1 31.0 17.1 42.7 27.1 17.4 23.0 25.1 23.9 48.9 49.0 19.9 24.9 40.6 34.0 22.5 41.0 16.5 17.6 66.4 63.8 27.0 35.5 18.4 20.0 17.5 24.8 35.1 63.5 38.6 32.2 20.6 31.3 52.2 13.0 34.3 29.8 104.8 33.1 35.4 28.3 15.1 27.5 35.8 18.9 17.8 37.6 49.0 104.8 43.7 35.3 21.4 18.1 101.2 79.2 84.2 110.8 71.3 48.3 113.6 64.2 79.3 87.4 91.2 130.1 101.7 127.1 70.0 71.7 78.9 89.8 95.1 143.4 64.2 61.9 41.0 138.8 123.4 105.1 72.0 145.5 204.7 55.0 106.5 49.2 101.4 85.5 78.7 86.4 86.6 59.8 86.0 90.8 105.3 76.6 50.4 140.5 75.3 38.4 72.8 165.1 169.9 226.7 40.4 71.2 72.4 166.7 78.9 61.0 112.1 77.2 36.1 53.8 93.0 83.6 86.8 69.8 54.5 77.7 91.7 104.1 78.7 57.9 43.0 52.8 44.8 47.6 34.8 33.3 36.3 41.9 43.6 27.6 37.9 37.4 13.6 39.0 47.6 35.1 50.4 51.9 17.1 17.1 17.4 23.0 16.5 17.6 18.4 20.0 17.5 20.6 15.1 17.8 18.1 5.4 41.7 25.3 7.5 20.1 8.7 23.3 50.2 11.4 6.8 20.8 15.9 46.8 30.0 39.4 27.6 12.5 83.7 16.5 83.2 43.0 44.4 6.4 16.6 13.8 9.0 26.5 43.8 4.8 34.7 64.8 16.4 41.8 20.5 23.5 20.0 13.2 74.7 51.1 8.4 4.7 47.1 63.1 35.9 11.9 10.9 15.2 23.2 21.4 2.8 26.8 30.4 27.8 3.0 2.0 39.0 35.8 13.5 39.4 18.0 85.4 80.7 19.4 11.1 13.1 10.6 25.2 33.2 28.5 30.6 9.2 62.1 23.9 28.5 74.0 23.7 INTU "CPLANE4, KIAA1284, PDZD6, PDZK6" ENSG00000164066 "Inturned planar cell polarity protein" Q9ULD6 4 127623271-127726737 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.3" "Cell type enhanced" "Detected in many" "Astrocytes: 133.5;Cone photoreceptor cells: 137.6;Endometrial ciliated cells: 81.4;Oligodendrocytes: 78.0;Respiratory ciliated cells: 84.0;Rod photoreceptor cells: 181.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036714, HPA036715, HPA061467" Approved Uncertain Cytosol NA NA Cytosol "HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: " "unprognostic (1.09e-1)" "unprognostic (2.89e-1)" "unprognostic (4.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-1)" "unprognostic (2.88e-3)" "unprognostic (4.30e-2)" "unprognostic (2.91e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (1.22e-1)" "unprognostic (9.49e-2)" "unprognostic (3.28e-1)" "unprognostic (2.36e-1)" "unprognostic (5.33e-2)" 1.5 1.6 9.3 1.2 6.6 2.7 2.9 4.5 7.7 1.4 4.4 1.3 2.1 2.6 5.2 1.3 2.5 1.5 0.9 5.3 2.1 1.9 0.7 1.6 1.1 2.4 2.9 4.6 3.4 1.2 1.1 2.8 1.0 3.1 1.8 1.6 13.3 1.8 1.2 1.1 3.9 1.0 1.3 0.7 1.3 2.2 2.3 4.2 0.6 2.8 2.5 0.7 1.2 1.6 6.9 2.5 1.7 8.7 3.1 1.1 2.7 0.7 1.4 0.7 1.0 1.9 1.2 2.2 1.8 2.1 1.2 2.8 1.5 7.0 1.3 2.9 0.8 2.1 2.6 3.3 3.0 1.1 2.3 1.2 1.2 1.5 2.9 0.7 2.6 2.7 0.9 3.4 2.0 1.4 1.2 0.8 1.2 4.0 0.9 1.6 0.8 2.0 0.5 1.8 1.8 4.1 2.9 2.9 1.6 1.0 4.3 1.8 1.3 2.1 2.5 1.9 2.2 2.0 1.2 1.9 0.6 2.1 1.0 1.5 1.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 1.4 0.3 0.2 0.4 0.1 0.0 9.3 6.6 4.5 7.7 5.3 2.1 2.4 2.9 4.6 3.1 0.7 4.2 6.9 8.9 22.4 15.4 133.5 0.6 6.0 10.4 7.2 12.0 56.3 13.7 24.8 15.6 10.0 18.8 3.7 137.6 8.3 0.4 2.7 7.9 7.6 10.2 81.4 30.5 8.2 11.5 3.8 36.0 5.1 6.2 18.7 10.2 15.8 5.1 22.9 6.4 2.5 3.0 37.0 36.6 5.9 10.2 1.6 9.6 11.9 14.0 3.0 7.2 23.4 0.5 16.5 0.0 19.6 78.0 3.4 1.5 11.7 0.0 6.9 1.1 11.2 84.0 181.8 0.0 17.8 10.9 8.7 20.4 7.9 6.1 1.9 1.7 12.9 7.0 6.4 RNF123 "FLJ12565, KPC1" ENSG00000164068 "Ring finger protein 123" Q5XPI4 3 49689538-49721529 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 157.4;tongue: 113.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065983, HPA071879" Supported Approved Cytosol NA NA 140000 Cytosol "HPA065983: AB_2685592, HPA071879: AB_2686468" "unprognostic (2.68e-1)" "unprognostic (3.34e-1)" "unprognostic (2.67e-1)" "unprognostic (1.04e-1)" "unprognostic (2.21e-1)" "unprognostic (9.51e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (5.03e-3)" "prognostic favorable (1.33e-8)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-2)" "unprognostic (3.83e-1)" 12.9 19.1 18.1 9.1 18.5 34.9 12.6 18.0 23.8 13.0 19.1 16.9 19.7 14.9 10.6 13.5 12.6 9.8 24.0 19.0 16.9 21.9 58.1 12.4 10.5 16.9 16.6 19.4 11.7 13.6 16.4 17.5 9.4 17.0 14.7 6.8 6.0 14.5 9.3 157.4 14.4 18.4 9.4 14.1 18.0 18.0 23.9 17.7 13.8 14.7 113.0 7.4 14.3 12.1 17.9 9.7 12.6 15.5 16.2 23.2 13.9 17.1 12.1 15.9 15.0 16.0 14.1 16.1 23.2 10.9 17.6 13.3 11.8 11.6 18.1 10.0 15.8 15.0 19.7 27.8 31.6 23.1 19.3 19.8 17.6 17.9 14.4 16.5 14.8 16.2 23.0 20.0 20.0 13.2 14.1 19.8 30.7 8.2 11.5 21.0 9.3 9.7 24.4 21.5 16.4 10.6 20.8 16.4 14.4 18.7 8.7 15.4 33.0 16.2 13.4 16.3 11.9 14.9 26.4 28.4 9.5 19.2 23.6 20.5 8.9 6.9 5.6 6.7 6.2 4.0 7.1 4.5 4.1 5.5 7.0 5.3 5.0 4.0 5.5 6.8 7.9 3.6 3.8 18.1 18.5 18.0 23.8 19.0 16.9 16.9 16.6 19.4 17.0 14.1 17.7 17.9 7.1 9.6 5.3 16.3 6.5 2.3 3.1 4.7 1.8 8.6 7.1 6.1 1.1 11.5 5.8 3.7 4.2 6.8 9.3 10.4 5.9 5.3 13.3 8.1 5.8 5.9 6.7 52.4 18.0 5.5 4.6 5.9 11.2 7.5 7.0 9.5 10.0 29.8 5.6 6.7 14.6 6.1 10.2 9.6 1.4 16.5 7.5 6.0 3.6 5.6 6.3 5.4 7.2 7.5 7.2 7.2 6.3 5.7 7.0 5.0 19.2 10.2 5.4 8.9 0.0 7.6 5.6 10.7 8.9 4.6 3.0 8.5 6.0 7.5 6.9 4.1 HSPA4L "APG-1, HSPH3, Osp94" ENSG00000164070 "Heat shock protein family A (Hsp70) member 4 like" O95757 4 127781821-127840733 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9;testis: 109.7" "Cell type enhanced" "Detected in many" "Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "HAP1: 82.3" "Low region specificity" "Detected in all" "CAB034450, HPA039149, HPA061446" Enhanced Approved Centrosome,Cytosol NA NA 1000000 "Centrosome, Cytosol" "CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (5.33e-2)" "unprognostic (9.40e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (1.23e-3)" "unprognostic (2.41e-1)" "unprognostic (3.90e-1)" "unprognostic (2.38e-4)" "unprognostic (1.40e-2)" "unprognostic (3.28e-1)" "prognostic favorable (3.80e-9)" "unprognostic (8.53e-2)" "unprognostic (1.56e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (6.78e-4)" 1.1 11.4 16.1 1.0 10.3 3.0 3.5 21.1 46.9 2.7 13.5 2.6 2.4 1.1 1.2 13.9 7.0 3.8 6.5 45.5 27.1 13.4 7.5 1.6 0.3 17.3 15.7 7.8 3.8 4.0 11.2 8.0 3.0 17.5 4.1 3.5 27.2 5.7 5.0 1.5 8.4 1.2 3.0 14.8 0.9 2.1 109.7 23.8 4.0 4.0 3.6 4.7 2.8 7.7 29.4 20.6 26.5 14.0 22.1 9.5 9.5 16.2 9.1 3.7 8.6 9.5 19.7 9.2 0.1 16.4 2.6 7.0 4.7 82.3 32.9 11.7 38.7 24.7 11.0 33.5 23.7 3.5 42.3 17.9 8.7 29.7 5.7 20.3 8.9 11.3 9.4 19.8 12.2 10.9 14.9 13.6 3.7 3.3 21.5 21.6 0.1 1.5 2.0 29.1 9.2 25.7 9.4 16.4 28.2 1.5 8.3 21.7 7.1 3.2 3.0 0.1 3.7 22.1 23.6 29.3 6.4 11.7 28.3 9.4 0.6 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 16.1 10.3 21.1 46.9 45.5 27.1 17.3 15.7 7.8 17.5 14.8 23.8 29.4 2.7 3.2 9.3 17.6 1.1 28.4 91.9 31.3 40.9 57.7 7.7 9.4 18.1 12.8 27.6 9.2 104.3 10.0 0.8 3.4 19.6 6.8 436.6 17.8 1.6 6.8 18.4 0.0 47.1 2.9 2.1 8.1 2.6 5.2 15.8 2.5 1.8 9.7 1.2 40.4 70.4 3.5 24.4 2.5 9.7 901.8 10.2 4.7 8.8 7.5 3.0 16.6 2.1 19.6 9.3 2.8 0.3 9.8 0.4 26.2 0.3 24.6 52.0 66.8 0.0 18.7 12.5 203.1 13.5 47.5 42.5 16.7 4.2 2.8 5.3 65.2 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917799-127966034 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favorable (2.21e-4)" 4.4 5.8 1.5 6.9 1.2 2.6 7.0 2.0 1.7 6.2 1.1 6.9 10.1 5.6 4.0 5.5 5.5 4.9 3.7 1.1 1.9 6.4 10.0 4.9 5.5 1.6 1.4 0.5 6.8 8.1 9.1 7.2 5.9 1.8 5.6 8.2 4.7 5.8 4.5 3.8 5.9 7.6 5.8 1.1 7.3 6.5 3.9 1.2 5.2 7.0 4.4 7.9 5.3 6.0 2.2 10.9 7.3 9.5 4.6 7.2 6.9 7.0 8.3 10.3 10.2 10.5 5.2 14.3 5.2 14.5 14.3 14.8 7.8 10.2 7.4 14.4 10.8 7.9 5.7 9.1 8.0 9.4 6.0 6.6 8.3 2.7 8.6 7.7 5.0 10.6 6.6 9.5 5.9 14.6 8.9 5.0 1.9 1.7 11.8 5.2 5.3 0.6 4.7 7.5 13.9 8.5 2.9 9.0 12.0 3.5 6.4 5.6 5.1 6.7 2.9 3.1 10.7 7.8 12.5 22.1 9.6 10.3 5.3 8.8 1.9 1.6 2.8 2.5 2.4 2.4 2.5 2.7 2.2 1.6 1.1 2.4 2.6 2.5 2.4 3.7 2.2 3.4 1.2 1.5 1.2 2.0 1.7 1.1 1.9 1.6 1.4 0.5 1.8 1.1 1.2 2.2 9.5 12.8 14.1 17.0 18.8 3.2 4.9 8.5 10.2 17.2 8.1 5.3 3.0 5.7 14.0 16.5 20.9 12.5 17.9 7.2 1.9 8.5 10.4 7.7 7.2 7.2 4.2 3.8 32.1 7.0 7.3 8.6 11.7 8.2 12.7 18.4 8.9 10.1 7.6 11.8 34.9 6.8 10.2 8.5 3.3 14.7 9.3 6.5 3.6 27.2 10.5 8.6 20.6 20.6 24.6 7.8 9.5 9.4 19.9 5.4 11.1 6.3 12.1 24.9 6.6 5.8 6.6 12.6 8.4 8.9 5.7 22.0 13.7 11.4 7.3 4.8 ABHD18 "C4orf29, FLJ21106" ENSG00000164074 "Abhydrolase domain containing 18" Q0P651 4 127965306-128039953 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050168, HPA051676" Approved Approved "Nuclear membrane" "Intracellular and membrane" NA NA "Nuclear membrane" "HPA050168: AB_2681040, HPA051676: AB_2681571" "unprognostic (1.91e-1)" "unprognostic (8.66e-2)" "prognostic favorable (5.35e-4)" "unprognostic (1.74e-2)" "unprognostic (4.99e-2)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (5.60e-2)" "unprognostic (3.34e-1)" "unprognostic (1.14e-2)" "unprognostic (1.76e-3)" "unprognostic (2.17e-3)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" "unprognostic (7.32e-2)" "prognostic favorable (9.13e-4)" 4.0 4.2 2.4 5.4 3.3 5.8 4.0 6.4 3.5 4.1 2.2 5.4 7.2 4.0 4.2 4.0 4.5 2.4 13.6 2.6 3.5 4.6 8.4 3.9 5.8 2.9 2.7 2.9 5.2 9.0 3.4 5.2 2.9 3.5 3.6 5.1 5.4 4.8 2.2 11.0 5.5 7.0 3.2 1.7 4.9 4.6 1.9 3.0 6.0 4.9 11.8 4.9 4.1 4.1 3.3 4.2 3.5 4.1 5.3 3.2 4.4 6.1 4.0 3.2 3.5 4.6 7.8 7.7 11.1 6.5 2.0 3.3 4.0 8.7 4.7 3.8 9.2 2.8 8.2 5.1 6.7 4.4 13.9 10.1 3.4 3.2 3.7 2.4 4.1 6.3 8.4 13.8 8.0 3.3 7.4 18.7 6.8 4.3 8.7 3.1 10.2 1.4 7.2 5.2 4.2 9.4 3.4 4.1 6.8 4.1 5.8 6.0 5.7 5.4 2.3 3.1 5.7 4.0 14.8 15.4 13.2 4.0 14.7 3.7 13.6 5.7 8.7 5.0 5.0 3.9 6.3 6.3 6.0 4.7 7.8 7.2 7.1 12.1 4.5 3.7 7.8 7.2 2.9 2.4 3.3 6.4 3.5 2.6 3.5 2.9 2.7 2.9 3.5 1.7 3.0 3.3 8.4 6.4 15.4 0.0 17.6 0.0 8.7 0.0 17.1 13.5 5.9 3.7 0.0 8.6 5.6 7.3 20.9 5.5 13.5 7.9 0.0 5.1 3.5 6.3 5.7 6.9 6.1 27.3 0.0 7.3 4.7 4.8 23.4 8.2 1.3 10.6 11.4 23.4 7.8 18.5 0.0 9.6 0.0 17.6 0.0 1.6 6.2 12.9 0.0 0.0 15.9 5.1 12.3 0.0 0.0 7.5 5.6 5.7 21.3 10.2 13.9 8.5 3.6 19.8 13.1 8.0 4.2 9.2 4.8 12.0 0.0 9.2 14.5 7.8 8.4 9.4 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49869935 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 97.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" Yes NA Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 0.0 0.9 49.6 0.0 97.5 0.0 0.0 0.0 90.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.5 42.9 0.0 0.0 0.0 0.0 18.5 11.1 92.0 0.0 0.0 0.0 8.6 0.0 24.4 0.0 0.0 7.5 0.0 0.0 0.0 0.1 0.1 0.0 5.4 0.0 0.1 2.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.2 7.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.1 0.9 0.2 34.1 0.0 0.2 1.3 0.0 6.9 0.0 0.0 17.7 8.3 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 49.6 97.5 0.0 90.2 78.5 42.9 18.5 11.1 92.0 24.4 5.4 27.8 46.7 0.0 0.0 0.0 3.9 0.0 0.3 0.0 0.0 0.0 12.2 0.1 0.1 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 1.2 0.0 32.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 27.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 4.7 0.0 0.2 0.0 2.5 3.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.3 0.0 0.0 0.1 0.0 MON1A "MGC13272, SAND1" ENSG00000164077 "MON1 homolog A, secretory trafficking associated" Q86VX9 3 49907160-49930173 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053752, HPA058032" Uncertain Approved Cytosol NA NA Cytosol "HPA053752: AB_2682250, HPA058032: AB_2683584" "unprognostic (1.81e-2)" "unprognostic (6.34e-2)" "unprognostic (1.48e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-2)" "unprognostic (3.51e-2)" "unprognostic (3.29e-2)" "unprognostic (2.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.30e-4)" "unprognostic (5.23e-2)" "unprognostic (2.07e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-1)" 5.9 8.3 13.3 3.2 13.4 2.2 5.6 11.7 18.3 6.1 8.4 8.6 15.3 7.1 1.3 7.8 4.5 1.9 7.8 13.3 12.2 7.6 11.9 5.3 2.8 12.5 13.0 14.0 4.8 7.2 3.1 9.6 2.3 13.6 6.8 1.7 1.6 4.8 3.0 14.8 6.4 9.9 2.8 12.1 5.4 7.0 13.8 12.8 3.8 7.7 5.3 2.2 7.9 6.3 13.1 5.7 4.7 2.8 8.9 8.9 5.2 4.0 8.0 3.9 7.6 8.5 7.0 3.7 17.4 7.2 7.5 6.6 7.1 6.2 10.1 3.2 14.5 15.6 7.6 5.5 9.2 11.0 8.9 10.5 7.3 10.8 14.8 5.1 3.9 11.1 7.3 11.9 5.9 5.8 9.4 10.2 13.1 6.4 12.4 23.9 6.3 3.2 13.4 5.4 4.1 8.1 5.0 3.4 6.6 8.4 1.9 5.1 6.0 8.9 5.0 6.0 14.0 13.0 12.3 13.2 10.7 7.7 13.7 7.6 0.2 8.0 4.3 13.8 6.2 15.9 12.2 11.6 14.3 9.8 5.2 14.1 11.6 2.5 17.7 5.2 4.9 13.1 10.4 13.3 13.4 11.7 18.3 13.3 12.2 12.5 13.0 14.0 13.6 12.1 12.8 13.1 8.8 3.2 5.4 5.2 3.5 14.9 2.5 6.1 9.1 3.3 4.5 3.6 7.3 1.5 4.2 1.8 4.2 4.6 5.0 5.9 1.9 4.8 14.9 2.5 3.8 6.1 6.7 7.8 5.1 6.7 3.3 3.9 8.2 2.1 4.5 2.8 4.6 14.3 5.4 0.0 5.1 5.6 6.1 3.5 4.2 33.4 3.4 2.4 5.4 1.9 3.0 4.5 7.2 4.5 4.2 12.9 5.9 5.7 8.1 6.0 15.9 13.1 3.6 2.9 0.0 4.5 7.3 16.2 7.2 11.1 9.1 4.0 6.1 6.5 7.1 2.6 MST1R "CD136, CDw136, PTK8, RON, SEA" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 62.8;stomach 1: 43.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 2.7 0.3 0.9 5.1 1.0 0.2 3.9 1.0 1.7 4.7 1.0 22.0 25.5 1.3 1.2 17.6 1.7 11.5 2.4 1.0 0.8 3.4 1.1 9.6 2.5 0.8 0.7 0.9 1.0 5.8 0.1 2.7 0.9 0.9 4.7 20.3 0.2 5.5 1.0 1.3 62.8 24.1 2.0 0.6 1.6 43.0 8.5 0.8 8.8 3.5 0.7 5.6 9.3 11.6 0.9 39.3 14.4 0.1 0.6 0.0 0.0 2.2 0.5 0.1 0.0 0.0 4.1 98.8 1.7 8.8 0.5 0.1 56.3 0.0 59.4 0.0 0.9 1.0 0.1 25.9 0.9 0.9 0.0 1.2 0.3 83.4 0.2 11.7 0.2 0.1 0.2 0.8 0.3 0.0 5.1 0.1 0.1 0.3 33.1 34.6 2.9 0.0 1.1 35.8 67.9 1.0 0.1 11.5 22.6 0.2 0.1 17.7 0.9 0.3 0.0 0.3 0.3 0.1 0.5 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 1.0 1.0 1.7 1.0 0.8 0.8 0.7 0.9 0.9 0.6 0.8 0.9 1.6 25.6 10.3 0.7 1.0 8.8 2.2 14.2 6.8 0.0 2.8 2.5 1.0 0.0 10.6 0.0 0.0 0.1 0.2 53.9 0.0 6.4 15.4 2.9 0.8 0.6 4.2 0.0 1.1 10.0 0.4 0.8 108.6 5.3 0.0 0.1 0.0 0.0 0.1 0.0 1.1 25.7 2.0 0.0 1.4 10.5 0.3 0.5 0.0 1.0 0.6 0.0 1.0 2.0 0.1 31.2 30.3 0.0 0.5 2.2 27.6 0.1 7.6 0.0 0.0 0.5 0.9 1.3 1.5 3.2 4.7 0.0 0.5 0.0 20.1 6.2 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.5 4.9 5.5 3.8 6.2 6.1 4.6 6.4 5.5 4.8 3.2 5.2 2.6 5.7 4.2 4.0 4.7 2.7 4.1 5.2 5.4 3.9 7.9 4.9 4.2 5.8 6.0 5.2 5.3 5.3 3.8 4.6 4.9 6.0 4.5 3.4 7.6 4.5 3.9 7.2 5.6 5.0 4.2 5.4 5.2 5.3 5.0 6.4 6.3 4.6 5.4 5.2 4.8 4.3 6.4 6.6 5.1 12.8 12.7 7.0 5.0 6.7 5.5 7.8 7.4 6.9 9.1 3.8 17.4 1.5 9.7 7.8 5.0 20.5 6.8 9.1 9.2 4.6 14.9 11.5 6.0 6.4 16.8 8.5 5.8 5.4 11.3 10.9 4.6 8.3 14.8 10.3 9.1 5.9 5.1 15.0 7.6 10.2 3.2 5.5 6.9 9.9 2.3 3.8 8.4 5.2 10.0 8.7 8.2 5.7 7.7 5.4 9.9 10.9 7.7 8.9 8.0 10.8 9.8 10.7 16.8 8.3 9.2 10.0 3.1 2.2 2.2 3.3 2.6 3.5 1.8 2.9 2.8 2.3 2.9 1.9 2.3 0.9 3.0 3.5 2.3 2.9 2.2 5.5 6.2 6.4 5.5 5.2 5.4 5.8 6.0 5.2 6.0 5.4 6.4 6.4 10.8 9.6 14.4 31.3 11.3 9.2 8.6 6.7 3.4 33.8 8.7 8.0 11.0 15.7 7.8 9.2 31.3 19.3 12.2 7.7 1.9 9.3 7.5 9.5 12.0 15.1 16.3 3.8 54.9 10.4 8.7 9.6 9.2 19.8 18.3 14.2 10.4 21.9 8.9 47.1 54.3 8.1 4.1 9.1 8.4 3.1 15.2 9.4 14.2 26.2 13.2 9.1 30.9 42.7 42.3 13.9 9.7 17.0 11.3 12.4 4.6 4.4 9.5 29.9 13.1 17.1 11.6 43.9 36.4 5.5 8.9 29.7 12.5 10.1 7.9 12.5 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264, ER-phagy receptor" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 374.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favorable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 34.0 74.0 40.5 23.3 42.4 22.5 35.9 45.7 52.1 37.4 47.2 40.3 39.3 34.5 41.5 41.4 44.4 40.1 39.4 40.4 43.4 67.7 65.8 30.1 33.8 43.6 42.1 40.3 31.6 54.7 89.3 26.4 29.7 42.8 45.5 34.8 20.6 59.2 47.4 34.5 67.6 37.9 26.5 42.8 41.2 47.1 112.4 42.3 29.4 49.1 29.8 26.5 36.2 35.2 44.9 36.5 65.5 11.6 59.3 116.8 56.4 23.5 31.0 72.0 50.1 50.1 35.2 84.2 51.6 21.9 44.1 84.2 34.7 32.7 61.6 23.7 42.0 51.9 49.6 40.2 47.8 104.0 31.5 53.6 74.8 96.9 56.3 57.1 45.3 36.9 39.0 26.6 87.7 51.9 42.1 50.9 73.3 12.6 59.8 72.7 24.3 15.3 98.7 79.7 50.1 16.5 26.8 37.4 101.5 48.0 15.7 49.6 66.0 27.3 49.8 20.8 53.0 41.2 61.0 71.3 26.4 61.5 65.9 50.9 99.2 110.1 69.3 119.7 115.6 120.3 98.6 122.6 113.6 104.6 102.4 100.9 103.1 23.5 76.1 115.6 92.4 159.9 139.9 40.5 42.4 45.7 52.1 40.4 43.4 43.6 42.1 40.3 42.8 42.8 42.3 44.9 63.6 35.3 21.9 12.4 36.7 34.8 46.7 123.9 45.5 33.5 69.9 68.2 24.4 65.8 68.2 99.3 58.4 142.9 52.3 70.3 62.6 83.1 57.7 44.9 31.8 54.8 32.9 24.8 6.5 75.7 88.9 41.4 29.0 48.2 16.5 45.3 38.9 63.1 105.4 42.1 9.1 56.5 118.0 48.3 45.5 61.2 51.0 47.8 65.8 8.4 56.1 62.6 89.6 7.5 12.3 59.6 76.4 48.9 36.0 45.6 137.6 126.7 49.7 55.4 26.3 30.8 30.7 374.8 111.7 46.3 35.4 76.3 61.9 110.4 86.0 49.9 GRM2 "GPRC1B, mGlu2, MGLUR2" ENSG00000164082 "Glutamate metabotropic receptor 2" Q14416 3 51707068-51718613 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "brain: 6.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.6;Cone photoreceptor cells: 6.2;Excitatory neurons: 16.2;Spermatocytes: 3.5" "Cancer enriched" "Detected in single" 4 "testis cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027868, HPA065166" Approved Supported NA NA "HPA027868: , HPA065166: AB_2685425" "unprognostic (1.01e-1)" "unprognostic (8.61e-4)" "unprognostic (7.66e-2)" "unprognostic (7.29e-3)" "unprognostic (1.98e-1)" "unprognostic (3.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.45e-1)" "unprognostic (1.74e-1)" "unprognostic (1.37e-2)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (2.93e-2)" "unprognostic (1.19e-2)" 0.2 0.0 0.9 0.0 2.3 0.4 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.8 0.6 0.0 0.0 0.1 0.0 4.6 0.9 2.1 0.0 0.1 0.0 0.1 0.0 6.4 0.1 0.0 0.4 0.1 0.0 0.3 0.4 0.1 0.0 0.0 0.2 0.0 0.6 0.9 0.1 0.1 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 0.0 2.5 1.8 0.6 4.6 0.9 2.1 6.4 0.0 0.9 3.4 0.4 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.1 0.0 0.0 0.0 6.2 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.1 1.5 0.0 0.0 16.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.4 0.0 1.0 0.8 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.0 0.0 0.2 0.1 3.5 1.1 0.2 0.3 0.0 0.1 0.2 0.0 0.1 DUSP7 "MKP-X, PYST2" ENSG00000164086 "Dual specificity phosphatase 7" Q16829 3 52048919-52056571 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 64.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.3;Squamous epithelial cells: 51.6;Suprabasal keratinocytes: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTCEpi: 109.8;hTERT-HME1: 92.6" "Low region specificity" "Detected in all" HPA073007 Approved NA NA "HPA073007: " "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (6.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-1)" "unprognostic (8.67e-3)" "unprognostic (7.38e-3)" "unprognostic (7.74e-3)" "prognostic unfavorable (8.84e-6)" "unprognostic (4.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.29e-2)" "unprognostic (9.46e-2)" 13.1 10.1 21.8 7.7 26.5 3.6 11.6 18.2 27.4 20.1 8.1 8.2 4.2 14.7 4.0 64.7 10.2 8.7 21.8 23.5 20.4 10.6 5.3 25.1 10.3 24.9 26.5 21.2 8.8 7.1 6.3 7.2 14.2 28.3 11.6 3.9 2.6 13.3 8.0 23.3 55.4 7.9 6.8 18.2 26.4 9.2 12.1 25.0 8.1 9.2 20.6 10.9 13.6 45.9 36.5 21.3 4.4 5.2 11.9 16.4 14.1 6.2 21.0 39.8 20.4 14.7 5.8 10.6 5.8 5.7 31.3 10.3 24.6 19.8 76.0 13.8 5.0 8.1 27.8 10.9 10.3 13.3 25.1 16.2 14.8 109.8 26.5 92.6 14.1 19.8 16.8 16.2 16.4 16.5 5.9 18.7 35.2 12.9 5.9 37.6 15.5 4.5 15.6 8.5 9.1 6.5 19.0 9.4 8.5 14.9 4.2 3.0 59.4 26.0 39.1 25.3 41.7 65.4 7.9 7.9 9.3 21.7 41.5 12.7 0.9 3.4 1.7 5.3 10.3 7.2 0.9 6.3 3.8 4.7 0.5 4.5 4.1 1.3 2.5 10.3 7.1 4.5 1.7 21.8 26.5 18.2 27.4 23.5 20.4 24.9 26.5 21.2 28.3 18.2 25.0 36.5 17.0 9.6 1.1 0.0 2.9 117.3 31.5 13.5 21.1 4.9 6.6 7.2 18.9 0.0 5.2 0.0 0.0 0.6 13.4 1.6 1.9 3.1 1.7 2.9 8.1 18.7 2.4 1.7 5.5 2.6 4.3 7.8 0.5 2.8 0.0 1.3 23.6 0.9 8.1 0.0 4.4 2.5 0.0 16.7 12.0 0.5 8.7 9.0 21.4 5.6 10.3 0.9 9.2 5.5 20.2 12.1 1.3 4.9 1.6 17.5 0.6 1.3 1.5 1.0 26.3 3.3 8.6 3.5 5.5 51.6 135.2 1.2 7.3 4.1 3.4 29.3 POC1A "DKFZP434C245, WDR51A" ENSG00000164087 "POC1 centriolar protein A" Q8NBT0 3 52075226-52154690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Dwarfism, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.9;testis: 17.7" "Cell type enhanced" "Detected in many" "Early spermatids: 47.9;Extravillous trophoblasts: 33.8;Late spermatids: 73.4;Spermatocytes: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040600 Approved NA Yes "HPA040600: AB_10672837" "unprognostic (2.68e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.78e-4)" "unprognostic (5.08e-2)" "unprognostic (3.61e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-3)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (9.43e-7)" "unprognostic (9.90e-3)" "unprognostic (1.96e-1)" "unprognostic (3.62e-2)" "unprognostic (2.32e-2)" 1.3 4.1 1.6 4.0 1.5 11.2 2.2 1.4 1.8 1.2 1.2 6.0 4.9 1.0 1.0 4.7 1.7 1.1 1.3 1.6 2.1 1.7 5.3 1.9 5.4 1.7 1.6 1.6 0.7 0.9 1.1 0.7 4.2 1.8 1.3 6.1 0.4 1.4 1.0 1.5 2.7 4.0 2.9 1.6 2.9 2.8 17.7 1.6 12.9 1.0 1.0 7.1 2.1 1.8 2.1 30.1 25.2 25.0 33.5 5.1 6.5 33.9 30.0 28.7 62.8 48.7 22.1 31.0 31.3 8.8 23.9 48.6 18.3 38.0 33.9 45.3 26.0 16.0 21.4 26.3 23.9 1.4 24.5 13.0 3.6 7.3 49.6 25.9 8.7 29.0 46.2 18.8 32.9 37.5 23.8 45.6 44.2 19.1 33.7 41.0 19.6 19.7 30.0 14.2 21.0 11.6 16.7 24.0 23.7 18.3 26.0 29.2 45.7 9.7 28.6 27.6 46.3 49.3 27.8 49.1 26.6 19.2 42.6 29.1 0.0 1.6 0.0 1.2 2.2 0.1 0.9 0.8 0.4 1.9 0.5 0.7 0.4 0.5 1.4 1.6 1.9 2.6 1.1 1.6 1.5 1.4 1.8 1.6 2.1 1.7 1.6 1.6 1.8 1.6 1.6 2.1 0.9 0.0 1.3 0.3 2.5 1.7 1.6 4.7 0.0 0.7 2.1 2.2 0.7 0.0 1.4 1.8 0.0 21.8 0.9 4.4 0.0 1.8 47.9 4.5 1.0 2.9 1.8 15.6 2.3 3.0 33.8 3.4 2.0 1.5 0.0 11.3 1.8 4.2 12.9 1.7 1.4 5.4 0.0 2.6 3.4 73.4 1.2 2.6 1.8 1.9 2.7 0.8 1.0 0.0 2.7 2.1 2.2 0.4 12.9 1.3 3.0 3.2 4.2 0.0 0.0 1.1 3.4 40.1 21.2 4.9 1.8 7.5 1.6 4.4 8.4 2.1 PPM1M "FLJ32332, PP2Ceta" ENSG00000164088 "Protein phosphatase, Mg2+/Mn2+ dependent 1M" Q96MI6 3 52245759-52250599 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036905, HPA062291" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA036905: AB_10602818, HPA062291: AB_2684740" "unprognostic (4.26e-3)" "prognostic favorable (7.73e-4)" "unprognostic (2.55e-2)" "unprognostic (4.85e-3)" "unprognostic (5.64e-2)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "prognostic favorable (6.69e-4)" "unprognostic (4.63e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.49e-1)" "unprognostic (4.14e-2)" "unprognostic (9.27e-2)" "unprognostic (4.37e-2)" 19.6 9.4 11.8 20.4 13.2 24.8 15.6 9.6 13.7 24.9 11.7 15.2 6.1 18.4 10.0 12.4 18.2 14.2 10.5 13.0 13.6 10.8 5.7 23.7 29.9 12.2 10.8 12.0 18.8 8.0 11.2 9.1 11.7 11.2 16.8 8.8 2.2 11.7 15.4 3.8 10.7 13.2 18.1 12.0 30.4 11.5 8.9 13.1 27.8 13.9 7.9 28.4 17.6 18.4 12.9 0.9 5.4 3.2 7.6 46.1 45.7 5.2 12.2 26.2 17.0 13.1 3.2 4.2 9.0 3.6 32.0 9.5 1.5 10.9 2.3 6.9 11.0 2.7 20.5 14.6 3.3 33.6 3.1 18.7 37.8 5.2 18.9 11.9 27.3 22.2 40.5 3.6 14.5 20.2 2.2 13.7 0.9 4.1 4.0 14.7 3.0 1.6 20.0 7.3 2.6 2.3 9.3 9.0 2.2 11.1 6.8 7.6 7.9 15.5 6.5 10.7 3.8 1.6 54.3 11.2 9.9 12.7 5.4 8.0 1.8 24.1 13.3 20.6 19.3 15.9 6.8 16.1 19.2 14.4 7.4 15.2 19.0 28.9 11.7 29.6 8.5 20.5 17.5 11.8 13.2 9.6 13.7 13.0 13.6 12.2 10.8 12.0 11.2 12.0 13.1 12.9 6.8 0.0 5.4 1.3 15.4 5.1 6.5 0.7 8.0 1.6 5.9 7.2 1.8 5.7 2.0 1.8 0.0 3.3 25.9 0.7 3.9 1.8 9.7 4.7 8.9 7.0 1.2 3.0 1.5 1.1 5.8 11.9 3.1 11.0 5.7 7.3 12.5 3.7 42.2 1.7 0.6 0.4 2.0 39.0 17.0 18.0 12.8 31.1 5.4 4.7 29.1 5.1 30.9 1.5 0.7 1.3 3.2 9.8 11.4 2.3 0.9 3.0 0.9 0.7 19.7 5.2 7.3 0.7 4.2 11.9 3.8 1.9 25.1 3.1 1.0 3.5 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742048-108763054 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 156.3;liver: 192.6" "Cell type enriched" "Detected in some" 8 "Astrocytes: 219.4" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Supported Approved Nucleoplasm Yes NA Nucleoplasm "HPA044546: AB_10962867, HPA072938: AB_2686560" "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favorable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 0.1 5.5 156.0 0.1 126.1 0.0 0.1 93.8 145.6 0.1 41.2 0.0 0.2 0.3 0.0 0.1 0.0 0.2 7.5 124.7 122.9 9.2 192.6 0.1 0.0 145.7 115.9 103.7 0.1 0.0 2.9 1.9 0.0 156.3 0.0 0.0 1.7 34.7 0.1 2.5 0.0 0.0 0.0 79.0 0.7 18.4 0.5 110.6 0.1 1.1 1.5 0.0 0.0 0.0 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.0 126.1 93.8 145.6 124.7 122.9 145.7 115.9 103.7 156.3 79.0 110.6 109.3 0.0 0.0 0.0 219.4 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 14.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.5 1.5 0.4 0.0 0.0 0.7 26.8 0.0 0.0 0.6 0.0 0.0 1.6 0.0 1.7 0.0 0.0 0.0 7.5 0.0 8.5 0.0 1.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 7.9 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 WDR82 "MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A" ENSG00000164091 "WD repeat domain 82" Q6UXN9 3 52254434-52288020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 185.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040427 Supported "Nucleoli rim" NA NA "Nucleoli rim" "HPA040427: AB_2676979" "unprognostic (7.43e-2)" "unprognostic (3.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.15e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (2.92e-3)" "unprognostic (9.32e-2)" "unprognostic (2.04e-1)" "unprognostic (8.54e-2)" "unprognostic (1.26e-1)" 40.7 38.2 35.7 47.3 38.8 56.1 34.3 39.9 36.9 49.0 37.1 37.2 34.1 56.7 30.4 47.1 44.2 35.6 48.4 38.3 39.9 29.0 32.8 36.3 58.2 32.7 36.0 36.5 55.1 28.3 35.6 22.2 43.7 35.4 41.6 39.5 35.8 31.5 49.1 66.1 36.9 33.9 52.7 35.8 49.5 31.7 33.6 40.9 73.8 40.7 67.6 61.3 47.8 36.4 39.0 46.0 54.3 100.4 75.5 93.7 77.3 50.3 76.6 63.3 74.0 61.1 63.9 44.9 121.4 29.2 82.4 64.8 40.7 139.3 82.2 86.2 88.5 53.3 155.9 67.3 65.8 64.9 148.2 78.6 78.1 79.6 87.3 79.3 68.8 79.0 97.7 70.8 84.8 72.4 46.3 115.6 58.1 91.1 60.0 104.2 58.7 67.0 90.8 77.2 83.1 23.9 100.3 82.1 24.5 47.8 67.4 46.4 58.8 81.6 69.0 78.2 72.9 89.3 82.3 129.1 120.6 59.0 110.6 77.3 9.4 7.4 10.1 15.3 7.5 18.5 8.8 13.9 15.0 6.5 7.0 15.8 16.2 14.2 8.9 12.0 6.1 12.9 9.8 35.7 38.8 39.9 36.9 38.3 39.9 32.7 36.0 36.5 35.4 35.8 40.9 39.0 45.9 28.9 42.8 12.1 43.0 51.5 33.9 23.5 34.1 54.6 40.7 41.4 53.1 32.9 26.3 14.7 20.9 28.8 66.2 45.4 13.7 17.4 45.3 62.6 71.0 42.7 44.3 41.2 20.4 18.9 31.2 38.3 31.1 91.5 15.2 51.0 40.0 42.9 32.5 62.2 22.0 35.2 12.2 61.9 40.2 185.1 58.4 43.2 37.4 21.5 50.2 36.5 63.8 15.1 18.1 30.4 30.8 62.8 33.4 40.8 26.0 21.7 21.4 35.0 52.6 53.3 36.6 21.5 30.7 41.5 56.8 30.8 62.5 42.9 40.5 40.3 PITX2 "ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS" ENSG00000164093 "Paired like homeodomain 2" Q99697 4 110617423-110642123 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease variant, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.3;skeletal muscle: 43.6;urinary bladder: 30.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 19.2;Fibroblasts: 69.6;Paneth cells: 20.6;Proximal enterocytes: 39.7;Skeletal myocytes: 49.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "hypothalamus: 16.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 24.8;HEK 293: 10.5;LHCN-M2: 25.1;RH-30: 20.5" "Group enriched" "Detected in some" 25 "hypothalamus: 5.4;midbrain: 1.5" "HPA050074, HPA062728" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050074: AB_2681005, HPA062728: AB_2684851" "unprognostic (1.08e-1)" "unprognostic (1.23e-2)" "unprognostic (9.29e-2)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-2)" "unprognostic (9.61e-4)" "unprognostic (3.22e-2)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.11e-15)" "unprognostic (6.97e-3)" "unprognostic (1.43e-1)" "unprognostic (5.98e-2)" "unprognostic (9.91e-2)" 0.2 0.0 0.0 7.8 0.2 0.0 0.4 0.0 0.0 0.9 0.0 3.9 0.0 0.1 0.0 2.6 0.2 1.1 2.0 0.0 16.3 0.2 0.0 0.0 0.0 3.7 2.2 0.0 0.0 0.5 0.0 16.3 42.3 0.1 0.9 0.2 0.0 13.6 0.1 43.6 0.9 3.2 0.5 0.2 0.0 0.5 0.5 5.0 0.0 0.0 12.4 0.0 30.1 3.9 0.3 1.4 2.6 0.0 1.0 2.4 2.1 4.0 0.8 0.4 2.6 2.0 24.8 0.0 0.0 5.2 5.1 3.2 0.4 0.1 0.0 1.4 0.0 10.5 0.0 2.0 0.0 8.8 0.0 5.0 2.5 0.2 0.5 0.0 0.8 0.0 2.7 0.6 0.0 25.1 0.7 2.7 0.0 0.4 0.0 0.5 0.0 20.5 0.0 0.4 3.4 0.0 0.0 2.0 3.3 0.3 0.4 0.2 0.0 0.0 3.1 7.5 0.0 4.1 0.1 0.1 1.0 1.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.3 3.7 2.2 0.0 0.1 0.2 5.0 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.6 0.0 1.2 0.0 0.1 0.3 19.2 0.0 0.1 0.0 0.0 5.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 0.4 5.7 69.6 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 9.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.2 39.7 2.3 0.0 0.0 0.0 49.8 5.4 2.3 7.0 1.7 0.1 10.5 0.0 0.0 14.1 0.1 C4orf3 "ALN, HCVFTP1" ENSG00000164096 "Chromosome 4 open reading frame 3" Q8WVX3 4 119296419-119304445 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1070.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026907 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA026907: AB_10600760" "unprognostic (2.97e-1)" "unprognostic (4.68e-2)" "unprognostic (3.32e-1)" "unprognostic (6.85e-3)" "unprognostic (9.30e-2)" "unprognostic (7.15e-3)" "unprognostic (2.04e-1)" "unprognostic (8.85e-2)" "unprognostic (4.90e-2)" "unprognostic (7.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.84e-1)" "prognostic favorable (3.46e-4)" "unprognostic (8.32e-2)" "unprognostic (2.65e-1)" "unprognostic (3.90e-1)" "unprognostic (1.59e-1)" 80.4 68.5 116.5 54.6 120.6 34.4 70.0 118.6 131.1 97.5 99.2 68.2 61.0 80.3 78.6 270.4 69.5 65.7 104.4 106.7 115.8 92.7 111.7 71.0 61.8 125.1 120.7 100.1 86.3 51.9 55.9 57.0 60.8 121.5 72.5 44.0 75.4 90.3 70.5 80.2 89.7 67.9 71.2 126.5 63.6 50.0 40.2 121.5 65.4 72.1 60.2 57.2 76.6 151.5 129.1 116.8 13.7 58.4 49.8 107.1 97.0 34.1 59.3 31.6 35.3 62.6 15.6 44.5 95.9 36.6 87.3 31.0 24.8 29.6 54.1 61.8 57.1 21.3 40.9 33.5 67.9 35.9 64.7 42.8 96.4 64.5 30.0 14.4 120.6 52.8 29.1 33.8 50.4 137.6 41.8 50.9 64.0 24.2 60.7 20.9 32.9 62.6 27.3 53.5 32.2 38.4 54.8 46.4 58.5 43.2 56.9 32.6 37.5 55.7 80.3 34.6 52.5 21.4 51.3 59.8 37.2 156.7 36.7 40.9 257.8 110.0 145.4 85.1 132.6 92.9 126.7 109.6 101.5 95.1 104.8 120.4 114.4 239.4 109.6 128.0 131.6 112.9 157.1 116.5 120.6 118.6 131.1 106.7 115.8 125.1 120.7 100.1 121.5 126.5 121.5 129.1 213.2 157.0 150.5 11.4 211.3 315.5 292.0 809.1 132.1 79.1 198.4 191.9 544.4 158.7 456.3 222.5 25.0 321.5 228.9 117.0 383.5 288.5 38.1 272.5 148.7 245.6 68.4 78.6 22.2 179.1 403.9 215.0 46.4 134.3 186.1 108.0 234.9 446.4 317.4 153.1 21.6 170.2 408.9 303.5 298.4 31.0 167.4 244.9 199.3 16.9 423.9 233.4 253.3 6.6 16.3 207.6 196.8 215.5 239.0 392.5 500.1 1070.2 542.7 78.9 197.2 145.8 246.0 182.7 67.0 245.9 346.6 445.7 203.2 150.3 135.8 428.1 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" NA NA "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favorable (2.66e-4)" "prognostic favorable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.6 0.5 1.4 1.6 0.9 0.1 2.3 0.7 1.4 14.5 11.6 6.8 2.7 1.9 0.7 3.3 10.6 9.9 0.0 2.8 0.6 0.8 0.6 7.6 0.1 0.5 1.8 0.5 1.7 7.7 0.1 0.6 10.7 0.5 1.4 6.4 0.3 2.5 2.0 0.2 6.0 4.8 1.3 0.5 0.0 9.3 10.1 0.8 1.0 0.2 1.3 5.8 3.9 12.7 0.6 5.2 0.2 1.8 0.0 0.2 13.3 0.1 46.0 41.5 9.7 16.1 0.1 18.7 0.0 0.2 70.2 4.9 0.8 31.1 9.5 12.7 0.2 7.2 0.0 3.6 0.0 1.4 0.0 0.2 4.1 17.5 3.4 9.9 31.2 0.1 0.6 0.0 0.0 8.0 0.3 0.5 9.6 2.2 36.4 2.9 0.0 38.7 0.0 0.0 7.0 5.1 215.4 0.0 0.2 3.0 30.9 0.0 100.6 0.0 19.2 2.8 12.2 9.1 1.0 0.1 0.0 1.0 3.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.7 1.4 2.8 0.6 0.5 1.8 0.5 0.5 0.5 0.8 0.6 0.3 6.4 4.6 0.7 0.2 8.4 0.8 16.4 2.2 0.6 0.8 0.8 1.4 10.0 34.3 1.8 0.0 48.0 0.0 26.8 0.0 0.4 9.9 19.7 16.8 0.9 5.3 0.0 10.5 10.2 4.5 7.1 17.9 2.6 7.0 3.3 0.0 0.4 3.8 0.0 14.3 2.7 10.2 0.0 4.2 18.3 0.0 0.4 5.4 7.5 0.0 0.0 0.0 0.5 0.2 8.1 12.8 0.0 0.2 0.4 9.4 0.6 76.1 0.2 0.0 0.6 4.9 10.1 13.3 3.6 4.3 11.9 0.7 21.8 5.3 4.7 NDST3 HSST3 ENSG00000164100 "N-deacetylase and N-sulfotransferase 3" O95803 4 118033618-118258634 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.5;liver: 1.3;lymphoid tissue: 2.9;retina: 2.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 299.6;Inhibitory neurons: 128.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "MOLT-4: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056189 Uncertain NA NA "HPA056189: AB_2683061" "unprognostic (1.95e-2)" "unprognostic (7.58e-2)" "unprognostic (4.34e-3)" "unprognostic (2.55e-7)" "unprognostic (4.05e-2)" "unprognostic (2.18e-2)" "unprognostic (2.86e-3)" "unprognostic (2.32e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-2)" "unprognostic (7.43e-2)" "unprognostic (1.99e-2)" "unprognostic (1.09e-3)" "unprognostic (1.37e-1)" "unprognostic (4.39e-3)" "unprognostic (6.83e-2)" "unprognostic (8.85e-2)" 0.0 0.5 0.7 0.0 4.5 0.0 0.0 3.7 3.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 1.9 0.1 1.3 0.0 0.1 0.8 2.1 2.4 0.1 0.0 0.0 0.5 0.0 2.1 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.5 2.9 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.5 3.7 3.0 1.7 1.9 0.8 2.1 2.4 2.1 0.0 0.5 0.6 0.2 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 20.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 299.6 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.6 0.1 6.7 128.6 0.2 0.0 42.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 12.1 18.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331376-173334432 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "bone marrow: 2367.6;lymphoid tissue: 947.8" "Cell type enhanced" "Detected in all" "Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 798.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 2454.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli "Secreted to blood" NA Yes 1200000 Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: " "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 90.2 31.3 36.5 147.4 37.9 2367.6 89.9 35.5 50.4 79.6 33.9 118.2 94.0 93.2 47.7 116.5 79.5 43.9 86.6 33.3 38.7 51.8 38.1 84.5 393.6 38.2 37.8 32.2 119.9 27.4 18.4 35.6 111.9 38.1 47.3 123.3 135.3 60.3 35.5 73.0 71.4 109.6 66.1 36.4 160.7 66.6 137.2 37.1 947.8 56.9 57.5 392.0 68.8 86.8 43.7 498.2 114.6 976.8 444.4 118.2 118.2 375.1 366.3 271.3 386.7 345.7 329.0 673.6 1645.5 79.2 203.0 207.4 190.3 645.0 196.1 601.0 1004.0 303.4 1823.2 308.8 487.8 115.7 1642.8 683.4 114.7 59.2 194.2 439.1 211.5 402.8 866.1 703.9 2282.4 358.9 409.9 2454.9 1513.7 355.4 289.4 199.3 1226.7 499.7 620.4 227.0 208.8 838.6 759.0 365.5 209.6 166.6 340.8 291.1 1173.2 236.0 175.5 513.6 219.0 554.9 734.8 437.1 1869.4 149.1 1178.4 464.4 798.0 135.9 407.0 94.1 57.6 86.2 72.5 137.8 131.1 112.8 57.6 88.4 85.3 316.7 83.0 49.1 43.2 266.4 107.6 36.5 37.9 35.5 50.4 33.3 38.7 38.2 37.8 32.2 38.1 36.4 37.1 43.7 167.0 28.9 64.1 5.9 153.2 158.8 141.5 131.8 75.1 48.9 75.3 107.8 229.0 38.6 78.3 55.2 35.5 472.6 222.9 116.5 142.8 25.9 30.4 71.2 71.7 128.0 74.7 1915.4 2.7 16.1 872.5 121.5 63.2 76.5 110.6 210.5 171.7 26.5 210.1 45.4 4.7 191.2 109.9 295.0 142.9 33.1 105.3 233.9 67.6 6.5 241.9 81.8 132.8 1.0 4.8 11.3 75.2 57.6 268.6 114.2 65.4 51.0 149.8 143.5 78.9 71.7 134.4 493.6 400.9 233.6 134.0 128.7 289.5 42.3 284.7 89.0 SAP30 ENSG00000164105 "Sin3A associated protein 30" O75446 4 173369969-173377532 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 77.2;Macrophages: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 181.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022627, HPA059012" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB022627: , HPA059012: AB_2683880" "unprognostic (1.53e-1)" "unprognostic (3.67e-2)" "unprognostic (3.26e-1)" "unprognostic (1.39e-1)" "unprognostic (5.83e-2)" "unprognostic (8.71e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (4.95e-2)" "unprognostic (7.23e-2)" "unprognostic (3.93e-2)" "unprognostic (4.48e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (3.97e-1)" "unprognostic (5.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" 16.8 13.0 17.8 13.5 20.0 23.6 12.9 19.3 21.8 13.4 16.5 20.7 9.6 13.3 9.6 10.0 17.0 8.7 18.0 17.3 18.6 6.2 9.1 12.9 8.1 19.8 18.6 15.8 14.7 7.3 4.5 8.1 7.2 19.5 11.5 7.1 16.4 11.7 9.8 10.6 8.5 12.6 12.5 19.5 15.8 18.6 24.9 18.7 10.4 10.7 7.4 6.6 19.7 12.7 26.0 49.0 16.3 46.3 45.2 29.0 17.9 10.1 22.5 19.3 24.7 30.4 7.0 19.4 43.9 10.3 26.3 31.1 12.0 37.8 19.1 18.9 49.6 35.9 58.7 39.6 20.0 27.5 34.0 35.9 29.8 9.2 21.1 21.2 34.7 29.3 31.5 30.8 181.4 32.2 20.9 48.4 38.0 20.5 21.7 31.3 38.9 16.5 31.6 15.1 7.8 37.5 79.1 31.8 31.9 14.9 11.8 13.5 20.0 29.1 17.6 23.9 41.4 52.8 101.5 39.1 41.8 56.8 81.6 51.2 0.4 1.3 0.0 0.6 0.7 0.2 0.1 0.3 0.4 1.0 0.2 0.0 0.2 0.5 0.0 0.4 0.0 0.4 0.2 17.8 20.0 19.3 21.8 17.3 18.6 19.8 18.6 15.8 19.5 19.5 18.7 26.0 42.1 0.0 2.3 11.1 7.2 51.7 6.6 3.9 16.5 26.2 25.5 29.3 28.9 4.3 3.7 7.3 22.9 2.1 22.5 4.8 0.0 2.2 23.1 23.6 34.3 27.3 19.7 20.2 12.5 3.5 9.3 19.9 19.4 7.4 7.0 13.5 14.6 9.0 9.3 25.2 14.6 10.5 0.0 77.2 13.8 6.2 10.2 77.0 33.8 3.7 15.2 57.7 2.1 7.1 15.4 2.4 2.7 6.4 17.6 8.6 6.4 6.2 9.9 46.3 52.6 12.5 31.7 63.7 15.2 16.1 53.0 1.2 27.0 12.3 11.1 4.1 SCRG1 SCRG-1 ENSG00000164106 "Stimulator of chondrogenesis 1" O75711 4 173384701-173406380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;choroid plexus: 14.5" "Cell type enhanced" "Detected in many" "Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1" "Cancer enriched" "Detected in many" 6 "glioma: 35.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "WM-115: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012882 Approved "Secreted in brain" NA NA 240000 "HPA012882: AB_1856635" "unprognostic (1.09e-1)" "unprognostic (1.83e-2)" "unprognostic (2.60e-5)" "unprognostic (2.58e-1)" "unprognostic (3.22e-2)" "unprognostic (7.51e-2)" "unprognostic (3.58e-2)" "unprognostic (1.14e-3)" "unprognostic (2.08e-1)" "unprognostic (2.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (3.95e-10)" "unprognostic (4.86e-2)" "unprognostic (2.21e-1)" "unprognostic (4.34e-3)" "unprognostic (8.74e-4)" 1.3 0.8 17.9 0.6 19.2 0.7 0.5 19.4 31.0 1.1 14.5 3.2 0.5 1.8 0.9 0.4 2.5 1.5 1.8 18.4 19.5 0.1 0.1 0.4 0.2 21.5 20.1 17.6 0.8 0.3 0.0 1.0 0.2 20.8 2.3 0.5 2.4 1.1 3.3 0.5 0.5 0.9 4.7 20.9 0.5 2.8 10.9 18.5 0.0 0.3 0.0 0.1 2.0 0.8 24.1 0.1 0.0 0.6 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.4 0.2 0.5 0.2 0.1 3.5 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 17.1 1.8 0.5 0.3 0.2 0.4 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.3 1.2 0.5 0.5 0.3 0.1 0.1 17.9 19.2 19.4 31.0 18.4 19.5 21.5 20.1 17.6 20.8 20.9 18.5 24.1 1.3 0.0 3.0 46.4 1.0 3.6 1.1 0.0 0.0 14.5 2.4 3.9 1.3 0.0 0.7 0.0 37.5 0.2 3.3 0.3 0.0 0.3 18.3 0.7 1.7 2.1 1.2 0.0 19.0 0.0 0.4 17.3 1.1 0.4 8.9 0.9 4.2 0.3 0.6 16.8 20.9 0.5 0.0 3.3 2.6 32.3 26.1 3.8 23.2 2.8 1.9 148.3 2.1 102.1 26.4 0.2 0.1 20.7 1.0 1.9 0.4 0.3 0.8 28.3 13.1 2.4 20.3 3.1 2.4 0.1 2.6 0.7 3.1 0.5 0.3 1.0 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.2;intestine: 43.0" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5;stomach cancer: 4.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "SH-SY5Y: 410.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019591, CAB025576" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB025576: , HPA019591: AB_2670199" "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 3.1 28.3 0.0 5.4 0.0 0.0 2.1 0.5 0.0 19.3 0.0 43.0 2.6 33.7 0.3 1.1 16.2 16.4 37.2 0.0 0.0 0.1 5.5 0.0 0.2 0.0 0.0 0.0 15.4 4.2 0.0 0.1 21.0 0.8 1.3 4.4 0.0 0.8 1.0 0.2 1.3 11.1 27.5 0.0 1.1 22.3 0.4 0.0 0.4 1.5 1.1 0.8 12.5 5.3 0.0 0.0 0.1 0.0 0.0 16.6 7.7 0.3 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 17.3 0.0 0.1 1.7 0.0 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 410.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.3 4.1 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.0 0.1 0.1 100.3 2.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.6 0.2 9.0 317.1 2.7 0.0 0.0 0.0 0.4 1.4 30.4 0.0 5.3 0.0 0.0 6.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 2.3 0.9 39.4 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.9 0.1 0.3 0.2 0.3 2.3 1.3 0.6 0.0 0.0 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055623-120066858 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.9;lymphoid tissue: 5.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (5.15e-5)" "prognostic unfavorable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavorable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 0.3 0.4 0.5 2.1 0.7 5.9 1.2 0.9 0.8 0.5 0.3 2.2 1.9 0.7 0.3 1.6 1.4 0.4 0.5 0.6 0.5 0.4 0.5 0.4 4.0 0.5 0.5 0.5 0.5 0.2 0.4 0.1 1.4 0.6 0.6 2.7 1.0 0.3 0.5 0.2 1.0 1.9 0.8 0.5 0.8 0.9 2.4 0.5 5.8 0.4 0.2 3.7 0.7 0.5 0.6 27.2 11.6 26.9 17.5 2.8 3.4 11.5 21.0 11.8 21.5 16.5 15.7 16.3 39.6 6.8 7.6 9.5 7.1 27.1 16.1 30.0 18.8 18.8 22.0 10.5 14.9 0.8 36.3 12.0 1.9 2.3 14.6 9.1 5.4 12.6 16.4 26.7 22.0 11.4 12.0 35.0 15.6 18.3 14.1 13.0 17.8 35.9 16.2 8.7 10.3 28.4 20.1 10.5 12.8 6.5 12.9 8.4 13.0 7.8 14.2 16.1 14.6 27.0 20.1 23.2 25.7 13.3 18.4 19.1 0.9 0.1 0.1 0.4 0.1 0.6 0.5 1.2 1.0 0.1 0.4 1.1 1.1 0.3 0.9 0.2 0.7 1.3 0.5 0.5 0.7 0.9 0.8 0.6 0.5 0.5 0.5 0.5 0.6 0.5 0.5 0.6 2.4 0.0 1.3 1.0 11.5 17.3 7.3 23.5 4.0 9.7 7.2 8.3 3.4 1.5 6.0 7.3 2.1 52.0 7.6 7.5 0.0 3.4 2.4 31.3 6.0 5.4 1.8 81.8 1.3 1.5 119.2 13.7 8.6 7.8 15.2 34.6 3.9 2.9 27.9 20.2 1.2 13.7 36.7 7.3 13.4 4.8 4.7 6.1 8.8 0.0 3.1 12.3 5.2 0.5 1.0 1.6 3.7 1.5 33.1 5.0 3.7 7.2 12.9 3.8 13.1 7.3 14.9 127.8 76.2 26.0 8.9 10.8 20.1 11.9 29.2 8.7 ANXA5 "ANX5, ENX2" ENSG00000164111 "Annexin A5" P08758 4 121667946-121696995 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Blood coagulation, Hemostasis" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 1156.8;Extravillous trophoblasts: 1125.1;Syncytiotrophoblasts: 1140.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003677, HPA035330" Approved Approved "Nuclear membrane" NA NA 5000000 "Nuclear membrane" "CAB003677: AB_425305, HPA035330: AB_2674574" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (9.70e-2)" "prognostic favorable (3.64e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.01e-5)" "prognostic unfavorable (1.64e-5)" "unprognostic (7.33e-3)" "unprognostic (3.09e-1)" "unprognostic (6.04e-2)" "unprognostic (6.49e-3)" "unprognostic (4.54e-1)" "prognostic unfavorable (9.29e-7)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.26e-4)" 495.0 288.9 115.2 243.9 127.1 97.0 316.7 142.3 146.0 432.7 146.1 162.7 97.3 291.4 164.0 136.3 226.9 275.5 204.4 110.8 162.9 175.5 150.7 301.6 137.3 155.2 134.2 104.6 226.7 164.3 134.8 178.0 469.9 150.1 213.6 157.0 78.8 276.2 252.8 85.9 123.3 132.0 373.6 148.6 177.2 187.6 111.4 144.4 63.9 184.4 115.9 136.3 301.0 180.1 160.9 463.5 339.6 438.0 256.1 2094.3 1645.5 503.4 1582.7 1464.9 841.3 744.8 246.2 200.6 35.7 282.9 2224.8 581.7 165.4 287.3 727.6 762.2 335.1 171.2 105.0 281.6 647.4 1213.9 221.1 178.3 945.5 344.7 705.1 665.9 927.4 1120.9 25.2 106.0 271.8 2133.5 306.7 225.5 75.1 231.9 417.7 718.5 8.2 1014.5 72.6 1368.9 66.3 117.1 141.4 579.7 227.6 1515.2 872.3 201.5 261.2 830.6 1322.1 632.1 955.2 478.0 240.8 308.6 76.0 847.8 123.5 1586.2 122.2 725.8 359.9 104.8 830.5 136.0 127.3 158.8 131.9 745.6 89.5 51.3 74.6 157.9 48.4 798.0 91.2 289.9 773.3 115.2 127.1 142.3 146.0 110.8 162.9 155.2 134.2 104.6 150.1 148.6 144.4 160.9 286.5 243.6 233.9 13.7 85.0 199.3 266.4 395.9 76.2 6.8 101.6 107.4 88.3 265.9 257.2 132.4 25.0 1156.8 53.2 15.6 297.4 703.5 16.2 239.7 318.1 287.7 48.6 29.0 15.4 338.2 1125.1 564.7 91.3 312.6 148.7 177.5 186.4 54.8 753.2 13.5 7.1 110.9 187.2 446.5 705.1 41.4 379.9 544.0 352.2 45.0 412.5 161.4 13.4 23.1 26.8 501.1 31.2 366.3 203.1 473.8 15.3 194.3 268.9 30.0 295.9 443.1 377.2 15.9 28.6 101.1 140.8 1140.8 122.0 185.7 43.2 188.2 SMIM43 ENSG00000164112 "Small integral membrane protein 43" Q4W5P6 4 121758881-121765427 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "brain: 6.3" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 16.7;Syncytiotrophoblasts: 4.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "basal ganglia: 6.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "MOLT-4: 3.2" "Region enhanced" "Detected in many" "cerebral cortex: 24.8" NA NA "unprognostic (9.67e-3)" "unprognostic (3.25e-3)" "unprognostic (3.13e-2)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (5.73e-3)" "unprognostic (3.63e-2)" "unprognostic (1.49e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-3)" "unprognostic (4.40e-3)" "unprognostic (1.38e-1)" "unprognostic (3.82e-7)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.02e-2)" "unprognostic (2.04e-1)" 0.0 0.0 0.6 0.0 6.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 2.0 0.3 2.2 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.3 0.0 2.5 1.0 0.0 2.0 0.3 2.2 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 ADAD1 Tenr ENSG00000164113 "Adenosine deaminase domain containing 1" Q96M93 4 122378966-122429802 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 573 "testis: 120.1" "Group enriched" "Detected in some" 4 "Early spermatids: 1043.4;Late spermatids: 988.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1043.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 988.3 8.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 248.8 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAP9 "ASAP, FLJ21159" ENSG00000164114 "Microtubule associated protein 9" Q49MG5 4 155342658-155376970 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.6;parathyroid gland: 34.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 114.4;Respiratory ciliated cells: 125.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.00e-2)" "unprognostic (1.60e-1)" "unprognostic (6.53e-2)" "unprognostic (6.11e-2)" "unprognostic (2.11e-1)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.01e-1)" "unprognostic (7.58e-2)" "unprognostic (2.98e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-1)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.04e-1)" "unprognostic (4.05e-2)" "unprognostic (9.54e-2)" 4.2 5.8 21.5 3.9 22.1 1.8 4.5 27.6 46.6 5.9 23.9 2.4 0.9 7.4 7.7 2.9 9.7 8.0 7.0 25.2 34.3 9.8 0.7 5.0 3.2 30.9 24.3 19.9 6.1 5.6 34.2 7.8 5.1 32.4 12.5 1.8 16.5 2.4 9.0 0.3 0.5 1.6 5.8 21.6 2.4 6.2 12.9 29.1 3.4 15.6 0.8 2.4 3.2 1.6 37.1 0.0 10.3 11.0 9.6 11.7 14.0 2.2 11.3 10.2 6.6 5.7 0.1 0.0 7.5 14.7 8.3 24.6 0.0 11.7 12.0 10.8 0.0 9.4 4.7 0.1 0.0 8.6 0.0 0.0 12.0 6.5 9.3 5.7 20.2 0.0 2.9 0.1 0.0 7.5 4.6 8.8 0.1 8.7 3.7 13.3 0.0 0.0 0.2 22.2 8.9 15.1 43.4 0.0 19.4 0.6 7.3 15.7 0.1 1.6 8.8 15.6 0.2 8.4 9.1 0.0 8.2 25.8 0.0 14.3 0.0 0.0 0.0 2.7 0.3 2.1 2.9 1.5 2.5 0.1 4.8 1.3 1.8 0.1 0.8 0.0 2.6 1.0 0.5 21.5 22.1 27.6 46.6 25.2 34.3 30.9 24.3 19.9 32.4 21.6 29.1 37.1 3.8 16.0 37.4 34.6 17.0 1.3 13.4 18.7 12.5 67.0 15.2 20.8 33.1 17.2 25.7 25.8 79.2 9.0 10.2 0.4 33.2 35.4 39.3 114.4 44.8 3.5 21.1 5.0 59.0 16.0 3.4 24.5 13.7 24.7 2.5 16.5 1.8 0.6 1.0 72.3 58.3 0.7 26.4 0.9 0.8 14.1 45.7 2.0 5.4 14.0 1.3 53.5 9.2 23.6 27.4 15.9 0.2 49.2 3.8 11.7 0.0 49.1 125.0 92.5 13.1 28.0 31.1 69.4 53.1 2.8 1.1 2.3 14.2 40.1 0.6 4.1 GUCY1A1 "GC-SA3, GUC1A3, GUCY1A3" ENSG00000164116 "Guanylate cyclase 1 soluble subunit alpha 1" Q02108 4 155666726-155737059 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5" "Group enriched" "Detected in many" 35 "dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2" "Cell line enhanced" "Detected in some" "HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010887, HPA056004, HPA058617" Uncertain Supported Nucleoplasm NA NA 7100 Nucleoplasm "CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624" "unprognostic (4.81e-3)" "unprognostic (2.60e-1)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.99e-2)" "unprognostic (7.77e-3)" "unprognostic (1.07e-1)" "prognostic favorable (2.38e-4)" "unprognostic (1.85e-3)" "unprognostic (6.46e-2)" "unprognostic (3.42e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.27e-1)" "unprognostic (6.55e-3)" 14.6 7.9 9.2 17.1 18.3 1.2 15.6 2.7 12.4 14.6 4.2 20.6 8.8 16.3 6.2 7.6 9.5 12.7 34.0 10.7 6.6 15.8 8.1 21.2 8.5 5.1 10.5 8.8 5.7 13.2 31.6 3.9 26.1 5.2 26.1 10.4 17.1 5.4 14.0 5.2 2.2 9.3 29.1 9.0 14.2 8.6 1.2 9.6 7.6 7.3 18.9 9.3 7.4 6.6 8.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 6.8 0.0 0.0 0.0 5.5 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 3.6 0.0 9.7 0.0 0.0 18.5 0.0 0.0 0.0 0.2 4.1 0.0 3.0 12.1 14.2 2.5 8.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.0 2.3 0.1 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.1 8.2 10.1 11.5 0.0 1.0 9.2 18.3 2.7 12.4 10.7 6.6 5.1 10.5 8.8 5.2 9.0 9.6 8.2 38.4 9.6 56.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 37.4 24.9 0.0 0.0 6.8 11.0 0.0 0.4 1.7 0.0 19.6 21.8 0.0 5.5 9.7 10.9 0.0 0.0 0.0 2.0 0.3 8.3 0.0 15.2 3.8 3.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 12.9 2.2 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174283667 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favorable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 15.8 18.8 13.9 10.6 15.1 10.3 18.0 16.0 17.7 14.4 14.4 16.4 16.4 12.7 20.0 17.1 15.7 15.6 21.5 13.8 17.6 23.1 47.9 14.1 13.0 16.1 15.9 12.5 17.1 14.3 21.3 14.4 31.1 16.0 14.9 16.2 17.9 15.4 12.7 6.7 16.0 16.6 16.5 15.6 13.2 15.1 11.3 15.1 16.0 22.4 10.2 12.7 16.1 13.8 18.1 10.0 6.3 12.3 4.3 31.5 33.2 9.8 18.8 19.2 13.3 13.6 5.2 19.9 6.9 19.5 15.7 12.2 6.7 9.2 11.7 13.8 22.5 20.9 7.2 10.4 7.4 23.5 8.5 7.5 19.1 24.5 12.9 13.4 20.5 13.4 8.0 14.9 40.5 18.3 7.9 9.8 8.6 4.4 15.4 7.6 4.9 8.2 12.5 17.8 4.1 13.9 80.8 8.7 16.1 22.4 11.8 11.0 11.0 17.0 9.1 7.3 23.5 11.3 18.5 9.7 6.2 25.2 6.4 13.0 29.4 6.5 14.0 12.1 8.4 15.2 13.2 13.7 12.1 9.0 11.9 12.7 11.6 6.6 10.5 10.0 9.1 16.6 8.4 13.9 15.1 16.0 17.7 13.8 17.6 16.1 15.9 12.5 16.0 15.6 15.1 18.1 18.9 3.2 10.0 6.5 15.8 20.6 17.0 26.0 19.4 13.2 16.9 11.4 10.8 15.7 19.5 22.0 6.2 36.6 10.1 20.3 50.9 19.0 20.5 24.9 13.2 15.8 12.1 11.2 10.1 10.9 60.6 32.7 14.8 16.3 2.5 5.3 21.0 58.1 21.2 18.5 13.0 21.5 28.5 19.6 8.2 5.5 17.4 12.2 10.6 11.2 16.3 29.1 9.2 9.0 17.8 12.4 21.4 26.4 9.1 16.8 21.5 44.6 26.2 18.1 13.1 14.9 18.4 34.7 17.6 19.8 31.4 89.6 14.3 10.3 13.7 22.7 CEP44 KIAA1712 ENSG00000164118 "Centrosomal protein 44" Q9C0F1 4 174283730-174333380 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 73.9;SH-SY5Y: 142.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041515, HPA041835" Approved NA NA "HPA041515: AB_10795638, HPA041835: AB_10794637" "unprognostic (2.43e-1)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (8.69e-2)" "unprognostic (6.96e-2)" "unprognostic (1.07e-2)" "unprognostic (6.62e-2)" "unprognostic (1.90e-2)" "unprognostic (1.11e-2)" "unprognostic (7.97e-2)" "unprognostic (2.72e-3)" "unprognostic (5.54e-2)" "unprognostic (2.44e-1)" "unprognostic (2.80e-1)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" 5.7 8.8 5.9 7.9 8.4 11.2 9.8 11.5 8.0 7.9 7.4 8.0 7.7 10.6 9.3 8.8 7.7 8.2 8.8 8.3 7.4 6.0 7.8 7.1 10.3 8.7 7.5 5.5 10.8 6.3 9.3 8.2 11.6 9.0 8.4 8.6 12.8 7.6 6.1 5.9 13.1 8.7 7.7 7.7 8.9 8.7 13.5 7.1 11.1 9.1 6.2 8.6 7.3 7.4 13.7 12.5 11.4 19.2 9.6 12.1 17.3 10.7 18.7 7.1 12.1 12.5 6.9 27.1 19.0 18.1 4.8 11.5 10.1 20.4 9.3 15.5 30.9 32.2 23.2 33.1 8.0 8.3 17.7 16.6 9.2 14.4 9.9 10.6 12.0 10.6 14.7 30.9 73.9 14.6 4.9 20.7 13.7 10.0 9.4 9.8 15.4 18.2 15.6 10.8 5.0 34.5 142.6 16.1 12.8 14.2 17.6 13.8 12.7 11.5 9.6 10.5 23.1 11.8 18.7 14.0 24.0 18.6 15.7 19.6 5.9 3.1 2.3 3.9 3.7 3.9 5.6 4.1 3.4 3.2 5.6 5.2 4.5 2.3 2.8 4.6 3.0 8.7 2.7 5.9 8.4 11.5 8.0 8.3 7.4 8.7 7.5 5.5 9.0 7.7 7.1 13.7 12.6 9.6 16.4 24.5 14.4 9.9 9.0 10.1 14.8 22.8 10.7 8.0 17.1 8.6 11.9 1.8 33.3 6.6 14.2 8.0 5.9 7.8 6.6 25.4 15.8 9.1 7.7 27.4 24.0 8.0 10.3 14.2 10.2 20.0 12.0 19.4 6.1 7.8 6.6 15.2 25.5 7.8 8.2 9.5 6.0 7.9 16.4 12.3 8.8 10.3 7.9 11.1 8.2 39.2 58.4 9.5 4.9 10.1 13.7 7.2 9.2 4.9 31.5 30.3 13.1 21.1 14.6 44.8 15.0 8.8 11.1 6.7 13.0 9.3 8.1 10.1 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490175-174523154 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 237.1;urinary bladder: 379.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 123.7;T-reg: 45.0" "Group enriched" "Detected in many" 73 "granulocytes: 123.7;T-cells: 45.0" "Cell line enhanced" "Detected in many" "A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol No NA 20000 Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favorable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 7.0 16.7 1.0 11.5 0.8 2.7 161.5 0.6 1.0 20.4 7.3 61.5 153.6 45.9 36.8 82.3 13.5 25.2 1.7 1.2 2.3 60.8 212.5 91.8 5.5 1.3 1.9 0.6 1.1 2.6 86.1 2.1 99.9 1.1 10.3 57.9 1.0 7.7 4.1 2.5 36.2 118.2 64.2 0.8 10.4 237.1 1.6 1.8 12.3 1.8 3.0 26.8 379.3 83.6 0.8 0.0 157.8 0.0 0.0 110.6 5.4 0.4 0.0 0.0 0.0 0.4 45.1 0.2 0.1 0.0 0.0 0.2 14.2 16.0 0.0 0.0 0.3 2.9 355.0 10.8 0.3 0.0 2.1 0.9 5.6 2.6 0.0 0.1 0.1 0.0 22.6 0.2 0.0 0.0 0.3 1.2 0.3 1.4 102.1 7.4 16.3 0.3 1.3 36.2 565.7 0.9 0.4 0.0 1.3 3.5 121.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 28.4 0.0 0.1 0.3 0.2 0.0 123.7 0.3 16.6 9.9 0.0 15.6 0.4 5.2 4.5 0.7 0.2 1.6 4.0 1.3 1.1 0.0 0.0 45.0 3.0 1.0 0.8 0.6 1.0 1.2 2.3 1.3 1.9 0.6 1.1 0.8 1.8 0.8 3.4 16.0 33.0 0.0 4.3 17.3 80.8 6.9 45.5 3.3 14.5 6.7 0.8 35.8 23.6 22.0 0.0 48.5 38.5 457.8 21.5 7.4 1.4 5.7 5.4 18.2 8.4 17.2 0.8 94.5 701.7 25.3 196.7 36.4 864.5 1.5 13.9 245.7 21.4 0.0 9.7 60.7 0.0 14.8 19.5 0.5 19.9 29.2 76.5 5.6 2.9 0.0 10.3 0.0 4.1 42.4 254.7 0.0 50.2 76.8 500.6 131.1 4.4 0.8 0.0 2.4 3.7 0.5 1.0 53.4 22.4 56.6 42.7 65.0 58.9 922.8 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 219.2;tongue: 67.6" "Cell type enhanced" "Detected in some" "Early spermatids: 52.7;Late spermatids: 293.6;Skeletal myocytes: 79.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5;prostate cancer: 1.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 1184.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 0.0 0.0 0.4 0.9 0.6 0.0 0.0 1.3 0.8 0.8 0.2 6.5 0.3 0.6 0.1 10.6 0.1 1.2 3.9 0.5 0.4 0.7 0.0 0.2 0.0 0.9 1.3 0.4 0.0 0.1 0.1 0.4 0.0 0.8 13.0 3.4 0.0 24.1 0.3 219.2 0.1 1.2 2.5 0.7 0.0 4.7 7.3 0.4 0.1 0.0 67.6 0.0 19.3 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 29.1 0.0 25.9 54.7 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 61.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1184.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 1.3 0.8 0.5 0.4 0.9 1.3 0.4 0.8 0.7 0.4 1.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.7 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 293.6 1.2 0.3 0.0 0.0 0.0 0.0 0.0 11.6 0.8 0.0 0.0 1.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 79.6 0.6 0.9 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 C4orf45 FLJ25371 ENSG00000164123 "Chromosome 4 open reading frame 45" Q96LM5 4 158893134-159038760 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 10.7" "Group enriched" "Detected in some" 18 "Early spermatids: 363.5;Late spermatids: 93.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (2.13e-1)" "unprognostic (9.87e-2)" "unprognostic (5.71e-2)" "unprognostic (2.55e-1)" "unprognostic (2.17e-1)" "unprognostic (7.82e-2)" "unprognostic (1.21e-1)" "unprognostic (3.09e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 363.5 0.0 0.1 0.1 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 93.0 2.5 0.0 0.0 1.9 0.0 1.5 0.0 4.5 4.1 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 8.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255416 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 419.0" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 994.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.1;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 10 "dendritic cells: 2.2;monocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria NA NA Mitochondria "HPA063554: AB_2685039" "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favorable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 8.7 13.0 85.3 3.7 217.4 3.2 15.5 156.9 157.1 7.7 23.3 14.5 29.6 6.1 15.7 5.4 6.9 12.6 15.1 97.1 137.6 3.9 3.2 6.4 2.4 221.8 161.0 58.9 13.6 7.4 4.6 1.3 6.6 200.1 9.0 16.0 0.6 5.9 11.0 2.8 3.4 20.9 7.2 139.5 4.0 11.3 27.2 158.9 1.9 17.1 2.6 1.6 6.7 2.6 419.0 4.7 12.1 0.2 2.6 8.6 11.8 36.5 1.9 3.9 1.7 2.8 15.1 17.8 0.0 2.8 0.6 10.0 2.2 5.1 16.7 2.4 0.0 5.5 8.5 3.0 13.5 2.8 10.7 2.3 8.9 20.0 7.0 3.0 0.5 9.7 1.7 5.5 0.2 12.8 5.1 0.0 0.0 3.2 15.1 2.9 0.0 0.0 0.4 4.2 12.3 1.9 0.0 0.5 19.6 4.2 7.1 12.6 2.4 1.8 3.9 2.7 0.7 2.1 0.0 1.1 0.9 5.4 1.4 3.1 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.3 2.2 0.0 0.3 85.3 217.4 156.9 157.1 97.1 137.6 221.8 161.0 58.9 200.1 139.5 158.9 419.0 2.9 9.6 9.1 53.2 0.3 3.1 7.7 5.2 2.8 0.9 12.4 10.7 12.7 12.8 8.4 0.0 0.0 13.7 1.5 36.6 0.0 15.4 231.8 14.5 8.6 4.8 4.9 3.0 10.9 13.3 6.5 4.4 14.8 24.5 4.5 14.6 4.6 1.2 29.0 0.0 12.5 21.4 8.2 20.8 5.0 98.2 10.5 12.9 3.6 12.2 10.6 1.3 0.0 5.5 994.4 9.0 18.9 9.1 0.2 3.5 44.1 6.4 8.8 0.2 0.0 8.5 2.6 3.0 2.2 5.8 5.1 8.8 0.9 6.8 18.6 6.4 GASK1B "C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155" ENSG00000164125 "Golgi associated kinase 1B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 208.2" "Cell type enhanced" "Detected in some" "Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0" "Group enriched" "Detected in many" 41 "dendritic cells: 15.1;monocytes: 50.6" "Cell line enhanced" "Detected in many" "ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA 13000 "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 74.6 208.2 29.2 40.2 27.7 2.8 47.8 24.4 24.3 47.4 17.1 23.6 13.4 78.4 22.0 17.3 19.6 37.5 78.6 29.2 39.6 9.6 8.7 14.2 11.3 50.9 33.3 16.4 141.5 14.3 11.5 2.8 29.3 30.6 23.9 23.5 0.8 23.8 30.3 12.5 7.3 18.7 70.9 33.9 20.9 12.0 10.5 33.7 5.8 17.9 16.8 6.9 43.6 9.3 34.2 12.5 9.9 6.1 1.1 77.0 143.3 11.4 3.1 2.4 0.6 3.7 13.3 4.9 0.1 0.3 5.0 5.1 0.2 70.7 18.9 1.8 0.1 0.2 1.0 0.0 37.0 51.4 0.6 0.3 166.4 4.6 24.2 2.6 8.0 193.3 0.0 13.0 0.0 35.7 0.8 0.0 0.2 0.4 43.4 0.2 0.1 0.5 0.2 0.0 27.5 0.4 0.1 0.0 27.8 8.2 33.4 5.4 0.3 9.3 16.0 17.1 9.6 6.1 0.0 0.1 44.8 2.5 0.3 74.3 0.1 50.6 0.0 0.1 28.8 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.7 0.1 14.0 0.6 0.0 17.8 29.2 27.7 24.4 24.3 29.2 39.6 50.9 33.3 16.4 30.6 33.9 33.7 34.2 22.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 1.2 14.5 0.0 0.0 0.0 0.0 0.0 0.0 67.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 NPY1R NPYR ENSG00000164128 "Neuropeptide Y receptor Y1" P25929 4 163323962-163344832 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 120.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 32.8;Excitatory neurons: 39.8;Hepatic stellate cells: 160.6;Sertoli cells: 46.0;Smooth muscle cells: 34.1" "Cancer enriched" "Detected in many" 13 "breast cancer: 65.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HEL: 128.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.68e-5)" "unprognostic (9.14e-3)" "unprognostic (1.55e-1)" "unprognostic (5.09e-2)" "unprognostic (2.60e-1)" "unprognostic (9.29e-2)" "unprognostic (5.28e-3)" "unprognostic (2.26e-1)" "unprognostic (4.14e-2)" "unprognostic (2.50e-1)" "unprognostic (1.89e-2)" "unprognostic (5.92e-2)" "unprognostic (7.39e-2)" "unprognostic (1.92e-3)" "unprognostic (5.48e-2)" "unprognostic (1.74e-1)" "unprognostic (2.21e-1)" 30.8 31.3 6.4 2.9 12.3 0.0 32.7 0.0 13.8 7.9 0.4 5.9 1.0 7.4 10.3 1.8 8.4 4.6 2.9 8.5 13.9 32.6 14.8 2.1 17.4 4.4 1.5 12.8 2.9 28.9 3.7 3.0 5.3 4.4 2.6 4.5 4.5 21.6 8.4 2.9 9.1 1.5 5.7 2.7 120.7 1.9 4.1 1.9 1.1 8.0 2.6 0.9 1.8 5.0 9.6 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.0 0.0 7.0 0.0 0.0 0.0 0.0 128.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.9 0.0 0.1 0.4 0.0 0.0 1.2 0.0 4.6 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.4 3.0 0.0 0.0 0.1 1.2 0.0 0.6 0.1 0.0 0.0 1.4 0.0 4.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.4 12.3 0.0 13.8 8.5 13.9 4.4 1.5 12.8 4.4 2.7 1.9 9.6 2.1 0.0 0.5 1.3 0.7 2.8 0.7 0.0 3.4 11.6 19.2 3.3 0.9 1.5 0.0 0.0 2.1 0.0 0.0 3.4 13.7 12.5 5.0 0.0 0.4 10.8 32.8 0.0 39.8 0.0 0.0 5.1 0.0 0.1 0.0 3.7 160.6 0.9 0.1 0.0 18.8 1.6 0.0 7.2 0.9 2.4 11.5 0.1 5.4 4.7 0.0 1.1 0.0 2.0 1.4 0.1 15.9 0.4 0.0 0.5 0.1 0.1 0.0 2.1 46.0 1.1 34.1 0.5 0.6 0.1 1.7 0.0 0.6 0.5 2.1 0.3 NPY5R NPYR5 ENSG00000164129 "Neuropeptide Y receptor Y5" Q15761 4 163343892-163351934 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 7.2;lymphoid tissue: 8.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.6;Granulosa cells: 1.4;Inhibitory neurons: 3.5;Smooth muscle cells: 3.1;Spermatocytes: 3.0" "Cancer enhanced" "Detected in single" "breast cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.63e-6)" "unprognostic (3.00e-1)" "unprognostic (2.79e-1)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "unprognostic (3.74e-2)" "unprognostic (3.94e-2)" "unprognostic (5.40e-2)" "unprognostic (4.30e-2)" "unprognostic (3.99e-2)" "unprognostic (1.76e-1)" "unprognostic (3.94e-1)" 7.2 3.3 0.8 0.3 2.3 0.0 1.7 0.0 1.4 0.7 0.0 0.3 0.0 0.7 1.0 0.2 0.8 0.5 0.6 1.2 2.3 4.6 1.0 0.3 2.4 0.8 0.5 1.5 0.2 1.0 0.7 0.3 2.9 0.6 0.2 0.3 0.2 3.7 0.9 0.1 0.8 0.1 0.7 0.6 8.9 0.2 5.2 0.8 0.1 0.7 0.4 0.1 0.3 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.0 1.4 1.2 2.3 0.8 0.5 1.5 0.6 0.6 0.8 1.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.5 0.0 0.0 4.6 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.1 3.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 NAA15 "FLJ13340, NARG1, NATH, TBDN100" ENSG00000164134 "N-alpha-acetyltransferase 15, NatA auxiliary subunit" Q9BXJ9 4 139301505-139420033 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023589, HPA050661" Approved Supported "Nuclear bodies,Cytosol" NA NA 140000 Cytosol "Nuclear bodies" "HPA023589: AB_1854311, HPA050661: AB_2681208" "unprognostic (6.25e-3)" "unprognostic (5.95e-2)" "unprognostic (7.80e-3)" "unprognostic (8.45e-2)" "unprognostic (2.88e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.16e-2)" "unprognostic (9.20e-3)" "unprognostic (1.07e-2)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "unprognostic (8.65e-2)" "unprognostic (7.37e-3)" "unprognostic (2.12e-1)" "unprognostic (8.28e-3)" "unprognostic (1.58e-1)" 9.2 8.9 7.1 11.5 7.8 16.5 10.0 12.8 8.4 7.4 7.7 8.5 7.7 9.0 6.1 12.6 7.1 7.1 10.1 7.2 7.1 7.5 11.0 6.5 14.6 8.0 7.6 6.6 8.0 7.8 9.8 5.8 10.7 9.2 8.3 9.2 9.2 6.2 7.3 17.1 9.4 7.0 8.8 7.8 8.6 8.0 13.2 7.1 13.5 9.0 16.5 15.6 14.7 7.8 11.1 44.7 32.1 30.4 49.2 21.7 26.4 37.3 42.2 27.6 39.9 30.6 45.3 38.2 91.1 25.3 35.0 34.6 28.1 80.5 51.7 57.2 42.8 29.6 49.0 29.6 29.8 23.0 90.5 30.5 18.7 31.0 50.4 39.1 21.1 40.5 35.2 92.1 38.7 42.9 35.6 86.8 26.8 50.7 83.4 25.0 53.4 40.9 47.0 31.8 37.2 39.3 30.8 28.2 45.7 28.8 30.6 27.8 35.2 35.0 38.3 27.0 36.7 48.7 46.5 89.0 88.7 32.9 64.6 37.4 4.2 3.4 1.1 5.0 3.9 5.9 4.8 5.3 5.9 4.7 5.3 5.1 5.8 2.6 4.5 3.9 4.0 5.5 2.1 7.1 7.8 12.8 8.4 7.2 7.1 8.0 7.6 6.6 9.2 7.8 7.1 11.1 28.4 48.1 33.8 28.4 39.7 93.4 69.6 20.7 29.0 34.0 28.1 15.7 46.9 22.8 32.3 20.2 20.9 39.9 22.8 14.4 15.6 28.1 9.0 40.3 38.9 31.5 15.6 34.5 44.0 19.5 50.8 32.9 21.4 40.5 34.8 35.7 16.8 28.1 32.5 40.4 45.9 20.8 18.3 24.1 35.0 11.3 25.4 27.8 28.4 29.0 26.6 27.7 32.0 42.3 57.6 26.5 16.2 29.0 23.4 53.8 10.2 16.4 34.0 36.3 32.9 69.0 47.4 90.0 59.7 44.0 99.3 41.7 31.7 32.1 32.5 70.2 IL15 "IL-15, MGC9721" ENSG00000164136 "Interleukin 15" P40933 4 141636583-141733987 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 78.0;monocytes: 72.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.6;Karpas-707: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004457, HPA037738" Approved Supported "Nucleoplasm,Nuclear speckles" "Secreted to blood" NA NA 182000 "Nucleoplasm, Nuclear speckles" "CAB004457: AB_2124575, HPA037738: AB_2675640" "unprognostic (1.10e-2)" "unprognostic (1.53e-1)" "unprognostic (1.04e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (2.90e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (5.20e-2)" "unprognostic (1.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.09e-1)" "unprognostic (4.03e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" 7.6 3.4 1.4 7.2 1.4 4.0 6.0 1.9 1.8 5.2 1.9 7.2 6.1 4.5 2.5 4.4 4.6 5.0 5.1 1.2 1.8 6.2 3.6 7.9 9.8 1.9 1.4 1.1 1.6 2.7 0.7 3.7 3.2 1.8 4.1 5.3 4.4 3.7 2.7 8.7 3.5 10.1 4.7 1.5 15.5 4.8 2.5 1.7 6.9 15.7 3.4 6.6 4.5 6.5 1.8 2.8 6.3 0.3 0.6 0.9 5.4 1.6 6.7 6.1 6.8 5.5 3.4 8.1 2.5 8.5 6.2 6.0 4.4 0.1 3.4 3.6 17.6 1.7 0.5 16.7 0.5 4.5 1.9 1.3 2.1 1.5 4.4 0.5 13.7 4.3 2.3 4.0 18.8 4.2 0.9 4.2 0.3 3.3 2.3 1.7 1.0 16.0 0.5 9.2 0.8 0.6 1.6 3.1 4.7 3.2 0.8 0.9 0.3 6.6 6.9 4.3 2.0 4.2 13.0 1.8 1.0 7.2 0.8 2.5 10.4 16.1 0.6 2.7 15.1 5.0 4.1 3.3 2.5 5.5 4.0 1.4 1.4 1.2 3.2 16.5 0.2 2.0 6.1 1.4 1.4 1.9 1.8 1.2 1.8 1.9 1.4 1.1 1.8 1.5 1.7 1.8 14.8 0.0 2.8 0.3 9.9 6.1 2.5 2.1 2.2 0.6 2.1 1.3 2.9 2.8 5.3 5.5 0.0 1.2 5.0 4.7 0.0 9.4 6.6 6.9 78.0 14.8 0.0 1.3 2.0 14.0 1.6 5.5 4.1 5.9 0.0 0.9 11.4 2.5 4.7 0.0 4.8 5.4 0.0 17.0 22.1 2.5 2.8 16.7 8.8 4.7 72.0 21.1 8.2 3.0 0.2 19.8 8.2 1.2 9.3 6.2 9.9 12.0 3.9 0.9 6.6 7.6 4.0 1.2 0.8 5.6 3.4 0.3 6.0 0.1 2.6 3.0 FAM160A1 FLJ43373 ENSG00000164142 "Family with sequence similarity 160 member A1" Q05DH4 4 151409176-151670503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 25.8;skeletal muscle: 34.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 11.9;Excitatory neurons: 15.8;Oligodendrocyte precursor cells: 19.1;Suprabasal keratinocytes: 14.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 13.6" "Immune cell enriched" "Detected in single" 14 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 14 "dendritic cells: 2.5" "Cell line enhanced" "Detected in many" "A-431: 8.6;HeLa: 10.0;hTERT-HME1: 9.2;SiHa: 8.9;SK-BR-3: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA046348 Enhanced Approved Cytosol NA NA Cytosol "HPA046348: AB_10966145" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.21e-3)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.33e-2)" "unprognostic (4.55e-2)" "unprognostic (1.52e-1)" "unprognostic (7.21e-3)" "unprognostic (1.30e-3)" "unprognostic (2.39e-1)" "unprognostic (1.51e-12)" "unprognostic (2.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (1.28e-1)" 0.3 1.3 1.6 0.3 0.7 1.8 4.4 13.6 1.0 3.2 25.8 3.4 1.9 1.6 4.1 7.9 2.7 0.9 3.5 1.2 2.9 3.4 0.7 1.9 0.2 0.5 1.1 0.9 2.4 10.3 8.3 1.3 0.5 5.4 2.2 3.5 6.7 4.8 1.6 34.8 13.5 2.0 1.1 0.5 0.5 2.5 3.4 0.4 1.6 6.8 16.6 2.3 2.2 3.4 0.2 8.6 0.7 0.0 0.2 0.0 0.1 2.9 0.3 1.4 0.8 0.2 3.6 3.0 0.0 0.8 0.3 2.6 7.4 2.1 6.1 0.9 0.0 3.3 0.0 10.0 0.9 0.0 0.0 0.2 0.2 7.0 0.0 9.2 2.4 0.2 0.7 0.0 0.0 0.5 1.2 0.0 0.0 2.8 2.8 0.8 0.0 2.0 0.2 5.1 5.5 1.2 0.4 8.9 7.8 0.2 2.2 3.3 0.0 0.0 0.4 3.7 0.2 1.4 0.0 0.0 0.0 1.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.6 0.7 13.6 1.0 1.2 2.9 0.5 1.1 0.9 5.4 0.5 0.4 0.2 0.1 3.2 2.0 1.3 0.0 11.9 6.6 2.9 10.8 0.1 2.7 1.9 1.8 0.0 5.2 0.0 0.0 0.3 0.5 5.9 0.0 1.6 3.3 5.9 0.6 0.4 0.0 0.0 15.8 1.8 0.6 0.6 6.1 10.8 1.3 0.3 0.0 0.5 0.3 8.4 2.4 2.3 0.0 0.0 2.1 1.5 0.0 0.6 0.0 1.0 0.0 2.5 0.0 19.1 1.3 1.9 0.3 0.0 1.4 7.9 2.2 0.7 1.3 4.7 0.0 1.0 0.4 6.1 5.8 11.6 14.5 1.6 0.2 0.3 1.8 8.6 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favorable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 17.0 14.9 8.4 15.9 9.3 3.7 23.7 10.5 10.9 22.7 10.6 28.4 23.4 21.9 20.6 21.1 18.7 20.1 10.3 7.9 12.2 20.0 15.6 17.0 15.2 9.9 9.5 7.3 17.7 10.6 22.6 10.6 18.2 10.0 21.3 28.1 20.4 13.8 17.3 6.7 17.5 21.5 20.0 10.4 18.5 23.0 12.3 9.0 12.2 20.3 10.5 14.9 23.7 15.3 12.0 25.8 18.4 25.1 25.7 37.2 37.9 30.6 29.5 40.5 28.7 26.9 21.3 51.3 20.6 9.9 40.5 22.7 18.1 26.3 29.1 35.3 16.9 16.2 20.0 18.0 20.5 26.1 38.2 41.7 26.6 30.9 24.8 23.8 30.7 26.4 11.8 23.5 43.3 39.8 28.6 22.7 19.8 21.8 29.9 18.5 12.6 14.7 19.2 50.7 32.1 32.8 26.0 22.1 40.7 30.2 23.5 37.7 19.6 17.3 27.8 20.1 26.8 21.4 48.2 42.8 28.1 35.3 38.2 40.0 31.5 27.3 42.2 14.5 31.1 14.6 19.0 11.2 12.2 24.8 17.7 8.7 11.8 81.6 29.1 30.7 3.1 18.5 18.7 8.4 9.3 10.5 10.9 7.9 12.2 9.9 9.5 7.3 10.0 10.4 9.0 12.0 28.5 6.4 31.8 40.5 20.3 29.6 18.4 30.7 34.1 17.2 26.2 19.7 10.2 20.0 29.1 38.6 0.0 28.6 15.6 40.9 27.4 27.4 46.3 42.2 33.0 23.8 38.9 12.0 44.5 18.3 27.0 28.8 40.2 50.7 22.8 14.2 17.2 19.8 22.1 18.5 42.8 39.1 34.6 23.8 18.0 21.6 22.4 24.5 21.4 89.9 19.5 35.9 23.7 76.4 75.6 24.4 28.2 21.8 11.8 23.6 23.8 34.2 31.9 24.2 32.9 20.6 27.8 31.7 29.5 31.9 34.0 43.9 17.7 89.2 31.7 30.3 ICE1 KIAA0947 ENSG00000164151 "Interactor of little elongation complex ELL subunit 1" Q9Y2F5 5 5420664-5490220 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054452, HPA061934" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA054452: AB_2682492, HPA061934: AB_2684641" "unprognostic (1.45e-2)" "unprognostic (9.73e-2)" "unprognostic (6.92e-2)" "unprognostic (2.39e-3)" "unprognostic (4.42e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.16e-1)" "unprognostic (4.29e-1)" "unprognostic (1.78e-1)" "unprognostic (3.51e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (4.59e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-2)" "unprognostic (2.33e-1)" 8.7 7.0 8.3 9.2 9.1 13.8 10.4 11.6 8.3 8.7 4.7 8.1 7.3 11.7 9.1 7.7 8.3 7.2 8.2 10.1 7.1 10.1 7.1 8.2 11.6 6.8 5.9 8.2 14.0 9.3 14.2 7.5 12.8 6.8 7.9 7.9 12.9 7.5 8.8 16.6 8.8 7.6 10.4 4.6 10.1 7.8 7.5 6.9 14.6 10.3 15.7 11.4 9.6 6.7 8.4 17.9 22.1 24.8 23.9 23.6 23.1 32.0 15.1 18.0 17.8 19.5 17.1 12.9 24.1 20.6 21.8 35.1 16.5 34.4 17.7 29.8 33.4 17.5 19.5 68.9 12.5 14.3 44.5 15.4 18.5 18.6 21.3 32.8 17.7 22.3 18.0 28.1 19.5 18.8 15.6 32.6 15.9 21.0 11.4 18.6 37.7 22.6 16.3 15.0 19.9 16.0 16.6 52.5 16.9 20.2 23.8 14.7 13.9 25.4 23.0 29.4 29.9 23.9 21.1 26.9 39.6 19.3 32.9 19.9 0.4 0.5 1.1 0.9 0.7 1.1 0.9 0.8 0.9 0.5 0.8 0.7 0.9 0.1 1.1 0.4 1.1 1.1 0.3 8.3 9.1 11.6 8.3 10.1 7.1 6.8 5.9 8.2 6.8 4.6 6.9 8.4 29.8 22.4 29.5 42.1 30.3 0.0 17.7 0.0 26.2 40.2 20.1 26.3 33.0 14.3 14.2 16.5 31.3 35.6 35.1 10.8 25.4 22.6 5.8 19.5 37.4 27.5 9.0 23.5 68.2 22.7 22.4 25.0 19.9 25.7 11.4 28.6 15.4 13.8 15.7 45.4 57.3 11.6 0.0 13.8 0.0 5.2 22.4 19.9 0.0 36.5 26.1 24.6 17.5 39.7 62.1 23.0 6.4 22.2 37.5 24.1 11.1 14.8 6.6 34.7 6.6 50.5 27.8 51.6 47.0 25.9 0.0 10.9 33.9 36.4 11.4 16.9 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646156-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;lung: 16.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 175.6;Leydig cells: 136.1;Oligodendrocytes: 413.3;Theca cells: 162.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "HUVEC TERT2: 322.6;TIME: 376.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 1.2 2.3 8.2 0.4 21.1 0.8 0.3 8.1 18.3 1.3 0.0 3.2 2.6 1.6 3.8 0.0 0.1 1.1 0.1 15.8 10.8 0.8 6.8 16.3 0.0 20.9 18.6 5.0 0.6 2.6 0.0 0.3 0.0 17.0 4.7 3.2 0.9 0.3 2.6 0.4 0.1 3.7 0.1 7.1 0.0 6.0 1.5 14.6 2.7 0.6 1.3 0.0 5.0 0.3 30.5 0.0 0.1 4.9 0.1 0.3 1.9 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.0 0.2 0.3 0.0 2.2 0.0 2.0 0.1 0.0 0.1 0.1 0.0 0.0 10.4 7.8 17.2 322.6 29.1 0.1 0.0 4.8 0.0 47.7 0.0 4.4 0.0 2.8 0.4 65.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 376.7 0.4 3.9 0.3 2.5 2.2 0.0 10.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.2 21.1 8.1 18.3 15.8 10.8 20.9 18.6 5.0 17.0 7.1 14.6 30.5 0.3 12.8 175.6 3.9 0.4 0.0 0.0 0.5 0.0 42.7 0.0 0.0 1.2 0.0 3.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.5 6.0 0.6 0.0 0.0 17.6 0.4 0.0 38.9 0.0 0.4 16.5 0.1 9.3 0.1 0.1 0.0 13.9 0.0 2.0 0.0 0.4 4.5 136.1 1.3 1.8 1.0 0.0 0.3 0.0 8.5 413.3 0.1 0.0 44.0 0.0 0.0 0.0 0.0 4.4 3.3 0.0 1.7 0.9 0.3 0.5 0.0 0.6 0.0 1.0 162.7 0.0 0.0 ANAPC10 "APC10, DKFZP564L0562, DOC1" ENSG00000164162 "Anaphase promoting complex subunit 10" Q9UM13 4 144831908-145098541 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044547 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA044547: AB_2678979" "unprognostic (2.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.04e-1)" "unprognostic (5.88e-2)" "unprognostic (2.66e-3)" "unprognostic (1.02e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (2.80e-2)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (5.55e-2)" 11.3 9.5 8.2 6.2 8.6 10.2 14.5 10.0 11.3 11.1 8.5 8.1 4.5 11.7 13.4 7.7 10.8 7.8 14.0 8.4 9.3 13.0 13.7 9.9 10.4 8.8 9.0 7.6 12.0 7.6 9.1 7.6 12.4 8.8 9.0 9.9 9.3 8.2 9.3 15.0 8.1 6.7 11.9 9.2 8.5 7.5 19.2 8.6 14.0 11.9 15.3 10.8 11.1 9.0 9.5 14.3 7.8 20.0 7.8 19.5 21.2 13.0 17.1 16.9 21.6 15.7 18.9 18.6 19.6 11.1 11.8 15.6 8.4 17.6 22.6 23.1 19.0 14.0 12.1 6.0 15.6 24.5 23.9 13.7 17.2 15.9 17.7 28.8 18.0 17.1 23.0 32.2 28.2 22.8 10.3 40.5 29.1 14.1 17.0 15.7 20.5 15.5 11.8 24.1 9.0 14.0 10.4 11.1 10.4 23.1 18.6 9.4 19.7 15.6 14.7 8.9 13.7 21.7 22.3 25.2 31.3 19.2 30.2 18.7 25.5 7.8 9.7 13.0 10.3 13.4 15.1 13.5 13.2 11.5 12.4 13.4 13.7 2.2 16.4 9.6 15.6 18.1 7.4 8.2 8.6 10.0 11.3 8.4 9.3 8.8 9.0 7.6 8.8 9.2 8.6 9.5 30.7 12.8 17.0 31.3 16.7 16.3 22.0 61.6 10.8 9.9 16.9 26.0 14.8 4.3 34.3 14.7 0.0 38.9 20.2 7.6 46.9 25.8 83.3 26.4 21.0 22.2 3.0 8.6 61.2 26.1 35.8 20.7 9.2 15.6 26.0 15.3 19.6 15.6 35.1 5.0 58.0 13.0 40.7 12.7 18.2 22.8 33.8 17.6 10.6 36.5 27.8 19.0 22.6 55.8 62.3 27.3 15.5 27.1 10.5 26.9 14.3 49.8 27.6 9.8 32.9 21.0 36.2 126.8 41.5 14.2 19.9 29.6 19.5 26.1 13.7 29.4 ABCE1 "OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I" ENSG00000164163 "ATP binding cassette subfamily E member 1" P61221 4 145098288-145129524 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Translation regulation" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012476, HPA036846" Approved Enhanced Cytosol No No 380000 Cytosol "CAB012476: , HPA036846: AB_2675346" "unprognostic (2.22e-3)" "unprognostic (8.11e-3)" "prognostic favorable (8.69e-4)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (5.51e-3)" "prognostic unfavorable (6.29e-4)" "unprognostic (5.68e-3)" "unprognostic (6.77e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.56e-2)" "unprognostic (1.38e-3)" "unprognostic (2.85e-1)" "unprognostic (2.40e-1)" "unprognostic (2.08e-2)" "unprognostic (2.21e-1)" 30.3 21.7 13.3 33.9 14.4 27.4 33.4 15.3 16.2 20.9 13.1 23.0 20.4 24.6 16.2 35.4 22.7 22.6 25.2 14.4 15.4 24.0 40.0 18.6 40.8 15.2 14.9 12.3 29.3 29.6 27.2 10.1 28.9 16.3 19.5 28.0 14.5 24.3 17.0 28.2 25.4 17.9 29.1 15.0 26.6 20.3 26.7 13.6 34.5 27.1 30.6 42.4 40.9 16.0 19.7 117.1 61.2 89.5 62.2 74.6 107.5 89.4 124.6 86.4 145.1 101.3 95.5 105.9 187.6 39.3 109.2 77.7 75.4 132.5 157.7 193.1 108.6 82.9 106.9 44.0 80.6 98.3 244.3 81.3 80.0 108.4 153.8 213.7 74.8 157.4 139.1 219.5 136.1 156.3 70.4 234.5 82.2 74.8 177.5 142.9 124.0 107.9 135.7 108.1 79.9 111.1 55.1 74.7 124.6 89.5 66.7 74.2 98.1 105.3 143.3 89.4 101.3 152.5 120.6 209.6 199.5 87.7 214.6 163.7 2.2 10.0 0.9 12.3 13.1 25.4 13.2 15.4 16.0 19.5 13.0 21.0 18.1 0.8 16.4 13.4 10.9 18.5 14.8 13.3 14.4 15.3 16.2 14.4 15.4 15.2 14.9 12.3 16.3 15.0 13.6 19.7 56.4 25.6 18.7 15.3 55.9 59.9 109.0 38.7 45.5 37.2 35.0 30.6 24.0 17.2 45.4 25.8 20.9 39.4 44.4 9.8 39.2 39.4 40.1 29.0 61.8 53.7 20.4 47.5 24.2 28.2 45.1 50.6 35.7 23.4 32.9 50.3 21.4 32.9 41.5 42.1 27.8 22.5 24.4 22.4 40.3 15.4 46.9 34.6 19.6 12.2 33.2 18.1 33.0 18.1 37.5 39.1 10.3 34.6 58.3 112.2 8.0 39.8 28.5 34.9 32.9 71.7 47.5 92.4 79.4 65.5 59.5 26.5 47.2 98.4 36.6 72.2 OTUD4 "DUBA6, HSHIN1, KIAA1046" ENSG00000164164 "OTU deubiquitinase 4" Q01804 4 145110838-145180589 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036623 Uncertain Supported Cytosol NA NA Cytosol "HPA036623: AB_10696780" "unprognostic (1.67e-1)" "unprognostic (4.18e-2)" "unprognostic (3.41e-2)" "unprognostic (1.95e-1)" "unprognostic (2.80e-1)" "unprognostic (4.06e-2)" "unprognostic (3.42e-2)" "unprognostic (2.66e-2)" "unprognostic (1.21e-1)" "unprognostic (1.74e-2)" "unprognostic (5.21e-3)" "unprognostic (2.03e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.62e-1)" 13.9 12.9 10.4 14.0 13.1 32.3 12.7 14.5 12.6 12.3 11.6 11.0 11.6 13.8 14.3 13.5 16.2 12.5 10.7 10.9 10.3 12.0 20.4 15.5 16.4 10.7 10.5 10.3 14.7 12.3 17.2 9.8 15.2 10.7 10.3 12.2 17.1 11.1 11.5 40.8 15.5 11.3 13.8 10.2 16.3 10.9 32.2 10.7 16.6 13.7 40.7 14.4 18.9 12.2 16.1 28.2 15.7 18.3 17.1 21.3 25.8 24.5 24.0 26.9 30.2 23.9 16.9 33.8 51.2 10.6 33.8 18.5 16.6 31.9 33.6 39.3 22.0 15.0 24.7 20.1 15.8 24.9 52.3 17.7 20.3 33.5 36.9 48.3 25.4 27.1 22.0 41.5 37.3 30.1 16.8 32.4 22.7 20.5 27.0 17.7 26.3 20.0 12.1 29.4 20.1 17.7 14.6 22.2 33.0 24.3 24.1 11.0 21.2 33.1 33.8 21.5 17.7 32.2 27.2 28.7 33.0 23.4 36.5 33.4 0.0 0.4 0.8 0.9 0.6 0.6 0.8 0.6 0.7 0.4 0.6 0.6 0.6 0.1 0.5 0.8 0.7 0.5 0.3 10.4 13.1 14.5 12.6 10.9 10.3 10.7 10.5 10.3 10.7 10.2 10.7 16.1 24.8 64.1 23.5 27.7 19.6 63.2 55.3 13.9 18.2 16.1 20.3 11.8 20.2 22.8 20.5 27.6 25.0 21.5 28.2 16.3 9.8 12.7 185.2 52.8 29.1 44.7 15.1 21.4 36.4 14.7 21.4 30.3 14.8 45.7 20.3 19.6 21.0 24.0 12.7 6.7 30.8 15.2 20.3 20.8 42.4 82.4 20.2 23.6 32.0 30.0 17.7 8.3 11.3 40.2 53.7 23.9 11.7 30.1 20.1 64.7 13.1 7.7 45.3 20.9 0.0 39.4 24.2 27.9 48.5 27.4 54.4 16.0 22.9 20.7 15.6 60.4 LSM6 YDR378C ENSG00000164167 "LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated" P62312 4 146175703-146200000 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing, tRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045079 Approved Approved "Actin filaments" NA NA 30000 "Actin filaments" "HPA045079: AB_10961320" "unprognostic (5.04e-3)" "unprognostic (4.91e-2)" "unprognostic (6.81e-2)" "unprognostic (1.67e-1)" "unprognostic (6.34e-2)" "unprognostic (3.72e-2)" "unprognostic (6.57e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.88e-4)" "unprognostic (2.28e-2)" "unprognostic (4.36e-1)" "unprognostic (8.20e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.51e-1)" "unprognostic (2.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.08e-3)" 11.3 6.3 8.1 10.1 8.6 11.5 7.0 11.5 13.6 5.4 6.6 10.2 5.9 5.5 5.9 5.3 5.5 4.7 4.1 7.4 8.5 7.9 10.0 6.3 18.5 8.9 8.8 7.8 6.9 6.4 3.9 4.3 9.2 9.2 7.5 7.7 8.3 6.8 4.6 4.4 4.8 8.3 4.9 8.8 10.5 8.9 7.6 8.7 12.6 4.2 5.8 14.3 8.6 4.5 8.8 21.1 11.1 28.0 11.3 9.4 9.7 19.2 17.7 17.8 17.2 18.9 12.1 23.7 27.9 6.3 10.3 16.3 8.8 22.7 10.8 27.5 35.1 15.7 18.4 8.9 32.2 16.0 50.1 16.1 7.0 15.9 17.2 7.8 10.5 16.6 19.7 25.4 31.0 13.7 17.5 56.4 37.0 21.7 21.9 14.3 29.9 14.8 14.3 13.4 23.2 23.8 11.3 9.7 12.6 22.0 15.3 9.8 37.1 12.2 16.2 17.9 11.8 29.9 17.7 23.5 32.9 20.2 16.0 18.6 3.5 27.4 18.4 18.2 43.9 24.1 32.3 23.8 21.6 26.6 33.3 26.6 24.1 16.2 26.8 59.6 21.3 28.3 30.8 8.1 8.6 11.5 13.6 7.4 8.5 8.9 8.8 7.8 9.2 8.8 8.7 8.8 143.3 22.4 34.1 11.8 86.7 69.3 91.2 141.8 56.9 22.5 55.3 88.0 25.1 51.5 55.9 27.6 2.1 132.7 53.5 38.2 68.4 67.2 3.6 53.4 44.9 68.7 23.4 82.6 12.3 67.1 183.4 65.6 30.1 33.1 56.4 52.1 54.7 65.8 124.9 18.5 13.3 66.2 61.1 96.2 98.0 13.8 76.1 98.2 51.6 7.5 171.2 33.7 74.2 16.6 13.1 53.1 83.6 57.9 60.6 162.8 92.7 111.5 64.3 25.0 32.9 47.5 82.2 107.3 196.2 78.0 71.7 73.7 77.1 71.6 85.5 99.8 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617386-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 132.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054013: AB_2682343" "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favorable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 14.1 20.9 7.6 12.5 9.8 8.0 13.0 9.9 16.0 16.2 10.0 14.9 17.4 14.3 11.3 13.0 13.7 13.5 14.4 10.0 13.2 20.5 20.6 12.8 11.5 8.6 8.9 6.4 16.7 15.5 132.7 7.1 19.7 8.5 16.9 16.6 16.4 17.5 16.9 14.9 11.8 17.0 14.4 9.5 11.3 15.5 12.1 9.7 12.8 32.9 16.5 13.9 14.6 7.7 11.3 17.4 27.3 33.7 25.6 45.0 44.6 22.3 32.6 37.5 23.7 26.9 22.7 32.7 16.3 15.7 25.1 23.2 20.5 28.4 24.6 25.8 36.4 16.2 21.1 19.8 16.2 36.3 28.8 29.8 33.2 33.0 26.3 26.9 34.9 30.7 18.4 27.2 44.1 33.6 27.0 24.8 10.2 21.7 40.4 15.7 24.3 11.6 28.2 26.3 32.6 25.8 33.4 18.3 27.0 28.5 25.8 26.8 17.5 31.5 29.2 15.7 24.3 21.0 47.9 68.0 21.5 34.9 17.0 32.7 20.5 12.9 14.7 15.3 16.5 19.4 10.4 13.9 13.9 15.8 12.1 13.0 12.4 10.0 14.6 17.9 10.8 14.3 11.0 7.6 9.8 9.9 16.0 10.0 13.2 8.6 8.9 6.4 8.5 9.5 9.7 11.3 8.3 9.6 9.3 7.8 9.5 4.6 8.0 6.3 6.8 8.6 8.3 5.7 19.8 8.6 11.5 5.5 12.5 14.3 12.5 9.8 1.9 12.8 34.6 8.0 11.1 10.0 5.4 8.2 10.4 12.7 12.0 10.6 7.7 9.9 21.5 7.3 8.2 11.8 10.4 11.8 12.7 7.7 6.1 11.9 5.1 13.7 10.8 9.1 5.4 6.5 6.4 8.5 7.2 8.5 14.1 8.6 6.7 14.7 9.0 7.8 9.7 5.8 5.2 6.5 6.6 9.5 8.8 6.5 5.4 10.6 3.4 8.6 12.0 10.6 11.3 7.0 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684163 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Rod photoreceptor cells: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: AB_2678043" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 3.3 9.9 1.4 2.8 1.9 8.6 4.1 2.9 2.5 2.8 1.8 2.3 1.4 4.7 3.1 2.9 3.3 3.0 2.6 2.0 3.6 4.4 3.5 3.3 3.5 1.5 1.9 1.6 11.3 3.4 6.2 3.6 3.0 1.8 3.4 2.6 5.3 2.7 3.3 3.3 2.8 1.9 2.7 1.4 2.9 3.2 7.2 1.7 4.6 5.8 2.5 3.0 2.5 2.3 1.9 2.8 1.8 4.3 3.3 3.3 5.6 3.8 3.1 4.9 4.6 4.8 1.4 3.1 9.8 1.3 2.7 2.3 1.9 5.1 2.6 6.3 3.5 3.0 5.4 3.6 2.3 2.5 8.0 2.8 3.9 2.7 2.8 2.5 3.7 3.9 4.8 5.4 5.5 3.9 1.6 6.8 3.1 2.2 2.7 3.2 4.5 3.7 3.6 3.7 2.2 2.7 4.1 4.9 3.8 2.5 2.8 1.6 1.7 3.3 2.9 2.4 3.3 3.4 6.2 5.3 6.1 3.3 4.8 2.2 6.1 4.2 8.6 4.7 4.7 4.6 7.4 5.7 5.8 3.0 7.2 7.1 6.2 2.8 4.3 3.5 4.4 5.5 2.1 1.4 1.9 2.9 2.5 2.0 3.6 1.5 1.9 1.6 1.8 1.4 1.7 1.9 8.7 0.0 5.3 9.8 40.4 0.0 4.2 0.0 26.7 56.5 11.7 21.8 5.9 7.2 0.6 35.0 112.6 14.5 51.6 6.2 5.9 7.0 73.1 9.2 9.5 8.4 17.4 10.3 29.8 6.5 14.8 12.9 11.2 13.0 33.7 15.6 12.8 6.9 17.2 50.5 29.8 7.2 0.0 36.5 0.0 13.4 18.0 63.7 0.0 17.8 10.9 48.1 16.5 20.6 16.3 7.4 6.2 17.0 18.4 4.1 7.4 5.5 1.5 81.1 13.1 6.2 18.5 36.5 19.6 4.3 0.0 15.2 61.2 18.5 6.3 2.0 ITGA2 CD49B ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989340-53094779 "Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol Yes No 43000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.4 13.0 2.7 4.9 6.0 0.4 7.9 4.2 5.0 4.4 1.0 6.1 7.8 5.0 7.5 11.1 2.6 9.1 1.1 2.3 4.0 9.9 0.5 12.6 0.9 4.6 4.7 1.1 1.0 1.6 9.4 1.2 4.8 6.0 6.7 5.9 2.4 10.5 11.2 0.5 17.2 7.7 2.4 3.9 6.9 7.6 0.4 4.7 4.3 2.3 0.7 4.7 15.7 8.1 13.1 60.4 15.4 1.3 0.8 3.9 7.1 4.5 60.2 91.4 2.2 3.6 29.0 41.8 0.1 9.8 25.4 33.5 92.5 4.9 67.1 8.5 0.0 4.4 4.3 3.7 17.5 13.3 0.7 1.3 2.9 11.4 59.2 10.5 83.2 83.5 3.1 0.1 0.2 1.6 11.4 0.6 0.1 3.7 15.7 29.6 0.0 0.4 0.1 18.9 32.0 0.6 3.2 3.2 4.1 6.1 2.3 9.6 0.2 71.2 10.8 6.3 1.7 12.1 0.0 0.1 0.1 64.0 0.0 48.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.7 6.0 4.2 5.0 2.3 4.0 4.6 4.7 1.1 6.0 3.9 4.7 13.1 7.4 57.7 13.7 9.1 0.6 151.0 406.2 141.3 56.9 2.7 24.4 39.0 1.3 15.7 133.2 53.3 4.2 1.9 0.9 23.2 9.8 144.0 0.1 20.3 5.0 39.0 13.8 0.0 0.5 169.3 2.2 11.6 13.3 90.6 1.3 45.4 5.3 0.2 0.3 0.0 0.9 37.8 20.3 0.0 6.1 0.2 1.2 2.5 12.4 14.0 1.1 14.7 0.0 0.0 370.9 558.7 20.3 0.0 2.6 299.3 20.6 3.8 103.6 4.3 0.0 4.4 12.1 0.0 1.3 57.0 37.2 0.4 5.8 23.7 30.9 363.9 MOCS2 "MOCO1, MOCS2A, MOCS2B" ENSG00000164172 "Molybdenum cofactor synthesis 2" "O96007, O96033" 5 53095679-53110063 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 573.2;Proximal tubular cells: 281.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037679, HPA037680" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear speckles" "HPA037679: AB_2675604, HPA037680: AB_10673635" "unprognostic (3.27e-1)" "unprognostic (3.11e-2)" "unprognostic (2.82e-1)" "unprognostic (8.37e-3)" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.60e-2)" "unprognostic (1.33e-1)" "unprognostic (6.66e-2)" "unprognostic (7.59e-2)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" "prognostic favorable (3.68e-6)" "unprognostic (1.04e-1)" "unprognostic (1.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.86e-2)" 49.2 80.2 79.2 25.1 84.4 9.2 42.5 79.8 108.5 35.0 75.2 36.1 41.2 30.3 46.3 35.5 26.8 31.6 87.8 83.0 83.9 115.8 127.3 28.4 26.3 79.0 79.9 78.3 43.9 42.8 90.4 30.7 36.2 80.8 37.1 32.6 59.8 49.3 45.3 110.4 16.7 40.5 34.7 83.5 23.8 37.6 26.3 84.7 28.5 55.9 112.8 25.4 31.1 24.8 86.5 79.4 62.7 42.9 109.9 85.0 83.2 51.6 99.5 91.9 74.4 89.8 79.7 56.5 76.7 143.5 69.9 127.1 45.0 91.7 96.7 117.2 19.6 84.8 61.7 58.2 75.9 94.4 65.0 43.0 65.1 41.7 91.7 83.5 81.0 85.1 101.4 58.7 44.2 129.5 115.5 72.7 31.8 37.0 34.2 130.1 36.0 93.0 67.0 144.1 56.6 29.4 33.7 69.4 57.3 72.9 56.9 107.2 15.4 55.6 76.9 81.0 69.1 120.5 49.4 84.8 91.5 106.7 16.8 125.1 14.5 21.8 15.6 36.9 26.9 46.2 37.5 42.7 42.8 29.8 40.5 55.3 49.2 3.8 43.5 25.4 27.8 44.9 28.9 79.2 84.4 79.8 108.5 83.0 83.9 79.0 79.9 78.3 80.8 83.5 84.7 86.5 51.7 54.5 29.7 14.4 23.5 13.4 40.1 48.5 19.9 30.2 55.7 50.5 122.9 62.9 37.9 69.9 27.1 95.4 19.4 18.2 573.2 43.7 7.3 22.6 29.0 37.6 26.4 18.7 19.1 43.7 37.3 55.7 19.9 26.8 10.1 38.8 26.0 132.6 41.3 6.7 18.4 22.7 44.7 31.2 20.1 14.6 50.7 28.7 23.2 6.5 12.2 67.5 29.9 4.5 11.9 22.1 18.2 68.8 26.7 34.5 65.7 281.7 32.9 21.7 32.9 73.8 49.4 46.7 62.9 37.5 15.6 32.3 25.8 64.2 30.9 34.5 SLC45A2 "AIM-1, MATP, OCA4" ENSG00000164175 "Solute carrier family 45 member 2" Q9UMX9 5 33944623-33984693 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Sensory transduction, Vision" "Albinism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 1.2;skin 1: 1.0;testis: 1.0" "Cell type enhanced" "Detected in some" "Early spermatids: 3.1;Excitatory neurons: 4.1;Inhibitory neurons: 5.4;Late spermatids: 5.1;Melanocytes: 12.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.7" "Cancer enriched" "Detected in some" 18 "melanoma: 47.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 28 "SK-MEL-30: 60.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (3.99e-2)" "unprognostic (3.55e-1)" "unprognostic (2.39e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (8.45e-2)" "unprognostic (5.34e-3)" "unprognostic (4.06e-2)" "unprognostic (8.45e-2)" "unprognostic (7.39e-4)" "unprognostic (1.40e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.39e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 60.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.0 0.3 0.0 0.2 0.4 0.1 0.0 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.6 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.1 0.3 0.1 0.3 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.4 5.1 0.0 0.0 12.4 0.0 0.0 0.1 0.0 2.5 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.1 0.0 EDIL3 DEL1 ENSG00000164176 "EGF like repeats and discoidin domains 3" O43854 5 83940554-84384880 "Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 270.9" "Group enriched" "Detected in many" 6 "Oligodendrocyte precursor cells: 561.4;Oligodendrocytes: 2119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 547.0;LHCN-M2: 169.8;TIME: 203.3;U-2 OS: 163.2;U-87 MG: 112.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020415 Approved "Secreted to blood" NA NA "HPA020415: AB_2670434" "unprognostic (9.93e-3)" "unprognostic (2.38e-1)" "unprognostic (2.71e-2)" "unprognostic (8.63e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (9.19e-2)" "unprognostic (6.64e-3)" "unprognostic (2.98e-1)" "unprognostic (1.56e-1)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.28e-3)" 14.1 21.9 69.5 13.7 129.3 0.2 6.3 102.2 114.2 17.6 28.8 37.3 17.1 27.1 45.3 17.2 11.0 34.3 20.8 83.9 103.0 10.8 0.7 21.1 0.8 127.6 105.0 60.0 10.1 3.4 4.2 2.9 4.6 128.3 13.6 38.8 40.6 3.9 22.3 0.8 9.8 26.4 26.0 114.8 3.2 19.9 2.4 103.6 0.3 4.1 0.7 3.6 15.9 9.6 270.9 0.1 1.5 1.4 0.0 3.7 0.2 0.1 4.8 0.0 12.6 16.9 0.0 21.2 0.0 0.1 0.1 8.8 19.6 0.0 0.8 9.3 0.1 9.2 0.0 54.5 0.0 99.9 1.0 0.2 25.6 2.6 61.0 8.5 547.0 21.7 0.0 0.0 0.3 169.8 0.1 0.1 0.3 8.7 0.0 39.4 0.1 41.4 0.1 28.2 0.0 4.5 0.5 0.0 0.3 0.1 26.1 0.2 0.2 203.3 60.8 163.2 2.1 56.6 1.6 0.0 0.1 112.6 0.1 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.5 129.3 102.2 114.2 83.9 103.0 127.6 105.0 60.0 128.3 114.8 103.6 270.9 3.1 9.6 6.0 14.0 0.1 12.1 1.7 13.7 14.8 179.2 0.3 11.7 13.3 0.0 4.5 3.7 2.1 0.3 0.1 5.9 0.0 0.1 32.8 0.4 7.2 10.4 22.9 0.0 219.9 0.0 0.0 34.8 0.0 0.3 5.7 1.3 1.4 0.1 0.3 5.0 216.5 9.2 2.0 0.0 3.3 19.8 2.5 0.3 3.6 32.8 0.0 5.4 0.0 561.4 2119.7 0.4 8.1 3.8 0.0 0.9 0.0 0.9 1.2 11.6 6.6 0.2 40.2 1.9 1.5 9.3 16.1 0.4 0.6 16.2 8.4 0.7 TMEM161B MGC33214 ENSG00000164180 "Transmembrane protein 161B" Q8NDZ6 5 88189633-88269476 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 82.1;HMC-1: 85.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044562 Uncertain NA NA "HPA044562: AB_10794291" "unprognostic (2.08e-1)" "unprognostic (6.02e-2)" "unprognostic (2.06e-2)" "unprognostic (5.64e-2)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" "unprognostic (3.07e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-1)" "unprognostic (1.01e-1)" "unprognostic (6.96e-3)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-3)" "unprognostic (9.35e-2)" 4.4 5.9 4.9 5.9 5.0 6.2 16.1 7.9 6.7 6.6 2.9 9.8 12.5 6.5 14.4 7.8 7.2 5.7 4.6 4.7 4.7 9.8 12.0 10.1 9.2 3.6 4.1 5.0 11.3 14.2 23.2 4.8 8.2 4.5 12.4 11.4 18.4 14.3 9.0 6.5 15.7 11.6 5.9 2.8 6.4 23.1 12.6 3.9 8.7 21.0 7.1 9.6 7.5 6.1 6.0 11.8 8.0 8.7 9.5 5.4 10.3 18.6 10.3 15.4 14.6 21.2 8.9 30.2 18.2 5.2 7.7 26.6 12.3 10.2 13.3 18.4 16.4 10.7 82.1 10.3 5.9 14.0 15.9 85.2 9.2 19.1 12.4 18.3 10.4 6.5 11.9 40.5 16.0 12.7 5.5 11.6 13.9 5.6 8.7 14.3 9.7 10.1 19.9 13.0 16.4 11.1 9.3 5.9 16.3 24.5 7.7 9.8 14.5 5.4 9.5 8.7 13.7 18.9 19.6 33.3 14.9 23.3 15.7 13.4 1.5 1.4 1.0 2.9 2.8 2.9 2.2 2.4 2.1 0.8 2.1 2.4 1.9 0.8 2.9 1.1 2.6 2.1 1.2 4.9 5.0 7.9 6.7 4.7 4.7 3.6 4.1 5.0 4.5 2.8 3.9 6.0 9.8 28.9 16.4 37.2 19.2 7.8 8.0 12.0 5.7 15.8 13.6 9.7 16.3 11.5 15.0 9.2 16.7 9.3 17.9 14.7 3.9 8.8 3.6 10.2 11.4 7.7 14.3 10.3 43.4 9.7 4.1 9.8 12.2 14.0 16.5 14.4 15.0 23.1 5.3 6.7 46.3 13.7 6.1 11.8 5.5 3.1 10.5 8.2 0.0 28.1 7.1 15.6 22.6 59.3 55.0 11.3 6.6 12.8 13.1 9.4 11.3 6.4 9.4 22.2 6.6 8.9 8.9 35.8 12.6 9.3 7.1 15.1 15.8 11.3 14.3 7.5 ELOVL7 FLJ23563 ENSG00000164181 "ELOVL fatty acid elongase 7" A1L3X0 5 60751791-60844274 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Microglial cells: 190.2;Oligodendrocytes: 90.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.9;neutrophil: 1.3" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "GAMG: 41.9;HDLM-2: 29.3;HEL: 37.3" "Low region specificity" "Detected in all" HPA036337 Approved NA NA "HPA036337: AB_10670797" "unprognostic (6.34e-2)" "unprognostic (1.96e-2)" "unprognostic (1.51e-2)" "prognostic unfavorable (3.87e-5)" "unprognostic (3.84e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.54e-9)" "unprognostic (6.95e-2)" "unprognostic (1.01e-3)" "unprognostic (2.94e-1)" "unprognostic (6.30e-3)" 7.9 5.5 24.9 2.2 24.7 1.0 22.4 29.5 26.5 3.7 35.7 8.9 11.9 2.2 0.9 5.1 2.8 19.5 0.8 18.7 29.0 16.4 1.0 3.8 2.6 32.3 26.8 15.1 0.5 8.6 21.2 2.7 0.8 32.1 22.2 11.6 10.6 4.7 1.2 0.5 26.4 21.5 3.7 30.5 0.5 3.3 0.8 34.0 1.8 16.9 1.0 4.1 7.7 6.8 32.8 20.7 7.6 0.1 0.5 0.0 0.0 18.6 0.0 4.3 2.5 8.4 9.6 21.4 0.0 9.1 0.0 41.9 1.2 11.9 8.3 3.8 29.3 6.9 37.3 0.9 3.2 0.2 3.0 15.2 0.1 14.6 0.3 12.3 0.9 0.0 6.5 5.9 7.2 0.0 17.8 0.1 0.3 2.4 1.9 0.1 1.6 1.9 1.2 19.4 18.5 7.8 1.2 10.9 8.8 5.0 2.0 14.2 0.6 0.2 1.5 9.0 0.2 7.2 18.5 19.7 0.3 13.2 0.8 0.4 1.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.5 24.9 24.7 29.5 26.5 18.7 29.0 32.3 26.8 15.1 32.1 30.5 34.0 32.8 14.5 12.8 3.1 4.9 0.5 31.1 13.1 1.4 4.6 2.3 3.1 1.4 0.7 20.0 4.8 12.9 0.0 0.2 0.3 8.8 5.9 6.8 0.1 6.5 1.6 21.1 4.8 1.3 29.5 3.1 0.0 2.0 5.6 20.4 12.7 0.4 0.4 0.0 0.1 0.0 26.0 17.0 0.0 0.0 16.6 0.0 0.0 4.9 10.6 190.2 2.0 3.5 0.0 6.0 90.8 7.1 13.3 0.0 0.1 23.4 29.7 8.9 1.7 6.7 0.0 1.0 0.8 0.2 1.1 2.9 38.2 2.9 0.9 0.2 15.9 8.6 NDUFAF2 "B17.2L, mimitin, MMTN, NDUFA12L" ENSG00000164182 "NADH:ubiquinone oxidoreductase complex assembly factor 2" Q8N183 5 60945177-61154531 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA048082, HPA054776" Supported Enhanced Mitochondria NA NA Mitochondria "HPA048082: AB_2680254, HPA054776: AB_2682598" "unprognostic (7.28e-2)" "unprognostic (6.83e-2)" "unprognostic (1.37e-1)" "unprognostic (2.46e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (8.40e-3)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.79e-2)" "unprognostic (6.10e-2)" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" 40.5 39.5 36.6 23.5 37.6 18.1 38.8 36.4 56.4 34.3 35.3 41.9 21.2 31.9 17.7 36.7 31.6 17.2 53.2 36.8 38.4 31.7 32.5 25.1 19.9 38.2 37.8 36.4 38.0 36.0 31.5 45.5 14.6 38.8 32.2 26.5 22.2 26.0 23.3 80.8 21.7 25.1 26.1 36.7 18.5 36.2 31.4 37.6 13.1 23.2 46.9 18.9 43.8 33.7 38.8 109.0 51.9 41.6 129.1 80.7 113.8 70.3 129.8 71.1 85.2 103.7 99.4 84.0 150.8 127.5 91.2 141.2 44.2 72.6 113.8 103.6 66.0 104.3 52.1 95.7 99.4 115.6 72.5 26.2 59.7 119.2 74.9 226.0 53.9 74.7 64.0 79.5 76.3 90.9 89.6 64.2 108.0 35.3 41.2 135.0 77.3 115.1 192.7 83.1 46.1 84.8 33.0 74.7 72.7 136.0 35.8 86.1 40.4 68.6 55.5 82.8 125.3 134.2 46.0 73.2 170.8 75.9 123.2 66.3 0.4 18.3 2.4 17.3 19.1 21.1 23.0 22.3 21.1 32.1 15.2 18.6 20.1 0.8 27.1 15.8 11.0 31.7 12.2 36.6 37.6 36.4 56.4 36.8 38.4 38.2 37.8 36.4 38.8 36.7 37.6 38.8 40.8 12.8 28.0 23.8 32.8 60.5 64.6 62.2 34.1 27.9 47.9 59.8 87.6 45.8 39.6 38.6 12.5 20.8 18.7 29.8 93.9 55.1 175.7 41.8 95.1 35.8 24.7 28.8 62.2 56.6 49.2 60.4 28.5 40.3 20.3 27.2 31.8 94.6 51.4 42.1 68.8 59.3 40.7 29.5 59.1 22.2 76.7 29.0 44.4 40.3 24.7 34.0 22.6 61.9 71.3 69.8 52.2 62.1 29.0 144.1 32.2 151.4 25.9 29.1 26.3 55.2 60.1 108.4 73.9 63.0 63.6 14.2 34.0 48.5 65.7 71.1 ZNF474 "4933409D10Rik, FLJ32921" ENSG00000164185 "Zinc finger protein 474" Q6S9Z5 5 122129546-122153569 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.9;fallopian tube: 17.2;testis: 7.7" "Group enriched" "Detected in some" 5 "Early spermatids: 23.0;Endometrial ciliated cells: 23.2;Late spermatids: 12.4;Respiratory ciliated cells: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;CAPAN-2: 1.1;GAMG: 1.3;TIME: 1.2" "Low region specificity" "Detected in many" HPA036594 Approved "Nuclear membrane,Plasma membrane" NA NA "Nuclear membrane" "Plasma membrane" "HPA036594: " "unprognostic (9.98e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (5.90e-3)" "unprognostic (7.82e-2)" "unprognostic (2.49e-2)" "unprognostic (3.94e-2)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (1.51e-3)" "unprognostic (1.12e-3)" "unprognostic (9.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.09e-4)" 0.2 0.1 2.2 0.2 0.7 0.0 0.2 1.0 0.5 0.6 5.9 0.3 0.1 0.8 0.0 0.4 17.2 0.5 0.1 0.5 2.0 0.1 0.1 1.7 0.0 1.9 3.4 0.2 0.2 0.1 0.0 0.2 0.0 1.8 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 2.4 0.1 0.1 7.7 1.1 0.3 0.9 0.1 0.1 0.1 0.1 2.0 0.0 0.4 0.1 0.0 0.2 0.1 0.0 1.0 0.2 0.1 0.0 0.0 1.1 0.0 0.0 0.7 1.3 0.2 0.0 0.0 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.3 0.0 0.1 0.5 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.1 1.2 0.3 0.2 0.7 0.2 0.1 0.2 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.7 1.0 0.5 0.5 2.0 1.9 3.4 0.2 1.8 2.4 1.1 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.0 23.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.0 0.0 0.0 0.1 0.6 2.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LMBRD2 DKFZp434H2226 ENSG00000164187 "LMBR1 domain containing 2" Q68DH5 5 36098407-36151887 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 71.4;Inhibitory neurons: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 10.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012165 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA012165: AB_2136131" "unprognostic (9.43e-3)" "unprognostic (3.03e-1)" "unprognostic (1.80e-2)" "unprognostic (7.09e-2)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.58e-2)" "unprognostic (8.46e-3)" "unprognostic (6.45e-3)" "unprognostic (2.80e-1)" "unprognostic (8.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.30e-3)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (5.35e-2)" 4.6 6.7 5.6 5.1 8.8 1.7 6.2 5.1 10.7 4.8 2.8 6.4 7.1 3.4 4.9 4.8 3.2 4.1 6.1 9.1 6.5 7.3 10.4 4.1 6.0 3.9 5.3 6.8 3.2 5.1 10.8 4.7 6.1 4.3 6.7 6.4 6.9 6.1 4.5 5.6 5.6 7.1 3.8 4.1 5.1 7.4 3.8 6.0 6.0 9.1 8.7 5.4 4.2 2.9 7.7 5.5 4.0 4.8 7.9 9.7 8.5 16.8 11.1 5.8 8.0 8.0 5.0 11.7 9.8 5.5 5.9 8.2 7.3 6.4 3.9 13.1 14.1 3.9 7.6 13.6 0.9 6.2 9.3 9.7 5.1 6.7 6.9 6.8 6.0 4.4 7.4 9.1 10.0 9.8 3.6 8.0 6.1 2.6 8.5 5.0 6.0 11.1 6.0 6.8 4.7 8.9 6.9 16.1 9.4 3.9 4.7 10.7 11.1 5.9 9.5 2.5 12.3 6.0 8.2 12.8 8.5 9.0 10.4 6.7 10.6 0.8 1.4 1.0 0.8 0.7 1.0 0.9 0.9 0.7 0.8 1.2 1.2 0.6 0.7 0.8 0.8 1.6 0.5 5.6 8.8 5.1 10.7 9.1 6.5 3.9 5.3 6.8 4.3 4.1 6.0 7.7 8.8 9.6 9.8 33.3 10.2 6.9 4.8 6.3 7.4 11.9 10.8 6.1 24.1 12.8 7.3 12.9 8.4 9.0 7.5 19.4 3.9 5.0 2.1 6.8 6.4 7.3 6.7 9.0 71.4 7.6 6.6 10.3 15.8 6.5 7.0 7.3 9.3 30.2 11.8 15.2 51.1 12.6 8.2 11.0 6.0 1.4 4.7 8.7 7.2 14.0 9.7 14.3 6.2 36.2 37.8 6.0 6.5 7.2 11.9 6.3 13.0 12.3 12.0 11.2 13.1 10.5 9.7 27.5 10.0 9.7 10.1 19.4 10.0 7.2 12.0 4.0 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36246913-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;kidney: 24.8" "Cell type enriched" "Detected in some" 7 "Astrocytes: 355.9" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 3.8 1.7 26.6 0.3 25.6 0.0 7.6 6.3 32.3 1.2 7.8 0.6 0.2 0.7 1.8 0.5 1.2 1.9 1.5 26.8 13.2 24.8 9.9 2.0 0.2 13.5 15.7 17.4 2.1 0.4 0.2 2.9 5.1 15.1 13.6 0.4 5.3 0.6 3.0 0.4 0.3 0.4 0.6 12.0 0.2 1.8 4.8 18.5 0.1 2.2 3.0 0.6 6.9 0.8 16.8 0.0 0.0 0.1 0.2 12.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 25.6 6.3 32.3 26.8 13.2 13.5 15.7 17.4 15.1 12.0 18.5 16.8 0.3 0.0 0.0 355.9 0.0 0.0 0.1 0.0 0.6 0.4 4.1 2.3 0.3 0.0 0.0 9.2 0.0 0.0 1.3 0.0 46.9 0.0 0.1 0.1 0.7 0.4 0.0 0.0 5.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.4 1.3 1.9 0.0 4.5 0.0 0.0 0.0 0.3 0.8 2.1 0.2 1.8 23.4 0.0 16.1 0.0 5.5 2.8 0.0 0.0 2.2 0.0 1.3 0.0 0.2 0.0 0.6 13.1 0.6 8.3 0.0 0.1 0.0 0.0 0.1 0.0 3.0 0.0 0.1 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL cohesin loading factor" Q6KC79 5 36876769-37066413 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: AB_2683650" "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 11.6 9.5 5.3 14.9 8.4 25.3 13.6 12.1 7.4 13.0 8.3 12.3 10.1 13.5 6.7 11.5 10.6 11.2 7.8 5.4 6.8 11.7 12.8 12.0 16.7 7.0 6.8 3.0 17.8 13.2 19.7 5.0 14.0 7.8 11.2 12.3 22.6 11.3 10.8 9.6 14.3 13.3 12.5 7.0 15.4 13.6 14.4 6.4 30.1 17.3 14.5 16.8 12.7 7.5 11.3 22.5 13.1 33.3 15.6 20.7 22.3 24.4 17.6 19.3 18.9 15.7 18.2 22.6 33.5 11.3 21.6 22.2 19.2 28.9 15.9 27.0 27.9 14.7 40.9 57.4 13.3 14.0 48.4 26.4 16.5 19.3 21.3 28.1 18.1 24.0 20.8 39.3 24.5 17.9 10.8 33.8 18.1 16.0 12.9 11.3 28.2 51.9 13.0 13.1 31.4 24.5 17.2 84.6 22.5 18.0 26.2 23.0 27.3 26.3 24.9 27.1 21.0 13.3 17.7 25.5 39.1 13.6 32.4 19.1 10.9 2.9 4.3 3.2 2.2 3.0 2.8 2.7 2.9 2.3 3.1 2.9 3.3 7.7 2.8 3.3 3.4 2.1 1.6 5.3 8.4 12.1 7.4 5.4 6.8 7.0 6.8 3.0 7.8 7.0 6.4 11.3 80.6 131.4 108.6 169.8 84.8 48.4 66.2 34.2 58.1 62.6 43.6 49.4 87.0 38.6 63.3 33.1 77.2 44.1 107.1 45.9 5.9 55.5 13.4 72.9 75.7 74.1 41.5 85.4 179.2 46.7 34.1 64.3 61.2 91.7 84.0 77.7 44.6 28.2 37.1 40.4 165.5 46.3 38.7 51.8 46.6 15.1 66.5 86.7 24.9 236.1 103.3 49.2 97.9 229.2 303.7 55.0 48.6 56.4 84.5 66.4 45.2 12.2 65.2 72.8 52.6 102.9 80.1 185.8 133.6 58.2 47.0 75.9 92.0 73.8 42.9 88.0 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165843-64372869 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 25.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 90.5;Inhibitory neurons: 151.6;Oligodendrocyte precursor cells: 162.3" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol NA NA Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favorable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 5.5 5.1 3.8 1.5 4.4 0.3 3.6 2.6 5.5 4.1 2.7 2.5 1.7 7.8 7.8 4.3 5.0 4.2 7.1 2.8 7.2 8.1 4.5 3.7 1.3 4.4 5.6 2.3 7.7 4.3 25.5 3.5 0.6 4.5 7.4 1.3 6.0 4.6 10.7 2.8 4.2 1.4 5.8 3.4 3.1 2.6 3.5 5.4 0.7 14.1 4.2 1.0 3.4 2.3 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.3 1.2 0.5 1.2 0.7 0.0 0.1 0.0 0.1 0.9 0.7 0.2 0.0 0.5 0.2 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.3 0.1 3.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.6 0.0 1.4 0.1 3.7 29.4 2.1 0.3 0.3 0.1 0.0 0.3 0.0 1.8 1.5 0.1 0.1 0.0 3.5 0.1 3.3 0.0 0.0 0.0 0.6 0.0 3.9 1.2 0.6 1.7 0.6 0.2 0.9 0.5 1.0 1.1 0.2 0.8 1.4 1.3 1.0 0.8 0.3 0.4 0.7 0.0 3.8 4.4 2.6 5.5 2.8 7.2 4.4 5.6 2.3 4.5 3.4 5.4 4.8 9.5 16.0 12.3 51.6 0.5 4.6 8.9 1.3 7.4 16.6 8.1 4.2 10.9 10.0 4.9 16.5 14.6 0.0 0.0 0.0 7.9 5.8 12.5 14.2 6.1 6.3 1.2 0.0 90.5 2.6 0.1 7.9 6.1 32.9 0.0 5.7 14.3 5.9 0.1 11.8 151.6 1.9 0.0 0.6 1.1 8.8 34.5 0.5 5.4 32.8 0.0 30.1 0.0 162.3 50.1 3.1 2.7 25.2 0.0 6.4 1.2 15.9 1.9 16.9 39.5 24.2 20.4 18.9 12.0 2.9 7.4 0.0 0.3 4.1 1.6 4.5 ADGRV1 "DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1" ENSG00000164199 "Adhesion G protein-coupled receptor V1" Q8WXG9 5 90529344-91164437 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Hydrolase, Receptor, Transducer" "Deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 537.4" "Cell type enriched" "Detected in many" 8 "Astrocytes: 2207.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067503 Approved Approved "Lipid droplets" NA NA "Lipid droplets" "HPA067503: AB_2685856" "unprognostic (1.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.69e-2)" "unprognostic (1.38e-1)" "unprognostic (4.01e-2)" "unprognostic (2.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-3)" "unprognostic (1.48e-2)" "unprognostic (1.87e-1)" "unprognostic (3.95e-3)" "unprognostic (7.50e-3)" "unprognostic (9.73e-7)" "unprognostic (1.87e-2)" "unprognostic (5.24e-2)" "unprognostic (3.48e-2)" "unprognostic (7.14e-2)" 0.0 537.4 36.2 0.0 41.1 0.6 3.6 10.6 39.8 0.5 19.4 1.0 0.3 0.1 0.7 2.4 0.2 12.4 0.1 39.8 68.3 21.7 42.6 2.2 0.0 17.2 10.9 33.4 0.2 1.5 0.8 15.2 4.1 19.6 1.3 1.1 18.3 2.4 0.2 0.2 2.1 0.5 0.0 5.1 0.3 1.1 1.4 7.8 0.9 17.6 0.0 0.4 10.5 1.9 29.8 0.5 2.1 15.5 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.0 1.7 0.2 0.3 0.4 0.0 0.4 0.2 23.0 0.2 0.0 1.0 4.3 4.1 2.0 1.4 0.0 0.3 0.1 0.0 4.8 0.0 0.1 0.1 0.0 0.1 9.8 2.6 0.0 2.1 0.1 0.2 11.6 2.9 4.2 0.0 0.4 2.1 0.0 0.5 11.1 2.7 3.4 2.2 0.2 15.0 5.9 0.0 0.8 0.4 1.9 0.5 1.1 13.4 4.1 0.6 0.7 0.2 0.0 3.2 0.9 2.8 1.0 0.7 1.7 1.5 1.1 1.4 0.5 2.9 1.7 0.9 4.6 1.1 0.5 1.2 1.6 0.2 36.2 41.1 10.6 39.8 39.8 68.3 17.2 10.9 33.4 19.6 5.1 7.8 29.8 0.4 25.6 26.5 2207.3 0.0 0.0 6.1 0.0 1.8 28.0 15.5 7.4 2.4 2.8 5.6 5.5 264.8 3.0 0.4 0.6 1.9 1.9 43.5 3.3 0.3 1.1 7.3 0.0 54.0 4.2 2.6 1.1 4.6 1.9 0.0 6.7 0.0 12.4 0.2 10.1 21.9 0.4 0.0 0.8 0.0 54.8 0.6 0.5 0.0 51.5 1.2 8.9 1.0 40.2 7.4 1.7 1.2 0.4 0.1 2.1 0.1 24.2 7.3 84.4 0.0 0.3 0.4 3.6 4.5 2.9 0.0 4.1 0.6 0.2 1.2 9.0 SLC25A46 ENSG00000164209 "Solute carrier family 25 member 46" Q96AG3 5 110738136-110765161 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 238.9;Late spermatids: 448.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039601, HPA071582" Approved Supported Mitochondria NA NA Mitochondria "HPA039601: AB_2676592, HPA071582: AB_2686422" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "prognostic favorable (8.41e-4)" "unprognostic (4.91e-2)" "unprognostic (2.27e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "unprognostic (1.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.97e-2)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (2.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.98e-1)" 23.1 16.0 10.2 20.1 13.3 17.7 16.5 14.2 16.5 18.6 9.0 22.4 24.0 14.9 10.6 21.4 10.8 16.0 31.3 13.1 13.3 30.0 30.3 16.9 22.6 13.3 12.2 12.4 11.8 15.5 20.7 4.9 17.2 14.1 15.8 21.8 18.9 13.4 16.2 56.3 15.0 21.1 21.0 11.4 15.8 20.3 22.1 12.0 25.0 20.0 60.7 27.0 19.1 6.6 18.0 36.2 27.7 25.7 20.7 65.2 60.2 9.9 44.3 55.9 47.5 59.3 37.6 28.7 96.8 44.8 50.1 61.9 29.6 41.0 71.2 54.3 61.8 20.8 40.1 35.2 25.6 53.1 37.3 40.2 49.9 25.4 55.5 39.6 29.5 31.9 37.2 31.4 56.4 54.1 27.3 54.0 17.2 18.1 25.7 24.7 26.0 57.0 71.5 35.1 39.2 46.7 33.5 37.7 29.7 49.7 23.7 30.9 35.3 42.5 43.6 21.0 40.7 54.4 111.8 76.2 68.4 48.0 43.8 24.0 29.2 16.0 13.2 12.3 19.0 12.5 14.4 13.7 12.9 17.0 14.5 14.5 14.8 6.6 20.9 17.7 11.1 18.2 17.4 10.2 13.3 14.2 16.5 13.1 13.3 13.3 12.2 12.4 14.1 11.4 12.0 18.0 21.3 22.4 24.8 40.8 26.7 22.9 9.1 16.0 31.9 16.8 15.7 10.8 63.5 11.5 12.9 20.2 22.9 21.7 18.0 34.8 19.6 18.1 238.9 10.4 20.1 18.9 23.4 29.9 73.3 25.6 18.2 22.6 34.7 12.1 19.0 16.2 26.7 43.9 27.2 18.5 63.9 28.3 32.6 26.1 21.0 448.2 21.1 23.9 30.2 31.9 28.1 21.9 17.5 49.8 91.8 18.9 22.8 22.2 73.8 8.0 26.5 41.7 14.9 14.1 19.7 18.5 22.6 23.3 14.2 30.0 26.9 20.5 23.9 22.7 24.0 6.8 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 5.5 16.0 9.5 16.0 14.8 19.6 3.9 25.3 13.4 10.3 11.2 14.9 41.1 7.8 16.4 8.6 5.0 9.8 15.1 10.5 10.8 8.4 34.4 21.0 12.7 14.1 19.3 7.8 6.6 6.2 14.5 8.3 27.5 15.8 20.9 17.1 12.1 6.7 10.0 1.5 2.2 36.0 7.0 10.5 12.2 18.1 6.9 19.1 7.3 9.1 1.7 10.2 7.7 9.3 20.2 20.6 10.0 48.2 29.4 42.4 84.0 16.3 21.0 46.6 29.8 89.1 37.7 59.9 24.5 8.4 13.4 89.0 9.1 24.8 71.8 28.8 23.7 10.4 19.1 33.3 22.8 46.4 9.5 11.7 44.6 48.3 64.1 47.6 35.6 56.6 23.5 10.7 46.5 20.8 3.9 23.7 17.3 16.6 0.6 5.5 5.4 53.3 22.5 44.6 6.7 27.2 105.6 0.0 12.3 19.0 32.1 16.0 30.4 84.4 25.6 22.9 17.2 8.9 15.9 15.8 21.6 24.3 34.8 13.2 7.1 1.4 0.9 2.5 2.1 1.3 1.7 1.2 1.9 1.8 1.7 1.2 1.9 0.0 2.1 1.5 1.3 0.8 1.4 9.5 14.8 25.3 13.4 10.5 10.8 14.1 19.3 7.8 15.8 10.5 19.1 20.2 8.2 25.6 34.8 16.0 13.1 1.0 1.4 35.0 1.2 10.8 1.6 0.4 17.8 8.6 18.1 9.2 8.4 15.6 24.8 37.3 1.9 7.8 9.4 6.7 3.5 20.2 21.4 3.6 38.8 9.2 6.0 6.0 15.8 11.5 32.3 6.5 5.0 39.9 20.3 6.7 20.8 32.5 22.4 19.6 26.7 8.3 7.2 27.8 3.6 20.6 5.7 7.1 9.2 20.1 23.6 10.0 30.0 7.9 17.6 3.3 30.1 5.7 9.5 7.6 19.7 2.4 15.2 8.7 9.4 6.8 2.6 14.1 14.5 38.2 23.0 5.2 PGGT1B "BGGI, GGTI" ENSG00000164219 "Protein geranylgeranyltransferase type I subunit beta" P53609 5 115204012-115262877 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030646 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Endoplasmic reticulum" Cytosol "HPA030646: AB_10602019" "unprognostic (2.73e-2)" "unprognostic (1.67e-1)" "unprognostic (3.92e-2)" "unprognostic (7.34e-2)" "unprognostic (5.57e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (3.25e-2)" "unprognostic (1.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (4.38e-2)" "unprognostic (1.58e-1)" "unprognostic (3.75e-1)" "unprognostic (5.93e-3)" "unprognostic (1.15e-2)" 9.5 8.2 4.7 11.2 5.9 12.9 9.7 6.4 4.5 7.7 5.9 14.7 13.1 8.1 3.6 9.7 7.5 7.5 6.7 4.3 8.6 8.2 12.9 7.5 9.9 5.6 5.9 3.6 7.4 9.7 12.7 3.2 8.4 6.1 8.4 15.3 12.1 6.7 5.9 7.9 4.9 11.2 9.8 6.0 10.4 11.8 5.7 5.8 9.5 8.7 9.2 11.1 11.5 5.5 7.5 14.7 15.6 17.5 22.7 10.0 8.3 8.6 17.7 10.4 14.5 14.8 17.1 15.3 29.6 23.4 12.4 14.9 11.2 23.3 23.3 21.5 32.9 12.9 17.1 21.0 13.9 13.3 23.7 24.2 12.5 14.0 14.3 14.8 9.2 14.7 17.2 14.1 12.3 16.7 22.8 20.9 7.9 13.0 16.4 12.0 22.6 23.3 30.3 15.2 27.3 17.0 13.0 21.0 15.8 17.6 10.4 21.2 17.4 17.0 14.8 14.0 10.3 20.9 20.4 24.5 15.5 10.7 24.1 20.9 13.7 19.0 34.1 7.0 25.3 8.0 9.7 7.8 8.9 17.2 11.3 7.4 6.8 19.5 10.5 27.0 15.5 7.6 10.3 4.7 5.9 6.4 4.5 4.3 8.6 5.6 5.9 3.6 6.1 6.0 5.8 7.5 21.8 12.8 20.8 24.8 26.2 9.9 11.8 12.2 9.1 23.3 18.3 10.4 17.1 5.7 18.3 16.5 47.9 15.3 27.2 29.0 27.4 19.3 49.2 15.8 21.3 20.3 30.1 9.5 30.5 21.6 14.9 15.5 19.9 13.5 23.5 17.2 20.7 25.7 22.6 23.5 27.6 22.4 10.2 21.9 13.2 10.2 13.4 24.8 10.6 33.7 26.8 27.8 24.7 38.2 38.0 24.0 27.2 15.4 12.0 15.6 20.7 22.8 20.3 111.2 13.1 20.5 16.7 14.7 13.9 10.7 12.4 13.5 16.1 19.6 23.9 20.3 F2RL2 PAR3 ENSG00000164220 "Coagulation factor II thrombin receptor like 2" O00254 5 76615482-76623413 "G-protein coupled receptors, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 6.9" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 2.3;Fibroblasts: 3.9;Hepatic stellate cells: 10.0;Rod photoreceptor cells: 5.5" "Cancer enhanced" "Detected in many" "breast cancer: 9.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 9 "basophil: 10.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 10.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 53.5;HBF TERT88: 33.8;HEL: 78.4;hTEC/SVTERT24-B: 34.8;hTERT-RPE1: 73.2;U-138 MG: 54.0;WM-115: 69.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.35e-3)" "unprognostic (5.71e-3)" "prognostic favorable (4.69e-4)" "unprognostic (6.71e-2)" "unprognostic (4.16e-3)" "unprognostic (3.56e-2)" "unprognostic (9.71e-2)" "unprognostic (8.49e-2)" "unprognostic (3.78e-2)" "unprognostic (1.43e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-1)" "unprognostic (2.24e-8)" "unprognostic (7.64e-2)" "unprognostic (8.98e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" 0.3 0.4 1.4 1.8 1.3 0.3 3.8 5.0 0.7 1.3 0.2 2.7 1.6 2.3 0.1 0.8 0.3 6.9 1.8 0.3 3.9 0.3 2.0 0.6 0.1 3.3 4.1 0.1 0.1 1.0 0.3 0.4 0.2 2.7 0.3 1.7 5.0 3.7 0.1 0.0 2.3 2.3 3.8 2.0 0.3 1.3 0.0 4.9 0.8 0.2 0.5 0.3 1.0 0.3 0.6 0.0 2.0 0.2 0.2 2.3 12.1 0.0 31.3 53.5 8.3 30.0 0.0 0.1 0.0 1.8 0.2 24.8 0.1 0.0 0.2 33.8 0.0 0.1 78.4 0.7 0.2 4.7 0.1 0.1 6.7 0.2 34.8 0.1 73.2 2.9 0.2 0.0 0.1 3.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 54.0 16.2 2.4 0.4 2.7 0.0 0.0 6.4 0.0 69.8 10.4 0.4 0.1 0.7 0.2 0.6 0.1 0.7 0.4 0.1 0.1 0.3 0.7 0.9 1.1 0.1 1.1 0.9 0.0 1.4 1.3 5.0 0.7 0.3 3.9 3.3 4.1 0.1 2.7 2.0 4.9 0.6 0.0 0.0 0.0 0.3 0.3 0.9 0.1 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 2.3 1.0 0.0 0.0 0.2 0.0 0.0 3.9 1.1 0.3 0.0 0.0 10.0 0.3 0.1 0.0 0.3 0.0 0.0 1.2 1.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.1 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267190-115296693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.0" "Cell type enhanced" "Detected in many" "Spermatocytes: 201.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 113.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: AB_2679222, HPA050621: AB_2681191" "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 4.3 3.7 6.3 5.4 6.8 7.4 6.1 8.0 7.4 4.5 3.7 9.2 7.3 5.7 6.3 4.5 4.1 3.2 6.0 6.4 6.1 2.8 1.2 5.5 4.6 6.7 6.8 5.8 2.1 10.2 4.5 4.6 2.5 7.1 6.8 9.4 8.0 6.5 5.0 4.3 5.0 6.3 5.5 6.0 4.6 6.4 41.0 6.3 3.7 4.0 2.5 4.2 3.8 3.6 8.5 12.0 5.9 11.5 18.5 7.1 14.0 2.9 10.5 5.3 7.7 8.7 2.6 6.7 14.8 8.9 7.2 11.4 7.5 12.1 6.0 16.0 12.0 10.1 9.8 8.8 3.8 9.7 12.9 4.8 6.4 7.2 9.8 13.0 8.8 12.1 13.1 4.1 11.6 10.8 9.3 19.2 11.4 13.1 11.0 11.0 20.6 14.5 113.7 7.7 4.2 17.9 23.5 11.5 7.2 32.8 7.8 12.2 18.9 12.6 10.1 6.9 19.7 14.8 13.2 13.2 3.0 6.7 9.9 6.0 0.3 5.0 11.0 2.9 4.0 3.3 2.8 2.2 2.5 5.4 4.0 2.8 1.9 3.2 3.0 4.9 10.2 0.1 2.1 6.3 6.8 8.0 7.4 6.4 6.1 6.7 6.8 5.8 7.1 6.0 6.3 8.5 15.7 16.0 14.0 16.0 19.2 14.1 5.0 6.0 8.0 29.2 19.4 18.4 17.6 8.6 8.4 5.5 10.4 0.7 19.5 23.6 5.9 28.2 8.5 23.0 21.4 12.4 40.6 20.8 26.4 25.9 2.0 11.5 14.3 12.3 9.5 15.0 7.9 3.1 32.7 10.1 15.2 33.4 6.1 28.6 31.5 18.5 4.1 31.5 14.2 15.0 36.6 11.0 11.3 21.1 54.7 27.1 18.7 4.1 27.3 8.0 11.8 4.4 11.7 24.9 13.1 18.5 18.2 201.8 73.3 13.8 22.6 0.5 9.2 5.5 32.8 3.4 ANKRD33B ENSG00000164236 "Ankyrin repeat domain 33B" A6NCL7 5 10564070-10657816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;retina: 51.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 350.3;Excitatory neurons: 110.4;Rod photoreceptor cells: 73.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.4" "Region enhanced" "Detected in many" "hippocampal formation: 19.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 23.7;HDLM-2: 47.0;HMC-1: 29.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 7.7;basal ganglia: 16.2;cerebral cortex: 19.6;hippocampal formation: 16.0;olfactory bulb: 10.0" HPA056974 Uncertain Approved Mitochondria NA NA Mitochondria "HPA056974: AB_2683295" "unprognostic (6.19e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-2)" "unprognostic (5.65e-3)" "unprognostic (2.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (4.50e-3)" "unprognostic (4.41e-1)" "unprognostic (2.42e-3)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.16e-5)" "unprognostic (1.17e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (5.47e-2)" 2.7 0.1 5.2 2.3 5.0 9.2 1.7 0.0 12.9 1.9 0.1 1.8 0.4 5.0 0.5 1.9 3.5 0.9 4.3 19.1 1.0 6.0 0.4 1.7 3.5 0.6 0.3 4.6 0.5 1.5 0.3 0.5 2.1 1.9 1.8 1.1 51.3 0.8 2.4 4.5 7.0 2.4 3.8 0.0 7.3 1.7 1.0 0.7 7.1 0.4 8.5 4.5 3.0 3.2 4.4 4.3 6.3 0.4 0.5 14.3 6.7 18.5 1.2 2.1 2.5 2.9 7.8 3.4 23.7 20.7 4.0 3.0 4.3 2.1 2.1 2.8 47.0 1.4 9.3 5.7 0.0 6.5 7.1 29.8 3.3 1.6 1.3 8.3 0.6 3.1 1.7 2.1 11.1 0.6 0.0 0.3 8.6 4.9 0.0 1.9 1.9 4.7 0.8 8.3 3.0 0.1 0.2 0.1 0.4 0.7 15.5 0.0 8.8 9.0 1.4 9.0 7.5 2.3 12.9 15.3 2.0 0.4 11.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.0 0.0 12.9 19.1 1.0 0.6 0.3 4.6 1.9 0.0 0.7 4.4 1.6 12.8 1.5 9.8 14.4 0.4 2.5 0.0 2.2 26.5 0.6 0.4 5.6 4.3 0.6 3.7 350.3 1.6 0.7 0.0 1.9 1.7 6.5 14.2 20.7 2.4 0.0 2.1 110.4 0.2 0.8 8.6 0.5 24.2 0.0 0.0 3.3 0.0 0.2 6.7 24.5 0.0 0.0 0.0 0.8 0.6 1.5 4.3 1.8 6.5 15.4 10.2 0.0 5.5 1.5 0.2 0.0 0.0 30.8 7.3 0.0 18.4 0.0 73.4 0.0 7.8 6.0 0.1 3.3 6.3 1.1 0.5 2.9 2.8 0.0 2.0 CMBL FLJ23617 ENSG00000164237 "Carboxymethylenebutenolidase homolog" Q96DG6 5 10275875-10307902 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 170.0;liver: 173.8;skeletal muscle: 166.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 185.2;Distal tubular cells: 215.2;Proximal enterocytes: 716.0;Proximal tubular cells: 465.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 48.5;K-562: 51.4;PC-3: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036571 Uncertain NA NA 580000 "HPA036571: AB_10670114" "unprognostic (1.81e-2)" "unprognostic (2.55e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.20e-1)" "unprognostic (8.64e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.76e-1)" "unprognostic (4.44e-2)" "unprognostic (1.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-1)" 10.6 31.7 8.7 3.9 8.5 4.0 10.7 7.2 10.3 7.2 7.8 39.5 96.7 8.6 10.0 3.9 13.6 14.3 22.1 8.4 8.5 170.0 173.8 6.9 1.2 8.2 8.2 8.2 23.5 16.7 26.9 10.6 2.2 8.8 14.4 35.0 1.3 9.6 7.5 166.0 2.8 85.7 6.5 7.6 2.8 28.7 3.2 8.4 3.0 9.9 42.8 0.5 9.8 6.4 7.8 5.9 7.2 8.2 20.3 32.0 35.7 41.2 9.7 11.1 3.0 4.5 3.0 30.9 0.1 15.4 7.8 14.5 0.1 19.7 12.8 4.1 0.3 13.4 27.4 28.6 24.3 9.8 0.2 0.2 48.5 8.5 6.7 6.1 11.7 9.4 0.0 51.4 0.4 11.6 1.3 0.1 1.1 12.1 0.0 46.0 5.9 0.0 0.6 32.2 3.8 6.3 9.7 23.1 2.2 0.7 9.7 16.7 1.0 2.7 4.6 6.0 7.6 0.1 0.2 0.1 0.1 8.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 8.7 8.5 7.2 10.3 8.4 8.5 8.2 8.2 8.2 8.8 7.6 8.4 7.8 4.0 25.6 17.2 2.9 2.2 3.7 17.8 6.3 14.8 2.0 40.1 16.8 86.0 55.8 14.8 23.9 4.2 15.3 0.9 185.2 215.2 10.7 3.2 26.5 25.8 7.1 19.2 56.1 5.0 15.6 10.6 37.1 133.0 19.2 13.3 47.4 14.3 161.2 12.1 0.0 6.9 100.5 2.0 4.1 3.8 3.5 47.8 5.5 1.8 1.9 0.4 17.5 1.0 4.0 0.4 16.1 118.6 41.3 0.5 17.5 716.0 465.4 13.0 3.1 0.0 31.0 12.7 1.0 5.9 5.2 3.8 4.9 4.4 145.0 162.7 15.6 C5orf63 "FLJ44606, YDR286C" ENSG00000164241 "Chromosome 5 open reading frame 63" A6NC05 5 127042558-127073492 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 39 "brain: 766.2;choroid plexus: 253.3" "Cell type enhanced" "Detected in many" "Spermatocytes: 49.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043240 Approved Approved Mitochondria NA NA Mitochondria "HPA043240: AB_10962511" "unprognostic (2.71e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-1)" "unprognostic (2.63e-1)" "unprognostic (1.62e-1)" "unprognostic (1.93e-1)" "unprognostic (2.94e-4)" "unprognostic (1.34e-1)" "unprognostic (9.67e-2)" "unprognostic (3.40e-2)" "unprognostic (1.43e-4)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" 3.4 3.7 309.0 4.3 284.7 4.0 6.5 272.3 766.2 2.5 253.3 7.7 6.5 5.3 4.3 5.6 4.6 4.3 7.0 310.3 281.7 4.5 5.3 4.1 8.3 327.6 297.4 276.0 3.7 5.3 6.7 7.0 3.3 352.9 5.6 12.0 13.2 4.6 4.2 5.1 4.0 7.0 3.6 263.0 4.2 7.8 12.9 306.2 5.9 8.9 6.4 8.4 4.8 2.8 369.4 0.9 4.0 1.1 2.3 2.9 4.6 0.6 4.2 0.5 5.2 3.0 9.8 12.2 0.0 17.1 3.4 7.5 1.5 7.3 4.6 7.4 1.6 6.2 10.1 15.6 11.9 7.2 6.0 0.5 4.6 11.6 6.6 3.4 3.6 4.5 4.2 0.7 1.8 5.1 8.1 0.2 5.5 0.7 8.4 3.0 4.4 2.5 7.0 5.8 6.0 9.8 8.0 5.5 2.5 0.3 2.1 10.1 8.8 3.5 10.8 10.0 12.5 2.7 6.0 16.5 0.4 49.8 0.8 5.7 5.8 0.4 5.0 7.5 1.7 6.2 15.4 6.9 8.3 3.7 14.2 10.1 7.7 1.6 15.7 0.4 12.2 12.5 3.4 309.0 284.7 272.3 766.2 310.3 281.7 327.6 297.4 276.0 352.9 263.0 306.2 369.4 2.9 6.4 11.7 18.9 11.3 1.0 11.3 19.9 8.6 11.9 6.9 4.2 33.7 4.3 8.6 16.5 14.6 10.1 12.5 14.6 19.6 16.8 30.2 7.5 1.0 4.6 10.8 9.9 4.3 10.2 9.2 4.3 12.2 5.6 10.1 7.1 3.9 10.0 5.4 0.0 6.7 11.7 10.2 1.0 1.9 17.5 2.5 1.6 8.8 15.9 1.8 11.7 19.6 11.1 1.2 12.4 17.2 2.2 6.1 6.2 10.5 5.8 13.2 10.6 6.6 4.6 2.7 49.8 19.3 11.9 1.1 2.7 6.6 8.2 13.7 11.7 PRRC1 FLJ32875 ENSG00000164244 "Proline rich coiled-coil 1" Q96M27 5 127517640-127555085 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039212 Supported Approved Vesicles NA NA 170000 Vesicles "HPA039212: AB_10794634" "prognostic unfavorable (9.35e-5)" "unprognostic (9.01e-2)" "unprognostic (5.26e-3)" "unprognostic (6.36e-2)" "unprognostic (2.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" "unprognostic (6.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-3)" "unprognostic (5.53e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (2.19e-1)" 16.7 18.8 7.3 18.2 8.5 21.4 24.4 9.1 9.4 27.8 12.4 23.7 25.5 22.2 23.6 20.4 16.0 17.3 13.8 7.0 8.4 21.6 26.9 18.3 18.1 8.7 8.1 6.7 22.5 32.4 30.7 19.2 27.2 9.0 21.3 27.5 11.6 25.8 18.2 13.0 19.0 24.6 22.6 8.6 16.3 24.2 13.3 8.3 19.7 26.9 10.3 21.0 19.6 17.4 10.1 30.3 30.5 44.5 34.0 58.8 75.1 51.9 52.3 58.4 45.7 71.8 52.4 34.6 33.6 53.2 83.6 34.4 26.9 35.0 64.8 70.6 46.7 24.4 29.3 29.1 45.6 33.8 27.4 36.9 51.5 46.7 48.5 56.3 41.9 49.4 31.6 25.5 40.2 53.4 34.2 53.9 29.4 25.5 43.5 39.5 20.5 58.9 43.8 36.4 37.6 32.4 25.0 41.0 44.1 40.1 40.6 47.2 35.3 58.9 41.8 31.2 49.3 37.2 33.5 26.8 43.6 49.3 42.9 42.0 18.7 11.7 9.4 18.6 13.5 22.6 15.4 15.1 16.0 15.6 11.2 16.5 14.9 3.6 12.7 13.5 10.4 13.0 12.3 7.3 8.5 9.1 9.4 7.0 8.4 8.7 8.1 6.7 9.0 8.6 8.3 10.1 16.3 35.3 25.5 9.8 17.8 14.7 14.0 37.2 22.8 12.8 24.1 15.0 12.5 27.1 40.6 27.6 14.6 25.5 14.0 38.2 13.7 30.5 3.8 16.2 33.6 22.8 15.6 12.4 13.5 30.9 42.2 30.8 28.5 23.2 15.8 28.7 26.0 37.3 21.7 8.4 13.5 50.2 28.5 20.2 7.6 4.8 34.5 14.7 19.6 15.9 17.8 10.7 22.6 18.6 25.1 31.8 25.1 30.1 38.0 26.6 34.1 28.0 30.0 12.7 13.1 18.8 26.4 13.6 21.2 18.2 18.6 31.6 19.3 21.7 33.6 26.0 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 59.9;stomach 1: 44.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 42.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 42.0" "Cell line enhanced" "Detected in many" "PC-3: 126.0;RPTEC TERT1: 205.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB012989: AB_2533199, HPA014091: AB_2668939" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favorable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 1.1 1.3 1.1 6.3 0.9 1.7 8.0 0.8 0.8 3.6 7.5 59.9 46.3 3.0 4.8 8.3 8.3 30.2 3.8 0.6 1.0 32.1 7.2 4.2 1.4 1.8 1.6 0.4 0.5 23.8 5.2 1.5 4.0 1.3 5.0 53.5 2.6 9.0 11.6 0.3 34.2 41.3 2.7 1.1 3.9 44.4 0.6 0.9 1.1 8.3 0.2 1.6 27.7 5.9 0.9 32.7 52.1 4.3 0.2 1.5 4.0 33.1 1.6 17.1 0.9 2.7 45.0 81.8 0.0 69.5 3.7 78.1 54.4 27.1 24.0 1.5 0.1 26.8 0.8 1.0 32.8 10.6 0.0 0.3 5.5 67.3 8.0 49.8 8.0 84.9 7.8 0.4 0.0 0.1 17.6 3.8 0.1 5.7 17.9 126.0 0.1 0.0 0.8 205.9 58.5 2.1 0.4 12.3 12.6 0.3 48.5 5.3 0.3 57.1 0.1 31.8 0.1 0.3 4.8 1.0 0.1 18.7 0.0 1.4 11.9 10.0 1.8 0.4 3.2 2.1 0.5 3.8 1.9 4.7 0.1 3.4 2.1 42.0 0.7 0.5 0.5 1.0 4.0 1.1 0.9 0.8 0.8 0.6 1.0 1.8 1.6 0.4 1.3 1.1 0.9 0.9 0.3 9.6 3.7 0.0 0.9 109.9 17.8 4.5 10.8 0.5 10.5 6.3 0.3 32.9 12.7 31.3 0.0 5.4 0.2 124.7 1.9 28.0 0.0 40.9 5.1 1.2 13.1 2.5 0.2 15.0 7.9 2.9 74.5 74.7 2.5 1.0 1.1 9.6 0.9 0.0 1.4 50.8 4.1 1.9 3.8 0.0 0.0 2.1 1.8 1.0 2.6 0.0 0.0 0.0 0.0 44.7 86.1 0.0 0.1 34.1 62.9 19.3 25.0 2.0 0.0 0.4 2.8 0.9 1.3 37.0 168.4 2.1 2.1 0.1 50.7 116.0 AGGF1 "FLJ10283, GPATC7, GPATCH7, HSU84971, VG5Q" ENSG00000164252 "Angiogenic factor with G-patch and FHA domains 1" Q8N302 5 77029251-77065234 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (7.13e-2)" "unprognostic (1.04e-1)" "prognostic favorable (2.87e-4)" "unprognostic (1.67e-1)" "unprognostic (1.82e-1)" "unprognostic (6.52e-2)" "unprognostic (1.12e-3)" "unprognostic (4.27e-2)" "unprognostic (2.02e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-2)" "unprognostic (4.04e-1)" "unprognostic (1.58e-3)" "unprognostic (2.10e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (8.21e-2)" 9.9 10.6 12.3 11.6 12.1 9.3 10.6 12.1 12.2 9.2 10.4 10.6 14.2 9.1 21.6 8.8 7.8 8.7 10.1 12.2 12.3 13.0 13.9 9.5 13.7 13.1 13.3 12.1 10.7 8.2 16.1 6.2 11.0 13.2 9.8 11.7 22.5 8.6 8.9 13.1 12.6 13.4 9.0 12.2 12.7 10.2 16.4 13.8 14.5 11.1 11.2 14.2 9.5 6.6 13.8 21.6 14.5 18.4 23.2 20.8 21.5 17.9 17.7 18.8 12.9 16.3 9.6 23.2 14.4 21.7 12.4 22.6 19.2 9.9 18.1 20.0 21.9 17.2 14.6 16.8 13.2 15.6 15.6 22.8 15.3 22.0 13.3 15.3 17.4 15.9 21.4 17.7 11.9 18.5 21.6 27.3 15.7 0.0 9.0 10.4 21.5 30.2 34.1 21.9 17.1 18.5 22.5 19.0 14.7 21.9 15.8 28.3 20.1 15.2 11.6 14.6 19.1 20.5 23.5 28.6 3.3 21.1 24.5 22.0 17.5 14.0 28.9 14.8 12.6 11.8 13.2 13.6 13.8 13.0 13.5 15.8 13.2 12.7 14.9 12.6 14.3 15.8 9.7 12.3 12.1 12.1 12.2 12.2 12.3 13.1 13.3 12.1 13.2 12.2 13.8 13.8 9.0 28.9 21.7 22.5 28.2 7.1 16.9 20.4 39.3 49.2 9.2 9.0 45.0 22.8 10.0 5.5 35.5 29.5 14.0 26.6 7.9 12.8 44.5 8.5 10.2 22.9 15.0 47.1 23.6 14.5 19.9 21.6 30.5 8.6 14.0 15.3 34.2 34.0 32.1 33.7 26.0 32.3 10.2 41.1 15.6 14.0 29.2 26.6 10.6 20.6 34.1 42.2 38.1 19.1 30.1 12.3 25.5 31.6 36.5 28.2 37.3 15.3 18.0 61.7 32.9 27.2 15.5 69.8 52.0 37.9 9.8 12.9 23.2 13.8 30.1 19.7 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.4 9.5 15.1 13.8 16.4 19.5 15.8 14.9 18.4 13.5 10.0 12.9 8.9 11.0 12.4 19.8 16.7 11.8 17.3 15.6 15.3 13.0 14.9 14.1 15.3 16.7 16.0 14.4 7.7 21.2 13.9 6.9 11.5 16.5 11.4 13.2 20.8 12.2 11.0 21.6 12.2 8.8 19.3 15.0 11.9 11.5 27.8 14.9 11.8 22.6 21.2 17.4 15.0 10.9 18.6 17.7 29.8 42.6 62.1 41.9 60.1 32.2 55.5 59.6 26.3 47.5 28.1 28.7 54.1 24.6 53.1 44.4 22.3 31.6 77.8 27.6 65.5 37.1 21.6 32.0 24.7 63.7 46.1 50.0 38.5 96.1 30.1 63.1 28.3 42.0 29.6 21.7 56.8 42.2 39.1 24.7 29.7 15.4 17.8 11.7 58.1 56.1 38.7 27.9 14.8 23.5 29.7 48.2 31.0 47.9 49.9 29.4 57.8 38.2 34.3 28.0 19.1 41.3 51.3 44.8 96.7 48.1 20.7 59.4 25.4 28.5 50.1 11.3 33.8 10.9 19.0 6.5 10.2 51.0 13.3 4.4 8.0 13.7 31.8 38.5 23.2 5.8 16.5 15.1 16.4 14.9 18.4 15.6 15.3 16.7 16.0 14.4 16.5 15.0 14.9 18.6 10.2 38.5 12.3 63.3 12.6 12.0 25.2 31.0 14.2 34.8 11.6 12.3 17.3 12.8 16.5 18.4 20.9 8.8 16.4 4.4 37.2 22.7 178.8 17.7 25.6 11.3 6.0 13.5 41.3 20.9 25.5 23.7 9.2 8.3 15.8 11.7 8.9 11.5 26.3 23.5 46.7 8.5 14.2 20.2 29.5 87.5 9.6 23.9 17.8 36.5 16.4 14.9 15.5 56.8 78.9 15.2 7.4 8.2 25.6 26.8 5.0 18.7 17.0 19.2 6.6 12.7 22.3 56.4 44.5 23.9 14.2 6.3 11.4 35.5 10.9 28.0 PRDM9 "KMT8B, MSBP3, PFM6, ZNF899" ENSG00000164256 "PR/SET domain 9" Q9NQV7 5 23443586-23528093 "Enzymes, Predicted intracellular proteins, Transcription factors" "Meiosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;epididymis: 1.6;testis: 4.0" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 44.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "U-266/70: 6.9" HPA059555 Uncertain NA NA "HPA059555: AB_2684061" "unprognostic (1.23e-4)" "unprognostic (8.64e-2)" "unprognostic (2.18e-2)" "unprognostic (8.34e-2)" "unprognostic (4.11e-1)" 0.0 0.0 0.6 0.0 1.5 0.9 0.0 0.5 1.0 0.0 1.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.1 1.8 1.0 0.2 0.1 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 4.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.0 6.9 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.2 0.1 0.2 0.3 0.2 0.1 0.1 0.4 0.2 0.2 1.2 0.6 0.1 0.1 0.1 0.0 0.6 1.5 0.5 1.0 0.3 2.2 1.8 1.0 0.2 1.9 0.7 1.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683338 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 400.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 553.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria NA NA Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favorable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 88.4 81.3 73.4 37.3 73.1 51.4 100.9 76.6 102.6 77.0 73.2 92.3 84.3 65.6 69.2 81.2 70.1 50.6 171.9 71.2 78.3 138.5 149.1 56.2 46.1 74.4 75.3 70.4 102.6 45.8 126.9 58.7 63.5 74.6 66.5 90.4 59.6 64.1 74.3 349.5 77.3 72.5 72.8 77.4 43.2 81.4 38.3 74.5 60.4 74.7 400.9 61.2 72.0 73.7 78.3 118.8 102.9 200.5 119.1 133.9 192.7 167.9 140.7 136.6 153.0 185.8 126.7 151.4 83.9 180.2 121.1 146.3 85.3 72.0 167.9 175.4 77.4 137.2 57.8 97.1 115.6 142.4 141.0 95.8 161.2 190.2 105.8 184.8 167.7 135.1 93.4 50.2 88.5 141.9 110.5 106.7 116.9 60.9 45.3 115.1 126.4 113.1 166.2 165.1 113.0 92.7 99.5 96.4 92.5 175.2 106.8 148.2 145.2 104.4 93.6 98.9 68.7 186.9 67.6 91.5 102.1 99.7 202.7 137.3 19.4 83.9 7.9 49.1 101.8 55.3 72.7 61.9 58.0 121.6 50.3 68.2 70.0 6.8 79.4 108.3 93.8 72.4 68.2 73.4 73.1 76.6 102.6 71.2 78.3 74.4 75.3 70.4 74.6 77.4 74.5 78.3 62.1 38.5 56.6 49.0 52.6 125.8 150.4 382.0 56.3 44.8 100.0 119.1 328.4 82.9 170.6 84.6 41.7 168.4 43.2 124.5 553.7 174.1 61.5 65.5 87.7 84.6 90.4 47.1 55.9 167.3 163.3 113.1 47.9 68.7 76.0 146.9 99.2 137.8 144.3 30.3 73.2 135.3 215.7 76.4 127.3 61.5 157.5 70.4 117.4 38.4 161.4 113.6 63.8 52.8 68.4 179.4 153.4 152.7 38.4 95.3 188.7 425.9 112.2 76.0 124.9 145.1 173.4 76.8 75.0 79.3 101.4 179.9 50.0 96.4 171.2 158.2 SCGB3A2 "LU103, PNSP1, UGRP1" ENSG00000164265 "Secretoglobin family 3A member 2" Q96PL1 5 147870682-147882191 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 124 "lung: 1282.7" "Group enriched" "Detected in some" 8 "Alveolar cells type 2: 4396.4;Club cells: 6565.6" "Cancer enriched" "Detected in some" 10 "lung cancer: 211.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 50 "basophil: 71.6" "Lineage enriched" "Detected in many" 50 "granulocytes: 71.6" "Cell line enhanced" "Detected in many" "A-431: 89.1;EFO-21: 52.3;NTERA-2: 61.0;PC-3: 302.9;SuSa: 120.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 800000 "unprognostic (3.85e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (1.05e-2)" "unprognostic (1.90e-8)" "unprognostic (9.31e-3)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (9.11e-2)" 0.6 0.6 3.9 1.5 3.1 2.5 4.1 7.6 7.9 0.7 1.2 0.6 1.0 1.7 5.1 2.1 1.4 1.2 1.7 4.8 3.6 1.2 1.3 1282.7 2.9 3.9 1.6 1.5 2.1 0.6 0.7 1.1 2.0 6.1 1.1 1.8 10.3 6.2 1.5 2.2 5.0 1.4 0.9 0.5 4.2 4.1 1.9 3.4 1.3 7.2 0.8 2.2 0.7 0.1 4.5 89.1 1.3 1.1 2.0 1.1 0.6 2.3 1.4 0.3 0.2 0.2 0.5 1.1 0.4 52.3 0.3 0.8 0.8 2.5 1.3 0.5 0.3 1.6 3.4 10.5 0.3 0.0 0.7 3.3 1.4 0.8 0.7 0.0 2.0 0.2 0.3 2.4 1.1 0.2 1.7 0.9 0.8 61.0 0.0 302.9 0.2 0.9 0.3 1.2 0.7 4.3 1.1 12.3 1.1 0.2 120.6 1.3 0.6 1.7 1.2 35.5 1.6 1.3 1.7 1.4 0.4 0.4 1.5 4.1 71.6 1.0 0.2 0.4 0.7 0.1 0.2 0.2 0.2 0.6 0.4 0.0 0.2 0.4 1.4 0.9 0.3 0.2 0.1 3.9 3.1 7.6 7.9 4.8 3.6 3.9 1.6 1.5 6.1 0.5 3.4 4.5 0.0 618.6 4396.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 6565.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 14.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.2 106.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 623.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.2 SPINK1 "PCTT, PSTI, Spink3, TATI" ENSG00000164266 "Serine peptidase inhibitor Kazal type 1" P00995 5 147824572-147831671 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "pancreas: 53515.4" "Group enriched" "Detected in many" 9 "Exocrine glandular cells: 50621.7;Pancreatic endocrine cells: 16750.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 513.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "CACO-2: 417.2;RT4: 1139.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026366, HPA027498" Enhanced "Secreted to digestive system" NA NA 8000000 "CAB026366: , HPA027498: AB_10603115" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (9.96e-3)" "unprognostic (3.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.79e-4)" "unprognostic (8.34e-3)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "unprognostic (1.88e-1)" "unprognostic (3.82e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.44e-7)" "unprognostic (7.98e-2)" "unprognostic (2.07e-1)" "prognostic favorable (2.15e-5)" 8.9 1.5 0.1 36.8 0.2 6.9 4.1 0.3 1.0 1.7 0.5 432.2 397.9 5.5 0.9 3.0 1.3 113.0 12.1 0.2 0.2 138.8 495.9 2.7 2.8 0.1 0.1 0.1 25.8 53515.4 0.0 1.9 3.2 0.2 4.5 445.8 0.6 12.9 1.4 1.2 21.2 407.3 14.3 0.1 2.5 1488.3 0.9 0.2 0.4 1.0 0.0 0.3 1004.5 10.9 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 417.2 0.3 0.1 6.8 0.0 0.8 0.9 2.2 0.0 0.0 3.9 0.0 0.0 0.0 107.0 0.3 0.0 3.9 0.0 2.1 0.0 3.0 5.8 0.0 0.0 0.0 0.3 0.0 0.3 0.8 1.3 2.1 138.9 0.8 0.8 0.0 2.5 0.0 1139.0 0.5 1.7 0.0 0.2 0.1 5.4 0.1 0.0 0.0 0.1 13.7 1.1 3.8 2.2 5.9 3.0 16.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 1.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.5 0.0 0.0 3.6 0.0 9.7 0.0 15.1 0.3 0.0 0.0 5.5 0.8 0.1 1451.2 11.1 377.0 0.0 0.0 0.0 280.8 86.1 1286.7 0.1 0.3 0.4 9.4 517.2 18.7 1.0 50621.7 0.1 1.9 1580.5 5.0 4.5 2.0 39.3 3385.8 0.1 0.0 0.2 2087.4 0.0 30.9 0.0 0.2 0.0 13.7 0.0 0.0 269.8 0.0 0.0 0.0 0.1 16750.7 563.8 0.0 1.3 173.5 1457.1 1.6 0.7 0.0 0.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1365.3 649.1 HTR4 5-HT4 ENSG00000164270 "5-hydroxytryptamine receptor 4" Q13639 5 148451032-148677235 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 9.1;heart muscle: 4.6;intestine: 9.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 42.0;Inhibitory neurons: 44.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040591 Enhanced NA NA "HPA040591: AB_2677028" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" "unprognostic (7.74e-2)" "unprognostic (2.37e-1)" "unprognostic (5.02e-2)" "unprognostic (3.77e-2)" "unprognostic (4.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (2.25e-1)" "unprognostic (4.49e-2)" "unprognostic (8.83e-5)" 0.2 0.7 1.5 0.4 9.1 0.0 0.0 0.0 4.0 0.2 0.2 2.6 4.9 0.1 0.0 0.1 0.2 0.8 4.6 7.7 3.0 0.0 0.0 0.1 0.0 3.0 1.0 2.6 0.0 0.0 0.0 1.1 0.0 4.5 0.0 2.8 1.0 0.0 0.0 0.0 0.0 9.2 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 9.1 0.0 4.0 7.7 3.0 3.0 1.0 2.6 4.5 0.0 1.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 42.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 2.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.0 6.1 0.0 1.5 0.0 0.0 0.0 10.8 0.0 0.0 0.8 0.0 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 ESM1 ENSG00000164283 "Endothelial cell specific molecule 1" Q9NQ30 5 54977867-55022671 "Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 20.1;thyroid gland: 17.5" "Cell type enriched" "Detected in some" 8 "Endothelial cells: 142.4" "Cancer enriched" "Detected in all" 8 "renal cancer: 65.8" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "NK-cell: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 302.2;TIME: 568.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB047364 Approved "Secreted to blood" NA NA 1540000 340000 "CAB047364: " "unprognostic (4.70e-2)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.63e-3)" "unprognostic (2.31e-3)" "unprognostic (4.68e-2)" "unprognostic (1.55e-1)" "unprognostic (6.85e-3)" "unprognostic (1.59e-2)" "unprognostic (1.05e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.00e-4)" "unprognostic (7.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.94e-1)" 0.9 4.2 0.4 0.7 0.5 0.6 0.5 0.2 1.4 2.1 2.2 0.2 0.7 3.6 0.4 0.2 0.2 1.3 3.6 0.3 1.2 20.1 2.7 11.4 1.2 0.5 2.5 0.4 0.7 2.3 6.1 2.2 0.4 0.3 3.5 0.0 0.1 6.4 3.8 0.2 0.1 0.8 0.8 0.8 0.9 0.3 0.6 1.8 0.2 17.5 0.2 0.6 1.3 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 79.8 9.5 4.1 1.0 0.0 0.0 0.1 7.4 5.7 2.3 0.0 0.0 1.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.7 0.4 8.5 302.2 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 568.0 4.7 13.7 39.2 21.3 0.1 0.0 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.1 0.4 0.5 0.2 1.4 0.3 1.2 0.5 2.5 0.4 0.3 0.8 1.8 0.4 6.3 0.0 0.6 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 16.1 0.0 0.1 0.1 142.4 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.0 1.4 0.0 0.1 0.0 0.7 0.0 2.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 1.5 1.7 0.1 0.3 0.0 0.1 0.1 0.6 1.1 0.0 0.7 GRPEL2 "DKFZp451C205, FLJ23713, Mt-GrpE#2" ENSG00000164284 "GrpE like 2, mitochondrial" Q8TAA5 5 149345430-149354583 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "esophagus: 45.3" "Cell type enhanced" "Detected in many" "Endothelial cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018173, HPA023211" Approved Enhanced Mitochondria NA NA Mitochondria "HPA018173: AB_1850358, HPA023211: AB_1850360" "unprognostic (3.13e-2)" "unprognostic (1.69e-1)" "prognostic favorable (3.87e-5)" "prognostic unfavorable (2.21e-4)" "unprognostic (3.22e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.16e-8)" "unprognostic (1.34e-1)" "unprognostic (8.16e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.20e-1)" "unprognostic (2.26e-1)" 6.9 4.2 5.1 5.9 5.4 5.0 5.1 9.2 5.7 8.3 3.3 4.1 4.9 4.3 4.1 45.3 3.8 3.6 6.6 4.9 6.2 6.3 4.8 9.4 7.3 6.6 5.8 4.7 5.4 3.8 6.6 3.0 7.5 7.1 4.0 4.0 5.7 7.2 4.1 8.9 4.6 5.0 3.7 6.2 4.8 5.6 4.6 6.4 5.3 6.6 5.2 11.1 4.9 11.1 8.2 16.3 9.5 12.5 44.2 7.9 8.1 25.2 14.8 11.9 13.5 19.1 22.7 10.6 17.5 15.0 7.6 18.0 12.4 20.3 20.8 18.8 9.0 18.0 21.1 16.0 11.9 22.1 21.2 11.1 12.4 24.5 16.3 26.8 5.9 9.7 22.1 18.5 39.4 9.9 11.2 13.4 17.1 16.0 9.9 34.5 17.3 17.0 22.0 8.8 15.7 25.3 20.7 14.7 25.9 44.5 9.3 23.0 24.5 11.2 14.6 16.3 10.4 21.3 14.7 21.6 16.6 14.3 28.9 14.5 9.9 2.5 3.6 5.1 2.4 6.1 3.9 7.6 5.6 3.9 1.8 9.9 7.5 2.0 3.8 2.8 1.1 15.1 4.8 5.1 5.4 9.2 5.7 4.9 6.2 6.6 5.8 4.7 7.1 6.2 6.4 8.2 20.9 9.6 6.4 2.3 3.3 17.8 5.3 9.9 9.6 6.1 7.0 6.0 8.8 4.3 9.3 9.2 8.4 9.2 3.5 5.1 1.9 5.3 11.6 2.3 4.9 36.0 6.0 11.4 4.3 6.0 18.2 6.0 3.6 5.6 2.5 6.6 20.3 7.1 6.0 3.3 5.1 4.5 10.2 9.7 7.4 5.4 4.1 2.7 7.2 5.6 4.5 5.4 2.1 3.0 4.9 7.5 3.1 5.3 4.4 7.1 6.5 6.2 5.0 6.7 0.0 6.1 6.0 22.6 12.0 10.0 19.6 5.6 9.2 5.2 7.2 8.2 CDC20B FLJ37927 ENSG00000164287 "Cell division cycle 20B" Q86Y33 5 55112971-55173177 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 2.1;kidney: 1.1;testis: 2.6" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 18.8;Ionocytes: 12.2;Respiratory ciliated cells: 24.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA053900 Uncertain NA NA "HPA053900: AB_2682299" "unprognostic (7.39e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-2)" "unprognostic (1.78e-3)" "unprognostic (9.94e-2)" "unprognostic (1.59e-2)" "unprognostic (3.12e-1)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (7.84e-3)" "unprognostic (2.83e-2)" "unprognostic (3.06e-1)" "unprognostic (5.15e-4)" "unprognostic (1.99e-2)" "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.3 2.4 1.2 0.0 0.9 2.3 0.5 0.0 2.1 0.0 0.0 0.1 0.2 1.6 0.0 0.1 0.3 18.8 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.7 3.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.5 12.2 0.6 4.1 0.0 0.0 0.7 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 3.7 0.9 2.7 0.8 24.5 0.0 0.0 0.5 0.5 1.3 0.8 0.7 0.1 0.1 0.3 0.1 0.7 0.1 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555101-95605102 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 19.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 3.0 3.8 2.2 2.2 2.7 2.4 3.3 3.1 3.0 3.6 2.4 2.6 2.2 3.6 4.3 3.0 3.2 3.1 2.6 2.7 2.3 5.4 3.7 2.9 2.7 2.3 2.2 2.4 5.9 4.9 19.3 2.7 5.5 2.3 4.9 2.6 3.6 2.9 5.0 2.3 3.3 2.2 3.0 2.0 2.5 4.2 1.7 2.5 3.7 5.0 2.8 2.0 3.3 3.3 2.8 5.1 3.2 6.6 6.6 32.4 16.8 9.5 15.9 9.2 6.1 12.4 3.9 7.8 6.9 8.1 5.5 10.9 4.6 5.8 10.1 13.3 7.4 8.5 5.5 7.7 6.7 9.4 3.1 4.4 12.4 8.9 9.2 5.9 12.8 10.0 9.3 5.6 7.4 13.7 2.5 8.5 5.9 8.6 1.6 15.3 5.2 10.6 11.0 14.1 1.2 4.7 4.8 9.7 3.1 10.0 9.1 8.9 3.2 18.1 9.6 7.8 15.0 9.9 6.2 11.2 8.4 9.6 8.0 36.5 12.9 1.1 2.1 4.0 1.2 4.7 4.9 4.7 5.4 0.6 5.0 7.0 5.2 0.9 3.3 0.7 2.2 3.9 1.8 2.2 2.7 3.1 3.0 2.7 2.3 2.3 2.2 2.4 2.3 2.0 2.5 2.8 6.8 3.2 2.2 9.1 6.6 4.5 6.8 7.4 5.7 7.3 4.4 7.2 4.6 1.5 3.7 7.3 12.5 11.8 6.6 1.9 3.9 4.1 9.2 7.1 10.3 6.2 3.0 10.1 11.0 2.5 47.4 13.6 2.0 5.7 22.9 8.1 6.8 16.5 4.6 10.1 9.7 2.0 10.2 3.2 5.4 2.9 10.8 4.9 5.4 7.5 5.1 12.7 14.4 7.1 10.0 2.6 3.2 11.7 7.1 3.9 3.2 4.8 6.8 10.4 0.0 10.2 10.9 7.4 8.6 5.1 7.0 5.1 9.8 11.8 3.4 2.1 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Leydig cells: 397.3;Peritubular cells: 314.8;Skeletal myocytes: 347.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 7.3" "Group enriched" "Detected in many" 4 "granulocytes: 7.3;T-cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 250.6;HaCaT: 332.7;SuSa: 315.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 80.5 38.7 63.6 12.0 75.9 8.2 24.0 64.1 64.8 27.9 19.0 22.7 14.9 13.2 27.2 17.2 16.7 19.9 34.1 59.7 53.0 28.6 21.9 17.1 6.8 82.7 60.1 47.8 83.8 112.1 56.0 13.3 54.4 55.4 29.1 21.0 29.3 42.3 20.8 30.0 13.3 16.8 20.7 62.2 11.3 22.8 21.6 59.6 8.4 20.1 33.0 2.3 25.7 13.5 72.7 53.7 20.4 51.1 55.1 188.4 108.5 0.5 91.0 86.4 34.7 54.0 96.5 9.6 0.2 250.6 45.8 88.5 332.7 27.7 6.6 59.4 2.2 36.6 18.3 185.8 28.9 148.6 4.3 25.5 176.6 4.8 52.0 0.9 147.6 27.0 15.5 74.7 13.4 139.3 14.8 5.8 14.9 19.7 33.4 33.4 8.2 100.3 6.5 29.1 35.6 90.3 118.9 71.8 31.0 85.7 315.9 23.6 26.3 44.5 46.1 195.7 31.1 35.8 13.5 28.3 2.7 14.8 1.1 76.8 0.1 0.6 7.3 1.9 0.3 0.7 0.5 1.4 1.6 0.1 0.1 1.8 0.4 0.4 0.3 1.0 0.8 0.8 0.6 63.6 75.9 64.1 64.8 59.7 53.0 82.7 60.1 47.8 55.4 62.2 59.6 72.7 23.4 176.3 13.3 229.9 5.4 10.8 65.8 25.9 13.6 68.3 81.2 44.1 79.4 44.3 49.8 141.6 20.9 62.2 15.7 21.4 60.7 69.7 11.4 55.3 118.6 15.7 92.0 32.6 35.2 111.0 139.7 201.3 3.1 76.8 100.1 178.3 14.3 77.3 33.3 6.7 57.3 66.9 14.2 23.0 11.6 22.1 397.3 20.4 42.7 30.0 3.7 270.3 71.1 117.6 64.8 40.7 70.1 314.8 7.1 53.8 19.9 3.1 33.7 35.9 32.9 347.6 99.2 4.6 8.8 10.1 27.4 115.2 9.8 177.2 84.5 102.2 GPX8 "EPLA847, UNQ847" ENSG00000164294 "Glutathione peroxidase 8 (putative)" Q8TED1 5 55160167-55167297 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 62.7;Extravillous trophoblasts: 218.9;Fibroblasts: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 254.4;fHDF/TERT166: 246.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036720 Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA036720: AB_2675269" "unprognostic (4.85e-2)" "unprognostic (1.23e-2)" "unprognostic (6.53e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-2)" "unprognostic (9.74e-3)" "unprognostic (1.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.07e-2)" "unprognostic (4.34e-2)" "unprognostic (4.31e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (5.13e-9)" "prognostic unfavorable (7.96e-4)" "unprognostic (8.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.63e-2)" 13.4 6.2 2.7 12.6 1.1 0.1 12.7 1.3 3.0 37.4 7.0 7.3 3.0 21.3 22.1 6.3 14.5 17.2 11.3 1.1 2.3 6.6 2.2 6.9 3.8 1.6 1.3 0.6 27.6 4.6 9.3 2.4 40.0 1.4 10.3 8.5 1.3 7.3 16.0 1.5 5.0 4.1 27.5 2.3 4.0 5.7 5.6 1.3 1.3 22.5 6.3 3.0 17.9 9.9 3.7 37.2 39.0 75.3 77.0 180.7 223.9 36.6 179.8 254.4 97.0 192.7 3.2 82.1 0.0 199.0 246.4 86.5 28.2 46.0 51.5 131.5 0.5 17.3 2.1 49.1 6.9 64.4 0.0 0.0 157.5 60.8 68.3 35.5 126.5 122.7 0.0 1.1 0.1 137.4 14.4 0.0 0.0 32.6 1.0 42.8 0.1 40.2 0.0 65.9 1.3 0.1 1.4 56.6 4.6 68.0 80.8 56.6 3.4 102.7 63.6 65.6 84.5 102.3 0.1 0.5 0.5 103.0 0.1 118.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 1.1 1.3 3.0 1.1 2.3 1.6 1.3 0.6 1.4 2.3 1.3 3.7 10.9 0.0 1.1 0.3 0.3 7.1 6.0 38.3 9.1 0.2 8.9 6.1 4.3 0.0 33.3 25.8 0.0 49.5 0.2 0.5 5.9 13.7 0.4 6.5 62.7 18.6 0.0 0.0 0.1 38.8 218.9 76.6 2.6 4.9 4.5 30.9 19.2 0.2 10.2 0.0 0.1 4.7 4.1 0.0 6.9 0.6 51.3 1.1 24.9 5.6 1.1 7.9 0.0 0.0 0.1 15.8 0.3 39.9 1.4 2.6 0.1 0.5 36.5 0.3 13.1 20.1 38.2 0.1 0.4 3.1 6.1 13.3 1.8 29.9 0.9 2.4 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150000654 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favorable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 2.5 3.6 2.1 1.7 2.3 1.3 4.8 2.5 2.4 2.5 2.3 2.4 2.2 2.4 5.2 1.8 3.2 2.3 2.1 2.0 2.3 3.6 2.9 2.4 1.9 2.1 2.2 1.9 4.0 3.2 11.3 2.7 2.6 2.6 4.1 2.5 3.6 3.1 3.1 1.4 2.6 2.0 2.7 2.0 2.2 2.9 4.0 2.1 2.3 3.0 2.2 2.0 2.4 1.7 2.5 2.1 5.7 3.8 8.2 10.7 8.8 5.9 6.0 6.3 4.6 4.6 3.7 3.7 1.0 5.3 7.1 5.7 3.7 3.4 4.4 5.4 4.7 2.8 1.8 3.1 2.0 9.5 2.6 4.4 9.0 8.3 5.9 7.7 5.4 3.6 4.1 2.5 4.7 5.8 5.0 3.4 1.2 1.5 2.7 4.8 3.9 4.3 2.7 4.4 3.0 2.9 3.8 4.2 6.7 9.1 4.6 7.5 4.5 4.9 3.7 2.8 4.1 4.5 3.5 1.4 2.7 5.9 2.8 5.9 0.0 2.2 1.2 1.5 2.3 1.3 1.4 2.0 1.5 1.9 1.7 4.2 2.6 0.0 3.4 1.3 1.0 2.2 1.5 2.1 2.3 2.5 2.4 2.0 2.3 2.1 2.2 1.9 2.6 2.0 2.1 2.5 3.1 12.8 2.7 1.3 2.2 2.2 6.6 2.9 2.2 6.2 5.4 3.7 5.4 4.3 4.7 3.7 0.0 5.2 2.6 2.0 7.9 5.1 1.2 2.9 3.5 2.7 3.0 0.4 1.4 4.7 2.7 3.5 7.1 3.6 3.8 4.6 3.3 1.8 4.2 3.3 1.6 2.6 6.1 1.9 1.9 2.1 4.4 2.6 3.6 2.8 4.8 6.3 1.0 4.5 5.6 4.3 1.9 3.4 3.8 5.7 3.1 7.9 3.6 6.3 0.0 2.1 3.8 20.0 8.7 2.6 1.1 3.6 2.2 6.8 2.0 4.9 SPZ1 "FLJ25709, NYD-TSP1, PPP1R148" ENSG00000164299 "Spermatogenic leucine zipper 1" Q9BXG8 5 80319625-80321842 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 28.2" "Group enriched" "Detected in some" 40 "Early spermatids: 309.3;Late spermatids: 740.0" "Group enriched" "Detected in some" 20 "prostate cancer: 1.0;testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 309.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 740.0 3.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 3.8 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256048 "Predicted membrane proteins, Transporters" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 222.5;Urothelial cells: 254.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: AB_2675727" "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 13.0 35.2 17.2 9.9 27.6 6.4 11.9 26.4 19.7 16.5 15.7 28.5 9.3 9.3 21.3 17.7 16.3 14.3 4.8 15.8 22.0 6.2 45.8 14.2 8.2 24.4 26.5 10.8 15.3 7.7 7.1 4.2 16.6 24.9 34.0 29.7 16.4 13.4 7.1 2.7 19.3 9.8 7.7 22.5 4.9 16.7 29.5 25.2 7.9 5.9 2.9 11.5 18.0 11.4 44.1 11.3 19.7 6.6 4.2 8.9 9.5 19.6 9.0 6.0 3.9 4.0 40.0 56.7 1.7 9.0 11.7 9.2 31.7 8.9 23.9 5.6 1.6 4.8 1.4 2.2 21.7 3.3 1.3 4.1 10.8 13.1 10.2 26.0 11.0 7.3 54.0 3.6 9.4 10.4 19.4 22.8 5.5 9.3 15.8 6.8 26.9 5.8 3.0 11.5 54.4 0.4 6.3 8.0 18.5 35.4 33.5 8.2 6.9 8.0 11.3 3.2 11.6 11.3 7.1 3.5 28.1 21.0 3.9 46.9 10.4 9.1 6.7 2.1 4.9 1.6 0.8 18.7 5.7 5.8 1.1 23.3 14.1 5.2 0.6 1.5 1.4 6.6 7.5 17.2 27.6 26.4 19.7 15.8 22.0 24.4 26.5 10.8 24.9 22.5 25.2 44.1 48.5 60.9 30.2 46.0 10.5 6.4 56.8 5.6 19.9 3.6 27.7 14.1 8.2 31.5 18.3 16.5 0.0 16.1 12.9 127.4 9.8 26.5 1.7 82.0 29.6 24.5 60.1 24.8 20.9 19.5 25.7 24.9 40.2 157.0 8.2 27.6 35.3 82.7 21.8 3.3 78.3 60.0 4.1 29.2 27.8 7.6 18.3 38.4 5.4 66.5 44.8 65.1 1.0 223.2 222.5 35.4 56.4 39.9 8.7 148.2 27.7 5.1 4.3 5.3 32.9 7.5 17.4 3.1 12.8 44.4 9.8 129.2 37.7 15.2 85.9 254.2 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4;kidney: 30.9" "Cell type enhanced" "Detected in some" "Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042740, HPA069197" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 290000 "Golgi apparatus" "HPA042740: AB_10793984, HPA069197: " "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.2 0.3 3.3 0.9 11.2 0.9 0.8 13.5 7.4 0.2 3.6 1.0 1.7 0.2 6.2 1.0 0.3 0.5 0.2 3.0 8.1 30.9 0.1 0.3 0.9 16.9 10.0 2.0 12.6 0.1 0.0 4.2 0.1 16.1 2.3 1.0 0.1 0.7 6.2 0.2 0.1 2.2 0.1 15.9 1.0 1.3 2.5 11.5 1.9 0.1 1.3 2.8 0.7 0.4 29.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.9 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 3.3 11.2 13.5 7.4 3.0 8.1 16.9 10.0 2.0 16.1 15.9 11.5 29.4 0.5 0.0 0.0 5.9 0.1 0.0 0.2 0.9 0.6 0.0 0.1 0.5 0.9 0.0 0.4 1.8 0.0 0.0 0.0 0.0 3.9 1.1 1.0 0.0 0.0 0.5 0.0 0.0 4.3 0.2 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.4 4.1 0.6 1.8 4.7 1.1 0.0 0.0 6.6 119.9 0.0 0.0 35.3 0.5 0.1 0.0 31.3 0.2 0.0 0.0 5.1 0.6 0.1 1.6 0.0 0.0 0.0 0.3 23.9 0.0 0.3 CAGE1 "bA69L16.7, CT95, CTAG3" ENSG00000164304 "Cancer antigen 1" Q8TC20 6 7326656-7389742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "testis: 5.1" "Group enriched" "Detected in some" 9 "Early spermatids: 151.3;Late spermatids: 59.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029832 Uncertain NA NA "HPA029832: AB_10602412" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "unprognostic (1.80e-2)" "unprognostic (2.25e-4)" "unprognostic (4.80e-2)" "unprognostic (4.24e-1)" "unprognostic (2.44e-3)" "unprognostic (3.88e-2)" "unprognostic (2.79e-2)" "unprognostic (8.80e-2)" "unprognostic (1.09e-2)" "unprognostic (3.23e-1)" "unprognostic (4.38e-6)" "unprognostic (4.71e-2)" "unprognostic (3.29e-2)" "unprognostic (1.62e-4)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.3 0.3 0.7 0.8 0.0 0.4 0.6 0.6 0.3 0.0 0.3 0.0 0.0 0.1 1.6 0.6 0.0 0.1 151.3 0.5 0.5 0.4 0.0 0.0 1.4 0.0 0.2 0.3 1.5 0.8 0.0 0.1 0.0 0.0 0.2 0.0 1.6 1.0 0.0 0.3 0.9 59.2 0.3 1.2 0.0 1.0 0.1 0.1 1.0 0.0 2.5 0.1 0.0 0.4 0.6 0.6 0.3 0.1 0.1 0.6 0.0 1.0 0.5 11.2 2.0 0.0 0.3 0.1 1.5 0.4 0.4 0.6 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 118.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 571.0;eosinophil: 408.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 571.0" "Cell line enhanced" "Detected in all" "Karpas-707: 259.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Approved Nucleoplasm,Mitochondria NA NA 94000 Mitochondria Nucleoplasm "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favorable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 16.5 12.2 11.4 26.8 11.3 33.1 16.5 18.1 11.5 12.8 10.5 34.5 54.6 12.9 13.0 27.9 9.3 20.0 14.8 10.9 12.6 8.6 22.2 12.9 43.8 11.2 13.0 10.0 9.0 13.5 9.0 8.9 26.3 11.9 11.4 34.2 12.8 13.3 10.7 14.1 16.3 42.2 15.4 12.3 23.2 31.5 9.4 11.5 39.3 10.7 14.2 42.3 24.6 12.1 13.6 31.0 16.7 65.3 31.6 39.4 52.2 37.6 90.2 67.7 61.9 35.4 30.7 25.2 42.4 13.9 44.1 29.2 25.5 52.1 32.1 69.7 109.9 28.7 68.2 12.9 71.4 47.3 55.9 62.3 71.7 38.3 39.3 31.4 44.4 77.6 43.1 57.2 259.8 64.5 13.2 89.1 51.8 65.1 33.7 20.9 63.6 30.8 41.2 52.9 49.3 37.1 40.5 39.1 35.1 52.1 64.3 19.2 35.9 54.1 28.2 25.9 21.1 42.4 118.9 121.6 29.2 34.2 38.5 40.9 571.0 26.1 408.6 32.1 43.3 34.4 26.0 29.5 46.3 33.3 18.6 22.2 32.8 35.6 62.0 71.0 26.5 64.1 47.5 11.4 11.3 18.1 11.5 10.9 12.6 11.2 13.0 10.0 11.9 12.3 11.5 13.6 28.6 19.2 15.8 26.4 32.3 48.7 22.2 34.1 35.9 18.6 21.7 17.0 17.5 5.7 36.3 12.9 0.0 46.9 54.8 37.4 13.7 18.4 9.6 24.9 17.1 26.6 18.0 62.3 9.6 23.7 33.6 19.5 24.5 24.9 17.7 24.8 21.0 15.3 23.9 13.5 12.6 37.6 44.7 27.0 17.4 4.0 7.5 33.3 30.2 13.1 41.5 15.4 37.0 11.1 18.4 25.0 18.8 7.5 118.6 20.1 26.6 8.4 30.4 11.3 13.1 19.0 20.8 7.9 16.4 34.6 28.6 51.4 43.8 23.1 24.4 36.7 PRIMPOL "CCDC111, FLJ33167" ENSG00000164306 "Primase and DNA directed polymerase" Q96LW4 4 184649667-184694963 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 24.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054372 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA054372: AB_2682466" "unprognostic (1.68e-1)" "unprognostic (1.27e-3)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (2.67e-2)" "unprognostic (4.75e-2)" "unprognostic (2.02e-2)" "unprognostic (3.34e-2)" "unprognostic (3.32e-3)" "unprognostic (5.86e-2)" "unprognostic (2.52e-2)" "unprognostic (5.02e-1)" "unprognostic (3.04e-1)" "unprognostic (3.04e-2)" "unprognostic (3.81e-1)" "unprognostic (1.49e-1)" "unprognostic (1.05e-1)" 7.3 8.1 4.0 6.0 4.6 5.5 9.0 7.6 4.3 8.5 4.4 8.0 4.7 10.8 8.2 7.0 9.0 6.9 7.0 3.5 4.0 5.7 6.8 7.6 8.0 4.1 4.2 2.9 12.2 4.8 6.8 4.6 6.7 4.7 7.1 8.7 7.3 4.8 8.3 4.7 6.6 6.7 9.2 4.2 8.7 6.0 5.5 4.1 8.7 7.7 5.3 6.5 6.4 5.4 5.6 13.1 5.7 13.2 15.0 17.5 23.2 8.9 13.8 21.8 22.9 19.9 4.4 13.3 7.5 5.0 10.6 12.6 7.9 11.3 14.6 24.0 15.9 5.3 7.8 7.8 5.3 11.4 6.4 11.5 14.5 11.4 21.2 13.7 13.4 12.6 20.7 16.5 24.0 16.5 4.4 13.3 5.4 4.3 5.8 4.6 12.3 9.4 9.0 11.8 7.8 9.4 11.9 8.3 2.1 15.2 10.4 6.6 12.3 6.8 7.5 9.7 5.9 8.9 13.4 10.2 3.8 11.1 8.5 18.6 11.2 2.5 24.0 3.8 2.4 5.6 3.6 3.6 3.9 3.2 3.7 3.0 3.0 1.2 4.7 5.6 2.7 4.6 3.1 4.0 4.6 7.6 4.3 3.5 4.0 4.1 4.2 2.9 4.7 4.2 4.1 5.6 7.7 6.4 8.6 23.5 6.7 9.6 9.5 10.0 9.1 6.2 10.1 6.3 2.6 7.2 10.4 5.5 0.0 14.3 8.1 5.9 5.9 7.7 5.5 9.0 11.1 7.3 6.7 17.5 13.9 5.2 10.0 9.7 8.2 6.3 15.2 12.0 8.9 7.5 9.7 8.4 26.9 58.8 6.1 14.8 6.4 5.7 12.5 9.5 8.8 19.7 6.5 11.1 6.2 27.2 28.1 3.7 10.4 9.1 8.6 4.0 7.2 5.7 15.4 8.2 13.1 11.1 9.0 18.8 13.1 6.9 9.8 4.9 8.9 5.7 8.0 5.4 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 72.8;Inhibitory neurons: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 30000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: AB_2677946" "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 51.9 15.9 3.1 37.3 4.1 28.2 25.8 2.5 5.6 21.9 3.1 38.2 63.9 22.2 14.6 13.3 25.7 23.9 17.3 3.0 6.0 16.5 33.2 31.5 38.5 7.7 4.2 1.9 20.9 13.8 19.2 8.3 47.4 6.2 18.8 44.1 12.5 19.5 22.2 21.0 36.8 55.5 21.9 3.7 31.1 34.0 9.2 4.6 64.3 17.7 19.7 37.1 27.5 11.7 8.2 25.9 14.1 21.3 20.0 114.7 111.5 61.4 18.3 59.6 44.0 76.2 17.6 91.1 75.3 37.6 36.0 61.8 25.7 17.8 38.1 27.3 139.8 7.5 24.7 10.0 13.9 130.9 12.0 44.1 46.8 16.2 50.6 15.5 64.3 61.1 48.8 12.9 74.7 26.7 11.6 113.2 12.4 10.6 3.1 10.4 82.4 28.8 38.4 32.8 39.0 7.8 5.5 29.6 19.8 28.6 14.6 17.1 57.0 48.8 37.4 12.6 6.2 31.1 26.9 53.9 57.8 40.2 40.2 22.5 28.8 15.2 18.0 22.6 12.3 20.2 14.8 19.2 19.1 10.5 18.3 22.3 18.1 15.8 23.1 20.6 16.7 13.9 13.7 3.1 4.1 2.5 5.6 3.0 6.0 7.7 4.2 1.9 6.2 3.7 4.6 8.2 11.1 9.6 16.3 34.0 15.3 25.0 14.2 19.2 8.6 13.6 6.6 3.9 10.6 10.0 16.9 9.2 2.1 9.6 21.1 24.4 0.0 12.4 27.0 12.7 15.0 16.3 10.3 14.1 72.8 15.5 11.9 18.4 16.3 19.8 15.2 13.9 16.8 28.0 17.6 3.3 79.3 23.9 4.1 29.9 16.1 7.3 9.9 22.9 7.2 24.4 32.5 9.0 20.6 32.6 70.1 12.3 14.1 16.1 32.3 13.5 47.3 6.9 23.1 7.6 0.0 10.3 22.6 1.4 1.8 9.8 11.1 9.2 21.8 5.7 27.3 14.9 ERAP2 "L-RAP, LRAP" ENSG00000164308 "Endoplasmic reticulum aminopeptidase 2" Q6P179 5 96875986-96919703 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 176.1;GAMG: 105.0;hTEC/SVTERT24-B: 83.2;MOLT-4: 98.8;TIME: 188.7" "Low region specificity" "Detected in all" "CAB025618, HPA034498, HPA064360" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 11000000 "Golgi apparatus" "CAB025618: , HPA034498: AB_2674191, HPA064360: " "unprognostic (4.62e-2)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (8.71e-2)" "unprognostic (2.60e-2)" "unprognostic (1.17e-2)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.01e-1)" "unprognostic (9.54e-3)" "unprognostic (6.59e-2)" "unprognostic (8.48e-2)" "unprognostic (4.65e-2)" "unprognostic (3.05e-1)" 7.7 7.2 3.1 31.8 3.4 7.6 12.1 2.5 4.3 12.3 3.7 16.3 32.9 8.4 17.7 10.6 7.1 11.1 7.6 3.0 4.1 11.5 14.6 18.3 46.8 3.9 3.1 2.2 8.6 2.9 3.7 3.7 11.1 3.5 10.4 6.3 2.3 6.6 7.1 9.0 10.2 21.7 3.4 2.4 37.0 19.2 1.8 3.7 50.4 5.7 10.0 30.0 14.8 6.8 7.8 2.1 2.4 1.7 0.9 1.9 3.8 0.6 8.1 13.8 7.3 12.3 7.9 176.1 12.2 35.1 11.5 105.0 2.9 0.9 65.4 5.8 4.3 7.9 0.6 3.0 8.5 2.7 43.2 19.2 25.3 12.8 83.2 0.6 1.2 4.9 27.4 0.2 25.8 20.8 1.4 98.8 22.5 0.2 0.0 3.7 45.7 16.2 29.3 55.2 15.4 3.5 0.2 1.1 0.9 16.5 0.4 6.5 1.7 188.7 3.9 1.1 10.0 24.6 26.2 23.2 4.2 50.8 5.8 0.9 23.0 12.1 15.4 24.8 27.5 31.3 28.5 34.6 30.6 19.8 17.7 37.4 28.9 4.2 45.4 28.5 6.9 34.6 27.6 3.1 3.4 2.5 4.3 3.0 4.1 3.9 3.1 2.2 3.5 2.4 3.7 7.8 46.7 32.1 20.0 11.8 62.6 5.7 11.2 24.4 12.0 1.5 3.1 5.8 4.4 8.6 15.9 44.1 0.0 11.5 35.6 48.1 0.0 5.3 0.3 7.0 10.6 34.1 1.8 15.8 2.5 25.5 17.0 23.4 17.3 7.4 7.0 33.4 31.4 16.3 12.3 0.0 2.1 23.3 8.2 29.4 14.2 0.7 10.5 33.0 7.2 21.5 19.4 6.5 20.6 7.1 4.9 22.1 27.6 7.9 56.0 4.3 52.4 6.2 15.7 2.8 0.0 12.2 12.2 0.9 0.8 10.0 3.0 6.7 54.2 9.3 34.2 10.5 CMYA5 "C5orf10, DKFZp451G223, SPRYD2, TRIM76" ENSG00000164309 "Cardiomyopathy associated 5" Q8N3K9 5 79689836-79800240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 628.6;tongue: 806.6" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 3425.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.3;RT4: 1.5;THP-1: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA074081, HPA077831" Enhanced Approved "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Vesicles, Plasma membrane" "HPA074081: , HPA077831: " "unprognostic (5.53e-2)" "unprognostic (9.91e-3)" "unprognostic (1.21e-2)" "unprognostic (1.49e-2)" "unprognostic (9.01e-4)" "unprognostic (7.00e-2)" "unprognostic (7.39e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.75e-1)" "unprognostic (5.04e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "unprognostic (6.30e-3)" "unprognostic (3.88e-2)" "unprognostic (7.69e-2)" "unprognostic (9.74e-2)" 0.7 0.1 1.6 0.2 1.6 0.0 3.9 1.4 2.2 1.6 2.7 0.9 0.1 5.9 4.7 6.7 2.2 0.9 157.3 1.0 4.3 2.5 1.3 0.5 0.0 1.9 1.6 0.2 14.8 0.3 3.7 2.1 1.1 1.6 6.2 0.2 1.8 6.2 2.2 628.6 2.3 0.4 4.6 1.4 0.0 0.6 0.5 1.6 0.9 2.4 806.6 0.1 2.1 1.2 3.6 0.0 0.0 0.0 0.1 0.5 0.4 0.6 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 5.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.6 1.4 2.2 1.0 4.3 1.9 1.6 0.2 1.6 1.4 1.6 3.6 2.7 9.6 2.8 69.5 0.4 1.3 17.9 2.9 4.6 2.0 24.4 46.6 3425.2 5.7 12.2 25.8 0.0 21.4 1.3 0.4 17.6 0.7 0.3 29.3 7.2 19.7 1.8 0.0 32.9 0.4 2.9 113.7 3.6 55.2 1.3 2.5 0.4 2.3 2.1 217.0 10.7 0.2 8.2 0.6 1.6 2.3 14.9 1.4 0.0 6.5 0.1 8.8 2.1 156.3 2.9 0.6 0.2 13.5 0.6 4.8 0.0 15.4 6.2 3.0 0.0 165.6 23.1 2.5 2.0 2.2 5.4 32.8 1.2 1.7 0.2 18.1 EGFLAM "AGRINL, AGRNL, FLJ39155, PIKA" ENSG00000164318 "EGF like, fibronectin type III and laminin G domains" Q63HQ2 5 38258409-38465480 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 122.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9" "Cancer enhanced" "Detected in all" "testis cancer: 6.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066577 Approved "Secreted - unknown location" NA NA "HPA066577: " "unprognostic (2.05e-1)" "unprognostic (4.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-3)" "unprognostic (1.08e-2)" "unprognostic (3.63e-3)" "unprognostic (6.31e-2)" "unprognostic (2.83e-1)" "unprognostic (2.08e-2)" "unprognostic (1.71e-3)" "unprognostic (1.12e-1)" "unprognostic (5.80e-2)" "prognostic unfavorable (4.47e-5)" "unprognostic (7.02e-6)" "unprognostic (2.60e-1)" "unprognostic (9.90e-2)" "unprognostic (1.04e-2)" 39.6 20.0 2.0 2.8 2.3 0.2 47.5 1.9 2.3 15.0 3.2 5.3 1.9 5.7 6.9 4.0 8.3 4.9 16.4 1.4 5.8 6.9 4.7 2.9 14.3 2.8 4.2 1.6 23.9 3.2 4.0 5.8 52.1 3.5 14.3 3.2 67.3 6.9 20.8 72.7 5.9 4.7 6.7 1.4 9.9 3.4 15.2 3.0 20.6 9.1 122.2 9.1 7.7 13.1 2.4 3.2 0.0 6.5 0.2 0.8 0.2 0.0 2.9 0.0 0.5 0.1 0.0 0.0 0.1 10.2 0.1 0.1 0.0 0.0 12.6 0.0 0.0 1.6 0.0 6.1 0.0 2.8 0.0 0.1 5.4 0.0 0.1 16.4 0.0 16.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 3.9 0.0 3.7 0.1 1.3 0.0 0.2 0.0 0.1 15.6 0.6 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 1.9 2.3 1.4 5.8 2.8 4.2 1.6 3.5 1.4 3.0 2.4 11.4 0.0 0.0 0.3 0.0 2.7 0.3 0.0 0.0 1.3 2.4 9.8 2.6 0.0 0.0 0.0 120.9 0.3 0.4 0.0 3.9 0.5 50.7 0.2 3.2 5.4 0.0 0.0 0.6 1.0 0.5 17.8 0.0 0.3 0.0 1.6 1.4 0.0 0.7 0.0 0.9 0.0 0.0 0.0 4.2 49.1 155.4 0.6 5.4 1.9 0.0 3.4 0.0 1.0 0.1 1.3 0.0 30.9 0.0 0.2 0.0 6.5 0.0 33.1 85.5 22.0 70.9 9.8 3.3 0.3 2.0 0.5 0.4 23.5 0.0 0.3 CFAP97 "DKFZp434F1728, hmw, KIAA1430" ENSG00000164323 "Cilia and flagella associated protein 97" Q9P2B7 4 185159665-185209504 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 276.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049446, HPA053335" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA049446: AB_2680770, HPA053335: AB_2682117" "unprognostic (6.74e-2)" "unprognostic (1.11e-2)" "unprognostic (1.31e-2)" "unprognostic (4.40e-2)" "unprognostic (3.63e-1)" "unprognostic (6.01e-2)" "unprognostic (3.70e-2)" "unprognostic (2.85e-2)" "unprognostic (2.11e-2)" "unprognostic (3.96e-2)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (2.40e-2)" "unprognostic (3.81e-1)" "unprognostic (5.22e-2)" "unprognostic (1.29e-1)" 17.1 12.0 8.1 14.8 8.4 5.3 21.0 10.4 10.0 17.7 10.6 10.1 7.6 19.0 9.4 19.3 15.9 15.2 9.1 7.4 8.6 16.3 18.9 13.8 17.7 8.7 7.8 6.3 22.3 10.3 20.5 6.4 14.0 9.0 17.7 11.4 18.1 12.3 17.7 6.8 11.5 9.8 17.5 8.3 18.7 11.3 37.8 7.6 11.9 27.5 7.1 16.3 14.7 9.8 11.9 29.5 17.9 23.6 40.8 27.1 47.8 14.2 38.3 34.7 28.1 22.2 11.2 36.2 73.1 12.6 44.2 21.0 15.8 26.9 33.3 37.2 65.3 17.7 29.5 10.5 26.1 33.5 40.5 22.4 31.0 45.9 30.6 66.6 34.9 24.6 33.7 53.1 66.8 39.9 14.0 21.5 20.0 13.6 9.1 14.2 31.9 11.7 45.8 34.4 15.6 15.8 42.3 28.3 27.2 53.9 13.6 18.2 24.4 35.8 26.4 16.4 10.4 30.4 26.4 12.5 22.4 33.0 34.5 53.8 9.5 6.4 2.9 27.8 11.5 32.8 30.7 27.0 27.4 8.5 29.7 27.0 18.9 1.3 19.9 18.9 29.3 21.0 10.0 8.1 8.4 10.4 10.0 7.4 8.6 8.7 7.8 6.3 9.0 8.3 7.6 11.9 84.0 64.1 41.3 17.0 50.5 0.0 64.7 0.0 58.6 61.5 68.5 75.4 29.6 52.9 22.9 46.0 52.1 29.5 54.4 2.8 70.5 57.2 276.4 66.9 81.7 49.9 12.2 30.1 10.8 51.5 33.8 53.0 34.7 39.3 27.8 39.7 41.4 65.1 20.7 69.0 19.3 11.6 0.0 26.3 0.0 156.3 81.7 25.7 0.0 15.0 41.0 61.9 63.8 26.2 20.3 49.1 6.6 87.6 41.9 73.0 15.0 109.2 36.5 69.6 72.3 75.5 51.4 171.7 109.3 48.3 0.0 15.7 47.7 122.0 14.8 37.8 TMEM174 "FLJ31268, MGC13034" ENSG00000164325 "Transmembrane protein 174" Q8WUU8 5 73173193-73175143 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 304 "kidney: 154.6" "Cell type enriched" "Detected in some" 10 "Proximal tubular cells: 160.6" "Cancer enriched" "Detected in single" 126 "renal cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA037975 Enhanced NA NA "HPA037975: AB_10672732" "unprognostic (8.11e-2)" "prognostic favorable (3.30e-6)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 154.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 CARTPT CART ENSG00000164326 "CART prepropeptide" Q16568 5 71719275-71721048 "FDA approved drug targets, Human disease related genes, Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adrenal gland: 119.8;brain: 251.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 47.4;Early spermatids: 25.4;Prostatic glandular cells: 39.5;Spermatocytes: 55.7" "Cancer enriched" "Detected in many" 9 "breast cancer: 117.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 209.0" "CAB025515, HPA046278, CAB079776" Enhanced Supported "Secreted to blood" NA NA "CAB025515: , CAB079776: , HPA046278: AB_10961570" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (3.45e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.14e-1)" 2.4 119.8 87.8 4.4 23.1 0.0 9.4 8.4 59.1 0.0 9.3 11.1 5.5 2.9 0.7 0.3 0.4 0.2 0.1 32.3 71.3 0.0 0.0 0.1 0.0 76.0 116.3 16.1 0.1 0.5 0.0 5.3 0.0 236.6 8.6 4.6 21.6 0.1 0.0 0.0 0.1 3.4 15.3 25.6 0.0 14.7 7.2 122.3 0.3 5.5 0.0 0.0 0.0 0.3 251.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.8 23.1 8.4 59.1 32.3 71.3 76.0 116.3 16.1 236.6 25.6 122.3 251.1 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 47.4 0.2 0.3 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 25.4 1.6 0.1 1.0 7.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 39.5 0.0 0.0 0.0 8.1 0.0 0.0 0.1 55.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 RICTOR "AVO3, KIAA1999, MGC39830, PIA" ENSG00000164327 "RPTOR independent companion of MTOR complex 2" Q6R327 5 38937920-39074399 "Predicted intracellular proteins" "Host-virus interaction" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 258.9;Oligodendrocytes: 343.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 30.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037802, HPA037803" Approved Approved Mitochondria NA NA Mitochondria "HPA037802: AB_10672286, HPA037803: AB_2675676" "unprognostic (2.25e-2)" "unprognostic (8.30e-2)" "unprognostic (4.02e-1)" "unprognostic (7.94e-3)" "unprognostic (5.47e-2)" "unprognostic (2.95e-3)" "unprognostic (2.95e-3)" "unprognostic (1.33e-1)" "unprognostic (3.55e-2)" "unprognostic (4.37e-1)" "unprognostic (2.73e-2)" "unprognostic (8.29e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-2)" 7.2 5.5 8.0 8.9 10.6 24.8 9.5 18.3 10.6 7.4 2.4 6.6 5.5 9.3 6.4 5.5 7.0 6.3 10.1 9.6 8.5 7.1 7.8 9.9 11.4 10.0 8.1 5.3 10.1 6.3 6.7 5.0 9.0 11.1 6.7 6.7 26.5 6.4 5.2 11.8 8.2 8.0 6.8 9.7 10.2 7.1 9.4 8.9 12.9 8.7 11.6 9.2 7.1 7.3 17.7 5.9 10.6 7.6 7.6 9.5 10.8 11.1 8.1 18.7 8.7 8.7 6.5 10.5 9.7 3.0 8.0 13.2 9.5 6.7 8.8 10.5 8.6 6.0 11.4 25.4 7.9 6.1 9.7 14.6 9.2 6.4 10.8 11.8 8.6 14.6 7.8 9.4 18.1 5.9 3.1 9.9 16.0 4.9 3.1 8.2 7.9 13.6 8.6 7.2 9.7 6.4 4.4 21.1 7.8 10.9 7.1 5.4 10.5 12.5 17.6 8.5 7.2 6.1 8.0 5.3 9.5 7.5 12.7 6.6 8.7 1.4 8.5 4.9 1.4 4.0 3.8 4.9 4.3 1.5 4.6 5.2 6.0 30.3 3.7 3.4 5.1 3.3 0.8 8.0 10.6 18.3 10.6 9.6 8.5 10.0 8.1 5.3 11.1 9.7 8.9 17.7 32.9 64.1 50.2 72.8 62.4 48.8 39.6 38.7 27.3 69.6 28.6 13.5 38.4 28.6 34.7 27.6 204.3 40.5 65.6 28.0 0.0 25.9 2.3 33.0 31.1 43.0 43.6 73.4 153.8 15.9 20.6 37.4 30.1 35.1 33.0 32.9 49.2 33.0 19.3 52.2 153.9 26.0 22.4 40.6 47.6 5.3 47.5 36.3 33.8 108.7 45.2 28.8 74.2 258.9 343.1 28.1 29.9 32.4 48.7 65.8 30.7 15.3 38.0 176.0 13.1 43.6 34.6 36.5 33.2 18.3 45.0 96.5 70.9 21.3 19.6 74.6 TENT2 "FLJ38499, GLD2, PAPD4, TUT2" ENSG00000164329 "Terminal nucleotidyltransferase 2" Q6PIY7 5 79612120-79686648 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 37.6;Glandular and luminal cells: 33.2;Granulosa cells: 31.9;Hofbauer cells: 33.9;Syncytiotrophoblasts: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054468 Approved Cytosol No No Cytosol "HPA054468: AB_2682497" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.25e-3)" "unprognostic (1.91e-1)" "unprognostic (8.03e-2)" "unprognostic (2.80e-3)" "unprognostic (2.10e-2)" "unprognostic (1.10e-1)" "unprognostic (6.80e-2)" "unprognostic (1.57e-3)" "unprognostic (9.37e-2)" "unprognostic (2.21e-1)" "unprognostic (7.71e-2)" "unprognostic (2.38e-1)" "unprognostic (8.43e-3)" "unprognostic (5.84e-3)" "unprognostic (2.67e-3)" 18.0 15.2 12.1 20.6 14.5 44.8 25.3 13.6 15.8 18.0 16.9 18.6 18.0 19.8 23.8 16.6 16.1 17.5 14.6 11.8 14.6 17.8 24.0 18.0 30.4 13.7 13.3 10.5 22.9 15.3 15.6 11.6 21.2 13.9 15.9 21.0 14.4 15.2 15.4 16.3 24.0 19.2 18.5 12.9 28.0 17.9 17.7 12.9 27.5 22.6 14.4 28.3 19.3 16.1 17.3 22.5 15.3 16.8 26.7 28.8 33.2 26.8 26.6 40.6 30.5 48.3 13.8 26.1 41.8 13.6 29.6 35.9 21.1 21.8 29.6 34.6 31.3 19.9 23.9 19.4 21.6 37.3 35.7 31.6 29.5 31.4 21.6 40.1 29.7 26.2 30.0 27.7 30.0 34.0 12.3 40.8 45.6 15.6 17.0 10.8 36.2 16.8 47.2 29.4 31.8 11.0 20.1 21.1 22.8 42.8 26.4 19.6 55.6 24.2 16.4 11.1 16.0 29.9 31.3 27.8 40.7 28.9 36.8 23.4 30.7 21.5 21.6 19.0 24.8 31.3 21.6 20.5 21.0 21.9 17.2 19.5 20.6 19.2 21.8 26.0 12.0 23.4 19.0 12.1 14.5 13.6 15.8 11.8 14.6 13.7 13.3 10.5 13.9 12.9 12.9 17.3 25.9 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 24.2 16.5 0.0 0.0 0.0 27.6 0.0 26.3 37.6 0.0 17.6 10.2 0.0 21.3 29.0 7.2 0.0 0.0 0.0 10.2 22.6 8.7 0.0 33.2 0.0 31.9 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 33.7 11.0 23.7 0.0 0.0 EBF1 "COE1, EBF, OLF1" ENSG00000164330 "EBF transcription factor 1" Q9UH73 5 158695916-159099916 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 38.1" "Cell type enhanced" "Detected in many" "Adipocytes: 79.8;Fibroblasts: 108.4;Leydig cells: 285.5;Microglial cells: 255.8;Peritubular cells: 121.5;Sertoli cells: 98.6;Smooth muscle cells: 138.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "memory B-cell: 12.1;naive B-cell: 10.2" "Lineage enriched" "Detected in single" 24 "B-cells: 12.1" "Cell line enhanced" "Detected in many" "ASC diff: 30.0;HSkMC: 26.7;REH: 82.6;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061169 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (7.86e-2)" "unprognostic (3.08e-2)" "unprognostic (7.29e-2)" "unprognostic (4.70e-2)" "unprognostic (2.63e-1)" "unprognostic (1.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.60e-1)" "unprognostic (5.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (9.62e-7)" "prognostic unfavorable (7.80e-4)" "unprognostic (5.75e-2)" "unprognostic (5.81e-2)" "unprognostic (4.37e-3)" 38.1 2.8 5.4 3.8 5.1 3.3 20.7 16.0 4.9 13.2 4.7 4.8 1.1 10.6 4.1 3.6 12.6 8.1 7.5 3.7 5.0 3.3 0.4 4.3 9.4 9.9 7.2 3.2 8.6 1.7 1.6 2.4 10.9 8.4 4.8 3.2 2.0 4.7 4.4 4.7 6.6 5.5 7.7 8.5 4.8 3.5 4.0 5.7 2.6 7.6 7.4 9.2 10.5 10.4 6.2 0.0 0.5 12.8 0.0 30.0 11.9 0.2 0.3 0.0 0.7 1.7 0.0 0.0 11.9 0.0 4.0 2.4 0.1 0.5 0.1 0.2 2.8 0.2 0.0 3.5 0.0 1.0 0.1 0.3 26.7 0.0 11.4 0.4 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.1 0.2 1.2 0.0 0.0 82.6 0.6 0.2 0.0 0.0 6.8 1.7 0.7 0.3 0.0 0.2 0.0 0.1 0.0 15.3 1.8 17.5 0.3 0.0 0.1 11.1 10.2 1.2 13.0 0.5 0.0 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.0 10.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 5.4 5.1 16.0 4.9 3.7 5.0 9.9 7.2 3.2 8.4 8.5 5.7 6.2 79.8 0.0 0.5 5.2 76.3 12.2 0.3 0.0 1.8 5.9 0.8 1.9 5.0 0.0 0.7 1.8 0.0 0.2 0.2 0.1 0.0 3.9 28.2 1.5 54.2 56.3 0.0 0.4 0.4 0.0 0.3 108.4 1.5 1.4 0.0 0.0 4.6 2.2 0.8 0.0 1.6 0.1 0.0 0.3 16.6 21.7 285.5 1.9 14.2 255.8 9.3 1.9 0.0 3.0 0.9 0.1 0.0 121.5 7.7 0.7 0.0 0.1 0.9 2.3 98.6 4.6 138.8 2.7 1.3 1.6 7.0 0.4 5.0 10.7 0.0 1.7 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552190-73565667 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: AB_2685449" "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 7.2 11.4 5.2 5.8 5.8 14.1 10.2 6.3 5.4 9.5 5.6 9.0 9.7 12.5 13.2 7.5 11.6 9.8 8.2 4.9 5.6 5.9 10.9 7.1 10.0 5.5 5.5 4.7 14.2 8.3 8.1 7.5 10.1 6.0 12.5 10.5 10.0 10.9 8.4 7.7 9.2 9.7 8.4 5.3 8.9 10.1 6.8 6.0 10.1 14.4 6.7 8.2 7.4 7.8 6.8 6.6 4.5 6.6 7.5 12.3 19.3 20.6 9.0 13.2 7.6 11.0 1.4 9.4 6.2 7.0 8.8 7.3 4.5 3.1 15.4 10.9 11.9 5.5 5.4 3.6 6.5 9.6 3.1 9.3 19.8 21.0 9.1 9.2 13.6 8.7 6.7 5.3 9.9 8.6 3.8 5.6 8.5 3.9 2.5 3.7 3.5 7.1 8.7 5.6 8.2 9.0 6.9 6.9 5.3 11.0 10.2 8.2 5.0 11.2 3.0 3.4 4.9 6.3 19.7 15.1 5.3 7.5 5.1 8.8 19.9 5.1 11.2 7.6 4.5 9.3 9.9 8.9 10.7 4.6 8.0 13.3 12.4 8.4 7.3 7.8 5.3 11.5 6.8 5.2 5.8 6.3 5.4 4.9 5.6 5.5 5.5 4.7 6.0 5.3 6.0 6.8 10.7 3.2 11.5 10.4 23.5 15.8 30.1 29.8 26.2 26.2 20.7 15.9 8.9 31.5 22.7 18.4 10.4 26.3 27.1 16.0 27.4 14.1 1.3 18.1 11.0 12.8 24.1 21.5 10.0 16.6 22.2 13.8 10.7 13.4 19.0 18.8 15.7 23.8 10.5 23.5 12.9 22.6 36.7 18.5 6.7 2.2 32.6 11.1 12.4 16.9 15.1 16.2 17.5 21.1 22.3 16.9 20.0 29.0 14.6 25.7 21.5 18.0 21.4 21.2 26.3 11.3 17.8 25.6 15.9 16.0 12.4 48.8 20.4 16.3 17.0 36.8 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263290-159286036 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 19.2 16.4 8.9 24.8 9.2 23.5 20.7 9.3 14.2 20.1 6.4 15.9 12.7 23.8 17.4 21.3 15.2 17.3 16.6 9.6 9.7 19.4 18.4 22.6 34.0 9.7 9.4 8.0 16.0 15.0 19.9 5.6 23.8 10.4 17.7 17.1 18.4 14.4 19.8 11.0 15.6 12.8 23.0 8.5 27.0 16.0 30.7 10.8 36.7 16.7 13.9 37.6 21.5 11.8 13.1 39.9 28.6 57.9 64.1 58.9 54.5 34.1 42.5 64.6 42.8 56.6 23.5 27.1 35.7 46.1 53.7 60.9 29.7 36.3 81.8 74.3 71.3 35.7 27.3 23.8 21.9 74.0 62.7 41.1 48.1 76.8 38.9 77.2 34.0 41.4 36.4 38.4 47.0 60.8 12.9 33.5 22.9 41.7 20.0 17.1 42.3 56.5 42.8 44.4 30.4 30.4 42.9 42.7 29.0 115.8 34.6 30.2 45.6 44.2 44.0 37.8 22.8 54.9 36.9 39.8 53.5 46.1 43.9 66.1 47.6 10.8 27.5 25.5 22.4 28.4 18.5 23.9 26.7 14.2 16.7 26.9 29.1 30.8 42.8 24.5 17.8 28.3 13.6 8.9 9.2 9.3 14.2 9.6 9.7 9.7 9.4 8.0 10.4 8.5 10.8 13.1 31.9 12.8 41.6 12.7 43.0 15.9 10.3 43.0 35.3 12.7 22.5 14.4 16.8 10.0 34.4 14.7 4.2 31.8 36.8 13.2 35.2 23.0 8.5 23.2 32.1 24.2 10.7 30.1 26.3 24.9 18.7 27.1 29.6 17.4 45.0 16.9 28.5 15.6 39.0 20.2 25.0 14.6 18.3 40.0 16.4 4.2 20.5 33.1 17.8 14.0 30.9 17.6 32.0 22.6 25.6 22.5 10.1 24.8 39.3 13.2 8.8 34.5 37.4 13.1 19.7 18.8 26.2 74.0 61.5 51.8 20.6 17.8 40.8 30.7 14.5 10.1 FAM170A ZNFD ENSG00000164334 "Family with sequence similarity 170 member A" A1A519 5 119629559-119635822 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 11.7" "Cell type enhanced" "Detected in some" "Early spermatids: 30.5;Late spermatids: 11.7;Sertoli cells: 6.6;Spermatocytes: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037900, HPA037902" Enhanced NA NA "HPA037900: AB_2675728, HPA037902: AB_2675730" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (9.70e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-4)" "unprognostic (2.12e-1)" "unprognostic (2.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 54.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15 small subunit processome component" Q8TED0 5 73565443-73583380 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 37.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Approved "Nucleoli,Endoplasmic reticulum" No No "Nucleoli, Endoplasmic reticulum" "HPA044697: AB_2679050" "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 8.7 6.6 2.1 8.1 2.6 37.3 9.8 3.3 3.4 4.7 1.3 6.8 5.6 7.2 6.5 9.3 5.1 5.1 4.9 2.4 2.5 5.1 7.6 5.9 10.8 2.5 2.6 2.5 4.9 7.5 7.6 3.1 6.1 2.8 6.0 8.4 5.5 5.0 4.8 7.3 9.2 5.2 7.7 1.8 7.9 5.8 6.1 2.2 7.6 8.1 7.6 10.8 9.4 4.5 3.8 21.2 22.3 15.8 44.6 12.6 14.9 27.9 24.8 14.1 27.1 29.8 25.0 29.6 47.5 24.9 16.6 34.2 17.3 25.5 45.5 41.6 23.9 19.2 21.7 23.7 20.2 15.5 20.2 18.1 15.2 20.0 30.8 34.3 8.3 19.1 21.2 33.8 25.3 23.2 26.4 31.7 14.0 20.6 7.5 12.7 24.5 24.7 45.9 16.1 28.5 15.8 16.9 22.7 17.6 27.4 13.4 22.8 14.4 15.4 15.9 22.5 19.4 49.3 19.0 27.6 60.5 26.0 34.3 23.8 4.9 6.8 4.6 8.2 7.0 7.6 7.9 8.1 9.1 7.4 7.0 9.6 9.4 5.1 8.2 7.2 7.0 7.3 4.9 2.1 2.6 3.3 3.4 2.4 2.5 2.5 2.6 2.5 2.8 1.8 2.2 3.8 8.4 0.0 7.3 2.3 7.7 14.7 13.1 5.0 11.4 3.8 6.7 6.5 6.8 4.3 5.2 5.5 6.2 8.0 6.0 2.7 3.9 8.9 4.3 4.9 6.8 6.9 2.4 9.4 6.4 7.8 9.5 8.0 5.6 6.8 7.0 6.7 2.9 8.1 6.8 1.7 5.4 4.1 2.0 5.8 2.1 2.8 3.1 3.9 7.2 1.9 3.6 3.0 2.1 3.5 6.9 6.5 3.6 5.3 9.1 10.0 2.2 6.3 1.7 4.7 6.6 9.5 8.8 10.0 12.4 11.7 17.0 6.6 6.1 7.6 6.7 9.8 TLR3 CD283 ENSG00000164342 "Toll like receptor 3" O15455 4 186069155-186088073 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Receptor, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.7;Early spermatids: 70.2" "Cancer enriched" "Detected in many" 4 "renal cancer: 10.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 5.5;memory CD8 T-cell: 5.9" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;T-cells: 5.9" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;ASC TERT1: 20.0;BJ hTERT+ SV40 Large T+ RasG12V: 30.2;CAPAN-2: 48.4;HDLM-2: 19.3;HSkMC: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025658 Enhanced "Intracellular and membrane" NA NA "CAB025658: " "unprognostic (2.13e-2)" "unprognostic (2.15e-1)" "unprognostic (7.26e-2)" "unprognostic (7.47e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-2)" "unprognostic (9.28e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (1.17e-1)" "unprognostic (4.72e-3)" "unprognostic (1.18e-1)" "unprognostic (4.52e-3)" "unprognostic (3.89e-2)" "unprognostic (1.83e-1)" 7.4 5.6 0.8 3.4 1.1 0.3 6.7 1.4 1.1 5.4 1.6 11.8 18.4 6.2 3.3 9.1 10.1 11.4 3.3 0.9 2.2 11.9 14.9 11.6 1.0 2.4 1.0 0.4 8.9 5.9 4.1 0.5 17.5 2.7 7.7 12.6 1.6 10.6 11.0 1.0 3.4 17.0 8.3 1.7 5.3 11.0 5.4 1.3 2.5 7.6 3.4 2.0 8.5 2.8 3.2 3.5 0.9 0.5 0.0 19.3 20.0 1.6 0.1 14.4 8.8 30.2 0.0 48.4 0.1 2.0 2.1 17.2 4.9 0.0 10.3 1.5 19.3 0.2 3.1 0.7 0.0 8.6 3.2 1.2 20.0 3.9 11.8 0.5 5.3 4.2 3.3 0.0 0.0 5.1 0.0 3.7 0.0 1.5 0.0 0.6 4.6 0.0 0.2 8.2 5.0 0.0 0.1 2.6 2.1 4.0 0.2 0.6 0.0 3.0 1.5 1.0 0.0 2.1 0.0 0.0 0.0 4.1 2.0 3.4 0.5 0.0 0.0 5.5 0.0 3.1 0.0 1.2 5.9 2.0 0.0 0.8 2.7 0.2 0.6 0.0 0.0 0.1 0.9 0.8 1.1 1.4 1.1 0.9 2.2 2.4 1.0 0.4 2.7 1.7 1.3 3.2 12.9 19.2 7.8 0.3 0.8 3.8 5.2 8.1 9.1 0.1 4.0 3.4 1.4 12.8 13.2 14.7 0.0 20.5 2.0 33.7 0.0 10.3 70.2 8.5 5.4 5.8 1.2 4.4 0.1 10.1 4.2 10.8 8.6 19.7 2.5 5.0 6.1 7.9 2.6 0.0 0.0 6.4 4.1 0.6 5.0 6.4 8.4 3.6 0.0 10.3 0.0 4.8 4.1 0.5 0.0 5.8 8.4 3.8 0.5 2.2 20.7 4.9 7.5 0.6 0.0 6.7 3.3 0.1 0.4 7.3 1.0 19.6 1.3 3.1 4.6 5.2 KLKB1 KLK3 ENSG00000164344 "Kallikrein B1" P03952 4 186208979-186258471 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "liver: 331.1" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 280.5" "Cancer enriched" "Detected in some" 17 "liver cancer: 27.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted to blood" NA NA 28900000000 5300000000 "unprognostic (4.80e-2)" "unprognostic (4.53e-3)" "unprognostic (4.36e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-2)" "unprognostic (1.90e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (8.14e-2)" "unprognostic (1.35e-1)" "unprognostic (1.38e-2)" "unprognostic (1.15e-1)" "unprognostic (1.45e-2)" "unprognostic (6.01e-2)" "unprognostic (7.30e-2)" "unprognostic (1.20e-1)" "unprognostic (1.59e-2)" 0.5 1.8 6.7 0.3 6.8 0.0 0.6 6.4 7.6 1.3 8.8 1.9 2.9 0.6 1.0 0.4 1.3 2.6 2.5 6.7 6.4 5.7 331.1 1.0 0.7 7.2 6.7 6.5 0.7 4.8 1.0 3.6 0.2 7.2 1.7 1.4 13.3 0.7 0.6 2.4 0.2 2.6 0.7 6.7 2.4 0.8 2.0 6.4 0.4 1.9 1.8 0.4 1.5 0.9 6.6 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.8 6.4 7.6 6.7 6.4 7.2 6.7 6.5 7.2 6.7 6.4 6.6 0.1 0.0 0.0 48.3 0.7 0.0 0.1 0.2 0.6 5.1 0.3 0.5 4.3 14.3 0.1 1.8 16.7 0.0 0.5 0.6 0.0 1.8 2.8 0.6 0.2 1.0 3.0 2.7 10.2 0.5 0.0 0.4 0.0 0.4 0.0 0.2 5.7 280.5 0.2 0.0 15.6 0.4 0.0 4.4 0.0 2.2 0.6 0.3 0.0 6.5 0.1 10.6 2.1 8.0 7.7 0.4 1.4 0.0 0.1 0.0 2.6 1.6 1.1 5.1 0.0 0.6 0.3 1.3 1.3 0.1 0.0 0.0 0.6 0.1 0.7 0.1 NSA2 "FLJ94393, HCLG1, HUSSY-29, TINP1" ENSG00000164346 "NSA2 ribosome biogenesis factor" O95478 5 74766991-74780113 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043487 Approved Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA043487: AB_2678507" "unprognostic (4.79e-3)" "unprognostic (1.92e-1)" "unprognostic (5.49e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.14e-3)" "unprognostic (4.24e-1)" "unprognostic (2.15e-2)" "unprognostic (9.14e-2)" "unprognostic (8.66e-2)" "unprognostic (1.03e-1)" "unprognostic (4.92e-2)" "unprognostic (3.98e-1)" "unprognostic (1.64e-1)" "unprognostic (2.31e-2)" "unprognostic (1.44e-1)" 32.2 36.8 18.2 33.5 20.2 39.6 29.0 20.2 22.3 41.8 17.4 33.3 30.7 30.1 25.2 27.0 35.3 12.3 27.2 18.3 19.9 28.9 26.9 20.4 37.2 20.1 19.1 17.3 61.0 38.0 20.7 28.3 17.4 20.1 28.8 23.0 22.8 28.3 11.6 68.5 20.5 26.2 17.1 21.0 26.0 31.5 32.1 19.5 23.7 22.3 19.2 32.2 36.2 30.8 21.3 65.2 35.4 42.5 57.6 26.6 48.9 64.8 45.8 24.5 29.5 24.9 61.2 62.3 53.0 94.0 27.3 70.2 39.6 34.6 51.9 41.9 36.1 53.7 27.9 65.8 68.3 24.8 47.9 61.7 32.4 48.2 39.8 29.6 46.5 25.5 47.3 28.0 42.8 32.2 50.1 81.4 120.4 28.3 27.8 29.9 58.4 49.8 100.5 37.7 70.9 45.3 58.5 27.8 52.8 135.7 32.6 49.5 135.8 28.0 22.0 67.4 41.8 133.3 42.7 61.1 90.0 54.6 84.3 33.3 9.3 12.1 7.5 16.3 20.6 23.5 27.1 24.6 24.7 18.5 19.5 28.7 29.8 2.2 21.4 15.9 17.2 26.4 10.3 18.2 20.2 20.2 22.3 18.3 19.9 20.1 19.1 17.3 20.1 21.0 19.5 21.3 125.8 80.1 95.9 6.5 237.4 94.1 162.1 95.9 215.1 34.6 164.2 218.3 83.7 140.2 94.5 62.5 14.6 142.3 183.7 122.9 150.6 143.1 418.6 145.2 303.6 101.1 139.6 129.2 13.1 237.9 196.2 107.6 112.1 192.8 119.2 165.4 129.2 207.7 137.4 50.5 13.2 234.6 52.9 233.2 100.2 159.1 278.4 161.9 83.6 7.5 229.6 85.8 188.4 10.1 13.4 181.2 147.9 171.5 139.4 144.4 147.5 281.7 55.9 37.7 138.1 132.8 138.0 250.2 96.3 171.7 86.0 135.4 176.1 176.8 246.1 192.5 GFM2 "EF-G2mt, EFG2, FLJ21661" ENSG00000164347 "GTP dependent ribosome recycling factor mitochondrial 2" Q969S9 5 74721206-74767147 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036863, HPA069871" Uncertain Approved "Nucleoplasm,Midbody ring,Mitochondria" Yes NA Mitochondria "Nucleoplasm, Midbody ring" "HPA036863: AB_2675354, HPA069871: " "unprognostic (2.58e-3)" "unprognostic (7.04e-2)" "unprognostic (8.54e-3)" "unprognostic (1.98e-1)" "unprognostic (4.49e-2)" "unprognostic (2.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.64e-1)" "unprognostic (1.40e-1)" "unprognostic (3.80e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.33e-5)" "unprognostic (9.55e-2)" "unprognostic (4.15e-1)" "unprognostic (8.52e-3)" "unprognostic (9.82e-2)" 9.7 18.3 9.0 10.3 10.3 15.1 14.2 10.0 14.6 10.8 13.8 14.0 9.4 11.2 17.6 12.0 23.6 9.0 33.6 9.9 9.7 23.5 34.3 9.1 12.3 9.6 8.7 8.6 11.5 10.0 30.6 10.7 13.6 9.9 13.1 15.9 17.0 13.5 11.3 30.9 11.4 10.9 10.9 8.6 8.6 18.1 16.0 12.0 17.4 13.2 38.9 15.6 13.0 7.1 12.8 39.5 34.3 27.2 52.2 20.3 27.1 28.2 41.5 24.7 41.5 44.1 36.4 24.9 39.7 44.9 21.9 65.7 32.1 55.0 59.6 54.8 34.8 35.5 22.9 31.7 27.0 27.1 23.6 26.0 32.1 26.3 33.6 40.5 29.8 30.3 39.4 40.7 32.9 48.5 23.3 32.1 15.1 11.4 14.8 29.7 41.1 43.5 49.3 32.0 24.7 46.6 24.8 46.3 38.1 44.3 30.1 33.0 44.0 24.0 16.2 27.8 20.5 27.2 19.0 38.3 40.1 24.1 34.2 24.6 22.8 6.9 9.2 6.7 7.2 6.6 8.3 5.5 7.5 6.7 7.2 7.5 7.3 3.5 16.0 11.8 4.4 7.0 5.2 9.0 10.3 10.0 14.6 9.9 9.7 9.6 8.7 8.6 9.9 8.6 12.0 12.8 6.4 12.8 12.9 19.9 8.5 6.0 7.1 13.0 8.6 9.1 7.7 6.9 11.0 7.2 12.5 7.3 6.2 20.1 7.5 8.9 21.5 9.5 11.5 42.4 9.2 6.4 5.4 17.9 35.7 5.3 15.9 6.3 15.3 13.7 2.5 10.4 5.3 22.4 9.9 16.8 34.1 9.7 30.5 8.5 2.4 2.6 7.2 6.8 8.8 13.1 17.9 13.0 7.2 34.2 29.1 9.8 9.9 7.5 11.4 4.6 8.5 11.2 61.5 9.6 0.0 5.6 7.8 15.2 11.7 10.0 7.0 16.0 7.3 11.1 10.0 7.5 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295068 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Intestinal goblet cells: 1.0;Plasma cells: 2.8;Spermatocytes: 1.5;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 438.0;fHDF/TERT166: 429.4;HBEC3-KT: 929.2;hTEC/SVTERT24-B: 560.1;LHCN-M2: 252.2;TIME: 799.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: AB_2682554, HPA065897: AB_2685576" "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 213.2 438.0 3.2 0.0 173.9 31.7 59.4 0.3 0.1 3.0 0.2 429.4 0.1 0.1 1.0 929.2 29.1 0.0 1.7 0.1 0.0 0.4 0.1 0.5 1.2 0.0 22.9 560.1 6.8 1.3 1.5 1.8 2.9 0.2 252.2 0.4 0.2 9.4 2.9 0.1 1.3 2.1 0.0 5.4 23.9 0.5 0.2 2.1 0.1 0.0 0.2 0.0 0.1 0.3 799.9 0.0 0.0 0.0 0.0 0.9 0.5 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 SLC6A18 "FLJ31236, Xtrp2" ENSG00000164363 "Solute carrier family 6 member 18" Q96N87 5 1225381-1246189 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 76 "kidney: 8.3" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 55.6" "Cancer enriched" "Detected in single" 44 "renal cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA011885 Enhanced NA NA "HPA011885: AB_1857198" "unprognostic (2.02e-1)" "unprognostic (5.69e-3)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 55.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 CCDC127 FLJ25701 ENSG00000164366 "Coiled-coil domain containing 127" Q96BQ5 5 196868-218153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045052 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA045052: AB_10960630" "prognostic unfavorable (7.01e-4)" "unprognostic (4.26e-2)" "unprognostic (1.93e-2)" "unprognostic (9.18e-2)" "unprognostic (2.78e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.04e-6)" "unprognostic (2.41e-1)" "unprognostic (1.57e-1)" "unprognostic (9.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.95e-5)" "unprognostic (2.42e-1)" "unprognostic (9.06e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-1)" 4.6 7.9 4.1 4.2 4.2 2.1 4.1 4.7 5.5 5.0 4.6 5.1 4.8 6.3 4.0 7.5 5.5 7.1 9.9 3.8 4.4 4.1 3.8 3.6 7.7 5.5 4.4 3.9 8.2 4.8 2.8 4.4 4.0 6.4 5.7 1.9 20.5 4.5 3.0 12.2 7.0 5.8 3.2 2.5 4.1 5.3 6.4 4.7 3.0 13.4 5.1 2.3 4.6 4.0 5.7 5.6 7.3 8.0 14.5 9.6 7.3 7.8 10.6 5.5 4.7 4.6 7.6 11.5 11.6 15.0 4.9 6.1 7.2 4.9 4.1 4.5 29.8 8.8 4.1 35.8 6.8 5.6 3.1 7.3 6.0 6.5 4.4 3.1 11.1 3.9 6.3 7.0 4.0 5.0 4.5 6.0 6.7 6.8 3.4 8.8 7.0 5.9 9.6 8.8 5.7 8.7 13.8 14.7 10.0 9.7 6.3 13.1 6.2 8.3 11.8 6.9 4.8 4.4 6.7 6.0 8.0 7.7 5.6 7.5 3.5 3.1 5.1 5.2 3.6 5.7 6.6 5.4 6.4 3.1 6.0 6.3 7.1 1.8 6.3 3.3 5.6 4.4 3.9 4.1 4.2 4.7 5.5 3.8 4.4 5.5 4.4 3.9 6.4 2.5 4.7 5.7 13.8 16.0 10.4 3.9 7.8 14.1 13.6 29.2 10.2 17.4 11.4 15.0 28.0 5.7 16.8 5.5 18.8 33.1 13.9 9.8 3.9 30.7 7.8 16.6 17.9 14.8 8.4 6.5 3.8 15.1 28.8 19.9 4.6 15.5 9.5 17.2 14.6 12.5 19.9 38.7 4.6 9.6 16.2 6.5 10.7 7.3 20.8 10.6 8.8 1.9 20.3 34.8 11.3 7.5 5.8 15.8 3.7 19.9 8.7 14.9 20.0 8.6 19.3 31.4 13.1 11.6 13.4 40.1 30.8 6.9 8.0 30.1 11.1 21.1 7.6 12.9 FOXQ1 HFH1 ENSG00000164379 "Forkhead box Q1" Q9C009 6 1312098-1314758 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 108.1;urinary bladder: 54.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059700 Supported Nucleoplasm Yes NA Nucleoplasm "HPA059700: AB_2684107" "unprognostic (2.04e-3)" "unprognostic (3.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.18e-2)" "unprognostic (1.50e-3)" "unprognostic (2.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.68e-4)" "unprognostic (1.49e-2)" "unprognostic (3.16e-3)" "unprognostic (2.82e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 0.3 0.0 7.5 0.2 4.8 0.0 1.4 6.4 6.6 6.7 4.1 0.5 10.5 0.9 0.3 11.4 3.9 5.5 0.0 4.6 4.8 6.2 6.4 4.0 0.0 6.2 5.8 4.6 0.0 6.6 0.1 2.5 1.1 5.4 9.0 0.4 0.1 30.6 1.1 0.2 25.7 0.6 0.0 4.9 0.0 108.1 0.2 6.6 0.6 3.7 0.6 8.0 54.0 17.1 6.8 16.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 13.5 0.1 0.1 39.0 22.6 0.0 0.7 0.0 0.1 44.7 0.0 1.7 0.0 0.0 1.1 0.0 8.2 93.8 0.0 0.0 2.4 0.0 16.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 117.1 0.8 0.0 0.0 0.0 0.4 38.2 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 4.8 6.4 6.6 4.6 4.8 6.2 5.8 4.6 5.4 4.9 6.6 6.8 0.3 16.0 10.6 0.0 0.0 60.4 3.2 24.9 6.8 0.0 5.3 5.1 0.8 0.0 16.8 40.5 0.0 0.0 0.0 0.0 1.9 3.0 0.0 5.2 3.0 0.4 0.0 0.0 1.2 13.4 0.0 1.4 67.2 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 2.9 0.0 0.0 0.7 1.8 15.9 0.0 0.0 0.0 0.0 0.5 11.8 0.0 0.0 0.2 0.6 0.0 6.2 5.0 0.0 0.0 0.0 1.6 0.0 0.0 22.2 45.5 0.0 0.3 0.0 0.0 3.9 ADGRF2 "GPR111, hGPCR35, PGR20" ENSG00000164393 "Adhesion G protein-coupled receptor F2" Q8IZF7 6 47656436-47697797 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 1.0;skin 1: 2.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Early spermatids: 1.0;Endometrial ciliated cells: 1.6;Excitatory neurons: 1.2;Glandular and luminal cells: 1.3;Squamous epithelial cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035507 Uncertain NA NA "HPA035507: AB_10601809" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.74e-2)" "unprognostic (5.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (2.51e-4)" "unprognostic (3.05e-2)" "unprognostic (3.86e-2)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (7.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.6 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.8;brain: 34.4;retina: 46.2;testis: 20.9" "Cell type enhanced" "Detected in many" "Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 7.6;U-937: 6.2" HPA040470 Enhanced NA NA "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.1 4.2 18.6 1.4 19.9 22.8 0.2 28.3 34.4 0.0 2.0 0.4 4.7 0.1 0.5 0.3 0.2 0.3 1.4 20.8 13.7 1.9 2.1 0.3 2.4 20.7 20.5 15.7 0.0 1.1 11.4 4.3 0.6 20.9 0.3 0.3 46.2 0.3 18.2 2.3 0.1 2.4 0.1 13.4 1.1 0.6 20.9 26.3 0.6 0.4 1.4 1.0 0.2 0.1 16.3 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 6.2 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.7 1.6 0.0 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.3 18.6 19.9 28.3 34.4 20.8 13.7 20.7 20.5 15.7 20.9 13.4 26.3 16.3 0.6 25.6 29.2 229.2 1.4 1.9 1.5 0.0 2.2 65.2 2.1 0.4 0.0 1.5 16.1 1.8 229.4 0.3 3.3 0.6 7.9 0.6 43.7 0.3 0.1 3.9 2.4 110.5 70.6 0.2 0.1 4.2 0.0 0.2 10.1 0.2 1.8 8.4 0.1 21.9 110.6 1.8 0.0 1.0 15.9 7.9 0.3 6.4 0.0 15.9 0.9 24.5 0.0 41.7 9.8 0.3 1.6 1.9 0.8 1.1 1.8 0.4 8.1 130.0 0.0 2.3 1.1 45.3 1.7 0.1 1.3 0.3 15.3 0.1 0.4 1.3 IL3 "IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF" ENSG00000164399 "Interleukin 3" P08700 5 132060655-132063204 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "HMC-1: 2.8" "Not detected" "Not detected" "Secreted to blood" NA NA 17800 "unprognostic (9.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CSF2 "GM-CSF, GMCSF" ENSG00000164400 "Colony stimulating factor 2" P04141 5 132073789-132076170 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lung: 2.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 11.4;Basal respiratory cells: 11.3;dendritic cells: 17.7;Ductal cells: 18.3;Pancreatic endocrine cells: 24.9;T-cells: 28.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "NK-cell: 6.2" "Lineage enriched" "Detected in single" 12 "NK-cells: 6.2" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 91.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA057404, HPA062006" Enhanced Vesicles "Secreted to blood" NA NA 23900 Vesicles "HPA057404: AB_2683428, HPA062006: AB_2684654" "unprognostic (7.29e-2)" "unprognostic (2.49e-3)" "unprognostic (8.77e-2)" "unprognostic (2.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (1.47e-2)" "unprognostic (2.64e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-8)" "unprognostic (4.81e-2)" "unprognostic (1.22e-1)" "unprognostic (9.07e-2)" "unprognostic (2.06e-2)" 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.1 9.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 91.3 0.1 5.1 0.0 7.4 0.0 1.5 0.0 5.3 0.2 0.0 6.8 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 20.8 13.8 2.5 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.3 3.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.2 11.4 0.0 0.3 1.5 0.1 11.3 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 17.7 0.1 0.0 18.3 0.0 0.3 0.2 4.8 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.7 1.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.6 0.0 28.6 0.0 0.0 1.1 SEPTIN8 "KIAA0202, SEP2, SEPT8" ENSG00000164402 "Septin 8" Q92599 5 132750819-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 402.9" "Cell type enhanced" "Detected in some" "Adipocytes: 7.0;Cardiomyocytes: 14.1;Cytotrophoblasts: 31.0;Extravillous trophoblasts: 12.1;Fibroblasts: 9.5;Hofbauer cells: 12.1;Smooth muscle cells: 8.8;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Enhanced Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: AB_2797226" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 26.1 19.7 211.5 18.2 271.8 8.4 22.4 283.4 237.2 25.9 129.0 25.1 26.5 19.0 18.7 34.2 21.6 25.4 33.3 200.0 235.1 28.4 13.1 26.4 15.0 302.4 277.4 183.5 25.4 23.5 24.1 22.5 44.7 303.9 20.7 27.1 75.3 33.7 20.8 11.0 49.8 26.0 21.5 291.1 15.0 27.0 6.9 259.3 18.2 32.6 12.5 18.7 36.5 31.4 402.9 55.8 26.4 37.3 76.7 50.8 49.5 122.0 58.9 56.2 54.7 66.5 46.6 39.2 0.3 51.1 57.3 32.4 42.3 70.5 96.4 59.9 71.3 50.8 54.4 35.5 40.5 37.2 19.4 76.0 35.9 30.6 25.3 35.8 53.5 77.4 47.7 84.6 10.6 29.7 53.0 63.3 18.2 19.8 33.7 17.0 57.4 43.5 4.7 32.0 141.1 50.0 31.0 50.0 11.5 32.9 107.4 100.6 25.4 80.9 60.6 39.2 15.1 42.5 14.3 14.3 2.0 38.7 28.6 46.5 0.5 1.0 0.0 2.0 0.6 2.0 0.4 1.6 2.5 1.2 0.1 0.4 1.0 0.0 0.2 0.3 0.0 1.9 1.0 211.5 271.8 283.4 237.2 200.0 235.1 302.4 277.4 183.5 303.9 291.1 259.3 402.9 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 31.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 12.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 10.1 0.6 0.0 0.0 0.0 SHROOM1 "APXL2, KIAA1960" ENSG00000164403 "Shroom family member 1" Q2M3G4 5 132822141-132830659 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 53.7;liver: 117.8;prostate: 74.5;urinary bladder: 62.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 135.0;Hepatocytes: 79.2;Proximal enterocytes: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037690, HPA037691" Uncertain Approved Vesicles NA NA Vesicles "HPA037690: AB_2675613, HPA037691: AB_2675614" "unprognostic (2.50e-1)" "unprognostic (1.06e-1)" "unprognostic (4.52e-2)" "unprognostic (2.66e-1)" "unprognostic (1.45e-2)" "unprognostic (3.47e-1)" "unprognostic (9.26e-2)" "unprognostic (1.33e-2)" "unprognostic (3.74e-1)" "unprognostic (3.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.22e-2)" "unprognostic (2.91e-2)" "unprognostic (2.88e-2)" "unprognostic (2.26e-3)" 7.2 2.4 28.8 2.6 28.2 0.2 8.3 25.9 23.7 10.8 11.1 13.8 6.2 11.4 2.1 5.1 8.5 6.8 6.2 16.7 22.0 8.3 117.8 10.6 0.6 39.1 28.8 13.8 5.7 16.3 5.0 6.9 11.9 34.8 74.5 11.2 3.5 7.0 15.3 1.7 1.4 16.7 3.9 28.7 2.3 11.0 1.7 27.8 0.6 7.0 1.3 0.5 62.9 9.4 53.7 8.6 5.1 0.9 0.8 1.4 4.0 9.0 9.1 7.7 7.0 7.8 11.2 5.7 1.5 12.5 4.9 3.8 0.8 3.1 5.7 4.3 9.5 11.0 0.3 8.7 10.5 4.1 0.7 3.1 1.7 3.0 4.9 3.0 4.8 4.8 0.1 7.3 8.1 6.1 4.8 0.2 4.0 1.4 6.7 8.1 0.5 0.0 0.8 1.2 24.4 5.7 1.5 8.8 0.7 4.9 4.5 5.2 2.9 4.5 8.1 11.7 1.1 11.5 9.2 6.8 0.1 7.9 0.0 2.5 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 28.8 28.2 25.9 23.7 16.7 22.0 39.1 28.8 13.8 34.8 28.7 27.8 53.7 18.3 25.6 22.3 18.9 1.8 1.3 15.4 2.3 3.4 3.7 9.3 5.5 2.2 30.0 11.3 9.2 10.4 6.8 1.0 135.0 1.9 6.0 0.9 7.1 17.3 18.1 22.8 2.7 3.0 10.7 4.8 6.1 33.6 15.1 8.2 9.0 25.0 79.2 6.6 16.8 1.0 28.6 0.0 8.7 5.5 1.1 4.7 4.6 0.0 23.4 8.1 19.9 3.1 6.6 37.5 7.1 53.6 4.9 3.6 31.6 65.5 3.5 9.1 13.3 26.3 2.8 5.1 7.6 5.1 1.8 2.0 2.9 2.5 1.4 35.5 17.3 GDF9 ENSG00000164404 "Growth differentiation factor 9" O60383 5 132861181-132866884 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 9.0" "Cell type enhanced" "Detected in some" "Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2" "Cancer enriched" "Detected in some" 5 "breast cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069146 Supported Approved "Golgi apparatus,Cytosol" "Secreted in female reproductive system" NA NA "Golgi apparatus" Cytosol "HPA069146: AB_2686094" "unprognostic (4.64e-1)" "unprognostic (1.22e-1)" "unprognostic (1.25e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.61e-2)" "unprognostic (4.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.70e-3)" "unprognostic (1.04e-1)" "unprognostic (1.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (4.75e-3)" "unprognostic (3.10e-2)" 0.3 0.6 1.5 0.2 1.5 0.3 0.8 1.4 2.0 0.4 0.9 0.3 0.4 0.3 4.1 0.3 0.8 0.2 0.3 1.4 1.4 1.0 0.7 0.3 0.5 1.4 1.5 1.3 0.5 1.0 0.7 1.7 0.2 1.4 0.6 0.3 1.3 0.8 0.5 0.7 1.1 0.4 0.2 1.4 0.4 1.0 9.0 1.3 0.7 1.0 0.7 0.4 0.6 0.3 1.5 0.2 0.1 0.5 1.1 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.3 0.8 0.2 0.6 0.1 0.9 0.2 0.4 0.4 0.1 0.4 0.7 0.5 0.5 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.3 0.1 0.0 3.9 0.0 1.2 0.2 0.2 0.7 0.8 0.2 0.1 0.0 0.6 0.0 0.2 0.3 0.2 1.0 0.9 0.2 0.1 0.5 0.7 0.5 0.1 0.1 0.9 0.4 0.2 0.1 1.3 1.7 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.5 1.4 2.0 1.4 1.4 1.4 1.5 1.3 1.4 1.4 1.3 1.5 0.9 0.0 0.0 1.6 0.1 0.1 0.4 0.1 0.0 0.4 1.9 2.2 0.6 0.0 0.1 0.0 4.2 0.4 0.3 0.7 3.9 0.1 19.9 1.4 0.9 0.5 0.0 0.0 0.5 0.2 0.3 0.4 0.0 1.9 0.0 0.5 0.4 0.2 0.1 0.0 0.8 0.9 0.0 0.3 0.0 5.2 0.6 0.5 0.0 0.0 0.0 1.0 0.0 2.0 0.9 0.1 0.1 0.4 0.1 0.6 0.3 0.4 0.6 1.0 0.0 1.6 0.8 15.2 2.5 1.1 0.1 0.7 0.2 0.2 0.5 0.2 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866630-132868847 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3312.4;Hepatocytes: 5039.2;Proximal tubular cells: 3336.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria NA NA 18000 Mitochondria "HPA046693: AB_10968453, HPA053323: AB_2682112" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 202.8 381.8 290.6 92.6 292.4 133.7 190.8 318.9 395.0 143.7 301.2 273.6 222.8 149.2 213.1 335.1 139.8 79.0 1052.1 291.6 321.0 460.4 1045.1 150.2 69.7 302.5 297.9 285.0 121.0 271.7 321.3 224.5 89.7 304.9 275.2 234.4 189.0 255.9 123.3 1034.5 177.0 246.5 99.4 302.0 153.0 375.4 129.9 301.2 131.5 168.7 881.3 93.0 221.8 194.9 308.0 300.9 391.1 246.7 599.9 364.2 292.2 209.3 216.3 310.6 341.7 424.9 556.4 353.8 126.5 433.4 291.5 424.5 302.7 229.5 536.6 300.7 222.9 466.0 169.4 606.3 459.9 312.7 188.8 276.2 314.0 366.5 247.4 341.6 229.6 274.1 258.3 219.2 398.6 369.7 547.5 450.5 442.1 175.3 568.1 367.0 288.4 271.7 541.7 460.9 573.4 410.7 335.8 269.1 302.7 493.9 170.4 451.9 422.5 168.3 316.0 392.1 257.2 438.7 423.1 616.3 236.6 417.9 350.0 320.6 474.1 528.3 355.5 245.6 431.0 251.8 317.2 280.3 280.2 472.0 260.6 273.5 263.6 258.8 322.9 410.0 516.7 326.1 658.2 290.6 292.4 318.9 395.0 291.6 321.0 302.5 297.9 285.0 304.9 302.0 301.2 308.0 252.0 250.0 349.3 17.6 258.1 348.3 334.0 1046.6 235.6 97.8 575.5 657.7 3312.4 993.7 556.9 787.2 120.9 720.4 200.6 1678.3 1813.7 685.6 470.0 424.1 308.5 288.4 549.3 319.4 13.9 947.7 484.1 330.2 438.3 467.5 294.5 277.0 333.8 5039.2 771.4 72.3 17.0 1047.6 807.7 421.1 448.6 1116.6 282.4 301.6 715.1 11.2 394.7 459.2 260.6 13.6 23.5 705.7 1460.8 288.9 416.2 537.1 2476.1 3336.0 512.5 271.5 184.1 217.8 388.7 308.1 174.7 570.1 514.0 562.7 205.0 235.9 1205.6 500.2 LEAP2 LEAP-2 ENSG00000164406 "Liver enriched antimicrobial peptide 2" Q969E1 5 132873444-132875046 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "liver: 536.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 1650.6" "Cancer enriched" "Detected in many" 17 "liver cancer: 40.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;Hep G2: 4.7;U-266/84: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 790000 "unprognostic (2.14e-2)" "unprognostic (8.78e-2)" "unprognostic (4.75e-1)" "unprognostic (2.16e-1)" "unprognostic (2.82e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-3)" "unprognostic (6.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.62e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "unprognostic (1.02e-1)" "unprognostic (2.39e-1)" "unprognostic (3.97e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.68e-4)" 0.9 0.9 0.8 0.3 1.0 0.5 1.1 2.2 1.2 1.3 0.5 1.7 12.4 0.8 0.2 1.3 1.2 4.5 1.2 0.9 0.9 12.0 536.4 1.1 0.5 0.9 0.9 0.9 1.2 1.9 0.7 1.1 0.2 1.2 2.4 1.6 1.0 1.3 0.2 1.5 1.4 23.6 0.1 0.7 2.2 2.0 1.1 0.9 0.3 1.9 0.5 0.5 7.9 1.6 1.9 0.1 0.7 0.4 1.5 0.6 0.4 0.4 0.1 0.1 0.4 0.6 3.4 0.5 0.2 0.1 0.1 0.4 0.7 1.4 0.6 0.0 1.2 1.0 0.3 1.2 4.7 0.1 0.5 0.2 0.1 0.5 0.0 0.1 0.3 0.1 1.1 0.5 0.4 0.0 0.3 0.8 0.6 1.1 1.1 0.5 0.0 0.2 1.1 0.0 0.2 0.5 0.3 0.3 0.7 0.5 0.4 0.8 0.4 0.0 0.2 0.3 0.6 0.1 1.1 3.8 1.1 0.0 0.7 0.2 1.3 0.7 0.3 0.6 0.4 0.8 1.0 0.6 0.7 0.6 0.8 1.0 0.8 1.7 1.0 0.3 0.8 1.1 0.3 0.8 1.0 2.2 1.2 0.9 0.9 0.9 0.9 0.9 1.2 0.7 0.9 1.9 2.5 0.0 2.6 1.3 7.9 10.1 10.8 4.1 2.8 17.1 4.9 2.8 1.9 64.3 2.6 0.0 33.3 3.3 7.6 39.2 9.8 2.9 6.2 4.8 3.8 5.2 4.8 9.3 1.1 9.8 7.9 5.8 1.5 10.3 7.0 6.7 14.3 1650.6 1.4 13.5 1.4 12.1 0.0 17.3 14.1 0.5 1.5 4.2 5.4 1.0 2.2 5.2 13.4 2.0 1.8 2.9 30.9 1.9 3.1 14.0 279.9 51.8 1.7 25.2 0.0 13.5 4.8 7.0 2.9 1.4 7.7 7.3 6.2 4.1 8.0 10.2 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282980-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "fallopian tube: 7.1;pituitary gland: 5.6;placenta: 2.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 10.4;Endometrial ciliated cells: 12.8;Ionocytes: 22.4;Respiratory ciliated cells: 18.4;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.5;HDLM-2: 7.6;MCF7: 4.1;OE19: 4.8;RT4: 3.6;SuSa: 2.4" "Not detected" "Not detected" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.2 0.0 0.1 0.3 0.0 1.1 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 7.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.4 0.2 0.1 0.0 0.0 0.1 5.6 2.7 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.6 1.5 0.0 0.1 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.1 1.2 4.8 0.0 0.1 0.0 0.0 0.0 3.6 0.1 0.0 0.8 0.0 0.0 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.6 0.1 0.1 0.4 0.2 0.1 0.4 0.0 0.1 0.6 0.2 0.0 0.0 0.7 0.1 0.0 0.0 1.3 0.0 2.5 0.6 0.3 0.2 0.0 0.5 0.0 0.0 10.4 0.5 0.1 0.0 0.2 1.1 12.8 0.8 0.3 0.0 0.0 0.7 0.2 4.4 0.6 0.0 3.0 0.0 0.1 0.4 0.0 0.5 0.0 1.1 0.0 22.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 18.4 0.6 0.0 1.7 0.3 0.3 0.3 0.0 0.0 7.3 0.5 0.2 0.3 0.2 SLC35A1 "CMPST, hCST" ENSG00000164414 "Solute carrier family 35 member A1" P78382 6 87470623-87512336 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 103.0;Inhibitory neurons: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.04e-2)" "unprognostic (1.93e-1)" "unprognostic (6.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.82e-1)" "unprognostic (4.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.58e-2)" "unprognostic (3.01e-3)" "unprognostic (7.26e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.70e-6)" "unprognostic (2.85e-1)" "unprognostic (8.51e-2)" "unprognostic (5.48e-2)" "unprognostic (1.04e-1)" 16.5 24.2 25.2 15.7 26.8 11.3 31.3 29.6 31.9 28.0 29.1 40.0 18.9 25.1 22.3 14.0 20.4 19.7 16.2 26.9 26.7 21.4 33.2 37.9 18.0 25.5 25.8 25.9 23.3 16.0 23.9 19.0 19.9 26.3 37.1 48.0 14.5 31.9 16.6 13.9 25.1 21.7 22.2 24.9 19.2 29.4 13.4 26.0 16.4 17.0 15.8 16.5 21.7 16.8 27.0 4.8 11.5 20.4 24.1 54.4 49.3 16.4 13.9 12.2 11.4 15.6 9.9 86.0 17.6 16.8 17.3 31.7 18.5 24.8 11.3 14.6 25.3 18.4 20.0 14.7 17.8 35.7 26.3 13.3 25.3 26.6 13.5 26.1 26.8 27.5 25.5 26.1 28.4 17.0 44.6 7.3 39.6 11.0 60.4 18.6 22.4 19.9 19.0 35.6 20.4 13.3 14.6 25.7 47.4 23.2 23.3 42.2 53.0 26.0 16.4 11.1 18.2 11.3 21.1 32.7 6.5 13.7 46.2 23.7 52.1 54.1 22.8 17.5 42.8 27.1 17.8 18.7 21.5 46.9 16.7 23.7 22.3 13.2 17.5 44.2 17.3 26.8 36.9 25.2 26.8 29.6 31.9 26.9 26.7 25.5 25.8 25.9 26.3 24.9 26.0 27.0 14.7 44.8 33.6 19.2 11.7 14.8 18.1 37.1 18.8 6.2 23.6 16.6 6.2 20.0 25.5 16.5 12.5 25.0 16.1 27.1 7.9 10.1 10.6 6.3 9.9 15.8 15.0 8.2 103.0 8.9 19.7 19.2 13.3 6.8 21.6 14.2 42.8 20.7 15.6 11.8 87.2 73.5 48.8 28.2 11.1 7.1 16.4 15.8 21.4 24.4 27.4 17.3 16.5 42.3 26.9 11.5 19.0 19.2 9.4 17.5 14.5 11.3 25.4 7.0 19.7 8.9 16.9 9.6 14.2 9.0 14.8 27.5 14.9 12.5 32.7 8.9 GRIK2 "GluK2, GLUR6, MRT6" ENSG00000164418 "Glutamate ionotropic receptor kainate type subunit 2" Q13002 6 101181257-102070083 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "brain: 96.4" "Group enriched" "Detected in some" 26 "Excitatory neurons: 724.6;Inhibitory neurons: 2376.0;Oligodendrocyte precursor cells: 1234.0" "Cancer enriched" "Detected in some" 5 "glioma: 3.9" "Region enhanced" "Detected in many" "cerebellum: 96.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 16.4;BJ hTERT+: 26.6;fHDF/TERT166: 20.8;HAP1: 10.2;SiHa: 11.1;WM-115: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014395, HPA014623, CAB022463" Approved "Intracellular and membrane" NA NA "CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305" "unprognostic (1.43e-3)" "unprognostic (1.26e-2)" "unprognostic (3.99e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-1)" "unprognostic (3.48e-2)" "unprognostic (2.57e-1)" "unprognostic (4.32e-2)" "unprognostic (8.46e-2)" "unprognostic (9.19e-2)" "unprognostic (4.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.34e-5)" "unprognostic (1.94e-3)" "unprognostic (7.78e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-4)" 0.2 1.9 13.6 0.4 20.5 0.3 0.3 96.4 18.8 1.5 0.0 0.5 0.6 0.4 1.1 0.4 0.3 0.5 4.6 18.4 24.4 0.8 0.1 0.2 0.1 3.9 14.3 24.7 0.4 2.6 0.0 1.6 2.4 24.0 0.9 0.4 4.2 0.8 1.2 0.9 1.7 0.6 0.3 0.7 0.4 0.3 0.8 16.5 0.0 3.4 0.1 0.0 0.5 0.4 13.4 0.1 0.1 3.1 0.2 3.6 0.1 0.0 16.4 26.6 0.8 0.5 0.0 0.3 0.1 0.0 20.8 0.0 5.1 10.2 0.0 0.3 0.0 0.0 1.7 8.5 0.0 0.9 0.0 0.2 0.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.4 6.2 0.0 0.0 0.2 2.7 0.0 0.2 0.1 0.4 0.1 0.7 0.0 3.3 7.0 11.1 0.0 0.5 0.5 0.0 0.8 0.0 2.1 0.5 0.1 1.3 0.1 0.0 0.1 1.5 0.0 24.6 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 13.6 20.5 96.4 18.8 18.4 24.4 3.9 14.3 24.7 24.0 0.7 16.5 13.4 0.2 0.0 0.5 54.9 0.0 0.6 1.0 0.1 0.6 11.4 0.1 0.0 5.9 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.8 3.4 1.9 0.4 1.8 0.0 724.6 0.6 0.0 1.8 0.0 0.5 0.0 13.0 0.0 0.0 0.1 0.0 2376.0 0.0 0.0 0.0 0.0 7.7 0.3 0.1 1.8 38.4 0.0 0.5 0.0 1234.0 40.5 0.1 1.1 0.4 0.0 0.8 0.1 0.0 2.2 1.1 0.0 0.7 4.6 0.0 0.5 0.1 0.6 0.0 0.0 4.3 0.1 0.9 CGAS "C6orf150, MB21D1" ENSG00000164430 "Cyclic GMP-AMP synthase" Q8N884 6 73413515-73452297 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell type enhanced" "Detected in some" "Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031700, HPA031702" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA031700: AB_10601693, HPA031702: AB_2673999" "unprognostic (2.49e-1)" "unprognostic (2.36e-1)" "unprognostic (4.61e-2)" "unprognostic (4.95e-2)" "unprognostic (2.49e-2)" "unprognostic (1.81e-1)" "unprognostic (4.84e-3)" "unprognostic (1.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.25e-2)" "unprognostic (2.20e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.27e-7)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-1)" 2.4 1.1 2.9 6.4 2.2 14.1 1.8 2.4 7.9 2.2 3.4 1.9 2.7 1.9 0.6 2.3 1.8 2.6 1.5 3.1 2.9 0.9 0.8 3.5 7.5 2.9 2.3 1.3 1.2 1.2 0.6 0.6 3.1 3.0 1.9 1.8 0.2 1.8 1.8 0.6 1.1 2.6 2.0 2.7 5.3 2.3 1.0 3.8 2.3 1.6 0.9 4.8 4.4 2.1 5.3 19.9 5.8 0.1 0.2 1.2 2.7 0.1 10.1 3.7 11.3 12.6 20.7 14.2 0.2 20.9 4.3 6.3 10.1 9.8 0.2 12.0 31.9 0.0 16.9 8.2 0.1 4.0 12.3 11.5 1.6 3.2 11.8 0.1 0.0 3.5 0.1 0.0 37.1 8.7 8.0 0.0 27.1 6.2 2.4 11.2 23.4 43.8 45.2 0.0 7.3 0.3 0.1 17.3 0.4 10.2 0.2 0.0 33.9 5.0 0.0 9.1 8.5 0.2 8.1 19.8 0.2 0.1 17.5 11.4 26.3 12.7 19.0 6.0 17.5 4.7 8.4 7.9 5.9 7.5 6.7 1.8 3.4 8.5 4.2 11.6 17.6 8.0 6.0 2.9 2.2 2.4 7.9 3.1 2.9 2.9 2.3 1.3 3.0 2.7 3.8 5.3 10.2 3.2 4.8 0.0 4.7 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 0.6 0.0 0.0 0.2 12.0 0.0 0.0 2.0 0.0 8.4 8.5 6.0 0.0 0.0 0.0 3.9 0.7 2.3 0.0 12.5 5.1 1.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.3 8.0 0.7 0.0 0.0 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779716-122784074 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 369.2;choroid plexus: 148.8;retina: 176.8;tongue: 201.1" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 1407.3" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7" "Region enriched" "Detected in all" 5 "olfactory bulb: 1195.2" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130" "prognostic favorable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 1.9 0.4 165.3 0.1 191.2 0.3 38.3 209.6 369.2 1.0 148.8 0.7 0.1 0.1 0.2 0.8 0.1 0.1 0.2 176.3 161.0 0.8 0.3 0.0 0.1 164.8 153.6 173.2 0.1 0.1 0.0 8.1 0.4 160.3 0.3 0.1 176.8 8.9 3.9 8.9 36.9 0.1 0.0 150.6 0.0 0.4 0.2 151.9 1.8 0.0 201.1 0.1 0.2 0.4 163.3 0.0 0.1 105.5 0.0 0.0 0.0 3.8 0.0 0.9 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.0 0.1 0.2 0.1 0.2 0.0 0.1 28.8 0.0 0.0 0.0 1.2 0.1 63.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 165.3 191.2 209.6 369.2 176.3 161.0 164.8 153.6 173.2 160.3 150.6 151.9 163.3 0.1 0.0 0.0 14.0 0.0 12.2 0.3 0.0 0.0 11.6 44.5 38.9 1.3 0.0 0.0 0.0 12.5 4.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 2.9 0.0 228.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 5.0 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 30.2 0.0 0.0 1407.3 0.0 41.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 48.0 0.0 0.5 0.3 0.0 0.3 0.0 18.9 7.1 0.3 0.0 0.0 0.0 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309248-171312139 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "brain: 7.9" "Cell type enriched" "Detected in some" 6 "Extravillous trophoblasts: 7.7" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enhanced" "Detected in many" "cerebellum: 7.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 25.9" "Region enriched" "Detected in single" 7 "cerebellum: 2.2" "Region enriched" "Detected in some" 8 "cerebellum: 15.5" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.9 0.3 0.0 0.1 2.1 0.3 0.0 1.1 2.8 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 TXLNB "C6orf198, dJ522B19.2, DKFZp451A175, MDP77" ENSG00000164440 "Taxilin beta" Q8N3L3 6 139240061-139291998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "heart muscle: 82.7;skeletal muscle: 302.8;tongue: 190.8" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 260.7;Late spermatids: 67.2" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 5.0;HSkMC: 3.0;REH: 2.6;RPMI-8226: 3.8;U-698: 7.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030401, HPA030402, HPA030403" Enhanced NA NA "HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461" "unprognostic (1.54e-1)" "unprognostic (7.01e-3)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (5.75e-3)" "unprognostic (2.94e-1)" "unprognostic (1.09e-2)" "unprognostic (6.00e-2)" "unprognostic (2.06e-1)" "unprognostic (8.10e-3)" "unprognostic (4.79e-1)" "unprognostic (5.15e-2)" "unprognostic (2.16e-4)" "unprognostic (2.19e-2)" "unprognostic (2.21e-1)" "unprognostic (2.65e-1)" "unprognostic (8.05e-4)" 1.1 1.5 0.8 2.5 0.7 0.2 2.3 0.7 0.9 0.9 0.7 1.1 0.6 2.8 0.6 4.4 1.9 2.2 82.7 1.3 2.2 0.1 0.3 1.3 3.1 1.6 1.0 0.5 11.5 0.2 2.8 1.2 0.7 1.6 3.0 0.9 0.3 2.4 0.3 302.8 0.6 1.5 2.2 2.1 2.3 0.9 3.8 1.0 7.8 0.3 190.8 3.5 1.1 0.6 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 1.3 0.2 3.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.4 0.2 0.2 0.5 0.6 0.1 0.0 0.3 2.6 1.1 3.8 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.9 0.0 0.0 0.0 0.1 0.8 1.4 7.1 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.8 0.1 0.3 0.0 0.8 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.8 0.7 0.7 0.9 1.3 2.2 1.6 1.0 0.5 1.6 2.1 1.0 1.9 2.0 0.0 0.0 4.9 5.9 0.5 0.3 0.6 0.0 0.1 2.0 0.5 260.7 0.0 1.6 1.8 0.0 0.1 0.7 0.0 0.0 0.0 38.5 4.3 0.3 4.9 0.0 2.7 8.7 0.0 0.0 11.4 0.5 0.4 0.0 0.2 0.7 0.4 1.7 0.0 17.4 0.0 0.0 6.6 6.0 67.2 0.6 4.1 5.4 12.2 0.6 6.5 2.1 2.5 4.0 0.0 0.0 2.2 7.4 0.1 0.0 0.0 17.8 0.1 0.0 25.8 2.2 3.8 1.2 0.3 0.4 0.0 2.0 5.9 0.0 0.1 CITED2 MRG1 ENSG00000164442 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2" Q99967 6 139371807-139374648 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Stress response, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Atrial septal defect, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 685.3;Plasma cells: 619.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 27.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 618.3;fHDF/TERT166: 1070.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016157, CAB069879" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB016157: AB_668099, CAB069879: AB_10003446" "unprognostic (7.42e-2)" "unprognostic (2.06e-2)" "unprognostic (1.56e-2)" "unprognostic (8.34e-2)" "unprognostic (4.03e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (1.11e-2)" "unprognostic (3.61e-3)" "unprognostic (1.00e-2)" "prognostic favorable (3.40e-4)" "prognostic unfavorable (3.33e-4)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (2.03e-1)" 179.3 108.3 5.1 50.3 1.4 316.3 118.5 28.6 34.0 46.0 6.5 82.7 37.1 189.5 39.1 76.2 209.5 32.9 60.9 3.9 6.9 71.4 205.1 135.1 38.2 6.2 7.9 0.6 272.5 75.3 180.4 17.8 105.0 8.0 44.6 42.9 36.8 121.5 43.2 108.5 120.7 65.8 82.5 0.4 137.7 70.1 22.2 15.8 25.3 229.9 25.1 30.7 38.2 64.5 18.8 23.7 13.7 46.7 138.2 191.8 203.7 175.6 618.3 456.0 274.7 255.7 122.5 35.2 17.0 88.5 1070.3 58.5 28.0 14.2 14.5 192.4 467.0 45.8 346.9 76.0 10.1 157.1 103.1 36.5 164.6 64.4 121.3 91.4 177.9 51.2 10.1 132.9 80.1 359.2 51.0 17.5 128.3 43.8 15.0 21.2 24.7 34.2 152.3 131.7 52.5 51.8 0.8 45.2 167.6 21.2 106.8 72.3 348.3 283.6 219.9 69.5 66.4 35.0 23.4 22.6 26.3 68.0 86.9 15.8 3.1 8.2 27.7 3.4 4.6 5.0 1.2 5.4 4.9 3.6 3.1 4.7 2.4 4.0 3.0 6.6 1.6 3.6 3.3 5.1 1.4 28.6 34.0 3.9 6.9 6.2 7.9 0.6 8.0 0.4 15.8 18.8 157.1 115.4 272.8 3.6 138.8 35.8 111.5 12.7 347.8 30.6 164.4 180.0 114.1 80.1 36.5 103.0 12.5 173.1 156.5 159.6 185.9 20.5 1.5 122.6 131.7 68.9 99.7 274.3 6.9 14.9 685.3 200.3 121.8 262.3 46.9 133.9 61.1 65.5 372.6 30.3 22.2 111.6 20.3 124.4 67.7 7.7 99.4 188.9 83.6 9.4 44.2 51.9 55.6 1.0 1.3 23.1 97.7 60.9 619.4 46.6 88.8 121.0 27.4 52.5 98.6 107.9 179.1 1.8 20.8 200.8 33.8 269.3 291.8 272.9 112.6 38.4 CALHM4 "C6orf78, FAM26D, FLJ32239" ENSG00000164451 "Calcium homeostasis modulator family member 4" Q5JW98 6 116529013-116558868 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "placenta: 23.3" "Group enriched" "Detected in some" 24 "Cytotrophoblasts: 28.2;Syncytiotrophoblasts: 54.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA048014 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA048014: " "unprognostic (7.95e-2)" "unprognostic (3.44e-4)" "unprognostic (1.99e-1)" "unprognostic (1.44e-2)" 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 23.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.2 0.0 0.0 TBXT T ENSG00000164458 "T-box transcription factor T" O15178 6 166157656-166168700 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "parathyroid gland: 2.6;pituitary gland: 1.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "testis cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HeLa: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA003322 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003322: AB_1080176" "unprognostic (5.68e-2)" "unprognostic (4.59e-2)" "unprognostic (6.21e-3)" "unprognostic (8.64e-3)" "unprognostic (9.34e-3)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CREBRF "C5orf41, LRF" ENSG00000164463 "CREB3 regulatory factor" Q8IUR6 5 173056352-173139284 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 21.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015329 Supported Nucleoplasm NA NA Nucleoplasm "HPA015329: AB_2669192" "unprognostic (8.00e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (3.14e-2)" "unprognostic (5.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.35e-1)" "unprognostic (6.03e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.17e-2)" "unprognostic (4.69e-2)" "prognostic favorable (3.20e-7)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.52e-1)" "prognostic favorable (9.30e-4)" 11.4 10.9 10.5 10.5 12.7 68.7 11.2 15.3 12.1 12.3 12.7 8.7 8.4 11.7 11.4 8.8 8.7 9.9 11.3 8.9 12.0 14.7 10.9 11.9 13.3 12.6 12.0 7.8 19.1 8.0 16.0 5.8 12.8 13.2 10.1 8.6 11.3 8.8 11.7 8.5 11.5 9.6 10.5 12.4 15.3 8.4 13.5 11.7 12.5 23.5 12.0 10.5 10.4 9.4 15.4 1.2 2.8 2.6 4.1 11.7 15.6 6.1 3.7 18.0 3.4 6.5 3.8 6.3 2.3 8.7 3.8 6.3 1.5 1.2 2.9 4.8 8.4 2.5 1.8 1.9 1.2 9.0 1.4 10.0 9.5 7.3 3.7 9.2 8.3 4.2 2.9 1.6 11.7 4.0 2.3 2.2 2.0 0.8 1.9 1.4 2.1 1.8 3.6 4.8 2.5 2.0 3.0 3.7 1.6 13.6 5.5 1.7 2.6 6.9 5.2 1.7 3.5 1.0 13.0 11.7 4.0 3.8 2.5 1.8 5.6 2.7 6.1 3.6 2.4 3.3 2.9 3.6 3.1 1.4 5.6 4.4 3.6 21.8 1.5 3.3 3.1 3.6 1.8 10.5 12.7 15.3 12.1 8.9 12.0 12.6 12.0 7.8 13.2 12.4 11.7 15.4 103.6 51.3 48.4 33.6 95.9 79.2 26.0 19.7 105.3 50.1 68.3 48.1 61.4 44.3 25.9 38.6 68.8 11.6 104.1 50.8 15.6 17.4 5.3 68.9 51.1 66.3 76.7 70.7 57.3 15.7 11.1 67.5 21.4 154.0 48.1 75.2 64.6 39.5 20.4 112.7 64.2 30.3 32.6 96.2 57.7 8.4 51.9 76.7 65.8 70.3 81.7 33.1 55.6 40.2 65.3 17.4 31.8 54.9 78.9 67.6 42.4 23.2 34.8 65.0 59.2 89.8 65.6 74.8 48.0 42.7 92.9 37.4 83.5 26.2 20.5 40.9 DCBLD1 "dJ94G16.1, MGC46341" ENSG00000164465 "Discoidin, CUB and LCCL domain containing 1" Q8N8Z6 6 117453817-117569858 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA059667 Approved Approved Cytosol NA NA 22000000 Cytosol "HPA059667: AB_2684099" "unprognostic (1.00e-1)" "prognostic unfavorable (6.44e-5)" "unprognostic (1.08e-1)" "unprognostic (3.23e-3)" "unprognostic (2.47e-1)" "unprognostic (2.29e-3)" "unprognostic (1.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.74e-2)" "unprognostic (8.99e-2)" "unprognostic (5.69e-3)" "unprognostic (6.33e-2)" "prognostic unfavorable (8.57e-8)" "unprognostic (6.99e-2)" "unprognostic (4.72e-2)" "unprognostic (7.44e-2)" "unprognostic (1.36e-1)" 7.8 3.5 4.0 6.0 5.1 0.6 5.7 4.1 5.1 8.7 3.2 6.6 6.6 5.1 3.3 5.4 2.5 9.2 4.7 5.5 3.6 3.8 9.7 10.0 3.5 3.8 4.1 3.9 1.9 6.4 6.9 8.4 8.8 4.1 2.7 6.1 1.0 4.9 2.9 5.6 2.8 8.1 3.8 4.1 3.9 7.7 5.7 3.3 1.2 5.9 5.2 2.5 6.4 5.8 4.8 8.0 17.9 6.3 7.0 10.8 13.5 17.9 45.1 58.1 36.9 27.8 37.9 16.7 0.0 21.8 19.1 45.9 17.9 12.1 19.9 38.7 3.5 9.4 6.8 18.5 62.3 46.7 10.0 5.7 15.4 45.5 33.6 31.4 42.5 52.3 6.7 14.8 6.7 48.9 6.4 0.1 6.7 4.7 21.4 7.4 0.0 1.3 4.7 8.2 9.4 19.0 0.3 33.0 3.6 5.3 9.0 4.7 13.1 38.9 0.0 44.1 12.6 19.8 18.9 5.4 5.3 18.7 9.6 16.5 0.0 0.2 0.0 0.6 0.2 0.1 0.0 0.8 1.2 0.2 0.0 1.0 1.3 0.0 0.4 0.1 0.4 0.9 0.5 4.0 5.1 4.1 5.1 5.5 3.6 3.8 4.1 3.9 4.1 4.1 3.3 4.8 16.0 16.0 18.8 5.2 3.0 5.2 3.7 12.3 0.6 8.4 4.8 3.6 5.3 12.8 14.4 5.5 6.2 31.5 4.9 9.5 1.9 7.0 33.0 5.3 15.1 11.0 4.2 3.2 20.8 4.8 6.1 6.6 13.7 7.9 1.3 13.9 17.2 9.6 5.8 5.0 3.3 8.5 6.1 7.0 15.0 10.9 0.9 5.8 8.8 13.1 2.5 1.1 6.2 12.1 11.6 10.4 7.7 0.4 1.6 3.0 11.1 2.7 5.7 3.5 13.1 5.1 27.6 2.2 10.6 6.8 6.0 18.2 5.1 2.1 11.1 5.4 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 100.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 99.8" "Group enriched" "Detected in all" 5 "granulocytes: 99.8;T-cells: 36.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Approved Enhanced Mitochondria NA NA 23000 Mitochondria "HPA019543: AB_1856789, HPA063745: AB_2685111" "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 7.7 15.5 13.2 18.4 15.5 22.1 8.2 15.6 18.0 8.0 13.9 28.3 19.4 8.6 8.1 14.8 8.8 9.9 12.4 13.5 15.9 42.0 100.5 5.9 27.2 12.8 13.9 12.9 18.9 13.3 15.9 13.0 15.4 14.0 9.7 17.8 20.9 9.7 10.5 11.0 8.9 20.3 11.4 12.2 10.6 14.7 6.7 14.5 24.2 10.6 15.8 27.3 13.9 11.3 15.4 39.9 123.1 61.7 67.0 21.0 44.4 99.2 99.1 41.5 81.3 78.3 156.5 77.6 82.3 74.9 51.9 100.4 49.7 119.0 171.9 87.8 202.1 102.4 60.6 103.4 69.0 30.3 119.6 73.3 36.5 33.1 90.3 39.2 48.3 63.3 74.9 89.1 63.4 60.2 138.3 140.3 9.7 48.7 66.5 41.1 116.3 63.1 87.8 31.3 154.2 104.6 66.7 95.6 88.9 47.8 50.5 43.1 38.3 62.3 63.9 100.3 47.5 130.2 80.2 101.8 184.6 105.1 104.9 68.1 99.8 5.1 26.3 26.2 6.7 21.4 10.7 36.4 29.2 7.3 9.3 28.4 29.3 1.6 12.7 4.3 3.5 32.3 14.2 13.2 15.5 15.6 18.0 13.5 15.9 12.8 13.9 12.9 14.0 12.2 14.5 15.4 6.0 3.2 13.5 55.2 29.1 19.5 33.5 30.6 48.9 59.3 13.7 9.9 18.1 17.2 18.8 18.4 47.9 41.4 19.0 68.9 25.4 27.7 1.2 10.9 23.3 14.2 31.2 45.4 77.3 18.7 74.2 24.8 26.0 11.3 9.5 38.1 12.8 98.7 17.2 77.4 62.9 23.9 26.4 8.1 11.4 4.0 47.2 9.5 10.6 30.9 9.0 19.8 37.0 55.3 60.1 31.8 20.1 35.0 63.4 31.6 89.8 51.1 15.5 49.9 26.3 21.7 23.1 2.8 7.4 43.6 21.6 30.9 61.9 67.2 21.7 27.0 SAMD3 "bA73O6.2, FLJ34032" ENSG00000164483 "Sterile alpha motif domain containing 3" Q8N6K7 6 130144315-130365425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.5" "Cell type enhanced" "Detected in many" "dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 47 "NK-cells: 128.4;T-cells: 113.8" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 2.1" "HPA028992, HPA028993" Uncertain NA NA "HPA028992: AB_10598914, HPA028993: AB_10601891" "unprognostic (2.91e-3)" "unprognostic (5.35e-3)" "unprognostic (4.15e-2)" "unprognostic (2.70e-2)" "unprognostic (1.50e-2)" "unprognostic (2.48e-4)" "unprognostic (1.20e-2)" "unprognostic (2.42e-3)" "unprognostic (2.39e-2)" "unprognostic (2.46e-2)" "unprognostic (5.61e-2)" "unprognostic (1.98e-1)" "unprognostic (5.07e-6)" "unprognostic (7.09e-2)" "unprognostic (1.14e-1)" "unprognostic (6.62e-2)" "unprognostic (3.45e-2)" 1.0 2.3 1.5 4.0 1.7 4.3 0.9 0.6 1.6 1.9 0.8 1.2 0.7 4.4 1.9 0.8 1.6 2.3 0.6 3.0 1.0 1.1 1.8 3.3 10.5 1.1 1.0 0.9 1.8 1.2 0.1 4.8 0.7 0.6 0.7 2.3 1.4 0.7 0.4 0.8 0.5 1.4 1.8 0.3 9.3 1.6 3.2 1.6 6.3 0.8 0.7 4.2 1.3 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.3 0.5 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.8 3.4 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.0 2.2 0.1 1.9 0.2 0.4 0.1 0.0 0.2 0.0 0.1 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.5 113.8 0.4 90.0 2.5 39.8 102.1 0.6 0.3 28.8 68.9 2.3 128.4 0.6 0.6 41.7 41.4 1.5 1.7 0.6 1.6 3.0 1.0 1.1 1.0 0.9 0.6 0.3 1.6 0.9 1.1 0.0 2.3 1.3 2.3 0.4 0.0 0.0 0.6 3.0 0.6 0.5 0.8 0.0 0.0 0.0 0.0 0.0 157.0 1.6 0.0 0.2 25.4 1.0 2.1 0.8 3.6 6.6 12.1 0.0 0.0 0.7 0.0 0.5 1.3 14.8 2.9 0.4 0.0 0.0 5.7 0.3 0.0 3.4 1.4 6.7 0.6 1.8 5.4 12.2 2.3 0.0 271.9 1.5 0.6 0.0 1.5 1.9 43.7 0.0 0.1 0.6 0.7 0.4 0.0 0.3 1.4 2.3 1.6 0.2 0.4 0.0 84.3 2.0 0.5 0.1 TMEM200A "KIAA1913, TTMC" ENSG00000164484 "Transmembrane protein 200A" Q86VY9 6 130366017-130443067 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 39.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 26.5;Distal enterocytes: 23.3;Endometrial stromal cells: 18.6;Enteroendocrine cells: 24.6;Granulosa cells: 49.9" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "NK-cell: 4.0" "Lineage enriched" "Detected in single" 5 "NK-cells: 4.0" "Cell line enhanced" "Detected in many" "HBF TERT88: 40.8;hTEC/SVTERT24-B: 67.1;hTERT-RPE1: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014396 Uncertain NA NA "HPA014396: AB_2204904" "unprognostic (1.07e-1)" "unprognostic (4.89e-2)" "unprognostic (2.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.62e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (2.91e-1)" "unprognostic (7.25e-2)" "unprognostic (9.29e-2)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.27e-3)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (1.91e-3)" 4.6 17.3 1.8 3.9 2.2 0.1 5.9 0.2 2.4 11.2 0.4 11.2 7.3 39.7 5.4 1.3 13.0 6.5 0.6 4.8 2.1 13.7 0.4 6.8 3.8 1.3 2.1 1.9 15.7 1.6 0.8 5.3 3.3 1.1 2.7 22.5 11.3 1.6 1.4 0.6 1.8 8.3 18.9 0.7 1.1 6.4 2.7 3.5 4.7 5.6 0.4 3.5 5.6 3.6 1.6 0.1 0.1 0.2 0.0 11.7 14.6 0.1 10.6 13.0 11.1 19.6 16.6 0.0 0.0 0.0 22.3 2.5 2.5 1.0 0.0 40.8 15.5 0.0 0.0 0.0 0.8 5.3 0.3 0.0 16.7 0.0 67.1 13.3 33.5 0.4 0.3 0.0 1.5 5.2 0.0 0.0 0.1 8.4 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 13.4 12.5 4.0 1.1 1.9 8.2 0.0 0.0 7.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.8 0.4 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.1 1.8 2.2 0.2 2.4 4.8 2.1 1.3 2.1 1.9 1.1 0.7 3.5 1.6 0.5 0.0 0.5 1.3 0.2 2.0 0.1 0.1 1.2 26.5 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.5 0.4 23.3 0.0 0.0 2.0 5.2 18.6 0.8 24.6 2.7 7.1 0.0 1.7 3.6 2.0 0.7 0.0 49.9 0.0 0.0 0.2 13.5 4.3 1.6 0.0 0.0 0.9 1.8 5.9 0.3 1.8 1.9 0.0 0.5 0.0 1.0 0.3 0.1 6.0 10.5 3.3 0.0 4.6 9.9 0.0 2.1 0.0 0.8 8.4 3.3 2.6 0.1 1.4 0.5 5.8 11.3 4.0 0.1 IL22RA2 "CRF2-S1, IL-22BP" ENSG00000164485 "Interleukin 22 receptor subunit alpha 2" Q969J5 6 137143820-137173648 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "breast: 3.7;lymphoid tissue: 3.2" "Group enriched" "Detected in some" 5 "Breast glandular cells: 8.9;Breast myoepithelial cells: 9.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030582, CAB034906" Uncertain "Secreted to blood" NA NA 40500000 "CAB034906: AB_2124501, HPA030582: AB_10600716" "unprognostic (1.09e-1)" "unprognostic (7.97e-4)" "unprognostic (1.32e-3)" "unprognostic (1.24e-2)" "unprognostic (4.03e-3)" "unprognostic (1.11e-1)" "unprognostic (4.51e-1)" "unprognostic (1.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.10e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" "unprognostic (1.62e-1)" "unprognostic (6.61e-2)" 0.0 0.0 0.0 1.4 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.3 0.0 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.1 0.0 0.0 0.0 8.9 9.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 DACT2 "bA503C24.7, C6orf116, DAPPER2" ENSG00000164488 "Dishevelled binding antagonist of beta catenin 2" Q5SW24 6 168292830-168319777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4;placenta: 13.0" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8" HPA030251 Enhanced Supported NA NA "HPA030251: AB_10611108" "unprognostic (5.22e-6)" "unprognostic (3.13e-2)" "unprognostic (1.04e-2)" "prognostic favorable (1.07e-5)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (4.04e-1)" "unprognostic (1.31e-1)" "unprognostic (7.05e-3)" "unprognostic (2.48e-1)" "prognostic favorable (5.76e-5)" "unprognostic (1.51e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-4)" "unprognostic (4.23e-2)" 1.5 3.3 3.7 0.4 16.4 0.0 0.6 2.6 4.7 1.7 1.1 0.9 0.8 2.8 0.1 1.5 1.7 0.4 3.6 2.5 3.2 3.6 5.8 1.6 0.4 5.9 3.1 1.8 0.1 2.9 0.0 0.6 13.0 7.8 7.4 0.3 5.9 6.5 0.4 0.2 5.7 0.6 0.2 2.4 0.0 0.7 1.0 4.8 1.9 0.3 0.0 0.6 1.1 1.2 2.9 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 11.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 16.4 2.6 4.7 2.5 3.2 5.9 3.1 1.8 7.8 2.4 4.8 2.9 0.0 0.0 2.0 0.0 0.0 3.1 1.9 0.8 0.0 10.7 0.1 3.0 0.6 1.5 1.3 1.8 0.0 58.2 0.0 0.1 0.0 1.3 0.0 11.8 0.5 0.7 5.3 0.0 0.1 0.2 6.1 3.4 0.0 11.0 0.0 3.3 0.0 0.3 5.3 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.1 3.6 6.5 0.0 26.3 0.0 0.0 0.1 0.3 1.2 0.0 0.0 1.1 0.0 5.7 0.0 0.9 0.0 0.5 0.1 0.0 0.3 0.0 1.4 216.3 0.2 0.0 1.9 0.1 PDSS2 "bA59I9.3, C6orf210, COQ1B" ENSG00000164494 "Decaprenyl diphosphate synthase subunit 2" Q86YH6 6 107152562-107459564 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Cancer-related genes, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029685, HPA029686" Approved Supported Cytosol NA NA Cytosol "HPA029685: AB_10600219, HPA029686: AB_10602309" "prognostic unfavorable (1.34e-5)" "unprognostic (1.44e-1)" "prognostic favorable (5.74e-5)" "unprognostic (5.76e-2)" "unprognostic (1.42e-1)" "unprognostic (3.30e-2)" "unprognostic (3.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (9.38e-2)" "unprognostic (2.19e-1)" "prognostic favorable (3.75e-7)" "unprognostic (2.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" 8.0 18.0 4.6 6.3 5.2 9.1 8.2 6.2 5.7 9.3 6.7 12.5 9.4 6.9 6.6 8.6 8.7 8.8 14.0 4.7 5.4 21.8 27.3 8.1 7.7 5.1 4.8 4.0 9.1 8.5 13.3 8.6 6.9 4.9 14.7 13.3 6.1 15.5 7.5 12.6 6.4 9.7 8.6 4.9 6.8 9.7 7.8 5.1 8.2 13.4 13.8 7.2 7.6 6.1 6.3 7.6 10.0 8.3 13.2 14.2 18.0 19.2 13.1 16.5 12.4 11.8 10.0 10.8 14.4 11.7 14.7 13.1 10.2 20.3 16.5 16.7 9.1 9.8 14.4 11.4 16.9 15.0 18.5 11.1 13.5 19.1 19.5 15.3 10.8 13.1 16.5 20.7 19.0 12.2 9.3 5.4 19.7 5.3 17.3 12.7 9.7 7.4 11.7 15.2 10.2 8.2 7.1 9.0 15.4 19.7 9.0 12.7 22.3 8.3 8.8 5.2 12.4 11.4 5.3 6.8 11.3 16.3 27.4 16.3 3.2 5.1 2.8 3.7 5.9 5.9 4.7 3.8 4.7 7.0 5.5 5.0 4.8 0.6 3.6 9.9 3.3 5.5 3.4 4.6 5.2 6.2 5.7 4.7 5.4 5.1 4.8 4.0 4.9 4.9 5.1 6.3 11.4 16.0 19.1 64.9 12.3 4.2 13.8 11.7 13.6 8.2 9.7 8.3 17.4 12.8 13.9 14.7 2.1 26.9 8.3 15.1 35.2 12.7 37.3 16.3 9.3 8.4 10.3 8.0 53.5 14.5 17.3 9.5 8.2 10.9 14.0 11.9 7.5 32.6 11.8 6.7 67.3 15.3 14.2 9.8 5.1 12.7 5.3 10.2 7.2 82.4 8.5 11.8 6.2 72.9 74.5 13.7 14.4 9.4 13.0 12.2 14.2 40.8 21.0 11.5 26.3 8.7 7.9 21.7 11.5 14.3 5.8 11.9 9.8 13.4 17.0 12.5 SPATA48 C7orf72 ENSG00000164500 "Spermatogenesis associated 48" A4D263 7 50095883-50159256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-698: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA026094 Uncertain NA NA "HPA026094: AB_1859516" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STXBP5 "LLGL3, tomosyn" ENSG00000164506 "Syntaxin binding protein 5" Q5T5C0 6 147204425-147390476 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 116.6" "Cell type enhanced" "Detected in many" "Astrocytes: 325.8;Excitatory neurons: 441.9;Inhibitory neurons: 300.1;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 150.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 3.8;eosinophil: 9.2;neutrophil: 3.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.2" "Cell line enhanced" "Detected in many" "HEL: 210.2;HMC-1: 219.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039991, HPA049727, CAB079016" Enhanced Supported Enhanced Cytosol NA NA Cytosol "CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863" "prognostic unfavorable (4.48e-4)" "unprognostic (4.60e-3)" "unprognostic (2.28e-3)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.52e-1)" "unprognostic (9.56e-4)" "unprognostic (6.01e-2)" "unprognostic (3.60e-1)" "unprognostic (2.74e-2)" "unprognostic (1.70e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.74e-7)" "unprognostic (8.01e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-3)" 7.1 9.2 4.6 9.5 13.9 34.6 7.8 25.6 13.8 7.5 0.0 14.3 8.1 8.4 7.8 13.8 5.9 9.6 5.9 8.7 6.7 3.7 4.0 6.6 7.9 2.6 2.2 8.8 5.5 15.6 116.6 7.7 6.4 7.6 11.5 16.5 20.3 5.6 14.6 7.8 15.6 11.3 11.0 0.0 8.3 8.1 22.4 1.6 9.5 6.3 8.1 9.7 8.5 10.0 9.2 10.8 9.4 4.9 16.5 23.4 48.8 5.4 24.5 36.1 17.8 19.9 8.0 7.0 7.8 5.6 48.8 30.5 12.7 14.1 21.5 21.6 17.1 11.0 210.2 27.2 9.0 26.8 72.7 219.6 35.6 15.0 35.6 72.0 42.1 23.2 12.2 57.8 9.6 35.4 15.7 11.6 18.8 4.0 8.9 21.4 1.7 25.4 3.0 9.7 18.4 10.6 7.6 18.9 13.3 8.2 8.7 3.9 28.0 26.9 25.4 9.2 12.6 22.5 7.9 0.1 9.1 14.0 26.2 18.5 3.8 0.3 9.2 0.9 0.4 0.9 0.3 0.5 1.1 0.4 0.9 0.8 1.3 3.1 0.4 0.5 0.3 0.2 0.3 4.6 13.9 25.6 13.8 8.7 6.7 2.6 2.2 8.8 7.6 0.0 1.6 9.2 12.1 16.0 8.8 325.8 5.7 3.6 2.6 1.9 3.4 38.8 6.7 7.7 14.1 11.5 6.7 16.5 31.3 5.2 9.5 18.7 0.0 4.8 39.0 10.1 10.5 10.8 41.1 10.1 441.9 12.9 4.6 10.1 14.3 20.5 44.2 5.1 8.9 4.5 4.7 33.7 300.1 30.3 0.0 7.8 3.1 42.8 7.8 7.8 10.6 97.4 8.5 5.4 6.2 206.1 150.4 11.7 21.4 7.2 5.8 10.4 29.3 1.9 2.2 29.0 13.1 12.7 5.6 13.1 11.5 11.0 6.7 3.8 9.3 5.4 19.3 3.6 H2AC1 "bA317E16.2, H2AFR, HIST1H2AA" ENSG00000164508 "H2A clustered histone 1" Q96QV6 6 25726063-25726562 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851357-55922854 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.6;lymphoid tissue: 2.2;testis: 1.9" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;Late spermatids: 1.2;Spermatocytes: 2.5;Syncytiotrophoblasts: 1.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 26.3;HBEC3-KT: 10.3;HHSteC: 9.5;hTERT-HME1: 11.5;U-2 OS: 16.8;U-87 MG: 20.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA051532: , HPA068114: AB_2732779" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.1 1.9 0.0 2.2 0.0 0.6 0.1 0.1 0.0 0.1 0.1 1.4 0.0 0.0 0.1 0.4 0.5 0.2 0.5 0.3 0.1 0.0 0.2 0.0 0.0 0.4 26.3 0.0 0.0 10.3 2.2 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 7.3 2.9 4.8 11.5 0.6 4.1 0.1 0.0 0.4 1.4 0.0 0.0 1.2 0.0 0.0 6.8 0.0 1.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 2.0 0.5 16.8 0.0 0.8 0.0 0.0 0.0 20.8 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.3 0.3 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.1 2.5 0.6 0.0 0.1 1.1 0.0 0.7 0.0 0.0 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099680-56233330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.6;liver: 3.1;lymphoid tissue: 3.7;testis: 9.9" "Cell type enhanced" "Detected in some" "Early spermatids: 161.3;Hepatic stellate cells: 41.7;Inhibitory neurons: 103.5;Late spermatids: 29.1;Spermatocytes: 59.3" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 22.9;eosinophil: 20.7;naive CD4 T-cell: 19.8" "Group enriched" "Detected in many" 74 "granulocytes: 22.9;T-cells: 19.8" "Group enriched" "Detected in some" 6 "HEL: 34.4;HMC-1: 17.1;NB-4: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: AB_2681326, HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.4 0.1 3.3 0.7 3.2 0.7 0.1 0.0 2.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.1 1.1 5.8 0.5 3.1 0.3 3.7 4.2 3.1 1.4 0.1 0.0 0.0 0.2 0.6 4.2 0.0 0.2 0.4 1.0 0.0 0.0 0.4 1.3 0.1 2.6 1.6 0.3 9.9 6.6 3.2 0.2 0.0 2.1 0.3 0.1 5.6 0.2 0.3 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.2 1.3 0.0 1.6 17.1 0.0 0.1 0.0 0.0 0.1 4.2 0.1 2.9 1.1 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 1.7 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 2.0 0.4 22.9 0.2 20.7 0.1 0.1 0.0 0.0 4.3 0.0 0.1 0.0 19.8 0.8 2.0 0.0 0.1 0.0 1.0 2.8 3.3 3.2 0.0 2.1 1.1 5.8 4.2 3.1 1.4 4.2 2.6 6.6 5.6 0.3 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.5 1.5 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 161.3 0.4 0.8 2.2 0.0 0.0 1.3 0.2 0.3 0.6 0.5 7.5 2.5 0.1 41.7 0.6 0.7 0.0 103.5 0.0 0.0 3.2 1.9 29.1 0.6 1.4 1.8 1.0 0.9 0.9 3.1 18.6 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 59.3 0.6 0.0 0.0 1.2 3.9 0.5 0.0 0.2 RAET1E "bA350J20.7, LETAL, ULBP4" ENSG00000164520 "Retinoic acid early transcript 1E" Q8TD07 6 149883375-149898102 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.3;skin 1: 21.8;vagina: 27.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 12.4;Early spermatids: 10.0;Late spermatids: 5.6;Respiratory ciliated cells: 14.6;Squamous epithelial cells: 17.2;Suprabasal keratinocytes: 6.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 19.6;HeLa: 24.4;hTCEpi: 19.1;SiHa: 9.9;U-87 MG: 7.7" HPA054022 Supported "Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Focal adhesion sites" Cytosol "HPA054022: AB_2797250" "unprognostic (1.67e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (1.36e-3)" "unprognostic (4.80e-4)" "unprognostic (1.11e-1)" "unprognostic (3.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (7.47e-5)" "unprognostic (2.41e-2)" "unprognostic (3.18e-2)" "unprognostic (3.17e-2)" "unprognostic (1.06e-1)" 1.9 0.8 0.7 0.1 0.5 0.1 1.9 1.0 0.7 10.6 0.7 0.2 0.1 0.3 0.0 63.3 0.8 0.1 0.4 0.5 0.3 2.2 0.1 0.3 0.1 0.8 0.4 0.4 0.1 0.1 0.0 0.2 0.5 0.6 0.3 0.3 0.1 13.0 0.3 1.6 21.8 0.1 0.5 0.3 0.9 0.3 0.5 0.6 0.1 0.3 0.2 11.7 1.9 27.8 0.6 1.8 1.0 0.0 0.0 0.2 1.3 0.0 0.1 0.9 0.1 0.3 0.0 4.3 0.0 2.6 4.4 1.4 1.7 0.0 19.6 0.2 0.3 0.0 0.1 24.4 0.0 0.0 0.0 0.0 0.4 19.1 1.0 3.9 0.4 0.1 0.1 0.0 1.3 0.8 0.0 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.3 0.4 0.9 0.2 0.0 9.9 1.5 0.0 0.0 1.2 0.0 1.8 0.8 0.3 0.2 0.9 0.0 0.0 0.0 7.7 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.0 0.7 0.5 0.3 0.8 0.4 0.4 0.6 0.3 0.6 0.6 1.0 0.0 0.0 0.3 0.0 2.2 1.1 12.4 1.8 0.6 0.3 0.6 0.3 1.5 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.0 2.5 0.1 1.0 0.0 0.0 0.9 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.3 5.6 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.5 1.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.4 0.0 0.3 0.4 0.0 0.2 17.2 6.5 0.0 0.2 0.1 0.2 1.6 PI16 "CD364, dJ90K10.5, MGC45378, MSMBBP" ENSG00000164530 "Peptidase inhibitor 16" Q6UXB8 6 36948263-36964837 "CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 141.8;urinary bladder: 117.2;vagina: 128.7" "Cell type enhanced" "Detected in many" "Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7" "Cancer enhanced" "Detected in many" "glioma: 15.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 66.1" "Lineage enriched" "Detected in many" 5 "T-cells: 66.1" "Cell line enriched" "Detected in some" 6 "JURKAT: 29.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 7 "spinal cord: 33.2" HPA076574 Approved "Secreted to blood" NA NA 2900000000 "HPA076574: AB_2732314" "unprognostic (6.24e-3)" "unprognostic (6.00e-3)" "unprognostic (7.34e-2)" "unprognostic (9.53e-2)" "unprognostic (3.38e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-2)" "unprognostic (5.06e-2)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (3.25e-2)" "unprognostic (4.46e-2)" "unprognostic (1.59e-3)" "unprognostic (5.82e-2)" "unprognostic (2.31e-1)" "unprognostic (1.28e-1)" "unprognostic (8.76e-2)" 58.3 3.6 12.4 3.2 16.7 0.2 66.8 14.3 15.2 141.8 11.1 11.1 1.5 5.8 29.2 10.7 15.1 46.8 91.7 9.8 17.2 1.5 0.7 11.5 2.2 21.4 15.3 9.6 3.4 5.7 0.9 8.4 2.5 22.3 31.5 8.0 0.0 14.1 34.6 15.3 49.1 4.5 8.5 13.5 1.3 22.3 14.8 14.7 2.4 23.4 33.9 6.0 117.2 128.7 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.9 0.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 29.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 1.8 0.6 19.7 5.7 0.0 1.3 6.4 2.2 0.5 13.5 0.0 0.5 66.1 3.3 12.4 16.7 14.3 15.2 9.8 17.2 21.4 15.3 9.6 22.3 13.5 14.7 19.5 10.9 0.0 1.5 3.3 0.7 21.5 0.1 0.0 0.6 0.0 0.4 0.4 4.5 0.0 0.6 1.8 0.0 0.0 0.4 0.0 1.9 0.1 10.8 0.1 0.2 11.0 0.0 0.0 0.1 0.0 0.0 204.8 4.1 0.1 0.0 0.0 10.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 39.6 19.0 205.9 1.9 10.6 3.7 0.0 0.0 0.0 0.0 67.3 0.1 0.0 149.7 0.6 0.1 0.0 0.2 0.0 0.0 0.0 7.7 4.2 2.4 1.3 0.4 18.5 0.1 3.5 0.3 0.0 0.2 TBX20 ENSG00000164532 "T-box transcription factor 20" Q9UMR3 7 35202430-35254100 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "medulla oblongata: 1.2;pons: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.2;HEL: 3.2;HHSteC: 3.4;HMC-1: 3.9;RH-30: 3.8;SH-SY5Y: 7.4;WM-115: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA007840 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA007840: " "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.87e-2)" "unprognostic (8.47e-2)" "unprognostic (3.95e-2)" "unprognostic (2.75e-1)" "unprognostic (1.74e-1)" "unprognostic (9.75e-2)" 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 36.3 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.5 3.7 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.7 2.3 0.0 0.4 0.0 0.1 0.2 3.2 0.0 0.0 1.7 2.5 3.2 0.9 0.0 3.4 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 3.8 0.0 0.0 0.0 0.2 7.4 0.3 0.0 0.0 1.9 0.0 2.9 0.0 0.0 0.1 2.7 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.2 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 DAGLB "DAGLBETA, KCCR13L" ENSG00000164535 "Diacylglycerol lipase beta" Q8NCG7 7 6409126-6484190 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069377 Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA069377: AB_2686132" "unprognostic (2.39e-1)" "unprognostic (4.61e-2)" "unprognostic (2.13e-3)" "unprognostic (1.42e-1)" "unprognostic (9.04e-3)" "unprognostic (3.68e-2)" "unprognostic (1.78e-3)" "unprognostic (2.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (7.18e-5)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (2.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.81e-2)" 6.8 15.7 8.5 6.8 10.0 15.1 6.7 7.4 11.2 6.3 6.2 6.2 7.7 5.9 3.6 8.1 5.9 6.5 5.2 10.7 9.5 4.8 8.0 9.4 7.5 9.8 8.0 10.1 7.9 7.0 7.0 4.3 8.8 8.3 5.4 5.1 3.4 7.8 4.5 13.4 11.7 7.7 5.8 9.1 8.5 7.2 5.5 8.1 8.2 7.6 7.1 6.7 5.9 7.4 9.8 21.6 23.9 10.9 14.3 16.1 12.5 8.4 29.8 21.3 26.6 28.7 13.6 24.4 12.3 12.5 15.4 64.8 32.4 17.8 16.7 15.2 5.8 11.7 6.6 26.9 9.4 17.3 18.8 10.1 11.3 27.2 17.9 17.5 10.7 11.7 15.6 18.2 6.1 15.9 16.2 6.7 26.9 39.6 11.3 18.5 57.4 12.7 25.5 16.8 8.1 13.5 8.4 17.7 26.7 5.3 17.2 19.0 34.7 14.4 22.4 41.9 28.1 13.9 6.2 11.2 10.4 11.3 28.9 28.2 10.8 22.8 22.0 6.2 21.3 5.5 8.2 4.8 4.1 28.6 4.7 11.4 6.7 10.2 3.9 19.5 5.0 4.3 12.2 8.5 10.0 7.4 11.2 10.7 9.5 9.8 8.0 10.1 8.3 9.1 8.1 9.8 6.5 9.6 12.6 5.9 7.9 16.8 3.6 6.2 12.0 4.5 5.7 5.7 3.1 4.3 5.0 5.5 2.1 5.1 4.8 12.2 0.0 7.0 0.4 10.3 6.8 9.0 2.4 13.3 13.8 6.2 8.9 5.4 19.4 19.9 3.8 5.5 8.9 8.0 17.2 0.0 9.2 5.8 6.1 16.1 17.4 1.7 6.2 16.3 5.4 26.2 15.8 1.4 7.2 2.5 6.5 12.2 8.0 2.2 5.0 5.7 10.6 1.6 3.8 4.3 0.0 4.0 5.0 8.5 7.1 9.4 13.4 12.4 6.7 7.4 7.6 4.3 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324152-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Cell type enhanced" "Detected in many" "Early spermatids: 87.9;Endometrial ciliated cells: 41.8;Late spermatids: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: AB_2670571, HPA061066: AB_2684423" "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 0.7 8.2 5.9 0.7 6.2 2.5 3.7 15.0 5.7 2.4 8.9 2.0 1.8 3.1 6.2 2.4 5.8 3.2 1.8 5.4 7.8 9.2 5.5 3.0 0.2 4.5 6.3 5.2 8.7 9.2 11.7 6.4 1.2 6.7 2.9 1.3 15.1 2.8 2.7 1.5 5.8 1.1 2.9 4.0 0.6 11.2 22.5 5.9 3.3 3.7 1.4 0.4 1.3 1.2 5.3 10.7 6.3 13.2 12.4 0.4 0.3 2.9 2.8 3.3 6.5 7.5 2.8 5.5 0.1 3.0 0.7 11.0 6.1 18.1 5.6 5.4 0.9 10.1 0.2 9.7 2.5 2.3 1.9 0.4 1.5 9.5 6.0 7.0 7.7 0.2 5.8 4.4 0.2 0.6 3.8 6.0 4.0 0.6 2.6 1.5 2.2 0.5 0.0 13.8 1.3 38.1 13.6 4.8 12.5 4.0 9.0 11.8 1.5 0.0 0.8 3.2 1.8 4.2 6.2 14.6 0.1 2.4 0.5 2.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.9 6.2 15.0 5.7 5.4 7.8 4.5 6.3 5.2 6.7 4.0 5.9 5.3 1.5 6.4 2.7 7.5 1.4 9.7 5.1 3.5 17.6 17.8 13.3 8.1 3.7 5.7 3.7 3.7 27.1 2.3 0.9 0.9 5.9 5.0 87.9 41.8 2.2 1.6 8.4 0.8 22.4 2.9 1.2 2.1 11.2 13.3 1.3 8.3 0.4 5.6 0.5 11.8 25.9 1.5 0.0 0.0 0.4 65.4 2.8 0.4 3.6 1.0 0.1 5.7 0.0 12.1 13.1 3.9 1.7 0.4 3.2 3.0 0.2 10.0 25.9 16.3 6.6 5.7 2.1 28.8 11.9 4.7 8.7 0.7 1.2 7.6 1.6 2.0 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43650713 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018138, HPA037979" Uncertain Supported "Nuclear speckles,Plasma membrane" Yes No "Nuclear speckles" "Plasma membrane" "HPA018138: AB_2669784, HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 6.7 8.2 3.6 8.0 4.2 4.8 5.3 6.8 4.9 3.7 4.0 5.7 3.2 3.5 1.2 7.2 3.9 5.4 10.0 3.9 4.1 4.6 4.6 9.5 14.5 3.3 4.4 3.4 6.2 9.2 0.8 4.3 3.2 4.0 4.3 2.4 5.5 5.8 2.2 10.0 4.5 11.6 3.3 3.6 12.7 9.6 9.1 3.9 9.1 3.8 2.6 13.6 5.7 5.1 4.2 5.8 8.2 9.0 5.3 7.8 8.3 1.9 12.3 15.1 6.6 5.9 7.5 3.1 7.9 20.2 15.3 17.8 8.5 3.6 17.4 10.4 16.9 7.0 9.3 8.2 8.4 4.9 21.1 5.6 6.4 26.4 8.2 8.6 36.4 12.6 11.0 16.7 15.1 9.6 3.6 18.2 8.0 17.3 4.1 18.3 8.4 6.9 14.2 15.6 6.7 6.9 11.2 8.1 8.5 6.1 13.6 6.5 10.8 16.9 20.7 8.3 14.3 17.2 13.3 11.2 13.5 18.4 14.0 31.7 0.5 0.0 2.7 2.0 0.0 1.5 2.4 2.0 3.2 0.1 2.2 3.0 3.0 1.6 4.9 0.1 0.4 1.3 0.9 3.6 4.2 6.8 4.9 3.9 4.1 3.3 4.4 3.4 4.0 3.6 3.9 4.2 44.2 121.8 33.1 29.0 237.8 181.9 644.6 64.5 99.6 2.9 17.7 37.8 28.7 7.2 69.8 20.2 10.4 54.8 222.3 54.4 33.2 153.0 47.0 129.1 17.4 35.2 7.2 54.1 9.5 95.4 23.3 39.1 78.0 88.3 38.8 17.7 17.9 9.6 16.9 0.0 5.6 34.3 38.7 20.3 65.9 14.7 5.9 60.9 35.6 34.7 42.1 7.9 221.4 39.2 3.7 89.4 73.0 2.6 81.2 192.6 23.8 13.2 42.4 26.3 6.6 39.4 51.3 75.8 36.1 42.3 136.1 66.8 273.7 27.0 18.0 326.1 TRA2A "AWMS1, htra-2-alpha" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 32.3 39.4 61.1 37.4 63.1 114.3 32.4 63.0 76.4 46.6 62.8 37.4 26.7 43.2 44.3 47.7 43.0 21.5 30.1 60.3 63.0 32.7 35.2 33.8 48.0 62.3 63.4 60.1 53.5 32.9 25.8 40.7 33.2 62.7 41.7 39.6 42.3 33.4 22.3 23.3 43.2 37.1 41.3 62.5 53.2 33.3 31.1 62.2 46.5 36.2 21.5 54.1 38.2 43.3 70.1 57.2 61.2 94.1 148.4 49.1 30.9 60.4 71.4 33.6 70.5 57.4 51.2 76.4 107.4 39.9 53.7 82.3 92.1 115.6 66.9 88.4 64.6 65.7 65.9 67.9 81.8 52.0 78.0 59.2 37.1 44.9 53.1 66.1 62.7 80.9 46.7 129.5 51.0 79.7 55.6 96.5 128.7 84.5 69.5 62.5 106.1 74.8 64.3 81.8 81.0 80.7 65.8 66.0 75.8 49.8 69.1 59.6 85.5 73.8 55.4 79.0 51.0 83.4 56.6 76.1 86.9 47.7 103.8 75.3 16.8 17.1 23.6 24.6 28.8 21.6 17.6 23.3 23.1 20.6 16.1 19.6 23.7 25.4 19.1 27.0 30.0 25.2 10.2 61.1 63.1 63.0 76.4 60.3 63.0 62.3 63.4 60.1 62.7 62.5 62.2 70.1 110.6 60.9 72.2 112.3 141.9 104.4 95.6 61.7 94.4 54.5 118.5 74.8 42.5 60.1 60.8 88.3 52.1 83.2 153.3 84.9 25.4 54.8 62.1 155.7 137.1 74.8 118.5 77.5 113.1 43.9 84.6 91.5 89.2 166.7 86.7 62.5 84.6 71.4 54.8 37.0 115.4 100.3 48.8 89.5 125.4 23.7 65.0 88.9 56.9 107.7 71.5 48.1 70.0 203.1 245.1 59.2 92.0 67.7 125.4 97.7 59.7 41.8 71.3 101.8 72.3 119.2 88.2 99.8 65.0 138.6 113.1 117.9 130.4 49.1 112.6 92.1 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 66.4" "Cell type enhanced" "Detected in many" "Microglial cells: 74.0;Oligodendrocyte precursor cells: 156.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 284.9;TIME: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 12.2 15.7 11.0 14.5 13.0 19.5 13.6 12.8 10.0 24.3 29.8 14.8 14.5 6.3 6.0 5.0 14.7 16.9 9.1 9.8 22.3 9.8 4.5 15.7 10.0 16.4 13.5 8.8 66.4 9.9 13.7 11.6 4.8 12.6 9.1 14.9 7.9 13.6 3.7 5.5 5.7 12.7 11.7 9.8 15.9 22.2 4.6 12.9 7.9 16.8 8.2 9.5 11.2 5.2 12.8 25.6 85.3 20.3 17.8 42.2 37.3 15.6 71.7 39.9 27.9 26.7 12.1 56.7 16.6 49.3 121.4 49.9 4.4 9.4 56.0 25.4 43.2 6.7 45.4 16.0 16.5 32.4 9.9 42.3 46.7 12.9 22.7 33.2 284.9 54.4 12.5 10.5 50.9 48.4 26.4 1.1 6.8 8.0 71.1 17.3 5.1 10.7 16.6 38.6 17.1 2.7 6.6 31.8 117.0 9.4 29.6 45.6 7.4 161.2 67.5 15.9 16.8 77.7 14.5 15.0 8.7 44.2 19.3 21.1 2.0 1.2 2.4 3.1 1.6 2.8 1.9 1.8 2.0 1.4 2.1 0.8 2.1 2.5 1.9 1.8 1.1 1.6 1.0 11.0 13.0 12.8 10.0 9.8 22.3 16.4 13.5 8.8 12.6 9.8 12.9 12.8 17.4 9.6 46.4 32.7 17.4 4.8 3.9 5.6 1.8 4.6 12.4 8.6 5.0 5.7 8.7 14.7 4.2 0.7 27.7 23.0 9.8 9.1 10.3 12.4 7.4 14.1 3.0 21.4 14.3 30.1 1.5 13.7 30.5 22.3 10.2 10.5 23.9 5.3 8.5 0.0 15.9 20.4 6.1 19.5 7.8 22.5 38.2 12.4 0.0 74.0 11.9 17.4 44.3 156.9 66.9 36.8 13.6 50.0 15.4 8.2 15.3 2.7 0.7 10.5 6.6 5.6 7.8 2.0 4.0 1.2 3.7 0.8 21.7 27.3 12.2 4.2 SAP30L "FLJ11526, NS4ATP2" ENSG00000164576 "SAP30 like" Q9HAJ7 5 154445997-154461053 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048665, HPA078308" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA048665: AB_2680486, HPA078308: " "unprognostic (3.79e-3)" "unprognostic (1.44e-2)" "unprognostic (1.25e-1)" "unprognostic (7.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" "unprognostic (1.32e-1)" "unprognostic (4.33e-2)" "prognostic favorable (2.06e-5)" "unprognostic (3.36e-1)" "prognostic favorable (1.71e-4)" "unprognostic (1.62e-2)" "unprognostic (3.34e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.69e-4)" 9.4 8.4 13.4 5.3 13.7 1.6 11.4 13.7 13.5 13.6 10.8 13.1 10.6 13.6 9.1 7.1 13.0 6.8 9.8 11.6 13.3 13.2 8.1 9.4 6.8 13.8 13.9 10.9 19.9 6.4 13.9 5.1 7.8 13.7 10.6 8.8 6.2 7.3 12.5 14.2 11.5 11.1 11.7 14.6 9.0 9.0 7.8 13.3 10.0 9.3 15.4 8.4 11.0 10.1 14.4 9.0 7.3 13.3 8.8 28.4 22.5 6.5 9.2 19.9 10.4 11.2 4.9 5.0 9.7 7.2 14.0 12.1 7.1 10.1 7.5 11.6 4.9 9.9 7.9 6.8 3.6 8.5 10.5 5.7 8.2 13.4 4.6 11.3 16.0 8.5 9.1 3.3 6.0 8.8 4.5 9.9 6.7 3.3 8.2 5.0 9.4 13.3 4.8 6.0 4.4 8.0 10.5 7.3 15.6 17.6 12.4 5.6 12.8 12.1 7.2 5.3 9.6 6.6 5.6 8.6 5.0 10.6 8.1 4.2 0.0 0.3 0.3 0.5 0.4 0.6 0.2 0.6 0.6 0.3 0.5 0.6 0.4 0.2 1.4 1.2 0.4 0.6 0.3 13.4 13.7 13.7 13.5 11.6 13.3 13.8 13.9 10.9 13.7 14.6 13.3 14.4 25.7 19.2 6.9 7.8 7.1 17.3 8.7 4.2 8.0 4.5 17.0 14.1 19.8 17.2 6.3 3.7 6.2 7.7 15.5 26.5 3.9 4.8 22.4 15.6 18.4 17.6 7.2 11.0 6.6 8.2 12.3 18.1 4.6 9.8 1.3 16.4 15.7 16.3 8.5 10.1 6.5 11.4 0.0 9.7 12.4 18.0 20.5 11.3 10.6 9.4 10.7 21.4 14.4 6.0 12.1 10.6 13.9 18.0 7.8 16.9 32.7 10.5 9.5 5.8 0.0 14.9 16.0 16.1 17.2 5.5 18.2 6.3 8.9 10.5 12.1 13.3 RPS14 "EMTB, S14" ENSG00000164587 "Ribosomal protein S14" P62263 5 150442635-150449739 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018504 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 810000 "Endoplasmic reticulum, Cytosol" "HPA018504: AB_1856463" "unprognostic (5.70e-3)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (8.17e-3)" "unprognostic (7.51e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (3.26e-1)" "prognostic unfavorable (8.69e-4)" "unprognostic (1.47e-1)" "unprognostic (8.81e-2)" "unprognostic (2.29e-1)" "unprognostic (8.14e-2)" 1387.6 1023.1 778.9 696.0 785.8 1896.4 1580.7 760.7 937.2 1596.5 787.4 1244.1 569.0 1224.4 1010.6 1537.7 1351.1 473.3 998.4 747.3 824.5 952.5 1036.2 944.1 1135.3 789.9 778.3 735.0 2414.4 2451.3 738.3 816.0 641.5 795.4 1238.5 804.0 303.1 1321.7 696.8 1549.5 2189.3 1208.3 690.2 841.0 1354.0 1330.1 347.5 810.5 1153.1 1021.7 1039.1 1180.6 1300.0 1457.0 810.7 1196.9 1768.7 1201.2 2749.6 1497.8 2857.8 1828.0 815.2 1278.2 1298.3 1158.5 2702.9 1799.1 2098.0 1280.9 1583.7 1411.4 1091.9 1548.1 3878.5 782.1 1066.7 2153.7 879.0 1504.7 2171.0 2252.7 2642.0 1164.7 2193.0 1297.4 1441.2 3088.3 1496.2 1933.8 1975.8 1067.3 1250.1 1720.0 2804.7 1499.8 2478.0 1323.5 1935.2 1959.3 1446.0 1134.7 3166.8 2005.3 1827.0 1339.8 1410.9 634.1 3959.4 3109.0 892.6 1703.5 3152.8 1107.3 925.5 711.0 723.0 1229.2 1511.3 1853.6 1722.2 1174.2 2578.4 634.9 2439.8 6736.3 1518.4 6807.8 4685.2 9622.7 14519.2 11377.7 8377.3 7039.4 12461.6 16778.9 11703.6 982.1 6730.0 4055.3 8079.0 8024.6 34303.5 778.9 785.8 760.7 937.2 747.3 824.5 789.9 778.3 735.0 795.4 841.0 810.5 810.7 1954.3 1336.5 2464.0 15.0 5469.0 11670.8 9205.1 9468.6 4143.2 501.8 11009.9 13334.3 1873.1 3179.9 4229.9 1478.7 185.6 7225.8 4299.3 2121.7 4527.4 3485.4 1233.0 1626.2 3782.1 3867.8 2390.3 3230.5 23.3 8687.4 8833.9 3287.4 1852.2 2336.3 2293.4 4816.8 4223.5 4186.4 4707.3 203.6 20.0 5595.6 2931.6 5536.1 9991.5 1739.5 4356.7 3703.4 6474.4 21.5 6224.3 2062.0 4655.1 13.0 31.1 5196.5 4753.4 2235.0 3173.0 7998.6 5612.4 5302.3 1902.7 691.9 1604.1 3185.0 5116.9 726.4 815.9 6399.3 15358.6 7126.8 5488.0 4091.6 6155.8 10058.0 HCN1 "BCNG-1, BCNG1, HAC-2" ENSG00000164588 "Hyperpolarization activated cyclic nucleotide gated potassium channel 1" O60741 5 45254948-45696498 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "brain: 7.3;retina: 17.7" "Group enriched" "Detected in some" 4 "Excitatory neurons: 671.7;Inhibitory neurons: 766.5;Rod photoreceptor cells: 199.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "WM-115: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019195 Enhanced NA NA "HPA019195: AB_2670094" "unprognostic (1.30e-1)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (6.82e-2)" "unprognostic (1.10e-1)" "unprognostic (9.63e-3)" "unprognostic (4.11e-3)" "unprognostic (6.78e-2)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (3.68e-3)" 0.0 0.4 1.1 0.0 2.7 0.1 0.0 2.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 1.2 0.0 0.0 0.0 0.0 0.2 0.2 2.7 0.0 0.3 0.0 0.3 0.0 1.2 0.0 0.0 17.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.7 2.7 7.3 2.4 1.2 0.2 0.2 2.7 1.2 0.0 0.3 2.8 0.0 0.0 0.0 24.5 0.0 0.1 0.1 0.0 0.0 29.4 0.0 0.0 7.4 0.0 0.0 0.0 133.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 671.7 0.7 0.0 0.6 0.0 0.1 0.0 0.6 0.0 0.0 0.0 6.7 766.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.5 0.0 14.8 0.0 21.1 14.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 199.4 0.0 0.3 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 MYOZ3 "CS-3, CS3, FATZ-3, FRP3" ENSG00000164591 "Myozenin 3" Q8TDC0 5 150660882-150679368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 26 "skeletal muscle: 236.4;tongue: 200.2" "Cell type enriched" "Detected in some" 6 "Peritubular cells: 44.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.3;NTERA-2: 9.2;REH: 14.8;SuSa: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA039166 Enhanced NA NA "HPA039166: AB_10671871" "unprognostic (2.74e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-3)" "unprognostic (1.41e-2)" "unprognostic (1.26e-1)" "unprognostic (3.46e-2)" "unprognostic (2.59e-2)" "unprognostic (8.77e-2)" "unprognostic (9.19e-4)" "unprognostic (6.99e-2)" "unprognostic (5.19e-2)" "unprognostic (7.21e-3)" "unprognostic (7.31e-9)" "unprognostic (2.19e-2)" "unprognostic (2.79e-1)" "unprognostic (8.46e-2)" "unprognostic (4.20e-2)" 0.4 0.5 1.8 0.1 2.3 1.1 0.6 1.9 1.0 1.7 0.8 0.3 0.3 1.5 1.4 5.4 0.8 1.5 5.4 1.6 2.5 0.6 0.1 0.8 0.1 8.4 2.4 0.4 0.9 0.2 0.0 1.4 0.1 2.9 4.2 0.2 0.2 3.3 1.0 236.4 0.1 0.7 0.8 5.4 0.2 0.5 3.8 3.0 0.4 0.7 200.2 0.0 0.7 0.5 3.1 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.3 0.0 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.5 0.7 0.0 0.0 0.1 0.0 0.7 1.4 9.2 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.6 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 2.3 1.9 1.0 1.6 2.5 8.4 2.4 0.4 2.9 5.4 3.0 3.1 3.5 0.0 0.0 1.0 0.1 0.4 0.4 0.5 0.6 1.1 1.7 1.5 2.9 0.0 0.1 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.3 0.5 0.7 2.5 0.0 0.0 0.9 0.2 0.3 1.8 0.0 1.4 0.0 4.3 2.9 0.0 0.2 0.0 3.0 0.3 2.0 0.3 1.1 1.2 3.1 0.7 0.0 1.0 0.1 0.5 1.0 0.0 0.2 0.0 0.1 44.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 7.0 0.8 0.4 1.5 0.0 0.4 0.7 0.5 0.4 0.5 0.1 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201372-107564261 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: AB_2677564" "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (1.15e-1)" 11.5 12.2 6.4 9.5 7.8 14.3 10.9 7.5 8.6 19.5 7.9 12.1 9.4 17.2 10.1 12.9 9.1 13.0 18.7 7.4 6.6 9.8 6.8 10.3 9.5 7.0 6.0 5.7 12.5 14.8 19.6 10.3 10.6 7.4 18.0 12.6 11.9 23.0 11.1 14.1 12.8 10.2 14.6 5.9 9.0 11.8 8.6 6.7 6.3 20.5 15.5 10.5 10.6 16.8 9.1 39.3 14.9 16.1 15.1 14.7 16.2 12.6 27.0 28.2 11.7 20.5 12.0 17.5 7.9 14.9 27.0 26.5 15.5 10.7 16.0 18.2 23.5 9.6 8.7 9.9 15.1 17.4 18.8 19.0 15.4 15.3 20.4 24.0 32.1 31.7 17.1 16.6 25.1 21.5 18.5 19.2 17.8 5.9 30.0 19.1 6.8 13.6 18.6 13.6 17.9 7.6 21.8 16.6 27.2 31.2 23.8 6.2 12.2 36.6 12.6 16.0 39.7 17.2 16.3 16.9 17.3 24.2 21.0 33.9 9.4 6.6 7.5 6.1 7.6 8.4 6.0 7.7 6.9 5.4 5.8 6.4 6.4 3.4 5.1 9.3 3.7 6.5 5.9 6.4 7.8 7.5 8.6 7.4 6.6 7.0 6.0 5.7 7.4 5.9 6.7 9.1 14.8 3.2 15.5 124.4 21.7 12.2 15.0 11.1 24.5 23.2 10.0 7.7 27.6 7.2 16.5 14.7 33.3 10.2 16.5 15.8 1.9 10.5 22.6 11.8 21.8 11.0 10.3 5.9 147.0 10.9 8.5 14.4 14.8 19.8 3.8 12.3 9.7 5.8 11.3 11.8 196.1 36.2 18.3 14.8 12.3 22.1 11.8 15.3 12.4 147.1 15.7 9.0 11.3 136.7 183.2 10.8 10.1 12.4 20.7 20.6 14.5 6.5 16.3 17.4 26.3 15.4 10.2 18.2 14.0 19.0 13.4 10.5 18.9 7.5 14.9 16.1 NEUROD6 "Atoh2, bHLHa2, Math-2, Nex1, NEX1M" ENSG00000164600 "Neuronal differentiation 6" Q96NK8 7 31337465-31340726 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 24.5" "Cell type enriched" "Detected in some" 10 "Excitatory neurons: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "SCLC-21H: 6.5" "Region enhanced" "Detected in all" "hippocampal formation: 225.0" "Group enriched" "Detected in many" 9 "cerebral cortex: 20.9;hippocampal formation: 81.8" HPA074530 Enhanced NA NA "HPA074530: AB_2732257" "unprognostic (3.68e-2)" 0.0 0.0 7.3 0.0 12.9 0.0 0.0 4.6 13.5 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 6.1 0.0 0.0 0.0 0.0 4.5 3.8 10.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 12.9 4.6 13.5 24.5 6.1 4.5 3.8 10.0 6.3 3.8 3.6 10.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMT2 "C7orf60, DKFZp762M126, FLJ31818, SAMTOR" ENSG00000164603 "Base methyltransferase of 25S rRNA 2 homolog" Q1RMZ1 7 112819147-112939875 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Extravillous trophoblasts: 25.9;Hofbauer cells: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044405, HPA050733" Uncertain Approved Cytosol NA NA Cytosol "HPA044405: AB_10959783, HPA050733: AB_2681223" "unprognostic (5.26e-2)" "unprognostic (3.95e-2)" "unprognostic (2.86e-1)" "unprognostic (2.39e-1)" "unprognostic (2.48e-1)" "unprognostic (1.11e-1)" "unprognostic (7.61e-5)" "unprognostic (1.50e-3)" "unprognostic (1.61e-2)" "unprognostic (9.82e-3)" "unprognostic (1.68e-1)" "unprognostic (2.30e-1)" "unprognostic (1.04e-1)" "unprognostic (6.94e-2)" "unprognostic (1.13e-1)" "unprognostic (8.22e-2)" "unprognostic (9.10e-2)" 3.8 4.0 7.2 4.9 7.8 4.9 5.9 9.3 9.0 5.9 5.8 4.1 2.6 7.3 4.2 7.3 4.4 5.0 12.8 8.5 7.8 5.5 2.3 4.3 5.9 5.9 7.3 6.4 5.8 3.1 4.8 2.9 5.1 6.5 5.6 4.3 9.3 5.0 6.4 3.3 3.9 3.4 7.3 6.6 6.1 3.1 8.1 7.9 8.3 5.3 4.3 5.8 6.3 4.3 8.6 5.9 4.9 12.3 11.1 16.3 18.6 3.7 6.1 27.5 10.8 15.6 3.0 4.6 2.0 7.7 11.2 11.9 2.8 6.6 9.1 17.6 6.2 6.7 10.3 3.1 3.7 7.3 4.0 9.6 14.2 7.1 8.5 7.4 13.5 8.8 3.7 3.3 3.8 13.2 4.5 9.5 11.5 2.7 4.2 5.1 4.7 16.1 6.2 8.3 7.8 4.9 12.5 11.5 4.7 6.8 11.8 2.3 3.6 6.2 13.8 3.3 8.9 4.8 4.9 4.9 3.7 14.9 5.9 8.2 6.7 3.8 6.5 3.2 3.9 3.9 2.5 3.1 3.7 3.9 2.4 4.2 3.7 8.7 3.7 4.4 2.3 5.2 1.6 7.2 7.8 9.3 9.0 8.5 7.8 5.9 7.3 6.4 6.5 6.6 7.9 8.6 6.8 6.4 5.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 7.9 7.6 0.0 0.0 1.8 12.9 0.0 6.9 4.8 0.0 0.0 3.4 0.0 4.6 8.5 2.6 0.0 0.0 0.0 2.5 25.9 2.7 0.0 5.4 0.0 8.9 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.6 0.0 0.0 6.6 3.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 8.2 2.6 5.8 0.0 0.0 GPR85 SREB2 ENSG00000164604 "G protein-coupled receptor 85" P60893 7 113078331-113087778 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 39.4;choroid plexus: 18.4;retina: 12.2;skeletal muscle: 32.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 36.7;Early spermatids: 183.6;Horizontal cells: 84.1;Microglial cells: 40.3" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "HEL: 107.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.80e-2)" "unprognostic (1.93e-2)" "unprognostic (6.98e-3)" "unprognostic (3.92e-2)" "unprognostic (2.68e-2)" "unprognostic (2.41e-2)" "unprognostic (9.90e-2)" "unprognostic (1.94e-1)" "unprognostic (6.09e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.34e-5)" "unprognostic (5.89e-3)" "unprognostic (9.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-2)" 1.7 0.7 27.4 0.9 26.1 1.7 0.6 26.1 39.4 0.4 18.4 0.5 0.7 0.7 0.6 0.4 1.4 3.8 2.2 28.6 24.2 0.4 4.2 2.0 1.3 25.8 23.8 24.4 0.2 1.3 1.1 2.1 4.7 25.5 0.8 0.3 12.2 2.5 0.5 32.2 0.5 0.8 0.9 22.8 3.7 0.6 3.1 26.1 0.4 0.6 0.2 0.6 1.9 0.3 25.9 0.2 0.2 0.6 0.6 2.1 3.1 0.6 2.8 4.2 5.7 7.4 0.1 0.9 0.3 0.7 2.5 1.8 0.5 0.6 2.5 12.1 0.4 0.3 107.7 1.2 0.3 1.0 19.7 0.7 4.1 0.6 9.9 0.2 0.2 0.3 0.8 0.5 0.9 6.8 0.3 2.0 13.1 1.2 0.1 0.5 0.5 1.3 0.5 0.1 1.3 2.8 2.3 0.2 1.4 1.0 0.6 0.6 4.6 0.3 6.3 0.9 1.7 2.5 2.2 0.3 1.2 7.6 7.5 2.6 0.6 0.2 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.4 0.1 0.1 0.1 27.4 26.1 26.1 39.4 28.6 24.2 25.8 23.8 24.4 25.5 22.8 26.1 25.9 2.0 0.0 1.5 1.3 0.3 8.8 13.9 0.4 1.8 36.7 3.6 2.5 3.9 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 183.6 0.9 1.7 14.1 0.0 0.0 9.1 0.2 0.9 3.4 0.0 0.8 1.3 0.6 0.4 0.2 13.2 84.1 6.5 0.2 0.0 7.2 11.3 21.0 1.2 2.8 10.6 40.3 0.3 1.6 1.0 6.6 1.0 0.1 0.0 0.4 0.0 14.8 0.0 0.3 0.6 4.3 0.0 14.4 4.4 5.3 0.5 0.1 10.5 0.4 1.8 0.7 0.0 10.3 SLU7 9G8 ENSG00000164609 "SLU7 homolog, splicing factor" O95391 5 160401641-160421711 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035907, HPA058120" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA035907: AB_10671717, HPA058120: AB_2683612" "unprognostic (3.70e-2)" "unprognostic (7.18e-2)" "unprognostic (1.86e-2)" "unprognostic (9.96e-3)" "unprognostic (8.01e-2)" "unprognostic (3.52e-1)" "unprognostic (3.38e-3)" "unprognostic (3.76e-2)" "unprognostic (2.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (7.69e-2)" "prognostic favorable (1.98e-4)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" 22.3 23.4 28.2 19.7 28.9 49.0 27.7 29.6 46.9 21.3 24.9 21.0 17.1 20.1 26.1 22.1 18.1 18.9 26.1 29.3 28.6 24.6 24.6 23.5 27.5 27.7 28.0 27.0 21.5 16.5 24.8 11.0 21.3 29.2 21.4 21.1 29.7 25.0 19.9 32.9 22.8 21.6 18.4 26.8 28.1 23.6 27.5 28.1 30.7 32.5 33.3 31.6 21.7 12.3 30.6 24.5 29.6 26.0 36.2 33.4 35.1 33.1 33.9 49.3 35.9 43.8 40.1 29.1 39.5 34.2 36.6 36.9 27.0 22.9 37.7 45.2 65.1 33.0 29.4 39.0 26.2 33.7 49.8 34.9 38.1 34.3 33.8 38.1 37.7 25.7 35.3 26.7 36.0 33.2 21.5 24.7 32.1 18.6 25.2 26.5 21.4 53.4 40.4 31.6 37.8 30.9 42.7 40.1 35.6 62.2 21.6 47.7 46.4 32.7 34.5 18.2 26.1 36.3 40.1 48.8 34.9 51.2 33.1 33.4 49.9 22.2 39.2 26.7 24.9 25.5 30.0 25.2 27.2 20.2 26.1 27.2 26.7 54.2 33.9 36.5 21.6 29.4 22.8 28.2 28.9 29.6 46.9 29.3 28.6 27.7 28.0 27.0 29.2 26.8 28.1 30.6 42.7 67.3 67.8 9.8 53.7 44.7 39.9 55.5 24.5 70.2 25.7 26.3 71.4 24.3 57.1 25.8 25.0 38.1 70.9 34.1 50.9 52.2 126.2 43.0 41.6 44.1 39.5 68.8 19.8 55.8 39.7 43.0 17.9 51.3 46.3 34.7 35.3 24.6 38.4 57.2 18.3 34.7 54.9 47.3 57.3 34.3 47.8 46.9 65.8 20.6 65.8 61.6 64.9 9.0 15.2 50.5 45.3 47.4 33.1 40.0 39.8 39.5 62.0 49.4 46.0 49.6 50.1 88.9 54.6 27.4 41.5 94.1 52.0 41.9 27.8 52.5 RP9 PAP-1 ENSG00000164610 "RP9 pre-mRNA splicing factor" Q8TA86 7 33094797-33109404 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: AB_2681233" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 12.5 15.1 26.0 8.7 25.2 21.8 12.7 27.0 51.6 16.4 25.7 15.5 9.1 14.5 15.6 10.2 14.1 6.3 25.9 25.4 24.9 14.5 13.9 12.1 15.8 25.6 25.3 24.4 16.4 20.4 10.6 10.4 10.3 26.1 14.5 9.9 16.9 11.6 11.8 36.6 13.8 16.0 8.5 25.1 21.0 13.7 18.2 26.2 14.0 16.2 34.6 16.9 14.4 13.2 28.7 20.9 28.8 29.7 34.1 18.5 17.2 14.3 26.4 21.6 28.9 23.0 25.6 14.6 26.2 17.0 21.1 35.4 20.4 36.4 22.0 36.8 11.9 25.1 19.2 22.8 24.4 32.4 26.0 13.0 17.5 20.2 32.8 64.5 23.3 24.0 27.1 35.2 23.0 29.1 42.6 27.7 69.6 25.4 27.2 21.9 28.2 26.4 17.1 21.1 19.3 28.7 39.5 18.7 39.6 46.2 35.1 20.8 35.0 19.4 28.4 40.9 25.6 42.8 38.1 37.2 51.7 20.0 36.3 56.1 21.9 12.0 21.6 15.2 9.8 14.1 57.8 16.3 17.4 13.2 77.3 19.1 18.0 2.0 15.7 12.5 28.4 15.8 8.8 26.0 25.2 27.0 51.6 25.4 24.9 25.6 25.3 24.4 26.1 25.1 26.2 28.7 21.3 12.8 10.1 4.9 35.6 21.0 15.1 11.3 29.0 15.8 17.7 27.9 41.7 17.2 10.9 14.7 14.6 20.2 16.8 12.6 21.5 16.0 5.6 14.6 28.2 24.1 10.2 19.4 6.5 15.8 20.0 20.4 20.4 16.6 3.8 26.8 15.4 16.4 18.4 8.4 7.5 19.3 24.4 10.1 14.9 3.2 18.0 12.0 23.2 5.6 10.1 21.9 21.6 3.0 8.7 14.6 8.0 16.1 24.4 22.9 16.1 18.6 8.5 16.4 26.3 19.4 30.3 31.6 54.3 24.4 18.0 10.4 19.9 22.9 18.4 12.0 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "PTTG1 regulator of sister chromatid separation, securin" O95997 5 160421855-160428739 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 161.5;lymphoid tissue: 146.0;testis: 177.2" "Cell type enhanced" "Detected in many" "Early spermatids: 770.5;Erythroid cells: 415.9;Langerhans cells: 412.3;Spermatocytes: 708.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 218.0" "Lineage enriched" "Detected in all" 7 "T-cells: 218.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 3.7 3.6 7.0 25.4 7.8 161.5 11.0 7.0 10.4 5.9 7.0 34.2 24.9 4.9 9.7 60.2 5.0 6.2 2.9 11.0 8.7 2.7 5.3 8.8 82.2 6.7 7.2 7.4 1.8 1.5 2.3 4.4 21.4 7.2 3.1 44.6 2.4 10.4 2.7 2.5 36.3 24.3 19.4 7.3 18.8 11.9 177.2 8.2 128.2 80.0 1.4 146.0 12.7 20.0 9.1 345.4 178.2 385.8 279.5 64.4 63.3 120.8 177.5 406.1 463.4 503.5 341.1 294.9 373.3 154.7 204.2 527.5 176.1 243.5 496.1 661.2 428.3 220.3 196.7 241.8 208.6 13.0 181.5 165.6 29.6 81.5 315.4 189.5 139.9 333.4 243.3 160.7 282.3 485.4 162.3 220.7 446.1 197.5 279.3 251.4 199.4 452.4 320.7 239.6 82.6 241.0 151.3 258.6 156.3 535.6 309.3 319.9 195.7 144.8 208.3 275.9 164.9 531.3 239.2 235.6 432.3 225.9 310.4 379.6 9.7 3.2 10.3 25.5 8.7 9.6 30.9 52.3 60.6 23.9 23.5 12.7 31.4 3.0 14.6 5.8 22.6 218.0 19.8 7.0 7.8 7.0 10.4 11.0 8.7 6.7 7.2 7.4 7.2 7.3 8.2 9.1 11.8 6.4 21.5 0.0 40.0 247.9 64.5 163.6 142.3 3.4 15.8 40.5 4.0 4.3 31.1 5.5 0.0 125.4 38.3 17.7 3.9 5.8 770.5 22.7 9.3 20.6 6.0 415.9 1.3 5.3 196.2 35.6 28.1 16.7 37.5 66.2 18.5 7.1 87.5 0.0 1.6 39.2 126.1 36.3 412.3 105.1 11.1 39.1 87.2 0.0 24.7 3.5 6.2 0.0 0.6 3.0 10.7 7.9 91.4 54.1 9.0 2.0 17.1 1.0 6.6 18.6 43.2 708.0 57.3 232.0 156.1 31.9 73.7 16.8 70.3 50.3 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738495-134752157 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 845.6;Late spermatids: 1655.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA052636: AB_2681893, HPA056472: AB_2683143" "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 46.8 37.6 56.0 17.6 57.2 31.9 42.5 55.9 70.0 57.5 53.7 45.9 34.8 46.1 48.6 29.8 45.6 27.7 26.5 56.9 61.5 29.9 29.5 28.8 26.4 57.5 59.7 55.6 69.2 31.0 27.3 43.5 18.0 58.1 35.2 16.1 29.4 29.3 32.1 60.9 36.6 30.7 28.7 58.7 26.4 36.8 51.7 57.5 26.0 27.2 36.0 25.6 44.6 41.4 58.7 27.5 22.2 33.0 64.1 76.3 118.3 14.4 39.0 55.8 26.8 52.8 38.9 40.1 113.9 56.2 27.5 42.7 34.2 29.2 46.9 35.0 54.3 54.5 29.9 33.2 32.8 56.3 13.7 89.2 96.9 49.5 35.1 57.9 92.3 54.8 49.0 18.6 47.1 39.9 31.2 43.1 58.2 17.1 34.7 21.5 46.2 40.7 44.3 46.0 26.4 52.2 36.9 27.1 15.3 97.1 40.8 48.4 33.9 53.2 24.5 16.4 40.2 35.2 45.8 55.1 42.5 46.2 48.5 14.8 62.0 26.4 60.7 30.5 31.8 41.1 43.5 43.5 38.4 29.1 39.5 45.0 44.2 47.9 31.4 44.6 26.1 52.6 31.6 56.0 57.2 55.9 70.0 56.9 61.5 57.5 59.7 55.6 58.1 58.7 57.5 58.7 86.8 38.5 36.4 13.7 92.9 167.1 107.0 113.6 157.1 80.5 121.9 124.7 45.1 100.1 68.9 42.3 25.0 50.3 93.3 42.8 92.0 63.9 845.6 57.6 116.4 99.5 62.4 76.6 29.4 90.9 62.5 107.4 32.6 61.7 123.4 66.6 102.4 69.1 69.9 55.5 32.0 69.4 107.8 111.5 130.8 1655.8 168.0 76.6 96.0 10.3 126.9 127.7 90.6 15.1 18.6 67.5 58.0 132.4 55.2 148.6 158.2 199.1 51.3 71.4 98.6 119.5 109.7 241.5 68.6 119.3 201.6 73.2 101.6 67.9 90.9 107.9 BMPER "CRIM3, Cv2" ENSG00000164619 "BMP binding endothelial regulator" Q8N8U9 7 33904308-34156427 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Excitatory neurons: 286.9;Hepatic stellate cells: 117.8;Inhibitory neurons: 90.1;Oligodendrocyte precursor cells: 105.1" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 14.5;fHDF/TERT166: 17.0;HBF TERT88: 17.2;HSkMC: 15.5;hTEC/SVTERT24-B: 14.9;U-138 MG: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (4.50e-2)" "unprognostic (2.68e-1)" "unprognostic (2.83e-2)" "unprognostic (3.19e-2)" "unprognostic (1.93e-1)" "unprognostic (1.96e-4)" "unprognostic (5.34e-3)" "unprognostic (3.10e-1)" "unprognostic (9.98e-3)" "unprognostic (3.50e-3)" "unprognostic (8.01e-4)" "unprognostic (1.96e-1)" "unprognostic (5.67e-5)" "unprognostic (2.54e-1)" "unprognostic (2.62e-1)" "unprognostic (2.06e-2)" "unprognostic (3.47e-3)" 3.1 0.5 0.7 3.9 1.1 0.0 1.8 1.6 1.5 3.8 0.2 1.0 0.6 1.6 2.2 0.6 1.3 0.8 1.1 1.1 0.8 0.2 5.1 5.1 0.5 0.9 0.8 0.9 2.2 0.1 0.1 1.7 5.6 1.2 3.5 0.8 0.3 0.8 0.2 1.8 0.2 2.3 1.1 0.6 0.2 4.0 0.4 0.7 0.3 0.4 3.8 0.0 1.5 1.4 1.0 0.0 0.6 0.0 0.0 14.5 7.9 0.0 10.8 4.1 8.1 6.9 0.0 0.0 0.0 0.0 17.0 4.1 6.3 0.0 0.0 17.2 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 15.5 0.0 14.9 0.1 0.8 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 2.1 0.8 0.0 0.0 22.5 1.1 9.2 0.0 0.7 0.0 0.0 8.4 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 1.6 1.5 1.1 0.8 0.9 0.8 0.9 1.2 0.6 0.7 1.0 1.1 0.0 0.0 29.0 0.2 0.0 0.6 0.3 0.0 0.4 0.2 0.0 4.6 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 0.1 1.9 0.2 3.2 1.3 4.2 2.7 286.9 0.0 0.5 14.3 0.0 0.4 0.0 1.5 117.8 0.3 0.1 0.0 90.1 0.1 0.0 2.8 0.0 1.0 0.0 0.3 0.0 18.7 0.0 0.2 0.0 105.1 9.8 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.0 0.5 0.0 5.0 2.1 1.3 5.8 0.1 0.1 0.1 0.2 0.3 0.1 0.3 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.2;parathyroid gland: 16.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 28.5;Horizontal cells: 65.6;Inhibitory neurons: 28.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 31.7;JURKAT: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles NA NA Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 1.0 6.0 16.1 1.3 13.2 1.0 1.3 19.1 38.4 1.2 6.0 1.2 1.5 2.1 0.6 3.5 0.8 1.0 1.0 14.7 17.7 3.6 1.9 3.3 2.6 30.5 19.3 13.5 0.9 1.4 16.3 15.8 2.3 31.6 2.1 0.7 3.6 2.8 0.5 0.3 2.7 2.8 0.8 10.4 5.8 1.1 6.0 31.6 4.9 2.8 0.0 2.5 1.5 1.8 39.2 1.6 4.3 4.3 7.7 3.2 1.1 2.0 3.6 6.7 11.4 16.9 16.6 1.6 0.2 1.7 5.4 24.9 7.0 4.1 15.1 2.9 4.7 2.5 10.3 10.0 7.8 5.2 3.5 31.7 2.2 9.3 10.6 7.7 2.5 3.1 32.9 3.4 5.3 2.6 2.1 5.8 1.6 4.8 5.7 2.3 0.4 1.0 6.7 3.6 3.9 7.0 7.6 3.3 15.1 2.7 0.6 5.4 8.4 3.8 8.8 4.1 7.1 6.6 3.2 9.0 23.4 4.5 14.5 5.6 0.0 0.8 0.0 1.6 2.0 0.6 1.4 1.7 1.6 1.3 0.8 1.5 0.8 0.6 0.0 1.4 4.5 3.2 1.2 16.1 13.2 19.1 38.4 14.7 17.7 30.5 19.3 13.5 31.6 10.4 31.6 39.2 1.1 0.0 0.6 4.2 6.0 4.6 1.5 2.6 2.8 10.5 2.3 2.4 0.3 1.5 2.0 1.8 12.5 0.2 10.0 4.2 1.9 3.3 1.8 0.3 0.8 2.0 1.2 0.0 28.5 2.5 4.1 0.8 0.5 0.2 0.0 0.4 0.4 0.2 4.2 65.6 28.8 2.4 4.1 4.4 3.5 4.7 0.6 5.1 7.2 4.7 2.3 6.6 5.2 2.5 2.8 2.1 5.0 1.5 1.7 2.7 1.2 5.6 1.9 8.6 0.0 0.3 1.3 17.8 7.5 3.6 4.3 6.2 5.5 0.9 0.9 2.2 KCNK5 "K2p5.1, TASK-2, TASK2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188971-39229475 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.7;kidney: 36.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059148 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059148: AB_2683929" "unprognostic (1.46e-1)" "prognostic favorable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favorable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favorable (4.45e-4)" 4.0 3.7 0.1 2.2 0.1 9.7 5.3 0.0 0.1 3.9 0.1 12.2 28.7 2.2 0.2 6.2 2.4 19.0 1.1 0.0 0.3 36.3 23.7 6.2 2.7 0.2 0.2 0.0 6.5 20.5 2.0 1.2 8.7 0.1 3.6 8.6 0.1 27.3 2.5 0.2 25.4 35.7 1.3 0.1 2.2 16.9 0.7 0.3 1.8 10.0 0.1 1.9 3.2 6.7 0.1 6.6 5.9 7.7 2.9 0.0 0.0 6.6 0.0 0.0 0.0 0.0 34.9 14.3 0.0 10.2 0.0 0.8 13.2 6.0 0.2 0.0 0.0 4.5 36.1 3.1 0.2 0.0 7.5 31.8 0.0 0.1 0.2 0.0 0.0 0.0 7.8 34.3 0.1 0.0 11.4 16.7 8.1 14.4 27.4 0.0 0.0 1.4 13.6 5.3 5.4 1.9 1.5 5.7 7.3 0.0 2.9 25.9 12.1 0.2 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.1 0.3 0.1 2.3 0.0 19.2 0.0 0.1 3.7 2.5 1.5 5.7 0.0 4.2 3.2 0.6 48.6 7.7 1.8 0.0 28.8 0.8 55.6 5.9 14.5 0.1 2.6 0.3 6.9 0.0 6.1 0.0 11.8 5.3 3.2 31.6 5.3 0.0 2.2 0.0 27.5 2.1 0.0 0.0 15.3 8.2 0.6 3.5 0.7 0.6 0.8 1.8 0.0 0.6 0.0 0.0 0.0 0.0 12.1 25.1 0.0 0.4 2.6 66.5 45.4 1.0 0.0 0.0 2.4 0.6 0.0 1.1 8.2 2.7 45.6 3.5 1.4 11.1 10.4 KIF6 "C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317" ENSG00000164627 "Kinesin family member 6" Q6ZMV9 6 39329990-39725408 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;testis: 5.3" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 220.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 22.1;RPMI-8226: 9.2;SCLC-21H: 12.2;SK-MEL-30: 5.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.7" "HPA038811, HPA058624" Enhanced Approved Centrosome NA NA Centrosome "HPA038811: AB_10795140, HPA058624: AB_2683781" "unprognostic (4.94e-2)" "unprognostic (3.38e-2)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (1.55e-1)" "unprognostic (8.25e-4)" "unprognostic (3.12e-3)" "unprognostic (1.00e-1)" "unprognostic (3.06e-1)" "unprognostic (3.48e-2)" "unprognostic (9.12e-4)" "unprognostic (1.08e-1)" "unprognostic (3.07e-2)" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" 0.3 0.3 8.2 0.1 14.1 0.1 0.5 10.6 7.5 0.3 1.5 0.2 0.5 0.2 0.5 0.3 3.8 0.4 0.3 6.8 7.8 0.3 0.3 0.8 0.3 10.3 9.4 4.1 0.2 0.5 0.3 1.2 0.3 11.9 0.2 0.1 3.1 0.1 0.1 0.4 0.2 0.2 0.1 8.2 0.2 0.2 5.3 9.8 0.1 0.6 0.2 0.1 0.0 0.0 18.6 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.5 0.1 0.0 0.0 0.1 1.0 22.1 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.5 9.2 0.2 0.0 12.2 0.1 0.0 0.1 5.0 0.3 0.1 0.1 0.1 0.0 0.1 2.9 0.7 0.2 0.0 0.0 0.7 0.0 1.5 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.6 0.0 0.0 8.2 14.1 10.6 7.5 6.8 7.8 10.3 9.4 4.1 11.9 8.2 9.8 18.6 0.2 0.0 0.6 31.3 0.1 0.1 0.7 1.0 0.0 3.9 0.5 0.5 1.3 0.0 2.2 0.0 10.4 0.3 0.0 0.0 1.9 1.5 9.1 23.9 1.0 0.8 2.4 0.0 8.6 0.9 0.5 2.7 0.0 1.0 0.0 0.4 0.0 0.0 0.3 3.3 15.6 0.0 0.0 0.0 1.5 10.3 0.3 0.3 0.0 1.9 0.1 12.9 0.0 5.0 220.3 0.1 0.1 0.0 0.1 0.3 0.0 3.5 40.0 16.3 0.0 3.1 0.8 17.0 3.1 0.1 0.4 0.3 0.2 2.2 0.0 0.4 ZNF12 "GIOT-3, KOX3, ZNF325" ENSG00000164631 "Zinc finger protein 12" P17014 7 6688433-6706947 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 8.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063402 Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA063402: AB_2685005" "unprognostic (2.68e-1)" "unprognostic (6.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.84e-1)" "unprognostic (8.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-3)" "unprognostic (1.41e-1)" "unprognostic (6.67e-2)" "unprognostic (2.89e-3)" "unprognostic (5.52e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" "unprognostic (2.10e-2)" "unprognostic (4.36e-2)" "unprognostic (8.46e-3)" 8.8 8.8 9.8 8.3 9.2 8.6 13.8 13.4 9.3 12.2 10.5 9.7 10.1 13.9 13.9 10.4 10.4 9.3 9.0 9.1 9.2 9.8 10.3 8.6 13.5 9.8 9.8 7.6 14.4 9.1 18.7 8.7 13.4 10.3 11.4 10.5 15.4 10.1 12.2 6.8 10.6 11.3 9.8 9.0 13.4 10.3 5.3 10.9 12.4 14.0 10.1 13.5 9.9 10.1 10.0 16.5 7.7 15.0 18.9 15.1 15.2 14.4 10.2 18.3 12.8 13.3 10.5 9.4 12.5 6.9 12.7 28.8 19.3 12.5 9.9 19.4 4.7 9.4 12.6 11.9 10.6 14.1 20.2 13.1 16.7 21.6 9.2 14.8 19.0 9.4 9.9 20.3 11.2 17.1 13.1 7.8 18.6 18.2 5.2 11.7 10.2 21.5 7.7 10.4 16.2 13.7 24.2 11.8 21.2 12.4 18.7 13.5 22.7 9.4 14.3 18.0 11.5 13.7 10.6 7.3 12.6 11.7 13.4 19.4 8.8 0.5 0.7 1.4 0.4 1.9 1.1 1.1 1.6 0.5 1.1 1.5 1.9 0.5 1.2 0.4 1.1 1.0 0.2 9.8 9.2 13.4 9.3 9.1 9.2 9.8 9.8 7.6 10.3 9.0 10.9 10.0 15.1 9.6 8.9 16.3 14.1 26.9 16.3 8.0 11.4 27.9 16.3 15.1 17.2 12.8 10.7 3.7 16.7 11.7 15.3 8.3 1.9 8.7 1.2 10.4 15.8 13.9 7.7 12.4 15.9 6.8 9.0 14.9 6.6 12.7 11.4 27.3 15.4 10.3 10.1 37.0 16.7 11.9 2.0 13.0 10.9 2.7 22.4 8.4 5.4 18.7 11.3 20.9 15.5 9.5 19.9 9.1 8.8 22.6 11.6 13.3 10.1 7.0 12.6 18.9 26.3 17.6 16.7 12.7 7.8 16.7 22.4 8.6 11.2 23.9 12.1 18.1 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306912 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 43.7;choroid plexus: 44.8" "Group enriched" "Detected in many" 5 "Enteroendocrine cells: 103.2;Horizontal cells: 168.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 49.2;SH-SY5Y: 70.7;U-2 OS: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052829 Approved "Microtubules,Cytokinetic bridge" Yes No "Microtubules, Cytokinetic bridge" "HPA052829: AB_2681967" "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favorable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 43.7 8.2 12.7 0.7 11.6 0.6 13.4 17.0 19.5 4.8 44.8 2.7 4.6 5.5 5.1 1.1 4.0 1.7 2.7 26.6 24.1 5.3 9.3 0.9 0.2 22.7 24.9 10.3 2.2 15.5 1.7 3.7 0.6 25.9 5.9 1.8 4.2 1.3 0.7 2.7 2.4 5.6 1.9 14.9 1.7 6.6 2.6 26.0 0.3 9.8 0.4 0.1 2.4 2.1 14.9 0.0 21.7 12.6 49.2 0.6 0.2 2.4 1.8 0.1 1.6 0.9 12.3 0.4 0.0 2.4 1.9 8.1 0.3 4.8 0.4 0.5 0.1 2.8 0.2 0.7 18.3 3.8 0.2 3.0 1.5 16.2 0.3 0.9 2.9 1.5 4.5 3.6 0.1 1.2 10.8 2.0 0.9 16.0 1.5 1.3 8.3 2.1 1.9 3.2 0.5 8.4 70.7 1.3 4.4 0.9 10.7 5.5 5.9 0.7 17.3 23.4 1.6 0.5 1.1 0.0 0.1 2.2 0.7 8.0 0.8 0.3 0.2 0.2 0.1 0.4 0.2 0.1 0.2 0.1 0.4 0.2 0.2 1.3 1.6 0.1 0.3 0.1 0.1 12.7 11.6 17.0 19.5 26.6 24.1 22.7 24.9 10.3 25.9 14.9 26.0 14.9 0.5 3.2 0.5 8.8 0.0 0.1 0.2 0.1 0.0 6.9 0.7 0.6 2.5 0.0 0.2 0.0 16.7 0.3 0.2 6.3 0.0 5.3 0.1 3.3 3.0 0.6 103.2 0.0 2.4 0.2 0.4 2.2 2.0 0.7 0.0 25.7 0.0 1.0 0.4 168.2 14.3 4.4 0.0 0.3 0.7 0.7 0.3 0.3 0.0 0.0 0.1 4.8 0.0 4.0 0.6 1.4 0.5 0.4 0.1 2.3 0.8 0.2 1.4 1.6 0.0 0.5 2.2 0.4 4.2 0.1 0.3 0.3 0.3 1.7 1.0 0.2 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 6.3" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 2.2 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 1.1 0.5 0.8 2.2 0.6 1.1 0.7 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STEAP1 "PRSS24, STEAP" ENSG00000164647 "STEAP family member 1" Q9UHE8 7 90154456-90164829 "Cancer-related genes, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 84.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 140.5;Club cells: 72.6;Prostatic glandular cells: 85.1;Theca cells: 64.4;Urothelial cells: 54.0" "Cancer enriched" "Detected in all" 6 "prostate cancer: 94.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 105.1;CAPAN-2: 135.2;U-138 MG: 169.2" "Low region specificity" "Detected in many" HPA030985 Uncertain NA NA "HPA030985: AB_2673686" "unprognostic (2.88e-3)" "unprognostic (2.29e-1)" "unprognostic (1.19e-1)" "unprognostic (3.21e-3)" "unprognostic (9.20e-3)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" "unprognostic (6.74e-3)" "unprognostic (6.36e-2)" "unprognostic (6.45e-3)" "unprognostic (8.31e-3)" "unprognostic (3.79e-1)" "unprognostic (2.60e-2)" "unprognostic (4.39e-2)" "unprognostic (2.42e-1)" "unprognostic (6.09e-2)" "unprognostic (1.38e-1)" 33.2 2.2 1.3 33.2 1.7 0.0 18.7 1.1 2.3 9.7 1.6 18.3 5.2 4.2 0.8 12.7 10.8 16.6 4.8 1.4 1.3 6.7 27.8 14.3 0.3 1.6 1.1 1.5 6.1 6.0 0.3 3.7 0.7 1.3 84.6 13.8 0.7 15.2 2.1 1.3 4.3 7.9 27.1 1.2 2.5 14.0 4.2 1.3 0.9 5.0 2.5 4.7 34.9 5.9 1.4 26.9 52.5 3.3 9.8 105.1 89.5 0.9 17.8 20.5 2.4 2.7 38.8 135.2 0.3 0.9 28.9 43.5 5.3 22.0 22.6 5.1 0.0 7.6 0.1 0.5 13.0 4.3 0.0 0.1 59.7 3.7 68.0 37.4 16.6 92.6 7.3 1.2 74.0 29.6 0.4 0.0 0.9 15.7 1.3 23.2 0.1 0.0 0.3 20.8 5.5 0.0 1.2 6.4 0.2 12.1 1.9 29.4 0.4 50.8 169.2 8.0 83.9 22.8 14.0 0.5 0.1 83.4 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 1.1 2.3 1.4 1.3 1.6 1.1 1.5 1.3 1.2 1.3 1.4 1.8 0.0 0.5 2.3 0.3 4.2 41.9 140.5 7.4 0.1 12.8 11.4 0.8 5.7 72.6 1.8 0.0 0.0 0.6 7.0 0.0 3.4 0.4 1.3 4.9 4.5 7.2 0.0 5.3 38.6 0.1 25.2 10.7 4.6 0.0 10.5 1.8 33.1 0.5 0.0 1.7 4.3 24.4 0.8 5.4 1.1 0.9 1.3 7.2 0.0 0.0 10.5 0.0 1.5 1.3 44.4 20.5 1.5 1.3 85.1 2.5 14.7 13.1 0.3 6.6 6.0 26.9 17.1 36.9 12.2 2.3 0.3 0.4 64.4 16.6 54.0 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900899-21945903 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 52.2" "Cell type enhanced" "Detected in many" "B-cells: 51.0;Spermatogonia: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 101.0;naive B-cell: 124.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory bulb: 10.1" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No Yes "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 4.2 1.4 6.1 15.1 9.1 52.2 15.9 5.6 4.6 6.8 15.0 17.2 10.8 13.9 5.6 11.3 11.6 8.2 25.6 3.7 3.1 2.6 4.8 14.1 37.4 6.9 4.7 3.2 22.0 13.1 1.8 1.1 4.7 6.4 7.3 19.2 5.1 9.0 7.7 6.3 18.7 13.7 12.0 6.2 13.4 18.0 18.7 5.2 49.5 30.1 3.4 32.1 6.4 8.1 10.0 84.5 27.6 26.0 0.6 14.5 17.9 0.0 65.9 58.2 51.8 73.5 11.3 75.4 173.6 21.8 59.3 102.4 51.1 41.4 69.4 103.6 0.3 28.6 42.3 83.8 7.4 21.1 111.1 0.4 35.2 12.7 40.0 116.9 54.9 104.8 133.5 58.3 0.1 41.4 34.5 146.1 46.1 153.2 17.4 36.2 141.0 94.0 119.8 15.4 14.8 96.9 79.7 30.3 19.9 29.9 34.4 45.6 54.6 43.0 57.1 68.5 101.3 83.8 90.6 63.6 223.0 55.7 154.6 54.5 1.1 2.3 43.2 2.2 3.8 0.3 101.0 6.4 3.2 14.9 124.5 30.9 12.8 3.8 3.4 4.9 75.9 9.9 12.2 6.1 9.1 5.6 4.6 3.7 3.1 6.9 4.7 3.2 6.4 6.2 5.2 10.0 1.0 19.2 31.5 7.5 51.0 27.1 23.7 6.9 17.1 1.5 12.5 20.7 38.7 11.5 19.0 0.0 2.1 0.5 30.7 8.4 3.9 8.9 7.3 5.4 2.7 4.8 10.7 21.9 0.5 6.2 0.3 13.4 18.3 5.3 8.8 14.9 1.4 4.0 10.8 13.5 1.0 26.1 8.2 15.2 3.5 5.2 4.1 7.0 8.8 1.9 1.6 2.4 1.0 15.1 8.7 3.9 7.4 2.6 20.2 14.2 1.5 0.1 4.2 2.7 13.1 6.8 12.4 4.6 63.5 9.6 7.7 0.3 5.4 8.3 23.0 6.2 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782279-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.0;prostate: 6.6" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 3.5;Inhibitory neurons: 5.3;Paneth cells: 1.2;Prostatic glandular cells: 2.9;Spermatocytes: 1.1;Spermatogonia: 1.5;Urothelial cells: 1.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HUVEC TERT2: 6.4;NTERA-2: 12.6;PC-3: 21.6" "Group enriched" "Detected in many" 11 "basal ganglia: 15.3;olfactory bulb: 54.5" "Region enriched" "Detected in some" 11 "olfactory bulb: 29.8" HPA054006 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054006: AB_2682340" "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.0 0.0 1.0 0.0 2.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 6.6 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 1.2 0.0 0.0 0.0 4.3 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.6 0.1 21.6 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 2.7 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.0 0.0 4.0 0.8 1.5 3.8 0.0 0.5 0.4 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.0 0.0 0.0 0.0 0.0 0.2 1.0 MIOS "FLJ20323, MIO, Sea4, Yulink" ENSG00000164654 "Meiosis regulator for oocyte development" Q9NXC5 7 7566875-7608932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 86.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042928, HPA052223" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042928: AB_10795610, HPA052223: AB_2681768" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (6.93e-2)" "prognostic favorable (6.51e-4)" "unprognostic (3.42e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (1.44e-2)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.28e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-2)" "unprognostic (7.67e-3)" "unprognostic (2.72e-1)" 10.1 9.6 6.7 15.4 6.2 19.0 14.7 12.1 8.5 10.6 22.2 11.4 8.9 10.0 10.5 23.1 10.8 10.0 12.0 5.4 8.2 12.7 17.5 11.8 22.6 6.3 7.2 5.1 13.4 17.5 28.4 9.0 11.7 6.4 21.9 13.1 19.0 13.7 11.3 86.2 18.0 9.3 12.3 7.3 15.4 13.5 19.4 6.5 16.3 9.4 51.5 30.2 14.0 14.4 7.6 42.4 18.8 21.8 26.4 17.1 35.9 18.3 32.9 26.8 20.6 20.6 23.2 16.5 37.1 9.9 19.7 55.3 37.6 23.1 24.2 27.0 14.8 19.5 9.5 22.5 16.1 24.3 40.1 10.2 30.9 29.0 18.3 46.2 20.1 18.2 12.4 47.2 29.4 88.0 29.1 9.2 17.0 45.3 21.3 19.8 27.4 33.4 36.3 19.0 21.3 23.0 37.2 17.7 49.1 19.3 40.5 26.7 35.1 15.7 31.3 33.2 17.4 27.7 25.9 30.9 33.2 27.6 23.0 37.2 0.0 5.4 8.8 4.3 9.9 3.6 10.1 4.6 4.2 7.6 8.8 6.0 4.9 0.6 5.4 5.0 4.5 5.1 4.0 6.7 6.2 12.1 8.5 5.4 8.2 6.3 7.2 5.1 6.4 7.3 6.5 7.6 8.2 9.6 11.9 18.6 30.3 12.1 14.8 6.6 15.4 8.2 13.2 10.8 18.2 12.8 9.2 7.3 12.5 16.8 12.2 9.0 17.6 11.7 38.5 22.7 11.4 7.5 4.2 15.6 22.9 17.5 8.7 9.3 16.3 18.6 9.5 15.4 6.8 17.0 15.5 11.8 21.0 7.2 4.1 22.7 12.2 57.9 5.9 18.4 7.2 27.2 10.1 9.4 13.4 23.1 18.2 14.1 11.3 7.5 19.4 24.9 6.7 11.3 11.0 17.0 13.1 13.1 9.3 36.0 30.4 24.8 18.9 21.2 15.3 15.3 11.1 19.7 ELAPOR2 "EIG121L, FLJ31340, KIAA1324L" ENSG00000164659 "Endosome-lysosome associated apoptosis and autophagy regulator family member 2" A8MWY0 7 86876906-87059654 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.4" "Cell type enhanced" "Detected in some" "Adipocytes: 12.9;Cardiomyocytes: 2.8;Endothelial cells: 2.2;Fibroblasts: 2.3;Smooth muscle cells: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.9;NK-cells: 2.3;T-cells: 2.7" "Cell line enhanced" "Detected in many" "AF22: 31.2;hTERT-HME1: 36.0;HUVEC TERT2: 30.8;K-562: 49.6;SCLC-21H: 38.7;SuSa: 33.8;TIME: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044527, HPA076093" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044527: AB_10963793, HPA076093: AB_2686776" "unprognostic (2.78e-2)" "unprognostic (9.37e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-4)" "unprognostic (3.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.33e-3)" "unprognostic (1.89e-1)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (6.82e-2)" "unprognostic (8.82e-3)" "unprognostic (3.86e-3)" "unprognostic (1.25e-1)" "unprognostic (4.32e-1)" "unprognostic (1.37e-1)" 10.4 3.6 9.5 2.0 23.2 0.9 4.6 12.7 16.7 3.1 0.0 4.3 1.5 3.5 0.5 3.7 3.2 4.3 4.9 6.3 15.5 2.4 1.2 22.0 3.4 17.3 15.2 2.6 2.1 4.7 8.4 3.1 7.9 22.2 6.2 5.4 5.8 2.3 5.1 2.4 1.9 2.4 5.4 17.2 5.9 3.2 3.1 19.1 3.7 5.1 4.0 3.6 5.2 1.6 50.4 1.9 0.0 31.2 0.0 0.4 0.0 8.2 0.7 0.0 0.1 0.0 0.1 0.5 0.3 7.8 0.7 0.3 0.0 3.4 0.0 0.1 7.8 0.7 24.8 8.6 2.9 0.3 0.2 3.1 2.5 0.1 0.0 36.0 0.2 30.8 12.1 49.6 0.8 3.4 9.9 0.7 0.0 17.1 0.1 7.9 0.0 2.2 5.2 3.2 14.3 38.7 28.9 8.5 11.1 3.6 33.8 3.3 0.6 36.5 0.4 11.9 0.3 0.0 17.2 10.9 0.2 9.1 0.0 0.4 0.0 0.0 0.2 0.3 0.0 2.7 0.4 0.9 0.6 0.2 1.9 0.9 0.5 0.0 2.3 0.0 0.4 0.4 0.3 9.5 23.2 12.7 16.7 6.3 15.5 17.3 15.2 2.6 22.2 17.2 19.1 50.4 12.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 USP49 MGC20741 ENSG00000164663 "Ubiquitin specific peptidase 49" Q70CQ1 6 41789896-41895361 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 48.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 5.1" "Cell line enhanced" "Detected in all" "REH: 46.7;U-698: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030254, HPA030255" Uncertain NA NA "HPA030254: AB_10600198, HPA030255: AB_10601218" "unprognostic (1.71e-1)" "unprognostic (4.86e-3)" "unprognostic (1.93e-1)" "unprognostic (2.57e-4)" "unprognostic (4.46e-2)" "unprognostic (2.84e-4)" "unprognostic (7.17e-3)" "unprognostic (5.06e-2)" "unprognostic (1.19e-2)" "unprognostic (3.22e-1)" "unprognostic (5.59e-3)" "unprognostic (8.28e-2)" "unprognostic (1.26e-5)" "unprognostic (5.39e-2)" "unprognostic (4.58e-2)" "unprognostic (4.37e-3)" "unprognostic (3.24e-3)" 2.5 2.8 4.9 2.6 3.7 5.4 2.6 6.2 4.3 3.4 0.7 2.2 1.7 3.0 1.6 1.9 2.6 1.6 2.0 3.9 3.3 1.7 1.6 2.8 2.6 3.6 2.9 3.6 3.2 2.0 1.5 2.7 1.4 3.9 2.3 1.5 9.4 2.1 1.6 3.0 3.0 1.7 1.6 1.1 2.6 1.9 4.8 3.3 6.8 7.0 1.0 2.5 2.5 2.6 4.3 6.0 1.8 23.6 11.6 2.8 3.0 9.7 2.3 2.2 3.4 4.3 7.5 1.4 24.5 2.5 2.9 4.9 2.6 14.7 2.2 5.1 6.1 11.0 8.8 10.3 2.7 2.0 6.9 5.2 3.1 1.7 5.0 3.1 3.1 2.2 24.9 18.7 6.4 2.6 3.5 26.7 10.5 6.5 6.4 2.2 46.7 11.3 5.4 1.4 4.1 15.8 6.5 3.1 1.1 1.3 5.5 3.5 6.1 6.1 8.1 8.0 2.6 3.1 12.2 11.4 63.9 1.0 6.9 1.5 5.1 0.4 0.6 0.3 0.4 0.2 0.6 0.2 0.3 0.1 0.4 0.4 0.3 1.0 0.4 0.5 0.3 0.2 0.2 4.9 3.7 6.2 4.3 3.9 3.3 3.6 2.9 3.6 3.9 1.1 3.3 4.3 2.4 0.0 9.7 20.2 2.0 5.0 3.0 3.9 1.2 27.5 3.6 3.3 4.6 4.3 6.5 5.5 43.8 2.9 4.5 1.4 1.9 1.9 6.5 4.1 5.0 2.8 0.0 8.2 42.8 2.0 1.6 4.3 3.1 4.6 1.3 4.8 1.4 2.1 2.0 15.2 48.6 1.9 4.1 3.1 4.6 7.2 3.7 3.1 3.6 14.0 5.0 2.8 2.1 56.3 31.8 2.6 1.9 6.0 3.0 4.5 2.1 1.1 7.1 10.9 6.6 6.2 3.4 13.3 14.3 2.7 6.3 5.7 2.4 5.1 2.2 4.6 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "basophil: 232.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 232.0" "Cell line enhanced" "Detected in many" "HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favorable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 4.9 1.8 2.0 7.6 1.7 14.0 4.3 2.5 1.6 6.1 19.8 3.8 3.8 3.5 6.4 4.1 14.5 4.9 6.4 2.2 5.3 4.8 2.5 17.0 8.4 3.8 3.1 0.6 2.8 1.5 1.9 2.1 1.6 3.3 5.4 2.4 0.4 15.4 5.8 15.1 3.2 10.0 2.8 3.5 19.9 7.1 3.8 2.5 17.6 25.5 8.3 6.1 5.0 3.7 4.2 7.1 1.0 0.1 0.5 0.9 0.9 0.4 3.1 2.0 0.8 2.1 0.6 5.8 0.1 0.5 5.3 2.6 0.8 0.1 0.9 2.9 15.1 0.4 5.8 0.2 0.0 1.7 1.7 23.9 3.1 2.1 6.1 1.0 2.6 1.4 1.1 0.3 5.6 6.8 0.3 0.1 2.0 0.1 1.3 1.0 0.0 5.6 0.7 2.8 0.4 15.6 1.2 1.0 9.7 0.8 0.3 2.0 0.3 8.8 18.9 19.1 0.5 0.6 28.5 7.1 0.6 12.0 8.3 0.6 232.0 16.0 0.8 37.3 3.3 22.0 1.0 14.7 25.3 4.6 0.3 15.7 19.3 35.5 43.1 1.4 1.3 16.4 18.9 2.0 1.7 2.5 1.6 2.2 5.3 3.8 3.1 0.6 3.3 3.5 2.5 4.2 2.8 16.0 13.1 2.3 23.5 4.6 2.9 4.4 1.8 0.2 4.4 3.7 4.1 1.5 15.9 14.7 2.1 1.3 334.2 1.0 5.9 0.8 10.8 51.0 3.0 4.2 0.0 4.4 3.4 0.6 0.5 4.8 17.3 37.4 135.4 0.4 3.9 1.9 4.2 0.0 4.8 1.8 4.1 11.5 20.3 18.1 0.0 26.6 10.6 28.1 17.6 0.1 132.8 2.0 2.5 0.6 0.1 0.7 135.2 1.8 2.0 1.9 51.5 0.5 0.0 2.3 2.4 2.1 8.4 2.6 4.4 1.9 230.2 0.9 1.3 3.1 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452193-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 33.7" "Group enriched" "Detected in many" 7 "Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Intermediate filaments, Cytosol" "HPA049626: AB_2732554" "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.1 0.6 1.0 0.0 0.4 0.0 0.6 1.8 1.0 0.8 3.2 0.0 0.0 0.7 1.1 0.0 5.1 0.9 0.1 0.2 1.4 3.0 0.0 0.8 0.0 1.6 1.5 0.0 0.2 0.3 1.7 1.0 0.1 1.1 0.5 0.0 1.1 0.2 0.6 0.1 0.1 0.0 0.2 1.4 0.0 0.1 33.7 0.6 0.0 3.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.8 1.0 0.2 1.4 1.6 1.5 0.0 1.1 1.4 0.6 0.5 1.1 6.4 0.5 19.6 0.0 0.5 0.7 3.8 0.0 2.5 1.9 1.8 1.8 0.0 11.4 18.4 4.2 0.4 0.1 0.1 1.9 1.1 283.9 82.6 3.2 0.9 1.8 0.0 12.0 0.4 0.3 1.1 0.0 1.7 1.3 0.3 0.7 0.0 0.1 3.3 8.6 0.2 8.2 0.0 0.3 157.5 2.5 0.4 0.0 4.7 0.3 1.8 0.0 5.0 2.6 0.2 0.0 3.0 0.0 0.5 0.0 5.7 88.2 9.0 6.6 0.7 2.7 116.2 6.0 0.2 0.1 0.7 0.3 2.9 0.0 0.3 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79762371-79767857 "Cancer-related genes, Predicted intracellular proteins, Transcription factors, Transporters" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 105.2;Endothelial cells: 47.6;Extravillous trophoblasts: 112.6;Skeletal myocytes: 74.5" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "HEK 293: 125.7;PC-3: 28.8;SK-MEL-30: 93.3;WM-115: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055599: AB_2682858, HPA063472: AB_2685018" "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 20.7 2.2 17.7 2.1 21.5 0.6 19.1 20.5 19.2 7.3 12.9 6.1 1.7 3.6 0.9 2.8 3.9 4.2 21.7 18.3 20.2 2.4 2.8 15.4 2.3 18.2 21.1 17.5 2.0 3.4 3.3 18.5 18.0 18.6 6.1 2.6 5.4 10.2 1.7 19.7 3.8 5.8 3.2 18.3 2.4 4.8 3.1 20.6 3.4 6.5 16.3 2.5 9.3 5.2 18.0 1.7 0.1 1.1 9.1 0.8 0.7 22.0 2.1 2.1 0.3 0.3 0.1 0.1 3.3 2.3 1.0 1.0 4.6 4.9 0.1 0.2 0.5 125.7 0.0 4.1 2.1 1.4 0.0 0.7 1.3 3.7 0.1 16.2 0.4 3.4 0.0 9.0 3.6 1.3 0.1 0.0 0.5 0.1 0.3 28.8 0.0 4.6 3.3 0.4 3.9 5.2 14.6 0.1 2.4 93.3 19.6 0.1 0.1 2.0 0.7 2.4 0.0 1.8 3.3 0.7 0.2 3.4 0.0 31.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 0.0 1.3 0.0 0.0 0.0 17.7 21.5 20.5 19.2 18.3 20.2 18.2 21.1 17.5 18.6 18.3 20.6 18.0 105.2 0.0 1.8 15.0 0.8 3.2 3.4 27.6 2.8 6.8 8.6 12.2 4.3 0.0 19.5 0.0 0.0 6.8 1.8 5.3 15.6 2.6 4.6 12.6 4.1 47.6 36.8 0.0 7.7 1.2 112.6 5.3 1.5 33.5 10.8 1.9 41.0 0.9 1.8 21.9 8.0 2.0 26.4 0.6 5.7 3.2 0.0 2.3 33.8 20.6 0.0 10.9 0.0 18.6 1.0 0.7 7.5 0.4 0.8 1.7 0.2 0.4 7.7 12.2 0.0 74.5 12.1 0.6 15.4 3.4 3.0 23.4 1.1 1.5 2.5 2.6 ZNF704 "FLJ16218, Gig1" ENSG00000164684 "Zinc finger protein 704" Q6ZNC4 8 80628451-80874781 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 170.8;Oligodendrocyte precursor cells: 299.6;Oligodendrocytes: 342.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 72.8;RH-30: 46.0;SH-SY5Y: 58.4;SK-BR-3: 72.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024285, HPA024302" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024285: AB_2219847, HPA024302: AB_1859427" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.27e-1)" "unprognostic (3.39e-3)" "unprognostic (6.86e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (1.34e-1)" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (1.26e-1)" "prognostic favorable (4.02e-4)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.90e-2)" 10.0 5.4 16.0 1.8 17.1 0.7 8.6 27.8 12.0 18.8 0.5 7.4 2.8 17.1 7.3 3.0 13.4 6.4 12.3 12.2 9.9 9.3 3.8 7.5 1.4 17.2 14.9 7.2 20.0 20.2 13.9 2.2 5.1 15.4 10.3 6.1 2.5 15.0 8.4 6.5 5.0 4.8 7.2 13.9 3.2 5.2 4.5 13.9 7.0 6.0 8.0 1.1 6.5 7.6 30.5 0.0 2.6 11.5 0.1 0.0 0.0 15.7 0.1 0.0 0.1 0.0 1.3 1.9 0.1 4.5 0.0 0.9 72.8 1.1 2.0 0.0 0.0 12.1 4.3 5.7 9.8 0.0 0.8 0.3 0.4 0.1 0.0 0.3 0.1 4.7 0.6 0.0 0.4 0.1 7.6 11.2 0.2 1.0 6.3 1.1 7.7 46.0 0.2 0.0 25.4 14.5 58.4 2.3 72.2 21.3 3.8 11.6 1.6 0.2 0.0 11.8 0.2 2.5 0.1 0.1 0.3 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.0 17.1 27.8 12.0 12.2 9.9 17.2 14.9 7.2 15.4 13.9 13.9 30.5 31.6 51.3 25.9 63.0 0.4 18.5 25.5 4.8 16.5 21.3 28.6 23.4 35.0 21.5 16.5 25.8 0.0 8.8 1.1 20.7 5.9 21.6 20.0 25.5 52.6 21.9 13.8 3.8 112.8 24.5 6.5 40.1 10.7 35.9 27.8 28.7 30.0 10.6 3.2 20.2 170.8 24.7 8.2 5.7 15.7 46.8 32.9 3.6 32.0 56.2 0.0 17.0 0.0 299.6 342.4 9.4 26.5 25.6 0.2 34.7 17.9 18.1 12.8 3.1 13.1 45.1 29.5 1.8 4.2 5.4 5.1 2.9 3.4 60.3 26.2 36.2 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280536-81284777 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "esophagus: 3720.6;vagina: 2621.6" "Cell type enhanced" "Detected in all" "Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0" "Group enriched" "Detected in all" 4 "cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 1167.2;MOLT-4: 1213.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 14000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: AB_2681654" "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 334.5 15.6 125.4 139.0 120.9 112.7 243.8 122.3 147.7 653.8 284.7 259.2 84.1 63.3 4.8 3720.6 22.6 88.5 248.7 124.3 151.1 16.5 27.8 274.9 193.0 179.1 125.6 109.3 12.2 73.8 447.2 33.0 341.7 163.4 23.1 212.6 33.6 519.0 17.2 120.3 612.9 123.3 52.9 143.2 128.4 182.9 45.5 126.6 138.9 75.5 308.8 295.3 366.0 2621.6 151.6 76.9 215.9 133.1 0.3 615.7 59.0 0.3 158.0 8.9 123.2 153.3 2.2 100.3 1167.2 86.7 38.3 1.1 69.2 328.9 254.8 103.7 597.6 603.2 449.0 136.2 345.0 54.2 421.6 107.9 45.0 507.0 146.8 306.1 121.3 708.9 328.6 125.9 124.1 73.7 69.3 1213.7 199.9 170.5 785.1 732.1 526.0 0.4 127.7 198.9 951.4 514.4 190.7 74.1 24.7 61.0 230.2 1.2 201.6 97.0 0.1 331.3 1.6 1.4 155.6 70.1 902.2 52.2 396.8 184.9 8.1 14.3 0.9 6.1 16.6 9.3 17.2 6.9 13.7 55.9 10.4 3.1 11.9 5.2 22.3 5.5 54.8 9.8 13.4 125.4 120.9 122.3 147.7 124.3 151.1 179.1 125.6 109.3 163.4 143.2 126.6 151.6 2511.2 288.4 1891.0 30.7 93.0 121.0 90.0 881.2 727.3 23.7 22.3 48.6 5.7 2.8 649.8 22.0 45.9 28.0 97.5 420.3 3.9 35.4 29.5 55.7 579.5 662.2 197.2 74.4 7.7 23.8 272.4 140.6 278.8 29.6 55.8 70.1 35.3 1.4 2385.2 21.9 10.9 216.3 175.0 182.2 764.3 46.0 6.2 405.5 206.3 4.7 697.1 273.0 15.5 6.0 16.3 43.3 561.0 5.3 132.9 71.3 10.4 2.3 115.7 43.5 361.6 140.0 336.8 179.4 182.5 9211.0 168.6 27.0 102.3 68.8 419.2 232.6 SHH "HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS" ENSG00000164690 "Sonic hedgehog signaling molecule" Q15465 7 155799980-155812463 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein, Hydrolase, Protease" "Disease variant, Holoprosencephaly, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 8.8;liver: 13.7;stomach 1: 10.6;urinary bladder: 16.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 8.3;Cholangiocytes: 18.6;Collecting duct cells: 9.2;Gastric mucus-secreting cells: 9.7;Hepatocytes: 20.1;Intestinal goblet cells: 8.6;Pancreatic endocrine cells: 11.7;Urothelial cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.9;GAMG: 39.8;OE19: 10.2;RT4: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 5500000 "unprognostic (7.17e-2)" "unprognostic (7.68e-3)" "unprognostic (6.70e-2)" "prognostic favorable (8.62e-5)" "unprognostic (1.59e-1)" "unprognostic (2.50e-2)" "unprognostic (2.39e-3)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.16e-2)" "unprognostic (3.47e-1)" "unprognostic (1.56e-1)" "unprognostic (1.77e-3)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (3.43e-2)" "unprognostic (2.66e-2)" 0.0 8.8 1.5 0.3 1.0 0.0 0.0 1.6 1.5 4.5 0.2 1.3 1.4 0.4 3.0 0.0 0.1 3.8 0.0 0.8 5.3 2.8 13.7 1.8 0.0 3.0 1.3 0.7 0.0 0.2 0.0 0.1 0.0 5.3 1.2 1.0 0.3 0.0 1.2 0.0 0.1 1.4 0.0 0.9 0.0 10.6 0.1 2.4 0.0 0.0 0.0 0.0 16.3 0.3 2.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.2 0.0 8.9 0.0 39.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 10.2 4.0 0.0 0.0 0.0 2.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.5 1.0 1.6 1.5 0.8 5.3 3.0 1.3 0.7 5.3 0.9 2.4 2.2 0.0 3.2 7.8 0.0 0.0 0.0 8.3 0.0 0.0 1.5 0.0 0.0 0.7 18.6 1.3 9.2 0.0 0.0 0.0 3.7 0.0 1.2 4.7 5.4 0.5 0.2 0.0 0.0 0.1 0.8 0.2 0.1 9.7 7.6 0.0 0.0 0.4 20.1 0.0 0.0 0.4 8.6 0.0 0.6 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.7 0.5 0.4 0.1 1.3 2.5 6.6 0.0 0.1 0.0 0.0 0.1 2.7 0.2 0.0 0.0 0.0 0.0 0.0 3.0 8.3 TAGAP "ARHGAP47, FLJ32631, IDDM21" ENSG00000164691 "T cell activation RhoGTPase activating protein" Q8N103 6 159034468-159045152 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 148.0;lymphoid tissue: 48.0" "Cell type enhanced" "Detected in many" "B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4" "Low region specificity" "Detected in all" "HPA031000, HPA039982" Uncertain Approved Cytosol NA NA Cytosol "HPA031000: AB_10610560, HPA039982: " "unprognostic (9.86e-3)" "unprognostic (7.55e-2)" "unprognostic (2.41e-2)" "unprognostic (1.56e-2)" "unprognostic (6.36e-2)" "unprognostic (3.10e-3)" "unprognostic (1.04e-1)" "unprognostic (5.25e-2)" "unprognostic (3.35e-3)" "unprognostic (8.39e-2)" "unprognostic (6.19e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (5.24e-2)" "unprognostic (7.39e-2)" 5.0 2.9 1.2 29.2 1.1 148.0 4.0 1.4 1.9 3.5 4.1 6.0 4.4 9.6 2.3 4.1 2.0 6.9 1.6 1.1 2.0 1.3 4.2 8.5 39.9 2.0 1.2 0.4 2.2 0.9 0.7 0.8 3.4 2.0 2.9 8.3 1.5 3.0 1.8 0.7 1.2 10.3 26.2 2.9 23.0 7.3 1.6 1.7 24.5 1.6 2.3 48.0 10.1 1.2 3.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 30.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 6.2 0.0 0.0 0.0 15.6 42.5 0.3 0.0 0.0 0.0 0.0 0.0 9.0 0.1 43.8 0.0 0.0 4.0 8.2 12.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 0.3 0.2 0.0 0.1 0.1 1.2 0.0 6.9 0.2 0.0 0.0 0.0 0.0 4.7 20.6 39.6 0.0 33.4 0.0 163.6 27.8 88.4 54.8 20.4 62.6 45.9 73.9 64.6 27.9 46.6 56.9 40.8 169.7 45.6 27.6 9.3 57.5 60.9 1.2 1.1 1.4 1.9 1.1 2.0 2.0 1.2 0.4 2.0 2.9 1.7 3.2 5.2 3.2 6.6 0.0 249.5 2.8 0.3 0.2 3.4 0.3 4.4 6.0 0.6 0.0 1.4 0.0 0.0 0.7 152.3 0.2 0.0 0.1 0.3 0.5 0.4 5.2 0.0 8.8 1.2 0.0 0.6 4.3 16.8 0.5 19.0 1.8 1.4 0.8 24.9 0.0 1.0 0.0 0.0 21.9 60.2 1.1 1.2 91.1 28.4 20.6 21.5 0.4 86.5 1.5 0.0 0.0 0.0 22.6 272.1 0.3 0.0 0.3 1.2 0.2 0.0 0.8 2.0 0.1 0.1 2.0 2.7 0.8 223.6 4.6 0.4 0.3 COL1A2 OI4 ENSG00000164692 "Collagen type I alpha 2 chain" P08123 7 94394895-94431227 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 1847.5;gallbladder: 1389.8;smooth muscle: 1429.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 133.7" "CAB032650, HPA059738" Approved Supported "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 27000000 "Endoplasmic reticulum" "CAB032650: AB_2082039, HPA059738: AB_2684116" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.32e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-2)" "unprognostic (2.81e-1)" "unprognostic (5.15e-2)" "unprognostic (7.38e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-2)" "unprognostic (5.83e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.35e-2)" "unprognostic (5.25e-2)" "unprognostic (1.15e-1)" "unprognostic (3.31e-3)" 519.5 52.8 8.5 268.6 8.2 2.0 317.6 7.0 37.9 1847.5 42.0 151.6 61.7 415.1 62.1 265.7 208.5 1389.8 277.8 5.8 35.1 40.5 27.6 231.5 92.4 8.4 7.0 4.9 299.9 57.6 32.8 33.8 629.8 9.3 197.9 143.2 1.6 60.7 234.5 52.1 428.1 104.1 1429.0 8.3 69.9 89.8 137.8 13.5 33.1 87.1 103.0 60.6 813.3 297.7 10.8 0.1 0.0 22.8 1488.5 3899.2 4637.0 1.3 3995.6 2901.2 642.6 850.5 0.0 2.8 0.3 2.7 13615.1 0.0 0.6 2.2 1.5 160.9 0.1 0.2 0.1 0.0 0.0 1018.6 1.1 0.5 4058.4 0.1 507.9 2.4 0.3 0.5 0.0 0.3 0.3 551.0 0.0 0.6 1.5 2.5 0.0 6.3 0.5 0.8 0.8 0.1 0.0 12.9 1.4 0.3 1.0 0.1 296.0 2.1 0.1 15.9 1626.3 0.8 1022.7 115.5 1.2 0.1 0.4 408.6 0.5 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 8.2 7.0 37.9 5.8 35.1 8.4 7.0 4.9 9.3 8.3 13.5 10.8 112.9 3.2 12.9 1.0 0.8 223.1 0.7 9.3 4.6 0.2 7.2 8.6 21.7 0.0 3.3 1.8 0.0 31.5 2.5 0.0 0.0 3.0 8.4 183.2 774.5 57.2 0.0 0.0 0.0 0.2 31.7 2148.2 26.5 592.2 10.1 16.4 258.8 1.9 116.9 0.0 0.1 0.0 0.0 1.0 394.5 45.1 991.9 16.7 238.3 97.4 2.6 3.2 0.0 0.0 0.2 5.2 0.0 501.0 4.5 1.0 0.0 0.5 0.8 0.4 302.4 249.9 770.7 9.9 4.5 6.2 187.4 70.7 30.6 214.8 0.0 0.8 FNDC1 "bA243O10.1, dJ322A24.1, FNDC2, KIAA1866" ENSG00000164694 "Fibronectin type III domain containing 1" Q4ZHG4 6 159169400-159272108 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 14.3;thyroid gland: 20.5" "Group enriched" "Detected in some" 4 "Fibroblasts: 28.7;Smooth muscle cells: 11.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 5.8;hippocampal formation: 9.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;fHDF/TERT166: 2.9;SuSa: 3.1" "Region enhanced" "Detected in many" "olfactory bulb: 7.0" "Region enhanced" "Detected in many" "spinal cord: 10.3" "HPA030962, HPA030963" Approved Approved "Nuclear speckles" "Secreted to extracellular matrix" NA NA 14000 "Nuclear speckles" "HPA030962: AB_10696212, HPA030963: AB_2673676" "unprognostic (4.59e-2)" "unprognostic (9.17e-3)" "unprognostic (7.62e-2)" "prognostic favorable (6.10e-5)" "unprognostic (4.57e-1)" "unprognostic (2.11e-1)" "unprognostic (5.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "unprognostic (4.18e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.93e-6)" "unprognostic (6.49e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.76e-3)" 5.4 0.5 0.9 1.9 0.4 0.0 2.1 0.4 5.8 6.5 0.4 9.6 2.5 2.2 0.0 1.1 0.6 14.3 3.8 9.0 1.7 0.6 0.7 1.6 2.8 0.1 0.6 0.1 1.2 1.1 0.3 0.2 0.9 0.2 0.4 1.8 0.1 0.9 0.8 2.1 0.9 4.2 11.8 0.2 0.5 0.4 0.4 0.3 0.1 20.5 9.7 2.4 1.0 1.7 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.4 5.8 9.0 1.7 0.1 0.6 0.1 0.2 0.2 0.3 1.2 2.6 0.0 0.6 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.1 0.5 2.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.3 0.4 4.7 0.7 0.0 0.0 0.2 0.0 0.2 28.7 0.0 0.3 0.0 0.1 1.4 0.0 0.2 0.0 1.7 0.0 0.0 0.0 3.1 0.0 0.3 0.2 1.8 2.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 3.0 11.5 1.1 1.4 0.0 1.4 0.1 0.5 0.1 0.0 0.0 CHMP4C "MGC22825, Shax3, VPS32C" ENSG00000164695 "Charged multivesicular body protein 4C" Q96CF2 8 81732448-81759515 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 42.2" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023763, HPA023799" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes NA "Microtubules, Cytokinetic bridge" "HPA023763: , HPA023799: AB_1846670" "unprognostic (3.98e-2)" "unprognostic (6.75e-3)" "unprognostic (1.58e-1)" "unprognostic (5.19e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (9.33e-5)" "unprognostic (7.54e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.99e-2)" "prognostic favorable (1.96e-6)" "unprognostic (3.29e-3)" "unprognostic (4.95e-1)" "unprognostic (2.67e-1)" "prognostic favorable (6.45e-4)" 1.3 5.8 1.2 2.1 1.1 1.2 16.8 1.4 1.2 7.6 2.5 16.3 42.2 2.3 5.9 22.8 8.7 8.0 3.6 1.0 0.9 11.8 7.8 7.3 0.5 1.3 1.1 0.9 0.5 20.3 16.0 10.2 5.9 1.4 10.1 15.0 0.2 28.3 7.7 0.2 26.4 32.0 0.8 1.0 8.6 24.0 1.1 1.3 1.9 17.6 0.5 5.3 9.8 14.4 1.7 37.2 7.6 0.0 0.2 0.0 0.0 16.6 1.9 2.2 0.1 0.0 14.3 41.5 0.1 28.8 0.0 6.4 22.1 0.2 15.7 0.0 0.0 17.9 0.7 9.9 13.6 0.8 0.1 0.1 0.0 51.4 0.0 41.6 15.3 0.0 0.0 10.0 12.4 0.0 18.4 0.1 0.3 0.1 73.1 14.9 0.1 0.0 8.3 36.3 22.0 7.9 0.1 9.9 16.3 0.1 8.5 23.9 0.2 0.0 0.1 8.9 0.1 0.2 6.5 4.3 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 0.1 0.0 0.1 1.2 1.1 1.4 1.2 1.0 0.9 1.3 1.1 0.9 1.4 1.0 1.3 1.7 5.3 25.6 21.5 0.0 3.2 4.6 35.4 17.1 18.2 0.0 27.2 29.3 4.1 21.5 22.4 5.5 0.0 40.2 0.6 42.0 25.4 47.4 0.4 18.6 2.9 4.0 9.1 1.7 0.1 71.6 38.9 1.0 25.5 31.0 1.3 6.5 4.2 7.6 4.4 0.0 0.1 36.4 12.2 0.3 0.7 1.3 0.0 0.9 8.8 1.0 0.0 0.0 1.0 0.0 0.1 78.7 52.8 0.0 5.7 28.9 80.4 22.6 19.1 0.0 0.0 0.2 7.0 0.3 0.7 25.0 17.5 44.5 1.3 0.1 34.4 33.6 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "choroid plexus: 659.0" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 786.0" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Region enhanced" "Detected in many" "hippocampal formation: 49.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048582 Enhanced NA NA "HPA048582: AB_2680450" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.0 0.0 2.3 0.0 0.6 0.0 0.0 9.4 14.3 0.3 659.0 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.1 49.0 0.9 0.0 0.0 0.0 0.0 0.9 8.6 0.2 0.0 0.2 0.0 1.4 54.9 3.1 0.0 0.0 2.4 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 3.9 10.5 0.0 0.0 0.0 2.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 5.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 30.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 2.4 0.1 0.1 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 9.4 14.3 49.0 0.9 0.9 8.6 0.2 3.1 0.6 10.5 0.7 0.0 0.0 0.0 3.3 0.0 0.0 0.5 0.1 0.0 3.4 0.1 0.1 1.9 0.0 0.1 0.0 4.2 189.9 0.0 0.0 0.0 0.2 0.6 0.5 0.5 1.0 0.0 0.0 2.7 0.0 9.5 1.2 0.0 0.1 0.0 0.1 0.0 0.0 14.9 3.3 3.0 0.0 0.0 0.0 0.3 0.5 0.3 0.4 0.0 1.0 0.0 2.1 0.0 3.5 2.5 0.1 0.0 0.0 0.1 0.5 0.0 0.1 4.3 14.9 0.0 0.6 0.3 0.3 0.5 0.0 0.1 786.0 0.1 0.1 0.0 0.4 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065567 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 1023.4;skeletal muscle: 4392.1;tongue: 1770.0" "Group enriched" "Detected in many" 6 "Early spermatids: 539.1;Late spermatids: 1891.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 38000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 4.2 3.7 42.6 0.1 31.4 0.1 3.0 37.1 43.5 2.5 23.4 1.7 2.0 1.8 0.7 59.4 2.4 2.5 1023.4 25.9 53.4 6.8 1.8 2.0 0.4 33.0 32.0 22.2 2.0 2.1 4.1 13.6 0.1 51.0 16.7 0.3 4.3 33.9 0.6 4392.1 1.5 1.3 0.5 27.0 1.2 1.7 195.4 47.6 24.2 5.2 1770.0 0.5 0.7 2.0 109.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 65.8 7.0 0.0 0.3 0.4 0.1 0.7 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.7 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 42.6 31.4 37.1 43.5 25.9 53.4 33.0 32.0 22.2 51.0 27.0 47.6 109.4 0.7 0.0 0.0 6.8 1.2 1.1 0.3 0.1 0.6 15.6 0.2 0.6 0.0 0.0 0.3 0.0 10.4 0.0 0.0 0.2 80.3 0.1 539.1 4.0 0.4 1.5 22.9 0.0 0.1 0.5 0.0 0.6 1.5 5.6 0.0 0.4 0.0 0.3 0.0 0.0 0.7 0.4 4.1 0.3 1.4 1891.7 7.8 1.5 1.8 1.9 0.0 5.6 0.0 1.0 0.5 0.3 1.2 6.0 1.4 0.2 0.4 9.2 0.1 4.6 26.3 78.3 18.6 187.6 7.0 0.2 0.6 0.0 0.6 0.1 0.2 0.5 BRI3 ENSG00000164713 "Brain protein I3" O95415 7 98252379-98310441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 42.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042215 Uncertain NA NA "HPA042215: AB_10794790" "unprognostic (1.51e-2)" "unprognostic (5.03e-2)" "unprognostic (7.08e-3)" "unprognostic (3.48e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.35e-4)" "unprognostic (2.04e-2)" "unprognostic (1.88e-2)" "unprognostic (3.93e-1)" "unprognostic (4.68e-1)" "unprognostic (1.66e-1)" "unprognostic (6.60e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-1)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.71e-1)" 127.0 160.6 39.4 37.3 37.9 95.7 103.0 41.5 42.0 82.5 48.9 90.7 68.2 80.8 32.0 64.1 72.7 45.7 127.8 32.9 46.7 121.7 180.9 168.7 33.1 44.6 41.4 30.3 74.5 128.5 24.3 99.2 69.7 41.7 85.3 36.2 10.9 94.3 26.6 238.9 80.8 81.9 33.9 42.7 123.3 134.2 53.6 49.4 14.2 79.4 65.7 18.4 100.1 70.0 42.8 130.5 20.6 36.6 47.3 231.8 104.0 86.6 105.1 122.4 86.6 114.5 17.1 60.0 13.6 220.3 191.8 275.6 45.5 46.9 66.7 59.9 46.5 53.4 8.7 15.0 29.9 228.2 10.0 43.3 85.7 95.3 74.2 135.2 119.8 107.6 15.9 26.6 84.2 164.4 9.1 32.1 32.9 44.1 87.8 55.3 30.8 20.2 43.7 83.2 9.3 30.6 62.3 27.7 114.4 279.2 63.2 12.2 64.0 108.4 175.1 103.4 228.1 82.6 91.5 128.3 35.9 199.5 44.4 91.8 2.5 15.0 24.2 0.9 25.3 1.3 0.9 0.9 1.0 7.0 1.1 1.5 1.3 42.8 0.2 24.0 10.3 3.0 3.1 39.4 37.9 41.5 42.0 32.9 46.7 44.6 41.4 30.3 41.7 42.7 49.4 42.8 354.9 83.3 120.3 18.3 52.8 146.3 278.2 24.1 47.3 90.6 191.1 277.6 121.9 204.5 37.4 134.3 33.3 122.9 118.4 193.5 569.4 62.1 680.8 176.9 149.2 223.9 78.5 49.0 13.8 119.5 431.4 161.6 122.3 192.0 22.8 140.8 238.1 258.0 695.0 129.5 17.8 161.9 26.4 482.9 329.4 132.1 100.3 503.0 167.2 20.6 167.5 291.4 28.8 15.1 26.6 82.4 234.2 121.5 37.4 416.5 261.5 670.8 35.8 84.2 111.7 166.2 145.6 61.6 58.5 59.0 171.5 169.4 48.7 131.3 154.6 473.3 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106862-98209638 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 50.7;Excitatory neurons: 114.9;Inhibitory neurons: 69.0;Oligodendrocyte precursor cells: 52.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 24.3" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: AB_2677698" "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavorable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 3.5 7.0 2.1 3.9 5.4 13.9 3.6 0.0 24.3 4.5 0.0 9.8 8.9 4.0 4.0 9.5 4.1 4.2 12.5 4.9 3.1 6.7 6.3 6.6 3.6 2.8 0.6 5.0 5.1 15.0 10.8 7.0 3.2 6.7 5.1 8.0 8.3 7.9 4.0 11.2 9.1 9.9 3.7 0.0 4.6 6.5 5.2 0.9 4.9 5.8 7.1 4.9 5.9 6.2 8.1 12.5 14.5 11.0 11.4 5.8 4.6 10.2 5.1 5.5 4.9 5.9 11.5 11.1 6.5 14.3 6.5 18.6 13.4 12.8 7.8 7.6 9.4 9.0 4.4 13.0 11.6 7.0 8.0 7.6 3.2 10.5 10.1 13.6 4.9 7.4 7.4 11.8 13.4 4.5 16.9 8.5 4.8 13.4 17.1 7.0 9.2 7.5 13.0 8.2 21.7 7.8 15.7 10.2 18.4 7.4 11.0 5.1 3.2 9.2 10.2 16.6 20.5 11.7 5.9 11.2 12.8 6.8 6.2 12.3 0.5 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.4 1.4 0.1 0.3 0.2 0.2 0.1 2.1 5.4 0.0 24.3 4.9 3.1 2.8 0.6 5.0 6.7 0.0 0.9 8.1 6.0 28.9 17.0 28.7 7.8 9.7 4.3 6.2 14.8 14.2 5.5 3.9 22.4 15.7 11.8 1.8 14.6 2.8 7.5 50.7 1.9 6.1 1.1 13.2 7.6 5.7 12.0 8.4 114.9 9.1 1.9 5.4 21.4 26.4 2.5 5.3 2.5 8.4 2.2 6.7 69.0 14.7 4.1 1.6 2.3 2.0 1.8 3.2 1.8 16.9 2.8 6.1 7.2 52.3 29.6 10.3 23.8 4.5 12.9 8.8 14.0 3.0 15.8 10.6 0.0 8.6 5.7 6.9 6.3 15.5 10.9 3.0 8.6 2.7 14.7 20.5 SLC35G3 "AMAC1, FLJ40154, TMEM21A" ENSG00000164729 "Solute carrier family 35 member G3" Q8N808 17 35192520-35194523 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 2.3" "Cell type enriched" "Detected in some" 9 "Early spermatids: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.88e-1)" "unprognostic (2.67e-1)" "unprognostic (6.17e-3)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869533 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1" "Group enriched" "Detected in all" 6 "dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" NA NA 100000000 Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favorable (5.76e-4)" "prognostic unfavorable (9.02e-4)" 427.7 307.0 57.8 403.2 60.0 87.7 251.1 60.8 94.1 479.1 93.5 295.6 121.9 382.3 117.9 425.0 371.7 232.6 391.4 57.8 188.8 413.7 501.3 432.6 292.0 94.7 70.5 51.3 170.5 136.5 80.2 158.0 255.3 85.2 257.6 160.9 33.9 440.9 158.0 239.3 183.2 262.4 319.1 94.3 525.3 196.0 33.4 172.2 61.5 1160.1 100.2 104.9 435.9 481.8 161.9 66.6 283.4 4.0 94.9 657.3 754.5 128.3 885.0 1607.5 258.4 299.5 10.3 294.4 1.5 32.2 1436.1 419.3 279.5 65.3 157.1 195.6 25.9 52.6 58.8 10.0 397.1 479.2 7.7 73.7 296.4 532.2 327.2 427.3 611.5 33.4 20.2 81.7 260.7 194.6 62.5 6.5 23.1 16.3 839.7 91.3 33.6 39.3 202.7 2.6 121.1 4.9 68.6 165.1 68.6 514.6 110.1 97.8 68.7 922.4 766.5 111.9 129.9 259.3 182.7 178.5 4.8 432.5 22.9 249.4 390.6 610.1 90.6 26.3 467.3 35.4 44.1 79.0 31.5 287.4 38.8 48.3 21.5 97.8 31.3 307.6 410.1 78.7 703.7 57.8 60.0 60.8 94.1 57.8 188.8 94.7 70.5 51.3 85.2 94.3 172.2 161.9 87.7 109.0 171.4 17.6 54.8 54.7 441.6 563.2 54.7 55.2 94.1 74.5 320.1 165.8 331.7 114.0 41.7 279.4 122.4 147.9 27.4 294.6 15.6 105.8 240.1 163.0 154.7 210.2 36.2 238.2 341.7 155.0 44.4 183.5 179.4 105.9 204.2 239.5 2744.5 58.9 42.8 94.2 158.7 1774.9 436.5 18.5 76.4 1224.3 161.9 70.3 373.1 117.4 24.7 19.1 12.9 363.9 154.0 92.9 47.3 295.5 198.6 351.8 180.8 40.0 39.5 39.4 149.9 10.8 21.0 160.3 40.5 649.6 56.0 32.1 139.6 321.4 SOX17 ENSG00000164736 "SRY-box transcription factor 17" Q9H6I2 8 54457935-54460892 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 38.4;breast: 32.9" "Group enriched" "Detected in many" 8 "Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0" "Group enriched" "Detected in many" 4 "endometrial cancer: 122.8;ovarian cancer: 96.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "EFO-21: 108.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025594, HPA068399" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB025594: , HPA068399: AB_2685981" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (1.76e-3)" "prognostic favorable (2.76e-4)" "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (3.34e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (7.90e-2)" "unprognostic (3.62e-2)" "unprognostic (1.18e-1)" "unprognostic (4.98e-2)" "unprognostic (7.28e-3)" "unprognostic (1.12e-1)" "unprognostic (3.76e-1)" "unprognostic (1.88e-1)" 38.4 1.6 3.1 1.4 2.3 0.0 32.9 2.6 2.9 20.6 2.2 7.1 0.7 19.0 1.2 3.7 23.2 7.8 14.4 2.2 2.6 3.1 1.3 10.0 0.7 2.9 2.6 1.6 4.2 1.9 0.8 2.3 5.7 3.5 6.1 0.8 0.1 4.0 1.1 10.4 5.1 5.0 4.4 2.5 13.3 5.8 3.4 2.8 0.4 5.8 5.9 0.4 8.5 9.5 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.6 0.0 0.0 0.0 0.0 1.8 0.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.3 2.6 2.9 2.2 2.6 2.9 2.6 1.6 3.5 2.5 2.8 2.7 464.9 0.0 0.0 0.0 0.2 13.9 0.3 0.0 0.0 0.1 0.7 1.3 2.1 1.5 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 2.6 377.3 44.5 171.5 0.0 2.7 0.0 0.2 0.1 7.7 0.0 520.0 0.0 0.0 46.8 0.1 0.1 0.0 0.0 0.0 0.0 0.9 16.6 1.8 2.5 3.5 19.6 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 7.3 5.1 3.2 6.4 0.3 13.5 0.0 4.5 0.2 0.0 3.7 DLC1 "ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12" ENSG00000164741 "DLC1 Rho GTPase activating protein" Q96QB1 8 13083361-13604610 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 4.3;non-classical monocyte: 1.1" "Group enriched" "Detected in many" 19 "granulocytes: 4.3;monocytes: 1.1" "Cell line enhanced" "Detected in many" "HBF TERT88: 83.2;U-2197: 98.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017753 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA017753: AB_10600805" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.11e-4)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (8.46e-3)" "unprognostic (6.49e-2)" "unprognostic (2.02e-2)" "unprognostic (3.56e-3)" "unprognostic (2.79e-2)" "unprognostic (7.33e-2)" "unprognostic (1.67e-1)" 42.5 10.7 18.2 8.9 26.4 2.6 29.9 20.2 17.7 13.1 4.7 16.2 5.6 16.2 5.4 6.4 14.8 19.2 20.5 22.1 19.8 10.7 20.6 43.3 3.8 26.3 23.2 9.5 9.6 9.1 6.2 5.4 24.4 26.2 6.8 6.3 1.5 5.7 4.2 7.2 7.0 11.6 19.3 21.9 16.5 13.7 4.1 23.3 2.2 15.9 10.4 1.8 15.6 11.2 36.9 0.1 0.7 6.6 0.0 69.4 35.5 20.3 39.3 33.7 40.7 48.6 11.5 6.6 0.0 9.7 51.4 39.4 6.6 4.3 7.4 83.2 0.0 7.2 39.5 0.1 21.7 31.8 0.0 13.7 36.6 0.6 62.6 46.7 43.3 46.7 0.1 2.7 0.0 33.6 0.8 0.0 0.0 0.7 1.4 4.7 0.0 0.0 0.0 19.7 24.4 0.0 2.9 0.0 1.1 31.8 27.4 0.0 0.0 61.7 45.5 18.8 98.7 15.3 0.1 0.0 0.0 31.6 0.3 63.4 4.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 18.2 26.4 20.2 17.7 22.1 19.8 26.3 23.2 9.5 26.2 21.9 23.3 36.9 171.7 250.0 225.9 177.3 2.3 14.8 2.5 4.8 5.2 0.9 9.3 8.3 37.8 24.3 19.7 3.7 0.0 7.8 0.6 0.4 1.9 3.1 8.4 15.3 36.1 138.4 1.2 25.2 208.8 4.4 2.3 74.2 4.6 27.3 68.2 0.1 193.1 25.7 3.6 13.5 151.8 1.2 0.0 18.6 17.0 4.3 72.4 6.2 24.9 317.6 0.2 1.0 0.0 244.3 707.2 3.0 1.3 36.1 1.9 1.4 6.1 1.9 3.0 1.9 223.5 50.0 138.0 6.2 11.4 1.8 9.2 2.7 3.6 31.1 2.9 1.7 ADCY1 "AC1, DFNB44" ENSG00000164742 "Adenylate cyclase 1" Q08828 7 45574140-45723116 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, cAMP biosynthesis" "Calmodulin-binding, Lyase" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 32.7;liver: 19.3;retina: 53.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 521.3;Excitatory neurons: 147.2;Inhibitory neurons: 117.9;Rod photoreceptor cells: 174.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.2;SH-SY5Y: 25.5;SK-MEL-30: 30.1;WM-115: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018364, HPA068274" Uncertain Approved Mitochondria NA NA Mitochondria "CAB018364: AB_2223098, HPA068274: " "unprognostic (9.41e-3)" "unprognostic (7.30e-4)" "unprognostic (9.31e-2)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (3.07e-3)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (1.64e-3)" "unprognostic (2.89e-1)" "unprognostic (7.73e-3)" "unprognostic (1.54e-1)" "unprognostic (4.74e-6)" "unprognostic (2.49e-1)" "unprognostic (7.65e-3)" "unprognostic (2.87e-1)" "unprognostic (2.23e-1)" 1.9 1.8 7.6 0.3 20.3 0.0 4.7 15.2 32.7 5.3 0.0 0.4 0.2 1.8 0.5 0.6 2.0 0.7 2.9 30.9 4.9 1.9 19.3 0.6 0.4 1.8 2.2 19.0 0.9 3.3 1.9 2.6 0.4 10.8 2.8 0.4 53.5 0.3 1.2 7.8 0.3 0.3 0.9 0.0 1.7 1.1 2.8 4.4 0.3 2.4 8.5 0.3 0.8 1.3 23.8 0.8 5.9 2.1 3.2 4.1 0.1 4.0 0.2 0.0 0.8 0.3 0.6 0.0 0.0 0.2 0.2 5.8 1.9 3.8 0.3 0.1 10.7 2.7 0.0 0.0 0.6 0.0 0.2 0.1 4.9 2.8 0.5 22.2 0.0 0.1 8.6 0.3 7.0 0.3 7.1 0.0 0.0 8.3 5.1 0.0 0.0 0.0 11.7 0.0 5.7 13.4 25.5 2.1 0.0 30.1 3.1 2.0 3.5 0.0 0.6 4.2 0.5 3.6 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 20.3 15.2 32.7 30.9 4.9 1.8 2.2 19.0 10.8 0.0 4.4 23.8 3.5 0.0 0.0 30.7 0.3 0.3 0.6 0.0 0.0 43.8 10.6 5.7 11.4 2.8 0.0 0.0 521.3 0.1 0.3 0.5 1.9 0.0 2.9 1.0 23.1 10.8 31.2 0.0 147.2 0.9 0.2 4.2 0.0 0.7 0.0 0.2 15.7 52.3 0.3 42.1 117.9 1.0 2.0 3.2 0.4 0.7 1.8 0.2 3.6 17.8 0.0 13.8 0.0 63.3 4.0 0.5 0.1 7.5 0.1 2.6 0.0 0.4 0.0 174.4 0.0 2.3 8.8 0.5 6.8 0.1 0.1 0.0 0.6 0.6 0.6 0.3 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566869-13568288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 7.0" "Group enriched" "Detected in many" 5 "Early spermatids: 33.3;Late spermatids: 51.9;Spermatocytes: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.5;U-87 MG: 11.5;WM-115: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 1.2 0.2 1.0 0.6 2.1 0.0 1.8 1.2 1.5 1.3 0.2 0.4 0.4 1.1 2.9 0.6 1.9 1.2 1.3 1.1 1.7 1.2 0.9 1.2 0.4 2.2 1.7 0.8 0.6 0.4 0.3 0.5 0.6 2.3 0.2 0.4 4.9 0.4 0.4 0.1 1.3 0.4 1.0 1.4 0.2 0.9 7.0 1.5 0.2 4.4 0.4 0.2 0.8 0.3 2.6 0.0 0.1 1.8 0.0 6.0 6.0 0.0 5.5 6.1 2.9 4.9 0.0 0.0 0.0 0.0 2.9 13.5 0.6 0.2 1.1 5.7 0.0 0.6 0.6 0.0 0.0 2.1 0.0 0.9 1.9 3.6 3.9 1.0 0.7 3.8 0.0 0.1 0.0 7.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 3.2 0.0 0.2 6.3 2.0 0.0 0.0 1.7 5.1 4.9 6.0 5.0 0.0 0.0 0.0 11.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.1 1.2 1.5 1.1 1.7 2.2 1.7 0.8 2.3 1.4 1.5 2.6 1.0 0.0 0.0 2.0 0.0 1.0 0.0 1.0 0.0 0.2 0.9 0.8 0.3 0.0 0.9 0.0 2.1 0.0 0.0 0.1 0.0 2.7 33.3 1.8 3.0 0.7 0.0 0.0 0.6 1.1 0.0 2.7 0.0 0.2 0.0 0.3 1.1 0.5 0.1 0.0 0.3 0.0 2.0 0.0 0.0 51.9 5.0 0.2 5.4 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.0 3.0 0.0 0.0 0.0 3.6 1.9 4.3 6.6 1.2 4.5 18.2 2.3 0.8 0.4 0.0 0.1 3.4 0.0 0.1 SUN3 "MGC33329, SUNC1" ENSG00000164744 "Sad1 and UNC84 domain containing 3" Q8TAQ9 7 47987148-48029119 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 42.0" "Cell type enriched" "Detected in some" 7 "Early spermatids: 582.2" "Cancer enriched" "Detected in single" 4 "testis cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 7.0;U-2 OS: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA008344, HPA076890" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA008344: AB_1857656, HPA076890: " "unprognostic (5.11e-2)" "unprognostic (4.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-4)" "unprognostic (2.31e-2)" "unprognostic (5.62e-2)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" "unprognostic (1.59e-5)" "unprognostic (4.88e-1)" "unprognostic (1.47e-1)" "unprognostic (2.65e-1)" "unprognostic (1.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.48e-1)" "unprognostic (2.58e-1)" 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 3.1 0.1 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 1.3 20.6 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.1 1.9 0.0 582.2 0.1 0.0 0.1 0.0 0.0 3.6 0.0 25.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 3.4 0.0 0.0 0.0 0.0 79.3 2.1 0.3 0.0 1.0 0.1 0.0 0.0 1.0 0.4 0.2 0.1 1.5 0.1 0.0 0.0 0.6 0.0 0.0 6.6 0.0 0.2 19.1 7.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 C7orf57 ENSG00000164746 "Chromosome 7 open reading frame 57" Q8NEG2 7 48035511-48061304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.3;fallopian tube: 14.0" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 52.7;Respiratory ciliated cells: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.4;hTERT-HME1: 5.5;U-266/70: 3.2;U-698: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021286 Enhanced NA NA "HPA021286: AB_1845760" "unprognostic (1.74e-2)" "unprognostic (4.82e-2)" "unprognostic (3.13e-2)" "unprognostic (1.28e-2)" "unprognostic (2.77e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.37e-1)" "unprognostic (4.98e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-5)" "unprognostic (5.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.42e-3)" "unprognostic (1.20e-1)" 0.0 0.0 2.1 0.0 0.9 0.2 0.1 1.2 0.5 0.3 5.3 0.0 0.1 0.4 0.0 0.8 14.0 0.0 0.1 0.6 3.2 0.1 0.0 2.2 0.0 3.3 3.0 0.1 0.0 0.0 0.6 0.2 0.0 2.2 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 3.7 1.3 0.1 0.2 0.0 0.1 0.0 0.4 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.3 0.0 0.1 0.1 3.4 0.2 0.0 0.5 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.3 3.2 0.5 1.9 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.9 1.2 0.5 0.6 3.2 3.3 3.0 0.1 2.2 3.7 1.3 2.0 0.0 0.0 3.0 0.3 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.1 1.0 0.0 15.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.9 52.7 0.6 0.2 0.0 0.0 0.5 0.0 0.1 0.6 0.0 1.1 2.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 6.1 0.0 0.4 3.5 0.0 0.3 0.0 0.0 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 127.6 0.9 0.0 0.0 2.7 16.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566834 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 115.6" "Cell type enhanced" "Detected in many" "Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA005438: AB_1850822, HPA010610: AB_2668318" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.0 0.4 2.5 0.4 0.0 1.0 0.3 0.3 2.3 0.1 20.8 101.4 0.4 1.2 0.3 1.0 12.3 0.0 0.3 0.3 17.5 13.0 0.2 0.1 0.5 0.4 0.2 0.0 5.6 0.0 0.0 0.1 0.3 0.6 19.8 0.0 0.4 0.4 0.0 0.0 115.6 0.9 0.4 0.1 8.2 3.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.4 1.1 4.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 16.1 0.0 2.2 0.0 1.8 0.0 2.0 0.0 0.0 0.0 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.3 10.0 4.8 0.0 0.0 0.3 2.7 0.1 0.3 1.6 0.3 0.1 0.0 0.2 0.2 5.5 0.0 0.3 0.1 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.3 0.3 0.3 0.5 0.4 0.2 0.3 0.4 0.3 0.4 0.0 0.0 1.1 39.8 0.5 0.0 0.6 0.4 2.2 0.0 1.3 0.5 0.2 17.2 1.5 3.7 0.0 0.0 0.0 51.0 5.9 3.2 3.1 3.6 0.2 0.0 16.3 0.0 0.5 4.3 0.0 0.1 8.2 3.2 0.0 0.0 0.0 10.7 0.0 0.0 0.6 32.3 2.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.2 0.6 5.6 54.3 0.0 0.0 1.6 165.3 18.5 8.1 0.0 0.0 0.1 0.4 4.8 0.0 0.4 0.0 0.0 0.2 0.0 36.9 2.9 PEX2 "PAF-1, PMP35, PXMP3, RNF72, ZWS3" ENSG00000164751 "Peroxisomal biogenesis factor 2" P28328 8 76980258-77001044 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010983, HPA011410, HPA027729" Approved Supported Vesicles NA NA Vesicles "HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416" "unprognostic (6.42e-2)" "unprognostic (2.90e-2)" "unprognostic (4.64e-2)" "unprognostic (2.35e-1)" "unprognostic (9.91e-2)" "unprognostic (2.33e-1)" "unprognostic (6.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-2)" "unprognostic (9.57e-3)" "unprognostic (2.48e-1)" "unprognostic (9.49e-2)" "unprognostic (3.06e-2)" "unprognostic (1.09e-3)" 40.2 46.3 31.8 33.8 35.2 36.1 54.4 33.8 46.0 41.1 36.2 43.5 40.1 33.6 42.7 33.2 42.2 32.2 40.1 30.9 33.6 54.1 44.1 36.8 39.8 35.8 34.0 29.9 33.6 39.3 58.2 27.5 24.9 35.7 44.6 40.0 67.1 51.3 84.2 62.4 24.7 41.3 35.6 36.5 36.8 48.8 22.3 33.7 49.3 53.6 45.0 36.0 36.0 31.6 42.8 88.2 29.3 46.9 47.9 50.7 63.2 24.5 64.4 75.3 49.9 55.2 18.4 76.9 50.2 93.6 59.9 39.7 33.3 33.1 50.1 61.2 93.3 28.5 61.1 26.0 28.3 33.9 51.5 46.5 70.9 43.5 37.8 45.6 77.0 55.3 79.3 34.4 46.7 53.9 26.4 90.4 30.1 27.2 126.4 26.3 16.5 37.4 42.1 59.9 61.6 16.7 43.0 41.9 192.0 36.9 39.8 58.7 36.1 54.7 44.4 58.1 57.7 32.4 86.0 53.8 87.9 56.5 26.7 50.2 179.9 55.6 102.6 57.2 58.0 51.2 46.1 39.6 46.5 46.3 50.5 51.6 49.3 38.6 83.1 67.8 46.8 48.6 71.7 31.8 35.2 33.8 46.0 30.9 33.6 35.8 34.0 29.9 35.7 36.5 33.7 42.8 28.0 48.1 25.2 32.3 29.7 18.1 31.0 57.8 28.5 28.9 38.9 33.1 27.2 28.6 38.4 27.6 12.5 42.8 38.3 30.2 133.1 52.3 5.6 36.5 19.9 20.7 28.9 25.6 11.9 49.1 24.8 29.8 20.4 22.2 18.3 20.2 25.7 36.7 26.6 13.5 15.2 37.5 48.8 39.1 22.4 7.3 29.5 26.8 28.4 16.9 36.3 68.4 53.5 31.7 45.9 42.0 28.2 35.7 41.7 36.3 43.3 61.4 36.6 34.4 6.6 34.9 24.6 13.7 20.8 28.6 21.0 34.8 37.6 27.7 30.0 43.0 RAD21 "hHR21, KIAA0078, SCC1" ENSG00000164754 "RAD21 cohesin complex component" O60216 8 116845934-116874776 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Activator, Developmental protein, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 424.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020044, CAB022065, HPA073277" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB022065: , HPA020044: AB_1856035, HPA073277: " "unprognostic (7.85e-2)" "unprognostic (4.92e-1)" "unprognostic (3.05e-1)" "unprognostic (5.43e-3)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.86e-3)" "unprognostic (8.99e-2)" "unprognostic (8.80e-2)" "unprognostic (5.58e-3)" "unprognostic (3.56e-2)" "unprognostic (4.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" 76.1 81.3 69.0 74.7 79.1 207.8 72.6 81.3 76.0 50.9 62.6 73.8 57.8 68.3 55.0 71.9 51.1 49.8 90.6 64.6 76.0 68.8 65.2 68.5 123.8 75.4 77.7 60.8 68.4 42.3 83.0 34.1 90.9 80.5 58.0 83.3 115.2 57.4 65.6 77.4 54.5 60.9 60.8 80.8 76.1 56.9 89.5 73.3 178.9 81.6 96.3 120.5 60.3 44.9 104.1 301.6 143.9 277.3 156.7 136.5 117.0 124.2 202.1 191.4 220.8 202.4 119.8 275.2 438.6 109.4 146.0 117.4 162.4 238.5 132.1 257.6 589.1 153.1 447.6 167.2 153.7 85.5 145.7 253.1 100.2 106.0 129.4 156.0 146.1 176.4 625.8 183.6 595.6 193.1 181.1 665.4 86.2 163.6 385.4 179.2 241.8 201.5 223.4 133.5 173.3 348.2 179.1 212.2 569.4 140.6 144.5 238.3 178.5 128.5 154.6 223.5 164.4 217.1 313.3 383.9 391.9 132.8 206.7 189.7 35.3 7.9 28.0 17.4 8.7 17.5 14.4 20.3 20.6 9.0 12.8 20.8 20.6 29.7 14.3 12.7 7.6 43.7 11.4 69.0 79.1 81.3 76.0 64.6 76.0 75.4 77.7 60.8 80.5 80.8 73.3 104.1 115.7 256.4 157.1 24.5 111.2 95.6 77.5 62.5 78.0 75.4 65.8 53.0 155.2 51.5 101.0 55.2 31.3 142.4 118.1 90.4 43.0 54.0 258.0 67.0 86.7 97.0 84.4 249.8 39.3 44.9 157.0 89.4 57.1 88.2 153.5 112.9 75.0 72.1 67.9 67.3 48.1 72.7 69.2 93.1 100.0 424.9 116.5 93.4 69.4 45.9 110.8 112.5 77.2 41.2 58.3 63.5 66.3 106.5 124.0 100.0 35.7 59.4 70.5 67.9 72.3 88.6 85.3 33.2 88.6 103.7 100.4 113.7 134.1 85.5 94.1 95.5 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 62.4" "Cell type enhanced" "Detected in some" "Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "U-266/70: 48.0;U-266/84: 36.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 4.1" HPA076165 Enhanced NA NA "HPA076165: AB_2732304" "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.0 0.0 0.2 0.0 0.4 0.3 0.6 0.2 0.3 0.1 0.0 0.3 0.6 0.7 0.0 0.2 0.1 0.2 0.2 0.3 0.1 4.4 0.0 0.1 0.1 0.2 0.1 0.2 0.0 62.4 0.3 0.3 0.3 0.4 0.1 0.2 0.2 13.0 0.0 0.0 0.8 1.0 0.2 0.0 0.0 1.1 2.0 0.1 0.1 0.1 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 48.0 36.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.3 0.1 0.2 0.1 0.2 0.4 0.0 0.1 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 4.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.0 0.9 5.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.8 5.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 MED30 "THRAP6, TRAP25" ENSG00000164758 "Mediator complex subunit 30" Q96HR3 8 117520713-117540262 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 169.9;Suprabasal keratinocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045767 Approved Nucleoplasm NA NA Nucleoplasm "HPA045767: AB_2679446" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (3.86e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-1)" "unprognostic (3.20e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-2)" "unprognostic (8.41e-2)" "unprognostic (4.02e-2)" "unprognostic (1.51e-2)" "unprognostic (7.73e-2)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.38e-3)" "unprognostic (2.80e-1)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" 17.7 9.4 10.7 11.7 11.4 44.9 17.8 11.4 14.5 15.6 10.4 14.1 9.4 15.8 8.4 12.7 18.5 6.7 10.6 10.5 11.3 8.1 15.3 13.1 17.4 11.0 11.5 10.3 20.2 9.2 7.3 10.1 11.5 11.0 11.5 11.7 5.1 9.8 10.4 10.5 16.4 12.5 9.4 11.6 14.1 11.3 11.5 11.3 25.3 12.2 10.5 15.4 13.4 15.1 12.7 54.0 5.6 20.8 13.9 14.2 13.3 22.9 15.9 16.9 23.8 29.4 10.2 26.2 42.7 24.7 8.7 18.3 23.7 18.6 12.4 30.4 57.4 23.0 34.7 3.2 13.2 15.6 27.7 28.9 12.3 13.8 12.3 27.5 8.8 14.9 60.7 19.7 25.2 11.4 12.7 85.9 70.9 11.6 50.6 38.7 31.5 26.1 19.1 12.2 9.3 29.2 24.7 18.8 42.6 25.6 18.8 10.3 35.1 7.1 11.5 30.2 21.2 28.0 22.0 16.1 50.1 10.7 31.2 19.7 64.0 37.9 111.3 46.7 46.2 49.7 56.3 46.8 46.7 42.8 63.6 51.8 49.4 90.7 44.5 69.9 82.5 55.6 43.4 10.7 11.4 11.4 14.5 10.5 11.3 11.0 11.5 10.3 11.0 11.6 11.3 12.7 47.6 9.6 21.7 9.1 71.4 169.9 81.2 65.2 52.9 6.0 33.7 46.6 5.5 25.8 32.2 9.2 6.2 45.3 62.8 27.9 11.7 22.6 32.7 49.5 38.0 33.2 37.7 35.7 10.0 22.7 69.4 46.9 15.8 42.0 21.5 15.7 30.0 21.9 30.4 0.0 12.7 43.4 42.7 28.8 65.4 11.9 59.7 37.7 40.9 6.5 23.5 10.4 43.3 9.0 18.4 20.5 34.4 37.2 37.5 76.5 24.2 16.9 64.8 5.3 32.9 68.4 44.6 47.8 37.1 46.4 152.3 61.6 60.4 13.5 35.5 72.1 TNFRSF11B "OCIF, OPG, TR1" ENSG00000164761 "TNF receptor superfamily member 11b" O00300 8 118923557-118951885 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 30.2;thyroid gland: 102.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 134.3;Collecting duct cells: 73.5;Ductal cells: 32.7;Proximal tubular cells: 117.3" "Cancer enhanced" "Detected in all" "renal cancer: 22.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 40 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 40 "dendritic cells: 3.9" "Group enriched" "Detected in many" 4 "BJ: 546.7;BJ hTERT+: 2013.0" "Low region specificity" "Detected in all" CAB034939 Approved "Secreted in other tissues" NA NA "CAB034939: " "unprognostic (1.39e-2)" "prognostic unfavorable (6.22e-4)" "unprognostic (5.27e-2)" "unprognostic (2.33e-2)" "unprognostic (4.27e-3)" "unprognostic (1.10e-3)" "unprognostic (1.21e-3)" "unprognostic (5.50e-2)" "unprognostic (9.94e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (2.43e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.32e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-3)" "prognostic unfavorable (3.88e-4)" 3.2 3.3 2.9 5.4 2.9 0.0 2.6 2.6 4.1 1.1 3.9 2.6 1.4 10.3 0.5 0.4 1.4 5.9 9.5 2.2 3.4 30.2 14.3 9.5 7.1 4.9 2.6 2.1 0.3 1.8 0.5 1.8 5.0 3.0 1.6 3.5 0.3 1.4 1.0 0.4 0.5 2.2 2.6 3.1 2.6 1.2 0.1 2.9 1.3 102.7 0.8 2.9 10.8 0.3 3.6 0.0 0.9 8.6 0.0 27.5 5.3 0.0 546.7 2013.0 25.9 7.2 6.3 1.1 0.0 143.7 302.4 0.0 5.6 0.0 0.0 13.2 0.1 0.0 0.0 23.1 0.0 3.6 0.0 0.0 2.9 0.0 26.7 0.0 10.9 0.3 0.0 0.0 0.0 73.8 13.6 0.0 0.1 0.9 2.6 3.3 0.0 1.0 0.0 23.6 0.0 1.3 0.0 4.8 0.2 0.0 0.3 0.0 0.1 1.2 16.9 8.6 10.1 1.2 0.6 0.0 0.1 2.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 2.9 2.9 2.6 4.1 2.2 3.4 4.9 2.6 2.1 3.0 3.1 2.9 3.6 2.1 3.2 0.0 7.2 0.7 2.2 0.6 1.4 0.0 0.2 134.3 4.1 3.8 22.8 1.0 73.5 0.0 0.0 0.2 2.5 9.8 32.7 0.1 0.6 1.4 7.4 9.5 0.0 0.8 1.3 0.2 9.4 0.0 1.7 0.0 0.0 4.6 2.0 0.5 0.0 0.3 9.2 2.0 0.3 3.9 0.3 0.3 1.1 0.0 0.0 8.3 1.2 0.0 3.0 0.3 9.2 0.8 0.0 0.0 6.8 1.1 117.3 0.1 0.1 0.0 0.4 4.3 0.1 0.3 0.0 1.1 0.0 0.4 0.0 2.8 0.3 SBSPON "C8orf84, RPESP" ENSG00000164764 "Somatomedin B and thrombospondin type 1 domain containing" Q8IVN8 8 73064543-73124088 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 36.5;Collecting duct cells: 42.3;Muller glia cells: 48.5;Peritubular cells: 26.7;Smooth muscle cells: 28.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "medulla oblongata: 7.4;pons: 5.0;spinal cord: 8.0;white matter: 17.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ: 9.5;RPTEC TERT1: 16.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA029595 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 40000 Vesicles "HPA029595: AB_10600763" "prognostic favorable (7.18e-4)" "unprognostic (5.08e-3)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (2.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.65e-2)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (9.54e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (6.14e-2)" "unprognostic (3.54e-1)" "unprognostic (2.12e-2)" "unprognostic (6.25e-2)" 6.4 3.0 0.3 1.4 1.3 0.3 3.5 1.4 0.7 4.7 0.5 4.0 0.9 4.5 4.6 9.6 8.3 1.3 1.6 0.8 1.8 8.3 0.6 3.9 1.5 7.4 1.0 0.4 3.3 1.2 0.1 1.6 9.5 5.0 15.2 1.1 9.1 4.7 10.9 0.6 1.8 2.5 9.0 8.0 1.1 9.6 2.7 0.8 0.2 2.6 1.5 0.2 18.0 4.7 17.6 0.2 0.2 0.4 0.5 0.0 0.0 1.3 9.5 0.0 0.0 0.0 0.1 0.2 0.4 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.3 0.4 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.3 0.9 0.5 0.2 0.2 0.1 0.0 16.9 0.1 0.5 0.5 1.0 0.4 0.1 3.1 0.2 0.1 0.5 0.1 1.5 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 1.3 1.4 0.7 0.8 1.8 7.4 1.0 0.4 5.0 8.0 0.8 17.6 0.6 9.6 0.0 1.0 0.2 1.3 6.9 0.0 36.5 2.4 5.8 11.6 3.8 4.3 0.0 42.3 2.1 0.2 1.0 0.5 1.9 1.3 10.3 7.2 1.4 1.7 0.0 0.0 0.5 0.0 0.4 13.2 10.7 14.9 0.0 0.2 1.4 0.2 0.4 0.0 0.4 0.2 0.0 0.0 0.4 3.2 12.2 0.4 3.6 0.0 0.0 48.5 0.0 1.0 0.2 0.6 0.0 26.7 0.0 1.8 0.0 3.6 0.0 2.2 6.6 0.9 28.7 11.4 4.4 0.6 1.3 0.4 0.5 0.2 0.1 0.5 PHKG1 PHKG ENSG00000164776 "Phosphorylase kinase catalytic subunit gamma 1" Q16816 7 56080283-56092996 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 267.1;tongue: 173.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 48.6;Hepatocytes: 46.5" "Cancer enriched" "Detected in many" 18 "glioma: 23.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012057 Enhanced NA NA "HPA012057: AB_1855305" "unprognostic (2.00e-3)" "unprognostic (1.09e-1)" "unprognostic (7.09e-3)" "unprognostic (5.87e-3)" "unprognostic (2.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (6.69e-3)" "unprognostic (2.10e-1)" "unprognostic (1.99e-1)" "unprognostic (9.14e-4)" "unprognostic (1.92e-1)" "unprognostic (7.97e-9)" "unprognostic (6.61e-3)" "unprognostic (2.34e-1)" "unprognostic (1.12e-2)" "unprognostic (3.85e-2)" 3.4 4.1 12.4 0.7 13.2 1.7 2.8 14.7 11.7 1.7 7.6 6.1 1.2 1.3 0.7 5.3 1.9 1.6 17.9 10.9 16.8 1.1 1.6 1.7 0.8 16.2 14.9 8.9 1.8 1.2 1.0 2.4 0.3 14.0 2.3 0.7 0.9 5.2 0.5 267.1 3.1 2.5 1.1 15.5 1.5 1.6 1.0 17.1 0.7 2.0 173.8 0.9 4.1 1.2 14.8 1.1 0.8 0.2 0.7 1.1 2.0 0.6 0.1 0.2 0.4 0.3 0.3 0.5 0.3 0.2 0.3 0.5 0.6 0.5 0.1 0.3 0.3 0.9 0.3 1.5 0.3 0.2 0.6 1.2 1.2 0.8 0.5 0.2 0.3 0.0 0.8 0.9 1.5 0.0 0.5 0.9 2.4 0.3 0.3 0.5 0.5 0.0 0.3 0.2 0.8 0.6 0.6 0.1 0.8 0.0 0.1 0.4 0.8 0.3 0.2 0.6 1.7 0.5 0.6 0.3 0.9 0.4 0.6 0.4 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.0 12.4 13.2 14.7 11.7 10.9 16.8 16.2 14.9 8.9 14.0 15.5 17.1 14.8 12.6 12.8 4.2 16.0 10.4 1.3 7.7 0.2 0.6 3.9 25.6 6.7 1.7 48.6 3.7 27.6 0.0 7.5 17.7 9.0 1.9 14.6 2.7 20.8 11.3 8.2 16.7 6.6 3.1 12.3 14.5 10.4 2.6 16.4 8.2 4.6 23.6 46.5 12.1 11.8 3.8 12.6 0.0 36.8 1.2 5.9 18.0 8.9 1.8 3.7 10.7 5.0 8.2 3.5 5.2 11.0 10.1 16.1 5.2 11.6 17.8 16.8 2.2 5.4 13.1 34.0 7.2 11.1 9.1 1.2 1.0 7.3 8.2 3.7 24.1 8.4 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "brain: 18.1" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Region enhanced" "Detected in many" "cerebellum: 18.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9" "Region enriched" "Detected in some" 8 "cerebellum: 27.8" "Region enriched" "Detected in some" 5 "cerebellum: 52.3" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli, Nucleoli fibrillar center" "HPA045646: AB_2679404, HPA069809: AB_2686205" "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavorable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.1 0.1 0.1 0.0 0.3 0.0 0.1 18.1 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.7 4.4 0.0 0.7 0.3 0.5 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.7 41.1 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.1 0.0 1.4 0.0 9.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 5.5 0.0 0.0 0.0 0.0 2.0 0.0 3.2 0.0 0.1 0.3 0.0 0.0 3.0 0.0 12.9 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 18.1 0.5 0.1 0.4 0.7 4.4 0.0 5.6 0.2 1.7 1.9 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.6 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.4 1.5 0.6 0.0 0.1 0.0 0.1 0.3 0.0 0.0 KCNV1 Kv8.1 ENSG00000164794 "Potassium voltage-gated channel modifier subfamily V member 1" Q6PIU1 8 109963636-109975771 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 4.5" "Group enriched" "Detected in some" 6 "Enteroendocrine cells: 7.1;Excitatory neurons: 28.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 36.6" HPA067233 Supported "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane, Cytokinetic bridge" "HPA067233: " "unprognostic (1.41e-1)" "unprognostic (1.81e-2)" "unprognostic (5.01e-4)" "unprognostic (2.30e-1)" "unprognostic (3.76e-2)" "unprognostic (1.13e-2)" "unprognostic (3.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.17e-2)" 0.1 0.1 2.1 0.1 4.3 0.5 0.1 0.0 4.5 0.0 0.0 0.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 3.1 1.2 0.1 0.1 0.1 0.2 1.2 0.3 3.2 0.3 0.4 0.1 0.3 0.2 1.4 0.2 0.4 0.7 0.2 0.1 0.1 0.4 0.3 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.5 0.6 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.5 0.1 0.0 0.1 0.2 0.1 0.3 0.6 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.6 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.8 0.2 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.2 0.5 0.4 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.1 4.3 0.0 4.5 3.1 1.2 1.2 0.3 3.2 1.4 0.0 0.2 2.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 7.1 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113436939 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 7.5" "Group enriched" "Detected in some" 12 "Excitatory neurons: 915.9;Inhibitory neurons: 867.9;Oligodendrocyte precursor cells: 1761.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029007, HPA029008" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA029007: AB_10601802, HPA029008: " "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 0.0 0.0 7.5 0.0 5.1 0.0 0.0 0.4 6.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.6 3.8 0.0 0.0 0.0 0.0 2.8 2.2 5.6 0.0 0.2 0.0 0.1 0.0 1.7 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 5.1 0.4 6.6 6.6 3.8 2.8 2.2 5.6 1.7 0.4 3.5 3.2 0.0 0.0 3.0 21.5 0.2 0.3 0.1 0.0 0.0 7.3 0.0 0.0 1.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.5 0.1 0.4 0.0 0.0 915.9 0.0 0.0 0.9 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 867.9 0.0 0.0 0.0 0.8 6.3 0.0 0.3 0.0 19.7 0.0 0.5 0.0 1761.3 92.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.2 17.1 8.2 0.0 0.6 0.0 0.0 0.0 0.0 0.3 SPIDR KIAA0146 ENSG00000164808 "Scaffold protein involved in DNA repair" Q14159 8 47260878-47736306 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 122.4;Excitatory neurons: 255.4;Inhibitory neurons: 214.4;Microglial cells: 216.4;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027201, HPA041582" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027201: AB_10603774, HPA041582: AB_2677563" "unprognostic (5.58e-2)" "unprognostic (2.24e-2)" "unprognostic (2.71e-2)" "unprognostic (7.45e-2)" "unprognostic (4.72e-3)" "unprognostic (7.99e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-3)" "unprognostic (2.93e-2)" "prognostic unfavorable (8.91e-4)" "unprognostic (1.74e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.43e-2)" "unprognostic (1.35e-2)" 18.2 16.7 17.8 16.3 17.7 15.3 19.3 20.3 20.0 18.8 17.5 16.3 11.1 16.7 14.9 23.8 18.4 21.0 11.8 17.8 18.0 12.8 15.2 19.1 16.7 17.1 16.5 17.5 23.8 18.3 11.9 17.9 18.6 17.4 18.4 14.6 18.2 17.8 10.7 14.0 20.5 13.5 11.9 14.5 20.7 17.8 10.7 16.4 12.4 19.8 4.2 12.1 17.5 16.3 19.4 16.4 24.2 16.5 28.7 19.6 24.9 15.0 22.8 18.1 16.5 25.5 13.4 39.4 31.5 22.6 19.8 16.9 8.5 18.3 17.3 23.7 9.1 15.6 21.5 23.0 25.7 21.9 16.0 13.3 15.9 13.5 13.7 19.9 20.0 12.4 19.7 16.9 11.2 19.9 38.8 30.3 40.5 19.6 38.2 6.5 15.2 10.1 2.2 22.4 55.6 9.0 19.5 35.2 25.7 12.3 17.4 23.9 33.0 20.4 12.0 17.8 17.8 13.4 12.7 25.1 21.8 14.2 22.3 12.0 4.6 10.6 3.1 9.3 6.5 9.4 7.1 4.1 5.5 8.6 6.0 4.4 3.9 4.4 7.9 7.7 1.3 8.8 5.5 17.8 17.7 20.3 20.0 17.8 18.0 17.1 16.5 17.5 17.4 14.5 16.4 19.4 25.8 35.3 33.7 122.4 22.2 10.7 16.6 17.8 30.7 11.2 20.1 18.0 19.5 12.8 18.0 12.9 18.8 17.8 15.7 8.8 7.9 8.2 8.5 18.1 20.4 21.4 11.5 12.4 255.4 8.8 11.5 21.7 26.0 21.0 12.6 20.6 10.8 8.3 11.1 13.5 214.4 9.7 10.2 33.1 11.3 7.6 14.6 27.4 8.8 216.4 24.9 8.7 15.5 207.6 141.4 7.1 10.1 14.7 16.6 15.1 6.0 4.9 26.5 12.2 6.6 17.5 16.9 21.7 29.7 27.6 8.7 16.4 15.1 10.9 12.3 18.6 ORC5 "ORC5L, Orc5p, ORC5T, PPP1R117" ENSG00000164815 "Origin recognition complex subunit 5" O43913 7 104126341-104208047 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019730 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019730: AB_10696205" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (4.77e-2)" "unprognostic (7.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" "unprognostic (3.47e-2)" "unprognostic (9.26e-2)" "unprognostic (2.33e-1)" "unprognostic (1.77e-1)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (2.53e-2)" "unprognostic (7.73e-2)" 8.8 9.8 11.1 7.8 11.9 5.8 13.4 15.0 12.6 10.0 8.3 12.1 8.5 10.9 13.8 10.7 9.0 6.7 6.4 11.3 11.3 10.5 17.5 6.4 12.3 11.0 10.7 10.6 10.8 14.6 10.2 7.6 9.6 10.2 17.1 12.9 14.2 9.0 10.7 9.1 11.5 7.5 11.0 9.8 9.1 10.4 19.5 11.7 13.4 10.3 7.9 13.5 11.1 10.1 12.0 37.1 39.2 21.2 38.1 21.8 21.5 18.8 31.0 30.8 34.2 28.5 25.9 23.7 55.4 26.9 19.5 37.9 33.1 42.4 29.9 40.8 32.3 30.5 20.2 19.1 24.8 30.8 37.9 16.5 22.3 27.9 39.4 36.2 14.4 32.8 30.1 65.0 29.3 30.8 52.6 52.4 38.7 23.2 48.6 37.9 21.6 38.0 53.4 26.4 26.4 28.9 23.5 30.2 58.7 41.3 16.5 19.7 28.4 19.2 32.8 36.0 51.8 41.6 33.7 75.8 69.3 22.2 49.7 39.8 14.2 10.6 8.4 20.2 12.7 26.5 24.0 21.6 23.9 12.3 18.7 25.7 28.9 1.4 20.6 10.9 11.4 18.4 13.7 11.1 11.9 15.0 12.6 11.3 11.3 11.0 10.7 10.6 10.2 9.8 11.7 12.0 6.7 3.2 7.2 22.2 11.2 4.5 3.6 11.4 10.8 6.6 6.6 5.7 6.2 8.6 9.8 3.7 0.0 22.1 2.6 4.4 1.9 10.3 5.7 3.8 9.8 9.1 5.4 12.8 54.4 9.0 14.3 8.6 9.7 4.5 5.1 11.6 4.6 9.7 8.8 3.3 48.8 8.9 6.1 4.8 4.2 5.7 6.2 6.0 1.8 35.6 7.8 3.4 7.2 31.2 55.9 7.4 5.4 7.9 13.9 4.9 5.9 7.2 12.9 12.5 0.0 4.1 10.9 40.1 24.6 12.6 8.5 10.5 9.5 10.3 8.1 2.0 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056739 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 767 "intestine: 9841.1" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" Yes NA 110000 Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favorable (9.44e-5)" "unprognostic (3.91e-2)" 0.2 0.4 0.1 12.8 0.1 0.3 0.5 0.1 0.5 0.0 0.1 36.6 5232.0 3.9 0.1 0.8 0.0 0.0 0.4 0.1 0.1 0.2 1.1 0.4 6.0 0.1 0.2 0.1 0.4 0.8 0.0 1.1 0.0 0.2 0.7 0.2 0.2 0.7 0.0 0.3 0.3 9841.1 0.1 0.1 0.4 1.0 0.8 0.2 0.4 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 2.5 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 325.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 399.9 0.0 0.0 0.0 1740.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1753.0 0.0 DNAAF5 "CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2" ENSG00000164818 "Dynein axonemal assembly factor 5" Q86Y56 7 726699-786475 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020243 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020243: AB_1848750" "unprognostic (9.77e-2)" "unprognostic (9.53e-3)" "unprognostic (2.55e-1)" "unprognostic (2.57e-1)" "unprognostic (8.22e-3)" "prognostic unfavorable (8.42e-4)" "prognostic unfavorable (3.83e-4)" "unprognostic (8.07e-3)" "unprognostic (2.02e-1)" "unprognostic (7.59e-2)" "unprognostic (8.26e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-3)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "unprognostic (8.70e-3)" 8.3 8.8 7.8 6.8 6.4 7.7 8.6 11.0 7.5 10.4 10.0 11.3 7.4 12.8 4.8 11.7 14.2 5.1 12.0 6.5 8.2 8.1 9.0 7.0 6.6 8.0 7.8 5.4 10.7 11.0 8.0 13.1 6.5 8.8 8.0 5.8 4.0 11.6 8.0 24.3 9.0 9.3 6.3 7.8 7.3 9.5 7.8 8.7 6.3 9.1 9.6 5.0 10.6 9.2 8.1 83.1 64.3 18.8 44.0 12.1 13.3 47.2 16.8 16.0 20.5 19.4 64.5 42.8 50.5 23.9 17.7 49.0 49.2 35.0 42.2 15.7 8.6 59.5 12.4 37.4 47.2 16.6 38.1 21.7 16.1 17.8 25.8 19.0 13.7 28.1 25.2 80.0 10.3 15.0 81.5 22.7 34.1 69.3 27.4 50.5 41.4 6.1 34.8 24.3 34.5 39.3 65.1 27.5 66.9 19.9 21.4 59.1 31.5 23.7 11.4 40.1 39.4 38.4 19.9 25.5 29.0 25.1 39.2 60.8 0.0 0.7 0.6 0.8 1.1 1.3 0.6 1.3 1.8 1.1 1.4 1.2 0.9 0.0 1.3 0.8 1.7 0.3 0.8 7.8 6.4 11.0 7.5 6.5 8.2 8.0 7.8 5.4 8.8 7.8 8.7 8.1 7.1 19.2 9.1 6.2 3.8 0.0 6.1 0.0 6.8 6.3 8.3 7.1 13.1 4.3 4.3 9.2 27.1 8.0 5.7 4.9 15.6 6.4 0.7 28.2 13.9 7.8 3.6 9.7 12.5 4.2 13.2 7.8 11.7 15.3 0.0 17.6 6.8 8.5 5.8 10.1 10.4 7.4 0.0 7.5 0.0 1.7 7.2 4.8 0.0 7.5 2.4 8.6 2.1 10.6 8.9 9.6 4.1 8.6 6.0 5.1 6.4 11.1 8.0 15.0 0.0 11.4 6.1 7.2 17.4 10.8 0.0 4.5 3.5 12.0 9.1 4.2 DEFA4 "DEF4, HP-4" ENSG00000164821 "Defensin alpha 4" P12838 8 6935820-6938306 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "bone marrow: 2725.9" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Hepatocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 13 "neutrophil: 13.1" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.1" "Cell line enriched" "Detected in single" 8 "THP-1: 6.8" HPA051266 Enhanced "Secreted to blood" NA NA 98000 "HPA051266: AB_2681414" 0.6 0.1 0.0 0.2 0.0 2725.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.3 2.7 14.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.4 2.1 0.1 0.0 0.0 46.8 0.1 0.1 0.0 9.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 DEFA6 "DEF6, HD-6" ENSG00000164822 "Defensin alpha 6" Q01524 8 6924697-6926076 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 862 "intestine: 4860.0" "Group enriched" "Detected in some" 6 "Proximal enterocytes: 448.9;Undifferentiated cells: 904.1" "Group enriched" "Detected in many" 5 "cervical cancer: 21.2;colorectal cancer: 75.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 14.7;NB-4: 15.9;RPMI-8226: 19.7;SH-SY5Y: 12.2;U-2197: 5.7" HPA019462 Enhanced "Secreted to digestive system" NA NA 260000 "HPA019462: AB_1847595" "unprognostic (7.48e-3)" "unprognostic (1.63e-1)" "unprognostic (1.34e-1)" 0.1 0.2 0.0 5.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 16.3 2888.7 2.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.2 3.4 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.1 0.3 3.4 0.0 0.3 0.0 0.2 0.5 4860.0 0.0 0.0 0.2 0.4 0.6 0.0 2.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 1.1 12.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.0 0.0 0.0 0.5 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.0 448.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 904.1 0.0 OSGIN2 "C8orf1, hT41" ENSG00000164823 "Oxidative stress induced growth inhibitor family member 2" Q9Y236 8 89901849-89927888 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 246.6;Granulosa cells: 144.4;Late spermatids: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 22.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 22.2" "Cell line enhanced" "Detected in all" "SK-BR-3: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028515, HPA050595" Approved Approved Nucleoli NA NA Nucleoli "HPA028515: AB_10602014, HPA050595: AB_2681186" "unprognostic (3.29e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (4.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.26e-2)" "prognostic unfavorable (3.91e-6)" "prognostic unfavorable (2.93e-4)" "unprognostic (2.32e-1)" "unprognostic (2.22e-3)" "unprognostic (4.38e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-1)" "unprognostic (1.09e-1)" "unprognostic (7.25e-2)" 19.3 7.7 11.2 8.7 11.1 52.4 12.2 12.7 12.2 8.6 9.8 9.4 8.0 18.6 5.8 8.4 6.0 16.4 14.9 11.9 42.4 17.3 18.7 16.6 10.9 14.0 12.2 8.8 17.9 7.9 33.5 9.8 7.0 14.7 10.0 9.0 13.0 7.5 7.8 15.3 5.2 7.1 21.3 16.2 9.4 6.0 23.3 11.5 9.0 14.2 18.9 10.1 11.1 4.7 19.8 32.1 30.6 7.9 16.2 17.5 14.0 9.9 23.5 49.9 21.7 22.2 14.3 29.6 21.9 45.7 13.0 26.1 11.6 16.0 18.8 34.6 33.3 11.7 34.2 11.7 8.0 31.9 17.0 20.4 16.1 23.2 24.5 22.6 20.9 28.6 28.7 19.7 38.3 16.2 24.8 29.7 11.7 4.4 33.6 16.7 13.1 11.5 18.6 33.2 24.2 7.1 18.1 17.3 149.6 29.5 12.9 30.1 27.9 20.2 23.2 20.2 20.1 22.2 35.0 32.2 24.2 38.6 21.9 17.5 22.2 1.6 7.5 1.9 1.2 2.7 3.5 2.8 1.7 1.8 2.0 2.3 2.6 12.4 2.5 1.5 1.3 3.1 1.6 11.2 11.1 12.7 12.2 11.9 42.4 14.0 12.2 8.8 14.7 16.2 11.5 19.8 9.8 64.1 14.8 49.3 10.4 6.0 6.9 9.2 2.8 9.0 13.3 6.7 13.9 17.2 12.5 7.3 2.1 6.8 10.6 4.2 9.8 13.6 246.6 11.6 10.8 7.4 9.6 8.6 14.9 16.0 8.4 13.7 2.0 14.1 17.1 144.4 13.6 17.6 16.5 3.3 14.9 3.8 20.3 19.1 9.4 216.8 12.5 15.7 7.2 9.4 13.3 25.3 5.2 7.5 7.8 14.0 3.4 12.4 6.1 7.2 3.0 14.8 15.2 6.0 13.1 18.9 9.0 28.9 8.8 4.5 4.3 1.6 8.3 3.0 5.1 7.6 DEFB1 "BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822" ENSG00000164825 "Defensin beta 1" P60022 8 6870592-6877936 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 1745.1;pancreas: 754.1;salivary gland: 1991.2" "Cell type enriched" "Detected in many" 6 "Distal tubular cells: 13300.4" "Cancer enhanced" "Detected in many" "renal cancer: 522.9" "Group enriched" "Detected in many" 4 "amygdala: 1.1;cerebellum: 1.5;hypothalamus: 1.1;midbrain: 2.3;thalamus: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 43.3" "Not detected" "Not detected" "Secreted in other tissues" NA NA 2500000 "unprognostic (2.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.24e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-3)" "unprognostic (4.41e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (2.77e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (5.94e-4)" "unprognostic (3.24e-1)" "prognostic favorable (1.90e-5)" "unprognostic (9.62e-2)" "unprognostic (2.86e-2)" "unprognostic (2.21e-2)" "unprognostic (1.16e-1)" 8.3 0.7 1.1 1.5 0.0 5.3 41.9 1.5 0.4 307.9 0.3 18.7 5.1 6.3 16.5 192.2 21.4 55.4 1.1 0.0 1.1 1745.1 250.5 5.8 0.0 0.1 2.3 0.3 0.5 754.1 7.0 12.8 2.1 0.1 38.2 11.6 2.0 1991.2 24.7 2.9 206.5 8.7 0.3 0.0 0.3 33.6 0.4 2.3 3.1 3.6 0.0 9.1 11.7 153.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.5 0.0 2.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.5 4.2 0.0 0.1 0.3 0.0 2.7 1.2 43.3 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.5 0.4 0.0 1.1 0.1 2.3 0.3 0.1 0.0 2.3 0.2 0.7 3.2 4.5 0.0 6.8 90.1 641.5 210.5 134.9 0.4 46.9 26.9 0.1 1976.0 57.2 982.1 0.0 11.8 0.4 117.6 13300.4 1860.0 0.0 339.5 223.6 8.8 15.7 0.0 0.0 295.4 0.9 19.0 1.5 1529.3 0.0 0.0 3.3 319.3 3.6 0.0 0.0 8.6 46.8 4.4 7.3 0.1 17.4 17.0 7.2 0.0 15.3 0.6 0.0 0.0 0.0 156.9 91.2 0.0 1.2 537.6 59.1 218.9 9.5 0.7 0.0 1.4 14.3 0.0 0.0 237.0 537.6 3.7 13.8 0.0 15.4 257.0 SUN1 "FLJ12407, KIAA0810, UNC84A" ENSG00000164828 "Sad1 and UNC84 domain containing 1" O94901 7 816615-896435 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 343.8;Late spermatids: 576.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008346, HPA008461" Enhanced Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA008346: AB_1080462, HPA008461: AB_1080461" "unprognostic (2.70e-2)" "unprognostic (1.51e-2)" "unprognostic (1.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.25e-1)" "unprognostic (2.57e-3)" "unprognostic (1.82e-1)" "unprognostic (1.67e-1)" "unprognostic (4.57e-2)" "unprognostic (3.32e-2)" "unprognostic (1.69e-1)" "unprognostic (8.10e-2)" "unprognostic (1.08e-2)" "unprognostic (1.47e-2)" "unprognostic (4.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.33e-2)" 66.2 27.1 26.7 18.1 24.9 8.4 61.3 41.0 29.8 73.9 26.9 50.5 34.1 74.0 38.9 44.2 66.7 28.4 78.1 24.6 23.9 42.2 28.4 42.0 23.8 23.0 25.3 24.9 84.8 34.4 53.4 59.5 47.7 28.8 39.6 30.5 41.7 45.0 34.3 120.3 87.8 42.5 41.9 23.3 39.1 48.5 45.9 23.0 20.2 44.7 100.0 25.3 39.2 57.9 24.6 128.7 34.2 40.2 65.5 43.4 61.6 39.2 31.7 53.4 58.0 59.0 29.1 139.8 30.5 32.2 43.7 113.5 156.8 33.3 55.9 55.9 13.2 33.3 10.0 51.0 27.8 55.3 15.2 24.3 31.0 65.6 46.3 76.4 53.7 42.7 19.0 41.9 22.4 58.6 44.5 10.1 25.2 56.0 44.3 39.0 21.9 22.3 28.7 59.1 40.7 77.2 49.9 40.1 81.4 31.5 64.6 64.6 15.4 32.5 52.8 47.6 55.1 53.2 20.4 25.6 19.0 36.6 12.7 74.4 11.6 9.4 2.5 4.0 8.3 4.2 6.8 7.9 4.6 7.5 5.5 11.0 7.2 0.5 6.6 6.4 1.5 7.3 6.4 26.7 24.9 41.0 29.8 24.6 23.9 23.0 25.3 24.9 28.8 23.3 23.0 24.6 107.0 44.8 36.4 63.0 26.5 106.7 96.9 73.2 50.7 72.4 48.0 38.1 103.7 31.5 68.5 40.5 87.6 37.4 14.1 61.9 27.4 41.5 343.8 168.5 40.3 79.9 40.7 31.5 76.5 23.2 23.5 52.6 60.1 143.7 17.1 73.4 62.4 39.1 17.9 112.7 64.5 45.1 59.0 20.0 34.3 576.2 57.2 16.8 42.7 43.1 16.6 24.0 10.3 48.7 49.8 55.8 68.4 42.5 26.4 84.6 37.7 21.9 163.5 67.6 65.7 53.5 73.4 40.9 49.4 36.1 85.7 38.4 22.0 26.1 38.2 137.4 OXR1 TLDC3 ENSG00000164830 "Oxidation resistance 1" Q8N573 8 106270144-106752694 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Stress response" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 1458.0;Inhibitory neurons: 1366.9;Late spermatids: 405.5;Microglial cells: 496.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027375, HPA027380, HPA027395" Enhanced Approved Vesicles NA NA 12000 Vesicles "HPA027375: AB_10600087, HPA027380: AB_10601569, HPA027395: AB_10601554" "unprognostic (8.16e-3)" "unprognostic (1.39e-1)" "unprognostic (5.52e-2)" "unprognostic (3.12e-1)" "unprognostic (4.84e-2)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (6.59e-2)" "prognostic favorable (5.82e-5)" "unprognostic (1.89e-1)" "unprognostic (1.32e-1)" "unprognostic (2.58e-1)" "unprognostic (2.86e-1)" 29.0 58.3 14.1 11.2 33.0 18.8 29.3 18.8 53.9 30.8 1.4 20.3 14.3 27.9 54.9 29.0 22.6 22.3 30.7 27.7 17.4 30.0 38.6 20.2 14.5 23.9 14.7 23.1 27.3 17.3 24.1 12.3 17.2 28.4 21.3 21.9 80.2 49.0 48.0 52.5 27.6 12.3 21.9 7.0 19.7 27.6 56.6 16.4 22.5 21.5 60.1 16.5 23.9 18.0 30.0 29.5 11.0 32.3 6.5 41.2 51.4 15.0 23.7 28.3 21.6 27.5 9.7 35.6 29.6 26.8 25.6 13.2 20.4 18.5 21.2 37.3 24.9 20.0 39.8 15.3 18.0 25.5 12.8 22.8 30.3 32.1 23.7 34.9 30.0 24.7 24.2 20.3 106.5 24.6 26.2 38.3 17.3 4.2 43.5 19.4 9.9 25.7 55.7 24.0 36.8 19.4 6.0 10.5 7.3 25.8 14.1 34.1 21.2 18.4 24.6 17.1 22.6 15.6 19.7 13.3 12.1 29.2 3.7 30.9 38.1 9.3 17.8 3.9 17.6 6.5 11.4 6.7 6.2 11.2 7.9 16.0 7.1 4.7 11.0 19.4 7.9 5.2 7.8 14.1 33.0 18.8 53.9 27.7 17.4 23.9 14.7 23.1 28.4 7.0 16.4 30.0 54.9 67.3 25.5 125.0 47.1 67.6 57.2 42.6 60.9 89.8 36.7 33.5 58.2 15.7 37.3 35.0 58.4 32.6 44.1 44.3 33.2 16.6 231.2 75.3 32.1 41.8 27.5 19.5 1458.0 17.0 20.0 41.3 39.8 65.3 30.4 29.1 44.6 34.5 19.5 26.9 1366.9 28.2 34.6 33.0 41.4 405.5 34.2 36.3 24.9 496.5 41.1 55.6 22.6 294.0 142.6 23.6 24.9 48.9 73.7 60.4 16.5 16.4 53.5 125.8 19.7 46.4 41.6 140.4 51.6 56.7 75.6 71.1 26.5 33.5 26.4 86.1 TMEM74 "FLJ30668, NET36" ENSG00000164841 "Transmembrane protein 74" Q96NL1 8 108606850-108787594 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015672, HPA076461" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA015672: AB_1858132, HPA076461: " "unprognostic (8.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.25e-2)" "unprognostic (6.33e-2)" "unprognostic (2.05e-1)" "unprognostic (4.18e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-2)" "unprognostic (2.01e-2)" "unprognostic (3.97e-2)" "unprognostic (3.75e-4)" "unprognostic (8.77e-2)" "unprognostic (6.36e-2)" "unprognostic (5.95e-2)" "unprognostic (1.46e-3)" 0.3 0.2 2.0 0.1 2.5 0.0 0.2 5.0 2.6 0.2 1.4 0.9 0.0 0.1 0.0 0.5 0.1 0.1 1.3 3.7 4.6 0.0 0.8 0.1 0.0 3.8 2.1 1.8 0.1 0.5 0.0 0.4 0.0 3.3 0.1 0.1 2.5 0.2 0.1 0.8 0.3 0.2 0.4 6.1 0.1 0.3 0.4 1.9 0.3 0.1 0.2 0.1 0.2 0.4 9.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 1.7 0.7 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 1.5 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.5 5.0 2.6 3.7 4.6 3.8 2.1 1.8 3.3 6.1 1.9 9.0 0.4 0.0 0.0 2.0 0.0 0.9 0.7 0.0 4.6 4.7 0.2 0.6 0.8 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.3 1.8 0.0 5.1 0.2 0.8 0.7 0.0 0.1 0.0 0.5 0.0 0.7 0.1 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 8.3 0.0 0.8 0.9 0.2 4.1 2.0 0.6 0.1 0.1 0.1 0.0 0.0 GPR146 PGR8 ENSG00000164849 "G protein-coupled receptor 146" Q96CH1 7 1044546-1059261 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 96.3;Endothelial cells: 45.3;Extravillous trophoblasts: 243.2;Syncytiotrophoblasts: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 95.2;naive CD4 T-cell: 25.6" "Group enriched" "Detected in many" 4 "granulocytes: 95.2;T-cells: 25.6" "Cell line enhanced" "Detected in many" "BEWO: 23.0;NB-4: 7.1" "Low region specificity" "Detected in all" NA NA "unprognostic (3.39e-2)" "unprognostic (7.83e-2)" "unprognostic (6.27e-4)" "unprognostic (5.51e-3)" "unprognostic (1.78e-1)" "unprognostic (2.33e-1)" "unprognostic (2.30e-1)" "unprognostic (2.69e-1)" "unprognostic (2.99e-2)" "unprognostic (3.48e-3)" "unprognostic (2.51e-2)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (3.27e-3)" "unprognostic (1.41e-1)" "unprognostic (4.19e-2)" "unprognostic (1.03e-2)" 44.1 2.7 15.1 2.0 14.6 9.1 42.2 14.4 21.1 9.8 18.0 11.8 2.8 13.3 2.8 4.7 12.4 7.6 10.1 11.6 13.7 5.3 20.6 25.1 4.1 17.9 15.7 10.1 7.5 6.0 1.6 3.4 10.3 16.5 7.2 1.1 3.6 9.7 5.5 10.8 11.0 8.2 3.5 14.6 6.8 13.0 2.7 19.4 1.7 11.6 8.8 1.2 13.3 8.8 18.2 1.2 1.0 0.4 1.0 1.3 0.3 23.0 0.1 0.9 0.2 1.1 0.8 1.1 0.4 0.7 0.1 3.5 0.8 0.0 0.3 0.1 0.8 0.9 1.7 0.7 1.9 1.5 0.1 0.2 0.5 0.0 0.7 0.0 2.4 1.7 0.6 1.1 1.2 0.2 0.7 0.0 7.1 1.6 1.3 0.6 5.5 0.0 1.5 0.3 0.1 1.2 1.7 1.8 0.2 2.0 0.9 1.1 2.2 0.5 1.0 1.1 1.6 0.8 1.9 2.1 0.1 6.1 2.2 2.1 0.0 0.2 95.2 0.6 0.1 1.2 0.0 8.4 0.7 1.7 0.1 25.6 4.8 0.1 1.3 0.3 14.3 14.5 4.3 15.1 14.6 14.4 21.1 11.6 13.7 17.9 15.7 10.1 16.5 14.6 19.4 18.2 96.3 0.0 2.8 7.2 3.3 1.8 0.8 1.8 1.2 3.7 7.6 3.4 0.3 1.5 2.1 1.8 0.0 9.3 1.4 0.3 1.9 1.0 0.1 3.2 0.4 45.3 4.2 30.5 0.9 0.6 243.2 4.8 2.0 3.7 2.5 1.7 16.4 21.3 10.9 3.3 1.4 0.3 2.0 0.6 6.1 1.1 3.1 1.7 3.6 3.7 0.2 21.2 2.1 4.5 1.7 0.7 0.3 3.4 0.9 0.7 0.8 3.4 0.0 5.7 0.0 2.3 1.4 0.5 1.5 0.4 2.3 82.4 2.5 0.9 1.0 0.4 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 45.7" "Cell type enhanced" "Detected in many" "Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8" "Group enriched" "Detected in many" 19 "dendritic cells: 5.8;monocytes: 2.9" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016718, HPA027052" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Nucleoli "Nucleoplasm, Vesicles, Cytosol" "HPA016718: , HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favorable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 10.3 12.7 11.2 1.6 10.7 0.2 8.5 7.7 16.0 4.7 6.9 9.0 0.6 5.8 0.3 2.3 4.3 1.3 5.6 8.7 8.1 8.1 28.1 12.2 2.0 10.9 8.9 7.7 2.5 2.1 0.4 6.2 6.4 9.8 7.2 1.5 1.0 2.9 5.0 4.4 2.7 3.7 1.8 6.8 8.6 45.7 1.5 9.2 0.9 9.8 1.3 1.0 6.1 4.7 9.1 1.1 0.4 0.3 11.5 2.7 2.6 1.1 6.7 4.4 2.1 3.7 0.2 0.3 12.1 1.1 8.6 0.1 0.6 0.1 0.0 0.2 2.6 2.1 0.0 1.4 22.8 0.4 0.1 0.7 1.5 0.0 1.3 0.0 1.6 0.6 0.2 0.1 0.1 0.5 0.8 0.0 0.4 2.2 2.4 7.9 1.1 0.0 0.0 0.2 0.0 0.1 4.5 0.0 0.5 2.5 0.8 0.2 0.1 1.6 0.4 2.8 6.9 2.1 0.0 0.0 4.4 3.8 0.2 0.2 0.0 2.9 0.0 0.0 2.8 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.4 11.2 10.7 7.7 16.0 8.7 8.1 10.9 8.9 7.7 9.8 6.8 9.2 9.1 9.6 0.0 0.0 1.0 1.2 0.5 0.0 0.5 1.8 0.0 0.5 0.5 2.8 0.0 0.0 5.5 0.0 0.0 0.0 15.4 0.0 0.1 0.0 4.4 0.1 11.3 1.2 0.0 0.8 3.1 0.6 1.5 0.5 1.0 0.0 0.4 1.1 23.5 0.6 0.0 0.5 2.8 0.0 16.9 2.7 0.7 2.8 2.9 0.0 1.9 0.6 4.4 0.0 0.5 0.1 0.8 7.4 1.2 0.1 0.8 0.2 5.6 0.0 0.4 0.0 0.7 7.2 0.5 2.7 0.1 0.3 0.0 0.0 0.1 2.0 0.1 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232872-1237326 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "brain: 17.4" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 17.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "NB-4: 98.5" "Region enriched" "Detected in single" 5 "cerebellum: 3.2" "Region enriched" "Detected in single" 8 "cerebellum: 7.5" HPA063294 Approved Nucleoplasm NA NA Nucleoplasm "HPA063294: AB_2684977" "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.0 0.0 0.7 0.0 0.3 0.0 0.0 17.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 1.8 3.0 0.0 0.0 0.0 0.0 0.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 17.4 0.6 0.0 2.8 1.8 3.0 0.0 5.4 0.7 1.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 95.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 65.9;Intestinal goblet cells: 40.4;Paneth cells: 41.7;Proximal enterocytes: 60.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 34.2;RT4: 37.9;SCLC-21H: 40.8;SK-BR-3: 58.4;T-47d: 53.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.3 0.3 1.4 0.1 0.7 3.0 0.1 0.9 11.9 0.2 9.2 24.7 1.1 0.3 95.3 7.1 3.6 0.3 0.1 0.2 6.2 24.6 2.2 0.2 0.2 0.1 0.0 0.2 23.1 5.2 11.5 1.7 0.5 11.4 6.6 0.1 22.7 4.6 4.9 36.2 23.8 0.3 0.0 0.1 12.7 3.8 0.1 0.6 0.7 0.6 4.4 12.9 41.3 0.7 23.7 15.0 0.1 0.0 0.0 0.1 5.0 0.8 0.3 0.9 0.1 20.9 25.4 0.5 7.6 0.3 7.5 17.0 0.0 9.7 0.3 0.2 0.9 0.1 15.3 9.7 0.2 0.0 0.0 0.0 8.9 0.3 8.0 0.4 0.1 6.3 0.2 0.1 0.0 34.2 0.2 0.1 0.7 13.5 19.3 0.5 0.0 10.9 7.3 37.9 40.8 0.1 6.4 58.4 0.1 0.5 53.7 0.1 0.0 0.0 8.2 9.7 1.1 0.1 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.1 0.2 0.2 0.1 0.0 0.5 0.0 0.1 0.7 2.9 3.2 4.4 0.0 1.6 4.0 5.8 7.2 2.2 1.1 12.1 5.5 7.5 11.5 18.2 9.2 0.0 7.1 1.4 65.9 1.9 13.2 0.0 19.3 3.4 1.4 7.2 0.0 0.3 11.0 8.7 1.7 23.4 31.7 1.3 0.5 0.0 14.2 0.8 0.0 0.1 40.4 14.2 0.6 2.6 0.0 0.0 1.4 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.1 41.7 0.0 4.6 10.4 60.5 5.1 28.0 0.6 0.0 1.8 3.0 0.0 0.1 15.4 9.2 16.8 1.2 0.1 19.4 16.0 NOS3 "ECNOS, eNOS" ENSG00000164867 "Nitric oxide synthase 3" P29474 7 150991017-151014588 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 62.9" "Cell type enhanced" "Detected in some" "Adipocytes: 20.4;Early spermatids: 81.9;Endothelial cells: 32.6;Hepatic stellate cells: 29.3;Late spermatids: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "BEWO: 23.1;HUVEC TERT2: 44.7;K-562: 16.6;TIME: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002168 Enhanced NA NA "CAB002168: AB_564072" "unprognostic (6.53e-2)" "unprognostic (3.36e-1)" "unprognostic (1.63e-2)" "unprognostic (8.46e-2)" "unprognostic (2.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (6.97e-2)" "unprognostic (2.56e-1)" "unprognostic (9.40e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" 15.6 6.4 8.9 5.9 5.6 0.8 13.3 5.0 7.6 7.4 6.7 5.7 2.7 9.8 0.4 5.8 8.1 4.8 18.2 4.8 5.2 9.9 4.3 11.3 2.7 8.5 7.0 3.1 3.3 2.9 1.2 7.2 4.8 7.2 7.7 1.2 0.8 4.5 1.8 4.0 4.2 6.7 3.8 6.3 62.9 5.5 7.3 9.1 0.6 9.2 3.6 1.2 9.7 7.5 7.7 0.4 0.1 1.3 4.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.3 2.2 0.4 2.1 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.4 2.2 0.3 6.4 0.6 0.5 10.4 0.1 0.2 0.0 0.0 0.1 44.7 5.1 16.6 3.6 0.0 0.0 0.2 0.5 1.7 0.7 0.1 3.0 0.0 1.8 0.0 0.3 0.5 0.4 0.2 1.4 0.0 0.4 0.1 1.4 82.5 0.2 0.7 0.4 0.1 2.4 8.9 2.2 0.0 7.5 0.0 0.2 0.1 0.1 1.1 0.2 0.7 0.3 1.7 0.9 0.2 0.5 2.3 0.9 0.3 0.2 0.2 0.2 2.1 0.5 8.9 5.6 5.0 7.6 4.8 5.2 8.5 7.0 3.1 7.2 6.3 9.1 7.7 20.4 9.6 2.2 0.3 0.7 0.9 0.1 0.1 0.0 0.2 0.2 0.3 3.1 0.0 0.7 0.0 0.0 0.2 0.7 0.1 0.0 1.0 81.9 4.9 0.7 32.6 0.0 0.0 0.2 0.0 0.1 2.9 0.5 3.2 5.7 0.7 29.3 0.7 0.4 0.0 0.2 0.4 0.0 0.6 0.5 29.3 0.9 0.4 0.0 7.5 0.0 0.3 0.0 0.0 0.0 0.8 0.0 1.2 1.5 0.4 0.1 0.2 2.2 0.3 0.0 0.6 2.6 6.9 5.3 0.2 0.6 3.6 1.6 0.9 0.1 0.9 SPAG11B "EDDM2B, EP2, EP2C, EP2D, HE2" ENSG00000164871 "Sperm associated antigen 11B" Q08648 8 7442684-7463674 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1635 "epididymis: 871.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 871.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MICALL2 "FLJ23471, JRAB, MGC46023, MICAL-L2" ENSG00000164877 "MICAL like 2" Q8IY33 7 1428465-1459470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 103.2;Distal enterocytes: 85.4;Gastric mucus-secreting cells: 171.8;Proximal enterocytes: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 27.7;OE19: 30.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025695 Enhanced NA NA "HPA025695: AB_10610140" "unprognostic (2.46e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-2)" "unprognostic (6.01e-3)" "unprognostic (2.23e-3)" "unprognostic (3.51e-2)" "unprognostic (9.02e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (6.40e-2)" "unprognostic (1.03e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (6.53e-9)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.84e-2)" 4.4 18.5 0.8 4.9 0.2 7.6 4.7 0.4 2.4 6.4 0.0 12.0 12.5 5.2 0.2 8.3 5.6 3.5 4.1 0.8 0.3 5.2 5.5 7.9 2.3 1.1 0.6 0.0 1.4 4.6 0.7 6.6 0.7 1.2 9.6 1.8 0.0 8.4 2.2 1.5 6.3 18.7 2.2 0.0 15.5 12.9 2.7 1.8 1.7 6.8 0.0 1.0 9.9 6.2 1.6 16.6 1.8 0.5 2.2 1.7 4.2 4.5 7.6 2.9 3.4 1.2 2.2 6.3 0.3 4.6 2.4 6.9 9.4 0.0 8.8 0.2 1.2 2.0 11.0 3.0 1.3 2.1 0.5 27.7 5.5 2.0 2.4 0.3 2.1 3.9 1.5 18.3 0.5 1.6 17.4 0.4 17.6 1.5 30.2 5.3 2.9 3.1 11.7 2.3 4.5 0.4 1.5 6.3 11.5 6.0 0.7 9.6 6.3 13.4 2.5 19.6 9.3 7.7 0.8 0.2 0.0 8.1 6.0 16.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.4 2.4 0.8 0.3 1.1 0.6 0.0 1.2 0.0 1.8 1.6 5.3 3.2 10.8 103.2 2.0 8.7 7.0 39.0 16.5 1.9 13.2 10.9 7.7 18.6 22.5 14.7 2.1 0.5 1.9 85.4 1.9 11.4 5.9 13.5 7.7 10.0 6.0 7.8 13.0 15.4 6.6 9.9 171.8 14.3 5.7 5.4 10.4 3.2 3.3 3.3 10.0 49.0 18.3 3.5 6.2 5.3 4.1 3.3 3.6 4.7 2.3 1.2 0.0 29.1 5.7 18.4 51.9 0.4 1.5 12.8 70.2 1.5 25.3 1.6 6.6 4.1 11.4 5.3 6.2 14.6 6.1 1.2 1.7 3.3 36.9 8.0 CA3 "CAIII, Car3" ENSG00000164879 "Carbonic anhydrase 3" P07451 8 85373436-85449040 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 5323.9" "Group enriched" "Detected in many" 8 "Erythroid cells: 221.3;Skeletal myocytes: 304.0" "Group enriched" "Detected in many" 7 "glioma: 23.1;prostate cancer: 9.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 47.3;RH-30: 78.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004967, HPA021775, HPA026700" Enhanced NA NA 53000000 "CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991" "prognostic favorable (4.24e-6)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (2.22e-3)" "unprognostic (4.71e-2)" "unprognostic (8.43e-3)" "unprognostic (3.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-1)" "unprognostic (4.71e-2)" "unprognostic (3.54e-1)" "unprognostic (3.19e-2)" "unprognostic (1.18e-1)" "unprognostic (9.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.19e-1)" 43.8 3.9 3.7 0.3 2.2 9.9 6.5 2.5 3.7 5.1 1.2 1.6 1.9 8.3 2.1 65.3 9.8 2.2 19.6 2.1 3.6 2.0 2.4 24.8 0.4 2.8 2.0 1.8 1.4 1.3 1.0 3.8 0.3 2.2 90.3 1.1 5.6 15.5 2.7 5323.9 5.3 4.4 19.2 2.3 0.8 4.1 2.9 2.0 1.4 3.0 1027.8 0.6 1.5 5.5 2.7 2.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.5 0.2 47.3 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 78.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 2.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.7 2.2 2.5 3.7 2.1 3.6 2.8 2.0 1.8 2.2 2.3 2.0 2.7 0.3 3.2 4.2 2.3 0.1 0.5 1.7 0.6 1.2 0.0 14.5 0.6 1.0 5.7 0.6 0.0 6.2 1.1 0.4 0.4 0.0 0.6 24.1 0.4 0.2 2.2 0.0 221.3 2.2 0.2 0.2 9.1 0.0 0.7 0.0 0.2 2.5 0.3 0.4 0.0 2.5 0.4 0.0 0.3 0.4 7.0 0.3 2.5 0.0 0.0 0.0 29.6 0.0 1.5 0.7 0.2 1.7 0.0 0.0 0.5 8.5 0.6 1.0 1.6 0.0 304.0 5.1 0.6 1.3 0.2 1.0 1.6 1.4 0.3 0.9 0.3 INTS1 "DKFZp586J0619, INT1, KIAA1440, NET28" ENSG00000164880 "Integrator complex subunit 1" Q8N201 7 1470277-1504389 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021658, HPA053009" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA021658: AB_1852402, HPA053009: AB_2682016" "unprognostic (3.20e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-2)" "unprognostic (2.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (7.72e-3)" "unprognostic (3.11e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.83e-4)" "unprognostic (4.30e-1)" "unprognostic (5.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" 18.8 20.5 10.3 13.3 6.7 26.0 20.4 2.1 16.9 23.4 1.2 23.2 15.1 23.6 2.1 21.8 24.1 8.1 22.0 9.1 2.3 23.1 23.7 20.1 15.7 10.5 6.8 8.8 28.3 31.4 9.1 25.3 9.6 7.8 25.1 4.1 4.8 21.4 10.1 56.4 23.7 24.2 5.5 2.5 26.8 23.0 48.3 6.4 22.6 26.0 11.7 6.3 22.5 19.7 8.0 63.9 54.4 20.8 54.2 15.0 11.5 72.3 26.5 14.6 20.1 17.6 60.3 48.3 34.1 27.2 19.1 40.4 64.6 11.8 31.5 5.6 16.7 64.8 24.3 80.3 40.5 17.4 42.6 35.0 15.5 14.6 20.7 14.5 12.0 22.1 47.5 68.8 26.5 12.4 77.1 24.2 115.9 114.0 23.3 48.2 60.4 23.6 34.9 9.6 47.7 39.2 96.4 38.1 68.8 24.1 11.9 54.7 42.2 41.3 32.8 92.8 27.6 44.1 55.0 31.6 33.6 36.8 36.2 68.7 2.0 0.9 1.0 1.4 0.6 0.9 0.8 1.1 1.2 1.2 2.7 0.6 0.9 0.7 1.0 0.6 0.6 1.5 0.8 10.3 6.7 2.1 16.9 9.1 2.3 10.5 6.8 8.8 7.8 2.5 6.4 8.0 16.5 12.8 25.8 19.9 14.0 5.9 4.9 11.1 9.6 34.7 20.7 17.4 52.0 14.3 11.5 11.0 25.0 12.9 14.6 44.6 0.0 16.3 23.2 21.4 15.2 18.3 18.0 5.9 22.4 23.6 13.3 15.8 30.1 27.4 1.3 43.6 15.4 26.3 15.0 48.8 14.5 23.4 12.2 19.8 8.1 41.4 13.4 12.8 5.4 12.2 12.6 14.9 7.2 12.5 11.0 19.9 21.7 15.4 17.9 9.1 28.8 12.9 13.7 36.1 26.3 16.6 15.7 20.8 11.6 13.3 8.0 15.2 12.2 23.5 29.3 6.1 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053815-151057897 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB008909: , HPA064535: AB_2685280" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 6.3 17.0 50.6 9.5 56.2 11.3 8.7 47.3 66.3 8.7 41.3 9.4 11.0 6.8 25.1 10.3 8.2 9.6 9.9 57.6 56.8 13.6 12.6 8.3 9.9 50.1 47.8 56.6 4.6 9.6 23.0 14.8 8.7 52.0 8.9 10.0 11.4 9.7 10.3 8.6 9.6 8.7 10.5 45.0 9.4 8.0 4.9 53.5 14.4 10.1 7.3 11.7 8.9 6.0 57.1 31.9 40.8 37.3 59.7 48.8 36.1 17.8 24.4 41.7 47.9 40.3 31.2 31.0 34.7 71.3 31.8 63.5 23.5 67.8 40.6 22.6 24.9 43.3 38.2 32.4 30.7 31.6 29.0 64.4 37.9 28.7 39.0 13.5 62.8 38.8 57.6 36.3 24.0 50.7 68.4 76.4 57.9 39.3 57.2 80.5 38.9 14.8 41.5 46.2 27.9 23.0 97.8 30.9 37.7 43.8 36.0 18.6 25.9 22.7 42.2 10.3 31.2 39.2 52.1 61.4 13.7 66.4 46.5 75.8 18.9 39.4 20.1 13.5 46.2 11.1 13.3 12.8 13.6 44.7 12.8 9.8 11.8 5.7 19.9 36.4 26.9 31.9 23.8 50.6 56.2 47.3 66.3 57.6 56.8 50.1 47.8 56.6 52.0 45.0 53.5 57.1 7.6 0.0 6.0 1.6 6.2 3.6 8.2 18.0 6.2 12.1 9.6 10.4 3.1 8.6 14.7 11.0 2.1 26.8 5.4 8.0 39.2 21.4 0.8 14.9 10.9 8.9 9.0 12.2 5.8 18.9 12.3 7.6 9.7 9.3 30.5 23.6 7.9 11.1 41.9 0.0 6.4 8.9 18.3 21.9 6.2 1.3 4.7 16.6 10.6 1.9 19.9 12.6 12.3 1.5 3.7 22.8 15.0 11.3 12.4 4.3 20.2 35.7 14.4 7.1 6.6 4.5 13.1 3.9 11.2 11.4 6.3 9.0 7.3 14.2 9.5 9.0 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076526 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "choroid plexus: 394.0" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019339 Enhanced Uncertain "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 26.3 35.1 18.4 19.4 24.2 12.8 23.9 25.7 15.7 36.5 394.0 39.1 22.7 40.6 4.9 21.2 31.4 19.8 29.5 36.0 17.9 38.9 52.7 33.5 13.2 29.0 24.3 7.0 32.1 52.9 73.0 13.9 27.3 31.8 28.4 7.2 4.8 23.3 14.1 19.0 21.4 29.5 16.7 20.1 27.3 82.9 13.8 21.5 12.5 25.6 12.4 6.3 32.2 26.0 37.2 60.9 196.9 37.8 78.9 37.6 17.9 87.1 72.9 37.0 56.9 48.0 113.0 91.6 35.8 154.1 35.0 84.6 58.2 38.2 31.4 9.8 105.3 59.1 48.5 91.9 57.5 59.6 25.2 147.0 29.0 27.4 65.6 15.7 60.9 31.3 50.6 151.8 27.1 44.3 118.0 69.2 43.3 90.4 80.7 73.2 55.2 21.2 42.2 44.6 41.0 31.5 113.9 67.0 118.4 62.0 27.3 51.2 46.7 72.0 78.1 39.1 77.5 106.5 31.2 47.7 20.5 118.7 61.4 160.6 0.0 1.6 0.4 0.8 1.6 0.7 0.9 0.7 0.7 1.0 0.3 0.7 0.8 0.2 0.1 1.0 2.1 0.2 0.9 18.4 24.2 25.7 15.7 36.0 17.9 29.0 24.3 7.0 31.8 20.1 21.5 37.2 15.6 9.6 8.2 9.8 7.2 11.1 5.9 13.6 15.4 7.7 14.5 11.9 4.0 18.6 9.6 20.2 25.0 36.1 14.2 17.6 17.6 35.7 1.0 21.9 18.9 13.6 27.6 2.5 0.4 35.8 9.4 13.6 30.1 17.0 47.1 62.1 17.9 34.6 26.0 15.2 1.4 12.1 16.2 16.1 12.0 1.6 13.7 17.0 26.6 4.7 11.6 21.6 3.1 3.0 16.8 43.8 14.0 19.9 9.9 5.9 24.9 19.1 11.4 8.2 13.1 12.8 17.6 3.1 7.9 10.6 7.0 91.5 8.5 11.2 22.1 4.5 SLC7A13 "AGT-1, XAT2" ENSG00000164893 "Solute carrier family 7 member 13" Q8TCU3 8 86214063-86321146 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 234 "kidney: 42.4" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.96e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 22.3 36.8 31.4 13.5 29.4 8.2 21.9 28.5 51.0 23.5 25.8 30.6 26.4 23.4 12.0 39.8 21.3 14.6 56.0 30.5 28.6 35.0 58.5 18.9 14.5 30.2 30.0 29.7 24.8 28.3 31.2 41.5 9.5 30.5 34.4 11.9 8.0 28.0 19.0 123.8 28.2 25.2 11.9 28.5 25.0 29.2 21.9 31.7 14.9 27.2 96.2 10.5 27.0 25.3 32.0 39.3 45.0 13.9 34.9 50.4 22.4 22.8 29.9 40.1 25.3 29.7 31.5 34.9 9.2 41.0 40.9 46.9 24.1 13.5 36.4 6.1 26.9 23.8 11.4 12.7 27.8 62.7 9.0 25.2 29.8 51.8 29.4 21.5 20.9 30.0 22.4 17.0 20.2 29.2 80.4 20.4 23.5 24.6 47.8 50.8 13.2 17.4 30.4 34.2 27.8 16.4 18.2 40.3 62.5 43.0 11.5 34.4 31.2 24.0 32.7 7.5 31.7 28.0 50.5 33.0 6.5 66.2 19.0 39.8 18.0 31.5 30.1 22.3 32.5 23.4 19.5 23.4 23.4 28.4 21.6 25.5 21.9 6.8 20.4 32.5 38.2 28.3 21.9 31.4 29.4 28.5 51.0 30.5 28.6 30.2 30.0 29.7 30.5 28.5 31.7 32.0 21.2 0.0 7.0 17.9 34.3 24.6 37.8 68.8 23.3 42.9 31.7 26.9 18.9 30.0 43.6 25.8 25.0 49.2 38.2 59.2 86.1 49.4 10.0 22.5 21.3 22.9 44.9 28.2 12.7 47.6 26.8 33.8 54.6 24.8 38.8 38.6 23.6 37.1 43.3 37.0 13.6 54.9 59.0 26.3 22.5 20.2 36.4 25.8 94.3 7.5 35.3 54.7 44.3 9.5 10.7 38.6 40.0 34.3 46.1 27.7 86.6 66.3 24.9 51.1 13.1 33.7 35.0 58.5 70.7 36.0 25.3 60.5 34.8 50.1 61.2 35.0 TMUB1 "C7orf21, HOPS, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081085-151083493 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 191.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 32.4 53.7 22.6 25.8 19.5 23.2 34.6 20.3 38.9 34.2 13.9 51.8 47.7 33.9 8.7 54.6 33.1 15.1 50.2 19.4 18.8 56.5 132.4 41.9 26.5 24.3 20.4 17.4 37.3 94.2 20.5 69.4 20.6 21.9 51.6 8.4 5.2 44.4 15.0 85.2 46.7 57.1 9.1 18.8 54.0 67.3 26.1 23.5 18.0 51.7 20.1 12.2 41.2 39.3 22.9 88.3 77.5 18.0 93.2 11.6 14.2 67.2 35.3 29.3 30.8 34.3 67.5 104.6 58.6 73.9 17.4 39.9 58.6 20.0 31.2 6.8 108.0 74.4 24.8 74.8 104.7 29.5 31.3 84.8 22.0 25.4 25.8 6.9 23.4 22.9 59.3 159.4 77.4 14.0 141.2 104.5 134.5 77.2 51.7 48.3 64.8 22.7 108.5 32.2 67.4 65.6 73.2 28.6 43.6 47.9 10.6 34.0 42.9 28.3 39.0 28.5 49.3 59.1 121.2 72.5 41.4 89.8 58.2 50.4 4.2 3.1 23.8 5.7 4.3 5.0 5.3 8.7 6.4 3.2 11.2 8.7 4.8 5.3 3.7 2.6 4.8 12.1 2.4 22.6 19.5 20.3 38.9 19.4 18.8 24.3 20.4 17.4 21.9 18.8 23.5 22.9 24.0 6.4 3.2 7.5 51.2 26.4 25.9 26.0 31.9 15.2 45.7 34.8 9.9 28.6 15.9 22.0 14.6 93.1 50.2 136.7 35.2 73.1 11.9 15.8 11.7 21.5 41.3 23.2 4.5 109.6 60.2 18.3 52.0 29.3 15.9 23.3 25.4 51.4 44.2 20.2 5.3 85.9 46.8 30.4 61.2 5.1 12.5 32.4 32.0 6.5 44.8 28.9 70.0 2.5 7.2 96.3 109.7 16.6 67.8 39.3 191.0 37.9 6.4 16.0 39.5 9.3 21.8 22.3 15.6 39.5 36.9 94.5 52.8 25.4 84.0 37.9 FMC1 "C7orf55, HSPC268" ENSG00000164898 "Formation of mitochondrial complex V assembly factor 1 homolog" Q96HJ9 7 139339457-139346328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 84.6;Distal tubular cells: 199.6;Proximal tubular cells: 196.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045663, HPA050553" Approved Approved Mitochondria NA NA Mitochondria "HPA045663: AB_2679410, HPA050553: AB_2681173" "unprognostic (3.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.69e-1)" "unprognostic (3.80e-2)" "unprognostic (8.90e-2)" "unprognostic (9.00e-2)" "unprognostic (4.39e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.19e-1)" "prognostic favorable (5.63e-6)" "unprognostic (1.04e-3)" "unprognostic (2.39e-2)" "prognostic favorable (2.05e-5)" "unprognostic (1.50e-1)" "unprognostic (3.40e-2)" "unprognostic (4.67e-1)" "unprognostic (3.02e-2)" 8.6 11.6 17.5 2.8 18.5 6.2 8.3 18.5 23.3 6.7 18.3 9.1 7.1 8.2 11.7 5.6 9.4 5.2 23.5 17.7 18.1 16.2 17.9 5.2 5.5 18.2 18.2 17.7 11.3 10.4 11.1 12.1 3.3 18.4 11.3 5.1 3.1 12.9 7.7 30.8 4.9 7.1 3.8 17.7 6.5 11.4 5.8 18.0 7.5 10.8 39.4 3.1 8.7 5.8 20.0 5.6 19.5 11.2 11.7 6.0 5.2 4.9 1.8 4.6 13.2 9.8 6.6 7.1 12.6 11.3 5.9 10.5 4.3 11.0 4.8 3.2 6.3 67.5 6.1 19.9 29.3 12.8 5.3 8.8 13.5 9.3 4.4 3.7 4.8 10.8 8.6 12.4 18.9 7.6 39.2 12.8 35.7 11.1 9.9 28.2 7.7 5.5 17.6 11.1 5.0 22.1 14.5 6.3 5.2 8.1 1.8 2.5 4.3 5.1 4.7 4.4 5.6 5.0 6.7 7.2 14.4 12.1 11.7 7.7 13.3 10.3 10.9 11.2 6.7 9.9 25.3 13.7 11.4 12.0 20.5 15.7 11.2 3.3 16.1 7.6 21.4 16.9 6.6 17.5 18.5 18.5 23.3 17.7 18.1 18.2 18.2 17.7 18.4 17.7 18.0 20.0 31.3 44.8 47.6 0.0 10.1 0.0 0.0 0.0 0.0 0.0 57.1 57.4 0.0 0.0 19.8 84.6 0.0 63.0 11.9 0.0 199.6 35.4 0.0 67.8 40.1 14.5 0.0 0.0 0.0 35.3 24.2 20.3 0.0 43.9 12.6 27.6 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 12.9 0.0 0.0 0.0 0.0 23.6 0.0 0.0 4.1 0.0 0.0 196.2 37.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 47.6 9.4 40.9 0.0 0.0 GBX1 ENSG00000164900 "Gastrulation brain homeobox 1" Q14549 7 151148589-151174745 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 13.0;testis: 5.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 1.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.5" "Region enhanced" "Detected in some" "basal ganglia: 3.3" "Low region specificity" "Detected in single" HPA055783 Approved NA NA "HPA055783: AB_2682919" "unprognostic (4.24e-2)" "unprognostic (3.87e-2)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.91e-1)" "unprognostic (3.14e-1)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 1.0 0.0 0.0 5.2 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.5 0.2 0.7 0.9 0.0 0.2 0.3 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHAX "FLJ13193, RNUXA" ENSG00000164902 "Phosphorylated adaptor for RNA export" Q9H814 5 126600925-126627252 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059630, HPA070326" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059630: AB_2684088, HPA070326: AB_2686253" "unprognostic (1.06e-3)" "unprognostic (4.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.64e-2)" "unprognostic (6.11e-2)" "unprognostic (1.22e-1)" "unprognostic (4.59e-3)" "unprognostic (9.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (4.91e-3)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.07e-2)" 8.3 8.9 10.3 7.2 10.3 4.5 8.2 12.5 11.1 7.0 8.5 6.2 5.1 9.2 7.5 9.0 8.0 7.2 9.7 10.9 9.5 7.7 8.3 6.5 11.0 9.8 10.0 10.3 11.5 7.2 8.9 5.2 7.4 10.2 8.5 6.3 8.5 7.3 6.3 12.2 10.7 5.5 8.4 9.7 7.1 6.3 5.7 11.6 7.3 8.8 10.1 10.5 7.8 5.5 10.9 15.5 15.9 13.5 25.6 19.0 18.3 14.9 21.4 16.0 17.6 16.4 21.8 15.1 15.2 19.0 27.7 21.2 12.2 19.1 29.7 25.7 24.7 20.4 13.0 18.5 8.8 11.3 10.8 13.5 18.6 16.4 17.2 15.6 16.5 15.0 8.7 10.4 17.2 27.4 13.3 15.2 13.4 16.9 10.3 12.4 12.1 19.1 12.4 16.4 18.1 17.3 19.9 19.3 16.4 22.7 13.0 22.0 14.7 23.2 29.0 16.1 16.3 32.7 13.3 13.6 17.0 20.8 17.4 21.3 8.7 4.8 6.6 7.1 5.7 8.1 8.2 7.1 7.4 4.8 7.1 7.9 8.3 3.8 10.7 6.1 6.4 6.5 5.5 10.3 10.3 12.5 11.1 10.9 9.5 9.8 10.0 10.3 10.2 9.7 11.6 10.9 34.6 25.6 40.2 10.7 36.1 28.6 31.6 72.1 26.7 60.0 27.7 42.2 56.6 20.0 47.3 35.0 39.6 51.5 42.4 29.5 74.3 53.6 37.2 32.8 44.6 36.8 27.5 26.9 14.2 33.3 50.3 41.8 16.3 28.3 46.9 35.0 28.2 28.5 30.1 75.7 14.8 26.9 65.1 17.2 17.6 9.7 42.0 21.9 21.4 5.6 43.4 86.9 37.0 8.0 11.8 40.3 23.1 41.3 29.7 31.9 16.5 56.1 63.3 72.3 46.0 50.3 51.7 64.5 86.4 32.3 25.9 51.4 34.2 43.2 27.7 27.8 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595362 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 256.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023296, HPA053675" Enhanced Supported Mitochondria,Cytosol Yes No 430000 Mitochondria Cytosol "HPA023296: AB_1844738, HPA053675: " "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favorable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 23.9 38.7 45.6 9.2 46.1 1.9 47.6 44.5 46.1 33.0 39.3 29.8 23.9 25.3 8.9 36.2 29.1 19.2 28.1 45.5 41.4 116.1 163.6 15.9 8.6 58.1 42.2 36.7 65.9 27.2 34.3 8.8 45.3 50.0 42.3 27.6 19.9 41.0 28.2 12.4 29.6 21.2 23.8 43.0 7.0 23.9 12.4 44.0 18.5 48.0 26.8 17.2 18.3 21.1 45.1 64.9 41.9 116.6 193.4 95.5 56.4 147.8 76.1 93.4 86.5 110.5 118.6 60.7 0.0 75.5 60.0 36.1 47.1 36.5 256.2 78.8 0.1 44.6 12.3 63.1 102.1 46.3 0.2 0.0 69.0 59.2 67.3 47.7 64.2 70.0 0.0 0.0 0.1 77.1 42.1 2.6 0.3 79.4 47.5 35.2 38.9 131.8 0.0 81.2 48.4 39.4 47.2 0.0 41.1 44.7 89.0 75.2 2.7 86.1 24.8 75.6 28.8 53.1 0.1 0.1 0.4 13.4 0.2 40.6 0.7 0.2 0.1 0.1 0.0 0.2 0.8 0.2 0.1 1.8 0.6 1.2 0.6 0.1 0.1 0.0 6.4 0.0 0.4 45.6 46.1 44.5 46.1 45.5 41.4 58.1 42.2 36.7 50.0 43.0 44.0 45.1 17.6 16.0 29.3 99.3 5.0 25.9 59.5 110.0 87.0 23.6 40.6 91.1 39.9 27.1 43.5 42.3 22.9 414.1 3.7 15.2 76.3 43.5 31.4 18.7 44.3 19.1 21.7 5.2 16.0 13.8 107.8 34.0 27.0 21.4 7.0 50.4 18.9 74.6 51.1 25.2 21.5 25.9 20.3 9.4 7.6 41.7 25.4 9.1 55.2 12.2 7.5 102.1 0.0 41.7 30.0 12.6 15.6 37.2 2.0 27.5 23.4 302.1 23.4 13.6 19.7 19.4 25.8 1.0 5.1 59.2 16.1 222.3 4.6 39.3 46.4 50.4 FOXK1 IMAGE:5164497 ENSG00000164916 "Forkhead box K1" P85037 7 4682295-4771442 "Predicted intracellular proteins, Transcription factors" "Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Late spermatids: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017998, HPA018864" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA017998: AB_1849077, HPA018864: AB_1849079" "unprognostic (3.05e-2)" "unprognostic (5.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (3.03e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (2.34e-2)" "unprognostic (2.62e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-3)" "unprognostic (4.96e-2)" "unprognostic (3.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (4.34e-2)" "unprognostic (3.72e-1)" 6.2 11.4 7.3 4.2 7.5 9.6 5.8 1.5 9.0 6.8 0.0 8.5 3.0 9.1 2.1 7.6 7.7 2.3 7.3 9.3 5.6 6.0 4.9 8.7 4.0 9.4 6.9 6.7 7.8 6.5 2.7 12.6 3.0 9.0 5.9 2.6 3.7 4.7 4.1 11.1 9.1 5.8 4.8 5.7 6.3 6.3 9.3 8.1 4.1 4.9 4.9 3.4 7.0 7.5 8.1 11.8 14.8 9.4 18.6 9.0 6.8 11.6 5.3 4.6 3.7 4.2 14.8 13.0 19.9 6.0 8.5 11.9 18.9 10.2 12.9 3.7 5.8 6.3 9.4 16.1 8.4 8.8 11.7 10.3 13.0 7.1 8.9 12.3 6.0 7.2 7.5 20.5 4.3 4.5 13.5 4.5 20.9 14.1 4.8 7.4 16.7 9.4 12.7 5.4 17.2 8.4 10.6 8.0 17.2 6.2 7.2 9.6 15.4 22.4 6.4 20.1 10.0 11.4 11.9 10.5 12.9 8.6 13.4 10.3 0.9 0.9 0.4 1.7 1.6 2.5 1.2 1.7 1.7 1.1 1.1 1.8 1.8 0.5 1.6 1.6 0.9 0.9 1.4 7.3 7.5 1.5 9.0 9.3 5.6 9.4 6.9 6.7 9.0 5.7 8.1 8.1 15.7 32.1 17.5 25.5 16.8 33.4 15.2 31.9 12.0 18.0 15.7 15.2 12.9 8.6 14.4 14.7 22.9 13.6 26.0 11.4 5.9 10.6 44.7 17.8 20.4 17.2 13.1 3.6 42.0 15.2 4.0 18.6 9.7 25.1 7.6 29.5 16.1 11.6 10.6 23.5 35.2 11.3 12.2 17.5 17.9 113.2 19.3 11.4 16.0 30.9 21.4 10.3 54.6 25.1 58.2 19.7 9.6 28.6 6.0 29.1 8.1 15.5 14.7 13.9 19.7 17.6 25.3 19.1 20.4 15.3 50.0 4.0 19.3 17.9 17.9 21.5 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99893707 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 210000 Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 129.4 148.7 203.6 53.4 206.7 153.8 126.7 209.4 293.3 150.4 211.2 264.3 337.9 195.6 177.1 198.9 191.2 20.6 634.0 211.4 216.4 204.4 331.2 109.4 71.7 208.4 216.5 203.2 163.3 108.2 102.6 160.7 90.6 212.2 164.0 111.5 148.3 109.0 58.6 672.4 119.9 173.7 43.1 206.3 123.9 181.5 172.2 217.0 45.2 130.2 559.0 51.9 190.3 149.8 234.9 137.6 57.8 63.8 251.3 140.0 100.5 103.1 44.5 42.7 30.1 34.3 54.7 284.5 326.8 320.1 70.1 47.7 176.4 36.4 363.3 51.0 60.5 89.1 684.6 66.9 160.4 88.9 319.3 201.9 95.1 475.3 26.0 56.4 129.2 45.1 103.8 49.8 571.1 51.6 134.2 337.9 289.6 117.9 205.5 127.7 381.0 21.2 320.6 453.4 713.3 191.8 115.2 30.9 654.2 351.5 65.0 461.7 201.1 40.1 220.4 286.0 235.8 63.8 140.7 126.3 209.6 310.2 128.2 200.8 345.8 134.7 114.1 177.8 210.5 189.0 209.7 270.6 193.5 212.9 189.8 319.7 294.9 16.6 187.7 266.5 301.9 272.7 252.9 203.6 206.7 209.4 293.3 211.4 216.4 208.4 216.5 203.2 212.2 206.3 217.0 234.9 527.8 403.8 485.1 29.7 382.1 490.8 493.5 1431.9 279.4 217.6 561.3 642.7 2146.4 491.8 731.2 605.1 102.2 978.9 416.1 1263.2 2226.5 673.6 834.3 579.3 778.7 436.9 807.5 400.2 27.6 849.4 853.9 502.0 440.4 551.9 362.5 219.3 384.1 1855.5 1066.5 156.5 33.5 1221.3 1027.4 451.1 539.5 266.5 664.8 440.8 732.8 23.4 778.0 545.0 449.0 22.6 32.1 808.6 1338.7 587.5 412.2 448.4 2173.5 1791.0 702.9 282.0 493.0 367.1 555.9 1180.5 505.2 666.4 640.6 1784.9 452.1 428.0 1246.7 715.5 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 164.3;endometrium 1: 156.4;fallopian tube: 156.6" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 16 "ASC diff: 542.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 34.1 10.0 0.0 2.4 0.0 0.6 26.2 0.3 0.2 164.3 0.0 8.4 0.6 156.4 54.2 15.2 156.6 13.0 4.0 0.1 0.0 1.3 0.3 3.6 2.4 0.0 0.0 0.0 94.0 4.2 3.0 2.7 8.3 0.1 40.6 3.8 0.0 6.8 72.9 5.6 27.6 25.1 47.5 0.0 0.2 5.1 35.9 0.0 0.9 5.7 5.1 1.2 27.5 84.5 0.0 32.3 4.5 0.0 4.4 542.4 17.2 4.3 17.6 33.1 13.7 13.6 3.4 3.9 0.0 2.9 26.7 0.8 12.4 2.7 4.7 6.7 1.5 13.0 0.6 3.3 1.6 8.9 0.9 0.6 17.0 9.8 2.3 1.6 0.8 0.0 4.8 4.0 0.4 0.6 14.6 2.9 5.7 0.0 2.6 2.8 13.8 1.6 1.1 1.1 2.7 1.4 0.1 1.9 7.5 0.4 0.3 4.3 7.5 0.2 2.1 0.1 13.9 1.0 0.7 0.5 0.3 0.9 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 14.1 6.6 3.4 1.2 0.0 7.9 5.3 0.7 0.0 3.3 0.0 0.0 17.2 0.9 0.7 0.0 0.0 5.8 7.8 243.1 3.7 0.0 0.0 0.0 0.0 138.4 71.7 0.5 5.9 0.0 0.2 0.0 0.0 9.3 0.0 0.0 18.4 10.2 1.9 21.9 24.1 784.1 2.7 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 758.3 4.6 3.6 103.9 0.1 1.7 0.0 32.9 8.8 21.3 5.1 4.5 0.3 9.1 24.2 2.3 95.6 22.3 2.2 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916523-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005065 Approved NA NA 320000000 "CAB005065: AB_2218378" "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (2.28e-5)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 382.4 265.4 268.1 377.6 357.9 532.0 254.2 177.3 346.5 271.9 130.8 479.7 330.2 278.2 222.8 901.1 246.1 335.9 189.0 362.1 324.8 227.0 192.4 278.2 432.7 193.0 229.4 336.1 229.7 193.2 235.2 109.9 342.0 230.6 268.2 450.2 287.8 246.8 294.0 95.8 402.7 378.5 359.6 188.4 275.1 368.7 228.8 267.4 438.9 292.3 170.4 570.8 505.9 346.0 308.3 1902.4 879.2 1605.4 457.7 396.6 490.9 808.0 877.6 1099.2 1124.6 1098.2 602.4 1149.5 816.5 857.1 1349.3 937.2 785.0 1025.5 1213.5 1630.1 765.1 454.2 779.5 579.0 378.1 524.8 311.5 840.3 475.4 1524.0 936.7 1430.1 923.8 1008.7 584.9 887.8 758.9 920.2 660.6 1357.1 535.4 548.0 2269.0 1026.7 569.7 468.6 544.8 1023.1 963.5 889.7 642.7 669.5 609.8 1365.4 1094.7 896.0 374.6 879.0 554.6 834.3 693.7 798.3 503.6 625.3 994.6 925.8 595.2 2303.2 1340.5 427.5 705.8 559.0 589.1 559.3 484.8 463.3 537.3 497.3 395.9 348.3 441.8 616.5 503.7 726.9 313.4 663.9 1087.2 268.1 357.9 177.3 346.5 362.1 324.8 193.0 229.4 336.1 230.6 188.4 267.4 308.3 199.4 250.0 228.9 43.1 637.6 1007.0 438.4 309.3 507.6 120.4 285.9 209.9 87.0 188.8 321.3 263.0 89.6 243.4 491.2 552.7 121.3 405.2 1092.9 359.6 245.6 216.0 265.3 137.3 150.2 421.3 551.6 277.4 448.5 578.8 452.9 122.1 183.1 104.5 276.3 134.6 92.5 525.2 244.1 303.5 641.2 2118.0 125.6 456.9 391.3 56.2 334.9 110.9 407.8 51.3 91.5 771.0 452.7 147.1 457.2 427.2 310.6 160.4 292.0 96.3 131.5 229.4 290.4 170.2 92.6 908.0 1184.7 408.9 596.5 116.5 371.7 794.9 BAALC ENSG00000164929 "BAALC binder of MAP3K1 and KLF4" Q8WXS3 8 103140713-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 274.4;choroid plexus: 118.5" "Cell type enhanced" "Detected in many" "Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 28 "NK-cell: 3.7" "Lineage enriched" "Detected in single" 28 "NK-cells: 3.7" "Cell line enhanced" "Detected in many" "AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: AB_2685971" "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 8.6 15.7 202.6 2.2 208.0 3.5 7.0 192.6 228.4 1.5 118.5 2.8 0.9 1.8 0.4 0.7 3.8 1.6 2.3 201.9 215.3 2.4 2.9 7.4 1.4 238.3 242.3 173.4 3.3 2.2 0.4 26.1 5.3 222.7 1.1 1.6 19.6 1.0 0.9 2.0 1.9 2.8 1.9 233.0 14.6 2.4 1.3 274.4 0.6 4.5 1.5 0.8 2.5 1.4 214.9 0.5 3.0 51.7 0.5 0.5 14.9 0.0 2.6 18.1 0.1 0.2 0.5 0.1 0.2 0.5 10.1 0.2 0.8 0.9 0.1 0.1 0.1 3.1 0.5 0.8 0.1 1.2 0.0 1.1 3.0 2.9 0.6 0.0 2.7 0.4 0.1 0.0 0.4 0.1 0.4 0.0 0.2 1.3 0.4 1.0 0.2 0.3 1.2 0.0 0.1 27.9 20.5 0.6 0.0 0.1 4.5 0.2 0.3 3.0 16.0 1.0 0.4 1.0 0.0 0.2 0.2 75.7 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 202.6 208.0 192.6 228.4 201.9 215.3 238.3 242.3 173.4 222.7 233.0 274.4 214.9 67.8 0.0 1.8 198.2 0.3 5.5 0.7 4.5 0.6 2.1 2.0 1.1 0.8 17.2 5.9 0.0 0.0 0.1 2.1 0.3 7.9 32.0 2.9 15.6 2.3 33.4 17.8 6.1 131.4 25.6 0.1 1.6 0.0 34.0 0.0 0.0 23.6 0.8 0.9 0.0 62.3 3.4 22.4 1.3 6.2 8.7 1.5 2.1 14.2 18.7 4.6 132.4 2.1 125.7 46.1 4.1 1.2 0.0 0.8 0.8 0.1 0.1 21.7 3.3 0.0 2.1 8.1 0.1 0.1 0.3 4.0 0.0 1.3 0.3 0.1 1.1 FZD6 Hfz6 ENSG00000164930 "Frizzled class receptor 6" O60353 8 103298433-103332866 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 4.0" "Lineage enriched" "Detected in single" 4 "NK-cells: 4.0" "Cell line enhanced" "Detected in many" "hTCEpi: 127.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017991 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA017991: AB_1849138" "unprognostic (8.22e-3)" "unprognostic (2.64e-1)" "unprognostic (4.75e-2)" "unprognostic (2.57e-1)" "unprognostic (1.22e-2)" "unprognostic (6.99e-2)" "unprognostic (4.01e-2)" "unprognostic (2.74e-1)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.20e-6)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (2.86e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (7.54e-2)" 10.7 10.7 3.2 4.2 3.2 1.0 15.3 3.4 4.4 14.3 5.6 7.0 5.8 13.1 9.6 18.8 23.7 10.7 9.2 3.1 5.2 14.6 4.1 18.7 5.2 4.1 3.4 2.8 5.5 11.3 25.5 9.9 15.2 4.1 12.7 7.0 4.7 11.8 10.4 2.1 24.2 4.7 9.3 3.3 4.0 7.5 3.7 3.4 10.1 22.5 5.6 10.0 21.8 10.3 3.5 59.8 11.0 29.6 0.0 7.9 20.6 17.1 31.0 34.1 27.2 17.6 6.2 47.8 0.0 51.4 29.7 9.1 90.3 16.8 65.7 51.0 13.5 18.0 31.4 12.2 8.5 93.4 0.0 0.0 23.0 127.6 29.4 91.5 67.1 58.2 7.0 3.2 27.0 31.5 25.5 29.8 2.7 6.7 4.7 20.6 2.3 12.3 0.0 59.1 39.5 10.0 7.9 44.8 22.8 59.9 15.8 0.0 11.6 4.1 6.1 32.0 24.9 32.7 6.4 3.7 13.3 18.0 0.0 40.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.8 0.4 0.3 0.5 0.9 0.4 0.0 4.0 0.0 0.1 0.4 0.2 3.2 3.2 3.4 4.4 3.1 5.2 4.1 3.4 2.8 4.1 3.3 3.4 3.5 38.3 25.6 22.5 10.1 2.8 46.9 15.9 51.1 42.7 4.1 16.1 12.7 4.8 8.6 35.4 12.9 2.1 22.7 2.1 4.9 0.0 11.7 9.6 51.0 5.8 42.0 5.3 6.7 19.9 8.2 7.1 7.0 14.8 73.6 0.0 11.2 13.9 3.7 2.4 6.7 7.3 7.4 26.4 1.0 5.1 2.9 1.2 1.3 14.2 16.9 0.7 11.8 1.0 8.5 3.6 9.5 3.2 1.5 8.6 13.4 2.8 7.1 53.8 4.8 0.0 1.6 7.7 7.0 0.8 41.9 44.6 14.6 3.0 1.7 5.6 23.2 CTHRC1 ENSG00000164932 "Collagen triple helix repeat containing 1" Q96CG8 8 103371538-103382989 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 88.5;placenta: 90.8;urinary bladder: 85.4" "Cell type enhanced" "Detected in many" "Endothelial cells: 95.2;Fibroblasts: 181.6;Langerhans cells: 45.9;Melanocytes: 49.8;Smooth muscle cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 294.6;fHDF/TERT166: 138.1;HHSteC: 197.1;HSkMC: 406.6;WM-115: 386.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059806, HPA061896" Approved Approved Nucleoplasm "Secreted in other tissues" NA NA 420000 Nucleoplasm "HPA059806: AB_2684130, HPA061896: AB_2684633" "unprognostic (2.04e-2)" "unprognostic (4.58e-1)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (4.17e-2)" "unprognostic (3.64e-2)" "unprognostic (8.63e-2)" "unprognostic (1.12e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.22e-14)" "unprognostic (2.33e-3)" "unprognostic (3.21e-2)" "unprognostic (7.96e-3)" "unprognostic (2.37e-3)" 46.7 2.9 1.8 15.5 1.9 0.5 39.4 5.9 7.6 12.9 1.2 6.6 6.3 18.8 3.3 9.8 5.3 88.5 9.0 3.1 1.1 2.3 0.9 9.0 13.9 2.0 1.7 1.1 4.3 3.8 2.2 3.8 90.8 4.0 4.8 6.3 2.4 17.1 5.7 3.6 23.7 3.5 19.9 2.3 2.6 3.7 3.6 2.7 6.3 9.2 4.2 16.1 85.4 6.6 6.4 12.1 0.9 3.3 0.8 90.6 294.6 0.2 34.8 9.3 3.7 5.0 1.1 8.3 1.5 36.6 138.1 0.2 0.4 0.1 0.2 17.7 0.5 0.0 0.5 0.6 19.2 197.1 0.9 0.7 406.6 0.5 30.7 0.4 1.4 60.2 2.3 0.5 91.6 18.7 1.7 17.2 41.1 11.0 0.4 58.0 35.8 30.9 1.1 2.9 0.2 5.7 4.3 0.1 0.2 110.8 12.6 0.1 0.2 49.0 4.6 1.8 4.8 0.4 3.0 0.8 0.6 2.2 0.2 386.9 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.2 0.0 0.1 1.8 1.9 5.9 7.6 3.1 1.1 2.0 1.7 1.1 4.0 2.3 2.7 6.4 36.9 3.2 2.3 1.0 6.7 32.0 0.2 12.1 0.0 0.3 0.9 1.4 0.8 1.5 3.6 3.7 0.0 5.6 0.9 0.0 0.0 4.1 0.5 6.4 9.8 95.2 1.2 0.8 2.3 0.6 11.3 181.6 0.0 11.5 0.0 0.5 17.5 0.1 8.0 0.0 2.0 0.0 4.1 0.3 45.9 0.8 12.5 0.9 49.8 3.7 0.6 5.5 1.0 4.5 1.8 1.8 0.0 0.4 24.2 0.8 0.0 0.5 0.8 1.2 0.0 4.7 77.4 4.3 16.5 0.3 27.3 16.6 3.5 1.2 0.2 0.5 SLC25A32 MFTC ENSG00000164933 "Solute carrier family 25 member 32" Q9H2D1 8 103398635-103415189 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024763, HPA047402" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA024763: , HPA047402: AB_2680032" "unprognostic (2.45e-3)" "unprognostic (8.19e-2)" "unprognostic (3.87e-3)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.06e-2)" "unprognostic (6.50e-3)" "unprognostic (1.22e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (9.47e-2)" "unprognostic (8.43e-2)" "unprognostic (2.08e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (7.82e-2)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (4.49e-2)" 13.5 7.2 4.0 12.6 4.8 14.7 11.3 5.1 4.9 8.5 4.0 7.4 6.9 10.8 7.5 7.4 9.4 11.6 9.8 4.9 5.3 9.7 18.0 8.5 17.0 5.6 5.6 3.6 9.7 8.6 8.9 11.4 10.2 5.4 8.0 7.7 1.4 6.5 7.5 9.6 6.7 7.6 11.0 5.9 12.8 7.0 6.5 4.9 8.8 7.2 9.3 12.9 15.1 7.0 6.3 33.7 11.5 10.5 18.3 21.3 23.3 10.3 27.4 39.9 30.6 31.4 14.0 19.6 73.8 25.8 29.5 17.7 20.4 22.5 22.5 47.0 45.5 16.1 53.5 8.5 18.3 37.4 26.5 23.1 23.1 17.9 34.5 51.2 8.6 32.5 19.4 33.9 25.9 30.5 13.5 45.0 21.6 17.1 39.3 23.6 33.6 16.3 50.8 20.8 12.7 28.0 17.2 13.6 22.3 48.9 10.5 19.3 18.5 22.6 36.7 24.9 44.2 36.2 19.2 19.7 76.8 31.0 38.1 27.5 0.6 3.3 1.6 6.0 3.7 7.3 7.0 6.4 6.9 4.1 4.8 6.5 6.7 0.8 5.2 4.3 3.5 5.5 5.7 4.0 4.8 5.1 4.9 4.9 5.3 5.6 5.6 3.6 5.4 5.9 4.9 6.3 28.9 3.2 3.3 10.1 46.9 23.1 16.7 6.9 32.5 9.4 10.3 6.7 10.4 11.5 5.4 5.5 6.2 11.9 20.9 4.1 7.9 9.8 4.8 8.3 14.0 22.2 11.4 16.2 30.3 9.4 13.6 19.6 27.0 9.1 8.9 8.0 20.0 15.2 10.2 8.4 25.8 7.1 8.2 7.3 11.6 4.7 9.3 16.2 10.6 24.4 9.9 7.6 15.5 25.6 46.6 10.0 3.1 8.6 56.3 14.4 4.1 9.5 2.6 8.1 19.7 13.5 14.7 22.9 17.1 32.6 25.9 14.0 27.7 9.5 7.5 15.1 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: AB_2678963" "prognostic unfavorable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavorable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 16.1 19.4 11.3 23.1 12.0 15.3 24.1 12.4 15.7 17.9 13.4 20.9 16.2 16.4 19.3 21.4 18.1 12.9 16.4 11.9 12.9 32.7 20.9 13.0 24.9 12.0 12.1 10.6 13.7 18.7 20.1 15.8 18.8 12.2 14.8 21.6 13.9 14.4 12.9 19.0 15.8 14.6 18.4 12.5 14.4 15.7 32.5 11.9 25.0 18.3 16.2 30.7 33.9 14.7 13.0 96.5 84.2 76.9 79.0 54.7 62.7 57.6 70.1 53.2 64.4 65.9 83.1 90.9 132.2 116.1 73.3 64.0 69.9 105.8 89.0 124.1 127.7 74.9 183.0 48.0 95.9 62.2 76.1 75.7 51.8 59.9 95.9 157.5 40.3 91.4 89.6 125.3 56.7 99.9 78.0 144.9 79.3 118.0 268.9 129.6 92.6 93.3 136.4 95.3 78.6 97.6 92.3 43.5 67.3 83.1 67.4 103.9 51.2 60.6 65.3 105.3 85.5 94.7 61.7 116.5 188.0 88.0 162.8 85.7 19.6 37.6 22.1 35.5 46.5 48.8 60.8 37.5 38.2 54.4 50.8 37.0 38.2 4.2 52.8 35.2 28.3 58.0 44.9 11.3 12.0 12.4 15.7 11.9 12.9 12.0 12.1 10.6 12.2 12.5 11.9 13.0 40.0 16.0 17.0 9.1 39.7 79.5 76.6 92.4 38.1 19.6 21.6 24.9 20.8 12.8 53.8 33.1 25.0 57.9 34.8 11.0 39.2 55.0 54.6 26.9 35.4 39.9 14.5 22.1 9.5 48.4 75.0 37.4 17.9 24.7 40.6 49.3 17.5 16.9 42.7 16.8 9.0 17.5 69.2 14.8 23.9 16.7 24.2 22.9 26.6 11.2 28.5 28.8 27.8 16.1 20.0 43.6 12.3 17.7 30.3 51.1 24.3 79.1 36.0 23.7 13.1 50.2 48.0 102.0 86.3 37.1 77.0 33.9 33.1 41.7 28.1 56.9 DCSTAMP "DC-STAMP, FIND, TM7SF4" ENSG00000164935 "Dendrocyte expressed seven transmembrane protein" Q9H295 8 104339087-104356689 "Predicted membrane proteins, Transporters" "Differentiation, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.7;epididymis: 2.0;lung: 3.8" "Group enriched" "Detected in some" 5 "Hofbauer cells: 7.1;Macrophages: 6.5" "Cancer enriched" "Detected in some" 46 "thyroid cancer: 45.3" "Region enhanced" "Detected in some" "amygdala: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (1.11e-2)" "unprognostic (1.22e-2)" "unprognostic (8.41e-2)" "unprognostic (2.96e-2)" "unprognostic (8.48e-4)" "unprognostic (2.14e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-2)" "unprognostic (3.08e-2)" "unprognostic (1.18e-2)" "unprognostic (5.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.61e-3)" "unprognostic (8.84e-2)" "unprognostic (1.36e-1)" "unprognostic (8.05e-2)" "unprognostic (8.34e-3)" 0.5 0.0 4.7 0.1 2.2 0.2 0.3 0.0 0.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 0.4 3.8 0.2 0.6 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 2.2 0.0 0.7 0.9 0.1 0.6 0.1 0.7 0.7 0.0 0.7 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53INP1 "DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B" ENSG00000164938 "Tumor protein p53 inducible nuclear protein 1" Q96A56 8 94925972-94949378 "Predicted intracellular proteins" "Apoptosis, Autophagy, Transcription, Transcription regulation" "Activator, Antioxidant" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 175.6;Plasma cells: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 54.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.6" "Cell line enhanced" "Detected in many" "Karpas-707: 79.7;U-266/70: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005856 Uncertain Supported Cytosol NA NA Cytosol "HPA005856: AB_10600832" "unprognostic (1.39e-2)" "unprognostic (4.47e-3)" "unprognostic (7.17e-2)" "unprognostic (2.70e-1)" "unprognostic (5.31e-2)" "prognostic favorable (1.11e-4)" "unprognostic (5.72e-2)" "unprognostic (1.16e-3)" "unprognostic (1.28e-1)" "unprognostic (7.54e-2)" "unprognostic (5.00e-3)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (9.83e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-2)" "prognostic favorable (5.45e-5)" 11.1 10.7 6.4 23.3 7.9 42.5 12.8 6.6 7.5 10.2 9.7 16.7 17.3 12.8 12.7 11.0 14.9 11.0 11.0 5.7 6.7 11.6 102.8 25.5 36.3 8.9 7.1 4.9 9.1 60.9 10.2 7.1 14.5 7.7 22.7 20.4 17.8 18.0 9.3 9.3 13.2 35.8 12.3 7.7 40.9 25.8 28.8 7.8 29.6 10.2 8.7 41.4 13.4 8.8 8.4 0.5 2.5 24.1 9.3 29.4 27.6 24.8 5.8 13.5 2.6 6.2 2.2 0.6 5.3 12.4 11.2 2.3 4.2 0.0 9.5 5.8 0.3 3.0 3.4 5.3 14.8 19.7 0.0 16.8 45.4 22.2 6.9 2.8 22.4 39.8 2.6 1.8 79.7 12.4 1.7 4.0 1.5 2.3 0.1 0.7 3.4 1.9 29.4 6.3 26.5 3.3 19.5 3.6 2.0 5.2 38.5 11.8 3.3 27.6 4.8 5.8 0.0 0.9 85.4 18.9 2.3 8.4 0.0 0.0 54.6 3.7 11.7 1.4 3.6 1.3 11.5 4.0 2.7 1.4 9.7 0.8 0.6 16.9 5.2 2.3 1.4 6.6 2.5 6.4 7.9 6.6 7.5 5.7 6.7 8.9 7.1 4.9 7.7 7.7 7.8 8.4 18.5 35.3 35.7 10.7 70.0 4.6 3.0 17.9 8.0 5.2 27.4 11.6 13.2 75.8 27.9 11.0 27.1 6.1 10.1 27.5 3.9 9.3 17.3 39.9 18.1 14.2 83.9 6.7 0.9 21.3 1.5 11.4 11.2 35.9 4.5 18.8 29.3 175.6 12.5 1.7 2.9 20.9 20.3 44.2 5.6 43.3 7.2 12.6 16.0 16.9 17.7 5.3 3.1 12.1 11.0 18.0 32.2 10.1 233.2 18.1 21.6 9.6 66.4 19.8 6.6 11.0 12.7 18.9 5.6 10.8 6.5 5.7 17.9 26.8 4.8 8.7 INTS8 "C8orf52, FLJ20530, INT8, MGC131633" ENSG00000164941 "Integrator complex subunit 8" Q75QN2 8 94813311-94881746 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057299 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA057299: AB_2683403" "unprognostic (1.08e-2)" "unprognostic (3.12e-2)" "unprognostic (1.28e-1)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.07e-2)" "unprognostic (6.87e-2)" "unprognostic (9.77e-3)" "unprognostic (4.84e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.24e-1)" "unprognostic (5.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.96e-2)" 8.7 7.6 5.5 14.0 5.1 15.7 8.2 8.5 6.5 14.6 6.3 12.9 7.8 13.4 4.2 10.6 9.6 7.4 9.6 4.7 6.6 6.4 9.0 7.6 17.6 5.8 5.0 4.1 11.5 13.6 10.2 8.4 9.5 5.4 10.5 15.0 10.4 11.1 8.8 12.7 10.4 10.7 13.8 4.1 10.0 10.7 30.8 5.2 20.8 8.9 12.1 13.7 10.5 10.4 6.6 52.4 31.9 49.2 43.4 17.7 41.7 25.5 27.5 26.0 35.7 33.0 22.5 38.0 52.3 25.2 20.7 44.3 31.5 61.3 29.2 47.6 58.1 28.8 45.7 19.3 22.1 21.1 24.6 31.7 17.1 13.5 34.7 29.6 40.8 40.1 35.1 44.4 38.9 22.0 34.5 53.7 20.4 28.1 114.9 55.8 42.7 19.7 29.0 30.0 26.6 34.6 18.4 26.8 7.7 24.1 40.3 37.3 31.6 28.1 16.1 18.9 31.1 25.1 22.0 43.0 45.2 21.6 49.4 32.2 2.1 9.6 15.1 4.6 6.8 7.5 13.4 10.8 11.8 9.3 10.4 11.0 6.5 9.3 9.6 6.6 5.5 10.0 4.5 5.5 5.1 8.5 6.5 4.7 6.6 5.8 5.0 4.1 5.4 4.1 5.2 6.6 11.0 16.0 8.6 16.6 19.4 5.9 11.6 9.1 9.6 13.7 6.1 4.6 8.3 5.7 11.6 7.3 33.3 10.0 9.7 10.3 3.9 8.3 36.0 15.0 12.1 11.8 18.0 17.7 44.8 13.4 12.9 10.8 8.6 6.1 12.7 15.2 8.9 5.5 9.5 28.6 40.9 11.8 8.2 11.6 6.6 6.4 16.1 14.0 7.2 25.3 21.6 8.0 16.5 33.2 31.2 10.9 14.6 16.1 18.0 8.8 9.5 5.1 19.7 18.9 6.6 10.6 13.1 54.7 32.5 9.0 7.0 8.5 14.2 11.0 11.1 8.1 VIRMA "DKFZP434I116, fSAP121, KIAA1429" ENSG00000164944 "Vir like m6A methyltransferase associated" Q69YN4 8 94487689-94553529 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031530 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA031530: AB_10600818" "unprognostic (2.51e-2)" "unprognostic (7.41e-3)" "unprognostic (3.43e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (7.83e-2)" "unprognostic (7.54e-3)" "unprognostic (1.98e-3)" "unprognostic (1.27e-1)" "unprognostic (2.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (2.48e-1)" "unprognostic (1.68e-1)" "unprognostic (3.82e-2)" "unprognostic (9.87e-2)" 12.6 7.9 7.5 11.7 9.0 27.5 17.7 12.2 7.8 13.2 7.7 10.0 8.2 13.8 8.7 9.8 11.5 9.0 10.0 6.7 7.8 10.9 12.6 10.8 14.6 7.8 7.9 6.0 16.9 10.4 14.9 6.3 13.4 8.0 10.8 11.8 12.4 9.6 10.4 8.7 9.7 9.1 14.0 8.3 11.5 11.7 16.7 7.7 20.2 13.4 9.4 15.3 10.6 8.1 9.9 40.5 25.2 26.8 14.9 32.4 42.5 17.1 27.5 27.9 29.4 29.9 17.9 33.2 43.6 25.5 36.1 23.0 25.9 36.2 33.5 42.9 38.7 20.0 52.0 19.6 17.6 23.6 25.9 17.9 32.8 13.4 35.4 33.7 30.1 37.5 28.2 54.0 26.6 30.0 23.8 50.7 14.6 17.5 41.4 19.1 29.9 24.4 24.3 19.1 27.6 20.9 28.9 21.6 5.5 23.8 26.3 31.2 20.7 37.3 26.9 15.9 23.1 25.7 20.8 27.8 51.0 26.4 33.7 26.2 14.2 5.0 8.7 6.7 6.4 10.7 6.6 7.4 9.1 5.2 5.0 9.0 7.9 6.0 9.5 13.8 3.3 6.9 5.8 7.5 9.0 12.2 7.8 6.7 7.8 7.8 7.9 6.0 8.0 8.3 7.7 9.9 24.2 25.6 21.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 16.9 16.4 0.0 0.0 14.9 7.3 0.0 26.4 20.0 0.0 7.9 14.4 0.0 23.8 32.2 9.8 0.0 0.0 0.0 12.2 23.7 10.6 0.0 22.4 5.1 28.5 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 14.7 0.0 0.0 5.2 0.0 0.0 6.9 8.7 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 16.8 9.9 25.0 0.0 0.0 FREM1 "C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR" ENSG00000164946 "FRAS1 related extracellular matrix 1" Q5H8C1 9 14737152-14910995 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 19.8;epididymis: 36.8" "Group enriched" "Detected in many" 7 "Early spermatids: 73.7;Inhibitory neurons: 126.1;Late spermatids: 144.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HEL: 163.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 58000 "unprognostic (1.13e-5)" "unprognostic (2.59e-3)" "unprognostic (2.89e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.66e-3)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (3.62e-2)" "unprognostic (6.23e-2)" "unprognostic (8.95e-13)" "unprognostic (2.28e-3)" "unprognostic (8.53e-2)" "unprognostic (3.41e-2)" "unprognostic (2.86e-1)" 5.4 2.5 1.1 0.8 1.2 0.3 4.9 4.4 1.3 4.0 1.9 5.0 2.1 19.8 36.8 1.1 4.1 3.7 4.9 1.2 2.9 11.1 0.9 2.4 0.0 2.1 1.6 0.8 1.4 6.7 5.0 1.0 5.6 1.7 1.1 1.7 1.3 0.8 3.4 0.9 3.3 5.5 14.3 3.4 0.4 1.0 4.3 1.1 1.2 0.7 0.9 0.5 2.1 2.3 3.7 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.8 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.4 3.7 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 4.4 1.3 1.2 2.9 2.1 1.6 0.8 1.7 3.4 1.1 3.7 0.4 0.0 0.6 13.1 0.3 1.3 0.2 0.0 0.6 2.0 0.1 0.1 2.9 2.8 0.0 1.8 0.0 0.5 0.0 0.2 0.0 0.3 73.7 1.5 7.7 0.4 0.0 3.0 16.2 0.0 0.3 11.2 0.5 1.3 5.1 0.2 3.9 0.0 0.5 0.0 126.1 2.4 0.0 0.6 1.2 144.7 0.6 0.1 0.0 6.5 0.6 4.0 0.0 7.1 4.3 0.2 0.0 1.5 0.0 0.1 13.0 1.3 0.0 0.1 0.0 0.6 2.8 0.8 0.9 0.0 1.1 0.3 0.1 6.1 4.7 0.1 GEM KIR ENSG00000164949 "GTP binding protein overexpressed in skeletal muscle" P55040 8 94249253-94262350 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 231.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 721.1;Fibroblasts: 395.9;Langerhans cells: 155.5;Smooth muscle cells: 359.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "hypothalamus: 62.2" "Immune cell enriched" "Detected in single" 5 "myeloid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 83.0;U-266/70: 140.6;U-87 MG: 104.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 24.3" HPA024798 Approved NA NA "HPA024798: AB_10602137" "unprognostic (1.24e-1)" "unprognostic (2.12e-1)" "unprognostic (4.82e-3)" "unprognostic (1.22e-1)" "unprognostic (4.76e-1)" "unprognostic (3.94e-1)" "unprognostic (2.17e-1)" "unprognostic (4.00e-1)" "unprognostic (1.45e-1)" "unprognostic (9.04e-2)" "unprognostic (7.92e-2)" "unprognostic (9.15e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (1.65e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.93e-3)" 43.6 59.0 10.2 35.9 8.6 2.6 37.0 8.5 11.9 53.7 34.1 81.2 16.8 98.1 9.8 60.0 39.3 231.6 43.1 10.3 62.2 22.9 20.4 33.4 24.0 12.3 10.2 7.3 20.1 15.8 3.0 27.5 7.4 9.9 32.0 36.2 44.8 13.2 16.9 4.2 10.5 31.4 77.9 8.1 22.0 48.4 3.8 11.0 12.8 23.8 10.9 14.3 91.5 33.9 11.7 1.6 6.1 2.7 0.6 22.9 30.4 0.4 16.1 83.0 21.4 29.8 2.3 4.1 0.0 1.0 6.1 40.1 0.5 2.7 1.4 28.0 12.2 1.4 0.0 0.6 0.0 3.0 0.0 26.3 13.1 0.1 34.1 18.9 24.4 0.9 1.4 0.7 2.7 12.7 0.8 1.0 0.2 4.0 3.4 18.3 0.0 4.9 0.1 7.8 0.0 20.4 12.1 0.0 0.1 2.8 3.4 2.0 0.1 1.2 29.4 8.1 19.2 33.4 140.6 0.9 0.1 104.7 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 10.2 8.6 8.5 11.9 10.3 62.2 12.3 10.2 7.3 9.9 8.1 11.0 11.7 18.4 6.4 25.4 22.2 8.9 68.1 85.7 9.6 721.1 26.8 8.6 35.1 90.8 4.3 4.0 1.8 18.8 0.4 4.1 8.2 0.0 7.3 4.7 26.0 49.2 19.0 25.0 0.0 0.7 0.4 1.4 395.9 54.0 50.3 13.4 1.0 7.1 0.1 2.8 30.3 3.4 2.6 2.0 0.6 155.5 0.3 3.4 43.3 92.5 0.0 0.8 41.9 0.0 0.0 0.3 2.7 17.2 5.7 46.5 20.2 2.1 2.6 1.2 21.4 32.9 55.5 359.5 1.3 1.1 24.1 49.9 3.4 33.4 0.9 4.2 10.6 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926068 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 80.0;Early spermatids: 144.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 64.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 117.8;hTERT-RPE1: 117.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 10.7 63.2 10.0 10.6 22.9 14.5 16.2 0.0 64.8 14.3 1.9 9.0 7.2 15.7 17.1 14.3 12.3 19.6 49.6 23.4 16.8 13.0 4.3 12.8 13.0 3.8 5.7 18.2 19.5 20.1 30.1 5.4 13.9 9.3 10.4 12.5 14.2 11.8 9.5 73.6 4.4 7.7 11.3 0.0 13.4 11.8 27.0 2.6 11.7 19.0 17.0 12.5 14.1 6.8 21.9 25.7 12.0 25.9 10.9 21.0 37.9 8.6 19.3 21.7 22.1 25.8 12.7 90.3 13.9 63.8 30.8 117.8 54.4 11.0 16.1 32.8 1.5 5.6 6.6 15.7 4.5 23.9 3.3 9.0 24.5 31.5 37.7 59.8 117.1 50.9 12.4 2.4 22.8 27.6 6.0 20.3 10.3 12.1 26.8 15.4 4.8 15.5 2.6 15.3 17.0 2.4 11.4 12.7 1.4 61.8 20.9 4.0 3.9 90.9 27.5 17.2 63.8 23.3 12.6 5.8 12.1 34.2 11.7 25.1 6.4 27.9 14.5 9.2 25.3 8.9 15.6 15.1 12.0 22.5 17.9 8.9 7.8 3.1 5.4 41.1 3.7 34.9 18.0 10.0 22.9 0.0 64.8 23.4 16.8 3.8 5.7 18.2 9.3 0.0 2.6 21.9 10.7 12.8 7.8 15.0 18.0 13.0 12.7 36.3 68.9 38.3 11.6 7.0 80.0 14.3 35.6 16.5 8.4 4.3 13.7 27.5 5.9 33.3 144.2 33.3 14.9 15.0 10.2 1.3 73.6 14.0 3.9 20.8 16.3 70.2 6.3 3.7 12.5 3.3 6.3 10.1 23.4 5.5 10.2 19.2 19.1 28.1 11.5 19.9 10.6 19.7 22.4 18.8 10.3 13.0 8.5 24.5 9.6 13.5 8.1 15.6 4.9 11.4 30.5 11.5 6.6 35.4 13.1 10.1 11.4 26.5 10.9 4.4 19.3 7.1 10.7 23.9 TMEM67 "JBTS6, MGC26979, MKS3, NPHP11" ENSG00000164953 "Transmembrane protein 67" Q5HYA8 8 93754844-93819234 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 66.7;Excitatory neurons: 59.8;Respiratory ciliated cells: 95.8;Rod photoreceptor cells: 83.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.57e-3)" "unprognostic (1.22e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (3.08e-1)" "unprognostic (2.25e-5)" "unprognostic (2.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (2.51e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (8.41e-2)" "unprognostic (2.21e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" 2.5 2.5 5.5 1.3 2.9 1.4 3.5 2.8 3.0 3.2 8.6 2.1 1.4 4.3 6.4 1.8 13.5 2.9 5.1 2.4 5.0 3.1 1.2 3.6 1.4 6.1 4.7 1.9 4.2 2.6 4.7 5.9 2.1 2.6 2.9 2.2 6.2 1.9 3.2 1.2 3.7 1.3 2.4 4.7 2.0 2.0 6.8 2.8 1.4 6.1 0.6 1.8 2.5 2.2 4.1 5.8 3.7 5.2 4.1 4.4 9.8 3.1 3.3 5.4 3.8 7.5 2.1 13.0 1.5 6.9 3.6 6.9 5.9 1.9 3.3 5.6 1.1 4.3 3.6 4.8 1.8 4.0 2.7 1.5 4.2 3.0 6.8 3.0 7.1 4.0 6.1 2.5 0.9 4.0 1.4 4.5 2.0 4.3 2.3 3.4 1.6 1.7 0.0 4.7 2.5 3.4 5.7 3.3 0.9 5.6 4.6 6.8 1.4 2.1 4.1 1.7 5.7 3.0 1.8 5.5 1.6 7.4 0.8 3.9 1.7 0.5 0.2 1.5 0.2 1.2 0.7 1.3 1.3 1.0 1.5 1.5 1.5 0.5 1.8 0.2 1.1 0.3 0.5 5.5 2.9 2.8 3.0 2.4 5.0 6.1 4.7 1.9 2.6 4.7 2.8 4.1 5.0 12.8 8.7 27.4 6.3 2.8 5.6 12.2 2.2 14.6 6.0 5.6 31.9 5.7 12.5 20.2 66.7 3.4 5.6 1.2 0.0 6.4 24.5 50.9 15.1 6.8 9.0 4.6 59.8 2.7 5.6 9.8 4.1 4.9 5.1 16.1 10.0 1.6 2.2 23.5 34.2 2.4 8.2 2.9 2.6 7.7 16.1 1.8 1.8 13.1 1.5 9.3 3.1 17.6 3.4 2.1 0.5 10.5 2.7 2.1 0.4 3.9 95.8 83.2 6.6 18.9 6.9 47.6 16.5 2.6 1.4 2.3 5.6 13.7 2.8 1.6 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 18.3 18.8 9.3 18.6 15.1 21.5 19.8 13.4 13.2 17.3 14.0 18.7 18.3 16.3 15.9 16.7 13.5 18.0 16.3 10.0 12.0 23.1 18.6 17.3 19.7 12.9 13.2 8.1 15.8 13.1 25.0 9.6 21.4 13.3 17.6 20.3 11.5 14.4 16.3 16.0 13.7 14.8 20.4 13.0 19.5 16.2 9.6 12.8 22.0 23.5 18.6 21.2 21.3 10.4 23.9 40.0 45.4 24.9 30.6 55.3 58.8 16.3 42.0 63.6 43.0 45.8 17.0 42.1 36.1 29.1 54.1 25.3 30.6 40.2 37.7 56.8 47.5 23.1 48.1 26.5 22.8 53.8 14.8 46.6 58.7 25.1 35.5 31.2 33.2 49.9 30.9 28.3 35.6 53.0 87.6 44.3 11.8 23.7 66.7 46.7 29.8 22.4 36.7 33.2 48.5 13.1 26.3 48.8 109.2 39.5 25.8 47.3 25.5 44.7 23.6 51.9 39.4 37.7 31.7 31.2 31.7 62.4 27.5 33.4 10.4 17.0 12.5 13.5 20.9 14.3 9.5 12.8 13.9 19.7 10.6 10.1 14.3 5.8 17.2 29.3 7.2 16.9 13.0 9.3 15.1 13.4 13.2 10.0 12.0 12.9 13.2 8.1 13.3 13.0 12.8 23.9 10.9 3.2 19.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 14.4 9.3 0.0 0.0 5.0 11.0 0.0 13.4 6.9 0.0 5.9 12.2 0.0 9.9 13.5 4.9 0.0 0.0 0.0 17.2 11.0 5.4 0.0 14.8 8.8 11.1 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.9 0.0 0.0 17.2 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 3.8 9.6 0.0 0.0 RPP25L "bA296L22.5, C9orf23, MGC29635" ENSG00000164967 "Ribonuclease P/MRP subunit p25 like" Q8N5L8 9 34610486-34612104 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.4" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 132.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052187, HPA059698" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052187: AB_2681755, HPA059698: AB_2684106" "unprognostic (1.56e-1)" "unprognostic (1.43e-2)" "unprognostic (7.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.78e-1)" "unprognostic (4.78e-2)" "unprognostic (2.56e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-2)" "unprognostic (3.39e-2)" "unprognostic (2.44e-1)" "prognostic favorable (3.01e-9)" "unprognostic (4.63e-3)" "unprognostic (6.20e-2)" "unprognostic (3.40e-1)" "prognostic favorable (8.21e-4)" 15.9 23.4 28.1 13.9 28.7 9.7 18.4 30.1 36.5 20.6 25.9 24.1 27.8 20.0 12.7 28.4 20.3 14.6 38.4 28.1 28.8 28.4 51.8 11.9 20.9 29.2 28.1 27.0 19.6 23.2 24.2 17.6 12.3 29.8 24.7 14.6 4.9 23.3 15.2 119.4 17.6 26.6 10.6 27.9 26.7 22.1 16.1 30.5 22.7 18.6 104.0 14.1 20.7 18.6 28.1 42.6 54.0 21.9 21.4 21.4 20.2 21.5 18.1 18.5 28.9 33.1 24.3 28.2 32.8 27.1 11.0 13.5 28.1 33.2 44.2 10.4 66.1 44.5 19.5 37.9 36.2 46.1 20.5 28.3 35.2 42.4 24.3 55.3 25.1 30.8 44.5 31.6 34.1 22.7 45.8 42.9 76.4 20.1 43.4 48.7 37.2 23.0 33.2 31.9 22.1 14.6 8.5 32.9 36.6 21.6 10.8 33.6 35.7 14.5 9.1 26.3 22.3 15.1 16.4 30.8 38.6 27.6 41.3 44.7 71.2 55.6 56.4 38.2 48.5 47.3 57.1 44.5 40.3 47.8 67.3 51.8 49.8 51.9 56.6 57.5 39.3 68.4 39.6 28.1 28.7 30.1 36.5 28.1 28.8 29.2 28.1 27.0 29.8 27.9 30.5 28.1 12.9 0.0 15.1 6.5 20.7 11.1 50.4 61.9 24.5 7.8 30.9 39.9 34.4 22.8 30.5 20.2 2.1 61.8 14.4 55.7 99.7 31.0 3.3 10.3 21.5 17.5 33.6 12.6 3.0 19.8 38.1 18.4 17.9 13.7 10.2 16.4 27.1 77.5 32.0 0.0 3.9 44.7 38.7 33.6 10.4 6.0 22.4 18.4 12.4 3.7 33.1 25.6 51.5 2.0 3.4 18.9 61.6 15.4 14.7 40.8 132.7 82.2 21.0 12.3 6.6 18.2 18.8 50.3 24.0 30.6 14.8 41.9 17.4 47.7 50.1 44.4 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.5" "Cell type enhanced" "Detected in many" "Horizontal cells: 53.8;Late spermatids: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: AB_2681986" "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favorable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 19.2 14.1 93.0 9.0 76.2 3.8 17.7 73.6 87.5 18.4 27.2 14.5 5.4 22.7 6.2 9.9 15.8 5.7 28.2 76.7 79.8 15.8 12.8 18.9 6.5 91.8 84.0 64.0 15.4 13.3 6.4 26.5 13.5 102.5 16.4 4.6 19.5 12.2 7.1 43.0 16.2 12.0 12.0 85.7 15.3 12.8 9.7 83.7 8.3 15.0 12.7 5.0 17.9 15.8 89.9 27.9 10.6 24.5 14.0 22.3 8.5 23.8 16.5 12.4 14.0 17.7 7.4 6.3 6.1 16.6 16.1 27.7 11.4 19.6 10.6 14.0 96.0 11.2 2.5 14.6 8.0 12.5 6.1 13.6 9.0 10.5 21.0 11.7 17.4 23.4 10.6 6.1 29.6 11.0 5.6 9.5 8.5 15.8 3.8 15.6 12.1 4.1 5.3 10.1 5.9 7.8 24.8 14.3 10.3 8.5 22.2 5.2 6.1 28.0 15.4 11.9 32.3 23.2 7.8 12.0 5.1 44.2 13.9 27.8 0.6 0.1 1.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.5 0.2 0.2 0.1 0.4 0.1 93.0 76.2 73.6 87.5 76.7 79.8 91.8 84.0 64.0 102.5 85.7 83.7 89.9 14.3 6.4 3.3 17.3 3.3 6.2 3.7 5.6 4.0 21.1 5.1 2.9 11.7 1.5 2.5 3.7 4.2 9.4 4.3 2.1 0.0 6.1 13.8 2.0 6.0 17.4 10.8 0.4 28.6 5.1 16.8 7.8 6.1 2.8 2.5 3.4 9.3 2.8 5.9 53.8 31.8 2.3 8.2 5.5 2.6 35.1 3.7 4.1 8.8 15.0 4.5 9.3 3.1 22.1 15.9 6.6 1.7 5.7 3.0 5.1 1.3 3.0 2.3 11.0 6.6 5.2 9.1 9.9 3.8 3.0 6.5 20.7 3.5 2.9 0.9 2.7 C9orf24 "bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1" ENSG00000164972 "Chromosome 9 open reading frame 24" Q8NCR6 9 34379019-34397810 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.3;choroid plexus: 86.7;fallopian tube: 109.6;testis: 91.3" "Cell type enhanced" "Detected in many" "Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 17.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053008 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053008: AB_2682015" "unprognostic (3.62e-3)" "unprognostic (9.06e-3)" "unprognostic (1.00e-1)" "prognostic favorable (3.23e-5)" "unprognostic (7.66e-2)" "unprognostic (1.21e-2)" "unprognostic (2.40e-1)" "unprognostic (1.25e-1)" "unprognostic (2.72e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.50e-1)" "unprognostic (7.43e-3)" "unprognostic (4.72e-2)" "unprognostic (1.90e-2)" 1.2 0.6 28.7 0.3 21.6 0.0 0.7 21.0 30.0 4.5 86.7 2.8 1.9 0.7 0.1 0.4 109.6 0.3 15.5 16.9 27.1 3.2 0.3 18.6 0.2 31.3 25.9 14.7 0.4 1.0 0.1 10.7 0.2 25.6 1.6 0.7 1.2 1.9 0.4 1.4 0.6 5.5 0.5 30.8 0.2 1.4 91.3 20.7 0.3 0.6 1.7 0.3 0.9 0.4 22.4 0.2 0.0 0.4 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.6 0.3 0.0 0.4 1.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.1 0.2 0.6 0.4 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.8 0.3 0.0 0.2 0.0 0.0 0.4 0.1 28.7 21.6 21.0 30.0 16.9 27.1 31.3 25.9 14.7 25.6 30.8 20.7 22.4 0.4 6.4 15.1 11.4 0.3 2.2 3.3 67.3 2.2 1.4 1.6 1.8 37.0 1.5 116.4 7.3 0.0 0.6 0.1 11.3 72.4 1.1 744.6 841.0 6.1 2.1 12.1 0.0 11.3 1.5 0.3 3.5 0.5 9.8 8.8 0.2 1.4 4.1 0.4 0.0 12.6 13.4 81.4 1.0 1.0 3115.3 10.5 2.7 0.0 1.0 0.0 2.2 1.0 4.0 5.4 0.2 7.3 7.2 0.5 4.5 142.5 13.7 1312.6 0.9 32.9 0.5 25.5 21.0 6.9 0.4 1.0 0.5 1.6 0.0 20.5 2.4 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 121.7;Late spermatids: 270.7;Spermatocytes: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: AB_2682055, HPA066031: AB_2685600" "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 4.0 6.6 5.6 4.0 5.4 1.7 3.8 10.6 7.7 6.4 4.8 5.7 4.2 5.9 5.4 5.5 5.1 3.8 6.8 7.3 5.4 4.6 3.4 4.4 4.4 5.4 6.0 5.2 7.2 4.4 4.9 5.2 6.3 6.4 4.9 5.2 11.4 4.6 3.8 8.0 5.0 5.4 4.5 4.6 5.0 4.8 5.6 8.4 3.5 4.5 6.3 4.0 5.1 6.0 8.2 4.7 5.9 12.3 4.7 9.6 10.0 7.2 7.2 3.1 4.2 4.9 2.8 2.0 3.3 2.7 4.6 5.9 2.8 6.6 3.4 5.1 15.5 7.7 11.9 13.4 4.0 4.8 2.7 8.9 6.5 6.6 2.9 3.3 17.7 7.8 7.7 3.4 5.3 9.7 1.4 3.2 8.5 3.9 3.5 15.4 6.6 1.5 1.8 7.3 2.8 13.1 9.2 2.5 2.2 1.7 10.7 5.3 5.5 6.5 7.0 2.7 3.0 9.3 6.9 9.0 4.2 4.4 3.5 3.3 4.9 14.2 7.8 7.6 24.6 7.6 15.2 7.6 7.0 11.2 16.5 10.9 10.5 1.7 7.8 32.2 9.2 12.2 8.9 5.6 5.4 10.6 7.7 7.3 5.4 5.4 6.0 5.2 6.4 4.6 8.4 8.2 13.8 19.2 11.9 31.6 21.1 9.6 14.1 18.1 8.6 19.7 9.7 6.9 39.5 7.2 16.8 20.2 31.3 12.4 14.5 21.3 13.7 17.6 121.7 15.2 14.8 18.7 15.0 19.4 56.0 9.2 17.3 15.3 11.2 14.7 17.2 22.2 20.3 14.8 16.1 35.3 63.9 15.7 38.7 25.0 10.7 270.7 33.8 16.3 19.6 26.2 21.5 13.8 18.6 46.8 46.3 12.4 27.9 30.5 18.0 9.8 36.4 28.4 23.9 19.0 13.1 11.6 32.0 113.3 27.1 9.1 11.9 9.7 13.4 34.6 17.7 11.7 MYORG "KIAA1161, NET37" ENSG00000164976 "Myogenesis regulating glycosidase (putative)" Q6NSJ0 9 34366666-34376898 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 55.5;Exocrine glandular cells: 11.8;Pancreatic endocrine cells: 10.3;Proximal tubular cells: 9.2;Syncytiotrophoblasts: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 35.4;SK-BR-3: 56.8;T-47d: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060533, HPA067487" Enhanced Approved Mitochondria NA NA Mitochondria "HPA060533: AB_2684311, HPA067487: AB_2685848" "unprognostic (6.56e-2)" "unprognostic (1.51e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (2.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (4.68e-3)" "unprognostic (1.91e-3)" "unprognostic (3.20e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.08e-3)" "unprognostic (3.68e-1)" "unprognostic (3.09e-1)" "unprognostic (1.00e-3)" 8.2 6.3 29.9 3.4 29.5 2.0 3.5 27.6 31.2 1.7 16.1 19.2 27.5 2.8 2.0 5.4 4.5 6.2 3.3 27.7 27.5 14.6 41.8 3.2 1.5 33.1 30.6 25.1 1.0 11.2 1.6 5.5 19.9 29.4 3.2 16.3 3.5 5.7 5.2 85.0 3.8 26.0 4.5 22.9 1.4 15.2 1.3 30.8 1.1 2.0 39.6 1.9 3.1 2.4 26.4 8.1 5.5 9.2 5.6 3.8 1.2 19.7 1.4 1.1 0.8 1.3 13.9 8.3 4.4 15.9 1.4 4.0 16.4 6.7 15.5 1.1 1.4 3.6 0.8 24.6 35.4 0.5 0.8 2.7 1.8 7.2 2.6 3.0 4.3 3.8 3.3 1.1 4.2 2.0 13.4 2.5 1.2 5.5 27.4 4.4 4.0 4.6 1.3 4.9 2.9 1.3 13.0 10.8 56.8 0.9 7.8 52.8 1.3 3.2 1.8 11.0 1.6 3.5 2.8 6.5 1.6 1.6 3.1 1.6 0.4 0.1 0.2 0.7 0.1 0.5 0.2 0.4 0.4 0.0 0.2 0.2 0.3 0.3 0.4 0.1 0.1 0.6 0.1 29.9 29.5 27.6 31.2 27.7 27.5 33.1 30.6 25.1 29.4 22.9 30.8 26.4 3.9 9.6 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.0 0.0 2.5 3.7 0.0 55.5 0.3 0.0 1.9 5.7 0.0 3.4 0.7 2.1 0.0 0.0 0.0 11.8 3.6 1.1 0.0 2.0 1.3 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 9.2 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 17.4 0.3 0.1 0.0 0.0 NUDT2 APAH1 ENSG00000164978 "Nudix hydrolase 2" P50583 9 34329506-34343711 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004684, HPA044903, HPA058623, HPA067639" Uncertain Approved Nucleoplasm NA NA 65000 Nucleoplasm "CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877" "unprognostic (2.74e-3)" "unprognostic (2.58e-2)" "unprognostic (3.37e-1)" "unprognostic (2.05e-3)" "unprognostic (3.08e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (6.55e-2)" "unprognostic (7.06e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-2)" "unprognostic (2.80e-1)" "unprognostic (2.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (1.91e-1)" 20.6 32.2 35.5 10.7 36.1 15.1 26.2 35.7 47.7 25.5 32.3 26.3 16.4 22.5 36.1 26.2 25.4 14.0 27.5 34.1 35.7 19.2 27.2 13.7 17.4 36.0 35.2 34.5 35.1 34.8 19.6 31.0 18.3 36.1 27.0 19.2 21.0 21.2 15.8 44.4 25.8 18.8 18.6 36.9 20.4 25.7 16.3 36.1 23.9 7.2 15.1 18.1 28.6 22.8 38.9 59.3 24.2 30.8 10.9 20.7 37.7 22.0 28.1 62.7 31.8 33.0 16.5 27.4 16.7 22.8 35.0 12.2 25.4 28.1 68.7 32.1 61.7 24.8 35.2 44.6 31.4 61.1 28.1 13.9 38.5 45.1 41.4 77.0 43.3 66.2 55.9 10.3 64.7 46.9 36.8 29.1 26.1 19.4 26.8 67.7 36.7 19.2 41.7 31.3 19.2 6.3 24.9 45.1 16.9 27.3 27.4 14.0 29.5 43.2 27.1 24.4 18.0 29.8 14.9 25.7 28.8 33.9 26.0 35.4 20.8 16.2 13.0 14.7 14.6 20.6 22.6 23.9 19.0 20.7 22.2 27.2 23.8 5.8 19.9 15.1 19.1 27.1 15.7 35.5 36.1 35.7 47.7 34.1 35.7 36.0 35.2 34.5 36.1 36.9 36.1 38.9 26.3 3.2 4.1 9.1 17.0 28.2 20.5 44.6 14.2 13.6 39.1 53.1 24.9 37.1 20.6 16.5 6.2 39.0 16.7 20.2 88.0 26.7 11.4 20.2 18.5 24.7 22.2 21.0 6.9 40.0 37.8 21.5 13.7 11.5 13.3 21.6 28.5 36.2 36.9 8.4 7.7 34.7 14.2 31.1 23.0 26.8 27.4 20.3 23.2 11.2 25.8 25.9 18.6 12.5 19.0 32.6 26.5 19.2 31.8 18.5 28.7 65.4 25.4 16.5 26.3 21.0 23.9 39.7 19.2 25.0 31.5 18.9 17.8 35.0 30.0 23.6 TMEM65 ENSG00000164983 "Transmembrane protein 65" Q6PI78 8 124306189-124372701 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 72.6;Horizontal cells: 99.3;Inhibitory neurons: 139.8;Microglial cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025020 Uncertain NA NA "HPA025020: AB_2205178" "prognostic unfavorable (2.17e-4)" "unprognostic (3.52e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.24e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (2.26e-2)" "unprognostic (1.84e-1)" "unprognostic (4.71e-2)" "unprognostic (7.95e-2)" "unprognostic (8.26e-2)" "unprognostic (5.67e-2)" "unprognostic (8.25e-2)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (3.78e-1)" 3.8 3.2 5.6 5.0 5.7 3.5 5.1 5.9 5.8 5.0 4.6 4.1 15.5 4.9 2.2 5.6 3.0 4.7 12.0 5.3 5.3 4.7 2.7 3.6 4.5 4.6 6.5 5.4 4.2 4.8 6.6 2.1 3.4 4.9 2.8 4.5 2.7 8.7 2.0 14.0 10.1 5.6 3.7 4.0 4.7 2.9 1.7 6.8 3.7 5.4 12.6 4.5 3.3 5.4 6.0 7.9 5.4 11.2 4.0 3.4 6.1 0.9 4.5 4.4 6.9 7.9 0.9 3.1 7.4 4.4 8.0 5.3 3.6 5.8 4.3 8.2 23.2 5.9 5.0 4.6 1.6 9.5 3.4 4.8 4.4 8.1 10.0 7.9 9.4 15.8 3.6 2.3 6.2 8.5 6.1 2.4 1.3 3.0 3.5 7.5 1.4 10.6 4.5 7.3 3.4 9.1 5.4 16.6 41.9 7.8 5.7 3.7 4.3 10.3 5.8 13.9 19.4 7.7 4.2 3.3 3.0 8.2 24.6 8.4 0.4 0.1 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.4 0.1 0.2 0.3 0.0 5.6 5.7 5.9 5.8 5.3 5.3 4.6 6.5 5.4 4.9 4.0 6.8 6.0 14.0 12.8 3.9 34.3 15.1 13.4 9.4 3.0 11.4 6.0 14.0 11.8 37.2 15.7 4.8 7.3 0.0 0.6 10.0 17.0 23.5 10.9 3.9 12.1 12.9 14.0 1.2 6.3 72.6 7.8 1.6 13.0 5.6 9.7 1.3 31.2 23.9 4.7 8.9 99.3 139.8 3.7 4.1 19.1 10.5 1.0 9.9 19.8 8.8 70.3 9.3 4.4 14.4 52.3 45.0 9.8 4.7 11.7 10.2 7.8 5.3 19.2 5.8 2.3 6.6 25.9 8.9 3.3 4.5 31.9 12.5 0.7 14.8 7.5 5.2 11.6 PSIP1 "DFS70, LEDGF, p52, p75, PSIP2" ENSG00000164985 "PC4 and SFRS1 interacting protein 1" O75475 9 15464066-15510995 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 279.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 860.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013718, HPA019697" Enhanced Enhanced Nucleoplasm NA NA 24000 Nucleoplasm "CAB013718: , HPA019697: AB_1852779" "unprognostic (8.54e-2)" "unprognostic (3.70e-2)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (2.89e-3)" "unprognostic (5.10e-2)" "unprognostic (5.93e-2)" "unprognostic (2.53e-2)" "unprognostic (6.49e-3)" "unprognostic (5.49e-2)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.99e-1)" "unprognostic (7.14e-2)" "unprognostic (1.39e-1)" 33.2 41.3 74.5 47.4 80.1 62.5 27.6 91.0 89.9 45.2 59.0 35.8 23.3 58.0 36.3 26.5 43.2 31.1 34.7 77.2 75.2 32.9 22.5 33.1 81.4 72.8 72.3 70.5 86.8 17.3 30.5 52.6 39.8 73.2 36.7 31.2 155.7 19.3 41.4 39.0 26.2 34.7 43.5 68.2 55.2 28.7 82.3 72.7 130.9 37.4 29.8 69.9 31.5 32.6 79.7 117.5 76.5 254.7 187.4 54.0 65.2 56.7 138.3 98.1 121.7 143.6 32.1 59.5 248.1 31.4 73.5 68.2 32.0 160.1 75.0 174.9 164.8 96.6 860.4 194.9 60.8 65.1 101.7 91.7 54.8 21.0 102.1 74.4 121.0 108.0 115.2 144.4 134.1 80.2 42.8 211.5 250.9 395.2 2.7 117.2 194.7 138.8 50.7 68.3 40.5 161.1 176.7 123.7 54.0 67.1 157.5 54.5 134.9 76.7 88.0 88.6 66.7 133.2 57.1 85.3 221.8 70.2 100.8 51.6 13.7 2.6 5.4 6.1 2.0 7.7 11.0 12.5 8.8 3.0 17.5 18.7 11.6 8.4 9.5 5.7 3.1 12.9 2.4 74.5 80.1 91.0 89.9 77.2 75.2 72.8 72.3 70.5 73.2 68.2 72.7 79.7 93.7 54.5 31.9 27.4 98.1 31.9 49.1 8.1 48.9 231.0 22.0 35.6 57.8 31.5 23.1 47.8 66.7 122.7 82.1 24.7 62.6 9.5 95.5 92.9 62.5 84.8 38.1 160.1 73.4 8.5 76.2 74.8 23.0 35.1 15.2 104.2 65.3 18.0 32.1 138.0 76.9 34.1 2.0 36.5 45.9 58.5 125.9 45.8 40.9 20.6 47.9 162.2 83.4 49.8 67.6 3.6 20.6 134.3 60.4 19.6 14.1 54.5 42.1 279.1 124.9 85.2 89.8 217.9 243.8 34.5 21.2 41.3 111.6 68.6 45.8 20.3 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553043-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.4" "Cell type enhanced" "Detected in many" "Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 7.5;HEL: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 0.8 1.1 2.4 0.7 3.1 2.1 1.6 4.1 3.5 1.4 0.1 0.9 0.8 5.9 1.1 1.0 2.0 1.5 1.0 2.7 0.8 1.2 0.4 1.1 1.1 1.9 1.1 2.2 3.0 1.3 1.4 1.1 0.9 2.4 1.2 1.1 5.5 0.8 1.3 0.8 2.4 1.0 3.3 0.4 0.6 1.4 11.4 0.8 4.9 2.0 1.1 1.0 0.8 0.9 3.8 1.4 0.7 1.6 1.6 0.9 1.9 1.0 1.0 0.8 1.0 1.1 0.4 0.6 7.5 0.5 0.6 1.9 0.3 0.7 1.0 1.1 1.6 0.7 11.7 1.2 1.0 1.3 1.6 1.4 1.1 1.9 0.8 1.5 0.8 0.5 4.1 0.3 2.0 1.2 0.5 3.3 1.5 1.3 0.6 1.6 3.8 1.2 0.2 0.7 1.1 2.3 1.1 2.1 0.7 2.8 1.3 0.9 1.1 0.8 2.1 1.2 0.6 0.7 1.1 1.4 4.8 0.9 1.0 1.5 2.4 0.2 0.0 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 2.4 3.1 4.1 3.5 2.7 0.8 1.9 1.1 2.2 2.4 0.4 0.8 3.8 4.4 0.0 7.5 56.8 2.6 2.8 5.8 1.8 7.4 27.7 5.0 8.0 8.5 0.0 5.9 3.7 16.7 6.7 1.4 3.6 5.9 2.9 194.5 24.3 7.8 3.8 1.2 3.8 92.4 3.5 4.1 5.7 8.2 12.9 1.3 7.6 3.3 0.8 1.9 10.1 70.6 3.5 6.1 1.0 1.1 172.4 5.9 2.1 0.0 16.9 1.6 12.5 5.2 54.8 63.1 2.5 1.0 6.0 1.9 0.8 2.8 2.1 12.0 44.0 13.1 11.6 5.7 148.2 40.6 5.4 3.3 5.6 3.6 10.7 4.9 3.7 UBAP1 UBAP ENSG00000165006 "Ubiquitin associated protein 1" Q9NZ09 9 34179005-34252523 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019804 Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA019804: AB_1858494" "unprognostic (1.83e-1)" "unprognostic (4.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-1)" "unprognostic (2.01e-2)" "unprognostic (6.53e-2)" "unprognostic (1.25e-2)" "unprognostic (3.63e-1)" "prognostic favorable (7.49e-6)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (1.17e-1)" 37.9 56.0 46.4 24.7 46.5 132.6 36.1 48.0 53.9 39.3 46.2 34.4 22.5 34.3 25.7 70.3 34.2 30.7 37.8 45.6 50.4 35.1 53.6 42.9 24.0 49.5 47.7 42.3 41.3 28.2 34.6 25.8 29.5 50.1 30.6 25.0 45.2 29.8 30.9 110.9 39.6 26.5 35.5 46.8 28.5 33.8 48.3 50.4 31.9 25.9 72.3 33.0 38.3 46.2 49.9 56.7 31.7 35.2 38.4 63.6 39.3 29.8 44.4 61.6 48.4 65.6 34.3 23.0 39.3 19.5 66.5 41.1 28.3 49.2 69.5 46.4 57.1 22.3 35.1 65.4 35.5 57.8 39.3 44.8 48.7 113.0 57.5 75.0 73.4 54.4 37.9 27.4 38.0 45.7 23.7 36.5 55.0 38.2 38.8 45.9 32.6 24.8 22.8 104.2 36.9 19.9 28.1 49.0 50.2 22.5 31.1 24.6 38.5 39.2 24.7 38.0 37.4 41.5 18.9 25.3 41.0 49.5 31.5 74.2 26.8 50.9 66.6 38.0 45.2 65.8 26.8 38.1 40.0 47.1 23.2 36.3 29.8 120.2 50.1 41.0 26.7 52.9 55.0 46.4 46.5 48.0 53.9 45.6 50.4 49.5 47.7 42.3 50.1 46.8 50.4 49.9 21.6 67.3 26.0 44.4 22.4 46.9 66.3 20.4 45.5 15.8 27.9 23.1 13.1 20.0 33.5 7.3 25.0 33.2 21.6 25.8 19.6 34.8 77.5 56.9 37.2 21.4 16.1 50.7 33.1 40.1 35.4 31.2 44.4 90.0 25.9 15.4 17.5 25.3 22.0 6.7 42.9 18.5 30.5 21.4 39.8 62.9 29.2 38.2 24.9 26.2 23.1 26.0 13.4 38.7 35.4 44.3 23.0 42.5 25.0 47.9 22.5 21.0 22.5 10.9 19.7 44.0 32.5 51.0 22.9 54.6 59.0 89.6 28.6 20.8 18.8 70.9 DIRAS2 "Di-Ras2, DKFZp761C07121" ENSG00000165023 "DIRAS family GTPase 2" Q96HU8 9 90609832-90642862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 82.1;retina: 39.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 105.3;Excitatory neurons: 103.0;Horizontal cells: 70.7;Oligodendrocytes: 25.9;Rod photoreceptor cells: 23.9" "Group enriched" "Detected in many" 4 "glioma: 5.7;renal cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;EFO-21: 2.4;SCLC-21H: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.20e-3)" "unprognostic (4.39e-2)" "unprognostic (1.35e-1)" "unprognostic (6.57e-2)" "unprognostic (4.27e-5)" "unprognostic (3.94e-2)" "unprognostic (4.37e-2)" "unprognostic (9.75e-3)" "unprognostic (9.85e-3)" "unprognostic (1.86e-1)" "unprognostic (5.70e-2)" "unprognostic (2.14e-1)" "unprognostic (5.39e-1)" "unprognostic (2.64e-3)" "unprognostic (2.05e-1)" 0.2 2.9 25.0 0.2 49.9 0.5 0.8 82.1 67.1 9.3 0.0 0.4 2.3 0.4 0.4 0.1 0.6 5.2 0.1 57.0 26.8 0.9 0.5 0.2 0.4 3.7 14.5 36.9 0.1 1.4 4.0 1.0 0.7 24.5 0.1 0.2 39.8 2.2 0.4 0.1 0.9 2.6 0.3 4.9 0.4 1.3 0.3 14.6 0.2 2.8 0.0 0.1 0.1 0.0 63.3 0.0 0.8 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.1 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 25.0 49.9 82.1 67.1 57.0 26.8 3.7 14.5 36.9 24.5 4.9 14.6 63.3 0.1 0.0 0.0 9.8 0.0 0.1 0.0 0.0 0.0 105.3 2.3 1.0 0.5 7.2 0.1 3.7 2.1 0.0 0.0 0.0 0.0 2.0 0.2 6.7 0.8 0.4 0.0 0.0 103.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.9 0.0 70.7 21.8 0.0 0.0 0.0 0.3 0.1 0.9 0.0 1.8 13.1 0.0 10.3 0.0 21.6 25.9 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 23.9 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 74.4;parathyroid gland: 88.3" "Cell type enhanced" "Detected in many" "B-cells: 91.3;Hofbauer cells: 73.1;Kupffer cells: 96.7;Macrophages: 95.2;Microglial cells: 114.3;monocytes: 92.5;Plasma cells: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "classical monocyte: 77.3;eosinophil: 83.5;intermediate monocyte: 64.0;memory B-cell: 74.5;myeloid DC: 85.1;naive B-cell: 58.4;neutrophil: 112.1;NK-cell: 30.0;non-classical monocyte: 60.2;plasmacytoid DC: 63.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 125.8;HEL: 72.8;HL-60: 101.6;HMC-1: 64.1;REH: 84.4;THP-1: 76.8;U-698: 58.8;U-937: 70.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" No NA 290000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.4 4.6 3.9 42.8 4.5 51.4 6.9 4.7 4.9 7.7 5.2 20.3 31.1 4.2 16.2 17.7 17.1 13.0 3.0 3.8 7.2 11.3 4.5 20.8 62.3 6.8 5.0 2.7 1.7 9.2 88.3 2.4 12.1 6.8 3.9 20.7 0.8 8.4 4.3 1.1 10.0 36.6 9.4 7.2 40.6 19.2 7.0 5.8 50.1 25.8 2.4 74.4 17.7 8.3 8.2 22.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 14.3 125.8 3.5 0.0 4.2 19.1 2.7 10.2 0.0 0.0 17.0 72.8 0.0 0.0 0.0 101.6 64.1 0.0 14.0 0.0 1.4 0.0 0.0 15.5 2.0 9.9 0.0 15.4 0.1 44.4 0.7 47.0 0.0 84.4 0.1 34.6 2.6 18.6 6.4 5.7 0.1 8.7 0.1 0.3 7.9 76.8 0.2 0.0 0.4 0.1 0.1 0.2 0.0 58.8 0.0 70.3 0.0 5.3 77.3 83.5 0.3 64.0 0.3 74.5 0.2 0.2 85.1 58.4 0.2 0.1 112.1 30.0 60.2 63.2 0.1 44.6 3.9 4.5 4.7 4.9 3.8 7.2 6.8 5.0 2.7 6.8 7.2 5.8 8.2 0.5 12.8 20.2 0.0 91.3 3.4 3.7 8.7 12.0 1.4 6.3 2.8 1.6 14.3 12.8 14.7 0.0 1.3 70.4 16.5 15.6 15.0 7.1 10.7 1.0 2.1 10.3 37.9 0.4 12.5 2.6 2.1 22.4 12.6 43.6 0.0 3.3 1.0 73.1 0.0 0.7 24.4 0.0 96.7 28.8 6.2 0.6 95.2 12.4 114.3 92.5 0.0 62.8 1.5 0.5 18.2 25.1 0.0 83.1 2.5 31.4 0.4 10.4 0.2 6.6 0.7 2.3 0.8 0.7 30.4 5.7 1.4 8.3 0.0 31.1 8.0 NIPSNAP3B FLJ11275 ENSG00000165028 "Nipsnap homolog 3B" Q9BS92 9 104764129-104777764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 20.6;tongue: 19.7" "Cell type enhanced" "Detected in many" "Adipocytes: 11.8;Cardiomyocytes: 21.6;Excitatory neurons: 10.7;Microglial cells: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "REH: 3.0;SH-SY5Y: 2.1;THP-1: 2.2;U-266/70: 2.3" HPA042491 Uncertain NA NA "HPA042491: AB_2678023" "unprognostic (1.72e-2)" "unprognostic (1.47e-2)" "unprognostic (9.76e-2)" "unprognostic (1.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (8.36e-2)" "unprognostic (1.41e-3)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (4.25e-5)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (5.61e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (4.81e-2)" 6.6 5.1 1.8 1.2 2.1 0.7 4.3 1.3 2.2 2.2 1.7 1.0 0.5 3.1 3.5 1.0 1.9 1.3 10.5 2.0 2.1 1.4 0.5 1.4 1.5 1.7 1.6 1.9 3.3 1.9 1.0 2.7 3.0 1.8 2.7 0.9 2.5 1.4 3.6 20.6 1.3 1.2 1.6 1.3 2.0 1.2 1.0 1.7 0.8 2.0 19.7 1.8 0.9 1.5 2.0 0.0 0.3 0.4 0.1 0.4 0.4 0.7 0.1 0.2 0.2 0.1 0.3 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.0 0.5 1.4 1.2 0.1 0.4 0.2 0.4 0.4 0.1 0.3 0.0 0.5 0.1 0.7 1.2 0.0 0.0 0.2 0.6 1.2 0.2 0.0 0.2 3.0 0.0 0.1 0.1 0.0 0.9 2.1 1.2 0.0 0.1 0.2 1.1 2.2 0.1 0.2 0.4 0.2 0.1 2.3 0.8 0.2 0.0 0.2 0.0 2.8 0.0 0.6 0.0 0.1 0.1 0.7 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 1.8 2.1 1.3 2.2 2.0 2.1 1.7 1.6 1.9 1.8 1.3 1.7 2.0 11.8 0.0 1.1 2.0 8.5 0.4 1.5 0.8 1.2 4.0 0.9 1.7 21.6 0.0 0.3 3.7 0.0 0.8 0.1 0.0 5.9 0.7 0.0 2.2 2.0 3.4 1.2 5.9 10.7 0.2 0.2 3.9 2.6 1.2 1.3 2.5 6.1 0.3 6.2 0.0 9.8 0.3 4.1 0.9 3.9 0.9 2.5 3.0 0.0 16.9 4.1 1.2 0.0 4.5 1.1 0.2 0.0 6.8 2.3 0.3 0.0 0.4 3.2 0.5 0.0 2.0 3.7 0.8 1.1 1.7 0.9 0.8 1.1 0.8 0.2 0.2 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781006-104928155 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Translocase "Atherosclerosis, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Hepatocytes: 175.5;Kupffer cells: 169.1;Langerhans cells: 109.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 13.1;neutrophil: 10.6" "Lineage enriched" "Detected in many" 8 "granulocytes: 13.1" "Cell line enhanced" "Detected in many" "HSkMC: 34.1;U-87 MG: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: AB_2683396" "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 24.9 36.8 11.7 11.1 26.2 20.9 13.4 15.0 16.6 6.9 6.0 13.5 4.6 5.7 8.3 5.0 8.1 15.1 4.4 9.1 23.5 7.3 39.0 12.4 9.0 18.4 21.9 5.4 9.0 4.1 1.8 2.5 22.9 22.1 4.2 10.0 3.8 5.7 5.0 11.0 13.5 8.2 7.7 16.0 7.2 6.7 3.6 22.1 11.1 5.1 3.4 5.4 19.9 7.7 20.1 0.0 5.6 4.6 0.0 13.1 4.9 4.1 5.9 22.6 1.9 2.1 0.8 0.8 8.2 6.4 5.9 21.7 0.0 2.5 0.3 1.7 0.0 0.0 0.9 1.9 20.3 23.5 0.0 13.8 34.1 1.5 22.7 0.4 21.6 2.2 0.7 0.0 20.2 0.5 0.8 5.2 11.1 6.5 1.2 1.7 0.1 0.0 0.4 3.7 3.9 0.7 0.2 6.2 1.0 1.2 8.7 0.1 4.1 2.1 6.0 0.4 8.0 6.5 7.9 4.0 4.8 79.0 0.0 0.1 2.4 0.8 13.1 0.1 1.0 0.2 1.2 0.3 0.0 0.2 1.5 0.6 0.0 10.6 0.1 1.7 0.1 0.1 0.2 11.7 26.2 15.0 16.6 9.1 23.5 18.4 21.9 5.4 22.1 16.0 22.1 20.1 35.8 105.8 9.3 71.5 21.1 29.7 5.9 6.3 61.5 18.4 4.6 7.0 8.9 22.8 11.7 11.0 47.9 31.1 2.4 8.4 0.0 4.5 1.9 17.1 76.0 18.7 9.1 1.3 8.1 1.5 6.9 44.0 14.3 29.4 46.9 3.6 31.4 175.5 75.0 0.0 22.5 2.2 8.2 169.1 109.5 2.5 31.1 74.8 26.6 38.4 6.4 0.5 0.0 57.8 7.7 4.9 5.0 28.2 2.2 2.6 0.1 18.0 8.4 6.7 46.0 24.3 23.4 1.0 1.8 17.1 19.5 8.9 6.5 39.5 3.2 13.3 NFIL3 "E4BP4, IL3BP1, NF-IL3A, NFIL3A" ENSG00000165030 "Nuclear factor, interleukin 3 regulated" Q16649 9 91409045-91423832 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 122.0;Endometrial stromal cells: 127.4;Glandular and luminal cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 57.9;neutrophil: 26.9" "Lineage enriched" "Detected in many" 35 "granulocytes: 57.9" "Cell line enhanced" "Detected in all" "ASC diff: 152.6;HDLM-2: 179.1;hTCEpi: 141.2;hTERT-HME1: 149.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003261 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA003261: AB_1079477" "unprognostic (2.18e-1)" "unprognostic (7.30e-2)" "unprognostic (4.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.13e-1)" "unprognostic (4.91e-3)" "unprognostic (1.00e-1)" "unprognostic (2.34e-2)" "unprognostic (2.54e-2)" "unprognostic (6.45e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (3.23e-6)" "unprognostic (5.44e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (3.37e-2)" 114.5 84.9 13.1 37.8 13.0 213.2 80.9 16.7 21.1 73.4 14.4 46.2 18.2 62.5 15.2 23.1 94.8 47.9 50.8 12.6 68.8 36.3 122.6 69.3 9.5 16.7 14.7 11.7 93.4 30.5 16.0 31.8 47.8 17.1 60.5 22.0 33.9 23.1 16.6 134.6 57.9 29.5 53.0 14.1 20.2 44.5 18.7 14.5 18.3 26.9 25.2 11.7 61.8 65.4 19.2 18.3 10.7 12.8 7.1 152.6 117.9 62.1 21.3 61.1 23.8 35.8 7.4 8.9 7.9 12.9 17.8 69.5 11.7 14.9 21.4 27.1 179.1 6.4 8.7 10.2 62.2 124.4 12.1 50.8 120.3 141.2 21.5 149.2 13.5 10.8 20.2 14.3 89.6 15.8 9.2 1.3 16.1 9.8 31.3 9.7 29.3 13.9 11.7 29.5 8.7 16.0 11.8 14.9 13.2 21.5 22.6 7.4 15.8 11.6 52.0 11.5 45.2 10.9 76.3 18.9 3.5 27.8 11.3 9.4 57.9 1.6 10.3 1.2 0.7 0.6 0.4 0.0 0.3 0.9 0.1 0.1 0.2 26.9 0.1 1.0 0.6 0.0 0.6 13.1 13.0 16.7 21.1 12.6 68.8 16.7 14.7 11.7 17.1 14.1 14.5 19.2 60.1 22.4 32.4 1.3 7.8 46.1 14.7 15.2 22.2 17.7 31.7 28.6 81.8 8.6 16.4 0.0 16.7 9.6 75.6 23.7 9.8 10.5 24.1 122.0 127.4 34.3 16.1 1.3 5.1 9.8 24.9 55.0 9.7 152.6 9.5 27.5 13.9 29.4 10.6 20.2 5.6 9.5 6.1 25.3 78.0 6.4 10.8 75.4 33.8 2.8 15.4 17.8 6.2 3.5 2.9 7.8 9.1 11.7 24.3 25.6 17.7 10.0 10.3 15.5 6.6 60.2 83.8 0.8 3.9 23.3 39.5 23.1 22.6 6.8 9.6 13.1 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 24.0" "Cell type enhanced" "Detected in many" "Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 21.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 21.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.2;hTERT-HME1: 26.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 24.0" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 0.8 1.0 3.9 1.1 3.7 5.4 0.7 5.4 5.0 1.6 2.8 0.7 0.8 1.4 1.1 1.2 1.4 1.2 0.8 3.2 3.0 2.4 0.7 2.0 1.3 2.6 3.0 3.2 2.1 0.7 1.6 1.3 1.8 3.5 1.1 0.9 4.3 0.4 0.8 0.2 1.1 0.5 0.6 2.0 1.6 2.7 24.0 3.2 2.4 1.0 0.3 1.5 1.9 0.7 4.4 21.2 4.5 3.0 2.9 2.3 7.0 2.5 7.5 9.2 10.6 6.2 1.5 8.3 2.8 16.5 1.5 3.1 2.2 5.9 25.2 11.7 1.2 2.9 3.2 2.3 4.2 2.7 0.7 2.8 1.7 7.2 11.7 26.9 5.9 10.7 3.4 2.6 3.9 9.3 4.2 7.5 1.8 0.8 1.6 18.2 2.9 4.8 1.6 16.8 1.1 2.4 2.3 2.5 0.4 0.9 1.8 2.4 1.2 20.0 3.3 22.5 7.4 1.7 2.6 1.6 2.0 5.6 3.3 2.5 1.3 4.1 0.7 0.9 1.6 2.0 1.5 0.9 1.5 1.7 1.8 1.7 1.7 21.5 1.4 5.0 0.7 5.2 1.3 3.9 3.7 5.4 5.0 3.2 3.0 2.6 3.0 3.2 3.5 2.0 3.2 4.4 3.0 3.2 6.4 2.3 10.3 0.5 13.9 7.6 6.8 6.6 2.1 3.3 1.8 4.3 3.2 5.5 6.2 2.6 10.1 1.4 1.9 4.0 76.9 21.8 7.1 4.2 0.0 0.8 3.6 20.5 7.9 5.0 16.8 20.5 9.5 1.1 1.4 0.0 1.4 6.7 7.3 1.9 2.0 2.2 2.3 57.6 2.1 3.6 1.8 1.0 2.0 3.6 1.0 1.5 1.6 48.6 0.1 1.5 4.5 2.9 0.3 3.0 4.9 8.4 0.0 4.5 3.3 54.8 3.3 2.5 0.9 8.1 9.1 1.5 1.3 4.5 METTL2B "FLJ11350, METL, METTL2" ENSG00000165055 "Methyltransferase like 2B" Q6P1Q9 7 128476729-128506602 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.88e-1)" "unprognostic (4.00e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-1)" "unprognostic (1.81e-3)" "unprognostic (9.91e-2)" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (3.40e-2)" "unprognostic (4.57e-2)" "unprognostic (1.37e-1)" "unprognostic (1.35e-3)" "unprognostic (3.46e-2)" "unprognostic (8.38e-2)" "unprognostic (5.67e-2)" 6.7 7.1 3.3 3.3 3.5 3.3 6.3 4.7 4.9 5.5 1.7 6.3 2.5 6.6 5.2 7.8 5.7 1.9 7.3 2.5 3.4 5.4 10.0 5.2 3.8 3.3 3.3 2.3 5.7 7.8 2.8 5.3 3.8 3.7 5.5 4.2 6.4 6.2 2.6 11.5 7.9 5.6 3.4 1.7 5.9 6.3 3.8 3.5 2.7 4.9 3.6 4.3 6.1 5.6 5.2 9.1 11.6 8.5 14.6 6.1 6.9 5.6 8.1 4.6 7.5 6.2 11.5 10.7 8.5 3.0 8.0 13.6 9.9 13.2 7.7 10.8 8.2 12.0 10.6 15.7 9.4 9.7 13.1 7.4 6.1 8.8 9.6 8.9 7.1 8.6 11.1 18.8 6.8 9.4 9.2 17.8 18.3 12.9 9.4 10.6 7.4 8.0 8.5 11.3 8.7 7.4 13.7 7.1 33.0 9.6 10.1 8.7 9.1 9.7 9.2 3.7 9.5 16.7 10.7 10.3 20.5 18.8 15.3 11.7 2.7 1.7 1.1 2.1 1.4 1.4 1.3 1.9 1.7 1.2 2.2 1.9 2.4 1.8 1.7 1.4 1.9 1.6 1.3 3.3 3.5 4.7 4.9 2.5 3.4 3.3 3.3 2.3 3.7 1.7 3.5 5.2 20.5 12.8 23.5 7.8 14.7 16.4 22.4 14.0 15.4 31.8 10.6 8.0 11.5 10.0 19.9 12.9 39.6 21.8 14.5 11.6 5.9 18.6 1.6 13.9 17.8 16.6 8.4 15.3 13.4 17.9 13.4 15.7 10.7 14.4 18.3 17.3 9.3 12.7 10.7 37.0 14.3 15.7 18.3 7.3 9.1 1.9 14.6 10.2 8.8 9.4 18.4 23.2 17.5 9.5 13.2 19.3 8.0 15.8 19.0 24.1 9.1 15.2 28.8 34.7 6.6 28.6 14.7 15.5 15.7 11.8 18.8 24.4 16.7 19.4 18.3 23.2 PRKACG PKACg ENSG00000165059 "Protein kinase cAMP-activated catalytic subunit gamma" P22612 9 69012504-69014113 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 151 "testis: 24.8" "Group enriched" "Detected in some" 27 "Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004530, HPA071185" Supported Uncertain "Cytokinetic bridge,Cytosol" Yes NA Cytosol "Cytokinetic bridge" "CAB004530: AB_628137, HPA071185: AB_2686356" "unprognostic (2.74e-1)" "unprognostic (3.61e-2)" "unprognostic (7.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FXN "CyaY, FA, FARR, FRDA, X25" ENSG00000165060 Frataxin Q16595 9 69035751-69079076 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022164, HPA068304" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB022164: , HPA068304: AB_2685970" "unprognostic (3.38e-2)" "unprognostic (1.54e-1)" "unprognostic (7.47e-2)" "unprognostic (2.37e-3)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.71e-3)" "unprognostic (1.10e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-1)" "unprognostic (4.74e-2)" 9.5 20.3 8.3 7.9 8.8 29.4 10.2 9.3 9.0 9.1 10.6 10.5 7.4 12.3 12.2 9.6 10.3 5.4 22.4 8.6 9.5 11.1 46.7 7.2 9.9 9.5 9.6 8.2 17.8 15.3 22.4 8.1 9.2 9.3 10.3 12.4 4.1 11.8 13.7 25.8 5.2 7.7 13.4 9.2 12.7 10.2 10.7 9.1 5.5 10.5 20.0 10.5 12.4 7.9 9.8 27.0 22.1 34.2 17.0 15.7 23.1 34.3 18.6 16.3 28.0 21.2 11.8 16.6 45.9 14.0 19.5 28.8 28.6 41.8 42.6 34.9 53.9 47.5 66.2 14.1 87.2 26.7 48.7 27.7 25.7 33.7 27.8 29.9 9.6 37.7 28.0 50.3 43.9 26.1 25.6 14.0 21.0 47.5 53.1 42.8 32.7 24.0 32.0 32.2 21.5 26.9 12.1 19.2 12.5 20.7 24.3 14.1 14.4 22.7 18.0 32.0 24.1 27.6 11.6 11.4 27.8 8.5 39.7 18.5 8.1 39.9 0.4 48.6 45.4 37.5 36.3 48.0 48.4 42.8 22.7 61.6 59.8 1.9 60.8 36.2 33.2 43.3 49.5 8.3 8.8 9.3 9.0 8.6 9.5 9.5 9.6 8.2 9.3 9.2 9.1 9.8 11.0 3.2 11.5 13.1 19.9 9.7 19.8 36.6 14.8 6.8 16.9 20.8 38.2 10.0 10.5 14.7 4.2 39.9 14.9 4.9 21.5 17.5 2.4 11.7 22.5 16.9 7.2 56.1 14.2 14.7 22.3 14.7 14.3 8.7 7.0 15.4 11.0 69.0 33.4 0.0 18.6 15.3 18.3 22.1 16.1 6.3 15.8 13.9 17.8 9.4 18.3 7.6 28.8 6.6 10.8 15.0 3.7 13.2 42.0 17.1 5.8 27.2 7.4 1.6 13.1 10.1 19.8 5.1 32.3 29.8 8.1 14.6 17.1 27.9 17.5 14.1 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 16.4;retina: 4.5;thyroid gland: 16.5" "Group enriched" "Detected in some" 6 "Excitatory neurons: 220.9;Inhibitory neurons: 507.5" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 86 "NK-cell: 8.6" "Lineage enriched" "Detected in single" 86 "NK-cells: 8.6" "Group enriched" "Detected in some" 5 "AF22: 22.5;U-2197: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli No NA "Nucleoplasm, Nucleoli" "HPA069813: AB_2686206, HPA071585: AB_2686423" "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.79e-3)" 0.0 0.7 3.7 0.1 5.6 0.0 0.1 1.7 14.5 1.4 0.0 0.5 0.0 0.3 0.1 0.0 0.1 0.1 0.5 6.5 3.1 0.2 0.0 0.0 0.1 14.2 4.6 3.1 0.4 0.1 0.0 1.8 0.1 16.4 0.6 0.2 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 12.4 0.3 16.5 0.0 0.1 0.0 0.0 15.2 0.0 1.3 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.7 3.6 0.0 0.0 0.0 0.6 14.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.1 3.7 5.6 1.7 14.5 6.5 3.1 14.2 4.6 3.1 16.4 0.0 12.4 15.2 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 8.5 0.1 0.0 0.9 2.8 0.0 0.0 6.2 0.0 1.0 0.0 1.9 0.0 19.7 0.0 0.1 0.0 1.8 0.0 220.9 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 507.5 0.0 0.0 0.0 0.0 55.2 2.8 0.0 0.0 7.5 0.0 1.3 42.2 13.0 4.0 0.0 0.0 2.2 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.3 0.6 0.1 0.1 NKX6-3 FLJ25169 ENSG00000165066 "NK6 homeobox 3" A6NJ46 8 41645177-41650817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 10.9;stomach 1: 28.2" "Cell type enriched" "Detected in single" 5 "Gastric mucus-secreting cells: 2.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.1;stomach cancer: 3.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Daudi: 4.9;THP-1: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.87e-1)" "unprognostic (9.91e-3)" "unprognostic (4.04e-1)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (1.13e-1)" "unprognostic (2.17e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-1)" 0.0 0.0 0.4 0.1 0.6 0.1 0.0 2.6 1.1 0.0 0.4 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 1.5 0.5 1.1 0.5 0.0 0.9 1.8 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.3 28.2 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.6 1.1 0.5 0.5 0.5 1.1 0.5 1.3 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.8;heart muscle: 37.4" "Cell type enhanced" "Detected in many" "dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 269.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 269.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA058401: AB_2683707, HPA070655: AB_2686292" "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 5.6 2.0 1.1 13.2 1.1 33.8 8.6 1.2 8.6 2.5 3.3 8.4 2.2 1.3 1.1 2.9 1.9 5.5 37.4 1.1 4.0 1.5 3.9 8.2 13.3 1.6 1.2 0.7 1.0 2.4 0.7 1.1 1.9 2.2 2.0 3.5 0.5 5.7 2.3 1.6 1.1 7.3 3.6 1.2 18.6 2.8 1.0 2.1 19.3 2.0 4.6 10.7 4.6 1.9 1.9 0.4 0.0 4.9 0.0 0.0 0.0 0.0 1.3 12.7 0.5 0.9 0.0 0.0 0.1 0.6 4.1 0.1 0.0 0.0 0.3 1.5 54.5 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.1 0.0 0.1 2.0 1.4 1.0 6.7 0.0 11.1 2.4 0.0 2.9 2.2 1.2 0.0 0.4 0.1 1.8 0.8 4.8 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 2.1 0.5 0.9 1.2 5.7 0.1 2.9 0.0 9.0 31.6 3.7 61.9 55.9 101.6 31.3 16.1 57.9 6.6 22.8 22.2 33.7 4.7 33.9 25.1 269.0 12.9 14.7 1.1 3.0 39.0 1.1 1.1 1.2 8.6 1.1 4.0 1.6 1.2 0.7 2.2 1.2 2.1 1.9 0.5 0.0 3.0 0.0 6.9 0.9 1.0 2.5 0.6 0.0 4.2 2.7 15.9 0.0 5.5 0.0 0.0 0.0 39.9 0.1 0.0 0.0 6.5 0.1 0.3 1.5 0.0 8.8 0.5 0.0 0.0 4.1 1.1 0.2 1.3 0.0 3.3 0.2 3.2 0.0 1.3 0.2 0.0 20.7 25.7 5.1 0.0 26.2 5.4 17.8 25.5 1.9 54.6 0.0 0.1 0.1 0.0 0.0 11.3 0.1 0.0 0.4 2.9 0.0 0.0 3.7 0.8 0.0 0.6 0.4 0.3 0.3 35.9 0.1 0.0 4.5 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043848-70226972 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 75.2" "Cell type enhanced" "Detected in many" "Early spermatids: 42.5;Excitatory neurons: 37.0;Fibroblasts: 38.7;Inhibitory neurons: 42.9;Leydig cells: 96.6;Microglial cells: 45.9;Peritubular cells: 82.0;Sertoli cells: 39.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 55.7;HHSteC: 57.2;LHCN-M2: 75.0;TIME: 71.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" NA NA "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (2.79e-3)" 15.5 8.3 1.1 1.2 1.2 0.2 15.8 0.8 2.2 30.6 2.5 36.5 8.5 75.2 19.3 21.4 59.0 13.1 12.3 1.0 2.5 2.6 1.2 37.5 0.5 0.8 1.2 0.8 49.5 3.7 1.8 0.8 4.4 1.0 7.8 12.4 5.7 9.9 11.0 6.7 9.2 21.8 25.6 1.1 16.2 19.2 7.6 2.1 1.6 8.1 17.3 3.1 32.6 18.7 1.2 0.3 0.0 0.7 0.0 55.7 18.8 1.7 11.1 5.0 2.7 4.6 0.0 1.2 0.0 0.7 2.1 1.5 9.1 0.1 0.8 2.3 0.0 0.0 0.0 15.6 0.1 57.2 0.0 0.0 3.6 0.7 1.7 0.9 19.9 4.9 0.0 0.0 0.5 75.0 0.0 0.0 0.1 7.7 0.1 0.0 0.0 8.8 7.3 24.6 0.0 0.7 0.0 0.1 0.1 0.0 20.8 0.0 0.0 71.0 0.0 1.8 0.1 2.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 1.2 0.8 2.2 1.0 2.5 0.8 1.2 0.8 1.0 1.1 2.1 1.2 2.0 0.0 1.5 20.2 0.5 6.1 0.5 0.4 0.6 0.8 0.5 10.8 4.3 0.0 0.1 3.7 4.2 0.2 0.2 0.2 0.0 0.1 42.5 0.7 13.7 3.9 0.0 0.0 37.0 0.2 6.6 38.7 0.5 0.5 1.3 0.3 0.4 0.0 3.3 0.0 42.9 0.1 0.0 0.0 17.5 11.4 96.6 13.6 10.6 45.9 0.0 13.8 0.0 11.6 23.3 0.4 0.2 82.0 0.0 0.1 0.0 0.5 0.1 0.5 39.5 4.8 22.4 0.4 0.4 1.1 4.8 0.3 0.8 0.1 0.1 0.1 PRSS37 ENSG00000165076 "Serine protease 37" A4D1T9 7 141836300-141841487 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 41.6" "Group enriched" "Detected in some" 138 "Early spermatids: 612.8;Late spermatids: 325.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA020541 Enhanced "Secreted in male reproductive system" NA NA "HPA020541: AB_1853004" "unprognostic (4.70e-2)" "unprognostic (5.56e-2)" "unprognostic (2.69e-1)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (1.30e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-2)" "unprognostic (8.30e-7)" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (2.72e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 41.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.2 0.0 0.3 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 612.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 325.7 2.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPA6 CPAH ENSG00000165078 "Carboxypeptidase A6" Q8N4T0 8 67422038-67746378 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.4;prostate: 2.8;retina: 2.2" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 31.7;Early spermatids: 21.7;Microglial cells: 12.2;Muller glia cells: 22.5;Pancreatic endocrine cells: 21.5;Paneth cells: 12.8;Prostatic glandular cells: 11.3;Urothelial cells: 36.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;EFO-21: 1.5;Hep G2: 3.4;OE19: 1.5" "Region enriched" "Detected in some" 9 "olfactory bulb: 12.6" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (2.85e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (2.58e-1)" "unprognostic (2.24e-1)" "unprognostic (2.08e-1)" "unprognostic (2.88e-1)" "unprognostic (9.35e-2)" "unprognostic (1.65e-1)" "unprognostic (5.23e-2)" "unprognostic (6.99e-2)" "unprognostic (3.57e-4)" "unprognostic (9.61e-5)" "unprognostic (1.75e-1)" "unprognostic (9.09e-2)" "unprognostic (1.41e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.4 2.2 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 31.7 0.0 5.7 0.2 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 21.7 0.1 0.0 0.1 2.4 0.0 1.6 0.4 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.7 1.3 2.2 0.0 0.0 0.0 3.2 1.8 0.2 0.0 12.2 0.1 22.5 0.0 3.0 1.3 21.5 12.8 0.0 0.0 11.3 0.0 0.0 0.0 1.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.6 0.0 5.7 36.6 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330955-68819023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.9;fallopian tube: 9.2;parathyroid gland: 7.4" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 396.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 2.7 0.3 8.9 0.2 6.3 0.5 0.7 4.4 4.8 2.1 2.0 0.2 0.2 0.6 0.6 1.0 9.2 0.6 0.6 7.1 7.9 0.3 0.2 2.5 0.2 6.4 6.6 2.8 0.4 1.1 7.4 1.7 0.3 5.5 2.1 0.3 1.0 0.6 1.0 0.3 0.9 0.2 0.1 5.8 0.2 0.8 0.7 4.4 0.8 0.4 0.9 0.2 0.4 0.2 6.6 0.1 0.0 0.3 0.1 0.6 1.0 0.1 0.9 2.3 0.3 0.3 0.1 0.2 0.1 0.3 0.5 0.1 0.1 0.1 0.3 0.1 0.0 2.3 0.3 0.5 0.2 0.1 0.0 0.2 0.1 0.3 0.4 0.8 0.1 0.0 0.3 0.1 0.4 2.7 0.3 0.0 0.2 1.0 0.0 0.0 0.1 2.7 0.0 0.2 0.2 0.5 0.0 0.1 0.1 0.0 0.2 1.4 0.1 0.0 0.4 0.2 1.6 0.0 0.4 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.5 0.2 0.1 0.4 0.1 0.1 8.9 6.3 4.4 4.8 7.1 7.9 6.4 6.6 2.8 5.5 5.8 4.4 6.6 0.2 16.0 18.7 9.4 0.0 1.7 0.8 0.2 0.0 1.5 0.2 0.0 1.2 0.0 3.9 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.5 26.4 0.7 0.5 0.0 0.0 79.2 0.0 0.3 1.9 0.0 4.3 1.3 0.1 0.0 0.0 0.3 0.0 396.6 0.1 0.0 0.0 1.2 1.3 0.3 0.4 1.8 3.7 0.1 0.0 0.0 9.5 10.1 0.5 0.0 0.4 0.0 0.8 0.0 0.0 20.8 0.7 0.0 0.6 1.7 0.6 0.4 0.1 0.9 0.4 0.4 0.2 0.0 0.4 TMC1 "DFNA36, DFNB11, DFNB7" ENSG00000165091 "Transmembrane channel like 1" Q8TDI8 9 72521608-72838297 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Transport" "Ion channel" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "cervix: 1.0" "Cell type enhanced" "Detected in some" "Astrocytes: 19.2;Early spermatids: 7.9;Endometrial stromal cells: 5.5;Microglial cells: 5.6;Urothelial cells: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HAP1: 5.2;NTERA-2: 1.9;SuSa: 1.0;U-266/70: 1.3;U-266/84: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.19e-3)" "unprognostic (3.97e-1)" "unprognostic (5.67e-4)" "unprognostic (1.63e-1)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (3.74e-1)" "unprognostic (3.94e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.5 0.5 1.0 0.1 0.0 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.4 0.5 0.7 0.0 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.5 0.4 0.5 0.6 0.5 0.3 0.5 0.5 0.4 0.8 1.3 0.0 0.0 19.2 0.0 0.3 2.9 0.1 0.6 0.2 0.1 0.1 0.4 0.0 0.0 1.8 0.0 4.0 0.1 0.4 0.0 0.2 7.9 1.4 5.5 1.2 0.0 0.0 1.5 0.6 2.8 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 2.6 0.3 0.1 0.0 5.6 0.6 1.1 0.0 1.5 1.3 0.5 2.2 0.0 0.0 3.1 0.0 3.0 0.0 0.0 0.0 0.3 0.2 1.8 3.1 0.5 0.0 2.6 0.1 0.5 0.0 6.8 ALDH1A1 "ALDH1, PUMB1, RALDH1" ENSG00000165092 "Aldehyde dehydrogenase 1 family member A1" P00352 9 72900671-73080442 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 1513.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7" "Cancer enhanced" "Detected in all" "liver cancer: 399.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "classical monocyte: 87.3" "Lineage enriched" "Detected in many" 33 "monocytes: 87.3" "Cell line enhanced" "Detected in many" "A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "midbrain: 378.3" "HPA002123, CAB020690" Enhanced Approved Enhanced Cytosol NA NA 58000000 Cytosol "CAB020690: , HPA002123: AB_1844722" "unprognostic (8.46e-3)" "prognostic favorable (7.77e-5)" "unprognostic (5.59e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-2)" "unprognostic (8.71e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (4.53e-2)" "unprognostic (6.83e-2)" "unprognostic (4.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.24e-3)" "unprognostic (2.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-3)" 110.4 184.2 56.7 28.7 75.8 32.0 64.9 128.3 74.7 119.2 43.9 180.4 554.6 140.7 588.5 41.7 185.9 177.0 35.8 67.1 65.5 338.6 1513.1 143.9 31.5 96.3 331.0 45.7 224.7 502.3 24.5 165.7 32.3 88.3 57.7 89.7 0.4 105.4 247.7 67.3 15.5 306.9 118.1 109.8 78.1 573.8 150.8 78.7 20.0 213.6 83.8 21.8 31.9 91.5 116.0 0.0 4019.8 0.4 0.0 22.4 0.2 1.4 139.6 0.0 0.1 0.1 136.2 0.0 0.1 50.5 0.0 0.3 2.6 0.0 0.2 0.1 0.4 0.1 232.1 0.6 1269.3 13.7 0.6 0.3 6.7 0.1 0.0 0.0 0.3 143.0 0.0 16.9 0.0 153.3 7.2 0.2 1.8 0.7 7.2 0.4 0.5 44.0 1.8 710.6 1.1 0.3 1.4 0.3 0.4 2.9 0.2 0.0 0.5 0.7 0.0 3.5 0.5 0.3 0.4 0.2 1.0 0.0 1.7 0.4 0.0 87.3 1.4 0.0 14.9 0.0 0.0 0.2 0.1 1.4 0.7 0.0 0.0 2.6 0.0 1.1 1.0 0.0 30.3 56.7 75.8 128.3 74.7 67.1 65.5 96.3 331.0 45.7 88.3 109.8 78.7 116.0 4.9 96.1 107.6 31.3 6.9 2.7 18.3 168.3 1.2 0.4 12.6 1.7 4.3 187.3 361.1 115.8 0.0 1.7 0.1 20.2 389.4 71.6 12.6 6.3 125.2 26.4 54.9 96.1 3.5 349.7 1.0 102.7 258.4 8.1 158.9 0.2 133.5 624.4 134.4 0.0 0.5 168.9 138.4 109.6 5.1 37.8 406.4 61.7 7.2 17.8 46.0 0.0 2.1 0.0 0.7 128.4 77.4 207.3 1.3 2.0 267.4 375.4 583.7 0.3 26.3 334.2 28.6 8.6 4.6 21.5 3.1 2.5 8.8 129.6 131.7 26.5 KDM1B "AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2" ENSG00000165097 "Lysine demethylase 1B" Q8NB78 6 18155329-18223854 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031269, HPA055597" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031269: AB_10601587, HPA055597: " "unprognostic (1.93e-1)" "unprognostic (7.53e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.57e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (5.57e-3)" "unprognostic (1.32e-2)" "unprognostic (8.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (3.17e-2)" "unprognostic (6.68e-2)" "unprognostic (3.02e-2)" "unprognostic (2.90e-1)" "unprognostic (7.36e-2)" "unprognostic (3.53e-1)" 6.0 7.7 5.9 11.5 7.7 27.5 6.4 5.6 7.9 6.8 7.4 14.2 8.1 5.8 3.7 9.1 13.5 6.1 6.8 6.8 6.4 7.9 7.4 8.9 10.5 6.5 6.7 6.0 6.7 5.9 3.3 5.9 4.6 6.5 5.2 12.3 12.2 5.8 4.7 17.5 11.2 8.9 6.9 5.7 10.6 5.7 15.9 6.0 10.9 27.5 9.2 9.5 7.8 8.2 9.8 15.1 9.7 11.2 23.0 13.8 20.5 24.5 11.7 12.6 7.5 10.2 16.3 7.4 34.1 31.6 19.2 22.8 15.5 17.8 20.8 16.0 31.6 14.6 17.2 8.6 15.0 6.7 25.5 17.5 10.3 23.4 21.5 17.7 12.1 7.7 15.9 38.3 5.2 12.7 12.6 14.1 10.5 3.8 31.6 12.8 26.8 20.3 24.4 10.7 19.8 34.2 10.6 9.7 23.5 22.9 11.7 22.3 20.3 6.5 16.9 9.5 11.9 15.5 5.2 15.9 20.0 6.4 18.9 37.8 1.2 4.6 7.2 0.5 8.6 0.3 1.2 0.5 0.5 3.7 1.3 0.5 0.2 4.9 0.3 6.9 1.6 0.7 1.3 5.9 7.7 5.6 7.9 6.8 6.4 6.5 6.7 6.0 6.5 5.7 6.0 9.8 4.9 0.0 8.2 14.7 8.7 12.7 5.7 3.8 7.4 5.0 7.6 6.6 10.4 11.5 10.4 1.8 10.4 2.7 3.0 23.0 1.9 6.6 0.7 36.2 10.0 4.2 6.7 3.8 19.0 4.3 5.1 5.8 8.2 15.5 2.5 3.3 4.2 7.7 7.5 5.0 10.8 9.6 10.2 36.7 11.7 0.7 3.7 20.6 7.2 22.5 27.7 6.6 8.2 16.1 23.8 7.2 21.2 6.8 3.7 5.4 6.2 11.2 21.0 15.5 0.0 6.9 6.2 0.7 18.2 9.7 15.9 1.4 5.6 3.1 10.6 6.6 HGSNAT "FLJ32731, HGNAT, TMEM76" ENSG00000165102 "Heparan-alpha-glucosaminide N-acetyltransferase" Q68CP4 8 43140464-43202855 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease variant, Mucopolysaccharidosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029578 Approved NA NA "HPA029578: AB_10602423" "unprognostic (5.35e-2)" "unprognostic (4.61e-2)" "unprognostic (4.31e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.94e-3)" "unprognostic (1.10e-1)" "unprognostic (6.54e-3)" "unprognostic (5.02e-2)" "prognostic favorable (6.33e-5)" "unprognostic (2.55e-2)" "unprognostic (5.48e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "unprognostic (1.55e-1)" "unprognostic (1.72e-1)" "unprognostic (3.45e-2)" 30.1 20.1 13.0 17.6 12.8 21.9 28.0 10.3 13.4 34.3 13.9 24.2 18.5 30.3 30.8 24.3 29.2 26.2 22.9 12.9 15.8 20.1 26.8 24.7 11.8 13.0 11.9 13.4 36.2 30.1 22.9 30.9 28.6 13.4 27.1 17.4 12.6 26.1 23.5 14.5 35.7 21.1 25.3 10.8 17.8 23.4 7.7 14.8 11.4 27.1 17.7 15.8 25.4 28.9 14.3 27.4 36.0 8.9 18.0 71.7 53.8 13.3 30.5 36.2 21.8 19.3 5.1 39.2 14.8 20.5 42.9 15.2 15.5 4.0 18.5 12.7 6.4 6.9 16.3 22.2 8.1 23.0 3.7 2.5 36.2 25.9 11.7 24.9 34.5 39.2 7.0 7.5 22.1 40.4 10.0 14.8 7.2 8.0 16.3 5.4 1.6 16.1 7.7 36.1 22.8 4.7 14.0 39.0 12.6 17.4 19.0 43.7 20.9 46.3 33.2 5.4 20.9 12.7 17.9 18.2 6.1 26.8 6.3 20.8 0.2 8.8 9.4 2.7 5.4 3.0 1.9 2.3 2.8 15.8 2.1 1.7 1.9 3.2 8.8 8.6 2.0 1.7 5.0 13.0 12.8 10.3 13.4 12.9 15.8 13.0 11.9 13.4 13.4 10.8 14.8 14.3 39.1 16.0 31.9 48.0 26.7 18.0 19.5 22.6 8.6 50.6 23.9 21.7 10.5 28.6 17.8 51.5 50.1 39.2 30.1 27.2 3.9 26.7 0.5 23.5 42.1 37.8 24.1 15.3 61.8 28.1 39.4 34.3 32.6 36.5 8.2 51.2 49.6 23.5 29.2 25.2 76.3 28.0 18.3 34.3 58.8 3.2 35.1 43.3 19.6 44.0 33.5 13.5 34.0 50.8 43.8 29.9 17.0 31.6 19.8 20.7 31.4 9.9 23.5 39.6 26.3 30.2 28.2 1.1 3.0 22.3 21.2 30.1 25.0 37.4 21.7 17.7 RASEF "FLJ31614, RAB45" ENSG00000165105 "RAS and EF-hand domain containing" Q8IZ41 9 82979590-83063177 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 41.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 53.2;RT4: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021431, HPA078596" Approved Uncertain Microtubules NA NA Microtubules "HPA021431: AB_1856087, HPA078596: " "unprognostic (1.22e-1)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-1)" "unprognostic (2.59e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-3)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (8.60e-2)" "unprognostic (1.66e-3)" "unprognostic (3.67e-1)" "unprognostic (1.41e-3)" "unprognostic (5.07e-2)" "unprognostic (6.05e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" 1.1 1.6 15.3 2.8 16.2 3.6 17.8 21.2 22.6 2.9 15.1 15.4 6.3 2.7 10.3 7.1 6.4 12.7 1.1 14.6 10.4 5.4 2.5 8.3 1.5 10.5 7.2 18.3 1.6 23.3 5.4 3.9 3.4 15.4 15.3 15.4 5.2 15.5 3.8 2.0 3.8 8.7 1.1 1.1 1.5 41.4 4.0 6.5 3.4 26.1 0.0 3.5 13.9 2.4 25.5 14.0 15.5 1.8 1.5 0.3 0.5 5.6 1.0 0.2 1.6 3.9 8.7 16.9 2.3 13.7 0.4 11.0 16.3 0.3 0.4 1.9 1.4 17.3 1.9 11.9 2.2 0.2 1.7 1.6 0.3 6.7 7.6 0.2 2.1 0.1 2.4 2.5 16.8 0.2 27.2 2.3 1.8 10.5 53.2 6.1 2.5 4.8 6.0 18.0 38.5 5.6 8.3 2.8 26.8 1.1 6.7 22.9 2.0 2.6 2.6 14.6 2.1 1.7 11.3 10.1 1.4 5.8 1.0 3.0 6.5 2.0 1.9 3.7 1.4 3.5 3.9 3.5 2.9 1.1 5.3 3.8 3.3 9.8 3.6 1.6 3.8 2.9 0.7 15.3 16.2 21.2 22.6 14.6 10.4 10.5 7.2 18.3 15.4 1.1 6.5 25.5 0.7 76.9 101.7 0.3 1.1 0.8 5.4 7.9 4.0 1.1 61.3 21.1 0.6 42.9 59.7 9.2 4.2 5.5 0.5 61.8 7.9 35.4 0.6 39.7 7.9 4.5 3.6 0.8 1.0 37.4 10.3 5.7 356.8 88.2 22.1 0.4 0.7 1.7 0.8 0.0 0.6 85.7 48.8 0.0 0.4 2.1 0.3 4.2 1.8 4.7 1.6 0.1 0.0 0.0 0.2 46.2 40.0 0.0 1.5 106.4 10.4 8.3 100.6 1.3 0.0 0.7 2.8 0.5 4.8 28.2 0.9 7.5 3.1 1.2 35.7 107.7 GKAP1 "FKSG21, GKAP42" ENSG00000165113 "G kinase anchoring protein 1" Q5VSY0 9 83739425-83829516 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 50.5;testis: 201.3" "Group enriched" "Detected in all" 6 "Early spermatids: 1339.6;Late spermatids: 481.5;Spermatocytes: 642.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035117, HPA035118, HPA066173" Enhanced Supported Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740" "unprognostic (1.91e-1)" "unprognostic (2.94e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (9.62e-2)" "unprognostic (2.50e-1)" "unprognostic (2.52e-3)" "unprognostic (7.66e-3)" "unprognostic (3.04e-1)" "unprognostic (1.86e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.18e-1)" "prognostic favorable (1.05e-6)" "unprognostic (9.73e-2)" "unprognostic (1.38e-2)" "unprognostic (2.06e-1)" "unprognostic (6.24e-3)" 7.9 6.4 21.3 2.7 20.4 4.0 6.2 27.5 23.7 7.3 24.8 9.4 4.4 8.9 6.7 3.8 8.3 5.0 13.8 19.0 20.6 6.7 9.5 4.2 4.0 21.3 19.8 16.9 13.0 8.5 10.3 12.6 2.4 21.5 8.9 3.6 22.7 5.2 9.1 50.5 2.0 5.4 6.2 20.5 4.1 7.7 201.3 21.0 9.2 10.0 26.7 3.9 7.9 4.7 26.0 7.2 8.4 6.0 8.0 0.8 0.0 9.0 2.6 2.1 4.1 4.2 1.1 3.7 10.8 2.7 1.2 13.7 1.4 6.0 0.7 7.0 13.2 5.6 6.4 4.1 6.2 8.7 2.9 0.6 0.2 4.8 2.1 2.2 11.9 3.8 10.2 5.3 8.6 1.2 6.6 16.1 9.8 5.1 3.3 4.9 10.9 13.7 3.7 4.3 1.1 20.3 11.9 6.0 2.7 4.8 9.2 1.2 5.8 1.3 1.4 10.0 0.9 4.7 14.6 34.5 4.3 3.0 2.0 1.6 1.2 0.2 0.2 0.5 0.0 0.5 0.7 0.5 0.5 0.2 0.6 0.3 0.7 1.1 2.0 0.1 0.1 0.6 0.0 21.3 20.4 27.5 23.7 19.0 20.6 21.3 19.8 16.9 21.5 20.5 21.0 26.0 14.2 6.4 11.2 32.0 17.9 7.0 14.7 2.7 2.8 54.1 21.1 17.3 51.7 20.0 2.6 14.7 45.9 8.8 13.1 5.4 13.7 13.4 1339.6 18.4 5.4 12.6 13.1 14.3 19.7 6.6 2.9 8.6 5.1 13.6 2.5 28.9 10.0 21.3 4.1 121.1 32.6 10.8 4.1 4.4 6.2 481.5 26.4 7.7 10.6 27.2 2.3 51.1 8.2 36.2 42.0 4.9 7.4 21.4 15.0 17.5 9.0 14.3 5.4 85.2 26.3 32.0 11.0 642.9 79.4 4.2 4.5 2.9 13.7 15.4 12.2 8.9 KIF27 DKFZp434D0917 ENSG00000165115 "Kinesin family member 27" Q86VH2 9 83834099-83921465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 20.4;testis: 26.5" "Cell type enhanced" "Detected in all" "Early spermatids: 181.2;Endometrial ciliated cells: 72.2;Late spermatids: 125.4;Spermatocytes: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.1" "Lineage enriched" "Detected in many" 9 "granulocytes: 16.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (9.75e-2)" "unprognostic (3.86e-2)" "unprognostic (1.46e-1)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (2.83e-3)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" "unprognostic (3.86e-3)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (2.55e-1)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (1.85e-1)" "unprognostic (2.01e-1)" 2.8 2.5 8.2 2.0 5.0 2.4 3.7 5.5 5.3 4.1 20.4 2.1 2.2 5.1 4.1 2.4 7.6 2.9 2.4 4.4 10.5 2.8 2.2 3.3 2.6 8.7 8.3 3.6 4.8 3.1 4.7 3.4 3.2 6.9 3.2 2.1 10.0 3.1 3.0 2.5 4.3 2.5 2.1 8.4 3.1 2.9 26.5 5.3 3.2 8.2 1.8 2.0 2.0 2.6 8.1 4.6 4.8 3.5 5.4 2.5 2.3 6.7 2.2 2.4 1.4 1.1 1.2 2.4 0.5 1.9 1.0 4.2 4.0 1.5 1.6 1.6 4.7 1.2 1.3 1.8 1.9 3.9 3.5 1.3 1.4 3.9 1.9 5.1 5.3 2.1 5.2 1.4 1.7 0.6 3.4 4.5 3.3 1.9 3.3 2.5 4.4 3.3 1.1 2.7 1.5 3.8 3.1 3.2 0.8 2.8 4.7 1.6 2.7 1.1 2.5 2.7 2.6 2.2 2.9 2.2 0.6 1.5 1.3 2.5 1.4 0.7 2.4 0.6 0.7 0.6 1.7 0.7 0.6 0.8 1.1 1.0 0.6 16.1 1.2 0.3 1.3 0.2 0.3 8.2 5.0 5.5 5.3 4.4 10.5 8.7 8.3 3.6 6.9 8.4 5.3 8.1 8.9 6.4 9.8 28.1 4.6 3.4 4.6 2.2 1.2 5.8 5.8 6.5 8.7 1.5 14.0 3.7 16.7 3.1 6.7 2.1 1.9 4.5 181.2 72.2 7.3 6.3 1.8 1.7 21.7 3.8 1.9 5.5 6.1 11.8 3.8 8.3 3.9 2.4 1.4 11.8 27.2 2.4 2.0 2.8 2.4 125.4 9.9 3.7 3.6 24.4 2.1 9.6 2.1 20.1 27.6 2.3 2.1 6.8 4.1 3.5 3.0 2.4 50.2 15.5 6.6 16.9 5.0 67.4 22.6 2.2 2.4 2.6 3.9 4.3 2.9 2.1 C9orf64 MGC10999 ENSG00000165118 "Chromosome 9 open reading frame 64" Q5T6V5 9 83938311-83956986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054903, HPA066190" Uncertain Approved "Golgi apparatus" NA NA 9400 "Golgi apparatus" "HPA054903: AB_2682636, HPA066190: AB_2685633" "unprognostic (2.07e-1)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (1.04e-1)" "unprognostic (4.00e-3)" "unprognostic (2.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.49e-2)" "unprognostic (3.89e-1)" "unprognostic (1.63e-2)" "unprognostic (8.48e-3)" 8.1 9.2 4.9 8.5 5.5 2.3 8.0 5.3 5.6 9.0 10.3 7.9 23.8 10.3 11.4 5.9 11.5 6.3 8.5 4.7 6.1 13.6 24.7 8.9 8.5 5.8 5.6 4.5 11.0 6.1 14.1 4.7 8.1 5.6 8.9 8.3 5.6 6.7 8.7 7.8 4.4 22.3 10.5 5.4 6.7 9.8 8.3 5.6 10.1 16.2 7.2 8.2 7.8 4.9 6.8 23.4 19.7 0.3 0.1 9.9 13.4 23.7 15.0 4.3 14.2 15.8 17.9 20.5 0.1 12.5 16.9 5.7 14.2 0.0 0.5 18.4 25.2 13.1 10.4 25.6 34.9 22.8 0.0 30.1 15.4 19.8 13.6 0.0 3.2 9.3 0.1 25.3 0.3 17.4 23.0 4.9 0.8 18.7 14.8 9.6 0.1 29.9 1.1 11.4 3.7 19.2 18.9 27.0 6.4 21.1 0.3 8.4 20.1 2.9 1.7 20.0 31.7 4.4 6.3 0.3 0.9 13.1 0.8 10.2 7.0 10.4 9.8 6.5 11.8 6.2 2.4 4.9 6.6 11.9 3.3 5.3 6.3 4.2 12.6 12.9 8.3 5.8 4.6 4.9 5.5 5.3 5.6 4.7 6.1 5.8 5.6 4.5 5.6 5.4 5.6 6.8 6.5 12.8 10.8 2.0 3.6 2.2 4.5 5.2 4.0 4.3 5.5 4.2 5.4 4.3 3.3 3.7 4.2 12.7 4.1 6.2 11.7 11.6 6.7 11.1 9.0 5.4 4.2 3.4 2.6 8.7 19.4 8.5 8.6 8.4 9.5 6.0 4.6 24.7 12.3 3.3 2.9 7.2 14.2 12.8 4.6 2.9 8.1 8.7 1.8 1.9 13.2 11.9 7.2 3.0 3.8 10.6 10.4 10.9 3.6 3.7 22.1 17.3 6.5 7.3 0.0 11.3 6.7 9.6 5.5 3.7 1.4 4.4 4.2 10.7 10.5 3.0 HNRNPK "CSBP, HNRPK, TUNP" ENSG00000165119 "Heterogeneous nuclear ribonucleoprotein K" P61978 9 83968083-83980616 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004435, HPA007644, CAB016225, HPA044105" Supported Enhanced Nucleoplasm NA NA 7100000 Nucleoplasm "CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812" "unprognostic (4.84e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (8.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.83e-3)" "prognostic unfavorable (6.68e-5)" "unprognostic (3.46e-3)" "unprognostic (8.11e-2)" "unprognostic (1.47e-1)" "unprognostic (8.85e-3)" "unprognostic (2.81e-2)" "unprognostic (2.76e-3)" "unprognostic (2.23e-3)" "unprognostic (6.50e-2)" "unprognostic (4.59e-1)" "unprognostic (2.82e-1)" 286.2 311.0 193.9 329.2 202.8 642.9 268.0 208.1 238.6 266.7 233.2 272.7 289.6 299.8 229.3 279.3 272.0 245.9 278.4 192.5 264.2 281.8 349.7 242.5 405.2 209.2 205.0 187.7 320.4 249.5 353.6 199.7 328.6 207.6 253.6 280.2 345.2 244.3 253.7 317.9 258.2 285.2 290.1 205.6 300.8 252.3 185.0 200.7 553.5 299.9 315.7 427.2 354.5 232.6 246.1 926.1 624.2 1048.4 625.7 492.2 540.7 840.0 634.1 785.0 778.2 726.4 527.0 641.2 1087.2 425.8 671.1 673.8 689.5 1061.5 772.9 941.8 753.7 624.2 765.1 511.9 754.6 648.7 958.6 726.5 554.6 577.4 665.6 876.1 583.7 806.1 605.5 792.8 541.4 776.4 809.0 1198.4 652.1 934.7 929.3 599.3 1030.2 835.0 727.6 760.3 747.6 677.1 802.6 669.6 703.8 645.5 721.8 698.6 801.6 665.8 537.9 631.7 552.7 844.2 564.7 795.5 784.6 514.3 762.6 779.5 582.0 438.9 559.2 302.2 419.8 378.9 347.8 346.6 348.7 457.5 324.4 354.8 327.2 546.1 477.9 429.1 270.8 457.4 1012.5 193.9 202.8 208.1 238.6 192.5 264.2 209.2 205.0 187.7 207.6 205.6 200.7 246.1 354.7 205.1 270.0 58.4 398.4 506.0 540.7 421.5 313.0 180.9 281.6 203.3 195.0 230.2 322.4 263.0 89.6 585.3 379.9 288.1 395.2 448.2 43.4 326.2 329.0 331.7 387.0 447.9 45.9 368.3 738.5 323.4 233.9 384.2 336.8 300.0 260.9 356.6 388.4 156.5 51.2 379.2 307.2 352.9 412.9 45.4 334.6 333.4 327.3 58.1 448.9 362.5 338.8 71.9 116.2 397.0 282.7 321.2 281.0 353.3 260.0 416.7 308.1 182.6 276.1 340.9 479.7 345.9 241.7 309.5 448.7 728.5 368.6 334.9 406.9 453.2 SSMEM1 "C7orf45, FLJ40316" ENSG00000165120 "Serine rich single-pass membrane protein 1" Q8WWF3 7 130206344-130216844 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 159 "testis: 32.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 474.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.08e-1)" "unprognostic (1.79e-1)" "unprognostic (5.24e-1)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 474.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 54.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.2 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SVEP1 "bA427L11.3, C9orf13, FLJ13529, POLYDOM" ENSG00000165124 "Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" Q4LDE5 9 110365248-110579880 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 38.8;placenta: 62.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 92.8;Inhibitory neurons: 50.3;Leydig cells: 42.0;Oligodendrocytes: 140.5;Syncytiotrophoblasts: 67.3;Theca cells: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "ASC diff: 147.1;ASC TERT1: 84.7;BJ hTERT+: 62.3;HHSteC: 53.8;HSkMC: 66.7" "Region enhanced" "Detected in some" "cerebellum: 2.8" "Region enriched" "Detected in all" 5 "cerebellum: 20.8" "HPA020610, HPA021520" Enhanced "Intracellular and membrane" NA NA 160000000 "HPA020610: AB_2197021, HPA021520: AB_1855533" "unprognostic (4.47e-2)" "unprognostic (6.01e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.62e-2)" "unprognostic (9.13e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (3.31e-3)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (9.84e-2)" "unprognostic (2.21e-1)" "unprognostic (1.55e-3)" 38.8 4.2 0.8 2.5 6.1 0.0 23.4 7.8 3.4 10.0 1.1 9.0 1.2 8.7 5.6 3.5 12.5 6.3 5.5 0.6 2.8 3.9 2.9 19.8 3.8 2.5 4.7 0.3 3.9 4.8 5.4 0.8 62.3 6.0 1.7 5.2 0.0 4.1 2.1 4.4 9.3 8.7 9.6 0.4 5.2 7.8 1.0 3.3 1.8 7.4 5.6 2.5 9.7 12.2 2.8 0.0 0.1 1.2 0.0 147.1 84.7 0.0 16.3 62.3 1.2 1.9 1.5 0.0 0.0 0.0 3.9 0.1 0.0 0.0 12.2 1.0 0.0 0.3 0.1 1.4 0.0 53.8 0.0 2.9 66.7 0.0 12.1 3.2 1.4 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.2 7.5 2.0 0.0 10.6 0.0 0.0 0.0 2.3 0.0 1.0 0.0 1.3 2.5 0.0 7.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.1 7.8 3.4 0.6 2.8 2.5 4.7 0.3 6.0 0.4 3.3 2.8 7.4 0.0 0.5 2.9 0.1 5.7 0.6 0.5 1.2 0.5 0.4 0.9 1.8 5.7 0.1 0.0 0.0 12.2 0.3 0.0 0.0 0.9 0.3 0.5 13.8 2.0 0.0 0.0 16.9 0.2 1.6 92.8 4.1 0.3 0.0 0.0 2.2 0.0 3.0 0.0 50.3 0.0 0.0 0.0 8.2 0.6 42.0 0.6 7.2 13.1 0.0 0.0 0.0 3.0 140.5 0.0 1.2 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 3.5 7.8 0.4 1.5 0.4 3.3 67.3 1.2 34.1 0.2 0.2 TRPV6 "CaT1, ECAC2" ENSG00000165125 "Transient receptor potential cation channel subfamily V member 6" Q9H1D0 7 142871208-142885745 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 38.6;prostate: 23.7;salivary gland: 69.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 18.6;Collecting duct cells: 27.6;Cytotrophoblasts: 17.0;Ductal cells: 80.1;Early spermatids: 25.9;Late spermatids: 37.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 16.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.6;HaCaT: 18.0;RT4: 30.7;SK-BR-3: 23.5;T-47d: 52.8" "Low region specificity" "Detected in single" HPA062864 Approved NA NA "HPA062864: AB_2684885" "unprognostic (9.85e-2)" "unprognostic (1.60e-2)" "unprognostic (6.29e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (5.43e-2)" "unprognostic (3.50e-1)" "unprognostic (4.56e-2)" "unprognostic (3.89e-2)" "unprognostic (3.27e-2)" "unprognostic (8.49e-2)" "unprognostic (9.39e-3)" "unprognostic (1.69e-1)" "unprognostic (7.17e-3)" "unprognostic (3.53e-2)" 0.0 0.0 0.8 0.0 0.9 0.1 4.3 0.8 1.0 0.5 0.9 0.1 8.2 0.1 0.3 2.8 0.2 8.3 0.0 0.8 0.8 4.9 0.9 0.2 0.0 0.9 0.9 0.8 0.0 38.6 1.5 0.5 12.0 1.0 23.7 0.0 0.0 69.9 1.6 0.0 5.8 2.2 0.0 0.9 0.0 4.5 1.2 0.9 0.0 1.8 0.0 0.2 0.4 1.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 1.9 0.1 0.0 23.5 0.6 0.9 52.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.8 1.0 0.8 0.8 0.9 0.9 0.8 1.0 0.9 0.9 0.9 0.0 3.2 0.0 0.0 0.0 0.5 1.1 0.2 5.2 0.6 2.4 2.0 1.9 18.6 1.4 27.6 0.0 17.0 0.1 0.1 0.0 80.1 25.9 0.7 0.2 0.2 0.0 0.0 0.1 3.3 0.8 0.2 3.6 1.6 0.0 0.0 0.4 0.0 1.6 3.3 0.1 0.3 0.0 0.0 0.0 37.3 0.9 0.2 0.0 0.0 2.0 0.7 0.0 0.0 6.8 8.9 0.1 0.0 0.0 10.6 0.1 0.3 0.7 0.2 0.0 1.0 0.3 0.3 0.4 4.3 1.8 6.0 0.0 0.0 0.2 3.1 LLCFC1 "C7orf34, CTM-1" ENSG00000165131 "LLLL and CFNLAS motif containing 1" Q96L11 7 142939343-142940868 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 66.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (5.05e-2)" "unprognostic (9.94e-2)" "unprognostic (5.49e-3)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.85e-3)" "unprognostic (3.54e-1)" "unprognostic (2.02e-1)" 0.0 0.0 1.0 0.0 2.6 1.6 0.1 1.5 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.4 0.2 0.0 0.2 0.2 4.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 3.2 1.1 0.0 66.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 2.6 1.5 1.9 0.2 1.4 4.7 2.8 0.0 4.4 3.2 2.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 52.8;Inhibitory neurons: 48.6;Oligodendrocytes: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.5 4.9 9.2 3.3 9.4 1.5 4.7 14.4 10.2 9.4 7.8 9.4 4.2 8.9 4.9 8.8 10.3 3.3 3.6 8.8 8.4 8.1 2.7 6.7 2.4 12.6 9.9 7.4 10.4 12.9 5.5 4.9 2.0 13.7 5.5 4.9 2.3 5.4 2.3 3.7 4.9 7.8 4.9 8.6 3.3 11.6 5.7 9.9 2.7 13.7 1.0 2.9 8.8 5.3 10.9 8.2 12.3 10.9 19.3 9.0 7.3 7.4 5.9 10.0 6.5 7.7 6.7 5.8 15.2 4.4 8.4 9.2 23.9 8.1 9.9 3.4 21.2 8.3 3.6 7.7 2.9 8.8 2.0 2.3 8.9 12.0 8.7 8.9 7.9 7.4 13.8 26.0 3.5 5.0 13.5 0.9 3.9 17.3 36.3 12.2 10.2 26.8 1.2 11.7 5.1 7.1 8.1 2.5 14.2 6.7 8.8 0.0 4.1 7.6 6.5 7.2 18.4 5.8 6.8 12.1 2.4 9.4 6.8 9.8 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 9.2 9.4 14.4 10.2 8.8 8.4 12.6 9.9 7.4 13.7 8.6 9.9 10.9 3.5 6.4 10.5 16.0 2.4 1.8 0.9 8.2 5.2 12.0 1.5 2.2 4.4 10.0 7.7 12.9 8.4 3.1 1.5 5.1 3.9 4.2 3.0 3.7 5.3 3.2 4.9 0.8 52.8 8.9 2.7 4.9 7.7 3.9 1.3 6.2 1.8 1.7 1.9 0.0 48.6 7.1 0.0 1.3 0.9 5.8 2.8 0.9 0.0 9.4 0.7 1.9 2.1 14.1 54.2 9.3 3.1 4.5 1.4 3.9 4.8 5.9 11.1 0.8 0.0 2.7 3.2 3.8 5.9 5.6 1.1 1.1 2.4 6.2 10.4 2.9 FBP1 FBP ENSG00000165140 "Fructose-bisphosphatase 1" P09467 9 94603133-94640249 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 327.4;kidney: 300.6;liver: 900.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 404.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005857, HPA012513, CAB033869" Enhanced Approved Mitochondria NA NA 21000000 Mitochondria "CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (1.40e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.13e-2)" "unprognostic (1.37e-1)" "prognostic favorable (1.79e-4)" "unprognostic (6.94e-3)" "unprognostic (4.52e-2)" "unprognostic (7.79e-2)" "unprognostic (7.59e-2)" "unprognostic (1.12e-1)" "prognostic favorable (6.86e-7)" "unprognostic (6.91e-2)" "unprognostic (3.22e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.64e-5)" 13.1 27.6 1.9 12.8 2.4 15.1 41.8 2.2 5.7 20.1 3.0 30.1 327.4 3.6 15.9 2.8 7.1 34.7 2.0 1.8 4.6 300.6 900.5 167.4 6.9 3.1 2.7 1.6 1.1 41.8 108.7 8.7 3.0 3.0 26.1 30.8 0.7 53.7 29.2 1.3 5.9 260.2 8.9 2.8 12.3 86.3 2.5 3.0 2.3 16.9 1.0 7.8 71.4 6.8 3.5 0.5 0.1 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.6 3.8 0.0 0.3 0.8 0.1 75.2 0.1 0.0 0.1 0.0 0.3 0.6 2.9 1.3 0.0 1.5 18.8 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.2 243.4 0.1 4.4 1.1 54.5 9.5 0.0 0.9 1.9 0.0 157.0 0.7 5.6 0.6 44.5 0.0 0.9 26.7 7.7 0.2 0.1 1.0 0.8 0.0 0.3 1.1 170.4 0.0 1.4 0.1 63.3 68.4 404.3 7.9 162.3 11.7 3.0 4.6 4.6 90.1 3.2 16.2 8.3 12.1 15.4 90.7 32.1 2.3 33.1 1.9 2.4 2.2 5.7 1.8 4.6 3.1 2.7 1.6 3.0 2.8 3.0 3.5 2.8 76.9 182.8 0.0 10.3 0.8 8.9 0.7 0.0 0.1 62.4 24.3 0.7 102.9 41.0 62.5 0.0 11.1 14.8 26.1 111.6 21.5 0.1 4.0 0.4 4.8 31.9 24.4 0.9 62.7 1.7 5.4 102.4 5.2 47.4 16.0 12.1 500.4 177.6 0.0 0.8 61.4 0.0 79.9 32.1 1.5 1.5 238.6 12.4 1.9 20.1 2.6 8.2 0.5 0.3 24.0 77.6 4.1 18.3 11.9 1095.0 864.1 9.1 0.2 6.6 0.6 2.0 0.6 1.3 0.8 1.0 10.1 12.1 0.5 90.4 68.1 PGAP4 "C9orf125, MGC12992, TMEM246" ENSG00000165152 "Post-GPI attachment to proteins GalNAc transferase 4" Q9BRR3 9 101473170-101533537 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 16 "Cardiomyocytes: 52.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 25.5;hTERT-RPE1: 28.8;OE19: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011318, HPA054041" Uncertain Approved Mitochondria NA Yes Mitochondria "HPA011318: AB_2668482, HPA054041: AB_2682353" "unprognostic (2.58e-2)" "unprognostic (4.76e-2)" "unprognostic (5.52e-1)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (9.15e-2)" "unprognostic (1.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (3.51e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.62e-1)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (9.16e-2)" 3.4 10.4 19.7 2.2 23.1 0.5 2.5 20.7 27.5 16.7 5.4 13.5 8.5 7.2 3.7 14.5 13.8 6.9 30.7 23.9 25.8 4.3 2.4 5.5 0.5 18.9 18.9 23.7 19.7 11.2 16.7 12.4 0.6 23.4 6.9 11.3 10.0 6.2 9.4 4.9 12.1 7.7 6.8 8.6 1.6 16.2 2.8 26.5 0.9 4.2 6.1 2.5 6.5 11.9 31.8 0.0 14.6 11.3 0.0 0.3 0.2 0.0 9.8 14.1 7.0 13.8 0.7 7.8 0.0 3.2 17.9 0.8 23.1 0.0 16.1 4.2 0.0 5.8 8.1 10.3 0.0 0.5 0.0 0.0 6.2 25.5 0.0 3.8 28.8 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 14.0 48.1 0.0 0.0 5.7 0.0 10.5 2.7 18.9 17.8 5.5 0.0 0.0 2.7 0.0 13.8 0.0 10.7 6.6 0.0 0.0 1.0 0.0 0.0 15.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 23.1 20.7 27.5 23.9 25.8 18.9 18.9 23.7 23.4 8.6 26.5 31.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZHX1 ENSG00000165156 "Zinc fingers and homeoboxes 1" Q9UKY1 8 123248451-123275541 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 146.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055357 Supported Nucleoplasm No No Nucleoplasm "HPA055357: AB_2682793" "unprognostic (4.36e-3)" "unprognostic (6.73e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (8.73e-3)" "unprognostic (5.61e-2)" "unprognostic (9.22e-2)" "unprognostic (1.51e-1)" "unprognostic (2.01e-1)" "unprognostic (6.00e-2)" "unprognostic (7.97e-2)" "unprognostic (1.44e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (1.76e-2)" 28.4 15.0 26.1 12.2 25.5 13.7 18.9 29.5 28.4 21.0 23.4 15.7 18.6 17.5 15.3 37.3 18.7 15.2 15.4 25.5 39.4 23.1 39.8 14.5 12.7 27.8 28.9 20.9 21.0 17.3 23.0 12.8 14.5 28.1 18.1 14.9 35.3 17.6 18.8 15.6 28.1 19.4 19.4 26.1 15.9 14.9 10.2 28.2 20.0 38.0 19.6 15.1 20.0 18.0 31.8 29.7 13.2 18.0 21.3 34.3 28.3 11.6 35.3 19.6 25.6 29.6 23.5 12.4 44.7 46.1 42.8 11.4 19.6 51.3 32.5 32.4 89.5 26.5 72.6 29.1 14.2 23.3 26.9 33.3 21.4 36.9 35.1 30.0 21.9 20.5 21.2 86.0 34.1 38.3 89.7 62.0 12.1 4.8 62.1 27.7 31.3 16.2 32.0 22.9 66.0 86.3 32.1 40.3 113.6 14.1 10.5 45.4 30.6 19.3 40.1 53.4 32.6 23.8 32.1 95.1 49.6 27.2 49.7 11.2 1.5 3.6 3.6 3.8 6.4 4.8 3.3 4.8 3.5 4.9 3.9 4.5 4.8 1.3 6.5 14.0 2.7 5.7 2.9 26.1 25.5 29.5 28.4 25.5 39.4 27.8 28.9 20.9 28.1 26.1 28.2 31.8 35.0 25.6 25.7 0.0 15.7 37.1 28.0 19.7 47.3 46.3 28.8 27.1 30.7 25.8 26.8 20.2 47.9 10.4 22.8 33.5 31.3 16.6 10.9 13.0 52.5 30.8 43.3 19.8 0.0 22.3 6.6 33.0 19.4 13.8 28.5 19.1 28.9 71.5 15.0 146.4 0.0 23.1 14.2 24.2 19.0 21.7 46.6 19.4 26.6 0.0 20.5 46.3 27.8 0.0 0.0 16.7 25.8 64.3 15.3 21.2 35.8 33.2 21.4 34.3 39.5 34.4 38.0 38.5 27.6 84.4 62.5 9.6 20.0 27.0 22.8 29.2 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385317 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.6;choroid plexus: 6.1;fallopian tube: 4.8" "Cell type enhanced" "Detected in some" "Astrocytes: 45.4;Endometrial ciliated cells: 66.2;Respiratory ciliated cells: 20.4;Rod photoreceptor cells: 14.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 1.6;U-266/70: 3.0" "HPA044633, HPA054859" Uncertain NA NA "HPA044633: AB_10960684, HPA054859: AB_2682627" "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.0 0.0 6.8 0.0 2.4 0.0 0.0 2.1 1.3 0.2 6.1 0.0 0.0 0.1 0.4 0.0 4.8 0.0 0.0 1.5 6.5 0.0 0.1 0.5 0.0 7.6 4.7 0.4 0.0 0.0 0.4 1.8 0.0 4.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.7 2.8 0.0 0.3 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 2.4 2.1 1.3 1.5 6.5 7.6 4.7 0.4 4.1 5.7 2.8 5.6 0.1 0.0 0.0 45.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 2.5 1.8 8.4 0.2 0.0 0.0 0.0 0.0 6.0 66.2 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 2.1 0.3 0.1 0.0 1.9 0.0 0.6 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 20.4 14.7 0.0 0.0 0.1 2.2 4.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 CYBB "CGD, GP91-PHOX, NOX2" ENSG00000165168 "Cytochrome b-245 beta chain" P04839 X 37780059-37813461 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 162.4;lymphoid tissue: 160.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 276.3;intermediate monocyte: 261.6" "Group enriched" "Detected in many" 4 "dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3" "Group enriched" "Detected in some" 5 "Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051227 Enhanced NA NA "HPA051227: AB_2681395" "unprognostic (5.83e-2)" "unprognostic (1.77e-2)" "unprognostic (2.15e-3)" "unprognostic (1.48e-2)" "unprognostic (1.27e-1)" "unprognostic (5.65e-2)" "unprognostic (2.29e-2)" "unprognostic (4.45e-2)" "unprognostic (9.14e-2)" "unprognostic (2.32e-2)" "unprognostic (5.73e-2)" "unprognostic (5.18e-2)" "unprognostic (5.92e-2)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (1.32e-1)" "unprognostic (9.72e-2)" 40.9 28.7 4.9 160.3 8.3 162.4 15.4 6.9 7.4 12.4 16.2 22.5 19.5 9.4 4.3 9.0 10.0 26.4 8.1 4.3 17.0 8.1 27.7 92.3 97.9 15.1 8.1 3.0 6.9 4.1 4.5 2.5 55.1 12.3 6.7 30.9 1.8 7.0 9.8 3.8 2.2 22.5 56.0 14.7 89.8 17.3 4.8 12.1 18.5 5.4 5.6 73.8 47.2 2.3 18.1 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 52.8 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.4 3.6 0.6 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.1 64.2 0.2 0.0 0.3 54.6 0.0 210.4 0.0 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.1 20.0 0.0 0.0 0.1 0.1 0.2 0.6 1.6 3.4 0.0 8.9 0.0 2.2 276.3 110.5 0.4 261.6 0.5 39.6 0.3 0.4 62.8 32.8 0.3 0.2 19.2 0.6 237.1 90.9 0.9 162.5 4.9 8.3 6.9 7.4 4.3 17.0 15.1 8.1 3.0 12.3 14.7 12.1 18.1 2.4 25.6 25.4 0.7 99.9 1.0 0.1 0.0 0.6 0.1 1.0 3.0 11.0 2.8 13.0 1.8 0.0 0.9 82.7 2.0 0.0 0.0 0.6 0.2 0.1 8.1 0.0 5.2 1.6 0.4 1.1 4.4 4.1 0.1 7.6 0.1 5.0 3.2 157.2 1.7 1.6 0.7 0.0 456.0 25.0 0.7 0.6 469.3 1.8 76.8 396.6 0.1 14.4 0.0 0.1 0.1 0.5 0.0 13.6 0.0 0.6 0.5 7.3 0.7 13.1 1.6 1.2 0.0 0.6 1.9 1.3 1.8 7.5 0.0 1.3 0.1 DYNLT3 "TCTE1L, TCTEX1L" ENSG00000165169 "Dynein light chain Tctex-type 3" P51808 X 37836757-37847571 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 738.3;Glandular and luminal cells: 265.2;Late spermatids: 445.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003938 Approved NA NA "HPA003938: AB_1847920" "unprognostic (1.27e-1)" "unprognostic (5.14e-2)" "unprognostic (1.00e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (1.13e-1)" "unprognostic (5.15e-3)" "unprognostic (6.91e-2)" "unprognostic (2.72e-1)" "unprognostic (2.37e-1)" "unprognostic (3.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.65e-3)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (2.72e-1)" "unprognostic (2.69e-2)" 29.2 61.4 29.4 17.8 32.0 27.3 24.6 30.4 34.4 33.5 28.2 21.7 12.3 33.1 25.7 64.2 18.9 37.8 32.3 34.1 41.6 50.8 45.2 24.9 14.8 37.2 36.0 29.8 23.2 14.0 40.6 23.6 26.6 42.8 27.4 22.4 33.4 19.4 28.0 12.7 11.5 15.0 37.6 31.1 18.5 23.7 17.0 37.9 15.0 26.7 18.4 22.1 33.1 31.0 41.9 48.2 13.9 1.4 0.1 58.1 67.0 7.5 32.0 35.0 17.7 29.2 25.8 25.2 16.9 15.5 65.5 51.2 18.9 20.1 27.5 34.8 28.7 23.4 13.4 66.0 13.6 29.1 0.0 9.5 29.3 38.4 43.2 19.1 53.0 55.3 0.0 6.9 23.9 82.5 15.7 0.4 20.8 8.1 24.7 69.2 24.0 0.1 27.9 32.4 34.7 30.8 13.1 58.9 12.0 97.7 2.8 14.7 14.3 29.8 36.7 19.9 43.0 36.7 15.9 15.4 19.7 88.8 22.0 46.4 20.6 9.5 7.3 17.2 14.0 35.9 17.5 24.0 22.9 6.3 12.3 20.5 20.2 7.6 16.5 8.7 7.3 14.7 14.7 29.4 32.0 30.4 34.4 34.1 41.6 37.2 36.0 29.8 42.8 31.1 37.9 41.9 62.0 38.5 28.9 6.2 37.8 15.4 121.8 48.7 10.8 28.2 38.9 20.8 31.8 25.8 46.8 64.4 2.1 12.5 31.9 26.0 133.1 53.8 738.3 80.4 75.6 47.4 55.7 8.6 22.9 46.9 29.1 64.7 42.8 265.2 87.6 15.4 42.8 34.0 38.2 70.7 24.8 18.4 85.5 31.5 80.0 445.7 44.1 42.5 42.7 12.2 49.0 57.2 28.8 7.1 7.6 102.1 28.0 103.4 22.9 116.7 20.2 143.6 53.0 50.8 39.5 53.2 81.6 13.1 5.8 74.7 22.7 45.4 68.0 27.4 17.7 118.8 METTL27 WBSCR27 ENSG00000165171 "Methyltransferase like 27" Q8N6F8 7 73834590-73842516 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Collecting duct cells: 20.2;Distal tubular cells: 29.4;Ductal cells: 16.5;Endometrial ciliated cells: 66.7;Proximal tubular cells: 68.8;Respiratory ciliated cells: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.7;RPMI-8226: 82.2;T-47d: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA074662 Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA074662: " "unprognostic (6.70e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.38e-2)" "unprognostic (2.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (1.20e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.86e-1)" "unprognostic (2.15e-2)" "unprognostic (6.49e-2)" "unprognostic (1.24e-2)" 2.4 1.5 1.4 0.4 1.1 0.2 2.9 3.0 2.2 5.5 6.6 2.3 1.9 4.1 1.1 1.6 7.3 2.0 0.7 1.4 2.1 7.9 2.0 2.6 1.2 2.1 2.0 1.0 2.7 9.0 6.8 3.1 2.0 2.4 5.3 0.7 0.4 5.2 3.3 0.6 1.8 2.7 0.7 1.4 3.1 1.5 5.2 1.5 1.0 4.0 0.1 0.3 2.5 2.8 2.9 12.8 15.5 0.1 1.2 2.3 6.6 2.5 0.1 0.2 0.5 0.4 0.8 18.7 3.1 2.8 2.6 10.7 1.2 0.0 5.0 0.2 2.1 0.1 0.1 4.7 4.8 2.6 0.0 0.1 2.6 1.1 7.8 3.8 0.8 2.9 1.0 0.3 2.6 1.8 3.6 0.1 0.0 0.3 10.2 4.0 0.9 3.4 82.2 4.1 2.4 1.3 0.5 1.7 1.3 1.4 3.5 23.0 0.7 3.4 4.9 1.2 9.4 5.1 3.5 1.3 0.0 1.0 0.1 1.5 0.0 0.6 1.3 0.0 2.2 0.0 2.1 0.3 0.0 0.9 0.6 0.7 0.5 0.6 0.0 0.5 0.7 6.3 0.2 1.4 1.1 3.0 2.2 1.4 2.1 2.1 2.0 1.0 2.4 1.4 1.5 2.9 3.8 6.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.3 0.0 0.0 2.5 20.2 0.0 5.4 0.5 0.0 29.4 16.5 0.0 66.7 5.2 1.2 0.0 0.0 0.0 2.3 2.2 2.2 0.0 6.1 2.5 0.7 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 68.8 30.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.4 0.9 0.2 0.0 0.0 MID1IP1 "FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL" ENSG00000165175 "MID1 interacting protein 1" Q9NPA3 X 38801432-38806537 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 188.8;skeletal muscle: 151.6" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 217.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 15.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038816 Uncertain NA NA "HPA038816: AB_10670908" "unprognostic (5.35e-2)" "unprognostic (1.75e-1)" "unprognostic (1.24e-1)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.62e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-2)" "unprognostic (2.88e-1)" "unprognostic (2.31e-3)" "prognostic favorable (1.15e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (1.18e-2)" "prognostic favorable (8.06e-4)" 37.9 34.4 104.8 14.0 130.6 104.5 34.8 106.6 90.9 20.1 50.5 38.7 17.1 18.5 7.0 35.8 31.1 7.6 33.5 77.1 96.9 24.8 56.6 44.0 11.2 110.6 120.6 68.7 33.7 79.3 4.0 15.6 8.8 188.8 23.2 5.1 3.4 25.2 13.5 151.6 27.8 25.4 9.4 103.0 12.4 50.1 23.1 129.2 9.2 13.9 26.1 6.2 35.8 24.5 126.6 60.3 55.2 14.3 10.9 67.9 31.8 15.4 33.2 23.2 7.1 13.5 18.5 44.3 57.7 28.4 10.7 6.0 55.3 47.7 39.4 4.7 39.9 18.7 49.4 48.7 14.9 51.6 23.1 36.7 46.4 31.1 27.7 24.2 19.1 7.2 68.9 46.5 60.7 10.1 50.4 40.8 64.3 49.5 17.6 95.9 111.2 17.6 116.4 18.5 29.8 34.0 41.3 17.6 34.0 90.9 28.2 28.0 70.5 10.0 20.2 22.4 25.5 24.6 155.5 65.0 53.6 61.1 37.4 22.3 3.8 1.9 15.7 0.9 1.3 1.0 0.5 1.4 1.0 1.3 0.7 1.2 1.2 8.0 0.8 2.0 1.3 0.5 0.9 104.8 130.6 106.6 90.9 77.1 96.9 110.6 120.6 68.7 188.8 103.0 129.2 126.6 20.3 80.1 217.9 11.4 17.4 23.7 48.5 63.0 44.3 12.5 22.4 21.1 40.5 52.9 28.2 20.2 4.2 3.7 16.6 23.3 37.2 36.7 8.3 65.6 25.0 25.3 25.8 54.1 1.7 70.0 20.2 57.7 49.5 20.8 48.8 13.2 24.3 40.5 40.4 15.2 2.7 33.2 63.1 53.2 73.8 12.7 39.4 60.5 26.6 5.6 130.4 20.7 8.2 3.5 47.6 67.0 24.4 49.7 6.9 36.7 18.1 47.9 48.0 12.4 39.5 42.7 52.8 2.4 3.7 63.0 16.3 4.9 35.4 16.3 25.5 116.9 SHOC1 "C9orf84, FLJ32779, MZIP2, Zip2" ENSG00000165181 "Shortage in chiasmata 1" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Endothelial cells: 1.0" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 4 "U-2 OS: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA032108 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.0 2.4 0.9 0.0 0.7 0.1 0.0 2.0 1.4 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.8 2.2 0.0 0.1 0.0 1.2 1.5 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.1 1.1 17.2 1.5 0.0 0.0 0.0 0.3 0.1 0.2 2.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.0 1.1 0.4 0.0 0.0 0.3 0.1 0.0 21.7 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.7 2.0 1.4 1.2 1.8 1.2 1.5 0.5 1.2 0.8 1.5 2.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXorf58 FLJ25444 ENSG00000165182 "Chromosome X open reading frame 58" Q96LI9 X 23908006-23939509 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 3.9" "Cell type enhanced" "Detected in some" "Early spermatids: 33.3;Late spermatids: 6.9;Respiratory ciliated cells: 5.5;Spermatocytes: 19.7;Spermatogonia: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "GAMG: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031542, HPA031543, HPA031544" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929" "unprognostic (9.74e-2)" "unprognostic (9.17e-3)" "unprognostic (2.52e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-2)" "unprognostic (1.24e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-2)" "unprognostic (1.43e-1)" "unprognostic (4.14e-3)" "unprognostic (8.19e-2)" "unprognostic (3.82e-2)" "unprognostic (1.10e-1)" "unprognostic (3.21e-2)" "unprognostic (7.39e-2)" "unprognostic (5.06e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 3.9 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.2 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 2.0 0.2 0.0 0.2 0.4 0.0 0.5 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.9 0.2 33.3 1.6 0.1 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 6.9 0.0 0.1 0.0 1.0 0.6 0.7 0.0 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.2 5.5 2.8 0.0 0.0 0.1 19.7 8.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 KIAA1958 FLJ39294 ENSG00000165185 KIAA1958 Q8N8K9 9 112486827-112669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Cell type enhanced" "Detected in many" "Astrocytes: 169.8;Excitatory neurons: 64.2;Inhibitory neurons: 55.1;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 166.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020625 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020625: AB_1852451" "unprognostic (3.09e-3)" "unprognostic (1.04e-1)" "unprognostic (1.61e-2)" "unprognostic (1.33e-1)" "unprognostic (7.48e-2)" "unprognostic (2.08e-2)" "unprognostic (2.01e-1)" "unprognostic (4.95e-2)" "unprognostic (1.14e-1)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (7.67e-2)" "unprognostic (5.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.58e-1)" 1.2 6.7 5.8 1.2 9.5 4.9 2.2 8.9 5.9 4.8 3.5 1.4 1.7 3.5 0.9 1.5 3.0 1.3 1.3 3.4 6.0 5.8 3.4 2.1 1.4 8.0 8.1 2.7 10.0 2.6 1.5 1.9 0.7 8.2 1.5 1.5 10.1 3.0 2.4 0.9 1.6 1.9 3.1 5.2 1.5 4.8 5.8 9.5 4.0 2.4 0.8 1.3 1.4 1.9 14.7 3.7 5.2 20.7 6.0 1.4 0.3 9.9 2.7 0.9 3.2 3.6 9.5 2.4 11.8 3.1 8.9 2.2 3.2 15.3 1.5 4.5 3.6 6.2 4.6 7.3 6.7 0.8 7.0 5.6 0.6 1.2 4.2 2.0 2.9 2.6 11.0 11.0 2.9 1.0 4.2 11.0 4.0 11.4 8.6 2.4 8.8 11.8 3.3 4.3 5.1 10.6 11.2 4.5 4.7 2.7 11.4 4.3 7.1 0.5 1.1 6.1 0.7 3.3 5.3 10.4 6.9 1.4 4.8 0.8 0.4 0.7 0.0 0.5 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 0.4 5.8 9.5 8.9 5.9 3.4 6.0 8.0 8.1 2.7 8.2 5.2 9.5 14.7 0.5 3.2 19.3 169.8 3.7 4.7 3.4 1.5 6.8 20.6 7.9 4.2 4.3 4.3 6.2 1.8 14.6 1.2 3.0 4.6 7.9 3.2 4.1 12.1 8.1 1.4 4.8 3.8 64.2 6.7 1.0 3.3 8.2 8.0 0.0 20.3 0.4 8.0 1.0 6.7 55.1 4.4 12.2 7.5 4.6 2.5 6.5 4.2 1.8 15.9 2.5 8.3 3.1 127.6 166.4 3.3 6.2 5.3 5.0 6.5 5.0 11.0 5.9 12.1 6.6 2.5 4.1 1.5 8.0 5.3 4.7 0.8 1.6 29.9 5.2 5.7 PTCHD1 FLJ30296 ENSG00000165186 "Patched domain containing 1" Q96NR3 X 23334849-23404374 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Autism, Autism spectrum disorder" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" "Astrocytes: 34.6;Breast glandular cells: 9.6;Excitatory neurons: 22.0;Sertoli cells: 13.1;Skeletal myocytes: 11.9" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.7;RT4: 1.6;WM-115: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046110 Uncertain NA NA "HPA046110: AB_2679541" "unprognostic (1.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.43e-3)" "unprognostic (1.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-4)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" "unprognostic (2.78e-1)" "unprognostic (2.13e-1)" "unprognostic (3.50e-1)" "unprognostic (3.19e-2)" "unprognostic (3.68e-4)" "unprognostic (5.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 0.4 0.6 3.1 0.1 3.4 0.1 2.1 14.6 3.0 2.1 0.0 4.1 0.3 2.8 0.6 1.3 0.3 0.1 0.1 2.8 3.9 0.1 0.0 0.2 0.0 3.8 4.3 3.3 0.1 0.0 0.0 0.8 0.0 5.9 1.3 0.8 0.4 1.0 4.0 0.2 0.1 0.9 1.7 1.6 0.3 1.7 0.2 4.2 0.0 0.4 0.1 0.0 1.8 0.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.4 14.6 3.0 2.8 3.9 3.8 4.3 3.3 5.9 1.6 4.2 3.0 0.3 0.0 2.0 34.6 0.5 0.3 2.3 0.0 0.0 3.7 9.6 4.2 1.9 0.0 1.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.1 1.0 0.4 1.8 0.0 22.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 1.1 0.8 6.5 0.3 0.0 1.9 0.1 1.7 0.0 2.5 0.4 0.0 0.0 0.4 0.0 7.7 0.0 0.2 1.5 0.4 13.1 11.9 1.5 0.5 1.7 0.0 0.0 2.2 0.1 0.2 0.0 0.7 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.6;kidney: 11.2" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 15.9;Club cells: 9.8;Endometrial ciliated cells: 13.4;Glandular and luminal cells: 20.5;Ionocytes: 22.4;Proximal tubular cells: 26.4;Respiratory ciliated cells: 13.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057675 Uncertain NA NA "HPA057675: AB_2683499" "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.1 0.1 0.3 0.4 0.2 0.0 1.0 0.2 0.4 1.5 0.2 0.4 0.4 1.2 16.6 4.9 1.3 5.8 0.1 0.2 0.1 11.2 0.2 0.3 0.0 0.2 0.2 0.1 0.3 0.3 0.1 2.0 0.0 0.2 1.0 0.4 1.2 6.9 0.3 0.0 0.4 0.3 0.0 0.3 0.1 3.4 5.1 0.3 0.0 0.4 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.5 0.0 0.4 15.9 0.0 0.6 3.8 2.9 0.4 5.7 9.8 5.5 0.0 0.0 0.2 0.9 1.9 0.2 0.2 13.4 1.1 0.5 8.4 0.0 0.0 0.9 0.1 0.2 4.6 20.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 22.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.2 0.7 0.4 0.0 0.5 0.2 26.4 13.0 3.3 0.0 0.4 0.6 3.3 0.7 1.4 0.0 0.0 0.3 0.1 1.5 1.0 ASB11 DKFZp779E2460 ENSG00000165192 "Ankyrin repeat and SOCS box containing 11" Q8WXH4 X 15281697-15315640 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "heart muscle: 33.7;skeletal muscle: 115.8;tongue: 61.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.7;Ionocytes: 6.1;Melanocytes: 7.2" "Cancer enriched" "Detected in single" 20 "melanoma: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (5.89e-3)" "unprognostic (1.04e-1)" "unprognostic (9.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.42e-2)" "unprognostic (5.54e-2)" "unprognostic (2.04e-2)" "unprognostic (2.36e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (6.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 0.0 115.8 0.8 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.2 0.2 0.1 8.7 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.4 0.1 0.3 1.7 0.3 0.1 6.1 0.3 0.8 0.3 0.3 0.2 7.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.4 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 14.5" "Cell type enhanced" "Detected in many" "Adipocytes: 29.9;Excitatory neurons: 24.5;Inhibitory neurons: 51.8;Oligodendrocyte precursor cells: 40.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.6;ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol NA NA 83000 Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 1.7 0.1 7.1 0.2 8.5 0.0 1.7 0.0 11.1 1.6 0.0 1.3 0.2 1.1 0.2 0.8 0.6 0.4 0.3 11.0 11.7 0.2 0.0 0.1 0.2 1.1 3.1 6.9 1.0 0.1 0.1 0.7 0.1 2.6 0.2 1.7 1.8 0.6 0.3 0.4 1.0 0.4 0.9 0.0 0.0 0.5 0.6 14.5 0.8 0.2 0.9 0.0 0.8 0.6 2.3 0.0 0.0 18.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 3.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 8.5 0.0 11.1 11.0 11.7 1.1 3.1 6.9 2.6 0.0 14.5 2.3 29.9 0.0 0.5 13.4 0.0 3.1 0.1 0.9 4.6 12.9 0.5 0.8 1.8 7.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.4 6.2 11.3 1.8 0.0 24.5 0.0 0.1 2.9 0.0 1.4 0.0 2.5 1.1 0.0 0.1 0.0 51.8 0.1 0.0 0.3 3.4 2.2 3.4 0.1 0.0 7.5 0.0 1.9 0.0 40.7 2.2 0.1 0.1 0.4 0.0 0.4 0.0 0.2 1.3 1.9 0.0 5.9 7.8 0.1 1.5 1.0 1.6 0.0 0.2 0.7 0.0 0.1 PIGA GPI3 ENSG00000165195 "Phosphatidylinositol glycan anchor biosynthesis class A" P37287 X 15319452-15335554 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 83.5;Suprabasal keratinocytes: 55.0;Urothelial cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 22.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001174 Approved NA NA "HPA001174: AB_2666220" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.92e-2)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (2.99e-3)" "unprognostic (2.24e-2)" "unprognostic (7.37e-3)" "unprognostic (3.93e-3)" "prognostic unfavorable (7.64e-4)" "unprognostic (1.85e-3)" "unprognostic (5.97e-3)" "unprognostic (2.24e-1)" "unprognostic (3.94e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-2)" 2.1 2.9 2.2 2.9 3.3 9.3 3.1 2.3 3.6 2.8 1.1 3.7 1.9 3.0 3.5 5.1 2.8 3.7 2.0 1.9 6.0 3.8 4.5 6.8 3.5 3.7 3.6 1.8 2.4 4.0 3.3 0.6 3.6 2.6 2.7 3.7 4.5 4.6 1.7 1.3 1.4 2.4 2.5 2.9 2.0 2.8 2.6 2.6 4.1 4.4 1.3 4.7 10.4 1.9 6.2 14.5 8.3 9.1 5.0 2.6 2.8 7.0 3.7 5.7 7.4 7.3 9.2 6.5 6.6 2.9 2.9 9.0 5.8 14.3 11.4 12.6 6.1 9.5 5.5 11.0 5.8 4.5 8.8 2.9 3.3 8.1 10.0 16.0 2.4 5.0 5.2 6.4 7.0 5.1 9.2 9.0 3.4 4.7 5.5 8.2 3.0 12.4 10.7 5.6 9.4 6.2 9.4 6.9 6.8 14.4 8.7 6.6 7.4 4.2 6.2 2.4 14.0 7.3 5.4 7.2 9.9 9.4 5.6 7.9 22.9 3.8 4.3 2.6 6.3 3.7 3.0 4.1 2.6 3.9 2.1 3.8 2.9 5.2 1.8 8.6 2.6 4.1 2.7 2.2 3.3 2.3 3.6 1.9 6.0 3.7 3.6 1.8 2.6 2.9 2.6 6.2 6.4 19.2 83.5 6.8 7.2 29.6 41.9 10.6 13.6 3.5 13.2 10.5 6.9 5.7 20.1 3.7 0.0 6.3 7.4 8.4 11.7 7.6 5.4 30.8 9.8 7.9 10.7 9.3 2.2 5.8 10.2 12.7 17.9 45.6 33.6 3.0 3.6 4.4 8.8 3.3 2.0 5.0 2.0 8.4 43.4 4.4 3.1 18.1 28.4 2.8 3.6 4.2 4.1 1.0 7.7 8.3 5.1 3.0 5.5 32.0 2.1 6.6 19.8 3.0 13.1 10.6 16.3 2.7 3.7 35.5 55.0 28.0 11.7 2.9 6.0 62.2 VEGFD "FIGF, VEGF-D" ENSG00000165197 "Vascular endothelial growth factor D" O43915 X 15345596-15384413 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 43.0" "Cell type enriched" "Detected in some" 12 "Fibroblasts: 39.8" "Cancer enhanced" "Detected in some" "liver cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;ASC TERT1: 2.8;EFO-21: 1.3;HSkMC: 2.8" "Group enriched" "Detected in many" 4 "amygdala: 2.1;cerebral cortex: 3.5;hippocampal formation: 3.3;white matter: 2.6" "Not detected" "Not detected" HPA027342 Uncertain "Secreted to blood" NA NA 592000 450000 "HPA027342: AB_1848597" "unprognostic (5.90e-2)" "unprognostic (9.79e-3)" "unprognostic (1.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-1)" "unprognostic (6.06e-3)" "unprognostic (5.57e-2)" "unprognostic (2.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.59e-5)" "unprognostic (3.08e-2)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (1.75e-2)" 11.5 10.0 1.8 0.8 1.8 0.0 20.5 1.6 2.3 14.2 1.5 4.4 1.2 3.8 5.0 2.7 4.2 2.8 9.2 1.7 2.0 1.7 1.6 43.0 0.4 1.8 1.8 1.7 4.5 0.8 2.7 7.0 0.2 2.1 1.5 2.0 0.4 2.3 1.9 17.7 1.1 4.3 3.4 1.5 2.9 5.9 0.6 2.0 0.3 1.5 23.2 1.3 6.1 8.2 2.2 0.0 0.6 0.5 0.9 3.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.3 2.8 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.3 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 1.6 2.3 1.7 2.0 1.8 1.8 1.7 2.1 1.5 2.0 2.2 3.1 3.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.3 1.6 0.0 0.0 OR1Q1 "HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106" ENSG00000165202 "Olfactory receptor family 1 subfamily Q member 1" Q15612 9 122614738-122615682 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "retina: 1.2" "Cell type enriched" "Detected in some" 8 "Excitatory neurons: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044828 Uncertain NA NA "HPA044828: AB_10960565" "unprognostic (5.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.98e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1K1 "hg99, MNAB" ENSG00000165204 "Olfactory receptor family 1 subfamily K member 1" Q8NGR3 9 122800123-122801073 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.77e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRBP "FLJ11307, ILF3L, SPNR" ENSG00000165209 "Spermatid perinuclear RNA binding protein" Q96SI9 9 123109500-123268586 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 415.7;Inhibitory neurons: 256.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 157.0;U-698: 141.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020651 Approved NA NA "HPA020651: AB_1857616" "unprognostic (1.92e-2)" "unprognostic (3.56e-2)" "unprognostic (4.47e-2)" "unprognostic (4.07e-1)" "unprognostic (9.06e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (5.89e-2)" "unprognostic (1.10e-1)" "unprognostic (8.11e-2)" "unprognostic (1.10e-1)" "unprognostic (8.86e-2)" "prognostic favorable (1.70e-10)" "unprognostic (3.25e-2)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (2.13e-1)" 3.9 4.4 4.8 11.6 6.4 14.5 12.7 9.3 17.2 9.2 7.1 17.6 15.5 6.3 19.1 16.4 14.9 6.9 5.1 5.6 4.6 11.8 8.2 6.6 29.7 4.0 5.4 4.9 3.8 12.2 37.9 15.4 5.6 5.2 9.1 17.1 22.2 16.0 6.9 5.3 5.5 14.1 5.6 3.7 11.1 11.1 37.9 8.7 24.3 17.8 2.9 35.4 7.5 6.8 8.7 24.7 22.7 30.8 16.6 3.9 2.0 40.6 6.3 1.8 9.6 7.1 24.5 28.6 157.0 13.1 4.9 42.7 22.6 36.3 13.1 15.3 23.1 18.3 33.9 23.9 24.2 7.6 70.4 9.0 1.3 16.1 2.6 11.0 4.4 11.9 46.6 71.6 67.7 2.9 38.2 59.0 31.0 40.8 56.0 17.8 94.5 26.4 51.3 22.8 19.4 45.8 16.5 26.3 28.2 23.0 36.0 37.3 45.3 7.0 1.7 14.3 16.9 19.0 80.4 92.9 141.5 8.5 26.9 11.4 3.8 0.4 1.1 1.3 0.2 1.2 8.1 1.2 1.3 0.4 6.3 1.7 1.3 1.2 2.0 0.6 5.1 1.0 0.7 4.8 6.4 9.3 17.2 5.6 4.6 4.0 5.4 4.9 5.2 3.7 8.7 8.7 7.1 19.2 28.8 62.7 94.2 8.9 22.9 7.6 14.8 39.5 29.9 16.1 28.0 21.5 26.0 16.5 87.6 18.3 34.5 33.7 17.6 20.8 80.4 81.5 23.5 9.7 32.4 38.9 415.7 19.0 10.0 5.5 15.8 42.4 12.0 16.7 10.8 15.2 9.8 16.8 256.3 25.2 12.2 2.1 14.0 32.4 5.3 8.3 17.8 88.1 8.2 47.1 5.2 100.5 52.1 18.2 25.7 4.9 52.9 25.3 32.5 17.9 92.5 61.6 0.0 5.5 8.8 128.7 34.4 40.0 10.4 12.9 17.9 5.1 29.8 32.2 CLDN3 "C7orf1, CPE-R2, CPETR2, HRVP1, RVP1" ENSG00000165215 "Claudin 3" O15551 7 73768997-73770270 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 170.9;pancreas: 97.4;thyroid gland: 117.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 529.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4" "Region enhanced" "Detected in single" "basal ganglia: 1.5" "Region enhanced" "Detected in many" "midbrain: 9.7" HPA014361 Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA014361: AB_2668982" "unprognostic (1.84e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-1)" "unprognostic (5.27e-2)" "unprognostic (2.61e-1)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (8.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.28e-3)" "unprognostic (1.42e-1)" "prognostic favorable (3.39e-5)" "unprognostic (1.46e-2)" "unprognostic (1.87e-1)" "unprognostic (5.18e-2)" "unprognostic (6.72e-2)" 0.7 0.2 0.8 7.9 0.4 0.2 26.9 4.5 0.6 8.0 30.0 149.3 54.9 7.5 1.5 1.3 29.8 2.2 0.1 1.2 1.5 46.4 40.8 10.8 0.2 0.9 1.6 0.0 0.5 97.4 1.5 27.9 1.0 1.3 58.8 17.7 0.4 73.5 8.4 0.1 8.9 170.9 0.8 0.6 0.2 1.4 0.7 0.7 1.1 117.3 0.0 1.2 1.5 0.2 0.3 2.5 3.6 0.0 0.4 0.0 0.0 17.8 0.0 0.0 0.0 0.0 4.2 35.7 0.0 9.9 0.0 0.0 1.0 0.4 0.0 0.0 0.1 4.9 0.0 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 230.7 0.4 1.2 2.1 9.1 47.6 0.1 0.0 40.5 2.1 0.2 58.0 0.7 0.0 33.6 0.0 0.2 105.4 0.0 0.2 0.2 0.6 0.9 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 4.5 0.6 1.2 1.5 0.9 1.6 0.0 1.3 0.6 0.7 0.3 1.6 38.5 37.8 0.0 13.2 0.1 60.3 43.7 0.0 0.7 289.9 182.5 0.6 287.4 86.3 126.9 4.2 63.9 5.1 1839.9 9.8 297.5 0.0 1221.7 130.5 10.3 606.1 5.3 0.0 19.1 17.7 4.1 16.8 1555.7 28.0 1.5 0.4 40.5 5.1 0.0 0.0 1471.3 116.0 0.3 0.0 0.3 2.5 9.9 10.6 0.0 2.0 11.8 0.0 0.0 0.0 36.7 2326.0 0.0 4.4 433.2 3162.1 58.6 498.4 10.6 0.0 0.0 20.3 0.1 0.3 2.7 0.0 72.4 17.5 0.0 1266.0 607.3 GAPVD1 "DKFZP434C212, KIAA1521" ENSG00000165219 "GTPase activating protein and VPS9 domains 1" Q14C86 9 125261794-125367207 "Predicted intracellular proteins" Endocytosis "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029386, HPA029387, HPA074882" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA 46000 "Plasma membrane" Cytosol "HPA029386: AB_10599604, HPA029387: AB_10600311, HPA074882: " "unprognostic (8.43e-3)" "unprognostic (3.84e-2)" "unprognostic (3.53e-1)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (4.04e-2)" "unprognostic (7.08e-2)" "unprognostic (1.31e-2)" "unprognostic (7.56e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "unprognostic (2.54e-3)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (1.67e-2)" "unprognostic (5.82e-2)" 12.4 9.9 8.0 12.3 10.8 23.2 12.1 11.6 10.0 12.3 12.4 10.4 8.1 11.2 9.9 17.2 10.8 10.4 9.8 8.3 9.3 13.1 11.3 15.8 12.7 9.7 9.2 7.7 12.2 10.6 18.9 8.3 18.6 9.6 10.6 9.9 16.7 9.4 12.5 19.2 14.9 9.2 13.5 9.2 12.8 9.7 27.1 9.5 14.2 19.0 18.9 15.1 12.3 10.2 14.2 22.8 23.2 21.8 20.0 26.2 28.6 30.5 25.0 28.9 29.0 24.2 37.0 15.9 30.2 13.3 31.9 28.7 44.9 46.2 25.8 31.1 28.1 27.1 34.6 53.1 18.4 30.1 41.4 56.0 20.1 25.2 34.6 27.2 18.7 35.0 23.8 68.8 16.3 24.3 33.2 31.2 18.0 21.6 41.2 26.2 27.2 47.6 29.1 16.2 23.2 28.8 18.9 36.9 32.6 20.0 21.7 40.9 20.9 36.1 19.9 14.3 35.7 27.2 20.7 42.3 29.9 24.1 22.9 26.4 25.6 15.9 19.6 13.0 15.4 12.7 10.0 13.5 14.6 15.4 9.5 13.3 14.3 19.5 15.2 19.8 5.8 11.8 11.3 8.0 10.8 11.6 10.0 8.3 9.3 9.7 9.2 7.7 9.6 9.2 9.5 14.2 30.0 109.0 58.0 35.6 28.3 31.9 18.2 23.0 32.5 29.9 21.0 17.5 66.8 14.3 34.8 27.6 52.1 42.3 20.7 16.6 9.8 16.2 58.3 35.7 30.7 26.8 12.6 77.0 68.4 19.3 23.7 26.2 18.3 31.4 15.8 27.6 21.4 15.2 27.6 35.3 69.7 15.9 10.2 25.4 28.5 17.7 23.0 30.5 17.8 51.5 31.2 22.8 18.6 45.2 62.7 22.3 13.9 24.0 26.5 20.0 15.4 16.1 57.2 39.1 19.7 27.8 32.0 85.6 34.5 32.3 36.9 67.0 28.3 32.5 17.0 29.8 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096217-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Macrophages: 142.0;Pancreatic endocrine cells: 121.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 134.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria NA NA Mitochondria "HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938" "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 11.7 13.8 2.1 3.7 2.1 3.3 11.4 4.4 4.6 11.0 2.9 14.3 6.1 12.1 2.6 11.1 10.9 5.9 9.5 1.8 6.2 16.2 10.9 10.9 4.0 3.8 2.8 1.7 8.0 5.5 6.2 6.6 3.4 4.7 8.7 3.2 0.1 9.5 4.3 14.3 10.8 9.6 4.3 3.5 10.6 13.0 19.3 3.2 3.1 8.8 5.6 2.6 11.6 11.6 5.2 33.0 31.3 4.1 9.2 5.3 10.1 12.9 26.7 13.0 18.2 8.2 7.8 10.6 7.0 18.3 9.5 15.4 56.0 3.3 21.9 1.5 134.9 12.3 12.4 6.5 18.4 21.1 11.2 11.4 23.5 8.1 13.2 5.2 20.0 21.4 6.1 5.7 13.8 12.4 64.7 12.1 30.0 3.6 21.1 70.8 8.2 20.7 29.4 22.9 12.1 9.8 17.3 14.4 6.9 30.6 0.8 15.6 11.6 21.6 9.3 18.6 17.9 8.4 10.4 10.1 1.5 39.0 11.3 32.4 27.8 37.4 23.6 10.2 30.0 10.5 12.6 10.0 10.9 30.6 7.5 9.0 8.9 40.3 18.4 17.3 11.1 21.7 22.4 2.1 2.1 4.4 4.6 1.8 6.2 3.8 2.8 1.7 4.7 3.5 3.2 5.2 29.3 22.4 20.9 0.0 14.4 0.0 52.8 0.0 25.6 12.0 81.2 75.6 0.0 27.1 5.6 16.5 16.7 22.9 25.7 27.7 62.6 76.6 49.5 19.4 26.8 34.1 15.8 7.8 0.0 58.1 34.6 26.2 36.2 20.3 30.3 8.2 41.7 13.9 79.0 5.0 0.0 19.8 0.0 41.3 0.0 15.3 45.7 142.0 0.0 0.0 68.3 21.9 17.5 0.0 0.0 121.6 10.3 43.6 15.0 58.7 38.9 61.7 2.2 29.8 59.2 30.4 31.1 98.7 26.4 27.9 0.0 21.6 34.0 8.5 18.6 71.0 WNK2 "KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43" ENSG00000165238 "WNK lysine deficient protein kinase 2" Q9Y3S1 9 93184916-93320572 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 76.6;skeletal muscle: 62.9" "Cell type enhanced" "Detected in many" "Astrocytes: 76.4;Cone photoreceptor cells: 160.6;Excitatory neurons: 128.5;Inhibitory neurons: 98.8;Intestinal goblet cells: 77.3;Rod photoreceptor cells: 106.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 18.8;Hep G2: 31.0;SCLC-21H: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015555, HPA016519, CAB017813" Enhanced Approved Cytosol NA NA Cytosol "CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380" "unprognostic (5.02e-2)" "unprognostic (1.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.04e-1)" "unprognostic (1.79e-3)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.31e-3)" "unprognostic (2.23e-1)" "unprognostic (4.48e-3)" "unprognostic (6.51e-2)" "unprognostic (1.44e-1)" "unprognostic (4.38e-4)" "unprognostic (1.62e-1)" 1.6 3.0 14.6 3.4 14.1 0.0 4.9 3.6 39.4 3.6 0.1 34.2 18.1 5.8 4.2 5.7 15.6 1.3 76.6 19.3 6.6 0.8 1.3 0.9 0.5 16.0 5.0 17.9 1.1 43.2 2.3 29.9 3.0 8.6 16.8 12.0 29.0 47.7 12.4 62.9 15.9 21.7 4.5 1.2 2.8 14.8 6.7 16.7 7.1 1.8 31.3 1.0 5.6 3.4 15.7 7.4 6.6 4.6 13.2 0.0 0.0 8.8 0.0 0.0 0.1 0.0 2.7 0.2 18.8 2.4 0.0 1.3 0.3 10.4 0.0 0.0 0.0 12.1 0.0 5.8 31.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.0 9.8 0.2 0.2 11.5 7.2 0.4 0.0 0.0 15.3 0.0 1.1 37.6 14.8 2.4 10.2 0.9 1.3 1.3 2.2 0.1 0.0 4.8 0.2 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.6 14.1 3.6 39.4 19.3 6.6 16.0 5.0 17.9 8.6 1.2 16.7 15.7 0.3 0.0 0.0 76.4 0.3 1.3 8.5 3.1 0.0 62.0 19.4 18.7 58.1 31.5 14.1 0.0 160.6 15.5 0.2 34.3 0.0 17.1 1.2 7.7 9.2 1.3 32.4 0.0 128.5 9.1 6.7 2.7 3.6 15.8 0.0 8.6 0.4 0.2 3.4 1.7 98.8 77.3 6.1 1.3 2.2 2.6 0.9 0.1 1.8 29.0 0.6 60.3 0.0 9.0 3.2 3.2 57.0 6.0 0.2 11.1 47.7 1.1 6.6 106.8 13.1 3.5 5.0 0.7 7.7 1.1 5.5 15.6 0.4 0.1 59.0 8.9 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ionocytes: 61.1;Microglial cells: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012887: AB_1845205, HPA048107: AB_2680266" "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 3.0 4.3 1.4 3.6 1.9 5.9 6.4 2.3 2.2 3.9 1.9 3.4 3.9 3.6 5.1 4.9 3.5 3.6 2.6 1.4 2.1 4.4 2.3 4.6 4.1 2.3 2.2 1.4 3.6 2.4 7.4 2.5 4.0 2.9 5.3 3.4 3.0 5.2 3.5 1.8 11.1 3.4 3.2 1.3 4.8 5.6 1.6 1.9 4.8 4.7 2.9 4.7 3.9 2.8 3.0 3.2 8.3 5.4 5.5 5.0 5.3 0.9 4.8 6.6 2.8 5.7 1.0 3.6 4.7 6.9 4.8 3.3 3.8 7.1 3.9 5.2 7.0 4.8 2.4 7.8 0.8 6.3 4.1 4.1 5.6 1.6 5.9 1.8 6.5 7.3 4.7 19.6 17.4 5.2 2.8 4.6 1.4 1.5 11.2 1.7 3.7 9.0 15.8 4.6 8.8 1.6 20.4 11.9 2.8 6.0 3.3 2.2 1.3 9.4 3.7 3.6 5.2 1.9 5.6 10.7 5.2 6.0 2.5 5.7 7.1 1.5 4.5 1.8 1.5 0.9 1.8 1.2 1.2 1.0 1.4 1.4 2.1 8.1 1.2 1.9 1.0 0.4 1.0 1.4 1.9 2.3 2.2 1.4 2.1 2.3 2.2 1.4 2.9 1.3 1.9 3.0 14.3 0.0 8.4 15.7 12.6 7.4 5.1 5.8 13.1 6.4 17.3 10.0 5.1 1.5 8.2 9.2 4.2 2.0 15.0 4.5 1.9 5.6 0.5 5.3 9.2 9.7 4.8 22.5 11.1 13.6 2.2 9.4 20.4 8.8 9.5 6.4 14.6 3.6 14.3 1.7 12.5 4.8 61.1 11.7 6.7 1.1 7.2 12.6 19.6 44.0 5.5 4.4 11.3 37.7 35.0 6.2 4.1 9.8 10.5 4.8 4.1 5.5 10.2 4.1 32.9 10.3 8.7 1.8 5.4 20.5 16.6 2.2 13.8 6.7 5.2 6.6 ZNF367 FLJ33970 ENSG00000165244 "Zinc finger protein 367" Q7RTV3 9 96385941-96418370 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA015319, HPA015785" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA015319: AB_2669185, HPA015785: AB_2217750" "unprognostic (5.91e-2)" "unprognostic (2.78e-3)" "unprognostic (2.17e-2)" "unprognostic (1.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.57e-3)" "unprognostic (7.76e-3)" "unprognostic (1.60e-3)" "unprognostic (4.35e-2)" "unprognostic (3.01e-1)" "unprognostic (3.78e-3)" "unprognostic (2.71e-2)" "unprognostic (4.88e-3)" "unprognostic (3.23e-3)" "unprognostic (1.72e-1)" "prognostic favorable (2.34e-4)" "unprognostic (2.28e-1)" 1.5 0.6 1.0 3.7 1.5 26.3 1.7 1.5 1.3 0.8 0.6 3.0 2.9 1.1 0.1 2.4 0.7 1.0 2.1 0.9 1.3 3.0 10.9 1.1 4.6 1.7 1.5 0.8 1.0 1.4 1.6 0.3 1.9 1.6 1.2 3.4 1.3 0.7 0.5 1.5 3.5 3.0 2.4 1.2 1.4 2.2 6.1 1.3 8.8 1.1 2.7 4.7 1.5 1.2 2.9 25.4 10.3 9.9 8.9 3.8 5.3 13.4 34.6 20.4 16.9 20.0 6.4 17.5 19.2 14.4 16.5 12.6 30.5 11.6 12.6 19.9 21.2 10.0 14.0 19.1 5.3 0.0 19.8 16.5 0.9 0.8 13.7 6.9 3.7 6.3 13.3 13.0 45.4 21.7 16.9 30.4 16.1 6.7 27.9 16.7 15.3 49.9 11.7 4.9 16.8 17.4 12.0 15.3 18.1 10.6 8.0 9.4 17.3 5.7 27.6 15.8 25.6 26.6 17.6 32.0 7.8 16.7 17.0 23.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.1 1.0 1.5 1.5 1.3 0.9 1.3 1.7 1.5 0.8 1.6 1.2 1.3 2.9 1.1 0.0 0.0 2.9 3.8 9.9 1.3 0.4 10.8 0.7 2.2 2.3 2.6 0.0 0.9 0.0 0.0 3.2 2.5 2.4 0.0 0.5 0.7 0.6 1.1 2.0 0.0 22.3 5.1 1.2 4.2 1.7 2.6 1.8 0.0 4.7 1.1 3.8 1.9 0.0 5.3 3.6 0.0 2.1 2.6 0.8 0.6 8.3 3.6 2.8 0.1 0.6 1.0 3.0 7.9 0.7 0.5 0.7 9.6 0.6 0.9 2.5 0.0 1.5 6.6 2.0 3.6 10.3 1.7 10.9 6.5 0.8 5.0 0.3 5.6 1.1 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4 Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell type enhanced" "Detected in many" "Astrocytes: 48.0;Basal squamous epithelial cells: 45.5;Excitatory neurons: 146.1;Inhibitory neurons: 108.0;Oligodendrocyte precursor cells: 220.7;Oligodendrocytes: 46.7" "Cancer enhanced" "Detected in many" "glioma: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.1;fHDF/TERT166: 25.3;HDLM-2: 30.2;hTCEpi: 21.1;SuSa: 19.9;U-138 MG: 23.1" HPA001651 Approved "Intracellular and membrane" NA NA "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.0 1.4 3.8 0.5 2.3 0.0 1.1 0.0 15.5 0.0 0.0 1.5 0.4 0.0 1.8 2.0 0.0 2.4 0.4 7.2 0.0 1.1 2.2 0.6 0.4 6.0 0.0 0.0 0.0 1.6 1.8 2.1 0.3 8.2 6.3 1.4 1.4 1.8 7.6 0.3 1.0 0.9 0.0 0.0 0.4 0.9 0.5 8.1 0.1 1.1 2.2 1.1 3.4 0.0 19.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 7.1 32.1 2.0 2.6 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 5.0 30.2 0.0 0.0 0.0 4.9 3.3 0.1 0.0 10.7 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 2.2 0.0 6.4 0.1 0.0 0.0 2.0 0.0 7.5 12.4 4.2 0.0 0.0 0.0 0.1 19.9 0.0 0.7 9.3 23.1 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 2.3 0.0 15.5 7.2 0.0 6.0 0.0 0.0 8.2 0.0 8.1 19.3 0.0 0.0 1.3 48.0 1.1 3.4 10.8 12.0 45.5 9.0 0.0 0.0 1.0 5.7 6.4 7.3 0.0 0.3 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.0 0.0 0.0 146.1 0.0 0.2 8.6 2.0 0.0 0.0 0.0 0.0 0.6 0.2 6.7 108.0 0.0 4.1 0.0 5.1 0.2 2.8 0.1 1.8 29.0 2.6 4.3 0.0 220.7 46.7 0.0 0.0 8.2 0.4 14.1 0.0 0.8 3.3 0.7 0.0 4.7 1.1 0.4 0.8 12.3 3.1 0.3 0.9 0.0 0.2 11.8 HDX "CXorf43, FLJ30678" ENSG00000165259 "Highly divergent homeobox" Q7Z353 X 84317874-84502479 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.1;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 45.8;Oligodendrocytes: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 7.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047189 Uncertain Approved Cytosol NA NA Cytosol "HPA047189: AB_10965463" "unprognostic (7.26e-2)" "unprognostic (3.53e-2)" "unprognostic (1.64e-2)" "unprognostic (1.51e-5)" "unprognostic (3.23e-4)" "unprognostic (5.52e-2)" "unprognostic (1.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (6.40e-6)" "unprognostic (1.14e-1)" "unprognostic (7.20e-2)" "unprognostic (3.86e-3)" "unprognostic (2.34e-1)" "unprognostic (1.30e-2)" "unprognostic (3.66e-2)" 1.3 1.6 0.7 0.7 1.0 0.0 1.6 3.1 1.8 1.9 0.2 1.1 0.3 1.8 1.5 1.1 1.6 1.3 1.1 1.1 1.2 0.9 1.0 1.0 0.5 1.0 1.0 0.8 2.1 0.5 1.2 1.2 0.3 1.4 1.4 1.1 1.8 1.3 1.5 0.4 0.4 0.7 1.7 0.8 1.0 0.7 1.0 0.7 0.4 1.4 0.4 0.6 1.3 1.0 1.4 0.0 1.5 7.5 0.0 4.4 3.9 0.0 2.3 3.2 5.0 4.9 0.3 0.8 0.0 0.4 1.8 6.2 0.3 0.1 0.5 4.3 0.0 0.3 0.0 1.4 0.0 3.6 0.0 0.0 2.2 0.0 3.1 2.2 3.2 5.4 0.0 0.0 0.0 4.9 0.1 0.0 0.0 4.7 0.0 2.2 0.0 5.7 0.0 2.4 1.0 0.2 3.9 0.0 0.1 0.0 2.7 0.4 0.0 6.4 2.5 1.9 0.8 2.2 0.1 0.0 0.0 1.5 0.0 0.9 0.0 2.3 0.0 0.7 3.5 0.1 1.8 0.2 0.2 3.2 0.5 0.6 0.4 0.0 0.9 3.5 0.3 0.1 0.6 0.7 1.0 3.1 1.8 1.1 1.2 1.0 1.0 0.8 1.4 0.8 0.7 1.4 7.8 0.0 2.7 19.2 2.8 2.5 23.1 2.8 5.7 9.4 4.8 5.2 1.9 1.5 3.5 5.5 12.5 0.0 2.7 1.7 0.0 7.0 8.7 2.9 7.1 6.7 7.1 0.4 51.1 1.8 0.0 7.7 2.0 6.6 1.3 4.1 1.8 0.7 1.0 6.7 56.7 1.5 0.0 1.9 3.6 2.1 4.1 4.1 0.0 20.6 3.8 4.1 1.0 45.8 26.5 2.9 1.9 3.4 1.2 12.4 0.5 2.9 1.3 5.3 0.0 8.8 7.5 2.4 0.3 3.0 1.7 0.1 1.5 4.7 1.3 19.6 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32553001-32573184 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 583.9;Distal tubular cells: 534.1;Early spermatids: 889.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria No No Mitochondria "HPA044001: AB_10959448, HPA053334: AB_2682116" "unprognostic (4.09e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 38.9 51.2 43.0 31.0 45.5 31.2 36.2 46.9 48.5 32.7 43.1 41.7 45.0 38.5 27.0 44.1 36.3 17.7 126.2 44.5 46.8 64.7 67.3 30.8 27.1 45.5 44.1 43.7 29.9 31.3 42.2 40.6 22.7 45.0 28.8 29.4 30.9 37.3 22.3 169.6 28.0 44.0 26.9 46.3 29.0 43.9 53.9 44.7 29.0 33.4 102.7 24.7 34.4 33.6 47.7 106.4 63.7 69.6 80.1 46.7 43.0 44.5 69.5 56.5 62.8 68.8 62.8 46.5 78.4 70.5 48.2 65.1 58.8 66.5 76.8 47.0 108.6 106.0 187.2 88.8 65.9 45.2 94.4 46.3 44.8 36.7 56.8 42.9 47.5 57.6 118.4 61.0 86.1 71.9 61.2 128.1 221.2 73.6 90.7 140.1 86.7 58.4 73.1 72.0 39.3 69.7 78.4 80.2 91.1 50.7 52.0 86.3 72.0 51.4 67.9 103.8 75.7 103.8 38.0 77.0 131.5 113.7 65.6 32.7 126.3 97.6 136.1 76.9 94.3 74.5 106.0 81.4 80.0 108.8 89.0 82.3 87.4 302.1 91.9 116.3 152.7 112.4 110.2 43.0 45.5 46.9 48.5 44.5 46.8 45.5 44.1 43.7 45.0 46.3 44.7 47.7 69.5 125.0 111.6 15.3 76.2 94.2 106.2 222.9 90.0 44.1 64.6 72.6 583.9 101.5 141.4 108.5 6.2 191.8 69.4 115.8 534.1 172.5 889.5 106.9 86.1 101.0 64.6 196.7 21.8 166.7 143.0 109.5 83.6 86.4 90.5 64.3 74.3 182.2 160.8 18.5 23.8 152.5 209.5 55.0 96.4 146.9 91.6 78.4 160.1 3.7 108.6 115.3 90.6 18.1 21.3 144.4 124.9 89.9 165.7 80.0 201.0 520.3 152.3 56.5 105.2 94.8 151.3 182.0 125.9 139.7 96.7 104.1 81.0 95.6 167.3 103.8 AQP7 "AQP7L, AQP9, AQPap" ENSG00000165269 "Aquaporin 7" O14520 9 33383179-33402682 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 254.9;breast: 105.7;heart muscle: 81.7" "Cell type enhanced" "Detected in many" "Adipocytes: 129.7;Cardiomyocytes: 86.0;Early spermatids: 128.5;Proximal enterocytes: 160.7;Proximal tubular cells: 61.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 43 "ASC diff: 196.0" "Not detected" "Not detected" NA NA "unprognostic (3.25e-2)" "unprognostic (3.81e-3)" "unprognostic (1.25e-5)" "unprognostic (7.22e-3)" "unprognostic (1.50e-1)" "unprognostic (3.32e-1)" "unprognostic (4.67e-2)" "unprognostic (3.06e-2)" "unprognostic (9.99e-2)" "unprognostic (4.65e-2)" "unprognostic (8.56e-4)" "unprognostic (1.21e-1)" "prognostic favorable (9.21e-8)" "unprognostic (2.42e-1)" "unprognostic (1.28e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" 254.9 5.1 1.0 1.9 1.2 0.0 105.7 4.1 1.8 1.3 0.1 5.6 18.1 1.7 2.9 2.8 5.9 3.4 81.7 0.9 1.1 24.4 23.7 1.2 0.7 4.1 1.5 0.8 1.8 3.8 18.4 0.3 0.5 5.9 1.2 4.0 0.3 6.5 2.5 34.1 5.5 27.1 2.5 0.4 1.3 2.9 30.7 0.9 1.0 4.9 52.3 0.2 4.8 2.3 3.5 0.1 1.9 0.2 0.1 196.0 4.5 0.2 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.1 0.1 0.1 0.3 0.1 1.1 0.0 0.1 0.0 0.1 0.4 2.2 0.2 0.0 0.2 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 4.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 1.2 4.1 1.8 0.9 1.1 4.1 1.5 0.8 5.9 0.4 0.9 3.5 129.7 6.4 7.3 0.3 0.2 1.5 0.3 0.3 0.0 0.0 0.8 1.5 86.0 14.3 0.9 35.0 0.0 0.0 0.6 30.7 5.9 1.9 128.5 9.1 0.2 11.2 0.0 0.0 0.1 0.2 0.3 4.1 0.0 0.7 0.0 0.2 2.9 20.1 0.1 0.0 0.1 9.2 0.0 0.3 0.3 21.4 2.1 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.2 22.5 1.9 0.1 0.5 160.7 61.4 7.7 0.0 6.6 1.7 9.6 4.1 0.7 1.3 2.6 0.0 0.3 0.9 4.3 2.1 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461353-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA055891: AB_2682959, HPA061002: AB_2684410" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (4.09e-1)" 17.7 22.2 16.0 13.6 15.9 20.1 18.0 14.7 17.9 19.5 14.5 15.2 8.7 19.7 9.3 29.9 17.3 8.1 19.3 17.0 15.3 15.4 27.2 18.3 14.5 15.7 15.1 16.7 19.4 28.6 13.7 24.4 12.2 16.0 23.7 11.9 6.9 17.5 10.2 31.2 27.8 16.4 13.8 14.0 23.6 18.1 29.0 15.6 13.9 17.4 12.1 16.2 23.2 20.8 17.7 37.5 52.3 20.0 45.6 30.5 20.6 33.6 41.2 30.8 46.7 39.3 57.8 13.5 65.3 18.3 46.4 20.7 25.7 58.8 59.1 49.5 41.5 23.9 33.8 62.9 33.1 29.8 78.2 47.0 23.7 48.0 62.9 60.9 19.7 31.6 23.5 54.8 24.5 38.1 33.1 43.3 77.1 71.4 42.0 47.6 36.9 19.9 33.5 36.7 44.1 23.3 31.8 34.0 43.9 14.9 21.3 17.7 44.1 34.7 28.2 38.5 36.6 72.7 22.9 34.4 54.5 25.3 40.6 33.4 0.0 3.0 0.2 3.6 5.9 4.1 2.8 2.7 3.6 5.0 2.2 3.3 3.2 0.1 2.8 6.3 2.7 3.0 2.7 16.0 15.9 14.7 17.9 17.0 15.3 15.7 15.1 16.7 16.0 14.0 15.6 17.7 4.8 3.2 12.9 5.2 5.7 20.0 6.6 3.7 4.0 6.5 6.7 6.5 6.6 4.3 8.6 3.7 6.2 4.2 5.4 3.8 3.9 6.3 30.4 7.1 7.7 6.5 10.2 5.7 11.6 4.0 6.1 4.8 9.2 13.6 3.8 7.3 4.2 8.8 5.0 3.3 7.3 5.6 2.0 1.6 4.0 22.0 5.9 3.4 5.4 4.7 3.8 4.2 4.1 6.0 5.9 5.7 2.1 6.0 4.8 10.6 2.4 3.0 6.0 3.8 0.0 6.9 4.5 2.7 5.6 9.5 25.9 3.0 4.9 7.0 7.2 9.5 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441156-33447596 "Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 1538.3;urinary bladder: 695.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4" "Group enriched" "Detected in all" 5 "cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3" "Region enhanced" "Detected in many" "pons: 21.3" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 181.7;T-reg: 205.4" "Lineage enriched" "Detected in many" 18 "T-cells: 205.4" "Cell line enhanced" "Detected in many" "HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 8.4 2.1 1.6 16.9 1.0 19.9 37.0 1.9 3.4 90.8 1.3 10.4 74.0 11.0 3.0 1538.3 25.6 9.5 23.2 4.6 1.4 113.2 119.6 115.0 16.2 13.7 7.1 1.1 12.2 43.5 2.0 2.8 6.1 21.3 86.4 10.2 1.7 403.2 37.1 5.3 514.5 101.3 3.3 0.3 111.0 36.1 2.8 1.0 236.0 2.3 26.9 174.0 695.4 534.2 6.7 0.6 38.6 1.9 0.0 67.7 12.2 1.0 0.3 0.9 0.9 1.1 20.5 12.0 0.5 9.1 0.0 0.5 127.1 6.2 0.7 0.2 61.6 6.0 4.3 213.2 1.9 0.4 1.3 1.3 1.9 6.5 0.5 0.2 0.2 0.5 130.7 67.4 58.8 6.9 29.1 60.4 23.0 5.3 88.6 0.7 0.9 94.3 10.8 1.3 216.6 1.7 4.7 32.3 149.7 0.1 8.0 0.9 10.6 1.2 0.0 1.0 0.4 0.4 151.2 213.6 14.5 0.5 0.4 0.2 1.6 0.5 0.1 20.2 0.4 181.7 11.3 171.9 52.8 0.3 3.0 97.3 47.1 2.3 3.0 0.5 11.1 205.4 43.0 1.6 1.0 1.9 3.4 4.6 1.4 13.7 7.1 1.1 21.3 0.3 1.0 6.7 9.2 38.5 249.9 0.0 42.4 1923.3 982.0 381.4 811.0 9.7 56.8 27.8 3.4 157.3 436.3 1609.3 2.1 0.9 21.6 2.7 0.0 37.4 2.2 82.3 21.4 37.1 8.3 71.4 0.3 48.9 2.0 27.5 16.3 96.2 20.8 0.2 16.4 137.3 2.2 0.0 0.1 104.0 315.3 3.5 122.9 0.6 33.2 15.3 158.3 0.0 1.6 0.4 4.1 0.5 0.2 28.5 8.1 1.2 246.9 1430.8 343.1 31.9 546.0 0.5 0.0 10.2 35.8 0.7 1.9 2189.3 2485.4 50.2 73.4 1.6 7.3 2455.4 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favorable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favorable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 5.4 7.0 7.7 5.7 8.7 6.1 6.3 10.6 8.1 8.1 6.3 7.6 4.5 7.1 4.4 5.5 7.7 4.2 4.8 7.4 7.8 6.2 6.5 5.0 7.5 8.6 8.3 7.3 9.6 8.0 3.9 6.7 3.8 8.6 8.4 3.5 7.4 6.2 4.2 4.5 10.8 7.2 4.0 7.3 8.2 6.7 3.4 8.1 4.0 7.7 2.1 4.2 7.7 7.2 9.7 4.7 5.6 7.0 6.2 4.2 3.3 3.1 4.4 3.3 4.5 3.9 3.3 4.1 8.7 3.3 3.4 2.7 5.3 3.3 5.5 4.1 3.7 5.6 7.8 14.8 3.5 7.6 8.0 5.2 3.8 5.5 4.3 7.4 5.3 4.7 10.4 6.2 3.6 3.4 3.3 8.1 6.2 6.2 5.0 6.7 8.1 2.4 4.6 4.3 4.2 9.4 9.0 3.7 4.7 4.1 4.4 5.0 5.7 4.8 3.6 5.1 5.9 4.0 4.2 6.1 6.9 2.1 6.1 7.3 3.4 2.7 1.5 3.1 2.4 3.8 3.3 2.8 3.1 1.2 4.3 3.3 3.0 2.8 2.4 1.7 2.3 1.9 1.5 7.7 8.7 10.6 8.1 7.4 7.8 8.6 8.3 7.3 8.6 7.3 8.1 9.7 13.2 3.2 8.9 30.3 20.3 7.4 11.4 8.9 15.9 16.2 13.5 16.5 7.4 14.3 8.4 3.7 6.2 16.1 11.0 7.9 11.7 11.3 2.1 7.1 14.1 12.8 13.8 13.7 25.4 12.5 8.6 14.0 13.7 9.1 14.5 17.3 13.6 8.1 8.2 16.8 27.5 14.0 8.2 10.4 9.5 0.9 14.6 12.2 10.6 19.7 15.5 15.9 25.7 37.2 45.7 10.0 6.7 23.7 9.1 14.2 11.4 9.0 7.8 13.5 26.3 13.0 11.1 4.2 5.3 9.7 7.5 12.2 16.4 12.3 10.9 9.4 VCP "CDC48, IBMPFD, p97, TERA" ENSG00000165280 "Valosin containing protein" P55072 9 35053928-35072668 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 540.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005593, HPA012728, HPA012814" Supported Enhanced Nucleoplasm,Cytosol No No 34000000 "Nucleoplasm, Cytosol" "CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.15e-2)" "prognostic favorable (7.30e-4)" "unprognostic (5.78e-2)" "unprognostic (1.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.13e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-2)" "unprognostic (2.19e-2)" "unprognostic (3.24e-1)" "prognostic favorable (9.63e-7)" "unprognostic (1.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (9.11e-2)" 59.9 89.1 56.5 34.0 59.1 52.4 54.7 59.0 58.3 58.3 69.1 50.6 34.2 59.5 52.0 85.6 49.8 35.6 99.7 58.9 63.4 59.3 88.2 57.7 42.9 64.5 62.3 56.1 46.5 61.7 66.3 57.8 46.4 65.8 54.9 36.9 26.6 63.7 59.4 177.4 64.0 52.3 42.9 63.4 64.6 63.0 45.5 63.4 60.1 50.1 136.5 53.8 58.5 55.7 70.5 167.6 223.8 124.6 57.5 187.4 135.3 98.3 153.8 215.0 244.1 197.6 160.0 60.1 140.8 137.2 242.9 173.1 69.5 253.1 230.7 227.6 146.2 126.0 95.3 216.5 238.0 146.5 92.4 106.2 148.5 136.4 239.2 115.6 104.4 276.2 56.3 97.6 71.4 219.2 154.7 114.3 234.9 152.2 82.7 219.1 80.7 111.8 72.8 204.1 175.7 65.7 84.1 100.4 81.2 45.1 152.2 71.5 60.3 215.5 77.5 112.5 63.7 118.6 41.9 116.5 104.3 139.5 67.0 105.4 142.0 62.7 75.0 58.8 70.0 62.4 59.2 59.0 65.6 75.3 53.0 42.3 44.4 71.1 67.1 80.4 49.8 91.2 111.8 56.5 59.1 59.0 58.3 58.9 63.4 64.5 62.3 56.1 65.8 63.4 63.4 70.5 86.5 80.1 73.7 22.9 124.3 77.0 120.8 147.6 111.5 86.6 66.0 47.2 220.4 47.1 115.1 55.2 118.9 276.8 91.0 111.9 74.3 188.6 43.6 97.8 85.6 127.7 84.2 137.0 27.4 187.5 164.7 109.7 133.5 105.8 62.1 106.2 111.0 126.0 133.1 74.0 27.7 108.3 89.5 57.9 65.6 47.0 83.9 81.5 76.5 16.9 159.6 88.7 54.6 18.6 31.4 247.9 69.0 86.9 267.6 118.3 77.2 113.4 102.5 90.0 138.1 74.1 154.9 144.5 118.7 126.2 90.6 540.6 105.4 129.6 96.4 135.6 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 8.6 13.0 5.2 9.3 6.7 6.0 11.0 7.2 6.1 9.4 7.8 11.8 14.6 10.6 11.3 10.6 15.7 9.6 7.4 4.8 7.0 14.8 15.5 10.1 9.2 7.3 6.3 4.5 12.6 16.6 33.4 9.5 12.4 6.6 12.7 13.0 10.6 13.1 12.0 6.9 10.1 11.4 8.7 6.6 11.4 13.2 12.3 5.8 11.5 20.2 4.8 10.3 9.5 8.7 9.3 30.5 51.5 14.4 20.8 12.5 13.8 25.6 12.7 22.0 30.0 24.5 19.0 30.2 17.1 22.7 15.4 41.8 21.6 24.2 39.6 18.0 19.0 15.7 10.3 31.2 14.5 24.5 13.9 17.1 17.1 42.8 26.8 43.7 23.9 15.8 25.1 11.4 23.7 24.9 16.8 16.5 15.9 9.2 18.9 20.8 16.9 11.6 18.8 32.9 20.8 11.9 16.1 17.5 42.8 10.0 15.7 32.2 9.1 9.7 21.8 19.1 11.8 23.6 14.4 22.9 7.1 23.4 10.3 27.8 5.3 5.1 6.3 6.4 6.7 6.6 3.5 3.5 7.3 10.4 4.8 4.5 5.4 1.8 5.7 4.6 7.3 6.0 3.5 5.2 6.7 7.2 6.1 4.8 7.0 7.3 6.3 4.5 6.6 6.6 5.8 9.3 6.3 3.2 13.9 4.6 7.9 2.5 4.5 7.9 8.6 9.1 6.1 3.8 3.1 14.3 12.2 16.5 2.1 21.0 10.2 13.3 0.0 13.6 1.2 11.3 5.5 5.2 3.0 2.1 1.7 14.0 16.0 5.6 11.7 10.1 7.0 7.9 4.2 11.7 11.6 11.8 1.9 7.4 8.2 6.6 4.2 1.0 4.4 5.8 3.6 2.8 6.7 14.3 5.2 1.5 3.9 8.4 7.7 3.0 8.7 3.7 11.4 7.4 16.1 11.8 6.6 5.1 4.8 20.0 10.4 6.7 2.0 22.6 7.2 7.2 10.8 4.0 STOML2 "HSPC108, SLP-2" ENSG00000165283 "Stomatin like 2" Q9UJZ1 9 35099776-35103195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015944, HPA062016" Supported Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 44000 "Plasma membrane, Cytosol" "CAB015944: , HPA062016: AB_2684659" "unprognostic (2.49e-1)" "unprognostic (2.69e-1)" "unprognostic (1.20e-2)" "unprognostic (9.43e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (5.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.74e-2)" "unprognostic (5.26e-1)" "unprognostic (2.67e-1)" "unprognostic (5.47e-2)" 62.6 94.1 46.8 39.5 46.9 67.2 62.5 48.8 49.4 56.2 58.0 73.9 56.1 64.7 49.8 85.4 57.8 33.5 105.7 46.1 47.3 75.6 100.0 44.1 47.0 46.2 46.2 45.6 59.9 70.1 72.5 42.7 46.6 46.4 49.4 67.9 23.7 59.8 48.9 172.6 71.2 61.7 54.5 45.9 53.6 76.4 43.1 48.5 55.6 49.0 112.7 59.9 65.0 56.9 46.8 219.6 248.1 130.3 195.7 93.3 111.1 139.5 105.9 153.5 292.6 212.5 283.2 99.6 183.2 72.9 135.2 210.6 91.4 201.3 235.8 193.7 158.1 185.0 112.7 202.6 269.7 272.1 215.8 124.0 141.9 181.1 238.6 283.2 92.2 193.8 183.6 186.5 109.1 144.8 176.0 193.5 377.6 205.3 162.4 155.2 166.6 110.3 197.0 159.5 128.9 120.4 146.3 60.0 158.0 141.7 92.5 109.7 139.1 106.2 99.7 141.1 84.4 190.4 76.1 140.3 173.8 132.7 134.3 137.1 67.8 73.0 42.5 64.7 65.8 77.8 91.4 73.1 74.1 98.0 87.0 69.2 63.8 12.9 98.1 49.3 121.8 115.5 114.4 46.8 46.9 48.8 49.4 46.1 47.3 46.2 46.2 45.6 46.4 45.9 48.5 46.8 63.9 41.7 33.1 6.5 66.8 96.4 123.8 172.9 83.6 36.6 104.5 118.7 83.4 108.7 92.5 49.7 8.4 233.6 48.3 116.1 250.5 144.3 77.2 72.7 76.3 66.4 98.8 106.2 7.8 153.4 245.2 74.9 66.3 47.3 84.3 111.3 61.4 111.3 132.7 18.5 8.1 145.9 73.2 41.0 68.3 22.9 75.2 47.9 99.6 5.6 84.5 83.9 56.7 2.5 8.8 137.2 117.5 69.6 126.1 177.6 197.7 290.1 85.8 37.1 52.6 66.5 95.6 73.1 110.0 119.2 114.5 166.4 51.2 153.2 222.2 148.7 BRWD3 "FLJ38568, MRX93" ENSG00000165288 "Bromodomain and WD repeat domain containing 3" Q6RI45 X 80669503-80809877 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 69.4" "Cancer enhanced" "Detected in all" "testis cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012802 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012802: AB_2066662" "unprognostic (1.13e-2)" "unprognostic (2.14e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-3)" "unprognostic (7.04e-3)" "unprognostic (2.00e-1)" "unprognostic (1.50e-1)" "unprognostic (7.18e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-1)" "unprognostic (7.18e-2)" "unprognostic (1.62e-2)" "unprognostic (1.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.01e-1)" "unprognostic (3.35e-1)" 2.9 2.2 1.7 4.1 2.3 5.2 3.1 5.9 1.9 2.8 1.7 3.0 3.6 3.1 2.5 4.4 3.3 2.4 1.8 1.8 2.2 2.2 3.2 3.4 4.3 1.8 2.6 1.1 4.5 3.1 2.1 3.1 3.6 2.9 2.4 3.3 5.9 3.3 1.9 1.5 6.2 4.1 1.9 2.0 4.0 3.1 4.0 2.2 5.2 3.5 1.7 3.9 2.8 3.5 2.1 4.4 4.6 7.1 4.6 2.8 3.4 5.0 2.5 2.1 3.1 4.2 2.2 5.9 4.7 5.7 2.3 3.8 7.7 10.7 4.2 4.2 4.0 4.5 9.6 7.8 3.3 2.1 5.5 6.2 2.3 2.9 3.5 4.9 4.6 4.8 4.1 7.1 11.5 3.7 0.8 3.3 5.6 10.6 4.8 1.9 2.8 12.2 2.9 3.8 3.7 1.6 4.0 6.1 3.3 2.7 12.9 1.5 5.5 4.4 3.7 4.5 3.4 2.7 5.1 5.7 5.4 3.0 11.0 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 1.7 2.3 5.9 1.9 1.8 2.2 1.8 2.6 1.1 2.9 2.0 2.2 2.1 16.1 12.8 13.4 48.3 14.5 17.5 8.0 8.6 13.6 27.7 9.7 6.2 8.2 15.7 15.4 5.5 16.7 5.7 13.1 13.8 0.0 6.5 2.8 11.5 15.6 13.3 7.2 12.0 47.0 6.0 7.7 10.5 21.9 16.6 11.4 22.4 8.2 5.6 5.5 62.2 54.2 10.8 2.0 13.2 17.7 3.7 9.9 19.7 1.8 45.9 17.5 8.1 6.2 69.4 53.5 8.8 22.4 10.1 13.5 13.0 17.1 4.0 12.7 20.8 6.6 14.3 11.9 6.7 9.6 16.8 20.9 7.7 15.1 12.7 12.1 19.2 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.9;fallopian tube: 3.0;salivary gland: 3.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 9.7;Excitatory neurons: 20.4;Horizontal cells: 21.9;Inhibitory neurons: 13.3;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.0;HeLa: 3.7;hTERT-RPE1: 3.2;U-138 MG: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013843, HPA073230" Uncertain Approved Vesicles NA NA Vesicles "HPA013843: AB_1857233, HPA073230: " "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.0 0.1 1.0 0.0 2.1 0.0 0.1 0.9 2.9 0.1 0.0 0.2 0.0 0.0 0.4 0.1 3.0 0.0 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.1 0.3 1.9 0.3 0.3 0.0 0.2 0.0 0.9 0.8 0.1 0.7 3.8 1.3 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.1 1.2 0.0 0.9 0.1 0.1 0.0 0.5 1.4 0.0 0.7 7.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.3 0.9 3.7 0.0 0.4 0.0 0.0 1.5 0.1 0.0 0.6 3.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.7 0.1 0.1 0.2 0.0 1.1 0.1 0.0 0.2 0.0 0.0 0.5 1.7 0.0 2.4 0.0 0.0 0.4 1.1 0.0 0.0 2.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 2.1 0.9 2.9 1.8 0.8 0.1 0.3 1.9 0.9 0.2 1.2 1.4 0.0 0.0 1.1 1.3 0.0 0.1 1.5 0.0 0.0 9.7 0.6 1.7 1.8 1.5 0.0 0.0 4.2 0.0 5.9 0.2 0.0 0.4 0.7 2.1 0.5 1.0 0.0 2.7 20.4 0.0 0.0 1.6 0.0 5.0 1.3 0.5 0.0 0.0 0.0 21.9 13.3 1.9 0.0 0.0 0.0 1.0 5.9 0.5 0.0 1.0 0.1 7.0 0.0 11.1 0.9 0.0 0.1 4.9 0.0 2.5 0.0 0.1 1.5 1.6 0.0 4.6 0.3 5.5 0.2 0.4 0.0 0.0 0.1 0.0 0.2 1.1 MELK KIAA0175 ENSG00000165304 "Maternal embryonic leucine zipper kinase" Q14680 9 36572862-36677683 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.1;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 16.1;Erythroid cells: 15.2;Extravillous trophoblasts: 44.1;Spermatocytes: 23.2;Spermatogonia: 21.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "T-reg: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017214 Uncertain NA Yes "HPA017214: AB_1853798" "unprognostic (5.03e-2)" "unprognostic (9.57e-2)" "unprognostic (2.27e-2)" "unprognostic (3.42e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.91e-7)" "prognostic unfavorable (3.99e-4)" "unprognostic (1.26e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (4.69e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (8.86e-3)" "unprognostic (1.37e-1)" "unprognostic (2.40e-1)" "unprognostic (1.35e-1)" 0.9 0.5 0.0 5.8 0.0 10.1 1.4 0.0 0.1 0.9 0.1 6.9 5.3 1.0 0.0 8.0 0.3 0.6 0.1 0.0 0.2 0.3 0.7 1.0 10.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 5.4 0.1 0.3 8.6 0.0 1.2 0.1 0.0 3.4 4.5 2.5 0.1 2.1 3.2 9.3 0.2 21.2 0.3 0.1 11.8 1.7 2.3 0.5 123.4 62.1 81.6 48.5 11.1 18.8 47.1 88.8 62.2 121.5 148.2 47.8 47.3 40.9 27.8 43.8 106.5 41.0 71.7 55.5 133.1 112.3 28.6 32.0 69.1 48.1 4.3 50.2 39.0 6.9 9.8 93.9 53.0 15.6 62.2 61.9 41.7 63.2 100.9 40.9 63.1 23.4 65.1 55.1 47.9 57.4 54.9 25.8 37.7 40.7 55.1 40.8 47.4 45.3 28.6 45.2 38.0 23.7 30.8 65.4 81.8 56.1 82.3 12.3 47.9 60.7 41.2 36.8 91.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 1.7 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.7 1.9 4.6 0.9 3.5 0.0 0.0 0.9 0.8 0.4 0.0 2.0 0.0 0.0 16.1 0.7 4.5 0.0 1.1 2.8 2.9 1.4 1.3 0.0 15.2 0.8 1.1 44.1 3.3 4.6 2.1 0.0 7.8 1.4 0.7 10.1 0.0 0.7 4.7 4.1 1.6 3.0 2.7 1.2 1.9 0.0 0.0 3.1 0.0 2.1 1.0 0.4 1.7 2.7 0.0 10.2 0.5 0.6 0.1 2.0 0.0 0.0 0.0 3.7 23.2 21.3 9.3 1.7 8.9 2.7 0.7 8.9 2.3 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 13.7;choroid plexus: 29.3;fallopian tube: 44.9;testis: 33.9" "Cell type enhanced" "Detected in some" "Early spermatids: 364.4;Endometrial ciliated cells: 169.1;Late spermatids: 90.1;Respiratory ciliated cells: 204.6;Spermatocytes: 70.0" "Group enriched" "Detected in some" 5 "endometrial cancer: 4.0;ovarian cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "CAPAN-2: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037823, HPA037824" Enhanced NA NA "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.0 0.0 8.4 0.0 4.0 0.0 0.0 4.9 2.8 1.2 29.3 0.0 0.0 1.5 0.1 0.1 44.9 0.0 0.1 2.2 13.7 0.4 0.0 3.6 0.0 10.3 9.1 0.9 0.0 0.3 0.0 1.3 0.0 8.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 9.9 0.0 0.0 33.9 4.9 0.1 0.3 0.1 0.0 0.0 0.0 8.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.4 4.0 4.9 2.8 2.2 13.7 10.3 9.1 0.9 8.0 9.9 4.9 8.8 0.0 0.0 1.1 8.1 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.1 0.3 0.0 22.4 0.0 6.2 0.0 0.1 0.0 0.0 0.4 364.4 169.1 1.4 0.8 0.0 0.0 9.1 0.0 0.0 0.4 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 12.2 0.0 0.0 90.1 3.4 1.5 0.0 2.8 0.0 0.0 0.0 1.5 9.0 0.0 0.0 3.8 0.0 0.3 0.0 1.5 204.6 1.1 0.0 0.0 3.0 70.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439075-23442377 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 11.6 11.8 8.8 10.3 9.2 60.9 10.4 10.3 11.0 8.4 9.6 8.7 6.9 10.3 6.9 7.9 11.3 9.8 34.5 9.4 9.2 19.9 7.7 19.9 14.5 9.1 8.6 8.7 13.8 7.0 19.6 8.0 12.2 8.6 8.9 7.6 6.0 6.7 7.7 29.6 20.3 8.3 9.5 10.0 13.8 23.1 7.5 9.2 6.8 13.4 22.8 12.6 12.0 7.7 9.9 4.8 2.3 2.4 1.1 9.3 4.6 3.2 1.9 4.2 4.4 4.0 0.9 38.1 2.2 4.1 2.4 1.5 36.5 2.5 4.5 2.9 17.4 7.1 0.1 5.7 1.5 8.0 0.4 3.2 4.8 19.4 1.3 6.1 3.9 1.5 2.2 0.5 15.1 2.5 2.3 1.5 1.4 1.9 2.7 1.3 2.4 10.8 2.2 5.8 4.0 1.1 2.6 23.4 4.1 11.3 6.3 1.7 3.3 2.7 2.5 3.7 7.0 0.8 7.6 15.0 1.1 3.8 1.5 1.0 2.5 0.5 1.0 0.3 0.6 0.3 0.7 0.5 0.3 0.3 1.2 0.4 0.6 1.3 0.0 1.9 0.2 1.3 0.2 8.8 9.2 10.3 11.0 9.4 9.2 9.1 8.6 8.7 8.6 10.0 9.2 9.9 17.3 67.3 11.5 3.3 55.9 32.0 7.1 5.0 13.6 20.1 12.3 9.1 149.0 7.2 4.9 5.5 2.1 3.3 9.6 47.2 11.7 6.0 8.0 35.0 44.5 25.6 6.0 13.5 4.3 7.1 3.2 20.8 47.4 33.8 5.7 10.4 16.4 10.1 51.0 53.8 4.8 77.9 10.2 68.2 219.1 7.6 6.5 105.7 33.8 8.4 9.3 33.8 10.3 4.0 6.5 10.1 16.3 13.2 50.0 7.7 8.0 25.1 9.8 26.2 6.6 82.2 19.4 7.2 4.7 15.1 30.5 7.9 16.5 7.5 24.3 10.9 ARHGAP12 "FLJ10971, FLJ20737, FLJ21785" ENSG00000165322 "Rho GTPase activating protein 12" Q8IWW6 10 31805398-31928876 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000412 Enhanced NA NA "HPA000412: AB_10964051" "unprognostic (1.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.52e-1)" "unprognostic (3.42e-1)" "prognostic favorable (1.36e-4)" "unprognostic (5.88e-3)" "unprognostic (6.44e-2)" "unprognostic (6.60e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "unprognostic (5.68e-3)" "unprognostic (1.04e-1)" "prognostic favorable (4.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.29e-1)" "unprognostic (9.01e-2)" "unprognostic (5.48e-3)" 8.7 12.6 9.7 8.6 12.6 4.2 16.6 19.0 9.3 13.3 14.5 15.8 15.6 9.4 10.9 9.4 7.9 15.4 11.9 8.3 15.1 14.8 16.4 12.4 7.2 22.5 19.0 6.2 15.1 21.5 19.7 6.7 10.9 20.9 11.7 14.8 17.9 16.8 8.1 7.9 8.1 15.9 8.1 21.3 17.9 29.7 6.6 15.1 5.9 16.2 9.7 8.0 10.9 7.0 29.7 23.3 30.8 18.8 16.6 28.0 31.3 12.4 14.4 19.3 11.0 16.1 16.5 56.6 6.8 8.6 23.6 18.9 13.1 9.1 16.6 19.3 3.0 8.8 1.3 5.5 31.5 17.7 1.2 1.3 19.9 14.0 16.7 12.0 18.2 11.7 6.3 14.0 2.1 25.1 16.5 4.4 2.5 6.6 31.0 4.7 6.0 22.1 5.7 19.7 22.2 10.2 9.8 7.4 7.1 37.0 16.9 4.8 4.7 17.3 12.6 18.8 29.2 11.0 2.0 2.7 7.5 18.9 9.4 16.4 0.0 1.2 0.0 3.0 2.7 2.4 2.5 2.5 3.3 0.7 2.2 3.1 3.2 1.7 4.2 2.5 1.0 3.1 1.6 9.7 12.6 19.0 9.3 8.3 15.1 22.5 19.0 6.2 20.9 21.3 15.1 29.7 19.0 48.1 45.3 54.5 17.8 24.6 14.9 17.1 37.5 14.5 34.2 19.3 33.5 34.3 29.4 22.0 29.2 9.1 20.0 32.9 11.7 28.5 1.3 21.2 24.2 14.9 33.0 3.8 39.1 29.6 5.4 34.0 69.8 28.6 3.8 24.5 13.6 19.4 19.2 58.9 103.2 38.1 8.2 18.7 12.6 3.3 18.0 13.4 21.4 156.4 6.5 20.7 22.6 94.0 81.5 34.3 28.3 22.2 12.9 22.1 26.9 21.3 27.1 25.1 13.1 49.5 17.8 12.6 24.5 16.5 20.6 9.7 17.3 37.4 24.1 22.9 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92224818-92896473 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 15.8" "Cell type enhanced" "Detected in some" "Astrocytes: 265.8;Excitatory neurons: 512.9;Inhibitory neurons: 149.2;Oligodendrocyte precursor cells: 88.4" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.3;fHDF/TERT166: 2.2;NTERA-2: 2.5;SuSa: 2.2;U-2 OS: 2.1;U-251 MG: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026878, HPA074824" Uncertain Approved "Cell Junctions" NA NA 4700 "Cell Junctions" "HPA026878: AB_1848430, HPA074824: " "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.4 0.0 3.7 0.0 15.8 0.0 0.1 1.9 9.3 0.6 0.0 0.2 0.0 0.6 0.6 0.1 0.6 0.0 0.1 3.2 14.4 0.2 0.0 1.2 0.0 3.5 4.2 3.9 0.5 0.0 0.0 2.9 0.1 6.3 2.0 0.1 1.3 0.0 3.8 0.1 0.1 0.0 0.1 0.6 0.1 2.2 0.7 6.9 0.1 0.0 0.2 0.2 2.3 1.0 1.0 0.0 0.3 7.3 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.4 0.0 0.0 0.0 1.4 2.2 0.0 1.2 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 2.1 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 15.8 1.9 9.3 3.2 14.4 3.5 4.2 3.9 6.3 0.6 6.9 1.0 0.0 0.0 0.0 265.8 0.0 0.1 0.3 0.9 0.0 20.8 0.1 0.5 1.8 0.0 0.1 14.7 0.0 0.1 0.0 0.1 0.0 0.7 4.8 0.1 0.2 0.2 0.0 0.0 512.9 0.0 0.1 1.9 0.0 0.0 0.0 3.7 1.4 0.0 0.1 0.0 149.2 0.0 24.4 0.0 0.0 3.8 1.2 0.3 0.0 13.1 0.0 0.8 0.0 88.4 7.0 0.2 0.0 7.5 0.0 0.6 0.0 0.0 0.0 1.7 0.0 2.5 4.4 1.0 6.5 0.1 0.0 0.0 0.0 44.8 0.0 0.1 DEUP1 "CCDC67, FLJ25393" ENSG00000165325 "Deuterosome assembly protein 1" Q05D60 11 93329971-93438487 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 4.8;testis: 16.6" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 16.8;Respiratory ciliated cells: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.68e-1)" "unprognostic (3.25e-1)" "unprognostic (3.93e-1)" "unprognostic (7.24e-3)" "unprognostic (2.09e-1)" "unprognostic (4.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.79e-2)" "unprognostic (1.16e-1)" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-3)" "unprognostic (1.33e-1)" "unprognostic (6.03e-3)" "unprognostic (8.59e-2)" "unprognostic (2.25e-1)" 0.0 0.5 0.7 0.0 0.3 0.0 0.4 0.1 0.1 0.1 1.5 0.1 0.0 0.0 1.1 0.0 4.8 0.1 0.0 0.4 1.4 0.3 0.0 0.3 0.0 0.5 0.7 0.1 0.4 0.8 0.3 1.5 0.0 0.6 0.9 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.1 0.7 0.1 0.0 16.6 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.1 0.4 1.4 0.5 0.7 0.1 0.6 0.7 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 16.8 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 21.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 HECTD2 FLJ37306 ENSG00000165338 "HECT domain E3 ubiquitin protein ligase 2" Q5U5R9 10 91409280-91514829 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 127.5;Inhibitory neurons: 99.4;Microglial cells: 60.0;Oligodendrocyte precursor cells: 87.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.8" "Cell line enhanced" "Detected in many" "AF22: 29.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 56.1" HPA037767 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA037767: AB_10671378" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.26e-2)" "unprognostic (3.34e-1)" "unprognostic (6.65e-3)" "unprognostic (1.10e-2)" "unprognostic (9.37e-4)" "unprognostic (1.42e-1)" "unprognostic (1.59e-1)" "unprognostic (2.31e-1)" "unprognostic (2.54e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.67e-5)" "unprognostic (6.98e-3)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.84e-2)" 6.3 5.9 6.8 3.7 8.2 1.6 7.4 8.1 9.2 8.8 3.3 6.8 3.1 12.1 11.4 5.4 9.5 8.0 4.6 7.2 5.2 5.1 3.2 7.0 3.4 4.4 4.4 6.8 11.9 5.4 7.5 7.0 7.3 5.0 16.9 5.1 11.8 5.7 16.6 5.9 4.7 4.6 12.7 3.2 3.8 5.5 7.1 4.7 3.9 6.8 7.3 2.3 8.2 7.4 7.3 5.8 2.9 29.0 12.0 6.2 6.8 5.2 4.7 6.2 9.2 8.5 0.3 5.4 0.0 3.9 4.8 5.4 0.4 7.9 3.3 11.3 6.3 9.8 3.4 23.1 1.8 3.1 0.7 2.1 7.0 2.9 6.7 5.7 13.0 7.0 7.1 4.5 14.6 14.5 2.7 3.6 1.8 12.1 0.5 2.9 9.0 19.1 3.5 6.5 1.6 6.8 7.2 9.1 2.0 9.4 8.8 13.2 2.0 7.3 9.2 6.3 0.6 8.9 1.0 2.0 8.2 8.1 0.1 5.4 0.0 0.0 0.0 0.4 0.4 0.3 0.1 0.2 0.3 0.2 0.2 0.2 0.2 0.0 2.8 0.1 0.0 0.0 0.2 6.8 8.2 8.1 9.2 7.2 5.2 4.4 4.4 6.8 5.0 3.2 4.7 7.3 9.4 0.0 5.1 45.4 3.5 6.1 8.8 3.6 8.6 20.6 6.3 8.4 7.9 4.3 6.0 5.5 27.1 0.4 1.2 1.1 21.5 2.7 2.8 6.8 14.2 8.9 9.0 1.3 127.5 3.7 0.4 12.8 7.1 7.3 3.8 7.8 8.2 1.2 6.5 28.6 99.4 2.7 4.1 7.0 6.5 2.0 12.2 7.0 7.2 60.0 2.3 13.1 0.0 87.0 21.2 2.5 1.4 14.3 4.5 4.9 0.5 1.4 7.2 9.1 13.1 15.8 10.5 9.5 9.5 8.4 4.4 0.4 3.0 4.5 1.2 4.3 SLC7A3 "ATRC3, CAT-3, FLJ14541" ENSG00000165349 "Solute carrier family 7 member 3" Q8WY07 X 70925579-70931125 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.5;Early spermatids: 6.9;Granulosa cells: 1.5;Inhibitory neurons: 1.6;Late spermatids: 2.3" "Cancer enriched" "Detected in some" 12 "testis cancer: 43.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 64.2;NTERA-2: 130.9;SuSa: 154.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.42e-4)" "unprognostic (4.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.81e-2)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (3.66e-1)" "unprognostic (9.18e-3)" "unprognostic (1.89e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (5.42e-4)" "unprognostic (3.57e-2)" 0.0 0.0 3.5 0.1 0.7 0.9 0.7 0.1 1.1 1.5 0.2 0.1 0.1 5.3 1.3 0.4 1.6 0.1 0.0 0.8 2.7 0.0 0.0 0.0 0.3 0.9 1.9 0.7 1.0 0.0 0.0 0.3 0.0 1.6 5.9 0.0 0.1 0.2 5.4 0.0 0.0 0.2 2.7 0.3 0.0 3.1 0.8 4.1 19.9 0.0 0.0 0.3 1.0 0.8 0.8 0.0 0.0 4.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.5 0.0 0.2 0.0 64.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 130.9 0.0 0.0 28.4 9.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 154.2 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.1 1.1 0.8 2.7 0.9 1.9 0.7 1.6 0.3 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 FBXO33 Fbx33 ENSG00000165355 "F-box protein 33" Q7Z6M2 14 39397669-39432500 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046657 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046657: AB_10960398" "unprognostic (8.84e-3)" "unprognostic (6.72e-2)" "unprognostic (3.65e-2)" "unprognostic (2.79e-1)" "unprognostic (1.08e-1)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.94e-4)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.58e-4)" "unprognostic (9.61e-2)" "unprognostic (4.54e-1)" "unprognostic (4.41e-2)" "unprognostic (8.58e-3)" 7.0 9.7 11.7 8.2 13.3 53.0 6.5 11.7 17.3 8.1 16.2 5.9 7.3 6.6 10.2 5.3 6.1 7.4 5.3 15.6 12.4 7.4 7.0 8.0 9.5 13.3 12.1 13.0 6.2 6.0 13.3 10.9 7.8 12.3 7.6 5.8 8.4 6.7 7.4 3.0 5.7 5.7 6.6 11.0 7.9 6.1 12.2 12.1 11.9 11.7 6.7 9.8 7.3 4.9 13.9 12.8 7.8 7.0 10.8 24.7 11.5 11.6 12.6 16.9 6.9 8.0 4.7 11.1 14.3 15.2 19.7 6.9 6.4 18.3 12.4 12.3 13.7 11.8 5.7 10.5 12.2 7.0 21.7 20.9 10.7 13.2 11.8 3.8 11.9 5.8 14.0 5.0 12.6 13.6 13.7 19.4 13.5 7.2 11.5 11.6 16.6 11.4 13.0 13.2 16.1 12.1 5.5 11.3 11.8 14.0 10.4 8.7 13.7 7.5 11.6 10.4 17.4 10.1 17.0 21.6 22.6 9.0 10.1 8.8 0.9 0.9 1.8 1.6 1.1 1.4 1.2 1.6 1.7 0.8 1.1 2.2 2.1 3.9 2.8 1.1 0.7 1.7 0.6 11.7 13.3 11.7 17.3 15.6 12.4 13.3 12.1 13.0 12.3 11.0 12.1 13.9 14.7 9.6 20.1 21.9 25.7 34.5 13.6 6.4 27.9 24.0 19.1 16.4 8.9 4.3 8.1 9.2 43.8 8.4 40.8 18.0 7.9 8.1 42.1 25.7 14.3 14.7 23.9 16.2 82.6 9.3 9.5 14.8 12.8 39.8 10.2 10.1 13.9 10.6 10.5 28.6 46.7 14.2 2.0 19.2 23.3 10.7 8.4 22.6 19.6 23.4 14.8 12.4 10.3 34.7 36.7 14.0 10.1 5.3 32.7 21.5 13.9 4.0 8.4 17.9 0.0 18.8 17.8 28.5 12.2 24.0 56.4 21.2 31.4 8.0 13.7 24.7 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520659-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 20.7;U-937: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" NA NA Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589" "unprognostic (2.03e-1)" "prognostic favorable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favorable (2.94e-4)" 3.2 7.6 2.9 6.4 2.8 13.2 3.8 8.1 3.8 6.2 2.8 6.1 2.6 4.6 2.9 4.7 6.6 3.9 3.4 2.8 3.3 3.2 1.1 4.4 12.7 3.2 3.3 2.6 8.3 2.1 1.8 6.7 3.3 4.3 5.1 7.1 5.2 12.1 3.6 1.1 6.1 7.3 3.8 3.4 10.3 3.4 6.4 3.1 8.5 3.4 0.8 11.4 5.8 5.2 3.5 0.1 0.0 7.5 8.9 2.2 2.5 0.0 1.9 4.0 2.2 6.6 0.7 3.2 7.5 6.3 1.6 5.4 5.6 8.4 2.5 1.5 5.8 3.0 6.5 0.7 0.0 1.9 6.8 0.5 3.3 2.4 2.5 2.5 3.8 2.8 4.9 4.3 11.8 1.6 5.5 6.5 20.7 3.5 8.0 3.1 5.3 2.4 6.4 1.8 3.0 1.2 2.7 2.6 2.6 0.2 3.2 2.8 12.5 1.6 5.6 3.2 0.0 2.2 13.5 11.2 11.3 1.9 19.0 1.1 0.0 1.6 1.4 2.9 1.4 3.8 3.3 3.4 3.5 2.3 3.5 5.2 3.4 0.8 1.9 1.8 2.2 2.0 2.5 2.9 2.8 8.1 3.8 2.8 3.3 3.2 3.3 2.6 4.3 3.4 3.1 3.5 6.8 12.8 5.8 0.0 7.3 0.0 0.0 0.0 0.0 0.0 7.2 14.0 0.0 0.0 3.7 3.7 0.0 2.1 15.9 0.0 0.0 1.3 0.0 16.0 5.3 3.3 0.0 0.0 0.0 1.6 0.3 3.3 0.0 11.1 25.2 7.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.3 0.0 0.0 1.0 6.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 6.9 11.1 0.0 0.0 GPR101 ENSG00000165370 "G protein-coupled receptor 101" Q96P66 X 137023929-137033995 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 128 "brain: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 12.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 38.3" "Low region specificity" "Detected in many" HPA001084 Uncertain NA NA "HPA001084: AB_1078920" 0.0 0.0 2.7 0.0 12.7 0.0 0.0 0.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.0 1.7 0.5 0.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 12.7 0.4 3.4 0.1 10.5 1.7 0.5 0.7 1.7 0.9 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 92.2;gallbladder: 102.5;kidney: 166.7;seminal vesicle: 90.9" "Cell type enhanced" "Detected in some" "Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in many" 6 "hippocampal formation: 8.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 296.4" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9" "Region enhanced" "Detected in some" "medulla oblongata: 1.7" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: AB_2681530" "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favorable (1.70e-4)" "unprognostic (9.76e-2)" 0.7 3.0 0.2 2.2 0.1 0.1 0.6 1.5 1.2 0.0 92.2 2.1 21.1 0.1 34.0 0.1 0.3 102.5 0.0 8.8 0.0 166.7 44.6 1.4 0.0 0.2 1.2 0.1 0.0 13.3 0.0 0.2 0.0 0.3 1.2 4.6 0.7 0.1 90.9 0.2 0.3 24.7 0.2 0.1 0.0 7.8 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.2 27.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 296.4 0.2 0.0 0.0 0.1 46.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 1.2 8.8 0.0 0.2 1.2 0.1 0.3 0.1 1.1 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 14.3 0.0 1.8 0.0 0.0 0.0 0.3 15.6 77.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 49.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.9 0.0 0.0 0.3 2.7 0.0 0.8 0.0 1.4 0.0 0.7 0.0 0.0 1.6 1.6 0.0 1.0 0.2 30.9 3.6 0.0 0.0 0.0 32.9 153.1 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 14.2 0.0 LRFN5 "C14orf146, FIGLER8, SALM5" ENSG00000165379 "Leucine rich repeat and fibronectin type III domain containing 5" Q96NI6 14 41606876-41904549 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.1;parathyroid gland: 11.2" "Group enriched" "Detected in some" 19 "Excitatory neurons: 873.9;Inhibitory neurons: 581.5;Oligodendrocyte precursor cells: 296.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 16.4;HSkMC: 3.1;RPTEC TERT1: 5.2;SCLC-21H: 8.8;U-138 MG: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001177 Uncertain "Intracellular and membrane" NA NA "HPA001177: AB_1079274" "unprognostic (5.23e-3)" "unprognostic (1.37e-1)" "unprognostic (5.10e-1)" "unprognostic (6.24e-2)" "unprognostic (2.39e-1)" "unprognostic (3.54e-1)" "unprognostic (1.31e-1)" "unprognostic (6.38e-3)" "unprognostic (2.61e-2)" "unprognostic (5.78e-2)" "unprognostic (2.70e-2)" "unprognostic (9.27e-2)" "unprognostic (6.02e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (6.07e-3)" "unprognostic (2.92e-3)" 0.9 2.2 3.3 1.0 7.9 0.0 1.4 0.0 17.1 9.6 0.0 1.5 0.2 2.6 0.6 0.5 3.4 1.1 0.5 7.2 6.9 0.2 0.3 0.8 0.0 1.2 3.0 8.3 1.6 0.3 11.2 0.8 1.1 3.4 2.4 1.0 2.6 0.3 6.4 0.2 0.5 0.4 1.5 0.3 0.6 0.7 0.9 2.3 0.3 0.5 0.5 0.2 6.1 5.2 8.3 0.0 0.0 1.7 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 8.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 7.9 0.0 17.1 7.2 6.9 1.2 3.0 8.3 3.4 0.3 2.3 8.3 0.5 0.0 0.0 29.7 0.0 0.3 0.0 0.0 0.0 8.2 0.1 0.6 1.0 2.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.2 0.3 7.8 0.9 0.0 0.0 873.9 0.0 0.1 7.9 0.0 0.6 0.0 0.2 0.0 0.5 0.1 0.0 581.5 0.0 0.0 0.0 0.8 1.7 8.4 0.1 1.8 24.4 0.0 0.4 0.0 296.1 11.8 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.4 1.5 0.0 2.1 0.0 0.3 0.1 0.2 2.1 0.0 0.1 LRRC18 "MGC34773, UNQ933, UNQ9338, VKGE9338" ENSG00000165383 "Leucine rich repeat containing 18" Q8N456 10 48909483-48914232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "choroid plexus: 9.8;fallopian tube: 7.6;testis: 14.1" "Group enriched" "Detected in some" 8 "Early spermatids: 222.0;Late spermatids: 64.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039256, HPA076699" Enhanced Approved Cytosol NA NA Cytosol "HPA039256: AB_10671873, HPA076699: " "unprognostic (1.31e-2)" "unprognostic (3.66e-2)" "unprognostic (9.83e-4)" "unprognostic (3.10e-1)" "unprognostic (4.82e-2)" "unprognostic (1.98e-1)" "unprognostic (2.00e-1)" "unprognostic (8.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.16e-2)" "unprognostic (8.57e-3)" "unprognostic (4.08e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.4 0.4 0.4 0.4 0.3 0.6 0.3 0.6 9.8 0.4 0.2 0.2 0.0 0.1 7.6 0.3 0.3 0.8 0.8 0.0 0.0 1.5 0.2 0.7 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.7 0.0 0.1 0.0 0.0 0.8 0.4 0.2 0.8 0.1 0.2 14.1 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.6 0.3 0.8 0.8 0.7 0.8 0.1 0.7 0.8 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.0 6.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 64.1 1.8 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 SPTSSA "C14orf147, ssSPTa" ENSG00000165389 "Serine palmitoyltransferase small subunit A" Q969W0 14 34432788-34462240 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 405.2;Melanocytes: 435.8;Suprabasal keratinocytes: 443.8;Syncytiotrophoblasts: 512.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 180.0" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (6.24e-3)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (4.00e-1)" "unprognostic (3.19e-2)" "unprognostic (2.44e-2)" "unprognostic (6.64e-2)" "unprognostic (1.19e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-1)" "unprognostic (3.25e-1)" "unprognostic (5.86e-2)" 25.3 71.8 16.4 21.3 16.5 5.7 39.7 17.0 17.5 21.2 16.5 38.7 21.0 17.1 25.8 25.5 21.6 27.3 16.0 15.7 28.4 23.7 47.3 33.9 12.3 21.4 18.2 14.9 20.2 14.0 18.3 13.4 29.1 20.6 22.7 36.4 15.5 34.5 24.9 24.6 21.2 22.1 27.5 18.6 13.3 20.7 7.2 17.4 8.5 19.9 19.2 13.1 30.9 26.3 19.3 67.4 38.3 37.6 14.0 61.6 42.8 44.4 44.1 27.2 34.1 41.0 31.3 39.4 56.0 38.8 25.1 25.0 28.2 34.1 37.5 53.7 29.7 21.1 35.2 74.0 153.7 48.5 46.5 19.9 39.8 58.9 25.2 40.8 26.4 40.9 15.7 25.6 58.3 30.4 71.0 19.2 47.0 28.9 32.2 47.4 24.8 180.0 41.2 42.8 29.5 24.6 32.6 100.9 87.7 71.3 29.4 39.9 50.0 43.4 26.8 17.5 27.7 33.4 48.1 34.1 41.0 18.0 40.8 30.4 21.5 36.9 4.9 5.4 29.9 5.3 8.3 4.9 5.3 19.6 7.1 5.1 6.2 2.0 20.8 25.5 7.0 5.3 21.5 16.4 16.5 17.0 17.5 15.7 28.4 21.4 18.2 14.9 20.6 18.6 17.4 19.3 51.0 144.2 123.5 14.4 33.1 405.2 166.6 192.0 217.9 40.9 165.5 63.1 33.2 70.1 108.9 88.3 10.4 265.8 31.5 189.6 154.6 257.7 1.3 62.2 165.4 65.5 49.7 66.1 11.2 96.8 126.2 100.9 34.7 100.6 32.4 24.1 50.3 79.1 78.3 40.4 13.5 74.9 120.1 67.1 127.6 2.7 45.7 56.5 435.8 15.0 71.0 43.8 18.6 14.1 30.5 71.0 102.4 60.2 70.9 118.3 75.0 96.7 30.8 31.2 46.0 78.5 98.6 1.9 6.1 167.7 443.8 512.4 33.8 82.9 107.6 153.5 WRN "RECQ3, RECQL2" ENSG00000165392 "WRN RecQ like helicase" Q14191 8 31033788-31176138 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028661 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA028661: AB_10602255" "unprognostic (8.73e-2)" "unprognostic (9.33e-2)" "unprognostic (1.51e-3)" "unprognostic (3.85e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-2)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.27e-2)" "unprognostic (6.63e-2)" "unprognostic (1.53e-2)" "unprognostic (6.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-2)" "unprognostic (2.66e-1)" 3.1 3.7 2.1 3.2 2.3 8.3 4.9 4.3 2.7 3.0 2.8 3.5 1.5 6.4 3.2 2.7 2.9 2.4 1.7 2.1 2.1 2.1 2.6 2.4 2.5 2.4 2.2 1.1 5.2 2.7 2.0 2.2 3.6 2.3 3.5 3.0 4.4 3.6 2.6 2.1 4.1 2.5 4.2 1.7 3.1 2.3 3.0 2.0 3.2 3.2 2.2 3.0 2.6 2.3 3.6 4.4 5.9 10.8 5.3 6.7 9.8 5.0 4.7 4.9 6.4 6.6 2.7 1.5 10.0 4.6 4.3 4.4 2.4 6.4 3.8 9.7 3.3 4.3 9.6 4.9 4.4 5.4 8.7 4.3 7.1 3.7 3.6 6.2 3.9 7.7 6.1 14.5 5.0 6.8 2.0 17.5 6.6 7.7 5.1 3.2 7.5 7.5 6.7 2.9 4.4 3.3 5.2 6.9 2.7 3.8 4.9 2.9 5.3 9.1 6.2 3.8 3.1 4.9 1.4 3.0 14.6 5.5 3.8 4.2 0.8 0.2 0.3 0.3 0.1 0.4 0.5 0.5 0.3 0.2 0.5 0.3 0.4 0.3 1.1 0.1 0.1 0.3 0.1 2.1 2.3 4.3 2.7 2.1 2.1 2.4 2.2 1.1 2.3 1.7 2.0 3.6 17.5 9.6 10.6 74.7 15.1 13.5 11.7 5.3 18.8 14.5 14.7 10.5 7.5 15.7 8.8 16.5 22.9 7.1 18.0 5.3 1.9 6.7 116.3 15.8 32.3 12.5 2.4 49.2 59.7 9.8 5.7 15.2 21.9 17.1 2.5 18.5 7.1 9.7 5.3 15.2 54.9 13.8 8.2 5.3 6.6 12.8 19.0 7.8 10.6 51.5 6.9 14.3 4.1 61.3 88.6 9.1 4.2 14.3 16.6 15.3 3.9 2.7 10.0 19.8 6.6 20.2 15.3 10.9 19.2 10.1 10.2 5.6 13.0 15.2 7.7 11.0 MARCHF8 "c-MIR, CMIR, MARCH-VIII, MARCH8, MIR, RNF178" ENSG00000165406 "Membrane associated ring-CH-type finger 8" Q5T0T0 10 45454585-45594906 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014597 Approved NA NA "HPA014597: AB_1853580" "unprognostic (1.38e-1)" "unprognostic (3.69e-2)" "unprognostic (1.74e-1)" "unprognostic (1.68e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (3.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (2.04e-1)" "prognostic favorable (2.71e-4)" "unprognostic (1.28e-1)" "prognostic favorable (6.64e-4)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (3.12e-2)" 14.4 19.4 10.9 12.5 16.4 49.5 17.0 18.1 10.5 13.9 11.4 21.5 14.4 14.5 10.5 10.7 15.4 13.5 20.7 9.3 13.6 15.7 17.0 15.1 17.0 16.6 13.3 7.5 19.7 26.7 19.9 16.2 12.4 15.2 11.6 18.5 18.3 14.9 15.4 14.9 10.0 22.6 13.9 15.5 18.9 14.5 57.6 14.4 18.0 16.5 15.6 20.5 11.5 9.1 25.9 16.6 16.4 13.7 12.4 19.4 24.2 10.1 7.5 35.0 13.6 14.8 4.2 16.8 23.8 12.6 21.9 12.3 3.0 15.2 12.4 12.6 36.3 16.7 9.2 7.4 10.0 13.6 11.3 39.1 19.8 16.3 6.8 17.9 13.4 22.5 22.4 26.5 23.2 10.5 5.8 11.5 7.1 4.5 2.4 5.3 12.7 13.7 7.0 10.2 9.5 12.2 17.0 14.7 3.5 14.0 13.3 21.2 5.2 15.1 10.6 13.6 15.6 12.0 39.8 34.2 10.5 21.0 15.5 2.9 13.9 1.1 10.8 3.0 1.9 4.5 3.5 3.4 3.3 1.6 5.4 2.5 3.2 14.1 8.5 0.9 1.6 3.6 2.5 10.9 16.4 18.1 10.5 9.3 13.6 16.6 13.3 7.5 15.2 15.5 14.4 25.9 6.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 2.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 1.3 0.0 0.0 0.0 TSHR LGR3 ENSG00000165409 "Thyroid stimulating hormone receptor" P16473 14 80954989-81146306 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "thyroid gland: 276.5" "Group enriched" "Detected in some" 4 "Astrocytes: 5.5;Excitatory neurons: 7.0;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 9.5;Plasma cells: 11.7;Skeletal myocytes: 4.1" "Cancer enriched" "Detected in some" 116 "thyroid cancer: 100.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "naive B-cell: 1.7;T-reg: 6.9" "Group enriched" "Detected in many" 5 "B-cells: 1.7;T-cells: 6.9" "Cell line enhanced" "Detected in some" "JURKAT: 58.4;MOLT-4: 23.8;SCLC-21H: 23.0;U-266/70: 11.3" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.3" CAB000473 Approved "Intracellular and membrane" NA NA "CAB000473: AB_2303782" "unprognostic (3.36e-3)" "unprognostic (1.31e-3)" "unprognostic (1.02e-2)" "unprognostic (4.17e-6)" "unprognostic (3.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.83e-1)" "unprognostic (2.66e-2)" "unprognostic (3.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" "unprognostic (7.11e-3)" "unprognostic (5.08e-7)" "unprognostic (1.32e-1)" "unprognostic (7.40e-2)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" 0.5 0.6 1.4 0.8 1.7 1.2 0.8 4.4 2.6 0.2 0.2 0.5 0.3 0.6 0.5 0.2 0.8 0.5 0.3 1.5 0.6 0.3 0.5 0.2 1.9 1.3 0.4 1.2 0.3 0.4 0.3 0.2 0.4 1.9 0.5 0.3 2.3 0.6 0.2 0.8 1.1 0.4 0.2 0.1 0.8 0.5 0.7 0.9 21.0 276.5 0.2 0.8 0.4 0.1 2.9 0.4 0.2 0.7 0.4 0.1 0.1 0.3 0.2 0.0 0.0 0.1 0.4 0.5 0.7 0.2 0.1 0.5 0.3 0.3 0.0 0.1 0.3 0.1 0.3 0.8 0.4 0.0 0.2 0.4 0.3 0.1 0.1 0.3 0.1 0.0 58.4 0.3 0.7 0.1 0.4 23.8 0.5 0.4 0.1 0.2 0.8 0.2 0.9 0.0 0.5 23.0 0.4 0.2 0.2 0.3 0.5 0.3 0.1 0.2 0.7 0.5 0.6 0.3 11.3 6.3 0.6 0.3 0.3 0.5 0.5 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.3 0.1 1.7 0.2 0.1 0.9 0.1 0.2 0.5 6.9 0.1 1.4 1.7 4.4 2.6 1.5 0.6 1.3 0.4 1.2 1.9 0.1 0.9 2.9 0.2 0.0 0.5 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.1 0.2 0.3 1.8 0.0 7.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 6.5 0.0 0.1 0.0 6.6 9.5 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.6 0.0 4.1 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34709113-34714823 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 376.3;skeletal muscle: 726.7;tongue: 692.4" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 522.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 47000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 49.1 52.9 78.4 28.9 103.7 18.3 24.8 95.5 111.6 40.1 64.8 68.3 14.4 74.0 19.6 69.7 42.9 24.4 376.3 78.3 93.6 31.7 126.9 25.1 10.7 98.2 94.0 65.3 41.5 9.5 24.6 11.0 35.6 98.1 76.1 28.4 41.4 17.2 108.4 726.7 7.2 24.2 116.0 86.5 12.8 36.4 21.9 89.7 10.5 29.7 692.4 10.0 57.3 24.5 138.8 87.1 77.7 49.5 32.0 51.1 185.6 27.9 146.6 170.5 145.6 151.4 61.9 38.5 30.6 58.5 245.2 104.9 17.1 107.4 32.5 268.6 4.2 45.0 6.6 87.4 144.5 81.6 8.2 5.3 139.3 12.4 122.2 67.7 96.8 145.9 4.5 9.9 26.8 186.9 25.5 6.3 4.3 16.3 15.4 118.9 5.4 158.1 4.7 55.1 17.7 10.3 41.7 96.6 21.5 51.2 36.2 47.8 7.5 124.6 140.9 93.0 66.1 72.9 34.3 22.8 11.7 51.7 11.4 34.5 1.8 1.0 1.3 1.9 1.0 3.1 4.9 2.2 2.1 1.6 3.0 1.7 1.8 0.3 1.8 0.4 1.6 2.1 0.9 78.4 103.7 95.5 111.6 78.3 93.6 98.2 94.0 65.3 98.1 86.5 89.7 138.8 39.6 105.8 41.6 6.2 17.0 20.0 88.6 31.3 23.9 62.8 19.6 16.6 522.2 22.8 26.3 22.0 20.9 32.2 11.5 0.9 60.7 45.2 2.6 40.3 60.5 45.1 9.5 11.4 9.6 39.7 60.5 69.9 6.1 56.2 5.7 25.8 47.2 112.0 15.6 77.4 14.2 2.4 57.0 15.7 14.4 10.1 57.2 10.6 30.2 11.2 5.7 112.9 15.5 8.0 93.8 24.7 4.0 98.6 60.4 84.0 1.0 101.9 24.7 57.8 32.9 83.9 115.8 49.3 51.9 16.1 19.5 21.3 21.1 47.9 4.6 58.5 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 17000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: AB_2678745" "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 25.8 31.7 39.0 25.7 39.7 32.3 23.8 40.4 46.6 21.6 35.7 25.7 27.6 19.8 20.5 30.3 19.6 19.8 37.3 39.5 37.5 32.0 36.8 22.6 27.6 39.2 36.6 31.7 21.7 30.8 19.9 27.1 26.2 40.6 19.8 27.2 22.4 25.4 16.5 29.9 24.7 27.1 22.3 38.2 23.4 27.0 34.8 40.9 30.0 21.3 28.3 30.2 27.5 24.5 52.1 47.0 50.2 72.9 55.6 70.4 57.0 69.8 100.8 66.3 61.7 49.0 110.3 114.7 102.4 27.9 62.8 89.5 79.0 90.6 57.9 90.0 85.3 37.7 95.1 65.8 84.4 51.1 74.8 68.7 40.0 51.7 63.9 48.2 79.0 105.0 64.8 90.5 32.7 95.7 33.4 70.3 136.6 85.3 183.9 47.8 79.6 42.4 44.4 108.0 51.7 24.1 30.7 52.1 42.2 49.8 82.6 43.5 70.3 76.1 51.3 59.9 59.6 87.6 25.7 38.9 91.5 30.8 59.2 75.5 63.6 29.0 49.0 24.3 34.5 23.9 30.9 31.4 33.2 32.9 30.3 23.8 26.6 4.1 33.2 34.1 41.0 46.0 25.2 39.0 39.7 40.4 46.6 39.5 37.5 39.2 36.6 31.7 40.6 38.2 40.9 52.1 82.1 38.5 36.0 22.2 46.1 39.8 65.4 68.2 38.1 52.6 40.6 55.8 126.2 32.9 51.8 51.5 25.0 67.0 78.3 52.3 78.2 88.3 185.6 112.0 79.0 65.9 34.1 65.2 19.9 89.0 143.0 60.9 50.0 75.1 36.8 49.7 43.5 38.3 97.8 50.5 23.0 58.2 54.9 44.5 43.9 95.7 58.7 54.3 48.0 13.1 123.7 91.8 58.7 21.1 47.6 85.2 55.0 59.8 58.3 44.1 74.3 100.9 67.8 56.6 26.3 72.4 92.1 146.7 101.0 45.7 43.2 74.4 61.1 56.1 55.5 52.3 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 10.5 10.2 4.6 13.0 6.0 7.4 13.1 13.8 11.2 11.1 0.7 10.2 9.7 12.1 14.8 13.4 8.8 10.0 10.3 5.2 7.5 11.5 14.6 9.1 16.3 3.6 4.3 1.6 13.1 9.9 14.6 5.7 13.3 4.7 10.9 11.1 13.6 8.4 9.1 10.8 11.4 9.2 10.5 3.0 12.7 10.7 19.8 4.4 21.2 23.4 15.6 14.8 10.8 7.5 6.7 20.5 20.0 41.0 27.8 22.8 19.0 15.7 25.9 24.7 21.6 19.4 30.0 20.1 33.9 20.5 20.1 15.9 15.5 28.7 18.2 38.0 31.1 9.0 31.4 21.5 17.9 22.5 21.6 30.6 17.9 13.6 29.8 38.4 22.5 22.4 27.1 19.5 44.0 27.9 34.0 54.9 12.5 22.9 15.5 19.8 30.0 36.6 20.8 14.4 41.2 40.2 23.7 59.8 22.8 25.6 19.6 34.6 17.8 29.4 21.9 17.0 30.7 25.9 35.9 42.2 34.5 17.5 24.6 35.8 7.3 0.7 1.3 1.3 0.5 1.0 0.7 1.2 0.7 0.4 0.6 1.0 1.2 1.2 1.0 2.6 1.9 0.7 0.5 4.6 6.0 13.8 11.2 5.2 7.5 3.6 4.3 1.6 4.7 3.0 4.4 6.7 27.0 19.2 13.6 25.5 22.3 18.0 8.6 11.9 10.8 24.9 18.4 19.7 26.5 5.7 14.0 23.9 35.5 15.1 21.4 21.2 1.9 12.0 59.4 14.5 26.5 20.7 18.6 32.0 32.9 13.0 14.4 20.0 17.9 18.9 30.4 37.2 16.8 25.9 17.0 40.4 33.4 17.5 10.2 25.2 22.1 8.0 12.8 25.0 10.6 29.0 30.9 22.0 18.6 26.7 26.4 12.4 15.8 13.5 56.2 16.6 13.0 15.0 11.4 15.8 26.3 22.0 23.7 28.6 26.5 23.9 24.4 26.0 21.7 16.2 11.6 12.0 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 169.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 66.0;Hepatic stellate cells: 64.2;Hepatocytes: 59.2;Leydig cells: 68.6;Oligodendrocyte precursor cells: 184.5;Oligodendrocytes: 130.6;Peritubular cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 135.0;ASC TERT1: 115.1;BJ hTERT+: 91.6;HSkMC: 120.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 40.8 12.0 127.6 13.9 144.3 2.6 32.8 120.4 104.6 37.1 56.9 49.0 6.2 43.2 9.0 14.1 34.3 24.0 34.0 99.9 107.7 8.7 33.4 22.9 7.5 142.6 153.4 80.4 26.7 8.5 4.0 9.5 16.3 169.1 32.5 9.0 3.8 12.1 27.5 58.4 12.5 18.4 36.4 131.6 11.0 25.7 8.9 137.3 2.7 18.6 26.7 4.3 43.5 23.1 140.3 3.3 3.1 10.4 9.0 135.0 115.1 2.5 24.6 91.6 14.2 16.5 2.6 0.1 0.1 13.1 49.5 5.0 0.3 1.7 0.6 11.9 6.2 6.5 1.3 7.2 3.1 35.1 3.8 2.0 120.5 1.3 12.8 3.5 42.1 2.9 0.9 4.8 5.3 12.3 1.1 0.1 14.9 2.5 0.6 30.1 0.6 12.3 2.2 1.7 4.0 0.3 12.9 7.7 0.9 31.5 9.7 3.5 7.0 2.0 13.6 12.4 37.4 8.5 9.2 6.5 0.1 27.9 4.9 49.4 0.0 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.1 0.1 127.6 144.3 120.4 104.6 99.9 107.7 142.6 153.4 80.4 169.1 131.6 137.3 140.3 36.2 0.0 2.6 29.0 1.4 7.6 1.4 1.5 1.8 0.1 5.6 5.7 20.2 5.7 1.2 0.0 0.0 0.6 4.5 0.3 0.0 0.8 2.0 2.3 66.0 29.5 0.0 4.4 0.3 0.8 0.9 40.9 5.1 2.6 1.3 4.1 64.2 59.2 10.7 0.0 0.5 0.4 0.0 17.1 14.5 4.8 68.6 7.4 16.0 30.0 5.6 16.7 1.0 184.5 130.6 0.9 0.1 65.5 5.0 2.9 0.0 1.8 1.2 1.1 13.1 38.7 24.0 0.7 1.7 1.4 4.5 1.5 3.6 8.9 0.1 1.3 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330316-74398433 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 90.1;Exocrine glandular cells: 124.5;Pancreatic endocrine cells: 140.1;Respiratory ciliated cells: 95.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 16.6;LHCN-M2: 19.9;RH-30: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria No No 140000 Mitochondria "HPA056995: AB_2683305, HPA060948: AB_2684394" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 1.9 2.6 10.9 3.7 24.1 3.2 1.9 0.0 14.3 4.2 0.0 3.2 1.3 4.5 0.8 1.1 3.2 3.3 1.0 20.7 15.0 1.3 1.0 1.8 3.0 2.5 4.8 19.5 0.9 3.1 0.7 3.9 1.1 3.0 2.9 3.5 2.7 2.6 1.3 6.0 0.7 1.5 4.0 0.0 1.5 2.2 1.3 4.7 8.2 2.7 11.2 2.7 6.5 1.9 13.2 2.7 3.8 14.5 2.7 4.3 1.9 0.4 3.5 2.6 3.0 3.3 1.4 6.8 0.3 8.5 2.3 5.3 1.3 2.9 0.7 2.8 1.1 1.5 2.1 2.0 1.1 0.5 2.4 3.2 1.0 0.7 6.8 1.2 3.2 16.6 5.0 2.8 1.8 19.9 0.3 9.9 2.1 2.9 2.0 3.3 3.1 18.9 0.1 7.8 0.5 0.7 2.9 5.7 1.3 2.6 3.9 0.2 0.4 14.0 6.6 6.0 2.7 3.7 2.4 3.8 0.3 0.6 3.4 1.6 1.2 0.3 0.5 0.9 0.3 1.3 1.1 1.6 1.1 0.2 0.8 1.5 0.8 0.3 1.4 0.2 0.8 3.9 0.5 10.9 24.1 0.0 14.3 20.7 15.0 2.5 4.8 19.5 3.0 0.0 4.7 13.2 19.6 6.4 6.4 8.5 20.9 7.6 41.2 14.3 10.8 23.9 26.5 19.4 7.3 17.2 30.2 9.2 16.7 0.6 17.6 13.8 5.9 37.4 14.1 28.1 23.5 32.1 11.9 47.5 90.1 124.5 5.3 21.0 7.1 25.5 8.2 16.1 29.3 1.0 5.4 8.4 64.8 16.2 18.3 23.0 21.6 3.6 2.5 9.9 16.0 20.6 4.6 4.4 12.3 14.6 7.1 140.1 9.3 3.8 13.4 50.4 4.2 5.3 95.4 11.0 26.3 21.3 16.7 34.2 21.2 9.0 5.3 0.1 25.0 8.8 20.9 55.6 PHYHIPL "Em:AC025038.1, KIAA1796" ENSG00000165443 "Phytanoyl-CoA 2-hydroxylase interacting protein like" Q96FC7 10 59176643-59247774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 18.6;brain: 49.1;retina: 30.7" "Cell type enhanced" "Detected in many" "Astrocytes: 210.6;Early spermatids: 208.4;Horizontal cells: 144.7;Inhibitory neurons: 170.2;Late spermatids: 241.4;Muller glia cells: 246.1;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 357.1" "Group enriched" "Detected in many" 5 "glioma: 21.1;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.3;Hep G2: 34.3;SCLC-21H: 6.1;SH-SY5Y: 19.4;SK-BR-3: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038746 Uncertain Approved Cytosol NA NA Cytosol "HPA038746: AB_10673293" "unprognostic (6.34e-3)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-3)" "unprognostic (7.06e-2)" "unprognostic (3.37e-1)" "unprognostic (5.63e-2)" "unprognostic (3.78e-2)" "unprognostic (1.06e-1)" "unprognostic (4.00e-3)" "unprognostic (2.67e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.60e-7)" "unprognostic (1.29e-3)" "unprognostic (1.30e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 0.3 18.6 28.0 0.4 32.8 0.0 0.4 36.0 37.2 1.6 4.6 1.6 8.6 0.7 1.8 0.3 1.1 0.1 0.3 25.6 38.9 11.1 1.1 0.2 0.0 43.1 36.1 24.0 0.8 5.4 0.0 6.8 1.8 38.6 2.9 0.3 30.7 0.7 2.6 0.6 0.3 8.9 0.1 41.0 0.1 0.6 6.6 32.2 0.0 0.2 0.0 0.0 0.2 1.2 49.1 0.0 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 19.4 0.0 8.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 32.8 36.0 37.2 25.6 38.9 43.1 36.1 24.0 38.6 41.0 32.2 49.1 3.1 0.0 0.0 210.6 0.0 0.0 14.0 0.0 0.0 135.2 0.2 1.0 0.5 2.8 0.0 3.7 12.5 1.0 0.0 0.1 13.7 0.6 208.4 24.1 8.0 1.6 0.0 2.7 97.3 6.5 0.3 1.2 0.0 71.9 0.0 0.8 0.7 1.8 0.5 144.7 170.2 3.0 0.0 0.0 0.0 241.4 13.1 1.3 1.8 11.2 0.0 246.1 0.0 264.9 357.1 1.7 6.3 0.4 0.0 4.0 24.0 80.3 0.0 53.9 0.0 3.0 2.4 137.1 27.2 0.1 0.0 49.0 0.6 0.3 9.6 2.8 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650764-59736002 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 152.8;kidney: 192.8" "Group enriched" "Detected in many" 4 "Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4" "Cancer enhanced" "Detected in many" "renal cancer: 21.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049286: AB_2680699" "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favorable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 1.2 152.8 13.5 1.2 12.9 1.8 1.7 13.1 15.0 18.7 17.2 12.6 0.4 16.3 5.3 11.0 22.2 3.2 3.4 13.5 24.5 192.8 2.5 1.1 1.7 14.2 13.7 10.0 34.4 3.1 29.4 7.0 0.1 11.9 7.8 16.9 5.7 2.9 10.3 4.3 0.4 1.2 7.2 13.5 41.1 6.1 9.0 12.8 1.2 14.1 2.8 2.8 2.2 9.1 15.7 0.0 0.3 5.2 6.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.7 0.0 0.0 0.9 10.8 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.1 2.3 0.0 0.5 0.2 0.0 2.8 0.1 0.4 5.4 8.0 0.1 0.6 4.2 3.0 0.0 20.1 2.0 9.3 3.6 0.2 7.2 0.0 0.3 3.4 9.6 0.1 0.4 0.0 10.1 3.4 4.5 3.2 0.5 1.1 0.1 10.6 0.0 0.0 0.0 0.0 18.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 12.9 13.1 15.0 13.5 24.5 14.2 13.7 10.0 11.9 13.5 12.8 15.7 0.3 0.0 0.0 83.9 1.0 0.1 2.1 9.4 0.6 4.3 3.1 1.5 3.9 0.0 26.2 7.3 0.0 0.0 0.0 108.6 25.4 1.0 0.2 2.3 2.0 1.5 20.0 4.2 2.5 0.0 1.7 4.1 3.6 2.4 0.0 28.4 0.4 0.0 0.1 3.3 4.8 19.1 4.1 18.8 0.7 1.5 13.7 1.5 3.6 1.9 0.6 11.8 0.0 14.6 1.0 0.1 23.2 12.0 0.0 17.7 2.2 252.6 7.4 1.0 0.0 2.4 3.4 0.3 0.2 17.0 0.1 0.0 0.7 99.4 11.9 6.5 FOLR2 FRβ ENSG00000165457 "Folate receptor beta" P14207 11 72216601-72221950 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 169.9" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 1114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 64.2;intermediate monocyte: 50.6" "Group enriched" "Detected in many" 4 "dendritic cells: 18.7;monocytes: 64.2" "Cell line enriched" "Detected in some" 5 "U-698: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 15000000 "unprognostic (2.03e-1)" "unprognostic (6.58e-3)" "prognostic unfavorable (8.42e-4)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-1)" "unprognostic (2.51e-1)" "unprognostic (8.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.91e-3)" "unprognostic (6.16e-3)" "unprognostic (1.14e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.98e-3)" 120.1 55.6 10.0 28.5 9.7 10.9 32.0 6.7 18.7 28.1 18.3 36.4 19.6 13.7 12.5 31.9 16.9 80.8 38.9 9.7 16.0 10.9 45.2 40.0 79.1 8.4 8.3 8.4 16.1 7.2 7.9 6.1 169.9 8.7 6.1 47.2 0.2 12.9 16.8 6.0 8.9 29.8 46.7 7.4 27.9 21.2 13.1 11.2 29.0 9.2 26.5 29.2 82.0 6.3 12.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.2 0.0 18.6 0.5 0.8 0.0 0.0 64.2 0.0 0.3 50.6 0.0 9.5 0.0 0.0 18.7 4.0 0.0 0.0 1.1 1.8 13.7 0.2 0.0 20.4 10.0 9.7 6.7 18.7 9.7 16.0 8.4 8.3 8.4 8.7 7.4 11.2 12.9 3.4 0.0 0.6 0.0 8.0 7.9 0.1 0.0 1.2 0.0 0.1 1.1 2.2 1.5 0.0 0.0 0.0 7.6 0.6 0.0 0.0 0.0 0.9 0.3 0.1 2.3 0.0 0.0 0.0 0.0 6.0 2.4 0.0 0.5 2.5 0.0 2.2 1.7 1114.8 0.0 0.0 0.0 0.0 229.3 98.8 2.5 1.5 199.4 0.0 15.9 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.1 0.0 0.2 0.0 0.3 0.0 2.5 1.2 0.6 0.7 1.3 5.1 16.0 1.2 0.1 0.0 0.1 INPPL1 SHIP2 ENSG00000165458 "Inositol polyphosphate phosphatase like 1" O15357 11 72223701-72239147 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Immunity" "Actin-binding, Hydrolase" "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 344.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037601 Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA037601: AB_10672281" "unprognostic (2.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.68e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (1.99e-3)" "unprognostic (2.07e-1)" 43.2 56.9 31.5 34.7 31.9 51.8 45.0 37.0 40.8 59.6 40.6 75.5 36.2 56.5 18.4 34.9 61.9 34.0 66.5 26.7 37.1 59.8 36.9 62.4 37.1 45.2 34.9 19.7 69.2 56.2 36.7 61.0 40.1 46.0 69.3 23.5 15.0 54.3 39.9 117.7 31.6 57.6 33.7 36.9 66.6 61.3 24.4 37.3 19.5 68.3 43.4 23.4 60.4 43.8 36.3 28.7 62.1 71.5 49.8 35.4 41.1 122.5 118.9 61.2 80.6 49.6 84.3 72.2 79.5 125.6 101.7 57.8 106.7 60.4 37.6 28.0 101.9 59.1 84.8 344.5 31.9 68.1 56.1 176.7 58.2 39.1 78.0 31.4 100.5 44.2 29.3 59.7 34.7 45.1 78.8 42.1 224.9 67.7 20.7 93.7 185.0 161.0 18.2 94.8 48.6 33.8 48.6 133.9 85.1 182.8 36.6 88.8 106.0 74.5 86.4 96.7 129.9 43.1 94.5 17.5 80.1 24.7 51.7 47.2 2.5 3.5 3.3 1.9 2.0 1.7 0.9 1.6 1.3 2.4 1.0 1.1 1.6 2.3 2.2 3.6 1.8 1.5 1.8 31.5 31.9 37.0 40.8 26.7 37.1 45.2 34.9 19.7 46.0 36.9 37.3 36.3 13.9 3.2 12.8 47.0 8.1 7.1 4.9 10.8 14.2 1.7 20.3 17.3 13.6 11.5 11.7 12.9 27.1 27.9 9.1 28.3 1.9 11.6 1.5 14.6 16.3 11.2 22.7 5.7 2.6 12.5 15.4 10.8 24.5 25.5 7.6 21.0 8.9 12.5 21.7 10.1 2.2 16.4 18.3 27.6 16.2 2.1 9.9 29.8 10.6 18.7 17.6 16.8 14.4 15.1 6.1 14.9 17.5 13.9 7.8 7.8 15.2 16.2 10.2 17.2 6.6 12.9 14.5 1.4 4.9 6.7 4.8 32.4 11.6 10.1 21.8 5.4 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2A" O14813 11 72239077-72245664 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 20.1;brain: 10.2" "Cell type enriched" "Detected in single" 4 "Spermatogonia: 2.9" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enhanced" "Detected in some" "pons: 10.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 226 "SH-SY5Y: 569.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA053810, HPA065621, HPA078004" Enhanced Supported Nucleoplasm No NA Nucleoplasm "HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367" "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 20.1 0.1 1.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 2.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 4.4 0.0 0.0 0.2 0.0 0.5 0.0 10.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 1.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 569.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.8 1.6 4.4 0.0 10.2 0.2 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBL2 "COLEC1, MBL" ENSG00000165471 "Mannose binding lectin 2" P11226 10 52765380-52772784 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2833 "liver: 283.2" "Cell type enriched" "Detected in some" 66 "Hepatocytes: 238.5" "Cancer enriched" "Detected in single" 275 "liver cancer: 22.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "Hep G2: 2.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "basal ganglia: 1.1" "HPA002027, CAB016782" Enhanced "Secreted to blood" NA NA 1220000000 1900000000 "CAB016782: , HPA002027: AB_1079324" "unprognostic (1.72e-2)" "unprognostic (3.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 283.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 238.5 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 GJB2 "CX26, DFNA3, DFNB1, NSRD1" ENSG00000165474 "Gap junction protein beta 2" P29033 13 20187463-20192938 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 818.6;vagina: 524.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9" "Cancer enhanced" "Detected in all" "head and neck cancer: 447.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9" "Low region specificity" "Detected in all" "CAB013093, HPA014362" Uncertain Approved Mitochondria NA NA Mitochondria "CAB013093: AB_2533903, HPA014362: " "unprognostic (2.21e-1)" "unprognostic (1.25e-3)" "unprognostic (2.43e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (4.45e-4)" "unprognostic (9.77e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.33e-1)" "unprognostic (3.69e-3)" "prognostic unfavorable (2.90e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (2.53e-6)" "unprognostic (5.78e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (8.93e-3)" 1.6 0.7 1.5 6.8 1.1 3.8 3.8 2.3 3.1 157.0 4.7 21.0 13.0 2.9 3.4 818.6 0.9 14.1 0.4 1.1 2.9 9.9 47.8 0.7 0.4 1.8 1.6 1.2 0.3 1.4 0.1 4.1 0.2 1.6 1.2 17.5 0.0 146.3 0.3 0.4 65.0 10.7 2.6 1.7 0.2 8.1 1.3 6.0 12.6 1.7 1.2 91.2 28.2 524.0 1.7 8.7 0.6 0.0 0.2 0.0 2.9 1.7 0.0 0.0 0.0 0.0 1.3 144.6 0.0 0.7 0.1 1.1 28.9 5.3 14.4 0.1 12.6 1.8 0.1 0.1 0.3 0.0 0.0 5.1 2.4 105.4 1.9 19.5 0.0 0.0 2.1 0.1 10.7 0.2 1.4 1.3 0.0 0.3 76.9 14.4 0.2 0.0 8.3 0.2 169.9 0.1 0.0 0.3 0.1 0.3 1.9 2.2 0.4 0.0 0.2 0.0 2.5 22.2 8.7 9.6 0.0 17.1 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 2.3 3.1 1.1 2.9 1.8 1.6 1.2 1.6 1.7 6.0 1.7 0.1 3.2 0.0 2.0 0.6 69.8 16.1 237.4 55.8 0.0 1.3 1.3 0.5 4.3 37.3 1.8 0.0 0.1 0.0 28.0 0.0 4.4 1.5 5.0 1.5 1.3 4.2 0.0 0.0 9.8 0.2 1.7 4.1 19.1 0.0 0.0 0.0 25.2 0.6 0.0 0.0 6.1 50.8 0.6 13.3 1.3 0.0 3.9 1.8 0.0 4.6 0.0 0.0 0.0 0.0 9.2 13.3 0.0 2.7 8.6 10.7 17.5 7.5 0.0 0.0 0.1 4.7 0.8 2.1 160.9 28.7 0.1 0.9 0.0 25.0 21.7 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 332.9;liver: 256.1" "Cell type enhanced" "Detected in all" "Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040403, HPA058848" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 690000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632, HPA058848: " "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 30.4 32.1 68.5 15.5 78.1 11.3 27.3 74.0 78.8 33.3 63.1 62.7 191.9 30.8 52.1 24.9 26.8 30.3 28.3 63.8 75.0 332.9 256.1 20.1 19.6 81.6 71.7 59.6 20.0 47.3 31.6 38.4 16.2 73.8 32.5 49.8 20.9 41.9 36.9 17.2 15.4 132.7 23.0 77.2 23.5 45.6 4.9 70.4 18.2 35.3 20.9 16.4 21.1 23.8 88.9 8.1 6.9 6.4 42.7 31.6 36.1 5.8 11.1 20.0 4.8 3.9 2.6 7.8 0.1 20.6 15.5 10.9 1.9 5.7 9.9 4.9 19.4 4.7 14.2 0.8 55.1 18.1 4.6 12.2 21.5 6.4 3.9 22.0 17.1 51.7 20.3 1.0 5.8 12.7 29.2 12.7 7.2 0.4 68.7 10.2 6.4 3.8 1.0 40.8 16.9 4.2 5.0 6.6 3.1 51.0 3.0 21.2 18.0 50.1 5.8 2.6 14.3 7.1 7.6 1.6 0.0 11.1 7.9 24.5 5.8 50.7 3.2 23.2 59.6 18.9 20.5 30.6 22.1 60.5 23.1 23.5 22.2 1.7 15.6 50.6 6.4 37.5 43.8 68.5 78.1 74.0 78.8 63.8 75.0 81.6 71.7 59.6 73.8 77.2 70.4 88.9 29.2 6.4 10.3 57.8 17.7 10.3 15.9 29.7 6.2 6.1 22.0 11.6 10.5 35.8 25.6 77.3 12.5 22.0 10.0 138.5 485.2 26.1 3.6 32.5 8.8 29.1 9.1 6.9 54.5 31.6 11.2 29.8 34.1 27.2 25.3 8.8 50.7 306.1 71.4 1.7 35.3 89.0 32.6 91.6 34.3 4.3 26.1 51.3 37.4 13.1 19.3 112.2 9.2 33.7 114.1 43.2 219.1 24.0 14.3 23.0 509.9 1033.9 20.9 12.6 19.7 23.4 14.7 1.0 2.7 13.0 9.2 20.8 20.1 20.7 105.2 15.0 REEP3 "C10orf74, Yip2b" ENSG00000165476 "Receptor accessory protein 3" Q6NUK4 10 63521401-63625128 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 346.0;Urothelial cells: 270.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.85e-2)" "unprognostic (7.07e-3)" "unprognostic (2.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.50e-3)" "prognostic unfavorable (7.83e-4)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.13e-2)" "unprognostic (9.33e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (4.06e-2)" 26.7 16.2 11.0 10.4 20.6 2.1 16.1 20.0 15.1 23.7 18.8 16.5 28.5 20.1 16.4 17.3 10.7 15.7 10.6 10.3 15.8 14.1 21.2 17.3 8.9 23.5 21.5 7.1 7.4 9.1 29.4 7.1 20.9 22.9 21.8 17.3 6.7 20.0 19.2 7.0 15.6 29.3 25.9 21.6 11.4 13.4 9.2 17.7 6.2 21.1 8.1 9.2 23.8 10.0 36.6 53.6 23.7 21.6 20.7 77.9 76.9 24.3 40.0 66.0 29.9 42.2 33.5 81.2 4.9 14.9 58.5 9.9 61.7 8.7 56.1 52.6 16.3 17.8 11.2 9.7 21.5 50.4 12.5 0.2 65.0 43.2 42.0 63.3 74.2 52.6 6.4 5.5 23.4 54.9 16.3 9.0 19.3 7.5 10.2 50.0 16.0 14.5 10.1 43.1 31.0 6.4 21.7 37.1 36.1 34.7 30.5 35.7 28.6 39.9 28.6 8.6 26.0 31.2 20.0 32.6 7.5 25.8 0.1 30.6 0.1 3.3 2.1 1.6 4.6 3.4 2.0 3.5 2.4 2.9 1.5 1.3 1.9 1.5 1.7 3.0 3.1 5.1 1.6 11.0 20.6 20.0 15.1 10.3 15.8 23.5 21.5 7.1 22.9 21.6 17.7 36.6 96.6 28.9 30.4 46.0 25.4 64.5 108.2 46.8 31.9 13.6 76.4 57.1 24.5 34.3 65.9 82.8 27.1 66.7 23.1 113.8 29.4 71.5 346.0 28.9 56.1 64.2 43.0 21.0 96.7 72.1 97.4 56.2 37.8 34.4 9.5 10.7 65.3 71.8 44.2 20.2 37.5 47.0 54.9 38.5 45.4 107.5 105.9 47.6 39.2 65.6 47.1 16.9 13.4 75.9 145.3 156.4 88.3 124.8 47.2 190.8 179.2 46.5 52.1 22.5 98.6 32.0 72.0 133.6 8.8 38.6 73.2 117.5 30.4 42.7 29.4 270.2 HEPACAM "FLJ25530, GLIALCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919205-124936412 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 229.3;choroid plexus: 85.0" "Group enriched" "Detected in some" 9 "Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "Hep G2: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles NA NA Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 15.7 0.3 172.6 0.2 192.6 0.0 2.5 177.7 165.0 0.1 85.0 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.2 160.8 153.1 0.1 16.3 0.0 0.2 229.3 183.2 139.1 0.0 0.0 0.0 0.8 0.0 194.4 0.2 0.2 1.8 0.2 0.5 0.1 0.0 0.2 0.1 205.2 0.0 0.1 0.2 175.8 0.0 0.0 0.4 0.6 0.0 0.1 217.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 172.6 192.6 177.7 165.0 160.8 153.1 229.3 183.2 139.1 194.4 205.2 175.8 217.8 0.1 0.0 0.0 184.8 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 11.2 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 15.5 0.0 72.9 163.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176552 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.8;lymphoid tissue: 12.2;testis: 6.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle" "Centrosome, Cytosol" "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.2 0.1 0.1 2.5 0.2 4.8 0.8 0.1 0.3 0.1 0.0 1.7 1.0 0.5 0.0 1.9 0.2 0.4 0.0 0.4 0.2 0.1 0.2 0.2 4.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.0 0.0 0.2 0.0 0.0 1.8 2.1 1.1 0.1 0.7 1.0 6.4 0.2 12.2 0.1 0.1 3.7 0.4 0.5 0.4 26.1 13.0 25.8 20.5 0.9 5.1 19.1 35.0 14.8 42.1 28.7 23.4 27.8 35.6 10.0 19.3 18.5 24.4 34.4 15.2 54.7 30.3 15.9 47.3 7.7 12.7 0.0 39.5 17.7 1.5 1.0 34.9 15.4 4.2 20.7 30.6 26.3 14.2 33.9 21.0 60.7 37.8 27.9 42.8 23.8 36.5 50.3 15.8 12.2 9.9 30.1 11.1 11.8 17.1 8.1 17.9 15.3 33.5 8.7 16.0 23.8 17.0 43.9 9.0 19.7 34.5 4.4 31.1 51.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.1 0.2 0.1 0.3 0.4 0.2 0.2 0.1 0.0 0.2 0.1 0.2 0.4 0.4 0.0 0.0 0.0 2.6 2.0 0.7 2.4 0.0 0.1 0.9 0.8 0.8 0.0 1.8 0.0 0.0 8.7 1.0 2.1 0.0 1.2 6.3 2.8 0.9 1.4 0.0 12.8 0.8 1.3 21.0 2.1 1.5 1.6 0.0 5.8 1.8 0.4 5.5 0.0 0.6 1.8 2.0 1.9 2.9 7.7 1.5 1.6 0.0 1.9 0.8 0.3 3.1 0.0 0.2 1.0 1.6 1.2 8.5 0.3 0.4 0.6 2.0 0.4 0.0 0.3 2.3 21.7 18.2 5.8 2.8 2.2 1.2 0.5 5.0 0.7 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604181 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: AB_2683821" "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 22.8 44.8 22.3 24.8 23.6 36.6 32.8 26.2 30.0 26.4 25.4 38.0 26.7 22.3 28.0 23.4 25.3 20.4 58.0 22.9 25.1 77.0 32.5 23.2 27.2 24.2 23.0 22.2 22.9 21.5 46.3 27.2 24.7 23.9 28.7 34.4 46.1 23.6 22.3 57.0 23.1 27.7 21.3 22.4 22.8 30.9 27.2 22.8 29.0 37.9 62.0 29.9 23.7 18.8 26.7 35.2 20.0 46.2 29.6 40.4 53.8 39.7 58.3 47.5 60.8 42.0 29.0 55.6 54.4 36.8 56.0 31.3 45.9 45.9 49.1 83.4 55.5 46.5 94.2 20.5 34.3 48.7 71.4 52.7 46.8 47.7 34.5 24.4 54.4 41.2 50.5 33.9 23.9 100.3 30.8 47.9 68.1 31.5 123.2 30.3 51.9 117.2 36.6 121.3 28.6 36.9 28.6 39.8 46.4 39.6 40.2 45.3 66.7 51.1 26.4 23.6 54.1 48.9 17.7 24.8 39.6 26.1 59.0 66.8 34.0 24.8 35.1 30.6 30.5 28.0 42.1 26.9 30.9 27.3 24.4 23.7 30.2 23.3 30.2 25.6 25.1 40.3 23.9 22.3 23.6 26.2 30.0 22.9 25.1 24.2 23.0 22.2 23.9 22.4 22.8 26.7 22.0 38.5 26.8 70.2 51.3 30.0 39.8 51.9 26.2 27.1 24.0 17.8 74.5 30.0 46.8 51.5 22.9 60.7 31.8 52.2 144.8 43.3 40.7 39.7 28.4 24.3 30.5 65.2 126.1 27.2 42.6 32.0 27.0 28.7 24.7 26.5 17.9 24.0 36.5 42.1 142.5 25.7 57.0 28.8 22.1 16.2 33.8 28.5 48.0 55.3 43.1 63.9 43.3 77.9 121.7 36.9 51.7 36.1 29.3 27.8 31.3 108.4 56.0 49.0 59.2 37.6 30.7 86.9 48.5 23.0 25.6 70.3 45.5 47.4 34.2 30.0 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.9;testis: 10.9" "Cell type enhanced" "Detected in many" "Plasma cells: 8.2;Spermatocytes: 17.2;Spermatogonia: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 0.9 0.4 0.6 3.3 1.0 7.9 2.1 0.8 0.9 0.4 0.3 1.8 1.6 1.2 1.0 2.9 0.5 0.7 0.5 0.6 0.7 0.4 1.2 3.4 4.5 0.6 0.8 0.6 0.5 0.9 0.1 0.1 1.9 0.6 0.5 2.2 0.5 0.8 0.4 1.0 2.3 1.5 1.9 0.6 2.9 0.9 10.9 0.7 5.4 0.4 0.9 6.3 3.5 0.9 1.7 13.6 22.6 21.0 15.2 1.9 3.1 15.3 25.4 10.5 26.8 31.0 22.4 16.2 16.1 36.1 5.7 21.6 24.7 36.0 15.5 36.8 30.7 19.7 23.1 10.6 9.1 0.2 28.6 19.7 0.7 1.4 33.8 15.6 2.3 12.8 20.5 23.9 27.0 23.9 19.6 27.0 23.2 25.1 36.5 24.4 20.0 40.5 20.6 5.7 23.3 15.6 21.5 15.2 15.6 5.7 20.2 16.5 11.7 6.0 26.7 35.9 71.1 30.4 15.4 44.3 56.4 8.4 20.2 26.3 0.7 10.3 4.1 0.5 7.9 0.2 1.1 0.3 0.7 4.5 1.7 0.6 0.4 5.5 2.2 8.5 1.4 0.5 3.2 0.6 1.0 0.8 0.9 0.6 0.7 0.6 0.8 0.6 0.6 0.6 0.7 1.7 0.3 0.0 0.0 0.0 4.3 0.0 0.6 0.0 1.8 0.0 1.1 1.1 0.9 1.5 0.0 0.0 0.0 2.7 1.0 0.6 0.0 0.9 4.2 1.0 0.6 0.8 0.0 6.5 0.6 0.6 5.5 0.8 1.1 1.2 0.0 2.5 0.7 0.7 2.5 0.0 0.3 0.7 0.0 6.4 0.0 1.9 0.3 3.5 0.0 1.9 4.5 0.0 4.1 0.5 0.6 0.5 0.1 0.7 8.2 0.7 0.3 0.3 0.0 0.0 0.0 0.8 1.1 17.2 18.2 5.4 0.0 0.3 1.5 0.5 1.6 0.9 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 124.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA040779: AB_2677133" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favorable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favorable (2.03e-5)" 20.3 14.1 11.1 23.7 15.6 42.9 23.9 30.0 14.3 19.4 8.9 19.8 16.4 22.6 15.4 19.6 17.9 17.4 13.6 10.9 12.1 15.0 17.1 23.0 32.6 14.6 13.7 8.7 28.5 17.1 16.7 10.4 16.9 15.5 18.9 20.1 26.8 15.5 16.4 26.6 28.0 21.0 24.0 12.7 29.0 16.5 24.9 12.3 33.7 24.5 19.7 29.9 17.1 13.6 18.9 26.3 18.4 29.4 25.3 34.4 33.4 23.5 24.7 18.2 23.2 17.7 31.5 25.7 58.9 18.1 18.0 21.9 25.8 43.2 17.0 22.3 42.1 14.8 34.5 26.3 22.4 19.4 40.9 36.8 23.9 32.1 17.7 25.6 31.2 23.8 38.8 40.9 27.9 21.9 27.9 38.7 45.2 30.7 44.6 20.5 36.4 37.1 35.2 20.2 38.4 24.4 27.0 30.1 23.7 24.3 26.9 23.7 28.0 24.6 33.0 16.9 24.5 16.6 25.0 45.2 124.6 14.5 26.8 26.0 14.8 7.2 14.9 10.1 6.8 8.5 10.9 6.9 7.3 6.9 9.9 7.8 8.2 17.1 13.5 5.5 7.1 5.5 5.8 11.1 15.6 30.0 14.3 10.9 12.1 14.6 13.7 8.7 15.5 12.7 12.3 18.9 96.4 41.7 63.5 58.1 90.6 53.7 79.8 30.7 101.9 48.4 84.4 81.0 42.7 35.8 43.4 46.0 33.3 30.2 90.1 49.8 25.4 22.9 203.3 55.5 70.8 66.8 31.8 62.5 32.0 18.1 26.9 58.8 40.2 83.6 37.2 48.0 56.7 21.7 37.6 55.5 37.9 51.0 26.4 57.8 41.0 40.3 60.3 87.4 28.4 45.0 52.5 34.5 58.7 40.7 72.0 19.2 46.2 45.1 69.0 71.6 83.4 14.2 29.0 55.3 39.5 227.3 66.8 46.7 17.9 100.4 62.7 39.4 81.7 42.7 50.3 71.1 PKNOX2 ENSG00000165495 "PBX/knotted 1 homeobox 2" Q96KN3 11 125164687-125433389 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 36.6" "Cell type enhanced" "Detected in many" "Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5" "Cancer enhanced" "Detected in many" "melanoma: 8.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028867, CAB034342, HPA055368, HPA066962" Supported Enhanced "Nucleoplasm,Cytokinetic bridge" Yes NA Nucleoplasm "Cytokinetic bridge" "CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757" "unprognostic (2.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-2)" "unprognostic (7.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.44e-2)" "unprognostic (7.66e-2)" "unprognostic (3.70e-1)" "unprognostic (4.10e-6)" "unprognostic (1.76e-3)" "unprognostic (7.11e-2)" "unprognostic (1.71e-2)" "unprognostic (6.48e-3)" 3.7 3.3 2.9 2.0 7.4 0.0 1.2 2.5 13.4 3.2 7.7 2.3 0.9 3.3 2.7 1.4 6.2 1.8 5.8 5.8 3.2 1.5 0.6 10.1 1.4 3.7 1.2 4.7 15.0 4.0 0.9 5.6 8.5 5.3 6.4 1.4 2.8 2.5 5.2 15.1 2.4 1.8 2.7 1.8 2.3 2.3 4.9 1.4 3.2 12.3 36.6 1.1 3.1 2.8 5.7 0.0 0.0 39.1 9.6 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 4.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 11.6 0.3 0.0 0.0 3.9 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 6.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.4 2.5 13.4 5.8 3.2 3.7 1.2 4.7 5.3 1.8 1.4 5.7 0.6 0.0 0.0 31.3 0.0 0.9 0.0 0.0 0.0 0.9 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 1.4 46.8 0.0 1.1 0.5 0.0 0.0 132.9 0.2 0.0 3.1 0.0 0.0 0.0 12.2 1.8 0.0 0.3 8.4 137.4 0.0 0.0 0.0 0.3 9.6 5.0 0.0 8.8 22.5 0.0 2.9 0.0 85.5 3.8 0.1 0.0 17.7 0.0 1.9 0.0 0.1 0.0 0.3 6.6 8.8 2.9 1.2 0.4 0.0 0.4 0.1 0.0 6.9 0.0 0.0 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651781 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 92.7" "Group enriched" "Detected in some" 17 "Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 43 "U-2 OS: 41.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 92.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 41.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 10.4 0.3 0.0 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.2 0.0 2.2 0.0 0.0 581.2 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.3 19.2 224.4 6.2 0.9 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 0.0 6.6 0.1 0.1 0.1 0.0 6.6 2.9 20.8 310.1 14.7 0.0 18.8 0.3 2.4 0.2 2.0 4.3 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598761-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.3" "Cell type enhanced" "Detected in many" "Early spermatids: 129.5;Spermatocytes: 151.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" No No "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: AB_2685537, HPA069364: AB_2686129" "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.3 5.5 1.6 9.1 1.6 22.8 5.6 1.7 2.1 3.0 1.6 12.3 9.7 3.7 2.4 6.7 3.3 3.6 3.1 1.5 1.9 3.1 6.2 4.2 14.1 1.8 1.7 1.4 2.4 4.4 2.9 1.2 4.1 1.8 3.2 10.1 3.3 4.1 3.5 4.0 4.8 10.2 6.1 1.8 7.5 4.6 29.3 1.7 23.4 3.4 4.9 13.4 5.4 3.5 2.0 66.5 39.3 34.2 38.4 15.1 10.6 38.2 35.0 30.8 72.5 68.7 38.4 49.1 60.9 25.1 22.9 23.2 41.7 42.2 29.8 64.1 56.5 31.3 27.4 29.4 24.6 8.5 64.5 34.2 6.9 11.3 33.9 19.4 9.2 35.8 49.2 29.3 45.4 49.2 55.2 87.2 60.1 22.5 31.7 53.0 54.8 56.2 41.4 25.4 27.1 36.9 21.7 33.1 35.3 25.4 12.1 49.9 49.6 13.1 50.6 83.1 24.8 44.4 23.6 35.9 69.0 23.6 47.7 42.9 22.4 14.2 25.4 10.1 22.7 13.5 16.1 13.3 14.8 15.0 12.6 10.8 12.3 8.2 11.1 16.9 17.7 15.7 10.5 1.6 1.6 1.7 2.1 1.5 1.9 1.8 1.7 1.4 1.8 1.8 1.7 2.0 6.4 3.2 6.5 2.0 12.1 15.6 5.7 12.0 4.6 3.8 6.5 5.6 3.6 5.7 9.3 3.7 2.1 12.6 9.2 11.8 1.9 16.8 129.5 3.4 5.3 8.9 4.8 48.4 0.9 22.7 34.2 7.8 6.6 2.9 14.5 9.5 6.8 6.6 21.6 1.7 1.1 11.0 12.2 10.4 19.2 41.6 7.5 11.5 10.6 2.8 16.7 8.1 13.4 1.0 2.0 14.1 3.7 3.4 31.3 11.2 8.7 7.5 4.3 5.2 6.6 5.5 8.0 151.7 14.0 8.8 14.9 7.7 10.5 7.5 14.5 7.0 RPL36AL RPL36A ENSG00000165502 "Ribosomal protein L36a like" Q969Q0 14 49618530-49620626 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA Yes "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (1.55e-2)" "unprognostic (2.44e-2)" "unprognostic (8.73e-2)" "unprognostic (3.15e-3)" "unprognostic (1.52e-1)" "unprognostic (2.55e-2)" "unprognostic (1.31e-1)" "unprognostic (6.37e-2)" "unprognostic (4.18e-2)" "unprognostic (1.38e-3)" "unprognostic (2.29e-1)" "unprognostic (4.72e-1)" "unprognostic (1.16e-3)" "unprognostic (8.32e-2)" "unprognostic (2.80e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.00e-1)" 277.5 313.5 237.0 248.6 243.0 407.6 331.9 234.8 352.7 372.2 228.9 321.1 262.8 283.0 497.0 279.6 318.6 164.0 270.7 227.6 239.1 248.0 375.4 242.6 314.5 245.2 240.4 220.0 505.6 634.1 221.8 254.9 178.2 244.5 252.9 251.2 102.9 330.4 255.6 381.7 234.5 287.3 199.6 247.8 296.6 363.3 138.7 245.4 286.0 213.1 208.4 380.2 300.4 288.3 248.8 635.8 473.9 330.1 192.6 471.3 649.8 194.9 508.9 569.9 475.4 534.7 499.0 426.1 833.4 474.5 430.3 327.9 443.5 287.6 441.3 554.8 288.1 331.1 521.6 527.5 652.8 595.1 838.8 426.0 667.8 668.2 362.7 485.9 553.7 614.6 367.3 339.5 714.4 372.8 831.7 496.5 752.6 186.0 452.1 482.0 308.6 519.5 449.5 730.7 964.2 290.3 178.1 448.5 350.8 544.1 313.0 762.2 460.1 468.2 291.3 463.0 382.3 399.8 427.6 487.0 842.7 210.5 376.9 283.7 1308.9 603.0 935.1 823.8 582.2 1113.2 959.3 1070.1 1040.5 614.8 729.1 984.7 937.6 654.0 806.3 542.2 1008.3 1096.2 1506.1 237.0 243.0 234.8 352.7 227.6 239.1 245.2 240.4 220.0 244.5 247.8 245.4 248.8 453.2 307.7 395.4 11.4 666.4 945.7 1352.2 1151.7 422.3 110.9 674.6 1022.1 662.4 652.0 643.5 312.6 25.0 690.0 778.0 871.5 995.9 739.8 614.3 490.0 431.4 515.5 366.2 535.9 14.1 1371.2 720.9 523.6 381.3 543.7 716.4 369.2 591.8 920.1 778.5 80.8 16.0 793.7 520.8 814.1 1020.0 236.4 725.7 585.0 843.1 22.5 1045.3 368.1 930.0 11.6 22.9 1311.2 1063.8 534.1 853.2 1279.2 1151.2 1194.4 579.1 127.7 486.4 693.6 898.3 364.7 150.2 390.6 839.3 516.3 888.1 355.4 620.5 1412.3 DNAAF2 "C14orf104, CILD10, FLJ10563, KTU, PF13" ENSG00000165506 "Dynein axonemal assembly factor 2" Q9NVR5 14 49625174-49635244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002894, HPA004113" Enhanced Supported Cytosol NA NA Cytosol "HPA002894: AB_1078316, HPA004113: AB_1078315" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (7.57e-2)" "unprognostic (5.85e-2)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-2)" "unprognostic (2.53e-2)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "unprognostic (2.25e-2)" "prognostic favorable (6.74e-7)" "unprognostic (6.72e-2)" "unprognostic (2.54e-1)" "unprognostic (5.04e-2)" "unprognostic (3.44e-2)" 3.8 4.7 4.3 4.4 3.2 3.4 5.7 4.0 3.3 4.3 5.5 5.4 7.6 4.1 4.1 4.4 8.7 3.7 4.4 3.2 3.7 6.9 9.3 3.8 5.6 3.5 4.0 3.0 3.5 7.0 3.9 3.4 3.4 3.9 4.1 4.7 4.8 5.6 3.0 5.1 3.2 6.2 3.3 4.3 4.1 5.2 6.4 3.5 4.7 5.3 5.4 4.7 4.7 3.4 3.8 14.2 8.3 18.0 14.1 8.6 9.9 17.1 7.5 8.3 8.2 9.0 8.1 13.4 20.7 11.6 5.0 6.7 15.3 15.0 10.6 10.2 14.6 8.9 10.6 6.2 14.1 6.7 17.3 8.6 6.6 11.3 7.0 9.5 8.4 8.5 11.3 16.0 13.8 8.2 17.7 11.4 17.8 19.6 14.7 15.1 14.0 13.9 7.0 11.7 11.8 27.4 20.4 11.2 12.0 13.8 11.3 13.7 6.9 7.0 7.6 21.7 7.9 9.5 27.5 18.4 17.1 2.9 10.5 8.5 7.8 4.9 6.8 7.4 4.5 8.9 11.6 8.2 9.9 5.7 9.3 7.9 7.8 1.8 12.4 5.8 5.1 8.5 4.8 4.3 3.2 4.0 3.3 3.2 3.7 3.5 4.0 3.0 3.9 4.3 3.5 3.8 9.8 3.2 5.6 5.9 38.5 41.0 25.0 38.9 41.5 7.0 21.4 20.3 10.6 15.7 14.6 12.9 0.0 21.6 16.2 13.0 31.3 28.4 25.9 30.3 22.9 17.1 9.6 13.9 6.8 24.0 29.4 17.6 19.4 13.8 12.0 12.2 19.2 26.6 14.0 3.3 8.0 15.3 48.8 9.2 21.1 7.5 18.3 10.2 19.6 2.8 10.5 11.3 19.6 6.6 6.2 25.7 13.0 16.6 43.7 36.2 30.8 37.9 27.2 11.9 6.6 16.0 15.4 22.4 17.9 38.6 44.0 12.4 28.0 30.2 22.8 20.0 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1 autophagy regulator" Q9NTK1 10 44970981-44978809 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 742.3;breast: 703.3" "Cell type enhanced" "Detected in many" "Adipocytes: 192.0;Ductal cells: 146.3;Exocrine glandular cells: 113.0;Glandular and luminal cells: 87.1;Syncytiotrophoblasts: 300.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 143.2;HDLM-2: 106.7;HHSteC: 258.2;HSkMC: 201.6;HUVEC TERT2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: AB_2675685" "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavorable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 742.3 48.8 76.9 19.6 69.0 4.5 703.3 60.6 72.3 137.5 55.3 124.7 16.9 169.9 16.7 66.3 337.0 69.1 190.1 56.6 81.2 94.9 132.6 513.2 63.5 186.8 73.0 56.3 300.3 352.7 23.2 85.9 77.1 91.3 83.3 12.1 28.4 120.6 23.1 167.2 145.1 95.6 69.4 102.9 33.1 105.5 19.5 92.5 25.4 202.1 52.7 48.0 179.1 140.3 178.9 30.2 0.2 0.5 0.4 143.2 69.5 7.4 0.2 10.2 0.4 1.8 1.1 11.2 0.0 1.6 13.5 7.1 1.2 1.2 9.1 0.7 106.7 4.0 0.1 0.1 11.0 258.2 0.1 0.1 201.6 0.4 0.1 1.4 24.9 165.0 0.0 0.2 63.2 0.6 0.0 0.1 1.7 0.2 0.6 0.9 5.1 1.7 25.7 0.5 10.9 5.6 0.3 0.0 1.3 5.8 17.0 0.2 7.0 1.6 7.8 5.6 0.5 7.3 1.7 2.8 0.4 44.2 2.6 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.4 76.9 69.0 60.6 72.3 56.6 81.2 186.8 73.0 56.3 91.3 102.9 92.5 178.9 192.0 0.0 24.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 47.0 27.8 0.0 0.0 6.2 31.3 0.0 53.8 1.4 0.0 37.2 146.3 0.0 61.3 33.2 60.0 0.0 0.0 0.0 113.0 14.7 79.3 0.0 87.1 0.0 8.4 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 65.0 0.0 0.0 0.5 0.0 0.0 25.5 5.8 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 300.2 1.8 0.8 0.0 0.0 MAGEC3 "CT7.2, HCA2, MAGE-C3" ENSG00000165509 "MAGE family member C3" Q8TD91 X 141838316-141897832 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 9.8;Inhibitory neurons: 10.9;Oligodendrocytes: 36.7" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 2.1" HPA052067 Approved NA NA "HPA052067: AB_2681717" "unprognostic (3.45e-1)" "unprognostic (2.39e-1)" "unprognostic (4.01e-1)" "unprognostic (2.95e-1)" "unprognostic (2.10e-2)" "unprognostic (3.45e-2)" "unprognostic (2.35e-11)" "unprognostic (3.21e-2)" "unprognostic (4.29e-2)" 0.0 0.0 2.1 0.0 2.5 0.0 0.1 1.6 3.0 0.1 1.2 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 2.2 2.4 0.1 0.0 0.0 0.0 2.9 3.1 2.2 0.1 0.0 0.1 0.8 0.0 2.7 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 1.8 1.0 0.0 1.1 2.2 0.0 0.2 0.0 0.0 0.1 0.1 5.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.5 1.6 3.0 2.2 2.4 2.9 3.1 2.2 2.7 1.8 2.2 5.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF22 "HKR-T1, KOX15, Zfp422, ZNF422" ENSG00000165512 "Zinc finger protein 22" P17026 10 45000923-45005326 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 184.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016736, HPA054893" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016736: AB_1859133, HPA054893: AB_2682632" "unprognostic (2.87e-2)" "unprognostic (1.10e-1)" "unprognostic (2.65e-1)" "unprognostic (5.77e-2)" "unprognostic (3.50e-3)" "unprognostic (3.42e-2)" "unprognostic (4.77e-2)" "unprognostic (2.01e-1)" "unprognostic (1.01e-3)" "unprognostic (9.31e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.11e-5)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.39e-1)" "unprognostic (9.96e-2)" "unprognostic (4.58e-2)" 28.5 13.6 21.4 22.1 22.8 25.9 41.5 22.4 26.3 23.0 20.3 21.2 19.1 30.9 23.7 11.0 25.9 17.7 24.1 20.9 24.6 25.4 39.0 23.3 36.4 27.2 22.6 20.1 36.1 40.0 13.4 8.7 40.3 23.0 23.0 21.8 19.4 22.9 19.7 21.3 8.4 18.4 24.2 23.2 27.4 23.0 9.1 22.5 71.0 24.1 26.0 35.4 18.2 11.0 24.8 46.7 7.4 63.3 39.3 32.1 23.2 0.5 21.6 44.5 54.7 58.8 25.5 38.6 48.4 33.5 32.5 12.0 7.8 62.1 23.2 77.3 30.3 1.1 50.3 11.3 0.3 68.8 98.5 17.0 41.6 33.3 22.3 0.9 0.5 87.7 127.8 67.8 84.9 43.7 1.4 184.0 148.5 38.0 26.8 12.9 133.8 87.8 69.4 43.0 39.2 60.5 52.7 19.3 38.8 32.3 57.5 8.4 96.7 48.4 39.2 72.2 27.2 73.3 48.0 51.0 46.4 24.4 3.6 42.6 28.2 28.1 37.6 51.7 27.5 62.5 42.2 33.6 53.8 37.8 54.4 45.3 56.6 2.9 70.8 18.3 64.7 21.1 38.1 21.4 22.8 22.4 26.3 20.9 24.6 27.2 22.6 20.1 23.0 23.2 22.5 24.8 69.3 28.9 27.4 5.9 45.7 19.2 65.5 34.1 42.1 33.6 51.2 68.6 9.9 68.6 25.2 33.1 10.4 71.7 48.0 7.0 56.7 58.7 6.3 22.1 48.7 72.9 40.0 67.5 5.0 43.3 55.8 49.5 21.4 25.4 33.5 59.1 91.8 58.6 49.3 38.7 7.6 37.2 38.7 28.7 28.4 3.6 44.4 32.7 19.6 4.7 61.4 57.2 89.6 7.5 11.3 35.7 15.1 51.1 31.9 57.9 6.9 54.6 28.4 32.7 32.9 77.1 48.4 40.1 37.1 23.9 13.2 53.2 36.4 58.7 34.7 27.6 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49768130-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 19.3 22.4 12.2 8.7 12.6 10.1 19.8 13.0 16.2 18.5 13.6 22.6 18.5 20.8 15.0 15.1 17.2 14.0 38.4 13.3 13.1 34.4 49.5 14.6 11.0 11.9 12.1 13.0 25.4 30.6 16.9 17.8 12.8 13.4 18.6 18.2 24.1 20.3 20.3 53.5 18.5 21.7 14.2 12.6 12.4 24.6 23.5 12.6 15.3 28.4 38.5 10.6 22.5 16.3 14.4 14.7 12.2 22.5 11.0 31.7 27.5 23.7 15.0 28.8 18.8 19.0 7.1 19.6 29.1 20.4 27.4 10.8 12.8 13.9 13.9 15.9 20.1 14.7 9.1 8.6 17.0 23.1 19.6 7.8 28.6 23.5 8.6 16.9 23.1 17.4 24.6 11.8 21.5 15.1 17.3 20.1 8.6 16.6 17.0 34.8 15.3 24.0 18.1 8.6 31.2 27.4 22.0 25.1 46.4 17.1 17.2 17.8 7.4 14.9 17.2 13.3 13.7 7.8 29.0 19.7 17.1 9.7 10.0 9.2 12.3 9.1 19.9 11.1 6.1 13.8 18.2 16.8 17.4 9.0 19.0 23.5 15.8 8.4 16.8 5.8 6.8 18.0 12.3 12.2 12.6 13.0 16.2 13.3 13.1 11.9 12.1 13.0 13.4 12.6 12.6 14.4 40.6 41.7 52.4 30.3 42.1 48.9 53.5 64.8 53.5 65.1 48.6 40.9 9.3 77.2 53.9 47.8 50.1 102.5 40.7 68.9 107.6 59.8 96.8 44.8 41.9 36.4 57.2 47.8 30.6 85.8 68.6 51.2 67.2 38.7 30.4 62.8 45.3 91.8 33.2 65.6 35.4 75.3 63.1 28.7 33.6 27.1 81.4 26.5 39.2 18.7 36.3 73.9 54.6 28.1 33.1 54.8 78.9 77.5 74.5 53.9 143.9 170.1 27.8 98.1 65.7 46.3 90.5 238.7 93.2 42.7 66.3 82.4 44.9 54.7 78.9 55.5 EML5 "EMAP-2, FAP16, HuEMAP-2" ENSG00000165521 "EMAP like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.3;ovary: 17.6;retina: 9.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Excitatory neurons: 79.5;Granulosa cells: 98.7;Inhibitory neurons: 106.8;Oligodendrocyte precursor cells: 98.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 18.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 11.5;SH-SY5Y: 23.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 41.5" "HPA054019, HPA055379" Uncertain NA NA "HPA054019: AB_2682345, HPA055379: AB_2682799" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.3 3.9 3.4 0.7 2.4 0.3 0.8 18.3 2.9 0.6 0.0 1.1 0.2 0.4 0.2 0.8 1.1 0.1 0.2 3.4 2.2 0.6 1.6 0.6 0.2 0.6 5.7 1.3 17.6 0.9 2.4 3.9 0.0 4.8 4.4 0.3 9.6 0.8 0.3 0.1 0.4 0.8 0.2 0.1 1.0 0.6 2.7 2.8 0.7 1.6 0.1 0.6 0.8 0.5 1.2 1.3 0.5 0.0 1.0 0.0 0.0 2.6 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.2 3.5 4.1 0.1 0.1 2.2 2.2 1.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.5 11.5 0.1 1.2 2.9 0.0 0.2 0.4 1.0 1.4 0.0 0.4 0.1 3.1 3.9 23.8 1.1 1.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.7 4.7 1.0 3.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.4 18.3 2.9 3.4 2.2 0.6 5.7 1.3 4.8 0.1 2.8 1.2 0.2 0.0 5.8 31.3 3.5 0.5 1.0 0.0 0.6 28.2 2.0 0.9 1.5 1.5 1.3 0.0 60.5 0.2 0.7 1.2 0.0 0.9 3.1 2.0 1.2 0.8 10.7 2.1 79.5 0.4 0.1 1.2 3.1 1.9 1.3 98.7 0.0 0.1 0.0 20.2 106.8 0.3 0.0 0.0 0.0 2.9 0.6 0.3 3.6 17.8 0.2 3.6 0.0 98.0 34.5 0.3 1.1 1.2 4.5 5.7 0.0 0.4 4.6 30.1 0.0 1.9 7.4 13.6 8.1 1.5 0.4 0.1 1.7 5.1 0.1 0.6 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49852821 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 830000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 16.6 13.9 9.2 18.2 12.2 42.4 14.9 17.8 14.9 16.3 5.5 13.7 10.1 16.3 13.6 22.7 12.3 13.3 17.9 7.6 9.7 15.0 12.0 13.9 18.1 12.3 11.4 5.3 15.3 15.3 25.0 10.4 18.3 13.0 16.2 14.7 14.9 14.7 16.0 23.1 14.5 13.7 15.8 10.6 15.6 14.3 10.8 10.1 16.4 18.6 21.7 18.1 18.1 11.7 18.3 34.3 39.2 35.9 24.1 37.3 31.0 32.1 42.0 28.3 27.6 27.3 23.2 35.3 13.3 32.0 35.7 21.2 47.5 34.1 26.7 42.2 38.9 22.7 38.7 40.3 29.1 23.8 50.7 33.4 26.8 19.6 29.9 27.2 36.3 39.8 23.8 47.3 36.2 37.7 30.6 31.2 17.9 21.9 28.6 36.8 32.6 35.5 20.8 33.7 44.8 23.6 22.2 41.6 40.4 39.2 37.2 37.6 31.1 47.2 39.2 34.4 26.6 28.9 24.5 47.6 40.9 14.7 23.9 35.5 76.4 38.9 45.8 45.7 36.9 44.8 83.7 47.1 44.4 33.9 86.7 55.6 59.1 61.3 47.8 54.4 79.7 46.1 20.3 9.2 12.2 17.8 14.9 7.6 9.7 12.3 11.4 5.3 13.0 10.6 10.1 18.3 66.2 41.7 76.7 65.3 81.1 34.4 67.4 81.6 29.6 92.1 31.7 43.1 97.2 34.3 74.4 44.1 100.1 85.8 78.4 51.8 37.2 57.0 13.9 52.2 60.1 65.2 54.0 57.0 75.7 39.1 58.1 53.0 41.8 60.7 89.3 68.0 49.6 28.1 58.9 131.2 80.7 48.9 71.2 48.7 57.0 13.1 65.9 57.9 24.9 62.8 79.4 54.8 82.4 56.8 99.5 46.4 68.5 67.4 50.0 66.1 59.4 29.9 82.4 90.0 72.3 65.7 70.7 83.0 58.3 32.5 34.1 108.4 66.9 64.1 54.6 88.6 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridine synthase D4" Q96CM3 11 126202096-126211692 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 136.8;tongue: 75.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 14.8 12.8 10.4 9.9 10.8 10.7 14.1 10.9 11.3 13.8 10.8 12.2 10.5 12.7 7.7 15.2 13.0 8.2 20.8 10.7 10.9 11.6 20.7 9.5 13.9 10.7 10.4 10.3 18.4 27.0 7.8 8.8 6.9 10.8 11.6 10.2 6.1 14.5 7.1 136.8 16.9 12.2 9.3 11.0 14.6 20.2 8.8 10.8 13.3 10.2 75.9 15.6 12.5 13.5 11.0 15.6 14.0 17.0 19.7 24.5 34.3 12.5 16.2 22.7 16.6 15.1 46.4 27.3 35.7 16.8 14.1 23.7 25.1 40.3 25.8 17.3 32.4 23.9 84.1 15.0 40.5 18.3 42.5 17.1 29.8 35.0 18.4 22.9 24.8 33.4 28.8 51.8 25.1 20.2 13.5 26.6 46.3 18.4 49.3 29.1 31.0 25.2 33.3 25.7 19.8 29.3 20.5 21.5 29.7 16.7 17.0 46.2 21.9 20.9 18.6 13.3 15.4 19.9 10.1 12.4 30.7 8.8 47.2 19.7 1.6 12.7 1.4 15.9 11.7 19.6 14.4 18.0 14.3 16.3 14.5 20.4 16.8 0.9 14.3 14.0 7.0 18.1 13.3 10.4 10.8 10.9 11.3 10.7 10.9 10.7 10.4 10.3 10.8 11.0 10.8 11.0 10.0 3.2 8.4 6.8 15.3 27.5 20.4 13.2 17.1 9.9 13.1 9.1 35.4 12.8 7.4 7.3 8.4 14.0 12.3 7.2 9.8 12.3 1.8 6.7 7.1 11.9 15.5 6.7 7.0 19.6 17.1 10.2 10.7 7.4 5.7 15.2 13.6 11.3 13.3 11.8 8.4 10.7 2.0 15.9 8.7 2.3 9.6 8.6 10.6 8.4 21.0 5.3 14.4 6.6 7.8 13.5 7.4 8.6 12.4 17.4 15.6 14.5 7.0 8.2 6.6 15.6 9.9 10.3 16.7 13.2 24.0 13.3 13.1 18.3 18.8 14.7 ARF6 ENSG00000165527 "ADP ribosylation factor 6" P62330 14 49893082-49897054 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 716.1;Suprabasal keratinocytes: 673.3;Urothelial cells: 703.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002778, CAB079914" Approved Supported Cytosol NA NA 310000 Cytosol "CAB002778: , CAB079914: AB_2539861" "unprognostic (1.21e-1)" "unprognostic (2.75e-3)" "unprognostic (1.80e-1)" "unprognostic (7.02e-2)" "unprognostic (2.85e-1)" "unprognostic (1.83e-1)" "unprognostic (4.12e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (3.10e-5)" "unprognostic (1.61e-1)" "unprognostic (1.67e-1)" "unprognostic (8.37e-3)" "unprognostic (1.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.49e-2)" 32.4 25.6 14.2 44.0 14.4 83.8 32.9 15.7 15.5 27.0 17.1 53.9 46.8 21.9 26.8 109.1 28.6 33.0 18.2 12.5 15.2 29.9 46.5 31.8 62.5 15.2 14.9 11.4 15.4 24.9 20.5 12.7 36.6 15.6 32.4 51.5 13.3 36.6 19.3 26.3 64.4 51.7 24.0 16.0 50.0 47.1 15.9 16.3 45.7 21.3 17.2 67.2 47.3 56.2 16.1 141.5 58.2 38.4 44.8 51.5 68.4 78.3 86.5 62.6 60.3 62.2 42.6 96.2 91.3 43.7 72.7 46.3 101.7 43.7 69.3 71.3 181.4 34.9 47.2 30.6 38.3 58.1 87.2 60.7 53.7 81.5 48.9 93.7 72.1 67.6 58.3 45.9 176.9 84.7 101.5 77.7 76.5 42.0 75.9 82.8 59.4 50.1 53.9 157.6 112.9 56.4 37.4 68.9 102.3 89.0 46.5 78.0 70.0 90.0 111.9 57.4 66.7 66.1 94.3 104.4 68.6 40.1 50.9 81.3 34.2 20.7 21.1 34.7 33.0 37.6 33.5 33.7 35.3 23.9 26.6 23.0 29.6 14.7 29.1 31.4 15.8 36.2 23.4 14.2 14.4 15.7 15.5 12.5 15.2 15.2 14.9 11.4 15.6 16.0 16.3 16.1 102.9 51.3 29.9 2.9 233.7 599.8 529.1 47.9 231.6 22.9 154.4 80.1 18.5 127.2 47.6 101.2 2.1 152.7 298.8 276.0 158.5 125.4 5.8 95.6 98.5 117.1 99.3 140.1 5.3 80.0 208.1 94.9 115.7 143.7 79.9 40.3 108.5 143.3 168.0 33.7 5.9 167.0 20.3 195.6 716.1 8.3 33.5 184.5 304.1 15.0 204.9 42.2 192.6 6.0 8.9 130.4 161.6 32.7 182.4 443.4 190.8 166.5 30.3 21.6 46.0 68.8 90.7 62.7 48.7 361.4 673.3 202.9 311.0 52.6 182.5 703.8 TTC8 "BBS8, RP51" ENSG00000165533 "Tetratricopeptide repeat domain 8" Q8TAM2 14 88824153-88881078 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.8;Theca cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.8" "Cell line enhanced" "Detected in all" "SH-SY5Y: 118.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-2)" "unprognostic (1.08e-1)" "unprognostic (5.47e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.49e-1)" "unprognostic (7.10e-2)" "unprognostic (5.00e-3)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic favorable (7.77e-4)" "unprognostic (3.54e-2)" "unprognostic (2.51e-1)" "prognostic favorable (4.89e-4)" "unprognostic (1.65e-2)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (3.80e-2)" 8.4 39.3 15.3 6.6 14.9 9.3 18.8 12.4 14.3 15.7 19.4 9.5 6.1 13.6 36.2 13.1 23.4 15.6 11.7 14.6 17.9 13.7 13.3 9.0 4.3 14.4 14.1 14.2 69.5 12.1 22.7 22.6 6.9 12.9 23.8 10.0 37.8 10.1 18.8 2.6 8.9 5.8 14.5 14.6 6.8 8.5 23.9 14.7 5.9 37.4 4.2 5.0 16.5 5.0 13.6 19.8 28.1 16.7 16.2 35.1 43.5 14.0 24.0 37.6 31.8 21.5 7.9 37.2 8.7 20.6 30.3 19.3 28.5 18.1 19.4 32.2 6.6 7.3 5.5 9.1 11.1 25.4 10.6 1.9 27.3 23.9 23.0 19.9 30.4 19.3 11.6 20.5 9.8 27.3 33.9 10.9 10.2 8.9 10.3 27.0 3.3 23.0 5.2 31.3 30.6 19.6 118.5 38.0 21.3 22.4 11.5 52.6 8.3 11.7 22.6 11.9 20.2 16.6 1.2 6.8 3.8 33.3 2.8 9.9 13.8 0.7 3.8 0.4 0.9 0.6 0.4 0.5 0.5 1.9 2.2 0.2 0.4 0.7 1.7 1.5 0.7 0.0 0.5 15.3 14.9 12.4 14.3 14.6 17.9 14.4 14.1 14.2 12.9 14.6 14.7 13.6 3.7 3.2 9.0 38.8 2.1 8.8 8.0 12.3 19.4 17.0 11.7 9.1 6.0 10.0 11.2 9.2 39.6 10.2 0.6 4.3 13.7 13.5 8.1 24.1 10.6 4.9 10.8 4.8 51.1 6.2 9.7 12.8 6.1 11.7 0.0 66.8 5.3 8.0 6.7 20.2 53.4 6.1 6.1 3.5 6.6 7.4 19.6 4.4 7.2 14.0 0.4 12.5 1.0 51.3 21.3 7.8 2.4 25.2 3.7 4.9 2.3 15.5 28.3 41.7 19.7 5.8 12.2 14.6 6.9 8.3 6.5 1.8 1.2 69.0 6.6 4.7 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pituitary gland: 42.3" "Cell type enhanced" "Detected in some" "Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1" "Cancer enhanced" "Detected in many" "breast cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.2 9.7 7.0 0.6 5.6 0.8 3.4 28.0 11.1 1.4 0.0 4.2 1.2 0.1 4.6 6.5 0.2 0.2 0.5 5.6 19.7 0.5 0.1 0.5 0.3 4.5 10.1 6.7 0.1 4.8 1.6 42.3 0.7 13.3 0.2 3.1 2.4 2.7 0.0 0.5 8.6 2.7 0.6 1.4 3.3 2.0 11.4 14.4 0.1 2.2 0.4 0.3 0.0 7.2 5.3 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 18.5 3.4 0.0 3.0 2.5 3.8 1.5 0.0 1.2 1.4 0.3 1.8 0.0 0.0 3.2 0.1 0.0 7.5 0.0 0.2 0.0 0.0 8.7 0.0 24.1 0.0 9.3 2.6 0.1 0.8 0.0 0.0 0.0 1.2 12.7 0.3 0.0 32.5 4.9 0.4 29.1 0.0 0.6 2.8 1.6 0.0 0.0 5.9 0.0 0.0 1.9 0.1 0.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.1 7.0 5.6 28.0 11.1 5.6 19.7 4.5 10.1 6.7 13.3 1.4 14.4 5.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 3.3 2.2 0.8 0.7 0.0 1.7 0.0 2.1 0.0 1.5 3.8 1.9 0.0 9.5 0.3 0.4 0.1 19.2 0.0 25.8 0.2 0.1 0.3 0.0 2.4 0.0 0.2 0.0 0.0 2.7 3.3 22.2 3.0 4.1 0.0 0.0 6.2 0.0 0.2 0.0 3.7 0.6 0.3 0.0 16.1 1.1 0.2 7.0 0.4 0.1 0.0 0.5 0.2 0.1 0.6 0.0 0.0 0.3 0.6 0.1 2.4 0.0 0.0 0.2 0.7 0.7 0.1 NGB ENSG00000165553 Neuroglobin Q9NPG2 14 77265483-77271312 "Predicted intracellular proteins, Transporters" "Apoptosis, Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 45.4;choroid plexus: 12.1;pituitary gland: 17.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.0;Excitatory neurons: 1.6;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 3.5;Spermatogonia: 1.8" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "RPMI-8226: 6.1;SCLC-21H: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042615, HPA058596" Enhanced NA NA "HPA042615: AB_2678079, HPA058596: AB_2683769" "unprognostic (1.02e-1)" "unprognostic (3.55e-2)" "unprognostic (8.86e-2)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (3.14e-1)" "unprognostic (4.08e-2)" "unprognostic (6.65e-2)" "unprognostic (6.58e-2)" "unprognostic (3.37e-4)" "unprognostic (1.80e-1)" "unprognostic (3.12e-1)" 0.1 7.6 25.5 0.2 18.5 0.0 0.0 13.3 27.0 0.0 12.1 3.8 0.2 0.0 0.1 0.1 1.3 0.0 0.0 15.9 45.4 0.0 0.0 0.0 0.0 26.0 27.8 18.0 0.0 5.0 0.0 17.0 0.0 26.3 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.0 0.1 15.7 0.0 1.0 0.5 34.0 0.2 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.1 0.0 0.0 12.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 18.5 13.3 27.0 15.9 45.4 26.0 27.8 18.0 26.3 15.7 34.0 19.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "retina: 5.9;testis: 7.0" "Group enriched" "Detected in some" 25 "Early spermatids: 137.8;Late spermatids: 125.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055658, HPA060408" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA055658: AB_2682878, HPA060408: " "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.2 0.6 1.3 0.1 0.6 0.2 0.5 0.4 0.4 0.2 1.5 0.5 0.5 0.5 0.5 0.3 0.5 0.6 0.1 0.5 1.0 0.3 0.3 0.3 0.7 0.7 0.7 0.4 0.3 0.4 0.3 0.7 0.3 0.6 0.3 0.5 5.9 0.2 0.4 0.1 1.1 0.3 0.4 1.1 0.5 0.2 7.0 0.4 0.6 0.9 0.0 0.4 0.2 0.2 0.7 0.3 0.7 0.3 0.4 0.1 0.7 0.5 0.3 0.5 0.3 0.2 0.4 0.3 0.7 0.1 0.6 0.1 0.2 0.1 0.1 0.4 0.3 0.2 0.4 0.0 0.7 0.2 0.1 0.6 0.4 0.9 0.3 0.5 0.4 0.2 0.8 0.1 0.5 0.1 0.8 0.2 0.2 0.0 0.2 0.6 0.2 0.1 0.0 0.3 0.1 0.7 0.5 0.4 0.1 0.1 0.7 0.7 0.4 0.9 0.2 0.2 0.4 0.1 0.7 0.7 0.4 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.6 0.4 0.4 0.5 1.0 0.7 0.7 0.4 0.6 1.1 0.4 0.7 0.2 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 4.2 0.0 0.0 0.3 0.0 0.0 137.8 0.6 0.1 0.2 1.8 0.0 4.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 3.0 0.0 0.0 0.3 0.2 125.8 0.9 0.3 0.0 0.0 0.0 0.4 0.0 3.0 4.4 0.1 0.0 1.2 0.1 0.1 0.3 0.1 0.2 1.5 0.0 0.0 0.1 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 CDX2 CDX3 ENSG00000165556 "Caudal type homeobox 2" Q99626 13 27960918-27969315 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 41.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 287.5;Intestinal goblet cells: 214.5;Paneth cells: 181.7;Proximal enterocytes: 226.9;Undifferentiated cells: 194.4" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 63.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002221, HPA045669, HPA049580" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823" "unprognostic (1.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.92e-1)" "unprognostic (8.11e-3)" "unprognostic (4.19e-6)" "unprognostic (1.73e-4)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" "unprognostic (5.51e-2)" "unprognostic (6.07e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" 0.1 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.4 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 31.6 0.0 0.0 0.1 0.0 0.0 36.2 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.4 4.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.7 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 0.0 287.5 0.0 28.9 0.0 0.0 0.0 0.0 62.4 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 214.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.9 181.7 0.0 0.0 0.2 226.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.3 0.4 0.0 194.4 0.3 AMER2 "FAM123A, FLJ25477" ENSG00000165566 "APC membrane recruitment protein 2" Q8N7J2 13 25161679-25172288 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 117.5" "Cell type enhanced" "Detected in some" "Astrocytes: 99.3;Bipolar cells: 105.5;Cone photoreceptor cells: 81.3;Horizontal cells: 153.1;Muller glia cells: 313.0;Oligodendrocytes: 337.1;Rod photoreceptor cells: 112.1" "Cancer enriched" "Detected in single" 24 "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 3.3;SCLC-21H: 2.3;SuSa: 2.3;U-266/70: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039458 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA039458: AB_10795677" "unprognostic (1.69e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-3)" "unprognostic (2.32e-1)" "unprognostic (3.00e-3)" "unprognostic (5.00e-3)" "unprognostic (7.28e-2)" "unprognostic (2.34e-2)" "unprognostic (5.90e-4)" "unprognostic (1.60e-2)" "unprognostic (1.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (1.34e-1)" 0.1 0.1 34.9 0.0 69.4 0.0 0.0 37.4 54.7 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 40.5 41.7 0.0 0.0 0.1 0.0 56.9 51.2 30.8 0.0 0.0 0.0 4.1 0.0 56.6 0.1 0.0 26.1 0.0 0.2 0.2 0.1 0.0 0.0 35.5 0.0 0.0 1.2 51.5 0.0 0.0 0.0 0.0 0.0 0.0 117.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 69.4 37.4 54.7 40.5 41.7 56.9 51.2 30.8 56.6 35.5 51.5 117.5 0.0 0.0 0.0 99.3 0.1 0.1 0.0 0.0 0.0 105.5 0.1 0.1 1.1 0.0 0.0 0.0 81.3 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.6 0.8 0.0 0.0 21.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 153.1 24.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.8 4.7 0.0 313.0 0.0 28.6 337.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 112.1 0.0 0.2 0.0 2.8 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 AKR1E2 "AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 19.1" "Group enriched" "Detected in some" 5 "Early spermatids: 153.8;Late spermatids: 174.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 12.3;RT4: 10.4;U-2197: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037821, HPA037822" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA037821: AB_2675687, HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 2.0 0.8 1.8 0.8 2.1 2.1 3.1 1.7 2.0 1.6 0.2 1.2 1.4 1.1 1.0 1.4 1.0 1.3 2.0 2.0 2.5 0.9 0.5 2.0 0.8 1.7 3.5 1.4 0.7 2.2 1.0 0.5 1.8 2.8 0.9 1.2 3.5 1.1 1.8 1.5 1.1 1.0 2.1 0.6 1.2 1.5 19.1 1.4 0.7 3.3 0.8 0.5 1.2 1.3 1.9 0.5 5.9 2.2 1.0 0.0 0.0 0.1 2.3 0.2 0.1 0.1 9.0 0.8 0.0 0.0 6.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 1.1 6.2 1.1 0.0 0.0 6.5 12.3 5.6 0.0 0.0 5.4 0.7 0.0 2.2 6.9 4.4 0.0 0.0 0.0 1.6 10.4 0.0 4.8 8.2 2.4 4.7 2.4 4.6 2.6 4.1 0.0 2.0 19.5 0.0 2.8 0.0 0.0 0.1 0.0 1.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.8 2.1 1.7 2.0 2.0 2.5 1.7 3.5 1.4 2.8 0.6 1.4 1.9 0.9 0.0 0.0 1.6 0.2 0.0 0.1 0.5 0.6 0.2 1.1 0.6 0.8 0.0 0.6 1.8 0.0 0.1 0.1 0.0 0.0 0.3 153.8 0.5 0.7 1.4 0.0 1.3 7.1 0.0 0.0 2.2 0.0 0.6 0.0 0.6 2.2 0.0 1.2 1.7 8.9 0.1 0.0 0.6 0.6 174.2 2.8 0.8 3.6 5.6 0.6 0.3 0.0 9.0 0.0 0.1 0.1 1.5 0.0 0.2 0.0 0.5 0.3 1.2 0.0 0.8 1.2 32.0 10.0 0.7 0.1 0.0 0.2 0.2 0.1 0.5 KBTBD6 DKFZp547E1912 ENSG00000165572 "Kelch repeat and BTB domain containing 6" Q86V97 13 41127569-41132802 "Predicted intracellular proteins" "Unfolded protein response" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046861, HPA048914" Uncertain NA NA "HPA046861: AB_2679843, HPA048914: AB_2680554" "unprognostic (6.21e-2)" "unprognostic (2.07e-3)" "unprognostic (3.55e-1)" "unprognostic (1.68e-3)" "unprognostic (4.25e-3)" "unprognostic (9.16e-3)" "unprognostic (1.79e-2)" "unprognostic (1.87e-2)" "unprognostic (9.85e-2)" "unprognostic (9.79e-2)" "unprognostic (1.62e-2)" "unprognostic (2.88e-1)" "unprognostic (1.40e-2)" "unprognostic (5.21e-2)" "unprognostic (1.59e-1)" "unprognostic (6.91e-3)" "unprognostic (3.41e-1)" 2.8 6.2 11.4 3.1 12.5 5.5 6.0 10.8 11.9 5.3 6.6 2.6 2.6 5.6 3.3 2.8 8.3 2.0 6.6 11.0 14.4 5.2 3.7 2.4 4.2 9.6 10.8 11.3 5.9 3.6 4.9 6.6 3.6 10.3 4.8 2.1 4.3 3.4 4.2 2.8 3.2 2.3 2.9 8.2 3.3 2.7 5.4 13.8 5.2 5.2 4.2 4.6 2.6 2.6 12.9 3.6 6.9 12.8 16.2 15.0 11.4 4.0 7.5 7.4 8.7 7.4 9.6 4.1 4.8 4.5 6.4 5.6 10.7 20.8 9.4 13.7 4.5 22.0 9.9 9.2 11.2 7.9 7.3 3.7 9.8 9.6 6.2 13.3 7.6 6.3 7.6 8.3 2.7 11.4 5.2 8.9 7.3 9.6 7.9 8.1 6.9 12.2 3.1 8.9 7.8 5.1 11.4 10.4 10.5 7.6 4.4 7.2 9.9 7.0 4.5 5.3 4.5 6.3 2.0 1.9 6.8 6.8 7.8 8.7 3.6 1.6 0.4 1.8 1.2 2.0 1.1 2.8 2.3 1.6 1.3 3.3 3.5 0.8 1.4 2.9 1.1 1.7 1.4 11.4 12.5 10.8 11.9 11.0 14.4 9.6 10.8 11.3 10.3 8.2 13.8 12.9 3.8 9.6 4.2 4.6 3.7 3.2 3.3 4.7 3.4 20.6 7.6 6.9 14.6 5.7 2.4 7.3 10.4 4.2 4.3 1.2 7.9 2.6 5.0 3.9 9.5 5.2 3.0 2.5 9.9 1.8 7.6 6.8 2.0 3.5 0.0 8.2 13.6 8.2 1.7 18.5 18.0 2.1 0.0 2.2 3.7 2.9 8.7 2.0 8.8 2.8 2.2 8.0 3.1 12.1 10.6 1.5 0.5 11.7 2.6 3.4 1.1 8.6 2.2 11.1 6.6 11.1 5.9 7.8 9.7 3.2 3.4 2.9 5.1 10.7 3.2 2.4 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196795 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Cell type enriched" "Detected in single" 7 "Spermatogonia: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "BEWO: 4.7" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.7 0.5 0.2 0.5 0.3 0.5 0.8 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346427-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 13.6" "Group enriched" "Detected in some" 26 "Spermatocytes: 52.7;Spermatogonia: 118.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "Karpas-707: 2.1" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.7 118.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56816693 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "choroid plexus: 89.6;retina: 282.3" "Group enriched" "Detected in some" 11 "Bipolar cells: 170.6;Cone photoreceptor cells: 168.9;Rod photoreceptor cells: 202.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 249.6;hTERT-RPE1: 57.0;NTERA-2: 199.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.0 0.0 3.6 0.0 1.2 0.0 0.0 7.7 0.7 0.0 89.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 2.3 0.0 0.0 0.0 0.0 2.3 11.9 0.1 0.0 0.0 0.0 2.5 0.0 1.1 0.0 0.0 282.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 12.0 0.0 0.0 0.8 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 249.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.2 7.7 0.7 6.1 2.3 2.3 11.9 0.1 1.1 0.1 12.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.6 0.0 0.0 0.3 0.0 0.0 0.0 168.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAAH2 "AMDD, FAAH-2, FLJ31204, RP11-479E16.1" ENSG00000165591 "Fatty acid amide hydrolase 2" Q6GMR7 X 57286706-57489193 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 75.7;Excitatory neurons: 110.2;Inhibitory neurons: 131.2;Oligodendrocyte precursor cells: 110.6;Oligodendrocytes: 105.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 16.7" "Lineage enriched" "Detected in many" 9 "T-cells: 16.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.0;HDLM-2: 13.0;RPMI-8226: 26.6;U-266/70: 20.9;U-266/84: 11.4" NA NA "unprognostic (1.37e-1)" "unprognostic (1.78e-2)" "unprognostic (7.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.02e-1)" "unprognostic (4.51e-2)" "unprognostic (7.93e-3)" "unprognostic (4.47e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.99e-4)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.47e-13)" "unprognostic (9.16e-3)" "unprognostic (2.27e-1)" "prognostic favorable (2.66e-4)" "prognostic favorable (6.83e-5)" 0.5 1.6 1.2 1.6 0.9 0.4 6.9 3.2 1.1 3.6 0.9 3.2 3.1 1.3 4.5 5.0 6.1 1.7 0.2 0.8 2.2 7.3 10.6 3.2 2.6 1.3 1.2 0.9 0.4 15.2 13.5 6.7 0.8 1.6 7.4 4.0 7.1 7.2 4.2 0.1 9.6 3.0 0.3 0.6 0.7 4.7 0.1 1.8 7.4 4.8 0.2 7.1 3.4 3.4 1.0 3.4 0.3 0.1 0.2 0.1 0.1 3.1 0.0 0.1 0.0 0.0 2.4 14.0 0.1 4.0 0.0 0.0 0.6 1.1 2.5 0.0 13.0 6.9 0.4 3.1 1.0 0.0 1.5 0.0 0.0 4.2 0.0 0.0 0.1 0.0 1.4 1.6 6.3 0.0 1.4 0.8 0.0 2.4 2.9 0.0 0.0 2.4 26.6 8.1 4.5 2.4 0.1 0.2 3.9 0.0 5.7 3.9 0.1 0.0 0.0 0.3 0.0 0.2 20.9 11.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 5.0 1.8 8.0 3.4 0.0 0.5 7.7 0.9 0.3 0.9 0.0 1.2 16.7 1.6 1.2 0.9 3.2 1.1 0.8 2.2 1.3 1.2 0.9 1.6 0.6 1.8 1.0 0.2 3.2 7.8 75.7 4.0 2.7 12.1 19.0 15.4 4.4 6.0 4.2 0.3 4.3 14.9 5.5 18.8 5.5 0.2 4.2 9.8 11.9 0.0 12.6 1.1 0.4 13.2 0.0 110.2 14.1 2.5 1.1 15.8 12.2 0.0 0.9 1.1 11.3 0.7 1.7 131.2 5.4 26.4 0.0 0.3 0.0 0.6 0.6 3.6 45.0 0.6 1.2 0.0 110.6 105.3 11.9 3.8 0.4 14.4 7.4 4.8 5.6 25.1 11.8 0.0 0.5 1.0 0.0 0.0 7.1 6.7 5.6 16.7 0.3 4.0 9.2 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364066-49396089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "adrenal gland: 5.4;brain: 11.0" "Cell type enhanced" "Detected in some" "Langerhans cells: 1.2;Melanocytes: 1.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7" "Region enriched" "Detected in single" 6 "pons and medulla: 3.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.1 5.4 0.4 0.2 0.8 0.1 0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 9.2 2.6 0.2 0.0 0.0 0.0 0.2 0.0 11.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 17.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.2 1.6 0.1 0.6 9.2 2.6 0.2 11.0 4.3 1.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.8 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165330-12196144 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA 1500000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavorable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 30.3 32.6 24.1 30.9 27.1 24.3 27.0 27.4 30.8 24.0 28.6 32.3 27.8 14.4 23.9 41.0 24.8 18.5 14.0 23.8 26.3 36.7 89.6 26.2 39.7 27.4 25.3 22.4 18.1 26.1 33.3 35.8 31.3 26.9 21.2 36.3 27.7 25.4 14.1 6.2 33.5 25.6 17.8 25.4 34.4 22.8 13.2 26.0 54.0 28.1 7.7 47.8 29.1 28.0 31.9 136.4 98.0 114.6 107.1 107.5 105.6 100.8 96.9 61.5 111.9 119.1 142.5 125.9 134.2 82.4 79.2 70.0 133.1 162.0 150.6 102.1 110.8 160.8 111.9 114.3 209.3 112.0 77.1 75.2 111.7 88.4 122.3 61.7 86.3 144.9 209.4 153.5 88.9 103.2 123.8 143.5 87.0 100.4 215.0 60.1 128.0 42.4 157.2 106.0 46.1 56.6 82.3 117.4 90.8 142.2 132.0 155.9 77.9 91.6 47.0 90.6 134.3 121.9 74.3 141.6 179.3 99.7 97.3 36.0 29.6 60.8 115.2 69.9 65.7 80.4 72.7 73.9 82.6 87.6 64.6 50.4 68.4 163.8 57.4 52.2 149.2 123.4 71.6 24.1 27.1 27.4 30.8 23.8 26.3 27.4 25.3 22.4 26.9 25.4 26.0 31.9 42.1 25.6 55.1 23.2 43.8 43.0 57.8 121.2 28.5 21.1 28.6 30.7 4.5 32.9 72.3 23.9 16.7 82.6 49.8 35.0 74.3 82.2 35.3 61.1 44.4 42.6 38.3 43.5 34.6 82.9 150.6 40.3 33.1 31.9 31.7 41.4 41.7 131.8 128.7 21.9 38.2 41.2 79.3 41.8 32.2 11.7 39.4 39.7 30.2 12.2 85.0 37.4 62.8 34.2 41.2 73.8 35.2 29.0 66.1 33.7 52.6 130.6 103.9 25.5 32.9 21.2 40.1 20.2 33.6 52.4 60.5 58.1 49.7 54.4 57.4 46.9 DACT1 "DAPPER, DAPPER1, FRODO, HDPR1, THYEX3" ENSG00000165617 "Dishevelled binding antagonist of beta catenin 1" Q9NYF0 14 58633967-58648321 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 56.0;Late spermatids: 17.9;Peritubular cells: 27.8;Smooth muscle cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.5;SuSa: 17.2;U-138 MG: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003016, HPA074619" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA003016: AB_1078623, HPA074619: " "unprognostic (2.47e-2)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (3.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-2)" "unprognostic (4.79e-2)" "unprognostic (1.93e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" 7.6 8.0 5.2 4.2 4.2 1.6 6.6 17.6 3.1 9.6 2.8 5.6 6.0 7.7 5.9 3.0 5.9 25.2 6.9 3.3 3.6 5.6 2.7 9.3 4.1 1.6 3.0 3.3 24.6 2.3 8.0 3.8 12.2 5.9 11.9 6.8 2.0 3.6 13.2 2.4 2.6 4.0 9.0 1.9 7.3 6.9 9.9 2.2 3.7 10.7 4.5 2.3 14.1 6.7 3.0 0.0 0.0 4.0 0.1 4.5 5.0 0.1 2.3 2.9 2.4 2.1 0.3 0.2 0.0 0.1 6.9 4.0 3.6 11.5 0.0 1.3 2.7 2.4 0.0 0.1 0.0 8.2 0.0 1.3 5.9 0.3 9.0 0.0 9.0 0.1 0.8 0.0 0.0 1.6 0.0 0.9 0.1 3.8 0.2 0.9 4.9 5.6 0.0 0.0 0.0 0.1 0.0 6.5 0.0 13.5 17.2 0.0 0.4 0.0 31.7 10.8 0.5 8.5 4.4 1.8 0.0 3.4 1.4 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.2 4.2 17.6 3.1 3.3 3.6 1.6 3.0 3.3 5.9 1.9 2.2 3.0 1.1 0.0 0.0 0.3 1.0 0.8 1.2 0.0 1.2 0.4 0.3 1.5 3.9 7.2 0.0 1.8 0.0 0.2 0.2 0.3 0.0 1.7 56.0 0.4 9.3 1.4 0.0 0.0 2.7 2.3 0.8 11.7 2.0 0.3 0.0 2.3 4.2 0.0 1.2 0.0 4.0 1.0 0.0 2.9 2.1 17.9 12.2 0.6 1.8 6.5 0.0 4.5 0.0 1.5 0.8 3.1 0.0 27.8 0.6 0.4 0.0 1.0 0.0 0.5 0.0 2.9 15.7 12.6 8.6 0.3 1.3 0.1 0.5 3.6 0.5 0.4 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 13 "Extravillous trophoblasts: 49.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "myeloid DC: 1.2;plasmacytoid DC: 2.1" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.1" "Cell line enhanced" "Detected in some" "RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 1.0 0.0 1.2 1.3 0.8 0.1 4.2 0.5 1.4 1.0 0.5 2.0 0.2 0.5 2.5 2.2 1.6 0.1 0.1 0.8 1.9 4.1 0.0 0.4 0.1 1.2 1.3 0.9 0.1 0.6 0.3 0.3 0.9 0.9 0.5 1.6 0.0 3.0 0.4 0.2 2.5 0.4 0.5 0.7 0.4 0.2 0.1 2.7 0.3 0.5 0.3 0.8 1.8 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.1 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 1.2 0.8 0.5 1.4 0.8 1.9 1.2 1.3 0.9 0.9 0.7 2.7 1.1 0.8 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.7 1.4 0.2 0.0 0.0 0.0 0.0 2.4 0.1 0.2 1.9 0.0 0.2 0.7 0.1 0.8 1.2 0.0 0.6 0.0 49.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.5 0.0 0.0 0.4 0.1 0.0 0.3 3.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 3.7 0.0 0.0 1.2 0.0 UCMA "C10orf49, GRP" ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221766-13234374 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;ovary: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" NA NA 20000 "HPA046718: AB_2679771" "unprognostic (4.25e-1)" 0.0 0.0 1.2 0.0 1.4 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.0 2.7 0.2 1.1 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.2 0.7 0.2 0.2 2.7 0.2 1.1 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 167.3;Late spermatids: 268.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.5;hTERT-RPE1: 17.3" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Yes No "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 7.7 6.0 4.5 2.5 4.7 0.8 9.4 6.3 4.8 6.6 4.6 9.7 16.7 7.4 13.7 2.2 12.5 6.6 6.7 4.7 5.0 18.6 9.1 9.2 1.1 4.7 5.0 4.2 8.4 12.2 14.9 10.4 4.4 5.2 5.8 6.6 15.5 15.3 6.5 16.5 2.9 19.5 6.1 4.4 3.0 11.2 16.5 4.8 0.5 23.7 13.5 1.0 6.8 4.4 4.5 9.9 5.9 6.0 2.2 0.1 0.0 8.7 3.8 0.1 9.3 5.6 2.4 17.5 0.0 5.1 7.3 5.2 0.4 9.8 2.1 8.3 0.0 8.7 0.0 0.0 11.4 3.9 0.0 0.0 0.2 5.7 1.2 0.0 17.3 10.3 1.4 4.3 0.0 9.3 4.0 0.1 0.0 1.8 0.0 1.0 0.0 4.4 0.0 8.0 1.3 0.4 4.7 10.7 0.0 0.1 9.1 0.1 4.7 9.2 1.1 13.8 11.6 4.8 0.0 0.0 0.0 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.5 4.7 6.3 4.8 4.7 5.0 4.7 5.0 4.2 5.2 4.4 4.8 4.5 33.6 22.4 11.6 23.5 1.9 3.4 23.6 1.1 1.8 14.4 15.4 11.4 11.0 22.8 9.8 20.2 8.4 3.0 2.6 13.2 3.9 13.0 167.3 25.0 5.8 16.7 7.8 0.0 7.5 16.5 2.9 8.0 9.7 36.2 6.3 14.7 22.5 9.6 3.0 1.7 10.2 8.5 6.1 9.4 1.9 268.7 5.0 2.5 3.6 24.4 4.5 20.3 12.3 47.7 0.7 21.8 9.5 6.0 0.5 23.9 45.2 52.0 9.7 32.2 0.0 14.1 8.4 21.5 20.0 3.3 1.8 2.5 3.5 3.4 10.3 36.1 ATP5F1C "ATP5C, ATP5C1, ATP5CL1" ENSG00000165629 "ATP synthase F1 subunit gamma" P36542 10 7788147-7807815 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 903.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 517.1;Distal tubular cells: 890.2;Ductal cells: 453.9;Extravillous trophoblasts: 428.5;Hofbauer cells: 423.4;Proximal tubular cells: 938.6;Theca cells: 413.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060949 Approved NA NA 70000 "HPA060949: AB_2684395" "unprognostic (1.81e-2)" "unprognostic (8.34e-2)" "unprognostic (3.87e-2)" "unprognostic (1.69e-2)" "unprognostic (2.17e-2)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (8.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.31e-3)" "unprognostic (1.62e-1)" "unprognostic (4.12e-1)" "prognostic favorable (9.26e-4)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-2)" "unprognostic (4.08e-2)" 124.8 267.2 85.4 104.1 88.6 150.3 166.4 113.1 111.9 123.5 101.3 243.1 257.0 101.9 151.4 147.3 115.6 113.6 716.3 82.6 94.3 403.6 371.7 94.3 134.0 86.1 87.4 78.1 87.6 183.8 415.0 77.3 148.7 88.9 118.5 277.3 163.0 169.8 137.5 542.9 111.6 207.4 147.4 90.7 97.2 175.9 71.8 96.2 194.3 163.2 903.0 176.8 165.4 91.8 103.6 301.2 266.8 255.2 219.3 212.5 276.7 241.2 211.1 176.1 365.7 351.6 511.4 293.8 323.8 163.3 248.0 95.3 337.9 318.3 342.8 325.5 222.3 381.6 351.7 169.3 479.8 172.2 193.6 249.6 222.9 234.1 224.7 134.5 315.7 426.7 321.8 283.4 230.1 352.6 419.0 451.9 217.7 173.3 623.4 201.8 301.9 179.1 460.6 637.5 301.0 141.3 168.2 186.0 417.5 417.1 287.3 437.9 315.9 202.7 151.7 205.3 349.2 229.8 159.2 194.7 265.5 224.7 286.2 127.3 373.0 273.8 241.9 158.5 363.1 185.3 199.2 180.7 174.5 370.4 158.6 146.4 159.6 88.5 226.9 428.2 237.8 261.4 349.3 85.4 88.6 113.1 111.9 82.6 94.3 86.1 87.4 78.1 88.9 90.7 96.2 103.6 196.2 118.6 95.4 0.0 30.4 0.0 0.0 0.0 0.0 0.0 156.2 239.3 0.0 0.0 60.7 215.2 0.0 517.1 85.3 0.0 890.2 453.9 0.0 160.9 125.4 76.7 0.0 0.0 0.0 381.8 428.5 89.5 0.0 170.4 97.1 163.2 0.0 0.0 423.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.0 0.0 140.6 0.0 0.0 0.0 0.0 304.4 0.0 0.0 12.0 0.0 0.0 938.6 64.8 0.0 0.0 0.0 102.0 0.0 0.0 0.0 0.0 371.9 49.1 413.9 0.0 0.0 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586939-13630859 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: AB_2680221" "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 14.7 16.0 8.8 14.5 10.1 43.4 19.8 12.7 10.5 12.9 9.3 16.2 17.0 14.1 28.4 15.9 11.8 15.7 14.5 9.0 9.1 20.9 22.1 15.0 18.4 9.5 9.3 7.2 13.1 17.1 18.8 10.8 17.5 9.9 14.4 18.3 10.2 14.4 13.1 23.4 14.1 16.6 15.2 9.1 13.8 15.1 19.0 9.5 25.3 23.8 22.4 19.9 16.6 12.4 10.5 29.5 21.7 18.9 16.4 25.9 24.7 23.5 33.6 16.6 35.9 34.2 20.8 43.8 24.4 18.3 31.1 16.3 23.8 25.1 27.8 41.3 36.3 24.9 28.4 18.5 16.3 30.7 22.6 32.9 19.4 44.3 31.3 15.4 21.9 35.3 35.0 29.9 32.1 33.1 30.5 42.2 15.6 17.8 29.0 10.7 29.8 22.8 30.6 23.9 12.6 13.2 32.7 26.6 18.8 29.1 23.0 29.0 36.6 30.2 22.2 26.1 36.5 25.5 31.2 35.8 34.8 32.8 27.9 15.4 27.2 27.3 36.5 27.7 25.1 24.0 26.9 24.8 23.9 27.4 25.8 26.4 32.6 40.3 39.7 37.4 23.3 33.5 16.8 8.8 10.1 12.7 10.5 9.0 9.1 9.5 9.3 7.2 9.9 9.1 9.5 10.5 24.5 19.2 22.4 14.7 32.8 45.6 24.0 35.7 25.0 13.5 22.6 15.0 9.4 30.0 32.9 22.0 10.4 30.5 28.7 21.1 41.1 30.9 29.8 27.5 22.8 21.1 12.6 25.9 27.0 29.1 40.4 18.9 19.4 22.0 27.1 10.5 16.4 28.4 26.0 21.9 25.3 21.8 46.8 20.7 18.0 16.5 17.7 19.4 24.9 18.7 29.7 20.2 36.0 28.1 29.3 33.7 28.9 13.2 27.1 16.2 30.2 50.6 31.8 21.7 19.7 20.8 18.3 105.8 41.1 17.1 46.9 41.7 33.2 11.6 19.0 25.8 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818505-8016631 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA066184: AB_2685631" "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 5.4 4.9 7.7 4.8 8.0 6.9 4.5 9.7 9.1 4.7 5.3 4.4 2.9 5.3 2.2 3.1 4.4 3.4 5.5 6.3 7.7 4.1 3.7 3.9 6.1 8.5 8.1 5.7 7.0 4.4 5.2 3.2 4.6 8.7 3.5 3.5 5.3 3.6 4.4 10.8 5.3 3.8 4.2 7.6 5.6 3.8 7.6 8.2 7.0 4.3 7.6 4.7 5.1 4.2 7.3 7.9 7.2 8.0 4.3 9.0 6.2 11.1 9.2 3.5 6.8 7.7 15.6 5.8 13.4 6.9 5.4 2.8 8.4 8.9 7.9 8.5 10.9 9.8 11.5 5.0 10.0 7.7 7.8 10.1 4.2 7.8 9.5 4.6 4.3 6.5 14.5 13.0 13.5 7.8 14.9 17.7 5.5 6.1 11.5 4.2 14.2 7.6 9.0 3.9 4.9 4.3 6.1 10.0 7.2 9.4 7.8 13.1 8.1 8.1 6.1 10.7 16.3 9.1 8.0 10.3 14.4 5.9 8.8 5.6 5.8 3.9 5.7 6.0 3.4 7.1 5.2 5.4 5.9 3.2 5.6 6.7 5.8 1.5 6.2 6.6 3.1 4.9 3.9 7.7 8.0 9.7 9.1 6.3 7.7 8.5 8.1 5.7 8.7 7.6 8.2 7.3 26.2 28.9 29.5 41.1 45.2 32.0 20.7 13.3 23.3 28.6 15.3 16.5 40.1 14.3 10.5 27.6 35.5 26.6 32.0 18.0 0.0 17.0 39.6 16.7 22.9 29.9 18.7 25.2 45.1 14.7 36.8 23.2 19.9 16.7 22.1 18.0 19.6 14.5 19.8 26.9 54.4 14.6 8.2 21.3 24.2 22.0 27.4 25.3 24.9 71.2 25.7 27.0 53.5 43.2 63.9 15.0 5.9 28.6 37.7 14.1 20.5 4.5 16.3 47.8 26.3 39.3 31.0 58.9 46.2 16.4 43.0 20.0 48.6 16.4 16.5 17.6 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014236-49115522 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.25e-4)" 18.8 41.9 7.1 3.3 8.5 0.3 9.9 8.0 6.9 22.5 8.0 6.8 2.5 12.4 7.4 7.9 8.6 10.6 12.3 6.3 7.6 12.5 3.9 10.9 3.5 8.8 9.2 5.8 35.5 1.6 27.0 5.1 10.5 9.3 13.6 5.6 2.3 3.5 11.8 5.6 5.0 5.0 11.5 8.8 2.3 5.7 9.4 8.0 6.6 28.1 6.0 4.6 12.1 7.6 9.4 0.0 0.0 3.1 0.1 1.3 0.7 0.1 2.6 4.1 0.9 0.2 0.0 0.1 0.1 0.1 6.1 3.4 0.1 0.2 0.0 0.4 3.2 1.4 0.2 0.1 0.1 0.1 0.1 0.0 4.7 0.0 4.2 0.0 0.0 0.0 0.8 8.6 0.1 0.8 0.1 0.0 0.2 0.6 0.0 0.0 0.0 9.3 5.0 0.0 0.1 0.1 7.9 0.1 0.0 0.0 0.4 0.1 0.3 0.0 10.6 1.2 24.0 0.1 0.0 6.8 0.0 11.6 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.3 0.1 0.1 0.0 0.0 7.1 8.5 8.0 6.9 6.3 7.6 8.8 9.2 5.8 9.3 8.8 8.0 9.4 9.4 3.2 17.5 17.3 1.3 6.5 1.6 0.1 0.6 5.4 1.2 1.1 16.7 0.0 9.4 0.0 2.1 0.4 3.7 0.2 1.9 0.1 88.5 0.8 10.7 6.2 0.0 0.0 11.1 0.0 0.3 29.7 0.0 0.7 12.6 96.9 5.3 5.0 0.7 5.0 7.0 0.0 0.0 2.2 11.1 140.6 9.6 2.9 7.2 4.7 1.0 9.1 2.1 20.1 33.3 0.2 0.1 14.7 0.7 0.8 0.0 9.4 3.8 2.9 59.2 20.6 37.7 1.3 4.4 0.4 4.3 0.4 2.0 44.7 0.0 0.7 VDAC2 ENSG00000165637 "Voltage dependent anion channel 2" P45880 10 75210154-75231448 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043475 Enhanced Supported Mitochondria NA NA 490000 Mitochondria "HPA043475: AB_10795615" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (9.47e-2)" "unprognostic (9.00e-3)" "unprognostic (5.74e-2)" "prognostic unfavorable (4.51e-4)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.83e-3)" "unprognostic (5.89e-2)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (1.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (6.28e-2)" "unprognostic (1.34e-2)" 134.6 151.5 98.5 94.2 99.3 139.8 117.2 116.5 115.9 132.3 115.4 198.3 152.7 117.5 91.5 324.6 118.4 86.1 395.4 100.6 109.3 179.1 116.8 113.0 84.2 108.9 108.6 98.7 133.9 151.9 194.3 85.9 116.5 111.1 109.8 186.2 200.2 152.6 135.3 543.8 166.7 149.7 150.5 110.5 78.3 160.7 105.5 106.7 93.6 112.0 570.9 149.5 165.0 208.8 116.8 304.4 245.0 291.0 370.5 253.3 342.1 305.2 384.9 430.4 412.7 386.6 367.5 281.8 358.6 210.9 324.3 228.6 398.2 539.2 382.2 402.1 196.0 313.5 209.4 191.4 425.2 252.6 402.0 223.4 305.6 441.7 352.8 747.3 578.2 310.0 222.9 359.9 283.7 439.4 222.6 262.6 325.7 250.7 341.2 937.6 308.2 230.0 228.3 408.9 187.5 183.4 216.5 212.4 701.7 467.4 337.8 409.7 177.4 241.4 204.4 279.8 305.7 419.8 226.7 333.1 369.0 296.3 390.4 178.1 168.2 179.0 138.9 106.7 193.1 130.8 154.2 144.3 119.4 220.4 127.9 144.2 134.5 61.5 135.5 238.4 107.3 178.6 221.6 98.5 99.3 116.5 115.9 100.6 109.3 108.9 108.6 98.7 111.1 110.5 106.7 116.8 130.3 96.1 54.9 30.3 135.5 381.4 417.8 575.6 280.6 149.6 149.5 159.1 325.1 128.7 246.3 112.2 43.8 315.0 128.0 583.7 669.1 413.3 257.6 172.2 110.9 146.5 149.7 148.5 22.1 345.7 437.6 142.6 158.0 199.9 112.3 197.5 165.9 79.2 266.1 129.5 30.7 305.1 284.8 164.8 220.3 110.8 169.9 180.2 224.1 16.9 264.3 275.5 92.7 23.1 26.0 443.5 497.2 166.3 172.2 386.3 610.9 324.3 119.5 161.1 177.5 170.3 289.0 359.7 149.7 493.3 420.4 396.5 129.6 210.5 355.7 568.1 SOHLH1 "bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2" ENSG00000165643 "Spermatogenesis and oogenesis specific basic helix-loop-helix 1" Q5JUK2 9 135693407-135704498 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 29.1;choroid plexus: 12.1;testis: 17.0" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 78.3" "Group enriched" "Detected in some" 5 "cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 20.9;U-266/84: 39.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA059439 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA059439: AB_2684017" "unprognostic (2.93e-1)" "unprognostic (1.23e-3)" "unprognostic (9.85e-3)" "unprognostic (2.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.59e-3)" "unprognostic (4.98e-3)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.1 0.0 13.4 0.0 15.7 0.0 0.0 12.8 29.1 0.0 12.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.1 12.7 0.0 0.0 0.0 0.0 16.4 13.4 14.5 0.1 0.0 0.1 3.2 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 12.3 0.1 0.1 17.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.7 12.8 29.1 15.1 12.7 16.4 13.4 14.5 16.8 12.3 12.8 18.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.0 15.9 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.0 0.0 0.0 0.0 5.1 0.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 78.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233641-75236030 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 71.2;pancreas: 129.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 10.0 18.0 1.1 1.1 1.4 1.5 9.9 1.1 1.8 12.3 4.9 15.0 7.4 7.6 0.4 71.2 7.2 0.4 26.9 1.2 1.3 27.4 37.8 11.8 0.6 1.6 1.9 1.3 8.1 129.6 3.4 17.2 0.9 1.7 11.9 1.0 1.1 24.1 1.0 28.4 22.7 25.4 0.5 1.0 12.5 28.0 3.5 1.4 0.5 18.6 0.7 0.7 8.4 29.2 1.4 6.9 2.2 0.5 1.3 0.1 0.7 19.0 2.1 1.0 0.3 0.6 1.6 6.0 20.0 3.5 0.4 1.1 9.0 0.9 1.9 0.1 3.2 30.2 0.8 4.8 3.3 1.1 3.5 3.3 0.6 3.2 0.1 2.9 1.3 0.3 3.6 7.8 4.7 0.1 6.2 5.3 11.0 1.2 5.1 38.3 10.6 1.3 24.5 1.8 0.6 8.4 2.3 2.4 16.0 4.8 0.5 8.9 0.5 1.4 0.6 5.9 1.2 2.1 21.5 4.5 9.8 0.7 3.4 0.6 0.0 7.1 3.9 10.6 10.0 11.6 7.1 10.6 11.0 8.5 5.6 3.5 6.1 1.4 7.3 9.4 15.3 8.9 6.8 1.1 1.4 1.1 1.8 1.2 1.3 1.6 1.9 1.3 1.7 1.0 1.4 1.4 23.6 19.2 11.5 1.6 18.2 29.4 40.5 54.1 133.1 6.0 29.3 37.1 31.1 57.2 33.8 53.3 10.4 33.4 30.8 334.8 144.8 162.8 1.6 10.5 7.7 13.5 40.2 16.0 3.4 249.5 79.1 13.4 148.8 33.4 12.7 10.3 25.4 84.0 35.1 1.7 3.9 206.0 42.7 24.2 21.3 3.5 9.6 21.8 37.4 6.5 31.8 10.7 24.7 1.5 0.5 109.2 272.5 7.2 50.8 38.7 435.9 140.3 11.3 34.5 32.9 6.2 25.6 2.6 3.4 285.3 38.2 30.4 29.2 10.7 143.8 56.7 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241093-117279430 "Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease variant, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.3;cervix: 30.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 636.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "midbrain: 67.3;pons: 44.8" "Immune cell enriched" "Detected in some" 15 "basophil: 59.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 59.5" "Cell line enriched" "Detected in some" 19 "HMC-1: 351.0" "Region enhanced" "Detected in many" "midbrain: 62.7" "Region enriched" "Detected in all" 4 "midbrain: 111.6" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.0 14.7 0.3 0.9 0.8 2.4 1.8 0.0 1.6 30.3 0.1 2.3 1.5 2.6 1.6 2.5 0.5 3.7 0.6 0.2 12.7 0.9 2.8 7.5 0.6 4.1 67.3 0.0 10.5 3.4 0.2 0.2 0.2 44.8 9.3 3.5 0.5 0.8 1.4 0.8 6.3 2.2 2.3 0.0 0.3 4.4 0.9 10.8 6.1 0.0 0.5 1.0 2.9 8.0 12.0 0.2 1.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.7 18.6 0.1 0.2 0.0 1.0 351.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 0.7 0.0 0.1 1.0 0.3 0.2 0.3 0.6 0.2 0.4 0.2 0.0 0.2 3.4 0.7 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.1 2.5 0.3 0.8 0.5 0.4 0.2 0.4 1.9 0.3 59.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 3.8 0.0 2.0 0.3 0.8 0.0 1.6 0.2 12.7 4.1 67.3 0.0 44.8 0.0 10.8 12.0 0.0 9.6 16.2 1.0 0.2 1.9 0.0 0.0 0.0 2.1 0.2 0.0 0.3 0.0 2.5 0.0 4.2 0.0 5.7 0.4 0.0 0.0 0.0 13.1 16.1 0.7 8.9 4.2 1.1 0.0 0.0 3.4 4.1 112.4 636.0 2.4 9.7 0.3 0.8 0.0 1.7 0.0 0.0 1.0 3.6 0.2 0.6 3.5 1.8 0.0 0.1 0.4 0.0 0.5 0.6 0.1 0.1 4.9 1.9 3.8 0.0 0.1 0.7 0.8 0.0 0.4 1.3 0.2 2.1 0.0 2.7 0.0 5.6 9.8 0.1 0.1 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375440 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 73.7" "Cell type enhanced" "Detected in all" "Early spermatids: 208.7;Late spermatids: 477.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 124.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 7.1 7.1 10.3 4.7 12.0 73.7 4.8 15.7 9.1 8.0 15.5 9.4 14.1 9.2 14.2 10.9 6.9 9.8 5.2 8.7 11.8 13.2 16.0 6.1 3.3 12.5 13.6 6.6 9.0 14.3 28.5 4.2 5.5 12.5 6.5 11.3 14.2 13.0 10.6 5.0 5.6 10.6 6.9 12.7 3.8 10.4 13.3 12.5 5.9 6.8 5.9 3.6 6.7 5.9 13.6 12.6 21.1 7.6 14.7 12.8 11.4 4.3 11.9 10.2 5.2 4.2 10.7 16.4 14.7 10.5 18.1 6.0 18.4 13.4 12.6 10.3 9.4 11.8 124.3 8.6 10.6 9.4 52.4 11.2 11.2 14.7 9.5 27.9 19.3 9.3 12.1 11.5 15.0 13.0 5.1 10.2 6.7 6.0 6.6 18.8 8.2 29.2 6.4 15.5 9.0 6.0 9.6 12.6 5.4 9.7 6.9 3.7 7.6 15.1 8.6 9.4 15.8 20.5 8.0 7.2 10.5 10.8 23.6 7.7 1.4 0.5 2.6 0.9 0.5 0.9 0.3 0.7 0.7 0.7 0.4 0.5 0.7 2.3 1.2 0.9 0.5 0.3 0.2 10.3 12.0 15.7 9.1 8.7 11.8 12.5 13.6 6.6 12.5 12.7 12.5 13.6 22.1 12.8 30.7 32.3 13.7 29.7 24.4 10.3 24.5 31.9 16.4 17.0 19.8 40.0 21.0 18.4 22.9 9.8 36.1 26.9 9.8 31.9 208.7 78.3 46.7 24.0 33.7 82.0 49.2 81.9 7.2 27.3 48.4 111.2 44.2 14.6 18.9 58.6 7.5 32.0 61.0 38.8 10.2 16.0 31.8 477.6 23.6 25.2 23.2 30.0 15.5 29.0 23.7 51.8 56.4 57.6 23.1 28.6 28.1 41.1 27.0 26.5 28.5 45.0 26.3 46.3 24.5 25.8 29.1 36.3 32.4 6.7 28.4 90.8 50.2 44.6 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401764 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 13.2 40.2 7.2 3.2 9.4 2.0 9.3 4.2 4.9 31.6 1.3 14.1 8.2 44.4 10.4 20.3 24.0 2.4 8.0 7.4 6.2 25.6 7.2 14.3 1.5 12.5 8.1 3.8 46.7 25.6 4.6 4.8 3.3 8.1 17.7 1.8 1.4 9.6 17.8 3.6 5.3 8.6 7.8 9.7 8.1 16.5 2.5 8.7 1.1 7.9 2.1 1.0 13.9 18.3 7.1 5.2 4.9 1.1 6.3 10.6 7.1 1.6 4.6 2.8 1.9 1.7 7.5 20.4 0.0 13.4 4.6 1.1 9.4 0.7 4.9 1.4 0.0 115.1 0.0 12.4 24.8 8.5 6.1 12.9 19.1 4.8 3.5 2.0 16.6 0.5 0.5 0.1 0.2 2.6 2.7 0.2 18.8 0.1 3.8 149.2 0.0 5.6 0.1 2.8 4.1 4.1 5.2 8.5 0.6 27.1 1.0 1.0 4.2 3.9 14.6 16.3 30.7 13.0 0.0 0.0 0.0 44.9 27.2 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 9.4 4.2 4.9 7.4 6.2 12.5 8.1 3.8 8.1 9.7 8.7 7.1 27.2 38.5 11.6 2.3 1.7 27.1 35.6 15.0 255.0 23.7 7.7 42.3 20.4 10.0 10.1 40.5 20.9 0.5 2.1 0.8 58.7 45.9 0.1 53.2 72.2 41.0 3.6 5.3 12.6 34.7 0.3 60.1 18.3 48.1 6.3 2.7 44.6 10.3 13.5 6.7 3.2 6.7 10.2 27.4 30.5 2.0 59.7 30.7 24.9 13.1 8.2 7.7 0.0 4.0 0.7 33.2 1.5 49.2 3.9 19.7 13.4 32.5 1.7 26.3 39.5 10.2 78.1 0.2 6.0 189.3 13.9 0.3 4.0 24.5 9.7 14.3 ABRAXAS2 "ABRO1, Em:AC068896.4, FAM175B, KIAA0157" ENSG00000165660 "Abraxas 2, BRISC complex subunit" Q15018 10 124801819-124836667 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Collecting duct cells: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037591, HPA037592, HPA074089" Approved Supported Cytosol Yes No Cytosol "HPA037591: AB_10671877, HPA037592: AB_2675566, HPA074089: AB_2686659" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (6.81e-2)" "unprognostic (3.72e-2)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.09e-2)" "unprognostic (1.58e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" 9.2 10.6 8.0 10.4 8.8 12.4 12.3 8.5 10.0 8.9 7.3 10.0 10.3 9.5 9.4 9.9 9.1 8.3 10.0 8.6 9.2 12.4 13.8 9.4 12.6 8.3 8.4 8.3 10.5 8.4 12.8 4.0 10.4 8.6 9.6 10.4 5.4 8.6 8.9 19.2 11.7 10.8 10.6 7.9 10.0 9.6 6.8 8.5 13.0 12.8 16.3 13.4 9.8 6.9 8.7 22.2 14.9 15.7 21.6 19.9 19.6 13.5 22.4 35.1 26.2 24.1 12.1 20.9 24.7 18.6 24.4 14.2 24.4 25.0 21.0 27.5 21.6 17.2 18.8 11.8 15.0 25.4 32.6 18.9 21.6 25.1 25.8 46.4 28.3 20.1 21.7 20.0 16.6 21.6 14.5 25.1 29.1 13.5 20.0 13.8 20.0 16.6 15.1 19.5 11.1 10.8 19.8 17.9 17.0 24.4 15.8 14.0 22.2 17.4 14.0 11.2 16.5 27.1 17.2 17.1 23.6 18.3 15.9 10.1 22.8 10.5 9.8 7.6 14.5 10.5 10.5 8.8 10.6 12.9 11.6 9.3 10.3 4.1 7.7 11.8 8.7 11.4 7.0 8.0 8.8 8.5 10.0 8.6 9.2 8.3 8.4 8.3 8.6 7.9 8.5 8.7 15.1 25.6 14.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 9.4 10.3 0.0 0.0 6.2 23.9 0.0 16.9 7.0 0.0 17.6 13.7 0.0 11.1 15.6 6.3 0.0 0.0 0.0 12.5 13.0 5.5 0.0 12.3 12.6 12.4 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 20.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 1.6 0.0 0.0 18.6 12.4 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 16.0 4.3 13.5 0.0 0.0 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245812 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 9600000 "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: AB_2669565" "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 6.4 7.7 7.4 11.3 7.5 16.0 5.9 12.7 8.0 6.9 5.5 6.4 5.1 8.3 10.7 5.4 8.6 4.6 7.2 7.2 7.1 6.5 8.6 7.0 17.6 7.3 7.7 7.7 9.5 18.9 8.2 32.5 4.9 9.0 6.4 5.5 12.4 6.0 3.8 5.7 10.8 11.9 6.8 5.9 15.9 7.1 10.9 7.5 8.2 11.8 3.4 14.7 6.3 5.8 7.5 14.7 35.0 28.6 38.2 15.8 19.0 35.9 18.3 20.4 34.9 31.9 26.4 31.1 22.6 29.5 24.7 64.1 46.7 34.2 26.5 28.0 33.5 17.2 12.1 59.8 29.3 22.5 36.4 17.8 15.3 26.3 34.8 41.8 15.4 25.9 23.3 29.8 59.1 18.8 25.0 13.6 24.2 34.0 44.2 22.3 24.8 37.1 37.2 12.0 13.1 30.5 23.1 28.9 22.6 15.9 18.5 16.3 21.1 15.0 42.2 30.4 35.1 42.6 20.9 29.9 49.7 28.3 18.9 40.5 0.4 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 7.4 7.5 12.7 8.0 7.2 7.1 7.3 7.7 7.7 9.0 5.9 7.5 7.5 8.8 9.6 7.9 13.7 17.7 5.7 2.8 2.2 1.8 24.4 2.3 2.9 4.3 0.0 4.4 5.5 18.8 1.3 5.8 1.6 1.9 3.4 6.7 5.7 7.4 6.6 16.3 14.5 10.1 4.0 2.8 5.2 4.1 5.6 1.3 7.1 2.9 4.4 2.3 5.0 11.1 3.8 0.0 3.7 8.2 7.3 5.9 3.3 0.0 8.4 4.3 2.6 4.1 6.0 10.7 3.4 0.7 7.2 5.4 7.9 0.9 2.3 9.0 8.8 6.6 9.2 4.7 19.4 24.2 1.8 11.5 1.0 5.1 7.3 3.9 3.6 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297925-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: AB_2684663" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 27.7 19.5 17.4 22.7 19.1 54.9 31.7 15.4 23.8 22.4 14.2 23.7 21.0 26.9 32.5 26.4 20.2 22.0 35.7 18.8 17.9 27.9 29.3 25.2 27.6 19.7 17.3 17.0 28.7 25.0 30.5 14.2 21.1 17.0 20.9 24.4 16.1 25.5 22.3 37.0 18.9 18.7 26.7 16.8 25.0 21.9 49.6 17.6 28.6 29.6 27.9 28.1 26.1 17.3 17.9 56.4 24.9 40.2 56.2 39.1 42.4 22.8 43.6 81.4 61.6 55.4 29.4 51.2 39.7 26.3 47.2 27.7 47.3 34.0 45.5 55.6 62.8 42.0 33.0 23.4 26.2 58.4 86.7 44.9 29.4 54.8 45.3 94.3 51.7 53.3 50.2 35.3 45.5 51.6 31.5 53.6 80.1 28.6 24.7 22.0 45.2 77.7 29.3 56.0 28.2 25.8 40.5 29.9 27.7 66.8 19.6 44.0 61.7 37.4 32.2 30.1 28.8 67.4 32.4 31.0 57.0 62.8 92.2 33.3 73.5 57.5 70.4 36.9 64.2 39.0 50.6 41.8 34.4 59.6 35.2 35.6 41.8 32.0 34.4 69.3 43.0 51.5 57.1 17.4 19.1 15.4 23.8 18.8 17.9 19.7 17.3 17.0 17.0 16.8 17.6 17.9 71.9 60.9 55.7 54.5 66.0 55.6 63.0 60.9 63.7 38.8 61.0 67.4 78.6 52.9 47.3 44.1 73.0 39.5 84.8 30.2 135.0 85.5 255.8 62.5 79.4 67.8 41.9 59.5 49.9 113.7 49.8 72.4 41.8 60.3 68.4 140.6 64.6 49.8 62.4 33.7 48.3 56.0 63.1 69.4 76.2 132.0 76.4 73.0 60.5 27.2 77.2 62.5 92.7 53.3 45.4 95.3 68.9 70.0 62.9 54.6 35.4 115.7 44.2 55.4 26.3 73.7 78.3 258.5 170.3 55.6 50.6 30.6 62.8 62.6 48.4 61.6 NSD1 "ARA267, FLJ22263, KMT3B, STO" ENSG00000165671 "Nuclear receptor binding SET domain protein 1" Q96L73 5 177133025-177300213 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048431, HPA070333, HPA073705" Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239" "unprognostic (3.48e-2)" "unprognostic (7.46e-2)" "unprognostic (7.14e-3)" "unprognostic (2.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.67e-2)" "unprognostic (2.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.68e-3)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (2.09e-1)" "unprognostic (7.77e-3)" "unprognostic (3.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.51e-2)" "unprognostic (7.32e-2)" 8.8 7.3 7.4 12.1 11.8 21.3 11.0 24.8 9.2 11.2 8.4 10.1 8.4 11.6 10.4 11.5 10.2 8.1 9.2 7.0 9.3 10.7 6.6 9.3 13.9 11.3 10.3 5.2 12.4 11.4 12.9 9.0 10.8 13.2 9.4 10.9 12.0 10.5 9.7 13.7 12.1 9.4 12.1 6.8 11.4 9.0 23.4 10.3 20.4 15.6 11.6 14.8 9.3 7.9 17.0 20.5 25.9 26.0 22.8 12.5 16.1 0.9 18.2 17.9 24.6 22.8 5.7 16.6 41.7 19.9 24.8 22.7 17.0 41.9 40.0 29.7 72.9 25.9 18.6 29.5 0.2 20.7 40.4 21.2 15.2 23.6 29.4 27.3 17.5 36.4 26.0 25.9 14.3 25.2 42.3 28.3 13.1 28.5 13.7 22.5 31.0 3.4 12.9 15.9 24.4 31.6 21.9 46.7 20.1 13.8 24.1 20.2 33.0 27.4 17.1 25.0 11.0 22.6 16.7 15.7 29.5 9.9 19.3 18.7 14.7 9.0 10.5 7.2 6.1 6.0 8.5 6.1 5.0 7.2 10.3 7.5 6.0 18.6 11.3 12.2 9.4 6.4 3.4 7.4 11.8 24.8 9.2 7.0 9.3 11.3 10.3 5.2 13.2 6.8 10.3 17.0 37.4 22.4 31.4 84.9 71.7 17.0 32.8 27.2 34.1 94.4 29.8 25.7 44.5 34.3 35.0 55.2 150.1 43.6 66.1 19.7 17.6 27.8 31.9 27.1 65.7 36.4 41.9 48.3 107.0 21.2 23.7 32.7 41.8 41.9 41.7 64.0 33.5 19.9 27.7 89.2 110.3 25.6 12.2 36.8 25.7 50.3 51.0 47.1 16.0 115.2 75.0 29.2 95.8 140.8 157.5 23.7 31.0 33.1 55.8 29.4 33.6 19.2 17.3 112.3 52.6 42.9 36.1 83.7 62.1 41.8 20.6 35.4 62.0 55.9 28.2 30.0 PRDX3 "AOP-1, AOP1, MER5, SP-22" ENSG00000165672 "Peroxiredoxin 3" P30048 10 119167720-119178812 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1060.4;Proximal tubular cells: 937.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008656, HPA041488, CAB079909" Enhanced Supported Mitochondria NA NA 1600000 Mitochondria "CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508" "unprognostic (8.29e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (1.72e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (2.06e-1)" "unprognostic (3.65e-2)" "unprognostic (1.29e-2)" "unprognostic (9.48e-2)" "unprognostic (6.03e-3)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" 167.2 338.2 97.1 96.9 98.0 83.0 139.7 105.9 117.0 104.3 133.4 134.5 139.0 87.8 121.8 84.1 117.7 88.7 280.7 98.5 108.1 389.3 575.9 75.6 109.3 102.0 100.0 94.1 75.6 97.1 225.8 60.5 127.4 103.0 127.8 141.1 53.0 133.2 132.9 379.5 38.0 133.2 131.2 103.9 77.0 98.4 48.7 102.0 99.2 178.3 406.3 104.9 113.9 65.6 106.4 350.6 392.2 234.1 267.3 241.7 259.8 145.9 244.8 414.8 364.5 380.7 303.4 339.9 407.2 208.8 290.8 173.4 155.5 391.5 296.1 408.8 401.5 411.4 183.7 149.7 542.4 252.5 347.8 212.7 306.8 186.4 292.1 269.7 261.2 268.6 245.2 230.0 82.5 338.7 140.2 265.1 292.7 218.9 264.0 229.3 276.5 339.7 281.5 623.8 164.6 103.0 149.2 259.8 346.1 332.2 201.0 179.6 411.5 190.5 118.3 178.1 170.9 323.1 128.0 200.7 327.0 185.7 507.4 107.3 144.4 429.1 246.9 110.5 369.5 142.7 179.9 145.6 134.6 382.1 149.8 149.5 134.0 239.9 132.8 333.9 214.8 205.7 510.2 97.1 98.0 105.9 117.0 98.5 108.1 102.0 100.0 94.1 103.0 103.9 102.0 106.4 61.4 48.1 74.5 14.4 65.1 69.8 117.8 274.0 81.4 27.5 145.2 105.2 236.5 131.5 119.0 147.1 10.4 328.4 50.6 84.5 1060.4 124.5 5.0 105.1 76.0 78.3 110.9 132.8 15.4 75.1 212.0 100.8 116.7 77.3 52.6 131.0 73.2 390.0 247.6 40.4 15.4 132.5 221.8 164.2 96.0 10.5 77.3 127.9 133.4 10.3 158.4 76.9 39.1 12.5 18.8 63.8 99.3 101.2 153.7 95.1 176.1 937.8 163.4 24.8 72.3 63.1 105.3 11.2 23.2 146.4 52.6 155.0 56.1 440.0 207.0 119.6 ENOX2 "APK1, COVA1, tNOX" ENSG00000165675 "Ecto-NOX disulfide-thiol exchanger 2" Q16206 X 130622325-130903317 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Growth regulation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 132.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000514, HPA003027" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA000514: AB_1078558, HPA003027: " "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (6.07e-2)" "unprognostic (6.27e-3)" "unprognostic (5.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.09e-5)" "unprognostic (6.42e-2)" "unprognostic (4.60e-2)" "unprognostic (3.02e-1)" "unprognostic (1.38e-1)" 6.5 7.7 5.9 5.7 9.1 3.4 6.5 5.5 6.6 6.9 5.5 5.0 4.1 8.9 5.5 7.2 7.7 6.6 10.9 6.2 7.3 4.4 5.4 5.2 8.3 7.5 6.8 5.1 7.9 3.8 7.9 1.7 6.0 9.0 6.2 5.4 2.8 4.6 8.1 6.7 4.5 4.7 8.3 5.8 7.3 5.6 5.9 7.7 8.6 6.4 8.3 9.6 7.0 3.1 9.0 15.7 12.9 16.2 7.4 15.3 13.2 7.3 12.6 15.3 8.5 5.3 6.0 12.9 11.3 30.1 11.6 11.4 10.9 11.4 13.0 10.7 15.3 12.1 24.6 7.4 6.6 10.6 20.2 16.6 10.7 19.3 10.1 11.3 4.0 12.8 9.9 17.1 8.6 7.0 21.4 13.2 3.7 9.0 20.8 16.0 8.7 10.4 12.9 10.0 10.5 5.5 9.6 12.2 7.2 17.0 6.1 4.6 10.1 10.5 8.3 4.9 13.2 26.4 9.2 4.9 7.6 23.6 19.2 13.8 7.0 11.1 12.9 9.4 14.1 9.6 11.7 10.5 9.7 10.8 11.9 11.2 9.7 1.8 10.8 7.7 5.8 12.4 9.3 5.9 9.1 5.5 6.6 6.2 7.3 7.5 6.8 5.1 9.0 5.8 7.7 9.0 11.8 3.2 7.4 15.0 11.5 4.2 6.9 5.1 19.4 4.4 8.1 5.3 13.0 5.7 7.5 3.7 0.0 6.2 7.9 4.9 7.9 8.0 1.0 8.3 13.3 8.6 4.8 11.6 18.7 9.3 5.5 9.7 10.7 5.4 6.3 7.4 7.5 12.3 6.9 3.3 31.2 6.7 14.2 21.3 7.7 2.2 5.6 12.6 8.8 23.4 18.4 4.3 19.6 51.3 132.2 10.1 2.6 6.4 11.9 6.4 4.5 8.4 13.1 8.3 6.6 11.6 9.5 11.4 10.6 13.8 4.8 7.3 11.1 7.6 5.7 5.7 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139509-84153568 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1114.2;Late spermatids: 2559.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria NA NA Mitochondria "HPA016464: AB_1849656, HPA061664: AB_2684579" "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favorable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 115.0 180.9 128.7 87.8 139.5 111.6 94.7 144.4 152.6 73.7 148.2 172.9 165.0 77.5 86.9 115.3 72.0 69.5 368.8 137.7 148.9 303.5 273.3 74.7 88.0 139.8 134.4 133.6 73.4 78.3 199.0 89.5 70.9 144.1 81.3 168.0 145.5 95.2 85.0 372.8 78.6 138.3 86.4 130.9 74.4 124.1 116.7 138.2 87.3 106.9 460.6 104.1 93.2 77.1 156.5 228.2 230.8 97.1 223.5 162.6 143.3 171.6 153.3 267.4 193.7 180.2 283.1 183.8 178.9 167.7 203.2 170.9 199.9 208.4 200.0 185.9 179.8 157.4 127.7 227.3 281.0 306.5 402.0 200.0 162.7 384.1 200.4 577.8 201.8 169.9 150.5 299.9 324.3 180.4 197.4 143.6 318.9 98.3 184.8 203.2 128.3 89.4 270.5 271.4 179.2 79.4 92.4 154.7 134.1 325.1 111.2 273.7 254.2 145.3 94.0 126.5 138.5 251.1 227.9 265.7 199.9 246.8 364.4 67.1 293.7 284.9 276.5 173.9 304.7 194.2 211.0 178.9 186.0 279.9 177.9 166.6 178.8 223.7 206.7 281.3 145.3 235.3 578.0 128.7 139.5 144.4 152.6 137.7 148.9 139.8 134.4 133.6 144.1 130.9 138.2 156.5 94.1 96.1 87.6 23.2 138.0 170.3 185.1 440.9 87.0 135.9 102.2 71.8 689.3 140.2 235.8 158.2 70.9 260.4 134.0 376.0 579.2 295.3 1114.2 58.7 68.6 120.7 125.6 242.9 33.6 232.3 234.9 119.6 107.6 67.1 102.0 79.3 88.5 326.1 267.7 101.0 34.5 206.0 443.5 156.2 169.2 2559.1 110.3 153.0 163.7 16.9 228.3 269.0 114.4 14.6 24.3 223.3 276.3 136.9 167.3 180.1 343.7 802.9 173.4 159.9 144.7 114.5 219.8 263.1 153.2 150.4 170.3 386.0 141.6 158.4 281.4 212.9 CLEC1B CLEC2 ENSG00000165682 "C-type lectin domain family 1 member B" Q9P126 12 9985642-10013424 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 65.8" "Cell type enriched" "Detected in some" 8 "Hepatic stellate cells: 535.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 13.8" "Group enriched" "Detected in many" 4 "granulocytes: 13.8;monocytes: 5.0" "Group enriched" "Detected in some" 6 "Karpas-707: 11.3;U-266/84: 28.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA051108 Approved NA NA "HPA051108: " "unprognostic (2.03e-1)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-2)" "unprognostic (7.71e-2)" "unprognostic (4.98e-2)" "unprognostic (1.58e-1)" "unprognostic (8.13e-2)" "unprognostic (1.49e-3)" "unprognostic (1.46e-2)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (2.91e-2)" 0.1 0.4 0.0 0.9 0.2 9.3 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.2 0.1 65.8 2.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 2.9 0.2 2.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 3.3 0.0 13.8 5.0 7.5 0.0 4.4 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 3.3 0.1 4.1 1.2 0.0 13.8 0.0 0.2 0.1 0.2 0.0 0.2 0.3 0.1 0.0 0.3 0.1 0.4 0.4 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 7.4 0.0 53.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 535.8 5.0 0.1 0.0 0.0 0.0 0.0 49.9 0.0 0.3 0.0 64.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.6 0.0 0.0 0.0 1.1 0.6 0.0 0.0 SNAPC4 "FLJ13451, PTFalpha, SNAP190" ENSG00000165684 "Small nuclear RNA activating complex polypeptide 4" Q5SXM2 9 136375577-136400168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028939, HPA046627, HPA073243" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028939: , HPA046627: AB_10961152, HPA073243: AB_2686585" "unprognostic (3.34e-2)" "unprognostic (2.12e-1)" "unprognostic (5.26e-2)" "unprognostic (1.75e-2)" "unprognostic (3.17e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.52e-5)" "unprognostic (3.15e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (6.41e-2)" 5.8 5.4 3.6 6.0 2.7 8.6 6.6 1.9 6.4 7.8 2.1 6.3 5.7 6.8 3.1 5.9 9.8 3.9 5.3 2.9 0.8 7.4 10.9 6.6 7.0 1.7 0.7 2.7 8.1 11.4 5.9 11.3 3.8 1.6 8.1 4.1 5.5 6.7 4.6 6.4 8.2 7.3 4.6 0.1 10.2 6.1 19.8 0.6 5.2 8.7 2.4 6.1 6.8 6.4 2.2 9.2 10.5 10.6 14.8 6.7 12.9 19.4 11.7 7.8 12.0 9.5 24.3 8.2 14.0 8.2 9.3 8.3 29.0 12.9 15.0 7.1 19.9 20.3 9.5 30.3 11.6 5.9 20.2 10.8 10.3 12.4 10.4 9.8 10.4 10.8 11.3 19.8 10.1 8.4 20.6 11.7 22.7 21.9 14.5 13.7 19.0 10.7 19.9 6.9 16.4 30.4 21.2 11.7 19.1 6.2 9.1 19.7 11.6 15.4 12.3 11.2 22.3 16.9 6.3 7.9 11.2 8.6 9.3 7.3 0.0 0.5 0.4 0.7 0.3 0.3 0.5 0.3 0.3 0.1 1.5 0.2 0.1 1.0 0.7 0.1 0.5 0.2 0.1 3.6 2.7 1.9 6.4 2.9 0.8 1.7 0.7 2.7 1.6 0.1 0.6 2.2 3.6 6.4 9.0 12.1 4.8 5.4 2.8 3.9 5.7 8.2 6.0 5.0 5.9 5.7 3.8 3.7 2.1 2.6 5.9 5.4 0.0 6.2 4.1 15.1 5.6 4.1 5.3 7.0 12.2 4.5 2.0 4.1 4.6 7.1 1.3 7.0 5.7 8.1 3.2 3.3 8.5 5.0 10.2 4.2 7.7 2.5 5.0 3.4 0.0 5.6 3.2 4.4 3.1 7.1 5.5 6.8 5.8 4.9 4.6 3.7 3.6 4.3 20.3 12.2 0.0 4.2 4.4 9.5 10.0 3.0 6.8 1.4 5.7 6.2 6.1 2.9 TMEM52B "C12orf59, FLJ31166" ENSG00000165685 "Transmembrane protein 52B" Q4KMG9 12 10170542-10191801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "kidney: 177.4" "Cell type enriched" "Detected in some" 15 "Distal tubular cells: 712.1" "Cancer enriched" "Detected in some" 5 "renal cancer: 6.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "CACO-2: 95.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA058096 Enhanced Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058096: AB_2683603" "unprognostic (1.10e-2)" "unprognostic (7.61e-2)" "unprognostic (1.37e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (5.33e-3)" "unprognostic (1.37e-1)" "unprognostic (8.65e-2)" "unprognostic (7.14e-4)" "unprognostic (2.23e-1)" "unprognostic (6.36e-2)" "unprognostic (7.33e-2)" "unprognostic (3.24e-2)" "unprognostic (5.80e-2)" "unprognostic (5.51e-2)" "unprognostic (1.66e-1)" "unprognostic (3.18e-1)" 0.1 0.1 0.6 0.8 1.0 3.5 0.3 0.8 1.2 0.1 0.8 0.1 0.2 0.0 0.3 0.0 0.1 0.4 0.0 0.7 1.0 177.4 0.2 0.7 0.2 0.9 0.7 0.4 0.0 0.3 0.1 0.0 6.1 1.3 0.1 0.1 0.1 1.9 0.0 0.0 0.4 0.2 0.4 1.5 0.1 0.4 0.3 0.8 0.1 0.2 0.0 0.2 0.2 0.0 1.6 2.3 0.1 0.0 0.1 0.0 0.0 1.1 2.2 0.0 0.1 0.0 95.9 0.1 0.0 0.1 0.7 4.9 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 11.7 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 7.0 8.9 0.0 3.0 5.0 1.4 0.0 0.2 0.4 0.0 0.0 0.1 0.1 0.1 0.2 4.7 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.6 1.0 0.8 1.2 0.7 1.0 0.9 0.7 0.4 1.3 1.5 0.8 1.6 0.1 0.0 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 12.9 0.0 44.7 0.0 0.1 712.1 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.8 0.0 2.5 3.2 0.0 0.1 0.0 0.0 0.0 0.0 10.8 0.0 0.2 0.0 0.0 0.8 1.1 0.1 0.3 4.2 1.8 2.8 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 19.4 0.1 0.0 0.0 0.1 PMPCA "Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2" ENSG00000165688 "Peptidase, mitochondrial processing subunit alpha" Q10713 9 136410641-136423761 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021648, HPA063735" Supported Enhanced Mitochondria NA NA Mitochondria "HPA021648: AB_1855491, HPA063735: AB_2685108" "unprognostic (9.80e-2)" "unprognostic (1.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.69e-2)" "unprognostic (4.01e-2)" "unprognostic (8.19e-2)" "unprognostic (6.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.97e-1)" "unprognostic (3.32e-2)" "prognostic favorable (8.00e-5)" "unprognostic (9.47e-3)" "prognostic favorable (2.14e-6)" "unprognostic (4.27e-3)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (3.54e-2)" 27.8 58.6 23.4 20.8 24.5 31.7 27.3 23.8 34.9 29.2 30.7 31.5 25.1 27.0 10.5 34.7 27.7 18.1 61.4 24.8 24.4 37.3 111.7 25.6 27.4 24.0 24.4 24.5 29.5 29.1 27.1 39.1 20.9 24.1 32.1 15.4 8.8 28.7 16.2 69.8 37.7 30.8 15.5 22.4 38.5 35.6 38.1 24.1 21.6 29.7 50.5 17.1 28.2 28.0 24.3 48.7 87.7 41.8 84.5 30.8 45.0 63.2 49.3 39.6 67.2 48.9 101.1 56.5 67.4 50.5 50.3 36.2 110.2 77.9 72.0 30.0 97.2 92.8 54.6 113.2 123.6 53.9 71.7 44.9 66.3 48.9 52.6 27.0 38.2 58.0 61.2 140.2 43.4 42.6 132.1 68.1 90.1 85.4 86.2 82.2 83.0 59.1 149.9 46.3 33.9 85.4 56.1 66.6 92.9 58.6 28.6 127.6 95.5 48.2 47.8 50.7 39.8 63.8 26.2 37.4 73.5 62.9 61.3 43.9 37.4 50.5 36.5 53.2 51.9 51.4 52.5 49.0 57.2 61.7 48.8 57.9 50.2 11.9 67.2 51.5 31.4 52.7 62.2 23.4 24.5 23.8 34.9 24.8 24.4 24.0 24.4 24.5 24.1 22.4 24.1 24.3 17.3 16.0 26.7 14.7 24.2 27.5 40.2 65.0 27.9 24.7 19.3 15.2 35.9 15.7 32.8 22.0 22.9 103.1 22.5 28.0 49.0 32.9 24.6 25.6 23.5 21.7 20.8 23.5 13.8 30.7 50.4 23.7 21.9 26.2 24.7 44.2 19.6 57.2 37.8 18.5 11.4 24.2 44.7 19.2 14.6 15.8 19.0 17.4 16.0 6.5 21.0 22.9 14.4 8.5 8.0 31.6 20.9 22.6 26.6 22.6 25.6 46.9 22.6 27.4 39.5 22.4 27.9 37.7 42.4 23.2 26.9 103.8 21.7 77.0 38.6 28.5 ENTR1 "NY-CO-3, SDCCAG3" ENSG00000165689 "Endosome associated trafficking regulator 1" Q96C92 9 136401922-136410614 "Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 20.4;Breast glandular cells: 15.7;Breast myoepithelial cells: 21.5;Endometrial stromal cells: 22.5;Granulosa cells: 18.7;Hofbauer cells: 18.2;Pancreatic endocrine cells: 18.3;Theca cells: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029303 Approved NA NA "HPA029303: AB_10602222" "unprognostic (8.94e-2)" "unprognostic (1.70e-1)" "unprognostic (3.20e-1)" "unprognostic (8.84e-3)" "unprognostic (6.35e-2)" "unprognostic (8.97e-2)" "unprognostic (2.56e-3)" "unprognostic (1.12e-1)" "unprognostic (2.39e-2)" "unprognostic (2.29e-2)" "unprognostic (1.51e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (6.23e-2)" 18.6 18.2 11.2 14.3 12.1 10.6 18.2 12.5 13.8 18.9 13.5 20.3 14.4 17.5 4.2 20.9 18.0 11.0 15.6 11.4 11.7 17.8 47.3 16.8 21.1 12.8 11.9 10.8 18.6 25.6 7.9 13.6 8.6 13.3 18.1 9.1 5.2 15.2 8.7 27.1 20.9 20.9 11.1 11.8 27.9 20.0 33.5 12.8 11.0 17.5 10.7 13.3 21.5 18.5 14.5 39.0 47.7 30.4 63.6 29.8 27.7 61.6 36.2 21.1 36.6 23.2 61.2 29.3 32.8 29.4 28.6 45.3 94.0 57.5 42.0 21.4 63.7 39.0 28.5 87.3 42.4 41.1 46.0 31.1 25.9 59.5 35.1 74.1 19.1 28.8 49.3 66.9 23.6 33.8 72.2 19.6 48.1 107.4 101.5 49.3 36.7 33.2 130.8 30.2 31.7 60.3 49.4 38.6 61.2 60.5 23.1 88.2 50.7 31.0 55.5 33.1 72.9 71.6 18.1 36.1 48.9 47.6 56.5 56.5 0.0 0.6 1.0 0.6 0.2 1.9 2.3 1.0 0.8 0.3 1.2 1.1 1.3 0.4 1.0 0.6 0.9 1.1 0.5 11.2 12.1 12.5 13.8 11.4 11.7 12.8 11.9 10.8 13.3 11.8 12.8 14.5 20.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 15.7 21.5 0.0 0.0 0.0 9.2 0.0 4.3 12.8 0.0 0.0 9.3 0.0 10.9 22.5 4.9 0.0 0.0 0.0 13.6 6.0 6.2 0.0 11.7 0.0 18.7 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 3.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 2.9 5.0 24.0 0.0 0.0 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076990-132128020 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Neurogenesis "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "endometrium 1: 2.9;kidney: 2.8;smooth muscle: 2.3" "Cell type enriched" "Detected in single" 19 "Distal tubular cells: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.5" "Region enriched" "Detected in many" 28 "olfactory bulb: 65.7" "Region enriched" "Detected in single" 86 "olfactory bulb: 21.3" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.9 0.5 0.0 0.5 0.0 0.1 0.1 0.1 2.8 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AK8 "C9orf98, FLJ32704" ENSG00000165695 "Adenylate kinase 8" Q96MA6 9 132725578-132878777 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 19.5;fallopian tube: 26.1;testis: 16.1" "Cell type enhanced" "Detected in many" "Early spermatids: 102.3;Endometrial ciliated cells: 26.1;Late spermatids: 134.1;monocytes: 49.2;Respiratory ciliated cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 6.2;naive B-cell: 4.9;NK-cell: 3.1" "Group enriched" "Detected in many" 30 "B-cells: 6.2;NK-cells: 3.1" "Cell line enhanced" "Detected in some" "MCF7: 3.1;RPTEC TERT1: 3.6;T-47d: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021443, HPA023894" Enhanced NA NA "HPA021443: AB_1845852, HPA023894: AB_1845854" "unprognostic (4.14e-2)" "unprognostic (1.20e-4)" "unprognostic (1.31e-2)" "unprognostic (1.70e-3)" "unprognostic (2.16e-1)" "unprognostic (2.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.18e-1)" "unprognostic (3.43e-1)" "unprognostic (1.71e-1)" "unprognostic (7.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.61e-4)" "unprognostic (9.89e-2)" "unprognostic (3.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.43e-1)" 0.6 1.3 3.4 0.5 2.2 0.2 1.0 2.4 2.4 2.5 4.6 0.4 0.0 1.3 19.5 0.9 26.1 1.3 0.2 1.6 4.6 2.3 0.1 2.1 0.6 3.5 4.1 1.4 1.6 0.7 3.1 1.8 0.4 3.9 0.9 0.3 2.7 1.7 2.7 0.0 1.6 0.1 0.7 3.7 0.1 0.8 16.1 2.1 1.5 4.8 0.2 4.3 0.5 0.5 2.2 1.1 0.7 0.3 1.6 0.2 0.4 0.3 0.1 0.1 0.1 0.0 0.3 1.2 0.0 0.3 0.2 0.3 0.2 0.3 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.0 1.0 0.5 0.3 0.4 0.4 0.0 0.8 0.0 0.0 0.3 3.1 0.7 0.3 0.1 0.4 0.5 0.0 0.0 0.0 3.6 0.0 0.6 0.6 1.5 0.0 0.2 0.3 2.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 4.9 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.1 3.4 2.2 2.4 2.4 1.6 4.6 3.5 4.1 1.4 3.9 3.7 2.1 2.2 0.2 3.2 1.7 9.4 1.5 0.5 0.5 3.9 0.6 0.3 0.8 0.5 1.2 0.0 3.4 3.7 0.0 0.4 0.1 0.3 0.0 2.8 102.3 26.1 1.1 1.1 0.0 0.4 4.9 0.5 0.3 0.8 0.0 1.3 0.0 0.4 0.7 0.0 1.7 0.0 5.1 0.9 2.0 0.3 0.3 134.1 6.2 1.8 1.8 0.0 49.2 0.8 0.0 4.5 5.0 1.2 0.3 4.1 0.0 0.6 0.0 6.0 36.7 1.8 0.0 0.8 2.7 24.3 5.6 0.4 1.6 0.4 0.2 1.0 0.5 0.7 SPACA9 "C9orf9, Mast" ENSG00000165698 "Sperm acrosome associated 9" Q96E40 9 132878027-132890201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 74.7;testis: 132.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Distal tubular cells: 33.2;Endometrial ciliated cells: 99.8;Proximal tubular cells: 23.9;Respiratory ciliated cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "JURKAT: 48.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022243, HPA051600" Enhanced Approved Mitochondria No No Mitochondria "HPA022243: AB_1845844, HPA051600: AB_2681546" "unprognostic (2.69e-1)" "unprognostic (2.14e-3)" "unprognostic (8.00e-3)" "prognostic favorable (8.61e-4)" "unprognostic (1.59e-1)" "unprognostic (5.73e-2)" "unprognostic (3.76e-3)" "unprognostic (2.60e-1)" "unprognostic (6.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.15e-2)" "unprognostic (9.51e-2)" "prognostic favorable (8.31e-4)" "unprognostic (5.11e-2)" "unprognostic (1.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" 4.8 7.7 18.6 1.3 17.0 1.6 5.3 17.8 19.6 9.5 16.3 8.5 1.4 8.4 74.7 9.6 39.5 5.4 9.3 15.7 24.3 10.3 2.4 7.5 2.3 19.8 19.5 15.5 11.4 5.3 3.9 11.6 3.2 17.9 7.0 1.9 8.3 9.9 7.2 1.7 11.2 3.7 4.9 20.6 3.7 6.5 132.3 17.7 8.0 15.8 1.8 3.2 6.2 8.2 18.1 3.0 3.2 4.8 3.9 6.6 8.4 5.7 1.9 3.5 2.6 2.8 0.8 9.1 0.7 4.3 8.7 5.4 4.2 2.0 5.4 2.3 3.5 3.9 0.8 2.3 1.0 9.6 2.2 0.3 9.6 11.4 6.4 6.9 10.6 3.0 48.5 0.8 2.4 7.1 6.4 7.6 8.6 1.0 5.6 3.0 3.6 1.0 2.1 10.5 1.1 1.2 4.7 8.0 1.3 6.3 3.6 10.3 0.7 2.9 5.5 3.7 5.3 0.8 1.0 1.7 2.6 10.2 0.8 2.7 4.0 1.1 1.9 1.1 1.1 1.3 3.0 1.2 0.6 1.6 2.6 1.3 1.3 1.5 4.4 1.9 0.5 2.0 0.9 18.6 17.0 17.8 19.6 15.7 24.3 19.8 19.5 15.5 17.9 20.6 17.7 18.1 3.6 3.2 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.3 17.9 0.0 0.0 5.0 23.9 0.0 18.2 0.8 0.0 33.2 8.6 0.0 99.8 7.1 1.9 0.0 0.0 0.0 7.1 12.4 3.9 0.0 8.1 0.0 6.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 23.9 63.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.3 0.8 7.7 0.0 0.0 TSC1 "hamartin, KIAA0243, LAM, TSC" ENSG00000165699 "TSC complex subunit 1" Q92574 9 132891348-132946874 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011568, CAB012481, HPA074132" Supported Enhanced Cytosol NA NA Cytosol "CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-1)" "unprognostic (6.67e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.96e-2)" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.01e-4)" "unprognostic (1.84e-2)" "prognostic favorable (7.91e-4)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 11.0 14.6 3.7 5.2 5.4 9.1 12.3 7.7 6.0 13.5 2.5 12.5 5.2 12.1 6.6 10.2 11.9 5.4 12.1 4.9 4.4 13.1 11.0 11.5 6.3 3.9 5.0 4.1 18.4 12.9 7.4 16.3 9.4 4.7 13.2 7.1 8.3 11.5 5.5 15.1 15.9 12.7 8.0 1.4 15.0 12.3 23.0 3.0 6.8 17.4 14.7 8.6 11.5 12.8 6.2 8.3 9.7 13.0 10.7 13.0 12.2 24.2 10.3 17.6 11.5 11.0 16.5 9.5 19.4 4.7 20.9 17.0 21.0 15.4 11.0 11.3 9.4 8.2 6.1 19.9 13.6 15.6 9.4 8.0 13.6 8.2 14.3 17.4 11.1 13.0 16.9 11.1 10.2 12.9 15.4 8.3 7.8 17.8 12.1 7.8 9.9 24.5 11.0 5.0 10.7 6.4 10.0 12.7 7.9 6.2 15.2 14.4 5.5 13.8 18.1 10.8 11.4 7.7 5.7 13.8 18.5 10.3 5.2 8.2 2.1 2.3 2.8 3.2 3.8 3.5 0.9 1.7 2.9 1.7 1.2 2.9 2.6 0.9 3.0 1.8 0.9 3.1 1.5 3.7 5.4 7.7 6.0 4.9 4.4 3.9 5.0 4.1 4.7 1.4 3.0 6.2 14.7 22.4 27.2 35.3 10.8 7.5 6.2 5.1 9.6 26.6 11.2 9.5 29.2 7.2 10.3 11.0 37.5 15.1 13.5 7.1 13.7 11.7 45.9 18.0 22.2 12.7 16.8 15.8 53.6 7.2 24.0 14.0 14.3 25.8 8.8 27.4 9.7 5.9 9.2 25.2 59.0 10.0 10.2 7.7 7.9 133.1 15.5 12.8 12.4 19.7 10.8 9.7 7.2 30.7 47.8 12.5 7.9 11.3 12.4 9.0 8.9 7.3 16.2 24.4 19.7 19.5 15.4 22.4 20.0 11.8 8.7 21.1 11.9 23.2 10.6 11.0 GFI1B ZNF163B ENSG00000165702 "Growth factor independent 1B transcriptional repressor" Q5VTD9 9 132944000-132991687 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "bone marrow: 39.3" "Cell type enriched" "Detected in some" 4 "Erythroid cells: 99.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 20 "basophil: 195.6;eosinophil: 395.8" "Lineage enriched" "Detected in many" 26 "granulocytes: 395.8" "Group enriched" "Detected in some" 5 "HEL: 168.9;HMC-1: 104.6;K-562: 53.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004420, HPA006291" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB004420: AB_2110132, HPA006291: " "unprognostic (1.79e-2)" "unprognostic (2.90e-4)" "unprognostic (6.54e-2)" "unprognostic (1.76e-1)" "unprognostic (2.33e-1)" "unprognostic (1.54e-2)" "unprognostic (2.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.54e-1)" "unprognostic (4.61e-2)" "unprognostic (3.71e-2)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (1.53e-2)" "unprognostic (1.41e-1)" 0.0 0.0 0.1 0.3 0.2 39.3 0.0 0.2 0.2 0.0 0.2 0.5 0.9 0.0 0.1 0.1 0.0 0.3 0.2 0.1 0.2 0.0 0.2 1.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.5 1.0 0.1 0.1 1.9 0.3 2.2 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 1.9 0.3 23.8 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 168.9 0.2 0.1 0.0 0.1 104.6 0.0 1.4 0.0 0.2 0.0 0.0 0.0 53.0 0.2 0.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 195.6 0.3 395.8 0.1 1.9 0.1 0.1 0.1 0.0 1.9 0.2 0.5 0.1 3.9 0.5 15.1 1.0 0.0 12.5 0.1 0.2 0.2 0.2 0.1 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.5 0.2 0.0 0.6 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.3 0.0 1.8 0.0 0.0 0.1 0.1 0.8 0.0 0.1 3.8 0.0 0.3 0.4 1.2 99.1 0.4 0.0 0.2 0.3 0.0 0.1 14.5 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.0 12.9 0.0 15.8 0.0 0.0 0.6 0.0 0.0 0.5 0.2 0.0 24.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.3 0.2 1.0 0.6 0.1 HPRT1 "HGPRT, HPRT" ENSG00000165704 "Hypoxanthine phosphoribosyltransferase 1" P00492 X 134460165-134520513 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant, FDA approved drug targets, Gout" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 226.9;Spermatocytes: 213.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006360, CAB012200" Enhanced Supported Cytosol NA NA 9400000 Cytosol "CAB012200: AB_297217, HPA006360: AB_1079082" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (1.46e-1)" "unprognostic (2.32e-3)" "unprognostic (8.55e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.58e-2)" "unprognostic (4.77e-3)" "unprognostic (4.93e-2)" "unprognostic (2.02e-2)" "unprognostic (7.05e-2)" "unprognostic (1.38e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" 15.0 26.5 40.4 24.5 48.9 55.2 20.6 35.2 58.6 13.2 32.4 25.7 20.5 14.1 63.2 20.5 17.1 14.7 24.7 46.7 52.7 33.6 46.2 14.7 32.4 39.7 40.5 43.8 16.9 37.4 22.1 31.8 16.4 43.5 15.5 23.7 74.7 13.6 16.1 22.8 14.9 26.8 17.5 34.3 17.0 32.4 76.8 41.5 31.6 22.3 18.0 30.8 25.6 14.0 59.4 138.0 64.9 18.0 37.2 39.4 56.1 54.1 71.6 68.7 89.5 116.8 58.7 85.5 154.4 158.7 46.7 106.8 82.0 117.4 98.2 153.4 129.2 219.3 84.0 85.0 60.2 38.9 182.9 74.0 41.6 36.1 80.1 126.4 49.5 104.9 90.3 65.5 3.8 71.0 141.0 141.9 157.0 37.0 160.7 171.8 83.8 91.1 158.6 109.6 65.7 113.0 61.6 51.7 41.5 50.1 48.8 35.5 75.2 52.4 60.5 45.6 175.0 181.5 56.5 105.1 0.9 74.6 199.5 33.8 5.8 21.9 20.4 20.8 36.5 30.0 24.0 30.4 27.6 37.9 24.8 24.8 26.9 5.6 39.4 35.5 15.7 57.4 25.3 40.4 48.9 35.2 58.6 46.7 52.7 39.7 40.5 43.8 43.5 34.3 41.5 59.4 32.1 19.2 8.2 11.1 39.6 39.6 55.7 75.6 18.8 38.3 26.4 22.0 23.8 30.0 29.9 57.0 4.2 17.9 28.1 16.8 226.9 50.1 11.9 30.1 28.3 39.2 27.5 101.8 55.3 32.3 30.5 29.5 30.1 41.8 34.9 29.0 20.7 22.2 71.2 25.2 43.1 30.4 63.1 60.7 81.7 32.2 40.7 56.2 55.2 10.3 122.5 37.2 26.8 22.1 30.7 36.6 28.2 26.7 30.9 78.1 24.1 30.2 28.9 78.0 52.6 31.6 39.4 213.5 172.6 40.4 38.8 6.0 53.8 30.2 51.3 46.8 BORCS5 "LOH12CR1, LOH1CR12" ENSG00000165714 "BLOC-1 related complex subunit 5" Q969J3 12 12357078-12471233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 42.6;T-cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039509, HPA043627" Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA039509: AB_2676550, HPA043627: AB_2678588" "unprognostic (1.82e-1)" "unprognostic (2.87e-1)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (6.78e-2)" "unprognostic (6.16e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-1)" "unprognostic (9.51e-2)" 6.2 8.2 4.1 2.5 6.5 6.3 6.1 4.6 5.2 5.9 1.7 5.6 1.7 5.8 5.8 8.1 5.7 2.4 6.9 3.6 5.3 5.9 8.5 6.5 2.9 6.0 4.9 3.6 4.9 7.3 3.8 7.1 2.7 6.1 6.0 2.3 2.8 5.4 1.9 8.5 8.4 4.7 3.0 4.9 6.3 5.9 9.2 4.7 3.1 4.6 3.3 3.9 5.6 6.9 7.7 3.9 4.1 2.9 3.0 6.4 8.7 3.3 3.4 3.9 4.1 5.1 10.0 3.9 4.9 2.0 5.5 2.9 2.7 5.0 4.9 4.4 14.0 4.5 2.7 3.9 5.7 6.1 2.9 3.8 4.9 3.5 5.6 6.5 6.5 4.9 6.1 3.8 6.6 5.4 8.4 4.2 3.0 9.0 4.1 2.6 3.4 4.1 5.3 5.1 2.6 3.6 4.1 3.3 3.0 7.5 9.6 2.3 3.1 4.1 2.7 6.1 3.5 3.1 3.4 3.2 11.1 5.8 4.4 4.6 2.8 6.1 9.5 10.1 10.3 11.9 7.7 11.5 11.2 7.3 5.9 7.6 7.7 6.7 12.4 6.7 5.1 14.2 7.0 4.1 6.5 4.6 5.2 3.6 5.3 6.0 4.9 3.6 6.1 4.9 4.7 7.7 11.1 9.6 2.3 0.0 37.9 0.0 11.9 0.0 10.8 16.9 10.5 8.4 0.0 10.0 2.5 7.3 12.5 9.2 42.6 2.2 9.8 9.5 5.6 8.8 9.0 6.7 4.9 5.9 0.0 12.4 11.7 8.3 19.9 8.9 2.5 7.4 6.1 5.1 14.5 13.5 0.0 3.8 0.0 11.0 0.0 3.9 5.3 26.3 0.0 0.0 19.0 12.5 14.4 0.0 0.0 9.5 3.5 7.2 33.0 9.1 10.3 14.1 2.9 16.6 26.3 8.3 8.1 23.4 8.6 14.6 0.0 14.5 39.5 7.5 4.6 8.3 DIPK1B "C9orf136, FAM69B, MGC20262" ENSG00000165716 "Divergent protein kinase domain 1B" Q5VUD6 9 136712572-136724742 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 15 "Adipocytes: 23.1;Cardiomyocytes: 7.3;Endothelial cells: 6.9;Extravillous trophoblasts: 6.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.8" "Group enriched" "Detected in many" 9 "B-cells: 2.8;dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "EFO-21: 56.4;HEK 293: 58.2;HUVEC TERT2: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054443 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA054443: AB_2682489" "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favorable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 14.6 4.8 20.4 3.7 18.9 9.2 14.1 24.1 25.9 12.7 16.8 10.4 5.4 17.0 2.1 5.0 16.8 5.6 33.4 19.0 18.6 13.9 11.5 16.5 5.8 21.2 20.5 19.6 11.6 14.4 12.9 25.3 18.8 22.9 13.7 0.8 5.9 9.9 3.2 9.0 11.6 7.7 3.0 16.0 8.7 6.8 15.1 23.5 1.7 16.9 3.8 1.4 8.1 7.7 20.4 3.2 11.3 25.3 21.0 0.0 0.0 19.5 2.9 0.0 0.8 0.9 27.7 6.6 9.2 56.4 0.0 7.9 13.5 11.7 0.3 0.2 8.1 58.2 13.5 4.7 5.9 0.2 7.0 9.0 0.2 0.0 0.3 0.1 10.1 65.2 19.7 14.8 4.2 0.0 14.8 10.8 28.3 36.9 12.6 9.7 49.9 1.9 26.2 1.4 3.7 38.5 38.3 1.8 8.2 27.4 8.7 18.3 21.9 33.3 5.6 18.7 5.3 6.8 12.9 3.3 8.9 3.2 6.7 10.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 2.8 0.2 0.1 0.0 0.0 0.0 1.0 0.1 0.3 20.4 18.9 24.1 25.9 19.0 18.6 21.2 20.5 19.6 22.9 16.0 23.5 20.4 23.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 6.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ZMYND19 MIZIP ENSG00000165724 "Zinc finger MYND-type containing 19" Q96E35 9 137582081-137590512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 290.3" "Group enriched" "Detected in many" 14 "Cone photoreceptor cells: 244.0;Rod photoreceptor cells: 680.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020642, HPA050761" Supported Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA020642: AB_1859078, HPA050761: AB_2681228" "unprognostic (2.30e-2)" "unprognostic (9.62e-3)" "unprognostic (3.45e-2)" "unprognostic (7.99e-2)" "unprognostic (2.66e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.18e-1)" "unprognostic (2.48e-1)" "unprognostic (1.35e-1)" "unprognostic (9.33e-2)" "unprognostic (1.99e-2)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (4.30e-2)" "unprognostic (1.62e-1)" "unprognostic (1.72e-1)" 11.1 16.6 18.6 9.5 19.2 9.2 12.0 18.1 24.1 13.7 17.3 12.1 8.9 11.3 5.0 26.7 11.5 7.2 12.0 19.2 18.6 13.0 21.3 12.1 12.0 17.9 18.5 19.2 13.1 16.2 8.1 17.0 8.6 19.0 16.6 5.8 290.3 16.1 7.2 14.4 27.4 12.5 6.9 17.8 15.3 22.3 49.9 18.9 9.6 10.9 8.9 9.5 13.4 16.7 19.0 28.9 44.7 41.8 45.5 22.1 21.3 42.1 38.8 25.8 41.7 31.8 53.1 28.7 51.7 43.6 25.8 40.2 71.7 51.3 38.9 13.2 33.8 49.7 26.9 86.1 41.8 34.4 58.4 33.9 16.8 58.7 38.0 37.1 18.4 22.3 40.5 66.3 22.2 25.6 97.2 68.4 88.7 60.7 86.4 61.9 73.8 36.8 79.6 25.7 24.2 60.1 39.4 37.4 79.4 35.4 18.5 53.7 89.9 21.3 51.1 38.9 76.8 63.8 21.4 54.9 56.8 31.6 44.8 35.9 0.0 0.3 0.3 0.5 1.6 1.2 0.8 0.3 0.2 0.3 0.3 0.5 0.4 0.0 0.1 0.2 0.9 1.0 0.1 18.6 19.2 18.1 24.1 19.2 18.6 17.9 18.5 19.2 19.0 17.8 18.9 19.0 6.1 9.6 7.2 3.6 4.0 17.5 5.6 3.2 5.2 23.6 14.9 19.2 6.2 2.8 2.4 1.8 244.0 5.2 6.8 5.3 0.0 3.2 4.5 6.5 12.8 5.6 2.4 6.9 4.1 3.6 6.8 6.3 10.7 8.1 1.3 10.6 3.9 7.6 4.4 11.8 4.0 8.8 6.1 3.2 5.7 4.4 2.8 3.6 5.4 1.9 2.2 31.6 5.2 2.0 2.1 4.2 4.6 3.0 10.9 10.2 1.9 3.1 1.3 680.0 0.0 6.9 6.7 27.8 28.7 4.5 22.9 4.5 4.6 8.5 7.8 7.1 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827531-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5;choroid plexus: 28.6" "Group enriched" "Detected in many" 5 "Astrocytes: 85.2;Endometrial ciliated cells: 67.4;Respiratory ciliated cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.6;HAP1: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 6.3 5.2 26.5 0.5 23.5 0.2 4.3 14.4 33.5 1.6 28.6 1.6 1.2 1.6 7.5 1.4 12.6 1.0 0.3 24.4 21.1 2.8 0.3 1.3 1.2 18.3 23.0 23.0 1.1 1.4 6.6 7.2 0.8 18.9 1.3 1.6 0.7 1.6 1.1 1.4 0.8 2.1 0.8 15.8 0.4 3.4 2.5 24.0 6.8 3.1 0.8 1.0 2.5 0.7 22.1 1.8 2.0 4.2 8.6 1.8 0.0 2.5 0.2 0.1 1.2 1.3 1.8 2.6 1.7 2.4 0.0 3.3 0.5 8.1 0.0 0.6 2.0 3.4 0.1 0.4 2.6 0.2 2.3 3.1 0.2 0.1 0.2 0.0 0.2 0.1 4.5 0.4 0.2 0.1 1.8 3.9 2.8 1.4 0.4 1.2 2.8 0.1 0.0 2.6 4.6 1.3 3.9 3.1 0.8 0.6 2.7 1.9 1.8 0.0 0.0 0.2 0.0 1.3 0.7 1.6 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.0 1.0 0.0 0.0 26.5 23.5 14.4 33.5 24.4 21.1 18.3 23.0 23.0 18.9 15.8 24.0 22.1 0.3 0.0 0.5 85.2 0.3 1.5 4.5 0.9 1.2 0.7 5.1 4.1 0.5 0.0 5.6 1.8 0.0 1.6 3.1 0.4 3.9 0.1 0.3 67.4 1.7 0.4 0.0 1.7 11.4 0.4 0.5 0.6 0.5 4.2 2.5 0.8 0.0 0.2 0.1 0.0 9.9 2.5 2.0 0.3 0.7 0.7 1.2 0.2 0.0 1.9 0.1 1.9 2.1 6.0 2.1 0.1 0.3 0.0 0.6 1.7 0.8 1.8 42.8 0.4 6.6 1.5 5.0 1.4 8.8 0.4 0.4 1.2 0.7 6.9 5.3 1.8 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077064-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 21.0;brain: 25.0;parathyroid gland: 32.0" "Group enriched" "Detected in some" 4 "Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "midbrain: 53.3;spinal cord: 19.4" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 2100000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 21.0 3.1 1.4 1.8 0.4 1.1 4.8 6.0 0.9 0.2 2.9 1.5 0.6 0.3 0.4 0.6 0.6 1.3 1.1 5.0 0.9 3.0 0.4 0.6 12.8 25.0 1.3 0.4 1.4 32.0 5.3 0.5 12.7 1.8 1.5 4.8 5.1 2.1 5.9 0.9 1.4 1.0 5.7 0.2 2.3 2.7 7.6 1.6 0.8 3.1 0.2 0.6 1.4 15.4 0.1 0.4 0.1 1.7 0.0 0.0 0.1 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 5.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 42.2 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 329.3 0.1 0.0 0.1 0.5 4.1 95.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 3.1 1.8 4.8 6.0 1.1 5.0 12.8 25.0 1.3 12.7 5.7 7.6 15.4 0.4 0.0 0.5 1.6 0.0 0.3 0.8 0.0 0.0 1.7 6.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 1.5 0.0 0.3 1.1 0.0 0.0 4.2 0.2 2.3 6.8 0.0 0.0 1.3 0.5 0.0 1.2 0.1 79.1 8.6 1.9 26.4 0.0 0.6 1.5 0.3 0.5 0.0 1.0 0.0 0.8 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 1.7 0.0 23.1 1.2 1.1 4.7 0.0 0.6 0.0 0.2 0.3 0.2 0.1 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956170-68985068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 589.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No 40000 "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 51.7 28.1 8.4 53.1 9.2 104.4 36.5 9.4 9.4 22.1 8.9 26.7 25.7 25.5 13.5 40.6 24.2 32.7 20.6 8.0 14.9 24.0 42.4 31.7 50.4 11.5 10.0 7.1 20.3 46.1 24.7 13.0 38.3 11.3 19.1 32.3 8.2 20.7 17.7 48.3 29.1 21.9 28.6 11.4 30.5 26.7 22.7 9.4 33.9 25.3 27.2 51.4 82.5 23.7 11.9 194.4 112.5 64.5 199.7 56.7 74.4 135.6 129.8 104.3 163.8 138.3 366.7 128.8 289.5 77.8 108.2 77.2 168.1 250.4 161.8 217.5 90.7 176.1 203.2 76.9 153.3 121.2 488.9 184.7 76.8 205.2 196.2 324.5 76.1 121.3 106.8 393.8 140.5 116.8 88.1 192.9 106.1 176.3 91.8 236.8 170.1 105.3 143.0 108.2 102.7 132.5 141.6 116.6 254.8 155.5 76.8 144.9 101.1 125.6 95.5 136.0 129.8 230.7 160.4 228.2 418.2 79.3 362.4 66.5 7.6 10.9 20.4 8.7 17.1 15.9 14.0 11.4 11.8 13.0 12.3 10.6 11.8 4.9 9.4 21.2 12.1 9.2 7.5 8.4 9.2 9.4 9.4 8.0 14.9 11.5 10.0 7.1 11.3 11.4 9.4 11.9 199.4 102.5 141.6 8.1 243.7 550.2 346.2 103.8 174.2 25.9 159.9 113.7 74.2 94.4 144.1 71.7 41.7 80.8 139.5 134.0 72.4 141.2 50.8 116.7 260.7 196.7 86.7 98.6 18.5 187.8 151.8 162.2 120.8 201.8 168.5 57.1 104.2 215.3 112.4 25.2 16.0 202.7 67.1 154.5 266.8 19.7 89.5 199.1 124.5 12.2 138.1 25.8 64.9 13.6 18.2 222.9 77.7 77.1 148.9 465.3 59.9 128.2 72.8 29.8 26.3 302.6 174.9 105.5 114.8 224.8 589.7 137.5 159.6 99.4 210.7 375.5 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1 ribosome biogenesis factor" Q14692 10 42782795-42834937 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 8.0 8.4 6.8 9.0 7.6 10.8 8.6 8.9 8.4 8.1 8.6 7.8 6.3 8.3 6.8 9.6 7.4 5.2 8.3 6.5 7.7 7.0 8.2 7.7 10.1 7.7 7.3 6.1 8.5 8.9 11.5 7.6 8.3 8.2 7.4 8.0 6.5 8.8 7.0 17.9 10.2 7.9 7.8 7.1 8.8 7.4 8.2 7.5 9.6 7.3 13.5 10.8 10.1 8.4 7.8 32.0 26.7 25.3 29.0 18.8 15.5 24.5 26.1 27.5 30.3 25.9 37.1 24.4 16.9 18.1 22.7 17.0 27.3 42.0 33.8 39.4 24.7 29.3 22.7 20.7 31.9 16.2 61.7 20.4 13.9 16.9 32.7 31.5 16.9 23.2 19.4 40.4 17.7 21.8 27.1 34.6 20.3 32.3 22.0 28.0 31.3 26.7 18.1 16.8 27.7 19.3 20.4 22.9 25.1 21.7 26.2 30.6 17.6 28.3 14.0 50.7 28.4 43.2 14.1 18.7 48.5 20.5 44.9 11.0 3.8 4.6 2.7 7.2 8.2 8.5 8.7 8.9 7.9 7.5 6.1 9.6 8.3 0.6 6.1 7.1 3.9 6.9 5.3 6.8 7.6 8.9 8.4 6.5 7.7 7.7 7.3 6.1 8.2 7.1 7.5 7.8 25.6 32.1 33.1 19.6 29.7 22.9 33.9 28.4 14.2 20.7 18.8 17.1 48.0 20.0 37.4 23.9 10.4 27.7 23.6 10.2 21.5 32.3 14.6 28.8 34.5 31.3 16.8 19.5 31.4 34.9 30.0 26.4 16.3 30.0 22.1 36.8 21.4 18.6 19.7 21.9 28.8 11.5 22.4 15.3 22.6 12.1 23.6 19.9 33.8 10.3 35.2 12.8 24.7 20.1 24.0 38.2 8.9 16.6 31.3 32.2 8.8 30.1 49.5 28.7 19.7 35.3 31.4 40.3 56.1 17.1 25.4 24.9 25.3 33.5 18.7 41.4 STK32C "MGC23665, PKE, YANK3" ENSG00000165752 "Serine/threonine kinase 32C" Q86UX6 10 132207492-132331847 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.5" "Group enriched" "Detected in many" 4 "Early spermatids: 278.9;Late spermatids: 83.3;Spermatocytes: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 55.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017894 Uncertain NA NA "HPA017894: AB_1857591" "unprognostic (2.11e-1)" "unprognostic (8.40e-2)" "unprognostic (4.80e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.65e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (1.68e-6)" "unprognostic (2.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.31e-6)" "unprognostic (8.65e-2)" "unprognostic (3.20e-1)" "unprognostic (5.05e-2)" "unprognostic (1.36e-1)" 9.8 12.6 30.0 7.2 34.3 7.6 9.0 17.2 36.3 8.0 12.6 8.4 5.3 7.0 14.9 5.5 9.5 6.5 7.5 30.1 22.0 10.8 5.0 8.9 10.1 24.1 24.7 34.5 6.8 7.5 6.0 12.4 4.9 23.2 6.7 4.7 8.0 5.8 5.2 13.8 7.6 6.8 5.0 20.6 15.2 6.3 54.5 30.0 10.9 6.4 9.1 6.5 8.4 6.6 27.0 69.4 43.5 13.3 33.5 18.4 23.3 2.7 14.1 10.7 17.4 22.2 10.0 46.0 14.8 10.3 16.4 22.0 14.9 18.6 5.5 16.9 8.9 31.1 8.9 46.1 47.1 22.9 7.9 31.1 17.6 20.8 15.7 17.3 22.0 15.6 25.1 15.4 10.2 19.0 21.1 10.4 30.4 8.8 12.6 31.4 12.2 8.2 4.9 23.3 11.7 34.6 27.3 10.2 9.3 20.9 7.9 10.5 19.2 10.6 13.6 14.2 18.2 11.3 19.1 3.8 38.7 31.4 7.4 7.1 55.3 17.9 16.5 5.8 19.6 7.3 6.2 4.7 6.6 25.1 10.2 5.8 4.5 2.4 6.1 17.3 14.5 9.2 7.0 30.0 34.3 17.2 36.3 30.1 22.0 24.1 24.7 34.5 23.2 20.6 30.0 27.0 6.6 0.0 7.2 13.4 7.3 5.2 6.8 5.7 4.6 8.4 10.3 11.0 3.7 2.8 6.1 12.9 12.5 3.4 9.3 3.2 19.6 5.4 278.9 25.9 8.2 8.2 19.2 15.8 22.9 8.7 2.3 7.2 6.6 11.8 15.8 6.0 13.6 5.5 14.6 37.0 13.9 7.4 12.2 24.3 28.5 83.3 9.0 14.8 12.4 7.5 14.0 11.0 6.2 9.5 10.0 6.0 5.1 6.8 4.8 11.4 3.8 13.2 13.7 14.6 6.6 10.5 5.6 89.8 20.0 5.9 5.1 1.5 9.3 10.1 7.6 7.3 JCAD KIAA1462 ENSG00000165757 "Junctional cadherin 5 associated" Q9P266 10 30012803-30115494 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017956 Enhanced Approved "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA017956: AB_1852408" "unprognostic (1.78e-1)" "unprognostic (8.33e-2)" "unprognostic (5.37e-2)" "unprognostic (8.07e-2)" "unprognostic (6.32e-2)" "unprognostic (7.09e-2)" "unprognostic (9.36e-2)" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (2.54e-4)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.34e-2)" 31.5 7.6 14.5 5.3 18.7 0.1 13.1 5.9 13.4 6.2 5.5 25.7 1.4 17.5 7.6 6.0 12.6 10.5 18.5 11.0 7.7 6.6 1.8 24.4 3.5 13.2 9.1 7.0 11.0 17.1 4.9 4.5 33.8 13.2 7.9 3.9 13.2 2.4 9.6 10.0 3.2 3.8 17.5 7.3 0.9 4.6 14.1 11.0 6.2 13.8 15.0 1.8 18.5 4.4 9.7 15.3 6.7 5.9 0.0 3.7 0.9 8.6 8.1 8.5 1.2 2.0 2.6 0.1 0.0 0.6 29.3 1.7 0.3 1.6 0.5 3.3 1.7 3.6 0.0 0.0 0.1 16.0 0.0 1.0 9.1 0.2 19.9 1.5 0.5 29.9 0.4 0.0 0.0 24.9 0.5 0.0 0.7 1.2 0.9 10.2 0.0 3.3 0.0 1.2 0.3 0.8 0.1 0.3 0.1 0.0 8.4 0.0 1.4 67.8 14.9 3.6 4.7 0.7 6.2 0.8 0.0 3.5 10.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 18.7 5.9 13.4 11.0 7.7 13.2 9.1 7.0 13.2 7.3 11.0 9.7 106.8 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 16.4 0.0 1.3 8.5 30.3 0.0 0.0 0.0 0.4 0.9 2.2 0.0 0.8 1.3 72.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 0.2 7.1 0.0 0.0 OR4K2 ENSG00000165762 "Olfactory receptor family 4 subfamily K member 2" Q8NGD2 14 19875142-19883932 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FUNDC2 "DC44, HCBP6" ENSG00000165775 "FUN14 domain containing 2" Q9BWH2 X 155025980-155060304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.4;tongue: 19.6" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1375.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059129 Approved NA NA "HPA059129: AB_2683915" "unprognostic (2.23e-1)" "prognostic favorable (9.20e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (2.07e-2)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.78e-5)" "unprognostic (6.56e-2)" "unprognostic (6.19e-2)" "unprognostic (2.81e-2)" "unprognostic (1.49e-3)" "unprognostic (3.14e-2)" "unprognostic (1.17e-1)" "unprognostic (2.74e-1)" "unprognostic (5.67e-2)" "unprognostic (7.37e-2)" "unprognostic (2.81e-1)" 3.7 3.6 3.3 1.6 3.6 3.3 3.3 4.4 3.5 3.6 3.6 3.3 2.0 3.3 3.5 2.4 3.8 2.8 10.5 3.4 3.6 4.4 2.5 2.6 2.5 3.9 3.6 2.9 6.6 7.8 4.4 3.0 2.5 4.0 3.3 2.5 3.1 3.3 2.9 18.4 1.4 2.2 4.0 3.7 1.9 3.3 2.5 3.7 2.9 3.2 19.6 2.3 3.0 2.5 3.7 5.3 2.7 4.9 3.7 6.5 5.0 3.7 3.1 3.6 3.8 7.7 2.8 2.1 7.0 7.7 4.0 2.9 2.2 5.3 4.3 2.6 3.6 6.2 2.2 3.8 1.6 2.9 4.6 2.8 5.6 6.5 3.1 2.7 2.5 2.6 3.0 2.9 4.9 4.0 2.4 3.4 2.6 3.3 4.3 6.4 2.9 3.5 7.0 3.9 2.1 2.6 5.5 2.6 2.7 3.9 2.4 2.8 4.4 2.7 2.8 4.0 5.1 4.9 3.0 5.4 7.3 2.8 5.7 2.3 1.5 2.1 2.1 2.5 2.3 2.3 2.5 2.3 2.4 2.7 2.2 2.4 2.6 0.1 1.7 2.8 2.4 2.6 3.3 3.3 3.6 4.4 3.5 3.4 3.6 3.9 3.6 2.9 4.0 3.7 3.7 3.7 92.7 44.8 43.5 8.8 77.4 72.3 109.7 85.1 68.3 39.6 65.1 77.8 141.8 85.8 46.8 64.4 6.2 71.1 67.4 28.7 223.0 116.3 297.0 43.4 49.9 73.8 47.8 84.6 5.5 113.7 95.3 109.2 35.7 45.2 68.9 69.8 48.9 76.1 81.8 45.4 7.1 48.8 61.1 55.4 52.6 1375.2 107.8 66.2 67.6 5.6 60.0 109.3 64.9 7.5 12.8 104.9 35.4 76.3 104.7 142.4 78.2 193.0 39.5 49.2 26.3 141.6 90.9 31.6 46.2 54.6 60.1 79.9 69.4 54.3 51.1 85.8 PIP4P1 "C14orf9, MGC26684, TMEM55B" ENSG00000165782 "Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1" Q86T03 14 20457681-20461465 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 78.4;Hofbauer cells: 54.9;Syncytiotrophoblasts: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048528 Approved NA NA "HPA048528: AB_2680427" "unprognostic (1.84e-1)" "unprognostic (6.23e-2)" "unprognostic (1.81e-1)" "unprognostic (7.07e-2)" "unprognostic (2.04e-1)" "unprognostic (8.51e-2)" "unprognostic (1.71e-2)" "unprognostic (3.37e-3)" "unprognostic (4.94e-2)" "unprognostic (1.33e-1)" "unprognostic (7.78e-3)" "unprognostic (1.85e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.80e-2)" "unprognostic (1.47e-1)" "unprognostic (7.53e-2)" "unprognostic (1.96e-1)" 22.1 27.5 36.4 13.8 38.1 49.5 22.6 36.1 38.8 21.4 31.7 25.2 18.0 21.8 27.2 25.7 21.7 13.5 21.4 37.2 39.1 27.5 25.3 24.1 19.0 37.7 38.1 36.6 21.1 24.6 30.9 28.5 16.7 40.5 23.8 15.8 26.3 23.7 15.6 35.3 33.6 29.0 16.0 35.9 31.5 28.0 21.4 37.6 17.0 22.7 22.9 21.3 24.4 21.5 39.3 21.1 32.4 21.3 25.1 32.7 20.2 39.5 19.6 38.1 26.2 31.5 19.3 33.2 18.8 16.5 24.6 75.9 21.6 26.3 21.5 22.9 24.9 19.7 13.5 15.5 28.6 44.6 25.2 26.7 26.3 28.9 30.2 30.5 23.8 24.5 28.7 11.5 37.1 21.9 24.2 34.3 22.1 14.3 32.9 44.5 25.1 20.7 12.6 24.6 46.6 30.7 23.0 20.1 32.6 25.8 18.3 16.4 23.6 17.2 23.8 30.1 36.0 17.6 42.0 58.0 27.6 16.5 19.2 26.5 1.3 3.2 7.3 4.2 2.3 3.5 12.4 5.2 4.8 4.1 10.3 5.8 6.1 4.1 4.4 2.0 10.4 4.5 2.5 36.4 38.1 36.1 38.8 37.2 39.1 37.7 38.1 36.6 40.5 35.9 37.6 39.3 23.5 9.6 12.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 29.8 22.7 0.0 0.0 3.1 22.0 0.0 78.4 23.8 0.0 19.6 36.8 0.0 19.1 13.5 9.1 0.0 0.0 0.0 40.0 35.0 8.2 0.0 24.3 3.8 15.6 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 12.9 0.0 0.0 0.0 0.0 36.9 0.0 0.0 7.6 0.0 0.0 20.4 5.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 167.2 9.9 18.4 0.0 0.0 METTL17 "FLJ20859, METT11D1" ENSG00000165792 "Methyltransferase like 17" Q9H7H0 14 20989973-20997035 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002955, HPA059802" Uncertain Enhanced Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA002955: AB_2144183, HPA059802: AB_2684129" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.00e-2)" "unprognostic (2.23e-3)" "unprognostic (1.90e-1)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (4.02e-2)" "unprognostic (3.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-1)" "unprognostic (3.29e-2)" 11.5 32.4 11.4 11.2 12.2 26.9 12.3 13.1 16.2 13.8 13.4 20.7 17.8 13.0 11.3 22.6 13.2 10.4 22.8 11.4 11.8 20.1 19.9 11.8 18.1 12.8 12.0 11.4 13.9 18.9 19.6 9.6 12.3 12.4 12.4 21.9 8.0 15.8 14.0 21.5 15.7 21.7 14.3 12.5 23.5 17.7 18.7 12.8 21.9 13.7 29.4 19.5 12.3 14.8 13.2 37.5 48.0 41.8 16.1 25.3 12.2 32.0 22.3 32.8 69.1 58.2 34.3 44.9 85.8 24.4 29.1 43.7 54.0 57.5 48.5 49.6 32.5 44.7 41.8 27.5 56.6 31.5 71.5 42.8 23.4 41.7 35.1 27.8 23.0 27.9 70.5 40.4 38.6 33.8 24.9 48.9 72.2 49.6 62.7 56.2 56.8 42.9 48.2 37.5 34.4 30.2 36.5 30.0 43.9 24.8 31.1 29.4 60.0 15.5 22.4 72.0 25.1 30.2 28.7 49.8 62.1 15.5 46.0 29.3 28.8 8.1 8.6 11.7 9.8 7.0 13.9 12.7 13.2 16.8 10.8 12.4 11.7 0.1 10.7 5.5 11.1 11.5 6.9 11.4 12.2 13.1 16.2 11.4 11.8 12.8 12.0 11.4 12.4 12.5 12.8 13.2 11.2 9.6 17.7 21.9 33.6 18.9 17.9 21.2 46.1 37.5 16.5 16.4 5.4 21.5 17.9 11.0 43.8 30.8 23.0 19.3 5.9 20.4 49.2 11.8 16.2 13.5 12.2 26.9 9.7 15.4 17.4 17.7 36.2 11.1 29.7 22.0 11.7 24.2 18.1 21.9 9.3 24.0 16.2 11.3 12.4 10.2 33.5 16.3 3.6 6.5 19.8 23.4 26.8 8.5 11.0 13.8 32.5 21.4 33.6 11.0 27.9 18.0 21.4 53.1 13.1 14.6 17.0 23.4 17.3 40.6 17.8 12.7 27.6 29.0 35.6 24.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 18.9;prostate: 12.3;seminal vesicle: 33.5;skin 1: 36.6;vagina: 14.2" "Cell type enhanced" "Detected in some" "Muller glia cells: 22.3;Squamous epithelial cells: 12.0;Suprabasal keratinocytes: 6.0;Urothelial cells: 4.4" "Group enriched" "Detected in many" 4 "cervical cancer: 5.1;colorectal cancer: 3.3;head and neck cancer: 6.1;melanoma: 1.9;urothelial cancer: 6.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 71 "HaCaT: 23.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.0 0.2 0.1 0.2 0.0 2.0 0.2 0.3 4.2 0.2 1.9 0.0 0.3 0.1 18.9 0.5 0.4 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.3 0.2 0.2 0.0 0.0 2.3 0.1 0.3 0.2 12.3 1.3 3.7 4.2 33.5 0.2 36.6 0.1 0.2 0.2 0.0 0.0 0.1 0.2 2.8 0.0 0.0 2.8 0.3 14.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.9 0.0 0.2 0.8 0.3 0.4 0.0 0.7 0.0 2.1 0.1 0.0 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 12.0 6.0 0.3 0.0 0.0 1.4 4.4 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1723.6;salivary gland: 2099.8;skeletal muscle: 1846.2" "Cell type enhanced" "Detected in many" "Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "myeloid DC: 204.4" "Lineage enriched" "Detected in all" 11 "dendritic cells: 204.4" "Cell line enhanced" "Detected in many" "Hep G2: 57.0;HMC-1: 39.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 460000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 181.7 403.9 1583.8 27.6 1723.6 2.8 324.7 1615.9 1677.2 386.6 1170.0 184.5 72.8 231.6 262.6 231.6 307.7 131.9 292.4 1538.6 1521.7 143.4 548.9 116.5 49.0 1674.3 1621.2 1407.1 480.4 94.5 280.8 89.2 45.7 1687.1 172.7 112.0 135.3 2099.8 210.0 1846.2 210.8 126.5 128.8 1528.5 153.2 131.9 33.6 1684.3 40.5 100.7 1605.5 101.2 159.3 268.1 1578.6 10.9 2.3 6.8 12.6 1.1 0.0 1.0 0.2 4.5 3.9 2.2 15.1 20.0 0.6 4.0 0.3 6.2 17.6 30.3 6.3 5.4 0.1 10.9 14.3 2.2 57.0 1.3 1.3 39.0 11.8 13.1 0.9 1.9 6.3 0.0 12.6 29.0 1.2 0.6 9.4 5.0 4.0 17.9 35.2 0.8 14.6 0.7 3.7 7.6 27.4 0.1 19.4 3.0 3.3 14.4 17.3 26.6 8.2 0.0 1.2 20.8 0.4 0.4 6.1 4.8 0.3 1.8 0.3 4.7 0.0 6.5 0.7 8.3 1.5 11.4 6.4 12.6 11.9 204.4 4.4 18.7 14.0 1.4 3.0 0.1 7.0 9.4 15.3 1583.8 1723.6 1615.9 1677.2 1538.6 1521.7 1674.3 1621.2 1407.1 1687.1 1528.5 1684.3 1578.6 98.0 0.0 11.9 379.0 6.7 28.7 83.7 86.4 12.0 6.3 240.7 201.2 180.2 151.5 110.9 40.5 10.4 11.5 9.1 81.4 485.2 104.9 6.3 33.3 11.0 53.9 33.5 8.4 1.1 21.7 0.7 62.3 18.8 40.2 48.8 79.0 164.2 214.9 20.7 3.3 3.9 77.4 57.0 30.8 137.6 14.4 348.6 30.4 321.9 47.8 8.7 548.0 1.0 42.7 71.0 16.3 37.9 166.3 1.2 68.5 18.5 41.3 70.8 15.5 598.2 167.7 162.8 1.7 5.5 21.6 30.4 21.6 11.9 66.8 118.9 155.9 RNASE7 RAE1 ENSG00000165799 "Ribonuclease A family member 7" Q9H1E1 14 21042316-21044234 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 75.6;lymphoid tissue: 24.3;skin 1: 28.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.2;Cholangiocytes: 8.6;Prostatic glandular cells: 7.3;Urothelial cells: 27.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 24.7;hTCEpi: 10.3;hTERT-HME1: 53.3" "HPA005690, CAB062560, CAB068225" Enhanced "Secreted in other tissues" NA NA 280000 "CAB062560: AB_2665595, CAB068225: AB_2665594, HPA005690: AB_1079819" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.71e-1)" "unprognostic (8.27e-2)" "unprognostic (7.80e-2)" "unprognostic (8.73e-2)" "unprognostic (3.28e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.17e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "unprognostic (3.24e-1)" "unprognostic (3.42e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 75.6 0.0 6.7 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.5 0.0 4.8 0.5 0.3 28.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.0 0.0 0.0 24.3 0.2 9.4 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 24.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.1 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 30.2 1.5 0.0 0.0 0.1 2.4 0.5 8.6 0.4 0.0 0.0 1.5 0.0 0.1 0.0 4.5 0.9 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.3 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 5.3 0.3 0.0 0.2 27.2 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070273-21090248 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 19.6 47.6 8.9 5.4 9.1 1.7 18.6 9.0 8.3 24.6 5.8 13.4 3.8 19.0 12.3 3.6 13.4 14.9 12.1 8.2 16.4 10.1 27.1 14.3 2.3 11.8 9.6 5.5 19.5 24.2 10.7 9.1 6.5 12.0 12.4 6.2 2.8 20.4 18.8 10.6 6.8 8.0 9.8 10.1 28.1 9.5 4.3 9.7 3.2 15.9 6.1 1.7 13.9 13.4 10.5 3.3 2.9 30.8 5.8 24.5 37.1 1.1 11.4 28.1 12.1 9.4 1.4 7.5 0.0 1.8 20.9 12.2 5.0 2.6 3.7 4.3 6.6 1.1 4.6 3.4 9.0 3.5 3.0 16.5 15.5 2.4 10.3 3.1 22.6 0.0 0.0 1.4 1.3 9.6 0.3 0.0 8.6 8.1 0.8 0.5 1.0 23.2 1.4 7.6 4.1 0.7 11.6 6.4 0.6 8.9 6.0 2.7 10.1 5.9 25.4 17.5 11.9 5.9 2.6 0.0 0.0 8.8 4.2 7.5 0.0 1.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.4 8.9 9.1 9.0 8.3 8.2 16.4 11.8 9.6 5.5 12.0 10.1 9.7 10.5 12.7 6.4 5.0 32.0 2.5 4.8 8.0 5.8 1.8 9.2 6.6 11.3 13.4 47.1 3.2 14.7 0.0 1.4 0.5 10.0 19.6 21.2 1.0 17.6 13.1 11.0 7.8 1.7 0.3 10.2 0.9 20.4 18.3 3.5 38.0 11.6 8.2 31.5 14.1 5.0 6.2 9.1 4.1 46.9 14.6 2.3 24.2 22.0 23.2 17.8 23.6 24.6 1.0 21.1 8.9 16.4 6.6 24.0 3.1 6.3 1.0 7.1 1.7 6.8 26.3 18.6 21.9 3.1 2.8 0.6 4.4 1.2 3.5 14.6 18.7 6.1 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447570-137459334 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 364.2" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Peritubular cells: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 3.5;intermediate monocyte: 13.8;myeloid DC: 6.3;non-classical monocyte: 12.1" "Group enriched" "Detected in many" 5 "dendritic cells: 6.3;granulocytes: 3.5;monocytes: 13.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favorable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 23.1 14.7 157.2 12.7 146.6 12.4 20.5 67.0 364.2 23.6 61.9 21.8 30.2 33.1 10.8 16.4 28.9 9.8 14.4 347.6 102.4 30.5 23.7 20.0 13.1 98.8 131.0 144.2 22.7 31.8 18.1 71.1 7.2 93.5 31.5 10.5 12.2 20.4 14.0 8.9 20.5 25.1 14.0 99.4 17.1 23.7 19.0 209.6 8.5 24.1 4.0 10.3 22.4 17.7 120.5 24.4 19.3 33.7 50.4 77.1 36.4 28.9 23.0 30.2 21.5 16.5 51.7 14.3 30.2 30.3 34.0 48.1 72.7 50.0 30.9 12.9 39.7 53.8 23.5 46.7 69.5 41.7 16.2 51.5 41.7 57.9 25.1 58.3 48.5 23.1 0.8 55.0 4.9 29.2 56.4 0.7 69.8 42.9 97.6 51.4 14.6 53.3 68.0 14.9 12.1 135.7 112.8 55.0 30.3 35.7 13.9 21.5 33.0 58.6 37.9 30.9 92.9 39.6 10.3 17.0 45.8 21.6 21.2 35.6 1.6 2.1 3.5 1.5 13.8 0.3 0.2 0.5 0.9 6.3 0.1 0.5 0.7 0.3 0.0 12.1 0.2 0.8 1.8 157.2 146.6 67.0 364.2 347.6 102.4 98.8 131.0 144.2 93.5 99.4 209.6 120.5 9.9 0.0 3.9 71.5 5.9 13.6 9.4 3.6 7.4 9.6 14.3 12.4 6.1 11.5 2.3 11.0 8.4 0.4 17.7 40.7 5.9 8.2 7.1 7.6 18.3 9.5 19.2 1.7 24.2 21.4 1.3 11.0 10.2 11.1 2.5 12.0 9.7 26.3 6.7 28.6 14.9 21.3 8.2 8.6 21.2 15.3 23.9 10.5 16.0 15.9 9.8 10.3 6.2 16.1 5.3 21.4 34.3 71.5 8.5 32.6 43.4 29.7 2.9 12.9 13.1 8.3 10.9 3.0 5.9 6.3 14.6 1.5 8.0 11.0 20.5 16.7 ZNF219 ENSG00000165804 "Zinc finger protein 219" Q9P2Y4 14 21090077-21104722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030761, HPA056168" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA030761: AB_2673598, HPA056168: AB_2683052" "unprognostic (9.82e-3)" "unprognostic (4.50e-3)" "unprognostic (3.35e-1)" "unprognostic (1.11e-3)" "unprognostic (4.49e-2)" "unprognostic (1.96e-1)" "unprognostic (2.54e-1)" "unprognostic (6.79e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.80e-3)" "unprognostic (6.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.56e-2)" "unprognostic (2.35e-2)" 39.1 77.7 15.8 7.5 12.2 4.5 35.8 29.7 18.0 33.3 11.5 67.7 22.6 42.0 9.5 49.5 29.8 5.5 41.1 20.8 13.2 17.5 17.3 33.1 2.5 19.4 23.0 8.5 31.0 25.0 12.5 23.7 6.5 19.0 38.6 10.4 11.1 28.4 21.9 34.3 45.1 33.4 9.3 12.0 13.2 33.6 11.9 17.8 11.0 32.6 6.0 3.6 45.1 36.4 16.8 8.1 26.6 33.6 49.5 4.5 4.3 48.1 9.8 15.0 4.9 7.7 15.5 17.7 12.0 7.2 3.7 5.4 59.1 10.8 31.4 3.4 24.6 11.5 7.1 42.2 32.7 2.8 1.5 10.9 6.6 25.9 8.0 14.7 6.5 6.0 11.0 6.9 3.5 2.7 22.4 16.2 11.3 47.5 15.3 5.7 33.7 5.6 3.1 3.8 44.0 38.2 34.4 13.5 7.9 7.8 6.7 9.5 4.2 1.2 6.0 26.4 14.7 4.0 6.1 4.2 2.7 3.8 6.0 11.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.4 0.0 0.0 15.8 12.2 29.7 18.0 20.8 13.2 19.4 23.0 8.5 19.0 12.0 17.8 16.8 5.6 3.2 10.7 12.7 1.8 14.8 13.3 13.5 11.4 36.6 14.4 19.6 7.6 10.0 4.3 3.7 27.1 9.6 3.4 33.0 1.9 10.3 9.2 2.5 1.9 6.3 7.8 8.2 3.5 11.3 1.0 6.0 5.1 4.6 14.7 35.1 9.3 8.0 7.4 11.8 4.9 17.4 10.2 7.5 11.8 5.6 9.9 5.9 8.8 7.5 0.8 33.0 1.0 13.6 2.5 7.8 10.0 12.4 3.9 12.0 23.6 6.8 4.3 27.4 13.1 9.3 14.7 8.9 8.7 13.5 15.6 12.4 5.2 6.3 26.6 12.7 C12orf50 FLJ35821 ENSG00000165805 "Chromosome 12 open reading frame 50" Q8NA57 12 87980035-88034037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 204 "testis: 50.4" "Group enriched" "Detected in some" 11 "Early spermatids: 787.4;Late spermatids: 1339.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.23e-2)" "unprognostic (6.61e-3)" "unprognostic (4.91e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (4.80e-2)" "unprognostic (1.34e-1)" "unprognostic (6.03e-2)" "unprognostic (8.85e-3)" "unprognostic (3.47e-1)" "unprognostic (2.84e-7)" "unprognostic (6.31e-2)" "unprognostic (2.17e-2)" "unprognostic (3.03e-1)" "unprognostic (7.20e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 83.3 96.2 0.3 0.0 0.1 0.2 0.1 0.0 1.1 0.2 0.1 0.4 0.0 47.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 787.4 0.1 0.2 6.0 0.0 0.0 0.5 0.0 0.0 5.1 0.0 0.4 39.1 0.2 0.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1339.3 5.6 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 4.1 0.0 0.2 0.0 0.1 43.8 1.2 0.0 0.2 0.2 31.9 5.5 0.0 0.0 0.0 2.5 0.2 0.0 0.0 CASP7 "CMH-1, ICE-LAP3, MCH3" ENSG00000165806 "Caspase 7" P55210 10 113679162-113730907 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 229.1;Paneth cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB025563 Enhanced NA NA "CAB025563: " "prognostic favorable (2.11e-4)" "unprognostic (3.18e-2)" "unprognostic (2.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-3)" "unprognostic (3.96e-1)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (5.90e-4)" "unprognostic (5.45e-3)" "unprognostic (2.62e-1)" "unprognostic (2.86e-1)" "unprognostic (4.33e-3)" 20.8 10.4 12.6 26.4 12.1 8.5 18.8 11.4 16.4 18.5 12.5 75.8 65.9 16.4 10.5 15.5 18.0 17.0 10.9 13.2 13.8 17.8 23.8 25.1 17.0 12.5 11.5 10.4 16.3 22.6 10.5 7.1 21.1 12.3 21.5 58.8 6.8 34.4 12.4 14.0 17.5 68.7 18.7 11.3 17.6 45.9 6.9 13.0 20.0 10.3 14.6 18.5 31.9 16.3 15.6 28.9 29.4 24.1 13.0 43.4 37.5 16.7 32.9 49.9 56.1 69.7 22.4 51.0 30.1 19.0 29.8 21.1 24.8 30.4 24.2 39.5 46.9 41.0 19.6 22.0 38.0 28.9 20.9 24.7 24.5 15.9 32.0 13.3 25.0 75.4 28.2 5.3 39.8 21.1 38.2 51.1 16.0 4.4 31.7 17.3 51.7 98.0 18.1 44.8 21.4 1.9 14.4 24.9 35.5 17.6 23.1 43.1 18.4 37.8 12.8 24.1 13.5 27.7 30.7 20.1 0.8 13.1 38.7 14.3 22.9 14.7 11.7 11.1 21.3 9.5 11.5 9.2 14.1 10.4 9.2 7.1 9.7 2.6 7.4 18.5 1.4 14.0 9.8 12.6 12.1 11.4 16.4 13.2 13.8 12.5 11.5 10.4 12.3 11.3 13.0 15.6 36.3 9.6 12.3 27.4 13.8 19.8 21.2 26.0 13.1 0.6 15.8 9.9 2.5 11.5 26.2 22.0 0.0 12.4 10.3 229.1 11.7 46.1 0.3 21.0 22.9 23.8 9.6 4.0 1.6 39.0 25.5 16.2 30.1 13.5 12.7 10.9 17.2 15.6 17.0 0.0 1.1 81.1 28.5 12.8 6.9 0.6 9.6 18.4 7.2 10.3 68.9 7.9 13.4 1.0 0.8 37.2 113.4 4.1 21.5 42.6 88.0 25.9 42.8 1.7 19.7 12.3 16.3 2.9 28.2 13.3 14.8 10.9 15.7 5.2 50.7 39.0 PPP1R36 C14orf50 ENSG00000165807 "Protein phosphatase 1 regulatory subunit 36" Q96LQ0 14 64549920-64589381 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.6;testis: 37.4" "Group enriched" "Detected in many" 4 "Early spermatids: 350.6;Late spermatids: 791.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077492 Enhanced NA NA "HPA077492: AB_2732348" "unprognostic (3.43e-4)" "unprognostic (5.75e-2)" "unprognostic (4.48e-2)" "unprognostic (6.04e-4)" "unprognostic (1.12e-2)" "unprognostic (9.37e-2)" "unprognostic (1.52e-3)" "unprognostic (9.21e-2)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (4.80e-3)" "unprognostic (9.77e-3)" "unprognostic (3.53e-1)" "unprognostic (7.12e-2)" "unprognostic (5.46e-2)" 1.9 0.5 1.5 0.4 1.9 0.0 1.4 1.6 1.9 1.0 1.6 6.5 6.7 0.9 3.0 0.6 12.6 2.0 0.5 1.5 1.8 2.0 0.1 1.2 0.2 2.1 1.8 1.2 0.1 10.9 0.4 1.9 0.9 2.4 0.2 5.6 0.1 3.8 0.3 0.2 1.0 4.7 0.5 2.3 0.1 7.2 37.4 1.8 0.2 0.2 0.6 0.3 1.0 0.3 2.5 0.2 0.1 0.3 0.1 1.4 0.7 1.0 0.8 0.4 0.5 1.2 0.2 13.9 0.0 0.1 0.7 0.5 0.4 0.0 0.0 0.6 0.1 0.1 0.4 0.8 0.1 0.8 0.0 0.1 0.9 0.7 0.2 0.5 0.9 0.3 0.1 0.0 0.0 0.7 0.8 0.1 0.4 0.0 0.4 0.0 0.1 0.1 0.1 0.5 0.6 3.0 0.1 1.4 0.1 0.0 0.2 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.0 1.5 1.9 1.6 1.9 1.5 1.8 2.1 1.8 1.2 2.4 2.3 1.8 2.5 1.5 0.0 0.6 2.3 0.5 0.5 0.5 1.6 1.8 0.0 2.7 4.6 0.7 4.3 6.3 3.7 0.0 0.4 1.5 5.0 1.9 0.9 350.6 44.3 1.6 3.2 4.2 0.0 1.7 8.2 2.5 0.8 6.6 6.4 0.0 0.1 2.9 0.0 0.4 0.0 1.4 7.3 0.0 0.6 0.7 791.2 3.4 1.4 0.0 3.7 0.1 0.8 2.1 0.0 5.8 6.8 3.4 3.8 0.3 0.2 8.1 0.1 36.2 0.2 0.0 3.2 1.4 124.8 8.0 1.8 0.4 0.5 0.5 0.2 6.6 0.9 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 203.4;breast: 201.7" "Cell type enriched" "Detected in many" 6 "Adipocytes: 900.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 9.9;U-698: 37.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 203.4 13.4 20.1 3.0 15.1 1.0 201.7 16.4 20.7 9.7 12.5 10.3 1.9 11.1 5.4 6.0 20.2 9.4 68.9 21.2 15.1 22.1 7.9 103.2 7.2 21.4 16.8 13.0 5.4 12.0 6.0 4.8 10.6 23.6 8.4 3.7 1.2 7.0 2.7 47.1 11.5 10.9 4.0 13.9 57.8 12.9 4.5 32.8 9.9 29.8 20.9 13.9 10.6 10.4 20.6 0.0 0.2 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.4 0.1 0.2 1.4 0.0 0.0 0.2 0.7 0.1 0.0 0.2 3.7 1.5 0.4 0.2 0.0 0.7 4.2 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.9 0.3 0.0 0.1 0.1 0.2 0.1 9.9 2.3 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.1 5.5 0.1 0.0 0.3 0.1 37.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 20.1 15.1 16.4 20.7 21.2 15.1 21.4 16.8 13.0 23.6 13.9 32.8 20.6 900.4 0.0 3.8 1.3 9.8 2.3 0.6 0.1 0.6 0.6 2.4 3.6 40.6 0.0 0.8 0.0 0.0 0.1 3.9 1.0 3.9 0.0 0.7 1.1 0.5 127.0 4.2 0.4 8.4 0.2 0.1 10.2 0.5 3.4 1.3 7.0 144.9 0.6 0.1 0.0 1.2 3.5 0.0 8.3 1.1 1.4 2.1 1.7 3.6 54.4 0.1 0.3 0.0 1.0 0.6 0.1 1.2 0.4 1.2 0.4 0.0 0.1 2.4 0.3 13.1 8.4 37.5 4.0 9.8 5.5 2.3 0.1 2.2 88.9 1.5 0.5 CCDC186 "C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104" ENSG00000165813 "Coiled-coil domain containing 186" Q7Z3E2 10 114120862-114174232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 49.3" "Group enriched" "Detected in all" 4 "dendritic cells: 49.3;granulocytes: 26.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014569, HPA018019" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014569: AB_2066352, HPA018019: AB_1845513" "unprognostic (1.66e-2)" "unprognostic (1.76e-2)" "unprognostic (9.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.85e-3)" "unprognostic (2.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.06e-1)" "unprognostic (3.20e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "prognostic favorable (7.65e-8)" "unprognostic (8.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" 7.5 7.4 3.3 9.1 3.9 33.1 12.7 9.3 5.7 8.5 8.4 12.5 15.5 7.5 9.7 12.6 8.3 6.8 9.5 3.1 5.6 15.0 7.3 10.8 9.2 4.2 3.5 2.6 8.0 21.3 13.2 7.2 9.5 4.3 15.3 12.0 14.2 15.7 9.3 7.2 12.7 16.3 6.2 3.2 11.1 16.9 16.8 4.3 12.1 14.8 9.3 10.3 7.8 6.9 4.8 17.9 6.1 6.0 6.9 6.8 7.9 7.8 11.0 13.2 5.1 8.1 11.2 18.3 4.2 7.0 9.1 6.3 14.1 7.1 9.8 9.8 21.9 7.3 3.3 7.0 6.6 6.3 9.6 14.6 5.9 11.1 6.0 16.9 12.6 7.7 11.1 6.1 13.5 6.0 6.5 8.8 5.3 3.5 10.6 3.9 8.4 20.7 6.6 9.0 10.9 4.2 4.4 9.7 13.4 6.6 9.7 8.6 4.1 11.2 3.9 7.8 3.9 9.3 7.6 13.3 8.4 4.1 0.1 3.0 26.5 3.3 11.7 8.6 3.8 8.5 7.9 6.6 7.8 4.0 8.6 6.4 6.4 19.9 5.8 3.7 49.3 8.7 2.6 3.3 3.9 9.3 5.7 3.1 5.6 4.2 3.5 2.6 4.3 3.2 4.3 4.8 63.2 141.1 85.7 23.8 46.7 0.0 79.5 0.0 63.2 63.8 73.5 49.0 57.4 38.6 57.6 77.3 62.6 94.9 174.6 107.1 66.5 78.2 221.9 98.4 40.6 41.3 64.6 33.1 53.0 70.7 40.7 43.7 48.9 108.9 24.7 28.1 21.0 20.9 21.4 107.7 49.9 78.9 0.0 25.0 0.0 143.6 50.1 37.1 0.0 33.7 40.0 31.7 70.0 25.6 27.7 74.9 89.9 44.4 77.8 94.8 91.4 84.0 64.1 74.0 26.3 61.7 28.3 83.7 69.2 56.1 0.0 113.6 62.1 32.5 53.7 120.3 VWA2 "AMACO, CCSP-2, FLJ16213, FLJ45857, NET42" ENSG00000165816 "Von Willebrand factor A domain containing 2" Q5GFL6 10 114239254-114294489 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 8.5" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 6.8;Early spermatids: 9.6;Gastric mucus-secreting cells: 5.1;Late spermatids: 15.8;Microglial cells: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 5.7;HaCaT: 3.0;SCLC-21H: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037847 Uncertain "Secreted to extracellular matrix" NA NA "HPA037847: AB_10670961" "unprognostic (6.03e-2)" "unprognostic (8.29e-2)" "unprognostic (3.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (3.02e-2)" "unprognostic (9.33e-3)" "unprognostic (2.44e-1)" "unprognostic (3.70e-1)" "unprognostic (1.37e-3)" "unprognostic (3.14e-1)" "unprognostic (7.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (9.30e-2)" "unprognostic (1.22e-1)" 0.5 0.0 2.6 0.4 1.7 0.5 3.1 2.2 1.9 4.0 0.5 1.4 1.6 0.9 1.0 1.2 6.5 0.2 0.0 1.6 1.5 0.5 0.0 3.4 0.2 2.1 1.8 1.1 0.1 2.3 0.2 0.3 0.4 1.9 5.4 1.0 0.3 4.6 1.0 0.3 6.4 1.4 0.1 1.8 1.4 8.5 1.1 2.4 3.5 0.8 0.2 0.5 0.7 0.9 2.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.3 0.0 0.0 3.0 0.0 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 1.7 2.2 1.9 1.6 1.5 2.1 1.8 1.1 1.9 1.8 2.4 2.0 0.4 0.0 0.0 0.0 0.0 0.3 4.1 2.8 6.8 0.0 1.1 0.3 0.5 0.0 1.7 1.8 0.0 1.3 0.0 0.1 0.0 2.1 9.6 0.7 0.1 0.2 0.0 0.0 4.1 1.6 0.0 0.1 5.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.4 2.0 0.0 0.0 15.8 0.3 0.0 0.0 16.9 0.0 0.0 0.0 2.5 0.1 2.2 0.2 0.0 0.0 2.0 0.6 0.1 0.6 0.0 0.0 0.2 0.1 0.8 0.3 1.1 0.0 0.7 0.0 0.1 0.5 1.3 METTL3 "M6A, MT-A70, Spo8" ENSG00000165819 "Methyltransferase like 3" Q86U44 14 21498133-21511342 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Oogenesis, Spermatogenesis" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 188.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.19e-5)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "prognostic favorable (2.78e-4)" "prognostic favorable (2.72e-4)" "unprognostic (4.52e-2)" "unprognostic (4.64e-3)" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (5.36e-2)" "unprognostic (1.22e-1)" 11.9 18.7 11.8 11.4 12.4 5.9 16.1 12.3 13.1 12.9 12.1 11.4 7.7 13.3 18.2 11.8 19.0 9.9 16.9 11.9 17.2 12.7 11.8 13.0 19.2 13.6 12.5 11.4 15.1 11.6 19.2 13.1 15.3 13.1 17.5 13.0 8.7 14.3 16.9 16.9 16.7 10.7 16.4 12.9 14.0 11.3 20.0 13.2 17.9 17.0 18.7 21.4 14.6 12.5 13.1 39.6 57.7 55.0 22.2 40.5 33.4 27.5 35.9 26.0 41.7 48.5 22.0 46.4 40.8 22.6 22.3 54.2 41.6 66.4 35.2 65.7 39.1 39.8 25.9 31.9 88.1 16.6 34.8 28.2 25.0 30.3 26.0 30.2 18.6 54.8 20.8 32.0 23.5 55.9 29.1 31.0 28.6 46.4 66.1 70.7 30.7 42.6 36.5 38.8 26.6 33.4 36.6 38.7 50.6 37.5 42.7 39.8 22.8 36.6 15.0 24.8 27.6 24.9 24.9 32.5 29.0 18.2 27.7 32.0 6.5 8.9 8.9 8.0 11.5 12.4 14.3 10.0 9.4 10.9 10.8 10.3 9.3 0.9 15.7 9.6 13.0 15.5 8.4 11.8 12.4 12.3 13.1 11.9 17.2 13.6 12.5 11.4 13.1 12.9 13.2 13.1 12.5 12.8 20.1 15.7 16.2 14.9 23.3 21.2 21.1 23.4 15.1 16.5 30.6 12.8 13.6 12.9 14.6 31.1 16.2 5.4 3.9 14.5 188.2 11.7 11.4 14.7 10.8 20.4 15.0 10.0 15.7 15.3 7.1 10.0 8.8 20.4 9.7 9.5 16.6 21.9 13.7 8.7 14.2 10.0 9.9 24.3 17.1 10.8 16.0 10.3 17.9 14.9 15.5 19.1 21.7 10.8 6.5 19.9 14.9 18.8 5.5 9.1 15.3 21.0 32.9 16.4 17.5 42.4 20.3 12.4 12.4 25.3 13.2 13.2 13.4 19.0 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521080-21537216 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Cell type enhanced" "Detected in many" "Astrocytes: 13.4;Bipolar cells: 13.9;Horizontal cells: 13.5;Muller glia cells: 11.2;Oligodendrocyte precursor cells: 10.6" "Cancer enhanced" "Detected in many" "glioma: 16.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 109.2;NTERA-2: 85.7;SuSa: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA004162: AB_2667155" "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favorable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 3.6 5.5 38.3 1.4 34.4 0.2 5.6 43.2 31.3 12.0 15.7 10.2 1.7 13.6 6.3 2.9 12.8 3.2 4.6 29.6 41.7 4.8 1.0 4.5 1.8 41.3 43.9 24.0 17.4 4.4 20.7 27.2 1.2 37.1 7.0 2.1 17.0 3.1 9.3 1.6 2.6 6.7 9.5 36.5 2.9 6.1 1.6 44.7 6.6 10.6 2.8 1.7 8.8 6.4 30.0 0.1 2.4 109.2 24.2 1.9 1.6 0.0 2.1 2.7 7.1 7.2 2.3 1.2 0.1 2.2 3.2 3.1 0.2 24.5 2.7 10.0 2.0 12.5 0.0 0.7 2.2 3.2 0.0 0.1 7.3 0.9 3.4 0.0 18.4 2.2 10.9 16.6 0.0 6.2 2.1 16.0 0.1 85.7 0.1 0.5 14.3 2.3 0.0 8.3 11.6 30.4 17.3 0.0 0.6 0.3 36.2 9.2 0.2 0.0 0.9 11.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.5 0.5 0.1 38.3 34.4 43.2 31.3 29.6 41.7 41.3 43.9 24.0 37.1 36.5 44.7 30.0 0.8 3.2 3.6 13.4 0.0 0.6 0.6 1.1 8.0 13.9 3.4 2.8 0.9 2.8 1.5 5.5 8.4 0.1 0.2 0.0 1.9 1.8 0.3 0.5 3.2 1.0 0.0 0.4 2.5 0.0 0.1 3.9 0.0 0.4 0.0 7.2 2.5 0.1 0.1 13.5 9.3 0.0 4.1 0.0 0.3 0.7 5.0 0.2 0.0 0.0 0.0 11.2 0.0 10.6 2.6 0.3 0.0 6.0 0.2 0.4 0.0 0.8 0.0 2.8 0.0 3.9 3.0 0.0 0.5 1.0 0.6 0.1 0.8 3.9 0.0 0.1 PRAP1 UPA ENSG00000165828 "Proline rich acidic protein 1" Q96NZ9 10 133347368-133352683 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 1144.8;liver: 680.6" "Cell type enriched" "Detected in some" 9 "Proximal enterocytes: 17736.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 348.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 34.2;Hep G2: 128.3" "HPA038713, HPA052451" Supported "Secreted to digestive system" NA NA 210000000 "HPA038713: AB_10673117, HPA052451: AB_2681839" "unprognostic (1.63e-3)" "unprognostic (1.79e-2)" "unprognostic (1.09e-1)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.11e-1)" "unprognostic (8.90e-2)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (4.35e-3)" "unprognostic (4.91e-2)" "unprognostic (8.23e-3)" "unprognostic (2.25e-1)" "unprognostic (3.15e-1)" "unprognostic (2.92e-2)" "unprognostic (2.22e-3)" 0.6 0.5 0.7 4.2 0.7 0.5 0.3 0.4 0.7 0.2 5.3 75.3 1063.3 0.8 0.1 0.4 0.7 2.7 0.3 0.6 0.4 146.7 680.6 0.3 1.5 1.2 0.5 0.4 0.4 0.1 0.1 0.8 0.1 1.3 0.3 36.0 0.0 1.7 0.3 0.2 1.4 1144.8 1.7 0.6 0.8 2.8 12.3 0.6 0.4 0.2 0.3 0.1 0.3 0.2 0.6 0.2 0.5 0.1 1.2 0.1 0.0 14.6 0.0 0.0 0.0 0.0 34.2 0.6 0.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.5 128.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.0 3.5 0.4 5.0 0.0 0.2 0.9 2.9 0.0 0.0 0.9 4.6 0.4 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.4 1.3 0.0 1.4 0.1 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.4 0.7 0.6 0.4 1.2 0.5 0.4 1.3 0.6 0.6 0.6 0.0 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.6 0.0 9.2 0.0 0.2 0.0 773.7 33.2 0.1 1.9 0.6 0.0 0.6 18.4 13.5 0.1 0.2 0.2 0.2 1.5 0.1 8.9 0.0 12.5 1021.3 0.2 0.0 0.0 676.2 0.0 20.9 0.0 7.3 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1815.7 1.5 0.0 0.1 17736.9 412.0 0.1 0.0 0.0 0.0 0.1 140.2 38.2 0.0 0.0 0.3 3.5 0.0 607.1 0.1 TRUB1 PUS4 ENSG00000165832 "TruB pseudouridine synthase family member 1" Q8WWH5 10 114938195-114977676 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 62.2;Theca cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037914, HPA057552" Approved Approved Vesicles NA NA Vesicles "HPA037914: AB_10672399, HPA057552: AB_2683465" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (1.27e-2)" "unprognostic (2.93e-2)" "unprognostic (3.20e-3)" "unprognostic (9.79e-2)" "unprognostic (9.26e-2)" "unprognostic (4.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (1.50e-3)" "unprognostic (7.54e-2)" "unprognostic (2.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" 7.5 29.6 7.0 7.6 8.6 4.2 11.4 6.2 8.5 9.8 7.7 9.6 9.0 12.9 9.4 8.4 9.8 7.7 21.7 8.3 8.3 16.1 13.1 6.6 10.1 6.8 7.2 7.2 17.0 6.9 16.0 4.9 7.5 7.2 11.8 10.5 6.7 9.4 10.0 7.5 6.6 8.2 11.2 6.1 9.3 8.8 18.1 7.4 11.6 12.4 9.8 10.2 7.9 4.8 8.2 25.5 19.6 18.8 47.0 13.3 17.7 25.3 21.4 24.1 28.4 32.0 16.1 25.5 31.4 24.2 16.9 12.4 21.3 25.6 26.5 41.8 23.9 27.5 14.4 9.2 28.8 22.8 27.2 20.7 18.2 35.8 20.2 39.6 30.1 16.2 24.9 15.1 12.5 34.1 12.3 25.7 21.6 17.8 17.0 19.1 25.4 47.5 19.2 37.4 12.7 17.5 19.3 18.0 26.4 47.7 20.0 21.1 16.6 14.5 13.0 13.0 20.8 26.5 23.6 20.4 26.3 18.3 34.2 11.9 4.0 2.6 0.9 4.4 4.0 6.5 7.3 4.7 4.7 4.8 5.9 6.2 5.8 0.2 8.1 7.3 4.3 6.2 4.6 7.0 8.6 6.2 8.5 8.3 8.3 6.8 7.2 7.2 7.2 6.1 7.4 8.2 6.9 12.8 8.4 8.8 11.2 5.6 4.7 15.3 6.2 13.9 11.9 8.1 13.6 4.3 12.0 9.2 2.1 9.1 10.5 7.1 21.5 7.6 62.2 11.1 12.8 6.6 7.7 9.0 23.0 4.9 6.6 11.2 6.6 12.0 10.2 26.7 12.1 20.2 7.6 25.2 22.0 8.2 6.1 7.3 4.2 9.6 8.4 5.0 3.6 8.4 5.4 10.4 9.2 31.2 16.7 7.0 3.6 10.1 12.7 4.2 6.2 27.9 9.8 5.6 6.6 8.4 9.3 14.5 23.3 15.9 7.0 6.2 8.0 74.1 12.9 5.8 ERICH6B "FAM194B, FLJ32682" ENSG00000165837 "Glutamate rich 6B" Q5W0A0 13 45534522-45615739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 2.0" "Group enriched" "Detected in some" 4 "Early spermatids: 39.7;Late spermatids: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043559 Uncertain NA NA "HPA043559: AB_2678552" "unprognostic (6.77e-3)" "unprognostic (3.52e-3)" "unprognostic (3.80e-2)" "unprognostic (2.06e-2)" "unprognostic (2.05e-1)" "unprognostic (7.08e-2)" "unprognostic (1.25e-1)" "unprognostic (7.98e-3)" "unprognostic (7.27e-3)" "unprognostic (9.81e-2)" "unprognostic (3.05e-3)" "unprognostic (3.37e-3)" "unprognostic (5.70e-8)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (9.74e-2)" "unprognostic (7.89e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.5 0.9 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CYP2C19 "CPCJ, CYP2C, P450IIC19" ENSG00000165841 "Cytochrome P450 family 2 subfamily C member 19" P33261 10 94762681-94855547 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 191.7" "Group enriched" "Detected in some" 11 "Gastric mucus-secreting cells: 3.1;Hepatocytes: 9.5;Proximal enterocytes: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015066, HPA074424" Supported Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA015066: AB_1847433, HPA074424: " "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.2 32.7 0.0 0.1 1.6 0.0 1.7 0.0 0.1 0.0 0.0 191.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.7 14.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 3.1 0.0 0.0 0.0 0.4 9.5 0.0 0.0 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 ZFYVE1 "DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1" ENSG00000165861 "Zinc finger FYVE-type containing 1" Q9HBF4 14 72969451-73027131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 45.8;Late spermatids: 108.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002898 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA002898: AB_1080653" "unprognostic (2.19e-1)" "unprognostic (1.50e-1)" "unprognostic (4.65e-2)" "unprognostic (1.23e-1)" "unprognostic (3.47e-1)" "unprognostic (2.40e-2)" "unprognostic (7.42e-3)" "unprognostic (6.82e-2)" "unprognostic (1.05e-2)" "unprognostic (2.40e-2)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" "prognostic favorable (5.07e-12)" "unprognostic (4.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (7.48e-2)" 10.2 13.6 9.7 5.8 10.5 12.5 9.4 9.6 9.5 8.4 7.0 9.8 9.4 9.1 5.7 13.3 7.3 8.1 9.5 9.1 10.4 12.2 11.3 8.3 7.1 11.0 10.5 9.1 9.6 7.8 11.2 6.4 9.5 10.8 7.7 6.7 9.2 8.4 7.2 16.5 12.4 9.1 9.5 10.0 8.2 7.8 17.0 10.6 8.1 12.6 13.8 7.3 9.2 9.3 10.6 8.0 11.3 10.6 10.3 26.9 18.5 7.2 11.5 17.9 12.4 19.5 7.8 6.9 4.2 8.6 14.7 14.6 5.7 7.5 7.1 12.7 16.6 4.2 5.2 5.3 5.5 23.0 1.9 18.7 24.3 18.6 12.2 10.2 18.7 19.7 11.3 4.8 10.8 16.3 9.5 8.3 5.9 5.0 6.4 10.3 11.7 7.4 5.2 11.2 8.3 5.7 9.9 10.4 10.5 12.0 14.6 14.3 7.1 22.0 22.7 9.3 6.4 3.9 15.7 16.9 5.9 12.4 4.2 10.7 2.2 7.0 9.6 6.7 6.3 4.6 3.0 3.4 4.6 6.1 3.0 3.6 4.5 10.9 3.7 5.9 3.5 5.7 5.5 9.7 10.5 9.6 9.5 9.1 10.4 11.0 10.5 9.1 10.8 10.0 10.6 10.6 5.6 12.8 5.5 10.1 5.1 6.5 1.8 3.6 8.0 6.2 6.8 4.1 7.8 1.5 3.7 9.2 4.2 3.7 6.8 10.2 1.9 6.4 45.8 6.5 6.3 6.3 7.2 23.1 14.8 5.3 4.4 6.3 7.7 7.0 8.2 9.7 7.1 8.6 5.5 16.8 14.3 7.6 4.1 7.1 3.3 108.9 8.7 7.1 12.4 10.3 6.6 7.6 6.2 13.0 20.6 6.1 9.7 9.1 6.9 3.3 13.1 8.3 3.5 5.4 0.0 5.5 7.6 5.5 3.6 9.0 5.4 9.3 6.4 7.5 4.5 6.2 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 85.2" "Group enriched" "Detected in some" 113 "Early spermatids: 1053.9;Late spermatids: 1926.7" "Cancer enhanced" "Detected in many" "breast cancer: 2.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 103 "basophil: 10.2" "Lineage enriched" "Detected in single" 103 "granulocytes: 10.2" "Cell line enhanced" "Detected in some" "BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5" "Not detected" "Not detected" HPA043022 Approved Mitochondria Yes NA Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.2 1.8 0.2 0.2 0.2 0.0 0.9 0.1 0.4 0.3 0.0 0.7 0.1 0.0 0.2 0.3 0.2 0.1 0.3 0.2 0.5 0.5 0.0 0.0 0.0 0.4 0.4 0.2 3.6 1.1 0.0 1.0 0.0 0.3 0.9 0.2 0.1 0.2 0.7 0.0 0.2 0.4 0.0 0.2 0.1 0.4 85.2 0.7 0.0 1.6 0.1 0.0 0.3 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.5 0.4 0.4 0.2 0.3 0.2 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 1.1 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1053.9 0.3 0.2 0.5 1.2 0.0 0.5 0.2 0.1 0.1 0.0 0.7 0.0 5.6 0.0 0.0 0.1 0.0 1.8 1.1 0.0 0.0 0.0 1926.7 9.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 5.3 0.0 0.7 0.1 0.1 0.0 0.0 13.1 0.4 0.2 10.5 8.0 0.0 0.0 0.0 0.1 8.0 1.2 0.3 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0" "Group enriched" "Detected in many" 14 "B-cells: 1.7;T-cells: 1.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: AB_2686586" "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 14.8 22.1 12.1 1.5 13.0 0.0 8.9 11.4 26.9 12.9 5.8 9.5 0.7 9.3 12.6 3.9 10.4 2.3 8.9 15.4 13.2 17.5 1.6 3.0 2.7 14.5 11.6 14.4 20.7 2.8 20.2 8.0 0.8 17.7 5.7 2.0 11.1 2.6 5.5 4.9 5.6 4.2 4.6 3.8 3.9 4.7 6.3 30.7 2.1 9.5 3.5 2.9 7.9 10.1 23.5 8.0 10.0 0.1 7.1 6.6 4.4 0.1 5.5 10.1 1.9 1.0 10.0 2.8 0.0 4.1 7.6 5.2 6.1 8.4 0.7 4.9 0.0 3.2 0.0 0.8 5.5 1.9 0.0 1.0 1.7 6.6 7.3 0.9 13.9 0.0 3.3 0.0 0.0 2.1 4.0 0.0 0.0 1.2 0.0 0.1 0.0 1.0 1.2 22.1 1.8 5.3 12.7 4.0 2.9 3.0 2.4 3.2 0.0 0.0 1.4 5.5 12.3 10.2 0.1 3.2 0.0 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 12.1 13.0 11.4 26.9 15.4 13.2 14.5 11.6 14.4 17.7 3.8 30.7 23.5 2.1 6.4 3.6 27.7 1.0 11.1 1.6 0.5 2.8 35.8 5.2 6.9 7.8 2.8 2.0 12.9 22.9 0.1 0.1 1.6 15.6 4.2 4.4 12.5 16.1 3.1 0.0 0.0 205.0 3.5 0.1 17.8 0.0 4.4 0.0 2.4 2.9 0.4 0.1 30.3 186.4 0.3 0.0 0.0 5.2 9.7 63.3 0.5 26.6 9.4 0.0 35.8 0.0 27.6 54.8 2.4 0.0 68.4 0.1 2.1 0.0 25.4 11.3 10.2 13.1 14.7 14.9 1.0 5.2 0.5 5.1 0.3 0.8 82.0 0.3 0.7 FRAT1 ENSG00000165879 "FRAT regulator of WNT signaling pathway 1" Q92837 10 97319271-97321915 "Predicted intracellular proteins" "Wnt signaling pathway" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.2;Early spermatids: 31.3;Kupffer cells: 26.1;Late spermatids: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 8.7;neutrophil: 10.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB046472, HPA055258" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB046472: AB_1849131, HPA055258: AB_2682763" "unprognostic (1.48e-2)" "prognostic favorable (5.92e-4)" "unprognostic (3.54e-1)" "unprognostic (1.13e-2)" "unprognostic (1.45e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.11e-2)" "unprognostic (4.44e-3)" "unprognostic (5.73e-2)" "unprognostic (2.50e-2)" "unprognostic (6.36e-3)" "unprognostic (1.89e-1)" "prognostic favorable (6.36e-5)" "unprognostic (6.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.43e-2)" 3.3 2.9 2.5 5.0 2.7 10.7 2.4 4.1 3.6 2.4 2.1 2.8 4.5 2.7 1.0 2.4 3.0 1.3 2.7 2.9 3.1 1.9 11.8 3.4 3.8 3.7 3.4 2.3 2.4 3.9 2.0 2.1 1.2 3.3 4.0 1.9 2.0 3.7 1.6 3.9 4.0 4.5 1.5 2.9 12.7 4.8 11.0 3.5 4.1 2.0 2.6 2.4 2.3 2.1 3.7 0.7 1.3 1.4 6.7 1.8 0.9 1.5 0.8 2.9 0.5 0.6 0.2 0.8 4.5 1.5 0.5 1.0 2.0 1.1 1.4 0.1 4.0 2.0 3.8 0.8 1.8 0.6 1.4 4.0 0.8 2.0 0.2 0.9 2.7 1.2 6.1 1.6 3.1 0.4 4.2 4.0 7.9 1.9 4.8 5.5 3.3 0.3 2.9 0.5 1.0 0.7 2.2 1.0 2.1 1.5 1.4 7.7 5.4 1.1 0.3 0.4 1.0 0.3 2.9 1.7 1.5 0.5 7.0 0.0 0.9 2.0 8.7 0.5 1.3 0.4 0.5 0.4 0.7 1.0 0.5 0.7 0.5 10.1 0.2 1.5 0.6 0.3 0.5 2.5 2.7 4.1 3.6 2.9 3.1 3.7 3.4 2.3 3.3 2.9 3.5 3.7 4.1 3.2 5.8 1.0 5.8 1.1 1.1 0.9 1.2 25.2 2.9 1.9 3.3 5.7 0.9 1.8 0.0 0.6 16.8 6.0 0.0 1.4 31.3 5.8 1.6 4.0 4.2 4.2 0.7 2.0 1.7 1.5 2.0 4.1 0.0 5.0 3.3 15.6 3.9 3.3 1.6 4.9 4.1 26.1 1.8 85.2 1.2 15.5 3.6 0.0 12.5 4.9 13.4 0.5 0.7 1.1 2.3 1.9 1.1 2.5 3.8 1.0 3.3 8.4 0.0 3.4 1.7 1.2 0.6 1.6 1.6 2.3 9.0 4.7 2.8 2.2 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498924-97571206 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.4;neutrophil: 6.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 17.1 11.2 12.6 5.7 11.9 8.9 14.9 14.7 17.1 16.1 10.1 8.2 1.9 13.6 4.1 9.6 13.7 7.0 31.6 11.0 12.8 20.6 18.7 30.1 3.1 15.1 14.3 10.1 8.8 9.7 3.6 16.1 3.9 13.5 13.5 0.6 6.1 11.3 7.5 34.5 49.5 5.6 3.6 13.3 11.1 9.5 60.8 15.7 1.6 14.7 11.3 1.1 12.5 16.4 15.8 18.1 17.7 4.6 23.0 18.9 17.8 5.4 20.3 29.4 21.3 16.3 12.0 15.4 2.2 24.1 13.8 13.4 21.4 4.6 27.2 3.0 5.6 9.1 2.2 5.5 15.2 27.2 2.0 5.9 24.6 9.0 23.3 5.7 32.8 34.3 4.7 1.2 3.3 13.9 8.6 0.9 18.5 7.5 3.4 32.1 1.8 8.1 2.1 16.7 6.7 1.5 4.8 9.2 5.6 27.1 4.0 20.8 13.6 37.5 26.9 16.4 28.4 26.8 4.2 5.1 0.9 22.7 12.3 14.3 1.0 2.6 6.4 0.1 0.7 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 6.6 0.0 0.7 0.9 0.3 0.5 12.6 11.9 14.7 17.1 11.0 12.8 15.1 14.3 10.1 13.5 13.3 15.7 15.8 5.0 41.7 28.6 13.1 1.1 26.0 8.8 32.2 19.4 3.8 10.0 4.8 15.5 8.6 21.2 7.3 4.2 3.5 0.6 1.5 11.7 18.9 53.5 8.2 8.7 23.8 0.0 0.4 5.6 12.8 12.8 11.6 2.6 4.0 0.0 0.8 7.9 7.0 25.8 6.7 5.9 0.2 10.2 10.1 18.9 33.8 12.8 10.3 10.6 12.2 8.4 16.5 2.1 2.0 14.5 22.1 0.1 9.4 3.0 14.0 0.0 10.4 19.1 18.6 13.1 8.5 10.3 7.5 7.9 8.2 29.7 2.9 1.9 1.5 0.4 7.6 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 238.3;skeletal muscle: 989.2;tongue: 831.1" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 218.3" "Cancer enhanced" "Detected in many" "renal cancer: 4.9;testis cancer: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles NA NA 110000 Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 0.4 0.8 2.6 0.1 2.4 0.0 0.5 2.6 3.8 0.2 2.0 0.2 0.0 0.3 0.3 1.0 0.1 0.3 238.3 2.5 2.7 5.6 0.3 0.8 0.2 2.6 2.5 2.4 0.1 0.9 0.0 0.6 0.0 2.6 2.9 0.0 0.3 3.4 1.0 989.2 1.9 0.2 0.2 2.2 0.1 0.2 0.5 2.9 0.0 0.5 831.1 0.1 0.1 0.4 3.1 17.6 5.4 0.0 0.0 0.2 0.0 0.4 0.9 0.0 7.3 4.7 0.3 5.3 0.0 0.6 0.2 0.4 13.0 0.0 4.7 5.0 0.2 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.8 2.1 4.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.4 0.8 0.0 0.0 0.0 4.4 0.0 0.4 2.1 0.3 0.0 0.1 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 2.4 2.6 3.8 2.5 2.7 2.6 2.5 2.4 2.6 2.2 2.9 3.1 0.1 0.0 0.0 1.3 0.0 0.1 0.7 1.7 1.2 0.0 0.2 0.4 218.3 2.8 0.2 3.7 0.0 0.2 0.0 0.0 31.3 1.2 0.6 0.1 0.3 1.6 0.0 0.0 1.3 0.2 0.4 1.0 0.0 0.1 0.0 0.7 0.4 0.2 0.1 0.0 1.5 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.5 0.4 0.9 0.0 1.9 0.0 0.1 0.0 19.1 0.0 0.1 0.0 13.6 1.1 2.5 3.5 0.6 0.3 0.3 0.2 0.1 0.0 0.5 E2F7 ENSG00000165891 "E2F transcription factor 7" Q96AV8 12 77021248-77065569 "Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.0;lymphoid tissue: 8.3" "Cell type enhanced" "Detected in many" "Early spermatids: 46.9;Endometrial ciliated cells: 17.2;Late spermatids: 70.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "midbrain: 5.8;pons: 6.4;thalamus: 11.3" HPA064866 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA064866: AB_2685374" "unprognostic (1.21e-1)" "unprognostic (8.92e-2)" "unprognostic (7.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.54e-1)" "unprognostic (3.80e-2)" "unprognostic (6.14e-5)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (3.57e-2)" "unprognostic (5.67e-5)" "unprognostic (1.42e-1)" "unprognostic (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-1)" 0.2 0.1 0.5 1.1 0.2 5.0 0.2 0.1 0.2 0.2 0.2 0.9 0.7 0.2 0.0 1.5 0.6 0.7 0.1 0.1 0.3 0.0 0.2 0.3 1.5 0.5 0.5 0.0 0.1 0.2 0.1 0.5 1.0 0.4 0.2 1.5 0.2 0.2 0.1 0.0 1.1 0.8 0.4 0.7 0.3 0.6 2.9 0.3 8.3 0.1 0.1 1.6 0.6 0.5 0.2 20.1 9.4 25.7 10.1 0.8 2.5 31.1 27.6 29.8 14.2 17.0 12.8 6.6 11.2 5.4 5.5 29.5 15.1 15.5 29.8 27.1 4.4 10.4 9.8 27.3 7.3 5.9 8.5 8.8 0.8 7.7 37.4 22.9 8.3 14.2 19.0 10.4 8.9 29.5 10.1 31.9 0.1 18.1 6.7 21.9 23.0 22.2 6.2 3.5 16.8 16.3 10.7 22.9 7.9 6.5 10.9 12.6 8.7 39.3 53.5 26.8 23.0 36.7 9.5 5.8 7.1 19.3 3.8 34.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.5 0.2 0.1 0.2 0.1 0.3 0.5 0.5 0.0 0.4 0.7 0.3 0.2 0.1 0.0 0.5 2.3 0.5 0.3 1.0 1.4 4.6 0.0 0.6 0.9 2.1 0.0 2.2 0.0 0.0 1.8 0.4 1.5 0.0 0.3 46.9 17.2 0.8 1.5 0.0 7.4 0.4 1.1 3.1 0.8 6.1 3.1 4.5 6.3 0.0 0.0 0.9 0.0 0.2 1.2 2.0 0.3 1.2 70.2 0.3 1.3 0.0 3.7 0.0 1.6 0.0 0.5 0.0 12.0 0.1 0.7 6.9 1.7 0.0 0.0 3.1 0.1 0.0 0.0 1.2 1.2 2.1 6.3 0.6 0.3 0.8 0.4 2.1 4.3 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" A6NI28 11 100687288-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 31.9" "Cell type enhanced" "Detected in many" "Astrocytes: 102.8;Early spermatids: 74.7;Oligodendrocyte precursor cells: 226.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.2;RH-30: 20.4;RT4: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 6.7 3.0 5.9 3.9 6.6 1.2 3.7 6.4 6.7 6.4 7.7 6.8 7.7 5.9 3.1 3.3 3.4 6.7 4.8 5.5 9.2 9.3 10.2 6.2 4.7 7.1 6.3 4.4 3.2 1.2 5.7 1.3 15.2 6.9 2.8 6.1 31.9 3.1 2.9 3.3 3.2 8.0 4.2 6.6 4.7 9.5 2.1 6.9 9.4 8.2 5.1 2.9 5.4 1.7 7.6 0.6 4.6 5.0 0.1 2.7 4.7 4.0 0.7 1.1 1.2 2.7 6.3 30.2 0.9 8.3 2.1 5.5 9.4 2.8 1.6 1.2 0.0 2.7 15.3 13.0 2.1 5.2 0.1 0.1 3.6 2.8 5.3 0.9 2.9 1.9 3.9 0.5 0.0 4.2 0.9 1.8 0.0 6.8 7.5 6.7 5.4 20.4 0.5 6.8 21.1 3.4 1.8 10.9 0.4 8.0 10.6 1.0 1.8 4.0 4.1 5.3 4.6 2.3 4.6 0.0 6.2 4.1 3.3 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 5.9 6.6 6.4 6.7 5.5 9.2 7.1 6.3 4.4 6.9 6.6 6.9 7.6 8.7 48.1 5.3 102.8 3.7 2.4 6.5 1.5 2.2 3.1 2.9 4.6 6.8 14.3 13.4 3.7 25.0 0.7 3.4 22.2 1.9 4.5 74.7 16.0 19.6 6.1 1.8 3.6 2.4 3.9 2.1 12.6 16.3 18.1 0.0 21.8 6.8 6.3 1.6 1.7 47.7 3.6 2.0 0.3 1.2 38.9 1.2 1.4 10.6 39.4 0.0 32.2 0.0 226.2 0.5 10.0 12.1 2.6 5.6 14.6 7.9 19.8 11.8 62.0 39.5 4.5 38.6 3.6 2.3 2.3 3.4 6.4 0.6 6.2 4.7 18.3 ISCA2 "HBLD1, ISA2" ENSG00000165898 "Iron-sulfur cluster assembly 2" Q86U28 14 74493756-74497106 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030492 Approved NA NA "HPA030492: AB_10603772" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "unprognostic (5.73e-2)" "unprognostic (5.62e-2)" "unprognostic (2.51e-1)" "unprognostic (5.89e-3)" "unprognostic (6.03e-3)" "unprognostic (7.98e-2)" "unprognostic (1.66e-1)" "unprognostic (2.59e-2)" "unprognostic (1.31e-2)" "unprognostic (2.21e-1)" "prognostic favorable (1.68e-7)" "unprognostic (3.98e-2)" "unprognostic (1.47e-1)" "prognostic favorable (8.98e-5)" "unprognostic (5.23e-2)" 15.2 34.2 20.3 9.8 20.5 15.6 17.0 22.7 24.1 13.6 25.6 17.1 14.3 11.1 46.8 15.5 19.6 7.7 32.1 19.7 22.8 30.8 22.2 13.0 17.2 22.0 21.3 19.0 18.2 18.3 13.0 23.5 12.9 21.4 18.6 17.7 19.3 17.9 12.2 38.6 13.1 16.1 8.4 21.3 20.1 18.2 20.8 22.1 18.7 26.2 29.4 17.5 13.8 13.5 21.7 43.4 30.7 28.4 18.1 25.5 37.2 35.9 19.7 26.3 30.2 36.3 36.3 39.3 21.8 25.3 16.6 38.2 30.7 27.8 25.9 40.7 30.7 20.2 13.7 13.1 39.6 38.3 17.7 30.2 31.2 29.0 18.2 20.6 28.0 30.8 44.4 18.2 25.5 32.7 51.0 42.9 34.5 21.0 60.2 28.3 29.8 31.9 21.8 42.6 34.1 19.1 19.6 20.8 24.4 31.8 30.5 60.2 20.9 16.9 17.1 39.5 25.3 17.7 43.3 60.3 40.2 28.0 20.6 25.4 130.8 109.1 159.0 91.8 108.0 93.5 172.3 127.6 111.6 111.0 165.4 148.5 122.1 87.5 101.5 106.6 218.1 157.4 161.3 20.3 20.5 22.7 24.1 19.7 22.8 22.0 21.3 19.0 21.4 21.3 22.1 21.7 25.2 19.2 20.4 7.2 36.2 15.4 27.2 74.9 13.6 22.1 36.2 38.2 113.3 22.8 42.7 33.1 12.5 70.8 28.8 45.5 146.8 62.0 41.0 38.3 17.6 27.2 29.3 73.2 4.4 55.0 70.1 28.8 24.5 18.1 12.6 31.8 28.9 42.4 81.5 28.6 5.5 36.3 63.1 33.2 18.3 19.3 33.5 30.4 8.8 2.8 49.0 69.8 41.2 3.0 7.2 59.5 50.8 18.0 25.0 40.2 51.4 133.5 78.6 31.6 13.1 15.1 25.1 107.2 63.7 25.4 13.2 25.4 30.7 43.1 42.3 27.6 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380880 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 1.6;kidney: 5.2" "Group enriched" "Detected in some" 5 "Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.3;U-87 MG: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 4.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.1 0.0 0.3 0.0 0.8 0.0 0.1 0.0 1.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 1.6 0.4 0.4 5.2 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.2 0.0 0.3 0.5 0.2 0.1 0.1 0.5 0.0 0.1 0.5 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 1.0 0.4 0.4 0.1 0.0 0.6 0.2 0.0 0.0 0.6 0.1 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.4 0.1 0.1 0.2 0.0 0.0 51.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 42.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 LARGE2 "FLJ35207, GYLTL1B, PP5656" ENSG00000165905 "LARGE xylosyl- and glucuronyltransferase 2" Q8N3Y3 11 45921621-45929096 "Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 36.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 189.8;Syncytiotrophoblasts: 116.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 4 "B-cells: 2.1" "Cell line enhanced" "Detected in many" "BEWO: 34.3;NTERA-2: 32.5;SK-BR-3: 23.5;T-47d: 71.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA056621 Approved "Intracellular and membrane" NA NA "HPA056621: AB_2683194" "unprognostic (9.82e-2)" "unprognostic (3.63e-2)" "unprognostic (3.65e-2)" "unprognostic (2.43e-2)" "unprognostic (6.20e-2)" "unprognostic (4.46e-3)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.30e-2)" "unprognostic (6.94e-2)" "prognostic favorable (3.04e-12)" "unprognostic (2.31e-1)" "unprognostic (9.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" 0.1 2.4 0.1 2.3 0.0 0.5 4.4 0.4 0.1 3.7 9.9 1.0 1.3 2.1 4.9 17.3 3.9 0.6 0.2 0.8 0.4 16.0 3.3 1.9 4.7 0.2 0.1 0.0 2.0 27.4 12.6 11.6 36.9 0.2 10.0 0.7 3.6 17.8 8.4 0.6 18.3 3.7 0.1 0.0 2.5 11.3 1.6 0.1 4.1 11.4 0.0 2.3 2.2 6.9 0.2 1.2 1.6 0.1 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.9 0.0 0.8 8.0 0.1 15.2 0.0 0.0 4.7 0.0 1.2 9.3 0.2 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 2.0 9.7 0.0 0.0 2.7 0.2 0.0 32.5 12.2 1.1 0.9 0.0 3.1 0.5 0.6 9.6 1.1 0.3 23.5 0.1 1.9 71.4 0.0 0.0 0.2 10.4 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.1 0.4 0.0 2.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.8 0.4 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.2 3.2 2.2 0.0 4.0 0.0 0.0 0.0 0.0 0.0 13.5 8.3 0.0 0.0 0.6 7.3 0.0 189.8 0.4 0.0 3.9 4.6 0.0 10.9 3.4 0.9 0.0 0.0 0.0 6.4 11.3 0.9 0.0 28.0 0.0 9.4 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 116.2 0.8 0.1 0.0 0.0 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177522-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 146.1;skeletal muscle: 485.5;tongue: 281.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 112.0;Extravillous trophoblasts: 60.6;Muller glia cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 127.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 14.2 67.1 18.2 4.6 26.0 0.4 18.6 24.1 20.8 29.9 17.2 35.8 4.8 33.8 11.5 53.1 29.4 7.3 146.1 16.8 19.6 14.0 43.9 16.0 2.1 32.6 27.0 14.1 23.4 33.3 11.1 6.2 16.2 29.1 35.5 2.8 4.5 41.1 20.8 485.5 41.7 11.4 21.4 26.1 4.6 33.7 4.6 22.4 2.0 24.7 281.9 5.3 21.7 32.1 38.6 56.4 27.1 12.5 51.5 10.3 10.2 59.8 19.4 24.6 33.9 19.1 40.8 7.3 0.3 5.9 9.2 23.0 90.0 23.7 40.2 13.0 8.7 44.8 8.4 105.5 91.7 19.9 2.0 8.4 28.2 52.3 17.9 28.3 27.2 15.3 15.2 18.4 0.7 13.9 106.7 0.7 40.8 15.5 43.7 58.7 33.1 48.0 9.0 14.3 49.3 0.3 42.6 28.2 17.9 24.6 24.6 127.3 6.9 6.9 57.6 62.5 7.5 47.1 10.1 4.4 5.3 18.6 19.2 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.2 26.0 24.1 20.8 16.8 19.6 32.6 27.0 14.1 29.1 26.1 22.4 38.6 6.1 0.0 8.1 4.9 0.3 35.9 29.1 25.1 30.7 0.7 32.2 24.3 112.0 38.6 18.1 5.5 0.0 31.0 0.6 0.2 9.8 37.7 0.0 3.1 8.4 7.8 0.0 2.7 0.8 15.5 60.6 12.6 9.7 6.2 0.0 3.0 8.6 33.1 6.0 0.0 1.1 0.2 14.2 1.6 4.6 0.4 16.1 1.0 17.8 2.8 0.0 63.6 0.0 0.0 9.5 41.0 0.0 12.4 2.6 56.8 1.5 24.3 5.0 3.2 32.9 18.5 25.4 0.2 7.5 39.7 29.8 18.3 0.7 4.8 1.4 29.8 TTC7B TTC7L1 ENSG00000165914 "Tetratricopeptide repeat domain 7B" Q86TV6 14 90524564-90816479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 88.8;Excitatory neurons: 116.7;Inhibitory neurons: 132.8;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 5.6;eosinophil: 8.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "HMC-1: 72.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058363, HPA059577" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA058363: AB_2683692, HPA059577: AB_2684069" "unprognostic (9.37e-2)" "unprognostic (4.20e-2)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.58e-1)" "unprognostic (2.67e-4)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (5.38e-2)" "unprognostic (7.60e-2)" "unprognostic (2.75e-3)" "unprognostic (2.87e-2)" "prognostic favorable (3.20e-6)" "unprognostic (2.74e-2)" "unprognostic (7.41e-2)" "unprognostic (4.48e-2)" "unprognostic (1.07e-2)" 23.9 11.7 41.1 9.2 41.9 10.3 18.3 42.6 55.6 19.5 0.9 28.1 5.0 24.4 6.2 15.7 18.2 9.3 33.4 49.9 22.1 16.9 17.8 18.6 4.1 33.6 33.0 41.0 16.0 24.9 15.8 18.4 18.6 37.4 16.2 4.4 14.5 12.9 14.0 61.4 9.2 11.1 17.7 10.4 15.6 22.6 4.2 45.6 3.6 9.6 28.2 2.7 25.7 13.2 37.7 19.4 17.2 20.0 14.8 18.2 21.5 65.5 15.5 13.2 20.2 21.7 4.5 5.1 0.2 23.6 17.4 23.9 0.4 13.1 10.8 19.6 35.3 14.1 43.6 8.9 4.1 18.3 1.0 72.8 16.1 7.1 10.9 13.2 18.5 29.4 16.9 24.7 35.3 19.7 20.5 0.5 17.2 11.4 1.1 14.8 37.8 33.0 6.6 6.6 14.4 30.5 20.9 15.4 6.3 33.3 12.7 9.0 13.3 33.7 20.6 16.1 15.2 25.4 12.0 6.3 0.2 29.6 4.1 20.6 5.6 0.2 8.0 0.1 0.5 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 1.0 0.3 0.1 0.5 0.9 0.5 41.1 41.9 42.6 55.6 49.9 22.1 33.6 33.0 41.0 37.4 10.4 45.6 37.7 13.1 3.2 1.1 88.8 0.5 2.8 2.1 1.1 0.6 13.4 2.7 2.8 21.6 2.8 0.4 5.5 16.7 13.1 0.6 0.1 1.9 2.3 5.9 1.3 5.2 7.9 1.2 2.5 116.7 2.4 7.4 7.3 0.5 2.0 7.6 20.0 10.8 9.9 8.1 30.3 132.8 0.1 4.1 5.6 4.3 3.2 6.8 7.2 12.4 36.5 2.7 6.0 0.0 69.9 70.7 0.8 0.1 7.2 0.4 3.0 0.3 4.0 5.5 17.8 26.3 9.9 9.2 1.7 1.6 0.7 2.0 30.1 1.1 2.1 0.0 1.2 SLC39A13 FLJ25785 ENSG00000165915 "Solute carrier family 39 member 13" Q96H72 11 47407132-47416496 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 13 "Early spermatids: 298.2;Late spermatids: 905.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043971 Approved NA NA "HPA043971: AB_10959744" "unprognostic (7.84e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.18e-1)" "unprognostic (8.56e-3)" "unprognostic (3.81e-2)" "unprognostic (7.44e-3)" "unprognostic (1.36e-1)" "unprognostic (5.40e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (1.39e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (8.61e-2)" "unprognostic (4.12e-1)" 40.2 42.8 24.8 24.4 26.6 8.4 37.8 26.3 36.6 50.0 25.3 44.0 14.2 78.5 8.8 22.0 48.5 20.4 58.5 21.9 22.7 73.2 26.9 62.0 18.3 28.6 26.4 20.2 51.3 42.6 27.4 51.7 41.0 28.7 53.1 6.9 11.1 31.6 26.4 31.6 32.3 32.1 26.9 22.7 36.8 41.6 74.0 30.0 12.4 47.2 12.7 8.8 46.0 37.7 24.6 23.3 20.4 23.5 26.7 56.3 78.2 6.8 89.7 66.2 50.4 57.0 8.1 15.7 8.8 22.9 69.6 49.6 38.3 7.1 61.7 13.9 25.7 25.9 4.7 52.7 16.7 84.3 8.1 11.0 65.4 43.4 31.9 26.1 62.9 53.4 16.9 4.5 19.6 54.8 20.7 17.4 11.5 11.0 19.8 28.2 20.6 33.6 8.9 86.1 11.1 19.9 37.0 26.9 49.1 26.2 8.7 32.8 11.7 76.0 76.6 34.6 88.1 42.7 14.9 5.2 4.1 85.2 11.2 57.3 2.1 3.6 3.2 12.4 13.3 8.5 4.1 8.2 8.9 4.6 5.1 7.5 6.4 6.6 7.4 15.3 4.9 4.5 5.9 24.8 26.6 26.3 36.6 21.9 22.7 28.6 26.4 20.2 28.7 22.7 30.0 24.6 20.0 9.6 6.4 18.6 6.7 18.2 18.3 23.0 17.1 24.0 11.5 15.6 18.3 15.7 8.0 29.5 12.5 11.1 11.6 3.4 9.8 32.9 298.2 6.5 20.3 20.9 9.6 4.4 9.6 20.7 16.4 37.8 6.6 13.1 5.7 15.4 21.8 6.2 18.9 32.0 11.7 7.9 14.2 5.3 12.2 905.5 32.9 9.3 19.6 4.7 26.6 16.7 11.3 8.0 10.1 35.5 8.3 40.3 8.1 23.5 8.2 8.8 4.5 17.0 46.0 16.1 36.2 12.7 6.4 2.4 4.1 19.6 9.6 36.7 5.7 8.3 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 290000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 83.0 86.8 106.9 65.3 112.3 97.0 78.5 104.8 132.0 71.5 103.6 96.0 52.7 90.7 63.0 89.4 69.6 44.4 150.3 106.5 106.5 74.1 118.7 76.9 65.9 108.7 113.9 104.1 58.7 82.1 74.6 55.8 79.4 108.7 74.8 59.7 31.2 73.6 70.5 294.4 101.7 64.5 78.2 104.6 68.4 88.4 75.3 112.3 91.4 70.0 164.3 77.1 81.5 72.3 107.9 223.7 248.2 233.5 173.3 109.6 117.3 226.5 181.5 267.4 445.7 313.8 223.3 126.8 179.5 110.1 230.1 195.7 218.3 206.7 237.7 199.0 269.4 268.1 173.1 301.1 218.5 141.4 203.7 177.0 131.4 126.1 181.6 202.5 98.4 253.8 182.7 249.2 164.7 276.0 497.0 259.5 258.4 229.5 280.7 296.1 269.3 458.8 157.3 209.5 165.2 170.0 147.1 148.7 206.9 116.2 98.2 255.7 209.8 181.3 253.7 321.1 363.8 474.7 176.5 220.0 209.2 262.4 201.7 325.1 111.5 154.3 121.8 160.8 194.6 146.7 146.8 132.9 147.8 160.6 122.4 116.5 118.6 33.9 173.3 211.6 160.0 191.0 254.7 106.9 112.3 104.8 132.0 106.5 106.5 108.7 113.9 104.1 108.7 104.6 112.3 107.9 81.5 57.7 42.0 3.9 59.5 86.3 112.8 198.5 50.7 41.2 61.4 64.1 217.6 81.5 103.7 68.0 16.7 265.9 60.0 143.9 152.6 199.2 152.5 72.0 75.7 96.0 64.5 136.6 6.4 202.6 257.9 100.4 54.0 70.1 75.3 79.2 77.1 144.2 158.2 37.0 5.3 111.5 75.3 62.4 80.0 217.6 88.6 62.5 99.6 1.9 132.0 120.2 74.2 3.0 5.2 214.2 110.8 100.1 96.3 102.8 127.7 191.3 76.9 47.4 118.3 75.1 193.3 147.0 63.6 51.3 77.3 352.9 61.8 74.1 117.6 101.6 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437764-47449143 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 89.7;tongue: 33.4" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 63.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 238.7" "Low region specificity" "Detected in some" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 0.2 1.5 0.4 0.2 0.4 0.3 0.2 0.3 1.2 0.1 0.7 0.7 0.1 0.0 0.1 1.2 0.1 0.1 2.6 0.5 0.4 0.3 0.5 0.4 0.2 0.4 0.4 0.2 0.0 0.2 0.0 0.1 2.1 0.4 0.8 0.0 0.1 1.3 0.0 89.7 0.4 0.5 0.1 0.4 0.7 0.2 0.3 0.5 0.1 0.2 33.4 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.2 0.7 0.1 0.2 1.2 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 59.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 238.7 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.3 0.1 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 1.2 0.5 0.4 0.4 0.4 0.2 0.4 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 2.7 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.5 0.0 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.3 0.3 13.8 0.0 0.5 0.0 0.0 0.6 1.3 0.0 0.5 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.0 0.0 63.8 0.5 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.2 0.1 AGBL2 "CCP2, FLJ23598" ENSG00000165923 "ATP/GTP binding protein like 2" Q5U5Z8 11 47659591-47715389 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.7;testis: 12.6" "Cell type enhanced" "Detected in many" "Early spermatids: 37.5;Endometrial ciliated cells: 25.7;Respiratory ciliated cells: 77.2;Spermatocytes: 19.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.3;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007718 Uncertain NA NA "HPA007718: AB_1078110" "unprognostic (3.44e-5)" "unprognostic (1.16e-1)" "unprognostic (5.84e-2)" "unprognostic (5.33e-4)" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (9.83e-3)" "unprognostic (4.11e-2)" "unprognostic (5.56e-2)" "unprognostic (1.79e-1)" "unprognostic (8.24e-6)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (9.62e-2)" "unprognostic (1.17e-3)" 0.3 1.3 0.6 0.4 0.4 0.2 0.5 0.8 0.3 1.1 2.1 0.7 0.3 0.6 1.1 0.4 7.7 0.3 0.2 0.2 0.9 1.4 3.0 1.6 0.5 0.9 1.2 0.0 1.3 0.8 0.3 1.7 0.2 0.7 1.2 0.2 0.3 0.5 0.4 0.0 0.3 1.2 0.1 1.1 0.9 0.6 12.6 0.5 0.7 1.5 0.0 0.4 1.1 0.6 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.2 0.6 0.2 2.3 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.3 0.7 0.1 0.1 1.1 0.8 0.3 0.0 0.3 0.6 0.2 0.3 0.2 0.2 0.0 0.8 0.1 0.5 0.3 0.9 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.3 1.0 0.8 0.1 0.2 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.3 0.0 0.5 0.4 0.4 0.1 0.3 0.0 0.3 0.5 0.1 0.6 0.4 0.8 0.3 0.2 0.9 0.9 1.2 0.0 0.7 1.1 0.5 0.4 0.1 0.0 2.7 2.6 1.3 0.1 1.3 2.6 2.2 0.1 0.9 0.6 0.6 0.0 6.5 7.3 0.0 0.4 0.5 0.7 0.0 0.4 37.5 25.7 1.3 0.1 1.2 0.8 0.6 0.0 0.3 1.2 1.5 0.9 0.0 0.8 0.4 0.8 0.1 0.0 0.6 0.5 2.0 0.6 0.0 8.2 0.3 0.3 0.0 1.0 1.0 0.7 0.0 1.0 0.5 0.3 0.6 1.5 0.4 0.4 2.4 0.2 77.2 0.5 0.0 0.3 1.1 19.3 1.8 0.6 0.0 0.4 1.3 1.3 0.9 0.5 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779746-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 103.9" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 84.6" "Group enriched" "Detected in many" 47 "NK-cells: 39.2;T-cells: 84.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favorable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 12.1 2.3 0.6 14.3 0.8 5.2 27.9 0.2 0.7 9.6 1.9 16.6 12.2 11.5 5.2 21.7 11.9 25.4 6.1 0.2 2.6 5.3 2.9 14.5 22.1 2.8 0.4 0.2 6.6 103.9 20.0 7.0 1.6 1.6 17.4 15.4 0.5 46.9 7.8 3.1 13.7 14.6 5.9 1.7 11.2 25.1 5.9 0.5 11.6 12.6 1.3 24.8 18.6 14.0 0.8 9.2 1.5 0.0 0.0 1.6 0.0 12.2 0.0 0.2 0.0 0.0 6.5 19.1 6.0 0.4 0.1 0.2 1.0 9.0 9.0 0.0 0.1 4.7 0.0 2.4 0.0 0.0 0.0 0.0 0.2 9.3 0.0 0.5 0.0 0.0 0.5 0.1 4.7 0.0 16.3 0.0 0.0 1.3 63.8 0.0 0.1 0.0 0.0 4.3 37.3 7.0 0.0 0.8 43.9 0.0 2.4 22.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 38.4 0.1 84.6 0.7 42.0 49.0 0.1 0.2 33.6 28.7 1.3 39.2 0.2 0.2 14.8 22.5 0.6 0.8 0.2 0.7 0.2 2.6 2.8 0.4 0.2 1.6 1.7 0.5 0.8 10.0 41.7 79.6 0.7 12.4 53.4 31.3 38.1 33.6 0.4 94.3 34.3 0.9 48.6 73.1 25.8 0.0 1.0 39.6 50.2 1.9 73.3 18.5 51.4 13.6 10.9 31.8 1.7 14.4 211.7 3.6 21.2 124.4 118.6 7.0 2.5 5.7 0.6 0.3 0.0 1.8 58.5 48.8 3.0 12.7 32.7 56.8 4.0 60.5 10.3 3.1 3.5 53.5 0.5 1.6 91.7 40.0 12.8 15.6 49.1 13.6 7.5 81.0 0.1 0.0 13.2 4.5 33.8 11.8 45.4 82.5 5.5 111.0 0.1 51.7 86.8 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121969-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 14.9 14.7 7.3 25.2 9.6 11.6 11.9 9.5 10.2 13.8 12.5 16.2 14.8 15.1 15.1 18.4 11.8 15.1 13.2 7.0 9.6 13.7 19.9 14.8 21.2 9.7 9.2 6.1 12.7 15.0 18.4 10.8 16.8 10.5 15.8 17.0 14.0 13.7 14.3 27.4 11.1 14.5 17.9 8.9 18.8 17.5 26.2 8.2 27.5 18.5 25.8 25.0 16.8 12.4 12.4 48.1 46.9 47.0 48.6 23.9 21.1 69.5 60.7 59.0 55.1 54.3 41.4 64.9 51.3 38.9 65.1 37.2 69.2 65.2 55.2 79.2 83.3 22.4 75.4 46.1 39.5 70.5 76.3 60.6 34.7 46.2 52.5 93.8 36.5 52.2 54.5 68.8 62.9 62.1 69.6 88.3 26.8 53.3 76.8 42.3 86.0 72.7 45.9 37.5 67.1 51.7 34.7 71.7 39.9 51.1 41.9 82.9 47.4 56.3 43.9 27.7 33.4 52.4 37.6 66.2 103.0 53.0 58.9 69.7 16.6 12.9 9.3 7.8 11.7 10.4 7.6 6.9 8.4 11.3 4.0 6.1 8.6 4.4 11.1 9.8 7.3 12.1 9.5 7.3 9.6 9.5 10.2 7.0 9.6 9.7 9.2 6.1 10.5 8.9 8.2 12.4 14.2 28.9 31.8 23.2 22.9 10.3 15.2 15.1 15.9 12.7 13.4 9.5 27.1 10.0 25.5 7.3 29.2 24.0 19.8 14.6 13.7 18.0 28.2 24.3 30.0 22.9 13.8 33.0 13.6 24.0 22.7 20.0 17.3 16.8 30.4 26.2 20.7 27.2 24.8 11.8 17.5 17.3 12.2 32.9 8.8 11.2 19.0 31.1 3.6 19.7 41.2 16.9 27.8 18.6 27.9 23.8 14.0 23.0 35.4 29.9 12.5 16.3 34.1 22.7 32.9 19.6 23.2 61.7 41.3 27.2 12.8 25.3 22.8 26.6 18.2 20.2 SMCO2 "C12orf70, LOC341346" ENSG00000165935 "Single-pass membrane protein with coiled-coil domains 2" A6NFE2 12 27466810-27502185 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 14.8;Excitatory neurons: 9.4;Inhibitory neurons: 3.7;Late spermatids: 5.7;Prostatic glandular cells: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;HDLM-2: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA014366 Uncertain NA NA "HPA014366: AB_1845544" "unprognostic (2.64e-2)" "unprognostic (3.11e-1)" "unprognostic (1.33e-2)" "unprognostic (4.10e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (7.86e-3)" "unprognostic (5.44e-3)" "unprognostic (2.81e-1)" "unprognostic (8.86e-2)" "unprognostic (9.21e-5)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (5.48e-2)" "unprognostic (3.01e-1)" "unprognostic (3.65e-1)" "unprognostic (1.69e-1)" 0.0 0.1 0.8 0.4 0.7 0.0 0.1 0.4 0.9 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.7 0.5 0.0 0.2 0.1 0.1 0.5 1.1 0.6 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.3 0.9 1.5 0.1 0.0 0.0 0.4 0.2 0.3 0.8 0.9 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.6 0.0 1.4 0.0 0.3 0.0 0.5 0.2 0.1 0.2 0.4 2.2 0.0 0.0 0.5 0.0 0.0 0.8 0.1 0.4 0.2 0.3 1.2 0.3 0.7 0.3 0.0 0.6 0.0 0.1 0.3 0.9 0.3 0.6 0.7 0.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.6 0.3 0.7 1.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.4 0.9 0.7 0.5 0.5 1.1 0.6 0.6 0.4 1.5 0.8 0.2 0.0 0.0 0.3 0.0 0.3 0.6 0.4 0.0 0.0 0.1 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 14.8 0.2 0.0 0.2 0.0 0.0 9.4 0.8 0.1 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 1.1 5.7 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.4 0.0 4.4 0.2 0.4 0.3 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.3 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182199-93184923 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000939, HPA076948" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA000939: AB_1079402, HPA076948: " "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favorable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 16.9 32.5 33.3 11.4 43.0 40.9 19.2 22.0 56.8 26.1 15.3 30.3 14.0 21.0 27.1 17.6 24.2 17.3 56.3 45.4 52.8 31.0 20.5 21.7 19.5 31.4 38.1 45.2 19.3 19.4 46.0 37.3 16.4 39.8 32.7 16.1 93.2 21.0 30.9 44.6 17.4 22.4 22.5 23.7 19.3 26.8 10.4 41.6 23.4 24.3 34.9 17.7 24.3 12.4 75.6 9.8 8.2 19.1 25.0 16.3 6.4 11.1 10.2 14.4 12.4 11.5 8.4 8.9 30.4 19.7 14.6 8.5 16.5 13.9 12.7 13.9 10.7 15.8 16.2 17.4 11.5 19.7 15.8 25.0 9.3 18.4 7.6 13.4 30.3 15.9 35.6 6.2 15.6 11.5 40.4 24.1 10.8 7.5 20.8 8.6 12.7 23.3 14.7 29.4 28.7 36.7 31.0 9.1 16.4 48.4 14.8 25.3 12.1 14.6 4.1 5.6 9.9 5.1 30.9 31.3 15.1 12.8 10.2 7.5 53.5 5.9 19.6 15.5 6.9 19.8 6.8 19.1 19.4 6.2 11.9 23.1 21.1 6.1 16.1 8.8 5.4 16.6 12.1 33.3 43.0 22.0 56.8 45.4 52.8 31.4 38.1 45.2 39.8 23.7 41.6 75.6 20.4 32.1 32.1 11.8 21.8 16.2 18.2 11.4 13.1 91.8 18.7 12.4 71.9 24.3 13.9 20.2 50.1 28.9 33.7 10.2 41.1 36.2 4.7 26.5 15.3 18.2 48.5 9.9 37.4 15.1 5.7 16.3 12.2 60.6 27.8 36.0 16.8 8.2 16.5 84.1 35.0 21.0 34.6 13.7 9.8 1.7 17.7 15.9 12.4 12.2 16.1 85.4 50.4 18.1 16.3 22.3 7.5 27.4 15.8 21.2 15.7 19.4 7.5 96.0 19.7 15.5 21.8 27.9 22.2 10.5 15.5 47.7 28.2 23.7 16.2 23.9 IFI27L1 FAM14B ENSG00000165948 "Interferon alpha inducible protein 27 like 1" Q96BM0 14 94081301-94103846 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 98.4" "Cell type enhanced" "Detected in all" "Early spermatids: 328.4;Late spermatids: 160.8;Theca cells: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 16.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 202.4" NA NA "unprognostic (7.89e-3)" "unprognostic (1.47e-1)" "unprognostic (6.31e-2)" "unprognostic (8.54e-3)" "unprognostic (2.53e-1)" "unprognostic (4.81e-2)" "unprognostic (1.84e-2)" "unprognostic (2.63e-1)" "unprognostic (3.68e-1)" "unprognostic (7.63e-3)" "unprognostic (2.50e-1)" "unprognostic (2.00e-1)" "unprognostic (3.90e-2)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" "unprognostic (5.93e-3)" "unprognostic (2.92e-1)" 15.2 51.4 27.1 6.6 26.4 20.1 13.3 27.1 31.9 10.6 30.4 14.1 12.0 10.2 23.2 11.6 11.3 9.5 16.9 26.5 29.4 14.4 10.7 14.1 6.8 27.7 27.7 25.9 28.7 9.6 12.9 13.4 4.5 28.5 7.6 14.0 17.4 11.9 7.2 20.3 13.2 12.7 9.7 26.8 12.7 16.7 98.4 29.5 13.1 9.2 14.5 10.3 6.7 11.1 27.8 16.8 16.3 23.9 23.7 29.6 27.2 10.9 20.2 21.8 19.5 47.0 5.5 38.1 16.1 31.5 16.5 20.4 17.7 3.5 12.0 13.9 43.0 20.0 14.1 34.4 10.9 14.4 16.9 15.6 25.3 14.0 22.0 15.6 33.0 15.7 70.8 28.8 202.4 32.3 14.6 18.5 16.0 8.1 32.3 13.9 33.6 21.1 25.4 23.4 3.1 20.7 11.3 35.1 15.8 29.4 16.0 22.4 27.3 17.4 9.6 7.4 19.0 15.2 43.6 46.3 24.4 31.4 18.4 12.3 16.2 1.6 2.3 2.3 1.8 2.1 2.4 4.0 3.2 1.5 2.8 2.7 3.3 0.8 3.9 1.6 4.6 5.4 1.6 27.1 26.4 27.1 31.9 26.5 29.4 27.7 27.7 25.9 28.5 26.8 29.5 27.8 28.7 28.9 13.7 15.7 15.3 17.1 22.9 34.4 18.2 17.9 20.7 21.5 18.8 14.3 23.0 20.2 10.4 19.3 11.1 53.5 27.4 27.4 328.4 33.7 14.4 20.1 15.5 12.8 4.6 26.7 14.0 26.5 23.4 18.8 5.7 72.2 30.4 14.3 35.7 13.5 5.5 59.4 44.7 10.0 12.2 160.8 42.6 11.8 26.6 3.7 5.5 44.6 14.4 6.0 7.5 26.2 43.5 57.2 44.7 13.6 88.1 33.5 20.0 30.1 13.1 11.7 17.6 30.0 39.0 21.6 14.2 7.1 14.0 125.3 31.6 23.8 IFI27 "FAM14D, ISG12, P27" ENSG00000165949 "Interferon alpha inducible protein 27" P40305 14 94104836-94116698 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 3792.9;Distal enterocytes: 2150.5;Endothelial cells: 1972.1;Exocrine glandular cells: 1603.8;Intestinal goblet cells: 1638.8;Pancreatic endocrine cells: 1678.1;Paneth cells: 2179.2;Proximal enterocytes: 3048.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 7.0" "Group enriched" "Detected in many" 6 "monocytes: 7.0;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 2026.8;BJ hTERT+ SV40 Large T+ RasG12V: 1782.5;EFO-21: 547.7;Karpas-707: 501.5;SK-MEL-30: 607.2" HPA028875 Uncertain NA NA "HPA028875: AB_10601434" "unprognostic (1.15e-1)" "unprognostic (1.19e-1)" "unprognostic (2.43e-2)" "unprognostic (6.68e-2)" "unprognostic (4.74e-2)" "unprognostic (1.59e-2)" "unprognostic (6.78e-3)" "unprognostic (5.26e-2)" "unprognostic (2.10e-1)" "prognostic favorable (8.80e-4)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.65e-1)" 436.4 326.0 174.4 116.8 161.2 164.6 413.8 163.4 234.5 232.8 151.6 378.0 130.4 138.9 40.3 313.1 164.6 347.2 354.7 153.6 172.5 219.5 151.6 613.5 48.7 184.4 161.9 147.4 76.3 39.6 30.5 65.8 185.3 185.3 85.7 223.5 6.2 158.1 47.4 114.1 130.8 258.4 118.4 175.6 804.2 703.1 141.2 171.9 204.7 151.0 153.8 54.7 117.9 215.5 181.3 181.3 0.4 1.3 0.4 0.5 21.7 1.7 2.8 8.8 2026.8 1782.5 3.8 146.8 1.5 547.7 115.3 33.8 5.7 1.1 0.2 79.7 2.1 3.7 1.0 1.4 0.9 13.7 0.6 1.1 2.0 2.0 353.8 0.1 1.1 284.0 1.3 1.1 501.5 0.1 0.5 1.7 1.1 0.5 0.5 24.7 1.8 0.5 0.6 1.2 0.6 0.4 1.1 0.0 0.1 607.2 1.4 0.9 3.0 0.3 0.2 2.7 325.8 1.0 9.4 14.6 3.9 0.9 0.5 1.4 0.0 1.3 0.5 0.3 7.0 0.3 0.0 2.6 0.7 0.8 0.1 0.0 0.4 0.0 0.4 2.1 0.1 2.5 2.1 174.4 161.2 163.4 234.5 153.6 172.5 184.4 161.9 147.4 185.3 175.6 171.9 181.3 3792.9 391.0 82.7 1.3 26.8 171.2 6.5 126.9 91.6 4.9 23.4 38.2 45.9 151.5 237.4 12.9 8.4 7.3 14.9 2150.5 1.9 50.6 13.6 1035.5 188.3 1972.1 267.8 42.3 0.6 1603.8 221.2 330.8 892.5 838.5 45.1 1174.4 742.5 5.8 158.3 5.0 0.4 1638.8 107.8 106.9 163.5 36.7 172.1 59.6 350.4 84.3 26.1 8.3 0.0 0.0 0.7 1678.1 2179.2 417.5 6.3 11.1 3048.1 23.7 548.1 20.5 276.1 45.2 295.8 20.3 12.1 151.9 140.4 5.2 34.1 302.4 523.4 80.4 SERPINA12 "OL-64, Vaspin" ENSG00000165953 "Serpin family A member 12" Q8IW75 14 94487274-94517844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 344.3" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 20.9" "Group enriched" "Detected in some" 5 "liver cancer: 1.8;melanoma: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "Hep G2: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 6500000 "unprognostic (1.82e-3)" "unprognostic (6.44e-2)" "unprognostic (3.25e-1)" "unprognostic (1.00e-2)" "unprognostic (5.98e-2)" "unprognostic (2.97e-2)" "unprognostic (7.64e-3)" "unprognostic (6.67e-2)" 0.2 0.0 0.0 0.0 0.0 0.1 28.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 344.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319908 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.2" "Cell type enhanced" "Detected in many" "Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 11.2 1.2 11.9 4.3 31.9 1.1 11.0 7.3 20.2 7.6 3.0 11.6 3.0 4.9 7.5 2.9 9.3 5.8 4.3 10.4 13.7 13.4 14.2 4.9 1.3 22.7 23.4 5.0 2.9 17.4 1.7 3.0 2.3 29.9 7.0 12.9 9.9 9.2 5.1 3.8 3.0 6.8 2.9 6.5 3.0 7.3 33.0 27.5 1.1 6.0 5.5 1.7 4.8 7.0 63.2 6.3 8.4 1.3 0.2 4.9 2.2 0.5 0.1 0.0 0.4 0.3 0.7 10.5 0.0 0.9 0.0 13.8 5.5 0.6 3.7 0.0 4.3 1.5 0.2 0.3 5.0 0.5 0.0 0.1 2.4 3.6 1.6 5.8 1.9 4.2 2.3 0.0 1.2 3.0 5.6 0.3 0.5 0.5 7.7 2.0 4.8 4.4 2.8 3.9 10.3 1.7 1.6 2.1 16.0 8.2 1.2 13.5 0.4 1.2 0.1 3.6 0.0 0.3 1.6 0.1 5.8 2.9 2.5 15.5 7.3 6.9 0.6 0.0 2.4 0.0 3.0 0.0 0.0 1.4 1.5 0.0 0.1 5.7 0.0 1.5 2.4 0.0 2.1 11.9 31.9 7.3 20.2 10.4 13.7 22.7 23.4 5.0 29.9 6.5 27.5 63.2 12.9 16.0 3.4 21.9 18.0 6.2 39.2 11.7 37.0 61.8 39.0 22.2 58.6 42.9 17.3 58.8 14.6 2.5 3.5 93.1 27.4 53.1 161.8 76.7 16.9 11.4 23.4 0.4 9.3 47.5 1.8 12.2 33.6 37.3 4.5 0.4 2.2 81.9 7.3 38.7 11.5 72.5 8.2 11.9 7.2 313.5 22.4 15.6 3.6 1.0 17.1 3.5 0.0 5.0 418.6 40.1 44.1 10.9 21.9 62.3 15.9 21.0 115.6 28.2 105.2 4.8 100.6 4.2 15.3 7.1 2.6 2.9 2.8 0.2 50.2 51.5 PDZRN4 "DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4" ENSG00000165966 "PDZ domain containing ring finger 4" Q6ZMN7 12 41188320-41574745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 18.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 371.6;Inhibitory neurons: 125.6;Oligodendrocyte precursor cells: 561.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "U-266/70: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042101 Enhanced Approved Mitochondria NA NA Mitochondria "HPA042101: AB_2732496" "unprognostic (6.74e-2)" "unprognostic (6.86e-2)" "unprognostic (3.82e-2)" "unprognostic (2.88e-2)" "unprognostic (1.49e-1)" "unprognostic (5.34e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-2)" "unprognostic (8.19e-2)" "unprognostic (7.85e-3)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" "unprognostic (7.44e-2)" "unprognostic (1.90e-3)" "unprognostic (1.80e-1)" "unprognostic (7.33e-2)" "unprognostic (1.41e-3)" 1.2 0.9 1.1 1.1 2.2 0.0 2.0 0.3 2.2 2.2 0.2 7.9 0.8 0.9 2.2 3.9 2.2 1.7 0.4 1.5 1.0 0.5 0.6 0.3 0.0 1.7 2.8 1.2 1.9 0.4 0.2 0.4 4.0 1.6 6.6 3.1 1.0 0.3 18.0 0.3 0.5 2.9 2.5 1.1 0.2 3.3 2.4 1.5 0.0 0.3 1.9 0.3 3.9 2.6 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 0.3 2.2 1.5 1.0 1.7 2.8 1.2 1.6 1.1 1.5 2.0 0.1 0.0 0.0 37.5 0.3 0.8 0.0 0.0 2.8 9.8 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.3 0.0 0.0 371.6 0.0 0.2 17.3 1.1 0.0 0.0 19.8 1.4 0.0 0.4 0.0 125.6 0.0 0.0 0.0 0.3 1.6 28.0 0.2 0.0 5.6 0.0 0.4 0.0 561.9 13.7 0.0 0.0 56.4 1.2 0.1 0.0 0.0 0.7 1.1 0.0 0.1 5.7 0.1 0.2 0.8 0.6 0.4 0.0 34.1 0.0 0.1 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599594-20659285 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "brain: 20.2" "Group enriched" "Detected in some" 39 "Early spermatids: 20.6;Late spermatids: 66.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "medulla oblongata: 20.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "pons and medulla: 49.3" "Group enriched" "Detected in many" 8 "medulla oblongata: 30.5;spinal cord: 18.3" CAB079052 Supported NA NA "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.0 3.6 0.0 1.1 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 20.2 0.6 0.0 0.0 0.0 0.0 0.6 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.1 1.2 1.2 0.1 0.0 20.2 0.6 0.0 18.4 7.7 6.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 66.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC38 FLJ40089 ENSG00000165972 "Coiled-coil domain containing 38" Q502W7 12 95867048-95942635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.0" "Group enriched" "Detected in some" 31 "Early spermatids: 93.8;Late spermatids: 33.8;Spermatocytes: 60.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (7.54e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-1)" "unprognostic (5.22e-2)" "unprognostic (1.61e-3)" "unprognostic (3.29e-1)" "unprognostic (5.11e-2)" "unprognostic (8.37e-2)" "unprognostic (1.17e-3)" "unprognostic (2.25e-2)" "unprognostic (2.32e-1)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (4.96e-5)" "unprognostic (1.08e-2)" 0.1 0.7 0.3 0.2 0.2 0.7 0.1 1.1 0.4 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.3 0.2 0.3 2.8 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.5 0.2 0.0 0.8 0.2 0.1 0.1 0.0 0.7 0.1 17.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.6 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.1 0.3 0.2 0.2 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.7 0.2 0.2 0.4 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.0 0.3 0.4 0.2 0.2 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.0 0.3 0.2 1.1 0.4 0.3 0.2 0.2 0.1 0.1 0.4 0.0 0.1 0.6 0.4 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 93.8 0.1 0.1 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.0 0.1 0.0 1.3 0.0 0.0 0.3 0.0 33.8 1.2 0.2 0.0 0.0 0.0 0.5 0.0 1.5 0.9 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 60.7 1.8 0.0 0.0 0.1 0.3 0.1 0.0 0.1 NELL1 "FLJ45906, IDH3GL" ENSG00000165973 "Neural EGFL like 1" Q92832 11 20669551-21575686 "Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;kidney: 16.8" "Group enriched" "Detected in some" 9 "Excitatory neurons: 279.0;Inhibitory neurons: 175.8;Oligodendrocyte precursor cells: 323.2" "Cancer enhanced" "Detected in many" "melanoma: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051535 Approved "Secreted in other tissues" NA NA 160000 "HPA051535: AB_2681524" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.29e-2)" "unprognostic (5.35e-4)" "unprognostic (3.78e-4)" "unprognostic (1.67e-2)" "unprognostic (3.91e-1)" "unprognostic (4.38e-2)" "unprognostic (4.65e-2)" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" "unprognostic (4.23e-2)" "unprognostic (1.83e-1)" "unprognostic (2.29e-1)" 0.1 0.1 3.7 0.1 6.5 0.0 0.0 0.1 9.3 0.3 0.0 0.2 0.0 0.3 1.6 0.6 0.1 0.4 0.0 9.3 5.2 16.8 0.0 0.4 0.0 3.2 1.8 5.2 0.1 0.0 0.0 3.5 0.0 3.0 5.1 0.3 0.8 0.4 2.5 0.0 0.6 0.1 0.1 0.0 0.1 0.6 1.0 2.7 1.2 0.0 0.3 0.7 0.1 0.6 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.0 0.0 0.7 0.0 0.0 0.1 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.5 0.1 9.3 9.3 5.2 3.2 1.8 5.2 3.0 0.0 2.7 6.6 0.1 0.0 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.8 0.7 0.0 0.0 1.8 0.0 0.8 0.0 0.0 5.9 0.0 28.8 0.8 0.1 0.0 0.0 0.0 279.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 175.8 0.0 0.0 0.0 0.0 22.3 0.3 0.0 0.0 13.1 0.0 0.0 0.0 323.2 7.6 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.2 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.2 PTER ENSG00000165983 "Phosphotriesterase related" Q96BW5 10 16436943-16513745 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.8" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 190.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038044, HPA038045" Approved Approved Nucleoplasm,Cytosol NA NA 8600 Nucleoplasm Cytosol "HPA038044: AB_2675803, HPA038045: AB_10672616" "unprognostic (5.57e-2)" "unprognostic (1.04e-1)" "unprognostic (2.76e-2)" "unprognostic (3.14e-2)" "unprognostic (9.72e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.17e-1)" "unprognostic (4.51e-2)" "unprognostic (2.86e-1)" "unprognostic (2.05e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.52e-6)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.54e-2)" "unprognostic (5.36e-3)" 6.9 5.5 6.6 5.6 17.7 2.3 10.4 1.2 8.5 6.0 0.0 8.4 12.9 4.9 4.5 4.6 5.1 5.3 7.2 12.7 4.5 31.8 14.1 6.0 8.0 0.0 0.0 7.6 2.1 7.5 9.3 1.3 5.6 0.0 7.1 8.1 11.9 8.4 4.6 9.3 5.5 10.0 3.4 0.0 7.0 14.3 1.1 2.3 7.4 10.7 10.1 8.0 9.0 3.8 0.8 26.9 11.7 0.1 4.8 7.0 13.0 14.7 6.9 0.7 2.6 3.5 10.7 20.9 25.0 5.9 4.5 1.2 11.4 8.3 4.3 4.3 30.2 9.9 24.9 6.1 5.6 7.2 8.2 8.0 8.2 17.0 8.0 1.3 0.1 1.5 22.9 17.5 8.4 4.1 7.8 17.8 9.5 5.7 15.9 2.5 13.7 2.4 13.1 43.2 6.4 22.7 1.4 12.5 3.7 23.3 5.2 8.6 30.4 3.4 0.2 6.3 5.5 0.1 6.3 7.6 25.2 3.3 14.7 8.7 3.4 7.2 4.7 7.5 11.6 8.1 9.2 8.8 8.1 7.6 5.8 6.8 7.1 2.2 5.6 10.3 6.7 14.2 5.9 6.6 17.7 1.2 8.5 12.7 4.5 0.0 0.0 7.6 0.0 0.0 2.3 0.8 12.1 28.9 26.3 2.9 13.5 11.0 14.7 7.7 9.6 0.9 13.6 9.4 29.5 15.7 20.6 29.5 0.0 19.6 10.2 19.5 52.8 22.5 0.3 10.7 5.5 8.3 11.5 9.4 0.5 34.4 18.7 10.2 41.8 17.8 24.1 5.1 11.4 24.3 15.6 0.0 0.2 13.1 18.3 17.1 6.5 0.3 0.9 12.3 8.8 10.3 14.6 13.9 33.0 0.0 0.2 26.8 26.7 0.0 8.1 11.4 19.8 190.5 14.4 9.9 6.6 7.7 16.0 1.1 6.5 7.6 12.4 12.0 13.2 3.0 19.2 22.2 C1QL3 "C1ql, C1QTNF13, CTRP13, K100" ENSG00000165985 "Complement C1q like 3" Q5VWW1 10 16513734-16521879 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 49.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.5;Excitatory neurons: 4.8;Oligodendrocyte precursor cells: 1.0;Rod photoreceptor cells: 2.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 28.1;basal ganglia: 44.2;cerebral cortex: 35.5;hippocampal formation: 49.4;olfactory bulb: 31.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 32.3;SCLC-21H: 19.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 72.1;cerebral cortex: 57.7;hippocampal formation: 51.2" "Secreted in brain" NA NA "unprognostic (7.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (8.19e-3)" "unprognostic (6.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.76e-2)" "unprognostic (2.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "prognostic favorable (6.29e-5)" "unprognostic (3.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.59e-2)" "unprognostic (6.12e-2)" 0.8 0.9 28.1 0.4 44.2 0.1 0.3 0.6 35.5 0.2 0.0 0.2 1.8 0.2 0.0 0.2 0.2 0.1 0.8 49.4 6.4 1.2 0.3 0.4 0.7 2.8 0.1 31.2 0.0 0.4 0.0 0.1 0.1 1.0 0.5 0.0 7.5 0.6 0.0 1.2 1.0 0.7 0.0 0.0 0.5 0.5 0.0 5.6 0.0 1.0 0.1 0.0 0.3 0.2 5.1 0.1 1.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 2.1 1.1 3.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.3 0.3 1.9 1.3 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.2 0.2 0.1 1.2 1.2 0.1 1.2 0.3 1.9 0.1 0.7 19.3 1.7 1.8 0.2 1.1 0.3 0.1 0.3 0.0 0.0 0.1 0.9 0.0 0.7 1.1 0.9 0.1 1.8 0.8 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.3 0.3 0.1 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.4 0.1 28.1 44.2 0.6 35.5 49.4 6.4 2.8 0.1 31.2 1.0 0.0 5.6 5.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNB2 "CACNLB2, MYSB" ENSG00000165995 "Calcium voltage-gated channel auxiliary subunit beta 2" Q08289 10 18140424-18543557 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5" "Group enriched" "Detected in many" 5 "Astrocytes: 863.5;Excitatory neurons: 545.7;Inhibitory neurons: 357.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.4;HSkMC: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035326 Enhanced NA NA "HPA035326: AB_10669903" "unprognostic (3.03e-3)" "unprognostic (3.04e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (4.58e-3)" "unprognostic (4.67e-4)" "unprognostic (8.03e-2)" "unprognostic (3.76e-2)" "unprognostic (8.10e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-4)" "unprognostic (1.40e-1)" "prognostic favorable (3.56e-5)" "unprognostic (3.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.03e-1)" "unprognostic (8.16e-2)" 2.6 9.5 1.6 2.2 4.4 1.3 3.8 6.0 13.6 7.1 0.2 14.3 1.2 12.9 2.7 5.0 10.2 2.2 16.3 5.3 5.3 3.0 10.8 3.9 0.9 0.0 0.3 4.4 13.7 7.6 0.6 19.5 0.5 2.1 8.6 3.2 35.5 3.9 8.9 1.1 3.6 11.5 5.3 0.0 1.5 7.8 2.1 1.4 0.7 2.5 0.7 0.2 16.9 4.6 2.2 0.2 1.0 0.7 0.5 0.3 0.3 0.5 0.3 0.0 0.0 0.3 0.4 0.5 0.9 0.2 0.2 0.3 0.7 6.4 0.0 0.0 0.3 2.4 0.8 1.7 1.5 1.6 0.5 1.5 8.1 0.0 0.0 0.0 0.3 0.0 1.4 0.9 1.6 0.0 0.7 0.8 1.0 2.4 0.0 0.0 0.7 0.7 0.8 0.0 0.8 2.9 0.8 0.1 0.0 0.4 0.8 0.1 0.9 0.0 0.6 1.5 0.3 0.6 1.6 1.8 1.7 0.2 1.2 0.3 1.4 0.1 0.2 0.2 0.2 0.4 0.4 0.3 0.1 0.0 0.5 0.5 0.8 0.1 0.3 0.2 0.2 1.1 0.0 1.6 4.4 6.0 13.6 5.3 5.3 0.0 0.3 4.4 2.1 0.0 1.4 2.2 2.1 0.0 0.6 863.5 0.1 3.3 1.3 0.0 1.8 31.9 1.1 1.3 22.4 0.0 0.0 0.0 108.4 0.4 0.7 2.8 1.9 0.4 0.9 1.1 13.9 1.5 37.1 0.8 545.7 0.2 0.0 3.0 0.0 2.6 0.0 3.8 0.0 0.9 0.1 8.4 357.8 9.4 0.0 0.0 1.1 0.8 0.9 0.5 1.8 96.5 0.0 15.9 0.0 95.5 13.7 0.2 2.4 4.5 0.3 2.1 5.9 0.8 0.0 75.7 6.6 2.6 14.2 0.1 0.1 0.0 4.1 0.3 1.0 5.3 5.7 1.3 HACD1 "CAP, PTPLA" ENSG00000165996 "3-hydroxyacyl-CoA dehydratase 1" B0YJ81 10 17589032-17617374 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Developmental protein, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 64.8" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 143.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "T-reg: 55.7" "Lineage enriched" "Detected in many" 12 "T-cells: 55.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-1)" "unprognostic (2.62e-2)" "unprognostic (4.10e-1)" "unprognostic (5.67e-3)" "unprognostic (4.21e-2)" "unprognostic (3.04e-2)" "unprognostic (2.38e-1)" "unprognostic (1.70e-2)" "unprognostic (2.61e-2)" "unprognostic (3.43e-1)" "unprognostic (2.46e-2)" "unprognostic (2.93e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (6.49e-2)" 9.3 7.1 3.6 5.1 3.8 8.1 8.9 10.5 4.7 6.2 3.5 22.6 2.9 22.3 3.3 7.9 10.4 3.6 64.8 3.4 5.6 3.1 1.6 9.8 1.3 5.3 4.9 3.7 4.3 2.7 0.5 3.8 1.6 5.8 12.0 3.9 2.3 2.7 16.9 36.8 3.1 7.0 25.6 3.0 1.7 15.2 3.6 5.3 2.6 7.7 16.6 1.3 18.2 6.9 8.8 29.3 24.6 6.8 33.4 30.1 5.8 0.6 40.5 24.4 51.9 48.5 16.4 34.6 0.2 5.9 66.4 74.5 7.1 17.3 12.3 28.6 19.1 10.4 67.1 18.4 45.6 39.0 0.3 4.8 14.0 17.2 29.9 11.6 39.8 10.1 35.1 0.6 1.3 69.0 21.0 50.4 6.7 14.6 2.2 6.6 44.7 7.1 0.8 20.5 5.6 7.5 19.1 34.6 0.6 58.9 21.2 24.2 16.7 9.8 30.3 17.4 18.7 18.8 0.9 0.8 0.3 22.3 7.7 4.3 4.7 0.9 0.7 1.2 0.1 0.3 0.4 5.0 1.0 3.0 1.3 0.9 0.7 2.6 3.3 0.3 1.5 55.7 1.3 3.6 3.8 10.5 4.7 3.4 5.6 5.3 4.9 3.7 5.8 3.0 5.3 8.8 2.4 28.9 15.0 0.3 0.4 0.0 23.1 0.0 8.0 0.8 6.9 21.6 143.7 10.0 2.5 31.3 0.0 0.5 4.4 0.4 3.9 16.5 11.1 5.6 8.0 5.4 3.6 29.2 10.4 8.0 1.9 7.1 8.2 12.4 6.3 17.5 20.7 1.0 5.4 0.0 11.7 2.5 0.0 2.2 0.0 2.7 1.8 3.6 0.0 5.6 0.8 0.5 1.0 2.5 31.8 15.6 0.8 0.7 0.6 23.9 0.5 2.3 0.7 0.6 0.0 5.7 32.5 7.4 5.2 17.7 0.0 3.0 2.9 10.8 3.5 6.2 ARL5B ARL8 ENSG00000165997 "ADP ribosylation factor like GTPase 5B" Q96KC2 10 18659431-18681639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 314.7;Langerhans cells: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027002 Approved NA NA "HPA027002: AB_10601685" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (4.04e-2)" "unprognostic (4.32e-2)" "unprognostic (1.77e-2)" "unprognostic (7.86e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (8.34e-2)" "unprognostic (6.54e-2)" "unprognostic (1.83e-1)" "unprognostic (7.54e-2)" "unprognostic (2.62e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" 8.7 21.0 3.9 7.8 4.0 19.8 6.6 6.5 6.2 8.1 4.8 7.6 9.4 9.4 3.7 8.6 4.8 14.2 5.7 3.8 6.6 5.8 30.1 9.8 7.1 4.0 4.3 3.3 8.0 9.1 6.2 6.8 13.2 4.2 6.4 8.5 5.7 7.3 3.6 4.3 6.5 10.1 6.7 4.7 5.7 6.5 5.8 4.9 13.6 8.3 6.2 7.2 12.7 6.0 4.8 14.8 8.1 36.5 14.2 10.4 11.9 22.1 12.5 6.0 11.8 19.9 26.7 12.4 18.3 5.0 6.5 7.6 14.2 25.5 9.1 15.0 5.9 19.5 18.4 9.5 38.2 26.7 8.8 10.3 11.9 12.4 11.3 12.3 11.5 18.7 13.8 23.7 19.0 9.4 7.0 21.1 6.4 25.2 15.4 3.5 26.1 23.8 12.0 10.5 12.7 4.7 30.4 9.6 10.0 17.9 27.9 5.9 10.1 12.7 6.7 20.5 12.9 10.6 10.1 13.8 24.9 6.7 7.3 6.2 1.2 0.7 0.5 0.5 0.8 0.7 0.5 0.5 0.6 0.9 0.5 0.8 0.6 0.9 1.0 0.5 0.5 0.7 0.5 3.9 4.0 6.5 6.2 3.8 6.6 4.0 4.3 3.3 4.2 4.7 4.9 4.8 70.1 38.5 26.0 10.4 36.1 152.3 76.0 42.9 122.9 9.9 84.3 50.4 16.7 21.5 36.9 9.2 6.2 26.7 53.5 96.8 5.9 25.9 74.5 117.1 52.1 54.5 65.4 16.4 12.4 15.8 39.1 44.9 72.9 314.7 101.1 26.6 15.7 44.8 13.4 10.1 12.1 65.2 14.2 25.3 304.3 15.8 6.8 94.1 58.7 12.2 8.0 9.1 7.2 19.1 14.7 20.8 81.6 5.7 49.0 63.8 58.5 8.1 34.5 7.4 6.6 41.9 50.8 27.8 15.5 134.6 167.1 43.2 47.1 21.5 43.5 153.1 SMCO4 "C11orf75, FN5" ENSG00000166002 "Single-pass membrane protein with coiled-coil domains 4" Q9NRQ5 11 93478472-93543391 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 197.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 211.3;Paneth cells: 165.3;Proximal enterocytes: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 113.7" "Low region specificity" "Detected in all" HPA041120 Uncertain NA Yes "HPA041120: AB_2677309" "unprognostic (7.45e-2)" "unprognostic (1.70e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-1)" "unprognostic (6.47e-2)" "unprognostic (8.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.43e-1)" "unprognostic (5.51e-1)" "unprognostic (4.23e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (5.81e-7)" "unprognostic (1.61e-1)" "unprognostic (3.05e-1)" "unprognostic (1.55e-2)" "unprognostic (5.01e-2)" 18.4 71.0 9.0 30.9 8.4 7.4 23.2 8.2 12.7 16.8 16.0 35.6 46.3 19.1 14.0 23.3 28.2 17.0 52.9 10.0 18.1 46.7 136.2 36.1 31.7 10.4 11.2 7.3 25.5 60.5 5.8 48.3 11.5 10.9 55.6 26.0 3.4 197.5 11.6 17.1 20.9 37.9 15.4 11.4 62.3 50.6 43.8 25.0 17.7 72.3 6.0 23.0 12.5 23.0 13.6 8.3 15.3 23.9 5.5 8.0 10.6 15.4 25.2 7.5 10.8 19.9 26.6 33.0 24.6 29.0 22.1 16.8 5.0 24.1 3.5 7.3 68.6 22.2 5.9 32.4 58.0 7.4 24.4 26.1 15.0 13.2 5.0 3.8 13.6 16.7 81.5 13.8 113.7 3.3 13.9 24.4 50.2 25.0 62.6 23.9 42.8 12.0 11.2 21.5 19.8 4.2 18.5 19.6 26.3 2.1 30.2 10.4 33.7 10.9 9.7 40.6 33.4 20.8 4.6 0.7 19.7 7.6 40.9 4.9 40.2 263.5 6.9 4.1 316.4 18.4 25.0 26.9 8.0 150.3 26.9 3.7 3.2 61.4 32.0 296.3 155.5 11.7 91.5 9.0 8.4 8.2 12.7 10.0 18.1 10.4 11.2 7.3 10.9 11.4 25.0 13.6 26.0 25.6 18.4 0.3 11.5 32.8 33.4 17.4 6.2 2.1 62.0 50.5 36.7 70.1 17.2 49.7 0.0 6.6 27.7 105.1 211.3 43.2 123.5 14.3 2.9 24.9 44.9 6.1 4.8 70.2 9.0 19.0 27.5 16.1 2.5 21.3 15.7 103.9 140.4 3.3 10.6 116.4 6.1 91.3 80.3 146.8 12.8 87.7 30.2 13.1 123.3 6.4 11.3 0.5 4.4 31.1 165.3 10.5 15.0 92.8 200.0 64.8 9.6 1.3 6.6 4.2 14.1 11.2 46.6 16.6 21.3 4.8 15.0 6.4 58.7 47.3 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661682-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106" "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 6.1 5.8 8.2 6.4 8.8 16.1 8.3 14.8 10.5 7.5 5.5 7.8 6.3 7.1 7.5 5.8 6.9 5.2 5.3 8.0 7.4 6.2 5.1 6.1 11.2 7.3 7.2 7.9 8.4 6.7 4.7 8.5 6.3 8.8 8.4 6.9 14.9 5.5 5.3 5.4 9.0 7.5 5.5 5.3 9.5 6.2 12.2 8.0 10.3 8.8 5.8 7.5 7.8 6.7 10.8 10.5 9.4 23.9 20.4 10.8 10.4 11.6 13.2 9.7 12.2 14.2 17.3 19.2 3.1 19.1 8.3 16.9 18.7 11.8 9.5 12.4 15.0 9.4 19.0 28.2 8.6 6.5 17.1 17.4 7.7 5.6 11.6 10.0 11.5 10.4 16.9 21.6 19.4 15.8 8.8 8.9 28.1 7.5 19.6 9.7 17.7 22.6 12.6 10.1 17.9 13.9 12.9 20.9 13.8 3.7 14.8 22.8 9.4 9.6 11.3 14.8 20.9 10.1 6.9 16.7 20.2 6.7 19.7 15.9 3.3 1.7 3.6 1.5 0.9 1.2 3.2 1.3 1.0 0.8 3.5 1.6 1.4 5.2 1.6 1.3 1.7 1.1 0.4 8.2 8.8 14.8 10.5 8.0 7.4 7.3 7.2 7.9 8.8 5.3 8.0 10.8 10.9 9.6 14.3 24.2 14.0 0.0 3.3 0.0 5.2 30.5 7.0 8.9 9.4 5.7 5.6 5.5 27.1 12.8 8.6 2.5 3.9 7.8 78.7 12.4 15.0 9.6 3.6 25.7 41.2 7.8 10.3 8.8 11.2 10.2 16.4 48.8 6.8 4.2 8.0 18.5 40.8 5.5 0.0 7.9 0.0 21.4 12.8 7.7 0.0 15.0 10.3 10.3 10.3 23.6 33.5 5.3 4.1 14.3 12.2 5.6 5.8 4.0 5.1 38.1 6.6 9.4 8.7 48.8 18.6 7.5 0.0 6.6 9.8 15.8 5.8 2.8 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209839 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.5" "Group enriched" "Detected in some" 51 "Excitatory neurons: 389.6;Inhibitory neurons: 1425.5" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain NA NA "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.0 0.0 11.4 0.0 16.2 0.0 1.8 0.0 47.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 6.9 8.5 0.0 0.2 0.0 0.0 22.4 16.2 20.3 0.0 0.0 0.0 7.1 0.0 27.3 2.6 0.0 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 48.5 0.0 0.0 0.1 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 16.2 0.0 47.3 6.9 8.5 22.4 16.2 20.3 27.3 0.0 48.5 38.6 0.0 0.0 0.0 17.6 0.0 0.0 2.9 0.0 0.0 15.9 16.7 7.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.3 0.0 0.0 389.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1425.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 2.6 0.0 14.1 14.8 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 10.1 9.4 3.1 18.3 3.9 16.5 12.7 5.6 7.4 7.7 1.4 9.6 13.8 14.3 9.1 9.6 7.8 15.5 7.2 3.6 2.2 6.9 7.0 8.2 20.8 2.8 2.1 0.9 13.9 21.0 5.4 5.0 18.1 2.9 10.0 12.6 8.3 10.2 7.4 8.1 11.5 13.4 9.1 0.9 12.0 12.0 5.6 2.3 11.0 10.2 7.2 13.2 14.0 7.3 8.6 18.2 8.6 17.5 17.9 14.0 47.8 29.2 27.0 11.5 18.4 13.8 28.6 38.8 32.6 34.0 15.6 12.6 44.3 21.5 25.9 21.2 10.6 7.8 34.8 55.6 20.2 16.4 31.9 25.1 19.5 25.8 16.0 35.7 35.0 23.7 22.7 24.2 50.4 22.8 5.0 25.8 66.4 12.1 16.7 9.6 23.3 19.1 30.9 22.7 17.4 10.7 19.5 10.8 38.2 16.5 19.3 32.7 12.4 28.7 26.9 30.5 44.2 28.7 22.9 26.2 32.5 11.2 36.9 10.3 44.2 16.7 28.8 17.3 12.5 17.7 39.1 24.9 19.8 12.0 39.8 28.4 24.1 42.7 18.1 10.8 26.1 18.2 5.2 3.1 3.9 5.6 7.4 3.6 2.2 2.8 2.1 0.9 2.9 0.9 2.3 8.6 106.7 89.8 95.5 20.9 246.1 244.2 252.4 66.6 255.0 86.6 129.4 130.9 26.2 134.4 105.3 29.5 39.6 176.0 162.5 94.5 45.0 95.2 19.9 144.9 184.9 121.3 110.2 98.4 41.6 146.3 170.2 147.1 125.4 245.6 104.4 257.2 63.1 54.2 69.3 69.0 38.2 148.0 24.4 103.7 153.6 16.5 128.6 112.0 80.0 24.4 102.1 34.8 89.6 35.2 44.0 110.4 87.5 67.7 162.2 269.2 71.1 101.5 67.7 78.2 72.3 187.4 123.1 49.0 71.5 251.4 203.0 160.9 182.3 119.7 174.1 356.8 ABTB2 "ABTB2A, BTBD22, DKFZP586C1619" ENSG00000166016 "Ankyrin repeat and BTB domain containing 2" Q8N961 11 34150987-34358010 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "eosinophil: 5.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;granulocytes: 5.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020065, HPA030699" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA020065: AB_1844459, HPA030699: AB_2673576" "unprognostic (3.00e-1)" "prognostic unfavorable (5.70e-5)" "unprognostic (2.61e-1)" "unprognostic (9.09e-2)" "unprognostic (3.17e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-3)" "unprognostic (2.86e-1)" "prognostic favorable (3.51e-5)" "unprognostic (1.50e-1)" "unprognostic (1.42e-1)" "unprognostic (3.81e-2)" "unprognostic (6.58e-2)" 2.3 13.1 10.2 2.0 12.3 2.6 2.0 17.1 6.7 7.7 1.6 3.1 8.9 6.1 4.4 4.1 4.6 2.1 11.4 5.2 8.5 9.5 11.7 2.9 2.1 19.6 16.2 3.9 2.6 2.3 0.5 3.5 3.2 15.0 5.0 2.5 2.6 6.8 4.4 17.0 6.7 7.1 2.5 15.7 0.9 2.5 2.7 14.8 2.4 2.0 7.3 2.0 3.7 5.6 21.9 5.6 16.2 6.4 1.8 1.7 0.1 6.4 3.2 2.5 2.8 5.3 4.0 4.0 0.2 5.3 4.1 16.5 10.5 3.6 3.7 2.3 0.2 8.8 0.1 9.8 17.4 1.0 8.9 1.2 0.9 2.0 5.6 2.4 10.1 0.0 0.7 1.9 0.5 1.8 13.8 0.3 10.7 8.0 8.1 8.8 1.7 3.8 6.3 10.0 13.0 8.1 6.6 8.1 24.6 6.5 4.2 5.3 3.8 0.9 3.1 0.5 9.8 5.8 0.9 0.4 0.1 7.1 2.5 9.7 0.0 0.1 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 10.2 12.3 17.1 6.7 5.2 8.5 19.6 16.2 3.9 15.0 15.7 14.8 21.9 0.7 0.0 2.3 18.9 1.1 4.7 3.2 1.3 1.2 2.1 3.0 3.3 10.0 2.8 1.1 12.9 0.0 2.7 2.5 12.2 5.9 4.6 1.2 3.4 4.5 0.9 7.2 0.0 4.0 4.5 1.1 5.8 4.6 10.7 1.3 0.3 0.0 6.8 0.8 0.0 8.9 2.3 4.1 0.8 6.1 0.3 1.2 1.2 1.8 6.5 9.3 7.5 0.0 50.3 126.2 10.5 9.1 6.0 2.1 9.3 15.5 2.0 0.3 0.6 0.0 4.3 2.4 0.5 1.1 1.0 4.8 28.3 2.9 0.4 2.9 7.5 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 51.5;Oligodendrocytes: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 11.4 8.6 9.1 7.8 10.0 17.5 11.7 11.1 11.2 13.7 9.3 11.5 6.4 9.0 9.8 13.2 9.2 5.9 8.4 8.7 9.4 11.2 13.6 11.0 12.3 9.6 9.5 8.3 8.7 11.1 10.6 8.7 8.4 9.9 12.8 10.2 10.1 11.9 6.6 10.0 14.3 12.4 6.5 9.9 15.4 9.5 31.4 9.6 13.8 10.2 8.1 13.1 12.5 13.2 11.1 14.6 9.4 13.9 12.4 11.7 12.4 11.5 16.1 22.4 15.4 17.0 12.8 10.0 20.4 8.5 9.6 8.7 16.0 14.2 9.7 17.4 15.4 9.6 12.1 7.3 14.4 14.4 16.7 14.1 11.4 10.9 13.6 20.0 13.6 10.1 12.6 10.6 12.4 12.2 14.0 13.2 17.3 10.1 6.9 12.1 13.4 15.9 8.2 11.2 8.5 4.8 10.2 8.3 6.0 32.9 17.7 10.8 10.4 11.2 10.3 11.0 11.6 12.2 12.5 14.1 34.4 14.8 17.1 7.7 12.2 6.3 17.8 8.6 8.8 7.8 9.2 8.9 8.9 5.0 8.6 7.7 7.7 7.6 10.4 13.4 5.5 13.4 5.5 9.1 10.0 11.1 11.2 8.7 9.4 9.6 9.5 8.3 9.9 9.9 9.6 11.1 11.8 16.0 15.1 30.0 13.2 3.3 4.8 3.9 6.8 6.7 5.9 5.0 8.9 10.0 6.5 7.3 6.2 9.8 15.6 13.5 5.9 7.8 28.4 10.8 10.5 9.5 6.0 11.8 39.9 6.9 9.8 8.3 14.3 10.1 17.1 9.7 6.1 4.5 6.9 5.0 35.8 12.2 2.0 8.7 5.1 13.1 5.3 13.5 12.4 51.5 9.5 6.5 13.4 34.2 59.8 10.5 5.4 5.7 11.9 5.4 9.6 3.4 13.0 14.2 0.0 7.6 7.1 36.6 23.9 6.3 3.8 13.0 12.8 8.7 9.5 7.5 AMOTL1 JEAP ENSG00000166025 "Angiomotin like 1" Q8IY63 11 94706431-94876748 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.9" "Cell type enhanced" "Detected in many" "Early spermatids: 127.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 111.4;WM-115: 105.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001196 Approved Approved "Cell Junctions,Cytosol" NA NA 59000 Cytosol "Cell Junctions" "HPA001196: AB_1078147" "unprognostic (2.21e-1)" "unprognostic (5.25e-2)" "unprognostic (4.23e-2)" "unprognostic (5.43e-2)" "unprognostic (7.58e-2)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.40e-1)" "unprognostic (2.09e-1)" "unprognostic (7.97e-2)" "unprognostic (1.85e-1)" "unprognostic (5.95e-2)" "prognostic favorable (5.03e-6)" "unprognostic (7.47e-3)" "unprognostic (1.39e-1)" "unprognostic (1.68e-2)" "unprognostic (1.29e-2)" 15.5 10.4 14.1 7.7 10.0 1.8 15.1 8.5 6.4 11.5 9.9 25.8 4.6 14.4 5.9 30.6 13.5 13.5 19.3 12.4 14.4 5.5 7.8 15.9 3.6 11.3 28.1 5.1 4.8 15.8 13.9 14.2 24.3 11.0 32.7 7.4 6.7 11.0 23.3 112.9 21.9 8.4 20.7 6.1 9.3 12.5 11.9 37.7 28.2 9.8 72.3 9.8 27.8 14.1 6.3 57.1 16.0 41.9 0.0 44.1 38.1 19.9 31.0 53.7 13.9 16.2 29.7 1.5 2.7 14.9 42.2 11.4 72.4 20.1 111.4 14.6 4.6 15.4 30.7 16.2 0.1 10.2 6.8 0.2 22.7 67.3 47.7 78.9 35.9 29.3 11.9 79.0 2.9 33.1 16.6 21.3 4.1 6.3 0.1 10.5 0.0 76.2 4.9 19.4 23.6 31.7 38.3 2.0 42.4 11.2 28.1 2.2 9.6 27.1 38.0 27.6 0.8 21.6 1.5 0.0 16.0 10.6 0.1 105.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 14.1 10.0 8.5 6.4 12.4 14.4 11.3 28.1 5.1 11.0 6.1 37.7 6.3 28.4 35.3 35.0 17.0 0.8 35.4 19.7 11.7 29.0 4.7 6.9 14.9 51.0 10.0 10.1 7.3 4.2 30.1 1.0 0.0 0.0 17.3 127.0 22.3 12.7 31.1 0.0 6.3 26.8 17.0 15.6 30.9 0.5 27.4 2.5 4.9 36.4 17.0 4.9 15.2 61.3 0.0 4.1 4.0 10.0 62.9 8.1 3.2 10.6 46.9 1.4 14.4 0.0 20.6 1.4 10.8 0.0 12.4 0.7 19.4 0.0 4.0 4.2 1.1 13.1 32.7 30.2 16.7 11.4 21.7 26.9 27.9 1.4 3.4 0.0 8.4 HTRA1 "ARMD7, HtrA, IGFBP5-protease, PRSS11" ENSG00000166033 "HtrA serine peptidase 1" Q92743 10 122458551-122514907 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036655 Approved Supported "Plasma membrane" "Secreted to blood" NA NA 24800000 7600000 "Plasma membrane" "HPA036655: AB_10671966" "unprognostic (3.84e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-3)" "unprognostic (8.71e-3)" "unprognostic (2.33e-2)" "unprognostic (3.83e-1)" "unprognostic (7.22e-2)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.90e-7)" "unprognostic (7.12e-3)" "unprognostic (9.13e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.62e-6)" 240.2 82.1 412.5 37.3 461.2 0.5 204.5 451.1 528.6 300.6 354.6 129.2 21.0 198.8 249.3 58.3 123.9 303.8 115.8 404.8 434.9 226.4 228.2 70.5 40.3 512.4 479.8 391.2 429.1 56.4 112.7 185.5 284.3 485.8 86.4 52.3 245.7 101.9 115.6 31.3 130.9 74.1 153.6 429.4 54.6 88.0 19.6 453.1 21.4 79.4 81.6 27.5 138.6 189.9 496.3 0.3 45.6 19.4 5.7 2417.8 889.4 0.8 108.3 196.8 44.4 23.6 0.2 0.6 0.0 29.0 862.3 68.6 12.8 7.6 124.4 6.2 0.1 4.9 0.1 65.4 0.3 123.7 0.1 0.9 1581.4 444.6 25.8 205.3 503.6 207.1 0.0 0.1 1.5 1238.2 22.3 0.1 0.7 20.9 0.2 67.6 0.2 1.3 0.4 282.6 2.2 1.2 3.9 272.1 0.2 122.2 91.4 8.6 0.2 136.0 309.9 4.5 141.3 94.1 0.2 0.1 0.3 1004.6 0.2 148.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 412.5 461.2 451.1 528.6 404.8 434.9 512.4 479.8 391.2 485.8 429.4 453.1 496.3 55.1 22.4 6.9 116.5 0.9 44.1 32.5 10.8 23.9 53.3 5.4 31.2 26.4 14.3 0.9 64.4 54.2 30.9 1.3 0.0 0.0 2.0 3.5 11.3 76.5 107.0 0.0 2.7 2.2 4.6 164.6 269.3 4.6 14.4 1.3 731.6 57.8 157.8 51.3 625.9 31.2 0.3 8.2 18.1 59.9 4.2 31.7 22.0 46.2 86.2 8.5 373.8 0.0 193.0 112.5 2.7 1.3 77.5 1.9 8.7 0.2 22.6 10.1 150.3 6.6 63.3 140.5 0.2 0.7 7.0 30.5 87.7 7.2 2.5 0.6 11.9 LIPC "HL, HTGL" ENSG00000166035 "Lipase C, hepatic type" P11150 15 58410569-58569844 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "liver: 172.5" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 161.7" "Group enriched" "Detected in some" 14 "liver cancer: 20.4;renal cancer: 10.4" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 7 "granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 5500000 "unprognostic (1.76e-2)" "unprognostic (9.15e-3)" "unprognostic (7.89e-2)" "unprognostic (7.15e-4)" "unprognostic (1.40e-1)" "unprognostic (1.33e-2)" "unprognostic (9.93e-3)" "unprognostic (6.25e-2)" "unprognostic (3.79e-2)" "unprognostic (1.10e-2)" "unprognostic (3.06e-1)" "unprognostic (2.31e-1)" "unprognostic (2.82e-2)" "unprognostic (1.41e-1)" "unprognostic (2.87e-2)" "unprognostic (1.80e-2)" "unprognostic (2.27e-2)" 0.3 0.1 0.6 0.3 0.6 0.2 1.5 0.9 1.0 0.4 0.1 0.6 1.8 0.2 0.9 0.6 1.0 0.8 0.4 0.7 0.4 6.0 172.5 0.3 0.7 0.8 0.8 0.6 0.8 2.5 0.0 1.5 0.4 0.9 0.2 0.8 0.1 0.2 0.9 0.0 0.6 0.8 0.1 0.7 0.8 0.5 0.1 0.4 2.1 1.3 0.3 0.2 1.6 0.3 1.3 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.1 0.8 0.0 0.0 8.5 0.0 0.0 6.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 24.4 0.5 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.2 0.1 5.5 0.8 0.0 0.1 0.0 1.1 0.3 0.0 2.6 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 18.4 0.0 0.1 0.0 0.1 0.2 0.5 0.0 1.6 0.1 0.0 1.3 0.1 1.8 0.0 0.3 0.9 0.1 0.0 0.4 1.3 0.2 1.5 0.2 0.0 0.9 1.1 0.6 0.6 0.9 1.0 0.7 0.4 0.8 0.8 0.6 0.9 0.7 0.4 1.3 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.8 11.5 0.7 3.7 0.0 0.0 0.9 1.2 5.9 7.8 0.0 0.4 0.5 1.2 0.0 2.7 6.1 3.7 0.1 2.9 0.5 2.7 0.0 0.2 4.2 161.7 0.1 0.0 4.3 0.0 0.0 3.8 0.8 0.1 0.3 0.3 1.8 16.9 0.6 0.0 3.1 0.0 12.9 0.2 0.0 0.0 0.0 0.2 0.3 15.7 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.3 0.6 0.0 1.1 1.2 0.0 0.1 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 462.9;Late spermatids: 372.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA018315 Approved Approved Microtubules,Cytosol "Intracellular and membrane" NA NA Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favorable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 15.3 14.1 12.0 19.4 12.4 29.3 21.8 16.0 13.4 19.1 13.3 17.9 32.7 22.0 20.0 15.1 17.9 27.6 15.7 11.2 12.2 15.9 45.0 17.1 30.3 13.1 12.1 10.8 31.5 23.0 12.3 15.1 16.2 12.0 16.4 18.8 26.1 14.2 17.5 13.0 17.9 22.1 15.6 12.1 20.7 17.9 28.1 12.1 34.5 22.9 14.4 30.8 14.1 15.3 13.3 26.7 13.1 42.0 32.7 19.4 38.6 34.4 29.8 48.6 41.4 46.1 47.5 55.1 47.1 39.6 22.4 24.2 43.8 34.7 29.5 43.8 38.1 21.8 66.4 36.9 38.4 33.9 67.0 37.2 25.9 42.5 43.2 80.4 39.3 33.4 49.6 43.8 25.3 33.8 13.1 74.7 89.1 23.3 30.2 29.2 43.8 53.2 40.7 34.8 27.8 21.5 28.9 36.1 34.4 38.3 29.7 35.1 44.0 17.2 35.2 28.3 52.0 28.2 16.9 38.1 51.7 14.6 74.4 31.0 19.0 11.8 24.3 19.5 14.4 25.9 23.6 25.7 22.7 15.6 21.7 24.8 23.5 11.6 26.0 13.2 21.1 33.7 17.5 12.0 12.4 16.0 13.4 11.2 12.2 13.1 12.1 10.8 12.0 12.1 12.1 13.3 43.7 54.5 51.1 35.9 58.5 36.3 30.6 35.7 51.2 72.3 30.6 42.7 41.3 85.8 41.7 29.5 35.5 44.1 42.8 16.2 54.8 34.2 462.9 52.2 33.0 38.2 28.8 88.1 68.0 25.7 50.8 41.1 18.3 33.0 27.3 58.4 30.7 71.5 33.1 57.2 78.3 34.0 16.2 35.0 37.3 372.7 33.8 33.2 17.8 27.2 37.6 29.6 44.3 57.8 60.9 26.2 23.9 35.7 57.8 28.8 45.2 40.2 52.6 59.0 65.7 34.4 37.8 75.8 46.1 42.0 32.0 38.4 59.1 53.0 47.2 27.6 TCP11L2 MGC40368 ENSG00000166046 "T-complex 11 like 2" Q8N4U5 12 106301929-106347003 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.4;choroid plexus: 63.5" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 111.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 67.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 67.0" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039483, HPA042188" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA039483: AB_10795291, HPA042188: AB_10794415" "unprognostic (1.41e-1)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (8.15e-2)" "unprognostic (1.97e-1)" "prognostic favorable (9.52e-4)" "unprognostic (3.87e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-1)" "unprognostic (9.05e-3)" "unprognostic (5.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-2)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-2)" "unprognostic (3.67e-1)" 11.6 8.9 20.9 8.0 36.0 30.6 10.4 30.6 23.3 9.3 63.5 7.8 7.6 10.0 4.3 23.1 13.2 9.6 22.8 10.5 20.0 6.7 6.6 16.9 10.3 43.1 29.2 5.2 9.1 6.0 10.3 4.9 14.6 37.5 6.7 9.1 10.4 12.2 6.6 18.1 14.0 9.9 8.3 31.1 11.8 12.2 10.7 26.2 13.7 11.7 23.2 17.0 8.6 9.4 97.4 3.3 8.1 1.1 2.3 10.6 12.2 5.0 2.1 10.2 1.3 3.2 1.3 4.3 1.1 3.2 8.1 3.0 15.2 1.0 4.5 2.3 1.7 3.3 0.7 3.4 5.1 10.4 0.3 2.1 15.4 10.2 1.6 7.6 25.1 7.5 5.9 2.0 1.5 1.9 2.4 2.0 1.7 1.4 4.4 5.0 1.0 0.3 3.8 10.1 15.2 5.0 3.6 5.5 1.7 6.0 8.4 4.6 0.3 5.7 1.9 1.6 2.9 0.5 10.0 0.8 3.8 5.3 0.3 1.0 29.6 6.9 11.0 4.8 3.1 3.6 12.4 9.9 5.4 1.7 10.6 12.2 8.3 67.0 4.3 5.3 1.2 12.3 3.8 20.9 36.0 30.6 23.3 10.5 20.0 43.1 29.2 5.2 37.5 31.1 26.2 97.4 12.6 12.8 14.4 15.0 23.1 1.1 3.4 4.4 5.7 8.1 3.5 5.5 10.5 0.0 8.6 3.7 22.9 1.5 13.4 4.2 1.9 3.6 6.3 28.6 7.3 12.1 4.2 33.7 7.7 2.6 0.8 10.5 11.2 20.5 2.5 4.3 6.1 1.5 1.2 21.9 23.9 5.0 2.0 3.1 2.0 4.5 5.9 5.2 3.6 12.2 8.0 3.1 10.3 9.0 111.0 3.7 4.8 2.6 9.9 4.0 5.9 1.2 16.7 13.4 13.1 11.8 7.2 4.3 3.0 6.3 2.6 15.1 12.4 8.0 1.2 8.7 PASD1 CT63 ENSG00000166049 "PAS domain containing repressor 1" Q8IV76 X 151563675-151676739 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 163 "testis: 16.2" "Group enriched" "Detected in some" 5 "Spermatocytes: 19.3;Spermatogonia: 57.5" "Cancer enhanced" "Detected in some" "melanoma: 0.7;testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8" "Not detected" "Not detected" "HPA011122, HPA011152" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA011122: AB_1854990, HPA011152: AB_1854991" "unprognostic (3.34e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 19.3 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPRED1 "FLJ33903, PPP1R147" ENSG00000166068 "Sprouty related EVH1 domain containing 1" Q7Z699 15 38252836-38357249 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 173.7;Excitatory neurons: 163.4;Microglial cells: 199.5;Oligodendrocyte precursor cells: 277.9;Oligodendrocytes: 146.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 4 "monocytes: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042193, HPA061805" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042193: AB_10794079, HPA061805: AB_2684617" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "prognostic favorable (7.08e-4)" "unprognostic (1.20e-1)" "unprognostic (2.38e-1)" "unprognostic (1.21e-3)" "unprognostic (5.71e-2)" "unprognostic (3.84e-2)" "unprognostic (2.81e-3)" "unprognostic (9.27e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (7.37e-5)" "prognostic unfavorable (8.29e-5)" "unprognostic (6.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.01e-1)" 12.8 8.2 19.1 8.9 23.4 0.7 11.0 17.7 20.8 11.6 10.2 11.5 8.3 11.0 5.8 6.2 7.0 12.9 7.4 19.4 19.0 9.2 5.6 17.6 7.2 22.1 22.5 18.0 8.0 4.5 6.9 4.0 14.1 19.0 7.2 11.0 7.5 5.6 8.7 2.7 6.2 8.5 9.6 18.8 9.1 10.4 8.3 20.2 4.4 31.4 8.1 5.0 13.3 6.8 21.5 11.0 8.2 59.0 11.3 21.4 39.0 4.8 25.1 24.7 13.1 16.2 7.6 8.7 0.1 9.0 21.7 9.5 8.6 6.2 17.3 26.2 1.5 2.0 13.0 5.2 7.3 26.3 7.1 34.6 25.5 8.5 25.5 23.4 33.6 10.7 6.5 11.7 12.1 32.2 2.9 2.6 5.2 12.0 37.6 22.0 0.0 13.3 7.3 21.2 16.9 2.9 13.0 7.2 3.5 26.7 9.3 2.8 1.7 18.2 32.0 15.7 19.7 15.4 10.1 7.1 16.7 22.5 2.8 52.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 19.1 23.4 17.7 20.8 19.4 19.0 22.1 22.5 18.0 19.0 18.8 20.2 21.5 26.4 99.3 26.9 173.7 2.5 28.3 24.6 9.4 45.5 12.6 17.2 20.8 7.2 28.6 12.6 1.8 6.2 1.3 1.5 15.7 1.9 9.5 40.3 12.0 29.4 28.2 6.7 4.6 163.4 4.9 0.9 33.0 17.3 14.8 41.8 5.4 26.7 4.1 57.8 5.0 100.0 21.2 6.1 48.2 24.6 9.6 21.8 38.7 28.4 199.5 7.3 25.4 0.0 277.9 146.9 15.1 7.8 30.5 1.6 12.7 6.6 12.8 11.4 5.2 6.6 44.4 44.1 8.0 5.0 18.1 9.7 1.4 2.4 21.4 15.3 14.7 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 140 "testis: 91.5" "Group enriched" "Detected in some" 104 "Early spermatids: 1153.9;Late spermatids: 3910.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA056530, HPA064017" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA056530: AB_2683167, HPA064017: " "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 91.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1153.9 0.2 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3910.6 13.4 1.1 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 1.1 0.0 6.6 0.0 0.0 24.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 GPR176 Gm1012 ENSG00000166073 "G protein-coupled receptor 176" Q14439 15 39799008-39920266 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 22.3;Excitatory neurons: 32.0;Inhibitory neurons: 56.8;Oligodendrocyte precursor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 276.1;fHDF/TERT166: 186.5;U-138 MG: 119.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039943, HPA039979" Approved NA NA "HPA039943: AB_10697711, HPA039979: AB_2676782" "unprognostic (4.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (1.04e-2)" "unprognostic (2.75e-2)" "unprognostic (1.38e-3)" "unprognostic (9.32e-2)" "unprognostic (3.23e-2)" "unprognostic (2.74e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (9.38e-7)" "prognostic unfavorable (6.84e-5)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (3.26e-2)" 11.2 6.2 8.8 4.2 11.0 0.3 6.6 11.9 10.5 6.4 2.4 3.5 2.0 5.7 2.0 1.7 4.4 7.1 4.1 10.0 11.5 3.6 1.9 7.6 6.3 9.6 10.4 10.9 1.8 1.6 2.0 5.1 2.5 11.0 7.1 2.3 6.4 2.9 3.6 1.8 3.2 3.4 4.6 5.5 4.1 2.2 7.3 9.6 2.2 5.0 1.1 5.8 6.5 5.4 12.9 52.3 2.6 3.2 0.6 36.9 64.6 0.0 108.3 276.1 64.3 99.5 3.7 8.3 0.7 8.7 186.5 37.1 1.6 7.7 8.4 100.7 1.7 11.2 7.7 7.7 0.1 41.1 0.0 0.4 50.7 1.0 56.7 47.6 65.7 24.6 2.4 1.0 1.1 91.8 2.1 0.1 0.0 3.2 0.4 9.3 2.7 32.3 0.3 1.6 0.6 12.0 47.8 27.9 0.0 4.4 0.7 9.0 0.5 31.8 119.5 33.9 7.2 40.7 1.1 3.6 0.1 24.9 0.0 47.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 11.0 11.9 10.5 10.0 11.5 9.6 10.4 10.9 11.0 5.5 9.6 12.9 3.0 0.0 0.0 8.5 0.9 1.8 0.2 0.8 0.0 1.1 0.4 0.6 0.9 1.5 0.1 0.0 0.0 0.0 0.3 0.1 0.0 9.3 22.3 0.1 3.1 1.8 0.0 0.0 32.0 3.9 0.0 3.4 0.0 0.2 0.0 0.1 0.7 0.1 0.1 1.7 56.8 0.0 0.0 0.0 1.8 13.5 1.2 0.7 1.8 3.7 0.0 14.9 0.0 40.7 1.4 12.0 0.0 1.2 3.1 3.0 0.0 1.2 0.0 1.1 13.1 3.8 15.2 2.9 3.8 0.5 1.0 0.0 0.4 0.8 0.0 0.1 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134069071-134152001 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.3" "Group enriched" "Detected in many" 7 "B-cells: 5.3;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 99.5;RH-30: 122.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" NA NA 44000 "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: AB_2681126" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.68e-4)" 21.0 18.8 60.6 10.2 86.6 1.3 19.3 72.3 72.8 32.1 58.0 41.8 6.7 41.2 17.7 21.7 29.0 24.7 31.3 60.1 68.1 10.8 3.2 29.9 7.9 78.7 82.1 55.1 49.1 5.2 17.9 33.5 103.6 80.0 32.8 13.0 47.7 13.4 44.9 7.1 12.3 22.7 43.2 69.6 13.6 22.6 36.0 73.7 17.7 16.0 14.7 7.5 42.0 23.6 121.1 0.0 1.0 87.9 42.5 85.3 62.7 75.4 37.0 49.1 15.1 14.8 0.3 0.6 0.0 38.7 53.3 56.2 0.5 70.0 0.7 28.2 0.2 29.6 0.3 0.0 6.9 24.9 0.4 36.2 43.2 0.0 10.7 9.6 35.8 99.5 40.8 0.3 0.2 64.5 1.0 27.5 0.2 18.9 0.6 2.9 0.5 122.8 0.0 0.9 0.2 57.5 32.2 0.0 0.2 1.0 35.3 0.2 0.2 0.6 25.1 18.4 40.3 24.7 0.1 0.1 0.4 27.6 1.2 48.0 0.0 0.0 0.1 1.3 0.0 1.6 5.3 1.6 0.9 0.0 3.1 2.3 1.7 0.5 0.0 0.0 0.0 0.0 1.8 60.6 86.6 72.3 72.8 60.1 68.1 78.7 82.1 55.1 80.0 69.6 73.7 121.1 22.2 0.0 6.0 12.7 10.9 5.1 5.6 0.9 0.0 21.7 0.3 9.3 15.7 0.0 0.7 5.5 8.4 6.0 1.2 0.1 1.9 0.4 2.1 0.8 23.3 35.5 0.0 0.4 84.3 0.2 71.2 29.6 1.5 0.5 1.3 11.7 12.5 0.0 8.6 8.4 44.2 0.0 12.2 0.6 4.2 4.9 42.9 10.9 17.8 24.4 0.2 20.2 1.0 76.4 342.8 0.3 0.0 64.3 0.9 2.2 0.0 0.2 1.5 75.6 26.3 19.0 24.3 15.5 19.2 0.2 3.8 6.2 3.5 9.7 0.0 1.0 IL25 "IL-17E, IL-25, IL17E" ENSG00000166090 "Interleukin 25" Q9H293 14 23372809-23376403 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "Cardiomyocytes: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB024864 Uncertain "Secreted to blood" NA NA 4230000 "CAB024864: " "unprognostic (1.49e-1)" "unprognostic (6.82e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376773-23379772 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 185.9;choroid plexus: 55.1" "Cell type enhanced" "Detected in some" "Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 20.8" "Lineage enriched" "Detected in many" 19 "granulocytes: 20.8" "Cell line enriched" "Detected in some" 7 "HEL: 91.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 540000 "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 0.9 1.0 78.2 0.5 115.7 8.3 0.9 123.6 94.5 2.7 55.1 4.3 0.5 0.8 1.1 1.2 1.2 2.1 16.0 76.1 96.1 0.5 0.3 1.5 0.3 138.5 111.1 66.8 0.8 0.2 0.1 0.6 0.8 130.8 2.1 0.8 2.3 2.2 3.2 3.1 0.7 1.7 0.8 123.6 2.8 1.4 0.1 105.5 0.1 0.5 0.9 0.0 1.3 2.7 185.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.2 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 20.8 0.7 0.9 0.1 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.4 30.0 78.2 115.7 123.6 94.5 76.1 96.1 138.5 111.1 66.8 130.8 123.6 105.5 185.9 0.5 0.0 0.0 6.5 0.4 1.0 0.1 0.0 1.2 0.2 1.3 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.4 0.0 0.0 93.7 5.4 0.0 1.5 32.0 0.0 20.6 106.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 3.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 GLB1L3 FLJ90231 ENSG00000166105 "Galactosidase beta 1 like 3" Q8NCI6 11 134274245-134319564 "Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;prostate: 8.0;seminal vesicle: 4.4" "Cell type enhanced" "Detected in some" "Early spermatids: 9.8;Excitatory neurons: 39.5;Inhibitory neurons: 20.9;Oligodendrocyte precursor cells: 11.6;Spermatogonia: 7.5" "Cancer enhanced" "Detected in some" "prostate cancer: 5.0" "Region enhanced" "Detected in many" "cerebral cortex: 4.0" "Group enriched" "Detected in many" 11 "gdT-cell: 1.2;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.9;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.9;T-reg: 1.5" "Lineage enriched" "Detected in single" 31 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "HEK 293: 5.5;JURKAT: 11.4;NTERA-2: 3.4;PC-3: 4.5;SCLC-21H: 6.8" "Not detected" "Not detected" HPA039916 Uncertain NA NA "HPA039916: AB_2676746" "unprognostic (1.64e-3)" "unprognostic (7.80e-3)" "unprognostic (5.12e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (8.69e-3)" "prognostic favorable (1.97e-4)" "unprognostic (6.58e-3)" "unprognostic (3.81e-1)" "unprognostic (6.95e-3)" "unprognostic (9.73e-2)" "unprognostic (1.52e-5)" "unprognostic (1.39e-1)" "unprognostic (6.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.07e-1)" 0.0 1.0 0.5 0.4 1.0 0.1 0.3 2.2 4.0 0.4 0.0 0.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.0 0.0 0.9 0.6 0.0 0.8 0.0 0.0 0.0 0.7 0.0 1.0 8.0 0.0 1.6 2.7 4.4 0.0 3.2 0.1 0.0 0.0 0.1 0.0 1.3 0.1 0.1 1.4 0.0 0.1 0.1 0.8 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 2.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 2.2 0.0 3.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 6.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 3.1 1.9 0.0 0.0 2.4 1.9 0.0 0.0 0.0 0.0 1.5 0.6 0.5 1.0 2.2 4.0 0.4 0.5 0.6 0.0 0.8 1.0 0.0 0.1 1.2 0.0 0.0 0.0 1.3 0.1 0.5 0.1 1.3 0.0 0.5 0.4 1.3 0.7 0.0 0.1 0.0 0.0 1.3 0.3 0.0 0.0 0.0 9.8 0.1 0.3 0.3 0.0 0.0 39.5 0.0 3.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 20.9 0.0 0.0 0.0 0.0 1.2 0.6 0.1 0.0 1.9 0.0 0.3 0.0 11.6 0.9 0.1 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.7 0.0 0.0 0.1 4.3 7.5 0.0 0.1 1.2 0.3 0.0 0.0 0.1 ADAMTS15 ENSG00000166106 "ADAM metallopeptidase with thrombospondin type 1 motif 15" Q8TE58 11 130448974-130476641 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 26.7" "Cell type enhanced" "Detected in some" "Adipocytes: 8.6;Cardiomyocytes: 11.0;Endometrial stromal cells: 15.6;Fibroblasts: 9.6;Gastric mucus-secreting cells: 8.2;Glandular and luminal cells: 7.5;Granulosa cells: 6.8;Skeletal myocytes: 6.9" "Cancer enhanced" "Detected in many" "breast cancer: 13.2" "Region enhanced" "Detected in many" "medulla oblongata: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 72.0;ASC TERT1: 43.0;EFO-21: 36.6;hTERT-RPE1: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA042867 Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "HPA042867: AB_10794535" "unprognostic (7.64e-2)" "unprognostic (1.49e-3)" "unprognostic (7.15e-2)" "unprognostic (1.34e-3)" "unprognostic (1.07e-3)" "unprognostic (7.07e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (6.18e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (5.95e-3)" "unprognostic (6.68e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.63e-5)" 26.7 1.2 0.6 1.7 0.5 0.0 15.4 0.4 0.9 3.4 1.9 3.2 0.5 4.3 1.3 3.7 9.9 2.3 13.7 0.4 1.0 3.6 0.4 7.3 1.2 4.6 0.6 0.4 2.7 1.5 0.4 1.3 17.1 1.3 1.9 1.9 0.3 1.3 1.1 1.8 4.2 3.6 4.7 0.9 2.3 5.5 0.9 1.1 1.1 7.1 1.0 0.3 8.9 2.6 1.2 0.0 2.6 1.6 0.8 72.0 43.0 0.0 2.7 5.2 1.0 0.2 0.5 1.2 0.0 36.6 0.2 2.6 7.0 0.6 0.7 0.2 0.0 1.7 0.0 3.3 0.0 0.7 0.0 0.0 14.1 0.0 0.6 0.1 19.5 0.0 0.3 0.0 0.0 0.0 0.1 0.1 8.1 1.3 0.0 5.7 0.0 4.1 0.0 0.1 0.1 0.6 0.0 12.1 0.0 0.0 5.2 3.9 0.0 0.0 0.6 8.5 7.0 3.5 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.9 0.4 1.0 4.6 0.6 0.4 1.3 0.9 1.1 1.2 8.6 0.0 0.0 0.3 0.2 0.5 0.1 3.5 0.0 1.3 5.6 2.7 11.0 0.0 0.5 1.8 0.0 0.6 0.0 1.0 0.0 0.0 0.0 4.4 15.6 1.7 0.0 0.0 0.4 0.8 0.6 9.6 8.2 7.5 0.0 6.8 0.4 0.1 0.9 0.0 1.6 0.5 2.0 0.0 0.3 0.0 5.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.9 0.7 0.0 0.0 0.1 1.0 0.5 0.0 0.0 6.9 3.6 0.2 0.3 0.0 0.3 0.8 0.1 0.0 1.8 0.1 SVOP DKFZp761H039 ENSG00000166111 "SV2 related protein" Q8N4V2 12 108907741-109021068 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 14.1;pituitary gland: 7.5;retina: 13.2" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 41.7;Early spermatids: 65.4;Excitatory neurons: 70.3;Inhibitory neurons: 75.8;Late spermatids: 121.5" "Group enriched" "Detected in some" 9 "glioma: 0.6;pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Karpas-707: 2.8;RPMI-8226: 3.0;SCLC-21H: 1.5;SH-SY5Y: 1.3;U-266/84: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016573 Uncertain NA NA "HPA016573: AB_2197027" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (6.51e-3)" "unprognostic (2.18e-2)" "unprognostic (3.79e-1)" "unprognostic (1.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "unprognostic (4.29e-3)" "unprognostic (3.07e-1)" "unprognostic (4.28e-3)" "unprognostic (3.94e-2)" "unprognostic (2.26e-2)" "unprognostic (6.17e-2)" 0.0 1.6 7.9 0.1 13.4 0.1 0.0 3.2 12.5 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.6 12.6 8.8 0.1 0.2 0.0 0.0 3.9 4.9 14.1 0.0 0.8 0.0 7.5 0.0 5.8 0.0 0.1 13.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.5 5.8 0.0 0.0 0.1 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.5 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 7.9 13.4 3.2 12.5 12.6 8.8 3.9 4.9 14.1 5.8 0.0 5.8 9.9 0.2 12.8 9.6 2.6 0.1 0.0 0.7 0.0 0.0 19.7 0.1 0.0 1.3 0.0 5.0 1.8 41.7 1.3 0.0 0.1 0.0 0.1 65.4 0.1 0.1 1.0 16.8 0.0 70.3 0.0 0.3 0.6 0.0 0.2 2.5 0.1 1.1 0.1 0.1 11.8 75.8 0.0 0.0 0.0 0.0 121.5 0.3 1.0 0.0 1.0 0.1 2.1 0.0 4.0 2.8 0.1 0.0 0.7 0.0 0.3 0.0 0.1 0.0 21.9 0.0 1.5 0.7 0.7 0.9 0.0 0.0 0.8 0.5 0.1 0.0 0.4 SPATA19 "CT132, FLJ25851, SPAS1, spergen1" ENSG00000166118 "Spermatogenesis associated 19" Q7Z5L4 11 133840631-133845538 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 320 "testis: 135.7" "Group enriched" "Detected in some" 162 "Early spermatids: 771.9;Late spermatids: 2291.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040082 Enhanced NA NA "HPA040082: AB_2676836" "unprognostic (9.90e-3)" "unprognostic (3.34e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 771.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2291.2 9.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPT2 ALT2 ENSG00000166123 "Glutamic--pyruvic transaminase 2" Q8TD30 16 46884362-46931289 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 269.7;skeletal muscle: 178.0;tongue: 186.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 159.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051514 Approved Approved Mitochondria No No Mitochondria "HPA051514: AB_2681516" "unprognostic (1.65e-2)" "unprognostic (3.32e-2)" "unprognostic (2.87e-1)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.95e-3)" "unprognostic (3.44e-2)" "unprognostic (6.12e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.90e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.44e-2)" "unprognostic (4.86e-1)" "unprognostic (3.54e-3)" "unprognostic (3.18e-1)" 57.3 10.5 47.0 4.1 42.6 3.8 17.1 43.9 57.4 4.6 30.7 7.8 1.7 3.7 31.6 78.5 7.7 9.9 6.0 46.5 40.4 23.8 104.5 2.1 4.3 64.0 39.2 39.6 2.3 269.7 8.4 13.1 3.1 57.4 24.4 5.0 6.9 49.2 11.0 178.0 38.1 3.9 3.2 53.1 2.3 59.1 15.2 48.5 7.7 7.7 186.2 13.5 2.8 7.7 57.3 42.6 19.0 23.8 90.6 32.7 7.0 43.1 28.9 10.9 30.7 19.2 65.3 17.6 29.9 24.7 20.7 15.6 33.6 43.3 42.8 20.4 14.0 21.1 10.5 10.8 159.9 22.4 75.6 9.5 15.2 37.0 30.0 46.3 20.3 15.1 56.1 8.7 23.3 10.3 75.8 15.1 62.9 25.3 52.2 54.2 0.3 26.3 71.1 12.4 21.0 73.7 37.7 14.9 76.4 39.0 9.4 19.6 67.6 11.3 21.1 40.9 14.2 23.4 110.2 36.9 87.1 32.6 48.3 11.7 0.4 0.2 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.4 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.0 42.6 43.9 57.4 46.5 40.4 64.0 39.2 39.6 57.4 53.1 48.5 57.3 1.3 6.4 3.4 54.9 4.8 15.9 4.9 6.8 64.3 14.5 6.7 8.4 14.9 8.6 9.1 18.4 22.9 9.2 0.3 10.2 11.7 7.0 9.6 12.2 7.2 2.3 13.1 5.2 16.7 30.2 44.8 7.5 37.2 37.5 3.8 14.9 5.0 123.9 3.8 6.7 18.8 13.4 6.1 3.2 7.3 22.9 4.7 2.3 8.8 1.0 1.1 42.5 1.0 13.6 26.0 25.6 5.2 15.4 7.9 12.4 2.0 38.6 5.4 5.9 0.0 5.2 3.6 2.5 17.3 53.1 16.3 83.3 1.4 2.6 6.3 4.2 AMN amnionless ENSG00000166126 "Amnion associated transmembrane protein" Q9BXJ7 14 102922663-102933596 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protein transport, Transport" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 84.2;kidney: 38.8;liver: 38.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 672.6;Intestinal goblet cells: 283.9;Paneth cells: 724.4;Proximal enterocytes: 2014.8;Proximal tubular cells: 348.9;Undifferentiated cells: 272.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;CACO-2: 8.1;Hep G2: 9.9;U-698: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA000817 Approved "Secreted in other tissues" NA NA "HPA000817: AB_1078146" "unprognostic (2.02e-2)" "unprognostic (1.67e-1)" "unprognostic (3.94e-3)" "unprognostic (7.39e-3)" "unprognostic (9.32e-2)" "unprognostic (1.88e-3)" "unprognostic (8.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (2.97e-2)" "unprognostic (7.57e-2)" "unprognostic (2.43e-2)" "prognostic favorable (9.62e-5)" "unprognostic (8.02e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" 0.7 0.0 0.2 1.1 0.1 0.1 0.5 0.1 0.2 1.0 0.0 25.8 43.9 0.1 0.0 5.7 1.1 1.9 0.0 0.2 0.1 38.8 38.1 1.7 0.1 0.3 0.1 0.0 0.1 0.7 0.0 0.5 0.0 0.3 0.7 3.1 0.0 1.2 0.0 0.0 2.0 84.2 0.1 0.1 0.5 8.0 0.8 0.1 0.1 0.8 0.0 0.0 0.3 2.5 0.3 0.3 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 9.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.7 1.2 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.7 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 0.0 0.3 0.1 0.1 0.3 0.2 9.6 0.5 0.7 18.0 13.4 23.4 1.3 12.0 3.3 13.1 2.0 1.5 140.2 6.1 20.2 0.0 2.7 4.7 672.6 33.2 1.8 4.8 8.2 1.1 0.6 19.2 0.8 0.1 0.7 4.1 0.9 61.7 10.5 4.5 1.9 0.4 52.6 0.6 1.7 0.1 283.9 6.1 1.6 2.3 6.3 0.6 3.1 7.2 0.0 0.1 0.2 1.0 0.0 0.1 11.1 724.4 0.7 4.5 28.1 2014.8 348.9 4.5 1.2 0.0 0.5 0.9 21.2 25.7 17.1 20.9 1.4 5.2 0.4 272.4 65.7 RAB8B ENSG00000166128 "RAB8B, member RAS oncogene family" Q92930 15 63189560-63267776 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.9" "Cell type enhanced" "Detected in all" "Early spermatids: 220.6;Langerhans cells: 195.6;Late spermatids: 399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 125.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 4700000 "unprognostic (7.67e-2)" "unprognostic (3.33e-2)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.20e-2)" "unprognostic (4.01e-2)" "unprognostic (1.46e-2)" "unprognostic (5.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.97e-2)" "unprognostic (3.14e-2)" "unprognostic (4.19e-2)" "unprognostic (7.47e-2)" 26.9 14.9 11.4 30.3 13.4 81.9 13.5 11.9 13.3 19.5 14.5 12.7 18.9 17.9 8.5 13.6 10.9 24.6 9.6 13.5 13.0 12.8 15.4 22.6 43.6 11.6 13.3 10.3 32.3 7.4 7.8 5.8 30.6 12.6 14.8 11.6 12.1 7.2 10.1 5.4 7.5 17.6 18.8 13.1 34.7 13.4 16.0 13.9 38.1 21.8 10.2 39.2 28.2 9.4 16.3 13.9 12.0 43.4 18.6 82.1 67.0 12.9 13.3 30.3 24.1 46.5 12.7 11.6 38.2 11.8 29.6 26.3 7.0 37.5 18.0 40.8 54.9 7.4 45.4 9.9 8.4 76.1 17.9 28.0 40.8 9.5 45.2 26.7 31.0 60.4 37.1 19.1 36.2 44.3 9.4 27.5 10.3 27.6 12.8 11.2 24.7 57.3 5.6 19.5 66.7 3.8 9.4 20.1 2.8 39.0 27.5 9.4 19.0 68.6 44.8 27.1 24.2 18.2 23.1 24.0 34.6 28.7 50.4 125.5 62.1 26.3 22.4 26.5 23.3 23.6 18.8 20.9 25.9 18.1 17.3 15.8 20.2 56.4 25.0 22.7 2.4 35.7 30.0 11.4 13.4 11.9 13.3 13.5 13.0 11.6 13.3 10.3 12.6 13.1 13.9 16.3 32.9 19.2 13.7 18.9 71.8 31.1 7.8 18.8 12.5 2.2 14.8 10.3 5.4 11.5 12.4 7.3 12.5 13.8 140.6 2.4 11.7 37.4 220.6 4.3 28.2 29.5 10.7 19.1 23.7 13.5 102.8 58.9 14.3 8.1 39.3 11.2 33.5 6.6 56.1 20.2 45.4 4.1 14.2 76.9 195.6 399.8 31.7 79.3 35.6 40.3 142.7 13.9 97.9 64.3 62.9 33.3 1.1 38.0 37.6 11.7 11.4 32.8 10.3 14.8 19.7 15.8 29.3 71.3 17.2 7.7 22.4 37.4 105.0 16.3 3.4 22.5 IKBIP "FLJ31051, IKIP" ENSG00000166130 "IKBKB interacting protein" Q70UQ0 12 98613405-98645113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 28.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.1" "Cell line enhanced" "Detected in all" "BJ: 206.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038677, HPA038678, HPA061541" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555" "unprognostic (3.06e-1)" "unprognostic (1.06e-3)" "unprognostic (2.13e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (4.00e-5)" "unprognostic (6.28e-3)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (7.37e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.60e-9)" "unprognostic (7.37e-2)" "unprognostic (1.66e-1)" "unprognostic (3.46e-1)" "unprognostic (3.16e-2)" 14.2 7.1 2.3 15.5 2.8 5.1 10.2 2.4 3.2 12.7 4.9 6.3 4.1 10.4 5.8 4.8 6.8 13.0 8.1 2.3 3.4 8.4 10.4 11.0 12.7 3.2 2.6 2.3 5.9 5.9 4.2 7.8 27.0 3.1 6.9 7.1 1.2 6.2 7.5 2.7 3.1 5.7 16.2 3.1 11.9 5.6 4.6 2.9 11.7 9.4 4.8 9.7 17.3 7.5 3.0 13.0 39.8 43.5 28.4 102.8 105.8 39.4 206.0 124.7 53.3 67.2 8.8 12.4 42.4 35.5 128.7 37.1 26.7 17.5 80.5 90.1 12.4 26.7 16.2 23.9 59.8 39.3 30.2 31.1 81.1 16.6 62.4 54.5 95.3 75.3 7.8 25.5 16.0 133.3 11.8 14.0 68.7 16.9 10.2 33.5 11.9 64.0 21.7 88.9 14.6 6.6 20.8 58.9 4.1 34.1 73.6 13.1 37.0 71.6 115.7 41.3 50.5 53.9 17.2 20.1 31.8 33.3 27.2 85.1 11.4 6.4 19.3 2.8 4.9 3.3 5.9 1.8 2.9 5.4 3.8 2.0 2.0 28.1 5.0 5.7 3.7 2.6 1.8 2.3 2.8 2.4 3.2 2.3 3.4 3.2 2.6 2.3 3.1 3.1 2.9 3.0 44.9 12.8 15.7 1.6 34.4 7.6 15.5 55.6 21.6 2.8 7.9 22.4 3.0 0.0 18.7 3.7 4.2 35.5 32.5 2.3 11.7 10.5 2.8 7.9 47.4 47.7 0.0 19.8 5.9 5.8 65.3 47.0 2.6 4.4 20.8 32.7 44.3 8.4 45.7 3.3 3.3 4.8 12.2 31.2 34.1 3.6 30.7 35.4 14.2 14.0 40.4 2.0 37.0 11.6 2.2 5.1 3.1 17.0 74.8 7.6 1.0 10.1 6.3 2.6 39.5 27.8 46.8 32.1 16.0 9.0 7.2 10.1 23.6 25.3 2.9 6.5 RPUSD2 "C15orf19, C18B11, FLJ31409, PUS9" ENSG00000166133 "RNA pseudouridine synthase domain containing 2" Q8IZ73 15 40569299-40574949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042079, HPA042194" Approved Approved Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA042079: AB_10794643, HPA042194: AB_10794416" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (1.32e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (1.31e-1)" "unprognostic (6.60e-2)" "unprognostic (8.32e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.63e-7)" "unprognostic (7.27e-2)" "unprognostic (8.28e-2)" "unprognostic (3.12e-2)" "unprognostic (2.75e-2)" 5.0 9.0 5.3 4.8 5.9 9.8 5.8 5.6 6.5 5.9 5.5 7.4 4.8 9.2 5.3 7.2 7.3 2.4 7.9 5.4 5.4 6.3 8.9 4.5 6.8 5.4 5.1 5.3 7.8 5.4 5.3 7.9 3.7 5.5 6.5 4.0 2.6 7.7 4.7 14.6 9.5 7.0 3.6 4.5 8.0 6.3 6.2 5.2 6.1 6.1 7.6 6.2 6.3 5.2 5.8 10.4 11.5 9.6 16.0 8.1 6.1 18.2 9.0 10.8 15.4 12.2 14.3 6.4 9.9 12.8 10.5 14.1 27.7 22.3 15.9 8.7 11.5 15.3 17.1 15.9 17.1 12.1 14.7 12.1 8.6 14.7 10.1 13.8 7.1 9.7 16.1 21.9 11.4 7.7 12.3 17.7 18.6 12.4 15.0 12.4 22.3 10.7 15.3 10.0 8.9 10.9 12.6 12.3 13.8 7.6 7.9 13.2 19.9 6.0 10.5 12.3 13.7 10.5 11.8 25.2 27.3 9.2 22.9 8.4 0.1 6.4 5.6 23.4 8.0 21.3 28.2 22.6 24.9 12.5 35.5 26.8 22.5 0.7 33.6 18.4 16.5 26.3 14.4 5.3 5.9 5.6 6.5 5.4 5.4 5.4 5.1 5.3 5.5 4.5 5.2 5.8 5.7 6.4 2.6 2.3 10.4 10.6 16.4 11.5 10.8 11.7 6.4 8.6 8.2 8.6 7.0 7.3 16.7 15.7 9.3 5.4 25.4 9.6 2.1 5.4 5.7 5.7 13.2 8.2 2.8 10.9 9.3 7.6 6.6 4.6 4.5 9.0 3.6 9.1 7.1 18.5 2.9 6.2 12.2 2.2 3.1 1.7 7.2 2.6 3.6 1.0 3.4 15.6 7.2 4.0 3.1 6.5 5.0 10.1 8.9 9.0 4.9 13.2 9.9 16.0 13.1 11.6 8.1 7.1 15.1 9.6 10.7 5.6 7.3 12.4 8.5 8.0 HIF1AN "DKFZp762F1811, FIH1, FLJ20615, FLJ22027" ENSG00000166135 "Hypoxia inducible factor 1 subunit alpha inhibitor" Q9NWT6 10 100529072-100559998 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 42.0;tongue: 41.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048742, HPA065302, CAB069903" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458" "unprognostic (4.07e-2)" "unprognostic (7.75e-2)" "unprognostic (2.35e-2)" "unprognostic (3.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.54e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-2)" "unprognostic (3.09e-2)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (3.24e-2)" 6.6 8.2 6.9 7.9 6.5 6.2 6.6 6.1 7.3 6.2 5.5 7.1 7.2 7.3 7.3 7.6 6.8 6.3 12.4 6.8 5.7 7.6 5.5 5.8 7.9 6.8 7.5 6.4 10.4 8.2 12.2 6.5 6.0 7.8 7.5 6.7 9.9 6.5 8.4 42.0 10.1 7.2 7.4 6.0 6.8 6.5 14.0 7.0 9.3 5.5 41.1 9.7 7.2 5.5 6.9 13.8 14.4 19.0 19.1 28.8 11.9 16.3 14.4 34.4 20.9 24.5 22.3 11.5 14.8 12.8 21.7 15.4 15.9 16.9 13.0 22.6 16.5 10.2 14.2 12.8 17.2 14.9 17.1 17.9 11.7 12.9 20.4 22.2 29.4 11.9 19.5 6.3 8.1 23.9 14.4 18.3 11.2 6.2 11.6 6.9 13.2 23.4 7.2 14.6 18.2 7.2 11.9 12.4 7.6 13.7 15.8 25.7 9.2 10.1 10.6 13.8 10.6 14.7 10.9 11.8 11.1 17.6 13.8 8.1 13.7 7.6 15.3 7.7 10.7 7.7 7.9 8.0 7.3 7.2 6.4 7.6 7.8 8.0 9.1 13.0 2.6 9.8 8.4 6.9 6.5 6.1 7.3 6.8 5.7 6.8 7.5 6.4 7.8 6.0 7.0 6.9 7.9 0.0 6.5 11.8 16.7 11.0 11.5 16.4 13.1 17.9 12.3 8.9 40.7 14.3 11.7 11.0 16.7 27.8 16.5 15.5 9.8 17.3 21.5 9.0 11.3 12.1 13.2 16.0 12.2 13.9 17.6 10.9 11.2 8.7 6.3 20.0 8.2 10.9 14.3 25.2 11.2 12.0 8.2 18.5 6.8 49.3 11.1 10.1 3.6 11.2 23.4 15.0 27.8 11.1 12.8 17.7 11.3 12.0 11.2 11.4 20.1 20.5 11.6 23.1 6.6 12.0 16.1 48.2 26.6 11.4 11.6 32.7 14.0 14.8 13.3 10.3 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 876.5;Proximal tubular cells: 881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003886, HPA065549" Supported Enhanced Mitochondria NA NA Mitochondria "HPA003886: AB_1079463, HPA065549: " "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 154.0 201.0 435.3 104.4 444.3 173.0 136.9 429.9 611.0 125.6 416.1 216.3 162.5 147.0 164.5 171.6 133.6 88.8 472.5 445.0 443.7 251.9 264.1 109.6 133.1 441.9 440.3 438.1 131.5 116.5 333.9 188.2 83.7 448.1 133.3 146.4 128.2 165.1 137.0 412.7 129.0 149.0 126.6 419.6 134.4 202.7 66.7 439.7 141.9 131.2 517.3 120.8 164.2 134.0 453.1 250.2 419.6 222.3 383.1 159.6 158.8 238.5 168.1 370.9 259.3 278.8 575.4 278.1 260.7 146.4 185.6 189.1 289.5 162.9 269.7 194.5 172.9 417.8 183.9 350.3 465.7 217.6 379.3 302.6 191.6 240.7 249.2 329.3 180.4 283.7 361.1 194.5 159.3 218.4 304.1 369.7 472.9 144.7 324.3 377.9 252.4 237.6 346.1 298.8 281.3 147.9 209.7 122.0 227.4 250.9 147.3 338.2 332.8 185.5 139.5 158.7 151.5 296.8 288.4 286.4 334.8 277.6 398.2 159.3 299.4 530.8 478.1 406.0 558.8 483.1 616.1 498.0 468.1 589.7 546.7 538.1 514.0 122.7 478.0 489.6 655.0 817.6 1113.4 435.3 444.3 429.9 611.0 445.0 443.7 441.9 440.3 438.1 448.1 419.6 439.7 453.1 184.8 76.9 132.7 41.8 107.6 0.0 187.1 0.0 12.5 186.4 162.2 210.2 392.9 204.5 48.3 198.6 58.4 333.1 175.8 109.0 876.5 268.1 24.9 105.8 86.3 142.7 105.6 114.3 72.6 264.7 305.1 128.8 35.2 87.1 109.7 112.0 153.8 346.5 399.1 153.1 82.6 171.6 0.0 184.4 0.0 56.0 218.1 142.2 0.0 33.7 231.0 219.5 158.6 40.2 62.3 250.6 191.7 217.4 59.3 203.2 560.2 881.6 85.2 183.5 170.9 117.2 176.0 85.5 83.1 31.5 0.0 307.7 112.9 225.5 237.6 221.5 ZFYVE19 "ANCHR, FLJ14840" ENSG00000166140 "Zinc finger FYVE-type containing 19" Q96K21 15 40807086-40815084 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040283, HPA041946" Uncertain NA NA "HPA040283: AB_10673369, HPA041946: AB_2677762" "unprognostic (3.59e-2)" "unprognostic (6.62e-2)" "unprognostic (1.15e-2)" "prognostic favorable (7.36e-4)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (1.84e-2)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (8.61e-2)" "unprognostic (7.69e-3)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (8.40e-3)" "unprognostic (1.72e-1)" 8.7 9.0 16.6 8.0 17.2 8.6 10.2 20.5 17.3 11.1 13.8 11.4 12.4 9.0 10.8 15.5 9.2 6.7 10.2 14.5 17.7 10.5 19.4 9.2 10.1 20.0 18.4 14.2 10.6 8.4 14.2 9.5 9.1 20.0 12.5 8.2 6.7 13.8 8.2 13.7 11.2 12.6 8.9 18.2 13.8 9.7 8.1 19.0 11.0 9.0 13.6 10.6 10.9 11.5 19.0 10.0 12.3 8.8 13.3 13.9 13.9 13.4 15.0 19.4 19.9 20.7 8.9 23.5 9.2 16.5 14.7 17.5 18.0 12.7 17.4 12.1 28.6 12.4 16.6 21.5 11.2 12.5 12.0 24.1 13.5 18.3 13.0 12.6 18.0 19.6 15.2 12.9 11.9 12.7 10.7 15.2 14.8 5.5 22.4 17.6 18.8 5.1 11.4 12.1 19.7 16.0 9.7 13.7 34.6 4.8 6.7 16.4 19.8 9.6 12.4 13.8 9.2 9.9 10.3 14.3 9.8 11.8 22.9 12.4 9.0 5.8 5.2 5.3 9.4 6.2 5.2 5.5 5.2 6.5 3.7 6.0 5.5 3.1 8.9 6.2 5.5 6.1 4.7 16.6 17.2 20.5 17.3 14.5 17.7 20.0 18.4 14.2 20.0 18.2 19.0 19.0 11.4 6.4 5.6 6.2 6.6 6.4 13.3 19.7 8.0 11.1 14.8 12.2 9.3 15.7 18.0 12.9 12.5 74.7 5.7 22.6 19.6 24.4 5.3 12.4 8.0 9.7 3.5 5.2 7.6 17.6 16.8 9.6 12.2 12.5 12.7 12.7 10.4 21.8 22.4 3.3 9.4 15.5 22.4 9.9 6.8 10.9 12.8 9.7 7.2 7.5 14.3 9.8 8.2 7.1 15.7 19.3 20.7 9.4 4.2 9.1 50.3 27.4 17.9 10.7 13.1 7.3 9.6 18.6 19.4 7.9 7.7 55.1 9.3 8.9 15.5 15.1 PPP1R14D "CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016" ENSG00000166143 "Protein phosphatase 1 regulatory inhibitor subunit 14D" Q9NXH3 15 40815451-40828709 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 112.1" "Group enriched" "Detected in some" 4 "Distal enterocytes: 334.5;Paneth cells: 338.1;Proximal enterocytes: 412.4;Undifferentiated cells: 108.9" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 45.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.6;RPMI-8226: 3.1;RT4: 1.9;SK-BR-3: 1.2;T-47d: 1.1;U-266/84: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA041846 Uncertain NA NA "HPA041846: AB_10794307" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (5.91e-3)" "unprognostic (1.17e-2)" "unprognostic (4.68e-2)" "unprognostic (1.89e-1)" "unprognostic (7.74e-2)" "unprognostic (2.86e-1)" "unprognostic (5.26e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.55e-1)" "unprognostic (1.43e-2)" "unprognostic (3.74e-3)" "unprognostic (3.11e-2)" 0.1 0.0 0.1 9.7 0.1 0.0 0.5 0.6 0.2 0.3 0.1 108.1 112.1 0.2 1.9 0.2 0.3 15.8 0.1 0.2 0.0 3.7 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.3 0.4 0.1 0.1 0.3 0.7 93.3 0.2 0.7 0.4 0.0 1.0 83.0 3.6 0.1 0.0 1.7 0.2 0.1 0.0 0.6 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 3.1 0.0 1.9 0.4 0.3 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.6 0.2 0.2 0.0 0.2 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.5 0.9 0.0 5.7 0.3 1.8 0.0 0.4 0.1 334.5 0.0 1.3 0.0 0.1 0.0 0.0 61.3 0.0 0.1 5.3 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 0.2 58.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 338.1 0.0 0.0 0.1 412.4 52.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.9 0.0 108.9 0.2 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 257.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 7400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.4 0.7 1.2 16.6 1.5 1.4 35.1 4.8 1.8 43.2 5.5 109.8 161.4 13.3 79.6 257.5 33.9 38.4 1.0 0.9 2.2 70.2 3.6 48.0 6.5 2.4 3.2 0.8 2.4 69.8 133.9 31.6 146.1 2.6 52.8 90.0 0.4 164.0 31.7 0.6 149.0 139.4 4.3 2.4 6.9 89.1 1.8 2.6 10.0 35.0 0.4 45.8 57.7 90.8 2.6 124.8 1.0 0.0 0.9 0.1 0.0 323.2 2.3 3.0 4.0 2.4 195.3 202.4 0.3 141.2 0.4 3.6 377.6 30.8 181.9 2.4 1.0 10.6 5.6 3.3 10.8 2.2 21.9 93.9 0.3 264.0 3.9 16.5 3.4 14.7 12.1 2.7 1.1 0.2 96.5 0.9 16.6 37.4 207.6 17.7 12.6 0.0 24.9 179.3 308.2 79.8 3.9 9.3 558.8 15.7 56.9 267.7 16.1 0.0 0.2 2.0 1.2 0.5 1.2 24.5 0.8 0.8 16.3 1.1 0.0 19.7 14.3 0.4 15.9 0.8 8.4 3.0 1.4 32.4 6.0 1.1 0.3 25.9 5.5 18.1 4.0 0.5 7.6 1.2 1.5 4.8 1.8 0.9 2.2 2.4 3.2 0.8 2.6 2.4 2.6 2.6 0.8 57.7 14.7 0.0 7.6 76.0 96.7 220.0 55.8 0.1 96.2 63.5 0.5 105.8 207.3 134.3 0.0 1254.0 1.4 477.6 25.4 429.4 0.8 63.3 14.2 6.9 147.3 4.8 0.5 255.1 105.1 10.4 106.5 155.6 10.2 1.9 0.4 0.5 135.4 0.0 0.5 169.4 221.8 10.0 23.8 1.1 3.7 19.8 14.2 0.0 68.6 0.0 0.0 0.0 0.0 309.8 375.2 0.0 2.1 135.7 514.5 44.2 46.6 0.3 0.0 0.1 12.6 0.6 5.9 93.2 87.9 1673.8 6.6 0.1 182.7 222.3 FBN1 "FBN, MASS, MFS1, OCTD, SGS, WMS" ENSG00000166147 "Fibrillin 1" P35555 15 48408313-48645721 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hormone" "Aortic aneurysm, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 61.5;placenta: 77.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002670, HPA017759, HPA021057, CAB058696, CAB068188" Enhanced Approved Cytosol "Secreted to blood" NA NA 520000000 Cytosol "CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586" "unprognostic (3.97e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "unprognostic (9.50e-2)" "unprognostic (1.51e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-2)" "unprognostic (4.79e-2)" "unprognostic (7.82e-2)" "unprognostic (1.50e-2)" "unprognostic (2.78e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.44e-5)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.25e-2)" "unprognostic (8.69e-3)" "prognostic unfavorable (5.11e-4)" 61.5 4.4 2.0 14.6 4.7 3.4 13.9 2.6 4.1 36.4 12.8 8.4 3.9 15.4 6.4 12.7 12.3 27.5 17.0 0.7 3.8 2.7 2.9 10.1 3.7 4.7 5.4 0.6 28.6 3.4 3.0 2.6 77.3 4.9 8.1 11.8 1.3 4.7 13.3 4.6 5.2 6.6 36.0 1.8 6.4 6.0 7.1 3.7 2.9 18.8 21.4 3.5 19.0 10.0 4.9 0.1 5.2 19.8 22.4 215.1 460.7 0.2 175.8 62.9 51.1 32.4 0.1 0.3 0.1 7.9 420.8 0.4 0.7 3.9 0.6 45.9 20.7 1.2 2.0 88.5 0.2 120.7 0.8 0.3 251.3 0.1 135.9 15.6 211.1 55.5 1.6 0.0 0.4 55.6 0.0 1.5 0.2 4.0 0.2 7.1 0.1 17.0 0.2 5.9 0.5 0.2 12.9 0.0 2.2 0.1 15.3 0.2 1.4 106.8 206.9 6.2 305.8 37.6 1.2 1.0 0.0 138.9 0.3 13.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.0 4.7 2.6 4.1 0.7 3.8 4.7 5.4 0.6 4.9 1.8 3.7 4.9 50.0 0.0 1.3 34.9 0.4 25.6 0.8 1.5 0.6 6.1 1.3 3.4 14.2 0.0 5.8 12.9 0.0 132.4 0.4 0.0 0.0 0.2 8.7 4.2 105.2 36.1 0.0 5.5 82.3 0.6 40.8 388.5 3.1 2.0 1.3 22.5 34.6 0.6 15.3 0.0 123.5 0.0 0.0 0.8 39.0 22.8 236.1 5.7 42.7 30.0 2.3 0.8 0.0 76.9 218.7 1.7 0.0 227.2 1.7 0.7 0.1 0.6 3.3 0.2 26.3 139.5 55.8 3.3 3.4 0.8 20.6 65.8 4.3 51.3 0.0 0.2 AVPR1A AVPR1 ENSG00000166148 "Arginine vasopressin receptor 1A" P37288 12 63142759-63151201 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 57.2" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 24.1;Hepatocytes: 62.7;Sertoli cells: 78.9;Smooth muscle cells: 100.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 8 "hypothalamus: 5.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "ASC diff: 5.6;Karpas-707: 13.1;U-266/84: 9.8" "Group enriched" "Detected in some" 5 "basal ganglia: 7.0;hypothalamus: 3.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (2.82e-1)" "unprognostic (9.90e-3)" "unprognostic (2.90e-1)" "unprognostic (1.59e-1)" "unprognostic (1.43e-3)" "unprognostic (3.79e-2)" "unprognostic (2.60e-1)" "unprognostic (3.58e-6)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.38e-3)" "unprognostic (4.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.77e-2)" "unprognostic (4.66e-4)" 17.4 57.2 0.3 1.5 0.2 0.0 9.1 0.0 0.3 9.1 1.2 1.6 0.7 11.0 1.1 3.0 4.8 6.2 1.7 0.3 5.1 4.7 21.1 0.5 1.2 0.5 0.1 0.2 1.3 2.3 2.2 0.6 0.3 0.2 2.3 1.2 1.4 1.1 4.2 2.0 1.7 0.9 12.3 0.1 0.8 1.7 0.6 0.6 1.4 10.5 3.5 0.6 2.5 2.6 0.2 0.1 0.2 0.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.3 0.3 5.1 0.5 0.1 0.2 0.2 0.1 0.6 0.2 14.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.6 0.3 0.2 0.3 3.4 1.5 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 3.1 24.1 4.5 0.0 2.7 0.1 0.0 0.5 2.7 0.5 1.6 0.0 0.2 0.7 62.7 0.2 0.0 1.0 0.0 0.0 1.3 0.3 0.0 2.8 1.4 0.0 0.0 0.0 7.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 78.9 2.9 100.9 0.2 0.2 0.0 0.3 0.1 0.6 2.1 0.0 0.3 C16orf78 MGC33367 ENSG00000166152 "Chromosome 16 open reading frame 78" Q8WTQ4 16 49373804-49399431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 287 "testis: 49.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1738.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 316.9 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1738.4 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 6.7 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 DEPDC4 "DEP.4, FLJ33505" ENSG00000166153 "DEP domain containing 4" Q8N2C3 12 100203669-100267079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 4.0" "Cell type enhanced" "Detected in many" "Early spermatids: 13.7;Late spermatids: 19.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039323 Uncertain Approved Microtubules NA NA Microtubules "HPA039323: AB_10674283" "unprognostic (8.89e-2)" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (4.33e-2)" "unprognostic (3.62e-1)" "unprognostic (7.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (9.09e-4)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-2)" 0.2 0.3 0.2 0.3 0.2 0.6 0.8 0.2 0.6 0.3 0.0 0.6 1.3 0.4 0.5 0.7 0.4 0.4 0.3 0.2 0.4 1.7 1.3 0.3 0.3 0.2 0.2 0.1 0.7 0.7 0.5 0.5 0.7 0.2 0.7 0.8 0.4 0.7 1.0 0.2 0.4 0.5 0.2 0.3 0.2 0.6 4.0 0.2 0.6 0.5 0.2 0.3 0.3 0.3 0.3 1.3 1.8 3.4 0.9 0.1 0.4 2.1 1.8 1.2 3.7 2.2 2.9 0.7 1.4 1.1 0.9 1.1 2.0 2.9 1.5 4.0 1.5 3.2 4.9 0.8 3.3 0.4 1.6 1.9 0.3 0.9 1.3 0.3 0.7 0.9 2.5 2.9 0.6 1.7 1.3 1.0 2.9 1.6 1.6 1.9 2.0 3.4 3.3 1.7 0.8 0.9 2.0 1.0 1.4 1.1 2.0 2.8 1.7 0.2 2.5 1.0 1.0 1.4 1.5 1.7 3.0 0.7 1.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.2 0.3 0.5 0.0 4.4 6.2 0.7 0.9 1.4 1.8 3.4 2.1 1.0 1.5 0.9 0.0 2.2 5.5 4.2 3.5 0.2 0.5 5.9 0.6 13.7 0.9 0.9 0.7 0.0 2.1 3.3 1.3 2.0 3.6 0.0 0.9 0.0 1.1 0.4 1.1 1.1 0.0 3.4 0.5 0.0 0.3 1.1 19.2 1.2 0.5 1.8 1.0 0.1 1.3 0.0 3.5 6.5 0.5 0.3 0.0 0.2 0.6 1.4 5.3 1.8 4.8 0.0 1.4 1.2 8.0 6.2 0.7 0.3 1.2 0.7 2.4 1.5 0.9 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836753 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 13.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.9;Excitatory neurons: 10.2;Horizontal cells: 11.8;Inhibitory neurons: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 4.3;SCLC-21H: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055094, HPA062745" Uncertain Approved Cytosol NA NA Cytosol "HPA055094: AB_2682693, HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.0 0.0 2.7 0.0 8.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 3.1 0.0 0.0 0.0 0.0 2.8 4.8 2.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 8.5 0.0 3.6 4.1 3.1 2.8 4.8 2.4 2.5 0.0 13.3 2.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 7.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 OPN1MW2 ENSG00000166160 "Opsin 1, medium wave sensitive 2" P0DN77 X 154219756-154233286 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 462 "retina: 46.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BRD7 "BP75, CELTIX1" ENSG00000166164 "Bromodomain containing 7" Q9NPI1 16 50313487-50368988 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042389, CAB046458, HPA060171" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214" "unprognostic (2.10e-2)" "unprognostic (9.52e-3)" "unprognostic (7.06e-2)" "unprognostic (3.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (4.85e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.38e-4)" "unprognostic (2.15e-1)" "unprognostic (8.97e-2)" "unprognostic (9.46e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (3.59e-2)" "unprognostic (6.34e-2)" 32.5 34.4 52.4 33.9 56.9 66.5 36.4 55.0 70.0 33.9 51.2 40.2 31.3 37.1 47.4 49.7 34.6 26.9 35.9 50.9 54.3 38.9 30.9 35.6 46.9 56.2 55.2 47.8 33.6 48.2 56.5 31.1 43.5 56.5 33.0 38.8 50.0 35.3 33.4 54.9 42.0 35.4 34.8 54.6 37.7 39.9 57.5 55.1 57.7 40.5 44.7 50.5 35.8 35.9 59.6 78.4 67.8 116.4 69.7 48.2 47.7 76.6 62.8 61.7 96.9 43.8 114.3 77.5 116.1 64.2 56.0 60.4 70.7 107.6 63.3 111.1 53.2 89.1 79.0 54.2 159.2 56.7 110.0 83.5 34.9 93.2 49.9 85.5 58.8 65.6 113.0 115.8 36.2 59.9 51.0 125.2 147.0 91.5 82.0 63.5 151.8 109.2 84.8 85.6 54.5 90.0 73.1 76.3 73.2 53.6 99.0 43.9 98.5 66.8 61.3 74.4 51.0 62.0 17.0 7.1 196.9 48.1 78.5 62.2 6.2 5.1 7.6 6.4 4.4 4.9 6.1 6.4 6.0 4.1 6.2 7.1 8.7 2.9 9.8 4.1 8.5 6.9 3.0 52.4 56.9 55.0 70.0 50.9 54.3 56.2 55.2 47.8 56.5 54.6 55.1 59.6 73.7 38.5 64.4 16.0 54.6 50.7 41.1 16.9 20.5 89.0 63.4 63.8 35.7 52.9 29.6 49.7 66.7 70.6 124.6 51.1 107.6 22.3 47.4 75.1 62.9 42.0 36.0 76.4 14.6 23.0 49.5 41.3 40.2 89.1 15.2 84.3 38.6 45.8 29.9 90.9 15.8 46.6 20.3 40.3 24.5 22.5 32.6 45.9 26.6 17.8 38.4 81.2 82.4 30.2 32.7 23.9 36.4 28.2 74.2 62.2 32.0 72.3 36.7 120.6 52.6 78.4 46.5 203.6 157.2 44.8 63.2 72.4 55.7 59.3 46.1 66.6 CKB CKBB ENSG00000166165 "Creatine kinase B" P12277 14 103519667-103522833 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 700.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 2767.4;Distal enterocytes: 4691.8;Distal tubular cells: 2281.3;Horizontal cells: 5042.4;Muller glia cells: 3639.8;Rod photoreceptor cells: 3789.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "non-classical monocyte: 290.8" "Lineage enriched" "Detected in many" 18 "monocytes: 290.8" "Cell line enhanced" "Detected in many" "CACO-2: 455.8;HEK 293: 1399.8;SCLC-21H: 792.2;SH-SY5Y: 352.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001254, CAB047313" Enhanced Supported Cytosol No No 38000000 Cytosol "CAB047313: , HPA001254: AB_1078528" "unprognostic (9.97e-2)" "unprognostic (1.33e-3)" "unprognostic (4.25e-3)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (3.62e-2)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (4.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.68e-3)" "unprognostic (9.89e-3)" "prognostic favorable (4.02e-8)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-2)" "unprognostic (2.13e-1)" 91.5 60.6 464.5 26.0 498.2 3.3 47.6 617.1 700.3 104.8 140.2 572.5 36.4 224.5 16.2 55.0 199.6 18.1 250.4 428.9 404.9 162.3 9.0 60.8 4.1 396.6 395.8 345.0 59.3 27.9 109.2 74.5 4.7 453.7 304.3 153.3 475.3 38.2 210.2 80.7 72.7 121.8 114.8 339.4 6.8 483.8 98.4 537.5 2.9 88.7 47.5 5.1 300.9 102.4 334.0 2.4 54.5 321.1 14.7 4.4 2.3 6.3 37.5 0.3 2.4 1.4 455.8 7.3 0.4 36.9 29.1 9.9 70.2 109.9 1.5 0.2 9.6 1399.8 111.0 242.1 165.4 16.6 0.7 87.9 14.7 0.6 3.9 0.8 3.3 0.0 5.1 198.7 3.7 4.8 20.0 2.3 3.9 109.1 48.3 213.6 13.9 6.8 275.9 65.9 2.5 792.2 352.2 65.3 10.6 25.2 21.6 21.1 40.9 2.2 1.5 56.3 4.7 147.3 21.1 2.7 7.2 6.4 2.1 14.1 2.4 0.5 14.6 0.3 28.5 0.4 0.0 0.2 0.1 16.4 0.2 0.1 0.5 1.0 0.2 290.8 0.0 0.7 6.0 464.5 498.2 617.1 700.3 428.9 404.9 396.6 395.8 345.0 453.7 339.4 537.5 334.0 14.8 195.5 103.5 515.8 13.5 153.7 296.2 257.6 56.3 2767.4 41.5 48.9 553.5 145.8 117.9 114.0 1909.9 4.4 3.4 4691.8 2281.3 127.6 445.8 773.2 205.7 60.8 467.1 9.9 178.0 42.5 11.7 96.6 359.4 408.5 28.6 476.1 74.6 9.2 8.2 5042.4 147.0 726.0 187.2 2.8 44.9 147.4 304.1 39.8 181.5 88.1 74.2 3639.8 0.0 93.5 161.2 131.4 1996.9 1089.3 6.6 279.8 9.5 118.0 456.1 3789.9 59.2 15.4 222.6 127.3 97.4 22.1 175.2 41.6 19.1 12.2 755.6 220.1 TRMT61A "C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61" ENSG00000166166 "TRNA methyltransferase 61A" Q96FX7 14 103529196-103537073 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024269 Approved Mitochondria NA NA Mitochondria "HPA024269: " "unprognostic (5.12e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (5.59e-3)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (3.70e-2)" "unprognostic (9.86e-3)" "unprognostic (2.88e-3)" "unprognostic (4.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-1)" 10.3 10.1 9.7 4.6 12.1 4.5 9.7 9.8 14.5 14.5 6.5 19.3 4.4 18.9 2.3 9.8 19.1 2.4 7.4 9.6 9.1 10.0 11.7 8.1 3.7 11.1 10.4 8.9 10.9 11.1 3.1 7.6 2.7 10.7 17.3 1.7 1.5 7.5 7.1 10.0 10.7 9.7 4.3 9.4 7.6 12.5 8.3 10.2 2.3 15.4 2.7 1.8 21.5 11.3 11.5 10.0 24.4 3.7 7.6 3.8 3.9 15.1 10.8 4.8 13.3 7.2 33.4 16.8 16.1 13.3 5.7 7.8 25.2 8.0 8.3 3.7 11.0 15.0 12.3 9.6 18.0 6.7 15.9 9.2 4.4 10.4 11.6 4.7 3.1 2.3 11.4 18.5 7.6 4.5 28.9 19.6 12.2 12.9 20.7 48.8 24.0 11.6 13.9 5.4 14.5 19.4 12.2 12.4 11.5 14.7 1.4 21.5 9.3 4.6 12.0 12.8 31.9 22.4 10.2 7.0 20.2 12.8 12.7 23.3 0.0 2.1 0.3 2.6 5.4 1.9 2.5 2.1 2.8 3.3 2.6 2.3 2.3 0.0 2.7 10.8 2.2 1.6 2.2 9.7 12.1 9.8 14.5 9.6 9.1 11.1 10.4 8.9 10.7 9.4 10.2 11.5 9.8 0.0 6.0 4.9 11.0 26.1 19.9 7.7 6.8 13.7 11.5 13.5 62.7 7.2 4.7 7.3 4.2 13.0 7.2 19.2 17.6 19.4 4.0 6.0 15.7 10.6 10.7 2.5 4.1 12.2 15.5 13.6 8.2 7.2 2.5 12.6 3.9 9.9 12.3 30.3 3.2 10.4 4.1 7.8 7.8 18.9 11.1 6.6 10.6 2.8 12.8 9.4 4.1 0.5 4.8 19.7 9.3 18.4 6.3 22.8 6.3 15.7 5.0 11.2 0.0 12.5 15.4 6.9 12.5 8.5 30.0 12.0 7.0 10.7 19.4 13.6 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 109.7;Excitatory neurons: 154.0;Inhibitory neurons: 144.4;Oligodendrocyte precursor cells: 183.5;Oligodendrocytes: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: AB_2673764" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 5.2 9.3 14.7 3.8 19.8 2.9 8.6 9.2 17.5 6.9 7.7 5.6 3.9 6.2 10.6 8.4 7.7 5.9 14.8 18.0 16.7 8.1 6.5 4.9 4.3 11.1 13.1 16.6 11.1 6.5 13.2 9.5 7.9 12.8 8.9 4.8 21.8 7.0 5.9 12.3 6.9 4.7 7.2 8.8 6.6 5.7 13.9 14.3 6.5 8.6 12.2 5.6 6.4 6.7 14.5 8.7 13.0 17.2 20.0 16.1 14.1 6.3 12.0 18.4 11.8 10.0 9.0 6.5 13.8 11.8 9.9 12.3 12.9 14.1 13.0 11.7 9.5 11.5 10.1 8.0 11.5 8.9 14.9 5.7 9.0 14.7 10.4 18.4 22.4 15.3 12.7 11.0 4.5 12.0 7.2 9.8 7.5 7.8 9.0 9.9 12.4 24.6 2.8 10.3 5.4 12.9 11.2 8.1 3.5 11.3 19.2 9.2 5.1 12.7 6.1 10.3 8.6 8.5 7.5 18.2 8.7 6.4 7.3 3.9 1.8 1.7 1.8 2.9 1.5 2.8 2.5 3.0 2.5 2.3 2.1 3.4 2.8 1.1 2.5 1.6 1.1 2.8 1.6 14.7 19.8 9.2 17.5 18.0 16.7 11.1 13.1 16.6 12.8 8.8 14.3 14.5 8.6 3.2 9.4 109.7 6.9 5.6 4.1 6.9 12.5 32.5 10.0 7.4 28.0 8.6 10.6 3.7 29.2 11.5 6.1 5.0 7.9 9.7 41.9 11.7 12.4 9.0 3.0 20.6 154.0 7.2 7.2 10.3 3.6 10.6 13.9 10.1 6.4 6.7 5.9 16.8 144.4 4.9 6.1 3.5 2.5 21.6 9.0 5.0 1.8 69.3 4.6 13.6 8.2 183.5 148.0 7.9 3.2 10.5 6.3 6.6 5.5 9.4 13.0 26.0 6.6 8.3 7.6 33.8 18.3 7.4 7.1 12.4 8.2 5.9 4.8 6.2 POLL ENSG00000166169 "DNA polymerase lambda" Q9UGP5 10 101578882-101588270 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076828 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA076828: " "unprognostic (3.71e-3)" "unprognostic (6.93e-3)" "unprognostic (1.73e-2)" "unprognostic (2.47e-2)" "unprognostic (9.52e-2)" "unprognostic (1.80e-2)" "unprognostic (2.11e-2)" "unprognostic (1.24e-1)" "unprognostic (8.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.12e-2)" "unprognostic (7.19e-2)" "unprognostic (4.74e-2)" "unprognostic (1.06e-2)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" "unprognostic (1.64e-3)" 16.4 22.6 15.3 12.5 15.9 12.9 19.8 14.0 19.1 20.3 15.6 20.8 17.0 19.6 22.8 18.2 22.3 15.7 19.0 15.8 14.2 24.9 27.1 15.8 17.1 16.1 14.4 15.9 26.5 46.0 21.5 28.7 13.9 15.4 26.2 17.2 17.6 20.9 15.5 34.7 16.0 18.8 14.4 12.0 22.9 27.9 41.8 14.9 7.5 26.3 18.4 17.3 21.1 17.9 15.6 23.5 21.0 16.2 23.0 16.2 30.0 22.7 15.3 26.4 22.9 23.9 15.5 27.8 5.7 23.5 13.9 12.6 28.8 18.4 22.6 18.4 20.8 24.8 18.1 23.1 17.7 29.8 19.0 16.2 27.5 30.3 25.0 51.8 64.1 24.7 11.1 20.4 19.2 14.7 18.8 0.0 20.8 8.6 13.0 12.4 0.1 14.6 9.9 19.2 14.1 11.2 16.6 9.4 15.7 26.5 23.8 47.3 11.0 13.5 8.1 16.4 9.8 16.8 28.4 15.3 8.9 17.5 16.6 6.3 0.6 9.2 1.3 6.5 6.6 10.6 8.4 7.4 6.8 11.6 6.8 11.7 8.0 1.0 9.5 6.7 0.2 10.2 7.6 15.3 15.9 14.0 19.1 15.8 14.2 16.1 14.4 15.9 15.4 12.0 14.9 15.6 7.5 6.4 12.9 13.7 11.4 3.7 6.7 9.7 7.4 16.9 14.7 19.0 8.6 11.5 7.4 7.3 47.9 16.9 7.5 9.1 5.9 9.6 25.2 7.3 7.5 7.6 13.1 25.9 10.4 21.5 9.8 9.6 20.9 6.6 14.0 20.9 8.6 10.9 11.2 21.9 7.9 13.6 18.3 17.7 6.0 51.6 14.0 9.6 10.6 2.8 18.0 10.1 13.4 8.5 9.9 13.7 9.2 11.3 10.9 6.5 13.7 11.6 7.2 24.0 13.1 10.8 9.6 35.5 11.0 8.4 2.0 11.5 9.4 14.4 15.6 5.6 BAG5 ENSG00000166170 "BAG cochaperone 5" Q9UL15 14 103556545-103562657 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 128.8" "Group enriched" "Detected in all" 13 "Early spermatids: 1734.2;Late spermatids: 1796.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016429 Enhanced Approved Vesicles NA NA Vesicles "HPA016429: AB_1845261" "unprognostic (3.02e-2)" "unprognostic (2.98e-2)" "unprognostic (1.05e-2)" "unprognostic (6.26e-2)" "unprognostic (2.54e-1)" "unprognostic (5.22e-2)" "unprognostic (1.99e-3)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (4.77e-3)" "unprognostic (2.34e-1)" "unprognostic (3.80e-2)" "prognostic favorable (1.58e-8)" "unprognostic (2.51e-1)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (2.53e-1)" 24.8 11.5 13.0 15.3 14.0 28.0 18.9 16.9 16.4 14.9 15.6 14.9 12.4 16.3 12.7 22.0 16.1 13.0 13.4 14.0 13.8 16.0 12.0 15.6 17.3 13.4 13.3 12.8 12.3 12.3 14.1 10.9 14.5 14.0 14.1 14.7 18.6 16.6 14.3 13.2 19.4 12.2 15.2 13.5 18.5 15.0 128.8 13.2 15.0 23.9 13.6 19.3 15.5 12.7 15.0 26.2 22.1 30.0 27.1 27.5 26.5 33.1 26.0 22.6 22.6 19.9 18.0 32.7 47.3 24.5 30.2 20.6 38.4 24.2 34.7 35.6 19.9 15.8 31.3 25.3 16.2 17.4 42.7 31.3 19.3 43.7 23.2 29.3 20.7 24.0 34.4 25.2 34.8 31.2 35.1 37.4 19.9 17.8 43.8 27.4 40.1 34.4 21.6 37.3 58.3 33.0 22.3 34.9 30.3 23.6 20.1 38.9 21.8 28.4 24.4 19.9 37.9 31.2 21.4 34.4 52.7 27.5 22.9 30.9 28.7 13.4 11.9 9.3 14.8 11.9 6.8 11.0 9.0 14.1 7.8 12.8 11.1 9.0 13.0 21.4 5.9 10.6 12.7 13.0 14.0 16.9 16.4 14.0 13.8 13.4 13.3 12.8 14.0 13.5 13.2 15.0 51.5 44.8 24.3 10.4 29.4 69.0 44.8 33.3 47.8 37.9 32.9 28.8 21.8 17.2 44.5 35.0 27.1 25.4 40.0 26.5 66.5 24.7 1734.2 78.6 43.7 41.2 31.7 29.5 18.9 19.1 17.7 31.7 26.0 89.5 32.3 19.3 52.5 25.6 22.1 75.7 14.7 25.0 32.6 29.2 26.4 1796.9 49.7 24.4 32.0 11.2 23.6 49.6 36.0 9.0 20.3 27.1 15.2 67.0 18.5 45.2 18.4 31.7 43.3 36.2 32.9 30.3 27.0 129.7 40.4 60.5 89.8 40.8 33.3 33.1 24.3 62.1 DPCD "DKFZP566F084, RP11-529I10.4" ENSG00000166171 "Deleted in primary ciliary dyskinesia homolog (mouse)" Q9BVM2 10 101570560-101609662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 133.4" "Group enriched" "Detected in many" 4 "Early spermatids: 579.4;Late spermatids: 1068.7;Respiratory ciliated cells: 329.7;Spermatocytes: 313.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 20.2;intermediate monocyte: 22.2;myeloid DC: 29.6;non-classical monocyte: 9.5" "Group enriched" "Detected in all" 14 "dendritic cells: 29.6;monocytes: 22.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036603, HPA036604" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036603: AB_2675212, HPA036604: AB_10673503" "unprognostic (1.22e-2)" "unprognostic (1.73e-3)" "unprognostic (4.66e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.90e-1)" "unprognostic (9.13e-2)" "unprognostic (4.00e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (1.64e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (5.04e-2)" "unprognostic (3.83e-2)" "unprognostic (7.54e-2)" 10.3 18.8 35.7 8.8 36.6 11.9 19.6 31.7 42.3 22.0 49.5 15.2 6.9 16.8 41.7 20.6 73.9 15.7 29.0 37.0 38.9 31.1 10.5 14.1 6.2 35.2 35.4 34.1 23.7 14.8 49.7 49.9 10.7 35.0 16.3 13.6 56.3 21.4 15.8 19.4 13.3 7.2 18.1 33.2 4.6 14.6 133.4 36.6 6.6 33.3 18.5 8.3 14.6 15.0 33.6 97.1 53.4 37.9 77.2 35.2 61.7 15.6 44.5 53.6 59.4 55.1 38.8 51.4 9.0 74.6 42.7 25.2 54.0 55.4 65.3 61.2 23.0 57.5 11.3 49.8 56.7 20.3 58.8 8.1 42.3 54.8 72.0 56.1 153.7 50.8 14.0 32.4 12.6 45.1 122.9 0.0 48.1 28.7 26.9 41.6 0.0 51.8 20.5 92.6 25.3 37.1 63.3 36.5 23.4 31.3 34.1 71.2 23.9 35.5 27.3 24.9 55.7 62.3 37.9 45.9 16.9 94.7 13.7 11.7 0.0 20.2 1.0 1.8 22.2 1.7 1.3 1.4 1.4 29.6 0.7 1.5 1.8 0.9 1.6 9.5 4.1 0.6 8.1 35.7 36.6 31.7 42.3 37.0 38.9 35.2 35.4 34.1 35.0 33.2 36.6 33.6 6.9 35.3 12.4 4.9 2.1 9.7 29.5 89.2 9.6 16.4 25.4 29.5 33.7 30.0 56.6 49.7 18.8 24.6 0.9 10.5 95.9 63.3 579.4 136.5 23.5 11.1 23.9 14.1 7.7 27.5 16.7 21.2 10.2 20.2 1.3 19.2 11.4 10.9 24.0 11.8 6.2 12.5 52.9 4.4 14.6 1068.7 23.6 8.7 16.0 3.7 6.9 27.8 2.1 4.0 1.4 33.9 12.4 27.8 5.6 18.6 3.5 117.3 329.7 49.1 0.0 12.4 29.0 313.8 77.4 8.7 14.2 10.7 2.9 25.3 22.1 23.9 LARP6 "acheron, FLJ11196" ENSG00000166173 "La ribonucleoprotein 6, translational regulator" Q9BRS8 15 70829130-70854157 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 94.3" "Cell type enhanced" "Detected in many" "Early spermatids: 429.0;Late spermatids: 259.8;Spermatocytes: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 232.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020338, HPA049029" Approved Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "HPA020338: AB_1844500, HPA049029: AB_2680604" "unprognostic (1.35e-3)" "unprognostic (1.95e-1)" "unprognostic (7.43e-2)" "unprognostic (2.63e-3)" "unprognostic (2.96e-2)" "unprognostic (4.70e-2)" "unprognostic (2.44e-2)" "unprognostic (2.80e-3)" "unprognostic (4.27e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (9.90e-5)" "unprognostic (4.51e-3)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" "unprognostic (3.43e-1)" 49.8 9.9 47.1 6.6 70.2 0.1 44.4 58.0 65.7 27.2 28.1 15.4 2.2 23.0 28.6 8.0 29.2 11.0 43.3 47.8 56.6 28.1 10.7 18.1 2.3 61.3 61.2 41.7 30.7 11.0 19.8 23.8 7.8 71.1 26.3 4.0 11.9 19.7 14.3 17.7 13.1 10.4 12.3 49.7 2.6 27.1 9.6 57.5 5.1 41.2 26.3 1.5 21.3 31.2 94.3 42.3 44.2 14.1 28.3 70.2 77.9 0.1 127.7 99.0 67.4 71.2 12.9 12.0 0.0 50.9 69.9 65.4 22.7 32.0 11.2 66.4 0.4 78.3 0.2 37.6 12.0 127.1 0.2 0.2 49.0 45.6 67.9 107.5 70.6 22.2 15.4 0.1 0.6 30.4 7.3 0.3 0.3 14.9 0.0 113.9 0.2 50.6 0.3 22.0 35.9 8.4 18.5 42.5 0.5 93.1 21.7 2.3 2.4 29.6 27.4 109.6 232.0 107.5 0.2 0.3 0.4 116.9 0.0 14.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 47.1 70.2 58.0 65.7 47.8 56.6 61.3 61.2 41.7 71.1 49.7 57.5 94.3 32.3 0.0 1.1 2.9 0.1 18.1 47.7 20.4 9.6 41.4 15.4 18.3 22.2 24.3 11.8 12.9 2.1 0.5 1.0 0.3 54.8 59.4 429.0 24.6 31.8 24.5 12.0 0.0 10.8 25.1 0.8 87.5 4.1 8.4 0.0 7.5 11.4 15.3 1.2 25.2 11.8 1.5 10.2 0.6 13.3 259.8 73.3 3.2 19.6 7.5 0.1 28.5 0.0 5.5 105.9 62.9 0.0 45.9 0.5 61.9 0.0 100.9 16.8 4.8 19.7 28.3 34.8 166.8 11.0 1.4 8.9 0.4 1.9 5.3 0.6 37.7 API5 "AAC-11, AAC11, API5L1" ENSG00000166181 "Apoptosis inhibitor 5" Q9BZZ5 11 43311963-43344529 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026598 Approved Enhanced "Nuclear speckles" NA NA 31000 "Nuclear speckles" "HPA026598: AB_1844927" "unprognostic (4.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.58e-3)" "unprognostic (6.08e-2)" "unprognostic (5.88e-2)" "unprognostic (3.46e-2)" "unprognostic (1.24e-2)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (1.45e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.06e-4)" "unprognostic (5.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.05e-2)" 38.0 33.4 30.4 43.8 33.5 35.6 46.1 41.2 37.7 39.7 29.0 44.7 43.2 42.5 34.8 45.1 36.9 32.7 28.5 33.5 33.2 49.6 58.2 35.1 53.9 32.2 32.1 31.4 35.4 46.3 47.0 19.2 30.2 32.7 40.8 47.1 44.5 39.4 39.8 37.4 40.4 45.9 47.0 33.8 40.6 41.5 27.0 32.2 62.7 51.8 36.2 57.6 44.6 27.8 40.7 90.2 93.0 119.4 75.2 82.7 82.4 82.9 83.8 89.4 116.3 110.2 69.4 38.8 106.4 67.2 90.2 86.9 107.7 143.2 99.7 160.6 122.4 134.9 96.5 53.0 60.8 74.8 165.6 88.9 64.2 104.6 59.0 102.9 72.4 98.9 65.8 160.3 93.9 82.1 57.0 141.2 71.1 214.6 111.1 86.0 145.2 126.3 85.3 89.5 103.8 95.5 64.2 100.7 88.7 81.4 88.4 109.1 76.6 86.5 102.0 78.3 139.8 144.5 77.5 122.7 172.1 88.8 95.0 62.3 61.3 47.3 51.5 66.5 64.5 75.1 61.7 64.8 69.3 62.1 60.4 66.3 68.7 9.9 116.3 67.3 40.0 61.4 88.4 30.4 33.5 41.2 37.7 33.5 33.2 32.2 32.1 31.4 32.7 33.8 32.2 40.7 26.4 16.0 27.3 30.0 35.9 43.8 16.6 21.6 47.3 23.8 27.8 17.8 14.4 31.5 28.0 20.2 10.4 30.4 31.8 20.1 31.3 21.3 13.6 23.5 25.8 26.2 24.0 48.0 40.2 19.7 30.4 28.3 35.2 28.2 32.3 25.9 22.1 48.0 26.3 28.6 33.5 27.5 12.2 33.6 28.8 6.5 18.6 30.0 32.0 27.2 41.7 21.1 17.5 25.1 45.4 24.9 19.8 20.3 44.2 24.0 29.4 37.3 20.8 19.0 6.6 28.9 31.1 28.4 26.6 43.1 51.9 38.9 33.8 26.6 31.4 19.2 ASPG C14orf76 ENSG00000166183 Asparaginase Q86U10 14 104085686-104115582 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 58.2;liver: 152.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA069761 Enhanced NA NA "HPA069761: AB_2686191" "unprognostic (1.45e-2)" "unprognostic (7.43e-3)" "unprognostic (2.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-2)" "unprognostic (1.74e-2)" "unprognostic (1.72e-2)" "unprognostic (3.47e-2)" "unprognostic (1.98e-1)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "unprognostic (1.10e-1)" "unprognostic (8.75e-2)" "unprognostic (7.98e-2)" "unprognostic (3.85e-1)" "unprognostic (1.52e-2)" "unprognostic (2.32e-2)" 1.2 1.4 0.2 0.2 0.2 0.0 0.7 0.0 0.4 3.3 0.2 4.7 1.5 2.3 1.1 34.3 6.3 0.1 58.2 0.3 0.5 12.9 152.4 2.3 0.0 0.4 0.6 0.1 11.5 0.2 0.8 2.3 1.8 0.2 0.3 1.9 0.3 2.9 0.1 0.5 10.0 0.5 1.2 0.0 0.2 3.1 1.1 0.7 0.1 6.0 0.0 3.8 2.3 9.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.6 0.5 0.4 0.3 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.3 0.5 0.4 0.6 0.1 0.2 0.0 0.7 0.2 0.0 6.4 1.7 0.3 0.5 1.8 0.2 0.7 0.0 1.1 0.6 0.8 21.4 2.8 2.4 0.0 0.0 0.2 0.0 21.2 3.9 0.0 0.4 0.7 0.1 0.5 1.8 0.0 0.1 0.2 0.2 4.3 4.6 0.7 0.0 66.8 3.6 93.9 0.2 5.0 0.1 16.0 0.0 1.6 0.3 0.7 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 7.6 1.2 0.0 0.1 0.9 49.7 1.6 0.3 0.0 0.0 0.6 0.3 1.5 8.4 9.1 0.5 0.3 3.9 5.4 3.0 ZNF319 "KIAA1388, Zfp319" ENSG00000166188 "Zinc finger protein 319" Q9P2F9 16 57994676-58000672 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 10.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052584 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052584: AB_2681873" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (3.82e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (7.63e-2)" "unprognostic (1.15e-1)" "unprognostic (4.87e-2)" "prognostic favorable (5.87e-5)" "unprognostic (8.69e-2)" "unprognostic (3.72e-3)" "unprognostic (4.49e-1)" "unprognostic (1.82e-1)" "unprognostic (3.53e-2)" "unprognostic (5.80e-2)" 3.6 4.6 4.1 3.6 3.8 11.9 3.6 5.0 4.8 4.7 1.8 4.4 3.1 6.6 2.3 3.1 4.9 1.9 4.4 4.0 4.2 3.1 3.4 3.7 4.1 4.9 4.4 3.1 5.9 5.2 6.2 3.8 2.6 5.3 4.1 1.7 2.2 3.9 3.8 5.1 4.0 4.0 3.5 3.7 6.7 3.7 3.9 3.9 4.0 6.4 5.2 2.9 5.8 3.2 4.2 4.5 10.8 6.1 8.7 5.5 6.9 4.8 6.2 6.7 6.6 3.1 5.5 2.9 6.8 10.7 5.2 4.9 4.4 5.4 6.6 4.2 2.9 4.2 3.3 6.4 5.7 10.8 3.9 10.2 8.9 8.1 4.8 11.6 6.2 3.9 5.7 6.2 1.2 5.7 4.3 8.1 5.8 3.7 2.2 10.5 11.5 3.4 7.6 4.1 11.4 4.1 4.4 9.1 4.3 4.3 4.6 1.5 5.8 6.4 5.1 3.1 2.7 4.6 5.6 3.2 6.0 4.0 3.8 5.8 0.0 1.0 3.4 2.1 0.7 1.2 0.5 1.0 1.4 1.1 0.5 0.7 1.1 1.9 0.7 0.6 0.4 0.9 1.4 4.1 3.8 5.0 4.8 4.0 4.2 4.9 4.4 3.1 5.3 3.7 3.9 4.2 2.7 3.2 3.4 1.6 1.2 0.9 0.5 2.4 1.2 2.0 1.9 2.4 5.3 5.7 1.6 0.0 0.0 1.6 4.1 1.6 3.9 2.4 0.3 3.2 2.9 2.2 4.9 0.4 0.9 3.0 1.0 2.1 0.0 2.7 1.3 3.3 3.9 2.2 2.3 0.0 1.2 1.5 0.0 7.6 1.0 0.1 3.1 1.8 0.0 1.9 4.3 3.2 10.3 4.0 1.7 2.7 0.5 3.4 1.0 0.8 2.0 1.3 3.7 3.1 0.0 2.4 1.4 2.8 1.1 0.8 1.3 0.3 2.8 3.2 1.2 0.2 HPS6 "BLOC2S3, FLJ22501" ENSG00000166189 "HPS6 biogenesis of lysosomal organelles complex 2 subunit 3" Q86YV9 10 102065349-102068036 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040687 Approved NA NA "HPA040687: AB_2677078" "unprognostic (4.15e-1)" "unprognostic (2.23e-1)" "unprognostic (8.74e-2)" "unprognostic (1.38e-2)" "unprognostic (3.30e-1)" "unprognostic (2.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.21e-2)" "unprognostic (3.04e-2)" "unprognostic (2.39e-1)" "unprognostic (1.23e-2)" "unprognostic (4.23e-1)" "unprognostic (5.86e-3)" "unprognostic (5.53e-2)" "unprognostic (1.66e-1)" "unprognostic (2.88e-1)" "unprognostic (5.50e-2)" 6.2 8.1 3.9 6.6 4.0 7.6 6.1 3.4 5.0 5.6 2.8 7.4 7.9 9.1 3.5 10.3 7.3 4.1 6.8 4.2 4.0 5.6 6.7 6.6 7.8 5.0 4.0 4.2 5.6 9.3 6.7 4.5 5.6 4.0 5.1 4.8 1.9 7.7 5.6 8.2 9.0 8.4 5.1 3.6 9.3 8.6 3.6 4.5 5.7 5.0 6.0 6.6 7.0 5.8 4.7 26.0 21.5 6.3 17.3 19.4 14.0 13.5 16.8 25.0 20.0 16.3 11.5 17.4 13.6 16.7 18.8 11.4 25.9 11.9 27.4 5.3 19.8 16.4 14.1 10.1 8.4 12.2 16.5 17.0 15.6 28.0 12.7 16.1 20.2 14.6 11.8 9.6 7.4 15.9 17.5 12.2 21.8 6.2 12.1 17.5 16.7 2.2 11.8 17.3 11.8 4.6 13.0 9.8 11.9 13.1 8.1 23.4 20.9 19.0 7.6 9.3 7.6 17.3 12.7 10.5 9.8 15.4 19.3 6.1 0.0 1.9 2.5 3.1 2.9 2.7 2.3 2.6 2.6 1.8 1.6 1.2 1.5 2.1 3.9 1.4 3.0 2.0 1.2 3.9 4.0 3.4 5.0 4.2 4.0 5.0 4.0 4.2 4.0 3.6 4.5 4.7 4.2 9.6 2.6 1.3 6.9 1.9 7.7 4.5 3.4 8.1 2.8 2.8 6.2 4.3 4.3 5.5 12.5 12.4 4.7 9.2 7.9 12.4 0.1 3.0 3.7 4.8 2.4 6.1 1.2 14.9 9.5 4.5 4.6 3.2 0.0 4.6 6.1 6.7 10.6 10.1 1.2 5.8 0.0 6.3 2.7 0.9 7.5 4.8 5.4 1.0 10.5 10.1 10.3 1.5 0.6 12.6 5.8 5.3 4.2 6.3 8.7 6.2 3.7 5.1 0.0 4.3 5.6 2.4 4.2 6.0 2.4 10.1 5.9 5.3 9.0 6.3 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.8" "Group enriched" "Detected in many" 11 "Early spermatids: 86.5;Late spermatids: 222.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 1.1 1.8 2.8 1.1 2.5 2.8 2.1 1.2 3.1 1.7 0.0 1.9 1.8 1.8 3.3 2.3 2.5 1.9 4.0 2.4 1.6 4.5 2.5 1.5 1.5 2.0 1.9 2.0 2.5 1.5 2.4 2.1 1.7 1.7 2.1 1.9 4.7 1.7 1.8 6.4 1.6 1.5 1.6 0.4 1.5 2.0 15.8 1.6 1.6 5.1 5.7 1.2 1.7 1.0 2.6 1.5 2.7 4.7 3.8 5.6 6.9 2.7 4.1 2.5 2.2 2.0 2.1 3.4 1.5 5.7 2.4 4.0 3.4 7.4 5.9 3.3 1.6 4.0 2.5 3.7 1.9 3.9 2.8 1.3 3.3 5.8 1.4 6.2 2.9 2.1 4.4 3.7 2.7 5.4 3.8 2.9 3.7 4.0 3.4 2.5 1.9 4.2 3.3 6.0 2.6 5.8 2.0 4.4 3.3 4.2 5.6 5.1 2.1 2.2 4.5 1.7 7.8 2.0 2.2 2.9 1.8 2.1 4.0 3.3 1.1 0.9 0.7 0.8 2.2 1.1 1.9 1.3 1.2 2.9 0.6 1.5 1.8 0.3 3.5 3.2 0.8 1.1 1.0 2.8 2.5 1.2 3.1 2.4 1.6 2.0 1.9 2.0 1.7 0.4 1.6 2.6 1.2 6.4 5.3 3.9 0.4 0.3 1.4 2.5 1.2 4.5 2.4 2.4 5.4 1.5 4.5 1.8 4.2 6.7 0.3 1.5 13.7 3.3 86.5 2.5 2.7 1.8 1.2 3.2 4.6 1.7 3.4 2.6 4.1 2.6 0.0 3.4 1.8 1.5 2.1 1.7 6.1 1.5 2.0 2.6 0.6 222.9 1.8 1.7 0.0 2.8 3.8 10.6 0.0 6.0 4.0 1.4 3.2 1.2 0.2 1.7 2.3 8.1 6.0 4.0 0.0 2.3 1.3 10.7 12.6 1.4 0.4 7.8 1.0 3.0 2.2 1.0 NOLC1 "KIAA0035, NOPP130, NOPP140, P130, Srp40" ENSG00000166197 "Nucleolar and coiled-body phosphoprotein 1" Q14978 10 102152176-102163871 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032654, HPA037366, HPA050388" Supported Enhanced "Nucleoli fibrillar center" No Yes 44000 "Nucleoli fibrillar center" "CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109" "unprognostic (3.23e-1)" "unprognostic (5.58e-2)" "unprognostic (9.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.89e-2)" "unprognostic (7.03e-3)" "unprognostic (2.36e-3)" "unprognostic (7.34e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (5.64e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (9.19e-5)" "unprognostic (3.15e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (8.25e-5)" "unprognostic (7.68e-2)" 36.9 24.2 10.0 42.3 11.6 37.5 32.6 13.9 19.8 27.3 3.8 32.1 22.0 30.6 18.9 33.6 34.7 29.3 24.2 12.1 12.3 21.3 37.8 25.1 43.5 11.3 10.4 8.3 34.7 38.7 43.3 14.7 38.6 10.8 31.8 39.5 38.3 26.5 26.8 45.7 22.1 23.0 34.1 9.1 27.8 27.7 19.5 10.8 54.7 37.9 46.8 56.2 64.8 19.8 17.5 202.1 175.1 98.2 209.0 84.7 66.0 166.6 108.5 87.8 150.1 130.5 302.1 132.4 401.5 118.1 69.5 73.9 225.1 285.0 236.1 173.3 127.0 194.8 267.9 143.6 200.3 112.0 389.8 122.8 86.3 169.8 158.3 328.7 94.5 96.5 194.3 286.6 172.6 102.6 170.3 373.7 95.0 196.5 150.7 137.1 277.3 261.6 233.3 100.2 123.5 148.3 141.9 103.5 124.1 144.5 95.6 207.5 99.3 79.3 67.7 93.5 81.3 256.9 165.5 254.4 442.4 110.5 422.7 60.7 2.4 12.5 11.6 20.4 14.4 24.9 16.6 16.1 19.2 16.2 12.1 18.5 22.6 1.3 17.3 17.2 12.4 13.0 17.9 10.0 11.6 13.9 19.8 12.1 12.3 11.3 10.4 8.3 10.8 9.1 10.8 17.5 47.8 60.9 74.7 6.2 47.6 120.4 112.6 37.7 101.9 20.8 52.6 48.0 35.3 20.0 68.2 16.5 14.6 49.2 29.1 28.3 25.4 42.2 29.0 38.5 56.3 47.3 27.6 56.8 8.8 23.1 62.7 63.9 43.3 73.1 44.2 28.6 16.8 23.4 27.1 10.1 7.9 38.3 18.3 11.2 46.0 9.7 23.0 26.8 26.6 4.7 22.9 15.1 32.0 2.5 6.8 48.8 21.0 21.1 62.3 89.5 10.2 19.9 56.6 20.0 6.6 85.8 58.9 32.1 53.5 103.3 117.5 48.6 44.5 40.1 49.1 100.5 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase" Q96Q83 11 43880811-43920274 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 90.9;Late spermatids: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: AB_2679671" "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 19.1 15.8 15.8 9.2 17.0 7.9 20.8 19.6 21.0 21.3 16.7 17.3 11.0 20.7 24.9 18.7 19.7 9.3 14.7 16.4 16.5 16.3 18.7 13.3 13.9 16.8 16.7 16.5 23.1 23.8 17.0 18.3 7.4 17.4 22.1 12.9 17.2 19.5 13.6 35.5 23.1 16.0 13.7 16.6 19.8 20.2 20.5 16.6 16.1 15.4 26.1 14.8 19.3 20.0 18.8 15.8 26.0 10.7 0.0 20.3 26.1 0.0 19.5 42.0 36.9 34.7 10.7 12.0 2.6 12.2 28.7 20.5 21.3 14.6 32.3 33.1 0.0 49.6 23.7 17.1 27.4 51.9 44.5 30.5 27.8 55.7 17.0 81.4 15.2 26.5 44.7 33.9 25.9 18.3 18.4 38.6 21.9 20.6 16.2 38.5 11.6 23.8 30.3 21.3 23.2 20.3 16.1 15.7 22.6 37.1 9.7 32.9 26.3 20.6 21.6 12.5 35.7 28.0 23.1 25.1 26.3 31.3 18.3 17.6 34.4 16.4 9.4 19.8 18.4 19.3 18.6 20.9 18.2 23.5 21.8 24.8 22.9 2.9 24.6 29.4 20.9 21.3 17.4 15.8 17.0 19.6 21.0 16.4 16.5 16.8 16.7 16.5 17.4 16.6 16.6 18.8 12.0 16.0 10.9 15.0 12.6 10.3 8.8 16.5 10.8 11.5 10.9 12.8 6.8 14.3 13.3 16.5 4.2 3.4 13.7 9.8 31.3 24.6 90.9 6.3 7.3 14.6 9.5 9.9 15.8 32.6 4.6 14.0 10.2 4.8 7.6 12.5 13.2 12.9 19.0 10.1 15.8 11.3 6.1 11.2 7.0 103.3 16.1 13.1 17.8 3.7 14.1 20.4 22.6 13.0 16.1 27.7 8.6 10.5 12.4 9.3 15.5 17.1 14.0 13.0 6.6 9.9 15.3 29.3 12.6 20.6 7.1 2.2 12.7 15.7 12.5 8.3 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" Yes No 190000 Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424" "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 62.3 43.8 27.0 34.7 31.4 125.6 67.7 37.0 37.1 62.4 30.0 39.4 43.7 58.9 44.4 63.8 43.6 54.2 62.1 29.1 31.8 61.4 58.1 35.3 45.9 33.3 33.4 25.4 77.3 54.4 66.2 26.6 45.4 34.8 45.6 42.0 32.5 40.4 47.4 93.4 35.7 37.5 57.0 35.3 32.2 36.7 51.4 29.4 50.1 62.4 113.1 49.2 59.6 35.6 43.7 92.0 53.1 111.6 94.4 134.2 189.9 76.7 157.3 149.8 135.4 123.5 113.0 49.1 151.1 105.2 152.2 108.7 131.9 160.3 130.9 148.0 103.3 64.5 141.0 105.4 91.7 102.6 134.7 70.7 161.2 104.3 110.4 193.3 149.3 144.0 82.5 184.4 78.8 149.3 49.5 72.3 67.3 72.6 128.4 68.9 78.2 105.2 227.7 143.5 136.5 108.4 78.6 90.7 96.4 127.8 129.4 95.6 133.3 93.4 132.1 71.0 249.6 167.9 71.0 196.3 191.0 123.4 215.1 109.4 11.7 17.9 12.2 13.1 23.5 24.4 14.6 19.7 19.2 21.0 13.9 24.8 16.2 7.4 16.6 22.9 13.3 28.4 16.0 27.0 31.4 37.0 37.1 29.1 31.8 33.3 33.4 25.4 34.8 35.3 29.4 43.7 72.8 76.9 56.1 14.4 50.0 87.1 57.1 90.8 80.8 23.2 47.6 59.3 104.3 27.1 69.8 23.9 10.4 56.1 48.2 18.5 54.8 40.3 28.2 56.7 91.6 53.6 20.8 50.1 35.2 29.9 71.0 79.6 36.2 94.0 52.6 39.3 46.1 32.5 43.9 33.7 36.1 25.1 32.6 47.5 44.9 21.6 55.3 46.1 35.6 19.7 49.3 24.8 27.8 21.6 48.7 35.9 21.6 53.4 63.5 53.0 41.0 84.8 47.4 19.7 19.7 74.6 109.0 93.1 43.3 63.2 98.9 131.9 54.0 58.6 34.6 64.4 GABRB3 ENSG00000166206 "Gamma-aminobutyric acid type A receptor subunit beta3" P28472 15 26543546-26939539 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7;retina: 32.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 152.4;Excitatory neurons: 519.6;Inhibitory neurons: 258.7;Oligodendrocyte precursor cells: 139.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 68.5;HAP1: 27.9;NTERA-2: 48.3;OE19: 21.6;SCLC-21H: 44.2;U-2 OS: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (3.20e-2)" "unprognostic (4.25e-2)" "unprognostic (1.66e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" "unprognostic (3.56e-3)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.33e-2)" "unprognostic (4.05e-1)" 0.6 5.6 11.0 0.5 25.2 0.0 0.8 5.3 26.6 2.3 0.0 1.2 0.8 1.8 1.0 1.2 2.3 13.8 5.4 25.2 17.3 7.4 0.9 0.9 0.1 3.2 3.6 27.7 1.9 4.8 2.1 15.8 0.0 5.8 5.0 0.9 32.2 0.5 1.2 0.1 0.7 0.6 1.4 1.5 0.6 5.8 4.0 8.9 1.5 8.7 0.1 0.2 1.1 0.5 17.8 0.0 68.5 10.7 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 27.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 5.4 3.3 0.0 0.0 0.0 0.0 0.0 14.8 2.1 0.1 0.0 0.0 4.8 0.0 48.3 21.6 3.4 0.0 0.0 0.0 4.7 0.0 44.2 16.6 0.0 0.1 0.0 5.0 0.1 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 25.2 5.3 26.6 25.2 17.3 3.2 3.6 27.7 5.8 1.5 8.9 17.8 0.4 12.8 3.6 33.3 0.0 0.0 0.8 0.7 1.2 152.4 1.0 0.8 15.3 24.3 1.7 5.5 39.6 0.4 0.0 1.4 0.0 4.6 10.7 1.4 4.0 1.2 10.3 0.0 519.6 0.4 0.0 1.7 2.6 0.6 0.0 1.1 0.7 0.4 0.0 75.7 258.7 1.9 0.0 0.6 0.0 5.6 1.8 0.0 0.0 5.6 0.2 7.9 0.0 139.7 8.7 1.7 0.4 3.4 0.0 3.3 0.2 7.0 13.5 53.7 0.0 1.0 0.9 8.6 29.3 0.7 0.1 0.3 0.1 0.5 0.9 0.4 SPIC "MGC40611, SPI-C" ENSG00000166211 "Spi-C transcription factor" Q8N5J4 12 101475336-101486997 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 31.0" "Group enriched" "Detected in some" 8 "Kupffer cells: 16.7;Macrophages: 11.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 8 "monocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.82e-2)" "unprognostic (2.43e-2)" "unprognostic (9.03e-3)" "unprognostic (2.51e-1)" "unprognostic (4.85e-2)" "unprognostic (5.78e-2)" "unprognostic (5.30e-2)" "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.0 0.1 0.1 0.0 1.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.2 0.0 0.0 16.7 0.0 0.0 0.0 11.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 TBATA "C10orf27, FLJ32820, spatial" ENSG00000166220 "Thymus, brain and testes associated" Q96M53 10 70771239-70785401 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "lymphoid tissue: 380.0" "Group enriched" "Detected in some" 20 "Early spermatids: 119.6;Late spermatids: 291.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 4.0" "Region enhanced" "Detected in many" "cerebellum: 21.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.54e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "unprognostic (6.24e-2)" "unprognostic (1.45e-1)" "unprognostic (4.88e-1)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 21.1 0.1 380.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 119.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 291.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SGPL1 SPL ENSG00000166224 "Sphingosine-1-phosphate lyase 1" O95470 10 70815948-70881184 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 112.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021125, HPA023086" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021125: AB_1856803, HPA023086: AB_1856804" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (7.60e-2)" "unprognostic (2.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (1.70e-2)" "unprognostic (2.12e-1)" "unprognostic (9.52e-2)" "unprognostic (3.42e-1)" "unprognostic (2.14e-1)" "unprognostic (9.21e-2)" "unprognostic (4.68e-3)" 12.1 12.8 16.5 18.1 17.5 6.8 13.1 16.1 16.9 17.7 12.8 16.8 16.2 14.5 18.9 28.1 15.5 12.7 6.0 15.2 18.7 15.6 23.1 10.8 18.2 19.2 17.1 13.7 9.1 18.7 21.2 9.5 10.1 17.3 17.7 18.1 10.9 14.4 12.5 9.7 29.5 23.0 14.0 18.5 16.2 12.4 14.1 17.7 18.0 20.3 6.1 20.2 25.2 14.8 20.8 26.9 35.2 33.2 38.1 8.9 11.5 22.1 15.5 16.4 16.5 21.4 38.4 57.8 24.2 18.0 15.8 15.9 44.1 28.8 31.0 23.5 39.1 15.6 2.5 17.5 46.2 33.6 10.6 20.9 21.8 51.4 22.1 57.6 34.6 10.4 22.3 7.2 20.4 23.6 29.6 13.2 7.1 15.0 35.4 19.5 16.6 25.2 9.1 26.3 112.1 22.6 27.5 30.9 46.6 28.5 25.9 24.3 7.5 20.3 14.8 38.7 11.6 30.1 8.4 12.6 11.0 14.7 19.3 10.7 1.1 18.2 14.0 18.0 34.6 16.5 7.2 11.5 14.7 16.2 8.7 8.5 13.5 15.0 18.8 44.9 8.9 11.8 12.4 16.5 17.5 16.1 16.9 15.2 18.7 19.2 17.1 13.7 17.3 18.5 17.7 20.8 3.8 16.0 6.4 32.3 11.0 12.2 17.8 21.4 8.0 6.3 15.8 9.8 6.3 27.1 23.2 46.0 20.9 7.3 16.0 41.5 3.9 36.2 2.9 30.2 13.3 7.3 25.1 4.4 48.7 37.6 13.8 10.1 6.6 46.1 14.7 23.1 7.1 44.5 27.6 15.2 38.8 21.2 22.4 43.1 16.1 5.2 11.5 25.7 7.2 35.6 22.7 9.8 25.7 41.7 43.8 55.6 18.8 20.3 5.9 26.0 53.5 12.0 26.6 9.7 6.6 13.3 19.0 20.0 34.0 15.9 22.7 6.3 11.1 18.2 20.9 25.3 FRS2 "FRS2A, FRS2alpha, SNT-1, SNT1" ENSG00000166225 "Fibroblast growth factor receptor substrate 2" Q8WU20 12 69470349-69579793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 104.5;Oligodendrocyte precursor cells: 76.9;Oligodendrocytes: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038323, HPA073385" Uncertain "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038323: , HPA073385: " "unprognostic (9.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.25e-1)" "unprognostic (1.28e-1)" "unprognostic (8.50e-2)" "unprognostic (9.29e-2)" "unprognostic (1.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.22e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-1)" "unprognostic (8.97e-2)" "unprognostic (2.34e-2)" "unprognostic (5.70e-3)" "unprognostic (3.80e-2)" "unprognostic (8.22e-2)" "unprognostic (6.66e-2)" 9.9 8.2 13.5 5.5 18.8 27.3 13.4 23.0 15.9 12.0 9.8 8.5 6.1 12.5 13.7 8.7 9.6 11.6 7.9 13.4 23.3 8.2 12.0 8.6 6.1 17.2 14.9 10.5 15.0 6.0 12.3 4.8 10.9 15.3 8.0 8.5 10.3 7.9 7.2 7.3 8.4 7.6 11.9 21.1 6.1 7.7 9.3 15.7 9.5 12.9 8.9 7.4 8.0 6.9 27.7 15.1 12.4 21.9 9.7 12.2 13.6 38.9 16.5 17.8 14.8 11.8 25.1 6.4 6.8 10.2 21.5 7.7 13.2 11.6 17.7 18.6 11.7 9.2 12.2 9.9 7.9 11.1 10.6 8.8 13.0 20.4 17.9 13.1 17.8 7.3 7.8 8.7 15.2 12.8 19.3 8.6 4.0 24.4 7.9 9.7 7.5 18.8 5.6 11.3 36.5 10.6 20.6 25.4 10.7 15.5 27.1 31.0 5.9 13.1 11.7 13.0 15.3 13.0 13.2 22.4 6.3 8.5 5.9 10.7 0.5 4.2 2.2 2.6 3.8 2.8 2.8 2.6 2.2 2.9 6.0 5.0 2.9 4.3 2.7 7.4 2.6 1.6 2.0 13.5 18.8 23.0 15.9 13.4 23.3 17.2 14.9 10.5 15.3 21.1 15.7 27.7 12.8 6.4 12.7 104.5 13.3 20.3 8.6 9.3 30.7 11.9 29.1 20.6 23.2 5.7 15.0 11.0 16.7 7.9 8.7 6.9 3.9 7.8 5.9 16.3 27.5 10.1 10.2 8.6 64.8 7.2 11.6 20.8 13.7 25.0 13.4 13.0 9.3 15.3 6.9 6.7 68.1 9.4 4.1 10.7 11.8 9.9 19.0 9.9 7.2 43.1 11.6 18.2 6.2 76.9 89.5 12.3 6.0 13.2 11.4 13.1 7.4 7.3 11.0 11.4 6.6 18.5 21.9 11.5 11.7 19.6 12.6 6.3 10.3 18.2 8.0 12.5 CCT2 Cctb ENSG00000166226 "Chaperonin containing TCP1 subunit 2" P78371 12 69585426-69601570 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1471.3;Spermatocytes: 625.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003197, HPA003198" Enhanced Supported Cytosol NA NA 3500000 Cytosol "HPA003197: AB_1078425, HPA003198: AB_1078424" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (1.40e-3)" "unprognostic (1.53e-1)" "unprognostic (4.42e-2)" "prognostic unfavorable (8.38e-4)" "prognostic unfavorable (3.61e-9)" "unprognostic (5.28e-3)" "unprognostic (2.15e-2)" "unprognostic (1.08e-2)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (6.53e-3)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.63e-1)" "unprognostic (7.21e-2)" 62.8 70.6 58.7 78.5 62.9 141.7 86.4 63.7 71.2 52.4 69.8 71.2 53.7 67.5 44.1 70.1 70.1 55.1 65.2 61.0 65.9 93.7 72.8 47.0 95.7 64.2 60.2 58.6 65.8 53.7 72.1 38.1 70.8 63.2 58.4 86.8 58.0 45.8 53.0 104.8 56.4 51.9 84.0 65.5 52.0 52.4 217.9 62.5 101.6 56.6 73.9 109.7 107.6 50.0 65.5 266.1 388.1 343.8 330.7 154.2 174.5 392.3 280.4 203.8 448.0 276.1 529.7 121.7 572.6 266.2 222.9 281.8 250.2 538.2 313.0 536.6 319.1 398.6 418.7 313.5 331.8 171.8 520.1 255.5 152.7 195.3 425.9 248.1 308.7 296.4 311.4 519.2 165.0 410.2 378.9 496.0 446.7 482.4 273.2 403.7 389.3 375.9 373.1 369.4 476.9 334.1 281.3 291.0 314.2 289.2 284.3 411.4 371.6 196.0 231.4 292.2 275.0 427.3 203.5 409.6 614.6 201.9 354.8 290.8 36.6 41.0 12.5 47.3 66.0 72.7 74.2 54.0 61.5 72.9 60.7 62.2 68.5 3.7 65.3 62.1 66.9 63.7 70.0 58.7 62.9 63.7 71.2 61.0 65.9 64.2 60.2 58.6 63.2 65.5 62.5 65.5 80.4 35.3 47.4 17.3 97.2 136.6 233.9 173.8 126.3 51.1 70.1 89.7 81.5 57.2 110.8 80.9 79.2 189.1 93.3 48.1 92.0 198.8 1471.3 150.9 126.5 95.3 106.2 226.4 21.5 128.4 209.1 102.1 60.6 107.1 105.4 112.3 52.5 46.2 127.1 42.1 31.3 94.4 109.9 44.3 74.9 430.3 76.7 70.5 46.2 11.2 87.7 67.9 57.7 21.6 20.6 150.7 50.8 66.5 100.7 165.8 34.4 127.4 127.5 56.6 85.5 128.4 178.3 625.4 391.5 112.1 117.3 153.4 93.9 154.1 154.8 161.9 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888565 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 433.0" "Cell type enhanced" "Detected in all" "Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 527.8;Hep G2: 527.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 170000 Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: AB_2684594" "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 78.0 103.9 121.9 31.3 105.5 22.0 68.6 106.0 134.4 58.5 108.2 81.7 54.9 48.6 92.0 54.8 112.5 47.8 153.7 107.0 121.6 165.0 433.0 58.4 31.3 121.6 112.9 104.1 64.8 176.4 136.3 61.9 33.7 126.4 74.5 89.1 49.0 50.3 79.1 110.8 25.8 64.6 76.3 116.4 25.8 85.5 20.2 126.7 26.1 87.1 110.1 36.1 69.9 39.6 145.4 158.3 374.3 21.4 223.8 80.9 76.0 29.4 50.0 84.5 77.7 61.6 527.8 270.3 32.2 141.4 56.3 57.9 101.7 138.9 81.3 53.2 86.2 251.9 28.6 57.5 527.1 84.9 28.5 99.2 74.1 88.5 76.5 35.8 114.1 212.3 19.9 57.1 2.8 55.2 270.2 3.5 94.7 30.1 420.5 346.0 15.1 29.7 103.6 328.6 164.7 94.0 158.8 41.5 277.1 111.5 59.9 81.1 53.8 86.2 12.7 102.9 18.9 123.8 1.1 6.7 1.1 68.3 93.1 19.5 0.2 24.8 8.7 19.6 47.1 15.3 25.7 25.8 28.3 49.6 10.9 8.4 17.1 1.6 19.6 34.4 35.8 41.1 18.7 121.9 105.5 106.0 134.4 107.0 121.6 121.6 112.9 104.1 126.4 116.4 126.7 145.4 25.5 41.7 91.5 8.5 25.9 49.8 169.1 88.2 103.0 39.0 197.9 249.6 151.5 138.7 86.0 187.6 6.2 124.6 18.5 113.8 453.9 185.0 2.3 138.7 49.3 40.8 176.4 36.2 4.9 169.9 81.6 82.2 86.6 175.3 31.1 64.6 37.9 603.7 180.3 35.3 8.5 313.3 65.1 79.9 55.7 11.2 67.4 73.1 78.2 5.6 68.0 153.0 22.6 9.0 4.6 154.8 164.7 95.5 35.1 212.7 232.1 877.7 78.4 33.2 85.5 57.2 63.3 4.4 12.3 147.8 45.7 77.6 32.6 95.9 230.2 187.5 ARIH1 "ARI, HARI, HHARI, UBCH7BP" ENSG00000166233 "Ariadne RBR E3 ubiquitin protein ligase 1" Q9Y4X5 15 72474330-72602987 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.2;testis: 42.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003295 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003295: AB_1845017" "unprognostic (3.31e-2)" "unprognostic (1.92e-1)" "unprognostic (2.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.21e-2)" "unprognostic (5.45e-2)" "unprognostic (1.73e-1)" "unprognostic (9.43e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.96e-2)" "unprognostic (9.19e-2)" "unprognostic (1.78e-1)" "unprognostic (2.93e-1)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-2)" 8.3 8.0 3.0 10.2 3.8 16.6 6.1 6.8 5.8 6.2 6.0 6.6 9.6 7.6 3.2 6.9 5.5 4.4 11.5 4.5 5.2 5.2 6.2 7.4 5.0 2.9 2.8 3.2 9.1 6.6 3.9 6.0 6.6 3.5 5.8 3.3 10.5 4.4 4.8 48.2 6.9 7.4 6.3 2.7 6.0 6.4 42.9 3.4 4.0 5.0 8.5 4.1 7.6 6.5 5.3 17.6 18.0 17.5 10.2 8.9 6.2 20.6 19.3 7.0 8.6 5.9 18.3 14.6 17.2 28.4 8.3 30.3 24.8 18.1 10.1 4.8 30.6 12.4 13.0 22.5 12.4 6.3 19.6 14.4 7.4 3.4 9.5 12.2 8.2 6.4 12.4 13.8 19.7 8.5 11.5 18.9 7.5 18.9 6.3 6.5 21.4 21.3 9.8 4.8 29.0 16.3 18.4 25.1 11.2 31.4 23.0 9.0 22.0 16.7 14.1 19.6 54.8 27.4 20.7 45.2 20.6 9.2 17.5 15.2 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.3 0.3 0.2 0.6 0.4 0.4 1.0 0.6 0.2 0.3 0.8 0.1 3.0 3.8 6.8 5.8 4.5 5.2 2.9 2.8 3.2 3.5 2.7 3.4 5.3 79.5 19.2 37.7 88.5 64.0 66.3 52.7 13.3 76.2 63.3 74.9 53.3 46.9 30.0 25.7 18.4 91.8 18.4 83.3 32.9 3.9 18.4 110.3 108.7 84.8 50.7 46.5 24.8 141.6 18.9 21.8 43.3 63.7 148.4 43.2 43.7 40.0 28.5 19.0 62.2 152.0 31.2 8.2 30.5 42.1 55.4 28.6 67.5 16.0 104.0 24.2 25.7 27.8 129.7 135.1 24.7 19.1 27.4 60.9 55.8 20.8 13.9 33.0 58.8 19.7 96.8 59.9 45.3 32.1 68.8 59.8 40.8 68.3 36.8 27.0 63.7 C16orf71 "DKFZp686H2240, FLJ43261" ENSG00000166246 "Chromosome 16 open reading frame 71" Q8IYS4 16 4734344-4749396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 22.7;testis: 74.5" "Cell type enhanced" "Detected in some" "Early spermatids: 37.1;Late spermatids: 62.0;Respiratory ciliated cells: 22.6;Spermatocytes: 122.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 4.6;U-2197: 5.0" "Low region specificity" "Detected in all" HPA049468 Enhanced Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA049468: AB_2680779" "unprognostic (1.24e-2)" "unprognostic (8.87e-2)" "unprognostic (2.39e-1)" "prognostic favorable (7.49e-4)" "unprognostic (7.06e-2)" "unprognostic (2.17e-2)" "unprognostic (5.36e-3)" "unprognostic (2.21e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-2)" "unprognostic (6.79e-3)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-5)" "unprognostic (1.65e-1)" 0.7 1.3 2.2 0.7 1.8 0.2 0.7 2.4 1.6 1.5 7.2 0.7 0.6 1.0 2.7 0.7 22.7 1.4 0.6 1.5 2.2 1.8 1.4 2.9 0.4 3.7 3.2 0.7 1.2 1.1 0.9 4.1 0.2 2.7 1.1 0.3 1.7 1.2 0.8 1.0 0.6 0.4 0.8 3.4 0.4 0.8 74.5 2.4 0.6 2.0 1.1 0.4 0.7 0.5 1.9 0.3 2.0 0.4 1.1 2.6 1.1 0.8 1.1 0.9 0.9 1.1 0.9 0.8 0.0 1.0 1.6 2.6 0.9 0.9 1.1 0.2 0.4 0.6 0.2 1.5 0.1 0.8 0.9 0.3 0.3 0.2 3.4 0.9 0.7 0.4 0.8 0.7 0.5 0.9 4.6 0.2 0.8 0.6 1.3 1.0 0.3 0.4 1.4 2.3 0.4 3.0 1.1 1.1 0.9 0.3 0.7 4.0 0.2 0.4 0.7 0.8 5.0 0.5 2.0 1.7 0.5 0.4 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.3 1.1 0.0 0.1 2.2 1.8 2.4 1.6 1.5 2.2 3.7 3.2 0.7 2.7 3.4 2.4 1.9 0.1 0.0 1.1 1.0 0.1 0.0 0.2 1.0 0.6 0.9 0.6 0.5 1.2 0.0 3.9 0.0 4.2 0.3 0.2 0.2 0.0 0.6 37.1 15.6 0.6 0.2 0.0 0.0 1.0 0.0 0.1 0.3 3.6 0.6 0.0 0.2 0.0 0.3 0.2 0.0 0.9 0.1 0.0 0.0 0.0 62.0 1.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.5 0.0 0.1 0.0 2.4 22.6 1.7 0.0 0.2 0.7 122.1 7.2 0.5 0.0 0.1 0.2 0.3 0.3 0.0 CLMP "ACAM, ASAM, FLJ22415" ENSG00000166250 "CXADR like membrane protein" Q9H6B4 11 123069872-123195248 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 63.8" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 75.7;Fibroblasts: 95.1;Inhibitory neurons: 31.9;Peritubular cells: 57.9;Skeletal myocytes: 65.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 124.8;BJ: 171.8;BJ hTERT+: 160.3;fHDF/TERT166: 126.6;hTEC/SVTERT24-B: 129.1;hTERT-HME1: 155.6;U-138 MG: 232.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 310000 "unprognostic (1.63e-2)" "unprognostic (6.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (3.46e-2)" "unprognostic (9.42e-3)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (9.66e-3)" "unprognostic (3.25e-2)" "unprognostic (4.02e-3)" "unprognostic (3.87e-2)" "unprognostic (9.78e-8)" "unprognostic (3.88e-3)" "unprognostic (1.26e-1)" "unprognostic (1.19e-2)" "unprognostic (1.69e-2)" 63.8 6.5 0.6 14.9 0.8 0.4 24.8 7.8 2.7 20.1 3.4 31.7 7.4 30.6 4.3 10.2 18.6 23.3 8.8 4.9 0.4 6.1 0.4 8.2 7.5 3.7 2.4 0.8 9.1 2.0 0.2 1.9 26.5 2.9 7.5 10.7 0.9 5.4 8.6 1.7 5.9 17.5 36.6 2.2 8.1 16.2 2.7 1.6 0.8 2.4 3.4 5.1 16.9 14.1 5.3 3.0 3.3 7.5 15.2 124.8 108.1 45.5 171.8 160.3 23.9 43.8 7.4 0.2 0.0 0.4 126.6 82.4 0.1 0.3 45.5 27.3 0.9 0.3 0.0 7.1 0.1 40.7 0.0 0.1 61.0 30.6 129.1 155.6 59.7 11.7 0.1 0.0 0.4 33.3 0.1 0.0 0.2 17.4 0.0 20.2 0.1 2.5 0.1 12.6 0.0 20.5 50.3 0.0 0.4 0.1 3.2 0.6 0.0 43.3 232.7 2.3 96.0 21.6 0.1 0.0 0.1 63.1 0.0 7.5 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.6 0.8 7.8 2.7 4.9 0.4 3.7 2.4 0.8 2.9 2.2 1.6 5.3 2.3 0.0 3.9 2.0 0.2 1.5 0.3 2.4 0.0 3.8 1.2 14.6 5.1 0.0 0.4 0.0 0.0 9.8 0.3 0.1 0.0 1.9 0.7 2.4 75.7 1.4 6.7 0.0 26.5 1.3 20.4 95.1 0.0 1.4 0.0 5.3 2.2 0.0 3.6 1.7 31.9 0.5 0.0 0.0 1.9 0.7 20.8 0.9 0.0 4.7 0.0 0.5 0.0 1.0 3.6 0.9 0.0 57.9 0.6 2.0 0.1 0.1 0.2 1.1 0.0 65.0 8.5 0.1 0.1 0.4 1.0 10.4 1.1 2.2 0.3 0.5 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.5;pituitary gland: 28.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 166.1" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 1.7 8.5 20.8 0.6 43.7 0.4 1.8 0.0 44.7 1.0 0.0 1.3 0.8 1.5 0.8 0.7 1.2 0.5 1.3 55.5 18.0 0.7 0.1 1.0 0.3 0.5 5.4 49.2 1.0 1.1 4.4 28.2 0.1 14.8 0.8 0.8 10.1 0.7 0.5 14.2 1.4 1.3 1.4 0.0 0.5 0.7 2.3 3.0 0.2 4.1 3.3 0.2 0.8 1.0 30.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.1 1.8 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 5.8 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.0 0.0 0.0 0.1 5.5 4.5 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 20.8 43.7 0.0 44.7 55.5 18.0 0.5 5.4 49.2 14.8 0.0 3.0 30.7 7.7 0.0 0.5 3.9 0.0 5.7 1.1 0.0 1.2 31.6 1.3 1.0 2.1 0.0 0.0 1.8 6.2 0.1 0.0 0.3 0.0 0.3 13.9 0.2 0.3 13.0 4.2 0.0 58.8 1.0 0.1 1.5 0.0 0.2 0.0 1.4 5.3 0.0 0.2 20.2 35.7 0.0 0.0 0.0 2.3 31.3 0.0 0.4 0.0 5.6 0.0 6.3 1.0 4.5 2.5 0.3 0.0 0.4 0.0 1.0 0.1 0.5 0.0 6.0 6.6 5.7 0.8 1.0 2.0 0.4 5.5 0.0 0.1 1.4 0.1 0.5 COX11 COX11P ENSG00000166260 "Cytochrome c oxidase copper chaperone COX11" Q9Y6N1 17 54951902-54968703 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044020 Approved NA NA "HPA044020: AB_2678777" "unprognostic (1.42e-1)" "unprognostic (6.59e-2)" "prognostic favorable (4.30e-4)" "unprognostic (3.13e-1)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (4.69e-2)" "unprognostic (2.85e-2)" "unprognostic (4.11e-2)" "unprognostic (8.12e-3)" "unprognostic (8.18e-2)" "unprognostic (3.65e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-2)" "unprognostic (9.25e-2)" "unprognostic (6.29e-2)" "unprognostic (7.85e-2)" 14.2 15.9 7.0 7.4 8.6 1.3 14.8 9.5 9.7 15.5 8.2 18.5 31.6 17.0 8.2 12.2 16.6 5.4 16.8 6.6 7.9 24.4 28.5 14.9 7.5 7.2 7.6 7.7 16.6 7.4 7.2 13.6 4.8 7.3 17.1 7.3 20.6 13.7 7.1 33.7 13.4 18.7 5.2 5.8 7.9 12.5 10.2 7.7 4.6 16.7 7.6 5.8 17.5 13.5 8.2 14.6 52.7 12.5 15.8 7.4 9.0 13.1 15.1 2.9 6.8 6.5 34.8 6.7 22.1 27.3 5.9 9.7 12.1 8.4 5.0 8.2 37.8 31.9 21.8 35.9 44.0 2.8 14.6 5.0 7.8 3.2 7.2 3.5 7.3 4.0 15.1 13.2 7.7 10.5 26.9 21.9 7.7 7.6 9.7 30.1 15.8 22.3 13.4 10.6 19.9 16.2 22.0 14.0 9.4 9.7 8.1 20.0 5.0 13.2 18.2 9.6 16.5 24.0 15.1 21.4 16.5 14.9 8.4 10.1 3.7 3.3 4.6 4.3 5.0 5.7 5.6 6.6 5.0 6.6 7.9 5.6 6.9 0.2 3.4 2.4 2.6 7.9 3.7 7.0 8.6 9.5 9.7 6.6 7.9 7.2 7.6 7.7 7.3 5.8 7.7 8.2 29.2 25.6 23.4 24.5 29.5 31.5 44.9 47.1 32.5 53.1 17.5 17.8 35.0 32.9 22.2 20.2 70.9 38.5 22.9 25.0 162.4 42.6 63.8 27.9 26.7 28.1 43.3 24.6 33.8 44.2 31.2 31.5 19.4 16.6 20.3 22.8 36.4 33.2 26.7 35.3 30.1 27.6 28.5 23.3 33.7 18.4 54.3 16.7 35.6 11.2 25.4 45.7 35.0 26.7 28.3 29.5 32.1 59.0 26.1 15.6 50.4 118.7 24.4 73.0 72.3 34.0 42.7 81.6 50.5 20.3 27.1 17.5 35.3 35.0 62.8 23.9 ZNF202 "ZKSCAN10, ZSCAN42" ENSG00000166261 "Zinc finger protein 202" O95125 11 123723914-123741675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 14.7;Spermatogonia: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059229 Approved "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" "Nuclear bodies" "HPA059229: " "unprognostic (3.12e-2)" "unprognostic (7.75e-2)" "unprognostic (2.20e-2)" "unprognostic (4.49e-2)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.23e-1)" "unprognostic (1.74e-3)" "unprognostic (2.80e-1)" "unprognostic (9.48e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (9.93e-7)" "unprognostic (2.61e-2)" "unprognostic (2.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" 5.5 4.7 5.7 6.8 5.9 5.3 7.7 6.0 6.6 7.8 5.5 6.3 4.4 9.8 9.4 6.0 6.8 4.7 4.4 5.9 6.1 4.5 5.2 5.2 9.0 5.6 5.7 5.9 10.5 9.8 5.2 6.0 6.3 6.4 7.3 8.0 6.1 6.0 5.3 6.2 8.4 6.6 7.3 5.3 10.0 6.2 9.9 5.9 6.7 7.0 4.0 8.8 7.0 6.5 7.5 6.0 9.3 15.3 18.5 6.6 10.1 11.9 9.3 7.4 8.5 7.6 10.5 15.7 17.7 8.6 7.2 13.7 14.3 15.9 10.6 11.7 7.3 8.9 31.5 6.6 10.2 9.0 18.5 8.9 7.2 21.0 9.7 28.7 7.3 10.0 14.8 17.1 11.8 11.2 6.3 16.0 25.3 25.2 21.0 12.8 19.2 9.5 6.5 8.3 11.4 11.3 12.6 7.8 9.4 6.2 12.5 17.8 12.8 8.7 16.3 10.5 11.8 9.5 7.6 5.9 12.1 4.3 20.2 10.8 0.0 1.2 0.0 1.7 1.8 1.6 1.6 2.3 2.5 1.9 1.9 2.6 2.4 0.0 1.6 0.7 1.2 2.2 1.7 5.7 5.9 6.0 6.6 5.9 6.1 5.6 5.7 5.9 6.4 5.3 5.9 7.5 3.1 6.4 0.5 7.8 3.8 2.9 3.8 1.9 0.6 3.1 3.4 3.2 3.1 2.8 9.7 3.7 0.0 2.2 2.1 1.5 1.9 2.2 5.1 1.4 3.3 3.1 3.0 1.7 8.9 3.5 1.7 2.8 4.6 2.0 3.8 6.0 2.2 1.9 1.8 6.7 8.3 3.9 0.0 2.0 2.0 5.0 1.8 3.1 0.0 3.7 1.6 2.4 1.0 6.6 11.0 3.2 2.4 1.2 3.6 2.5 1.0 1.4 1.3 3.1 6.6 5.0 2.2 14.7 14.5 3.6 3.0 0.8 3.0 3.1 3.2 2.9 FAM227B "C15orf33, FLJ32800" ENSG00000166262 "Family with sequence similarity 227 member B" Q96M60 15 49326962-49620929 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049774, HPA061695" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049774: AB_2680873, HPA061695: AB_2684588" "unprognostic (1.19e-2)" "unprognostic (2.57e-1)" "unprognostic (1.89e-2)" "unprognostic (4.74e-3)" "unprognostic (1.17e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-4)" "unprognostic (3.32e-2)" "unprognostic (9.21e-2)" "unprognostic (6.57e-3)" "unprognostic (6.32e-3)" "unprognostic (6.41e-2)" "unprognostic (7.48e-5)" "unprognostic (2.70e-1)" "unprognostic (9.01e-2)" "unprognostic (7.47e-2)" "unprognostic (1.76e-1)" 1.0 5.1 5.0 1.9 5.4 1.5 6.7 4.8 4.7 4.8 4.8 3.4 2.8 6.3 7.3 3.5 7.8 3.4 7.3 4.2 5.4 7.8 7.6 2.8 4.9 5.6 5.1 3.8 10.0 6.5 5.7 6.5 1.3 5.5 5.8 2.9 8.0 5.3 5.1 8.0 3.9 2.3 3.9 5.6 2.8 3.6 10.5 4.6 6.9 7.5 9.0 4.4 3.5 2.2 6.8 0.8 0.7 5.1 2.8 1.5 3.0 0.6 2.1 2.8 3.2 5.1 0.7 2.4 1.5 4.9 3.5 3.7 0.8 1.8 3.1 3.7 3.7 1.5 3.2 1.3 1.7 4.2 1.5 1.3 3.1 4.0 1.8 2.0 6.2 3.0 7.7 5.4 2.4 7.1 3.5 3.2 1.3 2.0 1.2 1.3 2.7 4.5 8.1 4.8 1.0 3.8 5.3 1.9 2.5 6.2 3.7 3.1 1.1 2.2 2.2 1.7 3.0 1.3 12.2 9.8 4.8 2.4 3.9 2.4 5.8 0.2 1.7 3.4 0.5 4.5 2.8 3.5 4.6 0.3 3.5 5.8 5.6 0.3 2.7 0.6 3.4 3.4 2.0 5.0 5.4 4.8 4.7 4.2 5.4 5.6 5.1 3.8 5.5 5.6 4.6 6.8 1.1 9.6 4.8 39.5 5.8 2.8 5.4 5.4 3.4 4.3 6.2 7.6 10.8 1.5 9.4 3.7 0.0 1.7 3.3 1.3 25.4 3.9 41.0 19.1 3.1 2.8 8.4 2.1 12.8 3.2 1.5 3.7 3.6 3.2 3.8 1.8 1.8 4.1 0.6 5.0 12.1 1.8 6.1 0.6 2.0 21.1 4.1 2.0 3.6 5.6 0.6 11.7 4.1 16.1 55.1 2.5 1.6 3.0 6.1 2.6 1.9 12.5 21.3 8.0 0.0 4.7 2.0 48.7 13.2 2.5 4.3 0.4 5.7 6.3 2.2 2.6 STXBP4 "MGC50337, Synip" ENSG00000166263 "Syntaxin binding protein 4" Q6ZWJ1 17 54968727-55173632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Cone photoreceptor cells: 41.7;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007760, HPA022138, HPA022888, HPA024227" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630" "unprognostic (5.89e-2)" "unprognostic (2.50e-2)" "unprognostic (1.30e-3)" "unprognostic (9.27e-2)" "unprognostic (1.03e-3)" "unprognostic (1.48e-1)" "unprognostic (5.00e-5)" "unprognostic (4.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.28e-2)" "unprognostic (3.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" 1.5 2.0 3.4 1.7 2.3 1.4 1.8 2.2 1.5 2.2 6.8 1.4 2.6 2.8 1.7 1.9 2.8 2.6 1.8 1.5 6.5 4.4 0.9 2.1 1.2 2.8 3.7 1.2 3.0 1.5 6.1 2.0 1.8 2.6 3.0 1.7 4.6 1.4 3.6 1.1 1.0 1.4 2.7 3.4 1.1 1.6 2.1 2.7 1.9 3.2 1.0 1.2 1.9 1.3 3.8 5.0 7.3 6.6 5.9 5.5 5.4 2.7 3.8 3.6 4.8 4.7 4.3 2.6 3.4 7.9 3.8 4.2 2.9 8.6 3.8 8.9 5.1 4.9 4.4 4.8 8.9 2.3 2.8 1.3 6.1 1.1 7.0 1.6 2.2 4.9 2.9 7.2 2.6 5.8 2.2 9.3 1.8 4.8 4.2 5.2 3.9 7.7 2.0 8.6 3.0 6.3 4.8 5.8 0.9 3.2 3.5 8.4 1.9 3.8 6.8 5.2 4.2 4.0 2.3 2.3 5.8 4.4 3.6 4.1 1.7 0.4 0.0 0.9 0.3 1.0 0.7 0.8 0.6 0.5 1.1 0.7 0.9 0.1 2.2 0.5 1.1 0.8 0.3 3.4 2.3 2.2 1.5 1.5 6.5 2.8 3.7 1.2 2.6 3.4 2.7 3.8 6.6 0.0 9.1 39.5 3.9 0.9 2.4 3.3 4.6 5.6 4.4 3.3 9.6 2.8 5.4 9.2 41.7 1.6 2.1 2.0 9.8 6.0 6.7 16.6 14.4 4.3 6.0 5.2 29.0 2.7 1.9 7.5 6.1 5.8 7.6 6.1 6.1 5.1 2.3 8.4 25.5 1.4 0.0 2.4 1.4 5.3 17.7 2.4 7.2 20.6 2.1 5.9 1.0 84.4 39.3 3.3 2.1 11.7 1.6 2.2 4.9 7.2 17.4 21.6 32.9 8.8 11.4 11.1 7.3 2.8 3.0 0.3 4.8 5.1 3.1 1.2 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573286 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 200.0;Endothelial cells: 150.0;Hepatic stellate cells: 79.9;Microglial cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 38 "plasmacytoid DC: 31.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 31.4" "Cell line enhanced" "Detected in some" "AF22: 14.1;NTERA-2: 39.2;PC-3: 11.0;RH-30: 16.6;SCLC-21H: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034921: AB_2089315, HPA067685: AB_2685887" "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 36.7 46.9 9.6 8.2 8.0 7.9 30.4 8.0 11.5 16.5 8.7 8.2 6.1 19.4 8.1 9.1 13.0 16.2 21.2 7.5 8.6 12.8 4.9 23.9 6.1 10.1 8.4 6.5 4.5 5.5 15.6 3.8 36.6 9.5 9.6 6.6 0.9 6.8 11.5 15.2 8.2 9.6 23.8 8.5 32.8 7.7 1.9 10.2 6.1 14.2 32.1 4.6 12.8 9.6 9.5 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.1 1.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 6.5 0.0 0.4 0.0 5.6 0.0 0.0 0.0 2.6 0.0 0.0 0.1 39.2 0.0 11.0 0.0 16.6 0.0 1.7 0.0 33.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 31.4 0.0 0.1 9.6 8.0 8.0 11.5 7.5 8.6 10.1 8.4 6.5 9.5 8.5 10.2 9.5 200.0 0.0 0.6 1.6 1.5 11.7 2.0 10.2 27.3 0.1 14.9 15.0 6.7 0.0 1.7 14.7 0.0 0.1 14.9 0.0 3.9 0.0 0.7 0.4 6.9 150.0 0.0 11.1 1.6 0.0 0.2 8.3 0.0 0.4 0.0 3.7 79.9 0.4 0.3 0.0 4.6 0.0 2.0 3.2 8.0 1.5 2.1 1.4 7.2 58.1 0.7 0.5 0.0 0.0 0.7 0.1 0.0 0.0 2.5 1.1 0.0 6.8 1.1 0.3 0.0 13.3 4.4 0.2 1.3 4.9 5.4 0.3 1.5 0.4 0.0 0.7 CUL5 VACM-1 ENSG00000166266 "Cullin 5" Q93034 11 108008898-108107761 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002185, CAB017787" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "CAB017787: , HPA002185: AB_1078587" "unprognostic (5.66e-2)" "unprognostic (6.58e-2)" "unprognostic (7.16e-3)" "unprognostic (1.30e-1)" "unprognostic (5.54e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" "unprognostic (2.80e-1)" "unprognostic (5.97e-3)" "unprognostic (1.78e-1)" "unprognostic (9.17e-2)" "unprognostic (1.77e-2)" "prognostic favorable (1.06e-5)" "unprognostic (3.83e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 9.9 11.6 7.3 9.6 7.5 28.5 13.1 11.5 8.8 11.9 7.5 9.1 9.1 13.2 9.9 10.7 9.7 8.5 15.4 7.2 8.5 16.4 14.3 8.9 11.3 7.0 7.9 5.7 12.5 9.0 13.5 5.8 11.5 7.0 12.2 9.2 12.8 8.6 9.6 46.8 11.5 8.6 10.6 7.9 9.9 9.5 6.6 7.4 12.9 14.5 37.8 10.4 10.1 7.1 10.8 14.4 6.6 19.6 15.1 12.5 20.2 9.7 15.0 16.3 13.4 15.0 21.3 16.5 20.1 27.3 18.8 14.0 18.0 18.4 12.3 19.4 13.2 11.1 18.9 6.2 15.7 21.1 21.8 14.9 15.8 16.1 14.1 18.6 17.5 18.7 16.2 25.0 7.2 21.4 7.9 20.9 18.1 10.3 18.4 11.6 15.0 14.6 21.8 16.4 21.2 13.9 19.6 20.4 21.1 12.3 12.0 31.1 17.0 19.7 24.6 11.4 17.6 16.2 7.2 6.2 26.5 9.6 24.0 16.0 1.2 2.3 1.6 2.1 2.1 2.0 1.7 2.1 1.9 2.3 2.2 2.3 2.3 0.4 1.6 2.2 2.5 1.7 1.3 7.3 7.5 11.5 8.8 7.2 8.5 7.0 7.9 5.7 7.0 7.9 7.4 10.8 50.2 57.7 42.5 66.3 49.0 29.8 29.3 26.0 44.3 52.7 35.1 25.7 111.9 37.1 39.2 31.3 66.7 37.6 49.2 21.8 50.9 29.6 6.0 45.4 48.7 41.3 17.6 34.3 84.9 23.5 23.6 42.6 33.1 40.9 43.1 42.8 40.0 54.8 27.1 55.5 83.8 28.7 22.4 41.6 20.3 8.0 30.7 41.2 14.2 61.8 51.7 31.5 30.9 74.4 101.7 29.1 29.0 38.0 48.4 36.6 27.9 76.7 36.6 59.4 19.7 56.0 53.1 35.5 44.0 43.9 30.3 35.8 38.8 48.0 30.3 32.9 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor like" Q96LU7 12 69825227-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 23.2" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 102.3;Late spermatids: 30.4;Oligodendrocyte precursor cells: 70.4;Proximal enterocytes: 30.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 5.2;SK-BR-3: 2.6;T-47d: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.2 0.4 1.8 0.0 1.4 0.0 0.5 3.2 1.6 0.1 1.1 0.2 23.2 0.1 0.9 0.1 0.1 0.1 0.3 1.6 1.5 2.0 0.3 0.2 0.2 2.0 1.3 1.1 0.0 0.8 0.0 0.9 0.2 2.7 0.7 0.1 0.5 0.6 0.4 0.0 1.3 21.4 0.1 1.7 0.1 0.1 2.5 1.9 0.3 0.2 0.0 0.4 0.0 0.1 4.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.2 0.1 0.0 0.0 0.0 0.9 0.8 0.0 0.2 0.1 0.0 2.6 0.0 0.9 11.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.4 3.2 1.6 1.6 1.5 2.0 1.3 1.1 2.7 1.7 1.9 4.8 0.0 0.0 0.0 3.6 0.0 0.1 0.1 0.0 0.0 0.7 0.7 0.1 1.5 0.0 0.3 5.5 0.0 0.2 0.0 0.3 3.9 0.7 13.9 0.4 0.0 0.0 0.0 0.4 9.4 0.0 0.0 0.4 1.1 0.7 0.0 0.1 0.0 0.0 0.1 0.0 102.3 3.2 0.0 0.0 0.0 30.4 0.9 0.1 0.0 1.0 0.0 0.2 0.0 70.4 10.8 0.4 4.8 0.4 0.0 0.1 30.8 0.8 0.7 0.2 0.0 0.5 0.2 1.0 0.6 0.0 1.1 0.0 0.1 0.1 4.7 0.0 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743948-102834516 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 35.3 43.6 21.1 22.5 21.5 5.0 26.1 20.7 19.5 24.4 27.2 24.8 15.4 27.6 19.0 21.3 29.7 25.3 23.2 19.4 23.6 20.9 42.4 24.8 21.6 31.8 23.3 17.4 26.8 15.7 42.1 23.0 23.7 24.3 27.1 15.1 5.7 22.8 22.6 55.1 35.8 20.1 26.5 24.6 21.5 25.9 14.3 22.8 34.0 41.5 49.5 19.1 24.8 20.7 23.7 21.0 26.8 14.5 24.5 47.0 37.9 29.5 21.0 56.7 20.5 25.8 18.3 31.9 18.1 27.8 32.5 16.5 22.7 10.7 18.2 15.5 18.3 11.3 36.6 11.6 13.3 30.3 17.8 41.7 41.2 32.0 26.4 20.3 47.0 40.5 21.6 18.1 22.0 35.6 27.5 21.7 19.8 11.0 16.1 12.9 42.9 38.3 11.7 18.2 20.4 3.4 13.9 11.5 11.6 24.1 26.0 47.2 19.5 30.4 19.6 20.1 22.3 19.1 40.6 22.9 13.0 27.7 33.6 8.8 7.8 12.2 16.2 8.7 14.8 7.0 6.5 7.3 8.4 8.7 6.1 6.5 6.9 15.2 12.9 19.4 5.4 8.2 10.6 21.1 21.5 20.7 19.5 19.4 23.6 31.8 23.3 17.4 24.3 24.6 22.8 23.7 13.3 22.4 19.0 29.4 12.2 8.2 8.0 17.0 11.4 6.4 25.0 15.4 15.7 12.8 17.8 12.9 0.0 33.9 17.2 26.4 1.9 14.2 2.0 9.7 11.0 20.4 9.1 11.1 24.6 25.3 14.6 29.3 16.8 12.7 38.1 16.4 27.1 56.2 27.7 13.5 26.4 14.6 14.2 46.6 13.1 1.8 13.1 28.8 10.6 40.3 28.9 9.8 29.9 19.1 26.3 24.6 13.7 19.5 9.0 29.9 18.3 8.9 20.5 3.8 19.7 16.6 17.7 4.4 5.8 11.3 11.8 40.0 14.4 8.9 12.2 11.3 BORCS7 "C10orf32, FLJ40752" ENSG00000166275 "BLOC-1 related complex subunit 7" Q96B45 10 102854259-102864961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 201.5;Proximal tubular cells: 208.5;Theca cells: 209.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA037648 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA037648: AB_10673634" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (1.35e-2)" "unprognostic (7.46e-3)" "unprognostic (3.16e-2)" "unprognostic (1.77e-1)" "prognostic favorable (9.08e-8)" "unprognostic (9.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.06e-1)" "unprognostic (1.67e-3)" 25.6 59.0 21.7 12.9 22.0 23.6 30.1 21.4 25.3 21.1 22.8 18.0 23.4 22.0 23.9 13.5 30.0 22.6 22.3 22.1 23.7 40.2 67.6 24.0 15.2 22.5 22.6 21.4 22.0 17.7 53.7 23.9 21.9 22.2 27.5 15.3 20.4 17.1 17.5 28.8 14.0 19.6 16.9 23.3 24.6 21.1 20.4 22.9 14.7 55.8 26.1 12.4 17.6 16.1 24.5 14.9 19.8 23.4 20.7 25.6 35.1 19.5 21.6 44.1 16.3 15.5 13.3 16.6 9.4 11.1 34.6 17.1 12.2 7.9 11.1 12.0 12.1 16.7 21.7 12.5 27.7 29.5 39.4 35.9 44.1 29.8 11.0 17.4 34.0 28.9 13.2 13.0 9.7 26.4 10.9 11.0 16.2 7.9 20.3 18.4 19.8 31.4 13.8 13.6 16.1 6.6 25.5 8.0 14.2 34.7 10.4 27.0 22.2 21.6 13.7 14.6 14.1 15.3 24.9 40.8 11.1 29.0 22.7 5.0 31.3 30.1 22.9 17.3 35.0 19.4 26.5 17.9 18.0 22.1 23.2 19.8 18.4 9.6 27.7 32.9 47.1 19.7 15.1 21.7 22.0 21.4 25.3 22.1 23.7 22.5 22.6 21.4 22.2 23.3 22.9 24.5 85.2 54.5 79.6 0.0 49.1 0.0 61.0 0.0 45.5 50.9 94.5 62.9 0.0 48.6 32.2 42.3 39.6 89.6 57.4 18.0 201.5 35.3 21.1 61.1 38.8 67.3 34.0 18.3 0.0 33.3 39.2 60.4 39.8 31.9 34.1 44.2 68.2 74.9 51.7 63.9 0.0 33.4 0.0 49.8 0.0 22.8 42.3 54.1 0.0 0.0 52.1 109.8 53.5 0.0 0.0 28.5 48.5 62.1 28.6 53.8 70.1 208.5 43.7 50.6 39.5 53.3 44.0 80.1 52.4 44.7 0.0 121.5 39.8 209.5 41.0 54.5 C2 ENSG00000166278 "Complement C2" P06681 6 31897785-31945672 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 481.8" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3" "Cancer enriched" "Detected in all" 9 "liver cancer: 100.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "intermediate monocyte: 21.1;non-classical monocyte: 25.9" "Lineage enriched" "Detected in single" 35 "monocytes: 25.9" "Cell line enriched" "Detected in some" 5 "Karpas-707: 284.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB016775 Supported "Secreted to blood" NA NA 34000000000 "CAB016775: " "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (7.68e-2)" "unprognostic (1.49e-3)" "unprognostic (7.40e-2)" "unprognostic (3.34e-2)" "unprognostic (1.36e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-1)" "unprognostic (2.59e-3)" "unprognostic (3.27e-2)" "unprognostic (3.15e-3)" "prognostic unfavorable (2.64e-7)" "unprognostic (2.05e-1)" "unprognostic (4.42e-2)" "unprognostic (7.37e-2)" "unprognostic (2.55e-2)" 36.4 12.2 1.1 27.8 0.9 3.2 11.8 0.9 2.9 8.2 2.3 14.5 16.8 7.1 1.3 7.6 12.1 23.2 6.7 0.7 7.4 22.5 481.8 80.7 28.0 3.3 2.3 0.8 5.3 1.9 0.9 3.8 48.8 2.2 5.5 13.1 0.4 9.2 0.9 2.1 5.3 30.5 23.8 1.8 46.7 12.1 4.2 3.1 5.5 3.3 2.7 12.6 23.8 5.4 10.2 0.3 0.1 0.1 0.6 0.1 0.0 6.8 0.5 0.3 0.4 0.3 0.4 0.3 0.6 3.5 1.0 0.6 0.5 0.1 0.0 0.3 0.2 0.4 0.3 0.4 52.8 1.1 0.1 0.7 2.7 0.3 0.6 0.1 0.6 0.0 0.7 0.5 284.0 0.0 0.0 0.4 0.5 0.3 0.1 0.0 0.2 16.5 3.0 0.0 0.1 0.3 0.3 2.6 0.3 0.2 0.3 0.2 9.5 0.2 0.2 0.7 0.5 0.1 0.9 31.6 2.7 0.8 0.9 0.1 0.1 5.6 0.0 0.1 21.1 0.1 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.5 0.1 25.9 0.0 0.0 2.2 1.1 0.9 0.9 2.9 0.7 7.4 3.3 2.3 0.8 2.2 1.8 3.1 10.2 2.1 25.6 142.4 2.6 1.9 3.3 1.1 2.0 0.6 1.4 1.3 1.3 0.6 25.8 11.2 1.8 0.0 2.1 0.1 1.8 0.0 0.6 0.3 1.5 18.7 1.9 2.4 10.7 6.6 2.7 2.7 19.8 3.1 1.3 3.8 0.2 21.0 380.3 282.7 1.7 6.3 11.3 0.0 99.3 5.0 1.3 6.8 32.6 3.6 7.5 7.3 0.1 0.0 1.0 1.7 4.5 33.1 1.2 0.4 4.0 55.2 35.7 9.4 0.9 0.0 5.6 3.5 0.8 1.4 0.7 2.8 4.0 2.0 0.5 15.8 4.5 PLEKHF1 "APPD, MGC4090, PHAFIN1, ZFYVE15" ENSG00000166289 "Pleckstrin homology and FYVE domain containing 1" Q96S99 19 29665459-29675477 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 77.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 59.2;Leydig cells: 78.3;NK-cells: 166.9;Peritubular cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 13 "NK-cells: 82.3;T-cells: 183.9" "Cell line enhanced" "Detected in many" "BEWO: 39.0;SK-BR-3: 32.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA025925 Uncertain NA NA "HPA025925: AB_1844958" "unprognostic (5.01e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-2)" "unprognostic (3.04e-2)" "unprognostic (9.43e-3)" "unprognostic (2.57e-1)" "unprognostic (4.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-2)" "prognostic favorable (4.54e-4)" 15.0 3.6 9.0 4.7 10.6 6.8 17.1 9.5 9.8 17.3 5.0 8.6 4.0 19.0 1.9 15.5 15.7 4.7 23.4 6.3 8.7 4.9 16.5 10.6 9.1 12.8 11.2 5.7 8.4 5.0 5.9 2.5 5.0 12.3 16.6 1.1 0.2 18.8 6.2 77.9 8.0 10.1 2.7 10.0 14.5 7.2 3.4 12.0 7.5 6.4 38.8 5.2 17.1 15.1 12.3 14.3 5.2 0.1 3.3 10.5 9.0 39.0 3.6 4.9 4.4 7.1 3.3 6.4 0.1 12.7 4.7 8.1 12.6 1.1 3.3 0.7 9.7 7.1 7.1 2.6 6.5 17.9 0.4 19.0 15.8 1.3 4.7 8.7 2.8 3.8 7.1 8.2 0.0 2.5 1.9 1.0 5.9 0.7 2.3 2.5 0.1 4.7 4.0 3.0 22.5 0.1 2.3 2.0 32.9 18.4 3.2 12.0 2.1 3.5 5.7 5.9 7.2 6.7 2.5 27.3 1.2 6.3 7.5 2.0 10.4 0.8 0.2 183.9 0.5 128.1 5.5 74.0 147.2 1.4 10.2 43.9 82.4 2.1 82.3 0.9 0.6 76.4 67.1 9.0 10.6 9.5 9.8 6.3 8.7 12.8 11.2 5.7 12.3 10.0 12.0 12.3 5.2 0.0 0.5 1.3 9.5 55.2 29.0 15.8 17.1 0.8 12.7 9.0 8.7 18.6 9.6 9.2 0.0 59.2 53.6 0.9 5.9 22.1 0.5 4.4 10.1 11.2 0.0 2.7 0.2 8.3 7.4 17.6 2.0 7.8 0.0 0.8 12.5 10.0 11.1 0.0 0.4 1.2 16.2 3.0 12.6 1.9 78.3 3.0 17.8 9.4 0.5 5.5 166.9 0.0 5.6 3.8 2.5 72.6 10.1 34.0 0.5 6.0 4.2 0.5 0.0 24.7 7.6 0.4 1.8 8.9 35.8 38.4 40.9 0.9 1.2 25.4 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 194.1" "Cell type enhanced" "Detected in some" "Adipocytes: 57.8;Endothelial cells: 25.5;Fibroblasts: 40.7;Leydig cells: 40.7;Peritubular cells: 52.6;Sertoli cells: 32.9" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 28.9;ASC TERT1: 19.5;HHSteC: 44.8;HSkMC: 20.6;U-87 MG: 13.9;WM-115: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 41.2 5.0 4.9 3.3 5.5 0.0 27.8 4.2 9.1 12.7 5.9 14.4 6.7 3.6 36.9 6.5 8.1 7.4 14.4 5.2 6.2 1.9 7.1 194.1 1.2 5.1 6.5 4.3 26.7 2.3 0.8 11.3 54.5 5.6 10.4 11.7 0.4 8.1 24.9 9.7 4.2 13.3 5.6 4.5 7.0 30.5 2.7 6.7 1.1 7.5 14.2 0.6 11.2 8.3 4.5 0.0 0.0 5.9 0.0 28.9 19.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 44.8 0.0 0.0 20.6 0.0 1.4 0.1 0.2 0.0 0.3 1.0 0.1 0.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 8.7 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.3 1.9 3.9 0.0 0.8 0.0 0.1 13.9 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 5.5 4.2 9.1 5.2 6.2 5.1 6.5 4.3 5.6 4.5 6.7 4.5 57.8 0.0 3.6 2.3 0.1 2.5 0.3 0.0 1.2 0.7 0.4 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 4.0 25.5 0.0 0.0 0.1 0.0 0.0 40.7 1.5 0.2 1.3 0.1 7.1 15.2 0.1 0.0 1.6 0.0 0.0 0.0 4.9 0.5 40.7 0.2 7.2 1.9 0.0 0.0 0.0 17.1 0.0 0.1 0.0 52.6 0.0 0.1 0.0 3.4 0.0 0.1 32.9 10.3 15.1 0.1 0.2 0.7 2.6 0.1 0.5 0.3 0.0 0.3 ANAPC16 "APC16, bA570G20.3, C10orf104, CENP-27, FLJ33728" ENSG00000166295 "Anaphase promoting complex subunit 16" Q96DE5 10 72216000-72235860 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 93.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037815 Approved Supported Cytosol NA NA Cytosol "HPA037815: AB_10672288" "unprognostic (2.87e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (7.12e-3)" "unprognostic (2.16e-1)" "unprognostic (6.20e-3)" "unprognostic (1.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.82e-1)" "unprognostic (3.10e-2)" "unprognostic (1.90e-2)" "unprognostic (2.11e-1)" "unprognostic (2.75e-3)" "unprognostic (7.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" 20.7 25.5 13.4 15.2 14.2 14.3 22.1 16.7 15.3 19.8 16.1 21.2 15.8 18.3 22.5 15.0 23.7 12.7 44.0 13.1 13.7 24.4 27.5 19.0 25.7 13.8 13.5 12.9 24.5 33.9 33.4 16.0 12.0 14.4 21.7 18.0 20.8 32.6 22.0 63.3 14.6 19.7 18.0 13.4 22.9 26.0 8.5 13.7 32.6 23.7 43.6 25.9 19.6 15.2 15.4 24.9 12.1 12.1 14.3 33.0 15.7 9.3 8.5 17.3 11.7 11.0 14.6 31.1 24.3 13.6 12.7 14.1 19.0 10.9 21.9 11.0 29.0 18.0 12.5 10.6 14.4 39.6 21.0 14.7 20.5 93.9 10.6 34.8 25.8 14.3 35.1 18.4 28.1 13.6 15.0 17.9 21.1 9.3 18.2 6.8 10.2 10.8 24.2 29.4 10.4 17.4 16.0 14.8 37.9 29.5 15.2 12.2 21.9 18.6 5.9 13.8 9.5 13.1 28.6 26.8 25.1 16.4 40.3 7.0 41.1 21.5 38.8 31.4 23.1 35.2 60.5 35.2 31.3 18.1 66.1 48.6 38.6 19.7 34.4 24.9 45.7 34.7 36.3 13.4 14.2 16.7 15.3 13.1 13.7 13.8 13.5 12.9 14.4 13.4 13.7 15.4 191.0 157.0 209.5 41.8 303.7 111.7 246.7 322.0 150.8 81.0 288.6 316.5 435.4 280.2 234.9 222.5 37.5 198.4 240.1 166.8 684.8 239.8 91.9 188.9 98.9 179.8 161.8 155.0 47.8 291.9 191.2 142.0 108.1 145.9 202.0 110.1 203.1 481.3 226.5 33.7 57.2 258.0 254.3 310.0 111.9 53.4 233.6 160.4 193.9 36.5 322.4 192.4 363.5 43.2 75.9 196.9 239.9 250.1 208.2 218.1 262.6 548.7 217.0 144.5 230.1 162.0 219.9 158.7 126.2 189.9 140.9 149.3 268.6 145.6 214.1 240.9 SMPD1 ASM ENSG00000166311 "Sphingomyelin phosphodiesterase 1" P17405 11 6390440-6394998 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease variant, Neurodegeneration, Niemann-Pick disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 131.3;Late spermatids: 200.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 139.1;fHDF/TERT166: 144.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 2700000 "unprognostic (8.76e-2)" "unprognostic (2.66e-1)" "unprognostic (6.99e-2)" "unprognostic (2.28e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (4.90e-2)" "unprognostic (8.06e-2)" "unprognostic (1.72e-1)" "prognostic favorable (7.47e-4)" "unprognostic (4.35e-2)" "prognostic favorable (4.57e-6)" "unprognostic (4.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (1.71e-1)" 21.1 36.8 39.4 14.0 45.0 7.4 20.3 44.0 43.3 20.0 33.7 23.0 17.0 21.1 14.5 20.8 14.7 21.7 51.2 39.2 44.1 73.3 96.1 31.6 14.8 43.7 43.0 36.4 18.0 33.1 34.5 42.2 21.8 45.0 29.7 15.0 8.5 29.2 20.2 38.2 36.6 24.0 17.7 41.6 21.3 25.6 14.1 45.1 17.9 34.3 29.7 11.1 23.8 21.1 46.9 16.4 13.1 10.1 26.5 139.1 72.2 17.1 60.4 95.0 27.7 33.0 22.0 11.9 4.7 27.4 144.0 59.3 7.4 8.4 12.7 13.0 21.0 9.6 5.1 19.5 6.0 62.3 3.7 37.4 96.0 23.4 25.9 17.7 100.9 61.6 1.7 9.1 30.5 58.9 17.0 0.1 6.5 3.9 23.2 22.3 1.2 5.5 7.0 23.9 6.2 17.0 9.7 27.6 19.5 38.5 12.9 7.3 7.0 53.9 103.0 10.9 59.1 15.4 37.6 44.0 3.5 93.7 10.8 47.1 1.9 2.5 3.4 6.4 2.1 5.0 1.5 5.5 5.0 1.3 3.1 10.0 10.1 2.5 6.6 0.6 1.7 4.7 3.2 39.4 45.0 44.0 43.3 39.2 44.1 43.7 43.0 36.4 45.0 41.6 45.1 46.9 14.1 25.6 14.4 10.7 12.2 7.9 22.8 15.3 6.8 12.6 13.7 9.0 37.7 24.3 12.8 25.8 25.0 38.8 11.5 131.3 11.7 53.4 50.0 6.2 13.0 18.6 23.8 9.9 5.8 38.2 14.4 31.4 15.8 21.0 10.8 9.4 26.7 88.5 34.1 20.2 5.5 20.3 24.4 15.5 6.2 200.7 11.5 15.8 55.2 4.7 7.8 16.4 36.0 6.6 15.5 24.7 83.1 13.5 23.1 26.0 51.7 75.1 2.4 5.2 0.0 8.9 17.1 1.4 3.1 7.5 8.0 34.3 23.3 10.2 18.0 15.4 APBB1 "Fe65, RIR" ENSG00000166313 "Amyloid beta precursor protein binding family B member 1" O00213 11 6395124-6419414 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 148.8" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 85.6" "Lineage enriched" "Detected in all" 5 "T-cells: 85.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 68.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038521, HPA038522" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA038521: AB_2676058, HPA038522: AB_2676059" "unprognostic (4.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.84e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (7.30e-2)" "unprognostic (3.22e-3)" "unprognostic (2.36e-1)" "prognostic favorable (1.86e-5)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-13)" "unprognostic (1.32e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" 17.9 24.0 100.7 12.0 112.6 2.7 18.2 108.1 125.8 37.6 58.6 32.6 7.1 43.8 4.4 15.1 38.7 11.5 40.5 119.7 101.4 21.5 3.9 22.7 14.0 119.6 107.4 108.1 39.5 16.4 21.6 61.8 8.7 129.3 23.9 4.8 23.5 13.5 26.1 42.7 11.4 19.4 33.4 107.9 14.0 19.6 12.8 107.1 29.1 19.2 54.5 11.2 31.4 23.7 148.8 0.0 14.9 50.6 22.8 26.7 27.4 0.2 24.6 41.7 41.2 51.4 26.4 10.3 0.0 3.6 44.3 36.9 0.5 44.4 7.5 19.4 27.8 33.7 0.3 9.3 0.9 19.3 0.2 9.9 24.8 1.9 19.4 2.9 35.3 51.7 1.2 1.1 0.7 15.3 0.5 0.5 0.1 18.3 0.8 15.5 0.2 2.0 0.2 1.7 0.2 68.1 37.6 3.6 3.0 15.9 15.2 2.1 3.4 22.8 4.2 24.8 27.5 5.0 13.8 6.8 2.0 21.1 0.0 14.3 8.4 1.7 0.3 23.2 1.5 25.2 6.7 32.5 30.2 1.7 16.2 85.6 51.7 1.6 16.5 0.6 0.3 48.7 29.9 100.7 112.6 108.1 125.8 119.7 101.4 119.6 107.4 108.1 129.3 107.9 107.1 148.8 9.6 19.2 5.4 22.9 7.5 5.0 12.1 3.6 12.0 45.8 6.6 5.7 50.5 11.5 5.4 5.5 22.9 0.4 4.6 1.1 25.4 18.2 5.6 7.6 9.5 13.9 19.3 4.0 47.1 4.2 0.7 15.2 4.6 2.3 1.3 10.8 15.7 3.3 1.2 40.4 44.8 1.2 0.0 1.9 4.0 13.1 9.6 1.8 8.8 7.5 3.2 24.7 9.2 49.3 102.3 8.0 1.7 19.2 1.4 8.3 0.4 21.6 17.3 20.1 6.6 10.0 17.3 6.9 13.7 3.2 2.8 0.8 20.1 7.0 1.3 5.4 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "heart muscle: 264.8;skeletal muscle: 281.9;tongue: 88.0" "Cell type enriched" "Detected in some" 52 "Cardiomyocytes: 665.1" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 0.1 0.5 0.6 0.1 0.8 0.3 3.6 0.8 0.8 0.2 0.1 0.0 0.1 0.1 0.1 11.9 0.1 0.1 264.8 0.7 0.4 0.1 0.1 1.3 0.2 0.8 0.6 0.4 0.2 0.4 0.0 0.1 0.6 0.7 3.1 0.0 0.4 4.8 0.0 281.9 0.3 0.0 0.0 0.5 0.2 0.1 0.3 0.5 0.1 0.2 88.0 0.2 0.1 1.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.5 0.6 0.1 0.0 4.1 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 3.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.6 0.8 0.8 0.8 0.7 0.4 0.8 0.6 0.4 0.7 0.5 0.5 0.7 0.5 3.2 0.0 0.3 0.9 1.5 1.4 0.0 2.2 1.9 1.0 0.8 665.1 0.0 0.7 0.0 2.1 0.2 0.5 0.0 0.0 0.0 2.6 0.1 0.4 5.0 0.0 0.0 0.3 0.0 0.2 12.6 0.0 0.3 1.3 0.3 0.0 0.4 0.2 0.0 0.9 0.0 0.0 0.6 2.1 1.1 0.9 0.8 1.8 1.0 0.3 0.4 0.0 1.5 1.1 0.0 0.0 0.4 0.3 0.9 0.0 0.2 0.7 1.2 0.0 12.0 5.2 0.8 1.3 0.4 0.4 0.0 0.7 0.2 0.0 1.0 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved NA No "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 1.7 3.2 1.3 1.9 1.7 2.5 2.0 3.6 2.0 1.7 1.1 2.4 3.0 1.7 3.9 1.6 1.9 1.8 3.3 1.3 1.3 3.0 6.3 1.5 2.4 1.4 1.4 1.1 1.8 3.1 3.0 1.7 1.5 1.8 2.1 1.9 3.0 2.1 1.0 4.2 3.1 2.5 1.2 1.0 2.6 2.9 2.4 1.7 1.5 1.9 2.1 1.5 2.5 1.7 2.1 4.7 3.3 5.3 6.6 3.2 2.7 1.1 4.1 3.6 2.1 2.3 8.7 9.6 2.3 2.0 2.5 3.4 5.4 0.5 3.8 2.1 1.7 9.3 6.4 5.9 4.9 0.3 3.5 2.5 2.0 4.1 2.7 1.5 5.6 1.6 4.1 5.5 3.5 2.1 2.2 2.1 5.0 2.0 3.0 10.5 4.7 0.9 0.1 2.9 2.1 2.3 3.4 2.0 5.4 1.9 2.2 3.0 2.3 3.1 1.8 7.1 0.7 1.6 2.5 3.1 3.1 5.0 6.5 1.7 0.0 1.1 1.1 0.7 1.1 0.8 1.3 0.5 0.6 0.8 3.7 0.9 1.0 0.4 2.2 1.6 0.3 1.7 0.4 1.3 1.7 3.6 2.0 1.3 1.3 1.4 1.4 1.1 1.8 1.0 1.7 2.1 1.9 6.4 2.0 2.6 1.9 0.9 1.9 2.8 0.6 1.1 1.6 1.7 6.2 1.5 2.2 3.7 4.2 3.6 0.4 1.1 3.9 1.8 5.5 2.9 1.3 1.8 1.2 1.3 4.7 0.7 0.9 1.1 1.5 2.7 0.0 1.8 0.4 3.7 1.7 0.0 5.1 1.7 2.0 2.9 1.0 5.0 0.9 1.8 0.0 5.6 2.8 0.9 2.1 4.5 8.1 1.6 3.3 0.7 0.7 1.2 2.5 6.2 5.3 1.9 0.0 2.3 1.4 2.9 0.9 1.4 1.4 1.1 0.8 2.3 1.3 1.1 C11orf65 "MFI, MGC33948" ENSG00000166323 "Chromosome 11 open reading frame 65" Q8NCR3 11 108308519-108467531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 51.3" "Group enriched" "Detected in many" 4 "Early spermatids: 689.1;Spermatocytes: 192.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (8.05e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-1)" "unprognostic (2.11e-2)" "unprognostic (4.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.07e-1)" "unprognostic (5.78e-2)" "unprognostic (3.54e-5)" "unprognostic (2.72e-1)" "unprognostic (2.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (8.87e-2)" "unprognostic (2.50e-2)" 0.5 1.0 0.8 0.7 1.6 0.3 0.6 1.3 1.2 0.4 0.8 0.3 0.1 0.3 2.5 0.3 1.5 0.8 0.7 0.7 1.1 2.1 2.6 0.3 0.7 1.3 1.2 0.3 0.4 0.9 0.9 0.5 0.4 1.5 0.6 0.4 2.9 0.5 0.5 0.5 0.7 0.3 0.1 1.5 0.6 0.4 51.3 1.3 0.8 1.8 0.2 0.4 0.4 0.2 2.5 0.6 0.2 0.5 0.7 0.8 1.5 1.3 0.5 0.2 0.1 0.1 0.9 2.0 0.6 1.8 0.5 0.7 1.0 1.3 1.0 0.5 0.7 0.5 0.9 0.3 0.1 0.6 0.9 0.1 1.6 0.6 0.3 2.2 0.5 0.5 2.7 1.6 0.8 1.1 1.0 0.9 0.6 0.3 1.5 0.7 0.7 0.6 0.9 0.9 0.7 1.8 0.3 0.8 0.3 0.8 0.4 3.5 0.1 0.8 0.7 0.8 0.3 0.1 1.2 0.6 2.5 0.6 0.8 0.7 0.4 0.0 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.8 1.6 1.3 1.2 0.7 1.1 1.3 1.2 0.3 1.5 1.5 1.3 2.5 1.0 0.0 1.1 23.2 2.2 0.4 1.8 1.3 1.8 16.9 1.4 1.3 1.3 0.0 1.8 3.7 31.3 1.6 0.4 0.3 3.9 2.0 689.1 10.7 1.6 1.1 1.2 0.0 3.4 2.0 0.9 1.3 1.1 1.5 2.5 1.1 0.7 2.2 0.7 6.7 4.9 0.6 2.0 0.0 0.3 97.2 5.3 0.6 3.6 11.2 0.2 5.9 1.0 17.6 25.1 1.1 0.1 4.1 0.9 0.3 0.6 5.2 6.1 43.2 6.6 2.4 0.9 192.1 33.5 1.1 0.1 1.0 1.6 2.5 0.5 1.0 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662775-35818007 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA049053: AB_2680613, HPA057633: AB_2683484" "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 12.7 10.8 19.7 12.4 18.6 6.0 11.2 20.7 23.9 11.0 10.4 12.0 10.7 11.0 10.3 9.1 11.2 11.7 11.7 18.2 19.0 18.1 14.5 12.0 12.9 18.4 18.9 16.3 10.4 15.6 11.2 8.0 13.4 19.2 10.5 11.2 27.2 9.5 11.5 11.6 8.3 12.1 12.4 19.9 14.2 11.4 6.8 19.5 12.2 15.1 9.9 13.3 11.2 8.7 21.0 20.1 16.9 26.4 12.3 19.6 29.6 0.1 18.5 21.9 22.7 20.6 19.7 13.3 26.7 17.1 24.3 25.7 15.4 9.1 21.1 25.4 17.6 17.4 28.7 23.0 11.4 26.0 22.7 23.7 22.4 23.2 13.3 36.0 25.1 24.3 9.2 45.4 9.3 24.1 12.1 24.1 11.1 14.9 4.2 14.5 16.6 68.4 14.5 21.0 26.9 18.1 15.5 27.7 19.6 21.0 14.3 29.5 19.0 27.4 28.9 23.8 16.6 21.2 15.7 15.0 0.1 23.9 23.7 22.2 0.2 0.9 0.3 0.9 1.2 0.8 1.1 0.9 0.9 0.8 1.5 1.1 1.2 0.0 1.2 1.5 1.8 0.3 0.5 19.7 18.6 20.7 23.9 18.2 19.0 18.4 18.9 16.3 19.2 19.9 19.5 21.0 67.5 60.9 72.6 78.4 68.5 26.8 57.9 19.8 74.0 221.5 45.3 38.2 58.9 55.8 45.6 25.8 204.3 55.4 72.1 70.3 33.2 62.8 18.8 78.0 74.0 62.4 51.4 39.3 151.7 71.1 25.9 49.4 74.9 54.4 58.9 107.1 49.2 53.3 42.7 84.1 134.5 57.6 16.2 65.7 37.8 13.4 36.1 70.3 19.6 84.3 76.9 72.2 72.1 121.7 171.0 53.3 50.4 37.2 59.6 90.3 50.9 75.6 48.4 173.4 98.6 71.9 52.1 88.2 81.5 46.1 26.7 52.1 47.0 58.5 54.5 59.9 CCDC182 ENSG00000166329 "Coiled-coil domain containing 182" A6NF36 17 57744495-57745299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 144 "testis: 28.7" "Group enriched" "Detected in some" 29 "Early spermatids: 250.6;Late spermatids: 180.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023446 Uncertain NA NA "HPA023446: AB_1859510" "unprognostic (1.22e-1)" "unprognostic (3.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 250.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 180.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 30000000 "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: AB_2680391" "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favorable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 106.5 77.8 46.2 85.9 48.1 44.1 92.6 48.9 49.9 147.7 52.3 297.3 67.0 362.1 82.6 116.6 165.7 88.8 177.6 44.4 55.4 78.8 66.5 108.9 73.0 48.8 47.5 42.1 101.8 90.1 73.8 47.5 99.7 47.3 184.3 117.9 28.6 70.1 416.1 91.5 58.6 118.4 367.9 49.1 96.2 151.0 26.7 49.4 46.3 72.6 92.8 71.0 228.6 119.8 49.6 127.8 94.4 148.9 51.8 224.8 159.4 67.2 182.2 360.0 211.9 256.0 102.7 145.7 47.0 47.0 304.1 206.9 99.5 84.4 155.6 213.0 83.5 74.3 69.1 84.9 82.8 150.8 55.9 74.7 153.2 72.8 143.8 108.9 217.7 206.9 40.5 63.7 55.0 282.8 97.1 49.4 97.4 94.3 107.5 110.8 51.0 77.8 50.5 160.3 100.8 25.6 57.4 86.0 118.4 103.6 144.0 82.2 62.2 238.8 263.9 118.0 111.1 90.7 38.9 25.9 67.1 195.6 82.8 125.3 314.9 260.0 417.6 127.3 258.1 124.9 96.9 114.4 122.3 242.7 92.9 70.2 88.5 165.5 257.8 254.8 98.5 142.8 402.8 46.2 48.1 48.9 49.9 44.4 55.4 48.8 47.5 42.1 47.3 49.1 49.4 49.6 79.5 44.8 17.9 24.2 33.6 50.5 73.7 100.6 24.5 21.5 43.1 68.2 0.5 70.1 49.7 57.0 8.4 119.8 46.0 71.9 58.7 136.1 64.6 33.2 78.1 69.4 37.9 53.7 14.6 125.0 177.7 83.2 50.4 52.5 30.4 41.6 76.4 31.4 127.4 8.4 17.1 50.1 69.2 51.5 97.7 143.7 71.4 115.9 85.4 30.9 143.0 54.3 77.2 15.6 15.3 117.1 60.0 147.4 35.1 42.0 74.5 98.6 31.0 32.9 157.8 53.3 165.8 31.7 17.1 32.3 43.2 110.0 49.3 65.0 50.1 43.9 TAF10 "TAF2A, TAF2H, TAFII30" ENSG00000166337 "TATA-box binding protein associated factor 10" Q12962 11 6606294-6612539 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 361.8;Late spermatids: 1039.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004148, CAB022405" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022405: , HPA004148: AB_1857736" "unprognostic (1.69e-3)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (6.21e-3)" "unprognostic (9.10e-2)" "unprognostic (6.99e-2)" "unprognostic (5.24e-3)" "unprognostic (9.03e-3)" "unprognostic (1.12e-1)" "unprognostic (1.24e-2)" "unprognostic (3.46e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.38e-1)" "unprognostic (2.55e-1)" "unprognostic (9.64e-3)" "unprognostic (3.80e-3)" 71.8 141.9 144.3 53.8 141.7 93.8 69.8 141.8 205.7 58.0 134.2 62.2 44.7 64.1 98.3 104.0 62.3 28.6 113.7 140.0 148.3 101.7 152.8 77.3 57.2 155.7 144.8 131.9 50.4 154.1 53.7 96.9 31.3 146.9 80.4 54.6 31.0 70.2 43.3 108.4 60.5 68.7 39.0 139.8 126.5 100.9 192.2 147.1 82.8 75.2 50.4 76.9 72.7 58.7 165.2 82.4 138.2 88.7 77.7 140.6 135.1 67.5 61.4 134.6 98.9 98.6 102.0 145.0 45.4 77.2 111.4 137.4 68.6 66.0 99.7 97.3 92.2 95.3 64.2 95.6 122.2 227.7 85.4 98.9 157.8 125.1 77.5 163.0 168.0 110.6 139.5 67.0 80.7 157.4 159.5 122.2 78.5 62.6 130.9 107.6 72.2 46.8 78.5 163.5 108.1 62.2 84.4 82.9 95.0 107.6 129.8 67.1 100.6 64.6 67.2 78.9 97.6 87.9 94.6 70.7 73.4 110.4 44.5 108.2 12.7 9.9 11.8 9.7 15.7 8.8 9.8 9.4 11.1 10.8 11.6 8.8 7.8 27.9 8.7 16.2 23.7 11.4 5.1 144.3 141.7 141.8 205.7 140.0 148.3 155.7 144.8 131.9 146.9 139.8 147.1 165.2 106.4 3.2 23.3 6.2 60.1 21.4 56.8 9.4 32.5 23.0 116.3 148.0 51.5 47.1 13.1 36.8 20.9 48.5 130.7 79.7 19.6 18.2 361.8 93.8 90.0 39.3 34.7 45.4 4.4 33.3 55.2 43.0 56.6 86.3 5.1 70.5 26.7 53.8 65.9 23.5 4.4 50.8 2.0 78.4 44.4 1039.1 24.5 91.2 26.6 9.4 36.3 84.7 53.5 2.5 9.9 30.7 68.5 19.2 89.6 85.8 55.5 43.1 14.0 27.1 0.0 36.3 50.0 108.8 33.2 75.0 29.1 53.6 65.0 124.1 44.2 88.7 TPP1 "CLN2, LPIC, SCAR7, TPP-1" ENSG00000166340 "Tripeptidyl peptidase 1" O14773 11 6612768-6619448 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037709, HPA044868" Enhanced "Intracellular and membrane" NA NA 9500000 "HPA037709: AB_10672913, HPA044868: AB_2679122" "unprognostic (8.27e-3)" "unprognostic (5.85e-2)" "unprognostic (7.12e-3)" "unprognostic (3.34e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (2.39e-2)" "unprognostic (1.31e-1)" "unprognostic (6.54e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (4.46e-4)" "unprognostic (3.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-2)" 75.4 147.1 68.1 75.3 76.1 112.7 44.7 78.0 82.1 51.5 108.2 59.4 60.4 74.6 43.5 39.8 47.6 65.7 56.2 66.3 83.3 72.3 93.5 82.2 78.4 82.8 75.2 60.4 50.2 36.5 54.6 64.1 95.0 78.4 39.2 60.3 49.0 42.8 58.0 31.7 39.4 73.9 92.8 76.0 136.1 48.8 20.2 74.6 47.8 46.1 39.3 61.4 69.1 43.1 104.4 26.1 48.1 25.9 50.5 309.9 160.1 21.8 50.9 220.7 36.9 62.0 20.1 122.5 37.4 32.6 136.6 220.2 85.8 48.3 68.7 57.9 37.3 27.6 32.2 23.8 54.9 210.9 45.8 182.6 231.8 104.5 45.9 102.6 240.4 158.8 32.9 59.8 124.6 110.4 30.2 16.6 52.4 18.0 61.5 57.1 36.1 21.6 77.0 62.8 38.2 4.5 20.4 52.6 44.6 91.0 76.5 30.8 79.7 188.0 119.7 33.1 101.1 19.8 92.3 95.3 14.0 139.8 101.7 64.5 67.0 167.1 38.2 39.9 171.2 30.0 35.1 31.4 41.0 185.9 37.0 20.1 27.2 27.5 29.1 125.1 93.1 60.3 138.8 68.1 76.1 78.0 82.1 66.3 83.3 82.8 75.2 60.4 78.4 76.0 74.6 104.4 32.0 25.6 37.3 31.6 53.0 23.7 28.4 29.8 13.1 24.8 21.1 23.9 41.8 50.1 26.8 16.5 12.5 35.4 71.0 55.2 5.9 42.2 11.8 13.3 30.2 40.7 16.7 37.5 12.5 13.4 45.3 40.3 16.3 24.8 62.2 25.6 75.7 81.0 261.6 15.2 12.4 31.3 26.4 376.5 126.5 11.2 27.1 219.8 90.7 15.9 156.0 37.9 49.4 8.0 21.9 17.4 44.1 26.4 26.4 23.5 99.7 51.6 14.5 23.8 6.6 19.0 20.3 0.8 1.1 27.6 20.0 88.0 42.2 24.6 32.5 26.5 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621330-6655809 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" NA NA 4000000 "Plasma membrane" "HPA017970: AB_2669718, HPA050246: AB_2681062" "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.5 2.5 6.1 8.5 6.1 0.7 9.3 5.5 6.3 17.9 1.7 14.8 4.1 29.1 2.4 5.1 13.3 8.4 8.7 5.9 7.7 4.3 2.0 10.2 4.0 7.0 4.9 5.0 11.7 3.4 2.0 3.2 10.2 5.1 9.4 3.4 0.6 3.6 11.7 4.2 3.7 8.3 16.4 3.4 13.0 8.3 3.0 6.4 3.8 4.1 4.6 2.2 15.0 9.4 4.0 0.0 0.1 33.5 0.1 0.0 0.1 0.3 1.2 8.7 5.4 6.0 0.3 0.0 0.1 5.1 9.9 0.4 0.0 2.7 0.1 3.7 0.1 0.9 0.7 0.0 0.0 0.3 0.2 0.0 1.0 0.1 2.5 0.0 0.0 47.1 0.1 0.2 0.0 2.0 0.0 1.2 0.6 5.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 2.4 32.4 0.0 0.3 0.2 3.5 0.0 1.3 20.4 0.1 10.0 0.1 0.0 0.1 0.0 0.1 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 6.1 6.1 5.5 6.3 5.9 7.7 7.0 4.9 5.0 5.1 3.4 6.4 4.0 34.8 0.0 0.5 12.1 0.2 2.9 0.3 0.0 0.0 1.5 1.7 3.0 3.8 4.3 0.0 0.0 0.0 0.2 1.4 0.2 0.0 1.0 3.1 0.8 17.3 29.0 0.0 2.7 2.0 0.4 0.3 17.0 1.1 0.7 0.0 19.3 61.1 0.2 2.2 0.0 7.4 0.7 0.0 4.7 4.2 3.4 1.2 2.4 16.0 4.7 0.2 0.9 0.0 10.1 1.4 0.1 0.1 1.9 0.2 0.3 0.1 0.1 0.0 0.5 0.0 7.4 4.9 4.9 0.6 0.5 1.7 0.3 1.2 4.6 1.1 0.1 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 21.5;retina: 34.9" "Group enriched" "Detected in some" 14 "Bipolar cells: 206.4;Excitatory neurons: 307.1;Inhibitory neurons: 345.9;Oligodendrocyte precursor cells: 172.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 21.9;REH: 20.6;RPMI-8226: 32.7;RT4: 24.7;SCLC-21H: 26.9;U-2 OS: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064630 Approved "Golgi apparatus" "Secreted in brain" NA NA "Golgi apparatus" "HPA064630: AB_2685305" "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 1.0 0.0 4.2 0.3 13.1 0.1 1.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 16.0 4.8 0.1 0.0 0.0 1.0 2.5 0.7 13.4 0.0 0.2 0.1 0.2 0.0 4.8 0.0 0.1 34.9 0.2 0.0 0.0 0.2 0.5 0.0 0.0 3.2 0.2 0.8 1.1 0.4 0.6 0.0 1.2 0.1 0.0 16.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 8.7 0.0 0.0 20.6 0.0 32.7 4.0 24.7 26.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.1 0.0 21.5 16.0 4.8 2.5 0.7 13.4 4.8 0.0 1.1 16.1 2.0 0.0 0.0 16.6 6.1 0.0 0.0 0.0 0.0 206.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 307.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 17.8 0.0 2.2 0.0 172.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 263.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.3;Excitatory neurons: 11.9;Inhibitory neurons: 9.7;Oligodendrocyte precursor cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 1.8 1.6 1.4 1.5 2.0 1.6 1.7 4.5 2.1 2.9 1.7 2.2 1.2 2.1 1.7 1.4 2.2 1.2 11.0 1.5 1.0 1.6 1.6 2.2 1.8 0.6 0.8 1.8 3.0 1.9 56.6 2.3 0.6 2.0 2.5 1.4 2.5 1.8 0.9 263.8 3.7 2.7 1.2 0.2 4.0 1.8 1.4 0.7 1.6 1.5 6.0 1.5 2.2 2.2 2.2 0.9 0.6 1.5 2.7 2.1 2.8 1.2 0.7 0.5 0.3 0.6 0.3 0.7 2.1 0.2 0.7 0.1 1.1 1.0 0.2 0.8 1.1 0.9 1.7 1.3 0.5 0.7 1.1 1.7 2.4 0.7 0.6 1.7 2.1 0.2 0.8 0.6 1.0 1.2 0.2 0.9 1.6 0.4 0.5 0.7 0.5 4.1 0.1 0.8 0.9 0.3 0.8 0.5 1.0 0.9 1.4 0.9 0.9 1.3 1.2 0.7 0.4 1.7 0.6 2.1 1.1 0.5 1.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.0 4.5 2.1 1.5 1.0 0.6 0.8 1.8 2.0 0.2 0.7 2.2 0.9 0.0 3.6 4.6 1.0 0.5 0.1 0.6 0.0 1.4 0.4 0.5 5.3 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.4 0.3 0.4 0.7 1.2 0.0 1.3 11.9 0.4 0.2 0.8 1.1 0.8 5.1 1.8 1.4 0.2 0.2 0.0 9.7 0.4 0.0 0.8 0.6 0.3 3.1 0.5 0.0 4.7 1.1 0.5 1.0 6.0 3.4 0.2 3.9 1.5 0.4 0.5 0.6 0.2 0.3 1.2 0.0 4.0 0.6 0.7 0.3 0.0 0.0 0.1 1.1 1.4 0.6 0.2 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250846-74291973 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 897.9;liver: 2492.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6" "Cancer enhanced" "Detected in all" "liver cancer: 43.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 1117.0;RT4: 513.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol No No 1400000 "Vesicles, Cytosol" "CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750" "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favorable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 312.3 110.5 37.1 31.5 37.7 25.6 255.6 40.7 45.6 86.7 37.2 133.0 442.2 45.3 177.7 78.7 82.6 304.0 72.9 36.0 37.0 897.9 2492.4 359.7 44.1 41.8 37.4 35.6 225.7 465.2 238.0 58.9 82.5 40.0 96.7 104.4 10.4 59.5 124.0 41.8 102.3 384.9 47.1 40.1 76.2 196.4 58.4 38.7 52.1 42.8 42.5 35.5 156.8 68.9 42.3 78.8 130.8 67.4 0.6 1117.0 198.2 89.5 52.6 113.8 111.0 163.8 156.2 82.7 95.6 36.7 97.6 54.4 170.6 0.1 73.1 86.9 179.8 91.7 34.9 65.6 418.1 174.6 67.3 44.1 334.1 57.4 63.0 32.3 66.0 63.6 85.8 58.6 35.0 93.7 140.9 38.3 80.5 30.4 110.0 86.8 93.6 21.9 2.3 111.9 513.2 190.4 79.7 51.4 137.1 65.8 56.6 271.5 63.7 57.9 0.6 85.8 26.6 68.1 24.6 109.2 30.3 67.0 19.2 64.3 4.1 29.5 7.5 51.3 36.3 116.2 93.7 55.6 60.2 53.7 112.7 54.5 68.6 3.7 36.3 45.7 47.8 48.8 43.2 37.1 37.7 40.7 45.6 36.0 37.0 41.8 37.4 35.6 40.0 40.1 38.7 42.3 169.7 637.8 1371.0 11.4 76.0 98.0 82.1 368.6 50.7 9.9 345.8 213.2 90.7 836.4 1053.2 842.4 4.2 229.3 29.4 197.0 2156.1 239.4 7.5 163.1 76.6 119.9 164.2 180.0 13.1 504.6 169.8 141.4 208.9 345.6 39.9 55.0 177.4 3376.3 97.4 8.4 12.6 236.5 457.7 128.6 72.9 26.7 158.1 60.8 90.7 10.3 224.1 39.2 32.0 14.1 22.7 266.7 358.9 149.7 33.4 142.0 1856.4 3630.6 619.5 14.0 52.6 49.6 85.0 15.3 42.0 141.2 223.9 44.5 52.6 1123.6 329.9 220.7 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625994 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 136.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "OE19: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047663, HPA063665" Approved Approved Mitochondria NA NA Mitochondria "HPA047663: AB_2680116, HPA063665: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favorable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 4.7 3.1 65.0 5.5 97.5 2.1 16.5 85.4 71.8 14.7 34.1 15.2 5.0 9.4 13.3 14.0 12.1 5.6 7.1 59.7 75.4 5.2 1.5 18.0 2.8 96.1 98.5 49.8 6.9 10.9 8.9 2.9 2.8 103.4 12.3 19.9 15.0 17.0 7.7 50.1 15.3 6.8 7.2 82.3 2.9 20.9 9.2 84.5 8.5 41.0 17.2 7.1 6.7 4.9 136.3 10.0 8.4 15.9 13.7 4.4 4.8 4.7 4.7 11.2 7.9 8.6 8.1 16.7 6.6 6.5 3.7 6.1 14.2 10.7 4.3 10.2 2.8 8.6 5.0 6.3 8.0 4.1 5.6 2.3 3.9 3.8 9.0 10.9 20.6 3.4 5.7 7.5 3.0 6.3 5.6 4.5 6.8 8.0 33.4 30.2 7.0 11.9 3.0 8.7 7.6 4.8 5.4 10.1 11.7 15.8 10.2 15.8 5.8 4.9 3.5 11.2 6.6 6.8 2.4 4.3 4.1 8.3 5.3 3.1 0.2 0.4 0.5 0.6 0.4 0.7 0.4 0.5 0.4 0.4 0.3 0.7 0.4 0.0 0.3 0.5 0.4 0.6 0.4 65.0 97.5 85.4 71.8 59.7 75.4 96.1 98.5 49.8 103.4 82.3 84.5 136.3 5.9 48.1 34.3 33.0 1.7 2.7 8.5 11.0 4.0 7.7 15.3 8.4 7.2 5.7 18.9 12.9 16.7 1.0 1.2 19.6 0.0 4.7 2.4 25.8 12.9 6.3 10.3 2.1 23.1 8.0 1.0 7.6 40.2 44.3 3.8 3.5 2.5 3.0 1.4 5.0 33.4 23.4 2.0 1.3 1.4 2.2 3.4 1.8 8.8 76.8 0.8 12.5 0.0 116.1 476.0 12.2 9.7 10.9 2.3 52.6 10.5 1.9 21.7 12.2 6.6 19.6 3.8 9.2 6.0 7.7 4.0 1.4 3.0 2.9 11.2 15.2 RAG1 "MGC43321, RNF74" ENSG00000166349 "Recombination activating 1" P15918 11 36510709-36593156 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA recombination, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "lymphoid tissue: 398.6" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Hepatic stellate cells: 8.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MOLT-4: 283.5;REH: 266.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA043939 Supported Nucleoplasm NA NA Nucleoplasm "HPA043939: AB_2732512" "unprognostic (7.35e-2)" "unprognostic (1.57e-3)" "unprognostic (8.75e-2)" "unprognostic (3.44e-1)" "unprognostic (2.14e-1)" "unprognostic (1.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.43e-1)" "unprognostic (1.54e-2)" "unprognostic (5.98e-3)" "unprognostic (1.28e-1)" "unprognostic (1.16e-9)" "unprognostic (2.16e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-4)" "unprognostic (1.53e-1)" 0.4 0.6 0.1 0.2 0.1 4.3 0.2 0.1 0.1 0.4 0.2 0.4 0.8 0.2 0.8 0.1 0.3 0.4 0.3 0.1 0.1 1.4 0.8 0.6 0.1 0.1 0.1 0.0 0.3 0.3 0.6 0.1 0.6 0.1 0.3 0.3 0.6 0.4 0.3 0.1 0.1 1.0 0.1 0.1 2.6 0.5 0.3 0.1 398.6 2.5 0.3 0.6 0.3 0.1 0.1 0.4 0.0 0.5 0.1 0.2 0.6 0.0 0.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 0.0 0.1 0.2 0.0 0.4 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.3 0.2 0.5 54.0 0.2 0.0 0.5 0.0 283.5 0.0 2.2 0.2 0.0 266.4 0.0 1.3 0.9 0.0 0.1 0.3 0.1 0.7 0.1 1.2 1.0 0.1 1.0 0.2 0.2 0.2 0.1 2.3 1.9 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.1 1.4 0.7 0.0 1.0 1.0 0.8 0.9 0.0 0.4 1.8 0.0 0.2 0.5 1.3 3.9 0.8 2.3 0.3 0.3 1.6 0.0 0.4 1.8 0.5 0.1 0.7 0.0 0.4 0.0 0.3 8.2 2.1 0.4 0.0 1.7 0.8 0.0 0.6 0.7 1.7 0.0 0.1 0.0 1.0 1.1 0.5 2.1 1.0 1.3 1.1 0.4 0.0 0.0 0.5 3.0 2.9 0.4 0.9 0.0 0.2 0.7 1.0 1.0 0.2 0.4 0.4 0.4 0.5 0.6 0.6 POTED "A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21" ENSG00000166351 "POTE ankyrin domain family member D" Q86YR6 21 13609858-13641585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFTAP "C11orf74, FLJ38678, HEPIS, NWC" ENSG00000166352 "Intraflagellar transport associated protein" Q86VG3 11 36594369-36675695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 10.0;Cardiomyocytes: 60.7;Cytotrophoblasts: 19.3;Extravillous trophoblasts: 19.0;Fibroblasts: 8.5;Hofbauer cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044880 Uncertain Approved Aggresome,Cytosol NA NA "Aggresome, Cytosol" "HPA044880: AB_10796908" "unprognostic (9.22e-3)" "unprognostic (6.79e-2)" "unprognostic (3.23e-2)" "unprognostic (7.47e-2)" "unprognostic (5.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.13e-2)" "unprognostic (9.86e-2)" "unprognostic (2.36e-1)" "unprognostic (3.65e-2)" "unprognostic (8.52e-2)" "unprognostic (1.92e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.24e-1)" 16.2 20.2 21.0 5.3 21.7 13.5 15.4 21.3 31.2 16.9 32.3 24.1 7.6 16.3 23.9 9.5 32.0 12.8 42.1 21.2 20.8 22.6 18.9 11.9 5.5 21.5 21.8 21.2 22.0 18.1 16.6 26.1 10.4 21.3 12.9 10.5 19.7 12.3 10.4 41.4 6.5 10.2 16.7 20.7 8.4 17.7 52.8 22.3 10.6 83.0 42.6 5.0 17.7 13.0 21.9 11.4 19.7 41.4 31.3 39.0 56.2 16.4 24.5 26.8 23.6 43.3 0.7 18.8 0.2 18.1 25.0 32.4 4.5 28.3 33.9 48.8 0.2 47.8 19.9 9.2 20.0 30.0 27.4 4.5 36.4 24.4 15.7 22.4 40.5 40.4 15.2 25.4 0.3 25.6 18.8 4.9 22.7 24.8 7.0 31.0 19.5 51.4 11.3 34.1 3.6 0.6 46.6 28.0 5.4 42.6 37.4 38.3 14.7 24.7 32.3 22.3 43.4 21.8 6.2 12.3 0.0 29.4 33.2 17.0 10.5 18.3 1.2 1.6 15.4 5.1 0.0 4.8 3.9 20.9 0.3 11.6 2.9 1.0 14.1 15.3 28.5 0.7 8.3 21.0 21.7 21.3 31.2 21.2 20.8 21.5 21.8 21.2 21.3 20.7 22.3 21.9 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 19.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 19.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.9" "Group enriched" "Detected in some" 5 "Early spermatids: 31.3;Late spermatids: 15.9;Spermatocytes: 24.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: AB_2681093" "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.2 0.4 0.3 0.9 0.8 0.9 0.1 0.8 0.7 0.1 0.0 0.2 0.6 0.3 0.0 0.6 0.2 0.5 0.9 0.5 0.3 0.3 0.1 0.2 1.2 0.4 0.3 0.4 0.8 0.8 0.0 0.2 0.2 0.5 0.4 0.0 1.5 0.8 0.0 0.2 0.7 0.7 0.0 0.1 0.6 0.3 8.9 0.3 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.5 1.1 0.7 1.3 0.3 0.0 1.0 0.4 0.0 0.1 0.0 0.5 1.1 1.3 0.6 0.0 0.8 0.4 0.0 0.1 0.0 2.8 0.4 1.3 1.0 0.2 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.9 1.4 0.0 1.7 0.5 0.6 0.5 0.4 0.4 1.1 0.4 0.2 0.0 0.6 1.9 1.9 1.3 0.6 0.3 0.9 1.6 1.0 0.7 0.3 1.0 0.6 0.2 1.2 0.9 0.7 0.2 2.1 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.8 0.8 0.7 0.5 0.3 0.4 0.3 0.4 0.5 0.1 0.3 0.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 15.9 0.3 0.0 0.0 1.9 0.0 0.0 0.0 2.5 4.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A5 "JCG6, OR10A1, OR11-403" ENSG00000166363 "Olfactory receptor family 10 subfamily A member 5" Q9H207 11 6845652-6846705 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.14e-5)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2D2 "hg27, OR11-610, OR2D1" ENSG00000166368 "Olfactory receptor family 2 subfamily D member 2" Q9H210 11 6891490-6892599 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.1 0.2 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ATP9B ATPIIB ENSG00000166377 "ATPase phospholipid transporting 9B (putative)" O43861 18 79069285-79378287 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 128.2;Alveolar cells type 2: 156.2;Excitatory neurons: 126.0;Inhibitory neurons: 115.0;Oligodendrocyte precursor cells: 114.6;Oligodendrocytes: 157.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029364 Approved NA NA "HPA029364: AB_10602595" "unprognostic (2.84e-3)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (7.32e-2)" "unprognostic (7.66e-4)" "unprognostic (2.45e-2)" "unprognostic (7.43e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (2.93e-1)" "unprognostic (1.92e-3)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.05e-2)" "unprognostic (1.09e-2)" 8.8 8.2 11.2 8.4 18.5 30.9 9.2 31.3 26.2 8.4 9.1 8.6 6.2 11.2 9.9 9.8 9.3 8.6 7.3 16.0 11.6 11.0 16.3 10.4 9.4 8.3 10.8 13.8 14.2 9.3 15.3 4.8 9.7 14.2 10.9 9.8 22.7 10.4 8.2 10.5 11.9 7.6 8.1 2.7 8.9 10.4 19.3 6.4 9.4 12.6 5.9 7.2 7.6 5.6 35.2 25.0 11.7 15.9 17.5 7.9 13.4 12.3 12.1 7.9 6.9 5.8 12.3 15.9 12.5 20.4 8.7 6.5 10.1 13.0 6.7 11.2 19.6 5.6 14.8 13.7 9.0 10.6 27.1 15.1 10.7 8.3 11.1 6.9 10.3 9.7 15.0 14.3 31.7 9.7 20.0 17.5 10.5 23.3 14.5 14.1 16.8 13.2 17.3 9.7 19.6 11.7 12.5 13.3 14.6 8.4 27.2 16.8 15.9 17.4 14.6 24.2 6.6 8.0 16.0 27.5 27.8 8.7 17.6 15.5 11.7 8.7 7.1 6.0 7.5 6.9 6.6 6.7 5.9 6.3 7.0 8.5 6.5 9.8 6.8 13.6 6.0 6.0 5.7 11.2 18.5 31.3 26.2 16.0 11.6 8.3 10.8 13.8 14.2 2.7 6.4 35.2 14.3 128.2 156.2 91.1 19.6 5.7 8.5 5.4 14.8 35.7 9.6 8.8 10.1 14.3 55.6 9.2 41.7 7.0 20.6 8.4 1.9 6.1 26.7 8.4 20.5 17.6 12.0 5.5 126.0 5.6 3.9 19.2 30.1 11.8 43.6 21.5 11.4 7.7 14.1 42.1 115.0 8.6 2.0 15.7 9.9 45.3 15.8 25.7 7.2 85.3 11.4 13.2 14.4 114.6 157.2 7.9 10.2 11.3 20.3 6.1 5.9 4.0 95.6 38.1 6.6 17.8 13.0 40.1 25.0 9.3 7.2 7.7 27.3 18.0 10.1 8.0 PPFIBP2 Cclp1 ENSG00000166387 "PPFIA binding protein 2" Q8ND30 11 7513298-7657127 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.4;Extravillous trophoblasts: 56.2;Oligodendrocytes: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 80.5;OE19: 100.4;RT4: 105.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001935, HPA003911" Enhanced Approved Mitochondria NA NA Mitochondria "HPA001935: AB_1079667, HPA003911: AB_1079666" "unprognostic (4.14e-2)" "unprognostic (7.04e-3)" "unprognostic (7.20e-3)" "unprognostic (5.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (2.32e-4)" "unprognostic (1.33e-1)" "prognostic favorable (2.26e-5)" "unprognostic (6.66e-3)" "unprognostic (2.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "prognostic favorable (5.39e-8)" "unprognostic (1.78e-1)" "unprognostic (3.38e-1)" "unprognostic (2.52e-2)" "prognostic favorable (1.34e-5)" 10.4 11.8 23.2 12.1 31.9 7.6 16.7 24.8 22.1 11.8 45.1 22.6 26.6 6.7 33.8 27.5 17.4 15.9 13.1 21.2 24.9 19.0 35.7 11.7 15.3 27.5 29.6 16.5 14.4 9.4 67.0 4.8 21.2 31.4 18.3 26.8 2.9 55.3 33.1 33.7 32.9 26.2 5.5 23.1 11.2 44.5 31.8 30.4 4.5 37.8 21.6 25.3 29.8 22.0 44.6 2.0 32.7 5.3 3.1 6.1 0.4 80.5 7.1 16.1 4.1 4.0 26.7 4.6 9.7 3.7 4.1 15.1 14.2 21.0 2.1 3.7 3.9 2.4 0.0 0.3 17.1 8.4 19.6 9.3 10.7 7.6 0.0 4.5 0.4 1.5 2.0 0.9 26.5 4.0 15.9 0.0 19.0 37.8 100.4 0.1 3.3 0.1 17.4 0.1 105.0 1.5 12.4 1.1 28.9 21.9 14.6 4.0 14.7 0.5 1.9 2.8 6.4 0.7 14.1 11.1 8.3 2.3 4.5 13.0 3.4 9.1 6.5 3.1 11.2 2.3 12.7 5.0 2.1 8.3 7.2 6.6 5.2 4.2 2.6 14.4 0.6 1.1 5.2 23.2 31.9 24.8 22.1 21.2 24.9 27.5 29.6 16.5 31.4 23.1 30.4 44.6 1.7 16.0 13.6 3.9 21.2 5.5 18.7 4.5 10.2 1.5 10.1 7.7 5.2 11.5 13.7 14.7 18.8 9.1 1.6 29.8 9.8 5.8 53.4 6.7 4.8 3.2 3.6 0.0 3.8 9.6 56.2 7.7 40.2 35.7 7.0 0.6 1.1 17.3 7.1 0.0 6.0 23.2 8.2 10.4 7.2 47.2 4.7 11.3 16.0 17.8 15.7 1.7 3.1 49.8 70.5 6.9 22.8 7.2 9.0 13.4 26.8 19.7 7.5 3.3 0.0 5.7 10.2 22.2 2.6 10.7 9.9 4.8 2.0 1.2 18.0 18.6 MOGAT2 "DGAT2L5, FLJ22644, MGAT2" ENSG00000166391 "Monoacylglycerol O-acyltransferase 2" Q3SYC2 11 75717838-75732958 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 48.6;liver: 25.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4" "Cancer enhanced" "Detected in many" "liver cancer: 6.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 4.5;RPMI-8226: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028834 Uncertain NA NA "HPA028834: AB_10601865" "unprognostic (5.63e-2)" "unprognostic (2.71e-2)" "unprognostic (6.37e-2)" "unprognostic (6.88e-3)" "unprognostic (1.15e-4)" "unprognostic (2.66e-3)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (4.21e-2)" "unprognostic (3.02e-1)" "unprognostic (1.24e-5)" "unprognostic (2.13e-3)" "unprognostic (1.84e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-3)" 0.0 0.0 0.0 1.9 0.2 0.0 1.4 0.0 0.1 0.1 0.0 14.0 45.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 25.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.7 0.0 0.2 0.2 0.0 0.3 48.6 0.7 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.3 1.5 0.2 0.0 0.0 0.0 0.0 73.8 0.0 0.0 0.0 0.1 0.0 0.0 2.4 2.7 0.0 0.5 0.0 0.0 2.6 0.1 0.0 0.0 0.4 79.6 0.0 0.0 0.0 36.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.3 0.0 0.0 0.6 159.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.4 0.1 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 140.4;testis: 134.6" "Cell type enhanced" "Detected in many" "Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8" "Group enriched" "Detected in many" 9 "B-cells: 10.6;granulocytes: 6.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3" "Low region specificity" "Detected in single" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: AB_2732668" "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 8.7 3.6 19.2 5.7 24.6 4.2 15.8 20.5 24.8 15.3 15.6 4.6 2.5 23.0 25.7 19.8 10.2 6.9 3.7 20.1 21.7 5.9 5.2 11.6 2.7 24.1 25.0 17.6 29.6 4.4 29.2 1.3 13.9 27.5 19.6 5.3 140.4 36.0 22.5 1.7 49.5 4.4 13.3 19.0 3.0 5.7 134.6 22.5 0.9 5.2 1.7 10.6 13.4 17.9 30.6 7.1 3.6 1.5 0.0 0.3 1.7 22.8 43.9 125.1 65.9 59.4 0.7 9.4 0.2 10.3 22.7 20.2 0.8 0.1 0.3 52.0 0.1 0.2 0.0 3.8 0.9 35.0 0.4 6.6 17.7 1.4 0.3 3.7 0.1 5.6 0.0 6.9 0.1 0.5 0.0 0.0 0.1 69.8 7.4 3.4 34.1 0.1 0.0 0.0 4.4 0.0 0.7 0.3 28.0 1.9 11.1 4.8 9.4 0.0 6.1 0.1 0.3 3.4 0.2 0.0 10.7 0.5 0.0 96.3 0.0 0.9 6.1 0.0 0.5 0.0 10.6 0.1 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 19.2 24.6 20.5 24.8 20.1 21.7 24.1 25.0 17.6 27.5 19.0 22.5 30.6 0.6 22.4 5.1 0.0 2.3 7.0 8.4 12.3 8.6 1.3 8.8 12.8 3.0 1.5 6.3 3.7 20.9 5.3 0.1 0.6 0.0 1.4 268.0 5.5 11.2 1.7 0.0 0.0 0.0 4.7 20.0 8.1 1.5 14.3 2.5 0.5 0.4 1.8 2.5 0.0 0.1 1.8 6.1 0.0 0.5 601.1 4.7 1.5 5.4 1.9 0.5 0.8 0.0 0.5 8.5 6.0 1.4 6.0 2.9 11.2 0.3 0.4 10.2 35.2 13.1 2.3 7.5 115.6 9.8 12.8 10.1 4.5 0.2 1.8 1.8 11.4 SERPINB7 MEGSIN ENSG00000166396 "Serpin family B member 7" O75635 18 63752935-63805376 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lymphoid tissue: 38.7;skin 1: 118.1" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 79.5;Basal respiratory cells: 353.3;Club cells: 120.7;Ductal cells: 157.8;Extravillous trophoblasts: 82.2;Pancreatic endocrine cells: 276.5" "Cancer enhanced" "Detected in many" "cervical cancer: 8.0;head and neck cancer: 8.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 240.4;fHDF/TERT166: 170.8;HaCaT: 412.8;HBEC3-KT: 131.9;HBF TERT88: 223.0;hTERT-HME1: 130.9;U-138 MG: 219.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "cerebral cortex: 12.9;hippocampal formation: 11.4" HPA024200 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA 160000 "Endoplasmic reticulum" Mitochondria "HPA024200: AB_1856730" "unprognostic (8.66e-3)" "unprognostic (6.31e-3)" "unprognostic (6.55e-2)" "unprognostic (4.03e-4)" "unprognostic (9.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (9.99e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (2.02e-1)" "unprognostic (6.81e-2)" "unprognostic (1.62e-1)" "unprognostic (3.37e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-3)" 0.4 0.0 0.0 0.5 0.0 0.0 13.2 0.0 0.0 1.4 0.0 0.7 0.0 0.7 0.0 1.9 0.0 0.3 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.7 0.0 0.5 118.1 0.0 0.1 0.0 0.0 0.8 0.4 0.0 4.6 0.0 0.0 38.7 0.0 4.8 0.0 28.2 0.1 0.0 0.1 0.0 3.7 0.0 240.4 48.2 36.0 26.6 0.0 1.0 0.1 0.1 170.8 62.5 412.8 0.1 131.9 223.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 8.6 22.9 5.5 130.9 1.8 0.0 0.0 0.0 0.8 21.7 0.0 0.0 0.0 0.6 0.0 11.9 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.8 0.1 0.2 0.0 219.4 8.1 4.7 22.8 0.1 0.0 0.0 22.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 79.5 0.9 353.3 0.0 0.0 0.1 0.0 0.0 0.0 120.7 0.0 0.0 1.9 0.0 0.5 0.0 157.8 0.1 0.0 0.0 0.5 0.0 0.0 0.2 8.8 82.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 2.0 0.0 3.0 0.0 0.0 0.2 3.6 0.0 1.6 0.0 0.0 0.5 0.3 276.5 1.1 0.0 0.0 4.5 0.0 0.3 13.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 21.9 6.2 0.1 0.0 0.0 8.2 GARRE1 KIAA0355 ENSG00000166398 "Granule associated Rac and RHOG effector 1" O15063 19 34254552-34355566 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 126.8;Cardiomyocytes: 15.7;Cytotrophoblasts: 23.8;Extravillous trophoblasts: 25.1;Syncytiotrophoblasts: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014570: AB_1852307" "unprognostic (1.88e-2)" "unprognostic (8.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.75e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-3)" "unprognostic (9.05e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.34e-1)" "unprognostic (7.73e-3)" "unprognostic (2.96e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" 17.9 5.6 6.1 7.3 6.2 3.5 17.0 7.4 5.1 10.6 7.3 7.8 5.4 11.1 3.0 8.1 10.2 9.6 11.1 3.2 5.8 8.1 7.4 12.5 9.2 6.7 6.9 2.0 9.4 10.5 10.8 7.8 23.5 6.5 8.4 5.7 8.2 7.5 6.4 15.5 10.0 8.3 8.7 5.8 16.3 6.7 7.2 7.0 8.6 11.0 17.2 7.5 8.1 10.0 10.2 3.4 10.2 8.9 4.6 6.0 5.7 11.6 7.6 6.2 5.7 8.4 8.1 3.9 7.7 16.4 7.1 7.1 2.4 6.6 3.6 6.2 11.0 5.8 4.7 3.9 6.2 7.6 2.1 3.7 6.7 6.2 7.5 11.0 22.6 23.7 4.3 14.4 3.8 6.2 1.8 1.4 1.9 6.8 4.6 3.7 3.4 6.2 4.1 4.8 3.8 10.3 8.5 8.7 33.9 10.9 12.9 2.7 3.8 19.7 19.5 7.2 5.0 8.1 6.4 9.5 2.4 3.7 0.8 9.7 0.0 0.7 0.0 0.8 1.4 1.3 2.3 1.8 0.8 0.8 2.8 1.6 1.0 2.2 1.5 2.1 1.1 3.0 0.8 6.1 6.2 7.4 5.1 3.2 5.8 6.7 6.9 2.0 6.5 5.8 7.0 10.2 126.8 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 23.8 10.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 25.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 34.1 2.3 0.0 0.0 0.0 SERPINB8 "CAP2, PI8" ENSG00000166401 "Serpin family B member 8" P50452 18 63970029-64019779 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 52.9" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 120.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB034300 Enhanced Approved Nucleoplasm,Cytosol NA NA 920000 Nucleoplasm Cytosol "CAB034300: AB_2186486" "unprognostic (8.49e-2)" "unprognostic (4.87e-2)" "unprognostic (4.10e-3)" "unprognostic (2.86e-2)" "unprognostic (1.52e-2)" "unprognostic (7.71e-2)" "unprognostic (4.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.58e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (8.73e-2)" "unprognostic (3.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.90e-1)" 10.9 9.6 3.0 16.0 3.6 30.5 9.6 3.7 3.9 7.4 3.8 8.7 6.4 4.8 1.5 30.4 4.4 18.3 5.0 3.1 8.2 4.9 38.2 12.2 13.6 5.4 4.3 2.8 4.2 7.1 2.7 3.8 7.3 4.9 4.7 9.8 2.3 10.8 3.3 3.0 52.9 8.9 7.4 4.5 7.9 7.2 2.8 4.1 6.6 5.4 2.3 18.5 23.9 17.2 5.0 24.2 4.8 4.0 28.8 13.9 19.7 2.0 75.6 72.9 46.8 46.4 1.0 10.8 0.4 27.2 45.6 23.3 38.3 0.8 48.2 66.3 33.4 0.9 0.0 8.7 2.5 32.1 120.0 10.0 19.1 41.3 63.6 20.9 30.3 51.4 5.1 0.7 13.4 32.9 2.1 2.1 13.5 1.7 3.8 23.6 1.7 10.5 2.1 21.4 27.1 2.3 2.4 15.0 2.3 28.8 3.3 0.8 45.4 79.2 71.0 15.4 8.8 31.1 5.9 1.0 0.1 72.5 69.2 63.0 2.7 44.2 2.0 7.6 34.2 6.8 7.1 6.3 4.7 53.8 9.9 3.3 5.2 12.4 4.6 18.1 28.8 8.9 11.2 3.0 3.6 3.7 3.9 3.1 8.2 5.4 4.3 2.8 4.9 4.5 4.1 5.0 6.0 3.2 8.3 0.3 9.1 41.0 25.9 38.9 5.7 0.4 5.5 3.8 1.2 8.6 25.5 0.0 0.0 4.9 13.4 12.3 0.0 30.0 1.3 7.6 3.3 8.7 1.8 3.0 1.8 19.2 5.6 8.6 8.2 16.3 4.5 0.9 7.5 9.6 15.3 0.0 1.3 3.5 12.2 24.8 35.1 1.1 0.9 35.9 16.0 1.0 29.0 1.6 5.2 1.5 2.9 42.2 10.7 0.0 3.5 13.0 8.5 2.9 12.9 0.3 0.0 12.3 9.8 1.7 2.3 18.2 48.4 31.3 8.2 1.4 5.0 33.3 TUB rd5 ENSG00000166402 "TUB bipartite transcription factor" P50607 11 8019244-8106243 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.9;retina: 83.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Excitatory neurons: 34.6;Horizontal cells: 30.3;Inhibitory neurons: 23.2;Oligodendrocyte precursor cells: 23.1;Rod photoreceptor cells: 55.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 26.8;HEK 293: 33.7;HeLa: 54.3;SCLC-21H: 51.0;SH-SY5Y: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Enhanced Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: AB_2680601" "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favorable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 6.3 17.5 26.4 2.5 27.3 0.2 6.7 15.1 26.7 26.5 2.3 6.5 2.0 24.6 10.4 3.2 19.9 4.7 11.4 37.8 28.3 11.5 0.9 3.9 1.9 19.2 72.9 23.1 18.4 4.7 13.8 32.0 4.3 25.9 8.7 2.4 83.3 5.4 8.2 2.9 6.4 4.0 11.4 16.6 1.7 3.7 5.0 24.2 2.5 10.8 8.3 0.9 11.1 14.0 18.9 0.0 9.8 14.2 16.7 13.2 4.3 0.0 9.4 2.5 9.9 13.2 0.0 0.1 0.0 0.8 13.2 4.6 0.1 26.8 2.0 9.2 0.0 33.7 0.0 54.3 6.1 2.2 0.0 0.4 6.8 2.4 4.7 0.0 0.8 0.9 15.7 0.0 0.1 4.8 1.4 0.1 0.1 9.4 0.0 0.1 12.6 0.2 0.0 0.0 0.5 51.0 38.1 6.9 0.1 2.6 6.3 1.4 0.2 0.0 5.4 12.5 0.9 3.9 0.1 0.0 0.0 4.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 27.3 15.1 26.7 37.8 28.3 19.2 72.9 23.1 25.9 16.6 24.2 18.9 0.5 0.0 0.0 15.0 0.0 0.8 2.0 0.1 1.2 15.5 0.8 1.9 3.5 1.5 0.7 0.0 41.7 0.2 0.1 0.0 5.9 0.1 4.2 4.4 14.1 0.5 1.8 0.0 34.6 0.0 0.4 6.8 0.0 0.4 1.3 10.1 1.4 0.2 0.2 30.3 23.2 0.0 0.0 0.0 0.7 4.9 14.6 0.2 1.8 8.4 0.0 12.6 0.0 23.1 1.9 0.0 0.0 14.7 0.1 1.5 0.0 10.2 5.1 55.6 0.0 6.8 1.5 1.6 1.4 0.2 0.9 0.0 0.5 0.5 0.0 0.4 RIC3 "AYST720, FLJ11608, PRO1385" ENSG00000166405 "RIC3 acetylcholine receptor chaperone" Q7Z5B4 11 8106056-8169055 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 175.2;Cone photoreceptor cells: 143.9;Rod photoreceptor cells: 204.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 12.8;granulocytes: 4.5;T-cells: 6.7" "Cell line enhanced" "Detected in some" "GAMG: 2.3;HMC-1: 2.6;NTERA-2: 5.0;SCLC-21H: 8.3;SH-SY5Y: 5.8;SuSa: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065016 Approved "Intracellular and membrane" NA NA "HPA065016: AB_2685404" "unprognostic (2.51e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-1)" "unprognostic (6.98e-4)" "unprognostic (3.22e-2)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (4.45e-4)" "unprognostic (1.28e-1)" "unprognostic (2.23e-9)" "unprognostic (4.37e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-2)" 2.3 13.6 16.9 5.2 18.0 2.0 6.4 24.9 21.8 7.8 13.5 8.5 1.9 11.0 21.7 5.8 10.2 3.5 9.1 16.6 18.3 10.2 3.5 3.7 7.8 15.6 15.2 17.2 19.9 18.2 11.8 31.5 0.3 18.7 17.1 2.1 42.6 16.1 10.4 5.9 14.3 8.3 6.1 12.9 7.4 8.5 7.4 15.5 2.1 23.1 2.4 7.1 10.6 6.0 19.0 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.3 5.8 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.9 0.1 1.2 0.5 0.0 0.0 0.1 0.0 0.1 4.5 0.6 1.3 2.2 0.8 1.4 11.9 4.6 2.4 0.6 12.8 6.7 5.9 1.9 1.8 1.7 1.6 2.6 0.8 16.9 18.0 24.9 21.8 16.6 18.3 15.6 15.2 17.2 18.7 12.9 15.5 19.0 1.5 6.4 15.5 56.2 79.1 36.3 55.9 8.2 58.6 175.2 34.8 47.0 14.0 42.9 20.7 23.9 143.9 0.5 7.2 0.1 0.0 33.5 2.9 0.2 1.6 4.2 7.7 4.4 95.3 28.5 0.3 10.8 2.0 0.2 24.6 9.5 6.4 4.9 0.2 95.9 90.1 4.4 8.2 1.0 2.2 4.5 33.5 2.2 12.4 17.8 3.3 52.3 4.1 101.0 50.4 14.6 1.4 46.6 18.6 38.6 3.1 6.6 19.4 204.9 0.0 9.0 7.0 51.0 39.5 15.9 39.6 0.5 19.8 1.1 1.5 38.2 LMO1 "RBTN1, RHOM1, TTG1" ENSG00000166407 "LIM domain only 1" P25800 11 8224309-8268716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;skeletal muscle: 29.6;tongue: 12.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 18.5;Distal tubular cells: 27.4;Early spermatids: 60.7;Horizontal cells: 40.4" "Cancer enriched" "Detected in many" 6 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 33.8;SCLC-21H: 12.5;SH-SY5Y: 38.5;SiHa: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.74e-3)" "unprognostic (1.45e-1)" "unprognostic (4.75e-6)" "unprognostic (9.34e-2)" "unprognostic (2.37e-1)" "unprognostic (1.98e-1)" "unprognostic (7.06e-3)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (9.05e-2)" "unprognostic (4.36e-12)" "unprognostic (1.76e-2)" "unprognostic (8.88e-2)" "unprognostic (2.58e-2)" "unprognostic (3.13e-2)" 0.1 1.2 2.3 0.1 2.2 0.0 0.3 4.0 3.4 0.0 0.9 0.1 0.2 0.1 1.6 0.3 0.1 0.0 0.7 3.1 2.4 0.9 0.0 0.0 0.0 4.4 9.7 2.2 0.1 0.8 0.0 2.4 0.1 5.8 0.1 0.0 2.0 0.3 0.0 29.6 6.2 0.0 0.2 2.1 0.5 0.7 2.2 5.3 0.0 0.1 12.5 0.0 0.3 0.1 2.4 0.1 0.9 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 33.8 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.3 0.0 4.3 0.0 0.0 0.0 0.6 1.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 38.5 7.9 4.4 0.2 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.1 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.2 4.0 3.4 3.1 2.4 4.4 9.7 2.2 5.8 2.1 5.3 2.4 0.1 0.0 0.0 3.3 0.0 18.5 0.1 0.3 1.8 7.1 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 27.4 0.1 60.7 0.1 0.1 0.4 0.0 0.0 1.1 1.2 8.4 0.1 0.0 0.5 1.3 0.2 0.0 0.0 0.2 40.4 0.6 0.0 0.0 0.0 0.4 6.8 0.0 0.2 0.0 11.2 0.0 0.5 0.0 3.0 0.3 2.0 1.1 0.4 0.1 0.1 0.0 0.2 2.3 4.0 0.0 0.5 0.7 0.6 1.3 0.3 3.4 0.3 0.0 0.0 0.0 0.0 IDH3A ENSG00000166411 "Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha" P50213 15 78131498-78171945 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 100.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 144.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041465, HPA062971" Supported Enhanced Mitochondria No No 110000 Mitochondria "HPA041465: AB_10794377, HPA062971: AB_2684913" "unprognostic (2.33e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-3)" "unprognostic (2.26e-1)" "unprognostic (1.02e-1)" "unprognostic (4.01e-1)" "unprognostic (2.29e-1)" "unprognostic (6.47e-2)" "unprognostic (1.69e-2)" "unprognostic (2.30e-1)" "unprognostic (3.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (6.49e-8)" "unprognostic (1.40e-1)" "unprognostic (3.08e-2)" "unprognostic (4.49e-2)" "unprognostic (3.39e-2)" 22.8 25.3 12.0 20.1 13.6 9.7 9.7 17.1 14.7 11.0 17.9 26.4 37.0 13.8 7.9 17.2 11.1 9.1 63.0 15.6 16.4 17.0 14.3 12.0 17.3 13.5 14.7 10.5 10.9 13.1 55.2 6.9 12.2 15.3 14.0 27.0 26.4 16.3 16.3 80.2 15.9 36.3 17.3 10.3 15.4 12.0 17.1 13.8 35.3 11.3 100.6 25.0 17.9 11.1 17.9 43.8 58.5 10.4 36.5 25.5 26.1 22.6 50.8 24.5 40.6 30.5 41.6 25.8 91.6 36.8 29.9 59.9 64.2 98.2 39.3 37.0 40.7 32.2 35.7 62.4 19.2 21.8 69.8 48.8 19.9 23.6 39.4 41.2 19.3 25.7 32.0 46.4 35.9 26.0 41.4 51.4 17.4 12.9 25.2 21.8 29.3 44.4 28.1 33.4 58.3 41.4 15.8 58.2 82.1 47.1 19.1 32.7 37.4 26.4 47.6 43.9 63.1 83.1 41.5 99.9 48.8 33.2 64.9 37.7 16.9 27.9 8.3 15.1 52.9 16.4 27.7 14.7 13.5 43.5 32.6 15.2 16.4 15.5 17.3 54.8 144.4 17.7 23.2 12.0 13.6 17.1 14.7 15.6 16.4 13.5 14.7 10.5 15.3 10.3 13.8 17.9 18.0 9.6 16.5 22.9 30.6 56.0 58.7 51.4 33.0 35.1 10.9 12.6 17.5 14.3 22.6 25.8 37.5 38.3 63.0 69.0 82.2 26.1 52.2 19.9 13.4 17.5 19.2 9.4 45.9 17.9 40.4 21.2 11.7 9.2 27.3 14.5 10.8 22.4 26.5 26.9 53.3 37.6 69.2 24.9 28.6 23.4 20.8 26.4 26.6 12.2 16.0 29.3 12.3 19.6 17.9 21.5 37.9 23.7 33.2 40.6 49.6 48.1 38.2 34.6 13.1 23.8 25.5 45.7 26.2 28.4 41.2 68.4 17.7 37.2 56.0 42.0 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 106.6;liver: 33.4;thyroid gland: 58.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 12.8;Collecting duct cells: 22.0;Glandular and luminal cells: 13.2;Hepatocytes: 44.3;Proximal tubular cells: 93.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.9;OE19: 18.3;RPMI-8226: 17.5;RPTEC TERT1: 10.1;SuSa: 15.2;U-266/70: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles NA NA Vesicles "HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133" "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favorable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.8 0.0 0.1 7.2 0.0 0.6 2.7 1.4 0.5 0.4 2.6 4.0 0.1 0.0 0.7 106.6 33.4 0.8 0.1 0.1 0.3 0.0 0.2 3.5 1.9 0.3 0.1 0.1 0.1 0.8 0.7 18.5 0.6 0.0 2.0 0.9 0.0 0.0 0.1 1.1 0.5 0.0 0.0 58.4 0.0 0.0 1.7 0.0 0.3 0.0 9.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 3.2 0.1 6.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 18.3 0.1 0.0 0.1 17.5 10.1 3.5 1.9 0.0 0.0 0.1 0.0 15.2 2.4 0.0 0.1 0.3 0.5 0.0 0.1 7.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.1 6.4 3.6 0.0 0.5 0.1 1.1 0.0 0.6 0.5 0.0 0.1 0.6 12.8 0.0 22.0 0.0 0.6 0.0 0.2 9.8 3.2 1.2 4.9 1.0 0.1 0.0 0.0 0.4 0.5 2.1 0.2 0.0 13.2 0.0 0.0 0.0 44.3 0.1 3.3 0.5 0.0 0.0 0.6 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 93.2 0.1 0.1 0.0 0.0 0.1 1.0 1.6 0.9 0.4 0.1 0.7 0.0 0.3 6.4 CRABP1 "CRABP, CRABP-I, CRABPI, RBP5" ENSG00000166426 "Cellular retinoic acid binding protein 1" P29762 15 78340353-78348225 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 548.8;thyroid gland: 174.9" "Cell type enriched" "Detected in some" 24 "Muller glia cells: 4845.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 117.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AF22: 1022.7;NTERA-2: 307.4" "Group enriched" "Detected in many" 5 "amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4" "Low region specificity" "Detected in all" HPA017203 Enhanced Supported NA NA "HPA017203: AB_1846512" "unprognostic (1.23e-1)" "unprognostic (3.76e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.01e-1)" "unprognostic (4.35e-2)" "unprognostic (1.05e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-2)" "unprognostic (9.79e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (9.37e-2)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (2.69e-1)" 0.6 1.7 18.7 2.5 26.0 0.2 56.7 26.2 26.6 1.3 26.7 6.4 0.8 2.4 2.0 0.6 0.3 1.6 0.4 9.6 40.4 15.1 0.0 0.7 0.2 59.1 49.5 11.3 0.4 0.7 0.0 27.8 15.1 54.2 2.6 1.7 548.8 1.1 47.9 0.2 26.9 5.0 1.8 24.5 75.8 7.2 0.5 52.7 1.7 174.9 0.2 1.2 0.6 2.5 95.4 0.0 0.2 1022.7 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 65.3 0.9 0.0 6.3 0.0 0.3 0.0 9.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 57.9 0.4 307.4 1.0 0.8 0.0 0.0 0.0 0.0 1.5 85.5 58.0 0.0 0.2 0.1 24.8 1.4 35.9 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 26.0 26.2 26.6 9.6 40.4 59.1 49.5 11.3 54.2 24.5 52.7 95.4 1.0 0.0 0.0 0.3 0.8 9.7 0.1 0.0 0.0 31.1 112.6 199.0 0.0 0.0 0.0 0.0 33.3 1.1 2.9 1.1 70.5 0.0 0.0 0.1 0.1 4.8 0.0 0.0 0.2 0.0 0.8 11.3 0.0 0.1 0.0 4.2 0.0 0.0 1.5 10.1 1.5 0.4 0.0 0.0 5.3 0.0 0.0 0.5 192.1 0.0 0.0 4845.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.4 0.5 0.0 91.2 0.0 0.0 1.0 0.1 2.2 0.0 2.6 1.4 0.9 0.0 1.6 0.1 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924713-104937761 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.5;brain: 15.8;lymphoid tissue: 11.4" "Cell type enriched" "Detected in many" 7 "dendritic cells: 284.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 3621.6" "Lineage enriched" "Detected in all" 5 "dendritic cells: 3621.6" "Group enriched" "Detected in some" 4 "HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2900000 "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.4 1.1 3.9 5.7 4.8 13.5 1.6 6.3 7.2 1.0 0.1 0.8 3.8 1.0 0.2 0.7 1.8 2.5 0.5 3.7 8.2 0.6 0.6 1.8 11.4 14.8 5.7 1.2 0.5 1.1 1.2 2.1 0.8 9.5 1.7 0.5 0.5 3.6 1.8 0.3 0.6 5.2 0.5 15.8 10.5 2.9 0.7 7.1 2.8 0.6 0.0 9.5 1.9 0.4 14.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 127.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.1 10.7 0.1 0.0 0.1 30.0 0.1 85.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 191.5 0.0 0.1 0.3 0.1 0.2 0.4 0.0 0.1 0.2 1.6 0.3 4.6 43.0 699.5 1.0 188.4 1.9 222.7 0.8 1.2 545.8 198.4 1.7 0.4 9.8 25.4 297.9 3621.6 1.0 72.9 3.9 4.8 6.3 7.2 3.7 8.2 14.8 5.7 1.2 9.5 15.8 7.1 14.0 0.8 0.0 0.0 0.3 34.7 0.4 0.1 0.0 0.0 2.7 0.6 2.8 1.4 0.0 0.0 0.0 0.0 0.2 284.8 0.0 0.0 0.0 0.7 0.1 0.3 2.7 0.0 5.5 0.1 0.0 0.4 1.1 1.1 0.4 3.8 0.0 0.0 0.0 30.6 1.7 0.1 0.0 0.0 1.3 32.0 4.7 0.0 38.0 5.4 22.5 11.3 0.1 2.1 0.5 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.1 0.0 1.1 6.6 1.6 0.3 1.6 1.6 0.0 0.4 0.3 2.2 0.0 0.1 0.0 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932079 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 190.3;Oligodendrocyte precursor cells: 111.1;Oligodendrocytes: 112.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 8.2;U-266/70: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.1 9.4 11.8 2.8 11.9 6.4 7.6 11.1 15.3 7.1 11.4 6.0 1.9 5.6 21.4 2.4 10.1 2.2 7.9 11.4 11.8 14.2 9.8 5.7 6.7 12.1 11.6 10.6 15.4 10.4 4.4 35.1 0.7 11.6 10.8 1.3 9.5 6.8 3.7 2.6 2.9 7.6 1.3 11.8 13.9 5.8 6.7 11.3 3.2 25.2 1.5 2.6 6.1 4.8 12.8 0.2 0.0 1.0 1.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 1.2 1.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.2 0.7 1.9 0.0 8.2 0.6 0.0 0.1 0.1 1.3 0.0 0.1 1.5 0.0 0.1 2.3 0.0 0.4 1.1 0.7 0.0 0.1 1.1 1.4 2.1 2.0 0.6 0.0 0.0 0.1 4.1 0.3 0.0 0.4 2.0 0.6 0.8 0.3 0.5 0.2 0.1 0.4 0.6 0.3 0.4 0.0 0.9 0.4 0.3 0.2 0.1 0.1 0.9 0.2 0.1 11.8 11.9 11.1 15.3 11.4 11.8 12.1 11.6 10.6 11.6 11.8 11.3 12.8 18.9 16.0 31.2 190.3 30.2 4.1 7.6 0.2 7.4 38.1 18.2 12.3 25.4 11.5 14.4 14.7 43.8 0.1 16.5 0.6 3.9 5.0 14.9 28.2 3.7 16.8 10.3 6.9 30.7 2.7 0.0 10.3 2.0 21.6 15.8 51.5 13.6 10.6 3.3 16.8 32.8 2.8 0.0 9.7 11.1 9.7 1.8 11.7 7.2 71.2 10.7 25.8 10.3 111.1 112.8 1.5 1.6 1.2 7.4 6.1 2.7 5.7 13.0 57.5 0.0 27.5 9.0 22.4 10.2 3.2 2.8 0.1 16.3 5.4 2.6 4.3 XRRA1 FLJ00225 ENSG00000166435 "X-ray radiation resistance associated 1" Q6P2D8 11 74807739-74949200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 19.6" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 139.7;Spermatocytes: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 36.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039263 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA039263: AB_2676419" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" "unprognostic (7.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (3.31e-1)" "unprognostic (1.23e-1)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (5.94e-3)" "unprognostic (2.13e-1)" "unprognostic (3.31e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-1)" 3.3 3.8 2.6 1.1 3.1 1.7 3.4 2.4 2.9 4.9 2.1 3.8 2.6 4.8 3.9 4.1 4.5 2.9 4.4 2.1 2.6 4.2 5.0 3.8 1.9 4.7 2.7 1.9 4.9 4.6 3.3 4.2 2.4 4.1 5.1 2.4 2.3 5.6 3.0 6.0 3.4 2.9 4.9 2.2 4.2 3.8 19.6 3.0 2.6 7.1 11.7 2.8 4.6 4.0 4.5 5.4 3.0 0.7 4.9 7.5 4.9 2.1 2.3 2.5 1.3 1.3 1.6 2.8 2.2 8.3 2.5 11.1 4.3 6.1 3.0 2.8 8.8 0.5 1.9 2.0 3.1 2.2 1.2 0.9 4.7 3.4 5.6 36.1 10.5 2.7 7.2 5.1 5.0 6.5 2.0 2.0 2.8 1.7 6.5 2.7 0.9 3.9 1.7 1.1 4.1 4.7 3.9 10.7 4.5 14.2 2.3 2.8 5.6 1.8 7.8 5.0 5.7 2.2 7.0 6.7 6.1 1.8 1.1 2.7 1.4 2.0 1.9 2.9 2.5 3.2 1.6 2.1 2.2 1.7 1.5 2.1 2.0 3.3 1.0 1.7 1.2 4.4 1.5 2.6 3.1 2.4 2.9 2.1 2.6 4.7 2.7 1.9 4.1 2.2 3.0 4.5 22.8 9.6 8.8 40.5 27.7 11.0 10.4 15.7 10.8 56.7 18.3 15.0 5.9 8.6 12.3 22.0 139.7 12.3 15.1 13.9 15.6 8.2 51.9 18.7 19.5 13.8 12.1 9.0 38.4 8.0 10.6 16.0 11.2 13.6 12.0 14.7 15.0 14.0 7.8 48.8 39.1 16.3 8.2 10.3 11.0 78.9 29.8 8.9 28.4 30.0 7.7 19.9 25.7 36.7 55.5 6.5 16.2 30.5 29.8 10.5 17.6 22.1 22.5 76.6 26.3 23.4 13.9 125.2 37.7 6.5 7.5 10.9 21.1 7.1 18.4 7.8 TRIM66 "C11orf29, KIAA0298, TIF1D" ENSG00000166436 "Tripartite motif containing 66" O15016 11 8612037-8682694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027420 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027420: AB_1858316" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.99e-2)" "unprognostic (1.37e-3)" "unprognostic (8.01e-2)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (6.79e-2)" "prognostic favorable (8.89e-4)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.67e-1)" "unprognostic (4.26e-1)" "unprognostic (4.67e-2)" "unprognostic (4.31e-1)" 3.9 6.0 5.2 4.0 5.1 2.8 4.7 1.9 3.8 3.9 4.0 4.1 3.5 3.8 8.3 5.2 4.2 3.0 2.4 2.3 3.2 4.1 11.0 3.6 5.4 3.3 3.5 1.4 3.6 8.9 3.1 9.5 1.5 4.3 4.3 4.6 3.7 4.4 3.3 3.6 12.0 5.5 3.5 2.5 5.7 5.4 17.5 3.3 4.6 6.2 3.1 5.2 4.3 4.2 3.9 5.3 4.9 2.9 10.2 6.0 4.5 3.6 3.2 3.7 2.2 2.9 6.5 9.9 5.2 2.2 2.9 2.1 7.2 3.1 2.8 2.7 6.1 2.4 5.0 9.2 3.6 2.5 4.5 3.9 7.1 2.8 1.9 6.6 2.4 2.9 13.1 2.7 5.5 2.9 5.8 2.1 3.4 1.8 2.7 4.6 3.0 2.2 2.1 3.1 6.7 2.1 2.0 4.6 3.2 2.2 2.8 4.2 1.0 2.3 4.2 3.8 2.5 2.8 2.3 3.7 6.4 2.8 4.6 2.4 0.0 0.5 0.6 0.7 0.1 0.4 0.6 0.7 0.9 0.7 0.8 0.7 1.1 0.3 0.8 1.3 1.3 0.6 0.3 5.2 5.1 1.9 3.8 2.3 3.2 3.3 3.5 1.4 4.3 2.5 3.3 3.9 3.0 3.2 5.6 47.7 4.0 1.8 2.3 3.6 2.2 8.0 5.1 5.6 1.9 4.3 5.1 5.5 12.5 3.6 3.1 4.5 0.0 3.4 46.0 5.0 4.0 3.2 6.0 5.7 14.2 3.2 1.8 2.6 5.1 3.7 1.3 6.7 5.0 9.8 2.6 11.8 17.1 4.2 0.0 5.2 2.2 27.3 1.8 3.8 0.0 13.1 5.9 4.3 3.1 9.5 22.6 3.9 3.9 2.2 3.1 1.6 8.3 2.4 5.4 9.0 13.1 6.5 2.5 14.6 7.2 3.8 1.1 1.4 3.3 8.0 4.4 1.0 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748849-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 4.0 2.9 5.3 6.7 6.2 14.5 5.7 6.7 5.2 5.1 5.4 4.4 4.0 7.7 4.2 10.2 5.6 4.8 3.2 4.2 4.7 4.7 5.1 5.9 6.4 5.4 5.3 3.8 7.7 4.4 5.7 2.1 4.7 5.8 5.2 5.3 6.1 4.5 4.4 6.8 5.5 4.4 7.7 5.2 7.4 4.6 2.9 5.4 7.8 5.9 5.8 6.8 5.3 5.5 9.7 10.2 7.7 9.1 9.0 5.8 7.7 3.7 7.9 7.4 8.6 7.4 13.0 7.5 18.2 7.9 9.5 5.8 9.6 12.4 9.3 11.2 9.1 8.0 12.6 15.3 5.1 6.6 6.8 10.1 7.1 7.2 9.8 22.1 9.6 14.0 12.2 11.4 14.1 8.7 8.6 11.6 12.0 3.6 12.9 5.0 10.7 21.7 9.9 5.5 10.6 4.1 7.4 10.6 8.0 16.6 7.3 9.9 8.6 9.4 14.2 11.8 9.0 7.1 10.2 5.8 21.1 2.8 7.3 8.4 1.2 0.5 0.4 0.4 0.3 0.3 0.0 0.4 0.2 0.2 0.1 0.3 0.2 1.4 0.3 0.3 0.2 0.3 0.2 5.3 6.2 6.7 5.2 4.2 4.7 5.4 5.3 3.8 5.8 5.2 5.4 9.7 18.8 9.6 11.4 51.6 18.4 19.9 30.6 7.1 20.5 58.2 12.6 9.8 3.0 17.2 8.3 3.7 52.1 5.5 24.6 9.8 5.9 10.2 2.8 30.5 26.7 17.2 12.0 18.3 40.8 11.1 6.4 16.0 14.8 30.1 7.0 24.4 10.8 12.3 8.5 37.0 43.2 8.7 2.0 15.6 19.9 3.1 7.5 16.6 10.6 25.3 12.6 22.9 26.8 42.7 68.7 10.1 6.8 10.5 18.5 49.7 6.3 12.1 8.9 33.7 26.3 31.9 18.7 9.4 11.7 16.4 18.6 8.1 22.2 14.0 10.4 42.2 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682788-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" NA NA 89000 "Endoplasmic reticulum, Cytosol" "HPA060776: AB_2684359, HPA063379: AB_2684997" "prognostic favorable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 1852.3 1599.5 1091.2 1148.8 1102.3 3268.9 2033.7 1072.2 1696.0 2206.5 1113.5 1844.8 1129.6 1522.0 1264.5 2552.9 1793.2 909.7 1446.0 1056.4 1161.3 1448.0 1526.0 1452.9 2489.2 1104.2 1081.4 1038.0 3207.5 3105.5 555.1 1339.6 1043.4 1105.8 1814.3 1365.6 567.3 1888.0 564.5 2188.1 2655.1 1891.0 920.5 1125.0 2281.7 1896.7 401.0 1105.8 1583.5 1620.2 1170.1 2296.8 1832.3 2206.2 1167.4 3374.8 2282.4 1427.2 1723.1 1917.9 3636.8 2160.5 2131.4 2659.7 2386.0 1819.2 2904.7 3041.6 4726.7 1635.8 1877.3 1019.4 2400.8 1914.2 2976.5 1781.2 1742.6 4109.6 2101.8 2068.1 3642.3 3180.6 3846.3 2350.4 4015.9 5180.1 380.2 3959.2 3267.2 2398.7 2766.7 2203.9 1446.0 2043.8 2521.0 2863.4 5717.8 2332.9 2478.6 2375.5 2469.8 1504.9 2920.6 2292.2 3298.8 1631.2 2917.9 797.7 2987.9 3547.0 1494.5 1322.2 4282.8 2203.9 778.3 2093.9 2005.3 2746.5 1629.9 3909.0 3975.9 1772.1 2585.6 1433.3 3535.7 5105.6 1567.8 7665.6 4887.2 9888.7 13013.7 10807.7 9082.0 7409.3 11343.1 12593.4 10685.9 1149.1 6890.0 4553.8 7100.8 8081.2 27172.4 1091.2 1102.3 1072.2 1696.0 1056.4 1161.3 1104.2 1081.4 1038.0 1105.8 1125.0 1105.8 1167.4 715.7 1121.8 1863.9 8.8 3163.6 4858.0 6358.1 4908.5 492.3 215.3 3316.7 1895.8 934.4 2174.7 2795.5 987.7 114.7 5885.0 2461.3 1680.5 2856.5 2520.9 861.4 1138.4 2272.9 2077.8 2118.2 1701.9 7.1 5396.5 7518.8 1703.8 407.8 1787.8 2132.2 1410.6 3162.6 2776.8 4393.9 80.8 8.6 5111.4 1617.4 4642.2 6081.0 1902.1 3623.5 2177.5 2833.5 7.5 4730.9 1006.9 4985.7 8.0 11.0 3962.9 4511.8 1957.0 678.2 5412.4 4146.2 3282.9 1236.0 352.8 1558.1 2338.6 2218.2 503.8 482.7 1064.4 6060.7 6015.7 2992.7 1341.3 5098.3 7041.0 DENND2B "HTS1, p126, ST5" ENSG00000166444 "DENN domain containing 2B" P78524 11 8693351-8910951 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Adipocytes: 3.2;Cardiomyocytes: 6.2;Cytotrophoblasts: 3.7;Extravillous trophoblasts: 1.8;Fibroblasts: 7.1;Hofbauer cells: 5.8;Smooth muscle cells: 5.7;Syncytiotrophoblasts: 2.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 4 "monocytes: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046796 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046796: AB_2679812" "unprognostic (1.88e-3)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.88e-2)" "unprognostic (4.17e-2)" "unprognostic (2.46e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-1)" "unprognostic (1.72e-1)" "unprognostic (5.56e-2)" "unprognostic (3.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" 22.1 60.5 21.1 19.4 18.0 3.5 26.9 23.6 23.4 71.8 31.2 66.0 29.0 131.4 33.4 63.3 105.6 34.9 32.2 18.5 30.6 22.5 27.6 29.0 12.2 29.0 29.9 13.7 69.8 27.8 15.5 21.7 26.6 17.2 45.8 26.9 36.8 37.8 63.5 22.1 20.5 30.6 118.2 20.8 60.2 57.3 41.4 28.2 17.7 36.9 11.2 15.2 65.6 50.8 19.9 32.6 4.9 51.8 9.0 16.8 17.6 2.5 28.9 95.8 27.5 25.4 6.8 34.0 1.0 17.2 52.7 12.1 32.2 10.0 41.7 10.8 4.4 12.7 0.0 16.7 22.8 26.9 0.2 0.2 60.8 11.6 15.6 20.1 56.0 5.5 5.0 6.7 2.8 45.4 3.5 1.8 1.5 7.9 32.2 7.7 1.1 31.5 2.0 37.5 23.4 9.8 31.7 25.7 32.1 19.8 17.7 5.4 1.1 14.9 15.8 24.7 50.6 22.8 8.0 15.5 0.2 24.1 0.2 30.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.0 2.9 0.0 0.1 0.4 21.1 18.0 23.6 23.4 18.5 30.6 29.0 29.9 13.7 17.2 20.8 28.2 19.9 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 7.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 CDYL2 FLJ38866 ENSG00000166446 "Chromodomain Y like 2" Q8N8U2 16 80597907-80804598 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 69.6;Glandular and luminal cells: 34.3;Late spermatids: 26.4;Microglial cells: 30.9;Oligodendrocyte precursor cells: 27.6" "Cancer enhanced" "Detected in all" "prostate cancer: 9.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 1.0;non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "HDLM-2: 15.9;HUVEC TERT2: 22.7;MCF7: 20.2;TIME: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041016 Approved NA NA "HPA041016: AB_10794183" "unprognostic (8.63e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-3)" "prognostic favorable (6.13e-4)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "unprognostic (2.40e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (4.33e-2)" "unprognostic (9.11e-2)" "unprognostic (2.12e-1)" "unprognostic (3.69e-3)" 3.0 1.3 4.3 3.4 5.6 5.7 3.1 12.9 9.8 4.3 0.1 1.2 3.2 2.3 1.9 1.9 0.8 1.6 0.9 5.3 5.0 3.6 1.8 2.2 3.7 2.7 7.7 5.2 0.3 1.2 2.7 0.8 11.1 6.0 9.9 1.4 1.2 2.6 6.1 0.4 0.8 2.9 2.9 0.9 2.2 1.8 11.2 8.0 1.7 1.4 0.7 3.4 3.5 1.2 5.2 0.0 0.0 0.3 0.0 5.3 5.3 4.6 5.6 3.7 1.5 0.4 0.2 2.8 0.5 1.8 3.4 0.0 0.1 0.2 5.6 0.8 15.9 3.1 2.0 8.3 0.2 0.2 0.2 0.2 1.7 2.1 2.9 2.6 8.1 22.7 1.8 0.0 0.2 0.8 20.2 0.0 0.1 1.7 0.2 6.1 0.0 0.0 0.0 8.8 7.1 1.4 0.0 0.7 4.6 0.0 1.3 4.5 3.3 33.9 0.1 9.9 0.0 1.4 0.0 0.0 0.0 3.4 4.3 0.1 0.3 0.1 0.5 0.1 1.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 4.0 0.0 0.2 0.1 4.3 5.6 12.9 9.8 5.3 5.0 2.7 7.7 5.2 6.0 0.9 8.0 5.2 5.2 3.2 1.7 15.0 1.7 2.8 2.7 0.3 0.6 0.6 7.7 2.7 1.6 2.8 1.0 3.7 0.0 11.8 2.7 0.7 3.9 2.4 13.1 7.4 7.2 7.0 1.2 4.4 69.6 4.2 5.9 3.1 0.5 34.3 0.0 3.1 6.1 4.5 2.3 0.0 21.8 2.6 0.0 9.1 1.7 26.4 2.8 4.3 0.0 30.9 16.2 0.7 0.0 27.6 2.0 2.1 0.5 4.5 1.1 8.3 4.8 5.9 0.2 0.4 0.0 0.1 3.8 4.7 10.2 0.7 1.1 16.3 4.9 4.3 2.0 2.9 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.5;brain: 128.8;pituitary gland: 101.0;testis: 37.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA 9400 "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 0.5 37.5 50.6 1.6 77.6 0.6 1.3 0.0 128.8 3.2 0.0 3.0 0.8 1.1 9.5 1.7 1.0 1.8 0.6 72.2 101.9 3.3 0.1 6.2 2.3 22.9 40.5 96.4 0.9 0.8 2.7 101.0 0.5 28.5 2.5 1.2 18.0 0.5 6.8 2.0 0.4 1.5 0.8 1.9 0.7 1.4 37.8 45.8 1.9 0.5 0.1 0.3 0.9 5.0 94.2 0.0 0.6 0.0 0.0 0.2 0.0 0.3 2.9 6.7 0.5 0.4 0.1 0.1 0.1 6.4 1.7 6.9 0.1 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 11.0 0.3 0.2 0.1 0.4 0.3 0.5 0.1 0.2 3.8 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.4 7.8 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.4 0.4 0.2 0.8 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.6 0.3 0.2 0.2 0.1 0.1 50.6 77.6 0.0 128.8 72.2 101.9 22.9 40.5 96.4 28.5 1.9 45.8 94.2 0.1 0.0 0.0 2.6 0.0 0.4 0.4 0.1 0.0 51.2 0.3 0.4 1.0 1.5 2.0 1.8 2.1 0.1 1.5 0.1 0.0 0.0 1.6 0.1 0.2 0.5 0.0 0.0 43.8 0.2 0.1 2.1 0.0 0.2 0.0 0.5 0.7 0.0 0.1 0.0 53.9 0.0 2.0 0.0 1.2 2.7 0.9 0.3 0.0 3.7 0.0 1.7 0.0 11.6 4.2 0.0 0.0 6.8 0.0 0.3 0.2 0.1 0.3 4.3 0.0 0.6 0.8 0.6 0.6 0.0 0.3 0.3 0.2 0.0 0.1 0.2 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611544-55743152 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 10.5;thyroid gland: 10.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 191.8;Oligodendrocyte precursor cells: 51.8;Rod photoreceptor cells: 62.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "AF22: 148.6;SuSa: 172.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 0.5 1.0 2.1 0.4 2.1 0.1 1.1 2.5 1.6 1.0 1.3 0.5 0.1 3.6 0.5 0.1 1.1 0.3 0.6 1.5 5.4 0.9 0.1 1.7 0.2 3.7 2.5 0.6 1.9 0.1 1.9 0.9 2.8 3.5 0.4 0.3 10.5 0.2 0.5 0.7 0.1 0.3 1.3 3.3 0.1 0.5 3.6 3.3 0.0 10.8 0.4 0.2 0.4 0.5 5.5 1.2 3.4 148.6 3.2 0.0 0.1 13.2 1.2 4.5 3.9 5.4 25.8 0.8 0.0 5.4 0.2 5.8 0.0 0.6 0.3 5.2 0.0 6.4 1.0 1.1 9.8 1.1 1.0 0.0 0.5 0.2 1.7 2.7 3.0 2.8 0.3 2.7 0.0 2.3 2.2 0.0 0.0 5.9 0.0 3.0 0.0 22.3 0.0 3.1 0.4 1.8 7.6 1.2 1.9 8.3 172.9 0.7 0.5 0.2 2.1 1.6 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 2.1 2.5 1.6 1.5 5.4 3.7 2.5 0.6 3.5 3.3 3.3 5.5 3.2 9.6 20.2 17.6 0.0 0.3 0.0 0.0 0.0 12.4 5.0 4.4 6.0 0.0 2.5 16.5 191.8 19.9 0.1 0.1 0.0 0.0 21.8 2.8 25.5 9.7 0.0 0.0 0.7 0.2 4.1 4.0 3.6 3.1 0.0 2.9 3.6 0.0 1.7 0.0 11.1 0.0 0.0 0.0 0.0 25.3 5.3 0.2 0.0 28.1 0.0 4.4 0.0 51.8 13.6 0.4 0.0 2.6 0.1 0.1 0.0 1.4 0.0 62.3 0.0 5.8 2.4 8.9 12.1 0.0 0.0 6.0 0.1 9.5 0.5 0.1 CENPN "BM039, C16orf60, FLJ13607, FLJ22660" ENSG00000166451 "Centromere protein N" Q96H22 16 81006552-81033114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 37.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 64.2;Extravillous trophoblasts: 91.1;Spermatocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052870 Supported Nucleoplasm NA NA Nucleoplasm "HPA052870: AB_2681978" "unprognostic (1.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.15e-1)" "unprognostic (1.76e-2)" "unprognostic (2.15e-1)" "unprognostic (1.76e-2)" "unprognostic (3.69e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (2.36e-3)" "prognostic unfavorable (1.46e-5)" "unprognostic (3.02e-2)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.34e-2)" "unprognostic (7.42e-2)" "unprognostic (1.41e-2)" "unprognostic (7.99e-2)" 5.2 5.1 3.3 8.0 4.2 37.8 3.6 3.1 4.9 2.8 2.2 8.1 7.9 2.3 3.1 7.6 1.6 3.2 5.7 3.5 3.4 5.4 9.1 3.3 11.1 3.8 3.6 3.5 1.5 5.3 8.7 1.6 8.9 4.2 18.8 7.7 1.4 2.5 2.7 4.6 3.9 6.4 6.5 2.9 4.3 5.3 11.3 3.5 18.3 2.9 2.7 12.1 6.1 2.9 5.9 86.2 81.0 64.9 58.4 16.9 15.1 82.6 97.5 59.3 137.0 59.6 150.8 64.6 48.1 52.4 48.9 62.7 69.9 53.1 61.5 172.9 29.3 47.9 43.0 63.3 100.9 9.6 64.6 80.4 14.0 6.6 123.3 40.8 18.0 62.6 59.1 83.6 65.9 66.9 160.1 78.0 79.6 69.7 37.2 45.4 90.9 64.5 51.3 22.5 58.6 43.2 38.9 140.3 31.8 40.1 38.9 76.2 34.0 38.5 97.7 101.1 66.8 96.8 46.4 112.1 186.8 45.8 43.7 85.8 0.9 1.4 2.4 2.1 2.8 2.0 1.6 2.7 1.5 6.6 5.9 1.3 1.5 1.7 3.6 3.1 2.2 7.9 2.0 3.3 4.2 3.1 4.9 3.5 3.4 3.8 3.6 3.5 4.2 2.9 3.5 5.9 2.8 0.0 4.8 1.0 10.2 24.0 15.7 9.6 14.8 1.0 6.0 7.0 4.8 5.7 5.8 3.7 0.0 47.1 10.0 7.4 0.0 5.7 41.8 4.5 3.8 5.8 1.2 64.2 1.9 6.5 91.1 9.7 11.7 6.4 6.3 13.2 6.8 6.3 27.2 0.0 1.1 12.8 12.2 9.7 20.2 40.9 2.8 10.4 7.2 1.0 4.4 0.8 0.0 0.5 6.1 5.1 4.0 3.4 34.7 13.6 5.1 8.8 1.8 0.4 0.0 7.1 10.0 52.3 39.1 32.7 16.3 27.2 10.9 6.3 22.0 16.6 AKIP1 "BCA3, C11orf17" ENSG00000166452 "A-kinase interacting protein 1" Q9NQ31 11 8911139-8920084 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061391 Supported Nucleoplasm NA NA Nucleoplasm "HPA061391: AB_2684499" "unprognostic (7.79e-3)" "unprognostic (5.65e-2)" "unprognostic (1.60e-1)" "prognostic favorable (5.15e-4)" "unprognostic (6.58e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.24e-9)" "unprognostic (1.03e-1)" "unprognostic (5.97e-2)" "unprognostic (5.77e-2)" "unprognostic (6.63e-2)" "unprognostic (8.88e-2)" "unprognostic (6.74e-3)" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-3)" "unprognostic (1.19e-1)" 15.5 33.3 21.2 12.5 21.6 11.0 15.0 20.8 22.1 21.1 20.8 19.9 13.9 22.9 17.4 22.6 19.3 13.6 25.3 21.1 22.6 21.4 15.6 17.4 11.4 21.3 24.3 20.8 19.8 13.1 14.0 18.9 16.2 21.9 17.5 11.4 16.5 14.7 15.1 38.0 10.3 14.3 15.1 22.4 25.7 16.8 17.8 22.4 16.2 18.7 22.3 9.1 19.0 17.5 22.7 81.5 73.2 31.1 30.4 29.2 37.0 25.0 58.6 45.6 35.0 33.4 39.2 48.1 14.7 45.2 42.5 36.9 53.4 15.6 28.3 24.2 72.4 40.3 25.1 39.7 34.9 34.3 33.6 29.1 31.7 37.8 17.2 62.9 26.8 32.2 29.0 52.2 15.3 65.3 26.6 27.3 31.2 26.3 39.3 54.6 28.5 22.9 18.7 35.7 33.4 22.0 21.6 67.2 29.3 31.7 20.1 33.7 27.6 53.1 49.0 44.5 84.2 56.7 23.0 63.0 3.6 51.0 40.5 52.6 3.1 31.5 1.4 15.3 29.0 16.1 9.2 17.8 17.4 41.1 8.5 11.9 21.0 1.9 13.1 14.5 43.7 58.8 18.1 21.2 21.6 20.8 22.1 21.1 22.6 21.3 24.3 20.8 21.9 22.4 22.4 22.7 16.1 19.2 9.9 6.8 7.8 10.7 15.1 54.0 16.5 15.9 13.2 17.0 11.7 20.0 22.2 20.2 10.4 40.9 12.5 7.0 25.4 41.4 54.6 7.6 20.6 24.5 2.4 15.3 8.3 36.0 41.5 22.0 9.2 10.7 49.4 25.9 22.9 15.2 65.9 25.2 10.3 9.8 75.3 25.5 17.3 28.0 22.1 25.6 16.0 8.4 33.4 32.3 7.2 9.5 5.2 33.1 18.6 48.2 9.0 8.3 11.5 21.0 15.7 15.5 19.7 15.4 22.2 39.8 35.1 18.5 7.1 11.8 14.7 48.9 13.7 11.8 ATMIN "ASCIZ, KIAA0431, ZNF822" ENSG00000166454 "ATM interactor" O43313 16 81035842-81047350 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 180.6;Late spermatids: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054967, HPA066900" Approved Supported "Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" "HPA054967: AB_2682654, HPA066900: AB_2685744" "unprognostic (9.92e-2)" "unprognostic (3.31e-1)" "unprognostic (4.47e-2)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (9.32e-2)" "unprognostic (4.69e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" "unprognostic (6.51e-3)" "unprognostic (1.48e-1)" "unprognostic (4.26e-2)" "prognostic favorable (6.80e-4)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (1.24e-1)" "unprognostic (4.60e-1)" 16.0 12.8 20.2 11.5 20.5 8.0 14.5 19.4 25.2 13.6 15.6 13.0 12.9 13.9 18.2 19.1 11.6 11.6 14.3 21.1 22.3 19.9 18.1 10.8 14.0 21.0 24.2 20.0 14.4 16.3 27.2 13.2 20.6 22.4 17.7 13.8 10.4 12.9 14.9 16.1 17.8 13.0 13.8 19.1 13.0 12.8 22.8 22.1 15.8 20.8 17.2 15.1 14.3 12.1 23.3 26.7 22.0 28.6 33.7 30.6 21.3 42.8 17.1 24.8 15.9 8.8 14.9 14.9 20.8 21.8 25.6 18.3 25.3 28.1 14.7 20.3 13.8 15.6 14.3 13.3 17.4 28.3 24.7 21.6 22.7 24.7 15.4 24.7 26.7 16.6 20.0 22.8 12.4 22.9 42.9 19.9 18.0 33.6 16.6 16.3 34.5 13.8 12.2 25.0 27.5 22.8 29.5 54.3 16.8 14.3 23.7 28.5 22.0 22.0 20.3 20.6 19.9 16.2 19.7 31.6 50.4 18.7 16.1 19.3 0.5 0.8 0.5 1.9 0.6 1.4 1.5 2.0 1.7 0.8 1.6 1.7 1.9 0.2 1.9 0.6 1.0 2.2 0.6 20.2 20.5 19.4 25.2 21.1 22.3 21.0 24.2 20.0 22.4 19.1 22.1 23.3 38.6 9.6 19.2 10.7 11.7 12.0 16.3 10.0 10.2 24.9 20.7 16.9 18.6 20.0 15.5 23.9 20.9 42.3 25.8 21.4 11.7 12.6 180.6 13.3 37.2 19.3 11.5 7.4 16.1 14.0 38.4 17.9 15.8 22.4 16.5 15.2 22.9 21.6 29.7 13.5 17.7 13.7 6.1 23.9 6.0 288.9 19.9 14.3 14.2 3.7 19.2 32.5 12.3 8.0 16.9 18.5 11.2 19.5 15.0 15.1 19.9 20.8 7.5 16.6 13.1 24.2 18.0 28.6 25.4 17.2 15.3 30.1 15.5 21.6 16.0 18.4 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.9" "Cell type enhanced" "Detected in many" "Early spermatids: 94.7;Late spermatids: 112.4;Respiratory ciliated cells: 31.8;Spermatocytes: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 0.5 0.6 2.4 0.4 2.2 0.6 0.8 1.9 2.8 0.7 3.6 0.3 0.2 0.7 1.2 0.3 2.7 0.4 0.3 2.5 2.2 0.7 1.0 0.4 0.1 2.1 2.3 1.7 0.4 0.7 0.5 1.9 0.7 2.2 0.9 0.2 1.3 0.5 0.4 0.7 0.1 0.2 0.4 2.1 0.2 0.3 5.9 2.1 0.2 2.8 0.3 0.2 0.6 0.4 2.4 1.2 0.2 0.4 0.2 2.0 0.4 1.1 0.2 1.5 0.8 0.5 0.2 1.7 0.3 0.7 0.3 1.0 0.4 0.4 0.8 1.5 0.3 0.3 0.3 0.9 1.1 1.2 0.4 0.9 0.8 0.6 2.0 1.2 0.9 0.7 0.6 0.8 0.6 0.6 0.9 0.1 2.4 0.5 0.4 0.2 0.9 0.1 0.2 1.4 0.7 0.6 0.5 1.7 0.5 0.3 0.7 0.5 0.6 0.6 0.4 0.2 0.3 0.3 0.6 1.0 0.7 0.7 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 1.9 2.8 2.5 2.2 2.1 2.3 1.7 2.2 2.1 2.1 2.4 1.0 0.0 2.3 11.4 0.5 1.9 8.9 6.4 2.2 2.3 5.7 3.2 2.3 4.3 4.6 0.0 4.2 8.2 0.3 0.6 5.9 1.2 94.7 17.3 2.0 1.7 1.2 0.4 12.1 0.4 15.8 2.1 0.5 1.7 0.0 0.3 1.1 3.3 3.3 0.0 9.0 1.7 8.2 0.6 1.0 112.4 8.1 1.5 5.4 1.0 0.3 5.6 1.0 7.1 16.3 0.5 0.6 7.5 0.5 7.5 0.1 3.9 31.8 8.1 0.0 3.1 2.0 32.7 6.8 0.8 2.7 6.3 0.7 0.8 0.8 5.0 TMEM41B KIAA0033 ENSG00000166471 "Transmembrane protein 41B" Q5BJD5 11 9280654-9314636 "Predicted membrane proteins, Transporters" "Autophagy, Host-virus interaction, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 108.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014946 Uncertain Approved Peroxisomes NA NA Peroxisomes "HPA014946: AB_2205037" "unprognostic (1.21e-1)" "unprognostic (2.19e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.18e-6)" "unprognostic (6.18e-2)" "unprognostic (9.37e-3)" "unprognostic (4.90e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "unprognostic (3.55e-2)" "unprognostic (8.18e-2)" 6.1 7.6 12.4 7.3 13.8 11.2 8.9 14.5 14.7 5.4 11.0 11.7 17.8 5.4 10.0 8.1 4.9 7.4 8.9 11.6 17.9 11.8 19.0 14.8 9.0 15.4 14.9 11.2 4.7 9.7 10.3 3.1 11.5 14.5 11.8 9.6 8.4 9.8 6.2 5.1 9.8 17.3 3.4 14.1 6.9 12.2 8.1 14.0 9.3 15.8 5.1 8.0 7.8 3.4 18.3 34.1 25.5 17.3 18.4 17.8 25.0 47.6 31.5 24.6 14.3 26.3 17.9 108.8 13.2 26.2 18.8 28.5 42.0 19.8 16.4 18.4 20.9 19.4 12.0 21.3 21.1 24.5 11.5 14.2 20.1 23.5 14.5 17.5 18.0 13.0 16.2 25.5 32.8 29.3 11.2 16.0 12.6 50.1 18.8 17.3 12.1 23.9 18.7 25.6 32.2 5.6 20.7 26.1 23.7 26.4 22.5 20.4 15.8 17.9 16.7 21.1 28.9 17.3 9.3 17.6 22.5 18.4 8.0 14.6 9.9 1.4 5.5 5.5 1.7 6.7 7.0 4.1 6.9 1.7 5.3 8.2 10.4 3.5 9.5 1.7 8.5 4.1 3.4 12.4 13.8 14.5 14.7 11.6 17.9 15.4 14.9 11.2 14.5 14.1 14.0 18.3 21.6 48.1 77.1 32.3 27.9 76.0 57.8 48.5 42.7 36.7 36.4 21.0 21.3 34.3 44.3 31.3 66.7 44.6 34.8 58.0 7.9 30.6 1.3 48.5 31.5 20.1 39.8 29.0 47.3 39.4 60.5 29.0 22.4 89.2 17.1 24.8 21.4 55.4 22.7 20.2 52.1 42.3 36.7 18.9 44.6 2.0 18.0 24.7 19.6 26.2 23.4 24.0 22.6 37.2 69.3 57.9 40.3 13.9 26.6 58.4 56.0 17.2 34.2 38.4 19.7 37.9 25.4 50.9 44.6 47.0 63.6 56.1 28.3 31.3 33.8 77.0 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971778 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "granulocytes: 272.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.3 11.5 9.3 14.0 9.7 9.1 15.6 16.0 13.0 11.7 7.6 17.2 13.4 10.5 10.1 20.0 8.8 13.3 8.2 9.1 9.5 13.8 22.4 9.8 18.1 9.3 9.3 8.0 8.6 8.2 19.0 9.1 12.2 10.7 12.4 19.4 12.1 18.6 8.6 14.1 20.9 14.6 11.8 8.2 10.5 13.3 9.4 9.3 22.3 11.2 11.8 18.1 19.5 14.1 11.2 28.0 63.9 40.3 32.6 40.7 35.0 28.8 44.4 36.6 37.3 33.9 44.3 17.9 56.2 25.3 45.8 41.3 53.2 54.2 39.6 35.8 37.5 24.5 88.5 50.6 78.5 32.0 80.7 118.2 37.9 30.5 29.2 37.6 35.2 37.0 46.5 54.6 30.1 44.9 118.7 43.0 61.1 17.4 82.6 27.0 47.6 69.7 58.9 32.8 77.0 28.5 43.4 33.9 51.5 36.5 43.8 42.8 72.6 44.4 36.8 25.5 34.3 53.7 23.4 78.2 50.7 32.2 113.1 40.0 11.5 14.5 15.7 27.4 23.3 25.7 18.7 27.2 22.3 23.8 16.4 27.9 25.2 3.3 30.9 26.0 17.8 31.7 16.3 9.3 9.7 16.0 13.0 9.1 9.5 9.3 9.3 8.0 10.7 8.2 9.3 11.2 16.2 35.3 24.6 10.1 15.2 26.1 16.8 33.4 18.2 38.2 11.8 10.2 21.2 17.2 37.0 7.3 10.4 24.9 24.8 24.6 15.6 26.3 2.4 19.5 38.8 18.0 7.7 12.4 16.5 24.2 26.7 19.9 15.8 29.8 272.8 16.2 10.0 18.0 19.5 26.9 16.9 17.9 26.4 14.8 6.0 2.7 8.1 13.0 3.6 5.6 12.8 23.1 22.6 13.0 13.3 18.2 14.7 13.5 11.0 9.0 20.5 23.3 31.4 23.2 6.6 18.5 29.3 21.5 11.0 19.5 24.7 17.6 25.0 23.8 17.0 21.2 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 9.0 6.1 10.5 11.5 10.5 18.7 9.7 17.7 10.0 9.8 10.6 8.5 9.5 10.6 14.5 9.9 10.1 8.4 9.4 8.4 13.0 8.7 9.7 9.2 15.8 10.6 9.5 7.1 13.8 7.7 7.9 7.2 10.5 11.5 8.8 10.0 16.2 8.9 8.0 17.5 10.3 8.3 9.6 11.5 11.2 7.8 17.0 9.8 19.1 14.7 11.6 14.2 11.3 8.5 15.6 20.0 18.8 23.4 15.2 18.9 17.4 21.5 21.8 17.3 16.4 17.9 26.7 24.3 19.6 9.7 17.7 14.0 22.5 23.1 17.3 24.5 20.0 27.7 18.5 27.7 18.7 15.6 25.9 17.8 15.3 20.4 22.2 19.4 21.4 16.3 17.9 20.5 23.3 18.3 17.1 24.1 10.6 26.3 23.0 19.9 21.4 21.2 12.3 14.7 24.0 16.1 15.8 24.0 16.0 14.3 20.6 14.9 14.6 15.6 21.4 15.3 15.1 19.6 11.5 21.6 33.4 13.8 14.8 12.5 39.1 24.6 57.3 28.0 24.9 25.0 23.0 24.6 22.9 20.9 18.2 22.8 19.6 45.1 19.4 28.2 10.1 29.7 19.6 10.5 10.5 17.7 10.0 8.4 13.0 10.6 9.5 7.1 11.5 11.5 9.8 15.6 17.9 6.4 12.1 6.2 14.7 26.6 34.1 12.1 17.6 9.3 8.7 13.2 15.5 7.2 10.3 5.5 8.4 10.0 17.1 10.1 3.9 12.5 20.3 18.7 14.9 13.0 6.6 25.4 8.1 11.5 16.2 14.5 9.7 16.3 14.0 7.7 6.8 7.6 9.9 5.0 7.4 6.9 14.2 8.3 22.0 10.0 11.8 15.8 10.6 12.2 16.3 15.5 17.5 7.5 9.8 14.1 7.7 6.8 15.4 20.1 6.3 7.7 15.0 14.3 59.2 18.3 16.7 50.5 21.3 12.8 23.4 18.3 18.1 7.3 7.9 26.9 TMX3 "FLJ20793, KIAA1830, PDIA13, TXNDC10" ENSG00000166479 "Thioredoxin related transmembrane protein 3" Q96JJ7 18 68673688-68715108 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014157 Uncertain "Intracellular and membrane" NA NA 36000 "HPA014157: AB_1858469" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.14e-2)" "unprognostic (9.47e-2)" "unprognostic (6.82e-2)" "unprognostic (7.20e-2)" "unprognostic (4.96e-3)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (5.20e-2)" "unprognostic (9.83e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.69e-2)" "unprognostic (1.53e-2)" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" 22.9 16.3 12.6 24.3 14.6 14.2 19.4 16.0 15.6 15.2 12.6 12.7 18.4 16.8 20.6 14.3 13.9 16.6 21.0 14.5 15.1 14.8 16.3 19.7 28.2 12.7 13.2 14.1 13.1 12.0 16.1 9.7 19.9 13.0 17.9 16.4 26.2 10.7 13.1 11.1 16.8 19.0 21.1 12.7 22.8 14.1 11.5 13.3 23.5 17.8 21.2 22.9 20.3 11.3 14.7 11.1 17.4 32.9 25.9 66.6 70.7 24.5 85.7 91.0 61.0 67.7 8.4 31.9 31.4 16.6 125.4 25.9 40.8 21.9 42.9 92.8 30.3 19.6 28.8 27.4 14.7 70.6 62.0 45.7 56.5 27.1 66.2 59.2 61.8 78.4 27.0 18.9 42.5 73.1 6.9 33.3 19.6 13.9 9.1 28.2 30.7 65.5 38.5 51.7 24.2 31.5 24.5 42.0 26.7 31.8 32.4 17.6 52.1 76.4 108.4 30.0 24.7 63.6 28.4 30.4 29.4 65.5 50.1 81.3 2.2 2.9 2.4 3.8 4.7 5.5 3.1 3.9 3.6 4.7 2.1 4.3 4.4 0.7 4.9 3.3 6.4 4.4 2.7 12.6 14.6 16.0 15.6 14.5 15.1 12.7 13.2 14.1 13.0 12.7 13.3 14.7 31.4 28.9 27.8 36.2 25.0 20.3 17.2 17.6 12.0 29.1 21.0 15.6 25.1 10.0 18.8 16.5 18.8 15.0 44.3 10.6 1.9 15.2 8.9 18.7 38.5 27.3 18.0 17.0 77.9 10.2 20.8 34.5 13.3 25.6 20.3 24.2 34.2 26.6 18.6 26.9 45.6 13.8 14.2 23.3 26.8 3.3 24.2 23.9 24.9 32.8 18.2 20.5 20.6 49.8 53.1 15.4 15.4 16.6 29.8 19.4 17.5 8.0 28.8 32.5 39.5 23.6 32.0 23.8 28.3 21.7 24.3 12.4 23.3 22.9 9.4 16.6 MFAP4 ENSG00000166482 "Microfibril associated protein 4" P55083 17 19383442-19387190 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Fibroblasts: 903.5;Peritubular cells: 240.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 15 "granulocytes: 1.0;monocytes: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054097 Supported Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 110000000 "Endoplasmic reticulum" "HPA054097: AB_2682378" "unprognostic (3.02e-2)" "unprognostic (9.07e-2)" "unprognostic (3.39e-1)" "unprognostic (8.56e-3)" "unprognostic (9.80e-2)" "prognostic favorable (3.51e-4)" "unprognostic (2.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.37e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.83e-7)" "unprognostic (1.07e-2)" "unprognostic (2.92e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.12e-4)" 261.1 82.7 6.7 74.7 8.1 2.7 199.4 6.7 11.9 280.8 21.8 252.5 102.9 239.3 291.6 295.9 229.5 651.9 241.6 5.5 12.8 61.4 46.0 640.3 66.2 7.5 8.1 4.7 328.7 71.9 7.1 88.1 158.0 7.0 228.7 140.4 17.4 109.0 131.1 41.9 122.4 189.2 265.1 6.4 60.3 177.6 32.0 7.3 42.8 115.4 251.9 79.3 493.5 246.7 7.0 0.3 0.7 0.6 0.1 394.8 597.9 0.8 44.8 160.0 4.6 3.2 0.2 0.0 0.2 0.1 284.0 0.1 0.2 0.1 0.0 0.8 0.3 1.2 0.0 0.3 0.0 275.4 14.4 0.2 417.8 0.0 2.6 0.1 4.7 0.0 3.9 0.1 0.0 0.4 0.0 375.8 33.8 7.1 0.1 0.4 26.4 24.9 0.7 0.0 0.2 35.8 350.2 0.4 0.2 0.3 2.4 0.4 82.4 0.2 50.9 3.3 2.3 0.1 0.4 0.5 0.1 48.9 15.4 0.1 0.0 0.1 1.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 6.7 8.1 6.7 11.9 5.5 12.8 7.5 8.1 4.7 7.0 6.4 7.3 7.0 35.1 3.2 12.1 0.0 0.3 47.5 0.7 0.2 5.7 0.7 2.3 4.2 10.7 0.0 3.1 1.8 0.0 7.2 1.3 0.0 0.0 0.2 0.7 0.3 21.4 15.9 0.0 0.0 0.0 0.0 3.6 903.5 6.1 0.4 1.3 0.1 15.4 0.2 9.4 0.0 0.0 0.0 0.0 0.0 62.9 6.3 78.3 3.9 67.6 14.0 0.0 80.2 0.0 0.5 0.1 0.1 0.0 240.0 2.6 2.2 0.0 0.0 2.9 3.3 19.7 38.6 103.1 0.4 0.5 8.8 41.1 19.4 6.9 0.2 0.0 2.2 WEE1 WEE1A ENSG00000166483 "WEE1 G2 checkpoint kinase" P30291 11 9573670-9593457 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 213.9;Glandular and luminal cells: 262.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 20.2" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004619, HPA068845" Approved Approved Nucleoli No No Nucleoli "CAB004619: AB_628447, HPA068845: AB_2686048" "unprognostic (6.04e-2)" "unprognostic (1.90e-3)" "unprognostic (1.09e-2)" "unprognostic (9.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-2)" "unprognostic (3.79e-3)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.79e-2)" "unprognostic (3.21e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.19e-4)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" 12.8 5.7 2.5 14.2 1.6 23.2 46.6 2.7 2.3 21.7 3.0 16.9 10.7 63.2 24.7 46.7 18.8 49.4 43.4 1.5 20.2 17.0 58.3 11.7 25.0 3.0 3.4 1.3 11.0 10.2 18.0 8.5 34.9 5.2 21.4 14.6 4.5 17.5 12.8 10.4 46.3 13.7 35.3 2.7 8.2 17.3 31.7 2.1 23.9 26.9 7.3 30.4 53.5 15.6 2.3 43.1 16.4 69.1 38.8 65.2 29.8 125.9 48.8 44.8 29.3 29.8 33.8 53.3 100.7 18.0 27.6 30.8 48.8 49.0 23.3 41.1 33.3 30.7 43.1 30.1 26.2 7.0 66.6 39.7 12.0 25.3 13.8 53.8 34.9 21.6 43.6 64.0 75.8 55.7 13.2 63.5 39.4 97.6 36.9 18.5 57.6 54.5 24.6 28.1 100.0 25.0 31.8 39.9 48.6 29.2 89.3 27.1 32.9 21.7 51.1 35.2 23.0 42.2 14.4 51.1 140.1 23.3 36.5 41.0 0.0 0.0 6.0 1.7 0.0 0.2 8.0 1.7 3.0 0.1 4.7 0.1 1.3 0.1 1.9 0.0 0.1 7.1 0.6 2.5 1.6 2.7 2.3 1.5 20.2 3.0 3.4 1.3 5.2 2.7 2.1 2.3 17.2 51.3 33.9 0.0 36.8 176.4 170.4 38.5 213.9 1.8 168.5 67.2 61.1 65.8 53.5 42.3 0.0 94.8 11.2 54.7 13.7 24.9 25.0 160.1 86.2 18.7 61.1 40.4 0.1 13.6 200.1 39.2 52.5 262.4 7.0 28.5 9.7 85.0 17.0 1.7 0.4 65.6 18.3 2.5 21.9 41.7 11.8 10.0 17.8 1.0 2.4 9.9 8.2 2.0 0.1 24.8 38.5 10.9 17.2 82.7 35.9 8.3 62.6 7.1 6.6 180.7 23.7 61.4 44.4 181.4 191.1 137.2 19.0 11.8 55.5 85.5 MAPK7 "BMK1, ERK5, PRKM7" ENSG00000166484 "Mitogen-activated protein kinase 7" Q13164 17 19377721-19383544 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 43.1;SuSa: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018561, HPA031031" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB018561: AB_2140544, HPA031031: AB_2673706" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.72e-1)" "unprognostic (2.90e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (5.67e-3)" "unprognostic (1.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-2)" "unprognostic (4.75e-2)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (5.71e-1)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 8.2 13.9 3.3 4.1 4.0 5.3 7.7 3.2 5.9 12.8 3.6 9.9 5.5 11.2 3.4 16.4 8.7 4.5 6.2 3.3 3.9 7.7 3.9 8.7 3.7 4.8 3.3 2.7 12.6 3.4 3.0 6.2 6.7 4.6 9.0 3.5 2.2 6.8 6.2 5.0 11.8 7.4 6.8 2.8 9.5 6.7 11.9 5.7 3.5 7.4 3.4 3.7 10.2 15.4 3.3 6.9 11.0 9.9 7.7 43.1 17.2 10.4 9.0 8.3 13.0 12.4 12.2 1.4 4.1 7.3 16.5 10.4 8.2 10.4 9.4 7.8 7.2 8.3 1.9 8.4 5.4 21.2 1.9 7.8 21.6 6.2 18.2 7.2 12.0 9.5 7.5 3.7 1.4 13.2 4.8 13.0 7.4 10.7 8.4 6.7 8.6 12.9 3.0 5.4 3.7 4.4 12.3 9.7 1.0 5.0 53.7 6.1 3.1 6.0 14.6 10.8 15.5 6.7 2.6 4.0 1.2 16.5 1.6 9.2 0.8 3.4 10.7 3.7 6.5 2.0 1.8 1.8 3.2 2.3 1.0 1.6 2.0 1.1 4.9 6.0 1.4 1.0 3.1 3.3 4.0 3.2 5.9 3.3 3.9 4.8 3.3 2.7 4.6 2.8 5.7 3.3 10.7 6.4 3.3 2.6 7.8 5.5 6.1 9.5 13.6 2.4 5.8 4.6 5.3 2.8 5.6 5.5 2.1 5.7 6.7 16.2 5.9 8.1 8.7 3.0 7.9 8.5 10.7 1.7 2.0 6.2 8.0 9.6 12.2 5.2 2.5 7.7 7.5 1.1 7.7 0.0 2.1 6.9 10.2 6.9 6.1 5.7 11.5 14.4 3.6 6.5 3.4 13.1 17.5 1.0 2.0 8.0 20.8 11.7 9.3 6.3 9.0 3.5 3.2 2.1 26.3 8.4 11.1 33.2 16.4 9.8 4.3 5.1 6.2 7.7 6.7 5.3 PRKCB "PKCβ, PKCB, PRKCB1, PRKCB2" ENSG00000166501 "Protein kinase C beta" P05771 16 23835983-24220611 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.3;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" "B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003843, HPA048321, HPA054203" Approved Supported Nucleoplasm,Cytosol NA NA 380000 Nucleoplasm Cytosol "CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416" "unprognostic (1.53e-3)" "unprognostic (4.53e-4)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (1.72e-1)" "unprognostic (7.13e-3)" "unprognostic (2.06e-1)" "unprognostic (1.67e-3)" "unprognostic (3.19e-2)" "unprognostic (1.79e-1)" "unprognostic (7.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.17e-3)" "unprognostic (2.08e-1)" "unprognostic (2.12e-2)" "unprognostic (3.28e-1)" "unprognostic (4.95e-2)" 4.4 1.6 17.2 31.1 41.3 32.4 1.5 0.7 83.3 4.3 0.0 8.2 6.0 3.8 0.6 3.5 3.8 4.5 1.1 32.3 23.9 1.4 4.3 7.8 47.5 11.4 2.7 29.6 0.6 1.0 0.2 1.4 2.7 22.1 7.4 5.2 18.4 1.5 10.3 0.8 5.6 19.5 7.3 0.0 46.6 5.7 8.5 3.2 47.6 4.5 1.0 40.3 8.7 1.8 37.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 1.0 0.0 0.3 0.5 0.5 0.0 0.0 0.0 3.2 161.8 7.5 0.0 0.0 23.6 154.8 0.0 0.7 0.0 0.0 0.0 0.0 27.3 234.9 0.6 0.0 0.0 52.1 51.4 1.5 0.0 0.0 49.0 0.4 9.5 0.5 14.1 27.2 0.0 0.2 0.2 2.4 0.8 0.0 72.7 1.1 0.0 0.3 0.1 0.0 4.1 0.0 1.4 0.2 64.4 0.3 39.3 13.3 27.8 24.8 20.0 11.5 44.2 15.9 29.9 11.3 40.0 13.0 32.0 39.1 39.9 28.6 33.8 12.7 15.5 17.2 41.3 0.7 83.3 32.3 23.9 11.4 2.7 29.6 22.1 0.0 3.2 37.5 1.1 3.2 4.9 21.5 185.1 6.0 4.1 0.1 0.6 208.6 0.9 0.8 2.0 2.8 1.8 1.8 2.1 0.2 166.3 1.4 0.0 0.0 26.5 0.1 0.1 4.1 0.0 26.3 877.7 0.2 0.3 1.7 1.5 0.1 71.5 1.9 11.4 3.1 50.5 79.1 320.2 1.5 0.0 221.9 20.5 11.7 0.0 100.9 3.6 110.5 154.4 10.8 120.5 102.1 132.5 0.0 9.6 0.4 61.8 1.0 6.7 0.8 1.6 9.9 0.0 4.4 1.6 3.4 3.6 0.5 14.3 0.8 68.1 0.2 3.8 4.5 HDGFL3 "Hdgfrp3, HRP-3" ENSG00000166503 "HDGF like 3" Q9Y3E1 15 83112738-83207823 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 96.9;Breast glandular cells: 34.3;Endometrial ciliated cells: 34.2;Endometrial stromal cells: 48.4;Granulosa cells: 41.4;Theca cells: 48.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 1.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040719 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA040719: AB_2677097" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (3.52e-2)" "unprognostic (3.38e-2)" "unprognostic (1.53e-1)" "unprognostic (2.55e-2)" "unprognostic (1.91e-2)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (4.68e-2)" "unprognostic (1.93e-3)" "unprognostic (3.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-2)" "unprognostic (3.55e-1)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" 5.9 5.9 12.4 2.9 13.6 2.4 5.6 13.1 15.1 4.9 9.1 5.4 1.2 6.1 8.4 3.6 4.8 4.0 5.7 13.1 12.8 3.6 0.8 5.2 2.9 12.1 12.1 12.1 5.0 1.7 17.8 6.8 3.0 12.1 5.0 2.7 8.5 2.4 4.7 2.5 1.9 2.9 5.3 13.0 3.4 2.9 9.7 12.9 4.4 6.6 2.5 2.2 5.7 3.8 12.8 7.2 6.2 17.9 9.3 7.4 10.1 5.9 6.7 11.9 7.0 7.3 0.5 13.2 0.1 8.0 1.8 7.5 2.9 19.9 10.3 10.1 33.5 10.2 11.6 3.0 0.1 10.3 0.4 1.8 6.0 8.4 8.0 13.9 10.8 17.0 12.4 9.0 0.3 13.2 7.4 7.1 0.7 13.3 0.0 3.5 0.1 17.4 0.1 10.5 14.6 22.5 17.1 10.1 2.4 8.9 12.9 2.8 1.3 14.7 14.5 10.8 3.0 20.9 2.1 0.8 8.6 6.7 5.5 10.0 0.7 0.3 1.0 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.8 1.8 0.1 0.2 0.0 0.1 12.4 13.6 13.1 15.1 13.1 12.8 12.1 12.1 12.1 12.1 13.0 12.9 12.8 96.9 12.8 17.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 34.3 27.3 0.0 0.0 10.5 20.2 0.0 0.3 14.1 0.0 15.6 21.1 0.0 34.2 48.4 25.8 0.0 0.0 0.0 22.9 0.6 15.4 0.0 25.6 5.1 41.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 23.6 0.0 0.0 3.1 0.0 0.0 0.3 9.5 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.3 3.5 48.1 0.0 0.0 NDST2 "HSST2, NST2" ENSG00000166507 "N-deacetylase and N-sulfotransferase 2" P52849 10 73801911-73811798 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 13.7;granulocytes: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 110.2" HPA051515 Approved Approved Cytosol NA NA 130000 Cytosol "HPA051515: AB_2681517" "unprognostic (8.84e-2)" "unprognostic (7.57e-2)" "unprognostic (2.53e-2)" "unprognostic (9.43e-3)" "unprognostic (5.69e-1)" "unprognostic (1.07e-2)" "unprognostic (5.83e-3)" "unprognostic (2.16e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-2)" "unprognostic (2.23e-5)" "unprognostic (1.49e-2)" "unprognostic (4.08e-7)" "unprognostic (3.71e-2)" "unprognostic (3.69e-2)" "unprognostic (5.93e-2)" "unprognostic (9.06e-2)" 14.6 16.8 11.6 19.7 11.6 54.1 13.4 15.6 14.3 15.1 11.4 13.4 10.8 15.8 11.7 16.9 15.1 15.3 11.0 11.6 12.5 12.3 11.0 17.1 24.8 13.0 11.4 11.4 16.0 14.2 18.6 15.9 12.6 13.1 15.7 12.2 15.0 17.9 14.3 9.0 18.9 17.5 15.9 10.2 35.6 13.7 13.7 12.2 32.2 13.4 8.6 24.1 15.4 15.5 11.4 10.0 7.9 16.7 26.2 20.9 23.0 9.1 12.3 24.5 13.4 13.3 4.6 12.4 9.5 7.1 21.8 13.6 11.6 8.1 11.8 9.6 23.4 8.5 9.3 7.0 7.3 36.7 11.8 110.2 22.9 14.5 21.4 22.4 41.1 17.5 17.9 9.2 33.8 16.6 8.1 12.7 13.4 4.5 6.4 36.4 8.5 8.2 5.9 11.5 7.2 5.5 9.0 9.9 23.5 7.5 11.3 18.6 18.6 29.5 6.3 7.8 9.1 8.4 17.4 8.0 11.8 7.2 17.0 5.5 0.7 2.7 1.1 2.7 1.9 3.1 1.2 2.3 2.3 2.0 1.3 2.6 3.4 2.8 1.1 1.7 3.4 1.6 1.8 11.6 11.6 15.6 14.3 11.6 12.5 13.0 11.4 11.4 13.1 10.2 12.2 11.4 1.5 0.0 3.0 13.7 5.4 1.3 0.8 0.6 1.2 0.7 4.1 2.3 1.8 0.0 1.8 0.0 0.0 1.4 3.6 4.7 0.0 5.4 7.5 0.8 1.2 1.1 2.4 7.8 7.5 9.6 1.5 1.9 4.6 0.7 14.5 0.3 1.4 4.2 5.2 1.7 7.6 2.6 2.0 8.5 3.1 10.4 0.0 10.8 1.8 2.8 5.4 0.8 0.0 5.0 5.0 7.0 3.2 0.0 10.6 1.3 2.4 7.4 2.7 0.8 0.0 1.4 1.5 2.3 1.7 4.7 1.6 6.2 5.3 0.3 2.2 1.9 MCM7 "CDC47, MCM2, PPP1R104" ENSG00000166508 "Minichromosome maintenance complex component 7" P33993 7 100092728-100101940 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 182.4;lymphoid tissue: 157.8" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 132.9;Erythroid cells: 173.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002163, HPA003898, CAB016312" Enhanced Enhanced Nucleoplasm NA Yes 150000 Nucleoplasm "CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.36e-1)" "unprognostic (5.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (2.18e-4)" "unprognostic (2.08e-2)" "unprognostic (5.79e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (9.34e-3)" "unprognostic (3.83e-2)" "unprognostic (5.41e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (2.38e-1)" 23.1 14.4 63.5 50.6 65.5 182.4 32.4 57.6 63.2 17.6 51.8 45.7 39.1 30.0 13.3 31.5 25.8 18.3 17.2 55.4 57.2 13.9 26.5 23.2 83.0 64.9 66.0 51.9 37.3 24.3 15.2 9.0 35.3 65.1 20.6 51.3 10.7 21.4 22.4 25.9 45.3 41.6 32.6 62.2 29.6 27.7 49.8 61.7 157.8 20.5 28.7 89.2 21.8 12.0 64.5 310.1 359.5 399.9 306.7 28.7 35.5 214.4 195.7 165.5 374.9 407.7 281.9 335.2 469.2 184.6 112.0 321.6 252.5 439.3 241.6 303.9 238.6 498.1 274.7 251.9 248.9 18.9 553.6 226.2 30.1 43.4 306.9 179.6 61.8 154.0 295.1 542.2 444.6 200.8 786.2 940.1 442.9 361.9 295.2 236.4 572.5 517.7 651.6 92.3 221.5 253.4 397.0 264.9 294.3 104.9 217.9 126.2 314.4 81.0 198.1 346.7 379.8 411.1 200.3 311.8 875.0 135.9 463.1 354.3 3.7 4.0 4.3 14.1 7.5 10.9 9.1 10.3 13.2 9.3 15.0 11.2 10.5 1.4 15.9 13.3 11.3 17.2 11.6 63.5 65.5 57.6 63.2 55.4 57.2 64.9 66.0 51.9 65.1 62.2 61.7 64.5 23.2 9.6 17.9 6.2 34.5 46.7 28.5 25.7 37.0 9.4 30.8 36.3 9.6 11.5 13.3 3.7 14.6 132.9 32.5 42.3 9.8 28.2 54.7 11.8 16.3 23.8 17.4 173.6 4.0 26.2 102.7 22.8 40.8 19.8 24.1 67.3 10.4 10.3 40.4 6.7 4.0 48.8 18.3 10.4 22.2 32.0 21.1 17.6 19.6 3.7 14.1 11.1 18.6 12.1 11.7 16.7 22.8 15.4 59.8 20.8 19.0 11.5 18.0 12.5 13.1 30.7 46.0 90.0 79.8 41.3 35.4 72.0 29.4 14.9 79.0 22.9 CLEC3A CLECSF1 ENSG00000166509 "C-type lectin domain family 3 member A" O75596 16 78022515-78066761 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1;breast: 9.5;urinary bladder: 5.9" "Cell type enriched" "Detected in single" 7 "Prostatic glandular cells: 4.7" "Cancer enriched" "Detected in some" 102 "breast cancer: 78.5" "Region enriched" "Detected in single" 6 "midbrain: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SK-BR-3: 7.4;T-47d: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051511 Uncertain "Secreted to extracellular matrix" NA NA "HPA051511: AB_2681514" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 4.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CCDC68 SE57-1 ENSG00000166510 "Coiled-coil domain containing 68" Q9H2F9 18 54901509-54959461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0;placenta: 32.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1" "Cancer enhanced" "Detected in many" "stomach cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA040865, HPA048197" Supported Approved "Golgi apparatus,Cytosol" No NA "Golgi apparatus" Cytosol "HPA040865: AB_2677176, HPA048197: AB_2680310" "unprognostic (1.36e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.38e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (2.65e-2)" "unprognostic (6.29e-2)" "unprognostic (2.71e-1)" "unprognostic (1.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.77e-2)" "unprognostic (9.71e-2)" "unprognostic (6.12e-2)" "unprognostic (2.38e-1)" 5.6 3.9 1.8 4.1 1.6 0.5 3.4 1.5 2.8 4.2 2.5 19.1 20.4 3.4 0.8 1.8 2.4 5.1 5.3 1.6 3.3 2.8 9.6 13.1 0.9 2.0 2.3 1.3 15.9 2.8 0.8 3.6 32.7 2.3 4.2 18.3 0.7 1.8 1.3 1.5 0.9 25.0 2.8 1.2 7.3 14.5 8.9 3.4 0.6 2.7 4.4 1.3 2.3 1.9 1.7 10.8 3.3 0.0 0.0 3.0 8.3 0.0 0.3 4.2 0.6 0.7 5.9 6.2 0.0 7.6 0.0 0.1 0.1 0.7 6.8 0.5 0.0 1.6 0.8 3.6 1.2 13.6 0.0 0.0 14.9 0.0 3.2 0.1 0.0 4.9 0.0 0.0 0.1 0.4 0.8 0.0 0.2 0.0 7.6 3.6 0.3 0.0 0.3 1.2 10.5 0.1 2.5 3.3 1.0 0.1 1.2 0.0 0.0 28.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 1.6 1.5 2.8 1.6 3.3 2.0 2.3 1.3 2.3 1.2 3.4 1.7 38.5 19.2 10.3 0.3 1.0 0.3 7.4 4.8 1.2 0.1 2.0 1.9 5.5 10.0 13.3 1.8 0.0 2.3 0.3 95.2 1.9 7.2 95.4 15.0 2.5 40.8 6.0 3.6 5.7 35.6 2.7 9.6 38.2 27.1 8.8 2.6 37.5 7.0 0.4 0.0 0.5 21.8 8.2 3.2 1.3 36.7 3.4 0.6 0.0 12.2 1.0 3.3 1.0 0.0 0.1 87.9 68.7 0.7 0.0 32.4 61.1 5.3 4.2 0.2 6.6 0.9 3.0 1.2 2.2 1.1 0.0 6.0 0.4 3.8 20.2 6.4 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540905 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 76.4;lymphoid tissue: 52.7" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5" "Cancer enhanced" "Detected in many" "testis cancer: 6.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 128.8;neutrophil: 448.8" "Group enriched" "Detected in many" 17 "granulocytes: 448.8;monocytes: 128.8" "Group enriched" "Detected in some" 4 "NB-4: 4.3;RPTEC TERT1: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 13.4 5.4 2.5 37.8 2.7 76.4 4.5 2.6 4.5 5.9 2.3 2.1 0.4 2.3 0.4 3.2 5.6 11.9 2.3 3.1 1.8 3.6 6.6 22.6 7.7 2.2 1.8 2.5 1.8 6.2 1.7 1.9 2.1 2.5 2.3 1.0 1.3 1.4 1.2 0.7 0.8 3.1 5.7 0.8 52.7 2.5 1.1 2.3 2.2 10.5 5.0 2.4 9.6 1.7 3.7 0.1 0.4 0.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.1 0.1 2.0 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.1 0.0 1.5 0.0 0.5 0.2 0.2 0.2 0.2 0.0 0.1 0.0 4.3 0.3 0.0 0.0 0.0 0.2 0.1 12.4 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.4 1.0 0.5 0.1 1.0 0.1 0.2 0.1 0.1 1.3 0.4 0.1 0.2 128.8 0.5 0.1 18.1 0.3 0.1 0.1 0.1 16.9 0.1 0.0 0.1 448.8 0.0 0.7 0.7 0.0 30.3 2.5 2.7 2.6 4.5 3.1 1.8 2.2 1.8 2.5 2.5 0.8 2.3 3.7 6.2 0.0 4.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 5.7 1.8 1.8 0.0 0.0 0.3 0.0 0.0 9.0 0.3 2.1 4.4 3.5 0.0 0.0 0.0 0.0 0.1 1.4 0.0 31.9 0.0 0.0 7.1 2.1 5.6 0.0 0.0 0.0 0.0 158.0 9.0 2.9 0.9 115.2 0.0 0.0 109.5 0.0 4.1 0.0 0.0 0.4 0.0 0.4 1.3 0.0 0.0 0.2 0.7 0.0 13.1 0.2 0.4 0.2 0.5 0.1 0.0 0.1 1.1 0.0 0.0 0.1 ZNF3 "A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113" ENSG00000166526 "Zinc finger protein 3" P17036 7 100064033-100082548 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003719 Supported Supported Approved Nucleoplasm No No Nucleoplasm "HPA003719: AB_1080701" "unprognostic (5.92e-2)" "unprognostic (3.82e-2)" "unprognostic (1.00e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (2.76e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.73e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.65e-1)" "unprognostic (2.50e-3)" "unprognostic (7.54e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-3)" "unprognostic (1.24e-1)" "unprognostic (3.41e-2)" "prognostic favorable (2.20e-4)" 12.4 11.2 18.6 10.0 20.2 27.3 20.0 20.0 20.7 17.8 18.6 17.1 20.5 21.5 22.4 13.6 36.8 12.0 11.4 17.6 18.5 15.3 18.7 12.4 13.0 20.3 19.6 16.0 21.9 16.2 19.4 13.1 11.8 21.3 15.0 18.6 15.0 14.4 15.8 18.5 14.0 21.2 14.4 20.0 14.1 16.7 8.9 19.2 18.8 18.7 19.7 15.6 14.4 13.9 25.6 13.2 14.1 39.1 54.9 18.8 14.5 23.1 16.8 18.5 23.8 20.4 18.4 19.0 19.2 28.8 15.7 19.6 17.2 29.3 18.2 19.8 20.1 23.7 15.5 20.8 26.6 22.4 28.7 13.6 18.5 21.5 16.8 37.3 26.4 21.4 27.6 44.9 29.3 22.0 36.1 67.3 28.9 54.9 24.2 25.7 27.7 31.4 49.0 22.8 25.9 40.9 60.5 20.1 57.2 26.1 37.1 16.5 27.1 17.5 29.5 21.8 22.0 22.0 39.9 47.3 38.1 14.8 24.6 29.3 13.1 10.2 19.5 14.2 9.8 16.6 13.4 11.8 14.7 10.5 15.5 13.6 14.9 3.9 18.6 14.5 11.8 12.7 10.1 18.6 20.2 20.0 20.7 17.6 18.5 20.3 19.6 16.0 21.3 20.0 19.2 25.6 13.5 12.8 31.9 8.1 16.9 7.6 10.0 8.1 12.0 18.7 15.1 12.2 10.5 14.3 13.2 3.7 16.7 12.5 12.6 17.0 7.9 19.3 2.7 42.3 16.1 17.4 26.3 26.1 5.8 11.1 7.6 16.4 15.8 13.0 15.2 28.5 14.6 14.5 6.6 18.5 6.2 20.0 10.2 12.6 5.9 1.8 15.2 7.8 3.6 2.8 11.5 16.5 30.9 9.0 20.4 16.1 18.1 15.1 11.6 12.7 32.5 13.5 32.1 19.5 6.6 9.3 12.1 16.2 17.0 9.9 8.9 10.4 11.1 14.0 20.1 8.2 CLEC4D "CD368, CLECSF8, Dectin-3, MCL, Mpcl" ENSG00000166527 "C-type lectin domain family 4 member D" Q8WXI8 12 8509475-8522366 "CD markers, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 65.3" "Group enriched" "Detected in some" 5 "Kupffer cells: 10.6;Macrophages: 11.9;monocytes: 15.1" "Cancer enriched" "Detected in single" 50 "testis cancer: 11.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "classical monocyte: 57.1;neutrophil: 98.7" "Group enriched" "Detected in many" 32 "granulocytes: 98.7;monocytes: 57.1" "Group enriched" "Detected in some" 5 "NB-4: 2.4;NTERA-2: 9.0;SuSa: 9.1;U-937: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004906 Approved NA NA "HPA004906: AB_1078535" "unprognostic (1.10e-1)" "unprognostic (4.94e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (4.39e-1)" "unprognostic (3.84e-2)" "unprognostic (7.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-1)" "unprognostic (3.81e-1)" "unprognostic (7.91e-5)" "unprognostic (1.12e-2)" "unprognostic (8.57e-2)" "unprognostic (7.89e-2)" "unprognostic (2.18e-1)" 2.3 0.2 0.0 7.4 0.1 65.3 0.2 0.1 0.2 3.2 0.3 0.1 0.1 0.1 0.5 0.4 0.7 0.4 0.2 0.0 0.1 0.2 0.5 3.1 0.6 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.2 0.8 0.0 7.1 0.2 0.2 0.3 0.3 0.1 0.7 0.3 2.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 9.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.9 57.1 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.4 0.0 0.0 0.1 98.7 0.0 1.2 0.7 0.0 12.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.6 0.8 0.0 0.0 11.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 ZSCAN21 "DKFZp434L134, NY-REN-21, Zipro1, ZNF38" ENSG00000166529 "Zinc finger and SCAN domain containing 21" Q9Y5A6 7 100049774-100065040 "Predicted intracellular proteins, Transcription factors" "Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016948, HPA023591" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA016948: , HPA023591: AB_1859037" "unprognostic (2.44e-3)" "unprognostic (3.77e-1)" "unprognostic (2.84e-3)" "unprognostic (1.36e-1)" "unprognostic (4.45e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (7.42e-3)" "unprognostic (8.59e-3)" "unprognostic (3.76e-2)" "unprognostic (1.67e-3)" "unprognostic (3.10e-2)" "unprognostic (3.13e-3)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (6.09e-2)" 7.7 7.8 11.2 4.6 12.6 6.1 8.1 13.1 11.8 10.0 10.6 9.7 4.6 9.8 9.2 5.8 10.7 6.0 7.1 11.1 11.5 9.7 13.2 6.2 6.3 11.7 12.1 10.6 10.0 10.1 7.1 7.7 8.0 12.4 10.9 5.3 9.4 10.4 7.3 14.2 7.0 6.9 7.8 11.5 7.5 9.1 12.3 11.7 7.2 8.4 13.0 5.0 9.5 7.5 14.8 5.9 9.8 16.0 18.7 14.8 9.5 13.1 6.7 10.3 13.0 13.0 7.8 6.7 6.4 8.2 7.9 22.1 5.3 14.5 9.7 12.9 8.5 11.9 5.8 8.6 7.3 16.0 8.4 2.3 11.3 16.8 12.7 21.1 10.8 10.5 13.0 14.0 5.4 9.7 15.1 14.0 13.8 19.9 8.2 7.3 9.5 12.8 7.8 10.8 9.2 8.2 20.9 9.2 19.4 12.9 22.6 7.8 7.0 4.6 11.8 14.6 10.4 9.4 10.7 10.6 14.1 5.5 5.3 16.1 12.9 6.0 12.9 9.9 5.8 10.8 6.6 6.0 9.0 6.3 6.5 6.6 7.5 0.8 10.7 3.9 5.9 7.4 4.9 11.2 12.6 13.1 11.8 11.1 11.5 11.7 12.1 10.6 12.4 11.5 11.7 14.8 5.1 3.2 5.1 5.5 4.3 1.5 3.4 4.1 5.2 6.0 3.5 3.6 1.6 2.8 4.4 3.7 2.1 16.6 10.6 2.9 7.9 7.1 2.7 4.0 7.7 4.7 1.8 11.0 3.7 4.0 6.5 5.4 2.6 3.8 2.5 8.0 3.6 5.2 5.2 10.1 4.1 2.5 8.2 2.5 2.1 0.7 5.9 2.9 3.6 7.5 3.0 16.5 3.1 7.1 7.5 4.4 5.0 9.8 3.4 4.0 3.2 11.9 2.5 5.9 0.0 7.7 6.7 14.1 19.7 2.9 3.8 17.6 2.9 8.0 2.8 1.7 RIMKLB "FAM80B, KIAA1238, NAAGS, NAAGS-I" ENSG00000166532 "Ribosomal modification protein rimK like family member B" Q9ULI2 12 8681600-8783095 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 184.2;Endometrial ciliated cells: 191.3;Glandular and luminal cells: 1012.9;Late spermatids: 300.3" "Cancer enhanced" "Detected in many" "testis cancer: 17.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 145.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059552 Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA059552: " "unprognostic (5.29e-3)" "unprognostic (2.26e-2)" "unprognostic (1.89e-5)" "unprognostic (2.40e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-2)" "unprognostic (6.56e-2)" "unprognostic (8.52e-2)" "unprognostic (8.67e-3)" "unprognostic (1.76e-1)" "unprognostic (3.25e-1)" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-2)" "unprognostic (3.02e-1)" "unprognostic (3.74e-1)" "unprognostic (3.99e-1)" 25.1 11.0 25.4 8.1 21.9 21.2 24.3 23.1 18.7 28.8 19.2 22.4 5.4 40.5 16.1 11.2 29.7 15.0 12.8 20.3 29.6 11.7 3.2 19.6 9.2 26.1 22.6 15.7 30.3 8.2 22.4 12.9 24.7 21.7 14.3 7.1 19.3 11.9 14.2 13.8 12.6 12.9 27.8 26.9 13.6 11.1 32.7 22.0 13.8 20.1 9.5 7.1 15.5 21.9 19.7 3.7 18.1 43.5 44.9 5.7 5.4 63.0 19.6 8.8 16.1 10.5 1.5 20.6 27.9 16.2 11.7 17.9 6.3 21.5 23.9 17.1 0.5 13.9 13.3 52.4 0.2 6.6 4.1 13.3 11.7 10.4 14.4 24.2 10.1 21.0 22.9 18.0 0.0 9.4 11.8 27.0 2.0 53.2 0.0 1.0 42.0 60.5 0.1 22.8 10.2 1.4 28.2 17.5 24.9 19.4 70.9 6.0 13.4 41.2 15.7 51.0 8.6 6.4 0.2 0.0 145.9 13.3 2.9 10.9 2.1 1.2 0.3 0.8 0.3 1.0 0.7 0.8 1.3 0.5 1.3 1.4 0.5 0.1 1.2 0.5 0.4 0.0 1.0 25.4 21.9 23.1 18.7 20.3 29.6 26.1 22.6 15.7 21.7 26.9 22.0 19.7 69.8 28.9 42.9 99.6 13.3 15.2 23.3 16.6 27.9 25.5 10.9 11.4 15.6 7.2 25.7 12.9 0.0 61.0 4.2 1.0 15.6 12.8 184.2 191.3 99.5 38.5 9.0 30.9 33.0 3.0 18.6 27.3 4.1 1012.9 12.0 72.3 22.9 0.0 19.9 13.5 52.7 2.1 16.2 8.8 8.0 300.3 23.3 12.4 33.8 41.2 2.0 34.2 5.2 78.9 9.5 5.8 3.7 30.9 3.8 23.4 6.7 9.1 33.9 3.6 13.1 15.6 29.6 77.1 38.3 17.8 13.4 136.5 11.0 27.7 1.5 21.5 A2ML1 "CPAMD9, FLJ25179, p170" ENSG00000166535 "Alpha-2-macroglobulin like 1" A8K2U0 12 8822621-8887001 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 560.7;vagina: 206.4" "Cell type enriched" "Detected in some" 6 "Squamous epithelial cells: 127.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 39.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 10.9;hTCEpi: 5.5;SK-BR-3: 13.9" "Low region specificity" "Detected in many" "HPA038847, HPA038848" Enhanced "Secreted in other tissues" NA NA 10000000 "HPA038847: AB_2676236, HPA038848: AB_10672654" "unprognostic (1.13e-2)" "unprognostic (7.64e-2)" "unprognostic (1.04e-2)" "unprognostic (9.46e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (4.59e-2)" "unprognostic (7.58e-3)" "unprognostic (2.63e-1)" "unprognostic (1.57e-1)" "unprognostic (1.15e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-9)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (5.88e-2)" "unprognostic (2.42e-2)" 0.2 0.1 2.5 0.0 2.0 0.2 4.2 1.3 2.5 55.8 0.4 0.1 0.0 0.5 0.4 560.7 0.7 0.2 0.4 2.0 1.7 0.1 0.3 0.1 0.2 2.0 2.1 1.6 0.4 0.2 0.9 1.4 0.7 1.6 0.6 0.0 0.7 99.8 0.0 0.3 72.6 0.1 0.1 1.5 0.1 0.7 5.0 2.8 3.0 0.1 0.0 51.9 1.2 206.4 1.3 0.1 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.0 2.5 10.9 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 13.9 0.0 1.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 2.5 2.0 1.3 2.5 2.0 1.7 2.0 2.1 1.6 1.6 1.5 2.8 1.3 0.0 0.0 0.0 20.2 0.0 0.4 0.5 1.0 1.8 0.7 0.3 0.1 0.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.4 4.4 0.9 0.3 0.0 0.0 4.9 0.0 0.5 0.4 0.0 11.9 0.0 0.8 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 0.3 0.0 0.4 0.3 1.0 0.4 127.6 12.6 0.1 0.1 1.9 0.0 8.2 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427295-66493529 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.8;Early spermatids: 10.7;Excitatory neurons: 9.9;Extravillous trophoblasts: 10.9;Inhibitory neurons: 7.7;Late spermatids: 13.6;Oligodendrocyte precursor cells: 7.5;Spermatocytes: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 9.2;BEWO: 4.2;RPTEC TERT1: 9.1;U-87 MG: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 0.7 0.3 1.3 0.3 1.6 0.8 0.6 2.4 4.0 0.8 0.0 0.5 0.2 0.8 0.3 0.6 1.1 0.4 0.9 2.5 1.1 0.5 0.8 0.6 0.2 4.3 2.1 1.1 0.9 0.5 0.6 0.3 1.6 5.0 0.4 0.2 1.7 0.5 0.1 1.0 0.9 0.4 0.2 0.6 0.4 0.4 1.1 3.1 0.0 0.7 0.1 0.2 0.6 0.6 3.3 0.5 0.8 0.8 9.2 0.1 0.1 4.2 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.6 0.0 0.0 0.3 1.6 0.4 0.1 1.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.4 0.0 0.1 0.3 9.1 0.3 0.0 0.1 0.1 0.1 1.4 0.5 0.1 0.0 0.1 0.2 2.0 0.0 0.3 0.3 0.0 0.0 4.8 0.1 1.0 0.2 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.9 0.0 0.0 1.3 1.6 2.4 4.0 2.5 1.1 4.3 2.1 1.1 5.0 0.6 3.1 3.3 0.1 0.0 0.0 2.0 0.0 0.1 0.3 0.2 0.0 0.6 0.2 0.6 1.4 0.0 0.2 0.0 0.0 5.8 0.0 0.1 0.0 0.4 10.7 0.2 0.2 0.4 0.0 0.0 9.9 0.0 10.9 0.4 0.0 0.2 0.0 0.3 0.7 0.0 1.0 0.0 7.7 0.0 0.0 0.8 0.4 13.6 0.3 0.1 3.6 3.7 0.0 0.0 1.0 7.5 2.6 1.7 0.0 2.2 0.0 1.7 0.0 0.1 0.1 1.4 0.0 0.2 0.3 6.6 0.3 0.0 0.1 2.9 0.1 0.5 0.0 0.8 TK2 SCA31 ENSG00000166548 "Thymidine kinase 2" O00142 16 66508003-66552544 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA synthesis" "Kinase, Transferase" "Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041162 Uncertain NA NA "HPA041162: AB_10961178" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.27e-3)" "unprognostic (3.94e-1)" "unprognostic (2.93e-1)" "unprognostic (1.10e-1)" "unprognostic (4.83e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-1)" "unprognostic (3.59e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.18e-6)" "unprognostic (3.05e-2)" "unprognostic (1.74e-1)" "unprognostic (2.71e-1)" "unprognostic (7.05e-2)" 48.5 30.4 22.9 11.9 24.3 8.5 25.9 23.3 23.5 20.2 18.6 14.3 11.0 16.3 29.6 12.5 19.2 21.3 17.8 22.7 23.9 25.4 37.6 18.9 11.8 24.9 26.6 20.1 27.0 24.6 38.3 22.6 15.2 26.2 19.4 12.8 11.8 22.8 20.1 11.6 12.2 13.7 19.1 24.5 23.2 15.9 34.2 24.9 13.1 25.8 14.7 10.0 17.9 15.5 26.6 13.3 26.5 12.1 14.5 64.3 52.2 0.7 22.0 22.3 15.1 16.8 6.5 26.4 0.1 23.8 63.9 19.0 11.8 5.3 17.7 10.4 8.5 6.2 4.1 17.2 12.9 45.1 5.6 9.2 39.4 15.3 18.5 26.1 62.5 19.9 13.1 6.8 28.1 37.9 4.1 5.5 14.9 5.9 5.1 15.4 7.0 21.0 28.1 44.1 12.5 4.4 8.9 63.2 6.1 26.9 6.6 9.6 16.3 29.7 30.8 15.9 26.3 7.6 30.3 12.2 11.6 38.9 5.7 18.4 5.6 9.4 6.0 1.8 5.1 1.2 0.1 1.3 1.0 8.7 1.7 0.6 0.9 8.5 2.7 4.3 1.8 1.2 2.5 22.9 24.3 23.3 23.5 22.7 23.9 24.9 26.6 20.1 26.2 24.5 24.9 26.6 25.0 22.4 9.3 19.6 7.3 5.7 5.1 5.8 12.5 15.5 15.4 11.4 8.0 17.2 7.5 22.0 22.9 10.0 7.6 6.0 9.8 15.7 25.2 15.2 23.2 14.4 9.6 10.3 10.1 22.4 6.0 19.9 11.7 13.0 24.8 20.6 31.1 48.9 21.7 21.9 12.0 6.5 2.0 55.6 10.1 40.5 23.3 23.6 10.6 10.3 22.6 18.4 12.3 14.6 19.4 28.9 3.3 19.2 12.4 4.3 14.4 45.9 9.0 20.5 0.0 14.4 10.6 48.9 11.1 9.6 3.8 2.9 8.6 22.2 7.6 4.2 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311112-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 413.1" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA049314: AB_2680708, HPA076949: AB_2686820" "prognostic unfavorable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 25.4 26.4 19.7 23.4 18.9 37.3 67.1 21.3 20.7 57.1 28.0 50.3 25.6 38.6 139.9 133.3 39.1 38.1 34.3 20.2 27.9 32.4 12.5 31.2 26.2 22.1 21.7 18.7 31.2 248.8 55.4 90.3 42.8 24.5 60.5 55.9 11.4 413.1 55.1 4.7 104.6 26.8 37.6 21.6 32.6 73.7 35.3 22.5 23.3 77.0 7.3 38.1 49.1 75.8 24.5 68.1 169.0 31.9 63.6 220.3 167.5 69.0 153.0 206.7 103.3 126.9 141.4 123.3 31.5 117.3 236.0 135.9 124.5 95.7 98.5 53.0 62.7 145.6 104.5 143.0 110.3 131.5 112.2 200.4 126.5 144.4 59.6 86.9 123.5 120.8 105.9 47.1 0.6 101.4 144.3 32.1 106.0 45.7 251.6 92.2 39.1 47.4 158.9 94.2 51.4 99.4 48.8 80.6 162.1 159.3 103.5 141.5 81.7 98.5 85.2 75.7 2.2 111.4 61.7 78.8 44.1 109.8 180.7 103.1 74.9 69.8 95.1 58.1 85.3 62.7 75.5 57.2 63.9 106.7 63.6 71.4 69.1 6.0 61.4 95.7 109.1 73.1 92.2 19.7 18.9 21.3 20.7 20.2 27.9 22.1 21.7 18.7 24.5 21.6 22.5 24.5 9.9 28.9 43.6 6.8 41.2 95.8 109.4 125.6 64.9 14.9 153.8 132.8 16.9 55.8 108.5 57.0 8.4 167.8 40.7 67.7 23.5 143.4 48.9 31.6 39.6 31.7 83.9 33.7 10.0 250.5 294.5 68.1 54.6 70.4 47.0 44.0 65.7 6.4 100.5 13.5 10.2 219.3 87.5 52.7 54.4 118.6 49.7 49.2 85.4 9.4 60.0 38.0 44.3 17.1 12.9 173.3 79.9 27.4 71.1 165.2 43.9 28.9 37.7 17.0 19.7 25.6 57.0 51.1 60.3 104.7 121.8 172.4 30.4 64.6 126.4 200.1 SLC38A8 ENSG00000166558 "Solute carrier family 38 member 8" A6NNN8 16 84009667-84042795 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "brain: 3.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 16.1" "Cancer enriched" "Detected in single" 14 "melanoma: 6.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (9.69e-2)" "unprognostic (6.16e-2)" "unprognostic (8.00e-3)" "unprognostic (6.40e-2)" "unprognostic (1.03e-1)" "unprognostic (8.20e-3)" "unprognostic (1.89e-1)" "unprognostic (7.70e-2)" "unprognostic (2.59e-1)" "unprognostic (2.16e-2)" "unprognostic (3.54e-2)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" 0.0 0.1 3.7 0.0 3.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 1.2 0.7 0.0 0.1 0.0 0.0 1.4 1.6 1.2 0.0 0.2 0.1 0.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 2.0 0.5 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.0 0.0 1.3 1.2 0.7 1.4 1.6 1.2 1.3 0.4 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 16.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139866-59158832 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 24.8 77.4 106.5 87.3 113.8 63.6 82.6 120.7 141.6 58.3 92.5 93.2 127.9 40.5 287.1 42.8 41.7 47.7 30.2 108.5 152.5 70.8 220.8 63.3 105.1 135.6 116.9 99.8 30.2 377.2 155.2 156.4 28.6 133.5 227.7 79.0 109.0 400.7 62.9 15.9 29.9 98.6 30.4 119.7 82.1 139.8 28.3 123.5 53.5 165.1 20.1 118.7 59.9 21.4 135.7 82.4 100.0 52.9 74.1 31.9 6.8 64.7 72.4 62.9 89.9 55.2 78.3 42.5 176.8 109.9 46.6 67.6 82.8 84.7 59.0 58.4 523.5 113.8 58.5 69.3 242.3 99.3 199.4 87.6 20.4 140.7 56.2 161.1 20.2 33.7 78.4 67.4 546.2 34.6 100.0 79.0 79.2 48.1 140.4 60.5 72.8 50.0 1150.0 67.5 76.1 223.2 90.5 43.1 162.5 252.8 29.9 76.0 148.5 24.7 98.5 45.4 36.5 86.9 587.3 434.4 176.0 99.4 131.8 124.5 76.4 70.7 57.9 146.1 97.6 187.6 197.8 150.4 142.5 78.8 127.9 77.7 105.4 12.2 108.3 108.8 299.6 223.7 222.1 106.5 113.8 120.7 141.6 108.5 152.5 135.6 116.9 99.8 133.5 119.7 123.5 135.7 64.8 28.9 120.7 19.2 295.9 32.6 49.3 92.4 12.5 63.6 120.0 128.3 59.3 144.4 102.5 60.7 50.1 70.8 148.7 76.3 88.0 164.4 45.4 58.7 34.2 60.3 339.3 43.8 12.2 263.1 109.1 29.2 60.6 147.1 47.5 21.5 56.4 224.7 112.9 50.5 13.3 223.1 685.6 37.1 56.9 18.8 12.5 63.9 256.1 10.3 46.4 544.7 96.8 17.1 31.2 148.9 78.4 23.0 1164.8 380.9 99.3 118.8 81.3 89.3 6.6 23.1 70.6 110.2 81.5 35.5 45.5 149.7 92.3 40.1 88.3 79.2 CPLX4 CPX-IV ENSG00000166569 "Complexin 4" Q7Z7G2 18 59275156-59318649 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "retina: 317.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 74.1;Cone photoreceptor cells: 112.6;Muller glia cells: 31.8;Rod photoreceptor cells: 173.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 1.1;midbrain: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047627 Enhanced NA NA "HPA047627: " "unprognostic (1.85e-1)" "unprognostic (4.46e-1)" "unprognostic (4.20e-2)" "unprognostic (4.05e-2)" "unprognostic (9.90e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 317.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.4 0.0 3.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.3 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 173.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77249848-77277900 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.5;brain: 1.4;pituitary gland: 1.5" "Cell type enhanced" "Detected in some" "Early spermatids: 68.1;Enteroendocrine cells: 17.6;Oligodendrocyte precursor cells: 42.7;Respiratory ciliated cells: 11.7" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 5.2" "Low region specificity" "Detected in many" HPA074584 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074584: " "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 0.1 1.5 0.8 0.1 0.6 0.2 0.1 0.2 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 1.0 0.0 0.2 0.0 0.0 1.0 1.3 0.8 0.0 0.0 0.2 1.5 0.0 0.7 0.2 0.1 0.6 0.0 0.2 0.0 0.1 0.2 0.0 0.9 0.0 0.1 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 1.0 0.7 1.0 1.0 1.3 0.8 0.7 0.9 1.4 1.0 4.2 0.0 3.6 0.0 0.0 0.0 1.1 0.0 0.0 4.2 0.0 0.0 0.6 0.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 0.0 68.1 0.3 0.1 0.3 17.6 0.0 1.4 0.0 0.0 1.0 0.0 0.3 1.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.3 0.0 0.0 0.1 0.2 1.0 42.7 0.3 0.0 1.1 0.0 0.0 0.8 0.0 0.1 11.7 0.4 0.0 3.1 0.2 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.2 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87328824 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 121.8;Excitatory neurons: 99.6;Inhibitory neurons: 93.7;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 88.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles NA NA Vesicles "HPA056685: AB_2683208, HPA069473: AB_2686139" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 26.3 15.0 4.4 5.7 6.1 3.7 14.4 2.9 5.5 5.7 5.4 10.6 15.7 6.4 4.8 4.5 6.1 8.4 5.8 4.5 4.4 12.1 24.9 6.6 6.0 5.6 5.1 5.0 7.4 6.2 9.5 5.5 10.3 5.6 10.8 8.6 7.0 10.1 6.5 8.5 3.8 14.6 6.9 2.8 5.8 7.5 10.3 4.3 6.6 10.2 7.5 4.8 5.6 4.5 6.8 8.8 15.7 9.8 13.7 31.3 28.6 9.2 6.5 16.7 7.6 17.0 27.1 39.9 24.2 17.1 8.9 19.9 8.3 13.3 14.9 8.5 22.7 7.5 18.5 14.0 88.5 17.6 10.8 9.2 34.8 9.2 11.0 7.6 10.2 19.5 26.4 19.3 35.9 9.0 5.9 28.3 10.8 11.5 47.2 11.7 12.5 7.5 19.2 17.5 28.1 4.8 11.0 9.6 30.0 13.6 18.8 42.0 9.6 10.3 7.9 10.3 30.6 4.6 13.4 28.2 28.2 6.0 11.5 15.7 0.9 4.8 1.4 7.5 5.1 6.7 4.7 4.7 8.1 5.6 3.4 5.3 5.1 1.5 7.2 2.2 5.7 5.4 4.1 4.4 6.1 2.9 5.5 4.5 4.4 5.6 5.1 5.0 5.6 2.8 4.3 6.8 14.4 9.6 7.5 121.8 7.1 4.2 4.0 4.6 8.6 5.6 12.7 7.1 6.3 5.7 6.8 1.8 4.2 2.6 7.7 10.5 5.9 2.8 2.8 5.8 11.0 8.1 3.6 3.8 99.6 3.2 8.6 11.0 8.6 4.2 9.5 11.5 7.9 16.2 4.9 1.7 93.7 6.8 10.2 7.8 6.0 7.7 7.2 5.4 5.4 48.7 4.1 5.0 9.2 123.1 202.4 3.1 10.9 7.2 10.3 6.1 21.8 10.6 8.7 4.2 32.9 5.7 8.4 2.2 3.8 4.8 4.8 1.5 8.3 24.6 8.7 3.8 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 22.2;testis: 44.6" "Group enriched" "Detected in many" 6 "Early spermatids: 155.2;Endometrial ciliated cells: 76.6;Late spermatids: 104.6;Respiratory ciliated cells: 125.8;Spermatocytes: 92.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.9;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.4;granulocytes: 1.9;monocytes: 1.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.2;RPTEC TERT1: 13.8;U-698: 15.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA046810: AB_2679818, HPA048782: AB_2680519" "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favorable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 0.6 0.9 3.9 1.0 2.5 0.3 1.4 3.3 2.5 2.1 7.0 0.7 0.2 1.9 2.0 1.9 22.2 1.0 1.3 2.3 3.7 3.0 0.2 2.6 1.0 3.9 4.4 1.8 1.5 1.0 5.2 3.9 0.6 3.4 0.8 0.8 3.8 1.1 1.2 0.4 0.7 0.4 1.0 4.1 0.2 0.6 44.6 2.9 0.7 1.8 0.1 2.7 1.9 0.8 4.1 3.6 4.1 1.3 1.1 1.5 1.6 0.9 0.5 28.2 1.4 1.9 0.7 10.9 3.9 3.0 0.8 11.0 0.7 0.6 1.2 2.3 0.3 1.2 1.3 1.5 0.7 0.8 0.4 0.9 0.6 0.8 4.3 1.4 7.6 0.9 1.5 0.2 0.3 0.3 4.1 0.2 7.6 0.3 1.9 1.0 0.2 0.6 1.0 13.8 4.3 3.1 1.3 1.0 1.4 4.5 1.0 5.0 2.2 0.3 0.6 2.0 1.3 0.8 1.1 0.9 15.6 2.0 0.2 2.4 1.9 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 3.9 2.5 3.3 2.5 2.3 3.7 3.9 4.4 1.8 3.4 4.1 2.9 4.1 0.7 3.2 1.7 4.2 0.6 2.4 3.2 10.1 1.2 0.5 2.4 2.8 4.3 4.3 16.2 5.5 14.6 1.4 0.3 3.7 13.7 3.7 155.2 76.6 3.4 0.5 6.6 0.0 1.2 0.8 0.3 2.7 1.1 11.6 0.0 1.0 1.1 0.4 2.1 0.0 1.0 0.7 6.1 0.3 0.6 104.6 2.1 2.3 3.6 1.9 2.5 7.2 1.0 0.0 2.9 0.7 3.4 5.3 0.3 1.8 0.2 16.6 125.8 5.2 0.0 1.2 4.1 92.9 4.8 0.7 1.7 1.9 0.9 1.5 0.3 4.8 NDEL1 "MITAP1, NDE1L1, NDE2, NUDEL" ENSG00000166579 "NudE neurodevelopment protein 1 like 1" Q9GZM8 17 8413131-8490411 "Predicted intracellular proteins" "Differentiation, Neurogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 134.5;Suprabasal keratinocytes: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 175.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017916 Approved NA NA "HPA017916: AB_1854337" "unprognostic (6.34e-2)" "unprognostic (4.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.35e-3)" "unprognostic (6.98e-3)" "unprognostic (1.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.77e-3)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (2.95e-3)" "unprognostic (4.66e-2)" "unprognostic (5.89e-2)" "unprognostic (6.73e-3)" "unprognostic (8.82e-2)" "unprognostic (1.01e-1)" "unprognostic (7.63e-3)" 40.8 60.9 14.9 37.3 20.7 110.7 33.4 18.1 26.4 32.6 16.9 28.7 18.6 29.5 20.5 55.2 32.3 41.0 27.1 21.3 59.1 19.8 44.3 44.8 23.3 16.9 18.5 18.1 47.0 28.0 18.2 35.2 40.3 20.4 25.7 23.3 25.6 32.8 22.5 43.9 88.7 25.0 26.9 14.1 29.2 26.0 26.6 18.0 24.7 23.4 31.4 27.0 38.2 40.1 22.1 41.9 36.6 34.2 29.4 50.9 61.9 28.1 87.2 72.6 61.4 64.0 32.0 22.2 24.0 28.9 97.1 34.8 47.7 30.9 34.6 62.9 40.1 50.1 48.0 59.8 38.7 54.5 18.4 98.4 41.2 66.7 52.8 60.0 44.7 49.8 37.0 29.0 27.6 54.1 17.9 27.2 15.7 14.9 26.2 20.4 28.2 26.9 19.8 27.7 23.6 16.2 17.8 52.9 25.4 29.4 36.0 17.3 12.6 65.6 48.7 18.4 45.4 48.4 19.3 42.5 19.3 61.0 27.4 50.3 85.5 28.3 98.2 35.1 27.6 37.0 25.5 31.3 34.8 23.9 26.1 30.4 27.9 175.0 32.8 24.7 20.6 36.5 36.3 14.9 20.7 18.1 26.4 21.3 59.1 16.9 18.5 18.1 20.4 14.1 18.0 22.1 48.4 12.8 20.9 12.1 33.8 79.0 55.3 18.3 27.3 13.9 24.1 20.4 17.5 12.8 18.1 12.9 20.9 18.9 39.7 36.8 9.8 13.6 86.8 34.8 21.5 26.4 4.2 37.5 27.0 12.2 37.1 26.4 47.9 63.5 80.5 13.3 18.5 12.8 14.1 8.4 22.0 37.1 20.3 13.2 74.0 134.5 12.8 40.8 32.0 18.7 13.2 8.8 19.6 14.6 19.6 24.0 42.6 14.7 38.2 36.0 21.8 5.8 11.3 14.1 6.6 24.7 40.1 8.3 10.0 25.0 136.7 57.3 40.1 11.8 17.6 73.4 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 100.4;Spermatogonia: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 1.3;memory B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 3.0 4.8 11.4 0.6 11.5 5.2 4.6 9.4 11.8 3.7 7.1 9.2 9.9 5.9 3.5 0.5 6.7 1.3 5.3 12.0 11.8 3.4 10.8 2.6 1.2 11.7 11.0 11.5 6.2 4.1 3.9 7.0 1.2 10.5 3.1 8.0 4.0 1.5 4.0 21.3 0.7 10.7 4.1 11.6 1.1 13.4 10.3 11.0 17.3 2.4 9.6 1.2 4.3 1.7 12.1 10.7 20.4 106.4 53.4 3.0 2.7 18.2 8.7 8.6 26.5 20.0 20.5 4.7 42.5 17.0 6.5 4.9 3.2 69.3 0.6 16.8 0.0 85.9 10.1 5.0 41.1 29.2 10.1 0.0 7.6 2.8 31.6 18.7 3.0 15.2 105.1 17.4 0.0 8.0 1.8 80.2 34.2 103.4 69.1 0.0 57.1 4.1 4.9 6.1 15.4 56.8 43.9 22.2 0.3 5.2 48.6 0.3 24.8 1.0 0.0 8.6 1.2 0.0 0.0 0.0 24.9 0.0 14.0 0.6 0.0 0.0 1.3 0.1 0.0 0.0 1.4 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 11.4 11.5 9.4 11.8 12.0 11.8 11.7 11.0 11.5 10.5 11.6 11.0 12.1 13.3 0.0 2.7 3.9 13.7 1.0 29.7 0.5 4.6 40.0 22.5 31.6 4.2 30.0 4.4 1.8 4.2 19.6 19.6 43.0 31.3 7.5 16.3 2.6 32.4 5.0 39.4 12.6 18.9 23.3 22.1 9.2 59.1 2.7 5.7 39.7 1.8 50.1 6.0 11.8 21.8 63.0 0.0 1.4 0.7 9.0 8.7 4.6 8.8 3.7 2.0 45.9 13.4 19.6 11.7 17.8 83.9 11.7 10.7 38.0 100.4 43.5 2.5 15.0 26.3 4.2 17.9 81.6 124.2 2.5 2.6 6.4 10.7 8.7 78.9 45.0 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918917 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 251.5" "Cell type enriched" "Detected in some" 4 "Collecting duct cells: 617.9" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 99 "RPTEC TERT1: 225.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB013526, HPA036260" Enhanced NA NA 130000 "CAB013526: , HPA036260: AB_2675027" "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favorable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 1.4 0.3 4.7 0.3 11.1 0.3 0.1 0.0 0.0 251.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.9 0.4 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 225.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.4 6.7 0.0 0.0 617.9 0.0 0.1 0.0 0.4 74.3 0.1 2.9 18.0 2.1 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 1.9 124.4 0.0 0.0 0.0 0.6 0.9 0.0 0.2 1.9 0.0 1.0 0.8 0.0 0.7 0.0 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925536 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 308.2;skeletal muscle: 776.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 302.0;Endometrial ciliated cells: 477.6;Glandular and luminal cells: 245.5;Respiratory ciliated cells: 214.9;Skeletal myocytes: 179.2;Smooth muscle cells: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HDLM-2: 194.2;U-87 MG: 51.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: AB_2677655" "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 39.4 18.2 3.5 5.5 5.2 4.7 24.6 13.6 14.5 28.7 10.1 14.7 3.4 21.2 1.7 102.0 35.5 12.0 308.2 4.7 4.6 45.3 5.1 52.8 4.1 3.6 4.5 2.1 18.9 2.5 1.7 14.5 32.9 4.9 18.6 1.1 2.5 29.7 3.5 776.0 15.5 11.0 6.4 4.5 2.8 14.1 6.8 5.2 1.7 13.8 28.5 3.2 27.7 33.2 6.0 0.1 8.5 0.2 0.1 0.0 0.8 0.3 4.9 0.5 0.8 4.2 2.2 5.9 0.2 4.8 0.3 1.5 0.4 0.2 0.3 0.7 194.2 0.3 0.0 0.3 2.1 8.0 0.0 0.6 2.3 0.9 14.3 0.2 3.3 0.0 0.1 0.2 3.8 0.6 0.2 0.0 0.5 0.7 0.0 0.3 0.6 0.2 0.0 0.9 0.1 0.3 0.6 4.5 0.0 0.0 0.7 0.0 0.5 0.0 0.4 0.5 0.3 0.4 6.2 0.2 0.5 51.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 5.2 13.6 14.5 4.7 4.6 3.6 4.5 2.1 4.9 4.5 5.2 6.0 17.0 70.5 150.0 3.3 33.6 9.4 3.7 11.3 4.0 21.4 10.7 15.9 302.0 0.0 18.9 68.0 10.4 4.1 22.5 9.7 23.5 47.4 1.6 477.6 36.7 18.1 10.7 0.0 0.8 3.2 8.2 39.4 10.7 245.5 34.2 26.4 0.7 0.0 1.4 1.7 1.0 7.8 14.2 1.9 36.2 0.7 0.6 24.6 23.2 1.9 0.6 2.4 0.0 0.5 0.6 55.3 5.0 5.3 59.5 30.7 3.4 11.3 214.9 3.2 111.7 179.2 232.6 1.7 5.2 148.1 10.1 5.6 12.4 0.5 6.9 2.6 CIAO2B "CGI-128, CIA2B, FAM96B, MIP18" ENSG00000166595 "Cytosolic iron-sulfur assembly component 2B" Q9Y3D0 16 66932065-66934423 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 143.6;Cytotrophoblasts: 204.8;Extravillous trophoblasts: 190.4;Hofbauer cells: 201.5;Syncytiotrophoblasts: 248.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041501, HPA041736" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041501: AB_10795123, HPA041736: AB_10793932" "unprognostic (2.49e-1)" "unprognostic (3.79e-2)" "unprognostic (8.06e-2)" "unprognostic (5.42e-3)" "unprognostic (3.93e-2)" "unprognostic (4.91e-2)" "unprognostic (4.98e-2)" "unprognostic (8.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-2)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (9.84e-2)" "unprognostic (6.48e-2)" "unprognostic (1.12e-2)" 83.6 132.4 142.5 59.8 149.9 49.6 79.2 157.7 177.7 86.4 137.6 94.1 63.9 77.4 63.1 157.6 85.0 58.3 185.5 142.6 152.6 159.0 154.2 93.2 84.3 150.7 146.6 136.7 90.9 70.5 116.1 113.1 66.6 149.7 81.1 60.3 32.9 70.1 49.3 350.3 59.6 81.0 53.3 154.8 82.4 83.6 77.5 149.4 70.6 87.7 120.7 63.9 87.3 83.3 161.5 131.6 291.8 96.8 122.1 119.9 112.7 118.2 117.3 130.7 175.7 219.5 309.5 147.8 118.4 148.6 139.4 151.1 169.7 140.0 141.7 125.1 148.9 198.1 72.3 83.6 368.3 227.1 107.8 275.1 112.2 135.5 208.4 180.8 133.2 120.8 206.9 124.1 76.7 144.9 252.6 184.6 258.8 129.7 112.5 351.2 155.5 103.3 228.6 264.9 117.0 170.0 190.0 251.4 67.2 186.4 74.4 74.5 176.7 103.6 130.9 156.2 74.5 165.9 167.0 146.7 311.7 231.9 111.3 174.4 209.5 190.1 202.2 169.9 222.3 167.9 226.6 180.2 186.1 216.7 189.7 142.8 159.1 94.9 185.8 241.3 389.8 270.1 207.5 142.5 149.9 157.7 177.7 142.6 152.6 150.7 146.6 136.7 149.7 154.8 149.4 161.5 56.8 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.6 0.0 0.0 0.0 0.0 204.8 53.1 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 190.4 38.9 0.0 0.0 0.0 0.0 0.0 0.0 201.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 248.6 10.9 0.0 0.0 0.0 CFAP52 "FLJ37528, WDR16, WDRPUH" ENSG00000166596 "Cilia and flagella associated protein 52" Q8N1V2 17 9576627-9643447 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 15.0;fallopian tube: 58.3" "Group enriched" "Detected in some" 6 "Early spermatids: 32.4;Endometrial ciliated cells: 99.6;Respiratory ciliated cells: 81.6;Spermatocytes: 33.9" "Group enriched" "Detected in some" 4 "endometrial cancer: 1.5;glioma: 1.7;lung cancer: 0.6;ovarian cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;MCF7: 2.1;OE19: 2.7;REH: 1.4;T-47d: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023247, HPA030635" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023247: AB_1858797, HPA030635: " "unprognostic (1.76e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (1.68e-2)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-2)" "unprognostic (2.11e-1)" "unprognostic (3.66e-1)" "unprognostic (2.22e-2)" "unprognostic (2.66e-1)" "unprognostic (7.85e-2)" "unprognostic (1.85e-1)" "unprognostic (9.23e-2)" "unprognostic (4.50e-2)" "unprognostic (7.09e-2)" 0.0 0.3 8.1 0.0 4.2 0.0 0.1 4.4 3.9 1.3 15.0 0.1 0.7 1.1 0.1 0.2 58.3 0.2 0.0 2.8 6.4 0.3 0.2 4.4 0.0 9.2 8.6 1.9 0.2 0.2 0.3 3.2 0.2 8.0 0.3 0.0 2.4 1.3 0.2 0.0 0.2 0.7 0.0 11.4 0.0 0.1 12.3 4.8 0.3 0.6 0.3 0.0 0.1 0.1 6.6 0.8 0.8 0.0 0.3 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.6 0.9 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.1 0.0 0.3 0.1 2.7 0.0 1.4 0.0 0.0 0.2 0.4 0.3 0.0 0.3 0.5 0.0 0.3 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 4.2 4.4 3.9 2.8 6.4 9.2 8.6 1.9 8.0 11.4 4.8 6.6 0.2 0.0 2.3 1.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.3 0.0 9.9 0.0 6.2 0.8 0.0 0.0 1.9 0.1 32.4 99.6 0.9 0.3 0.0 0.0 9.7 0.2 0.2 0.3 0.0 1.7 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 6.4 1.8 0.0 0.0 1.0 0.0 0.7 0.0 7.1 1.1 0.1 0.0 1.9 0.0 0.3 0.0 0.5 81.6 3.1 0.0 0.1 0.2 33.9 0.8 0.0 0.0 1.0 0.1 0.1 0.0 0.1 HSP90B1 "GP96, GRP94, TRA1" ENSG00000166598 "Heat shock protein 90 beta family member 1" P14625 12 103930107-103953931 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Plasma cells: 4874.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003901, CAB005224, HPA008424, CAB078151" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 330000000 "Endoplasmic reticulum" "CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184" "unprognostic (1.03e-1)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (5.70e-2)" "unprognostic (1.17e-2)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (7.22e-2)" "unprognostic (8.77e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.03e-10)" "unprognostic (2.95e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-2)" 333.4 343.8 178.8 427.3 185.3 442.7 345.4 189.8 205.9 366.3 229.4 343.7 263.8 305.0 1041.5 158.7 308.1 220.9 279.1 167.8 222.3 320.0 742.5 273.4 248.0 210.9 184.8 158.3 305.3 400.5 338.6 249.1 525.4 203.9 363.4 391.3 187.3 257.1 386.4 88.2 116.1 271.8 389.1 200.1 325.0 300.3 182.3 209.3 230.3 1424.6 92.0 330.7 359.9 166.0 254.2 856.5 459.9 926.2 940.0 960.1 897.5 1229.9 1449.4 1133.4 776.0 1038.1 839.1 805.3 243.8 1102.2 1579.2 995.1 583.2 934.6 1578.9 1063.2 607.3 307.4 684.5 447.6 861.0 1457.4 702.1 514.6 519.6 690.9 920.0 1342.8 2643.7 1513.9 293.8 560.0 914.8 1039.9 314.7 409.2 768.3 756.9 925.5 544.5 372.2 597.1 1079.2 1064.3 527.1 271.5 645.7 889.2 912.0 932.7 1468.4 743.9 1016.2 854.4 566.1 476.0 462.8 607.9 945.5 949.0 455.6 1106.9 494.7 904.5 113.8 81.3 30.3 199.7 88.6 244.9 108.5 118.5 187.8 111.8 71.1 75.9 133.8 18.7 199.3 83.3 322.7 81.1 188.5 178.8 185.3 189.8 205.9 167.8 222.3 210.9 184.8 158.3 203.9 200.1 209.3 254.2 507.5 237.2 373.8 28.7 646.0 309.3 905.1 743.6 196.9 50.3 261.4 334.0 687.8 235.9 475.3 257.5 156.4 568.4 480.6 424.0 56.7 471.2 89.6 570.8 751.1 439.6 406.6 213.5 34.0 250.4 1081.0 714.0 390.9 690.9 405.3 500.6 446.9 891.9 553.1 77.4 41.9 631.5 238.0 300.1 309.8 47.0 563.2 378.4 421.6 52.5 240.5 141.0 199.8 30.2 61.3 321.8 419.1 337.7 4874.6 760.6 246.1 271.4 404.2 111.6 216.9 325.7 569.3 489.0 154.4 196.3 260.7 921.0 316.0 542.6 494.6 620.0 MC4R ENSG00000166603 "Melanocortin 4 receptor" P32245 18 60371062-60372775 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 3.2;fallopian tube: 3.1;retina: 3.9" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 7.3" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 70 "fHDF/TERT166: 94.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 10.2" HPA016719 Uncertain NA NA "HPA016719: AB_1853617" "unprognostic (2.29e-1)" "unprognostic (5.31e-3)" "unprognostic (5.78e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.33e-1)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (2.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.59e-1)" 0.0 0.2 1.9 0.0 2.7 0.0 0.2 0.4 1.6 0.0 0.4 0.0 0.1 0.0 0.3 0.0 3.1 0.0 0.0 1.9 3.2 0.0 0.0 0.0 0.0 1.3 1.5 2.3 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 2.5 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 94.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.7 0.4 1.6 1.9 3.2 1.3 1.5 2.3 1.0 0.7 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLCAP BC10 ENSG00000166619 "BLCAP apoptosis inducing factor" P62952 20 37492472-37527931 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 470.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 358.9" "Low region specificity" "Detected in all" HPA047390 Approved Nucleoli NA NA Nucleoli "HPA047390: AB_2680025" "unprognostic (1.05e-2)" "unprognostic (7.91e-3)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.08e-2)" "unprognostic (1.27e-2)" "unprognostic (3.49e-1)" "unprognostic (3.51e-1)" "unprognostic (4.45e-1)" "unprognostic (1.91e-3)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.04e-3)" "unprognostic (1.96e-2)" "unprognostic (7.62e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.28e-5)" 63.4 56.6 165.1 27.5 188.8 36.3 60.0 109.1 150.6 47.5 152.4 51.9 51.6 34.8 52.9 87.0 142.3 29.2 72.5 148.1 158.6 60.9 101.8 37.6 40.3 129.0 130.4 147.6 41.2 27.6 51.3 150.3 76.6 138.4 60.0 52.7 71.5 57.7 56.9 470.2 89.0 48.4 34.3 109.9 47.2 39.5 30.9 175.1 42.0 45.9 121.2 53.5 73.2 60.5 139.5 138.0 38.8 45.8 48.6 86.2 66.0 63.8 64.3 62.2 56.4 45.5 137.9 109.3 70.7 62.1 90.1 53.7 259.1 34.4 268.1 57.5 14.7 31.5 23.2 94.0 130.5 55.8 46.5 29.9 84.8 283.9 54.3 101.0 46.1 79.6 51.3 22.7 51.9 114.1 77.0 39.0 37.1 36.9 77.6 109.6 36.6 171.0 47.2 64.6 358.9 41.8 50.2 77.3 221.2 54.7 46.5 73.6 44.4 75.2 144.6 37.2 51.3 28.2 28.1 37.5 34.2 60.4 42.4 26.5 74.9 56.6 69.9 45.2 56.0 49.6 93.9 51.3 48.4 52.8 113.6 67.1 52.6 59.3 48.2 53.8 22.6 55.4 52.8 165.1 188.8 109.1 150.6 148.1 158.6 129.0 130.4 147.6 138.4 109.9 175.1 139.5 24.4 80.1 31.0 14.0 38.4 147.0 97.3 135.9 137.1 43.0 29.0 60.8 56.8 30.0 68.7 40.5 22.9 115.1 25.5 72.4 82.2 35.7 73.7 58.8 26.3 54.0 40.9 15.6 26.8 33.9 84.8 29.5 17.9 18.1 29.2 32.1 89.6 81.0 55.8 42.1 29.8 58.8 52.9 41.9 36.2 161.7 29.8 29.1 35.6 13.1 30.1 64.0 24.7 16.6 11.4 54.0 31.4 59.5 16.5 88.6 69.9 55.7 63.2 36.2 32.9 28.6 27.0 30.8 27.1 66.8 122.9 65.0 26.1 54.0 33.3 133.4 SERPINB12 YUKOPIN ENSG00000166634 "Serpin family B member 12" Q96P63 18 63542369-63569329 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 59.5;vagina: 25.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 8200000 "unprognostic (7.35e-2)" "prognostic favorable (1.76e-4)" "unprognostic (1.57e-1)" "unprognostic (2.00e-1)" "unprognostic (8.10e-2)" 0.0 0.0 0.1 0.0 0.1 0.1 3.3 0.3 0.2 6.6 0.2 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.7 0.0 0.2 59.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 3.5 0.0 0.1 2.1 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CHRFAM7A "CHRNA7-DR1, D-10" ENSG00000166664 "CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion" Q494W8 15 30360566-30393849 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.2;parathyroid gland: 5.6" "Cell type enhanced" "Detected in some" "Horizontal cells: 11.8;Inhibitory neurons: 4.1;Proximal enterocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "eosinophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 3.6;HEK 293: 1.8;HEL: 3.8;RH-30: 2.6;SH-SY5Y: 2.0;U-937: 3.5" NA NA "unprognostic (3.61e-2)" "unprognostic (1.52e-1)" "unprognostic (5.59e-2)" "unprognostic (2.66e-3)" "unprognostic (2.40e-1)" "unprognostic (2.02e-1)" "unprognostic (3.55e-1)" "unprognostic (7.20e-2)" "unprognostic (3.53e-1)" "unprognostic (7.45e-2)" "unprognostic (2.41e-1)" "unprognostic (4.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.71e-4)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" 0.6 0.8 0.5 0.6 0.6 4.2 0.4 0.3 1.0 0.3 0.5 0.4 0.5 0.3 0.1 0.2 0.3 0.2 1.2 0.4 0.8 0.2 0.0 0.9 0.2 1.0 1.5 0.4 0.5 0.7 5.6 0.6 0.0 1.0 0.7 0.0 0.3 0.3 0.2 0.2 0.2 0.7 0.3 0.7 0.7 0.7 3.2 0.6 0.2 1.7 0.3 0.2 0.4 0.4 0.9 0.0 0.2 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.4 0.0 3.6 0.0 0.0 0.0 1.8 3.8 0.1 0.1 0.1 0.7 1.0 0.2 0.0 0.0 0.0 1.6 0.3 0.8 0.4 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 2.0 0.0 0.0 0.0 0.3 0.0 0.2 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.9 2.8 0.1 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.1 0.3 0.1 0.3 0.5 0.6 0.3 1.0 0.4 0.8 1.0 1.5 0.4 1.0 0.7 0.6 0.9 0.1 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.8 1.5 0.1 0.4 2.1 1.5 0.6 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.2 0.4 0.2 0.4 1.2 2.1 1.6 1.1 0.0 0.6 2.0 0.9 1.3 0.3 0.4 0.0 0.7 11.8 4.1 3.1 0.0 0.8 0.0 0.5 0.0 1.2 0.0 0.0 1.6 0.8 1.0 0.0 0.3 0.7 0.3 1.5 0.7 0.5 4.1 0.0 0.0 0.0 0.0 0.3 0.6 3.2 1.9 0.6 0.0 0.0 0.2 0.0 0.9 1.5 ATF7IP2 FLJ12668 ENSG00000166669 "Activating transcription factor 7 interacting protein 2" Q5U623 16 10326434-10483638 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.4" "Cell type enhanced" "Detected in all" "Spermatocytes: 145.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 14.2;THP-1: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.3;hippocampal formation: 2.3" "HPA041156, HPA041228" Enhanced NA NA "HPA041156: AB_10795536, HPA041228: AB_10795586" "prognostic favorable (4.98e-4)" "unprognostic (3.87e-2)" "unprognostic (1.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.56e-2)" "unprognostic (2.87e-1)" "prognostic favorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-3)" "unprognostic (2.43e-1)" "unprognostic (2.99e-1)" "unprognostic (2.41e-2)" "prognostic favorable (8.57e-5)" 1.9 6.8 2.5 4.3 1.8 5.8 1.5 0.9 3.8 3.1 1.4 2.0 3.0 1.4 3.6 1.5 4.8 1.3 5.3 3.2 1.6 2.5 9.3 2.1 8.8 1.5 1.1 2.3 2.2 5.7 0.6 1.2 3.2 1.2 1.4 2.1 4.7 0.8 1.7 1.6 2.9 2.0 2.2 1.3 5.1 6.3 19.4 1.6 10.8 3.7 1.3 8.7 5.2 1.1 2.8 0.7 1.6 1.3 4.3 3.3 3.8 6.9 1.7 0.3 0.4 0.0 0.5 7.2 0.0 3.5 0.0 1.4 1.0 6.3 1.5 0.4 6.2 4.3 8.4 1.3 6.0 1.6 7.8 3.5 4.2 1.4 0.1 0.0 1.7 2.9 13.1 14.2 0.0 4.0 1.3 9.9 6.1 7.0 9.6 1.5 13.0 0.0 4.3 1.4 3.3 0.0 0.8 6.8 1.3 0.7 4.3 2.4 13.9 1.6 0.0 1.9 0.1 0.0 2.8 7.3 1.2 0.0 4.8 1.9 0.1 0.5 0.0 4.5 1.0 11.6 2.4 4.6 4.4 1.6 3.6 3.8 4.3 0.1 3.5 1.0 2.5 7.2 2.0 2.5 1.8 0.9 3.8 3.2 1.6 1.5 1.1 2.3 1.2 1.3 1.6 2.8 28.5 12.8 16.2 26.1 62.1 11.5 11.6 37.3 19.9 18.5 11.0 8.4 53.9 7.2 22.8 12.9 100.1 60.1 38.9 15.4 99.7 16.8 30.7 24.2 8.2 17.6 23.2 30.9 71.4 10.9 60.5 12.8 81.1 14.9 1.3 19.9 13.2 115.2 23.6 5.0 45.5 14.6 24.4 23.6 23.5 31.6 7.5 33.5 16.0 82.4 13.8 38.2 24.7 39.7 8.4 6.7 20.7 6.8 37.1 6.1 10.0 39.0 88.7 35.4 13.1 6.0 13.2 145.8 89.2 19.6 19.5 27.1 46.0 17.3 16.8 21.7 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770502-102780628 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 34 "endometrium 1: 267.9" "Cell type enriched" "Detected in some" 38 "Basal respiratory cells: 3913.2" "Group enriched" "Detected in many" 4 "cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 765000 Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favorable (7.12e-4)" 0.1 0.0 0.1 7.7 2.2 0.1 0.1 0.0 0.7 0.7 0.0 0.3 1.1 267.9 0.0 0.2 0.0 1.3 0.0 0.2 0.4 0.0 1.0 2.0 0.1 0.3 0.3 0.0 0.2 0.2 0.0 0.0 1.3 0.4 1.4 0.3 0.0 1.6 0.0 0.0 0.0 0.8 0.2 0.0 0.0 2.9 0.5 1.8 0.6 0.0 0.2 0.7 4.5 3.2 0.2 0.0 0.1 0.8 0.2 0.0 0.0 0.2 11.8 0.6 0.1 0.1 0.3 0.0 0.0 3.3 1.8 0.2 2.7 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.5 0.0 15.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 2.8 0.5 1.6 0.0 0.0 0.0 0.0 0.6 4.7 0.0 2.4 0.0 0.0 0.8 0.0 0.0 1.9 3.5 1.2 0.4 0.5 0.0 0.0 0.1 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.7 0.2 0.4 0.3 0.3 0.0 0.4 0.0 1.8 0.2 0.1 0.0 0.0 0.0 0.0 0.8 51.3 3913.2 0.0 0.0 0.7 0.0 0.1 0.0 85.4 29.5 0.0 0.0 0.0 0.4 0.0 34.0 6.1 6.4 2.5 9.0 0.0 0.0 0.0 14.6 0.0 6.3 0.0 12.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.4 0.0 9.5 1.3 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 102.5 0.1 0.0 0.0 42.5 0.0 0.1 29.3 0.0 0.0 0.0 11.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 8.2 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.7" "Group enriched" "Detected in many" 6 "Excitatory neurons: 29.0;Granulosa cells: 92.1;Inhibitory neurons: 28.4;Langerhans cells: 47.6;monocytes: 29.1;Oligodendrocyte precursor cells: 23.6" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;NTERA-2: 1.3;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles NA NA Vesicles "HPA060582: AB_2684326" "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 0.8 1.2 4.8 1.1 5.1 1.9 0.6 3.2 5.7 1.4 1.3 0.8 0.8 0.9 0.5 0.6 1.6 0.9 1.2 4.7 4.4 0.7 1.1 0.9 2.1 3.6 3.5 4.8 3.7 1.1 0.0 2.2 0.1 4.0 2.0 0.2 2.2 0.7 0.9 0.5 0.7 1.3 0.6 2.9 1.7 0.8 1.0 3.9 0.8 0.9 0.0 0.6 0.7 0.8 3.8 0.1 0.4 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.2 0.1 0.6 0.3 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.3 1.3 0.1 0.0 0.6 0.1 0.2 0.0 0.4 0.2 2.1 0.1 0.2 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.3 0.1 1.0 0.1 0.3 0.3 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.6 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 4.8 5.1 3.2 5.7 4.7 4.4 3.6 3.5 4.8 4.0 2.9 3.9 3.8 0.2 0.0 1.8 5.2 0.8 1.1 0.0 0.1 0.6 6.4 0.1 0.4 0.6 0.0 0.1 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.7 0.6 0.4 0.4 0.0 0.0 29.0 0.6 0.6 3.3 0.0 0.3 0.0 92.1 0.0 0.2 0.8 1.7 28.4 0.0 0.0 1.0 47.6 0.3 2.8 4.5 1.8 1.9 29.1 4.7 0.0 23.6 1.1 0.3 0.0 1.5 0.2 0.0 0.0 1.3 0.2 1.3 0.0 0.2 3.6 2.2 3.1 0.1 1.0 1.4 0.5 0.1 0.1 0.1 BEX3 "Bex, DXS6984E, HGR74, NADE, NGFRAP1" ENSG00000166681 "Brain expressed X-linked 3" Q00994 X 103376395-103378164 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1607.8;Distal tubular cells: 1453.7;Granulosa cells: 700.3;Proximal tubular cells: 688.0;Syncytiotrophoblasts: 804.2;Theca cells: 696.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 150.9;T-reg: 137.1" "Lineage enriched" "Detected in all" 5 "T-cells: 150.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018886 Approved Supported Cytosol NA NA Cytosol "HPA018886: AB_1854453" "unprognostic (7.74e-2)" "unprognostic (6.56e-2)" "unprognostic (8.15e-3)" "prognostic unfavorable (7.23e-5)" "unprognostic (2.70e-1)" "unprognostic (1.93e-3)" "unprognostic (7.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.10e-2)" "unprognostic (3.85e-3)" "unprognostic (2.00e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.38e-1)" "unprognostic (3.32e-2)" "unprognostic (8.68e-2)" 91.1 348.6 371.2 39.9 400.4 31.4 112.0 354.1 436.1 145.4 442.3 105.7 31.5 150.3 503.8 73.4 152.3 77.8 216.2 406.1 459.3 224.2 93.5 117.8 29.5 374.7 377.2 373.3 467.6 121.0 233.0 376.6 208.7 374.3 168.1 53.5 137.1 100.4 227.0 20.0 61.0 56.8 117.5 358.9 98.1 95.4 141.0 405.6 97.9 276.8 44.9 28.7 108.7 105.5 392.7 218.5 305.3 561.5 222.3 508.5 567.3 256.6 244.7 409.8 299.5 475.0 317.9 238.1 0.3 427.8 288.7 222.0 85.3 394.1 302.5 299.4 0.8 280.6 98.7 502.9 87.4 396.2 0.8 37.4 613.4 252.2 397.3 348.0 533.6 469.5 225.0 0.1 1.0 542.2 486.1 227.2 2.7 750.5 0.1 232.3 0.4 350.3 0.5 317.9 365.3 377.3 391.4 264.7 3.2 380.3 359.8 142.4 31.8 291.5 191.6 123.3 374.6 110.0 2.2 1.0 1.6 395.3 0.3 189.1 0.3 3.7 1.1 4.1 0.9 2.2 4.6 71.8 19.1 6.4 1.2 150.9 70.8 13.9 28.9 0.8 14.5 137.1 66.5 371.2 400.4 354.1 436.1 406.1 459.3 374.7 377.2 373.3 374.3 358.9 405.6 392.7 118.5 326.9 227.7 0.0 12.6 0.0 0.0 0.0 0.0 0.0 217.4 433.2 0.0 0.0 104.0 518.6 0.0 1607.8 4.7 0.0 1453.7 201.3 0.0 187.0 284.8 132.3 0.0 0.0 0.0 70.9 471.7 189.2 0.0 144.1 16.4 700.3 0.0 0.0 172.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 2.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 1.7 0.0 0.0 688.0 23.3 0.0 0.0 0.0 117.8 0.0 0.0 0.0 0.0 804.2 12.8 696.8 0.0 0.0 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687547-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 57.3;choroid plexus: 27.1" "Cell type enhanced" "Detected in some" "Astrocytes: 26.4;Excitatory neurons: 5.4;Horizontal cells: 5.0;Oligodendrocytes: 15.5" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.0;CAPAN-2: 3.2;OE19: 2.0;WM-115: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm NA NA Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 1.2 0.5 34.0 0.2 40.3 1.4 2.0 31.4 38.6 0.8 27.1 0.6 0.1 0.5 0.2 0.5 0.7 0.7 1.0 33.6 33.4 0.7 1.0 0.7 0.2 40.4 35.5 32.3 0.7 0.5 0.0 1.6 0.2 41.6 0.8 0.3 1.1 9.7 0.3 2.6 2.0 0.7 0.3 35.0 0.8 0.8 2.1 38.4 0.3 0.6 0.5 0.3 0.7 1.0 57.3 0.2 0.3 2.0 1.1 0.2 0.1 0.3 0.5 0.2 0.3 0.4 1.1 3.2 0.1 1.4 0.2 0.3 0.4 0.1 0.2 0.1 0.2 0.6 0.4 0.3 0.0 0.1 0.5 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.7 0.4 0.2 0.4 0.0 0.4 0.6 0.2 2.0 0.1 0.4 0.2 0.0 0.3 0.2 0.3 0.4 0.2 0.0 1.6 0.2 0.2 0.2 0.2 0.4 0.7 0.3 0.3 0.2 0.1 0.0 0.1 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 40.3 31.4 38.6 33.6 33.4 40.4 35.5 32.3 41.6 35.0 38.4 57.3 0.2 0.0 0.0 26.4 0.2 0.3 0.2 0.0 0.0 0.5 1.0 0.9 0.5 0.0 0.1 1.8 2.1 0.0 0.2 0.2 0.0 0.3 0.1 0.3 0.2 0.3 0.0 1.3 5.4 0.9 0.0 0.3 0.0 0.4 0.0 0.4 0.4 0.2 0.1 5.0 2.8 0.0 0.0 0.0 0.3 0.3 0.3 0.1 0.0 2.8 0.1 3.2 0.0 3.5 15.5 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.1 1.3 0.0 0.5 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 COG1 "KIAA1381, LDLB" ENSG00000166685 "Component of oligomeric golgi complex 1" Q8WTW3 17 73192632-73208507 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029224 Supported NA NA "HPA029224: AB_10600698" "unprognostic (8.93e-2)" "unprognostic (4.36e-2)" "unprognostic (2.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.91e-6)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-3)" "unprognostic (5.31e-3)" "unprognostic (9.94e-3)" "unprognostic (2.63e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (2.21e-1)" 20.6 23.6 35.0 11.2 39.3 16.0 21.2 29.0 41.3 22.2 25.4 23.0 16.3 21.9 17.7 13.3 20.6 12.2 36.4 39.8 32.4 17.4 15.5 15.4 12.2 27.5 26.5 39.7 23.9 27.8 17.7 33.2 13.6 28.5 19.5 19.8 25.6 19.0 17.6 52.9 19.8 20.1 19.0 23.7 17.6 21.0 16.0 29.5 13.7 17.9 32.1 12.8 21.3 17.6 35.6 25.3 19.1 16.1 17.3 25.9 24.5 19.8 34.8 29.5 32.0 29.9 16.6 16.1 14.0 19.2 33.0 29.5 15.6 16.4 24.2 46.9 6.1 18.3 12.5 19.5 30.1 27.4 15.4 14.2 20.9 18.4 25.7 24.7 21.5 30.3 18.7 14.1 20.5 32.7 24.6 21.3 12.2 4.9 24.5 34.2 14.9 27.3 17.2 19.7 16.1 17.5 23.8 16.6 22.9 18.0 30.4 33.4 11.2 17.5 36.7 28.1 24.9 28.0 26.9 13.0 15.3 15.8 10.1 14.6 8.6 9.6 18.1 15.7 12.3 17.2 12.5 17.7 16.8 11.8 7.3 16.0 17.9 7.5 17.3 9.5 6.4 14.0 11.8 35.0 39.3 29.0 41.3 39.8 32.4 27.5 26.5 39.7 28.5 23.7 29.5 35.6 17.8 6.4 9.6 9.8 12.0 4.0 6.8 7.8 8.6 21.9 7.8 6.5 5.1 14.3 18.0 9.2 33.3 19.8 9.4 12.5 1.9 11.4 17.2 17.1 9.0 11.2 17.4 9.9 28.3 11.8 10.8 10.9 19.4 13.9 18.3 16.4 8.6 9.5 8.5 28.6 17.2 18.7 18.3 3.2 4.3 16.3 12.2 5.7 5.4 10.3 11.0 16.6 21.6 13.0 9.9 11.0 12.5 15.8 17.2 7.0 13.2 11.2 22.7 28.6 13.1 15.9 11.7 19.5 13.0 6.2 3.4 16.3 15.0 15.4 10.5 6.4 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777297-17014414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 3.7;MAIT T-cell: 2.0" "Group enriched" "Detected in many" 6 "granulocytes: 3.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 10.3 1.7 13.8 5.6 11.3 0.6 13.4 10.6 6.0 11.3 22.2 18.4 27.6 4.2 3.9 46.3 9.2 7.3 24.2 6.7 12.7 26.6 16.9 8.0 2.3 9.4 15.2 4.0 12.8 15.4 17.7 4.2 9.1 11.3 7.0 17.1 27.6 21.7 5.3 2.3 14.3 25.6 3.7 7.6 1.8 23.9 10.2 22.2 4.0 11.0 2.2 6.6 14.1 18.4 10.3 14.2 12.7 11.9 5.5 0.7 0.0 20.7 0.1 0.4 4.9 9.0 22.6 116.4 0.2 5.4 1.9 0.7 75.2 16.9 0.2 3.5 4.2 16.2 39.7 11.2 13.5 0.3 0.1 0.5 0.6 6.4 0.0 0.4 10.7 0.0 14.3 1.7 0.4 2.0 8.7 8.8 0.3 6.1 58.6 12.4 11.5 0.0 3.0 10.9 109.9 8.3 0.9 16.7 44.3 0.6 22.3 11.3 4.1 3.3 0.2 4.1 3.2 2.8 7.6 2.4 16.2 0.1 0.8 0.1 0.1 0.1 3.7 0.3 0.0 2.0 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.4 0.0 0.2 13.8 11.3 10.6 6.0 6.7 12.7 9.4 15.2 4.0 11.3 7.6 22.2 10.3 8.2 3.2 17.0 111.0 0.6 0.6 1.1 1.4 0.6 2.3 6.9 6.1 8.7 7.2 8.6 11.0 25.0 6.7 0.2 12.0 3.9 6.1 16.3 20.5 2.3 4.7 0.0 1.3 19.3 6.0 0.9 1.0 40.8 22.9 2.5 16.1 2.2 2.9 1.8 0.0 26.2 6.5 0.0 1.0 1.4 6.1 0.6 2.7 0.0 48.7 0.8 4.3 1.0 15.6 37.9 10.7 4.1 0.4 1.8 0.8 9.2 10.6 8.0 9.7 0.0 1.0 1.2 0.5 0.5 12.3 0.4 6.0 1.2 2.1 3.1 6.4 ZNF606 "FLJ14260, KIAA1852, ZNF328" ENSG00000166704 "Zinc finger protein 606" Q8WXB4 19 57977053-58003349 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041712, HPA043584" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041712: AB_10960410, HPA043584: AB_2678565" "unprognostic (1.05e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (6.21e-2)" "unprognostic (1.10e-1)" "unprognostic (6.83e-2)" "unprognostic (3.48e-3)" "unprognostic (4.26e-2)" "unprognostic (1.29e-3)" "unprognostic (4.09e-2)" "unprognostic (1.03e-1)" "unprognostic (5.00e-2)" "unprognostic (3.21e-2)" "unprognostic (4.01e-2)" "prognostic favorable (4.75e-6)" 3.9 5.4 7.6 5.1 9.2 4.0 8.1 10.3 8.0 7.5 10.7 5.8 5.7 8.1 9.0 5.0 10.1 3.5 5.4 7.3 9.6 7.0 5.7 5.4 8.1 8.9 8.5 7.3 10.5 6.4 9.4 11.4 4.3 9.1 9.0 4.6 10.1 8.0 6.1 3.9 7.2 8.4 3.5 8.7 9.1 6.7 7.7 8.2 8.6 13.4 2.9 6.7 6.3 6.0 12.5 1.7 3.1 13.1 10.9 3.9 5.4 9.4 4.0 1.4 3.9 2.4 4.1 4.7 2.7 3.1 2.7 4.2 4.0 1.7 3.9 5.2 0.0 23.5 6.6 1.3 3.7 3.0 0.0 5.1 6.4 1.9 3.4 1.9 6.1 2.8 7.7 3.4 0.1 5.0 1.6 9.0 1.5 7.9 2.1 5.8 9.9 4.8 4.0 4.2 8.2 12.1 8.0 7.2 0.2 3.0 6.3 6.3 6.3 3.3 3.1 4.4 1.1 1.3 7.8 9.1 1.9 0.2 0.7 4.1 10.2 2.3 6.5 2.2 2.0 3.2 6.5 3.6 2.7 2.1 7.4 6.4 3.7 6.2 5.5 2.3 6.5 2.6 1.8 7.6 9.2 10.3 8.0 7.3 9.6 8.9 8.5 7.3 9.1 8.7 8.2 12.5 4.3 6.4 7.8 9.1 9.6 1.0 3.5 2.5 5.2 15.4 3.5 2.9 10.8 2.8 5.6 12.9 25.0 3.2 6.2 1.7 3.9 4.0 2.8 8.6 4.6 5.9 0.0 9.0 8.4 1.6 1.1 3.9 6.1 2.2 5.1 14.4 5.3 2.6 2.0 11.8 9.8 2.4 4.1 0.8 3.0 1.2 8.1 2.5 0.0 7.5 2.2 8.6 10.3 10.1 12.9 2.2 2.4 3.4 3.0 4.1 4.2 2.2 22.6 29.2 6.6 2.9 4.6 12.3 12.7 3.1 2.0 3.4 4.4 6.8 2.2 3.2 ZCCHC18 "PNMA7B, SIZN2" ENSG00000166707 "Zinc finger CCHC-type containing 18" P0CG32 X 104112131-104115842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;ovary: 4.2" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 4.2;NK-cells: 9.2;Oligodendrocyte precursor cells: 6.6;Sertoli cells: 6.6" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.5;Karpas-707: 4.6;SH-SY5Y: 3.1" "Low region specificity" "Detected in all" "HPA034940, HPA078516" Uncertain Approved Vesicles NA NA Vesicles "HPA034940: AB_10671098, HPA078516: " "unprognostic (7.20e-2)" "unprognostic (7.71e-4)" "unprognostic (8.29e-2)" "unprognostic (4.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-3)" "unprognostic (2.20e-2)" "unprognostic (3.22e-2)" "unprognostic (7.59e-2)" "unprognostic (3.34e-1)" "unprognostic (4.44e-6)" "unprognostic (4.05e-2)" "unprognostic (1.02e-6)" "unprognostic (3.82e-2)" "unprognostic (4.02e-1)" "unprognostic (3.91e-2)" "unprognostic (4.14e-3)" 0.4 0.8 2.8 1.3 2.8 0.4 0.3 2.8 3.1 1.6 0.9 0.6 0.3 1.5 0.2 0.3 1.3 0.4 0.5 2.4 4.1 0.3 0.1 0.4 2.0 2.2 2.2 2.4 4.2 0.9 0.0 1.6 0.1 2.0 0.8 0.3 1.2 0.2 0.6 0.1 0.1 2.0 0.6 2.0 2.2 0.5 1.0 3.8 0.4 0.3 0.1 2.0 0.6 0.7 2.0 0.0 0.1 1.9 1.3 0.1 0.0 0.1 0.4 0.0 0.3 0.3 0.1 0.0 2.5 0.0 0.1 0.4 0.0 1.1 0.0 0.1 0.7 0.9 0.4 0.1 0.0 0.2 1.4 0.4 0.1 0.0 0.2 0.0 1.1 0.3 0.1 0.0 4.6 0.1 0.0 0.0 0.0 1.0 0.0 0.3 1.7 0.4 0.0 0.2 0.2 1.3 3.1 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.5 0.1 0.6 0.1 0.0 1.2 0.0 1.4 0.4 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.3 0.5 0.0 0.8 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.1 2.8 2.8 2.8 3.1 2.4 4.1 2.2 2.2 2.4 2.0 2.0 3.8 2.0 0.9 0.0 0.6 3.3 4.0 0.1 0.2 0.0 0.0 0.8 0.3 0.3 0.7 0.0 1.3 1.8 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.6 0.9 1.2 4.2 0.8 2.6 0.2 0.0 1.2 0.0 0.3 0.0 1.3 0.7 0.0 0.0 1.7 1.5 0.0 0.0 0.3 0.4 0.3 1.5 0.1 1.8 0.0 0.1 3.4 9.2 6.6 0.3 0.0 0.0 1.2 1.7 0.1 0.0 0.2 1.5 1.0 6.6 0.2 2.4 0.0 0.2 0.1 0.0 0.0 3.6 1.0 0.0 0.1 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711487-44718851 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Immunity "Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 31919.3;NK-cells: 24726.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1790000000 2100000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 3188.5 3245.3 727.6 5738.1 803.6 7911.2 2633.3 756.0 1154.7 2561.3 902.7 5187.3 5227.7 2212.9 1750.8 2304.6 1662.7 4992.6 2348.1 692.8 940.8 2485.0 6257.6 6212.8 9388.5 876.8 757.5 656.9 1962.9 1322.1 1957.9 320.9 3531.2 845.8 2365.8 5647.9 140.5 5708.2 1801.2 940.5 3039.7 5740.6 2567.8 879.8 7964.4 4922.2 620.9 819.3 4256.9 2362.8 2044.5 5377.7 5806.0 554.1 900.9 1735.4 378.9 226.0 633.6 4348.7 4719.4 1662.5 2045.5 4961.9 3609.7 6561.4 425.3 5417.9 554.8 2567.9 1948.8 2410.2 2537.0 497.2 878.7 1226.2 4762.2 435.9 2956.9 2263.6 600.3 3609.3 2074.5 3328.6 2735.9 609.8 1075.7 1044.4 2442.6 1884.1 965.4 611.9 3649.1 2195.5 476.9 1518.4 3213.8 206.5 629.8 1014.3 2240.2 1926.6 4789.2 2425.5 3486.4 254.1 179.1 1288.4 1571.2 1338.5 394.3 655.3 6180.6 2548.7 4531.4 676.5 5389.2 2193.3 4771.7 7118.6 1683.1 5384.6 3783.6 2567.3 48105.4 18117.1 33178.9 20639.1 17775.0 20836.8 15768.0 23783.0 22245.1 9978.8 11988.4 17122.9 22791.8 50453.6 18779.6 19034.9 12052.6 29659.1 56957.2 727.6 803.6 756.0 1154.7 692.8 940.8 876.8 757.5 656.9 845.8 879.8 819.3 900.9 12048.3 3387.8 3505.1 28.7 8472.8 7843.7 3197.1 8420.8 1628.8 33.3 2399.5 2015.2 1068.8 3593.1 5347.4 2100.3 27.1 1354.6 14028.8 8753.6 1038.9 13898.6 43.1 2073.7 2414.0 8385.6 2266.0 2087.2 7.3 9034.5 4397.5 3691.1 1981.7 2282.2 3029.5 1270.6 6835.7 3832.6 11985.7 5.0 22.0 5982.6 8701.4 12536.8 14507.0 158.8 3018.0 10687.9 6744.8 368.2 31919.3 322.0 24726.3 95.0 129.2 10115.7 7085.6 1688.8 11026.6 5300.4 18327.7 3122.5 8367.9 52.5 4016.7 2055.2 4107.1 64.2 72.1 1541.4 8619.8 804.8 14266.2 3229.8 3063.4 8248.6 ZNF592 "CAMOS, KIAA0211, SCAR5" ENSG00000166716 "Zinc finger protein 592" Q92610 15 84748592-84806445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020332, HPA021600" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020332: AB_1859365, HPA021600: AB_1859364" "unprognostic (2.83e-1)" "unprognostic (1.90e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (7.63e-2)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (5.04e-1)" "unprognostic (7.98e-2)" "unprognostic (2.84e-1)" "unprognostic (4.80e-3)" "unprognostic (3.64e-1)" "unprognostic (6.62e-2)" "unprognostic (3.90e-1)" "unprognostic (2.62e-1)" 9.1 8.8 9.3 6.7 9.7 11.2 9.7 10.2 9.4 9.6 7.5 9.3 8.0 9.2 7.9 7.5 9.9 4.9 9.6 9.7 8.5 8.7 11.0 9.1 9.6 11.4 10.0 8.0 11.9 11.0 9.2 8.0 6.0 9.9 8.8 7.1 7.6 7.6 6.5 18.4 10.1 10.7 6.8 9.1 11.3 8.2 8.1 9.7 11.5 8.9 14.6 9.4 8.5 8.3 10.5 7.7 12.8 11.6 6.5 12.7 8.5 12.8 5.3 7.5 8.6 6.8 12.2 8.9 11.1 6.7 11.9 7.4 13.9 18.0 7.6 6.0 9.0 10.8 12.9 12.9 11.0 7.8 10.6 9.9 9.4 10.6 6.7 11.0 10.2 7.6 7.7 13.0 6.8 9.1 12.0 7.2 13.0 10.6 7.3 5.0 10.3 10.4 9.8 9.2 15.4 10.5 11.4 12.1 10.7 9.0 16.1 6.0 22.3 10.8 12.7 7.4 7.1 10.2 7.8 9.0 11.8 8.0 15.5 7.5 0.0 1.2 0.9 1.2 1.4 0.4 1.5 0.7 1.2 1.3 1.4 1.0 0.9 2.6 1.0 1.3 1.0 0.8 0.8 9.3 9.7 10.2 9.4 9.7 8.5 11.4 10.0 8.0 9.9 9.1 9.7 10.5 9.2 9.6 10.5 23.8 15.2 8.4 4.2 8.2 6.2 9.0 14.3 8.8 5.3 8.6 7.5 3.7 8.4 5.6 9.6 18.8 0.0 8.4 7.8 24.7 10.8 9.8 7.8 12.0 21.7 8.1 8.9 8.7 13.7 40.3 3.8 10.2 10.4 16.7 11.3 3.3 20.7 10.8 4.1 21.1 9.8 11.8 4.7 14.6 7.2 28.1 14.9 3.7 11.3 10.1 29.9 9.8 11.1 9.8 16.9 5.6 16.2 6.3 8.4 8.5 6.6 13.1 9.2 13.2 12.4 8.9 7.1 4.8 11.6 8.1 11.4 5.1 GOLM2 "CASC4, DKFZp459F1927, H63" ENSG00000166734 "Golgi membrane protein 2" Q6P4E1 15 44288719-44415758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043015, HPA049488" Enhanced Enhanced "Golgi apparatus" NA NA 1200000 "Golgi apparatus" "HPA043015: AB_2678271, HPA049488: AB_2680790" "unprognostic (2.64e-2)" "unprognostic (2.63e-1)" "unprognostic (3.38e-1)" "unprognostic (1.81e-2)" "unprognostic (8.08e-2)" "unprognostic (1.35e-1)" "unprognostic (1.20e-2)" "unprognostic (2.20e-1)" "unprognostic (2.40e-1)" "unprognostic (1.68e-2)" "unprognostic (4.99e-2)" "unprognostic (2.60e-2)" "prognostic favorable (1.45e-5)" "unprognostic (2.15e-1)" "unprognostic (3.56e-2)" "unprognostic (9.65e-2)" "unprognostic (1.12e-1)" 39.8 85.3 52.6 32.7 51.0 16.7 43.6 49.2 59.8 58.4 62.4 46.1 29.0 50.9 54.0 23.9 54.3 50.9 33.4 47.8 60.1 54.5 61.4 41.3 31.0 54.7 55.3 42.8 55.8 37.8 82.6 39.0 34.7 51.5 68.1 44.2 34.0 48.2 56.6 22.5 13.3 30.0 44.8 51.0 35.7 49.8 35.0 56.1 29.2 85.4 26.5 29.7 39.6 24.5 57.9 45.0 38.7 51.9 92.6 141.4 121.8 32.0 78.6 125.2 44.9 57.1 19.3 80.0 13.5 106.4 119.3 47.8 53.8 34.4 25.5 48.2 64.6 19.5 21.4 41.8 35.9 65.1 42.5 68.1 72.1 28.3 49.8 38.4 126.8 53.4 34.2 33.0 103.4 56.2 23.2 36.7 33.2 14.8 60.8 27.5 30.5 29.3 43.3 58.8 54.4 23.3 53.2 60.7 57.0 26.6 28.1 64.1 49.2 76.4 78.1 39.8 112.5 69.5 79.0 145.1 27.9 92.6 58.5 51.7 20.9 14.7 20.8 15.2 9.8 16.3 11.9 12.4 15.2 12.0 10.7 9.5 9.9 37.8 10.5 18.2 10.6 13.2 13.6 52.6 51.0 49.2 59.8 47.8 60.1 54.7 55.3 42.8 51.5 51.0 56.1 57.9 19.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 16.3 16.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 19.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 12.7 2.9 0.0 0.0 0.0 HTR3A "5-HT3A, 5-HT3R, HTR3" ENSG00000166736 "5-hydroxytryptamine receptor 3A" P46098 11 113974881-113990313 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.0;pancreas: 2.6;salivary gland: 5.0" "Group enriched" "Detected in some" 11 "Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 15.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 15 "memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6" "Group enriched" "Detected in many" 127 "B-cells: 13.8;dendritic cells: 11.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5" HPA069442 Supported NA NA "HPA069442: AB_2732132" "unprognostic (6.46e-3)" "prognostic favorable (6.26e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.36e-3)" "unprognostic (8.36e-3)" "unprognostic (1.65e-5)" "unprognostic (1.46e-2)" "unprognostic (8.87e-2)" "unprognostic (6.21e-2)" "unprognostic (6.80e-3)" "unprognostic (3.00e-2)" "unprognostic (1.65e-2)" "unprognostic (8.72e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.40e-2)" 0.0 0.4 0.7 2.2 1.0 0.0 0.0 0.4 0.9 0.0 0.5 1.9 0.6 0.1 0.0 0.5 0.0 0.0 0.0 1.0 0.6 0.1 0.0 0.0 6.6 0.8 0.5 1.0 0.0 2.6 0.0 0.0 0.0 0.5 0.0 0.4 0.0 5.0 0.0 0.0 0.4 1.7 0.7 0.4 0.5 0.8 0.1 0.5 0.4 0.0 0.0 8.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 5.9 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 13.8 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.7 1.0 0.4 0.9 1.0 0.6 0.8 0.5 1.0 0.5 0.4 0.5 0.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.8 0.0 0.0 3.0 0.1 0.0 23.9 0.0 0.3 0.0 0.0 0.0 0.0 0.3 53.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 34.7 0.1 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313536 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 392.1" "Group enriched" "Detected in many" 6 "Hepatocytes: 3913.2;Skeletal myocytes: 1639.1" "Cancer enhanced" "Detected in all" "renal cancer: 204.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Golgi apparatus,Cytosol" NA NA 410000 "Golgi apparatus" Cytosol "HPA059180: AB_2683940" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-6)" "prognostic unfavorable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 122.4 11.5 1.1 25.4 1.0 0.9 92.7 1.4 2.3 30.0 3.0 33.7 1.5 31.2 2.8 15.5 55.4 43.5 27.5 1.3 2.5 23.6 392.1 65.2 9.7 4.0 1.8 0.9 21.5 11.5 1.6 10.7 24.0 2.8 32.2 8.8 0.3 21.3 3.1 73.7 45.6 32.4 30.4 1.8 37.0 30.4 2.2 1.2 2.8 33.3 5.3 8.8 49.0 34.2 3.1 0.2 17.6 0.3 18.6 92.0 118.3 0.1 21.2 58.7 35.2 69.2 0.0 17.5 0.2 58.1 45.1 4.2 0.2 0.0 8.0 34.1 0.2 0.0 0.2 16.7 0.0 123.3 0.2 0.0 255.3 89.4 24.1 37.3 29.8 50.1 0.1 0.3 0.2 144.1 0.1 0.1 0.2 0.1 0.0 0.5 0.2 79.0 0.0 479.6 0.1 0.2 0.2 97.7 0.1 0.3 5.3 0.0 0.2 37.4 18.3 34.3 23.8 3.1 0.3 0.3 0.4 6.4 0.3 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.1 1.0 1.4 2.3 1.3 2.5 4.0 1.8 0.9 2.8 1.8 1.2 3.1 411.8 44.8 411.3 1.0 11.2 103.6 13.2 16.5 2.2 1.9 38.5 73.9 4.7 75.8 13.3 80.9 0.0 1.0 1.6 0.0 9.8 238.3 0.3 19.0 89.9 190.0 5.3 147.2 1.3 157.0 2.5 452.2 5.1 80.5 13.9 0.5 195.2 3913.2 28.4 0.0 1.6 0.0 0.0 126.8 142.1 1.6 74.3 9.2 96.0 1.9 5.7 0.0 0.0 0.0 0.2 323.1 0.0 13.2 1.5 10.8 0.0 99.2 11.9 0.2 0.0 1639.1 154.3 0.3 0.8 1.9 92.1 2.2 20.1 0.0 0.0 3.1 ACSM1 "BUCS1, MACS1" ENSG00000166743 "Acyl-CoA synthetase medium chain family member 1" Q08AH1 16 20623237-20698890 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "breast: 227.5" "Cell type enhanced" "Detected in many" "Early spermatids: 13.2;Late spermatids: 23.2;Theca cells: 8.4" "Group enriched" "Detected in many" 8 "liver cancer: 14.7;prostate cancer: 36.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 1.3;memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "NTERA-2: 15.6" "Not detected" "Not detected" HPA046291 Uncertain NA NA "HPA046291: AB_10960704" "unprognostic (1.08e-2)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (5.49e-4)" "unprognostic (1.66e-1)" "unprognostic (3.50e-2)" "unprognostic (9.46e-2)" "unprognostic (3.10e-1)" "unprognostic (8.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.64e-1)" "unprognostic (8.24e-2)" "unprognostic (3.79e-2)" "unprognostic (3.01e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 0.3 0.5 0.3 0.0 0.3 3.6 227.5 0.4 0.4 1.7 0.2 1.0 0.5 2.1 0.4 0.4 2.2 0.4 0.4 0.3 0.3 1.1 10.8 0.5 0.3 0.4 0.3 0.2 2.6 1.6 0.9 0.1 0.0 0.5 3.8 0.6 0.1 1.8 0.6 0.3 1.3 0.7 0.8 0.3 0.5 2.2 4.4 0.4 0.4 0.5 0.2 0.2 1.0 1.4 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.1 15.6 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.5 0.0 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.2 0.5 0.3 0.4 0.4 0.1 0.0 0.0 0.3 1.0 0.6 2.6 1.2 1.2 0.0 2.5 2.4 1.0 5.7 1.4 0.0 0.0 0.2 0.2 1.6 1.9 4.2 13.2 1.4 0.2 1.5 1.2 1.3 0.8 2.3 0.1 0.7 2.0 0.8 0.0 2.8 3.6 1.3 0.2 0.0 0.7 2.9 0.0 0.3 2.8 23.2 4.4 0.6 0.0 0.0 1.7 0.0 0.0 1.0 1.3 1.2 3.7 7.2 0.0 2.5 0.6 1.4 3.7 0.0 0.0 0.1 0.2 0.8 0.2 1.1 1.6 0.1 0.3 8.4 2.5 1.4 AP1G1 "ADTG, CLAPG1" ENSG00000166747 "Adaptor related protein complex 1 subunit gamma 1" O43747 16 71729000-71809201 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 268.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009049, HPA041224" Approved Enhanced Vesicles,Cytosol NA NA 62000 Vesicles Cytosol "CAB009049: AB_2058329, HPA041224: AB_2677370" "unprognostic (4.84e-2)" "unprognostic (5.07e-2)" "unprognostic (2.65e-2)" "unprognostic (2.91e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (8.90e-2)" "unprognostic (9.16e-2)" "unprognostic (2.72e-1)" "unprognostic (2.22e-2)" "unprognostic (4.30e-2)" "prognostic favorable (2.96e-8)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-1)" 18.3 26.0 14.3 23.6 16.8 77.4 25.0 20.1 21.0 20.5 24.4 23.8 22.8 18.0 25.8 26.9 18.2 19.0 13.7 17.3 15.6 36.7 33.5 21.6 24.8 15.3 15.3 16.7 15.5 24.4 40.7 16.9 17.7 16.0 22.7 25.9 53.2 22.8 16.4 28.4 26.8 23.8 16.2 13.6 22.6 29.6 31.0 15.9 25.1 24.2 36.9 30.7 20.8 18.6 24.6 43.9 62.4 46.3 48.1 48.2 45.4 41.0 44.6 42.1 56.8 54.5 64.3 47.1 55.0 41.9 60.4 41.5 55.4 62.7 49.3 74.4 21.6 33.8 36.2 31.7 46.5 28.9 44.7 114.1 39.1 33.4 76.0 46.9 36.1 50.2 35.8 47.8 23.0 56.1 80.0 39.2 35.3 43.7 34.6 26.8 62.9 37.3 59.3 53.7 49.3 42.5 25.5 55.7 34.8 24.5 46.6 61.0 33.7 60.2 49.4 37.9 27.3 32.9 35.1 50.2 109.2 40.3 34.4 43.3 5.7 6.9 10.0 6.7 7.6 6.8 5.4 5.9 7.5 7.5 5.7 4.6 5.8 14.9 6.7 6.4 5.2 6.6 4.2 14.3 16.8 20.1 21.0 17.3 15.6 15.3 15.3 16.7 16.0 13.6 15.9 24.6 32.6 32.1 31.1 42.4 34.2 28.8 27.4 17.3 22.8 26.8 47.6 25.4 13.4 35.8 25.2 36.8 73.0 14.4 40.6 39.3 19.6 21.1 268.8 55.8 37.9 26.0 23.4 9.9 54.2 21.8 13.3 24.0 46.4 84.8 21.0 26.2 21.4 58.5 16.7 30.3 59.0 25.7 12.2 30.4 27.2 130.7 17.7 32.4 23.2 36.5 25.1 16.4 24.7 53.8 79.2 30.5 24.2 19.9 30.6 36.9 30.5 46.4 31.7 66.6 19.7 33.0 26.4 35.8 37.1 32.4 38.6 24.5 33.4 23.0 26.4 47.8 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243071-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 261.6;Respiratory ciliated cells: 133.0;T-cells: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 24.7;MAIT T-cell: 30.6;memory CD4 T-cell: 30.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 37.5;naive CD8 T-cell: 31.2;NK-cell: 42.3;T-reg: 68.8" "Group enriched" "Detected in all" 7 "NK-cells: 42.3;T-cells: 68.8" "Cell line enhanced" "Detected in many" "HHSteC: 108.6;hTERT-HME1: 146.8" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 18.0 8.8 2.9 24.2 2.5 5.4 11.7 2.1 2.9 20.2 4.0 6.4 7.1 14.2 3.5 9.0 14.1 12.2 8.7 2.6 3.8 5.1 5.9 21.3 32.7 6.2 3.0 1.4 5.6 3.7 6.8 1.5 14.2 4.8 10.4 7.8 2.3 18.1 15.9 20.8 5.1 8.1 11.6 4.9 26.0 10.0 2.0 3.1 41.3 11.6 10.2 28.4 20.1 5.2 8.0 21.3 10.7 1.7 1.8 30.2 52.2 4.2 54.3 85.4 44.5 49.2 0.2 13.5 2.7 34.1 54.0 11.8 87.1 1.0 24.5 30.9 0.7 1.9 0.4 11.6 1.3 108.6 1.6 0.6 59.9 60.5 34.0 146.8 26.8 20.6 22.0 0.2 31.1 31.4 1.7 26.9 1.3 1.7 4.7 8.0 0.0 17.9 0.2 11.6 51.8 3.6 0.0 6.0 5.6 93.7 6.0 35.9 0.8 81.2 17.6 6.8 12.9 12.5 6.0 0.6 0.4 51.9 0.3 26.0 6.3 4.3 2.9 24.7 6.4 30.6 0.9 30.7 28.9 3.6 1.6 37.5 31.2 1.8 42.3 7.8 1.2 68.8 18.2 2.9 2.5 2.1 2.9 2.6 3.8 6.2 3.0 1.4 4.8 4.9 3.1 8.0 126.9 60.9 71.7 1.6 8.4 4.6 27.1 97.8 8.0 1.6 16.5 15.9 10.1 28.6 92.3 18.4 0.0 0.3 75.6 1.8 1.9 71.7 1.9 95.0 23.2 90.4 1.2 3.6 4.1 38.8 5.3 30.3 18.8 56.0 61.3 1.4 79.2 4.7 13.2 6.7 3.6 4.6 46.8 26.5 14.4 0.4 7.5 22.6 12.4 12.2 49.1 6.7 261.6 3.0 10.1 70.0 3.8 1.5 17.6 122.5 1.7 1.9 133.0 4.2 13.1 34.9 29.8 0.5 1.9 10.2 4.0 0.3 128.6 5.4 1.0 74.2 CATSPER2 ENSG00000166762 "Cation channel sperm associated 2" Q96P56 15 43628503-43668118 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;retina: 23.0;testis: 15.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 254.4;Early spermatids: 73.6;Rod photoreceptor cells: 221.8;Spermatocytes: 117.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 14.1" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.88e-3)" "unprognostic (6.79e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.05e-1)" "unprognostic (1.05e-2)" "unprognostic (7.11e-3)" "unprognostic (1.48e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.37e-2)" "unprognostic (3.74e-3)" "unprognostic (1.15e-1)" "unprognostic (6.04e-2)" "unprognostic (8.87e-2)" "unprognostic (8.23e-5)" 1.2 1.4 2.4 0.8 2.3 4.3 1.8 14.1 3.9 1.2 0.2 2.3 3.3 1.4 5.5 2.5 1.4 0.7 0.9 2.5 1.3 1.2 1.5 1.3 2.0 1.9 1.5 2.8 1.6 1.2 4.1 3.2 0.8 6.8 1.6 2.3 23.0 1.6 2.2 1.2 5.5 3.8 0.6 0.2 1.5 1.8 15.6 1.3 0.9 1.9 1.5 1.5 1.8 1.3 3.6 2.0 2.8 1.2 4.4 0.0 0.0 2.0 0.7 1.7 1.2 2.9 0.7 1.1 2.4 1.0 0.5 1.4 4.4 1.1 3.9 1.2 2.0 5.4 7.0 11.2 1.0 1.8 1.6 2.2 0.2 3.0 1.7 4.3 3.2 1.5 4.3 2.8 2.4 0.4 0.5 1.3 2.8 0.4 2.7 1.2 1.9 1.4 1.1 2.4 3.2 2.6 0.9 1.1 1.6 0.1 1.6 3.2 1.5 0.4 3.0 1.3 0.0 1.8 0.4 0.3 5.1 2.1 4.9 1.1 0.1 0.3 0.1 0.3 0.1 0.4 1.1 0.2 0.4 0.2 0.3 0.3 0.7 0.5 0.5 0.3 0.4 0.1 0.0 2.4 2.3 14.1 3.9 2.5 1.3 1.9 1.5 2.8 6.8 0.2 1.3 3.6 4.8 0.0 4.5 0.0 4.9 7.0 8.2 8.3 1.8 56.7 6.9 6.9 4.2 5.7 8.0 7.3 254.4 6.0 6.0 3.9 3.9 3.2 73.6 5.2 2.5 6.0 21.5 2.7 0.0 2.7 2.1 3.2 6.1 4.2 9.5 29.7 8.6 3.9 4.3 38.7 0.0 4.6 4.1 5.0 6.5 37.4 6.2 4.5 1.8 0.0 4.5 13.4 7.2 0.0 0.0 2.0 3.3 7.2 1.1 6.7 11.1 4.1 10.8 221.8 0.0 9.3 5.1 117.4 17.1 2.7 8.0 3.0 4.6 5.8 8.5 8.4 BMERB1 "C16orf45, FLJ32618" ENSG00000166780 "BMERB domain containing 1" Q96MC5 16 15434475-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 135.6" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 57.0" "Cancer enhanced" "Detected in all" "glioma: 30.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 8.7" "Lineage enriched" "Detected in many" 4 "T-cells: 8.7" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 101.8;U-2197: 81.3;U-87 MG: 124.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favorable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 29.7 15.6 94.4 10.6 104.0 1.1 21.7 72.0 115.5 46.0 53.5 36.4 8.4 40.9 19.9 21.6 38.8 24.1 47.4 112.3 90.1 22.5 22.0 13.5 6.5 124.8 91.2 93.0 41.3 18.8 3.9 41.1 1.4 128.3 32.7 9.4 41.0 12.7 27.9 87.6 11.8 19.2 35.9 68.4 9.3 21.8 40.6 88.0 4.0 13.6 41.7 4.0 44.7 25.5 135.6 1.4 31.5 12.8 1.5 56.7 50.7 0.3 18.1 62.6 15.5 8.4 0.0 0.9 0.1 4.0 101.8 37.5 0.2 4.1 5.3 7.9 0.4 0.7 6.7 11.9 1.5 19.4 0.1 13.6 24.5 5.2 33.8 0.5 25.8 25.2 14.5 0.4 0.5 24.2 21.6 5.1 0.9 17.2 0.4 10.7 1.0 16.3 0.1 8.8 4.6 26.2 27.6 0.9 8.3 5.5 2.1 0.4 0.4 8.9 34.2 17.6 81.3 9.4 5.7 12.5 0.2 124.3 0.2 7.1 0.1 0.1 0.1 8.7 0.0 1.7 2.1 2.0 5.2 0.5 1.3 1.5 2.8 0.6 0.2 0.1 0.2 2.6 1.1 94.4 104.0 72.0 115.5 112.3 90.1 124.8 91.2 93.0 128.3 68.4 88.0 135.6 7.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 MARF1 "KIAA0430, LKAP, LMKB, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594387-15643154 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 9.8 7.1 2.3 10.9 4.6 9.8 9.5 1.1 6.3 10.1 2.5 13.5 10.5 12.9 1.1 12.4 13.8 12.6 9.3 3.5 2.5 13.7 8.4 9.4 14.7 2.8 4.2 0.4 18.4 13.0 12.4 6.0 9.5 2.8 10.5 12.2 8.5 14.5 13.8 18.5 10.1 11.3 12.1 0.1 12.2 10.2 4.9 2.0 12.8 14.9 15.3 22.2 12.2 8.9 3.2 8.3 9.4 15.0 8.2 12.1 22.4 7.2 9.6 12.4 8.2 13.5 2.7 6.2 29.8 17.0 12.3 6.7 5.6 7.7 12.4 13.6 11.6 5.0 13.1 12.3 10.4 13.4 15.7 10.5 13.4 13.4 15.3 15.5 16.9 19.5 12.8 12.6 13.3 15.6 7.7 13.9 2.6 5.6 7.1 7.2 19.5 22.0 5.9 7.1 6.4 9.1 10.8 7.7 8.9 14.3 6.7 9.2 13.2 19.7 11.2 5.5 11.6 6.3 12.3 12.9 15.9 12.4 9.6 16.4 2.5 0.7 4.6 1.1 1.2 0.7 4.1 1.7 1.3 0.8 5.2 1.9 1.4 7.1 0.9 1.8 0.3 1.7 0.9 2.3 4.6 1.1 6.3 3.5 2.5 2.8 4.2 0.4 2.8 0.1 2.0 3.2 21.4 22.4 28.7 0.0 10.7 0.0 0.0 0.0 0.0 0.0 26.3 19.8 0.0 0.0 18.6 23.9 0.0 5.7 14.7 0.0 15.6 10.4 0.0 17.8 27.5 8.4 0.0 0.0 0.0 14.2 5.9 7.7 0.0 20.0 11.4 23.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 13.7 0.0 0.0 6.8 0.0 0.0 19.0 17.5 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 7.7 7.8 17.9 0.0 0.0 SAAL1 FLJ41463 ENSG00000166788 "Serum amyloid A like 1" Q96ER3 11 18069935-18106087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039003, HPA039004" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039003: AB_2676303, HPA039004: AB_10673602" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (4.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (5.76e-2)" "unprognostic (4.10e-3)" "unprognostic (1.53e-2)" "unprognostic (4.75e-2)" "unprognostic (7.26e-2)" "unprognostic (3.36e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.78e-5)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (3.72e-1)" "unprognostic (1.87e-1)" 5.8 5.4 4.8 8.3 5.3 19.3 10.1 6.0 6.1 6.1 4.7 9.7 8.0 7.6 7.8 6.6 5.6 4.8 6.5 5.0 5.5 5.5 8.4 5.0 14.7 5.4 5.4 5.1 8.3 8.2 5.4 5.3 7.0 5.4 6.1 12.0 8.2 5.7 5.9 5.8 5.7 6.8 9.7 5.2 7.5 6.7 12.9 5.4 13.8 6.1 7.3 15.7 7.9 6.1 5.9 27.1 41.5 29.5 40.5 19.5 21.8 24.6 29.9 20.4 44.8 52.8 57.8 10.1 73.0 15.5 16.9 62.3 34.9 56.9 48.5 62.6 32.5 57.4 33.6 24.9 35.0 15.9 57.1 28.6 15.2 22.2 28.7 42.9 16.8 38.5 62.8 50.5 23.9 37.2 36.2 66.7 54.2 38.5 41.7 39.0 65.7 51.8 25.4 25.7 31.4 36.4 34.3 26.9 28.4 36.4 37.1 18.2 25.9 15.8 51.0 35.0 29.4 43.2 11.6 37.7 80.6 21.2 45.2 47.5 11.1 12.9 4.3 14.0 15.4 13.5 16.5 16.2 12.3 22.3 11.7 12.3 13.3 0.6 10.4 14.6 11.4 20.9 10.8 4.8 5.3 6.0 6.1 5.0 5.5 5.4 5.4 5.1 5.4 5.2 5.4 5.9 7.6 0.0 10.8 7.5 15.9 4.6 7.8 16.0 9.6 9.0 7.2 6.9 8.5 2.8 7.4 1.8 2.1 22.0 13.6 6.3 5.9 9.6 21.9 4.4 8.0 8.7 28.1 11.1 8.5 10.2 23.1 8.0 4.6 4.2 14.0 15.3 5.7 4.6 16.1 0.0 9.5 10.7 8.2 10.9 7.3 3.5 8.1 7.7 5.4 6.5 10.7 6.5 4.1 15.1 11.7 6.6 7.5 7.9 17.3 3.8 6.9 7.7 6.0 8.5 6.6 6.1 10.5 41.5 24.9 8.3 5.4 10.4 9.9 10.1 15.1 6.1 YPEL4 FLJ30213 ENSG00000166793 "Yippee like 4" Q96NS1 11 57645087-57649944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 34.0;Early spermatids: 29.7;Erythroid cells: 92.4;Langerhans cells: 15.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;ASC diff: 2.1;SK-MEL-30: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045621 Uncertain NA NA "HPA045621: " "unprognostic (6.91e-3)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (8.62e-3)" "unprognostic (2.40e-1)" "unprognostic (7.50e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" "unprognostic (4.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.18e-1)" "unprognostic (1.34e-6)" "unprognostic (1.50e-4)" "unprognostic (9.56e-2)" "unprognostic (1.86e-3)" "unprognostic (2.92e-1)" 1.6 3.3 9.9 0.3 14.5 7.3 1.9 13.2 23.5 4.4 1.6 1.6 0.4 3.6 0.2 0.6 2.0 1.2 0.8 13.0 11.4 0.4 0.5 1.6 0.2 13.3 9.0 13.5 5.4 0.4 0.1 5.5 0.7 15.0 0.8 0.2 3.2 0.7 0.4 0.4 0.9 1.1 1.3 5.4 1.2 0.8 2.4 10.8 0.3 0.8 0.8 0.1 0.8 2.9 18.6 0.2 0.1 3.2 0.2 2.1 1.9 0.4 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.9 0.1 0.3 0.0 1.8 0.0 0.7 0.0 0.2 0.1 0.0 0.7 0.3 1.2 0.0 0.1 1.3 0.3 0.2 0.0 0.0 0.0 0.8 0.1 0.1 4.4 1.8 0.3 0.0 0.0 0.1 0.7 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 14.5 13.2 23.5 13.0 11.4 13.3 9.0 13.5 15.0 5.4 10.8 18.6 0.7 0.0 0.0 1.0 0.9 1.1 0.8 0.1 0.6 34.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 29.7 0.6 1.7 1.2 0.0 92.4 13.4 0.0 0.6 4.3 0.5 0.6 3.8 0.1 0.4 0.1 1.0 8.4 15.0 0.0 0.0 1.3 15.7 12.8 1.2 3.3 5.4 1.0 0.1 1.0 0.0 5.5 12.3 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 2.8 0.0 4.4 2.6 0.3 0.1 0.4 1.3 3.3 2.5 0.1 0.0 0.1 PPIB "B, CYP-S1, CYPB, OI9, PPIase, SCYLP" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155740-64163134 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Isomerase, Rotamase" "Disease variant, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" No No 33000000 "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 355.0 380.6 228.0 453.5 235.6 576.8 365.6 246.7 261.2 616.6 261.1 404.8 368.3 387.6 906.9 301.2 404.9 382.6 224.2 226.3 279.4 313.0 743.5 354.2 347.4 256.4 239.3 220.4 389.4 649.6 348.3 420.1 519.5 250.5 379.1 415.3 73.0 517.5 493.2 62.7 202.3 337.0 486.6 245.9 363.4 378.4 111.0 245.0 318.5 678.8 91.9 349.3 515.7 298.1 259.1 675.6 847.9 736.7 1666.7 2577.0 1492.3 641.9 1570.3 2108.3 1248.7 1472.3 1242.6 1223.1 653.6 1227.4 2513.0 1235.3 1067.7 1384.6 1080.4 641.1 406.2 491.0 914.5 915.3 1643.7 2682.9 915.0 778.1 1374.2 1149.4 725.9 1751.3 1516.7 1539.2 301.1 645.9 2174.7 966.0 1102.6 280.6 1404.9 625.1 1879.0 529.5 520.6 784.1 3347.9 1312.7 1062.6 410.5 647.7 726.0 1224.5 1194.2 1086.0 727.6 2767.0 927.6 1213.7 975.8 679.2 1079.4 1152.5 1269.5 693.4 1129.0 1478.0 1238.2 716.7 712.5 491.7 929.6 547.3 931.8 827.8 645.0 762.4 930.9 541.4 411.3 558.0 347.5 668.1 369.3 2643.5 569.3 1512.3 228.0 235.6 246.7 261.2 226.3 279.4 256.4 239.3 220.4 250.5 245.9 245.0 259.1 389.3 125.0 209.0 16.6 375.3 160.2 426.2 614.6 234.5 34.5 264.3 303.8 0.8 270.2 328.7 272.2 31.3 625.9 560.0 271.0 90.1 665.1 19.0 295.8 910.1 285.0 297.0 172.6 10.2 566.4 1473.7 627.8 441.4 494.2 181.2 540.4 322.7 473.2 630.1 45.4 15.8 603.9 205.4 216.9 333.4 29.5 456.3 316.6 281.1 19.7 299.1 149.1 368.7 35.2 37.0 435.1 338.9 393.1 2242.6 569.3 338.6 287.4 168.2 43.7 230.1 204.3 445.6 38.4 76.6 337.0 144.8 1118.9 352.3 674.0 477.2 422.3 LDHC CT32 ENSG00000166796 "Lactate dehydrogenase C" P07864 11 18412318-18452063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 177 "testis: 267.6" "Group enriched" "Detected in many" 7 "Early spermatids: 1441.7;Spermatocytes: 1584.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-BR-3: 2.1;U-2197: 5.1;U-266/70: 4.5;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA045442 Enhanced NA NA "HPA045442: AB_10966720" "unprognostic (2.32e-2)" "unprognostic (3.42e-3)" "unprognostic (1.87e-1)" "unprognostic (2.83e-2)" "unprognostic (2.19e-1)" "unprognostic (8.56e-4)" "unprognostic (1.35e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-2)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (4.25e-1)" "unprognostic (1.93e-1)" 0.1 0.2 0.6 0.0 0.6 0.4 0.4 1.2 1.0 0.1 0.4 0.4 0.3 0.0 0.6 0.3 0.6 0.0 0.3 0.7 0.3 0.6 1.5 0.2 0.4 0.4 0.4 0.7 0.4 1.4 0.0 0.2 0.1 0.7 0.3 0.0 0.6 0.5 0.0 0.7 0.4 0.7 0.1 0.2 0.1 0.1 267.6 0.6 0.3 0.6 0.2 0.7 0.2 0.0 0.5 0.0 0.0 0.1 1.2 0.9 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 2.1 0.3 0.0 0.1 0.0 0.5 0.2 1.6 5.1 0.0 4.5 4.2 0.2 0.1 0.0 0.0 0.6 0.2 0.3 0.1 0.3 0.6 0.2 0.5 0.6 0.0 0.7 1.0 0.7 1.1 0.0 0.3 0.9 0.6 0.3 0.6 0.6 1.2 1.0 0.7 0.3 0.4 0.4 0.7 0.7 0.2 0.6 0.5 1.9 0.0 0.0 1.3 1.3 0.1 0.8 0.4 1.2 0.1 2.5 3.2 0.9 0.0 1.0 1.8 0.0 0.0 0.1 0.4 3.9 1.6 1441.7 3.7 0.8 2.0 0.0 0.4 1.0 6.3 0.1 1.3 0.5 1.9 0.0 0.3 0.4 0.2 0.2 0.0 0.9 0.2 0.0 0.0 0.4 209.5 23.3 2.7 0.0 1.9 0.0 1.5 0.0 1.0 2.0 2.0 0.0 18.0 0.9 0.3 0.0 3.5 1.2 0.6 19.7 1.2 1.2 1584.7 30.7 1.0 0.6 0.0 1.4 0.1 0.0 0.3 CIAO2A "CIA2A, FAM96A, FLJ22875" ENSG00000166797 "Cytosolic iron-sulfur assembly component 2A" Q9H5X1 15 64072565-64093857 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 264.5" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: AB_2685105" "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 28.1 69.2 22.6 54.1 25.2 71.4 49.0 25.3 26.9 31.8 37.1 83.5 108.9 22.8 41.4 30.3 32.3 43.4 78.7 21.6 26.3 82.0 264.5 43.8 106.1 25.7 23.6 20.4 20.8 60.3 76.1 24.8 66.1 25.8 39.4 69.1 25.0 44.3 27.1 126.7 19.6 87.5 24.1 25.9 53.3 69.4 20.8 25.0 60.8 80.9 98.3 67.4 46.7 20.5 30.1 114.6 168.6 104.3 71.7 91.7 110.7 61.2 92.7 105.4 120.2 133.5 157.7 172.9 186.9 157.4 56.2 155.7 118.3 197.9 90.2 95.4 171.3 124.2 156.2 137.7 161.2 70.7 240.5 123.1 90.8 87.2 76.7 67.6 84.5 130.1 118.5 222.3 148.8 89.5 197.8 100.1 202.8 144.6 148.9 96.3 154.5 139.8 410.4 154.3 127.0 112.2 87.5 76.8 150.9 180.6 113.9 120.6 243.6 83.0 98.2 129.4 104.7 193.6 144.4 353.8 186.4 109.5 429.3 96.9 122.4 255.8 117.0 67.3 254.1 83.0 346.0 94.8 88.1 231.6 345.5 75.5 74.4 132.0 86.9 228.3 386.5 146.1 269.0 22.6 25.2 25.3 26.9 21.6 26.3 25.7 23.6 20.4 25.8 25.9 25.0 30.1 10.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 116.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 100.6 13.2 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 88.8 2.0 0.0 0.0 0.0 LDHAL6A "LDH6A, MGC23940" ENSG00000166800 "Lactate dehydrogenase A like 6A" Q6ZMR3 11 18455824-18479601 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 9.9" "Cell type enhanced" "Detected in some" "Early spermatids: 13.3;Excitatory neurons: 3.5;Late spermatids: 7.4;Spermatocytes: 19.3;Spermatogonia: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HL-60: 11.0" NA NA "unprognostic (1.41e-1)" "unprognostic (4.84e-2)" "unprognostic (8.95e-2)" "unprognostic (5.35e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (7.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.23e-1)" "unprognostic (1.60e-1)" "unprognostic (2.35e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" 0.1 0.5 0.1 0.3 0.2 1.0 0.1 1.5 0.4 0.0 0.0 0.1 0.6 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.2 0.6 0.1 0.1 1.1 0.2 0.2 0.1 1.0 0.5 0.0 0.0 0.3 0.3 9.9 0.1 0.1 0.5 0.0 0.2 0.0 0.0 0.5 0.1 0.3 0.7 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.1 0.3 0.0 0.2 0.3 0.5 0.5 0.4 0.7 0.3 0.0 11.0 0.5 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.3 0.7 0.0 0.2 0.3 0.8 0.2 0.1 0.4 0.5 0.3 0.2 0.1 0.7 0.3 0.3 0.3 0.2 0.1 0.3 0.2 1.5 0.5 0.4 0.1 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.2 0.6 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.2 0.7 0.3 0.1 0.0 0.3 0.1 0.1 0.2 1.5 0.4 0.2 0.1 0.1 0.0 0.1 0.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 13.3 0.1 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 7.4 0.9 0.1 0.0 0.0 0.0 0.9 1.0 1.5 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.2 0.0 19.3 3.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" "DNA-binding, Hydrolase, Protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 14.6 19.0 7.0 23.3 7.1 20.4 16.1 7.3 9.7 20.6 12.8 15.8 22.7 13.9 17.5 12.9 16.6 18.9 10.8 6.6 9.4 20.1 18.0 25.4 36.4 8.7 7.6 5.7 14.7 15.2 17.0 14.4 19.6 8.1 33.5 19.5 9.2 19.1 10.8 5.5 18.9 27.8 11.0 8.4 42.9 22.7 7.2 8.4 42.7 26.8 4.1 30.3 14.9 17.6 9.1 66.0 16.2 7.9 7.5 16.9 21.4 5.1 91.6 50.8 38.5 56.3 24.9 59.0 94.3 37.1 29.7 51.2 21.9 26.9 40.4 47.4 86.0 1.2 36.3 22.7 7.6 17.8 58.7 45.7 14.5 9.6 36.2 11.1 22.0 37.7 57.2 4.8 76.7 42.2 18.0 85.6 36.9 3.5 19.5 17.5 59.9 28.7 22.8 25.4 57.6 0.2 2.3 48.6 38.5 17.5 4.1 80.1 24.7 37.0 61.9 55.5 42.5 42.7 39.0 43.4 15.3 34.3 39.5 75.9 6.0 5.0 4.8 4.2 3.4 5.3 2.6 2.7 3.2 4.6 2.6 2.4 2.5 5.4 5.0 1.9 1.2 3.1 2.2 7.0 7.1 7.3 9.7 6.6 9.4 8.7 7.6 5.7 8.1 8.4 8.4 9.1 38.9 64.1 43.7 14.4 27.4 8.5 10.7 21.3 26.2 1.7 24.2 24.3 5.5 14.3 24.7 16.5 0.0 11.1 40.5 20.8 9.8 13.8 0.2 31.5 26.0 25.9 6.0 42.5 0.2 7.7 1.4 22.7 30.5 20.7 27.8 83.9 30.0 8.1 28.2 0.0 0.2 24.8 22.4 31.3 19.5 1.8 13.1 39.2 7.2 21.5 40.2 25.2 47.4 12.1 3.9 7.5 17.6 6.8 29.7 14.2 19.4 10.3 36.9 7.3 0.0 17.0 14.3 0.4 2.1 24.3 8.8 4.4 41.3 48.8 18.6 14.0 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364304-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 129.8;lymphoid tissue: 74.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "T-reg: 23.6" "Lineage enriched" "Detected in many" 4 "T-cells: 23.6" "Low cell line specificity" "Detected in all" HPA047929 Supported Centrosome NA Yes Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.2 1.4 1.2 23.1 1.1 129.8 3.9 1.5 1.3 1.7 1.0 19.2 14.8 4.5 1.2 15.3 1.3 2.5 0.4 1.1 0.9 1.2 3.6 2.5 49.9 1.2 1.1 1.1 0.4 2.0 0.8 0.5 8.7 1.3 2.0 22.9 0.3 2.3 0.3 0.4 6.8 15.9 5.0 0.8 7.4 8.1 1.1 1.0 74.5 2.2 0.1 47.5 8.0 4.9 2.1 212.6 165.8 154.4 140.8 15.9 60.9 134.4 146.2 84.8 185.4 276.4 198.4 202.1 343.7 46.4 57.4 64.8 153.6 340.7 83.1 235.3 192.5 124.8 352.5 202.5 209.8 1.5 285.3 153.8 20.0 7.9 156.4 31.9 52.3 168.9 175.9 201.3 104.4 248.1 187.8 268.0 605.5 73.9 179.9 73.4 416.6 353.8 247.1 115.9 200.2 19.1 86.7 112.8 105.2 69.3 78.9 153.8 365.3 36.3 158.4 308.6 177.8 386.7 65.5 223.4 229.0 67.7 512.9 108.5 2.4 0.3 0.9 1.4 0.2 0.2 2.0 4.4 4.2 2.8 0.6 0.5 1.0 2.7 5.7 0.4 0.3 23.6 2.3 1.2 1.1 1.5 1.3 1.1 0.9 1.2 1.1 1.1 1.3 0.8 1.0 2.1 0.5 9.6 11.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 27.5 25.5 0.0 0.0 5.0 1.8 0.0 82.2 8.3 0.0 1.9 6.5 0.0 18.6 10.4 8.5 0.0 0.0 0.0 3.0 160.2 25.4 0.0 13.8 3.8 48.8 0.0 0.0 110.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.3 0.0 0.0 3.0 3.6 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 42.1 5.8 7.6 0.0 0.0 KIF7 JBTS12 ENSG00000166813 "Kinesin family member 7" Q2M1P5 15 89608789-89655467 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein, Repressor" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 14.4;Oligodendrocyte precursor cells: 10.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 33.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043145 Approved NA NA "HPA043145: AB_10969200" "unprognostic (9.52e-2)" "unprognostic (1.07e-1)" "unprognostic (2.74e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.81e-1)" "unprognostic (3.67e-3)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.81e-2)" "unprognostic (3.54e-1)" "unprognostic (4.01e-2)" "unprognostic (3.13e-1)" "unprognostic (1.39e-8)" "unprognostic (2.67e-1)" "unprognostic (2.92e-2)" "unprognostic (4.84e-2)" "unprognostic (1.66e-1)" 6.2 3.2 1.8 1.4 1.5 0.2 5.4 1.5 1.8 8.2 2.8 4.6 0.6 7.0 0.5 1.9 7.7 1.2 4.6 1.5 2.4 2.4 0.9 2.3 1.2 1.8 1.8 1.2 9.1 1.1 2.2 4.2 1.1 1.5 6.7 0.4 0.2 2.6 2.4 1.3 2.2 3.0 1.4 1.2 2.2 3.4 1.8 1.8 1.0 5.0 0.4 0.3 7.0 4.9 1.2 0.4 2.7 3.9 9.8 9.8 3.6 6.9 15.5 4.9 8.4 6.8 5.4 3.4 0.0 4.0 11.2 2.2 3.7 3.8 0.0 2.0 0.0 15.5 3.5 10.4 6.0 9.3 0.0 0.1 6.7 1.9 5.1 0.0 1.5 3.6 7.9 2.7 0.1 2.9 0.8 5.3 0.5 9.4 0.1 2.4 0.1 0.3 0.0 0.1 1.5 2.2 5.7 16.5 0.2 6.1 2.1 1.8 1.1 7.6 13.5 11.0 33.9 7.3 6.7 2.5 0.0 13.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 1.5 1.8 1.5 2.4 1.8 1.8 1.2 1.5 1.2 1.8 1.2 0.5 0.0 0.0 14.4 0.0 0.3 1.0 0.5 2.2 0.9 1.8 1.8 5.4 0.0 0.2 0.0 0.0 0.3 0.3 0.7 0.0 0.1 0.5 0.5 4.0 2.1 0.0 0.8 2.9 0.4 0.2 4.3 1.5 0.6 0.0 4.8 1.4 0.1 0.1 0.0 4.5 0.4 0.0 0.0 0.4 0.4 5.6 0.1 0.0 5.6 0.0 1.2 0.0 10.1 0.3 0.1 0.1 4.1 0.0 1.3 0.0 0.3 0.1 0.2 6.6 3.2 3.7 0.7 1.4 0.3 0.4 0.3 0.4 4.2 0.4 0.8 LDHD ENSG00000166816 "Lactate dehydrogenase D" Q86WU2 16 75111860-75116780 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 136.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1" "Cancer enhanced" "Detected in all" "liver cancer: 32.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 11.1" "Group enriched" "Detected in many" 45 "granulocytes: 11.1;monocytes: 4.8" "Cell line enhanced" "Detected in many" "Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041766, HPA048639, HPA066148" Enhanced Approved Cytosol No NA Cytosol "HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626" "unprognostic (8.75e-2)" "unprognostic (3.68e-3)" "unprognostic (1.27e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (1.53e-1)" "prognostic favorable (5.61e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.74e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-14)" "unprognostic (4.10e-3)" "unprognostic (4.49e-2)" "unprognostic (7.00e-2)" "unprognostic (2.20e-1)" 25.1 14.5 15.2 2.1 16.0 0.7 11.8 18.3 22.8 5.4 27.5 19.1 8.9 3.5 1.1 10.8 5.5 3.1 59.7 13.9 15.6 35.5 136.6 4.9 0.8 19.3 17.1 13.4 16.6 18.8 17.2 11.9 0.7 19.9 8.2 9.7 1.3 21.5 3.2 69.3 4.8 5.7 1.2 13.9 1.1 23.3 1.7 16.8 0.5 10.7 53.1 0.6 2.6 3.7 16.2 0.7 2.1 0.0 0.2 1.6 1.4 6.1 0.2 0.1 0.2 0.2 2.8 2.6 0.1 2.1 0.9 1.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.8 11.4 2.6 0.0 14.4 2.0 0.3 0.0 0.0 0.6 0.1 0.4 0.7 2.5 0.0 5.3 0.1 0.8 1.4 2.7 1.3 0.0 0.0 7.8 1.4 0.1 0.0 0.0 0.2 5.2 0.3 0.7 29.1 3.3 0.0 0.0 0.2 0.0 0.0 11.5 0.6 0.0 1.9 0.1 0.0 11.1 2.2 0.6 0.0 3.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.8 15.2 16.0 18.3 22.8 13.9 15.6 19.3 17.1 13.4 19.9 13.9 16.8 16.2 1.6 0.0 6.7 7.8 1.0 0.6 1.8 2.2 0.6 0.5 6.5 2.4 37.3 11.5 2.3 11.0 0.0 2.1 0.1 80.2 37.2 2.3 0.4 2.2 0.3 1.7 3.0 2.7 1.0 6.2 1.2 2.3 32.6 3.8 10.2 2.1 4.2 88.6 7.2 1.7 1.4 11.0 0.0 6.0 1.0 0.6 0.0 3.0 5.4 1.9 2.0 12.0 0.0 1.0 3.2 3.0 28.3 0.0 0.8 2.1 2.4 118.1 2.0 1.4 0.0 4.1 1.3 0.0 0.7 3.6 0.3 3.1 1.0 1.8 15.7 1.5 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664367-89679427 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "adipose tissue: 964.8;breast: 466.9" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 59.0" "Group enriched" "Detected in many" 5 "breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 171 "ASC diff: 208.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 22000 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 964.8 11.4 12.4 3.5 12.2 0.3 466.9 7.7 10.7 1.3 5.2 9.3 0.5 0.7 0.4 1.3 1.4 6.6 8.3 10.3 10.1 2.7 41.2 0.7 1.7 9.4 10.5 7.3 2.1 6.2 0.2 1.3 0.2 11.8 2.6 3.8 0.6 21.0 0.6 9.6 13.7 14.0 1.5 6.3 1.1 5.5 13.3 9.3 2.3 5.3 17.5 0.1 8.0 3.1 8.4 0.0 0.2 0.2 0.0 208.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.7 0.5 0.1 0.7 0.2 0.0 0.2 0.6 0.7 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.1 0.3 0.2 0.1 0.3 1.2 0.1 0.5 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 12.2 7.7 10.7 10.3 10.1 9.4 10.5 7.3 11.8 6.3 9.3 8.4 2.6 0.0 0.0 4.2 0.2 0.1 0.3 0.1 0.0 0.3 0.7 3.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 7.5 0.1 0.2 0.2 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.2 0.0 0.1 1.1 59.0 0.0 0.0 0.3 0.3 0.0 1.0 0.3 7.5 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 1.3 0.0 0.0 0.6 0.3 0.1 0.1 0.1 0.0 1.3 1.3 4.8 0.2 0.0 0.4 0.0 0.1 0.1 0.5 0.9 PEX11A "MGC119947, MGC138534, PEX11-ALPHA" ENSG00000166821 "Peroxisomal biogenesis factor 11 alpha" O75192 15 89677764-89690783 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 38.7;Late spermatids: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (1.40e-1)" "unprognostic (6.17e-2)" "unprognostic (6.80e-3)" "unprognostic (2.82e-2)" "unprognostic (2.38e-1)" "unprognostic (3.24e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-2)" "unprognostic (5.44e-2)" "unprognostic (4.82e-2)" "unprognostic (1.32e-2)" 25.9 10.5 7.8 3.4 7.8 0.8 20.2 6.9 8.6 7.1 11.2 14.7 16.5 6.0 10.6 6.6 9.7 5.5 7.0 7.7 9.7 11.9 39.4 6.2 2.5 7.0 7.3 6.9 13.2 11.9 10.1 5.6 3.6 6.9 18.5 12.1 12.8 11.4 10.2 18.0 4.9 12.3 5.6 6.9 4.1 11.4 11.5 7.7 2.3 11.0 12.1 3.7 9.3 6.2 7.5 10.2 6.1 4.6 0.3 23.4 8.4 3.7 5.0 8.5 7.4 12.0 4.3 11.9 4.7 5.5 5.8 10.6 13.3 0.0 7.6 8.5 7.5 16.8 7.1 7.2 6.0 16.8 4.7 2.4 10.4 9.2 4.3 7.1 5.8 5.2 4.6 0.1 1.8 5.6 10.2 0.0 0.6 2.6 20.6 11.1 0.0 0.0 4.2 6.1 6.8 3.4 8.7 16.0 54.4 15.5 8.3 14.4 4.4 4.7 4.9 4.8 13.2 4.0 5.3 9.5 0.2 11.9 0.7 4.3 1.2 0.7 2.3 3.6 1.0 2.0 1.6 1.8 2.0 1.8 0.9 2.2 2.5 0.8 3.1 0.7 0.4 1.7 1.5 7.8 7.8 6.9 8.6 7.7 9.7 7.0 7.3 6.9 6.9 6.9 7.7 7.5 1.5 6.4 8.4 12.4 2.0 1.8 9.3 5.2 7.4 8.6 15.3 10.9 8.7 10.0 11.4 5.5 2.1 10.8 1.3 22.1 5.9 7.6 24.8 7.1 5.5 3.1 3.6 0.8 3.0 4.6 7.1 4.6 3.1 5.2 1.3 6.2 4.6 38.7 4.0 18.5 3.5 8.9 6.1 3.5 0.8 39.0 5.3 1.6 3.6 2.8 1.9 14.5 1.0 3.5 3.5 5.5 11.6 2.6 0.6 11.5 20.7 12.6 16.2 9.7 0.0 6.4 4.6 22.6 8.7 5.0 2.0 2.7 1.5 11.0 11.8 11.9 TMEM170A "FLJ37611, TMEM170" ENSG00000166822 "Transmembrane protein 170A" Q8WVE7 16 75443054-75465497 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.49e-1)" "unprognostic (1.18e-1)" "unprognostic (2.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (1.02e-2)" "unprognostic (8.62e-2)" "unprognostic (7.97e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-1)" "unprognostic (7.15e-2)" "prognostic favorable (2.36e-9)" "unprognostic (4.37e-2)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (1.53e-3)" 6.6 9.8 9.0 10.7 10.9 36.9 6.0 9.4 9.1 7.4 7.9 12.2 14.6 8.0 6.1 8.4 7.7 7.9 7.0 7.2 8.7 8.5 12.8 8.0 12.0 10.8 9.5 7.7 10.3 10.3 3.9 8.7 10.3 9.3 7.7 10.2 15.0 6.6 3.2 3.7 7.9 13.9 6.3 9.2 9.3 7.3 17.5 8.7 6.8 9.8 4.9 9.8 8.2 7.9 17.2 14.2 17.1 21.8 22.3 9.5 7.7 38.9 9.2 5.2 7.4 11.3 35.3 30.7 19.6 17.0 4.4 16.4 25.9 18.3 8.9 13.0 12.0 11.4 10.6 16.4 22.4 6.3 25.3 27.3 6.7 6.8 12.5 9.4 8.7 6.5 22.7 21.8 15.2 3.9 28.8 22.3 16.8 26.1 17.2 9.2 43.5 8.5 15.7 5.1 18.3 12.8 14.9 22.4 7.0 12.6 25.6 9.4 11.6 9.6 12.6 21.4 10.1 10.2 13.7 17.3 60.3 9.8 14.7 14.4 14.5 26.6 38.2 27.9 29.1 36.6 28.9 29.1 31.8 24.0 28.8 30.9 27.3 33.3 25.4 26.9 26.8 23.1 21.6 9.0 10.9 9.4 9.1 7.2 8.7 10.8 9.5 7.7 9.3 9.2 8.7 17.2 39.7 19.2 15.0 20.5 49.0 19.9 45.7 37.8 26.7 25.6 37.7 27.1 9.3 40.0 25.3 20.2 37.5 73.0 65.0 86.2 25.4 26.8 40.5 62.5 23.6 37.2 34.1 17.1 17.6 19.3 51.5 24.3 16.8 67.7 28.6 57.3 35.3 24.2 37.2 37.0 15.9 37.6 22.4 31.8 29.7 8.7 24.2 38.3 21.4 11.2 41.2 43.7 42.2 24.1 29.8 23.3 67.6 21.4 29.2 57.5 53.5 30.2 32.4 38.3 32.9 19.9 20.1 88.5 61.8 19.7 20.0 53.4 49.0 36.7 56.0 67.8 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 4.5;prostate: 7.4;skeletal muscle: 4.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 52.2;Breast myoepithelial cells: 58.9;Distal enterocytes: 40.1;Exocrine glandular cells: 43.0;Spermatocytes: 41.5" "Cancer enriched" "Detected in many" 4 "prostate cancer: 26.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.5;HDLM-2: 3.1;HEK 293: 3.0;PC-3: 5.7;SCLC-21H: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 4.5 1.4 1.9 0.0 2.6 0.1 3.1 1.6 3.1 0.5 0.3 1.2 0.1 0.1 0.0 0.3 0.2 0.0 1.3 2.4 1.9 0.7 0.8 0.2 0.0 1.6 1.5 3.1 0.2 1.2 0.2 1.0 0.0 1.4 7.4 0.0 0.2 2.1 0.1 4.6 0.2 0.5 0.0 0.6 0.2 0.5 1.3 1.9 0.0 0.5 0.3 0.0 0.3 0.4 1.8 3.5 1.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 1.3 0.0 0.4 0.0 0.2 0.0 0.0 3.1 3.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.0 0.1 0.5 0.8 0.0 0.0 5.7 0.1 0.0 0.8 0.0 0.0 2.6 0.1 0.7 1.1 0.8 0.0 0.0 0.4 0.0 0.0 0.2 2.0 0.6 1.3 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.6 1.6 3.1 2.4 1.9 1.6 1.5 3.1 1.4 0.6 1.9 1.8 1.7 0.0 1.1 2.6 2.9 0.3 2.8 5.1 0.6 11.6 52.2 58.9 6.3 17.2 33.9 1.8 10.4 3.0 3.2 40.1 11.7 18.6 5.3 0.3 0.3 2.1 6.1 3.0 2.8 43.0 0.2 3.5 0.5 0.9 4.5 22.1 4.2 12.8 2.0 8.4 3.0 7.4 12.2 1.6 2.1 2.1 1.2 2.5 7.2 1.0 2.1 19.2 2.1 1.5 1.7 4.8 17.9 0.0 4.6 35.7 7.2 16.2 8.7 20.6 0.0 4.0 3.7 41.5 21.7 2.0 0.3 0.3 2.2 18.0 15.5 6.2 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784895-89815401 "CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 2405.7;pancreas: 680.7" "Cell type enriched" "Detected in many" 14 "Proximal enterocytes: 6315.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 227.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 227.1" "Cell line enhanced" "Detected in many" "ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "spinal cord: 14.8" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" NA NA 1200000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: AB_2667199" "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 41.7 7.1 1.8 37.0 1.8 104.4 56.4 1.5 8.2 41.7 3.8 269.3 2405.7 3.6 1.7 4.9 8.1 121.4 6.6 1.5 5.0 252.0 274.0 34.6 12.9 1.7 1.9 1.3 1.9 680.7 0.8 1.9 33.4 2.7 94.9 60.5 0.0 42.4 5.6 2.5 30.0 1986.9 30.0 1.4 26.1 8.1 2.1 13.4 7.2 8.3 3.8 4.7 17.0 15.1 4.1 0.1 45.6 0.0 0.5 613.7 764.2 6.2 738.4 1135.6 95.3 81.6 5.8 0.4 0.2 8.4 703.8 0.0 0.6 5.6 0.2 38.6 0.1 0.1 137.3 4.6 122.8 352.0 11.4 660.3 670.0 1.4 302.3 0.3 4.4 874.8 0.0 3.8 0.8 37.8 0.1 0.6 355.4 1.9 0.0 49.9 0.3 0.1 9.5 449.2 0.0 1.2 7.2 0.1 1.3 0.1 1.8 0.5 72.1 815.1 385.3 0.6 891.4 0.1 0.4 0.1 0.1 0.9 0.9 20.5 22.2 56.3 41.1 0.1 27.4 0.0 0.2 0.0 0.0 26.2 0.2 0.0 0.0 227.1 0.0 49.7 0.7 0.0 25.7 1.8 1.8 1.5 8.2 1.5 5.0 1.7 1.9 1.3 2.7 1.4 13.4 4.1 2.4 0.0 3.0 0.0 5.2 9.9 2.8 1.4 0.6 0.0 35.7 12.8 1.2 391.7 19.7 20.2 0.0 13.0 0.7 429.8 43.0 15.4 0.2 0.5 10.1 8.4 3.0 6.6 0.3 386.2 16.3 31.0 0.0 0.4 24.1 0.3 79.2 192.4 37.5 0.0 0.3 199.6 2.0 54.1 63.2 0.2 2.8 71.9 3.6 0.0 38.3 0.0 0.0 0.0 0.1 75.5 316.9 1.5 2.1 20.9 6315.2 435.0 3.3 0.0 26.3 0.8 8.1 0.3 0.5 0.2 5.8 6.4 3.7 187.8 290.9 1.4 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 subunit gamma" P51170 16 23182745-23216883 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.8" "Cell type enriched" "Detected in some" 4 "Collecting duct cells: 90.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enhanced" "Detected in some" "cerebellum: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTCEpi: 46.8;RT4: 21.7" "Region enriched" "Detected in single" 13 "cerebellum: 2.5" "Not detected" "Not detected" HPA071194 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071194: AB_2686359" "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 0.4 0.2 0.4 0.0 0.3 0.3 2.3 3.9 0.2 16.1 0.2 6.0 0.0 1.8 0.7 10.0 0.4 0.0 0.0 0.7 0.3 42.8 0.0 7.5 0.0 0.2 0.4 0.2 0.0 3.3 0.0 3.8 0.5 1.8 13.9 1.2 0.2 17.9 3.5 0.0 8.9 0.4 0.1 0.0 0.0 10.2 0.1 0.1 2.1 5.7 0.0 1.2 1.4 15.4 0.3 1.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 2.9 0.0 0.0 0.1 0.0 21.7 1.5 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 3.9 0.2 0.7 0.3 0.2 0.4 0.2 1.8 0.0 0.1 0.3 0.4 19.2 4.2 0.0 0.0 0.4 4.7 8.8 19.9 0.0 0.8 1.3 0.8 0.0 17.4 90.1 0.0 0.2 0.0 3.4 0.0 2.0 0.0 9.8 1.1 0.1 0.0 0.0 0.2 1.7 0.0 0.4 15.3 18.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 10.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.5 1.1 0.0 0.1 5.3 0.0 0.2 1.9 0.0 0.0 0.0 0.2 0.1 0.1 4.4 0.3 0.1 0.2 0.0 0.4 1.8 RBPMS2 ENSG00000166831 "RNA binding protein, mRNA processing factor 2" Q6ZRY4 15 64739891-64775589 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 268.0" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 215.3" "Cancer enriched" "Detected in all" 4 "testis cancer: 37.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.0;AN3-CA: 55.4;HEL: 86.2;NTERA-2: 76.4;SuSa: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.68e-1)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.79e-2)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (4.51e-2)" "unprognostic (6.41e-2)" "unprognostic (5.86e-2)" "unprognostic (2.21e-2)" "unprognostic (4.47e-2)" "prognostic favorable (1.48e-4)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 20.1 4.9 4.8 6.7 4.7 1.6 12.6 2.4 4.7 17.3 13.2 105.3 6.0 53.6 7.5 20.5 31.0 10.0 268.0 3.3 3.7 17.7 14.0 7.7 1.0 3.6 4.6 2.2 10.6 2.7 16.7 4.1 7.7 2.8 27.7 8.2 2.0 2.5 46.3 5.6 4.1 30.4 37.9 2.2 4.4 52.4 6.4 8.8 2.5 13.9 5.0 0.6 94.8 14.5 2.9 0.0 6.3 39.0 55.4 0.0 0.0 5.9 1.2 0.2 7.0 1.6 4.9 0.5 0.0 5.2 1.1 6.5 0.0 28.8 0.0 2.6 0.0 9.0 86.2 9.5 9.9 3.7 0.0 0.7 0.1 0.0 4.4 0.0 1.5 0.7 1.9 0.5 0.0 0.5 2.9 0.0 0.3 76.4 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 13.5 8.5 0.1 1.6 86.5 7.9 0.3 0.0 0.0 28.4 3.7 3.7 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 4.8 4.7 2.4 4.7 3.3 3.7 3.6 4.6 2.2 2.8 2.2 8.8 2.9 3.1 0.0 0.0 0.0 1.1 0.8 0.3 0.0 0.6 0.3 0.5 0.5 215.3 0.0 0.0 3.7 0.0 0.6 2.0 0.0 9.8 0.4 4.7 0.4 3.4 6.4 0.0 7.4 0.3 1.6 1.1 11.1 5.1 0.7 0.0 0.9 2.9 8.5 0.3 0.0 0.2 0.0 0.0 1.3 1.3 1.0 3.7 10.4 1.8 1.0 0.2 3.3 9.2 0.0 0.0 1.2 0.0 6.4 0.0 1.5 0.0 31.0 0.0 1.7 46.0 1.7 51.0 0.8 14.1 0.3 1.1 3.1 0.7 1.0 0.0 0.2 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121601 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.8;heart muscle: 61.8" "Cell type enhanced" "Detected in many" "Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 5.8 1.7 16.3 3.3 17.1 1.8 12.1 18.9 12.8 6.0 2.9 12.2 4.5 7.6 11.2 6.5 4.4 1.8 61.8 9.6 17.6 9.6 15.0 9.6 1.8 54.8 34.3 5.0 3.1 8.8 6.0 5.2 14.9 33.9 6.3 4.9 8.7 15.2 9.4 2.6 6.2 4.1 8.6 39.6 1.4 7.3 0.9 29.2 2.5 17.0 9.5 3.9 5.8 7.5 39.3 16.2 4.7 10.2 1.4 33.7 21.6 11.0 13.3 22.6 17.2 13.0 18.2 2.1 0.1 0.6 20.1 28.0 1.9 0.6 10.4 20.1 3.8 1.2 0.4 25.1 20.9 6.1 0.0 0.5 14.1 26.5 8.3 89.9 12.7 23.2 0.1 1.9 8.0 50.2 17.2 0.0 0.1 26.4 5.3 13.1 0.1 47.1 2.6 14.8 4.6 18.2 81.9 10.3 7.9 14.8 54.2 0.3 0.0 65.2 39.6 6.3 47.7 12.7 2.7 2.0 0.1 13.5 0.8 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.3 17.1 18.9 12.8 9.6 17.6 54.8 34.3 5.0 33.9 39.6 29.2 39.3 5.5 64.1 22.6 466.8 1.4 4.2 23.6 13.8 14.2 4.6 33.6 31.0 14.3 8.6 18.3 20.2 0.0 31.8 0.8 2.8 13.7 20.3 2.6 34.4 4.6 14.5 10.8 0.0 333.8 21.3 23.3 16.5 11.2 62.1 1.3 152.4 11.7 47.0 10.7 26.9 525.7 10.1 18.3 1.4 5.0 7.9 0.9 3.2 16.0 194.9 1.0 28.9 0.0 863.6 354.4 37.5 0.8 4.1 0.4 33.7 1.8 0.4 24.0 2.4 0.0 30.7 17.8 1.5 0.6 23.1 3.7 14.6 1.7 54.7 9.2 17.8 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 209.6;Leydig cells: 61.8;Peritubular cells: 78.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 24.1;RT4: 17.7;U-266/84: 25.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 13.8" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.0 9.0 4.6 2.7 4.6 2.7 1.5 1.8 5.5 2.3 0.3 1.2 1.2 2.2 1.9 3.6 4.0 2.9 2.2 3.8 2.8 0.8 0.4 2.6 4.9 4.9 2.5 5.4 3.9 4.4 4.4 1.2 1.6 4.1 2.3 0.4 2.8 2.4 2.1 1.2 3.3 1.8 1.6 1.8 10.8 1.7 3.6 3.2 0.8 2.6 0.1 1.3 3.0 2.0 2.7 1.2 3.7 1.6 1.6 2.7 2.1 6.9 1.6 4.4 1.7 2.5 2.1 1.7 1.6 1.9 3.8 1.4 1.3 3.7 0.3 1.4 0.7 1.1 1.5 4.6 1.5 2.0 1.2 2.5 1.6 0.5 1.1 0.6 0.9 1.2 1.7 0.3 24.1 0.5 3.5 0.6 2.6 2.2 0.6 1.7 0.8 1.0 12.1 0.2 17.7 3.2 4.5 1.0 1.2 1.8 1.5 1.2 1.5 1.8 3.2 3.3 2.8 1.6 6.4 25.4 1.2 3.6 3.0 1.0 0.5 0.4 0.0 1.0 0.9 0.3 0.4 0.5 1.4 0.7 0.3 0.3 0.4 0.7 3.1 0.9 0.0 2.1 0.4 4.6 4.6 1.8 5.5 3.8 2.8 4.9 2.5 5.4 4.1 1.8 3.2 2.7 8.0 0.0 1.3 209.6 1.5 5.6 4.2 1.1 4.0 11.2 0.7 1.0 1.4 1.5 1.3 0.0 12.5 3.1 3.8 0.1 0.0 0.9 1.1 1.7 9.6 12.7 1.2 0.0 37.7 2.3 5.6 6.5 0.0 3.6 5.7 1.1 5.3 0.0 5.4 3.3 24.6 0.0 2.0 6.0 25.4 4.1 61.8 7.1 10.6 19.7 1.1 28.9 5.2 30.2 10.7 2.8 0.1 78.6 6.2 2.7 0.0 0.3 0.2 8.2 13.1 11.8 7.1 2.6 1.3 0.8 3.7 2.2 3.0 3.3 0.1 5.2 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 581.1" "Group enriched" "Detected in some" 4 "Hepatocytes: 234.3;Proximal tubular cells: 797.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.3 0.4 0.1 0.3 0.4 1.6 0.1 0.7 0.1 1.3 0.9 0.0 0.1 0.3 142.7 581.1 0.0 0.1 0.9 0.4 0.0 0.0 1.7 2.6 0.0 0.0 1.1 11.2 0.3 0.2 1.9 0.0 0.0 0.5 0.2 0.0 0.3 0.1 2.7 0.1 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.1 0.5 0.4 2.0 0.0 4.9 0.0 0.3 0.4 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.3 0.9 0.4 0.0 1.1 0.3 0.2 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.3 12.8 0.0 14.7 0.0 0.0 0.0 0.1 107.6 0.1 0.0 2.5 0.1 0.5 0.0 8.0 0.7 0.6 0.0 0.1 0.0 0.1 0.0 0.1 5.0 234.3 0.0 0.0 0.8 0.1 0.0 8.1 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 1.3 0.0 797.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.9 0.1 0.9 0.2 C18orf54 "LAS2, MGC33382" ENSG00000166845 "Chromosome 18 open reading frame 54" Q8IYD9 18 54357906-54385218 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.5" "Cell type enhanced" "Detected in many" "Early spermatids: 100.0;Extravillous trophoblasts: 24.0;Late spermatids: 29.7;Oligodendrocytes: 23.0;Spermatocytes: 38.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040704 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA040704: AB_10959454" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (5.29e-2)" "unprognostic (8.63e-3)" "unprognostic (2.40e-1)" "unprognostic (1.05e-1)" "unprognostic (5.60e-6)" "unprognostic (1.11e-2)" "unprognostic (7.85e-3)" "unprognostic (2.55e-2)" "unprognostic (5.91e-3)" "unprognostic (1.13e-2)" "unprognostic (3.06e-5)" "unprognostic (2.29e-1)" "unprognostic (4.21e-1)" "unprognostic (1.28e-2)" "unprognostic (7.05e-2)" 2.1 0.6 1.7 2.3 3.5 1.3 1.1 2.6 2.6 1.9 1.3 1.4 0.8 2.3 0.4 1.0 0.9 1.1 0.9 1.6 2.6 0.8 0.4 1.3 3.0 3.2 3.0 1.3 1.4 0.2 0.6 0.2 3.1 3.4 0.7 1.3 1.2 0.4 0.8 0.3 1.0 0.8 1.8 2.8 1.7 0.8 17.5 2.7 3.5 0.9 1.2 2.7 1.0 1.0 5.3 10.2 6.6 22.8 11.7 5.8 10.0 8.2 16.0 6.8 15.5 19.6 4.4 5.2 6.9 4.3 5.6 6.4 9.7 16.9 9.3 20.1 26.5 5.2 7.8 7.2 6.1 1.3 9.4 8.0 3.4 1.8 20.9 10.6 6.7 21.6 9.6 7.8 15.6 22.6 3.8 9.7 4.7 12.5 1.6 11.2 7.7 18.3 5.3 7.1 6.9 14.4 7.8 7.0 2.6 4.2 11.7 4.7 6.8 17.5 32.0 13.3 5.3 8.8 9.8 11.8 10.6 8.1 14.5 22.4 0.5 0.2 0.0 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.4 0.3 0.3 0.0 0.2 1.8 0.1 0.7 0.2 1.7 3.5 2.6 2.6 1.6 2.6 3.2 3.0 1.3 3.4 2.8 2.7 5.3 3.9 0.0 0.6 1.6 1.1 0.4 0.7 0.8 0.0 2.2 0.9 0.9 1.5 0.0 0.2 1.8 0.0 0.9 2.3 0.6 0.0 0.2 100.0 1.4 2.3 3.2 0.0 11.2 0.6 0.2 24.0 2.9 0.5 0.8 0.0 14.2 3.6 0.3 2.5 0.0 0.7 0.4 0.0 3.1 2.1 29.7 1.5 1.7 1.8 3.7 1.3 2.4 3.1 4.5 23.0 0.4 0.9 0.7 1.9 0.5 0.2 0.3 0.3 0.9 0.0 2.1 3.0 38.4 14.5 0.8 0.4 2.1 1.2 0.9 1.7 0.8 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641466-23677472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: AB_2685101" "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 14.0 11.4 13.4 18.3 18.3 41.9 14.3 10.4 15.2 13.7 4.3 19.4 20.9 15.0 12.1 25.4 13.7 14.3 14.8 17.0 14.9 21.2 10.7 14.1 22.3 11.6 13.5 17.0 12.1 16.0 19.9 8.5 21.0 11.3 14.3 25.1 21.7 12.9 14.1 14.0 14.2 22.4 21.9 11.2 15.2 16.8 20.8 12.4 21.1 19.0 14.4 32.5 20.8 11.0 13.5 30.0 58.5 56.0 46.9 39.0 28.9 39.2 51.9 32.1 32.9 39.3 66.5 40.3 42.1 41.2 54.8 34.6 30.6 93.4 50.2 40.5 48.1 37.1 51.9 67.2 93.9 26.5 63.7 38.4 24.3 35.3 40.5 42.8 36.5 52.8 52.0 100.7 31.6 53.3 82.4 49.4 18.4 66.3 43.3 25.5 59.8 48.6 45.9 26.2 62.6 46.8 48.5 45.6 36.7 30.5 49.0 51.2 53.2 71.8 44.0 20.0 34.9 36.6 42.6 68.6 66.2 42.0 31.4 48.8 14.3 16.6 20.3 15.5 14.0 17.1 13.9 14.2 17.0 17.5 10.5 12.0 14.3 7.3 22.0 22.0 12.4 19.0 17.2 13.4 18.3 10.4 15.2 17.0 14.9 11.6 13.5 17.0 11.3 11.2 12.4 13.5 19.7 16.0 26.2 12.1 19.1 14.7 14.5 12.9 22.8 52.1 15.5 14.5 27.1 15.7 15.6 20.2 91.8 32.9 16.1 36.2 11.7 23.8 23.2 11.9 22.4 22.5 22.1 27.6 13.4 25.2 36.3 16.3 20.9 20.8 27.8 37.3 17.2 14.2 28.4 52.2 13.2 18.9 12.2 19.1 11.4 23.4 13.1 17.1 7.2 6.5 34.4 32.3 30.9 11.1 12.0 45.7 19.4 18.0 17.4 14.4 31.9 23.3 11.2 45.0 13.1 22.4 18.1 70.4 30.6 20.9 14.2 48.2 18.7 17.9 26.2 22.0 TERF2IP RAP1 ENSG00000166848 "TERF2 interacting protein" Q9NYB0 16 75647773-75761872 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006719, CAB018660, CAB018749" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267" "unprognostic (3.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.06e-3)" "unprognostic (7.83e-2)" "unprognostic (3.30e-1)" "unprognostic (1.99e-2)" "unprognostic (2.33e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-2)" "prognostic favorable (6.14e-5)" "prognostic favorable (1.46e-4)" "unprognostic (1.81e-1)" "prognostic favorable (2.15e-5)" "unprognostic (6.26e-2)" "unprognostic (1.85e-1)" "unprognostic (5.30e-2)" "unprognostic (2.99e-1)" 55.5 94.3 151.0 41.6 157.2 90.5 52.3 151.2 187.7 52.5 117.1 43.6 27.4 52.0 58.1 37.9 51.1 37.0 67.6 148.7 178.0 45.8 43.3 52.3 68.8 149.1 157.8 151.7 73.5 38.5 72.4 145.5 27.8 154.9 48.5 27.2 170.1 38.6 45.2 58.8 47.4 42.2 39.4 144.2 58.2 38.0 55.4 167.8 72.6 55.7 47.8 62.4 44.8 46.8 176.1 25.1 23.2 51.2 39.7 56.9 59.2 16.0 74.6 63.9 62.0 45.8 25.7 26.9 127.2 97.0 50.6 30.6 35.6 51.1 21.3 52.5 48.1 74.1 64.9 36.6 59.1 74.4 88.6 88.7 50.7 59.3 49.8 76.8 68.2 42.2 82.6 77.2 52.2 71.9 73.7 107.2 112.5 25.9 32.4 53.3 119.9 33.0 106.0 46.4 22.7 123.9 74.7 96.8 22.4 61.8 18.5 51.7 86.0 46.6 59.1 31.3 51.4 57.9 216.2 202.5 179.2 62.2 59.6 57.1 56.4 21.9 101.3 28.7 19.8 35.8 46.8 44.2 47.9 21.0 65.7 53.9 33.8 33.2 39.7 31.2 20.3 48.6 19.8 151.0 157.2 151.2 187.7 148.7 178.0 149.1 157.8 151.7 154.9 144.2 167.8 176.1 109.1 48.1 69.3 30.7 160.8 195.5 114.3 82.5 163.4 388.8 73.6 77.0 95.2 68.6 74.2 93.8 93.8 76.8 172.7 33.4 135.0 81.7 7.8 68.5 81.8 102.3 97.8 421.4 46.7 51.1 38.9 115.7 39.3 74.6 124.9 81.4 84.3 58.1 60.7 282.7 54.5 50.1 120.1 70.8 138.5 23.6 115.5 89.3 120.9 18.7 96.6 320.2 125.7 38.2 68.2 46.3 46.9 130.5 162.8 101.7 45.1 74.7 66.9 176.2 138.1 79.0 106.2 255.1 116.2 94.3 194.4 122.3 215.0 140.7 32.2 116.4 PLK1 PLK ENSG00000166851 "Polo like kinase 1" P53350 16 23677656-23690367 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.2;lymphoid tissue: 44.3;testis: 33.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 32.3;Early spermatids: 123.7;Erythroid cells: 38.3;Extravillous trophoblasts: 55.9;Spermatocytes: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "T-reg: 5.6" "Lineage enriched" "Detected in many" 5 "T-cells: 5.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051638, HPA053229" Approved NA Yes "HPA051638: AB_2681561, HPA053229: AB_2682084" "unprognostic (7.21e-3)" "unprognostic (1.77e-1)" "unprognostic (1.98e-3)" "unprognostic (4.97e-3)" "unprognostic (9.56e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (2.70e-7)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.55e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.33e-1)" "unprognostic (8.10e-2)" "unprognostic (1.19e-1)" "unprognostic (1.26e-2)" 1.4 1.5 1.9 13.5 1.8 32.2 1.5 2.0 3.2 1.6 1.5 9.7 10.5 1.2 0.4 14.0 1.0 1.4 0.9 1.8 1.8 1.4 1.9 2.0 28.1 2.0 1.9 1.5 1.3 1.1 0.2 1.2 6.5 1.8 1.2 10.2 1.2 2.4 0.3 1.0 5.8 9.3 4.0 1.6 9.2 6.2 33.3 1.9 44.3 0.9 0.4 30.3 2.8 4.0 2.4 199.9 207.5 166.2 90.9 5.2 11.7 92.8 111.0 74.5 172.5 127.0 184.3 131.0 99.1 56.3 76.5 90.1 112.8 229.5 93.5 206.1 139.5 128.0 125.2 163.4 257.1 1.7 147.5 133.7 4.8 5.2 124.7 125.2 21.6 127.9 127.5 200.7 133.9 134.8 187.8 139.8 151.4 189.5 82.1 103.5 217.2 111.7 160.0 49.3 43.9 94.3 65.3 126.8 88.9 55.8 94.4 114.4 92.1 65.1 82.7 102.7 79.9 194.1 93.2 156.8 173.6 69.3 127.7 137.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.3 0.3 0.0 0.0 0.0 0.4 0.9 0.0 0.0 5.6 1.4 1.9 1.8 2.0 3.2 1.8 1.8 2.0 1.9 1.5 1.8 1.6 1.9 2.4 0.6 3.2 0.0 3.3 7.6 1.3 1.2 6.5 0.0 1.4 1.7 2.3 0.6 0.0 1.4 0.0 4.2 32.3 0.4 5.5 0.0 0.8 123.7 3.4 1.3 2.5 0.0 38.3 3.1 0.8 55.9 4.7 10.2 1.8 1.3 19.9 3.3 1.1 20.8 0.0 2.3 7.3 4.1 6.9 3.2 13.9 1.2 7.2 0.0 2.8 0.4 1.1 0.0 1.5 2.3 1.2 0.3 0.7 23.0 2.0 1.5 0.1 1.3 1.3 0.0 2.3 6.1 79.5 13.5 12.2 1.8 3.8 2.5 1.2 17.9 2.0 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit X" O76031 15 65148219-65185342 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 242.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA 65000 Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 8.0 10.9 9.6 6.2 10.7 8.1 9.4 10.6 10.6 7.1 8.4 9.3 8.8 7.9 8.7 13.4 8.0 6.3 14.2 8.9 9.6 12.3 33.2 6.6 9.2 11.3 10.2 8.3 9.5 9.4 12.0 4.6 9.9 10.4 8.1 8.1 10.2 7.6 6.1 27.1 14.8 7.4 7.2 9.9 8.5 9.3 9.2 10.2 10.7 9.9 24.2 10.0 8.0 9.0 11.2 8.1 13.7 11.7 14.8 12.2 15.5 12.5 9.2 10.2 9.8 10.3 13.7 11.1 25.0 7.5 12.3 7.3 16.9 43.2 12.1 10.5 9.9 7.9 18.9 12.8 17.4 17.3 24.4 10.5 18.6 16.2 9.0 17.1 11.3 12.6 13.3 17.6 8.6 11.7 10.3 11.6 21.4 13.1 16.0 6.1 22.4 13.9 26.1 18.6 18.5 10.1 8.1 12.4 19.3 13.8 15.3 8.9 20.3 11.2 9.8 8.7 8.0 8.7 9.2 15.0 13.0 9.6 30.4 7.8 2.2 4.1 6.5 4.3 3.5 3.9 4.4 3.7 3.2 3.9 3.9 5.0 4.0 6.4 4.7 3.3 5.9 3.5 2.7 9.6 10.7 10.6 10.6 8.9 9.6 11.3 10.2 8.3 10.4 9.9 10.2 11.2 16.4 35.3 35.5 15.3 23.6 19.2 18.8 20.9 18.8 32.3 17.0 15.6 69.9 27.1 29.5 33.1 14.6 41.0 28.5 16.7 21.5 36.8 104.5 24.4 28.7 21.0 10.3 56.8 15.6 31.6 29.2 25.5 33.6 27.5 16.4 37.8 21.0 90.1 22.6 32.0 15.2 20.3 28.5 28.3 16.6 242.3 28.9 20.3 17.8 16.9 34.1 25.9 20.6 12.5 23.9 29.0 18.2 29.7 30.8 24.9 23.1 33.8 27.7 27.2 26.3 23.1 30.1 45.0 30.6 29.1 30.1 89.2 24.4 59.0 24.3 25.5 GPR182 "ADMR, AM-R, G10D, hrhAMR" ENSG00000166856 "G protein-coupled receptor 182" O15218 12 56994492-56998447 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 17.1;testis: 6.2" "Group enriched" "Detected in some" 38 "Early spermatids: 74.4;Hepatic stellate cells: 75.7;Late spermatids: 184.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027037 Enhanced NA NA "HPA027037: AB_1844622" "unprognostic (6.13e-2)" "unprognostic (6.23e-2)" "unprognostic (3.56e-2)" "unprognostic (5.88e-2)" "unprognostic (2.60e-2)" "unprognostic (3.30e-1)" "unprognostic (2.10e-4)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (4.94e-1)" "unprognostic (1.67e-2)" "unprognostic (8.13e-2)" "unprognostic (5.62e-3)" "unprognostic (9.31e-2)" "unprognostic (2.88e-2)" "unprognostic (1.42e-1)" "unprognostic (4.34e-3)" 0.4 3.1 0.2 0.5 0.1 0.0 0.5 0.4 0.2 0.4 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.1 0.1 0.2 0.0 1.5 4.0 0.8 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 17.1 0.2 6.2 0.0 0.0 1.2 0.1 0.1 0.3 0.3 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 2.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.7 0.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 184.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 ZBTB39 "KIAA0352, ZNF922" ENSG00000166860 "Zinc finger and BTB domain containing 39" O15060 12 56998836-57006546 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 16.7;Early spermatids: 19.9;Horizontal cells: 21.9;Late spermatids: 20.3;Spermatogonia: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "RH-30: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016866, HPA020306" Uncertain Approved Vesicles NA NA Vesicles "HPA016866: AB_2669470, HPA020306: AB_2670406" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "unprognostic (2.90e-2)" "unprognostic (3.07e-1)" "unprognostic (2.68e-2)" "unprognostic (4.10e-3)" "unprognostic (1.69e-1)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-3)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (5.74e-2)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (7.00e-2)" 2.6 1.6 1.7 3.0 1.9 5.9 2.8 2.1 2.0 2.1 0.8 2.4 2.2 3.2 2.5 2.4 3.1 1.8 2.2 1.6 1.6 1.9 3.4 2.8 3.9 1.8 1.9 1.4 4.4 2.9 3.3 1.1 3.7 2.0 2.6 2.4 3.0 2.6 3.3 2.6 3.0 2.9 2.8 1.4 4.2 2.6 7.1 1.8 4.2 2.5 2.7 3.7 2.1 1.7 2.2 3.4 5.5 15.3 7.9 3.4 3.6 10.1 3.2 4.1 5.2 3.7 5.7 2.3 10.8 4.2 3.2 3.3 4.5 11.8 5.0 5.0 5.0 8.2 12.1 3.6 4.6 3.2 9.3 9.6 2.8 4.8 4.1 6.6 5.6 6.0 12.2 15.2 9.7 3.8 3.9 13.7 7.8 15.2 3.5 4.6 13.0 46.9 5.2 2.4 6.7 7.5 9.7 4.7 6.0 4.7 14.2 5.1 10.1 4.8 4.3 9.5 2.0 4.1 12.5 8.7 11.5 2.7 5.2 2.7 0.7 0.3 0.0 0.4 0.2 0.4 0.3 0.4 0.6 0.4 0.4 0.3 0.6 0.0 0.7 0.0 0.5 0.1 0.3 1.7 1.9 2.1 2.0 1.6 1.6 1.8 1.9 1.4 2.0 1.4 1.8 2.2 2.9 0.0 0.6 3.3 3.5 1.5 2.3 1.6 7.4 11.6 1.7 1.5 3.5 2.8 1.9 0.0 16.7 3.1 3.0 0.9 0.0 1.5 19.9 1.2 3.3 4.3 1.2 2.1 1.8 1.8 1.8 2.3 1.5 1.2 1.3 3.6 8.6 2.5 1.9 21.9 1.8 2.5 2.0 3.0 2.0 20.3 1.8 1.4 1.8 0.0 3.6 1.8 3.1 1.5 2.8 2.5 3.2 5.7 3.2 3.5 1.5 1.4 3.1 7.4 6.6 3.4 2.2 10.1 17.6 3.2 1.6 2.2 2.1 1.9 2.4 1.4 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36560857-36703752 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 20.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 87.5;Horizontal cells: 26.9;Inhibitory neurons: 119.7;Oligodendrocyte precursor cells: 43.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.0 0.7 4.0 0.0 6.8 0.0 0.0 13.7 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.3 0.0 0.0 0.0 0.0 5.7 4.3 6.7 0.0 0.0 0.0 1.2 0.0 6.9 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.8 13.7 20.4 5.4 4.3 5.7 4.3 6.7 6.9 2.2 6.9 10.8 0.0 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 119.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.5 0.0 0.2 0.0 43.7 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TAC3 "LncZBTB39, LncZBTB39-1:2, NK3, NKB, NKNB, ZNEUROK1" ENSG00000166863 "Tachykinin precursor 3" Q9UHF0 12 57010000-57028883 "Disease related genes, Human disease related genes, Predicted secreted proteins" Neuropeptide "Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 435.3" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 13.9;Extravillous trophoblasts: 19.6;Inhibitory neurons: 40.0;Syncytiotrophoblasts: 18.3" "Cancer enriched" "Detected in many" 7 "urothelial cancer: 40.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 14.4;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA045919 Supported Supported Approved Vesicles "Secreted in female reproductive system" NA NA 130000 Vesicles "HPA045919: AB_10960533" "unprognostic (4.53e-2)" "unprognostic (1.97e-2)" "unprognostic (8.41e-2)" "unprognostic (3.00e-2)" "unprognostic (3.61e-2)" "unprognostic (1.76e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "unprognostic (5.28e-2)" "unprognostic (4.71e-14)" "unprognostic (1.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" 0.1 0.3 13.4 2.5 11.7 1.0 0.1 5.6 16.6 0.1 6.1 3.5 3.0 0.3 0.0 0.1 0.1 0.3 0.1 11.0 23.4 0.1 0.1 0.1 0.2 17.3 8.3 11.2 0.2 0.6 0.0 0.7 435.3 8.6 0.2 1.5 6.2 0.0 0.0 0.2 0.5 6.5 4.9 15.4 0.1 13.3 1.9 9.0 0.5 0.1 0.0 0.4 3.1 0.3 17.4 0.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 1.1 0.3 0.0 1.6 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 14.4 0.3 0.0 0.0 0.0 0.2 1.6 0.5 0.0 0.0 0.0 0.0 0.0 1.5 2.1 0.6 0.0 0.8 0.0 13.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 11.7 5.6 16.6 11.0 23.4 17.3 8.3 11.2 8.6 15.4 9.0 17.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 13.9 0.0 1.4 0.0 0.0 0.1 0.0 0.4 0.1 1.2 2.7 0.5 0.0 19.6 2.6 0.0 0.1 0.0 4.3 0.7 0.0 2.2 0.0 40.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.5 2.8 0.0 0.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 2.6 1.0 0.0 0.0 18.3 0.0 0.0 1.8 0.0 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 333.0" "Group enriched" "Detected in some" 4 "Distal enterocytes: 174.5;Proximal enterocytes: 690.2" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in many" "white matter: 7.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 43.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA053490: AB_2682168" "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.2 0.2 0.1 5.2 0.5 0.1 0.1 0.8 0.6 0.0 0.5 68.9 333.0 0.4 0.0 0.2 0.1 4.2 0.0 0.0 0.2 0.1 0.1 0.2 0.3 2.4 1.5 0.0 0.0 0.2 0.0 0.1 0.2 1.7 0.1 66.4 0.1 0.0 0.2 0.1 0.1 312.3 3.0 4.6 0.1 16.4 1.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 7.3 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 8.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 1.5 0.1 43.3 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.8 0.6 0.0 0.2 2.4 1.5 0.0 1.7 4.6 0.4 7.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 1.9 4.3 0.1 0.0 0.0 0.0 0.0 174.5 0.0 0.1 0.7 0.3 0.0 0.1 24.7 0.0 0.1 0.0 0.0 0.1 26.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 85.4 0.0 0.3 1.0 1.2 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 66.8 0.0 0.1 0.0 690.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.4 0.1 0.0 0.4 0.0 102.3 0.1 CHP2 ENSG00000166869 "Calcineurin like EF-hand protein 2" O43745 16 23755026-23758935 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "intestine: 307.8;skin 1: 150.9" "Group enriched" "Detected in some" 5 "Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055198, CAB072806" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "CAB072806: , HPA055198: " "unprognostic (4.82e-1)" "unprognostic (3.40e-1)" "unprognostic (4.93e-2)" "unprognostic (1.01e-2)" "unprognostic (8.85e-2)" "unprognostic (3.54e-1)" "unprognostic (4.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.38e-1)" "unprognostic (5.31e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-5)" "unprognostic (2.21e-1)" "unprognostic (5.97e-2)" "unprognostic (7.84e-2)" "unprognostic (9.01e-2)" 0.4 0.2 0.8 3.8 1.1 2.2 4.3 3.3 1.7 14.1 0.0 148.1 307.8 0.9 1.1 0.6 0.9 0.4 0.4 0.6 0.9 4.1 0.7 0.6 0.8 0.7 0.2 0.7 0.4 0.5 0.1 0.0 1.4 1.5 3.8 148.8 1.3 0.8 4.6 1.2 150.9 252.6 6.6 0.1 0.3 1.1 7.3 0.8 0.5 0.6 0.2 0.4 9.1 4.3 2.9 1.0 2.2 0.5 0.6 1.2 1.3 1.2 2.9 1.1 0.3 1.0 0.5 2.3 0.4 0.9 2.5 1.2 1.4 0.4 2.9 0.6 0.7 0.2 0.5 4.1 1.6 1.7 0.3 0.7 0.9 0.8 2.5 7.3 10.2 1.1 0.3 1.2 1.0 1.2 0.1 0.1 8.7 0.3 0.5 2.1 0.2 0.1 1.4 1.1 0.7 0.6 0.7 0.8 0.2 0.0 0.6 0.2 0.2 1.3 0.5 0.6 0.7 0.1 0.4 0.1 0.2 0.0 0.5 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.8 1.1 3.3 1.7 0.6 0.9 0.7 0.2 0.7 1.5 0.1 0.8 2.9 0.0 0.0 0.0 0.0 0.0 10.3 8.7 6.1 0.0 0.0 0.0 0.1 0.1 0.0 24.4 1.8 0.0 0.9 0.0 345.0 0.0 0.0 0.6 1.3 0.5 0.2 9.1 0.0 0.0 0.0 4.1 0.2 0.0 3.6 4.5 0.7 0.0 0.0 0.1 0.0 0.0 70.0 12.2 0.0 1.6 0.5 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 274.0 0.0 0.0 2.5 654.2 12.9 4.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 67.5 0.7 0.2 0.2 205.4 29.9 NEMP1 "KIAA0286, TMEM194, TMEM194A" ENSG00000166881 "Nuclear envelope integral membrane protein 1" O14524 12 57055643-57088063 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014394 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014394: AB_2204899" "unprognostic (9.24e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "unprognostic (4.97e-2)" "unprognostic (1.43e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (1.64e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.63e-2)" "unprognostic (7.05e-2)" 5.5 5.1 3.4 8.1 3.5 6.8 6.4 3.7 4.0 6.4 3.8 7.6 3.8 8.3 5.4 5.7 6.4 4.3 2.9 3.3 4.0 4.3 6.2 6.3 12.3 3.4 3.3 3.1 7.2 4.0 3.7 3.5 7.9 3.6 6.8 6.8 9.4 4.6 5.3 2.3 10.9 7.5 7.5 3.7 7.4 5.5 7.8 3.3 16.3 5.4 3.0 11.7 6.6 5.7 4.3 20.0 16.8 37.5 40.5 12.3 12.0 21.5 30.2 17.1 41.1 33.3 20.0 37.2 47.2 38.1 10.4 35.0 28.8 50.4 13.0 47.0 25.3 22.9 27.9 19.5 10.6 5.2 35.0 30.7 4.1 12.3 33.8 21.0 17.1 11.6 42.2 57.5 91.2 35.0 10.9 38.5 29.7 21.0 18.8 18.4 38.5 53.2 21.5 9.0 12.2 22.3 15.1 25.7 21.3 24.1 26.4 38.5 34.7 8.3 39.0 22.5 36.4 28.6 40.8 83.2 40.5 23.1 32.9 41.1 2.4 0.5 0.8 1.1 1.5 1.5 1.9 1.2 1.5 0.5 1.6 1.8 1.6 0.2 2.4 0.9 0.9 1.2 0.8 3.4 3.5 3.7 4.0 3.3 4.0 3.4 3.3 3.1 3.6 3.7 3.3 4.3 4.7 22.4 2.6 0.0 7.1 0.0 3.1 0.0 8.0 2.6 5.0 2.9 1.6 2.8 1.8 5.5 4.2 5.0 4.1 1.4 0.0 1.8 1.2 3.3 4.4 4.0 0.0 12.2 0.0 0.8 3.6 4.4 3.1 3.7 0.0 11.1 5.7 3.6 5.8 1.7 0.0 1.8 0.0 7.1 0.0 1.0 6.2 7.2 0.0 0.0 4.4 3.5 3.1 0.0 0.0 2.0 0.7 5.3 4.9 4.1 1.0 1.3 2.9 4.0 13.1 3.6 3.4 12.2 7.4 7.6 0.0 3.0 4.1 3.1 2.2 2.4 OR4D6 ENSG00000166884 "Olfactory receptor family 4 subfamily D member 6" Q8NGJ1 11 59456938-59457991 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.96e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAB2 MADER ENSG00000166886 "NGFI-A binding protein 2" Q15742 12 57089043-57095476 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 98.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004510, HPA027464" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004510: AB_627982, HPA027464: AB_10601138" "prognostic favorable (7.41e-4)" "unprognostic (4.04e-2)" "unprognostic (2.20e-3)" "unprognostic (2.43e-2)" "unprognostic (4.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.88e-3)" "unprognostic (1.80e-1)" "unprognostic (5.85e-2)" "unprognostic (1.19e-1)" "unprognostic (2.13e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (5.67e-3)" "unprognostic (6.19e-3)" 18.0 16.3 23.8 10.0 25.6 6.9 14.3 27.7 31.2 33.9 22.5 23.0 10.2 32.5 21.2 24.7 31.3 17.5 19.4 26.2 25.7 20.1 22.5 24.2 12.1 22.0 22.2 24.8 51.6 10.3 19.7 35.7 11.2 22.6 25.6 5.0 10.7 11.7 16.8 7.7 33.6 15.9 13.5 21.9 17.0 16.0 16.9 23.5 17.6 20.8 10.0 10.5 27.9 34.0 23.4 15.2 9.8 49.2 45.2 43.3 56.7 5.5 44.1 40.8 28.0 23.1 15.6 8.7 9.6 17.6 44.4 8.1 27.0 16.9 34.0 14.3 4.0 4.5 11.4 8.1 16.6 33.2 9.1 26.5 64.4 36.1 32.6 10.9 43.7 7.5 7.2 26.5 9.6 32.4 73.4 14.0 44.5 9.9 12.9 16.6 10.4 64.1 5.1 11.8 6.0 5.5 13.1 21.9 12.5 98.3 12.3 28.0 20.0 8.4 40.7 34.1 28.8 13.2 22.7 6.0 5.1 39.5 5.9 25.1 0.0 1.1 0.2 0.5 2.7 0.6 0.9 0.9 0.7 0.6 2.3 1.1 1.1 0.4 0.4 2.9 0.0 1.0 0.6 23.8 25.6 27.7 31.2 26.2 25.7 22.0 22.2 24.8 22.6 21.9 23.5 23.4 7.6 12.8 13.0 5.9 11.6 29.6 19.5 23.4 39.3 20.3 17.3 13.8 2.9 2.8 13.6 9.2 2.1 3.7 4.9 1.1 7.9 7.4 0.6 22.9 21.2 13.7 6.6 4.8 11.4 1.4 10.5 19.7 8.6 25.4 17.1 7.8 18.2 17.1 11.2 10.1 5.4 1.1 10.2 16.3 43.7 2.9 19.6 14.3 21.4 8.4 1.6 7.9 1.0 1.0 1.9 4.1 0.0 18.8 8.7 12.9 8.7 5.6 5.9 4.4 19.7 9.8 16.3 2.6 18.7 23.4 32.5 56.2 10.7 2.5 1.5 8.6 VPS39 "KIAA0770, VAM6" ENSG00000166887 "VPS39 subunit of HOPS complex" Q96JC1 15 42158701-42208307 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.39e-1)" "unprognostic (2.52e-1)" "unprognostic (1.28e-2)" "prognostic favorable (3.21e-7)" "unprognostic (9.85e-2)" "unprognostic (2.14e-2)" "unprognostic (3.40e-3)" "unprognostic (2.59e-2)" "unprognostic (2.71e-1)" "unprognostic (2.81e-2)" "unprognostic (1.01e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-3)" "unprognostic (1.53e-1)" "unprognostic (4.51e-1)" "unprognostic (3.28e-2)" "unprognostic (5.04e-2)" 24.4 25.1 13.9 18.7 15.8 24.0 19.1 12.7 20.0 23.7 11.1 20.8 18.7 24.0 25.0 20.5 25.5 20.8 28.6 15.9 15.8 22.5 13.1 24.8 23.2 14.5 15.5 13.8 21.2 26.7 44.1 20.0 22.2 15.1 24.3 20.0 21.5 22.2 26.3 36.8 29.7 21.6 27.5 14.1 23.1 21.1 21.1 16.4 31.9 26.8 35.0 26.4 20.5 17.6 15.3 15.6 21.6 30.7 35.0 55.2 52.9 19.5 27.3 49.1 32.5 34.1 18.5 13.2 13.9 27.0 50.1 34.0 36.0 24.1 27.4 29.8 43.6 13.7 33.7 34.6 17.4 38.1 30.8 25.0 46.6 38.8 30.5 31.4 38.0 34.3 38.2 25.2 37.4 36.4 13.9 23.7 17.2 19.1 34.9 18.4 17.9 28.6 22.0 23.7 36.0 27.2 39.7 22.5 21.5 14.4 31.5 34.5 39.7 37.6 28.0 11.8 33.9 20.3 31.7 45.3 20.2 34.2 27.6 23.2 38.5 14.7 18.2 14.9 16.4 15.1 15.2 13.3 16.1 15.6 11.9 13.4 12.7 16.6 20.8 15.6 6.7 13.1 18.5 13.9 15.8 12.7 20.0 15.9 15.8 14.5 15.5 13.8 15.1 14.1 16.4 15.3 14.4 22.4 43.2 27.1 15.7 3.6 3.3 5.6 10.8 11.7 14.0 13.2 57.0 15.7 11.4 9.2 14.6 10.3 12.6 17.5 1.9 7.3 11.4 16.0 16.8 14.4 9.6 16.6 31.2 8.0 7.8 13.7 24.5 15.7 9.5 15.3 9.7 11.8 12.2 11.8 32.2 11.9 10.2 16.9 4.4 21.6 12.2 14.7 3.6 30.9 16.0 13.5 8.2 29.1 34.4 10.2 11.4 13.9 28.7 5.8 14.7 6.2 13.3 11.6 0.0 8.9 10.7 5.2 4.5 12.6 7.0 13.4 13.7 10.5 10.0 4.5 STAT6 "D12S1644, IL-4-STAT" ENSG00000166888 "Signal transducer and activator of transcription 6" P42226 12 57095408-57132139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001861 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA001861: AB_1080106" "unprognostic (3.43e-3)" "unprognostic (1.87e-1)" "unprognostic (1.37e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" "unprognostic (6.70e-2)" "unprognostic (1.88e-2)" "unprognostic (3.65e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.55e-1)" "prognostic favorable (7.76e-4)" "prognostic favorable (1.14e-4)" 76.2 84.7 21.2 68.7 23.2 40.4 68.2 17.7 26.0 84.9 30.0 88.3 79.8 82.6 49.5 94.0 83.2 66.8 45.0 21.6 24.7 69.0 75.8 84.1 78.9 21.6 19.6 19.0 94.1 49.3 53.3 19.0 45.4 20.4 82.2 71.8 3.5 70.7 69.3 14.4 109.1 99.8 81.3 19.4 112.2 79.2 15.1 22.1 82.5 58.0 20.6 92.7 97.6 82.4 24.6 60.2 55.2 13.8 24.3 153.2 138.4 39.7 53.5 103.3 49.5 37.7 26.8 78.8 145.8 78.1 106.4 0.2 82.0 18.7 89.2 38.1 70.5 4.4 32.0 57.5 32.8 93.0 39.0 97.5 213.5 75.1 67.3 55.9 145.4 91.8 45.7 23.3 19.2 69.5 21.3 44.9 41.5 20.3 81.1 12.6 50.4 1.3 49.6 95.6 92.9 0.3 1.2 46.7 35.3 45.6 19.1 53.4 90.8 68.2 0.6 30.7 51.9 0.4 0.1 1.0 35.4 48.6 39.2 67.3 12.6 19.6 11.1 6.9 19.1 6.9 8.0 6.3 6.2 14.1 6.4 5.4 5.7 34.4 6.0 15.0 6.3 6.7 26.8 21.2 23.2 17.7 26.0 21.6 24.7 21.6 19.6 19.0 20.4 19.4 22.1 24.6 27.6 48.1 60.8 5.5 45.1 29.8 44.3 33.4 31.3 1.8 23.8 21.2 15.1 27.1 43.3 49.7 0.0 2.0 38.4 80.4 15.6 38.2 8.0 35.8 33.1 32.0 33.0 26.3 13.1 36.1 10.2 36.9 80.0 51.9 58.2 27.6 38.9 41.0 36.4 0.0 1.3 40.3 24.4 73.2 51.7 17.9 59.4 54.5 21.4 26.2 66.9 3.4 42.2 0.5 1.1 45.1 63.4 50.8 10.6 49.2 80.0 27.9 53.1 1.0 26.3 20.9 31.7 1.0 1.4 37.1 32.8 6.3 31.2 29.2 42.9 62.0 PATL1 "FLJ36874, Pat1b" ENSG00000166889 "PAT1 homolog 1, processing body mRNA decay factor" Q86TB9 11 59636716-59669037 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039030, HPA074680" Approved Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA039030: AB_10673232, HPA074680: " "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.56e-4)" "unprognostic (3.93e-3)" "unprognostic (3.03e-2)" "unprognostic (5.26e-2)" "unprognostic (6.37e-3)" "unprognostic (6.74e-3)" "unprognostic (2.16e-1)" "unprognostic (7.34e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.86e-2)" "unprognostic (4.54e-2)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (6.99e-2)" "unprognostic (2.18e-1)" 18.4 17.5 9.8 19.0 11.3 57.2 16.7 11.7 11.9 18.6 12.0 17.7 22.6 18.8 11.7 19.3 14.6 14.7 15.8 9.5 11.9 16.6 33.4 21.6 20.5 11.8 11.1 8.4 19.3 11.2 14.3 8.7 22.1 12.1 12.1 21.0 23.7 15.9 12.3 41.1 18.6 19.3 18.7 10.5 19.0 16.9 12.6 13.7 20.5 14.7 33.2 23.9 20.2 18.2 13.3 57.7 44.2 31.9 31.4 30.7 34.3 27.6 37.4 63.8 66.1 66.1 28.7 49.4 56.3 35.6 40.4 64.0 42.1 46.6 45.0 70.4 49.4 21.4 32.4 21.3 28.6 110.1 43.0 69.2 38.9 33.9 56.7 77.3 31.8 32.1 34.2 40.5 44.5 37.9 26.7 41.7 39.1 32.5 41.8 28.9 33.6 53.2 24.2 41.1 52.9 22.8 22.0 52.7 39.1 64.9 26.7 55.6 31.5 31.3 43.0 39.4 75.5 33.5 45.4 53.8 47.6 51.8 35.5 36.1 1.9 2.4 3.4 2.7 2.8 2.2 2.0 2.1 2.4 2.3 1.4 2.0 2.0 3.4 1.6 2.9 1.4 1.9 1.5 9.8 11.3 11.7 11.9 9.5 11.9 11.8 11.1 8.4 12.1 10.5 13.7 13.3 13.8 3.2 15.9 10.4 24.1 27.0 18.9 15.8 27.3 10.5 12.7 9.8 13.0 18.6 17.6 11.0 0.0 11.1 16.2 21.7 13.7 14.0 11.8 16.9 21.8 17.6 13.7 12.6 10.7 18.2 14.0 13.2 13.7 28.6 23.4 10.8 10.4 34.5 24.0 6.7 11.2 16.3 2.0 30.8 36.3 4.2 10.8 24.6 10.6 13.1 29.6 7.9 15.5 16.1 18.1 22.8 13.7 9.4 17.4 21.3 16.4 9.4 13.8 10.8 6.6 13.4 12.1 12.0 9.1 25.0 34.1 12.7 18.8 10.1 16.1 19.3 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57906039-57959148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.0" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.7;Cytotrophoblasts: 14.4;Distal tubular cells: 17.6;Extravillous trophoblasts: 15.2;Proximal tubular cells: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "A549: 1.0;Karpas-707: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: AB_2678361" "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 6.6 5.0 0.4 0.4 0.3 0.1 5.6 0.4 0.8 3.8 0.3 6.7 0.2 3.1 0.0 5.7 3.2 0.0 4.5 1.1 0.5 4.0 5.2 2.6 0.1 0.3 0.2 0.5 3.1 5.9 0.0 2.8 0.1 0.3 3.4 0.0 0.5 3.7 0.0 12.5 4.2 4.4 0.0 0.2 3.3 4.3 28.0 0.3 0.0 3.5 0.0 0.1 4.7 4.0 0.9 0.6 1.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.6 2.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.8 0.1 0.0 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.4 0.0 0.0 0.4 0.0 0.6 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.3 0.2 0.2 1.6 0.1 0.1 0.1 0.1 0.0 0.4 0.3 0.4 0.8 1.1 0.5 0.3 0.2 0.5 0.3 0.2 0.3 0.9 8.0 0.0 9.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 7.4 12.7 0.0 0.0 1.8 3.7 0.0 14.4 4.2 0.0 17.6 6.1 0.0 5.6 4.9 2.8 0.0 0.0 0.0 10.7 15.2 2.3 0.0 6.0 11.4 6.8 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.9 0.0 0.0 26.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 3.0 9.5 0.0 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427479 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 19.8;retina: 6.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 45.5;Excitatory neurons: 11.6;Inhibitory neurons: 16.2;Oligodendrocyte precursor cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 12.0;CAPAN-2: 11.2;GAMG: 12.3;RPMI-8226: 11.7;RPTEC TERT1: 21.5;U-2 OS: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 0.0 0.6 19.8 0.0 15.7 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.1 3.8 0.2 0.2 0.6 0.0 4.0 2.8 17.6 0.0 0.2 0.0 0.0 0.0 6.5 0.7 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 0.1 1.8 3.4 2.2 0.0 0.0 0.0 0.0 0.0 5.8 12.0 4.9 0.0 0.0 0.0 0.9 0.0 5.3 2.8 1.2 0.1 1.9 11.2 0.2 6.8 3.8 12.3 8.2 0.6 1.1 0.1 0.2 0.1 0.0 5.7 0.0 0.2 0.0 0.1 0.9 0.1 0.4 1.6 4.5 0.4 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.3 7.1 10.6 0.1 0.1 11.7 21.5 0.1 1.0 0.0 4.9 6.2 0.0 0.1 0.0 0.1 0.5 0.0 24.1 0.2 3.5 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 15.7 0.0 13.8 18.1 3.8 4.0 2.8 17.6 6.5 1.7 3.4 5.8 0.1 0.0 5.1 1.3 0.5 0.1 0.0 0.9 0.0 45.5 0.0 0.0 0.0 1.5 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.2 0.0 0.0 11.6 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.3 16.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 1.9 0.0 0.9 0.0 36.7 0.9 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.6 2.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 316.0" "Cell type enhanced" "Detected in all" "Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 74.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 167.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "HPA002191: AB_1080165, HPA069176: AB_2686098" "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 14.8 24.3 11.2 23.9 11.3 59.8 20.3 18.5 14.8 21.3 11.8 51.5 60.0 29.9 37.1 21.6 15.2 39.5 14.6 11.2 11.4 59.1 15.5 41.1 9.8 12.2 12.6 10.7 18.9 24.2 34.4 19.6 50.8 13.9 20.3 56.8 316.0 21.8 24.8 11.0 26.4 44.4 26.6 9.8 23.6 47.9 22.3 12.3 7.5 28.0 18.1 14.0 28.5 18.4 13.1 40.1 23.8 0.9 11.0 20.5 11.5 33.1 21.1 37.7 49.4 61.0 109.4 38.2 11.2 38.9 16.1 85.6 44.0 63.5 22.0 59.4 9.6 12.0 12.7 16.4 34.0 51.1 41.7 116.4 21.0 46.6 38.3 46.2 30.5 39.7 16.6 110.5 23.0 21.5 23.8 0.4 28.9 60.1 63.1 18.2 14.5 40.8 18.6 92.7 94.5 27.0 41.4 9.0 48.0 167.2 79.9 52.1 29.0 54.0 20.8 44.0 28.6 19.3 25.8 49.4 22.8 27.8 27.0 29.0 42.5 6.3 74.1 2.4 1.9 2.5 1.0 3.3 1.6 7.1 3.1 3.0 0.9 60.7 0.5 1.2 1.0 0.0 2.7 11.2 11.3 18.5 14.8 11.2 11.4 12.2 12.6 10.7 13.9 9.8 12.3 13.1 17.0 67.3 30.6 2.6 9.5 50.7 69.5 12.8 30.1 373.0 43.5 15.2 10.2 31.5 18.9 11.0 394.0 10.1 5.9 124.6 17.6 40.2 4.8 37.8 9.6 30.2 26.3 4.4 40.4 25.6 15.9 12.8 29.6 68.5 58.2 14.9 20.7 5.6 16.0 72.3 33.0 36.5 18.3 18.9 49.7 7.5 3.7 26.4 37.4 24.4 28.7 48.4 11.3 3.5 25.3 48.9 64.1 7.5 5.8 87.2 34.0 69.5 13.3 400.3 6.6 10.0 15.9 4.6 20.6 29.4 60.1 40.5 17.9 5.6 26.5 87.7 MRPL16 "FLJ20484, PNAS-111" ENSG00000166902 "Mitochondrial ribosomal protein L16" Q9NX20 11 59806140-59810778 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 248.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054133 Supported NA NA "HPA054133: AB_2682394" "prognostic favorable (1.04e-4)" "unprognostic (1.13e-1)" "unprognostic (3.45e-3)" "unprognostic (5.88e-2)" "unprognostic (2.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (2.40e-3)" "unprognostic (1.50e-3)" "unprognostic (2.67e-2)" "unprognostic (2.87e-3)" "unprognostic (3.01e-2)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (2.01e-2)" 35.6 61.9 44.0 29.8 44.6 57.5 34.9 45.2 55.1 30.6 44.9 50.2 42.5 32.9 23.3 34.0 29.3 20.8 77.0 44.4 44.4 48.5 78.9 25.9 44.6 43.6 44.2 43.5 31.7 38.9 56.5 23.2 30.0 43.8 25.6 48.7 21.6 43.6 29.1 86.6 24.8 35.0 36.6 44.0 41.9 44.7 34.3 45.5 51.2 20.9 104.4 46.4 29.7 25.9 44.9 76.3 75.4 53.4 50.1 74.9 59.1 48.0 52.1 68.9 93.9 80.1 75.1 79.5 174.0 87.0 68.2 50.3 72.8 178.0 96.9 84.0 58.9 89.5 92.7 69.9 89.5 57.8 139.4 55.1 71.1 52.4 78.8 56.4 54.5 92.4 112.6 278.4 51.2 70.9 150.6 97.8 224.1 84.1 89.8 124.2 85.4 78.6 91.1 137.2 103.3 50.2 34.9 83.4 83.8 134.3 49.4 100.1 132.0 46.3 36.9 50.7 77.4 63.7 57.9 69.8 240.7 44.9 88.1 40.8 80.8 95.1 72.9 87.4 118.1 91.0 118.7 96.5 91.5 116.1 121.2 102.8 91.4 18.1 116.8 94.5 166.9 108.2 149.7 44.0 44.6 45.2 55.1 44.4 44.4 43.6 44.2 43.5 43.8 44.0 45.5 44.9 44.3 48.1 31.4 10.4 43.6 31.9 19.7 87.9 34.1 9.9 29.4 47.0 146.1 31.5 42.6 42.3 12.5 94.2 45.9 35.5 248.4 47.9 18.0 28.5 41.5 41.0 34.1 64.8 9.0 53.4 74.1 46.7 46.9 28.5 61.4 104.6 35.7 73.6 75.3 8.4 10.9 67.7 46.8 45.6 24.4 11.8 39.7 34.5 44.4 10.3 54.4 45.4 42.2 9.5 8.0 43.0 42.2 37.6 66.0 19.4 65.6 125.2 44.0 17.0 72.3 34.1 53.1 54.8 46.5 64.4 36.8 28.5 34.9 120.3 82.2 22.3 PIP4K2C "FLJ22055, PIP5K2C" ENSG00000166908 "Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma" Q8TBX8 12 57591174-57603418 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 121.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028658 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028658: AB_10601245" "unprognostic (7.84e-3)" "unprognostic (1.51e-1)" "unprognostic (2.42e-1)" "unprognostic (2.77e-2)" "unprognostic (2.49e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (3.17e-2)" "unprognostic (6.00e-2)" "unprognostic (5.51e-2)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.06e-6)" "unprognostic (1.87e-1)" "unprognostic (2.16e-1)" "unprognostic (3.27e-1)" "unprognostic (3.42e-1)" 13.1 17.3 16.3 11.7 22.0 26.8 20.2 14.1 32.8 17.4 19.4 24.4 16.1 18.6 82.3 28.4 26.8 16.2 15.0 21.6 15.3 36.3 14.9 19.9 13.6 16.0 14.2 20.4 16.2 21.2 39.4 18.8 12.2 17.7 21.8 26.6 29.4 25.8 18.6 14.1 26.5 19.3 16.0 12.5 14.7 40.1 28.4 16.3 11.5 22.6 10.6 18.9 18.3 20.7 22.3 52.0 36.4 14.8 17.6 0.0 0.1 47.0 21.4 40.6 38.7 35.1 46.7 73.4 11.3 44.1 25.6 47.4 46.1 24.2 42.2 30.3 15.9 26.1 20.0 17.5 33.7 32.8 19.3 35.0 12.9 70.0 14.7 26.9 46.4 19.6 12.1 26.8 33.3 20.0 52.6 16.5 16.7 28.1 32.1 31.2 0.5 130.9 17.2 39.6 91.1 23.7 30.0 45.8 30.4 29.7 49.3 83.2 17.8 4.2 18.5 26.1 27.7 22.8 25.1 31.5 25.6 36.0 16.0 32.1 58.8 8.2 25.8 24.3 10.5 16.1 8.7 14.8 18.4 8.6 11.0 13.8 16.7 16.3 16.2 14.6 3.8 19.9 11.0 16.3 22.0 14.1 32.8 21.6 15.3 16.0 14.2 20.4 17.7 12.5 16.3 22.3 4.1 9.6 8.6 4.9 6.9 12.4 6.2 11.7 10.8 14.3 13.2 8.0 121.7 12.8 11.9 35.0 18.8 11.3 7.4 33.7 21.5 17.7 25.7 14.2 4.2 8.8 22.2 5.2 28.0 19.7 15.2 5.4 26.0 20.3 3.8 4.0 9.3 12.6 8.9 8.4 11.8 18.4 10.2 6.0 2.2 47.9 6.8 5.7 12.4 2.8 5.9 7.5 5.2 5.0 11.5 40.5 12.8 5.3 9.4 10.1 14.2 13.3 15.3 8.1 19.7 3.8 13.1 12.0 9.0 14.3 12.8 17.4 11.9 5.5 10.4 9.2 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.9" "Cell type enhanced" "Detected in many" "Astrocytes: 86.2;Oligodendrocytes: 149.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 18.7 9.6 30.9 10.8 44.5 18.9 10.4 49.1 32.6 11.3 24.9 10.0 12.9 9.5 9.5 21.1 7.6 9.7 12.9 27.8 35.9 30.8 24.4 13.7 12.1 56.0 49.1 23.1 11.6 12.5 21.4 1.9 26.1 52.6 11.1 10.4 12.2 15.1 11.5 29.7 11.3 11.7 10.1 53.2 15.2 13.1 8.6 41.0 16.8 14.3 24.2 10.7 10.2 5.5 67.9 8.1 9.0 8.2 5.2 17.7 9.6 7.2 11.9 23.9 9.4 9.4 5.9 3.5 3.9 15.5 15.5 9.1 11.5 6.5 7.0 8.9 12.5 2.1 5.5 6.2 10.4 10.3 8.9 12.2 13.2 5.4 6.1 6.7 10.8 23.7 10.9 4.9 9.2 8.9 2.3 9.3 5.6 4.7 9.7 4.3 6.7 6.7 19.5 35.6 12.7 3.0 7.8 5.4 6.3 2.4 10.4 4.2 16.4 10.9 10.6 8.0 5.6 6.8 9.4 7.8 9.0 6.7 4.7 13.4 3.7 3.2 3.1 0.7 4.0 0.8 1.9 0.8 0.6 3.1 2.8 1.2 1.2 13.5 1.4 7.4 3.7 1.2 1.7 30.9 44.5 49.1 32.6 27.8 35.9 56.0 49.1 23.1 52.6 53.2 41.0 67.9 15.8 25.6 15.2 86.2 11.3 8.9 4.3 3.3 8.0 0.0 6.7 4.6 24.1 10.0 7.0 33.1 0.0 19.3 12.9 12.7 1.9 3.4 13.6 10.1 9.6 16.8 6.0 5.2 15.4 3.8 3.1 8.6 13.3 19.7 17.1 9.4 11.4 33.9 11.8 0.0 13.6 7.7 2.0 24.9 16.2 24.9 10.5 19.0 8.8 55.3 13.8 0.0 3.1 25.6 149.3 5.6 9.2 7.5 8.0 6.7 14.4 18.6 4.7 0.0 0.0 10.6 8.9 11.1 8.9 33.6 11.1 38.4 6.8 6.7 8.2 8.7 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885702-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212" Enhanced Supported Cytosol NA NA 97000000 Cytosol "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334" "prognostic unfavorable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavorable (6.14e-4)" "prognostic unfavorable (1.91e-6)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 134.3 121.7 194.9 141.3 233.9 112.1 107.9 162.0 278.2 104.6 167.0 162.3 129.6 103.0 84.3 149.7 98.5 98.4 106.0 242.2 215.6 157.0 97.5 127.5 175.7 192.5 191.9 231.9 81.9 58.6 124.1 48.7 124.3 201.1 100.8 175.2 115.9 84.5 134.7 86.4 131.0 136.4 143.9 179.8 163.7 124.6 57.3 209.6 140.4 119.2 79.2 212.1 154.9 92.3 257.8 306.5 227.8 179.5 173.2 291.0 255.5 238.9 270.8 263.2 327.7 284.6 479.6 336.9 324.2 272.6 361.9 355.5 315.5 256.1 506.0 388.0 124.1 153.1 242.4 180.8 285.8 192.6 396.8 223.6 201.4 370.4 257.2 328.4 223.6 333.5 196.0 265.6 152.6 340.9 363.2 312.1 325.3 169.7 348.9 341.6 240.3 259.5 251.1 352.3 336.6 189.8 202.6 459.9 485.7 331.1 207.7 354.6 376.3 381.2 504.6 259.7 288.8 281.2 100.4 196.9 292.5 369.9 260.8 263.5 105.5 95.2 90.5 71.3 130.8 74.0 71.2 89.3 87.7 102.8 66.5 70.6 86.2 93.4 72.4 155.4 65.9 113.8 71.9 194.9 233.9 162.0 278.2 242.2 215.6 192.5 191.9 231.9 201.1 179.8 209.6 257.8 421.4 253.2 289.0 35.6 292.8 276.7 256.0 270.8 195.2 239.9 229.6 199.3 197.1 200.1 236.5 248.3 50.1 358.6 317.2 532.6 230.9 476.1 17.7 183.0 274.2 351.5 298.1 183.4 93.8 489.8 627.7 246.4 192.7 278.5 227.9 262.8 300.9 155.9 410.3 292.7 64.1 388.4 160.7 394.5 329.9 24.2 188.9 418.7 222.3 51.5 543.5 229.0 295.5 25.6 63.0 654.9 429.9 210.3 301.8 419.0 328.9 364.5 206.4 131.5 230.1 173.3 337.8 51.1 171.3 333.3 325.3 531.3 369.3 394.2 382.4 440.5 C15orf48 "COXFA4L3, MIR147BHG, NMES1" ENSG00000166920 "Chromosome 15 open reading frame 48" Q9C002 15 45430579-45448761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 932.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2962.4;Exocrine glandular cells: 2020.8;Langerhans cells: 2043.7;Pancreatic endocrine cells: 3493.6;Paneth cells: 2254.4;Proximal enterocytes: 2942.0;Undifferentiated cells: 1875.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.3;intermediate monocyte: 1.6;myeloid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 70.9;CAPAN-2: 128.8;GAMG: 126.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012943 Enhanced NA NA "HPA012943: AB_2668774" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (7.83e-2)" "unprognostic (1.17e-1)" "unprognostic (9.74e-3)" "unprognostic (1.48e-3)" "unprognostic (1.28e-3)" "unprognostic (1.59e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-3)" "unprognostic (5.95e-2)" "unprognostic (8.86e-2)" "unprognostic (2.37e-1)" "unprognostic (6.51e-2)" "unprognostic (1.39e-1)" "unprognostic (3.66e-1)" 2.2 0.4 0.6 99.4 0.5 88.7 31.0 0.5 2.9 18.9 0.7 871.5 62.4 5.4 0.2 174.0 6.9 46.3 0.6 0.5 0.8 5.8 6.0 11.6 5.8 0.6 0.5 0.4 0.7 13.1 0.1 0.5 46.8 1.4 14.0 932.9 3.7 23.2 11.6 0.4 65.8 344.1 31.6 0.7 2.3 108.5 129.2 1.0 7.0 5.3 0.2 85.5 39.2 46.9 1.1 70.9 18.1 0.2 0.3 0.9 0.0 2.7 3.5 25.1 4.6 12.7 2.9 128.8 0.2 3.1 0.4 126.2 1.8 2.3 0.9 10.7 7.0 1.9 0.0 0.2 0.5 11.2 0.1 29.1 1.3 1.2 22.9 0.0 0.0 0.0 0.5 0.1 0.5 0.6 3.5 0.1 1.8 0.1 31.4 0.3 0.0 0.4 0.4 2.7 5.7 0.1 0.6 4.1 8.0 0.3 14.0 1.4 1.6 0.6 0.4 1.6 1.0 0.9 2.1 1.2 0.4 1.9 0.7 0.5 0.0 1.3 0.1 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.0 0.8 0.6 0.5 0.5 2.9 0.5 0.8 0.6 0.5 0.4 1.4 0.7 1.0 1.1 5.5 16.0 15.0 0.3 20.4 66.4 20.2 846.0 1.2 0.5 143.2 111.9 1.0 188.8 1117.6 5.5 0.0 286.2 7.4 2962.4 3.9 811.3 188.3 29.2 11.0 11.6 645.1 0.0 0.2 2020.8 450.3 16.4 250.2 67.7 33.0 0.2 1.4 3.7 398.4 114.4 0.1 1408.8 270.6 25.9 2043.7 235.4 7.2 388.4 58.7 0.0 489.4 0.7 1.0 0.5 0.4 3493.6 2254.4 7.5 4.1 200.5 2942.0 18.7 700.9 1.2 0.0 1.2 75.2 567.9 124.4 10.6 61.2 165.5 13.9 0.1 1875.4 633.4 SCG5 "7B2, SGNE1, SgV" ENSG00000166922 "Secretogranin V" P05408 15 32641676-32697098 "Predicted secreted proteins" Transport "Chaperone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 134.1;pituitary gland: 405.8" "Cell type enriched" "Detected in many" 4 "Enteroendocrine cells: 470.8" "Group enriched" "Detected in many" 5 "glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013136, HPA074618" Enhanced "Secreted to blood" NA NA 100000 "HPA013136: AB_1856657, HPA074618: AB_2732262" "unprognostic (1.71e-1)" "unprognostic (9.87e-2)" "unprognostic (7.94e-2)" "unprognostic (1.30e-2)" "unprognostic (3.59e-3)" "prognostic unfavorable (9.64e-4)" "unprognostic (2.69e-1)" "unprognostic (1.27e-3)" "unprognostic (4.69e-2)" "unprognostic (1.97e-1)" "unprognostic (5.62e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (4.51e-9)" "unprognostic (3.57e-2)" "unprognostic (8.13e-2)" "unprognostic (3.08e-3)" "unprognostic (8.88e-2)" 1.1 61.7 59.7 3.3 69.5 0.3 3.7 61.3 90.1 0.9 80.9 7.9 18.1 5.4 42.9 0.5 3.5 5.6 0.9 69.7 74.9 0.9 3.7 3.9 1.3 68.7 63.7 67.8 3.3 134.1 74.2 405.8 0.3 68.3 5.0 9.9 27.0 0.2 0.9 0.2 1.3 5.7 6.7 59.6 0.5 38.1 5.3 62.1 0.3 5.8 0.1 0.3 2.6 2.7 92.8 0.5 0.2 0.1 0.2 0.6 4.5 0.1 4.2 0.4 0.4 0.4 0.1 0.0 0.5 1.9 0.4 1.7 1.2 0.5 0.2 1.2 0.7 0.3 0.6 0.0 0.1 26.9 0.2 0.7 33.5 0.1 0.8 0.4 0.9 0.7 1.0 0.3 0.6 0.8 0.0 0.3 0.3 15.3 0.1 0.8 0.1 0.4 0.6 0.4 0.0 31.5 36.4 0.2 0.0 0.2 0.4 0.1 0.4 0.0 5.2 3.8 0.3 0.5 0.6 2.3 0.4 47.2 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.7 69.5 61.3 90.1 69.7 74.9 68.7 63.7 67.8 68.3 59.6 62.1 92.8 0.2 0.0 0.5 20.2 0.3 0.6 0.2 6.2 0.0 51.0 0.5 16.5 0.4 0.0 3.9 0.0 2.1 0.2 0.1 1.1 0.0 0.6 52.1 3.7 19.3 1.1 470.8 0.0 82.8 78.3 0.3 17.9 23.0 0.6 2.5 51.4 0.4 11.9 6.0 50.5 97.8 14.5 97.6 0.6 0.8 80.0 2.1 1.6 3.6 20.6 0.6 15.6 0.0 52.3 79.7 22.9 1.1 7.9 0.3 1.4 0.5 0.0 0.5 32.6 0.0 0.3 34.2 39.2 2.9 0.1 0.3 0.3 0.3 51.8 2.4 1.0 GREM1 "CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS" ENSG00000166923 "Gremlin 1, DAN family BMP antagonist" O60565 15 32718004-32745106 "Disease related genes, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 113.9;smooth muscle: 68.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 66.2;Granulosa cells: 121.1;Oligodendrocytes: 40.5;Skeletal myocytes: 181.4" "Cancer enhanced" "Detected in many" "stomach cancer: 24.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 294.7;BJ hTERT+: 468.5;BJ hTERT+ SV40 Large T+ RasG12V: 286.8;fHDF/TERT166: 957.0;hTEC/SVTERT24-B: 227.8" "Group enriched" "Detected in many" 5 "hippocampal formation: 3.2;olfactory bulb: 10.9" "Low region specificity" "Detected in many" HPA007526 Uncertain "Secreted to blood" NA NA 242000000 "HPA007526: AB_1849971" "unprognostic (4.74e-2)" "unprognostic (2.78e-1)" "unprognostic (4.63e-2)" "unprognostic (6.80e-2)" "unprognostic (3.58e-1)" "unprognostic (1.72e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-3)" "unprognostic (2.79e-1)" "unprognostic (2.13e-11)" "unprognostic (1.77e-2)" "unprognostic (6.60e-2)" "unprognostic (3.29e-2)" "unprognostic (1.16e-3)" 16.1 0.5 1.2 6.6 2.9 0.2 5.6 0.7 3.5 40.0 0.0 32.6 2.6 9.7 0.0 13.7 1.1 113.9 0.8 1.3 1.6 0.9 1.1 2.2 1.1 3.0 2.9 0.6 0.3 2.2 0.0 0.2 0.3 3.0 8.3 27.0 0.1 0.6 3.8 0.6 5.9 52.7 68.9 0.6 0.8 37.1 0.5 2.4 0.0 2.3 0.0 1.7 21.9 50.8 5.1 0.0 3.5 0.0 0.0 11.1 12.5 0.0 294.7 468.5 112.5 286.8 0.3 0.0 0.0 0.0 957.0 0.0 0.0 0.0 0.0 109.7 0.0 0.1 0.0 0.1 0.0 3.3 0.0 0.0 3.1 0.0 227.8 0.1 70.6 0.0 0.0 0.0 0.0 143.4 0.1 0.0 0.0 1.2 0.0 0.9 0.0 20.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 57.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 2.9 0.7 3.5 1.3 1.6 3.0 2.9 0.6 3.0 0.6 2.4 5.1 0.7 0.0 0.0 0.3 0.4 6.6 6.5 0.0 0.6 2.1 1.7 0.9 3.4 0.0 0.0 66.2 2.1 0.2 0.7 0.4 0.0 0.4 0.2 0.6 2.3 1.9 0.0 0.0 2.5 0.0 0.1 17.7 0.0 0.7 0.0 121.1 0.7 1.2 1.0 1.7 0.5 0.6 0.0 0.3 12.8 0.0 0.0 2.3 3.6 0.0 2.7 0.3 0.0 1.5 40.5 0.3 0.0 0.4 0.2 9.9 0.1 0.3 0.0 1.3 0.0 181.4 16.1 0.1 1.4 0.3 4.5 0.3 2.1 0.1 0.1 6.5 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;pituitary gland: 22.1" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 1.4 2.5 7.9 0.3 10.0 0.1 1.6 0.0 24.9 2.9 0.0 1.1 0.2 4.7 0.0 1.1 2.2 0.2 0.5 13.2 2.7 0.8 0.4 0.3 0.1 7.3 2.3 10.0 5.3 0.9 0.0 22.1 0.3 10.1 2.0 0.1 1.9 0.9 1.0 0.1 1.4 0.8 0.5 0.0 0.8 0.8 9.2 2.1 0.1 0.7 0.1 0.0 0.7 2.0 10.2 0.0 1.1 3.0 1.4 2.0 1.2 0.2 0.1 1.0 0.1 0.4 0.4 0.2 0.0 1.0 0.3 7.8 0.1 0.6 0.1 0.0 1.4 0.2 0.1 0.3 0.2 1.4 0.0 0.8 1.3 0.0 0.4 0.5 0.3 3.9 0.2 0.5 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 9.4 0.3 0.2 1.0 1.1 0.1 0.0 1.4 0.0 1.9 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 10.0 0.0 24.9 13.2 2.7 7.3 2.3 10.0 10.1 0.0 2.1 10.2 3.2 0.0 0.0 9.4 0.0 0.1 0.2 0.1 0.6 6.2 0.3 1.9 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.2 0.4 1.4 0.0 0.8 11.1 0.0 0.0 0.9 0.0 0.4 0.0 5.6 0.7 0.0 0.1 13.5 10.3 0.1 0.0 0.0 0.7 0.7 2.5 0.1 0.0 2.8 0.0 3.3 0.0 2.5 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.5 0.7 1.3 2.6 0.2 0.1 0.0 0.1 0.8 0.0 0.0 TSC22D4 "THG-1, TILZ2" ENSG00000166925 "TSC22 domain family member 4" Q9Y3Q8 7 100463359-100479232 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 583.8" "Cell type enriched" "Detected in all" 4 "Muller glia cells: 778.8" "Cancer enhanced" "Detected in all" "glioma: 118.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 198.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006757 Uncertain Approved Cytosol NA NA 160000 Cytosol "HPA006757: AB_1080403" "unprognostic (2.34e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (9.96e-2)" "unprognostic (1.27e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (3.36e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-2)" "unprognostic (3.84e-2)" "unprognostic (7.36e-2)" "unprognostic (3.81e-3)" 35.5 53.1 399.8 33.9 509.8 72.6 36.5 478.7 460.5 43.4 187.6 44.0 23.7 40.8 10.2 73.6 37.1 14.5 56.1 345.1 402.7 52.4 30.2 43.0 40.9 583.8 521.0 279.9 44.4 37.6 18.6 52.5 22.9 495.8 56.2 10.8 22.1 98.5 22.4 26.5 57.5 44.8 14.1 425.1 95.9 38.9 37.0 452.4 31.5 34.8 28.9 23.4 38.2 47.2 525.5 42.0 30.8 10.3 33.7 34.2 40.5 19.9 30.5 49.6 28.3 25.8 16.9 25.0 36.8 36.1 24.4 66.0 31.2 12.2 26.7 9.9 65.6 25.2 34.2 34.5 14.6 54.4 44.1 86.3 45.7 24.0 32.4 32.2 33.0 58.3 29.0 75.2 64.2 22.9 74.3 55.6 198.4 14.0 35.7 42.6 89.7 8.1 51.6 23.2 22.3 8.8 25.1 41.4 78.8 65.5 16.7 22.5 63.1 50.2 38.4 39.1 95.0 22.8 40.9 42.6 27.1 35.7 66.4 47.8 9.7 18.7 30.0 19.0 20.2 14.9 11.9 16.3 17.9 12.7 11.8 15.2 16.2 56.1 18.8 20.5 13.3 25.0 18.2 399.8 509.8 478.7 460.5 345.1 402.7 583.8 521.0 279.9 495.8 425.1 452.4 525.5 16.7 12.8 8.9 123.4 50.8 32.8 35.9 50.7 37.5 15.4 47.3 61.3 17.7 44.3 32.5 40.5 6.2 30.7 69.3 60.3 137.0 63.5 1.7 14.0 25.5 26.1 33.6 60.6 3.8 33.9 35.3 29.8 21.4 19.9 15.9 36.1 42.1 11.1 79.9 18.5 4.6 32.1 38.7 57.7 67.1 5.2 45.7 56.7 55.2 14.0 77.2 778.8 116.4 50.8 162.6 60.6 52.7 39.9 31.8 59.2 62.8 21.0 13.7 18.2 46.0 16.1 34.5 1.7 5.4 32.8 33.8 79.1 78.2 28.9 31.7 80.3 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 35.9" "Cell type enriched" "Detected in some" 10 "Early spermatids: 1211.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA076623 Approved Vesicles NA NA Vesicles "HPA076623: AB_2686809" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 1.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 35.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1211.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 114.8 6.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MS4A7 "CD20L4, CFFM4, MS4A8" ENSG00000166927 "Membrane spanning 4-domains A7" Q9GZW8 11 60378485-60395951 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 311.4;Kupffer cells: 1060.3;Macrophages: 567.5;monocytes: 184.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 747.4;non-classical monocyte: 1486.0" "Lineage enriched" "Detected in many" 12 "monocytes: 1486.0" "Cell line enriched" "Detected in some" 25 "THP-1: 114.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA017418, CAB026387" Approved NA NA "CAB026387: , HPA017418: AB_1854137" "unprognostic (1.43e-1)" "unprognostic (2.60e-3)" "unprognostic (3.24e-2)" "unprognostic (9.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (3.02e-2)" "unprognostic (4.85e-2)" "unprognostic (5.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" "unprognostic (4.59e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" 47.4 38.0 5.6 51.4 6.4 10.8 31.1 4.7 16.2 18.4 18.0 21.6 17.7 7.6 4.1 12.8 6.7 47.2 10.0 5.4 18.9 8.1 67.1 76.4 23.4 10.9 7.2 2.9 6.1 6.1 9.1 4.8 44.2 10.5 4.9 23.6 1.2 6.8 9.1 1.9 2.2 25.3 16.0 8.2 198.3 14.9 4.8 12.3 18.4 7.4 4.1 18.7 41.6 4.0 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.1 0.0 0.1 1.1 0.1 0.1 0.0 2.8 0.0 0.1 0.1 0.8 0.5 0.0 0.0 114.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 3.0 0.0 3.1 0.0 8.3 188.0 2.5 0.8 747.4 1.1 22.3 0.6 0.5 120.9 19.7 0.8 0.4 9.3 0.8 1486.0 3.2 0.9 137.8 5.6 6.4 4.7 16.2 5.4 18.9 10.9 7.2 2.9 10.5 8.2 12.3 19.1 5.0 12.8 31.4 0.0 30.6 2.7 0.8 0.0 0.6 3.6 14.7 9.9 2.1 0.0 3.7 9.2 0.0 1.0 1.4 0.3 0.0 0.0 2.4 0.1 0.0 12.2 0.0 10.1 0.1 0.2 1.7 3.9 1.5 0.1 13.9 0.1 11.0 4.7 311.4 0.0 0.2 0.0 0.0 1060.3 93.4 1.2 1.2 567.5 1.8 59.0 184.8 0.4 4.1 0.0 0.3 0.1 1.1 0.0 1.8 1.1 0.0 0.7 7.3 0.5 19.7 2.2 1.2 0.0 0.4 0.9 1.8 1.9 5.3 0.3 0.1 1.0 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 73.6" "Group enriched" "Detected in some" 44 "Early spermatids: 262.3;Late spermatids: 672.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 5.5;non-classical monocyte: 8.0" "Lineage enriched" "Detected in many" 5 "monocytes: 8.0" "Cell line enriched" "Detected in single" 23 "THP-1: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA058973 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 5.1 3.7 6.2 3.5 6.4 0.6 3.7 6.1 11.3 1.2 9.3 2.5 0.7 0.9 0.6 0.9 1.3 0.9 2.4 6.7 8.2 1.8 2.0 12.0 1.3 7.4 6.6 5.3 0.7 1.3 0.3 1.5 2.4 7.2 1.9 1.1 0.4 1.9 0.5 0.9 0.8 2.7 1.2 6.9 10.5 1.2 73.6 8.1 0.3 1.5 0.3 1.9 2.0 1.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 5.5 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.9 6.2 6.4 6.1 11.3 6.7 8.2 7.4 6.6 5.3 7.2 6.9 8.1 8.9 0.2 0.0 1.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 262.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 7.3 5.5 672.0 4.1 10.4 0.0 3.7 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.7 0.0 6.6 0.1 0.0 6.5 3.4 0.0 0.3 0.1 0.1 0.0 0.0 0.0 MS4A5 CD20L2 ENSG00000166930 "Membrane spanning 4-domains A5" Q9H3V2 11 60429572-60455214 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 167 "testis: 44.9" "Group enriched" "Detected in some" 66 "Early spermatids: 700.0;Late spermatids: 1017.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043732 Uncertain NA NA "HPA043732: AB_10959759" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 700.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1017.8 5.6 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 13.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 10.5 11.9 7.8 6.2 9.5 7.7 9.3 8.6 8.7 10.2 7.2 10.0 5.2 11.2 9.6 7.6 9.7 5.6 12.8 7.9 8.7 8.4 11.0 6.0 7.7 8.9 9.3 6.3 11.2 13.0 15.9 10.1 5.4 9.6 8.8 6.0 11.5 9.0 9.0 23.4 7.5 7.8 8.9 8.6 8.7 9.1 9.9 8.9 7.9 11.1 28.5 7.3 9.7 8.1 12.2 14.0 32.6 10.6 14.1 12.2 16.4 12.4 9.5 11.1 14.3 13.2 17.6 10.1 51.6 10.3 13.4 14.9 23.3 25.7 9.2 9.2 12.0 24.1 26.7 25.1 20.1 9.5 27.7 10.1 6.9 9.7 4.5 14.8 9.7 13.1 17.7 18.6 12.6 14.4 12.3 13.8 17.3 15.4 12.7 20.0 18.3 42.1 30.0 5.7 18.9 17.1 15.7 22.3 7.6 11.4 10.0 10.6 21.8 14.4 18.7 16.8 7.4 18.7 10.1 36.9 24.0 6.4 35.9 7.8 8.5 5.1 4.3 7.6 6.1 10.2 6.5 7.7 10.0 8.5 7.8 8.8 7.3 0.6 11.7 13.2 6.7 8.0 6.7 7.8 9.5 8.6 8.7 7.9 8.7 8.9 9.3 6.3 9.6 8.6 8.9 12.2 7.1 6.4 16.2 22.5 14.6 4.2 5.5 4.0 17.1 15.6 9.4 7.6 30.3 15.7 7.1 3.7 4.2 17.0 9.6 5.0 5.9 6.5 7.1 8.3 14.6 10.2 3.0 24.2 11.4 3.5 4.5 12.4 10.7 7.3 16.5 25.1 7.1 19.2 9.6 10.1 17.2 10.6 8.2 12.3 7.8 9.9 19.9 10.1 1.8 13.1 14.4 17.7 12.3 22.6 23.1 3.3 5.1 20.3 18.4 4.8 5.4 9.8 8.1 23.2 19.7 9.5 10.1 28.5 17.2 12.1 5.4 3.7 16.0 16.5 14.0 3.8 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197177 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 20.2" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEL: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 3.3 1.4 2.3 1.4 2.2 20.2 2.1 4.0 2.7 1.3 2.0 1.6 1.5 1.4 2.1 1.2 2.0 1.0 1.2 2.2 2.5 1.5 1.8 2.7 2.2 2.5 2.3 2.3 0.8 1.3 1.1 1.2 1.4 2.9 1.4 1.9 1.8 1.6 1.1 1.7 2.9 2.6 1.2 2.0 2.7 2.1 0.9 2.5 1.5 1.7 1.3 2.0 1.7 1.1 2.9 0.2 0.2 0.4 0.2 1.3 0.8 0.4 0.3 1.6 0.3 0.3 0.4 0.3 0.5 0.4 1.1 0.1 0.5 1.1 0.5 0.2 0.7 1.1 13.5 0.6 0.5 0.9 0.7 0.7 1.5 1.2 0.1 0.2 1.3 1.0 0.2 0.8 0.4 0.4 0.0 0.4 1.4 0.9 0.5 0.3 0.4 0.5 1.2 1.7 0.6 0.6 0.9 0.5 0.4 0.3 0.5 0.0 1.1 1.2 0.2 0.1 1.0 0.2 1.4 0.6 0.1 1.3 1.4 0.4 21.8 1.9 5.6 5.1 3.7 5.4 4.7 5.5 5.2 1.8 5.3 5.6 5.9 6.2 4.8 9.5 3.0 8.4 1.8 2.3 2.2 4.0 2.7 2.2 2.5 2.5 2.3 2.3 2.9 2.0 2.5 2.9 59.8 48.1 54.9 11.1 81.8 34.7 55.7 83.3 25.0 28.9 38.0 40.9 52.6 40.0 78.6 29.5 20.9 362.7 92.0 63.6 90.1 64.0 24.2 61.6 33.8 45.2 46.2 361.2 20.7 59.3 82.1 55.9 45.3 37.0 57.0 40.2 53.6 31.0 85.4 45.4 17.8 47.7 154.6 83.5 36.2 12.6 47.2 57.1 64.0 11.2 137.8 55.9 74.2 9.5 23.4 68.6 55.8 29.3 54.2 42.1 85.8 47.5 128.0 66.0 46.0 35.2 49.4 124.3 61.6 27.8 40.3 1055.9 85.9 37.8 42.2 88.5 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221018 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 99.8" "Cell type enriched" "Detected in many" 33 "Erythroid cells: 480.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "HEL: 85.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 1400000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 3.1 0.0 0.0 0.0 0.0 99.8 0.5 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 2.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.8 1.9 1.5 0.5 0.0 4.0 0.0 0.0 0.6 1.5 0.5 0.0 6.2 4.5 0.0 1.5 0.0 0.0 14.4 0.0 0.0 1.2 0.0 480.0 0.1 0.0 2.3 0.8 0.0 0.0 4.5 0.0 2.5 1.1 1.1 6.7 0.1 0.9 4.1 2.2 2.8 10.5 2.8 1.1 1.8 0.0 3.6 2.5 14.4 0.0 0.0 0.0 1.7 0.7 0.4 1.5 2.4 0.0 0.6 8.4 6.6 1.0 1.0 13.5 4.6 0.0 2.8 6.7 3.8 0.0 0.8 2.0 TGM6 "dJ734P14.3, SCA35, TGM3L, TGY" ENSG00000166948 "Transglutaminase 6" O95932 20 2380901-2432753 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" HPA059196 Uncertain NA NA "HPA059196: AB_2683943" "unprognostic (1.18e-1)" "unprognostic (2.84e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMAD3 "HsT17436, JV15-2, MADH3" ENSG00000166949 "SMAD family member 3" P84022 15 67063763-67195173 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 162.5;Prostatic glandular cells: 149.3;Urothelial cells: 276.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008094, HPA046386, HPA067203, CAB069409" Approved Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (1.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-2)" "unprognostic (8.40e-3)" "unprognostic (1.80e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.93e-1)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (5.97e-2)" 29.5 6.4 18.7 16.0 22.2 18.9 22.4 8.6 16.3 29.3 28.8 15.4 17.8 20.5 13.7 52.3 23.5 21.3 23.5 17.0 22.7 23.7 20.0 21.6 16.9 18.3 9.8 15.6 31.0 18.4 10.5 14.6 17.0 12.2 24.6 13.0 6.3 17.3 13.9 55.5 29.3 21.8 21.3 10.9 15.5 22.4 4.0 11.9 19.7 30.4 39.3 25.9 44.0 31.8 14.8 49.3 157.0 30.6 13.9 50.8 115.9 22.5 27.6 114.0 37.8 30.7 33.7 125.3 16.5 36.6 79.4 169.8 111.3 31.2 116.9 38.1 13.1 11.9 1.8 43.4 26.2 38.2 6.6 2.7 106.5 26.7 33.2 27.7 83.2 128.2 5.2 40.3 40.8 47.1 24.2 1.5 26.0 17.7 26.1 50.5 1.6 9.1 5.9 25.2 149.4 0.8 10.3 36.6 19.5 32.5 59.2 5.3 30.2 109.4 50.4 47.1 36.5 31.7 16.5 5.0 21.0 45.8 7.0 45.9 0.0 1.0 2.3 3.2 0.9 3.3 1.2 3.6 3.4 1.0 2.8 1.6 1.4 0.0 0.3 0.9 1.5 1.9 1.1 18.7 22.2 8.6 16.3 17.0 22.7 18.3 9.8 15.6 12.2 10.9 11.9 14.8 18.2 48.1 19.9 28.4 33.9 89.0 90.2 70.6 53.5 10.8 13.3 10.5 12.2 17.2 49.6 36.8 6.2 1.1 19.7 48.2 3.9 61.9 1.0 23.6 30.2 26.6 3.5 9.1 63.2 50.7 4.2 42.6 28.5 75.2 24.1 162.5 11.4 12.6 10.7 0.0 6.9 13.0 24.4 6.2 40.8 5.7 26.8 18.8 21.4 67.5 9.7 8.5 20.6 140.2 1.3 99.7 49.2 20.7 10.6 149.3 34.2 14.0 52.2 0.6 26.3 28.9 27.5 0.6 2.3 70.3 48.9 1.6 21.6 18.8 16.6 276.2 MS4A8 "CD20L5, MS4A4, MS4A8B" ENSG00000166959 "Membrane spanning 4-domains A8" Q9BY19 11 60699585-60715807 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 130.9;intestine: 199.3" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.9;RPMI-8226: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007319 Enhanced NA NA "HPA007319: AB_1854138" "unprognostic (7.28e-3)" "unprognostic (2.11e-1)" "unprognostic (9.03e-2)" "unprognostic (1.91e-2)" "unprognostic (2.52e-2)" "unprognostic (9.41e-2)" "unprognostic (4.89e-3)" "unprognostic (9.33e-2)" "unprognostic (7.97e-3)" "unprognostic (2.40e-1)" "unprognostic (2.40e-9)" "unprognostic (2.46e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-3)" 0.0 0.8 1.7 3.6 1.4 0.0 0.0 0.2 1.0 25.8 4.4 18.4 191.5 8.3 0.0 0.3 130.9 10.9 0.0 0.6 0.7 0.1 0.0 16.7 0.2 0.1 0.2 1.0 0.3 2.2 0.7 7.6 0.1 0.1 1.7 17.1 0.0 0.6 7.2 4.7 0.0 199.3 1.0 0.0 0.0 46.0 0.5 0.5 0.1 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.2 1.0 0.6 0.7 0.1 0.2 1.0 0.1 0.0 0.5 0.3 0.0 6.4 6.4 0.0 0.2 0.0 0.2 11.9 0.0 0.0 0.0 0.0 0.3 18.6 58.8 1.8 0.0 0.0 0.0 15.0 0.0 0.3 1.3 376.4 3.2 0.3 473.4 0.0 0.4 2.5 0.0 2.0 14.3 11.6 1.3 0.0 0.0 0.0 0.0 0.0 0.1 42.5 140.4 0.0 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 46.1 0.0 0.0 1.7 694.6 0.2 502.8 0.0 0.0 0.0 3.5 0.3 0.7 0.0 0.0 0.0 0.5 0.2 24.7 0.4 CCDC178 "C18orf34, FLJ44050" ENSG00000166960 "Coiled-coil domain containing 178" Q5BJE1 18 32937402-33441101 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.6;testis: 15.4" "Cell type enhanced" "Detected in some" "Adipocytes: 29.2;Early spermatids: 89.0;Late spermatids: 76.8;Spermatocytes: 49.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "HUVEC TERT2: 5.1;U-87 MG: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.15e-2)" "unprognostic (2.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (9.88e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (2.58e-3)" "unprognostic (2.92e-1)" "unprognostic (5.95e-4)" "unprognostic (4.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.94e-4)" "unprognostic (2.86e-1)" "unprognostic (1.42e-3)" "unprognostic (9.03e-3)" 9.6 0.3 0.2 0.2 0.3 0.0 7.9 0.1 0.5 2.7 0.2 0.8 0.5 1.3 2.2 0.6 1.6 2.5 0.4 0.3 0.3 2.8 0.1 0.7 0.2 0.4 0.5 0.3 4.0 0.2 0.1 0.6 0.0 0.3 3.5 0.5 0.1 0.5 2.0 0.3 0.6 0.6 1.6 0.4 7.7 0.6 15.4 0.2 0.1 0.8 0.0 0.6 2.1 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.5 0.3 0.3 0.4 0.5 0.3 0.3 0.4 0.2 0.2 29.2 0.0 0.0 0.3 0.0 0.4 0.4 0.0 2.2 0.0 0.1 0.4 0.3 0.0 0.0 1.8 0.0 0.0 0.1 0.0 9.8 0.0 89.0 0.6 0.3 12.8 0.0 0.0 7.9 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 76.8 1.8 0.2 0.0 2.8 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.7 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.2 49.4 16.3 0.1 0.3 0.0 0.0 6.1 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756867-60776733 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lung: 44.3" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 1: 96.1" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 3.2" "Lineage enriched" "Detected in single" 12 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1" "Region enriched" "Detected in some" 28 "olfactory bulb: 166.8" "Region enriched" "Detected in single" 26 "olfactory bulb: 20.2" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.4 0.3 0.1 2.2 0.3 0.4 0.3 0.2 0.3 1.0 1.3 0.3 0.4 1.0 0.2 0.3 0.7 0.2 0.1 0.0 44.3 0.5 0.3 0.2 0.3 1.8 0.1 0.0 0.0 0.7 0.5 0.3 0.7 0.4 0.1 1.3 0.0 0.0 2.2 1.6 0.1 0.3 0.4 0.6 0.2 3.8 0.3 0.0 1.8 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.5 1.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 4.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 3.2 0.2 0.3 0.3 0.3 0.4 0.7 0.2 0.3 0.2 0.3 0.5 0.1 0.2 0.4 0.2 96.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.1 0.2 0.1 0.0 0.0 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 321.9" "Cell type enhanced" "Detected in many" "dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 61 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in single" 61 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol No No 55000 Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (1.09e-5)" "prognostic unfavorable (1.66e-5)" 5.2 6.0 68.8 3.9 82.2 0.9 4.4 42.3 321.9 8.0 0.0 12.3 1.2 8.3 2.5 3.0 7.3 4.2 14.4 109.2 36.4 1.2 0.2 2.2 1.0 183.5 60.7 76.1 5.1 1.0 2.1 11.8 2.7 194.9 4.9 3.5 21.9 2.5 7.5 4.5 2.9 4.0 13.3 29.0 0.9 4.3 3.8 111.0 24.2 4.1 5.2 0.9 12.0 4.6 191.5 0.3 2.5 11.1 6.4 60.7 41.5 0.1 36.3 61.8 10.5 10.1 4.4 0.1 0.2 15.3 94.0 3.3 0.5 15.0 0.1 6.1 5.5 1.4 14.2 3.5 0.3 5.8 0.4 5.8 31.3 0.1 58.1 0.3 15.8 8.0 41.3 24.0 0.3 42.8 0.5 26.6 0.8 8.1 0.0 1.0 7.2 32.1 0.1 0.2 0.1 34.8 10.6 1.2 0.1 0.3 14.6 2.3 0.6 1.5 33.7 11.3 11.3 0.5 0.0 1.6 5.0 121.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.1 68.8 82.2 42.3 321.9 109.2 36.4 183.5 60.7 76.1 194.9 29.0 111.0 191.5 6.7 3.2 1.1 11.8 2.2 5.5 1.4 1.4 2.8 43.4 1.7 3.6 55.1 0.0 7.9 3.7 25.0 0.3 90.9 1.0 0.0 0.4 13.1 33.2 19.5 5.7 11.4 3.0 34.4 0.0 0.6 46.9 2.6 1.0 7.0 16.7 4.2 0.0 2.4 299.5 45.1 1.7 10.2 0.3 7.4 5.6 51.0 9.4 8.8 12.2 0.7 16.7 0.0 9.5 51.4 0.7 0.0 76.3 1.1 0.5 0.0 0.5 63.6 27.2 32.9 45.7 48.2 10.6 25.6 1.1 4.1 1.1 5.6 3.1 1.4 0.5 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 3.5 8.9 4.2 3.0 4.7 4.7 3.5 6.0 4.9 6.6 5.0 5.9 5.1 5.5 3.5 6.6 6.0 2.0 5.8 4.4 4.2 6.2 6.7 2.6 4.0 3.7 3.8 4.7 7.4 9.3 5.2 3.0 2.3 4.5 5.4 4.5 3.1 5.1 2.9 3.8 7.4 4.8 2.8 3.2 4.3 6.8 5.9 4.1 4.7 4.6 1.0 4.7 5.5 5.7 4.5 8.0 11.7 2.7 5.7 6.6 7.8 20.2 9.1 1.6 2.6 2.7 5.6 14.9 28.0 14.2 5.6 0.2 16.8 8.9 2.4 4.3 23.7 18.2 20.3 21.2 8.0 5.5 9.8 7.7 5.8 8.0 2.6 3.6 10.3 4.3 16.2 15.7 18.0 7.8 2.7 11.8 10.2 10.4 9.6 4.8 14.0 13.6 30.4 12.0 3.6 8.8 10.1 15.8 10.0 11.6 14.2 11.5 18.7 6.9 1.6 11.2 6.6 0.4 31.9 14.1 16.9 3.0 21.4 7.7 0.0 0.2 0.0 0.2 0.6 0.5 0.8 0.4 0.7 0.4 0.5 0.8 0.2 0.0 0.5 0.3 0.6 0.6 0.2 4.2 4.7 6.0 4.9 4.4 4.2 3.7 3.8 4.7 4.5 3.2 4.1 4.5 6.0 0.0 2.2 7.5 9.7 7.4 11.3 9.0 7.4 6.2 9.9 10.9 8.5 4.3 5.3 7.3 4.2 20.9 5.0 14.9 3.9 8.0 3.1 3.2 8.2 5.0 22.1 56.8 9.6 4.9 18.4 8.0 8.2 5.7 0.0 12.5 4.2 8.5 12.0 0.0 11.3 20.5 6.1 8.1 4.0 6.5 8.7 5.7 5.4 3.7 4.3 11.1 10.3 8.5 2.0 5.0 11.7 7.9 9.4 9.8 17.4 13.7 2.9 2.9 26.3 9.7 9.2 22.2 20.1 17.2 8.9 9.0 4.6 10.2 25.7 7.3 AKTIP "FLJ13258, FTS" ENSG00000166971 "AKT interacting protein" Q9H8T0 16 53491040-53504411 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 168.3;Late spermatids: 325.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041794, HPA046300" Approved NA NA "HPA041794: AB_2677677, HPA046300: AB_2679619" "unprognostic (2.08e-2)" "unprognostic (5.92e-2)" "unprognostic (2.50e-2)" "unprognostic (5.44e-2)" "unprognostic (2.62e-2)" "unprognostic (9.90e-2)" "unprognostic (1.72e-2)" "unprognostic (3.41e-3)" "unprognostic (2.45e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "prognostic favorable (1.18e-14)" "unprognostic (2.39e-3)" "unprognostic (1.86e-1)" "unprognostic (2.67e-1)" "unprognostic (1.31e-1)" 27.3 20.7 50.2 15.8 52.4 32.4 24.9 51.5 55.9 23.1 42.7 26.1 15.6 22.5 31.9 33.5 21.6 17.6 50.7 55.2 51.3 37.5 32.1 24.6 22.7 54.7 50.7 47.3 30.7 17.4 45.3 29.3 30.4 56.3 24.9 18.0 77.6 20.7 31.3 136.2 25.1 20.2 25.9 52.8 15.6 21.4 44.4 54.2 13.4 32.0 82.1 24.4 25.3 26.3 55.3 40.2 25.7 17.2 22.7 22.8 17.2 50.5 24.7 18.6 21.5 5.3 35.0 20.6 6.6 14.9 25.4 16.2 34.0 14.9 20.0 28.8 9.7 23.6 1.9 13.6 28.1 29.6 9.2 17.1 14.6 55.1 21.4 18.4 31.2 37.1 13.4 3.6 14.1 19.2 31.2 8.0 13.7 11.9 19.2 24.6 9.6 28.5 30.3 28.4 33.2 13.5 16.8 14.9 52.4 22.4 22.9 46.7 5.7 35.2 23.1 25.1 15.2 24.4 20.6 19.6 13.5 24.9 8.1 15.0 22.3 4.5 11.0 32.4 3.4 19.5 9.1 31.1 33.9 2.0 13.7 47.7 39.3 29.3 27.1 3.4 3.0 46.4 19.1 50.2 52.4 51.5 55.9 55.2 51.3 54.7 50.7 47.3 56.3 52.8 54.2 55.3 41.9 25.6 15.4 11.8 9.3 7.0 15.1 29.0 5.7 28.4 17.9 11.9 32.2 17.2 25.4 23.9 16.7 80.3 13.6 15.0 82.2 29.8 168.3 11.2 7.1 22.2 6.0 3.6 19.4 20.5 44.3 16.4 8.2 12.9 3.8 9.6 26.0 26.3 13.3 21.9 20.2 6.5 44.7 7.0 5.6 325.9 14.0 6.2 23.2 7.5 8.0 58.8 28.8 8.5 21.5 20.6 6.0 38.4 12.2 15.0 36.2 38.2 22.0 27.3 6.6 22.1 22.2 16.1 40.4 11.2 12.8 77.3 28.7 8.4 11.5 19.0 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 163.3;Oligodendrocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 124.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm NA NA 13000000 Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 22.6 59.3 49.1 29.4 63.5 22.2 16.7 50.4 90.1 19.4 4.4 24.8 15.1 14.1 19.1 17.5 12.8 41.4 89.9 62.6 59.0 18.6 33.7 27.5 36.1 70.5 64.0 56.7 25.1 12.9 19.4 16.4 28.6 66.2 16.2 24.9 49.6 20.4 17.3 50.8 22.5 19.8 24.0 64.9 28.1 30.9 6.4 69.8 75.1 21.9 92.8 32.9 27.5 14.6 106.2 0.8 26.3 28.9 15.4 17.1 15.9 2.0 18.7 44.7 22.3 37.2 2.0 9.9 87.8 21.3 41.1 23.5 35.0 22.8 15.2 39.8 51.5 21.3 88.9 26.9 52.8 12.6 49.5 72.3 19.6 4.0 30.4 10.5 21.2 124.0 61.4 28.3 37.7 28.8 1.7 104.6 16.4 22.5 28.8 5.2 41.6 35.2 20.0 11.9 0.4 35.9 23.9 14.0 0.7 15.5 27.2 3.2 29.0 21.0 24.1 13.4 14.2 12.7 19.9 50.8 50.8 41.4 65.1 38.2 69.0 30.0 46.7 63.8 37.7 49.5 60.8 44.4 58.3 33.4 55.5 50.6 61.5 21.5 74.4 51.6 47.3 52.9 76.9 49.1 63.5 50.4 90.1 62.6 59.0 70.5 64.0 56.7 66.2 64.9 69.8 106.2 27.0 22.4 18.3 104.8 73.0 23.7 5.1 2.0 38.1 109.6 18.9 19.7 105.6 12.8 4.8 5.5 25.0 0.6 107.9 13.3 5.9 9.8 12.4 11.9 12.6 29.4 29.3 25.0 163.3 12.8 9.7 28.5 42.3 14.6 27.3 4.6 33.5 26.1 26.1 52.2 141.7 25.8 4.1 44.7 38.3 6.8 19.3 44.6 30.2 70.3 17.1 40.3 52.5 97.5 435.9 10.1 15.6 21.1 31.6 2.9 12.0 5.1 6.5 12.5 78.9 25.4 74.9 1.9 10.6 9.1 27.6 0.8 76.1 15.0 11.1 3.5 EVA1C "B18, B19, C21orf63, C21orf64, FAM176C, PRED34" ENSG00000166979 "Eva-1 homolog C" P58658 21 32412006-32515397 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 156.1;Late spermatids: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.1;gdT-cell: 3.1;MAIT T-cell: 3.8;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.2;naive CD8 T-cell: 1.6;NK-cell: 3.2" "Group enriched" "Detected in many" 7 "granulocytes: 1.1;NK-cells: 3.2;T-cells: 3.8" "Cell line enhanced" "Detected in many" "A549: 24.5;CAPAN-2: 22.4;HBEC3-KT: 18.1;hTCEpi: 18.1;HUVEC TERT2: 18.7;SK-MEL-30: 19.1;U-87 MG: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015720, HPA029944, CAB034174" Enhanced NA NA "CAB034174: AB_1564317, HPA015720: AB_1845705, HPA029944: AB_10601092" "unprognostic (7.55e-3)" "unprognostic (8.91e-3)" "unprognostic (5.51e-2)" "unprognostic (2.55e-1)" "unprognostic (3.16e-2)" "prognostic favorable (5.06e-4)" "unprognostic (1.40e-3)" "unprognostic (4.24e-3)" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.84e-2)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.73e-1)" "unprognostic (5.95e-3)" "unprognostic (4.25e-3)" 22.2 3.1 4.3 3.8 4.9 1.1 20.6 4.8 6.5 14.1 5.5 10.0 1.3 22.3 6.3 11.2 24.1 12.0 12.9 4.1 7.2 5.8 2.0 17.5 4.7 5.2 4.9 3.8 12.6 5.2 7.2 7.7 7.1 5.8 20.2 2.4 0.4 14.5 22.2 6.1 18.2 6.8 13.1 4.4 5.8 9.8 9.6 5.3 2.3 10.7 5.2 9.0 18.5 17.2 5.8 0.0 24.5 0.1 1.1 7.2 4.1 0.4 4.5 2.2 1.5 0.5 0.0 22.4 0.1 0.3 0.2 2.3 0.0 0.7 18.1 0.5 2.2 0.0 0.0 10.9 0.6 6.7 0.0 0.0 1.5 18.1 3.4 13.2 3.8 18.7 1.7 0.0 0.0 1.8 0.1 0.1 0.0 0.8 1.1 4.4 0.0 0.4 0.0 0.4 0.3 6.8 1.1 13.4 1.0 19.1 0.1 0.8 0.0 15.4 1.9 0.5 2.6 1.0 0.3 0.1 0.1 19.9 0.1 5.6 1.1 0.0 0.0 3.1 0.1 3.8 0.0 3.2 3.2 0.1 0.0 0.6 1.6 0.0 3.2 0.3 0.0 0.4 1.2 4.3 4.9 4.8 6.5 4.1 7.2 5.2 4.9 3.8 5.8 4.4 5.3 5.8 77.1 19.2 16.0 19.9 1.3 42.7 94.3 156.1 83.6 6.8 22.4 32.4 7.1 42.9 72.2 9.2 0.0 0.3 14.4 3.3 0.0 77.7 84.6 22.6 62.9 68.8 1.8 19.4 24.6 10.2 0.2 18.5 12.2 12.3 6.3 1.1 36.8 1.4 0.5 6.7 37.6 4.8 10.2 1.9 21.3 227.2 14.6 4.9 23.2 49.6 3.1 28.2 16.5 32.6 86.3 8.2 2.6 14.7 6.6 53.6 7.5 2.3 70.0 2.0 19.7 9.4 27.5 15.2 2.1 22.0 29.5 0.7 13.0 0.2 6.8 60.0 TCP10L2 bA517H2.3 ENSG00000166984 "T-complex 10 like 2, pseudogene" B9ZVM9 6 167146414-167196913 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.3;testis: 1.1" "Group enriched" "Detected in some" 13 "Early spermatids: 11.7;Late spermatids: 10.8;Spermatocytes: 39.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034197, HPA044709" Uncertain NA NA "CAB034197: AB_2202388, HPA044709: AB_10961410" "unprognostic (5.07e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (5.40e-4)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 39.5 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.0 MARS1 "CMT2U, MARS, MetRS, SPG70" ENSG00000166986 "Methionyl-tRNA synthetase 1" P56192 12 57475445-57517569 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 11.9;Cytotrophoblasts: 29.5;Extravillous trophoblasts: 22.0;Hofbauer cells: 19.3;Syncytiotrophoblasts: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 738.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004125, CAB017097" Supported Approved Enhanced Cytosol NA NA 23000 Cytosol "CAB017097: , HPA004125: AB_1079312" "prognostic unfavorable (1.73e-4)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.57e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (8.47e-2)" "unprognostic (1.73e-1)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.13e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (2.06e-2)" 32.8 47.6 65.3 36.2 66.3 31.9 31.8 62.9 84.3 30.9 61.4 44.1 21.7 41.1 39.3 54.7 30.4 19.5 45.9 68.7 66.8 38.0 61.1 43.1 34.7 64.9 66.8 64.7 24.4 64.9 41.0 59.4 27.6 68.4 39.0 29.9 40.0 39.9 34.3 48.9 32.7 37.6 41.7 64.2 54.3 53.6 51.1 67.1 32.9 40.3 33.4 44.8 45.2 33.8 69.4 110.6 149.6 99.7 171.9 107.1 64.6 180.2 149.0 178.4 158.1 168.6 162.9 119.0 192.3 97.6 187.2 98.3 119.4 226.0 196.4 166.2 167.4 96.9 136.7 52.8 89.4 238.1 207.7 147.5 96.2 302.9 181.5 467.5 76.6 114.8 238.1 212.9 400.3 112.1 150.4 187.9 148.1 184.8 173.0 162.3 155.5 738.3 200.0 117.0 86.4 131.6 134.0 79.8 120.9 215.8 109.6 161.0 260.7 86.9 57.5 162.8 82.8 91.6 357.5 395.8 232.5 139.7 154.8 199.1 29.9 29.8 39.3 35.1 53.6 31.7 24.4 23.4 32.0 57.9 14.7 20.0 27.4 14.5 30.0 45.6 55.9 26.3 34.2 65.3 66.3 62.9 84.3 68.7 66.8 64.9 66.8 64.7 68.4 64.2 67.1 69.4 5.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 29.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 22.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 38.0 1.2 0.0 0.0 0.0 MBD6 KIAA1887 ENSG00000166987 "Methyl-CpG binding domain protein 6" Q96DN6 12 57520710-57530148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 13.6" "Cell line enhanced" "Detected in all" "RH-30: 116.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038948, HPA038949" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038948: AB_2676285, HPA038949: AB_10671868" "unprognostic (2.56e-1)" "unprognostic (4.15e-2)" "unprognostic (1.64e-2)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (2.84e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.19e-1)" "unprognostic (1.83e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-1)" "unprognostic (1.01e-2)" 31.6 40.3 14.6 34.8 18.3 57.6 36.8 15.9 18.7 40.5 18.3 37.9 42.0 47.3 18.0 36.1 41.1 19.3 23.8 14.0 21.9 38.3 44.6 34.7 26.3 21.6 17.7 11.1 44.2 44.8 23.2 105.8 25.8 20.1 39.0 20.9 38.8 47.3 27.4 34.3 38.1 45.3 20.0 14.2 65.4 43.0 58.0 17.5 28.1 111.1 19.0 19.0 34.6 35.3 23.4 22.7 31.7 24.2 26.0 16.6 11.9 33.9 25.7 15.8 16.6 12.3 33.0 35.3 22.8 19.3 14.0 16.2 31.3 22.3 19.4 11.6 45.2 22.5 40.2 33.4 22.8 20.3 24.2 99.7 20.8 33.7 17.8 24.8 25.1 22.3 19.3 26.1 58.7 13.5 23.3 25.3 23.9 23.3 16.7 23.2 24.6 116.7 17.7 14.3 44.4 33.3 20.2 20.5 40.6 25.0 14.2 45.7 38.7 21.9 17.8 29.0 18.2 17.4 60.5 22.4 15.7 23.2 15.1 30.6 0.0 1.0 0.4 1.3 0.9 0.5 1.3 0.2 0.4 0.5 0.8 0.5 0.5 13.6 0.7 0.4 0.3 0.2 0.6 14.6 18.3 15.9 18.7 14.0 21.9 21.6 17.7 11.1 20.1 14.2 17.5 23.4 24.7 6.4 17.8 12.4 14.1 11.0 13.4 11.9 22.2 55.5 27.5 22.4 6.2 25.8 13.0 9.2 27.1 12.4 12.6 20.6 5.9 9.4 13.3 18.9 19.7 16.7 15.6 18.7 5.4 12.0 8.8 12.2 29.0 32.8 19.0 21.7 14.6 24.3 14.0 25.2 6.6 20.5 8.2 23.8 11.0 9.4 14.6 23.1 12.4 15.0 9.1 30.4 11.3 6.6 8.1 9.2 20.7 12.8 14.8 12.3 20.8 4.4 16.3 69.4 19.7 14.9 17.3 51.7 30.8 23.7 12.4 22.6 16.8 16.9 16.8 15.8 CNPY4 "MGC40499, PRAT4B" ENSG00000166997 "Canopy FGF signaling regulator 4" Q8N129 7 100119634-100125508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.3;Leydig cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014166, HPA025240" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA014166: AB_1853895, HPA025240: AB_2082630" "unprognostic (9.64e-2)" "unprognostic (1.59e-2)" "unprognostic (4.09e-3)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (6.16e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (6.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (1.35e-2)" 13.2 16.9 14.1 9.7 14.4 6.1 11.1 15.1 15.1 24.2 15.0 12.6 6.5 21.4 15.0 5.8 15.6 16.9 12.0 13.9 15.8 10.4 6.7 9.2 10.9 15.0 14.6 13.7 24.7 4.5 12.9 16.7 21.4 14.6 10.9 10.0 17.3 5.8 16.0 5.2 8.1 9.8 21.6 14.6 13.7 7.9 6.8 14.2 14.5 10.5 7.2 9.9 12.5 14.9 15.1 7.9 13.5 33.2 59.6 76.0 36.5 16.6 29.0 31.2 14.9 27.8 7.5 7.0 17.2 32.9 52.5 10.9 7.9 13.0 14.2 15.6 16.2 13.4 7.1 23.3 10.4 21.5 12.1 12.8 33.4 3.8 13.7 6.2 32.7 52.4 8.2 6.0 11.1 21.5 22.9 25.8 15.9 17.1 5.0 19.2 7.5 24.9 9.2 15.4 2.0 8.3 16.9 27.8 22.4 15.4 21.4 11.3 6.7 42.9 47.5 28.5 20.2 13.3 9.4 16.3 15.3 27.8 18.4 19.7 11.8 5.1 8.6 15.1 11.2 19.8 3.9 15.6 19.0 7.2 2.9 12.7 19.0 2.3 12.3 13.9 4.6 13.8 6.7 14.1 14.4 15.1 15.1 13.9 15.8 15.0 14.6 13.7 14.6 14.6 14.2 15.1 15.2 6.4 2.6 4.2 3.4 3.6 2.3 7.9 2.8 6.9 3.4 6.2 3.4 5.7 4.0 12.9 2.1 35.3 5.2 3.7 1.9 6.4 0.5 5.1 20.2 15.0 2.4 11.8 3.4 2.5 10.3 28.4 1.1 4.2 9.5 16.1 18.2 1.3 14.0 8.4 4.0 1.9 4.1 2.5 2.4 2.2 35.1 4.7 16.0 2.8 5.1 26.6 8.2 2.0 2.8 2.4 2.8 31.6 1.9 0.5 2.8 3.3 4.4 15.8 13.1 12.7 15.5 1.1 4.5 2.1 3.8 18.3 8.6 30.5 2.3 1.0 PDIA3 "ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC" ENSG00000167004 "Protein disulfide isomerase family A member 3" P30101 15 43746410-43773278 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1048.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002645, HPA003230, CAB011199, CAB015181, CAB075744" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 200000000 "Endoplasmic reticulum" "CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030" "unprognostic (9.20e-2)" "unprognostic (1.21e-3)" "unprognostic (1.34e-1)" "prognostic favorable (2.05e-4)" "unprognostic (2.40e-2)" "prognostic unfavorable (8.95e-5)" "unprognostic (1.67e-1)" "unprognostic (8.60e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.82e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (6.63e-2)" 15.1 16.7 7.7 16.7 7.9 27.4 15.8 9.2 7.6 24.9 13.0 20.8 23.8 16.5 45.1 19.1 15.5 13.6 15.4 7.7 12.2 15.2 34.8 17.0 18.8 9.4 8.5 7.3 16.7 36.3 22.8 16.4 24.0 9.0 25.4 22.7 8.5 21.8 19.3 7.6 16.5 21.6 17.1 9.4 12.6 20.6 10.9 9.4 9.7 56.5 4.1 12.4 15.7 15.3 9.6 29.4 11.9 24.6 55.1 48.9 51.9 70.8 58.6 62.1 46.0 56.7 33.6 32.1 33.8 37.4 72.9 30.8 47.8 31.8 61.5 39.7 24.3 44.7 47.2 17.6 30.9 80.1 26.0 33.8 33.6 49.8 35.0 58.5 54.0 81.3 11.1 27.7 17.4 45.5 11.1 9.1 30.4 24.4 48.5 44.0 17.9 36.7 26.2 39.3 26.0 22.9 25.4 48.7 49.0 19.4 25.0 33.1 28.1 50.9 37.7 18.9 29.7 29.1 7.1 8.6 33.9 48.1 41.2 28.8 11.6 8.8 13.3 12.1 9.2 12.8 5.4 6.8 9.5 8.3 6.1 6.0 7.1 2.4 12.7 9.9 17.6 5.8 15.8 7.7 7.9 9.2 7.6 7.7 12.2 9.4 8.5 7.3 9.0 9.4 9.4 9.6 224.9 192.3 183.9 31.6 177.8 192.2 313.7 665.2 114.4 56.5 137.9 95.5 58.3 124.4 427.7 167.3 41.7 655.2 319.6 228.7 70.5 401.2 24.3 178.8 300.3 223.7 186.1 95.3 29.2 390.4 807.8 350.7 261.0 328.5 261.6 255.1 233.1 342.2 426.0 70.7 38.3 523.1 231.9 157.3 292.2 26.7 253.5 246.5 243.7 36.5 258.0 128.3 279.1 29.7 38.8 279.9 196.8 276.8 341.1 286.5 234.3 129.1 245.6 61.9 124.9 138.4 389.7 186.4 147.6 138.9 148.5 1048.8 237.8 390.8 335.4 291.7 NUDT21 "CFIM25, CPSF5" ENSG00000167005 "Nudix hydrolase 21" O43809 16 56429133-56452199 "Predicted intracellular proteins" "Differentiation, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 445.9;Late spermatids: 230.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019863, HPA074228" Uncertain Supported "Nuclear bodies,Centriolar satellite" NA NA 12000 "Nuclear bodies" "Centriolar satellite" "HPA019863: AB_2670299, HPA074228: AB_2686675" "unprognostic (4.95e-2)" "unprognostic (4.42e-2)" "unprognostic (4.25e-3)" "unprognostic (1.31e-1)" "unprognostic (5.85e-3)" "unprognostic (1.29e-2)" "unprognostic (8.80e-3)" "unprognostic (6.87e-3)" "unprognostic (4.09e-2)" "unprognostic (3.19e-1)" "unprognostic (3.76e-3)" "unprognostic (4.27e-2)" "unprognostic (1.39e-2)" "unprognostic (2.85e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" 29.7 32.3 24.8 38.1 29.5 65.0 39.8 29.4 28.9 40.1 21.7 39.6 49.8 39.6 27.6 40.3 36.3 28.7 31.6 29.1 31.4 43.0 37.3 28.0 57.1 23.8 25.5 25.8 56.3 32.6 40.5 22.2 38.8 26.7 29.9 40.5 36.3 30.7 32.4 28.2 24.9 35.0 35.0 22.8 34.8 34.4 71.6 25.7 58.9 38.0 38.3 66.2 40.1 26.2 28.8 143.8 79.3 144.3 116.8 78.0 110.0 131.1 96.2 112.2 135.9 94.7 167.7 146.6 193.5 98.5 90.5 84.8 129.8 190.2 116.8 206.0 67.2 78.5 126.6 73.0 146.2 63.6 183.0 124.8 65.5 83.4 113.7 80.3 78.2 127.5 145.8 137.5 69.1 111.2 88.1 195.5 130.1 178.9 106.6 133.0 286.2 196.3 165.4 94.5 121.9 161.1 107.2 184.0 88.0 77.6 99.2 107.6 106.5 74.8 107.4 153.3 93.1 104.1 103.1 120.0 364.7 71.4 117.9 100.1 32.0 24.9 32.9 28.0 26.1 27.7 22.8 29.4 26.1 25.8 20.9 27.1 27.4 27.2 25.5 29.2 19.9 49.6 22.2 24.8 29.5 29.4 28.9 29.1 31.4 23.8 25.5 25.8 26.7 22.8 25.7 28.8 30.7 28.9 37.8 23.8 45.5 60.9 52.9 78.4 47.8 19.5 46.3 34.3 39.3 27.1 54.4 42.3 18.8 63.8 29.1 29.2 66.5 63.4 445.9 32.9 40.2 45.2 31.1 69.9 26.5 86.5 90.6 45.8 25.0 38.7 35.5 35.9 48.9 39.1 67.2 35.3 27.9 57.7 20.3 58.8 50.5 230.2 44.7 42.7 37.4 13.1 61.1 25.6 18.6 18.1 34.6 62.5 36.0 41.0 70.0 60.3 49.2 78.3 47.7 24.2 39.5 33.9 59.6 217.4 96.9 67.4 60.0 68.3 49.7 39.5 64.0 70.1 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170496-101180293 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 2.6;pancreas: 2.3;pituitary gland: 3.6;retina: 6.9;thyroid gland: 1.8" "Cell type enriched" "Detected in some" 36 "Horizontal cells: 292.7" "Cancer enhanced" "Detected in some" "glioma: 1.3;melanoma: 2.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.4;SH-SY5Y: 3.4;SK-MEL-30: 2.7;U-2 OS: 2.9;U-87 MG: 1.7" HPA021918 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.0 0.1 1.5 0.0 1.2 0.2 0.0 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.1 0.0 0.0 0.7 1.1 1.7 0.0 2.3 0.3 3.6 0.0 0.7 0.0 0.0 6.9 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.4 0.1 1.7 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.1 0.0 2.4 0.0 0.2 0.0 3.4 0.0 0.1 2.7 0.2 0.1 0.0 0.0 0.1 2.9 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 1.5 1.2 0.5 2.6 0.9 1.7 0.7 1.1 1.7 0.7 0.3 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 292.7 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.5 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956687-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 22.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX3-1 "BAPX2, NKX3.1, NKX3A" ENSG00000167034 "NK3 homeobox 1" Q99801 8 23678697-23682938 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 306.0" "Group enriched" "Detected in many" 6 "Basal prostatic cells: 51.0;Prostatic glandular cells: 124.8" "Cancer enriched" "Detected in many" 65 "prostate cancer: 392.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 54.0;neutrophil: 51.6" "Lineage enriched" "Detected in many" 21 "granulocytes: 54.0" "Cell line enhanced" "Detected in many" "GAMG: 25.7;SiHa: 26.1;U-138 MG: 25.8;U-251 MG: 23.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA025693, HPA078571" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025693: AB_1854522, HPA078571: AB_2732384" "unprognostic (1.47e-2)" "unprognostic (4.03e-2)" "unprognostic (2.67e-1)" "unprognostic (5.87e-2)" "unprognostic (2.56e-6)" "unprognostic (6.90e-3)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (9.42e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.37e-2)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.09e-2)" "unprognostic (1.69e-1)" 1.6 3.9 1.3 1.5 1.3 2.2 2.1 1.6 1.5 1.1 1.1 1.1 1.4 1.6 1.3 3.8 1.8 1.1 2.6 1.3 2.9 1.0 4.1 1.4 1.2 1.8 1.3 0.9 2.8 1.8 1.0 0.9 0.8 1.7 306.0 0.5 1.7 62.5 1.8 3.3 0.4 1.0 1.9 1.7 0.8 1.4 24.2 1.6 0.5 0.7 3.9 1.6 3.0 1.9 1.8 4.9 3.7 0.0 8.7 3.1 0.7 7.1 6.7 4.2 13.8 16.2 2.1 5.5 0.0 1.0 5.0 25.7 1.2 3.5 7.6 10.9 0.0 1.8 3.4 2.6 5.5 6.0 0.0 1.2 1.2 2.0 14.0 0.8 8.5 0.7 20.1 0.2 0.0 5.5 1.6 11.8 1.0 2.0 0.0 2.6 0.0 5.5 0.5 0.8 5.7 1.6 0.4 26.1 4.8 0.4 9.9 3.5 0.5 0.9 25.8 9.1 2.0 23.0 0.0 0.0 0.0 12.5 2.6 3.2 10.2 0.0 54.0 1.0 0.1 0.2 2.2 0.4 1.0 0.1 1.8 1.4 2.5 51.6 0.6 0.1 0.0 0.0 0.3 1.3 1.3 1.6 1.5 1.3 2.9 1.8 1.3 0.9 1.7 1.7 1.6 1.8 6.0 3.2 5.3 0.0 4.1 5.6 51.0 4.1 4.6 3.7 13.5 6.5 9.8 1.5 4.7 0.0 8.4 0.3 0.3 1.0 0.0 2.7 2.7 1.3 2.0 6.8 6.6 0.0 0.4 7.0 1.4 9.1 5.1 2.2 0.0 0.8 4.6 4.9 0.3 3.3 0.4 1.2 2.0 0.3 9.4 6.1 2.1 2.5 1.8 0.0 0.6 4.9 0.0 0.5 0.1 5.2 0.1 6.4 1.0 124.8 0.4 0.7 1.4 4.5 0.0 11.4 5.1 1.8 2.1 2.5 2.0 0.3 2.5 0.8 1.1 12.2 SGSM1 "KIAA1941, RUTBC2" ENSG00000167037 "Small G protein signaling modulator 1" Q2NKQ1 22 24806169-24927578 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;heart muscle: 10.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 97.0;Inhibitory neurons: 76.4;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 58.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.9;RPMI-8226: 2.2;SCLC-21H: 2.0;SH-SY5Y: 1.3;U-266/84: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003986 Approved NA NA "HPA003986: AB_1856513" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (1.97e-2)" "unprognostic (1.40e-4)" "unprognostic (4.79e-3)" "unprognostic (6.43e-2)" "unprognostic (1.39e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.50e-2)" "unprognostic (2.23e-3)" "unprognostic (1.37e-1)" "unprognostic (2.61e-6)" "unprognostic (1.46e-1)" "unprognostic (4.66e-1)" "unprognostic (2.25e-2)" "unprognostic (3.93e-2)" 0.5 3.4 12.5 0.4 12.6 0.2 0.9 7.6 12.7 1.2 5.0 1.7 0.4 0.6 1.0 0.3 4.7 0.7 10.9 10.3 17.9 1.8 0.2 1.1 0.4 11.7 15.0 11.0 1.8 3.7 7.8 10.6 0.3 15.4 1.6 1.6 1.5 1.3 0.8 0.6 3.2 1.0 0.5 8.0 0.3 3.0 1.8 17.0 0.3 2.1 0.2 0.3 1.7 1.1 17.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 2.9 0.3 0.0 0.0 2.2 0.0 0.3 2.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.1 12.5 12.6 7.6 12.7 10.3 17.9 11.7 15.0 11.0 15.4 8.0 17.0 17.6 1.4 3.2 6.9 2.6 0.7 3.8 9.8 0.1 2.2 3.2 1.5 1.9 26.4 1.5 1.5 5.5 4.2 0.3 3.2 3.1 3.9 1.7 0.5 10.3 0.9 3.7 17.3 0.0 97.0 1.9 0.1 4.5 7.1 6.6 1.3 0.1 11.4 0.1 1.9 1.7 76.4 6.4 0.0 0.3 8.4 0.5 0.3 0.8 10.6 12.2 0.1 2.1 5.2 33.7 58.6 1.3 5.4 0.4 0.5 5.6 0.5 0.7 1.5 1.5 13.1 3.1 2.5 1.2 7.9 0.4 3.8 0.3 2.3 0.3 4.8 4.8 DUSP18 DUSP20 ENSG00000167065 "Dual specificity phosphatase 18" Q8NEJ0 22 30652051-30667887 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 123.4;Late spermatids: 344.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034070, HPA051349" Uncertain Supported Nucleoplasm Yes No Nucleoplasm "CAB034070: AB_2094867, HPA051349: AB_2681450" "unprognostic (1.11e-1)" "unprognostic (2.34e-2)" "unprognostic (3.49e-3)" "unprognostic (4.88e-3)" "unprognostic (1.88e-1)" "unprognostic (9.12e-2)" "unprognostic (3.77e-4)" "unprognostic (1.83e-1)" "unprognostic (1.61e-1)" "unprognostic (3.53e-2)" "unprognostic (9.62e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-3)" "unprognostic (6.55e-2)" "unprognostic (1.97e-1)" "unprognostic (4.56e-2)" "unprognostic (1.02e-1)" 3.3 2.0 5.3 4.5 3.7 3.3 2.9 3.5 5.3 2.4 7.5 5.5 5.0 3.0 4.9 4.2 11.0 4.2 2.0 3.3 4.3 2.3 1.0 5.6 4.7 4.5 4.9 3.0 2.4 3.0 3.3 4.2 2.1 4.4 2.1 6.9 5.3 2.5 2.4 1.3 4.8 4.7 3.8 5.3 4.4 4.8 14.0 4.2 4.1 3.3 1.6 3.9 3.3 2.6 6.3 5.4 5.4 2.5 5.8 6.2 11.9 2.3 4.9 5.3 4.7 5.1 3.1 5.3 3.6 3.3 6.0 6.2 3.8 1.3 3.8 5.3 9.8 6.1 1.5 2.2 2.2 2.6 7.4 5.3 3.1 5.4 7.8 3.0 5.3 15.0 4.1 1.7 2.8 5.2 4.8 4.2 1.8 0.8 6.4 3.3 2.8 1.7 1.2 5.6 3.7 6.2 3.7 4.8 1.7 3.5 3.2 4.5 2.2 11.1 9.9 5.4 2.7 2.8 2.1 2.6 1.7 11.4 1.3 5.0 31.4 15.3 29.9 8.6 19.3 6.6 9.7 9.6 7.7 17.2 8.7 6.6 7.5 31.8 7.4 21.4 9.7 13.2 8.4 5.3 3.7 3.5 5.3 3.3 4.3 4.5 4.9 3.0 4.4 5.3 4.2 6.3 7.2 19.2 5.4 11.4 7.1 21.4 13.3 6.5 2.2 2.9 4.9 3.4 2.0 10.0 9.6 5.5 45.9 1.2 12.0 10.0 3.9 10.1 123.4 34.5 5.0 10.1 35.5 2.1 8.0 9.4 3.9 6.8 8.6 5.0 7.0 4.4 13.9 1.1 8.1 1.7 4.4 15.4 6.1 15.6 28.5 344.2 8.4 13.2 8.8 13.1 13.9 10.1 9.2 1.5 14.3 9.3 15.4 6.8 3.9 8.8 24.2 4.1 64.6 16.8 6.6 8.6 6.6 63.0 17.2 5.7 21.3 1.0 9.7 3.5 19.0 8.7 TEF KIAA1655 ENSG00000167074 "TEF transcription factor, PAR bZIP family member" Q10587 22 41367333-41399326 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "OE19: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.75e-2)" "unprognostic (5.24e-2)" "unprognostic (1.27e-2)" "unprognostic (2.57e-3)" "unprognostic (1.75e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (3.91e-3)" "unprognostic (7.87e-2)" "unprognostic (6.82e-3)" "unprognostic (2.12e-2)" "unprognostic (7.17e-3)" "prognostic favorable (3.47e-11)" "unprognostic (7.54e-2)" "unprognostic (2.87e-1)" "unprognostic (1.25e-1)" "unprognostic (6.55e-2)" 15.1 14.5 27.1 5.2 38.7 0.9 12.9 43.4 50.5 14.5 5.0 17.2 8.1 16.2 10.3 15.0 18.9 8.3 32.7 35.1 17.9 19.2 18.8 14.5 7.9 21.5 19.0 34.3 35.9 23.4 47.2 21.4 4.4 29.7 14.1 11.0 25.7 29.3 24.3 44.4 24.6 11.1 9.7 6.4 11.1 13.4 12.2 20.5 9.2 28.9 40.3 8.3 15.2 12.0 34.8 4.5 2.1 6.9 8.0 11.4 6.7 5.0 3.3 16.1 4.6 6.4 5.9 11.1 12.7 4.7 16.6 6.8 9.5 2.1 7.8 5.3 5.8 3.2 2.6 4.3 3.8 5.0 3.9 3.6 9.4 12.5 6.0 14.0 11.1 3.2 2.7 1.2 10.7 2.3 10.5 3.3 2.8 4.0 31.1 5.2 9.3 4.4 5.5 3.5 9.9 6.5 3.3 15.0 3.3 6.8 5.6 5.5 4.4 4.8 12.7 13.6 5.2 5.3 11.0 8.5 8.1 12.4 3.4 13.7 0.0 0.2 0.8 0.6 0.7 0.9 0.4 0.6 0.6 0.2 0.1 0.7 0.5 0.4 0.1 0.4 0.8 0.5 0.3 27.1 38.7 43.4 50.5 35.1 17.9 21.5 19.0 34.3 29.7 6.4 20.5 34.8 9.8 16.0 9.9 21.2 1.3 6.6 3.2 4.9 12.5 41.9 4.3 6.9 13.1 20.0 3.3 18.4 8.4 4.4 0.7 18.7 11.7 3.4 11.3 1.3 5.6 7.0 7.7 0.4 14.2 6.1 0.6 13.2 3.6 1.7 4.5 6.5 6.4 33.4 1.3 32.0 15.0 6.0 8.2 4.1 4.0 23.2 17.1 1.7 5.4 1.9 2.3 27.3 2.1 9.0 17.4 3.9 4.4 25.6 1.2 3.6 11.2 5.6 5.5 13.7 6.6 19.6 9.0 3.7 5.7 6.7 8.7 1.4 1.9 9.1 4.6 2.4 MEI1 "MGC40042, SPATA38" ENSG00000167077 "Meiotic double-stranded break formation protein 1" Q5TIA1 22 41699503-41799456 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.6;testis: 39.8" "Cell type enhanced" "Detected in many" "B-cells: 32.8;Early spermatids: 61.3;Late spermatids: 50.8;NK-cells: 29.9;Plasma cells: 94.7;Spermatocytes: 38.1;T-cells: 28.4" "Cancer enhanced" "Detected in many" "cervical cancer: 5.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 11.6;HMC-1: 8.5;Karpas-707: 26.8;U-266/70: 29.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 7 "olfactory bulb: 1.4" HPA049240 Approved "Intracellular and membrane" NA NA "HPA049240: AB_2680689" "unprognostic (1.95e-3)" "prognostic favorable (1.59e-6)" "unprognostic (6.13e-3)" "unprognostic (1.86e-2)" "unprognostic (9.70e-2)" "unprognostic (2.97e-3)" "unprognostic (9.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (5.96e-2)" "unprognostic (9.65e-2)" "unprognostic (2.62e-1)" "unprognostic (2.45e-10)" "unprognostic (2.82e-1)" "unprognostic (3.02e-1)" "unprognostic (1.85e-1)" "unprognostic (7.39e-2)" 1.3 1.0 1.8 6.8 3.0 12.2 3.0 1.6 2.9 1.5 1.3 6.4 2.6 0.7 0.4 1.6 1.8 1.3 0.9 1.6 1.6 2.4 1.4 4.6 6.7 2.2 3.1 1.9 0.8 0.6 0.1 0.9 0.9 1.9 1.5 3.0 1.3 7.1 0.5 0.5 1.3 8.5 0.8 1.6 22.6 4.4 39.8 5.0 2.6 2.3 0.1 8.2 2.7 1.3 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 2.3 0.0 0.3 0.6 0.2 0.5 0.5 0.2 0.2 0.2 0.0 0.0 0.0 6.7 0.0 2.0 11.6 1.3 1.8 1.4 8.5 0.1 0.1 0.0 0.0 0.3 0.5 0.8 0.4 26.8 0.1 0.0 0.0 6.5 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 3.7 1.0 0.5 0.0 0.0 0.1 29.9 5.1 1.2 0.4 2.8 0.1 18.5 7.2 15.7 29.9 5.6 29.1 21.7 30.1 25.8 6.5 15.4 21.7 24.0 1.3 16.9 2.3 2.3 57.2 18.1 1.8 3.0 1.6 2.9 1.6 1.6 2.2 3.1 1.9 1.9 1.6 5.0 2.4 0.7 0.0 3.2 0.0 32.8 0.9 0.3 0.3 0.0 0.6 0.3 0.3 0.9 0.0 0.1 0.0 0.0 0.1 19.9 0.0 0.0 0.1 61.3 0.3 1.0 1.4 0.0 0.4 2.1 0.0 0.2 2.0 2.0 0.1 14.0 0.5 3.3 0.5 7.0 0.0 1.1 2.9 0.0 1.2 3.5 50.8 0.6 11.1 17.8 3.7 15.5 0.1 29.9 1.0 1.1 5.3 0.0 1.2 94.7 0.3 0.1 0.4 0.1 1.1 0.0 0.7 1.7 38.1 26.1 0.0 1.0 0.0 28.4 0.1 0.4 0.3 B4GALNT2 "Cad, GALGT2, Sda" ENSG00000167080 "Beta-1,4-N-acetyl-galactosaminyltransferase 2" Q8NHY0 17 49132460-49176840 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 5.5;Distal enterocytes: 3.9;Glandular and luminal cells: 5.2;Intestinal goblet cells: 11.5;Ionocytes: 4.1;Proximal enterocytes: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015721 Approved NA NA "HPA015721: AB_1845245" "unprognostic (4.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.26e-3)" "unprognostic (2.03e-4)" "unprognostic (1.72e-2)" "unprognostic (2.62e-2)" "unprognostic (3.67e-2)" "unprognostic (7.67e-2)" "unprognostic (4.06e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-1)" "prognostic favorable (1.29e-5)" "unprognostic (3.53e-1)" "unprognostic (1.31e-1)" "unprognostic (7.81e-3)" "unprognostic (2.15e-1)" 1.2 1.3 1.7 7.9 1.3 4.7 0.7 6.7 2.5 0.2 2.1 33.8 2.1 1.2 0.6 0.7 0.4 2.2 1.0 2.0 0.6 9.2 0.9 1.4 2.2 1.1 0.4 1.0 1.0 1.7 0.1 0.0 0.7 2.3 0.7 14.3 7.6 2.0 0.3 0.8 2.8 8.5 2.8 0.2 2.2 5.9 1.6 0.8 0.2 6.0 0.1 0.9 0.6 0.0 2.2 0.9 1.7 1.7 3.0 0.1 0.0 0.9 1.3 1.0 0.0 0.1 4.0 1.4 2.1 2.1 0.0 0.6 0.9 0.7 0.1 0.2 1.8 1.8 2.2 5.1 2.1 0.0 1.1 3.5 0.2 1.4 0.3 0.2 0.7 0.0 1.6 1.3 3.3 0.0 1.1 1.4 1.5 2.1 0.3 0.8 2.5 0.7 0.6 5.4 1.4 1.4 1.5 0.6 0.7 0.6 1.7 1.8 1.4 0.6 2.2 1.3 1.3 0.7 2.6 0.9 2.3 0.7 1.4 0.9 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.7 1.3 6.7 2.5 2.0 0.6 1.1 0.4 1.0 2.3 0.2 0.8 2.2 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.3 0.5 0.0 0.9 5.5 0.0 0.0 0.0 3.9 1.9 0.6 0.7 0.6 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.5 4.1 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 14.8 0.1 0.8 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.1 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 154.2" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 13.9" "Lineage enriched" "Detected in all" 4 "dendritic cells: 13.9" "Cell line enhanced" "Detected in many" "THP-1: 90.1" "Region enhanced" "Detected in all" "olfactory bulb: 167.4" "Group enriched" "Detected in all" 5 "basal ganglia: 46.3;olfactory bulb: 161.9" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 10.8 56.5 11.1 13.0 15.7 6.9 10.1 17.5 11.7 23.6 8.5 34.6 6.9 9.9 20.2 11.9 14.4 22.7 38.3 7.5 15.5 6.9 18.3 13.1 8.0 19.2 18.6 7.4 58.7 18.9 154.2 12.7 6.8 18.3 31.1 13.8 28.2 11.9 28.3 8.6 19.5 14.4 22.8 19.6 12.9 21.7 8.3 16.0 16.8 35.4 5.8 7.0 20.9 22.0 22.9 11.6 11.0 50.0 43.1 13.1 19.1 8.5 29.9 16.8 19.2 14.5 14.3 21.1 11.3 3.6 22.1 20.8 8.5 28.3 12.3 38.3 12.4 20.5 9.7 7.9 5.8 17.2 9.6 15.5 9.5 13.7 14.5 10.0 45.3 23.1 7.2 0.4 10.3 43.5 5.9 10.0 4.9 35.8 14.2 7.4 18.9 73.3 1.5 15.6 6.4 25.9 45.1 20.2 3.8 9.4 18.8 15.7 90.1 26.6 40.0 10.2 23.8 57.1 7.2 12.8 11.5 19.7 15.2 20.6 2.3 1.7 2.2 0.8 1.4 0.9 1.0 0.9 0.7 1.9 1.5 1.7 0.7 1.4 3.2 1.3 13.9 0.8 1.0 11.1 15.7 17.5 11.7 7.5 15.5 19.2 18.6 7.4 18.3 19.6 16.0 22.9 7.3 9.6 16.7 17.9 10.0 22.7 10.3 3.0 6.8 7.5 11.5 8.3 60.3 2.8 8.6 12.9 37.5 0.6 20.7 1.3 7.9 13.5 15.2 1.1 14.0 11.9 11.5 6.3 44.3 2.5 0.9 23.4 5.6 1.5 16.5 9.4 9.7 12.6 15.3 42.1 19.3 5.7 6.1 29.0 23.7 11.4 19.9 22.9 7.2 91.8 13.6 11.5 6.2 136.2 192.2 3.1 12.1 11.3 3.8 13.0 0.9 2.8 8.5 43.1 0.0 5.3 13.0 33.7 16.0 10.4 26.3 0.4 10.5 8.7 3.4 8.7 GNGT2 GNG9 ENSG00000167083 "G protein subunit gamma transducin 2" O14610 17 49202791-49210574 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 158.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 73.0;Kupffer cells: 26.5;NK-cells: 52.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 66.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 64.8;HDLM-2: 54.5;HUVEC TERT2: 19.4;RH-30: 21.6;TIME: 19.9;U-698: 18.2" "Low region specificity" "Detected in all" HPA043381 Enhanced NA NA "HPA043381: AB_2678455" "unprognostic (9.11e-2)" "unprognostic (4.09e-3)" "unprognostic (1.99e-2)" "unprognostic (4.62e-5)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (1.75e-1)" "unprognostic (7.37e-2)" "unprognostic (1.30e-2)" "unprognostic (2.11e-2)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (1.23e-1)" 2.6 2.6 2.7 7.8 2.9 2.5 1.9 3.4 4.1 2.3 3.2 2.9 3.6 2.5 0.7 2.7 2.0 4.5 2.5 2.6 3.4 2.7 3.4 7.2 14.2 3.9 5.7 2.1 1.5 1.6 1.0 1.2 2.7 3.7 2.2 3.9 158.3 1.1 1.3 1.0 0.9 5.2 3.8 3.5 20.1 2.4 0.8 3.5 5.6 2.4 2.7 18.5 3.3 1.6 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.5 1.0 0.9 0.3 0.0 64.8 0.7 0.1 0.0 0.0 0.0 0.1 4.6 54.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.0 19.4 8.8 0.0 0.4 1.5 0.0 4.6 3.6 0.6 0.0 0.0 12.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 19.9 0.0 12.6 0.0 0.1 0.2 2.9 18.2 0.3 0.2 0.0 0.1 8.8 1.1 30.4 47.3 27.3 3.7 4.6 21.1 20.3 4.5 2.9 11.7 1.9 26.7 66.7 1.9 3.4 12.7 2.7 2.9 3.4 4.1 2.6 3.4 3.9 5.7 2.1 3.7 3.5 3.5 4.1 4.5 0.0 1.1 0.0 4.6 0.4 0.0 0.0 0.0 2.7 0.2 0.3 0.8 0.0 0.6 0.0 73.0 0.0 15.5 0.0 3.9 0.0 1.1 0.1 0.1 5.2 0.0 8.0 0.2 0.0 0.1 0.8 0.5 0.1 0.0 0.1 2.5 0.1 11.1 0.0 0.4 0.0 0.0 26.5 2.0 8.2 0.6 13.6 0.0 1.0 9.5 5.9 52.5 0.0 0.1 0.0 0.0 0.0 3.5 0.1 0.0 0.2 0.0 14.8 6.6 0.1 0.3 0.1 0.1 0.0 0.1 0.3 11.4 0.4 0.0 0.0 PHB PHB1 ENSG00000167085 Prohibitin P35232 17 49404052-49414901 "Plasma proteins, Predicted intracellular proteins" "DNA synthesis, Host-virus interaction" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 473.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 749.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003280 Supported Supported Mitochondria "Intracellular and membrane" NA NA 360000 Mitochondria "HPA003280: AB_1855732" "unprognostic (2.31e-2)" "unprognostic (5.70e-2)" "unprognostic (1.19e-2)" "unprognostic (7.88e-3)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.58e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (7.36e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.10e-2)" "unprognostic (1.77e-1)" "unprognostic (2.71e-2)" "unprognostic (3.09e-3)" 73.6 89.1 36.8 23.5 40.0 20.0 78.1 41.4 50.2 55.5 48.0 93.0 53.1 68.6 34.4 89.3 56.2 27.1 135.2 37.7 43.0 143.3 121.4 59.5 27.2 40.5 38.4 35.5 60.2 63.1 70.7 51.5 33.3 41.5 67.8 60.6 12.2 137.0 45.1 139.2 67.9 68.6 36.0 38.6 61.6 80.4 33.7 38.8 26.5 62.0 99.4 27.0 75.8 59.9 43.4 86.0 339.1 46.4 96.9 81.9 48.3 111.8 69.8 72.3 175.1 122.4 749.5 80.2 119.2 88.1 60.0 67.3 63.4 151.7 135.3 128.4 72.9 327.1 77.7 122.8 361.8 53.0 109.6 58.1 54.9 125.9 130.9 41.6 45.7 87.6 68.6 112.7 27.6 77.5 224.0 106.0 118.5 99.9 135.9 311.1 74.9 144.0 103.8 144.0 116.1 122.1 75.9 35.4 59.1 113.7 71.7 112.2 33.4 58.9 96.3 124.7 78.4 98.4 35.3 65.7 59.1 58.0 125.6 110.7 11.7 45.9 13.4 61.6 53.4 80.5 61.2 56.6 56.3 62.3 46.7 59.4 59.7 8.9 69.0 59.5 155.1 61.4 79.8 36.8 40.0 41.4 50.2 37.7 43.0 40.5 38.4 35.5 41.5 38.6 38.8 43.4 88.5 48.1 46.8 8.8 78.3 117.5 147.5 182.6 70.0 44.8 135.7 180.0 8.4 100.1 101.9 84.6 37.5 230.2 144.4 220.8 406.9 233.1 14.0 93.4 85.5 92.6 131.9 77.2 7.8 158.6 278.7 87.8 74.9 131.0 73.0 124.6 61.4 101.8 228.1 21.9 10.0 281.7 223.8 51.9 87.9 24.7 89.5 70.9 158.3 1.9 120.3 83.1 88.6 11.1 15.3 162.8 139.8 115.1 93.0 242.8 151.4 473.6 68.0 42.1 52.6 72.8 306.5 18.0 47.3 107.6 124.0 152.4 75.9 159.9 337.2 161.9 SNRPD1 "HsT2456, Sm-D1, SNRPD" ENSG00000167088 "Small nuclear ribonucleoprotein D1 polypeptide" P62314 18 21612314-21633524 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040516 Supported NA NA 480000 "HPA040516: AB_10673236" "unprognostic (1.83e-2)" "unprognostic (1.81e-1)" "unprognostic (7.85e-2)" "unprognostic (7.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.61e-2)" "prognostic unfavorable (1.82e-5)" "unprognostic (5.59e-2)" "unprognostic (2.15e-3)" "prognostic favorable (7.90e-6)" "unprognostic (1.87e-2)" "unprognostic (7.39e-2)" "unprognostic (3.87e-3)" "unprognostic (3.33e-2)" "unprognostic (2.06e-1)" "unprognostic (7.36e-2)" "unprognostic (3.83e-1)" 40.1 36.0 34.1 55.0 34.1 95.4 39.3 35.6 52.3 36.0 32.4 49.3 42.6 37.6 26.6 67.6 33.9 23.2 31.7 33.9 34.8 34.8 38.0 33.4 73.2 34.3 34.4 33.8 42.4 30.2 23.7 42.2 36.8 35.1 33.4 44.7 33.3 35.3 18.0 49.2 37.6 45.2 28.7 34.2 44.0 37.0 45.3 36.0 80.0 29.2 25.0 72.2 47.8 41.8 35.0 246.1 123.1 377.9 184.5 59.1 49.4 174.4 264.5 85.4 176.9 170.4 234.4 125.5 328.0 214.6 102.7 245.2 231.2 246.0 167.7 191.3 210.4 201.4 276.3 193.1 284.2 78.5 673.4 232.5 52.9 92.1 173.1 156.1 122.0 96.8 327.9 286.5 178.5 120.4 179.7 436.3 470.2 297.7 468.0 214.2 345.1 275.7 351.0 129.9 176.2 235.7 244.4 219.0 165.9 207.3 167.0 120.5 390.7 155.0 179.0 354.4 154.6 455.6 319.8 317.6 671.2 130.4 409.8 203.3 50.1 129.4 48.5 122.5 162.0 134.4 204.4 154.0 152.1 221.4 194.6 160.7 141.6 10.8 137.0 189.7 224.2 193.3 147.3 34.1 34.1 35.6 52.3 33.9 34.8 34.3 34.4 33.8 35.1 34.2 36.0 35.0 105.6 80.1 76.3 5.2 123.2 202.5 227.3 343.6 109.8 58.4 116.4 157.6 55.4 111.5 200.4 99.3 12.5 423.3 101.8 101.8 215.2 210.8 15.6 119.2 136.9 138.4 122.8 229.5 12.1 194.3 544.1 132.0 86.2 109.4 100.8 158.7 99.9 113.2 242.9 47.1 12.5 192.1 215.7 106.3 152.5 26.3 108.7 96.9 113.8 6.5 163.6 102.6 117.4 10.1 11.8 236.3 113.2 88.8 122.6 343.1 87.3 214.8 153.4 50.0 98.6 149.0 183.0 282.8 265.2 177.2 221.9 261.9 112.5 161.1 229.8 233.9 TTC16 FLJ32780 ENSG00000167094 "Tetratricopeptide repeat domain 16" Q8NEE8 9 127716079-127731590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "fallopian tube: 6.9;testis: 16.1" "Group enriched" "Detected in some" 4 "Early spermatids: 103.1;Late spermatids: 258.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (3.10e-3)" "unprognostic (1.63e-3)" "unprognostic (3.86e-3)" "unprognostic (2.02e-4)" "unprognostic (4.08e-3)" "unprognostic (2.25e-3)" "unprognostic (8.87e-4)" "unprognostic (2.91e-2)" "unprognostic (2.25e-2)" "unprognostic (2.36e-1)" "unprognostic (1.96e-3)" "unprognostic (7.32e-2)" "unprognostic (9.14e-3)" "unprognostic (6.35e-3)" "unprognostic (5.29e-2)" "unprognostic (1.17e-1)" "unprognostic (5.54e-3)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 6.9 0.1 0.0 0.1 0.1 0.1 0.0 0.8 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 16.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 1.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.2 0.1 0.1 0.1 0.3 0.4 0.0 0.2 0.3 0.1 0.1 0.1 0.0 0.6 0.0 0.4 0.1 0.1 1.0 0.0 0.0 0.2 0.1 0.8 1.5 5.7 0.0 0.0 0.0 13.7 0.0 0.0 0.0 103.1 6.0 0.1 0.5 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.3 0.0 258.3 1.2 0.3 1.8 0.0 0.3 0.2 9.2 4.5 0.1 0.0 0.0 3.8 2.6 0.0 0.0 0.4 41.8 0.5 0.0 0.1 0.4 17.9 1.6 0.0 0.0 0.0 7.4 3.8 0.0 0.1 SUN5 "dJ726C3.1, SPAG4L, TSARG4" ENSG00000167098 "Sad1 and UNC84 domain containing 5" Q8TC36 20 32983773-33004433 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 452 "testis: 45.2" "Cell type enriched" "Detected in some" 7 "Early spermatids: 510.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048529 Enhanced NA NA "HPA048529: AB_2680428" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 510.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 68.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50130160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3" "Cell type enriched" "Detected in many" 4 "Bipolar cells: 56.1" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: AB_2681662" "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 0.9 1.4 14.0 0.8 11.9 0.3 0.5 17.3 14.6 1.4 0.0 0.9 0.2 3.2 0.8 0.5 0.5 0.3 1.1 14.4 9.1 3.1 0.8 6.1 0.3 8.9 7.6 9.2 1.3 0.2 0.7 3.4 0.7 9.5 3.0 0.1 1.3 0.1 0.7 1.4 0.3 0.9 0.4 4.2 1.7 1.1 2.1 8.7 0.1 0.9 0.5 0.5 1.8 1.1 8.0 0.0 0.2 4.2 0.0 1.1 0.3 0.0 3.0 1.1 0.1 0.0 0.6 0.0 0.1 4.1 1.3 0.0 0.1 0.3 0.0 0.1 12.7 0.1 8.6 0.3 0.0 0.7 0.0 28.0 0.4 0.0 0.0 0.0 0.6 0.7 0.0 0.3 0.3 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 12.9 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.6 1.6 0.3 0.1 0.2 0.0 0.1 2.2 0.1 1.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 11.9 17.3 14.6 14.4 9.1 8.9 7.6 9.2 9.5 4.2 8.7 8.0 0.6 0.0 0.5 6.2 0.0 0.4 0.1 0.2 0.6 56.1 0.2 0.3 1.1 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.2 3.1 0.0 1.4 6.1 12.7 2.7 8.3 0.4 0.2 2.3 0.5 0.1 2.5 0.1 8.2 0.3 0.1 11.8 7.2 0.3 0.0 0.6 1.0 2.2 1.5 5.7 0.0 1.0 2.0 2.2 0.0 2.5 0.4 0.2 0.1 3.4 0.2 0.0 0.3 1.1 0.0 4.6 0.0 0.1 2.8 1.5 1.1 0.2 0.1 0.4 0.2 0.7 0.1 0.1 PIP5KL1 "bA203J24.5, MGC46424" ENSG00000167103 "Phosphatidylinositol-4-phosphate 5-kinase like 1" Q5T9C9 9 127920881-127930785 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 22.6;Late spermatids: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "Karpas-707: 45.5;RPMI-8226: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA056240 Uncertain Supported Cytosol NA NA Cytosol "HPA056240: AB_2683075" "unprognostic (2.15e-2)" "unprognostic (3.06e-1)" "unprognostic (1.23e-3)" "unprognostic (8.51e-5)" "unprognostic (1.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (5.20e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.57e-3)" "unprognostic (9.95e-8)" "unprognostic (1.87e-1)" "unprognostic (7.21e-2)" "unprognostic (6.05e-2)" "unprognostic (1.59e-1)" 0.6 0.2 0.9 0.1 1.0 0.6 1.7 1.6 1.7 2.2 0.1 0.8 0.1 1.3 0.2 3.2 1.7 0.3 0.2 1.0 1.1 1.3 0.2 1.9 0.1 1.8 1.0 0.9 0.9 1.3 3.0 3.8 0.6 2.4 3.1 0.0 0.2 3.2 1.4 0.1 3.5 0.5 0.3 0.6 0.6 1.5 2.5 1.3 0.1 1.7 0.0 0.2 1.0 3.6 2.4 0.0 0.7 0.7 0.8 0.8 1.9 4.1 0.8 0.8 0.2 0.2 0.3 5.5 0.5 1.6 3.7 1.6 1.7 0.0 4.1 0.2 0.3 2.7 0.0 1.4 0.1 1.3 0.0 0.2 2.1 2.6 0.6 0.0 1.3 0.0 3.7 0.0 45.5 0.0 4.0 0.0 1.6 0.4 1.7 0.6 0.4 0.1 31.5 0.0 0.1 1.4 2.7 0.3 1.0 0.0 0.4 1.7 2.2 0.6 0.5 1.3 0.9 0.1 4.0 2.8 1.0 8.0 0.6 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 1.6 1.7 1.0 1.1 1.8 1.0 0.9 2.4 0.6 1.3 2.4 0.5 0.0 9.3 0.3 1.1 2.2 4.7 5.1 8.6 0.7 3.2 4.7 0.5 0.0 2.0 5.5 0.0 0.9 1.5 0.6 1.9 1.4 22.6 2.3 3.5 0.8 0.0 3.2 0.9 1.5 4.4 0.9 7.7 4.1 0.0 1.7 0.4 0.3 0.3 5.0 1.7 0.4 2.0 0.3 0.6 24.6 0.9 0.3 0.0 0.0 0.2 1.9 0.0 0.0 0.1 1.2 0.1 0.4 2.0 2.9 0.1 0.1 7.4 0.8 0.0 1.0 1.3 1.8 2.2 2.3 1.1 3.1 0.9 1.2 0.7 2.1 BPIFB6 "BPIL3, LPLUNC6" ENSG00000167104 "BPI fold containing family B member 6" Q8NFQ5 20 33031648-33044047 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "salivary gland: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043057 Uncertain "Secreted in other tissues" NA NA "HPA043057: AB_10796683" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.2;stomach 1: 23.1" "Group enriched" "Detected in many" 4 "Proximal enterocytes: 285.4;Urothelial cells: 88.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.5;CACO-2: 14.1;CAPAN-2: 10.6;EFO-21: 21.4;OE19: 16.8;SuSa: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.1 0.0 0.5 1.0 0.3 0.4 0.3 0.2 0.5 2.1 0.1 1.5 16.2 0.8 0.0 0.7 0.6 4.5 0.0 0.3 0.3 0.2 8.4 2.7 0.1 0.7 0.3 0.1 2.1 1.1 0.0 0.0 0.0 0.4 0.7 1.4 0.0 2.7 0.0 0.0 0.2 19.2 0.3 0.3 0.2 23.1 0.2 0.7 0.0 0.0 0.0 0.1 1.5 1.5 0.6 0.7 7.5 0.1 0.0 0.0 0.1 1.5 0.2 0.1 0.0 0.0 14.1 10.6 0.0 21.4 0.2 2.8 0.1 0.1 1.6 0.0 3.6 0.2 0.1 0.7 0.9 0.2 0.0 0.1 0.2 1.4 0.0 0.4 1.6 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.2 3.1 16.8 3.5 0.2 0.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 18.3 1.2 0.5 0.0 0.3 2.0 0.0 0.1 0.0 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.5 0.3 0.3 0.7 0.3 0.1 0.4 0.3 0.7 0.6 0.1 3.2 21.7 0.0 0.0 0.5 15.8 26.5 1.8 0.0 9.7 0.0 0.3 18.6 16.1 7.3 0.0 0.1 0.0 5.9 0.0 7.9 0.1 2.3 2.1 1.2 5.4 0.0 0.0 19.6 2.8 0.8 34.1 19.5 0.0 0.0 2.2 15.6 0.4 0.0 0.0 24.4 0.0 0.6 0.7 0.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 45.1 14.8 0.0 0.2 19.1 285.4 0.0 3.5 0.0 0.0 0.0 1.5 0.1 1.6 0.2 1.0 0.0 0.3 0.0 19.8 88.3 FAM102A "bA203J24.7, C9orf132, Eeig1, SYM-3A" ENSG00000167106 "Family with sequence similarity 102 member A" Q5T9C2 9 127940582-127980989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036030 Approved Cytosol NA NA Cytosol "HPA036030: AB_10670675" "unprognostic (3.27e-1)" "unprognostic (1.66e-3)" "unprognostic (1.06e-3)" "unprognostic (4.69e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-2)" "unprognostic (2.97e-1)" "unprognostic (8.36e-2)" "unprognostic (1.01e-2)" "unprognostic (9.28e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (8.28e-3)" "unprognostic (6.98e-2)" 11.1 41.0 58.7 35.7 79.6 14.1 19.8 58.3 61.8 48.6 16.0 39.0 56.1 33.8 19.6 61.6 47.9 47.1 12.7 49.5 57.8 37.1 39.3 16.3 59.8 69.6 73.8 46.8 20.8 35.4 22.6 51.5 9.1 78.3 23.9 17.7 14.7 44.3 20.3 4.0 42.4 66.2 27.4 62.2 27.5 106.5 32.9 62.3 40.5 23.5 3.9 45.0 37.5 47.3 139.1 26.5 56.7 11.9 9.6 25.1 30.0 45.1 10.1 27.4 6.6 4.1 33.1 46.0 29.8 6.6 19.4 14.2 28.4 6.3 5.1 2.5 14.4 6.3 8.9 14.5 30.1 15.6 4.4 66.3 12.2 26.0 18.9 8.0 13.3 9.2 18.0 7.4 36.7 7.7 68.6 17.8 9.5 14.8 52.0 27.4 9.2 8.8 10.7 19.1 44.3 18.7 9.2 16.7 36.9 23.9 12.8 69.3 5.7 9.8 10.3 11.1 55.1 15.5 49.1 72.7 20.7 44.7 5.9 24.9 0.7 0.1 2.5 1.9 0.0 6.1 4.8 9.7 5.7 0.1 1.1 8.9 6.3 0.1 0.4 0.1 0.0 13.4 3.9 58.7 79.6 58.3 61.8 49.5 57.8 69.6 73.8 46.8 78.3 62.2 62.3 139.1 3.3 6.4 9.0 37.5 37.2 21.9 29.4 11.5 24.5 15.6 44.9 26.9 11.4 41.5 14.9 64.4 10.4 6.3 10.7 91.2 7.9 61.5 7.0 51.0 35.8 8.6 28.1 8.0 13.8 100.5 5.9 12.4 99.4 46.0 18.4 22.3 54.7 49.1 3.3 26.9 12.2 42.1 40.7 6.9 8.8 7.4 34.2 3.8 23.2 5.6 4.4 69.0 1.0 26.2 103.5 59.3 51.9 43.2 22.6 69.9 131.9 12.9 33.2 14.3 0.0 6.0 7.4 9.8 10.2 38.6 47.9 5.3 40.3 13.1 28.7 122.4 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 143.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 97.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 25.0 72.5 7.1 5.8 7.3 3.3 21.3 7.3 10.1 19.1 7.9 27.0 22.3 6.8 16.0 7.8 9.8 10.9 17.9 6.6 7.1 143.5 36.7 18.0 8.6 7.8 6.5 5.4 19.5 6.9 10.0 3.0 15.6 7.4 15.1 17.7 1.1 16.0 16.2 41.6 20.4 20.4 5.5 7.4 8.5 18.9 5.0 7.2 5.6 42.9 26.1 8.3 17.9 13.5 7.4 24.8 8.1 6.6 15.8 68.1 12.1 38.1 5.9 8.6 12.6 24.5 32.1 47.2 15.7 12.6 7.3 11.5 14.7 4.7 29.2 15.3 19.5 11.2 27.3 3.9 58.5 11.4 3.3 24.3 54.9 44.4 15.8 2.1 45.4 17.4 20.3 3.2 8.8 13.7 31.3 8.8 11.1 1.1 47.5 11.9 20.6 4.8 41.2 4.2 97.2 21.6 11.3 11.8 17.3 12.3 13.7 15.5 22.8 12.7 22.5 6.8 3.5 1.9 15.4 3.1 8.2 9.3 17.1 1.4 0.0 2.9 15.3 2.0 7.7 1.7 8.6 1.5 2.1 16.1 2.0 0.7 0.9 0.5 1.6 7.0 6.3 5.5 2.7 7.1 7.3 7.3 10.1 6.6 7.1 7.8 6.5 5.4 7.4 7.4 7.2 7.4 3.2 28.9 24.3 27.1 7.3 6.0 23.3 17.0 25.0 0.0 20.8 16.0 25.9 11.5 19.9 3.7 0.0 85.8 1.7 59.5 11.7 13.5 0.4 4.9 3.5 4.9 10.2 1.3 0.3 4.3 11.7 6.5 21.9 7.7 22.2 24.5 4.2 44.4 21.9 0.0 0.3 20.6 2.0 9.8 11.0 1.6 26.8 11.0 3.6 17.8 12.7 6.1 5.2 3.5 0.5 5.7 53.1 14.3 2.6 3.5 78.2 128.4 14.6 0.2 0.0 2.7 5.9 0.2 2.2 5.4 7.0 81.0 4.1 12.1 25.8 14.0 GOLGA2 "GM130, golgin-95" ENSG00000167110 "Golgin A2" Q08379 9 128255829-128275995 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015421, HPA021178, HPA021230, HPA021799" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841" "unprognostic (2.88e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (3.70e-2)" "unprognostic (4.34e-2)" "unprognostic (1.84e-1)" "unprognostic (3.20e-1)" "unprognostic (2.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.50e-1)" "unprognostic (4.07e-1)" "unprognostic (2.21e-2)" "prognostic favorable (9.77e-5)" "unprognostic (3.92e-2)" "unprognostic (6.44e-2)" "unprognostic (4.84e-2)" "unprognostic (4.27e-2)" 49.6 44.6 33.8 31.6 33.3 33.7 50.0 32.7 33.2 71.1 42.5 47.1 29.2 57.5 60.2 75.6 50.4 42.6 64.5 32.5 36.9 42.4 50.7 47.7 24.7 35.4 33.6 31.7 57.9 65.9 78.0 123.4 57.3 38.3 54.8 44.9 31.7 65.6 55.4 57.7 71.5 38.3 58.6 30.7 33.7 52.1 36.1 35.3 23.5 53.8 51.6 32.4 49.0 66.9 33.5 49.1 48.1 52.8 54.9 130.4 148.3 46.3 93.6 129.2 79.4 71.1 60.7 44.7 23.1 34.4 154.3 84.4 94.4 30.3 47.4 74.2 34.1 28.9 25.5 114.0 48.3 85.2 38.2 71.4 95.4 74.0 79.1 81.9 124.9 64.3 55.1 83.8 58.6 77.6 99.8 33.0 33.9 16.2 92.0 86.2 32.9 58.1 40.0 63.4 42.5 29.3 34.9 62.5 52.1 43.2 53.3 117.0 32.2 86.3 102.9 51.8 66.9 50.8 40.7 51.1 29.7 89.8 20.0 65.6 32.4 6.6 12.2 6.2 5.3 3.8 6.0 4.1 3.4 2.7 7.3 4.4 6.1 30.2 7.4 8.2 13.2 3.6 2.9 33.8 33.3 32.7 33.2 32.5 36.9 35.4 33.6 31.7 38.3 30.7 35.3 33.5 33.9 44.8 66.8 20.9 27.0 31.7 27.7 45.1 41.5 68.0 53.8 34.8 88.1 45.8 57.8 42.3 41.7 37.9 32.6 69.6 43.0 47.6 41.5 62.9 82.2 35.5 46.1 18.7 15.1 60.8 35.6 67.1 59.7 94.3 65.9 33.6 44.6 72.3 28.3 25.2 20.4 90.9 40.7 24.9 23.1 7.7 68.3 34.2 24.9 10.3 19.5 33.4 28.8 15.6 15.5 57.7 45.1 64.7 55.6 43.7 42.6 35.4 73.2 51.7 13.1 59.6 43.3 99.5 51.1 71.4 45.5 102.3 28.1 29.5 42.6 44.2 TRUB2 CLONE24922 ENSG00000167112 "TruB pseudouridine synthase family member 2" O95900 9 128305159-128322447 "Predicted intracellular proteins" "mRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021211 Uncertain NA NA "HPA021211: AB_1858375" "unprognostic (2.40e-1)" "unprognostic (2.02e-2)" "unprognostic (1.31e-1)" "unprognostic (3.72e-2)" "unprognostic (7.38e-2)" "unprognostic (2.47e-1)" "unprognostic (1.13e-1)" "unprognostic (4.52e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (3.04e-2)" "unprognostic (4.81e-3)" "prognostic favorable (5.57e-10)" "unprognostic (8.74e-3)" "unprognostic (8.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" 3.6 8.6 9.0 3.6 9.1 4.2 4.7 8.8 9.5 3.3 8.3 4.5 5.0 3.4 3.0 6.3 4.2 2.7 8.2 8.7 8.3 6.5 13.0 2.4 4.5 9.6 9.7 9.2 3.8 5.2 7.2 6.8 2.8 10.6 3.7 4.2 3.7 4.8 3.4 7.3 5.4 4.3 3.2 8.0 3.7 4.6 3.2 9.4 3.5 4.7 9.8 4.3 4.0 3.6 10.1 6.6 14.9 6.7 9.2 10.7 7.9 7.1 7.1 8.5 11.6 9.5 11.1 8.3 14.7 6.0 9.7 11.0 17.5 15.4 12.4 7.8 7.1 10.2 6.9 12.8 10.4 8.2 12.7 8.9 10.0 13.7 11.4 10.7 7.2 12.0 12.8 26.2 6.4 9.3 19.7 17.1 14.7 9.2 22.2 19.0 13.3 10.9 21.0 10.7 5.9 14.4 10.6 13.2 14.6 9.5 5.2 19.1 8.7 8.1 9.4 7.5 11.2 8.6 7.5 16.4 11.9 9.9 9.9 10.5 3.6 3.6 1.1 5.0 3.8 5.7 6.3 4.8 5.7 5.5 5.3 5.5 5.7 1.8 6.5 2.0 3.8 6.2 3.8 9.0 9.1 8.8 9.5 8.7 8.3 9.6 9.7 9.2 10.6 8.0 9.4 10.1 10.9 25.6 10.3 1.6 17.1 9.6 13.7 43.0 15.4 21.3 14.6 15.7 49.9 24.3 27.0 35.0 16.7 51.6 10.9 19.8 64.6 39.0 12.9 15.1 20.7 16.4 19.1 16.2 5.0 35.4 45.9 15.4 27.0 15.9 8.2 22.0 17.2 50.7 31.0 3.3 5.2 26.4 34.6 9.0 4.1 16.4 20.8 12.4 12.4 3.7 16.8 15.4 18.6 3.0 10.5 27.2 19.1 18.0 17.8 14.9 34.0 78.6 16.9 16.7 0.0 17.2 16.3 15.8 19.2 22.1 10.5 28.0 13.9 46.1 35.3 11.1 COQ4 CGI-92 ENSG00000167113 "Coenzyme Q4" Q9Y3A0 9 128322544-128334072 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021406, HPA042945" Supported Supported Mitochondria NA NA Mitochondria "HPA021406: AB_2670691, HPA042945: AB_10961047" "unprognostic (9.15e-2)" "prognostic favorable (2.97e-5)" "unprognostic (2.29e-1)" "prognostic favorable (4.93e-6)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (2.11e-1)" "unprognostic (1.31e-3)" "unprognostic (2.89e-2)" "prognostic favorable (5.76e-6)" "unprognostic (6.21e-3)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.14e-3)" 23.8 53.3 32.4 21.9 33.1 19.8 28.4 30.7 43.9 31.7 37.3 33.4 77.4 25.1 19.6 62.6 52.2 21.7 36.7 32.8 34.1 62.8 64.3 25.2 24.6 31.6 31.1 32.2 30.7 64.6 45.9 53.8 17.7 32.5 41.6 23.9 22.5 47.5 28.5 32.1 55.2 54.6 15.5 29.8 27.8 39.9 22.8 31.9 20.5 51.6 22.8 23.1 31.4 34.4 33.6 36.6 54.4 31.5 36.6 22.4 31.2 58.2 31.7 20.6 40.1 28.0 48.4 46.5 48.6 28.1 24.2 31.6 99.9 27.0 38.0 14.6 25.1 50.5 18.1 112.9 52.9 38.9 51.5 27.0 37.4 45.2 33.6 36.6 21.9 32.4 40.8 121.1 31.5 26.0 106.2 60.5 38.0 37.0 75.1 60.7 60.7 45.2 91.0 49.0 36.9 58.8 40.1 64.7 71.5 41.4 13.8 92.2 18.0 43.3 38.0 35.1 56.9 43.9 53.4 50.4 38.5 47.4 25.0 28.1 22.6 31.1 19.0 44.1 36.4 39.8 39.9 39.4 44.1 39.6 34.4 31.1 38.2 3.8 35.5 37.2 63.7 34.5 29.9 32.4 33.1 30.7 43.9 32.8 34.1 31.6 31.1 32.2 32.5 29.8 31.9 33.6 21.3 22.4 29.0 25.8 31.9 28.8 47.1 75.1 47.3 29.9 60.2 65.9 43.0 42.9 48.9 57.0 27.1 90.3 36.5 70.3 142.8 56.4 15.3 139.7 39.8 25.4 31.8 36.0 23.9 63.4 47.5 32.1 35.7 42.2 36.8 37.1 30.0 77.4 49.8 30.3 26.3 65.6 57.0 26.7 23.9 27.4 30.1 24.0 40.9 8.4 27.2 37.4 27.8 17.1 28.8 46.1 66.2 30.9 60.8 32.8 185.3 202.4 161.9 53.3 26.3 27.9 33.4 47.2 31.6 79.4 50.0 47.2 32.3 69.3 85.5 58.0 SLC27A4 "ACSVL4, FATP4" ENSG00000167114 "Solute carrier family 27 member 4" Q6P1M0 9 128340527-128361470 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 53.7;Proximal enterocytes: 100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007293, CAB009771" Approved Approved Vesicles NA NA Vesicles "CAB009771: AB_2270540, HPA007293: AB_1857062" "unprognostic (7.25e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-3)" "unprognostic (3.74e-2)" "unprognostic (2.03e-1)" "unprognostic (1.85e-3)" "unprognostic (1.31e-3)" "unprognostic (4.51e-1)" "unprognostic (4.69e-2)" "unprognostic (7.72e-2)" "unprognostic (5.07e-2)" "prognostic favorable (2.61e-5)" "unprognostic (7.29e-3)" "unprognostic (2.11e-1)" "unprognostic (3.45e-2)" "unprognostic (8.01e-3)" 11.1 14.9 22.0 8.6 22.1 2.7 11.7 24.4 29.8 14.3 11.5 18.6 67.5 14.5 6.4 62.3 10.5 7.4 17.3 21.6 24.8 29.0 40.4 11.9 6.4 27.3 23.6 23.3 8.3 21.7 15.6 12.2 5.6 28.5 13.2 9.5 6.9 16.5 7.5 16.3 41.8 41.5 9.3 19.5 11.7 16.5 26.0 27.1 5.8 15.6 6.2 9.7 15.6 23.7 30.9 20.8 41.8 21.1 28.1 31.5 9.8 23.3 16.7 11.7 20.3 14.5 30.1 20.7 19.1 13.5 19.8 24.8 70.6 25.5 20.7 6.7 19.5 37.2 11.4 35.6 28.5 17.1 21.0 17.8 12.7 29.6 21.2 17.0 9.4 23.1 26.3 27.5 13.7 20.2 56.2 26.0 22.7 9.2 51.6 63.0 30.4 19.6 36.4 38.1 32.0 34.8 19.2 27.6 57.0 20.3 11.3 26.7 8.8 32.4 23.7 22.9 26.6 22.0 11.4 17.4 6.5 24.3 13.0 27.7 0.0 2.5 1.7 4.7 3.3 3.4 2.1 2.9 3.6 4.4 0.9 2.3 2.4 1.0 1.4 4.3 3.9 2.2 2.4 22.0 22.1 24.4 29.8 21.6 24.8 27.3 23.6 23.3 28.5 19.5 27.1 30.9 4.7 0.0 1.1 12.7 2.0 2.8 1.4 4.0 1.2 9.6 5.8 3.0 5.2 7.2 2.8 9.2 12.5 6.1 2.1 53.7 1.9 13.1 4.8 3.6 5.2 5.3 13.1 4.0 27.7 16.0 6.8 3.5 14.3 9.3 8.9 5.9 3.6 20.1 11.3 8.4 29.2 18.6 8.2 6.1 1.9 5.4 1.2 5.4 1.8 15.9 10.0 5.0 6.2 8.5 26.4 26.4 30.0 4.1 3.2 3.2 100.6 9.7 1.8 7.8 6.6 4.4 4.4 11.8 7.9 11.9 6.1 5.2 2.4 7.9 25.7 2.8 ANKRD40CL "C17orf73, FLJ20694, LINC00483" ENSG00000167117 "ANKRD40 C-terminal like" Q53H64 17 50761029-50767557 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "intestine: 60.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "CACO-2: 8.1;HDLM-2: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.98e-1)" "unprognostic (1.96e-2)" "unprognostic (2.02e-3)" "unprognostic (2.76e-1)" "unprognostic (4.52e-1)" "unprognostic (1.95e-1)" "unprognostic (2.09e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-2)" "unprognostic (6.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.05e-3)" 0.3 0.2 2.3 2.6 1.6 4.1 0.1 4.8 2.0 0.0 2.7 26.9 59.8 0.7 0.6 0.5 0.2 2.3 0.4 2.0 2.7 0.2 0.3 0.4 0.8 5.2 2.1 1.3 0.3 0.4 0.0 0.2 3.9 0.4 21.3 0.6 0.6 0.3 1.0 1.9 60.5 1.2 1.6 0.6 2.8 0.5 2.6 0.0 0.6 0.1 0.2 0.3 8.0 0.4 0.4 0.4 0.9 0.0 0.3 1.0 0.1 0.0 0.0 0.0 8.1 0.8 0.5 0.2 0.2 0.1 0.7 0.0 0.1 0.1 6.0 0.5 0.3 1.9 1.1 0.0 0.6 1.1 0.3 0.0 0.1 0.0 0.3 0.0 0.5 0.2 0.7 0.0 0.3 0.2 1.2 0.2 1.4 0.3 0.6 0.3 0.4 0.2 1.3 0.6 0.5 0.3 0.8 0.2 0.3 0.7 0.0 0.9 0.8 0.5 0.8 0.3 0.3 0.2 0.6 0.2 0.5 0.3 3.8 0.8 0.5 0.3 0.4 0.2 0.5 0.4 0.3 0.1 0.7 0.5 0.5 2.8 0.7 0.5 0.8 0.3 0.3 2.3 1.6 4.8 2.0 2.0 2.7 5.2 2.1 1.3 3.9 1.6 2.6 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 URM1 "C9orf74, MGC2668" ENSG00000167118 "Ubiquitin related modifier 1" Q9BTM9 9 128371361-128392016 "Predicted intracellular proteins" "tRNA processing, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053645, HPA065160" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA053645: AB_2682215, HPA065160: AB_2685423" "unprognostic (7.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.04e-2)" "unprognostic (9.19e-2)" "unprognostic (5.61e-3)" "unprognostic (2.39e-2)" "unprognostic (2.36e-1)" "prognostic favorable (7.43e-6)" "unprognostic (1.77e-3)" "unprognostic (1.93e-1)" "unprognostic (2.47e-1)" "unprognostic (6.17e-2)" 20.2 24.0 35.0 16.5 39.1 26.4 20.2 37.2 38.0 20.9 28.0 21.9 20.4 21.4 15.2 22.1 19.0 11.3 27.3 33.5 35.2 23.6 24.8 17.7 21.8 39.8 41.2 31.9 19.6 30.2 19.0 18.0 14.8 40.6 22.9 16.6 12.5 17.3 14.3 25.5 20.6 20.9 16.9 35.6 28.2 23.4 12.6 38.1 23.8 19.4 25.7 20.9 22.1 18.9 42.3 17.9 36.6 34.5 21.6 31.2 29.9 29.9 17.8 27.8 40.1 27.4 28.5 32.7 41.6 14.2 37.8 26.0 63.8 40.3 38.7 20.7 27.7 27.5 37.2 53.4 32.9 28.7 40.8 30.9 40.5 33.3 31.4 28.2 30.6 49.0 44.7 43.9 26.2 29.5 39.9 54.7 54.9 39.5 71.5 41.0 44.5 41.8 48.6 33.5 16.3 27.6 37.6 31.5 51.3 41.4 18.5 50.7 32.2 32.1 31.6 30.0 30.3 30.0 25.2 54.2 39.8 31.4 33.6 38.7 6.1 14.1 10.0 14.5 18.3 12.2 11.7 12.7 13.6 16.8 12.3 12.4 13.5 3.5 12.2 17.6 12.2 15.7 12.6 35.0 39.1 37.2 38.0 33.5 35.2 39.8 41.2 31.9 40.6 35.6 38.1 42.3 49.9 16.0 24.5 13.7 36.8 22.7 32.9 60.0 16.5 19.2 37.1 32.9 22.4 25.8 26.1 27.6 14.6 84.1 37.1 57.3 70.5 69.2 2.5 21.5 31.6 47.4 22.2 53.0 12.6 112.2 85.1 32.1 35.7 19.8 37.4 34.6 38.9 23.1 81.6 10.1 13.3 53.3 28.5 42.6 27.7 4.2 31.1 31.6 53.4 4.7 70.5 32.2 59.8 15.1 38.7 89.5 49.3 31.2 29.4 38.4 90.4 51.4 17.4 14.4 19.7 26.3 32.6 24.1 27.1 29.4 23.9 71.7 37.4 48.1 66.7 31.7 CERCAM "CEECAM1, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Metabolic proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 566.7" "Cell type enriched" "Detected in many" 7 "Oligodendrocytes: 626.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 24.1 9.0 244.5 12.4 399.8 2.6 24.7 257.1 340.0 39.8 155.3 18.9 8.0 35.3 9.8 13.2 23.6 31.5 27.5 260.2 324.4 16.1 3.8 17.0 4.2 388.4 359.4 217.8 31.4 30.3 31.2 107.3 49.8 475.4 28.2 7.8 1.0 21.6 23.0 7.1 15.1 12.4 47.8 249.2 10.9 16.0 11.2 373.1 2.4 23.6 7.0 4.0 30.2 31.1 566.7 44.7 26.0 35.2 38.2 280.5 284.1 27.4 145.5 149.7 41.2 32.0 10.3 2.4 0.0 58.3 271.9 33.5 33.8 14.7 22.2 13.9 11.7 25.6 2.9 24.1 15.5 89.7 5.4 84.4 171.6 11.7 48.4 10.5 157.7 44.3 3.0 13.0 36.5 51.8 82.3 2.3 55.7 1.8 2.3 25.4 4.7 23.6 7.3 18.4 15.5 4.9 8.5 33.8 43.1 16.7 10.1 34.4 13.7 48.2 103.5 27.3 138.1 23.2 42.2 35.0 0.8 99.7 17.1 21.0 0.1 0.6 0.0 1.8 0.7 0.1 0.1 0.1 2.1 0.7 0.0 0.0 2.3 0.0 0.6 0.0 1.0 0.0 1.3 244.5 399.8 257.1 340.0 260.2 324.4 388.4 359.4 217.8 475.4 249.2 373.1 566.7 8.5 6.4 10.3 7.2 3.5 8.9 6.5 7.0 10.8 1.7 8.7 6.9 3.9 0.0 13.6 11.0 0.0 18.4 5.8 0.0 0.0 11.6 2.7 3.1 18.7 7.7 0.0 2.5 2.9 3.4 61.1 82.3 3.6 6.7 8.8 9.8 16.8 0.1 6.2 6.7 3.3 0.0 2.0 0.8 10.4 2.3 24.2 2.9 40.9 3.7 1.3 0.1 17.5 11.6 626.9 4.5 0.0 26.4 17.9 5.0 0.0 0.9 3.9 0.9 6.6 27.8 26.4 8.6 22.2 2.4 4.1 19.6 3.3 5.9 0.0 2.8 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081111-129090438 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 29.1;Proximal enterocytes: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" NA NA Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 5.6 11.5 11.9 6.4 12.8 8.1 5.9 12.4 14.0 6.7 8.4 15.7 26.5 5.3 6.1 19.4 5.6 5.8 4.2 11.8 12.2 6.0 22.6 5.0 6.6 12.9 13.1 11.3 5.3 10.5 8.8 6.3 7.7 13.7 8.5 12.7 3.8 10.0 4.7 5.0 10.4 22.8 5.4 13.0 7.8 10.9 8.1 13.0 10.2 5.4 4.9 6.7 6.1 8.4 14.8 8.7 33.6 31.4 29.6 10.3 9.1 36.2 20.9 12.2 39.3 22.0 42.9 28.4 16.7 18.2 13.0 30.2 61.8 32.6 17.8 16.6 19.9 20.6 22.0 22.3 34.5 18.8 23.0 26.4 9.5 24.4 25.5 20.3 8.9 17.5 30.7 37.3 16.2 11.4 44.7 26.5 24.8 27.4 64.7 28.2 30.8 25.3 31.2 14.2 14.1 35.9 24.2 27.1 24.1 9.4 18.4 44.8 15.0 14.5 33.5 16.4 33.4 29.0 20.3 41.6 25.3 15.3 4.6 22.8 7.9 8.2 12.6 10.2 10.5 25.2 11.4 12.6 12.6 10.5 7.7 12.5 11.9 1.7 11.2 11.0 15.8 13.6 8.9 11.9 12.8 12.4 14.0 11.8 12.2 12.9 13.1 11.3 13.7 13.0 13.0 14.8 3.1 6.4 6.3 4.2 3.9 2.3 3.0 6.9 1.2 3.7 7.3 5.2 2.1 10.0 6.3 1.8 6.2 18.8 2.8 29.1 1.9 7.1 0.5 3.9 5.0 3.4 3.6 13.0 3.1 9.6 14.2 3.9 10.2 5.4 5.7 3.8 5.3 18.3 7.5 3.3 4.4 10.1 6.1 2.9 1.9 0.5 2.1 2.7 5.4 1.0 4.2 8.6 6.2 3.5 6.4 6.6 16.2 4.1 6.7 3.8 42.0 4.1 3.2 3.7 0.0 3.1 4.0 6.3 9.7 11.0 4.0 16.4 4.4 8.1 13.5 4.1 CCDC103 "CILD17, FLJ13094, FLJ34211, PR46b" ENSG00000167131 "Coiled-coil domain containing 103" Q8IW40 17 44899142-44905390 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 15.3;testis: 27.5" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 14.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" "unprognostic (9.40e-3)" "unprognostic (1.75e-1)" "unprognostic (5.60e-2)" "unprognostic (1.99e-2)" "unprognostic (4.50e-2)" "unprognostic (7.43e-2)" "unprognostic (2.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.27e-1)" "unprognostic (4.35e-2)" "unprognostic (4.69e-1)" "unprognostic (1.05e-1)" "unprognostic (3.60e-1)" 0.3 1.2 2.2 0.5 1.5 0.4 0.5 1.6 1.4 1.1 2.1 0.5 0.3 1.2 1.5 0.2 15.3 0.8 0.2 1.1 3.0 1.7 0.4 1.5 0.2 2.5 2.2 1.1 0.9 0.5 1.4 0.9 0.3 2.0 0.4 0.4 1.9 0.3 1.1 0.3 0.3 0.2 0.9 2.3 0.2 0.6 27.5 1.6 0.4 1.8 0.0 0.2 0.3 0.3 1.7 2.5 14.4 1.4 2.4 2.3 1.6 1.3 1.0 2.5 1.3 0.8 2.9 3.3 0.3 2.0 0.7 5.7 3.5 0.5 1.7 0.6 6.9 4.9 0.8 3.3 0.1 1.2 1.7 0.4 1.1 3.2 1.6 0.6 2.4 1.1 1.1 1.9 0.2 0.3 2.0 0.3 0.6 0.5 1.8 2.3 0.5 0.7 0.7 6.6 1.3 4.1 1.0 0.6 0.3 1.8 1.3 3.7 1.4 1.6 0.8 2.8 0.8 2.0 0.6 0.7 0.7 7.0 0.8 0.7 0.4 1.6 1.3 0.2 0.9 0.1 0.1 0.0 0.3 1.1 0.3 0.1 0.1 0.2 0.4 0.8 0.4 0.0 1.0 2.2 1.5 1.6 1.4 1.1 3.0 2.5 2.2 1.1 2.0 2.3 1.6 1.7 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENDOG ENSG00000167136 "Endonuclease G" Q14249 9 128818500-128822676 "Plasma proteins, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 136.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 111.4;Late spermatids: 147.4;Respiratory ciliated cells: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021335, HPA021830" Approved "Intracellular and membrane" NA NA "HPA021335: AB_1848151, HPA021830: AB_1848152" "unprognostic (1.35e-1)" "unprognostic (3.41e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.12e-4)" "unprognostic (2.51e-1)" "unprognostic (3.95e-1)" "unprognostic (6.56e-2)" "unprognostic (2.64e-2)" "unprognostic (4.90e-1)" "unprognostic (6.97e-2)" "unprognostic (8.35e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.06e-7)" "unprognostic (1.69e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" 10.6 18.9 18.5 2.9 18.4 4.4 12.0 23.1 25.3 9.0 23.0 11.9 12.6 9.4 1.8 17.7 12.7 1.7 43.5 18.5 21.1 23.5 53.3 10.0 3.3 22.4 18.5 18.8 8.1 22.7 12.1 13.8 3.6 19.0 15.1 5.7 2.1 15.0 7.1 136.5 13.3 11.6 3.0 18.3 9.2 18.5 20.8 19.9 3.9 12.0 59.6 3.1 11.9 11.1 18.9 14.2 15.3 3.9 20.7 10.0 8.5 17.5 13.4 6.9 12.4 8.6 9.3 11.2 4.6 11.9 8.8 7.7 39.6 12.5 11.8 2.2 9.0 22.4 8.0 14.6 16.7 4.5 24.8 29.3 8.9 14.1 7.5 5.1 7.6 9.6 15.2 25.4 7.1 7.9 20.9 19.4 51.1 9.7 24.6 56.4 22.9 4.5 48.2 18.8 5.1 34.0 33.8 30.0 27.2 7.4 2.6 26.1 12.2 9.8 8.7 5.2 12.5 10.2 22.2 3.3 8.9 17.5 17.6 9.1 0.0 1.1 0.7 1.3 2.0 1.2 1.5 1.3 0.6 1.8 2.8 1.2 1.4 0.0 1.3 0.9 3.6 0.6 0.6 18.5 18.4 23.1 25.3 18.5 21.1 22.4 18.5 18.8 19.0 18.3 19.9 18.9 19.0 9.6 5.5 13.1 11.4 8.8 26.9 12.8 6.2 14.0 28.7 21.7 0.6 20.0 16.8 23.9 4.2 31.9 26.9 55.1 101.8 6.0 97.1 111.4 15.1 9.3 14.4 16.8 4.6 7.9 34.4 14.9 21.4 30.1 1.3 93.0 10.0 80.3 20.0 11.8 8.3 27.2 18.3 17.7 7.7 147.4 18.6 15.6 10.6 4.7 6.4 37.2 10.3 3.0 7.8 7.8 24.1 18.8 11.0 18.4 52.0 108.2 115.1 13.1 6.6 23.7 19.0 74.9 6.6 19.1 14.5 10.1 14.5 44.5 36.6 23.3 TBC1D21 "MGC34741, MgcRabGAP" ENSG00000167139 "TBC1 domain family member 21" Q8IYX1 15 73873564-73889214 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 296 "testis: 50.1" "Group enriched" "Detected in some" 112 "Early spermatids: 401.0;Late spermatids: 1080.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043319 Enhanced NA NA "HPA043319: AB_10966214" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1080.9 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 5.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRX2 "PMX2, PRX2" ENSG00000167157 "Paired related homeobox 2" Q99811 9 129665647-129722674 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 23.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 27.4;Early spermatids: 78.7;Fibroblasts: 44.2;Langerhans cells: 28.0;Smooth muscle cells: 21.2;Suprabasal keratinocytes: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.9;BJ: 28.7;BJ hTERT+: 20.3;fHDF/TERT166: 41.6;U-2197: 34.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "spinal cord: 1.3" "HPA006607, HPA026808" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006607: AB_2667623, HPA026808: AB_10603228" "unprognostic (4.02e-2)" "unprognostic (5.17e-2)" "unprognostic (7.65e-3)" "unprognostic (4.47e-3)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (2.16e-2)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.94e-10)" "unprognostic (6.66e-2)" "unprognostic (4.48e-1)" "unprognostic (2.65e-2)" "unprognostic (9.47e-3)" 11.8 2.4 0.5 1.2 0.4 0.0 11.8 0.3 0.8 21.2 1.2 2.0 0.2 4.0 0.2 5.4 3.4 1.3 5.8 0.5 1.2 1.0 0.1 4.6 1.1 0.4 0.4 0.4 1.3 0.9 0.5 4.5 1.4 0.5 14.2 0.3 0.0 7.6 2.8 1.6 23.4 1.6 0.6 0.3 0.1 2.8 10.8 0.5 0.3 9.6 0.6 0.8 10.8 18.5 0.6 0.0 0.7 0.0 1.1 3.3 12.9 0.1 28.7 20.3 3.6 4.0 0.0 0.0 0.0 10.2 41.6 1.5 0.3 0.8 0.0 0.3 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.0 0.0 4.4 2.1 6.4 0.0 0.0 0.0 0.9 0.0 0.0 2.7 1.3 0.1 0.0 1.4 2.7 0.5 0.0 0.0 8.3 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.8 0.5 1.2 0.4 0.4 0.4 0.5 0.3 0.5 0.6 3.9 0.0 0.0 0.7 0.1 27.4 1.1 16.0 0.6 0.0 6.0 6.0 0.3 0.0 10.1 0.0 0.0 0.2 0.1 0.0 1.9 0.1 78.7 1.0 6.3 3.0 0.0 0.0 0.4 0.0 0.4 44.2 0.5 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 2.0 0.0 28.0 10.2 2.8 0.3 8.8 0.0 0.0 0.0 0.0 5.0 0.1 0.9 0.0 3.4 0.0 4.0 0.0 0.1 7.9 0.0 0.0 0.4 21.2 3.6 6.8 0.5 29.7 0.4 0.8 0.0 0.0 6.2 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 72.0;liver: 144.4;urinary bladder: 89.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3" "Group enriched" "Detected in many" 5 "liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 1194.0" "Not detected" "Not detected" "CAB009819, HPA054065, HPA056023" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA Vesicles "Endoplasmic reticulum" "CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: " "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.9 0.0 1.8 5.9 0.1 2.6 16.2 0.0 3.5 0.0 0.0 0.0 72.0 144.4 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 1.4 0.0 2.6 3.6 0.0 11.2 2.6 0.0 0.0 0.0 17.5 0.4 0.0 1.2 0.5 0.0 5.8 89.6 5.6 0.0 4.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 53.8 1.6 0.0 80.2 0.1 0.8 294.5 0.1 4.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.3 0.0 31.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.0 1194.0 0.0 0.1 0.2 0.1 3.2 149.0 0.0 0.0 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 1.2 12.5 0.0 0.0 0.0 0.3 0.0 2.9 1.8 0.0 0.0 0.0 0.4 0.0 0.0 52.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.5 0.0 0.0 0.4 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.5 1.8 0.1 0.0 0.0 0.0 0.0 1.2 0.2 17.3 1.1 0.0 0.0 0.0 0.1 3.0 C15orf39 "DKFZP434H132, FLJ46337" ENSG00000167173 "Chromosome 15 open reading frame 39" Q6ZRI6 15 75195643-75212169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.5;testis: 74.2" "Cell type enhanced" "Detected in many" "Early spermatids: 50.9;Late spermatids: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.0;granulocytes: 23.5;monocytes: 16.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039961, HPA041907" Enhanced Enhanced Cytosol NA NA Cytosol "HPA039961: AB_10673024, HPA041907: AB_2677736" "unprognostic (3.53e-2)" "unprognostic (1.66e-1)" "unprognostic (4.57e-2)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.00e-1)" "unprognostic (2.20e-2)" "unprognostic (3.46e-2)" "prognostic favorable (7.94e-4)" "unprognostic (3.38e-2)" "unprognostic (2.74e-1)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (2.95e-1)" "unprognostic (1.14e-1)" 14.7 15.6 5.1 12.8 3.8 62.5 13.8 1.9 6.9 13.2 4.1 10.5 11.6 14.5 1.9 20.5 16.2 7.9 13.1 2.4 4.3 7.2 4.3 15.5 11.0 5.8 3.9 2.1 18.3 14.6 15.8 9.0 15.4 3.6 8.9 5.3 1.8 14.5 6.9 4.2 15.3 10.3 7.3 5.2 25.7 9.7 74.2 5.2 8.7 11.2 3.8 6.8 15.2 14.5 4.4 20.5 41.2 8.8 10.3 11.7 7.6 26.4 5.8 11.7 6.7 7.2 51.2 27.8 45.9 19.1 8.6 24.0 27.0 37.6 17.5 1.9 45.0 42.7 91.0 19.6 35.4 13.3 26.4 90.1 10.0 13.7 14.2 6.6 8.3 17.2 17.1 39.7 66.4 2.2 12.3 25.5 32.2 27.4 13.6 16.3 23.0 6.6 49.3 4.1 15.9 25.4 8.1 13.4 30.6 21.2 8.8 10.5 33.2 14.7 11.6 17.3 20.6 17.0 47.8 32.9 26.3 11.4 50.3 11.5 8.5 6.4 18.6 1.7 11.7 1.3 1.1 1.0 1.2 3.9 0.7 0.7 1.1 23.5 3.4 16.2 8.0 1.4 4.1 5.1 3.8 1.9 6.9 2.4 4.3 5.8 3.9 2.1 3.6 5.2 5.2 4.4 13.0 25.6 5.5 0.7 7.8 14.9 7.0 5.5 19.9 0.3 8.1 5.8 2.3 7.2 9.6 3.7 0.0 12.6 17.7 13.5 0.0 15.8 50.9 17.2 10.0 10.4 7.7 5.9 0.4 14.6 16.8 7.8 8.6 30.0 17.7 14.3 10.8 2.8 12.4 0.0 1.0 6.1 6.1 23.6 10.5 68.8 11.8 24.0 7.2 1.9 31.6 0.7 12.3 1.0 0.1 18.1 26.1 10.9 19.9 5.2 3.4 1.6 8.1 2.2 13.1 6.5 10.0 37.2 5.6 15.5 14.2 20.9 7.3 3.7 8.6 17.8 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 25.6;testis: 13.7" "Group enriched" "Detected in some" 5 "Early spermatids: 52.1;Late spermatids: 64.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SCLC-21H: 57.9;SH-SY5Y: 86.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012930, HPA067333" Uncertain NA NA 110000 "HPA012930: AB_2668772, HPA067333: AB_2685824" "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.5 1.3 7.8 0.6 25.6 0.1 1.6 0.0 9.7 1.7 0.0 1.0 0.6 2.7 0.2 0.7 1.2 1.0 4.5 9.9 6.7 0.2 0.1 0.7 2.2 9.9 0.3 15.9 0.2 0.8 0.6 0.6 0.2 3.6 0.4 0.4 1.2 0.7 0.5 2.2 0.6 1.2 1.1 0.0 0.9 0.6 13.7 5.0 0.2 0.4 3.2 0.2 0.4 0.3 8.8 0.0 0.3 5.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 57.9 86.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.2 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 7.8 25.6 0.0 9.7 9.9 6.7 9.9 0.3 15.9 3.6 0.0 5.0 8.8 9.8 0.0 0.6 0.7 0.0 0.1 0.0 0.1 0.6 1.9 0.2 0.3 6.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 52.1 0.3 3.8 3.3 0.0 0.0 5.4 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 64.1 0.3 0.2 0.0 6.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.3 0.4 1.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 SP2 KIAA0048 ENSG00000167182 "Sp2 transcription factor" Q02086 17 47896150-47928957 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003357, CAB010245" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB010245: AB_2121523, HPA003357: AB_1080070" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (6.30e-3)" "unprognostic (5.85e-2)" "unprognostic (1.18e-1)" "unprognostic (6.91e-2)" "unprognostic (5.66e-2)" "unprognostic (2.46e-1)" "unprognostic (6.46e-2)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (5.39e-2)" "prognostic favorable (1.82e-5)" "unprognostic (5.34e-3)" "unprognostic (4.28e-2)" "unprognostic (3.37e-2)" "unprognostic (8.66e-2)" 15.0 10.8 8.5 16.8 10.8 19.6 15.5 14.7 11.6 12.6 5.1 14.5 15.1 14.8 12.1 17.3 15.2 11.6 18.4 8.5 6.8 12.4 8.8 15.0 20.7 14.5 9.4 5.1 15.2 16.2 23.7 9.8 13.7 10.5 13.6 13.4 10.5 16.3 12.6 32.5 14.9 15.7 12.9 7.7 17.9 13.1 17.9 9.2 25.6 18.3 26.8 15.1 13.7 13.5 11.6 33.5 37.3 25.1 21.6 12.1 11.2 26.1 19.3 13.6 19.0 17.1 41.3 16.2 28.6 17.4 24.7 20.1 25.6 17.5 16.4 19.9 41.7 26.6 28.5 25.6 22.3 11.2 26.4 34.2 16.4 19.1 22.4 21.1 13.5 18.5 26.3 31.8 47.5 18.8 45.0 64.6 16.8 11.8 29.6 24.9 30.8 34.4 18.6 13.4 52.1 26.8 31.4 16.9 17.9 20.0 15.0 26.7 25.6 30.3 34.8 18.1 24.2 30.1 42.3 50.6 26.0 19.0 18.5 29.2 13.6 6.1 9.9 8.3 7.0 7.3 4.9 6.3 7.9 4.9 5.6 7.1 7.4 11.3 9.7 6.6 4.5 7.2 6.6 8.5 10.8 14.7 11.6 8.5 6.8 14.5 9.4 5.1 10.5 7.7 9.2 11.6 14.6 9.6 19.5 5.2 17.7 6.2 15.8 7.8 12.0 9.0 9.8 9.9 9.7 12.8 8.3 11.0 0.0 10.7 11.3 16.4 15.6 7.0 9.8 8.1 6.2 11.6 15.6 25.2 5.2 7.6 9.2 9.4 8.6 10.7 13.3 5.5 8.2 7.5 8.9 11.8 4.8 9.0 14.2 10.9 8.2 10.5 10.5 14.2 8.8 6.5 11.7 12.1 17.5 9.0 9.9 7.3 13.2 3.4 12.7 11.0 8.6 8.1 10.2 6.5 6.6 12.6 12.5 9.8 6.3 9.6 7.5 20.5 14.8 5.3 7.9 17.0 PRR15L "ATAD4, MGC11242" ENSG00000167183 "Proline rich 15 like" Q9BU68 17 47951967-47957883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 180.0;pancreas: 104.8;stomach 1: 85.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 205.6" "Not detected" "Not detected" HPA022918 Approved Approved Cytosol No NA Cytosol "HPA022918: AB_2060743" "unprognostic (9.91e-2)" "unprognostic (4.77e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-3)" "unprognostic (1.83e-1)" "unprognostic (2.31e-2)" "unprognostic (2.48e-1)" "unprognostic (5.22e-2)" "unprognostic (2.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.29e-13)" "prognostic favorable (1.69e-5)" "unprognostic (1.36e-1)" "unprognostic (8.26e-2)" "unprognostic (3.34e-2)" 1.1 0.1 0.0 7.9 0.1 0.1 39.2 0.2 0.2 13.5 7.4 112.3 180.0 1.4 18.4 13.0 26.7 22.2 0.2 0.8 0.0 28.1 1.9 21.9 0.2 0.1 0.0 0.0 0.3 104.8 0.8 8.6 0.0 0.1 17.9 125.5 0.0 52.2 15.9 0.1 8.8 129.5 3.3 0.0 0.1 85.1 2.6 0.0 0.4 68.4 0.0 2.0 2.7 6.7 0.1 3.8 0.6 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 8.6 5.8 0.2 0.3 0.0 0.0 20.5 0.0 0.1 0.0 0.4 0.7 0.2 0.0 2.6 0.0 0.4 0.4 0.0 4.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 19.7 0.4 0.4 0.0 205.6 0.7 0.3 0.0 1.4 1.1 2.6 11.7 0.5 0.0 35.7 0.0 0.0 24.1 0.0 0.1 0.3 0.0 0.7 0.1 0.1 0.1 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 22.4 19.8 0.3 0.1 0.0 2.6 2.4 0.0 0.0 16.7 8.9 0.1 80.1 19.8 16.5 0.0 0.0 0.1 203.0 170.2 35.6 5.5 9.8 0.3 0.2 31.6 0.0 0.1 36.1 0.0 0.4 55.5 3.9 0.0 0.0 0.0 0.8 0.1 0.0 0.1 127.8 24.4 0.0 0.0 9.0 1.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 11.6 226.4 0.4 0.2 15.6 263.7 30.0 19.2 0.0 0.0 0.0 1.0 11.1 0.1 7.3 0.0 0.0 0.6 0.0 100.9 9.9 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067614-19080095 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 40.4;neutrophil: 126.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 126.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067252: AB_2685813, HPA071922: AB_2686473" "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favorable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 10.3 13.8 11.1 7.0 11.0 4.9 13.5 11.0 11.7 10.7 11.3 14.3 12.6 15.7 12.4 12.5 15.7 10.8 23.6 10.5 10.5 14.3 12.4 10.1 8.4 10.9 10.9 10.1 20.1 10.4 24.6 9.7 10.1 11.2 17.9 13.3 14.2 10.5 14.8 46.3 8.0 11.9 11.7 9.9 10.1 12.9 21.1 10.5 10.4 16.4 45.3 8.5 10.3 8.9 12.8 23.5 24.8 21.1 12.4 11.6 12.2 17.7 13.5 11.0 18.0 18.5 15.9 19.1 17.8 63.9 10.4 19.4 24.5 29.6 16.9 13.0 15.2 29.9 9.5 22.8 49.3 14.4 22.9 20.1 10.3 14.6 16.8 12.2 14.8 14.8 20.9 26.4 16.2 12.9 42.4 24.0 18.4 16.1 9.1 13.1 29.0 23.3 22.8 15.7 15.5 30.4 17.4 12.6 27.4 16.2 10.2 25.2 30.7 16.3 19.0 10.9 14.1 19.7 15.0 26.2 19.7 20.4 13.1 12.5 40.4 11.4 17.8 9.9 10.6 9.4 16.3 8.9 8.7 12.6 15.3 12.2 10.8 126.5 12.9 12.3 15.6 6.2 5.6 11.1 11.0 11.0 11.7 10.5 10.5 10.9 10.9 10.1 11.2 9.9 10.5 12.8 13.3 16.0 12.6 6.2 35.5 11.0 26.3 20.9 13.6 31.2 18.3 21.1 21.8 31.5 14.9 16.5 39.6 21.2 28.7 38.1 45.0 25.2 14.8 23.7 16.2 16.1 24.0 4.8 6.0 18.0 17.9 14.9 32.1 23.2 25.4 31.1 20.7 11.1 23.3 20.2 8.8 39.0 30.5 29.4 12.9 8.5 18.6 18.8 10.6 4.7 11.6 39.5 8.2 5.0 9.4 13.2 30.4 13.9 11.6 17.8 71.5 23.7 24.4 53.9 19.7 20.0 20.2 81.3 53.1 12.8 12.4 32.2 23.9 38.2 39.8 24.0 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 487.3" "Cell type enhanced" "Detected in many" "Early spermatids: 197.7;Late spermatids: 269.9;Oligodendrocytes: 171.0" "Cancer enhanced" "Detected in all" "glioma: 52.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 92.5;HHSteC: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 24.9 7.0 227.7 4.4 389.4 0.1 19.7 354.2 220.1 11.5 16.7 8.1 5.8 13.2 15.0 8.2 20.3 15.4 41.0 214.2 251.8 20.7 3.3 5.9 7.9 357.7 315.5 161.5 22.8 21.9 46.3 14.2 15.8 307.6 9.7 2.4 17.6 40.4 17.9 73.4 6.7 11.2 7.5 282.5 2.6 41.7 34.3 297.2 3.2 13.9 74.4 3.4 12.9 8.7 487.3 1.2 29.9 29.0 5.2 29.3 2.0 5.3 0.3 7.4 2.9 1.8 28.0 1.0 0.0 92.5 1.0 18.9 1.6 21.6 0.2 1.7 0.2 8.6 0.0 0.1 0.0 60.3 0.0 0.0 2.5 0.0 4.9 0.0 7.9 14.3 0.7 6.6 0.6 6.7 1.5 0.1 0.1 31.8 0.0 15.6 8.9 0.0 0.2 1.1 13.8 22.9 1.9 3.6 1.9 27.2 9.1 0.1 0.6 2.9 0.0 3.5 14.4 0.8 0.4 0.1 0.3 1.4 0.3 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.5 227.7 389.4 354.2 220.1 214.2 251.8 357.7 315.5 161.5 307.6 282.5 297.2 487.3 71.4 0.0 3.0 75.4 1.2 1.3 5.3 2.6 9.1 30.7 22.5 16.3 15.7 40.0 7.2 31.3 0.0 5.0 0.3 0.2 1.9 65.3 197.7 4.1 20.7 44.8 0.0 0.0 2.4 64.5 1.4 14.8 31.6 13.7 0.0 0.4 9.3 0.2 4.1 0.0 13.5 0.0 38.7 1.6 2.6 269.9 23.9 2.2 16.0 7.5 1.0 24.8 0.0 51.8 171.0 72.8 0.0 26.7 1.3 12.3 0.0 0.3 3.3 6.0 13.1 3.3 13.0 4.9 1.6 2.4 1.7 2.5 0.8 7.0 0.2 1.6 CRK ENSG00000167193 "CRK proto-oncogene, adaptor protein" P46108 17 1420689-1463162 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010485, HPA068087" Approved Approved "Plasma membrane" NA NA 400000 "Plasma membrane" "CAB010485: AB_2085043, HPA068087: AB_2685950" "unprognostic (6.82e-3)" "unprognostic (1.94e-1)" "unprognostic (8.70e-3)" "unprognostic (5.34e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" "unprognostic (2.48e-1)" "unprognostic (1.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" "unprognostic (2.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (3.77e-1)" "unprognostic (1.56e-1)" "unprognostic (3.93e-2)" 48.7 23.4 29.7 21.0 29.2 5.8 30.9 29.4 28.7 26.6 27.5 34.4 27.1 28.4 32.4 27.1 21.2 29.9 28.0 29.1 32.0 31.8 50.5 30.5 17.4 31.9 30.9 26.9 25.1 27.6 25.5 11.3 42.5 31.6 24.1 34.7 22.8 24.0 27.3 32.3 20.4 24.4 35.9 32.1 20.6 26.4 20.6 31.8 17.8 37.0 38.2 20.3 31.9 21.9 31.6 45.9 69.8 50.8 54.6 83.7 70.2 47.5 77.3 64.8 59.7 55.3 90.7 26.3 22.0 37.6 89.1 41.7 69.1 68.2 55.8 87.2 11.1 46.6 24.5 43.7 50.2 77.9 10.6 20.9 68.3 64.7 61.9 77.1 45.8 74.3 20.2 42.1 20.3 84.4 46.3 11.5 12.1 46.3 50.4 34.6 24.3 25.7 20.1 78.4 48.4 18.8 49.2 73.5 45.2 54.6 47.7 44.5 17.7 79.8 59.7 33.9 63.8 77.3 9.6 15.8 13.5 50.4 20.6 66.6 6.2 3.9 5.3 3.0 4.2 3.0 3.6 3.2 2.7 4.4 5.2 2.4 3.5 13.9 2.7 4.4 3.9 2.6 1.7 29.7 29.2 29.4 28.7 29.1 32.0 31.9 30.9 26.9 31.6 32.1 31.8 31.6 89.5 67.3 51.5 12.7 34.6 149.5 68.8 29.6 50.7 43.8 62.7 45.5 35.2 48.6 33.8 33.1 27.1 63.3 22.1 92.6 41.1 62.1 4.3 55.2 64.5 89.7 49.8 39.5 17.5 65.3 61.6 52.7 47.4 94.1 7.6 33.0 92.8 65.6 45.3 53.8 17.6 61.9 22.4 47.1 91.6 8.3 43.8 46.3 53.4 19.7 45.3 43.5 24.7 12.5 13.6 76.7 60.5 44.0 25.7 77.9 58.3 39.7 32.6 38.9 46.0 59.6 72.9 29.0 58.6 62.8 167.8 85.0 29.9 35.4 66.4 92.2 C16orf92 FLJ25404 ENSG00000167194 "Chromosome 16 open reading frame 92" Q96LL3 16 30023198-30027736 "Predicted intracellular proteins, Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;retina: 36.1;testis: 15.4" "Group enriched" "Detected in some" 34 "Early spermatids: 107.8;Late spermatids: 35.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.4;MCF7: 1.5;NTERA-2: 1.5;RPMI-8226: 2.5;SCLC-21H: 8.0;SH-SY5Y: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.48e-1)" "unprognostic (4.97e-2)" 0.0 1.3 0.3 0.0 0.3 0.3 0.0 6.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 1.4 0.0 1.5 0.3 0.1 1.5 0.0 0.0 0.4 0.1 2.5 0.0 0.0 8.0 1.8 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 6.8 1.4 0.9 0.2 0.3 0.2 0.0 2.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 107.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 35.4 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 10.0" "Cell type enriched" "Detected in some" 6 "Early spermatids: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FBXO22 "FBX22, FISTC1" ENSG00000167196 "F-box protein 22" Q8NEZ5 15 75903876-75942511 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 183.5;Rod photoreceptor cells: 182.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (3.76e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "unprognostic (1.50e-2)" "unprognostic (4.12e-2)" "unprognostic (1.15e-1)" "unprognostic (1.14e-1)" "unprognostic (1.73e-2)" "unprognostic (4.03e-3)" "unprognostic (9.27e-2)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (8.51e-2)" "unprognostic (9.88e-2)" "unprognostic (3.24e-2)" 6.0 10.9 5.6 6.8 5.0 5.7 6.0 8.3 8.5 6.5 7.0 8.9 9.1 6.2 4.0 10.3 6.0 5.3 7.8 5.1 6.3 8.5 17.0 6.5 7.1 5.6 5.6 4.7 7.3 10.4 7.6 8.8 7.1 6.5 7.7 5.9 22.1 8.1 4.1 12.2 8.2 8.5 5.9 5.3 5.5 7.6 11.3 6.7 5.8 7.1 6.9 6.0 8.3 7.4 6.1 30.7 53.6 23.2 33.8 19.6 18.8 83.5 26.5 18.5 19.1 20.9 41.5 35.5 24.8 34.6 15.5 44.9 45.7 45.2 49.4 17.8 21.1 24.6 20.2 45.6 74.0 31.1 31.3 35.8 22.2 36.5 20.8 26.7 16.2 30.5 30.5 37.0 17.3 21.3 35.8 8.9 22.0 24.8 27.8 13.6 33.3 20.8 24.6 11.0 39.9 22.1 21.6 36.3 26.2 62.6 47.9 41.1 28.4 31.7 78.9 50.9 26.2 39.6 21.7 42.2 32.1 31.2 39.4 49.7 23.2 19.3 14.9 13.8 19.8 14.5 13.8 14.2 14.3 24.0 23.0 16.2 13.9 4.5 15.3 18.8 16.5 20.2 13.5 5.6 5.0 8.3 8.5 5.1 6.3 5.6 5.6 4.7 6.5 5.3 6.7 6.1 17.0 16.0 17.3 9.4 18.3 28.4 22.6 57.5 15.9 53.3 20.5 22.1 25.1 14.3 30.2 16.5 183.5 52.4 24.6 12.6 46.9 24.6 86.3 23.0 25.2 16.7 18.6 22.7 29.5 30.9 66.4 17.8 17.3 20.7 12.0 37.5 13.9 27.9 22.6 63.9 32.8 12.5 34.6 8.1 9.4 20.8 18.0 11.9 10.6 15.0 25.5 26.7 20.6 22.6 20.6 25.8 15.7 20.3 20.3 28.8 21.6 46.4 29.5 182.5 13.1 20.5 22.2 56.8 47.2 17.4 28.4 43.2 16.0 28.4 17.6 23.9 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 90.7;Theca cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol NA NA Cytosol "HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906" "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 23.3 15.6 5.1 20.6 5.4 22.7 17.5 4.6 5.3 24.2 9.9 16.0 13.0 23.5 11.8 11.5 21.0 28.5 10.3 4.3 8.4 7.8 16.4 34.2 23.3 10.4 5.8 3.3 46.5 18.5 17.2 5.9 25.2 5.9 11.7 17.6 4.6 8.8 14.4 5.2 13.5 16.1 21.3 6.0 25.7 13.1 12.7 6.5 24.0 12.2 10.9 19.4 19.3 15.1 6.6 12.0 9.4 11.1 10.5 76.2 60.4 19.3 27.1 40.7 24.9 27.3 12.0 4.8 18.5 10.6 23.0 13.8 17.1 24.4 29.9 18.9 35.2 18.8 11.8 9.1 8.2 36.1 30.1 17.3 59.2 20.4 16.5 11.0 36.8 28.6 23.5 6.2 12.5 32.5 13.2 11.2 19.7 8.8 9.3 9.0 16.8 50.9 4.1 12.7 45.1 5.9 16.0 25.3 17.0 31.9 10.2 5.6 31.1 35.5 27.1 17.8 8.6 14.5 20.9 23.8 9.7 9.3 39.8 14.6 0.0 0.8 0.3 1.4 0.6 0.8 0.0 0.9 1.6 0.5 0.1 0.7 0.6 1.4 1.4 0.2 1.2 0.5 0.6 5.1 5.4 4.6 5.3 4.3 8.4 10.4 5.8 3.3 5.9 6.0 6.5 6.6 13.9 3.2 17.3 26.4 6.4 9.3 7.3 13.9 1.8 10.7 5.3 4.3 3.3 14.3 9.7 5.5 6.2 20.6 24.0 12.8 0.0 8.8 10.0 7.1 33.7 16.1 7.3 4.4 23.3 10.0 6.9 28.0 17.3 6.3 9.5 6.3 21.4 90.7 19.0 15.2 20.3 19.7 10.2 31.9 29.3 10.3 42.6 21.5 14.2 45.9 23.7 6.2 6.2 12.5 10.4 15.3 13.4 42.2 9.5 6.3 15.3 4.3 10.9 8.9 26.3 19.4 18.2 6.0 7.1 4.5 9.9 28.5 26.0 79.0 15.7 8.1 NOD2 "BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1" ENSG00000167207 "Nucleotide binding oligomerization domain containing 2" Q9HC29 16 50693588-50734041 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.7;esophagus: 11.8;skin 1: 13.9;vagina: 12.4" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0" "Group enriched" "Detected in many" 5 "dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041985, HPA054494" Enhanced Approved "Golgi apparatus,Cytosol" No NA "Golgi apparatus, Cytosol" "HPA041985: AB_2677780, HPA054494: AB_2682505" "unprognostic (1.01e-1)" "unprognostic (4.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-3)" "unprognostic (9.91e-3)" "unprognostic (5.84e-2)" "unprognostic (5.90e-3)" "unprognostic (1.23e-1)" "unprognostic (4.17e-1)" "unprognostic (3.88e-2)" "unprognostic (6.94e-3)" "unprognostic (1.48e-2)" "unprognostic (2.31e-9)" "unprognostic (4.38e-2)" "unprognostic (1.08e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 1.5 0.5 0.4 5.9 0.3 13.7 1.5 0.2 0.8 3.0 0.8 0.9 1.5 0.6 0.3 11.8 0.9 1.3 0.7 0.3 1.0 0.6 1.7 4.3 2.7 1.1 0.9 0.1 0.4 0.3 0.2 0.4 1.2 0.5 0.9 0.9 0.0 4.4 0.4 0.6 13.9 1.3 1.8 0.3 4.4 1.4 0.5 1.1 0.8 0.4 0.3 2.3 1.7 12.4 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 11.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.1 0.0 1.5 0.0 0.0 5.8 7.3 0.0 0.0 0.0 0.0 0.0 15.9 7.2 0.0 0.3 0.1 0.0 3.0 23.0 6.0 0.4 13.1 0.7 0.1 1.3 1.4 21.3 0.0 0.1 0.5 10.5 3.4 9.0 1.0 0.9 11.1 0.4 0.3 0.2 0.8 0.3 1.0 1.1 0.9 0.1 0.5 0.3 1.1 1.1 0.2 0.0 3.7 0.0 1.9 5.9 0.3 1.2 0.0 0.0 1.4 1.1 0.4 1.5 2.3 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 5.6 0.8 0.6 1.2 0.8 0.1 0.0 0.0 0.4 0.0 8.3 1.3 0.5 0.0 0.5 2.5 0.0 0.1 0.0 2.0 9.0 22.5 0.0 0.0 15.2 1.8 1.9 15.6 0.0 1.0 0.0 0.2 0.0 0.0 0.4 4.3 0.4 0.0 0.1 1.0 0.0 0.0 0.1 0.4 0.1 0.4 6.1 15.5 0.3 2.3 0.1 0.1 0.3 SNX20 "SLIC-1, SLIC1" ENSG00000167208 "Sorting nexin 20" Q7Z614 16 50666300-50681353 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2;lymphoid tissue: 33.5" "Cell type enhanced" "Detected in some" "B-cells: 15.3;Cardiomyocytes: 16.4;dendritic cells: 23.7;Hofbauer cells: 17.6;Kupffer cells: 17.2;Langerhans cells: 25.2;Macrophages: 19.3;monocytes: 26.1;NK-cells: 24.7;T-cells: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 29.7;HMC-1: 78.5;NB-4: 48.0;RPMI-8226: 20.6;THP-1: 21.3;U-266/70: 25.7;U-937: 28.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043649 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043649: AB_10965697" "unprognostic (1.53e-2)" "prognostic favorable (9.07e-4)" "unprognostic (5.58e-2)" "unprognostic (5.06e-3)" "unprognostic (9.03e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.97e-1)" "unprognostic (1.26e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (4.06e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.00e-6)" "unprognostic (3.24e-1)" "unprognostic (3.37e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" 2.3 1.0 1.3 20.1 1.7 18.2 1.2 1.7 1.6 1.1 1.7 2.8 3.0 1.0 0.6 1.6 1.0 4.0 0.8 1.2 2.6 0.7 2.2 7.8 28.0 2.7 1.9 1.0 0.6 0.5 0.4 0.5 2.7 2.2 1.1 3.6 0.3 1.9 0.7 0.9 2.4 6.2 2.7 2.2 19.4 3.8 0.5 2.5 33.5 0.9 1.1 27.2 6.1 0.7 2.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 29.7 0.0 5.2 0.0 0.0 0.0 7.4 78.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 48.0 0.0 0.0 0.0 2.4 0.2 20.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.2 0.0 0.0 0.1 0.0 25.7 14.3 6.5 0.0 28.4 0.0 306.6 66.9 208.0 41.6 118.3 52.2 22.6 73.8 50.9 123.4 22.6 56.1 38.9 62.3 51.3 147.5 34.3 137.5 81.8 1.3 1.7 1.7 1.6 1.2 2.6 2.7 1.9 1.0 2.2 2.2 2.5 2.5 0.2 0.0 0.0 0.3 15.3 0.8 0.0 0.0 0.0 0.2 0.3 0.6 16.4 2.8 1.3 0.0 0.0 0.1 23.7 0.0 0.0 0.0 0.1 0.3 0.1 1.5 0.0 6.5 0.0 0.0 0.2 0.5 0.5 0.1 5.1 0.0 1.1 0.4 17.6 1.7 0.0 0.0 0.0 17.2 25.2 0.0 0.0 19.3 0.0 0.0 26.1 0.1 24.7 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.1 13.1 0.5 0.5 0.2 0.1 0.0 0.6 0.4 21.3 0.1 0.2 0.0 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 7.3;testis: 23.2" "Group enriched" "Detected in some" 70 "Early spermatids: 199.3;Late spermatids: 439.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077128 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 1.9 0.0 0.5 0.0 2.7 2.8 0.6 0.0 2.2 0.0 0.0 0.1 0.0 0.1 7.3 0.0 1.7 0.2 0.6 0.3 0.1 0.8 0.0 1.0 0.0 0.4 0.1 0.1 0.1 0.2 0.2 1.9 0.7 1.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.8 0.1 23.2 0.4 0.1 0.2 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.0 2.2 0.3 0.1 0.4 0.1 0.1 1.0 0.0 0.4 0.3 1.2 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 199.3 0.0 0.1 0.9 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 439.4 1.8 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 4.5 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 84.2;Early spermatids: 91.8;Inhibitory neurons: 41.8;Late spermatids: 71.4;Oligodendrocytes: 38.7;Spermatocytes: 58.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;Daudi: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" No No "Nucleoplasm, Intermediate filaments" "HPA040712: AB_2677092, HPA042029: AB_2677807" "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favorable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.3 3.5 11.1 1.8 11.9 2.7 4.0 14.9 14.8 3.4 20.9 2.6 1.5 2.3 5.6 2.6 7.2 4.4 3.8 9.9 9.0 8.7 6.9 3.4 3.2 11.0 11.0 7.5 3.3 2.9 18.1 8.1 1.7 13.5 4.3 2.5 10.8 4.4 2.7 6.1 7.5 2.2 1.8 9.8 3.7 2.2 15.6 11.4 1.9 17.6 2.9 2.1 2.3 3.2 18.2 2.7 5.7 3.5 21.5 7.1 7.9 1.6 2.4 2.1 1.9 2.5 0.2 7.5 28.2 2.2 4.2 2.6 0.9 6.9 0.7 1.6 2.6 3.7 1.3 2.0 0.4 2.8 1.7 2.4 16.5 2.6 3.5 0.9 4.9 0.7 12.8 1.0 2.3 11.5 2.7 1.9 3.7 7.6 4.0 3.9 7.8 1.5 0.1 6.4 0.4 7.6 8.8 2.7 0.5 1.0 11.9 15.5 16.7 1.5 7.1 0.7 2.7 1.7 1.8 1.5 19.7 3.7 18.0 13.4 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.0 0.6 0.3 0.3 0.2 0.1 0.2 0.1 0.0 0.0 11.1 11.9 14.9 14.8 9.9 9.0 11.0 11.0 7.5 13.5 9.8 11.4 18.2 3.7 0.0 1.1 84.2 1.0 1.5 3.0 2.9 8.0 9.9 1.6 1.3 2.9 1.5 5.2 3.7 6.2 0.0 0.2 2.5 13.7 0.9 91.8 22.6 6.2 2.5 0.0 1.7 28.2 0.2 0.0 3.1 3.6 1.6 0.0 3.9 2.2 4.2 3.6 11.8 41.8 0.7 2.0 1.9 0.9 71.4 1.5 1.5 3.6 18.7 0.9 2.6 0.0 26.7 38.7 0.2 0.3 2.2 0.4 1.0 0.2 12.1 35.2 2.3 0.0 7.5 1.9 58.7 4.6 2.8 1.1 0.1 0.6 2.6 2.3 1.9 HDHD2 DKFZP564D1378 ENSG00000167220 "Haloacid dehalogenase like hydrolase domain containing 2" Q9H0R4 18 47107408-47150500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040697, CAB045978, HPA059818" Approved Approved Vesicles NA NA 240000 Vesicles "CAB045978: AB_11124418, HPA040697: AB_2677084, HPA059818: AB_2684132" "unprognostic (3.22e-1)" "unprognostic (6.32e-2)" "unprognostic (9.95e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-1)" "unprognostic (3.11e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (5.35e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "prognostic favorable (3.52e-5)" "unprognostic (1.95e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (1.17e-1)" 13.9 26.6 31.0 10.6 32.7 10.6 17.2 39.3 33.7 11.0 29.3 17.4 13.5 12.0 16.1 14.4 16.4 12.0 27.5 30.6 33.5 24.1 30.5 13.6 19.8 35.3 34.7 28.9 14.3 18.0 27.2 15.7 11.7 37.2 17.7 16.6 22.3 14.2 17.2 15.6 11.8 13.9 13.7 32.5 13.6 15.9 11.5 33.0 28.3 26.6 24.3 21.4 13.2 10.1 39.6 14.1 9.1 34.5 16.9 20.6 28.4 9.6 15.8 15.3 24.9 25.0 4.7 11.1 23.0 13.4 17.7 11.3 12.2 19.0 21.2 35.3 19.2 17.6 22.1 15.0 23.5 28.2 31.1 19.6 23.4 25.5 14.0 31.3 27.1 21.0 37.2 22.8 26.3 32.6 19.0 29.2 19.6 33.9 11.9 9.3 28.1 22.0 31.2 31.4 21.5 31.2 26.0 15.0 10.6 19.5 23.7 16.0 42.7 15.2 18.9 15.2 5.4 11.5 33.1 16.9 19.9 23.3 32.1 18.8 21.4 24.7 19.7 20.7 22.9 21.8 27.3 21.5 20.5 23.9 26.7 27.1 21.6 2.3 30.5 23.3 15.8 24.2 21.4 31.0 32.7 39.3 33.7 30.6 33.5 35.3 34.7 28.9 37.2 32.5 33.0 39.6 8.8 16.0 18.2 21.5 16.9 7.1 11.1 10.7 13.6 22.5 17.7 10.5 13.1 15.7 14.0 11.0 14.6 25.0 9.7 15.6 72.4 18.9 1.9 11.0 8.5 11.5 13.8 13.9 28.9 17.9 15.0 11.0 12.8 6.4 7.6 15.6 13.9 28.1 21.7 45.4 29.2 16.2 14.2 20.3 15.0 2.7 17.7 15.0 16.0 20.6 22.7 53.1 14.4 36.7 45.4 16.4 19.3 23.7 9.7 17.5 16.0 57.7 16.4 27.0 19.7 15.1 19.7 20.2 35.1 13.1 6.0 19.7 12.2 29.8 21.6 13.0 ZNF91 "HPF7, HTF10" ENSG00000167232 "Zinc finger protein 91" Q05481 19 23304991-23395471 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell type enhanced" "Detected in all" "Early spermatids: 434.3;Late spermatids: 630.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 30.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (4.94e-2)" "unprognostic (1.18e-2)" "unprognostic (3.32e-3)" "unprognostic (5.62e-2)" "unprognostic (1.99e-3)" "unprognostic (5.85e-2)" "unprognostic (9.85e-4)" "unprognostic (6.74e-3)" "unprognostic (3.02e-2)" "unprognostic (4.47e-2)" "prognostic favorable (7.58e-4)" "unprognostic (7.38e-3)" "unprognostic (1.09e-1)" "unprognostic (2.21e-2)" "prognostic favorable (3.48e-4)" 3.8 4.9 3.6 4.9 8.0 2.9 9.3 30.4 9.6 6.6 0.0 10.4 12.3 6.9 7.8 5.6 6.5 4.2 5.6 8.7 1.1 7.5 5.5 4.7 8.0 5.8 5.7 0.0 9.4 4.3 10.0 6.5 6.6 6.4 7.6 10.7 14.7 6.7 4.6 9.1 6.1 13.6 4.5 0.0 7.0 7.2 3.5 4.3 8.2 10.5 9.7 6.8 5.5 5.7 7.3 5.1 0.8 16.1 7.7 4.6 7.3 8.7 3.6 6.1 9.4 11.6 4.2 5.0 0.2 7.5 4.7 3.5 6.2 12.9 3.9 11.7 0.5 12.3 2.3 4.2 3.1 3.6 0.2 4.0 6.2 7.6 7.5 8.8 8.5 3.3 10.2 8.1 1.1 7.2 3.1 15.5 5.9 11.3 0.1 4.5 11.5 10.2 8.8 5.7 12.9 9.8 7.7 0.3 0.3 4.1 10.9 4.8 9.8 4.7 2.7 1.7 4.4 7.0 0.4 4.3 15.2 0.1 0.4 1.5 4.5 1.8 2.1 5.9 1.5 5.2 5.3 6.9 6.3 2.1 6.9 9.7 7.9 3.7 4.6 3.2 4.9 4.4 3.0 3.6 8.0 30.4 9.6 8.7 1.1 5.8 5.7 0.0 6.4 0.0 4.3 7.3 28.7 41.7 43.5 24.5 29.7 10.5 29.5 11.8 20.5 128.9 35.3 32.1 139.0 24.3 24.8 38.6 83.4 17.8 31.1 61.9 37.2 16.2 434.3 22.2 26.7 24.7 36.7 9.2 47.7 13.5 21.0 25.8 27.0 24.1 22.2 60.4 23.9 15.7 11.3 138.0 51.7 45.8 4.1 13.2 12.4 630.5 32.0 15.8 10.6 27.2 10.9 95.9 45.3 46.8 45.2 17.2 47.2 25.9 17.5 27.7 60.7 27.6 26.8 106.9 26.3 37.5 20.8 24.4 31.9 14.8 12.4 81.3 29.7 35.3 45.6 33.6 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2141238 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 2772.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 70.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1200000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 91.9 58.9 17.9 9.3 21.1 0.9 42.2 12.7 70.0 76.1 253.4 18.2 4.7 75.9 53.2 18.9 129.5 35.1 74.0 6.6 7.5 29.0 308.4 9.9 3.4 21.7 11.7 2.5 118.9 37.9 5.3 25.6 2772.2 15.3 14.6 4.9 0.5 11.7 15.3 82.9 6.9 11.0 14.8 13.9 14.5 12.0 23.9 8.9 3.4 12.5 115.0 4.8 24.4 23.8 9.5 0.0 2.8 0.3 0.6 0.2 0.3 1.8 112.8 1.3 3.6 0.4 862.0 0.4 0.1 8.4 0.0 2.1 0.1 0.9 7.0 7.9 0.1 0.5 0.2 0.2 600.5 143.4 0.7 0.0 174.7 0.5 0.7 0.2 0.1 1.4 0.0 0.3 0.0 333.7 2.2 0.1 0.8 1.2 0.2 1.5 0.1 408.5 0.9 0.0 0.9 32.7 495.6 0.7 0.1 0.0 83.0 4.2 0.0 0.4 0.2 20.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 21.1 12.7 70.0 6.6 7.5 21.7 11.7 2.5 15.3 13.9 8.9 9.5 40.6 3.2 3.1 0.0 2.6 5.4 0.5 0.5 0.6 0.4 0.0 0.0 6.5 8.6 0.9 3.7 0.0 1104.3 0.0 0.0 0.0 0.0 13.1 0.0 0.0 498.4 0.0 16.0 0.0 0.0 3196.3 334.2 0.0 0.0 0.0 0.0 171.4 494.9 218.2 0.0 0.0 0.0 0.0 11.6 5.5 91.1 3007.5 3.4 3.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 643.9 0.0 1.1 0.0 0.0 0.9 0.5 65.7 33.5 37.5 3.8 6.3 1.5 4.1 1612.9 1.8 0.0 0.0 0.4 RNF214 DKFZp547C195 ENSG00000167257 "Ring finger protein 214" Q8ND24 11 117232625-117286454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 20.5" "Group enriched" "Detected in all" 5 "granulocytes: 6.4;T-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039332 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA039332: AB_10671874" "unprognostic (7.36e-2)" "unprognostic (4.91e-2)" "unprognostic (9.90e-2)" "unprognostic (1.66e-2)" "unprognostic (6.34e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.06e-1)" "unprognostic (6.47e-2)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (8.48e-2)" "unprognostic (1.25e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" 10.8 11.8 9.8 8.8 10.2 12.6 10.9 10.6 10.3 11.2 6.1 10.1 9.5 11.1 8.6 9.2 10.0 8.9 10.6 8.3 8.8 10.1 13.3 9.1 10.9 10.5 10.9 6.3 13.3 22.0 11.6 12.6 11.1 13.0 9.7 9.5 12.3 11.4 10.1 18.0 10.1 10.2 11.3 8.1 11.5 12.8 18.8 10.4 14.5 13.7 13.5 10.7 11.1 9.7 12.5 12.0 14.1 31.7 19.1 15.6 15.6 17.9 19.3 17.5 20.5 21.7 21.6 28.1 16.8 32.7 22.6 19.6 15.7 34.8 16.9 21.1 31.3 10.2 53.3 11.7 16.6 30.5 25.2 19.8 14.4 18.2 25.4 37.6 23.1 25.7 29.0 30.7 17.9 21.1 9.0 20.8 21.0 17.2 20.7 14.0 22.5 21.1 22.4 19.3 17.8 20.5 22.2 22.1 14.8 10.4 24.7 25.1 16.9 24.4 20.7 16.6 11.4 16.3 10.3 7.7 20.2 7.6 20.3 24.3 6.4 2.5 2.7 2.3 2.4 1.4 1.9 7.8 4.0 2.2 1.9 2.2 2.1 1.1 1.2 2.5 2.5 20.5 1.6 9.8 10.2 10.6 10.3 8.3 8.8 10.5 10.9 6.3 13.0 8.1 10.4 12.5 19.1 25.6 15.1 23.5 14.8 5.0 9.6 10.6 21.6 23.8 11.1 14.5 12.8 15.7 14.8 5.5 10.4 14.9 10.0 9.0 9.8 13.3 46.8 15.7 26.2 11.9 9.0 14.7 20.9 12.7 13.6 12.9 14.8 15.5 5.1 21.6 7.9 7.1 12.8 13.5 24.7 8.5 10.2 10.6 6.3 20.0 10.2 13.5 8.8 12.2 12.7 14.0 14.4 33.7 24.5 10.6 9.8 12.8 14.9 7.1 10.6 12.1 10.0 37.1 13.1 20.9 19.5 64.6 57.5 15.5 5.1 19.4 17.8 28.2 8.8 7.6 CDK12 "CRK7, CRKR, CRKRS, KIAA0904" ENSG00000167258 "Cyclin dependent kinase 12" Q9NYV4 17 39461486-39564907 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 307.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008038, HPA073305" Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA008038: AB_1078570, HPA073305: " "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (7.56e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.56e-3)" "unprognostic (2.37e-2)" "unprognostic (3.86e-2)" "unprognostic (3.00e-3)" "unprognostic (6.87e-3)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "unprognostic (9.10e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-2)" "unprognostic (5.32e-1)" 9.6 7.7 3.0 14.2 2.6 34.7 9.6 7.2 4.0 11.1 4.3 9.9 10.0 10.9 6.1 10.5 9.3 9.3 6.8 2.3 1.7 8.1 12.4 9.3 15.3 3.5 1.9 0.8 12.0 8.8 13.1 6.2 11.6 3.8 9.9 10.5 11.8 9.3 9.4 6.8 10.6 10.5 10.1 0.7 13.0 10.4 17.8 2.1 18.1 12.3 7.9 15.4 13.3 9.1 6.5 31.9 40.0 24.9 22.2 17.2 19.0 21.1 28.9 24.7 39.9 29.0 48.1 19.8 45.4 24.6 31.1 38.7 51.8 49.2 36.6 38.4 29.6 38.7 49.7 26.9 36.3 16.4 66.9 33.4 20.4 25.0 48.2 37.6 16.0 24.4 27.7 85.2 30.7 22.9 14.3 57.9 17.7 23.8 16.0 16.9 36.8 50.3 25.7 14.8 38.8 24.6 15.7 37.0 307.8 25.1 34.8 38.5 29.3 26.4 34.5 27.6 24.5 37.9 23.6 18.4 63.5 24.2 28.2 23.0 11.2 2.0 3.2 2.6 1.5 1.8 1.8 1.5 1.7 1.2 3.1 1.7 1.6 7.0 4.5 1.3 2.7 1.2 0.7 3.0 2.6 7.2 4.0 2.3 1.7 3.5 1.9 0.8 3.8 0.7 2.1 6.5 41.4 25.6 29.1 50.9 59.0 64.6 58.5 31.2 50.1 46.6 38.1 26.9 14.5 32.9 40.3 38.6 64.6 33.2 59.0 44.6 13.7 30.2 25.1 49.8 63.4 40.6 31.1 39.3 53.9 27.5 29.9 39.2 45.3 63.1 29.1 43.8 32.2 46.3 27.4 35.3 52.9 39.6 42.7 45.9 49.1 17.3 37.3 41.3 26.6 32.8 41.4 27.8 48.4 47.3 53.1 47.9 33.9 33.8 53.5 81.5 33.3 16.7 38.1 65.4 32.9 48.0 48.5 140.2 104.8 53.0 69.0 58.3 59.0 46.0 39.9 84.8 DPEP2 ENSG00000167261 "Dipeptidase 2" Q9H4A9 16 67987394-68000586 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.5;lymphoid tissue: 28.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 29.9;Kupffer cells: 55.0;Macrophages: 34.6;monocytes: 28.6;NK-cells: 25.7;Syncytiotrophoblasts: 54.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 410.0;eosinophil: 841.1;neutrophil: 358.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 841.1" "Cell line enhanced" "Detected in some" "HEL: 4.1;HMC-1: 18.1;NB-4: 4.1;U-937: 6.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 12.3" HPA035644 Approved NA NA 330000000 "HPA035644: AB_10670164" "unprognostic (8.81e-2)" "unprognostic (7.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (6.66e-3)" "unprognostic (1.03e-1)" "unprognostic (5.47e-2)" "unprognostic (3.69e-2)" "unprognostic (1.68e-1)" "unprognostic (6.01e-2)" "unprognostic (1.46e-1)" "unprognostic (3.91e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (7.78e-3)" "unprognostic (3.91e-2)" 6.1 0.9 4.8 12.7 4.9 23.5 2.8 4.8 9.3 2.3 5.1 4.1 3.4 1.4 0.6 1.8 2.9 6.3 2.4 4.4 5.0 1.8 3.8 18.7 18.9 5.9 5.1 3.7 0.6 1.0 0.9 0.7 13.5 6.2 1.5 4.2 0.2 1.7 1.2 1.4 1.1 12.0 4.1 5.1 28.8 3.2 2.9 6.2 9.1 2.5 3.3 18.4 8.2 1.3 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.2 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.1 0.0 0.1 18.1 0.0 0.1 0.0 0.0 0.1 0.1 1.3 0.3 0.1 0.0 0.0 0.1 4.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.5 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.0 6.3 0.0 410.0 82.6 841.1 17.0 101.9 19.8 30.3 29.5 13.7 33.0 35.9 34.7 17.8 358.8 44.7 126.7 5.3 31.8 48.9 4.8 4.9 4.8 9.3 4.4 5.0 5.9 5.1 3.7 6.2 5.1 6.2 6.7 0.9 0.0 7.9 0.0 20.4 2.0 0.0 0.3 1.2 0.0 0.2 0.3 1.8 0.0 1.7 0.0 0.0 10.0 8.7 0.1 0.0 0.1 0.2 0.1 0.1 4.8 0.0 2.1 0.1 0.0 0.7 1.0 0.5 0.1 2.5 0.0 18.9 0.1 29.9 0.0 0.2 0.0 2.0 55.0 21.0 1.1 0.0 34.6 3.6 10.3 28.6 0.0 25.7 0.0 0.1 0.0 0.0 0.4 3.4 0.0 0.0 0.3 8.6 0.0 0.0 0.3 0.8 12.0 9.4 0.1 1.3 54.0 13.1 0.0 0.0 0.1 DUS2 "DUS2L, FLJ20399, SMM1" ENSG00000167264 "Dihydrouridine synthase 2" Q9NX74 16 67987746-68079320 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 118.1;Late spermatids: 94.1;Spermatocytes: 53.1;Syncytiotrophoblasts: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042560, HPA043528" Enhanced Enhanced Cytosol NA NA Cytosol "HPA042560: AB_10965170, HPA043528: AB_10959753" "unprognostic (2.21e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (1.23e-2)" "unprognostic (8.12e-2)" "unprognostic (1.63e-2)" "unprognostic (1.23e-2)" "unprognostic (9.84e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-1)" "unprognostic (1.53e-1)" "unprognostic (3.18e-1)" "prognostic favorable (3.50e-5)" "unprognostic (1.44e-2)" "unprognostic (8.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.81e-1)" 5.9 6.8 5.0 12.7 5.6 9.7 5.9 6.4 7.5 5.4 4.3 8.7 5.7 5.4 4.9 12.3 5.1 5.6 5.7 5.0 6.5 5.9 9.3 6.8 18.9 6.7 5.4 4.8 4.8 4.4 7.6 4.9 10.0 6.8 5.5 8.5 5.3 5.9 5.0 9.7 10.6 10.4 8.0 5.3 16.1 6.5 27.7 5.5 7.6 5.4 9.0 20.4 7.0 7.5 7.1 17.1 25.5 11.0 17.1 8.8 14.8 20.4 16.1 15.6 33.4 23.7 27.5 29.9 39.7 14.3 17.0 9.8 22.8 26.6 28.5 25.5 6.1 16.0 13.4 15.6 20.6 14.9 15.1 18.4 14.5 21.9 27.5 26.8 12.8 21.3 29.9 16.1 6.5 16.0 24.9 16.0 22.5 12.2 16.9 13.5 26.8 12.5 28.3 18.4 11.8 13.0 11.3 31.8 12.3 7.1 14.1 25.1 8.4 11.7 14.8 13.3 12.9 13.6 18.4 24.5 36.6 10.6 19.7 8.8 12.1 29.2 89.9 9.5 25.8 9.2 56.9 6.5 10.3 21.9 48.4 9.4 8.5 27.8 21.3 37.7 8.6 13.5 17.2 5.0 5.6 6.4 7.5 5.0 6.5 6.7 5.4 4.8 6.8 5.3 5.5 7.1 2.5 9.6 4.6 6.8 17.1 2.7 2.0 12.8 4.6 3.9 2.4 2.2 2.6 4.3 6.2 7.3 8.4 29.2 6.0 5.7 5.9 10.4 118.1 1.7 3.5 5.3 4.2 3.0 7.2 5.4 17.3 3.8 4.6 2.6 7.0 7.2 9.3 7.9 13.4 15.2 8.0 5.5 6.1 11.9 2.3 94.1 3.7 6.2 3.6 2.8 13.5 4.5 9.2 5.5 7.3 9.5 3.6 7.9 7.7 3.4 4.2 10.8 4.1 2.9 6.6 3.4 4.7 53.1 15.0 5.2 2.6 61.4 4.2 10.0 6.0 2.1 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581402 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA047598: AB_2680096, HPA069204: " "unprognostic (1.50e-2)" "prognostic favorable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 25.5 51.7 4.4 5.6 5.1 9.6 25.8 5.1 9.0 20.3 5.0 23.2 6.1 22.0 2.4 26.1 20.3 5.1 39.4 4.5 5.9 38.3 40.8 19.2 10.9 5.1 4.8 4.0 17.4 25.4 7.4 26.4 2.1 5.1 24.5 2.8 1.2 25.4 4.8 23.1 21.1 24.8 3.6 5.3 32.1 25.6 10.3 4.7 8.0 27.6 3.6 4.3 24.5 21.1 5.5 22.2 43.4 3.8 8.7 10.1 4.5 14.7 14.2 5.7 13.6 11.2 36.6 6.6 13.4 26.9 7.8 6.1 15.7 8.0 30.1 1.1 41.4 42.1 13.5 20.3 26.5 12.1 11.7 11.3 14.1 11.2 13.5 2.4 3.4 8.9 30.2 18.2 5.6 7.5 45.0 18.9 11.2 8.0 14.6 36.5 20.5 9.8 28.5 11.5 18.5 7.4 8.7 27.7 6.5 15.7 2.8 27.5 20.7 11.8 8.1 13.2 13.6 19.8 16.1 35.8 16.7 20.5 21.6 13.3 4.5 12.7 3.1 17.7 14.9 16.4 25.2 14.2 16.2 16.8 18.0 17.6 16.3 0.9 16.0 14.1 26.6 15.8 20.8 4.4 5.1 5.1 9.0 4.5 5.9 5.1 4.8 4.0 5.1 5.3 4.7 5.5 24.2 12.8 27.6 10.1 47.8 19.6 38.6 83.7 34.1 22.0 37.5 50.4 60.5 37.1 59.3 77.3 14.6 51.7 49.3 21.6 154.6 44.9 1.7 39.9 30.5 25.4 22.1 30.1 6.4 44.9 42.9 33.8 32.6 24.8 54.6 24.0 24.3 58.3 53.2 18.5 6.9 30.5 54.9 19.8 21.7 5.0 36.1 35.7 49.8 7.5 33.4 79.3 52.5 10.6 8.2 40.0 21.9 37.6 56.8 23.6 31.2 136.2 45.2 34.4 19.7 27.5 39.4 22.7 43.8 53.3 24.7 17.6 46.1 106.3 44.2 33.5 ENGASE FLJ21865 ENSG00000167280 Endo-beta-N-acetylglucosaminidase Q8NFI3 17 79074824-79088599 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021551 Enhanced Approved Centrosome,Cytosol No No Cytosol Centrosome "HPA021551: AB_1848156" "unprognostic (7.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (6.16e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-3)" "unprognostic (9.62e-2)" "unprognostic (4.09e-2)" "unprognostic (9.07e-2)" "unprognostic (7.00e-3)" "prognostic favorable (2.60e-4)" "unprognostic (4.79e-2)" "prognostic unfavorable (8.97e-6)" "unprognostic (8.38e-3)" "unprognostic (6.03e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.73e-5)" 8.8 8.5 9.6 8.3 8.6 7.2 9.2 7.9 15.5 12.0 11.6 12.4 14.4 9.6 2.0 5.4 10.8 5.9 8.4 10.8 9.1 7.6 8.9 9.4 9.2 9.5 8.8 6.5 13.8 8.0 6.7 7.1 5.6 9.7 10.9 9.3 6.2 9.2 4.4 24.2 9.3 15.0 5.2 7.9 20.2 11.1 3.4 10.0 7.3 11.9 10.5 5.8 11.7 9.6 18.5 6.3 12.8 5.7 10.0 4.4 2.5 9.6 5.6 3.5 4.6 3.9 7.2 6.4 0.0 5.9 5.1 6.2 9.7 7.2 5.4 2.3 4.3 12.5 5.9 14.8 4.2 4.2 6.7 11.2 5.8 7.9 3.4 3.3 7.8 4.9 14.7 9.1 3.6 2.5 5.1 0.6 7.3 2.7 15.4 12.1 12.7 16.8 5.3 2.4 16.4 4.2 9.2 7.3 33.5 4.2 6.8 10.8 7.8 6.4 6.8 6.1 6.4 4.4 10.9 1.9 2.9 4.0 13.6 5.1 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.1 0.0 0.4 0.1 0.0 0.7 0.1 9.6 8.6 7.9 15.5 10.8 9.1 9.5 8.8 6.5 9.7 7.9 10.0 18.5 6.9 0.0 16.0 18.3 6.1 4.5 5.6 3.4 3.4 11.1 7.5 7.4 6.3 5.7 5.7 11.0 35.5 5.3 7.1 23.3 0.0 4.2 1.8 3.9 6.3 7.6 26.2 3.8 5.4 4.3 5.4 6.7 18.8 4.8 5.1 11.5 8.2 11.5 8.6 8.4 10.1 18.6 0.0 13.2 9.8 1.3 3.4 15.5 0.0 14.0 8.8 5.3 6.2 3.5 11.0 2.5 10.7 1.9 5.7 5.3 16.5 2.9 2.9 24.5 13.1 7.9 8.3 1.9 1.6 4.1 5.8 6.7 7.4 7.5 27.5 4.4 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 204.4;intestine: 68.0;urinary bladder: 81.1" "Group enriched" "Detected in many" 7 "Excitatory neurons: 320.4;Inhibitory neurons: 163.9;Skeletal myocytes: 124.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in many" "cerebellum: 204.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 16.1;NTERA-2: 14.2;SCLC-21H: 22.4;U-2 OS: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, HPA075862, CAB078782" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB078782: , HPA030790: AB_10602305, HPA075862: " "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 0.9 15.6 0.4 32.4 0.6 0.3 204.4 124.6 2.4 0.0 68.0 1.5 40.3 3.1 9.7 3.6 0.0 0.3 28.1 6.9 0.3 0.2 0.6 0.1 16.8 5.6 9.4 1.3 0.5 0.9 7.6 0.0 71.5 22.5 2.4 3.4 0.2 24.6 0.5 0.4 9.2 9.6 0.0 0.5 4.2 7.6 2.5 0.0 0.3 0.0 0.0 81.1 8.3 48.5 0.0 16.1 0.2 0.2 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 14.2 0.0 0.2 0.3 0.7 0.1 0.0 0.0 22.4 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 11.1 0.6 0.0 0.9 0.0 0.4 0.5 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.6 32.4 204.4 124.6 28.1 6.9 16.8 5.6 9.4 71.5 0.0 2.5 48.5 0.5 0.0 0.0 5.9 0.2 2.0 8.1 0.0 0.0 11.5 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 5.7 0.3 0.4 7.5 0.0 0.0 320.4 0.0 0.1 11.8 0.0 0.7 0.0 0.1 0.0 0.2 0.1 5.0 163.9 0.0 0.0 0.6 5.5 10.1 0.3 7.6 5.4 10.3 0.0 1.2 2.1 11.1 4.8 0.0 0.0 10.5 0.0 15.2 0.0 0.1 0.0 3.1 0.0 124.4 7.5 2.4 26.4 0.0 1.4 0.1 2.3 0.1 0.0 2.8 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401606-118431496 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1407.2;Distal tubular cells: 2907.4;Hofbauer cells: 1367.3;Proximal tubular cells: 2520.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044629 Approved Supported Mitochondria NA NA 44000 Mitochondria "HPA044629: AB_2679028" "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favorable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 120.8 138.5 157.2 104.3 159.5 167.0 133.9 160.4 185.8 81.8 167.9 155.1 147.7 80.0 144.6 118.0 97.3 68.7 332.9 157.7 162.2 207.0 155.8 78.6 151.3 157.6 154.0 151.5 113.0 111.9 141.9 49.9 84.4 158.1 84.2 165.8 101.7 135.1 93.1 343.9 55.8 119.1 96.1 155.1 86.8 113.3 47.3 157.8 205.9 88.3 376.9 184.6 106.3 41.9 160.0 163.1 87.9 209.3 183.1 167.6 198.0 200.1 149.0 175.9 138.4 146.6 259.9 259.9 314.3 352.7 167.5 206.2 190.4 204.4 214.8 155.3 247.6 138.0 472.8 112.5 197.4 175.3 279.3 210.2 207.1 203.4 169.0 162.9 164.1 189.8 216.6 227.4 253.1 199.5 305.8 365.2 497.3 130.1 427.9 224.0 247.0 174.9 422.9 371.1 260.3 184.3 161.9 232.3 361.1 161.9 221.6 303.0 307.7 172.8 123.0 144.7 109.2 190.9 112.8 184.8 402.1 93.8 353.0 154.7 325.4 437.2 299.0 241.8 360.8 339.7 462.7 398.8 321.5 481.2 378.5 472.9 379.7 214.8 357.2 333.3 534.3 464.5 1112.1 157.2 159.5 160.4 185.8 157.7 162.2 157.6 154.0 151.5 158.1 155.1 157.8 160.0 324.3 362.2 364.1 0.0 211.2 0.0 0.0 0.0 0.0 0.0 893.9 1061.2 0.0 0.0 166.5 610.6 0.0 1407.2 378.3 0.0 2907.4 748.6 0.0 449.8 327.9 188.9 0.0 0.0 0.0 986.0 935.6 204.7 0.0 404.6 258.6 368.2 0.0 0.0 1367.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 427.7 0.0 0.0 678.1 0.0 0.0 0.0 0.0 922.2 0.0 0.0 94.9 0.0 0.0 2520.3 188.0 0.0 0.0 0.0 217.5 0.0 0.0 0.0 0.0 1001.4 224.2 370.0 0.0 0.0 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118339075-118342705 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 30 "lymphoid tissue: 915.0" "Group enriched" "Detected in many" 14 "dendritic cells: 231.0;T-cells: 665.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 52 "gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4" "Lineage enriched" "Detected in all" 66 "T-cells: 1660.4" "Group enriched" "Detected in some" 4 "JURKAT: 621.5;MOLT-4: 1299.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB013055, HPA071778" Enhanced Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB013055: , HPA071778: " "prognostic favorable (3.00e-4)" "prognostic favorable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favorable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favorable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.16e-4)" 4.1 3.8 0.4 78.2 0.6 28.8 10.0 0.5 1.4 5.3 1.1 19.0 21.8 3.6 5.8 7.7 4.5 15.8 3.7 0.4 0.7 2.3 7.9 20.8 224.5 1.1 0.7 0.3 3.2 1.3 0.9 0.8 1.2 0.7 5.9 22.6 0.3 8.4 3.1 2.5 4.0 30.4 3.9 0.8 61.4 24.0 2.4 0.7 915.0 3.8 1.4 168.3 26.9 3.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 621.5 49.8 0.0 0.0 0.0 1299.8 237.2 1.2 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.2 0.8 0.0 0.5 0.0 1.5 1.1 0.0 0.9 1.1 0.4 0.0 0.1 0.0 10.1 5.3 4.6 1462.4 3.3 990.0 9.6 1206.1 1368.7 5.0 3.7 1091.4 1338.9 25.1 4.2 5.3 6.0 1660.4 1138.7 0.4 0.6 0.5 1.4 0.4 0.7 1.1 0.7 0.3 0.7 0.8 0.7 1.2 5.9 6.4 29.6 0.0 18.6 15.3 0.3 0.0 1.8 0.0 5.4 6.7 2.8 7.2 2.6 3.7 0.0 0.4 231.0 0.9 0.0 1.3 0.4 0.8 0.8 5.0 1.2 16.8 0.0 0.0 0.0 8.3 21.4 0.9 12.6 0.0 7.9 3.1 0.6 0.0 0.0 0.2 0.0 14.9 28.4 0.7 0.0 14.2 12.4 1.0 25.0 0.0 32.0 0.0 0.0 0.1 0.2 0.0 21.0 0.3 0.0 3.4 1.5 0.0 0.0 2.5 5.8 0.1 1.2 1.4 11.8 0.3 665.7 0.0 1.1 0.2 TBC1D16 "FLJ20748, MGC25062" ENSG00000167291 "TBC1 domain family member 16" Q8TBP0 17 79932343-80035872 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 307.9" "Cancer enhanced" "Detected in all" "melanoma: 35.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 2.3" "Lineage enhanced" "Detected in single" "monocytes: 2.3" "Cell line enhanced" "Detected in many" "ASC diff: 179.1;SK-MEL-30: 192.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024482, HPA065839" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA024482: AB_1857790, HPA065839: AB_2685566" "unprognostic (4.53e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" "unprognostic (4.92e-2)" "unprognostic (7.21e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (5.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-3)" "unprognostic (3.99e-3)" 37.6 8.2 14.8 8.8 22.6 0.9 18.6 19.1 16.1 10.3 4.5 7.9 8.0 12.5 11.6 10.2 13.1 9.6 10.8 7.7 11.6 17.3 7.4 9.0 7.9 14.4 19.9 7.1 11.9 15.8 13.0 7.0 7.5 19.2 17.9 6.0 7.7 29.7 10.9 5.2 17.4 9.1 10.6 9.6 7.3 8.5 4.1 32.1 4.0 10.2 6.7 3.5 8.6 6.2 12.4 30.3 28.2 43.1 50.8 179.1 93.7 8.2 17.3 17.1 10.7 12.0 53.6 10.3 0.1 11.9 29.2 20.3 9.4 45.8 16.2 8.2 1.5 21.5 0.0 13.3 25.1 30.5 0.6 4.1 106.1 28.1 23.2 16.7 17.1 45.9 19.8 7.2 19.6 20.2 18.4 8.1 2.7 51.8 39.3 15.4 25.4 27.2 17.5 12.6 36.5 43.8 56.8 15.4 42.5 192.4 26.7 27.9 13.6 31.3 37.1 26.1 29.5 15.3 59.9 11.4 3.3 15.9 11.2 47.8 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.2 14.8 22.6 19.1 16.1 7.7 11.6 14.4 19.9 7.1 19.2 9.6 32.1 12.4 5.7 0.0 7.9 15.7 1.7 5.5 5.2 4.3 2.8 8.5 12.3 7.5 8.1 17.2 5.5 7.3 10.4 6.1 0.3 3.1 9.8 15.1 0.9 15.3 22.7 10.4 31.8 3.6 7.3 22.1 1.5 17.5 9.7 26.0 7.6 23.8 14.6 17.9 3.2 307.9 8.9 6.3 14.2 58.4 3.1 2.2 5.9 6.4 76.5 37.5 0.9 23.1 2.1 14.6 4.9 17.4 4.8 7.9 0.4 12.5 3.5 13.5 8.2 7.0 6.6 19.3 10.3 0.3 4.3 5.8 4.5 1.9 2.7 7.6 7.0 5.9 TEPSIN "C17orf56, ENTHD2, FLJ31528" ENSG00000167302 "TEPSIN adaptor related protein complex 4 accessory protein" Q96N21 17 81228277-81239091 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 9.9;Syncytiotrophoblasts: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063410 Approved "Nuclear membrane,Nuclear speckles,Golgi apparatus" NA NA "Nuclear membrane, Nuclear speckles, Golgi apparatus" "HPA063410: AB_2685008" "unprognostic (6.90e-3)" "unprognostic (1.03e-2)" "unprognostic (4.26e-2)" "unprognostic (3.64e-2)" "unprognostic (1.00e-1)" "prognostic favorable (9.96e-4)" "unprognostic (1.16e-2)" "unprognostic (4.85e-2)" "unprognostic (8.52e-2)" "unprognostic (2.29e-1)" "prognostic favorable (6.95e-4)" "unprognostic (4.99e-2)" "prognostic unfavorable (7.31e-8)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (3.58e-1)" "unprognostic (3.16e-3)" 11.2 12.2 8.3 7.5 8.3 13.1 11.4 8.3 12.9 12.7 8.7 14.0 10.9 11.3 4.0 13.4 11.6 4.3 8.8 8.1 7.9 16.1 17.9 12.1 11.1 9.2 8.3 7.8 9.4 15.9 3.3 11.5 5.3 9.1 15.4 4.0 1.6 12.1 3.0 10.1 14.5 19.8 4.4 8.1 28.9 15.7 13.4 8.7 10.4 16.1 3.2 5.9 13.7 11.9 9.0 9.5 14.2 5.1 8.6 3.5 5.7 10.0 8.2 4.7 8.5 7.6 9.1 6.8 6.9 4.5 5.5 8.0 11.8 5.3 7.3 3.8 4.1 18.7 5.7 8.1 13.0 5.4 6.0 12.8 3.4 9.1 3.8 4.2 5.9 13.4 9.7 6.7 6.7 5.3 8.4 11.2 15.7 5.7 7.5 11.6 6.9 7.1 7.4 3.3 6.1 6.7 8.5 9.7 11.1 11.5 9.9 9.1 11.3 8.0 11.2 6.6 8.5 8.3 9.4 6.5 5.5 8.3 5.3 5.7 2.4 1.2 4.0 0.8 1.6 0.5 1.2 0.5 0.6 1.3 1.8 0.3 0.4 2.1 0.4 1.0 1.4 0.8 0.8 8.3 8.3 8.3 12.9 8.1 7.9 9.2 8.3 7.8 9.1 8.1 8.7 9.0 8.6 9.6 5.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 6.9 7.1 0.0 0.0 1.3 1.8 0.0 9.9 8.8 0.0 0.0 4.7 0.0 3.2 5.8 3.0 0.0 0.0 0.0 5.3 7.2 2.5 0.0 6.2 6.3 8.6 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 3.3 0.0 0.0 2.3 2.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 10.5 3.9 5.1 0.0 0.0 MYO5B KIAA1119 ENSG00000167306 "Myosin VB" Q9ULV0 18 49822789-50195147 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 147.3;Inhibitory neurons: 90.5;Pancreatic endocrine cells: 106.6;Proximal enterocytes: 177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 65.5;HaCaT: 100.3;RH-30: 152.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040593, HPA040902, HPA069773" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194" "unprognostic (2.51e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (6.17e-3)" "unprognostic (2.14e-1)" "unprognostic (8.84e-3)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (4.13e-2)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.26e-5)" "unprognostic (4.48e-2)" "prognostic favorable (1.45e-11)" "unprognostic (2.17e-3)" "unprognostic (1.50e-1)" "unprognostic (6.56e-2)" "unprognostic (3.28e-1)" 2.3 1.7 1.7 8.0 3.3 0.1 13.8 0.4 3.0 17.9 12.8 45.8 60.8 2.6 18.6 37.7 12.3 11.4 1.7 4.4 8.9 19.9 18.8 12.0 2.6 0.5 1.7 1.2 0.5 16.7 23.2 13.5 3.8 1.4 10.2 44.0 41.3 25.6 7.2 0.4 25.6 62.5 3.2 0.5 1.8 33.6 11.5 1.5 3.1 29.7 0.2 13.1 14.4 21.8 1.4 65.5 17.3 0.3 0.3 0.0 0.0 34.0 0.3 2.6 1.4 0.1 45.8 27.2 0.1 15.6 0.1 5.0 100.3 22.6 27.3 1.3 0.2 6.9 0.2 7.5 32.8 0.0 0.2 0.2 0.0 23.6 0.6 16.2 5.1 2.3 0.3 0.5 24.7 2.7 25.3 0.0 0.2 4.6 37.8 7.0 0.0 152.5 11.0 56.8 13.2 33.7 0.7 24.4 28.3 0.0 8.6 16.8 0.2 1.5 0.0 34.0 0.4 6.8 16.7 11.2 0.1 1.4 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 3.3 0.4 3.0 4.4 8.9 0.5 1.7 1.2 1.4 0.5 1.5 1.4 0.1 54.5 15.8 2.6 1.6 0.4 9.0 7.9 2.2 7.7 14.3 7.7 3.5 15.7 21.5 7.3 10.4 4.4 0.3 147.3 5.9 49.0 22.4 38.5 3.1 1.1 6.7 5.3 4.4 47.3 1.1 3.7 48.4 29.1 0.0 27.1 0.0 18.4 0.9 0.0 90.5 35.4 2.0 1.3 0.8 4.5 0.9 1.0 3.6 3.7 2.0 31.9 0.0 2.0 9.0 106.6 70.7 0.7 1.4 60.1 177.6 18.9 38.1 30.2 0.0 0.9 2.3 9.5 6.7 8.3 6.5 4.7 0.7 0.1 46.7 56.2 ART5 ARTC5 ENSG00000167311 "ADP-ribosyltransferase 5" Q96L15 11 3638512-3642316 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 13.6;testis: 29.6" "Group enriched" "Detected in some" 8 "Early spermatids: 18.3;Late spermatids: 18.5;Spermatocytes: 64.9" "Cancer enriched" "Detected in some" 4 "testis cancer: 4.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 13.9" "Not detected" "Not detected" "HPA041637, HPA044099" Uncertain "Secreted in other tissues" NA NA "HPA041637: AB_2677589, HPA044099: AB_2678808" "unprognostic (6.32e-2)" "unprognostic (3.26e-5)" "unprognostic (4.09e-3)" "unprognostic (2.06e-4)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-2)" "unprognostic (5.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.85e-4)" "unprognostic (3.10e-3)" "unprognostic (3.46e-2)" "unprognostic (1.96e-1)" "unprognostic (3.18e-1)" 0.7 0.2 0.3 0.0 0.3 0.0 1.0 0.3 0.5 4.1 0.5 0.2 0.0 3.6 0.7 0.6 1.5 1.4 1.5 0.3 0.7 0.8 0.9 0.9 0.1 0.3 0.4 0.2 8.4 0.4 2.9 0.7 0.1 0.6 1.1 0.0 0.6 1.6 0.9 13.6 0.4 0.2 1.1 0.2 0.0 0.5 29.6 0.4 0.3 2.9 10.6 0.0 0.7 2.2 0.3 0.0 0.1 1.6 2.0 0.0 0.0 3.2 0.2 1.6 0.7 1.8 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.5 0.0 0.4 0.0 2.2 0.0 0.3 0.1 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 13.9 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.7 0.3 0.4 0.2 0.6 0.2 0.4 0.3 0.1 0.0 1.8 0.0 0.0 0.3 2.2 0.0 2.8 0.8 0.3 1.3 2.5 0.0 0.6 0.0 0.0 0.6 0.0 0.1 0.0 0.6 18.3 0.1 0.2 0.4 0.0 0.0 0.0 0.2 0.5 1.3 0.0 0.2 0.0 3.3 0.0 1.8 0.1 0.0 0.0 0.2 0.0 0.3 0.0 18.5 3.4 0.1 0.0 1.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.0 0.6 0.0 0.9 0.0 1.3 0.2 64.9 3.9 0.1 0.3 2.9 0.0 1.2 0.0 0.3 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782164-49813953 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1020.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria NA NA 3800000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favorable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 127.4 74.8 55.2 44.8 60.5 32.7 79.7 62.9 64.4 23.0 64.2 170.3 171.5 29.3 30.1 30.6 24.6 47.3 165.0 51.9 60.5 381.7 1020.3 49.4 36.9 63.7 59.1 49.3 35.1 54.6 35.3 35.2 29.8 61.0 26.7 110.7 32.1 20.4 34.3 166.7 28.2 166.6 44.9 62.6 33.9 37.7 38.0 60.5 40.3 56.3 238.7 32.2 42.0 28.9 64.4 3.9 70.5 110.0 97.5 129.9 69.5 57.4 35.2 52.4 53.6 41.2 146.3 58.9 61.1 73.5 117.5 56.7 4.8 176.8 21.0 51.4 190.5 50.4 45.5 79.0 171.4 62.5 0.7 78.3 91.7 6.7 84.8 26.2 44.6 90.0 87.7 42.5 54.7 147.5 81.8 2.7 89.7 101.5 24.8 26.7 150.8 233.0 217.6 177.7 2.8 163.4 130.9 2.7 76.2 5.6 82.1 45.7 60.0 48.1 49.8 60.5 67.8 36.4 112.3 139.7 157.3 35.0 85.7 47.1 53.0 87.4 96.1 99.2 106.5 123.0 43.2 58.3 88.7 103.2 36.3 50.2 73.2 8.3 120.0 108.1 50.1 76.4 112.7 55.2 60.5 62.9 64.4 51.9 60.5 63.7 59.1 49.3 61.0 62.6 60.5 64.4 28.4 38.5 47.3 11.8 31.4 3.6 14.2 15.5 11.4 6.7 25.0 25.5 189.9 234.4 23.7 55.2 4.2 36.5 48.2 331.1 295.4 148.5 71.2 7.9 33.9 30.0 40.1 53.6 1.7 45.7 56.0 47.3 23.9 7.7 45.1 63.3 41.4 810.5 109.6 1.7 4.6 73.0 24.4 64.8 18.5 153.9 48.1 50.6 19.6 13.1 57.2 62.2 106.1 4.5 8.7 101.8 161.2 37.2 41.2 9.8 226.6 708.0 26.4 29.5 19.7 42.1 34.9 51.1 42.7 11.1 4.8 27.0 52.2 93.0 144.8 9.6 STIM1 "D11S4896E, GOK" ENSG00000167323 "Stromal interaction molecule 1" Q13586 11 3854527-4093210 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011088, HPA012123, CAB037128, CAB037288" Enhanced Enhanced "Endoplasmic reticulum" NA NA 1900000 "Endoplasmic reticulum" "CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882" "unprognostic (2.06e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.13e-2)" "unprognostic (4.12e-1)" "unprognostic (3.43e-1)" "unprognostic (1.59e-1)" "unprognostic (2.25e-1)" "unprognostic (7.41e-2)" "unprognostic (1.86e-1)" "unprognostic (2.88e-2)" "unprognostic (9.35e-2)" "unprognostic (1.40e-1)" "unprognostic (2.73e-1)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" 38.0 18.5 32.7 22.5 29.1 46.8 33.4 18.1 32.4 37.7 28.2 32.3 18.3 39.7 18.3 66.1 39.3 25.3 18.9 28.8 24.7 19.9 38.3 27.1 30.1 18.3 23.2 30.8 41.6 30.3 44.0 18.2 17.7 20.1 26.3 24.9 11.5 61.6 24.5 112.8 46.0 31.6 34.6 16.5 31.8 32.4 25.6 23.6 69.3 41.2 50.1 30.0 32.4 40.8 22.0 42.4 48.5 14.1 23.5 60.9 55.4 22.2 31.1 31.0 22.6 28.5 24.3 13.8 44.7 35.4 46.2 50.9 74.3 20.1 21.5 19.3 36.7 30.5 70.1 19.2 36.0 53.0 58.9 40.1 56.8 53.2 32.0 90.7 28.2 31.7 59.6 44.2 80.1 24.7 9.8 55.8 20.7 5.4 23.3 18.1 13.8 22.1 41.7 38.2 23.7 3.4 14.2 51.2 33.5 19.2 22.5 12.7 32.4 34.0 40.2 13.8 42.2 25.1 88.0 71.9 22.5 33.4 24.0 26.0 16.6 11.2 20.0 17.8 14.8 14.5 7.9 13.1 19.5 9.6 11.4 14.8 13.3 16.7 20.8 25.5 8.3 14.7 17.1 32.7 29.1 18.1 32.4 28.8 24.7 18.3 23.2 30.8 20.1 16.5 23.6 22.0 20.1 16.0 8.2 53.8 22.2 16.4 7.4 9.5 17.6 5.3 16.5 13.2 4.6 18.6 10.5 5.5 14.6 27.3 35.2 27.9 1.9 12.4 4.9 17.5 35.5 12.6 9.1 18.1 63.5 14.5 13.5 20.2 10.7 24.0 29.8 4.7 20.3 32.6 15.7 16.8 56.3 13.0 12.2 22.2 15.2 9.2 27.4 18.7 17.8 57.1 11.0 16.5 36.0 77.4 5.1 12.3 6.7 11.3 14.8 11.2 7.9 3.6 14.2 3.9 26.3 17.1 18.4 21.4 13.5 50.6 22.3 17.4 28.5 1.6 11.8 11.9 RRM1 ENSG00000167325 "Ribonucleotide reductase catalytic subunit M1" P23921 11 4094707-4138932 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Allosteric enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022093, HPA057265, HPA064297" Enhanced Supported Cytosol NA Yes 140000 Cytosol "CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236" "unprognostic (4.47e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-3)" "unprognostic (3.65e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.31e-2)" "unprognostic (3.43e-2)" "unprognostic (6.90e-2)" "unprognostic (1.06e-3)" "unprognostic (4.21e-2)" "unprognostic (6.88e-3)" "unprognostic (9.20e-3)" "unprognostic (6.16e-2)" "unprognostic (8.41e-2)" "unprognostic (9.93e-3)" 16.7 21.4 5.4 25.0 5.3 33.1 22.9 7.1 6.1 16.4 4.7 26.0 19.4 16.3 10.2 26.7 15.6 11.9 16.5 5.1 5.8 13.5 18.6 12.9 34.7 6.4 5.6 5.0 16.5 14.7 24.9 7.2 20.6 6.8 18.6 29.7 23.8 14.9 16.1 30.5 36.4 20.3 20.2 6.5 13.1 17.8 18.1 5.2 57.2 15.8 30.3 45.5 15.7 19.1 6.3 221.6 117.8 188.4 110.0 28.4 56.2 73.0 198.0 98.2 220.7 225.9 106.8 163.8 237.4 47.0 100.1 95.9 173.0 176.9 143.2 259.3 117.3 187.9 121.0 159.8 83.1 11.2 208.9 84.6 26.6 37.8 121.7 86.4 48.3 107.8 140.1 161.1 107.3 186.8 99.6 246.7 41.9 118.2 152.2 119.2 196.1 147.0 84.3 59.4 61.8 159.8 88.1 175.1 104.8 30.0 75.8 102.8 71.4 62.3 203.4 106.0 206.9 147.4 70.3 103.5 252.5 114.1 137.6 130.3 8.3 4.0 4.5 11.3 11.2 21.1 9.2 22.3 16.6 7.3 5.2 17.2 15.0 0.0 10.5 15.6 4.4 41.7 10.3 5.4 5.3 7.1 6.1 5.1 5.8 6.4 5.6 5.0 6.8 6.5 5.2 6.3 12.4 19.2 14.4 4.9 17.0 33.4 26.8 31.0 17.6 15.6 15.1 14.4 33.5 14.3 24.7 18.4 6.2 62.8 14.9 13.3 7.9 25.6 69.9 11.5 14.5 15.7 18.0 81.2 11.2 22.2 62.5 22.0 20.4 13.9 7.0 27.3 10.8 15.0 28.3 18.5 12.0 25.0 16.2 11.7 10.3 83.9 13.1 13.9 10.6 6.5 10.7 24.0 5.2 12.1 11.9 15.8 10.4 16.6 31.3 10.1 12.5 8.4 15.5 22.7 13.1 19.5 27.1 102.8 63.1 36.5 29.0 39.7 23.2 18.1 34.3 20.6 OR51E2 PSGR ENSG00000167332 "Olfactory receptor family 51 subfamily E member 2" Q9H255 11 4680171-4697854 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 8.5;prostate: 29.2" "Cell type enriched" "Detected in some" 6 "Enteroendocrine cells: 77.4" "Cancer enriched" "Detected in some" 274 "prostate cancer: 217.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;BJ hTERT+: 1.1;hTERT-RPE1: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.98e-3)" "unprognostic (1.91e-1)" "unprognostic (6.09e-3)" "unprognostic (1.57e-2)" "unprognostic (8.00e-4)" "unprognostic (3.61e-2)" "unprognostic (6.27e-2)" "unprognostic (1.66e-1)" "unprognostic (3.05e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-1)" "unprognostic (3.61e-1)" "unprognostic (5.04e-5)" "unprognostic (3.34e-2)" "unprognostic (4.66e-2)" "unprognostic (5.76e-2)" "unprognostic (3.29e-1)" 0.7 0.2 0.3 1.0 0.4 0.1 0.5 0.4 0.5 0.5 0.6 8.5 0.2 1.3 0.3 0.0 0.5 0.3 0.1 0.5 0.3 0.2 0.0 0.0 0.0 0.4 0.3 0.4 0.6 0.1 0.0 0.0 4.0 0.5 29.2 2.2 0.1 0.0 2.3 0.4 0.2 0.8 2.1 0.1 0.0 0.4 0.3 0.4 0.0 0.1 0.4 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.5 0.5 0.3 0.4 0.3 0.4 0.5 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 77.4 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 TRIM68 "FLJ10369, RNF137, SS-56" ENSG00000167333 "Tripartite motif containing 68" Q6AZZ1 11 4598672-4608231 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023455 Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023455: AB_1858319" "unprognostic (4.77e-2)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (4.10e-2)" "unprognostic (4.13e-2)" "unprognostic (8.63e-2)" "unprognostic (2.01e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "unprognostic (7.78e-2)" "prognostic favorable (4.14e-6)" "unprognostic (4.23e-2)" "unprognostic (2.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" 5.1 6.6 6.6 3.7 6.9 2.2 6.4 7.1 7.3 9.7 6.0 7.0 6.6 6.5 7.3 5.1 7.7 5.2 6.4 6.5 7.2 8.0 7.5 6.7 5.2 6.6 6.8 6.3 10.2 6.2 9.0 6.3 6.2 6.7 10.8 6.2 5.9 8.4 8.2 5.9 4.8 6.0 6.0 6.5 6.8 8.1 6.6 7.0 6.5 9.7 6.6 5.8 7.1 5.4 7.0 10.2 11.2 4.5 8.2 7.2 11.6 0.0 10.9 8.0 9.9 8.9 1.4 10.3 6.9 6.5 5.6 9.3 11.6 4.5 7.7 8.4 17.2 8.8 8.4 2.9 0.0 8.3 13.7 11.4 9.1 11.1 5.7 8.6 10.2 12.6 6.3 8.0 3.7 8.9 2.4 11.3 3.7 5.4 7.1 9.2 9.0 6.4 0.3 6.3 4.4 2.4 4.3 0.0 11.0 7.1 9.0 4.8 6.8 10.3 13.1 8.8 13.3 5.0 13.7 15.9 9.9 8.9 6.0 12.5 8.6 2.5 8.9 7.9 4.8 8.8 8.5 8.8 8.9 5.6 7.6 11.1 9.0 0.3 5.7 5.5 3.8 8.7 7.4 6.6 6.9 7.1 7.3 6.5 7.2 6.6 6.8 6.3 6.7 6.5 7.0 7.0 3.2 0.0 3.6 2.9 2.8 0.8 1.4 2.7 3.4 3.3 2.6 2.4 5.4 2.8 5.9 5.5 2.1 6.1 2.7 5.3 5.9 3.2 0.9 2.6 2.2 3.4 6.7 1.3 1.7 3.3 2.7 2.9 4.6 2.8 3.8 5.9 3.6 6.0 2.2 0.0 1.6 5.2 6.1 2.1 0.6 0.4 1.8 2.0 0.0 1.9 2.7 4.1 5.2 3.5 3.0 3.3 1.9 1.9 1.8 2.0 2.4 2.5 2.4 2.8 6.6 2.0 2.6 2.9 6.6 2.0 1.0 4.4 2.8 3.9 4.7 0.6 MMP26 "endometase, MGC126590, MGC126592" ENSG00000167346 "Matrix metallopeptidase 26" Q9NRE1 11 4704927-4992429 "Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "endometrium 1: 13.2" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 44.8;Glandular and luminal cells: 171.1" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 8.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (4.21e-3)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 44.8 14.6 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 171.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 OR51B5 ENSG00000167355 "Olfactory receptor family 51 subfamily B member 5" Q9H339 11 5303444-5505652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Astrocytes: 10.1;Excitatory neurons: 5.7;Microglial cells: 21.5;Oligodendrocyte precursor cells: 6.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 4.1;U-2197: 1.1" "Low region specificity" "Detected in many" HPA063124 Uncertain NA NA "HPA063124: AB_2684943" "unprognostic (9.22e-3)" "unprognostic (1.80e-1)" "unprognostic (2.01e-1)" "unprognostic (3.76e-2)" "unprognostic (4.75e-1)" "unprognostic (1.36e-1)" "unprognostic (7.37e-5)" "unprognostic (2.94e-1)" "unprognostic (2.43e-1)" "unprognostic (4.20e-2)" "unprognostic (2.71e-2)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 5.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.5 0.0 0.0 0.0 6.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 OR51I1 ENSG00000167359 "Olfactory receptor family 51 subfamily I member 1" Q9H343 11 5440570-5441514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "olfactory bulb: 3.0" NA NA "unprognostic (2.36e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "RT4: 2.8" "Not detected" "Not detected" HPA044998 Uncertain NA NA "HPA044998: AB_10794780" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FN3K ENSG00000167363 "Fructosamine 3 kinase" Q9H479 17 82735615-82751196 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 90.1;Proximal tubular cells: 167.2;Rod photoreceptor cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 34.3;Hep G2: 66.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059151, HPA061358" Supported Approved Mitochondria NA NA 180000 Mitochondria "HPA059151: AB_2683931, HPA061358: AB_2684490" "unprognostic (4.74e-2)" "unprognostic (9.19e-2)" "unprognostic (4.22e-2)" "prognostic favorable (1.10e-4)" "unprognostic (6.10e-2)" "unprognostic (1.39e-1)" "unprognostic (6.45e-2)" "unprognostic (9.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.61e-1)" "prognostic favorable (2.40e-4)" "unprognostic (6.66e-2)" "prognostic favorable (1.39e-6)" "unprognostic (2.68e-2)" "unprognostic (8.02e-2)" "unprognostic (4.77e-1)" "unprognostic (1.22e-2)" 14.5 47.6 44.1 2.9 57.0 12.1 8.5 58.9 56.2 10.4 31.9 13.9 22.6 9.5 7.1 4.6 12.6 6.9 47.9 43.3 49.7 49.3 48.5 7.9 2.4 60.4 54.0 43.9 22.5 18.3 22.1 22.6 5.3 60.0 12.6 9.6 13.9 28.7 12.2 23.7 5.3 14.6 6.7 48.7 4.6 17.5 5.3 51.8 1.0 10.3 11.0 2.3 8.8 8.0 76.2 1.3 16.1 4.4 23.2 6.9 5.7 2.9 2.9 2.2 5.4 2.7 21.0 3.3 0.2 3.9 2.6 4.5 0.6 34.3 2.5 2.0 1.0 2.4 12.5 12.9 66.2 18.8 0.3 10.1 4.9 9.0 2.1 0.0 5.7 10.6 1.0 22.4 0.6 1.1 1.8 0.2 0.2 2.9 7.6 13.0 2.1 0.3 0.1 11.5 4.5 7.0 22.7 5.3 1.2 15.8 3.8 15.4 4.5 2.5 0.4 1.6 5.6 4.3 1.2 0.3 0.1 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.1 57.0 58.9 56.2 43.3 49.7 60.4 54.0 43.9 60.0 48.7 51.8 76.2 3.9 3.2 2.0 8.8 1.9 1.5 3.7 1.5 14.8 41.9 4.5 3.7 5.8 4.3 2.5 31.3 47.9 11.7 2.6 5.7 90.1 3.2 0.2 11.6 3.0 5.2 5.4 49.2 10.2 1.2 2.6 8.6 47.9 25.9 1.3 6.9 4.2 5.4 8.2 32.0 13.0 10.4 6.1 1.0 3.4 0.4 5.3 5.7 12.4 5.6 1.2 36.2 1.0 6.0 17.1 1.7 7.3 3.0 9.1 3.9 28.2 167.2 2.5 72.9 0.0 6.1 9.8 0.8 4.1 12.8 1.8 8.3 3.1 18.6 9.5 3.5 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 125.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "NK-cell: 3.2" "Lineage enriched" "Detected in single" 7 "NK-cells: 3.2" "Cell line enhanced" "Detected in many" "AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5" "HPA014447, HPA019203, HPA048045" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 12.0 10.6 35.3 2.5 43.3 0.3 10.9 76.4 71.0 72.8 0.0 28.5 5.4 39.8 8.7 6.7 47.4 10.9 12.9 48.2 16.3 8.2 2.4 13.1 3.3 20.8 11.9 47.7 125.3 4.8 4.3 86.3 7.1 31.7 39.5 2.4 20.0 5.4 14.1 4.6 5.0 14.6 10.5 13.8 1.7 12.5 14.7 24.9 0.5 10.7 1.8 1.0 34.4 51.4 37.0 0.1 1.5 24.1 8.6 1.2 4.2 0.5 2.5 4.1 1.0 0.8 1.1 1.5 0.2 0.3 4.4 0.5 1.6 3.4 0.2 0.4 4.1 1.4 1.7 13.8 1.6 0.3 0.0 0.3 4.1 0.1 1.9 0.1 14.0 1.0 0.7 0.2 1.5 0.2 3.1 0.6 0.5 5.0 0.1 1.1 17.6 0.9 0.4 0.2 0.8 4.1 4.3 0.2 2.1 0.5 3.5 7.6 0.0 1.3 14.5 5.2 0.7 1.4 3.7 0.5 0.2 5.3 0.2 0.5 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 3.2 0.1 0.0 0.0 0.1 35.3 43.3 76.4 71.0 48.2 16.3 20.8 11.9 47.7 31.7 13.8 24.9 37.0 2.3 3.2 0.0 22.9 0.9 1.1 1.4 1.7 0.6 82.3 1.6 1.7 0.8 1.5 1.2 0.0 31.3 1.9 1.9 9.5 1.9 1.1 2.0 4.4 10.4 5.0 6.1 0.0 24.4 1.5 0.8 11.4 2.0 1.6 0.0 1.7 3.3 0.1 0.4 20.2 19.5 4.2 2.0 0.0 2.4 9.8 36.1 0.5 0.0 5.6 0.6 5.7 1.0 8.5 1.6 3.0 9.0 40.3 0.7 1.8 15.2 1.0 5.6 37.1 6.6 2.9 11.7 2.4 3.1 0.4 0.4 2.6 2.7 0.6 2.5 1.3 ZNF23 "KOX16, Zfp612, ZNF359, ZNF612" ENSG00000167377 "Zinc finger protein 23" P17027 16 71447597-71463095 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 16.0;Respiratory ciliated cells: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023534 Uncertain Approved Cytosol NA NA Cytosol "HPA023534: AB_1859140" "unprognostic (8.49e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" "unprognostic (9.89e-3)" "unprognostic (2.12e-1)" "unprognostic (8.37e-3)" "unprognostic (2.19e-2)" "unprognostic (2.62e-3)" "unprognostic (3.65e-1)" "unprognostic (6.94e-2)" "unprognostic (9.59e-2)" "unprognostic (6.04e-2)" 5.4 4.3 8.4 5.3 8.3 4.5 6.2 8.8 10.0 5.9 8.6 4.9 2.8 6.9 8.1 4.3 7.2 3.6 5.2 8.5 8.5 5.7 5.4 5.5 6.3 8.5 8.1 8.0 8.3 4.6 5.4 14.4 4.7 8.2 5.4 5.8 17.1 4.3 5.9 6.6 5.9 5.1 7.0 8.2 5.7 4.2 7.0 8.4 4.9 7.5 7.2 6.1 4.2 3.5 9.8 7.8 4.7 12.0 8.8 7.6 6.6 7.8 17.1 15.9 11.7 8.6 6.1 7.6 15.1 4.2 13.1 11.4 4.7 7.9 10.2 13.7 4.0 5.2 6.7 5.0 6.5 9.2 12.3 5.7 10.7 9.0 12.1 18.6 10.9 4.1 7.9 11.1 2.9 12.5 13.0 6.4 6.0 13.4 4.0 3.9 3.3 5.3 4.6 7.7 6.4 9.9 12.8 5.5 3.9 5.3 7.5 5.1 6.4 11.5 21.2 7.2 5.9 10.7 6.5 10.6 19.8 16.0 6.2 13.2 0.8 0.8 0.5 1.9 1.8 1.8 1.3 1.0 2.1 1.1 2.7 2.1 1.5 0.0 2.6 1.0 1.9 1.9 0.9 8.4 8.3 8.8 10.0 8.5 8.5 8.5 8.1 8.0 8.2 8.2 8.4 9.8 0.6 6.4 2.3 15.0 2.6 0.3 0.3 0.2 2.8 2.6 0.7 0.6 0.4 0.0 3.2 0.0 6.2 0.2 0.4 0.5 1.9 2.0 0.2 1.0 1.0 1.1 0.0 7.8 10.0 1.0 0.3 0.9 1.5 0.5 2.5 1.3 1.1 0.5 0.4 3.3 11.2 1.0 0.0 0.3 0.3 0.0 0.6 0.5 0.0 6.5 0.4 1.4 2.1 13.0 16.0 1.5 1.4 0.0 1.5 0.3 0.7 0.3 9.2 3.3 0.0 0.7 0.9 1.5 1.4 2.3 0.0 0.0 1.4 0.5 1.5 0.1 IRGQ "FKSG27, IRGQ1" ENSG00000167378 "Immunity related GTPase Q" Q8WZA9 19 43584369-43596135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043254, HPA050338" Approved Approved Vesicles NA NA 45000 Vesicles "HPA043254: AB_10794178, HPA050338: AB_2681094" "unprognostic (1.98e-1)" "prognostic favorable (5.17e-4)" "unprognostic (2.55e-1)" "unprognostic (2.07e-3)" "unprognostic (9.87e-2)" "unprognostic (3.20e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.96e-2)" "unprognostic (3.98e-1)" "unprognostic (7.48e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.24e-2)" "prognostic favorable (3.92e-4)" "unprognostic (2.82e-1)" "unprognostic (7.91e-2)" "unprognostic (5.18e-2)" "unprognostic (4.65e-2)" 2.3 3.0 4.8 1.6 7.0 7.1 2.4 2.4 6.8 3.5 0.0 2.7 1.6 3.4 1.5 2.8 3.3 1.2 4.3 8.4 4.4 2.5 2.4 3.8 1.0 13.2 6.8 7.6 4.4 2.8 2.2 4.3 1.5 5.8 2.8 1.3 3.3 3.1 1.6 6.1 2.9 2.0 1.6 1.5 2.3 2.7 2.2 9.2 1.0 2.7 3.9 1.5 2.7 2.9 6.0 2.6 4.3 3.5 7.1 3.7 2.6 3.5 2.3 1.4 2.6 2.6 3.3 1.5 1.6 3.6 2.8 2.5 3.7 3.3 1.8 1.6 3.1 2.4 2.3 6.0 2.7 2.3 3.1 3.2 2.6 3.6 3.3 1.8 2.8 3.3 2.7 3.4 3.3 2.5 2.2 3.9 2.2 1.8 0.8 2.3 7.2 3.2 1.3 2.1 5.4 6.7 6.0 6.3 6.4 1.8 3.7 4.2 2.8 5.2 8.7 6.3 2.2 3.2 3.4 3.1 2.8 5.2 1.4 7.0 2.3 0.5 0.3 0.2 0.4 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.2 1.0 0.3 0.5 0.5 0.2 0.3 4.8 7.0 2.4 6.8 8.4 4.4 13.2 6.8 7.6 5.8 1.5 9.2 6.0 5.3 12.8 18.1 9.8 5.4 6.5 10.9 8.8 8.6 17.1 16.5 11.0 28.8 17.2 10.5 3.7 27.1 5.8 5.0 15.7 1.9 12.6 7.4 12.6 14.5 10.9 36.0 4.4 11.7 13.0 3.8 8.0 9.7 18.6 12.7 18.3 8.2 14.3 8.6 20.2 12.3 14.4 2.0 11.1 9.9 5.7 3.1 12.0 5.4 4.7 7.2 11.9 0.0 9.0 9.1 17.8 8.6 10.5 5.9 18.5 10.5 10.9 7.0 20.8 0.0 13.8 9.3 2.8 2.6 12.5 6.7 7.7 5.3 9.6 11.8 16.4 ZNF226 ENSG00000167380 "Zinc finger protein 226" Q9NYT6 19 44165073-44178381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006145, CAB034353" Uncertain Approved "Nuclear bodies" No No "Nuclear bodies" "CAB034353: AB_2219110, HPA006145: AB_10696203" "unprognostic (1.30e-2)" "unprognostic (5.53e-2)" "unprognostic (3.06e-1)" "unprognostic (3.41e-3)" "unprognostic (1.79e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (8.34e-4)" "unprognostic (4.09e-2)" "unprognostic (6.60e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-1)" "prognostic favorable (2.37e-5)" 12.3 31.8 16.5 12.3 19.8 11.8 20.7 24.9 22.6 13.1 18.9 14.2 13.9 14.0 25.8 10.7 16.3 17.1 16.7 16.8 18.5 18.1 18.0 12.9 20.3 18.6 17.9 15.8 20.2 9.5 22.0 33.2 12.2 20.2 21.4 14.6 31.3 12.5 15.8 10.0 12.8 15.0 12.4 17.9 18.9 16.3 17.4 17.9 20.9 24.0 7.2 16.0 15.2 11.5 28.1 18.6 20.3 22.4 16.5 20.8 33.1 10.1 19.0 42.6 20.9 38.0 14.3 22.5 6.6 23.5 24.5 28.9 10.1 9.9 18.8 25.1 10.6 23.7 26.3 25.8 10.8 18.2 17.1 17.1 37.6 24.3 25.4 50.9 40.2 27.7 19.6 5.6 6.3 40.4 6.1 18.7 7.2 10.9 10.8 15.0 11.2 17.9 13.3 20.5 50.9 16.0 25.5 38.2 13.9 9.1 21.9 22.6 24.6 21.7 19.1 23.4 10.5 22.8 31.0 30.6 19.7 17.4 11.7 20.9 53.8 14.7 10.1 22.1 15.6 25.1 19.8 22.2 21.8 17.9 28.2 25.9 22.9 11.4 26.4 13.6 19.3 26.8 13.4 16.5 19.8 24.9 22.6 16.8 18.5 18.6 17.9 15.8 20.2 17.9 17.9 28.1 15.1 16.0 13.8 20.5 19.6 4.0 17.0 48.2 8.6 39.8 14.2 14.7 27.6 14.3 30.9 11.0 27.1 13.5 19.8 13.0 35.2 22.7 20.2 24.4 12.3 17.1 12.1 19.1 13.4 27.7 7.5 15.6 16.3 17.0 11.4 25.2 16.1 24.8 18.0 21.9 14.2 18.5 30.5 16.0 7.4 7.4 19.3 12.1 21.4 9.4 22.9 29.3 36.0 17.1 35.8 26.1 19.3 22.2 7.7 20.4 20.9 47.4 37.1 30.7 6.6 13.6 15.0 15.0 21.8 9.2 5.8 12.9 18.4 36.6 10.6 20.5 ZNF180 HHZ168 ENSG00000167384 "Zinc finger protein 180" Q9UJW8 19 44474428-44500524 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028979, HPA028980" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA028979: AB_10600328, HPA028980: AB_10611524" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.34e-3)" "unprognostic (1.37e-2)" "unprognostic (1.82e-1)" "unprognostic (7.13e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.09e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-2)" "unprognostic (6.49e-2)" "unprognostic (2.21e-1)" "unprognostic (2.02e-2)" "unprognostic (3.38e-3)" 2.8 2.8 1.8 2.4 2.0 2.7 4.5 2.5 2.2 3.3 2.4 2.9 2.4 3.5 2.7 2.7 4.1 1.6 2.4 2.0 2.0 2.9 3.4 3.0 3.3 2.0 2.1 1.8 4.7 3.3 8.2 2.5 2.7 2.1 5.3 3.4 4.7 2.4 3.0 2.6 3.0 3.0 3.2 2.0 3.2 3.1 2.8 2.0 4.0 4.5 2.2 4.1 2.7 2.8 2.2 7.0 2.0 9.1 6.5 2.1 3.9 5.5 4.0 4.3 6.3 7.4 3.6 0.9 0.6 3.1 5.5 4.5 2.2 5.5 8.0 7.8 8.0 3.3 7.7 1.6 2.7 2.0 11.7 4.8 3.8 3.3 3.8 4.8 5.8 4.4 3.4 3.7 5.6 4.4 1.3 6.2 4.1 6.0 6.5 4.4 3.7 4.9 5.2 6.1 11.4 7.5 6.4 7.1 6.8 3.3 5.8 3.6 9.8 3.5 10.8 4.3 1.4 5.7 1.5 5.7 3.2 2.4 5.0 5.6 2.1 1.1 2.3 1.1 0.6 1.6 1.8 1.7 2.0 1.7 1.7 1.9 1.8 0.3 1.7 1.2 0.4 4.6 1.3 1.8 2.0 2.5 2.2 2.0 2.0 2.0 2.1 1.8 2.1 2.0 2.0 2.2 3.4 6.4 1.5 4.2 4.3 2.5 2.2 2.4 4.0 6.7 3.2 2.4 4.5 2.8 4.1 1.8 4.2 5.5 4.2 3.5 7.9 4.2 5.8 3.0 4.7 2.8 4.2 8.2 5.7 4.2 4.0 3.5 4.1 2.9 1.3 5.7 5.3 3.7 3.4 1.7 5.8 4.9 6.1 4.6 1.1 1.3 2.8 2.6 5.4 8.4 5.4 6.0 7.2 6.6 9.0 3.9 5.7 4.5 1.7 2.2 4.3 3.5 4.3 4.4 6.6 4.3 3.5 2.7 4.6 2.5 1.3 3.1 4.0 3.5 4.0 1.7 PPP2R3B "PPP2R3L, PPP2R3LY, PR48, PR70" ENSG00000167393 "Protein phosphatase 2 regulatory subunit B''beta" Q9Y5P8 X 333933-386955 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.5;skeletal muscle: 104.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 18.5;U-698: 29.9" HPA026606 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026606: " "unprognostic (1.25e-1)" "unprognostic (4.35e-3)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.03e-2)" "unprognostic (2.46e-3)" "unprognostic (1.56e-2)" "unprognostic (2.73e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-2)" "prognostic favorable (2.92e-5)" "unprognostic (4.65e-2)" "unprognostic (2.29e-8)" "unprognostic (1.15e-1)" "unprognostic (4.97e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.90e-5)" 4.2 4.7 1.3 0.2 1.3 1.9 4.9 0.5 1.6 7.9 0.4 3.8 0.5 6.9 0.0 9.6 9.4 0.3 66.5 0.6 1.0 4.0 3.8 3.9 0.6 1.4 1.0 0.5 7.6 4.5 0.2 10.4 0.6 1.9 9.2 0.0 0.1 7.2 0.3 104.2 14.0 4.7 0.3 1.0 7.3 4.7 16.4 1.1 1.3 5.0 2.6 0.0 11.9 7.7 5.8 1.0 5.0 0.6 1.9 0.1 0.1 8.1 7.6 1.3 4.7 6.0 5.4 0.0 1.8 4.0 5.4 0.7 0.0 0.1 0.0 1.0 5.6 6.3 1.1 1.8 0.3 0.0 2.3 3.1 0.2 0.1 0.0 3.7 0.4 0.1 3.3 1.6 0.2 0.7 3.1 11.8 8.6 3.1 0.1 18.5 5.3 3.7 0.4 1.0 1.4 0.0 11.1 0.0 0.6 5.3 4.0 0.0 1.7 0.4 2.5 3.6 0.0 2.0 0.2 0.4 29.9 0.0 2.6 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.5 1.6 0.6 1.0 1.4 1.0 0.5 1.9 1.0 1.1 5.8 6.7 0.0 1.7 11.4 3.8 6.8 8.6 1.7 4.6 13.5 8.5 10.7 72.3 4.3 2.1 0.0 27.1 5.2 5.7 3.8 0.0 2.5 0.6 12.1 4.6 5.4 4.8 4.8 2.8 4.0 7.3 8.0 4.6 7.4 0.0 25.6 2.9 1.8 3.7 6.7 3.7 3.9 0.0 2.8 4.5 2.0 4.1 5.8 5.4 5.6 3.1 8.6 6.2 17.6 10.4 2.4 0.6 3.0 3.3 3.7 1.8 1.7 4.3 19.0 0.0 12.2 6.5 16.7 27.1 6.1 7.5 4.0 5.0 7.8 3.6 4.5 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 5.4 6.6 3.9 3.5 3.4 7.9 4.8 4.4 6.1 5.2 1.2 5.4 4.5 7.0 0.7 6.4 4.6 2.3 5.0 4.1 2.7 4.4 4.8 4.5 2.7 4.5 3.3 3.4 3.8 3.9 2.3 4.9 3.6 4.4 6.3 1.3 0.8 4.7 2.4 6.2 7.2 4.9 3.5 3.0 6.0 4.8 7.5 3.7 3.0 4.1 1.7 1.6 6.3 5.2 4.0 5.2 17.2 3.8 9.4 3.9 4.1 13.0 14.6 10.3 7.1 5.9 8.0 7.0 8.3 11.2 8.4 4.5 9.2 2.6 7.8 1.8 10.6 11.1 5.1 11.4 12.8 4.8 8.2 12.3 5.1 3.2 12.1 2.4 2.3 5.1 8.9 9.7 4.9 12.8 17.2 17.3 17.2 13.6 3.6 14.4 22.4 28.5 12.0 3.7 11.2 13.3 15.7 9.3 12.5 4.7 1.5 9.6 11.5 8.9 17.5 7.2 13.4 6.2 8.4 15.1 12.1 11.7 8.3 11.4 8.7 4.2 7.9 11.1 3.9 7.3 4.3 3.2 6.7 6.2 3.0 3.4 4.4 1.5 7.8 3.4 3.3 3.5 5.1 3.9 3.4 4.4 6.1 4.1 2.7 4.5 3.3 3.4 4.4 3.0 3.7 4.0 3.4 0.0 3.6 3.6 4.6 8.4 2.4 5.3 7.4 3.5 4.5 3.7 0.6 4.3 3.8 0.0 0.0 6.5 5.9 6.3 7.9 8.9 44.7 3.8 4.7 4.3 4.8 4.6 3.7 4.8 11.4 6.4 4.1 8.1 4.5 4.7 3.6 2.8 6.8 11.8 3.7 3.7 4.1 3.8 7.1 15.3 6.2 9.3 3.6 2.8 5.5 5.1 12.3 1.0 4.2 7.5 4.9 15.1 4.5 4.0 7.5 5.8 1.7 2.1 0.0 9.0 5.5 5.9 12.8 8.8 8.8 7.0 7.4 5.0 4.6 2.2 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.9" "Cell type enhanced" "Detected in many" "Early spermatids: 24.8;Spermatocytes: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 25.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: AB_2732746" "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 5.1 4.2 4.0 6.8 4.1 9.3 5.1 5.5 5.3 5.6 1.4 5.0 6.4 6.6 2.5 5.2 5.5 3.6 4.3 3.0 2.1 4.4 4.3 4.7 7.2 5.4 4.2 1.8 6.3 5.6 4.4 5.1 4.0 5.0 5.5 2.8 1.7 6.3 4.0 8.0 7.5 6.5 3.2 3.3 8.0 5.6 25.9 4.3 8.7 5.2 3.7 5.2 5.4 5.0 5.3 7.8 15.8 10.2 8.0 7.1 5.5 13.7 8.3 8.8 9.8 9.0 11.6 7.1 15.0 13.0 7.1 6.5 10.2 8.5 9.2 3.7 17.2 8.1 11.1 15.6 9.7 7.4 14.4 16.7 7.1 8.1 10.6 6.0 7.6 5.9 12.5 18.2 8.5 7.5 12.2 16.0 9.9 13.8 3.5 8.1 25.5 20.2 15.3 3.1 7.3 14.7 14.9 9.5 10.0 4.9 4.4 8.4 12.5 12.1 12.3 7.0 8.2 7.8 14.2 14.1 14.9 11.2 15.5 9.8 9.8 4.5 13.2 5.1 4.2 2.6 3.9 2.4 2.1 4.6 4.4 2.7 3.0 25.1 4.8 2.8 6.6 2.6 2.1 4.0 4.1 5.5 5.3 3.0 2.1 5.4 4.2 1.8 5.0 3.3 4.3 5.3 4.7 3.2 1.3 3.6 4.2 3.3 1.0 2.6 2.8 3.6 3.4 3.4 1.7 1.5 2.2 1.8 4.2 1.9 6.6 6.6 1.9 4.1 24.8 3.0 3.7 3.4 6.0 2.1 2.2 3.5 2.1 2.5 5.6 4.9 1.3 5.1 1.8 1.9 4.9 1.7 2.1 3.4 4.1 4.7 2.8 6.6 2.8 6.4 0.0 7.5 3.7 3.6 4.1 2.0 3.1 4.4 7.6 4.5 2.3 2.4 5.8 2.2 2.7 1.1 0.0 3.5 2.3 16.2 7.0 2.9 4.0 2.5 4.9 2.8 3.7 1.9 VKORC1 VKCFD2 ENSG00000167397 "Vitamin K epoxide reductase complex subunit 1" Q9BQB6 16 31090842-31095980 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 458.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 749.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 638.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042720 Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (5.99e-2)" "unprognostic (2.98e-1)" "unprognostic (7.11e-3)" "unprognostic (7.68e-3)" "unprognostic (5.49e-2)" "unprognostic (3.23e-3)" "unprognostic (3.02e-2)" "unprognostic (2.32e-2)" "unprognostic (2.42e-1)" "unprognostic (2.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.09e-10)" "unprognostic (1.11e-2)" "unprognostic (6.65e-2)" "unprognostic (3.12e-2)" "unprognostic (9.66e-2)" 96.9 108.5 57.9 38.8 61.9 55.7 87.8 61.2 74.1 111.0 67.0 84.9 44.6 110.9 87.9 52.3 91.5 59.4 91.8 58.8 69.1 122.3 458.6 78.0 36.1 66.0 61.7 55.3 116.1 169.5 51.7 116.6 46.0 64.6 76.9 41.5 23.2 93.2 70.4 34.7 81.0 82.9 85.5 62.3 62.7 88.8 56.0 67.7 35.3 77.0 32.5 32.9 101.5 88.7 66.4 73.6 187.7 57.2 165.4 638.0 389.6 68.2 269.0 229.3 128.9 218.5 79.0 83.3 54.9 141.6 331.6 87.2 66.2 79.4 103.5 139.5 81.9 204.8 52.5 239.9 378.2 103.1 104.1 74.1 225.0 54.2 173.4 146.6 336.8 141.0 78.2 70.3 130.6 253.6 271.1 74.4 205.9 106.8 98.0 175.9 132.7 160.3 286.8 127.7 61.8 119.5 146.9 118.7 84.2 137.8 91.2 138.3 123.9 126.8 171.1 61.5 159.6 101.9 76.1 80.2 50.7 445.8 174.5 90.8 77.0 127.5 196.2 118.1 94.7 116.8 91.7 116.7 119.4 127.6 102.6 102.9 101.4 104.0 84.2 98.2 157.4 143.1 112.8 57.9 61.9 61.2 74.1 58.8 69.1 66.0 61.7 55.3 64.6 62.3 67.7 66.4 95.1 57.7 51.0 5.9 30.6 84.6 68.0 157.0 10.8 12.3 93.3 117.3 20.9 141.5 64.3 108.5 8.4 85.7 48.1 34.3 62.6 204.2 6.1 25.8 83.7 89.5 67.1 32.4 8.8 129.4 293.6 132.8 10.7 48.8 55.3 60.3 118.9 749.9 184.1 10.1 7.5 44.2 46.8 80.1 94.3 13.9 158.1 66.9 115.6 5.6 107.4 68.8 51.5 6.6 17.6 103.8 28.2 172.3 29.5 59.5 152.9 204.6 33.4 19.3 59.2 78.4 99.8 30.6 34.2 10.7 112.0 39.5 39.7 82.4 49.0 55.2 GNG8 ENSG00000167414 "G protein subunit gamma 8" Q9UK08 19 46634076-46634685 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 111.8;choroid plexus: 42.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.6;Langerhans cells: 5.1;Melanocytes: 32.0;monocytes: 9.5;Oligodendrocytes: 5.0;Smooth muscle cells: 9.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 6.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 10.8;T-reg: 5.7" "Group enriched" "Detected in many" 5 "B-cells: 10.8;T-cells: 5.7" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 1157.3" "Region enhanced" "Detected in all" "white matter: 20.2" "Low region specificity" "Detected in all" NA NA "unprognostic (7.23e-4)" "unprognostic (4.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.14e-5)" "unprognostic (1.94e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.80e-1)" "unprognostic (9.60e-2)" "unprognostic (9.83e-2)" "unprognostic (5.90e-8)" "unprognostic (2.67e-2)" "unprognostic (1.70e-1)" "unprognostic (4.22e-2)" "unprognostic (4.41e-1)" 0.7 22.2 54.6 5.6 60.0 0.8 0.4 53.3 66.9 4.4 42.9 3.6 1.9 2.5 0.0 0.9 2.4 0.7 10.1 52.4 64.6 2.0 0.4 1.3 4.4 60.7 111.8 51.5 1.4 0.1 2.9 7.8 0.2 61.5 1.4 2.1 0.9 0.1 1.7 0.0 0.2 2.7 3.0 52.7 2.9 1.2 1.1 57.8 16.2 0.3 0.0 6.0 1.0 1.4 75.9 0.0 1.6 1.7 0.7 0.0 0.0 0.0 0.8 0.7 0.6 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.0 0.0 0.0 89.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.3 0.0 0.0 0.0 0.0 0.6 0.8 0.0 1.3 0.9 0.0 0.8 0.0 0.0 264.0 1157.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 10.8 2.2 1.0 1.7 0.0 0.0 0.0 5.7 4.3 54.6 60.0 53.3 66.9 52.4 64.6 60.7 111.8 51.5 61.5 52.7 57.8 75.9 0.0 0.0 0.0 1.0 1.6 0.1 0.1 0.1 0.0 0.0 0.0 0.1 12.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.1 3.1 0.0 2.0 32.0 0.0 9.5 0.0 0.0 1.5 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 9.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.0 0.1 LPO SPO ENSG00000167419 Lactoperoxidase P22079 17 58218548-58268518 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrogen peroxide" "Antimicrobial, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 524 "salivary gland: 1035.4" "Group enriched" "Detected in some" 6 "Breast glandular cells: 25.2;Early spermatids: 8.3;Late spermatids: 14.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "THP-1: 9.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028688 Enhanced Supported "Secreted to digestive system" NA NA "HPA028688: AB_10601909" "unprognostic (2.74e-1)" "unprognostic (5.12e-2)" "unprognostic (4.14e-3)" "unprognostic (1.56e-3)" "unprognostic (2.41e-2)" "unprognostic (9.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (2.40e-2)" "unprognostic (6.27e-3)" "unprognostic (6.32e-2)" "unprognostic (2.56e-1)" "unprognostic (0.00e+0)" "unprognostic (3.41e-2)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (1.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1035.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 1.9 0.0 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.7 25.2 0.5 0.7 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 8.3 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.4 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.0 14.1 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.5 1.4 0.1 0.0 0.3 0.0 0.2 0.1 2.6 0.4 0.0 0.3 0.0 0.2 0.0 0.5 0.5 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149942-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease variant, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 266.1" "Group enriched" "Detected in many" 16 "Adipocytes: 704.2;Distal enterocytes: 1289.3;Paneth cells: 2368.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 99.5" "Lineage enriched" "Detected in single" 995 "granulocytes: 99.5" "Cell line enhanced" "Detected in single" "OE19: 1.1" "Region enriched" "Detected in all" 5 "cerebellum: 300.3" "Low region specificity" "Detected in all" "HPA011089, HPA017258" Enhanced Uncertain Vesicles,Cytosol NA NA 190000 Cytosol Vesicles "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 83.7 2.4 19.2 3.1 20.6 19.7 81.6 80.7 29.3 8.7 16.4 266.1 3.8 6.1 52.3 1.1 5.0 38.6 34.5 23.3 16.3 47.7 0.7 88.0 0.6 17.2 26.2 19.6 6.3 32.1 17.1 15.8 8.7 36.3 8.3 174.2 0.1 10.5 37.3 30.8 3.4 11.3 2.7 14.8 16.1 10.1 1.3 16.9 1.6 75.2 42.7 0.1 6.3 5.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.5 0.0 0.0 0.0 0.0 0.1 19.2 20.6 80.7 29.3 23.3 16.3 17.2 26.2 19.6 36.3 14.8 16.9 18.8 704.2 0.0 2.4 1.3 1.5 1.5 0.3 0.0 2.2 0.0 2.3 2.5 9.1 0.0 0.6 14.7 0.0 0.0 1.2 1289.3 33.2 11.7 0.5 0.6 13.0 88.3 19.3 0.0 3.8 0.2 0.0 4.4 0.0 0.2 11.4 23.2 1.4 0.0 0.6 0.0 1.4 24.6 0.0 0.0 1.2 0.1 0.6 1.1 0.0 23.4 0.0 0.1 0.0 1.0 0.4 0.1 2368.3 0.0 1.2 0.1 14.9 72.4 0.7 0.0 6.6 5.0 23.4 0.1 0.0 0.1 1.1 0.0 2.4 0.4 41.7 0.3 SMG8 "C17orf71, FLJ10587, FLJ23205" ENSG00000167447 "SMG8 nonsense mediated mRNA decay factor" Q8ND04 17 59209400-59215239 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024841 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024841: AB_10600790" "unprognostic (2.68e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-3)" "unprognostic (9.91e-2)" "unprognostic (8.59e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (1.91e-1)" "unprognostic (1.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-3)" "unprognostic (4.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-1)" 6.0 7.1 5.0 6.4 5.2 11.0 8.6 5.6 6.9 7.5 5.1 6.0 5.9 7.5 7.0 6.6 8.5 5.1 7.5 5.3 5.8 7.2 7.8 6.3 9.6 5.2 5.5 5.1 11.3 5.2 9.5 4.1 9.3 5.6 6.7 6.0 4.7 6.4 7.0 8.4 7.3 5.4 7.3 5.2 7.5 5.9 7.6 5.8 10.3 8.2 8.5 10.2 6.8 4.0 6.1 16.2 22.6 17.4 17.5 21.4 18.0 23.5 23.1 23.5 31.7 27.3 15.5 14.1 23.8 35.2 22.1 24.6 19.2 28.3 21.4 30.6 31.5 27.0 27.3 12.2 22.2 24.6 26.8 22.6 23.6 26.2 23.2 17.2 21.0 21.1 14.7 33.5 12.2 22.0 36.2 25.9 12.4 17.1 23.3 22.0 17.3 26.0 22.5 14.9 11.5 15.4 24.9 16.2 8.9 19.3 21.7 26.9 18.7 20.5 11.9 27.0 13.0 20.8 23.7 36.3 27.3 15.2 14.0 19.8 26.7 18.6 9.6 8.7 24.2 10.2 10.0 8.1 8.3 15.0 6.2 8.0 7.3 4.7 10.2 26.4 5.0 8.3 9.0 5.0 5.2 5.6 6.9 5.3 5.8 5.2 5.5 5.1 5.6 5.2 5.8 6.1 1.0 3.2 2.6 4.6 3.8 0.6 0.3 0.9 1.8 0.8 0.7 0.4 0.9 0.0 1.8 0.0 0.0 1.0 1.2 2.4 0.0 2.7 0.3 1.6 1.9 1.8 1.8 1.3 3.4 2.8 1.0 1.6 3.1 1.6 5.7 1.5 1.1 1.0 0.8 3.3 3.7 0.5 0.0 2.4 0.0 0.0 0.9 2.4 0.0 0.0 2.3 0.6 1.0 4.5 5.0 2.9 6.3 0.7 3.6 0.2 0.8 0.6 3.5 1.1 0.0 1.6 3.0 1.2 1.3 3.1 0.6 1.4 2.3 2.1 1.5 0.3 TPM4 ENSG00000167460 "Tropomyosin 4" P67936 19 16067021-16103002 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 1297.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 2111.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004685, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" NA NA 370000000 "Actin filaments" Cytosol "CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.27e-1)" "unprognostic (1.53e-2)" "unprognostic (3.62e-3)" "unprognostic (7.38e-3)" "unprognostic (3.80e-1)" "unprognostic (2.40e-2)" "unprognostic (3.11e-2)" "unprognostic (2.75e-3)" "unprognostic (1.38e-2)" "unprognostic (3.61e-1)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.26e-10)" "unprognostic (3.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.78e-1)" 321.6 110.8 24.2 188.0 22.5 34.1 271.3 39.1 40.7 304.9 35.6 230.7 65.2 458.8 10.7 405.0 312.8 146.1 161.6 20.7 28.4 142.3 54.6 377.4 78.8 28.9 24.0 15.9 296.3 78.5 23.8 94.1 172.1 30.5 213.9 39.6 3.6 269.4 141.7 50.7 227.4 155.1 192.1 25.9 246.0 203.0 66.7 33.1 32.7 120.4 19.5 69.1 290.0 336.6 31.0 614.5 275.2 194.7 190.9 701.3 728.2 725.6 1082.9 470.3 356.4 357.7 325.5 473.5 31.1 724.2 492.9 383.9 331.6 72.9 386.7 141.6 503.8 138.8 305.4 270.2 232.3 357.0 52.3 728.3 715.2 94.0 327.6 331.1 353.2 427.2 115.7 46.2 217.9 360.8 290.2 152.4 233.0 227.1 461.2 380.4 201.4 413.2 143.4 87.3 387.9 75.3 315.3 670.4 155.5 298.8 90.6 5.3 60.8 1237.2 954.1 166.8 2111.0 875.3 82.4 167.3 142.5 651.4 144.5 337.0 130.8 81.4 5.9 96.0 93.9 71.4 59.6 69.0 84.3 96.6 53.0 18.6 47.2 82.1 75.2 50.4 76.8 151.0 158.4 24.2 22.5 39.1 40.7 20.7 28.4 28.9 24.0 15.9 30.5 25.9 33.1 31.0 389.4 400.6 156.6 9.4 148.6 431.1 1297.2 175.2 273.8 45.9 194.3 189.4 49.1 120.1 297.0 242.8 10.4 263.5 205.6 298.4 13.7 717.1 67.3 159.0 506.6 425.5 94.0 33.4 23.8 571.6 852.9 345.1 303.7 305.0 249.6 170.8 288.8 4.2 336.8 5.0 19.0 215.8 101.7 112.0 368.8 54.8 173.1 433.2 142.3 26.2 249.5 7.5 132.8 13.6 48.5 1017.2 258.8 547.2 310.9 900.2 61.2 29.0 133.1 11.7 335.2 170.0 516.6 29.5 10.1 328.2 343.8 568.9 192.0 222.3 162.7 1025.0 RAB8A "MEL, RAB8" ENSG00000167461 "RAB8A, member RAS oncogene family" P61006 19 16111889-16134234 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041945 Approved "Nucleoplasm,Plasma membrane" No No 4800000 "Nucleoplasm, Plasma membrane" "HPA041945: " "unprognostic (1.10e-1)" "unprognostic (3.95e-3)" "unprognostic (1.98e-2)" "unprognostic (2.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (2.57e-1)" "unprognostic (1.14e-2)" "unprognostic (2.52e-3)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (6.60e-2)" "unprognostic (7.25e-2)" "prognostic favorable (1.71e-4)" "unprognostic (9.99e-2)" 21.4 24.7 16.5 40.8 17.4 61.8 18.9 19.0 17.7 24.8 20.9 37.7 59.1 18.7 19.1 26.2 28.0 22.2 10.9 16.6 19.9 21.0 51.9 28.9 44.7 20.6 18.0 14.1 21.7 23.6 17.9 15.4 25.2 20.5 21.9 33.1 8.8 31.0 21.4 7.1 27.2 59.2 23.0 19.6 40.8 32.7 15.5 19.4 34.6 16.4 8.2 45.4 26.1 21.4 22.9 94.2 62.6 50.5 43.0 42.7 36.7 77.9 56.0 48.8 74.2 76.8 76.1 105.7 66.1 61.9 58.6 63.5 60.6 71.2 69.1 50.9 132.6 39.9 135.9 57.1 75.6 46.7 119.4 129.3 36.6 37.6 69.5 32.1 38.9 63.5 65.0 64.4 97.0 63.4 111.6 100.1 113.7 63.3 114.3 100.5 111.6 56.2 115.6 58.2 71.9 46.9 45.3 56.6 68.0 35.9 34.2 53.8 44.2 61.7 61.4 39.2 119.2 96.6 51.4 113.4 97.3 58.7 121.5 67.0 244.5 278.6 315.0 164.3 387.5 145.7 190.5 143.3 147.5 247.5 190.0 112.5 131.7 292.2 225.9 485.1 177.8 150.9 514.1 16.5 17.4 19.0 17.7 16.6 19.9 20.6 18.0 14.1 20.5 19.6 19.4 22.9 47.2 25.6 29.1 2.3 70.2 47.7 47.4 53.5 31.3 15.2 37.0 34.7 3.0 17.2 35.7 31.3 14.6 95.7 97.9 115.9 82.2 70.7 31.0 33.7 29.7 37.3 30.4 47.5 4.2 51.5 98.6 36.3 29.6 45.0 48.7 36.2 26.0 50.3 88.9 6.7 3.5 55.3 48.8 50.6 81.5 19.0 27.7 100.9 33.8 2.8 124.8 34.9 131.8 3.0 8.8 76.8 90.0 24.8 96.5 30.7 130.7 62.6 35.4 13.9 32.9 22.0 38.1 33.3 23.4 30.4 52.6 79.6 64.8 43.4 52.0 38.4 GPX4 "MCSP, PHGPx" ENSG00000167468 "Glutathione peroxidase 4" P36969 19 1103926-1106791 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Oxidoreductase, Peroxidase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 18580.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008630, HPA047224, HPA058546" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Mitochondria" "CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749" "unprognostic (8.42e-3)" "prognostic favorable (7.18e-4)" "unprognostic (8.14e-3)" "prognostic favorable (1.84e-5)" "unprognostic (1.00e-1)" "unprognostic (8.72e-2)" "unprognostic (2.53e-3)" "unprognostic (8.49e-2)" "unprognostic (2.69e-2)" "unprognostic (1.47e-1)" "prognostic favorable (7.72e-4)" "unprognostic (1.29e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.61e-2)" "unprognostic (2.20e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 852.5 539.6 395.8 128.6 401.2 179.5 739.5 417.5 523.2 280.1 435.1 229.7 261.3 190.0 321.7 222.1 200.9 198.4 427.3 389.3 422.0 535.8 693.4 310.6 218.2 405.7 420.0 376.2 262.5 159.3 288.0 401.5 148.4 417.2 324.9 112.0 168.9 307.4 195.6 677.9 285.5 238.2 88.6 398.6 214.9 220.8 1414.5 410.8 160.1 293.9 403.2 184.1 321.7 247.3 406.7 258.1 286.8 405.8 863.0 1202.1 706.0 449.3 199.3 713.5 371.1 375.9 590.5 339.8 92.8 211.8 405.8 313.5 283.1 239.7 289.3 180.5 522.3 436.5 175.0 246.9 849.2 697.4 207.6 269.4 707.3 432.1 188.3 314.7 665.9 527.1 317.5 249.4 225.7 311.1 660.4 353.8 354.9 386.2 569.7 458.9 482.8 55.3 271.3 408.9 629.9 348.3 220.6 390.5 366.1 422.1 246.7 358.1 498.0 450.9 392.3 257.4 680.6 254.6 786.5 582.0 224.3 369.4 412.2 230.9 578.9 539.6 564.4 219.8 405.4 256.9 352.7 319.7 230.7 404.0 309.9 339.4 245.0 265.1 196.6 462.2 278.8 310.3 841.7 395.8 401.2 417.5 523.2 389.3 422.0 405.7 420.0 376.2 417.2 398.6 410.8 406.7 415.9 179.5 189.7 21.2 281.7 510.0 525.8 1188.1 512.2 332.2 845.1 868.2 264.6 316.0 600.6 472.6 98.0 562.5 231.3 479.1 1592.6 515.8 4209.7 546.8 326.3 268.7 397.1 215.0 24.5 368.7 1327.3 536.1 99.9 442.3 346.1 242.6 322.0 826.2 1184.1 208.6 33.1 328.7 671.4 583.1 1304.8 18580.2 384.9 735.2 677.7 21.5 1786.8 502.6 192.6 13.6 35.4 484.0 507.9 312.9 189.2 694.7 1861.9 3024.7 800.9 246.0 243.3 244.6 587.1 1310.8 202.4 357.7 467.0 978.1 281.0 186.7 336.4 662.6 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 455.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 11.8" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA042018: AB_2677800, HPA049432: AB_2680765" "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 53.7 62.4 25.3 25.4 21.9 83.3 43.1 23.9 30.8 40.8 15.1 50.8 22.5 34.5 6.3 100.0 65.2 31.7 71.2 18.5 139.9 45.7 50.9 67.6 19.3 42.3 27.5 14.7 61.9 37.7 8.2 82.6 15.6 28.3 39.6 12.2 12.6 47.0 11.6 142.7 71.7 53.1 12.5 27.2 50.8 56.6 19.7 28.6 19.2 35.3 17.5 15.3 42.6 56.2 26.6 14.7 31.8 53.5 25.0 11.2 19.0 39.2 25.0 14.9 12.6 8.9 41.8 16.1 23.3 26.6 18.9 6.8 29.6 16.3 26.5 4.9 32.9 30.0 32.8 21.8 33.3 22.7 33.3 46.9 29.4 24.4 15.1 14.3 19.5 20.8 27.3 42.7 24.0 13.5 58.9 44.6 13.6 117.6 28.6 21.1 68.8 15.2 10.7 23.8 17.2 42.7 55.9 52.9 50.1 33.7 27.7 20.2 37.7 26.2 22.9 25.4 106.2 27.3 22.4 13.2 32.2 43.9 14.6 79.5 1.6 1.0 1.1 1.0 1.0 0.7 0.2 0.3 0.7 0.4 0.3 0.2 0.5 11.8 1.3 1.1 0.4 0.1 0.7 25.3 21.9 23.9 30.8 18.5 139.9 42.3 27.5 14.7 28.3 27.2 28.6 26.6 330.7 38.5 60.5 17.3 101.1 98.9 128.3 114.4 175.8 53.9 290.6 224.2 84.3 117.2 86.2 134.3 31.3 15.8 184.8 455.8 19.6 125.5 34.7 220.6 84.5 186.1 164.5 19.4 8.0 155.5 47.3 84.0 132.0 294.7 61.5 60.6 197.4 80.9 77.9 21.9 5.6 219.5 59.0 100.0 134.9 33.3 49.7 150.9 42.7 24.4 49.7 77.8 96.8 32.2 10.3 259.0 306.8 33.1 69.9 190.9 242.1 35.8 109.6 35.7 39.5 219.8 142.4 3.3 12.0 227.3 148.0 81.3 122.9 33.2 167.8 190.7 JSRP1 "FLJ32416, JP-45" ENSG00000167476 "Junctional sarcoplasmic reticulum protein 1" Q96MG2 19 2252252-2269759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "skeletal muscle: 338.6" "Cell type enhanced" "Detected in many" "B-cells: 31.7;Melanocytes: 46.2;Plasma cells: 139.4;Skeletal myocytes: 132.6" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 10 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "Karpas-707: 164.1;RPMI-8226: 109.8;U-266/70: 444.1;U-266/84: 57.8" "Group enriched" "Detected in many" 6 "amygdala: 8.4;basal ganglia: 11.6;cerebral cortex: 9.9;hippocampal formation: 4.4;white matter: 5.1" "Not detected" "Not detected" HPA044741 Enhanced Approved "Endoplasmic reticulum" NA NA 13000 "Endoplasmic reticulum" "HPA044741: AB_10794295" "unprognostic (9.41e-3)" "unprognostic (1.52e-2)" "unprognostic (1.39e-1)" "unprognostic (5.85e-2)" "unprognostic (2.15e-1)" "unprognostic (9.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.80e-2)" "unprognostic (2.44e-2)" "unprognostic (1.87e-2)" "unprognostic (8.64e-5)" "unprognostic (3.63e-1)" "unprognostic (4.43e-1)" "unprognostic (2.07e-1)" "unprognostic (2.71e-1)" 0.2 0.1 0.3 1.0 0.3 0.4 0.5 0.3 0.4 0.3 0.1 1.0 2.9 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.2 0.5 0.3 0.7 0.5 0.3 0.2 0.2 0.1 0.5 0.0 0.3 0.0 0.2 1.9 0.1 0.0 9.0 0.0 338.6 0.2 1.4 0.0 0.2 5.5 1.8 1.9 0.3 0.1 0.6 18.8 0.6 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 26.8 0.0 0.0 0.2 0.0 0.0 0.0 46.6 0.1 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.1 7.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 26.7 109.8 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 444.1 57.8 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.1 0.0 5.3 0.0 31.7 0.5 0.3 0.2 0.6 0.8 0.6 0.4 0.6 1.5 0.1 0.0 2.1 0.2 0.7 1.7 0.0 1.8 19.0 0.7 0.3 0.3 5.4 1.3 0.2 1.0 0.6 1.1 1.5 1.1 6.3 2.9 0.7 0.6 0.5 0.0 0.1 2.3 2.0 1.3 2.2 18.2 0.6 1.1 46.2 0.0 0.0 0.5 1.0 0.0 0.1 1.0 0.3 0.0 139.4 0.3 0.6 0.4 1.7 0.5 0.0 132.6 0.6 7.6 1.9 0.2 1.0 0.3 5.0 0.5 0.7 0.2 NIBAN3 "BCNP1, FAM129C, FLJ39802" ENSG00000167483 "Niban apoptosis regulator 3" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "bone marrow: 15.5;intestine: 16.8;lymphoid tissue: 35.0" "Cell type enriched" "Detected in some" 8 "B-cells: 11.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 379 "memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7" "Group enriched" "Detected in many" 476 "B-cells: 52.1;dendritic cells: 110.7" "Group enriched" "Detected in some" 19 "Daudi: 50.1;REH: 23.8;U-698: 33.2" "Not detected" "Not detected" HPA043277 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.2 0.0 0.1 10.8 0.1 15.5 0.1 0.1 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.4 0.1 1.0 0.1 0.1 0.1 0.4 0.3 0.5 26.2 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 16.8 0.0 0.1 35.0 0.7 0.5 0.1 1.8 0.6 0.0 12.3 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 52.1 0.0 0.1 0.0 0.0 0.0 110.7 0.0 2.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KLHL26 ENSG00000167487 "Kelch like family member 26" Q53HC5 19 18637025-18671721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023074 Uncertain NA NA "HPA023074: AB_2671060" "prognostic favorable (5.01e-4)" "unprognostic (1.50e-3)" "unprognostic (2.54e-2)" "unprognostic (2.26e-3)" "unprognostic (1.23e-2)" "unprognostic (2.70e-3)" "unprognostic (1.62e-2)" "unprognostic (5.32e-3)" "unprognostic (9.12e-2)" "unprognostic (1.77e-2)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "prognostic favorable (1.25e-6)" "unprognostic (1.82e-2)" "unprognostic (2.76e-1)" "unprognostic (3.92e-2)" "unprognostic (4.49e-2)" 6.9 4.5 8.7 2.6 9.2 3.1 6.1 7.1 12.0 6.1 1.5 5.2 1.9 5.5 2.2 3.6 6.7 1.7 5.9 8.9 8.6 4.2 3.8 4.6 2.4 7.0 6.8 9.6 6.6 5.2 2.7 6.4 1.4 6.8 5.8 1.3 1.6 4.2 3.3 8.1 5.4 4.1 1.5 5.7 3.9 5.8 4.4 6.3 1.9 7.2 3.4 1.1 5.3 4.9 7.4 6.0 2.6 2.2 3.7 5.0 2.2 8.0 2.2 0.6 2.5 1.6 3.6 4.9 4.3 7.5 1.8 1.9 4.5 2.9 1.4 1.1 3.1 7.6 2.2 4.5 3.3 6.4 3.2 3.6 2.2 2.5 1.3 0.9 2.4 1.5 5.0 5.0 4.9 0.9 5.7 7.8 4.8 3.8 3.4 9.0 7.2 0.2 4.5 2.5 2.9 2.4 5.0 5.5 4.0 2.8 1.3 3.6 6.4 4.7 1.2 1.1 0.2 4.2 7.4 4.6 6.5 4.4 5.6 1.7 0.6 1.5 0.8 1.5 0.9 2.4 1.3 1.5 1.8 1.3 1.5 1.5 1.5 1.1 4.4 0.9 1.2 0.6 1.3 8.7 9.2 7.1 12.0 8.9 8.6 7.0 6.8 9.6 6.8 5.7 6.3 7.4 2.3 3.2 1.1 7.8 1.9 1.0 1.7 2.1 7.4 4.4 4.2 3.6 3.3 5.7 1.1 0.0 4.2 3.1 2.2 2.4 13.7 3.9 0.8 2.1 2.2 2.2 6.7 2.7 3.3 2.3 1.4 4.7 3.6 2.9 11.4 3.1 2.9 4.0 4.0 6.7 2.1 3.3 6.1 3.5 2.2 0.7 3.1 2.5 1.8 3.7 4.9 11.6 1.0 1.0 3.0 2.8 2.1 2.2 0.7 1.6 1.8 3.4 1.2 2.3 6.6 8.9 4.9 3.2 6.5 3.3 1.8 1.9 3.7 1.7 3.6 1.0 GATAD2A p66alpha ENSG00000167491 "GATA zinc finger domain containing 2A" Q86YP4 19 19385826-19508931 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006759, HPA024373" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006759: AB_1079549, HPA024373: AB_1849522" "unprognostic (1.07e-1)" "unprognostic (2.79e-2)" "unprognostic (1.40e-1)" "unprognostic (5.64e-3)" "unprognostic (3.41e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-3)" "unprognostic (9.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.58e-2)" "unprognostic (6.62e-3)" "unprognostic (4.69e-2)" "unprognostic (3.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-2)" "unprognostic (9.84e-2)" 16.8 15.2 13.0 23.8 12.5 32.9 15.5 10.8 12.1 12.9 15.9 19.7 23.0 14.9 8.8 22.1 12.4 14.5 12.3 15.2 15.4 16.3 17.2 21.8 19.9 17.2 13.7 7.2 11.5 21.8 15.2 15.0 18.0 17.0 10.8 11.4 8.5 15.6 11.1 18.0 29.4 25.0 8.4 13.6 22.4 18.0 33.3 13.0 19.6 14.8 6.9 13.7 15.2 16.5 16.2 60.7 50.8 46.5 69.3 18.9 19.7 97.5 46.7 31.6 47.7 45.4 92.8 62.6 117.9 69.5 47.1 31.6 49.6 43.6 41.5 27.6 40.6 47.7 87.1 49.4 51.8 46.2 97.6 72.1 31.3 30.2 49.9 40.0 15.8 48.2 66.9 141.1 37.1 28.1 68.5 115.9 38.7 98.3 55.8 45.9 121.9 46.6 54.9 24.9 79.0 87.7 48.9 40.4 48.6 57.5 30.2 44.0 40.3 94.9 89.9 43.3 106.8 88.5 46.1 62.9 125.3 56.2 80.9 53.7 4.6 2.9 3.2 3.2 1.5 1.9 2.3 1.9 2.7 1.3 1.5 1.4 1.6 7.8 2.7 3.3 3.0 1.3 2.3 13.0 12.5 10.8 12.1 15.2 15.4 17.2 13.7 7.2 17.0 13.6 13.0 16.2 35.7 12.8 19.2 24.5 24.1 55.7 22.3 14.2 26.2 16.1 33.5 21.5 13.5 24.3 15.4 14.7 18.8 23.7 66.3 53.4 13.7 21.9 21.8 43.9 42.8 31.4 15.6 21.0 14.9 30.6 36.8 21.9 29.0 69.5 17.1 22.1 29.3 27.9 27.7 23.5 21.4 28.9 24.4 27.3 42.1 18.5 15.5 27.7 32.0 35.6 28.5 18.2 53.5 17.1 21.6 46.4 28.8 13.9 19.5 24.1 30.2 29.9 15.8 18.3 19.7 40.5 25.8 18.4 41.4 39.5 55.5 36.7 39.3 28.2 32.2 28.2 MVD MPD ENSG00000167508 "Mevalonate diphosphate decarboxylase" P53602 16 88651935-88663161 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 147.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041404, HPA048250" Uncertain Approved "Cell Junctions,Cytosol" NA NA 170000 Cytosol "Cell Junctions" "HPA041404: AB_2677457, HPA048250: AB_2680329" "unprognostic (1.67e-1)" "unprognostic (3.05e-1)" "unprognostic (2.42e-1)" "prognostic favorable (2.17e-4)" "unprognostic (1.89e-1)" "unprognostic (9.56e-2)" "unprognostic (9.26e-3)" "unprognostic (8.33e-2)" "unprognostic (6.68e-2)" "unprognostic (5.47e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-2)" "unprognostic (1.19e-3)" "unprognostic (4.12e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (5.00e-2)" 19.7 51.6 20.9 15.9 24.6 7.0 16.5 22.6 37.8 22.5 15.9 26.2 35.4 20.4 2.2 78.5 13.6 4.9 22.8 21.4 22.6 26.2 79.4 31.2 12.4 28.7 25.1 20.9 19.8 25.5 8.3 19.1 6.4 31.9 23.7 4.2 3.4 25.3 6.6 27.5 46.4 26.8 5.8 21.6 24.8 31.8 42.6 21.5 7.1 21.2 8.3 6.8 17.7 37.2 24.3 50.6 34.2 52.4 33.1 18.1 38.7 29.5 25.1 26.0 17.7 14.6 86.1 119.7 24.4 39.8 15.7 63.7 72.8 25.0 133.1 4.9 15.7 38.3 17.8 18.2 127.0 35.9 11.6 11.8 30.9 24.6 46.6 13.5 8.7 18.0 58.0 51.7 13.1 10.2 115.9 39.3 56.6 61.5 17.7 31.3 40.2 15.0 62.3 49.8 33.0 52.2 17.9 62.0 13.3 18.5 11.4 67.8 51.3 39.0 14.7 29.8 27.2 14.2 34.9 17.6 83.2 17.9 55.7 25.7 5.6 12.6 2.4 26.8 13.7 20.4 16.1 18.0 17.9 15.0 22.6 13.2 16.6 1.8 28.3 15.4 28.0 20.4 15.4 20.9 24.6 22.6 37.8 21.4 22.6 28.7 25.1 20.9 31.9 21.6 21.5 24.3 17.2 25.6 48.2 22.2 21.5 15.2 12.9 106.3 4.0 27.2 26.5 14.1 16.7 21.5 56.9 20.2 6.2 20.2 79.6 117.5 25.4 30.8 61.6 17.7 10.0 15.8 32.9 26.5 23.4 62.3 29.2 15.5 41.8 26.5 16.5 27.4 20.7 147.2 38.6 23.5 17.0 75.3 32.6 25.5 21.6 96.2 8.1 20.3 21.4 6.5 32.2 16.5 55.6 11.1 14.5 30.0 79.4 9.1 46.3 20.1 47.1 22.6 21.5 18.1 6.6 7.0 20.7 50.8 13.0 13.8 21.6 48.8 36.3 35.5 65.2 20.6 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803789-88809258 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 38.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 149.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.7 0.8 1.0 3.8 1.1 38.8 0.7 2.3 1.2 1.0 0.0 3.2 4.1 0.5 0.2 6.7 0.5 0.2 0.5 0.8 2.4 0.7 1.0 1.3 4.9 1.9 1.1 0.6 0.4 0.6 1.4 2.1 2.8 1.9 0.7 1.6 0.4 1.1 0.2 0.1 3.5 4.0 0.6 0.8 3.1 2.4 3.6 0.8 8.8 0.6 0.0 3.3 0.5 2.3 2.1 33.6 34.5 16.5 25.3 0.7 3.4 64.2 24.1 6.6 19.4 12.0 79.3 33.8 51.4 24.2 5.5 12.7 46.0 21.6 17.7 6.2 18.2 92.1 51.8 28.8 59.9 0.3 28.8 21.5 1.8 1.4 19.8 4.4 1.6 5.9 60.9 80.8 18.4 7.6 90.6 109.3 149.4 41.8 12.2 31.6 120.3 22.9 42.4 4.3 23.8 36.6 26.2 44.4 13.1 16.9 7.4 39.0 55.9 5.9 24.6 42.6 37.2 35.4 61.4 55.7 73.6 19.3 71.9 31.6 0.2 0.1 0.9 0.3 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.7 0.4 0.1 0.1 0.7 0.2 1.0 1.1 2.3 1.2 0.8 2.4 1.9 1.1 0.6 1.9 0.8 0.8 2.1 0.4 0.0 1.1 0.7 4.9 11.2 4.3 1.4 7.4 0.7 5.4 7.5 2.2 1.5 1.7 1.8 0.0 51.4 2.2 12.7 1.9 1.1 0.4 1.4 1.4 2.2 2.4 71.3 0.2 0.0 92.0 5.2 9.2 2.2 0.0 29.0 0.4 1.0 19.5 0.0 0.8 16.1 4.1 5.6 5.5 1.2 0.3 2.8 1.8 0.0 1.9 1.5 4.1 0.0 0.6 0.6 2.3 0.4 23.1 2.2 2.0 1.6 2.1 1.9 0.0 2.1 3.4 6.6 37.1 10.8 7.1 24.8 5.4 5.7 30.1 4.4 TRAPPC2L HSPC176 ENSG00000167515 "Trafficking protein particle complex 2 like" Q9UL33 16 88856220-88862686 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 403.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041714 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA041714: AB_10793930" "unprognostic (1.27e-2)" "unprognostic (2.32e-3)" "unprognostic (1.46e-1)" "prognostic favorable (3.75e-4)" "unprognostic (2.77e-1)" "unprognostic (2.69e-1)" "unprognostic (5.24e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-1)" "unprognostic (6.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.81e-1)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (1.00e-1)" "unprognostic (5.81e-2)" "unprognostic (1.94e-2)" 53.5 135.4 56.9 31.2 57.4 37.2 51.9 57.8 70.3 47.3 56.0 44.5 25.6 47.1 60.8 54.3 44.5 20.1 66.0 57.6 60.3 53.8 46.9 43.1 31.3 59.7 58.2 56.0 56.3 49.3 58.6 45.6 20.5 59.8 39.6 24.1 25.8 48.4 20.6 97.7 56.7 39.4 18.2 58.7 53.1 63.3 122.9 58.4 50.4 42.2 71.3 27.4 48.9 47.7 66.8 69.9 47.9 79.6 60.8 58.5 73.9 81.5 61.5 69.4 92.6 35.4 133.6 89.6 53.4 105.8 78.6 97.7 73.3 109.5 88.5 67.0 46.9 65.7 35.3 46.1 172.7 86.3 101.4 27.5 72.2 54.7 125.4 63.1 52.4 75.7 118.7 108.2 41.4 64.3 216.2 136.1 311.7 80.3 133.4 88.6 128.9 65.9 55.4 73.1 79.6 85.8 42.2 207.6 63.5 59.0 43.6 162.5 106.3 60.3 61.1 66.7 81.1 71.2 57.9 106.6 254.5 73.3 148.0 74.5 39.2 136.3 40.8 113.0 114.5 115.0 154.2 129.8 124.1 135.1 137.9 120.8 103.5 23.9 94.6 114.8 162.5 178.0 162.9 56.9 57.4 57.8 70.3 57.6 60.3 59.7 58.2 56.0 59.8 58.7 58.4 66.8 66.2 57.7 82.0 2.3 58.7 51.9 57.4 115.4 43.3 34.9 80.1 106.3 121.1 92.9 81.1 53.3 10.4 93.8 58.2 75.3 240.7 134.7 219.1 60.9 53.4 60.7 62.1 42.1 4.0 154.8 141.5 79.2 72.9 50.5 36.1 55.9 62.8 123.9 226.7 15.2 5.1 78.5 75.3 91.0 69.6 403.2 74.0 68.4 81.8 1.9 134.4 87.3 79.3 2.5 13.0 137.4 76.3 58.3 92.6 45.3 122.5 271.7 93.5 39.5 59.2 44.1 94.7 210.7 123.1 86.0 64.9 77.6 61.2 64.6 86.8 62.5 ANKRD11 "LZ16, T13" ENSG00000167522 "Ankyrin repeat domain 11" Q6UB99 16 89267630-89490561 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019288, HPA041593, HPA049470" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780" "unprognostic (7.31e-2)" "unprognostic (6.35e-2)" "unprognostic (1.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.67e-4)" "unprognostic (1.56e-3)" "unprognostic (1.79e-1)" "unprognostic (7.93e-2)" "unprognostic (5.78e-3)" "unprognostic (2.16e-1)" 24.4 21.3 32.5 26.2 27.7 54.4 14.6 21.6 39.5 17.5 17.2 17.0 21.6 22.2 12.9 22.7 18.6 18.8 22.5 36.2 20.6 15.9 12.3 19.1 26.5 28.8 25.0 26.4 29.5 26.8 24.9 24.3 18.0 29.2 16.2 13.7 14.2 20.3 17.2 25.0 35.3 21.2 14.6 19.9 26.8 21.9 18.5 23.2 25.2 19.6 15.1 19.2 19.4 16.6 30.5 55.5 67.9 66.8 51.5 40.3 41.4 64.5 61.7 41.1 36.5 25.8 79.7 57.8 51.0 41.6 44.9 41.1 54.6 46.0 56.8 41.2 25.5 55.3 40.3 49.3 64.7 60.8 30.0 44.0 46.4 56.4 47.9 61.5 52.8 44.4 84.1 88.4 39.6 46.5 52.5 50.1 75.2 58.8 28.7 61.9 101.6 77.0 43.3 38.0 45.7 39.1 47.9 89.0 18.5 65.1 33.9 43.3 46.6 83.2 76.4 71.4 42.9 68.7 71.5 27.1 62.9 61.6 48.6 42.2 7.6 2.9 3.0 2.7 3.1 3.1 2.6 3.1 3.3 1.6 3.0 2.7 2.4 8.5 7.1 5.1 5.4 3.3 1.5 32.5 27.7 21.6 39.5 36.2 20.6 28.8 25.0 26.4 29.2 19.9 23.2 30.5 133.0 131.4 103.0 94.7 136.3 116.5 150.3 49.5 91.6 181.3 57.4 65.8 233.3 84.4 52.5 71.7 158.4 42.7 203.7 109.7 31.3 80.1 118.5 200.9 162.6 135.4 106.9 58.5 122.1 72.7 36.3 118.2 96.8 312.8 55.7 164.5 80.7 69.4 48.4 156.5 97.7 89.8 30.5 63.5 117.9 39.5 103.8 112.0 48.0 119.0 110.9 83.1 146.2 117.1 110.0 122.4 66.9 106.1 143.3 147.6 64.6 35.1 45.6 112.9 39.5 148.3 126.3 92.2 98.9 102.6 122.2 38.7 133.8 137.4 87.3 179.0 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657740-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 114.9" "Group enriched" "Detected in all" 8 "Early spermatids: 1778.0;Late spermatids: 4200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: AB_2686570" "unprognostic (1.05e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 3.6 4.2 8.8 2.8 8.0 3.4 4.3 6.8 8.7 5.1 9.2 5.3 5.0 4.5 9.0 5.3 12.7 2.8 3.6 8.6 7.3 11.8 6.3 6.0 2.5 7.6 7.5 8.8 3.3 5.2 3.6 9.8 1.8 8.0 6.4 3.0 6.8 4.3 2.5 2.0 4.2 9.3 2.4 7.1 5.9 5.0 114.9 7.2 3.6 8.4 1.2 2.9 4.3 4.8 8.1 11.1 11.8 13.4 5.5 3.5 3.1 4.9 7.8 2.5 10.6 4.7 11.5 10.6 1.2 3.8 5.0 8.0 15.1 6.2 3.7 8.5 2.2 9.7 2.0 17.4 16.1 1.5 2.3 4.5 3.1 5.1 7.9 3.2 4.0 2.3 11.0 12.6 1.9 7.1 14.7 7.4 6.6 7.3 7.3 9.3 14.3 7.4 4.0 6.2 3.9 13.2 7.0 17.9 3.0 4.4 6.3 13.5 3.3 2.8 7.8 10.7 6.9 5.9 4.4 7.1 4.4 8.1 14.5 3.5 2.4 1.1 2.1 1.6 1.3 2.2 2.3 1.7 2.2 0.9 0.9 1.8 1.4 1.4 3.2 1.0 2.0 1.2 1.4 8.8 8.0 6.8 8.7 8.6 7.3 7.6 7.5 8.8 8.0 7.1 7.2 8.1 14.7 6.4 9.7 4.6 10.3 7.1 8.6 16.4 8.0 18.2 14.9 14.7 6.6 15.7 13.5 29.5 64.6 4.1 10.2 16.0 23.5 15.9 1778.0 94.9 13.3 13.3 17.5 22.7 7.0 17.7 5.6 13.0 32.1 11.9 1.3 11.4 8.9 14.6 9.0 23.5 4.4 9.9 12.2 2.9 8.0 4200.3 30.4 9.5 17.8 3.7 5.8 17.0 16.5 1.0 5.1 14.2 18.9 23.7 11.1 6.7 35.6 33.4 97.8 82.5 13.1 11.8 11.4 348.5 101.2 13.5 7.1 1.4 12.8 13.9 17.1 5.5 RSKR "FLJ25006, SgK494" ENSG00000167524 "Ribosomal protein S6 kinase related" 17 28601827-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 5.8" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 7.1;Extravillous trophoblasts: 2.4;Hofbauer cells: 4.1;Syncytiotrophoblasts: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 0.2 0.6 1.3 0.8 1.3 1.6 0.2 1.5 1.6 0.3 1.4 0.2 0.3 0.3 0.1 0.1 0.4 0.0 0.2 1.3 1.3 0.9 0.2 0.2 0.3 1.4 1.3 1.5 0.5 0.1 0.1 0.4 0.3 1.7 0.3 0.3 5.8 0.1 0.2 0.5 0.7 0.3 0.1 1.2 0.4 0.2 1.2 1.5 0.4 0.4 0.1 0.3 0.3 0.2 1.6 0.4 0.5 0.6 0.8 0.2 0.1 0.2 0.0 0.0 0.6 0.2 0.9 0.1 1.2 0.1 0.0 0.4 0.6 0.8 0.1 0.6 0.3 0.6 1.0 0.4 0.4 0.0 0.2 0.8 0.0 0.4 0.3 0.4 0.1 0.2 1.2 0.6 0.2 0.1 1.3 0.4 1.0 1.2 1.2 0.1 0.8 2.2 0.7 0.5 1.3 0.4 0.4 0.4 0.1 0.9 0.9 0.5 0.5 0.4 0.3 0.8 0.7 0.5 0.6 0.4 0.6 0.4 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 1.5 1.6 1.3 1.3 1.4 1.3 1.5 1.7 1.2 1.5 1.6 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 24.8 0.2 0.0 0.0 0.0 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "testis: 178.8" "Cell type enriched" "Detected in many" 4 "Late spermatids: 6882.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 5.6;NB-4: 6.0;REH: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023648, HPA030218" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA023648: AB_1855726, HPA030218: AB_10601152" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 2.1 1.7 3.1 1.4 3.1 1.5 1.9 3.8 4.9 3.7 2.9 2.0 1.1 2.9 0.4 1.5 4.3 0.7 2.3 3.0 3.2 5.4 1.2 2.7 2.2 3.4 3.5 3.0 6.1 0.9 0.3 3.0 0.6 3.4 3.5 0.4 1.2 1.7 0.5 0.9 1.4 4.0 0.7 3.2 9.9 2.0 178.8 3.1 1.4 1.8 0.5 0.8 2.3 2.7 3.7 0.6 0.9 1.6 5.6 1.0 1.6 1.6 0.9 0.6 0.7 0.6 0.9 2.0 0.0 0.3 0.8 0.1 0.8 1.7 0.2 0.3 1.1 0.4 2.7 1.7 0.4 0.4 4.5 0.1 0.7 0.3 1.2 0.0 0.7 0.1 0.7 2.6 1.6 0.6 0.2 3.3 6.0 4.4 0.3 0.5 7.1 2.4 0.1 0.6 0.2 0.4 0.7 0.4 0.1 0.5 1.0 2.5 3.9 0.5 0.2 1.0 0.6 0.3 0.7 1.0 1.2 0.4 4.1 0.8 4.9 1.1 3.5 0.5 1.6 0.2 1.9 1.1 0.3 0.6 0.5 0.4 0.8 0.7 0.6 1.2 2.5 0.6 0.5 3.1 3.1 3.8 4.9 3.0 3.2 3.4 3.5 3.0 3.4 3.2 3.1 3.7 2.3 0.0 1.1 4.6 2.8 1.0 1.2 1.0 0.6 3.7 1.5 1.9 6.6 1.5 1.9 0.0 4.2 0.8 3.9 0.8 0.0 0.6 1682.9 5.3 2.4 2.7 2.4 3.0 0.8 0.2 1.9 2.7 1.1 2.4 15.2 4.2 4.2 0.2 2.8 3.3 1.1 1.5 2.0 5.3 2.9 6882.6 25.4 6.8 0.0 3.7 2.5 7.9 1.0 2.0 0.9 0.6 0.3 19.5 1.2 0.8 2.0 1.2 3.9 4.4 19.7 1.5 2.4 79.2 21.7 1.1 0.3 0.7 2.6 7.5 1.7 0.7 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560677-89564542 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 190000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: AB_2681579" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 2353.8 1870.3 951.8 1024.5 934.3 2226.0 2536.3 902.1 1310.3 2833.2 947.2 2180.4 1092.5 1845.9 806.8 2826.7 2362.9 763.6 1652.2 872.3 929.0 1725.1 2159.9 1574.2 2123.8 1012.0 913.6 844.9 5043.9 4352.2 903.5 1593.3 642.2 962.6 2877.2 725.7 217.1 2434.7 834.4 2424.5 4231.2 2084.7 696.0 1059.0 2566.3 2166.3 863.5 994.4 1734.1 1623.0 1185.5 1648.6 2320.7 2705.2 1019.7 1402.1 1524.2 1063.0 1733.2 1869.8 3083.4 2218.9 863.7 1857.6 1768.8 712.9 2316.0 2113.8 1954.1 1729.3 1484.1 700.0 1903.0 1279.4 2281.5 873.2 551.7 3534.0 666.7 817.4 3149.0 3985.0 818.9 781.2 3770.4 4759.6 1136.6 2847.0 2870.3 1870.2 2424.6 2074.1 1084.5 1380.2 4385.7 2272.4 6404.2 2180.5 2755.6 1601.9 3323.5 1128.8 2786.0 2205.4 1162.1 1491.3 2176.3 1195.0 1544.6 2735.2 665.7 3044.3 4780.1 1101.8 1132.3 1218.4 1008.8 1211.3 1626.1 1668.7 2104.6 1479.4 2863.7 1220.5 1017.1 3191.4 507.1 3779.3 2446.7 7007.7 7792.3 6813.4 5173.6 3626.5 8215.0 8509.1 6722.0 323.4 4085.8 1910.1 5071.9 5277.8 13749.1 951.8 934.3 902.1 1310.3 872.3 929.0 1012.0 913.6 844.9 962.6 1059.0 994.4 1019.7 3260.3 1804.5 3489.0 39.8 9318.5 12528.7 15921.0 7329.9 8523.7 675.1 10709.1 13191.6 465.3 3808.9 4064.9 1616.6 189.7 6201.2 5935.5 1800.0 4652.6 4068.5 4125.7 2011.7 5627.8 4627.9 2937.8 3784.5 39.1 10909.9 11178.8 4536.6 2934.8 2679.4 2651.1 6392.0 5119.5 4261.1 5228.5 249.0 52.5 6292.1 2089.4 7058.1 8832.3 12884.5 8244.9 5051.4 5457.0 66.5 7569.8 1941.5 5395.5 158.3 86.4 7077.2 4715.7 3652.3 4667.7 14016.4 5245.4 7448.2 1834.7 786.9 2084.0 5936.3 5693.8 1721.1 1052.9 9022.1 16171.5 6165.5 7831.2 7839.7 7465.8 15137.1 ZNF641 FLJ31295 ENSG00000167528 "Zinc finger protein 641" Q96N77 12 48337180-48351414 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035189 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA035189: AB_10603333" "unprognostic (1.79e-1)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (9.82e-3)" "unprognostic (3.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.90e-2)" "unprognostic (1.35e-3)" "unprognostic (7.82e-3)" "prognostic favorable (3.91e-4)" "prognostic favorable (8.30e-5)" "unprognostic (3.67e-1)" "unprognostic (2.68e-2)" "unprognostic (7.61e-2)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" "unprognostic (7.85e-3)" 9.1 23.1 8.3 10.8 8.2 7.0 7.9 9.0 9.5 10.0 4.9 7.5 9.5 14.2 10.2 6.7 10.8 10.0 9.2 7.8 9.3 9.3 10.0 11.0 12.6 10.2 9.6 6.8 19.8 12.2 14.3 9.9 14.9 9.8 8.8 8.0 17.1 7.5 9.3 16.7 6.3 7.6 13.4 9.2 12.7 9.4 12.0 9.6 14.9 14.8 17.4 13.0 10.8 7.1 9.9 3.2 5.4 8.3 13.9 8.0 2.2 6.1 8.1 5.5 4.3 2.8 9.1 9.1 6.2 11.4 7.3 8.1 5.3 3.1 5.3 1.4 14.2 5.2 10.2 9.9 2.6 7.4 11.0 14.2 3.5 7.9 2.9 6.7 6.9 3.8 7.9 10.4 6.1 3.9 4.1 5.1 4.7 1.8 3.4 2.3 3.4 8.0 5.0 7.0 16.6 3.4 5.2 9.4 4.0 5.9 7.2 10.2 11.2 1.5 4.7 7.5 4.6 3.9 6.6 6.5 4.8 2.8 12.8 4.7 1.6 2.9 7.2 2.7 2.7 1.6 0.4 1.5 2.5 3.1 0.6 1.4 2.6 6.5 4.5 4.0 1.3 0.7 2.4 8.3 8.2 9.0 9.5 7.8 9.3 10.2 9.6 6.8 9.8 9.2 9.6 9.9 8.4 6.4 16.1 19.2 9.9 3.1 13.5 4.4 14.2 14.7 7.9 5.6 9.1 11.5 5.7 7.3 10.4 1.4 12.7 4.3 7.9 8.8 2.2 3.8 8.7 9.2 5.4 7.4 16.8 10.4 0.9 12.8 4.6 5.0 3.8 33.0 15.7 8.6 7.6 18.5 38.7 1.7 0.0 18.3 13.5 2.7 15.5 12.3 0.0 15.0 15.3 16.9 27.8 10.1 4.7 7.2 1.3 24.0 3.7 5.9 4.8 5.1 5.0 18.4 19.7 9.3 17.9 5.2 6.0 6.2 2.3 0.5 11.8 45.3 2.7 5.2 LALBA LYZL7 ENSG00000167531 "Lactalbumin alpha" P00709 12 48567684-48570066 "Cancer-related genes, Metabolic proteins, Predicted secreted proteins" "Lactose biosynthesis" "Milk protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 928 "breast: 2211.1" "Cell type enriched" "Detected in some" 160 "Breast glandular cells: 48911.9" "Cancer enriched" "Detected in single" 599 "breast cancer: 29.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026343, HPA029855, HPA029856" Enhanced "Secreted in female reproductive system" NA NA 91000 "CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362" "unprognostic (7.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2211.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.6 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.0 48911.9 305.6 0.0 0.0 0.0 0.0 0.0 0.0 108.5 0.0 0.0 0.0 0.6 0.0 0.0 15.9 0.0 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 58.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.7 0.0 0.0 0.0 32.6 0.0 0.0 0.0 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.8" "Lineage enriched" "Detected in single" 10 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.9;U-937: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA059515: AB_2684047" "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 9.3 4.0 64.5 2.8 66.3 1.3 9.0 52.6 84.9 32.5 41.7 17.4 4.1 31.4 8.5 21.7 19.7 7.3 7.5 66.3 57.6 11.9 1.9 11.9 1.8 48.8 54.1 68.5 44.1 4.5 5.1 12.4 5.8 55.8 13.8 8.3 4.7 13.1 9.2 2.8 11.5 10.9 23.3 43.8 6.1 9.3 8.7 53.3 7.7 9.7 5.9 4.2 14.6 20.4 58.7 17.3 13.2 21.1 46.1 26.8 18.0 12.9 16.8 39.4 25.6 14.5 4.5 13.4 2.2 21.5 30.7 4.4 17.2 21.6 19.5 10.1 18.4 5.9 8.5 11.7 0.6 11.0 1.7 9.1 11.7 10.6 10.2 5.5 75.9 31.1 18.6 1.2 7.2 16.9 42.6 22.1 2.2 13.3 18.1 10.9 24.0 5.0 6.6 19.9 31.6 32.9 31.8 5.5 37.1 12.0 18.6 25.2 7.7 27.3 15.5 21.7 7.7 9.5 7.1 3.5 0.7 12.9 109.9 5.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.6 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.2 64.5 66.3 52.6 84.9 66.3 57.6 48.8 54.1 68.5 55.8 43.8 53.3 58.7 5.6 3.2 4.3 1.0 0.5 2.9 3.2 5.9 4.0 3.2 8.7 5.7 2.8 1.5 5.1 1.8 4.2 0.8 2.1 12.6 1.9 9.5 1.0 10.0 22.0 5.9 10.2 0.8 15.1 4.3 10.4 7.9 6.1 7.1 1.3 12.0 3.6 0.2 1.6 0.0 4.5 9.5 16.2 0.6 2.9 2.7 13.4 2.4 1.8 3.7 3.7 1.0 2.1 2.0 1.1 10.4 4.6 10.9 1.3 2.9 8.7 0.7 9.4 1.0 0.0 1.5 12.2 1.6 8.1 9.6 5.1 1.1 3.5 6.1 14.4 1.9 DHRS13 "MGC23280, SDR7C5" ENSG00000167536 "Dehydrogenase/reductase 13" Q6UX07 17 28897781-28903079 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 55.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022991 Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA022991: AB_1853865" "unprognostic (8.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (2.38e-1)" "unprognostic (4.74e-2)" "unprognostic (5.65e-2)" "unprognostic (1.20e-2)" "unprognostic (7.57e-2)" "unprognostic (1.73e-2)" "unprognostic (3.72e-2)" "unprognostic (2.63e-1)" "unprognostic (7.22e-3)" "unprognostic (2.55e-1)" 2.9 7.1 10.8 5.7 8.5 42.2 5.5 16.3 9.6 6.4 10.4 4.9 4.5 3.0 6.6 8.8 4.2 2.9 2.8 8.2 13.4 8.2 23.8 4.8 6.7 12.4 11.9 7.8 3.6 6.7 7.9 6.4 4.5 13.8 19.6 3.7 8.4 12.8 10.7 1.3 7.4 4.0 2.3 9.8 10.3 6.0 3.1 14.8 4.6 4.8 2.4 6.9 9.6 6.4 13.4 12.1 7.6 17.4 22.2 2.6 3.8 16.8 6.4 8.3 11.6 17.7 23.5 7.1 32.8 10.7 1.4 13.4 10.5 24.8 7.1 4.9 33.5 23.9 18.4 13.9 13.0 6.5 9.5 2.1 2.8 6.3 7.3 7.7 8.1 3.6 22.7 42.3 11.0 2.3 21.7 20.9 15.9 10.7 31.4 1.0 32.8 16.4 25.5 21.8 20.2 24.8 20.8 10.1 69.5 13.9 9.1 46.4 15.2 1.2 3.7 11.1 9.0 8.9 25.5 25.7 20.7 11.0 11.9 9.4 0.9 4.4 3.1 8.5 6.9 10.4 7.1 10.8 10.7 5.9 8.6 10.9 8.1 55.3 9.4 6.8 3.2 11.4 5.8 10.8 8.5 16.3 9.6 8.2 13.4 12.4 11.9 7.8 13.8 9.8 14.8 13.4 2.4 3.2 4.2 2.3 6.7 1.5 10.2 12.3 12.0 6.1 7.1 5.7 0.4 8.6 5.4 7.3 2.1 27.7 4.4 4.3 9.8 10.6 11.9 3.4 1.1 4.5 3.0 106.1 0.7 2.7 22.2 2.1 7.7 6.3 1.3 1.2 6.4 5.5 6.2 5.0 4.4 4.2 2.0 0.8 3.0 5.2 1.2 2.1 5.4 1.0 15.5 8.2 10.3 3.0 1.0 2.5 2.4 0.4 12.8 11.5 2.8 3.2 2.2 5.0 6.6 0.9 1.1 6.1 22.5 9.4 1.7 13.5 7.0 0.5 6.4 5.8 TP53I13 DSCP1 ENSG00000167543 "Tumor protein p53 inducible protein 13" Q8NBR0 17 29566052-29573157 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 110.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (4.90e-2)" "unprognostic (2.50e-3)" "unprognostic (9.31e-3)" "unprognostic (4.94e-3)" "unprognostic (1.05e-2)" "unprognostic (2.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.47e-2)" "prognostic favorable (3.13e-5)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (2.92e-2)" 69.4 35.0 16.8 30.6 17.1 37.7 59.0 16.6 28.5 41.2 23.0 43.0 45.6 37.1 5.7 31.4 35.8 19.7 51.4 14.9 20.9 67.7 112.2 50.6 42.8 20.2 15.9 12.2 33.4 47.6 15.8 92.5 13.6 18.2 43.5 9.0 1.5 35.9 14.6 30.3 28.0 79.8 10.4 18.1 78.7 48.5 61.0 17.2 11.8 58.5 11.1 16.3 42.3 38.9 18.9 27.9 73.9 22.2 64.0 37.0 25.4 41.0 45.6 20.5 27.2 29.2 31.3 11.1 19.3 49.1 27.9 38.5 66.8 10.4 13.4 3.9 84.2 41.3 11.8 85.0 29.0 33.0 19.7 34.5 21.9 19.0 23.9 8.4 18.5 16.6 39.6 17.3 34.8 12.1 45.4 48.7 79.1 9.8 32.4 28.1 91.0 53.4 69.0 24.9 17.8 10.0 32.5 56.9 21.0 22.4 8.1 60.7 81.5 19.1 26.9 40.6 28.9 36.2 71.7 33.9 15.8 47.5 11.9 32.4 52.6 11.2 20.8 26.5 14.5 26.4 24.1 25.4 20.1 26.0 23.4 19.8 17.9 0.9 28.8 9.7 110.9 25.0 13.6 16.8 17.1 16.6 28.5 14.9 20.9 20.2 15.9 12.2 18.2 18.1 17.2 18.9 19.5 0.0 3.0 16.3 31.2 13.8 42.4 48.1 25.6 0.8 28.2 38.9 28.1 12.8 23.2 40.5 6.2 50.8 47.7 30.2 7.9 33.9 17.9 19.7 32.4 14.1 19.9 9.0 5.6 28.7 40.0 47.5 30.1 28.1 15.9 33.9 13.2 22.1 27.4 6.7 4.0 28.6 24.4 10.7 31.2 8.4 34.5 28.9 30.2 18.7 23.1 20.0 12.3 3.5 5.6 27.4 31.7 18.8 31.8 30.6 51.9 17.7 16.2 9.0 19.7 31.9 26.0 87.8 33.4 13.9 7.4 22.6 30.4 23.9 27.1 37.6 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018978-49060794 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Yes No Cytosol "Nucleoplasm, Plasma membrane" "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 20.0 22.1 13.8 17.2 12.9 62.6 20.4 14.0 18.2 19.4 3.9 20.8 13.3 27.1 14.6 25.7 24.3 11.8 21.5 11.8 4.8 17.9 20.7 25.3 17.6 11.5 8.3 8.1 25.5 33.5 23.1 25.6 16.4 10.8 19.4 14.8 48.4 22.3 16.3 45.4 30.6 28.2 15.6 2.9 36.9 25.7 23.8 11.2 29.2 26.7 22.1 17.4 19.5 19.6 13.1 32.3 31.9 31.0 24.7 29.3 20.4 32.6 17.3 17.1 20.3 10.9 54.8 14.1 33.4 21.2 23.9 14.0 21.5 38.1 19.9 17.7 22.4 26.7 47.2 37.7 29.9 20.5 59.1 43.2 18.4 25.8 30.7 32.0 27.3 31.8 33.2 55.1 19.2 23.7 37.4 26.8 48.0 29.9 45.4 25.0 37.4 22.4 12.0 18.1 37.2 24.6 21.2 28.1 25.5 19.5 26.1 24.0 44.1 49.8 15.5 30.7 14.5 30.5 24.8 20.9 31.7 17.1 28.0 12.5 0.5 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 1.5 0.5 0.0 0.2 0.0 0.1 13.8 12.9 14.0 18.2 11.8 4.8 11.5 8.3 8.1 10.8 2.9 11.2 13.1 12.9 9.6 19.1 17.6 13.3 14.0 7.8 8.1 14.2 26.8 12.1 7.1 7.8 12.8 10.9 18.4 52.1 8.2 15.3 12.3 1.9 6.3 2.8 10.7 12.7 13.2 13.1 16.0 17.4 6.0 6.0 8.8 24.5 13.1 8.2 23.3 17.9 13.0 9.8 21.9 16.5 10.0 6.1 15.7 18.4 2.4 9.6 15.4 10.6 15.0 14.9 6.4 17.5 12.5 19.8 8.8 9.5 10.9 10.1 11.0 13.3 4.5 9.0 38.4 6.6 14.4 12.5 6.5 3.8 18.9 17.6 11.4 15.3 10.8 10.3 9.6 CORO6 FLJ14871 ENSG00000167549 "Coronin 6" Q6QEF8 17 29614756-29622907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 604.9;tongue: 254.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 38.1;Excitatory neurons: 64.1;Extravillous trophoblasts: 32.7;Horizontal cells: 30.3;Inhibitory neurons: 73.8;Skeletal myocytes: 25.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "REH: 16.5;RH-30: 17.8;SH-SY5Y: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021556 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA021556: " "unprognostic (7.12e-3)" "unprognostic (2.68e-2)" "unprognostic (2.60e-4)" "unprognostic (9.25e-4)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.62e-1)" "unprognostic (3.00e-4)" "unprognostic (6.70e-2)" "unprognostic (6.61e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.61e-7)" "unprognostic (8.48e-2)" "unprognostic (4.09e-1)" "unprognostic (1.92e-1)" "unprognostic (1.13e-2)" 10.7 3.2 6.4 1.2 9.4 0.5 10.4 2.0 25.4 6.3 0.0 18.9 1.4 14.5 2.0 15.4 16.0 4.1 71.3 7.9 7.6 1.9 0.7 9.8 0.7 12.2 6.6 11.2 4.8 1.5 16.1 4.3 28.1 12.8 14.7 2.3 2.0 16.2 4.4 604.9 5.7 11.8 12.0 1.1 1.4 9.0 1.9 8.0 1.8 100.2 254.8 0.8 21.9 8.6 16.3 10.2 4.4 3.8 0.0 5.9 3.2 6.0 3.3 1.2 2.1 0.8 0.3 0.0 0.1 0.8 5.3 0.3 10.5 2.9 0.6 1.0 0.2 4.9 0.0 9.8 1.3 9.4 0.0 0.6 11.5 0.9 1.1 0.0 5.4 2.2 0.0 0.7 0.2 7.1 0.0 6.8 0.3 1.2 0.0 0.2 16.5 17.8 0.4 0.5 0.0 0.1 21.9 0.9 3.0 0.0 2.8 0.0 1.4 0.6 1.4 0.0 1.7 1.4 8.3 4.7 1.2 3.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 9.4 2.0 25.4 7.9 7.6 12.2 6.6 11.2 12.8 1.1 8.0 16.3 1.1 0.0 0.0 4.6 0.4 1.5 2.5 0.6 1.8 3.5 0.8 1.9 38.1 0.0 0.6 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.2 0.1 2.4 1.8 0.0 0.0 64.1 0.0 32.7 7.7 0.5 0.2 0.0 1.0 2.2 0.1 1.3 30.3 73.8 0.0 2.0 1.2 0.8 0.6 7.2 0.7 0.0 7.5 0.0 0.2 2.1 5.0 6.6 0.0 0.0 4.1 0.7 1.0 0.0 0.3 0.2 1.5 6.6 25.6 6.0 2.4 3.9 0.2 0.4 2.5 1.3 1.1 0.0 0.2 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064676-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2" "Cell type enhanced" "Detected in many" "dendritic cells: 10.6;Granulosa cells: 12.2;NK-cells: 14.4;Plasma cells: 8.2;Respiratory ciliated cells: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 16.1" "Group enriched" "Detected in all" 5 "granulocytes: 16.1;T-cells: 10.4" "Cell line enhanced" "Detected in many" "HDLM-2: 30.8;U-266/84: 61.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA053111: AB_2682047, HPA061001: AB_2684409" "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 0.8 0.2 2.4 1.5 2.5 2.1 0.8 2.3 4.2 0.3 2.1 0.5 0.5 1.4 1.0 0.4 2.6 0.5 0.5 2.5 2.3 0.3 0.3 1.2 3.7 2.5 2.3 2.5 0.3 0.2 0.2 0.3 0.6 2.4 0.2 0.8 0.8 0.4 0.2 0.2 2.7 0.9 0.5 2.2 2.6 0.6 1.5 2.3 1.6 0.3 1.1 1.9 0.4 0.4 2.6 1.7 3.4 2.2 4.8 1.2 0.2 2.1 1.4 4.8 9.1 9.9 3.2 2.9 4.7 1.5 0.4 4.7 1.8 1.5 1.8 3.9 30.8 0.4 4.9 2.9 1.9 1.0 2.4 10.1 0.5 0.8 4.5 1.4 0.6 3.5 8.3 6.1 14.8 3.3 1.7 2.3 13.3 3.0 6.0 3.9 4.7 3.2 7.9 0.7 0.2 1.0 2.9 1.4 1.3 8.4 2.6 0.5 3.5 1.3 2.7 4.4 5.3 1.7 17.8 61.0 3.0 2.3 7.2 1.2 16.1 0.3 0.7 7.6 1.8 10.4 2.0 3.2 4.1 0.8 2.9 1.0 3.8 0.7 1.4 1.7 1.0 6.7 1.4 2.4 2.5 2.3 4.2 2.5 2.3 2.5 2.3 2.5 2.4 2.2 2.3 2.6 2.8 0.0 0.0 0.3 6.8 1.3 0.5 1.9 4.0 1.8 1.2 1.7 1.5 1.5 1.8 0.0 0.0 0.1 10.6 0.1 0.0 0.5 0.5 2.8 0.3 2.6 0.0 8.0 6.9 0.2 0.5 1.4 0.5 0.4 0.0 12.2 1.8 0.1 1.8 3.3 2.3 0.2 0.0 0.3 2.0 0.6 0.0 3.7 0.0 0.0 4.5 0.6 14.4 0.5 0.3 0.2 0.0 0.0 8.2 0.4 0.1 0.1 12.0 0.4 0.0 1.3 1.8 0.9 5.4 4.8 2.0 0.1 5.7 0.2 0.4 0.2 TUBA1A "B-ALPHA-1, FLJ25113, TUBA3" ENSG00000167552 "Tubulin alpha 1a" Q71U36 12 49184686-49189080 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1363.6" "Cell type enhanced" "Detected in all" "Ductal cells: 1162.0;Respiratory ciliated cells: 1173.3;Smooth muscle cells: 1005.3" "Cancer enriched" "Detected in all" 9 "glioma: 942.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1660.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 3100.7;SCLC-21H: 1983.9" "Low region specificity" "Detected in all" "CAB008686, HPA039247, HPA043684, HPA063394" Enhanced Enhanced Microtubules NA NA Microtubules "CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.11e-1)" "unprognostic (1.61e-1)" "unprognostic (3.77e-1)" "unprognostic (1.14e-1)" "unprognostic (4.73e-1)" "unprognostic (1.15e-2)" "unprognostic (2.56e-2)" "unprognostic (2.12e-1)" "unprognostic (3.49e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (9.79e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.07e-2)" "unprognostic (4.27e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-3)" 151.7 134.8 810.9 168.4 965.6 153.3 181.5 1075.1 906.0 187.4 692.1 349.9 54.9 409.7 168.0 141.2 345.0 194.8 152.0 780.8 1157.8 57.3 21.3 216.2 72.3 1212.1 1009.6 779.7 174.4 54.0 79.8 164.6 124.9 1123.6 174.9 127.7 262.0 105.5 269.9 37.8 108.7 127.0 872.5 1122.3 85.4 136.8 69.5 995.0 164.2 40.1 94.9 56.4 212.1 118.1 1363.6 3.2 154.4 3100.7 419.3 263.1 613.9 10.5 286.4 325.6 163.2 390.4 9.4 54.8 120.7 322.4 824.7 304.0 6.4 388.0 97.3 120.3 97.0 138.1 41.5 27.6 34.4 54.1 70.2 3.2 359.5 33.8 325.0 31.8 627.1 945.9 237.2 45.0 124.5 888.7 70.3 276.5 59.2 335.0 3.6 112.5 225.4 232.3 14.1 718.9 13.8 1983.9 1150.3 79.1 4.5 106.0 449.9 210.4 97.3 929.1 178.6 108.5 21.2 80.5 41.5 126.9 234.2 93.8 117.2 191.6 503.5 260.5 824.7 159.0 554.9 118.1 158.2 140.0 146.7 314.0 166.9 134.2 125.2 1660.9 89.9 812.8 101.1 172.8 495.5 810.9 965.6 1075.1 906.0 780.8 1157.8 1212.1 1009.6 779.7 1123.6 1122.3 995.0 1363.6 296.9 230.8 181.5 49.9 220.8 87.2 250.6 179.3 59.7 233.0 140.0 291.6 187.9 25.8 148.1 64.4 77.2 10.5 202.9 4.5 25.4 1162.0 10.0 414.9 413.6 334.2 785.8 48.0 78.2 16.2 12.8 391.5 63.2 102.4 547.9 695.0 165.6 2.8 452.0 249.0 60.6 15.5 329.6 80.7 277.6 20.7 193.6 204.2 183.2 37.5 616.6 788.9 77.2 73.4 432.6 333.3 12.8 142.6 32.5 60.4 1.5 73.3 1173.3 349.6 164.3 542.7 1005.3 15.4 31.2 20.9 99.3 15.9 266.5 40.6 12.4 95.7 TUBA1C "bcm948, MGC10851, MGC14580, TUBA6" ENSG00000167553 "Tubulin alpha 1c" Q9BQE3 12 49188736-49274600 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 483.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 98.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 4114.3" "Low region specificity" "Detected in all" "HPA039247, HPA043684, HPA063394" Supported Supported Microtubules NA Yes 160000000 Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-2)" "prognostic favorable (7.37e-5)" "unprognostic (3.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.88e-2)" "prognostic unfavorable (8.48e-8)" "prognostic unfavorable (6.85e-4)" "unprognostic (2.11e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (5.64e-6)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.26e-7)" "unprognostic (2.95e-1)" "unprognostic (1.26e-1)" "unprognostic (2.49e-1)" "unprognostic (5.45e-3)" 93.5 58.2 11.8 111.5 11.4 150.0 55.3 13.4 18.1 62.6 36.1 159.7 107.9 60.1 63.2 483.3 51.2 92.9 55.3 12.2 32.2 88.0 69.9 74.7 79.2 15.2 14.0 10.7 38.6 53.0 22.6 28.2 110.8 15.8 44.1 158.0 2.5 140.1 46.8 45.7 167.5 118.5 131.0 15.5 42.4 116.2 26.5 19.3 104.3 56.8 42.9 172.1 224.6 170.2 14.6 1295.3 987.5 211.7 363.9 220.5 368.4 816.3 1010.1 1126.1 1742.1 927.3 966.9 947.0 578.9 1053.2 1194.2 1047.3 580.5 1246.0 1412.1 1150.2 564.1 449.7 703.4 406.7 943.7 165.2 550.9 498.4 269.8 663.0 1485.6 619.9 550.6 1139.5 320.6 1026.8 308.3 1521.8 811.1 306.5 535.8 639.6 4114.3 1928.6 344.0 414.5 319.7 770.3 602.8 169.8 9.1 875.5 574.4 386.0 828.3 559.4 426.0 835.1 819.3 911.5 821.9 1717.4 101.6 306.5 565.2 431.6 536.1 725.9 98.8 14.6 29.9 12.3 17.3 19.7 10.5 13.1 11.7 27.0 7.4 7.0 7.9 12.2 13.6 13.1 21.6 17.6 20.8 11.8 11.4 13.4 18.1 12.2 32.2 15.2 14.0 10.7 15.8 15.5 19.3 14.6 94.3 118.6 136.1 2.6 54.9 194.5 354.2 317.7 306.7 1.3 61.3 75.8 0.9 45.8 150.9 58.8 0.0 291.9 50.1 432.7 70.5 285.8 7.9 107.7 65.8 83.0 77.5 155.5 2.1 559.2 1118.2 109.7 153.4 204.4 67.2 110.8 39.3 55.9 276.8 0.0 1.9 190.5 101.7 65.6 121.7 8.4 68.0 163.3 46.2 2.8 265.5 2.8 6.2 1.0 1.4 465.6 330.2 40.6 71.0 206.3 234.1 137.1 51.9 0.6 39.5 84.3 258.2 9.0 65.5 530.8 183.1 161.6 77.6 46.1 187.9 293.4 ZNF610 FLJ36040 ENSG00000167554 "Zinc finger protein 610" Q8N9Z0 19 52336243-52367778 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 35.6;Late spermatids: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.0" "HPA055771, HPA078134" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA055771: AB_2682914, HPA078134: AB_2732372" "unprognostic (1.13e-1)" "unprognostic (5.48e-3)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (3.65e-2)" "unprognostic (1.27e-1)" "unprognostic (3.34e-1)" "unprognostic (2.84e-1)" "unprognostic (1.83e-1)" "prognostic favorable (3.38e-4)" "unprognostic (5.54e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.05e-7)" "unprognostic (2.46e-2)" "unprognostic (1.11e-2)" "unprognostic (1.88e-2)" "unprognostic (5.73e-3)" 1.2 2.8 5.6 0.8 6.0 0.3 3.2 6.0 7.4 3.8 4.9 1.4 0.7 3.0 6.7 1.1 4.3 2.6 2.6 5.2 5.8 3.6 0.4 1.9 1.6 6.2 6.2 4.7 8.3 1.5 4.1 2.4 2.7 6.4 4.6 1.5 6.3 1.2 2.6 1.1 0.7 1.0 2.5 5.3 2.4 1.5 12.2 5.8 3.1 4.6 1.6 1.1 1.8 1.2 6.4 0.1 0.0 5.0 4.2 3.5 2.8 4.2 1.5 3.5 0.9 3.0 0.0 0.3 0.4 3.1 0.7 6.6 0.1 0.0 0.0 2.1 0.1 2.3 0.1 0.3 0.2 5.1 0.0 1.0 3.8 0.1 0.9 0.2 2.5 3.0 2.8 0.2 0.1 5.0 1.0 2.9 0.8 5.7 0.0 0.3 1.9 3.9 0.5 2.3 3.7 6.4 3.9 0.0 0.3 1.6 7.4 3.0 2.3 2.3 0.2 1.5 0.0 2.0 0.1 11.0 0.0 0.0 0.1 2.0 1.7 0.2 0.5 1.1 0.0 1.7 1.0 0.9 0.8 0.5 1.1 1.6 0.7 0.4 1.2 0.0 0.6 1.3 0.7 5.6 6.0 6.0 7.4 5.2 5.8 6.2 6.2 4.7 6.4 5.3 5.8 6.4 0.9 0.0 0.5 4.2 0.5 0.0 0.6 0.5 1.2 3.1 1.3 1.8 3.1 2.8 2.1 3.7 4.2 1.3 0.3 0.2 5.9 1.9 35.6 3.0 1.0 1.5 0.0 1.7 3.8 0.0 1.6 1.2 0.5 1.7 2.5 4.4 0.7 0.0 0.6 0.0 5.5 0.3 0.0 0.3 0.0 10.0 0.9 0.2 1.8 0.0 0.0 4.3 0.0 5.5 7.5 0.2 0.1 1.2 0.1 0.7 0.3 0.8 2.3 2.5 6.6 0.4 1.2 5.7 3.6 0.1 0.3 0.7 0.6 1.6 0.5 0.5 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 51.2;U-266/84: 69.0" HPA065435 Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 8.0 9.3 8.9 5.4 11.9 5.8 11.0 16.6 9.5 10.0 8.7 7.3 5.0 13.6 18.9 9.0 13.7 10.2 10.2 8.0 8.1 9.7 4.7 8.1 9.2 10.6 11.4 6.0 18.4 5.3 12.8 9.3 10.0 12.0 11.7 8.9 19.9 10.8 9.4 6.5 11.5 6.7 8.4 4.4 11.4 9.4 13.2 9.4 9.9 17.9 5.8 10.8 9.8 8.6 14.5 0.2 0.0 6.1 36.5 13.6 16.9 15.0 13.6 22.3 8.2 18.1 0.2 6.9 0.3 3.3 16.9 20.4 4.1 0.0 8.6 10.5 0.1 9.8 5.7 2.0 3.5 20.4 0.1 15.2 17.2 15.5 9.0 0.0 2.5 19.7 0.3 3.8 0.6 11.9 0.2 21.5 2.9 15.9 0.3 9.4 0.2 24.5 6.5 10.1 51.2 25.1 20.8 0.0 1.1 9.1 21.2 24.2 3.3 23.3 14.2 16.3 5.6 18.8 0.6 69.0 12.9 7.1 0.2 22.5 7.6 5.1 11.8 6.6 5.4 12.7 7.8 8.2 10.2 5.4 11.1 7.7 6.9 1.4 17.6 5.5 8.8 9.6 3.9 8.9 11.9 16.6 9.5 8.0 8.1 10.6 11.4 6.0 12.0 4.4 9.4 14.5 9.8 6.4 3.2 8.8 5.8 3.7 4.1 5.2 1.2 19.6 8.6 7.1 12.2 2.8 7.4 1.8 14.6 4.1 6.0 4.1 3.9 5.6 2.9 13.1 7.7 8.8 1.2 0.8 13.2 1.9 4.5 6.0 2.0 13.2 8.8 16.7 6.1 1.3 3.5 21.9 12.7 4.0 4.1 3.8 4.7 3.1 5.0 4.7 1.8 7.5 0.7 12.3 11.3 20.6 10.3 7.1 6.3 4.1 1.5 4.7 4.0 3.9 10.4 21.8 0.0 6.1 6.9 17.6 10.2 2.3 3.1 3.1 7.6 7.3 3.0 4.1 ZNF701 FLJ10891 ENSG00000167562 "Zinc finger protein 701" Q9NV72 19 52555457-52587174 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 28.6" HPA005532 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA005532: AB_1080746" "unprognostic (1.21e-1)" "unprognostic (4.98e-3)" "unprognostic (5.58e-2)" "unprognostic (3.40e-1)" "unprognostic (7.74e-2)" "unprognostic (1.13e-2)" "unprognostic (8.86e-2)" "unprognostic (4.67e-2)" "unprognostic (5.46e-4)" "unprognostic (3.75e-1)" "unprognostic (2.86e-1)" "unprognostic (1.16e-2)" "unprognostic (8.17e-3)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (2.79e-1)" "prognostic favorable (4.89e-5)" 4.8 4.2 5.6 6.4 6.5 10.2 7.9 6.6 6.0 5.7 7.7 5.7 5.0 5.8 7.2 4.3 6.2 5.0 5.7 6.6 5.0 5.2 2.7 5.7 8.1 6.2 5.2 4.2 6.2 4.7 6.3 4.4 7.6 8.0 6.6 6.8 6.4 5.9 4.8 5.7 7.4 6.4 4.7 4.2 7.3 6.4 6.1 5.5 9.4 9.5 5.7 7.2 5.5 5.7 9.2 2.3 0.3 5.0 8.9 5.5 6.5 9.2 5.9 5.8 7.8 8.1 4.6 5.5 11.0 3.3 4.6 7.6 3.5 2.3 6.3 8.3 0.4 6.6 3.0 9.3 1.1 5.6 0.4 14.1 6.8 5.0 6.0 10.1 4.0 7.4 5.8 15.0 1.4 7.2 1.8 11.3 5.2 4.8 2.9 8.0 11.8 6.6 4.6 6.2 28.6 4.9 5.4 3.9 10.1 3.1 10.1 12.9 6.2 7.3 6.2 3.1 3.0 10.7 1.1 7.1 14.4 0.2 12.4 10.1 21.6 9.0 18.1 9.3 9.8 7.9 9.2 7.3 8.2 6.7 9.0 8.5 9.1 23.0 14.2 7.7 6.6 9.1 7.0 5.6 6.5 6.6 6.0 6.6 5.0 6.2 5.2 4.2 8.0 4.2 5.5 9.2 7.2 0.0 6.1 4.6 11.1 2.2 6.7 6.0 0.6 5.4 6.3 7.6 4.8 4.3 7.7 14.7 14.6 13.5 13.8 8.9 3.9 6.8 2.3 9.2 7.8 7.3 2.4 5.2 2.1 3.9 9.7 5.5 5.6 9.7 2.5 13.6 6.4 0.6 5.3 3.3 2.4 6.2 8.2 5.5 8.2 1.2 6.2 6.8 3.6 3.7 9.9 3.8 15.5 3.5 5.9 5.5 8.8 3.8 3.0 8.2 13.1 3.7 9.7 6.0 0.0 3.7 7.0 3.8 10.8 3.0 3.7 23.5 9.9 7.2 3.8 11.7 SERTAD3 RBT1 ENSG00000167565 "SERTA domain containing 3" Q9UJW9 19 40440844-40444335 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 187.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068262 Approved Nucleoli NA Yes Nucleoli "HPA068262: AB_2685965" "unprognostic (1.56e-2)" "unprognostic (3.57e-2)" "unprognostic (1.10e-1)" "unprognostic (6.55e-3)" "unprognostic (6.50e-2)" "unprognostic (6.74e-2)" "unprognostic (2.24e-2)" "unprognostic (3.51e-3)" "unprognostic (7.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.28e-3)" "unprognostic (2.80e-2)" "unprognostic (8.74e-3)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.18e-1)" "unprognostic (4.66e-3)" 28.4 21.7 11.4 18.9 12.8 22.9 23.5 12.9 11.8 20.1 13.3 27.4 21.7 22.7 26.9 26.2 25.0 25.8 28.1 11.1 18.8 21.3 17.5 24.2 22.0 14.8 13.3 10.2 26.1 15.0 22.6 17.8 31.7 13.4 29.3 23.1 2.5 18.2 27.2 27.8 18.6 19.9 27.6 13.1 25.0 24.6 16.2 12.6 16.1 25.0 37.5 16.4 26.3 24.7 14.6 36.6 65.3 22.4 30.4 25.7 38.4 32.6 28.3 38.8 39.7 34.3 24.9 27.2 16.6 12.6 37.9 23.9 12.6 23.0 28.3 21.7 19.2 10.7 11.4 21.5 21.3 31.4 3.2 34.7 35.7 37.3 24.6 17.9 31.7 33.3 8.0 34.6 11.9 32.0 55.4 7.1 14.2 12.7 30.8 17.5 10.1 15.1 14.6 31.4 27.6 3.6 15.1 25.6 42.1 22.9 33.7 37.3 30.6 28.7 34.2 27.7 27.4 23.2 19.0 10.5 14.7 27.5 12.7 15.6 44.8 59.0 66.1 18.5 59.2 19.0 39.9 20.4 20.5 64.7 36.6 14.8 17.7 80.3 22.5 51.7 69.8 17.6 40.0 11.4 12.8 12.9 11.8 11.1 18.8 14.8 13.3 10.2 13.4 13.1 12.6 14.6 78.4 9.6 12.0 2.9 42.0 46.1 55.8 139.9 91.6 4.6 81.5 50.9 10.5 11.5 45.4 23.9 4.2 89.8 44.2 40.7 31.3 32.1 11.4 26.0 24.8 42.1 49.1 3.0 0.3 30.5 105.4 38.9 27.5 30.7 21.0 13.2 33.9 6.6 35.0 3.3 0.5 50.8 42.7 27.0 55.3 6.9 28.6 32.1 33.8 8.4 29.1 19.3 4.1 1.5 3.7 37.1 48.5 30.5 16.3 50.5 47.8 22.7 28.0 0.8 59.2 20.2 50.4 15.7 20.0 64.2 43.0 187.4 33.6 17.6 30.6 49.8 NCKAP5L KIAA1602 ENSG00000167566 "NCK associated protein 5 like" Q9HCH0 12 49791146-49828750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Leydig cells: 68.3;Peritubular cells: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041034 Approved NA NA "HPA041034: AB_10796235" "unprognostic (3.35e-2)" "unprognostic (1.68e-3)" "unprognostic (2.87e-3)" "unprognostic (1.06e-1)" "unprognostic (4.79e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.51e-2)" "unprognostic (8.65e-2)" "unprognostic (1.85e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.94e-1)" "prognostic unfavorable (1.16e-5)" "unprognostic (3.29e-2)" "unprognostic (3.80e-1)" "unprognostic (5.94e-2)" "unprognostic (1.15e-1)" 13.2 27.8 7.9 6.4 9.5 3.1 11.3 7.5 14.2 14.3 5.9 9.9 2.9 12.5 1.4 6.4 12.0 5.4 20.8 7.3 7.9 12.9 11.0 16.3 4.4 11.2 9.1 5.9 14.7 7.9 5.0 14.1 9.0 12.7 15.2 1.0 2.7 8.4 4.6 10.1 6.4 6.8 4.8 7.1 13.2 8.7 15.8 9.6 5.8 14.2 4.6 2.0 11.7 10.4 12.2 5.3 8.9 15.5 15.4 9.7 7.2 20.6 8.9 9.6 12.8 10.6 12.4 1.6 3.2 15.0 9.1 4.9 1.8 6.4 9.4 3.4 3.3 9.0 11.7 11.3 12.1 24.4 4.6 24.4 17.0 10.8 13.8 6.4 16.1 15.1 11.7 11.4 0.1 8.3 12.9 12.0 16.5 18.7 1.7 9.9 14.5 16.0 0.9 9.9 7.3 5.4 24.3 13.6 14.6 25.4 8.4 25.6 9.4 11.9 11.9 12.5 6.1 4.3 0.3 0.0 4.1 9.6 5.3 3.6 0.0 0.6 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.2 0.2 0.4 0.5 0.0 0.3 7.9 9.5 7.5 14.2 7.3 7.9 11.2 9.1 5.9 12.7 7.1 9.6 12.2 18.0 6.4 1.1 16.6 7.6 12.7 8.2 8.4 22.8 44.6 19.2 15.6 2.7 5.7 6.2 11.0 112.6 10.6 19.2 1.2 0.0 5.3 1.2 15.6 16.9 11.6 9.0 1.7 10.0 3.8 12.9 17.4 3.1 8.6 0.0 29.5 10.8 4.6 15.9 30.3 13.2 1.3 8.2 12.9 24.8 4.8 68.3 20.7 5.4 13.1 12.4 7.0 7.2 13.0 21.8 3.2 0.4 82.8 2.2 5.7 0.2 2.4 6.6 25.2 0.0 49.3 15.5 3.0 4.8 8.2 7.2 2.5 10.0 43.2 1.6 3.5 RAB4B "FLJ78649, MGC52123" ENSG00000167578 "RAB4B, member RAS oncogene family" P61018 19 40778216-40796942 "Enzymes, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 80.4;Syncytiotrophoblasts: 102.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (9.11e-3)" "unprognostic (2.67e-3)" "unprognostic (4.23e-3)" "unprognostic (4.02e-2)" "unprognostic (1.62e-1)" "unprognostic (4.73e-3)" "unprognostic (5.74e-2)" "unprognostic (7.93e-2)" "unprognostic (5.32e-1)" "unprognostic (2.46e-2)" "prognostic favorable (2.08e-4)" "unprognostic (7.73e-2)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "unprognostic (1.01e-1)" "prognostic favorable (1.99e-5)" 24.9 51.7 61.2 20.9 68.3 18.3 23.8 72.7 82.2 24.8 48.2 24.7 17.6 21.7 5.3 30.6 19.4 13.8 23.2 60.3 67.3 32.4 25.1 31.2 32.1 78.3 69.6 59.0 15.2 19.1 11.1 48.2 16.5 72.3 26.7 9.5 15.5 20.4 14.0 17.1 18.9 30.5 8.9 71.7 51.1 27.2 22.6 69.2 24.5 29.0 8.1 18.2 23.3 24.2 80.3 11.8 37.5 9.1 14.9 19.7 14.3 12.6 15.0 14.1 6.5 17.5 21.1 12.5 19.3 25.6 12.8 21.2 10.6 4.0 13.6 3.2 45.7 17.1 15.4 7.2 12.7 30.4 13.7 54.6 24.3 13.6 14.2 3.5 11.2 25.5 38.3 8.6 33.6 13.8 18.8 20.8 22.1 7.0 20.7 17.8 18.4 7.4 18.9 18.9 23.0 7.9 14.1 34.4 10.5 16.3 8.9 10.6 29.4 18.8 16.2 11.6 14.5 6.3 19.9 13.0 20.1 31.3 17.5 17.3 86.5 65.7 116.9 61.3 83.9 33.8 71.6 39.7 53.4 82.9 89.2 36.2 44.5 113.6 38.9 62.5 151.2 59.6 70.0 61.2 68.3 72.7 82.2 60.3 67.3 78.3 69.6 59.0 72.3 71.7 69.2 80.3 2.6 9.6 18.8 0.0 19.8 7.8 15.0 47.0 3.4 22.2 2.0 2.2 5.6 12.8 33.6 1.8 6.2 52.8 23.3 80.4 0.0 1.1 3.2 3.0 2.2 16.5 26.3 4.4 0.0 1.0 19.1 8.7 25.0 7.3 21.5 1.4 23.9 15.2 40.9 32.0 0.0 17.7 40.7 29.0 34.8 3.3 8.7 16.6 32.0 0.0 14.6 26.3 42.2 0.0 0.0 0.7 68.2 10.5 3.0 17.6 49.9 0.8 33.8 15.0 26.3 7.7 15.7 16.6 21.6 7.7 9.9 102.7 17.2 1.4 16.5 26.2 AQP2 ENSG00000167580 "Aquaporin 2" P41181 12 49950737-49958878 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Diabetes insipidus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 92 "kidney: 390.4;seminal vesicle: 214.4" "Cell type enriched" "Detected in some" 440 "Collecting duct cells: 4143.6" "Group enriched" "Detected in some" 6 "renal cancer: 1.7;stomach cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA046834 Enhanced NA NA "HPA046834: AB_2679830" "unprognostic (2.10e-1)" "unprognostic (3.77e-2)" "unprognostic (6.96e-3)" "unprognostic (4.48e-3)" "unprognostic (3.60e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (7.38e-3)" "unprognostic (5.92e-2)" "unprognostic (4.60e-2)" "unprognostic (2.01e-2)" "unprognostic (1.11e-1)" 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.2 0.7 0.0 0.0 390.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 214.4 0.0 0.2 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4143.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.1 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 GPD1 ENSG00000167588 "Glycerol-3-phosphate dehydrogenase 1" P21695 12 50103982-50111313 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 615.3;skeletal muscle: 582.7" "Group enriched" "Detected in many" 4 "Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4" "Cancer enhanced" "Detected in many" "liver cancer: 18.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC diff: 134.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044620, HPA058621" Enhanced NA NA 4700000 "HPA044620: AB_10796803, HPA058621: " "unprognostic (2.65e-2)" "unprognostic (5.60e-2)" "unprognostic (3.28e-2)" "unprognostic (3.37e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-3)" "unprognostic (7.19e-2)" "unprognostic (9.42e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.37e-1)" "unprognostic (9.58e-2)" "unprognostic (3.37e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" 615.3 4.7 10.8 1.6 17.2 0.2 231.1 24.4 11.4 0.3 6.9 6.5 77.1 0.2 5.3 4.9 0.5 16.7 9.0 11.7 17.4 150.7 148.8 18.6 1.0 30.5 19.9 8.5 0.3 7.3 13.1 1.3 0.0 25.7 1.3 3.3 1.0 33.2 1.4 582.7 10.0 77.5 1.3 36.7 0.4 3.3 0.8 19.5 1.5 2.8 217.6 0.4 4.2 1.0 55.1 0.1 0.2 0.1 0.1 134.0 0.0 0.3 0.1 0.0 0.0 0.0 27.0 0.1 0.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.1 0.6 25.2 0.0 0.2 0.0 0.3 0.2 0.1 0.3 0.1 0.0 0.7 0.7 0.3 0.0 0.2 0.1 0.4 0.1 3.7 0.0 0.2 0.2 30.2 0.2 0.0 0.6 0.2 0.0 1.5 1.0 0.0 1.8 0.0 0.0 0.0 0.3 0.2 0.1 0.6 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 17.2 24.4 11.4 11.7 17.4 30.5 19.9 8.5 25.7 36.7 19.5 55.1 3.4 3.2 3.2 0.0 2.4 0.0 0.2 0.3 0.6 3.2 3.4 3.7 5.8 11.5 1.8 5.5 8.4 0.0 0.0 3.0 43.0 0.9 0.1 0.5 0.1 0.2 1.2 5.3 0.2 0.7 0.0 0.8 4.1 0.2 0.0 0.1 1.1 99.1 2.3 3.3 0.2 9.7 0.0 1.0 0.4 0.0 0.0 5.2 1.8 0.0 1.0 2.8 0.0 0.0 4.0 0.6 8.0 0.0 0.0 0.1 247.0 298.4 0.4 1.7 0.0 7.0 1.1 0.0 0.0 0.8 0.4 0.0 1.2 0.0 10.6 0.2 PROSER3 "C19orf55, FLJ30657" ENSG00000167595 "Proline and serine rich 3" Q2NL68 19 35758143-35771028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 89.6;Rod photoreceptor cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 10.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058492 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA058492: AB_2683733" "unprognostic (1.35e-2)" "unprognostic (1.29e-2)" "unprognostic (6.74e-3)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (9.29e-3)" "unprognostic (1.25e-3)" "unprognostic (5.13e-2)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (2.52e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (3.74e-7)" "unprognostic (8.60e-2)" "unprognostic (2.41e-1)" "unprognostic (2.87e-2)" "unprognostic (9.54e-2)" 2.3 2.4 3.2 4.3 3.3 5.3 2.4 1.8 5.3 3.4 5.1 2.7 1.8 3.8 2.8 2.5 4.3 3.3 2.5 2.8 0.2 1.9 1.3 2.7 3.0 2.8 1.3 1.3 4.1 5.1 3.1 3.8 2.8 2.2 2.5 1.9 3.7 2.6 3.1 1.7 5.8 2.6 3.4 0.0 2.9 4.0 8.9 1.4 4.7 3.9 1.4 2.6 3.1 2.9 2.3 9.3 26.7 9.4 9.3 3.7 3.8 3.1 6.7 7.6 7.3 7.7 8.2 6.3 5.2 7.3 6.4 3.5 5.5 4.0 11.8 4.9 12.5 6.8 7.5 12.2 3.4 3.2 6.0 15.6 4.6 6.5 10.2 9.0 5.7 3.2 6.7 6.6 9.3 6.4 4.6 10.7 2.5 2.6 5.4 3.9 8.2 2.3 3.9 4.7 9.8 9.2 8.1 7.4 5.4 1.0 3.5 8.7 5.1 8.2 7.7 8.1 8.0 7.2 11.9 8.6 4.2 8.0 3.8 6.1 5.7 1.7 4.0 1.1 1.0 1.9 2.4 1.7 1.0 0.4 2.6 1.4 0.5 10.3 0.8 1.0 1.5 1.6 0.2 3.2 3.3 1.8 5.3 2.8 0.2 2.8 1.3 1.3 2.2 0.0 1.4 2.3 2.6 9.6 1.5 1.6 7.4 0.0 12.8 0.0 6.2 10.8 3.1 2.9 1.4 8.6 1.8 11.0 89.6 8.2 9.4 5.3 0.0 5.9 30.0 8.9 6.3 3.4 9.5 9.5 3.7 1.9 5.4 5.6 10.2 3.6 2.5 4.4 7.5 2.6 2.8 6.7 2.1 3.9 0.0 2.8 0.0 21.2 14.3 3.3 0.0 1.0 7.0 6.0 13.4 1.0 2.1 5.3 3.4 4.1 3.4 9.2 5.3 1.8 14.6 39.5 6.6 7.9 5.0 27.2 6.5 4.0 0.0 7.3 6.6 15.4 4.7 5.7 CYP2S1 ENSG00000167600 "Cytochrome P450 family 2 subfamily S member 1" Q96SQ9 19 41193210-41207539 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 102.2;stomach 1: 121.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 31.0;Gastric mucus-secreting cells: 110.6;Intestinal goblet cells: 29.2;Langerhans cells: 73.0;Proximal enterocytes: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 24.7;myeloid DC: 84.4" "Group enriched" "Detected in many" 131 "dendritic cells: 84.4;monocytes: 24.7" "Cell line enhanced" "Detected in many" "A549: 99.4;CACO-2: 49.8;HaCaT: 50.3;NTERA-2: 69.6;OE19: 158.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049227, HPA069248" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049227: AB_2680681, HPA069248: AB_2732128" "unprognostic (1.49e-2)" "unprognostic (7.45e-2)" "unprognostic (2.45e-2)" "unprognostic (6.03e-2)" "unprognostic (3.93e-2)" "unprognostic (7.46e-2)" "unprognostic (1.27e-2)" "unprognostic (4.85e-2)" "unprognostic (2.18e-1)" "unprognostic (1.54e-2)" "unprognostic (6.25e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (1.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (7.66e-2)" 1.3 1.1 1.6 6.7 1.7 1.9 0.9 3.1 2.0 1.7 1.4 27.0 102.2 0.5 0.2 14.6 6.4 5.6 0.5 1.3 3.7 0.9 1.4 7.1 1.8 5.6 8.7 1.0 0.3 0.6 0.7 1.2 1.6 6.4 1.3 18.8 0.2 5.1 0.9 0.2 3.7 65.9 1.8 2.4 6.1 121.4 0.8 2.8 3.2 0.6 0.2 13.3 3.6 4.0 5.6 3.8 99.4 0.0 0.1 0.0 0.0 4.5 0.6 0.8 1.0 0.2 49.8 13.6 0.2 10.4 0.7 0.1 50.3 16.6 25.0 0.4 0.0 0.3 12.9 5.1 19.1 19.4 0.0 0.4 0.8 1.4 1.4 0.8 0.2 0.8 4.3 5.8 0.2 0.0 2.0 0.3 0.2 69.6 158.6 12.5 0.2 0.0 0.9 1.5 20.4 0.1 0.6 9.1 0.0 0.0 27.8 12.2 4.7 10.6 0.1 4.0 1.7 0.0 0.5 0.0 0.0 0.5 2.1 0.1 0.0 24.7 0.0 0.0 5.9 0.4 0.0 0.0 0.1 84.4 0.0 0.0 0.0 0.2 0.1 3.7 3.2 0.0 11.4 1.6 1.7 3.1 2.0 1.3 3.7 5.6 8.7 1.0 6.4 2.4 2.8 5.6 0.3 0.0 6.9 1.0 0.7 2.5 2.0 18.2 23.3 0.0 0.1 0.3 1.2 0.0 7.6 1.8 0.0 24.9 0.1 31.0 0.0 0.7 0.3 7.4 0.3 0.4 0.0 0.0 0.4 1.0 1.1 0.8 110.6 0.3 1.3 0.1 0.4 0.0 14.5 0.0 0.5 29.2 0.0 5.7 73.0 0.0 0.0 16.0 0.0 1.0 7.2 0.0 0.0 0.5 0.1 23.7 22.3 0.0 0.4 0.5 50.7 0.2 10.8 0.0 0.0 0.3 0.9 0.1 0.4 4.0 2.8 10.3 0.3 0.0 14.1 0.5 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219223-41261766 "Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 147.2;Kupffer cells: 187.5;Langerhans cells: 185.5;Prostatic glandular cells: 123.4;Sertoli cells: 210.4;Smooth muscle cells: 171.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 11.1;plasmacytoid DC: 25.7" "Group enriched" "Detected in many" 12 "dendritic cells: 25.7;NK-cells: 11.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 501.2;U-251 MG: 540.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" NA Yes 12100000 72000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 39.3 19.0 16.1 15.6 20.3 1.7 26.8 19.5 17.8 35.7 13.5 34.4 11.9 34.7 8.8 17.7 25.6 22.6 21.6 15.7 26.4 9.0 15.1 26.2 6.3 26.2 18.5 11.5 24.9 6.3 10.8 7.3 34.5 22.1 19.3 12.7 5.8 10.7 24.8 9.4 17.6 19.2 37.5 19.7 38.0 21.6 18.8 21.3 7.2 16.7 11.4 5.0 32.7 25.4 20.5 408.0 160.0 9.7 1.3 34.6 34.7 0.5 314.5 280.2 450.9 278.2 8.5 185.5 0.2 124.7 501.2 235.3 33.3 0.4 211.8 384.8 0.7 0.3 0.0 100.4 6.3 125.0 0.3 0.3 26.4 3.8 266.7 409.5 254.8 169.8 0.1 15.8 0.5 284.6 0.5 0.2 0.4 4.1 1.0 76.3 0.2 165.3 0.3 202.3 0.2 0.1 0.1 81.5 0.6 1.8 57.4 0.9 7.2 351.8 317.8 214.6 307.7 540.8 0.5 0.9 1.0 211.5 0.5 241.8 1.5 0.3 0.2 0.1 0.4 0.2 0.1 0.3 0.1 6.0 0.1 0.3 0.3 0.3 11.1 0.2 25.7 0.4 0.3 16.1 20.3 19.5 17.8 15.7 26.4 26.2 18.5 11.5 22.1 19.7 21.3 20.5 13.5 9.6 3.6 35.9 1.9 41.7 88.3 10.3 3.4 0.5 2.3 14.2 8.6 1.5 4.4 5.5 0.0 4.2 0.8 0.1 0.0 6.9 8.7 6.0 45.8 17.7 0.0 0.0 0.8 0.2 2.1 147.2 1.5 5.4 0.0 17.3 11.0 1.2 28.8 1.7 1.1 0.1 2.0 187.5 185.5 5.5 61.5 61.4 26.6 30.9 3.1 26.8 0.0 11.1 0.5 14.5 0.1 79.7 0.8 123.4 0.3 0.1 2.8 1.2 210.4 38.1 171.1 1.9 2.0 1.2 29.1 11.5 3.6 2.5 0.1 28.0 NFKBID "IkappaBNS, IkBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.1" "Cell type enhanced" "Detected in many" "B-cells: 152.7;granulocytes: 90.3;Langerhans cells: 418.5;Macrophages: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054778 Uncertain "Nuclear bodies,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear bodies, Plasma membrane" "HPA054778: " "prognostic favorable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favorable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.34e-6)" 3.1 1.8 1.2 4.4 0.8 16.1 2.6 2.4 1.7 1.9 2.1 2.1 1.1 1.8 0.0 2.2 3.0 2.4 1.2 1.1 1.3 2.5 1.5 5.6 4.9 1.3 0.8 0.4 3.3 2.1 0.9 4.3 0.8 1.1 2.3 0.8 0.7 1.6 0.5 0.4 2.2 4.0 0.6 1.5 5.4 2.0 0.4 1.3 5.2 4.0 0.2 3.1 2.3 2.0 2.5 3.3 3.0 0.6 2.0 0.3 0.5 1.4 2.0 2.4 2.1 1.5 0.7 2.6 4.0 1.5 2.1 1.9 1.7 2.1 1.6 0.9 2.3 0.4 2.4 4.9 0.7 0.5 2.1 7.0 0.7 1.0 3.9 0.9 0.5 0.8 1.8 0.5 2.4 0.4 2.6 1.7 2.5 0.8 0.6 0.6 0.9 0.4 0.8 1.8 1.4 1.0 0.8 2.7 2.1 0.2 0.5 0.9 2.1 0.8 3.3 3.0 1.5 1.4 1.7 0.6 4.6 1.8 4.9 0.5 0.0 0.9 1.7 1.4 0.6 1.1 3.3 0.6 1.1 0.9 5.5 1.0 0.6 3.2 1.5 1.1 1.2 1.5 0.5 1.2 0.8 2.4 1.7 1.1 1.3 1.3 0.8 0.4 1.1 1.5 1.3 2.5 11.7 0.0 11.3 2.9 152.7 29.7 14.3 12.9 34.7 8.0 10.9 7.5 1.1 5.7 5.6 1.8 20.9 1.3 58.9 5.7 0.0 2.5 0.1 27.8 6.8 21.5 3.0 1.7 4.9 1.0 2.8 11.3 2.0 80.8 90.3 3.8 9.3 0.3 39.2 0.0 3.4 5.7 2.0 31.0 418.5 0.4 1.2 89.4 19.6 2.8 40.0 1.0 13.4 1.5 0.5 2.8 2.1 1.9 38.1 13.8 9.2 1.7 3.9 9.2 0.0 3.3 6.7 0.4 1.0 20.7 33.4 1.0 45.3 2.4 6.2 10.0 TMC4 ENSG00000167608 "Transmembrane channel like 4" 19 54160108-54173250 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 46.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 160.1;Paneth cells: 119.7;Proximal enterocytes: 228.6;Respiratory ciliated cells: 155.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 17.3;T-47d: 30.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA048635 Approved Approved Vesicles NA NA Vesicles "HPA048635: AB_2680470" "unprognostic (7.55e-2)" "unprognostic (1.66e-1)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (7.04e-2)" "unprognostic (1.68e-1)" "unprognostic (4.82e-2)" "unprognostic (2.19e-2)" "unprognostic (1.03e-1)" "unprognostic (2.68e-3)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "prognostic favorable (1.54e-8)" "unprognostic (6.70e-2)" "unprognostic (2.48e-1)" "unprognostic (8.94e-2)" "unprognostic (1.79e-2)" 2.2 0.4 0.3 0.4 0.3 0.0 12.6 0.3 0.7 7.6 0.2 22.5 33.4 3.2 0.0 14.9 17.0 8.5 4.7 0.3 0.5 24.8 2.7 12.0 0.1 0.6 0.3 0.2 1.1 46.0 4.6 21.2 0.7 0.7 21.8 12.1 0.0 42.4 5.0 1.4 5.3 37.5 0.4 0.2 0.2 32.2 0.5 0.4 0.0 31.6 0.1 0.5 19.0 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 17.3 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.7 0.3 0.5 0.6 0.3 0.2 0.7 0.2 0.4 0.3 1.5 28.9 30.0 0.7 1.5 2.4 26.9 78.6 24.5 0.3 42.5 19.8 1.7 51.5 94.4 46.0 0.0 22.7 3.7 160.1 13.7 78.2 0.0 59.7 6.6 2.2 41.6 0.0 0.6 64.1 6.1 1.8 102.4 56.2 5.7 0.5 1.1 0.6 3.9 0.0 0.6 92.7 57.0 1.3 3.0 0.1 1.2 3.2 1.8 0.0 2.1 0.1 4.1 1.0 0.7 50.7 119.7 0.7 2.4 22.0 228.6 29.0 155.7 0.5 26.3 0.9 13.6 0.4 1.9 22.0 1.7 23.4 2.8 2.1 77.1 43.1 ANKRD33 "C12orf7, DKFZp686O1689, PANKY" ENSG00000167612 "Ankyrin repeat domain 33" Q7Z3H0 12 51888009-51891727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 18.5" "Group enriched" "Detected in some" 17 "Cone photoreceptor cells: 166.8;Rod photoreceptor cells: 166.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058753 Enhanced NA NA "HPA058753: AB_2683808" "unprognostic (4.42e-2)" "unprognostic (2.13e-5)" "unprognostic (8.25e-4)" "unprognostic (2.37e-1)" "unprognostic (3.25e-5)" "unprognostic (2.42e-1)" "unprognostic (4.07e-1)" "unprognostic (6.21e-2)" "unprognostic (5.51e-10)" "unprognostic (4.41e-3)" "unprognostic (5.56e-2)" "unprognostic (2.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.4 0.0 0.0 0.0 166.8 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 LAIR1 CD305 ENSG00000167613 "Leukocyte associated immunoglobulin like receptor 1" Q6GTX8 19 54351384-54370558 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 28.4;lymphoid tissue: 46.7" "Cell type enhanced" "Detected in many" "dendritic cells: 106.6;granulocytes: 109.3;Hofbauer cells: 190.9;Kupffer cells: 100.9;Macrophages: 128.9;NK-cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 7.5;Karpas-707: 19.4;THP-1: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011155 Enhanced Supported "Plasma membrane" NA NA 350000 "Plasma membrane" "HPA011155: AB_1852685" "unprognostic (1.91e-1)" "unprognostic (1.12e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (2.03e-2)" "unprognostic (4.38e-2)" "unprognostic (2.16e-2)" "unprognostic (1.74e-1)" "unprognostic (5.00e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (5.01e-5)" "unprognostic (1.72e-1)" "unprognostic (2.72e-3)" "unprognostic (3.52e-2)" "unprognostic (5.22e-2)" 21.5 11.7 0.7 3.0 0.7 4.4 12.4 1.6 1.3 3.2 0.7 6.0 0.4 3.8 0.2 2.6 5.5 0.9 3.7 0.6 1.2 4.6 3.5 28.4 5.8 1.2 0.7 0.6 2.3 3.8 0.1 4.4 1.0 1.1 5.4 0.2 0.1 5.8 0.2 1.3 1.9 14.4 2.0 0.9 46.7 5.0 1.7 1.1 3.9 3.3 0.1 0.9 6.3 3.0 2.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 3.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 19.4 0.0 0.0 2.6 1.8 0.0 0.0 0.0 2.6 0.2 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 22.9 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 3.2 0.3 13.1 4.2 11.7 7.7 9.8 4.8 2.1 2.3 4.1 0.1 5.8 3.4 4.4 0.7 6.3 11.0 11.2 1.7 3.8 0.7 0.7 1.6 1.3 0.6 1.2 1.2 0.7 0.6 1.1 0.9 1.1 2.1 1.9 16.0 25.6 0.3 26.1 0.6 0.6 0.2 0.0 5.6 1.1 2.9 1.5 1.5 11.2 0.0 37.5 5.3 106.6 0.2 0.0 0.1 32.2 0.6 0.7 5.0 0.0 10.9 0.4 0.0 5.2 2.5 0.0 0.7 109.3 0.6 3.6 1.2 190.9 1.7 0.5 0.0 0.0 100.9 17.7 26.1 0.3 128.9 0.0 13.1 22.5 0.9 98.9 0.0 0.6 0.1 0.0 0.0 5.1 0.7 0.3 0.3 11.0 15.4 0.0 0.9 1.3 2.9 1.0 0.4 1.1 10.0 32.1 0.2 0.2 0.9 TTYH1 ENSG00000167614 "Tweety family member 1" Q9H313 19 54415219-54436904 "Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.5;testis: 53.8" "Cell type enhanced" "Detected in many" "Astrocytes: 257.6;Bipolar cells: 138.6;Muller glia cells: 653.4;Oligodendrocytes: 97.5;Rod photoreceptor cells: 155.3" "Cancer enriched" "Detected in many" 15 "glioma: 63.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;AN3-CA: 11.7;U-2 OS: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005725, HPA023617, HPA050655" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA005725: , HPA023617: AB_10600836, HPA050655: AB_2681204" "prognostic favorable (3.64e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.50e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (5.94e-3)" "unprognostic (1.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.60e-1)" "unprognostic (0.00e+0)" "unprognostic (2.09e-1)" "unprognostic (1.41e-1)" "unprognostic (4.45e-2)" "unprognostic (1.69e-1)" 0.8 0.9 54.9 0.0 57.4 0.0 3.5 55.8 81.5 3.1 28.9 7.2 0.2 1.6 0.0 1.1 10.5 0.2 3.3 50.0 51.6 0.4 0.7 0.2 0.0 71.5 59.9 49.6 1.5 19.6 0.0 17.9 0.0 67.7 3.6 0.0 3.3 3.6 0.4 3.3 5.5 2.6 0.0 62.7 1.4 2.5 53.8 59.1 0.0 0.4 0.0 0.0 1.7 4.2 59.8 0.1 0.0 7.9 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.7 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.1 2.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 57.4 55.8 81.5 50.0 51.6 71.5 59.9 49.6 67.7 62.7 59.1 59.8 0.4 3.2 0.6 257.6 0.4 0.8 1.2 0.6 0.0 138.6 44.3 42.2 1.3 4.3 3.0 0.0 20.9 0.9 1.3 0.2 0.0 30.4 3.9 0.3 0.9 2.8 1.2 0.0 26.4 0.6 0.7 1.5 0.0 0.7 0.0 13.7 0.7 0.1 0.3 10.1 3.3 0.0 0.0 0.0 1.5 4.8 1.8 0.3 23.2 19.7 0.3 653.4 0.0 48.2 97.5 2.2 0.0 0.7 0.1 1.9 0.4 0.7 2.8 155.3 6.6 2.3 7.8 2.2 5.1 0.0 0.9 4.2 0.6 0.5 0.3 1.9 LENG8 "KIAA1932, MGC40108, pp13842" ENSG00000167615 "Leukocyte receptor cluster member 8" Q96PV6 19 54448887-54462016 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Rod photoreceptor cells: 598.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 479.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042004, HPA061571" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042004: AB_10794642, HPA061571: AB_2684562" "unprognostic (2.09e-2)" "unprognostic (3.24e-3)" "unprognostic (5.14e-3)" "unprognostic (2.19e-1)" "unprognostic (4.42e-2)" "prognostic favorable (7.59e-4)" "unprognostic (1.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.92e-2)" "unprognostic (4.45e-3)" "unprognostic (5.11e-3)" "unprognostic (8.85e-3)" "prognostic unfavorable (3.30e-7)" "unprognostic (3.64e-2)" "unprognostic (6.92e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.73e-6)" 236.1 245.5 42.7 85.1 48.8 80.2 267.2 44.4 95.2 321.2 55.9 302.9 113.6 320.9 40.9 200.6 387.6 25.7 230.1 41.7 42.5 298.7 194.8 295.6 71.4 54.4 38.5 33.4 428.6 550.1 15.8 383.5 31.1 65.9 356.6 29.2 225.6 269.2 28.3 135.3 230.3 339.1 41.5 26.1 389.9 302.5 240.4 54.7 38.7 377.9 10.4 34.8 286.3 282.2 67.2 70.5 57.6 68.0 37.1 20.7 33.6 37.8 58.1 8.9 11.2 21.7 45.3 100.8 55.9 24.6 46.5 2.7 91.0 21.7 27.0 8.2 93.9 479.3 84.0 179.4 32.0 24.4 12.9 68.5 74.9 39.5 6.7 26.4 91.4 17.2 42.6 66.7 84.1 14.0 24.6 53.1 66.8 17.6 17.5 11.9 84.3 20.5 78.6 27.1 19.4 54.4 29.9 6.3 42.7 15.1 34.1 42.7 18.1 81.7 47.2 48.3 7.6 63.0 77.7 38.4 25.7 40.7 89.9 32.4 3.2 1.0 1.4 0.8 0.7 0.9 0.7 0.5 0.9 0.6 2.5 0.8 0.7 4.5 0.9 0.5 3.1 0.9 0.4 42.7 48.8 44.4 95.2 41.7 42.5 54.4 38.5 33.4 65.9 26.1 54.7 67.2 46.7 19.2 30.7 77.1 50.2 28.8 21.3 26.4 35.9 122.7 57.2 47.1 2.2 44.3 35.7 40.5 112.6 20.2 57.5 73.5 1.9 18.5 35.4 52.4 33.8 32.5 105.0 43.3 62.8 31.6 11.9 35.3 128.4 64.8 11.4 67.4 35.3 39.2 25.3 95.9 53.4 84.9 42.7 48.2 28.0 12.4 43.5 59.6 24.9 52.5 45.9 36.1 25.7 64.3 86.5 30.8 52.2 36.9 48.2 39.9 74.2 9.8 68.9 598.6 19.7 25.6 44.3 23.7 13.9 40.5 38.5 21.1 37.6 45.7 59.5 43.1 CDC42EP5 "Borg3, CEP5" ENSG00000167617 "CDC42 effector protein 5" Q6NZY7 19 54465026-54473296 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 60.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 435.6;Intestinal goblet cells: 547.3;Paneth cells: 288.4;Prostatic glandular cells: 193.3;Undifferentiated cells: 257.0;Urothelial cells: 385.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 8.4;BJ hTERT+: 5.9;CAPAN-2: 6.5;EFO-21: 9.6;HHSteC: 6.6;TIME: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043449 Approved NA NA "HPA043449: AB_10961041" "unprognostic (7.67e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-1)" "unprognostic (3.36e-1)" "unprognostic (7.30e-3)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (6.49e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.73e-2)" "unprognostic (5.41e-2)" "unprognostic (6.37e-3)" "prognostic favorable (1.36e-4)" 22.1 8.2 0.5 0.3 0.5 0.0 23.6 0.4 1.1 26.2 1.2 55.3 18.6 13.7 0.0 16.8 17.0 0.8 18.8 0.3 0.3 13.6 3.5 24.3 0.4 1.1 0.9 0.2 12.8 14.7 0.1 5.6 1.4 0.9 60.9 4.4 0.1 40.5 2.1 3.9 11.4 52.9 0.4 0.3 9.3 19.8 6.1 0.6 0.2 11.1 0.5 0.3 42.9 23.1 0.8 0.0 0.0 0.7 0.4 0.7 4.8 3.3 8.4 5.9 0.4 0.1 1.4 6.5 0.0 9.6 2.2 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 2.9 0.1 0.0 0.4 1.5 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.7 0.1 2.2 0.1 3.8 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 8.9 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 1.1 0.3 0.3 1.1 0.9 0.2 0.9 0.3 0.6 0.8 123.5 0.0 0.0 0.3 1.3 10.3 75.4 2.3 13.1 0.9 107.8 114.7 1.3 0.0 2.4 18.4 0.0 0.4 2.3 435.6 0.0 3.1 6.4 4.3 37.0 50.7 39.0 0.0 0.5 11.4 12.6 33.8 50.0 5.0 8.9 0.8 61.1 0.3 0.8 0.0 0.2 547.3 0.0 1.9 5.9 12.0 10.2 1.5 17.8 7.5 0.6 26.7 0.0 0.0 0.5 11.2 288.4 9.1 0.0 193.3 117.0 0.3 0.4 2.5 6.6 3.8 17.6 0.5 1.2 18.3 7.5 0.7 2.4 17.3 257.0 385.7 LAIR2 CD306 ENSG00000167618 "Leukocyte associated immunoglobulin like receptor 2" Q6ISS4 19 54497879-54510687 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.7;pituitary gland: 2.6" "Cell type enriched" "Detected in some" 7 "Extravillous trophoblasts: 696.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 9 "gdT-cell: 14.0;memory CD4 T-cell: 13.8;memory CD8 T-cell: 19.5;naive CD8 T-cell: 13.2;T-reg: 49.5" "Lineage enriched" "Detected in many" 40 "T-cells: 49.5" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Hep G2: 1.0" "Low region specificity" "Detected in some" "Secreted to blood" NA NA "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (4.19e-2)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (4.86e-4)" "unprognostic (1.06e-2)" "unprognostic (8.37e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (2.21e-1)" "unprognostic (9.52e-2)" "unprognostic (3.68e-9)" "unprognostic (1.21e-2)" "unprognostic (3.15e-3)" "unprognostic (3.40e-5)" "unprognostic (6.71e-2)" 0.2 0.0 0.2 0.4 0.3 0.8 0.1 0.3 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 1.1 0.1 0.1 0.7 1.7 0.4 0.3 0.3 0.0 0.1 0.0 2.6 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 1.1 0.3 0.3 0.5 0.6 0.1 0.2 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 14.0 0.1 0.4 0.0 13.8 19.5 0.1 0.1 2.4 13.2 0.2 1.2 0.3 0.1 49.5 7.8 0.2 0.3 0.3 0.7 0.5 1.1 0.4 0.3 0.3 0.5 0.2 0.5 0.6 0.8 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 10.7 95.4 0.9 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.2 696.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 1.8 0.0 0.5 0.0 46.4 0.0 0.1 0.6 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 32.2 23.2 0.0 0.0 0.0 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313309-42325064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 62.7;pituitary gland: 18.5;retina: 29.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 64.5;Cone photoreceptor cells: 29.2;Excitatory neurons: 26.5;Horizontal cells: 69.0;Inhibitory neurons: 54.3;Rod photoreceptor cells: 33.0" "Cancer enriched" "Detected in many" 5 "glioma: 8.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 6.8;neutrophil: 14.2" "Lineage enriched" "Detected in many" 11 "granulocytes: 14.2" "Cell line enhanced" "Detected in many" "HMC-1: 13.7;PC-3: 11.6;SCLC-21H: 26.2;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.0 4.3 17.3 0.7 19.4 2.0 0.7 62.7 37.3 0.2 0.7 0.6 1.2 0.6 1.0 0.5 0.6 0.8 0.9 17.1 16.1 0.5 0.7 0.3 1.1 17.8 23.3 18.4 0.6 2.5 1.8 18.5 0.2 35.2 0.5 0.6 29.0 0.5 0.5 1.8 2.3 0.6 0.6 8.5 0.9 1.2 4.2 18.5 0.4 0.7 0.8 0.5 0.6 0.2 21.1 0.7 3.2 2.4 7.3 0.2 0.2 1.0 0.3 0.1 1.1 3.0 0.6 0.9 1.9 0.3 1.2 0.7 0.3 1.7 0.6 1.5 8.5 2.0 3.5 3.5 3.1 0.2 2.0 13.7 0.7 0.6 0.4 0.8 0.2 1.4 1.0 1.9 6.6 0.1 0.7 0.5 2.5 1.7 2.4 11.6 0.3 0.8 6.2 0.1 1.3 26.2 12.7 1.2 0.9 1.7 0.2 2.3 2.1 0.5 2.0 2.3 1.6 0.9 1.4 4.2 1.9 0.9 1.4 6.1 6.8 0.9 1.0 0.6 0.8 0.3 1.2 0.6 0.4 0.3 1.2 0.6 0.9 14.2 0.8 0.8 0.8 0.5 1.2 17.3 19.4 62.7 37.3 17.1 16.1 17.8 23.3 18.4 35.2 8.5 18.5 21.1 0.5 0.0 0.0 16.3 0.1 0.3 0.4 0.0 0.0 64.5 0.7 0.9 0.5 0.0 0.0 0.0 29.2 0.0 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.8 0.0 0.0 26.5 0.2 0.1 0.1 0.0 0.2 1.3 0.1 1.1 0.0 0.4 69.0 54.3 0.0 0.0 0.6 0.3 0.2 0.0 0.2 5.4 1.0 0.0 10.3 2.1 15.1 5.7 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 33.0 0.0 1.4 0.3 9.5 17.9 0.0 0.1 0.0 0.1 1.4 0.1 0.1 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220312-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 33.3;granulocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: AB_2671057, HPA056609: AB_2683189" "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 3.1 2.5 2.0 2.8 2.3 3.8 3.1 4.0 2.7 3.8 1.9 3.2 3.3 3.6 2.4 3.1 3.5 1.9 2.6 2.0 1.9 2.3 2.9 2.6 4.1 2.3 2.2 1.9 4.5 3.6 3.9 3.0 3.1 2.7 3.3 2.1 2.0 4.7 3.3 5.1 5.3 3.2 2.4 1.6 3.7 3.2 3.5 2.0 4.2 2.8 4.1 3.6 3.5 3.5 3.4 7.8 24.8 7.1 6.4 8.0 7.7 6.2 8.9 8.2 9.2 10.1 13.0 5.5 12.6 6.3 9.5 4.2 5.7 7.7 9.7 5.7 7.5 9.2 12.6 12.0 12.5 7.5 8.1 7.8 7.6 7.7 9.2 9.6 5.7 5.8 6.7 12.3 7.8 5.9 10.8 8.2 5.2 4.7 6.8 8.7 9.4 8.7 5.7 4.2 14.0 7.3 6.4 10.2 10.1 7.2 5.4 4.1 14.4 7.8 11.3 7.7 4.8 11.2 9.3 5.9 8.5 7.5 7.8 9.5 1.8 3.6 1.4 4.5 3.6 6.9 4.7 3.5 4.1 2.8 4.4 4.2 5.3 0.7 3.4 5.3 4.2 3.9 3.3 2.0 2.3 4.0 2.7 2.0 1.9 2.3 2.2 1.9 2.7 1.6 2.0 3.4 3.0 22.4 33.3 2.0 6.9 5.5 4.4 2.8 4.0 7.4 3.1 2.4 3.2 0.0 17.1 3.7 14.6 8.0 3.2 5.7 3.9 4.1 5.8 1.7 4.0 7.1 13.8 9.5 1.4 3.0 8.3 7.4 4.6 2.3 25.2 4.9 3.6 2.6 4.6 6.7 1.5 4.2 2.0 6.8 1.8 6.3 7.2 7.0 0.0 1.9 5.8 4.1 11.3 1.0 1.4 2.9 2.8 3.0 6.1 4.6 7.8 2.8 9.2 9.6 0.0 5.7 3.6 9.9 10.1 1.9 5.1 10.3 6.7 3.7 5.7 2.6 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139727725-140458579 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 89.5;Excitatory neurons: 121.8;Inhibitory neurons: 136.3;Late spermatids: 119.0;Microglial cells: 105.9;Oligodendrocyte precursor cells: 93.5;Oligodendrocytes: 170.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favorable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 8.4 13.5 9.2 7.0 9.4 11.2 9.0 9.2 12.8 10.3 10.0 11.0 8.1 11.4 5.1 12.4 12.3 5.9 14.9 9.8 9.3 13.8 11.7 9.6 8.1 12.8 10.8 8.7 10.5 12.0 27.7 20.9 7.3 12.6 11.8 6.1 14.3 11.7 8.4 33.9 11.4 10.9 7.2 9.3 11.4 12.6 9.1 9.9 11.4 13.0 17.8 6.9 11.2 10.9 12.3 9.6 16.6 7.4 20.8 15.5 9.0 4.9 6.0 9.9 3.1 5.0 6.2 11.2 11.6 14.0 11.9 4.7 12.2 10.0 9.4 3.4 16.8 6.1 18.6 9.8 6.2 11.2 4.7 14.5 8.9 9.3 2.5 7.9 11.1 12.9 13.1 6.7 10.1 5.1 27.0 29.2 6.2 2.3 31.3 14.0 12.2 2.7 19.4 11.6 11.6 19.1 10.6 9.8 4.7 10.6 7.6 15.3 6.8 7.7 4.6 7.9 10.8 4.9 14.1 10.9 7.8 9.6 10.1 7.4 15.4 3.5 2.9 4.2 3.3 4.6 2.7 2.9 3.3 3.5 4.4 2.8 3.6 5.0 4.9 3.4 4.2 2.1 3.5 9.2 9.4 9.2 12.8 9.8 9.3 12.8 10.8 8.7 12.6 9.3 9.9 12.3 5.1 3.2 8.3 89.5 9.6 2.3 4.7 3.1 5.7 14.2 5.5 4.1 13.9 5.7 5.3 11.0 20.9 10.9 5.4 15.2 9.8 6.5 47.9 8.4 3.7 6.5 30.5 3.4 121.8 6.2 4.4 5.3 29.6 10.2 8.8 7.9 4.6 9.2 7.5 28.6 136.3 14.4 10.2 10.5 3.7 119.0 5.9 10.3 10.6 105.9 5.3 13.6 11.3 93.5 170.6 5.1 6.6 7.9 11.0 3.7 13.4 19.9 15.7 13.7 6.6 9.0 5.3 3.6 6.6 8.7 3.0 14.6 10.5 8.6 12.0 5.4 KIR3DL1 "AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B" ENSG00000167633 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1" P43629 19 54816468-54830778 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.6" "Cell type enhanced" "Detected in some" "dendritic cells: 18.8;NK-cells: 9.2;T-cells: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Not detected" "Not detected" NA NA "unprognostic (3.18e-1)" "unprognostic (8.01e-2)" "unprognostic (3.53e-2)" "unprognostic (4.85e-1)" "unprognostic (5.18e-3)" "unprognostic (6.19e-2)" "unprognostic (4.37e-2)" "unprognostic (9.97e-2)" "unprognostic (1.89e-2)" "unprognostic (3.28e-1)" "unprognostic (7.34e-2)" "unprognostic (2.07e-3)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.73e-1)" "unprognostic (2.19e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 NLRP7 "CLR19.4, NALP7, NOD12, PAN7, PYPAF3" ENSG00000167634 "NLR family pyrin domain containing 7" Q8WX94 19 54923509-54966312 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Cell type enhanced" "Detected in some" "dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6" "Cancer enriched" "Detected in many" 30 "testis cancer: 146.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0" HPA051382 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA051382: AB_2681461" "unprognostic (2.15e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-3)" "unprognostic (1.24e-2)" "unprognostic (5.29e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.34e-1)" "unprognostic (3.25e-8)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 8.2 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.6 0.0 0.0 1.9 0.3 0.0 0.0 0.6 ZNF146 OZF ENSG00000167635 "Zinc finger protein 146" Q15072 19 36214602-36238771 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003358 Supported Supported Nucleoli NA NA Nucleoli "HPA003358: AB_1080674" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (5.35e-3)" "unprognostic (2.11e-3)" "unprognostic (1.82e-2)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" "unprognostic (3.95e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-2)" "unprognostic (1.92e-1)" 24.3 21.3 25.1 25.8 32.8 12.6 42.0 28.6 33.0 34.0 24.2 27.1 23.4 37.4 22.1 24.9 28.4 22.6 23.8 24.7 29.2 26.3 32.7 23.6 35.5 31.7 34.2 23.3 40.9 22.9 33.7 28.5 32.6 36.3 30.8 31.8 31.5 24.6 26.7 46.7 27.3 21.9 32.9 29.0 27.2 25.5 12.2 31.5 40.0 34.2 46.8 37.9 34.7 23.4 39.4 70.2 96.0 79.8 77.1 57.8 64.5 42.5 60.2 55.4 57.1 56.2 43.5 49.6 67.7 94.6 56.0 37.4 31.8 102.6 70.5 102.3 105.5 57.2 113.0 37.4 52.7 67.4 180.1 74.9 52.8 106.5 55.1 156.0 60.0 71.7 72.6 122.2 72.3 69.4 45.9 84.1 42.2 108.1 122.2 57.7 96.1 80.3 58.2 69.4 67.7 100.7 63.5 74.7 93.0 66.1 81.6 41.5 90.9 55.0 64.0 76.8 50.6 107.1 50.2 63.7 95.2 44.9 88.0 83.1 7.9 11.2 8.7 15.8 13.8 22.7 19.1 18.1 16.0 13.6 17.4 23.2 21.4 2.6 14.9 22.4 6.9 16.8 14.9 25.1 32.8 28.6 33.0 24.7 29.2 31.7 34.2 23.3 36.3 29.0 31.5 39.4 21.4 44.8 29.0 21.5 29.7 23.6 30.8 20.5 22.8 10.8 26.7 22.1 45.4 21.5 28.4 20.2 10.4 34.3 26.3 11.6 35.2 27.7 18.3 16.7 35.5 22.8 14.5 25.0 29.2 18.0 48.7 26.9 16.3 23.6 20.8 28.5 20.3 20.8 18.9 11.8 33.4 24.6 14.2 17.8 14.0 20.9 25.1 15.5 10.6 19.7 18.8 9.0 28.8 37.2 121.1 25.0 13.7 19.2 18.6 38.1 9.0 21.2 23.7 10.3 6.6 30.2 29.6 13.0 10.7 24.5 29.8 23.5 29.9 20.0 26.4 29.6 ZNF283 ENSG00000167637 "Zinc finger protein 283" Q8N7M2 19 43827321-43852017 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Oligodendrocytes: 20.4;Rod photoreceptor cells: 42.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 22.4" "Low region specificity" "Detected in all" HPA072977 Approved Nucleoplasm NA NA Nucleoplasm "HPA072977: AB_2686563" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-2)" "unprognostic (1.54e-1)" "unprognostic (5.42e-2)" "unprognostic (1.05e-3)" "unprognostic (6.49e-2)" "unprognostic (8.47e-2)" "unprognostic (3.08e-2)" "unprognostic (3.84e-1)" "unprognostic (1.16e-2)" "unprognostic (8.18e-3)" "unprognostic (4.93e-2)" "unprognostic (1.92e-1)" "unprognostic (6.88e-2)" "unprognostic (1.26e-1)" "unprognostic (4.63e-2)" 2.4 2.9 2.6 2.1 3.8 0.8 4.8 6.9 3.2 2.7 1.3 2.7 2.9 3.4 4.3 2.9 3.4 2.9 4.1 3.2 2.7 2.3 1.9 2.0 2.8 3.3 2.9 2.4 4.9 2.1 4.4 4.0 3.2 3.7 3.6 3.6 8.4 3.3 2.8 2.2 4.5 3.2 2.9 1.6 3.2 3.5 1.8 2.9 2.7 3.9 4.7 3.1 2.4 2.9 6.2 6.4 3.7 4.5 9.0 4.4 6.8 3.8 3.8 5.4 4.5 6.4 3.8 3.2 0.0 3.1 5.6 5.2 5.6 6.5 4.8 6.7 1.4 7.5 6.6 9.6 2.6 3.5 3.3 3.7 5.7 6.6 5.5 4.6 5.7 4.5 1.9 6.8 1.5 5.8 2.5 2.1 2.5 4.4 3.3 2.9 0.0 3.5 1.9 3.7 9.0 5.4 7.1 7.2 4.9 3.7 4.5 2.7 5.6 3.8 6.1 22.4 3.5 4.9 5.0 4.9 0.3 3.0 0.3 4.9 2.2 0.9 0.9 1.4 1.1 1.9 1.1 1.7 0.9 0.8 0.8 1.8 1.0 0.9 1.2 0.9 0.6 1.8 0.6 2.6 3.8 6.9 3.2 3.2 2.7 3.3 2.9 2.4 3.7 1.6 2.9 6.2 4.0 9.6 14.1 9.1 2.5 2.4 2.5 1.2 4.0 9.3 3.3 2.2 5.0 1.5 6.3 0.0 22.9 2.9 2.0 2.3 7.9 2.8 1.4 2.5 5.1 4.0 6.0 2.1 14.1 1.8 2.3 5.6 3.1 2.8 3.8 5.6 6.4 1.0 2.4 6.7 14.3 4.1 4.1 1.9 1.4 0.7 2.5 3.0 1.8 5.6 4.6 3.4 2.1 14.6 20.4 2.5 4.8 3.4 2.4 2.5 2.9 1.5 2.5 42.7 0.0 5.7 4.8 2.9 3.6 3.8 1.6 2.9 2.5 5.9 4.0 2.6 PPP1R14A "CPI-17, PPP1INL" ENSG00000167641 "Protein phosphatase 1 regulatory inhibitor subunit 14A" Q96A00 19 38251237-38256532 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 464.6" "Cell type enhanced" "Detected in many" "Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9" "Group enriched" "Detected in many" 24 "B-cells: 299.4;dendritic cells: 246.9" "Group enriched" "Detected in some" 4 "A549: 164.1;EFO-21: 112.2;K-562: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005044, CAB009803, HPA042097, HPA054534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 880000 Nucleoplasm "Nuclear bodies" "CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518" "unprognostic (5.40e-2)" "unprognostic (4.00e-3)" "unprognostic (4.02e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-1)" "unprognostic (8.92e-3)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.25e-5)" "prognostic unfavorable (7.12e-4)" "unprognostic (4.13e-1)" "unprognostic (5.81e-2)" "unprognostic (2.22e-2)" 127.6 145.3 165.3 22.3 295.3 2.9 112.9 283.9 222.3 145.7 69.2 314.7 18.8 275.8 5.2 47.9 155.0 14.9 72.9 143.4 250.1 52.8 18.0 164.5 2.6 347.4 300.4 95.2 126.1 31.4 2.8 12.7 34.4 353.1 143.2 12.7 0.3 19.2 86.9 27.7 24.5 82.8 57.7 222.8 102.0 141.5 78.2 259.9 1.8 26.0 12.4 1.4 304.1 107.0 464.6 0.0 164.1 0.4 0.0 1.0 0.0 6.1 10.8 0.0 0.1 0.0 12.8 0.2 0.0 112.2 1.0 0.0 0.5 13.6 0.2 0.0 1.4 0.0 25.5 0.0 0.0 4.6 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 64.5 0.3 0.0 0.8 0.0 0.3 4.9 0.0 0.0 0.2 2.4 0.4 0.4 0.0 3.5 0.2 0.0 0.0 0.1 9.2 0.0 0.4 0.4 0.0 0.8 0.4 0.0 0.4 0.0 0.5 0.2 0.0 0.1 11.3 0.6 1.2 0.1 0.7 0.2 299.4 0.2 0.4 44.3 283.9 0.6 0.1 1.7 8.7 0.2 246.9 0.2 21.6 165.3 295.3 283.9 222.3 143.4 250.1 347.4 300.4 95.2 353.1 222.8 259.9 464.6 332.5 0.0 1.1 1.3 29.9 9.6 3.0 1.2 3.4 0.4 8.8 209.8 19.6 2.8 0.7 0.0 0.0 48.3 48.7 32.7 0.0 0.7 14.1 15.4 239.5 108.5 1.8 34.7 0.5 10.9 7.4 66.8 2.0 10.8 3.8 435.0 224.5 2.3 9.5 0.0 0.6 0.4 0.0 5.6 24.6 42.1 341.1 41.4 8.8 14.0 66.1 0.5 4.1 3.5 155.6 2.2 2.6 656.0 4.8 2.4 3.8 0.3 0.0 1.6 979.5 8.7 465.2 9.9 46.2 0.6 8.0 26.4 3.7 66.0 0.4 1.2 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292615 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" No NA "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favorable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 10.6 45.0 57.0 65.9 60.1 81.9 180.3 49.6 66.8 146.8 77.3 299.8 249.7 45.0 272.0 354.7 191.4 106.1 13.7 60.7 82.5 207.3 14.4 139.5 37.7 54.7 57.3 59.3 84.1 236.1 255.0 439.3 157.7 56.1 183.4 254.1 23.8 508.3 112.3 1.8 246.0 269.3 19.2 49.4 50.6 221.4 217.4 68.5 83.4 324.3 0.9 102.2 141.5 158.9 61.8 852.5 603.0 3.0 3.4 0.4 0.0 387.4 16.2 1.7 1.2 2.6 426.8 1219.1 6.7 65.8 4.6 1.2 274.6 42.7 587.0 1.4 7.9 51.7 159.4 15.3 0.9 0.9 1.5 0.8 0.1 662.5 0.7 278.6 71.5 2.0 144.2 4.0 0.4 1.0 652.8 25.6 2.8 60.4 1500.4 172.1 87.9 0.6 386.2 896.7 707.4 222.2 3.4 246.5 789.2 2.1 231.0 353.7 104.5 0.7 1.2 4.7 3.4 3.2 56.1 76.4 47.6 1.0 11.2 1.0 515.9 127.4 531.9 3.8 91.1 7.9 143.2 44.2 21.5 297.7 160.4 86.1 80.4 56.4 19.0 64.4 523.5 19.1 142.8 57.0 60.1 49.6 66.8 60.7 82.5 54.7 57.3 59.3 56.1 49.4 68.5 61.8 8.0 368.6 233.9 10.4 90.9 376.9 563.9 954.0 278.9 14.3 487.2 518.2 2.8 316.0 655.6 559.1 6.2 1371.3 79.5 1028.3 101.8 866.9 61.8 401.4 47.3 24.3 360.5 83.9 20.7 659.8 502.0 34.6 234.5 490.4 115.5 371.8 32.5 2.0 230.3 3.3 39.8 672.8 734.5 55.5 139.0 55.6 19.0 133.6 88.9 24.4 364.3 129.6 1.0 4.5 9.0 910.4 889.4 17.0 61.3 684.9 918.6 208.8 495.1 17.2 52.6 1.2 76.7 545.2 264.1 507.7 428.3 1413.2 42.6 3.4 582.2 989.6 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304164-38305006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 519.5;skin 1: 332.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "myeloid DC: 22.2" "Lineage enriched" "Detected in many" 10 "dendritic cells: 22.2" "Cell line enhanced" "Detected in many" "A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8" "Not detected" "Not detected" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 460000 Nucleoplasm "Plasma membrane, Cytosol" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 24.1 5.0 2.4 17.7 2.4 3.6 25.8 2.6 4.4 50.7 4.3 189.2 188.4 6.1 0.6 519.5 92.2 50.0 18.8 2.0 2.3 28.3 1.3 92.1 0.9 2.9 2.7 2.0 4.7 8.9 0.5 12.8 8.0 2.6 26.4 105.1 0.1 124.3 18.4 3.9 332.3 191.1 4.1 2.3 10.8 152.9 1.5 3.0 4.1 19.1 4.3 31.1 103.1 226.2 2.8 745.5 1228.0 0.0 0.6 0.0 0.0 1.2 1.0 0.0 0.0 0.0 77.1 767.1 0.0 394.2 0.0 0.7 300.1 0.0 744.6 0.0 0.4 0.5 0.4 244.2 20.0 5.4 0.0 0.2 0.0 799.2 0.3 493.3 3.3 10.2 0.9 0.4 0.5 0.8 220.4 0.1 1.9 0.4 678.3 659.8 0.2 0.2 2.8 469.5 255.2 0.8 0.8 416.6 340.8 0.8 1.6 103.7 2.3 141.6 0.5 201.9 0.7 2.8 0.7 2.4 3.7 0.1 0.2 0.2 2.1 0.6 2.2 0.2 0.0 0.4 0.1 0.5 0.1 22.2 1.4 0.7 0.3 1.0 0.4 0.1 1.8 0.0 18.2 2.4 2.4 2.6 4.4 2.0 2.3 2.9 2.7 2.0 2.6 2.3 3.0 2.8 29.1 535.2 172.9 0.0 5.4 225.3 28.4 508.7 436.5 0.0 32.5 25.5 2.4 267.4 418.0 55.2 0.0 8.6 1.7 2060.3 1.9 207.7 0.7 144.3 26.0 18.4 76.1 3.6 0.1 753.8 1.3 44.7 353.7 273.2 38.2 3.7 3.6 0.4 1.3 0.0 0.0 842.0 99.7 1.4 15.1 5.1 4.1 32.9 1.8 0.0 4.9 0.0 0.0 0.0 0.0 2590.4 1697.3 0.0 5.7 35.7 1756.4 51.7 212.5 0.0 0.0 0.4 14.3 1.8 1.9 629.0 348.4 3.1 7.9 0.0 691.9 188.4 YIF1B FinGER8 ENSG00000167645 "Yip1 interacting factor homolog B, membrane trafficking protein" Q5BJH7 19 38303558-38317273 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039328, HPA055257, HPA062675" Approved Approved "Golgi apparatus,Vesicles" NA NA 37000 Vesicles "Golgi apparatus" "HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830" "unprognostic (2.51e-1)" "unprognostic (3.34e-1)" "unprognostic (1.38e-1)" "unprognostic (6.81e-2)" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.37e-1)" "unprognostic (1.45e-2)" "unprognostic (5.53e-2)" "prognostic favorable (1.88e-4)" "unprognostic (4.57e-2)" "unprognostic (2.40e-2)" "unprognostic (3.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.64e-1)" "unprognostic (3.94e-3)" 27.4 30.9 27.1 33.3 29.2 69.7 26.9 34.0 38.6 32.0 25.3 26.8 20.6 24.3 11.0 33.5 25.8 16.7 33.9 27.8 29.0 27.2 58.8 36.0 32.3 32.9 29.2 26.8 26.9 27.3 17.1 29.3 23.7 35.9 23.9 16.3 13.7 30.4 12.6 35.3 25.0 24.2 18.3 30.7 48.0 22.2 23.3 31.1 21.1 20.0 26.9 21.0 27.1 25.8 35.5 43.7 108.9 48.3 57.5 68.4 63.5 37.8 103.2 79.0 75.7 110.7 53.5 32.6 75.7 44.4 121.1 81.5 27.4 85.9 54.6 28.7 81.1 43.3 117.0 48.2 56.5 94.8 82.4 132.9 52.3 47.9 78.0 33.8 76.1 71.3 99.4 152.9 205.3 68.5 46.0 87.6 98.9 37.0 74.9 33.7 89.0 58.6 117.9 48.9 40.6 34.8 58.1 34.5 76.7 55.4 37.2 29.9 163.2 68.8 74.6 73.2 108.4 83.9 76.4 122.1 51.8 96.1 150.5 54.6 81.9 155.7 179.0 60.8 119.4 54.4 49.3 57.3 54.8 300.3 42.7 46.7 47.5 42.8 44.0 70.8 127.0 59.0 120.2 27.1 29.2 34.0 38.6 27.8 29.0 32.9 29.2 26.8 35.9 30.7 31.1 35.5 27.4 0.0 5.5 5.5 22.8 17.7 19.4 25.8 18.2 12.2 22.6 18.7 4.7 18.6 14.2 22.0 12.5 44.7 17.0 16.0 0.0 39.4 6.3 17.5 18.2 23.9 14.4 33.2 7.3 27.7 52.9 23.8 16.3 18.6 22.9 43.4 37.1 30.5 94.4 11.8 7.4 24.7 32.6 42.3 37.4 8.5 9.0 53.3 35.6 3.7 34.4 20.8 16.5 4.0 12.7 15.5 13.5 9.1 69.4 14.8 8.1 16.1 20.7 15.5 6.6 11.1 40.3 20.6 31.9 30.7 20.0 27.6 18.8 26.2 25.9 19.5 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" Q8N9W5 19 55158661-55166722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "fallopian tube: 41.1;testis: 65.9" "Group enriched" "Detected in many" 5 "Early spermatids: 395.2;Late spermatids: 722.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 26.2;HEL: 31.6;K-562: 25.3;U-937: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056220 Approved "Nuclear bodies,Mitochondria" No No Mitochondria "Nuclear bodies" "HPA056220: AB_2683071" "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.2 1.8 3.4 0.0 1.2 0.0 0.6 2.2 1.2 2.0 5.0 0.3 0.1 0.9 3.4 0.6 41.1 0.6 5.0 0.9 2.8 2.1 0.6 4.4 0.1 3.1 4.0 0.3 0.2 1.6 3.5 0.7 0.1 4.4 0.3 0.1 0.4 0.4 0.9 0.1 0.8 0.3 0.2 4.1 0.3 0.4 65.9 1.5 0.5 2.3 0.0 0.1 0.1 0.4 2.0 8.8 6.6 0.6 6.7 0.1 0.0 0.6 0.1 0.2 1.0 0.7 0.3 4.0 10.5 2.5 0.3 1.9 10.1 1.5 3.0 0.4 0.0 26.2 31.6 0.5 0.5 0.2 13.6 3.1 0.2 4.0 1.7 2.2 0.9 0.5 4.7 25.3 13.9 0.4 5.9 0.4 0.3 0.5 9.5 15.0 16.5 1.0 3.2 5.4 0.2 0.8 2.6 1.1 1.1 1.6 0.2 8.3 0.4 1.0 0.8 3.9 4.0 0.2 0.4 2.5 0.6 4.9 18.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 1.2 2.2 1.2 0.9 2.8 3.1 4.0 0.3 4.4 4.1 1.5 2.0 0.2 0.0 0.5 0.0 0.0 3.2 0.0 4.7 4.6 0.0 1.1 0.6 3.0 1.5 7.5 7.3 0.0 0.0 0.0 0.3 7.9 2.7 395.2 55.8 0.5 0.6 0.0 0.0 0.5 1.0 0.1 1.2 0.0 1.3 0.0 1.9 0.7 0.4 0.2 0.0 0.5 0.5 12.2 0.0 0.4 722.0 4.4 4.2 0.0 0.0 0.0 2.1 0.0 0.5 0.1 0.2 0.1 3.0 0.0 0.1 0.0 5.1 75.2 0.0 0.0 0.0 2.3 104.8 18.6 0.3 1.3 0.0 0.1 1.1 0.4 0.2 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682725 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "stomach 1: 3043.6" "Cell type enriched" "Detected in many" 4 "Gastric mucus-secreting cells: 5332.3" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "spinal cord: 38.2" "HPA030783, HPA056418" Approved Supported "Plasma membrane" NA NA 18000 "Plasma membrane" "HPA030783: AB_2673611, HPA056418: AB_2683123" "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 2.7 0.4 0.4 0.5 0.4 0.2 1.9 0.2 0.9 33.4 0.1 5.0 4.0 0.4 0.6 336.7 8.0 10.1 0.3 0.5 0.2 5.7 0.7 6.4 0.1 0.4 0.2 0.3 0.6 3.2 0.0 0.6 2.4 0.4 232.6 4.8 0.0 23.6 2.0 0.3 10.2 2.5 0.1 0.1 0.4 3043.6 1.4 0.3 0.4 0.4 0.0 15.2 634.3 169.1 0.4 10.7 0.7 0.0 0.0 2.1 6.8 10.6 4.9 1.1 2.1 1.8 0.1 22.4 0.0 0.4 0.4 8.1 2.1 0.0 0.4 1.3 0.6 0.0 0.0 45.7 0.0 0.1 0.0 1.5 6.0 7.8 4.6 0.0 0.6 0.0 0.0 0.0 0.0 1.7 5.8 1.7 0.6 1.2 17.6 1.2 0.7 0.0 0.9 1.0 61.7 0.2 0.5 5.1 15.6 3.5 0.3 0.2 0.2 1.0 1.5 1.7 2.7 0.0 1.9 0.1 0.0 2.9 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.9 0.5 0.2 0.4 0.2 0.3 0.4 0.1 0.3 0.4 0.2 3.2 1.5 1.6 7.7 0.9 26.0 120.0 0.0 0.0 3.9 2.7 1.2 71.4 894.2 1.8 0.0 2.3 0.0 1.9 7.9 3.2 0.3 1.3 0.1 1.1 275.1 0.0 0.3 1.2 5.0 3.3 5332.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.2 12.9 179.0 0.6 1.0 0.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 57.1 0.2 0.0 13.4 238.7 0.3 0.4 994.9 0.0 0.0 0.0 48.9 0.0 0.5 13.1 1.3 28.5 4.6 0.0 0.9 1241.5 ATCAY BNIP-H ENSG00000167654 "ATCAY kinesin light chain interacting caytaxin" Q86WG3 19 3879864-3928082 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Neurogenesis, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 46.8;pituitary gland: 25.8;retina: 17.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 128.5;Excitatory neurons: 67.0;Horizontal cells: 47.1;Inhibitory neurons: 82.2;Oligodendrocyte precursor cells: 94.0" "Cancer enriched" "Detected in some" 8 "glioma: 15.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 7.3;SCLC-21H: 13.2;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017755 Enhanced NA NA "HPA017755: AB_2669655" "unprognostic (7.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.63e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" "unprognostic (3.05e-2)" "unprognostic (4.89e-2)" "unprognostic (9.83e-4)" "unprognostic (7.22e-2)" "unprognostic (8.78e-3)" "unprognostic (1.78e-1)" "unprognostic (1.36e-1)" "unprognostic (1.24e-2)" "unprognostic (2.67e-1)" 0.1 6.9 21.9 0.6 34.5 0.3 0.0 0.2 46.8 0.6 0.0 0.9 0.5 0.1 0.1 0.2 0.0 0.2 0.1 26.3 25.1 0.1 0.0 0.1 0.2 17.0 11.6 34.9 0.1 0.3 0.0 25.8 0.1 27.7 1.8 0.3 17.8 0.1 3.2 1.2 0.3 0.6 0.2 1.5 0.1 0.4 0.2 12.1 0.0 0.1 0.0 0.0 0.1 0.6 30.8 0.5 0.1 2.7 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.6 0.5 0.2 0.0 1.5 0.4 0.2 0.0 0.0 0.2 0.2 0.8 1.1 0.2 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.5 0.1 0.2 0.2 0.4 7.3 0.1 0.1 0.2 0.4 0.2 0.1 0.2 13.2 9.3 0.2 0.2 0.1 1.2 0.2 0.2 0.5 0.3 0.6 0.4 0.7 0.3 0.3 0.2 0.3 1.3 0.2 0.6 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.3 0.1 0.1 0.1 0.1 21.9 34.5 0.2 46.8 26.3 25.1 17.0 11.6 34.9 27.7 1.5 12.1 30.8 0.2 0.0 3.4 3.3 0.6 0.6 0.8 0.0 0.0 128.5 0.2 0.1 1.9 2.8 0.0 0.0 22.9 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.9 0.7 0.0 0.0 67.0 0.0 0.2 1.1 0.0 0.8 7.0 0.1 0.7 0.1 0.1 47.1 82.2 0.2 0.0 0.6 2.6 0.0 0.0 0.5 3.6 5.6 0.1 5.4 2.1 94.0 3.9 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 18.7 0.0 1.9 0.7 0.7 1.7 0.0 0.4 0.0 0.6 0.0 0.1 0.4 LY6D E48 ENSG00000167656 "Lymphocyte antigen 6 family member D" Q14210 8 142784882-142786539 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 2091.0;skin 1: 855.3;vagina: 495.3" "Group enriched" "Detected in many" 9 "Basal keratinocytes: 1171.6;Squamous epithelial cells: 1913.0;Suprabasal keratinocytes: 3866.1" "Group enriched" "Detected in many" 7 "cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "A-431: 162.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024755, HPA064317" Enhanced NA NA 210000 "HPA024755: AB_1853410, HPA064317: AB_2685244" "unprognostic (2.13e-2)" "unprognostic (7.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-2)" "unprognostic (8.97e-2)" "unprognostic (1.51e-2)" "unprognostic (3.84e-1)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (8.68e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.50e-1)" "unprognostic (3.97e-1)" "unprognostic (5.40e-4)" "unprognostic (1.06e-1)" 1.1 48.0 0.4 0.2 0.5 0.0 20.7 0.4 1.4 143.5 0.4 0.9 0.0 0.3 0.0 2091.0 1.0 1.4 0.7 0.6 0.4 0.3 0.8 0.5 0.0 0.4 0.4 0.4 0.5 1.0 0.0 1.0 2.6 0.5 15.4 0.2 0.0 237.3 0.3 2.6 855.3 0.5 0.0 0.4 0.5 12.5 0.4 0.4 4.7 0.4 0.0 76.2 65.7 495.3 0.6 162.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 6.0 0.0 1.3 0.0 0.2 0.0 0.0 4.0 11.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 1.2 4.0 0.2 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 1.4 0.6 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.1 3.2 0.0 0.0 0.0 1171.6 9.4 244.9 138.3 0.0 14.8 14.1 0.2 0.0 154.0 1.8 0.0 0.9 0.1 0.4 1.9 1.1 0.0 0.4 0.1 10.7 0.0 0.0 0.3 0.2 5.7 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 22.4 0.0 137.3 0.0 0.0 0.8 163.7 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.0 2.5 18.9 0.0 1.2 12.2 0.0 0.0 0.6 16.1 0.0 0.0 1913.0 3866.1 8.2 4.0 0.0 0.4 164.6 DAPK3 "ZIP, ZIPK" ENSG00000167657 "Death associated protein kinase 3" O43293 19 3958453-3971123 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Translation regulation" "Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028569 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028569: AB_10794319" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.34e-3)" "prognostic favorable (2.01e-5)" "unprognostic (1.83e-1)" "unprognostic (2.37e-1)" "unprognostic (7.72e-3)" "unprognostic (2.16e-1)" "unprognostic (2.46e-2)" "unprognostic (4.95e-2)" "unprognostic (1.84e-3)" "unprognostic (7.64e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" 47.8 25.6 13.3 29.2 12.9 19.0 47.6 13.2 25.4 56.2 16.2 75.6 31.2 85.7 8.3 37.3 55.9 36.3 102.4 15.2 12.0 27.7 30.7 73.1 21.4 14.8 13.0 13.8 48.8 36.7 19.1 38.8 32.2 17.6 53.8 11.1 9.0 41.7 39.7 114.5 48.5 44.8 36.9 10.3 29.8 61.9 42.9 19.3 15.5 31.2 21.3 11.4 60.0 45.7 15.6 79.2 61.1 37.5 47.6 27.5 30.9 57.8 106.0 84.5 84.7 55.5 113.4 23.3 43.4 50.8 93.8 59.6 61.7 36.9 60.3 30.7 64.0 61.2 17.5 76.7 65.9 87.2 42.7 63.1 70.6 73.6 77.0 44.0 50.8 71.2 29.2 56.3 73.2 52.5 51.0 42.4 31.9 58.5 31.8 48.6 52.5 55.3 40.5 51.0 60.9 59.1 41.1 71.4 84.9 61.1 43.8 61.4 33.1 134.8 108.3 49.3 98.1 134.5 81.1 72.4 50.7 86.3 44.0 59.0 32.5 18.0 32.5 23.0 20.3 16.7 15.9 17.8 21.6 16.2 16.6 13.1 12.9 29.8 24.3 14.3 18.6 23.6 14.6 13.3 12.9 13.2 25.4 15.2 12.0 14.8 13.0 13.8 17.6 10.3 19.3 15.6 24.1 25.6 10.5 6.5 17.0 100.7 99.7 84.1 27.9 15.2 23.9 15.6 29.2 24.3 35.0 11.0 2.1 50.5 14.5 69.2 17.6 90.3 40.3 27.9 28.2 38.3 27.4 7.0 9.6 88.2 79.1 27.8 40.8 37.5 20.3 24.8 21.4 7.9 22.9 11.8 7.1 48.2 48.8 13.6 22.8 23.6 22.7 16.6 37.4 8.4 25.7 12.8 30.9 6.0 6.7 117.7 49.9 22.6 13.3 46.1 59.6 14.3 18.8 10.7 32.9 19.9 53.0 34.6 15.7 24.4 71.7 93.2 15.1 26.2 29.7 46.3 EEF2 "EEF-2, EF2" ENSG00000167658 "Eukaryotic translation elongation factor 2" P13639 19 3976056-3985463 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007795, HPA040534, HPA057351" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 17000000 "Plasma membrane, Cytosol" "CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417" "unprognostic (5.47e-2)" "unprognostic (9.59e-2)" "unprognostic (3.75e-1)" "prognostic favorable (1.81e-6)" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.11e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.25e-5)" "unprognostic (4.46e-2)" "unprognostic (5.60e-2)" "unprognostic (6.82e-2)" "unprognostic (9.86e-2)" 973.6 1045.5 776.0 511.9 770.3 928.2 954.8 754.8 1068.1 953.6 834.7 1012.7 828.8 895.0 568.6 1070.9 864.8 505.7 1247.0 767.6 748.4 843.0 1162.4 672.7 691.0 789.3 778.3 727.9 1641.3 3220.8 498.1 844.5 389.4 801.0 826.2 347.8 226.6 1287.4 504.9 2341.7 1120.6 805.6 388.9 791.5 727.4 1277.0 494.4 774.7 546.0 800.2 1122.3 503.2 935.6 804.4 753.8 1456.8 1018.4 579.3 1539.4 1515.6 2706.7 830.9 1110.4 1479.8 1036.7 1012.7 1618.1 652.7 3000.6 644.1 1032.3 461.1 1069.8 919.4 1719.4 544.2 755.0 1533.0 768.5 919.9 1677.0 2204.8 1668.0 1277.6 3515.5 1777.2 916.0 1404.1 1497.5 1086.6 1434.4 1526.7 2145.4 642.1 2095.7 1510.1 1266.3 1537.0 518.3 1015.7 1654.2 860.3 1938.3 871.2 1270.2 1575.4 1466.4 699.0 1377.1 2058.3 543.1 1344.7 1992.7 1321.8 738.2 765.7 1521.4 1738.7 2276.4 1644.3 1485.3 1100.4 2065.8 986.6 81.2 455.7 64.1 259.8 333.1 460.2 578.5 453.0 344.6 430.7 478.1 497.2 404.1 43.1 355.3 342.1 358.7 429.4 756.5 776.0 770.3 754.8 1068.1 767.6 748.4 789.3 778.3 727.9 801.0 791.5 774.7 753.8 323.1 221.2 392.2 24.5 1125.5 1321.1 1071.3 754.3 1269.7 212.6 981.3 694.3 627.9 597.7 448.3 255.6 77.2 958.1 535.9 556.9 986.1 716.0 799.2 318.2 675.4 568.2 744.2 934.8 23.2 1816.8 1305.0 679.7 619.3 428.5 373.4 596.1 656.8 690.6 610.1 203.6 28.9 982.1 411.0 885.4 859.5 1195.6 1008.4 514.2 645.7 36.5 907.5 429.1 614.8 27.2 42.2 868.2 815.5 832.8 992.8 1010.5 1562.7 1078.8 194.5 134.1 585.1 797.7 697.3 371.5 308.4 1343.0 1347.1 1243.1 727.1 1044.3 1168.4 1051.6 TMIGD2 "CD28H, IGPR-1, MGC23244" ENSG00000167664 "Transmembrane and immunoglobulin domain containing 2" Q96BF3 19 4292232-4302431 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 35.6" "Group enriched" "Detected in some" 4 "dendritic cells: 49.9;NK-cells: 104.0;T-cells: 45.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 114.3" "Group enriched" "Detected in many" 38 "dendritic cells: 109.4;NK-cells: 89.8;T-cells: 114.3" "Group enriched" "Detected in some" 4 "BEWO: 12.4;HEL: 30.0;MOLT-4: 27.2" "Low region specificity" "Detected in single" HPA011081 Approved NA NA "HPA011081: AB_1079372" "unprognostic (1.08e-3)" "unprognostic (6.55e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-4)" "unprognostic (4.31e-2)" "unprognostic (8.68e-3)" "unprognostic (7.78e-3)" "unprognostic (2.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.28e-1)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" "unprognostic (7.10e-5)" "unprognostic (2.62e-2)" "unprognostic (4.54e-1)" "unprognostic (5.12e-4)" "unprognostic (8.89e-4)" 0.3 0.2 1.2 4.3 1.1 4.8 0.2 1.1 1.7 0.1 0.5 1.4 1.4 0.5 0.0 0.5 0.4 0.7 0.1 1.3 1.7 0.2 0.8 0.9 6.5 1.7 1.4 0.9 0.0 0.1 0.0 0.1 0.4 1.5 0.3 0.5 0.1 0.2 0.1 0.1 0.2 4.2 0.1 1.2 6.5 0.8 0.6 1.3 35.6 0.2 0.1 3.4 0.6 0.3 2.0 0.0 0.1 0.3 0.3 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 30.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 27.2 0.0 0.1 0.0 0.0 5.2 1.4 0.0 0.0 0.2 0.1 3.3 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.8 9.0 0.1 114.3 0.2 15.0 22.5 0.4 0.3 82.9 43.2 2.7 89.8 0.5 109.4 1.3 23.3 1.2 1.1 1.1 1.7 1.3 1.7 1.7 1.4 0.9 1.5 1.2 1.3 2.0 0.3 0.0 0.6 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.5 0.0 0.0 0.0 1.8 49.9 0.1 0.0 0.1 0.0 0.2 0.3 0.2 0.0 14.9 0.2 0.0 0.5 1.2 7.1 0.2 1.3 0.4 1.4 0.6 0.3 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 1.7 1.8 3.7 1.6 0.0 104.0 0.0 0.1 0.0 0.0 0.4 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.1 0.8 45.4 0.0 0.0 0.2 CHAF1A "CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150" ENSG00000167670 "Chromatin assembly factor 1 subunit A" Q13111 19 4402640-4445018 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 50.3;Spermatocytes: 94.3;Spermatogonia: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 4 "dendritic cells: 15.7;granulocytes: 4.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB015186 Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB015186: AB_628065" "unprognostic (1.91e-1)" "prognostic favorable (8.22e-5)" "unprognostic (2.49e-1)" "unprognostic (4.71e-2)" "unprognostic (2.06e-1)" "unprognostic (1.89e-3)" "unprognostic (5.30e-3)" "unprognostic (8.78e-2)" "unprognostic (2.06e-2)" "unprognostic (2.12e-2)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.54e-2)" "prognostic favorable (4.15e-6)" "unprognostic (1.71e-1)" "unprognostic (2.11e-3)" "unprognostic (4.03e-2)" 4.6 4.4 4.3 9.8 3.2 31.7 4.9 5.1 6.7 3.9 1.5 6.9 6.5 3.9 2.1 10.3 4.1 2.7 3.7 3.9 2.4 2.4 4.1 4.1 13.5 3.6 3.7 2.7 3.8 3.9 3.3 3.7 6.2 4.7 5.9 6.7 3.5 5.6 3.0 12.4 10.8 6.7 4.1 2.6 7.0 5.2 14.6 3.0 16.5 2.9 4.2 10.6 4.8 5.7 4.7 65.8 44.0 71.8 45.3 7.0 8.5 36.7 61.2 24.8 50.5 56.7 53.5 22.8 100.4 24.7 19.6 28.6 50.3 61.6 41.5 59.8 58.1 67.2 62.9 69.4 42.7 3.5 73.7 48.8 4.8 8.6 41.5 17.7 9.4 24.0 54.9 76.8 88.0 31.3 37.8 119.2 40.7 80.1 33.5 35.6 87.2 56.8 57.2 13.1 76.7 50.6 39.2 41.6 29.1 24.5 45.2 25.7 53.9 17.5 41.3 35.9 71.1 74.9 43.7 71.0 96.3 34.7 92.8 49.9 3.8 2.3 4.7 0.5 2.3 0.4 1.6 0.6 0.1 2.1 1.0 0.5 0.4 1.2 1.2 0.4 15.7 0.9 0.9 4.3 3.2 5.1 6.7 3.9 2.4 3.6 3.7 2.7 4.7 2.6 3.0 4.7 2.3 0.0 3.9 2.0 12.5 9.7 4.6 3.5 6.2 12.1 5.1 3.6 5.7 1.5 2.6 5.5 2.1 25.3 17.3 13.9 1.9 8.5 6.7 5.3 4.2 4.6 1.8 50.3 4.1 6.7 37.9 6.1 10.7 6.5 2.5 19.3 3.3 4.8 12.1 1.7 3.6 10.7 0.0 4.8 21.4 6.7 3.1 11.8 1.8 1.9 11.5 5.2 5.2 2.5 2.9 6.8 1.7 3.8 32.5 4.1 4.6 1.8 5.0 8.4 32.9 5.7 5.5 94.3 103.8 18.7 14.9 14.6 7.7 9.4 14.6 5.9 UBXN6 "UBXD1, UBXDC2" ENSG00000167671 "UBX domain protein 6" Q9BZV1 19 4444999-4457794 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1342.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040906, HPA041313, HPA061872" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.50e-2)" "prognostic favorable (5.68e-5)" "unprognostic (1.67e-1)" "unprognostic (2.65e-3)" "unprognostic (1.83e-2)" "unprognostic (1.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.48e-1)" "prognostic favorable (6.95e-4)" "unprognostic (3.93e-2)" "prognostic favorable (2.78e-5)" "unprognostic (4.61e-2)" "unprognostic (2.67e-1)" "unprognostic (1.43e-1)" "unprognostic (1.79e-1)" 97.5 190.3 51.8 35.4 53.5 86.6 90.2 44.2 92.3 93.8 53.8 83.7 49.7 95.3 21.2 90.4 89.9 34.0 111.9 65.7 45.9 118.0 123.2 72.6 35.4 55.8 58.6 52.8 116.2 101.2 65.3 147.2 35.1 57.7 94.6 14.2 24.0 86.8 51.2 218.3 112.0 68.2 23.4 44.2 78.4 89.2 176.2 47.9 27.1 112.7 85.1 18.2 92.6 86.1 50.4 71.7 49.4 23.3 50.6 57.7 70.6 35.1 71.3 84.3 50.9 54.1 30.8 58.8 31.8 63.5 70.8 26.3 40.8 18.2 54.8 18.6 56.3 39.4 26.4 53.5 41.4 94.5 33.6 51.1 65.2 70.4 40.1 38.7 62.3 62.9 42.7 55.6 83.6 38.3 45.4 67.2 56.8 37.6 27.4 42.9 30.4 33.3 76.0 48.3 43.9 67.1 97.3 40.1 40.9 116.7 10.8 48.5 54.4 76.8 67.4 51.4 145.0 47.7 186.6 80.7 33.2 128.7 62.5 61.4 6.4 6.6 10.4 3.8 8.0 6.2 5.3 4.5 5.2 6.7 6.0 5.3 4.2 6.7 2.7 4.9 10.2 5.5 4.9 51.8 53.5 44.2 92.3 65.7 45.9 55.8 58.6 52.8 57.7 44.2 47.9 50.4 26.7 41.7 30.1 13.7 25.1 37.2 44.9 26.7 15.9 37.2 36.3 25.1 47.2 64.3 21.2 44.1 27.1 54.5 31.9 105.0 80.3 58.1 297.0 29.1 35.6 30.5 46.8 172.0 14.4 65.0 43.1 39.0 28.5 32.2 34.3 50.0 47.5 61.6 54.8 13.5 11.9 66.2 20.3 52.8 35.9 1342.0 100.0 37.5 53.4 1.9 49.0 60.1 25.7 5.5 10.3 65.6 90.1 73.0 16.4 50.9 136.9 112.2 21.4 35.2 72.3 38.8 29.5 139.9 68.9 20.4 41.1 79.6 18.5 41.4 58.4 48.5 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472297-4502208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 37.0;Endometrial stromal cells: 31.0;Extravillous trophoblasts: 30.1;Granulosa cells: 44.7;Theca cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 5.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favorable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 27.1 29.2 23.5 16.7 23.4 14.5 28.4 22.5 32.5 43.0 15.7 36.3 15.9 39.6 9.7 29.6 36.0 10.1 30.6 26.2 19.7 30.9 31.5 25.6 17.9 21.7 21.0 22.1 49.9 27.1 12.6 38.6 15.1 21.8 36.7 7.7 10.9 26.2 18.8 68.4 28.9 27.2 12.8 18.1 33.7 28.3 75.2 21.8 18.7 29.5 19.3 11.9 34.4 35.1 23.3 71.6 41.2 70.1 65.5 29.9 30.3 49.0 56.2 30.1 60.4 53.3 47.5 30.4 62.6 32.1 41.6 31.8 40.2 46.9 51.1 35.2 70.4 74.7 38.6 32.4 63.5 38.5 38.3 52.8 43.5 27.4 41.6 20.2 42.8 55.9 57.8 45.1 76.3 29.6 50.6 86.9 76.4 80.2 28.5 73.3 85.4 57.6 40.6 38.0 35.8 77.0 76.1 54.7 31.0 47.2 38.1 30.6 60.2 74.8 38.0 51.7 72.3 54.1 94.1 52.9 43.6 53.2 60.8 41.1 0.0 0.9 1.7 0.6 0.6 0.1 0.5 0.7 0.5 0.7 5.6 1.1 0.4 0.2 1.3 0.3 1.0 1.0 0.5 23.5 23.4 22.5 32.5 26.2 19.7 21.7 21.0 22.1 21.8 18.1 21.8 23.3 25.5 6.4 5.4 0.0 2.3 0.0 0.0 0.0 0.0 0.0 13.3 15.2 0.0 0.0 5.0 12.9 0.0 37.0 14.3 0.0 19.6 26.4 0.0 26.9 31.0 9.8 0.0 0.0 0.0 19.8 30.1 13.9 0.0 19.8 1.3 44.7 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.3 0.0 0.0 23.6 9.5 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 15.2 7.1 42.7 0.0 0.0 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 771.7;breast: 319.2;skeletal muscle: 252.0" "Cell type enhanced" "Detected in some" "Adipocytes: 12.3;Astrocytes: 12.1;Cardiomyocytes: 35.9;Hepatocytes: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "ASC diff: 249.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Enhanced "Lipid droplets,Plasma membrane,Cytosol" NA NA 55000 "Plasma membrane, Cytosol" "Lipid droplets" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (8.31e-4)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 771.7 3.9 8.0 6.4 7.9 2.7 319.2 7.9 5.1 8.6 2.0 50.7 2.3 29.0 2.0 9.7 18.7 8.5 91.5 4.4 5.9 7.6 87.8 3.4 0.8 9.8 9.3 3.1 22.0 24.9 0.1 4.4 0.1 8.4 13.5 3.9 0.2 22.8 15.3 252.0 13.6 19.1 20.6 7.8 4.9 25.3 2.7 10.7 0.9 4.1 164.9 0.2 34.6 7.3 6.6 0.1 0.4 0.1 0.7 249.6 1.6 8.4 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.4 0.0 1.2 0.1 0.0 1.8 0.0 0.6 0.3 0.0 0.1 1.4 3.6 0.1 0.1 8.1 4.7 0.0 0.4 0.1 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.2 0.3 0.1 5.7 0.3 0.0 0.2 0.0 29.7 0.1 0.4 0.3 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.1 0.2 0.1 0.4 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 7.9 7.9 5.1 4.4 5.9 9.8 9.3 3.1 8.4 7.8 10.7 6.6 12.3 0.0 7.2 12.1 0.2 0.3 1.2 0.4 0.6 0.3 0.9 3.9 35.9 7.2 2.1 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.3 1.6 0.4 1.0 0.0 0.0 0.3 1.5 0.3 1.7 3.6 0.6 0.0 1.0 7.5 30.6 0.1 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.6 0.0 0.5 0.0 0.6 0.0 4.1 0.0 0.4 0.0 0.9 0.9 0.0 6.6 5.9 1.8 0.5 0.4 0.3 0.3 0.4 0.1 0.3 0.3 1.9 SEMA6B "SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ" ENSG00000167680 "Semaphorin 6B" Q9H3T3 19 4542593-4581776 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.2" "Cell type enhanced" "Detected in many" "Adipocytes: 43.6;Alveolar cells type 1: 28.9;Alveolar cells type 2: 44.6;Endothelial cells: 40.1;Excitatory neurons: 30.6;granulocytes: 29.7;Hepatic stellate cells: 37.5;Inhibitory neurons: 30.3;Macrophages: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 124.5;HMC-1: 198.1;HUVEC TERT2: 83.8;TIME: 107.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025157, HPA055778, HPA058523" Enhanced NA NA 1100000 "CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741" "unprognostic (4.03e-1)" "unprognostic (9.69e-3)" "unprognostic (6.38e-3)" "unprognostic (2.15e-1)" "unprognostic (1.15e-1)" "unprognostic (7.94e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (6.61e-2)" "unprognostic (1.90e-1)" "unprognostic (4.21e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (1.26e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (9.55e-2)" 22.9 19.9 43.9 11.1 29.1 7.9 17.2 0.7 72.2 8.4 0.0 6.5 4.0 10.7 0.4 3.6 8.9 5.9 15.2 61.5 11.7 8.5 2.9 10.8 1.2 14.8 11.2 40.1 3.3 4.1 9.3 7.3 9.0 17.0 7.1 1.0 1.4 4.0 1.3 6.1 4.4 7.4 7.0 0.5 32.2 6.2 1.9 28.3 0.7 9.2 4.3 0.7 10.1 6.7 17.3 7.2 25.0 2.3 21.4 0.1 1.2 0.2 0.0 0.7 2.4 0.6 0.2 2.0 0.0 23.7 0.0 3.8 4.4 6.5 0.0 0.9 0.1 1.0 0.0 0.4 124.5 0.4 0.0 198.1 7.5 0.1 0.2 0.2 24.9 83.8 0.1 1.6 0.3 0.7 6.5 0.0 0.0 26.8 1.7 0.3 0.4 46.8 0.6 1.7 0.1 17.7 1.7 0.1 1.7 11.5 1.8 2.7 1.1 107.8 3.1 34.7 0.5 18.6 1.3 0.0 0.4 0.8 1.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 29.1 0.7 72.2 61.5 11.7 14.8 11.2 40.1 17.0 0.5 28.3 17.3 43.6 28.9 44.6 2.6 2.3 4.7 1.5 0.5 0.0 9.0 2.1 1.9 1.9 1.5 19.3 1.8 4.2 0.6 2.3 0.2 0.0 1.1 1.1 1.1 2.5 40.1 0.0 8.4 30.6 0.2 0.6 8.2 0.0 2.0 29.7 0.5 37.5 6.0 3.3 18.5 30.3 0.1 0.0 6.1 18.1 0.4 0.6 35.2 7.2 7.5 1.4 2.0 1.0 19.1 1.4 0.2 0.1 0.7 1.1 1.2 0.0 0.4 17.7 4.1 0.0 8.8 1.8 2.0 2.2 0.0 5.1 0.3 5.4 1.6 0.1 0.9 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 118.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 12.7 23.6 31.5 6.3 28.8 3.3 16.0 27.5 36.5 23.3 27.6 27.6 11.5 25.1 7.7 16.7 26.4 9.4 22.6 29.0 27.7 23.8 64.9 18.3 5.7 37.1 30.4 27.8 26.3 46.8 7.9 29.5 4.8 32.1 35.5 4.2 5.7 21.8 19.8 18.8 14.5 19.1 5.9 27.5 17.8 32.3 21.5 30.4 16.2 29.0 7.1 4.4 26.0 17.9 30.4 11.3 21.1 19.0 16.7 8.0 8.1 12.5 14.0 9.2 11.7 12.6 23.1 12.4 19.7 12.2 8.1 5.9 10.3 11.8 9.5 4.9 17.3 118.4 19.6 15.3 42.4 13.0 8.7 17.4 9.5 8.5 9.5 7.3 17.6 10.6 24.1 25.7 8.6 8.3 14.6 28.4 24.4 20.5 22.3 38.2 32.7 12.3 10.7 13.0 10.2 20.4 28.0 7.1 23.2 11.2 10.3 23.2 15.7 14.4 20.8 18.2 4.6 15.6 20.5 18.9 15.1 13.1 11.8 13.9 1.9 1.1 2.4 2.3 0.9 2.5 1.2 4.0 4.0 1.2 2.3 4.0 2.7 0.1 2.2 0.6 2.1 2.9 1.4 31.5 28.8 27.5 36.5 29.0 27.7 37.1 30.4 27.8 32.1 27.5 30.4 30.4 12.2 3.2 18.1 26.1 11.0 3.1 17.4 15.3 5.2 17.9 13.9 11.8 13.9 28.6 17.6 11.0 8.4 18.8 5.6 15.6 9.8 26.4 28.6 16.2 8.9 15.1 29.3 6.1 10.0 21.9 9.7 10.0 20.9 9.2 10.2 16.8 18.5 38.9 10.7 20.2 10.0 28.0 20.3 7.2 6.1 39.2 12.2 5.5 16.0 5.6 13.6 17.7 12.3 14.6 19.0 18.3 9.9 12.0 8.6 13.5 18.7 26.9 18.3 13.4 26.3 8.5 12.6 13.6 25.6 3.4 5.3 12.4 11.2 43.4 22.9 11.0 NXN "FLJ12614, NRX" ENSG00000167693 Nucleoredoxin Q6DKJ4 17 799310-979776 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Oxidoreductase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.0" "Cell type enhanced" "Detected in many" "Late spermatids: 91.5;Microglial cells: 87.1;Urothelial cells: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 100.7;HHSteC: 106.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023566 Approved Approved Cytosol NA NA Cytosol "HPA023566: AB_1854737" "unprognostic (1.68e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (3.48e-2)" "unprognostic (7.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.75e-2)" "unprognostic (6.98e-2)" "unprognostic (1.65e-3)" "unprognostic (2.27e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-1)" "unprognostic (5.76e-2)" "unprognostic (3.56e-2)" "unprognostic (2.34e-1)" "unprognostic (2.68e-2)" "unprognostic (2.05e-3)" 16.7 7.6 13.9 8.8 11.0 1.1 19.2 10.9 15.2 38.9 19.0 51.1 5.5 47.6 11.7 27.4 29.3 13.8 15.1 12.0 11.5 10.6 9.6 24.8 5.1 12.2 11.9 9.8 14.9 33.9 2.6 6.8 14.6 11.6 40.1 4.6 9.0 20.9 25.2 100.0 24.7 19.9 23.3 10.9 6.5 28.6 9.7 16.1 13.3 13.0 36.0 13.9 43.8 42.9 13.0 14.3 21.2 81.5 52.8 5.3 1.1 4.5 44.6 29.3 46.1 73.3 50.4 14.8 0.6 83.6 57.5 10.8 100.7 52.9 83.2 36.3 0.6 30.9 0.2 12.7 44.8 106.1 0.3 2.3 32.2 75.6 6.0 36.0 9.3 41.9 11.3 7.4 0.0 12.3 5.8 2.9 1.0 39.2 42.3 1.4 6.2 2.1 0.3 32.9 20.6 20.9 13.6 21.1 0.1 1.1 50.3 14.9 13.0 0.0 1.0 19.1 0.4 12.5 7.5 5.2 0.4 0.4 1.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 13.9 11.0 10.9 15.2 12.0 11.5 12.2 11.9 9.8 11.6 10.9 16.1 13.0 36.5 32.1 11.7 13.4 0.9 17.5 53.6 18.8 12.0 2.6 7.6 12.4 8.6 2.8 13.2 3.7 33.3 0.4 0.4 0.1 0.0 3.5 25.1 20.2 52.1 34.7 1.8 2.7 6.9 24.6 0.7 23.0 1.1 12.6 1.3 1.0 14.6 8.2 6.3 5.0 10.7 0.0 0.0 0.3 8.8 91.5 15.5 1.9 7.2 87.1 0.6 11.4 0.0 23.1 3.3 5.9 0.0 7.2 0.4 36.0 0.0 0.5 15.5 18.0 13.1 14.5 19.2 13.1 10.1 13.1 12.4 0.4 1.5 27.2 0.0 59.0 TLCD3A "CT120, FAM57A, FLJ22282" ENSG00000167695 "TLC domain containing 3A" Q8TBR7 17 732412-742968 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 72.2" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 20.1;Hofbauer cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.46e-1)" "unprognostic (6.16e-2)" "unprognostic (5.64e-2)" "prognostic favorable (3.53e-6)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "unprognostic (1.32e-3)" "unprognostic (2.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (4.88e-2)" "unprognostic (1.60e-1)" "unprognostic (8.05e-2)" "unprognostic (1.39e-2)" 7.8 3.5 4.3 6.2 4.6 2.5 8.3 9.1 5.5 9.2 7.8 10.8 12.6 7.4 2.7 23.8 7.2 12.4 4.8 4.5 4.9 4.9 3.7 7.1 3.2 3.9 4.5 4.3 7.4 9.8 6.2 8.4 8.3 6.3 9.7 10.1 3.9 11.7 11.0 2.8 72.2 8.7 8.6 4.1 2.9 18.6 12.2 4.4 4.7 8.1 2.9 9.2 18.7 16.0 5.0 63.8 39.4 27.5 36.6 35.5 47.1 27.3 53.9 46.1 53.2 59.4 19.2 9.8 14.4 28.3 51.7 17.1 61.3 57.3 44.3 58.9 38.3 53.1 14.8 26.8 46.6 28.1 12.4 20.7 39.6 38.8 24.2 63.5 24.5 37.3 19.6 13.6 1.7 31.2 22.1 5.3 3.7 12.2 40.7 13.7 25.6 10.8 1.4 38.1 48.9 13.2 25.0 25.7 2.5 16.7 18.0 10.3 13.7 29.1 51.9 23.6 60.8 65.3 4.6 13.3 15.2 47.2 23.9 32.1 0.0 0.0 0.0 1.2 0.0 1.1 0.1 0.2 0.5 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.1 1.5 0.1 4.3 4.6 9.1 5.5 4.5 4.9 3.9 4.5 4.3 6.3 4.1 4.4 5.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 20.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Cytosol NA NA 3500000 Cytosol "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 42.9 47.2 28.4 33.8 32.2 22.7 34.8 26.8 33.6 28.6 33.6 72.0 81.2 31.9 33.9 43.3 45.3 32.9 37.6 30.9 35.2 76.4 68.2 31.8 47.3 28.3 28.3 30.0 40.2 40.8 37.9 23.4 37.0 29.4 38.1 48.7 25.8 39.8 27.5 40.1 44.7 73.3 32.2 28.5 37.2 86.1 19.6 33.8 35.5 47.8 23.2 40.4 41.9 22.6 31.5 121.1 106.8 120.9 67.1 52.0 51.5 73.8 94.4 57.6 75.0 56.7 87.4 84.0 142.9 100.2 42.8 69.7 85.5 106.6 60.1 78.0 105.4 91.2 69.0 55.7 115.5 51.6 72.1 87.5 36.2 81.9 75.5 66.0 47.7 70.4 116.9 115.1 90.4 80.2 73.9 124.1 55.3 88.7 118.8 36.3 122.7 49.0 65.9 74.5 81.2 54.8 91.8 74.8 53.6 124.6 75.3 66.6 75.2 92.2 71.0 56.8 99.9 120.4 50.3 100.0 89.1 83.6 79.5 75.9 26.1 51.8 48.7 68.1 64.1 73.2 70.0 81.0 82.2 45.9 75.4 68.9 75.7 7.1 64.0 70.4 47.2 99.1 75.9 28.4 32.2 26.8 33.6 30.9 35.2 28.3 28.3 30.0 29.4 28.5 33.8 31.5 52.2 57.7 35.2 11.4 48.5 47.9 40.4 91.1 40.5 39.6 39.2 36.3 30.9 54.3 70.4 101.2 29.2 104.5 43.2 39.3 178.1 77.3 34.0 44.0 34.3 43.8 28.9 54.7 12.7 57.4 85.9 41.5 71.4 40.8 40.4 42.1 31.1 58.8 82.3 13.5 13.6 52.0 97.6 30.1 26.5 63.3 38.8 40.8 67.6 7.5 61.7 39.8 44.3 10.1 13.2 58.7 52.0 46.6 27.5 39.4 110.5 186.1 66.8 38.7 46.0 30.3 45.8 23.5 32.9 53.6 54.8 69.1 53.3 57.2 63.7 39.3 MFSD3 ENSG00000167700 "Major facilitator superfamily domain containing 3" Q96ES6 8 144509070-144511213 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056013 Uncertain Approved Vesicles NA NA Vesicles "HPA056013: AB_2683009" "unprognostic (7.92e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (2.00e-1)" "unprognostic (5.18e-2)" "unprognostic (6.50e-2)" "unprognostic (3.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.06e-1)" "unprognostic (5.49e-2)" "unprognostic (5.29e-2)" "prognostic favorable (5.44e-7)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" 8.3 22.8 7.5 3.4 7.0 1.9 10.8 6.6 12.1 7.7 4.7 15.9 13.6 8.4 4.1 16.2 8.5 2.5 20.8 8.2 5.9 27.3 45.0 7.6 2.8 10.4 6.6 8.5 6.8 19.0 12.4 17.9 1.6 8.8 19.3 3.3 1.5 19.7 5.5 23.7 16.4 15.5 1.3 4.5 10.8 15.7 6.4 9.6 2.4 24.1 6.1 1.7 9.8 9.3 8.3 16.2 21.7 5.4 4.6 5.9 4.4 17.6 5.1 5.3 2.8 4.2 7.3 11.2 23.3 17.3 4.8 5.6 15.5 2.5 12.1 0.5 11.0 44.0 7.5 19.9 18.3 11.0 3.6 9.9 6.5 22.3 1.8 7.7 12.1 7.3 16.0 14.2 6.2 6.8 53.7 9.0 18.9 14.3 22.9 36.9 9.9 2.8 41.7 13.2 9.5 39.1 19.7 13.0 31.6 11.3 3.4 33.1 5.2 7.9 3.7 9.9 4.2 7.1 6.0 2.6 8.1 8.0 11.3 6.5 1.8 7.4 3.8 3.9 6.7 3.7 4.9 3.9 4.0 11.0 2.5 3.5 3.6 0.4 3.8 3.6 19.2 4.4 4.1 7.5 7.0 6.6 12.1 8.2 5.9 10.4 6.6 8.5 8.8 4.5 9.6 8.3 3.0 3.2 3.7 6.5 8.0 6.0 10.3 17.3 8.6 8.2 18.8 14.5 9.3 30.0 11.8 27.6 10.4 16.5 3.7 31.3 37.2 17.6 0.6 5.1 3.9 3.8 19.8 8.2 6.2 21.0 15.0 4.0 16.3 7.4 0.0 9.7 3.3 27.6 15.5 16.8 6.2 19.6 24.4 7.0 3.2 1.8 4.4 6.4 8.8 1.9 7.5 14.8 6.2 2.5 3.8 15.7 19.1 4.9 14.8 12.8 33.1 63.6 3.2 10.0 0.0 7.0 3.4 3.8 11.7 19.0 7.1 9.3 3.5 16.9 27.1 9.8 GPT "ALT1, GPT1" ENSG00000167701 "Glutamic--pyruvic transaminase" P24298 8 144502973-144507174 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 181.1;skeletal muscle: 50.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9" "Cancer enriched" "Detected in many" 7 "liver cancer: 38.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031059, HPA031060, CAB032997, CAB032999" Enhanced NA NA 17000000 "CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178" "unprognostic (8.22e-3)" "unprognostic (2.52e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (3.38e-1)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-5)" "unprognostic (9.42e-2)" "unprognostic (2.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.41e-1)" "unprognostic (9.22e-2)" "prognostic favorable (2.19e-4)" "unprognostic (2.83e-2)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.98e-2)" 18.8 2.4 2.0 4.7 1.3 2.3 12.6 2.5 4.7 0.7 2.6 20.4 18.5 0.5 0.4 2.4 1.3 2.4 26.7 1.9 0.2 14.1 181.1 0.4 0.3 1.0 0.3 1.7 1.1 10.4 1.4 2.9 0.1 1.9 1.8 5.9 0.6 14.7 1.3 50.6 14.7 18.1 0.4 0.1 0.7 15.2 2.7 0.6 0.0 0.9 24.5 0.2 0.6 1.3 1.1 0.2 0.8 0.2 0.5 0.4 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.9 0.4 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.7 1.3 0.3 1.5 2.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.4 0.2 2.8 0.0 1.3 0.4 0.4 0.3 0.6 0.5 0.5 0.1 1.5 0.0 0.9 0.5 0.8 0.2 0.7 0.1 0.1 1.9 0.1 0.2 0.1 0.6 0.7 0.1 2.9 0.2 0.2 0.4 0.9 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.0 1.3 2.5 4.7 1.9 0.2 1.0 0.3 1.7 1.9 0.1 0.6 1.1 0.2 0.0 0.0 14.4 5.3 1.7 1.3 1.2 0.6 0.9 14.1 4.6 8.5 34.3 1.8 7.3 0.0 0.0 0.4 176.9 21.5 1.1 16.5 0.5 0.4 1.1 2.4 43.2 0.8 2.4 3.3 0.3 51.0 0.7 8.9 0.3 14.3 237.3 0.1 3.3 0.5 30.4 0.0 14.4 2.1 48.1 0.6 1.2 1.8 1.0 0.1 15.6 0.0 2.0 0.0 1.3 88.4 0.4 0.1 1.2 139.7 164.9 0.5 2.0 0.0 2.0 0.4 1.0 0.6 2.4 4.5 0.0 1.8 0.4 62.1 1.6 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 59.8;Gastric mucus-secreting cells: 38.7;Inhibitory neurons: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 11.5 17.4 67.6 6.2 74.5 7.2 14.1 53.9 114.6 21.0 33.0 20.4 12.0 11.5 6.8 45.3 15.4 6.1 9.8 74.0 47.8 33.0 20.7 17.4 7.3 54.4 41.6 80.1 13.1 25.1 9.7 45.3 3.3 59.1 31.8 6.4 3.8 19.3 8.1 4.3 69.1 24.6 2.5 31.4 27.8 19.8 26.0 42.7 5.5 24.4 1.7 4.9 22.4 32.1 67.4 13.5 12.7 6.1 13.2 8.7 5.2 13.2 5.3 6.4 4.7 4.6 4.9 18.1 11.6 3.6 5.0 7.9 24.2 6.1 8.1 2.0 10.2 3.7 8.6 34.5 6.6 11.1 2.6 23.4 6.7 28.3 4.7 6.1 21.8 3.0 14.7 7.0 15.9 3.6 25.4 10.3 7.1 0.9 16.5 15.2 24.1 0.3 8.8 19.9 23.1 18.4 16.4 6.2 19.3 6.9 4.3 50.4 5.0 7.6 9.0 22.9 9.4 7.7 6.3 2.9 3.9 17.6 12.3 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 74.5 53.9 114.6 74.0 47.8 54.4 41.6 80.1 59.1 31.4 42.7 67.4 3.7 9.6 11.3 35.3 4.9 6.0 3.0 2.1 6.2 16.2 7.9 5.8 0.8 7.2 5.2 14.7 6.2 2.0 12.1 29.1 1.9 3.5 13.2 6.8 4.4 2.0 23.4 3.2 59.8 1.4 2.0 2.0 38.7 13.8 8.2 3.3 2.5 8.7 2.7 15.2 39.7 12.2 0.0 5.3 9.1 8.0 7.8 6.4 3.6 12.2 3.5 7.5 3.1 8.5 6.9 2.2 18.5 3.0 7.0 3.4 11.3 5.1 4.5 4.6 0.0 1.8 2.9 7.3 7.5 10.6 11.4 3.0 8.0 6.6 18.0 3.3 SLC43A2 MGC34680 ENSG00000167703 "Solute carrier family 43 member 2" Q8N370 17 1569268-1628886 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 61.0" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 399.3;Syncytiotrophoblasts: 943.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021564 Enhanced NA NA "HPA021564: AB_1857169" "unprognostic (5.95e-3)" "unprognostic (4.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.42e-2)" "unprognostic (2.58e-2)" "unprognostic (2.80e-2)" "unprognostic (1.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.96e-1)" "prognostic favorable (5.40e-5)" "unprognostic (1.84e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-1)" "unprognostic (2.20e-1)" 13.7 8.4 5.3 12.1 5.4 12.6 12.4 5.8 6.9 5.0 0.9 8.3 6.1 6.8 3.2 3.4 12.1 3.0 5.4 4.8 10.1 37.0 3.4 21.8 2.9 10.9 4.9 4.6 4.2 6.1 1.8 15.9 22.6 10.4 7.9 1.8 1.4 14.8 2.0 61.0 5.3 16.0 2.3 4.4 30.9 10.0 4.7 7.5 3.1 13.1 4.8 1.7 11.3 3.9 7.7 1.1 2.9 0.9 8.6 1.6 1.4 11.5 0.6 0.3 2.1 0.9 17.8 2.0 5.2 5.8 0.9 0.8 2.1 5.2 1.0 0.3 0.0 0.4 0.9 2.4 4.5 2.0 0.2 1.6 1.8 1.6 1.2 0.5 0.2 8.3 0.6 2.3 0.0 0.3 4.2 10.9 1.0 0.9 2.8 0.4 3.0 0.0 6.2 3.8 10.1 3.4 1.8 2.6 7.1 0.2 3.6 7.0 6.2 10.3 0.2 1.2 2.3 0.7 0.5 11.1 2.5 0.4 1.0 0.3 3.2 6.5 6.2 0.3 4.9 0.1 1.3 0.2 0.2 3.4 1.1 0.2 0.2 15.6 0.5 5.2 1.7 0.2 2.8 5.3 5.4 5.8 6.9 4.8 10.1 10.9 4.9 4.6 10.4 4.4 7.5 7.7 16.4 16.0 35.9 17.3 19.0 4.8 6.0 20.8 0.0 29.4 12.2 10.7 2.9 12.8 37.4 36.8 25.0 399.3 13.2 13.7 19.6 26.7 3.4 11.5 12.1 10.9 11.3 0.8 20.5 7.1 42.0 11.6 6.6 12.1 12.0 0.7 12.1 1.2 90.2 20.2 18.3 13.6 87.5 102.6 91.3 3.0 10.8 93.5 0.0 14.0 84.3 19.6 6.2 11.1 5.0 6.7 17.8 9.1 15.7 6.3 92.2 25.6 33.2 39.3 0.0 10.1 8.0 3.4 2.9 1.6 4.3 943.4 5.5 11.7 11.4 5.3 RILP FLJ31193 ENSG00000167705 "Rab interacting lysosomal protein" Q96NA2 17 1646145-1649866 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 47.1;skeletal muscle: 48.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 101.4;Proximal enterocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.5;eosinophil: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.4;neutrophil: 3.3;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;granulocytes: 3.3;monocytes: 3.5" "Cell line enhanced" "Detected in many" "HEL: 40.6;HMC-1: 19.5;K-562: 15.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 18000 "prognostic favorable (7.97e-4)" "unprognostic (7.93e-2)" "unprognostic (3.11e-1)" "unprognostic (1.05e-1)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-2)" "unprognostic (8.84e-3)" "unprognostic (1.61e-1)" "unprognostic (2.64e-1)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "prognostic favorable (8.51e-5)" "unprognostic (2.26e-1)" "unprognostic (4.73e-2)" "unprognostic (1.00e-1)" "prognostic favorable (7.12e-4)" 17.3 18.1 2.9 0.9 2.7 8.2 15.7 2.6 5.1 4.8 8.9 12.3 10.6 5.9 0.6 5.4 6.9 1.1 47.1 2.6 2.8 15.2 29.3 13.2 1.0 3.2 2.8 2.1 3.3 10.5 1.8 4.5 0.8 3.4 6.1 1.4 0.4 11.6 1.2 48.5 6.0 13.1 0.9 2.3 15.2 13.7 3.3 3.4 0.3 29.8 8.4 0.4 11.4 5.1 2.7 2.3 1.6 0.2 1.7 1.1 2.7 7.7 1.5 1.0 1.6 0.9 3.6 0.5 0.4 5.2 1.2 0.5 5.5 0.2 0.2 0.3 0.2 3.6 40.6 0.5 4.6 1.7 0.3 19.5 2.2 0.7 0.4 0.0 0.8 1.4 0.3 15.8 0.4 0.5 2.2 1.4 3.1 0.4 0.4 8.1 5.8 0.0 1.1 0.0 1.3 0.1 0.6 0.8 1.0 2.0 0.2 1.0 0.3 7.8 0.5 1.0 1.9 1.5 0.3 0.5 0.0 3.0 1.8 0.3 0.3 3.5 1.0 0.1 1.2 0.1 0.3 0.2 0.1 2.4 0.0 0.2 0.0 3.3 0.5 0.2 1.3 0.1 0.7 2.9 2.7 2.6 5.1 2.6 2.8 3.2 2.8 2.1 3.4 2.3 3.4 2.7 42.6 19.2 17.7 3.3 3.2 8.8 13.3 7.5 2.8 1.6 11.1 13.1 59.9 17.2 8.9 7.3 0.0 15.8 12.1 101.4 50.9 29.2 0.1 3.2 5.1 21.9 3.0 65.9 3.1 25.4 9.4 12.9 24.5 5.1 0.0 2.1 26.0 30.6 57.1 3.3 2.4 27.6 8.2 35.2 34.3 2.6 6.8 34.1 14.2 5.6 28.1 9.9 5.2 2.0 1.3 20.2 59.7 8.2 10.3 8.4 84.9 20.8 3.1 1.3 13.1 8.3 9.2 0.6 12.2 7.4 8.2 34.6 5.2 9.4 28.7 21.0 SERPINF2 "A2AP, AAP, ALPHA-2-PI, API, PLI" ENSG00000167711 "Serpin family F member 2" P08697 17 1742836-1755265 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 1591.4" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 1007.7" "Cancer enriched" "Detected in all" 6 "liver cancer: 450.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "plasmacytoid DC: 44.7" "Lineage enriched" "Detected in many" 23 "dendritic cells: 44.7" "Cell line enriched" "Detected in some" 24 "Hep G2: 145.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001885, CAB024863" Approved "Secreted to blood" NA NA 11900 61000000000 "CAB024863: , HPA001885: AB_1079922" "unprognostic (2.17e-3)" "unprognostic (2.56e-3)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (3.69e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.09e-3)" "unprognostic (7.05e-2)" "unprognostic (2.81e-1)" "unprognostic (7.68e-3)" "unprognostic (2.93e-1)" 10.7 2.0 1.5 4.4 1.6 0.4 18.5 1.3 2.2 6.9 9.2 3.9 0.7 8.7 102.3 3.1 19.8 0.7 2.4 2.0 1.5 72.5 1591.4 13.0 3.0 1.6 1.7 1.2 7.8 9.2 0.1 1.9 0.8 2.5 21.6 0.5 0.5 6.1 32.9 4.3 5.3 11.7 1.8 2.1 7.2 3.8 12.6 1.6 2.6 8.0 0.4 3.5 7.4 5.8 2.1 1.8 6.1 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.9 0.0 0.3 0.9 0.0 3.3 0.0 0.0 0.0 0.1 0.9 145.9 1.1 0.8 0.1 1.6 1.2 0.0 0.7 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.7 0.1 0.3 0.3 0.1 0.9 1.3 0.0 0.3 0.0 0.2 0.6 0.0 1.1 0.0 0.2 0.1 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.9 1.4 0.0 0.8 0.0 0.5 0.0 0.0 10.7 0.5 0.0 0.0 0.0 1.2 0.0 44.7 0.0 1.2 1.5 1.6 1.3 2.2 2.0 1.5 1.6 1.7 1.2 2.5 2.1 1.6 2.1 1.6 3.2 19.6 0.3 5.3 1.5 4.9 10.3 8.0 0.2 20.5 8.8 0.7 27.1 7.0 1.8 6.2 0.2 32.1 0.7 9.8 0.0 0.6 0.1 2.7 3.4 4.2 23.6 1.6 4.9 0.3 2.7 0.0 0.3 1.3 0.3 14.6 1007.7 7.7 0.0 1.9 2.1 12.2 32.2 20.1 0.8 33.8 8.2 1.8 1.0 10.9 0.1 0.0 1.0 0.7 3.8 2.7 26.7 3.2 2.8 2.2 87.5 4.4 0.4 0.0 1.3 1.2 0.4 0.5 1.3 1.6 0.3 2.6 0.0 3.3 1.8 WDR81 "CAMRQ2, FLJ33817, PPP1R166, SORF-2" ENSG00000167716 "WD repeat domain 81" Q562E7 17 1716523-1738599 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023044, HPA063703" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023044: AB_1858822, HPA063703: " "unprognostic (1.00e-1)" "unprognostic (4.67e-2)" "unprognostic (6.63e-2)" "unprognostic (4.90e-3)" "unprognostic (6.10e-2)" "unprognostic (7.75e-3)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.60e-2)" "prognostic favorable (3.30e-4)" "unprognostic (3.26e-1)" "unprognostic (8.72e-2)" "unprognostic (2.25e-1)" "unprognostic (8.43e-2)" "unprognostic (7.99e-2)" "unprognostic (3.90e-2)" 16.7 16.3 4.4 4.7 5.1 4.9 17.0 4.7 6.9 17.4 6.1 11.5 4.9 19.0 2.4 10.0 17.5 1.6 10.0 4.7 4.4 11.8 33.0 13.8 5.7 5.9 5.1 3.5 21.6 11.1 2.4 13.2 3.9 8.8 16.1 1.7 0.8 11.1 6.0 18.3 17.6 17.9 5.2 5.4 24.5 11.1 7.6 5.3 6.6 10.6 2.1 4.2 15.5 13.8 5.9 0.7 12.3 1.7 9.1 12.4 7.0 9.2 0.9 0.2 0.6 0.0 1.8 4.4 4.9 6.5 5.4 6.2 12.2 6.3 8.4 0.4 9.5 12.8 0.3 8.8 5.9 22.1 4.1 7.6 17.8 8.8 5.9 4.1 1.9 5.0 3.7 1.0 6.3 7.6 6.8 1.3 7.6 3.9 4.2 9.4 6.4 2.9 6.8 3.7 2.0 2.2 5.0 4.3 3.4 15.4 0.1 6.0 6.1 6.8 4.8 5.4 7.9 6.7 0.5 1.3 3.1 7.7 5.9 2.4 0.0 1.4 2.8 1.1 2.3 1.3 1.3 1.2 1.2 1.8 1.0 0.8 1.1 0.3 2.1 2.3 3.3 1.2 1.1 4.4 5.1 4.7 6.9 4.7 4.4 5.9 5.1 3.5 8.8 5.4 5.3 5.9 6.3 12.8 10.3 6.5 4.2 2.5 2.9 4.4 8.6 4.5 4.8 5.3 3.6 4.3 3.8 0.0 4.2 2.5 9.9 6.8 1.9 3.1 0.7 2.1 6.2 5.4 1.2 14.3 5.3 4.5 1.9 8.2 6.6 2.9 4.5 6.2 4.6 27.7 23.8 5.0 5.3 4.6 10.2 22.3 4.5 1.2 16.4 15.3 0.0 9.4 7.5 2.5 9.2 5.0 7.6 4.8 4.8 15.1 5.3 2.9 8.7 20.1 6.4 1.8 19.7 5.9 4.5 0.7 2.0 3.4 1.7 2.3 4.7 5.8 4.4 1.7 SRR "ILV1, ISO1" ENSG00000167720 "Serine racemase" Q9GZT4 17 2303383-2325260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Isomerase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007529, CAB015343" Approved Approved Vesicles NA NA Vesicles "CAB015343: AB_2195009, HPA007529: AB_2667853" "unprognostic (2.96e-1)" "unprognostic (7.86e-2)" "unprognostic (6.01e-2)" "prognostic favorable (6.20e-5)" "unprognostic (3.05e-1)" "unprognostic (1.57e-2)" "unprognostic (4.32e-2)" "unprognostic (9.97e-2)" "unprognostic (9.09e-2)" "unprognostic (4.85e-2)" "prognostic favorable (8.16e-4)" "unprognostic (5.17e-2)" "prognostic favorable (2.45e-6)" "unprognostic (6.14e-2)" "unprognostic (1.99e-1)" "unprognostic (1.89e-1)" "unprognostic (5.84e-2)" 10.6 7.9 11.9 6.7 11.5 14.0 8.9 13.1 13.2 6.9 12.4 9.5 7.0 7.6 10.4 11.0 8.8 8.3 11.0 10.0 13.0 9.1 8.2 6.2 6.6 12.1 12.3 9.5 8.5 12.0 12.4 5.0 5.5 12.1 8.4 7.5 16.7 10.8 7.8 15.8 11.9 6.0 7.1 11.8 6.9 8.1 7.1 12.8 9.1 11.9 6.8 5.4 8.5 5.4 12.3 14.8 27.0 42.7 17.9 24.9 24.4 22.8 29.8 20.2 19.4 20.5 25.3 18.1 27.5 4.1 29.1 14.3 30.2 12.2 11.4 24.6 32.6 26.0 14.6 20.3 9.6 22.5 4.3 8.0 22.9 11.5 41.4 21.0 21.2 28.6 28.2 15.2 19.8 43.9 8.4 28.7 5.8 10.0 13.8 19.9 45.5 48.8 13.3 22.9 6.9 9.2 23.4 26.8 3.3 14.3 14.6 20.7 10.3 21.3 21.4 14.7 24.7 19.0 16.7 26.0 5.1 36.9 13.7 29.8 4.3 8.1 5.6 8.8 8.4 9.1 10.1 11.2 9.1 15.6 10.2 9.2 12.1 1.0 15.7 14.0 11.0 8.8 8.5 11.9 11.5 13.1 13.2 10.0 13.0 12.1 12.3 9.5 12.1 11.8 12.8 12.3 5.0 3.2 3.7 3.6 2.1 2.9 3.5 17.4 1.8 8.5 5.5 4.6 4.2 1.5 8.4 1.8 0.0 5.9 3.4 3.0 13.7 9.6 1.9 6.6 5.5 5.4 1.8 5.2 3.5 6.6 3.2 5.7 3.6 4.6 0.0 13.2 8.2 3.2 9.3 16.8 4.9 2.5 12.2 4.6 4.9 1.5 4.1 3.7 5.4 4.7 9.3 11.0 5.2 5.0 7.8 6.7 0.8 5.3 6.1 2.9 2.9 6.3 10.2 5.6 0.0 4.6 6.5 23.3 13.1 4.7 2.4 3.4 2.3 9.7 3.5 4.0 TSR1 FLJ10534 ENSG00000167721 "TSR1 ribosome maturation factor" Q2NL82 17 2322396-2336657 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024434, HPA053087" Approved Approved Nucleoplasm NA NA 13000 Nucleoplasm "HPA024434: AB_1858413, HPA053087: AB_2682040" "unprognostic (1.45e-2)" "unprognostic (1.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.53e-1)" "unprognostic (4.76e-2)" "unprognostic (2.74e-1)" "unprognostic (1.95e-3)" "unprognostic (9.80e-3)" "unprognostic (6.16e-2)" "unprognostic (2.38e-1)" "unprognostic (6.74e-2)" "unprognostic (1.60e-2)" "unprognostic (8.61e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (9.46e-3)" 18.4 11.0 12.1 17.3 12.6 15.6 17.5 11.9 12.5 10.5 11.8 11.8 9.5 14.9 12.3 20.3 12.4 10.9 17.3 12.3 12.3 12.4 14.9 10.2 16.1 12.5 12.5 11.4 15.3 20.1 16.2 8.3 14.7 12.4 13.5 14.7 14.2 12.9 14.0 49.9 19.7 9.5 18.5 13.2 11.1 11.9 18.3 13.2 15.4 11.9 31.0 19.4 22.4 11.9 12.8 80.2 85.1 39.6 77.6 31.6 36.9 80.4 65.5 36.3 39.8 30.6 138.2 33.4 85.5 54.6 52.2 36.4 70.3 86.5 76.8 50.7 39.1 97.3 63.9 66.4 65.5 44.0 59.4 42.3 37.4 48.1 76.6 87.2 43.5 39.5 45.5 84.1 46.5 49.1 49.8 56.6 29.3 94.0 60.0 50.6 59.6 55.1 57.6 49.1 52.5 27.7 61.7 57.6 43.4 45.7 37.6 40.4 26.0 43.9 54.6 43.3 65.7 122.8 33.3 45.7 49.7 53.5 67.3 67.3 1.9 7.1 1.5 8.3 10.5 11.0 7.1 6.8 7.7 11.5 8.7 7.4 9.0 1.3 6.5 11.5 4.8 9.1 6.3 12.1 12.6 11.9 12.5 12.3 12.3 12.5 12.5 11.4 12.4 13.2 13.2 12.8 13.5 32.1 29.3 7.2 21.5 34.4 42.8 18.1 31.3 16.2 18.3 13.7 17.6 12.8 30.7 14.7 18.8 29.9 17.3 7.8 3.9 27.7 68.2 18.0 32.6 20.8 10.3 30.5 7.7 16.5 39.7 24.0 18.3 24.8 43.1 24.4 12.5 13.2 16.0 18.5 6.7 12.0 10.2 12.4 10.2 73.6 13.1 14.4 16.0 3.7 18.2 12.6 10.3 3.0 6.4 23.3 5.8 12.0 23.2 35.8 4.8 11.4 21.9 19.7 19.7 36.4 27.7 29.7 47.7 42.2 41.2 24.2 16.1 25.4 15.7 33.1 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557812 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease variant, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.3;skin 1: 4.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 18.7;Plasma cells: 15.9;Proximal enterocytes: 26.1;Suprabasal keratinocytes: 24.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.3;BEWO: 5.0;CACO-2: 3.1;RH-30: 11.9;T-47d: 5.2;U-266/70: 3.1;U-266/84: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.1 0.0 1.0 0.5 1.0 0.5 0.2 0.0 0.8 0.1 0.0 0.9 2.0 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.3 0.0 0.6 0.1 0.3 0.4 0.3 0.3 0.2 0.0 0.1 0.3 0.2 0.8 0.1 1.7 0.2 0.1 0.0 1.5 4.8 5.3 0.1 0.1 0.2 0.9 0.4 0.5 0.0 0.0 0.5 0.5 0.2 0.3 1.5 3.3 0.0 0.3 0.0 0.2 0.3 5.0 0.1 0.0 0.0 0.0 3.1 0.8 0.1 1.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.5 0.2 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.2 0.4 0.1 11.9 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 5.2 0.1 0.0 0.0 0.1 0.1 0.0 3.1 2.7 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.0 0.0 0.8 0.5 0.3 0.4 0.3 0.3 0.8 0.1 0.5 1.5 0.2 0.0 2.5 2.9 5.8 18.7 3.9 0.2 10.2 1.2 0.9 0.5 3.5 1.5 0.2 0.0 0.0 0.3 2.6 8.9 1.9 0.0 0.3 0.7 0.9 1.6 0.0 0.0 1.6 0.0 0.9 3.7 6.1 0.9 0.0 1.1 0.0 0.3 0.3 5.0 0.6 2.7 0.0 0.0 3.8 0.4 3.1 0.8 7.2 0.0 0.1 2.2 3.1 0.5 2.3 1.2 2.5 3.4 15.9 5.9 26.1 2.3 0.2 1.0 0.0 6.9 1.8 0.0 1.5 2.9 24.6 0.5 1.8 2.8 0.9 3.7 HSD11B1L "HSD1L, SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 19.0" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" NA NA Vesicles "HPA049078: AB_2680622" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.8 9.9 45.4 1.3 45.3 2.7 5.1 30.6 58.7 5.3 32.1 6.7 1.6 5.5 5.1 3.7 6.7 3.0 5.9 44.7 38.3 11.1 5.5 4.4 1.4 37.6 35.6 48.3 6.8 7.1 7.3 21.3 1.5 38.9 6.1 1.0 6.3 5.8 4.1 11.0 9.0 3.4 1.6 31.0 3.2 6.3 8.2 39.3 1.6 8.7 3.3 1.0 6.1 4.3 41.4 3.6 3.0 11.3 2.1 5.0 5.7 2.2 2.7 4.4 1.1 4.8 1.3 3.3 0.8 5.9 2.2 0.9 1.7 1.4 1.8 1.0 3.2 3.6 2.3 3.0 2.2 3.6 0.9 7.9 5.5 3.9 1.6 1.6 10.4 1.8 5.1 2.4 2.9 4.6 0.3 2.1 2.1 3.0 14.2 4.1 3.6 0.5 3.1 9.5 0.8 3.2 19.0 0.5 1.6 12.8 3.8 2.6 0.7 3.2 2.7 5.0 4.9 2.2 7.6 2.8 0.9 7.7 1.2 2.4 1.5 1.0 0.5 0.6 2.7 0.6 0.5 1.4 1.6 1.0 1.1 1.8 1.7 1.9 0.7 1.8 2.2 0.4 0.9 45.4 45.3 30.6 58.7 44.7 38.3 37.6 35.6 48.3 38.9 31.0 39.3 41.4 8.2 0.0 2.6 13.7 2.6 8.2 8.6 12.9 9.6 11.3 23.7 23.1 2.3 10.0 8.6 23.9 14.6 4.7 3.0 4.5 15.6 12.4 9.5 21.8 6.0 6.1 25.7 1.3 24.7 4.7 6.5 8.1 4.6 5.4 10.2 12.4 8.9 4.1 5.1 8.4 20.4 4.6 12.2 2.8 6.0 13.9 7.2 2.4 5.4 1.9 3.1 30.5 1.0 14.1 4.6 4.8 4.3 12.8 0.9 8.4 4.1 33.3 31.2 12.9 0.0 8.1 9.5 10.8 12.7 4.8 10.2 2.9 3.1 16.6 3.7 9.7 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011032, HPA042299" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA011032: , HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favorable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favorable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favorable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 17.6 21.9 17.9 6.1 17.5 4.3 18.4 18.0 20.3 16.1 14.2 10.5 15.3 15.7 28.7 11.0 18.9 16.4 12.3 16.9 19.3 25.7 29.2 9.8 9.4 18.7 18.1 16.9 20.9 19.9 31.1 24.3 10.9 18.4 13.6 7.4 9.3 20.1 17.7 16.3 13.5 12.2 8.4 17.6 9.7 16.1 29.5 17.5 10.3 22.9 15.0 7.2 13.0 11.7 19.0 16.2 21.6 11.8 12.7 74.7 22.5 5.2 15.7 31.5 11.0 10.9 6.3 10.3 5.3 13.6 17.4 9.2 22.5 4.9 7.1 4.4 17.9 25.7 5.0 13.5 10.5 13.7 2.1 9.5 28.8 17.0 6.2 11.7 22.3 20.1 11.5 5.1 31.2 8.3 20.6 7.8 3.4 4.3 13.7 11.5 9.2 10.6 12.5 25.1 8.5 9.3 8.1 17.2 9.9 23.5 13.1 25.6 3.2 28.5 15.7 4.0 14.5 8.0 5.8 4.9 3.9 19.9 4.5 6.2 0.6 10.8 13.6 5.9 9.2 6.7 8.1 9.3 7.4 10.5 7.1 8.6 8.0 9.5 5.5 8.7 11.3 11.2 8.2 17.9 17.5 18.0 20.3 16.9 19.3 18.7 18.1 16.9 18.4 17.6 17.5 19.0 57.4 12.8 10.3 9.1 17.2 53.7 18.4 36.0 12.5 26.9 35.4 36.7 9.8 45.8 21.8 31.3 58.4 55.7 11.4 18.5 52.8 34.3 28.5 36.6 20.0 34.4 13.8 33.3 7.6 27.0 29.1 23.8 19.4 23.4 11.4 22.3 41.0 32.9 21.4 40.4 10.4 16.0 36.7 24.0 23.8 30.6 28.9 17.3 14.2 4.7 15.4 37.6 15.5 8.5 10.0 26.9 18.9 28.6 17.6 8.3 39.7 55.7 38.5 30.4 0.0 15.2 20.1 130.3 29.2 9.5 42.9 38.6 15.8 39.3 16.6 15.8 GGT6 FLJ90165 ENSG00000167741 "Gamma-glutamyltransferase 6" Q6P531 17 4556927-4560818 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 54.3;intestine: 53.9;salivary gland: 56.3;skin 1: 55.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 208.5;Intestinal goblet cells: 69.4;Paneth cells: 135.8;Proximal enterocytes: 130.9;Undifferentiated cells: 86.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "RT4: 58.5;SK-BR-3: 19.4;T-47d: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023362, HPA027213" Approved NA NA 72000 "HPA023362: AB_1848955, HPA027213: AB_10601326" "unprognostic (2.23e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-3)" "unprognostic (4.51e-2)" "unprognostic (9.71e-2)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "prognostic favorable (4.35e-4)" "unprognostic (2.10e-1)" "unprognostic (2.33e-1)" "unprognostic (3.07e-2)" "unprognostic (5.06e-2)" "prognostic favorable (9.42e-7)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (9.17e-2)" "unprognostic (8.07e-3)" 0.3 0.6 0.4 5.0 0.5 0.2 9.1 0.6 0.6 4.2 0.4 53.9 44.9 0.4 41.4 54.3 8.5 5.3 0.0 0.5 0.3 39.5 0.5 3.5 0.0 0.5 0.4 0.5 0.5 47.2 0.0 0.5 0.0 0.5 6.5 34.4 0.1 56.3 6.4 0.4 55.7 38.7 0.8 0.2 0.1 23.9 0.7 0.4 0.7 0.2 0.0 9.1 18.6 18.9 0.8 3.6 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 6.3 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 58.5 0.2 0.2 0.0 19.4 0.0 0.0 60.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.4 0.5 0.6 0.6 0.5 0.3 0.5 0.4 0.5 0.5 0.2 0.4 0.8 0.1 35.3 6.9 0.0 1.1 4.1 14.7 12.5 5.2 0.0 17.9 11.0 0.2 20.0 38.0 23.9 2.1 0.0 0.3 208.5 21.5 23.8 0.1 7.4 0.3 0.5 6.0 0.0 0.0 38.2 0.0 0.9 24.5 2.6 0.0 0.1 0.4 0.0 0.1 0.0 0.0 69.4 12.2 0.0 1.8 0.2 0.6 0.6 0.0 0.0 2.0 0.1 0.0 0.0 0.0 10.6 135.8 0.0 0.0 5.5 130.9 39.5 45.9 0.3 0.0 0.4 2.3 0.0 0.1 30.6 20.9 0.0 1.0 0.0 86.1 26.7 KLK1 Klk6 ENSG00000167748 "Kallikrein 1" P06870 19 50819146-50823787 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 88 "pancreas: 9639.0;salivary gland: 5536.6" "Group enriched" "Detected in many" 7 "Exocrine glandular cells: 788.4;Intestinal goblet cells: 1317.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 50.9;renal cancer: 84.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 9.5;naive B-cell: 4.0" "Lineage enriched" "Detected in single" 13 "B-cells: 9.5" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 43.8" HPA059690 Approved "Secreted to digestive system" NA NA 10000000 "HPA059690: " "unprognostic (1.51e-3)" "unprognostic (1.23e-2)" "unprognostic (4.20e-1)" "unprognostic (1.73e-2)" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (1.92e-2)" "unprognostic (7.47e-3)" "unprognostic (1.66e-1)" "unprognostic (2.49e-2)" "unprognostic (8.06e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-2)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.23e-2)" 1.4 2.4 0.1 4.1 0.0 0.4 1.8 0.0 0.4 1.8 0.0 69.5 9.7 2.0 0.0 1.3 0.6 0.1 3.0 0.2 0.0 86.6 0.6 0.5 0.5 0.0 0.0 0.0 4.8 9639.0 0.4 0.2 1.1 0.0 2.8 53.6 0.0 5536.6 0.1 0.2 26.4 9.8 2.8 0.0 3.3 1.5 0.1 0.0 0.2 2.9 0.2 1.5 0.2 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.4 0.2 0.3 0.5 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.1 0.1 0.4 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.1 0.0 0.0 9.7 0.0 0.1 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 9.5 0.0 0.0 0.1 4.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 18.9 19.5 1.2 2.9 1.2 0.0 1.0 1.1 0.3 0.0 2.5 0.0 0.0 0.0 0.2 62.2 45.0 3.3 0.6 0.1 1.4 0.4 117.1 0.0 0.0 788.4 0.0 7.7 1.5 0.0 8.9 8.8 0.4 0.0 0.6 0.0 0.0 1317.5 14.2 1.6 5.3 0.3 6.2 1.5 5.4 0.0 6.2 0.0 0.0 0.0 0.0 125.8 134.4 0.0 10.9 9.8 57.1 0.3 0.3 0.0 0.0 0.0 1.1 0.3 0.9 1.7 54.0 0.0 2.1 2.5 148.5 3.8 KLK4 "EMSP, EMSP1, KLK-L1, PRSS17, PSTS" ENSG00000167749 "Kallikrein related peptidase 4" Q9Y5K2 19 50906352-50910738 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Hydrolase, Protease, Serine protease" "Amelogenesis imperfecta, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 32 "prostate: 288.8" "Cell type enriched" "Detected in some" 15 "Prostatic glandular cells: 106.1" "Cancer enriched" "Detected in many" 55 "prostate cancer: 463.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.4;HaCaT: 7.9;OE19: 7.3;SK-BR-3: 5.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "spinal cord: 4.5" HPA051839 Enhanced "Secreted in male reproductive system" NA NA "HPA051839: AB_2681632" "unprognostic (3.58e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-3)" "unprognostic (1.66e-3)" "unprognostic (3.11e-2)" "unprognostic (4.35e-1)" "unprognostic (3.18e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-2)" "unprognostic (8.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.20e-3)" "unprognostic (3.27e-3)" "unprognostic (2.21e-2)" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" 0.4 2.9 0.6 1.5 0.3 1.1 1.7 1.6 1.1 4.6 0.0 3.0 7.3 4.4 1.1 2.1 0.6 1.0 0.1 0.3 0.3 0.6 1.2 0.3 0.8 1.5 0.7 0.1 0.1 0.9 1.0 0.0 0.3 1.4 288.8 3.7 0.5 4.9 2.7 3.5 9.0 5.1 0.3 0.4 0.3 1.9 1.2 0.5 0.1 3.9 1.3 0.8 1.2 0.2 1.1 4.1 1.6 0.2 0.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.5 6.4 0.4 0.3 0.1 0.2 7.9 0.0 4.2 0.0 1.1 1.1 1.3 3.8 1.4 0.0 1.4 1.7 0.0 1.9 0.0 0.0 0.2 0.0 0.3 0.7 3.3 0.0 1.0 0.1 2.0 0.1 7.3 0.3 0.3 0.4 0.9 0.0 2.6 0.0 0.4 0.3 5.1 0.0 0.2 4.0 0.3 0.9 0.2 0.2 1.0 0.2 2.0 0.9 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.6 1.1 0.3 0.3 1.5 0.7 0.1 1.4 0.4 0.5 1.1 0.1 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.0 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 2.6 0.1 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 106.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.6 0.0 0.0 3.3 1.0 2.6 KLK2 ENSG00000167751 "Kallikrein related peptidase 2" P20151 19 50861568-50880567 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 87 "prostate: 571.2" "Cell type enriched" "Detected in some" 40 "Prostatic glandular cells: 777.2" "Cancer enriched" "Detected in some" 1666 "prostate cancer: 989.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.5;NB-4: 5.6" HPA000764 Supported "Secreted in male reproductive system" NA NA "HPA000764: AB_1079700" "unprognostic (3.05e-2)" "unprognostic (2.40e-1)" "unprognostic (1.69e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (6.44e-2)" "unprognostic (8.06e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-3)" "unprognostic (7.56e-2)" "unprognostic (8.10e-2)" "unprognostic (1.68e-1)" "unprognostic (2.04e-1)" 0.7 1.2 3.8 1.2 2.8 6.5 0.5 5.1 5.0 0.1 2.4 0.4 1.5 0.6 1.1 0.5 0.3 0.2 0.3 2.8 1.8 0.4 0.8 0.5 1.0 3.1 2.2 3.1 0.4 0.0 0.8 0.0 0.2 3.7 571.2 0.3 1.8 1.9 0.4 1.0 0.8 1.0 0.1 1.5 0.7 0.5 3.0 2.2 0.0 1.9 0.0 0.2 0.2 0.0 4.1 0.9 0.6 0.3 0.7 0.0 0.4 3.5 0.2 0.1 0.1 0.1 0.3 0.4 1.0 0.1 0.0 0.3 0.9 0.1 0.0 0.1 0.9 0.6 0.0 0.7 0.0 0.0 0.1 1.7 0.2 0.1 0.1 0.2 0.2 0.0 0.6 0.7 0.9 0.2 1.0 0.6 5.6 0.5 0.9 0.0 0.4 0.0 1.6 0.0 1.1 0.5 0.5 0.1 0.7 0.6 0.1 0.5 0.2 0.4 0.6 1.0 2.6 0.9 0.8 1.8 0.4 1.0 0.6 0.7 0.4 0.6 0.5 0.3 0.3 0.2 0.3 0.2 0.3 0.1 0.6 0.2 0.4 1.7 0.4 0.2 0.5 0.1 0.2 3.8 2.8 5.1 5.0 2.8 1.8 3.1 2.2 3.1 3.7 1.5 2.2 4.1 0.0 0.0 0.6 0.0 0.2 0.3 10.2 0.0 0.0 0.0 16.1 2.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 5.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 777.2 0.0 0.1 0.0 0.0 0.0 0.0 1.8 19.3 7.2 0.0 0.9 0.0 0.6 1.7 0.0 12.0 KLK5 "KLK-L2, SCTE" ENSG00000167754 "Kallikrein related peptidase 5" Q9Y337 19 50943303-50953093 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 185.1" "Group enriched" "Detected in some" 4 "Early spermatids: 85.4;Late spermatids: 193.2" "Group enriched" "Detected in many" 5 "head and neck cancer: 73.1;melanoma: 32.1;ovarian cancer: 112.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 41 "A-431: 485.1;HaCaT: 455.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014343, CAB025503, CAB026341, HPA073512" Enhanced "Secreted in other tissues" NA NA 2500000 "CAB025503: , CAB026341: , HPA014343: AB_1852603, HPA073512: " "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.30e-4)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.79e-4)" "unprognostic (3.04e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" "unprognostic (2.21e-1)" "unprognostic (2.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.16e-3)" "prognostic unfavorable (3.85e-6)" 2.2 0.0 1.1 0.0 1.1 0.0 30.5 0.4 2.6 7.5 0.6 0.0 0.1 0.1 0.0 23.2 0.5 0.0 0.1 1.0 0.9 0.5 0.1 6.1 0.0 0.9 1.1 1.2 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 23.8 0.0 1.1 185.1 0.0 0.0 0.5 0.3 0.0 14.3 1.0 0.1 0.1 0.0 0.6 0.0 13.6 1.2 485.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.1 455.4 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.0 1.1 0.0 1.5 0.1 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.4 2.6 1.0 0.9 0.9 1.1 1.2 1.3 0.5 1.0 1.2 0.2 16.0 0.0 0.0 0.0 26.8 1.8 2.4 12.0 0.0 33.0 27.2 0.3 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 85.4 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 193.2 1.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 1.6 0.8 2.8 10.9 0.0 0.3 0.0 0.0 0.1 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 259.4;esophagus: 95.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 575.5;CAPAN-2: 1346.5" "Region enhanced" "Detected in all" "pons and medulla: 167.8" "Region enhanced" "Detected in many" "spinal cord: 371.7" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 10000000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.1 0.0 91.6 0.0 135.3 0.0 7.3 172.1 120.8 25.4 59.3 0.1 0.2 1.5 0.4 95.0 29.1 3.5 0.0 82.8 115.3 19.8 0.0 0.0 0.0 188.9 143.3 69.9 0.9 0.0 0.0 0.7 0.0 173.7 0.1 0.0 0.0 15.9 2.2 0.0 7.2 0.0 0.0 167.0 5.8 0.1 0.9 130.7 1.5 0.0 0.0 36.8 0.0 27.6 259.4 575.5 0.0 0.0 1.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 67.7 1346.5 0.0 8.1 0.0 0.6 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.1 131.0 2.2 0.1 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 5.6 18.2 1.0 1.9 0.0 1.1 46.3 0.0 1.3 0.0 0.4 0.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.6 135.3 172.1 120.8 82.8 115.3 188.9 143.3 69.9 173.7 167.0 130.7 259.4 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.5 0.0 0.0 23.9 16.1 0.3 0.0 1.7 11.0 0.0 0.1 0.4 0.0 0.0 0.1 2.3 0.6 7.5 0.4 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.5 87.9 7.8 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.9 0.3 1.6 0.0 0.3 0.1 0.0 0.0 2.4 KLK11 "PRSS20, TLSP" ENSG00000167757 "Kallikrein related peptidase 11" Q9UBX7 19 51022216-51028039 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 326.8;salivary gland: 170.9;skin 1: 232.6;vagina: 188.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 152.1;Club cells: 217.9;Late spermatids: 339.0;Prostatic glandular cells: 234.8;Squamous epithelial cells: 176.4;Suprabasal keratinocytes: 217.1;Urothelial cells: 186.1" "Cancer enhanced" "Detected in many" "prostate cancer: 53.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 13.0;HaCaT: 41.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB026340 Approved "Secreted in other tissues" NA NA 1800000 "CAB026340: " "unprognostic (4.23e-2)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.78e-4)" "unprognostic (2.08e-2)" "unprognostic (4.67e-1)" "unprognostic (5.32e-2)" "unprognostic (3.72e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.92e-2)" "unprognostic (4.16e-6)" "unprognostic (3.90e-2)" "unprognostic (2.73e-1)" "unprognostic (4.40e-2)" "unprognostic (2.53e-1)" 13.2 0.2 0.0 0.4 0.0 0.0 17.3 0.9 0.1 55.0 35.5 2.0 0.7 7.3 2.6 326.8 34.5 59.9 1.4 1.7 0.0 0.1 0.8 19.1 0.0 0.1 0.5 0.0 1.6 89.8 0.0 8.9 0.0 0.2 65.5 0.6 0.7 170.9 4.2 2.0 232.6 1.4 0.3 0.0 0.1 114.2 14.5 0.5 2.5 0.4 0.3 27.4 1.4 188.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.4 0.1 13.0 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 1.7 0.0 0.1 0.5 0.0 0.2 0.0 0.5 0.2 0.2 86.6 10.4 0.0 0.4 106.9 152.1 131.6 13.1 0.2 33.4 35.3 0.8 88.6 217.9 0.0 0.0 0.0 0.0 0.1 0.0 9.2 111.6 4.7 1.1 3.8 20.3 0.0 0.0 130.2 0.0 9.1 91.3 15.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 10.7 118.0 0.0 11.4 339.0 2.8 1.8 8.8 0.0 0.1 0.1 0.0 0.0 0.0 79.4 0.0 0.4 0.5 234.8 0.1 0.0 26.9 1.3 0.0 0.2 7.9 2.1 2.5 176.4 217.1 0.0 1.7 0.0 0.4 186.1 KLK13 KLK-L4 ENSG00000167759 "Kallikrein related peptidase 13" Q9UKR3 19 51055626-51065114 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 524.0" "Group enriched" "Detected in some" 4 "Late spermatids: 246.9;Squamous epithelial cells: 68.3" "Group enriched" "Detected in many" 4 "cervical cancer: 20.6;head and neck cancer: 42.3;melanoma: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA062136 Enhanced "Secreted in other tissues" NA NA "HPA062136: AB_2684694" "unprognostic (1.99e-3)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (3.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.69e-1)" "unprognostic (6.76e-2)" "unprognostic (2.18e-2)" "unprognostic (8.30e-2)" "unprognostic (7.07e-6)" "unprognostic (7.33e-2)" "unprognostic (2.53e-1)" "unprognostic (6.38e-2)" "unprognostic (7.06e-2)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.2 46.1 0.7 0.6 1.6 0.5 0.4 524.0 0.5 1.2 0.2 0.1 0.1 0.1 0.2 0.7 0.0 0.1 0.1 0.0 0.2 4.4 0.4 0.3 0.0 0.1 0.6 0.1 0.0 75.5 0.0 0.1 10.9 0.8 0.3 0.1 0.1 1.4 4.4 0.2 0.2 0.3 0.0 64.1 0.2 123.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 27.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.6 1.1 4.0 0.0 0.9 1.9 0.4 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.1 0.1 0.3 1.8 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 246.9 0.3 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.7 68.3 1.3 0.0 0.4 0.4 0.0 2.1 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA025970 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavorable (9.20e-4)" "prognostic favorable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favorable (6.92e-6)" 40.7 54.9 39.0 24.9 51.1 30.4 46.0 52.8 45.3 81.9 38.5 46.1 15.0 51.2 92.8 28.9 88.9 28.5 35.3 36.4 39.1 80.4 13.2 43.2 36.5 45.4 44.0 34.2 101.7 36.8 26.3 77.9 30.3 46.7 81.9 24.5 68.0 33.6 40.9 9.9 29.3 40.7 29.5 38.5 49.3 34.5 22.3 40.3 19.3 72.1 8.9 29.9 50.6 61.5 52.8 19.6 1.0 27.0 19.6 23.7 47.4 15.0 29.9 20.4 17.6 23.7 7.2 16.5 20.2 14.9 20.3 13.0 8.6 16.3 20.1 24.5 2.7 18.4 16.5 18.9 9.3 19.5 12.3 23.1 38.4 24.2 14.7 73.0 61.8 19.9 22.6 19.3 15.7 29.2 13.2 17.4 20.5 7.4 3.4 18.3 17.3 23.2 13.5 45.0 39.1 15.2 12.5 19.2 18.6 7.7 42.9 19.8 12.7 27.0 17.7 10.7 8.5 31.1 1.4 18.3 27.5 1.0 12.8 14.2 4.1 3.0 7.5 5.7 3.2 6.1 5.7 7.0 7.5 3.6 9.3 6.0 6.7 2.7 10.9 4.7 2.5 3.8 3.2 39.0 51.1 52.8 45.3 36.4 39.1 45.4 44.0 34.2 46.7 38.5 40.3 52.8 28.1 35.3 20.0 53.8 20.3 10.3 52.9 23.6 11.4 25.2 23.1 20.7 15.4 12.8 38.1 40.5 35.5 48.4 22.6 10.6 19.6 21.2 24.5 35.2 30.7 28.9 10.8 14.1 26.9 6.9 20.8 32.9 16.3 47.4 37.2 130.5 23.2 1.1 13.5 48.8 57.2 11.3 18.3 5.7 15.8 17.3 42.6 12.0 30.2 46.9 14.6 16.6 37.0 56.8 80.0 10.7 18.5 34.6 9.9 90.8 8.2 23.9 34.9 38.3 6.6 43.3 21.4 15.4 15.8 6.4 9.7 64.0 26.0 62.5 8.8 116.2 KRT80 KB20 ENSG00000167767 "Keratin 80" Q6KB66 12 52168996-52192014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 215.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 25.9;Ductal cells: 63.0;Endometrial ciliated cells: 33.0;Glandular and luminal cells: 33.5;Pancreatic endocrine cells: 48.4;Suprabasal keratinocytes: 37.4;Syncytiotrophoblasts: 58.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 202.5;MCF7: 287.3;SK-BR-3: 127.7;U-2 OS: 174.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA077836, HPA077918" Enhanced "Intermediate filaments" No No 230000000 "Intermediate filaments" "HPA077836: AB_2686857, HPA077918: AB_2686871" "prognostic unfavorable (1.05e-4)" "unprognostic (5.45e-3)" "unprognostic (5.35e-2)" "unprognostic (9.19e-3)" "unprognostic (2.85e-4)" "unprognostic (6.68e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-3)" "unprognostic (5.60e-2)" "unprognostic (4.06e-2)" "unprognostic (7.06e-3)" "unprognostic (1.02e-1)" "unprognostic (8.79e-3)" "unprognostic (8.85e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.98e-2)" 0.4 5.3 0.1 0.3 0.1 0.1 8.8 0.3 0.5 9.2 0.0 0.1 0.5 1.2 0.9 51.4 3.4 2.7 0.3 0.2 0.1 2.3 0.7 3.5 0.0 0.0 0.0 0.1 0.2 11.7 7.0 0.4 7.4 0.1 1.5 0.1 0.5 25.0 3.4 1.3 215.1 0.3 0.1 0.0 0.1 0.5 0.4 0.0 0.8 0.8 0.1 41.5 10.0 36.8 0.0 202.5 66.7 0.0 0.0 0.0 0.0 54.2 2.9 1.8 15.3 4.6 4.5 85.9 0.0 94.4 2.3 99.4 98.5 0.0 1.3 5.3 0.4 0.0 0.0 99.4 2.4 10.1 0.1 0.1 1.1 11.9 3.5 23.0 70.2 23.2 0.0 0.0 0.1 5.4 287.3 0.2 0.1 0.4 58.5 10.1 0.2 79.4 3.0 87.1 35.7 24.5 1.3 50.1 127.7 1.2 5.6 24.1 1.0 13.5 0.3 174.4 0.2 71.6 0.1 0.3 0.5 18.0 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.2 3.9 4.4 0.0 0.0 14.7 4.6 0.4 10.0 9.4 11.0 0.0 25.9 0.1 0.3 0.0 63.0 0.9 33.0 3.7 0.5 0.0 0.0 0.1 20.4 3.4 0.4 0.0 33.5 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 12.2 0.0 1.6 0.5 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 4.8 0.1 1.8 21.7 0.0 0.0 0.4 2.2 0.1 0.0 2.9 37.4 58.3 0.3 0.3 0.3 8.5 KRT1 "EHK1, KRT1A" ENSG00000167768 "Keratin 1" P04264 12 52674736-52680407 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skin 1: 13111.3" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 10030.4" "Group enriched" "Detected in many" 5 "head and neck cancer: 313.8;melanoma: 478.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Group enriched" "Detected in some" 14 "HaCaT: 94.9;hTCEpi: 39.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002153, HPA017917, HPA062908" Enhanced NA NA 35000000000 "CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901" "unprognostic (8.05e-2)" "unprognostic (8.49e-3)" "unprognostic (5.06e-3)" "unprognostic (6.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (3.24e-1)" "unprognostic (1.30e-1)" "unprognostic (2.16e-1)" "unprognostic (9.24e-2)" "unprognostic (6.63e-2)" "unprognostic (3.23e-4)" "unprognostic (1.58e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (1.09e-2)" 6.9 1.4 0.0 0.1 0.0 7.7 469.4 0.0 0.1 226.7 0.0 2.2 0.2 1.3 0.4 31.0 0.4 0.3 4.1 0.0 0.0 1.2 3.6 2.7 0.0 0.0 0.0 0.0 1.4 3.7 0.0 1.4 1.6 0.0 1.6 0.1 0.0 272.2 0.1 48.2 13111.3 2.1 0.2 0.0 1.6 2.1 1.9 0.0 77.5 2.0 0.8 0.5 0.9 1267.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 39.3 0.0 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1681.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 22.3 0.0 0.0 0.0 17.4 0.0 0.0 234.7 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 267.0 0.0 0.0 0.3 265.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 10.5 0.0 0.0 1.1 10030.4 0.0 7.8 0.0 0.3 0.4 ACER1 ASAH3 ENSG00000167769 "Alkaline ceramidase 1" Q8TDN7 19 6306142-6333612 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 84.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.7;Inhibitory neurons: 2.1;Melanocytes: 1.8;Spermatocytes: 1.7;Suprabasal keratinocytes: 5.8" "Group enriched" "Detected in some" 7 "head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.2" "Cell line enhanced" "Detected in single" "T-47d: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-2)" "unprognostic (2.87e-4)" "unprognostic (5.04e-2)" "unprognostic (6.18e-2)" "unprognostic (8.16e-4)" "unprognostic (7.27e-4)" "unprognostic (2.17e-2)" "unprognostic (1.61e-1)" "unprognostic (1.99e-1)" "unprognostic (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.30e-5)" "unprognostic (2.11e-1)" "unprognostic (4.44e-2)" "unprognostic (4.22e-1)" "unprognostic (2.24e-1)" 0.1 0.1 0.1 0.1 0.0 0.1 3.3 0.3 0.1 1.7 0.2 0.0 0.0 0.2 0.2 12.3 0.2 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.7 0.0 0.0 3.3 0.1 0.5 84.3 0.2 0.1 0.0 0.3 0.0 1.1 0.1 1.3 0.0 0.0 0.7 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.5 0.0 0.1 0.7 0.7 0.1 0.3 0.0 0.1 0.8 0.2 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.1 0.9 1.0 1.8 0.0 0.0 0.0 0.0 1.0 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.7 1.0 0.0 5.8 0.0 0.4 0.0 0.0 0.1 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 500000 "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 44.8 57.5 60.0 43.4 75.6 64.1 47.7 49.4 94.1 50.5 35.7 52.2 42.3 49.4 37.8 86.1 56.3 36.2 58.2 72.9 63.2 61.7 47.3 47.5 60.3 60.8 57.3 72.6 44.8 44.3 47.5 49.0 49.7 67.7 54.0 39.7 25.8 54.8 43.0 70.8 78.1 52.3 38.3 45.7 59.1 54.5 57.5 60.6 56.5 52.3 48.9 57.6 53.0 57.2 73.7 113.4 198.9 107.2 95.7 70.7 77.8 83.0 66.0 97.1 143.6 105.1 138.1 104.5 59.3 122.0 106.6 124.4 138.1 140.4 165.4 88.1 69.9 111.7 99.3 114.1 172.9 98.8 99.2 104.3 83.4 106.4 110.2 69.8 74.4 137.2 54.6 71.2 65.3 97.9 237.2 109.2 133.0 126.5 95.4 94.1 88.3 41.8 102.5 151.1 162.1 81.5 117.5 74.6 114.1 123.3 72.9 178.2 86.3 100.1 75.8 74.2 103.3 88.4 76.2 51.7 86.4 98.4 64.0 74.5 228.8 186.8 189.9 165.5 244.2 131.2 149.6 152.1 153.6 203.1 139.3 117.1 130.4 184.6 161.8 218.9 140.7 224.7 313.4 60.0 75.6 49.4 94.1 72.9 63.2 60.8 57.3 72.6 67.7 45.7 60.6 73.7 37.0 19.2 56.5 15.0 67.2 48.3 70.9 137.8 83.6 44.4 42.5 48.8 31.9 37.1 82.5 46.0 39.6 146.2 56.5 104.7 74.3 80.7 72.6 55.4 36.2 43.4 87.8 35.5 17.8 85.5 109.2 50.0 71.9 44.3 48.7 54.6 35.7 33.2 90.4 30.3 16.9 70.8 101.7 57.4 65.9 87.1 34.2 61.0 51.6 8.4 98.0 43.2 78.2 12.5 18.8 90.1 92.0 25.6 80.8 51.8 90.8 85.2 89.2 55.7 26.3 28.1 62.0 48.0 71.4 77.7 52.6 194.8 73.7 51.7 62.7 71.6 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911230-63917164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 20.7;Excitatory neurons: 5.9;Extravillous trophoblasts: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 35.7;NTERA-2: 47.0;SCLC-21H: 72.6;SH-SY5Y: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.3 0.5 1.5 0.2 3.0 0.0 0.4 1.5 3.7 1.2 0.2 0.9 0.8 2.8 1.0 0.4 1.5 0.4 2.7 2.6 1.4 0.3 0.1 0.3 0.0 1.7 1.4 2.4 1.2 0.5 1.4 3.5 0.7 1.9 0.9 0.6 3.5 0.9 0.6 1.5 0.3 0.6 1.0 1.1 0.1 0.7 3.2 1.1 0.9 0.2 0.7 0.0 1.2 0.6 2.4 0.0 1.0 35.7 2.5 0.5 2.9 10.9 0.2 0.6 0.5 1.2 1.4 0.3 0.3 0.4 0.8 0.7 0.4 15.8 0.0 0.3 0.6 2.0 0.5 0.3 11.9 5.9 0.0 0.3 3.5 0.0 0.6 0.0 0.0 0.3 4.8 2.0 0.0 0.0 3.3 3.4 13.2 47.0 4.8 0.1 12.4 2.1 1.0 0.1 0.1 72.6 48.7 0.3 3.2 1.8 8.7 2.7 4.5 0.3 0.1 2.3 0.1 0.1 0.3 0.1 0.4 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 1.5 3.7 2.6 1.4 1.7 1.4 2.4 1.9 1.1 1.1 2.4 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 20.7 0.6 0.4 2.2 0.0 0.1 0.0 0.0 0.5 0.0 1.0 0.0 0.1 0.1 0.3 3.3 0.6 1.2 0.0 5.9 0.2 4.4 1.1 0.0 0.6 0.0 1.2 0.0 0.0 0.2 3.3 1.5 1.2 2.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 2.1 1.0 1.0 1.5 0.2 0.2 0.4 0.0 0.0 0.3 0.1 0.2 2.2 0.0 0.3 0.7 0.7 2.9 0.0 0.3 0.8 0.1 1.2 0.8 0.1 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374370 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 191.9;breast: 166.4;liver: 185.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 318.9;Hepatocytes: 148.4;Pancreatic endocrine cells: 230.4;Proximal enterocytes: 146.3;Skeletal myocytes: 198.3" "Cancer enriched" "Detected in all" 4 "renal cancer: 212.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 3.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "ASC diff: 54.6;HBEC3-KT: 226.5;LHCN-M2: 60.9;TIME: 114.6;U-138 MG: 65.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 7750000 3100000 "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 191.9 23.2 24.7 15.5 28.8 1.4 166.4 24.9 32.9 12.2 13.7 21.0 11.6 6.8 0.1 41.5 8.0 9.5 35.8 27.8 38.4 51.7 185.2 47.0 2.0 26.1 28.5 20.3 9.2 71.4 1.0 16.2 18.5 29.7 30.6 0.9 3.2 19.2 2.6 25.0 30.5 28.2 6.0 26.5 13.2 21.8 6.8 40.3 0.7 34.3 6.3 2.8 26.8 32.4 32.9 0.1 2.2 1.2 3.3 54.6 12.0 0.7 4.4 0.5 0.7 0.2 0.0 20.9 0.2 30.6 8.8 4.5 3.0 0.0 226.5 0.4 1.9 0.4 0.3 0.9 0.9 1.2 0.1 0.2 5.6 1.0 34.0 0.7 6.2 17.4 0.6 1.1 0.5 60.9 1.8 0.2 2.1 0.3 0.0 1.8 1.3 0.1 1.0 11.1 4.0 0.2 0.5 26.2 2.7 4.3 1.5 6.8 0.4 114.6 65.1 0.3 33.3 0.0 0.3 0.1 0.2 44.9 0.0 12.4 3.3 0.1 0.4 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.3 0.0 0.1 0.2 0.1 24.7 28.8 24.9 32.9 27.8 38.4 26.1 28.5 20.3 29.7 26.5 40.3 32.9 53.5 38.5 5.8 128.0 1.2 14.0 39.8 318.9 17.1 0.2 71.8 49.0 5.3 1.5 85.7 14.7 0.0 7.4 2.5 17.1 0.0 107.1 0.7 4.2 6.9 28.9 0.0 0.0 0.4 18.0 111.2 89.1 46.9 13.8 2.5 1.5 17.9 148.4 8.3 0.0 0.6 14.2 16.2 1.6 10.3 2.2 88.0 5.0 8.8 2.8 2.0 2.7 0.0 1.0 4.5 230.4 8.4 131.7 1.0 38.3 146.3 4.5 19.0 0.1 32.9 198.3 121.5 0.0 3.1 21.8 11.5 40.1 2.3 20.7 6.7 77.7 CD320 "8D6, 8D6A" ENSG00000167775 "CD320 molecule" Q9NPF0 19 8302127-8308358 "CD markers, Disease related genes, Predicted membrane proteins" "Growth factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 419.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 418.4;RPMI-8226: 381.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014500, HPA073489" Approved Approved Cytosol NA NA 61000 Cytosol "HPA014500: AB_1846295, HPA073489: AB_2686609" "unprognostic (9.97e-2)" "unprognostic (2.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.54e-3)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (4.19e-2)" "unprognostic (7.13e-2)" "unprognostic (1.31e-1)" "unprognostic (9.35e-3)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (8.92e-2)" "unprognostic (3.14e-1)" "unprognostic (9.90e-2)" 53.8 45.1 35.9 16.0 29.7 8.1 58.0 34.9 43.2 25.5 38.4 42.4 19.0 34.5 64.0 15.9 28.6 16.7 44.4 28.2 34.5 31.2 24.3 26.1 15.4 37.7 32.6 26.2 27.9 45.7 15.7 25.9 11.5 41.4 35.5 15.7 4.7 21.4 12.9 34.5 15.3 44.2 13.1 34.4 57.6 45.9 38.6 35.7 10.6 44.7 16.8 7.1 32.7 21.4 35.0 71.7 71.5 15.5 201.1 49.2 25.6 36.6 36.6 48.5 71.2 54.3 77.0 41.7 63.7 111.4 26.8 53.3 44.7 0.1 57.7 13.8 90.0 216.7 30.8 58.4 111.5 33.1 58.8 74.6 24.4 13.6 41.7 34.4 31.7 70.3 42.3 95.4 214.4 28.4 67.6 63.1 418.4 109.3 62.1 293.6 76.6 21.5 381.7 53.9 1.7 143.4 62.3 75.5 32.1 94.5 11.5 2.6 26.2 40.5 82.0 60.6 122.9 117.0 200.5 136.3 71.0 58.4 214.3 90.2 0.5 2.7 0.1 219.9 3.0 125.9 48.4 140.0 117.7 5.1 49.4 94.1 107.1 3.3 91.0 2.2 113.8 102.4 69.4 35.9 29.7 34.9 43.2 28.2 34.5 37.7 32.6 26.2 41.4 34.4 35.7 35.0 419.5 12.8 18.8 6.2 34.4 18.5 29.8 39.3 25.6 53.7 42.6 47.6 34.6 14.3 13.0 18.4 33.3 42.7 53.4 126.2 13.7 46.5 25.2 14.6 28.2 146.8 50.9 22.5 6.1 18.5 54.0 53.3 23.0 22.5 11.4 65.6 143.5 20.0 29.5 21.9 10.2 69.6 26.4 7.5 20.2 57.9 21.8 6.4 39.2 34.7 6.2 21.6 33.0 9.0 5.5 18.6 54.7 17.0 121.2 60.8 3.3 48.0 8.8 46.2 13.1 32.0 26.3 122.1 30.2 10.4 14.1 35.4 43.3 119.3 128.6 21.1 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079404 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Vesicles, Plasma membrane, Actin filaments" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 32.3 29.4 62.7 18.5 81.2 6.5 30.5 37.7 85.9 32.4 38.7 29.6 19.0 38.4 36.5 32.0 45.5 20.6 41.8 77.2 67.7 27.6 22.3 23.9 17.6 62.6 57.0 75.6 43.9 50.4 43.7 61.2 14.2 70.1 34.7 17.2 39.7 44.2 40.9 21.4 26.3 23.5 31.8 42.3 24.5 36.1 11.6 57.7 13.8 34.9 23.3 20.8 36.8 31.0 77.5 28.4 43.0 5.6 11.5 45.4 22.4 7.3 42.6 22.2 16.1 10.1 7.4 23.8 18.6 34.2 53.5 19.2 26.0 7.6 32.9 10.5 19.4 11.3 11.5 25.5 16.9 34.0 22.3 20.1 20.2 51.6 23.1 34.9 31.6 33.5 9.3 10.4 45.3 28.5 62.3 16.3 11.7 3.2 23.1 30.8 7.1 9.5 38.4 20.6 22.3 9.4 8.9 37.3 34.6 18.1 3.0 31.8 16.7 46.4 18.1 17.9 40.9 29.0 24.7 24.1 5.4 53.8 19.5 22.4 29.9 16.7 47.5 32.7 28.9 30.9 14.6 22.4 26.9 15.5 11.3 18.8 22.7 25.8 17.0 32.8 7.4 13.5 28.9 62.7 81.2 37.7 85.9 77.2 67.7 62.6 57.0 75.6 70.1 42.3 57.7 77.5 13.4 3.2 10.1 4.9 13.3 5.7 19.5 12.0 13.1 46.4 11.3 8.8 20.4 17.2 10.4 18.4 8.4 6.2 8.8 9.1 11.7 30.4 0.9 21.2 10.9 17.1 11.5 2.1 14.4 36.5 14.6 22.9 15.8 16.1 10.1 5.1 18.9 9.1 11.8 43.7 13.5 13.8 10.2 11.7 5.7 2.7 16.1 10.3 10.6 3.7 15.0 38.5 16.5 4.5 5.6 28.6 9.3 33.1 19.1 20.8 10.7 15.6 18.2 23.8 19.7 11.1 20.0 4.5 3.9 12.0 9.5 4.2 14.9 5.1 7.9 16.4 IGFBP6 ENSG00000167779 "Insulin like growth factor binding protein 6" P24592 12 53097436-53102345 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 145.7" "Region enriched" "Detected in all" 5 "hypothalamus: 263.0" "Immune cell enhanced" "Detected in many" "eosinophil: 31.6;non-classical monocyte: 20.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "spinal cord: 120.2" "HPA008005, HPA075088" Uncertain "Secreted to blood" NA NA 199000000 300000000 "HPA008005: AB_1851499, HPA075088: " "unprognostic (4.93e-3)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (8.62e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.55e-1)" "unprognostic (9.79e-2)" "unprognostic (2.00e-2)" "unprognostic (2.08e-2)" "unprognostic (1.05e-1)" "unprognostic (3.52e-2)" "unprognostic (4.05e-2)" "unprognostic (1.23e-3)" "unprognostic (6.97e-3)" "unprognostic (1.22e-1)" "unprognostic (9.35e-2)" "unprognostic (1.35e-1)" 145.2 91.1 28.9 9.3 30.6 0.4 151.8 32.0 51.6 271.3 87.2 68.2 21.0 118.2 130.7 76.5 239.4 37.1 73.1 28.0 263.0 30.2 7.8 40.7 8.8 32.2 30.1 28.1 137.9 16.1 4.8 107.2 15.8 33.4 130.4 28.3 6.6 36.2 123.4 38.9 35.9 53.0 39.3 36.5 45.6 68.2 22.4 39.1 6.9 58.9 103.1 9.2 128.2 215.9 32.2 135.3 219.6 0.2 177.3 313.9 1163.6 0.8 476.9 683.3 126.9 69.0 23.2 294.7 0.0 68.5 1045.9 96.4 453.3 3.0 42.3 26.2 1.2 2.8 4.4 37.1 33.3 111.9 0.8 1.1 325.5 2.3 57.4 11.9 468.5 30.5 7.5 0.6 9.3 53.1 0.5 6.6 1.0 6.8 4.1 150.4 2.3 4.9 5.6 10.1 3.3 1.3 8.7 152.2 0.0 10.9 4.0 6.3 0.5 132.2 87.2 41.2 95.5 18.0 5.3 10.7 0.6 631.6 6.7 49.5 0.0 0.0 31.6 0.6 6.8 3.4 0.1 1.0 5.4 2.1 0.0 0.5 6.8 0.0 0.0 20.1 0.0 0.0 1.5 28.9 30.6 32.0 51.6 28.0 263.0 32.2 30.1 28.1 33.4 36.5 39.1 32.2 83.9 6.4 4.2 2.0 3.4 113.6 41.0 580.8 23.9 2.5 5.9 29.0 21.1 10.0 37.6 20.2 0.0 3.0 3.5 0.2 11.7 87.9 9.6 4.9 99.2 71.9 0.0 3.2 3.1 8.0 4.9 1360.5 30.5 2.5 0.0 2.3 116.4 0.8 7.6 0.0 3.6 0.3 50.8 6.8 122.8 32.6 1030.8 15.2 144.1 19.7 2.5 51.1 0.0 1.5 0.9 77.1 0.0 1495.9 9.6 94.9 0.0 15.2 13.9 2.8 1170.1 102.3 420.9 3.8 6.8 8.0 87.8 3.4 14.1 0.4 0.0 34.1 SOAT2 ACAT2 ENSG00000167780 "Sterol O-acyltransferase 2" O75908 12 53103486-53124535 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 19.6" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 14.3" "Group enriched" "Detected in some" 8 "liver cancer: 5.2;testis cancer: 5.5" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Group enriched" "Detected in some" 5 "CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.53e-1)" "unprognostic (2.72e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (1.30e-4)" "unprognostic (3.88e-3)" "unprognostic (9.26e-2)" "unprognostic (4.20e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (9.05e-2)" "unprognostic (2.37e-1)" "unprognostic (7.58e-3)" "unprognostic (3.28e-1)" 0.3 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.7 0.0 0.2 11.7 0.4 0.3 0.1 0.6 0.4 0.1 0.0 0.0 0.4 2.9 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.4 0.1 0.0 0.2 19.6 0.0 0.0 2.1 0.2 0.2 0.0 0.1 0.3 0.1 0.2 0.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 9.5 0.1 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.7 0.0 0.0 1.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.4 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.2 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.7 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 1.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.2 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 2.5 0.0 0.0 0.0 14.3 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 ZNF558 FLJ30932 ENSG00000167785 "Zinc finger protein 558" Q96NG5 19 8806170-8832314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003151 Uncertain NA NA "HPA003151: AB_1859344" "unprognostic (2.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (2.09e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.04e-4)" "unprognostic (1.61e-2)" "unprognostic (1.58e-2)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (3.20e-1)" "unprognostic (5.89e-3)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.28e-2)" "unprognostic (6.92e-2)" "unprognostic (1.09e-1)" "prognostic favorable (9.30e-5)" 8.9 10.1 7.7 6.6 8.0 4.7 9.6 8.5 9.3 14.0 8.2 10.3 6.0 13.7 9.5 8.0 14.8 5.5 6.4 7.6 8.4 8.5 11.1 8.4 7.4 8.1 8.1 7.2 15.2 11.6 10.4 8.5 5.6 8.0 11.6 8.0 14.7 8.4 8.8 6.9 10.1 9.3 10.4 7.9 9.8 9.6 6.3 8.2 8.0 12.3 6.7 8.1 10.0 10.8 8.5 8.1 2.8 12.8 17.6 11.8 13.2 10.9 5.6 8.5 8.2 12.8 4.1 4.9 4.0 14.5 6.4 10.0 7.2 10.9 0.8 11.5 9.6 0.5 0.3 5.0 2.1 9.4 5.9 9.3 12.7 18.5 5.2 0.0 20.0 0.0 12.3 8.6 15.4 10.8 3.3 5.4 31.4 8.0 3.0 4.0 2.8 10.1 3.5 15.2 8.9 2.7 12.7 6.5 3.7 11.5 15.0 7.9 8.5 0.1 10.4 5.9 16.5 6.7 7.0 6.4 8.8 2.4 5.8 3.5 0.4 0.6 0.3 1.0 0.6 0.8 0.3 0.7 1.1 0.7 1.0 1.2 1.5 0.7 2.0 0.5 1.0 0.5 0.5 7.7 8.0 8.5 9.3 7.6 8.4 8.1 8.1 7.2 8.0 7.9 8.2 8.5 3.8 9.6 5.6 8.1 3.2 3.6 2.9 3.1 9.1 4.8 5.5 5.5 3.6 2.8 5.5 3.7 8.4 4.0 3.9 3.6 1.9 4.5 9.6 4.5 9.3 4.0 1.2 4.0 4.0 3.3 3.7 4.6 11.2 5.0 3.8 5.1 2.9 5.3 2.9 8.4 3.3 3.3 0.0 4.7 1.3 5.2 2.1 2.9 0.0 3.7 2.4 5.9 5.2 5.5 7.9 4.2 2.7 2.6 1.8 3.3 2.8 1.9 3.6 8.6 0.0 5.2 4.8 4.1 3.9 5.4 2.7 1.5 3.9 2.8 3.9 1.5 CABP2 DFNB93 ENSG00000167791 "Calcium binding protein 2" Q9NPB3 11 67518912-67524517 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "retina: 7.4" "Cell type enriched" "Detected in some" 14 "Bipolar cells: 100.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 9.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.2 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67605653-67612554 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 531.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 482.4;Proximal tubular cells: 499.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No 37000 Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 91.7 127.5 82.7 52.9 84.3 73.1 91.6 96.9 107.9 93.1 90.6 124.2 125.6 85.9 34.1 115.0 85.3 47.5 342.2 83.0 88.1 189.2 188.5 77.8 67.2 93.1 85.8 83.2 102.7 118.2 171.2 85.2 47.1 102.0 78.1 74.4 82.3 90.9 73.9 531.1 116.3 97.4 51.6 78.2 99.6 133.1 76.6 92.4 52.1 108.5 444.4 63.4 88.8 89.3 96.8 132.9 133.6 68.8 141.3 85.6 83.4 130.6 84.1 76.4 122.2 82.6 256.8 155.3 241.9 167.3 69.2 99.7 176.8 146.1 126.4 38.4 125.2 114.9 100.0 189.1 127.9 119.0 136.9 106.9 126.7 119.0 100.4 88.0 76.9 109.3 173.9 180.9 192.6 75.8 190.2 163.1 268.0 68.5 295.3 168.8 184.5 135.8 399.1 99.3 95.3 109.9 104.6 104.3 347.4 275.3 46.0 177.4 138.0 90.7 118.9 88.8 172.3 87.5 187.7 116.8 122.6 138.0 144.6 117.7 39.0 72.8 38.1 65.1 83.4 71.6 59.8 55.0 63.2 110.7 60.1 50.2 63.7 13.1 104.0 51.2 73.0 78.1 77.0 82.7 84.3 96.9 107.9 83.0 88.1 93.1 85.8 83.2 102.0 78.2 92.4 96.8 54.6 60.9 75.0 33.3 76.2 80.3 95.9 187.6 77.4 68.7 82.1 94.4 482.4 61.5 120.7 86.5 50.1 203.5 72.8 235.7 397.2 114.9 74.0 43.1 47.5 56.7 98.5 85.0 32.9 112.1 158.8 82.4 137.1 55.2 61.4 99.6 56.4 136.2 136.5 63.9 36.5 155.9 152.5 68.8 81.4 222.7 65.6 68.4 113.8 13.1 81.0 89.3 60.8 19.1 34.6 70.1 122.8 59.0 146.6 55.0 199.4 499.2 80.3 78.5 46.0 90.8 136.9 100.7 83.3 127.0 80.6 189.1 79.3 145.9 274.8 111.7 CDK2AP2 "DOC-1R, p14" ENSG00000167797 "Cyclin dependent kinase 2 associated protein 2" O75956 11 67506497-67508649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038872, HPA047599" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038872: , HPA047599: AB_10963069" "unprognostic (2.44e-1)" "unprognostic (5.01e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.80e-4)" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (8.85e-3)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (3.85e-3)" "unprognostic (4.91e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (7.58e-2)" "unprognostic (3.11e-1)" "unprognostic (6.96e-2)" "unprognostic (1.73e-3)" 39.6 69.8 80.7 46.5 76.4 32.4 34.5 80.5 107.9 41.0 67.0 44.2 43.3 41.6 86.5 45.6 37.8 27.5 78.5 72.8 81.1 88.0 110.6 46.5 65.4 91.0 76.0 66.6 28.1 68.5 25.3 44.0 30.1 84.4 42.3 28.3 25.9 47.6 46.1 23.5 19.0 40.9 30.5 81.5 47.5 48.2 12.7 89.0 56.2 78.7 22.8 48.6 43.2 27.4 90.2 92.9 77.6 33.3 72.4 55.0 19.8 46.9 30.0 25.7 54.8 43.6 104.2 121.6 58.1 111.0 32.6 64.4 67.7 59.5 77.4 16.7 156.0 29.7 36.2 60.8 81.8 113.2 32.7 48.8 17.5 84.8 47.3 93.5 44.2 64.3 86.9 32.5 204.4 23.7 183.5 196.6 111.3 35.2 221.7 83.4 83.6 18.4 245.3 129.1 30.4 23.2 50.9 44.2 130.5 150.8 30.3 73.0 70.0 35.6 26.5 46.4 61.7 27.7 55.0 39.8 65.7 73.2 49.3 34.6 284.3 119.2 266.2 297.9 222.7 261.5 229.6 221.4 267.7 174.8 222.3 117.4 176.3 97.5 292.7 266.1 793.7 291.1 215.2 80.7 76.4 80.5 107.9 72.8 81.1 91.0 76.0 66.6 84.4 81.5 89.0 90.2 54.6 64.1 86.2 4.2 112.0 67.0 47.0 118.3 186.1 27.8 88.8 75.3 76.6 88.6 80.3 117.7 31.3 94.9 206.5 187.0 215.2 85.1 1.7 98.2 50.4 56.8 102.8 42.5 3.5 53.2 192.7 49.0 78.5 104.1 74.8 49.5 45.7 131.3 84.6 33.7 3.6 151.1 81.4 46.8 94.9 2.6 24.5 71.5 113.8 11.2 109.8 61.1 171.0 6.0 14.0 99.1 158.5 30.5 240.8 71.1 139.6 329.7 64.6 29.4 26.3 22.0 76.2 10.2 31.1 170.3 51.0 194.4 131.4 30.1 123.2 76.4 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629937 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 72.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 222.8;Intestinal goblet cells: 102.5;Proximal enterocytes: 139.4;Proximal tubular cells: 237.1;Squamous epithelial cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 218.9" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favorable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 10.0 5.3 6.6 1.9 7.9 3.2 10.0 9.9 10.5 7.8 6.2 10.3 14.4 4.3 2.2 58.0 5.1 1.7 72.8 5.7 8.1 25.4 59.2 6.1 1.8 8.5 8.4 5.5 4.7 13.2 12.1 3.0 1.7 8.3 9.4 5.5 0.8 24.3 4.4 59.4 30.0 11.7 1.5 7.7 4.6 9.2 4.4 8.5 2.5 20.6 42.1 3.7 3.7 12.7 8.8 33.5 13.3 5.1 8.4 4.7 5.9 8.1 6.9 3.2 2.7 2.8 11.0 8.5 35.1 10.6 5.4 3.9 16.1 5.9 4.1 0.3 34.3 14.7 2.0 6.1 34.2 1.4 11.2 16.0 3.6 8.1 3.4 1.1 0.7 6.0 42.6 9.9 30.1 2.2 55.9 18.6 16.0 3.1 58.7 28.0 11.4 2.7 218.9 8.4 5.8 2.6 3.7 1.8 18.7 7.1 1.8 10.2 4.6 1.6 7.1 10.1 45.7 1.3 21.6 15.3 7.1 5.0 14.8 4.1 0.0 1.1 1.1 2.9 4.7 2.5 3.2 1.7 3.5 4.6 6.4 1.5 1.8 0.0 9.5 13.7 12.4 1.3 2.1 6.6 7.9 9.9 10.5 5.7 8.1 8.5 8.4 5.5 8.3 7.7 8.5 8.8 8.7 0.0 6.5 6.2 12.0 12.1 12.7 9.4 17.6 4.5 42.3 39.9 79.5 15.7 12.1 29.5 0.0 29.7 7.2 76.5 84.1 14.3 3.3 8.2 11.0 9.2 2.4 34.5 0.6 23.9 21.4 12.5 23.4 13.8 8.9 3.7 8.6 222.8 9.4 5.0 0.7 102.5 12.2 5.3 10.8 8.0 5.0 5.0 28.4 0.0 2.5 7.9 4.1 1.0 2.9 9.9 26.4 5.3 15.7 18.5 139.4 237.1 4.5 7.8 6.6 7.8 17.7 13.9 8.8 129.6 25.6 17.4 7.6 6.6 69.8 25.0 TBX10 "TBX13, TBX7" ENSG00000167800 "T-box transcription factor 10" O75333 11 67631303-67639560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "intestine: 9.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5" "Low region specificity" "Detected in single" "HPA047881, HPA076197" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA047881: AB_2680199, HPA076197: " "unprognostic (4.66e-2)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (1.83e-4)" "unprognostic (3.12e-1)" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (4.90e-1)" "unprognostic (1.17e-10)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (2.95e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 8.5 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.4 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.0 0.0 0.0 103.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 20.4 0.0 0.0 0.2 42.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.1 PRDX2 "MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA" ENSG00000167815 "Peroxiredoxin 2" P32119 19 12796820-12801800 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1316.7;Erythroid cells: 3153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB008713 Approved NA NA 800000000 "CAB008713: AB_1620974" "unprognostic (1.12e-1)" "unprognostic (1.98e-3)" "unprognostic (8.58e-2)" "unprognostic (4.40e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (2.44e-1)" "unprognostic (2.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.26e-2)" "unprognostic (9.18e-2)" "prognostic favorable (5.66e-11)" "unprognostic (7.01e-3)" "unprognostic (2.15e-1)" "unprognostic (3.51e-2)" "unprognostic (1.41e-1)" 200.7 627.1 333.1 89.1 342.7 692.3 161.1 382.1 465.1 159.1 323.7 209.9 254.0 180.3 145.8 273.9 154.8 135.1 710.6 347.4 369.0 281.7 312.7 110.1 119.3 372.7 363.3 336.9 220.0 203.3 458.5 317.1 88.5 385.3 176.8 142.9 208.9 201.9 125.5 729.8 252.7 202.8 128.1 329.6 119.0 228.5 33.1 378.7 182.9 157.6 855.4 130.3 165.0 173.0 443.0 420.4 1.1 553.9 721.3 79.5 54.2 408.4 189.0 188.0 253.9 143.4 438.1 102.8 122.7 430.9 185.0 30.2 389.5 354.7 309.7 72.9 528.5 561.4 222.6 537.4 665.1 212.4 0.7 1.4 233.6 140.5 191.1 93.0 327.6 238.8 255.3 485.7 187.0 98.7 763.3 500.1 190.2 409.1 289.6 789.4 485.8 0.7 593.0 343.1 450.0 683.8 538.5 449.5 454.9 153.7 100.7 408.0 318.0 105.7 188.2 156.9 526.7 417.7 226.3 242.1 573.5 178.9 75.5 43.8 35.4 170.0 85.6 436.1 129.4 460.6 375.2 589.8 446.2 211.6 288.5 594.7 460.9 22.4 213.2 148.0 124.5 697.4 686.6 333.1 342.7 382.1 465.1 347.4 369.0 372.7 363.3 336.9 385.3 329.6 378.7 443.0 192.2 22.4 36.7 39.5 117.5 221.3 255.6 877.7 187.2 317.9 271.2 322.2 37.1 265.9 347.7 279.6 100.1 692.8 83.5 367.4 1316.7 329.5 3.1 138.6 218.5 130.3 333.7 3153.4 31.8 167.2 558.8 204.3 214.6 197.7 47.0 466.0 137.8 489.7 234.0 215.4 50.8 360.7 754.8 63.8 128.8 13.0 293.9 58.7 281.1 23.4 61.4 531.2 56.7 41.7 29.1 179.6 250.6 321.2 263.4 169.3 765.6 1097.9 152.7 373.2 157.8 142.4 273.2 4.8 7.7 368.5 229.4 508.4 144.4 816.6 475.7 243.1 OR8J3 ENSG00000167822 "Olfactory receptor family 8 subfamily J member 3" Q8NGG0 11 56134721-56140201 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5I1 "HSOlf1, OLF1" ENSG00000167825 "Olfactory receptor family 5 subfamily I member 1" Q13606 11 55935456-55936400 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.1;Spermatogonia: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: AB_2672700" "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favorable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 1.8 1.2 4.4 1.1 4.4 0.4 1.9 4.3 4.2 2.2 3.9 2.4 1.0 2.4 2.4 1.6 2.3 1.3 1.9 4.0 4.1 2.3 2.1 1.5 1.9 4.4 4.4 3.6 3.4 2.8 1.9 1.7 1.5 4.4 2.1 1.3 2.3 1.9 1.4 2.1 1.4 1.9 1.9 4.1 1.9 2.2 2.6 4.4 1.6 2.4 1.8 1.4 1.8 1.8 5.1 5.8 4.3 6.9 7.0 2.4 1.0 3.7 2.8 1.4 2.7 3.7 6.7 1.4 11.5 3.4 1.0 4.0 3.9 4.9 2.8 1.6 4.6 7.4 2.0 10.0 6.0 3.5 0.0 3.4 1.9 3.0 2.9 2.5 1.9 2.0 13.7 10.0 4.1 3.3 2.8 10.1 4.0 13.5 4.9 4.6 8.5 4.4 7.8 2.2 0.8 7.2 4.7 5.4 2.1 4.6 5.2 1.1 2.8 3.2 2.7 4.6 2.1 5.5 5.5 9.3 3.0 6.9 0.3 4.6 1.3 1.9 1.9 4.2 2.0 5.2 12.5 4.7 5.8 3.9 11.4 7.0 6.5 0.1 5.7 1.2 7.4 4.3 3.5 4.4 4.4 4.3 4.2 4.0 4.1 4.4 4.4 3.6 4.4 4.1 4.4 5.1 4.2 0.0 2.6 2.0 5.2 4.2 2.9 4.0 5.7 5.7 3.8 6.6 5.6 0.0 3.9 5.5 0.0 3.9 3.5 3.1 3.9 7.0 8.6 5.5 6.8 5.2 1.2 2.1 3.4 4.0 5.0 3.4 1.5 2.2 0.0 4.0 3.6 3.9 6.1 0.0 3.3 2.4 0.0 3.8 1.3 6.9 3.7 2.9 0.0 3.7 1.8 4.2 0.0 3.0 8.1 3.7 7.6 5.3 1.4 4.1 2.6 3.2 6.5 3.9 0.0 4.4 4.4 18.1 21.7 3.3 4.7 2.1 3.2 3.4 3.8 1.8 MIS12 "hMIS12, KNTC2AP, MGC2488, MTW1" ENSG00000167842 "MIS12 kinetochore complex component" Q9H081 17 5486285-5490814 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 117.7;Late spermatids: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044482 Approved NA NA "HPA044482: AB_10963834" "unprognostic (3.86e-2)" "unprognostic (4.85e-2)" "unprognostic (1.36e-1)" "unprognostic (4.22e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (4.68e-2)" "unprognostic (2.34e-3)" "unprognostic (3.41e-2)" "prognostic favorable (8.00e-4)" "unprognostic (4.13e-3)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (3.65e-2)" 11.7 11.4 11.3 16.3 13.4 17.8 15.6 12.1 12.3 12.2 11.8 12.2 12.3 13.8 31.9 10.2 13.4 10.1 9.6 10.8 12.0 11.3 16.4 11.0 21.7 12.8 12.8 10.1 12.0 14.9 10.7 13.9 10.8 13.3 12.1 14.2 28.3 11.1 13.1 13.7 10.5 14.0 13.2 12.0 18.3 11.8 15.2 12.0 26.4 19.0 13.0 21.4 13.5 8.8 17.0 19.0 21.8 45.4 28.7 18.5 18.4 23.4 26.9 20.1 40.6 36.2 20.4 14.0 47.7 22.9 14.4 19.7 42.2 36.9 25.3 41.3 28.0 24.9 26.7 42.1 24.0 32.6 15.7 31.0 18.4 38.3 34.9 54.3 19.4 21.4 36.8 29.9 46.5 26.0 11.9 34.8 15.6 25.6 24.6 19.4 31.6 44.2 23.0 16.3 19.3 15.7 30.8 28.3 13.2 30.0 32.8 20.0 13.1 14.2 25.8 20.7 22.6 34.0 22.1 21.6 26.8 23.2 22.6 23.9 6.5 8.5 6.6 14.6 9.8 15.5 11.9 12.3 14.4 9.7 9.2 15.5 14.8 4.4 16.1 13.8 12.9 8.8 10.3 11.3 13.4 12.1 12.3 10.8 12.0 12.8 12.8 10.1 13.3 12.0 12.0 17.0 13.6 12.8 15.3 14.0 21.0 12.9 25.8 9.7 19.4 14.4 15.4 12.3 7.6 14.3 12.3 5.5 14.6 13.1 18.7 16.5 23.5 10.4 117.7 11.0 13.1 14.2 21.4 16.8 7.0 7.1 12.7 12.8 10.2 10.3 32.4 11.7 10.0 13.0 10.1 5.0 7.2 20.7 18.3 9.9 17.2 235.3 5.9 9.9 10.6 6.5 7.3 19.9 17.5 7.1 22.2 9.9 19.8 9.4 23.7 19.8 7.9 7.6 13.9 22.1 19.7 16.7 12.2 27.2 11.5 11.7 18.0 21.9 19.5 11.3 13.4 20.6 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541073-74546115 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.8;lung: 8.5;lymphoid tissue: 7.4" "Group enriched" "Detected in some" 5 "granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 228.3;non-classical monocyte: 242.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2" "Low region specificity" "Detected in some" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 4.0 1.3 0.6 6.9 1.2 9.8 0.8 0.8 4.7 0.6 1.1 1.3 1.1 0.6 0.1 0.6 0.7 2.1 0.7 0.6 2.7 0.6 1.5 8.5 2.1 1.5 1.2 0.5 0.3 0.6 0.4 0.4 2.9 2.0 0.5 1.3 0.0 0.7 0.5 0.3 0.4 1.2 3.1 1.2 7.4 0.8 0.3 2.2 1.0 1.0 0.2 1.1 3.9 0.4 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 3.3 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.9 16.2 0.0 51.8 142.1 7.0 0.7 228.3 0.4 2.7 0.3 0.3 158.8 2.4 0.2 0.2 5.2 43.9 242.7 10.5 0.2 64.6 0.6 1.2 0.8 4.7 0.6 2.7 1.5 1.2 0.5 2.0 1.2 2.2 1.8 0.1 0.0 1.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.3 0.1 0.0 0.0 15.2 0.0 0.0 0.2 32.1 0.0 0.0 0.0 0.0 26.3 15.3 0.1 0.0 36.1 1.8 1.0 19.6 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 1.3 0.0 0.0 0.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466399-74484794 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 96.0" "Cell type enhanced" "Detected in some" "dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 10.7 7.5 6.7 31.4 7.4 24.7 4.6 7.4 27.0 2.8 8.9 9.3 11.4 3.6 1.8 3.6 3.1 14.3 3.8 6.9 11.9 3.5 14.7 18.2 27.2 11.5 7.7 6.1 1.5 3.3 1.4 3.7 14.0 13.1 4.0 8.6 1.0 4.0 2.5 1.6 4.5 13.6 11.8 9.6 96.0 5.0 1.2 10.7 14.3 2.4 2.7 11.8 9.6 2.6 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 5.5 104.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.5 45.9 0.0 0.0 0.0 0.2 0.0 88.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 17.1 0.0 845.6 170.3 481.9 226.4 374.2 48.3 18.9 45.5 67.5 159.2 6.4 16.7 52.5 560.5 456.5 387.6 149.7 3.1 197.0 6.7 7.4 7.4 27.0 6.9 11.9 11.5 7.7 6.1 13.1 9.6 10.7 11.1 1.0 0.0 7.4 0.3 7.8 0.9 0.1 0.2 0.0 0.0 0.6 1.8 0.6 1.5 0.7 0.0 0.0 0.7 103.5 0.1 0.0 0.1 0.0 0.6 0.2 2.5 0.0 5.7 0.1 0.0 1.2 0.8 0.5 0.7 59.5 0.0 2.2 1.3 114.0 0.0 0.3 0.2 0.0 97.6 24.0 0.4 0.0 90.9 3.6 5.6 36.6 0.0 225.6 1.0 0.0 0.0 0.1 0.0 14.5 0.1 0.0 0.4 0.6 0.1 6.6 0.6 0.5 0.0 0.4 0.2 0.6 1.5 33.2 0.0 0.2 0.2 TEKT1 ENSG00000167858 "Tektin 1" Q969V4 17 6789133-6831761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 50.9" "Group enriched" "Detected in some" 6 "Early spermatids: 412.2;Endometrial ciliated cells: 173.1;Late spermatids: 146.2;Respiratory ciliated cells: 288.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 7.8" "HPA044444, HPA062285" Approved NA NA "HPA044444: AB_10961038, HPA062285: AB_2684737" "unprognostic (7.28e-3)" "unprognostic (7.24e-3)" "prognostic favorable (6.08e-4)" "unprognostic (2.88e-2)" "unprognostic (8.04e-2)" "unprognostic (3.73e-2)" "unprognostic (1.91e-1)" "unprognostic (4.22e-1)" "unprognostic (2.88e-2)" "unprognostic (1.62e-1)" "unprognostic (7.63e-6)" "unprognostic (6.28e-2)" "unprognostic (2.78e-2)" "unprognostic (9.53e-3)" "unprognostic (3.13e-1)" 0.0 0.0 4.6 0.0 1.8 0.6 0.0 2.4 1.2 0.9 8.1 0.0 0.0 1.2 0.3 0.9 50.9 1.0 0.5 1.5 5.0 0.0 0.2 4.6 0.3 5.2 4.2 0.5 0.3 0.0 0.0 0.8 0.0 4.0 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.1 5.8 0.1 0.1 10.0 2.2 0.1 0.3 0.0 0.0 0.6 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.8 2.4 1.2 1.5 5.0 5.2 4.2 0.5 4.0 5.8 2.2 4.3 0.1 0.0 1.5 2.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.5 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 412.2 173.1 1.5 0.2 0.0 0.0 1.9 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 18.3 0.0 0.0 146.2 2.8 0.3 0.0 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.0 0.7 0.0 0.2 0.0 0.1 288.1 0.0 0.0 0.0 5.3 38.2 3.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950742-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 112.1;salivary gland: 87.0" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA031406: AB_2673866" "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.34e-4)" 12.9 5.9 15.0 6.7 21.1 2.0 23.4 34.3 33.6 20.1 0.4 16.5 39.4 12.0 29.4 5.5 19.1 21.8 11.2 19.3 19.8 12.4 4.5 20.6 5.4 24.4 20.5 20.4 3.0 112.1 14.5 44.3 20.3 28.9 36.5 18.1 8.8 87.0 20.4 4.6 6.8 27.5 6.4 7.3 16.9 69.3 6.9 22.8 2.8 16.9 5.8 6.4 12.4 7.7 32.6 5.2 11.4 1.3 15.8 0.0 0.0 2.7 0.0 0.6 1.1 1.0 10.6 5.8 0.0 1.0 0.0 1.4 4.9 14.5 1.0 0.8 0.0 11.4 0.1 0.3 10.1 2.7 0.0 1.1 0.2 6.0 0.1 2.4 0.3 26.0 3.8 0.7 4.0 0.0 115.9 0.7 0.2 0.4 99.2 7.1 0.2 0.0 21.8 14.5 44.8 21.1 56.7 0.0 172.6 0.0 3.6 101.2 0.0 0.5 0.1 1.4 0.4 0.0 2.0 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.9 0.7 0.0 0.1 1.0 1.1 0.0 0.0 0.0 2.6 0.0 0.4 15.0 21.1 34.3 33.6 19.3 19.8 24.4 20.5 20.4 28.9 7.3 22.8 32.6 21.4 0.0 5.5 4.9 4.6 1.5 2.6 3.1 0.6 14.3 20.4 12.3 3.8 4.3 8.6 0.0 0.0 26.3 1.1 16.0 3.9 19.0 0.4 10.2 3.0 19.1 35.3 0.0 16.1 26.9 1.7 1.0 71.4 20.3 0.0 1.1 20.7 0.4 2.5 20.2 15.5 89.5 16.2 0.8 0.4 1.0 0.9 0.7 7.2 6.5 0.6 2.8 0.0 8.0 50.9 22.9 87.8 0.0 22.7 17.8 107.4 0.5 6.5 4.4 0.0 1.5 1.8 0.4 2.1 0.5 0.4 35.0 1.8 0.1 15.6 13.9 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003634, HPA076987" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA NA Mitochondria "Nucleoplasm, Plasma membrane" "HPA003634: AB_1851388, HPA076987: " "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 22.4 36.6 21.7 18.2 22.2 23.0 24.8 23.9 23.2 16.4 29.5 25.5 19.3 19.5 18.4 32.3 17.6 13.2 44.9 21.1 23.0 35.1 47.6 16.5 24.6 23.1 22.1 20.8 14.3 27.7 25.2 14.1 19.4 23.1 18.8 23.0 11.3 22.0 18.8 79.7 28.3 21.9 19.0 23.0 21.8 26.2 10.6 22.9 18.4 18.8 50.8 24.0 24.7 20.0 24.2 81.1 111.4 36.5 42.1 38.3 37.9 50.5 46.7 50.7 95.7 80.7 86.3 49.5 56.0 37.3 46.8 58.9 56.3 75.6 80.7 100.2 28.1 87.7 43.8 50.5 72.2 72.5 92.5 28.8 40.9 37.8 63.3 101.0 32.3 73.8 57.0 71.7 39.9 54.8 100.9 80.7 63.4 27.5 125.3 147.1 41.2 64.8 81.2 71.1 58.5 33.5 64.1 40.3 72.5 92.9 46.7 97.5 75.6 31.6 50.8 56.0 54.3 89.7 41.0 34.8 63.2 58.5 102.5 43.5 26.6 41.2 21.4 30.8 40.9 27.1 33.8 38.0 31.4 55.3 29.3 27.8 31.1 4.0 42.2 36.1 37.2 67.2 42.5 21.7 22.2 23.9 23.2 21.1 23.0 23.1 22.1 20.8 23.1 23.0 22.9 24.2 18.8 32.1 8.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 22.5 32.8 0.0 0.0 8.1 25.8 0.0 60.1 11.4 0.0 56.7 50.9 0.0 29.3 18.3 8.4 0.0 0.0 0.0 60.3 40.5 8.9 0.0 19.0 1.3 22.3 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 15.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.8 0.0 0.0 121.1 21.1 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 29.1 7.4 43.5 0.0 0.0 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Metabolic proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1142.6;Hofbauer cells: 465.0;Proximal tubular cells: 1059.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria NA NA 60000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 256.1 273.2 276.2 157.4 281.2 188.9 231.1 290.6 388.6 177.8 299.2 340.3 297.8 172.1 282.4 358.8 175.0 141.3 949.3 278.7 289.7 469.6 458.0 175.5 167.4 286.1 275.7 273.2 148.8 224.1 430.7 205.4 175.6 282.9 179.5 326.7 258.3 242.9 202.4 1113.3 258.6 259.5 213.2 280.3 156.3 309.9 94.5 279.5 176.9 266.1 1034.6 223.0 232.3 223.4 300.5 522.8 445.4 335.6 439.8 532.6 647.4 449.1 437.2 571.3 478.5 452.2 351.8 397.1 349.8 282.5 550.2 450.2 462.2 409.0 571.6 637.5 171.6 346.0 359.1 340.2 703.1 524.2 463.5 225.8 555.3 444.8 390.7 552.7 380.9 646.8 268.5 380.1 462.6 595.1 503.3 461.8 515.6 257.1 1185.3 626.9 322.3 970.4 652.3 1007.3 499.7 335.8 368.5 515.5 811.0 730.7 496.9 805.1 463.2 337.4 591.1 413.2 520.0 520.4 369.0 315.5 360.8 530.2 455.4 390.3 410.8 440.7 481.0 274.8 540.9 320.8 364.5 467.5 341.7 509.7 292.8 416.1 388.9 253.0 301.6 458.0 453.6 492.8 495.9 276.2 281.2 290.6 388.6 278.7 289.7 286.1 275.7 273.2 282.9 280.3 279.5 300.5 173.8 173.1 156.4 0.0 35.0 0.0 0.0 0.0 0.0 0.0 159.6 234.2 0.0 0.0 102.8 259.3 0.0 384.3 74.0 0.0 1142.6 313.6 0.0 188.2 153.6 70.4 0.0 0.0 0.0 379.5 328.4 82.7 0.0 207.6 88.3 84.6 0.0 0.0 465.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.1 0.0 0.0 208.8 0.0 0.0 0.0 0.0 284.3 0.0 0.0 13.8 0.0 0.0 1059.2 101.3 0.0 0.0 0.0 88.3 0.0 0.0 0.0 0.0 336.3 54.4 155.9 0.0 0.0 TMEM88 "FLJ20025, MGC71744" ENSG00000167874 "Transmembrane protein 88" Q6PEY1 17 7855066-7856099 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Adipocytes: 177.3;Endothelial cells: 142.1;Hepatic stellate cells: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Group enriched" "Detected in many" 6 "AN3-CA: 65.2;HHSteC: 42.3;HUVEC TERT2: 51.4;NTERA-2: 26.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052991 Approved NA NA "HPA052991: AB_2682006" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (3.44e-2)" "unprognostic (3.03e-1)" "unprognostic (6.49e-2)" "prognostic favorable (4.43e-6)" "unprognostic (1.98e-1)" "unprognostic (2.64e-2)" "unprognostic (2.18e-1)" "unprognostic (5.68e-3)" "unprognostic (9.04e-2)" "unprognostic (1.09e-2)" "unprognostic (2.68e-3)" "unprognostic (1.71e-1)" "unprognostic (7.56e-2)" "unprognostic (2.72e-1)" 39.3 22.5 10.5 8.0 9.7 7.0 29.8 11.0 21.2 18.6 12.5 16.7 5.8 24.3 3.6 6.4 26.7 12.8 69.1 10.1 13.5 37.5 5.9 14.2 3.7 11.7 10.5 8.7 8.5 10.8 7.4 21.5 23.9 11.3 19.5 2.7 2.5 9.4 6.3 35.7 3.4 15.6 10.2 9.7 16.0 18.3 4.9 10.6 2.6 40.0 37.2 0.8 19.3 14.1 11.1 0.2 0.8 8.1 65.2 0.0 0.3 3.9 0.4 0.2 0.1 0.2 1.9 0.3 0.4 0.3 0.7 0.4 0.5 0.6 0.4 0.1 0.0 0.1 0.5 1.2 1.1 42.3 0.6 2.6 1.0 1.8 1.2 0.3 0.6 51.4 0.9 1.2 0.1 0.8 5.0 0.5 1.2 26.5 0.3 0.0 0.3 0.2 0.1 0.6 1.6 0.7 3.7 0.5 0.8 2.0 2.2 1.4 0.2 5.2 0.4 1.6 2.2 0.5 0.2 0.1 0.4 0.2 0.4 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 10.5 9.7 11.0 21.2 10.1 13.5 11.7 10.5 8.7 11.3 9.7 10.6 11.1 177.3 6.4 2.2 2.0 6.2 4.1 4.0 1.4 2.2 4.7 7.9 5.2 5.9 0.0 2.4 1.8 4.2 3.1 3.1 2.0 0.0 2.2 3.0 3.1 2.0 142.1 6.6 0.0 0.6 2.2 1.0 19.2 4.6 6.7 4.5 1.8 109.9 2.4 2.6 3.3 0.9 2.5 0.0 7.3 9.3 8.6 0.9 9.9 0.0 5.6 0.2 0.6 0.0 0.0 0.1 4.0 5.7 0.0 1.0 6.5 2.4 0.6 1.5 1.4 0.0 11.3 6.5 1.7 1.8 2.7 3.1 5.2 2.5 0.8 1.5 3.2 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027306 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 283.4;skin 1: 146.6;vagina: 102.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 26.7;Squamous epithelial cells: 94.1;Suprabasal keratinocytes: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 59.8;MCF7: 40.4;RT4: 87.8;SK-BR-3: 43.2;T-47d: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: AB_2682326" "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 1.1 0.3 0.6 1.0 0.5 2.5 2.6 1.1 1.1 23.6 0.7 8.6 11.1 1.5 1.7 283.4 2.1 1.7 0.2 0.6 0.5 13.2 0.3 9.5 0.6 2.4 1.0 0.5 0.3 4.0 3.4 1.5 0.3 2.8 8.1 1.5 0.6 42.7 1.8 1.4 146.6 9.1 1.0 0.5 0.3 5.3 0.8 0.6 0.4 10.8 0.1 8.0 12.8 102.8 1.5 28.1 23.4 0.0 0.3 0.2 0.0 9.6 0.2 0.0 0.0 0.0 2.6 16.7 0.0 0.1 0.0 0.0 59.8 0.1 7.8 0.1 0.1 0.2 0.7 19.4 17.4 0.0 0.2 4.2 0.2 12.3 0.2 0.0 0.0 0.0 3.7 0.1 1.1 0.0 40.4 1.0 3.6 0.1 11.9 10.5 11.5 0.1 0.4 16.7 87.8 1.1 0.0 11.4 43.2 0.0 0.2 54.1 0.8 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.6 0.5 1.1 1.1 0.6 0.5 2.4 1.0 0.5 2.8 0.5 0.6 1.5 0.2 19.2 19.5 0.0 0.0 11.7 4.7 10.5 26.7 0.3 5.1 2.9 3.7 4.3 16.5 5.5 0.0 0.2 0.2 10.8 1.9 4.4 0.0 4.3 0.6 0.3 20.4 1.3 0.3 0.5 0.2 0.5 12.8 8.9 12.6 0.2 0.0 0.0 0.0 0.0 0.1 5.7 2.0 0.6 2.1 0.1 0.9 0.2 1.8 0.0 0.1 0.0 0.0 0.0 0.1 8.4 7.4 1.9 1.2 4.6 19.3 3.4 13.1 0.1 0.0 0.7 0.7 0.1 1.2 94.1 25.9 0.0 0.4 0.4 15.5 12.9 SRP68 ENSG00000167881 "Signal recognition particle 68" Q9UHB9 17 76038775-76072517 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 319.4" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 162.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "medulla oblongata: 319.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023303, HPA055617" Approved Supported Cytosol NA NA 23000 Cytosol "HPA023303: AB_1857477, HPA055617: AB_2682863" "unprognostic (1.25e-1)" "unprognostic (8.97e-2)" "unprognostic (3.47e-2)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.28e-5)" "unprognostic (3.31e-2)" "unprognostic (8.31e-2)" "unprognostic (1.62e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-2)" "unprognostic (4.42e-2)" "unprognostic (8.73e-2)" "unprognostic (4.75e-2)" "prognostic favorable (2.65e-4)" "unprognostic (4.02e-3)" 37.7 34.9 22.0 25.0 23.3 22.1 36.6 23.4 70.0 37.4 22.0 42.7 21.5 40.1 35.4 50.2 37.7 17.5 40.3 31.4 24.8 31.4 37.3 34.2 29.2 319.4 23.3 21.3 40.1 66.2 38.0 38.0 33.4 39.7 30.9 27.6 28.2 38.8 26.3 103.9 43.8 32.5 34.8 27.9 31.8 41.8 22.4 23.2 31.1 33.1 47.4 37.0 42.2 38.3 25.3 98.0 89.8 51.0 54.9 71.5 57.2 94.3 72.4 50.7 80.7 62.9 75.5 45.5 81.6 36.8 70.5 69.2 66.2 98.2 74.2 119.2 34.3 118.1 72.6 63.4 102.8 86.3 83.9 54.7 48.5 81.3 70.7 61.1 60.0 95.1 47.4 109.0 70.9 67.2 60.1 84.6 43.5 50.3 81.2 91.0 70.1 137.1 79.9 59.2 80.6 63.2 64.9 61.9 103.8 81.8 85.2 91.5 76.4 62.3 89.2 70.7 42.7 99.4 70.5 34.7 87.1 64.0 62.2 66.4 7.6 28.6 37.3 24.5 26.3 26.4 30.5 34.8 37.9 34.3 25.3 39.2 29.4 4.3 45.4 27.1 27.1 34.6 19.4 22.0 23.3 23.4 70.0 31.4 24.8 319.4 23.3 21.3 39.7 27.9 23.2 25.3 20.9 28.9 22.9 12.1 27.9 31.4 49.3 30.2 22.2 24.2 18.2 19.2 27.2 28.6 25.9 12.9 37.5 86.9 21.2 18.3 37.2 43.6 15.0 24.3 26.1 28.1 14.4 41.3 11.1 41.4 63.2 26.8 16.8 28.5 17.1 25.6 21.8 23.2 37.9 37.0 10.8 22.8 20.3 18.5 17.4 20.0 24.2 17.8 24.9 11.2 31.8 36.8 29.9 7.1 11.5 39.0 15.8 28.2 37.9 46.5 20.7 30.4 23.7 26.7 0.0 28.5 31.7 47.2 24.4 26.6 31.7 162.3 25.2 30.2 24.1 48.9 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B" Q3V5L5 17 76868404-76950393 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 12.9" "Cell type enhanced" "Detected in some" "Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Region enhanced" "Detected in many" "cerebral cortex: 12.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 0.2 0.2 3.1 0.2 2.0 0.1 0.1 0.0 12.9 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 4.4 1.9 0.2 0.0 0.3 0.1 1.3 0.0 6.1 0.2 0.0 0.2 0.9 0.2 2.9 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 1.2 0.3 0.2 0.2 0.1 0.0 0.1 0.1 3.0 3.7 32.1 6.4 3.4 0.0 0.0 3.7 0.4 1.3 11.7 6.9 0.1 0.7 0.0 2.5 1.5 13.7 0.2 1.6 0.2 3.0 0.1 0.5 0.0 1.7 0.1 0.0 0.0 0.2 0.1 0.2 0.0 1.8 5.2 2.0 0.7 0.2 0.0 0.0 1.5 0.1 0.0 1.8 0.8 3.5 4.8 5.6 7.1 8.9 0.1 15.9 6.1 5.5 2.4 5.0 0.4 0.2 0.2 5.8 19.2 20.9 0.3 6.3 0.0 0.0 0.7 0.6 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.0 0.0 12.9 4.4 1.9 1.3 0.0 6.1 2.9 0.0 0.3 3.0 0.1 0.0 0.0 16.0 0.1 0.1 0.1 0.0 0.0 5.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.1 0.1 0.8 0.0 0.0 26.2 0.0 3.2 0.2 0.0 0.2 0.0 0.6 0.7 0.0 0.1 0.0 21.9 0.0 0.0 0.0 0.0 8.1 0.6 0.0 0.0 2.8 0.0 0.2 0.0 5.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 1.1 2.4 0.0 0.0 0.1 0.1 0.2 0.0 0.0 TMC8 "EVER2, EVIN2" ENSG00000167895 "Transmembrane channel like 8" Q8IU68 17 78130770-78142968 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 92.6;intestine: 55.1;lymphoid tissue: 117.9" "Cell type enhanced" "Detected in many" "B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047387, HPA054429" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA047387: , HPA054429: AB_2682485" "unprognostic (8.54e-3)" "prognostic favorable (8.45e-6)" "unprognostic (1.32e-1)" "unprognostic (2.33e-3)" "unprognostic (3.59e-1)" "prognostic favorable (4.19e-5)" "unprognostic (6.38e-3)" "unprognostic (6.47e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-1)" "unprognostic (6.06e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.24e-2)" "unprognostic (1.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" 6.3 3.0 3.5 56.5 4.4 92.6 3.7 3.9 5.2 3.4 4.6 5.7 10.4 2.5 0.7 4.8 4.1 7.5 2.4 3.5 6.8 5.2 7.1 18.5 101.3 5.2 4.4 3.1 1.3 2.0 0.5 2.3 4.0 5.7 5.0 4.6 0.1 5.9 1.4 1.8 3.6 55.1 2.5 4.8 117.9 10.5 1.2 6.2 60.6 6.5 0.9 47.1 6.5 5.0 6.2 0.5 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 46.3 2.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.1 16.4 0.1 0.8 0.0 63.0 119.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 4.0 103.9 0.0 1.3 20.9 2.8 0.2 3.5 0.5 1.4 0.3 66.6 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.1 6.9 12.7 0.1 0.0 0.1 0.1 0.0 49.3 2.0 4.6 0.1 51.9 0.1 2.6 2.0 6.6 13.4 3.4 9.7 5.5 10.8 13.3 2.3 4.8 9.4 8.6 3.3 7.5 7.9 2.1 6.5 5.5 3.5 4.4 3.9 5.2 3.5 6.8 5.2 4.4 3.1 5.7 4.8 6.2 6.2 3.6 3.2 10.2 1.0 44.9 5.4 10.4 4.9 4.6 0.2 1.2 1.5 1.9 1.5 6.5 0.0 0.0 0.4 52.3 3.7 0.0 1.0 0.7 1.0 0.6 3.2 1.2 17.1 0.4 1.3 1.4 2.3 2.0 1.8 41.2 0.1 5.7 0.5 30.5 0.0 0.4 1.4 14.2 28.2 44.6 0.5 0.0 22.0 7.2 24.4 30.2 0.2 85.5 1.0 2.7 0.6 3.6 0.4 20.2 2.9 0.9 0.4 2.1 0.2 0.0 0.3 2.0 0.4 0.6 8.4 4.5 0.5 68.6 2.7 7.0 10.7 TK1 ENSG00000167900 "Thymidine kinase 1" P04183 17 78174091-78187233 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA synthesis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 78.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 92.8;Erythroid cells: 108.6;Extravillous trophoblasts: 210.4;Hofbauer cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 34.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Region enhanced" "Detected in some" "white matter: 3.6" "Low region specificity" "Detected in many" CAB004683 Enhanced NA Yes "CAB004683: AB_437067" "unprognostic (7.09e-2)" "unprognostic (1.17e-3)" "unprognostic (1.82e-1)" "unprognostic (2.14e-3)" "unprognostic (3.22e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.87e-4)" "prognostic unfavorable (3.03e-5)" "unprognostic (4.05e-2)" "unprognostic (3.18e-3)" "unprognostic (6.64e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (6.50e-11)" "unprognostic (5.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (4.94e-2)" 3.8 2.8 2.4 20.6 3.0 78.5 6.0 3.1 2.6 3.6 1.4 24.7 18.1 3.0 0.2 27.4 5.0 3.4 2.3 2.2 2.6 8.7 9.3 9.1 35.1 3.0 2.9 1.5 1.3 5.6 0.6 0.6 14.9 3.1 3.5 15.9 0.1 6.3 1.5 5.5 14.3 18.5 10.2 2.2 12.5 18.1 3.1 2.9 25.3 2.0 1.6 30.9 5.5 9.0 3.9 443.9 357.7 68.2 92.5 7.6 28.0 47.3 207.6 113.2 323.1 442.3 324.2 178.7 144.1 72.9 131.7 133.9 204.2 63.4 187.1 158.0 51.2 230.4 252.5 119.9 213.3 2.2 107.1 162.9 13.8 7.1 166.1 22.5 22.3 137.9 49.4 156.7 311.9 130.8 352.0 56.0 68.6 36.7 259.1 240.9 152.6 276.4 324.1 90.6 138.5 33.6 94.2 162.0 481.2 59.7 59.4 303.9 156.1 57.8 302.3 305.7 219.9 292.1 132.5 71.4 181.9 149.0 71.9 142.1 0.0 1.1 0.0 1.8 2.1 0.7 5.8 7.9 4.0 3.4 1.7 0.4 2.2 1.8 10.8 1.7 1.1 34.0 5.5 2.4 3.0 3.1 2.6 2.2 2.6 3.0 2.9 1.5 3.1 2.2 2.9 3.9 1.6 0.0 2.7 0.0 17.1 28.4 13.3 17.8 2.2 0.0 10.6 9.4 0.9 2.8 8.3 12.9 0.0 92.8 3.6 35.0 7.9 7.7 3.0 9.2 3.3 10.6 5.4 108.6 0.3 11.2 210.4 15.7 19.4 7.0 0.0 15.9 7.5 10.5 65.2 0.0 0.2 32.7 8.2 15.5 19.1 6.8 0.6 10.9 3.6 0.0 5.7 0.0 3.1 0.0 1.0 9.6 7.5 0.7 53.6 4.9 3.1 17.5 5.8 0.0 0.0 1.7 20.1 3.8 16.8 24.7 11.2 51.0 8.7 1.7 60.8 24.0 TMEM68 FLJ32370 ENSG00000167904 "Transmembrane protein 68" Q96MH6 8 55696424-55773407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018216, HPA019173" Uncertain Approved Vesicles NA NA Vesicles "HPA018216: AB_2205185, HPA019173: AB_1858129" "unprognostic (4.43e-2)" "unprognostic (3.10e-2)" "unprognostic (8.04e-2)" "unprognostic (2.40e-1)" "unprognostic (4.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.46e-3)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (3.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.41e-2)" "unprognostic (1.63e-1)" 8.9 13.0 7.1 8.3 7.3 11.0 13.2 13.5 8.5 10.3 14.0 14.0 12.8 10.6 14.4 13.1 22.2 10.9 6.0 7.6 7.1 17.5 12.9 10.3 9.5 6.1 6.1 7.1 13.5 10.7 17.8 5.7 12.0 7.7 13.4 14.7 11.5 12.7 10.3 5.1 14.4 12.9 9.5 5.6 8.3 11.2 8.4 6.8 11.1 16.6 5.3 9.3 11.9 7.7 11.0 22.3 13.4 21.5 13.1 17.0 20.3 38.5 19.6 14.6 18.2 17.1 18.3 41.3 24.0 21.8 12.7 22.5 27.0 17.0 25.5 20.2 33.3 19.2 29.0 12.4 19.5 19.1 12.7 15.7 14.1 38.1 18.4 43.2 26.0 16.3 24.9 29.2 23.6 26.3 11.8 31.8 17.0 24.1 46.1 6.5 22.6 8.9 15.7 29.9 16.9 18.0 16.2 12.6 20.3 39.9 27.7 30.2 16.0 13.2 13.8 17.6 23.6 16.2 20.1 27.4 31.4 18.7 20.6 21.1 35.0 7.6 5.9 7.8 5.0 11.1 10.0 9.1 8.1 8.3 9.7 7.5 10.9 8.4 9.4 9.3 7.6 7.4 4.4 7.1 7.3 13.5 8.5 7.6 7.1 6.1 6.1 7.1 7.7 5.6 6.8 11.0 10.5 12.8 12.7 10.7 13.4 34.2 28.0 38.4 19.9 18.2 14.2 12.1 5.2 15.7 30.4 25.8 14.6 32.9 14.6 15.3 13.7 16.4 2.3 42.0 10.4 11.1 15.0 20.0 17.0 8.0 21.1 12.2 13.3 10.4 5.7 12.6 11.4 12.5 13.2 21.9 21.6 26.5 40.7 12.6 11.0 1.2 13.1 9.0 7.2 20.6 13.0 17.2 9.2 26.7 16.9 15.8 21.6 13.9 14.6 26.9 17.4 22.0 66.7 15.3 26.3 9.2 10.8 16.2 15.3 17.5 35.5 22.2 11.7 15.3 15.8 29.3 CYP7A1 CYP7 ENSG00000167910 "Cytochrome P450 family 7 subfamily A member 1" P22680 8 58490178-58500163 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 49.9" "Cell type enriched" "Detected in single" 17 "Hepatocytes: 7.0" "Cancer enriched" "Detected in single" 96 "liver cancer: 28.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.20e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-2)" "prognostic favorable (3.19e-4)" "unprognostic (7.60e-2)" "unprognostic (5.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (8.43e-3)" "unprognostic (3.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977768 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skin 1: 52.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 44000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 3.5 0.7 0.2 0.9 0.3 0.4 3.6 0.4 1.0 0.4 0.3 0.8 0.6 0.4 6.7 3.2 0.3 0.8 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.2 0.1 0.2 0.1 0.3 1.3 0.1 1.6 0.3 0.1 1.2 0.0 0.8 0.0 0.4 52.2 0.6 0.6 0.1 0.2 0.3 0.3 0.3 0.5 0.1 0.1 3.4 1.2 1.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.5 0.4 0.2 0.0 0.1 0.8 0.0 2.7 0.5 5.4 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.9 0.1 0.1 2.2 0.0 2.6 0.0 1.3 0.8 0.1 0.1 0.6 0.9 0.7 0.1 0.1 0.2 0.5 0.5 0.2 0.3 0.4 1.0 0.3 0.3 0.2 0.1 0.2 0.3 0.1 0.3 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 3.7 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 5.0 0.0 0.1 0.7 0.0 5.6 0.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.2 2.8 0.0 0.0 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703752 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 179.4;lymphoid tissue: 76.9" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0" "Group enriched" "Detected in some" 4 "cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 7.0" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Low region specificity" "Detected in some" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" No NA 300000000 "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 8.0 0.0 0.1 16.8 179.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 5.9 0.2 2.3 1.6 0.0 0.0 0.3 0.5 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 76.9 2.6 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 4.0 0.0 0.0 0.0 0.0 GHDC LGP1 ENSG00000167925 "GH3 domain containing" Q8N2G8 17 42188799-42194532 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031650 Uncertain "Intracellular and membrane" NA NA "HPA031650: AB_10601014" "unprognostic (2.30e-2)" "unprognostic (1.63e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.21e-4)" "prognostic unfavorable (6.81e-5)" "unprognostic (5.13e-2)" "unprognostic (3.35e-2)" "unprognostic (2.56e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (6.69e-3)" "unprognostic (5.18e-2)" "prognostic favorable (2.00e-6)" "unprognostic (2.08e-1)" "unprognostic (7.93e-2)" "unprognostic (9.66e-2)" "unprognostic (4.02e-2)" 15.6 33.2 12.7 10.2 13.7 11.9 15.9 13.4 16.4 17.4 13.7 14.9 16.0 15.2 11.0 8.9 16.1 10.7 11.8 12.3 14.2 24.5 18.8 16.1 13.3 16.7 14.4 11.8 22.4 26.6 12.9 16.9 9.4 15.1 20.9 5.4 3.8 24.3 14.3 7.8 9.7 19.5 5.3 13.3 32.5 19.7 5.9 13.7 7.4 27.0 5.8 6.6 15.6 13.4 14.7 7.5 26.1 1.8 20.5 6.8 6.0 16.1 9.9 7.7 5.0 6.5 8.4 35.4 11.4 34.9 9.2 6.1 0.6 5.8 0.2 1.2 18.8 21.1 17.3 11.9 18.0 17.7 13.9 70.4 9.1 5.3 13.7 4.2 6.1 7.8 6.9 16.8 50.0 2.6 9.2 9.0 27.1 4.4 28.1 0.0 8.7 9.5 49.8 13.8 6.0 4.0 13.9 0.3 46.1 34.4 0.4 31.8 22.0 6.7 23.3 9.2 20.4 4.7 37.3 31.3 7.7 19.7 17.3 9.6 0.8 3.2 1.8 2.3 3.0 1.0 2.5 1.5 2.3 2.7 4.1 1.5 1.8 1.6 1.1 4.1 2.4 1.4 2.6 12.7 13.7 13.4 16.4 12.3 14.2 16.7 14.4 11.8 15.1 13.3 13.7 14.7 16.2 0.0 9.6 4.9 9.9 2.9 9.3 8.8 2.2 7.6 8.8 7.1 2.1 14.3 6.7 16.5 6.2 13.1 8.7 5.1 3.9 12.9 1.0 5.6 8.5 12.6 13.8 4.6 2.6 19.3 11.6 10.0 6.1 8.9 13.3 6.5 28.5 15.3 27.9 8.4 4.3 10.7 8.2 25.5 5.4 1.3 11.5 12.6 8.8 2.8 9.3 16.2 13.4 1.0 3.5 10.3 4.8 13.9 4.7 6.5 25.6 16.5 7.8 5.5 0.0 12.8 6.3 2.8 0.5 2.2 1.8 7.3 9.5 15.9 9.4 5.4 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234521-272183 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA 5300000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 60.0 58.4 21.9 25.3 33.4 20.1 46.9 37.4 30.8 38.1 33.7 66.6 102.1 52.9 21.7 60.2 41.1 37.9 105.9 18.9 30.5 57.8 51.9 36.9 19.3 49.7 34.3 17.5 39.8 69.0 48.5 58.6 38.9 46.8 52.9 30.3 9.9 41.5 39.7 177.2 48.6 65.2 41.0 39.7 30.5 60.3 45.4 32.3 16.8 50.9 77.7 15.1 60.6 38.6 68.4 29.5 67.1 72.3 152.1 110.2 66.3 39.2 71.5 92.7 41.9 54.2 67.6 76.9 30.2 104.2 90.8 37.3 55.2 27.6 48.4 35.7 40.5 48.5 35.7 38.8 53.2 81.0 21.4 22.5 74.4 58.7 67.1 48.1 119.8 74.1 39.1 42.1 6.0 44.9 140.0 22.1 25.2 89.1 44.2 31.1 66.5 48.0 120.5 73.9 29.6 83.1 73.9 107.9 58.3 61.5 63.3 81.5 31.4 63.3 76.7 25.2 43.8 21.3 15.6 7.1 37.6 54.4 30.1 104.9 11.7 17.7 13.3 10.1 17.7 5.2 7.1 8.9 10.0 18.0 9.5 10.0 11.3 6.1 15.8 17.2 6.5 9.4 13.9 21.9 33.4 37.4 30.8 18.9 30.5 49.7 34.3 17.5 46.8 39.7 32.3 68.4 20.2 9.6 12.6 0.0 7.4 0.0 11.3 0.0 9.6 8.9 23.9 19.7 0.0 21.5 5.0 31.3 25.0 58.7 8.8 25.2 7.9 49.4 27.9 22.2 26.8 18.1 35.2 14.5 0.0 26.1 48.8 21.0 23.4 33.2 8.8 59.2 22.9 23.5 25.7 10.1 0.0 26.4 0.0 14.4 0.0 78.1 16.8 10.9 0.0 0.0 39.6 11.1 10.3 0.0 0.0 18.4 41.5 21.8 5.7 14.8 102.1 18.6 6.6 12.0 19.7 16.9 20.1 29.2 30.8 18.2 0.0 66.2 6.8 73.3 40.4 10.7 SOST "DAND6, VBCH" ENSG00000167941 Sclerostin Q9BQB4 17 43753738-43758791 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" Heparin-binding "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "kidney: 13.0" "Cell type enhanced" "Detected in some" "B-cells: 1.4;Collecting duct cells: 1.8" "Cancer enhanced" "Detected in some" "lung cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "HaCaT: 5.2;SuSa: 3.0" "Group enriched" "Detected in some" 11 "basal ganglia: 1.7;cerebellum: 1.0" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA 16000 "unprognostic (1.26e-1)" "unprognostic (4.06e-2)" "unprognostic (6.57e-2)" "unprognostic (2.55e-3)" "unprognostic (3.37e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-1)" "unprognostic (8.35e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-1)" "unprognostic (8.92e-2)" "unprognostic (1.56e-1)" "unprognostic (7.90e-2)" 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 13.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 ZNF598 "FLJ00086, HEL2" ENSG00000167962 "Zinc finger protein 598, E3 ubiquitin ligase" 16 1997654-2009821 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041760, HPA041896" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041760: AB_10792490, HPA041896: AB_10796464" "unprognostic (9.43e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (6.76e-3)" "unprognostic (3.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.22e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (4.45e-2)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (4.69e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.81e-2)" "unprognostic (7.81e-2)" 14.9 10.2 2.1 6.9 1.7 11.9 14.0 1.7 5.4 14.7 0.4 14.6 7.1 15.5 0.0 19.6 13.2 2.6 11.1 2.0 1.5 10.8 21.2 15.4 5.5 2.4 1.9 1.4 12.5 32.6 2.3 16.4 5.0 2.3 16.3 1.4 0.4 18.9 4.4 26.9 28.8 14.9 2.1 1.0 18.7 15.0 17.8 1.8 5.2 10.9 3.8 2.9 15.9 15.4 1.5 22.8 30.1 7.0 17.5 4.9 6.6 22.0 17.3 7.4 10.5 8.3 31.9 12.4 23.4 20.0 6.7 7.7 27.0 9.3 17.3 1.7 31.2 69.9 18.6 33.5 18.3 22.3 29.3 20.0 7.9 23.2 16.6 18.9 1.1 11.6 27.2 41.3 31.5 4.0 40.5 25.2 45.0 21.6 8.9 35.4 62.4 14.2 52.9 4.0 8.7 33.5 28.9 17.4 20.4 28.3 1.3 14.5 46.6 20.6 23.0 27.6 21.0 32.4 39.2 36.3 29.6 9.7 27.6 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 2.1 1.7 1.7 5.4 2.0 1.5 2.4 1.9 1.4 2.3 1.0 1.8 1.5 11.7 6.4 11.5 6.2 7.5 29.7 12.9 9.0 10.2 12.8 13.9 12.4 1.0 10.0 8.8 1.8 16.7 9.1 11.1 21.2 0.0 8.1 5.6 10.1 11.6 12.7 11.4 10.8 5.4 26.5 12.8 10.5 36.2 13.7 12.7 11.9 6.8 20.1 9.5 16.8 5.3 36.2 12.2 8.4 10.3 9.7 13.4 8.8 1.8 5.6 8.2 7.8 9.2 1.0 6.7 19.6 9.5 8.2 9.3 23.9 13.5 3.3 12.7 10.7 0.0 11.2 9.1 9.0 11.9 14.0 34.8 9.3 9.8 13.1 20.8 19.7 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.5;choroid plexus: 39.7;liver: 46.3;pancreas: 43.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 36.1;Enteroendocrine cells: 99.4;Excitatory neurons: 52.0;Inhibitory neurons: 28.3;Intestinal goblet cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 20.1;HeLa: 23.2;MCF7: 13.5;SCLC-21H: 27.2;SK-BR-3: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" No No "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favorable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.3 1.2 47.2 0.1 52.4 0.2 0.9 54.8 85.5 1.7 39.7 3.9 5.6 0.2 1.9 1.6 0.6 0.8 1.4 56.5 46.0 1.4 46.3 0.3 0.3 44.4 43.0 51.5 0.2 43.1 3.5 34.2 0.0 47.2 4.9 5.1 6.9 18.6 0.8 1.1 1.5 6.5 0.1 40.6 0.7 13.8 1.0 43.7 0.3 1.7 2.2 0.8 0.8 0.7 48.6 1.7 20.1 0.1 5.1 0.3 0.1 0.1 0.9 1.6 0.7 1.3 0.6 4.0 0.3 1.4 1.3 0.6 3.2 1.1 0.4 0.1 2.2 2.1 0.8 23.2 1.8 0.8 0.0 0.6 0.8 0.2 0.2 0.3 4.6 0.4 3.2 0.4 0.0 2.3 13.5 0.1 1.0 1.2 6.5 1.8 1.7 1.6 3.5 7.7 1.4 27.2 5.4 0.6 24.9 1.0 0.3 8.2 0.3 0.9 0.0 3.5 0.4 0.4 2.9 0.1 0.3 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.2 52.4 54.8 85.5 56.5 46.0 44.4 43.0 51.5 47.2 40.6 43.7 48.6 0.2 0.0 1.1 6.5 1.3 1.3 1.6 1.4 8.0 36.1 1.4 1.4 1.6 1.5 3.4 0.0 4.2 0.0 0.0 2.6 0.0 0.4 0.1 1.0 0.3 0.4 99.4 0.0 52.0 1.0 0.0 0.4 12.8 0.4 0.0 0.5 1.1 8.1 0.2 1.7 28.3 41.9 4.1 0.3 0.0 0.1 0.0 0.1 3.6 8.4 0.0 10.7 0.0 20.1 3.6 0.5 1.8 0.0 3.8 1.5 10.5 0.6 2.3 9.1 0.0 0.3 0.3 0.0 2.4 1.5 0.1 0.1 0.2 0.3 3.2 2.6 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209453 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 15.7 29.6 25.3 9.9 25.3 13.5 17.3 25.0 51.5 15.2 18.4 16.2 12.6 15.6 5.7 25.0 14.7 9.2 22.6 26.2 23.2 26.0 31.5 13.4 10.6 25.5 25.2 24.0 19.6 36.1 13.4 19.9 11.2 27.3 20.6 4.6 5.8 19.8 8.1 39.8 22.2 15.7 4.5 22.6 16.7 22.5 33.9 26.1 9.8 22.6 21.9 5.2 16.9 15.6 27.7 20.5 61.9 23.1 60.5 29.6 20.8 38.2 17.9 20.4 26.7 22.9 83.4 29.5 51.3 40.6 20.1 12.7 25.8 23.1 51.4 3.1 39.4 113.4 36.0 61.0 51.7 44.7 57.3 49.7 29.7 34.8 31.7 41.8 22.6 28.6 74.1 54.9 35.9 14.8 89.4 55.5 74.9 47.3 18.1 57.4 55.6 23.4 93.8 20.7 13.4 73.5 40.1 26.6 62.1 46.3 8.7 38.6 54.2 22.4 33.5 38.9 27.3 23.7 43.0 26.4 57.8 17.6 47.5 29.9 0.0 25.0 4.2 14.1 29.9 11.8 14.4 13.1 15.2 24.6 12.5 15.0 15.1 2.8 14.6 30.1 13.3 13.1 20.7 25.3 25.3 25.0 51.5 26.2 23.2 25.5 25.2 24.0 27.3 22.6 26.1 27.7 11.5 6.4 16.0 10.4 24.6 14.7 16.2 29.6 21.6 31.5 24.7 29.8 3.3 15.7 16.2 16.5 20.9 63.2 13.0 44.6 35.2 34.4 48.7 9.6 13.1 16.8 28.8 26.9 8.9 42.6 50.4 19.2 42.8 11.2 8.2 26.8 20.3 16.7 46.9 30.3 8.4 37.9 22.4 19.1 14.6 105.4 14.9 18.4 17.8 1.0 28.0 29.4 19.6 5.5 5.9 28.6 37.9 15.1 34.1 17.9 43.2 36.3 11.1 30.6 19.7 11.6 16.5 34.7 28.2 29.4 15.5 52.7 15.4 26.8 49.3 17.4 E4F1 E4F ENSG00000167967 "E4F transcription factor 1" Q66K89 16 2223580-2235742 "Enzymes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052042, HPA069007, HPA071325, HPA072309" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: " "unprognostic (3.05e-1)" "prognostic favorable (9.13e-4)" "unprognostic (7.31e-2)" "unprognostic (4.57e-3)" "unprognostic (2.89e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.16e-2)" "unprognostic (4.23e-2)" "unprognostic (3.08e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (8.49e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.85e-1)" "unprognostic (1.03e-1)" "unprognostic (5.12e-1)" "unprognostic (8.93e-3)" 13.4 16.1 6.7 6.6 7.0 11.4 15.2 8.2 13.7 17.6 3.3 16.4 6.2 18.9 1.9 16.2 15.4 3.3 14.1 6.6 5.6 16.2 19.2 13.5 6.9 8.4 6.7 7.2 16.0 15.3 4.5 19.2 5.3 8.9 21.5 1.9 3.0 16.1 5.6 19.2 23.7 15.1 2.8 4.5 20.6 14.9 14.6 6.4 6.5 22.8 4.3 2.8 16.3 16.5 8.0 10.9 20.2 8.3 16.4 4.8 4.4 20.0 14.8 6.6 10.0 6.7 32.7 16.2 15.8 15.8 5.7 5.6 14.6 6.8 7.6 1.8 17.2 25.6 11.2 36.1 18.0 9.3 14.2 19.1 6.6 8.5 9.0 4.1 5.6 6.9 13.5 26.7 10.6 3.8 30.1 18.8 30.6 18.7 6.6 18.8 34.7 9.1 27.9 6.2 7.6 21.4 15.5 18.4 21.9 10.7 3.0 19.4 20.0 12.3 12.0 15.7 12.0 12.4 20.7 10.9 32.0 5.0 10.0 12.3 6.8 8.1 11.7 10.2 9.8 8.8 8.2 8.4 9.7 8.8 8.0 9.0 8.4 11.4 6.9 11.8 5.2 11.4 7.5 6.7 7.0 8.2 13.7 6.6 5.6 8.4 6.7 7.2 8.9 4.5 6.4 8.0 9.1 16.0 8.2 8.5 14.4 7.1 7.9 12.2 9.1 13.8 12.3 10.8 4.9 5.7 13.9 11.0 37.5 20.4 18.5 26.5 11.7 11.1 19.6 12.6 10.2 10.3 25.8 6.5 8.1 10.5 17.2 8.7 31.1 11.6 2.5 12.3 6.8 10.5 12.6 30.3 7.2 19.8 20.3 7.3 7.8 5.0 11.5 7.3 7.2 10.3 9.1 11.3 13.4 5.0 5.5 11.1 14.5 16.1 13.2 9.7 15.4 8.0 12.0 15.7 13.1 9.6 11.2 19.0 16.1 7.6 8.9 13.4 11.8 12.6 15.3 6.4 DNASE1L2 DNAS1L2 ENSG00000167968 "Deoxyribonuclease 1 like 2" Q92874 16 2235816-2238711 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 43.6" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Excitatory neurons: 2.5;Inhibitory neurons: 2.6;Ionocytes: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044714 Uncertain Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA044714: AB_10962870" "unprognostic (9.88e-2)" "unprognostic (1.11e-3)" "unprognostic (6.80e-4)" "unprognostic (4.29e-2)" "unprognostic (2.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (2.50e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-3)" "unprognostic (2.17e-2)" "unprognostic (4.67e-4)" "unprognostic (1.40e-4)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.94e-4)" 0.7 1.1 4.9 0.4 4.6 0.5 1.2 6.4 8.4 1.6 1.6 1.0 0.5 1.2 0.2 0.9 1.2 0.3 0.8 4.1 4.1 2.7 1.7 0.9 0.4 5.5 4.6 4.4 2.0 1.9 0.1 4.8 0.7 7.8 2.3 0.1 1.1 0.8 0.1 0.7 43.6 1.0 0.1 3.3 2.6 1.0 1.5 5.2 0.7 6.0 0.1 0.8 0.9 1.6 7.3 1.4 2.9 1.2 1.3 1.0 0.5 5.0 0.5 0.3 1.1 0.6 3.2 3.0 1.9 1.5 0.1 0.4 0.5 0.4 0.2 0.1 3.8 2.8 0.8 5.6 0.7 0.1 0.9 3.0 0.6 1.0 0.8 0.2 1.1 0.2 2.1 2.7 2.8 0.4 3.4 2.7 5.6 1.2 0.4 1.9 5.0 1.4 2.7 0.6 0.6 2.5 1.3 0.7 1.1 2.1 0.3 4.5 2.0 0.1 2.4 3.1 1.4 1.0 6.8 3.5 1.8 0.8 1.8 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 4.6 6.4 8.4 4.1 4.1 5.5 4.6 4.4 7.8 3.3 5.2 7.3 0.2 0.0 0.6 2.9 0.1 0.1 0.1 0.4 0.0 0.7 0.7 0.5 0.7 1.5 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.2 1.0 0.3 0.0 0.0 2.5 0.0 0.1 0.1 1.1 0.4 0.0 0.6 0.4 0.4 0.1 1.7 2.6 0.1 4.1 0.0 0.0 0.1 0.6 0.1 0.0 1.0 0.1 0.9 0.0 1.0 1.8 0.0 0.1 0.0 0.5 0.2 0.8 0.1 0.1 1.8 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.0 0.2 0.3 0.3 0.1 ECI1 DCI ENSG00000167969 "Enoyl-CoA delta isomerase 1" P42126 16 2239402-2252300 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 301.3;Hepatocytes: 246.5;Proximal tubular cells: 272.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041746, HPA043227" Enhanced Enhanced Mitochondria NA NA 7300000 Mitochondria "HPA041746: AB_10960693, HPA043227: AB_10960273" "unprognostic (4.99e-2)" "prognostic favorable (3.04e-5)" "unprognostic (3.75e-1)" "unprognostic (2.92e-3)" "unprognostic (8.90e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.07e-4)" "unprognostic (1.98e-1)" "unprognostic (2.17e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-2)" "unprognostic (2.66e-2)" "prognostic favorable (8.99e-8)" "unprognostic (2.61e-2)" "unprognostic (3.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.08e-3)" 50.2 57.8 29.8 12.8 32.0 19.8 52.4 33.2 46.3 46.5 49.5 71.5 60.4 45.3 10.7 57.5 51.1 11.4 156.1 26.3 32.0 123.5 237.6 37.5 13.9 33.4 32.2 25.5 38.9 75.3 44.2 50.8 14.7 29.7 57.1 15.2 12.9 79.4 24.4 222.4 49.5 59.3 9.3 31.7 35.6 70.1 18.3 34.0 13.5 105.9 88.6 9.6 50.8 43.9 31.1 29.5 68.0 25.7 107.4 9.6 13.6 96.6 29.5 19.1 23.1 33.7 120.0 88.0 42.3 71.2 17.7 16.9 71.6 29.6 27.5 3.2 74.2 157.1 12.9 61.7 151.7 87.3 38.6 6.0 25.2 63.1 18.9 41.7 16.4 23.6 1.1 71.7 87.1 8.0 119.1 4.0 57.8 60.1 46.8 68.8 134.3 27.7 207.1 45.5 32.5 88.8 56.2 70.0 131.4 92.7 12.6 84.7 67.7 19.6 18.4 68.0 19.9 33.0 95.8 61.0 72.2 23.9 35.4 26.2 1.7 3.6 1.6 1.9 3.8 3.1 4.4 2.8 1.6 3.0 4.9 3.4 2.9 2.0 3.6 2.5 3.6 4.0 0.8 29.8 32.0 33.2 46.3 26.3 32.0 33.4 32.2 25.5 29.7 31.7 34.0 31.1 47.1 3.2 28.2 13.4 28.0 21.3 115.6 11.3 21.1 53.2 77.2 95.1 92.3 94.4 15.0 77.3 43.8 179.6 20.5 151.7 301.3 35.1 10.9 128.2 54.8 28.2 45.5 61.7 4.2 36.9 80.7 33.1 33.1 122.8 5.7 62.2 34.2 246.5 47.9 21.9 6.7 105.9 20.3 31.0 23.8 5.3 24.5 29.8 39.2 4.7 17.5 89.9 5.2 13.0 10.0 33.2 91.1 24.0 36.8 72.8 176.1 272.3 14.6 77.6 0.0 73.4 42.7 6.3 19.6 32.9 22.3 109.9 21.7 50.2 104.7 110.5 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196605 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 46.8" "Cell type enhanced" "Detected in some" "Astrocytes: 39.5;Bipolar cells: 22.9;Excitatory neurons: 20.8;Horizontal cells: 42.1;Inhibitory neurons: 26.4;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 28.6" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.8;HDLM-2: 14.7;HEK 293: 3.2;SCLC-21H: 6.4;SH-SY5Y: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, HPA076882, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB079050: , HPA055990: AB_2682997, HPA076882: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 0.0 0.2 14.3 0.0 15.4 0.0 0.4 0.7 46.8 0.5 0.0 0.3 0.0 0.4 0.0 0.2 0.3 0.0 1.9 21.2 5.2 0.2 0.0 0.0 0.0 26.8 9.8 17.6 0.5 0.5 0.9 4.0 0.0 19.6 0.5 0.0 2.1 0.6 0.1 0.1 0.9 0.1 0.0 0.0 0.0 0.1 1.2 18.2 0.0 0.7 0.0 0.0 0.0 0.3 17.2 0.0 0.4 1.6 3.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.7 0.0 0.0 0.0 1.0 0.3 0.0 14.7 3.2 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.9 0.1 0.0 1.1 0.0 0.8 0.6 0.0 0.0 0.8 0.0 0.3 0.1 0.0 6.4 3.1 0.1 0.2 0.2 0.1 0.8 0.4 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 15.4 0.7 46.8 21.2 5.2 26.8 9.8 17.6 19.6 0.0 18.2 17.2 0.0 0.0 0.0 39.5 0.1 0.4 0.2 0.6 1.2 22.9 1.2 1.3 3.5 0.0 0.1 0.0 8.4 0.0 0.2 0.4 0.0 0.1 0.0 0.6 1.1 0.3 0.0 0.0 20.8 0.2 0.2 0.3 0.0 0.9 0.0 0.4 0.0 0.0 0.1 42.1 26.4 0.1 0.0 0.0 0.3 0.1 0.3 0.1 0.0 4.7 0.0 20.2 0.0 28.6 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 6.4 0.0 0.1 0.1 0.4 1.6 0.4 0.4 0.1 0.1 0.1 0.0 0.1 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 2: 427.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.9 8.8 15.8 3.0 18.1 0.7 6.8 7.9 25.7 2.6 0.0 6.1 2.0 3.7 3.6 3.0 4.4 2.7 5.6 20.7 11.6 6.5 1.1 92.0 3.7 16.5 11.7 19.4 3.4 13.2 11.3 11.1 4.4 17.9 5.0 1.2 7.4 9.2 4.3 6.3 4.3 3.9 4.7 8.8 3.4 4.9 9.0 16.6 11.4 24.8 3.8 6.6 4.6 2.3 17.3 0.7 21.6 4.1 33.1 0.8 0.0 0.3 5.8 1.4 2.3 2.4 3.0 3.4 0.2 8.4 2.7 2.1 0.6 19.2 0.3 0.8 34.6 12.9 2.2 2.5 0.5 2.9 0.4 3.6 0.3 0.5 0.3 1.1 13.4 32.4 0.2 24.0 0.0 0.1 29.3 0.1 2.4 4.4 5.2 10.4 5.4 0.7 3.8 18.7 0.7 45.9 33.0 4.1 23.4 0.6 1.6 76.5 2.0 9.3 0.2 1.1 9.0 9.8 6.1 2.9 0.1 4.7 11.7 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.1 15.8 18.1 7.9 25.7 20.7 11.6 16.5 11.7 19.4 17.9 8.8 16.6 17.3 4.3 70.5 427.4 30.0 1.1 0.6 0.5 0.2 2.2 20.7 8.4 6.7 6.7 4.3 9.5 18.4 12.5 0.0 2.1 0.3 0.0 5.7 7.7 1.3 0.3 6.3 5.4 0.0 60.3 3.8 0.0 2.7 0.0 2.9 29.7 7.7 5.3 0.7 1.0 18.5 58.6 0.8 4.1 1.2 1.8 3.8 1.8 3.1 1.8 13.1 2.2 7.1 2.1 32.2 37.2 1.9 0.4 3.4 3.6 1.5 0.4 2.0 2.4 12.5 6.6 7.2 2.9 5.1 15.0 1.2 1.6 0.0 3.9 1.3 0.4 0.2 KCTD5 FLJ20040 ENSG00000167977 "Potassium channel tetramerization domain containing 5" Q9NXV2 16 2682523-2709030 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 62.6" "Group enriched" "Detected in all" 5 "dendritic cells: 62.6;granulocytes: 16.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.48e-2)" "unprognostic (1.87e-1)" "unprognostic (6.72e-2)" "unprognostic (5.15e-3)" "unprognostic (1.60e-1)" "unprognostic (9.95e-3)" "unprognostic (1.47e-3)" "unprognostic (1.45e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (2.43e-3)" "unprognostic (8.21e-2)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.42e-1)" "unprognostic (1.96e-1)" 11.6 12.0 12.6 15.6 13.5 14.9 10.5 13.4 15.9 12.4 10.4 23.5 16.9 10.8 6.5 34.6 9.8 11.1 10.9 12.3 13.4 10.3 17.9 12.1 21.3 14.5 13.7 12.0 9.9 9.9 8.3 10.9 11.9 14.3 10.7 15.6 6.4 15.3 6.8 16.2 18.7 17.7 8.4 14.8 18.3 16.6 13.1 13.6 15.8 8.9 10.6 16.7 15.0 16.9 15.1 46.9 27.2 23.0 33.6 17.0 20.1 25.9 37.3 21.2 48.1 37.6 32.2 61.9 39.4 26.8 36.3 27.7 40.2 32.5 37.3 24.4 32.0 27.2 41.1 16.0 40.7 33.1 41.1 53.9 21.5 37.6 43.1 38.2 24.6 22.4 40.1 41.2 44.3 29.5 54.6 49.5 41.2 36.2 30.5 48.4 64.7 30.3 73.8 24.2 15.8 38.3 35.2 47.6 48.3 43.8 14.7 40.6 40.1 27.1 60.2 33.0 38.0 44.6 39.9 27.5 58.7 24.3 36.9 47.5 1.1 7.2 16.5 5.1 7.0 4.6 5.4 4.4 6.0 11.5 7.4 4.3 4.8 3.8 6.3 7.0 62.6 4.3 4.3 12.6 13.5 13.4 15.9 12.3 13.4 14.5 13.7 12.0 14.3 14.8 13.6 15.1 13.3 9.6 5.9 2.9 19.5 26.9 13.3 7.3 12.5 10.3 14.8 14.4 8.6 5.7 5.6 3.7 2.1 21.5 55.6 46.3 7.9 17.8 1.2 10.0 11.7 10.1 9.0 16.6 5.2 11.8 27.2 9.7 31.6 17.4 4.5 6.4 4.6 8.3 21.1 18.5 4.7 22.3 8.2 27.7 15.4 2.8 7.5 24.0 17.8 8.4 22.1 16.3 12.3 9.0 9.7 30.5 29.6 8.2 13.0 11.3 18.3 7.7 5.6 8.5 13.1 11.0 12.9 5.8 16.6 17.9 31.3 39.4 17.0 9.4 22.7 18.4 SRRM2 "Cwc21, KIAA0324, SRL300, SRm300" ENSG00000167978 "Serine/arginine repetitive matrix 2" Q9UQ35 16 2752626-2772538 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 150.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041411, HPA066181" Supported Enhanced "Nuclear speckles" NA NA 17000 "Nuclear speckles" "HPA041411: AB_10796671, HPA066181: AB_2685630" "unprognostic (8.48e-2)" "unprognostic (1.80e-1)" "unprognostic (2.44e-1)" "unprognostic (1.81e-1)" "unprognostic (4.23e-2)" "prognostic favorable (6.77e-4)" "prognostic unfavorable (5.08e-4)" "unprognostic (7.39e-2)" "unprognostic (1.64e-1)" "unprognostic (4.74e-2)" "unprognostic (2.72e-1)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.05e-1)" "unprognostic (5.35e-2)" "unprognostic (1.26e-2)" "unprognostic (7.84e-2)" 178.9 217.2 263.4 116.8 268.8 272.8 195.1 280.3 377.7 257.4 285.6 232.0 128.1 221.5 70.6 224.6 256.0 95.1 214.8 265.4 248.8 214.0 254.5 200.3 126.4 282.4 260.1 247.1 267.7 317.7 116.7 172.3 89.9 291.5 219.7 103.8 135.3 245.0 87.7 309.1 206.1 263.7 101.2 238.8 252.7 271.8 148.0 272.6 109.4 233.3 97.8 96.0 213.3 213.5 283.1 108.1 134.7 212.9 147.1 147.1 141.9 125.1 119.8 68.1 105.5 93.5 111.5 123.1 192.2 87.3 134.6 88.2 151.6 170.2 153.6 110.9 139.3 177.5 164.8 284.5 192.9 65.6 171.9 229.6 146.3 145.6 155.0 182.8 210.4 110.5 136.5 187.5 184.1 98.7 186.5 162.6 270.9 196.9 76.4 75.1 286.2 84.0 150.4 136.4 109.7 138.1 120.8 158.1 162.0 98.7 141.7 147.2 137.4 157.1 148.8 150.3 97.9 149.8 161.2 131.6 402.9 51.7 124.0 102.2 150.8 24.0 13.3 8.2 10.6 7.9 15.9 10.4 8.1 5.8 22.9 9.1 12.0 48.2 60.5 10.5 31.9 5.9 3.0 263.4 268.8 280.3 377.7 265.4 248.8 282.4 260.1 247.1 291.5 238.8 272.6 283.1 286.4 141.1 232.4 134.8 221.3 310.5 430.1 204.0 178.2 416.5 271.8 283.3 139.0 147.3 180.5 167.3 291.9 179.3 289.0 244.4 66.5 156.3 83.1 285.4 457.7 230.3 189.6 191.6 71.1 179.5 204.8 235.0 296.2 379.3 134.8 273.1 158.8 183.8 157.2 439.1 76.7 245.2 162.8 124.5 238.7 77.2 251.6 208.1 120.9 116.2 160.9 239.8 195.7 94.0 109.6 159.9 188.4 192.2 262.3 352.3 192.5 99.3 146.6 358.1 197.2 366.8 391.0 231.8 253.7 219.2 365.1 276.2 237.5 339.5 236.5 377.8 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432414-3443504 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 8.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 1.7 1.9 1.0 1.5 1.2 1.9 1.7 1.1 1.4 1.4 0.9 1.1 1.2 1.6 2.1 1.1 1.4 1.9 1.3 1.1 1.3 1.1 1.8 2.4 2.2 1.1 1.2 1.0 2.0 1.6 1.4 1.3 2.3 1.1 1.4 1.0 2.3 1.1 1.2 0.7 1.3 1.3 1.2 1.0 1.8 1.3 3.9 1.4 1.6 2.0 1.1 1.8 1.6 0.9 1.3 0.0 1.2 1.5 3.7 1.1 1.7 5.9 1.8 2.2 1.7 2.1 0.0 2.3 3.1 1.7 2.0 1.3 1.0 3.5 1.6 2.2 1.9 1.4 5.3 3.6 2.2 1.6 3.2 3.1 2.2 2.5 1.9 2.1 1.7 4.7 1.6 1.1 2.0 2.0 1.0 2.3 3.3 5.0 1.4 0.0 1.4 4.5 2.1 1.4 4.9 2.0 2.8 3.5 1.8 1.4 4.1 1.5 4.7 3.1 2.8 1.4 0.0 1.7 2.6 2.9 0.4 0.0 1.8 1.7 3.1 0.8 8.8 0.9 1.7 1.5 0.9 0.7 0.8 0.8 0.7 1.2 0.9 0.2 0.7 0.8 0.4 1.2 0.6 1.0 1.2 1.1 1.4 1.1 1.3 1.1 1.2 1.0 1.1 1.0 1.4 1.3 8.3 25.6 2.6 0.0 4.3 0.1 1.8 0.3 2.8 2.1 4.3 3.8 1.9 1.5 5.2 1.8 0.0 1.2 3.6 1.4 0.0 1.1 8.1 3.8 2.1 4.2 2.4 0.4 2.9 1.0 1.8 2.6 1.5 4.5 3.8 3.0 2.5 1.4 1.2 0.0 1.9 2.1 0.0 1.0 0.7 4.1 1.2 2.7 0.0 4.7 3.0 1.8 0.0 1.0 2.0 1.8 1.0 2.2 2.1 2.4 0.7 1.3 0.9 3.1 6.6 2.7 2.6 5.3 8.0 1.9 0.4 1.5 3.3 1.1 2.4 2.3 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 6.6;lymphoid tissue: 13.7" "Cell type enhanced" "Detected in many" "B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" NA NA Cytosol "Vesicles, Centriolar satellite" "HPA048062: AB_2680242" "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.8 0.8 0.7 7.8 0.5 4.1 0.7 0.8 0.8 0.9 0.8 1.2 1.8 0.9 0.4 0.8 1.2 1.4 1.5 0.4 0.1 1.3 1.1 2.4 13.7 0.4 0.4 0.4 0.7 0.5 0.2 0.9 0.9 0.6 1.1 1.2 1.1 1.1 0.3 1.1 0.5 6.6 0.5 0.2 11.9 2.1 0.9 0.3 11.4 1.5 0.9 11.2 1.5 0.8 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 8.8 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.2 8.7 0.1 0.0 0.0 18.6 9.0 0.0 0.0 0.0 0.0 0.5 0.2 9.2 0.2 0.0 0.0 0.4 7.7 19.7 0.0 0.0 0.1 5.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.1 4.9 0.5 0.3 0.1 0.2 0.1 0.4 0.2 28.9 0.2 13.6 0.1 2.9 0.0 0.0 2.3 0.0 2.1 0.8 1.7 2.2 0.0 0.6 1.4 1.5 0.0 2.6 0.0 0.0 2.0 2.1 0.7 0.5 0.8 0.8 0.4 0.1 0.4 0.4 0.4 0.6 0.2 0.3 0.3 1.7 3.2 0.0 1.0 10.3 0.0 0.3 0.0 0.0 1.6 0.4 0.3 4.6 1.5 0.6 1.8 4.2 0.0 18.8 0.0 0.0 0.0 4.0 1.3 0.8 2.3 0.0 6.5 3.8 0.0 0.0 0.5 1.5 0.7 2.5 0.2 3.9 0.1 0.1 0.0 3.7 0.0 0.0 1.0 0.0 1.3 0.0 1.1 0.0 1.9 1.3 0.3 37.0 1.0 0.6 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.7 5.1 0.0 0.9 0.7 0.5 0.3 0.0 0.0 0.0 23.8 0.1 0.0 0.3 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61446733 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 27.7 37.4 35.5 26.6 36.2 46.0 29.2 37.0 38.2 23.8 36.3 27.5 24.9 24.0 35.2 29.0 28.9 25.8 37.7 35.1 42.1 31.4 46.8 24.0 40.2 37.2 37.0 35.1 27.2 24.2 33.2 41.3 25.1 37.1 29.2 29.4 23.6 26.5 21.1 39.3 26.2 27.3 27.1 36.6 35.0 27.9 22.3 36.9 38.4 28.9 45.1 41.9 33.1 21.9 38.5 45.0 58.4 36.5 25.1 57.2 52.2 27.0 33.3 58.0 48.9 41.8 52.8 46.8 42.3 58.4 55.6 62.8 45.4 45.4 51.4 56.6 60.4 39.7 33.2 35.5 71.9 52.8 41.4 48.1 55.6 58.7 50.2 45.8 35.3 80.8 43.5 42.2 50.9 63.5 86.0 49.2 89.3 56.1 47.0 78.6 45.9 45.9 76.6 63.7 57.9 36.9 40.6 46.9 53.5 99.0 38.5 83.0 40.2 53.3 45.0 32.7 54.3 37.5 31.2 51.2 54.7 43.4 37.3 46.0 125.3 68.8 126.6 82.5 64.5 103.1 89.7 93.0 91.7 55.9 84.8 101.5 97.5 97.9 97.9 53.3 63.3 126.7 78.6 35.5 36.2 37.0 38.2 35.1 42.1 37.2 37.0 35.1 37.1 36.6 36.9 38.5 32.8 35.3 33.2 11.1 28.9 20.6 34.6 53.7 10.2 14.0 27.9 35.1 22.3 14.3 33.5 29.5 6.2 77.0 41.9 29.5 54.8 55.3 15.8 19.3 21.7 36.5 34.2 30.3 13.2 60.3 51.4 28.4 16.8 19.0 32.3 22.2 42.5 42.3 52.7 15.2 13.3 31.4 59.0 36.5 22.8 17.8 31.4 29.7 44.4 8.4 66.4 49.4 69.0 16.6 18.1 62.9 34.9 30.9 16.3 30.8 34.0 51.9 31.5 19.7 32.9 17.3 27.2 23.1 25.8 10.9 22.4 99.6 41.5 45.1 27.6 38.8 DDB1 ENSG00000167986 "Damage specific DNA binding protein 1" Q16531 11 61299451-61342596 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032821, HPA045174, HPA068456" Approved Enhanced Nucleoplasm NA NA 440000 Nucleoplasm "CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992" "unprognostic (3.45e-1)" "unprognostic (8.38e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (6.56e-2)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" "unprognostic (9.74e-3)" "unprognostic (1.09e-1)" "unprognostic (7.42e-3)" "unprognostic (3.11e-1)" "prognostic favorable (1.51e-8)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 53.3 166.2 30.2 44.4 31.0 47.6 59.6 30.0 29.0 61.8 35.4 50.4 53.7 48.4 80.4 50.2 79.0 40.3 65.7 28.8 35.7 65.4 56.3 43.5 47.3 30.2 30.2 25.2 90.1 42.9 233.9 44.9 130.8 34.8 57.1 52.8 163.9 54.6 71.6 134.2 61.1 50.3 62.4 30.2 42.2 44.8 69.7 31.1 81.9 65.5 126.2 67.1 59.1 39.6 34.9 160.3 168.1 159.0 142.2 151.4 139.2 237.8 140.9 193.6 174.4 129.2 188.7 130.7 237.6 126.8 203.4 107.4 141.4 245.5 177.5 188.0 115.7 131.3 128.0 144.3 192.0 109.4 182.7 112.6 169.1 121.7 174.0 146.2 123.5 195.7 86.0 278.4 119.9 158.9 194.7 238.4 77.4 214.5 104.3 146.3 197.9 198.5 254.3 119.7 177.3 140.3 143.0 154.6 183.8 145.9 144.8 226.0 85.6 150.9 120.9 113.6 138.2 106.4 139.5 157.0 194.7 134.9 103.7 121.1 38.4 43.6 36.5 46.7 47.1 61.1 35.8 42.0 47.3 60.5 30.5 37.8 43.3 4.6 46.4 45.3 34.2 49.6 54.6 30.2 31.0 30.0 29.0 28.8 35.7 30.2 30.2 25.2 34.8 30.2 31.1 34.9 34.2 28.9 69.9 46.4 48.8 52.6 53.6 61.1 51.2 87.0 52.0 39.9 105.6 34.3 54.5 53.3 352.3 283.5 57.5 45.0 17.6 43.9 15.7 46.6 40.8 48.1 74.2 102.3 27.8 42.4 130.1 50.6 46.4 51.3 30.9 102.7 45.0 67.4 75.5 87.5 31.6 55.4 44.7 45.3 33.5 18.8 85.1 38.3 42.7 30.0 61.1 64.4 71.1 24.1 31.0 52.6 36.4 62.1 65.4 55.7 63.2 46.7 64.4 451.4 32.9 51.5 44.5 114.0 120.9 52.3 59.8 389.4 46.0 303.8 60.0 57.1 VPS37C FLJ20847 ENSG00000167987 "VPS37C subunit of ESCRT-I" A5D8V6 11 61130257-61161615 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 1.4;eosinophil: 1.7;intermediate monocyte: 2.6;myeloid DC: 1.0;neutrophil: 3.8;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.0;granulocytes: 3.8;monocytes: 2.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favorable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 14.0 14.0 10.8 13.3 10.0 10.4 14.2 9.4 12.3 13.7 10.4 16.6 17.2 16.1 5.2 22.2 12.6 11.3 15.6 11.9 9.1 16.5 10.8 14.7 8.2 11.6 11.0 9.7 14.2 24.3 12.0 20.2 14.2 10.7 21.0 10.6 22.9 23.5 14.8 23.8 22.0 15.6 14.6 9.4 13.4 27.9 15.5 12.0 6.3 12.2 12.0 10.1 18.5 16.0 11.7 33.8 13.1 16.7 16.1 8.0 16.6 37.2 16.4 44.0 23.9 16.2 15.7 15.6 8.8 22.5 22.5 19.7 18.5 15.2 17.3 12.3 19.2 11.4 11.2 9.0 17.8 25.7 9.0 13.7 15.0 26.3 20.6 25.7 14.3 15.8 6.0 29.6 14.6 16.4 41.1 2.0 13.7 20.6 14.7 18.8 3.1 7.2 21.4 18.9 17.2 10.3 25.1 16.4 52.2 28.8 14.0 49.5 22.2 12.1 23.9 17.2 24.4 20.8 6.9 10.0 7.2 21.6 11.1 16.5 0.4 1.4 1.7 0.3 2.6 0.4 0.5 0.2 0.4 1.0 0.5 0.3 0.1 3.8 0.2 2.4 0.1 0.2 0.7 10.8 10.0 9.4 12.3 11.9 9.1 11.6 11.0 9.7 10.7 9.4 12.0 11.7 6.3 16.0 6.0 5.9 4.1 12.5 14.3 9.4 10.2 5.8 14.9 9.3 7.5 12.8 10.0 12.9 10.4 30.6 1.2 15.6 11.7 17.4 8.9 5.0 4.0 11.2 16.3 4.2 8.9 19.8 20.9 10.6 13.7 6.8 0.0 5.1 7.1 6.7 17.3 25.2 7.1 18.3 8.2 13.7 11.4 6.5 7.8 13.9 7.2 13.1 12.3 11.5 2.1 4.5 8.3 21.7 11.3 13.5 2.2 17.7 19.0 7.2 12.2 41.7 0.0 6.7 9.2 12.9 16.7 8.4 19.9 35.2 2.9 7.4 10.6 14.5 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295316 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.4;ovary: 8.0" "Cell type enhanced" "Detected in many" "Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2200000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.3 1.1 0.8 0.1 1.0 1.7 1.6 0.3 1.6 2.2 0.0 0.6 0.3 1.3 0.6 0.9 3.6 0.6 0.7 1.0 0.8 0.5 14.4 0.3 0.2 0.6 0.9 0.8 8.0 0.3 0.1 0.6 2.4 0.5 1.0 0.4 0.9 0.9 0.5 0.7 0.6 0.4 0.5 0.0 0.4 0.4 1.8 0.5 2.5 0.8 0.4 0.1 0.6 1.2 0.4 0.0 0.1 1.5 0.2 0.2 1.8 0.6 0.2 2.0 0.0 0.3 7.2 0.0 0.5 0.0 0.4 0.1 0.0 2.3 0.0 0.1 0.4 0.0 0.8 0.0 26.3 1.2 0.0 0.3 13.4 0.6 0.7 0.0 0.1 2.3 3.3 0.2 0.3 0.3 0.1 5.5 0.0 2.2 0.0 0.0 14.0 0.2 0.0 0.1 0.1 0.6 1.0 0.0 0.1 0.7 2.4 0.9 0.0 0.8 0.3 0.3 0.5 0.2 0.2 0.6 1.2 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.3 1.6 1.0 0.8 0.6 0.9 0.8 0.5 0.0 0.5 0.4 2.1 3.2 1.7 19.2 0.3 1.8 1.8 3.8 3.4 3.6 1.7 0.5 1.0 1.5 2.3 0.0 29.2 1.0 0.5 0.2 0.0 0.1 0.5 2.9 1.0 5.5 1.8 6.1 7.5 0.5 5.0 2.6 0.0 1.8 3.8 6.5 2.5 16.4 1.2 0.0 5.8 0.1 2.0 3.5 2.4 0.8 6.8 2.6 1.8 2.8 2.3 2.3 1.0 2.5 1.4 0.0 0.0 1.9 0.4 1.1 0.1 0.3 5.4 21.1 0.0 0.9 1.1 1.1 3.4 1.3 2.3 4.4 0.9 7.7 0.3 0.7 RAB3IL1 GRAB ENSG00000167994 "RAB3A interacting protein like 1" Q8TBN0 11 61897301-61920269 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 110.9;Hofbauer cells: 65.3;Late spermatids: 133.8;Leydig cells: 56.2;Peritubular cells: 45.1;Theca cells: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 36.9;HHSteC: 36.9;K-562: 34.4;RPMI-8226: 44.3;U-2197: 56.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039723 Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA039723: AB_10795406" "unprognostic (1.62e-1)" "unprognostic (3.59e-2)" "prognostic unfavorable (6.08e-4)" "unprognostic (1.97e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (7.93e-2)" "unprognostic (2.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.86e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.42e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.59e-3)" 29.0 9.5 8.9 8.0 9.1 13.9 23.0 8.7 13.5 34.7 11.5 12.2 4.8 30.3 4.6 6.3 24.2 11.4 19.0 8.9 11.3 15.9 7.0 11.9 6.5 10.6 9.0 7.6 37.4 5.2 7.8 9.5 16.1 9.7 10.7 2.6 3.1 12.3 5.2 7.6 13.7 10.0 9.4 9.6 28.4 9.5 41.5 12.3 9.1 15.3 10.1 2.4 19.2 20.8 10.8 6.9 13.3 0.4 7.3 26.9 19.9 1.5 5.5 13.7 8.0 5.4 1.9 1.5 0.1 10.1 8.4 36.9 3.7 9.6 0.5 1.2 0.0 2.1 12.8 5.1 7.2 36.9 0.5 0.3 10.7 6.9 3.9 9.1 1.3 0.7 7.1 34.4 0.3 4.7 12.3 0.0 0.1 4.3 1.2 14.1 0.7 1.9 44.3 0.7 0.5 0.6 4.9 3.4 2.9 25.0 2.2 2.2 1.6 0.6 29.3 13.2 56.5 2.3 0.4 2.1 0.0 5.7 15.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 9.1 8.7 13.5 8.9 11.3 10.6 9.0 7.6 9.7 9.6 12.3 10.8 5.5 0.0 0.0 1.6 0.8 5.1 0.9 0.0 0.6 0.5 1.3 1.9 1.9 2.8 0.6 1.8 0.0 1.3 0.1 0.1 1.9 2.2 110.9 1.9 27.8 9.6 0.0 34.5 0.4 1.0 2.0 24.3 1.1 1.8 0.0 1.1 16.1 1.4 65.3 1.7 1.3 0.0 0.0 19.9 10.2 133.8 56.2 6.8 8.8 8.4 0.0 6.5 0.0 1.0 0.7 1.1 0.0 45.1 0.0 1.6 0.0 15.9 0.0 8.2 0.0 3.4 8.2 1.7 9.1 0.2 4.0 1.4 0.6 47.6 0.2 0.2 BEST1 "BEST, BMD, RP50, VMD2" ENSG00000167995 "Bestrophin 1" O76090 11 61950063-61965515 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.5;brain: 45.3" "Cell type enhanced" "Detected in many" "Langerhans cells: 272.8" "Group enriched" "Detected in some" 6 "glioma: 2.0;melanoma: 6.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 37.6" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 71.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057464 Enhanced NA NA "HPA057464: AB_2683444" "unprognostic (2.41e-3)" "unprognostic (3.67e-2)" "unprognostic (5.91e-3)" "unprognostic (1.21e-1)" "unprognostic (1.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.07e-3)" "unprognostic (2.06e-1)" "unprognostic (4.27e-10)" "unprognostic (1.38e-1)" "unprognostic (4.93e-2)" "unprognostic (3.59e-3)" "unprognostic (2.72e-3)" 7.8 3.7 20.4 8.3 31.2 26.5 5.4 27.2 23.2 5.1 13.6 3.8 1.7 4.1 10.0 2.8 6.0 5.2 4.5 18.6 24.7 3.4 2.6 10.4 2.3 29.5 30.2 15.9 4.7 2.5 0.3 3.4 2.4 39.4 4.1 1.0 6.8 2.3 2.0 1.6 2.6 3.9 1.8 24.5 11.1 3.4 5.5 27.1 0.4 2.7 1.4 0.4 5.4 4.7 45.3 0.8 0.8 0.4 0.7 17.7 3.8 1.4 1.0 1.8 0.4 1.3 0.5 0.5 0.1 1.7 1.1 2.0 1.1 0.0 0.0 0.3 0.3 0.2 0.0 6.7 0.9 4.9 0.2 0.5 5.6 1.6 1.9 4.1 1.8 0.0 0.8 0.8 7.6 1.9 0.6 0.1 0.6 0.0 0.8 2.1 0.0 0.1 0.3 0.0 2.0 1.0 0.9 1.6 0.1 71.6 0.8 0.7 2.3 0.2 0.9 0.5 0.7 0.3 10.3 0.8 0.7 4.8 0.6 1.2 2.6 3.9 3.9 0.2 4.6 0.2 0.7 0.2 0.1 2.6 0.2 0.1 0.1 37.6 0.1 5.1 0.4 0.3 1.9 20.4 31.2 27.2 23.2 18.6 24.7 29.5 30.2 15.9 39.4 24.5 27.1 45.3 2.7 25.6 59.3 9.1 11.4 36.3 6.3 54.8 18.8 2.0 22.0 7.4 3.3 14.3 57.2 1.8 0.0 14.5 5.6 22.5 0.0 3.8 8.3 5.3 9.0 16.4 10.3 29.0 0.3 3.3 23.4 32.4 9.2 9.0 76.4 1.9 21.0 13.8 37.1 0.0 0.7 10.7 22.4 75.4 272.8 2.9 15.2 49.0 55.2 1.0 14.1 6.0 3.1 17.1 43.0 3.1 21.0 6.8 5.9 11.8 28.0 5.6 37.7 9.6 6.6 16.1 20.8 3.2 4.1 6.2 32.7 20.4 24.5 0.9 11.9 13.2 FTH1 "FHC, FTH, FTHL6, PIG15, PLIF" ENSG00000167996 "Ferritin heavy chain 1" P02794 11 61959718-61967634 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Iron storage" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 49889.9;monocytes: 34409.9;Proximal enterocytes: 28837.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 23933.9;HHSteC: 24849.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB008623 Approved NA NA 5600000 "CAB008623: " "unprognostic (7.15e-2)" "unprognostic (1.52e-2)" "unprognostic (2.27e-1)" "unprognostic (2.00e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (6.18e-4)" "unprognostic (3.08e-2)" "unprognostic (2.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.44e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (2.99e-1)" "unprognostic (4.89e-2)" "unprognostic (3.44e-1)" "unprognostic (5.83e-2)" 6601.3 5234.2 6776.8 3578.2 5981.3 4775.8 5744.6 6104.0 8037.8 3510.2 5399.6 4251.7 1836.4 3743.9 2443.0 4057.2 3223.3 2013.2 4587.1 5777.6 6784.7 6015.1 3529.6 6110.5 1472.5 6976.4 6429.8 5574.3 3095.6 3916.4 1710.5 2121.9 1815.3 7046.4 2802.5 3389.6 3150.9 3562.0 1529.0 4734.1 2071.8 4367.9 2059.1 7118.6 3524.5 4077.5 775.4 6620.4 1120.0 3193.7 2791.3 1301.8 4757.8 3190.4 8451.6 3029.8 8290.2 1236.6 3293.8 23933.9 11490.1 6794.4 2684.1 11547.3 2694.6 2698.6 1011.0 4065.8 345.3 16669.6 7830.0 10259.7 5035.8 1118.8 2235.9 1733.9 1439.0 542.9 1720.3 10802.1 6692.1 24849.2 821.6 2626.6 15711.1 10758.7 5384.0 10038.1 8476.6 3427.6 1970.7 2622.1 3874.4 9546.5 4080.7 935.3 1361.8 2114.6 10461.4 13675.6 914.9 1508.5 2502.3 13877.6 8068.8 1044.8 1325.0 9113.3 1005.9 4645.6 4045.3 1790.3 1098.4 3791.5 8310.7 1978.7 3727.4 1732.0 662.7 2516.5 1088.1 11353.7 363.1 2030.4 29466.0 19068.5 15453.6 2306.3 22407.8 2274.9 4088.8 3267.1 2296.9 9762.5 4113.3 2710.5 2108.2 45110.1 1981.1 27515.2 7217.1 4321.5 22214.4 6776.8 5981.3 6104.0 8037.8 5777.6 6784.7 6976.4 6429.8 5574.3 7046.4 7118.6 6620.4 8451.6 3864.7 1317.3 2890.3 319.3 3200.9 5157.7 7723.2 23426.3 3495.0 881.7 9884.9 10192.4 11.7 4466.7 11711.1 1918.2 573.4 4541.1 4513.5 13653.9 10888.0 10748.7 274.2 4921.8 2908.5 4303.3 2520.6 6318.6 252.8 11073.9 6803.9 5931.3 2059.7 8005.0 6736.0 1798.6 3266.1 5199.9 18411.3 738.6 153.7 3927.4 10379.8 13784.1 49889.9 527.7 4666.1 22792.0 7116.5 183.6 34409.9 12189.1 1699.3 153.3 1031.0 7813.2 7936.8 3818.1 1789.1 12995.8 28837.7 21355.6 5978.6 3311.6 2084.0 2686.9 6139.1 585.4 927.1 1983.6 3555.6 4622.6 5225.4 2496.8 4921.7 18650.3 BSCL2 "GNG3LG, seipin, SPG17" ENSG00000168000 "BSCL2 lipid droplet biogenesis associated, seipin" Q96G97 11 62690275-62709845 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid degradation, Lipid metabolism" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 250.4;pituitary gland: 238.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 35.9;Late spermatids: 53.1;Plasma cells: 86.3;Spermatocytes: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 242.1;RPMI-8226: 176.1;SCLC-21H: 181.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042394 Approved NA NA "HPA042394: AB_10794047" "unprognostic (7.78e-2)" "unprognostic (8.74e-2)" "unprognostic (1.24e-1)" "unprognostic (8.17e-2)" "unprognostic (3.08e-2)" "unprognostic (2.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (9.30e-2)" "unprognostic (4.44e-2)" "unprognostic (5.13e-3)" "unprognostic (2.41e-1)" "prognostic favorable (7.55e-5)" "unprognostic (3.56e-1)" "unprognostic (1.69e-1)" "unprognostic (1.70e-1)" "unprognostic (1.96e-1)" 22.5 88.9 130.7 7.5 147.9 12.1 26.4 91.0 156.8 38.6 92.3 24.4 10.9 28.7 158.1 24.3 64.2 21.7 18.6 141.4 250.4 51.2 39.6 26.9 15.5 139.7 163.1 150.6 32.9 80.1 62.2 238.8 10.1 177.3 35.7 13.4 53.1 66.7 30.6 31.1 24.4 17.3 13.8 97.7 16.3 37.4 191.8 163.0 14.5 38.2 15.6 9.0 17.7 26.3 197.4 18.0 61.7 49.6 83.8 130.8 41.5 7.2 7.2 34.4 13.6 14.5 9.6 26.3 11.9 16.5 25.2 11.8 62.1 5.2 21.8 7.0 30.7 5.0 10.9 33.4 7.8 27.7 9.7 13.5 27.8 16.6 26.9 10.9 19.7 10.8 33.0 7.8 242.1 19.8 44.0 11.4 21.8 132.4 13.9 13.0 21.3 4.2 176.1 65.0 2.4 181.2 29.4 28.2 13.9 25.3 5.7 41.3 15.3 6.5 16.5 3.7 24.5 4.2 32.2 72.5 16.6 82.4 3.2 14.5 26.6 59.2 34.6 24.7 46.2 27.4 27.5 25.5 26.1 42.4 29.7 25.7 27.0 14.2 41.0 40.3 54.3 33.1 43.3 130.7 147.9 91.0 156.8 141.4 250.4 139.7 163.1 150.6 177.3 97.7 163.0 197.4 0.8 16.0 5.6 0.0 7.1 1.7 1.0 1.4 35.9 2.5 3.6 2.2 0.2 1.5 1.6 3.7 0.0 2.4 0.9 1.7 3.9 2.0 25.5 4.8 1.5 2.9 0.0 8.8 0.0 1.1 1.9 9.2 20.4 1.5 2.5 0.7 1.4 2.1 1.9 3.3 0.0 1.6 6.1 2.5 3.1 53.1 2.5 6.2 12.4 0.0 0.7 0.8 1.0 0.0 0.0 0.5 1.6 3.0 86.3 0.9 2.5 6.0 23.9 1.2 6.6 1.2 4.1 32.6 18.1 24.7 4.0 1.5 6.5 0.7 1.2 0.5 POLR2G "hRPB19, hsRPB7, RPB7" ENSG00000168002 "RNA polymerase II subunit G" P62487 11 62761565-62766710 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053000 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053000: AB_2682010" "unprognostic (7.58e-3)" "unprognostic (2.75e-1)" "unprognostic (2.37e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.39e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (6.02e-5)" "unprognostic (8.50e-2)" "unprognostic (6.01e-2)" "unprognostic (6.26e-3)" "unprognostic (9.41e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (2.21e-1)" 59.6 70.1 76.1 48.7 79.4 71.2 76.1 82.5 101.9 55.3 74.5 54.4 37.6 53.0 86.6 59.7 64.9 41.9 54.0 75.6 86.4 64.6 68.5 49.5 89.8 84.6 79.6 73.6 55.1 41.5 58.4 41.4 61.2 83.5 55.7 66.7 76.7 42.3 52.3 45.8 60.3 44.4 66.8 83.1 63.2 50.3 32.9 77.4 113.3 54.1 47.8 107.1 53.6 50.5 92.0 124.4 212.7 225.1 142.9 114.0 111.7 56.7 85.7 107.8 199.8 159.9 129.3 141.4 173.9 192.5 129.8 86.2 118.9 103.6 159.8 176.4 342.3 129.7 116.6 157.2 156.5 159.6 159.7 103.2 108.8 161.2 93.0 185.9 105.6 157.9 160.5 148.5 115.4 143.4 389.4 230.6 209.4 142.3 130.7 218.2 185.6 207.0 234.8 150.8 103.8 95.7 162.1 143.8 112.8 226.2 84.6 318.6 132.6 62.7 101.7 109.0 199.1 101.0 89.0 177.6 192.8 103.7 99.8 139.1 169.9 147.5 164.1 127.2 160.7 124.2 150.4 109.0 126.0 174.9 146.7 103.5 129.6 64.0 154.6 175.3 184.5 151.0 230.5 76.1 79.4 82.5 101.9 75.6 86.4 84.6 79.6 73.6 83.5 83.1 77.4 92.0 50.9 38.5 60.7 3.3 69.1 44.9 46.6 209.0 43.3 43.5 47.0 56.3 46.4 55.8 102.3 77.3 8.4 222.1 79.3 27.5 140.8 120.3 7.4 51.3 66.4 73.3 58.6 59.3 1.9 111.3 138.4 69.5 30.5 61.2 90.0 69.6 73.5 73.8 191.6 38.7 2.2 55.1 148.5 74.5 80.7 14.9 70.8 86.4 88.9 2.8 149.2 147.2 118.4 2.5 8.5 93.1 48.3 62.1 39.3 35.1 44.1 150.4 58.0 55.9 78.9 51.8 65.7 36.4 38.9 62.9 60.4 139.0 79.7 91.7 77.6 41.4 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856004-62888880 "Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 780.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 1441.0;SiHa: 1287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 170000000 "Nucleoplasm, Plasma membrane" "CAB010455: AB_638288, HPA017980: AB_2669723" "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favorable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavorable (1.48e-4)" 96.5 106.4 121.0 47.1 119.7 123.1 109.9 125.3 161.7 100.4 99.5 56.9 51.9 98.0 65.9 113.8 94.8 36.1 50.8 110.1 117.1 170.3 72.4 118.8 35.1 124.6 114.4 99.1 93.8 110.6 191.1 65.8 55.8 120.8 101.7 23.3 23.0 111.5 42.3 123.3 122.5 80.3 34.1 123.3 78.0 90.9 65.6 136.5 30.4 111.1 26.2 29.0 78.3 95.9 116.8 155.5 675.7 60.2 213.2 89.7 69.7 596.7 267.5 106.2 154.0 126.3 643.3 293.0 173.9 290.5 185.4 284.5 540.0 123.1 588.9 84.3 319.3 114.0 117.5 422.4 299.2 825.7 136.0 169.4 144.9 1441.0 175.3 528.8 46.2 83.6 380.7 232.9 347.4 95.1 792.6 149.8 181.3 106.9 222.5 214.2 153.8 92.7 341.8 113.9 84.0 112.5 53.5 1287.0 499.6 948.5 121.2 161.5 182.6 146.2 138.3 200.0 204.4 195.5 436.0 556.1 561.2 135.0 225.1 418.0 37.8 149.0 49.7 117.9 147.4 157.7 58.3 107.3 122.1 88.6 72.1 90.1 97.2 31.2 90.3 123.9 304.7 112.5 186.3 121.0 119.7 125.3 161.7 110.1 117.1 124.6 114.4 99.1 120.8 123.3 136.5 116.8 97.8 48.1 37.3 91.1 78.8 218.1 244.2 321.7 399.5 58.4 124.2 120.8 13.4 30.0 141.1 49.7 66.7 222.5 136.2 109.6 33.2 161.9 31.5 122.0 96.3 149.2 84.3 117.7 16.9 151.1 143.7 102.9 71.4 179.7 84.3 43.2 99.2 27.0 202.9 53.8 25.1 60.4 223.8 54.1 140.9 28.9 30.4 141.5 224.1 29.0 104.7 188.4 40.2 21.1 11.3 130.6 58.7 30.5 140.9 156.9 120.7 227.4 63.4 61.2 6.6 71.8 114.6 21.3 31.9 160.7 150.6 780.7 118.1 52.4 60.7 194.9 PLAAT5 "HRASLS5, HRLP5, iNAT, PLAAT-5" ENSG00000168004 "Phospholipase A and acyltransferase 5" Q96KN8 11 63461404-63491194 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.6;pancreas: 13.7;testis: 53.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0" "Cancer enhanced" "Detected in many" "breast cancer: 3.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 64 "basophil: 5.4;eosinophil: 16.4" "Lineage enriched" "Detected in single" 97 "granulocytes: 16.4" "Group enriched" "Detected in some" 5 "HAP1: 11.4;NB-4: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042493 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042493: AB_10797499" "unprognostic (3.16e-1)" "unprognostic (3.45e-2)" "unprognostic (2.83e-3)" "unprognostic (4.24e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (7.11e-3)" "unprognostic (2.14e-1)" "unprognostic (6.66e-2)" "unprognostic (9.46e-2)" "unprognostic (8.89e-3)" "unprognostic (3.15e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-5)" "unprognostic (1.52e-1)" "unprognostic (1.21e-2)" "unprognostic (2.57e-3)" "unprognostic (4.50e-4)" 16.6 0.2 1.1 0.3 0.9 0.1 3.4 0.9 0.8 0.1 0.0 0.6 0.2 0.5 0.2 0.8 0.9 0.6 0.6 0.9 2.3 0.1 0.0 0.6 0.1 1.4 0.5 0.6 0.6 13.7 0.0 0.0 0.0 0.9 0.4 0.2 0.5 0.8 1.4 0.1 0.2 0.3 1.4 1.3 0.1 0.5 53.9 0.7 0.0 0.1 0.1 0.0 0.5 0.1 3.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.9 0.8 0.9 2.3 1.4 0.5 0.6 0.9 1.3 0.7 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 SPINDOC "C11orf84, SPIN-DOC" ENSG00000168005 "Spindlin interactor and repressor of chromatin binding" Q9BUA3 11 63813456-63827716 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040128, HPA050313" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA040128: AB_10673027, HPA050313: AB_2681083" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-2)" "unprognostic (2.82e-3)" "unprognostic (1.13e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (2.20e-1)" "unprognostic (3.78e-3)" "unprognostic (1.44e-2)" "unprognostic (1.20e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" 9.7 10.4 31.9 12.2 25.4 6.2 9.0 26.0 36.6 16.0 20.8 15.5 5.5 19.3 5.2 10.2 15.5 9.3 15.6 33.3 27.9 13.5 5.2 16.5 15.1 26.6 24.8 24.8 16.7 8.1 3.3 17.4 26.7 33.1 18.3 3.7 9.9 9.0 10.5 8.1 6.0 11.4 8.3 22.8 14.0 11.5 39.1 28.9 12.4 13.5 7.3 9.9 18.2 12.4 44.3 34.9 45.7 65.7 57.6 12.5 12.3 24.7 26.6 22.7 47.4 32.9 48.7 23.4 58.1 60.6 15.5 60.8 44.9 60.3 13.7 17.1 55.6 26.4 64.2 46.4 42.0 20.1 36.4 53.6 14.2 14.1 37.2 13.6 24.9 28.5 54.8 36.1 27.6 20.2 48.0 75.7 98.2 112.9 10.0 42.1 100.3 45.5 19.7 16.5 20.2 50.0 63.2 40.6 25.6 55.3 39.7 35.3 43.0 32.2 52.9 60.8 64.0 47.3 40.1 61.9 58.2 27.3 31.8 38.1 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 31.9 25.4 26.0 36.6 33.3 27.9 26.6 24.8 24.8 33.1 22.8 28.9 44.3 7.2 3.2 1.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 6.7 8.6 0.0 0.0 0.6 0.0 0.0 13.3 9.4 0.0 0.0 2.2 0.0 5.6 8.0 3.1 0.0 0.0 0.0 1.8 3.0 2.7 0.0 6.5 0.0 9.6 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.4 0.0 0.0 0.7 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 3.8 2.8 4.0 0.0 0.0 ATG16L2 "ATG16B, FLJ00012, WDR80" ENSG00000168010 "Autophagy related 16 like 2" Q8NAA4 11 72814406-72843674 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 138.1;lymphoid tissue: 130.1" "Cell type enhanced" "Detected in many" "Paneth cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 45.4;neutrophil: 59.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045444, HPA050312" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045444: AB_2679324, HPA050312: AB_2681082" "unprognostic (7.20e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" "prognostic favorable (7.06e-4)" "unprognostic (2.49e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (4.38e-2)" "unprognostic (1.08e-1)" "unprognostic (4.83e-2)" 16.9 18.2 18.4 33.3 19.6 138.1 15.0 19.5 24.3 20.5 17.1 17.9 10.9 14.7 7.6 26.3 22.3 19.1 18.0 18.2 16.7 20.0 18.6 41.5 34.5 18.9 16.7 16.5 23.6 15.3 6.3 13.8 10.3 19.0 14.6 17.1 3.0 13.7 8.3 7.8 73.5 34.3 15.2 16.4 130.1 17.9 6.5 18.1 9.8 16.1 7.4 25.4 19.1 22.4 20.7 2.7 2.5 7.5 5.9 8.7 7.2 4.6 6.1 5.9 2.9 4.4 3.1 6.4 18.3 4.0 7.7 5.3 5.2 0.9 20.1 5.0 14.2 3.0 14.5 14.4 5.1 6.4 18.8 58.2 6.9 2.7 6.6 8.0 32.2 9.0 32.7 1.9 24.1 3.4 9.1 22.5 32.0 1.1 12.0 2.9 10.6 5.5 8.6 9.7 9.2 5.5 4.4 2.6 13.2 5.8 5.9 6.6 25.5 12.6 7.9 2.9 14.4 5.0 11.0 2.9 8.1 3.5 16.4 4.5 5.9 16.3 45.4 2.7 9.3 2.7 2.6 3.9 5.4 10.9 4.6 2.2 2.6 59.6 5.2 11.8 1.7 4.0 4.0 18.4 19.6 19.5 24.3 18.2 16.7 18.9 16.7 16.5 19.0 16.4 18.1 20.7 19.5 6.4 14.4 11.4 37.6 16.7 5.1 6.1 10.2 3.6 8.7 9.0 5.0 4.3 6.2 5.5 2.1 9.6 29.0 13.0 0.0 5.0 0.8 8.9 12.0 12.7 13.1 9.9 14.0 1.0 3.7 7.1 17.9 7.9 22.9 10.6 18.9 3.8 16.2 5.0 11.1 9.1 8.2 48.5 18.1 2.1 10.2 45.7 3.6 23.4 39.2 4.4 30.9 18.1 9.7 2.7 59.1 7.9 17.3 2.5 8.3 2.5 8.1 3.5 0.0 8.8 11.4 4.9 13.4 15.7 17.3 12.3 21.3 7.2 14.0 6.0 C2CD3 DKFZP586P0123 ENSG00000168014 "C2 domain containing 3 centriole elongation regulator" Q4AC94 11 74012718-74171210 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Alveolar cells type 2: 114.6;Excitatory neurons: 57.4;Respiratory ciliated cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 17.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038552, HPA038553, HPA040433" Approved Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981" "unprognostic (3.94e-1)" "unprognostic (7.89e-2)" "unprognostic (3.68e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (8.48e-5)" "unprognostic (1.99e-1)" "unprognostic (4.96e-3)" "unprognostic (2.20e-1)" "unprognostic (1.74e-1)" "unprognostic (5.86e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "unprognostic (3.11e-1)" "unprognostic (1.18e-1)" "unprognostic (2.92e-1)" 4.0 4.7 14.8 5.1 14.6 9.9 3.7 20.5 23.1 4.2 15.1 4.0 3.9 4.8 4.6 3.9 7.8 3.7 2.9 17.9 14.7 5.0 5.8 4.2 5.0 16.1 13.2 15.2 4.7 2.2 6.3 3.7 5.9 15.7 4.3 5.2 8.3 4.3 3.5 3.5 6.1 4.3 4.2 10.8 5.9 4.3 11.1 13.8 7.8 7.1 3.4 5.5 3.9 2.7 18.8 9.3 14.3 11.7 14.3 5.2 4.8 5.6 13.7 8.8 16.0 13.0 24.4 7.4 9.0 9.2 5.2 15.5 13.9 14.7 3.8 19.3 12.4 7.0 12.4 21.3 10.8 8.8 12.0 16.9 4.8 4.8 13.4 9.7 5.1 9.0 11.1 14.2 15.7 13.3 7.7 14.1 8.3 9.4 17.8 7.7 14.3 60.4 9.0 4.6 13.0 15.6 9.2 22.4 8.4 21.2 11.9 16.5 7.8 12.7 10.3 17.0 10.1 11.0 11.7 8.5 26.1 4.0 6.0 11.1 17.8 2.0 3.0 2.2 2.3 2.0 2.3 1.4 1.8 1.3 4.4 2.1 2.1 12.6 2.9 4.7 2.0 1.0 0.7 14.8 14.6 20.5 23.1 17.9 14.7 16.1 13.2 15.2 15.7 10.8 13.8 18.8 6.5 70.5 114.6 28.1 10.5 5.2 3.6 4.8 9.6 8.7 6.2 5.8 5.1 4.3 36.0 9.2 4.2 3.8 5.6 7.6 0.0 4.0 33.0 18.4 9.4 9.8 7.7 12.2 57.4 2.6 2.9 9.6 15.3 8.9 36.6 8.5 5.0 3.0 5.0 11.8 52.1 5.0 4.1 7.6 6.6 24.7 4.4 12.7 7.2 26.2 4.9 4.8 10.3 37.7 38.5 3.8 2.8 6.4 9.5 3.4 3.4 1.8 57.1 14.8 6.6 7.2 5.2 11.1 6.9 6.4 4.5 2.3 14.0 5.4 5.4 4.7 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826819-36945057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 45.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 56.5;Granulosa cells: 73.0;Inhibitory neurons: 91.8;Microglial cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 115.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 115.1" "Cell line enhanced" "Detected in many" "Daudi: 67.9;HMC-1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 6.6 4.6 2.1 14.1 2.4 10.1 6.4 5.7 7.9 24.3 0.9 14.9 11.2 18.1 5.2 3.2 45.4 9.7 4.7 2.1 2.2 3.4 10.0 8.8 18.9 2.0 1.8 2.8 15.8 2.4 3.2 6.7 5.2 2.8 16.6 13.5 1.4 6.9 6.3 1.1 2.3 16.8 8.9 1.5 13.2 8.2 2.4 2.8 17.7 6.2 2.6 21.0 16.8 10.1 2.9 1.4 1.7 0.4 0.0 4.5 17.9 0.0 1.4 9.1 3.9 8.0 0.0 7.2 67.9 2.8 5.3 13.5 0.5 0.2 1.0 0.7 3.7 0.1 11.6 4.8 0.0 5.5 3.1 26.1 5.7 3.5 3.1 0.2 1.1 5.4 7.6 9.5 9.9 2.4 0.1 8.9 1.3 0.5 0.0 1.9 2.5 0.3 1.4 1.5 3.3 0.6 0.0 7.2 1.9 0.7 0.8 1.2 3.8 3.7 3.4 1.3 0.2 1.2 9.3 2.2 15.8 0.6 2.6 0.4 7.3 2.0 11.5 14.9 2.9 10.7 10.9 12.3 15.3 1.4 17.5 11.0 10.6 115.1 8.5 3.9 0.2 11.6 3.0 2.1 2.4 5.7 7.9 2.1 2.2 2.0 1.8 2.8 2.8 1.5 2.8 2.9 5.4 16.0 7.8 18.3 18.8 0.8 1.3 1.7 6.8 4.4 1.6 2.3 3.6 1.5 4.0 3.7 2.1 1.3 16.5 40.9 0.0 3.1 0.4 6.1 15.1 5.5 5.4 12.6 56.5 1.8 1.6 7.1 18.8 8.8 6.3 73.0 5.7 17.7 5.0 0.0 91.8 16.7 0.0 6.6 0.8 0.0 4.4 7.4 5.4 52.5 8.7 1.6 26.8 23.6 13.2 3.2 16.9 6.0 21.9 1.6 16.7 0.9 5.2 0.7 0.0 2.6 5.2 0.3 0.3 2.6 0.9 0.7 21.8 3.7 4.0 1.5 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.3" "Cell type enhanced" "Detected in many" "Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.1 0.1 0.8 0.4 0.5 0.1 0.2 0.3 1.1 0.2 1.4 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.1 0.4 0.6 0.1 0.1 0.2 0.3 0.6 0.7 0.4 0.3 1.1 0.2 0.1 0.1 0.5 0.2 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.0 0.5 0.2 0.1 21.3 0.4 0.2 0.2 0.1 0.3 0.1 0.1 0.5 0.1 0.3 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.3 0.0 0.3 0.3 0.2 0.2 0.2 0.0 0.4 0.2 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.8 0.3 0.0 0.8 0.0 0.2 0.0 0.1 0.7 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.3 1.1 0.4 0.6 0.6 0.7 0.4 0.5 0.5 0.4 0.5 3.7 0.0 3.0 20.2 10.4 0.6 4.4 4.0 0.6 5.3 2.6 2.4 6.4 4.3 5.4 1.8 8.4 1.7 1.8 2.5 0.0 2.1 82.3 24.0 3.6 3.0 4.2 0.4 15.0 1.8 1.7 2.1 4.1 5.2 1.3 3.2 5.0 1.3 1.6 5.0 13.3 2.5 0.0 2.2 0.9 84.7 7.2 1.6 3.6 4.7 2.6 3.4 0.0 5.0 3.2 1.7 2.0 6.0 3.7 2.1 2.3 1.2 56.0 15.3 6.6 7.8 2.7 59.8 3.4 0.1 0.6 3.7 1.3 2.1 2.4 2.3 RPSA "37LRP, LAMR1, LRP, p40, SA" ENSG00000168028 "Ribosomal protein SA" P08865 3 39406716-39412542 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB009561 Approved Supported "Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" "CAB009561: AB_2182543" "unprognostic (3.67e-3)" "unprognostic (2.92e-1)" "unprognostic (3.97e-2)" "unprognostic (3.72e-2)" "unprognostic (5.38e-2)" "unprognostic (5.10e-2)" "unprognostic (5.84e-3)" "unprognostic (2.54e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (8.56e-2)" "unprognostic (7.50e-2)" "unprognostic (2.91e-2)" "unprognostic (3.18e-1)" "unprognostic (2.77e-1)" "unprognostic (1.73e-1)" "unprognostic (1.46e-1)" 981.0 936.7 817.7 692.0 817.9 1588.4 1077.6 784.3 987.0 1241.4 772.0 1139.5 611.3 1030.6 354.1 1938.0 1138.0 375.8 790.1 779.9 835.7 885.1 980.4 902.0 1291.9 819.7 809.2 768.7 2171.8 2638.2 610.6 819.7 472.7 825.1 1222.9 880.5 275.7 1048.3 451.1 1096.1 1472.9 1142.6 724.5 852.9 1538.1 1219.2 360.8 827.0 1271.4 869.7 736.9 1478.6 1137.1 1304.0 839.1 1800.4 1646.5 1367.5 2265.9 1203.3 2661.2 2155.0 1251.2 2005.9 2775.9 1611.8 1811.6 1513.7 3949.6 737.0 2535.3 747.6 695.4 2983.8 2945.7 2402.3 1459.6 1599.6 1783.6 1390.5 1750.2 2322.7 2546.4 1649.2 3043.3 4729.8 2147.2 3475.3 2030.8 2942.7 2343.5 1909.3 1883.8 2031.1 1282.1 3031.0 1960.4 4574.2 2756.9 2755.1 1412.2 1958.4 2974.8 2004.4 814.2 985.3 1989.0 674.8 5156.5 2202.9 1843.5 1509.0 3544.5 1156.6 845.2 1545.8 1422.3 3102.3 1440.6 2363.4 2437.5 1355.7 2481.7 1143.9 98.3 240.5 56.7 572.9 294.6 993.1 1010.3 942.1 758.8 654.2 951.8 1036.2 936.1 34.3 726.0 247.5 723.6 765.5 1499.7 817.7 817.9 784.3 987.0 779.9 835.7 819.7 809.2 768.7 825.1 852.9 827.0 839.1 532.1 519.2 800.2 10.7 2802.5 1802.5 2606.9 1585.5 2040.3 270.4 1864.7 1423.4 64.0 1095.2 906.4 325.5 95.9 2852.5 1768.9 625.4 992.0 1598.4 144.3 536.7 1178.5 891.2 1033.6 1733.9 21.3 3417.4 4473.1 927.1 821.6 747.7 778.4 1654.5 937.3 717.7 1608.4 173.3 21.5 1847.0 455.7 1304.9 1469.6 283.7 1240.5 1086.9 738.2 12.2 1605.2 621.1 1858.9 19.1 29.3 1889.5 1184.2 747.4 1501.8 2136.7 724.4 1257.1 476.2 364.4 473.3 1053.5 1002.2 352.2 1255.8 2879.8 1916.2 2420.7 2100.0 1539.2 2442.4 2884.6 ENTPD3 "CD39L3, HB6, NTPDase-3" ENSG00000168032 "Ectonucleoside triphosphate diphosphohydrolase 3" O75355 3 40387184-40428744 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 21.5;salivary gland: 22.6" "Cell type enriched" "Detected in many" 4 "Inhibitory neurons: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "plasmacytoid DC: 3.5" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;HBEC3-KT: 13.0;hTCEpi: 8.4;RT4: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.00e-1)" "unprognostic (1.54e-2)" "unprognostic (2.75e-2)" "unprognostic (9.84e-3)" "unprognostic (2.27e-2)" "unprognostic (2.04e-1)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (8.40e-2)" "unprognostic (9.88e-3)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (3.25e-1)" "unprognostic (6.53e-2)" "unprognostic (5.99e-2)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" 4.3 1.4 3.2 1.1 16.5 0.1 2.4 2.4 6.7 21.5 0.8 3.0 1.3 3.2 2.4 6.5 0.9 2.0 0.6 4.7 4.9 2.6 0.1 3.9 0.4 6.9 4.3 4.9 1.7 16.0 0.5 2.9 0.5 6.6 3.5 2.9 2.6 22.6 4.1 1.2 2.7 1.4 1.9 2.2 4.3 6.8 0.5 5.5 0.9 5.5 2.6 1.8 13.1 3.6 6.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 3.6 0.0 13.0 0.3 0.4 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 1.0 0.0 0.0 0.0 1.5 18.4 1.8 0.2 0.4 1.1 0.2 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.5 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.0 3.5 0.2 0.0 3.2 16.5 2.4 6.7 4.7 4.9 6.9 4.3 4.9 6.6 2.2 5.5 6.3 5.5 3.2 4.2 4.9 0.2 2.3 1.3 2.3 8.0 0.7 6.1 0.3 0.5 0.0 5.1 0.0 0.0 0.0 1.3 1.0 0.0 2.7 0.4 7.6 2.5 0.7 2.4 0.0 22.6 22.5 0.0 0.4 2.6 14.9 0.0 0.0 0.0 0.0 0.1 0.0 92.6 0.1 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.9 0.0 3.7 0.0 7.1 5.9 6.9 0.0 0.7 0.1 1.4 0.0 0.0 1.9 0.8 19.7 0.6 19.9 0.2 0.1 14.5 2.3 0.0 0.2 0.1 0.2 4.7 CTNNB1 "armadillo, beta-catenin, CTNNB" ENSG00000168036 "Catenin beta 1" P35222 3 41194741-41260096 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway" Activator "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 539.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000108, CAB001950, HPA029159, HPA029160" Supported Enhanced "Plasma membrane" NA NA 2000000 "Plasma membrane" "CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996" "unprognostic (2.47e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.54e-4)" "unprognostic (1.61e-1)" "unprognostic (9.55e-2)" "unprognostic (1.05e-2)" "unprognostic (3.20e-3)" "unprognostic (2.79e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-2)" "unprognostic (1.88e-2)" "unprognostic (9.05e-2)" "unprognostic (1.97e-3)" "unprognostic (1.82e-2)" "unprognostic (1.17e-1)" "unprognostic (2.61e-1)" "unprognostic (9.79e-2)" 131.9 113.2 106.9 99.6 88.1 163.8 196.3 151.1 90.1 180.9 99.6 142.5 138.1 150.8 85.1 114.8 132.2 122.8 110.9 88.9 239.6 107.5 149.1 134.1 82.6 107.4 113.8 76.9 175.4 94.1 138.3 85.4 201.7 97.3 133.5 135.9 89.5 111.9 127.4 88.1 98.9 144.1 180.0 115.0 93.3 82.5 60.0 122.4 96.5 141.9 90.7 100.3 159.8 110.2 113.4 161.6 210.0 423.6 242.8 226.9 184.7 333.8 179.6 249.7 288.2 284.3 146.3 224.0 131.7 157.8 314.1 129.0 119.6 315.8 510.0 306.2 123.3 215.7 215.5 261.0 523.7 169.5 121.8 99.1 271.6 226.7 345.5 208.7 235.7 258.1 63.0 153.7 80.3 324.1 161.8 87.3 68.3 397.2 211.0 159.3 64.9 281.9 88.3 177.9 494.8 102.9 172.4 296.2 147.1 809.4 509.8 242.1 248.6 340.8 217.1 163.6 139.3 264.0 50.7 82.7 138.4 221.5 150.5 369.7 4.7 7.3 6.4 9.2 12.3 10.9 7.7 8.6 10.1 11.8 8.0 8.6 9.4 6.6 9.6 12.6 10.0 10.8 5.6 106.9 88.1 151.1 90.1 88.9 239.6 107.4 113.8 76.9 97.3 115.0 122.4 113.4 171.7 137.8 179.5 58.1 71.7 213.5 130.1 75.3 116.1 40.7 232.5 168.1 84.7 90.1 119.2 62.5 33.3 318.9 99.0 251.6 35.2 132.2 11.0 90.3 125.9 187.3 93.8 43.8 50.9 78.5 115.6 116.8 53.0 95.5 116.6 137.0 139.2 172.5 115.1 13.5 82.4 145.9 42.7 154.6 228.1 9.5 59.7 161.1 202.7 124.6 98.3 89.2 49.4 70.9 62.9 139.8 249.5 86.9 55.5 128.3 160.3 93.2 96.1 62.0 46.0 175.6 137.3 78.4 40.1 70.9 174.9 539.5 77.0 245.6 189.6 127.9 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962130 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.6" "Cell type enhanced" "Detected in many" "Early spermatids: 352.3;Excitatory neurons: 108.6;Inhibitory neurons: 99.2;Late spermatids: 405.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 2.7 3.1 5.8 2.9 2.0 8.6 2.5 1.8 2.2 8.3 13.9 1.6 1.2 6.7 4.5 1.5 9.1 1.9 5.1 2.3 6.5 3.9 2.1 3.6 3.1 6.0 5.1 1.0 2.2 2.0 8.0 2.9 2.8 3.5 2.2 1.7 6.0 1.7 2.4 0.4 2.1 2.0 3.6 7.0 2.1 2.4 23.6 2.0 3.0 4.9 0.4 2.8 1.9 3.7 2.0 8.3 2.9 2.8 3.8 1.1 1.7 4.8 2.7 2.7 3.2 3.0 1.0 2.3 9.5 1.6 6.3 3.5 4.1 3.7 2.1 2.9 1.5 1.0 2.1 5.7 3.3 4.1 6.5 1.8 1.6 2.3 16.1 3.2 4.4 2.2 6.4 2.1 7.5 2.3 6.4 8.1 4.9 3.4 2.1 3.4 1.7 9.1 4.5 7.2 7.6 1.6 10.3 3.1 1.3 2.8 1.8 3.1 2.0 6.6 2.0 2.4 14.2 2.5 4.5 9.0 3.9 11.5 6.3 2.5 3.7 3.7 4.0 5.0 4.3 4.1 3.7 5.3 4.5 3.3 4.7 4.0 5.7 6.6 1.8 2.3 3.3 7.7 3.0 5.8 2.0 1.8 2.2 2.3 6.5 6.0 5.1 1.0 3.5 7.0 2.0 2.0 6.4 9.6 6.9 84.9 11.2 2.0 3.0 4.0 5.2 5.6 5.7 4.6 14.8 4.3 5.1 3.7 54.2 3.1 9.9 2.0 0.0 3.4 352.3 45.3 27.4 6.0 1.8 2.1 108.6 2.4 4.1 8.7 10.2 7.5 1.3 49.6 1.8 6.6 7.3 11.8 99.2 1.2 2.0 3.1 4.0 405.2 6.5 6.9 0.0 80.6 5.9 10.4 3.1 49.8 62.0 3.0 0.7 4.1 5.1 0.9 1.1 5.9 47.3 26.7 6.6 4.4 10.5 38.9 9.6 3.3 3.7 4.2 10.8 3.6 1.9 1.2 FADD "GIG3, MORT1" ENSG00000168040 "Fas associated via death domain" Q13158 11 70203296-70207390 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 75.0;Ductal cells: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 331.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001464, CAB010209" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB010209: AB_2100622, HPA001464: AB_1848348" "unprognostic (2.08e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (6.91e-2)" "unprognostic (9.51e-2)" "unprognostic (3.89e-1)" "prognostic unfavorable (8.22e-5)" "unprognostic (7.25e-3)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" "unprognostic (2.45e-3)" "unprognostic (2.78e-3)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "prognostic favorable (3.45e-4)" "unprognostic (7.29e-2)" 9.9 13.9 10.3 14.1 9.9 8.8 13.8 10.5 10.2 13.3 10.1 14.9 14.2 12.7 17.7 14.4 13.4 12.2 8.5 9.5 10.6 14.3 16.2 10.7 17.0 12.3 10.8 9.1 12.6 8.3 9.1 6.4 15.5 11.8 9.3 12.9 4.0 11.4 13.5 11.1 12.6 14.0 10.4 11.2 13.3 15.0 5.8 12.0 20.5 11.4 9.1 17.0 11.5 9.2 11.1 331.2 54.7 26.6 24.3 31.6 25.4 23.8 55.3 43.6 47.5 31.6 47.1 52.3 48.7 51.9 37.1 44.8 47.7 26.3 49.3 36.8 45.7 28.8 22.3 30.6 24.3 28.5 28.0 28.4 25.4 34.5 51.4 64.7 38.1 45.3 26.7 37.0 24.4 42.1 48.5 34.4 49.5 42.1 75.1 89.1 26.3 64.3 47.0 46.8 24.1 23.5 22.3 41.0 38.0 117.1 30.3 41.3 30.7 51.0 36.6 35.7 56.7 53.9 33.8 27.8 28.6 53.2 28.0 52.6 37.1 36.2 28.2 41.7 38.4 47.5 38.7 44.1 48.9 37.1 33.9 44.6 40.7 88.6 37.7 45.3 33.7 45.7 36.1 10.3 9.9 10.5 10.2 9.5 10.6 12.3 10.8 9.1 11.8 11.2 12.0 11.1 7.8 0.0 5.3 0.7 12.1 11.9 14.8 18.1 6.2 6.8 14.0 15.7 0.1 14.3 7.7 18.4 0.0 75.0 9.3 22.9 21.5 55.9 0.7 7.3 11.7 15.6 2.4 19.8 1.4 34.7 37.3 10.0 12.8 10.6 1.3 13.8 14.6 8.5 31.2 3.3 1.6 14.3 0.0 11.0 8.8 2.4 13.4 10.8 32.0 2.8 20.9 10.0 18.6 0.5 1.4 49.0 15.3 16.6 9.6 11.8 24.5 33.7 5.4 4.1 0.0 5.2 14.5 10.4 14.2 14.4 10.5 30.8 13.3 18.9 17.4 14.4 LTBP3 LTBP2 ENSG00000168056 "Latent transforming growth factor beta binding protein 3" Q9NS15 11 65538559-65558930 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Amelogenesis imperfecta, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 61.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 293.8;U-87 MG: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 2200000 "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (8.50e-3)" "unprognostic (4.01e-2)" "unprognostic (1.04e-1)" "unprognostic (1.59e-1)" "unprognostic (2.24e-2)" "unprognostic (9.22e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-2)" "unprognostic (4.52e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" 64.7 80.8 37.4 21.6 38.0 11.3 68.5 40.8 56.5 117.7 40.6 83.6 17.0 131.9 37.1 37.0 113.5 40.3 108.5 33.2 63.4 67.8 49.2 72.8 24.9 50.0 41.1 27.7 156.8 70.7 45.0 111.9 25.7 39.0 109.9 8.5 13.0 64.8 56.8 55.2 39.7 56.3 36.0 49.9 58.6 62.5 20.5 37.8 17.8 115.0 31.3 12.2 85.6 88.8 51.9 16.5 65.9 8.7 43.2 60.7 97.0 8.5 64.7 43.6 8.2 5.3 25.3 85.5 2.0 53.6 64.2 20.4 71.9 11.8 12.2 3.7 9.5 26.4 15.9 25.2 26.2 40.3 2.2 13.4 109.9 4.9 12.1 1.5 293.8 31.9 5.2 4.9 12.7 6.0 39.4 10.9 5.9 7.6 14.6 81.2 29.3 1.1 32.1 6.7 5.5 2.9 41.8 17.3 24.9 35.3 3.7 46.0 5.8 107.0 24.8 32.2 42.5 17.6 13.9 27.1 1.4 157.8 2.6 52.3 0.2 7.3 2.9 8.8 11.2 14.1 61.2 12.6 10.4 8.9 47.6 10.5 11.2 2.9 10.8 13.2 17.8 14.2 7.8 37.4 38.0 40.8 56.5 33.2 63.4 50.0 41.1 27.7 39.0 49.9 37.8 51.9 47.1 12.8 11.7 64.0 26.8 73.8 27.7 22.0 50.7 55.7 42.2 43.1 16.7 35.8 16.2 40.5 2.1 24.7 24.4 19.7 21.5 28.1 1.1 19.3 37.5 29.8 30.6 11.2 21.3 12.0 10.5 86.1 14.8 25.3 24.1 92.5 37.5 61.6 20.7 28.6 17.9 15.1 8.2 11.0 34.4 4.3 86.6 14.6 30.2 17.8 11.5 71.4 24.7 29.7 20.2 18.1 15.0 123.8 20.9 35.8 25.3 15.7 8.2 14.3 39.5 89.4 44.0 9.5 37.5 46.9 79.3 16.3 24.4 26.0 20.4 26.5 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "intestine: 100.1" "Cell type enriched" "Detected in many" 11 "Proximal enterocytes: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 182.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047123 Enhanced Uncertain Cytosol NA NA Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 12.5 3.2 3.7 6.7 3.5 21.3 12.2 3.9 6.0 22.7 5.9 16.7 20.0 18.9 4.6 7.3 15.4 9.4 9.3 3.3 3.7 7.4 2.6 11.0 11.0 3.9 3.5 3.0 16.8 2.3 2.0 6.1 2.3 3.8 14.0 7.2 2.0 5.0 11.6 2.8 5.3 100.1 10.6 3.7 15.4 8.2 8.7 3.9 3.5 5.7 4.2 7.0 12.8 14.6 4.4 0.0 0.0 0.1 0.2 0.5 5.8 1.0 2.3 0.0 2.8 1.3 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.0 0.2 0.1 0.9 0.4 0.0 0.2 3.5 20.2 0.0 0.0 13.5 0.0 2.7 0.0 0.1 3.6 0.1 0.0 0.3 0.0 0.2 0.2 0.7 0.0 0.1 0.1 0.1 0.0 1.0 0.2 0.0 10.5 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.8 0.0 0.1 0.1 182.0 21.2 35.9 29.6 14.6 15.8 25.7 23.8 14.8 16.3 29.8 27.0 15.0 3.7 80.2 8.8 0.7 45.2 24.6 3.7 3.5 3.9 6.0 3.3 3.7 3.9 3.5 3.0 3.8 3.7 3.9 4.4 19.1 0.0 0.0 0.0 8.0 3.6 3.4 5.6 6.2 2.0 0.8 9.1 1.8 1.5 0.4 0.0 0.0 0.2 9.8 31.3 3.9 0.1 0.8 0.4 5.8 11.1 1.2 2.5 0.3 0.8 0.3 11.4 1.1 0.2 19.7 4.3 16.8 0.4 2.8 10.1 0.4 21.0 2.0 5.6 5.7 2.6 11.8 5.2 16.0 1.0 17.3 12.2 41.2 1.0 0.1 0.2 50.0 18.0 1.1 0.5 588.6 0.5 0.5 0.9 0.0 8.3 11.1 1.6 3.5 1.3 3.3 0.4 11.1 3.9 11.8 0.4 SAC3D1 "HSU79266, SHD1" ENSG00000168061 "SAC3 domain containing 1" 11 65040901-65044828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 94.1;Late spermatids: 121.5;Spermatocytes: 166.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042677 Uncertain Approved Cytosol NA NA Cytosol "HPA042677: AB_10797506" "unprognostic (1.35e-1)" "unprognostic (5.45e-3)" "unprognostic (5.00e-1)" "unprognostic (8.01e-2)" "unprognostic (3.56e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (9.67e-6)" "unprognostic (4.11e-1)" "unprognostic (1.70e-1)" "unprognostic (4.45e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (2.97e-3)" "unprognostic (5.71e-1)" "unprognostic (4.53e-2)" "unprognostic (2.49e-1)" 3.9 3.5 9.6 2.8 8.7 4.1 2.1 9.1 10.6 3.1 6.8 3.6 3.2 3.1 0.6 3.6 2.9 0.7 2.3 9.3 8.5 2.0 3.7 2.1 2.8 11.3 9.5 8.6 2.5 2.8 1.3 2.8 1.4 10.5 2.8 1.3 0.6 2.7 2.0 9.4 3.7 2.6 2.0 9.1 3.1 2.9 13.6 9.9 7.2 1.4 2.1 2.1 2.6 2.6 9.8 48.3 27.4 13.3 15.1 6.8 5.0 18.9 28.2 6.3 15.9 13.8 13.4 11.3 20.8 22.2 7.7 17.6 32.1 14.4 15.6 2.7 33.0 44.9 15.5 24.5 42.3 5.1 14.5 11.6 3.9 13.4 12.2 5.4 4.4 5.5 20.3 25.7 16.3 6.1 32.6 39.7 75.9 12.1 13.5 61.2 38.0 19.4 31.7 6.8 10.6 29.9 19.6 21.9 22.2 19.4 3.8 20.8 15.3 6.7 13.6 36.9 37.8 20.0 35.6 30.8 22.7 8.0 15.2 4.5 0.0 1.4 0.2 0.6 1.1 0.5 0.9 0.9 0.7 0.7 1.1 1.0 0.6 0.1 0.2 1.5 1.6 0.9 0.4 9.6 8.7 9.1 10.6 9.3 8.5 11.3 9.5 8.6 10.5 9.1 9.9 9.8 7.6 3.2 0.5 3.6 7.1 8.7 5.4 2.5 15.9 6.9 19.0 22.7 5.8 11.5 1.5 9.2 0.0 21.9 11.2 26.3 7.9 3.1 94.1 6.4 13.6 6.4 7.2 16.2 4.0 1.6 42.9 10.7 8.2 7.1 5.7 28.0 5.3 17.9 30.4 5.0 4.2 18.5 0.0 15.1 5.5 121.5 17.7 10.4 10.6 1.0 10.5 13.6 13.4 2.5 5.5 2.4 15.2 13.9 11.3 11.2 14.5 14.7 1.3 9.3 0.0 8.1 10.6 166.7 42.2 20.1 7.7 6.7 11.1 22.2 27.6 3.9 BATF2 MGC20410 ENSG00000168062 "Basic leucine zipper ATF-like transcription factor 2" Q8N1L9 11 64987945-64997018 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 21.2;Intestinal goblet cells: 8.5;Proximal enterocytes: 7.9;Undifferentiated cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.1;intermediate monocyte: 5.3;neutrophil: 7.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "granulocytes: 7.3;monocytes: 5.3" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 13.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.0;GAMG: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA062496 Approved Approved Nucleoli NA NA Nucleoli "HPA062496: AB_2684783" "unprognostic (5.29e-2)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (4.59e-2)" "unprognostic (2.31e-2)" "unprognostic (6.11e-2)" "unprognostic (5.08e-2)" "unprognostic (6.92e-3)" "unprognostic (1.03e-1)" "prognostic favorable (9.39e-5)" "prognostic unfavorable (2.12e-4)" "unprognostic (1.28e-1)" "unprognostic (9.09e-3)" "unprognostic (2.34e-3)" "unprognostic (3.17e-2)" "unprognostic (3.82e-2)" "unprognostic (1.12e-2)" 2.1 4.4 2.7 8.8 3.0 0.5 1.5 2.2 2.9 1.4 2.8 8.7 9.4 1.2 0.7 1.0 2.7 4.0 2.2 2.3 2.4 5.7 4.8 7.0 3.3 3.9 2.6 1.9 3.1 9.3 0.9 2.4 2.9 3.8 2.8 6.3 0.5 13.5 4.5 5.0 0.4 6.6 2.7 2.4 13.6 4.6 0.7 3.0 1.6 2.0 2.7 1.2 4.6 1.0 4.4 1.5 1.0 0.2 0.0 0.1 0.8 0.0 0.5 6.5 13.1 20.0 1.9 5.8 0.1 2.7 1.0 19.5 0.1 0.0 1.7 0.9 0.2 0.4 1.8 0.0 5.3 4.8 0.0 1.1 0.4 0.4 1.7 2.2 0.5 3.2 0.1 4.3 0.1 0.3 0.4 0.0 0.1 0.5 0.0 0.6 0.0 1.3 0.6 1.6 0.1 0.1 0.0 0.8 0.3 6.9 0.1 0.5 1.0 2.4 0.7 0.7 1.1 0.0 0.1 0.2 0.4 1.1 0.5 0.6 0.0 2.1 1.0 0.0 5.3 0.0 1.0 0.0 0.0 0.2 0.3 0.0 0.0 7.3 0.1 2.8 0.0 0.0 0.8 2.7 3.0 2.2 2.9 2.3 2.4 3.9 2.6 1.9 3.8 2.4 3.0 4.4 3.7 3.2 2.0 1.0 1.3 0.0 0.5 1.8 0.0 0.2 1.2 0.5 0.6 4.3 2.6 1.8 0.0 0.0 0.0 21.2 1.9 4.8 0.8 0.4 1.2 2.7 2.4 0.0 0.2 6.6 0.3 1.8 2.6 0.1 0.0 0.1 5.0 0.9 4.7 0.0 0.1 8.5 0.0 3.5 0.3 2.4 0.0 1.0 0.0 1.0 1.0 0.9 0.0 1.0 0.1 4.9 7.6 0.7 0.0 0.2 7.9 4.1 3.5 0.2 0.0 1.7 1.7 0.1 0.6 0.0 0.0 0.0 0.1 1.1 8.4 2.4 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555690-64572875 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 72 "epididymis: 10.7;kidney: 32.2;placenta: 33.7" "Group enriched" "Detected in some" 19 "Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6" "Cancer enriched" "Detected in some" 4 "renal cancer: 15.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;Hep G2: 1.0" "Not detected" "Not detected" HPA026076 Enhanced NA NA "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 654.0 0.0 0.0 5.9 0.0 1.2 0.0 0.2 1.7 0.0 0.0 0.0 0.4 22.5 3.4 0.0 0.0 0.0 0.0 0.4 0.2 50.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.3 0.3 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1520.6 0.2 0.1 0.2 0.0 SF1 "ZCCHC25, ZFM1, ZNF162" ENSG00000168066 "Splicing factor 1" Q15637 11 64764606-64778786 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018883 Supported Supported Nucleoplasm NA NA 130000 Nucleoplasm "HPA018883: AB_1856763" "unprognostic (1.24e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.01e-2)" "unprognostic (1.50e-1)" "unprognostic (4.35e-1)" "prognostic unfavorable (4.85e-5)" "unprognostic (3.72e-1)" "unprognostic (4.51e-3)" "unprognostic (1.39e-1)" "unprognostic (4.62e-3)" "unprognostic (6.20e-2)" "unprognostic (8.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.78e-1)" 106.1 89.8 42.8 73.8 41.2 232.5 101.7 61.7 74.3 106.7 31.9 105.5 62.9 111.5 46.7 99.0 119.7 54.3 92.5 40.6 40.5 86.8 101.3 85.7 96.6 55.5 42.0 27.1 143.6 104.2 52.4 98.5 53.9 43.3 106.6 42.9 46.7 88.1 59.0 150.4 93.3 111.4 64.0 24.4 134.7 105.4 111.0 40.9 92.0 100.4 73.9 81.1 99.2 93.1 53.6 141.2 165.4 151.1 131.0 82.4 65.5 178.8 98.9 83.6 130.3 100.3 142.0 154.8 223.6 120.2 111.4 119.4 163.8 172.2 171.0 110.3 167.1 115.0 144.6 107.6 107.0 130.7 155.0 143.7 86.0 87.1 165.2 172.3 77.0 118.9 145.0 216.4 141.5 100.8 145.1 294.2 217.9 206.5 126.2 117.5 253.2 104.7 177.7 87.5 151.8 119.6 157.4 138.1 118.8 138.3 95.6 182.7 163.6 104.6 145.1 131.7 134.5 158.2 163.6 139.4 205.6 129.1 132.2 180.2 3.4 9.7 10.7 12.9 10.8 12.9 9.3 9.6 12.7 9.6 7.3 11.2 11.9 13.7 9.2 9.7 10.9 10.5 9.4 42.8 41.2 61.7 74.3 40.6 40.5 55.5 42.0 27.1 43.3 24.4 40.9 53.6 131.9 60.9 88.7 82.3 326.5 184.2 205.1 121.4 350.0 267.2 158.4 127.8 63.5 107.2 87.2 55.2 225.2 118.6 194.5 133.6 37.2 80.4 156.9 156.6 180.5 134.3 209.8 115.7 60.6 73.8 116.8 126.1 138.6 170.1 107.8 212.6 164.2 120.7 98.2 175.0 52.1 115.6 109.9 137.2 167.6 67.1 157.5 122.0 96.0 72.1 146.4 121.9 166.9 62.4 141.0 88.3 106.3 113.2 188.1 192.8 118.5 56.0 83.1 325.8 78.9 145.3 132.0 116.8 84.3 246.9 183.8 148.7 250.2 249.6 129.6 194.3 MAP4K2 "BL44, GCK, RAB8IP" ENSG00000168067 "Mitogen-activated protein kinase kinase kinase kinase 2" Q12851 11 64784918-64803241 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007330 Enhanced Approved Vesicles NA NA Vesicles "HPA007330: AB_1079361" "unprognostic (1.66e-1)" "unprognostic (2.83e-1)" "unprognostic (3.07e-3)" "unprognostic (4.37e-3)" "unprognostic (2.67e-1)" "unprognostic (9.23e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (4.51e-2)" "unprognostic (3.65e-1)" "unprognostic (5.28e-2)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" 5.0 4.0 8.9 7.0 7.2 15.7 4.2 9.9 10.0 4.5 5.1 5.0 3.3 4.9 2.5 2.8 3.9 4.3 3.9 7.8 7.1 4.2 2.1 9.7 17.7 7.8 8.4 7.1 3.4 5.0 3.2 5.8 8.9 8.5 4.7 3.1 5.4 6.6 5.8 2.5 3.5 9.0 3.7 6.1 18.1 5.3 4.6 10.3 7.5 7.1 1.5 14.3 4.6 3.5 8.9 9.4 8.4 5.4 9.8 4.7 2.9 12.7 7.0 6.5 8.2 5.8 3.7 4.3 16.4 12.6 8.0 14.5 2.8 6.5 6.8 4.9 21.5 3.1 28.9 12.0 7.9 5.8 15.3 10.4 2.9 3.4 6.4 4.1 5.7 20.3 28.0 2.5 1.5 2.5 11.8 9.2 15.2 3.6 5.6 11.2 18.8 0.6 18.9 4.6 4.7 6.4 9.3 6.0 7.8 6.4 6.1 15.5 23.2 15.8 6.8 15.0 6.3 2.9 1.8 3.8 18.1 6.0 22.8 5.1 2.2 4.3 5.9 4.9 12.5 4.9 9.9 6.5 4.4 4.4 6.6 7.7 6.0 8.0 2.5 15.8 5.0 9.5 7.3 8.9 7.2 9.9 10.0 7.8 7.1 7.8 8.4 7.1 8.5 6.1 10.3 8.9 21.6 3.2 4.8 6.8 32.9 1.3 2.8 1.8 6.2 20.6 8.1 10.4 4.7 7.2 2.4 1.8 25.0 7.6 9.4 6.8 3.9 1.7 33.8 2.6 3.8 20.0 6.0 5.0 5.9 1.7 11.3 4.9 9.2 6.0 1.3 7.7 24.3 2.0 11.0 11.8 4.6 1.8 6.1 8.9 3.1 46.8 4.1 16.2 1.8 18.7 13.4 7.2 14.4 2.0 7.2 0.9 16.2 7.2 15.6 1.8 1.6 3.6 1.5 14.6 6.6 3.7 4.3 2.1 13.8 5.2 1.4 5.1 19.9 22.6 2.2 2.0 MAJIN C11orf85 ENSG00000168070 "Membrane anchored junction protein" Q3KP22 11 64937517-64972108 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.8" "Group enriched" "Detected in some" 8 "Distal tubular cells: 3.9;Proximal tubular cells: 9.5" "Cancer enhanced" "Detected in some" "cervical cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 5 "B-cells: 1.3" "Group enriched" "Detected in some" 10 "CAPAN-2: 7.5;SiHa: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.37e-1)" "unprognostic (6.43e-3)" "unprognostic (3.69e-2)" "unprognostic (7.05e-2)" "unprognostic (9.64e-3)" "unprognostic (2.92e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" "unprognostic (9.11e-2)" "unprognostic (4.11e-2)" "unprognostic (1.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.48e-2)" "unprognostic (2.43e-1)" "unprognostic (2.79e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-2)" 0.0 0.2 0.3 0.2 0.6 0.1 0.2 2.1 0.7 0.1 0.0 0.1 0.0 0.0 2.0 0.1 1.1 2.9 0.0 0.4 0.1 1.4 1.2 0.2 1.5 0.6 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.3 0.2 0.2 0.1 0.6 0.0 1.2 0.4 0.0 0.4 0.6 0.2 22.8 0.2 0.1 0.9 0.0 1.4 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 2.1 0.7 0.4 0.1 0.6 0.4 0.0 0.5 0.4 0.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340204-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.0;lymphoid tissue: 86.8" "Cell type enhanced" "Detected in many" "NK-cells: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA026652 Approved Supported Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA "Centrosome, Cytosol" Nucleoplasm "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 7.0 6.7 14.0 15.2 14.0 48.0 5.3 19.2 21.7 5.1 14.4 12.3 4.1 3.5 0.3 13.0 6.5 8.6 5.2 14.3 15.2 6.5 7.3 21.3 28.9 15.8 14.5 13.1 3.1 4.2 0.9 4.6 1.7 16.5 7.9 3.6 1.4 14.5 2.6 1.2 4.1 34.4 1.2 14.8 86.8 9.0 17.5 14.2 17.6 5.4 0.8 14.0 8.4 7.7 15.1 0.3 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.0 0.0 3.4 19.7 2.9 1.1 0.5 1.6 0.1 0.6 0.0 21.7 0.0 15.0 4.6 1.1 0.8 9.4 83.3 0.0 0.0 0.2 0.0 1.3 0.5 6.3 0.5 22.0 0.7 0.9 12.7 7.7 0.7 3.7 0.5 11.9 0.3 18.5 0.3 0.3 4.8 0.0 0.0 0.5 1.1 0.1 2.6 34.5 0.0 0.0 0.7 0.1 0.2 4.7 1.5 15.8 1.0 25.3 0.4 2.9 4.6 6.7 3.5 3.6 1.0 1.6 2.0 2.9 1.6 2.0 1.8 2.2 9.2 6.5 2.5 2.7 0.6 1.3 14.0 14.0 19.2 21.7 14.3 15.2 15.8 14.5 13.1 16.5 14.8 14.2 15.1 3.3 0.0 10.7 5.2 30.3 2.7 4.5 10.5 0.6 45.2 5.7 4.8 13.5 4.3 9.9 9.2 0.0 2.9 34.9 46.0 0.0 12.8 11.1 8.7 2.6 4.4 18.0 7.0 2.6 28.9 5.8 3.1 51.0 6.8 26.6 2.2 6.1 10.4 14.5 0.0 2.0 24.4 8.2 26.0 26.6 15.8 1.5 27.3 5.4 12.2 35.0 15.4 64.9 2.0 0.6 35.0 33.2 0.7 24.9 2.9 36.1 3.2 22.7 4.7 0.0 2.8 2.8 13.7 8.7 2.0 1.6 1.4 31.7 10.0 32.4 15.7 SCARA3 "APC7, CSR, CSR1, MSLR1, MSRL1" ENSG00000168077 "Scavenger receptor class A member 3" Q6AZY7 8 27633868-27676776 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 129.1" "Cell type enhanced" "Detected in many" "Astrocytes: 238.6;Collecting duct cells: 66.2;Cytotrophoblasts: 45.8;Muller glia cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 179.9;HeLa: 203.2;HUVEC TERT2: 140.1;U-2 OS: 120.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029861, HPA047386" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029861: AB_2673225, HPA047386: AB_2680024" "unprognostic (2.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.68e-3)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.17e-1)" "unprognostic (4.31e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (3.41e-2)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (6.31e-3)" "unprognostic (6.03e-3)" 23.1 7.3 46.4 15.9 55.4 0.0 17.8 53.1 58.3 46.4 24.2 25.0 5.1 88.7 9.5 23.9 87.6 30.7 9.7 44.0 74.4 7.3 4.0 15.4 13.5 129.1 75.3 37.3 13.9 4.1 1.5 9.7 19.7 67.4 25.8 8.6 8.9 36.0 67.1 2.6 15.9 15.5 68.7 73.3 2.8 14.8 3.2 80.8 16.1 51.7 8.1 23.2 31.3 20.9 78.1 1.8 61.0 9.4 0.2 49.9 179.9 40.0 23.8 38.2 25.8 19.1 22.7 15.8 0.0 52.7 50.3 21.1 44.5 0.1 44.9 12.7 0.2 5.1 17.8 203.2 0.8 5.3 0.0 0.1 75.6 2.9 40.2 2.3 35.0 140.1 4.6 0.0 0.2 15.0 11.8 0.2 0.1 12.3 0.0 22.3 0.1 0.0 0.3 8.2 27.4 0.2 5.9 5.7 32.0 0.1 4.8 31.1 0.5 49.9 20.7 120.1 77.2 12.8 0.1 0.1 0.2 35.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 55.4 53.1 58.3 44.0 74.4 129.1 75.3 37.3 67.4 73.3 80.8 78.1 2.3 0.0 0.5 238.6 0.0 3.6 16.2 4.8 14.8 1.0 12.6 19.8 2.2 8.6 6.0 66.2 0.0 45.8 0.6 0.1 0.0 0.4 2.9 3.8 10.1 6.4 0.0 0.0 38.4 0.8 20.4 25.1 1.5 2.0 0.0 5.3 15.4 0.4 4.7 0.0 30.4 0.1 0.0 0.3 2.1 1.3 15.8 0.5 17.8 21.5 0.6 52.4 0.0 19.1 18.1 2.2 0.1 6.4 0.0 5.4 0.0 0.0 6.5 1.5 6.6 1.8 14.7 0.2 1.5 6.2 3.8 8.2 0.3 1.9 0.3 10.3 PBK "CT84, FLJ14385, Nori-3, SPK, TOPK" ENSG00000168078 "PDZ binding kinase" Q96KB5 8 27809624-27838082 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 23.0;testis: 70.9" "Group enriched" "Detected in many" 5 "Early spermatids: 364.9;Spermatocytes: 436.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 282.8" "Group enriched" "Detected in many" 4 "basal ganglia: 4.7;white matter: 13.9" "Not detected" "Not detected" "HPA005753, HPA050656" Enhanced Supported Approved Cytosol NA Yes Cytosol "HPA005753: AB_1855018, HPA050656: AB_2681205" "unprognostic (7.17e-2)" "unprognostic (7.21e-3)" "unprognostic (1.04e-3)" "unprognostic (2.77e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.29e-5)" "unprognostic (3.65e-3)" "unprognostic (7.38e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.18e-12)" "unprognostic (9.61e-2)" "unprognostic (1.86e-1)" "unprognostic (8.30e-2)" "unprognostic (8.68e-2)" 1.1 0.6 0.1 6.7 0.1 9.2 2.3 0.1 0.1 1.1 0.1 8.9 8.4 1.2 0.0 6.6 0.6 0.7 0.2 0.1 0.3 0.4 1.1 0.7 12.9 0.1 0.3 0.1 0.2 0.4 0.2 0.0 5.2 0.1 0.4 10.2 0.0 0.9 0.0 0.2 4.9 8.2 2.7 0.1 1.5 3.7 70.9 0.3 23.0 0.6 0.1 12.5 1.6 2.1 1.0 282.8 94.2 94.4 57.9 8.3 15.7 36.9 129.5 63.0 133.2 112.3 33.7 51.2 156.4 43.3 51.7 150.2 76.4 87.6 44.7 145.7 35.8 48.0 35.0 64.6 49.2 0.6 25.7 54.1 4.4 36.0 62.6 32.8 24.3 68.5 75.9 54.3 100.6 160.4 34.5 87.7 29.1 15.6 80.1 80.0 54.4 126.9 41.2 51.2 44.9 36.1 53.2 48.2 56.0 75.0 26.2 58.0 37.3 40.6 85.6 207.3 111.5 141.5 15.4 39.4 70.1 54.0 43.4 188.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.3 1.0 0.2 0.0 0.0 0.0 4.2 8.9 2.8 10.8 0.0 0.0 2.9 2.4 0.5 2.8 2.6 0.0 0.0 29.8 1.3 5.5 0.0 0.6 364.9 2.5 2.2 2.4 0.0 61.7 0.1 0.0 49.3 6.7 6.6 3.5 0.0 13.5 5.7 1.7 5.0 0.0 0.1 9.4 6.1 1.9 1.6 76.8 8.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 3.0 14.0 2.0 1.5 0.3 0.1 0.0 6.6 0.1 5.8 436.4 38.1 9.4 2.4 6.7 1.9 2.4 18.7 3.8 SCARA5 "FLJ23907, MGC45780, NET33" ENSG00000168079 "Scavenger receptor class A member 5" Q6ZMJ2 8 27869883-27992673 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 77.7" "Group enriched" "Detected in some" 4 "Fibroblasts: 174.0;Leydig cells: 135.8;Theca cells: 44.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 121 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 211 "dendritic cells: 21.1" "Cell line enriched" "Detected in some" 20 "ASC diff: 229.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "spinal cord: 19.5" HPA024661 Approved NA NA 1400000 "HPA024661: AB_1853902" "unprognostic (2.76e-2)" "unprognostic (7.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.53e-2)" "unprognostic (2.34e-2)" "unprognostic (4.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.15e-1)" "unprognostic (9.13e-2)" "unprognostic (2.40e-1)" "unprognostic (4.21e-2)" "unprognostic (1.10e-1)" "unprognostic (7.09e-6)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" 59.5 4.1 0.4 7.3 0.8 0.0 35.0 0.8 1.8 15.3 5.5 37.0 8.7 2.9 8.3 21.3 23.9 22.8 60.8 0.5 0.7 1.0 4.2 20.4 2.4 0.4 0.5 0.6 11.2 2.4 0.2 5.5 12.6 0.3 8.4 34.0 0.3 29.2 3.4 15.2 27.7 26.5 6.5 0.5 3.4 27.6 11.7 0.2 3.2 21.2 34.8 2.1 77.7 37.1 0.3 0.0 7.9 0.0 0.0 229.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 11.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.1 0.4 0.8 0.8 1.8 0.5 0.7 0.4 0.5 0.6 0.3 0.5 0.2 0.3 7.1 0.0 0.0 0.0 0.1 6.5 0.1 0.0 0.6 0.0 0.5 0.6 4.6 0.0 0.0 0.0 0.0 0.1 6.7 0.2 0.0 0.0 1.5 0.7 27.9 2.4 0.0 0.0 0.3 0.0 0.4 174.0 4.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 2.9 0.0 0.0 0.0 17.0 4.6 135.8 1.3 7.2 5.6 0.0 1.9 0.0 0.0 0.2 0.0 0.0 11.3 0.8 0.1 0.0 0.0 0.0 0.1 0.0 7.4 3.6 0.7 1.1 0.9 6.0 0.1 1.1 44.5 0.3 0.1 PNOC "N/OFQ, NOP, PPNOC" ENSG00000168081 Prepronociceptin Q13519 8 28316986-28343355 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Neuropeptide, Neurotransmitter, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 28.1;fallopian tube: 18.4;lymphoid tissue: 25.3" "Cell type enhanced" "Detected in some" "B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4" "Cancer enriched" "Detected in many" 8 "ovarian cancer: 32.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0" "Group enriched" "Detected in many" 20 "B-cells: 260.3;dendritic cells: 194.0" "Group enriched" "Detected in some" 6 "Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044507, HPA056724" Enhanced "Secreted to blood" NA NA 12300 "HPA044507: AB_10795043, HPA056724: AB_2683216" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (3.53e-2)" "prognostic unfavorable (2.94e-6)" "unprognostic (3.71e-2)" "unprognostic (5.16e-5)" "unprognostic (1.03e-1)" "unprognostic (1.50e-1)" "unprognostic (7.81e-4)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" "unprognostic (7.57e-9)" "unprognostic (2.19e-2)" "unprognostic (5.45e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-1)" 0.2 0.8 5.6 10.0 5.5 2.7 0.7 1.5 28.1 0.2 1.5 2.9 4.3 0.1 0.0 0.6 18.4 1.1 0.1 3.1 8.3 0.5 0.2 1.0 25.3 10.7 5.8 3.1 0.5 0.0 0.0 0.0 0.0 10.0 0.2 1.6 0.0 1.6 0.1 0.0 0.1 5.8 0.5 10.6 14.5 3.3 0.6 7.7 2.8 0.4 0.0 23.8 3.7 0.2 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.0 4.4 23.0 0.1 0.1 0.0 0.2 11.5 2.3 0.2 7.7 0.1 231.2 0.2 0.1 1.1 260.3 0.1 0.1 1.3 1.2 3.2 194.0 0.5 11.1 5.6 5.5 1.5 28.1 3.1 8.3 10.7 5.8 3.1 10.0 10.6 7.7 7.0 0.1 0.0 1.9 1.3 61.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.4 0.4 0.2 0.0 23.3 0.1 0.0 0.0 0.3 2.8 0.3 1.7 14.2 1.0 3.0 0.0 1.0 0.0 0.9 0.1 0.0 0.0 80.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 1.1 0.0 0.3 0.5 COPS6 "CSN6, MOV34-34KD" ENSG00000168090 "COP9 signalosome subunit 6" Q7L5N1 7 100088969-100092187 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044315 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 110000 Nucleoplasm "HPA044315: AB_10959750" "unprognostic (1.48e-2)" "unprognostic (2.43e-2)" "unprognostic (6.56e-3)" "unprognostic (1.38e-1)" "unprognostic (5.84e-2)" "unprognostic (2.09e-2)" "unprognostic (3.62e-3)" "unprognostic (2.93e-2)" "unprognostic (2.00e-1)" "unprognostic (2.45e-2)" "unprognostic (4.96e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (6.72e-4)" "unprognostic (1.20e-1)" "unprognostic (3.58e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-2)" 70.7 86.2 99.7 49.1 103.6 52.3 69.2 103.8 102.8 83.3 99.2 87.0 44.5 87.2 84.7 91.4 78.7 53.4 106.8 101.9 103.2 71.5 72.2 57.0 50.7 103.2 99.8 100.7 75.5 60.7 101.6 79.8 64.5 101.6 69.4 58.3 61.9 65.6 74.9 148.5 61.2 58.9 79.1 102.1 63.6 79.1 57.9 101.0 63.7 62.1 154.1 61.1 91.3 75.3 107.5 167.6 233.4 136.2 163.5 116.1 138.4 86.6 147.7 223.5 239.7 174.9 191.9 153.8 114.4 186.1 242.2 267.3 124.1 155.1 247.9 240.4 114.9 242.6 98.2 215.9 149.3 243.3 112.1 97.6 137.5 161.4 259.2 273.9 159.5 333.0 172.7 142.7 160.5 286.4 413.7 251.6 164.8 124.0 241.3 273.2 117.6 226.6 275.4 193.6 153.8 213.4 158.6 152.7 298.5 114.1 176.4 123.7 109.2 177.9 231.3 211.1 280.5 264.8 118.1 140.2 235.3 175.5 150.0 350.6 231.8 187.8 168.2 178.8 206.6 180.7 168.0 176.8 170.9 211.3 170.3 137.4 153.6 73.5 163.5 194.6 157.8 225.8 146.6 99.7 103.6 103.8 102.8 101.9 103.2 103.2 99.8 100.7 101.6 102.1 101.0 107.5 87.8 51.3 44.2 24.8 73.4 110.6 118.1 208.1 70.0 108.3 62.8 76.3 166.3 88.6 117.2 86.5 52.1 197.3 84.2 55.1 211.3 138.3 76.5 61.6 103.4 94.9 75.3 69.0 20.9 113.5 133.7 116.0 52.5 48.3 90.7 100.5 90.3 63.2 128.8 95.9 21.0 67.4 158.7 69.6 82.5 197.1 127.7 55.1 156.5 13.1 101.4 147.0 115.4 17.6 24.0 115.1 64.7 125.3 84.3 95.0 84.2 214.2 117.9 127.1 98.6 76.3 261.5 80.5 100.2 81.2 100.3 137.9 82.7 137.9 87.1 96.1 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144284-117176894 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 250000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 23.4 34.7 40.2 21.4 43.8 41.5 20.8 46.0 44.4 21.0 31.7 21.9 22.6 24.0 22.9 24.1 21.1 20.1 28.4 37.7 49.9 25.6 24.0 21.9 20.8 49.8 48.8 35.0 23.5 20.5 22.1 24.7 25.6 53.0 22.5 20.2 23.4 17.6 16.3 15.9 22.2 19.6 20.6 53.4 20.6 23.3 30.3 46.1 21.7 32.2 20.4 22.3 27.2 21.1 56.9 43.4 48.5 54.9 79.7 60.1 41.7 42.6 71.0 61.7 38.8 35.2 89.2 92.9 46.6 99.4 85.8 38.7 67.7 80.6 92.0 50.9 41.8 31.1 120.0 41.3 57.9 53.8 42.1 44.0 46.6 71.7 77.4 96.7 42.4 64.8 25.6 65.0 34.6 60.3 27.7 40.8 61.7 50.4 60.0 37.8 44.9 62.2 51.2 59.8 66.7 60.9 80.5 82.2 61.6 28.1 46.6 68.4 35.6 103.8 70.4 46.3 34.8 51.4 10.8 17.9 61.5 28.3 78.8 60.4 63.4 51.4 48.6 39.0 58.7 46.4 43.8 44.7 41.0 37.4 41.2 45.8 49.2 63.7 33.1 66.3 27.4 35.1 53.1 40.2 43.8 46.0 44.4 37.7 49.9 49.8 48.8 35.0 53.0 53.4 46.1 56.9 48.5 28.9 34.8 17.9 41.4 122.4 44.5 45.9 54.7 38.6 55.4 32.1 37.6 58.6 32.8 66.2 47.9 40.4 44.4 48.0 46.9 61.3 13.1 63.6 54.8 64.8 82.6 39.4 29.2 39.5 86.7 40.8 33.6 78.4 19.0 36.8 79.6 47.0 43.0 47.1 32.5 41.8 36.7 65.4 175.9 13.7 45.4 52.1 49.8 20.6 59.3 36.2 21.6 13.0 61.2 99.0 50.5 34.3 28.9 67.0 33.7 54.8 32.9 38.3 13.1 42.8 40.0 54.7 84.7 53.2 115.9 54.6 41.6 35.2 45.4 50.6 ANKS3 "FLJ32345, FLJ32767, KIAA1977" ENSG00000168096 "Ankyrin repeat and sterile alpha motif domain containing 3" Q6ZW76 16 4696510-4734378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;Rod photoreceptor cells: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041409, HPA041482" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041409: AB_10794375, HPA041482: AB_10795594" "unprognostic (3.02e-1)" "unprognostic (2.19e-1)" "unprognostic (3.06e-2)" "unprognostic (2.55e-2)" "unprognostic (5.44e-2)" "unprognostic (1.31e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "unprognostic (4.42e-2)" "unprognostic (7.36e-3)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (9.96e-2)" "unprognostic (1.57e-3)" 4.7 5.0 4.9 2.4 4.8 1.9 4.7 5.5 8.0 7.0 4.4 6.9 2.7 6.4 1.5 3.9 6.8 2.9 4.7 4.7 5.0 7.9 5.1 4.6 3.0 4.9 4.8 4.6 8.7 5.6 2.8 7.2 2.4 5.3 7.0 1.2 2.5 6.5 4.1 6.5 4.2 4.2 2.8 4.4 4.3 5.0 5.1 4.8 2.0 6.3 3.3 2.0 7.0 5.7 5.3 2.5 29.4 3.7 8.3 7.1 5.8 8.6 11.0 8.9 10.0 8.9 15.3 6.1 5.5 13.4 7.4 3.9 4.9 8.2 6.0 4.4 7.2 15.6 5.2 14.6 3.8 7.7 2.8 4.3 3.7 6.2 9.6 9.2 6.0 1.9 3.6 12.4 1.7 5.9 9.3 5.5 10.3 10.0 3.7 5.4 8.6 9.3 10.0 7.6 3.1 12.1 11.6 5.7 8.3 4.7 2.1 8.2 3.6 3.4 7.3 9.9 13.7 5.7 8.6 16.4 8.6 4.0 2.8 8.5 0.0 0.4 0.0 0.8 0.5 1.2 1.2 1.0 0.7 0.8 1.3 1.5 0.9 0.0 0.6 0.6 2.2 0.7 0.5 4.9 4.8 5.5 8.0 4.7 5.0 4.9 4.8 4.6 5.3 4.4 4.8 5.3 9.0 6.4 14.3 18.3 9.9 7.6 13.2 12.9 8.0 42.9 11.6 11.0 4.9 14.3 11.7 22.0 110.5 12.6 9.9 9.8 19.6 16.5 6.1 10.1 15.1 9.4 9.0 5.5 28.8 8.6 8.5 13.1 13.7 6.8 0.0 21.4 14.6 8.1 8.1 50.5 27.7 13.6 14.2 4.4 4.3 6.4 27.1 4.9 10.6 6.5 12.5 12.5 20.6 17.1 21.2 13.3 13.3 28.2 7.5 16.1 8.8 16.1 15.1 92.2 6.6 13.8 12.3 29.1 25.4 6.0 9.7 6.7 10.6 19.1 12.8 6.2 NUDT16L1 "SDOS, TIRR" ENSG00000168101 "Nudix hydrolase 16 like 1" Q9BRJ7 16 4693694-4695859 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044186, HPA063605" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044186: AB_10968571, HPA063605: AB_2685058" "unprognostic (1.35e-2)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.17e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-2)" "unprognostic (3.14e-1)" "prognostic favorable (2.79e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (6.12e-3)" "unprognostic (6.81e-2)" "prognostic favorable (1.02e-6)" "unprognostic (2.78e-1)" "unprognostic (1.47e-1)" "unprognostic (4.08e-2)" "unprognostic (6.81e-3)" 18.4 46.7 41.0 12.1 41.3 22.4 21.7 40.7 53.0 22.0 40.6 24.2 21.9 21.5 15.5 29.1 23.6 8.5 50.8 41.0 39.3 43.5 64.6 17.3 18.1 42.5 40.6 39.9 22.9 24.8 20.6 40.3 8.1 39.8 35.1 12.0 14.6 26.8 14.8 25.3 25.0 29.4 8.6 40.5 34.0 30.4 23.0 44.3 18.3 31.0 17.1 13.2 22.9 22.0 43.0 14.7 23.8 21.2 28.7 15.7 12.1 19.4 17.2 12.9 20.4 12.8 26.9 11.6 15.2 24.4 20.7 10.3 16.8 23.1 23.4 9.5 22.6 38.9 16.8 21.1 32.8 17.0 24.4 19.2 18.7 21.3 17.2 10.7 13.9 15.1 22.6 31.2 18.5 20.1 57.3 36.8 36.0 33.6 24.4 27.0 50.9 22.4 24.2 24.8 18.0 41.8 31.5 25.1 25.9 11.7 16.5 38.4 56.4 20.0 16.7 25.3 39.8 15.9 32.1 20.5 26.1 10.4 32.3 34.8 56.6 54.3 96.2 52.6 48.2 63.1 60.7 63.4 62.8 50.2 65.3 74.0 63.5 68.2 63.9 53.5 83.6 78.3 98.1 41.0 41.3 40.7 53.0 41.0 39.3 42.5 40.6 39.9 39.8 40.5 44.3 43.0 23.3 16.0 22.4 14.4 32.6 14.0 19.7 37.4 27.9 52.1 36.0 36.2 52.6 24.3 28.0 42.3 10.4 53.8 43.6 47.7 109.5 28.7 5.2 28.7 33.6 21.4 43.1 23.1 10.2 30.9 31.8 24.0 30.5 29.0 27.9 31.7 17.9 41.8 40.9 47.1 11.8 51.7 89.5 18.3 18.7 8.7 31.4 20.8 30.2 3.7 43.3 83.5 34.0 9.5 15.0 30.0 48.5 50.0 33.0 17.9 77.8 98.2 20.1 58.3 46.0 14.2 22.8 14.8 34.7 24.9 16.6 49.1 43.6 58.0 51.4 17.6 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.0;Erythroid cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 4.1 4.8 1.9 3.6 2.8 8.6 5.4 9.8 4.1 4.7 0.0 2.6 2.1 6.1 3.7 3.3 2.8 4.6 3.6 2.4 3.6 3.6 5.0 2.8 4.6 3.2 3.1 1.8 7.7 2.8 5.3 3.7 9.5 3.6 5.2 2.6 4.0 2.7 3.7 1.6 2.5 2.5 4.4 1.6 4.5 2.1 8.1 2.9 5.9 5.7 3.4 4.0 4.8 2.6 3.7 8.6 3.5 21.9 25.1 8.5 13.7 12.0 14.1 11.6 12.0 14.4 5.9 2.7 3.4 11.4 10.4 10.6 4.2 16.7 8.3 16.4 10.7 12.7 35.9 8.0 13.3 11.1 29.0 12.7 10.1 5.9 10.6 11.7 8.5 11.5 9.1 49.9 2.7 14.4 6.8 14.0 17.5 14.2 3.0 5.0 12.8 16.0 8.4 8.0 17.6 18.5 16.8 9.3 3.0 10.6 15.1 7.2 26.0 9.4 18.6 7.7 17.9 10.2 10.9 15.4 16.8 11.5 21.0 7.7 0.2 2.5 2.0 2.3 2.0 2.7 3.7 3.4 3.0 3.9 3.1 4.2 3.6 0.1 5.3 2.0 4.0 4.4 1.9 1.9 2.8 9.8 4.1 2.4 3.6 3.2 3.1 1.8 3.6 1.6 2.9 3.7 15.4 9.6 6.3 10.4 8.8 10.5 4.5 13.0 13.1 15.4 7.4 11.7 23.1 1.5 7.8 7.3 2.1 43.3 11.7 1.0 11.7 7.0 87.0 4.6 29.6 12.5 5.4 74.9 32.4 5.4 33.2 21.4 3.1 3.2 13.3 30.5 8.2 4.0 12.5 10.1 32.7 2.4 6.1 6.6 7.1 21.9 12.8 8.9 3.6 12.2 9.7 9.6 15.5 23.6 24.4 2.8 0.9 14.7 13.0 2.3 0.7 14.6 8.4 8.2 19.7 19.5 17.6 23.4 17.9 8.7 4.4 10.7 10.6 29.5 3.2 1.6 RAB4A "HRES-1/RAB4, RAB4" ENSG00000168118 "RAB4A, member RAS oncogene family" P20338 1 229271062-229305894 "Enzymes, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 32.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.21e-2)" "unprognostic (7.58e-2)" "unprognostic (1.81e-2)" "unprognostic (2.09e-1)" "unprognostic (2.09e-2)" "unprognostic (1.21e-1)" "unprognostic (2.83e-1)" "unprognostic (8.53e-2)" "unprognostic (6.41e-2)" "unprognostic (3.85e-2)" "unprognostic (2.99e-2)" "unprognostic (2.47e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (2.11e-1)" "unprognostic (4.26e-2)" "unprognostic (1.72e-2)" 11.5 13.0 32.5 7.7 30.5 7.2 19.6 31.4 35.9 19.6 26.9 17.5 17.2 12.6 13.5 17.9 15.3 15.1 38.9 27.8 30.1 15.9 31.1 10.9 11.0 29.6 34.5 26.7 15.8 24.9 14.4 9.2 11.4 29.6 34.6 19.3 17.4 39.1 21.1 34.6 17.1 13.5 13.5 29.8 7.8 27.0 11.6 37.7 12.6 20.0 35.3 11.9 15.6 14.0 31.4 10.3 13.8 22.6 15.7 31.7 35.1 18.9 15.4 18.3 9.2 8.8 25.6 16.8 0.0 25.1 20.7 7.7 11.1 15.2 21.6 12.9 13.1 30.7 13.9 11.8 40.2 20.5 28.2 10.9 27.1 30.4 6.4 8.9 27.1 20.8 14.9 14.8 0.0 16.1 13.3 14.4 18.8 20.4 63.1 19.1 4.6 3.6 7.2 48.6 24.4 19.4 25.3 12.7 19.1 27.6 11.9 18.1 49.5 14.6 0.0 7.3 14.6 21.4 11.9 11.8 0.1 6.4 23.9 21.8 21.4 5.5 32.7 2.2 6.5 2.2 3.0 2.9 2.9 6.8 3.7 1.8 2.4 1.2 2.2 4.2 3.8 3.7 3.5 32.5 30.5 31.4 35.9 27.8 30.1 29.6 34.5 26.7 29.6 29.8 37.7 31.4 43.9 16.0 22.1 37.5 48.4 137.0 155.0 135.3 153.1 29.4 82.3 88.8 91.7 154.4 60.5 44.1 47.9 77.7 61.1 81.9 113.5 89.0 158.0 81.7 45.7 45.3 48.6 52.0 23.6 115.4 88.5 47.2 68.3 47.1 24.8 41.5 52.5 119.2 67.8 30.3 24.2 82.6 79.3 78.4 96.3 169.4 46.6 76.0 64.0 16.9 80.4 33.2 50.4 23.6 38.0 84.9 105.7 83.8 47.6 145.2 73.0 128.1 63.2 58.4 46.0 41.6 46.0 92.6 35.2 83.8 122.6 58.0 50.5 39.5 110.5 161.9 OR1F1 "Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145" ENSG00000168124 "Olfactory receptor family 1 subfamily F member 1" O43749 16 3204247-3205188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.6" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.72e-1)" "unprognostic (2.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.94e-2)" "unprognostic (4.88e-1)" "unprognostic (4.16e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.4 0.0 0.8 0.0 0.0 2.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.5 0.1 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 1.0 0.6 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.8 2.6 1.9 1.8 0.5 1.0 0.5 0.3 1.2 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B2 "hs6M1-10, OR2B2Q, OR2B9, OR6-1" ENSG00000168131 "Olfactory receptor family 2 subfamily B member 2" Q9GZK3 6 27911185-27912396 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ4 "HIR, hIRK2, HRK1, IRK3, Kir2.3" ENSG00000168135 "Potassium inwardly rectifying channel subfamily J member 4" P48050 22 38426327-38455199 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 28.7;heart muscle: 29.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.3;Excitatory neurons: 14.3;Horizontal cells: 10.1;Inhibitory neurons: 11.1;Microglial cells: 3.7;Muller glia cells: 6.2" "Cancer enhanced" "Detected in some" "glioma: 2.1;liver cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 14 "amygdala: 5.9;basal ganglia: 13.7;cerebral cortex: 14.7;hippocampal formation: 12.3;olfactory bulb: 15.9" NA NA "unprognostic (4.76e-2)" "unprognostic (2.60e-3)" "unprognostic (2.21e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.07e-1)" "unprognostic (3.15e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-1)" "unprognostic (5.41e-2)" 0.1 0.2 10.1 0.0 21.2 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.8 0.6 29.8 21.3 6.5 0.2 2.1 0.0 0.0 5.5 1.3 24.8 0.0 0.0 0.1 2.0 0.0 8.6 0.0 0.0 0.8 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.1 0.9 1.2 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.1 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.4 0.8 0.0 0.3 0.1 0.0 1.7 0.0 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 21.2 0.0 28.7 21.3 6.5 5.5 1.3 24.8 8.6 0.0 0.9 10.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 11.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 3.7 0.0 6.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SETD5 FLJ10707 ENSG00000168137 "SET domain containing 5" Q9C0A6 3 9397615-9479240 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Autism, Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 263.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017093, HPA035574" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB017093: , HPA035574: AB_2674681" "unprognostic (6.46e-2)" "unprognostic (1.64e-1)" "unprognostic (3.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.22e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.21e-4)" "unprognostic (5.52e-2)" "unprognostic (2.29e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (6.65e-2)" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (5.15e-3)" 24.7 28.4 22.9 19.4 22.7 15.1 25.6 33.8 25.1 29.7 21.9 27.7 15.3 27.8 30.4 25.2 30.4 19.0 22.6 23.6 23.7 17.7 27.8 33.8 23.3 21.3 21.8 21.7 33.5 28.8 18.1 26.7 24.2 25.2 25.9 21.2 34.2 28.5 20.6 24.1 33.1 25.9 23.4 20.1 26.3 24.1 18.0 22.9 25.7 30.8 21.6 27.0 26.7 28.4 24.8 25.3 28.6 57.8 27.0 36.5 33.6 138.5 24.9 30.2 31.6 35.4 29.1 30.2 53.5 14.3 33.4 29.8 20.0 50.6 29.8 35.5 38.4 27.6 50.6 56.4 29.8 36.7 42.0 31.9 35.0 52.2 49.3 55.1 37.3 35.7 35.6 50.0 40.0 32.6 36.4 35.7 38.1 42.2 19.5 23.9 37.7 47.6 26.2 29.6 37.7 22.3 34.6 34.2 29.8 22.6 52.6 39.7 30.8 41.6 35.3 41.6 21.0 28.9 27.4 34.2 83.6 26.9 30.4 33.2 0.4 0.4 0.2 0.9 0.2 0.8 0.7 0.6 0.7 0.3 0.7 0.5 0.5 1.1 1.1 0.2 0.8 0.1 0.1 22.9 22.7 33.8 25.1 23.6 23.7 21.3 21.8 21.7 25.2 20.1 22.9 24.8 51.5 41.7 50.6 136.1 53.6 93.9 54.4 28.5 86.6 110.6 45.1 26.2 25.5 41.5 50.0 42.3 114.7 38.9 50.4 39.1 3.9 37.3 7.9 45.9 60.3 62.5 62.4 34.3 175.0 34.0 41.3 62.2 45.9 49.4 48.1 60.6 63.1 50.1 24.4 55.5 188.5 51.9 26.4 32.4 70.7 11.7 66.8 30.8 44.4 108.7 39.7 33.4 39.1 263.9 131.7 44.2 46.2 53.8 67.7 88.2 39.4 12.8 52.9 60.9 13.1 65.3 52.8 50.6 37.8 75.2 91.5 57.3 49.6 56.2 47.8 84.2 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383538 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 21.8;MCF7: 18.4;U-2197: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2000000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 47.8 15.6 1.6 5.8 2.2 2.8 31.8 1.6 3.1 43.7 2.6 12.1 3.5 30.5 0.0 34.4 24.8 7.4 23.7 1.1 1.2 55.7 32.1 45.3 2.9 5.9 3.4 0.1 40.3 10.4 0.0 12.9 10.5 2.4 18.0 0.0 0.3 16.0 0.0 7.0 34.1 11.3 0.0 1.7 13.2 13.5 16.9 3.2 0.0 27.0 0.0 0.0 26.7 39.2 2.8 4.2 0.0 0.6 0.5 0.2 0.2 12.6 21.8 0.1 0.0 0.0 1.9 5.5 0.0 4.5 0.3 2.6 0.3 0.0 0.0 0.0 13.7 2.2 0.9 15.9 14.9 0.6 0.0 0.4 7.9 0.0 0.3 0.0 3.1 0.0 0.1 3.1 0.8 0.0 18.4 1.0 5.3 2.2 0.4 2.4 1.0 0.0 0.0 0.0 0.1 1.4 9.3 6.5 13.5 0.6 2.2 6.8 2.5 0.0 17.5 12.5 78.4 4.6 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 1.6 3.1 1.1 1.2 5.9 3.4 0.1 2.4 1.7 3.2 2.8 10.0 6.4 13.1 5.5 1.4 9.6 7.8 4.2 9.1 0.5 21.9 10.9 16.2 32.9 6.4 23.9 0.0 5.4 2.8 1.5 7.9 13.1 1.1 12.1 58.7 4.6 0.0 0.0 1.1 2.9 7.2 104.2 16.8 20.5 3.8 4.6 2.9 15.3 3.4 0.0 0.9 2.0 2.0 0.6 21.7 2.8 50.1 2.0 14.2 2.8 0.0 18.3 0.0 0.5 0.3 28.3 1.2 60.9 0.8 6.4 0.2 12.3 2.7 0.7 98.6 12.6 80.9 0.8 4.1 3.7 7.5 10.0 3.5 2.3 0.8 4.9 FAM83B "C6orf143, FLJ30642" ENSG00000168143 "Family with sequence similarity 83 member B" Q5T0W9 6 54846771-54945099 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 14.6;skin 1: 26.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 33.8;Basal prostatic cells: 32.5;Basal squamous epithelial cells: 43.3;Squamous epithelial cells: 31.9;Suprabasal keratinocytes: 41.1;Urothelial cells: 25.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 13.3;HaCaT: 18.1;HBEC3-KT: 9.8;hTCEpi: 19.7;hTERT-HME1: 23.8;RT4: 19.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031464, HPA031465" Enhanced NA NA "HPA031464: AB_10599973, HPA031465: AB_10601566" "unprognostic (2.29e-1)" "unprognostic (3.93e-2)" "unprognostic (3.71e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (7.27e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (1.62e-1)" "unprognostic (3.19e-2)" "unprognostic (1.85e-1)" "unprognostic (4.35e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.86e-5)" 0.0 0.0 0.1 1.1 0.1 0.1 2.3 0.1 0.1 1.9 0.0 8.1 7.5 0.3 1.2 14.6 1.6 2.2 0.9 0.1 0.3 2.5 0.1 0.1 0.0 0.1 0.8 0.1 0.0 1.5 0.0 0.0 4.3 0.1 1.8 8.3 0.1 4.8 1.1 0.7 26.1 7.4 0.2 0.0 0.0 4.0 0.6 0.0 2.3 3.7 0.1 3.7 4.4 9.9 0.2 13.3 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 6.5 3.6 0.0 0.0 0.0 0.1 18.1 0.0 9.8 0.1 0.0 2.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 19.7 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.6 4.1 0.0 0.0 0.0 0.0 9.1 19.2 0.2 0.0 2.9 0.6 0.0 3.3 4.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 33.8 32.5 6.6 43.3 0.0 1.5 3.0 3.1 5.7 6.5 7.3 0.0 11.2 0.1 9.0 0.0 6.1 6.3 8.8 0.8 0.3 1.2 0.0 0.2 3.5 11.9 0.4 9.2 8.1 0.0 0.0 0.4 0.0 0.6 0.0 0.1 5.4 6.1 0.0 1.5 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 17.4 0.0 0.1 9.1 12.6 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.6 31.9 41.1 18.7 0.1 0.0 8.8 25.4 H3-4 "H3.4, H3/g, H3FT, H3t, HIST3H3" ENSG00000168148 "H3.4 histone" Q16695 1 228424845-228425360 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB001386, CAB003812, HPA042570" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056" "unprognostic (4.45e-1)" "unprognostic (4.66e-2)" "unprognostic (1.36e-1)" "unprognostic (3.78e-3)" "unprognostic (1.75e-2)" "unprognostic (4.04e-2)" "unprognostic (1.39e-2)" "unprognostic (2.26e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.6 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.6 0.1 0.3 0.6 0.2 0.0 0.7 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THAP9 FLJ34093 ENSG00000168152 "THAP domain containing 9" Q9H5L6 4 82900684-82919969 "Predicted intracellular proteins, Transcription factors" "DNA integration, DNA recombination" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 40.5;Late spermatids: 52.9;Oligodendrocytes: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037420, HPA037421" Uncertain Approved Mitochondria No No Mitochondria "HPA037420: AB_2675467, HPA037421: AB_10673631" "unprognostic (7.54e-3)" "unprognostic (8.52e-2)" "unprognostic (4.14e-2)" "unprognostic (1.51e-2)" "unprognostic (2.06e-1)" "unprognostic (1.18e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (1.17e-1)" "unprognostic (2.30e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-2)" "prognostic favorable (3.50e-5)" "unprognostic (1.39e-1)" "unprognostic (1.62e-1)" "unprognostic (4.64e-3)" "unprognostic (8.74e-4)" 1.3 1.6 3.2 1.0 3.8 2.0 3.2 3.5 4.5 2.0 2.7 1.5 1.5 2.5 3.6 1.3 1.7 1.4 2.7 3.1 3.3 3.0 3.2 1.6 1.8 3.5 3.6 2.8 3.2 2.5 3.2 2.7 2.1 4.1 2.5 1.6 4.4 2.1 1.9 5.2 1.8 1.5 1.5 3.3 1.4 1.4 6.7 3.3 2.5 4.2 6.9 1.7 1.5 1.6 6.0 1.1 1.5 5.7 3.2 1.7 2.0 4.0 1.1 1.8 1.1 1.0 2.3 2.0 6.3 2.0 1.5 2.1 1.4 4.6 1.8 1.3 2.4 1.7 2.7 2.2 2.9 2.0 2.5 2.1 2.1 2.9 0.5 2.8 1.7 1.7 5.1 2.4 4.2 1.4 1.5 6.1 3.0 4.6 2.2 0.8 5.5 2.4 3.7 2.0 1.3 4.8 3.3 2.2 3.0 4.1 4.7 1.8 2.2 1.1 1.4 1.6 1.1 0.8 2.7 1.3 6.0 1.7 1.5 2.2 0.0 0.9 0.1 0.5 1.4 0.7 1.3 0.4 0.5 1.0 1.1 1.2 1.0 0.0 0.6 1.0 0.6 0.2 0.5 3.2 3.8 3.5 4.5 3.1 3.3 3.5 3.6 2.8 4.1 3.3 3.3 6.0 3.2 3.2 3.6 8.5 2.8 0.8 2.8 2.3 2.2 2.8 2.4 2.3 5.0 0.0 2.2 1.8 6.2 3.2 3.6 1.3 0.0 1.6 40.5 4.0 2.8 2.0 3.0 2.5 4.6 2.5 2.0 2.3 5.6 4.2 1.3 4.2 1.4 1.3 1.3 0.0 4.7 1.7 2.0 0.8 1.3 52.9 1.8 2.6 0.0 3.7 1.3 4.0 2.1 7.5 20.8 0.9 0.7 0.0 2.3 1.8 1.1 2.5 1.9 4.7 6.6 4.6 2.8 6.1 5.2 2.6 1.7 3.3 2.0 1.4 1.5 2.0 OR2C1 "OLFmf3, OR2C2P" ENSG00000168158 "Olfactory receptor family 2 subfamily C member 1" O95371 16 3355889-3357306 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.40e-1)" "unprognostic (1.46e-1)" "unprognostic (7.58e-2)" "unprognostic (1.01e-2)" "unprognostic (2.76e-1)" "unprognostic (7.11e-3)" "unprognostic (5.26e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-2)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487382-228496188 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 189.0" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 25.9 67.1 15.2 7.5 16.9 11.4 26.0 16.1 25.2 37.7 3.6 26.3 8.6 32.0 4.4 59.6 29.0 5.6 35.6 17.6 17.0 39.9 52.4 23.9 7.4 21.0 16.5 19.4 39.6 34.8 22.7 48.1 5.6 20.1 33.8 3.7 9.1 40.0 8.2 64.7 45.3 22.7 5.7 15.1 37.3 27.8 21.0 19.5 8.6 36.4 20.0 6.1 30.1 41.5 19.5 26.7 23.1 14.8 28.9 16.8 12.5 26.6 21.5 17.3 15.6 12.7 12.8 19.2 65.9 43.1 28.9 11.4 20.9 19.1 22.1 5.8 25.9 28.5 20.8 13.2 12.6 46.1 22.1 34.4 20.4 44.7 11.6 15.8 18.3 14.0 52.6 35.6 115.2 12.4 17.7 35.2 20.8 30.7 19.1 24.0 27.8 12.5 61.5 11.4 17.2 29.9 30.0 21.9 44.1 62.3 4.3 34.6 50.2 27.8 18.3 16.9 19.6 19.3 189.0 56.7 36.4 46.7 22.7 28.7 0.0 0.5 3.6 0.6 1.0 0.7 0.5 0.7 1.0 0.6 1.0 0.6 0.7 0.1 0.4 1.4 0.7 0.6 0.3 15.2 16.9 16.1 25.2 17.6 17.0 21.0 16.5 19.4 20.1 15.1 19.5 19.5 54.0 25.6 15.5 8.1 47.2 36.2 42.9 10.6 38.7 85.2 59.5 58.5 70.8 65.8 14.2 40.5 18.8 19.7 52.2 39.8 113.5 15.2 0.8 35.5 47.2 32.1 40.0 118.4 16.6 24.5 27.1 54.4 34.7 32.0 44.5 45.0 41.7 67.4 27.4 55.5 17.2 36.6 2.0 40.1 30.5 4.2 24.5 35.8 39.2 12.2 29.7 145.3 62.8 7.1 12.6 21.4 23.4 25.9 35.4 44.0 32.9 126.4 10.3 47.7 19.7 52.2 38.4 4.2 21.5 57.0 55.3 17.6 54.6 217.5 38.6 31.7 HOOK3 HK3 ENSG00000168172 "Hook microtubule tethering protein 3" Q86VS8 8 42896946-43030535 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024756 Approved Supported "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA024756: AB_1850913" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.73e-1)" "unprognostic (8.61e-3)" "unprognostic (6.05e-2)" "unprognostic (1.77e-3)" "unprognostic (2.36e-1)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.63e-1)" "unprognostic (3.78e-1)" "unprognostic (2.55e-1)" "unprognostic (7.12e-2)" 9.9 6.2 3.7 7.5 8.6 11.2 8.9 12.4 9.3 8.3 1.5 7.6 7.6 8.4 8.3 10.7 7.0 14.5 4.7 4.7 6.5 6.7 7.3 8.1 6.6 6.5 6.3 1.4 6.1 7.7 7.2 4.2 8.7 8.0 12.5 7.8 8.9 9.7 7.2 10.7 8.1 9.0 6.8 4.4 6.7 9.6 11.6 5.5 6.4 21.9 8.3 7.5 9.4 6.0 16.0 11.2 10.9 26.2 14.2 19.0 16.7 10.1 14.0 11.6 11.5 10.7 14.5 12.8 13.9 13.9 18.8 10.9 6.4 22.1 9.5 18.5 9.5 6.4 26.3 9.2 10.2 10.6 2.8 14.9 13.7 6.6 15.4 13.2 15.9 16.7 9.7 14.7 15.9 14.0 2.7 21.7 5.2 9.5 8.8 3.3 12.6 27.3 3.5 8.6 16.5 6.7 10.6 15.9 6.7 7.4 11.4 12.2 9.4 30.2 17.1 13.2 20.9 9.0 15.6 18.6 18.1 14.5 9.9 25.8 9.4 2.0 2.0 1.2 2.0 0.4 0.9 1.1 0.9 2.4 0.9 0.6 0.8 2.2 1.2 1.9 1.4 0.8 1.1 3.7 8.6 12.4 9.3 4.7 6.5 6.5 6.3 1.4 8.0 4.4 5.5 16.0 75.3 93.0 60.6 90.1 43.2 68.3 36.2 28.7 43.3 40.1 29.4 22.4 48.2 44.3 43.6 25.8 33.3 43.6 40.6 26.1 27.4 47.1 120.3 60.0 84.0 65.2 65.4 34.5 102.1 32.8 25.9 65.8 33.1 93.8 53.8 37.9 60.3 36.4 38.0 75.7 107.6 26.9 20.3 79.4 96.4 36.3 44.7 82.8 55.2 78.7 118.6 36.3 37.0 119.1 157.8 59.7 27.6 53.8 43.6 43.5 37.3 21.4 35.2 32.2 65.7 63.4 74.6 28.0 21.5 39.8 74.7 113.7 40.9 42.6 16.2 71.1 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051647-55070194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favorable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 31.5 26.6 15.8 27.7 16.8 84.0 26.7 17.3 22.5 26.3 16.3 24.7 19.1 30.5 29.7 27.8 29.1 26.7 33.6 15.9 24.1 37.7 27.5 25.9 29.7 19.1 17.1 14.9 34.8 22.0 23.6 22.5 30.4 17.5 24.9 25.1 19.3 30.5 24.8 25.9 25.4 21.4 35.9 16.3 24.4 23.3 21.8 17.2 24.1 26.0 20.1 36.8 34.5 22.0 17.6 49.0 42.3 73.1 46.8 57.8 56.6 56.5 53.7 56.8 65.2 75.2 34.1 42.2 56.3 44.4 72.0 39.2 52.5 79.3 81.3 90.7 51.4 50.6 54.3 39.4 51.7 63.0 67.3 57.4 73.6 60.0 54.5 85.9 47.5 87.9 35.4 51.2 48.7 95.6 59.0 56.9 51.7 53.1 46.2 70.4 48.1 80.4 34.0 89.9 54.1 47.5 55.0 51.9 36.7 51.6 65.1 65.5 38.4 66.8 66.6 87.0 41.7 48.6 29.9 46.3 73.3 53.3 34.7 49.0 44.1 26.7 32.1 24.2 37.4 32.0 31.8 28.3 26.3 29.0 27.4 26.0 26.1 19.7 26.0 36.4 37.2 37.9 25.1 15.8 16.8 17.3 22.5 15.9 24.1 19.1 17.1 14.9 17.5 16.3 17.2 17.6 73.5 70.5 66.9 25.5 106.3 71.9 164.0 77.3 53.5 22.9 44.1 36.2 71.2 40.0 66.3 47.8 37.5 121.2 78.0 60.3 70.5 65.0 28.5 73.7 57.1 69.5 57.9 57.7 34.3 69.4 112.3 60.7 70.3 86.2 83.1 41.5 43.2 51.5 75.1 38.7 32.2 54.8 50.8 64.4 88.4 14.1 51.3 72.9 49.8 28.1 65.0 60.0 49.4 27.2 38.1 94.4 44.2 54.2 109.5 104.8 44.1 103.4 39.6 24.9 32.9 59.1 66.5 81.1 60.6 53.6 71.6 151.3 86.4 40.5 46.9 145.3 DDIT4 "Dig2, FLJ20500, REDD-1, REDD1, RTP801" ENSG00000168209 "DNA damage inducible transcript 4" Q9NX09 10 72273919-72276036 "Predicted intracellular proteins" "Antiviral defense, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 776.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 657.6;hTCEpi: 2252.5;hTERT-HME1: 877.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034507, HPA034508" Approved Supported Cytosol NA NA Cytosol "HPA034507: AB_2674199, HPA034508: AB_10601206" "unprognostic (2.84e-3)" "unprognostic (1.05e-3)" "unprognostic (1.06e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (7.65e-2)" "unprognostic (1.62e-3)" "unprognostic (2.90e-1)" "unprognostic (4.96e-3)" "prognostic unfavorable (2.78e-4)" "unprognostic (9.72e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (8.52e-2)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" "unprognostic (1.66e-1)" 268.7 283.2 93.6 84.5 83.8 124.9 289.7 87.8 107.2 289.2 92.3 94.1 21.0 99.5 12.7 428.4 119.6 48.2 170.0 79.6 83.4 168.6 339.9 199.6 90.9 99.1 85.6 73.4 747.7 681.1 95.3 170.8 52.2 85.4 172.6 13.5 87.5 226.8 68.9 280.3 224.3 112.6 25.6 84.4 167.6 122.2 32.3 91.6 103.4 106.0 60.5 115.3 318.1 602.5 113.8 139.2 95.2 20.0 179.3 124.0 74.3 52.1 40.3 45.6 13.5 56.7 11.1 280.5 14.3 113.7 6.5 19.1 143.0 28.9 657.6 33.7 213.9 35.8 15.1 115.4 74.0 501.2 47.7 57.7 291.1 2252.5 59.2 877.9 127.1 60.1 33.9 135.3 347.2 51.5 58.7 28.5 62.1 4.2 67.6 22.2 15.2 22.4 265.7 115.9 30.9 33.2 46.2 98.3 152.0 583.9 43.0 20.9 104.4 118.7 4.6 35.4 8.7 22.3 234.3 135.1 42.3 252.9 99.9 29.8 68.8 7.6 51.1 236.4 14.5 249.6 97.4 163.8 141.3 40.3 122.4 274.5 213.7 17.1 408.1 13.0 197.4 136.9 215.0 93.6 83.8 87.8 107.2 79.6 83.4 99.1 85.6 73.4 85.4 84.4 91.6 113.8 366.5 12.8 27.1 136.1 290.6 228.5 383.5 534.1 290.8 87.8 129.8 112.5 16.1 77.2 226.6 60.7 79.2 9.9 680.2 109.2 60.7 310.7 3.1 46.4 101.8 177.9 75.1 129.0 2.1 165.3 141.1 203.8 116.2 69.2 415.0 30.8 249.1 83.8 89.7 30.3 3.8 105.6 173.0 102.4 485.9 7.0 88.3 280.5 396.6 5.6 38.9 682.8 249.3 7.1 5.5 131.5 177.7 128.2 776.1 143.5 41.6 19.3 100.6 143.3 72.3 124.2 338.3 2.1 5.7 519.6 251.5 19.0 537.4 126.0 70.6 359.6 RBPJ "CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH" ENSG00000168214 "Recombination signal binding protein for immunoglobulin kappa J region" Q06330 4 26163455-26435131 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 422.1;Oligodendrocytes: 378.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000251, HPA060647" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA000251: , HPA060647: AB_2684337" "unprognostic (2.68e-1)" "unprognostic (2.71e-3)" "unprognostic (2.61e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.15e-3)" 41.3 18.5 32.3 33.3 45.5 51.8 28.7 35.8 38.0 32.2 30.3 29.1 20.4 36.8 18.2 28.8 23.8 25.7 22.0 31.1 38.2 21.6 18.0 31.6 27.7 41.9 41.2 27.8 34.5 22.5 26.5 13.0 54.9 41.8 28.2 28.3 33.4 19.5 22.7 21.9 25.9 22.9 38.3 37.9 25.9 25.6 28.9 39.0 28.0 25.0 29.2 26.7 32.1 21.9 62.1 68.2 19.1 60.0 39.0 91.5 138.8 44.9 54.4 47.0 50.9 60.1 14.5 36.4 56.0 34.1 36.2 39.5 12.2 51.9 33.4 98.1 30.4 28.4 42.5 24.2 27.9 47.9 76.9 35.9 64.0 28.5 104.9 39.7 70.3 28.5 34.3 43.0 21.5 93.2 20.1 54.5 76.4 163.5 20.3 30.3 48.0 112.4 25.4 26.8 22.4 84.5 36.5 28.0 20.6 24.3 54.4 22.0 53.3 38.5 50.5 25.2 86.3 51.9 40.2 51.9 55.7 132.3 86.3 43.4 23.8 94.6 112.9 31.4 77.8 42.6 37.2 49.8 34.1 136.4 33.4 41.4 35.9 220.5 70.9 77.1 31.5 68.1 68.6 32.3 45.5 35.8 38.0 31.1 38.2 41.9 41.2 27.8 41.8 37.9 39.0 62.1 72.5 48.1 66.8 62.0 54.6 152.8 86.2 104.6 55.8 94.6 48.9 51.2 44.2 62.9 83.3 46.0 129.3 102.7 47.3 26.6 74.3 64.3 44.4 54.5 96.3 73.2 78.4 46.9 81.7 65.4 74.4 129.0 29.0 62.8 57.0 130.7 65.3 53.1 365.2 85.8 85.9 51.0 59.0 208.5 422.1 56.7 135.5 234.2 80.0 60.9 125.1 95.0 44.3 215.1 378.1 76.5 35.1 84.2 54.9 113.7 44.9 55.4 67.5 102.9 85.5 71.7 95.8 134.7 158.4 45.9 109.3 83.9 102.8 57.0 47.0 75.7 LMBRD1 "bA810I22.1, C6orf209, cblF, FLJ11240" ENSG00000168216 "LMBR1 domain containing 1" Q9NUN5 6 69672757-69867236 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Endocytosis, Gastrulation, Host-virus interaction, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive B-cell: 21.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016491, HPA019547" Uncertain Supported Vesicles NA NA Vesicles "HPA016491: , HPA019547: AB_2281256" "unprognostic (1.44e-1)" "unprognostic (3.84e-2)" "unprognostic (7.67e-2)" "unprognostic (7.64e-2)" "unprognostic (2.41e-1)" "unprognostic (5.37e-2)" "unprognostic (2.26e-1)" "unprognostic (4.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.47e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.99e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-2)" "unprognostic (2.68e-2)" 32.4 49.8 10.4 11.6 10.9 4.3 31.7 20.9 17.2 27.4 12.7 25.4 13.7 22.7 27.9 25.9 26.6 16.1 27.8 11.0 15.4 53.5 43.2 28.2 12.2 13.5 12.1 9.9 34.8 36.8 31.9 26.7 17.3 12.5 19.2 20.7 10.7 33.4 20.1 29.0 28.0 28.9 12.8 11.9 22.0 29.9 10.5 12.2 9.2 35.4 13.2 16.9 30.4 29.6 16.2 3.8 3.8 6.0 10.2 16.5 23.7 17.9 2.2 7.1 2.6 5.6 4.8 8.2 6.5 9.2 8.8 5.8 7.5 3.8 9.8 2.4 16.3 11.9 6.2 4.9 7.8 13.7 3.4 8.7 7.6 9.6 0.8 5.7 19.1 7.4 5.5 9.4 6.1 6.0 8.1 2.5 4.7 4.6 8.5 4.8 0.3 15.4 37.8 17.0 13.8 5.5 8.5 0.9 7.0 13.3 3.0 4.6 25.3 1.1 3.9 4.6 4.3 2.8 8.8 5.5 2.8 2.3 4.0 12.3 6.5 2.2 3.9 2.0 2.5 2.5 12.1 2.9 1.9 1.7 21.0 3.1 2.3 11.4 2.6 4.8 2.2 3.7 2.1 10.4 10.9 20.9 17.2 11.0 15.4 13.5 12.1 9.9 12.5 11.9 12.2 16.2 49.7 64.1 38.3 82.3 93.4 29.1 41.9 45.2 71.2 73.7 39.2 25.4 40.6 50.1 56.0 58.8 110.5 69.6 36.2 79.0 19.6 49.0 28.8 48.3 22.7 41.1 18.7 18.5 119.2 49.6 59.2 56.1 36.7 61.7 40.5 15.7 44.6 60.5 42.1 55.5 144.6 37.6 44.7 66.9 36.3 9.3 35.4 52.0 32.0 79.6 49.3 56.3 28.8 122.2 156.6 42.0 51.0 33.8 82.7 19.6 78.7 64.1 65.5 90.8 26.3 36.4 33.9 22.5 16.9 43.4 38.1 77.4 43.2 26.9 31.7 34.2 ZCCHC4 "FLJ23024, HSPC052, ZGRF4" ENSG00000168228 "Zinc finger CCHC-type containing 4" Q9H5U6 4 25312774-25370383 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 19.6;Oligodendrocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035575, HPA035576" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles, Golgi apparatus" "HPA035575: AB_2674682, HPA035576: AB_10671516" "unprognostic (5.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (5.84e-2)" "unprognostic (2.80e-3)" "unprognostic (1.71e-1)" "unprognostic (3.00e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (1.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.59e-2)" "unprognostic (1.07e-2)" 4.1 3.6 3.2 3.5 3.8 3.8 5.1 4.0 3.5 4.4 3.8 3.8 3.8 5.3 4.1 3.4 4.4 3.3 4.6 2.9 3.3 3.8 3.5 3.6 5.2 3.5 3.4 2.9 6.1 3.5 6.0 2.7 3.3 3.8 3.9 4.0 4.8 4.0 3.9 7.5 4.3 4.0 3.8 3.3 4.5 3.5 4.4 3.4 4.8 4.6 5.6 4.5 4.1 3.7 4.6 4.5 2.8 9.1 4.2 6.9 8.8 8.1 11.4 12.1 13.1 15.0 4.4 11.9 7.5 3.1 7.0 12.9 3.5 8.9 8.3 18.2 1.8 4.8 7.0 5.8 7.4 8.8 11.6 4.9 7.0 9.2 12.5 9.8 7.8 6.3 11.4 12.7 3.6 11.3 3.4 12.0 15.2 12.5 7.4 6.0 8.0 13.9 4.6 7.1 4.7 8.4 5.8 4.9 4.1 7.4 8.8 6.0 6.9 5.0 11.0 4.6 7.2 15.7 7.2 9.6 11.0 11.8 11.0 10.8 1.4 1.9 0.6 3.0 2.4 4.4 3.5 3.9 3.8 2.8 3.6 3.7 4.1 1.1 4.4 2.3 2.1 4.3 2.3 3.2 3.8 4.0 3.5 2.9 3.3 3.5 3.4 2.9 3.8 3.3 3.4 4.6 5.9 0.0 5.8 12.1 7.6 3.7 4.0 4.3 6.8 3.7 3.0 2.9 6.4 1.5 5.5 0.0 2.1 5.9 4.2 2.1 3.9 3.8 1.5 5.5 5.1 4.6 2.4 2.1 10.7 2.3 4.5 4.8 3.1 3.9 1.3 6.4 2.2 3.1 5.1 3.3 15.5 3.6 6.1 4.4 2.2 0.5 4.1 3.3 3.6 5.6 2.6 5.5 5.2 19.6 23.6 2.9 3.9 5.3 3.7 2.7 5.7 4.5 8.2 5.2 0.0 5.2 5.7 9.0 9.1 4.9 3.4 3.7 5.4 4.0 4.4 2.5 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267698-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 7.9;lymphoid tissue: 6.4" "Cell type enhanced" "Detected in some" "dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.0" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "gdT-cell: 68.0;NK-cell: 90.3" "Group enriched" "Detected in many" 33 "NK-cells: 90.3;T-cells: 68.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA049668 Enhanced NA NA "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 2.0 0.5 0.2 2.2 1.1 1.4 1.2 0.8 0.7 1.9 2.6 5.6 0.7 1.5 1.1 0.4 1.3 1.7 1.4 0.1 0.7 0.5 1.1 1.7 3.2 1.9 0.8 0.2 0.8 0.3 0.4 2.1 0.2 0.6 0.8 7.9 0.0 1.1 0.4 0.6 0.5 1.4 0.8 1.8 6.4 1.3 0.2 0.7 0.9 1.1 0.4 1.1 0.9 1.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 68.0 0.0 33.5 0.1 9.0 40.9 0.1 0.0 1.4 22.5 2.3 90.3 0.4 0.2 0.2 12.9 0.2 1.1 0.8 0.7 0.1 0.7 1.9 0.8 0.2 0.6 1.8 0.7 0.2 2.9 3.2 0.0 0.0 0.9 0.5 0.0 0.0 0.6 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 50.6 3.2 0.0 0.0 0.0 0.2 0.1 2.0 1.2 2.7 0.2 0.0 0.0 1.5 1.1 0.1 1.3 0.2 2.2 0.5 0.1 0.0 0.2 7.5 0.0 1.9 0.4 0.0 0.0 4.6 1.8 1.0 0.4 0.0 187.4 0.0 0.1 0.0 2.8 0.0 4.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 5.5 0.0 0.0 0.1 0.1 0.0 31.4 2.2 14.6 0.0 TTC39C "C18orf17, FLJ33761, HsT2697" ENSG00000168234 "Tetratricopeptide repeat domain 39C" Q8N584 18 23992773-24135610 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.0;retina: 144.4" "Cell type enhanced" "Detected in many" "Early spermatids: 149.8;Hepatocytes: 169.3;Late spermatids: 320.0;Rod photoreceptor cells: 241.5" "Cancer enriched" "Detected in all" 4 "liver cancer: 19.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 115.9" "Lineage enriched" "Detected in all" 4 "T-cells: 115.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065705, HPA065713" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA065705: AB_2685538, HPA065713: AB_2685542" "prognostic favorable (1.48e-4)" "unprognostic (6.37e-2)" "unprognostic (3.66e-1)" "unprognostic (9.97e-2)" "unprognostic (4.37e-2)" "unprognostic (2.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (2.32e-1)" "unprognostic (3.51e-1)" "unprognostic (8.94e-3)" "unprognostic (4.48e-3)" 19.0 30.7 7.2 12.4 7.1 36.7 19.1 3.8 27.1 20.1 10.0 10.2 9.2 15.8 7.4 16.2 18.7 23.8 6.4 17.9 4.1 5.9 95.0 15.2 19.2 2.0 4.6 6.5 10.3 15.9 1.9 20.2 2.7 4.3 20.2 7.5 144.4 25.4 5.4 10.3 54.0 13.5 8.4 1.9 13.3 12.9 33.6 3.3 15.5 7.2 1.6 21.5 13.4 19.8 7.0 12.6 10.4 6.1 3.7 38.3 39.8 22.9 16.4 39.0 13.9 13.5 1.3 6.8 19.7 16.8 30.4 11.1 15.8 12.3 16.5 10.9 28.7 13.1 6.6 50.6 26.3 7.7 31.4 15.3 33.4 21.8 8.4 11.7 26.9 1.1 14.6 0.1 0.2 8.7 10.7 4.9 10.0 14.5 5.5 25.1 28.1 9.5 7.8 14.7 19.7 15.9 12.4 34.5 10.6 11.4 6.5 8.2 10.6 8.3 11.8 9.6 8.7 8.7 0.4 0.1 32.0 16.0 32.9 8.3 2.4 5.4 0.2 32.8 6.1 84.0 16.4 71.7 40.3 7.8 10.0 30.0 25.0 1.5 18.5 5.2 27.8 115.9 13.1 7.2 7.1 3.8 27.1 17.9 4.1 2.0 4.6 6.5 4.3 1.9 3.3 7.0 6.9 0.0 3.4 13.7 23.0 46.0 17.1 10.1 30.1 14.7 28.6 24.1 3.0 64.3 5.0 7.3 45.9 0.7 52.0 2.0 0.0 14.2 149.8 72.9 34.9 7.0 4.2 20.6 114.3 11.5 15.2 16.5 15.8 30.0 2.5 11.5 4.6 169.3 12.6 13.5 80.3 9.4 18.3 26.6 44.5 320.0 11.1 21.5 14.2 20.6 18.9 27.8 38.1 41.7 2.3 8.9 1.5 7.9 7.1 20.8 11.4 1.3 16.7 241.5 0.0 5.2 6.7 42.4 8.0 26.8 86.1 0.5 95.9 9.2 9.0 20.1 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52295257 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 277.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" NA NA Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 12.7 8.3 0.9 4.5 0.9 6.8 9.3 0.5 1.5 2.8 0.9 7.0 22.6 3.2 0.6 3.8 2.7 2.2 4.1 0.9 0.9 24.6 277.3 4.3 4.7 1.4 0.7 0.7 2.4 5.9 2.6 2.9 2.2 1.6 3.7 3.6 0.6 3.1 1.0 3.6 1.9 21.9 1.6 0.4 9.0 8.6 2.3 1.1 2.3 4.1 1.1 3.2 3.3 2.5 1.1 2.9 5.8 3.4 1.2 15.7 2.4 1.8 2.4 2.6 4.6 3.9 12.1 2.4 6.7 1.6 2.7 3.7 1.6 1.7 7.8 0.8 2.0 1.8 9.3 7.5 16.2 1.7 2.8 5.0 2.4 3.5 7.6 3.2 2.1 10.2 5.2 2.4 4.5 3.6 1.9 5.9 2.7 1.5 14.2 4.2 1.9 2.5 11.1 5.8 3.9 1.9 1.9 2.6 1.4 3.0 1.0 3.2 1.7 3.8 3.5 4.1 2.4 6.1 5.1 3.9 5.4 2.7 4.9 2.2 2.2 5.2 6.6 5.6 2.8 2.6 4.4 4.2 4.9 5.6 2.6 3.3 4.3 4.4 3.6 3.5 3.4 6.6 3.7 0.9 0.9 0.5 1.5 0.9 0.9 1.4 0.7 0.7 1.6 0.4 1.1 1.1 5.4 6.4 3.2 0.7 8.2 0.4 3.2 4.1 1.8 1.6 2.1 1.4 1.6 18.6 3.0 9.2 0.0 7.9 9.2 18.4 19.6 5.4 0.3 4.4 2.7 8.3 23.4 26.5 0.6 6.2 5.3 2.9 27.0 8.6 1.3 3.4 14.6 183.0 13.2 0.0 0.4 15.8 2.0 16.6 2.4 0.0 1.2 9.1 3.6 1.0 7.7 1.2 9.2 0.5 0.7 4.0 40.6 0.0 13.5 2.8 105.2 83.0 2.4 1.5 0.0 2.7 2.7 1.8 8.3 2.1 1.3 11.1 9.3 7.7 24.9 4.3 GNG4 ENSG00000168243 "G protein subunit gamma 4" P50150 1 235547685-235650754 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.3;ovary: 32.4;pituitary gland: 32.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 24.4;Enteroendocrine cells: 43.0;Inhibitory neurons: 43.3;Intestinal goblet cells: 16.2;Oligodendrocyte precursor cells: 25.1;Prostatic glandular cells: 24.1;Proximal enterocytes: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "NTERA-2: 151.4;SCLC-21H: 158.4;SH-SY5Y: 222.8;U-2197: 67.2" "Region enriched" "Detected in all" 6 "olfactory bulb: 469.3" NA NA "unprognostic (1.50e-3)" "unprognostic (8.33e-3)" "unprognostic (7.14e-2)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (4.94e-2)" "unprognostic (2.22e-2)" "unprognostic (3.10e-2)" "unprognostic (3.47e-2)" "unprognostic (3.49e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (2.56e-9)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (1.68e-3)" "unprognostic (5.01e-3)" 1.4 11.4 18.3 1.8 24.5 0.1 0.6 6.9 21.9 4.0 2.6 3.6 2.5 9.6 0.1 14.5 3.4 0.5 0.1 14.9 37.3 1.4 0.3 0.1 5.7 19.6 22.7 20.1 32.4 5.1 0.0 32.2 1.7 18.8 22.8 3.0 2.5 2.0 0.7 0.1 0.4 5.3 6.7 13.0 0.1 3.2 1.7 28.6 5.0 0.3 0.0 3.5 1.0 2.5 14.3 37.2 2.0 26.4 0.0 0.0 1.3 2.4 0.1 0.4 3.3 4.5 0.1 1.5 0.0 0.3 11.2 9.0 3.3 28.4 1.2 6.7 19.4 10.2 0.1 0.7 14.4 0.4 0.2 12.1 2.4 0.2 0.4 0.9 0.0 0.0 2.0 0.3 0.1 2.1 0.1 7.6 1.2 151.4 0.1 0.1 0.0 13.8 0.7 0.0 1.1 158.4 222.8 0.9 0.3 3.2 1.7 0.2 5.3 0.0 1.7 5.0 67.2 5.2 3.5 0.2 0.0 4.9 0.1 44.5 1.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 18.3 24.5 6.9 21.9 14.9 37.3 19.6 22.7 20.1 18.8 13.0 28.6 14.3 0.1 0.0 0.0 2.9 0.2 0.5 2.6 0.3 0.0 2.3 0.2 0.9 0.5 0.0 1.0 0.0 0.0 7.7 2.7 1.6 0.0 0.0 1.1 1.5 24.4 1.4 43.0 0.0 2.3 9.0 10.0 1.7 0.0 0.8 0.0 3.8 0.0 0.0 0.9 1.7 43.3 16.2 4.1 0.0 3.6 1.0 0.3 1.1 0.0 4.7 1.0 0.4 0.0 25.1 0.8 1.6 1.3 0.4 0.1 24.1 24.5 4.9 0.2 1.3 0.0 0.2 1.6 1.8 4.4 0.0 0.0 6.3 1.1 0.3 4.6 1.5 UBTD2 "DC-UbP, MGC30022" ENSG00000168246 "Ubiquitin domain containing 2" Q8WUN7 5 172209646-172283764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 76.1;Late spermatids: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035891, HPA035892" Uncertain NA NA "HPA035891: AB_2674846, HPA035892: AB_10670670" "unprognostic (2.89e-1)" "unprognostic (1.66e-1)" "prognostic favorable (5.92e-5)" "unprognostic (3.45e-2)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.50e-2)" "unprognostic (1.08e-1)" "unprognostic (9.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (5.92e-2)" "unprognostic (5.12e-2)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.52e-1)" 13.6 11.5 8.2 8.8 9.4 1.6 17.7 25.5 9.5 24.8 9.2 15.1 18.6 21.2 9.4 10.7 12.1 16.2 10.4 8.6 9.9 15.7 15.9 13.4 9.3 9.1 9.6 7.4 21.3 12.6 11.1 7.1 17.2 12.8 13.5 15.9 9.3 12.0 12.8 9.8 10.0 22.3 18.0 8.8 7.3 12.4 35.6 8.6 12.1 11.6 15.8 10.2 14.6 11.4 9.1 21.9 16.7 78.1 61.0 48.1 42.9 38.0 27.8 33.2 29.9 43.8 36.5 15.9 18.7 23.5 43.6 51.4 15.1 41.7 30.3 40.1 18.0 30.3 5.7 17.6 28.4 32.6 13.3 10.3 33.1 37.1 31.9 25.7 25.8 36.5 28.8 2.3 7.5 28.6 23.8 23.7 27.8 33.4 19.0 21.1 43.5 38.0 7.2 36.3 23.0 22.9 57.9 30.1 27.0 28.4 39.9 23.3 21.7 26.6 39.6 29.2 21.0 23.9 6.8 19.9 17.8 13.9 18.2 31.0 0.0 0.3 0.0 0.2 0.4 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.2 0.0 0.1 0.2 0.7 0.5 0.1 8.2 9.4 25.5 9.5 8.6 9.9 9.1 9.6 7.4 12.8 8.8 8.6 9.1 15.2 6.4 4.8 14.0 3.7 22.0 25.7 12.8 15.9 8.4 22.2 12.1 5.5 11.5 11.9 9.2 0.0 9.8 5.6 22.8 17.6 14.5 76.1 9.7 28.3 12.3 8.9 0.0 14.9 12.0 21.7 31.4 8.6 23.6 0.0 14.2 13.9 15.1 6.8 25.2 22.5 12.2 14.2 6.5 44.5 130.9 24.8 9.8 14.2 9.4 5.8 16.2 1.0 25.6 19.8 21.6 9.8 21.1 2.9 29.8 20.5 17.2 6.8 3.4 6.6 16.7 19.6 5.8 9.7 17.0 18.8 8.1 4.0 11.9 13.7 39.6 POLR2J3 ENSG00000168255 "RNA polymerase II subunit J3" 7 102537918-102572653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 87.4;Extravillous trophoblasts: 65.6;Hofbauer cells: 42.5;Syncytiotrophoblasts: 110.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.5" "HPA011403, HPA046970" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011403: AB_2668503, HPA046970: AB_2679882" "unprognostic (3.55e-2)" "unprognostic (2.04e-4)" "unprognostic (4.55e-3)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (9.26e-2)" "unprognostic (2.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.12e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (1.00e-1)" "unprognostic (5.90e-4)" "unprognostic (3.04e-1)" "unprognostic (7.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" 2.4 2.3 1.2 1.7 1.0 2.1 1.7 1.4 3.1 3.4 0.7 2.2 2.9 3.2 0.4 1.9 3.6 0.6 1.4 0.9 0.8 2.0 2.5 2.0 1.2 1.1 1.0 0.9 3.2 1.6 1.6 2.0 1.5 1.2 2.3 1.8 0.7 3.3 0.5 1.0 3.8 3.1 1.6 0.8 3.2 2.2 0.9 1.0 1.5 3.1 2.7 2.9 2.3 1.8 1.1 10.3 4.8 1.9 0.1 0.2 0.8 0.9 6.0 1.7 3.8 4.3 3.8 2.8 1.4 0.4 0.0 5.5 4.8 3.1 2.4 4.1 25.5 5.5 2.9 3.8 1.2 1.1 3.7 2.5 0.4 2.1 1.9 1.9 7.4 6.0 2.4 3.2 2.0 0.6 8.0 8.9 0.5 0.0 3.6 6.0 0.4 3.3 2.4 0.9 1.3 2.0 0.4 10.9 1.0 5.5 2.3 0.0 1.7 4.9 3.4 9.1 0.0 1.5 0.3 0.8 4.6 5.9 2.9 3.9 9.6 4.1 6.5 2.2 1.7 1.3 3.5 2.2 3.2 4.6 3.9 2.7 2.7 9.4 3.9 3.1 3.1 3.3 3.0 1.2 1.0 1.4 3.1 0.9 0.8 1.1 1.0 0.9 1.2 0.8 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 65.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.0 0.0 0.0 0.0 0.0 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062861: AB_2684884" "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 21.9 15.9 13.3 21.0 15.9 25.8 18.6 14.2 15.1 17.7 15.4 19.6 15.3 19.2 11.1 33.0 14.5 18.0 46.2 13.8 13.4 17.0 19.4 16.9 17.9 14.1 12.5 12.6 16.1 13.4 19.5 10.9 34.1 13.2 16.2 16.5 13.8 16.3 18.2 50.5 26.0 16.3 26.6 11.3 15.2 17.0 21.0 14.0 22.3 13.6 37.1 19.1 20.9 20.3 15.2 22.4 42.5 57.4 31.1 39.8 26.8 33.7 36.4 28.1 56.6 41.6 43.6 31.3 37.4 57.3 38.6 38.4 47.1 47.3 28.6 29.6 30.6 54.2 32.9 37.1 33.0 62.8 45.8 25.9 41.0 50.8 38.1 29.8 38.6 71.3 47.8 47.1 36.9 33.8 23.7 87.3 30.4 34.4 30.0 30.0 67.9 63.7 35.8 40.3 23.2 68.5 90.0 26.6 84.0 38.6 55.6 51.5 55.5 50.3 36.2 38.8 40.5 41.5 47.4 82.7 30.0 24.6 27.5 52.2 54.5 54.2 46.1 14.2 45.1 14.1 15.4 14.2 14.4 43.5 17.1 14.4 14.0 30.7 27.0 50.0 48.4 13.4 25.2 13.3 15.9 14.2 15.1 13.8 13.4 14.1 12.5 12.6 13.2 11.3 14.0 15.2 26.6 16.0 10.3 3.9 19.0 17.0 18.7 27.2 12.5 21.0 19.9 17.1 26.3 10.0 23.8 16.5 20.9 52.3 13.8 19.1 21.5 30.0 27.8 11.9 18.5 27.1 19.2 21.2 5.4 28.1 39.7 20.1 11.2 16.3 14.0 28.1 19.2 15.6 37.9 23.5 4.8 17.5 42.7 31.1 29.1 6.6 19.6 27.8 10.6 5.6 37.2 24.7 14.4 1.5 4.5 30.4 14.7 18.4 13.3 20.8 20.9 19.0 10.9 26.6 6.6 15.3 24.5 34.7 41.3 21.0 25.7 62.3 12.8 23.3 15.2 21.6 DNAJC7 "TPR2, TTC2" ENSG00000168259 "DnaJ heat shock protein family (Hsp40) member C7" Q99615 17 41976421-42021376 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023015, HPA052395" Approved Supported Nucleoplasm,Cytosol NA NA 22000 Nucleoplasm Cytosol "HPA023015: AB_1847804, HPA052395: AB_2681811" "unprognostic (3.21e-2)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (8.40e-2)" "unprognostic (1.16e-1)" "unprognostic (5.31e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (7.71e-2)" "unprognostic (2.58e-2)" "unprognostic (1.90e-2)" "unprognostic (2.48e-2)" "unprognostic (8.37e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (2.32e-2)" "unprognostic (8.93e-3)" 41.7 50.9 136.0 43.9 138.9 40.7 39.9 137.0 205.6 35.8 137.1 46.9 37.6 28.6 50.9 67.2 34.1 26.5 71.1 138.1 140.3 63.1 67.5 39.2 53.9 139.8 138.4 133.5 43.4 55.4 54.9 55.6 36.2 139.6 37.7 45.9 49.6 39.5 25.2 100.6 48.3 38.4 27.8 140.1 45.5 49.6 46.3 138.3 57.0 38.5 73.7 68.2 41.1 41.6 142.2 99.2 129.6 130.8 100.1 68.5 106.5 120.0 103.6 98.8 139.7 110.6 143.5 93.9 142.0 118.2 113.2 118.4 140.6 192.3 127.9 169.7 123.6 220.1 102.6 116.0 189.7 100.8 185.0 102.7 92.4 82.3 131.5 104.4 101.5 114.8 122.4 160.7 98.9 122.2 66.5 210.8 155.0 139.4 92.3 87.1 124.0 175.4 123.6 116.9 104.8 117.7 104.7 84.9 243.6 126.1 128.7 139.3 177.8 110.3 80.1 105.0 100.1 163.3 72.0 159.4 122.9 103.0 124.0 97.1 49.7 55.9 35.9 30.9 57.8 35.2 39.6 36.3 36.1 57.7 41.9 33.4 32.6 19.8 49.4 59.8 98.5 43.8 38.8 136.0 138.9 137.0 205.6 138.1 140.3 139.8 138.4 133.5 139.6 140.1 138.3 142.2 62.2 35.3 38.3 39.2 87.1 65.4 94.4 107.8 37.5 80.5 46.7 43.4 57.6 61.5 54.0 66.2 135.5 108.6 139.0 81.1 115.4 107.6 108.3 83.7 77.8 71.8 111.4 52.4 33.9 132.5 103.8 50.9 38.7 70.6 57.0 105.5 71.4 56.4 102.4 63.9 37.3 63.4 67.1 102.1 99.6 52.3 67.4 94.6 48.0 34.7 166.5 100.0 121.5 36.7 142.0 125.2 62.1 61.3 79.7 77.4 79.2 155.8 61.7 143.5 46.0 78.9 78.5 104.7 111.9 49.3 68.8 126.8 81.9 127.2 79.1 94.6 KCNV2 Kv8.2 ENSG00000168263 "Potassium voltage-gated channel modifier subfamily V member 2" Q8TDN2 9 2717510-2730037 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "retina: 291.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 515.0;Rod photoreceptor cells: 530.1" "Cancer enriched" "Detected in single" 78 "testis cancer: 6.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031131 Enhanced NA NA "HPA031131: AB_10609996" "unprognostic (5.06e-2)" "unprognostic (1.47e-3)" "unprognostic (3.45e-3)" "unprognostic (6.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "unprognostic (1.12e-3)" "unprognostic (5.38e-2)" "unprognostic (1.39e-2)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" "unprognostic (7.96e-8)" "unprognostic (3.01e-1)" "unprognostic (4.90e-2)" "unprognostic (9.90e-2)" "unprognostic (1.06e-2)" 0.0 0.1 1.1 0.0 1.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.8 0.6 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.0 291.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.1 0.7 0.8 0.6 0.1 0.0 1.2 0.4 0.0 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 49.6 0.0 0.0 0.2 0.0 0.0 0.0 515.0 0.0 0.0 0.0 0.0 0.0 81.5 0.0 0.0 2.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 1.3 0.0 0.0 0.0 0.0 25.3 0.6 0.0 0.0 0.0 0.0 69.1 0.0 0.5 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 530.1 13.1 0.0 0.0 7.4 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRF2BP2 IRF-2BP2 ENSG00000168264 "Interferon regulatory factor 2 binding protein 2" Q7Z5L9 1 234604269-234610178 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 277.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027815, HPA062269" Approved Enhanced Nucleoplasm NA NA 13000 Nucleoplasm "HPA027815: AB_10609994, HPA062269: AB_2684732" "unprognostic (1.15e-3)" "unprognostic (1.02e-1)" "unprognostic (3.90e-1)" "unprognostic (2.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.74e-3)" "unprognostic (1.97e-2)" "unprognostic (8.77e-2)" "unprognostic (2.19e-1)" "unprognostic (3.69e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.25e-1)" "unprognostic (2.70e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" 35.9 39.9 48.7 25.8 50.4 158.6 45.5 51.2 46.7 50.4 44.7 42.9 39.9 56.3 26.7 47.5 45.5 41.0 41.6 43.7 58.6 34.5 54.1 44.0 36.6 57.0 50.1 37.8 55.3 50.0 45.8 24.3 29.9 58.8 39.6 49.8 27.1 55.4 33.8 47.8 61.4 42.6 32.0 53.5 28.6 44.8 18.1 47.6 29.9 57.8 40.9 30.6 39.0 44.0 63.5 28.0 41.5 29.8 45.7 61.2 48.1 35.1 21.8 18.4 12.7 14.2 24.5 33.5 0.0 49.4 21.2 43.3 37.4 16.2 28.3 20.2 45.2 36.8 26.7 32.9 72.3 49.4 101.0 91.0 57.0 65.8 28.3 53.4 74.4 33.0 24.5 23.0 55.6 33.2 8.4 25.5 107.2 27.1 65.1 15.7 49.6 13.8 66.8 25.1 22.9 58.8 41.8 35.2 46.7 72.7 29.8 45.1 277.5 36.8 45.5 19.0 34.7 41.6 122.9 33.8 9.1 23.1 89.6 63.4 10.1 4.5 8.5 3.9 3.6 4.0 4.3 4.8 4.6 4.7 4.0 4.9 4.1 2.3 3.0 1.9 17.8 4.0 2.5 48.7 50.4 51.2 46.7 43.7 58.6 57.0 50.1 37.8 58.8 53.5 47.6 63.5 96.0 134.6 191.3 28.1 75.6 325.9 440.4 142.3 139.5 34.6 126.6 109.7 63.6 133.0 143.8 51.5 10.4 44.6 168.3 84.2 13.7 65.8 24.9 180.8 126.2 101.9 145.5 76.6 14.3 50.0 58.0 97.3 47.4 285.2 107.5 39.6 117.4 185.7 88.9 58.9 22.9 117.1 71.2 131.8 271.2 27.1 69.6 159.7 110.3 30.9 83.2 87.7 38.1 20.6 64.2 68.9 92.0 81.3 39.2 138.2 81.7 40.2 95.1 19.5 78.9 117.1 102.9 29.5 24.1 182.1 396.2 79.4 91.3 15.5 162.7 370.6 PTF1A "bHLHa29, p48, PTF1-p48" ENSG00000168267 "Pancreas associated transcription factor 1a" Q7RTS3 10 23192312-23194245 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "pancreas: 105.0" "Group enriched" "Detected in some" 4 "Early spermatids: 2.1;Exocrine glandular cells: 4.8;Spermatocytes: 3.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.6;pancreatic cancer: 1.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB022612 Approved Nucleoplasm NA NA Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.9 1.6 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.9 0.9 0.0 0.0 0.0 0.0 1.1 0.8 0.7 0.1 105.0 0.0 0.2 0.0 1.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.9 2.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.9 1.6 0.9 0.9 1.1 0.8 0.7 1.1 0.8 0.7 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NT5DC2 FLJ12442 ENSG00000168268 "5'-nucleotidase domain containing 2" Q9H857 3 52524385-52535054 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 69.2;Peritubular cells: 135.4;Sertoli cells: 111.7;Smooth muscle cells: 83.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050683 Approved NA NA "HPA050683: AB_2681215" "unprognostic (1.40e-1)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-2)" "unprognostic (7.82e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (6.14e-2)" "unprognostic (1.35e-1)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (2.99e-3)" "unprognostic (1.44e-1)" "unprognostic (2.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" 29.2 73.9 23.8 18.8 25.1 15.6 28.1 33.6 30.0 44.2 35.8 18.3 13.8 36.6 27.7 70.0 29.7 12.3 95.3 21.6 29.9 27.8 7.9 33.9 16.5 34.8 29.7 19.8 45.7 15.8 16.6 51.2 33.0 45.8 75.5 12.8 8.6 43.9 39.6 10.3 49.2 16.3 21.0 24.3 18.8 16.5 50.0 25.7 10.0 26.5 11.0 23.1 41.1 39.0 25.2 138.8 73.7 238.9 128.4 186.2 252.3 188.3 139.6 121.2 95.4 78.0 216.5 66.8 174.4 15.1 177.9 76.0 47.3 194.9 179.8 90.0 71.0 123.8 104.1 122.1 337.4 274.9 0.1 88.8 333.0 40.9 162.9 49.4 175.4 203.0 125.2 194.9 57.5 112.0 145.5 72.7 179.2 318.1 125.6 234.6 104.6 100.3 168.8 52.7 35.5 111.1 323.3 54.7 101.2 71.8 178.6 96.0 98.5 95.1 123.7 153.8 123.8 298.9 25.9 47.3 129.4 369.4 0.7 152.1 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 23.8 25.1 33.6 30.0 21.6 29.9 34.8 29.7 19.8 45.8 24.3 25.7 25.2 20.9 9.6 11.5 2.6 12.9 7.8 26.6 15.2 30.1 18.4 54.6 69.2 14.0 5.7 13.0 12.9 0.0 3.4 3.3 3.1 17.6 10.1 6.9 5.3 20.0 12.6 12.6 8.0 0.9 2.3 24.8 24.8 8.6 10.8 18.4 36.4 11.0 1.2 10.4 1.7 1.2 6.0 10.2 10.1 8.8 19.7 49.7 7.8 16.0 1.9 2.8 36.6 1.0 5.0 1.5 7.0 0.6 135.4 21.4 23.4 0.6 9.3 2.7 4.7 111.7 18.6 83.4 6.2 37.9 23.5 13.8 2.3 2.8 15.8 7.2 12.7 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109734 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 43.3;salivary gland: 11.5" "Cell type enriched" "Detected in some" 4 "Ionocytes: 132.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "MCF7: 1.4;SuSa: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Supported Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.1 3.0 0.0 0.0 11.5 1.5 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.2 0.0 0.0 7.6 6.5 0.3 0.0 0.3 1.8 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 132.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 122.9;skeletal muscle: 131.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 252.4;Distal tubular cells: 213.2;Proximal tubular cells: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047771: AB_2680150" "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favorable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favorable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 22.3 122.9 14.7 13.0 14.8 7.5 22.3 21.6 20.7 15.5 18.7 18.9 12.4 14.5 10.5 16.5 14.6 3.8 94.5 14.8 31.7 37.5 20.4 20.5 10.6 15.3 15.1 13.5 41.8 25.9 31.9 56.8 6.2 15.8 26.4 10.5 14.0 29.2 13.8 131.5 19.6 15.2 5.1 15.4 15.9 20.6 17.4 15.2 6.7 49.0 50.6 8.7 20.4 13.4 17.5 58.7 19.0 22.9 58.5 26.5 13.7 47.0 25.9 12.0 29.2 25.3 24.6 15.4 25.1 11.6 10.9 29.4 30.2 7.6 20.9 11.8 16.9 60.1 23.6 58.2 50.2 40.1 28.4 31.6 29.6 12.7 24.6 17.7 15.8 26.8 27.0 31.9 36.4 19.9 25.4 26.4 39.4 39.1 31.9 42.4 18.1 22.2 50.1 17.0 25.2 24.9 31.4 50.6 16.5 52.6 12.9 17.0 23.6 24.0 16.0 53.1 76.4 53.5 42.3 50.6 57.3 87.9 52.2 22.5 8.1 44.1 17.3 19.1 35.8 18.8 24.6 27.3 23.9 49.7 22.7 29.1 27.0 1.6 22.5 15.2 26.5 29.6 20.0 14.7 14.8 21.6 20.7 14.8 31.7 15.3 15.1 13.5 15.8 15.4 15.2 17.5 35.4 48.1 46.3 1.3 30.3 27.1 37.3 52.2 41.5 17.6 80.9 84.1 252.4 60.1 63.1 53.3 12.5 42.9 26.6 58.3 213.2 52.9 21.9 71.9 30.6 32.8 79.3 22.1 1.9 86.1 24.7 36.0 34.1 48.9 59.5 16.9 55.6 160.4 116.4 3.3 2.1 62.9 30.5 80.8 46.7 15.1 65.0 51.1 37.4 0.0 28.5 102.8 15.5 2.5 3.2 57.8 39.9 101.2 19.7 19.7 89.5 215.6 52.1 15.3 46.0 22.8 56.8 9.8 14.2 34.8 34.5 27.6 25.8 44.3 73.5 23.6 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234385080 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria NA NA 13000 Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favorable (7.12e-4)" 20.5 34.5 38.4 21.8 43.3 17.3 21.3 37.3 45.5 15.4 39.2 30.7 45.2 15.2 32.5 32.1 15.4 16.3 35.5 41.0 38.8 36.0 37.0 15.5 31.2 38.2 38.1 41.1 16.1 26.1 26.6 16.6 14.3 38.6 22.8 25.8 16.4 24.5 13.3 102.4 14.9 31.5 14.1 38.5 21.3 27.9 9.1 38.0 26.0 17.4 61.4 21.3 22.0 19.5 40.8 69.6 87.2 31.0 35.2 31.7 62.3 98.2 49.9 29.7 51.0 47.8 67.6 90.2 68.4 90.0 28.6 95.7 86.6 48.6 61.4 40.5 86.0 207.1 30.9 92.8 181.4 121.9 77.0 57.6 41.4 80.8 67.2 51.6 44.5 63.9 75.0 153.4 60.2 56.2 37.1 73.7 148.0 76.2 155.5 41.0 43.0 37.1 135.6 65.0 64.6 55.0 39.9 48.5 84.7 162.1 19.7 75.2 130.0 48.9 60.2 50.2 81.7 151.7 71.2 149.8 86.0 46.2 120.3 110.3 59.4 70.3 23.2 40.0 68.2 39.0 65.4 63.3 49.7 76.3 43.4 65.0 49.2 18.8 44.9 59.0 52.2 85.9 48.6 38.4 43.3 37.3 45.5 41.0 38.8 38.2 38.1 41.1 38.6 38.5 38.0 40.8 31.2 9.6 24.0 5.9 29.6 57.2 50.2 80.7 34.1 13.6 35.6 57.0 88.1 30.0 51.1 47.8 4.2 50.8 21.1 61.4 103.7 55.2 4.2 63.3 32.9 27.8 22.2 33.7 19.0 69.4 79.2 31.0 31.1 40.9 22.2 35.4 26.7 52.4 84.3 11.8 13.6 64.2 52.9 37.7 32.3 4.9 26.1 39.6 30.2 5.6 45.5 28.1 28.8 9.0 5.9 62.7 42.0 28.2 24.3 77.0 83.4 131.3 64.0 17.8 19.7 22.8 31.9 23.7 26.9 57.9 58.7 43.6 30.6 63.5 72.4 81.8 KIF5C ENSG00000168280 "Kinesin family member 5C" O60282 2 148875227-149026759 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 65.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 252.2;Early spermatids: 568.4;Excitatory neurons: 267.2;Inhibitory neurons: 249.1;Late spermatids: 702.5;Oligodendrocytes: 270.7" "Cancer enhanced" "Detected in many" "glioma: 11.7;prostate cancer: 19.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 117.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035210, HPA062272" Enhanced Approved Vesicles NA NA Vesicles "HPA035210: AB_10671931, HPA062272: AB_2732678" "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (2.54e-1)" "unprognostic (4.70e-4)" "unprognostic (1.89e-1)" "unprognostic (3.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.90e-2)" "unprognostic (2.86e-1)" "unprognostic (1.41e-2)" "unprognostic (6.61e-3)" "unprognostic (1.56e-1)" "unprognostic (6.55e-6)" "unprognostic (8.34e-3)" "unprognostic (3.69e-1)" "unprognostic (3.63e-2)" "unprognostic (4.46e-2)" 0.5 5.2 44.5 0.6 23.3 0.0 0.5 16.9 65.1 1.1 0.0 0.9 0.3 0.5 3.7 0.1 0.9 0.1 0.4 33.8 19.0 0.1 0.0 0.2 0.3 23.5 17.6 16.1 1.6 2.4 0.3 5.6 0.0 28.1 10.5 0.7 7.8 0.2 2.8 0.3 0.2 0.8 0.4 17.9 0.2 0.6 12.2 25.2 0.1 1.4 0.9 0.2 0.6 1.4 36.5 0.0 0.0 17.8 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.0 0.7 0.0 0.2 5.4 0.0 14.1 0.0 1.3 13.7 3.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.7 0.0 0.7 0.0 0.1 0.0 0.8 0.0 0.0 22.4 0.0 9.2 0.0 0.1 0.1 0.0 3.6 117.1 27.1 0.2 0.5 0.2 2.8 0.0 0.0 0.0 0.0 3.3 0.0 3.7 3.0 0.4 0.0 8.8 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 23.3 16.9 65.1 33.8 19.0 23.5 17.6 16.1 28.1 17.9 25.2 36.5 1.8 0.0 0.0 33.6 2.4 1.3 6.1 0.1 2.2 252.2 8.0 3.7 14.9 4.3 0.0 18.4 108.4 0.0 0.8 1.1 0.0 0.3 568.4 0.9 1.6 6.1 129.7 0.0 267.2 0.0 0.1 4.9 2.0 0.2 0.0 1.1 0.7 0.0 0.2 99.3 249.1 2.7 4.1 0.3 1.9 702.5 8.1 0.8 5.4 10.3 0.8 8.5 2.1 125.2 270.7 0.9 3.4 12.8 1.7 35.8 0.1 0.1 0.0 15.1 6.6 1.6 9.1 15.8 10.7 0.2 0.4 0.0 11.9 0.3 4.9 2.3 MGAT2 GNT-II ENSG00000168282 "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" Q10469 14 49620799-49623481 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043721, HPA056824" Approved Supported "Golgi apparatus" NA Yes 5100000 "Golgi apparatus" "HPA043721: AB_2678636, HPA056824: AB_2683248" "unprognostic (1.20e-2)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.84e-1)" "unprognostic (5.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (3.77e-1)" "unprognostic (1.92e-2)" "unprognostic (1.14e-1)" "unprognostic (7.44e-2)" "unprognostic (7.12e-2)" "unprognostic (5.63e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-2)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" 16.9 17.7 6.2 24.5 6.2 10.4 13.4 7.2 6.8 17.6 9.0 23.8 23.3 12.8 21.9 11.9 12.0 15.4 11.8 5.8 8.2 14.3 41.1 14.0 25.5 6.6 6.7 5.5 13.2 24.0 8.2 7.9 22.2 6.7 14.2 22.1 8.3 15.9 13.8 5.0 9.4 22.7 16.1 7.5 20.4 21.2 24.5 7.4 16.6 13.4 5.7 25.3 21.1 8.8 7.4 63.5 30.7 23.2 39.2 53.6 51.7 15.1 68.6 67.7 62.2 55.8 37.5 47.1 63.7 56.9 62.9 36.0 49.5 32.9 39.7 66.7 65.5 29.1 40.7 21.7 37.2 42.3 94.5 91.2 39.8 31.2 36.8 51.8 45.5 75.5 31.4 31.7 170.4 66.3 24.2 32.9 60.1 23.8 22.2 49.1 36.7 67.1 55.6 49.3 36.2 24.0 25.6 49.3 12.9 39.8 22.2 39.1 63.6 78.9 56.1 60.8 41.1 49.6 182.8 94.6 56.7 27.3 46.5 38.6 49.4 38.6 39.3 36.6 34.1 39.3 25.1 33.3 33.1 39.9 15.9 19.3 26.8 11.6 22.3 39.8 47.2 31.6 44.8 6.2 6.2 7.2 6.8 5.8 8.2 6.6 6.7 5.5 6.7 7.5 7.4 7.4 17.4 12.8 8.6 2.0 31.7 15.7 25.7 28.8 14.2 13.7 15.5 8.9 0.1 24.3 18.0 11.0 4.2 26.4 46.9 34.6 9.8 31.0 7.9 12.5 20.7 20.8 12.1 19.0 3.0 34.4 40.3 24.3 13.7 11.7 17.1 27.7 27.1 63.0 37.2 18.5 4.3 20.5 40.7 34.5 28.8 6.0 17.4 26.3 21.4 2.8 40.6 16.7 63.8 6.0 4.5 36.5 25.1 22.2 77.1 27.0 26.7 15.2 23.5 15.8 6.6 15.8 34.6 56.4 13.0 15.2 14.1 5.3 31.5 23.2 20.0 25.5 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321099-22331484 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 134.0;Late spermatids: 165.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 508.3;U-937: 583.9" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 29.3 31.4 31.5 25.3 38.3 22.1 36.4 33.8 38.4 27.8 32.0 26.2 19.8 31.0 30.0 22.1 22.8 24.1 20.7 29.8 38.7 26.2 35.9 23.6 28.0 34.5 34.7 27.6 21.9 25.9 57.4 25.2 29.0 35.2 34.0 21.7 40.8 20.1 26.4 44.8 14.5 21.0 36.5 36.2 36.5 22.8 35.6 32.5 25.2 24.1 35.8 27.2 24.0 14.9 50.0 74.9 36.1 41.2 12.7 68.9 54.6 40.5 49.7 22.2 37.3 43.5 37.6 93.4 38.1 32.8 45.6 42.2 26.1 59.1 35.0 45.4 508.3 72.8 104.7 28.7 42.9 41.1 39.8 55.7 35.5 58.8 41.2 45.3 47.0 26.2 62.1 105.4 63.3 48.6 30.2 106.9 11.4 9.3 36.3 83.4 79.6 57.1 37.3 35.3 25.2 33.8 66.0 32.7 42.5 57.3 17.8 38.5 153.8 56.4 41.4 122.6 99.6 67.6 76.1 110.8 83.1 59.5 583.9 27.4 15.1 1.3 2.5 5.2 3.0 7.0 4.4 5.3 5.0 0.9 2.2 4.4 4.3 0.6 5.2 2.1 1.6 4.1 2.0 31.5 38.3 33.8 38.4 29.8 38.7 34.5 34.7 27.6 35.2 36.2 32.5 50.0 18.9 25.6 24.0 0.0 23.1 15.9 20.5 12.4 22.8 20.9 24.4 20.3 19.0 22.8 19.8 12.9 8.4 12.7 14.2 5.6 13.7 16.3 134.0 12.1 25.3 24.0 13.2 19.1 0.0 18.2 22.2 19.8 7.7 9.8 12.0 12.6 28.5 30.7 9.9 30.3 0.0 9.9 14.2 19.7 25.6 165.1 36.1 13.8 37.4 0.0 17.5 13.9 15.5 0.0 0.0 22.9 7.3 36.5 33.9 29.1 4.6 13.0 16.9 15.2 19.7 26.5 28.6 19.8 22.2 11.2 14.6 6.7 22.4 17.0 10.3 20.4 THAP11 "CTG-B43a, CTG-B45d, HRIHFB2206, RONIN" ENSG00000168286 "THAP domain containing 11" Q96EK4 16 67842320-67844195 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041434, HPA042189, HPA072537" Supported Supported Nucleoplasm,Cytosol NA No Nucleoplasm Cytosol "HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: " "unprognostic (1.43e-1)" "unprognostic (2.51e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-3)" "unprognostic (1.93e-3)" "unprognostic (1.40e-2)" "unprognostic (1.56e-3)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-1)" "unprognostic (9.51e-2)" "unprognostic (2.97e-1)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (4.59e-2)" "unprognostic (5.87e-2)" 16.7 14.5 20.1 15.0 20.3 10.3 16.5 20.9 21.4 21.2 18.7 24.0 12.4 24.7 13.1 19.7 22.6 10.2 22.8 20.1 20.4 15.5 15.1 15.6 21.0 21.4 20.2 19.8 21.1 19.4 17.0 16.5 12.4 20.2 16.3 11.2 11.0 15.8 19.8 48.6 24.9 22.3 17.3 22.4 25.0 21.0 12.7 20.6 23.7 15.0 26.6 19.2 24.1 18.6 22.7 31.3 40.2 27.4 25.9 37.5 25.7 28.7 15.5 27.0 37.1 31.9 51.9 23.6 68.0 31.7 15.9 22.3 35.6 48.6 29.0 21.1 25.4 55.3 27.1 22.5 64.1 34.2 34.9 29.4 23.6 28.4 25.6 22.4 26.8 27.7 45.9 39.5 15.4 22.9 49.1 37.7 62.6 55.1 36.9 34.7 73.6 32.7 61.4 19.0 20.2 38.2 43.1 45.4 16.4 33.2 19.6 40.1 35.2 22.3 23.4 28.4 21.3 19.2 60.9 65.9 67.5 18.3 38.2 25.8 7.6 13.6 14.7 26.3 18.4 20.7 13.8 23.6 24.2 14.3 18.8 29.9 24.0 4.1 21.3 17.5 11.3 31.5 17.9 20.1 20.3 20.9 21.4 20.1 20.4 21.4 20.2 19.8 20.2 22.4 20.6 22.7 20.4 22.4 13.1 3.3 24.4 29.2 25.0 6.6 22.8 25.6 27.4 23.6 15.1 12.8 5.3 11.0 4.2 19.6 32.8 12.5 52.8 7.6 1.2 18.6 18.0 21.3 13.2 23.8 4.6 9.5 25.9 17.4 7.1 14.3 7.6 20.3 24.3 14.0 22.4 8.4 4.6 16.2 6.1 19.6 20.0 2.2 23.6 19.1 10.6 4.7 24.5 29.8 43.3 7.1 6.1 6.5 5.9 31.2 18.9 25.0 13.5 19.8 6.1 16.9 19.7 24.2 22.2 16.1 27.4 20.9 39.1 13.5 32.5 28.6 16.5 20.2 MMADHC "C2orf25, cblD, CL25022" ENSG00000168288 "Metabolism of cobalamin associated D" Q9H3L0 2 149569637-149587778 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037531, HPA037532" Supported NA NA "HPA037531: AB_10671628, HPA037532: AB_2675526" "unprognostic (5.67e-2)" "unprognostic (8.86e-2)" "unprognostic (1.98e-2)" "unprognostic (1.80e-3)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (4.18e-3)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.14e-2)" "unprognostic (5.64e-2)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" 65.5 63.1 34.6 53.5 35.7 145.6 97.7 38.2 41.0 71.6 42.2 78.7 67.0 69.0 56.0 89.5 65.1 58.5 115.0 34.7 38.8 98.0 196.7 54.2 75.9 36.1 36.2 33.4 68.2 87.7 92.4 38.9 77.2 36.7 77.4 91.0 38.1 86.8 70.2 202.9 86.2 62.6 79.7 38.5 56.7 69.3 71.1 36.1 89.7 66.4 189.5 94.1 86.5 58.1 39.3 124.8 90.8 113.9 282.4 134.4 222.9 173.9 198.7 262.0 204.8 175.1 174.8 135.3 199.0 109.5 214.0 121.1 156.7 160.8 203.2 257.5 134.9 130.4 159.0 111.0 193.4 218.0 241.0 145.6 180.2 204.4 265.7 273.1 190.3 233.8 130.5 216.2 205.3 245.0 134.7 106.3 151.8 163.6 168.5 182.9 129.2 130.5 170.9 219.4 209.6 144.0 80.4 148.4 135.4 196.7 122.7 139.6 133.4 160.1 162.5 153.4 120.8 155.2 130.1 177.2 213.9 159.5 143.9 220.6 183.5 77.1 129.6 75.0 87.4 88.3 103.2 94.0 83.4 113.8 85.2 98.4 81.5 150.0 119.7 106.0 96.3 124.0 119.8 34.6 35.7 38.2 41.0 34.7 38.8 36.1 36.2 33.4 36.7 38.5 36.1 39.3 50.3 48.1 57.4 12.1 78.3 131.7 183.9 262.2 106.4 24.7 64.2 70.0 162.8 80.1 147.3 49.7 12.5 150.4 63.2 76.7 201.5 148.8 179.9 68.6 48.0 77.5 97.4 156.5 14.7 186.0 178.7 86.5 82.6 53.5 66.0 47.5 79.9 135.6 129.5 20.2 21.1 128.2 166.8 101.9 69.3 46.4 66.5 67.2 78.2 11.2 93.8 55.9 87.6 18.1 19.1 154.5 80.1 78.2 125.8 177.3 95.9 215.0 143.2 19.2 98.6 74.3 89.7 223.0 53.6 114.2 141.5 245.0 68.1 90.3 87.1 237.0 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 subunit beta" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 275.2;tongue: 302.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 300.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 61000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 60.4 77.1 53.9 42.6 55.2 26.0 43.4 58.0 63.3 43.6 64.1 57.4 42.9 38.9 45.0 57.9 38.0 36.3 176.6 54.0 56.0 101.7 111.6 36.8 53.5 56.1 54.2 52.5 26.8 36.7 89.6 44.4 57.4 55.6 48.9 61.0 30.9 46.3 52.6 275.2 36.5 37.9 64.4 55.2 43.2 54.3 42.7 56.4 53.6 41.2 302.0 56.5 50.1 36.2 60.4 66.5 90.9 92.3 69.8 91.7 111.1 110.4 81.6 101.3 117.9 120.6 165.1 62.6 140.3 44.9 103.8 109.0 37.6 113.2 74.9 90.0 81.7 83.0 125.4 163.7 126.0 92.5 103.0 67.9 97.9 67.7 95.5 55.8 137.5 103.1 114.2 65.9 61.5 129.5 63.1 98.2 107.8 127.2 69.2 101.3 46.3 71.8 136.1 188.1 89.1 63.7 70.2 75.6 107.2 85.4 131.3 159.0 108.7 76.3 62.9 83.7 66.8 94.2 85.2 129.9 99.2 96.2 120.8 60.7 57.8 98.9 98.7 83.2 115.1 87.9 102.2 81.7 80.5 141.1 103.4 90.9 82.4 19.6 129.4 109.7 94.7 113.2 124.1 53.9 55.2 58.0 63.3 54.0 56.0 56.1 54.2 52.5 55.6 55.2 56.4 60.4 57.8 60.9 34.5 5.9 45.3 27.9 40.7 142.0 26.7 31.8 29.4 31.6 300.6 48.6 96.0 35.0 25.0 174.1 35.3 41.0 230.9 95.9 76.3 37.0 37.3 58.0 58.0 22.5 10.9 72.2 101.6 54.1 29.6 34.2 39.3 48.5 46.1 76.1 84.6 57.2 13.3 50.4 162.8 37.9 26.6 16.9 60.3 37.2 56.9 9.4 76.5 61.7 70.0 9.0 13.6 55.9 43.0 51.1 38.8 19.1 45.8 146.8 70.7 45.9 65.7 30.8 72.3 98.2 88.3 42.8 29.8 157.2 44.7 224.4 53.0 37.7 PXK "FLJ20335, Slob" ENSG00000168297 "PX domain containing serine/threonine kinase like" Q7Z7A4 3 58332880-58426127 "Enzymes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 314.9" "Cell type enriched" "Detected in all" 9 "Oligodendrocytes: 732.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 159.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024068 Supported Supported "Plasma membrane,Centriolar satellite,Cytosol" NA NA Cytosol "Plasma membrane, Centriolar satellite" "HPA024068: AB_1855967" "unprognostic (2.98e-2)" "unprognostic (3.29e-1)" "unprognostic (2.71e-3)" "unprognostic (1.61e-1)" "unprognostic (2.40e-1)" "unprognostic (6.62e-3)" "unprognostic (5.03e-3)" "prognostic favorable (5.68e-4)" "unprognostic (3.90e-1)" "unprognostic (8.09e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-3)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" 20.0 16.8 73.8 31.8 145.8 73.8 15.9 101.1 120.2 45.7 20.6 20.5 10.7 23.7 8.5 11.4 17.7 15.6 15.4 76.9 105.1 17.1 11.7 20.7 43.4 138.9 130.3 52.9 18.4 15.8 21.3 13.5 29.9 149.7 12.9 10.6 35.9 14.9 11.8 18.9 14.1 19.4 18.9 94.5 25.4 16.4 12.5 114.3 13.8 63.7 14.4 45.3 19.6 30.4 314.9 13.7 6.9 6.8 12.0 79.7 70.0 17.8 22.6 42.5 19.7 27.3 4.0 3.1 74.7 5.1 33.6 28.4 4.2 18.7 13.2 21.8 18.5 12.5 13.1 11.3 5.8 87.5 112.8 22.5 57.4 31.6 24.6 42.0 72.5 17.8 49.1 15.7 26.1 35.7 5.3 26.2 122.2 7.8 4.1 19.7 40.7 9.4 13.4 12.6 8.0 6.0 4.0 14.2 11.0 19.0 10.7 34.8 122.9 17.9 24.9 11.0 48.5 23.9 19.4 21.6 73.7 36.2 159.3 10.7 39.5 44.6 69.1 23.8 37.2 20.7 62.6 17.1 20.3 41.8 69.6 15.3 17.5 73.5 21.6 57.1 32.1 21.1 32.0 73.8 145.8 101.1 120.2 76.9 105.1 138.9 130.3 52.9 149.7 94.5 114.3 314.9 20.1 9.6 6.3 28.4 59.8 14.1 5.8 5.6 7.4 31.0 5.9 7.1 13.1 7.2 6.0 23.9 20.9 19.7 31.7 8.3 33.2 7.1 69.7 9.1 33.0 14.2 7.8 19.3 33.8 5.7 6.8 41.5 6.1 16.0 19.7 15.2 16.4 7.5 13.6 20.2 53.7 5.0 2.0 24.5 31.1 38.3 30.7 25.2 17.8 30.0 28.6 32.7 30.9 79.4 732.6 3.0 5.5 25.2 17.6 6.0 8.7 12.2 6.4 22.2 19.7 18.7 18.2 16.8 21.9 10.1 13.1 35.2 16.9 18.3 5.0 3.9 H1-4 "H1.4, H1e, H1F4, H1s-4, HIST1H1E" ENSG00000168298 "H1.4 linker histone, cluster member" P10412 6 26156329-26157115 "Disease related genes, Predicted intracellular proteins" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 52.8;brain: 46.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 11.2;Cytotrophoblasts: 8.0;dendritic cells: 18.6;Extravillous trophoblasts: 11.3;Hofbauer cells: 7.7;Plasma cells: 6.7;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 46.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 10.5;U-266/70: 12.5;U-266/84: 15.1;U-87 MG: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011506, HPA055907" Supported Supported "Nuclear speckles" NA Yes 8300000 "Nuclear speckles" "CAB011506: AB_470256, HPA055907: AB_2682966" "unprognostic (6.96e-2)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-2)" "unprognostic (5.78e-3)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.72e-13)" "unprognostic (4.54e-3)" "unprognostic (3.46e-2)" "unprognostic (1.30e-3)" "unprognostic (2.18e-2)" 1.7 0.3 0.0 0.3 1.5 52.8 2.7 46.1 18.5 2.2 6.0 1.4 0.3 0.6 0.3 1.2 0.7 0.4 0.4 5.6 6.8 1.1 1.2 1.2 2.6 9.4 1.3 0.0 1.8 1.8 0.3 2.0 0.9 3.3 2.5 0.4 0.0 3.0 0.2 0.4 2.8 2.7 0.1 1.9 1.4 1.4 1.4 4.0 2.7 0.9 0.1 0.5 0.9 2.8 11.3 2.6 0.3 0.5 5.5 0.1 0.0 6.6 0.0 0.4 1.2 0.9 0.1 1.6 1.3 0.7 0.1 0.5 1.2 0.3 0.7 0.5 1.8 1.6 0.9 0.5 0.4 0.1 0.8 1.1 0.1 0.3 0.3 0.6 0.1 0.5 1.4 4.4 7.0 0.2 0.5 8.6 7.8 2.0 0.8 0.8 4.0 1.3 10.5 0.3 0.0 4.0 0.9 3.3 0.8 1.2 0.6 1.1 2.8 0.5 2.5 3.8 1.5 2.6 12.5 15.1 6.1 12.6 2.3 1.2 257.4 43.0 106.3 66.4 42.1 76.6 73.6 52.1 61.6 49.0 119.6 39.4 37.1 60.4 70.7 39.5 48.6 56.9 31.4 0.0 1.5 46.1 18.5 5.6 6.8 9.4 1.3 0.0 3.3 1.9 4.0 11.3 3.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 8.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 11.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.3 1.8 0.0 0.0 0.0 PCMTD1 FLJ10883 ENSG00000168300 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1" Q96MG8 8 51817575-51899186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025696, HPA061444" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA025696: AB_1855077, HPA061444: AB_2684519" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.73e-3)" "unprognostic (2.58e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (2.18e-2)" "unprognostic (8.38e-2)" "unprognostic (3.73e-1)" "unprognostic (2.48e-2)" "unprognostic (1.13e-1)" "unprognostic (3.11e-3)" "unprognostic (3.11e-3)" 36.8 35.5 19.5 23.5 21.6 16.9 38.6 26.8 22.1 34.1 25.0 33.4 26.1 35.6 47.9 28.3 31.1 29.3 35.8 18.2 21.5 38.7 30.6 28.5 29.0 21.3 21.3 16.4 43.0 74.6 78.5 25.7 26.5 21.6 36.4 26.1 25.7 58.1 32.3 84.2 33.8 27.1 28.5 20.6 46.7 29.8 15.0 20.3 35.4 53.8 67.7 27.5 32.8 31.3 23.1 11.7 5.7 24.3 5.4 34.1 28.4 14.0 13.4 22.8 5.5 9.0 3.1 23.6 12.0 18.0 17.3 8.4 27.2 4.7 15.8 9.3 11.9 8.5 12.6 11.7 8.3 43.9 5.2 12.4 30.4 31.7 6.9 17.4 35.8 24.4 16.0 9.5 36.0 12.0 4.2 24.5 13.7 8.9 16.7 3.0 8.0 4.5 13.8 24.7 21.7 16.2 15.0 10.9 14.8 17.1 18.5 14.2 7.6 22.2 6.8 5.9 8.8 5.2 21.6 15.6 3.9 16.4 11.4 7.0 18.7 8.4 23.2 8.6 11.0 10.4 13.1 11.5 9.4 8.1 13.0 13.5 12.4 29.4 21.6 12.7 14.7 13.2 9.1 19.5 21.6 26.8 22.1 18.2 21.5 21.3 21.3 16.4 21.6 20.6 20.3 23.1 98.4 115.4 68.1 78.7 78.1 54.0 66.0 49.7 58.6 80.7 66.7 61.0 92.7 48.6 52.0 84.6 10.4 38.1 80.7 28.7 64.6 32.9 4.7 66.6 63.9 79.3 46.7 51.4 144.7 39.8 37.2 79.2 45.9 92.2 53.0 107.2 76.4 37.1 25.1 58.9 159.7 39.0 61.1 51.8 56.8 10.4 104.1 62.7 71.2 144.3 52.5 120.8 55.6 106.1 122.3 43.8 32.2 120.0 101.8 98.0 45.5 92.8 56.7 24.0 39.5 73.2 68.2 16.4 24.2 38.3 59.2 68.5 62.1 87.6 30.9 94.6 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492096-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 62.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favorable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 9.5 9.4 33.3 5.2 35.4 17.3 12.9 42.2 39.5 13.0 35.1 10.8 6.7 14.0 31.2 14.2 13.8 10.0 10.1 37.4 32.2 20.9 17.3 7.8 8.6 33.0 35.0 34.8 14.8 8.2 11.3 20.7 12.9 35.6 11.2 9.1 46.2 7.8 10.3 8.8 8.6 8.0 12.7 32.7 11.2 8.4 6.9 32.0 8.5 14.1 12.6 8.9 9.8 14.6 44.2 10.2 9.5 27.8 12.0 23.9 16.9 10.4 12.0 10.7 17.4 20.3 9.2 5.5 20.0 3.9 8.6 20.3 5.4 22.8 7.0 15.4 20.7 10.4 9.3 24.4 11.2 11.3 7.1 7.2 10.4 10.8 13.8 8.7 41.0 11.6 6.9 5.2 9.2 15.2 9.6 11.0 11.3 20.4 9.1 17.8 10.9 7.7 14.3 16.7 4.7 15.5 13.6 6.6 15.5 8.7 21.2 62.9 5.3 6.3 15.6 14.4 20.1 18.4 10.1 16.9 23.6 13.7 14.8 12.2 27.2 16.3 11.4 14.5 17.0 16.9 14.3 10.6 13.8 23.1 11.3 11.9 10.1 5.3 9.6 12.5 8.9 11.4 8.2 33.3 35.4 42.2 39.5 37.4 32.2 33.0 35.0 34.8 35.6 32.7 32.0 44.2 5.7 3.2 2.7 30.3 6.9 8.9 10.5 4.1 8.6 20.8 6.7 4.6 8.8 10.0 8.0 9.2 25.0 10.1 10.7 4.2 19.6 8.5 5.0 3.8 6.8 8.7 9.1 8.6 14.8 4.0 6.8 11.9 2.0 3.9 0.0 52.2 8.9 6.9 6.7 25.2 19.7 4.4 10.2 9.1 14.3 2.2 10.8 6.5 12.4 5.6 11.7 23.2 10.3 14.1 19.6 3.7 5.8 12.0 3.7 9.3 4.5 28.4 3.7 19.2 0.0 9.3 8.2 13.8 22.9 11.5 10.1 8.8 5.0 12.9 6.4 4.0 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126027-40134622 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 2.8 3.8 2.7 2.0 2.9 2.4 2.9 4.5 3.2 2.7 3.0 2.6 2.2 2.6 2.1 3.1 2.5 1.2 2.1 2.7 2.5 3.7 8.1 2.1 2.7 2.6 2.5 2.8 2.8 2.9 2.6 3.0 1.8 3.3 2.5 1.9 3.1 2.7 1.5 2.4 3.0 2.6 1.1 2.4 3.1 2.4 2.4 2.6 3.4 3.0 1.4 2.0 2.5 2.7 4.1 8.2 2.5 4.8 6.6 4.3 4.9 4.9 3.1 3.3 4.4 4.3 3.1 4.0 6.8 4.2 3.0 8.7 10.3 3.0 5.3 5.6 5.2 9.2 5.4 3.7 6.9 4.9 6.7 5.2 4.8 6.7 3.4 4.1 4.5 5.1 7.5 13.1 5.5 4.4 4.1 6.8 20.4 6.7 6.7 7.4 9.6 3.3 8.9 5.0 2.1 7.1 8.4 5.0 4.8 7.7 6.2 6.1 9.3 5.5 2.8 7.5 3.6 4.7 8.6 9.6 10.9 4.4 10.5 7.6 20.6 11.2 16.8 8.0 10.8 9.0 16.9 10.1 9.4 11.8 15.3 11.3 9.9 9.2 10.6 10.4 13.1 14.2 13.1 2.7 2.9 4.5 3.2 2.7 2.5 2.6 2.5 2.8 3.3 2.4 2.6 4.1 49.8 51.3 34.5 6.5 53.3 110.1 96.2 151.8 58.6 43.5 53.8 66.2 18.0 67.2 79.6 58.8 25.0 110.8 41.3 60.3 117.4 66.6 118.4 73.6 62.3 58.0 48.6 52.2 7.4 54.6 79.7 51.1 35.7 56.6 51.3 63.6 47.2 133.4 69.0 53.8 8.1 63.4 85.5 59.3 62.6 38.6 75.8 50.4 58.7 7.5 74.6 52.9 66.9 12.1 12.5 59.9 97.2 55.3 36.3 76.2 61.6 190.5 91.1 50.1 52.6 57.1 58.4 66.6 53.9 67.1 134.1 95.6 46.8 125.7 82.3 105.7 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537283 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 178.7" "Cell type enhanced" "Detected in many" "Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol No No 29000 Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 8.8 8.4 3.8 2.1 3.9 0.1 5.9 4.1 4.5 8.0 14.2 10.5 25.7 9.5 5.9 6.4 10.9 8.2 16.9 4.0 5.3 42.5 178.7 6.3 1.7 5.1 4.0 3.0 11.3 4.7 9.7 4.7 3.4 4.0 10.9 8.4 1.8 7.3 9.9 8.2 2.5 21.8 11.3 4.0 1.4 4.1 4.9 4.1 4.0 16.3 17.1 1.2 8.8 6.1 4.0 0.0 0.0 0.2 0.0 16.4 25.9 4.7 3.1 0.2 0.0 0.4 0.8 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 2.3 0.0 0.0 17.4 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.9 4.1 4.5 4.0 5.3 5.1 4.0 3.0 4.0 4.0 4.1 4.0 1.9 3.2 5.8 11.1 0.6 0.6 7.6 0.5 5.7 0.3 1.3 3.8 14.3 4.3 0.9 3.7 0.0 0.7 0.0 4.2 15.6 0.3 0.1 0.4 1.3 1.6 3.0 2.7 0.6 1.9 0.4 8.6 2.0 0.2 1.3 8.6 6.1 89.0 5.2 1.7 0.6 5.1 0.0 1.9 0.4 1.8 10.8 1.7 0.0 1.0 0.5 10.8 0.0 0.5 0.0 0.4 0.8 8.6 0.1 0.6 27.9 51.0 0.0 0.8 6.6 7.0 5.2 0.4 0.4 3.0 0.3 0.8 0.3 9.6 4.6 3.8 FAM107A "DRR1, TU3A" ENSG00000168309 "Family with sequence similarity 107 member A" O95990 3 58564117-58627610 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Stress response" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "brain: 1939.6;choroid plexus: 1251.6" "Cell type enhanced" "Detected in many" "Adipocytes: 196.3;Astrocytes: 81.9;Endothelial cells: 121.3;Hepatic stellate cells: 150.6;Muller glia cells: 125.0" "Cancer enriched" "Detected in many" 6 "glioma: 110.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 20.7;HUVEC TERT2: 64.9" "Low region specificity" "Detected in all" HPA055888 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA055888: AB_2682957" "unprognostic (1.20e-2)" "unprognostic (1.19e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.11e-1)" "unprognostic (7.80e-3)" "prognostic favorable (3.38e-4)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (5.73e-2)" "unprognostic (7.82e-3)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (7.95e-3)" 67.6 7.6 1685.6 8.4 1572.9 0.3 59.1 1364.8 1939.6 34.4 1251.6 35.2 5.4 36.6 53.7 29.5 87.8 16.2 100.5 1623.1 1580.3 43.8 5.6 94.0 3.1 1515.9 1472.5 1496.7 11.9 23.5 5.9 110.4 29.6 1482.5 81.2 16.2 85.8 40.9 38.3 26.5 22.6 45.6 42.9 1412.5 26.0 38.0 5.7 1535.0 44.3 51.9 33.1 8.6 69.5 42.0 1663.4 0.0 0.0 0.9 0.0 20.7 1.3 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.1 5.8 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.4 0.0 0.1 0.1 0.3 64.9 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.0 3.6 0.3 0.2 0.2 0.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1685.6 1572.9 1364.8 1939.6 1623.1 1580.3 1515.9 1472.5 1496.7 1482.5 1412.5 1535.0 1663.4 196.3 6.4 5.5 81.9 0.5 2.2 50.8 0.3 2.2 5.2 2.3 1.3 26.5 4.3 3.2 38.6 52.1 0.1 0.4 0.0 9.8 1.1 14.5 23.2 2.4 121.3 3.6 2.7 1.4 0.2 0.0 18.4 0.0 39.3 1.3 5.9 150.6 1.6 0.0 3.3 5.3 0.0 0.0 2.2 3.7 32.4 32.9 1.9 5.4 14.0 0.0 125.0 0.0 2.0 0.6 0.3 0.0 11.7 1.3 7.3 0.2 4.5 2.3 50.2 6.6 6.6 10.4 0.7 0.4 0.4 2.7 0.0 1.0 0.5 0.0 2.2 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387729-184474550 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 163.6;Karpas-707: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410" "prognostic favorable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favorable (8.34e-5)" "unprognostic (1.31e-3)" 23.8 30.3 17.9 48.2 22.3 18.1 22.1 21.4 19.2 25.8 20.7 28.1 31.4 22.0 22.9 26.9 25.5 25.2 19.7 16.8 22.9 18.7 37.7 27.9 63.0 25.1 21.4 13.7 28.4 14.9 20.3 12.3 29.2 23.7 20.8 29.0 9.4 29.3 21.4 28.4 19.3 33.6 23.4 21.4 55.3 31.8 6.1 21.0 50.2 21.9 24.0 52.6 35.9 22.7 29.3 20.3 14.9 17.5 12.0 37.4 37.9 10.5 14.4 44.8 34.8 36.0 4.2 37.9 12.2 7.4 21.7 28.4 18.3 12.0 27.4 22.1 163.6 6.6 34.4 7.9 26.8 37.1 21.1 27.7 41.2 24.8 19.8 50.1 29.8 26.7 14.5 6.9 165.3 14.6 14.1 40.6 25.8 4.0 18.5 10.7 52.7 6.9 55.1 26.6 30.4 7.5 11.6 20.4 16.8 31.3 7.3 13.0 18.9 22.0 9.9 10.7 11.3 12.8 47.3 40.6 11.0 20.9 20.3 17.8 106.7 95.7 175.8 76.4 126.3 77.9 104.9 74.5 82.2 79.6 107.7 78.8 78.8 407.6 94.8 145.7 20.2 111.7 100.3 17.9 22.3 21.4 19.2 16.8 22.9 25.1 21.4 13.7 23.7 21.4 21.0 29.3 58.9 38.5 24.5 53.5 68.9 49.1 50.5 60.4 45.5 13.1 25.8 27.3 21.9 27.1 36.0 25.8 6.2 31.3 48.8 40.3 37.2 30.9 0.2 53.4 40.2 42.9 30.6 62.7 23.8 30.1 16.2 35.8 34.1 63.2 26.6 23.1 38.2 37.6 48.5 20.2 27.8 29.5 44.7 90.3 53.5 3.0 37.3 65.9 19.6 41.2 144.0 23.4 70.0 43.7 77.1 28.7 38.9 53.0 63.4 72.9 42.1 46.1 58.7 8.4 39.5 25.4 44.8 0.6 2.4 49.5 44.5 26.7 56.3 37.7 22.8 70.9 MOBP ENSG00000168314 "Myelin associated oligodendrocyte basic protein" Q13875 3 39467198-39529479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 933.7" "Cell type enriched" "Detected in some" 14 "Oligodendrocytes: 1607.0" "Cancer enriched" "Detected in single" 63 "glioma: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "HAP1: 18.6" "Low region specificity" "Detected in all" HPA035152 Enhanced Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA035152: AB_10603020" "unprognostic (1.76e-2)" "unprognostic (2.34e-1)" "unprognostic (3.53e-2)" "unprognostic (7.35e-2)" "unprognostic (5.67e-2)" "unprognostic (3.60e-2)" "unprognostic (7.47e-2)" "unprognostic (2.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.04e-5)" "unprognostic (2.28e-1)" "unprognostic (8.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" 0.1 0.1 471.7 0.1 548.1 0.0 0.1 472.4 448.0 0.1 168.7 0.7 0.0 0.5 0.0 0.0 1.5 0.1 0.2 340.0 446.2 0.1 0.1 0.7 0.0 838.5 614.4 252.2 0.8 0.1 2.5 0.4 0.0 711.3 0.1 0.2 0.2 0.3 0.0 0.2 0.1 0.1 0.1 693.8 0.1 0.1 5.5 586.0 0.0 0.1 0.0 0.0 0.3 0.1 933.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 471.7 548.1 472.4 448.0 340.0 446.2 838.5 614.4 252.2 711.3 693.8 586.0 933.7 0.1 0.0 0.0 3.3 0.0 0.6 0.1 0.0 0.0 0.1 0.2 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 105.1 1.5 0.1 0.2 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.8 11.4 40.9 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 1.6 113.0 1.5 0.2 0.0 1.0 0.0 0.2 0.0 4.0 1607.0 0.1 0.4 0.7 0.0 0.1 0.0 0.0 1.1 0.4 0.0 0.1 0.5 41.8 6.1 0.0 0.4 0.0 0.1 0.0 0.4 0.0 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263495-39281735 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.6" "Group enriched" "Detected in some" 5 "Microglial cells: 177.1;NK-cells: 350.1" "Cancer enriched" "Detected in many" 4 "glioma: 21.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 449.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 21 "RPMI-8226: 589.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB032478: AB_638830, HPA046587: AB_2679708" "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.4 3.8 5.1 7.0 8.6 1.1 5.1 8.6 5.8 2.7 1.9 1.1 1.2 2.8 4.3 0.8 6.2 2.6 2.4 6.9 10.7 2.5 2.0 10.0 2.1 17.5 10.0 4.0 1.6 0.7 4.6 1.1 4.7 18.6 3.5 1.1 0.5 7.6 7.3 6.6 2.3 0.9 3.5 24.6 12.0 1.4 1.9 15.4 2.0 2.4 2.2 5.4 2.4 0.3 24.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.2 6.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 24.5 0.0 0.2 0.2 0.5 0.1 0.0 0.0 0.2 0.1 589.8 0.0 0.0 0.1 0.1 0.0 8.1 0.0 0.2 0.1 16.5 0.0 0.0 0.1 0.1 0.0 0.5 1.0 0.1 0.0 28.6 0.0 7.7 99.6 1.8 264.0 261.2 3.4 0.8 55.9 145.2 94.4 0.7 19.0 122.4 20.8 39.7 449.2 7.1 1.5 232.7 5.1 8.6 8.6 5.8 6.9 10.7 17.5 10.0 4.0 18.6 24.6 15.4 24.4 0.8 0.0 0.5 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.8 3.8 0.4 0.0 0.6 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.2 0.2 0.1 3.5 0.0 2.1 0.3 0.0 0.0 0.3 0.0 0.0 5.1 0.1 0.7 0.3 4.1 0.0 0.6 0.0 0.0 15.0 28.0 0.3 0.3 43.2 0.0 177.1 50.3 0.1 350.1 2.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.7 0.2 6.6 0.4 1.3 0.7 0.2 0.0 0.6 0.0 22.6 0.1 0.1 0.0 PPDPFL C8orf22 ENSG00000168333 "Pancreatic progenitor cell differentiation and proliferation factor like" Q8WWR9 8 49054311-49076093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 955.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "glioma: 0.7;renal cancer: 2.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HEL: 1.3" HPA060329 Uncertain NA NA "HPA060329: AB_2684255" "unprognostic (6.33e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.06e-10)" 1.6 0.1 0.2 0.0 0.5 0.0 1.1 0.6 0.5 0.0 0.2 0.1 0.0 0.0 0.0 2.5 0.1 0.0 0.9 0.3 1.1 0.0 0.1 0.1 0.0 1.0 0.3 0.1 0.1 0.1 0.0 0.3 0.0 1.2 2.3 0.0 0.3 9.9 0.2 955.9 1.4 0.2 0.0 0.7 0.0 0.1 0.2 0.7 0.0 0.3 113.8 0.0 0.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.5 0.3 1.1 1.0 0.3 0.1 1.2 0.7 0.7 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 601.1;skeletal muscle: 386.6" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 850.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;LHCN-M2: 1.1;RH-30: 3.0" "Not detected" "Not detected" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.1 0.3 0.3 1.2 0.0 0.0 0.2 1.6 0.7 0.0 0.0 0.7 0.0 0.2 0.0 5.6 0.0 1.0 601.1 1.1 0.2 0.1 0.1 1.7 0.0 0.6 0.2 0.0 0.1 1.2 0.0 0.5 0.7 0.3 3.4 0.0 0.0 5.1 0.0 386.6 0.4 0.5 0.4 0.3 0.6 0.3 0.0 0.2 0.5 0.2 97.3 0.0 3.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.7 1.1 0.2 0.6 0.2 0.0 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 850.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534164-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.5;retina: 2.7" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 7.2;Spermatocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 114.0" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044885: AB_10794779, HPA051925: AB_2681664" "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.0 0.3 0.7 0.0 0.9 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.5 0.0 0.0 0.0 0.0 1.9 0.9 0.8 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 114.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.1 2.1 0.8 3.5 1.9 0.9 0.8 2.2 0.3 1.6 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.4 0.0 0.0 0.0 2.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 4.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100159645 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.3;intestine: 35.1;skin 1: 53.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 10.9;granulocytes: 6.6" "Group enriched" "Detected in some" 16 "OE19: 69.3;T-47d: 104.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.1 6.2 1.0 7.1 0.2 6.1 18.1 7.1 3.3 3.9 9.0 24.9 3.3 0.5 37.3 2.1 6.6 0.2 5.4 4.9 4.8 0.9 1.7 0.6 6.5 5.8 4.6 1.0 6.9 0.4 3.3 0.4 7.6 2.4 4.6 0.2 8.6 2.1 0.3 53.4 35.1 0.5 4.8 0.8 20.3 1.1 5.6 0.1 2.4 0.0 1.9 6.6 10.2 5.2 0.0 0.3 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 2.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.6 0.0 0.0 4.2 0.4 0.3 0.1 69.3 0.0 0.4 0.0 3.6 0.0 1.6 5.2 0.1 0.0 3.1 0.0 0.1 104.4 1.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.5 0.4 6.6 1.6 0.0 0.0 10.9 0.1 0.7 0.7 6.8 0.0 1.0 0.2 0.2 0.0 0.1 0.0 0.7 6.2 7.1 18.1 7.1 5.4 4.9 6.5 5.8 4.6 7.6 4.8 5.6 5.2 0.7 3.2 5.0 5.2 3.7 1.8 3.3 22.9 1.2 4.6 24.2 15.2 0.6 37.1 34.8 82.8 0.0 7.7 3.3 24.2 1.9 19.0 1.2 15.3 4.3 3.8 55.3 1.3 0.5 1.5 4.9 1.3 54.6 28.9 9.5 0.9 0.4 0.3 1.6 0.0 0.4 53.5 34.6 0.9 0.6 1.6 0.3 1.5 0.0 3.7 0.5 1.2 12.3 0.0 1.5 2.4 77.0 0.0 3.7 1.7 298.9 0.4 144.8 22.0 0.0 1.1 3.1 3.2 4.0 86.9 15.3 37.4 2.5 0.2 69.6 21.0 SCN11A "NaN, Nav1.9, SCN12A, SNS-2" ENSG00000168356 "Sodium voltage-gated channel alpha subunit 11" Q9UI33 3 38845764-39052157 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.0;placenta: 1.9" "Cell type enhanced" "Detected in some" "Adipocytes: 5.4;Astrocytes: 7.8;Early spermatids: 7.0;Sertoli cells: 6.6;Spermatocytes: 4.4;Spermatogonia: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036746, HPA036747" Uncertain NA NA "HPA036746: AB_10696785, HPA036747: AB_2675287" "unprognostic (6.11e-2)" "unprognostic (5.16e-1)" "unprognostic (1.66e-1)" "unprognostic (4.75e-2)" "unprognostic (4.21e-2)" "unprognostic (2.34e-2)" "unprognostic (2.79e-2)" "unprognostic (5.66e-2)" "unprognostic (4.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.30e-4)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (5.02e-2)" "unprognostic (2.95e-1)" "unprognostic (3.12e-2)" "unprognostic (8.30e-4)" 0.5 0.1 0.4 0.3 0.3 0.0 0.4 0.2 0.3 0.0 0.1 0.6 0.3 0.0 0.4 0.0 0.1 0.1 0.0 0.4 0.3 0.2 0.2 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.0 0.3 1.9 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.4 0.5 0.3 0.3 3.0 0.1 1.3 0.4 0.2 0.1 0.0 0.1 0.8 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.3 0.4 0.3 0.4 0.3 0.2 0.3 0.3 0.4 0.4 5.4 0.0 0.0 7.8 0.1 0.8 0.9 0.0 0.0 0.2 0.2 0.3 1.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 7.0 0.4 0.5 2.5 0.0 2.7 1.6 0.2 0.1 0.6 0.0 0.2 0.0 1.1 1.4 0.4 0.3 0.0 1.0 0.0 0.0 0.3 1.6 2.1 0.0 0.2 1.8 0.0 0.1 0.5 0.0 1.5 2.4 0.1 0.0 0.0 0.1 0.7 0.0 0.2 2.3 0.5 6.6 1.0 0.4 4.4 6.3 0.0 0.9 0.3 0.6 0.7 0.0 0.8 ARF4 ARF2 ENSG00000168374 "ADP ribosylation factor 4" P18085 3 57571363-57598220 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3100000 "unprognostic (1.75e-1)" "unprognostic (2.11e-2)" "unprognostic (8.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.32e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.29e-7)" "unprognostic (4.78e-1)" "unprognostic (1.14e-1)" "unprognostic (1.24e-2)" "unprognostic (1.76e-2)" "unprognostic (2.47e-2)" "unprognostic (4.22e-2)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.30e-4)" "unprognostic (4.98e-3)" 120.1 164.0 58.8 108.3 61.5 73.2 139.9 61.0 74.0 210.5 78.7 160.4 124.6 122.8 228.7 109.7 97.0 156.2 107.4 60.9 80.1 115.5 174.1 127.4 74.5 62.7 63.1 56.8 114.5 152.4 102.3 106.6 183.3 62.8 139.7 199.1 54.4 183.7 134.1 65.3 66.4 110.1 170.6 66.6 67.1 132.1 101.7 64.2 75.6 145.3 70.1 98.1 205.6 92.2 67.3 251.8 90.4 218.5 182.1 516.7 533.3 212.8 617.9 585.5 382.0 483.4 264.4 235.0 89.2 110.3 774.3 334.8 95.4 234.0 353.1 491.3 111.7 76.9 183.4 196.6 351.3 647.1 115.7 127.8 517.3 308.8 355.4 423.8 482.6 480.1 86.8 134.5 173.8 672.8 123.1 69.7 146.8 263.8 333.5 306.5 40.7 173.3 170.5 459.6 175.8 67.5 164.1 252.9 240.1 325.0 298.5 167.9 193.4 369.8 299.8 174.9 447.9 360.6 126.3 116.3 124.0 331.4 220.8 378.3 249.4 85.3 95.4 41.1 72.8 72.2 53.2 58.3 53.5 72.3 48.1 71.4 55.5 102.8 58.2 65.9 109.2 59.9 90.8 58.8 61.5 61.0 74.0 60.9 80.1 62.7 63.1 56.8 62.8 66.6 64.2 67.3 172.5 76.9 90.8 18.3 150.2 350.1 505.9 429.6 195.8 32.2 249.8 204.7 48.4 91.5 259.6 97.5 6.2 322.3 146.7 226.5 191.7 287.1 179.1 195.5 197.2 146.5 164.5 232.4 25.2 232.6 448.2 298.4 200.3 301.4 101.7 121.8 101.7 161.0 197.2 18.5 26.9 403.7 248.2 90.1 264.9 72.6 177.0 139.4 241.9 15.9 112.8 156.2 35.0 30.2 30.2 396.8 238.1 185.8 346.8 399.6 180.8 178.5 201.2 27.2 78.9 115.1 345.5 132.4 80.7 188.2 321.9 698.2 133.0 230.4 272.3 599.7 SEPTIN2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" Yes No 3300000 "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favorable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 248.2 156.4 200.3 161.2 220.8 126.4 179.1 219.2 222.6 235.8 195.7 181.4 142.1 211.0 178.3 162.6 170.2 195.5 213.7 190.5 256.3 214.6 118.1 186.2 158.5 241.4 216.5 176.1 223.7 216.1 221.8 113.5 219.1 234.0 187.7 190.5 115.0 164.7 220.2 162.1 120.0 156.1 255.3 235.1 166.3 153.9 146.2 208.3 143.1 226.7 165.0 182.0 223.1 117.6 258.2 245.1 207.7 561.7 370.8 511.5 555.0 289.1 517.3 508.9 329.1 417.2 118.7 258.4 96.1 119.4 599.0 176.7 209.6 377.7 347.9 535.5 241.9 262.2 388.9 200.5 444.5 311.6 374.4 228.0 495.1 224.8 275.0 259.1 369.8 576.2 240.9 357.4 138.0 491.9 171.5 226.7 227.3 412.5 215.2 152.8 216.2 707.4 204.7 483.5 359.9 401.4 270.0 363.0 245.7 353.0 397.9 146.9 333.4 555.5 399.2 166.2 392.9 320.6 267.7 251.9 340.9 344.7 225.1 571.6 172.0 165.0 98.3 101.0 184.1 125.1 87.4 97.9 104.2 183.8 77.2 84.4 89.6 58.9 191.4 144.8 138.7 108.0 241.2 200.3 220.8 219.2 222.6 190.5 256.3 241.4 216.5 176.1 234.0 235.1 208.3 258.2 89.9 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.5 0.0 0.0 0.0 0.0 135.9 39.9 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 190.1 50.4 0.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 139.0 6.5 0.0 0.0 0.0 FILIP1L "DOC-1, GIP130" ENSG00000168386 "Filamin A interacting protein 1 like" Q4L180 3 99830141-100114513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 2.1;monocytes: 2.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8" "Region enriched" "Detected in many" 7 "olfactory bulb: 18.0" "Low region specificity" "Detected in all" HPA043133 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA043133: AB_10793991" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (7.73e-2)" "unprognostic (5.25e-2)" "unprognostic (6.68e-2)" "unprognostic (1.06e-2)" "unprognostic (4.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.08e-2)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (2.46e-2)" "unprognostic (9.44e-2)" "unprognostic (5.30e-2)" "unprognostic (1.82e-3)" 77.8 21.9 5.1 52.8 6.7 0.8 32.9 5.0 8.0 64.3 7.8 49.0 28.6 118.7 24.0 56.5 31.5 91.7 55.3 6.2 7.1 24.2 28.3 31.0 30.3 9.3 5.4 5.0 77.1 35.8 17.7 3.9 44.3 11.7 68.5 30.1 4.8 9.4 54.9 141.7 15.8 41.6 153.0 4.6 43.3 47.2 22.2 3.8 12.0 20.2 162.9 22.5 102.5 22.1 7.8 59.0 0.0 22.3 0.1 35.8 30.2 2.0 29.4 58.8 50.2 56.5 17.8 0.2 0.2 5.0 84.2 13.2 7.1 0.0 14.4 59.0 79.9 0.6 4.8 0.2 23.3 17.8 1.4 0.0 24.2 5.1 5.6 0.0 32.0 22.8 0.0 3.8 0.5 7.7 0.1 5.2 1.2 1.3 3.1 0.0 0.1 26.1 0.7 33.5 1.0 2.0 3.7 0.4 0.4 0.1 11.7 0.0 10.5 145.8 8.8 0.2 1.9 15.5 4.2 0.2 0.3 6.5 0.4 0.0 0.2 0.4 0.0 0.1 1.0 0.0 0.6 0.1 0.1 2.1 0.6 0.0 0.1 0.2 0.4 2.9 0.4 0.1 0.3 5.1 6.7 5.0 8.0 6.2 7.1 9.3 5.4 5.0 11.7 4.6 3.8 7.8 92.9 16.0 23.1 9.4 4.1 27.8 56.7 7.9 2.2 11.8 12.3 6.5 145.7 35.8 2.3 5.5 8.4 1.1 1.8 2.1 1.9 210.1 376.7 2.3 60.5 77.2 3.0 0.0 42.0 109.3 0.7 145.2 21.9 2.4 34.8 16.3 41.0 0.7 3.2 106.0 25.8 5.7 6.1 36.3 98.9 180.2 83.0 86.1 17.8 25.3 17.7 0.9 0.0 22.1 21.6 43.7 0.2 104.2 3.0 5.1 5.4 2.6 1.9 6.0 256.4 184.2 351.9 40.1 2.5 1.5 22.7 3.1 8.8 41.8 3.2 3.5 MFSD2A "FLJ14490, MFSD2" ENSG00000168389 "Major facilitator superfamily domain containing 2A" Q8NA29 1 39955112-39969968 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Symport, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 97.8;liver: 163.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3" "Group enriched" "Detected in many" 12 "dendritic cells: 24.3;monocytes: 13.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 52.0;THP-1: 169.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043107 Uncertain Approved "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "HPA043107: AB_10794387" "unprognostic (2.20e-1)" "unprognostic (1.15e-1)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (6.92e-2)" "unprognostic (2.61e-2)" "unprognostic (2.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.33e-1)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (9.26e-2)" "unprognostic (4.11e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.33e-4)" 3.4 1.4 32.4 3.4 29.0 8.5 13.6 32.7 36.3 3.2 20.7 7.2 14.7 8.5 97.8 12.6 3.5 2.3 1.1 29.1 30.8 5.7 163.3 36.4 2.4 36.6 32.2 25.8 2.2 0.6 0.8 8.0 17.2 34.6 2.4 5.1 2.6 4.0 80.0 0.5 76.6 32.3 3.5 31.1 1.5 1.9 34.2 33.7 1.6 7.6 0.1 3.6 20.4 14.2 31.3 6.2 2.7 12.5 18.9 8.7 1.6 0.0 5.9 11.2 12.8 15.1 0.8 3.4 38.0 3.4 3.0 8.8 15.0 12.4 21.8 9.8 4.9 6.0 4.6 0.1 0.1 28.8 6.8 21.8 9.7 13.3 52.0 21.5 2.3 3.1 11.5 0.0 9.5 5.7 0.8 10.6 10.4 10.1 21.4 4.7 7.4 18.5 8.7 2.1 17.9 4.4 6.7 4.5 31.7 3.0 1.1 1.5 169.8 2.0 2.7 5.3 9.5 24.9 1.8 3.5 8.5 28.9 26.0 9.2 0.0 13.2 1.4 0.1 6.6 0.2 1.5 0.1 0.2 14.7 0.2 0.0 0.1 0.7 0.2 1.2 24.3 0.0 3.6 32.4 29.0 32.7 36.3 29.1 30.8 36.6 32.2 25.8 34.6 31.1 33.7 31.3 0.5 19.2 136.2 3.3 6.3 52.8 21.2 40.0 51.2 2.0 6.3 2.3 0.6 12.8 30.8 16.5 0.0 0.5 5.7 62.2 0.0 3.4 1.0 25.8 5.5 22.9 1.2 5.7 1.5 24.8 7.6 9.7 24.5 61.8 17.2 0.1 7.1 299.6 6.7 0.0 1.3 34.5 12.2 9.8 43.3 2.7 0.6 16.1 0.0 38.4 5.5 38.8 0.0 0.0 1.6 27.2 39.3 0.4 5.0 13.9 235.1 6.1 33.9 2.7 0.0 5.0 3.3 1.0 1.3 49.3 54.8 52.5 3.3 0.1 20.7 26.6 DTYMK "CDC8, TMPK, TYMK" ENSG00000168393 "Deoxythymidylate kinase" P23919 2 241675747-241686944 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 108.6;Extravillous trophoblasts: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042593, HPA042719" Approved Approved Mitochondria NA NA 7000 Mitochondria "HPA042593: AB_10959590, HPA042719: AB_10960633" "unprognostic (1.90e-1)" "unprognostic (6.95e-2)" "unprognostic (4.14e-1)" "unprognostic (8.61e-2)" "unprognostic (1.89e-1)" "unprognostic (9.45e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (5.50e-2)" "unprognostic (2.60e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (7.13e-2)" "unprognostic (6.81e-2)" "unprognostic (5.07e-2)" "unprognostic (9.19e-2)" 12.2 16.1 14.5 15.8 15.6 37.3 11.9 15.0 20.0 10.9 15.1 15.3 13.3 10.9 6.2 19.2 10.3 8.7 9.8 13.4 15.0 14.4 19.0 9.8 25.0 15.3 14.9 13.1 8.3 9.6 7.5 5.1 11.2 15.1 11.2 12.3 4.3 9.9 7.5 8.2 19.0 14.1 13.6 14.2 17.3 13.4 8.3 15.1 24.3 8.8 6.4 19.4 10.7 11.3 16.9 102.6 112.3 93.6 120.1 30.2 33.3 103.2 82.1 63.2 110.8 125.6 54.8 120.1 48.3 24.6 66.8 126.8 84.4 87.8 102.2 56.7 118.8 104.6 103.9 88.3 105.1 26.3 69.1 83.1 23.7 27.3 102.7 42.4 32.1 104.8 74.4 123.6 38.4 114.1 112.6 132.2 125.0 100.7 113.1 94.2 111.4 139.8 71.8 62.3 59.5 115.0 74.0 53.4 81.5 67.9 27.0 74.2 120.0 66.5 147.5 110.4 99.0 152.5 47.3 49.1 144.6 122.4 112.2 184.9 20.5 26.2 17.4 30.4 46.7 29.6 35.6 28.5 32.6 19.7 36.7 28.1 25.0 4.2 32.6 37.1 38.5 42.1 28.5 14.5 15.6 15.0 20.0 13.4 15.0 15.3 14.9 13.1 15.1 14.2 15.1 16.9 28.9 9.6 5.8 8.1 21.4 15.2 17.7 47.7 16.5 19.1 36.3 44.8 11.0 24.3 22.2 25.8 2.1 79.5 24.0 22.9 21.5 39.6 2.1 17.6 25.0 29.2 14.4 108.6 3.3 34.1 149.1 26.9 25.5 22.3 15.2 52.3 23.9 22.3 84.9 5.0 4.7 35.7 36.7 17.0 13.9 2.1 16.4 21.7 23.2 5.6 39.3 23.0 38.1 6.0 9.2 33.7 10.6 19.2 37.6 21.7 12.7 37.7 12.9 17.4 26.3 21.4 31.2 27.5 63.4 32.6 11.9 27.5 17.4 28.2 52.2 19.5 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853816 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 126.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Approved "Endoplasmic reticulum,Centriolar satellite" NA NA "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: AB_2686513" "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 26.2 25.1 16.5 50.6 16.7 13.8 20.8 16.2 20.5 19.9 17.0 24.9 36.3 20.6 2.6 31.9 18.0 12.8 21.1 15.0 18.8 22.0 19.5 53.2 50.4 20.7 16.5 14.3 12.2 14.6 7.1 11.6 12.2 21.4 22.0 12.6 1.7 26.2 7.1 16.4 49.9 43.0 11.6 17.8 73.6 33.7 11.6 18.7 25.8 17.1 7.5 21.4 24.2 24.6 21.2 22.9 13.7 0.1 16.1 8.8 11.4 126.2 8.1 34.3 59.3 86.5 2.0 27.3 41.8 25.0 12.6 48.9 45.8 4.5 20.6 5.3 81.0 6.1 26.5 4.1 10.8 42.3 0.1 17.5 15.0 17.9 17.1 10.4 8.6 15.4 8.4 1.9 55.0 10.6 10.5 17.7 27.4 0.8 3.1 11.1 47.6 5.2 32.8 25.0 10.5 0.2 1.2 6.7 38.0 33.4 1.7 30.9 37.4 9.7 21.5 8.1 53.1 11.4 59.9 82.6 12.6 16.6 16.6 16.4 176.8 99.5 270.1 155.8 101.6 133.8 137.3 125.2 153.7 95.0 107.5 120.9 124.6 295.6 132.9 94.6 94.8 213.8 221.2 16.5 16.7 16.2 20.5 15.0 18.8 20.7 16.5 14.3 21.4 17.8 18.7 21.2 72.1 25.6 24.0 9.1 62.1 74.7 47.1 54.5 27.3 4.8 21.5 15.9 7.3 24.3 33.1 5.5 0.0 5.6 108.0 78.8 5.9 81.6 0.5 31.3 39.3 63.6 16.8 12.6 1.1 75.3 95.0 26.9 42.8 77.9 26.6 13.8 27.1 11.1 45.9 15.2 1.9 55.9 57.0 31.9 90.6 0.3 13.1 43.9 23.2 16.9 115.9 25.1 149.3 12.1 3.6 91.3 38.8 10.5 84.8 70.2 84.6 6.9 29.4 2.8 6.6 18.1 27.8 1.0 1.3 20.4 76.4 4.8 92.3 18.2 54.5 52.1 ING5 "FLJ23842, p28ING5" ENSG00000168395 "Inhibitor of growth family member 5" Q8WYH8 2 241687085-241729478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 21.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042685 Approved NA NA "HPA042685: AB_10797507" "unprognostic (1.87e-2)" "unprognostic (3.66e-1)" "unprognostic (1.65e-3)" "unprognostic (9.15e-3)" "unprognostic (1.79e-1)" "unprognostic (1.07e-3)" "prognostic unfavorable (2.86e-5)" "unprognostic (8.25e-2)" "unprognostic (2.30e-2)" "unprognostic (7.87e-2)" "prognostic favorable (1.60e-4)" "unprognostic (2.15e-1)" "unprognostic (5.88e-2)" "unprognostic (8.43e-2)" "unprognostic (5.01e-2)" "unprognostic (5.90e-2)" "unprognostic (4.74e-3)" 11.9 11.4 17.1 9.0 17.1 12.3 12.7 20.3 18.7 19.1 15.2 13.5 9.6 15.1 15.9 13.9 19.0 7.3 12.5 17.0 16.0 14.9 17.2 12.3 13.1 16.0 14.8 16.5 25.4 24.2 10.8 24.8 7.9 16.8 22.0 9.2 10.2 20.0 9.9 14.4 18.8 15.6 8.2 12.3 15.9 16.9 9.7 16.3 12.1 23.4 9.6 10.9 14.5 16.3 18.5 12.0 10.9 24.4 14.9 18.5 21.1 30.4 13.2 10.5 13.0 10.4 11.5 11.6 12.0 4.6 12.4 14.0 17.7 22.9 11.8 15.8 12.9 21.6 28.7 17.2 35.0 15.7 30.6 18.2 18.1 18.7 12.8 20.8 15.2 14.4 19.9 28.1 8.0 12.4 20.2 24.6 42.5 28.6 20.5 8.0 42.9 30.1 11.0 12.2 19.2 31.4 19.0 7.0 13.7 18.8 16.0 9.4 20.3 10.2 17.3 18.7 11.2 14.5 17.7 6.7 33.8 12.4 18.4 13.0 21.5 4.0 8.8 2.5 3.2 3.0 3.3 4.2 3.4 2.3 3.7 4.6 3.1 3.9 2.5 3.5 3.7 5.8 2.8 17.1 17.1 20.3 18.7 17.0 16.0 16.0 14.8 16.5 16.8 12.3 16.3 18.5 13.4 44.8 33.7 25.1 25.4 9.4 34.6 10.0 21.1 14.7 24.6 26.4 13.9 14.3 19.5 18.4 14.6 20.4 21.3 15.1 31.3 9.3 26.7 23.4 31.6 12.4 8.4 11.3 24.2 10.1 15.3 17.6 13.3 25.1 15.8 22.9 13.6 12.3 7.2 15.2 22.6 16.7 16.2 7.7 7.0 10.4 17.1 11.6 8.8 4.7 8.8 16.3 6.2 18.6 26.9 8.9 9.4 11.3 20.1 26.4 11.6 17.7 11.5 18.8 19.7 22.5 17.4 7.5 11.9 18.1 14.2 17.4 19.9 17.3 15.6 17.7 ATG4B "APG4B, AUTL1, DKFZp586D1822, KIAA0943" ENSG00000168397 "Autophagy related 4B cysteine peptidase" Q9Y4P1 2 241637213-241673857 "Enzymes, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037195, HPA069803" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB037195: AB_1078237, HPA069803: AB_2686200" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "unprognostic (2.67e-3)" "unprognostic (1.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.60e-1)" "unprognostic (6.63e-2)" "unprognostic (1.66e-1)" "prognostic favorable (9.64e-4)" 12.1 17.7 20.4 8.2 21.2 14.8 13.3 20.4 24.9 17.3 19.1 19.2 11.5 16.9 5.3 16.4 16.9 7.6 17.6 20.8 22.2 19.9 18.2 12.5 13.3 22.2 21.6 21.1 16.7 16.6 12.2 21.7 7.3 22.7 22.8 5.5 8.6 14.5 9.7 18.9 15.9 18.4 6.7 20.6 20.1 16.3 19.8 21.4 16.3 18.8 7.7 7.9 16.4 14.7 23.4 8.8 15.6 16.9 13.5 15.8 10.5 29.5 23.8 9.8 16.5 12.4 15.0 9.8 7.4 7.2 11.8 10.5 16.5 16.0 20.3 3.8 18.8 31.8 19.6 14.1 40.2 20.1 13.6 12.0 13.8 15.0 9.0 7.1 16.8 11.0 44.3 23.4 5.1 8.6 32.6 33.4 36.9 30.9 23.8 25.9 51.3 25.1 16.2 11.4 14.9 26.2 21.3 17.5 13.9 27.8 14.1 15.5 24.6 15.4 7.1 12.0 14.8 13.3 21.1 17.0 34.6 18.8 21.4 17.6 3.9 17.9 19.2 18.5 15.6 15.9 15.8 14.2 15.6 20.4 16.5 18.0 12.8 12.8 11.8 18.9 17.0 20.4 16.8 20.4 21.2 20.4 24.9 20.8 22.2 22.2 21.6 21.1 22.7 20.6 21.4 23.4 23.2 32.1 33.8 41.1 25.6 24.3 27.2 41.3 25.0 22.2 24.4 21.8 16.2 25.8 29.9 27.6 33.3 35.8 33.5 61.8 19.6 37.5 18.1 28.6 21.9 25.3 35.9 31.8 38.5 40.2 28.5 22.6 40.8 43.3 19.0 36.5 20.3 27.9 33.4 42.1 33.8 36.4 42.7 28.5 34.5 25.9 22.1 30.7 28.4 31.9 51.2 24.5 41.2 20.1 41.0 41.5 41.5 24.8 28.6 35.6 70.5 25.1 26.7 26.8 19.7 22.7 22.8 58.3 63.3 19.9 25.4 53.9 29.4 27.6 35.6 32.5 BDKRB2 BK-2 ENSG00000168398 "Bradykinin receptor B2" P30411 14 96204679-96244166 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 41.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA003551, HPA050841" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA003551: , HPA050841: AB_2681254" "unprognostic (1.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (8.79e-3)" "unprognostic (2.68e-2)" "unprognostic (1.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.84e-2)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-3)" "unprognostic (3.11e-2)" "unprognostic (9.40e-2)" "unprognostic (9.90e-2)" "unprognostic (1.49e-2)" 10.6 1.4 0.9 5.5 1.0 0.0 5.8 3.7 1.3 14.9 0.9 12.5 8.0 6.7 2.4 17.3 7.2 21.0 1.1 1.0 1.4 9.3 0.7 2.6 0.3 4.6 1.6 0.9 1.0 9.5 0.9 0.8 1.3 5.3 4.8 12.3 0.0 3.5 6.2 0.9 5.4 9.8 10.3 1.0 0.1 5.0 0.2 1.4 0.9 3.7 1.8 1.7 41.5 15.5 2.3 1.7 6.1 0.1 11.0 16.2 49.2 0.0 5.5 94.5 3.2 3.7 0.3 10.4 0.0 0.2 8.7 3.7 14.8 0.0 2.4 2.8 1.2 0.1 0.0 1.1 0.0 7.8 0.0 0.0 15.1 7.5 9.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.1 20.4 0.0 0.0 2.2 0.0 3.2 0.0 3.4 1.1 1.8 15.6 0.1 2.1 1.0 0.0 0.0 0.3 0.3 3.3 0.1 0.2 0.0 0.0 39.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 1.0 3.7 1.3 1.0 1.4 4.6 1.6 0.9 5.3 1.0 1.4 2.3 8.2 3.2 3.1 0.0 0.0 9.2 0.7 5.3 6.8 0.0 0.2 0.5 0.6 10.0 11.6 9.2 0.0 1.2 0.0 19.3 7.9 11.5 0.0 7.5 16.1 18.2 7.1 0.0 1.8 3.8 3.6 25.8 1.1 4.6 0.0 0.0 3.3 0.2 0.2 0.0 0.4 7.2 8.2 0.0 15.2 0.0 0.9 0.4 5.4 0.0 0.0 0.0 0.0 1.0 1.9 6.9 6.2 1.2 0.0 1.0 10.6 0.2 12.5 0.0 0.0 4.5 1.2 0.0 0.0 15.3 5.8 4.0 0.3 0.1 0.9 2.9 MLKL FLJ34389 ENSG00000168404 "Mixed lineage kinase domain like pseudokinase" Q8NB16 16 74671855-74700960 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA078638 Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane" "Cell Junctions, Cytosol" "HPA078638: " "unprognostic (7.53e-2)" "unprognostic (1.74e-2)" "unprognostic (2.57e-1)" "prognostic favorable (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.07e-1)" "unprognostic (5.69e-2)" "unprognostic (3.67e-3)" "unprognostic (1.90e-1)" "unprognostic (6.64e-3)" "unprognostic (1.37e-1)" "unprognostic (2.74e-1)" "unprognostic (1.60e-3)" "unprognostic (5.30e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.53e-3)" 16.1 7.2 11.1 20.5 8.4 31.0 12.2 8.4 21.8 8.3 10.7 10.7 11.1 6.0 2.0 15.7 8.0 11.6 9.9 9.7 10.4 10.7 9.3 25.8 15.6 9.6 8.4 6.1 3.0 9.9 1.6 3.8 9.2 10.2 8.5 11.5 0.3 13.4 4.3 3.1 4.6 14.5 7.7 8.8 36.4 10.9 1.2 10.4 6.8 8.7 3.2 13.9 12.4 11.6 11.9 13.5 24.4 0.1 0.1 6.0 12.4 0.2 17.0 14.8 15.4 22.4 13.9 26.6 0.3 19.1 14.2 13.7 21.7 4.3 24.9 5.8 8.3 0.6 18.8 17.6 16.2 4.2 12.3 18.6 8.5 2.4 16.8 5.7 9.0 37.3 21.3 2.7 2.5 11.9 22.0 7.0 24.3 2.2 29.3 30.0 13.5 1.8 23.8 22.0 10.2 1.0 0.8 13.4 8.7 7.2 0.1 6.2 12.5 41.4 7.8 4.8 7.0 11.7 11.2 40.2 3.2 13.7 42.3 3.9 21.9 36.2 45.8 11.2 22.2 15.4 8.1 12.6 12.0 18.9 6.7 6.8 10.4 48.6 3.6 23.3 1.2 17.4 16.0 11.1 8.4 8.4 21.8 9.7 10.4 9.6 8.4 6.1 10.2 8.8 10.4 11.9 32.1 3.2 10.7 1.0 9.8 3.4 6.8 3.1 7.4 0.2 3.3 3.4 3.1 2.8 5.5 1.8 0.0 0.2 9.6 8.9 1.9 4.6 3.5 1.2 1.9 25.9 1.2 3.4 0.5 5.2 0.8 7.1 15.3 1.6 29.1 0.3 16.8 1.3 16.6 1.7 0.5 10.9 0.0 18.2 7.8 5.2 0.9 28.9 7.2 11.2 16.7 0.1 11.3 1.5 5.2 4.9 9.4 0.4 18.5 2.8 5.5 0.6 2.0 0.6 0.0 3.0 3.1 0.1 0.2 13.4 2.8 0.3 16.5 0.2 9.5 7.5 RFWD3 "FANCW, FLJ10520, RNF201" ENSG00000168411 "Ring finger and WD repeat domain 3" Q6PCD5 16 74621399-74666877 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.2" "Cell type enhanced" "Detected in many" "Spermatocytes: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048258, HPA075649" Approved Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA048258: AB_2680332, HPA075649: AB_2686761" "unprognostic (4.79e-2)" "unprognostic (6.45e-3)" "unprognostic (6.35e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-3)" "unprognostic (5.04e-2)" "unprognostic (3.64e-2)" "unprognostic (1.01e-1)" "unprognostic (4.03e-3)" "unprognostic (2.53e-3)" "unprognostic (1.73e-3)" "unprognostic (2.84e-1)" "unprognostic (4.31e-1)" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" 5.2 3.9 2.3 10.0 3.3 48.2 7.6 3.9 3.2 5.6 4.1 8.1 6.6 6.3 5.3 9.5 6.8 6.5 3.0 2.3 3.4 6.8 5.8 6.1 15.5 3.2 3.1 2.2 7.1 10.3 6.9 3.8 8.1 3.2 4.9 9.4 6.2 5.8 5.2 3.4 12.7 6.1 6.2 2.8 8.2 6.2 25.5 3.1 27.4 6.7 2.7 16.9 7.3 6.8 4.7 46.1 57.5 42.6 31.2 8.8 11.9 47.8 40.5 30.9 63.0 54.5 75.4 46.8 63.6 32.1 31.8 31.6 53.9 70.3 42.1 76.9 20.0 42.1 56.3 46.0 43.0 7.6 57.3 56.3 8.6 13.2 79.6 48.7 16.3 27.3 53.2 86.7 27.7 48.1 72.8 84.0 52.2 84.0 26.8 27.7 128.7 28.8 55.9 22.7 47.8 31.5 33.6 65.2 22.8 28.8 38.2 41.7 48.4 26.7 46.0 43.9 26.2 51.4 37.4 75.1 188.3 32.8 43.5 57.0 12.1 4.4 6.5 5.5 4.1 6.1 4.9 4.5 5.1 4.6 5.4 6.7 4.8 4.9 6.2 7.7 3.5 7.2 4.4 2.3 3.3 3.9 3.2 2.3 3.4 3.2 3.1 2.2 3.2 2.8 3.1 4.7 6.0 0.0 5.9 4.2 13.2 10.8 6.8 4.0 10.2 6.6 8.4 8.3 3.9 2.8 5.4 1.8 10.4 12.1 15.3 7.6 11.7 6.2 5.4 6.9 5.7 7.2 9.5 22.5 8.9 7.6 8.3 5.9 5.1 6.6 4.5 13.5 11.7 7.4 8.9 3.3 7.1 9.7 2.0 12.2 6.0 6.3 3.7 7.8 16.0 15.0 7.6 3.0 10.3 6.6 15.2 10.0 2.7 4.1 11.6 12.7 4.3 4.6 5.9 6.7 6.6 6.4 5.6 48.5 31.7 9.5 9.2 7.5 10.6 3.6 9.5 11.4 MTNR1A MEL-1A-R ENSG00000168412 "Melatonin receptor 1A" P48039 4 186533655-186555567 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.0;intestine: 1.2;kidney: 2.1;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.99e-2)" "unprognostic (2.27e-1)" "unprognostic (2.16e-1)" "unprognostic (3.67e-1)" "unprognostic (2.14e-1)" "unprognostic (9.88e-2)" "unprognostic (9.20e-2)" "unprognostic (8.81e-2)" 0.0 0.0 0.0 0.6 0.1 0.0 0.0 1.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNG4 Kv6.4 ENSG00000168418 "Potassium voltage-gated channel modifier subfamily G member 4" Q8TDN1 16 84218667-84239750 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 3.4;retina: 4.3" "Cell type enriched" "Detected in some" 14 "Bipolar cells: 56.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "cerebellum: 90.5;pons and medulla: 27.0" "Low region specificity" "Detected in many" HPA063516 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA063516: " "unprognostic (3.54e-1)" "unprognostic (6.67e-2)" 0.1 0.4 0.6 0.0 0.8 0.3 0.0 3.3 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 3.4 1.5 0.3 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 4.3 0.0 0.0 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.6 0.8 3.3 0.6 0.5 0.6 3.4 1.5 0.3 2.5 1.3 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 56.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 RHOH "ARHH, TTF" ENSG00000168421 "Ras homolog family member H" Q15669 4 40191053-40246967 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 63.4;lymphoid tissue: 99.1" "Cell type enhanced" "Detected in many" "B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6" "Cancer enhanced" "Detected in many" "breast cancer: 4.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030345, HPA061314" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA030345: AB_10601607, HPA061314: " "unprognostic (4.00e-2)" "unprognostic (1.83e-4)" "unprognostic (1.24e-2)" "unprognostic (2.22e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-3)" "unprognostic (1.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.07e-2)" "unprognostic (1.38e-1)" "unprognostic (3.31e-6)" "unprognostic (2.96e-1)" "unprognostic (3.91e-2)" "unprognostic (4.46e-2)" "unprognostic (2.44e-2)" 2.3 0.9 0.7 36.7 0.7 63.4 13.4 0.5 1.2 2.9 1.1 6.3 4.9 1.6 0.9 2.9 1.5 6.5 0.7 0.6 1.9 1.1 2.7 5.8 86.7 1.0 0.9 0.5 0.9 1.4 0.4 0.7 0.9 1.0 2.8 5.7 0.0 3.9 0.9 0.6 1.2 20.8 1.5 0.9 43.0 8.3 0.7 0.9 99.1 1.8 0.3 85.9 10.6 1.6 1.0 0.2 0.4 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 126.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 2.6 0.0 18.8 0.1 0.0 0.0 21.1 92.5 1.5 0.0 0.0 0.0 0.1 0.1 123.7 1.4 1.2 0.0 0.0 179.4 13.3 2.3 0.0 0.4 19.1 0.3 4.3 0.0 0.0 0.1 0.1 0.3 0.8 0.2 0.1 5.7 0.5 0.5 0.0 0.5 0.1 0.2 65.5 56.8 116.3 0.1 4.4 0.1 210.3 1.1 168.7 112.2 0.8 99.3 164.3 176.9 151.1 1.9 212.1 274.3 220.5 8.4 74.2 1.2 26.1 268.4 124.1 0.7 0.7 0.5 1.2 0.6 1.9 1.0 0.9 0.5 1.0 0.9 0.9 1.0 2.9 3.2 9.9 0.3 273.0 7.1 1.4 0.3 1.8 0.0 11.1 6.7 1.1 1.5 2.9 0.0 0.0 0.1 90.5 0.3 0.0 0.1 0.6 0.6 0.5 2.3 0.0 23.4 0.3 0.0 0.2 3.6 9.7 1.0 141.8 0.0 1.8 0.2 2.2 0.0 0.3 0.4 0.0 4.4 16.2 0.7 0.0 28.4 56.9 8.4 11.3 0.0 64.9 0.5 0.1 0.0 0.1 0.0 183.1 1.4 0.0 0.4 1.0 0.0 0.0 2.0 2.0 0.3 0.2 0.3 7.0 0.3 223.6 0.1 0.3 2.0 KLHL30 FLJ43374 ENSG00000168427 "Kelch like family member 30" Q0D2K2 2 238138668-238152947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 150.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 13.5;Skeletal myocytes: 9.8;Smooth muscle cells: 3.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CAPAN-2: 1.6;EFO-21: 1.5;REH: 1.4;RH-30: 4.5;THP-1: 2.3" "Region enriched" "Detected in single" 35 "olfactory bulb: 9.4" "Not detected" "Not detected" HPA062095 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA062095: AB_2684680" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (2.07e-4)" "unprognostic (6.02e-5)" "unprognostic (1.29e-1)" "unprognostic (1.22e-2)" "unprognostic (1.31e-1)" "unprognostic (4.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "unprognostic (8.17e-4)" "unprognostic (2.75e-2)" "unprognostic (2.30e-1)" "unprognostic (2.06e-1)" 3.9 0.1 0.2 0.1 0.2 0.0 1.4 0.5 0.3 2.0 0.4 0.9 0.2 1.2 0.0 1.0 1.3 0.5 13.7 0.1 0.4 0.5 0.1 0.9 0.0 0.8 0.3 0.1 0.4 0.1 0.0 0.1 0.3 0.3 1.0 0.1 0.1 1.0 0.8 150.3 0.6 0.7 0.7 0.1 0.2 0.5 0.1 0.2 0.0 0.6 15.3 0.0 1.6 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.1 0.0 0.0 1.4 4.5 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.1 0.4 0.8 0.3 0.1 0.3 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 9.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COG7 ENSG00000168434 "Component of oligomeric golgi complex 7" P83436 16 23388493-23453189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040758, HPA041824, HPA064645" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311" "unprognostic (1.72e-1)" "unprognostic (1.02e-2)" "unprognostic (8.21e-2)" "prognostic favorable (6.95e-4)" "unprognostic (3.71e-1)" "unprognostic (2.15e-1)" "unprognostic (5.95e-2)" "unprognostic (2.70e-2)" "unprognostic (3.10e-1)" "unprognostic (4.15e-1)" "unprognostic (6.07e-3)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-4)" "unprognostic (3.77e-1)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 8.8 13.2 10.0 7.3 8.6 9.9 10.4 7.4 9.8 14.9 15.0 12.7 8.4 11.0 11.3 12.2 15.2 8.5 10.1 8.5 9.3 12.8 9.6 10.1 6.8 8.9 9.1 9.1 13.5 10.2 16.5 24.0 7.5 9.7 16.3 11.9 13.9 13.5 10.5 9.9 12.3 10.6 8.7 7.5 9.9 12.8 10.1 8.8 8.1 14.7 6.5 7.3 11.5 12.3 10.7 10.2 19.5 11.9 13.5 10.4 16.9 10.8 11.2 14.1 12.9 12.9 8.3 17.6 4.8 11.6 17.8 8.2 15.2 10.8 13.8 9.8 15.7 16.3 5.0 15.3 22.2 11.0 13.9 14.2 11.0 11.0 9.9 10.4 16.0 15.2 15.7 12.2 13.6 10.5 29.9 9.3 10.2 10.7 15.7 9.3 18.7 10.3 17.3 14.0 10.0 7.2 9.2 12.6 14.2 9.7 8.9 21.0 17.8 10.7 14.3 7.5 13.4 8.2 12.4 14.1 6.5 19.1 8.1 14.0 8.4 6.7 7.3 6.0 7.7 7.6 3.9 5.5 5.7 8.0 4.6 5.6 8.5 1.6 5.6 10.0 5.7 7.0 4.9 10.0 8.6 7.4 9.8 8.5 9.3 8.9 9.1 9.1 9.7 7.5 8.8 10.7 8.0 25.6 16.9 30.3 6.2 6.6 10.1 13.7 10.2 10.1 12.0 12.2 7.2 8.6 19.9 12.9 31.3 12.5 5.5 19.4 1.9 12.0 5.0 24.4 10.8 7.7 19.2 10.8 39.7 13.8 7.6 9.8 27.5 14.2 8.2 13.1 6.1 6.0 6.4 11.8 39.8 19.3 8.2 4.0 2.3 3.6 9.9 7.7 8.8 19.7 4.4 9.2 5.2 45.8 40.6 12.9 11.3 12.4 7.2 9.3 11.6 8.7 39.1 22.4 13.1 10.1 8.6 16.5 13.3 9.1 5.4 11.8 8.9 7.2 15.9 10.7 CDC40 "EHB3, FLJ10564, PRP17, PRPF17" ENSG00000168438 "Cell division cycle 40" O60508 6 110180141-110254275 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 257.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046620 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA046620: AB_2679722" "unprognostic (4.19e-3)" "unprognostic (2.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (3.64e-2)" "unprognostic (3.42e-2)" "unprognostic (5.24e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (9.27e-2)" "unprognostic (1.92e-1)" "unprognostic (4.68e-2)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (3.01e-1)" "unprognostic (2.09e-1)" 11.2 14.8 7.6 13.5 10.9 38.6 13.7 7.4 11.0 11.4 8.1 11.2 11.2 11.8 10.4 10.8 11.1 10.5 10.6 10.6 6.9 16.5 17.0 11.1 19.7 6.0 5.9 9.0 16.3 12.5 14.1 9.5 10.0 6.8 12.6 12.2 14.9 11.1 9.5 11.7 10.7 11.1 10.2 5.5 16.1 11.5 11.9 6.6 18.8 16.1 11.7 18.7 12.7 8.5 10.2 11.3 10.4 18.2 31.8 18.3 18.8 14.8 21.5 26.4 21.3 26.9 22.8 11.3 37.8 23.7 19.2 22.7 15.8 28.2 17.5 30.1 30.5 21.3 31.0 14.4 12.4 24.2 40.2 39.8 17.1 16.4 22.5 18.1 15.9 21.6 24.3 31.5 22.0 21.3 11.0 29.9 14.9 18.1 15.1 11.2 26.0 21.4 13.1 15.5 23.6 19.4 19.1 15.8 13.8 15.9 16.6 12.8 38.1 24.5 11.5 11.4 27.3 24.1 11.0 15.9 33.8 18.6 33.2 17.4 28.6 18.7 20.4 13.8 20.3 13.7 29.5 13.7 14.3 15.9 28.3 16.2 14.1 20.8 16.5 23.4 24.9 16.8 10.2 7.6 10.9 7.4 11.0 10.6 6.9 6.0 5.9 9.0 6.8 5.5 6.6 10.2 38.9 32.1 37.6 18.3 85.7 26.4 26.2 43.1 36.5 94.4 32.2 32.8 21.5 30.0 37.5 27.6 43.8 32.9 79.2 20.9 56.7 35.8 257.8 34.6 48.4 35.5 26.4 44.2 65.4 37.3 30.9 35.8 35.2 30.4 49.4 43.0 38.9 56.6 37.8 94.2 25.6 29.8 22.4 44.9 28.6 84.6 67.4 49.6 10.6 24.4 76.0 46.1 57.7 27.2 43.6 28.5 28.9 45.1 27.8 23.4 29.1 74.0 31.0 84.0 78.9 38.2 39.3 20.9 22.5 37.6 27.1 28.7 59.0 70.6 35.5 22.4 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 58.0 129.0 147.0 70.8 124.1 61.8 50.1 127.7 263.1 68.0 127.2 68.1 40.8 74.7 49.5 80.2 73.0 43.9 94.6 164.0 133.3 68.5 69.4 71.4 73.5 148.0 134.5 115.2 88.3 53.8 61.9 72.3 78.1 153.5 61.2 56.6 63.4 56.5 56.6 141.5 59.6 54.4 67.3 138.2 69.5 66.6 127.3 157.8 66.8 58.1 93.0 88.9 81.9 64.4 204.1 321.0 486.3 298.1 251.7 161.8 108.1 271.5 277.2 150.1 393.9 228.1 361.3 265.2 371.1 322.9 220.3 475.4 329.7 745.4 280.3 427.6 302.1 311.7 521.5 302.6 336.7 142.8 278.7 325.1 109.4 174.5 327.1 242.7 162.4 284.2 276.1 537.2 209.5 232.1 468.8 432.0 388.6 366.4 306.0 407.2 418.3 279.1 385.6 282.8 271.8 242.7 217.3 314.4 338.9 266.7 310.3 357.1 194.0 253.8 252.0 310.9 333.1 389.0 189.8 434.0 388.0 328.8 282.6 374.1 61.0 66.8 57.4 87.6 95.1 88.2 85.9 65.5 79.5 69.9 68.5 72.7 81.6 20.0 108.2 114.6 58.1 66.1 119.1 147.0 124.1 127.7 263.1 164.0 133.3 148.0 134.5 115.2 153.5 138.2 157.8 204.1 31.3 44.8 32.9 7.8 40.0 80.4 184.1 61.5 40.9 37.5 32.5 29.8 46.1 31.5 59.1 20.2 41.7 124.8 39.8 38.3 49.0 76.3 31.0 65.8 48.6 45.9 67.3 69.0 9.5 55.2 146.1 49.6 24.5 51.1 79.3 47.8 14.3 27.4 91.5 63.9 14.9 39.9 97.6 21.9 90.3 77.5 27.4 46.7 62.2 12.2 51.8 36.9 53.5 11.1 17.2 69.5 32.7 39.9 56.4 75.7 22.3 39.6 85.8 36.7 26.3 36.1 65.4 96.3 118.6 47.6 72.0 211.0 67.0 62.8 48.6 95.3 SCNN1B ENaCbeta ENSG00000168447 "Sodium channel epithelial 1 subunit beta" P51168 16 23278231-23381294 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 83.5;intestine: 56.8;vagina: 56.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Club cells: 64.8;Collecting duct cells: 57.0;Distal enterocytes: 262.8;Ionocytes: 107.8;Paneth cells: 73.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 26.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 33.3;RPMI-8226: 9.2;RT4: 18.5;U-266/70: 55.4;U-266/84: 20.2" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Low region specificity" "Detected in many" HPA015612 Uncertain NA NA "HPA015612: AB_1856629" "unprognostic (7.45e-2)" "unprognostic (1.76e-3)" "unprognostic (1.39e-1)" "unprognostic (6.74e-3)" "unprognostic (1.74e-2)" "unprognostic (5.11e-3)" "unprognostic (7.74e-2)" "unprognostic (5.49e-3)" "unprognostic (2.60e-1)" "unprognostic (2.40e-1)" "unprognostic (3.68e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.32e-1)" "unprognostic (4.66e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-2)" 14.6 0.4 0.0 1.2 0.0 0.2 17.9 0.9 0.0 48.9 0.0 56.8 2.5 2.8 0.1 83.5 3.7 0.5 0.2 0.0 0.2 23.2 0.2 24.1 0.8 0.0 0.0 0.0 0.7 2.1 0.3 1.0 3.6 0.3 10.6 36.0 0.0 39.9 2.4 1.5 36.2 4.3 0.8 0.0 3.8 24.3 0.3 0.0 0.7 9.3 0.8 5.4 8.4 56.9 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 0.0 7.0 0.0 0.0 9.2 0.0 18.5 0.2 0.0 0.0 0.5 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 55.4 20.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 25.7 99.3 28.3 0.0 7.1 3.1 15.4 27.8 5.7 0.0 4.4 3.0 0.7 0.0 64.8 57.0 0.0 0.7 0.1 262.8 0.0 0.0 0.1 11.9 1.6 6.2 7.7 0.0 0.3 0.4 0.3 1.0 36.7 23.4 8.2 0.0 1.1 0.1 0.1 0.0 0.3 21.4 107.8 0.0 0.0 0.2 0.0 1.0 10.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 73.7 0.0 38.7 6.1 0.0 0.1 9.2 0.0 0.0 0.1 0.7 0.1 0.4 29.8 5.4 2.2 1.4 0.0 15.2 19.7 HR "ALUNC, AU" ENSG00000168453 "HR lysine demethylase and nuclear receptor corepressor" O43593 8 22114419-22133384 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Oxidoreductase" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.0;skin 1: 53.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 91.4;Cone photoreceptor cells: 33.3;Distal enterocytes: 27.5;Gastric mucus-secreting cells: 26.5;Paneth cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.2;HaCaT: 81.7;OE19: 39.9;SiHa: 28.8;T-47d: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054888 Supported Nucleoplasm NA NA Nucleoplasm "HPA054888: AB_2682630" "unprognostic (9.11e-2)" "unprognostic (2.12e-2)" "unprognostic (7.32e-2)" "unprognostic (4.68e-3)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" "unprognostic (1.75e-1)" "unprognostic (2.27e-2)" "unprognostic (8.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" 2.2 1.0 2.3 1.8 4.8 0.0 2.7 5.1 12.1 2.1 0.0 7.8 4.9 1.6 0.1 21.0 1.1 1.4 2.0 2.8 3.2 0.6 0.4 0.8 0.3 9.3 7.9 0.3 0.6 0.5 0.0 2.8 0.1 10.3 3.8 3.2 1.8 5.1 4.3 0.7 53.1 4.7 1.5 1.2 0.5 7.8 5.3 6.4 0.6 4.3 0.9 1.2 3.1 11.8 8.3 1.9 21.2 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.0 2.6 0.0 20.7 1.5 1.0 81.7 0.0 2.0 0.0 0.0 0.0 0.0 17.8 0.1 4.7 0.0 0.1 4.1 12.9 0.0 1.4 1.3 0.0 2.1 0.0 0.2 0.0 12.7 1.5 0.3 0.0 39.9 16.3 1.9 0.0 0.5 0.3 5.7 1.0 4.7 28.8 6.4 6.5 0.3 30.0 0.0 0.0 0.4 17.2 0.0 0.9 0.0 0.0 0.0 0.2 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.8 5.1 12.1 2.8 3.2 9.3 7.9 0.3 10.3 1.2 6.4 8.3 1.9 0.0 0.0 1.3 0.0 12.0 4.5 4.3 10.8 91.4 4.0 3.9 2.7 0.0 1.4 1.8 33.3 0.1 0.1 27.5 0.0 0.1 0.3 1.6 1.2 0.6 7.8 0.0 8.7 0.7 0.2 2.1 26.5 2.1 0.0 0.3 1.8 0.3 0.0 10.1 3.9 8.1 0.0 0.0 2.1 1.9 3.4 0.1 21.4 0.0 0.0 3.2 0.0 2.0 9.2 0.3 31.2 7.2 0.0 3.0 11.0 0.1 1.3 8.8 0.0 5.8 3.3 0.1 0.3 15.5 17.8 0.8 0.3 0.2 19.5 6.8 TXNDC2 SPTRX1 ENSG00000168454 "Thioredoxin domain containing 2" Q86VQ3 18 9885726-9889275 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 310 "testis: 106.0" "Group enriched" "Detected in some" 98 "Early spermatids: 307.9;Late spermatids: 125.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.5;U-2 OS: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016414, HPA018817" Enhanced NA NA "CAB016414: , HPA018817: AB_2241329" "unprognostic (1.21e-2)" "unprognostic (3.55e-3)" "unprognostic (6.31e-2)" "unprognostic (5.25e-2)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (6.13e-1)" "unprognostic (1.21e-1)" "unprognostic (3.17e-2)" "unprognostic (8.95e-3)" "unprognostic (3.75e-2)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (2.18e-2)" 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 106.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.2 0.5 0.3 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 0.2 0.1 0.0 1.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.4 0.2 1.1 0.5 0.3 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.9 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 125.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 RAB31 Rab22B ENSG00000168461 "RAB31, member RAS oncogene family" Q13636 18 9708275-9862551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 180.9;Kupffer cells: 283.8;Langerhans cells: 208.9;Macrophages: 221.6;monocytes: 193.2;Oligodendrocyte precursor cells: 184.0;Syncytiotrophoblasts: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 137.9" "Group enriched" "Detected in many" 8 "dendritic cells: 44.9;granulocytes: 137.9;monocytes: 51.6" "Cell line enhanced" "Detected in many" "GAMG: 175.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019717 Approved NA NA "HPA019717: AB_10601493" "unprognostic (4.61e-2)" "unprognostic (1.65e-2)" "unprognostic (8.53e-2)" "unprognostic (1.13e-1)" "unprognostic (1.23e-2)" "unprognostic (5.70e-2)" "unprognostic (3.07e-2)" "unprognostic (5.99e-2)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (1.71e-2)" "unprognostic (1.75e-1)" "unprognostic (6.26e-2)" "unprognostic (3.98e-3)" "unprognostic (8.71e-3)" "unprognostic (1.61e-1)" "unprognostic (6.34e-2)" 35.3 105.8 83.3 42.6 86.7 60.3 22.4 90.9 93.4 85.9 70.0 36.6 11.2 56.7 9.5 32.1 29.1 46.0 17.6 77.2 92.0 16.3 10.6 59.4 22.6 97.0 90.9 72.9 44.6 7.1 8.6 10.1 57.0 95.5 21.5 17.8 12.7 13.8 49.2 5.4 11.5 23.9 86.5 92.9 31.5 32.0 42.9 92.8 9.9 26.1 10.6 22.8 55.0 35.5 95.5 2.7 14.4 105.0 0.2 136.7 70.5 74.6 25.4 71.0 18.2 15.8 4.1 14.4 0.1 16.6 99.7 175.3 9.9 25.9 32.6 21.1 6.5 14.6 89.3 104.4 1.8 158.0 7.4 94.2 76.5 6.6 42.1 32.5 78.0 47.4 0.0 22.2 0.4 42.6 11.9 0.1 11.5 22.2 1.2 6.3 0.1 11.5 3.7 13.9 0.3 2.0 6.8 96.4 60.7 34.7 87.5 6.9 48.4 51.9 112.9 56.4 78.3 37.5 19.4 5.7 0.1 153.7 0.1 47.1 137.9 51.6 21.3 0.1 47.2 0.1 9.8 0.2 0.1 44.9 6.7 0.1 0.1 74.4 4.3 50.2 5.2 0.2 19.5 83.3 86.7 90.9 93.4 77.2 92.0 97.0 90.9 72.9 95.5 92.9 92.8 95.5 10.0 176.3 33.3 91.4 32.4 15.8 17.7 30.8 23.3 3.2 13.2 12.6 10.6 12.8 51.2 11.0 0.0 180.9 11.0 8.7 7.9 7.9 5.4 10.2 86.0 33.1 0.0 2.5 8.1 19.6 19.0 55.5 5.6 6.2 7.6 72.9 30.0 1.9 157.0 151.4 19.6 0.6 8.2 283.8 208.9 10.9 17.7 221.6 7.2 75.9 193.2 21.5 4.1 184.0 7.0 19.4 1.4 117.4 12.0 27.3 0.0 4.0 47.0 3.9 39.5 14.0 87.3 1.7 4.2 14.5 16.1 186.6 5.1 36.3 0.3 38.8 REEP4 "C8orf20, FLJ22246, FLJ22277, PP432, Yip2c" ENSG00000168476 "Receptor accessory protein 4" Q9H6H4 8 22138020-22141951 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 90.1;skin 1: 85.5" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042683 Approved Supported "Endoplasmic reticulum" No Yes "Endoplasmic reticulum" "HPA042683: AB_2571730" "unprognostic (2.38e-1)" "unprognostic (9.96e-3)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (3.41e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.88e-5)" "unprognostic (5.72e-2)" "unprognostic (1.06e-1)" "unprognostic (2.25e-1)" "unprognostic (6.65e-2)" 12.7 8.5 6.8 12.6 8.3 28.7 11.7 8.6 9.8 18.9 7.6 16.6 11.1 9.4 2.1 90.1 11.2 5.7 7.7 6.7 10.2 9.2 12.4 18.2 11.3 10.7 8.1 5.7 7.4 13.0 5.0 11.0 14.7 9.8 13.8 10.9 2.1 22.0 6.5 4.2 85.5 17.0 5.9 9.1 33.4 18.1 43.1 9.2 10.0 14.9 2.6 10.3 19.7 49.4 10.7 42.2 79.7 24.9 39.7 10.5 10.6 47.9 36.7 19.2 44.6 40.2 46.7 38.8 53.0 46.8 18.4 38.5 100.3 29.6 59.3 21.9 28.2 37.4 57.4 41.2 46.9 11.8 25.8 77.9 9.8 110.3 33.3 27.5 13.9 27.1 58.1 44.5 158.7 22.6 60.6 63.7 88.9 37.4 58.0 53.3 37.0 22.5 101.8 19.9 40.0 21.7 40.1 30.0 31.7 52.7 16.5 64.3 35.9 30.5 29.2 50.1 66.6 50.3 40.0 33.5 34.6 32.6 54.7 59.1 49.8 54.8 64.1 24.3 53.6 19.6 10.5 21.1 21.1 42.7 4.9 9.7 13.1 15.5 26.3 37.0 16.9 15.4 27.6 6.8 8.3 8.6 9.8 6.7 10.2 10.7 8.1 5.7 9.8 9.1 9.2 10.7 6.8 3.2 9.2 4.9 7.9 28.0 15.1 45.5 15.4 6.5 5.8 5.7 1.8 7.2 21.9 12.9 2.1 54.0 13.8 27.3 0.0 21.9 16.0 3.8 4.9 9.2 17.4 48.2 0.7 15.0 50.4 8.1 21.9 5.9 10.2 14.0 15.4 6.6 55.4 0.0 0.6 33.0 22.4 38.8 21.5 9.4 9.0 26.1 3.6 10.3 16.5 1.8 10.3 1.0 2.6 25.6 34.7 8.2 19.3 19.0 19.2 1.9 8.1 1.5 13.1 2.3 9.7 61.0 17.9 41.1 39.2 94.1 13.5 8.9 31.1 24.5 TNXB "TNXB1, TNXB2, TNXBS, XB, XBS" ENSG00000168477 "Tenascin XB" P22105 6 32041153-32115334 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "adrenal gland: 277.1" "Cell type enhanced" "Detected in many" "Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 1500000000 "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-3)" "unprognostic (9.57e-2)" "unprognostic (1.16e-1)" "unprognostic (9.51e-4)" "unprognostic (5.71e-2)" "unprognostic (2.30e-1)" "unprognostic (6.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.61e-2)" "unprognostic (2.17e-1)" "unprognostic (9.70e-2)" "unprognostic (3.13e-2)" "unprognostic (2.02e-1)" "unprognostic (1.90e-2)" "unprognostic (1.01e-1)" 61.5 277.1 2.8 0.9 2.1 3.4 40.4 4.6 2.9 44.5 4.2 31.4 3.1 67.2 3.2 18.2 37.7 4.7 59.8 1.1 1.0 13.0 17.8 51.6 0.8 1.6 1.6 0.1 67.6 3.7 0.4 6.8 3.9 2.8 15.7 1.7 0.3 19.6 1.0 14.3 24.7 29.3 3.2 2.2 31.0 18.9 11.5 3.0 0.7 27.9 7.3 0.4 34.8 35.5 1.9 0.1 0.3 0.3 0.2 12.4 20.1 0.2 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.4 1.2 0.0 0.1 0.0 0.0 0.1 1.3 1.1 0.2 0.6 0.0 2.8 0.0 0.3 0.2 0.2 0.5 0.0 0.5 0.0 0.5 0.7 0.4 0.0 0.2 0.0 0.1 0.3 0.0 3.5 0.3 0.1 0.2 0.0 0.1 0.1 0.2 1.3 0.0 0.1 0.1 0.0 0.3 0.2 0.1 0.4 15.8 0.0 0.4 0.4 0.2 8.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 2.1 4.6 2.9 1.1 1.0 1.6 1.6 0.1 2.8 2.2 3.0 1.9 54.7 3.2 2.4 2.6 0.5 32.9 0.2 0.3 0.6 1.3 1.3 1.8 2.5 4.3 0.2 0.0 0.0 0.5 1.0 0.0 0.0 0.2 3.0 1.3 39.7 38.8 0.0 25.0 7.1 0.0 2.6 318.4 6.1 1.1 0.0 94.8 12.8 0.9 0.7 0.0 4.2 0.1 0.0 0.6 39.1 2.8 27.1 4.7 32.0 17.8 0.0 1.2 0.0 1.0 1.2 0.0 0.1 4.5 2.5 0.5 0.0 0.3 0.9 0.6 0.0 21.7 20.8 4.1 2.1 1.6 26.6 1.0 4.8 5.6 0.2 0.4 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146830-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 107.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4" "Group enriched" "Detected in many" 5 "glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" NA NA Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 0.3 3.4 50.0 0.2 70.8 0.1 0.2 72.3 82.7 2.2 2.5 0.7 0.4 1.2 0.3 6.5 1.6 0.1 1.4 43.7 62.1 0.4 0.1 16.1 0.0 79.2 69.7 37.5 0.2 0.8 0.3 2.8 0.0 84.3 1.3 0.1 3.9 1.7 2.8 0.2 15.1 0.5 0.6 60.7 0.1 0.9 0.8 70.7 0.3 13.1 0.1 0.3 0.2 2.5 107.9 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.6 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 70.8 72.3 82.7 43.7 62.1 79.2 69.7 37.5 84.3 60.7 70.7 107.9 0.0 0.0 22.2 2.0 0.0 2.3 0.0 0.0 0.0 2.7 0.1 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.8 0.0 17.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.4 0.0 0.3 0.1 40.9 2.8 0.0 1.2 0.0 6.6 58.4 0.1 0.0 7.2 0.0 0.0 0.0 0.8 0.0 2.9 0.0 0.0 0.6 0.1 0.1 1.4 0.6 0.0 0.0 0.9 0.0 0.0 SFTPC "BRICD6, PSP-C, SFTP2, SMDP2, SP-C" ENSG00000168484 "Surfactant protein C" P11686 8 22156913-22164479 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 795 "lung: 18623.0" "Cell type enriched" "Detected in some" 12 "Alveolar cells type 2: 107013.9" "Cancer enriched" "Detected in some" 218 "lung cancer: 226.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.5;NB-4: 12.4;SCLC-21H: 5.1;U-2197: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010928 Enhanced "Secreted in other tissues" NA NA "HPA010928: AB_1857425" "unprognostic (1.84e-1)" "unprognostic (1.96e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.97e-1)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-2)" 1.7 23.4 12.2 10.4 13.8 0.0 0.9 12.2 15.9 1.6 9.8 0.9 0.0 0.4 0.3 0.9 0.4 0.0 2.7 11.6 11.9 1.0 2.8 18623.0 0.0 13.3 12.6 11.1 21.7 1.7 0.0 1.1 4.8 13.3 3.1 0.0 0.0 0.8 9.0 2.1 3.1 2.3 0.0 11.9 14.1 6.5 2.8 12.1 0.0 4.3 0.1 0.2 0.1 0.9 16.8 0.0 0.1 0.0 0.0 0.5 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 12.4 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 5.1 0.4 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.1 24.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 13.8 12.2 15.9 11.6 11.9 13.3 12.6 11.1 13.3 11.9 12.1 16.8 0.0 8535.2 107013.9 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1416.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 67.8 0.0 0.0 0.9 0.0 0.0 174.6 0.0 0.0 986.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 30.4 0.0 106.6 23.2 0.0 0.0 0.0 0.0 0.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 339.6 0.0 6.6 0.0 0.3 0.1 0.1 0.0 0.6 0.0 163.4 0.4 0.0 0.1 BMP1 "BMP-1, PCOLC" ENSG00000168487 "Bone morphogenetic protein 1" P13497 8 22165140-22212326 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 69.3;Endometrial stromal cells: 52.8;Smooth muscle cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014572 Enhanced "Secreted to extracellular matrix" NA NA 9200000 "HPA014572: AB_1845390" "unprognostic (1.24e-1)" "unprognostic (8.01e-2)" "unprognostic (3.75e-2)" "unprognostic (5.89e-2)" "unprognostic (1.34e-2)" "unprognostic (6.76e-2)" "unprognostic (9.53e-2)" "unprognostic (2.64e-3)" "unprognostic (1.66e-1)" "unprognostic (9.75e-3)" "unprognostic (7.05e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (3.37e-9)" "unprognostic (2.11e-2)" "unprognostic (6.57e-2)" "unprognostic (1.50e-3)" "unprognostic (3.34e-2)" 11.1 17.6 4.1 6.4 4.5 1.4 9.0 4.9 4.4 14.5 4.8 8.1 4.9 12.8 3.9 7.1 11.9 9.9 5.7 4.5 6.5 7.7 14.8 8.4 1.7 5.2 4.4 3.8 6.0 4.4 3.5 3.5 27.5 4.4 9.7 5.4 0.6 3.8 6.2 3.4 5.9 5.9 14.5 4.5 5.0 4.3 2.4 4.3 1.5 10.1 3.1 1.8 10.5 10.4 4.6 15.2 20.4 7.4 30.2 47.8 41.8 23.2 54.1 50.1 33.8 27.6 5.1 27.4 3.7 32.0 56.9 18.9 51.2 5.1 27.8 6.5 3.6 6.9 6.7 24.5 7.9 31.7 2.9 14.3 49.8 26.5 25.2 11.4 78.3 31.4 5.2 7.1 10.6 19.6 4.6 1.4 3.0 4.7 17.0 8.3 6.4 8.2 15.2 26.7 4.1 2.8 10.6 52.5 3.1 13.4 20.4 5.0 8.3 41.4 17.0 18.4 32.3 23.9 4.0 2.2 0.6 23.8 10.1 28.0 0.0 0.4 0.0 0.6 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.1 4.1 4.5 4.9 4.4 4.5 6.5 5.2 4.4 3.8 4.4 4.5 4.3 4.6 12.5 6.4 69.3 5.5 0.8 6.2 5.2 22.6 4.0 2.6 5.0 6.1 4.9 2.8 6.7 5.5 0.0 3.3 3.2 31.9 0.0 25.1 0.7 3.1 52.8 14.1 3.0 0.8 3.5 8.2 9.5 28.7 1.1 5.7 15.2 13.9 14.6 20.1 4.3 1.7 2.7 6.2 0.0 3.4 6.1 1.1 10.2 5.4 10.6 4.7 1.0 2.2 3.1 6.6 6.7 15.3 18.6 10.9 2.8 4.7 13.2 4.1 2.2 1.1 26.3 6.4 43.7 1.5 4.0 6.5 5.3 24.4 3.3 34.2 10.7 8.0 ATXN2L "A2D, A2lp" ENSG00000168488 "Ataxin 2 like" Q8WWM7 16 28823035-28837237 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041506, HPA043391, HPA071955" Approved Enhanced Cytosol NA NA Cytosol "HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478" "unprognostic (1.64e-2)" "unprognostic (1.72e-1)" "unprognostic (7.33e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-1)" "unprognostic (6.63e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (5.59e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (7.99e-7)" "unprognostic (1.79e-1)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (2.98e-1)" 64.8 78.9 74.5 52.0 78.4 83.6 65.9 82.5 117.7 84.0 65.4 75.1 44.2 71.9 21.1 82.6 78.4 29.4 64.9 76.1 71.2 86.3 96.9 86.6 63.2 79.5 74.2 73.1 82.0 97.6 34.0 117.3 39.3 82.2 81.3 27.2 56.9 70.7 28.2 64.4 75.0 87.0 33.7 69.1 118.0 83.3 180.3 77.1 53.0 83.7 23.9 47.3 76.2 78.4 79.3 77.8 97.6 99.0 112.1 59.9 61.5 116.1 76.3 73.7 82.1 91.3 124.1 90.1 178.6 95.4 54.4 128.6 110.2 93.9 76.9 90.5 140.9 83.3 119.5 124.3 127.4 107.5 135.9 161.2 78.8 90.1 116.4 166.1 72.4 73.2 174.4 158.9 219.9 68.4 109.9 166.1 228.0 100.6 46.9 67.2 216.4 68.5 125.6 48.9 79.6 102.8 81.9 44.6 83.5 95.8 62.3 91.3 141.0 88.2 101.2 83.6 65.8 106.2 311.9 238.1 159.4 76.3 128.1 119.6 0.4 2.1 1.4 1.6 1.9 1.6 4.3 1.9 2.0 1.6 2.9 1.8 2.3 2.4 1.9 1.6 5.6 1.7 1.1 74.5 78.4 82.5 117.7 76.1 71.2 79.5 74.2 73.1 82.2 69.1 77.1 79.3 30.2 28.9 33.3 26.1 48.2 36.6 25.1 20.2 66.0 31.6 29.8 26.3 2.1 21.5 19.8 20.2 45.9 23.0 39.1 19.8 1.9 17.8 71.7 37.7 34.9 27.8 24.6 23.1 37.3 20.2 21.9 20.8 31.6 53.1 25.9 23.4 27.1 14.7 24.8 26.9 37.5 23.4 14.2 29.3 33.3 25.7 21.5 36.5 8.8 24.4 26.4 10.0 33.0 18.6 31.5 32.2 19.4 19.9 65.1 33.0 19.7 4.8 18.8 48.9 13.1 28.9 22.1 83.9 28.3 46.3 31.1 34.3 48.4 24.5 23.4 27.4 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219703-22232101 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 229.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4" "Cancer enhanced" "Detected in many" "glioma: 6.3;thyroid cancer: 6.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 9.3;SH-SY5Y: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8" "HPA068030, HPA069318" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068030: AB_2685944, HPA069318: AB_2686117" "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 8.2 33.4 115.5 1.5 165.5 0.0 9.4 116.4 229.2 10.8 0.0 10.5 1.3 14.6 2.8 9.9 25.8 6.8 3.9 225.3 67.1 9.2 0.7 2.5 0.2 82.5 32.3 163.6 7.1 1.6 0.2 36.0 2.5 94.2 12.0 0.6 2.2 1.8 6.0 0.9 52.4 5.1 8.1 2.2 11.6 3.7 10.8 38.5 0.2 3.9 0.3 0.2 12.2 15.3 150.5 0.6 1.6 0.3 0.0 0.2 0.5 0.8 0.2 0.9 0.2 0.2 0.1 1.4 0.0 1.5 0.5 1.0 2.6 0.0 0.4 0.0 0.0 0.1 0.0 3.0 1.0 1.1 0.0 0.0 0.6 0.0 0.6 0.0 2.5 1.7 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.2 9.3 0.0 0.0 2.9 3.5 2.0 0.0 2.4 0.2 0.0 0.2 0.7 0.0 1.4 1.1 0.5 0.6 0.1 0.0 1.4 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.5 165.5 116.4 229.2 225.3 67.1 82.5 32.3 163.6 94.2 2.2 38.5 150.5 1.1 0.0 0.0 7.2 0.0 18.9 5.5 5.6 14.8 1.5 0.7 1.3 1.4 1.5 1.9 3.7 0.0 0.1 0.1 0.2 0.0 0.2 0.8 0.4 3.6 1.5 0.0 0.0 48.5 2.1 0.4 5.6 0.5 0.2 0.0 0.0 1.4 1.0 0.2 0.0 15.4 0.7 0.0 0.0 1.4 1.8 3.1 0.1 1.8 5.6 0.0 0.6 0.0 7.5 5.8 0.8 0.0 3.8 0.0 1.3 2.6 3.5 0.3 1.1 0.0 0.2 8.0 0.4 0.4 8.2 10.9 2.2 0.2 0.1 0.1 5.0 CCDC110 "CT52, KM-HN-1, MGC33607" ENSG00000168491 "Coiled-coil domain containing 110" Q8TBZ0 4 185445182-185471752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pancreas: 31.0;testis: 100.9" "Cell type enhanced" "Detected in many" "Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0" "Low region specificity" "Detected in many" HPA078808 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA078808: " "unprognostic (1.18e-1)" "unprognostic (7.26e-3)" "unprognostic (5.42e-2)" "unprognostic (9.84e-4)" "unprognostic (3.72e-2)" "unprognostic (3.08e-3)" "unprognostic (1.95e-5)" "unprognostic (4.92e-2)" "unprognostic (5.81e-2)" "unprognostic (9.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.64e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-2)" "unprognostic (1.21e-2)" 0.5 1.0 2.0 1.0 3.3 0.0 3.6 2.9 2.3 2.7 1.5 1.8 0.9 1.4 5.1 1.8 3.0 1.2 1.1 1.2 1.8 2.5 0.8 0.9 1.2 2.0 1.8 1.1 4.6 31.0 2.0 2.9 0.8 2.7 2.3 1.9 8.0 6.2 2.0 2.1 1.1 0.8 1.4 1.7 0.6 2.5 100.9 1.5 0.4 7.8 0.9 0.7 1.3 0.5 1.4 0.4 0.0 0.2 0.1 2.2 2.4 0.1 0.0 0.0 0.0 0.2 0.0 1.7 2.7 0.3 0.0 2.3 0.3 1.7 0.0 0.2 1.0 1.7 0.0 0.2 0.0 1.1 0.0 0.0 0.6 0.0 1.0 0.0 1.4 0.8 0.7 0.2 0.2 2.9 0.7 0.0 0.0 0.2 0.3 1.3 0.1 0.0 0.4 0.6 0.0 8.4 1.5 0.0 0.9 0.7 0.4 3.8 0.0 0.5 0.3 0.7 0.1 0.1 5.3 8.8 0.0 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.3 2.9 2.3 1.2 1.8 2.0 1.8 1.1 2.7 1.7 1.5 1.4 0.4 0.0 0.0 0.7 0.9 0.3 0.4 0.3 1.8 0.5 2.9 4.7 4.2 0.0 0.0 1.8 0.0 0.1 0.0 0.3 1.9 2.6 796.2 1.8 0.2 1.2 0.0 0.0 3.5 3.5 0.1 2.1 0.5 1.0 0.0 0.2 2.2 0.5 0.1 0.0 1.3 1.1 4.1 0.0 0.3 175.5 7.2 0.9 3.6 1.9 0.1 3.1 1.0 0.5 1.8 2.2 0.3 6.0 9.3 0.4 0.0 2.3 4.4 5.3 0.0 1.7 2.5 552.8 6.1 1.5 0.4 0.0 0.3 0.7 1.1 0.1 POLR3D "BN51T, C53, RPC4, TSBN51" ENSG00000168495 "RNA polymerase III subunit D" P05423 8 22245133-22254601 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061331, HPA067875, HPA068461, HPA069089" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081" "unprognostic (2.33e-1)" "unprognostic (2.27e-1)" "unprognostic (9.38e-3)" "unprognostic (9.33e-3)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.02e-1)" "unprognostic (2.19e-2)" "unprognostic (3.27e-1)" "unprognostic (8.03e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.15e-6)" "unprognostic (1.15e-1)" "unprognostic (3.13e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.12e-4)" 12.0 12.0 3.6 4.4 3.2 6.6 10.7 3.1 3.9 13.5 3.1 10.7 2.5 10.5 3.3 15.3 11.4 4.1 13.4 2.9 3.5 10.5 10.0 11.2 4.7 3.6 3.6 2.6 15.0 17.6 4.0 13.9 6.6 3.8 12.9 4.6 4.0 10.7 3.8 33.1 10.9 8.6 5.9 3.4 11.5 10.7 19.5 3.8 3.4 10.7 8.4 4.3 15.2 14.5 4.2 5.1 10.7 11.0 7.8 10.0 16.6 11.3 18.9 9.1 10.7 8.7 10.5 3.6 27.8 10.2 12.5 8.9 9.1 16.9 9.2 11.0 6.9 9.4 20.7 10.5 11.2 13.6 5.0 9.5 13.8 12.9 13.4 21.8 13.1 8.9 14.9 28.9 9.5 8.7 7.2 22.2 10.4 18.9 13.0 9.0 14.7 12.2 18.0 6.1 6.0 7.8 24.2 8.5 5.9 17.7 11.9 5.4 8.0 13.0 9.4 9.1 18.8 11.4 17.0 22.7 18.9 9.2 10.1 14.0 0.1 1.4 0.3 1.8 1.1 2.5 2.4 2.3 2.6 1.6 2.2 3.0 1.9 0.1 2.9 1.6 3.5 1.8 1.3 3.6 3.2 3.1 3.9 2.9 3.5 3.6 3.6 2.6 3.8 3.4 3.8 4.2 15.0 9.6 6.5 4.6 15.8 19.5 43.6 21.2 13.6 12.8 15.2 14.5 10.9 4.3 13.3 11.0 16.7 16.2 18.5 6.9 11.7 20.2 42.7 11.6 37.7 15.6 21.5 10.3 2.4 11.8 33.2 21.3 12.8 14.8 18.4 18.7 11.7 3.8 13.7 3.3 2.8 19.1 12.2 8.8 8.2 40.5 15.8 8.6 8.8 1.0 13.4 4.5 14.4 2.5 3.5 22.5 6.7 12.8 20.5 52.3 6.7 12.6 11.2 12.2 19.7 22.1 21.3 44.2 52.0 12.1 19.2 27.0 15.0 25.1 12.3 41.8 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792911-61797238 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 46.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 160000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 5.9 10.5 8.7 21.5 8.7 39.8 10.3 11.8 10.3 6.3 9.6 15.6 11.3 6.4 7.1 14.3 5.7 4.4 6.6 8.6 8.8 5.9 10.0 5.6 34.3 10.4 9.5 8.9 3.9 6.8 5.7 8.4 13.0 11.7 6.3 16.3 17.6 6.1 5.9 13.2 9.7 11.5 9.0 7.8 12.9 8.5 19.2 10.5 46.4 4.9 9.7 37.7 8.2 5.0 11.2 154.6 139.7 149.3 81.3 14.9 18.0 94.9 133.3 76.1 160.9 181.4 123.4 112.8 222.6 100.3 57.3 150.5 158.3 214.3 117.7 163.3 117.8 117.6 117.6 187.7 127.3 11.0 184.7 115.4 12.7 15.8 148.1 39.0 23.3 63.1 122.1 181.3 155.1 136.0 195.4 259.7 165.4 165.3 120.3 134.7 173.8 173.7 228.9 64.4 144.7 170.0 140.7 89.6 115.0 79.1 70.1 167.4 127.1 43.2 141.5 178.1 182.3 134.6 120.4 204.3 228.9 98.4 121.9 124.6 24.7 6.7 14.2 16.2 12.9 16.8 14.4 12.3 15.1 8.0 14.8 14.0 13.8 2.7 20.0 12.9 24.5 25.2 10.3 8.7 8.7 11.8 10.3 8.6 8.8 10.4 9.5 8.9 11.7 7.8 10.5 11.2 2.7 0.0 2.2 0.3 14.0 10.3 5.2 18.2 7.4 23.8 7.4 7.4 5.8 5.7 7.7 0.0 12.5 53.0 15.9 6.7 7.9 17.3 21.7 4.2 5.5 5.5 4.8 87.5 2.0 12.2 70.9 8.6 7.1 6.3 0.0 18.6 1.1 7.2 25.7 15.2 2.4 8.0 18.3 5.4 6.8 14.4 5.6 6.2 5.4 0.0 12.4 31.3 13.4 1.5 3.1 12.2 9.4 7.2 45.3 6.5 3.7 5.7 6.4 23.3 0.0 6.8 12.2 61.0 62.1 11.3 6.1 30.9 11.0 9.0 22.0 5.2 CAVIN2 "cavin-2, PS-p68, SDPR, SDR" ENSG00000168497 "Caveolae associated protein 2" O95810 2 191834310-191847088 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 166.3" "Group enriched" "Detected in some" 4 "Adipocytes: 1296.7;Alveolar cells type 1: 413.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "basophil: 49.0;neutrophil: 24.3" "Lineage enriched" "Detected in many" 16 "granulocytes: 49.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039325, HPA062122" Enhanced Enhanced "Plasma membrane,Cytosol" Yes No 88000000 "Plasma membrane" Cytosol "HPA039325: AB_10805473, HPA062122: AB_2684688" "unprognostic (6.85e-3)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (4.47e-2)" "unprognostic (2.83e-1)" "unprognostic (1.46e-1)" "unprognostic (3.19e-2)" "unprognostic (6.14e-2)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.45e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (4.39e-3)" 166.3 25.3 21.7 13.1 17.6 6.6 61.4 16.5 20.3 57.3 14.0 52.4 11.6 39.3 13.4 48.6 54.3 52.2 97.6 14.6 15.8 26.2 31.4 94.7 15.5 20.0 16.9 11.8 53.5 22.7 13.0 7.2 34.3 20.1 30.5 25.1 1.2 7.2 30.3 32.6 6.7 21.3 58.6 15.1 112.9 15.1 4.4 19.9 4.2 79.0 60.4 5.6 43.0 19.6 17.8 0.0 20.2 6.8 0.1 1.0 3.4 0.1 4.1 3.5 0.8 1.5 0.0 0.0 0.1 24.8 162.3 0.0 3.4 0.0 31.8 2.3 0.1 0.0 119.8 1.4 45.6 43.6 0.0 0.0 8.4 20.5 3.4 9.6 2.2 362.3 0.0 43.9 0.0 561.1 0.0 0.0 0.1 0.1 0.0 1.0 0.0 32.3 0.2 41.7 0.0 0.0 0.1 0.0 0.0 0.0 9.1 0.0 0.1 148.9 0.0 12.4 7.4 0.0 0.0 0.0 0.1 0.0 1.0 0.0 49.0 2.4 1.2 0.2 0.8 0.3 0.1 0.0 0.0 2.3 0.3 0.2 0.0 24.3 1.3 1.5 3.1 0.5 121.3 21.7 17.6 16.5 20.3 14.6 15.8 20.0 16.9 11.8 20.1 15.1 19.9 17.8 1296.7 413.5 76.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.7 15.6 0.0 0.0 81.7 0.0 0.0 0.2 2.6 0.0 5.9 1.6 0.0 0.4 5.4 164.5 0.0 0.0 0.0 0.2 0.2 15.0 0.0 0.6 185.4 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 29.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.1 1.5 16.4 0.0 0.0 MTCL1 "CCDC165, KIAA0802, SOGA2" ENSG00000168502 "Microtubule crosslinking factor 1" Q9Y4B5 18 8705661-8832778 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.8;retina: 34.3" "Cell type enhanced" "Detected in many" "Early spermatids: 26.0;Excitatory neurons: 86.4;Granulosa cells: 28.9;Inhibitory neurons: 80.4;Oligodendrocyte precursor cells: 24.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 81.8;pons: 35.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 32.0" HPA046245 Uncertain NA NA "HPA046245: AB_10962580" "unprognostic (2.64e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.35e-1)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-1)" "unprognostic (4.41e-4)" "unprognostic (1.30e-2)" "unprognostic (7.19e-2)" "unprognostic (9.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.82e-1)" "unprognostic (3.67e-1)" "unprognostic (7.17e-3)" "unprognostic (1.08e-2)" 1.1 0.9 0.7 2.5 0.9 0.5 1.4 81.8 9.2 4.2 0.0 20.1 1.8 2.3 0.7 2.7 1.1 8.1 2.9 1.3 1.0 1.5 1.3 1.2 0.8 4.4 4.8 1.1 1.1 3.7 2.9 5.7 2.3 35.1 1.7 1.7 34.3 1.4 3.0 2.1 2.3 4.4 5.3 1.4 0.6 9.0 8.1 0.4 3.8 0.4 1.1 0.5 9.5 4.6 6.6 16.8 35.3 17.4 10.2 7.6 14.1 0.7 22.9 16.9 18.6 13.4 10.4 5.8 10.5 12.8 16.1 13.9 2.5 5.5 9.4 8.5 2.1 4.5 5.1 10.1 9.4 10.9 0.1 7.3 8.3 6.8 10.5 7.2 12.1 14.8 8.8 1.1 17.8 8.7 5.0 0.7 2.5 7.9 40.2 15.2 14.0 12.5 3.8 26.9 29.9 39.3 8.8 10.5 3.0 2.7 14.3 1.0 0.6 28.2 33.8 17.6 27.4 23.8 3.4 2.8 5.1 8.4 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.9 81.8 9.2 1.3 1.0 4.4 4.8 1.1 35.1 1.4 0.4 6.6 0.4 0.0 1.1 9.4 1.3 0.0 2.8 0.0 4.6 0.0 1.5 1.9 6.5 8.6 0.6 1.8 0.0 5.0 1.8 1.8 1.9 5.6 26.0 2.8 2.3 2.1 1.2 4.6 86.4 3.5 0.4 1.5 5.6 7.8 2.5 28.9 4.6 1.0 0.6 0.0 80.4 1.5 0.0 0.6 0.0 8.8 1.2 0.3 0.0 8.4 0.1 0.0 0.0 24.1 18.3 8.6 0.2 0.4 1.9 4.6 0.2 1.9 0.0 0.0 0.0 0.8 1.9 0.9 5.2 3.0 0.0 1.0 0.4 1.3 1.2 1.3 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168386 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "brain: 11.0" "Cell type enriched" "Detected in single" 4 "Early spermatids: 2.8" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 47.5;BEWO: 8.3;PC-3: 14.2;TIME: 7.7" "Region enhanced" "Detected in single" "thalamus: 1.3" "Group enriched" "Detected in some" 4 "midbrain: 2.5;pons: 2.7;thalamus: 6.4" HPA067809 Approved Nucleoplasm Yes NA Nucleoplasm "HPA067809: AB_2685900" "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.0 0.0 1.4 0.0 1.4 0.0 0.0 2.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.5 0.0 0.0 0.0 0.0 4.8 5.1 0.1 0.0 0.0 0.0 0.1 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.6 0.9 47.5 1.8 0.0 0.0 8.3 0.7 0.0 1.3 0.0 1.1 0.0 0.0 0.9 0.0 1.4 0.0 0.4 0.1 0.3 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 3.9 0.0 3.4 0.0 0.6 1.2 0.0 0.4 1.2 0.0 14.2 0.0 5.1 0.0 0.4 0.0 0.6 0.3 1.6 0.0 0.5 1.5 0.0 0.0 7.7 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 2.5 0.8 0.4 7.5 4.8 5.1 0.1 3.3 2.7 11.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 HJV "haemojuvelin, hemojuvelin, HFE2, HFE2A, JH, RGMC" ENSG00000168509 "Hemojuvelin BMP co-receptor" Q6ZVN8 1 146017468-146036746 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "liver: 241.5;skeletal muscle: 596.7;tongue: 294.2" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 96 "liver cancer: 87.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.5;K-562: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA 69000 "unprognostic (2.30e-1)" "unprognostic (6.98e-4)" "unprognostic (7.06e-2)" "unprognostic (1.11e-2)" "unprognostic (2.77e-3)" "unprognostic (2.55e-1)" "unprognostic (8.50e-2)" "unprognostic (2.36e-1)" "unprognostic (7.14e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-8)" "unprognostic (6.61e-2)" "unprognostic (2.72e-1)" "unprognostic (1.76e-2)" 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 8.0 0.1 0.1 68.2 0.1 0.1 0.2 241.5 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 6.0 0.0 596.7 0.2 0.1 0.2 0.4 0.2 0.1 1.6 0.1 0.3 0.1 294.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.0 0.1 0.4 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCGB1D1 "LIPA, LPHA, MGC71958" ENSG00000168515 "Secretoglobin family 1D member 1" O95968 11 62190216-62193539 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "cervix: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "endometrial cancer: 23.3;ovarian cancer: 16.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "SCLC-21H: 6.0" "Secreted in other tissues" NA NA "unprognostic (6.95e-3)" "unprognostic (9.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 HEXIM2 FLJ32384 ENSG00000168517 "HEXIM P-TEFb complex subunit 2" Q96MH2 17 45160700-45170040 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.4;testis: 44.9" "Group enriched" "Detected in many" 5 "Early spermatids: 150.9;Late spermatids: 274.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023323, HPA028455" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA023323: AB_1850651, HPA028455: AB_10602603" "unprognostic (9.03e-3)" "unprognostic (2.18e-2)" "unprognostic (4.01e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.36e-1)" "unprognostic (6.35e-3)" "unprognostic (9.70e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "prognostic favorable (9.85e-4)" "unprognostic (2.34e-3)" "unprognostic (1.93e-1)" "unprognostic (1.29e-2)" "unprognostic (2.32e-3)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.90e-2)" 4.8 10.2 7.1 5.2 8.2 4.7 4.6 11.3 9.9 4.9 10.8 6.3 10.3 4.8 4.6 4.7 5.6 7.9 5.9 6.3 6.0 10.6 15.2 4.3 7.3 8.2 7.3 6.2 6.3 10.9 7.6 8.0 3.4 9.4 6.0 2.7 4.9 11.6 5.8 57.4 6.6 7.7 2.9 7.5 6.5 8.1 44.9 8.0 5.0 8.8 15.2 3.3 5.9 4.0 7.9 9.0 31.7 6.9 15.3 7.5 12.3 13.1 4.9 5.9 7.8 8.6 12.1 23.4 5.6 25.0 3.5 4.0 14.6 6.8 6.0 2.4 12.9 10.9 4.2 33.4 55.1 5.4 3.6 8.9 10.7 5.6 6.8 2.4 15.1 3.9 11.3 4.6 13.4 3.6 15.6 5.7 7.6 7.5 12.5 13.8 7.7 10.4 17.1 9.8 8.8 8.2 7.2 4.4 8.8 20.7 4.8 23.3 6.1 3.8 14.0 7.5 9.4 11.7 20.7 23.9 5.2 11.0 6.6 10.7 8.2 11.7 10.6 4.8 9.4 8.0 10.1 3.5 5.8 10.2 5.5 2.7 5.0 8.2 8.1 3.1 12.9 4.7 12.0 7.1 8.2 11.3 9.9 6.3 6.0 8.2 7.3 6.2 9.4 7.5 8.0 7.9 3.1 0.0 1.5 1.6 4.8 2.0 4.0 3.1 5.7 13.1 6.8 7.2 0.3 5.7 2.5 1.8 4.2 11.7 4.1 2.7 19.6 5.5 150.9 4.9 3.0 4.3 4.8 0.8 2.2 1.6 5.4 3.9 3.6 3.4 7.0 8.8 5.3 7.7 7.0 3.3 3.0 6.2 4.1 9.3 3.3 274.9 5.9 16.4 3.6 1.0 4.9 11.6 5.2 1.5 3.1 1.6 3.1 7.2 7.2 2.0 18.3 36.2 1.8 9.9 0.0 5.4 4.6 41.4 13.7 3.3 3.0 6.2 2.1 7.2 6.1 2.5 FNTA "FPTA, PGGT1A, PTAR2" ENSG00000168522 "Farnesyltransferase, CAAX box, alpha" P49354 8 43034194-43085788 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010149, HPA018830" Approved Approved Cytosol NA NA 170000 Cytosol "CAB010149: AB_2106299, HPA018830: AB_1848992" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-1)" "unprognostic (1.86e-3)" "unprognostic (2.64e-1)" "unprognostic (4.70e-3)" "unprognostic (1.83e-2)" "unprognostic (3.69e-2)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (3.25e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (2.94e-12)" "unprognostic (3.63e-2)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (1.29e-3)" 50.8 33.6 62.0 26.6 72.3 27.1 46.5 78.0 74.6 41.4 57.9 40.8 36.2 34.2 43.6 45.8 33.7 27.4 44.8 58.6 67.5 36.4 47.6 35.0 45.9 79.0 69.8 56.8 33.3 44.2 34.6 36.9 50.4 75.7 38.6 32.8 34.1 36.8 34.4 74.9 50.2 33.2 31.7 81.9 37.0 35.7 27.2 68.0 40.3 31.9 65.3 44.5 41.2 43.5 93.0 78.8 37.5 50.9 16.7 88.6 112.5 43.4 44.9 52.4 50.1 46.3 62.1 56.9 88.5 35.5 54.1 67.6 41.9 63.1 71.5 59.4 26.2 42.2 70.9 25.5 54.2 112.7 30.4 35.8 87.6 119.0 36.3 104.2 74.4 89.4 47.9 86.1 50.4 58.5 9.9 72.3 47.1 91.3 66.4 27.1 63.1 83.0 47.8 70.5 58.4 29.7 47.4 56.6 47.3 78.9 59.1 59.1 55.3 69.9 17.9 22.1 68.6 48.0 47.7 46.2 89.2 43.0 56.4 41.3 3.1 7.7 14.3 9.5 10.7 11.3 14.1 9.7 12.6 13.3 15.2 12.9 12.9 4.3 16.1 7.8 12.6 14.3 6.4 62.0 72.3 78.0 74.6 58.6 67.5 79.0 69.8 56.8 75.7 81.9 68.0 93.0 68.7 57.7 20.3 33.0 57.4 87.7 82.3 55.3 58.1 22.5 35.5 34.8 44.9 34.3 41.2 33.1 37.5 135.6 69.1 29.6 70.5 73.0 41.2 40.7 55.1 55.8 32.2 38.9 27.9 70.1 124.4 58.7 28.5 46.2 32.4 58.6 56.0 25.9 80.5 20.2 31.9 39.6 34.6 47.5 60.7 52.8 48.1 49.2 94.3 33.7 75.7 42.8 69.0 25.6 79.8 69.4 41.2 60.2 40.8 109.3 67.0 54.8 46.7 57.5 52.6 56.2 47.2 65.9 37.1 73.9 95.6 207.6 60.4 69.6 49.1 76.6 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 237.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 466.3;Distal enterocytes: 530.1;Ductal cells: 735.4;Pancreatic endocrine cells: 457.4;Paneth cells: 465.1;Proximal enterocytes: 422.0;Syncytiotrophoblasts: 446.6;Urothelial cells: 432.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "plasmacytoid DC: 10.4" "Lineage enriched" "Detected in many" 4 "dendritic cells: 10.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 305.6;HaCaT: 349.2;HBEC3-KT: 553.0;hTCEpi: 307.8;RT4: 381.9;SK-BR-3: 311.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 5.4 24.0 1.1 15.2 1.3 8.1 34.1 1.6 1.3 69.5 2.7 112.0 119.7 15.4 21.5 121.7 19.0 59.6 2.8 0.9 4.0 105.3 237.4 21.0 3.5 1.8 1.9 0.6 0.9 38.0 46.2 9.8 44.9 2.1 57.1 56.7 0.1 152.2 62.7 77.5 52.8 106.5 2.6 1.5 3.4 91.5 5.0 4.5 8.8 28.6 24.7 9.6 117.6 39.6 1.9 87.3 20.5 17.7 57.0 37.3 50.4 48.2 162.8 119.5 10.6 13.1 31.1 305.6 57.0 209.5 154.6 12.9 349.2 2.3 553.0 2.1 5.5 13.2 0.0 17.2 16.6 42.0 0.5 64.1 46.0 307.8 66.5 144.2 45.5 6.7 6.9 2.6 0.5 18.2 14.2 2.1 2.0 18.3 172.1 42.4 0.4 34.8 19.5 57.9 381.9 7.6 42.4 41.7 311.0 6.5 8.5 182.8 9.9 40.7 2.8 13.0 1.8 3.4 2.9 2.1 2.6 1.4 1.6 13.7 0.0 2.4 2.2 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 10.4 0.0 0.6 1.1 1.3 1.6 1.3 0.9 4.0 1.8 1.9 0.6 2.1 1.5 4.5 1.9 2.2 16.0 8.9 0.0 2.7 12.4 108.7 374.7 37.0 0.0 162.9 72.9 0.7 138.7 173.3 117.7 0.0 466.3 4.2 530.1 72.4 735.4 6.4 61.6 18.2 8.8 116.6 3.6 0.4 326.3 91.2 5.4 80.0 140.7 0.0 1.6 5.7 54.5 47.5 0.0 0.4 195.0 183.1 5.1 5.0 12.9 2.1 13.1 40.9 1.0 48.4 0.6 0.0 0.0 0.2 457.4 465.1 0.0 0.1 192.2 422.0 71.0 54.3 0.0 0.0 23.5 19.3 0.7 9.5 30.8 21.2 446.6 3.5 0.1 145.7 432.5 MYL1 ENSG00000168530 "Myosin light chain 1" P05976 2 210290150-210315174 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 88 "skeletal muscle: 22012.9;tongue: 15729.5" "Cell type enriched" "Detected in some" 246 "Skeletal myocytes: 492.9" "Group enriched" "Detected in some" 18 "head and neck cancer: 36.0;prostate cancer: 12.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HSkMC: 51.4" "Region enriched" "Detected in single" 4 "olfactory bulb: 4.0" "Low region specificity" "Detected in all" "HPA046859, HPA063034, HPA073827" Enhanced "Intracellular and membrane" NA NA 21000000 "HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: " "prognostic unfavorable (6.59e-4)" "unprognostic (1.88e-1)" 1.7 0.5 0.1 0.0 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.9 0.0 0.5 0.0 214.5 0.0 0.0 1.8 0.2 0.0 0.8 1.0 0.9 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.4 0.0 0.0 165.7 0.0 0.0 171.6 0.0 22012.9 2.7 0.7 0.0 0.2 0.4 0.7 0.5 0.0 7.4 2.4 15729.5 0.9 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 11.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 492.9 2.0 0.1 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 TRAPPC11 "C4orf41, FLJ12716, foigr, gry" ENSG00000168538 "Trafficking protein particle complex 11" Q7Z392 4 183659267-183713594 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038173 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA038173: " "unprognostic (2.24e-1)" "unprognostic (6.03e-2)" "unprognostic (9.92e-3)" "unprognostic (1.31e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.14e-2)" "unprognostic (6.24e-2)" "unprognostic (2.63e-1)" "unprognostic (6.50e-2)" "unprognostic (5.78e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.66e-5)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (2.25e-2)" "unprognostic (3.92e-2)" 12.2 16.1 3.2 13.5 4.8 11.5 15.7 7.8 6.4 12.5 13.0 13.3 11.1 14.2 11.9 14.0 12.5 11.1 12.5 4.6 4.9 15.0 17.0 13.7 15.0 3.2 3.6 4.1 20.9 14.3 19.3 6.8 13.9 4.4 14.2 15.1 13.9 14.9 12.3 15.3 12.2 11.8 15.8 3.0 14.4 13.7 16.1 4.0 18.0 15.0 18.8 17.7 13.7 8.1 5.7 15.1 14.4 23.2 23.1 28.5 31.3 17.6 21.6 21.7 17.8 16.2 9.0 19.1 20.7 6.0 21.8 13.9 10.8 21.2 20.5 20.4 23.1 9.3 26.0 12.0 12.8 26.2 28.3 24.8 24.2 21.5 17.8 20.6 23.2 26.5 23.9 21.1 41.8 22.5 10.8 34.1 13.8 8.7 10.2 10.7 23.4 13.8 15.8 22.8 15.3 15.6 20.7 21.1 21.6 21.4 20.5 16.6 31.0 26.7 10.1 11.9 9.7 12.4 21.8 12.7 12.4 20.6 18.7 18.0 3.8 12.9 8.2 5.7 14.9 7.6 4.7 6.2 6.1 12.8 3.4 5.7 5.9 3.7 10.0 25.6 3.3 5.4 7.6 3.2 4.8 7.8 6.4 4.6 4.9 3.2 3.6 4.1 4.4 3.0 4.0 5.7 9.5 3.2 14.5 33.0 12.3 4.5 3.1 7.4 9.1 11.0 5.7 6.2 14.8 8.6 9.1 7.3 8.4 7.9 10.0 9.8 3.9 7.4 57.7 8.2 13.3 9.1 13.1 12.0 47.5 9.3 8.4 12.0 12.2 8.0 7.6 18.7 9.3 8.5 11.6 8.4 47.4 7.2 0.0 16.0 6.8 7.3 13.4 16.1 3.6 30.0 19.5 6.4 11.3 37.2 35.2 9.0 7.1 11.3 10.6 5.5 11.7 4.6 12.9 13.6 0.0 9.9 8.6 7.7 14.9 10.4 6.1 7.0 9.4 12.4 7.9 5.9 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 27.2;prostate: 29.9;salivary gland: 29.1" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Breast myoepithelial cells: 3.6;Excitatory neurons: 8.7;Inhibitory neurons: 7.8;Intestinal goblet cells: 3.2;Melanocytes: 3.6;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 4.4" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 3.7;OE19: 12.3" "Low region specificity" "Detected in many" HPA014101 Enhanced Supported NA NA "HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.0 3.3 12.2 0.3 22.9 0.0 2.7 0.0 27.2 0.0 0.0 0.8 0.4 0.1 0.0 0.3 0.2 0.1 0.1 21.8 6.3 0.2 0.0 2.5 0.0 4.0 1.2 25.0 0.0 0.6 0.3 0.2 0.2 6.9 29.9 0.8 0.1 29.1 0.0 0.0 2.6 0.7 0.0 0.0 0.0 1.4 0.1 1.3 0.0 0.2 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 12.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.4 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 22.9 0.0 27.2 21.8 6.3 4.0 1.2 25.0 6.9 0.0 1.3 12.7 0.1 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.0 0.0 1.8 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.8 3.2 0.0 0.0 0.3 0.0 0.0 0.0 3.6 1.0 0.0 0.0 0.0 3.0 1.0 0.0 0.1 0.0 0.0 4.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 COL3A1 EDS4A ENSG00000168542 "Collagen type III alpha 1 chain" P02461 2 188974373-189012746 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 2389.5;gallbladder: 2110.4;placenta: 1998.4;smooth muscle: 2159.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 2812.0;Fibroblasts: 1764.2;Smooth muscle cells: 643.0;Theca cells: 466.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebral cortex: 53.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 1362.4;ASC diff: 2465.0;ASC TERT1: 4252.6;fHDF/TERT166: 1815.7;HHSteC: 1690.0;HSkMC: 3189.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 61.1" "HPA007583, CAB016766, CAB059993" Approved Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 32000000 "Endoplasmic reticulum" "CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548" "unprognostic (1.12e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-1)" "unprognostic (2.04e-1)" "unprognostic (6.94e-2)" "unprognostic (6.77e-3)" "unprognostic (3.57e-3)" "unprognostic (2.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.59e-10)" "unprognostic (1.70e-3)" "unprognostic (3.76e-2)" "unprognostic (7.61e-2)" "unprognostic (6.17e-3)" 770.5 49.3 2.0 580.6 1.7 1.1 343.4 1.3 53.6 2389.5 24.1 245.2 85.3 776.1 61.5 301.3 179.2 2110.4 236.6 1.2 9.7 42.9 98.2 188.6 120.0 1.9 1.7 0.9 148.1 45.6 37.3 13.7 1998.4 1.9 148.8 338.1 0.0 66.1 279.5 67.7 332.5 153.8 2159.6 1.8 135.9 158.4 64.0 8.7 41.3 72.4 72.5 73.7 1108.0 276.1 5.0 0.0 0.2 1362.4 53.0 2465.0 4252.6 0.9 558.6 495.3 239.4 212.8 8.1 0.0 0.6 0.3 1815.7 0.1 0.8 1.1 1.0 26.4 0.0 0.9 0.7 228.9 0.2 1690.0 2.0 0.6 3189.5 0.0 291.5 46.9 1.0 12.5 0.0 0.4 0.0 146.4 0.0 0.2 1.4 2.6 0.1 1.7 0.3 38.5 0.5 0.0 7.2 1.3 21.1 14.5 0.4 0.0 954.8 0.1 0.0 0.7 2.3 28.0 117.3 0.5 2.8 1.3 0.4 0.5 1.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.7 1.3 53.6 1.2 9.7 1.9 1.7 0.9 1.9 1.8 8.7 5.0 111.8 3.2 13.7 0.0 0.6 171.6 0.4 1.9 3.4 0.0 7.7 9.9 11.1 0.0 1.3 0.0 0.0 57.9 1.6 0.0 0.0 2.4 29.0 75.4 2812.0 68.4 6.0 0.0 0.0 0.0 58.1 1764.2 4.1 60.7 6.3 9.7 235.2 0.9 91.1 0.0 0.2 0.0 0.0 0.6 275.3 20.8 323.1 17.5 172.5 20.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 235.9 1.5 0.6 0.0 0.2 1.6 0.0 453.6 224.3 643.0 0.9 1.5 2.2 155.7 126.3 29.1 466.8 0.0 0.4 GFRA2 "GDNFRB, NTNRA, RETL2, TRNR2" ENSG00000168546 "GDNF family receptor alpha 2" O00451 8 21690398-21812357 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.5;thyroid gland: 8.8" "Group enriched" "Detected in some" 4 "Early spermatids: 91.9;Horizontal cells: 220.4;Late spermatids: 238.1" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 6.2" "Region enhanced" "Detected in many" "cerebral cortex: 5.6" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 9.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.5;monocytes: 9.2" "Cell line enhanced" "Detected in some" "HEL: 9.1;HMC-1: 21.4;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024704, CAB032791" Uncertain Approved Vesicles "Intracellular and membrane" NA NA 9000000 Vesicles "CAB032791: AB_2110428, HPA024704: AB_1849629" "unprognostic (4.24e-2)" "unprognostic (1.11e-2)" "unprognostic (4.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.93e-2)" "unprognostic (1.08e-2)" "unprognostic (7.48e-4)" "unprognostic (2.87e-1)" "unprognostic (6.11e-2)" "unprognostic (4.40e-3)" "unprognostic (2.11e-3)" "unprognostic (7.82e-2)" "unprognostic (1.50e-4)" "unprognostic (8.45e-4)" "unprognostic (1.74e-1)" "unprognostic (4.68e-2)" "unprognostic (9.63e-3)" 2.4 1.8 0.7 2.0 1.1 0.6 0.6 0.0 5.6 2.6 0.0 2.1 1.9 0.5 0.2 1.5 1.3 0.6 1.0 1.4 2.1 0.2 1.0 1.2 1.6 0.0 0.3 0.1 0.3 0.3 0.1 0.4 7.2 1.4 0.4 1.1 2.7 0.9 1.5 0.1 0.5 1.8 2.1 0.0 7.6 1.0 9.5 1.6 1.1 8.8 0.6 0.8 1.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.9 0.8 0.0 9.2 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.4 0.0 1.3 0.0 0.0 0.9 0.7 1.1 0.0 5.6 1.4 2.1 0.0 0.3 0.1 1.4 0.0 1.6 0.1 0.3 0.0 1.8 1.3 0.1 1.8 0.2 0.0 0.0 4.3 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 91.9 0.0 1.2 0.3 0.0 0.0 39.5 0.0 0.1 1.8 0.0 0.1 1.3 0.0 0.7 0.2 0.6 220.4 6.5 0.0 0.0 30.6 25.2 238.1 0.6 11.8 0.0 3.7 0.5 1.9 0.0 2.5 1.1 0.0 0.0 1.9 0.1 0.1 0.0 0.0 0.0 2.1 6.6 0.7 1.8 1.2 7.0 0.0 0.9 0.3 0.2 0.1 0.0 0.1 ING2 "ING1L, p33ING2" ENSG00000168556 "Inhibitor of growth family member 2" Q9H160 4 183505058-183512429 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019486, HPA021517" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA019486: AB_1851780, HPA021517: AB_10601914" "prognostic favorable (5.43e-4)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (3.74e-2)" "unprognostic (3.89e-3)" "unprognostic (4.56e-2)" "prognostic unfavorable (8.87e-4)" "unprognostic (7.47e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-3)" "unprognostic (1.65e-2)" "unprognostic (1.97e-1)" "unprognostic (2.30e-3)" "unprognostic (6.19e-2)" "unprognostic (4.43e-1)" "unprognostic (5.52e-2)" "unprognostic (7.82e-2)" 9.3 42.6 5.7 5.3 6.1 21.9 8.8 7.3 7.3 6.9 5.6 8.5 10.7 5.2 10.3 14.7 8.9 9.0 7.1 5.5 14.3 12.2 10.5 8.6 6.0 6.9 6.5 4.6 37.7 15.9 6.1 23.5 6.2 6.6 8.8 6.7 8.7 10.8 4.5 26.3 11.8 14.4 4.6 5.7 9.2 11.6 33.6 7.5 12.6 9.3 15.0 6.7 11.5 9.9 6.6 19.1 11.4 15.5 12.3 28.1 16.4 12.7 20.1 17.4 15.6 13.3 10.4 20.2 13.5 5.2 14.7 12.7 8.3 10.4 15.6 19.8 10.4 7.6 23.4 11.4 13.5 8.5 19.3 25.1 12.7 14.3 17.0 7.1 12.8 7.5 13.0 13.2 49.8 11.5 18.8 24.7 19.6 12.5 5.5 11.1 10.3 8.6 22.5 18.8 8.7 15.3 11.5 13.3 17.6 5.3 10.0 8.3 13.9 6.4 10.5 16.5 7.2 13.0 10.7 8.6 9.1 19.3 14.3 7.6 15.2 6.3 19.7 3.2 6.6 5.0 11.9 6.3 5.7 7.8 8.4 8.8 7.6 6.4 3.8 8.5 7.6 5.4 3.7 5.7 6.1 7.3 7.3 5.5 14.3 6.9 6.5 4.6 6.6 5.7 7.5 6.6 18.7 6.4 21.0 6.2 20.1 49.3 20.5 20.7 105.9 25.7 36.3 41.8 12.1 25.8 18.2 16.5 12.5 26.1 18.8 32.7 74.3 20.9 68.4 93.0 26.3 21.7 18.6 26.7 7.1 34.9 94.9 29.1 11.7 82.9 40.0 85.4 15.4 24.1 30.0 25.2 5.3 24.2 16.2 24.2 43.3 35.2 82.6 27.3 26.6 1.0 13.9 40.5 6.2 3.5 5.1 33.3 28.3 53.8 19.5 34.2 112.9 47.8 39.8 23.6 19.7 23.7 28.0 95.3 74.9 71.6 46.2 21.2 25.6 50.4 23.0 39.3 CDKN2AIP "CARF, FLJ20036" ENSG00000168564 "CDKN2A interacting protein" Q9NXV6 4 183444635-183449064 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 207.0;Glandular and luminal cells: 333.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 161.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041397, HPA062142" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041397: AB_10794297, HPA062142: AB_2684696" "unprognostic (9.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.52e-2)" "unprognostic (7.65e-3)" "unprognostic (6.70e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.93e-2)" "unprognostic (4.69e-2)" "unprognostic (2.25e-3)" "unprognostic (2.23e-2)" 10.7 11.8 10.5 12.0 11.0 38.3 15.7 13.8 13.5 12.1 10.2 14.4 19.2 15.8 12.5 22.4 11.9 13.0 10.4 10.6 11.5 18.5 17.7 11.3 20.0 10.5 10.9 9.9 22.8 18.6 15.5 11.5 14.0 10.9 12.9 13.8 13.2 12.9 13.1 9.0 11.7 17.5 9.8 11.6 14.4 18.0 20.3 11.1 24.2 13.7 14.3 18.9 11.9 12.4 12.7 14.4 8.1 23.2 16.8 19.0 14.0 17.7 23.9 19.9 23.9 16.0 11.9 13.5 47.1 4.9 16.1 10.0 11.3 21.0 17.3 25.1 19.4 12.6 49.7 39.4 15.9 14.8 37.3 19.5 16.3 15.6 14.3 18.7 12.6 19.1 18.0 25.1 50.4 16.5 7.8 41.6 30.5 17.0 5.5 16.2 36.1 11.2 19.5 161.1 13.5 23.9 20.7 17.2 72.0 29.9 14.9 10.5 32.0 11.0 8.5 12.3 7.9 19.6 24.4 10.9 25.0 13.3 31.4 13.9 61.0 8.0 18.6 14.4 9.7 14.9 12.2 17.4 15.4 7.7 14.1 22.6 20.8 9.7 15.0 10.3 5.2 19.2 14.6 10.5 11.0 13.8 13.5 10.6 11.5 10.5 10.9 9.9 10.9 11.6 11.1 12.7 49.6 16.0 33.1 3.6 58.9 35.9 38.5 9.1 130.3 21.2 35.5 40.1 18.9 17.2 24.2 16.5 10.4 21.8 51.8 36.4 17.6 12.5 150.8 207.0 48.9 33.5 30.4 32.0 5.8 15.5 14.7 38.8 62.2 333.9 62.1 29.7 16.4 13.5 15.7 21.9 5.8 25.5 20.3 12.6 24.2 70.5 21.1 25.7 21.4 7.5 13.2 24.3 22.6 7.5 9.9 17.6 21.1 17.3 47.2 31.5 37.8 13.1 28.8 21.2 13.1 60.8 37.5 36.6 40.3 124.7 39.8 18.7 55.3 22.4 33.3 60.9 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590198-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavorable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 5.2 3.8 5.3 5.5 5.3 10.5 6.9 8.8 6.1 6.8 4.9 5.4 5.7 6.5 4.6 4.8 5.7 4.0 7.0 5.2 5.1 6.0 7.4 4.5 7.3 5.8 5.3 4.8 7.7 5.7 3.8 3.6 5.3 6.5 5.8 5.6 7.3 5.4 4.4 9.8 6.4 6.8 5.4 5.2 6.2 5.5 2.8 5.4 7.1 5.8 7.2 5.9 5.6 5.9 6.2 10.0 7.9 16.2 30.3 8.5 12.5 10.9 11.2 10.4 12.0 13.1 16.9 8.1 23.6 11.8 9.4 11.5 12.6 20.2 12.1 18.2 18.2 19.8 17.0 24.1 32.7 8.9 20.5 10.9 8.8 18.3 13.5 10.2 14.2 10.5 20.8 24.1 3.6 16.8 5.7 33.7 29.6 21.9 17.1 8.8 35.8 13.9 31.6 10.8 8.7 25.0 6.8 21.8 5.6 19.6 29.7 10.9 7.2 11.8 15.8 7.1 9.5 19.6 5.8 34.6 14.5 5.3 16.1 28.9 0.1 0.7 0.4 0.7 0.5 1.2 0.6 0.8 0.9 0.9 1.1 0.7 1.3 2.3 1.1 0.3 1.0 0.7 0.6 5.3 5.3 8.8 6.1 5.2 5.1 5.8 5.3 4.8 6.5 5.2 5.4 6.2 18.6 19.2 10.3 8.1 15.7 35.7 20.2 13.6 12.0 18.7 12.6 14.6 32.1 15.7 17.3 9.2 20.9 16.3 22.7 19.2 11.7 18.0 2.5 18.0 14.8 20.5 11.4 17.7 20.4 20.1 15.6 18.0 8.2 19.6 24.1 16.8 20.3 23.4 15.9 5.0 18.8 18.2 0.0 15.1 22.1 2.5 17.7 14.9 8.8 13.1 21.7 15.5 19.6 14.6 23.8 12.1 17.9 16.6 11.5 21.4 27.1 20.1 8.5 17.8 6.6 20.9 23.2 16.1 17.0 11.5 34.0 16.3 18.5 11.2 17.1 20.1 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792006 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 12.4 21.1 10.7 9.5 11.8 6.4 12.9 12.5 13.5 12.8 10.7 13.7 11.1 13.0 9.7 13.4 11.8 5.5 22.3 10.5 10.6 17.2 22.6 11.2 12.1 11.7 10.5 11.2 11.5 20.0 8.0 13.3 7.2 12.4 15.0 7.5 5.3 15.5 7.3 16.3 13.1 14.6 5.3 10.0 16.7 15.5 6.8 10.6 7.3 13.9 8.6 7.0 12.3 11.2 11.1 29.2 24.4 14.3 19.6 11.8 13.5 19.5 15.3 13.4 16.9 14.1 21.5 34.9 21.6 36.8 11.1 22.5 43.3 17.3 18.9 9.6 34.7 32.5 16.1 26.9 25.9 20.6 20.0 18.4 14.4 18.8 11.2 13.9 20.3 13.9 28.2 24.8 15.8 12.6 42.3 20.3 44.3 28.2 30.2 29.2 24.7 17.3 48.8 26.8 18.3 24.3 32.0 16.0 32.3 43.0 14.5 48.1 18.4 13.9 20.2 24.4 18.7 18.5 32.1 27.5 25.1 24.0 17.8 21.5 21.0 41.3 25.0 71.3 46.2 68.8 77.6 69.8 69.9 46.8 81.8 74.9 73.0 19.0 66.2 29.8 75.6 66.8 41.5 10.7 11.8 12.5 13.5 10.5 10.6 11.7 10.5 11.2 12.4 10.0 10.6 11.1 31.9 12.8 5.6 4.2 24.1 13.5 15.3 39.7 8.6 17.9 27.6 45.0 18.8 52.9 25.2 20.2 12.5 49.4 22.8 30.2 62.6 37.2 2.6 29.1 26.9 28.9 20.5 18.5 6.1 44.3 42.9 22.0 15.3 22.3 19.7 22.4 31.8 36.0 37.6 6.7 8.0 32.6 38.7 20.1 13.6 3.4 32.6 16.2 19.6 4.7 16.2 16.5 35.0 6.0 5.7 36.1 19.3 26.4 25.4 22.4 32.1 52.3 39.6 18.0 19.7 22.3 17.9 6.9 19.7 21.3 13.9 14.2 24.3 34.2 43.4 17.1 SLC20A2 "Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1" ENSG00000168575 "Solute carrier family 20 member 2" Q08357 8 42416475-42541926 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.5" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 132.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026540 Approved NA NA "HPA026540: AB_1855408" "prognostic unfavorable (7.67e-4)" "unprognostic (3.22e-1)" "unprognostic (3.24e-2)" "unprognostic (2.27e-2)" "unprognostic (2.12e-2)" "unprognostic (2.95e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.95e-1)" "unprognostic (7.62e-2)" "unprognostic (2.06e-1)" "unprognostic (3.43e-2)" "prognostic favorable (1.01e-4)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (5.86e-2)" "unprognostic (4.95e-2)" 11.7 8.1 34.4 9.9 43.1 3.1 12.2 56.5 37.4 12.6 112.9 23.0 47.1 18.6 10.0 33.0 24.7 15.2 63.7 30.1 46.1 17.7 40.0 15.2 6.5 46.4 54.9 27.3 8.2 52.0 15.1 10.6 13.6 51.1 13.7 19.2 7.6 88.7 17.8 132.5 23.0 19.0 18.1 42.2 7.5 15.3 16.1 58.1 12.0 83.6 58.2 9.2 22.3 21.9 52.6 52.7 14.3 19.0 16.0 10.4 8.8 41.1 46.9 80.8 23.9 58.7 38.9 132.9 17.4 53.6 42.1 13.5 81.1 11.4 45.2 41.6 4.3 8.7 27.8 4.8 22.0 14.9 9.9 12.3 9.5 40.2 24.7 22.7 16.7 12.0 13.7 27.2 14.0 47.3 14.4 18.1 16.1 19.2 50.5 8.8 14.9 20.9 18.5 21.4 47.5 5.1 19.2 12.8 21.8 12.8 15.0 17.5 17.3 34.9 50.0 17.4 12.3 25.7 9.0 22.2 12.6 15.8 19.5 28.3 3.2 2.2 0.2 3.6 1.6 4.3 2.1 4.0 3.5 3.7 2.1 4.8 3.7 0.8 6.8 1.3 2.0 4.1 3.1 34.4 43.1 56.5 37.4 30.1 46.1 46.4 54.9 27.3 51.1 42.2 58.1 52.6 11.1 28.9 18.6 51.6 9.1 98.9 250.2 22.7 96.2 13.4 21.7 14.9 60.2 14.3 21.7 16.5 16.7 23.9 14.3 76.2 13.7 29.6 10.4 79.9 15.8 18.9 12.0 6.9 88.9 31.4 23.7 15.8 15.8 61.2 3.8 17.1 6.4 30.7 10.2 6.7 88.4 11.5 18.3 7.7 12.2 10.0 7.2 10.2 10.6 78.7 7.3 14.4 14.4 63.3 151.7 47.4 35.8 11.7 8.6 76.6 20.0 7.3 57.6 10.2 6.6 22.9 28.3 5.2 7.2 73.9 74.3 25.4 14.2 23.7 12.5 170.3 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163589 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.7 0.6 0.5 0.3 0.3 0.4 0.3 0.3 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNLRB2 "DNCL2B, DNLC2B, ROBLD2" ENSG00000168589 "Dynein light chain roadblock-type 2" Q8TF09 16 80540734-80550811 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 61.3;testis: 228.9" "Cell type enhanced" "Detected in many" "Early spermatids: 2380.9;Late spermatids: 965.0;Respiratory ciliated cells: 523.6;Spermatocytes: 706.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;MCF7: 5.6;RPTEC TERT1: 2.8;SCLC-21H: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.41e-2)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.91e-5)" "unprognostic (2.29e-2)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (1.17e-1)" "unprognostic (1.05e-3)" "unprognostic (1.41e-1)" "unprognostic (8.82e-3)" "unprognostic (1.73e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-4)" "unprognostic (1.55e-4)" 0.8 2.5 9.8 0.5 5.9 0.0 3.4 6.9 7.6 1.7 11.8 0.6 0.4 1.3 18.0 1.0 61.3 1.9 0.5 5.2 11.9 5.1 1.0 6.2 0.4 12.2 9.9 4.3 1.3 1.2 4.6 4.3 0.9 10.0 2.2 0.2 4.2 1.1 2.8 0.3 1.8 0.5 0.3 10.9 0.3 0.7 228.9 7.0 0.9 3.3 0.4 0.6 0.9 0.6 9.8 0.1 0.0 0.3 0.0 0.7 0.5 0.1 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 5.6 0.0 0.0 0.1 0.2 1.1 0.1 0.0 0.0 2.8 0.7 1.7 0.2 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.3 0.2 0.4 0.3 0.0 0.1 0.6 1.3 1.8 0.5 0.0 1.3 1.3 0.2 9.8 5.9 6.9 7.6 5.2 11.9 12.2 9.9 4.3 10.0 10.9 7.0 9.8 0.7 3.2 7.4 4.2 0.2 5.1 4.5 25.9 5.2 1.0 9.8 12.6 0.2 2.8 32.0 1.8 0.0 3.0 0.1 0.4 35.2 5.9 2380.9 274.1 2.8 2.0 3.0 0.0 2.5 1.5 0.7 2.7 0.0 5.1 7.6 1.1 1.1 0.8 0.6 0.0 2.3 1.3 30.5 0.8 0.3 965.0 19.6 2.3 0.0 1.0 3.1 23.9 1.0 0.5 1.5 1.2 0.1 15.4 0.5 2.7 0.3 44.7 523.6 2.6 13.1 0.5 7.8 706.2 22.1 0.8 2.8 3.4 0.9 2.9 0.2 3.0 TMUB2 MGC3123 ENSG00000168591 "Transmembrane and ubiquitin like domain containing 2" Q71RG4 17 44186970-44191929 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043137 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043137: AB_10794388" "unprognostic (4.57e-2)" "unprognostic (1.58e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-2)" "unprognostic (6.37e-2)" "unprognostic (1.85e-2)" "unprognostic (6.43e-3)" "unprognostic (1.07e-1)" "unprognostic (2.05e-1)" "unprognostic (3.35e-2)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "unprognostic (9.75e-3)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.78e-3)" 32.1 36.0 31.8 23.1 32.1 44.3 32.7 32.4 38.4 36.4 30.3 37.5 24.7 32.8 22.1 37.6 34.2 25.5 31.3 31.9 32.7 37.1 36.1 31.7 26.6 31.4 31.6 32.4 35.5 37.2 27.7 33.2 26.1 30.9 42.3 22.1 17.0 36.4 26.5 32.9 32.0 36.8 21.9 29.9 53.2 37.0 47.1 31.4 23.4 43.0 20.2 20.7 35.6 34.6 32.0 22.8 43.0 27.6 25.1 41.6 32.8 21.6 29.5 31.6 53.7 54.4 22.7 41.5 15.8 31.1 36.1 40.5 42.3 19.3 28.0 33.4 38.7 39.7 16.5 40.9 35.1 43.8 18.7 35.5 40.1 39.8 36.9 22.9 45.1 37.8 25.8 19.2 45.4 35.7 15.9 26.0 23.8 9.1 19.0 35.7 23.2 33.3 25.5 33.8 25.2 21.8 22.2 15.5 14.4 29.4 27.6 42.2 23.0 31.8 44.4 27.0 31.1 26.7 33.5 26.1 15.4 34.0 15.7 30.4 84.1 30.0 57.3 17.1 26.7 14.5 16.6 14.3 16.5 19.1 23.8 13.4 15.3 65.4 13.9 29.0 23.1 18.1 20.4 31.8 32.1 32.4 38.4 31.9 32.7 31.4 31.6 32.4 30.9 29.9 31.4 32.0 24.8 35.3 25.9 21.2 40.8 13.0 21.2 27.0 25.6 30.8 29.8 25.3 16.7 22.8 27.2 22.0 31.3 46.3 24.9 42.5 3.9 21.0 51.0 13.9 16.8 20.4 33.5 25.7 15.8 18.8 29.6 22.0 23.0 25.1 22.1 25.6 18.9 13.9 42.6 21.9 16.4 27.1 12.2 37.9 25.9 28.4 21.8 30.9 14.2 16.9 31.5 29.1 25.7 14.6 12.2 25.8 33.2 24.0 18.8 20.5 39.6 10.7 18.9 27.9 26.3 14.6 19.6 81.5 37.1 17.2 14.9 96.7 27.6 30.0 27.0 23.4 ADAM29 "CT73, svph1" ENSG00000168594 "ADAM metallopeptidase domain 29" Q9UKF5 4 174829668-174978180 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 41.5" "Group enriched" "Detected in some" 25 "Early spermatids: 429.2;Late spermatids: 280.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.40e-3)" "unprognostic (2.03e-2)" "unprognostic (4.72e-3)" "unprognostic (4.93e-2)" "unprognostic (1.16e-6)" "unprognostic (1.35e-1)" "unprognostic (1.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 429.2 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 280.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STAT3 APRF ENSG00000168610 "Signal transducer and activator of transcription 3" P40763 17 42313324-42388540 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001671, CAB003859, HPA058603, CAB068241, CAB068242" Supported Supported Nucleoplasm,Cytosol NA NA 55000 "Nucleoplasm, Cytosol" "CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772" "unprognostic (1.83e-2)" "unprognostic (2.42e-1)" "unprognostic (9.23e-3)" "unprognostic (2.91e-1)" "unprognostic (5.59e-3)" "unprognostic (1.78e-2)" "unprognostic (8.26e-2)" "unprognostic (1.51e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-1)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (6.47e-3)" "unprognostic (7.75e-3)" "unprognostic (2.21e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" 97.1 68.7 30.5 79.2 32.2 63.8 85.2 38.3 29.5 62.5 34.9 71.2 46.4 72.2 28.4 82.2 74.6 72.3 88.5 27.0 71.8 61.8 144.3 106.9 55.7 46.9 37.4 24.2 66.0 67.9 35.6 53.8 56.0 41.3 63.4 46.9 30.2 64.0 48.7 125.0 66.0 68.6 72.7 41.8 68.6 62.8 24.8 40.7 51.0 62.4 92.9 65.7 89.4 64.9 42.4 61.5 116.0 47.4 48.2 103.7 97.6 35.4 66.5 89.7 59.6 58.3 30.3 55.8 18.5 68.2 71.2 90.3 89.2 45.8 72.6 47.7 160.6 31.4 131.2 60.4 62.4 77.3 31.8 79.0 152.1 69.8 47.4 68.9 62.2 81.1 33.4 80.1 56.4 40.1 43.8 118.7 31.3 28.5 63.4 0.0 26.6 133.8 28.1 91.3 77.2 45.2 29.8 81.4 184.9 29.2 57.2 100.5 49.1 68.7 88.9 44.9 54.8 56.5 82.9 75.3 16.4 56.1 32.8 41.6 121.1 78.4 100.0 79.5 79.9 64.4 40.2 57.5 62.6 54.3 36.6 58.7 56.5 262.6 58.3 80.8 29.3 47.9 124.5 30.5 32.2 38.3 29.5 27.0 71.8 46.9 37.4 24.2 41.3 41.8 40.7 42.4 216.0 93.0 173.7 46.0 111.6 129.5 105.3 76.8 138.3 92.6 147.1 113.0 59.7 54.3 103.2 134.3 281.5 25.2 115.1 148.9 17.6 83.2 33.5 129.3 187.0 164.7 124.0 54.3 24.2 96.8 38.2 154.0 109.1 153.9 142.0 86.3 115.3 115.7 69.1 25.2 35.8 97.8 69.2 71.0 121.7 13.7 71.7 111.7 72.9 51.5 94.1 131.3 78.2 30.7 41.7 82.9 94.5 60.9 104.6 147.9 206.4 46.3 88.5 406.7 65.7 189.5 169.7 31.5 15.3 93.4 160.1 31.2 170.2 102.3 117.5 90.6 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041147: AB_2677329, HPA046751: AB_2679785" "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 3.0 4.1 2.6 3.7 2.5 6.1 3.6 4.3 3.1 3.2 2.6 4.2 4.6 3.5 3.6 3.5 4.2 3.2 4.9 2.6 2.2 3.6 1.9 3.3 5.1 2.7 2.5 2.8 5.9 4.2 4.9 1.1 4.0 3.1 4.1 3.5 8.2 4.9 3.5 16.0 6.6 4.5 3.5 1.7 4.7 4.3 3.8 2.5 4.0 4.5 5.1 5.0 3.5 1.4 2.9 7.2 8.6 6.4 7.8 11.2 6.3 6.5 4.8 5.9 10.2 9.3 19.5 8.4 8.4 13.9 6.7 11.2 17.0 10.1 12.9 7.7 3.4 6.1 10.7 11.5 14.0 6.8 9.2 10.9 9.2 10.6 8.6 8.2 7.8 7.9 7.3 9.8 6.7 6.0 20.8 10.0 7.9 3.6 8.1 9.7 7.8 9.1 6.0 6.7 10.1 8.6 5.5 16.2 24.0 5.8 5.7 14.6 7.2 7.0 11.5 7.3 6.4 7.0 6.6 5.0 8.2 9.2 6.8 6.0 2.4 1.4 3.6 0.5 1.8 0.3 2.4 1.7 0.7 0.7 2.2 2.3 2.1 1.6 0.6 1.8 2.2 1.4 0.8 2.6 2.5 4.3 3.1 2.6 2.2 2.7 2.5 2.8 3.1 1.7 2.5 2.9 0.8 3.2 2.7 0.7 1.4 1.1 2.4 2.4 2.2 3.0 0.8 0.5 5.7 4.3 1.2 0.0 0.0 2.9 0.3 4.2 3.9 2.4 0.6 1.1 1.7 1.7 2.4 4.4 0.8 3.8 2.8 1.9 4.1 1.5 3.8 2.5 2.5 2.1 1.7 6.7 0.9 2.8 2.0 1.4 1.9 0.7 3.4 0.7 0.0 0.0 1.8 1.6 1.0 0.0 0.8 3.3 3.7 1.5 0.5 1.6 2.4 1.2 0.4 3.8 0.0 2.0 1.8 1.0 2.0 1.4 1.6 2.3 1.8 3.6 3.0 2.0 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996754-39105445 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 179.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" NA NA 740000 Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavorable (1.14e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 33.4 28.2 7.2 29.1 7.5 2.1 21.7 8.4 9.2 35.1 10.7 33.2 24.7 29.9 15.3 29.9 19.4 47.5 28.9 5.9 14.3 35.2 13.6 51.8 9.8 10.2 7.1 5.3 17.0 12.8 52.9 7.9 47.8 8.8 35.2 42.2 18.7 55.3 35.1 24.3 15.1 23.2 52.1 9.4 24.2 44.6 11.2 9.3 5.9 40.3 25.2 13.3 56.7 24.5 10.6 188.3 163.6 63.5 32.6 117.2 374.0 67.0 259.6 382.4 191.7 177.9 82.7 147.1 10.1 86.1 247.2 156.7 79.5 30.8 249.7 373.2 6.9 21.5 12.1 102.8 73.0 226.4 8.9 19.1 287.5 139.2 193.3 212.7 341.0 268.9 15.2 21.5 53.2 406.2 25.0 7.2 4.4 8.3 175.2 46.7 3.8 106.3 27.6 299.3 62.4 6.4 11.5 78.4 90.9 57.8 72.9 67.3 12.0 374.2 109.9 97.9 213.9 124.1 12.9 29.5 7.7 175.8 12.0 72.1 0.3 4.0 0.5 0.1 1.3 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.1 0.5 0.8 0.6 0.3 0.1 0.9 7.2 7.5 8.4 9.2 5.9 14.3 10.2 7.1 5.3 8.8 9.4 9.3 10.6 14.4 48.1 37.0 16.0 3.8 35.9 66.6 78.3 26.7 19.3 23.4 9.8 49.7 24.3 82.1 35.0 20.9 24.1 8.9 44.4 3.9 90.2 14.4 42.1 35.3 20.5 10.7 2.5 47.5 115.4 85.1 42.0 80.5 82.1 5.1 26.4 25.0 7.5 125.9 5.0 38.0 32.2 44.7 60.2 44.8 7.8 28.6 54.7 21.4 33.7 21.8 17.5 1.0 30.7 26.7 179.4 30.6 24.8 5.2 108.7 24.9 41.1 51.9 25.1 13.1 31.3 31.9 4.3 2.5 20.2 21.5 34.3 5.6 11.2 32.7 103.8 ADAM18 "ADAM27, tMDCIII" ENSG00000168619 "ADAM metallopeptidase domain 18" Q9Y3Q7 8 39584489-39730065 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 9.3" "Cell type enhanced" "Detected in some" "Early spermatids: 63.5;Late spermatids: 26.8;Spermatocytes: 141.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.10e-4)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 63.5 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 26.8 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 141.1 3.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37840041 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 10.2" "Cell type enhanced" "Detected in some" "Fibroblasts: 3.3;Skeletal myocytes: 11.5;Spermatogonia: 3.4;Theca cells: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 41.4;SuSa: 12.6;U-87 MG: 12.6;WM-115: 46.5" "Region enhanced" "Detected in single" "basal ganglia: 2.8" "Low region specificity" "Detected in some" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: AB_2686246" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 0.1 0.4 1.8 1.6 1.8 0.1 0.3 5.4 1.1 0.7 0.0 6.2 1.4 1.3 2.5 1.0 1.0 0.9 0.5 0.5 1.4 0.9 0.7 0.0 0.1 0.7 3.2 0.6 3.7 0.0 0.0 0.1 5.1 1.2 1.3 2.5 0.3 0.2 4.6 10.2 1.3 2.0 2.1 0.3 0.4 1.6 0.4 6.3 0.1 0.1 4.4 0.0 0.7 0.8 2.8 0.0 0.0 0.1 0.1 1.8 1.0 0.0 5.5 3.4 1.1 1.6 0.0 0.1 0.1 0.0 7.4 0.1 0.2 0.0 0.1 2.2 0.0 0.2 0.0 0.4 0.5 0.2 0.1 0.1 1.8 0.1 41.4 0.0 1.4 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.1 0.4 0.1 0.0 0.1 9.0 0.0 0.0 0.2 0.5 0.0 0.3 0.2 2.7 12.6 0.1 0.0 0.0 5.5 0.0 1.4 6.2 4.0 0.0 0.0 12.6 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.8 5.4 1.1 0.5 1.4 0.7 3.2 0.6 1.2 0.3 6.3 2.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.6 0.6 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.1 3.3 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.7 0.1 0.0 0.0 11.5 1.8 0.9 3.4 0.0 0.3 0.1 0.0 2.6 0.0 0.5 MUCL3 "bCX105N19.6, C6orf37, DPCR1, PBLT" ENSG00000168631 "Mucin like 3" Q3MIW9 6 30934523-30954221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "stomach 1: 204.7" "Cell type enriched" "Detected in some" 20 "Pancreatic endocrine cells: 239.5" "Group enriched" "Detected in some" 9 "pancreatic cancer: 56.8;stomach cancer: 55.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA014036 Enhanced NA NA "HPA014036: AB_1847841" "unprognostic (2.81e-1)" "unprognostic (4.49e-2)" "unprognostic (9.13e-4)" "unprognostic (6.74e-2)" "unprognostic (4.29e-2)" "unprognostic (8.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.79e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (4.76e-2)" "unprognostic (9.80e-2)" "unprognostic (3.20e-2)" "unprognostic (3.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 0.0 10.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 204.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 239.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 WFDC13 "C20orf138, dJ601O1.3, WAP13" ENSG00000168634 "WAP four-disulfide core domain 13" Q8IUB5 20 45702038-45708817 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "epididymis: 90.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.53e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-3)" "unprognostic (7.96e-3)" "unprognostic (2.04e-1)" "unprognostic (1.02e-11)" "unprognostic (1.17e-1)" "unprognostic (1.44e-2)" "unprognostic (2.22e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 90.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561648 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 33.7;Extravillous trophoblasts: 102.6" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 27.2;CACO-2: 52.3;Hep G2: 78.8;OE19: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favorable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 6.5 11.0 6.8 5.4 7.2 0.9 5.4 9.6 8.3 14.3 4.7 12.4 7.1 24.1 6.0 5.9 20.0 6.7 7.6 9.9 6.2 2.8 2.7 17.1 3.5 8.7 9.1 5.3 15.1 4.2 4.3 6.3 18.6 9.5 14.1 14.7 3.4 5.2 9.0 14.7 15.0 7.5 17.4 7.1 7.5 13.7 6.8 9.5 17.5 12.4 7.9 2.7 11.5 8.0 5.4 0.0 13.9 27.2 0.5 9.6 4.1 12.0 0.4 1.3 0.9 1.7 52.3 5.0 1.0 1.7 8.0 1.0 0.4 5.7 0.1 1.9 2.4 3.1 0.0 2.4 78.8 1.0 0.1 0.1 2.4 2.1 2.2 0.6 1.6 2.4 5.1 0.2 1.2 1.4 0.3 13.9 0.1 5.3 86.9 0.6 9.9 1.6 0.1 2.6 0.3 8.4 5.5 0.5 0.3 4.8 20.0 1.0 0.3 6.3 5.3 9.6 7.6 1.7 0.1 3.0 3.8 2.5 0.6 2.6 3.2 0.0 0.0 0.1 0.0 0.4 0.5 1.1 0.2 0.0 1.8 2.3 0.4 0.0 1.0 0.0 0.0 0.0 0.3 6.8 7.2 9.6 8.3 9.9 6.2 8.7 9.1 5.3 9.5 7.1 9.5 5.4 2.4 0.0 9.0 9.8 1.0 11.2 2.2 1.0 11.4 3.7 5.2 8.1 8.7 1.5 8.1 0.0 4.2 18.1 0.7 15.2 0.0 1.4 33.7 7.8 15.1 5.3 5.4 0.0 8.4 0.9 102.6 10.3 5.6 16.5 0.0 3.1 1.1 2.0 3.8 1.7 8.7 17.4 0.0 0.0 7.5 17.5 6.5 0.6 17.8 9.4 1.0 3.3 0.0 8.0 2.0 0.8 18.9 10.9 0.9 2.9 1.9 0.9 1.3 2.5 13.1 1.6 10.6 6.2 12.9 3.3 5.5 14.2 4.6 3.6 19.8 1.3 NDUFS5 CI-15k ENSG00000168653 "NADH:ubiquinone oxidoreductase subunit S5" O43920 1 39026318-39034636 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2057.9;Proximal tubular cells: 1739.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042582 Supported NA NA "HPA042582: AB_2678062" "unprognostic (1.49e-2)" "unprognostic (2.62e-2)" "unprognostic (3.58e-1)" "unprognostic (1.41e-2)" "unprognostic (5.00e-2)" "unprognostic (2.93e-2)" "unprognostic (2.97e-3)" "unprognostic (8.96e-2)" "unprognostic (7.31e-2)" "prognostic favorable (3.54e-4)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.87e-3)" "unprognostic (2.88e-1)" "unprognostic (2.52e-3)" "unprognostic (8.08e-2)" 317.5 376.0 595.2 186.1 598.4 268.4 299.4 587.9 837.2 244.8 573.3 408.9 222.1 318.1 570.2 366.2 268.0 168.6 1123.6 602.8 595.7 399.5 382.4 238.9 178.3 603.4 592.0 589.5 307.4 236.1 357.3 335.9 171.6 599.2 294.9 345.6 208.5 276.4 302.3 961.8 276.4 242.5 261.7 580.0 186.7 342.7 122.2 599.3 242.3 252.6 1125.5 247.6 325.1 276.2 623.4 447.7 781.3 548.2 698.8 593.9 622.8 749.7 501.6 406.3 488.6 490.3 868.9 596.3 469.0 700.2 541.6 248.9 308.9 732.5 688.3 543.1 546.2 856.8 491.8 1291.1 1622.7 407.4 1015.6 366.8 650.5 816.8 537.4 476.0 497.3 858.3 500.8 817.0 430.9 250.4 1030.4 468.4 1291.3 1000.5 654.5 785.8 648.7 815.5 806.7 1027.9 1482.9 741.7 710.6 583.9 773.6 712.8 1174.2 520.2 753.1 545.7 390.9 463.1 409.8 874.3 353.5 770.5 732.6 449.7 1110.5 567.4 186.2 264.6 159.6 227.6 293.9 262.8 196.4 353.2 268.4 275.3 158.3 359.9 316.3 51.7 205.9 282.5 340.5 361.7 341.2 595.2 598.4 587.9 837.2 602.8 595.7 603.4 592.0 589.5 599.2 580.0 599.3 623.4 260.1 166.7 196.0 16.6 197.1 460.9 390.6 958.6 187.2 128.6 337.9 400.8 2057.9 391.7 407.6 551.8 37.5 638.9 248.2 570.5 1367.6 581.1 134.7 487.4 454.0 288.4 407.8 230.8 17.0 543.4 647.0 377.8 246.2 508.5 209.8 544.6 271.6 638.8 545.9 99.3 18.7 652.0 539.1 298.1 385.5 121.4 351.9 297.5 457.2 10.3 361.8 307.3 207.0 13.6 24.0 609.1 517.7 422.8 247.6 484.1 576.2 1739.7 343.3 180.6 282.7 417.4 450.5 121.8 99.2 418.8 460.3 525.2 292.2 275.9 697.1 454.2 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 22.5;testis: 30.2" "Group enriched" "Detected in many" 5 "Early spermatids: 467.1;Late spermatids: 995.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "hippocampal formation: 7.1" "Low region specificity" "Detected in all" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036700: AB_2675261, HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 3.7 0.0 1.9 0.0 0.0 1.9 0.8 0.5 4.0 0.1 0.0 0.2 0.0 0.0 22.5 0.0 0.0 1.1 3.4 0.0 0.0 2.5 0.0 5.6 4.5 0.2 0.2 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 30.2 2.5 0.7 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.9 0.8 1.1 3.4 5.6 4.5 0.2 3.6 6.5 2.5 2.9 0.3 0.0 1.1 11.8 0.1 0.3 1.7 2.2 0.0 1.0 0.1 0.3 0.9 0.0 12.1 1.8 31.3 0.0 0.0 0.8 0.0 0.0 467.1 53.8 0.6 0.6 1.8 0.0 1.9 0.4 0.2 0.8 4.6 1.6 0.0 0.1 1.1 0.0 0.2 0.0 1.0 2.8 6.1 0.0 0.8 995.9 4.7 0.7 0.0 3.7 0.6 0.7 0.0 1.5 0.7 0.2 2.7 5.7 0.2 0.4 0.2 0.0 124.5 0.5 0.0 0.5 1.0 17.6 6.0 0.0 0.4 0.0 0.1 0.2 1.0 0.8 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 15.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 15.4;Horizontal cells: 13.5;Inhibitory neurons: 13.2;Oligodendrocytes: 15.6;Rod photoreceptor cells: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 2.1 2.9 4.8 1.4 5.4 0.5 2.6 8.4 6.0 2.5 3.0 2.4 2.0 2.1 1.5 1.9 3.0 1.2 2.4 4.8 4.5 2.4 3.6 2.7 2.7 4.8 4.7 4.9 2.4 3.7 3.0 3.3 1.6 5.5 3.3 2.0 15.7 2.3 2.2 2.7 2.6 2.4 2.3 4.2 3.7 2.3 2.5 4.5 1.8 2.1 2.8 2.5 2.3 2.3 6.0 3.4 7.3 3.1 7.8 5.3 3.3 0.1 3.2 2.2 2.9 3.2 5.3 1.1 0.0 4.2 2.2 1.1 2.0 9.0 4.6 3.6 0.0 4.3 2.4 4.2 4.1 2.5 3.3 2.2 2.9 4.0 2.7 3.9 1.1 4.6 6.5 8.0 0.0 4.6 2.5 2.4 1.4 4.3 8.2 3.8 3.1 2.4 0.7 2.2 2.9 4.0 5.8 0.0 0.1 2.9 3.2 3.0 0.8 3.4 6.1 3.2 2.2 4.4 2.1 11.1 0.9 1.2 0.0 3.6 1.8 0.1 0.1 3.1 0.3 3.1 2.2 2.5 1.4 0.9 1.3 4.7 4.9 0.0 4.7 0.0 0.8 2.7 1.3 4.8 5.4 8.4 6.0 4.8 4.5 4.8 4.7 4.9 5.5 4.2 4.5 6.0 3.6 0.0 1.1 8.8 1.3 0.4 0.4 0.5 1.8 6.4 1.2 0.9 3.6 0.0 0.4 1.8 6.2 0.1 2.6 0.1 3.9 1.1 0.6 1.0 2.5 3.6 1.2 6.1 15.4 1.3 0.5 1.4 2.0 0.9 5.7 2.4 5.0 1.0 0.8 13.5 13.2 1.2 0.0 1.9 0.3 0.8 2.1 0.5 1.8 3.7 0.3 4.4 6.2 9.0 15.6 1.0 0.7 2.2 1.0 0.5 0.5 1.4 2.5 11.5 0.0 1.4 1.5 2.7 2.6 1.2 0.1 0.0 2.3 2.1 1.5 0.4 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035021-36071358 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.5;lymphoid tissue: 14.8;skin 1: 10.4" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0" "Low region specificity" "Detected in many" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.0 0.8 0.1 0.0 0.1 6.5 1.1 0.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 2.7 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.1 0.9 0.2 1.2 0.4 0.0 0.1 0.1 0.0 0.1 10.4 0.0 0.0 0.1 1.2 0.1 2.9 0.5 14.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.8 0.0 0.1 0.0 0.0 0.3 0.4 0.0 1.3 0.0 0.5 6.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 12.4 0.0 5.3 0.0 0.0 29.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 7.2 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.2 0.9 0.4 0.0 1.2 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 1.1 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 LRATD2 "BCMP101, FAM84B, NSE2" ENSG00000168672 "LRAT domain containing 2" Q96KN1 8 126552443-126558478 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 44.1" "Cell type enhanced" "Detected in some" "Adipocytes: 20.9;Cardiomyocytes: 6.8;Cytotrophoblasts: 5.4;Endothelial cells: 4.0;Syncytiotrophoblasts: 2.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 78.5;AN3-CA: 104.6;MCF7: 112.1;PC-3: 72.5;SuSa: 162.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050782, HPA062115" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA050782: AB_2681235, HPA062115: AB_2684686" "unprognostic (2.46e-3)" "unprognostic (6.37e-2)" "unprognostic (7.36e-2)" "prognostic unfavorable (9.71e-4)" "unprognostic (2.75e-3)" "unprognostic (1.54e-1)" "unprognostic (1.79e-1)" "unprognostic (4.52e-2)" "unprognostic (1.32e-1)" "unprognostic (4.49e-2)" "unprognostic (2.42e-3)" "unprognostic (1.07e-2)" "prognostic favorable (1.96e-8)" "unprognostic (2.04e-3)" "unprognostic (1.58e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.75e-5)" 6.0 2.6 6.0 3.2 7.1 3.1 16.5 8.7 5.3 7.4 22.1 7.7 13.2 7.4 6.8 19.6 8.4 8.2 4.1 5.8 13.3 27.6 8.2 12.1 3.8 8.8 7.4 3.8 3.0 16.4 9.3 4.5 7.5 6.9 8.4 8.3 19.3 44.1 6.9 2.5 6.9 7.4 4.7 8.0 3.2 17.8 2.1 6.5 3.3 7.5 5.3 6.3 6.5 5.8 13.2 78.5 9.8 5.8 104.6 0.0 0.0 6.9 1.1 2.7 0.8 1.2 3.0 44.9 0.0 48.5 0.2 8.4 34.3 3.1 14.7 1.3 0.1 63.0 0.0 0.2 0.5 1.4 0.1 1.6 0.6 20.3 0.0 9.0 17.6 6.3 19.7 0.1 0.0 0.5 112.1 2.6 0.0 5.3 65.7 72.5 0.0 2.3 0.8 41.8 32.5 29.7 0.0 2.4 34.9 32.4 162.9 52.0 0.7 0.0 0.3 9.4 0.1 2.0 1.3 0.2 0.1 0.9 5.0 19.6 1.7 0.0 1.5 1.4 0.0 1.4 0.3 1.8 2.7 0.0 0.8 2.0 2.1 0.1 1.1 0.0 0.0 2.6 0.9 6.0 7.1 8.7 5.3 5.8 13.3 8.8 7.4 3.8 6.9 8.0 6.5 13.2 20.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 5.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 2.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 1.5 0.0 0.0 0.0 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 338.9;Inhibitory neurons: 308.5;Late spermatids: 231.5;Microglial cells: 429.1;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 284.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 35.3;JURKAT: 37.4;MOLT-4: 131.3;REH: 31.6;U-698: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles NA NA Vesicles "HPA047633: , HPA065246: AB_2685444" "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 6.5 4.4 17.9 7.4 40.5 9.8 6.4 35.4 23.3 7.5 35.3 5.0 6.1 12.5 0.9 3.9 11.4 4.6 12.5 12.1 19.0 2.8 10.4 4.7 6.5 46.8 34.8 8.1 2.4 3.4 2.9 6.9 6.2 48.0 8.6 2.1 7.1 3.0 5.4 15.5 3.8 7.2 5.8 26.6 5.7 5.1 9.2 35.8 49.7 4.4 9.6 3.8 5.4 5.4 39.3 0.2 0.3 1.4 0.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.7 1.6 0.8 0.4 0.0 0.0 0.0 17.1 1.7 35.3 7.0 1.2 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.4 37.4 0.4 0.7 0.0 2.6 131.3 1.1 2.9 0.3 8.9 31.6 0.1 1.2 0.0 1.1 2.4 3.9 0.5 2.2 0.0 1.9 3.8 4.7 2.4 1.3 11.5 0.2 1.9 5.6 0.4 26.1 0.0 6.9 6.4 12.8 7.0 2.1 6.5 7.7 5.7 5.2 5.8 5.6 3.9 4.4 8.2 7.6 12.1 9.1 8.5 5.9 3.4 4.5 17.9 40.5 35.4 23.3 12.1 19.0 46.8 34.8 8.1 48.0 26.6 35.8 39.3 19.4 3.2 4.7 143.3 79.2 10.5 2.7 0.8 0.0 5.4 26.0 16.9 18.4 0.0 5.0 1.8 70.9 0.6 21.0 6.8 1.9 5.1 135.2 16.3 22.0 16.6 58.7 7.6 338.9 3.6 0.7 16.5 13.3 7.8 23.5 7.6 25.0 24.4 21.1 0.0 308.5 9.1 2.0 27.4 160.5 231.5 11.1 56.2 14.2 429.1 13.6 4.7 3.1 318.7 284.9 0.7 2.6 24.5 11.7 13.5 15.6 2.3 13.7 18.7 6.6 2.3 9.7 5.4 4.9 0.4 7.7 1.6 66.0 0.2 8.8 3.2 KCTD19 FLJ40162 ENSG00000168676 "Potassium channel tetramerization domain containing 19" Q17RG1 16 67289428-67326760 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 33.2" "Group enriched" "Detected in some" 8 "Early spermatids: 49.2;Spermatocytes: 72.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.6;neutrophil: 2.9;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 2.9" "Cell line enhanced" "Detected in some" "JURKAT: 6.4;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049310, HPA053321" Uncertain NA NA "HPA049310: AB_2680706, HPA053321: AB_2682110" "unprognostic (2.44e-1)" "unprognostic (2.14e-2)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.60e-2)" "unprognostic (9.01e-2)" "unprognostic (9.32e-2)" "unprognostic (1.75e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-4)" "unprognostic (4.44e-1)" "unprognostic (2.76e-3)" "unprognostic (1.19e-2)" "unprognostic (2.91e-2)" "unprognostic (9.71e-2)" "unprognostic (8.44e-2)" 0.1 0.0 2.2 0.8 3.0 3.3 0.1 3.3 3.3 0.2 0.8 0.1 0.3 0.5 1.3 0.5 0.4 0.8 0.0 2.5 1.8 0.2 0.1 0.2 0.1 3.7 2.4 2.0 0.0 0.1 0.1 0.2 0.3 5.5 0.1 0.2 0.3 0.3 0.1 0.6 1.5 0.3 0.2 1.5 0.4 0.4 33.2 2.8 0.5 0.4 0.1 0.1 0.4 0.0 5.2 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.6 0.4 0.6 0.3 0.6 0.3 0.5 0.3 0.0 0.0 0.0 0.6 0.0 2.0 0.4 1.5 0.6 0.4 0.0 0.3 0.2 0.2 0.4 0.5 0.6 0.3 0.0 0.1 6.4 0.4 0.1 0.0 0.0 0.5 0.5 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.2 0.4 0.8 0.1 0.3 0.1 0.6 0.1 0.3 0.6 0.0 0.4 1.7 0.0 5.6 1.1 0.3 0.6 0.0 0.5 1.6 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.2 2.9 0.4 0.2 2.7 0.2 0.4 2.2 3.0 3.3 3.3 2.5 1.8 3.7 2.4 2.0 5.5 1.5 2.8 5.2 0.1 0.0 2.3 0.7 0.1 0.4 1.5 0.0 0.0 1.1 0.3 0.1 1.3 0.0 1.3 0.0 6.2 0.2 4.2 0.0 0.0 0.1 49.2 0.1 0.1 0.3 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.3 7.5 0.9 0.5 3.6 0.0 0.6 0.2 0.0 1.0 0.4 0.0 0.0 0.7 0.1 1.0 0.1 0.1 0.0 2.5 0.0 1.2 0.6 72.7 6.1 0.0 0.3 0.1 0.4 0.2 0.2 1.4 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362851-110391082 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 125.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 71.7;Proximal tubular cells: 192.3" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.1 2.9 3.0 4.6 3.1 1.1 7.0 5.9 4.4 4.2 13.5 3.0 9.5 3.0 22.6 2.7 4.1 13.8 3.6 3.6 11.6 125.3 16.5 9.3 3.5 4.1 3.5 2.5 21.6 0.9 0.5 3.9 28.9 4.8 3.8 1.6 2.3 3.7 5.8 1.3 1.3 11.5 3.4 4.3 2.7 2.8 5.2 3.2 0.6 8.6 4.0 1.1 7.9 3.5 4.4 0.4 9.8 2.3 2.7 6.3 12.9 20.4 5.3 20.7 1.8 5.3 3.1 30.8 0.6 5.7 17.1 0.1 0.5 0.1 1.9 1.9 0.5 2.5 0.5 2.7 3.3 19.2 0.9 0.5 10.0 0.3 3.0 0.2 42.6 4.1 0.8 0.5 1.2 3.3 1.0 0.4 0.6 0.9 0.0 0.3 0.2 1.3 0.1 3.7 0.4 1.2 0.9 0.6 9.8 30.6 9.0 0.7 0.1 0.4 1.4 0.7 0.3 1.5 0.5 0.1 1.6 1.1 0.4 6.1 0.0 0.2 0.1 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.1 3.0 3.1 5.9 4.4 3.6 11.6 4.1 3.5 2.5 4.8 4.3 3.2 4.4 1.9 12.8 20.8 2.3 5.8 3.1 6.1 11.2 1.2 11.5 14.7 6.5 1.1 11.5 6.8 71.7 6.2 39.5 5.8 0.9 3.9 2.7 0.5 3.3 6.8 4.6 3.5 2.7 8.2 0.9 34.6 18.2 1.5 3.3 5.1 5.2 4.2 5.0 4.2 3.3 7.1 0.9 4.1 1.6 3.0 2.2 18.0 1.8 10.6 15.0 1.8 2.4 9.2 2.5 4.7 1.9 1.2 11.7 1.2 3.1 38.4 192.3 3.5 20.1 0.0 4.5 5.4 3.4 1.9 0.5 3.7 35.2 3.9 7.0 1.4 7.2 IL7R "CD127, IL7RA" ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 185.4" "Group enriched" "Detected in many" 4 "monocytes: 271.8;T-cells: 973.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2" "Group enriched" "Detected in all" 33 "NK-cells: 113.2;T-cells: 369.5" "Cell line enhanced" "Detected in many" "BJ: 99.8;BJ hTERT+ SV40 Large T+: 87.7;fHDF/TERT166: 187.7;HBF TERT88: 168.3;REH: 406.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 610000 "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 7.7 14.5 1.6 138.9 2.0 14.2 20.6 6.4 4.2 12.1 4.5 17.5 15.1 3.9 1.6 11.1 5.8 32.7 1.9 2.1 2.4 4.3 12.6 64.5 140.6 1.9 1.2 2.3 2.2 5.4 0.8 1.7 2.9 2.5 8.8 20.6 0.9 3.3 3.1 4.2 3.8 57.3 5.6 0.9 70.7 34.4 4.7 3.5 185.4 7.7 1.7 124.1 48.5 7.2 6.4 0.6 0.4 0.7 0.4 0.7 0.6 0.6 99.8 50.6 87.7 51.3 0.5 0.6 9.6 0.3 187.7 15.9 16.0 0.2 6.0 168.3 8.6 1.1 3.2 10.3 0.0 1.5 0.6 7.2 1.6 0.0 18.7 4.3 2.4 2.6 0.7 0.7 0.9 71.3 0.2 2.3 1.0 0.3 0.3 4.6 406.2 5.2 0.6 0.0 5.3 0.4 0.2 15.9 1.7 0.2 0.3 0.6 0.4 7.0 34.5 58.4 14.8 13.4 0.6 0.2 10.4 17.4 9.2 27.8 4.3 1.6 1.0 102.1 1.2 369.5 1.5 213.8 151.1 0.7 2.1 179.5 124.6 7.3 113.2 1.5 1.8 39.7 87.7 1.6 2.0 6.4 4.2 2.1 2.4 1.9 1.2 2.3 2.5 0.9 3.5 6.4 8.9 16.0 16.0 0.0 47.4 11.6 2.7 0.0 5.2 0.0 8.6 6.1 4.9 0.0 2.5 0.0 0.0 0.2 136.0 0.6 0.0 1.0 0.1 1.1 0.4 13.2 0.0 16.4 0.0 2.0 0.2 11.6 53.5 1.2 19.6 0.2 13.2 4.4 10.6 0.0 0.0 0.5 0.0 10.6 98.5 0.8 0.0 58.8 21.4 2.8 271.8 0.0 11.3 0.0 0.0 0.1 1.4 0.0 93.5 1.4 0.0 0.8 5.8 0.0 0.0 5.5 7.9 0.2 0.1 1.5 10.4 0.3 973.8 0.4 0.4 3.5 TMEM208 HSPC171 ENSG00000168701 "Transmembrane protein 208" Q9BTX3 16 67227103-67229278 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041868, HPA041949" Supported NA NA "HPA041868: AB_10962347, HPA041949: AB_10959903" "unprognostic (9.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.36e-3)" "unprognostic (2.05e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (6.40e-2)" "unprognostic (1.31e-2)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (7.73e-2)" "unprognostic (9.42e-2)" 32.5 84.5 41.6 32.0 41.5 22.7 40.7 43.7 50.5 35.0 48.0 43.3 46.2 29.5 58.0 41.4 33.0 28.0 26.4 41.6 43.4 53.2 125.7 35.2 28.2 43.4 43.8 41.4 25.4 65.8 68.1 63.0 32.9 43.1 34.4 42.1 13.9 45.2 31.3 26.7 32.5 39.4 28.3 43.4 38.5 47.8 30.7 42.7 26.7 41.6 19.2 32.4 37.3 29.0 44.6 64.6 82.1 40.0 48.6 124.3 59.3 73.4 66.3 83.3 72.1 61.4 106.4 80.1 63.4 76.1 93.8 64.6 86.2 64.4 89.8 45.6 27.9 90.1 34.9 64.0 110.1 128.6 56.2 91.6 79.9 112.7 95.1 82.1 51.5 54.3 57.6 61.2 81.4 85.7 128.0 56.2 82.5 67.2 105.5 56.1 61.0 48.7 186.2 97.4 42.9 66.2 67.6 119.1 50.2 54.8 27.2 65.0 70.7 33.8 54.5 35.9 78.3 74.0 122.7 127.9 131.8 96.0 54.1 79.8 79.2 108.5 59.4 74.0 102.7 66.5 70.7 68.7 63.9 85.1 58.5 56.1 61.6 69.7 53.3 81.3 168.5 74.2 93.9 41.6 41.5 43.7 50.5 41.6 43.4 43.4 43.8 41.4 43.1 43.4 42.7 44.6 51.7 25.6 36.9 8.1 71.8 51.7 79.5 131.0 48.9 44.7 92.1 96.9 29.8 102.9 111.1 57.0 33.3 98.9 69.2 81.8 60.7 158.8 19.8 57.6 54.3 49.5 76.8 31.6 7.8 202.0 142.9 66.7 50.0 64.1 53.3 47.1 43.5 209.6 120.5 26.9 9.3 119.0 140.4 54.7 53.6 7.4 62.1 59.4 88.9 6.5 90.2 102.6 55.6 9.0 12.3 129.7 107.8 41.8 197.3 137.6 145.4 162.7 109.7 55.5 26.3 43.6 100.6 68.4 58.4 62.7 51.9 143.7 52.4 65.9 95.4 128.0 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131016 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 23.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2119.8;Excitatory neurons: 3755.5;Inhibitory neurons: 2917.8;Oligodendrocyte precursor cells: 5568.9;Oligodendrocytes: 1203.1" "Cancer enhanced" "Detected in some" "breast cancer: 0.8;glioma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.5;HEK 293: 1.7;U-138 MG: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles NA NA 370000 Vesicles "HPA069094: AB_2686082, HPA074788: AB_2797273" "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 2.4 1.4 13.4 0.0 23.0 0.0 1.7 7.2 19.3 0.2 0.0 0.3 0.0 0.0 2.2 0.0 0.3 0.1 0.2 22.2 8.6 0.4 0.2 0.1 0.0 8.2 10.1 18.0 0.6 0.1 0.1 1.9 0.0 8.4 0.9 0.0 2.6 0.6 1.0 4.5 0.3 0.1 0.0 2.9 0.0 0.4 0.3 11.5 0.2 5.7 3.5 0.0 0.1 0.9 20.5 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.2 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.4 23.0 7.2 19.3 22.2 8.6 8.2 10.1 18.0 8.4 2.9 11.5 20.5 1.4 0.0 0.0 2119.8 0.0 0.3 0.5 0.0 3.4 14.9 0.2 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.9 0.1 1.7 0.2 0.0 0.0 3755.5 0.0 0.0 9.1 0.0 0.5 0.0 0.1 0.0 0.5 0.0 0.0 2917.8 0.0 0.0 0.0 0.5 5.4 1.2 0.1 0.0 142.4 0.0 2.4 0.0 5568.9 1203.1 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.8 0.0 1.1 0.4 0.2 0.3 0.2 0.3 0.0 0.1 0.2 0.0 0.8 WFDC12 "C20orf122, dJ211D12.4, WAP2" ENSG00000168703 "WAP four-disulfide core domain 12" Q8WWY7 20 45123425-45124465 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 42.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.6;Collecting duct cells: 5.5" "Group enriched" "Detected in many" 7 "head and neck cancer: 18.9;melanoma: 14.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 86000 "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "unprognostic (1.18e-2)" "unprognostic (5.42e-2)" "unprognostic (2.25e-1)" "unprognostic (2.86e-1)" "unprognostic (3.40e-3)" "unprognostic (1.72e-2)" "unprognostic (8.70e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (4.49e-2)" "unprognostic (3.91e-1)" "unprognostic (5.50e-3)" 0.1 0.1 1.2 0.1 1.0 1.0 2.5 0.4 1.3 0.4 0.3 0.2 0.5 0.2 1.8 6.8 0.1 0.2 0.0 1.2 0.2 0.3 0.2 1.1 0.2 0.6 0.3 0.7 0.3 0.0 0.1 0.0 0.1 0.9 1.9 0.2 0.7 2.2 3.0 0.6 42.3 0.2 0.2 0.1 0.2 0.1 1.7 0.5 1.2 0.3 0.0 1.5 0.1 9.9 1.1 0.2 0.1 0.0 0.1 0.9 0.1 0.3 0.1 0.4 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.6 0.4 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.2 0.4 0.3 0.1 0.2 0.3 0.3 0.1 0.1 0.3 0.4 0.4 0.1 0.0 0.5 0.1 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.4 1.3 1.2 0.2 0.6 0.3 0.7 0.9 0.1 0.5 1.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.5 5.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 AHCYL1 "IRBIT, PPP1R78, XPVKONA" ENSG00000168710 "Adenosylhomocysteinase like 1" O43865 1 109984765-110023742 "Metabolic proteins, Predicted intracellular proteins, Transporters" "One-carbon metabolism" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 330.5" "Cell type enhanced" "Detected in all" "Astrocytes: 328.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042589 Approved Supported Cytosol NA NA 160000 Cytosol "HPA042589: AB_10793885" "unprognostic (8.72e-2)" "unprognostic (2.34e-1)" "prognostic favorable (7.00e-4)" "unprognostic (1.83e-3)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (2.72e-2)" "unprognostic (3.09e-2)" "unprognostic (1.32e-1)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.68e-1)" "unprognostic (2.38e-2)" "unprognostic (3.79e-2)" "unprognostic (2.89e-1)" "unprognostic (8.87e-2)" "unprognostic (4.84e-3)" 68.6 66.7 213.1 33.8 239.0 14.9 52.0 249.7 240.0 67.1 162.1 49.6 128.0 54.8 92.6 48.4 73.5 65.8 38.6 180.8 261.2 103.1 69.8 45.0 31.8 330.5 252.6 166.1 53.4 74.0 180.0 51.9 56.7 260.7 44.6 52.1 69.4 51.3 64.7 92.5 38.8 64.7 57.8 280.9 34.9 56.8 28.6 296.5 32.5 76.0 45.0 37.8 49.7 40.2 292.1 100.9 83.4 77.3 80.5 182.8 106.8 127.2 78.1 87.7 72.2 70.7 65.3 56.4 42.5 64.9 115.5 55.0 63.0 69.2 89.1 95.0 355.3 59.8 70.8 106.5 69.5 188.4 61.1 47.7 109.7 55.2 90.0 131.0 175.5 92.2 70.7 51.8 84.1 75.7 80.1 51.3 30.2 91.5 140.6 64.1 54.9 161.1 47.7 157.7 99.8 75.4 49.1 121.1 142.9 165.2 116.8 76.5 60.3 80.3 69.3 67.3 82.8 70.4 68.8 30.5 36.0 142.2 65.7 145.1 3.9 5.0 4.6 2.2 5.4 2.3 3.9 2.3 3.1 3.5 4.4 2.4 2.3 4.7 2.5 3.8 3.2 5.0 2.2 213.1 239.0 249.7 240.0 180.8 261.2 330.5 252.6 166.1 260.7 280.9 296.5 292.1 67.3 35.3 74.8 328.1 30.1 89.2 100.1 61.7 47.8 62.3 105.9 71.2 49.8 85.8 68.0 117.7 223.1 80.7 29.4 72.0 125.2 142.2 41.6 226.2 69.1 59.0 85.5 42.0 48.7 110.5 50.4 107.4 69.8 181.1 31.7 81.1 61.8 158.2 42.8 63.9 50.4 71.1 65.1 75.8 67.7 29.6 93.5 62.2 62.2 53.4 57.2 99.9 19.6 60.8 53.2 100.8 38.5 81.6 27.0 108.1 134.3 143.6 83.5 105.7 46.0 87.9 105.7 31.6 13.1 75.6 108.4 100.3 26.8 61.4 78.9 134.2 DNAJC21 "DNAJA5, GS3, JJJ1" ENSG00000168724 "DnaJ heat shock protein family (Hsp40) member C21" Q5F1R6 5 34929559-34958964 "Disease related genes, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040789 Approved Supported Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040789: AB_10794147" "unprognostic (1.37e-1)" "unprognostic (6.01e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (1.42e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.77e-3)" "unprognostic (3.04e-2)" "unprognostic (6.68e-3)" "unprognostic (5.99e-2)" "unprognostic (6.02e-2)" "unprognostic (9.27e-3)" "unprognostic (1.54e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" "unprognostic (6.02e-2)" 18.4 12.8 11.1 13.9 12.0 24.3 16.3 11.0 11.5 22.4 11.0 17.8 15.3 16.5 14.5 20.9 11.5 13.7 32.3 9.5 11.7 23.3 23.2 17.6 18.6 12.0 11.6 9.0 11.9 20.2 19.6 8.2 24.7 11.9 18.2 18.6 9.4 15.9 17.7 58.9 15.3 16.0 18.4 11.6 12.8 19.0 61.9 11.7 18.1 18.1 42.7 19.8 21.0 16.9 12.1 36.2 25.3 32.0 41.6 39.1 46.4 57.1 47.4 38.9 37.7 25.2 41.6 42.8 75.9 20.1 44.3 46.6 24.3 37.9 49.0 43.8 45.2 27.8 41.7 90.7 35.2 64.6 60.7 37.7 33.2 44.8 41.6 67.7 26.2 35.3 27.8 65.6 59.7 28.1 30.4 51.3 45.2 22.6 39.8 21.4 45.5 79.2 33.7 37.9 44.9 16.5 17.5 128.1 59.4 40.2 35.2 40.1 64.4 43.4 46.5 44.7 27.8 37.7 40.2 40.0 51.0 37.6 71.8 25.1 2.2 1.5 4.7 1.7 1.2 2.5 3.1 2.5 1.6 2.5 2.0 2.5 2.5 0.4 4.0 2.0 2.3 3.4 1.0 11.1 12.0 11.0 11.5 9.5 11.7 12.0 11.6 9.0 11.9 11.6 11.7 12.1 53.5 76.9 111.3 23.8 42.0 37.0 73.9 22.4 33.6 52.6 57.0 56.6 151.1 47.1 36.1 36.8 43.8 51.2 59.1 34.6 88.0 21.5 117.5 49.2 77.8 44.9 18.0 40.0 26.9 30.5 25.7 44.4 32.6 68.4 8.2 42.0 37.5 59.5 24.3 75.7 40.4 36.9 6.1 31.4 32.9 47.7 40.4 38.8 37.4 15.0 50.8 31.2 45.3 20.1 32.1 26.6 27.7 38.0 41.4 85.8 28.2 62.5 22.8 73.0 13.1 57.0 44.0 117.4 50.3 43.4 46.7 65.7 52.7 51.4 41.4 77.1 PKIG ENSG00000168734 "CAMP-dependent protein kinase inhibitor gamma" Q9Y2B9 20 44531785-44624247 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "memory B-cell: 370.6;naive B-cell: 377.4" "Lineage enriched" "Detected in all" 11 "B-cells: 377.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 540.5;HSkMC: 211.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042703, HPA063690" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA042703: AB_10797018, HPA063690: AB_2685091" "unprognostic (3.15e-2)" "unprognostic (5.65e-2)" "unprognostic (8.07e-2)" "unprognostic (1.44e-3)" "unprognostic (3.16e-1)" "unprognostic (9.49e-2)" "unprognostic (3.96e-2)" "unprognostic (6.46e-3)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "prognostic favorable (4.90e-5)" "unprognostic (6.26e-2)" "unprognostic (9.08e-2)" "unprognostic (1.19e-2)" "unprognostic (1.35e-2)" "unprognostic (4.22e-1)" "unprognostic (3.96e-2)" 88.2 77.2 72.3 59.5 75.0 20.9 74.9 65.2 96.4 98.8 75.9 142.4 30.5 112.3 38.1 77.1 102.6 74.5 292.7 77.3 93.7 86.6 44.9 164.3 49.8 75.9 70.8 73.3 58.0 32.6 67.3 69.7 83.0 66.9 103.3 31.8 27.2 46.3 76.0 105.7 29.8 72.8 93.5 66.8 43.0 82.5 68.8 78.2 19.5 68.9 91.9 47.1 170.4 69.5 68.2 27.8 27.9 44.7 28.8 67.0 135.7 6.2 66.0 540.5 73.6 55.4 64.7 12.5 108.3 52.7 58.5 61.2 10.6 9.0 14.4 23.9 54.8 16.3 16.7 4.1 45.7 61.7 2.1 1.1 211.7 28.5 35.8 7.9 36.4 167.5 29.3 13.4 2.6 6.8 35.0 17.2 27.5 23.7 0.2 39.4 2.8 1.2 2.6 40.7 5.5 18.0 58.7 16.9 7.9 45.6 19.3 21.0 13.6 108.5 99.9 44.2 44.8 32.3 13.9 41.9 76.3 49.5 1.9 43.8 2.9 1.8 0.7 1.5 1.7 1.3 370.6 1.9 1.8 9.1 377.4 5.4 8.8 2.2 4.4 1.6 35.8 1.0 17.8 72.3 75.0 65.2 96.4 77.3 93.7 75.9 70.8 73.3 66.9 66.8 78.2 68.2 93.3 9.6 6.1 26.8 82.9 25.2 14.4 20.3 10.2 24.6 37.6 45.1 233.6 24.3 15.7 46.0 20.9 15.1 6.2 44.2 127.2 70.6 110.1 104.2 91.5 122.3 44.2 34.9 65.9 30.8 17.8 93.2 5.1 18.5 47.5 27.8 65.0 37.8 8.2 10.1 42.7 15.7 32.6 3.8 20.4 40.1 73.0 14.2 49.8 22.5 8.1 94.1 3.1 25.6 25.4 39.1 46.9 61.3 11.8 11.6 19.3 156.6 78.3 28.7 118.3 19.5 153.0 155.9 27.4 5.3 30.0 36.7 8.5 80.8 29.1 10.2 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 138.2;thyroid gland: 236.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA 120000 "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 19.5 6.4 9.9 5.6 7.7 0.2 27.2 4.7 7.7 30.9 6.8 23.9 56.6 21.0 22.4 11.0 22.6 30.8 5.3 7.5 13.6 104.2 4.0 138.2 4.5 5.7 26.1 8.5 11.0 40.4 1.0 47.8 3.4 6.6 83.6 25.5 2.4 9.0 18.9 5.0 7.6 74.7 14.2 4.1 14.9 15.0 3.2 10.9 14.3 236.4 11.6 5.4 9.7 22.3 6.1 0.0 0.2 0.3 0.6 0.0 0.0 30.9 0.2 0.1 0.0 0.0 14.9 19.1 0.2 0.8 0.2 0.0 1.7 7.4 0.0 0.0 0.0 8.4 0.8 32.3 27.1 0.1 0.0 0.2 3.2 2.4 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.0 24.3 0.4 1.5 0.3 0.1 12.0 0.0 0.1 0.3 37.7 1.6 1.7 0.6 1.8 14.1 0.0 4.1 51.2 1.3 0.0 0.6 0.4 0.5 1.1 0.3 1.1 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 7.7 4.7 7.7 7.5 13.6 5.7 26.1 8.5 6.6 4.1 10.9 6.1 5.2 185.9 103.7 15.3 0.0 1.9 5.2 13.1 1.8 1.1 22.2 7.0 2.5 27.1 56.4 33.1 0.0 2.4 0.7 5.9 1.9 24.7 11.0 1.0 1.5 18.4 15.6 0.0 1.0 2.5 0.2 8.3 1.1 1.9 0.0 3.3 2.9 0.3 0.3 0.0 10.0 10.6 4.1 0.0 1.5 15.4 2.5 0.6 5.4 14.0 0.0 0.0 0.0 2.0 0.3 7.5 3.4 0.0 0.0 28.4 19.6 4.3 6.4 0.2 0.0 1.9 26.4 2.4 2.0 3.6 1.1 1.5 0.3 1.5 11.0 5.7 CA7 ENSG00000168748 "Carbonic anhydrase 7" P43166 16 66844414-66854153 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 57.5" "Cell type enriched" "Detected in some" 40 "Paneth cells: 3026.3" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 1.1;THP-1: 1.9" "Region enhanced" "Detected in all" "cerebellum: 67.2" "Low region specificity" "Detected in many" HPA047237 Uncertain NA NA "HPA047237: AB_2679994" "unprognostic (8.77e-4)" "unprognostic (5.23e-4)" "unprognostic (1.57e-1)" "unprognostic (1.96e-2)" "unprognostic (2.19e-1)" "unprognostic (2.16e-2)" "unprognostic (7.90e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "unprognostic (9.62e-2)" "unprognostic (1.69e-2)" "unprognostic (7.12e-3)" "unprognostic (8.47e-2)" "unprognostic (5.20e-1)" "unprognostic (1.90e-2)" "unprognostic (6.46e-2)" 0.0 0.0 5.0 0.2 6.3 0.0 0.1 5.0 10.8 0.0 2.6 57.5 6.9 0.1 0.9 0.1 0.0 0.0 0.0 8.1 4.3 0.0 0.0 0.0 0.0 4.5 4.0 6.7 0.0 0.0 0.0 0.1 0.0 5.5 0.0 49.1 0.0 0.0 0.2 0.0 0.0 10.1 1.1 3.0 0.0 0.0 0.6 5.2 0.1 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 6.3 5.0 10.8 8.1 4.3 4.5 4.0 6.7 5.5 3.0 5.2 5.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3026.3 0.0 0.0 0.5 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 39.9 0.1 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.0;brain: 10.4;epididymis: 5.6;lymphoid tissue: 12.2;testis: 8.2" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 88.3" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 25.7;OE19: 7.0;RPMI-8226: 28.0;WM-115: 27.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "spinal cord: 2.4" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 1.4 0.0 4.9 0.0 7.6 19.0 0.9 5.8 7.4 0.4 2.3 1.5 0.0 1.6 5.6 0.7 1.3 0.1 0.4 4.6 5.0 0.1 0.0 0.4 0.1 7.5 7.9 3.6 0.5 0.0 0.0 0.1 0.9 9.6 1.1 0.1 0.1 0.3 0.8 0.2 1.1 0.5 0.4 6.5 12.2 0.3 8.2 7.2 0.1 0.1 0.0 0.0 2.1 0.8 10.4 6.2 0.0 0.0 2.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.5 2.5 0.0 0.0 0.2 7.0 0.0 0.0 6.7 28.0 0.0 0.0 0.8 0.0 0.0 4.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 4.9 7.6 5.8 7.4 4.6 5.0 7.5 7.9 3.6 9.6 6.5 7.2 10.4 0.2 0.0 0.0 1.0 1.2 0.8 0.6 0.4 0.0 0.2 0.5 1.4 0.4 0.0 0.0 0.0 2.1 3.2 0.5 0.1 0.0 0.0 3.6 0.1 0.3 0.2 0.0 88.3 7.2 0.0 7.1 3.0 0.0 0.1 0.0 0.2 0.4 0.0 1.2 1.7 1.1 0.0 10.2 0.0 0.9 7.8 0.9 1.0 3.6 1.0 0.2 2.9 1.0 1.0 20.7 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.2 0.0 2.8 1.6 3.2 20.1 0.6 1.7 2.5 0.2 0.3 0.1 0.4 TSPY2 TSPYQ1 ENSG00000168757 "Testis specific protein Y-linked 2" A6NKD2 Y 6246223-6249019 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 7.6" "Group enriched" "Detected in some" 34 "Spermatocytes: 7.7;Spermatogonia: 27.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 656 "U-266/70: 107.3;U-266/84: 119.3" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (3.69e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.3 119.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEMA4C "Semacl1, Semaf, SEMAI" ENSG00000168758 "Semaphorin 4C" Q9C0C4 2 96859718-96870757 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 137.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 298.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011090 Approved NA NA 700000 "HPA011090: AB_2185705" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (7.10e-2)" "unprognostic (4.46e-2)" "unprognostic (1.57e-2)" "unprognostic (4.20e-3)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (3.56e-2)" "unprognostic (1.82e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (9.50e-7)" "unprognostic (4.78e-3)" "unprognostic (3.09e-1)" "unprognostic (7.31e-2)" "unprognostic (4.08e-1)" 18.9 9.0 7.8 11.4 19.8 3.0 17.8 15.4 14.9 27.9 0.1 32.0 7.5 37.5 6.0 14.1 33.6 15.4 18.4 9.2 14.7 12.0 13.4 14.5 9.9 21.5 19.2 6.8 23.3 9.5 7.2 10.2 42.1 23.2 21.0 5.7 7.1 16.6 20.8 7.5 16.1 14.7 19.4 15.9 28.7 15.2 2.7 16.4 6.6 12.4 13.5 5.3 32.5 22.5 34.0 8.0 11.7 35.6 39.7 8.4 10.5 298.5 13.9 17.4 13.4 13.5 11.8 13.3 0.0 22.3 8.5 13.3 8.1 10.2 6.9 6.5 15.2 11.8 5.4 10.5 22.2 19.2 2.2 13.7 16.1 5.4 12.3 10.4 14.9 9.9 2.6 36.5 11.6 12.7 41.0 0.1 17.4 49.1 0.4 10.6 12.5 20.0 13.8 4.8 17.1 22.4 32.4 11.2 24.6 60.8 27.6 8.7 21.4 3.1 21.9 27.3 30.9 14.6 0.2 1.0 0.1 10.6 17.2 37.1 0.5 0.0 0.0 0.6 0.2 0.8 0.0 0.2 0.4 0.0 0.0 0.4 0.1 0.0 1.4 1.5 0.8 0.3 0.4 7.8 19.8 15.4 14.9 9.2 14.7 21.5 19.2 6.8 23.2 15.9 16.4 34.0 28.1 0.0 10.3 15.3 1.1 11.5 7.9 7.6 18.2 32.2 9.9 8.3 6.9 12.8 8.6 5.5 10.4 46.8 9.7 1.8 1.9 9.7 0.5 7.4 15.8 26.6 5.4 2.1 7.2 5.0 137.3 17.3 3.1 11.6 1.3 10.2 23.9 9.8 7.9 15.2 4.1 5.7 6.1 4.4 6.1 1.5 13.4 9.2 21.4 18.7 3.2 23.6 12.3 4.5 35.5 10.5 1.2 9.1 3.6 9.4 0.1 0.8 7.4 38.8 19.7 11.4 24.1 0.6 4.2 13.0 10.2 45.0 9.5 4.9 3.9 4.8 CNNM3 ACDP3 ENSG00000168763 "Cyclin and CBS domain divalent metal cation transport mediator 3" Q8NE01 2 96816245-96835382 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016711 Supported Approved Cytosol NA NA Cytosol "HPA016711: AB_1847394" "unprognostic (1.50e-2)" "unprognostic (6.96e-2)" "unprognostic (2.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.03e-1)" "unprognostic (1.59e-1)" "unprognostic (8.32e-3)" "unprognostic (3.64e-1)" "unprognostic (5.31e-3)" "unprognostic (7.35e-2)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (4.48e-2)" 7.5 9.0 7.6 6.8 10.1 7.0 8.0 14.6 8.8 8.3 7.6 10.0 17.4 8.6 5.2 5.7 11.0 9.5 5.6 7.5 7.6 7.5 20.1 9.2 9.2 9.4 9.3 7.5 10.4 26.8 21.5 8.0 10.3 10.8 9.0 8.9 13.2 12.5 9.1 45.5 8.6 14.4 5.8 7.0 9.6 12.5 11.4 8.5 11.5 8.5 6.1 7.3 8.3 7.6 12.7 10.4 9.2 8.7 13.4 10.2 5.4 24.3 6.8 5.5 6.4 6.3 25.3 16.4 11.7 23.3 5.2 7.4 11.8 12.6 8.8 4.8 11.3 29.4 15.3 12.9 28.1 8.9 14.0 11.2 4.5 11.8 8.1 7.3 8.7 7.9 9.6 14.1 19.8 2.7 13.0 12.8 17.4 11.6 15.6 11.5 15.6 11.6 14.4 11.3 12.7 26.5 17.0 8.7 14.2 8.2 13.3 13.5 10.2 3.7 5.6 16.1 9.2 9.8 17.8 18.1 8.6 3.5 13.2 6.0 1.6 0.8 3.5 2.6 0.6 1.6 1.8 1.6 2.1 0.3 2.1 1.5 1.5 3.3 1.5 1.4 1.8 2.2 0.8 7.6 10.1 14.6 8.8 7.5 7.6 9.4 9.3 7.5 10.8 7.0 8.5 12.7 4.1 9.6 4.8 9.1 5.4 1.3 2.7 1.1 0.6 17.5 4.9 5.0 15.6 8.6 3.0 0.0 8.4 5.0 8.9 4.7 0.0 5.0 7.3 5.3 4.4 3.7 4.2 5.7 5.7 4.3 2.6 4.3 5.6 12.6 0.0 11.7 6.4 17.4 2.6 33.7 9.5 7.6 4.1 3.4 0.6 1.3 2.5 1.9 3.6 4.7 2.3 6.4 6.2 18.1 19.6 2.7 1.9 4.1 6.4 7.1 8.4 1.9 2.8 13.5 13.1 5.7 4.5 5.9 6.3 2.8 1.6 1.6 6.9 11.5 8.2 3.4 GSTM4 ENSG00000168765 "Glutathione S-transferase mu 4" Q03013 1 109656099-109674836 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 150.8" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 382.8;Proximal tubular cells: 109.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 9 "eosinophil: 351.7" "Lineage enriched" "Detected in all" 9 "granulocytes: 351.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" Yes NA Cytosol "Cytokinetic bridge" "HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "prognostic favorable (9.96e-5)" "unprognostic (1.96e-3)" "unprognostic (7.49e-2)" "unprognostic (9.92e-3)" "unprognostic (1.48e-1)" "unprognostic (1.08e-2)" "unprognostic (8.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.76e-2)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" 22.0 31.4 20.0 15.5 23.0 6.0 22.7 19.3 24.0 24.1 35.7 44.3 150.8 22.8 24.5 31.6 22.3 18.0 31.5 19.4 20.2 46.4 41.5 14.8 11.9 20.9 21.2 19.2 43.3 21.3 58.3 18.8 7.7 20.3 26.0 38.8 12.6 21.4 41.3 93.2 20.6 100.2 25.9 20.1 30.4 29.1 15.2 19.6 10.0 28.0 45.9 15.8 37.1 29.0 20.7 13.5 6.0 10.5 78.9 23.0 35.1 13.4 4.3 34.1 9.8 12.8 43.3 1.5 12.5 16.1 19.1 19.3 13.6 27.1 14.4 6.2 18.9 0.0 27.4 23.5 38.8 37.1 9.5 31.8 22.3 14.0 12.6 0.0 27.5 8.1 31.7 12.8 18.4 6.9 12.7 8.1 41.9 8.2 56.3 31.9 16.9 5.8 18.5 38.8 9.6 7.4 17.6 0.2 68.2 54.9 7.8 18.6 20.1 3.6 11.4 44.0 12.5 6.3 27.0 51.4 1.1 37.1 13.9 32.5 11.9 14.5 351.7 12.2 14.5 7.4 17.0 9.3 14.1 37.8 14.9 8.9 10.7 1.8 12.8 3.6 12.6 14.1 12.6 20.0 23.0 19.3 24.0 19.4 20.2 20.9 21.2 19.2 20.3 20.1 19.6 20.7 6.9 9.6 2.7 11.4 9.9 18.1 27.3 17.9 18.8 6.2 14.7 19.0 30.2 21.5 9.5 31.3 0.0 21.0 13.9 53.0 101.8 45.9 3.0 4.5 10.8 8.6 7.2 4.2 3.3 57.7 18.6 22.9 13.3 5.4 21.0 13.3 14.3 35.7 35.6 5.0 3.3 45.9 6.1 17.2 26.0 6.4 30.1 14.9 40.9 2.8 14.8 23.9 17.5 5.0 3.4 35.4 38.6 24.8 13.3 6.7 382.8 109.8 7.5 5.4 32.9 15.3 23.2 7.0 7.3 23.0 15.3 8.8 11.2 12.6 96.7 26.9 TET2 "FLJ20032, KIAA1546" ENSG00000168769 "Tet methylcytosine dioxygenase 2" Q6N021 4 105145875-105279816 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 55.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 55.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043135 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043135: AB_10794177" "unprognostic (6.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.69e-2)" "unprognostic (9.42e-2)" "unprognostic (4.15e-2)" "unprognostic (5.88e-2)" "unprognostic (6.12e-2)" "unprognostic (1.19e-3)" "unprognostic (1.15e-2)" "unprognostic (1.57e-2)" "unprognostic (5.77e-2)" "unprognostic (7.29e-2)" "unprognostic (2.70e-3)" "unprognostic (6.10e-2)" "unprognostic (1.89e-1)" "unprognostic (9.15e-2)" "unprognostic (7.84e-2)" 4.3 3.1 3.1 10.2 4.3 22.6 5.5 3.0 3.2 6.4 6.0 5.2 6.2 7.2 6.0 7.8 5.0 5.1 3.3 2.4 4.5 4.1 4.2 5.5 5.7 4.7 3.7 1.4 4.3 3.7 4.7 1.9 10.3 5.0 4.4 6.0 6.7 4.7 3.4 2.8 11.1 6.0 5.7 3.6 7.2 5.3 1.4 4.0 5.4 4.2 5.2 7.1 5.6 4.6 5.9 5.1 3.1 10.9 11.1 2.1 3.7 4.2 3.1 4.8 4.8 4.7 3.1 6.4 0.5 4.0 4.0 2.1 4.9 9.3 6.1 5.3 6.7 2.9 7.0 6.5 1.6 4.9 15.5 11.8 3.8 7.9 4.5 5.6 8.6 6.4 4.1 7.7 13.6 4.4 3.1 2.5 4.7 2.5 6.2 2.2 8.4 4.7 1.0 4.7 9.4 7.5 5.9 4.2 9.1 0.8 5.9 4.5 11.8 9.1 7.8 6.7 2.1 5.3 9.5 6.8 6.8 4.8 3.8 7.2 30.1 13.6 14.7 3.9 10.4 1.6 5.3 2.3 2.2 10.2 6.3 1.9 2.9 55.5 5.9 13.6 8.9 3.1 3.3 3.1 4.3 3.0 3.2 2.4 4.5 4.7 3.7 1.4 5.0 3.6 4.0 5.9 24.5 25.6 29.1 58.8 28.3 14.4 11.0 14.2 12.5 22.8 15.6 13.6 27.9 5.7 23.9 9.2 16.7 23.1 34.1 19.0 7.9 7.0 0.4 22.1 38.3 20.3 23.3 10.9 48.4 7.5 5.7 18.0 21.4 33.2 27.8 15.5 13.6 8.5 14.5 35.3 89.7 15.8 32.6 48.8 93.3 0.9 8.1 98.3 5.4 90.9 48.1 5.8 34.0 112.6 128.3 8.2 18.7 7.2 22.5 12.1 16.3 2.8 22.3 24.3 13.1 47.0 21.7 0.2 1.3 28.4 35.9 34.2 18.9 24.7 14.0 27.5 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468308-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.5;retina: 7.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 48.0;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 102.1;Horizontal cells: 45.4;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.0;AN3-CA: 9.7;Karpas-707: 9.0;RPMI-8226: 5.5;SCLC-21H: 12.0;U-266/70: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 0.6 1.4 5.4 0.1 4.2 0.0 1.4 3.2 14.5 0.6 0.4 1.1 1.9 0.5 1.7 0.1 2.3 0.3 1.9 4.9 8.9 0.4 0.8 0.6 0.0 5.4 5.6 3.9 1.8 3.1 0.7 4.4 0.3 3.9 0.5 0.8 7.3 2.9 0.4 0.3 0.2 2.0 0.4 4.4 0.4 1.3 1.7 9.6 0.5 2.4 0.2 0.0 0.2 0.3 4.7 0.0 0.2 7.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 9.0 0.0 0.0 2.7 0.0 2.5 0.1 0.1 0.0 0.0 5.5 0.0 0.1 12.0 2.2 0.0 0.6 0.0 2.8 0.3 0.0 0.0 0.0 1.5 0.0 0.1 9.7 2.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 4.2 3.2 14.5 4.9 8.9 5.4 5.6 3.9 3.9 4.4 9.6 4.7 12.4 0.0 6.4 10.4 0.1 0.3 1.0 0.8 1.2 48.0 8.4 5.6 15.9 2.8 2.2 0.0 31.3 0.2 0.8 0.4 0.0 0.1 0.3 13.0 0.9 2.9 102.1 0.0 23.8 3.3 0.0 1.0 0.0 0.6 0.0 1.2 1.1 2.7 0.1 45.4 27.5 6.2 0.0 0.3 0.3 0.9 0.3 0.1 1.8 0.0 0.0 13.8 1.0 64.3 30.8 1.5 1.2 10.9 0.3 0.6 10.2 1.1 12.6 26.7 0.0 15.6 0.9 0.0 4.8 0.1 0.0 0.3 0.5 0.1 2.6 0.5 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671110-123708399 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.6;Respiratory ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.1 4.4 8.0 2.6 6.0 1.9 7.3 5.8 5.7 9.8 25.5 5.1 2.2 11.2 11.1 3.4 28.8 6.5 4.9 4.9 10.8 10.1 1.4 8.3 3.3 7.8 9.3 4.5 14.8 7.0 14.2 16.4 4.6 5.9 9.7 4.0 17.7 9.2 8.7 1.8 8.4 3.8 6.1 7.0 4.2 5.4 11.2 6.3 2.5 12.5 2.1 3.0 5.3 6.7 4.2 14.9 15.1 10.7 15.6 15.0 16.5 13.1 5.4 10.9 11.5 8.7 7.9 14.5 0.5 9.2 8.9 10.0 19.6 6.2 4.9 11.2 2.5 7.6 1.2 10.6 7.2 5.0 3.7 4.8 8.0 8.8 16.3 4.8 34.9 15.7 5.1 7.1 0.3 7.1 7.9 4.5 7.4 6.8 5.9 9.1 4.0 10.8 1.5 13.7 11.1 6.5 8.3 18.2 6.0 8.4 11.0 25.5 5.6 9.8 16.0 8.2 14.7 7.1 4.3 8.9 1.4 20.9 0.4 9.7 1.7 0.2 1.2 1.9 0.6 2.7 1.9 2.2 2.0 0.4 2.1 2.4 2.4 0.3 0.8 0.5 2.5 1.4 0.2 8.0 6.0 5.8 5.7 4.9 10.8 7.8 9.3 4.5 5.9 7.0 6.3 4.2 2.7 3.2 5.3 6.5 1.8 4.1 2.3 2.6 1.2 4.4 4.8 2.3 3.8 5.7 3.9 7.3 12.5 2.8 2.1 1.2 0.0 2.9 6.1 27.6 5.0 1.7 1.2 2.5 10.4 2.1 3.0 4.6 2.6 4.3 3.8 5.0 2.9 0.4 1.3 0.0 14.4 1.8 2.0 0.3 1.2 2.8 2.5 1.0 5.4 2.8 1.4 4.6 1.0 2.5 1.3 2.0 0.8 4.9 1.1 1.4 0.2 1.9 32.1 14.5 0.0 6.0 2.7 11.5 10.9 0.6 2.3 1.1 2.4 2.3 3.0 1.0 SHOX2 "OG12, OG12X, SHOT" ENSG00000168779 "Short stature homeobox 2" O60902 3 158095905-158106420 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 25.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 90.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Region enhanced" "Detected in many" "thalamus: 25.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;THP-1: 38.7" "Group enriched" "Detected in many" 5 "midbrain: 36.0;thalamus: 54.8" "Group enriched" "Detected in some" 6 "midbrain: 10.6;pons: 16.3;thalamus: 32.1" NA NA "unprognostic (2.62e-1)" "unprognostic (6.32e-2)" "unprognostic (3.32e-2)" "unprognostic (1.08e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-3)" "unprognostic (2.28e-3)" "unprognostic (7.66e-2)" "unprognostic (7.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.31e-2)" "unprognostic (8.75e-3)" "unprognostic (0.00e+0)" "unprognostic (4.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" 4.4 0.1 7.7 0.0 2.2 0.1 5.5 0.3 0.9 3.7 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.2 2.0 0.1 4.9 0.0 0.0 0.2 1.7 10.1 12.5 0.1 0.2 0.2 0.3 0.2 0.2 7.0 0.1 0.0 0.0 2.3 0.4 1.3 1.8 0.1 0.0 0.5 0.0 0.2 3.5 25.5 0.0 0.5 0.4 0.3 0.4 1.1 2.8 5.5 0.6 0.3 8.1 24.2 15.3 1.5 8.9 3.4 4.8 8.2 1.8 0.7 1.2 0.2 12.8 9.5 0.1 10.1 0.0 1.9 5.1 2.9 13.7 2.7 0.0 0.0 1.2 10.7 6.9 0.3 4.4 0.5 14.8 0.0 0.7 3.8 0.9 2.1 0.3 0.0 0.7 0.0 0.1 0.5 6.2 7.4 1.4 0.0 0.0 2.7 20.5 1.0 0.2 5.2 0.1 0.2 38.7 0.5 15.0 3.1 16.6 14.8 1.1 2.9 0.9 14.5 7.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 7.7 2.2 0.3 0.9 0.1 4.9 10.1 12.5 0.1 7.0 0.5 25.5 2.8 3.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.2 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 90.3 0.1 1.7 0.9 0.0 0.0 0.0 0.2 0.7 9.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 1.9 1.2 13.9 2.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 13.1 1.1 8.5 5.7 2.8 0.0 0.4 0.3 0.1 0.0 0.2 0.0 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Excitatory neurons: 46.6;Inhibitory neurons: 37.6;Rod photoreceptor cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favorable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 6.4 15.0 6.0 7.3 10.1 5.9 10.4 43.2 21.6 8.4 1.2 17.8 24.9 7.5 15.3 11.7 9.5 8.4 7.6 8.3 5.2 8.5 5.7 5.8 7.8 7.1 2.5 8.3 9.2 9.5 34.0 21.7 4.6 17.4 10.1 17.8 54.2 14.0 8.4 20.2 20.1 24.5 7.8 0.0 8.6 15.6 15.6 2.5 5.4 14.4 21.4 10.1 9.1 10.0 9.7 14.5 9.3 8.1 15.0 4.8 3.0 13.8 7.1 9.0 10.0 14.6 11.0 13.5 13.5 10.5 9.8 14.9 38.6 15.8 30.6 10.1 13.3 12.5 20.3 29.9 5.9 11.0 23.4 20.2 5.4 26.6 12.2 18.6 13.5 10.7 31.0 15.0 19.4 7.4 11.3 7.8 13.2 3.9 27.0 10.0 16.7 8.2 6.8 10.7 25.9 24.1 7.6 18.3 17.2 6.7 11.4 31.7 19.4 4.7 8.7 10.2 11.1 17.4 4.3 5.7 16.4 16.3 26.5 8.5 2.4 0.5 0.0 1.0 1.1 1.3 2.0 1.2 1.3 1.2 1.2 0.9 0.9 0.3 1.5 0.8 0.9 0.3 1.3 6.0 10.1 43.2 21.6 8.3 5.2 7.1 2.5 8.3 17.4 0.0 2.5 9.7 2.3 0.0 2.2 11.4 5.2 4.0 1.5 3.2 7.4 16.5 3.2 3.3 5.4 2.8 3.4 7.3 41.7 3.3 2.9 9.2 0.0 2.1 2.7 2.1 1.4 2.9 2.4 5.5 46.6 1.5 0.9 1.8 20.9 2.8 0.0 9.5 3.3 1.8 1.9 10.1 37.6 5.9 0.0 2.8 1.8 2.4 1.8 2.1 0.0 15.0 1.8 3.9 0.0 11.6 11.0 1.9 5.2 7.2 3.1 1.2 12.2 1.5 2.3 44.2 6.6 2.3 3.2 8.1 3.3 7.3 3.3 2.2 3.1 3.5 8.2 3.2 TSPAN5 "NET-4, TM4SF9, Tspan-5" ENSG00000168785 "Tetraspanin 5" P62079 4 98470367-98658611 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 175.4;Excitatory neurons: 362.2;Inhibitory neurons: 248.3;Microglial cells: 195.8;Oligodendrocytes: 587.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 37 "B-cells: 3.0;NK-cells: 3.8;T-cells: 6.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 120.8;BJ hTERT+: 121.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-3)" "unprognostic (2.65e-1)" "unprognostic (2.44e-3)" "unprognostic (1.41e-2)" "unprognostic (1.54e-2)" "unprognostic (9.27e-2)" "unprognostic (1.79e-1)" "unprognostic (3.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.83e-5)" "prognostic unfavorable (8.56e-4)" "unprognostic (2.15e-1)" "unprognostic (3.23e-3)" "unprognostic (1.23e-1)" 2.4 1.2 32.4 3.9 37.1 10.5 15.5 62.4 42.8 13.6 20.5 5.1 1.5 20.1 29.5 13.0 7.2 5.0 3.3 40.3 33.1 5.1 0.6 4.4 6.7 33.4 32.3 36.3 46.8 0.9 4.0 5.2 8.0 36.1 5.3 3.9 28.4 10.9 8.8 3.8 20.2 3.0 16.5 29.8 9.9 8.9 12.7 32.3 8.5 18.7 3.3 9.3 8.9 9.7 47.3 27.8 10.8 11.0 0.7 41.2 120.8 3.7 111.9 121.4 39.4 48.3 9.6 14.6 0.0 1.1 40.2 21.6 7.0 9.6 52.6 87.7 34.3 5.2 16.9 1.5 0.4 42.5 9.5 0.9 70.1 1.6 72.5 89.1 60.5 64.5 11.3 6.6 29.1 95.3 0.7 29.1 0.1 7.2 23.8 49.2 8.8 10.5 4.2 3.5 8.1 77.5 14.8 2.0 35.4 0.2 3.7 1.2 1.4 66.4 82.7 37.4 29.8 39.9 20.0 31.8 0.0 32.4 22.5 28.8 0.0 0.0 0.0 3.3 0.0 3.6 1.3 4.7 4.7 0.1 3.0 2.4 1.6 0.1 3.8 0.0 0.0 6.0 1.1 32.4 37.1 62.4 42.8 40.3 33.1 33.4 32.3 36.3 36.1 29.8 32.3 47.3 4.6 22.4 9.1 129.3 5.6 22.0 24.8 9.1 10.8 63.9 30.9 26.0 2.3 0.0 9.3 29.5 27.1 1.0 17.2 1.4 5.9 2.3 69.6 8.5 45.9 19.7 80.9 175.4 362.2 7.1 0.9 26.0 10.2 15.1 2.5 11.6 8.2 0.9 2.3 111.0 248.3 4.6 20.3 3.4 15.4 91.4 46.0 7.1 28.4 195.8 0.3 21.5 39.1 94.5 587.2 25.3 0.5 17.0 9.3 45.9 0.4 0.6 3.7 41.9 6.6 9.7 13.1 10.1 4.1 33.0 57.7 2.9 31.4 79.7 3.8 44.8 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567037 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 26.4" "Cell type enhanced" "Detected in many" "dendritic cells: 79.4;Hepatocytes: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 18.3;MAIT T-cell: 6.6;NK-cell: 10.8;plasmacytoid DC: 23.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 19.4 3.8 3.4 6.2 4.0 8.2 10.7 3.9 3.6 4.6 3.8 7.4 11.3 4.5 3.3 4.7 4.7 5.2 4.7 2.9 5.0 8.9 26.4 6.1 9.2 4.8 3.9 2.5 3.0 8.2 8.0 9.1 4.5 4.4 4.7 6.6 1.6 5.2 3.8 2.6 4.7 11.3 4.0 4.2 10.0 8.3 1.8 3.8 4.6 5.8 3.8 8.2 5.6 4.6 4.6 5.8 22.1 2.7 7.7 29.0 12.6 11.3 7.8 8.6 7.6 6.9 5.1 2.9 8.6 5.6 8.4 13.4 15.6 9.7 3.3 4.2 26.5 7.3 3.5 11.0 6.5 8.8 9.0 15.4 9.4 8.9 7.3 1.4 5.6 5.6 5.0 4.6 8.0 4.1 7.8 8.5 10.4 0.6 19.5 6.5 19.7 10.5 20.0 13.7 8.8 1.9 3.1 11.7 5.2 3.1 2.9 13.2 20.5 6.9 4.4 5.5 11.1 7.0 13.3 9.6 4.4 8.8 5.6 9.6 18.3 0.6 2.8 2.6 0.3 6.6 1.4 1.4 2.2 1.5 2.5 0.4 1.3 0.6 10.8 0.2 23.6 1.2 1.1 3.4 4.0 3.9 3.6 2.9 5.0 4.8 3.9 2.5 4.4 4.2 3.8 4.6 2.4 3.2 4.1 2.6 11.7 1.3 1.1 2.5 2.2 0.1 3.8 2.4 3.0 2.8 4.3 7.3 0.0 1.5 79.4 12.0 0.0 3.0 0.3 4.7 3.1 2.9 7.2 7.0 0.3 7.6 1.4 4.0 2.0 5.1 2.5 2.9 4.2 30.2 7.2 1.7 0.5 6.1 2.0 6.7 8.4 0.7 4.7 9.5 5.4 2.8 5.6 1.1 15.5 0.5 1.2 5.6 2.5 4.5 5.2 1.5 17.7 5.6 5.2 0.9 0.0 3.5 1.9 0.8 0.6 2.0 2.4 0.3 11.8 4.5 7.4 1.2 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438102-37465450 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: AB_2670736" "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 4.7 6.2 4.8 5.6 5.6 13.7 7.5 5.8 5.2 6.1 4.8 6.0 6.4 6.3 7.8 17.9 6.0 5.5 5.4 4.5 5.2 7.3 13.0 8.0 9.1 5.8 5.3 3.9 8.5 8.4 7.7 4.7 6.2 5.3 7.3 5.9 9.3 7.9 6.7 5.2 12.0 7.2 5.3 5.1 7.2 7.2 8.9 5.3 9.6 10.4 7.3 12.2 5.7 9.4 7.7 9.3 10.5 26.6 16.6 6.7 4.7 11.4 7.5 5.8 9.0 7.4 7.8 6.7 18.8 7.9 5.6 6.6 11.1 17.5 6.2 6.9 13.9 9.1 6.9 28.7 9.1 6.5 8.6 5.8 4.5 15.5 4.5 9.5 10.2 10.2 14.8 16.6 15.6 6.8 5.9 18.2 6.3 6.8 10.0 5.3 16.3 12.8 7.2 8.7 8.2 12.2 21.9 7.3 11.7 5.8 13.3 18.7 8.3 7.0 6.3 17.3 3.7 7.2 8.3 9.8 16.3 5.8 7.3 6.8 0.1 0.4 0.0 0.6 0.2 0.7 0.9 0.5 0.5 0.8 0.7 0.8 0.9 0.0 0.3 0.0 0.2 0.5 0.3 4.8 5.6 5.8 5.2 4.5 5.2 5.8 5.3 3.9 5.3 5.1 5.3 7.7 4.0 16.0 6.5 12.7 5.1 14.3 8.8 5.0 11.4 2.0 8.4 6.6 3.2 7.2 9.3 1.8 6.2 3.9 3.7 6.5 0.0 4.0 2.2 7.3 4.2 5.6 8.4 2.1 8.9 3.2 2.2 4.2 5.1 7.3 1.3 6.6 3.6 8.6 2.4 13.5 9.1 5.2 4.1 1.9 4.8 5.3 4.1 3.4 3.6 10.3 3.7 3.3 1.0 13.6 15.5 4.1 3.7 3.8 4.2 12.6 3.1 3.5 6.0 5.1 0.0 5.4 4.0 7.5 7.9 17.9 18.2 5.7 2.7 4.4 5.1 8.2 CHTF8 "CTF8, FLJ20400" ENSG00000168802 "Chromosome transmission fidelity factor 8" P0CG13 16 69118010-69132588 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.86e-3)" "unprognostic (1.99e-2)" "unprognostic (2.59e-2)" "unprognostic (2.46e-2)" "unprognostic (6.44e-2)" "unprognostic (1.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.86e-3)" "unprognostic (9.88e-2)" "unprognostic (7.45e-2)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "prognostic favorable (3.59e-9)" "unprognostic (3.74e-2)" "unprognostic (1.85e-1)" "unprognostic (3.75e-2)" "unprognostic (1.45e-1)" 29.5 39.2 27.1 20.1 29.6 12.4 31.0 26.8 45.4 31.1 32.6 32.5 23.8 33.8 40.0 39.8 41.9 17.4 29.6 29.0 30.2 57.5 63.0 31.7 31.5 27.7 27.7 28.5 26.8 42.6 44.0 30.1 25.1 26.9 36.9 33.1 18.0 36.4 30.9 28.0 34.2 32.2 35.7 27.5 42.3 42.5 37.3 27.7 36.8 36.9 23.4 42.8 35.1 26.5 29.5 69.1 58.3 48.8 20.1 66.2 57.5 53.0 55.2 49.7 64.3 62.7 45.3 70.4 64.1 64.3 48.5 38.7 83.7 41.3 92.9 64.0 46.2 46.7 58.2 40.6 34.7 49.1 76.1 60.1 55.5 54.4 63.1 48.1 54.0 85.9 46.5 59.9 26.2 65.8 65.4 55.7 58.7 25.3 82.6 49.8 68.6 36.7 78.5 75.2 50.6 51.4 33.7 83.0 29.7 55.2 46.6 50.7 41.5 67.7 36.0 44.5 25.4 40.6 57.9 63.8 64.8 34.3 36.2 28.6 77.2 41.9 39.1 32.7 42.1 35.4 37.4 33.5 39.7 39.1 41.5 33.5 33.3 23.5 33.5 45.6 33.8 40.6 46.5 27.1 29.6 26.8 45.4 29.0 30.2 27.7 27.7 28.5 26.9 27.5 27.7 29.5 22.9 16.0 14.2 7.2 31.2 14.4 21.1 26.5 32.5 12.3 32.4 30.6 12.8 24.3 15.5 23.9 4.2 66.6 21.4 32.7 60.7 40.6 7.4 21.1 16.9 27.1 28.2 25.2 5.3 48.2 63.6 21.8 15.8 17.5 7.0 28.4 26.7 36.8 43.4 6.7 5.8 27.7 12.2 30.4 19.7 18.5 21.5 24.8 12.4 9.4 40.2 21.7 25.7 9.0 11.1 44.8 22.2 27.1 27.2 29.2 27.7 75.6 18.0 10.4 6.6 17.6 21.7 26.4 49.1 19.5 17.2 66.6 22.7 29.1 32.4 21.4 ADAL ENSG00000168803 "Adenosine deaminase like" Q6DHV7 15 43330672-43354569 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 81.3;Rod photoreceptor cells: 84.8;Spermatocytes: 99.5;Spermatogonia: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039879, HPA048175, HPA058795" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA039879: , HPA048175: AB_2680298, HPA058795: " "unprognostic (1.65e-2)" "unprognostic (1.53e-3)" "unprognostic (9.80e-2)" "unprognostic (3.15e-3)" "unprognostic (2.46e-3)" "unprognostic (1.86e-1)" "unprognostic (2.00e-1)" "unprognostic (5.83e-2)" "unprognostic (5.90e-2)" "unprognostic (2.68e-1)" "unprognostic (6.85e-3)" "unprognostic (1.69e-1)" "prognostic favorable (7.64e-9)" "unprognostic (2.37e-3)" "unprognostic (8.77e-2)" "unprognostic (5.31e-2)" "unprognostic (2.44e-2)" 6.3 6.7 7.0 4.2 7.6 4.5 5.9 7.9 9.7 3.5 9.8 5.2 5.9 4.4 8.5 4.2 3.3 3.9 21.1 6.7 7.8 12.0 8.2 3.5 4.8 7.1 7.4 6.4 3.6 3.6 10.4 6.2 2.7 7.5 6.2 4.8 21.4 4.2 6.4 20.6 2.6 4.6 4.7 7.3 3.8 4.1 11.2 7.2 5.5 11.0 23.6 4.9 4.6 3.0 7.8 6.8 3.4 13.3 15.1 5.5 7.1 6.3 8.1 8.2 12.6 19.3 14.2 3.5 8.0 13.0 8.9 16.7 7.5 0.0 5.7 10.8 8.5 8.0 19.0 23.1 12.0 6.9 0.0 14.8 9.1 10.3 8.5 8.7 8.1 2.7 19.4 21.1 16.2 13.2 4.6 12.3 9.7 5.5 7.8 4.6 15.9 19.9 12.7 11.0 4.1 16.3 11.6 13.1 11.7 12.4 7.2 12.5 12.5 3.7 21.9 10.6 16.6 16.5 16.6 29.9 3.4 12.2 21.2 18.1 5.9 1.4 3.8 2.4 2.0 1.8 2.0 2.2 1.9 2.0 1.6 2.3 2.9 1.1 2.3 1.9 2.9 4.5 1.3 7.0 7.6 7.9 9.7 6.7 7.8 7.1 7.4 6.4 7.5 7.3 7.2 7.8 5.9 9.6 10.3 32.7 10.0 7.0 7.4 9.3 7.4 40.7 9.2 9.9 51.2 10.0 6.9 18.4 81.3 7.1 13.3 7.0 58.7 8.9 17.6 10.6 10.3 8.2 7.7 19.1 24.4 8.5 7.0 10.4 5.1 6.8 7.6 15.7 11.0 30.8 8.9 42.1 26.7 7.2 10.2 8.8 7.0 12.7 9.6 8.9 8.8 10.3 5.4 35.5 24.7 19.1 18.3 5.7 1.3 8.6 6.9 7.1 13.0 29.0 10.9 84.8 6.6 11.6 7.3 99.5 82.5 8.8 4.4 2.6 7.0 12.6 11.6 4.4 LCMT2 "KIAA0547, MGC9534, PPM2, TYW4" ENSG00000168806 "Leucine carboxyl methyltransferase 2" O60294 15 43323649-43330582 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039401 Approved Approved Cytosol NA NA Cytosol "HPA039401: AB_10805478" "unprognostic (4.32e-2)" "unprognostic (1.44e-1)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "unprognostic (1.99e-1)" "unprognostic (2.27e-1)" "unprognostic (9.08e-2)" "unprognostic (5.14e-2)" "unprognostic (3.52e-2)" "unprognostic (2.20e-1)" "unprognostic (3.33e-3)" "unprognostic (9.57e-2)" "prognostic favorable (5.69e-9)" "unprognostic (2.28e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" 5.2 4.7 5.5 4.8 5.3 2.0 6.3 6.9 10.3 6.3 6.0 4.8 3.4 6.0 7.6 5.1 6.3 3.1 5.5 5.2 6.0 7.4 6.1 4.0 6.6 5.2 5.2 5.1 5.8 3.8 8.0 4.2 3.6 5.4 6.2 4.6 7.4 3.9 6.5 4.1 3.8 4.3 5.4 5.1 4.4 4.2 4.0 5.2 7.8 5.7 4.7 9.2 5.3 3.2 5.5 8.8 6.7 15.7 13.7 16.3 5.1 7.7 10.7 12.3 13.2 14.6 10.2 4.0 7.5 20.8 12.0 14.2 20.0 0.0 13.8 10.1 11.6 7.3 13.3 18.3 5.9 9.9 0.0 9.8 7.8 13.0 9.8 9.0 8.9 4.3 16.9 17.1 9.6 16.1 13.4 15.4 6.3 6.8 19.0 5.8 17.8 13.7 7.2 23.4 9.8 21.1 17.6 13.8 11.6 6.0 12.1 14.1 20.2 3.7 15.6 7.1 18.1 17.4 6.5 16.6 3.0 9.7 10.9 16.5 1.7 2.6 3.8 2.3 2.4 3.3 3.2 3.9 2.9 4.4 3.5 6.0 4.1 0.8 2.0 2.2 2.6 3.3 3.2 5.5 5.3 6.9 10.3 5.2 6.0 5.2 5.2 5.1 5.4 5.1 5.2 5.5 1.5 0.0 3.1 1.3 3.5 3.1 3.7 1.9 1.8 7.6 2.9 2.8 3.6 5.7 5.7 3.7 8.4 4.3 2.7 2.8 3.9 6.5 2.1 3.6 3.9 3.1 5.4 4.8 1.1 4.0 2.3 3.7 2.0 4.1 1.3 2.2 5.0 4.1 2.7 3.3 1.6 2.2 4.1 1.3 0.8 1.5 5.0 2.7 0.0 1.9 2.4 7.3 4.1 0.5 1.7 3.4 2.1 1.5 2.5 3.3 1.8 4.7 6.2 6.6 6.6 5.1 3.7 23.4 10.5 2.7 2.8 2.5 2.6 2.4 3.3 2.8 SNTB2 "D16S2531E, EST25263, SNT2B2, SNT3, SNTL" ENSG00000168807 "Syntrophin beta 2" Q13425 16 69187129-69309052 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SiHa: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001394 Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA001394: AB_1080170" "unprognostic (4.86e-1)" "unprognostic (3.26e-2)" "unprognostic (2.77e-2)" "unprognostic (8.07e-3)" "unprognostic (6.46e-2)" "unprognostic (9.68e-2)" "unprognostic (1.89e-2)" "unprognostic (5.50e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-2)" "unprognostic (3.64e-2)" "unprognostic (5.77e-3)" "unprognostic (1.71e-2)" "unprognostic (7.43e-2)" "unprognostic (1.73e-2)" "unprognostic (1.88e-1)" 10.7 5.1 3.5 5.3 3.7 2.7 8.9 1.2 5.3 10.5 9.0 6.3 3.7 10.5 5.1 7.1 8.7 7.1 4.5 4.4 8.0 6.8 3.9 8.6 5.7 2.8 1.2 3.9 6.2 4.1 12.5 4.0 5.2 1.7 8.3 5.3 21.8 5.2 5.5 5.7 8.3 6.1 8.8 0.9 5.7 6.1 7.2 1.5 5.8 10.6 3.8 4.9 8.7 8.7 4.1 7.2 10.9 7.4 5.8 26.6 35.6 9.1 13.9 19.3 10.7 11.8 10.7 6.5 9.0 8.3 16.2 5.6 12.9 10.0 6.8 13.9 4.0 5.5 4.0 11.1 9.2 8.8 0.3 5.9 25.6 4.9 17.6 7.1 11.1 32.4 2.5 2.3 13.8 13.1 8.2 3.0 1.4 5.0 4.2 8.6 18.1 6.5 16.8 5.7 10.9 2.8 6.1 42.6 6.0 4.4 5.5 7.1 0.5 25.4 20.0 9.6 14.2 13.0 3.1 5.2 10.0 12.8 1.4 9.3 0.4 0.2 0.3 0.9 0.3 0.9 0.2 0.4 0.5 0.2 0.2 0.2 1.1 0.9 0.7 0.3 0.1 0.5 0.3 3.5 3.7 1.2 5.3 4.4 8.0 2.8 1.2 3.9 1.7 0.9 1.5 4.1 55.9 19.2 11.7 36.6 9.0 38.0 28.0 17.1 70.0 33.2 19.0 25.0 9.2 10.0 10.4 27.6 41.7 9.5 33.7 29.0 3.9 9.7 25.9 20.6 61.3 81.4 10.3 4.8 151.4 24.1 7.9 53.1 20.9 28.7 1.3 15.8 126.7 11.1 6.9 5.0 62.6 16.6 8.2 33.1 29.3 27.5 59.0 12.9 30.2 33.7 8.6 214.1 47.4 30.7 27.9 16.3 32.8 65.1 20.7 40.9 12.7 34.5 10.0 136.7 6.6 26.0 35.6 27.9 15.4 30.7 38.8 3.7 32.8 20.2 19.6 28.7 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988835-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6" "Region enhanced" "Detected in single" "cerebral cortex: 2.8" "Not detected" "Not detected" HPA001886 Uncertain "Secreted to blood" NA NA "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.2 0.4 0.9 0.6 0.9 1.5 0.7 0.9 2.0 0.2 0.5 0.7 0.5 0.3 0.1 4.1 2.1 0.2 0.6 0.9 0.9 0.4 0.1 2.1 0.8 0.9 1.1 0.7 0.5 0.5 0.0 0.5 0.1 1.0 0.3 0.4 0.1 0.3 0.1 0.2 0.1 0.8 0.2 0.7 1.2 0.5 0.3 1.0 0.4 0.2 0.7 0.5 0.7 0.6 1.0 3.1 0.3 0.4 2.6 0.0 0.2 0.2 3.3 2.1 3.9 8.1 1.2 0.1 0.0 0.2 0.5 4.5 0.3 0.8 0.5 3.6 13.2 4.1 0.1 0.2 0.9 2.5 0.7 6.1 0.6 1.0 6.9 2.7 2.7 1.2 0.3 0.0 2.1 2.4 0.1 0.1 0.0 0.4 0.1 1.8 2.4 0.0 0.4 0.4 0.2 0.1 1.2 0.0 17.6 0.5 0.6 0.9 1.4 0.9 0.8 0.8 2.3 6.3 1.4 0.0 0.0 1.5 5.9 0.8 0.0 0.0 0.5 0.3 0.1 0.5 0.5 0.1 0.6 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.9 0.9 2.0 0.9 0.9 0.9 1.1 0.7 1.0 0.7 1.0 1.0 1.0 0.0 0.6 1.0 3.4 0.1 2.1 1.0 1.2 0.0 1.6 2.2 0.4 0.0 1.1 0.0 0.0 0.1 0.7 0.3 0.0 1.5 0.0 3.9 0.2 1.4 2.4 0.8 0.1 0.0 0.0 0.4 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.9 4.1 0.3 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 4.0 1.3 0.4 0.2 0.0 2.1 2.9 0.1 0.0 6.1 0.0 6.6 1.5 0.3 0.4 2.9 2.6 0.1 0.0 0.7 0.1 0.5 1.3 ZNF507 "KIAA1084, Zfp507" ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 5.2 4.2 4.6 4.6 6.1 6.9 6.9 6.7 5.6 6.0 3.7 4.4 5.8 6.9 4.4 5.2 6.0 4.3 5.6 4.6 4.9 4.8 6.4 4.4 6.8 5.1 5.6 4.3 9.6 5.3 6.3 3.7 7.0 5.6 5.9 5.4 8.1 6.4 4.8 9.2 4.7 6.0 6.1 5.0 5.2 5.3 13.2 5.1 8.6 10.8 8.8 5.9 4.4 4.1 7.6 10.0 16.2 13.5 8.2 9.3 14.6 11.4 8.5 8.1 7.3 8.1 9.8 7.6 15.1 10.5 7.8 8.3 5.9 19.4 10.5 14.8 10.6 15.3 14.8 8.7 7.7 11.0 12.8 8.0 9.5 8.9 9.0 15.4 8.6 10.9 11.9 21.0 10.7 8.6 5.8 13.5 5.2 14.9 15.0 5.8 14.0 16.1 6.4 5.5 9.9 11.9 10.5 11.2 7.8 10.2 10.7 5.9 9.5 10.4 12.6 13.3 8.0 11.9 10.4 12.9 14.1 8.7 9.3 11.5 0.2 0.0 0.5 1.0 0.0 1.1 0.7 0.8 0.8 0.0 1.0 1.1 0.9 0.5 0.6 0.0 0.1 0.6 0.4 4.6 6.1 6.7 5.6 4.6 4.9 5.1 5.6 4.3 5.6 5.0 5.1 7.6 13.3 9.6 17.7 22.5 13.2 2.8 8.8 5.3 13.6 22.2 9.3 7.6 16.1 5.7 9.0 0.0 14.6 10.9 7.7 7.6 1.9 5.6 22.1 10.0 22.7 11.0 9.0 12.4 31.3 5.5 5.3 11.9 12.2 11.4 3.8 17.1 13.6 12.1 3.7 58.9 36.0 11.5 4.1 0.3 1.8 11.0 9.3 0.8 1.8 16.9 0.4 17.2 10.3 31.2 46.6 4.9 8.0 7.2 6.4 12.0 15.6 4.2 16.1 23.5 0.0 16.1 13.9 25.8 18.9 10.9 2.7 8.8 11.3 12.6 11.2 7.6 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 120.9" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 191.1;Glandular and luminal cells: 249.4" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.84e-4)" "prognostic favorable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favorable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favorable (4.69e-4)" 10.3 16.1 8.6 11.0 9.7 12.1 11.0 9.1 10.5 120.9 13.5 13.0 18.3 54.4 8.3 10.8 49.0 14.1 13.1 8.5 9.7 29.5 15.9 10.9 13.3 10.2 9.1 7.9 11.4 22.7 17.0 14.7 12.9 9.8 10.7 13.5 8.4 12.2 9.0 16.6 12.1 15.8 15.9 7.9 10.7 18.6 30.7 9.8 9.5 11.4 10.0 12.5 11.1 11.9 9.7 26.6 16.7 19.3 20.0 16.2 23.7 26.1 30.1 26.9 27.6 22.8 35.5 37.3 35.1 69.7 27.1 24.9 13.9 34.6 17.2 27.0 15.1 18.6 22.0 22.3 43.4 24.2 38.6 17.8 22.2 14.7 23.4 16.9 15.4 23.5 27.5 21.7 30.0 19.9 14.0 35.6 27.2 26.0 21.3 36.1 31.4 14.6 28.2 28.2 15.6 24.7 22.0 22.2 14.7 26.4 16.5 21.6 18.3 27.2 16.7 18.4 15.4 32.1 21.6 35.4 40.1 20.4 29.3 21.0 10.6 15.6 10.8 15.1 16.0 18.2 16.7 14.0 13.7 23.8 14.4 11.7 13.4 3.1 16.9 20.6 37.6 14.3 14.0 8.6 9.7 9.1 10.5 8.5 9.7 10.2 9.1 7.9 9.8 7.9 9.8 9.7 17.5 32.1 9.0 52.5 15.8 7.9 8.3 20.3 9.6 39.3 14.4 11.6 20.4 18.6 25.3 20.2 20.9 31.0 27.9 33.8 70.5 32.5 80.6 191.1 38.4 14.8 4.9 15.6 40.2 27.9 19.0 18.5 23.9 249.4 8.2 21.6 6.8 10.8 28.1 10.1 48.0 22.8 32.6 13.7 12.4 76.5 14.0 21.3 14.2 48.7 26.5 25.8 16.5 37.7 56.4 36.5 28.8 14.7 20.4 15.7 32.8 25.2 34.5 17.7 6.6 13.1 18.1 94.9 35.7 13.1 9.7 31.7 18.9 27.2 20.0 13.9 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 128.6;pituitary gland: 136.2;skin 1: 121.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2" "Cancer enriched" "Detected in many" 4 "melanoma: 61.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6" "Lineage enriched" "Detected in many" 57 "T-cells: 61.9" "Cell line enhanced" "Detected in many" "HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favorable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 2.6 25.6 29.2 4.2 32.9 1.0 6.1 60.8 51.5 11.1 5.6 8.0 6.8 7.9 2.1 30.9 20.2 1.3 6.0 19.5 82.0 4.3 0.5 1.5 3.2 52.7 60.7 29.2 46.7 1.8 0.1 136.2 18.5 56.3 23.0 7.1 32.5 6.8 18.4 0.8 121.9 5.8 6.9 21.8 2.2 8.1 16.1 58.8 9.6 0.5 3.1 3.5 13.5 30.4 128.6 0.2 0.1 0.8 0.5 0.0 0.0 14.6 0.3 0.0 0.2 0.0 1.3 0.4 0.0 10.4 0.5 3.3 2.4 84.7 5.5 0.4 0.0 3.0 0.0 0.2 0.0 4.1 0.0 0.0 0.1 12.0 0.0 2.3 0.0 14.6 22.3 0.0 0.1 1.3 0.0 6.8 0.5 10.1 0.1 0.4 0.1 0.0 0.4 0.0 4.8 168.6 82.5 0.6 0.2 80.9 7.0 0.9 0.3 204.6 0.0 13.0 0.2 0.3 0.1 0.4 75.9 0.1 0.2 0.4 0.2 0.1 0.1 45.2 0.1 61.9 0.1 42.2 37.1 0.1 0.1 10.4 27.6 1.0 0.9 0.2 0.1 4.5 15.7 29.2 32.9 60.8 51.5 19.5 82.0 52.7 60.7 29.2 56.3 21.8 58.8 128.6 1.6 9.6 0.0 5.9 0.4 86.8 83.4 47.9 31.3 222.4 0.7 24.3 0.0 0.0 13.2 0.0 4.2 120.2 6.0 0.0 0.0 0.0 31.2 10.3 1.4 2.1 2.4 0.0 16.6 0.0 15.2 24.9 0.0 16.4 1.3 128.8 1.8 0.0 8.2 8.4 32.2 0.0 4.1 0.0 13.6 44.2 3.1 1.3 291.7 6.5 0.4 6.4 20.6 1.5 4.0 0.1 0.2 5.7 0.7 19.9 0.0 20.4 1.7 24.3 0.0 0.2 10.8 2.9 14.4 44.8 178.2 76.8 17.0 96.0 0.3 77.0 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favorable (2.88e-5)" 2.2 1.8 0.8 2.3 0.8 5.1 2.4 1.1 1.6 2.3 1.0 1.9 1.7 2.3 2.4 1.8 2.0 1.9 2.3 0.9 1.0 1.5 1.9 2.4 3.1 1.1 0.9 0.7 3.7 2.9 2.1 3.2 2.1 1.1 2.8 1.6 3.5 2.2 2.2 2.9 2.2 1.9 2.3 0.6 3.6 1.7 4.0 1.4 2.0 2.9 2.1 3.0 2.4 2.1 2.4 1.4 2.2 2.7 4.6 3.6 3.7 3.2 1.6 3.2 3.6 2.8 1.9 2.6 4.9 1.7 1.9 4.4 2.3 4.8 2.8 3.7 1.6 1.9 5.7 1.5 2.8 2.8 3.5 2.0 2.4 2.3 3.3 2.1 2.0 3.6 5.2 3.0 2.6 3.4 2.2 6.9 6.7 4.7 2.0 3.0 4.1 3.6 3.1 1.4 2.4 3.3 3.2 3.7 1.4 3.7 3.6 2.0 3.3 3.6 3.2 1.4 2.0 3.7 3.1 3.3 4.3 2.3 2.9 3.2 2.9 2.0 9.8 4.6 2.1 3.8 1.6 2.6 4.5 1.5 2.4 2.9 3.4 4.6 2.8 1.8 0.3 2.6 1.5 0.8 0.8 1.1 1.6 0.9 1.0 1.1 0.9 0.7 1.1 0.6 1.4 2.4 3.1 0.0 1.1 3.9 5.3 2.5 1.9 1.8 2.2 2.9 2.2 3.4 1.9 1.5 2.1 1.8 4.2 2.0 5.8 0.8 0.0 1.9 2.7 1.2 2.7 3.1 1.2 3.6 11.5 2.6 1.5 3.1 2.0 1.3 1.3 5.4 3.9 2.2 1.8 1.7 12.5 1.8 2.0 3.1 2.4 0.7 1.5 2.7 3.6 4.7 4.5 1.7 9.2 11.6 10.0 1.1 2.9 2.2 6.6 2.1 1.8 0.9 1.3 8.2 0.0 2.2 2.1 9.7 5.5 1.7 2.6 1.5 6.3 4.6 1.6 1.2 GFM1 "EFGM, EGF1, GFM, mtEF-G1" ENSG00000168827 "G elongation factor mitochondrial 1" Q96RP9 3 158644527-158695581 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034764, HPA034765, HPA061405" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (5.48e-3)" "unprognostic (4.48e-3)" "unprognostic (1.84e-1)" "unprognostic (3.40e-1)" "unprognostic (4.75e-2)" "unprognostic (6.05e-2)" "unprognostic (2.48e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.79e-1)" "prognostic favorable (1.16e-7)" "unprognostic (1.62e-1)" "unprognostic (4.78e-1)" "unprognostic (3.32e-2)" "unprognostic (8.78e-2)" 26.9 25.3 13.9 21.9 15.2 24.3 28.1 20.0 21.0 14.2 17.7 30.4 25.1 17.4 21.0 24.3 13.5 17.6 39.3 14.7 17.1 44.1 50.0 19.0 20.8 16.1 16.0 14.5 12.9 26.7 40.4 12.1 25.9 17.4 19.7 31.8 46.8 21.1 22.2 63.6 15.1 20.0 21.1 15.5 16.6 24.1 23.7 15.6 16.7 32.4 60.7 20.9 23.7 13.0 17.2 92.2 55.9 25.5 32.0 41.8 30.6 34.2 42.6 49.8 75.9 57.4 73.2 58.7 73.9 54.7 39.2 32.0 55.9 62.5 47.8 84.3 40.6 33.7 56.1 34.6 34.3 48.6 76.7 35.9 37.3 55.7 43.8 41.0 17.6 50.2 43.0 71.7 50.3 67.9 56.9 49.6 30.6 55.7 97.0 29.8 49.8 28.0 132.6 51.0 38.3 48.9 42.8 63.8 96.1 79.1 19.9 132.1 60.0 28.0 46.4 21.0 69.4 74.1 82.7 61.4 138.9 41.8 65.0 52.4 18.9 19.3 13.8 22.2 27.2 28.6 17.0 19.3 23.0 23.3 16.4 22.1 23.9 3.0 25.4 22.0 11.2 17.4 18.4 13.9 15.2 20.0 21.0 14.7 17.1 16.1 16.0 14.5 17.4 15.5 15.6 17.2 31.4 19.2 19.0 17.0 26.1 21.5 26.0 20.9 20.5 57.3 23.0 11.9 54.8 22.8 18.9 12.9 31.3 31.6 20.1 22.2 11.7 19.9 15.4 12.4 20.2 36.6 19.3 29.0 39.8 25.0 17.6 20.9 22.4 14.8 19.0 17.7 22.5 61.6 29.0 15.2 43.9 24.5 30.5 20.4 21.5 7.6 22.7 21.7 17.8 18.7 33.8 27.3 16.5 22.6 43.3 20.3 10.5 17.0 19.2 21.7 22.1 37.9 25.1 51.6 13.1 21.5 23.4 34.4 31.6 20.1 21.0 30.8 22.3 41.4 28.9 22.0 OR13J1 ENSG00000168828 "Olfactory receptor family 13 subfamily J member 1" Q8NGT2 9 35869263-35870601 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "retina: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" NA NA "unprognostic (6.58e-2)" "unprognostic (2.89e-2)" "unprognostic (1.82e-1)" "unprognostic (2.49e-1)" "unprognostic (9.58e-2)" "unprognostic (7.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.07e-1)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1E 5-HT1E ENSG00000168830 "5-hydroxytryptamine receptor 1E" P28566 6 86937528-87016679 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1;ovary: 4.3" "Group enriched" "Detected in some" 15 "Excitatory neurons: 125.4;Inhibitory neurons: 104.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "PC-3: 1.7;SH-SY5Y: 6.6" "Low region specificity" "Detected in many" HPA004931 Approved NA NA "HPA004931: AB_1856706" "unprognostic (2.25e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.25e-1)" 0.0 0.0 1.1 0.0 3.4 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 2.5 1.4 0.0 0.0 0.0 0.0 1.0 0.4 3.4 4.3 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 1.3 0.3 0.9 0.0 0.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.4 0.0 4.1 2.5 1.4 1.0 0.4 3.4 1.2 0.0 0.9 2.9 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 1.1 0.0 0.0 0.0 125.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 104.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 FSTL5 "DKFZp566D234, KIAA1263" ENSG00000168843 "Follistatin like 5" Q8N475 4 161383897-162164004 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "brain: 67.1;retina: 95.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 306.0;Cone photoreceptor cells: 462.9;Excitatory neurons: 184.7;Inhibitory neurons: 517.7;Rod photoreceptor cells: 139.6" "Cancer enriched" "Detected in single" 6 "melanoma: 1.7" "Region enhanced" "Detected in all" "cerebellum: 67.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 75.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 57.3" "Secreted in brain" NA NA "unprognostic (4.90e-2)" "unprognostic (4.46e-1)" "unprognostic (1.52e-2)" "unprognostic (2.03e-1)" "unprognostic (3.66e-2)" "unprognostic (2.99e-2)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.61e-1)" "unprognostic (1.08e-10)" "unprognostic (8.45e-4)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (6.60e-3)" 0.0 6.1 7.8 0.0 6.9 0.0 0.0 67.1 5.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.1 14.9 0.0 0.0 0.0 0.0 10.4 12.1 3.5 0.0 0.3 0.0 1.2 0.1 19.4 0.0 0.1 95.6 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.0 0.0 12.4 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 75.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 10.8 0.0 0.0 0.7 0.1 0.0 0.3 0.1 0.0 0.0 16.2 0.0 6.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.9 67.1 5.2 3.1 14.9 10.4 12.1 3.5 19.4 5.2 8.7 15.0 0.0 0.0 0.0 47.7 0.0 0.3 0.0 0.0 0.0 306.0 0.0 0.0 0.1 0.0 0.0 0.0 462.9 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 184.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 28.6 517.7 0.0 0.0 0.3 0.3 4.5 0.6 0.0 1.8 7.5 0.0 20.7 0.0 8.0 75.3 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 139.6 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDX19A "DDX19L, FLJ11126" ENSG00000168872 "DEAD-box helicase 19A" Q9NUU7 16 70346861-70373383 "Enzymes, Predicted intracellular proteins, Transporters" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045252, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045252: AB_10961128, HPA066668: " "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (9.07e-2)" "unprognostic (3.95e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.38e-4)" "prognostic unfavorable (8.05e-5)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.67e-1)" "unprognostic (1.30e-1)" "unprognostic (5.87e-2)" "unprognostic (1.24e-1)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (3.01e-2)" "unprognostic (6.68e-3)" 20.2 19.3 10.6 14.3 10.9 12.7 17.8 11.5 12.2 16.5 11.5 18.7 10.4 21.0 14.2 20.0 17.3 16.1 23.1 10.2 11.3 17.7 22.0 15.7 19.3 11.5 11.1 9.0 21.9 17.4 25.0 11.9 23.8 11.7 15.5 15.2 12.7 14.7 21.0 58.9 16.2 14.1 27.2 11.3 15.3 17.1 7.4 11.5 21.2 20.5 38.9 20.7 22.5 14.6 11.7 36.5 39.9 42.4 43.8 60.8 41.7 39.6 45.8 46.7 70.0 54.1 60.9 27.5 60.4 41.8 49.2 34.1 41.6 75.3 45.2 60.4 20.0 41.1 31.7 32.0 75.5 55.0 56.9 26.3 51.0 31.7 65.3 49.8 35.1 46.3 43.5 77.6 15.6 42.6 53.0 62.2 47.8 68.6 43.6 24.6 79.2 27.9 84.8 42.3 23.0 35.1 45.8 115.3 25.4 35.6 43.8 47.4 35.5 31.0 49.0 39.2 31.4 43.9 44.6 70.5 132.7 32.8 50.8 50.5 9.3 8.6 4.7 7.3 8.0 6.7 5.3 6.4 7.2 10.5 5.8 7.0 7.4 0.8 7.1 7.6 5.9 6.0 7.0 10.6 10.9 11.5 12.2 10.2 11.3 11.5 11.1 9.0 11.7 11.3 11.5 11.7 14.8 16.0 20.7 15.3 19.1 9.9 21.2 8.6 14.8 35.0 10.4 11.0 18.0 22.8 17.5 11.0 33.3 23.0 12.7 8.2 9.8 14.7 3.2 14.7 18.6 15.6 14.4 21.0 23.4 13.8 16.3 16.0 7.1 15.2 17.7 18.0 12.5 19.5 14.0 23.5 25.7 10.1 2.0 14.2 9.5 2.0 26.1 11.2 10.6 2.8 19.2 15.6 27.8 8.5 10.9 14.0 9.5 12.4 19.8 23.0 8.7 13.3 12.8 32.3 26.3 14.7 15.1 14.7 15.7 16.3 10.2 17.2 16.3 18.0 13.6 16.0 ATOH8 "bHLHa21, FLJ14708, HATH6" ENSG00000168874 "Atonal bHLH transcription factor 8" Q96SQ7 2 85751344-85791383 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 55.1" "Cell type enhanced" "Detected in many" "Adipocytes: 123.8;Endothelial cells: 41.7;Hepatocytes: 39.1;Muller glia cells: 32.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 15.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.2;fHDF/TERT166: 6.8;hTERT-RPE1: 5.0;RH-30: 9.5;RT4: 5.6;TIME: 7.9;U-2197: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028406 Supported Nucleoplasm NA NA Nucleoplasm "HPA028406: AB_2672587" "unprognostic (7.70e-2)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (2.84e-3)" "unprognostic (2.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.78e-1)" "unprognostic (6.28e-3)" "unprognostic (1.56e-1)" "prognostic favorable (8.98e-6)" "unprognostic (3.32e-2)" "prognostic favorable (3.80e-5)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-2)" 30.6 1.8 1.9 0.3 2.2 0.0 30.1 2.6 1.9 20.3 1.1 8.8 0.2 26.1 0.2 5.6 19.5 0.4 25.9 1.5 7.2 7.3 25.3 25.8 0.8 5.1 2.9 0.8 15.1 4.2 0.2 5.4 0.3 7.1 17.5 0.4 0.6 5.3 1.9 55.1 17.6 9.0 1.3 1.8 12.3 9.5 2.1 3.1 0.2 48.9 2.0 0.1 21.9 20.8 3.2 0.0 1.1 4.1 6.2 3.0 0.4 0.0 3.4 0.5 0.8 0.3 0.0 0.0 0.0 1.1 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.1 1.6 0.0 0.0 2.1 0.0 0.0 0.0 5.0 0.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 9.5 0.0 0.0 5.6 3.0 1.4 0.6 0.0 0.6 0.0 0.0 0.0 7.9 1.2 0.0 5.5 0.0 0.0 0.0 0.0 0.8 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.2 2.6 1.9 1.5 7.2 5.1 2.9 0.8 7.1 1.8 3.1 3.2 123.8 9.6 18.3 10.7 0.3 2.5 8.5 11.8 0.6 0.4 0.5 0.8 13.2 5.7 17.5 1.8 0.0 0.1 0.1 1.1 0.0 11.9 13.6 5.9 5.7 41.7 4.2 0.0 0.3 2.3 0.6 11.4 1.1 20.5 1.3 5.3 5.7 39.1 3.2 0.0 0.3 2.2 6.1 3.1 4.0 25.9 3.4 4.3 1.8 5.6 0.6 32.3 0.0 14.6 3.1 1.0 5.5 0.4 0.0 4.5 0.0 0.6 2.4 1.3 0.0 12.2 11.6 3.0 2.7 0.2 1.4 0.3 0.5 0.1 1.0 2.3 SOX14 SOX28 ENSG00000168875 "SRY-box transcription factor 14" O95416 3 137764315-137766334 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 8.8" "Cell type enriched" "Detected in some" 5 "Cytotrophoblasts: 18.4" "Cancer enhanced" "Detected in many" "prostate cancer: 2.8" "Region enhanced" "Detected in many" "thalamus: 8.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 1.7;midbrain: 4.9" "Group enriched" "Detected in some" 6 "midbrain: 7.1;pons: 4.5;thalamus: 11.8" NA NA "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.88e-2)" "unprognostic (2.49e-3)" "unprognostic (5.08e-1)" 0.0 0.0 1.6 0.0 0.3 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 1.5 0.4 0.0 1.5 0.5 4.1 0.0 1.5 0.1 8.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493979-94499578 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 7.4 6.9 8.5 12.9 8.8 25.4 13.3 11.1 11.5 9.5 8.3 10.9 11.6 10.5 18.4 9.6 8.6 8.5 5.3 8.5 8.1 7.9 8.6 7.6 21.0 8.6 8.1 7.9 12.7 13.5 9.4 9.0 12.2 8.9 11.0 13.8 11.9 10.8 10.9 5.8 10.3 16.3 8.9 8.2 15.8 12.8 5.5 8.0 17.3 14.3 7.4 21.0 8.0 8.6 9.4 8.9 4.4 11.0 9.4 10.2 12.0 13.5 13.3 12.0 14.9 17.1 20.7 18.4 23.4 20.9 8.5 12.5 20.5 14.0 9.8 12.2 17.9 12.1 18.9 16.8 7.8 11.1 17.8 15.8 9.1 23.1 10.7 14.9 10.4 11.3 20.9 18.4 14.4 9.4 6.1 19.8 32.8 6.3 17.5 9.8 14.9 11.3 12.0 12.9 9.2 10.5 10.9 10.2 9.8 8.7 18.4 18.0 12.9 7.5 13.0 9.3 13.8 7.2 7.6 20.0 24.6 4.4 21.8 7.4 77.8 23.1 23.9 21.9 19.5 23.7 34.1 23.4 19.4 18.4 28.8 28.4 25.9 42.7 27.2 15.8 30.5 31.4 17.8 8.5 8.8 11.1 11.5 8.5 8.1 8.6 8.1 7.9 8.9 8.2 8.0 9.4 20.5 12.8 9.3 11.1 43.2 5.6 10.0 15.1 14.2 16.3 14.0 11.3 9.1 24.3 15.4 25.8 14.6 31.1 36.1 27.8 21.5 20.3 10.1 11.9 18.1 15.4 13.3 40.0 11.1 23.0 13.8 16.5 27.0 15.1 21.5 18.7 16.4 18.8 14.3 11.8 9.5 23.6 8.2 28.5 8.4 3.7 35.8 18.5 10.6 8.4 28.1 21.8 57.7 5.5 12.7 22.8 35.2 23.7 28.0 11.3 45.3 19.3 8.1 14.4 26.3 11.3 18.4 21.0 19.9 11.6 6.8 28.0 36.5 9.8 22.0 5.8 SFTPB "SFTP3, SP-B" ENSG00000168878 "Surfactant protein B" P07988 2 85657314-85668741 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 32 "lung: 3597.3" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 15343.4" "Cancer enriched" "Detected in many" 5 "lung cancer: 1306.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.8;NB-4: 3.5;U-2197: 6.7;U-266/70: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002440, HPA034820, HPA062148" Enhanced "Secreted in other tissues" NA NA 80000000 "CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697" "unprognostic (6.46e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (2.25e-3)" "unprognostic (4.57e-3)" "unprognostic (8.57e-3)" "unprognostic (6.45e-3)" "unprognostic (1.13e-1)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.37e-1)" "unprognostic (1.09e-1)" "unprognostic (7.90e-2)" "unprognostic (4.38e-2)" 0.7 4.4 1.8 2.2 1.7 0.4 0.5 2.0 3.0 0.5 1.3 0.5 0.4 0.2 0.7 0.4 0.3 0.2 1.3 1.7 2.0 2.1 1.2 3597.3 0.3 1.7 1.5 1.5 11.1 1.0 0.2 5.5 1.5 1.8 1.3 0.4 2.9 0.5 2.0 1.2 0.8 0.7 0.1 1.2 4.1 5.1 0.5 1.7 0.3 114.0 0.3 0.2 0.2 0.4 1.9 0.1 0.2 0.2 0.5 0.3 0.5 2.8 0.2 0.2 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 2.0 0.2 0.0 0.0 0.3 0.2 0.3 0.7 0.3 0.1 0.1 1.4 0.0 0.3 0.2 0.1 0.5 0.0 0.4 0.3 0.4 0.1 0.3 1.1 3.5 1.6 0.5 0.4 1.3 0.2 0.3 0.2 0.3 0.4 0.3 0.0 0.4 0.2 0.3 0.3 0.3 0.0 0.2 0.6 6.7 0.1 2.4 0.6 0.2 0.6 0.5 0.1 0.3 0.6 0.2 0.2 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.6 0.2 0.7 0.2 0.4 0.4 1.8 1.7 2.0 3.0 1.7 2.0 1.7 1.5 1.5 1.8 1.2 1.7 1.9 0.0 3650.6 15343.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1930.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 14.4 0.0 0.0 0.2 0.2 0.0 26.9 0.0 0.0 262.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.2 0.0 0.3 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 185.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 36.5 0.0 0.0 0.2 USP39 "CGI-21, SAD1, SNRNP65" ENSG00000168883 "Ubiquitin specific peptidase 39" Q53GS9 2 85602856-85649283 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034823, HPA077350" Supported Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA034823: AB_10602488, HPA077350: " "unprognostic (1.10e-2)" "unprognostic (3.31e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.46e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (2.84e-6)" "unprognostic (1.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (5.17e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (4.05e-7)" "unprognostic (3.95e-3)" "unprognostic (2.25e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-1)" 21.8 16.2 17.4 20.0 17.6 41.1 21.4 18.2 20.8 21.4 21.2 23.2 17.3 23.7 26.3 22.9 19.6 12.8 21.8 17.3 19.6 19.6 18.7 21.6 26.7 18.5 17.7 16.7 20.2 17.3 22.0 14.4 27.1 18.2 18.8 22.9 22.2 19.2 21.4 55.6 23.5 19.7 21.5 18.4 21.0 20.8 15.7 18.0 41.3 20.0 43.0 32.5 24.9 20.8 19.6 71.0 70.0 70.0 77.5 49.7 38.7 79.5 59.2 54.6 84.1 74.5 113.9 49.8 83.0 53.4 54.6 62.3 50.6 135.7 62.5 105.8 83.9 86.4 103.4 39.1 100.6 49.0 127.4 67.5 27.9 49.3 65.1 57.8 39.3 68.1 85.3 129.8 47.2 62.8 81.4 125.2 94.8 92.8 84.9 64.2 114.1 150.0 63.1 45.0 53.8 65.1 53.7 36.4 58.9 51.4 56.7 39.5 60.5 43.9 51.7 65.0 62.7 97.2 42.0 83.0 87.7 44.9 130.5 63.6 51.1 35.8 44.5 40.2 42.4 46.6 34.7 41.8 41.7 40.6 37.0 40.4 37.0 23.1 40.4 41.6 32.0 53.4 43.6 17.4 17.6 18.2 20.8 17.3 19.6 18.5 17.7 16.7 18.2 18.4 18.0 19.6 18.4 19.2 25.2 19.9 17.5 20.5 16.7 17.9 22.2 8.5 14.1 14.0 17.3 11.5 19.9 12.9 8.4 54.1 17.8 14.8 21.5 21.1 26.1 9.8 15.4 17.1 12.1 18.3 13.9 18.8 31.8 17.1 9.7 11.7 17.1 16.3 17.5 14.2 25.6 5.0 18.2 13.4 24.4 11.9 14.7 13.0 19.3 17.6 19.6 17.8 26.4 15.3 12.3 16.1 33.1 19.2 8.5 18.8 14.0 16.0 11.2 14.6 15.6 11.6 0.0 13.0 17.7 19.5 17.1 15.5 16.2 35.7 21.3 12.7 15.7 16.3 TNIP2 "ABIN-2, FLIP1, KLIP, MGC4289" ENSG00000168884 "TNFAIP3 interacting protein 2" Q8NFZ5 4 2741648-2756342 "Predicted intracellular proteins" "Apoptosis, Inflammatory response, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020818, HPA049886, HPA063197" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960" "unprognostic (1.22e-1)" "unprognostic (2.09e-1)" "unprognostic (2.44e-1)" "prognostic favorable (1.13e-4)" "unprognostic (3.64e-1)" "unprognostic (9.87e-2)" "unprognostic (4.36e-2)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.77e-1)" "unprognostic (2.47e-2)" "unprognostic (8.34e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.94e-5)" "unprognostic (3.00e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-3)" "unprognostic (4.02e-3)" 30.2 20.1 16.0 16.6 15.1 24.1 26.5 15.3 18.6 19.9 14.8 31.9 17.9 20.4 6.4 27.4 18.3 10.7 27.9 13.7 22.4 37.3 30.3 30.2 17.8 16.8 15.5 13.1 18.9 23.0 5.6 19.9 15.8 16.0 24.7 10.6 2.7 19.3 9.2 41.9 19.1 39.7 10.0 16.1 31.4 28.0 23.0 16.2 10.9 22.4 13.7 16.1 30.5 20.9 18.4 24.4 32.6 10.1 15.4 31.5 21.6 43.7 25.8 22.9 23.6 22.9 37.2 38.5 22.1 28.7 28.3 52.9 15.8 18.3 29.8 13.8 17.2 23.0 26.4 19.9 41.9 39.0 21.9 32.2 27.9 26.5 26.1 23.5 18.1 33.9 19.8 27.4 30.4 16.5 50.6 29.0 53.6 26.6 35.9 55.0 18.9 15.3 11.6 25.5 26.9 15.1 17.0 20.2 21.0 29.6 17.2 23.0 32.0 40.0 18.2 20.1 29.0 40.4 31.3 22.8 16.0 33.3 39.1 20.2 7.6 8.9 27.1 7.4 13.9 8.1 9.6 11.3 12.5 8.7 14.4 9.2 7.6 8.4 5.7 14.8 4.0 13.3 6.3 16.0 15.1 15.3 18.6 13.7 22.4 16.8 15.5 13.1 16.0 16.1 16.2 18.4 48.2 6.4 9.8 3.6 40.7 61.3 49.3 42.5 19.4 2.0 25.3 17.8 13.2 7.2 19.0 14.7 2.1 52.4 44.6 56.0 13.7 58.2 2.3 26.0 26.4 46.7 19.2 8.2 1.1 59.6 106.1 28.4 28.5 33.3 13.3 21.4 41.0 16.7 34.5 0.0 0.7 38.0 24.4 21.2 112.7 7.5 21.5 34.6 26.6 3.7 71.8 12.4 48.4 0.5 3.4 71.8 63.0 17.7 21.2 86.6 174.3 46.8 13.0 6.8 19.7 18.7 38.0 23.6 62.4 28.1 79.0 95.6 44.9 17.1 38.0 84.7 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85605254-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: AB_2681360" "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.8 9.5 8.7 10.1 11.0 10.6 12.8 14.6 9.4 18.2 9.8 13.6 11.1 15.9 12.3 12.2 15.4 6.6 11.4 8.1 9.4 12.8 11.8 14.1 14.3 11.0 10.5 6.9 20.6 17.3 8.5 14.1 12.6 10.9 16.5 11.0 20.2 16.5 10.8 21.9 16.5 16.7 10.0 10.0 17.0 14.4 9.5 9.8 13.8 16.4 9.9 14.0 13.7 15.5 15.2 8.8 7.9 15.7 11.5 14.2 7.6 10.2 4.3 5.6 6.7 8.7 7.1 10.6 12.4 6.0 7.3 6.0 10.4 7.9 7.5 7.2 6.8 19.1 21.1 13.8 8.5 11.2 12.3 11.4 11.3 9.7 4.4 12.7 10.6 10.1 14.7 10.7 12.4 6.3 9.3 13.3 13.4 6.9 10.2 7.3 14.8 27.8 11.5 8.5 10.1 19.8 14.2 6.5 8.5 9.0 8.7 9.1 6.5 7.0 4.8 12.8 5.9 4.2 17.9 11.8 10.8 7.2 12.9 6.0 32.7 30.5 59.0 22.4 21.8 21.3 14.6 21.1 21.0 22.4 20.7 30.5 28.2 49.2 31.2 27.0 15.2 17.7 16.7 8.7 11.0 14.6 9.4 8.1 9.4 11.0 10.5 6.9 10.9 10.0 9.8 15.2 8.2 64.1 63.1 15.0 18.6 5.9 18.2 10.0 9.6 17.4 16.0 12.3 10.7 37.1 24.3 35.0 35.5 47.2 24.4 24.6 17.6 17.9 4.8 9.4 8.7 13.9 19.2 19.5 2.7 19.8 17.7 12.9 17.9 9.6 34.7 15.6 17.9 25.3 23.3 25.2 6.8 16.9 12.2 34.9 14.3 12.8 24.2 26.0 14.2 15.0 31.4 12.3 38.1 10.1 16.9 19.4 14.0 13.5 13.6 14.4 32.7 26.6 21.0 27.0 19.7 13.7 8.5 37.2 20.1 27.4 9.8 24.9 18.1 10.0 15.8 19.2 TMEM150A "FLJ90024, TM6P1, TMEM150, TTN1" ENSG00000168890 "Transmembrane protein 150A" Q86TG1 2 85598547-85603196 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.9;HHSteC: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019015 Uncertain NA NA "HPA019015: AB_2204758" "unprognostic (2.80e-1)" "unprognostic (1.62e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-3)" "unprognostic (4.09e-3)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-2)" "unprognostic (5.80e-2)" "unprognostic (2.64e-2)" "unprognostic (2.54e-3)" "unprognostic (7.16e-2)" "unprognostic (8.27e-3)" "unprognostic (2.09e-2)" "unprognostic (2.89e-1)" "unprognostic (1.37e-2)" "unprognostic (6.87e-3)" 17.7 16.4 8.7 5.2 9.2 1.2 17.1 8.5 11.1 16.0 9.8 17.7 6.6 17.8 6.3 11.1 17.3 10.5 15.4 8.3 10.7 32.5 38.8 19.4 6.1 10.4 9.2 7.4 17.3 38.2 8.1 11.8 22.6 9.2 17.5 4.2 1.4 15.0 10.3 54.2 9.1 13.0 11.6 8.9 9.8 20.8 24.5 9.5 2.5 15.0 27.4 4.3 22.4 13.2 8.8 2.7 5.1 6.3 9.3 52.9 23.7 15.3 5.2 9.1 4.3 2.0 23.6 7.1 0.8 19.8 15.3 8.0 2.2 6.8 13.7 2.0 1.2 6.7 1.5 3.0 39.9 49.6 0.4 4.7 28.5 18.4 7.0 9.9 20.6 15.2 1.0 14.0 1.5 17.5 11.9 0.4 6.9 11.5 10.8 5.1 4.1 0.6 15.8 13.4 10.6 1.0 3.9 5.4 35.4 13.5 5.9 8.7 6.2 12.6 5.2 4.4 4.5 1.8 10.6 2.8 5.2 8.5 6.0 2.3 0.0 15.2 7.2 5.5 17.9 6.5 5.3 6.2 5.6 12.8 8.1 6.9 4.2 0.7 8.4 15.1 7.6 1.5 6.0 8.7 9.2 8.5 11.1 8.3 10.7 10.4 9.2 7.4 9.2 8.9 9.5 8.8 24.1 9.6 14.9 10.7 9.0 4.5 15.3 16.0 10.2 6.8 15.3 12.7 5.2 12.8 16.2 14.7 0.0 133.5 10.4 3.5 29.4 16.9 137.5 5.0 9.0 14.9 3.0 1.7 3.9 14.4 18.2 14.3 5.6 6.0 10.2 5.2 15.7 19.7 37.9 3.3 5.0 5.2 16.2 10.3 13.1 64.8 19.9 14.6 10.6 9.4 15.2 6.5 7.2 5.5 5.9 12.8 7.0 24.5 5.9 20.3 16.4 85.0 8.3 3.4 13.1 14.6 11.7 2.4 5.6 7.9 3.7 146.0 7.0 9.2 7.0 13.1 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597708 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 851.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046112: AB_2679542, HPA062121: AB_2684687" "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favorable (4.59e-5)" "unprognostic (1.49e-2)" 111.0 136.1 89.1 60.7 92.4 77.4 110.8 93.8 102.7 101.5 88.3 98.2 75.8 85.9 85.7 118.9 88.2 50.7 139.1 89.8 97.2 174.7 170.9 115.0 69.6 93.9 90.6 88.2 91.4 169.9 80.8 62.4 83.6 93.4 111.9 69.7 36.3 110.9 73.7 173.5 102.4 92.1 65.8 94.6 102.1 122.8 108.4 92.5 60.0 94.5 106.0 90.3 108.4 99.5 98.5 125.7 120.4 96.3 103.8 94.3 113.4 152.2 104.7 195.4 207.7 199.7 185.2 132.2 118.8 196.8 150.6 206.2 117.5 83.5 164.8 223.8 133.9 104.0 91.6 58.5 224.7 168.0 104.8 122.1 122.0 208.5 144.5 237.1 166.2 175.4 110.8 109.1 119.7 282.7 193.0 97.8 235.6 68.6 164.9 180.2 105.1 202.5 171.7 200.8 109.3 57.2 74.5 88.4 126.2 171.7 114.8 125.4 136.2 160.1 104.9 77.2 218.4 149.6 170.3 143.5 143.1 166.4 144.9 95.5 213.9 418.5 339.7 176.1 326.0 164.6 251.9 181.4 169.2 321.4 214.8 156.4 153.0 356.6 195.5 254.9 360.4 262.0 439.0 89.1 92.4 93.8 102.7 89.8 97.2 93.9 90.6 88.2 93.4 94.6 92.5 98.5 89.3 147.4 104.8 7.8 89.3 116.9 102.5 343.7 75.7 27.1 92.8 95.4 122.8 124.4 200.2 150.8 2.1 237.1 104.2 148.1 416.7 236.5 365.7 70.5 63.6 102.8 70.2 85.2 2.2 290.4 260.2 113.7 55.0 93.2 102.7 59.0 99.6 214.4 263.4 18.5 2.2 138.4 185.1 154.0 182.3 250.6 88.3 147.6 170.7 3.7 188.7 80.4 94.7 2.0 6.9 304.0 201.5 78.2 113.8 123.8 271.9 851.7 141.7 29.1 59.2 66.3 108.8 121.3 33.1 97.9 118.6 221.2 86.7 62.6 102.0 115.6 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584431-85593406 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" NA NA 130000 "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 128.5 118.4 64.5 60.5 65.9 41.5 119.4 66.5 89.8 73.9 63.0 64.1 23.5 80.1 33.5 45.7 85.0 58.6 105.0 62.6 70.3 90.5 80.0 135.8 93.5 73.7 64.5 58.2 53.2 29.3 14.9 32.1 74.8 67.2 73.4 20.7 3.0 37.2 37.0 219.3 42.6 54.5 77.8 66.7 98.3 54.4 11.5 72.1 51.4 64.4 201.4 41.5 87.8 70.3 65.1 0.8 0.2 2.4 0.0 89.3 155.8 2.4 98.5 155.9 95.5 104.5 39.5 15.1 0.3 2.3 172.2 50.7 1.1 0.0 2.4 42.2 142.9 2.8 1.9 2.5 56.1 187.2 4.5 0.9 108.4 9.6 40.1 1.1 138.9 364.7 61.7 0.4 0.3 428.9 14.5 63.1 13.8 0.1 27.2 0.6 92.4 0.4 2.7 2.7 3.6 0.2 3.4 0.6 27.4 0.5 2.2 3.2 5.1 250.0 2.3 6.7 7.5 0.2 0.1 3.1 2.4 110.5 5.4 65.9 59.1 222.6 176.5 180.5 503.8 171.7 60.7 136.1 135.2 79.0 54.5 102.4 125.1 70.2 94.4 424.9 86.4 248.7 283.0 64.5 65.9 66.5 89.8 62.6 70.3 73.7 64.5 58.2 67.2 66.7 72.1 65.1 487.9 19.2 21.2 3.6 43.9 60.8 39.8 104.1 39.3 0.8 14.9 27.3 84.4 71.4 70.1 44.1 0.0 22.9 64.5 38.8 29.4 29.9 1.8 7.7 64.7 337.8 12.6 35.6 0.1 49.1 7.2 148.0 9.7 7.9 44.4 22.2 486.2 198.6 80.3 3.3 0.2 20.5 36.7 340.8 91.5 10.2 192.6 147.8 275.7 4.7 136.0 17.5 112.3 0.5 1.6 44.2 51.9 165.1 68.4 64.7 126.5 91.2 50.6 1.0 59.2 152.2 83.9 5.5 6.6 19.8 45.3 21.6 88.5 19.2 7.8 49.4 BTNL3 "BTN9.1, BTNLR" ENSG00000168903 "Butyrophilin like 3" Q6UXE8 5 180988846-181006727 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 65 "intestine: 116.3" "Cell type enhanced" "Detected in some" "Distal enterocytes: 118.3;Intestinal goblet cells: 36.4;Paneth cells: 50.5;Proximal enterocytes: 176.0;Undifferentiated cells: 26.2" "Cancer enhanced" "Detected in some" "colorectal cancer: 5.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 206 "neutrophil: 22.3" "Lineage enriched" "Detected in single" 206 "granulocytes: 22.3" "Not detected" "Not detected" NA NA "unprognostic (4.07e-2)" "unprognostic (3.64e-2)" "unprognostic (9.21e-2)" "unprognostic (4.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.57e-2)" "unprognostic (2.19e-2)" "unprognostic (5.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" 0.1 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 25.1 116.3 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.4 0.0 0.0 0.0 0.0 0.0 81.3 0.4 0.0 0.8 1.7 1.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.5 0.0 0.0 0.0 0.0 0.0 118.3 0.0 0.0 1.1 0.0 0.0 0.2 2.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 0.0 1.4 0.2 0.1 0.0 0.1 36.4 0.0 0.3 0.0 1.3 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 50.5 0.0 0.0 0.0 176.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.5" "Cell type enhanced" "Detected in many" "Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 7.2 7.9 3.9 4.5 5.2 8.7 6.5 4.6 5.8 5.7 4.2 8.1 17.1 5.9 7.5 9.7 4.8 9.2 9.7 5.0 4.0 19.6 47.5 5.3 7.0 4.2 3.6 4.8 5.0 19.7 9.5 4.2 6.2 3.9 5.4 9.8 6.8 6.2 6.7 18.5 9.9 16.6 7.9 3.5 5.0 8.2 28.7 4.0 22.8 6.6 18.5 9.5 6.6 6.3 5.1 4.0 9.8 9.5 12.3 13.2 18.7 4.0 4.2 11.9 7.1 8.3 7.4 8.6 8.2 7.6 10.1 8.7 8.8 7.0 13.5 10.3 5.0 10.2 5.5 4.0 7.7 11.7 5.5 8.6 11.1 18.2 6.7 13.4 16.0 22.7 13.0 4.9 8.1 14.9 8.0 15.2 8.9 4.0 31.2 3.7 9.3 8.0 7.6 15.1 12.8 4.3 5.5 10.1 5.4 16.4 14.4 8.4 10.2 8.3 7.0 4.8 5.4 8.4 15.9 24.1 5.1 8.8 5.4 13.3 23.4 9.3 32.0 7.2 7.8 5.8 6.2 6.7 7.7 8.4 5.8 6.2 5.4 5.0 5.1 8.0 6.9 10.4 6.1 3.9 5.2 4.6 5.8 5.0 4.0 4.2 3.6 4.8 3.9 3.5 4.0 5.1 13.2 16.0 4.1 29.0 13.5 13.8 14.5 14.5 12.5 19.9 8.9 12.4 13.4 12.8 11.0 11.0 22.9 17.5 11.4 18.6 27.4 12.7 159.2 7.4 8.4 11.9 9.1 12.4 127.4 29.5 22.6 8.5 15.8 6.5 2.5 15.0 12.8 37.0 19.3 21.9 86.8 16.0 20.3 19.8 20.1 406.4 12.8 15.3 14.2 37.5 19.1 14.4 14.4 63.3 63.0 14.8 24.2 8.6 14.7 8.4 72.3 74.1 10.1 19.8 0.0 10.7 11.7 77.1 39.0 15.1 15.8 13.0 11.3 18.0 19.5 15.4 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539168-85545281 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 882.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol NA NA 1800000 Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.87e-4)" "prognostic favorable (8.94e-4)" "prognostic unfavorable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 227.0 280.1 203.4 154.6 241.0 99.2 137.3 216.4 237.7 160.0 172.4 184.0 142.7 166.9 238.1 167.5 201.9 211.3 182.3 206.9 398.1 205.5 116.6 170.0 122.8 236.1 229.5 195.9 212.8 882.1 167.1 286.3 123.3 228.0 197.8 147.9 250.9 138.8 121.2 281.2 142.3 156.9 128.3 214.1 117.6 227.4 133.4 235.9 103.0 392.1 112.9 128.8 265.5 169.6 309.0 175.3 253.0 290.4 181.6 195.3 236.7 171.1 213.5 195.6 219.3 232.4 208.4 569.9 404.5 137.0 261.0 178.9 264.3 369.6 318.6 279.8 207.0 271.0 242.5 408.7 181.9 355.6 364.3 259.7 215.9 315.8 237.4 164.1 278.1 211.5 230.7 277.9 309.0 505.1 149.5 334.4 398.2 193.5 148.7 320.8 350.3 275.0 264.2 328.9 271.2 227.9 209.6 193.2 183.4 354.6 145.9 156.0 192.3 207.7 267.4 160.9 149.3 260.5 189.0 161.4 290.6 175.0 447.3 143.8 9.1 24.7 8.2 22.3 26.9 32.7 19.8 25.2 23.7 23.6 18.9 23.1 20.5 2.5 27.3 22.3 16.6 24.2 24.9 203.4 241.0 216.4 237.7 206.9 398.1 236.1 229.5 195.9 228.0 214.1 235.9 309.0 150.5 48.1 83.6 122.4 104.2 143.5 217.1 47.1 206.1 73.5 116.3 134.6 6.5 82.9 57.6 71.7 68.8 36.2 126.3 60.6 19.6 59.2 75.2 28.8 49.2 83.6 83.3 87.1 56.1 58.5 40.6 121.9 106.0 47.4 84.4 83.3 45.0 44.6 67.4 26.9 60.4 65.1 26.4 118.8 141.9 25.8 72.1 165.7 67.6 26.2 64.6 58.8 27.8 28.6 95.5 53.6 48.0 83.8 78.4 66.7 73.8 138.7 35.2 89.0 111.7 298.5 231.0 54.1 56.2 168.2 118.3 38.2 102.0 51.1 70.6 88.4 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 78.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 11.1;RT4: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.0 0.0 0.0 0.4 0.1 0.3 2.4 0.1 0.1 2.8 0.0 4.0 6.7 0.0 1.6 5.7 0.1 0.1 0.2 0.1 0.0 7.7 0.2 12.3 0.1 0.2 0.0 0.1 0.0 0.1 2.9 1.8 0.1 0.1 4.3 3.9 0.2 2.6 0.4 2.9 78.7 4.3 0.1 0.0 0.1 2.4 0.1 0.0 4.5 2.0 0.6 0.3 1.2 11.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 11.1 0.1 0.0 0.0 0.0 0.0 8.3 0.4 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 9.6 74.5 0.0 0.0 5.5 2.7 1.3 0.6 0.0 1.2 0.3 2.9 0.0 0.5 5.5 0.0 1.7 0.0 21.7 3.9 0.4 0.0 7.3 1.0 0.1 0.0 0.0 0.0 1.3 0.7 0.1 18.3 17.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 7.7 4.1 0.0 0.3 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 0.0 0.3 3.1 10.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.6 13.8 1.2 0.6 0.0 6.7 2.0 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521043-34522990 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 15 "brain: 479.5;choroid plexus: 214.5" "Cell type enhanced" "Detected in many" "Astrocytes: 71.2;Muller glia cells: 145.1;Oligodendrocyte precursor cells: 28.6" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "myeloid DC: 28.1" "Lineage enriched" "Detected in many" 8 "dendritic cells: 28.1" "Cell line enhanced" "Detected in many" "AN3-CA: 16.7;NTERA-2: 22.9;SCLC-21H: 11.6;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted in brain" NA NA 4240000 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.2 0.8 344.5 0.9 342.9 0.8 4.4 320.7 479.5 1.9 214.5 3.8 2.2 0.4 0.2 0.4 2.8 0.7 1.5 303.9 313.6 0.7 23.7 1.6 0.3 419.6 365.5 280.7 0.6 1.6 2.3 11.5 0.1 384.5 8.9 2.4 5.8 1.7 0.5 1.0 5.2 4.7 0.2 323.5 0.6 5.6 16.1 396.1 0.2 0.5 0.5 0.2 1.3 1.5 278.7 0.2 1.2 6.5 16.7 0.2 0.0 0.4 0.0 0.0 2.6 2.7 0.7 0.3 2.9 4.5 0.0 5.3 0.2 7.6 0.5 0.6 0.4 7.4 0.0 0.1 1.6 0.2 0.0 3.6 0.0 0.1 0.0 0.3 0.0 0.0 5.4 0.0 2.4 0.6 0.4 0.0 0.0 22.9 1.2 4.7 0.1 0.1 0.4 0.6 0.0 11.6 11.0 0.9 5.2 0.6 0.8 0.3 2.2 0.0 0.5 2.4 0.1 0.1 1.4 1.7 0.1 0.6 0.0 3.9 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 3.6 1.0 1.5 0.0 0.7 344.5 342.9 320.7 479.5 303.9 313.6 419.6 365.5 280.7 384.5 323.5 396.1 278.7 0.2 0.0 0.5 71.2 0.3 2.8 2.3 0.0 0.0 4.6 12.0 11.7 0.7 1.5 0.1 0.0 2.1 0.2 0.3 0.0 0.0 0.8 1.0 0.2 7.0 0.7 1.8 1.7 6.4 0.2 0.4 15.5 1.1 0.1 0.0 2.3 1.1 4.8 2.9 5.0 13.6 0.0 0.0 1.0 9.3 5.4 0.3 8.3 1.8 3.7 7.8 145.1 0.0 28.6 7.2 0.0 15.0 0.4 0.0 8.4 0.3 0.5 0.0 4.1 0.0 0.4 0.8 0.7 14.9 0.1 3.1 0.0 0.7 0.1 0.4 0.7 ZNF608 "DKFZp434M098, KIAA1281, NY-REN-36" ENSG00000168916 "Zinc finger protein 608" Q9ULD9 5 124636913-124748807 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 105.4;Inhibitory neurons: 141.2;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.5;naive B-cell: 1.6" "Group enriched" "Detected in many" 4 "B-cells: 1.6;granulocytes: 2.5" "Cell line enhanced" "Detected in many" "AF22: 61.0;AN3-CA: 39.2;REH: 110.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005545, HPA076984" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA005545: AB_1080742, HPA076984: " "unprognostic (3.82e-2)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (3.75e-1)" "unprognostic (2.26e-1)" "unprognostic (3.04e-2)" "unprognostic (5.02e-2)" "unprognostic (7.52e-2)" "unprognostic (5.24e-2)" "unprognostic (3.67e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (6.36e-2)" "unprognostic (2.80e-1)" "unprognostic (3.02e-1)" "unprognostic (9.56e-2)" 6.1 9.9 9.4 4.2 11.6 1.4 6.7 11.0 8.3 7.5 2.7 5.5 11.2 4.9 2.7 3.5 9.2 6.9 9.1 10.4 11.0 5.4 2.7 10.8 8.1 14.7 11.2 4.7 6.3 8.5 3.7 4.5 3.2 11.6 5.6 7.3 23.8 5.7 4.6 6.4 3.3 6.6 4.3 8.6 2.8 6.8 9.5 11.5 4.9 9.3 3.2 8.1 3.2 4.4 16.4 0.2 1.1 61.0 39.2 8.9 14.5 0.0 0.0 1.6 0.3 3.6 6.6 18.6 20.8 20.2 0.0 9.8 0.8 4.2 3.9 0.3 0.0 9.9 0.0 0.1 0.3 13.7 0.0 1.9 14.6 11.0 1.9 1.7 9.1 13.2 0.1 2.0 0.4 3.3 0.1 0.0 0.0 25.9 0.5 0.8 110.6 5.4 0.1 8.7 0.9 9.2 32.0 0.0 0.7 14.1 34.5 3.5 1.8 3.5 12.3 22.9 0.3 3.9 9.7 10.2 36.9 3.1 0.6 17.7 2.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 9.4 11.6 11.0 8.3 10.4 11.0 14.7 11.2 4.7 11.6 8.6 11.5 16.4 25.2 32.1 35.3 105.4 7.4 1.3 10.4 5.5 31.3 35.8 8.6 7.7 20.1 18.6 36.2 14.7 39.6 0.8 1.5 13.0 3.9 16.7 16.9 30.6 3.0 23.4 40.0 1.3 17.0 8.7 3.8 9.9 11.7 16.8 0.0 7.3 11.4 2.0 0.8 42.1 141.2 6.1 4.1 0.3 2.2 8.8 2.1 1.3 7.2 28.1 2.1 31.2 0.0 219.2 209.9 6.2 7.3 1.5 3.7 3.5 8.1 8.4 13.2 36.7 0.0 13.2 7.7 19.2 7.2 11.8 0.9 0.4 1.5 19.1 9.8 2.5 SLC35G2 "DKFZp564K2464, MGC3295, TMEM22" ENSG00000168917 "Solute carrier family 35 member G2" Q8TBE7 3 136818647-136855888 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052054, HPA064728" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA052054: AB_2681709, HPA064728: AB_2685336" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (6.91e-4)" "unprognostic (2.56e-4)" "unprognostic (5.34e-2)" "unprognostic (6.73e-2)" "unprognostic (1.16e-5)" "unprognostic (1.83e-3)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (1.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-2)" "unprognostic (2.30e-2)" 14.9 15.5 20.6 2.1 20.4 0.5 11.2 22.8 26.6 5.1 16.2 3.4 1.0 4.3 4.7 2.6 5.8 5.4 7.7 20.5 25.6 3.1 4.5 7.1 1.9 23.2 21.5 18.8 5.5 7.7 6.8 19.4 7.5 23.8 4.1 2.0 5.4 3.2 2.6 2.4 3.5 2.9 5.1 21.5 3.2 2.9 14.5 22.6 2.9 8.5 5.4 1.2 6.6 5.0 21.5 3.9 10.7 10.6 4.8 20.8 17.1 0.0 16.9 73.1 24.7 37.0 10.1 5.7 0.0 12.7 17.5 39.3 1.3 12.7 0.7 22.8 0.1 3.5 3.2 12.0 6.3 26.6 0.1 0.0 24.2 1.8 21.5 5.9 18.0 18.8 6.8 1.8 0.1 32.1 0.0 4.7 3.3 2.3 0.0 7.9 4.2 7.1 0.2 21.1 0.9 17.5 11.7 13.7 0.0 24.0 3.6 0.0 1.8 13.1 18.4 4.7 8.2 18.6 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 20.6 20.4 22.8 26.6 20.5 25.6 23.2 21.5 18.8 23.8 21.5 22.6 21.5 22.4 12.8 7.0 54.2 2.5 3.3 4.9 12.0 7.4 4.7 0.7 0.8 2.5 1.5 7.1 1.8 12.5 1.3 2.7 0.8 1.9 3.3 65.4 1.0 1.6 30.6 4.2 4.4 34.0 10.7 1.3 12.4 0.5 1.3 2.5 3.6 27.8 2.3 0.7 6.7 42.4 1.0 0.0 2.2 7.3 30.3 9.9 2.1 3.6 17.8 3.7 7.8 15.5 15.6 6.1 10.0 0.1 3.0 3.7 4.7 0.6 0.7 1.4 4.6 6.6 4.7 4.8 35.5 16.1 1.2 3.0 2.2 3.8 3.1 0.6 2.0 INPP5D "hp51CN, SHIP, SHIP1" ENSG00000168918 "Inositol polyphosphate-5-phosphatase D" Q92835 2 233059967-233207903 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.2;lymphoid tissue: 100.2" "Cell type enhanced" "Detected in many" "B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016300, HPA070455" Enhanced Supported Cytosol No No 4400000 Cytosol "CAB016300: AB_628250, HPA070455: AB_2686267" "unprognostic (5.29e-2)" "unprognostic (2.05e-3)" "unprognostic (1.99e-2)" "unprognostic (6.71e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (3.74e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (6.54e-2)" 14.3 5.8 6.5 20.0 6.8 33.0 11.5 7.6 6.4 8.8 6.9 7.5 3.8 6.4 2.8 7.5 9.3 6.0 7.6 5.6 8.9 9.5 6.5 25.4 34.4 10.0 8.1 4.4 3.2 3.2 1.2 6.9 8.5 10.4 11.9 4.7 0.3 26.5 2.9 4.0 7.9 51.2 3.6 10.8 100.2 6.3 3.5 10.1 14.6 7.8 1.7 32.2 9.9 8.5 11.0 0.1 0.1 0.6 0.0 0.0 0.2 4.8 0.1 0.2 0.1 0.0 0.0 1.2 17.9 0.0 0.0 0.0 0.1 0.0 44.7 0.1 15.4 0.2 94.6 0.1 9.0 0.7 28.7 94.8 1.6 87.1 0.3 9.6 0.3 12.7 2.6 0.4 8.0 0.4 0.0 13.2 89.4 2.9 0.0 0.1 27.5 0.1 6.5 0.1 5.5 0.1 0.1 0.0 1.7 0.0 11.1 0.0 62.9 10.7 0.0 1.5 0.0 0.0 0.2 5.2 26.7 0.1 36.5 0.2 13.2 10.8 11.4 16.0 15.8 10.9 14.0 7.1 12.0 12.3 12.6 5.8 8.4 10.3 12.5 20.0 6.1 10.5 17.9 6.5 6.8 7.6 6.4 5.6 8.9 10.0 8.1 4.4 10.4 10.8 10.1 11.0 18.1 3.2 15.5 3.3 94.5 1.7 1.6 5.4 9.1 0.5 3.2 5.8 3.6 4.3 5.2 3.7 0.0 0.6 95.8 1.1 0.0 0.5 13.0 0.8 0.3 20.8 0.0 35.7 2.6 0.5 0.8 1.7 2.0 0.5 15.2 0.1 15.0 2.2 29.2 0.0 1.1 0.2 0.0 65.6 17.1 13.4 0.0 51.5 0.0 181.8 51.4 0.0 193.6 4.0 1.8 0.4 2.5 1.2 34.0 0.6 0.1 0.4 5.7 0.0 0.0 2.0 1.7 0.5 1.0 3.1 1.1 1.1 60.6 0.1 0.5 1.5 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856156 "Human disease related genes, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria NA NA Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.77e-4)" "prognostic favorable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 11.8 16.4 13.9 8.0 13.4 7.7 10.9 11.2 12.7 7.7 9.9 16.6 14.0 8.5 3.2 24.0 8.1 4.5 16.6 13.0 12.6 13.4 16.6 9.0 7.0 12.4 13.3 13.9 9.3 12.6 11.5 8.9 5.0 12.1 8.4 10.8 4.6 9.7 4.2 18.9 15.1 11.8 5.2 11.2 10.8 13.9 14.6 14.2 26.0 10.8 11.0 7.9 8.5 10.7 11.3 22.9 38.1 11.6 36.1 17.4 12.2 20.7 22.1 10.7 21.8 16.9 35.5 24.7 37.5 15.4 23.3 34.0 22.7 29.8 31.2 13.2 25.1 31.1 38.4 30.9 25.6 22.6 39.3 30.3 19.9 22.0 24.9 21.8 10.1 19.0 22.6 51.5 22.9 15.3 25.1 57.3 44.7 30.5 24.7 43.2 32.4 16.2 21.9 17.0 31.3 29.5 26.0 25.2 31.5 13.3 10.0 29.7 20.3 28.8 24.8 14.8 21.1 37.3 19.8 32.7 29.3 22.0 33.8 20.2 3.9 3.7 2.0 5.8 5.0 5.7 4.2 4.9 4.9 4.1 3.6 3.2 4.6 0.5 5.9 5.1 12.9 4.2 2.1 13.9 13.4 11.2 12.7 13.0 12.6 12.4 13.3 13.9 12.1 11.2 14.2 11.3 12.2 16.0 11.5 15.0 19.2 40.0 40.7 13.4 8.0 19.4 19.7 10.5 23.3 11.5 14.0 27.6 33.3 17.5 24.9 116.1 31.3 25.5 32.2 9.1 19.4 16.7 15.6 20.4 14.3 31.3 22.6 17.0 32.1 14.7 10.2 17.9 16.1 33.3 21.5 15.2 12.4 29.5 12.2 18.4 19.8 45.1 20.2 13.0 19.6 4.7 13.9 12.7 28.8 9.5 13.2 42.4 52.7 16.6 17.8 58.8 48.8 46.1 5.6 28.4 13.1 23.8 16.1 54.2 44.4 25.2 51.1 15.2 16.7 21.9 53.2 48.4 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75218988-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2383 "pancreas: 134989.3" "Cell type enriched" "Detected in some" 21 "Exocrine glandular cells: 31269.6" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;HDLM-2: 1.6" "Secreted to digestive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 21.1 5.1 0.3 2.1 0.2 1.1 9.6 0.5 0.3 6.1 0.0 3.9 16.8 4.2 0.5 6.9 3.0 0.0 22.5 0.3 0.1 4.3 13.3 2.9 2.7 0.1 0.1 0.0 56.6 134989.3 0.0 7.2 6.6 0.1 5.6 0.0 0.0 22.5 0.2 3.9 4.7 8.9 0.0 0.1 11.8 7.6 3.5 0.2 0.0 2.8 0.1 0.0 2.4 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.1 0.1 2.0 0.0 0.0 0.1 31269.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 151.9 0.0 0.0 0.0 0.1 1430.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 CTRB2 ENSG00000168928 "Chymotrypsinogen B2" Q6GPI1 16 75204103-75207161 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2442 "pancreas: 99499.3" "Cell type enriched" "Detected in some" 9 "Exocrine glandular cells: 53114.3" "Cancer enriched" "Detected in single" 1696 "pancreatic cancer: 540.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;U-2 OS: 5.8;U-251 MG: 1.6;U-266/84: 1.8;U-698: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to digestive system" NA NA "unprognostic (9.41e-4)" "unprognostic (2.20e-1)" "unprognostic (1.28e-2)" "unprognostic (2.10e-1)" "unprognostic (2.92e-2)" "unprognostic (2.77e-1)" "unprognostic (5.95e-2)" "unprognostic (9.56e-2)" "unprognostic (3.54e-3)" "unprognostic (7.06e-2)" "unprognostic (2.17e-1)" "unprognostic (7.57e-2)" 20.5 4.9 0.3 1.5 0.2 1.9 9.2 0.5 0.4 5.2 0.1 4.4 9.2 4.8 0.1 6.7 3.8 0.2 13.9 0.2 0.2 4.4 12.9 3.1 2.9 0.2 0.2 0.2 40.7 99499.3 0.0 5.7 5.7 0.2 11.9 0.0 0.0 16.8 0.1 3.7 4.3 6.6 0.0 0.2 7.3 8.1 3.7 0.2 0.0 3.1 0.0 0.0 2.8 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 1.6 0.0 1.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 108.8 2.0 0.3 0.0 1.5 0.0 0.0 0.0 53114.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.3 6.0 0.0 0.0 215.5 0.0 0.0 0.0 0.0 5324.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 30.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 TRIM49 "RNF18, TRIM49A" ENSG00000168930 "Tripartite motif containing 49" P0CI25 11 89797655-89808575 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM129 D4S2561E ENSG00000168936 "Transmembrane protein 129, E3 ubiquitin ligase" A0AVI4 4 1715952-1721358 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Unfolded protein response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.07e-2)" "unprognostic (1.54e-1)" "unprognostic (2.12e-1)" "unprognostic (2.85e-1)" "unprognostic (4.04e-2)" "unprognostic (1.22e-3)" "unprognostic (7.35e-3)" "unprognostic (4.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.94e-2)" "unprognostic (2.51e-3)" "unprognostic (2.81e-1)" "prognostic favorable (9.64e-8)" "unprognostic (1.47e-1)" "unprognostic (6.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.36e-3)" 20.6 33.9 29.0 11.1 29.4 6.2 20.8 29.9 30.9 22.7 34.1 33.7 22.2 28.1 10.2 25.2 26.9 11.9 37.6 27.4 27.6 38.7 47.3 21.8 13.1 36.1 32.1 24.0 26.0 37.2 33.5 43.3 10.3 33.2 29.9 8.6 6.5 33.2 19.2 31.1 20.3 26.3 9.6 30.6 26.1 31.8 15.5 31.6 8.2 35.7 18.9 8.3 27.2 20.0 30.2 16.1 18.4 15.0 22.4 27.0 15.7 17.3 12.7 20.4 13.0 13.9 13.6 38.8 20.9 14.9 13.7 23.1 15.8 7.7 16.2 2.2 14.5 23.1 11.9 13.9 17.5 22.0 16.4 19.9 26.1 34.2 7.1 6.5 30.1 20.3 19.4 13.2 15.1 12.4 12.6 22.4 26.5 23.3 17.6 22.4 14.3 7.9 26.0 32.6 17.6 34.7 21.4 10.9 19.0 17.3 5.3 39.3 7.5 14.0 15.0 11.3 13.3 12.5 37.7 12.1 10.0 17.3 22.2 16.4 0.1 1.7 0.0 1.6 1.1 1.4 0.7 1.4 1.2 1.6 0.9 1.0 0.7 0.3 1.0 1.2 3.7 0.7 1.1 29.0 29.4 29.9 30.9 27.4 27.6 36.1 32.1 24.0 33.2 30.6 31.6 30.2 13.2 22.4 9.3 17.0 11.4 5.1 15.2 9.6 13.6 27.2 15.4 13.0 12.9 18.6 6.6 23.9 6.2 20.9 26.8 28.8 25.4 20.4 1.1 7.9 8.2 12.4 13.1 8.6 7.3 19.6 7.8 17.4 12.8 8.4 10.2 14.7 15.4 19.9 17.9 25.2 9.0 26.5 14.2 11.7 4.9 3.1 30.4 8.7 10.6 13.1 7.2 39.6 25.7 8.0 11.9 14.1 14.9 36.1 13.1 16.8 24.0 18.4 7.9 19.7 13.1 21.9 17.1 7.1 5.6 13.7 9.5 5.5 12.1 22.7 33.8 11.3 PPIC CYPC ENSG00000168938 "Peptidylprolyl isomerase C" P45877 5 123023250-123036725 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 251.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 229.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039163 Approved "Intracellular and membrane" NA NA 3700000 "HPA039163: AB_2676374" "unprognostic (7.81e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (3.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (3.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.38e-1)" "unprognostic (4.27e-2)" "unprognostic (2.43e-2)" 37.4 20.7 5.3 16.6 5.0 0.2 30.7 6.6 7.1 42.7 11.6 41.8 37.6 31.3 36.8 47.2 15.0 33.8 42.3 4.8 5.3 24.2 29.1 27.2 7.6 6.0 5.6 4.1 16.4 30.6 21.0 6.3 48.7 6.1 23.6 50.3 4.9 31.9 24.2 41.5 20.1 32.6 45.6 5.6 7.8 22.6 9.1 6.1 5.8 47.6 33.6 14.3 46.2 29.0 7.0 19.6 16.8 6.4 136.2 229.7 104.6 26.9 54.4 42.3 27.8 56.7 28.1 128.6 0.0 94.2 147.1 83.3 21.9 18.9 68.6 22.1 0.1 33.1 27.8 60.7 32.8 58.9 0.0 14.7 65.8 51.5 32.5 34.0 49.9 58.1 0.0 7.9 0.0 20.1 116.5 0.1 0.3 11.6 120.9 29.0 0.0 14.5 0.0 87.7 67.0 8.5 14.9 106.7 51.1 12.1 77.8 72.0 61.8 64.8 52.9 32.7 18.5 23.9 0.2 0.1 0.4 45.9 0.2 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.0 6.6 7.1 4.8 5.3 6.0 5.6 4.1 6.1 5.6 6.1 7.0 214.1 32.1 16.5 6.2 1.6 47.4 52.3 251.7 30.7 16.9 63.9 47.5 46.4 61.5 149.0 73.5 4.2 60.1 0.6 134.0 29.4 201.5 1.7 52.4 94.8 106.5 12.7 0.0 0.8 126.4 65.2 198.2 55.0 50.8 1.3 54.2 80.7 57.8 43.2 0.0 2.2 177.1 207.5 4.2 40.3 4.2 112.5 6.9 32.0 5.6 3.2 2.8 0.0 1.0 0.3 90.3 181.0 100.1 0.6 48.2 189.0 81.7 110.5 4.4 39.5 22.7 87.5 41.6 37.8 118.6 49.3 25.0 3.4 61.2 117.0 81.5 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155612572-155782459 "Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1" "Group enriched" "Detected in some" 7 "Astrocytes: 42.7;Excitatory neurons: 40.9;Inhibitory neurons: 43.5;Microglial cells: 62.8;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 20.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7" "Low region specificity" "Detected in many" CAB013505 Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.0 1.2 1.5 0.4 1.6 1.7 0.8 5.1 1.9 0.8 0.1 0.7 0.8 1.0 2.7 0.7 0.8 0.8 0.7 1.5 1.1 0.6 0.6 0.7 0.5 2.0 1.2 1.3 1.8 0.4 0.8 0.8 1.3 2.0 0.6 0.8 1.4 0.8 0.7 0.9 0.4 0.8 0.8 0.5 1.0 0.6 0.4 1.8 0.4 0.8 1.0 0.5 0.6 0.6 1.5 0.4 0.2 1.5 5.7 1.1 0.6 0.0 1.6 0.9 0.5 0.8 0.4 0.9 0.0 2.8 0.9 1.2 0.3 0.8 0.3 0.5 0.1 0.2 0.8 1.8 0.1 0.5 0.3 0.3 1.3 1.0 0.6 0.3 0.4 0.9 0.4 0.1 0.5 1.0 0.2 0.2 0.2 0.6 0.2 0.0 0.3 0.2 1.4 0.5 0.7 0.5 0.4 0.8 0.0 0.2 0.8 0.5 0.4 1.2 0.5 0.8 0.3 0.4 0.5 0.1 1.2 1.4 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.6 5.1 1.9 1.5 1.1 2.0 1.2 1.3 2.0 0.5 1.8 1.5 4.0 0.0 0.0 42.7 0.3 0.1 0.1 0.2 0.0 3.4 0.5 0.4 1.7 0.0 0.3 0.0 4.2 0.1 0.2 1.9 0.0 0.2 0.0 5.2 1.2 2.2 0.0 0.4 40.9 0.6 0.2 0.6 0.5 5.0 0.0 1.1 2.2 1.1 0.3 0.0 43.5 1.4 0.0 0.8 0.3 0.0 0.9 0.5 1.8 62.8 0.7 0.6 0.0 32.2 20.3 0.6 0.1 0.0 0.2 0.1 0.9 0.4 0.3 1.3 0.0 0.9 2.0 0.0 0.0 0.5 0.1 0.0 0.3 2.5 1.0 0.2 CEP120 "CCDC100, FLJ36090" ENSG00000168944 "Centrosomal protein 120" Q8N960 5 123344890-123423592 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028823, HPA051556" Uncertain NA NA "HPA028823: AB_10601355, HPA051556: AB_2681533" "unprognostic (3.65e-1)" "unprognostic (9.94e-2)" "unprognostic (3.69e-2)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (2.97e-2)" "unprognostic (4.41e-1)" "unprognostic (1.15e-1)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-1)" "unprognostic (4.94e-3)" "unprognostic (1.05e-1)" "unprognostic (1.69e-1)" "unprognostic (9.44e-3)" "unprognostic (1.58e-1)" 7.7 7.1 1.6 7.1 1.9 3.0 7.3 2.0 2.6 8.3 2.0 6.4 4.9 9.4 3.6 4.5 9.5 7.3 6.3 2.2 2.1 7.0 7.9 7.4 9.7 1.9 2.2 1.4 15.7 6.4 7.7 6.6 6.0 2.0 7.0 5.2 11.7 5.2 7.8 4.4 4.1 7.3 8.0 1.8 9.2 5.1 13.9 1.9 14.2 8.3 6.3 11.0 6.7 6.2 2.3 8.5 7.7 10.6 12.7 11.9 13.7 9.1 11.4 14.1 10.8 19.3 5.7 7.2 11.9 9.7 6.7 17.6 5.3 9.2 10.0 18.5 27.1 4.1 6.2 2.7 6.9 12.8 7.0 11.1 11.5 12.3 14.8 19.3 9.2 9.7 9.8 6.0 20.5 12.6 3.0 13.3 2.8 5.8 3.8 7.1 7.2 15.5 8.9 5.8 2.9 11.3 8.1 9.1 4.0 13.8 12.4 5.8 16.3 8.3 11.7 9.5 5.8 13.7 12.4 11.5 8.3 10.8 14.2 12.3 0.8 0.2 0.6 0.4 0.4 0.5 0.7 1.0 0.7 0.3 0.3 0.6 1.0 0.1 0.3 0.1 0.0 1.7 0.4 1.6 1.9 2.0 2.6 2.2 2.1 1.9 2.2 1.4 2.0 1.8 1.9 2.3 15.1 12.8 10.3 8.8 24.5 5.9 4.1 5.0 15.4 10.2 6.3 4.8 10.0 1.5 10.3 7.3 29.2 4.3 12.4 4.2 1.9 2.8 9.4 12.4 7.8 10.8 2.4 7.2 22.8 4.7 4.3 10.8 9.7 5.7 2.5 20.9 4.6 7.2 5.6 8.4 28.2 3.9 4.1 12.0 4.3 6.4 11.8 9.9 8.8 29.0 9.4 7.6 7.2 19.1 24.2 4.2 3.1 13.9 19.1 3.1 7.1 3.3 26.2 17.4 6.6 10.3 8.9 17.4 9.9 6.3 1.8 2.3 23.0 8.2 3.9 3.2 STXBP6 "amisyn, HSPC156" ENSG00000168952 "Syntaxin binding protein 6" Q8NFX7 14 24809656-25050297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 128.6;Inhibitory neurons: 180.6;Oligodendrocytes: 188.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 48.6;Daudi: 50.7;HBF TERT88: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003552, HPA074869" Approved NA NA "HPA003552: AB_10603343, HPA074869: " "unprognostic (1.52e-1)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.20e-2)" "unprognostic (9.01e-2)" "unprognostic (2.28e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.69e-1)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (6.73e-3)" "unprognostic (5.10e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-3)" 7.0 0.8 21.2 3.9 18.1 0.2 5.0 15.7 27.2 13.6 1.6 12.0 12.4 7.6 38.4 6.1 7.1 11.1 20.8 19.1 20.0 3.6 4.4 26.5 1.6 22.1 24.1 15.7 2.8 39.8 23.2 1.0 43.1 18.0 12.8 14.9 2.1 15.1 9.6 4.4 14.0 18.6 5.2 13.1 0.7 9.9 4.5 41.7 7.9 18.2 7.7 5.5 12.4 2.6 19.3 0.1 1.0 2.0 0.5 12.9 22.3 0.2 15.1 40.2 35.5 37.5 48.6 0.3 50.7 0.1 42.6 0.0 0.1 0.0 0.1 64.1 27.2 3.2 12.1 0.4 37.0 9.4 0.9 6.3 3.3 0.0 0.0 0.2 2.0 0.0 1.4 0.5 16.9 34.2 9.7 0.2 0.1 6.6 25.4 0.0 0.0 28.1 0.4 0.0 2.8 2.3 0.1 0.1 7.8 42.6 4.3 0.5 0.7 0.0 6.4 17.2 41.2 2.1 5.1 6.0 2.4 21.8 0.3 24.2 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.2 21.2 18.1 15.7 27.2 19.1 20.0 22.1 24.1 15.7 18.0 13.1 41.7 19.3 50.3 51.3 7.7 128.6 0.4 67.7 48.4 0.1 20.5 0.6 2.9 3.3 27.4 64.3 3.4 20.2 0.0 1.4 1.7 12.6 0.0 47.9 20.4 38.8 4.9 35.8 40.7 8.6 72.9 98.7 1.5 44.9 20.4 72.8 42.6 0.8 36.8 5.8 20.1 0.0 180.6 64.6 2.0 1.0 11.0 4.6 1.5 2.9 110.3 113.4 2.0 2.7 0.0 113.6 188.1 39.9 49.6 1.2 3.1 73.9 71.8 9.6 0.0 0.5 0.0 16.4 6.5 12.6 19.7 4.1 48.2 4.0 3.2 0.0 51.7 16.4 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362038-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 76 "intestine: 269.0" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 703.0" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;RPMI-8226: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506" "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.3 0.2 0.2 0.0 1.2 0.4 0.0 0.3 3.1 269.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.1 3.9 0.3 0.0 0.0 0.0 0.3 145.7 1.6 0.0 0.1 0.5 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.1 0.2 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 1.2 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 48.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.4 0.0 0.0 0.0 77.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.0 0.5 0.0 157.9 0.7 0.0 0.0 703.0 0.0 0.0 0.3 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 18.8 0.0 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 985.9;Late spermatids: 1746.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria No No 62000 Mitochondria "HPA010968: AB_1845714, HPA074625: AB_2686704" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 50.8 58.4 62.7 29.5 66.2 48.5 47.3 68.3 72.4 47.9 62.4 55.5 41.4 47.0 38.2 48.8 49.4 31.2 65.6 61.8 66.6 69.4 44.6 39.2 39.8 69.2 62.5 59.7 52.0 57.7 60.5 43.1 33.7 66.6 42.8 41.3 81.1 44.2 48.4 101.2 45.0 40.8 42.7 67.9 39.0 49.4 200.7 65.6 52.0 37.4 87.2 44.9 50.6 46.3 75.7 71.1 60.6 72.4 100.5 92.7 88.6 95.3 69.1 93.7 82.6 88.7 66.4 49.8 40.3 80.1 76.9 87.5 57.8 121.0 88.5 112.6 86.4 97.3 85.8 144.5 165.0 122.4 84.2 73.6 79.6 113.9 79.0 84.3 109.6 72.7 91.6 76.7 117.8 75.3 72.5 88.9 127.3 98.6 76.7 62.5 79.0 91.8 78.7 124.2 66.5 76.3 70.8 153.3 68.7 106.7 59.4 44.8 82.0 49.7 80.6 67.0 119.2 78.3 95.2 69.6 81.9 106.1 73.6 111.7 118.5 66.8 133.6 65.2 74.0 69.9 84.0 67.5 63.9 72.0 77.9 70.4 60.2 65.1 67.7 70.0 71.9 97.5 76.3 62.7 66.2 68.3 72.4 61.8 66.6 69.2 62.5 59.7 66.6 67.9 65.6 75.7 40.4 32.1 46.7 53.8 74.8 48.3 62.1 70.3 90.5 33.1 54.9 64.1 79.3 44.3 57.0 60.7 31.3 95.3 49.8 46.2 127.2 95.2 985.9 36.7 40.3 45.6 32.3 73.6 95.8 94.8 89.8 67.6 42.8 52.0 22.1 66.4 43.5 56.1 78.4 40.4 97.7 60.3 61.1 61.5 56.4 1746.9 88.0 63.0 81.8 47.8 64.0 204.4 74.2 135.2 151.3 91.7 63.8 85.7 127.7 66.5 69.5 135.7 32.3 65.5 59.2 69.1 62.1 392.3 96.9 87.6 47.3 91.9 57.2 63.7 73.0 71.6 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 22.5" "Group enriched" "Detected in some" 26 "Excitatory neurons: 903.1;Inhibitory neurons: 968.3;Oligodendrocyte precursor cells: 1040.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.0 0.0 8.9 0.0 17.4 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 18.6 13.6 0.1 0.0 0.1 0.0 2.4 0.2 22.5 0.0 0.0 0.0 0.2 0.0 4.4 0.0 0.0 3.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 17.4 0.0 16.8 18.6 13.6 2.4 0.2 22.5 4.4 0.0 3.6 10.4 0.1 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 7.5 0.1 0.0 0.0 0.0 903.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 968.3 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 22.5 0.0 0.8 0.0 1040.5 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.8 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 LGALS9 LGALS9A ENSG00000168961 "Galectin 9" O00182 17 27629798-27649560 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 100.1;stomach 1: 88.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 181.1;Gastric mucus-secreting cells: 174.8;Hofbauer cells: 298.2;Intestinal goblet cells: 183.5;Kupffer cells: 254.2;Paneth cells: 181.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 40.2;HMC-1: 124.9;MOLT-4: 44.8;REH: 48.4;THP-1: 83.2;U-937: 92.1" "HPA046876, HPA047218" Approved Approved Cytosol "Secreted to blood" NA NA 448000 Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (2.62e-2)" "prognostic favorable (2.35e-5)" "unprognostic (1.16e-2)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (2.46e-3)" "unprognostic (1.58e-2)" "unprognostic (8.60e-2)" "unprognostic (4.79e-1)" "unprognostic (1.80e-1)" "unprognostic (8.13e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (4.76e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" 20.9 6.5 11.8 46.4 12.3 69.2 9.6 12.6 21.0 25.8 13.5 100.1 46.7 12.9 3.0 14.6 28.6 38.5 8.8 11.1 14.3 2.5 11.7 34.5 61.4 15.5 13.1 8.8 5.3 5.2 2.8 1.2 16.9 15.6 3.7 90.1 1.0 21.4 8.0 3.9 4.3 42.2 19.6 15.0 51.1 88.3 3.8 13.9 29.3 4.2 4.1 39.2 40.0 1.9 18.0 2.0 0.7 0.6 0.3 0.1 0.2 1.6 0.4 1.3 8.9 29.6 0.1 12.6 1.5 14.2 1.1 1.5 4.1 0.3 0.1 0.5 9.4 0.9 14.9 0.9 0.0 1.0 40.2 124.9 0.3 0.0 0.4 0.0 0.5 16.5 13.6 0.6 0.5 0.0 0.1 44.8 15.0 0.4 28.4 0.0 48.4 0.0 3.6 5.9 1.0 0.3 0.8 0.0 4.4 0.2 0.9 0.2 83.2 3.1 0.0 0.3 0.1 0.2 0.1 0.1 0.3 0.2 92.1 0.2 32.6 116.2 78.2 5.6 214.9 2.6 32.3 15.6 5.9 165.5 41.7 9.6 4.0 41.7 22.0 217.4 28.5 40.3 75.1 11.8 12.3 12.6 21.0 11.1 14.3 15.5 13.1 8.8 15.6 15.0 13.9 18.0 32.2 9.6 6.3 2.0 42.2 3.2 7.7 32.9 18.8 0.2 10.5 13.2 1.7 20.0 40.5 7.3 0.0 2.3 19.0 181.1 3.9 124.1 1.5 11.4 11.6 43.5 40.5 64.3 0.4 126.9 3.1 7.4 174.8 12.9 31.1 11.2 26.0 2.2 298.2 0.0 0.6 183.5 26.4 254.2 85.4 2.2 4.4 154.1 1.8 25.3 150.7 0.2 41.2 3.5 0.9 146.0 181.6 3.0 3.5 4.4 20.6 1.4 15.4 0.6 19.7 1.6 6.2 0.1 0.7 8.8 1.7 3.7 19.6 86.2 126.7 31.1 JMJD7-PLA2G4B ENSG00000168970 "JMJD7-PLA2G4B readthrough" 15 41828095-41848155 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Club cells: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RT4: 2.6" HPA005726 Approved Approved Cytosol NA NA Cytosol "HPA005726: AB_1852017" "unprognostic (9.87e-3)" "unprognostic (5.65e-2)" "unprognostic (1.27e-2)" "unprognostic (6.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.84e-3)" "unprognostic (1.47e-1)" "unprognostic (7.21e-3)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (1.53e-2)" "unprognostic (1.02e-3)" "unprognostic (1.02e-3)" "unprognostic (3.98e-1)" "unprognostic (1.33e-1)" "unprognostic (2.15e-1)" "unprognostic (4.75e-3)" 0.9 0.3 0.1 0.8 0.1 1.1 1.0 0.3 0.4 1.1 0.4 0.8 0.2 1.1 0.4 1.9 1.1 0.4 0.6 0.0 0.1 0.3 0.3 0.9 0.2 0.2 0.0 0.0 1.2 0.6 0.9 0.4 0.1 0.4 0.7 0.2 0.2 1.5 0.4 0.8 2.6 0.8 0.6 0.1 0.6 0.8 0.3 0.1 0.4 0.8 0.5 0.3 1.0 1.4 0.2 0.2 0.0 0.6 2.0 0.5 1.3 0.7 0.4 1.1 0.5 0.8 0.8 0.0 0.2 0.8 0.5 0.0 1.8 0.2 1.2 0.1 0.0 0.2 0.3 0.4 0.2 1.9 0.0 0.9 0.7 0.9 0.2 0.4 0.0 0.2 0.7 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.4 0.1 0.3 0.0 0.8 0.5 2.6 0.6 0.8 1.8 0.0 0.2 0.0 0.4 2.1 0.3 0.3 0.2 2.0 0.7 0.5 0.2 0.0 1.0 0.2 0.2 0.0 0.3 0.0 1.1 0.4 0.5 0.2 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.3 0.4 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.1 0.2 0.2 9.6 4.8 0.0 0.9 0.1 0.2 0.1 2.2 0.6 0.4 0.1 0.6 1.5 2.7 0.0 0.0 0.2 0.1 1.1 0.0 0.6 0.0 0.1 0.3 0.4 2.4 0.0 0.0 0.5 0.1 0.2 1.5 0.4 1.3 0.1 0.0 0.2 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.1 1.0 0.0 0.1 1.1 0.5 0.0 2.3 0.1 1.2 0.0 0.9 0.6 0.0 0.1 0.2 0.0 0.1 2.0 1.0 0.1 1.0 0.1 1.2 0.1 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826129 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 243.2" "Cell type enhanced" "Detected in many" "Adipocytes: 45.5;Bipolar cells: 33.4;Endothelial cells: 29.6;Excitatory neurons: 44.2;Inhibitory neurons: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 84.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 15.9 13.5 29.4 1.2 26.3 0.1 18.3 52.0 243.2 16.4 0.0 5.0 1.0 10.9 0.1 5.7 16.5 0.4 10.3 31.2 56.7 9.8 8.4 9.5 0.8 107.1 25.0 0.0 9.5 3.3 1.4 12.9 0.3 140.4 13.9 0.2 5.8 9.7 0.7 4.1 3.3 5.2 0.5 6.2 27.4 4.9 8.6 126.5 3.6 7.6 0.2 0.2 8.3 13.0 147.9 5.7 0.5 0.1 0.8 0.0 0.0 0.3 0.2 0.0 0.0 0.0 16.3 1.7 4.2 1.9 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.4 0.0 1.8 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 2.3 2.0 0.3 0.0 2.5 2.3 0.0 2.6 4.4 2.6 0.1 0.0 1.6 0.0 0.4 84.3 11.8 0.4 5.5 0.0 0.2 8.5 0.3 0.1 0.0 0.5 0.1 0.1 0.2 4.7 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 29.4 26.3 52.0 243.2 31.2 56.7 107.1 25.0 0.0 140.4 6.2 126.5 147.9 45.5 0.0 0.0 5.9 0.4 1.0 3.2 0.4 1.8 33.4 7.8 8.1 3.6 0.0 1.9 0.0 4.2 0.1 2.8 2.5 1.9 1.2 1.4 1.1 5.4 29.6 21.5 0.0 44.2 0.8 3.2 1.8 2.6 1.4 0.0 0.3 14.3 4.8 0.2 18.5 90.7 2.1 0.0 0.3 1.9 2.3 1.8 0.5 1.8 8.4 0.0 16.8 0.0 8.0 4.7 0.8 5.2 0.0 0.6 2.6 0.3 1.2 0.0 21.7 0.0 0.4 2.3 4.3 9.8 0.2 1.1 1.0 1.6 0.8 2.7 1.3 PXDC1 C6orf145 ENSG00000168994 "PX domain containing 1" Q5TGL8 6 3722614-3751713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 170.1" "Cell type enhanced" "Detected in many" "Adipocytes: 103.6;Basal prostatic cells: 115.1;Extravillous trophoblasts: 131.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "HHSteC: 151.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019246 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019246: AB_2670113" "unprognostic (1.55e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.82e-2)" "unprognostic (3.80e-2)" "unprognostic (2.95e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" "unprognostic (2.01e-2)" "unprognostic (6.17e-3)" "unprognostic (1.10e-1)" "unprognostic (2.97e-1)" "unprognostic (2.84e-1)" 66.1 15.0 31.4 14.9 29.9 1.4 50.9 31.9 36.8 27.0 44.7 29.7 30.1 31.6 15.8 25.8 28.6 48.7 35.1 29.0 33.9 25.8 170.1 48.1 13.1 35.9 31.4 25.6 19.3 26.9 14.3 14.0 62.3 32.6 30.0 7.7 3.1 39.6 20.0 17.0 36.3 26.7 26.9 33.7 19.1 28.8 5.6 33.7 7.5 45.0 15.8 6.8 46.7 28.9 33.9 44.5 17.5 28.6 19.9 87.9 66.4 99.4 75.6 57.7 62.6 48.2 30.6 8.8 0.0 49.0 123.9 48.0 34.4 5.7 20.8 29.3 43.2 6.6 0.0 14.7 26.8 151.4 0.1 0.2 59.0 67.2 38.8 83.2 52.7 70.2 3.0 0.1 5.9 49.7 2.7 0.1 0.5 1.3 9.0 27.3 2.5 16.0 2.1 24.4 35.7 3.1 1.6 51.7 52.4 115.5 38.3 4.6 2.7 77.8 56.9 24.7 22.2 54.4 0.1 0.1 0.2 13.6 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 31.4 29.9 31.9 36.8 29.0 33.9 35.9 31.4 25.6 32.6 33.7 33.7 33.9 103.6 48.1 8.6 8.1 8.1 48.3 115.1 11.8 40.9 0.6 28.0 27.7 8.1 18.6 11.7 7.3 0.0 32.8 1.5 0.6 11.7 33.2 0.5 4.7 18.3 39.6 0.0 5.3 0.1 51.6 131.0 62.1 14.8 5.6 3.8 1.6 45.7 68.7 25.1 0.0 2.6 1.4 8.2 9.7 80.8 0.9 22.7 31.6 24.9 9.4 22.0 16.0 0.0 11.1 2.5 77.6 0.1 18.0 4.4 55.8 25.7 20.4 9.6 0.8 0.0 38.7 33.4 0.6 4.5 17.5 33.1 78.4 3.2 0.4 1.2 47.4 SIGLEC7 "CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2" ENSG00000168995 "Sialic acid binding Ig like lectin 7" Q9Y286 19 51142299-51153526 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.4" "Cell type enhanced" "Detected in some" "Hofbauer cells: 31.3;Kupffer cells: 57.4;Macrophages: 33.1;monocytes: 15.5;NK-cells: 69.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 242.1" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Karpas-707: 55.4;RPMI-8226: 33.7;U-937: 35.0" HPA075513 Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 2600000 "Plasma membrane" Vesicles "HPA075513: " "unprognostic (3.14e-1)" "unprognostic (5.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (4.95e-2)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.27e-2)" "unprognostic (6.61e-2)" "unprognostic (1.14e-3)" "unprognostic (2.58e-1)" "unprognostic (2.26e-2)" 3.7 3.0 0.8 10.7 1.2 4.7 1.1 1.0 2.0 0.5 1.3 1.9 1.6 0.5 0.4 0.4 1.2 2.6 1.1 0.7 3.1 1.0 7.5 5.1 7.8 2.1 1.1 0.6 0.4 0.6 0.7 0.6 6.2 1.7 0.7 2.5 0.2 0.7 0.4 0.2 0.2 2.2 3.8 1.3 19.4 0.9 0.9 1.8 1.5 0.5 0.3 2.4 3.1 0.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 1.2 1.1 0.0 0.2 35.0 0.0 3.2 140.2 242.1 10.6 105.8 18.9 3.8 0.2 4.8 65.5 0.2 0.3 4.4 116.7 96.8 44.0 2.9 0.0 80.9 0.8 1.2 1.0 2.0 0.7 3.1 2.1 1.1 0.6 1.7 1.3 1.8 2.3 0.4 0.0 2.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.8 0.0 0.2 8.3 0.1 0.0 0.0 0.4 0.0 0.2 0.6 0.0 8.8 0.0 0.0 0.2 0.3 0.0 0.0 1.3 0.0 6.1 0.8 31.3 0.0 0.0 0.0 0.0 57.4 3.5 0.0 1.5 33.1 0.0 0.0 15.5 0.0 69.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.5 0.4 0.0 0.0 NTSR2 NTR2 ENSG00000169006 "Neurotensin receptor 2" O95665 2 11658178-11670195 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "brain: 78.8;choroid plexus: 34.6" "Cell type enriched" "Detected in some" 32 "Astrocytes: 32.7" "Cancer enriched" "Detected in single" 15 "glioma: 6.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.40e-2)" "unprognostic (2.30e-2)" "unprognostic (2.36e-2)" "unprognostic (5.32e-2)" "unprognostic (2.23e-1)" "unprognostic (1.80e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-1)" "unprognostic (1.64e-1)" 0.3 0.9 67.1 0.0 68.1 0.0 0.2 59.8 78.8 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 62.6 0.0 0.0 0.0 0.0 63.6 71.8 53.2 1.1 0.2 0.0 0.2 0.0 60.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 49.8 0.0 0.0 0.2 66.3 0.0 0.0 0.0 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.1 68.1 59.8 78.8 58.1 62.6 63.6 71.8 53.2 60.9 49.8 66.3 52.1 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 E2F6 E2F-6 ENSG00000169016 "E2F transcription factor 6" O75461 2 11444375-11466177 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 17 "basophil: 7.8" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA075185 Supported Nucleoplasm NA NA Nucleoplasm "HPA075185: AB_2732282" "unprognostic (7.13e-2)" "unprognostic (2.44e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (4.18e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.90e-1)" "unprognostic (3.05e-3)" "unprognostic (7.58e-2)" "unprognostic (3.17e-3)" "unprognostic (3.64e-3)" "unprognostic (2.08e-3)" "unprognostic (2.72e-2)" "unprognostic (1.02e-1)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" 5.6 5.3 5.9 2.5 5.9 3.8 4.4 5.8 5.9 3.1 5.6 4.0 2.8 5.4 4.0 2.7 5.0 3.1 7.3 5.6 6.2 2.6 2.8 3.0 2.4 6.1 6.2 5.4 4.7 4.6 3.4 5.0 3.1 6.4 3.3 2.2 3.6 3.6 3.5 14.7 3.4 3.6 4.5 5.9 3.2 4.9 2.8 6.0 2.5 2.7 11.6 1.9 4.0 3.0 6.0 4.2 5.2 10.7 6.0 4.8 3.9 8.0 4.0 7.1 4.6 4.2 10.3 5.6 8.2 4.5 4.6 9.3 3.1 7.6 5.9 4.8 10.6 11.3 14.9 4.0 12.8 9.4 15.4 14.7 6.7 5.5 5.0 5.9 3.9 4.2 7.1 11.3 15.3 3.7 10.1 8.9 16.9 15.3 5.1 6.7 15.6 12.1 8.4 5.0 3.7 9.2 19.1 4.6 6.7 18.8 4.6 6.2 7.7 3.5 6.6 8.5 4.2 9.0 22.0 17.4 19.9 7.2 14.5 10.3 7.8 0.2 0.1 0.1 0.0 0.4 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.9 5.9 5.8 5.9 5.6 6.2 6.1 6.2 5.4 6.4 5.9 6.0 6.0 15.7 6.4 4.8 7.2 8.4 24.3 23.6 10.6 13.6 12.4 14.5 9.7 9.0 10.0 8.4 3.7 16.7 17.3 8.5 3.4 7.9 11.7 1.4 11.0 14.1 12.2 6.7 3.4 13.9 11.0 13.9 14.3 13.3 14.0 0.0 13.6 8.6 8.8 12.5 13.5 14.9 4.7 8.2 5.4 11.5 2.6 8.7 11.3 17.8 6.5 7.0 10.1 5.2 3.5 20.8 9.4 3.7 11.3 6.1 21.3 5.3 8.4 4.1 11.8 0.0 22.2 12.3 15.7 48.2 8.2 21.9 22.2 8.4 11.7 6.0 16.7 FEM1B ENSG00000169018 "Fem-1 homolog B" Q9UK73 15 68277745-68295862 "Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 835.0;Late spermatids: 289.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041920, HPA042192" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041920: AB_10796788, HPA042192: AB_10796574" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-1)" "unprognostic (6.84e-2)" "unprognostic (1.89e-2)" "unprognostic (3.49e-3)" "unprognostic (1.35e-1)" "unprognostic (2.89e-2)" "unprognostic (4.67e-2)" 17.4 13.7 14.6 16.3 18.4 60.6 23.9 22.7 22.1 18.2 9.0 17.6 15.5 27.0 14.7 24.8 15.4 15.0 20.0 17.1 18.1 13.8 20.2 16.5 15.9 14.2 18.0 15.2 20.2 11.7 18.1 9.1 19.1 16.2 18.7 16.5 22.8 12.8 21.0 49.7 22.1 16.8 30.5 15.7 17.4 13.0 72.2 14.8 19.1 17.2 27.6 18.7 22.2 16.2 24.1 17.3 31.2 31.7 29.9 27.8 25.6 21.1 24.1 25.1 24.5 22.3 21.1 22.7 39.8 17.1 33.2 17.6 61.6 66.5 30.7 20.3 19.1 26.3 43.7 36.8 13.4 24.1 35.8 26.1 23.8 64.9 29.6 71.3 34.9 19.5 19.9 37.3 47.2 20.9 20.1 26.0 18.2 32.2 13.9 10.0 37.1 35.5 51.6 15.5 62.1 42.2 26.6 25.0 25.6 67.4 39.8 23.1 33.0 25.6 42.2 37.1 14.8 22.3 30.7 71.2 42.4 24.1 38.3 25.6 0.0 3.1 2.0 3.0 4.2 2.8 2.0 2.9 3.2 2.4 2.3 3.5 2.7 2.3 3.7 3.6 1.7 1.6 2.0 14.6 18.4 22.7 22.1 17.1 18.1 14.2 18.0 15.2 16.2 15.7 14.8 24.1 25.2 22.4 35.4 12.7 16.9 98.7 56.3 32.1 48.3 31.5 29.2 25.7 51.6 21.5 23.7 18.4 12.5 17.1 20.8 25.8 0.0 23.4 835.0 21.7 34.3 24.4 19.9 21.4 33.4 12.0 12.7 26.5 15.3 25.6 14.5 26.9 16.1 30.9 31.8 38.7 29.4 23.2 12.2 27.3 33.4 289.6 24.5 24.9 40.9 30.0 22.4 17.6 10.3 17.6 33.5 20.8 17.9 27.8 14.9 37.0 22.2 13.3 29.4 13.1 26.3 26.7 31.3 25.2 8.9 49.5 111.2 16.8 17.2 23.6 20.3 59.3 COMMD8 FLJ20502 ENSG00000169019 "COMM domain containing 8" Q9NX08 4 47450787-47463702 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 231.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035887 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035887: AB_10600702" "unprognostic (9.04e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (5.13e-2)" "unprognostic (2.51e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-2)" "unprognostic (4.24e-2)" "unprognostic (3.47e-2)" "unprognostic (1.78e-1)" "unprognostic (3.78e-2)" "prognostic favorable (2.71e-5)" "unprognostic (1.06e-1)" "unprognostic (2.10e-1)" "unprognostic (7.76e-2)" "unprognostic (7.13e-2)" 13.5 15.7 10.7 20.5 10.7 21.6 13.7 11.0 14.8 11.9 13.5 17.9 18.5 10.5 22.8 24.4 11.4 13.8 27.4 10.5 13.2 45.7 12.8 13.6 30.6 10.9 11.0 10.1 10.2 10.5 27.1 13.5 19.2 10.8 10.7 18.2 13.6 8.5 10.1 8.9 17.7 19.1 15.1 11.1 18.2 14.4 24.3 11.6 21.8 21.5 12.7 25.6 17.0 11.9 11.3 32.6 17.6 15.2 7.8 31.6 44.8 21.1 47.8 31.5 30.7 41.5 29.9 37.4 51.7 39.0 45.3 69.4 17.0 49.4 39.1 55.0 30.8 22.1 29.8 17.7 23.2 43.0 73.6 36.8 38.7 51.6 29.2 32.3 28.5 39.5 33.7 22.5 20.6 75.8 18.1 44.1 59.4 10.4 21.8 22.8 21.8 34.7 11.2 88.1 26.3 29.8 15.2 19.9 16.1 39.6 26.5 29.5 48.0 32.7 43.6 41.8 39.2 57.9 21.6 27.6 42.1 47.3 95.2 32.2 114.3 58.2 68.9 44.6 80.4 48.1 48.1 40.5 44.9 74.0 43.4 37.5 43.2 29.0 57.4 89.4 34.3 51.2 71.4 10.7 10.7 11.0 14.8 10.5 13.2 10.9 11.0 10.1 10.8 11.1 11.6 11.3 31.3 22.4 16.5 3.3 41.6 22.6 11.4 60.5 21.6 18.2 12.8 16.6 46.1 18.6 32.6 29.5 4.2 86.6 39.1 20.9 107.6 42.8 68.4 43.0 21.6 26.7 21.0 14.5 5.5 46.3 116.3 28.6 16.8 19.2 33.0 11.3 22.5 12.7 90.9 6.7 7.3 19.4 42.7 54.4 42.1 18.9 54.3 50.7 12.4 4.7 82.0 37.2 72.1 2.5 5.3 25.1 23.8 40.6 22.9 8.6 28.0 231.8 57.4 23.8 19.7 16.9 29.9 141.5 59.0 37.3 30.0 105.8 53.9 36.9 28.8 10.2 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674330 "Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2067.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 886.5;Distal tubular cells: 1729.5;Proximal tubular cells: 2485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria NA NA 280000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 363.3 416.1 924.1 214.1 941.5 314.9 279.8 959.1 1181.6 246.2 905.6 560.9 464.5 239.4 244.8 516.0 220.7 95.3 1292.5 917.4 945.0 548.8 596.5 237.7 176.0 963.1 938.6 887.7 259.7 333.7 781.7 315.2 146.0 968.8 264.2 334.6 339.4 307.5 222.5 2067.8 282.6 440.3 174.3 936.0 283.6 418.4 131.6 946.5 318.6 272.3 1703.4 225.7 296.0 326.5 981.6 542.0 560.8 781.7 599.5 622.4 544.4 390.7 561.8 445.4 407.4 359.4 525.4 548.4 299.0 472.8 612.4 683.8 361.8 668.9 924.1 241.4 249.9 1082.7 854.6 1107.9 1435.2 659.0 1118.6 368.0 721.6 533.5 472.2 491.0 665.5 503.3 608.1 756.0 314.4 464.7 904.5 972.6 1337.3 861.9 1071.7 1438.9 584.4 555.0 620.7 863.9 1053.2 667.7 530.1 401.6 525.0 620.2 502.7 590.4 695.7 580.2 348.0 340.7 308.2 730.9 739.7 1273.2 947.0 528.0 712.7 391.3 1049.3 1044.5 1188.8 742.1 920.0 776.3 1470.4 909.2 839.0 1067.0 1131.6 837.1 811.9 962.2 943.5 822.7 1179.7 1086.3 1456.6 924.1 941.5 959.1 1181.6 917.4 945.0 963.1 938.6 887.7 968.8 936.0 946.5 981.6 311.8 153.8 199.7 0.0 88.6 0.0 0.0 0.0 0.0 0.0 461.7 421.8 0.0 0.0 121.9 886.5 0.0 404.9 188.8 0.0 1729.5 467.4 0.0 468.6 315.6 125.1 0.0 0.0 0.0 692.9 335.8 139.4 0.0 484.2 122.4 311.8 0.0 0.0 676.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.6 0.0 0.0 278.1 0.0 0.0 0.0 0.0 509.6 0.0 0.0 50.1 0.0 0.0 2485.3 183.6 0.0 0.0 0.0 156.7 0.0 0.0 0.0 0.0 274.9 97.8 146.6 0.0 0.0 UQCRFS1 "RIP1, RIS1, RISP, UQCR5" ENSG00000169021 "Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1" P47985 19 29205320-29213151 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 233.8;tongue: 288.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1474.9;Distal tubular cells: 1035.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041863, HPA050339" Enhanced Approved Mitochondria NA NA Mitochondria "HPA041863: AB_10794638, HPA050339: AB_2681095" "unprognostic (4.00e-2)" "unprognostic (2.23e-3)" "prognostic favorable (3.29e-4)" "unprognostic (7.91e-3)" "unprognostic (3.93e-2)" "unprognostic (8.68e-2)" "unprognostic (1.84e-1)" "unprognostic (7.53e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.92e-9)" "unprognostic (6.11e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (1.92e-2)" 27.7 50.5 26.8 17.5 27.0 53.3 24.9 29.5 31.4 18.5 31.6 49.5 43.6 19.3 23.3 33.4 19.4 13.3 117.6 27.1 28.3 63.0 51.4 17.7 17.3 27.2 27.8 26.2 15.5 29.7 47.7 20.0 17.4 26.9 19.0 53.1 26.9 26.9 22.1 233.8 27.1 34.3 25.1 26.8 21.3 39.6 26.1 29.1 26.3 16.9 288.4 26.1 25.9 20.4 27.8 63.0 103.7 37.7 34.1 60.6 45.9 41.8 47.8 49.7 64.7 71.1 63.3 37.7 56.7 49.2 54.4 52.7 64.8 83.4 56.9 77.6 38.7 83.2 80.2 39.2 58.1 51.3 77.2 67.5 55.5 60.4 44.2 66.9 38.0 52.4 69.0 58.0 34.5 70.2 58.0 54.5 57.6 39.6 132.2 39.7 48.9 50.3 43.1 80.9 74.4 45.8 22.4 43.5 84.9 58.2 42.0 39.6 63.4 33.4 43.5 66.4 30.2 50.4 16.4 33.3 52.5 38.4 66.4 31.7 51.4 90.7 43.8 50.0 90.9 50.3 54.8 53.2 51.9 106.6 48.0 56.1 53.6 27.3 49.2 78.3 59.3 68.4 166.2 26.8 27.0 29.5 31.4 27.1 28.3 27.2 27.8 26.2 26.9 26.8 29.1 27.8 69.7 54.5 46.6 16.6 104.9 147.6 279.7 466.7 105.9 71.8 119.5 128.4 1474.9 161.5 201.4 114.0 16.7 282.0 116.8 321.6 1035.0 245.2 258.4 106.1 66.8 106.8 160.0 147.9 18.1 235.1 271.7 126.7 139.7 88.5 90.7 114.2 83.9 272.1 266.1 52.2 19.2 293.6 317.3 160.6 109.6 146.0 92.2 136.6 165.4 13.1 206.6 124.6 132.8 19.6 15.8 205.0 225.8 81.6 159.4 257.3 338.6 758.4 132.4 84.1 98.6 107.5 131.0 348.8 80.5 203.9 160.3 381.9 109.5 209.1 407.4 372.1 SLC49A3 "FLJ22269, LP2561, MFSD7" ENSG00000169026 "Solute carrier family 49 member 3" Q6UXD7 4 681829-689271 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 12.8;Breast glandular cells: 14.6;Collecting duct cells: 14.7;Ductal cells: 19.2;Extravillous trophoblasts: 33.9;Hofbauer cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 8.7;CAPAN-2: 5.8;SK-BR-3: 8.2;T-47d: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043593 Uncertain NA NA "HPA043593: AB_10959611" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (8.77e-2)" "unprognostic (4.70e-2)" "unprognostic (9.40e-2)" "unprognostic (1.84e-3)" "unprognostic (2.22e-1)" "unprognostic (1.56e-2)" "unprognostic (1.83e-1)" "unprognostic (2.56e-1)" "unprognostic (9.22e-2)" "unprognostic (2.08e-1)" "prognostic favorable (2.66e-5)" "unprognostic (8.35e-2)" "unprognostic (4.92e-2)" "unprognostic (7.48e-2)" "unprognostic (1.11e-1)" 7.9 3.2 2.1 4.4 1.8 3.5 9.1 2.1 3.0 4.3 3.7 3.7 5.9 3.5 4.2 4.4 3.3 3.7 7.8 1.3 4.6 6.9 5.9 8.2 3.0 2.9 2.1 1.0 1.2 4.8 4.6 2.0 2.8 2.9 5.0 2.3 12.7 8.5 2.1 3.0 8.9 6.0 2.1 2.1 8.5 8.5 9.0 2.6 0.6 8.6 1.9 1.8 4.3 5.0 2.3 0.1 0.1 2.7 1.9 1.9 3.7 8.7 1.0 0.0 0.7 0.6 0.4 5.8 0.1 0.2 4.5 0.4 0.2 0.0 0.0 0.2 0.6 0.6 1.6 0.7 0.2 0.8 0.0 1.2 2.5 0.0 3.4 0.0 0.0 1.3 0.3 0.4 0.5 0.0 0.1 0.1 0.7 0.3 0.4 0.5 0.0 0.3 0.6 0.0 0.3 0.9 0.7 0.0 8.2 0.5 0.5 25.8 1.6 0.3 0.8 0.3 0.4 0.3 2.8 1.6 0.1 0.3 0.7 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.4 0.2 0.0 0.1 0.3 2.1 1.8 2.1 3.0 1.3 4.6 2.9 2.1 1.0 2.9 2.1 2.6 2.3 12.8 3.2 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 14.6 8.4 0.0 0.0 1.8 14.7 0.0 0.7 3.1 0.0 1.9 19.2 0.0 2.1 6.0 4.3 0.0 0.0 0.0 0.4 33.9 4.3 0.0 4.1 0.0 0.8 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 4.9 0.7 0.5 0.0 0.0 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164624-227314792 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 53.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 169.9;Bipolar cells: 62.1;Cone photoreceptor cells: 398.2;Muller glia cells: 143.1;Oligodendrocyte precursor cells: 84.9" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "HeLa: 18.8;hTERT-RPE1: 14.5;Karpas-707: 9.9;RPTEC TERT1: 11.0;U-266/70: 9.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favorable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.5 11.6 2.1 2.1 2.3 0.3 1.0 1.7 1.8 0.3 18.4 0.7 0.7 1.3 16.5 1.0 2.2 3.3 7.0 1.5 2.9 30.2 0.7 15.2 2.9 3.1 3.1 0.4 3.9 5.0 0.2 16.3 0.2 3.1 6.0 1.0 53.4 1.2 10.0 22.4 0.4 6.8 0.8 1.6 7.2 1.8 1.7 7.1 0.5 20.7 15.3 5.7 1.4 1.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.0 0.0 0.3 1.1 0.1 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 1.2 0.0 9.9 0.0 0.4 0.0 0.1 1.4 0.0 0.0 0.1 0.0 3.2 11.0 2.3 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 9.0 3.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 1.7 1.8 1.5 2.9 3.1 3.1 0.4 3.1 1.6 7.1 2.3 0.5 169.9 31.7 3.9 14.0 0.1 0.1 0.1 0.6 62.1 0.1 0.9 2.6 1.5 9.3 42.3 398.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 2.4 0.0 0.0 5.5 1.0 0.0 4.6 0.5 0.3 1.3 22.8 0.4 0.2 0.0 1.7 14.1 0.0 0.0 0.0 0.3 0.3 8.4 0.3 1.8 13.1 0.0 143.1 0.0 84.9 3.6 1.0 0.0 12.0 8.0 0.1 0.0 1.9 0.1 11.9 13.1 11.7 3.6 0.4 0.0 0.3 0.3 0.0 1.2 0.1 0.0 0.0 MAP2K1 "MAPKK1, MEK1, PRKMK1" ENSG00000169032 "Mitogen-activated protein kinase kinase 1" Q02750 15 66386837-66491544 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 172.5;Langerhans cells: 265.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003834, HPA026430" Approved Enhanced "Plasma membrane,Cytosol" NA NA 120000 "Plasma membrane, Cytosol" "CAB003834: AB_562310, HPA026430: AB_1853742" "unprognostic (4.05e-2)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (4.92e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.81e-3)" "unprognostic (5.78e-2)" "unprognostic (9.91e-3)" "unprognostic (1.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (9.40e-3)" 58.4 31.2 44.7 38.7 72.8 64.3 32.7 36.1 61.5 28.2 28.3 26.2 19.6 26.5 29.8 52.2 23.9 27.3 37.9 72.5 49.2 28.3 106.2 35.0 49.9 44.5 39.5 61.6 25.9 22.6 38.8 27.0 29.8 40.1 26.5 23.8 34.4 29.5 22.0 86.2 23.9 27.2 32.2 40.2 32.9 24.3 15.4 45.3 34.1 23.0 51.8 55.9 31.5 34.0 53.7 105.8 55.3 94.4 39.0 55.3 41.3 53.8 83.6 61.6 76.6 68.1 79.0 82.1 96.8 93.2 59.9 58.2 93.3 88.8 106.4 89.8 79.1 56.8 30.9 50.4 40.7 45.1 41.0 45.3 32.3 64.0 55.9 81.6 81.5 60.7 48.0 54.3 116.7 113.4 40.3 33.5 51.9 47.9 93.9 42.9 39.2 58.1 84.7 74.8 48.5 58.3 31.7 60.8 45.5 63.0 74.9 41.0 33.7 90.8 99.5 63.8 71.1 112.4 74.0 143.1 60.6 105.1 69.9 48.4 3.0 7.5 5.4 6.4 7.7 5.8 2.8 5.6 6.1 7.7 4.6 6.9 4.2 3.5 8.3 7.7 15.1 4.6 2.8 44.7 72.8 36.1 61.5 72.5 49.2 44.5 39.5 61.6 40.1 40.2 45.3 53.7 24.5 28.9 24.8 24.2 40.0 82.8 45.9 32.3 21.1 10.0 22.2 10.2 21.5 40.0 24.9 25.8 14.6 48.1 45.0 25.1 46.9 69.4 12.1 16.3 13.9 34.6 21.7 19.0 69.7 23.1 48.8 30.3 17.9 35.4 8.9 19.8 18.9 172.5 51.4 10.1 46.4 15.4 20.3 90.7 265.3 23.6 22.4 115.1 53.4 48.7 87.9 34.9 35.0 28.1 31.7 103.9 23.5 21.8 49.1 87.7 22.2 35.9 17.7 7.8 6.6 16.3 52.4 35.6 42.7 30.3 67.3 51.7 54.0 5.9 19.1 65.4 KLK7 "PRSS6, SCCE" ENSG00000169035 "Kallikrein related peptidase 7" P49862 19 50976468-50984099 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 95.4;skin 1: 190.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 139.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018994, CAB026342, HPA062126" Enhanced Supported "Nuclear membrane,Plasma membrane" "Secreted in other tissues" NA NA 3700000 "Plasma membrane" "Nuclear membrane" "CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691" "unprognostic (1.88e-2)" "unprognostic (6.41e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (8.06e-5)" "unprognostic (4.33e-3)" "unprognostic (2.28e-1)" "unprognostic (4.44e-3)" "unprognostic (2.99e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.10e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-1)" "unprognostic (4.47e-2)" "unprognostic (1.12e-2)" "unprognostic (5.60e-3)" 3.4 0.1 8.9 0.1 7.3 0.3 11.4 1.3 7.5 9.5 1.4 0.1 0.5 0.7 0.2 95.4 16.4 1.3 0.2 6.4 2.0 11.7 0.1 3.2 0.0 5.4 2.5 5.7 0.1 0.1 0.3 0.7 0.0 4.7 0.1 0.0 0.1 21.8 0.2 1.0 190.7 0.0 0.2 2.4 0.8 0.3 0.4 6.2 0.9 0.2 0.0 11.0 0.0 31.2 4.9 5.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.8 8.0 0.0 1.1 0.0 0.1 31.7 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 8.9 7.3 1.3 7.5 6.4 2.0 5.4 2.5 5.7 4.7 2.4 6.2 4.9 0.0 6.4 1.1 0.0 0.0 5.0 0.1 0.5 4.6 0.0 9.4 10.4 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.6 0.2 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 5.9 10.7 0.0 0.1 0.0 0.1 2.7 HNRNPH1 "hnRNPH, HNRPH1" ENSG00000169045 "Heterogeneous nuclear ribonucleoprotein H1" P31943 5 179614178-179634784 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000914, HPA001359, HPA016884, CAB032820" Supported Enhanced Nucleoplasm NA NA 2800000 Nucleoplasm "CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444" "unprognostic (9.01e-2)" "unprognostic (3.83e-1)" "unprognostic (3.45e-3)" "unprognostic (8.82e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.85e-4)" "prognostic unfavorable (3.29e-7)" "unprognostic (7.99e-2)" "unprognostic (6.22e-3)" "unprognostic (1.56e-1)" "unprognostic (8.65e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (1.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.40e-3)" "unprognostic (1.72e-3)" 101.3 109.4 82.0 104.2 87.1 245.0 91.2 99.0 100.4 130.7 92.0 110.5 73.9 121.4 68.5 113.6 110.5 72.0 89.7 83.8 81.5 119.1 138.3 103.4 176.5 83.4 84.1 82.2 149.6 124.5 100.0 96.3 92.0 87.2 118.5 79.9 164.4 93.3 84.9 143.5 111.4 138.5 103.8 80.9 211.0 105.9 122.1 88.5 212.7 131.9 85.0 168.0 116.8 113.0 91.8 425.0 432.1 496.0 291.0 155.8 135.0 391.5 227.3 188.7 472.0 271.1 519.4 222.0 618.0 205.4 235.2 297.1 227.0 517.8 345.3 552.9 582.8 322.2 335.5 497.3 528.4 196.1 426.0 295.5 104.7 249.1 379.8 230.0 182.6 247.1 293.8 494.4 281.7 279.8 338.5 724.8 371.1 534.9 249.0 226.8 660.7 507.2 368.3 180.4 485.0 431.5 364.3 410.7 232.7 421.8 344.6 275.7 567.1 250.5 415.3 304.2 184.8 556.0 252.0 674.2 723.6 213.0 405.1 501.6 55.7 44.8 46.5 61.4 73.2 82.6 63.4 65.8 66.4 67.9 52.1 81.5 86.8 9.1 62.9 57.6 87.3 83.1 38.9 82.0 87.1 99.0 100.4 83.8 81.5 83.4 84.1 82.2 87.2 80.9 88.5 91.8 374.3 115.4 238.0 80.6 263.0 775.3 182.3 89.2 202.1 118.0 332.7 242.1 136.4 165.8 125.5 156.3 131.3 158.3 419.8 183.0 78.2 97.1 151.3 178.7 246.3 237.8 255.2 189.8 81.8 124.1 181.8 241.7 128.0 258.9 247.3 178.6 189.5 225.3 108.2 70.7 85.8 213.7 81.4 186.2 621.4 86.6 111.6 224.0 334.4 104.9 148.3 93.4 110.2 148.8 121.8 105.2 153.0 117.4 269.3 200.4 142.7 75.4 95.9 166.0 184.1 306.3 253.2 189.1 120.6 181.0 718.0 192.5 311.9 87.4 266.4 191.5 IRS1 HIRS-1 ENSG00000169047 "Insulin receptor substrate 1" P35568 2 226731312-226799820 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 75.4;Theca cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005261, HPA046433" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005261: AB_649615, HPA046433: AB_2732524" "unprognostic (2.20e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.59e-2)" "unprognostic (3.86e-3)" "unprognostic (1.61e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-3)" "unprognostic (5.47e-2)" "unprognostic (2.24e-2)" "unprognostic (5.48e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.46e-2)" "unprognostic (6.92e-2)" "unprognostic (3.23e-2)" "unprognostic (7.55e-3)" 7.6 9.8 1.3 2.9 1.7 0.5 11.8 5.4 3.1 12.3 1.4 8.1 4.0 17.5 1.9 3.7 15.1 5.6 5.0 1.7 1.2 3.4 10.5 5.1 1.7 1.9 1.7 0.8 21.1 3.5 3.4 1.5 9.5 2.7 7.9 2.7 1.5 3.0 7.1 28.3 5.1 5.1 10.4 2.0 2.1 5.4 0.8 1.6 8.2 20.2 3.0 1.3 11.7 6.7 1.8 5.7 26.0 18.6 0.7 25.0 14.8 0.0 15.6 12.2 20.4 13.0 15.0 14.4 2.3 2.5 10.6 14.0 10.0 1.2 15.0 11.5 5.9 1.0 0.1 1.7 7.1 12.5 0.5 0.1 20.7 8.1 16.1 14.5 12.3 0.0 2.3 3.0 22.7 14.0 22.6 4.9 6.6 7.5 3.6 14.3 1.1 24.1 0.1 9.3 18.9 3.2 0.5 5.0 3.6 8.4 14.9 13.7 0.3 1.3 26.8 24.2 20.9 15.1 10.6 4.6 3.4 26.5 0.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 5.4 3.1 1.7 1.2 1.9 1.7 0.8 2.7 2.0 1.6 1.8 1.7 19.2 4.6 5.9 2.7 35.4 31.9 29.7 19.4 19.3 36.9 28.1 13.4 14.3 12.8 0.0 0.0 6.4 0.0 13.2 17.6 15.4 1.6 22.1 28.4 2.1 2.4 0.0 17.3 11.4 0.6 28.3 2.0 24.3 0.0 75.4 1.8 57.4 1.7 20.2 31.3 6.5 24.4 1.3 4.6 1.8 22.7 3.6 16.0 15.0 0.8 8.4 0.0 26.7 1.7 11.1 8.2 14.7 9.5 14.5 23.4 3.0 8.1 1.7 13.1 9.5 22.8 1.0 1.2 4.2 23.7 18.3 1.2 110.3 7.7 22.8 MECP2 "MRX16, MRX79, RTT" ENSG00000169057 "Methyl-CpG binding protein 2" P51608 X 154021573-154137103 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 206.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 47.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 47.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000593, HPA001341, CAB037264" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347" "unprognostic (1.27e-3)" "unprognostic (2.60e-3)" "unprognostic (2.16e-3)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.35e-1)" "unprognostic (3.66e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-2)" "unprognostic (8.81e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-3)" "unprognostic (4.22e-1)" "prognostic favorable (7.32e-9)" "unprognostic (7.63e-2)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" "unprognostic (6.05e-2)" 19.8 17.8 13.2 13.5 12.6 25.2 18.1 18.7 16.4 23.8 8.2 18.3 10.0 19.2 10.9 14.5 21.9 10.9 21.8 12.0 11.3 17.2 16.7 24.9 13.5 13.7 13.0 9.1 25.0 15.0 14.8 23.0 8.7 13.9 24.1 5.4 23.2 14.6 15.7 33.7 14.8 16.3 11.6 9.0 23.8 15.6 8.6 12.7 15.7 19.0 14.6 9.2 20.2 19.4 16.9 34.4 19.2 15.9 18.6 13.1 8.8 12.7 17.0 14.6 14.9 25.2 14.1 13.3 37.4 39.5 13.3 28.9 16.0 19.3 15.9 8.8 32.5 27.8 13.6 17.6 9.4 14.9 18.2 28.2 8.7 10.0 15.6 13.2 15.4 12.9 17.5 17.3 28.9 11.1 17.9 23.1 21.8 11.2 21.9 19.9 20.0 16.2 13.2 9.2 13.3 21.9 13.6 13.0 14.1 31.6 7.7 8.8 24.8 18.0 14.5 28.8 29.2 35.6 41.0 32.6 41.7 19.6 33.2 25.1 47.8 4.7 19.5 9.1 4.7 6.2 7.8 6.1 7.2 3.5 6.8 5.8 5.4 22.7 4.4 8.2 6.0 7.2 2.7 13.2 12.6 18.7 16.4 12.0 11.3 13.7 13.0 9.1 13.9 9.0 12.7 16.9 53.9 6.4 34.4 26.4 74.7 30.8 43.4 28.3 21.6 88.0 40.7 24.6 41.2 34.3 34.9 46.0 206.4 17.0 130.8 23.9 66.5 39.4 1.4 28.2 34.4 41.0 36.5 48.4 31.7 30.7 17.7 38.5 16.3 22.7 52.6 32.2 66.4 38.1 25.6 99.3 35.3 21.0 52.9 45.5 68.7 3.5 53.4 54.1 30.2 45.0 58.9 39.8 85.5 30.2 45.0 36.2 30.3 73.7 56.1 34.8 36.7 44.5 28.1 92.7 32.9 53.6 57.1 16.0 39.0 18.1 29.0 18.5 93.6 25.6 17.3 36.4 VCX3A "VCX-8r, VCX-A, VCX3" ENSG00000169059 "Variable charge X-linked 3A" Q9NNX9 X 6533618-6535118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 110 "testis: 56.6" "Group enriched" "Detected in some" 7 "Spermatocytes: 598.9;Spermatogonia: 754.0" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.9;PC-3: 2.5;U-138 MG: 7.4;U-2197: 1.8;U-266/70: 4.6" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (2.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.64e-2)" 0.0 0.1 0.3 0.0 0.3 0.0 0.1 0.2 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.2 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 56.6 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 7.4 0.0 1.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.5 0.3 0.2 0.3 0.2 0.2 0.4 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 33.6 6.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 92.1 0.0 0.0 598.9 754.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281601-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 480.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: AB_2684477" "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favorable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.71e-4)" 15.5 20.2 14.7 15.2 15.1 18.1 16.6 20.2 18.6 17.5 10.2 15.9 18.2 18.9 8.3 13.4 18.6 11.8 13.0 13.9 14.8 13.4 10.4 12.2 17.2 18.1 15.5 12.6 15.6 19.9 13.8 17.2 11.3 18.4 16.5 11.2 11.7 16.6 14.7 24.0 15.8 16.0 11.4 15.5 16.4 16.9 46.7 15.4 18.1 30.5 7.6 10.9 15.5 14.4 18.5 55.9 15.9 35.3 31.7 16.4 28.1 22.3 42.0 30.0 26.4 29.1 24.4 19.4 54.0 11.9 19.6 17.8 29.3 17.2 14.1 32.6 39.8 33.7 47.0 50.9 27.1 28.3 81.7 20.3 19.1 28.1 17.8 20.5 27.7 21.2 14.0 29.0 24.7 26.6 16.7 33.8 22.1 46.7 36.8 15.9 43.2 19.8 31.7 23.4 17.5 39.1 43.3 33.6 51.3 31.3 23.6 37.6 72.7 27.5 27.8 46.0 15.5 26.6 53.4 39.3 74.5 51.7 46.7 23.3 3.0 5.6 4.8 6.8 4.7 5.2 13.2 7.0 7.2 6.5 9.7 7.1 6.7 0.9 11.9 6.1 16.9 10.8 4.3 14.7 15.1 20.2 18.6 13.9 14.8 18.1 15.5 12.6 18.4 15.5 15.4 18.5 104.8 67.3 61.5 88.5 64.2 68.7 57.8 57.2 76.8 85.3 80.6 84.3 22.8 52.9 60.8 58.8 83.4 65.0 75.3 32.1 103.7 54.3 205.8 148.7 101.2 78.1 57.5 51.9 84.7 71.2 45.2 69.7 42.8 65.4 55.6 57.7 63.9 72.6 45.7 79.1 114.7 50.5 79.3 44.9 46.1 96.8 100.6 53.8 55.2 59.0 51.1 74.2 83.4 188.5 130.9 52.6 34.0 87.6 81.1 59.1 36.0 69.8 96.0 72.3 85.5 77.5 56.4 480.3 172.4 82.4 71.9 40.5 64.3 111.8 62.2 46.7 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167239843-167407874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 13.7;choroid plexus: 24.1;fallopian tube: 23.4;testis: 36.2" "Cell type enhanced" "Detected in some" "Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.0 0.2 11.7 0.0 2.7 0.0 0.0 2.9 2.9 0.4 24.1 0.0 0.0 0.8 0.1 0.0 23.4 0.0 0.0 2.0 7.8 0.2 0.0 3.5 0.0 12.6 9.5 0.7 0.0 0.0 0.3 2.0 0.0 6.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 36.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 2.7 2.9 2.9 2.0 7.8 12.6 9.5 0.7 6.4 13.7 2.7 6.5 0.0 0.0 1.1 7.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 423.4 107.4 0.6 0.6 0.0 0.0 80.1 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 23.8 0.0 6.1 0.0 0.0 232.4 1.5 0.4 0.0 1.9 0.0 0.0 0.0 4.5 1.1 0.1 0.0 1.5 0.0 0.1 0.0 0.2 226.2 0.0 0.0 0.0 1.2 37.4 11.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 ACTBL2 DKFZp686D0972 ENSG00000169067 "Actin beta like 2" Q562R1 5 57480018-57482811 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.1;Club cells: 1.0;Ductal cells: 1.7;Early spermatids: 2.4;Exocrine glandular cells: 1.1;Pancreatic endocrine cells: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.3;RPTEC TERT1: 1.6;SiHa: 2.9;U-2 OS: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041264, HPA041271" Uncertain NA NA 830000000 "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.83e-2)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (8.66e-2)" "unprognostic (2.57e-2)" "unprognostic (2.39e-1)" "unprognostic (3.63e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-3)" "unprognostic (3.20e-1)" "unprognostic (2.48e-3)" "unprognostic (1.60e-2)" "unprognostic (2.04e-2)" "unprognostic (1.92e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.3 1.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 2.4 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 ROR2 "BDB, BDB1, NTRKR2" ENSG00000169071 "Receptor tyrosine kinase like orphan receptor 2" Q01974 9 91563091-91950228 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 18.4;Endometrial stromal cells: 19.3;Fibroblasts: 14.4;Inhibitory neurons: 18.6;Microglial cells: 15.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 24.5;HHSteC: 63.1;HSkMC: 52.2;U-266/70: 38.3;U-266/84: 27.5" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "cerebellum: 7.2;spinal cord: 3.7" HPA021868 Uncertain NA NA "HPA021868: AB_1856406" "unprognostic (9.38e-3)" "unprognostic (4.69e-1)" "unprognostic (2.26e-1)" "unprognostic (8.48e-3)" "unprognostic (1.23e-1)" "unprognostic (2.38e-1)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (8.03e-2)" "unprognostic (2.03e-1)" "unprognostic (5.76e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (2.16e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (1.25e-2)" 4.2 5.7 1.3 4.0 0.6 0.1 4.4 0.6 0.8 18.8 23.2 23.5 2.2 23.9 1.5 8.3 11.7 8.7 6.0 1.5 2.1 1.3 0.5 5.5 0.5 1.5 1.5 0.3 14.1 1.6 16.7 1.6 3.5 0.9 14.0 2.2 1.0 1.6 13.4 0.3 4.1 7.8 11.1 1.3 3.3 12.9 3.5 0.8 3.1 5.7 0.7 1.0 17.7 10.7 0.9 0.0 0.2 24.5 0.0 5.3 0.5 6.8 0.4 6.3 4.0 7.8 0.0 0.0 0.0 0.1 0.8 3.9 0.2 5.2 0.0 1.7 0.0 4.2 0.0 18.3 0.0 63.1 0.0 0.0 52.2 0.0 5.6 0.0 0.0 0.0 0.2 14.7 0.0 0.0 0.4 0.1 3.6 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 7.2 0.6 0.0 0.0 5.0 14.8 0.0 0.0 0.0 4.8 2.0 0.0 38.3 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.6 0.8 1.5 2.1 1.5 1.5 0.3 0.9 1.3 0.8 0.9 0.3 0.0 0.0 1.6 0.1 3.1 11.3 0.9 1.2 1.4 3.7 3.0 8.2 1.5 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.5 4.5 18.4 19.3 1.4 3.0 0.0 1.4 1.5 0.2 14.4 2.6 7.5 1.3 0.1 0.4 0.0 0.8 0.0 18.6 2.8 0.0 0.0 4.8 8.6 5.9 0.4 5.4 15.9 1.6 7.4 0.0 27.6 0.4 0.6 1.6 9.1 0.1 8.6 0.0 0.0 0.2 0.5 6.6 0.0 2.9 2.3 14.3 0.1 2.3 0.4 0.7 0.4 0.8 5.3 AR "AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1" ENSG00000169083 "Androgen receptor" P10275 X 67544021-67730619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 38.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 93.7;Granulosa cells: 104.8;Hepatocytes: 269.2;Leydig cells: 77.9;Peritubular cells: 86.5;Skeletal myocytes: 75.0" "Cancer enhanced" "Detected in many" "breast cancer: 15.6;prostate cancer: 16.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.3;BJ hTERT+: 10.3;HAP1: 14.9;LHCN-M2: 16.1;RH-30: 23.6;T-47d: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000001, HPA004733, CAB065764" Enhanced Supported Cytosol NA NA Cytosol "CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: " "unprognostic (1.34e-1)" "unprognostic (8.10e-3)" "unprognostic (2.49e-2)" "unprognostic (5.95e-2)" "unprognostic (1.04e-2)" "unprognostic (3.35e-2)" "prognostic favorable (8.77e-4)" "unprognostic (4.99e-2)" "unprognostic (1.72e-1)" "unprognostic (7.79e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "prognostic favorable (1.03e-8)" "unprognostic (8.23e-3)" "unprognostic (8.90e-2)" "unprognostic (4.23e-2)" "unprognostic (7.97e-2)" 6.8 1.0 1.6 0.5 1.1 0.0 8.8 1.7 1.1 23.8 0.4 1.5 0.2 18.8 16.3 1.2 20.9 2.0 5.9 0.7 5.3 3.6 38.6 1.5 0.3 3.4 2.5 0.1 14.8 0.8 0.1 1.9 0.1 2.6 16.6 0.6 0.2 1.4 18.4 14.1 5.3 0.9 9.5 2.2 1.3 1.5 3.9 3.6 2.7 2.1 6.2 0.5 3.5 13.0 2.8 0.0 4.8 13.3 0.0 0.0 0.0 0.0 7.3 10.3 0.3 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 14.9 0.0 0.0 0.0 2.4 0.0 1.5 0.0 0.8 0.0 0.0 5.5 0.0 1.8 0.0 0.0 3.9 0.1 4.6 2.2 16.1 1.5 0.0 0.0 5.4 0.0 0.0 0.0 23.6 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 3.6 10.9 7.6 0.3 0.3 2.2 0.0 3.5 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 1.7 1.1 0.7 5.3 3.4 2.5 0.1 2.6 2.2 3.6 2.8 3.1 0.0 5.0 28.4 0.4 9.7 17.8 0.2 15.9 0.7 93.7 33.7 37.4 14.3 10.7 3.7 0.0 3.5 14.0 0.0 1.9 11.3 1.1 2.9 49.1 10.5 0.0 5.3 7.7 0.0 0.2 39.4 0.0 5.8 1.3 104.8 36.0 269.2 0.8 0.0 17.8 0.3 0.0 2.2 4.2 4.4 77.9 3.3 10.6 1.0 1.7 0.2 0.0 26.7 0.2 0.6 0.0 86.5 0.0 36.5 0.6 27.7 3.6 0.3 65.7 75.0 20.8 0.8 3.3 12.7 16.1 1.0 1.7 37.8 0.2 22.0 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219506-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003035, HPA075955" Approved Uncertain "Mitotic spindle,Cytosol" "Secreted to blood" Yes NA Cytosol "Mitotic spindle" "HPA003035: AB_1080631, HPA075955: " "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 12.9 16.3 8.0 4.8 7.1 5.2 12.3 6.7 7.8 12.6 10.5 12.4 6.6 13.1 8.1 6.1 11.1 8.9 19.3 5.6 9.8 14.8 30.9 10.4 5.6 11.0 7.5 2.8 12.7 22.1 11.6 10.7 8.3 7.7 13.3 8.4 2.2 14.9 7.0 12.5 8.9 10.9 7.0 8.4 10.2 16.7 6.4 10.7 6.2 13.4 7.1 4.0 11.3 9.3 11.5 8.1 35.7 23.9 11.0 28.8 18.0 18.5 17.8 29.9 13.3 17.9 26.9 16.8 12.6 22.6 21.5 31.4 3.9 16.4 14.3 9.4 24.1 26.1 12.2 17.9 21.2 33.8 6.6 9.5 22.3 17.7 11.6 11.4 22.7 10.9 13.9 14.0 6.1 21.7 9.2 28.5 9.7 6.9 10.6 9.9 10.4 12.4 3.5 14.5 19.3 24.3 22.9 17.0 20.3 14.2 14.8 8.7 10.8 15.6 14.5 3.6 8.4 10.6 7.1 0.1 33.2 9.7 8.7 6.7 14.9 38.3 34.6 15.1 30.6 16.0 25.0 13.5 12.7 35.1 20.1 12.3 10.6 56.4 17.7 19.5 28.3 18.2 21.0 8.0 7.1 6.7 7.8 5.6 9.8 11.0 7.5 2.8 7.7 8.4 10.7 11.5 8.7 19.2 9.3 64.3 19.2 10.6 22.9 58.0 20.5 9.5 19.3 16.9 23.4 25.8 24.4 25.8 10.4 42.9 17.0 32.9 13.7 52.3 0.6 16.1 15.9 14.8 19.2 13.7 41.2 81.2 43.5 26.9 21.4 14.4 17.8 27.1 15.0 50.6 38.4 3.3 42.7 21.4 32.6 20.8 30.7 3.0 24.2 26.3 12.4 61.8 35.9 9.4 14.4 46.3 31.9 71.0 28.8 25.2 29.1 65.3 49.2 43.7 14.8 6.2 19.7 12.0 18.3 12.0 21.2 11.3 6.5 107.3 14.0 14.6 24.1 29.2 VXN "C8orf46, MGC33510" ENSG00000169085 Vexin Q8TAG6 8 66493520-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 126.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.1;Proximal tubular cells: 3.4;Syncytiotrophoblasts: 1.0" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.5;GAMG: 5.4;HBF TERT88: 3.9;LHCN-M2: 4.4;T-47d: 5.8;WM-115: 4.5" "Group enriched" "Detected in all" 8 "amygdala: 159.7;basal ganglia: 78.9;cerebral cortex: 298.2;hippocampal formation: 219.3;white matter: 199.5" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA075134: AB_2686736" "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 0.3 0.5 62.0 0.3 81.2 0.0 0.5 58.1 87.1 0.7 30.7 1.3 0.0 0.7 1.3 0.0 0.5 0.2 0.2 126.1 60.2 0.6 1.4 0.3 0.0 62.2 64.4 78.7 0.3 0.6 0.4 0.4 0.0 64.5 1.5 0.3 0.2 0.1 5.4 0.5 0.2 0.5 1.1 65.5 0.1 1.2 0.3 62.6 0.0 0.2 0.0 0.3 0.3 0.4 91.6 2.7 0.1 1.0 1.3 0.1 0.1 0.0 0.2 0.4 1.2 1.3 0.1 4.5 0.0 0.1 2.9 5.4 0.1 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.1 4.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 1.9 0.1 0.2 0.0 0.1 0.1 3.0 0.1 5.8 0.0 0.0 0.4 0.9 0.0 1.9 2.0 1.1 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 81.2 58.1 87.1 126.1 60.2 62.2 64.4 78.7 64.5 65.5 62.6 91.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.3 0.0 0.0 HSPBAP1 "FLJ22623, PASS1" ENSG00000169087 "HSPB1 associated protein 1" Q96EW2 3 122739999-122793831 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Microglial cells: 52.5;Syncytiotrophoblasts: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044930 Approved Approved Mitochondria NA NA Mitochondria "HPA044930: AB_10961122" "unprognostic (3.40e-3)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (6.70e-3)" "unprognostic (3.40e-3)" "unprognostic (3.40e-2)" "unprognostic (8.61e-4)" "unprognostic (2.68e-2)" "unprognostic (6.95e-2)" "unprognostic (3.35e-2)" "unprognostic (2.36e-1)" "unprognostic (8.91e-2)" "unprognostic (1.24e-3)" "unprognostic (4.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.34e-1)" "unprognostic (4.12e-3)" 4.2 5.4 3.1 4.3 3.4 3.1 3.9 3.6 4.2 3.7 4.3 3.4 2.5 3.8 1.9 2.8 3.2 3.6 2.9 3.5 3.5 4.3 3.5 4.6 6.2 4.1 3.7 2.7 3.0 3.8 3.7 2.7 6.0 4.2 3.3 3.5 4.6 3.2 3.2 16.1 4.2 3.8 3.9 3.8 7.4 3.0 10.8 3.6 6.5 6.3 8.8 5.5 4.3 3.2 4.0 5.4 4.1 5.8 5.2 6.8 5.1 11.3 2.6 6.7 6.1 8.6 5.6 4.1 6.9 4.2 1.8 15.4 6.4 9.0 5.0 7.1 4.3 2.5 4.6 4.8 3.3 15.4 4.2 6.1 7.7 18.0 5.1 16.3 5.8 5.8 6.9 3.1 5.8 5.6 3.5 6.1 5.3 6.6 4.2 8.2 6.2 7.8 6.8 6.4 2.1 6.4 6.5 6.2 2.4 23.3 5.5 2.9 8.8 5.8 7.1 4.2 2.3 3.7 5.7 6.1 8.1 4.4 6.2 7.1 23.0 16.5 12.0 6.1 12.2 7.6 11.0 8.0 6.1 13.0 8.3 8.6 8.4 30.6 6.3 24.1 4.5 10.3 8.2 3.1 3.4 3.6 4.2 3.5 3.5 4.1 3.7 2.7 4.2 3.8 3.6 4.0 10.2 6.4 5.3 10.7 20.8 10.7 3.9 5.0 6.8 6.6 3.9 5.7 5.7 4.3 3.9 5.5 60.5 16.8 11.4 4.9 3.9 5.5 35.7 7.3 5.1 6.4 0.0 7.2 15.2 6.0 11.0 6.5 5.6 4.4 6.3 6.4 11.0 3.6 12.9 8.4 24.7 3.1 4.1 24.1 14.1 8.0 9.6 20.1 5.4 52.5 29.4 3.7 14.4 8.0 22.9 4.3 3.5 4.9 6.4 3.2 6.3 4.5 5.9 12.8 6.6 7.1 4.9 36.8 8.4 5.0 7.5 48.6 10.3 7.4 3.5 1.7 ASMTL ENSG00000169093 "Acetylserotonin O-methyltransferase like" O95671 X 1403139-1453762 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 92.5;monocytes: 106.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 131.0" "Low region specificity" "Detected in all" "HPA003630, HPA021865" Supported Enhanced Cytosol NA NA 17000 Cytosol "HPA003630: AB_1078230, HPA021865: AB_1845099" "unprognostic (3.89e-2)" "unprognostic (1.14e-3)" "unprognostic (2.28e-1)" "unprognostic (1.87e-2)" "unprognostic (7.99e-2)" "unprognostic (9.05e-2)" "unprognostic (8.17e-2)" "unprognostic (5.23e-2)" "unprognostic (8.40e-2)" "unprognostic (1.24e-1)" "unprognostic (1.91e-3)" "unprognostic (7.24e-2)" "unprognostic (3.26e-3)" "unprognostic (9.70e-2)" "unprognostic (8.38e-2)" "unprognostic (2.91e-1)" "unprognostic (2.20e-1)" 26.1 21.9 14.0 15.8 13.4 17.6 27.0 13.7 20.5 28.5 19.2 27.0 11.8 29.6 14.4 15.2 28.8 13.7 34.4 14.2 15.2 23.1 32.4 18.4 21.5 19.0 17.1 14.2 34.2 23.8 22.6 31.2 11.3 17.4 27.0 7.9 9.5 25.0 23.6 24.0 27.1 20.7 12.3 13.9 24.2 23.3 13.2 15.5 20.2 29.8 15.4 12.5 25.3 23.1 17.1 14.0 24.0 28.0 21.4 16.5 25.5 38.9 16.3 21.3 18.2 23.2 22.0 16.5 24.6 9.0 21.5 19.7 5.1 7.4 7.9 11.4 36.7 23.9 21.4 17.0 26.6 37.5 10.1 131.0 33.9 13.4 13.9 13.4 20.3 21.7 18.7 11.0 19.3 14.6 52.4 43.5 39.6 33.9 12.9 15.0 35.2 26.7 60.0 12.8 7.6 1.1 13.2 21.9 27.8 20.7 18.9 6.4 13.4 28.6 15.2 16.5 29.0 6.1 24.8 8.0 62.9 19.3 14.5 4.6 45.7 25.5 65.9 28.8 30.9 25.6 24.2 26.1 26.9 22.0 37.7 22.5 17.7 37.2 52.9 22.5 42.1 31.4 23.2 14.0 13.4 13.7 20.5 14.2 15.2 19.0 17.1 14.2 17.4 13.9 15.5 17.1 20.6 12.8 9.4 5.2 19.3 18.4 25.3 17.2 23.3 17.7 16.4 17.4 21.3 10.0 9.9 14.7 4.2 33.4 28.8 16.1 27.4 15.2 0.9 8.8 14.3 19.5 14.4 7.4 8.3 17.1 24.1 23.8 14.8 10.4 54.6 27.0 17.9 30.8 20.3 92.5 6.7 17.9 8.2 12.3 31.0 2.8 26.1 18.8 12.4 9.4 106.2 17.1 26.8 5.0 7.1 10.9 18.3 43.2 21.8 22.1 19.9 34.2 11.1 12.6 32.9 21.4 23.2 2.5 8.2 22.3 15.6 66.4 20.4 21.9 20.4 18.4 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392113 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 450000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 330.4 413.5 195.5 225.4 208.4 445.1 309.9 182.6 299.0 245.7 301.1 350.8 470.2 280.2 81.3 347.6 245.5 128.4 200.8 199.5 188.3 389.3 131.1 241.4 277.3 191.7 196.6 183.6 464.7 632.2 326.3 277.9 148.3 199.5 266.4 142.8 109.2 703.9 180.5 116.6 326.7 391.0 130.6 181.3 265.8 417.3 62.7 194.9 234.9 324.1 90.0 160.6 294.4 246.7 191.8 290.4 596.8 393.8 422.6 267.5 527.4 466.2 396.8 386.1 296.8 289.2 796.7 330.6 1023.0 334.1 264.9 445.6 179.2 269.5 482.0 89.8 260.3 886.0 545.0 396.0 899.7 642.2 398.1 649.8 870.1 882.2 235.8 335.9 367.5 441.6 315.7 407.2 233.8 284.5 575.4 791.1 733.3 516.0 105.5 802.2 378.8 333.8 828.3 351.4 693.6 682.9 1096.5 271.1 817.7 1239.7 224.1 466.1 832.5 505.5 305.1 169.6 596.5 422.1 606.7 110.5 705.9 48.7 389.9 170.3 34.2 739.8 47.2 319.5 808.7 466.9 671.4 431.3 377.9 985.9 532.5 396.1 399.7 34.4 359.9 832.3 461.2 447.6 1120.7 195.5 208.4 182.6 299.0 199.5 188.3 191.7 196.6 183.6 199.5 181.3 194.9 191.8 194.2 147.4 244.3 13.7 724.4 1151.2 1447.6 1800.6 421.8 286.1 981.3 710.8 106.0 371.8 704.7 316.3 98.0 1581.2 448.5 690.4 1659.2 752.6 11.4 164.4 388.1 473.0 928.4 471.3 15.1 1473.5 1229.8 507.8 374.1 245.3 343.6 698.0 529.4 149.7 1264.7 242.3 20.4 1208.1 819.9 1553.5 1299.4 45.8 667.9 764.0 754.2 17.8 1450.5 184.6 531.4 8.0 13.7 789.8 1127.8 366.3 604.9 1452.4 1564.9 1320.8 180.3 280.0 341.8 631.7 665.6 13.3 80.7 796.7 1321.5 1744.1 494.7 847.8 1524.3 1723.2 CHST14 "D4ST-1, D4ST1, HD4ST" ENSG00000169105 "Carbohydrate sulfotransferase 14" Q8NCH0 15 40470984-40473158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057697, HPA071601" Enhanced Approved "Golgi apparatus" NA NA 20000 "Golgi apparatus" "HPA057697: AB_2683505, HPA071601: AB_2686425" "unprognostic (5.46e-2)" "unprognostic (9.23e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-2)" "unprognostic (6.94e-2)" "unprognostic (1.70e-1)" "unprognostic (9.95e-2)" "unprognostic (2.84e-1)" "unprognostic (3.17e-2)" "unprognostic (5.85e-3)" "unprognostic (2.01e-3)" "unprognostic (1.94e-1)" "unprognostic (6.34e-2)" "unprognostic (2.25e-2)" 14.0 9.7 6.3 7.8 6.7 3.4 13.9 6.8 6.6 22.1 6.8 10.5 4.5 21.8 8.1 8.8 16.6 11.4 13.5 5.8 7.9 9.8 8.9 13.1 8.6 7.3 6.6 5.1 21.3 8.1 11.3 14.5 27.2 6.6 14.7 4.6 1.6 11.1 15.6 5.0 9.0 10.0 12.7 7.1 13.7 9.4 8.0 6.6 8.6 15.9 7.5 7.6 16.3 16.3 7.0 26.2 17.1 26.4 71.6 40.4 31.0 43.0 25.2 47.3 43.5 40.9 21.2 12.8 4.3 37.6 42.7 76.7 43.7 23.7 14.2 20.3 31.5 15.0 13.4 16.9 19.8 22.5 5.7 33.4 38.3 11.6 15.4 11.6 47.8 39.2 15.1 13.6 15.0 32.6 20.1 9.6 29.8 17.0 7.9 20.1 26.2 33.4 7.6 29.5 13.3 19.7 30.2 22.2 24.4 8.4 31.9 35.7 23.9 31.9 73.0 27.1 23.3 25.5 30.3 22.6 12.2 32.8 19.6 53.7 7.6 1.1 2.2 2.2 1.1 0.6 0.3 1.1 1.9 2.0 1.1 0.9 0.8 0.1 3.3 0.6 0.7 0.8 0.7 6.3 6.7 6.8 6.6 5.8 7.9 7.3 6.6 5.1 6.6 7.1 6.6 7.0 10.6 12.8 1.1 2.0 5.8 3.4 5.4 4.1 9.1 0.6 5.8 9.7 3.2 7.2 4.6 3.7 0.0 46.5 3.5 0.5 0.0 7.7 1.8 3.2 14.5 10.2 2.4 10.7 0.1 4.9 32.4 19.3 0.0 5.6 4.5 14.9 15.4 3.7 9.3 1.7 0.1 1.4 2.0 5.6 3.3 1.3 17.7 5.6 5.4 2.8 3.4 9.8 6.2 2.0 0.5 5.2 0.3 11.7 1.9 3.6 0.2 1.1 3.0 0.8 6.6 11.8 9.2 7.5 1.3 5.6 2.6 13.5 4.9 3.9 1.9 1.3 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 15 "memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6" "Group enriched" "Detected in many" 15 "B-cells: 8.1;dendritic cells: 4.0" "Cell line enhanced" "Detected in many" "ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 45.5 52.3 3.7 27.9 6.4 0.4 29.6 0.0 20.9 43.7 2.5 92.2 7.0 35.0 14.1 13.6 23.5 28.9 104.6 10.2 24.9 56.4 1.3 34.0 18.3 2.0 10.7 7.1 19.8 34.4 73.7 41.4 41.1 14.7 84.5 114.5 6.1 39.7 65.1 21.2 11.0 15.8 48.6 0.0 15.4 13.5 12.1 4.2 17.5 124.8 18.2 21.0 45.2 25.2 7.2 1.1 1.9 1.7 0.0 44.6 0.3 0.2 0.0 0.2 0.0 0.0 3.9 0.3 0.0 0.2 0.0 0.1 0.1 15.1 0.0 0.0 0.2 3.3 0.0 0.0 0.0 7.4 0.0 1.3 1.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 44.9 0.8 0.5 5.2 0.2 4.3 0.0 2.7 0.0 4.1 11.8 0.2 9.5 2.8 0.1 0.1 0.3 0.0 1.8 0.0 0.0 0.0 2.7 2.9 0.3 4.2 49.8 5.1 12.9 4.7 0.0 0.7 0.0 0.1 0.0 0.0 0.3 0.0 8.1 0.0 0.0 4.0 5.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 3.7 6.4 0.0 20.9 10.2 24.9 2.0 10.7 7.1 14.7 0.0 4.2 7.2 44.8 16.0 84.1 2.9 11.6 3.2 27.2 6.5 4.0 7.0 4.0 3.4 181.9 31.5 10.4 0.0 0.0 0.3 0.1 398.3 3.9 0.5 10.1 3.0 73.5 6.4 19.9 2.7 51.3 49.2 0.7 13.2 2.0 2.8 1.3 61.9 2.9 0.0 1.5 0.0 77.8 109.7 14.2 0.3 34.7 28.6 36.7 4.9 8.8 1.0 0.7 0.1 0.0 6.0 3.6 23.5 132.1 74.4 42.9 32.6 2.5 27.7 7.2 1.7 46.0 5.4 61.5 1.6 3.2 0.3 1.8 0.8 1.9 14.9 81.6 9.1 CSNK1G1 CK1gamma1 ENSG00000169118 "Casein kinase 1 gamma 1" Q9HCP0 15 64165525-64356173 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 35.3" "Cell type enhanced" "Detected in all" "Early spermatids: 130.6;Late spermatids: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018209 Supported Cytosol NA NA Cytosol "HPA018209: AB_1847278" "unprognostic (9.10e-2)" "unprognostic (8.09e-2)" "unprognostic (1.20e-1)" "unprognostic (2.65e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.02e-1)" "unprognostic (8.63e-2)" "unprognostic (3.75e-2)" "unprognostic (7.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.31e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" 4.0 3.5 6.5 6.2 7.3 9.1 6.0 6.2 7.8 5.5 6.1 5.0 4.0 4.5 6.7 7.9 7.4 4.1 2.9 10.2 6.5 5.3 2.9 5.4 6.0 3.6 4.3 6.1 5.3 4.1 6.3 4.7 5.0 4.7 3.8 5.4 14.6 3.6 4.4 4.2 6.6 3.9 5.4 3.0 6.0 4.3 35.3 6.2 9.4 7.9 3.3 6.8 5.5 4.7 5.9 6.8 14.2 10.0 13.2 8.3 11.4 8.9 8.3 8.5 13.8 12.5 11.5 13.2 10.8 4.3 13.3 14.2 15.4 26.7 16.5 16.1 20.6 6.8 10.1 11.2 8.0 9.8 18.9 11.4 10.3 21.7 14.0 20.0 11.9 15.4 10.6 12.3 10.4 12.8 9.4 9.7 5.8 9.4 8.9 7.4 16.1 12.5 8.6 11.2 26.8 16.2 9.9 11.1 6.5 9.5 16.4 11.4 7.4 16.8 12.6 14.9 9.8 10.5 12.3 26.0 8.8 11.6 13.5 7.9 0.4 1.9 3.1 2.8 2.8 4.0 1.8 2.5 2.1 1.4 1.8 2.4 2.3 4.5 2.8 2.3 2.1 2.2 1.3 6.5 7.3 6.2 7.8 10.2 6.5 3.6 4.3 6.1 4.7 3.0 6.2 5.9 10.9 28.9 11.3 35.6 12.9 11.6 10.5 13.7 19.9 47.1 11.6 7.9 7.3 11.5 12.7 5.5 68.8 6.9 12.6 12.2 1.9 9.6 130.6 37.4 17.9 12.2 22.8 7.8 69.4 7.0 9.0 10.3 15.3 24.6 3.8 15.8 10.4 4.4 10.4 10.1 49.8 10.5 6.1 9.7 10.0 261.1 6.2 14.1 7.2 40.3 13.5 7.9 5.2 40.2 41.3 12.0 7.5 10.1 14.3 11.1 8.2 9.7 23.3 29.3 6.6 14.4 11.8 31.9 19.8 26.7 15.6 4.1 13.2 7.9 10.4 13.2 FAM110B "C8orf72, MGC39325" ENSG00000169122 "Family with sequence similarity 110 member B" Q8TC76 8 57994509-58204279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Inhibitory neurons: 195.6;Oligodendrocyte precursor cells: 253.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 13.4;intermediate monocyte: 3.5;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 11 "granulocytes: 13.4;monocytes: 6.8" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008318, HPA011781" Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA008318: AB_1853892, HPA011781: AB_1853891" "unprognostic (2.07e-1)" "unprognostic (6.91e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.88e-8)" "unprognostic (4.09e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "unprognostic (8.72e-2)" "prognostic favorable (1.44e-4)" "unprognostic (1.06e-2)" "prognostic favorable (4.31e-8)" "unprognostic (2.23e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.15e-4)" 6.4 1.3 14.0 1.9 11.5 2.2 5.3 18.2 10.9 7.8 7.5 5.1 0.8 5.8 2.2 1.3 5.0 2.7 14.3 15.2 13.6 5.7 5.6 3.9 0.7 10.8 11.1 11.6 5.3 1.6 11.0 3.8 2.7 13.1 5.4 1.4 4.0 5.9 6.7 12.1 2.5 3.3 6.0 7.6 20.7 4.7 6.1 12.0 0.7 6.1 6.1 0.7 6.3 5.0 12.6 0.0 1.1 3.9 0.1 1.7 0.6 1.5 7.5 8.6 5.1 2.3 0.0 0.1 0.0 1.4 5.3 4.6 0.0 3.5 0.0 3.9 0.0 3.6 0.7 1.1 4.5 5.8 1.0 0.2 6.1 1.4 0.2 3.2 0.6 0.0 1.7 0.0 0.1 3.9 0.1 0.0 2.7 3.7 5.3 1.6 0.0 4.3 0.0 12.8 0.8 3.7 4.1 0.0 0.5 0.2 4.5 3.4 0.4 0.0 3.6 2.3 0.0 2.6 1.6 0.0 0.0 1.7 0.0 4.3 0.0 1.4 13.4 0.0 3.5 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.5 0.0 6.8 0.0 0.1 0.7 14.0 11.5 18.2 10.9 15.2 13.6 10.8 11.1 11.6 13.1 7.6 12.0 12.6 4.2 0.0 5.5 39.2 0.5 9.8 22.8 0.2 3.4 10.6 8.9 6.6 27.7 1.5 0.9 23.9 2.1 1.7 0.1 0.1 7.9 8.7 5.8 1.0 10.9 7.5 7.2 0.0 37.5 2.9 21.9 28.1 9.2 2.5 4.5 5.4 14.6 8.0 4.9 6.7 195.6 0.2 4.1 8.7 10.2 2.2 9.9 6.6 16.0 43.1 1.3 20.1 0.0 253.8 9.2 1.7 0.1 14.7 0.2 17.4 0.0 8.8 0.7 6.6 32.9 38.1 19.8 1.2 2.5 1.0 4.1 1.5 1.0 0.5 0.0 6.7 ARMC4 "CILD23, DKFZP434P1735, FLJ10376, FLJ10817, gudu" ENSG00000169126 "Armadillo repeat containing 4" Q5T2S8 10 27775186-27999079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 23.4;testis: 41.0" "Cell type enhanced" "Detected in some" "Early spermatids: 277.5;Endometrial ciliated cells: 45.3;Late spermatids: 85.1;Respiratory ciliated cells: 128.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 7.8;BJ: 8.2;fHDF/TERT166: 9.4;RH-30: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037829 Enhanced NA NA "HPA037829: AB_10670960" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (3.48e-2)" "unprognostic (4.43e-3)" "unprognostic (1.64e-1)" "unprognostic (4.28e-2)" "unprognostic (6.23e-2)" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-3)" "unprognostic (7.72e-2)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.15e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" 0.3 0.9 4.3 0.3 1.5 0.7 0.2 1.8 1.7 1.1 8.0 0.6 0.2 1.0 0.6 0.4 23.4 0.3 0.3 1.0 3.6 0.3 0.7 2.6 0.1 3.9 3.5 0.4 1.6 0.0 0.3 3.2 0.0 3.4 2.5 0.3 0.3 0.0 1.8 0.1 0.0 0.3 0.5 4.9 0.2 0.3 41.0 1.7 0.6 0.4 0.0 0.0 0.6 0.3 2.9 0.1 0.2 7.8 0.0 0.0 0.0 0.1 8.2 2.7 6.0 3.6 0.0 0.3 0.1 0.0 9.4 1.8 0.0 1.2 0.6 4.7 0.3 4.9 0.0 4.6 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 2.2 2.2 1.8 0.0 0.0 1.3 0.0 4.9 0.6 6.8 0.0 5.4 0.1 25.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.7 1.7 1.0 0.0 3.6 0.4 4.3 0.2 0.0 0.1 1.2 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.5 1.8 1.7 1.0 3.6 3.9 3.5 0.4 3.4 4.9 1.7 2.9 0.2 3.2 3.9 8.8 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.4 2.7 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 277.5 45.3 0.9 0.6 0.0 0.0 2.2 0.4 0.0 1.1 0.0 0.7 0.0 1.1 0.0 0.0 0.1 0.0 1.2 0.0 2.0 0.0 0.3 85.1 1.2 0.3 0.0 5.6 0.0 0.0 0.0 7.1 0.3 0.0 1.1 1.9 0.0 0.1 0.0 0.1 128.4 0.0 0.0 0.2 1.4 32.4 2.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 65.0;parathyroid gland: 69.2;thyroid gland: 82.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7" "Low region specificity" "Detected in all" HPA037843 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 6.9 2.4 17.3 4.3 11.6 0.1 10.3 21.2 13.5 20.6 6.9 10.7 3.9 24.1 13.3 9.4 23.2 4.6 4.8 12.2 11.9 14.6 1.7 5.3 4.4 13.4 12.2 10.9 15.2 12.0 69.2 2.4 18.6 13.6 13.2 5.1 3.8 6.9 24.1 3.1 9.9 6.5 19.1 14.0 65.0 5.9 1.4 12.1 13.6 82.9 4.5 7.6 6.0 14.8 13.1 74.4 10.8 10.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.1 77.4 0.1 56.4 0.6 1.1 98.7 0.2 27.2 0.2 1.5 0.1 0.0 0.7 0.0 3.0 0.0 2.7 0.0 28.9 8.1 7.1 0.3 0.3 2.8 0.0 0.2 0.0 3.1 1.9 0.1 0.5 2.0 0.5 0.9 0.8 51.3 59.7 0.6 0.3 0.5 2.3 1.7 2.9 16.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.1 1.6 1.1 1.2 0.0 1.6 0.3 0.9 0.1 0.4 0.0 0.1 1.8 0.6 17.3 11.6 21.2 13.5 12.2 11.9 13.4 12.2 10.9 13.6 14.0 12.1 13.1 14.6 0.0 0.0 0.7 1.2 12.4 7.3 3.1 5.2 0.8 1.8 5.3 2.2 0.0 1.8 40.5 0.0 1.5 2.4 8.1 0.0 0.6 1.0 5.3 7.4 14.5 0.0 0.8 6.5 14.3 1.2 10.7 3.1 9.5 0.0 0.3 13.2 0.0 0.5 1.7 10.1 1.8 0.0 0.0 3.7 3.0 3.1 0.5 5.4 34.7 0.6 3.2 0.0 122.6 0.6 23.2 1.7 1.9 0.1 3.7 2.2 0.4 1.5 0.6 19.7 21.4 24.7 0.0 0.8 2.3 6.8 0.3 3.4 2.4 2.2 4.3 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178711512-178730659 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 49.6" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 8.0 5.3 8.8 7.8 8.3 9.5 8.4 8.3 9.4 8.8 8.0 10.6 4.4 8.6 7.6 7.0 8.8 5.8 7.0 8.8 7.9 10.5 4.8 8.2 8.4 8.2 8.4 8.5 7.6 11.2 8.2 6.5 8.5 8.2 9.8 5.8 8.6 6.4 8.5 7.6 7.6 8.2 8.1 7.8 12.7 8.0 10.5 8.5 8.5 10.9 8.2 8.9 10.0 8.4 8.8 7.6 5.8 12.0 31.9 20.4 16.4 49.6 8.6 11.4 11.7 12.5 8.7 12.5 10.1 11.1 7.9 21.5 14.9 4.5 37.6 17.8 13.7 13.8 3.1 8.0 1.1 15.4 0.0 8.3 12.9 22.9 10.3 20.8 15.1 11.3 13.5 2.5 0.0 17.2 15.4 15.5 10.2 10.5 7.0 15.0 11.6 2.1 6.5 10.9 7.6 13.1 14.3 10.9 12.3 17.0 15.7 10.1 14.9 8.8 13.2 8.6 7.5 7.4 3.3 7.2 6.3 0.5 2.3 16.9 4.5 6.0 15.6 4.9 4.0 6.1 5.4 4.3 5.5 5.4 3.5 4.8 3.6 15.8 6.1 4.1 2.0 4.4 3.6 8.8 8.3 8.3 9.4 8.8 7.9 8.2 8.4 8.5 8.2 7.8 8.5 8.8 10.7 12.8 7.4 8.8 7.5 5.0 11.7 14.1 4.0 9.0 8.2 9.3 6.6 4.3 11.3 7.3 14.6 12.8 12.6 3.7 13.7 11.3 18.8 5.9 9.0 9.0 4.8 7.8 18.6 7.6 14.6 9.5 3.6 5.7 6.3 14.3 4.6 1.5 8.9 6.7 10.9 2.7 8.2 7.7 8.2 4.7 6.8 8.2 10.6 10.3 7.6 9.2 16.5 12.5 13.3 7.2 1.4 10.5 3.2 10.7 4.1 17.0 9.5 10.5 6.6 10.1 9.4 36.2 12.0 4.8 5.5 12.2 9.2 10.9 4.3 7.7 ATF5 ENSG00000169136 "Activating transcription factor 5" Q9Y2D1 19 49928702-49933935 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 21 "liver: 2500.3" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 1412.6" "Cancer enriched" "Detected in all" 7 "liver cancer: 200.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5" "Group enriched" "Detected in all" 9 "dendritic cells: 38.5;monocytes: 24.0" "Cell line enhanced" "Detected in all" "HDLM-2: 313.2;Karpas-707: 523.4;THP-1: 452.4;U-266/84: 715.6;U-698: 316.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030187 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030187: AB_10601666" "unprognostic (2.09e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.38e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.52e-1)" "unprognostic (6.70e-2)" "unprognostic (3.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.83e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (3.39e-7)" "unprognostic (3.06e-2)" "unprognostic (8.06e-2)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" 38.0 61.9 13.1 32.0 11.5 21.6 35.9 10.4 15.3 15.0 9.3 17.9 28.6 16.3 9.9 18.1 23.1 14.5 16.7 12.0 12.6 26.1 2500.3 17.2 23.5 14.6 12.7 9.3 14.2 29.4 10.1 14.8 12.4 14.6 23.4 10.4 12.6 21.3 10.4 30.8 17.7 23.4 10.3 12.9 27.5 24.7 44.7 12.3 13.2 119.7 9.6 20.2 24.6 14.4 14.9 68.5 47.3 17.8 12.0 18.3 15.5 17.8 48.6 40.8 49.4 30.2 35.7 36.5 60.7 24.3 28.6 34.0 24.2 22.7 20.0 23.5 313.2 22.6 41.7 14.8 27.4 12.5 162.7 113.6 108.3 31.5 36.5 8.5 12.2 21.4 132.6 38.1 523.4 24.7 64.3 23.5 35.9 8.8 18.6 62.6 194.2 19.1 24.9 56.6 90.9 28.2 20.1 113.2 47.8 34.9 6.6 39.2 452.4 36.6 95.5 61.3 11.3 49.8 13.8 715.6 316.2 75.1 63.6 36.4 0.4 24.0 1.0 1.4 22.4 2.0 1.6 1.4 1.7 14.3 0.8 1.2 1.8 3.6 3.2 6.0 38.5 1.9 4.7 13.1 11.5 10.4 15.3 12.0 12.6 14.6 12.7 9.3 14.6 12.9 12.3 14.9 16.3 12.8 11.9 2.6 41.7 22.6 12.3 11.1 39.9 3.8 31.9 29.3 7.4 38.6 9.4 16.5 6.2 33.9 23.5 22.0 13.7 13.1 260.8 36.5 17.4 21.1 21.5 64.2 1.2 29.8 19.4 27.3 34.1 35.3 6.3 27.1 40.0 1412.6 82.5 92.5 1.8 21.0 2.0 59.4 172.3 134.3 13.4 51.2 40.9 2.8 259.9 17.4 8.2 0.5 1.6 20.0 20.6 16.6 118.1 24.8 49.0 47.9 9.6 7.5 13.1 18.0 24.2 15.0 11.3 37.7 24.0 35.6 15.1 23.4 23.4 18.4 UBE2V2 "DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2" ENSG00000169139 "Ubiquitin conjugating enzyme E2 V2" Q15819 8 48008415-48064708 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052535, HPA053186" Supported Nucleoplasm NA NA 800000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.50e-3)" "unprognostic (3.27e-1)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (2.94e-3)" "unprognostic (1.21e-2)" "unprognostic (1.65e-3)" "unprognostic (4.97e-2)" "unprognostic (1.77e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (4.96e-6)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (2.45e-1)" "unprognostic (9.62e-2)" 37.0 43.3 43.7 32.4 48.5 23.2 35.9 42.4 50.8 26.4 37.9 38.6 35.5 33.2 26.9 49.4 26.4 27.7 24.5 47.6 52.6 36.1 61.3 23.5 39.5 48.2 46.4 43.4 24.6 21.5 37.2 36.3 31.7 51.0 34.3 36.4 52.5 23.4 31.1 56.8 25.6 33.2 38.6 43.4 23.9 33.1 34.6 49.0 52.6 37.5 56.5 40.0 42.1 31.9 56.4 112.7 63.9 140.0 78.0 75.4 83.6 49.4 114.8 80.1 113.8 99.2 80.9 85.3 136.9 65.7 110.5 97.4 66.1 128.6 107.8 152.1 47.2 89.8 123.6 74.4 68.8 94.0 68.2 35.7 79.5 109.9 91.7 145.6 86.1 97.6 115.8 154.0 83.0 145.3 85.7 218.3 131.6 130.3 166.7 42.2 108.3 61.8 67.6 122.7 90.0 152.9 99.4 96.7 85.1 107.5 103.8 143.0 89.7 54.1 95.8 87.8 86.6 108.7 82.3 151.5 175.8 124.3 118.7 104.0 73.9 70.5 74.4 58.9 84.9 71.6 77.4 72.6 72.8 87.2 76.1 72.2 81.7 45.1 110.6 85.0 73.3 104.6 94.2 43.7 48.5 42.4 50.8 47.6 52.6 48.2 46.4 43.4 51.0 43.4 49.0 56.4 52.4 48.1 34.7 20.2 53.1 45.2 75.5 172.5 36.5 87.1 40.9 51.8 58.9 35.8 89.0 51.5 16.7 93.3 39.9 29.9 129.1 81.9 51.6 46.7 58.3 45.4 32.3 57.0 41.6 88.3 149.6 67.9 30.5 36.9 50.8 55.5 32.2 50.8 90.4 80.8 38.1 49.2 109.9 35.4 53.1 34.6 56.2 51.6 37.4 20.6 76.0 110.8 56.7 21.1 28.4 83.6 56.0 73.4 46.7 95.9 51.9 130.2 71.4 65.2 59.2 48.3 122.1 134.7 82.2 46.8 57.1 149.7 47.2 76.2 59.3 75.0 GOT1L1 MGC33309 ENSG00000169154 "Glutamic-oxaloacetic transaminase 1 like 1" Q8NHS2 8 37934281-37940124 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 14.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 137.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028778 Uncertain NA NA "HPA028778: AB_10602138" "unprognostic (6.93e-3)" "unprognostic (5.46e-1)" 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 24.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favorable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 5.3 5.4 4.3 4.7 4.9 61.2 6.0 5.8 6.6 4.8 7.6 4.4 5.2 5.8 4.4 9.6 4.1 5.4 9.5 4.5 4.8 3.9 8.0 8.3 5.7 4.1 4.7 4.3 6.2 5.0 9.6 4.6 5.2 4.6 4.4 5.9 9.4 6.1 3.5 33.1 14.0 4.9 5.1 3.3 5.1 7.1 16.4 5.3 5.9 5.3 20.4 6.4 5.2 6.4 6.1 6.3 4.7 8.5 7.8 7.0 9.9 8.7 8.0 8.0 6.3 5.6 11.0 4.3 8.7 3.9 8.4 12.4 18.4 7.5 8.0 7.8 7.6 5.0 6.0 14.6 4.9 9.6 8.6 11.0 12.1 20.2 10.2 25.0 6.0 4.9 7.1 10.6 19.8 9.4 6.8 7.5 5.4 7.8 6.7 8.0 6.3 27.4 7.1 6.8 7.2 7.5 6.9 8.5 8.5 7.8 7.6 7.6 5.4 4.7 7.6 7.1 8.4 7.0 21.0 16.4 3.3 9.4 7.0 6.3 12.0 4.5 3.9 7.0 4.3 6.8 4.2 3.8 4.1 3.7 3.3 4.1 4.8 2.5 6.7 3.5 2.0 6.1 3.3 4.3 4.9 5.8 6.6 4.5 4.8 4.1 4.7 4.3 4.6 3.3 5.3 6.1 16.5 35.3 44.7 34.0 23.4 84.9 68.2 37.5 30.7 42.2 36.0 19.9 42.7 27.1 46.1 27.6 108.4 18.2 30.6 80.2 1.9 31.1 91.2 51.7 35.0 25.1 11.4 21.4 44.2 18.5 12.3 27.7 78.5 133.6 31.0 23.7 17.5 25.3 14.7 26.9 40.5 21.6 40.7 21.7 74.1 45.3 17.7 46.4 24.9 12.2 18.3 29.3 21.6 25.6 37.3 43.4 51.5 14.3 27.2 54.9 33.5 7.9 27.7 55.7 13.1 39.4 29.3 49.7 73.1 70.8 117.3 52.0 31.8 22.4 25.6 141.7 CPT1C "CATL1, CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;pituitary gland: 28.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 43.4;Excitatory neurons: 34.0;Horizontal cells: 32.0;Inhibitory neurons: 28.1;Late spermatids: 29.7;Oligodendrocyte precursor cells: 21.1" "Cancer enriched" "Detected in many" 5 "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.2;AN3-CA: 33.2;SCLC-21H: 27.4;SH-SY5Y: 70.1;U-87 MG: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome NA NA Centrosome "HPA014529: AB_1847206, HPA063621: AB_2732706" "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 2.3 5.4 12.6 1.6 13.9 0.0 2.1 7.7 18.3 6.2 14.7 2.4 1.3 8.1 2.3 1.1 4.9 4.5 3.0 18.9 12.8 1.4 0.9 2.1 1.3 9.9 9.0 16.2 5.2 1.4 1.4 28.6 0.7 9.1 3.4 0.6 12.5 1.0 2.5 0.7 0.9 1.9 4.7 2.8 5.0 1.6 3.5 10.6 0.2 2.4 0.2 0.6 2.7 3.7 13.6 0.0 0.0 40.2 33.2 14.0 11.0 0.0 12.6 25.2 16.2 22.4 0.7 0.0 0.8 0.0 12.7 2.0 3.0 0.0 0.0 8.5 0.6 0.1 0.0 0.1 0.0 22.7 0.0 0.0 12.7 0.0 13.3 0.1 4.3 22.2 0.1 0.1 0.0 0.9 0.7 0.2 0.0 1.8 2.7 8.8 0.0 0.0 0.0 0.9 0.0 27.4 70.1 0.1 0.1 0.0 0.6 0.1 0.1 18.3 1.0 0.2 7.7 6.7 0.2 3.2 0.4 29.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 13.9 7.7 18.3 18.9 12.8 9.9 9.0 16.2 9.1 2.8 10.6 13.6 3.8 0.0 0.0 7.5 0.4 2.2 3.1 0.5 3.4 43.4 0.9 1.3 1.4 1.5 0.0 0.0 16.7 1.1 0.3 0.1 0.0 0.0 8.9 0.5 14.1 7.4 0.0 0.0 34.0 0.0 4.4 6.0 0.0 1.2 0.0 1.9 5.0 0.1 0.3 32.0 28.1 0.1 0.0 0.9 1.2 29.7 3.4 0.8 0.0 7.5 0.0 18.3 0.0 21.1 14.9 0.3 0.0 13.2 1.4 2.1 0.0 0.0 0.0 19.1 0.0 5.8 6.3 3.1 7.0 1.0 1.8 1.1 0.7 4.4 0.2 1.6 PCSK9 "FH3, HCHOLA3, NARC-1" ENSG00000169174 "Proprotein convertase subtilisin/kexin type 9" Q8NBP7 1 55039447-55064852 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 49.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 22.4;Gastric mucus-secreting cells: 8.2;Hepatocytes: 32.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 82.5;CACO-2: 37.0;HaCaT: 108.8;HeLa: 90.7;RPTEC TERT1: 56.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "Secreted to blood" NA NA 143000000 420000000 "unprognostic (1.28e-3)" "unprognostic (6.93e-2)" "unprognostic (4.02e-1)" "unprognostic (2.19e-2)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.20e-3)" "unprognostic (1.14e-2)" "unprognostic (5.44e-3)" "unprognostic (1.22e-2)" "unprognostic (2.09e-3)" "unprognostic (3.70e-2)" "unprognostic (2.45e-4)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.40e-4)" 0.2 0.2 0.1 0.7 0.1 0.4 0.1 3.4 0.3 0.5 0.0 3.5 3.1 0.3 0.3 5.5 0.4 0.1 0.0 0.1 0.2 0.1 49.1 7.9 0.0 1.8 0.6 0.0 0.1 5.4 0.2 0.1 0.0 2.0 0.0 1.6 0.0 0.5 0.2 0.0 1.3 3.5 0.7 0.1 0.3 1.3 0.4 0.1 0.0 0.0 0.0 0.3 0.4 1.5 0.9 82.5 17.6 2.8 0.0 6.4 4.4 0.2 0.0 0.0 0.2 0.2 37.0 13.2 0.0 13.9 7.8 0.3 108.8 3.5 35.2 0.0 0.0 0.0 0.0 90.7 26.5 2.2 0.0 0.0 6.4 25.5 25.2 18.4 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 15.1 1.5 1.9 0.0 0.0 0.9 56.4 0.1 1.3 0.0 10.5 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.4 0.3 0.1 0.2 1.8 0.6 0.0 2.0 0.1 0.1 0.9 0.0 16.0 22.4 0.0 0.2 0.5 0.0 2.1 1.2 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 0.0 0.0 2.0 0.0 0.5 0.2 0.8 0.1 0.1 4.2 2.7 0.1 1.5 0.0 0.6 8.2 0.8 0.0 0.1 1.1 32.9 0.1 0.0 0.1 4.3 2.0 1.6 0.5 0.6 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.6 1.3 1.4 0.6 0.0 0.1 0.0 5.4 0.4 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097976-28211965 "Metabolic proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 202.1" "Lineage enriched" "Detected in all" 9 "granulocytes: 202.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" No No "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (8.80e-4)" 45.6 48.7 68.4 56.4 70.2 92.8 40.2 59.3 87.7 42.4 62.7 44.1 22.0 42.6 18.9 57.5 45.1 24.7 34.4 70.0 70.0 45.5 62.6 71.5 63.4 74.2 67.3 67.7 36.9 43.5 27.2 57.1 25.9 69.7 49.1 27.7 35.5 45.2 20.3 30.1 53.2 63.6 27.0 66.5 161.9 43.1 101.1 70.0 51.6 50.9 13.9 45.3 45.2 46.4 76.2 82.9 63.3 54.8 58.8 37.2 58.8 57.9 97.0 98.0 124.8 124.8 89.1 61.7 59.8 78.6 99.8 63.3 53.8 131.6 83.9 151.5 115.3 72.1 67.6 90.0 101.6 87.9 95.4 70.8 46.3 61.2 111.1 108.9 53.5 73.1 63.4 118.0 31.0 86.0 101.1 116.2 116.1 88.1 43.6 55.4 101.0 64.3 101.2 46.8 45.2 103.3 55.0 52.9 88.3 47.8 60.8 62.7 63.3 75.4 104.1 64.4 87.2 84.8 63.0 83.8 89.8 78.7 98.4 89.1 21.1 9.9 32.9 14.2 11.4 15.4 20.7 16.5 15.8 7.3 15.7 18.1 22.6 202.1 10.7 17.6 9.5 14.7 8.4 68.4 70.2 59.3 87.7 70.0 70.0 74.2 67.3 67.7 69.7 66.5 70.0 76.2 9.6 9.6 14.2 27.4 20.2 18.6 11.4 12.6 5.2 20.8 15.0 14.6 8.0 5.7 12.6 23.9 31.3 11.5 30.2 28.5 7.9 14.1 39.2 12.7 21.5 11.6 23.5 10.3 51.2 19.2 17.3 13.3 12.2 32.8 2.5 34.6 9.3 16.7 23.4 21.9 55.4 20.6 10.2 27.9 15.8 44.8 10.8 22.6 7.2 43.1 28.6 8.3 23.7 59.3 90.3 23.4 13.5 8.6 16.5 22.4 13.3 7.1 10.3 28.1 6.6 13.5 12.2 31.6 26.5 18.0 21.3 8.3 27.0 9.5 21.2 15.4 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787528-28063714 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.5;heart muscle: 12.3" "Group enriched" "Detected in some" 7 "Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 8.3;THP-1: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014479 Enhanced NA NA "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.2 0.2 14.8 0.1 16.6 0.2 0.1 9.3 16.0 0.2 3.6 0.4 0.3 0.3 0.3 0.1 1.5 0.0 12.3 15.7 9.8 0.3 0.4 0.4 0.1 21.9 17.6 12.7 0.1 0.1 0.0 0.5 0.9 13.8 0.2 0.1 2.4 0.2 0.1 0.3 0.8 0.4 0.0 9.8 0.3 1.2 1.6 23.5 0.0 0.3 0.0 0.0 0.4 0.1 11.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.3 0.5 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 3.2 0.7 0.0 0.5 0.0 0.1 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.8 16.6 9.3 16.0 15.7 9.8 21.9 17.6 12.7 13.8 9.8 23.5 11.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.1 8.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.8 7.4 0.1 0.0 0.0 26.0 0.0 0.0 1.8 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.7 7.4 0.4 0.0 0.0 0.0 3.6 0.0 0.1 0.0 4.7 0.0 0.2 0.0 89.5 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 3.7 0.3 0.5 1.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 MN1 "MGCR, MGCR1, MGCR1-PEN" ENSG00000169184 "MN1 proto-oncogene, transcriptional regulator" Q10571 22 27748277-27801756 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 17.6;skeletal muscle: 62.2;tongue: 42.9" "Cell type enhanced" "Detected in many" "Astrocytes: 12.1;Early spermatids: 22.3;Fibroblasts: 13.9;Langerhans cells: 11.2;Late spermatids: 15.2;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 30.7;HeLa: 12.7;hTERT-RPE1: 13.7;RH-30: 12.4;TIME: 20.1;U-2 OS: 16.3;U-2197: 17.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003072 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003072: AB_1079399" "unprognostic (5.64e-2)" "unprognostic (2.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (2.88e-2)" "unprognostic (2.52e-2)" "unprognostic (7.01e-2)" "unprognostic (3.03e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (4.00e-2)" "unprognostic (7.33e-2)" "unprognostic (5.13e-7)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (5.28e-3)" "unprognostic (2.21e-4)" 3.5 0.8 6.1 1.6 17.6 1.3 2.3 6.9 7.9 2.2 1.4 4.5 0.8 2.7 1.0 3.6 4.4 3.0 6.1 2.0 9.6 0.9 0.4 3.4 0.1 6.3 12.0 3.9 9.6 0.7 0.1 2.7 1.3 9.0 2.4 0.9 1.8 2.7 1.2 62.2 1.8 2.1 2.5 1.7 0.4 4.0 0.8 7.5 0.3 2.2 42.9 0.7 3.4 3.6 4.6 0.0 1.5 30.7 0.9 0.6 1.3 0.0 0.7 1.1 0.0 0.0 0.0 0.1 0.0 3.1 5.7 1.3 2.7 1.5 1.8 0.0 0.0 0.8 0.0 12.7 0.0 0.7 0.0 0.3 0.1 3.5 0.7 3.0 13.7 0.3 0.0 0.0 0.2 1.0 0.0 0.0 0.4 4.0 0.0 2.8 5.3 12.4 0.0 0.4 0.0 0.1 0.4 2.7 0.0 0.0 7.5 0.3 0.1 20.1 1.0 16.3 17.9 0.3 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 17.6 6.9 7.9 2.0 9.6 6.3 12.0 3.9 9.0 1.7 7.5 4.6 2.1 3.2 2.3 12.1 0.3 4.2 0.1 2.6 3.4 8.4 1.8 0.6 7.4 1.5 0.7 0.0 0.0 0.1 0.2 0.0 0.0 1.4 22.3 1.4 1.0 6.6 0.0 0.0 6.4 1.0 0.1 13.9 0.5 3.1 0.0 0.6 2.5 0.6 0.3 0.0 9.6 0.0 2.0 1.4 11.2 15.2 5.0 2.7 0.0 2.8 0.3 3.9 0.0 13.0 4.3 2.8 0.0 10.1 1.3 0.2 0.0 0.1 0.1 0.7 0.0 2.4 2.3 0.4 1.1 1.9 2.7 0.0 0.3 0.4 0.0 0.2 APEX2 "APE2, APEXL2, XTH2, ZGRF2" ENSG00000169188 "Apurinic/apyrimidinic endodeoxyribonuclease 2" Q9UBZ4 X 55000363-55009057 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" "DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048577 Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Vesicles "HPA048577: AB_2680448" "unprognostic (2.90e-2)" "prognostic favorable (6.17e-4)" "unprognostic (4.32e-2)" "unprognostic (2.39e-1)" "unprognostic (1.62e-1)" "unprognostic (5.62e-2)" "prognostic unfavorable (6.13e-7)" "unprognostic (5.89e-2)" "unprognostic (4.87e-2)" "prognostic favorable (5.21e-4)" "unprognostic (7.46e-2)" "unprognostic (3.16e-1)" "unprognostic (6.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.17e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.63e-4)" 7.2 8.9 6.0 8.9 6.2 10.1 7.2 6.0 6.7 7.2 6.4 9.0 9.0 7.5 8.6 15.6 7.4 6.4 8.2 5.8 6.4 10.8 11.1 7.3 11.4 6.3 6.2 5.6 9.7 7.5 7.2 7.1 9.1 6.4 7.8 10.6 2.3 7.1 6.6 7.6 12.2 9.2 7.1 6.3 11.2 8.0 4.2 6.4 11.0 6.4 7.4 13.6 10.3 9.5 6.5 36.9 32.4 12.5 18.3 17.9 11.9 21.3 14.8 19.8 28.0 27.2 17.8 30.0 24.1 22.7 14.0 33.0 26.9 29.1 28.2 21.0 19.7 22.1 29.4 31.6 18.3 11.5 18.3 26.6 11.8 22.6 39.6 14.2 13.2 22.6 25.3 15.4 15.9 21.2 35.7 24.9 23.8 25.0 17.4 38.6 21.8 20.8 26.4 15.2 18.1 11.6 12.7 28.0 33.4 14.7 28.5 26.4 14.1 13.1 16.6 23.9 33.7 19.6 16.4 22.9 19.9 17.7 30.9 20.1 16.2 11.5 13.1 10.2 14.4 8.6 8.2 9.6 10.2 13.7 8.5 8.5 8.4 4.1 42.0 13.4 7.4 11.6 10.1 6.0 6.2 6.0 6.7 5.8 6.4 6.3 6.2 5.6 6.4 6.3 6.4 6.5 6.1 3.2 11.8 1.6 12.7 12.9 12.5 20.1 6.8 3.6 7.2 7.1 5.9 15.7 14.9 11.0 0.0 52.7 7.1 17.9 15.6 31.5 0.3 6.0 5.7 11.5 6.1 31.5 0.8 15.1 35.3 7.6 10.2 9.7 8.8 13.1 10.4 11.4 24.2 6.7 0.7 10.1 10.2 10.9 11.1 1.1 5.9 12.0 0.0 1.9 21.7 5.2 16.5 1.0 1.9 20.5 19.1 8.6 9.8 10.5 16.6 21.6 11.8 2.1 19.7 4.4 6.9 1.4 10.6 13.8 12.6 47.6 11.6 12.4 13.7 13.2 NSMCE1 NSE1 ENSG00000169189 "NSE1 homolog, SMC5-SMC6 complex component" Q8WV22 16 27224994-27268772 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "granulocytes: 275.5;Late spermatids: 420.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041567, HPA043091" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041567: AB_10964260, HPA043091: AB_10962722" "unprognostic (6.27e-2)" "unprognostic (8.17e-2)" "unprognostic (2.52e-2)" "unprognostic (2.48e-3)" "unprognostic (4.17e-1)" "unprognostic (4.52e-3)" "unprognostic (1.59e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.91e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-3)" "unprognostic (3.58e-1)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 43.4 68.9 56.6 32.5 59.2 35.4 53.0 63.6 72.3 40.1 62.9 48.2 25.5 42.6 55.5 45.9 62.8 36.1 44.5 55.1 64.0 58.3 56.4 42.8 54.9 63.4 58.3 53.7 45.4 59.7 86.8 37.6 37.6 62.0 57.9 37.1 25.1 46.6 52.2 45.7 38.6 37.3 45.6 62.1 33.7 51.7 80.5 60.7 56.9 53.5 45.3 55.1 51.9 39.5 65.2 56.5 80.6 53.8 58.6 85.8 114.2 43.1 58.9 60.4 44.5 46.1 62.7 134.1 110.0 137.7 91.1 45.7 59.5 101.9 178.6 57.3 136.3 70.6 51.0 68.6 122.1 149.1 59.9 37.4 112.6 122.3 111.7 211.5 127.8 60.3 104.3 69.6 33.8 82.9 96.7 80.0 67.5 46.8 94.0 54.7 69.1 65.8 174.7 129.9 36.3 56.4 51.0 40.2 55.9 104.3 65.1 92.3 71.9 37.8 53.3 33.2 61.1 57.8 101.0 78.1 85.9 114.0 59.4 23.3 125.3 91.2 86.2 78.9 81.6 86.3 84.2 111.1 95.7 128.4 133.1 126.7 99.7 29.6 213.8 81.5 124.6 113.0 120.3 56.6 59.2 63.6 72.3 55.1 64.0 63.4 58.3 53.7 62.0 62.1 60.7 65.2 34.8 35.3 36.4 8.5 38.1 28.3 57.6 110.7 33.0 14.9 60.7 83.8 49.6 62.9 58.5 44.1 2.1 126.2 41.2 45.6 129.1 79.2 209.9 40.3 32.9 33.9 58.7 24.0 5.4 73.0 63.3 44.5 17.3 29.6 275.5 37.4 52.8 64.0 83.2 13.5 6.7 65.8 44.7 53.3 45.6 420.8 24.2 39.5 46.2 12.2 98.1 64.7 43.3 12.5 14.8 40.1 45.7 39.9 28.1 49.0 83.9 173.8 94.6 18.8 26.3 58.1 50.1 119.0 39.4 43.5 32.7 64.3 55.3 39.9 46.7 48.3 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597382-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Group enriched" "Detected in all" 18 "Early spermatids: 642.3;Late spermatids: 490.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "basophil: 479.0" "Lineage enriched" "Detected in all" 23 "granulocytes: 479.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 39000000 "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.5 7.6 4.3 4.5 4.7 7.7 8.4 7.1 5.5 6.6 3.2 5.2 8.6 7.3 4.8 6.0 6.4 5.9 5.0 4.1 5.0 7.3 11.7 6.1 9.0 5.8 6.0 3.5 6.8 8.5 11.8 4.3 4.5 5.1 5.6 6.2 8.4 5.4 5.5 7.2 4.9 7.1 6.2 4.8 6.4 6.6 34.9 5.0 5.5 9.5 10.0 8.8 6.4 4.4 5.8 6.0 4.1 8.9 11.3 14.6 8.1 20.4 7.4 7.3 6.2 9.0 4.3 1.9 12.8 11.3 6.2 11.8 3.4 3.9 3.5 8.1 2.7 5.1 2.2 1.6 5.6 5.8 5.9 10.9 8.7 10.0 2.0 1.9 5.2 8.4 5.3 5.2 3.5 7.6 2.8 4.1 7.1 4.2 7.9 5.1 2.7 14.0 3.9 6.5 2.7 5.4 10.2 7.6 7.2 5.6 13.8 6.1 5.4 10.2 3.7 6.5 8.4 5.9 9.9 10.5 9.2 4.1 8.5 20.2 479.0 18.0 86.7 14.7 17.0 17.6 20.7 15.8 17.0 15.6 19.3 19.2 15.0 35.2 16.8 17.1 3.2 19.3 15.6 4.3 4.7 7.1 5.5 4.1 5.0 5.8 6.0 3.5 5.1 4.8 5.0 5.8 17.3 6.4 8.1 12.7 12.8 19.1 7.9 8.0 13.6 14.1 15.4 10.7 9.0 12.8 8.2 12.9 8.4 10.2 9.3 7.3 7.9 10.1 642.3 11.1 9.0 10.8 15.0 4.8 14.0 9.1 6.8 11.5 13.3 9.5 7.0 3.7 10.8 15.2 6.9 8.4 17.4 8.7 16.2 7.9 9.6 490.0 11.5 9.5 14.2 12.2 11.4 7.7 14.4 18.6 20.1 10.4 7.3 14.3 12.8 8.3 8.4 8.9 14.6 14.1 13.1 12.0 12.9 31.1 26.3 12.1 23.7 20.2 11.3 29.2 5.9 6.9 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 24.5" "Cell type enhanced" "Detected in some" "Early spermatids: 96.7;Late spermatids: 200.7;Spermatocytes: 44.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 187 "HDLM-2: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 40000 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.6 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 24.5 0.1 0.6 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 96.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 200.7 2.8 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.5 44.4 1.2 0.0 0.6 0.0 14.7 0.0 0.0 0.0 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family member B12" F8W0I5 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 199.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 29.3" "Group enriched" "Detected in all" 4 "B-cells: 8.4;granulocytes: 29.3;NK-cells: 14.2" "Cell line enhanced" "Detected in all" "NB-4: 166.4" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 24.8 21.9 120.4 40.8 113.0 64.3 22.1 118.0 199.6 28.9 94.3 27.6 24.2 24.3 38.9 25.0 27.8 25.0 26.4 113.8 103.3 32.0 58.6 27.7 57.5 120.7 115.5 100.8 27.2 24.4 15.3 26.5 20.6 150.0 33.5 25.9 32.5 34.8 20.2 44.7 109.8 33.9 19.9 87.4 51.6 23.7 29.4 110.4 28.4 29.0 15.6 30.0 26.9 24.4 121.6 26.2 26.7 20.6 52.8 24.7 14.7 40.0 15.7 4.4 7.8 6.7 23.1 52.5 43.8 27.4 13.1 15.4 34.5 35.2 25.3 10.7 28.1 25.6 33.3 36.0 46.5 22.2 36.1 61.5 23.0 19.5 17.6 18.5 19.9 9.0 24.3 34.5 37.2 12.7 42.6 26.6 166.4 31.5 17.6 19.3 61.6 9.1 42.7 19.1 18.6 21.9 15.4 8.9 36.5 22.5 9.2 18.7 43.4 22.4 49.9 19.2 34.9 30.2 19.5 21.3 42.7 20.3 63.9 23.9 29.3 3.5 1.4 3.9 1.2 1.0 3.7 2.3 2.7 2.4 8.4 3.1 2.1 9.5 14.2 3.0 2.6 1.8 1.3 120.4 113.0 118.0 199.6 113.8 103.3 120.7 115.5 100.8 150.0 87.4 110.4 121.6 0.0 3.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 OR10G3 ENSG00000169208 "Olfactory receptor family 10 subfamily G member 3" Q8NGC4 14 21568520-21580076 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 11.7;Club cells: 2.5;granulocytes: 2.5;T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019766 Uncertain NA NA "HPA019766: AB_1854780" 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.0 0.1 0.3 0.1 6.4 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 RAB3B ENSG00000169213 "RAB3B, member RAS oncogene family" P20337 1 51907956-51990700 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 25.2;pituitary gland: 10.7;prostate: 11.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Alveolar cells type 2: 103.2;Enteroendocrine cells: 293.8;Pancreatic endocrine cells: 92.8" "Group enriched" "Detected in many" 6 "prostate cancer: 19.4;testis cancer: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 125.8;BJ hTERT+: 48.4;fHDF/TERT166: 45.8;TIME: 97.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003159, CAB023293" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB023293: , HPA003159: AB_1856005" "unprognostic (1.10e-1)" "unprognostic (2.20e-3)" "unprognostic (5.43e-3)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.20e-2)" "unprognostic (8.77e-3)" "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-2)" "unprognostic (2.02e-3)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 0.0 3.0 10.1 0.6 8.7 0.2 0.8 2.9 14.6 0.0 0.0 1.6 0.7 0.1 0.2 0.0 0.2 1.3 0.0 11.0 17.4 0.5 0.7 0.0 0.1 11.4 18.0 11.3 1.5 1.0 0.0 10.7 1.7 25.2 11.1 2.3 1.7 0.3 0.1 0.5 1.9 0.9 0.3 1.7 0.1 1.2 0.3 17.6 0.2 0.0 0.0 0.1 0.1 0.1 11.6 1.8 8.5 1.2 1.3 0.2 2.3 0.2 125.8 48.4 24.8 12.0 10.4 3.7 0.6 2.0 45.8 3.6 0.1 15.4 13.0 41.7 0.0 1.1 0.1 0.6 3.4 2.1 0.0 0.1 1.1 0.4 41.1 9.4 15.4 7.8 1.1 0.4 0.4 27.9 0.3 0.1 0.1 19.9 2.4 1.2 0.3 0.2 0.2 4.0 0.8 4.3 1.1 0.1 0.3 0.1 24.6 0.2 0.3 97.9 24.0 8.8 0.5 41.5 0.2 0.6 0.4 21.9 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 10.1 8.7 2.9 14.6 11.0 17.4 11.4 18.0 11.3 25.2 1.7 17.6 11.6 1.4 147.4 103.2 0.3 1.1 2.4 6.2 0.3 0.0 5.0 2.2 3.4 0.7 12.8 27.9 0.0 2.1 0.5 0.4 2.0 3.9 4.0 2.4 1.5 1.3 8.2 293.8 0.0 6.6 18.4 0.3 13.9 3.6 1.4 7.6 27.9 0.7 2.7 0.3 0.0 48.1 14.7 14.2 1.3 1.2 1.3 0.6 3.7 1.8 1.0 1.0 31.2 1.0 1.5 1.5 92.8 1.4 1.2 2.3 18.8 1.4 0.2 29.5 3.7 0.0 4.1 4.8 10.4 4.3 0.0 1.4 4.0 3.3 1.1 1.6 2.7 OR6F1 OST731 ENSG00000169214 "Olfactory receptor family 6 subfamily F member 1" Q8NGZ6 1 247711436-247716646 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.3" "Group enriched" "Detected in some" 65 "Early spermatids: 18.0;Late spermatids: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "GAMG: 1.7" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350773-30355308 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 31.4 49.7 40.4 34.3 41.6 24.1 33.2 38.9 42.9 38.9 35.6 37.3 30.2 45.3 25.1 35.6 41.3 22.2 34.2 41.1 41.7 37.5 27.5 33.1 39.1 42.7 41.1 39.4 37.2 41.1 42.8 43.0 24.6 40.1 38.6 23.9 16.3 30.3 35.8 47.3 33.0 35.5 31.8 41.0 46.7 37.2 24.2 42.1 36.1 42.8 26.8 44.1 37.3 30.4 43.3 55.4 65.7 54.4 49.4 44.3 41.9 46.0 60.0 71.5 66.8 71.3 50.6 64.9 84.6 72.3 65.5 61.4 59.4 57.0 70.3 53.6 50.6 66.6 35.9 67.7 60.3 63.6 51.3 63.4 45.2 58.7 74.2 47.3 45.6 70.3 62.1 41.4 63.2 67.7 132.1 71.6 43.6 73.8 42.9 38.5 104.2 45.3 64.3 54.2 54.7 44.7 85.1 40.2 69.9 42.0 44.7 66.4 41.1 50.6 76.3 53.3 38.9 53.1 105.0 82.3 78.5 52.5 47.2 64.0 107.4 61.7 116.6 71.3 76.3 56.8 87.5 57.3 66.7 55.8 97.3 47.6 58.9 121.9 74.5 102.7 67.1 94.4 79.6 40.4 41.6 38.9 42.9 41.1 41.7 42.7 41.1 39.4 40.1 41.0 42.1 43.3 38.1 32.1 29.0 7.2 39.5 28.8 49.6 58.4 31.9 29.8 33.2 29.6 26.5 45.8 41.2 36.8 20.9 61.0 57.0 50.5 60.7 83.6 19.9 41.7 30.7 42.8 33.0 22.3 6.7 97.5 58.1 36.4 28.1 45.2 47.6 33.4 28.2 13.9 69.7 11.8 7.1 32.7 36.7 38.3 23.6 14.2 35.4 34.0 39.2 8.4 84.1 47.6 97.9 3.5 10.7 87.8 64.9 35.7 52.7 40.7 60.3 81.5 46.3 29.0 39.5 30.5 44.6 38.5 40.1 27.4 30.4 88.7 41.9 38.9 31.6 50.7 RSPO1 "FLJ40906, RSPONDIN" ENSG00000169218 "R-spondin 1" Q2MKA7 1 37611350-37634892 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 28.1;endometrium 1: 41.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 7.7;Breast myoepithelial cells: 15.6;Fibroblasts: 5.4;Langerhans cells: 2.9" "Cancer enriched" "Detected in some" 13 "ovarian cancer: 11.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;THP-1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA046154, HPA062923" Uncertain Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA046154: AB_10964912, HPA062923: " "unprognostic (1.50e-2)" "unprognostic (1.97e-3)" "unprognostic (5.99e-3)" "unprognostic (2.22e-1)" "unprognostic (1.76e-1)" "unprognostic (3.75e-6)" "unprognostic (1.84e-2)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (2.08e-1)" "unprognostic (1.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.76e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-2)" 5.9 0.1 0.1 0.8 0.1 0.1 7.9 0.1 0.1 28.1 0.0 1.8 1.1 41.7 2.2 3.1 20.2 2.7 0.4 0.1 0.0 0.8 0.1 4.1 1.9 0.1 0.1 0.1 2.1 0.5 0.1 0.1 0.4 0.1 6.7 0.5 0.1 1.3 1.8 0.0 6.3 3.3 13.2 0.0 0.8 4.0 0.2 0.1 0.0 0.0 0.5 3.0 1.5 19.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.7 15.6 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.9 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.1 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357924-177372596 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9" "Group enriched" "Detected in many" 10 "amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8" "Region enhanced" "Detected in many" "basal ganglia: 102.1" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" No No Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: AB_2679836, HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 2.9 2.8 15.1 14.1 86.0 22.6 2.9 0.0 70.8 2.9 1.5 3.1 6.4 2.3 0.4 10.0 7.8 4.3 1.3 49.5 8.0 8.5 28.9 5.6 18.2 25.7 0.3 14.5 1.2 3.7 1.5 2.4 1.5 41.2 3.5 0.9 0.0 6.2 2.1 2.6 5.8 11.1 1.8 0.1 27.9 4.9 1.9 9.2 16.5 6.1 0.9 6.7 4.1 5.0 7.7 5.4 1.1 2.3 1.4 0.1 0.0 3.7 0.2 0.0 0.5 0.6 3.7 10.4 13.3 7.3 0.4 1.3 10.6 0.2 3.8 0.0 112.5 0.5 20.7 1.0 4.7 0.9 16.3 95.4 1.8 1.1 0.6 0.7 1.4 0.6 14.9 3.5 26.5 0.2 0.4 21.7 44.8 1.7 5.4 2.8 10.2 0.3 57.9 1.5 1.6 0.4 1.9 0.4 0.4 8.8 0.0 3.5 25.2 1.1 0.2 1.9 0.0 9.7 13.9 7.1 5.8 1.6 30.3 2.4 70.6 39.9 148.8 62.4 37.9 63.0 27.7 57.9 57.8 39.8 26.6 47.4 43.1 140.0 23.6 41.2 17.6 60.9 43.9 15.1 86.0 0.0 70.8 49.5 8.0 25.7 0.3 14.5 41.2 0.1 9.2 7.7 5.3 6.4 4.4 2.6 27.3 68.8 23.9 15.4 72.8 0.7 8.9 11.8 2.3 37.1 5.6 11.0 2.1 3.9 41.4 4.2 31.3 11.4 0.6 19.5 2.0 6.5 4.8 7.4 4.6 16.7 10.4 5.4 12.2 8.1 24.7 2.8 8.2 64.0 26.1 0.0 1.5 10.0 10.2 17.0 23.3 1.5 2.8 18.2 21.4 6.5 18.1 9.9 48.4 0.5 0.3 12.8 17.2 2.2 18.0 14.1 16.8 113.7 11.7 2.0 0.0 1.6 4.6 0.1 20.3 95.8 115.1 3.3 51.2 1.1 4.4 20.0 TBC1D10B "DKFZP434P1750, EPI64B, FLJ13130, Rab27A-GAPbeta" ENSG00000169221 "TBC1 domain family member 10B" Q4KMP7 16 30357102-30370494 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048894 Uncertain NA NA 250000 "HPA048894: AB_2680549" "unprognostic (2.55e-1)" "unprognostic (1.33e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (4.08e-3)" "unprognostic (2.85e-1)" "unprognostic (7.45e-2)" "prognostic unfavorable (8.94e-5)" "unprognostic (1.39e-2)" "unprognostic (3.58e-2)" "unprognostic (1.52e-1)" "unprognostic (4.17e-2)" "unprognostic (1.23e-3)" "unprognostic (2.03e-1)" "unprognostic (2.62e-2)" "unprognostic (7.42e-2)" "unprognostic (7.11e-2)" "unprognostic (2.59e-2)" 17.3 18.3 11.5 11.8 11.5 12.7 15.7 11.6 14.4 17.9 2.3 15.9 12.1 19.2 3.6 18.3 15.6 8.5 15.1 13.2 10.6 12.6 8.1 15.3 11.2 16.2 12.6 10.9 16.1 12.9 10.7 11.7 9.4 14.3 13.5 5.3 4.6 14.1 11.1 36.3 21.0 15.2 9.0 11.9 17.2 13.8 43.2 11.9 14.4 12.8 18.0 9.6 15.8 16.3 18.3 30.6 40.2 16.6 32.7 21.4 20.1 37.5 31.8 25.1 34.8 32.2 29.0 23.0 37.0 32.7 23.7 22.9 25.9 22.2 23.7 12.7 37.2 56.8 19.6 28.1 31.1 30.9 27.2 38.9 26.5 23.3 41.8 23.9 15.4 32.7 33.5 38.9 38.7 23.3 47.6 39.5 19.8 9.4 22.7 29.1 50.4 26.5 36.7 18.7 23.0 34.8 24.8 18.0 29.7 13.0 11.1 31.8 32.9 34.3 39.4 19.4 25.9 30.0 27.0 30.6 29.7 35.0 37.8 25.8 0.3 0.9 1.7 1.2 0.4 0.6 0.9 0.6 1.2 0.9 0.5 0.2 0.2 1.3 0.9 0.8 0.8 0.6 1.0 11.5 11.5 11.6 14.4 13.2 10.6 16.2 12.6 10.9 14.3 11.9 11.9 18.3 13.8 0.0 10.2 10.4 9.3 18.1 6.4 8.3 7.4 18.8 14.5 13.5 6.8 7.2 7.7 11.0 0.0 12.4 12.2 20.4 3.9 8.6 14.8 10.6 11.2 12.2 15.0 8.2 9.6 10.9 12.5 9.8 9.2 12.5 5.1 17.6 10.8 6.6 17.3 11.8 8.8 11.9 10.2 16.4 16.1 34.2 10.2 18.3 7.2 7.5 14.4 13.8 14.4 4.0 19.8 14.1 9.5 12.0 10.5 8.5 19.0 7.1 5.6 13.6 0.0 9.7 10.6 17.1 14.0 10.5 17.5 11.2 10.6 18.4 13.6 9.8 LMAN2 "C5orf8, GP36B, VIP36" ENSG00000169223 "Lectin, mannose binding 2" Q12907 5 177331567-177351668 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 530.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003927 Approved NA NA 88000000 "HPA003927: AB_1079257" "unprognostic (5.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.87e-2)" "unprognostic (1.85e-3)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (2.88e-3)" "unprognostic (2.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.51e-3)" "unprognostic (4.56e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (4.43e-2)" "unprognostic (6.13e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-1)" 62.8 80.2 35.2 63.7 37.1 78.3 65.9 37.6 49.7 76.6 55.1 64.7 92.2 74.7 137.3 148.2 71.0 57.6 73.1 38.0 42.8 85.2 209.5 79.4 66.8 39.4 36.2 31.8 70.2 157.2 50.4 61.3 73.2 37.1 65.2 40.5 14.8 118.9 49.1 51.0 63.7 81.9 36.6 36.8 87.6 83.1 94.3 41.2 55.3 98.1 29.5 43.0 67.5 73.7 39.0 108.6 196.4 57.3 317.9 201.5 76.2 298.0 122.1 120.8 105.6 132.9 326.2 254.0 115.9 286.2 162.7 196.3 163.9 69.6 242.9 39.6 556.7 166.6 73.9 136.7 196.5 196.2 155.4 210.7 140.5 94.2 106.0 94.8 118.3 142.3 100.3 90.8 452.0 79.3 318.5 115.8 268.3 82.7 159.7 174.8 132.4 97.6 404.9 99.5 122.6 94.9 105.4 113.3 191.9 205.0 51.9 150.4 349.5 145.5 168.2 108.0 89.2 182.7 252.0 200.8 114.8 234.5 217.8 186.6 569.9 411.8 476.9 408.9 379.2 349.7 252.1 295.6 342.9 358.8 256.6 241.0 280.7 552.6 364.8 346.1 500.9 350.2 828.4 35.2 37.1 37.6 49.7 38.0 42.8 39.4 36.2 31.8 37.1 36.8 41.2 39.0 82.7 57.7 74.5 12.1 114.8 57.0 147.9 384.3 47.8 33.2 100.9 74.4 44.6 124.4 229.9 108.5 16.7 312.7 147.4 168.3 52.8 233.2 103.8 87.2 99.5 99.5 58.9 71.8 7.0 237.3 444.4 120.4 70.8 131.2 77.4 97.2 81.8 223.4 240.4 55.5 8.3 190.0 266.5 105.0 85.3 28.2 88.0 107.4 120.9 13.1 116.4 89.0 162.7 13.0 9.7 226.1 130.9 63.9 388.4 146.1 186.1 111.9 151.9 46.5 65.7 70.8 108.9 275.8 192.0 134.1 69.9 530.3 112.5 111.8 160.6 165.6 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;prostate: 5.5" "Cell type enriched" "Detected in some" 24 "granulocytes: 223.3" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enhanced" "Detected in some" "cerebellum: 5.2" "Immune cell enriched" "Detected in single" 661 "basophil: 227.7" "Lineage enriched" "Detected in single" 661 "granulocytes: 227.7" "Group enriched" "Detected in some" 71 "HEL: 151.8;HMC-1: 564.8" "Low region specificity" "Detected in all" "HPA027507, HPA027510" Uncertain Approved Cytosol NA NA Cytosol "HPA027507: AB_10600756, HPA027510: AB_2672309" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 0.4 0.2 0.4 0.8 0.4 1.8 1.1 5.2 0.7 0.7 0.4 1.2 1.5 0.8 0.5 1.1 0.3 1.4 0.2 0.3 0.4 0.1 0.2 2.2 0.3 0.4 0.8 0.4 0.1 0.4 0.1 0.0 0.3 3.5 5.5 1.5 1.2 0.3 0.4 0.2 0.7 1.4 0.6 0.1 0.4 1.0 3.4 0.4 0.7 0.3 0.7 0.3 0.7 0.3 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.8 0.2 0.1 0.0 0.1 151.8 0.2 0.0 0.0 0.3 564.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.3 0.3 5.0 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.4 0.0 0.0 0.3 0.2 0.0 2.3 0.1 0.4 227.7 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.4 0.4 5.2 0.7 0.3 0.4 0.4 0.8 0.4 3.5 0.1 0.4 1.2 0.0 0.0 4.4 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 1.9 0.0 9.1 0.0 0.1 0.6 0.0 5.0 0.4 0.0 0.0 0.3 0.0 0.0 223.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.7 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.3 1.7 0.0 0.6 0.0 1.4 0.1 0.0 0.2 RAB24 ENSG00000169228 "RAB24, member RAS oncogene family" Q969Q5 5 177301198-177303744 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 55.2;Plasma cells: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 125.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034945 Uncertain "Focal adhesion sites" No No "Focal adhesion sites" "HPA034945: " "unprognostic (1.03e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (7.86e-2)" "prognostic favorable (6.22e-4)" "prognostic unfavorable (7.56e-5)" "unprognostic (1.28e-1)" "unprognostic (1.78e-2)" "unprognostic (9.66e-2)" "unprognostic (1.43e-3)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.54e-7)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (1.12e-2)" 22.0 39.2 29.8 20.2 31.8 26.1 24.5 27.4 32.8 28.7 32.6 23.1 13.9 20.2 22.3 42.8 20.4 11.6 22.8 31.3 32.3 32.8 30.8 27.4 15.8 31.6 29.3 29.5 27.2 60.2 18.0 49.0 12.1 31.8 31.4 10.6 11.7 34.6 12.6 30.6 41.1 24.7 11.8 27.8 54.1 22.4 11.5 30.5 11.3 24.3 17.6 20.8 23.7 32.6 33.5 6.9 17.7 13.0 25.3 20.8 18.0 19.5 19.8 28.6 27.8 33.7 20.9 8.8 7.2 24.2 18.5 30.7 4.9 17.7 24.8 15.7 125.9 9.8 25.2 17.4 18.6 43.2 15.6 21.3 30.4 20.2 29.9 21.0 41.4 17.3 21.4 18.0 42.6 20.1 26.2 5.7 38.3 8.0 15.2 17.8 3.6 18.5 28.0 19.1 12.6 14.1 20.1 6.8 13.1 59.6 15.9 23.0 41.0 16.2 8.5 14.2 19.8 19.1 31.4 15.9 9.8 16.5 24.3 17.9 42.6 87.1 166.7 19.0 185.2 17.7 33.2 10.3 16.6 60.1 29.0 10.9 16.6 137.3 37.4 183.6 13.6 9.3 48.4 29.8 31.8 27.4 32.8 31.3 32.3 31.6 29.3 29.5 31.8 27.8 30.5 33.5 6.3 3.2 7.1 31.0 33.7 5.4 1.6 16.3 55.2 3.7 12.1 8.4 2.4 1.5 12.9 1.8 2.1 7.6 7.3 28.5 3.9 24.5 0.6 2.4 3.9 5.9 18.0 12.6 42.7 20.1 6.3 10.8 31.1 3.2 12.0 1.3 5.3 1.7 4.3 13.5 45.1 12.8 6.1 8.8 6.9 0.6 5.0 37.7 3.6 10.3 11.1 2.0 9.2 14.6 15.6 18.9 27.7 1.2 71.1 1.9 26.0 6.9 5.5 4.2 0.0 2.4 8.0 2.2 3.6 43.8 6.0 30.6 15.4 2.2 13.3 2.0 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303799-177306949 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 79.7 107.3 61.3 90.0 60.8 91.5 79.6 61.3 71.1 65.7 61.0 103.5 110.3 69.8 37.8 148.1 61.9 37.4 65.8 61.2 62.4 139.4 183.8 76.7 79.7 61.2 62.7 60.2 64.6 264.5 48.5 68.0 59.1 63.0 75.5 86.6 24.6 96.4 30.1 32.4 108.1 122.8 47.7 62.7 118.4 104.1 43.3 64.2 31.2 66.5 13.9 88.1 82.2 79.4 61.6 221.4 193.8 116.1 307.1 103.3 111.0 400.6 154.5 106.6 214.6 206.1 443.2 232.5 181.4 181.6 143.7 236.0 118.1 212.5 400.0 145.8 826.0 291.9 154.9 195.7 291.1 109.6 243.6 215.1 102.7 142.2 170.6 144.9 89.1 269.0 129.2 181.4 247.7 210.5 556.7 160.5 362.5 242.1 251.6 319.7 52.7 232.1 324.5 140.0 171.5 186.3 237.7 136.8 266.9 267.5 144.4 172.5 293.4 148.5 189.3 174.9 157.4 365.5 155.4 270.9 267.4 162.2 328.0 200.4 411.1 764.6 1198.6 248.0 988.0 238.5 276.0 202.6 245.4 775.1 238.7 175.7 195.7 553.7 327.4 989.8 281.9 246.6 614.3 61.3 60.8 61.3 71.1 61.2 62.4 61.2 62.7 60.2 63.0 62.7 64.2 61.6 174.4 22.4 23.4 8.1 198.3 348.3 297.0 331.8 152.5 60.8 339.3 415.4 0.4 168.7 159.0 104.8 22.9 756.9 231.4 572.7 303.3 382.9 6.6 114.1 111.2 171.5 157.5 128.9 9.7 563.3 552.7 134.0 110.6 129.9 108.1 145.9 120.3 247.5 352.2 60.6 10.0 311.3 219.7 271.0 337.1 24.6 114.0 293.8 256.1 7.5 410.1 117.1 325.4 4.0 12.2 752.9 664.0 109.1 393.9 612.4 853.7 567.0 60.5 68.9 46.0 126.6 177.3 81.5 218.6 246.7 420.8 883.6 169.7 221.0 433.6 480.2 THBS3 ENSG00000169231 "Thrombospondin 3" P49746 1 155195588-155209051 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 29 "Early spermatids: 297.1;Late spermatids: 1075.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 76.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006293, HPA073242" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 9400000 Vesicles "HPA006293: AB_10602898, HPA073242: AB_2732223" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (2.43e-4)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (4.23e-1)" "unprognostic (4.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.38e-12)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (8.50e-3)" "unprognostic (2.26e-1)" 16.1 9.4 7.1 9.0 5.1 9.2 16.4 3.8 5.6 24.7 7.6 21.5 5.4 33.9 21.1 14.3 24.6 16.9 15.9 5.1 6.8 16.3 14.7 15.7 5.7 4.9 5.2 4.0 25.1 19.3 10.8 16.1 8.9 4.5 20.1 10.8 4.7 13.4 15.6 5.9 19.0 14.2 28.9 4.2 11.1 14.6 15.0 5.1 4.4 23.8 8.1 6.2 19.0 19.6 4.5 3.3 7.8 28.3 28.9 15.1 17.5 1.7 13.3 19.6 6.1 10.9 1.0 24.0 2.2 14.7 29.4 1.8 7.9 0.8 5.0 4.5 5.3 1.9 1.9 9.8 1.1 16.3 1.6 3.9 30.3 17.2 8.9 12.2 76.2 11.0 4.9 1.7 4.6 5.5 12.0 1.3 3.0 6.5 6.9 3.9 26.2 1.2 5.3 12.7 8.2 41.7 23.8 3.4 6.5 6.8 40.7 19.1 4.1 8.5 20.1 4.6 3.8 4.7 11.1 1.4 0.5 18.2 1.7 1.7 0.0 1.6 0.6 0.6 0.8 0.4 0.5 0.9 0.7 1.3 0.2 1.0 0.3 0.7 0.3 0.2 0.2 1.7 0.8 7.1 5.1 3.8 5.6 5.1 6.8 4.9 5.2 4.0 4.5 4.2 5.1 4.5 4.0 0.0 14.3 7.2 1.4 7.9 2.6 3.1 4.6 2.5 6.6 6.1 1.7 5.7 2.8 0.0 0.0 1.7 3.5 3.3 1.9 4.9 297.1 5.3 10.3 5.6 4.8 0.8 11.2 2.5 1.8 22.6 5.6 5.0 0.0 7.5 2.9 5.4 9.9 8.4 6.3 4.3 6.1 3.8 8.6 1075.2 23.3 3.7 10.6 0.0 1.9 1.5 1.0 0.0 3.2 3.7 2.9 10.1 1.4 2.3 2.7 3.8 2.6 3.7 0.0 11.8 8.1 20.8 4.8 3.7 5.3 1.4 2.2 2.4 3.4 2.2 CA5B ENSG00000169239 "Carbonic anhydrase 5B" Q9Y2D0 X 15688830-15788411 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 37.9;Muller glia cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.3;fHDF/TERT166: 27.0;hTERT-HME1: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA012618 Uncertain Supported Mitochondria NA NA Mitochondria "HPA012618: AB_1846000" "unprognostic (1.62e-2)" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-2)" "unprognostic (4.59e-5)" "unprognostic (2.50e-1)" "unprognostic (6.89e-4)" "unprognostic (4.11e-1)" "unprognostic (3.89e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.66e-6)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (8.94e-2)" "unprognostic (3.08e-1)" 5.1 3.1 5.4 4.2 5.6 3.6 8.4 4.2 5.5 21.7 6.2 2.8 1.6 7.4 2.6 6.5 7.6 7.4 2.8 4.0 7.0 4.8 2.1 6.0 5.6 7.8 6.4 3.2 12.0 3.5 9.2 2.5 3.1 7.0 4.9 3.7 10.6 4.6 4.6 1.6 5.7 2.6 7.6 5.7 4.4 4.5 10.4 6.4 4.3 7.2 5.5 6.9 5.3 5.6 4.8 4.3 2.6 2.9 4.8 8.5 22.3 1.7 4.4 5.6 3.2 4.6 1.3 2.8 1.2 4.5 27.0 6.1 4.6 10.3 5.0 5.7 1.2 4.8 2.3 3.3 1.1 8.3 3.0 5.0 5.3 5.3 4.3 34.2 5.7 4.8 3.5 1.2 3.0 15.4 2.3 2.5 2.3 1.2 0.8 18.6 1.4 2.1 2.2 4.9 3.1 2.6 5.3 6.1 2.2 3.8 3.4 3.1 3.0 6.5 3.8 2.5 20.4 2.5 2.2 2.4 1.4 4.2 6.0 7.2 4.4 3.9 0.4 16.7 4.8 14.5 4.6 16.6 15.5 4.7 5.0 12.1 10.4 2.2 11.0 3.1 0.7 14.3 10.0 5.4 5.6 4.2 5.5 4.0 7.0 7.8 6.4 3.2 7.0 5.7 6.4 4.8 9.6 0.0 7.9 14.0 19.1 4.2 6.3 3.4 6.2 9.5 7.3 5.2 2.4 0.0 7.1 1.8 16.7 1.8 37.9 1.6 1.9 4.4 1.1 9.6 7.1 13.9 3.0 11.2 11.5 4.0 1.8 10.5 11.7 6.2 2.5 6.7 6.1 2.7 1.9 1.7 11.8 2.2 8.2 9.3 11.1 1.8 7.8 10.8 3.6 19.7 9.1 35.9 32.0 8.5 10.6 4.1 1.6 5.3 18.7 11.5 1.2 2.9 12.2 7.8 6.6 8.1 8.3 4.2 5.6 5.5 4.5 1.9 30.0 12.1 1.5 7.9 SLC50A1 "HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1" ENSG00000169241 "Solute carrier family 50 member 1" Q9BRV3 1 155135344-155138857 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 130.7;Intestinal goblet cells: 195.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 166.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018095 Approved NA NA "HPA018095: AB_1856048" "unprognostic (4.75e-2)" "unprognostic (1.21e-1)" "unprognostic (7.57e-2)" "unprognostic (2.24e-1)" "unprognostic (3.29e-1)" "unprognostic (9.30e-2)" "unprognostic (1.64e-3)" "unprognostic (1.95e-1)" "unprognostic (1.38e-1)" "unprognostic (5.51e-2)" "unprognostic (3.53e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (4.36e-2)" "unprognostic (1.40e-1)" "unprognostic (3.50e-3)" "unprognostic (4.39e-2)" 21.5 42.7 10.0 17.2 10.0 14.3 22.8 10.6 11.1 28.5 11.9 45.8 40.8 16.1 102.3 34.6 21.5 14.1 12.9 10.1 12.3 31.8 48.5 26.6 21.6 11.1 10.2 9.9 13.4 58.3 34.6 18.2 18.3 12.3 30.1 54.2 2.6 29.2 15.4 6.5 30.5 36.4 15.8 10.0 35.7 47.8 12.0 11.2 17.3 27.8 6.7 27.2 20.5 19.8 11.7 48.0 15.0 13.5 16.9 42.9 42.4 31.2 19.1 28.9 24.6 31.7 28.7 166.5 34.1 58.8 27.3 34.6 62.6 16.3 52.5 14.7 72.7 8.4 29.2 17.9 18.3 72.0 18.2 35.1 44.0 144.2 41.3 98.0 43.1 25.7 20.5 32.2 53.1 23.6 56.0 15.0 21.6 18.7 99.7 59.1 26.3 9.5 117.8 53.0 16.9 23.5 19.2 31.2 63.7 50.6 21.0 140.3 19.3 13.3 18.0 17.9 25.6 9.8 68.5 45.1 32.0 30.1 42.0 19.4 22.9 24.1 24.5 20.0 36.2 24.3 54.5 25.2 24.0 29.7 60.6 27.0 23.8 10.3 51.7 34.6 30.3 28.8 30.8 10.0 10.0 10.6 11.1 10.1 12.3 11.1 10.2 9.9 12.3 10.0 11.2 11.7 33.0 22.4 33.6 2.6 40.4 16.2 21.1 43.5 18.8 7.4 78.8 22.5 5.3 12.8 41.3 23.9 12.5 37.0 26.3 66.5 13.7 43.7 0.6 28.7 20.7 33.2 23.4 20.4 4.3 48.8 130.7 21.4 60.6 42.2 24.1 17.7 24.7 22.1 45.2 6.7 4.8 195.0 71.2 32.2 33.4 1.5 13.4 35.8 28.4 5.6 33.8 5.3 16.5 4.0 1.8 42.1 54.3 5.7 47.0 40.8 69.8 23.8 38.6 7.2 6.6 11.1 20.4 8.2 5.2 27.9 18.5 62.8 23.2 28.5 52.5 39.3 EFNA1 "ECKLG, EPLG1, GMAN, LERK1, TNFAIP4" ENSG00000169242 "Ephrin A1" P20827 1 155127876-155134899 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 476.7" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 942.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 11.4;naive CD8 T-cell: 5.9" "Lineage enriched" "Detected in single" 23 "T-cells: 11.4" "Cell line enhanced" "Detected in many" "BEWO: 266.5;HaCaT: 95.5;SiHa: 156.9;SK-BR-3: 227.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069549 Approved "Secreted to blood" NA Yes 2800000 "HPA069549: " "unprognostic (5.14e-2)" "unprognostic (3.04e-3)" "unprognostic (5.03e-2)" "unprognostic (2.01e-1)" "unprognostic (1.59e-1)" "unprognostic (2.47e-2)" "unprognostic (1.78e-2)" "unprognostic (5.80e-3)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (2.00e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" 42.1 24.2 27.3 4.9 30.5 1.3 65.2 28.2 34.2 28.6 24.5 42.9 58.4 23.9 28.8 55.1 23.4 24.7 42.6 26.3 36.0 72.7 476.7 87.4 8.2 32.3 30.3 25.7 17.7 54.0 30.0 19.7 110.9 32.4 80.2 52.1 7.9 67.1 22.3 18.6 120.3 69.9 13.5 30.6 8.7 41.1 4.1 29.6 21.2 80.6 39.0 12.6 37.2 55.9 35.8 15.1 5.9 0.9 11.5 2.1 0.1 266.5 0.0 0.5 0.2 0.3 13.9 32.0 0.0 26.3 0.0 9.0 95.5 6.6 35.3 0.2 9.8 2.2 0.1 19.0 76.1 0.9 0.2 1.5 4.9 84.5 0.0 30.2 7.3 53.6 0.9 2.8 0.3 0.0 52.2 0.3 1.1 1.7 52.3 17.7 6.1 1.5 9.3 66.4 22.4 9.8 14.2 156.9 227.1 6.0 48.8 51.1 0.0 6.7 0.1 9.1 0.6 1.5 2.3 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 1.0 0.7 0.0 0.3 11.4 5.9 0.4 0.4 0.0 0.0 0.0 1.6 27.3 30.5 28.2 34.2 26.3 36.0 32.3 30.3 25.7 32.4 30.6 29.6 35.8 116.8 198.7 113.1 0.7 2.3 127.7 103.7 91.6 327.8 3.0 198.3 151.9 47.8 95.8 101.2 18.4 0.0 195.6 4.4 265.0 13.7 130.1 0.3 100.4 19.1 148.9 18.6 4.0 0.7 63.9 942.6 23.2 124.9 163.5 6.3 0.1 106.4 133.2 28.2 5.0 0.8 114.1 101.7 4.3 19.5 0.7 4.7 4.2 62.2 2.8 0.6 5.7 0.0 3.5 28.7 73.9 205.5 0.4 4.1 197.8 238.6 34.5 54.5 1.1 0.0 6.5 35.9 0.8 2.6 253.2 217.8 254.2 7.5 1.3 95.9 135.9 CXCL10 "C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10" ENSG00000169245 "C-X-C motif chemokine ligand 10" P02778 4 76021118-76023497 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 96.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 52.7;Glandular and luminal cells: 23.5;Kupffer cells: 41.1;Langerhans cells: 21.4;Macrophages: 45.7;Plasma cells: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9" "Lineage enriched" "Detected in many" 15 "monocytes: 52.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.1;BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;GAMG: 5.1;RPMI-8226: 4.3;RT4: 2.4;THP-1: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 253000 "unprognostic (1.94e-1)" "unprognostic (5.32e-2)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-1)" "unprognostic (7.59e-2)" "prognostic favorable (1.12e-5)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-2)" 3.9 5.9 1.2 96.4 1.5 1.2 20.8 0.7 2.6 7.4 1.1 10.8 11.3 7.2 0.7 8.1 4.1 10.7 4.4 1.0 1.4 7.6 29.2 35.4 68.5 7.3 1.0 0.7 3.1 0.9 17.2 2.1 10.3 10.8 44.3 16.0 0.4 20.3 1.8 1.2 1.8 11.2 15.9 1.1 20.5 19.4 3.1 2.2 35.6 3.7 1.1 17.5 45.6 3.7 4.2 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.1 2.2 2.2 0.2 0.1 2.0 0.2 0.0 5.1 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 4.3 0.1 2.4 0.0 0.0 0.0 0.4 1.3 0.0 0.1 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.0 0.0 21.5 0.0 0.0 52.4 0.0 1.4 0.3 0.0 3.5 0.1 0.0 0.0 1.1 0.0 36.9 0.0 0.0 7.6 1.2 1.5 0.7 2.6 1.0 1.4 7.3 1.0 0.7 10.8 1.1 2.2 4.2 3.8 0.0 2.2 0.0 2.2 0.9 9.4 52.7 0.6 0.0 2.6 7.0 0.3 1.5 2.8 0.0 0.0 0.1 0.0 2.7 0.0 5.9 2.6 12.5 10.9 8.0 0.0 0.0 0.0 0.0 0.0 6.9 3.1 23.5 1.3 0.0 0.0 0.1 17.3 0.0 0.0 1.0 10.2 41.1 21.4 4.0 0.3 45.7 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 11.4 6.4 2.6 1.3 0.0 0.0 1.3 12.4 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.9 1.4 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 2.8;Gastric mucus-secreting cells: 2.0;Skeletal myocytes: 3.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 161.9" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 50.6 47.5 118.2 37.5 113.0 150.7 48.2 103.9 185.7 70.1 88.1 66.6 28.7 38.6 52.3 44.8 59.1 28.8 54.4 103.5 93.1 70.2 65.6 66.9 77.6 117.9 100.6 80.1 50.0 47.6 13.2 71.1 22.1 130.6 75.6 35.2 52.2 43.9 22.8 88.7 142.0 77.3 28.4 68.9 100.6 51.7 46.9 117.9 54.1 76.2 24.3 35.1 48.5 53.0 102.3 37.9 37.2 24.5 40.1 30.0 18.1 73.5 25.7 9.6 13.3 14.1 57.5 44.0 56.4 24.1 38.9 17.7 47.0 13.6 41.4 12.5 30.8 20.6 26.6 58.7 161.9 25.6 48.8 46.0 8.8 16.8 35.3 44.3 20.4 19.4 52.5 49.7 77.3 20.4 69.7 51.8 114.0 41.0 22.5 42.5 75.7 25.4 35.0 28.8 23.2 27.8 21.1 15.7 32.5 25.9 47.2 35.7 20.7 29.5 62.9 36.4 6.4 40.4 37.8 30.8 49.2 25.0 38.3 34.9 3.5 2.3 1.5 2.6 1.4 1.2 2.2 1.5 1.6 1.2 2.4 2.0 1.3 2.1 2.0 1.1 4.8 0.9 0.1 118.2 113.0 103.9 185.7 103.5 93.1 117.9 100.6 80.1 130.6 68.9 117.9 102.3 0.1 0.0 0.0 1.6 0.5 2.8 0.4 0.2 0.6 0.0 0.1 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.7 0.0 0.0 1.7 0.0 0.0 1.0 2.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.2 1.8 1.9 0.0 0.0 1.0 1.5 1.3 0.0 0.0 0.0 0.7 0.8 0.0 0.0 1.7 0.0 0.0 3.1 0.8 0.0 0.0 1.3 1.7 0.0 0.8 0.2 0.0 0.2 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 12.8;retina: 3.9" "Cell type enriched" "Detected in many" 10 "Oligodendrocytes: 270.4" "Cancer enhanced" "Detected in some" "melanoma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;HBEC3-KT: 2.2;RT4: 3.6;SK-MEL-30: 5.2;WM-115: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA037683: AB_2675608, HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 0.1 0.0 5.4 0.0 7.7 0.1 0.1 5.0 4.9 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 3.5 4.8 0.0 0.0 0.0 0.0 6.9 7.2 2.1 0.0 0.0 0.0 0.0 0.4 7.9 0.0 0.0 3.9 0.1 0.1 0.2 0.1 0.0 0.0 6.5 0.0 0.0 1.5 6.2 0.0 0.0 0.1 0.0 0.1 0.0 12.8 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.3 0.1 2.6 1.5 0.0 1.8 0.1 0.6 1.9 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.1 1.6 0.0 1.3 0.0 0.7 3.6 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.2 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 7.7 5.0 4.9 3.5 4.8 6.9 7.2 2.1 7.9 6.5 6.2 12.8 1.9 3.2 3.7 0.3 0.1 0.9 0.8 1.0 0.0 1.4 0.7 0.4 1.7 1.5 3.8 0.0 4.2 0.8 0.0 0.6 0.0 0.6 6.4 0.3 0.1 2.8 0.0 0.0 0.4 0.2 0.4 0.5 0.0 0.5 2.5 0.1 1.4 0.3 0.4 0.0 0.4 0.0 2.0 1.8 0.7 2.3 0.3 2.2 0.0 4.7 0.1 2.3 0.0 0.0 270.4 1.6 0.0 0.0 0.1 1.2 0.0 0.1 4.1 25.4 0.0 0.3 0.4 2.3 0.9 1.0 0.9 11.9 0.3 0.1 0.2 8.8 CXCL11 "b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B" ENSG00000169248 "C-X-C motif chemokine ligand 11" O14625 4 76033682-76041415 "Human disease related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Basal prostatic cells: 2.6;Basal respiratory cells: 2.9;Distal enterocytes: 2.7;Exocrine glandular cells: 3.6;Macrophages: 4.3;Prostatic glandular cells: 3.7;Proximal enterocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 3.4;BJ hTERT+ SV40 Large T+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 5.3;GAMG: 1.4" "Region enhanced" "Detected in single" "spinal cord: 1.2" CAB009921 Uncertain "Secreted to blood" NA NA 187000 "CAB009921: AB_2088137" "unprognostic (2.00e-1)" "unprognostic (3.62e-1)" "unprognostic (6.94e-3)" "unprognostic (1.87e-2)" "unprognostic (9.95e-2)" "unprognostic (5.85e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.31e-7)" "prognostic unfavorable (8.18e-5)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.29e-6)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (4.48e-2)" "unprognostic (5.32e-2)" 1.6 0.4 1.6 11.2 1.4 0.3 3.7 1.1 2.4 1.4 0.9 1.7 0.8 1.5 0.2 1.0 1.6 1.2 1.2 1.4 1.2 1.3 2.4 6.0 12.0 2.3 1.3 0.9 0.5 9.0 0.1 0.3 3.7 2.2 5.2 4.4 0.0 3.2 0.3 0.3 0.2 1.2 1.7 1.2 5.8 6.4 0.9 2.2 6.4 1.3 0.0 1.4 4.7 0.6 1.5 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.4 5.1 5.3 0.0 0.1 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.4 1.1 2.4 1.4 1.2 2.3 1.3 0.9 2.2 1.2 2.2 1.5 0.5 3.2 0.0 0.0 0.2 0.1 2.6 2.9 0.0 0.0 0.2 0.3 0.2 1.5 0.2 0.0 0.0 0.0 0.0 2.7 0.0 2.0 0.0 0.7 0.9 2.2 0.0 0.0 0.0 3.6 0.0 0.5 0.0 1.6 0.0 0.0 0.4 0.2 1.8 0.0 0.0 0.1 0.0 2.1 0.3 0.0 0.0 4.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 2.8 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.2 1.4 ZRSR2 "U2AF1-RS2, U2AF1L2, URP, ZC3H22" ENSG00000169249 "Zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2" Q15696 X 15790472-15823260 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.96e-4)" "unprognostic (1.54e-2)" "unprognostic (7.31e-2)" "prognostic favorable (8.50e-5)" "unprognostic (8.08e-2)" "unprognostic (1.69e-1)" "unprognostic (6.14e-3)" "unprognostic (5.72e-3)" "unprognostic (8.46e-2)" "unprognostic (3.47e-3)" "unprognostic (6.90e-2)" "unprognostic (2.85e-2)" "prognostic unfavorable (4.87e-5)" "unprognostic (8.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.65e-2)" "prognostic favorable (2.97e-4)" 14.6 12.2 27.6 17.5 27.2 43.1 16.4 29.9 36.3 24.3 28.3 19.8 11.1 21.4 20.4 13.5 20.4 10.2 16.2 26.3 26.6 14.7 13.4 20.3 29.3 26.9 26.5 25.0 22.4 14.4 13.1 24.3 10.9 27.6 18.2 12.6 22.4 14.0 12.0 20.5 15.4 19.9 17.2 24.8 32.0 14.9 5.6 27.2 22.1 17.5 13.3 20.4 18.2 20.3 28.0 14.3 8.9 15.6 14.7 21.9 18.4 6.1 11.4 10.5 10.8 11.0 11.3 11.3 16.1 19.2 10.6 28.3 13.7 15.6 19.9 11.0 12.3 20.0 10.4 22.8 10.1 14.8 24.4 23.9 9.2 17.7 20.0 32.4 21.3 18.9 15.5 17.0 15.3 12.9 17.5 13.0 25.4 20.1 7.5 12.7 15.1 22.0 16.4 12.9 11.0 10.6 11.8 26.7 23.5 17.7 21.4 18.4 13.6 13.2 10.7 7.8 28.7 11.0 12.9 11.7 15.0 8.2 17.0 14.2 38.7 25.7 24.0 17.3 22.6 17.2 34.9 21.6 23.2 15.1 37.2 26.1 18.5 26.9 14.3 22.9 24.6 24.3 10.5 27.6 27.2 29.9 36.3 26.3 26.6 26.9 26.5 25.0 27.6 24.8 27.2 28.0 16.7 9.6 17.4 12.1 35.6 11.3 10.2 16.6 12.0 15.3 13.8 12.1 23.9 5.7 17.2 16.5 14.6 6.8 42.3 14.0 23.5 12.8 1.1 27.7 14.3 14.2 16.8 9.9 15.5 14.9 10.2 11.5 4.6 14.1 32.3 9.7 11.0 13.8 19.1 8.4 17.9 16.9 22.4 33.5 19.6 1.6 13.7 25.6 12.4 14.0 30.5 9.6 37.0 10.1 13.7 13.1 8.2 16.6 18.8 7.0 17.3 17.7 23.7 19.5 19.7 13.8 16.2 6.4 8.3 7.8 10.5 7.3 32.2 9.3 13.4 8.0 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 27.1 21.7 13.5 18.3 13.6 65.3 32.7 19.8 14.3 27.2 13.4 18.8 17.8 26.5 15.5 24.6 20.4 22.8 40.4 11.8 14.3 29.4 78.4 19.9 22.5 14.8 13.7 11.7 26.7 35.2 22.1 12.8 25.9 13.2 27.9 21.5 17.2 33.1 20.2 60.9 16.9 15.5 28.6 12.4 21.3 42.9 16.2 13.0 18.9 25.5 34.8 24.9 39.7 16.6 14.4 68.7 39.2 37.8 38.6 46.3 63.1 51.9 76.3 57.9 55.9 64.8 66.5 54.9 86.4 94.8 53.8 39.3 43.8 60.9 56.1 86.4 90.2 37.4 89.0 31.4 41.7 50.7 108.0 51.7 53.2 40.9 39.7 129.1 59.4 61.4 29.9 66.3 46.3 66.8 155.7 49.6 41.3 47.4 82.1 61.7 59.8 54.5 87.9 53.1 153.2 59.8 37.3 43.5 105.2 63.9 40.9 78.3 49.0 54.2 44.1 31.5 51.3 93.4 75.6 54.5 87.1 55.5 69.5 61.5 30.5 16.6 8.9 16.5 17.6 25.9 17.3 19.2 20.4 19.8 15.6 25.3 20.1 3.6 35.4 11.4 11.0 26.8 20.7 13.5 13.6 19.8 14.3 11.8 14.3 14.8 13.7 11.7 13.2 12.4 13.0 14.4 30.6 19.2 14.6 22.9 25.3 64.9 52.9 23.8 34.7 24.7 26.8 16.5 43.9 21.5 25.1 11.0 14.6 33.3 25.2 14.0 35.2 25.6 19.3 13.8 29.6 30.1 13.8 32.2 16.6 38.9 48.8 34.0 31.1 19.3 25.4 20.3 22.1 41.6 23.4 30.3 15.3 19.4 26.4 33.1 47.0 7.0 25.4 21.6 24.9 12.2 26.1 12.8 21.6 19.6 18.2 33.0 13.9 27.4 20.9 46.7 19.7 39.9 18.5 20.8 26.3 29.1 87.5 39.2 27.4 33.4 74.3 56.6 25.8 24.4 21.2 72.7 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148826611-148828623 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 196.1;Basal keratinocytes: 387.5;Basal respiratory cells: 146.6;Squamous epithelial cells: 276.0;Suprabasal keratinocytes: 245.4" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 72.4;hTERT-HME1: 74.1;PC-3: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 19.7 1.7 3.9 3.3 4.2 12.6 18.8 4.6 4.3 13.6 1.9 2.3 1.9 2.4 1.7 15.2 4.1 3.8 6.7 4.8 3.6 1.1 14.3 19.7 4.1 5.5 4.6 2.4 0.9 1.2 2.2 0.3 10.0 7.5 9.1 2.9 0.6 4.2 1.5 11.8 20.1 2.2 3.8 4.9 7.9 7.5 0.5 6.2 2.7 1.0 8.7 6.0 6.9 7.3 7.1 23.3 0.1 0.1 0.0 0.8 0.2 0.0 4.3 13.2 6.0 6.7 0.0 9.7 0.1 6.1 1.3 21.5 20.0 0.0 27.9 6.9 0.0 0.6 0.0 5.1 0.0 0.6 0.1 11.0 0.1 72.4 2.0 74.1 5.0 2.8 0.0 0.1 8.3 16.0 0.0 0.0 12.9 0.4 0.2 31.2 6.7 4.1 13.0 3.2 5.8 0.1 0.1 5.4 0.4 2.0 2.5 0.0 7.0 12.3 0.0 5.0 7.2 3.5 1.9 0.0 0.2 0.0 15.1 2.6 16.5 21.8 67.8 151.4 37.1 112.3 21.5 34.3 93.0 24.7 15.6 5.8 53.3 35.4 37.2 53.3 28.4 2.3 53.4 3.9 4.2 4.6 4.3 4.8 3.6 5.5 4.6 2.4 7.5 4.9 6.2 7.1 196.1 112.2 31.6 1.6 16.5 387.5 36.6 146.6 127.5 0.5 23.3 15.2 18.6 0.0 67.4 0.0 0.0 0.4 59.2 3.7 0.0 2.4 0.5 3.2 0.5 40.3 3.0 1.3 0.0 0.2 0.3 6.2 35.7 3.0 118.6 0.1 6.8 14.1 17.7 0.0 0.0 3.1 16.2 20.8 54.9 0.7 0.0 21.1 30.2 15.9 4.0 4.1 90.6 0.0 0.1 8.6 0.1 0.0 23.2 23.5 0.1 0.1 27.8 5.0 0.0 19.8 9.6 0.7 0.1 276.0 245.4 0.5 40.1 0.1 3.5 61.5 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105411 "Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 53.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 56.3;Cardiomyocytes: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 8.8;NK-cell: 22.1" "Group enriched" "Detected in many" 7 "granulocytes: 8.8;NK-cells: 22.1" "Cell line enhanced" "Detected in many" "RT4: 128.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles NA NA 400000 Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 5.3 7.3 19.0 3.9 22.3 4.8 9.9 15.4 17.8 20.2 8.3 2.3 1.9 10.0 8.6 6.9 14.3 10.0 53.8 20.5 25.2 19.6 1.2 14.7 4.9 13.1 19.3 19.4 19.0 11.2 8.7 9.8 14.0 15.6 11.7 2.5 26.8 22.5 8.6 1.4 2.4 2.4 10.0 11.1 6.3 10.8 8.4 23.0 2.8 27.2 3.3 5.5 12.4 5.5 15.7 17.3 0.3 7.5 0.1 1.0 2.8 0.1 9.3 8.7 22.3 7.3 11.3 13.2 0.0 35.7 8.0 12.7 3.9 0.0 16.9 7.5 0.0 0.0 9.0 5.7 0.0 11.2 0.2 0.0 23.3 5.4 6.1 1.4 15.6 31.6 0.0 0.0 0.0 8.3 29.4 0.1 0.0 17.4 0.2 38.9 0.1 0.0 0.2 9.3 128.3 15.1 0.1 23.7 8.8 6.3 3.0 35.6 13.3 0.0 0.2 15.5 0.5 0.2 3.6 0.1 0.2 14.7 0.0 0.0 8.8 0.2 0.0 0.4 0.2 0.4 2.3 0.2 0.4 1.7 0.2 0.4 0.9 0.4 22.1 0.1 1.1 0.0 0.7 19.0 22.3 15.4 17.8 20.5 25.2 13.1 19.3 19.4 15.6 11.1 23.0 15.7 5.0 19.2 2.2 10.1 2.1 5.0 5.2 5.7 6.2 56.3 7.5 6.2 56.9 0.0 8.0 14.7 12.5 21.2 1.2 0.1 11.7 3.5 0.7 4.9 5.8 7.7 1.8 17.0 22.3 8.5 13.0 13.3 4.6 8.7 10.2 13.0 6.1 0.2 9.8 6.7 27.5 0.1 6.1 2.1 6.8 2.2 7.2 3.4 10.6 9.4 4.3 12.6 1.0 14.6 3.2 9.8 0.1 5.3 0.2 6.2 0.1 15.8 3.1 8.4 0.0 5.3 13.2 6.5 20.7 8.4 2.6 5.1 1.2 4.6 0.7 4.5 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610156 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.9;pituitary gland: 8.2;retina: 6.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 12.8;Excitatory neurons: 7.5;Horizontal cells: 21.9;Inhibitory neurons: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 56.5;SCLC-21H: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA036478: AB_2675145, HPA070892: AB_2686321" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 0.4 1.6 18.1 0.8 17.5 0.2 0.3 7.9 15.4 0.3 0.0 0.9 3.8 0.4 0.0 0.8 0.1 0.4 0.3 23.9 12.2 0.6 0.4 0.4 0.8 5.4 4.3 19.3 0.0 0.6 0.1 8.2 0.3 7.7 0.2 0.4 6.9 0.3 0.0 0.3 1.0 3.2 0.7 1.7 0.4 0.8 1.5 11.7 0.9 0.2 0.2 1.2 0.3 0.2 9.3 7.5 7.9 9.8 14.1 2.1 4.6 8.3 9.8 5.1 7.5 9.7 9.6 4.8 17.0 19.6 5.3 22.0 6.5 6.3 6.8 6.5 56.5 4.3 0.3 4.1 3.4 0.9 0.4 4.2 2.3 5.1 8.1 1.2 1.5 5.5 3.8 9.1 24.0 6.3 19.7 1.8 0.0 9.9 5.0 15.4 31.7 10.9 10.1 8.4 7.7 59.5 34.1 11.4 3.2 17.7 1.2 7.4 6.5 6.8 13.8 16.0 5.3 14.5 0.4 2.3 4.8 11.9 0.8 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 17.5 7.9 15.4 23.9 12.2 5.4 4.3 19.3 7.7 1.7 11.7 9.3 0.4 0.0 0.0 0.3 0.5 2.4 0.1 0.3 0.6 12.8 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.3 1.9 0.4 0.0 0.5 0.6 1.0 1.8 0.0 7.5 1.8 0.9 0.4 0.0 1.2 0.0 0.3 0.0 0.0 0.9 21.9 8.0 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.0 1.9 0.1 1.1 1.0 2.5 0.3 1.6 0.1 0.0 0.8 0.2 0.0 0.3 0.4 3.1 0.0 1.5 0.3 0.7 2.7 0.4 1.4 0.1 0.3 0.4 0.2 0.1 HSPB3 HSPL27 ENSG00000169271 "Heat shock protein family B (small) member 3" Q12988 5 54455699-54456377 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Stress response" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "heart muscle: 410.0;skeletal muscle: 219.2;tongue: 220.9" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 398.1" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 86.3;fHDF/TERT166: 39.1;HSkMC: 16.3;LHCN-M2: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA062124 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA062124: AB_2684690" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.78e-3)" "unprognostic (3.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.13e-1)" "unprognostic (4.41e-3)" "unprognostic (6.42e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (2.73e-1)" "unprognostic (2.82e-2)" "unprognostic (7.15e-2)" 0.9 0.2 5.3 0.1 6.1 0.2 2.1 4.5 8.5 0.9 4.7 4.6 0.2 7.6 0.4 16.6 3.0 0.2 410.0 6.5 6.7 0.4 0.1 2.9 0.0 4.8 4.7 5.9 1.0 0.1 0.0 3.6 0.1 5.1 8.6 2.2 1.6 6.7 0.8 219.2 2.2 0.9 10.5 4.6 0.7 0.9 1.8 4.7 0.7 0.3 220.9 0.0 3.8 0.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 86.3 0.1 0.1 0.4 0.0 0.0 0.3 39.1 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 16.3 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 6.1 4.5 8.5 6.5 6.7 4.8 4.7 5.9 5.1 4.6 4.7 7.0 0.0 0.0 0.0 0.3 0.0 6.4 0.4 3.2 0.0 0.1 0.0 0.0 398.1 0.0 0.3 0.0 0.0 0.1 0.0 10.5 0.0 0.0 0.1 0.7 0.2 3.5 0.0 0.0 4.3 0.0 0.0 14.4 0.0 1.3 0.0 0.1 0.0 0.0 0.1 1.7 6.5 0.0 0.0 0.0 4.9 0.4 0.6 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 6.6 21.3 7.2 0.4 0.0 0.0 5.3 0.1 0.2 0.1 0.3 0.3 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 3.4;hTEC/SVTERT24-B: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 16.0 6.4 11.9 1.2 42.7 1.6 7.4 17.2 17.0 6.7 6.6 3.8 1.7 5.5 12.9 2.2 4.3 3.0 5.5 24.4 12.2 1.8 2.6 3.4 0.9 11.4 11.5 12.7 2.9 4.1 2.0 1.8 1.3 16.3 22.6 1.9 12.9 3.9 19.4 2.0 1.7 2.8 2.7 9.4 5.2 1.6 3.1 13.6 1.8 29.0 5.1 0.3 3.0 5.0 17.1 0.5 0.5 0.7 0.2 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.9 0.1 0.4 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.4 1.0 3.4 0.6 1.6 0.0 1.0 0.2 0.0 0.0 5.2 0.0 1.1 2.1 0.5 0.1 0.3 0.2 0.1 0.3 0.6 1.1 1.5 0.2 0.6 0.7 2.8 0.0 0.2 0.8 0.8 0.3 0.6 0.7 0.5 0.8 0.5 2.2 0.8 0.5 1.4 1.2 1.8 0.4 0.4 2.6 1.1 1.0 0.8 0.1 0.0 0.4 0.2 0.8 0.2 0.4 0.3 0.2 0.2 0.3 0.3 0.0 0.3 0.3 1.2 0.5 0.1 11.9 42.7 17.2 17.0 24.4 12.2 11.4 11.5 12.7 16.3 9.4 13.6 17.1 7.2 0.0 0.0 7.5 0.7 0.8 0.3 0.0 0.0 85.8 1.4 1.4 4.3 0.0 0.7 0.0 31.3 0.1 0.5 0.1 0.0 0.4 13.7 0.6 2.4 2.8 0.0 0.0 108.6 0.0 0.0 3.8 0.0 2.1 0.0 0.4 0.7 0.0 4.6 0.0 605.4 0.0 0.0 11.1 1.0 7.0 0.0 1.2 1.8 24.4 0.0 2.7 0.0 206.6 97.5 0.0 0.0 2.6 2.3 0.2 0.0 0.1 0.0 6.7 78.9 1.3 73.3 0.3 4.2 1.2 0.9 0.1 0.5 0.2 0.0 0.2 MRPL1 BM022 ENSG00000169288 "Mitochondrial ribosomal protein L1" Q9BYD6 4 77862830-77952785 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043656 Supported Approved Mitochondria NA NA Mitochondria "HPA043656: AB_2678601" "unprognostic (9.03e-3)" "unprognostic (3.25e-1)" "unprognostic (1.11e-3)" "unprognostic (2.88e-1)" "unprognostic (4.52e-2)" "unprognostic (5.29e-3)" "unprognostic (4.69e-3)" "unprognostic (5.44e-2)" "unprognostic (1.66e-2)" "unprognostic (5.14e-3)" "unprognostic (8.79e-2)" "unprognostic (2.22e-2)" "prognostic favorable (3.35e-5)" "unprognostic (7.63e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "unprognostic (9.17e-3)" 19.6 17.8 17.2 17.6 18.1 27.2 24.6 17.1 21.1 16.6 16.4 28.6 19.7 18.8 21.2 20.7 17.1 11.9 42.1 17.8 18.5 38.5 34.1 13.2 23.8 17.6 17.2 16.4 19.2 14.2 21.5 8.2 21.5 18.3 16.2 29.7 14.7 19.4 15.1 67.9 14.7 18.7 21.6 17.2 15.1 17.9 8.9 18.0 19.5 17.9 68.2 24.4 20.0 9.3 18.2 40.5 26.2 47.3 40.7 36.6 47.4 41.2 44.6 28.6 57.4 39.3 55.0 71.6 71.4 53.9 37.1 35.8 32.8 71.1 82.5 75.6 47.6 37.6 61.1 27.6 60.4 47.5 126.2 28.3 37.7 76.7 51.2 53.0 37.8 70.4 50.1 90.3 24.1 73.6 46.0 76.0 84.9 52.0 92.0 34.3 90.7 60.6 41.1 113.3 43.2 52.1 25.9 36.1 88.7 84.5 38.0 43.7 61.0 41.9 37.5 54.3 37.7 65.1 21.1 28.1 74.6 31.9 71.8 49.3 9.0 11.5 7.0 20.6 19.0 20.6 27.8 22.2 23.1 22.1 25.5 26.8 29.5 1.7 23.2 16.9 18.0 25.8 15.4 17.2 18.1 17.1 21.1 17.8 18.5 17.6 17.2 16.4 18.3 17.2 18.0 18.2 40.1 25.6 35.7 22.5 45.7 12.7 17.1 68.6 13.6 24.6 31.6 37.2 122.1 57.2 33.5 33.1 18.8 72.7 75.5 22.2 135.0 46.0 15.5 33.9 40.9 34.9 47.9 34.9 45.9 36.7 51.9 27.5 18.8 38.5 42.4 38.7 40.7 134.3 47.7 25.2 39.7 60.5 61.1 25.1 12.7 9.3 31.1 23.5 16.0 35.6 34.1 26.7 64.9 45.2 47.7 28.3 24.9 33.4 38.6 14.7 36.0 144.8 20.6 42.4 39.5 31.4 45.9 21.1 48.0 23.1 12.8 34.9 65.8 61.7 70.9 15.5 SHE ENSG00000169291 "Src homology 2 domain containing E" Q5VZ18 1 154469772-154502412 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 49.1;TIME: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037417 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA037417: AB_10672384" "unprognostic (3.24e-1)" "unprognostic (4.95e-2)" "unprognostic (7.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.80e-1)" "unprognostic (6.80e-3)" "unprognostic (7.24e-2)" "unprognostic (3.07e-3)" "unprognostic (3.10e-2)" "unprognostic (8.22e-2)" "unprognostic (4.04e-2)" "unprognostic (8.29e-2)" "unprognostic (2.40e-2)" "unprognostic (7.31e-2)" "unprognostic (1.62e-1)" "unprognostic (3.33e-3)" "unprognostic (1.33e-2)" 23.2 9.8 9.3 3.4 8.6 1.2 21.1 7.7 10.7 12.0 9.2 7.4 3.4 12.2 4.4 5.1 12.6 7.0 19.7 8.1 8.1 10.5 5.9 20.8 3.9 9.0 9.0 7.0 7.7 3.0 4.9 3.8 16.6 8.7 8.2 4.3 0.6 5.4 4.2 7.1 6.3 9.0 8.1 7.8 21.5 5.5 22.3 9.6 2.7 22.3 11.4 2.3 9.8 10.0 9.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 4.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 49.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.5 0.0 1.0 13.6 0.0 0.3 1.4 0.0 0.1 0.2 0.1 0.0 1.0 0.0 0.5 0.3 0.2 1.5 1.5 1.1 0.9 0.6 0.6 0.1 0.9 0.8 0.9 2.4 1.7 1.1 4.0 0.0 0.5 9.3 8.6 7.7 10.7 8.1 8.1 9.0 9.0 7.0 8.7 7.8 9.6 9.2 56.9 0.0 23.4 3.9 0.3 3.3 0.4 0.3 1.2 0.1 0.4 1.3 4.4 1.5 1.3 1.8 0.0 0.0 0.2 0.0 0.0 0.1 13.0 0.4 0.3 64.4 0.0 2.7 0.3 0.0 0.0 6.7 0.0 0.5 3.8 2.1 85.3 3.4 1.4 0.0 0.3 0.0 0.0 26.7 6.6 23.0 1.5 2.0 0.0 26.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 3.7 0.7 0.0 0.1 0.0 0.4 0.0 3.3 2.2 30.6 13.0 0.3 1.6 0.1 0.7 0.3 0.0 0.3 NR0B1 "AHC, AHCH, DAX1, DSS" ENSG00000169297 "Nuclear receptor subfamily 0 group B member 1" P51843 X 30304206-30309390 "Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Receptor, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 32.9;testis: 19.5" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9" "Cancer enhanced" "Detected in many" "lung cancer: 4.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 62.5;RT4: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA061948, HPA067207" Supported "Nuclear speckles,Vesicles,Centriolar satellite" NA NA "Nuclear speckles" "Vesicles, Centriolar satellite" "HPA061948: AB_2732673, HPA067207: AB_2732761" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" "unprognostic (9.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (7.45e-3)" "unprognostic (4.83e-2)" "unprognostic (9.00e-2)" "unprognostic (1.33e-3)" 0.2 32.9 1.3 0.0 1.2 0.0 0.2 0.9 1.5 1.5 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 0.0 1.2 1.1 1.0 3.6 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.7 19.5 4.1 0.0 0.0 0.0 0.0 0.0 2.0 1.3 0.0 62.5 0.0 0.0 2.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 8.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.9 1.5 1.2 1.5 1.2 1.1 1.0 1.2 1.1 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 8.2 0.0 0.0 1.9 1.2 0.1 1.8 0.0 2.6 0.0 0.0 10.6 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.8 0.0 0.1 0.0 0.0 4.9 0.0 0.1 PGM2 FLJ10983 ENSG00000169299 "Phosphoglucomutase 2" Q96G03 4 37826660-37862937 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 334.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040676 Uncertain Approved "Intermediate filaments" NA NA 1700000 "Intermediate filaments" "HPA040676: AB_2677076" "unprognostic (3.11e-2)" "unprognostic (1.01e-2)" "prognostic favorable (2.14e-5)" "unprognostic (2.29e-1)" "unprognostic (3.94e-1)" "unprognostic (5.44e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-3)" "unprognostic (5.32e-2)" "unprognostic (7.02e-2)" "unprognostic (5.37e-2)" "unprognostic (2.22e-2)" "unprognostic (6.72e-3)" "unprognostic (3.21e-2)" "unprognostic (1.88e-1)" "unprognostic (9.97e-2)" "unprognostic (1.02e-1)" 7.6 11.4 3.3 9.6 3.5 10.2 8.9 4.7 4.6 8.0 4.7 9.9 7.7 10.2 4.9 36.9 7.9 11.4 5.2 4.5 4.0 8.0 14.9 7.0 10.1 3.6 3.2 3.1 7.0 4.4 8.5 3.0 11.8 3.7 7.9 9.1 18.4 7.8 5.2 1.2 17.6 7.9 13.8 3.6 8.4 6.1 5.3 3.8 10.3 9.8 1.9 22.9 19.1 16.6 3.9 27.4 9.5 14.6 16.6 10.2 12.4 19.8 32.6 18.9 27.8 26.4 18.0 19.2 38.0 15.5 17.8 34.9 13.8 36.0 32.0 65.1 23.0 21.0 40.1 15.2 12.3 23.2 44.2 26.5 17.0 36.0 22.0 18.6 16.2 41.6 31.2 53.6 6.2 24.3 15.6 49.8 49.6 17.3 19.2 15.5 35.8 23.1 14.8 15.7 52.3 31.8 10.8 17.5 23.3 12.0 19.5 21.5 45.4 37.0 19.7 24.9 27.3 67.1 14.0 38.4 40.3 10.9 56.2 32.9 19.8 27.5 67.2 9.8 22.4 11.5 9.4 8.0 11.1 31.9 5.5 7.7 9.8 33.6 28.1 18.2 7.1 14.9 17.0 3.3 3.5 4.7 4.6 4.5 4.0 3.6 3.2 3.1 3.7 3.6 3.8 3.9 16.9 0.0 8.2 5.2 13.8 14.7 14.3 32.9 17.6 7.8 12.6 6.9 4.5 14.3 23.1 3.7 0.0 31.9 11.9 10.6 5.9 16.0 0.9 9.0 12.7 22.9 7.2 8.0 8.3 11.8 37.8 10.3 5.6 14.7 12.7 56.4 42.5 9.7 37.9 6.7 5.6 9.2 4.1 24.4 15.2 2.0 8.4 24.5 5.4 4.7 46.1 334.1 13.4 8.0 0.9 14.5 6.7 9.8 10.5 17.7 6.9 10.4 9.8 16.0 13.1 5.8 23.8 0.6 2.1 42.5 32.1 79.8 14.7 19.8 12.9 20.4 STK32A "MGC22688, YANK1" ENSG00000169302 "Serine/threonine kinase 32A" Q8WU08 5 147234963-147387855 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.1" "Cell type enriched" "Detected in many" 19 "Oligodendrocyte precursor cells: 306.6" "Group enriched" "Detected in many" 5 "glioma: 4.3;melanoma: 11.9;thyroid cancer: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RT4: 13.6;SK-MEL-30: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040236 Approved Centrosome NA NA Centrosome "HPA040236: AB_10795416" "unprognostic (1.90e-1)" "unprognostic (4.71e-4)" "unprognostic (5.32e-2)" "unprognostic (3.49e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (2.96e-3)" "unprognostic (4.85e-2)" "unprognostic (2.36e-2)" "unprognostic (3.87e-1)" "unprognostic (8.38e-2)" "unprognostic (2.50e-3)" "unprognostic (5.53e-5)" "unprognostic (2.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.67e-3)" 1.1 11.3 6.0 0.6 8.3 0.0 1.3 13.0 3.7 1.0 0.9 1.7 0.5 0.5 2.6 0.3 0.8 1.5 0.8 3.4 37.1 3.4 0.1 1.2 0.0 11.7 17.2 2.2 2.6 2.7 0.1 8.1 0.1 14.6 1.0 0.3 2.6 0.9 0.8 0.2 3.4 0.7 0.4 10.3 0.3 1.2 1.0 13.1 0.1 8.8 0.5 0.0 1.7 1.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.2 4.4 13.6 1.2 0.5 0.0 0.0 48.6 0.2 0.0 0.0 0.1 0.0 0.5 0.7 0.4 1.0 0.2 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 8.3 13.0 3.7 3.4 37.1 11.7 17.2 2.2 14.6 10.3 13.1 17.5 0.2 0.0 2.6 8.5 0.0 1.5 0.2 1.4 0.0 1.8 1.3 0.5 0.5 0.0 1.0 1.8 0.0 0.0 0.0 0.1 1.9 1.8 6.9 0.2 0.5 0.1 0.0 0.0 4.6 2.7 0.0 2.7 0.0 0.7 0.0 4.2 0.0 0.0 0.1 0.0 5.2 0.0 2.0 0.0 1.0 10.5 0.9 0.2 16.0 0.0 0.0 4.0 0.0 306.6 0.7 5.5 0.0 4.1 0.0 0.3 0.0 4.1 0.2 1.0 0.0 5.4 0.5 0.0 0.1 0.0 0.3 0.1 0.1 1.4 0.0 0.6 IL1RAPL1 "IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2" ENSG00000169306 "Interleukin 1 receptor accessory protein like 1" Q9NZN1 X 28587446-29956718 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Receptor" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "brain: 33.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1315.7;Inhibitory neurons: 2598.6;Oligodendrocyte precursor cells: 1954.3;Oligodendrocytes: 6420.8" "Not detected" "Not detected" "Region enhanced" "Detected in all" "white matter: 33.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 8.7;WM-115: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.51e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (3.75e-3)" "unprognostic (1.17e-1)" "unprognostic (3.98e-1)" "unprognostic (2.25e-2)" "unprognostic (4.45e-2)" "unprognostic (1.29e-1)" "unprognostic (5.85e-2)" "unprognostic (3.95e-2)" "unprognostic (8.02e-2)" "unprognostic (1.08e-2)" "unprognostic (5.74e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (3.58e-3)" 0.1 0.0 2.8 0.0 10.6 0.0 0.1 1.4 9.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.4 2.9 4.8 0.0 0.2 0.0 0.0 7.5 4.8 2.9 0.3 0.1 0.0 0.0 0.1 10.2 0.2 0.1 0.2 0.0 0.2 0.4 0.0 0.2 0.0 2.9 0.0 0.1 0.1 5.4 0.0 0.1 0.1 0.0 0.4 0.0 33.6 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 10.6 1.4 9.5 2.9 4.8 7.5 4.8 2.9 10.2 2.9 5.4 33.6 0.5 0.0 0.5 64.6 0.0 0.1 0.2 0.0 0.6 2.4 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1315.7 0.0 0.0 1.6 0.0 0.0 26.1 0.1 0.0 0.0 0.1 0.0 2598.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 1.8 42.2 0.0 0.3 0.0 1954.3 6420.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.7 1.5 0.0 0.1 0.1 1.1 0.4 0.1 0.0 P2RY12 "HORK3, P2Y12, SP1999" ENSG00000169313 "Purinergic receptor P2Y12" Q9H244 3 151336843-151384753 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;lymphoid tissue: 9.9" "Cell type enriched" "Detected in some" 27 "Microglial cells: 421.6" "Cancer enriched" "Detected in many" 14 "glioma: 17.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 8.3" "Group enriched" "Detected in many" 11 "dendritic cells: 3.2;monocytes: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013796, HPA014518" Enhanced NA NA "HPA013796: AB_1854884, HPA014518: AB_2669027" "unprognostic (2.39e-2)" "unprognostic (1.60e-3)" "unprognostic (5.93e-2)" "unprognostic (1.77e-1)" "unprognostic (2.41e-2)" "unprognostic (2.52e-2)" "unprognostic (8.09e-2)" "unprognostic (1.72e-3)" "unprognostic (6.46e-2)" "unprognostic (8.64e-4)" "unprognostic (4.84e-2)" "unprognostic (5.96e-2)" "unprognostic (2.03e-1)" "unprognostic (8.92e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-2)" "unprognostic (4.04e-1)" 8.6 4.1 4.6 2.0 6.4 0.5 3.8 5.3 6.2 1.3 2.6 1.6 1.2 0.7 0.6 1.2 2.6 2.2 1.3 5.5 7.8 0.6 2.5 2.5 9.9 8.4 7.2 3.8 1.6 0.9 1.6 0.3 2.3 11.5 0.9 1.4 0.3 2.9 2.1 0.1 0.4 2.8 1.6 12.0 5.5 1.1 0.2 8.0 1.0 0.5 0.6 8.7 1.2 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.3 0.0 0.3 0.0 0.0 3.2 0.5 0.0 0.0 0.3 0.0 2.2 0.3 0.0 1.3 4.6 6.4 5.3 6.2 5.5 7.8 8.4 7.2 3.8 11.5 12.0 8.0 14.1 0.2 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 2.6 0.0 0.0 0.0 3.1 0.0 421.6 0.7 0.4 0.0 15.6 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 C22orf15 "FLJ36561, N27C7-3" ENSG00000169314 "Chromosome 22 open reading frame 15" Q8WYQ4 22 23762990-23765863 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 18.4" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 198.2" "Cancer enriched" "Detected in single" 4 "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 1.2;BJ: 1.2;BJ hTERT+: 2.3;hTERT-RPE1: 3.2;MOLT-4: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted in female reproductive system" NA NA "unprognostic (2.37e-2)" "unprognostic (3.28e-3)" "unprognostic (1.28e-1)" "prognostic favorable (8.53e-5)" "unprognostic (1.86e-2)" "unprognostic (2.07e-2)" "unprognostic (4.38e-2)" "unprognostic (6.14e-2)" "unprognostic (3.60e-2)" "unprognostic (7.70e-2)" "unprognostic (4.58e-2)" "unprognostic (2.60e-1)" "unprognostic (9.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.28e-2)" "unprognostic (3.08e-3)" 0.0 0.0 0.8 0.0 0.2 0.3 0.1 0.4 0.2 0.4 0.4 0.1 0.0 0.2 0.0 0.0 18.4 0.2 0.0 0.2 1.1 0.1 0.0 1.8 0.1 1.0 1.1 0.1 0.5 0.0 0.0 1.1 0.2 1.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 1.1 0.2 0.1 2.8 0.5 1.1 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 1.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.8 0.2 0.4 0.2 0.2 1.1 1.0 1.1 0.1 1.0 1.1 0.5 0.3 0.0 0.0 1.8 1.3 0.0 0.1 0.0 9.1 0.0 0.5 0.0 0.5 0.1 0.0 15.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.0 35.8 0.2 0.2 0.0 0.4 2.3 0.0 0.0 1.4 0.0 0.3 2.5 0.1 0.7 0.1 0.0 0.0 2.0 0.0 16.2 0.3 0.4 3.5 0.0 0.3 0.0 1.0 0.1 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 198.2 1.9 0.0 0.1 3.5 10.9 4.2 0.0 0.3 0.0 1.0 0.5 0.0 0.1 OR5AU1 ENSG00000169327 "Olfactory receptor family 5 subfamily AU member 1" Q8NGC0 14 21148370-21159060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.5;Glandular and luminal cells: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.4 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 MINAR1 "KIAA1024, UBTOR" ENSG00000169330 "Membrane integral NOTCH2 associated receptor 1" Q9UPX6 15 79432336-79472304 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.3;brain: 4.5;retina: 6.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "melanoma: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 10.3 1.1 0.1 0.8 0.4 0.3 4.5 1.1 0.3 0.2 0.1 0.0 0.2 0.3 0.2 0.1 0.3 0.1 0.6 1.7 0.1 0.0 0.1 0.4 2.7 3.7 0.6 0.1 2.1 0.0 0.7 0.2 3.4 0.7 0.2 6.8 2.8 0.1 0.1 0.1 0.2 0.1 1.2 0.3 0.3 0.2 2.1 0.2 0.2 0.0 0.2 0.1 0.2 2.8 0.3 0.2 0.4 0.5 1.1 0.9 0.4 0.5 0.8 0.4 0.4 0.0 0.3 0.7 0.1 0.8 0.5 0.2 0.9 0.1 0.3 0.8 1.0 1.9 0.5 0.0 0.6 2.7 0.9 0.4 0.2 0.7 0.1 0.8 0.4 0.8 0.1 0.0 0.1 0.0 0.3 1.0 0.4 0.4 0.4 0.4 0.1 0.4 0.1 0.0 1.8 1.0 0.2 1.6 1.0 0.7 0.2 1.3 0.3 8.7 0.3 0.0 1.9 1.1 1.4 0.3 0.9 1.5 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.8 4.5 1.1 0.6 1.7 2.7 3.7 0.6 3.4 1.2 2.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDILT PDIA7 ENSG00000169340 "Protein disulfide isomerase like, testis expressed" Q8N807 16 20359175-20404737 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Chaperone, Developmental protein, Isomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "stomach 1: 123.7" "Cell type enriched" "Detected in some" 5 "Early spermatids: 136.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 1.0;HBEC3-KT: 3.0;hTCEpi: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041913 Approved "Intracellular and membrane" NA NA "HPA041913: AB_10795644" "unprognostic (1.99e-1)" "unprognostic (6.09e-2)" "unprognostic (2.05e-3)" "unprognostic (2.63e-1)" 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.1 123.7 18.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 3.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.2 3.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.2 0.0 0.3 0.1 0.2 0.5 0.7 0.1 2.8 0.0 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 23.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UMOD ENSG00000169344 Uromodulin P07911 16 20333051-20356301 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 694 "kidney: 2298.9" "Group enriched" "Detected in some" 146 "Collecting duct cells: 248.3;Distal tubular cells: 950.9" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" NA NA 55000000 66000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2298.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 248.3 0.0 0.0 0.0 0.0 950.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309574-20327808 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 966 "pancreas: 35681.9" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 504.1" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015739, HPA016668" Enhanced "Secreted to digestive system" NA NA 41000 "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 6.7 1.9 0.2 0.9 0.2 0.7 3.8 0.5 0.4 1.6 0.3 3.9 36.9 2.2 0.2 3.9 1.4 18.8 6.6 0.3 0.2 10.5 5.0 1.6 2.1 0.2 0.2 0.2 15.5 35681.9 0.0 2.9 2.4 0.3 33.7 6.2 0.1 7.6 0.0 1.6 1.6 10.2 0.1 0.1 2.5 27.6 1.9 0.2 0.1 1.3 0.0 0.2 1.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.5 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.2 1.1 0.1 0.1 87.2 0.0 0.0 0.0 0.0 0.0 1.7 9.8 1.3 7.5 0.3 0.5 0.2 0.0 0.0 0.0 504.1 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 0.3 15.6 0.3 0.4 0.0 0.0 4.2 0.2 0.0 0.0 0.0 20.7 13.9 0.4 0.0 69.7 2.0 0.0 0.0 0.3 0.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 19.9 2.1 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042430 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA042430: AB_10806238" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 8.4 11.1 3.9 4.9 4.6 2.9 8.5 4.4 4.7 12.5 8.3 7.0 6.9 8.9 13.1 8.1 9.5 7.8 7.5 4.5 7.4 10.5 17.4 8.5 5.0 5.0 3.9 3.0 8.0 31.2 11.7 6.0 6.6 4.2 8.4 6.4 6.9 11.3 11.1 4.7 6.4 7.8 7.2 4.8 5.8 8.9 5.5 5.0 7.1 19.0 4.9 6.3 6.8 7.9 6.5 18.9 17.7 7.3 8.3 24.4 23.5 12.9 13.1 21.2 19.8 18.7 8.5 22.0 9.9 24.1 13.1 19.8 17.1 14.3 15.2 20.8 16.5 13.3 11.3 6.5 15.8 41.5 13.3 8.9 18.4 26.7 9.7 49.5 20.5 19.8 12.4 8.6 27.8 14.3 14.3 5.0 3.7 6.8 17.7 14.9 5.6 8.1 29.1 9.7 11.8 7.9 5.9 11.1 24.5 21.4 11.3 8.1 11.2 21.4 10.1 4.9 17.9 13.1 33.2 14.4 12.3 14.6 8.8 14.0 12.7 8.4 6.2 8.9 6.3 9.6 5.4 6.0 6.8 10.4 3.5 5.4 5.5 1.7 6.6 6.5 16.1 5.7 5.9 3.9 4.6 4.4 4.7 4.5 7.4 5.0 3.9 3.0 4.2 4.8 5.0 6.5 9.0 22.4 25.0 16.0 14.8 8.9 11.7 20.8 18.2 17.5 16.0 9.0 23.8 18.6 21.5 11.0 27.1 18.2 21.1 14.2 5.9 15.3 13.7 11.2 20.3 13.7 12.5 8.4 17.9 15.4 28.3 19.7 20.9 16.6 12.0 12.8 16.4 64.3 19.5 18.5 17.4 18.1 12.2 14.7 15.8 13.2 18.6 15.2 12.4 10.3 19.0 15.4 12.3 11.1 20.8 14.4 5.3 21.4 33.3 19.5 18.9 17.1 23.4 23.0 13.1 16.0 16.0 19.5 9.2 12.2 9.5 37.6 15.3 10.2 13.9 10.9 SNUPN "RNUT1, SNURPORTIN-1, Snurportin1" ENSG00000169371 "Snurportin 1" O95149 15 75598083-75626469 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 137.1;Spermatocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005004 Approved NA NA "CAB005004: AB_425829" "unprognostic (2.37e-2)" "unprognostic (1.54e-1)" "unprognostic (2.36e-2)" "unprognostic (8.73e-2)" "unprognostic (2.25e-1)" "unprognostic (1.18e-1)" "unprognostic (4.76e-2)" "unprognostic (6.74e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.99e-3)" "unprognostic (9.07e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-1)" "unprognostic (2.14e-2)" 18.4 16.1 20.8 15.7 21.9 13.9 23.8 20.9 26.5 20.6 21.3 17.0 15.0 19.1 20.4 14.4 23.9 13.6 16.6 22.4 21.6 20.3 22.3 15.1 20.3 19.8 20.6 21.1 26.5 12.8 21.2 12.2 15.3 20.3 16.6 17.6 13.3 20.0 17.7 35.0 16.8 15.5 24.7 19.3 17.4 15.9 34.6 20.3 22.3 21.1 30.8 21.2 18.2 15.7 21.5 26.1 34.1 30.4 21.6 42.1 46.8 23.2 26.1 38.5 44.2 47.8 25.4 62.6 47.4 35.7 34.0 36.6 29.9 60.3 38.3 34.5 27.3 56.1 56.4 29.3 16.4 40.6 39.4 37.3 44.6 37.3 32.8 41.0 40.1 42.4 36.8 36.8 30.9 45.4 9.0 38.5 38.7 40.6 42.7 19.5 48.7 23.7 46.7 39.7 13.6 28.5 19.9 11.4 38.7 68.9 37.5 33.0 73.8 27.9 35.3 32.8 19.4 23.3 21.9 43.7 69.8 38.7 59.6 47.0 10.3 39.5 12.2 47.4 37.7 57.3 34.7 48.9 45.8 47.7 41.1 63.2 53.0 6.7 36.9 40.1 47.0 42.1 41.0 20.8 21.9 20.9 26.5 22.4 21.6 19.8 20.6 21.1 20.3 19.3 20.3 21.5 19.1 12.8 14.5 7.8 13.1 13.3 10.4 30.5 18.2 19.0 18.7 21.5 11.7 14.3 16.8 9.2 12.5 28.7 19.2 10.3 54.8 23.1 137.1 14.9 23.6 14.4 16.2 14.1 9.0 19.3 38.5 25.2 10.7 12.8 12.7 20.4 17.2 18.5 24.7 13.5 8.2 12.4 14.2 17.7 17.3 60.3 31.4 19.1 19.6 7.5 24.2 18.3 25.7 3.0 7.6 14.7 10.5 29.3 9.9 11.5 17.6 34.1 15.1 20.4 19.7 16.6 14.5 93.2 14.6 15.0 10.9 11.9 16.2 27.3 18.1 5.7 CRADD RAIDD ENSG00000169372 "CASP2 and RIPK1 domain containing adaptor with death domain" P78560 12 93677375-93894840 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 161.3;Early spermatids: 164.5;Inhibitory neurons: 122.3;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 287.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005337 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005337: AB_2085481" "unprognostic (1.07e-2)" "prognostic favorable (9.06e-5)" "unprognostic (9.65e-3)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (3.10e-1)" "unprognostic (3.79e-2)" "unprognostic (8.99e-2)" "unprognostic (1.54e-1)" "unprognostic (7.89e-2)" "unprognostic (6.06e-2)" "unprognostic (3.18e-2)" "prognostic favorable (4.04e-9)" "unprognostic (2.57e-2)" "unprognostic (6.86e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" 9.8 19.5 8.6 5.1 9.6 9.4 11.3 9.2 8.3 12.3 11.5 13.0 17.1 13.1 12.7 13.1 10.0 10.5 41.6 8.0 8.9 17.8 37.6 9.9 7.4 9.1 9.7 7.1 10.4 12.8 18.7 15.4 7.3 9.5 11.5 8.3 12.9 11.1 9.0 28.5 11.3 18.2 8.2 8.0 10.5 13.0 13.8 9.4 13.5 9.7 30.3 6.3 12.8 11.4 9.3 7.8 17.4 8.4 9.6 11.8 21.2 10.6 8.8 10.7 7.6 8.9 16.4 3.2 13.9 5.3 10.2 5.8 8.0 9.3 11.5 9.3 14.7 12.3 7.4 7.0 12.2 12.2 6.8 6.8 19.8 17.4 12.2 9.5 8.0 9.3 15.2 21.3 6.4 9.1 12.6 10.1 12.3 10.6 8.9 13.2 16.8 4.3 19.3 7.4 5.7 12.9 12.5 12.0 11.7 21.3 8.1 20.5 13.2 10.0 17.5 8.7 8.4 9.0 15.0 8.7 12.9 8.2 10.0 8.4 62.7 11.6 45.5 23.8 14.7 21.1 15.1 16.5 24.8 9.7 13.5 17.6 13.0 33.9 20.6 23.2 13.1 20.9 12.0 8.6 9.6 9.2 8.3 8.0 8.9 9.1 9.7 7.1 9.5 8.0 9.4 9.3 7.8 9.6 6.3 161.3 7.8 7.4 9.3 21.1 6.2 6.4 8.9 7.2 38.7 7.2 18.0 7.3 8.4 14.5 9.0 19.1 23.5 16.8 164.5 11.8 8.7 11.9 7.8 9.1 62.8 22.4 12.7 10.3 10.2 6.7 4.5 3.7 10.0 41.9 11.5 23.5 122.3 14.6 26.4 10.6 6.1 35.2 17.7 16.0 3.6 96.5 9.5 16.9 15.5 174.4 287.2 19.5 19.8 23.7 8.4 10.1 58.5 63.1 20.0 15.5 6.6 15.0 11.4 25.6 11.7 10.1 8.1 10.8 10.2 8.3 13.9 10.1 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 17.1 12.5 10.7 20.0 10.7 42.9 18.2 20.4 11.8 20.5 11.5 17.8 13.9 25.9 16.8 19.3 24.5 17.6 14.9 9.7 12.3 15.2 16.1 18.2 26.1 12.1 10.7 9.3 30.3 15.4 22.7 12.2 20.3 10.9 19.9 16.3 24.4 16.8 20.9 16.8 21.0 16.4 19.8 8.4 22.3 16.7 29.9 12.3 43.6 27.5 18.9 26.5 20.4 16.8 10.8 31.2 63.6 55.5 36.7 27.0 28.4 32.1 22.9 35.3 33.0 35.2 35.2 41.2 67.8 23.3 34.0 45.0 54.5 81.2 34.4 35.9 55.0 42.1 64.0 46.2 27.9 20.5 61.4 52.5 34.7 26.1 38.5 39.8 34.0 30.0 47.5 51.5 73.2 27.0 36.2 60.7 39.1 54.2 41.3 26.3 60.5 73.3 41.8 23.6 56.4 43.7 43.7 56.6 25.0 31.0 53.0 38.1 47.9 26.4 40.6 54.5 27.2 34.3 49.8 85.0 70.8 24.2 61.2 23.2 2.9 4.2 5.9 6.3 3.8 9.6 7.0 8.1 8.1 5.2 7.7 8.2 7.2 7.3 8.1 7.4 3.5 7.7 5.7 10.7 10.7 20.4 11.8 9.7 12.3 12.1 10.7 9.3 10.9 8.4 12.3 10.8 26.0 35.3 32.4 13.7 35.8 39.4 23.6 21.2 60.9 19.7 36.5 25.4 13.4 17.2 30.5 27.6 31.3 23.5 29.0 17.8 5.9 15.1 10.1 35.7 30.8 32.1 17.3 24.4 19.2 12.8 11.1 24.4 15.3 42.1 29.9 30.1 26.0 17.4 13.2 20.2 18.3 19.0 10.2 21.3 31.7 5.8 23.0 19.5 10.6 27.2 18.8 16.8 24.7 16.6 24.1 14.1 14.0 20.3 33.1 29.8 13.7 9.2 33.4 33.8 13.1 34.7 24.7 42.1 42.7 37.5 53.1 21.9 34.6 21.2 19.2 19.4 ARL13B "ARL2L1, DKFZp761H079, JBTS8" ENSG00000169379 "ADP ribosylation factor like GTPase 13B" Q3SXY8 3 93980139-94055678 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Rod photoreceptor cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048926 Approved Uncertain Microtubules,Cytosol NA NA Microtubules Cytosol "HPA048926: AB_2680559" "unprognostic (2.29e-2)" "unprognostic (2.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.94e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.42e-3)" "unprognostic (8.86e-2)" "unprognostic (2.73e-1)" "unprognostic (5.41e-2)" "unprognostic (7.50e-2)" 3.4 2.5 2.0 3.0 1.7 0.8 2.3 1.5 2.5 4.2 7.6 1.6 0.8 4.7 1.0 3.3 4.1 4.0 2.0 1.3 4.0 3.6 2.6 4.1 2.1 1.7 1.7 0.8 3.2 1.6 3.7 2.0 2.7 1.6 2.0 1.4 18.4 1.5 2.6 0.7 1.4 2.0 4.2 1.9 2.9 1.6 3.6 1.2 2.5 4.4 1.7 1.8 3.2 1.7 2.2 8.3 12.5 7.9 4.3 13.3 3.5 3.6 7.8 4.8 11.8 15.9 8.0 4.4 5.9 11.3 6.9 7.1 5.1 7.2 5.3 16.2 10.5 6.4 12.7 5.6 5.4 6.0 15.2 6.9 5.2 2.1 12.3 19.0 4.5 4.0 8.7 12.5 7.3 6.7 3.1 12.3 1.2 2.9 4.3 7.5 7.2 25.8 2.0 5.7 1.2 18.0 4.6 15.9 0.9 9.4 2.9 2.1 3.5 7.7 11.6 11.0 6.8 9.6 1.8 2.0 11.7 8.5 8.8 8.5 6.4 3.4 2.9 3.7 4.2 3.8 3.9 3.3 3.0 3.0 3.4 3.3 3.1 2.0 4.3 4.8 4.8 2.9 1.8 2.0 1.7 1.5 2.5 1.3 4.0 1.7 1.7 0.8 1.6 1.9 1.2 2.2 27.2 93.0 39.6 31.6 11.3 46.8 28.1 8.6 10.2 19.0 11.0 16.8 8.1 12.8 19.7 1.8 41.7 1.9 7.1 1.3 15.6 17.1 14.8 30.1 25.2 31.7 22.1 6.5 58.4 11.8 6.3 48.5 10.2 11.2 45.6 9.2 17.5 7.7 12.1 15.2 41.5 3.1 12.2 7.0 21.6 6.4 23.9 10.7 16.0 38.4 6.0 26.9 6.2 29.7 49.8 11.4 3.8 25.6 8.0 13.9 1.8 18.7 71.9 102.0 6.6 59.4 33.8 43.1 14.5 12.7 58.7 0.8 13.2 16.5 3.1 10.6 RNASE2 "EDN, RAF3, RNS2" ENSG00000169385 "Ribonuclease A family member 2" P10153 14 20955487-20956436 "Enzymes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "bone marrow: 1728.2" "Cell type enhanced" "Detected in some" "Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6" "Cancer enriched" "Detected in many" 7 "glioma: 14.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 457.5;eosinophil: 1352.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 1352.6" "Group enriched" "Detected in some" 303 "HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9" HPA044983 Enhanced "Secreted to blood" NA NA 200000000 "HPA044983: AB_10963689" "unprognostic (6.66e-2)" "unprognostic (3.00e-1)" "unprognostic (6.85e-2)" "unprognostic (7.68e-2)" "unprognostic (2.73e-2)" "unprognostic (9.26e-2)" "unprognostic (4.94e-3)" "unprognostic (6.77e-2)" "unprognostic (9.54e-2)" "unprognostic (3.24e-2)" "unprognostic (3.25e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.28e-13)" "unprognostic (2.27e-2)" "unprognostic (7.14e-3)" "unprognostic (5.33e-2)" "unprognostic (1.50e-1)" 5.0 6.1 3.0 9.1 3.8 1728.2 1.7 3.1 5.5 1.6 4.4 2.0 0.3 2.2 0.3 0.9 5.7 2.7 3.1 2.9 5.5 1.7 4.7 12.3 2.0 5.5 4.0 2.5 1.5 1.7 0.5 1.7 1.8 4.5 1.7 0.7 1.7 1.9 0.3 0.7 2.9 1.4 9.8 3.9 35.4 2.1 0.7 5.5 14.9 1.0 0.6 0.6 5.2 1.4 6.7 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.1 0.0 539.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 539.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 1405.4 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.7 0.0 1295.9 0.0 457.5 109.0 1352.6 0.4 19.3 0.8 0.3 0.4 0.0 191.8 0.4 0.4 0.4 9.8 0.1 2.8 2.6 0.1 39.9 3.0 3.8 3.1 5.5 2.9 5.5 5.5 4.0 2.5 4.5 3.9 5.5 6.7 0.2 3.2 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.4 0.0 1.9 0.0 0.5 0.0 0.0 1.3 0.0 30.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.4 2.2 13.0 0.0 0.0 0.0 0.0 174.3 0.7 1.7 0.3 82.2 0.0 0.0 54.6 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 19.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 ELSPBP1 "E12, EDDM12, HE12" ENSG00000169393 "Epididymal sperm binding protein 1" Q96BH3 19 47994632-48025154 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "epididymis: 2853.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 22.0;Cone photoreceptor cells: 16.7;Early spermatids: 32.0;Horizontal cells: 18.5;Late spermatids: 28.8;Muller glia cells: 20.4;Rod photoreceptor cells: 120.5" "Cancer enhanced" "Detected in single" "melanoma: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 10.1;NB-4: 5.5" "Not detected" "Not detected" "HPA044256, HPA050341" Enhanced "Secreted in male reproductive system" NA NA "HPA044256: AB_2678879, HPA050341: AB_2681097" "unprognostic (1.51e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2853.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 18.5 0.1 0.0 0.0 0.0 0.0 28.8 0.6 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 120.5 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE3 "ECP, RAF1, RNS3" ENSG00000169397 "Ribonuclease A family member 3" P12724 14 20891399-20892348 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "bone marrow: 942.7" "Cell type enhanced" "Detected in some" "Early spermatids: 22.9;Erythroid cells: 5.9;Kupffer cells: 4.5;Late spermatids: 10.9;Macrophages: 3.0;Rod photoreceptor cells: 3.5" "Cancer enriched" "Detected in single" 8 "glioma: 2.0" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 22 "eosinophil: 304.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 304.6" "Cell line enhanced" "Detected in some" "HL-60: 150.4;NB-4: 51.1;THP-1: 63.6;U-937: 301.8" HPA056183 Enhanced "Secreted to blood" NA NA 4200000 "HPA056183: AB_2683059" "unprognostic (2.54e-2)" "unprognostic (6.61e-2)" "unprognostic (1.84e-1)" "unprognostic (2.50e-1)" "unprognostic (1.37e-2)" "unprognostic (8.21e-2)" "unprognostic (6.45e-2)" "unprognostic (9.20e-3)" "unprognostic (1.20e-1)" "unprognostic (9.21e-2)" "unprognostic (8.62e-7)" "unprognostic (6.29e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (2.37e-1)" 0.3 0.4 0.5 0.5 0.7 942.7 0.2 0.6 1.2 0.1 0.4 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.2 0.6 0.8 0.1 2.0 2.7 0.7 1.0 0.8 0.4 0.2 0.1 0.0 0.4 0.6 0.9 0.2 0.1 3.8 1.2 0.1 0.1 1.7 0.1 1.0 0.7 9.9 0.1 1.8 1.0 9.5 0.1 0.0 0.0 0.3 0.1 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 150.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 301.8 0.0 11.3 8.8 304.6 0.0 1.2 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 4.3 0.0 0.5 1.6 0.0 4.4 0.5 0.7 0.6 1.2 0.6 0.8 1.0 0.8 0.4 0.9 0.7 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 10.9 0.3 3.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PTK2 "FADK, FAK, FAK1, PPP1R71" ENSG00000169398 "Protein tyrosine kinase 2" Q05397 8 140657900-141002216 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 295.2;Excitatory neurons: 584.9;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 791.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001842, CAB004036, HPA029671" Approved Supported "Vesicles,Focal adhesion sites,Cytosol" NA Yes 25000 "Focal adhesion sites" "Vesicles, Cytosol" "CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288" "prognostic unfavorable (3.21e-4)" "unprognostic (3.86e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" "unprognostic (3.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.96e-2)" "unprognostic (1.06e-2)" "unprognostic (2.38e-1)" "unprognostic (2.80e-2)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" 46.5 40.7 89.4 19.7 118.9 6.7 42.5 70.9 99.0 40.6 65.0 35.2 26.0 37.6 50.2 25.8 34.3 32.4 37.2 92.1 86.0 38.0 30.4 39.8 25.5 87.4 96.3 94.1 34.0 32.4 53.5 21.5 74.8 97.7 34.3 35.6 35.8 40.2 42.0 39.1 29.2 29.8 37.9 80.5 23.0 33.1 39.2 86.7 12.0 39.0 39.7 26.0 44.3 34.3 164.5 52.6 81.9 111.0 40.3 45.8 48.8 71.6 50.8 70.0 46.3 45.3 35.9 42.1 31.7 111.7 65.3 65.0 60.3 66.1 116.0 69.6 0.3 30.8 70.1 44.3 50.0 62.5 0.1 31.8 33.4 55.8 58.0 81.0 121.5 139.0 44.0 72.0 0.8 62.9 91.0 0.9 0.7 43.2 113.2 90.3 46.8 60.9 1.5 97.7 117.3 43.9 54.8 79.0 25.0 52.0 97.2 59.2 1.2 84.9 45.2 85.5 54.0 58.1 0.0 0.6 3.4 58.7 0.6 62.9 1.6 3.3 0.0 0.2 1.4 0.0 5.3 0.6 0.0 4.5 6.3 4.4 1.6 1.3 4.7 0.8 6.1 0.2 3.9 89.4 118.9 70.9 99.0 92.1 86.0 87.4 96.3 94.1 97.7 80.5 86.7 164.5 71.3 32.1 33.1 295.2 20.6 33.3 70.1 36.3 64.9 55.2 29.3 23.5 29.6 32.9 32.1 55.2 60.5 37.0 8.0 23.1 23.5 27.2 68.4 29.3 43.3 54.3 25.8 8.4 584.9 23.3 53.7 37.2 37.8 46.5 9.5 84.7 37.5 15.7 8.1 67.3 263.6 23.0 30.5 15.2 15.9 38.8 23.9 19.4 24.9 159.3 3.9 40.9 0.0 353.9 791.4 43.1 23.5 21.8 1.7 82.4 29.3 25.6 33.7 55.0 98.6 32.7 128.4 88.9 65.5 42.8 25.9 33.2 3.4 67.0 24.1 87.3 RSPH10B2 ENSG00000169402 "Radial spoke head 10 homolog B2" B2RC85 7 6754109-6799365 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.2;testis: 19.6" "Group enriched" "Detected in some" 8 "Early spermatids: 32.1;Late spermatids: 64.3;Respiratory ciliated cells: 47.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049182 Supported NA NA "HPA049182: AB_2680666" "unprognostic (7.74e-2)" "unprognostic (1.60e-1)" "unprognostic (2.28e-2)" "unprognostic (5.35e-3)" "unprognostic (3.41e-1)" "unprognostic (3.05e-3)" "unprognostic (2.58e-2)" "unprognostic (4.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-5)" "unprognostic (1.66e-1)" "unprognostic (4.38e-2)" "unprognostic (8.27e-3)" "unprognostic (7.02e-2)" 0.0 0.1 2.1 0.0 1.0 0.3 0.0 0.9 0.5 0.2 3.9 0.0 0.0 0.2 0.4 0.0 10.2 0.0 0.0 0.8 2.4 0.1 0.1 1.4 0.1 2.0 2.3 0.2 0.1 0.0 1.2 0.6 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.3 0.1 19.6 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 0.9 0.5 0.8 2.4 2.0 2.3 0.2 1.7 1.9 1.1 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 5.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 64.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.5;lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" "granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1" "Group enriched" "Detected in many" 5 "granulocytes: 906.5;monocytes: 256.7" "Group enriched" "Detected in some" 4 "HBEC3-KT: 36.6;HMC-1: 131.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 10.5 2.5 4.1 31.0 4.9 41.5 3.4 4.9 5.6 3.4 4.6 5.6 4.1 1.7 1.2 7.3 2.6 7.3 2.0 3.8 8.3 2.7 4.2 18.0 13.6 7.2 6.0 2.9 1.3 2.0 1.6 0.6 7.4 7.5 1.5 6.7 0.5 2.3 1.5 0.7 5.5 6.4 7.9 9.4 14.6 3.8 1.3 6.7 3.7 2.0 2.6 18.2 14.5 1.9 8.8 20.1 0.2 0.1 0.4 0.2 0.0 0.5 0.0 0.0 0.7 0.2 0.2 5.7 1.3 0.1 0.1 0.3 13.5 0.5 36.6 0.8 0.4 0.6 7.7 0.2 0.9 0.1 1.9 131.3 0.0 6.0 0.4 0.4 0.0 0.2 0.1 0.5 0.4 0.0 1.3 0.2 19.3 0.6 0.5 0.2 0.3 0.1 0.1 8.7 2.1 0.3 0.1 0.1 18.1 0.2 0.4 0.4 5.4 0.1 0.2 0.7 0.0 0.2 1.2 1.1 5.6 0.1 2.4 0.6 61.7 256.7 906.5 0.6 77.9 1.2 12.5 0.4 0.4 116.1 6.7 0.5 0.7 747.1 0.7 34.1 1.3 1.2 112.4 4.1 4.9 4.9 5.6 3.8 8.3 7.2 6.0 2.9 7.5 9.4 6.7 8.8 2.1 6.4 6.7 0.0 4.1 6.5 2.0 37.9 5.2 1.5 0.8 0.5 2.2 1.5 20.9 1.8 2.1 0.6 2.9 0.4 0.0 18.1 0.4 0.5 0.2 7.3 0.0 4.0 0.9 5.1 0.5 1.3 1.1 0.5 75.4 2.0 2.9 1.0 71.7 0.0 0.7 0.0 18.3 93.0 67.8 0.2 0.6 64.5 0.0 15.0 52.8 0.2 0.0 1.5 6.6 89.8 0.6 0.0 0.5 0.6 0.3 0.2 20.2 0.9 0.0 0.6 1.0 2.3 0.7 3.2 2.8 1.5 2.0 0.0 0.4 9.4 PTPN9 MEG2 ENSG00000169410 "Protein tyrosine phosphatase non-receptor type 9" P43378 15 75463251-75579315 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 63.0;Excitatory neurons: 66.1;Inhibitory neurons: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041922 Approved Approved Vesicles NA NA Vesicles "HPA041922: AB_10795269" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (2.42e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (7.38e-2)" "unprognostic (5.95e-2)" "unprognostic (3.93e-1)" "unprognostic (3.14e-1)" "unprognostic (9.25e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.49e-6)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (2.71e-1)" "unprognostic (2.39e-1)" 15.0 12.1 14.6 13.1 16.1 10.9 15.3 11.8 18.9 16.7 11.9 18.2 18.1 16.6 13.4 9.9 16.4 12.2 10.9 16.6 16.9 18.4 14.8 16.0 14.7 18.5 13.7 15.4 14.1 10.3 18.1 9.8 20.0 13.8 16.7 19.8 9.0 13.1 21.4 6.5 10.8 20.2 18.1 13.0 13.6 13.6 7.2 15.5 16.2 33.1 13.2 15.1 18.3 13.9 14.5 20.3 24.1 36.7 24.6 26.8 29.3 12.0 29.8 46.2 36.9 33.4 14.5 30.0 32.6 23.3 51.1 29.5 30.0 79.9 34.3 37.0 40.5 19.8 18.4 16.2 15.7 40.2 28.2 27.1 38.4 35.2 29.6 45.9 37.7 31.4 21.3 12.4 11.5 42.1 13.5 20.0 26.3 33.6 18.2 12.1 38.9 18.2 9.1 46.6 32.5 14.4 29.9 42.4 23.3 46.3 34.9 12.1 47.8 36.5 35.2 11.3 23.3 32.2 16.9 18.9 30.0 20.5 41.9 35.3 3.2 2.2 2.3 3.4 3.0 2.8 1.7 2.4 3.0 3.0 1.3 1.0 1.8 0.3 3.9 2.9 2.0 1.6 1.7 14.6 16.1 11.8 18.9 16.6 16.9 18.5 13.7 15.4 13.8 13.0 15.5 14.5 12.7 6.4 13.4 63.0 9.2 3.3 8.2 6.6 5.7 12.1 8.0 7.1 3.7 10.0 8.1 11.0 8.4 20.0 7.3 25.0 15.6 10.8 3.0 7.9 19.4 10.0 7.2 13.7 66.1 9.9 4.2 20.6 10.7 11.4 15.2 23.6 17.5 12.6 18.8 3.3 63.2 11.5 6.1 18.9 18.1 4.7 12.5 16.5 7.2 46.9 24.2 5.6 19.6 48.7 19.6 18.2 12.6 27.4 9.7 12.1 24.9 14.0 8.1 17.1 13.1 11.7 20.8 10.6 9.4 6.6 3.3 10.1 13.4 11.6 13.2 13.1 RNASE6 "RAD1, RNaseK6, RNS6" ENSG00000169413 "Ribonuclease A family member k6" Q93091 14 20781268-20782467 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5" "Cell type enhanced" "Detected in many" "B-cells: 108.0;dendritic cells: 221.7;Hofbauer cells: 207.9;Kupffer cells: 551.2;Langerhans cells: 198.4;Macrophages: 270.3;monocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 1238.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 65.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA000698 Approved "Secreted to blood" NA NA 2600000 "HPA000698: AB_2181340" "unprognostic (5.04e-2)" "unprognostic (5.21e-3)" "unprognostic (3.59e-2)" "unprognostic (4.05e-2)" "unprognostic (1.74e-1)" "unprognostic (7.31e-2)" "unprognostic (7.91e-2)" "unprognostic (2.29e-1)" "unprognostic (4.45e-1)" "unprognostic (1.65e-1)" "unprognostic (2.04e-1)" "unprognostic (2.73e-1)" "unprognostic (2.85e-3)" "unprognostic (9.62e-2)" "unprognostic (5.60e-3)" "unprognostic (3.46e-2)" "unprognostic (5.54e-2)" 25.5 29.7 7.8 60.2 9.4 27.8 24.2 8.2 13.8 31.9 13.1 28.0 17.5 10.7 79.1 16.1 11.4 48.1 11.8 7.3 11.8 12.3 21.3 29.9 111.5 11.9 8.6 5.9 10.0 8.4 9.0 4.4 45.1 11.8 8.0 34.3 1.9 11.3 17.4 2.0 8.7 33.7 23.8 11.0 62.6 15.1 4.5 11.9 44.2 5.6 6.1 85.2 43.7 5.2 19.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 1.7 4.7 0.6 0.2 0.0 0.0 1.9 4.6 0.0 0.0 0.0 0.2 0.0 65.6 1.1 0.7 0.0 0.1 0.0 0.0 0.1 0.1 0.0 8.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 441.1 537.3 12.8 5.3 124.8 12.0 324.7 13.6 5.6 513.3 410.3 6.4 1.0 199.0 36.7 2.0 1238.8 1.1 329.8 7.8 9.4 8.2 13.8 7.3 11.8 11.9 8.6 5.9 11.8 11.0 11.9 19.0 1.6 6.4 7.5 0.0 108.0 4.5 0.2 0.0 1.8 0.0 1.4 2.8 0.6 14.3 1.2 0.0 0.0 1.1 221.7 2.6 0.0 0.0 0.8 0.1 0.0 3.8 0.0 12.0 0.0 0.0 1.6 1.4 1.1 0.2 0.0 0.0 8.6 3.3 207.9 0.0 0.0 0.5 2.0 551.2 198.4 4.8 2.8 270.3 21.4 1.9 115.8 0.0 9.2 0.0 0.0 0.0 12.6 0.7 52.4 0.2 0.4 0.5 0.2 0.4 13.1 0.6 0.6 0.1 0.7 0.6 3.8 2.2 7.8 0.0 3.4 1.2 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678688-153693992 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 67.7" "Group enriched" "Detected in many" 6 "Adipocytes: 99.6;Endothelial cells: 52.5;Hepatic stellate cells: 132.8" "Group enriched" "Detected in all" 4 "ovarian cancer: 39.2;renal cancer: 12.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 158.5" "Region enriched" "Detected in all" 5 "olfactory bulb: 18.7" "Low region specificity" "Detected in many" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 67.7 8.8 1.5 3.4 1.2 0.0 44.6 1.2 2.3 8.8 2.3 10.1 1.5 31.2 5.6 4.3 36.7 5.9 14.5 1.2 1.2 28.8 4.3 24.5 2.3 1.4 1.4 0.9 27.9 3.9 8.5 3.8 17.8 1.3 4.5 2.0 0.1 3.7 12.3 7.3 6.1 9.4 9.7 1.6 2.2 8.8 1.3 2.3 1.9 14.2 11.2 1.3 12.9 9.8 1.3 0.0 1.3 0.1 0.0 158.5 0.6 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 28.0 0.0 19.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 15.9 0.0 0.0 2.1 0.0 0.1 0.0 1.9 0.0 5.7 1.0 0.1 0.0 0.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 1.2 2.3 1.2 1.2 1.4 1.4 0.9 1.3 1.6 2.3 1.3 99.6 0.0 6.9 0.0 0.2 1.5 0.5 0.0 0.6 0.0 0.5 0.5 4.5 2.8 0.0 14.7 0.0 0.2 0.1 0.0 0.0 0.7 9.1 6.2 8.8 52.5 0.0 0.0 0.0 0.0 1.3 15.2 0.0 15.4 0.0 0.0 132.8 2.4 0.3 0.0 0.0 0.0 0.0 4.7 4.0 11.5 10.2 0.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.0 0.0 4.1 0.0 0.5 0.0 4.0 0.0 0.0 0.0 1.4 2.2 0.5 0.1 0.2 1.0 0.7 0.3 1.4 0.2 0.0 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139704109 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 7.0" "Group enriched" "Detected in some" 4 "Excitatory neurons: 16.0;Inhibitory neurons: 8.0;Late spermatids: 9.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 7.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075842 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.0 1.6 0.0 0.1 0.0 0.0 0.0 7.0 2.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.9 0.2 0.0 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.4 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 2.0 0.5 0.1 0.6 0.9 0.2 2.1 0.0 0.5 1.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.9 0.3 2.1 0.0 0.0 0.0 0.0 0.0 16.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740541-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3332.6" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebral cortex: 115.9" "Immune cell enriched" "Detected in some" 451 "neutrophil: 483.0" "Lineage enriched" "Detected in single" 788 "granulocytes: 483.0" "Group enriched" "Detected in many" 5 "BJ hTERT+: 4072.6;GAMG: 1080.2" "Not detected" "Not detected" HPA057179 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 7260 "Golgi apparatus" "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 68.6 13.7 1.7 211.6 2.1 3332.6 3.7 1.9 115.9 55.0 8.8 10.7 3.6 41.3 0.2 3.7 9.0 178.8 21.4 1.6 2.6 10.8 78.4 92.0 1.2 2.1 1.8 1.8 6.0 16.2 1.9 3.2 41.5 14.9 9.7 7.4 0.9 25.7 1.5 1.4 3.2 5.0 12.8 1.9 10.4 8.9 0.7 3.9 15.3 3.4 8.2 8.8 461.2 4.0 2.5 2.7 1.4 0.0 0.1 3.9 19.4 0.2 25.7 4072.6 35.9 117.0 0.2 13.0 0.2 547.6 1.3 1080.2 48.2 0.0 1.0 562.3 1.8 0.2 0.9 0.4 6.5 6.8 41.0 2.5 12.4 1.7 119.0 2.9 12.9 124.9 0.0 1.4 0.8 0.7 0.0 0.0 55.7 0.0 14.7 20.3 0.3 0.5 0.9 317.3 17.2 0.1 0.0 1.9 0.1 61.1 0.8 0.1 5.6 308.3 56.8 5.1 15.1 55.0 0.4 0.7 1.7 252.5 30.9 88.2 1.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 483.0 0.0 0.0 0.0 0.0 0.1 1.7 2.1 1.9 115.9 1.6 2.6 2.1 1.8 1.8 14.9 1.9 3.9 2.5 28.6 51.3 254.1 0.0 26.4 0.0 13262.1 0.0 164.4 0.5 40.2 15.4 23.8 127.2 426.5 0.0 0.0 4.3 17.7 14.4 0.0 1695.0 3.2 717.6 257.1 712.2 19.1 8.0 0.0 260.7 5.2 1475.1 54.0 1708.7 51.2 0.5 15.7 3.6 367.1 0.0 0.0 26.4 0.0 543.0 0.0 1.9 0.6 3685.4 0.0 0.0 1178.5 0.5 0.0 0.0 0.0 584.9 0.3 0.4 27.3 8869.1 0.9 1.0 178.6 1.1 39.5 44.3 263.0 0.3 2.5 124.9 0.0 21.3 138.8 0.0 18.5 13149.4 SCN9A "ETHA, Nav1.7, NE-NA, NENA, PN1" ENSG00000169432 "Sodium voltage-gated channel alpha subunit 9" Q15858 2 166195185-166376001 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2" "Cell type enhanced" "Detected in many" "dendritic cells: 43.2;Hofbauer cells: 67.5;Inhibitory neurons: 48.2;Langerhans cells: 42.8;Oligodendrocyte precursor cells: 133.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 16 "plasmacytoid DC: 23.6" "Lineage enriched" "Detected in single" 26 "dendritic cells: 23.6" "Cell line enhanced" "Detected in many" "BJ: 23.0;BJ hTERT+: 16.8;HHSteC: 19.0;hTERT-RPE1: 15.6" "Region enriched" "Detected in many" 5 "hypothalamus: 9.3" "Low region specificity" "Detected in many" "CAB013679, HPA061843" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB013679: , HPA061843: AB_2684625" "unprognostic (2.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (8.98e-5)" "unprognostic (1.47e-3)" "unprognostic (9.43e-3)" "unprognostic (2.28e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.64e-1)" "unprognostic (1.45e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.69e-3)" "unprognostic (6.74e-2)" "unprognostic (2.46e-2)" "unprognostic (2.46e-1)" 1.7 1.8 5.9 0.9 4.4 2.0 0.7 0.5 2.8 0.6 0.0 3.1 0.5 0.2 0.1 0.5 0.4 1.2 0.4 2.8 17.2 1.7 3.9 2.0 0.6 7.2 9.2 3.4 0.3 2.0 0.1 1.5 4.4 8.6 0.3 3.2 0.7 0.4 0.4 0.2 0.7 1.8 2.4 2.3 3.1 0.4 5.1 14.2 1.6 0.3 0.6 0.4 0.5 0.5 6.7 0.0 2.5 0.1 0.0 9.6 7.9 0.0 23.0 16.8 5.2 1.7 0.5 0.1 0.0 0.0 2.8 0.2 0.1 6.5 0.6 8.6 0.0 2.1 1.7 1.8 1.9 19.0 0.1 0.0 0.6 0.2 9.1 1.7 15.6 1.1 1.2 6.1 6.6 0.8 0.0 3.6 0.0 1.9 0.1 0.6 0.8 3.3 9.0 2.4 9.5 1.0 9.5 0.0 0.1 0.3 4.8 0.3 0.0 0.1 0.0 1.5 0.1 0.4 0.1 0.1 0.0 3.2 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.5 0.1 23.6 0.0 0.1 5.9 4.4 0.5 2.8 2.8 17.2 7.2 9.2 3.4 8.6 2.3 14.2 6.7 0.9 12.8 23.8 0.7 1.3 1.0 0.4 0.5 0.6 0.6 0.8 0.9 2.5 8.6 4.4 5.5 0.0 0.3 43.2 9.0 3.9 23.4 2.5 0.1 0.1 5.7 33.0 4.2 15.8 31.5 0.3 2.0 0.0 0.1 3.8 18.1 13.6 9.5 67.5 0.0 48.2 19.3 10.2 1.9 42.8 3.2 1.2 11.3 3.6 2.8 1.0 2.3 0.0 133.7 0.4 12.7 7.8 0.0 1.2 0.3 14.7 11.5 2.2 0.2 0.0 7.8 1.6 1.3 0.4 0.5 0.4 1.1 0.9 4.4 12.9 0.2 RASSF6 ENSG00000169435 "Ras association domain family member 6" Q6ZTQ3 4 73571550-73620631 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.9;stomach 1: 35.2" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "memory B-cell: 2.7" "Lineage enriched" "Detected in single" 13 "B-cells: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037712 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA037712: AB_2675625" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (3.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.05e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (6.76e-2)" "unprognostic (3.89e-2)" "unprognostic (5.86e-2)" "unprognostic (2.95e-1)" "unprognostic (8.97e-3)" "unprognostic (5.03e-2)" 0.2 0.1 0.0 4.9 0.0 0.1 8.5 0.0 0.2 2.3 4.0 12.0 9.9 0.6 2.8 1.9 2.7 4.4 0.0 0.1 0.1 6.0 2.2 1.3 5.8 0.0 0.3 0.0 1.4 16.8 0.7 0.4 7.5 0.0 5.7 12.8 1.6 3.5 3.7 0.0 5.4 12.4 0.3 0.0 0.2 35.2 0.1 0.5 30.9 5.8 0.4 7.0 9.3 1.8 0.1 0.3 1.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.2 12.0 76.0 1.1 0.0 0.3 3.8 0.0 6.0 0.0 1.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 5.8 0.0 21.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 11.1 0.2 0.0 0.1 0.5 23.5 70.2 2.8 0.0 0.2 1.8 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 20.2 0.1 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.3 12.8 5.1 0.0 25.0 9.8 38.5 70.5 18.8 0.1 25.1 42.2 1.2 21.5 37.7 7.3 0.0 55.7 0.1 81.1 17.6 18.2 0.3 45.4 2.0 0.8 120.3 0.4 0.3 80.9 23.0 1.7 171.8 22.8 1.3 2.2 0.4 4.0 4.4 0.0 0.1 57.9 103.7 0.3 1.0 0.0 0.0 1.2 1.8 0.0 0.6 18.7 0.0 0.0 0.3 67.1 65.8 0.0 21.3 24.6 30.1 37.8 29.8 0.5 0.0 0.0 1.6 0.0 0.2 11.9 1.4 47.2 3.5 0.7 23.2 60.5 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914041 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pituitary gland: 44.4" "Cell type enhanced" "Detected in some" "Early spermatids: 39.6;Excitatory neurons: 13.0;Late spermatids: 33.7;Muller glia cells: 25.5" "Cancer enhanced" "Detected in many" "testis cancer: 9.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 29.5;RT4: 12.2;SCLC-21H: 8.1;U-2 OS: 6.8" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 7.7 1.0 0.6 0.7 0.0 0.0 2.8 0.5 0.6 0.3 0.7 0.3 1.9 0.2 0.1 0.4 0.3 0.2 0.2 4.4 1.9 0.0 0.0 0.5 2.9 1.3 0.2 0.2 0.1 1.4 44.4 0.0 0.7 3.0 0.1 5.2 0.9 2.4 0.7 0.0 0.5 1.6 4.4 0.2 2.2 1.1 1.5 2.1 0.2 1.1 1.2 0.9 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 12.2 8.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 2.8 0.5 0.2 4.4 2.9 1.3 0.2 0.7 4.4 1.5 2.5 0.0 0.0 0.0 0.3 0.0 0.0 3.7 2.5 0.0 0.3 0.2 0.3 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 39.6 0.1 0.2 0.8 0.0 0.0 13.0 0.2 0.0 0.2 0.0 0.6 0.0 0.6 0.0 0.0 5.9 0.0 0.8 0.0 8.2 0.0 0.0 33.7 0.3 0.3 0.0 1.0 0.6 25.5 0.0 0.5 0.3 3.0 0.0 0.0 0.0 4.8 0.0 0.1 0.2 1.6 0.0 0.1 0.3 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.1 1.9 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493813-96611790 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 464.5;thyroid gland: 428.4" "Cell type enhanced" "Detected in many" "Fibroblasts: 229.7;Hepatocytes: 235.5;Smooth muscle cells: 183.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.6" "Cell line enhanced" "Detected in many" "AF22: 643.1;EFO-21: 297.8;fHDF/TERT166: 288.4;RPTEC TERT1: 341.3;U-138 MG: 305.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB025123: , HPA044416: AB_2678934" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 110.5 36.7 34.4 36.3 38.1 10.3 67.2 36.2 50.3 158.3 28.2 64.1 22.0 76.6 15.3 50.6 85.4 44.9 66.4 30.9 75.3 89.8 464.5 57.3 19.1 40.3 42.0 28.8 172.0 61.7 30.5 62.0 125.5 35.1 64.0 40.5 30.0 25.2 105.4 20.1 24.9 40.1 91.7 35.1 26.1 42.3 25.7 42.2 5.4 428.4 59.0 8.0 84.7 58.6 31.4 0.5 0.3 643.1 0.3 230.2 214.1 0.6 94.8 113.4 54.3 60.5 19.8 0.2 0.2 297.8 288.4 8.0 0.5 114.3 1.8 47.1 0.3 44.4 0.6 56.7 250.2 7.4 1.9 2.9 83.1 2.8 123.5 3.1 210.2 1.9 0.1 64.3 0.3 23.1 6.0 0.3 16.9 68.1 0.0 0.7 0.7 101.5 2.4 341.3 57.2 19.1 49.5 0.2 0.3 4.9 217.8 27.6 73.0 51.3 305.1 91.5 1.5 53.2 6.0 0.3 1.1 96.9 0.4 97.5 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.6 0.0 0.1 0.0 0.0 0.6 34.4 38.1 36.2 50.3 30.9 75.3 40.3 42.0 28.8 35.1 35.1 42.2 31.4 11.9 57.7 38.1 93.7 1.7 53.8 78.9 29.6 15.9 36.6 41.4 30.2 32.7 37.1 5.1 57.0 12.5 1.9 0.5 0.1 29.4 14.4 31.6 29.3 65.1 10.7 3.5 10.7 4.6 15.3 2.5 229.7 9.7 76.4 1.3 44.3 17.5 235.5 109.8 5.0 22.0 1.5 138.4 20.5 154.7 18.6 52.5 62.9 62.2 21.5 68.2 17.4 0.0 7.1 1.7 8.9 1.2 104.9 2.5 41.7 0.8 56.4 4.0 12.5 32.9 100.0 183.1 5.5 57.6 1.3 39.2 3.8 4.2 33.3 5.7 17.6 CD52 "CDW52, EDDM5, HE5" ENSG00000169442 "CD52 molecule" P31358 1 26317958-26320523 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "epididymis: 36489.5" "Cell type enhanced" "Detected in many" "B-cells: 1861.9;granulocytes: 568.6;Hofbauer cells: 562.6;Langerhans cells: 674.3;Macrophages: 690.5;monocytes: 814.2;NK-cells: 602.5;T-cells: 1300.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Daudi: 708.6;REH: 1042.2;U-266/84: 1087.0;U-698: 1159.2" "Low region specificity" "Detected in all" NA NA "prognostic favorable (1.85e-5)" "unprognostic (3.28e-3)" "unprognostic (1.93e-2)" "prognostic favorable (2.06e-4)" "unprognostic (4.18e-2)" "prognostic favorable (4.45e-4)" "unprognostic (9.11e-2)" "unprognostic (2.98e-2)" "unprognostic (7.73e-3)" "unprognostic (6.27e-2)" "unprognostic (4.58e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.64e-1)" "unprognostic (6.14e-2)" "unprognostic (7.95e-2)" "unprognostic (1.26e-1)" 54.2 10.3 11.0 300.6 14.4 269.2 60.0 10.7 38.8 26.4 14.5 69.3 42.1 21.5 36489.5 35.3 18.5 90.0 18.1 11.5 12.2 18.6 55.4 453.2 1090.6 12.6 11.2 10.8 9.7 8.2 5.5 6.2 17.0 11.6 19.4 97.8 0.2 37.9 105.1 9.5 28.2 297.1 47.8 11.1 651.7 88.0 4.7 16.1 1061.2 25.1 13.9 1266.7 136.1 13.2 12.2 2.0 0.0 0.3 0.0 0.0 1.4 14.3 0.1 1.0 0.1 0.0 0.3 0.6 708.6 1.4 0.0 0.3 0.1 0.0 0.2 0.0 0.5 0.2 34.8 0.0 1.4 0.0 7.5 106.4 0.0 0.0 0.2 0.0 0.7 0.0 44.9 23.7 1.0 0.0 4.6 8.5 62.9 3.0 0.5 0.0 1042.2 0.9 16.6 0.0 0.0 2.1 9.3 0.4 1.1 1.3 9.2 0.3 12.5 1.6 0.0 2.7 0.7 1.2 2.9 1087.0 1159.2 0.1 17.8 0.1 599.3 4558.9 9769.3 6605.8 7389.3 5319.0 10570.4 8177.1 6530.7 3180.2 10064.7 5495.2 5664.3 334.5 3732.1 6667.9 1034.9 11684.0 22571.2 11.0 14.4 10.7 38.8 11.5 12.2 12.6 11.2 10.8 11.6 11.1 16.1 12.2 9.5 67.3 194.6 0.0 1861.9 45.4 0.8 0.2 3.4 0.0 8.4 5.8 6.2 14.3 50.1 49.7 0.0 4.7 415.9 1.9 0.0 1.3 0.8 3.9 2.6 29.5 0.0 60.6 0.3 0.2 5.8 18.1 29.6 7.1 568.6 0.0 17.5 3.6 562.6 0.0 0.1 2.3 0.0 262.6 674.3 1.4 0.0 690.5 106.7 1.9 814.2 0.0 602.5 0.0 0.1 0.2 2.8 0.0 133.7 3.1 0.7 11.5 17.5 0.0 0.0 7.3 9.1 0.3 0.5 3.2 31.4 5.6 1300.0 0.0 2.7 1.1 MMGT1 "EMC5, TMEM32" ENSG00000169446 "Membrane magnesium transporter 1" Q8N4V1 X 135960588-135974029 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032037 Approved NA NA "HPA032037: AB_10670705" "prognostic unfavorable (8.54e-4)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.90e-2)" "unprognostic (2.23e-3)" "unprognostic (8.94e-3)" "unprognostic (2.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-1)" "unprognostic (3.87e-1)" "unprognostic (2.35e-1)" "unprognostic (2.38e-1)" "prognostic favorable (1.94e-5)" "unprognostic (6.08e-2)" "unprognostic (2.94e-2)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" 17.6 11.1 9.0 12.3 9.5 26.5 12.6 8.5 9.2 15.4 7.0 15.3 11.4 16.5 11.5 17.3 13.8 16.1 18.2 7.7 22.0 17.3 9.1 13.2 11.4 9.4 9.9 7.2 14.2 13.5 17.4 9.4 12.5 9.2 12.2 15.2 13.5 14.3 11.8 17.5 10.4 12.9 16.6 9.1 10.4 12.3 4.3 10.2 14.7 24.5 20.2 12.5 15.4 9.7 10.3 28.6 12.9 16.5 25.5 29.6 32.6 21.9 33.1 31.1 27.1 53.2 15.1 43.3 18.7 61.0 32.2 30.3 23.7 45.0 22.9 39.3 22.3 26.3 13.3 16.5 8.9 22.8 26.5 18.9 27.3 36.1 46.1 29.2 27.0 20.1 21.5 18.1 38.9 26.8 20.8 21.2 12.6 12.4 30.9 27.2 17.7 27.6 36.7 20.2 14.2 23.2 23.8 18.2 17.6 41.2 23.5 17.7 12.9 21.9 32.4 18.6 50.7 42.7 23.1 41.4 22.8 28.5 35.6 37.5 12.9 12.1 7.5 8.2 11.8 10.1 7.0 10.5 9.7 11.1 5.7 10.5 9.1 6.6 9.8 13.0 6.7 13.4 10.0 9.0 9.5 8.5 9.2 7.7 22.0 9.4 9.9 7.2 9.2 9.1 10.2 10.3 17.6 12.8 13.7 5.5 25.3 22.2 19.8 12.0 37.0 16.6 14.8 15.1 25.3 11.5 12.0 14.7 8.4 7.9 17.9 19.4 7.9 12.1 0.3 12.3 24.4 15.5 25.8 18.7 5.9 12.4 12.6 20.1 13.3 17.1 14.0 3.9 15.7 10.2 14.1 20.2 5.6 15.1 18.3 33.7 23.2 0.6 13.7 29.7 26.6 1.0 25.1 17.9 7.2 6.0 7.4 13.7 9.2 19.2 28.7 23.6 17.0 13.4 9.2 12.6 6.6 20.6 25.0 2.2 7.5 35.6 24.7 11.5 22.3 4.4 17.9 19.6 SPRR1B "GADD33, SPRR1" ENSG00000169469 "Small proline rich protein 1B" P22528 1 153031203-153032900 "Cancer-related genes, Predicted intracellular proteins" Keratinization "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 2258.3;salivary gland: 741.4;vagina: 1790.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 100.1;Club cells: 167.8;Pancreatic endocrine cells: 67.1;Suprabasal keratinocytes: 380.9;Urothelial cells: 94.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 1812.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "hTCEpi: 364.3" NA NA "unprognostic (1.73e-1)" "unprognostic (2.39e-1)" "unprognostic (5.59e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (7.66e-5)" "unprognostic (2.22e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (7.64e-5)" "unprognostic (5.71e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.28e-4)" 0.9 0.6 0.0 0.0 0.0 0.3 6.9 0.0 0.0 662.4 0.0 0.4 0.0 0.6 0.2 2258.3 0.7 17.1 0.8 0.0 0.0 0.5 1.3 0.5 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.9 0.1 0.0 0.6 0.0 0.0 741.4 0.0 1.4 463.1 0.6 0.5 0.0 0.5 1.6 0.4 0.0 7.6 0.6 0.0 451.5 10.8 1790.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 0.0 39.5 0.0 5.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 364.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 2.4 100.1 0.0 0.0 0.0 0.0 0.0 0.0 167.8 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 8.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 67.1 2.2 0.0 0.0 0.6 0.0 0.0 10.7 0.0 0.0 0.0 5.8 0.0 0.0 14.9 380.9 0.3 0.3 0.0 0.0 94.7 SPRR1A ENSG00000169474 "Small proline rich protein 1A" P35321 1 152985231-152985500 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 9053.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 77.2;Club cells: 33.0;Squamous epithelial cells: 41.7;Suprabasal keratinocytes: 144.8" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 1736.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HaCaT: 23.8;hTCEpi: 68.6;RT4: 26.4" CAB011237 Enhanced NA NA "CAB011237: " "unprognostic (1.39e-1)" "unprognostic (5.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-2)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" 1.1 1.2 0.0 0.0 0.0 0.0 13.3 0.1 0.0 602.9 0.0 0.7 0.0 1.0 0.0 9053.1 1.2 70.1 3.7 0.0 0.0 0.9 2.1 0.6 0.0 0.1 0.1 0.0 1.7 2.4 0.0 2.1 0.0 0.4 1.3 0.0 0.0 899.1 0.0 1.6 208.9 1.0 0.6 0.2 1.3 5.5 0.6 0.0 18.6 0.9 0.0 926.7 225.7 1951.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 2.8 0.0 0.0 0.0 23.8 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 26.4 0.4 0.0 2.2 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.5 0.1 77.2 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 3.8 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.0 41.7 144.8 0.0 0.1 0.0 0.0 17.1 OR4K14 ENSG00000169484 "Olfactory receptor family 4 subfamily K member 14" Q8NGD5 14 20014143-20019307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K15 OR4K15Q ENSG00000169488 "Olfactory receptor family 4 subfamily K member 15" Q8NH41 14 19975444-19976659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055732 Uncertain NA NA "HPA055732: AB_2682900" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 218.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: AB_2679957, HPA050547: AB_2681168" "prognostic unfavorable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 20.3 24.6 16.5 16.1 17.6 13.2 20.0 18.6 22.4 19.9 23.8 15.9 18.2 18.6 26.7 16.6 17.6 23.3 18.2 17.3 19.1 33.2 30.0 20.7 17.9 16.9 17.8 15.9 22.2 14.0 23.8 16.0 34.1 17.1 22.4 16.5 17.3 18.0 22.3 15.8 18.2 16.3 18.0 17.4 22.5 19.8 27.9 18.1 11.9 26.7 17.8 15.3 20.2 16.8 20.0 35.7 56.5 25.7 35.7 58.8 39.0 35.4 73.8 44.9 54.6 49.1 43.4 30.0 12.5 56.7 54.9 61.5 37.8 27.5 44.5 59.0 15.0 21.7 28.6 32.3 47.3 51.8 8.6 35.3 47.9 42.8 43.1 20.9 40.0 71.1 21.2 32.2 35.7 73.5 22.1 21.3 28.9 32.6 53.2 22.0 17.8 33.2 21.0 62.2 27.9 8.6 16.9 28.2 19.5 37.8 45.1 48.1 17.9 64.6 44.0 33.0 64.9 37.7 24.9 59.1 21.9 33.6 19.4 31.6 64.5 28.5 27.3 29.7 34.2 33.3 24.9 35.1 33.0 30.4 26.2 33.1 32.0 7.9 33.0 29.8 60.5 41.8 35.3 16.5 17.6 18.6 22.4 17.3 19.1 16.9 17.8 15.9 17.1 17.4 18.1 20.0 30.4 12.8 14.7 3.9 13.8 35.1 56.9 64.3 20.5 25.1 22.5 25.1 17.7 32.9 44.5 51.5 20.9 91.3 28.2 12.9 29.4 59.9 62.2 24.1 33.3 36.0 10.3 5.9 7.6 38.4 98.2 38.6 17.3 25.8 22.2 44.3 58.2 38.4 218.5 23.5 9.2 12.6 40.7 33.6 33.9 46.6 36.1 40.6 26.6 7.5 70.8 45.4 15.5 6.0 5.4 74.9 19.4 24.8 14.5 52.5 35.1 61.4 29.4 34.0 0.0 25.4 26.5 60.8 58.1 16.3 15.5 79.9 17.8 39.3 16.7 48.5 HTRA4 FLJ90724 ENSG00000169495 "HtrA serine peptidase 4" P83105 8 38974228-38988663 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 67.5" "Cell type enriched" "Detected in some" 10 "Extravillous trophoblasts: 444.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "BEWO: 233.6" "Region enhanced" "Detected in single" "hippocampal formation: 2.1" "Low region specificity" "Detected in all" HPA045402 Enhanced "Secreted in female reproductive system" NA NA 23000 "HPA045402: AB_2679316" "unprognostic (1.20e-1)" "unprognostic (5.83e-4)" "unprognostic (8.02e-2)" "unprognostic (2.13e-2)" "unprognostic (8.20e-2)" "unprognostic (2.42e-2)" "unprognostic (1.80e-1)" "unprognostic (7.40e-3)" "unprognostic (1.40e-1)" "unprognostic (5.14e-4)" "unprognostic (1.01e-1)" "unprognostic (8.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.58e-1)" "unprognostic (5.19e-3)" "unprognostic (2.39e-3)" "unprognostic (1.19e-3)" 0.6 0.5 1.1 0.9 1.2 7.3 1.2 3.3 5.0 0.9 0.0 0.5 0.3 0.9 0.9 0.1 0.3 0.5 0.3 1.3 0.5 0.4 0.6 2.0 2.6 0.8 0.5 0.6 0.6 0.8 0.5 0.1 67.5 1.2 0.6 0.7 1.9 0.3 1.1 1.0 0.8 0.4 0.7 0.2 1.2 0.4 0.9 0.7 0.5 0.5 0.1 1.7 0.4 0.1 2.3 0.4 0.3 0.2 0.4 0.8 0.4 233.6 0.6 0.4 0.3 0.4 0.4 0.5 0.5 0.2 0.2 0.4 0.4 0.2 0.2 0.1 0.2 0.4 0.4 0.7 0.3 0.2 0.6 0.6 0.7 0.2 0.2 0.5 0.3 0.2 0.2 0.4 1.3 0.2 0.5 0.4 0.3 0.3 0.1 0.2 0.2 0.2 0.4 0.2 0.7 0.4 0.6 0.5 0.3 0.1 9.6 0.5 0.7 0.0 0.7 0.5 0.3 0.3 0.5 0.2 0.2 0.2 0.7 0.2 0.3 0.1 0.4 0.2 0.1 0.3 0.2 0.2 0.2 0.1 0.5 0.2 0.2 0.5 0.2 0.2 0.5 0.3 0.0 1.1 1.2 3.3 5.0 1.3 0.5 0.8 0.5 0.6 1.2 0.2 0.7 2.3 0.1 0.0 0.0 0.0 1.0 0.1 1.7 0.1 1.2 0.5 0.1 0.3 0.7 0.0 0.0 0.0 2.1 2.8 1.1 0.1 0.0 0.0 0.1 0.2 0.7 0.3 0.0 0.0 0.4 0.0 444.0 1.2 0.0 0.5 0.0 0.7 1.4 0.0 11.6 1.7 0.2 0.0 0.0 0.6 0.3 0.0 0.0 3.8 1.8 1.0 0.0 0.4 1.0 1.5 0.2 0.3 0.0 0.0 0.5 1.5 0.0 0.2 0.1 0.2 0.0 3.5 0.2 0.0 0.1 0.0 0.1 40.4 0.7 0.2 0.2 1.1 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.4" "Cell type enhanced" "Detected in many" "B-cells: 94.1;dendritic cells: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 164.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 17.6 15.8 13.7 35.7 11.4 40.1 10.7 7.0 18.5 17.0 13.6 14.3 10.2 15.1 10.7 14.1 15.9 17.9 43.1 25.6 12.1 17.3 9.4 20.3 79.4 11.1 7.1 9.8 19.3 6.7 21.4 8.8 17.9 10.9 10.2 12.6 5.5 7.4 19.0 4.6 8.0 16.1 19.1 11.2 43.4 12.7 5.9 8.5 18.0 19.5 8.1 66.6 17.5 10.4 14.6 30.0 6.5 4.1 10.0 10.2 20.1 4.6 35.7 27.2 25.9 21.5 3.7 19.4 164.7 41.3 31.9 22.9 17.9 10.8 21.6 38.4 42.8 1.0 84.7 54.4 4.0 36.9 28.0 32.9 46.3 14.7 13.2 23.6 60.1 4.4 26.3 8.7 45.0 24.1 3.7 56.0 12.8 3.9 23.2 10.2 14.1 22.4 34.6 31.3 24.9 0.5 6.5 41.9 7.4 27.9 6.1 16.9 13.0 6.5 18.5 14.5 3.2 28.5 14.7 14.8 76.3 29.3 28.7 4.2 6.9 1.5 8.1 1.9 2.0 2.0 10.0 2.2 2.3 1.8 12.7 1.4 2.6 3.3 3.9 2.2 5.4 1.9 1.0 13.7 11.4 7.0 18.5 25.6 12.1 11.1 7.1 9.8 10.9 11.2 8.5 14.6 8.8 3.2 17.9 15.0 94.1 8.8 15.7 17.1 6.8 1.8 7.2 5.2 40.7 12.8 17.3 40.5 0.0 7.7 132.0 9.0 1.9 7.4 1.0 17.8 28.7 10.9 13.1 12.2 21.2 5.5 17.7 22.2 9.2 25.4 36.8 21.3 19.6 10.2 48.8 58.9 7.7 11.8 6.1 79.6 55.3 2.5 22.7 49.7 16.0 35.6 48.4 12.1 64.9 52.3 4.7 24.5 4.7 25.2 56.4 9.9 15.9 16.3 23.5 1.4 13.1 35.8 24.8 0.7 7.9 5.1 6.7 4.5 53.9 4.4 12.8 35.7 CLIC4 "CLIC4L, DKFZP566G223, H1, huH1, P64H1" ENSG00000169504 "Chloride intracellular channel 4" Q9Y696 1 24745382-24844321 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 346.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 13.4;naive B-cell: 11.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008019, HPA060804" Enhanced Supported "Plasma membrane,Centrosome" NA NA 5800000 "Plasma membrane, Centrosome" "HPA008019: AB_1846946, HPA060804: AB_2684370" "unprognostic (7.35e-3)" "prognostic unfavorable (8.31e-4)" "unprognostic (5.54e-2)" "unprognostic (7.60e-2)" "unprognostic (2.92e-2)" "unprognostic (9.48e-2)" "unprognostic (6.78e-3)" "unprognostic (1.63e-2)" "unprognostic (5.50e-2)" "unprognostic (4.03e-3)" "unprognostic (1.98e-2)" "unprognostic (7.01e-2)" "prognostic favorable (1.48e-5)" "unprognostic (2.75e-3)" "unprognostic (2.17e-1)" "unprognostic (1.22e-2)" "unprognostic (3.82e-3)" 155.3 59.2 56.8 98.6 72.7 32.6 88.8 67.7 83.5 166.8 55.0 110.0 32.7 203.4 85.3 120.4 103.9 107.4 199.0 55.8 97.0 259.2 72.9 115.6 51.4 79.5 74.6 47.0 46.3 50.1 29.5 14.3 121.6 72.3 113.8 67.5 53.5 49.8 154.2 30.9 31.9 54.6 282.8 69.9 43.5 80.7 34.5 83.1 60.1 48.0 53.7 56.9 157.4 74.0 98.8 219.3 25.3 222.7 176.8 299.1 645.6 116.7 561.0 571.4 253.9 304.2 48.3 114.1 129.8 320.1 799.2 77.0 76.8 155.0 151.5 635.7 33.3 64.9 50.0 60.8 88.3 417.3 17.5 6.3 299.3 256.8 363.0 365.1 417.3 427.0 76.0 40.4 138.2 739.0 38.4 34.8 28.5 212.6 50.4 101.8 83.5 247.3 51.5 260.0 58.4 38.9 101.3 144.7 68.4 453.7 228.3 60.0 116.1 601.0 452.2 168.8 199.4 230.1 75.4 111.7 108.6 333.8 151.1 140.5 0.8 5.4 2.5 0.4 4.4 0.0 13.4 0.3 0.2 5.6 11.9 0.1 0.2 1.2 0.0 4.0 1.7 0.0 3.5 56.8 72.7 67.7 83.5 55.8 97.0 79.5 74.6 47.0 72.3 69.9 83.1 98.8 178.7 16.0 30.5 24.8 50.8 61.6 50.4 79.8 37.0 3.7 49.9 33.0 172.5 21.5 35.2 14.7 10.4 71.5 2.2 18.1 41.1 39.2 44.9 20.9 103.0 177.1 9.6 40.8 1.5 43.1 211.4 120.5 21.4 53.6 40.0 10.2 88.5 34.4 39.3 1.7 4.2 22.6 20.3 28.2 100.2 27.3 28.6 52.6 129.9 75.9 50.8 13.0 4.1 41.7 196.9 54.7 10.6 87.6 171.2 114.5 0.1 346.1 16.7 26.5 46.0 87.9 162.5 44.0 29.1 29.3 52.0 177.0 8.1 46.5 2.6 49.1 SLC38A11 "AVT2, FLJ39822" ENSG00000169507 "Solute carrier family 38 member 11" Q08AI6 2 164896186-164955525 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.7;epididymis: 39.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 28.6;Enteroendocrine cells: 174.1;Excitatory neurons: 53.4;Sertoli cells: 72.3;Smooth muscle cells: 39.8" "Cancer enriched" "Detected in many" 5 "prostate cancer: 7.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 1.6;naive B-cell: 3.9" "Lineage enriched" "Detected in single" 39 "B-cells: 3.9" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 249.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043432 Uncertain NA NA "HPA043432: AB_10793948" "unprognostic (1.52e-1)" "unprognostic (2.59e-1)" "unprognostic (4.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" "unprognostic (6.28e-3)" "unprognostic (3.53e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "prognostic favorable (2.00e-8)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (2.43e-2)" "unprognostic (2.36e-2)" 2.0 4.0 5.4 1.5 6.3 0.1 0.8 4.0 10.3 2.7 24.7 1.5 6.0 1.7 39.0 1.0 0.8 17.8 0.8 6.4 4.2 7.4 2.6 0.4 2.0 4.7 4.6 4.3 0.3 2.2 1.3 3.3 0.3 5.7 10.9 2.7 0.3 0.6 17.0 0.9 0.5 2.8 2.0 3.6 8.1 11.8 0.2 5.1 0.3 2.1 4.1 1.4 1.5 1.1 5.9 0.0 0.6 0.0 0.0 0.0 0.0 0.1 28.9 249.7 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 6.3 4.0 10.3 6.4 4.2 4.7 4.6 4.3 5.7 3.6 5.1 5.9 0.9 0.0 0.0 6.2 7.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.9 28.6 0.0 3.7 0.0 0.7 2.7 0.5 0.0 3.2 2.1 0.1 0.5 2.7 174.1 2.7 53.4 0.6 0.6 0.3 5.1 0.1 0.0 0.0 0.4 3.7 0.0 0.0 2.9 6.4 0.0 0.0 0.3 1.2 0.0 0.0 0.0 17.8 0.0 0.1 0.0 0.5 1.2 0.8 2.3 0.0 0.0 3.2 1.0 2.0 0.0 0.1 72.3 0.5 39.8 0.1 0.0 0.2 0.3 1.5 0.9 4.4 0.7 0.2 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294539-99307399 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 113.6;lymphoid tissue: 85.3" "Group enriched" "Detected in many" 4 "Langerhans cells: 2572.5;Macrophages: 809.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 1050.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 23 "HDLM-2: 157.7;HL-60: 108.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033690, HPA075590" Approved NA NA "CAB033690: AB_2114269, HPA075590: " "unprognostic (3.28e-3)" "prognostic favorable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 26.4 12.9 2.0 85.3 2.2 113.6 11.3 2.5 4.2 12.7 6.3 14.1 8.0 6.6 2.4 15.4 6.5 40.8 7.7 1.8 10.2 3.8 17.2 20.3 68.2 8.2 2.6 1.2 3.5 4.6 3.8 5.1 28.0 4.7 9.5 21.5 2.0 5.3 3.9 2.0 5.7 23.8 22.1 4.3 35.4 15.8 1.5 3.1 32.1 15.3 4.2 76.3 52.8 5.3 6.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.2 0.8 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.4 157.7 0.0 1.4 0.4 0.0 0.0 108.6 0.3 0.0 0.0 1.5 0.0 0.0 0.0 5.7 2.6 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.8 0.3 0.7 0.0 1050.9 10.4 391.6 43.7 3.8 264.5 364.1 463.0 240.9 77.9 172.1 286.1 39.8 9.9 487.0 3.9 255.2 401.6 255.9 2.0 2.2 2.5 4.2 1.8 10.2 8.2 2.6 1.2 4.7 4.3 3.1 6.4 6.0 16.0 26.3 0.0 413.9 61.6 0.8 0.5 2.2 0.3 2.5 3.9 4.6 1.5 6.3 0.0 6.2 1.0 168.8 0.5 1.9 0.2 0.7 0.6 1.3 17.1 0.0 4.4 0.2 2.9 1.5 12.8 11.2 0.9 60.9 0.1 0.7 1.2 113.4 0.0 0.2 0.0 18.3 119.1 2572.5 2.8 0.3 809.4 145.9 46.9 248.7 0.1 1.0 0.5 0.3 1.0 0.0 0.0 85.5 0.4 0.0 0.8 3.8 0.9 6.6 2.1 9.1 0.4 0.2 1.3 53.4 1.8 245.2 0.0 0.3 0.6 CRCT1 "C1orf42, NICE-1" ENSG00000169509 "Cysteine rich C-terminal 1" Q9UGL9 1 152514482-152516008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 1837.0;vagina: 874.8" "Cell type enhanced" "Detected in some" "Ductal cells: 22.7;Pancreatic endocrine cells: 125.4;Squamous epithelial cells: 44.1;Suprabasal keratinocytes: 37.1" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 68.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "CAPAN-2: 5.0" NA NA "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.30e-1)" "prognostic unfavorable (7.03e-4)" "unprognostic (1.56e-2)" "unprognostic (1.46e-1)" 0.6 0.3 0.0 0.0 0.0 0.0 4.1 0.0 0.0 276.6 0.0 0.2 0.0 0.3 0.0 1837.0 0.2 0.0 0.3 0.0 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.7 0.2 0.0 0.3 0.0 0.0 314.5 0.0 1.0 258.5 0.4 0.0 0.0 0.3 1.2 0.2 0.0 0.0 0.2 0.0 18.6 0.4 874.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.6 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 44.1 37.1 0.0 0.0 0.0 0.0 2.0 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410329-46413564 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 37.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 3.8 16.5 5.9 2.7 3.3 0.7 8.9 4.7 3.0 13.0 6.6 3.0 0.9 14.1 10.5 1.3 23.1 4.2 25.0 3.2 5.7 6.6 0.7 4.4 0.9 4.3 5.5 1.9 37.1 13.7 9.1 13.0 6.8 4.9 6.5 1.2 1.3 10.9 7.6 2.1 3.1 2.2 6.6 5.1 2.3 2.2 5.9 4.0 5.6 9.1 2.4 0.8 7.5 7.3 4.3 1.9 0.1 18.5 22.2 4.8 6.0 8.9 9.6 0.0 2.1 0.9 0.1 0.1 0.2 12.5 7.6 0.4 0.2 0.1 15.0 1.0 0.0 9.4 0.0 0.2 1.0 16.0 0.1 0.1 19.6 0.0 5.2 15.2 0.3 0.1 0.1 20.3 0.0 6.8 0.0 0.0 1.3 13.3 0.0 0.0 0.7 24.8 0.0 16.1 0.1 2.9 0.1 0.1 0.1 0.1 14.2 0.1 4.7 1.7 1.2 4.9 0.2 0.4 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.9 3.3 4.7 3.0 3.2 5.7 4.3 5.5 1.9 4.9 5.1 4.0 4.3 0.7 0.0 1.1 1.3 0.0 0.9 6.5 1.5 0.0 0.4 1.8 19.3 27.0 7.2 4.0 11.0 0.0 7.5 0.1 0.0 39.2 14.8 0.4 15.0 13.9 1.2 0.0 0.0 0.0 1.1 10.0 17.3 0.0 3.9 1.3 25.7 1.1 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.9 2.9 70.8 0.6 1.8 1.0 0.0 14.6 0.0 1.5 0.1 3.6 0.0 57.9 0.0 3.7 0.0 1.2 2.4 0.5 13.1 12.3 8.3 0.4 5.5 0.0 0.1 2.1 0.2 32.7 0.0 0.8 METTL15 "FLJ33979, METT5D1" ENSG00000169519 "Methyltransferase like 15" A6NJ78 11 28108248-28527041 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.2;Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039885 Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Golgi apparatus, Plasma membrane" "Actin filaments" "HPA039885: AB_2676725" "unprognostic (2.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-2)" "unprognostic (2.66e-2)" "unprognostic (1.83e-1)" "unprognostic (4.17e-2)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-3)" "unprognostic (2.28e-1)" "prognostic favorable (7.95e-5)" "unprognostic (7.77e-2)" "unprognostic (1.38e-1)" "unprognostic (6.58e-2)" "unprognostic (6.84e-3)" 4.4 8.1 5.2 4.2 4.7 2.4 6.2 5.7 5.6 6.1 6.0 7.0 5.1 5.1 5.8 4.6 5.8 4.6 7.8 5.1 5.5 7.8 9.4 4.3 5.4 5.2 5.3 4.6 6.0 4.5 7.0 4.3 5.1 5.4 6.3 6.9 7.1 4.5 5.6 8.8 5.1 5.1 4.6 4.8 4.3 5.4 3.3 5.0 5.2 7.7 11.3 5.3 4.5 3.3 6.3 8.8 9.2 9.3 7.1 11.3 18.0 6.5 10.6 8.1 10.6 10.9 6.3 5.9 20.2 6.2 8.8 6.7 7.3 12.3 10.9 20.2 12.5 10.8 6.4 6.5 7.3 12.6 12.1 5.6 10.2 16.0 5.9 15.1 11.5 10.3 6.7 13.7 8.9 12.6 6.0 8.4 7.4 7.2 9.2 6.8 4.5 20.2 7.4 15.8 5.0 8.2 6.7 8.8 7.8 12.7 8.9 15.4 7.4 7.8 9.6 7.4 12.3 9.4 6.0 7.6 11.7 13.5 12.0 10.6 2.1 1.4 3.7 2.2 1.0 2.7 3.6 2.6 2.9 1.7 1.8 2.8 3.6 0.6 4.4 1.2 1.8 3.1 1.5 5.2 4.7 5.7 5.6 5.1 5.5 5.2 5.3 4.6 5.4 4.8 5.0 6.3 16.5 12.8 24.3 130.2 21.3 44.0 38.1 37.1 23.9 13.6 21.6 15.0 14.3 14.3 20.3 11.0 18.8 11.3 28.7 18.2 11.7 10.6 34.5 19.6 24.7 15.7 9.6 17.0 96.8 11.8 14.1 23.5 16.3 28.2 5.1 18.1 12.8 15.0 10.4 13.5 93.9 17.6 10.2 14.2 50.7 12.6 10.8 17.9 14.2 105.9 6.1 8.7 19.6 132.7 146.1 9.9 13.3 8.2 21.0 57.2 13.0 14.9 18.9 16.1 6.6 60.7 23.2 17.9 10.0 17.4 35.7 8.5 35.5 21.3 16.2 53.1 ZNF280A "3'OY11.1, SUHW1, ZNF280, ZNF636" ENSG00000169548 "Zinc finger protein 280A" P59817 22 22513736-22520270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "adrenal gland: 1.4" "Cell type enhanced" "Detected in some" "Melanocytes: 1.8;Spermatogonia: 1.2;Syncytiotrophoblasts: 5.1;Theca cells: 1.9" "Cancer enhanced" "Detected in some" "melanoma: 1.7;testis cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.8;K-562: 8.2;SK-MEL-30: 2.1" HPA044475 Approved Nucleoplasm NA NA Nucleoplasm "HPA044475: AB_10960420" "unprognostic (7.53e-2)" "unprognostic (3.76e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (3.29e-1)" "unprognostic (4.65e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.3 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 0.0 5.1 0.0 1.9 0.0 0.0 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559032-26572263 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "epididymis: 1966.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 109.0;Respiratory ciliated cells: 168.3;Syncytiotrophoblasts: 665.9" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.6;pons: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;K-562: 11.7;SK-BR-3: 18.0;SuSa: 12.0;U-266/70: 7.8;U-266/84: 21.1" "Group enriched" "Detected in some" 4 "cerebellum: 1.2;thalamus: 1.4" "Low region specificity" "Detected in many" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" NA NA "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.0 0.3 0.4 0.0 3.6 0.0 15.5 0.0 0.6 3.2 1.0 0.0 0.0 0.4 1966.7 17.6 6.7 0.1 0.0 0.4 0.4 24.3 0.1 12.4 0.1 0.5 0.0 0.4 0.0 7.9 0.0 1.5 14.9 2.0 0.9 0.0 0.0 52.6 6.9 0.0 29.7 0.0 0.0 0.0 0.0 1.0 0.3 0.4 3.7 76.3 0.0 7.7 2.5 11.7 0.5 0.6 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.7 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.2 0.6 0.0 18.0 0.0 12.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 7.8 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.6 0.4 0.4 0.5 0.0 0.4 2.0 0.0 0.4 0.5 0.2 109.0 32.5 0.0 0.1 3.4 12.5 7.5 4.6 0.0 43.0 6.9 0.0 0.0 55.1 49.7 0.0 68.7 0.0 0.0 31.3 4.6 0.6 39.8 5.4 0.7 0.0 0.0 0.2 0.0 19.2 1.3 0.0 53.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 8.2 0.0 0.6 0.2 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 168.3 0.0 0.0 0.0 2.2 0.2 0.2 26.5 29.7 665.9 0.4 0.0 0.0 12.6 CT55 "CXorf48, FLJ20527" ENSG00000169551 "Cancer/testis antigen 55" Q8WUE5 X 135156540-135171398 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 3.8" "Group enriched" "Detected in some" 46 "Spermatocytes: 43.8;Spermatogonia: 57.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "K-562: 7.6" HPA059575 Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "HPA059575: " "unprognostic (6.20e-2)" "unprognostic (1.39e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.47e-1)" "unprognostic (2.67e-1)" "unprognostic (4.44e-2)" "unprognostic (1.49e-1)" 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.8 57.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144521057 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 327.4" "Cell type enhanced" "Detected in many" "Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 154.0;THP-1: 181.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 61.9 45.6 190.7 57.3 236.7 128.6 29.8 142.1 152.0 52.8 15.3 24.7 22.1 29.9 9.7 28.2 20.4 44.2 46.1 130.4 150.7 18.4 23.5 41.6 43.5 232.3 222.7 85.2 71.2 5.8 6.8 3.4 62.7 317.9 18.6 30.2 35.8 9.7 22.9 21.0 11.8 26.1 33.6 208.6 70.0 18.1 16.3 223.2 10.7 13.4 19.0 24.4 47.0 24.3 327.4 1.6 2.0 83.4 0.1 98.9 49.7 0.3 35.1 35.1 38.5 37.1 0.0 0.8 6.6 0.1 37.4 10.6 0.4 14.5 0.1 47.6 37.6 11.2 154.0 6.3 0.2 23.0 26.4 113.2 42.1 0.9 48.9 22.9 33.7 29.4 0.0 43.0 4.1 45.2 0.2 0.4 79.9 12.3 0.0 1.9 44.1 63.5 0.2 0.4 0.6 0.7 22.1 4.2 0.2 97.3 27.5 0.2 181.4 45.9 42.9 0.7 87.5 11.0 47.1 0.3 7.5 66.7 78.4 122.6 27.8 47.7 12.2 21.0 42.6 1.9 9.2 2.7 10.7 27.0 9.4 1.9 7.7 15.2 7.3 43.9 21.5 0.6 19.0 190.7 236.7 142.1 152.0 130.4 150.7 232.3 222.7 85.2 317.9 208.6 223.2 327.4 32.6 6.4 19.2 121.8 92.4 24.9 1.2 0.6 3.4 158.6 2.2 4.3 71.0 1.5 10.1 5.5 4.2 1.7 426.2 0.1 1.9 0.7 2.2 2.1 84.7 29.2 0.0 127.0 228.2 0.8 2.0 123.0 13.3 2.5 157.5 99.3 79.2 4.6 144.5 662.9 539.3 0.0 0.0 435.0 276.3 7.2 120.5 435.0 103.2 343.8 233.6 69.3 223.5 381.0 1489.6 0.2 1.1 66.5 132.3 1.8 0.0 10.3 4.0 11.9 184.1 185.0 198.7 2.9 11.3 3.4 19.6 4.7 136.7 108.8 0.4 2.2 GJB1 "CMTX, CMTX1, CX32" ENSG00000169562 "Gap junction protein beta 1" P08034 X 71212811-71225516 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 101.7;liver: 338.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1" "Cancer enhanced" "Detected in many" "liver cancer: 163.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 143.2;SK-MEL-30: 155.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012994 Uncertain NA NA "CAB012994: AB_2533228" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (8.78e-2)" "unprognostic (2.71e-3)" "unprognostic (2.70e-1)" "unprognostic (4.11e-1)" "unprognostic (2.92e-1)" "unprognostic (3.68e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (7.36e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.85e-6)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (4.97e-2)" 0.1 0.0 32.6 3.7 58.9 0.0 6.5 74.0 43.0 8.8 15.4 34.2 44.4 1.7 22.7 0.3 27.7 41.9 0.0 28.2 45.8 43.3 338.4 2.5 0.0 75.6 66.8 22.2 0.1 83.7 0.0 0.1 0.0 69.8 11.7 24.0 0.0 38.0 7.6 0.0 0.9 34.7 1.8 63.2 0.1 16.5 10.3 56.8 0.0 0.1 0.1 0.0 0.4 0.1 101.7 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.3 0.0 5.1 0.2 0.0 0.2 0.0 0.0 155.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 32.6 58.9 74.0 43.0 28.2 45.8 75.6 66.8 22.2 69.8 63.2 56.8 101.7 0.0 0.0 4.8 0.3 0.8 0.6 0.7 0.5 0.0 0.0 7.7 2.4 0.1 114.4 2.7 9.2 0.0 0.0 0.1 50.2 9.8 34.1 0.3 8.2 3.4 0.6 9.6 8.0 0.2 58.9 0.0 0.1 15.8 29.0 4.5 0.0 3.3 286.4 0.0 0.0 0.2 29.4 2.0 4.8 0.4 0.4 0.3 0.8 23.2 0.0 0.6 0.0 0.0 1.0 51.3 32.3 53.4 0.4 0.0 2.6 118.8 68.9 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 1.0 0.0 66.1 2.8 PCBP1 "hnRNP-E1, hnRNP-X, HNRPE1, HNRPX" ENSG00000169564 "Poly(rC) binding protein 1" Q15365 2 70087477-70089203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037113, HPA043803, HPA068497" Approved Enhanced "Nuclear speckles,Cytoplasmic bodies" No No 1600000 "Nuclear speckles" "Cytoplasmic bodies" "CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996" "unprognostic (1.63e-1)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (7.08e-2)" "unprognostic (5.37e-1)" "unprognostic (1.63e-2)" "unprognostic (8.33e-2)" "unprognostic (9.94e-3)" "unprognostic (2.01e-1)" "unprognostic (2.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-1)" "unprognostic (5.90e-2)" 280.0 278.6 155.0 201.6 158.7 393.4 242.5 173.3 182.9 202.4 170.2 241.0 174.4 256.1 143.8 280.6 195.5 136.1 223.2 155.6 180.1 212.8 306.8 235.6 229.0 171.1 155.4 142.8 187.5 252.0 176.0 141.3 196.4 166.2 145.2 127.0 91.3 186.5 140.8 788.7 216.8 204.8 173.9 182.8 243.3 216.2 95.9 162.9 303.7 172.2 311.1 211.3 235.7 207.8 195.8 384.9 387.5 327.1 257.5 345.1 262.4 525.9 280.5 257.2 272.0 227.0 453.0 250.6 522.9 140.9 320.7 293.7 334.7 388.4 408.6 276.5 376.2 299.9 419.2 219.5 701.3 388.0 350.8 385.8 230.3 261.6 224.5 310.5 203.4 350.7 138.9 437.2 375.6 346.2 475.7 454.7 524.7 331.5 361.1 253.2 362.9 358.0 527.1 375.5 389.6 309.7 249.1 230.3 465.8 342.1 229.8 277.6 314.2 325.1 253.5 317.6 217.6 359.4 495.7 551.2 531.7 268.6 480.4 319.5 42.6 89.7 141.5 80.3 92.5 73.8 41.1 62.1 69.3 82.9 36.4 62.8 71.2 138.2 95.4 80.5 58.9 81.7 100.5 155.0 158.7 173.3 182.9 155.6 180.1 171.1 155.4 142.8 166.2 182.8 162.9 195.8 241.0 153.8 132.7 27.4 312.7 484.0 296.0 192.1 196.9 64.9 270.8 212.6 0.6 208.8 134.5 196.8 22.9 372.4 208.7 401.7 272.0 196.0 34.4 187.6 220.8 242.8 178.6 485.3 19.1 199.2 470.1 196.9 227.9 284.8 114.2 129.6 227.0 392.7 385.7 58.9 18.0 239.8 138.4 509.2 795.9 34.4 186.1 382.4 300.6 30.0 422.9 122.3 347.1 14.1 49.1 211.7 311.7 186.5 357.1 278.5 338.4 481.0 128.6 56.1 170.9 222.9 241.9 131.0 65.5 267.0 545.8 703.4 291.2 148.4 232.9 366.6 HINT1 "HINT, PKCI-1, PRKCNH1" ENSG00000169567 "Histidine triad nucleotide binding protein 1" P49773 5 131155383-131224468 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 3537.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044577 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 2800000 Cytosol "Nucleoplasm, Plasma membrane" "HPA044577: AB_10795618" "unprognostic (2.00e-1)" "unprognostic (9.27e-2)" "unprognostic (2.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (8.30e-3)" "unprognostic (2.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.49e-2)" "unprognostic (6.50e-3)" "unprognostic (4.43e-2)" "unprognostic (4.39e-3)" "unprognostic (2.08e-1)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (3.68e-1)" 126.6 176.7 245.2 141.0 252.1 261.5 174.4 247.2 328.9 116.1 250.2 229.8 177.7 120.7 189.2 182.8 167.0 109.0 159.4 250.1 256.6 259.1 478.1 120.0 208.3 249.7 245.2 247.5 122.6 166.9 288.1 153.7 88.3 254.8 156.5 228.7 111.7 174.3 117.4 337.3 162.4 197.9 125.3 252.8 127.9 137.6 80.9 246.6 168.0 178.7 280.9 193.9 154.3 130.8 259.8 437.1 522.7 448.2 877.2 273.1 297.1 441.3 300.3 230.9 235.4 272.1 547.1 516.8 563.3 625.7 329.6 569.1 253.4 315.4 635.3 244.1 500.0 514.6 199.1 814.0 771.9 532.6 349.4 65.4 400.1 618.6 295.8 528.2 533.7 314.1 727.8 313.4 1132.1 338.8 419.9 548.0 945.6 415.6 425.6 362.0 407.9 436.1 988.1 500.6 567.0 563.3 351.9 380.5 243.5 612.0 574.4 291.2 520.8 396.0 351.7 244.0 323.0 684.2 342.3 561.4 578.8 497.8 586.8 346.3 179.8 187.9 85.0 196.3 109.9 298.0 384.9 462.0 294.2 396.9 332.6 416.0 325.5 35.6 269.0 128.0 521.4 362.5 608.6 245.2 252.1 247.2 328.9 250.1 256.6 249.7 245.2 247.5 254.8 252.8 246.6 259.8 582.7 282.0 279.1 34.3 718.2 1301.2 1472.2 1928.1 889.5 191.2 1134.3 1831.1 517.0 1028.0 882.2 715.4 45.9 780.9 641.6 1245.1 1663.0 1024.5 783.0 718.9 443.7 501.2 698.1 669.7 53.8 774.3 1632.8 400.2 355.2 753.7 108.2 666.5 436.2 2380.1 887.1 148.0 48.0 947.2 915.5 472.4 906.9 206.3 392.4 447.0 965.8 34.7 1269.4 405.1 488.1 26.7 55.4 894.3 1094.2 418.6 679.7 1998.9 1690.3 3537.5 708.3 194.0 243.3 287.0 730.3 625.5 197.9 1109.1 1146.1 456.8 671.1 464.3 1280.4 1713.2 DTWD2 FLJ33977 ENSG00000169570 "DTW domain containing 2" Q8NBA8 5 118836074-118988547 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.4;Inhibitory neurons: 61.8;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053173, HPA054864" Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA053173: AB_2682068, HPA054864: AB_2682629" "unprognostic (1.66e-1)" "unprognostic (1.60e-1)" "prognostic favorable (3.16e-4)" "unprognostic (4.80e-2)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.11e-1)" "unprognostic (2.77e-3)" "unprognostic (5.15e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.09e-5)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (5.93e-3)" "unprognostic (1.59e-1)" 3.2 3.3 1.5 2.3 1.4 1.2 3.7 2.5 2.0 5.1 2.1 3.3 3.2 2.6 2.3 4.3 2.3 3.2 6.6 1.4 1.1 6.5 4.5 2.4 2.3 1.2 1.8 1.4 1.7 3.0 4.8 0.8 1.8 1.5 3.5 3.3 3.4 3.3 2.7 10.6 3.3 2.7 3.2 1.0 3.0 2.8 2.4 1.5 2.0 9.2 6.4 2.3 2.9 1.3 1.7 4.3 2.6 3.6 5.3 2.0 1.0 3.6 3.9 2.7 5.5 6.3 1.8 3.2 3.6 6.9 3.4 2.6 4.8 6.0 4.4 6.9 1.2 4.2 4.9 4.3 2.9 1.7 5.9 6.1 1.5 7.4 2.4 2.4 3.2 1.8 6.4 3.8 5.5 3.7 4.2 4.9 3.6 3.8 3.1 1.4 2.0 3.3 1.9 7.0 6.2 1.8 3.3 3.9 4.2 5.4 2.9 9.7 3.9 2.2 6.9 5.1 2.3 5.7 3.8 6.6 2.8 4.0 3.5 3.4 0.9 0.3 0.1 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.6 0.4 0.4 0.6 0.5 0.3 0.5 0.1 0.4 1.5 1.4 2.5 2.0 1.4 1.1 1.2 1.8 1.4 1.5 1.0 1.5 1.7 2.7 9.6 3.6 33.6 5.7 2.8 2.7 3.9 8.6 12.0 5.4 2.8 11.7 8.6 4.7 7.3 16.7 2.7 3.7 4.0 9.8 2.9 12.8 4.2 1.9 2.0 4.2 12.6 70.4 8.3 1.1 3.0 9.7 3.6 0.0 4.5 1.8 5.6 3.9 20.2 61.8 2.0 4.1 2.6 2.5 20.3 2.5 4.5 7.2 21.5 4.6 7.3 4.1 49.3 43.9 1.9 5.2 2.2 8.0 2.1 3.7 12.1 3.1 9.1 0.0 4.5 2.8 12.7 17.4 10.0 3.7 0.7 2.8 7.3 3.4 3.4 VPREB1 "CD179A, VpreB" ENSG00000169575 "V-set pre-B cell surrogate light chain 1" P12018 22 22244780-22245515 "CD markers, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "bone marrow: 30.0" "Cell type enhanced" "Detected in single" "NK-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 5.7;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 4 "B-cells: 5.7" "Group enriched" "Detected in some" 11 "Daudi: 9.4;MOLT-4: 19.8;RPMI-8226: 5.4" "Not detected" "Not detected" HPA055886 Approved "Intracellular and membrane" NA NA 62000 "HPA055886: AB_2682956" 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLIC3 ENSG00000169583 "Chloride intracellular channel 3" O95833 9 136994608-136996568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 319.6;skin 1: 120.1;thyroid gland: 110.5;vagina: 133.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 130.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 9 "plasmacytoid DC: 2635.7" "Lineage enriched" "Detected in all" 9 "dendritic cells: 2635.7" "Cell line enhanced" "Detected in many" "BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005963 Enhanced Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA005963: AB_1078536" "unprognostic (4.30e-2)" "unprognostic (2.53e-1)" "unprognostic (3.54e-1)" "unprognostic (1.55e-2)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-3)" "unprognostic (1.39e-1)" "unprognostic (3.26e-3)" "unprognostic (7.73e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.74e-4)" 4.6 0.6 0.9 1.4 0.7 4.1 2.6 1.3 1.8 37.0 2.2 1.4 0.4 1.9 4.6 319.6 1.7 0.8 6.9 0.6 2.1 1.0 1.0 38.9 4.2 1.3 0.8 0.4 0.6 0.6 0.2 2.4 41.9 0.9 3.0 0.2 0.0 38.0 1.1 1.0 120.1 1.7 0.3 0.7 6.9 7.5 0.7 1.1 7.7 110.5 1.2 20.7 2.1 133.3 1.1 28.8 0.0 0.0 0.0 0.5 1.4 350.3 2.7 1.5 1.0 0.4 3.7 14.0 0.1 22.5 24.3 0.1 12.5 0.0 1.2 0.0 0.0 0.2 0.0 20.7 4.5 3.9 0.0 0.0 1.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.1 0.1 0.2 0.1 58.4 5.8 0.0 0.5 0.0 0.0 0.0 0.8 0.0 45.9 65.0 0.0 0.0 147.2 0.0 118.4 0.0 4.1 2.5 0.1 0.0 0.0 0.1 0.5 0.0 0.0 2.9 0.8 2.6 232.3 2.1 99.3 2.6 32.0 143.8 9.4 5.5 6.9 120.4 10.3 283.2 2.3 2635.7 11.5 168.3 0.9 0.7 1.3 1.8 0.6 2.1 1.3 0.8 0.4 0.9 0.7 1.1 1.1 11.5 214.7 42.0 0.0 11.6 3.8 3.6 86.6 8.0 0.0 7.3 20.6 3.2 2.8 95.2 1.8 0.0 811.8 456.0 25.2 9.8 1.8 1.7 16.7 2.3 13.4 4.9 5.3 0.0 6.4 1219.2 27.0 22.4 14.4 1.3 1.8 3.6 1.1 91.6 0.0 0.0 5.6 4.1 2.2 5.9 7.8 125.6 8.5 10.6 1.9 4.9 0.0 541.7 0.0 0.0 84.6 10.4 41.8 23.7 4.5 0.7 0.4 12.0 0.0 0.0 0.2 4.4 0.0 1.0 70.2 19.5 2039.4 78.4 1.0 5.2 18.1 INO80E "CCDC95, FLJ90652" ENSG00000169592 "INO80 complex subunit E" Q8NBZ0 16 29995715-30005793 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043146 Approved Supported "Nucleoplasm,Nucleoli rim" NA NA Nucleoplasm "Nucleoli rim" "HPA043146: AB_10794923" "unprognostic (5.61e-2)" "unprognostic (3.50e-2)" "unprognostic (3.46e-2)" "unprognostic (2.75e-2)" "unprognostic (3.38e-1)" "unprognostic (5.73e-2)" "unprognostic (7.14e-2)" "unprognostic (1.90e-2)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "unprognostic (1.13e-2)" "unprognostic (3.41e-2)" "unprognostic (2.02e-2)" "unprognostic (4.74e-3)" "unprognostic (5.21e-2)" "unprognostic (2.55e-1)" "unprognostic (3.98e-3)" 26.0 23.0 34.5 22.3 36.6 33.3 26.6 36.8 43.4 30.9 28.0 35.7 20.1 31.1 29.4 29.9 41.2 25.0 25.5 33.9 34.3 22.1 26.6 29.0 33.2 38.7 36.7 31.7 38.3 25.7 40.3 23.4 25.0 36.6 24.3 36.8 13.5 32.7 35.0 31.2 27.5 24.2 40.6 36.0 26.8 25.0 28.0 36.5 42.9 33.6 30.0 47.2 31.1 25.8 40.6 79.1 95.1 59.6 88.0 54.0 45.6 55.0 66.9 75.2 95.4 93.8 54.7 85.7 101.6 100.4 75.3 63.0 52.9 73.8 109.8 80.0 106.7 88.8 50.2 57.7 79.0 63.5 66.4 59.5 53.5 89.1 112.1 87.6 54.9 115.4 137.5 64.4 55.6 89.9 114.7 142.0 87.2 120.3 55.4 55.1 176.9 72.6 104.7 73.2 39.5 90.8 111.3 36.8 65.1 83.7 48.9 80.8 53.0 62.5 68.0 48.3 58.7 84.6 58.9 120.2 92.9 77.3 96.2 97.9 1.5 6.1 5.1 4.3 4.1 3.6 4.5 3.4 5.0 4.9 3.3 3.2 3.3 3.0 3.5 6.8 5.1 5.2 21.4 34.5 36.6 36.8 43.4 33.9 34.3 38.7 36.7 31.7 36.6 36.0 36.5 40.6 32.8 38.5 19.6 15.0 27.6 14.8 19.1 34.0 37.0 15.1 23.5 22.6 0.8 22.8 24.1 20.2 20.9 36.9 27.6 32.9 33.2 29.3 1.9 17.1 13.3 25.4 35.2 14.9 6.6 39.3 40.1 20.2 45.9 19.2 15.8 16.4 23.9 18.9 27.8 8.4 6.9 28.4 32.6 22.4 15.0 5.2 26.1 24.0 19.6 14.0 25.2 20.4 29.9 9.0 14.4 38.0 39.7 27.8 35.2 12.4 48.2 29.8 19.7 20.9 26.3 17.3 23.1 44.4 23.3 33.6 17.2 18.1 30.9 13.9 31.6 12.4 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.6;testis: 31.1" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 88.6;Early spermatids: 45.5;Late spermatids: 103.4;Suprabasal keratinocytes: 58.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 51.1;HBEC3-KT: 116.6;hTCEpi: 128.1;hTERT-HME1: 123.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 6.9 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.5 0.0 0.1 0.0 0.0 8.2 12.6 0.9 0.1 0.8 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.7 0.0 1.0 0.0 1.8 0.0 0.2 0.0 0.1 2.0 0.2 0.0 8.8 0.0 0.0 0.0 0.0 0.1 31.1 0.7 4.3 0.1 0.3 2.1 0.3 6.6 0.4 25.9 0.1 0.0 0.0 4.2 6.4 0.0 2.0 0.3 21.9 30.3 0.0 0.5 0.0 1.0 13.8 0.0 51.1 2.7 116.6 39.3 0.0 0.2 0.0 0.0 0.0 32.6 0.0 0.0 5.6 128.1 19.6 123.8 4.5 21.7 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 4.6 0.0 0.0 0.0 11.6 0.0 0.0 14.2 0.0 0.0 40.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 0.0 0.0 0.0 88.6 14.8 15.5 14.8 0.0 0.0 0.1 0.4 1.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 45.5 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 103.4 0.6 0.1 8.8 1.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.0 1.2 0.0 0.1 1.7 0.0 0.0 2.7 0.6 22.2 6.5 21.7 58.4 0.0 0.0 0.0 0.0 4.8 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 4.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Extravillous trophoblasts: 29.5;Oligodendrocytes: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: AB_2681985" "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favorable (6.29e-5)" 1.3 1.1 0.5 1.2 0.6 1.0 1.2 0.4 0.9 1.6 0.0 1.5 4.6 1.6 0.0 0.8 1.3 1.4 0.7 0.5 0.5 0.6 0.4 1.0 1.6 1.4 0.7 0.2 1.7 2.4 0.5 0.6 1.3 0.9 0.8 0.8 0.2 1.3 0.7 0.5 0.6 2.0 0.4 0.5 1.9 1.2 0.4 0.5 1.3 0.8 0.5 0.9 1.4 1.0 1.4 3.2 3.3 2.0 4.7 0.6 1.6 1.1 2.7 1.2 4.1 2.8 2.6 2.8 2.6 2.2 0.5 0.8 1.7 0.7 3.2 0.2 9.0 9.7 10.7 1.2 3.2 3.3 8.7 7.9 0.4 0.8 2.4 1.9 0.8 4.1 7.5 7.4 1.6 0.1 1.8 6.1 4.8 2.2 3.9 7.4 4.9 1.2 4.4 1.3 0.6 3.3 5.1 2.3 6.5 10.7 0.0 1.1 3.8 4.1 1.5 1.1 6.5 2.5 2.9 4.6 5.4 1.2 9.0 2.0 3.6 3.7 5.0 3.4 3.8 2.0 2.1 2.5 3.1 5.1 1.0 2.1 3.2 1.2 2.3 7.4 0.0 4.7 2.9 0.5 0.6 0.4 0.9 0.5 0.5 1.4 0.7 0.2 0.9 0.5 0.5 1.4 3.3 3.2 4.6 4.2 3.0 0.6 1.0 1.4 1.8 5.5 1.9 2.7 1.3 2.8 1.7 1.8 45.9 3.5 7.3 1.6 1.9 1.9 1.4 3.3 4.6 3.1 2.4 2.5 17.0 1.6 29.5 3.2 1.5 2.5 0.0 4.6 2.5 1.8 2.9 15.2 18.0 4.2 0.0 5.4 1.4 1.2 1.2 3.7 0.0 8.4 2.5 3.9 15.5 5.5 22.7 1.8 1.5 4.9 3.1 0.6 5.0 2.4 1.1 17.9 0.0 1.7 3.2 1.7 2.5 1.7 0.3 1.4 6.0 3.3 4.4 0.7 NFU1 "CGI-33, HIRIP5, NifU, NIFUC" ENSG00000169599 "NFU1 iron-sulfur cluster scaffold" Q9UMS0 2 69396113-69437628 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 189.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035826 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035826: AB_2674803" "unprognostic (4.49e-3)" "unprognostic (5.62e-2)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-3)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-1)" "unprognostic (2.21e-3)" "unprognostic (2.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.87e-1)" 67.4 46.7 39.8 22.7 41.8 33.6 57.3 42.3 56.4 35.3 40.9 47.0 31.6 36.2 52.4 28.1 35.6 29.3 82.5 40.2 43.6 61.5 39.8 32.1 30.3 42.9 42.2 38.9 38.3 40.2 43.7 45.5 38.4 44.5 34.5 38.5 57.4 41.5 36.9 142.1 22.4 33.7 33.4 41.1 31.2 44.2 34.9 42.0 23.0 42.2 121.3 29.8 45.2 31.4 44.9 59.3 59.2 56.1 55.5 70.4 75.4 61.6 61.0 62.0 59.0 47.8 114.7 56.9 42.4 30.0 57.0 85.6 25.4 63.7 64.2 79.5 77.8 62.3 43.5 38.2 102.0 70.1 73.7 59.2 58.4 37.2 67.5 41.2 56.0 65.6 41.8 80.1 41.8 99.1 11.9 39.1 119.0 53.9 62.9 64.3 42.6 85.5 15.6 83.5 57.6 45.9 34.3 35.2 32.2 92.5 57.6 40.8 49.4 67.8 71.3 47.1 52.2 80.8 53.8 48.4 23.1 54.2 74.7 55.8 20.2 13.6 25.5 15.9 18.6 15.6 21.7 16.3 18.9 12.4 25.1 16.9 18.6 4.3 18.0 28.5 25.0 24.8 12.3 39.8 41.8 42.3 56.4 40.2 43.6 42.9 42.2 38.9 44.5 41.1 42.0 44.9 30.6 32.1 22.5 9.8 37.0 16.2 35.9 96.7 21.1 23.9 33.2 29.6 92.3 37.1 42.6 38.6 12.5 113.9 34.1 34.6 189.8 56.9 111.0 40.0 27.1 34.9 53.3 25.7 15.4 60.9 70.5 30.9 20.4 25.3 58.3 21.6 33.5 32.0 82.6 18.5 18.8 47.7 57.0 35.8 24.0 34.2 34.8 30.2 39.2 10.3 66.8 55.6 46.4 21.1 27.1 50.3 39.7 36.9 25.4 28.8 56.3 163.0 58.9 33.4 46.0 36.9 44.1 82.9 60.4 18.8 14.9 61.3 33.3 42.7 46.3 35.4 ANTXR1 "ATR, FLJ10601, FLJ21776, TEM8" ENSG00000169604 "ANTXR cell adhesion molecule 1" Q9H6X2 2 69013176-69249327 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor Hypotrichosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 130.6;Endometrial stromal cells: 78.1;Oligodendrocyte precursor cells: 141.8;Skeletal myocytes: 111.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 367.9;TIME: 240.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054785 Uncertain Vesicles "Intracellular and membrane" NA NA 11000000 Vesicles "HPA054785: " "unprognostic (1.44e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (8.49e-2)" "unprognostic (4.77e-2)" "unprognostic (3.61e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (4.15e-3)" "unprognostic (9.05e-3)" "unprognostic (1.15e-1)" "unprognostic (3.48e-3)" "unprognostic (2.26e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.09e-2)" 34.7 63.7 24.9 20.5 23.6 0.2 33.0 32.4 18.4 78.4 64.0 29.2 13.0 82.2 25.4 34.2 44.5 115.6 32.9 28.2 96.6 10.9 8.3 45.2 12.2 41.8 40.4 11.2 108.2 6.8 35.6 14.7 79.5 42.5 48.3 21.7 9.6 28.8 55.9 11.3 39.6 20.4 62.6 37.2 28.5 14.7 11.8 41.9 10.5 43.7 24.2 13.1 52.8 42.8 39.8 36.8 39.5 36.4 33.9 162.7 78.8 0.6 57.1 115.6 63.2 51.5 0.4 3.0 0.0 31.6 147.4 41.7 31.7 30.7 33.8 59.9 0.1 24.4 9.5 90.5 11.9 71.1 7.6 5.1 129.7 13.4 55.5 36.4 140.9 17.3 19.4 6.7 0.1 367.9 15.2 22.1 0.5 35.8 0.0 26.5 0.1 186.3 0.6 13.8 27.9 21.1 91.0 104.3 0.5 37.5 23.7 11.0 2.3 240.4 71.3 61.6 72.1 59.6 0.2 0.1 0.2 37.3 6.7 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.9 23.6 32.4 18.4 28.2 96.6 41.8 40.4 11.2 42.5 37.2 41.9 39.8 4.7 6.4 20.0 130.6 0.0 49.5 21.1 15.4 17.6 1.7 7.9 13.8 6.8 0.0 8.3 0.0 0.0 0.7 0.1 0.0 0.0 1.5 37.9 5.5 78.1 4.3 0.0 0.0 61.9 2.6 1.9 68.2 0.0 11.7 1.3 22.1 3.3 0.1 4.0 0.0 64.3 0.0 4.1 0.8 19.8 33.9 42.6 2.9 24.9 40.3 0.6 13.6 0.0 141.8 1.3 1.1 0.0 67.7 1.2 10.1 0.0 0.1 9.9 0.8 19.7 111.7 59.6 5.2 2.7 4.6 23.4 1.4 1.7 26.4 0.0 8.9 GKN1 "AMP18, BRICD1, CA11" ENSG00000169605 "Gastrokine 1" Q9NS71 2 68974573-68980980 "Plasma proteins, Predicted secreted proteins" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1842 "stomach 1: 37772.3" "Cell type enriched" "Detected in some" 28 "Gastric mucus-secreting cells: 9780.9" "Cancer enriched" "Detected in some" 116 "stomach cancer: 255.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.5;HMC-1: 17.2;MOLT-4: 12.4;NTERA-2: 16.0;REH: 7.2;U-2 OS: 10.1;U-266/70: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA047684 Enhanced "Secreted to digestive system" NA NA 18000000 "HPA047684: AB_2680120" "unprognostic (5.40e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.54e-1)" "prognostic favorable (4.53e-4)" 1.6 1.8 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.4 0.0 1.3 0.0 0.3 0.0 3.6 0.4 0.0 0.6 0.0 0.0 1.8 0.8 3.5 0.0 0.0 0.0 0.0 0.4 4.8 0.0 0.3 20.5 0.0 0.7 0.3 0.0 0.4 0.1 1.0 0.5 0.4 0.0 0.0 10.5 37772.3 0.4 0.0 1.1 0.2 0.2 0.1 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.4 0.0 16.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 10.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 3.3 9780.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.5 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.5 0.0 0.0 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736349-112764664 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 13.3;lymphoid tissue: 12.2;testis: 4.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Microtubules,Mitotic spindle,Cytosol" Yes Yes "Microtubules, Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 0.4 0.1 0.1 2.6 0.2 13.3 0.4 0.4 0.3 0.3 0.0 1.6 1.5 0.3 0.1 2.4 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.3 5.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.2 0.1 2.2 0.2 0.3 0.0 0.0 1.5 1.1 1.1 0.0 0.9 1.0 4.6 0.1 12.2 0.2 0.0 5.3 0.8 0.6 0.4 47.9 9.6 35.4 16.2 2.0 3.3 7.2 38.5 32.2 37.9 36.1 8.7 13.3 32.0 15.5 15.1 48.3 18.0 20.4 19.6 64.1 44.8 8.9 53.6 12.7 7.7 0.1 25.2 30.9 0.9 1.9 47.4 27.2 10.1 17.5 22.8 14.3 44.9 31.2 6.9 31.0 10.6 15.4 20.0 29.5 22.3 37.0 8.4 6.9 18.7 19.7 12.7 15.2 12.8 13.3 13.2 12.4 11.8 12.9 42.7 33.7 34.5 28.5 9.9 20.1 26.6 18.5 18.1 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.1 3.2 0.6 0.0 1.2 3.3 2.1 2.7 0.6 0.0 0.5 0.8 0.5 1.5 0.4 0.0 0.0 11.1 1.3 1.3 0.0 0.4 2.4 1.1 1.6 1.1 0.0 25.2 0.3 0.4 10.6 2.0 1.5 2.1 0.0 12.5 2.9 0.1 6.6 0.0 0.2 3.1 2.0 1.9 1.4 2.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 5.6 1.1 0.1 0.1 0.4 0.0 0.0 0.4 2.8 33.0 35.7 9.5 1.7 1.0 2.5 0.7 3.8 1.1 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041947, HPA042980" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA041947: , HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favorable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 12.7 13.6 8.5 10.2 8.3 14.0 13.3 11.7 11.0 10.6 6.3 12.5 13.9 9.2 19.9 12.2 9.1 6.6 8.1 8.7 6.4 15.3 13.1 8.2 13.6 7.7 7.3 8.2 10.6 12.5 9.8 9.3 7.7 7.8 9.5 8.2 10.3 12.5 5.8 12.5 14.8 13.0 6.1 5.3 12.0 11.2 14.0 7.4 10.8 10.4 6.8 11.3 10.2 10.8 15.6 16.8 19.7 12.8 17.4 15.9 14.4 11.6 10.1 16.0 9.7 10.9 13.7 26.6 16.6 13.4 7.6 23.8 29.5 28.5 20.2 10.9 32.1 19.0 15.7 26.4 15.9 15.3 26.6 15.6 12.1 28.8 16.1 18.1 12.8 16.8 43.6 22.1 26.6 9.3 15.7 22.6 14.3 21.4 23.8 12.5 30.5 17.3 22.7 16.7 23.5 29.7 18.2 26.0 20.4 40.8 16.2 23.3 15.4 10.4 20.0 29.1 15.5 17.7 25.4 42.0 31.8 26.0 26.4 22.4 58.0 20.9 31.2 28.1 22.0 31.4 46.7 29.7 29.5 21.2 38.8 34.7 29.9 20.6 42.2 21.4 29.6 41.1 20.5 8.5 8.3 11.7 11.0 8.7 6.4 7.7 7.3 8.2 7.8 5.3 7.4 15.6 27.3 28.9 32.5 16.6 41.1 12.0 27.8 45.2 51.2 28.9 33.6 41.0 11.6 38.6 46.2 25.8 12.5 46.6 22.3 42.3 93.9 47.3 36.7 30.0 21.1 27.2 28.8 32.4 11.6 56.1 30.0 29.9 32.1 19.0 27.8 33.7 26.0 37.7 30.0 30.3 14.3 26.4 34.6 28.4 12.0 30.8 33.2 28.0 26.6 8.4 42.7 32.1 63.8 11.6 19.9 62.7 29.6 36.1 41.2 26.7 77.6 127.3 51.2 30.1 19.7 28.6 25.9 107.3 66.8 46.5 15.3 35.6 39.3 39.9 29.9 26.3 RAMAC "C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET" ENSG00000169612 "RNA guanine-7 methyltransferase activating subunit" Q9BTL3 15 82986210-82991057 "Predicted intracellular proteins" "mRNA capping, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041923, HPA041948" Supported Supported Nucleoplasm No No Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" "unprognostic (5.30e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (3.63e-3)" "unprognostic (2.09e-2)" "unprognostic (4.72e-2)" "unprognostic (7.46e-3)" "unprognostic (9.57e-2)" "unprognostic (2.72e-2)" "unprognostic (9.47e-2)" "unprognostic (2.45e-1)" 13.0 14.9 12.9 16.5 13.0 30.4 26.3 14.5 14.9 16.8 13.2 18.6 14.6 18.4 30.4 24.3 19.7 13.5 15.0 12.9 13.2 17.0 24.4 13.1 23.2 12.9 13.0 12.4 20.8 16.6 18.9 13.0 26.1 13.0 18.2 19.5 20.0 18.4 15.3 29.4 21.7 13.5 17.0 13.0 14.2 19.1 15.7 12.7 23.6 18.4 20.4 29.1 21.0 15.7 14.4 34.1 44.7 44.3 27.1 23.5 15.9 32.7 33.7 33.5 37.6 30.4 49.4 42.9 16.8 45.8 29.2 45.4 37.9 77.1 32.4 40.6 42.0 49.7 52.7 22.7 58.7 33.3 38.0 44.9 34.9 61.4 30.6 38.5 28.7 23.6 28.5 62.8 33.9 39.8 35.7 29.5 48.3 52.0 45.0 21.1 33.4 38.2 26.0 49.0 64.6 41.1 42.0 34.6 36.7 87.0 71.5 58.6 47.9 16.8 27.5 34.9 26.1 48.8 53.1 104.0 41.8 25.2 50.7 34.5 138.6 59.2 98.2 47.9 57.0 51.8 64.8 54.1 52.3 56.1 61.1 53.9 53.4 117.4 70.4 62.8 51.6 69.9 65.9 12.9 13.0 14.5 14.9 12.9 13.2 12.9 13.0 12.4 13.0 13.0 12.7 14.4 18.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 82.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 92.9 2.7 0.0 0.0 0.0 PROKR1 "GPR73, GPR73a, PKR1, ZAQ" ENSG00000169618 "Prokineticin receptor 1" Q8TCW9 2 68643579-68658251 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.7;epididymis: 3.6" "Cell type enhanced" "Detected in single" "Adipocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 2.0" "Low region specificity" "Detected in all" HPA029396 Uncertain NA NA "HPA029396: AB_10610285" "unprognostic (5.46e-2)" "unprognostic (1.60e-2)" "unprognostic (8.75e-2)" "unprognostic (4.99e-4)" "unprognostic (1.18e-1)" "unprognostic (2.55e-3)" "unprognostic (1.07e-1)" "unprognostic (2.91e-2)" "unprognostic (1.85e-1)" "unprognostic (4.52e-2)" "unprognostic (1.89e-1)" "unprognostic (9.72e-2)" "unprognostic (8.96e-7)" "unprognostic (4.07e-2)" "unprognostic (2.53e-1)" "unprognostic (4.19e-1)" "unprognostic (7.22e-2)" 1.7 1.1 0.0 0.2 0.2 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.6 0.6 0.4 0.0 0.4 0.4 0.1 0.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APLF "C2orf13, MGC47799, Xip1, ZCCHH1" ENSG00000169621 "Aprataxin and PNKP like factor" Q8IW19 2 68467572-68655862 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 103.7;Late spermatids: 164.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 7.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029396, HPA034642, HPA034643" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431" "unprognostic (9.37e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.29e-3)" "unprognostic (5.18e-3)" "unprognostic (2.39e-3)" "unprognostic (3.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (2.78e-1)" "unprognostic (1.25e-3)" "unprognostic (3.28e-1)" "unprognostic (5.02e-3)" "unprognostic (8.44e-2)" "unprognostic (5.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.85e-3)" 1.3 1.1 1.8 0.8 3.0 0.7 1.4 0.1 2.2 1.2 0.0 0.9 0.6 1.3 1.0 1.5 0.5 1.0 0.9 2.5 1.4 0.9 1.5 0.9 1.2 1.0 1.9 0.6 0.9 0.6 0.9 0.4 1.8 1.5 1.1 0.8 0.4 1.2 1.3 1.1 2.4 0.5 1.1 0.6 0.8 0.7 1.0 1.4 0.8 1.2 1.3 1.2 1.0 1.4 2.5 1.8 0.3 1.7 1.8 3.4 4.4 1.0 1.7 3.6 1.1 1.4 0.7 1.1 3.4 1.1 1.7 2.2 0.5 0.3 2.7 2.7 2.9 0.4 2.5 0.1 0.4 1.5 0.8 2.4 2.4 2.2 1.7 2.5 2.2 0.8 1.7 0.2 2.8 1.2 0.2 1.3 3.1 1.1 1.8 0.9 1.5 0.6 1.6 2.4 1.0 0.4 1.1 1.8 0.0 1.7 2.6 0.0 0.6 1.2 3.4 0.6 1.5 1.3 2.0 0.9 2.4 1.5 0.8 2.0 7.0 0.5 1.9 0.4 0.7 0.6 0.6 0.8 0.7 0.8 0.5 0.8 0.4 0.0 1.0 0.6 0.7 1.4 0.5 1.8 3.0 0.1 2.2 2.5 1.4 1.0 1.9 0.6 1.5 0.6 1.4 2.5 3.6 3.2 2.6 14.0 3.1 2.4 2.4 4.4 8.0 0.5 2.4 3.6 3.5 0.0 2.9 0.0 2.1 6.3 2.6 0.3 0.0 3.5 103.7 1.4 4.0 3.1 3.5 3.4 21.8 1.9 2.2 3.2 4.6 1.7 0.0 3.9 2.2 1.2 2.2 3.3 3.2 0.7 2.0 1.9 2.6 164.1 4.4 2.3 0.0 9.4 4.2 0.5 3.1 22.6 29.0 1.4 0.5 1.9 6.4 2.8 0.2 2.2 1.3 0.2 0.0 4.8 4.7 7.7 4.8 5.0 3.3 4.9 1.8 2.2 0.7 1.5 BOLA2B ENSG00000169627 "BolA family member 2B" Q9H3K6 16 30192932-30194306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 390000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" "unprognostic (2.49e-1)" "unprognostic (4.60e-3)" "unprognostic (8.49e-2)" "unprognostic (3.02e-3)" "unprognostic (9.80e-4)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (1.25e-1)" "unprognostic (3.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (2.94e-1)" "unprognostic (5.29e-1)" "unprognostic (2.21e-2)" "unprognostic (4.91e-3)" 29.4 29.8 78.2 64.2 81.0 99.4 37.2 84.4 116.1 26.5 80.3 85.2 76.9 15.5 31.0 41.6 18.2 26.5 32.7 78.3 84.4 36.0 24.8 27.7 77.3 85.2 80.5 74.6 13.8 47.3 69.9 28.9 31.8 83.3 20.8 49.0 8.6 43.7 18.3 45.3 29.7 56.8 21.5 81.6 48.6 55.1 28.4 83.3 59.4 17.0 60.7 59.6 61.7 23.0 86.1 277.0 624.3 120.0 300.3 66.6 93.3 224.4 103.3 111.9 161.0 201.1 317.6 309.1 104.5 304.9 86.7 212.3 174.0 129.9 272.4 63.5 257.0 1029.1 229.0 322.0 937.7 158.6 190.2 270.7 79.6 186.6 307.1 168.3 43.6 204.0 365.9 161.2 359.9 139.3 875.3 292.5 379.3 362.2 275.3 651.2 382.2 143.2 699.6 219.4 272.7 305.0 310.0 59.5 558.5 143.8 42.3 227.1 174.4 112.0 173.6 144.4 259.4 276.8 458.9 353.3 302.1 253.4 303.2 277.1 130.8 178.0 156.5 193.4 226.7 196.8 313.6 191.2 204.6 156.7 245.1 144.6 185.2 31.8 160.2 213.7 254.6 254.0 195.8 78.2 81.0 84.4 116.1 78.3 84.4 85.2 80.5 74.6 83.3 81.6 83.3 86.1 4.4 16.0 19.2 0.0 11.7 6.2 3.2 7.5 6.2 0.9 18.3 16.0 107.5 22.8 24.6 23.9 2.1 7.5 11.3 35.7 46.9 14.4 27.8 8.3 4.4 12.6 28.9 5.2 0.0 24.5 5.7 14.1 11.2 8.3 30.3 2.4 16.4 27.1 11.3 1.7 0.0 22.8 8.2 22.0 8.0 31.6 2.5 12.0 7.2 0.0 12.3 7.3 14.4 0.0 0.0 29.6 25.2 1.5 11.0 3.9 51.4 32.7 24.7 2.3 6.6 2.4 11.0 5.7 8.0 5.6 11.2 3.8 14.5 2.7 23.7 4.1 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2 like and GRIP domain containing 8" O14715 2 112368369-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 15.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 16.2;hTEC/SVTERT24-B: 13.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 4.3 1.8 3.0 2.8 4.0 10.7 4.6 8.4 8.0 2.8 5.0 2.1 1.6 3.2 5.4 1.4 2.2 2.9 1.8 3.9 3.9 2.4 5.1 3.4 2.5 2.7 2.4 3.2 3.2 3.0 2.2 2.6 3.3 3.2 2.6 2.3 8.0 2.5 2.9 1.7 3.9 2.2 2.7 1.4 3.0 1.8 15.8 2.6 3.2 2.5 2.2 3.0 2.6 1.6 5.9 6.1 2.6 4.3 2.6 1.6 3.6 0.1 2.4 1.9 2.3 1.5 5.3 0.4 0.0 1.7 4.0 2.0 2.9 12.3 1.7 2.4 8.7 4.0 16.2 4.5 4.1 2.2 0.1 0.2 0.6 2.2 13.4 3.4 5.7 1.9 2.8 8.4 0.4 3.6 2.5 8.7 2.1 3.0 0.9 3.7 0.0 0.5 0.1 1.3 2.5 2.7 0.5 8.1 0.1 1.7 3.0 1.2 6.8 8.9 1.3 1.8 6.9 4.4 0.0 0.0 0.0 0.5 2.9 0.3 1.3 0.4 0.4 1.0 0.3 1.4 0.5 0.7 0.9 0.4 0.6 1.0 0.6 0.3 0.5 0.8 0.7 0.4 0.3 3.0 4.0 8.4 8.0 3.9 3.9 2.7 2.4 3.2 3.2 1.4 2.6 5.9 1.0 9.6 3.6 1.6 2.8 0.4 0.4 0.2 5.2 0.8 0.3 0.3 8.0 1.5 1.9 0.0 2.1 0.2 0.7 0.1 0.0 0.5 24.3 0.6 0.5 1.5 0.0 2.5 9.8 1.1 0.1 2.2 2.6 0.6 5.1 0.6 0.7 0.2 0.4 0.0 7.0 0.4 0.0 0.6 0.8 10.1 0.3 2.0 0.0 9.4 2.3 0.4 0.0 7.5 5.2 0.9 0.0 0.0 2.4 0.0 0.0 0.1 6.7 0.7 0.0 0.9 0.9 6.8 2.7 2.7 0.0 0.4 3.1 0.0 0.0 0.3 HIC2 "HRG22, KIAA1020, ZBTB30, ZNF907" ENSG00000169635 "HIC ZBTB transcriptional repressor 2" Q96JB3 22 21417371-21451463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.6;Extravillous trophoblasts: 41.4;Syncytiotrophoblasts: 39.5" "Cancer enriched" "Detected in all" 5 "testis cancer: 17.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 69.2;K-562: 126.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031884, HPA059399" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031884: AB_10602234, HPA059399: AB_2684003" "unprognostic (2.37e-1)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.42e-5)" "unprognostic (1.83e-1)" "unprognostic (3.83e-1)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-4)" "unprognostic (1.28e-1)" "unprognostic (4.83e-3)" "unprognostic (7.34e-3)" "unprognostic (3.33e-1)" "unprognostic (3.86e-2)" "unprognostic (5.64e-2)" 1.9 1.2 2.7 1.5 2.8 3.7 1.5 0.7 2.8 1.7 0.0 1.9 1.3 2.0 0.5 2.6 2.2 0.8 1.4 2.9 0.9 1.7 1.8 1.8 1.5 1.2 0.7 3.0 3.4 2.2 1.1 2.6 5.9 2.1 1.2 0.8 1.5 1.4 0.7 1.2 1.5 2.1 0.7 0.2 2.5 2.4 7.5 0.9 1.7 2.4 1.1 0.9 1.1 1.6 2.3 2.2 2.7 14.4 4.3 1.1 0.9 69.2 1.4 0.5 1.4 1.2 27.2 0.8 5.1 1.4 0.9 0.9 5.9 10.2 0.9 0.8 3.4 15.0 6.8 4.0 15.0 1.2 6.0 3.1 1.1 0.5 2.1 0.9 0.7 1.1 2.1 126.9 2.1 0.7 2.1 2.7 6.2 15.3 4.8 2.0 6.7 6.4 0.8 0.7 3.6 4.0 7.0 1.8 2.1 2.6 14.9 1.2 9.0 1.9 2.2 5.4 2.1 1.6 4.2 3.6 5.4 1.8 2.5 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 2.7 2.8 0.7 2.8 2.9 0.9 1.2 0.7 3.0 2.1 0.2 0.9 2.3 10.3 3.2 1.1 3.6 7.7 5.5 5.4 2.6 23.9 14.8 4.7 4.2 3.9 7.2 1.7 1.8 14.6 39.6 4.4 10.0 0.0 2.6 14.2 8.3 7.6 6.5 6.1 5.7 11.8 2.6 41.4 6.6 11.2 7.6 1.3 6.4 2.9 3.0 10.3 8.4 7.5 7.4 6.1 3.8 4.3 29.9 5.6 5.6 5.4 1.9 4.5 3.0 2.1 5.0 2.3 2.8 4.6 10.1 10.4 8.1 7.0 1.6 1.5 7.3 6.6 10.7 6.0 12.2 24.5 27.1 4.5 39.5 5.8 2.6 9.3 7.5 LUZP1 LUZP ENSG00000169641 "Leucine zipper protein 1" Q86V48 1 23084023-23177808 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 349.1;Early spermatids: 291.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 39.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 127.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028506, HPA028542" Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA028506: AB_10600083, HPA028542: AB_10601986" "unprognostic (3.04e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (7.35e-3)" "unprognostic (7.20e-2)" "unprognostic (3.96e-2)" "unprognostic (8.27e-2)" "unprognostic (8.46e-3)" "unprognostic (9.77e-3)" "unprognostic (7.34e-2)" "unprognostic (2.56e-3)" "unprognostic (1.19e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.46e-7)" "unprognostic (4.49e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-1)" "unprognostic (1.33e-1)" 11.6 14.4 6.3 9.3 8.0 14.3 7.4 6.4 24.0 10.2 5.3 13.2 22.9 12.0 5.5 9.4 6.4 13.1 13.8 7.4 9.8 10.8 3.6 10.5 6.4 12.5 8.7 5.5 7.7 6.2 20.3 3.8 12.8 14.2 9.9 13.3 5.4 7.0 9.7 3.3 9.0 24.9 12.9 4.1 10.8 5.3 11.5 12.3 9.9 9.6 6.6 7.1 10.5 7.5 13.6 26.4 17.7 24.5 28.5 24.6 31.3 17.8 25.3 40.1 31.0 32.4 10.1 12.0 0.5 22.6 43.0 19.9 34.8 24.5 68.5 37.6 9.6 16.2 36.6 21.8 9.6 16.2 18.5 22.5 27.7 26.4 45.6 35.6 25.6 70.6 10.0 13.6 2.0 25.2 7.0 12.6 7.9 20.8 8.1 18.9 18.9 36.7 3.1 14.0 17.1 4.5 11.6 60.4 16.8 20.3 48.9 9.6 9.6 127.0 36.2 27.2 27.2 25.4 3.0 7.8 9.8 15.9 29.8 31.8 39.8 7.6 8.4 11.5 5.4 13.1 3.2 8.7 7.5 7.6 5.8 6.9 6.9 4.1 7.1 10.9 15.8 5.1 3.3 6.3 8.0 6.4 24.0 7.4 9.8 12.5 8.7 5.5 14.2 4.1 12.3 13.6 103.5 9.6 14.1 58.1 17.1 135.2 349.1 64.7 117.8 23.7 31.3 41.7 54.7 27.1 33.7 20.2 2.1 25.6 34.1 100.3 15.6 58.6 291.4 35.6 83.0 138.2 21.5 9.5 113.2 30.6 53.7 49.4 14.3 54.1 22.8 21.9 68.6 11.5 27.3 21.9 111.3 55.8 61.1 18.0 77.9 52.9 36.4 36.4 33.8 65.6 83.7 17.4 33.0 38.2 7.2 75.9 54.0 43.6 19.5 83.5 117.3 23.3 24.0 8.4 32.9 43.7 67.5 84.6 85.9 72.9 70.8 24.8 46.3 38.4 54.9 183.0 HEXD "FLJ23825, HEXDC" ENSG00000169660 "Hexosaminidase D" Q8WVB3 17 82418318-82442645 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 7.8;Cardiomyocytes: 6.1;Cytotrophoblasts: 5.9;dendritic cells: 10.1;Extravillous trophoblasts: 6.4;Hofbauer cells: 16.2;Plasma cells: 4.1;Syncytiotrophoblasts: 4.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 62.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022834, HPA023379, HPA027844" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center, Mitochondria" "HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711" "unprognostic (8.69e-3)" "prognostic favorable (7.70e-4)" "unprognostic (7.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.51e-2)" "prognostic favorable (2.71e-4)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.71e-1)" "unprognostic (1.14e-2)" "prognostic favorable (5.57e-4)" "unprognostic (9.04e-3)" "unprognostic (1.83e-1)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.52e-5)" 27.6 20.7 6.1 4.5 6.5 9.1 21.2 8.9 7.8 30.4 7.9 16.0 4.1 22.6 3.9 15.5 25.5 3.2 13.7 5.8 6.0 23.5 30.1 14.9 7.1 7.4 6.3 5.2 30.2 55.6 4.1 32.2 1.8 7.7 34.9 2.1 3.7 19.9 4.3 28.6 13.7 24.4 2.1 5.4 36.4 21.5 12.6 6.5 5.0 25.6 7.7 3.5 17.7 21.2 8.8 3.4 8.0 3.5 5.9 11.3 9.9 10.7 4.5 5.4 4.4 4.7 3.1 11.1 9.5 4.8 1.7 3.0 4.9 2.0 2.5 1.7 6.4 15.5 4.1 8.4 3.9 9.9 2.9 10.2 7.3 1.9 1.3 4.6 4.7 5.7 5.9 5.5 3.2 1.3 7.5 10.0 8.6 3.7 6.5 5.1 11.5 3.2 17.9 3.5 4.5 4.9 11.1 9.4 5.5 9.1 1.3 8.4 10.7 5.2 2.8 5.3 2.2 3.1 14.6 2.1 7.0 2.3 6.9 3.2 9.5 3.0 5.6 18.4 24.3 12.4 8.3 3.9 6.5 3.8 11.0 5.8 9.3 5.5 25.4 10.8 62.3 3.2 11.2 6.1 6.5 8.9 7.8 5.8 6.0 7.4 6.3 5.2 7.7 5.4 6.5 8.8 7.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 5.9 10.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.0 1.4 0.0 0.0 0.0 DRD5 "DRD1B, DRD1L2" ENSG00000169676 "Dopamine receptor D5" P21918 4 9781634-9784009 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Dystonia, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.6;stomach 1: 4.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.2;Horizontal cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 7.0" HPA048930 Supported NA NA "HPA048930: AB_2680562" "unprognostic (2.03e-2)" "unprognostic (2.63e-1)" "unprognostic (9.73e-2)" "unprognostic (4.27e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (1.32e-4)" "unprognostic (5.09e-4)" "unprognostic (6.51e-2)" "unprognostic (1.46e-1)" "unprognostic (7.36e-3)" 0.0 0.0 2.1 1.4 5.6 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.3 0.0 0.0 0.0 0.0 2.4 1.2 3.1 0.0 0.0 0.0 0.4 0.0 2.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.5 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 5.6 0.0 1.8 1.7 1.3 2.4 1.2 3.1 2.4 0.7 1.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637528-110678063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.0;lymphoid tissue: 27.8;testis: 30.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "white matter: 1.7" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 221.5" "Region enhanced" "Detected in single" "white matter: 1.7" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 0.5 0.4 0.1 8.4 0.2 12.0 1.2 0.1 0.2 0.5 0.0 4.4 4.0 1.1 3.5 4.7 0.5 0.9 0.6 0.1 0.4 0.3 0.6 1.2 16.1 0.1 0.3 0.0 0.4 0.2 0.8 0.0 3.2 0.2 0.3 5.7 0.1 0.9 0.1 0.1 2.7 3.6 2.2 0.1 5.7 1.9 30.5 0.3 27.8 0.4 0.2 17.1 2.5 1.6 1.7 96.0 29.4 68.5 46.8 3.8 5.3 38.8 50.9 32.9 85.6 62.3 58.3 55.0 64.7 30.9 30.1 80.1 43.2 93.9 35.0 105.7 51.4 45.6 221.5 26.2 50.6 0.8 63.5 57.0 1.7 2.8 65.2 33.1 12.7 49.8 73.2 96.8 126.5 76.8 33.7 126.3 39.0 71.2 39.4 55.3 69.3 64.2 102.7 18.3 27.0 48.3 21.4 34.2 31.4 27.2 44.1 24.0 60.6 19.1 39.7 57.5 28.8 69.0 67.3 65.5 75.4 24.2 48.6 69.8 1.1 0.0 0.2 0.2 0.0 0.3 0.5 0.9 0.5 0.1 0.5 0.6 0.4 0.0 0.5 0.0 0.9 1.5 0.3 0.1 0.2 0.1 0.2 0.1 0.4 0.1 0.3 0.0 0.2 0.1 0.3 1.7 0.2 0.0 1.5 0.0 5.5 0.5 0.5 2.0 0.6 0.0 0.9 0.8 1.1 0.0 1.6 0.0 0.0 5.8 2.5 2.4 0.0 0.3 13.5 4.5 1.5 1.1 0.0 24.8 0.2 0.0 9.8 2.2 2.0 2.2 0.0 66.1 1.8 0.3 8.1 0.0 0.2 3.1 4.1 1.6 1.4 7.5 0.3 2.0 0.0 0.0 0.6 0.0 0.0 0.5 1.0 0.1 0.0 0.4 35.2 0.5 0.3 0.1 1.8 0.0 6.6 0.2 3.7 85.6 20.0 4.0 0.4 0.7 2.9 0.5 5.9 0.9 SPNS1 "HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 26.1 31.1 14.1 19.4 14.2 37.3 25.0 14.1 26.6 27.7 15.0 30.8 22.6 31.1 6.7 26.1 23.2 18.1 24.4 13.9 15.0 32.0 34.2 31.8 20.3 15.9 13.8 12.8 22.2 24.6 21.0 21.3 20.0 14.7 26.7 10.1 6.5 24.6 15.1 25.2 34.9 28.0 15.3 13.0 34.1 28.4 20.5 16.0 21.0 28.0 15.1 10.6 30.7 25.4 15.4 25.9 59.6 22.2 51.9 41.5 22.8 62.9 28.2 28.9 46.1 40.9 55.0 60.4 16.4 67.8 25.5 38.2 53.3 36.4 31.2 16.4 19.0 61.6 23.8 57.1 69.3 70.4 26.7 49.2 38.4 40.9 49.7 21.0 26.8 42.9 30.0 54.4 28.7 23.4 68.8 29.3 75.8 52.6 20.8 39.1 36.7 26.7 73.6 24.9 24.8 39.5 51.3 20.1 59.3 44.9 18.5 59.2 31.9 36.6 37.3 28.2 52.7 22.0 43.2 36.7 15.6 47.7 40.4 30.8 13.4 32.8 13.5 9.9 42.1 8.3 5.7 9.8 13.0 27.6 4.3 10.0 6.8 5.6 7.7 28.8 11.5 12.1 18.1 14.1 14.2 14.1 26.6 13.9 15.0 15.9 13.8 12.8 14.7 13.0 16.0 15.4 24.4 6.4 7.2 8.8 14.9 21.3 21.3 29.8 14.8 31.0 17.2 15.7 0.3 20.0 20.1 20.2 29.2 63.3 26.5 10.5 13.7 58.1 2.1 15.3 19.2 24.1 12.2 21.8 10.2 45.7 72.3 24.6 16.8 18.9 22.7 40.9 19.2 14.3 98.7 26.9 10.3 13.8 46.8 45.6 28.4 3.7 22.7 61.8 33.8 15.0 32.7 28.5 24.7 7.1 8.6 37.3 16.0 16.6 18.6 14.4 41.5 18.2 26.2 38.6 6.6 17.4 23.8 24.8 33.5 16.4 22.7 87.3 20.7 37.8 20.0 19.4 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023305-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 6.1 2.1 3.8 2.0 7.1 5.9 7.2 5.4 6.1 1.7 7.6 5.8 5.4 0.9 10.4 9.1 1.6 4.6 2.2 1.7 7.5 18.1 6.4 3.2 2.7 2.4 1.9 4.5 10.2 2.1 6.0 2.4 4.4 8.5 1.7 0.6 9.7 2.2 2.6 8.1 8.7 1.2 2.0 9.6 10.6 4.1 1.8 3.2 9.0 0.5 1.5 6.1 6.9 2.1 18.6 20.7 6.2 12.7 2.5 3.3 24.0 12.7 5.2 7.5 6.3 18.6 12.4 13.9 11.2 2.5 7.8 21.3 6.0 7.6 1.7 8.5 38.6 8.8 43.1 25.5 2.1 10.4 21.2 3.3 3.1 4.5 1.2 3.1 11.1 13.0 6.3 6.0 2.0 31.6 23.5 34.5 6.4 15.0 27.4 19.0 12.2 7.8 4.8 16.9 19.1 18.6 5.8 29.9 11.2 3.0 24.4 12.0 6.5 13.1 16.3 20.8 21.9 11.5 3.1 2.1 7.0 8.9 13.9 2.3 1.2 1.5 1.4 0.9 1.4 0.6 1.6 1.6 0.8 0.7 0.8 1.1 0.0 1.1 0.4 1.3 1.4 1.4 2.1 2.0 7.2 5.4 2.2 1.7 2.7 2.4 1.9 4.4 2.0 1.8 2.1 3.9 6.4 2.2 4.2 4.1 4.5 5.0 2.9 1.8 5.2 8.5 8.6 2.7 14.3 7.0 3.7 0.0 12.7 7.8 18.1 5.9 7.3 1.5 19.0 3.4 3.7 4.8 10.3 2.5 4.7 27.9 4.8 13.3 5.0 4.5 13.3 7.1 12.6 8.7 5.0 2.9 12.2 4.1 6.3 3.2 4.4 7.2 4.2 8.8 0.0 4.3 5.6 7.2 1.0 1.8 5.8 9.4 6.4 8.5 2.4 10.9 10.2 24.4 4.1 0.0 2.8 5.2 2.3 11.9 6.3 2.4 3.0 7.0 4.9 18.4 3.7 CHRNA5 ENSG00000169684 "Cholinergic receptor nicotinic alpha 5 subunit" P30532 15 78565520-78595269 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 13.0;Extravillous trophoblasts: 11.5;Intestinal goblet cells: 9.8;Spermatocytes: 12.4;Spermatogonia: 28.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA054381 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Focal adhesion sites" "Plasma membrane" "HPA054381: AB_2682468" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" "unprognostic (3.20e-3)" "unprognostic (6.66e-2)" "unprognostic (1.29e-3)" "unprognostic (7.03e-5)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.34e-2)" "unprognostic (1.31e-2)" "unprognostic (4.52e-2)" "unprognostic (8.97e-2)" "unprognostic (6.50e-11)" "unprognostic (4.37e-1)" "unprognostic (5.39e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" 0.8 2.0 2.0 1.9 1.8 0.5 1.5 2.5 4.1 0.9 2.7 4.1 4.8 1.3 1.1 1.6 0.6 4.4 1.1 2.1 1.7 0.4 0.3 0.5 0.7 2.0 2.3 1.5 0.7 1.9 0.3 0.2 1.1 2.0 1.9 4.3 2.6 0.7 0.4 4.0 0.6 2.4 2.1 1.8 0.3 2.9 3.1 2.4 0.7 0.3 0.5 1.1 1.8 1.1 2.7 16.5 41.8 22.4 12.5 2.7 1.9 9.1 12.0 5.8 13.0 23.4 16.1 76.7 9.8 28.6 2.6 34.7 14.3 43.5 17.6 13.2 20.1 51.9 18.3 29.5 16.2 1.4 12.4 24.7 0.7 3.1 3.5 4.7 4.8 24.5 13.6 18.2 12.5 8.3 36.1 15.9 4.3 18.2 32.4 11.5 20.1 25.8 9.9 15.7 39.2 37.7 55.0 28.6 27.5 14.1 12.7 61.2 3.2 5.3 17.6 21.0 13.0 38.0 14.3 63.4 11.3 10.6 19.8 16.5 1.0 0.4 0.7 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.3 0.7 0.3 0.4 0.2 0.0 0.1 2.0 1.8 2.5 4.1 2.1 1.7 2.0 2.3 1.5 2.0 1.8 2.4 2.7 0.9 0.0 0.0 0.3 1.4 3.2 13.0 0.5 8.6 7.6 1.2 2.9 1.2 2.8 0.2 0.0 0.0 2.6 0.4 1.2 0.0 0.3 1.2 0.5 0.6 2.0 3.5 0.8 1.0 2.0 11.5 1.0 0.5 0.6 0.0 1.5 0.0 0.3 1.0 5.0 1.1 9.8 0.0 0.0 2.3 2.6 0.3 0.8 1.8 0.0 0.2 0.4 1.0 0.5 0.9 0.7 0.1 0.4 0.9 6.7 0.1 0.4 0.1 0.7 0.0 1.3 1.6 12.4 28.8 2.9 1.6 1.0 2.0 0.2 2.1 3.2 MT1B "MT1, MT1Q" ENSG00000169688 "Metallothionein 1B" P07438 16 56651886-56653204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "liver: 23.1" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 4.4;Hepatocytes: 12.8;Proximal enterocytes: 3.2;Proximal tubular cells: 6.7" "Cancer enriched" "Detected in single" 209 "liver cancer: 57.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.66e-1)" 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.9 0.0 0.0 0.7 12.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 3.2 6.7 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 CENPX "CENP-X, FAAP10, MGC14480, MHF2, STRA13" ENSG00000169689 "Centromere protein X" A8MT69 17 82018702-82024107 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 172.6;Breast myoepithelial cells: 190.2;Cytotrophoblasts: 197.7;Extravillous trophoblasts: 455.2;Hofbauer cells: 146.1;Pancreatic endocrine cells: 151.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (3.11e-1)" "unprognostic (3.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.76e-2)" "unprognostic (2.60e-1)" "unprognostic (2.95e-3)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-3)" "unprognostic (2.74e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.57e-2)" "unprognostic (3.48e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" 37.2 29.3 53.9 28.1 54.1 44.6 42.0 58.4 71.1 32.3 50.1 51.0 38.8 26.4 11.7 63.6 29.3 15.1 30.7 52.7 54.8 46.0 90.2 33.7 25.5 55.2 55.4 52.9 29.4 33.3 26.5 18.4 30.4 55.4 65.6 30.9 16.3 50.5 18.5 38.0 43.9 41.2 17.3 53.8 29.9 50.7 22.5 54.3 25.7 34.4 21.3 20.9 42.5 38.7 56.8 131.3 352.7 78.4 116.6 30.0 27.6 62.2 91.9 78.1 116.7 79.3 144.1 101.1 47.8 83.9 50.0 113.0 76.1 71.3 88.6 52.7 51.1 259.0 86.0 157.1 247.8 32.2 103.6 61.5 26.8 43.4 90.4 31.6 34.7 111.8 88.4 153.9 75.0 72.7 376.1 174.3 94.3 51.9 329.6 230.9 78.0 84.4 70.9 69.5 157.5 177.5 113.1 51.3 302.0 49.4 38.0 238.1 80.1 40.7 125.0 154.5 215.1 161.3 50.4 27.5 65.6 86.3 84.7 103.2 47.9 112.3 61.5 82.4 99.4 80.6 106.1 79.4 78.7 85.4 83.8 85.3 72.5 24.5 74.4 90.3 105.4 110.7 99.6 53.9 54.1 58.4 71.1 52.7 54.8 55.2 55.4 52.9 55.4 53.8 54.3 56.8 61.2 41.7 59.6 0.0 11.3 0.0 0.0 0.0 0.0 0.0 172.6 190.2 0.0 0.0 29.1 44.1 0.0 197.7 33.7 0.0 129.1 102.4 0.0 41.1 34.6 27.6 0.0 0.0 0.0 128.8 455.2 33.4 0.0 49.3 11.4 60.5 0.0 0.0 146.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 51.1 0.0 0.0 0.0 0.0 151.5 0.0 0.0 5.5 0.0 0.0 139.3 17.5 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 105.2 21.8 40.1 0.0 0.0 AGPAT2 "BSCL, LPAAT-beta" ENSG00000169692 "1-acylglycerol-3-phosphate O-acyltransferase 2" O15120 9 136673143-136687457 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 347.1;breast: 262.1;liver: 448.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 688.9;Late spermatids: 387.3;Paneth cells: 670.7;Proximal enterocytes: 1298.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 186.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019544 Uncertain NA NA "HPA019544: AB_1844646" "unprognostic (3.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.01e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (9.30e-3)" "unprognostic (5.06e-3)" "unprognostic (8.98e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (2.17e-1)" "unprognostic (5.61e-2)" "unprognostic (2.60e-1)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" "unprognostic (2.93e-1)" 347.1 38.6 9.9 11.9 8.0 34.5 262.1 7.6 16.0 32.0 11.8 59.6 112.4 26.6 9.7 86.3 29.9 15.9 81.4 7.8 10.5 66.0 448.6 61.4 9.3 10.2 10.6 8.0 17.9 130.7 18.5 41.8 8.0 9.1 34.6 12.3 0.9 48.5 13.0 37.7 50.9 120.4 6.8 9.3 39.5 52.4 24.3 11.2 5.5 47.3 10.0 5.3 35.8 37.0 8.7 55.0 75.2 8.9 41.4 63.3 19.8 37.3 35.5 28.5 24.1 18.5 86.0 105.7 17.8 77.8 21.0 38.6 145.1 12.7 22.2 2.8 186.9 57.3 26.5 30.3 19.2 42.6 28.1 62.1 19.0 30.9 20.9 11.0 20.9 12.5 23.6 32.7 2.9 10.4 98.5 1.9 87.4 22.5 101.0 135.0 41.0 31.3 100.3 28.5 33.9 19.5 31.4 45.8 47.6 60.3 6.8 30.6 109.3 24.7 31.5 32.1 10.4 23.0 4.4 0.4 11.8 0.4 59.7 32.1 20.1 88.8 111.8 6.8 83.5 6.5 12.8 5.8 7.9 47.8 22.7 4.6 5.5 61.1 7.2 75.7 65.6 8.1 35.2 9.9 8.0 7.6 16.0 7.8 10.5 10.2 10.6 8.0 9.1 9.3 11.2 8.7 25.9 16.0 64.4 0.7 20.2 45.2 60.0 64.0 22.8 3.5 23.4 22.4 39.6 87.2 45.3 73.5 0.0 7.3 30.8 688.9 54.8 155.2 136.4 50.4 17.4 27.9 35.8 8.0 1.9 219.5 37.1 30.1 81.6 63.8 13.4 31.4 31.1 228.0 131.2 40.4 2.6 197.3 126.1 53.4 57.4 387.3 26.8 57.6 136.9 4.7 48.8 14.6 23.7 0.0 0.3 169.5 670.7 20.3 13.4 93.5 1298.3 41.9 46.3 3.8 46.0 15.3 29.8 1.8 27.2 47.5 81.3 6.8 26.6 16.4 207.7 196.2 ASPSCR1 "ASPL, ASPS, TUG, UBXD9, UBXN9" ENSG00000169696 "ASPSCR1 tether for SLC2A4, UBX domain containing" Q9BZE9 17 81976807-82017406 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "Hep G2: 298.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026749 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA026749: AB_1845114" "unprognostic (5.01e-2)" "unprognostic (1.19e-3)" "unprognostic (7.61e-2)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.02e-1)" "unprognostic (2.07e-2)" "unprognostic (3.43e-1)" "unprognostic (1.71e-3)" "prognostic favorable (2.67e-4)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.16e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (1.01e-2)" 16.1 20.6 14.8 8.4 15.0 15.1 17.0 14.7 20.6 16.1 14.9 16.1 13.7 15.7 7.9 16.9 14.1 7.7 22.5 14.2 14.3 27.3 58.3 17.4 12.3 18.1 14.9 14.4 13.5 23.0 14.9 30.8 13.1 16.8 21.7 4.6 5.7 18.4 6.7 44.6 20.5 18.3 5.2 13.3 20.9 22.9 30.3 15.1 8.4 26.1 5.8 6.4 16.2 14.3 19.8 19.3 33.3 13.0 17.9 7.5 9.3 55.4 17.7 12.6 19.3 19.5 20.3 21.3 19.2 18.1 12.4 16.3 9.8 12.0 13.1 6.2 12.9 41.0 21.4 28.7 298.1 25.5 19.1 29.9 10.9 13.9 9.5 6.6 10.0 19.5 16.0 22.0 25.0 11.6 65.0 16.9 41.8 15.5 32.8 23.5 19.2 18.7 39.4 18.0 17.0 32.4 34.8 14.6 42.2 35.2 12.3 27.2 41.4 16.6 35.7 24.5 26.4 22.8 20.2 12.5 21.6 19.2 19.3 21.3 24.0 11.7 8.6 6.6 8.0 3.7 9.0 10.0 8.8 14.7 9.0 7.7 5.8 2.7 8.0 10.4 9.3 5.3 5.6 14.8 15.0 14.7 20.6 14.2 14.3 18.1 14.9 14.4 16.8 13.3 15.1 19.8 13.9 9.6 44.7 19.9 24.1 13.4 23.7 24.4 23.3 23.3 19.6 15.6 13.6 27.1 19.8 14.7 41.7 73.7 25.8 29.3 39.2 24.2 49.1 16.2 14.9 16.1 25.0 17.9 12.4 26.2 222.6 17.5 46.9 20.1 21.5 31.0 12.8 56.1 44.7 50.5 12.1 31.5 20.3 26.7 18.6 96.0 11.8 21.7 19.6 1.9 23.8 57.8 19.6 10.6 14.1 17.6 25.8 17.7 27.3 24.9 42.5 58.3 18.5 39.4 13.1 14.7 37.4 41.7 51.0 20.3 14.3 59.4 18.4 23.6 33.3 23.1 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060779-129062406 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.2;lung: 3.3;lymphoid tissue: 9.0" "Cell type enriched" "Detected in some" 8 "Macrophages: 151.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 29.5;neutrophil: 13.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 29.5" "Cell line enriched" "Detected in some" 14 "HEL: 85.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 2600000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.1 0.0 0.1 0.0 0.0 5.2 0.1 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.0 0.1 1.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 1.2 0.2 0.2 0.7 0.3 0.0 0.0 0.3 0.6 0.1 0.1 0.0 13.9 0.0 0.2 3.0 0.0 51.9 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 14.4 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 2.9 0.1 1.7 0.0 0.0 0.6 0.0 1.3 0.0 18.3 0.0 151.9 0.0 0.0 4.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.3 0.0 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078338-82098294 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 346.4;breast: 273.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 1109.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" No No 3400000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 346.4 31.1 23.3 15.0 45.6 18.9 273.9 57.4 48.0 21.8 0.0 21.1 11.6 18.2 6.3 64.1 15.4 6.6 16.4 43.5 18.4 11.8 192.9 54.5 7.3 82.8 75.7 33.9 16.5 18.7 8.6 72.9 12.2 89.0 69.6 3.1 4.3 38.7 14.4 28.1 77.8 29.0 5.3 17.3 8.9 64.1 11.9 33.7 9.7 21.4 2.3 3.1 27.2 32.1 75.9 179.1 182.0 81.7 56.7 130.1 87.2 176.9 34.3 43.3 35.5 64.6 190.6 116.7 58.8 29.2 26.3 99.5 144.0 79.2 157.8 6.5 30.0 358.0 123.9 140.0 257.2 36.8 67.5 19.2 84.2 40.4 90.8 21.0 12.1 40.1 54.8 193.2 50.7 12.6 304.1 78.9 105.5 161.1 28.1 107.1 64.1 47.8 116.5 40.3 220.7 205.0 117.0 50.6 1109.2 93.6 29.5 199.4 123.4 71.1 52.3 107.0 45.2 88.4 68.5 17.1 60.6 31.2 71.1 79.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 23.3 45.6 57.4 48.0 43.5 18.4 82.8 75.7 33.9 89.0 17.3 33.7 75.9 9.6 25.6 126.0 28.4 7.4 7.8 12.7 33.2 8.0 28.7 442.9 165.4 5.9 21.5 28.4 11.0 6.2 32.0 12.8 35.7 3.9 19.2 1.5 19.6 19.8 10.8 18.1 20.6 11.9 29.2 77.7 13.4 33.6 17.1 12.7 29.9 10.8 244.1 13.9 30.3 12.5 22.3 22.4 9.8 6.2 3.4 16.4 7.0 17.8 4.7 6.2 14.1 8.2 11.6 17.6 19.1 23.6 11.3 9.7 60.4 6.5 5.9 23.7 13.1 0.0 9.0 14.9 1.8 11.7 34.1 13.8 29.6 10.6 27.9 27.4 19.6 CNBP "CNBP1, DM2, RNF163, ZCCHC22, ZNF9" ENSG00000169714 "CCHC-type zinc finger nucleic acid binding protein" P62633 3 129167827-129183922 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063097 Approved Nucleoplasm,Cytosol NA NA 160000 Nucleoplasm Cytosol "HPA063097: AB_2684939" "unprognostic (1.74e-1)" "unprognostic (3.11e-2)" "unprognostic (4.84e-1)" "unprognostic (3.35e-2)" "unprognostic (6.28e-2)" "unprognostic (7.38e-2)" "unprognostic (7.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (6.39e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.72e-3)" "unprognostic (4.62e-3)" "unprognostic (1.89e-1)" "unprognostic (2.03e-1)" "unprognostic (2.51e-1)" "unprognostic (1.58e-1)" 288.0 311.2 184.2 182.8 190.7 256.3 277.0 206.6 213.2 283.9 188.3 274.6 200.3 288.5 199.3 267.0 278.1 196.9 491.7 178.2 208.7 229.2 437.2 260.5 253.0 193.9 192.2 175.5 389.3 309.9 280.2 170.8 216.1 193.4 258.8 221.1 233.8 252.9 285.1 1217.6 287.1 200.9 237.0 205.0 202.4 264.2 132.4 186.7 256.6 264.1 805.0 252.8 320.2 271.4 219.1 452.7 266.4 369.9 294.6 355.2 303.9 294.9 344.2 535.7 362.2 412.4 389.2 305.7 589.8 292.2 318.1 269.6 328.3 484.3 396.4 484.6 404.5 357.9 569.2 251.7 420.2 355.7 622.4 314.5 295.5 449.2 254.8 897.8 247.6 324.1 328.1 437.6 391.9 384.0 538.9 578.6 454.1 452.7 399.7 439.1 502.4 343.4 707.7 379.1 425.4 501.2 402.8 271.5 263.0 766.3 214.4 305.6 421.3 347.9 268.4 266.2 374.1 353.7 367.3 365.4 932.3 277.3 419.2 362.4 1077.7 810.5 930.9 551.8 596.8 699.0 691.0 658.8 595.3 552.8 603.8 700.3 610.5 1102.3 601.1 485.5 320.4 704.3 2029.8 184.2 190.7 206.6 213.2 178.2 208.7 193.9 192.2 175.5 193.4 205.0 186.7 219.1 253.7 259.6 263.9 27.1 292.8 524.7 417.0 262.9 259.6 153.7 177.5 272.5 608.0 141.5 235.1 79.1 33.3 252.3 188.1 143.9 373.7 226.9 36.0 141.4 195.1 267.5 171.3 246.5 28.2 290.7 396.6 309.4 142.8 172.8 314.5 173.0 167.0 138.5 246.5 92.5 33.7 178.6 140.4 194.4 463.0 42.9 316.0 232.4 318.4 35.6 392.7 350.3 236.9 32.6 42.8 230.1 158.0 319.7 311.7 405.1 196.5 237.4 164.8 153.8 263.0 343.6 571.0 305.2 271.5 286.5 586.7 291.7 304.2 277.7 213.6 376.2 MT1E "MT1, MTD" ENSG00000169715 "Metallothionein 1E" P04732 16 56625475-56627112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1802.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 4001.6;Paneth cells: 4625.0;Proximal enterocytes: 5720.1;Proximal tubular cells: 8933.3;Undifferentiated cells: 2966.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.8;T-cells: 20.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 1095.1;LHCN-M2: 827.5;RPTEC TERT1: 946.2;U-2 OS: 527.7" HPA041152 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041152: AB_2732490" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.77e-2)" "unprognostic (1.19e-2)" "unprognostic (3.63e-1)" "unprognostic (9.80e-2)" "unprognostic (7.85e-2)" "unprognostic (3.45e-2)" "unprognostic (2.78e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.86e-1)" "unprognostic (9.53e-2)" "unprognostic (1.97e-1)" "unprognostic (3.78e-2)" 538.2 341.9 329.3 52.7 336.7 2.8 266.3 366.1 514.0 106.3 283.4 239.9 106.1 60.8 12.7 136.5 302.3 41.2 121.9 316.8 333.8 499.1 1802.1 232.3 11.8 346.2 343.1 314.1 73.0 541.8 16.4 53.8 19.3 367.3 242.3 191.0 37.1 95.4 20.8 325.7 188.7 360.7 86.3 323.2 30.6 589.5 11.5 364.0 4.1 385.7 93.3 8.0 89.9 142.1 352.4 102.2 0.0 0.0 0.0 154.5 177.0 1.6 263.8 278.6 70.7 82.1 0.9 133.0 0.0 20.3 91.6 10.7 216.7 241.2 1095.1 96.8 102.7 0.0 4.1 139.4 17.5 69.2 0.6 0.6 122.7 362.4 185.5 211.6 426.7 43.5 0.1 0.2 0.7 827.5 0.2 0.4 67.3 94.3 0.0 1.1 0.3 0.0 2.9 946.2 0.0 14.2 0.7 0.7 0.2 1.0 17.4 0.5 124.1 108.6 0.4 527.7 82.5 51.5 0.5 1.9 2.8 296.9 170.2 0.9 0.0 2.9 0.0 14.7 2.1 5.0 0.5 8.2 20.3 5.8 0.0 3.7 14.7 0.1 0.2 1.8 0.3 20.6 3.8 329.3 336.7 366.1 514.0 316.8 333.8 346.2 343.1 314.1 367.3 323.2 364.0 352.4 1237.9 394.2 158.2 83.9 59.6 178.6 240.1 86.9 306.2 0.0 214.2 311.0 106.8 589.0 168.4 496.6 0.0 18.4 32.7 2403.7 1402.9 392.8 1.8 710.8 161.7 210.0 241.9 186.9 0.2 193.7 908.6 522.8 880.2 1646.2 28.5 184.3 222.8 4001.6 34.9 0.0 0.2 2467.0 22.4 110.6 29.0 4.6 149.5 121.0 110.3 8.4 61.9 0.0 1.0 7.5 2.0 314.3 4625.0 51.1 20.6 998.6 5720.1 8933.3 137.6 0.0 216.9 818.8 513.7 3.2 3.7 286.4 148.0 79.8 96.0 14.7 2966.9 84.3 ACTRT2 "Arp-T2, ARPM2, FLJ25424" ENSG00000169717 "Actin related protein T2" Q8TDY3 1 3021467-3022903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1104 "testis: 156.5" "Group enriched" "Detected in some" 112 "Early spermatids: 1270.8;Late spermatids: 3615.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006480, HPA025079" Enhanced NA NA "HPA006480: AB_1845047, HPA025079: AB_1845048" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1270.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3615.6 10.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 21.8 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUS1L "DUS1, PP3111" ENSG00000169718 "Dihydrouridine synthase 1 like" Q6P1R4 17 82057506-82065887 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023384 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023384: AB_1847879" "unprognostic (4.42e-2)" "unprognostic (2.19e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-2)" "unprognostic (1.73e-3)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (5.17e-2)" "unprognostic (1.10e-1)" "unprognostic (4.16e-3)" "unprognostic (5.23e-3)" "unprognostic (3.13e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (4.17e-2)" "unprognostic (8.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.70e-3)" 81.0 87.4 34.1 51.6 34.4 94.9 89.8 32.1 50.1 82.8 36.5 94.1 67.3 74.6 23.2 118.8 82.5 27.2 86.0 35.3 31.8 90.3 175.8 81.2 65.3 37.2 33.6 34.5 83.0 149.6 32.2 100.5 27.3 37.8 119.8 30.1 17.1 106.7 30.7 145.4 121.7 108.1 19.1 31.6 132.4 120.4 94.4 34.2 38.0 94.3 27.5 33.6 88.7 85.7 34.6 169.4 109.0 37.7 44.3 28.9 28.4 115.0 57.5 26.8 56.5 40.2 99.7 77.9 133.7 65.3 33.0 39.8 112.0 46.1 60.9 21.9 54.6 263.1 89.2 167.3 178.8 65.3 138.8 101.0 43.1 75.1 37.3 46.4 27.0 64.1 124.8 147.1 69.4 28.5 268.6 192.9 114.9 43.7 87.6 151.7 143.7 43.1 151.7 42.3 114.3 193.9 118.7 45.2 192.6 127.1 35.8 112.3 133.1 49.1 91.7 89.0 79.3 150.1 164.5 48.9 113.0 58.8 102.2 65.0 3.0 3.5 5.0 4.0 3.9 6.0 3.9 4.0 5.0 3.6 3.3 6.5 5.6 1.2 5.9 5.3 7.9 7.6 2.0 34.1 34.4 32.1 50.1 35.3 31.8 37.2 33.6 34.5 37.8 31.6 34.2 34.6 36.8 28.9 19.1 17.6 30.0 22.0 20.0 10.0 10.8 28.3 78.3 69.8 21.3 24.3 15.0 11.0 29.2 16.1 60.1 65.2 7.9 12.1 87.2 30.5 28.4 21.0 43.2 21.7 15.9 39.1 19.1 19.1 37.2 37.6 3.8 46.3 13.9 77.8 21.0 18.5 15.8 58.1 8.2 26.8 14.3 146.2 14.3 27.0 10.6 10.3 19.2 17.8 27.8 10.1 18.2 32.0 32.2 13.5 33.7 40.9 32.4 24.5 15.3 47.8 13.1 18.0 23.9 43.3 9.6 23.3 28.4 15.6 28.4 52.2 75.4 37.5 GPS1 "COPS1, CSN1" ENSG00000169727 "G protein pathway suppressor 1" Q13098 17 82050691-82057470 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047448, HPA052848" Enhanced Nucleoplasm,Cytosol NA NA 78000 Nucleoplasm Cytosol "HPA047448: , HPA052848: " "unprognostic (1.96e-1)" "unprognostic (5.89e-2)" "unprognostic (1.50e-1)" "unprognostic (9.65e-2)" "unprognostic (3.41e-1)" "unprognostic (2.19e-1)" "unprognostic (4.75e-3)" "unprognostic (2.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.18e-3)" "unprognostic (1.92e-1)" "unprognostic (4.96e-3)" "unprognostic (4.07e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-1)" "unprognostic (2.15e-1)" 54.6 64.9 48.5 32.3 49.1 43.0 55.0 51.9 81.2 53.7 43.9 55.2 35.3 56.8 31.2 51.4 49.9 28.3 81.2 51.5 49.3 81.3 102.6 49.0 37.8 53.0 52.3 50.7 56.9 70.3 48.8 63.1 30.0 51.4 65.0 18.3 20.6 59.3 41.1 149.7 56.6 47.2 25.7 46.9 55.4 66.0 71.2 53.2 37.6 59.2 64.3 25.1 54.2 48.5 52.5 112.5 204.9 74.7 98.0 51.7 49.5 105.4 73.6 58.2 114.1 93.9 180.7 68.1 55.0 64.5 74.1 83.1 83.1 71.6 94.2 38.7 37.0 256.7 93.5 112.2 203.5 85.5 102.9 86.8 71.2 67.9 101.3 60.0 45.9 120.4 93.4 89.1 62.0 64.3 220.8 176.8 116.4 95.3 107.2 151.3 107.0 102.5 89.5 71.1 114.8 127.6 199.8 74.9 136.6 110.0 56.7 155.1 91.7 69.3 113.3 133.3 88.6 120.5 112.6 51.4 58.9 88.7 65.5 104.5 57.6 85.7 65.9 77.5 81.0 81.8 64.5 80.9 78.3 93.4 64.2 56.9 71.8 13.2 81.6 78.1 64.2 115.2 98.7 48.5 49.1 51.9 81.2 51.5 49.3 53.0 52.3 50.7 51.4 46.9 53.2 52.5 24.0 12.8 24.8 27.1 24.9 25.1 22.5 37.1 17.6 30.6 31.0 27.6 53.7 30.0 30.7 20.2 25.0 71.1 22.7 78.6 60.7 50.7 33.0 22.7 22.4 30.0 41.3 21.7 12.1 69.4 67.6 31.0 35.7 23.3 24.7 45.2 28.5 50.6 60.9 48.8 14.2 42.7 52.9 37.3 31.5 76.7 30.1 32.0 33.8 7.5 42.4 46.3 29.9 10.6 16.4 48.1 56.1 31.6 50.1 25.4 58.4 100.9 33.9 27.2 6.6 28.3 36.3 50.9 50.3 27.1 30.0 54.0 31.1 41.9 57.2 23.2 RFNG ENSG00000169733 "RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q9Y644 17 82047902-82051831 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HHSteC: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011564, HPA031673" Uncertain Approved Nucleoplasm No No 1100000 Nucleoplasm "HPA011564: AB_1079803, HPA031673: AB_2673989" "unprognostic (4.17e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-3)" "unprognostic (2.49e-1)" "unprognostic (2.05e-1)" "unprognostic (2.65e-2)" "unprognostic (1.62e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "prognostic favorable (4.81e-4)" "unprognostic (1.20e-1)" "unprognostic (6.96e-3)" "unprognostic (1.77e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (4.14e-2)" 26.7 24.5 7.8 3.8 7.8 10.2 24.8 7.3 11.9 24.1 6.1 23.3 11.2 25.5 1.6 24.3 23.2 11.0 18.6 7.1 7.5 22.7 79.2 18.9 5.4 8.9 7.8 7.2 29.9 43.0 11.2 20.1 5.9 7.5 23.7 3.2 1.4 22.2 6.9 45.8 25.9 16.8 7.8 7.4 15.0 28.0 23.3 7.8 4.7 20.0 10.6 2.7 24.2 18.7 8.3 20.3 19.2 5.6 19.1 13.9 11.8 24.4 18.5 10.1 8.2 6.2 11.6 13.7 4.5 13.0 29.1 17.4 10.8 3.9 15.8 1.5 6.0 19.7 6.7 4.4 48.5 69.3 2.4 14.2 22.5 9.9 14.7 24.9 16.5 15.8 15.2 8.5 16.9 6.6 24.1 15.1 6.5 5.5 13.5 20.1 10.2 7.0 10.6 9.5 11.8 9.7 24.9 7.1 10.7 54.7 6.2 32.1 13.7 6.1 13.1 17.9 12.7 10.2 22.9 4.5 5.0 16.8 4.4 11.7 1.0 1.9 2.0 1.7 0.5 0.6 1.0 1.1 1.6 1.4 1.2 1.1 0.6 0.7 0.2 0.7 1.1 2.5 0.6 7.8 7.8 7.3 11.9 7.1 7.5 8.9 7.8 7.2 7.5 7.4 7.8 8.3 24.3 6.4 12.4 30.7 7.6 9.7 11.9 8.3 6.8 26.9 33.3 35.4 12.8 18.6 5.6 23.9 25.0 5.5 14.2 20.9 7.9 7.8 3.7 14.9 24.4 12.1 11.4 5.7 20.7 15.1 3.3 27.2 18.8 19.0 1.3 52.5 21.8 47.1 9.6 11.8 20.3 14.0 12.2 15.2 6.3 13.3 21.8 14.7 10.6 16.9 6.2 29.8 3.1 20.6 13.5 12.4 16.3 19.9 4.9 15.9 14.0 31.3 6.8 27.8 0.0 28.0 19.4 14.4 6.2 9.0 10.2 3.7 10.4 32.8 13.5 8.7 DCXR "DCR, HCR2, KIDCR, P34H, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037709 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "liver: 1866.7" "Cell type enhanced" "Detected in all" "Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4" "Group enriched" "Detected in all" 5 "liver cancer: 305.9;prostate cancer: 163.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 365.2;MCF7: 446.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 4000000 "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 100.5 44.3 79.1 15.3 82.3 25.5 108.6 87.2 112.0 46.9 68.5 42.7 29.4 39.8 283.7 97.4 59.7 10.9 101.1 72.5 85.3 242.2 1866.7 61.5 16.8 95.8 84.6 70.1 70.6 72.2 46.5 64.4 20.3 91.2 139.2 21.1 9.8 104.3 33.9 188.8 81.9 44.8 10.5 76.3 36.0 168.3 45.1 90.6 26.3 61.2 81.3 19.8 49.3 62.6 85.2 50.3 68.2 32.8 56.4 123.2 31.8 80.4 25.0 33.9 68.5 48.4 122.0 21.3 100.3 47.4 35.9 9.4 57.4 59.6 52.6 24.1 21.4 145.9 96.9 48.8 365.2 143.2 75.6 114.5 44.6 62.2 22.7 79.8 16.0 41.1 61.1 112.4 76.3 36.5 446.2 63.7 184.1 35.0 242.9 71.3 57.9 42.0 135.3 53.3 71.9 85.5 51.0 35.5 287.5 46.0 19.7 213.4 74.5 20.5 36.6 45.0 48.9 48.2 73.7 56.2 50.2 31.4 83.0 26.7 49.5 92.6 77.9 66.5 92.0 64.1 86.8 83.0 64.7 151.3 99.2 117.7 85.4 47.2 108.9 88.1 121.6 98.9 110.1 79.1 82.3 87.2 112.0 72.5 85.3 95.8 84.6 70.1 91.2 76.3 90.6 85.2 29.0 51.3 198.2 16.6 133.6 58.5 200.3 113.5 109.8 16.0 301.8 269.2 120.7 183.0 123.4 178.4 18.8 372.1 116.6 152.9 812.0 41.4 6.0 67.0 50.9 44.6 54.7 335.7 4.7 42.6 450.6 65.0 151.4 102.3 64.7 62.7 138.5 3510.3 164.7 21.9 9.0 170.4 189.2 165.7 65.6 22.6 70.8 82.3 179.7 1.9 52.8 145.1 78.2 5.5 10.5 30.4 135.7 47.4 98.6 215.2 158.9 2919.4 55.4 26.5 19.7 40.6 79.6 10.3 48.2 219.9 73.2 342.6 135.7 118.6 154.6 178.8 ZNF32 "KOX30, Zfp637, ZNF637" ENSG00000169740 "Zinc finger protein 32" P17041 10 43643860-43648881 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" Yes No "Nuclear bodies" Nucleoplasm "HPA039148: AB_2676365" "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favorable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 33.1 33.5 72.1 13.4 73.8 8.3 46.3 73.4 102.4 45.5 71.5 45.3 12.8 43.3 58.1 23.3 40.4 23.6 56.1 71.4 73.2 40.9 32.7 26.7 22.3 73.8 73.2 70.6 53.2 48.5 48.1 45.4 16.7 74.0 48.9 23.6 41.2 31.2 38.5 85.1 29.9 29.9 37.1 73.2 36.3 38.1 16.4 73.2 33.1 42.3 73.6 26.1 41.5 33.2 75.8 25.0 21.8 32.3 48.9 58.1 62.1 10.6 21.9 65.5 39.9 35.8 14.8 12.5 0.1 37.7 46.7 18.8 14.5 20.7 21.2 29.2 27.5 23.0 6.6 13.2 17.2 54.4 0.7 19.7 64.1 48.0 24.7 29.7 38.2 30.6 86.8 19.5 0.0 50.9 22.8 25.2 22.8 25.2 25.2 11.3 38.5 36.3 5.7 40.8 9.7 41.2 36.7 18.1 13.3 35.4 35.3 49.0 23.0 13.1 22.3 26.8 16.4 5.4 14.3 40.2 0.1 8.0 15.9 21.1 14.0 13.9 18.2 36.5 12.9 36.8 26.0 29.2 41.1 22.9 27.2 37.0 41.6 1.1 50.4 11.6 19.3 22.8 20.7 72.1 73.8 73.4 102.4 71.4 73.2 73.8 73.2 70.6 74.0 73.2 73.2 75.8 26.1 9.6 14.3 14.0 18.8 11.0 24.4 28.6 33.0 23.2 41.4 57.8 11.7 22.8 16.9 18.4 8.4 18.0 31.9 7.5 105.7 44.7 2.3 16.2 25.6 23.8 27.7 16.8 9.7 47.4 17.1 27.3 16.3 11.5 30.4 34.1 25.7 25.5 29.4 16.8 11.1 16.0 22.4 22.3 10.1 2.1 42.3 19.0 17.8 9.4 15.8 52.7 58.7 16.6 23.0 28.4 10.3 54.5 9.5 36.2 10.0 53.1 12.6 24.1 32.9 38.3 34.2 17.0 14.3 26.4 15.3 6.7 27.1 33.0 17.9 17.9 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898678 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 13 "NK-cells: 2.0" "Cell line enhanced" "Detected in many" "AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 55.9 15.6 16.2 8.1 26.7 0.4 52.6 8.7 43.8 43.9 15.7 12.5 6.6 66.1 23.6 15.9 28.3 31.4 33.1 26.6 18.1 27.9 26.3 58.7 11.6 10.4 15.9 21.5 18.4 7.7 17.2 9.1 59.3 15.4 18.1 8.6 5.4 10.9 13.8 14.1 9.2 12.9 54.3 10.4 50.8 11.6 5.0 13.5 8.4 31.6 24.5 4.9 22.7 23.0 24.5 0.0 0.0 18.3 0.1 10.5 16.9 0.0 10.2 8.0 1.2 2.7 0.0 0.0 0.0 0.0 19.0 0.0 0.0 34.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 9.5 0.0 12.5 0.0 2.7 65.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.7 0.0 0.1 8.8 0.0 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.0 4.9 0.0 0.0 17.1 25.7 0.1 1.2 0.0 8.3 0.1 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.2 16.2 26.7 8.7 43.8 26.6 18.1 10.4 15.9 21.5 15.4 10.4 13.5 24.5 236.5 0.0 5.5 44.7 1.5 8.7 0.3 0.0 2.8 27.1 1.7 2.2 8.7 2.8 0.0 0.0 0.0 0.2 6.8 0.0 0.0 4.4 1.3 1.4 36.5 194.4 0.0 8.0 1314.4 0.2 0.2 44.4 4.1 1.1 5.7 0.1 364.8 3.1 0.4 0.0 196.5 0.0 0.0 16.4 13.2 2.6 38.2 1.4 8.8 117.1 0.0 10.4 3.1 120.6 36.7 0.2 0.0 50.4 0.0 0.3 0.0 0.1 0.7 2.1 6.6 2.8 19.3 0.2 0.7 1.3 6.8 0.1 4.9 39.7 0.0 0.5 RAC3 ENSG00000169750 "Rac family small GTPase 3" P60763 17 82031678-82034204 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 45.0;Extravillous trophoblasts: 152.1;Spermatogonia: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "CACO-2: 230.8;HEK 293: 274.7;NB-4: 156.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047820 Uncertain NA NA "HPA047820: AB_2680167" "unprognostic (3.48e-2)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (6.21e-5)" "unprognostic (1.62e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (3.36e-2)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (1.22e-2)" "unprognostic (3.67e-1)" "unprognostic (4.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (1.25e-3)" 12.1 5.0 18.9 1.8 18.9 7.8 13.8 24.4 29.7 5.2 7.2 4.2 3.5 2.8 7.4 11.0 3.8 3.0 2.7 18.8 21.7 9.4 20.9 4.1 1.7 20.4 19.4 19.4 4.8 4.7 9.4 23.0 5.6 21.8 11.2 1.5 2.8 18.3 4.3 0.8 10.9 3.8 1.3 13.3 1.9 11.9 28.3 22.4 2.2 9.8 0.2 1.5 3.2 7.6 25.6 11.1 15.1 45.6 63.1 9.7 18.2 50.5 7.8 7.2 26.1 22.3 230.8 21.4 5.8 11.5 4.8 1.7 15.6 43.0 17.8 4.1 3.6 274.7 64.6 20.2 16.7 47.0 28.0 12.2 27.5 13.0 3.5 12.0 19.5 60.3 33.8 103.1 30.2 10.8 35.6 7.3 156.4 61.4 39.2 27.6 47.6 4.5 27.7 20.0 5.4 109.8 111.5 4.1 57.2 55.7 16.1 58.6 40.7 21.6 10.8 9.8 5.5 12.1 14.6 9.9 4.4 6.6 17.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 18.9 18.9 24.4 29.7 18.8 21.7 20.4 19.4 19.4 21.8 13.3 22.4 25.6 1.6 0.0 0.0 2.3 0.9 8.7 16.3 12.2 19.9 5.3 36.9 45.0 0.2 4.3 3.6 5.5 0.0 30.0 1.8 3.3 21.5 9.8 19.1 5.9 5.4 2.3 3.0 6.9 5.2 3.3 152.1 10.7 8.2 12.6 4.5 17.8 1.4 11.3 9.7 6.7 8.3 5.1 22.4 0.0 2.6 16.6 5.6 0.9 14.2 0.0 2.0 6.0 0.0 3.5 2.0 5.5 2.4 1.9 2.6 16.4 4.2 26.0 2.4 7.3 0.0 0.8 5.3 2.2 58.0 15.8 7.5 14.1 3.1 8.6 5.2 8.4 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 4.0;retina: 4.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 16.1;Exocrine glandular cells: 23.3;Gastric mucus-secreting cells: 31.1;Rod photoreceptor cells: 22.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 4.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 6.8;HL-60: 2.1;U-937: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010957 Uncertain "Secreted to digestive system" NA NA "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.0 0.1 0.8 0.1 0.4 1.0 0.2 4.0 0.8 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.7 0.1 0.4 0.2 0.2 0.5 0.5 0.1 0.1 0.9 0.0 0.0 0.4 1.4 0.2 0.1 4.4 0.5 0.1 0.8 0.7 0.1 0.0 0.7 0.1 0.9 0.7 0.5 0.1 0.1 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.4 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.6 0.3 0.0 0.0 0.9 0.6 0.1 0.0 0.1 0.4 0.1 6.8 0.0 0.0 2.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.2 0.2 0.0 0.0 0.1 0.4 1.6 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 4.0 0.8 0.5 0.7 0.5 0.5 0.1 1.4 0.7 0.5 0.6 0.7 0.0 0.0 3.9 0.9 7.5 1.2 3.9 0.6 3.7 0.5 0.0 0.2 0.0 3.9 1.8 14.6 2.2 0.5 1.1 1.9 0.3 16.1 6.1 1.2 0.7 1.2 0.0 13.3 23.3 2.5 2.6 31.1 1.4 2.5 0.9 0.7 3.4 0.3 6.7 9.7 0.1 2.0 0.0 0.8 8.9 0.6 0.3 1.8 0.0 0.2 1.9 1.0 3.5 0.8 9.6 3.2 0.0 0.3 2.3 0.1 0.1 10.7 22.9 0.0 0.5 1.1 7.6 1.3 3.4 1.3 0.8 0.4 0.6 0.5 4.5 LIMS1 "PINCH, PINCH1" ENSG00000169756 "LIM zinc finger domain containing 1" P48059 2 108534355-108687246 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 379.6;Macrophages: 405.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 402.5" "HPA058455, HPA061230" Approved Approved "Focal adhesion sites,Cytosol" NA NA 10000000 Cytosol "Focal adhesion sites" "HPA058455: AB_2683723, HPA061230: AB_2684456" "unprognostic (1.79e-1)" "unprognostic (8.82e-3)" "unprognostic (5.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.52e-1)" "unprognostic (4.23e-2)" "unprognostic (1.08e-3)" "unprognostic (1.09e-1)" "unprognostic (8.96e-2)" "unprognostic (1.18e-1)" "unprognostic (5.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.88e-4)" "unprognostic (7.51e-2)" "unprognostic (8.60e-3)" "unprognostic (1.43e-2)" "unprognostic (2.11e-1)" 41.4 45.5 8.9 34.1 9.8 33.2 29.2 9.6 10.4 22.8 12.3 19.9 16.8 36.1 11.7 27.1 31.8 31.4 38.4 6.4 13.7 16.9 20.2 37.3 38.2 13.0 9.9 5.1 20.7 15.2 12.1 8.0 32.5 12.1 19.7 18.2 11.6 17.7 26.9 99.9 14.3 20.2 36.1 14.4 21.2 22.4 16.9 13.4 21.6 25.0 36.1 33.0 30.3 17.7 18.6 44.7 49.0 19.0 22.8 30.8 44.5 91.6 49.0 56.0 37.1 37.6 85.3 93.7 43.1 145.4 63.0 55.0 28.3 29.0 50.2 49.3 106.7 52.0 225.6 32.1 45.8 70.4 42.7 402.5 43.5 45.5 98.3 80.3 44.2 135.9 37.3 81.0 58.2 115.4 36.5 41.4 31.4 37.5 29.0 49.6 52.2 65.9 35.0 70.2 79.5 34.3 46.3 76.6 32.5 34.5 25.0 16.8 39.6 184.2 166.6 75.6 37.5 101.2 56.4 81.6 60.6 139.3 47.6 43.6 211.9 69.6 196.2 16.6 119.3 30.5 18.7 72.3 22.4 59.4 18.0 19.2 7.3 31.6 35.9 156.2 7.7 89.0 140.3 8.9 9.8 9.6 10.4 6.4 13.7 13.0 9.9 5.1 12.1 14.4 13.4 18.6 143.5 99.3 55.6 80.6 43.2 74.1 63.0 65.1 63.7 26.2 34.9 37.0 61.6 38.6 53.4 29.5 54.2 45.1 40.6 19.2 39.2 80.9 22.5 266.8 122.9 187.6 118.1 84.5 32.6 233.5 130.3 109.4 32.6 379.6 101.4 107.0 76.1 34.6 189.0 15.2 34.6 24.0 48.8 181.1 265.4 12.0 81.4 405.4 44.4 115.2 118.5 69.2 41.2 54.3 66.8 122.3 17.2 88.0 76.3 82.1 33.5 44.0 84.8 18.8 65.7 116.2 161.2 45.4 51.1 75.2 77.0 27.9 82.4 51.3 32.4 66.4 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059958-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 8.5;skeletal muscle: 5.9;tongue: 2.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enhanced" "Detected in many" "cerebellum: 8.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.3" "Region enriched" "Detected in all" 6 "cerebellum: 58.7" "Region enriched" "Detected in many" 5 "cerebellum: 26.8" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.0 0.9 0.9 0.0 1.1 0.0 0.1 8.5 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.5 0.0 0.5 0.1 0.6 1.2 1.0 0.0 1.1 0.0 1.2 0.9 2.9 0.1 0.0 1.1 0.0 0.0 5.9 0.5 0.0 0.0 0.5 0.1 0.0 0.6 1.3 0.3 0.0 2.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 8.5 1.7 1.2 1.2 0.6 1.2 1.0 2.9 0.5 1.3 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.5 0.5 0.0 0.0 0.0 1.8 10.4 16.0 0.0 0.0 1.9 0.0 7.0 0.2 0.1 0.4 0.0 0.0 0.0 0.2 2.2 0.9 1.5 0.1 0.0 0.2 0.4 0.4 4.5 1.7 0.0 0.0 0.0 0.3 0.0 19.7 0.0 0.4 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.7 0.0 1.0 0.0 0.7 1.5 9.1 6.6 1.3 0.2 0.5 6.3 0.0 0.0 5.9 0.2 0.5 0.0 0.7 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Biological rhythms, Cell adhesion" "Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;retina: 13.9" "Group enriched" "Detected in many" 31 "Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA NA 82000 "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 2.0 1.0 12.8 0.5 11.2 0.0 0.7 31.8 9.3 3.1 0.0 1.5 0.2 2.1 2.5 2.5 3.0 1.7 3.2 11.5 11.4 2.9 0.0 0.4 0.2 5.5 7.4 12.7 1.3 0.8 0.7 1.8 0.5 10.5 2.2 0.9 13.9 0.3 3.1 0.2 0.2 0.6 2.8 2.5 0.0 0.8 7.0 15.4 0.2 0.9 1.0 0.1 2.9 1.3 10.5 0.1 0.0 6.1 0.0 11.8 12.4 0.0 5.2 12.8 0.6 0.8 0.0 0.5 0.0 0.2 25.9 4.7 0.0 3.7 0.0 1.3 0.0 6.0 1.7 0.1 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 10.0 24.9 0.0 0.0 1.7 0.1 0.0 0.0 0.0 7.2 0.0 1.7 0.0 26.2 6.4 4.7 0.1 2.5 1.7 0.0 0.0 12.3 1.1 0.6 0.0 3.1 13.5 1.3 9.9 11.6 11.7 0.0 0.0 4.6 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 11.2 31.8 9.3 11.5 11.4 5.5 7.4 12.7 10.5 2.5 15.4 10.5 0.3 0.0 0.5 66.6 0.0 0.8 0.4 0.0 0.6 14.3 0.1 0.0 4.4 0.0 0.0 3.7 4.2 0.3 0.0 0.0 0.0 0.3 55.9 0.6 12.4 0.8 0.0 0.0 1484.7 0.0 0.2 8.2 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1700.0 0.0 0.0 0.0 0.3 12.5 25.7 0.4 14.2 60.9 0.0 24.9 0.0 4004.1 1261.9 0.1 0.0 14.3 0.0 2.6 0.0 8.5 0.0 10.3 6.6 2.9 2.1 0.4 1.6 0.1 0.9 0.1 0.1 1.6 0.0 0.3 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7;Late spermatids: 163.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042567 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA042567: AB_2678055" "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favorable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favorable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favorable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favorable (4.18e-4)" 7.5 15.3 19.6 6.1 20.5 25.9 10.1 19.4 21.6 8.3 17.2 8.4 6.5 10.1 9.2 6.2 9.6 6.8 9.2 19.1 18.9 12.5 30.7 12.0 9.7 20.7 19.6 18.6 8.1 8.1 13.1 8.6 6.9 20.7 7.5 8.2 25.0 7.6 6.5 35.9 7.8 7.5 9.3 19.7 8.6 8.0 11.2 19.5 12.3 11.6 20.1 8.1 7.7 7.0 21.7 4.9 3.6 6.0 7.0 8.9 6.8 2.5 7.8 6.0 7.4 8.1 4.9 8.5 31.7 8.3 5.0 10.8 4.0 5.2 4.0 9.3 2.9 6.3 6.2 5.0 5.2 8.4 12.6 6.2 4.2 7.7 7.3 5.3 9.1 3.8 19.3 9.7 14.5 7.2 3.5 18.7 10.1 4.0 9.3 8.4 45.0 8.4 5.8 12.0 5.1 10.0 8.0 7.4 6.2 9.5 4.1 11.5 12.3 7.1 6.2 4.1 4.2 10.3 13.9 12.2 24.2 12.4 30.9 7.3 1.1 0.3 0.0 0.2 0.2 0.0 1.0 0.7 0.4 0.5 2.5 0.9 0.7 0.6 0.3 0.3 0.8 0.5 0.3 19.6 20.5 19.4 21.6 19.1 18.9 20.7 19.6 18.6 20.7 19.7 19.5 21.7 12.0 32.1 62.6 47.3 20.2 9.1 6.3 4.2 4.0 24.5 15.0 9.9 14.3 10.0 8.7 7.3 114.7 4.2 16.2 11.1 3.9 6.7 79.0 14.2 12.6 12.8 14.4 16.6 42.6 8.2 3.1 10.2 8.6 12.0 2.5 17.5 8.6 46.0 4.2 70.7 43.6 9.8 4.1 10.3 18.9 163.1 9.9 11.1 16.0 45.0 6.5 33.1 8.2 60.8 68.2 9.5 9.4 15.1 8.9 7.1 10.7 8.7 14.4 62.4 6.6 17.0 11.5 33.3 5.7 7.1 8.0 7.0 10.8 16.5 9.0 6.6 PRYP3 ENSG00000169763 "PTPN13 like Y-linked pseudogene 3" O14603 Y 23681440-23694579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 1.5;epididymis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "A549: 4.5;HDLM-2: 7.7" HPA059887 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA059887: " 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.7 1.5 0.6 0.0 1.0 0.9 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGP2 "SVUGP2, UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840952-63891562 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 865.6;tongue: 762.8" "Cell type enhanced" "Detected in all" "Distal enterocytes: 849.9;Hepatocytes: 559.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 417.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria NA NA 13000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 269.7 72.6 82.5 66.4 89.4 40.5 121.0 73.7 108.6 66.5 82.0 179.6 66.6 75.9 51.1 98.4 69.5 61.2 230.1 87.3 79.6 106.4 865.6 66.0 66.2 77.3 78.6 83.3 47.4 75.0 114.3 50.2 138.9 80.2 58.0 160.8 37.1 93.7 66.8 502.1 58.0 68.2 79.2 77.8 51.2 70.1 38.6 85.9 107.2 65.0 762.8 74.3 89.1 64.3 91.2 122.3 77.6 63.1 42.0 176.1 222.4 220.6 129.1 116.1 82.7 89.4 170.0 104.5 149.5 48.3 165.6 79.9 57.4 73.4 102.6 137.0 99.2 35.7 86.5 50.4 117.9 87.0 79.1 73.9 148.1 175.8 76.1 80.3 108.4 119.4 38.9 48.2 58.1 327.8 56.7 104.6 75.2 122.9 207.7 50.1 80.4 117.9 84.5 147.4 77.7 36.5 29.6 103.3 149.8 64.3 162.6 51.7 59.2 144.3 84.4 125.9 113.8 90.5 101.3 51.4 174.9 99.2 122.7 225.7 417.1 33.0 53.1 48.0 40.7 51.8 33.0 53.6 50.1 27.9 31.8 57.6 53.6 45.4 70.0 39.5 29.7 127.2 62.0 82.5 89.4 73.7 108.6 87.3 79.6 77.3 78.6 83.3 80.2 77.8 85.9 91.2 73.4 28.9 54.0 107.4 65.3 75.8 87.8 245.9 34.7 49.6 360.6 87.1 264.3 104.4 171.6 47.8 64.6 414.3 81.1 849.9 242.6 140.6 91.5 53.0 106.3 69.8 44.5 56.0 86.1 103.6 445.5 159.3 79.0 49.5 67.8 42.4 63.5 559.4 120.9 87.5 78.4 179.8 144.5 102.4 90.2 86.1 79.2 89.1 96.0 62.8 139.7 58.8 154.5 37.2 79.3 91.6 313.9 77.5 60.7 81.2 176.2 284.4 139.3 57.3 72.3 50.5 129.2 84.9 54.9 50.9 57.8 472.8 143.1 90.6 189.5 109.1 TAS2R1 "T2R1, TRB7" ENSG00000169777 "Taste 2 receptor member 1" Q9NYW7 5 9627347-9712378 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 7.6" "Group enriched" "Detected in some" 36 "Early spermatids: 46.0;Late spermatids: 70.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051879 Uncertain NA NA "HPA051879: AB_2681649" "unprognostic (2.19e-1)" 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.1 1.1 0.4 0.1 0.2 0.1 0.2 0.6 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.1 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 70.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.0" "Group enriched" "Detected in many" 4 "Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Supported "Plasma membrane" NA NA 25000 "Plasma membrane" "HPA074653: AB_2686706" "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.4 1.1 42.2 1.2 38.0 0.0 3.5 0.0 55.6 4.4 0.0 2.2 1.5 4.6 2.2 0.9 2.7 2.1 11.9 46.3 5.3 4.2 0.8 1.0 0.7 9.6 0.7 56.0 2.3 2.5 4.2 1.9 6.8 20.6 1.6 0.8 16.3 3.2 2.1 0.8 2.8 1.7 4.7 0.0 3.3 1.5 5.4 1.9 0.3 2.3 1.4 0.3 2.4 2.9 29.7 0.0 2.1 23.9 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.4 0.0 0.4 0.1 30.2 0.0 0.0 0.0 21.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 13.5 0.0 0.0 56.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 4.2 1.2 0.1 2.4 4.9 21.6 0.3 0.4 2.1 0.0 5.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 38.0 0.0 55.6 46.3 5.3 9.6 0.7 56.0 20.6 0.0 1.9 29.7 2.1 0.0 0.0 271.0 0.0 0.3 0.1 0.0 0.0 21.8 0.7 0.3 7.3 1.5 0.0 0.0 2.1 0.1 0.0 1.8 0.0 0.3 8.6 0.8 3.7 2.3 0.0 0.0 271.6 0.2 0.2 1.8 0.0 0.2 0.0 14.9 4.2 0.0 0.3 132.9 220.5 0.3 0.0 0.0 0.0 16.5 0.3 0.1 3.6 167.7 0.0 51.1 0.0 240.8 324.2 0.2 7.7 0.4 0.0 0.0 0.0 0.0 0.0 19.5 26.3 0.0 21.9 0.2 3.1 0.0 0.1 0.3 0.1 0.5 0.2 0.0 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13 like Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059887 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA059887: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1F MGC33094 ENSG00000169800 "RNA binding motif protein Y-linked family 1 member F" Q15415 Y 22168542-22182982 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 325 "U-266/70: 29.7;U-266/84: 35.2" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13 like Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059887 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA059887: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HNRNPF HNRPF ENSG00000169813 "Heterogeneous nuclear ribonucleoprotein F" P52597 10 43385617-43409166 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA016884, HPA069667" Supported Enhanced Nucleoplasm NA Yes 2500000 Nucleoplasm "HPA016884: AB_1856444, HPA069667: AB_2686166" "unprognostic (9.93e-2)" "unprognostic (2.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.65e-2)" "unprognostic (6.39e-2)" "unprognostic (3.33e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.51e-2)" "unprognostic (6.37e-2)" "unprognostic (6.33e-3)" "unprognostic (4.89e-3)" "unprognostic (1.07e-2)" "unprognostic (1.95e-2)" "unprognostic (3.77e-3)" "unprognostic (3.35e-1)" "unprognostic (3.71e-1)" "unprognostic (2.22e-1)" 103.1 78.3 46.7 135.1 47.8 162.7 103.9 52.2 48.3 87.5 64.0 125.7 135.4 79.1 59.5 115.8 120.4 89.6 64.3 41.5 63.9 79.7 174.6 98.4 182.9 53.6 48.9 36.9 88.0 88.2 73.7 50.9 114.5 50.7 91.6 120.0 81.1 85.9 75.5 94.4 105.4 131.8 89.9 53.6 124.6 119.1 84.8 47.6 195.1 73.3 80.3 184.3 161.5 82.5 59.2 292.1 302.9 184.2 280.7 220.5 239.5 269.1 222.5 371.0 305.6 358.2 285.5 394.7 581.8 139.2 242.0 179.3 401.7 496.8 363.6 249.5 245.6 297.2 371.2 178.6 370.9 271.4 550.5 360.9 293.2 282.4 237.6 434.6 177.1 266.4 281.3 382.0 256.2 234.2 453.4 542.5 300.5 139.5 439.1 252.4 449.0 172.7 276.8 314.9 442.7 226.1 226.8 226.6 410.4 344.3 199.2 457.4 265.3 200.4 140.1 264.4 231.8 356.8 228.5 415.8 352.6 227.1 520.0 139.7 205.5 234.9 227.2 247.0 269.2 301.0 238.9 256.6 273.3 251.8 200.7 213.8 204.0 152.2 287.9 253.6 140.6 315.8 460.5 46.7 47.8 52.2 48.3 41.5 63.9 53.6 48.9 36.9 50.7 53.6 47.6 59.2 223.8 134.6 102.8 13.4 206.9 336.0 336.5 204.9 189.5 51.4 156.8 126.4 66.3 157.3 147.9 112.2 47.9 292.9 201.7 164.7 176.1 218.6 360.1 203.8 153.3 176.6 126.8 199.6 10.8 142.2 414.8 157.0 154.9 147.0 116.1 106.9 127.5 222.3 226.0 48.8 12.0 230.1 164.8 193.3 181.7 92.7 146.0 178.5 99.6 24.4 213.0 116.9 219.4 16.6 32.7 161.4 152.1 117.8 163.3 280.8 189.7 233.1 242.0 163.6 98.6 179.7 278.1 184.5 167.3 210.2 330.5 210.4 229.9 126.3 238.8 314.0 BTD ENSG00000169814 Biotinidase P43251 3 15601341-15722311 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052275 Uncertain "Secreted to blood" NA NA 2800000000 "HPA052275: AB_2681782" "unprognostic (6.04e-2)" "unprognostic (2.42e-1)" "unprognostic (9.37e-3)" "unprognostic (5.84e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-2)" "unprognostic (6.37e-3)" "unprognostic (4.26e-2)" "unprognostic (3.29e-2)" "unprognostic (1.23e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "prognostic favorable (2.60e-9)" "unprognostic (2.44e-2)" "unprognostic (4.90e-2)" "unprognostic (1.67e-3)" "unprognostic (3.73e-2)" 25.5 16.9 10.6 8.1 12.5 13.3 16.6 19.0 12.7 13.8 10.2 16.1 46.6 13.3 62.9 10.0 18.5 20.0 10.3 11.1 11.3 38.0 96.7 16.0 9.6 12.1 10.4 11.2 25.5 44.5 27.9 6.0 17.1 12.6 19.7 17.1 35.5 16.2 21.3 7.9 9.6 30.9 14.2 10.3 11.4 24.7 18.4 10.5 10.7 27.0 11.5 10.5 14.4 7.5 19.0 9.2 22.0 7.8 7.3 51.7 15.3 39.6 15.4 18.4 16.2 28.3 10.1 21.5 4.1 16.3 31.6 7.1 9.7 5.3 16.7 18.7 7.6 11.7 12.9 28.8 24.8 12.7 8.8 14.7 18.3 16.9 42.9 5.1 39.7 30.5 5.9 8.7 32.3 44.7 11.1 4.5 8.2 8.5 16.9 13.0 5.9 18.4 27.9 16.5 17.7 5.3 11.8 17.9 5.2 24.4 15.1 19.9 11.3 24.3 20.5 13.6 19.1 10.1 8.9 11.4 4.1 21.4 7.7 14.4 74.1 20.7 44.9 22.9 19.6 21.0 14.7 23.3 19.2 21.4 13.1 19.7 15.4 19.8 15.0 15.8 24.9 28.8 16.5 10.6 12.5 19.0 12.7 11.1 11.3 12.1 10.4 11.2 12.6 10.3 10.5 19.0 14.9 6.4 11.0 11.8 11.7 5.9 12.4 25.0 6.2 13.5 9.1 7.9 6.0 45.8 16.7 18.4 18.8 25.3 19.7 9.9 5.9 21.1 31.0 9.5 6.0 9.1 7.2 4.0 6.6 28.5 22.4 14.5 9.7 5.7 5.1 8.9 20.3 63.3 14.9 5.0 12.2 8.5 16.2 8.2 5.9 17.9 32.3 9.2 10.6 5.6 8.7 19.2 6.2 27.2 23.9 12.0 17.9 18.0 16.6 6.3 52.1 32.0 19.8 54.1 13.1 8.5 8.6 45.3 7.5 7.7 5.5 23.1 13.6 17.4 8.9 9.5 CSGALNACT2 "GALNACT-2, GALNACT2, MGC40204, PRO0082" ENSG00000169826 "Chondroitin sulfate N-acetylgalactosaminyltransferase 2" Q8N6G5 10 43138445-43185302 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 135.2" "Cell type enhanced" "Detected in many" "Langerhans cells: 121.6;Macrophages: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031540 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031540: AB_10599943" "unprognostic (1.65e-1)" "unprognostic (2.70e-2)" "unprognostic (9.10e-2)" "unprognostic (6.41e-2)" "unprognostic (1.95e-1)" "unprognostic (8.28e-3)" "unprognostic (2.85e-3)" "unprognostic (4.95e-2)" "unprognostic (2.96e-1)" "unprognostic (3.43e-3)" "unprognostic (7.65e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (3.53e-7)" "unprognostic (2.68e-2)" "unprognostic (1.40e-1)" "unprognostic (2.47e-1)" "unprognostic (4.05e-3)" 19.9 10.7 9.9 24.4 11.3 135.2 13.0 15.9 13.5 14.4 12.8 12.8 9.3 19.7 8.5 10.6 15.7 25.6 11.0 9.2 12.3 8.9 14.1 27.0 22.7 11.5 11.4 8.0 17.2 7.8 8.1 11.7 26.6 11.4 13.5 11.7 9.9 7.9 11.0 14.7 11.1 11.6 21.0 10.9 26.7 10.2 9.3 10.5 28.2 10.0 17.3 17.5 24.3 12.2 14.3 12.6 8.2 15.1 14.4 23.0 38.5 3.7 44.7 59.8 19.3 30.0 2.9 12.7 20.8 10.8 40.6 9.2 11.4 12.6 16.8 31.3 24.9 9.3 10.8 7.9 8.6 50.0 25.3 21.8 38.6 18.1 43.1 89.3 24.3 25.0 30.7 4.6 60.1 39.9 6.5 19.3 15.1 6.5 4.2 10.7 11.9 15.0 8.8 17.1 6.6 13.6 26.8 11.6 11.9 28.8 13.0 15.7 20.5 37.3 16.5 26.2 52.3 30.4 15.4 23.2 10.9 35.1 60.8 7.9 14.7 11.9 19.4 7.3 14.2 6.4 3.0 5.5 5.7 14.4 3.0 6.4 5.4 11.2 11.3 21.8 4.1 7.1 6.9 9.9 11.3 15.9 13.5 9.2 12.3 11.5 11.4 8.0 11.4 10.9 10.5 14.3 16.3 16.0 18.7 23.8 20.5 17.7 13.3 7.0 6.2 13.1 10.7 8.5 10.9 5.7 9.6 11.0 10.4 2.1 47.8 1.7 0.0 5.9 2.1 12.0 22.0 16.8 9.0 18.5 42.5 6.9 6.1 31.4 4.6 11.3 48.1 23.5 11.4 11.9 16.4 8.4 41.1 1.6 4.1 68.6 121.6 1.4 17.1 82.6 8.8 16.9 41.5 4.1 35.0 45.2 54.5 13.7 3.1 12.4 33.8 12.7 1.5 4.4 5.8 8.5 26.3 27.7 25.3 17.8 18.3 3.6 12.1 1.5 37.4 7.2 1.6 7.0 TACR3 "NK3R, NKR, TAC3R" ENSG00000169836 "Tachykinin receptor 3" P29371 4 103586031-103719985 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "brain: 5.5;retina: 2.7;urinary bladder: 1.9" "Group enriched" "Detected in some" 9 "Bipolar cells: 13.1;Excitatory neurons: 6.7;Extravillous trophoblasts: 4.5;Oligodendrocytes: 10.5;Skeletal myocytes: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "BEWO: 7.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA009418 Uncertain NA NA "HPA009418: AB_1857727" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (3.21e-1)" "unprognostic (5.52e-1)" "unprognostic (3.80e-1)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.2 0.0 0.1 0.0 1.5 3.0 0.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 1.9 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.1 0.6 0.3 2.0 1.5 3.0 0.2 5.5 1.0 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 6.7 0.0 4.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 1.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792483-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "brain: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enriched" "Detected in some" 5 "hypothalamus: 5.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.3 0.2 5.0 0.4 0.1 0.2 0.2 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7" "Group enriched" "Detected in many" 8 "Astrocytes: 311.8;Excitatory neurons: 1152.0;Inhibitory neurons: 882.3;Oligodendrocyte precursor cells: 917.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 43.4;RH-30: 120.4;RT4: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" NA NA 340000 "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: AB_2679682" "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 1.9 3.3 7.8 5.3 15.1 0.0 3.0 0.0 34.4 24.1 0.0 14.1 3.2 17.0 25.3 14.5 9.8 8.1 19.3 20.9 37.7 2.0 1.0 2.9 1.4 13.5 10.1 15.3 4.8 0.9 1.1 0.2 0.2 16.8 10.7 7.9 3.4 0.8 18.3 0.6 11.7 5.1 22.3 1.6 18.8 11.5 1.0 31.4 1.4 4.1 0.4 1.2 16.5 5.9 23.1 0.0 1.1 14.4 20.1 29.5 28.5 0.0 3.8 0.0 1.9 0.9 1.9 26.5 0.0 0.1 0.2 0.0 15.3 1.3 38.5 3.4 0.0 43.4 0.1 26.8 0.0 30.4 0.6 0.0 17.2 8.8 1.0 10.7 17.5 7.5 0.0 0.0 0.0 9.0 0.1 0.0 0.1 8.8 9.3 4.0 0.0 120.4 0.0 0.9 65.2 0.9 0.2 0.4 1.2 1.3 8.2 1.8 6.9 0.0 24.1 6.2 6.7 0.0 0.0 0.0 0.0 18.8 0.1 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 15.1 0.0 34.4 20.9 37.7 13.5 10.1 15.3 16.8 1.6 31.4 23.1 1.1 0.0 0.0 311.8 0.3 85.0 92.4 25.7 46.7 46.8 0.7 9.0 83.2 0.0 13.7 64.4 0.0 0.1 0.0 0.3 0.0 0.6 16.9 66.8 8.4 7.6 0.0 0.0 1152.0 0.7 0.1 24.0 20.9 60.4 1.3 0.8 19.2 0.1 0.3 10.1 882.3 0.5 4.1 1.0 3.5 10.4 0.3 1.3 21.4 43.1 0.0 1.3 0.0 917.3 26.4 26.5 0.0 28.6 1.3 26.1 0.0 0.2 27.0 3.4 0.0 51.3 11.0 1.1 2.7 18.5 38.6 0.1 1.8 1.7 0.3 50.3 ROBO1 "DUTT1, FLJ21882, SAX3" ENSG00000169855 "Roundabout guidance receptor 1" Q9Y6N7 3 78597239-79767998 "Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 309.4;Inhibitory neurons: 1518.9;Oligodendrocyte precursor cells: 348.3;Oligodendrocytes: 479.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013524, HPA052968, HPA074461" Uncertain Enhanced "Plasma membrane" NA NA 16000000 "Plasma membrane" "CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256" "unprognostic (2.89e-1)" "unprognostic (6.42e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-1)" "unprognostic (4.77e-2)" "unprognostic (1.61e-3)" "prognostic unfavorable (9.88e-4)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (2.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (6.77e-2)" "unprognostic (1.91e-1)" "unprognostic (2.39e-2)" "unprognostic (1.16e-2)" 12.5 8.7 12.7 10.8 11.9 0.2 4.9 3.5 9.2 13.5 0.0 5.9 3.1 9.6 7.2 12.5 4.7 7.8 6.4 7.7 19.7 3.1 3.6 7.7 9.4 9.3 11.0 8.7 16.5 2.0 1.8 7.5 7.9 9.4 13.0 6.0 3.9 5.4 12.0 4.6 20.7 4.3 10.6 5.8 9.0 4.9 10.4 14.6 13.5 4.9 5.5 18.4 14.0 11.2 12.5 0.2 26.9 25.7 41.3 35.0 22.8 1.4 21.1 28.0 16.3 13.8 0.6 11.5 0.0 0.1 26.2 13.0 10.9 31.5 21.6 20.5 0.4 39.1 16.4 51.4 43.4 8.4 0.3 4.1 38.3 28.9 61.9 29.1 30.5 16.5 0.0 2.2 49.0 16.8 13.1 0.0 0.1 32.8 7.9 9.6 0.9 27.2 0.3 0.1 8.9 19.7 13.7 45.5 9.9 16.2 24.6 31.8 0.4 0.3 54.1 23.4 32.7 36.1 1.7 0.0 0.0 49.2 0.1 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 12.7 11.9 3.5 9.2 7.7 19.7 9.3 11.0 8.7 9.4 5.8 14.6 12.5 4.3 3.2 11.0 81.0 1.9 33.1 20.6 17.9 39.9 11.7 4.1 3.6 3.6 0.0 9.0 7.3 4.2 9.7 0.0 0.1 0.0 0.5 23.9 1.6 23.2 14.3 1.2 4.0 309.4 0.2 8.3 34.6 3.6 2.3 1.3 5.1 16.1 0.3 1.5 1.7 1518.9 1.4 22.4 2.6 10.0 65.9 19.9 1.5 14.2 51.5 1.9 5.7 0.0 348.3 479.3 0.2 5.1 24.5 1.3 20.5 4.9 0.4 2.9 1.0 13.1 24.7 16.8 2.7 7.0 30.3 33.8 5.6 0.9 71.1 2.6 52.7 ONECUT1 "HNF-6, HNF6, HNF6A" ENSG00000169856 "One cut homeobox 1" Q9UBC0 15 52755053-52791078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 6.0;liver: 13.0;pancreas: 13.7;retina: 4.7" "Cell type enriched" "Detected in some" 16 "Horizontal cells: 647.8" "Group enriched" "Detected in some" 7 "liver cancer: 2.9;pancreatic cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;Hep G2: 1.4;MCF7: 1.3;NTERA-2: 1.8;SuSa: 1.9;WM-115: 1.2" "Region enhanced" "Detected in single" "hypothalamus: 1.0" "Low region specificity" "Detected in many" HPA003457 Enhanced NA NA "HPA003457: AB_1079525" "unprognostic (5.12e-2)" "unprognostic (2.45e-2)" "unprognostic (2.64e-2)" "unprognostic (4.82e-2)" "unprognostic (9.19e-2)" "unprognostic (7.05e-2)" "unprognostic (5.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.70e-7)" "unprognostic (9.76e-3)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" 0.0 0.0 1.0 0.0 0.7 0.5 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.4 1.0 0.0 13.0 0.0 0.0 1.8 1.9 0.1 0.0 13.7 0.0 0.0 0.0 1.8 0.0 0.0 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 1.8 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.0 1.8 0.1 0.1 0.3 0.0 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.2 1.9 0.3 0.0 0.0 0.6 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.4 0.3 0.4 1.0 1.8 1.9 0.1 1.8 0.7 0.7 1.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.3 40.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 21.1 1.4 0.1 0.0 0.3 0.0 0.0 0.4 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 647.8 0.2 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 15.6 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AVEN PDCD12 ENSG00000169857 "Apoptosis and caspase activation inhibitor" Q9NQS1 15 33858782-34075155 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 44.0;Oligodendrocytes: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020863 Approved Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane, Actin filaments" Centrosome "HPA020863: AB_1845219" "unprognostic (1.54e-3)" "unprognostic (1.99e-1)" "unprognostic (8.93e-2)" "unprognostic (5.77e-2)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (6.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (4.14e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.29e-10)" "unprognostic (7.66e-3)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-3)" 12.9 11.5 9.4 7.2 9.4 4.4 10.9 9.8 10.1 10.5 11.1 12.9 7.5 12.6 5.3 12.4 11.4 6.5 22.9 9.1 10.5 5.5 17.0 7.3 4.8 10.1 9.9 8.9 10.6 21.0 3.0 5.8 12.5 10.3 9.5 9.5 2.5 8.0 9.2 31.3 10.9 7.6 12.6 9.8 6.5 12.4 10.8 10.0 7.0 5.6 13.7 8.0 16.4 10.9 10.0 16.4 26.3 26.0 8.6 21.4 24.1 14.7 41.1 36.2 31.9 19.9 7.2 11.3 15.2 24.8 34.8 24.2 10.4 12.2 26.9 25.7 14.6 7.7 26.1 15.9 20.5 31.5 26.6 18.2 19.8 50.9 18.4 45.8 38.6 35.2 7.6 26.6 21.1 45.6 17.3 10.5 46.1 11.9 22.2 8.5 15.7 14.6 32.2 26.4 21.0 13.4 16.8 22.6 11.6 11.4 10.7 12.6 29.4 24.5 27.7 9.5 12.0 34.6 21.2 17.7 31.1 13.3 31.0 15.2 0.0 0.2 0.0 0.5 0.6 0.6 0.4 0.5 0.2 0.2 0.1 0.2 0.3 0.0 0.5 0.2 2.3 0.9 0.1 9.4 9.4 9.8 10.1 9.1 10.5 10.1 9.9 8.9 10.3 9.8 10.0 10.0 9.0 3.2 5.3 16.6 5.6 5.7 8.7 1.8 3.4 5.6 7.5 9.0 32.7 2.8 0.8 0.0 6.2 11.0 10.5 7.4 0.0 2.9 13.8 4.4 14.3 10.2 4.8 9.5 21.8 8.6 44.0 8.5 5.6 5.6 0.0 14.7 8.6 19.1 7.4 8.4 24.1 7.7 0.0 4.1 4.4 6.5 7.5 5.0 3.6 22.5 3.5 10.9 7.2 26.7 86.6 7.0 5.2 10.5 15.6 21.5 9.4 4.6 1.5 5.3 6.6 4.9 9.7 6.2 7.4 12.9 9.7 9.4 6.5 23.1 6.0 14.7 P2RY1 "P2Y1, SARCC" ENSG00000169860 "Purinergic receptor P2Y1" P47900 3 152835131-152841439 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 25.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.3;Cholangiocytes: 21.5;Distal enterocytes: 25.4;Kupffer cells: 21.1;Squamous epithelial cells: 45.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.0;non-classical monocyte: 2.6" "Group enriched" "Detected in many" 9 "granulocytes: 6.0;monocytes: 2.6" "Cell line enriched" "Detected in many" 5 "HEL: 45.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015577 Enhanced NA NA "HPA015577: AB_1854882" "unprognostic (3.30e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.76e-2)" "unprognostic (9.70e-2)" "unprognostic (1.40e-3)" "unprognostic (3.32e-2)" "unprognostic (2.53e-1)" "unprognostic (5.14e-1)" "unprognostic (2.58e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (2.04e-7)" "unprognostic (1.36e-1)" "unprognostic (8.98e-2)" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" 1.6 1.4 6.1 2.3 14.1 5.7 1.5 3.6 5.8 4.1 1.3 8.8 3.2 6.5 0.5 19.4 2.1 2.0 2.9 6.0 11.4 0.8 1.5 7.0 0.8 4.1 6.0 3.8 8.9 3.3 0.3 1.6 25.7 5.8 7.8 6.8 9.1 3.2 2.2 7.8 9.0 6.2 4.5 5.0 2.3 0.9 1.1 5.9 1.6 1.3 3.4 2.7 2.4 8.1 4.1 0.0 0.7 7.0 0.0 1.1 0.1 0.0 0.0 0.1 0.2 0.6 9.0 0.1 0.0 0.7 0.0 1.1 1.5 3.9 1.3 0.3 0.0 3.4 45.9 0.1 0.0 0.0 5.4 4.0 0.5 8.7 0.0 0.4 3.5 0.0 1.5 1.4 0.0 0.0 0.1 0.8 0.1 6.4 0.0 5.5 0.0 0.2 1.3 0.0 3.1 1.1 0.0 0.0 0.0 0.9 1.6 0.0 2.4 0.0 0.7 1.8 0.0 3.9 0.0 0.0 0.0 4.5 0.0 5.2 6.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.1 6.1 14.1 3.6 5.8 6.0 11.4 4.1 6.0 3.8 5.8 5.0 5.9 4.1 1.0 0.0 0.5 12.7 0.8 1.9 6.7 3.3 15.9 23.3 0.5 0.1 7.1 21.5 1.0 0.0 0.0 0.2 1.6 25.4 0.0 1.3 0.2 1.9 12.0 7.1 0.0 10.8 0.0 0.0 0.3 5.6 0.0 2.7 10.1 0.1 11.7 0.3 7.4 0.0 0.2 8.9 0.0 21.1 0.3 0.8 14.9 15.9 0.0 1.0 1.8 19.1 0.0 0.0 0.6 0.9 12.3 6.0 0.0 6.3 13.4 0.2 0.2 1.5 0.0 1.2 1.0 0.4 2.2 45.4 2.0 0.1 0.5 3.5 8.3 4.9 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971836-11904446 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 100.9" "Cell type enhanced" "Detected in many" "Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339, HPA071124" Enhanced Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "CAB037339: , HPA015077: AB_2669150, HPA071124: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 0.2 0.7 78.6 0.2 69.0 0.0 0.9 53.8 76.3 0.1 15.4 0.8 0.1 0.1 0.3 0.1 0.2 2.7 3.7 83.3 53.6 0.0 0.5 0.7 0.1 100.9 68.8 64.5 0.5 16.0 0.0 9.1 0.3 69.1 0.9 0.3 7.1 0.8 0.2 0.1 0.5 0.5 0.1 70.3 4.0 0.6 2.6 72.7 0.2 0.2 0.1 0.0 0.1 0.2 74.9 0.0 0.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 9.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 3.4 0.0 17.5 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.6 69.0 53.8 76.3 83.3 53.6 100.9 68.8 64.5 69.1 70.3 72.7 74.9 0.1 0.0 0.0 2382.9 0.1 0.0 0.1 0.0 0.0 24.0 7.9 4.1 12.7 28.6 0.0 1.8 0.0 0.0 0.0 0.1 3.9 6.5 25.6 0.8 0.1 0.8 4.9 0.0 1253.9 6.1 0.2 0.5 0.0 0.9 0.0 0.0 0.0 0.2 0.1 8.4 1124.0 0.1 0.0 0.0 0.7 31.1 1.5 0.2 0.0 69.3 0.0 33.0 0.0 1418.0 433.8 2.2 0.0 0.0 0.0 2.8 0.0 0.4 0.0 3.6 0.0 3.3 0.3 4.6 5.9 0.0 0.0 0.0 0.1 0.5 0.3 0.1 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085481-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.13e-4)" 13.5 11.4 13.9 14.5 13.6 6.7 13.0 12.7 11.8 14.6 14.0 11.9 11.8 13.6 13.5 12.5 14.9 7.6 9.6 10.4 16.2 11.1 10.9 17.9 15.5 17.0 14.1 8.8 19.2 10.2 9.7 8.7 9.0 15.9 15.0 9.8 2.1 14.1 13.1 12.1 15.9 14.8 8.6 13.1 21.6 12.5 3.9 16.0 13.0 12.8 6.8 12.5 12.7 13.5 16.0 16.4 20.1 8.5 10.9 19.1 19.7 10.2 13.4 11.7 21.2 19.6 9.6 23.0 19.2 14.0 11.1 29.3 18.4 3.5 12.3 14.2 19.2 5.5 12.2 28.9 7.1 17.1 21.6 26.4 12.6 17.3 13.8 22.4 20.7 11.2 12.2 21.6 23.7 14.8 22.4 18.3 24.0 8.5 8.8 16.7 16.8 13.9 12.7 11.1 16.9 0.4 0.3 14.8 40.8 11.6 10.8 9.3 14.0 21.6 29.4 26.1 22.4 14.4 11.7 12.4 14.7 14.6 17.2 23.6 1.7 1.2 1.2 1.8 0.8 1.4 1.1 1.4 1.2 0.4 1.6 1.3 1.7 3.9 4.1 1.2 1.1 0.7 0.6 13.9 13.6 12.7 11.8 10.4 16.2 17.0 14.1 8.8 15.9 13.1 16.0 16.0 62.5 73.7 82.7 3.3 45.7 5.2 82.2 6.7 28.5 3.1 30.4 27.2 21.7 108.7 32.8 51.5 2.1 41.6 45.4 51.9 3.9 61.4 2.1 60.8 53.7 80.6 29.1 43.5 0.1 48.1 25.7 40.0 33.1 42.5 15.2 129.9 114.5 48.1 19.3 10.1 0.1 40.9 4.1 48.7 4.5 5.2 132.3 33.3 1.8 8.4 60.0 20.4 141.1 2.5 3.6 56.9 45.4 94.4 24.9 79.9 76.5 11.4 51.0 4.0 65.7 76.7 38.9 5.4 7.2 15.9 3.3 29.8 44.3 64.5 41.1 60.5 MUC17 ENSG00000169876 "Mucin 17, cell surface associated" Q685J3 7 101020072-101058859 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 62 "intestine: 43.0" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 320.9" "Cancer enhanced" "Detected in some" "stomach cancer: 22.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031634 Enhanced "Intracellular and membrane" NA NA "HPA031634: AB_10603021" "unprognostic (2.37e-2)" "unprognostic (2.41e-1)" "unprognostic (8.17e-3)" "unprognostic (5.57e-3)" "unprognostic (6.07e-2)" "unprognostic (8.79e-8)" "unprognostic (1.28e-1)" "unprognostic (2.47e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 43.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 14.8 0.0 0.0 0.1 320.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 22.0 0.0 AHSP "EDRF, ERAF" ENSG00000169877 "Alpha hemoglobin stabilizing protein" Q9NZD4 16 31527900-31528803 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 62 "bone marrow: 1683.5" "Cell type enriched" "Detected in some" 296 "Erythroid cells: 8721.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 3.0;K-562: 1.5" "Low region specificity" "Detected in some" HPA040940 Enhanced NA NA 5300000 "HPA040940: AB_10796231" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (8.44e-2)" "unprognostic (3.76e-1)" "unprognostic (1.53e-1)" "unprognostic (3.10e-1)" "unprognostic (2.16e-1)" "unprognostic (3.70e-3)" "unprognostic (2.04e-2)" "unprognostic (9.02e-2)" "unprognostic (3.25e-2)" 0.8 0.1 0.7 0.2 0.7 1683.5 0.4 0.9 2.6 0.2 1.1 0.1 0.0 0.1 0.0 0.2 0.2 0.0 1.3 0.7 0.7 1.8 4.8 4.6 0.2 0.9 1.0 0.6 0.2 0.3 0.1 1.4 27.3 0.8 0.1 0.3 0.0 0.5 0.0 0.2 1.4 0.1 0.0 0.8 23.9 0.2 4.1 0.8 2.9 0.7 9.0 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 4.7 0.7 0.7 0.9 2.6 0.7 0.7 0.9 1.0 0.6 0.8 0.8 0.8 0.9 0.1 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.6 0.0 8721.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 2.9 4.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 29.4 0.3 2.8 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.0 0.0 2.1 0.0 0.0 0.1 WNT10B "SHFM6, WNT-12" ENSG00000169884 "Wnt family member 10B" O00744 12 48965340-48971735 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 18.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.3;Extravillous trophoblasts: 21.7;Fibroblasts: 4.8;Inhibitory neurons: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 7.3;T-47d: 8.2;U-266/84: 7.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA055048, HPA062539" Enhanced Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA055048: AB_2682683, HPA062539: AB_2684793" "unprognostic (1.13e-1)" "unprognostic (2.14e-2)" "unprognostic (5.73e-4)" "unprognostic (2.27e-2)" "unprognostic (3.09e-2)" "unprognostic (3.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.14e-1)" "unprognostic (4.99e-3)" "unprognostic (3.05e-2)" "unprognostic (5.39e-6)" "unprognostic (4.29e-2)" "unprognostic (3.74e-2)" "unprognostic (4.50e-1)" "unprognostic (1.25e-1)" 1.2 0.2 13.9 1.5 16.8 1.2 0.6 5.4 16.9 0.6 4.3 1.0 1.4 0.3 1.5 1.4 1.0 0.5 1.0 16.7 11.1 0.4 0.4 1.1 1.7 9.4 8.2 18.6 0.2 0.3 0.1 2.5 0.3 10.4 0.8 0.7 0.1 0.9 0.6 0.7 3.0 4.4 0.1 5.5 4.1 1.1 3.3 10.0 1.9 1.0 0.4 1.6 1.3 1.0 12.0 1.9 1.2 0.0 1.7 0.0 0.0 4.6 1.3 2.4 0.5 0.1 3.6 4.0 0.0 0.3 0.2 1.5 2.2 4.8 0.3 0.2 1.1 6.3 2.1 1.7 0.1 0.0 0.7 2.9 0.0 0.4 0.1 2.1 4.1 0.0 1.5 7.3 0.3 0.7 2.4 0.1 2.5 0.0 1.3 2.5 0.0 0.6 2.2 0.0 0.4 0.1 0.0 0.3 0.1 0.6 2.2 8.2 2.7 0.0 2.5 4.9 0.4 0.6 2.6 7.8 0.0 1.0 5.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.9 16.8 5.4 16.9 16.7 11.1 9.4 8.2 18.6 10.4 5.5 10.0 12.0 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 1.8 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.8 0.2 0.1 0.0 0.0 0.0 7.3 0.0 21.7 4.8 0.0 0.1 0.0 0.0 0.7 0.0 0.3 0.0 4.7 0.2 0.0 0.0 1.2 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.7 3.0 0.9 1.3 1.4 1.6 0.0 0.0 0.1 CALML6 CAGLP ENSG00000169885 "Calmodulin like 6" Q8TD86 1 1915108-1917296 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 19 "skeletal muscle: 156.0;tongue: 110.8" "Cell type enriched" "Detected in some" 22 "Skeletal myocytes: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;BEWO: 1.3;CAPAN-2: 1.2;hTCEpi: 1.4" NA NA "unprognostic (3.85e-2)" "unprognostic (3.04e-2)" "unprognostic (1.59e-4)" "unprognostic (1.66e-1)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-3)" "unprognostic (9.72e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-2)" "unprognostic (9.76e-2)" "unprognostic (5.21e-10)" "unprognostic (5.06e-3)" "unprognostic (1.93e-1)" "unprognostic (1.23e-2)" "unprognostic (6.48e-2)" 0.4 0.3 1.4 0.2 1.5 0.2 0.6 1.4 2.9 0.7 1.3 0.3 0.1 0.3 0.8 7.0 0.3 0.0 0.2 1.4 1.4 0.7 2.0 0.3 0.2 1.4 1.4 1.4 0.3 1.6 0.2 0.7 0.1 1.4 1.5 0.3 0.2 2.9 0.4 156.0 1.7 0.3 0.2 1.3 0.5 0.5 1.3 1.4 0.2 0.5 110.8 0.4 0.3 1.1 1.5 0.0 0.0 0.1 1.6 0.7 0.3 1.3 0.3 0.0 0.1 0.1 0.0 1.2 0.4 0.1 0.5 0.1 0.7 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.3 1.4 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.4 0.1 0.8 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 1.4 2.9 1.4 1.4 1.4 1.4 1.4 1.4 1.3 1.4 1.5 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 22.8 1.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 REPS2 POB1 ENSG00000169891 "RALBP1 associated Eps domain containing 2" Q8NFH8 X 16946658-17153272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 117.9;Inhibitory neurons: 142.7;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 204.0" "Cancer enhanced" "Detected in all" "prostate cancer: 13.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 5.8;eosinophil: 4.5;neutrophil: 14.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 14.3" "Cell line enhanced" "Detected in some" "HDLM-2: 30.2;Karpas-707: 11.7;RH-30: 8.4;RPMI-8226: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000565, HPA026073" Uncertain "Intracellular and membrane" NA NA "HPA000565: AB_1079800, HPA026073: AB_1856176" "unprognostic (6.58e-2)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (7.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.70e-3)" "prognostic favorable (5.36e-4)" "unprognostic (4.85e-2)" "unprognostic (2.87e-2)" "unprognostic (5.53e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (1.83e-1)" "prognostic favorable (4.08e-4)" "unprognostic (5.89e-2)" "unprognostic (1.03e-1)" "unprognostic (2.43e-2)" "prognostic favorable (4.56e-4)" 2.4 11.2 5.0 1.3 10.5 3.0 3.4 2.4 24.1 16.0 1.7 4.3 2.1 4.2 12.7 1.4 2.1 2.1 1.6 10.4 9.1 11.1 7.6 4.7 0.5 3.1 5.3 9.5 4.1 10.4 9.4 6.1 2.7 5.7 8.3 4.7 9.4 5.1 7.9 0.9 0.9 2.0 4.2 1.8 1.2 6.4 2.1 9.8 0.7 2.0 1.3 0.6 1.9 1.0 12.6 1.4 0.6 0.0 0.1 0.8 0.5 0.1 0.0 0.0 0.1 0.2 0.1 5.2 0.0 0.6 0.0 3.9 0.2 1.1 2.8 0.5 30.2 0.6 0.0 0.7 0.0 0.7 0.0 0.1 5.3 0.9 0.0 4.7 4.9 1.6 0.0 0.0 11.7 0.3 1.4 0.0 0.4 0.2 4.3 0.9 0.0 8.4 9.4 0.3 2.8 4.2 0.3 2.2 2.1 1.7 1.7 3.9 0.2 0.2 0.0 0.2 0.1 0.4 0.5 0.0 0.4 0.0 0.4 0.2 5.8 0.3 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 14.3 0.0 0.2 0.3 0.0 0.1 5.0 10.5 2.4 24.1 10.4 9.1 3.1 5.3 9.5 5.7 1.8 9.8 12.6 11.7 32.1 13.5 6.5 0.9 0.6 9.6 4.4 1.2 49.5 7.9 5.5 6.6 4.3 8.8 14.7 0.0 0.2 1.5 10.4 1.9 3.0 0.2 7.1 4.0 2.3 9.5 4.4 117.9 14.6 9.1 4.1 9.7 9.6 0.0 7.9 4.2 15.1 4.2 38.7 142.7 7.8 0.0 5.7 6.4 0.9 9.3 6.6 1.8 21.5 4.9 0.9 0.0 84.9 204.0 7.9 5.1 12.8 1.3 10.6 2.3 11.6 2.7 2.6 0.0 0.8 2.0 0.7 2.6 0.9 1.3 0.7 0.5 16.3 10.2 6.5 MUC3A MUC3 ENSG00000169894 "Mucin 3A, cell surface associated" Q02505 7 100949534-100968347 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 14.0;intestine: 42.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 220.6;Intestinal goblet cells: 114.2;Paneth cells: 157.1;Proximal enterocytes: 360.1;Undifferentiated cells: 129.5" "Group enriched" "Detected in many" 5 "colorectal cancer: 16.4;pancreatic cancer: 14.0;stomach cancer: 29.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.3;CAPAN-2: 2.4;MCF7: 1.6;OE19: 3.7" "Region enriched" "Detected in many" 7 "cerebellum: 16.5" "HPA010871, HPA047868" Uncertain Uncertain "Cell Junctions" "Intracellular and membrane" NA NA "Cell Junctions" "HPA010871: AB_1854201, HPA047868: " "unprognostic (1.12e-2)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (4.22e-3)" "unprognostic (2.91e-1)" "unprognostic (5.16e-2)" "unprognostic (2.06e-1)" "unprognostic (5.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.33e-1)" "unprognostic (7.01e-2)" "unprognostic (2.99e-1)" "unprognostic (6.50e-3)" "unprognostic (8.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (4.51e-2)" 0.9 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.4 0.0 0.0 9.5 42.1 0.0 0.0 0.0 0.0 14.0 2.0 0.0 0.6 0.1 8.7 0.2 0.3 0.1 0.1 0.0 0.0 0.6 0.8 0.0 0.0 0.7 3.1 12.0 0.0 0.1 0.0 5.0 0.1 33.8 0.8 0.0 0.1 2.7 0.1 0.1 10.0 0.8 0.5 0.3 0.4 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.3 2.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.6 0.0 0.0 1.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.1 0.0 0.7 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.2 0.0 27.2 0.0 0.0 0.0 1.0 0.4 2.1 28.6 0.0 1.8 0.0 0.7 0.0 220.6 0.0 18.8 0.8 0.0 0.1 0.8 10.3 0.0 0.1 28.8 1.1 0.4 15.8 0.0 0.0 0.0 0.4 5.3 0.3 0.0 0.0 114.2 0.0 0.8 0.0 0.4 0.3 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.1 28.9 157.1 0.0 0.0 65.7 360.1 0.3 0.0 0.0 0.0 0.4 6.4 0.8 6.8 0.0 0.1 0.3 0.4 0.0 129.5 21.3 SYAP1 "FLJ14495, PRO3113" ENSG00000169895 "Synapse associated protein 1" Q96A49 X 16719612-16765340 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000175, HPA000882, HPA048047" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 13000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240" "unprognostic (4.66e-2)" "unprognostic (2.99e-2)" "unprognostic (1.25e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (9.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.82e-1)" "unprognostic (1.62e-2)" "unprognostic (1.95e-1)" "unprognostic (3.95e-3)" "unprognostic (1.14e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-3)" 15.4 25.4 5.9 11.3 6.6 25.7 12.5 7.4 7.9 13.2 11.0 14.7 17.6 9.3 8.8 11.4 11.2 13.3 9.6 7.0 10.4 16.2 29.7 9.2 10.4 7.2 6.9 5.7 11.0 11.9 15.7 7.6 8.7 7.0 13.0 13.1 7.9 10.8 8.0 12.7 10.4 15.7 10.0 6.9 7.1 13.4 6.4 7.4 8.0 11.6 7.7 10.8 10.9 8.3 9.0 29.2 24.1 17.0 32.0 22.6 25.6 7.8 22.7 16.2 18.6 18.4 22.8 23.5 22.6 32.4 22.3 37.9 16.9 21.0 29.7 24.7 14.8 41.9 9.0 25.4 21.9 16.2 15.5 13.4 17.6 13.7 32.2 27.1 21.5 26.0 6.9 19.8 12.2 25.4 34.2 8.4 16.6 19.9 16.1 26.3 9.1 21.5 22.8 27.8 18.9 17.3 21.3 42.2 29.7 23.1 22.0 39.5 13.8 20.6 23.7 12.5 48.7 18.6 13.4 12.2 26.1 23.3 7.7 19.8 7.4 7.2 9.3 9.9 7.9 8.1 9.0 8.4 9.2 7.8 7.0 8.3 8.7 12.0 10.1 11.4 6.5 10.5 6.5 5.9 6.6 7.4 7.9 7.0 10.4 7.2 6.9 5.7 7.0 6.9 7.4 9.0 60.4 64.1 75.6 14.4 96.0 64.1 107.0 69.5 37.0 20.2 116.0 78.2 74.3 88.6 92.2 79.1 22.9 66.5 273.8 164.3 111.6 119.6 214.8 219.3 84.7 53.3 106.1 45.9 13.9 132.1 83.3 65.5 72.4 176.3 210.0 38.3 71.4 216.0 49.5 23.5 16.0 107.4 63.1 70.8 241.0 296.2 42.3 171.5 67.6 8.4 55.7 49.4 64.9 11.6 26.9 183.6 159.2 54.5 185.5 80.3 148.3 164.3 169.7 21.5 59.2 56.9 68.1 15.3 21.5 42.0 52.6 150.5 156.6 48.5 118.6 104.4 ITGAM "CD11B, CR3A, MAC-1" ENSG00000169896 "Integrin subunit alpha M" P11215 16 31259967-31332892 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Innate immunity" "Integrin, Receptor" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 184.5" "Group enriched" "Detected in many" 4 "dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HMC-1: 50.0;NB-4: 19.9;U-937: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002274, CAB025091, CAB072870" Enhanced NA NA 1000000 "CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435" "unprognostic (1.82e-2)" "unprognostic (1.70e-2)" "unprognostic (8.78e-2)" "unprognostic (2.54e-2)" "unprognostic (2.40e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.86e-1)" "unprognostic (1.73e-1)" "unprognostic (3.29e-3)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.93e-5)" "unprognostic (9.89e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (3.99e-2)" "unprognostic (5.03e-2)" 13.5 4.7 3.0 24.9 3.6 184.5 3.0 4.5 4.9 3.3 7.2 3.0 2.2 2.0 0.7 2.6 2.4 5.9 2.9 3.3 10.4 1.0 3.5 16.5 7.5 6.6 4.5 1.8 1.6 2.3 1.3 0.1 7.7 6.3 1.5 3.5 0.3 2.5 2.3 1.4 1.7 3.5 11.3 7.5 13.3 3.1 1.4 6.8 5.2 1.0 3.1 10.5 8.0 0.2 7.3 0.8 1.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.5 0.8 1.3 0.9 0.0 0.4 0.1 0.0 0.4 0.0 7.6 0.0 1.0 0.0 0.0 0.0 1.8 50.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.3 0.1 1.0 0.0 2.2 0.0 0.0 0.0 0.5 0.4 0.0 0.2 4.3 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 22.6 0.1 93.3 55.7 70.2 31.1 20.9 1.9 4.8 3.3 9.5 9.5 1.0 0.9 7.7 58.4 54.4 3.2 0.6 1.2 27.0 3.0 3.6 4.5 4.9 3.3 10.4 6.6 4.5 1.8 6.3 7.5 6.8 7.3 1.4 3.2 9.8 0.7 9.3 1.1 0.3 1.5 0.0 0.0 1.8 3.8 2.3 4.3 1.8 0.0 0.0 0.3 45.4 0.0 0.0 1.2 0.5 0.3 0.4 1.6 3.6 9.4 1.0 0.0 0.7 1.1 1.1 0.5 35.5 0.5 2.2 1.2 47.2 0.0 1.0 0.1 0.0 117.7 45.5 1.8 0.3 83.2 0.0 41.2 87.4 0.0 75.2 3.0 0.3 0.9 0.0 0.0 4.5 0.5 0.0 0.2 0.9 0.0 13.1 1.2 0.5 0.7 0.9 0.5 1.0 0.8 14.9 0.0 0.3 0.2 PYDC1 "ASC2, POP1" ENSG00000169900 "Pyrin domain containing 1" Q8WXC3 16 31215962-31217135 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 8.2;skin 1: 13.3" "Group enriched" "Detected in some" 5 "Breast glandular cells: 3.2;Breast myoepithelial cells: 2.5;Suprabasal keratinocytes: 6.3" "Cancer enriched" "Detected in some" 8 "breast cancer: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.72e-3)" "unprognostic (1.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.61e-1)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.62e-1)" "unprognostic (5.34e-2)" "unprognostic (3.15e-2)" "unprognostic (2.60e-10)" "unprognostic (3.62e-1)" "unprognostic (1.74e-1)" "unprognostic (1.70e-1)" "unprognostic (9.47e-2)" 0.0 0.0 5.5 0.0 4.3 0.0 0.5 7.4 8.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.4 0.0 0.0 0.0 0.0 2.3 2.0 3.8 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 1.1 13.3 0.0 0.0 1.3 0.0 0.1 0.0 3.7 0.4 0.0 0.0 0.2 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.5 4.3 7.4 8.2 4.9 3.4 2.3 2.0 3.8 3.5 1.3 3.7 2.8 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.0 3.2 2.5 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 6.3 0.0 0.1 0.1 0.0 0.1 TPST1 TANGO13A ENSG00000169902 "Tyrosylprotein sulfotransferase 1" O60507 7 66205317-66420543 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 76.5;Excitatory neurons: 101.9;Inhibitory neurons: 107.1;Spermatocytes: 97.1" "Cancer enhanced" "Detected in all" "glioma: 36.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 52.2;neutrophil: 35.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047415, HPA061837" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA047415: AB_10964056, HPA061837: AB_2732672" "unprognostic (7.46e-2)" "unprognostic (1.45e-1)" "unprognostic (8.62e-2)" "unprognostic (3.43e-2)" "unprognostic (3.52e-2)" "unprognostic (1.78e-3)" "unprognostic (5.71e-2)" "unprognostic (8.21e-2)" "unprognostic (3.59e-1)" "unprognostic (9.25e-3)" "unprognostic (4.12e-2)" "unprognostic (4.98e-1)" "prognostic unfavorable (8.16e-6)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.48e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.73e-5)" 17.1 15.9 24.6 10.9 21.3 6.0 13.6 19.4 21.8 35.7 13.6 10.0 3.2 22.0 14.5 10.9 11.3 38.4 7.3 20.4 47.4 14.1 46.3 11.6 5.9 39.0 24.3 19.3 13.6 7.8 11.1 19.6 26.6 26.3 15.2 8.1 5.2 6.9 16.6 2.7 8.3 8.7 16.4 22.6 12.1 11.0 23.2 30.7 2.1 11.4 5.6 5.4 37.1 22.3 31.4 12.1 6.5 16.5 22.4 52.7 42.0 5.7 22.3 49.8 25.7 37.1 21.9 6.6 1.4 17.7 45.1 38.9 8.9 16.2 24.8 33.3 3.5 9.3 2.3 15.1 16.5 62.3 1.8 1.9 59.5 19.0 50.2 22.1 27.8 32.7 2.9 1.0 10.2 40.2 6.2 0.1 3.1 15.5 0.4 9.6 7.8 14.6 11.4 27.3 11.5 10.4 44.5 27.8 2.1 62.2 32.4 8.6 4.7 62.3 33.1 21.3 24.2 40.6 9.2 13.3 4.7 29.6 6.8 48.2 52.2 2.3 23.9 0.8 0.1 0.8 6.1 0.5 0.6 0.3 14.0 2.2 4.1 35.2 8.8 0.0 0.0 0.0 1.9 24.6 21.3 19.4 21.8 20.4 47.4 39.0 24.3 19.3 26.3 22.6 30.7 31.4 33.8 0.0 8.9 38.8 11.5 10.8 7.7 24.4 33.6 8.5 4.0 13.3 1.6 5.7 9.6 31.3 2.1 1.8 3.8 0.2 9.8 23.0 11.2 13.3 76.5 17.9 7.7 1.3 101.9 47.6 4.3 58.5 12.2 9.7 4.5 12.2 10.0 34.1 16.2 6.7 107.1 0.8 8.2 8.9 8.9 11.6 48.1 6.2 14.2 32.8 15.8 5.0 1.0 61.3 38.8 23.7 0.1 37.2 7.1 5.3 0.0 3.2 19.5 3.6 6.6 16.4 21.6 97.1 41.3 15.1 7.5 3.8 2.8 12.6 0.7 7.7 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149474697-149503394 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "gallbladder: 954.4;intestine: 656.7;liver: 709.6" "Group enriched" "Detected in some" 17 "Cholangiocytes: 2070.3;Hepatocytes: 578.1" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 1.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.5 656.7 0.6 2.3 0.7 0.5 954.4 0.3 0.0 0.0 0.8 709.6 0.3 0.8 0.0 0.0 0.0 0.0 73.1 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 519.1 0.9 0.0 0.1 21.5 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.6 0.3 0.2 4.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.8 0.1 20.3 0.0 0.0 0.5 1.4 36.5 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.1 0.1 0.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 4.1 2070.3 0.6 0.0 0.0 0.0 0.0 0.8 0.0 25.9 1.1 3.1 0.3 0.6 3.0 13.5 0.1 2.0 0.2 0.1 10.7 3.3 0.0 0.0 7.1 578.1 0.1 0.0 0.1 41.6 0.0 11.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 8.2 17.5 0.0 0.3 0.0 76.6 4.8 0.1 0.0 0.0 0.0 0.7 4.1 0.3 0.0 0.0 0.1 0.5 5.6 2.0 0.2 TOR1AIP2 "IFRG15, LULL1, NET9" ENSG00000169905 "Torsin 1A interacting protein 2" "Q8NFQ8, Q9H496" 1 179839967-179877803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051849, HPA058348, HPA070542" Uncertain Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278" "unprognostic (1.22e-1)" "unprognostic (8.49e-3)" "unprognostic (2.61e-1)" "unprognostic (2.25e-2)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.82e-1)" "unprognostic (6.17e-2)" "unprognostic (7.64e-3)" "unprognostic (3.06e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.99e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (1.36e-1)" 12.6 19.7 10.1 8.4 9.7 41.9 10.7 10.6 10.1 8.8 13.6 9.6 16.4 9.0 19.5 15.3 8.3 10.8 9.4 11.5 12.1 12.1 41.8 14.4 7.1 11.2 10.5 9.4 14.1 14.5 17.0 10.8 22.0 10.8 9.0 8.5 9.8 8.9 12.8 19.8 14.0 20.0 11.5 9.7 9.9 12.1 9.5 11.5 8.2 10.6 15.9 10.2 10.4 9.8 10.6 25.3 23.3 19.0 40.2 45.5 24.1 78.1 32.7 39.6 26.0 25.5 36.6 40.5 21.0 39.7 35.3 14.0 35.9 34.4 34.7 33.5 23.4 18.9 25.4 40.8 32.1 35.7 27.4 27.3 41.4 26.2 34.4 37.1 22.7 37.5 19.4 51.3 21.5 31.2 15.0 20.1 19.9 47.8 27.4 6.2 21.8 27.3 30.4 20.0 43.0 16.3 41.8 36.4 41.9 33.3 37.9 40.0 19.5 48.9 37.8 34.2 20.2 25.3 34.1 47.8 41.5 20.2 19.2 35.4 21.5 6.1 7.7 6.3 8.3 6.0 6.8 6.1 5.5 4.2 5.9 6.6 6.5 12.7 5.0 8.3 9.0 5.6 2.6 10.1 9.7 10.6 10.1 11.5 12.1 11.2 10.5 9.4 10.8 9.7 11.5 10.6 48.4 153.8 59.0 27.7 22.6 250.7 70.3 37.0 62.0 28.5 52.5 27.7 37.0 125.8 57.9 77.3 37.5 109.6 39.5 67.9 25.4 65.2 30.9 77.1 71.0 50.2 22.0 36.0 52.5 63.8 187.8 51.9 36.2 117.2 19.0 45.7 45.3 237.1 43.0 32.0 43.2 52.5 44.7 53.1 118.6 19.2 58.4 39.2 48.0 29.0 49.8 46.6 41.2 30.7 38.3 85.8 43.1 85.4 30.2 67.3 215.2 44.6 41.3 34.8 52.6 47.4 43.7 27.5 31.4 66.1 249.6 180.3 41.9 69.9 51.0 118.1 S100G "CABP1, CABP9K, CALB3" ENSG00000169906 "S100 calcium binding protein G" P29377 X 16650158-16654670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 201 "intestine: 240.6" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 5 "breast cancer: 4.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.5" "Region enriched" "Detected in single" 5 "pons and medulla: 1.1" "Not detected" "Not detected" "CAB017688, HPA028920, HPA055873" Enhanced Approved Cytosol NA NA Cytosol "CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952" "unprognostic (2.68e-2)" "unprognostic (2.78e-1)" "unprognostic (9.88e-3)" 0.0 0.0 0.1 0.1 0.4 0.1 1.1 0.7 0.3 0.0 0.1 0.2 240.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.3 0.2 0.6 0.5 0.1 0.1 0.4 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TM4SF1 "L6, M3S1" ENSG00000169908 "Transmembrane 4 L six family member 1" P30408 3 149369022-149377692 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 5463.1;Endothelial cells: 1843.0;Pancreatic endocrine cells: 2557.3;Prostatic glandular cells: 2717.0;Urothelial cells: 4902.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 703.8;hTERT-RPE1: 925.5;HUVEC TERT2: 633.3;LHCN-M2: 687.7;OE19: 672.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002760, HPA002823" Uncertain NA NA "CAB002760: , HPA002823: AB_1079221" "unprognostic (1.94e-1)" "unprognostic (2.25e-2)" "unprognostic (5.20e-2)" "unprognostic (4.79e-2)" "unprognostic (2.89e-2)" "unprognostic (2.47e-3)" "unprognostic (3.85e-3)" "unprognostic (2.74e-2)" "unprognostic (5.09e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.06e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (4.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.43e-6)" 263.5 72.0 42.6 51.0 39.5 2.6 194.5 40.8 68.3 61.4 64.5 58.7 38.6 75.6 58.7 212.8 75.4 239.6 165.6 38.9 41.6 89.1 93.4 231.8 25.5 42.7 41.9 35.3 50.1 213.5 20.1 20.4 196.2 43.2 80.6 60.5 6.1 182.4 32.3 50.7 63.2 62.7 95.4 42.5 121.6 130.8 19.7 48.7 17.1 73.1 64.8 60.7 152.3 116.4 44.6 367.9 401.9 0.0 1.0 108.4 422.2 0.6 115.2 455.5 23.9 8.8 159.7 703.8 0.1 351.3 23.5 545.5 434.0 1.9 80.0 22.9 0.9 0.0 3.9 391.8 521.8 39.4 0.0 0.5 40.0 19.1 169.7 81.5 925.5 633.3 0.0 0.3 0.8 687.7 0.5 0.0 0.7 1.5 672.9 170.7 0.2 0.9 0.8 449.3 54.8 0.2 0.5 46.8 25.1 4.4 6.0 0.8 1.7 404.7 233.6 38.9 4.8 244.3 0.5 0.7 1.1 337.4 0.4 62.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 39.5 40.8 68.3 38.9 41.6 42.7 41.9 35.3 43.2 42.5 48.7 44.6 1131.0 576.9 342.3 0.3 7.5 278.0 5463.1 668.3 272.6 0.1 956.5 363.1 24.0 274.5 984.3 57.0 0.0 0.8 17.0 176.6 0.0 1383.5 5.2 514.1 168.0 1843.0 39.2 15.6 0.0 1600.9 0.9 297.2 147.8 1807.5 31.5 0.2 1263.6 21.8 1.9 0.0 0.0 15.9 382.5 27.8 222.1 11.3 255.7 35.6 300.6 30.9 26.4 0.0 0.0 0.0 0.3 2557.3 251.8 176.0 11.1 2717.0 0.3 1.2 238.5 0.0 322.1 37.7 311.0 6.6 1.4 925.8 253.7 1.4 44.1 44.2 46.6 4902.9 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882395-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 3.3 5.8 4.2 3.3 5.1 6.5 4.8 5.4 6.1 6.2 2.4 6.0 5.1 7.7 6.0 3.9 5.7 3.4 3.4 4.8 3.9 4.3 3.1 4.9 3.6 3.4 3.7 5.1 6.8 4.7 4.1 5.6 2.4 4.0 5.9 3.9 9.4 4.0 4.1 5.0 6.4 5.8 5.7 2.4 4.8 4.8 10.8 3.8 3.8 3.9 4.4 3.0 4.5 4.9 5.3 5.8 2.2 9.5 11.4 4.0 3.5 9.3 6.1 3.5 3.0 3.0 10.2 5.4 9.2 4.8 13.5 2.2 5.6 8.9 3.5 5.9 6.0 11.9 8.8 13.4 7.2 2.2 6.5 7.8 2.9 3.4 4.8 6.2 6.4 4.1 9.2 6.3 3.8 5.3 3.2 5.0 6.5 4.5 4.6 5.6 11.5 24.2 3.4 5.1 6.3 8.4 5.9 4.4 3.5 4.6 9.2 5.2 4.8 5.0 7.3 9.3 8.2 5.3 4.4 4.0 5.6 5.1 8.6 3.4 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.0 4.2 5.1 5.4 6.1 4.8 3.9 3.4 3.7 5.1 4.0 2.4 3.8 5.3 5.0 16.0 7.5 11.4 5.6 14.1 5.9 2.4 4.6 14.9 10.2 9.1 4.7 4.3 2.0 9.2 16.7 2.7 6.5 4.7 0.0 5.1 16.0 11.7 7.8 5.1 12.0 6.1 32.6 4.5 5.4 7.0 5.1 8.3 1.3 16.4 7.9 2.2 1.9 26.9 28.5 7.0 4.1 2.6 8.9 16.4 5.6 5.2 5.4 6.5 4.1 8.9 5.2 21.1 16.6 5.0 6.7 6.0 8.6 9.8 4.7 4.2 9.7 15.5 6.6 7.8 6.1 23.5 21.4 5.7 8.8 2.5 7.0 4.7 7.0 4.8 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.9" "Cell type enhanced" "Detected in many" "Astrocytes: 135.2;Excitatory neurons: 303.6;Inhibitory neurons: 219.7;Oligodendrocyte precursor cells: 100.0;Oligodendrocytes: 506.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;HAP1: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 1.0 0.5 6.0 0.4 8.7 0.1 1.0 7.1 12.5 1.3 0.0 1.1 0.3 1.3 0.5 0.7 1.1 0.3 1.1 7.1 7.7 0.9 0.4 0.8 0.4 8.7 7.5 6.8 1.0 1.4 1.2 1.5 0.0 9.2 0.7 0.4 1.6 0.7 0.4 1.1 2.3 0.9 0.6 6.2 0.6 0.8 4.2 8.0 0.3 1.0 0.2 0.4 0.8 0.8 20.9 0.0 0.0 0.1 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 0.8 0.0 0.2 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.5 0.0 0.0 0.1 3.6 1.8 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.0 8.7 7.1 12.5 7.1 7.7 8.7 7.5 6.8 9.2 6.2 8.0 20.9 3.5 3.2 0.0 135.2 0.1 0.4 0.7 0.0 1.8 25.7 1.1 1.3 3.2 0.0 0.6 1.8 2.1 0.0 4.3 1.3 0.0 0.5 1.4 0.4 1.2 1.3 3.6 0.0 303.6 1.0 0.1 1.8 0.5 0.4 0.0 1.0 1.4 0.8 0.2 25.2 219.7 1.7 0.0 0.0 0.3 2.0 0.9 0.3 1.8 28.1 0.2 3.9 13.4 100.0 506.1 0.3 0.7 2.6 2.6 1.9 0.4 1.7 0.0 3.1 0.0 4.1 1.5 4.6 8.3 1.8 0.4 0.1 3.1 0.9 1.5 1.0 GUSB ENSG00000169919 "Glucuronidase beta" P08236 7 65960684-65982215 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 213.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036322, HPA036323" Approved Supported Vesicles "Intracellular and membrane" NA NA 330000 Vesicles "HPA036322: AB_10670796, HPA036323: AB_2675059" "unprognostic (1.54e-2)" "unprognostic (6.49e-2)" "unprognostic (1.18e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.89e-1)" "unprognostic (1.56e-3)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (7.00e-3)" "unprognostic (1.91e-1)" "unprognostic (3.34e-2)" "unprognostic (8.83e-3)" "unprognostic (1.98e-1)" "unprognostic (5.06e-1)" "unprognostic (1.45e-1)" 27.0 18.3 11.8 22.5 13.1 84.9 81.7 13.1 16.3 26.9 15.9 38.5 36.5 26.4 42.2 16.5 24.8 27.9 17.4 11.6 14.6 25.3 104.8 36.0 25.8 14.1 13.1 10.9 20.0 33.8 30.6 12.7 48.6 13.8 20.4 42.3 9.8 33.2 21.4 11.0 18.2 30.0 19.2 13.1 34.3 38.4 19.7 13.2 22.9 27.9 14.5 24.2 27.6 15.5 14.5 67.0 26.5 25.2 56.3 80.9 49.1 35.3 21.3 56.8 45.0 42.1 37.0 67.8 30.9 32.3 26.8 24.1 27.5 16.5 25.1 26.8 27.3 34.1 41.5 40.9 27.3 39.7 89.6 67.1 33.4 26.7 26.3 33.3 54.5 39.3 18.0 63.2 213.5 30.5 50.3 34.2 92.0 17.9 103.0 21.0 34.4 55.9 172.4 29.4 42.8 36.2 32.7 55.6 129.1 72.3 29.9 71.1 88.8 28.5 55.3 49.3 21.8 53.6 119.6 151.9 50.0 41.0 116.3 68.3 26.0 80.1 65.7 32.0 103.0 28.4 27.7 24.7 28.4 80.5 22.6 16.8 19.5 13.2 46.6 93.5 34.2 34.5 51.4 11.8 13.1 13.1 16.3 11.6 14.6 14.1 13.1 10.9 13.8 13.1 13.2 14.5 53.1 51.3 58.7 10.1 33.0 18.0 32.0 51.9 29.0 12.2 26.1 19.9 12.2 48.6 48.9 29.5 8.4 81.9 32.6 52.2 5.9 41.1 59.1 28.9 26.5 39.7 43.0 47.1 12.3 30.3 61.2 49.5 49.5 49.4 36.8 38.3 37.9 72.7 126.4 16.8 10.6 51.6 30.5 88.1 33.2 46.7 43.2 78.0 39.2 14.0 44.8 28.0 20.6 8.5 14.2 29.4 49.5 28.6 87.5 25.3 50.6 26.8 43.2 20.1 26.3 27.1 26.0 49.6 31.0 16.0 14.8 66.9 32.2 24.4 44.3 29.6 BRD3 "KIAA0043, ORFX, RING3L" ENSG00000169925 "Bromodomain containing 3" Q15059 9 134030305-134068535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051830 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA051830: AB_2681627" "unprognostic (3.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-1)" "unprognostic (6.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.98e-2)" "unprognostic (3.48e-2)" "unprognostic (1.11e-2)" "unprognostic (6.75e-2)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "prognostic favorable (2.71e-7)" "unprognostic (1.00e-1)" "unprognostic (4.71e-2)" "unprognostic (2.57e-2)" "unprognostic (1.42e-1)" 10.0 10.4 13.5 7.3 14.1 8.3 10.3 13.1 13.5 12.4 6.3 13.6 8.0 14.7 9.5 8.7 12.6 7.0 9.5 12.1 11.0 7.5 11.1 9.2 7.5 15.9 12.9 10.4 11.7 10.8 10.1 9.3 9.1 13.8 11.9 5.6 10.7 9.7 11.7 19.5 12.6 9.7 9.1 10.5 12.5 10.0 13.1 14.0 13.5 11.9 11.6 5.9 11.9 10.4 14.7 8.5 25.3 31.4 24.6 17.1 13.8 28.7 8.4 9.5 9.2 9.3 21.2 13.7 3.2 8.7 7.7 10.4 28.7 29.4 11.7 7.2 20.1 16.5 18.2 29.1 24.1 15.3 24.1 15.7 14.8 14.1 10.6 12.0 14.9 15.2 30.0 16.7 9.3 9.5 28.4 44.9 32.2 42.0 21.9 19.2 32.8 45.3 16.1 13.1 8.9 45.8 42.3 37.7 14.1 10.1 18.7 20.3 39.6 19.5 22.3 12.3 14.6 7.6 5.0 5.6 3.0 11.2 16.4 15.1 6.6 12.9 15.8 11.4 10.1 9.6 6.9 9.1 10.2 12.9 6.7 8.6 9.1 15.0 16.3 8.6 17.1 4.6 9.4 13.5 14.1 13.1 13.5 12.1 11.0 15.9 12.9 10.4 13.8 10.5 14.0 14.7 27.6 32.1 21.9 13.1 18.3 32.4 21.2 19.8 42.1 60.9 32.8 24.3 24.3 28.6 25.7 23.9 37.5 26.0 31.8 22.6 19.6 42.7 49.2 22.9 37.9 32.1 54.0 70.1 13.4 24.4 20.5 32.4 21.9 25.3 15.9 53.2 35.7 34.0 18.7 57.2 16.8 26.6 14.2 27.9 22.8 20.7 57.2 33.6 23.2 10.3 33.6 45.6 30.9 12.5 19.3 27.7 21.4 67.4 9.1 51.0 19.2 15.7 20.1 58.0 59.2 55.8 40.0 20.7 53.1 31.9 35.7 32.7 26.4 178.7 30.8 22.3 KLF13 "BTEB3, FKLF-2, NSLP1, RFLAT-1" ENSG00000169926 "Kruppel like factor 13" Q9Y2Y9 15 31326835-31435665 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 275.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.13e-2)" "unprognostic (9.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.63e-3)" "unprognostic (3.10e-1)" "unprognostic (9.32e-2)" "unprognostic (2.96e-1)" "unprognostic (5.94e-2)" "unprognostic (1.15e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (2.09e-1)" "prognostic favorable (2.37e-9)" "unprognostic (2.16e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-2)" "unprognostic (2.03e-2)" 25.2 11.8 1.9 13.1 5.9 62.6 19.4 13.5 12.9 12.5 0.0 18.5 15.2 17.6 8.7 18.7 21.2 2.7 27.8 10.0 4.4 17.4 20.7 32.1 17.8 8.6 3.4 0.5 14.3 44.7 10.9 11.7 4.9 7.2 10.0 13.7 4.0 12.9 10.8 38.9 31.7 29.4 21.0 0.4 29.9 22.7 6.8 6.6 49.2 28.6 19.0 18.2 15.4 13.2 16.7 10.7 0.9 14.8 6.0 34.3 18.2 1.3 10.5 16.7 5.7 6.9 8.8 7.4 2.1 21.5 19.8 18.6 16.1 4.1 12.6 4.3 50.9 3.5 25.6 27.6 7.0 49.3 23.3 33.1 10.7 85.8 4.6 31.9 9.4 0.2 17.3 11.2 5.2 2.9 3.3 32.2 28.1 2.9 42.5 21.0 18.4 14.6 17.3 11.2 4.6 16.7 36.5 13.4 21.6 0.0 17.7 3.3 13.6 22.3 4.3 11.6 16.7 0.1 32.3 19.2 6.6 3.7 34.6 5.1 2.2 4.7 7.0 13.1 2.3 13.8 26.5 7.7 12.6 1.2 24.2 6.7 21.0 8.6 1.5 1.9 21.0 21.3 4.3 1.9 5.9 13.5 12.9 10.0 4.4 8.6 3.4 0.5 7.2 0.4 6.6 16.7 56.6 131.4 66.0 7.5 65.4 58.5 32.9 20.2 33.0 34.7 18.9 22.1 47.9 50.1 24.8 16.5 0.0 14.7 149.3 74.0 9.8 19.2 7.7 49.5 36.2 45.1 40.6 74.5 18.6 26.5 25.0 46.0 24.5 67.1 26.6 13.3 42.5 102.5 11.6 275.9 9.1 39.1 10.2 84.8 28.5 6.5 25.4 34.4 32.0 4.7 90.7 28.7 120.5 12.1 40.6 29.8 22.4 46.6 150.0 40.5 56.7 26.0 9.5 12.3 26.3 68.6 52.5 1.5 8.2 35.1 51.3 14.6 82.1 54.2 45.8 44.1 FRMPD4 "KIAA0316, PDZD10, PDZK10" ENSG00000169933 "FERM and PDZ domain containing 4" Q14CM0 X 11822423-12724523 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 7.3;parathyroid gland: 3.8;retina: 4.1" "Group enriched" "Detected in some" 5 "Excitatory neurons: 941.1;Inhibitory neurons: 772.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;U-2197: 2.1;U-266/70: 3.3;U-266/84: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.05e-1)" "unprognostic (3.70e-2)" "unprognostic (3.50e-2)" "unprognostic (2.68e-3)" "unprognostic (8.84e-2)" "unprognostic (1.05e-2)" "unprognostic (3.56e-2)" "unprognostic (2.09e-2)" "unprognostic (1.62e-2)" "unprognostic (6.32e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.25e-1)" 0.0 0.0 2.7 0.0 4.8 0.0 0.0 0.3 7.3 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.7 3.9 2.6 0.0 0.0 0.0 0.0 0.0 1.1 3.7 0.0 0.0 3.8 0.1 0.0 1.4 0.2 0.1 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.1 0.0 0.1 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.2 3.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.8 0.3 7.3 3.9 2.6 0.0 1.1 3.7 1.4 0.0 1.9 4.1 0.2 0.0 0.0 50.3 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 3.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 941.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.2 772.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 11.2 0.0 0.5 0.0 39.7 11.7 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.2 0.0 0.0 ZFPM2 "FOG2, hFOG-2, ZC2HC11B, ZNF89B" ENSG00000169946 "Zinc finger protein, FOG family member 2" Q8WW38 8 104590733-105804539 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Gonadal differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.1;ovary: 33.6" "Cell type enhanced" "Detected in many" "Astrocytes: 115.2;Excitatory neurons: 524.4;Inhibitory neurons: 159.8;Microglial cells: 152.7;Oligodendrocyte precursor cells: 689.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 65.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.4;BJ hTERT+: 14.2;HHSteC: 9.9;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.9;K-562: 6.0;TIME: 6.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 39.4" HPA004094 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004094: AB_1859058" "unprognostic (4.48e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-3)" "unprognostic (1.36e-2)" "unprognostic (3.51e-1)" "unprognostic (1.53e-1)" "unprognostic (8.37e-2)" "unprognostic (8.35e-3)" "unprognostic (1.97e-2)" "unprognostic (1.04e-1)" "unprognostic (1.97e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-6)" "unprognostic (4.10e-3)" "unprognostic (5.41e-2)" "unprognostic (1.63e-4)" "unprognostic (2.61e-2)" 9.2 2.8 8.2 1.6 3.8 0.0 4.6 65.1 13.0 5.3 0.7 3.3 0.5 10.8 2.3 4.5 12.4 5.9 10.3 16.9 3.5 1.1 2.7 3.8 2.8 11.0 9.0 2.2 33.6 0.8 0.4 1.1 4.2 19.8 0.9 2.1 1.1 1.0 2.0 18.1 1.4 2.0 18.0 0.4 2.9 2.8 4.3 4.6 1.3 6.9 17.3 1.5 7.0 4.9 10.0 0.0 0.0 6.4 0.0 5.4 1.7 0.0 0.5 14.2 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 4.9 1.6 0.0 0.0 9.9 0.0 0.0 0.5 0.0 5.7 0.0 1.9 10.9 0.0 6.0 0.0 1.3 0.0 1.4 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 4.3 0.0 6.5 0.3 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 3.8 65.1 13.0 16.9 3.5 11.0 9.0 2.2 19.8 0.4 4.6 10.0 10.0 0.0 0.6 115.2 0.1 3.6 0.3 0.0 0.6 2.9 0.1 0.3 21.3 0.0 1.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 55.2 0.6 9.8 7.9 0.0 0.0 524.4 0.0 0.1 17.1 1.1 1.5 0.0 24.6 7.1 0.0 0.3 8.4 159.8 0.2 0.0 0.0 1.7 34.0 23.9 0.3 1.8 152.7 0.6 0.1 0.0 689.7 10.0 0.1 0.0 13.5 0.0 0.6 0.0 0.0 0.0 0.7 6.6 22.5 8.1 0.9 2.2 0.1 2.8 0.4 0.2 1.4 0.2 0.4 ZNF764 MGC13138 ENSG00000169951 "Zinc finger protein 764" Q96H86 16 30553764-30558374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003203 Uncertain Approved Cytosol NA NA Cytosol "HPA003203: AB_1080753" "unprognostic (9.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.47e-2)" "prognostic favorable (6.84e-4)" "unprognostic (6.62e-2)" "unprognostic (9.75e-3)" "unprognostic (8.26e-3)" "unprognostic (2.64e-3)" "unprognostic (2.00e-1)" "unprognostic (3.64e-1)" "unprognostic (1.77e-3)" "unprognostic (3.43e-2)" "unprognostic (3.55e-1)" "unprognostic (2.87e-1)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (3.05e-1)" 3.5 4.5 2.3 3.1 2.3 4.2 3.6 3.9 2.6 4.7 1.0 4.4 4.9 4.9 1.1 3.5 4.8 2.2 5.7 2.4 2.3 4.0 5.9 3.2 4.5 2.3 2.0 2.2 5.7 4.4 3.3 5.0 2.1 2.5 4.8 2.9 2.9 3.5 2.3 3.9 3.4 4.8 1.8 1.5 5.2 6.8 5.8 2.1 3.6 3.6 2.4 2.8 3.7 3.8 2.6 2.9 3.6 6.8 6.6 2.9 2.8 4.1 3.7 2.9 3.5 2.6 2.7 2.8 5.3 4.3 2.1 2.1 4.1 3.6 2.4 2.7 6.0 9.7 3.6 4.5 5.1 3.4 3.4 5.5 2.2 2.9 2.9 3.8 4.6 3.2 12.8 6.8 6.0 3.1 6.6 9.6 5.5 4.0 1.8 4.7 13.0 2.8 7.2 2.8 1.5 13.0 10.1 2.5 5.8 3.6 4.1 5.0 6.2 2.9 4.8 2.6 2.7 3.7 8.1 6.0 4.5 3.4 4.8 6.7 2.3 1.4 4.4 2.9 1.7 3.9 1.8 3.0 3.7 1.8 2.4 3.1 3.0 1.4 7.2 1.8 2.0 2.1 1.8 2.3 2.3 3.9 2.6 2.4 2.3 2.3 2.0 2.2 2.5 1.5 2.1 2.6 3.9 0.0 3.2 2.9 5.0 1.7 2.7 1.9 2.8 5.4 3.9 2.8 5.2 7.2 3.1 1.8 0.0 2.6 5.0 4.4 0.0 3.4 0.6 5.3 4.6 3.8 2.4 3.0 1.7 3.0 2.1 2.8 5.6 3.6 1.3 4.6 4.2 2.5 3.7 1.7 1.9 4.2 0.0 3.5 1.2 0.8 3.4 3.2 0.0 0.0 4.2 3.3 6.2 2.5 2.0 3.8 10.4 2.6 3.3 2.6 4.7 2.9 6.3 5.7 6.6 2.6 3.8 10.5 4.3 3.5 0.4 1.0 6.0 2.7 4.4 1.9 HSFY2 FLJ25453 ENSG00000169953 "Heat shock transcription factor Y-linked 2" Q96LI6 Y 18731440-18773735 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074968 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA074968: " 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF747 MGC2474 ENSG00000169955 "Zinc finger protein 747" Q9BV97 16 30530367-30535347 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003203, HPA069173" Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA003203: AB_1080753, HPA069173: AB_2686097" "unprognostic (3.82e-2)" "prognostic favorable (6.53e-4)" "unprognostic (3.73e-2)" "unprognostic (1.31e-2)" "unprognostic (4.01e-2)" "unprognostic (4.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.22e-3)" "unprognostic (2.45e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.46e-4)" "unprognostic (1.01e-2)" "unprognostic (2.60e-3)" "unprognostic (2.27e-1)" "unprognostic (4.66e-2)" "unprognostic (3.00e-1)" "unprognostic (1.01e-1)" 6.4 7.5 6.8 4.1 7.1 2.7 6.8 7.5 7.4 7.6 5.2 8.2 4.2 8.4 3.3 5.4 7.9 3.0 8.1 6.6 6.4 6.7 10.8 5.2 4.5 7.4 7.2 6.9 7.4 6.2 7.7 6.9 2.6 7.3 7.7 3.9 4.7 5.7 6.2 9.8 6.1 7.2 4.2 6.4 7.4 7.3 6.3 7.0 5.4 7.0 6.2 4.0 8.3 5.8 7.4 4.6 4.4 1.3 7.1 5.5 4.8 7.1 3.7 5.6 5.3 5.1 2.6 5.8 9.9 2.5 4.4 0.7 6.7 3.3 4.7 2.3 11.9 7.3 8.6 4.7 4.1 6.0 4.0 11.8 5.5 5.9 4.3 6.6 3.5 3.5 12.3 2.4 8.2 3.7 5.0 18.1 5.5 8.4 2.4 2.9 21.3 0.5 9.2 4.7 2.3 9.8 8.6 5.6 3.7 4.2 3.3 7.2 7.9 2.8 6.7 3.0 5.3 0.1 15.7 11.8 5.5 1.4 6.1 8.1 7.7 3.1 4.4 2.7 1.7 3.1 4.6 3.1 3.1 3.9 5.3 5.2 4.0 1.7 4.4 1.5 5.1 2.4 3.0 6.8 7.1 7.5 7.4 6.6 6.4 7.4 7.2 6.9 7.3 6.4 7.0 7.4 5.7 3.2 6.3 1.3 5.8 1.5 3.4 4.8 4.6 8.7 6.1 5.7 6.0 5.7 3.1 0.0 4.2 2.6 8.3 4.4 7.9 6.2 2.6 4.9 5.4 6.2 7.3 8.6 1.9 5.8 2.3 5.8 2.6 3.9 3.8 8.6 6.8 8.7 7.0 6.7 2.0 4.4 0.0 8.8 1.6 1.2 5.9 4.3 0.0 0.0 10.4 7.1 7.2 3.5 2.8 5.2 12.6 9.8 3.6 3.9 9.7 7.6 5.8 7.5 13.1 6.9 5.4 13.1 4.2 4.2 1.1 1.2 4.0 5.7 5.0 2.1 ZNF768 FLJ23436 ENSG00000169957 "Zinc finger protein 768" Q9H5H4 16 30524004-30526821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024630, HPA066512" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA024630: AB_1859446, HPA066512: AB_2685683" "unprognostic (2.33e-1)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" "unprognostic (1.73e-1)" "unprognostic (7.94e-3)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "unprognostic (2.74e-1)" "prognostic favorable (9.30e-6)" "unprognostic (4.49e-2)" "unprognostic (1.94e-1)" "unprognostic (3.13e-1)" "prognostic favorable (6.46e-4)" 21.4 23.4 30.6 10.0 29.9 13.4 22.8 29.2 35.3 27.5 25.4 41.9 30.1 31.1 10.0 23.0 27.8 10.2 43.0 25.9 25.6 32.8 38.9 19.1 7.3 32.1 29.8 24.5 29.2 25.9 30.4 27.4 11.4 30.7 30.5 17.2 13.8 25.8 21.3 94.7 28.4 31.4 13.5 26.6 22.3 31.2 39.6 29.5 6.0 23.9 53.6 7.5 35.2 23.2 28.4 27.1 33.3 37.0 36.1 17.6 20.3 29.1 20.2 22.5 32.7 28.4 21.3 36.8 17.1 30.1 14.2 26.3 35.4 24.8 24.1 19.4 38.5 52.6 40.0 24.0 30.0 44.1 26.8 121.3 17.9 52.5 25.1 32.4 30.2 21.9 6.7 47.4 28.0 17.1 74.9 10.0 64.7 34.8 22.0 27.1 50.7 24.7 42.5 23.9 14.0 43.6 48.4 11.5 59.9 77.3 15.9 59.3 66.5 14.9 34.2 25.9 19.4 22.8 41.3 32.4 21.1 28.5 41.4 35.2 0.0 0.4 1.0 0.0 0.6 0.1 1.1 0.1 0.0 0.6 0.4 0.1 0.0 0.5 0.6 0.1 0.5 0.0 0.2 30.6 29.9 29.2 35.3 25.9 25.6 32.1 29.8 24.5 30.7 26.6 29.5 28.4 9.7 9.6 1.9 8.8 4.1 5.5 6.7 9.5 6.8 13.3 15.4 12.6 7.6 14.3 5.5 16.5 2.1 7.2 2.0 50.4 11.7 12.2 18.4 10.9 9.9 9.2 18.0 3.8 2.6 16.2 8.0 6.5 10.7 13.3 3.8 15.5 14.6 17.9 12.7 21.9 3.4 29.1 8.2 8.1 7.7 7.4 10.8 6.1 5.4 4.7 6.8 16.5 0.0 4.0 4.5 11.6 38.2 13.2 2.2 7.9 38.9 17.0 7.4 12.7 6.6 11.8 10.5 15.2 5.1 10.0 5.7 3.6 2.1 14.1 31.3 5.3 TAS1R3 T1R3 ENSG00000169962 "Taste 1 receptor member 3" Q7RTX0 1 1331280-1335314 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 12.2;salivary gland: 7.9" "Cell type enhanced" "Detected in some" "B-cells: 2.9;Cardiomyocytes: 3.8;Muller glia cells: 1.3;Plasma cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 17 "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Cell line enhanced" "Detected in some" "Karpas-707: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053439 Uncertain NA NA "HPA053439: AB_2682150" "unprognostic (1.35e-2)" "unprognostic (1.45e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-3)" "unprognostic (4.32e-2)" "unprognostic (2.05e-1)" "unprognostic (6.95e-2)" "unprognostic (4.22e-1)" "unprognostic (8.44e-3)" "unprognostic (7.59e-3)" "unprognostic (8.37e-2)" "unprognostic (1.18e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-1)" 0.2 0.3 0.6 1.3 0.8 0.5 0.3 0.9 0.7 0.4 0.0 0.7 1.5 0.3 12.2 1.2 0.4 0.1 0.9 0.4 0.2 0.4 1.0 0.4 1.3 0.6 0.4 0.3 0.4 0.2 0.0 1.5 0.2 0.5 0.3 0.1 0.0 7.9 0.1 1.1 0.3 2.0 0.0 0.4 3.7 0.7 0.7 0.3 0.2 0.6 0.0 0.9 0.4 0.6 1.1 0.6 0.5 0.1 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.3 1.2 0.7 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.6 0.4 0.1 1.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 2.5 0.0 0.3 0.1 0.2 0.3 0.2 1.4 0.4 0.2 0.3 0.0 0.1 0.9 0.1 0.2 0.9 0.8 0.1 0.8 0.1 0.1 0.2 0.0 0.7 0.3 1.5 1.5 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.9 0.7 0.4 0.2 0.6 0.4 0.3 0.5 0.4 0.3 1.1 0.4 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.2 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.3 0.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861904-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 70.0;Late spermatids: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 14.3 21.9 15.3 2.2 16.2 2.1 13.7 16.2 18.1 16.9 14.6 11.0 2.5 12.4 11.4 11.5 13.0 3.5 14.6 15.2 16.3 18.4 23.0 11.6 4.8 15.9 16.1 15.1 18.7 14.2 7.4 26.0 3.8 16.1 17.7 3.6 4.4 11.8 5.2 20.8 12.5 10.2 3.8 16.3 14.3 13.7 26.6 16.0 9.5 20.4 8.9 4.2 13.7 14.2 17.0 6.0 6.1 1.8 3.5 22.4 17.7 0.2 4.9 7.0 5.9 6.0 1.4 11.9 4.1 9.3 9.8 2.6 4.1 0.4 7.5 6.1 6.3 0.1 2.6 8.1 6.7 23.7 3.0 0.2 18.4 19.3 6.2 13.7 12.7 10.3 10.3 0.1 8.4 9.2 4.8 2.7 5.0 3.3 7.4 2.4 2.1 1.0 1.0 13.3 2.4 1.9 2.3 5.9 2.0 2.5 5.7 4.4 5.2 6.8 5.2 0.6 7.6 5.5 2.8 2.2 1.2 10.4 3.6 2.4 5.8 9.0 4.7 7.6 8.7 8.4 15.4 11.6 7.2 11.5 13.0 15.7 12.7 1.7 10.7 11.9 12.6 10.0 9.7 15.3 16.2 16.2 18.1 15.2 16.3 15.9 16.1 15.1 16.1 16.3 16.0 17.0 8.0 22.4 7.7 0.0 14.0 6.1 14.4 31.5 19.4 8.9 17.5 21.2 11.3 18.6 13.0 33.1 2.1 22.5 15.1 4.5 13.7 19.9 70.0 16.0 14.0 10.5 12.0 12.0 0.0 10.2 14.0 18.3 7.1 13.0 3.8 24.7 13.2 18.5 22.7 18.5 0.0 10.2 24.4 10.6 6.0 85.6 27.4 11.7 7.2 0.0 11.2 21.5 10.3 0.0 0.0 14.3 9.3 19.5 6.2 19.1 11.7 21.7 19.9 15.8 6.6 15.4 9.0 33.8 19.9 13.0 8.9 9.7 12.8 29.2 10.7 9.4 MAP3K2 "MEKK2, MEKK2B" ENSG00000169967 "Mitogen-activated protein kinase kinase kinase 2" Q9Y2U5 2 127298730-127388465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 11.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021540 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021540: AB_2670742" "unprognostic (5.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.58e-1)" "unprognostic (9.46e-2)" "unprognostic (1.02e-1)" "unprognostic (5.76e-2)" "unprognostic (7.19e-2)" "unprognostic (4.50e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.97e-3)" "unprognostic (7.56e-2)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (2.11e-1)" 12.8 8.9 10.8 13.5 14.7 38.0 10.6 13.6 14.1 12.1 12.6 12.6 15.5 11.3 8.3 9.6 9.1 13.0 6.7 9.8 16.0 12.0 22.5 10.9 13.0 17.8 14.1 7.8 10.7 10.7 14.1 7.9 10.0 20.5 8.9 10.2 15.7 10.3 9.1 13.5 12.7 14.3 12.8 16.6 13.6 14.9 11.4 15.4 14.5 18.0 9.1 14.0 10.5 8.4 24.5 29.4 12.3 9.6 9.7 13.2 17.4 16.0 17.9 19.4 17.2 13.9 14.8 12.7 19.2 30.0 25.7 16.0 24.3 15.6 12.0 19.3 48.6 12.1 17.9 22.3 13.0 15.2 18.2 37.2 15.7 12.9 21.0 25.5 15.1 8.1 14.2 8.6 37.3 17.2 10.7 21.4 12.9 9.9 8.2 15.8 14.0 18.0 14.5 7.0 27.1 19.0 10.2 26.1 15.8 16.4 7.8 10.3 13.7 18.7 33.6 31.3 15.7 24.5 38.4 30.0 19.5 16.1 11.7 14.8 3.4 2.5 1.7 1.3 1.5 1.6 2.7 1.2 1.3 2.1 2.2 1.5 1.6 11.3 2.0 2.0 4.2 1.1 1.0 10.8 14.7 13.6 14.1 9.8 16.0 17.8 14.1 7.8 20.5 16.6 15.4 24.5 45.7 83.3 46.0 53.8 88.9 72.0 36.9 34.3 55.2 53.6 42.2 32.1 30.1 45.8 44.2 29.5 106.3 20.5 107.9 72.6 13.7 21.2 4.6 77.0 71.0 36.9 45.4 27.8 60.6 34.0 19.8 54.9 42.3 90.2 60.9 42.2 25.4 69.1 47.7 72.3 57.7 40.1 30.5 80.1 113.7 7.6 42.3 107.7 56.9 50.6 79.1 25.9 30.9 49.8 87.7 49.0 28.8 51.9 57.3 48.3 54.5 33.1 58.5 59.2 19.7 69.2 47.4 42.3 52.6 43.5 78.6 26.3 65.5 51.7 31.8 46.1 PUSL1 FLJ90811 ENSG00000169972 "Pseudouridine synthase like 1" Q8N0Z8 1 1308597-1311677 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032057, HPA039999" Uncertain Enhanced Vesicles NA NA Vesicles "HPA032057: AB_10601251, HPA039999: AB_2676792" "unprognostic (2.04e-2)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (7.55e-2)" "unprognostic (4.35e-2)" "unprognostic (1.47e-1)" "unprognostic (2.44e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (1.62e-5)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.45e-1)" "unprognostic (2.44e-1)" 7.8 14.1 5.9 3.3 5.4 4.5 8.8 5.3 9.1 11.5 6.7 8.9 4.5 11.1 4.1 21.1 10.7 2.6 9.8 5.9 5.1 9.4 14.5 8.3 4.0 7.0 5.3 5.6 9.2 15.0 3.4 15.0 3.2 6.1 11.8 2.0 2.0 13.8 4.3 8.0 18.2 9.0 2.6 5.5 10.2 10.9 11.0 5.7 4.2 7.6 2.4 3.6 10.4 12.4 6.7 21.9 9.8 9.7 16.6 4.6 7.4 13.1 19.4 10.7 18.8 12.6 33.9 14.1 13.3 15.4 9.6 8.0 17.8 10.8 17.8 3.3 15.1 71.0 18.5 17.7 20.5 17.4 22.2 17.1 7.2 9.2 10.4 7.9 5.1 8.6 18.3 24.1 6.0 8.8 18.2 21.1 28.9 13.2 18.4 42.6 19.2 7.3 32.0 14.8 8.3 44.3 16.2 15.3 45.1 16.1 4.5 12.7 14.6 10.2 12.1 12.5 19.9 18.8 23.4 8.1 57.4 15.0 20.0 7.4 3.7 12.5 6.2 10.2 17.5 10.3 8.5 11.1 8.6 11.7 9.2 7.2 7.3 4.9 9.0 15.9 7.3 14.4 8.4 5.9 5.4 5.3 9.1 5.9 5.1 7.0 5.3 5.6 6.1 5.5 5.7 6.7 5.7 0.0 5.3 1.0 8.9 22.0 12.0 19.9 11.4 8.1 16.3 14.0 2.5 8.6 13.5 7.3 6.2 27.0 8.4 15.0 11.7 20.9 11.5 7.7 9.3 6.6 5.3 3.4 2.4 23.1 41.9 9.3 12.2 5.2 7.0 6.3 4.6 10.5 20.9 3.3 2.4 12.5 16.2 8.8 17.4 18.2 8.7 7.4 7.2 0.0 7.7 5.9 10.3 1.5 2.2 26.1 9.9 11.3 14.2 16.8 13.4 18.9 12.0 7.9 0.0 5.2 9.3 17.1 18.5 13.4 19.2 34.5 9.7 18.3 13.2 25.6 SF3B5 "MGC3133, SF3b10, Ysf3" ENSG00000169976 "Splicing factor 3b subunit 5" Q9BWJ5 6 144094884-144095573 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054408 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054408: AB_2682479" "unprognostic (1.22e-1)" "unprognostic (7.12e-2)" "unprognostic (4.54e-2)" "unprognostic (6.86e-2)" "unprognostic (1.42e-1)" "unprognostic (3.08e-2)" "unprognostic (1.07e-3)" "unprognostic (1.74e-1)" "unprognostic (6.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (2.47e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (1.90e-2)" "unprognostic (1.49e-1)" 104.9 181.9 114.5 80.3 117.3 254.1 111.2 123.0 141.8 98.3 119.9 122.3 94.0 102.7 101.7 153.5 128.9 86.7 137.7 117.5 119.7 160.9 192.6 95.1 130.7 120.7 115.5 109.3 108.2 148.2 133.6 150.7 76.2 118.1 105.2 112.1 32.6 113.4 84.6 159.8 133.2 105.5 92.5 121.4 120.2 114.5 94.4 121.3 148.4 115.2 162.7 126.5 118.0 98.5 121.9 124.1 164.2 184.6 343.4 211.9 239.3 109.8 125.5 209.6 252.3 286.8 175.0 110.2 204.7 219.7 205.3 244.5 143.6 214.0 288.5 177.2 213.0 302.5 223.8 136.0 391.3 203.4 441.2 138.0 246.0 382.5 277.7 275.3 162.8 310.0 278.0 292.3 290.1 229.7 436.5 287.1 396.2 119.3 192.9 196.8 176.5 241.7 208.0 276.0 109.8 252.6 159.6 175.1 211.5 242.2 93.0 154.1 266.9 169.0 129.0 175.5 233.6 276.7 216.3 284.6 197.3 208.8 366.8 162.5 181.9 377.9 191.8 171.5 277.7 213.0 211.2 192.2 203.6 326.2 197.2 190.3 189.1 101.0 199.0 256.3 364.0 241.3 364.1 114.5 117.3 123.0 141.8 117.5 119.7 120.7 115.5 109.3 118.1 121.4 121.3 121.9 97.8 89.8 137.8 5.2 151.9 271.1 168.4 282.5 97.3 45.5 178.4 238.9 87.2 170.1 171.2 123.2 12.5 224.5 180.9 244.9 457.8 253.7 240.9 149.3 159.3 136.6 267.7 157.8 3.8 315.5 221.8 151.6 100.4 138.5 178.7 156.6 163.9 265.6 328.1 43.7 4.9 423.3 201.4 224.0 239.5 109.8 134.8 165.3 252.5 7.5 258.0 132.2 176.1 6.6 13.2 259.8 259.6 108.7 214.7 233.7 304.2 625.7 153.3 58.4 105.2 119.8 135.6 169.6 59.1 164.7 324.2 206.5 168.9 203.9 342.4 222.7 ZNF35 "HF.10, HF10, Zfp105" ENSG00000169981 "Zinc finger protein 35" P13682 3 44648732-44660791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051859, HPA054738" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051859: AB_2681642, HPA054738: AB_2682588" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (8.91e-3)" "unprognostic (9.91e-2)" "unprognostic (6.68e-2)" "unprognostic (1.48e-1)" "unprognostic (2.01e-2)" "unprognostic (4.54e-2)" "unprognostic (1.47e-2)" "unprognostic (1.69e-2)" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (8.64e-2)" "unprognostic (1.60e-3)" "unprognostic (3.30e-1)" 3.5 2.7 2.6 1.6 2.6 1.9 3.2 3.0 2.6 3.1 1.7 3.6 1.3 4.3 2.8 4.0 2.9 1.7 3.7 2.5 2.6 2.7 2.0 2.8 1.4 2.8 2.6 2.1 2.3 2.8 2.0 3.5 1.5 2.6 3.5 1.6 2.5 3.1 2.1 3.8 3.3 2.9 3.2 2.5 3.1 3.3 7.2 2.4 1.3 3.1 2.3 2.4 3.6 3.3 3.1 3.2 2.4 6.2 8.0 4.0 3.2 1.1 3.9 5.4 6.7 6.4 4.3 1.4 2.8 1.7 5.4 2.9 2.2 0.3 5.6 6.9 0.1 2.2 9.3 4.3 0.2 3.6 9.3 6.8 3.3 4.1 6.0 5.3 3.3 5.4 0.0 6.3 2.6 7.4 1.9 0.2 3.0 13.9 2.3 6.7 0.1 6.6 4.9 3.6 9.0 3.4 8.8 4.9 3.0 0.8 5.1 8.0 5.7 5.7 7.1 5.2 3.9 7.8 7.1 11.8 1.6 6.1 4.5 5.6 0.0 1.7 0.7 0.9 1.9 0.6 1.5 0.2 1.0 1.8 1.9 0.4 0.5 0.1 2.3 1.8 0.7 0.1 1.0 2.6 2.6 3.0 2.6 2.5 2.6 2.8 2.6 2.1 2.6 2.5 2.4 3.1 6.6 6.4 8.7 6.8 5.3 2.8 3.9 3.0 1.8 4.9 4.8 3.4 3.2 2.8 3.3 1.8 0.0 0.3 3.7 2.8 1.9 8.1 10.2 2.2 4.2 9.3 2.4 3.8 7.5 8.7 0.1 5.8 2.6 3.5 0.0 5.7 5.0 1.5 3.8 6.7 8.5 2.4 10.2 2.8 1.4 6.5 1.2 3.2 1.8 4.7 3.6 4.4 7.2 8.0 11.2 10.3 3.3 4.5 4.0 4.3 2.0 3.8 3.4 6.4 0.0 4.8 5.5 30.7 11.7 3.0 2.8 0.4 2.6 5.7 3.0 3.3 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779730 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 22.3" "Group enriched" "Detected in many" 4 "Early spermatids: 107.6;Rod photoreceptor cells: 30.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.1;U-266/70: 4.5;U-266/84: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035649, HPA073768" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035649: AB_10670956, HPA073768: " "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.2 0.3 1.0 0.2 0.8 0.0 0.4 0.7 0.9 0.8 1.2 0.2 0.3 0.7 1.2 0.1 2.0 0.2 0.3 0.5 1.3 0.7 0.1 0.4 0.1 1.0 0.9 0.5 0.5 0.2 1.5 1.2 0.1 0.8 0.4 0.2 22.3 0.7 0.3 0.4 0.4 0.2 0.2 1.4 0.2 0.3 4.9 0.7 0.3 0.7 0.8 0.1 0.2 0.1 0.8 0.4 0.4 2.0 0.8 0.1 0.2 0.2 0.0 0.4 0.2 0.4 0.3 0.9 0.7 0.1 0.1 0.9 0.4 0.8 0.3 0.3 0.7 0.1 1.0 0.6 0.2 0.1 0.4 0.2 0.0 0.3 0.3 0.2 0.4 0.1 1.5 0.3 3.1 0.2 0.2 2.0 0.2 0.9 0.3 0.3 0.3 0.4 0.0 1.3 0.1 0.9 1.0 0.1 0.2 1.9 0.9 0.5 0.1 0.0 0.2 0.4 0.3 0.4 4.5 9.4 0.4 0.6 1.1 1.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.0 0.8 0.7 0.9 0.5 1.3 1.0 0.9 0.5 0.8 1.4 0.7 0.8 0.4 0.0 1.5 8.5 0.6 0.0 0.4 0.6 0.6 7.9 0.8 0.8 0.1 0.0 0.3 1.8 12.5 0.2 0.8 0.2 0.0 0.7 107.6 6.9 0.6 0.7 1.2 0.4 6.5 1.1 0.2 0.4 1.1 1.4 0.0 0.2 0.0 0.1 0.5 1.7 6.3 0.4 0.0 0.3 0.0 14.0 0.3 0.5 0.0 5.6 0.0 14.1 0.0 5.5 2.1 0.4 1.1 0.4 0.0 0.4 0.4 2.0 9.3 30.3 0.0 1.0 0.5 8.3 3.2 0.0 0.0 0.3 0.6 0.1 0.4 0.3 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904280-18956676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "esophagus: 43.4;skin 1: 161.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 121.0;Basal prostatic cells: 83.0;Suprabasal keratinocytes: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "basophil: 12.6" "Lineage enriched" "Detected in single" 18 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "HDLM-2: 139.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: AB_2685296" "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 5.3 9.3 7.5 8.3 6.1 10.5 12.7 19.4 10.8 8.2 1.6 7.2 2.0 7.5 2.5 43.4 5.2 7.1 4.0 6.4 12.5 6.8 5.9 7.6 8.7 11.2 9.7 5.9 3.4 19.3 10.8 6.5 7.3 11.0 9.5 2.9 4.4 14.5 9.2 7.9 161.3 3.9 7.2 7.3 6.4 4.4 1.8 9.4 6.3 6.5 4.2 14.2 8.6 21.8 8.8 23.3 37.2 9.9 27.4 6.2 4.9 16.0 17.2 11.4 9.2 6.4 51.5 26.6 0.3 21.6 13.1 10.6 57.6 7.6 36.6 7.4 139.3 6.7 0.4 7.1 20.4 4.5 4.0 21.3 3.2 36.3 12.4 15.7 15.2 19.9 1.2 1.4 4.6 6.1 4.9 3.9 3.7 4.2 23.9 8.8 13.1 6.1 9.8 5.4 14.9 31.6 1.7 13.1 18.2 12.6 10.1 4.9 2.1 54.6 12.4 17.2 7.3 50.5 9.7 11.3 0.8 8.3 5.7 14.8 12.6 0.2 0.0 0.4 0.3 0.5 0.5 0.3 0.4 0.1 0.2 0.3 0.6 0.0 0.2 0.0 0.4 0.3 0.1 7.5 6.1 19.4 10.8 6.4 12.5 11.2 9.7 5.9 11.0 7.3 9.4 8.8 4.1 3.2 5.4 5.5 6.0 121.0 83.0 24.1 40.5 6.8 11.5 13.5 6.8 12.8 9.7 1.8 0.0 5.1 20.9 4.9 1.9 17.3 1.3 23.3 5.9 7.7 2.4 3.2 8.5 17.6 5.4 4.7 3.1 10.2 3.8 0.8 4.6 3.4 2.4 25.2 9.6 1.3 2.0 1.6 17.1 4.5 1.2 6.8 14.2 1.0 3.5 4.4 8.2 11.6 8.8 14.6 3.3 3.0 15.5 15.0 0.8 9.3 23.1 1.8 0.0 3.5 7.5 0.8 0.4 32.4 100.3 4.0 13.9 0.4 1.3 44.2 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 32.7;Horizontal cells: 57.2;Oligodendrocyte precursor cells: 45.8;Sertoli cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 42.2" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria NA NA 14000 Mitochondria "HPA055321: AB_2682783, HPA069278: AB_2686105" "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 22.1 18.2 25.2 4.8 20.8 0.4 21.3 12.7 25.2 58.5 0.0 28.5 1.5 58.4 7.5 10.3 46.5 7.8 16.4 23.2 15.3 16.3 9.4 16.8 2.7 17.8 14.8 20.7 67.2 9.5 7.7 23.9 3.8 16.7 29.9 2.2 15.7 13.7 9.0 11.8 14.5 16.7 12.4 10.4 17.0 16.4 6.7 17.5 0.8 14.3 2.4 1.8 31.5 32.7 18.7 7.1 9.8 42.2 24.4 12.6 18.0 1.0 11.6 18.2 19.4 17.9 2.2 2.4 0.1 5.5 16.4 11.4 3.9 7.9 4.9 10.0 10.8 7.9 3.1 9.6 1.6 6.3 3.1 10.4 14.1 3.8 15.9 2.4 29.1 6.5 3.9 2.9 5.6 7.9 6.6 1.4 3.1 7.2 0.4 4.7 12.9 5.0 1.4 5.6 1.5 0.6 17.0 5.3 2.5 3.0 8.3 6.9 0.4 9.0 16.6 20.6 10.5 5.7 6.4 2.2 1.2 17.3 2.8 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 20.8 12.7 25.2 23.2 15.3 17.8 14.8 20.7 16.7 10.4 17.5 18.7 5.4 0.0 2.6 25.8 0.5 4.7 3.1 3.3 7.4 32.7 5.6 5.2 11.0 5.7 1.0 0.0 8.4 0.4 3.4 0.1 0.0 2.7 2.0 1.5 25.3 6.8 0.0 0.0 23.5 0.4 6.3 11.5 0.5 2.3 0.0 5.8 6.1 3.2 1.0 57.2 24.8 0.3 0.0 0.8 1.8 2.9 17.1 0.7 1.8 5.6 0.6 22.3 0.0 45.8 13.6 1.6 0.0 22.2 0.3 3.0 0.1 1.3 0.8 16.8 32.9 10.8 10.7 0.5 1.1 1.2 3.8 0.8 1.7 4.3 0.3 1.2 MYO7B ENSG00000169994 "Myosin VIIB" Q6PIF6 2 127535802-127637729 "Predicted intracellular proteins" Differentiation "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 114.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 127.7;Intestinal goblet cells: 48.3;Paneth cells: 74.9;Proximal enterocytes: 151.4;Undifferentiated cells: 45.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 17.2" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 5.7;naive B-cell: 5.9" "Group enriched" "Detected in many" 22 "B-cells: 5.9;dendritic cells: 2.6;monocytes: 5.7" "Cell line enriched" "Detected in some" 10 "MOLT-4: 286.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039131 Enhanced NA NA "HPA039131: AB_10672771" "unprognostic (4.10e-3)" "unprognostic (3.81e-2)" "unprognostic (3.80e-2)" "unprognostic (2.23e-4)" "unprognostic (1.14e-2)" "unprognostic (2.23e-1)" "unprognostic (2.07e-1)" "unprognostic (8.51e-2)" "unprognostic (3.76e-1)" "unprognostic (3.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.80e-2)" "unprognostic (8.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.88e-1)" 0.1 0.0 0.4 5.0 0.2 6.6 0.1 0.2 0.2 0.0 0.1 36.2 114.2 0.0 6.7 0.3 0.4 13.1 0.2 0.7 1.4 8.3 0.3 1.0 4.0 0.7 1.0 0.2 0.0 0.2 0.0 0.0 1.7 1.1 0.1 25.5 0.0 0.2 0.2 0.8 0.3 85.1 1.2 0.7 11.4 0.4 1.4 0.3 9.1 0.2 0.0 1.6 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 14.5 5.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.2 0.0 28.1 0.0 0.0 0.2 0.0 286.1 0.8 0.0 0.5 1.7 0.5 1.9 0.3 0.5 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.1 0.5 0.1 0.6 8.6 0.4 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.1 0.0 2.2 0.0 0.8 0.0 0.0 2.6 5.9 0.0 0.2 0.1 0.0 1.4 0.7 0.0 2.4 0.4 0.2 0.2 0.2 0.7 1.4 0.7 1.0 0.2 1.1 0.7 0.3 0.8 2.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 12.8 0.0 5.5 0.0 0.1 1.5 127.7 1.9 0.2 0.1 0.0 0.0 1.0 25.8 0.0 0.2 0.2 2.0 0.1 1.5 0.0 0.0 0.1 2.9 0.2 0.1 0.0 0.4 48.3 0.0 0.0 0.3 0.4 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 1.6 74.9 0.0 0.0 0.0 151.4 9.9 0.0 0.0 0.0 2.8 0.1 0.6 1.1 0.0 0.1 0.3 0.6 0.0 45.7 0.1 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884796-7912760 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Supported "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Nucleoplasm, Nucleoli" "Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 25.2 29.6 18.8 35.4 30.5 43.1 28.7 0.0 41.9 71.2 7.1 46.3 16.9 64.5 31.4 35.4 57.3 28.1 17.2 36.9 13.1 34.0 5.7 32.7 41.6 6.1 4.3 23.3 60.5 35.1 45.1 48.1 16.7 10.9 69.3 22.4 19.2 40.6 38.3 8.0 33.0 34.9 45.4 3.2 31.8 36.6 21.1 6.6 58.7 45.3 9.2 37.0 41.6 43.1 22.2 44.9 108.7 61.6 81.2 72.2 60.9 32.8 51.7 66.1 40.8 43.5 21.1 36.7 122.8 38.3 73.0 34.0 59.6 117.7 52.5 53.0 65.5 67.2 62.7 148.5 2.7 38.3 17.8 112.1 79.2 27.5 55.4 36.9 108.7 76.9 54.1 41.5 2.0 38.8 42.6 48.2 19.6 9.8 45.3 40.3 137.8 82.1 19.3 40.0 107.7 41.9 56.3 126.4 47.9 24.6 16.9 55.7 27.1 99.7 89.4 68.8 22.3 72.5 8.8 1.6 68.3 46.1 47.4 77.6 1.7 2.6 3.3 4.1 1.4 3.6 1.1 4.2 4.0 1.3 1.2 4.6 3.1 2.8 3.2 3.2 3.0 2.5 2.5 18.8 30.5 0.0 41.9 36.9 13.1 6.1 4.3 23.3 10.9 3.2 6.6 22.2 20.9 32.1 63.2 10.4 19.6 36.6 47.6 21.1 65.4 60.7 43.8 34.2 14.3 17.2 35.2 80.9 8.4 16.8 57.3 39.8 17.6 22.9 11.3 48.6 51.9 29.4 56.8 19.1 20.6 23.4 20.5 39.9 31.1 70.7 39.9 59.7 22.9 2.7 9.0 45.4 25.2 17.0 12.2 24.7 34.7 18.5 44.4 26.7 8.8 6.5 43.7 12.4 59.8 12.1 2.5 20.9 10.8 57.2 17.4 55.5 10.9 9.7 24.8 17.3 26.3 31.8 43.5 25.5 46.8 52.8 20.5 16.4 62.9 52.0 30.3 60.3 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618628-152680012 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 58.9;skin 1: 59.0" "Cell type enhanced" "Detected in many" "B-cells: 108.6;Basal keratinocytes: 74.2;Glandular and luminal cells: 75.0;granulocytes: 101.2;monocytes: 82.1;Squamous epithelial cells: 119.2;Suprabasal keratinocytes: 194.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 6.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 8 "basophil: 403.7;eosinophil: 305.7;neutrophil: 477.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 477.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 63.0;HMC-1: 71.1;Karpas-707: 55.6;U-266/70: 69.7;U-937: 56.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 3.1 0.5 0.2 17.4 0.6 18.8 4.4 0.6 1.4 3.0 0.8 3.1 2.6 1.6 0.7 58.9 1.4 5.1 0.7 0.3 1.2 0.6 5.9 5.1 14.4 0.7 0.5 0.2 0.2 1.0 0.3 0.8 3.8 1.1 2.0 2.6 0.2 7.0 2.3 0.4 59.0 3.6 1.8 0.7 12.5 6.0 0.2 0.9 6.3 3.6 1.9 26.7 11.7 8.0 0.9 32.1 0.1 0.3 0.1 0.5 8.7 14.1 8.0 29.1 8.5 16.2 0.4 4.2 32.5 3.3 7.6 9.3 22.8 0.0 63.0 15.5 0.1 0.1 1.8 0.5 0.0 8.9 25.7 71.1 8.3 29.7 27.1 23.4 0.0 21.4 19.7 0.1 55.6 0.7 2.3 10.1 8.0 1.6 0.1 7.8 1.2 0.1 0.2 47.5 19.4 0.1 1.2 2.2 6.2 1.0 8.4 1.0 17.8 8.6 1.2 5.1 0.7 11.1 69.7 26.0 18.1 11.7 56.6 6.6 403.7 37.8 305.7 4.9 38.2 9.2 51.6 10.9 7.9 19.6 45.1 10.7 7.4 477.5 0.8 43.7 2.5 22.5 17.2 0.2 0.6 0.6 1.4 0.3 1.2 0.7 0.5 0.2 1.1 0.7 0.9 0.9 6.5 12.8 19.3 0.0 108.6 74.2 9.0 23.6 20.5 0.1 8.8 4.8 1.7 0.0 20.9 22.0 2.1 25.0 9.8 0.9 0.0 6.4 0.1 31.9 13.4 6.7 1.2 6.6 0.5 3.7 14.5 5.2 8.2 75.0 101.2 0.1 0.7 4.6 4.5 3.3 0.3 0.7 14.2 9.8 15.7 0.2 0.6 28.2 5.4 15.9 82.1 0.1 5.2 3.5 0.1 21.5 7.1 0.0 45.7 5.4 0.0 0.3 60.5 0.7 0.0 3.0 3.6 0.1 0.5 119.2 194.4 25.9 28.6 0.5 2.6 27.2 MYRIP "DKFZp586F1018, exophilin-8, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 295.6;Inhibitory neurons: 507.3;Microglial cells: 210.8;Oligodendrocyte precursor cells: 98.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HUVEC TERT2: 15.6;REH: 3.7;SCLC-21H: 3.2;SH-SY5Y: 9.4;T-47d: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 3.6 1.0 16.7 1.3 13.9 0.0 3.7 10.2 17.5 5.7 13.8 2.7 1.7 3.3 2.2 1.3 2.9 2.7 1.7 18.2 8.1 1.5 11.6 0.8 1.7 11.1 14.0 14.0 3.1 9.0 2.1 2.9 0.1 11.6 2.0 2.7 4.3 12.6 0.8 1.7 1.1 2.4 2.3 3.7 7.2 5.7 0.9 10.4 0.5 1.5 0.5 1.7 1.4 2.6 17.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.1 3.7 0.0 0.0 0.4 2.0 3.2 9.4 0.0 0.0 0.0 0.0 3.8 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 13.9 10.2 17.5 18.2 8.1 11.1 14.0 14.0 11.6 3.7 10.4 17.9 15.8 0.0 3.2 36.2 0.4 0.8 0.1 0.0 1.2 2.7 0.5 0.3 2.4 5.7 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 19.9 1.1 0.7 21.3 0.0 1.7 295.6 2.8 0.0 1.6 3.1 6.2 2.5 14.0 42.8 17.4 0.0 5.0 507.3 11.9 0.0 2.8 0.7 6.1 0.9 0.1 0.0 210.8 0.0 6.6 0.0 98.0 24.5 0.6 0.1 0.0 0.0 1.4 0.1 1.8 0.1 4.2 0.0 0.3 0.7 3.1 0.6 0.1 0.6 0.0 0.3 0.1 0.7 0.1 ALCAM "CD166, MEMD" ENSG00000170017 "Activated leukocyte cell adhesion molecule" Q13740 3 105366909-105576900 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Cell adhesion, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 442.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 29.6" "Lineage enriched" "Detected in many" 6 "dendritic cells: 29.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 393.4;U-138 MG: 473.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002148, HPA010926" Enhanced Uncertain Vesicles "Secreted to blood" NA NA 1600000000 Vesicles "CAB002148: AB_442053, HPA010926: AB_1078449" "unprognostic (6.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.19e-1)" "unprognostic (9.48e-3)" "unprognostic (2.08e-2)" "unprognostic (1.63e-3)" "unprognostic (3.89e-2)" "unprognostic (1.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.15e-4)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (9.57e-2)" "unprognostic (7.76e-2)" 6.1 33.0 36.0 12.3 53.0 10.5 81.8 45.4 47.6 28.2 22.1 13.5 17.1 15.6 35.7 8.2 49.5 23.5 9.7 37.4 75.1 22.4 48.3 74.8 10.0 55.2 49.7 34.6 58.1 32.9 442.6 19.3 12.2 57.3 33.0 14.7 3.6 34.0 40.0 0.8 10.9 17.5 16.4 47.0 6.3 33.7 4.5 50.7 14.4 62.9 5.0 14.7 25.8 6.5 90.5 248.4 93.7 65.9 33.7 97.6 42.7 0.6 197.7 115.1 124.9 173.8 0.8 50.5 17.3 80.3 280.6 68.8 186.5 10.6 157.4 366.1 16.6 16.6 2.4 65.8 4.6 109.6 101.3 0.8 76.0 114.9 159.9 393.4 346.8 139.3 17.9 0.3 28.6 165.9 16.9 14.5 37.0 13.7 79.3 104.8 9.4 5.9 1.0 188.9 27.2 47.5 131.9 20.6 19.6 12.9 25.9 37.7 66.3 291.6 473.7 162.3 20.9 237.2 0.3 0.6 1.8 108.0 21.1 207.4 0.0 4.7 3.5 0.6 2.1 1.9 4.7 1.5 0.9 29.6 3.0 0.3 0.2 5.3 0.6 1.2 10.5 2.4 3.2 36.0 53.0 45.4 47.6 37.4 75.1 55.2 49.7 34.6 57.3 47.0 50.7 90.5 4.5 737.2 143.6 238.6 17.9 12.1 22.8 65.8 12.0 3.0 112.4 47.9 10.1 62.9 255.3 16.5 2.1 0.7 19.5 9.1 1.9 18.5 66.5 108.6 20.1 11.9 16.8 6.3 143.0 43.0 0.7 37.0 23.4 158.1 11.4 29.5 3.6 44.1 57.5 1.7 287.0 16.3 46.8 51.0 162.6 60.1 3.7 86.4 24.9 40.3 93.4 1.3 1.0 680.1 981.1 55.2 8.5 6.4 21.8 117.5 9.6 24.2 318.3 0.8 0.0 7.9 21.8 8.1 5.5 30.1 20.2 0.8 8.9 22.8 10.4 105.4 YWHAG "14-3-3γ, 14-3-3GAMMA, PPP1R170" ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326799-76358991 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 404.3;skeletal muscle: 353.1" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 408.8;Suprabasal keratinocytes: 425.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918" Approved Approved Approved Cytosol NA NA 66000000 Cytosol "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566" "unprognostic (3.71e-2)" "prognostic unfavorable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 189.8 100.1 146.5 61.2 220.3 27.5 61.5 111.5 362.8 39.7 47.8 47.5 48.3 51.4 20.9 65.1 38.2 55.0 112.4 216.0 238.2 51.2 73.0 47.5 43.6 226.7 167.8 217.0 41.1 60.2 50.5 32.8 55.8 244.5 46.5 44.4 88.0 40.2 40.4 353.1 43.3 41.9 67.0 119.7 44.6 38.5 29.2 233.3 40.6 29.9 240.5 49.0 79.6 46.7 404.3 189.0 231.9 200.5 256.7 200.5 114.9 90.5 213.3 105.0 129.6 139.5 147.0 196.7 263.5 71.7 190.8 215.2 171.6 254.3 235.8 180.5 179.9 110.9 250.2 150.0 164.5 182.6 309.0 234.0 127.1 221.0 151.5 310.8 137.3 208.9 140.2 349.9 289.0 195.8 177.6 222.3 227.1 223.0 150.7 160.4 256.3 203.0 291.7 204.5 126.3 107.0 297.1 236.7 299.2 156.0 256.9 208.5 184.2 222.6 250.7 145.7 225.4 290.1 95.1 191.6 399.5 225.5 285.3 273.8 1.5 2.3 0.5 0.8 2.0 1.4 1.3 1.0 1.1 2.4 0.7 0.7 0.9 0.5 0.5 1.8 2.6 0.9 0.9 146.5 220.3 111.5 362.8 216.0 238.2 226.7 167.8 217.0 244.5 119.7 233.3 404.3 73.7 32.1 26.4 23.2 51.8 408.8 128.3 87.9 126.9 102.9 107.0 70.1 234.0 40.0 55.1 38.6 12.5 36.5 39.3 49.9 37.2 52.4 91.2 96.0 82.9 92.0 85.4 72.8 99.9 38.2 84.1 97.4 61.2 127.9 67.3 38.7 50.0 93.1 83.5 124.5 78.5 35.7 44.7 90.3 229.0 25.2 46.3 87.8 94.3 40.3 64.2 27.1 20.6 23.1 57.1 71.1 29.9 43.2 56.6 129.8 34.1 61.3 47.2 35.3 32.9 92.5 91.5 13.4 19.0 160.1 425.4 67.2 41.5 46.4 45.1 177.1 UBE2E3 UbcH9 ENSG00000170035 "Ubiquitin conjugating enzyme E2 E3" Q969T4 2 180967248-181076585 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 654.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA030445" Approved NA NA "HPA003303: AB_1858521, HPA030445: AB_10669599" "unprognostic (8.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (2.96e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.08e-5)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.00e-3)" "unprognostic (4.99e-2)" "unprognostic (8.46e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (8.75e-2)" "unprognostic (3.86e-1)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (4.40e-1)" 55.5 46.2 63.6 40.5 65.2 48.7 58.7 64.4 72.1 56.7 55.4 51.9 47.1 52.1 56.3 47.1 58.8 72.0 54.7 75.0 63.6 72.5 58.7 40.2 39.9 61.5 64.6 63.8 52.9 57.0 80.0 35.6 49.0 60.8 40.4 54.9 69.0 55.1 40.0 176.8 57.4 42.9 43.3 65.0 40.6 59.7 57.3 63.5 68.6 74.4 89.4 48.8 62.2 47.3 68.2 104.8 46.6 654.4 22.8 189.8 243.1 104.0 137.1 171.9 112.8 139.2 51.0 124.0 51.4 117.1 188.5 94.5 43.8 400.7 140.5 202.1 125.9 120.3 177.2 59.0 142.5 91.6 83.5 81.3 96.7 127.9 99.3 94.8 114.6 150.9 105.4 91.9 93.3 280.7 57.5 152.6 77.7 125.6 71.2 217.6 147.0 66.8 122.1 193.2 91.1 113.4 126.3 59.7 62.8 58.1 178.3 33.7 121.5 140.1 218.2 143.2 129.4 162.0 81.1 55.0 143.7 215.7 32.6 124.3 29.1 28.2 53.7 17.6 25.4 21.3 15.0 13.6 22.7 18.4 9.5 14.3 15.7 25.6 18.5 36.3 60.0 5.9 20.5 63.6 65.2 64.4 72.1 75.0 63.6 61.5 64.6 63.8 60.8 65.0 63.5 68.2 69.3 9.6 24.2 100.9 50.3 102.9 83.7 111.2 70.6 151.8 84.4 74.4 37.7 108.7 63.7 55.2 29.2 31.9 84.8 56.4 229.0 95.8 36.9 54.3 51.6 59.8 59.8 108.8 115.4 101.9 83.4 81.2 60.6 57.8 23.5 61.8 72.1 55.9 85.3 75.7 67.7 39.4 91.6 71.4 63.9 79.7 62.7 76.3 129.9 71.2 62.4 103.9 79.3 160.9 158.3 113.7 41.6 36.1 87.7 74.8 58.9 172.6 51.8 73.3 26.3 56.4 81.7 83.1 191.6 77.3 122.3 36.0 55.4 57.9 50.9 103.4 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949920 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 16.9 14.8 18.7 13.7 19.1 32.5 17.5 19.2 20.6 25.4 17.8 23.3 10.8 38.3 18.2 20.2 20.2 12.9 14.7 19.0 19.6 18.7 18.2 28.9 15.3 19.9 19.4 18.0 20.9 16.9 20.0 18.2 12.1 20.1 19.6 19.1 18.1 16.6 12.6 12.7 26.4 17.4 25.8 18.2 19.1 16.8 66.0 20.1 29.5 19.8 9.8 17.8 18.9 19.7 20.1 51.1 31.0 48.7 25.5 19.1 26.7 15.0 43.9 40.5 59.8 44.0 26.5 18.0 50.2 22.4 38.5 26.9 41.2 36.8 29.9 64.9 50.6 27.4 33.6 58.6 21.5 28.6 31.9 52.8 24.2 21.1 42.0 41.7 28.5 36.6 53.0 24.6 25.9 40.8 15.9 49.5 29.6 10.4 18.5 25.6 51.9 32.6 20.2 26.5 16.1 16.2 29.4 34.3 17.8 14.8 25.2 24.6 20.0 33.2 32.8 27.6 45.2 61.0 38.7 27.1 35.1 28.4 39.6 47.2 6.4 1.8 0.7 1.8 2.5 1.7 1.4 1.4 2.4 1.3 0.9 0.9 1.6 0.2 2.5 1.1 5.3 2.0 2.1 18.7 19.1 19.2 20.6 19.0 19.6 19.9 19.4 18.0 20.1 18.2 20.1 20.1 4.2 6.4 19.6 6.5 4.2 7.9 7.5 5.2 4.6 6.6 6.7 6.5 3.4 7.2 6.9 12.9 8.4 4.4 7.4 5.9 1.9 5.8 3.1 5.8 18.0 5.4 3.0 14.1 3.8 6.9 4.7 6.4 6.6 5.4 18.4 10.9 5.7 3.5 6.5 3.3 5.5 7.0 2.0 6.7 9.1 4.8 5.3 9.2 3.6 5.6 1.9 6.4 6.2 4.5 4.3 6.6 3.1 7.9 7.5 5.5 4.4 3.5 5.7 6.2 0.0 5.8 5.4 44.4 8.1 9.0 8.7 2.5 5.7 5.5 8.4 4.5 TRAPPC1 "BET5, MUM2" ENSG00000170043 "Trafficking protein particle complex 1" Q9Y5R8 17 7930345-7932123 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052398 Approved NA NA "HPA052398: AB_2681813" "unprognostic (1.07e-1)" "unprognostic (3.89e-3)" "unprognostic (1.49e-2)" "unprognostic (7.81e-3)" "unprognostic (1.20e-2)" "unprognostic (3.58e-2)" "unprognostic (1.93e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (9.86e-2)" "unprognostic (1.83e-2)" "unprognostic (1.88e-1)" "unprognostic (1.31e-2)" "unprognostic (2.22e-2)" "unprognostic (1.71e-1)" "unprognostic (8.06e-2)" "unprognostic (2.64e-1)" 106.3 146.4 125.8 92.7 123.7 101.5 101.7 129.0 143.6 96.6 120.2 117.4 83.7 130.9 125.9 157.9 94.8 75.0 151.7 125.9 130.9 159.6 124.6 133.6 141.6 131.4 129.0 120.8 80.4 102.0 110.4 125.3 115.6 129.4 94.5 88.8 68.1 104.5 66.4 140.2 110.5 122.9 103.3 121.9 172.1 118.9 73.1 140.8 167.6 102.2 95.2 154.2 109.8 105.5 140.0 178.9 306.2 161.1 186.5 262.9 258.9 101.5 221.7 233.9 206.2 233.3 172.3 104.1 192.0 164.7 337.5 203.1 159.6 173.8 282.3 235.9 279.3 278.6 93.4 165.5 193.6 196.0 114.3 243.0 302.5 197.9 218.6 162.2 262.2 240.4 174.3 74.9 130.4 314.4 166.7 246.3 157.9 101.2 130.4 138.6 122.7 137.7 165.5 392.3 131.0 68.4 165.7 150.6 78.3 166.5 217.3 163.8 124.2 271.5 146.6 105.3 138.0 179.9 139.6 130.9 100.2 294.5 132.4 176.5 315.1 235.5 427.0 190.0 225.2 157.4 243.2 189.5 196.8 270.7 215.8 158.4 177.2 244.3 192.5 235.5 293.0 288.7 304.6 125.8 123.7 129.0 143.6 125.9 130.9 131.4 129.0 120.8 129.4 121.9 140.8 140.0 90.4 67.3 46.7 11.4 160.1 54.0 81.2 257.4 78.0 32.8 120.1 158.7 13.0 131.5 124.3 240.9 8.4 375.1 182.9 135.1 340.4 280.8 33.6 60.5 76.3 97.5 118.1 105.2 10.1 259.0 427.6 84.2 67.2 74.1 102.1 78.0 153.8 136.1 362.8 45.4 9.9 155.1 193.3 210.5 135.3 72.6 115.5 195.9 149.4 8.4 374.8 97.8 303.8 6.0 15.5 256.6 162.0 83.5 120.1 62.9 200.0 530.3 87.6 33.7 39.5 31.8 117.1 67.8 69.3 139.5 72.6 271.4 169.7 113.0 144.3 100.2 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;gallbladder: 2.3;retina: 2.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 4.3;Ductal cells: 3.6;Early spermatids: 2.8;Late spermatids: 5.9;Muller glia cells: 16.0;Pancreatic endocrine cells: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 6.5" "Region enriched" "Detected in single" 7 "olfactory bulb: 2.8" "Low region specificity" "Detected in many" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.2 1.1 0.2 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 2.3 0.0 0.1 0.2 0.5 0.0 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 1.1 0.2 0.1 0.2 1.1 0.2 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.8 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.5 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNAB3 "AKR6A9, KCNA3B" ENSG00000170049 "Potassium voltage-gated channel subfamily A regulatory beta subunit 3" O43448 17 7921859-7929803 "Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 14.4;retina: 12.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 29.3;Horizontal cells: 131.2;Inhibitory neurons: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 13.2;SH-SY5Y: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077993 Approved Mitochondria NA NA Mitochondria "HPA077993: AB_2686872" "unprognostic (3.02e-2)" "unprognostic (5.59e-2)" "unprognostic (6.95e-2)" "unprognostic (2.62e-2)" "unprognostic (6.13e-2)" "unprognostic (5.84e-4)" "unprognostic (2.19e-1)" "unprognostic (5.72e-2)" "unprognostic (8.50e-2)" "unprognostic (8.55e-2)" "unprognostic (3.27e-4)" "unprognostic (7.47e-3)" "unprognostic (3.03e-6)" "unprognostic (2.12e-1)" "unprognostic (5.00e-2)" "unprognostic (4.97e-2)" "unprognostic (9.54e-3)" 1.4 0.6 3.8 1.4 4.2 3.2 1.3 9.9 7.9 3.7 2.3 1.3 0.5 14.4 1.0 1.0 4.8 0.9 0.5 4.3 3.3 2.1 1.5 1.5 2.1 3.6 8.9 3.6 2.8 1.4 0.1 4.1 0.7 5.5 3.1 0.9 12.9 1.2 0.5 0.4 1.7 2.3 5.6 3.3 3.1 1.3 2.0 5.5 1.4 2.2 0.0 1.7 0.9 1.3 4.7 1.2 1.0 4.7 1.2 0.5 1.2 1.7 4.2 2.7 3.6 4.0 0.6 0.3 2.0 0.2 0.7 0.1 0.4 1.3 0.6 5.0 1.6 1.9 0.6 1.0 0.0 4.2 0.2 2.5 1.8 1.3 3.8 0.2 0.2 0.3 5.3 0.4 0.3 0.6 0.9 0.7 2.3 0.7 0.0 0.6 13.2 1.3 0.5 0.4 1.5 0.2 6.8 0.4 0.0 0.9 0.2 1.2 0.1 0.3 0.6 2.3 0.9 0.3 1.0 1.1 1.1 1.8 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 3.8 4.2 9.9 7.9 4.3 3.3 3.6 8.9 3.6 5.5 3.3 5.5 4.7 1.6 3.2 2.7 2.6 1.0 0.5 0.6 0.4 0.6 29.3 0.6 1.4 0.8 0.0 0.7 0.0 4.2 0.3 2.2 0.8 0.0 0.8 0.6 0.9 15.7 0.8 0.0 0.0 6.8 0.5 0.3 2.2 0.5 1.3 1.3 3.6 0.4 0.3 0.7 131.2 40.3 0.4 0.0 0.6 0.7 0.7 1.8 1.1 0.0 0.0 1.5 11.3 2.1 10.6 2.1 0.7 0.1 0.7 0.9 0.6 0.3 0.2 0.1 7.6 0.0 0.5 1.1 8.3 2.6 0.1 0.4 0.1 1.3 3.0 0.6 0.2 SERPINA9 "CENTERIN, GCET1, SERPINA11b" ENSG00000170054 "Serpin family A member 9" Q86WD7 14 94462717-94479689 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 73.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "stomach cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 66 "Daudi: 69.5" "Region enriched" "Detected in many" 16 "basal ganglia: 71.8" "Secreted to blood" NA NA "unprognostic (1.32e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-2)" "unprognostic (3.89e-3)" "unprognostic (6.10e-2)" "unprognostic (6.67e-2)" "unprognostic (1.38e-2)" "unprognostic (1.16e-1)" 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.7 0.8 0.1 0.0 0.3 0.2 0.0 0.0 1.4 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM153A NY-REN-7 ENSG00000170074 "Family with sequence similarity 153 member A" Q9UHL3 5 177707981-177783398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;testis: 19.6" "Cell type enhanced" "Detected in many" "Early spermatids: 73.5;Excitatory neurons: 45.2;Inhibitory neurons: 20.6;Late spermatids: 20.0;Peritubular cells: 22.2;Sertoli cells: 39.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 9 "T-cells: 1.9" "Not detected" "Not detected" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain NA NA "HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836" "unprognostic (5.92e-5)" "unprognostic (1.41e-1)" "unprognostic (5.94e-2)" "unprognostic (4.20e-3)" "unprognostic (1.58e-2)" "unprognostic (5.55e-3)" "unprognostic (1.70e-2)" "unprognostic (3.41e-2)" "unprognostic (1.44e-1)" "unprognostic (1.77e-2)" "unprognostic (4.75e-2)" "unprognostic (4.33e-2)" "unprognostic (1.30e-1)" "unprognostic (5.33e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" 0.2 0.4 3.6 0.5 2.4 0.7 0.0 7.5 6.6 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.4 0.2 0.2 7.1 1.1 0.3 0.1 0.3 0.8 0.2 0.0 2.8 2.4 0.7 0.2 3.2 0.0 4.3 1.3 0.0 0.3 0.4 0.2 0.1 0.9 0.2 0.0 0.0 2.2 0.3 19.6 0.2 0.3 0.7 0.0 0.8 0.0 0.2 1.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.9 0.8 0.0 0.0 0.0 0.1 0.1 0.1 3.6 2.4 7.5 6.6 7.1 1.1 0.2 0.0 2.8 4.3 0.0 0.2 1.6 0.1 0.0 3.1 2.6 0.1 0.6 3.3 1.0 5.2 2.7 0.2 0.1 2.2 1.5 1.7 0.0 4.2 0.0 1.4 0.0 0.0 1.0 73.5 0.2 0.2 1.1 0.0 0.0 45.2 0.0 0.4 3.5 1.1 0.2 2.5 2.9 0.7 0.0 0.1 0.0 20.6 0.0 0.0 0.0 2.6 20.0 14.0 0.3 0.0 1.0 0.2 0.2 1.0 3.0 0.8 0.6 0.0 22.2 0.1 1.3 0.0 0.1 2.1 0.7 39.5 0.1 4.6 1.0 0.6 0.9 0.6 0.0 2.0 0.2 0.1 0.3 GPR37L1 ETBR-LP-2 ENSG00000170075 "G protein-coupled receptor 37 like 1" O60883 1 202122917-202133592 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 75.1" "Cell type enhanced" "Detected in some" "Astrocytes: 91.7;Muller glia cells: 59.6;Oligodendrocyte precursor cells: 89.0;Oligodendrocytes: 20.4" "Cancer enriched" "Detected in some" 57 "glioma: 36.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 1.2;MCF7: 1.5;T-47d: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061629, HPA064454" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "Vesicles, Plasma membrane" "HPA061629: , HPA064454: AB_2685268" "unprognostic (2.12e-2)" "unprognostic (1.83e-1)" "unprognostic (2.96e-1)" "unprognostic (1.61e-3)" "unprognostic (4.52e-1)" "unprognostic (8.20e-2)" "unprognostic (2.26e-4)" "unprognostic (5.83e-2)" "unprognostic (3.46e-3)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "unprognostic (3.28e-2)" "unprognostic (4.86e-3)" "unprognostic (1.14e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (3.49e-1)" 0.0 0.2 52.9 0.0 60.8 0.2 0.0 61.4 50.2 0.2 9.7 0.7 0.2 0.1 0.1 0.1 0.1 0.0 0.1 46.8 45.7 0.0 0.2 0.0 0.0 70.0 64.6 33.7 0.0 0.0 0.0 0.6 0.0 75.1 0.2 0.2 2.8 0.1 0.3 0.1 0.1 0.3 0.1 52.5 0.0 0.2 0.3 67.3 0.0 0.1 0.1 0.0 0.0 0.1 49.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 52.9 60.8 61.4 50.2 46.8 45.7 70.0 64.6 33.7 75.1 52.5 67.3 49.7 0.0 0.0 0.0 91.7 0.1 0.4 0.5 0.7 0.0 1.2 0.3 0.3 1.1 1.5 1.7 0.0 4.2 0.1 0.0 4.9 0.0 3.2 4.5 0.9 0.2 0.1 0.0 0.0 0.4 1.2 1.0 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.8 0.9 0.1 0.0 2.8 0.0 59.6 0.0 89.0 20.4 2.1 2.7 1.9 0.0 0.8 1.3 0.1 1.1 4.9 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.7 0.1 0.2 0.7 1.0 SIMC1 "C5orf25, FLJ44216, OOMA1, PLEIAD" ENSG00000170085 "SUMO interacting motifs containing 1" Q8NDZ2 5 176238367-176345991 "Predicted intracellular proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 47.4" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.2;Inhibitory neurons: 57.4;Spermatocytes: 83.1;Theca cells: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037889, HPA037890" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA037889: AB_2675720, HPA037890: AB_2675721" "unprognostic (1.15e-1)" "unprognostic (9.97e-2)" "unprognostic (3.81e-3)" "prognostic unfavorable (2.32e-6)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.20e-2)" "unprognostic (5.59e-2)" "unprognostic (2.75e-1)" "unprognostic (1.97e-3)" "unprognostic (1.60e-1)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (3.59e-2)" "unprognostic (9.20e-2)" 4.7 28.3 6.4 4.0 6.7 3.8 4.4 7.4 7.2 11.6 7.1 6.9 5.9 12.3 10.0 4.3 13.5 4.0 3.8 6.2 6.4 3.6 8.8 5.0 5.3 5.1 5.2 6.0 47.4 6.6 6.1 14.2 5.1 5.6 9.6 7.0 4.7 3.8 6.5 12.2 5.4 7.6 8.6 4.1 10.3 10.3 33.8 7.1 6.9 4.0 4.5 5.5 8.5 6.5 6.3 2.8 6.9 21.6 17.2 11.1 11.3 11.2 9.6 8.7 9.8 11.2 25.7 7.3 0.1 11.5 10.7 20.0 2.5 24.2 18.1 11.9 4.8 17.9 12.7 4.7 3.3 24.5 13.7 9.3 7.4 7.1 6.4 12.1 6.9 9.3 4.6 32.6 11.5 11.5 12.5 13.2 12.3 8.2 3.3 7.5 19.2 15.2 16.6 6.8 5.1 14.3 15.0 11.0 1.7 10.6 8.3 6.1 26.4 6.6 11.6 6.2 10.6 8.4 3.1 3.5 18.9 4.3 9.2 6.9 7.2 3.7 7.0 3.3 3.5 4.0 4.4 4.0 2.6 5.2 4.1 3.3 2.7 0.4 7.3 2.8 2.6 2.9 2.7 6.4 6.7 7.4 7.2 6.2 6.4 5.1 5.2 6.0 5.6 4.1 7.1 6.3 4.9 9.6 5.6 24.2 12.6 2.9 5.9 3.2 8.6 18.1 2.1 3.0 4.0 2.8 3.4 1.8 4.2 0.4 15.0 8.9 1.9 3.8 46.5 2.9 15.6 3.6 13.2 2.5 49.1 3.6 2.9 9.2 19.9 4.9 0.0 58.2 5.3 7.2 2.2 18.5 57.4 9.9 0.0 5.7 2.0 14.4 29.8 4.2 5.4 30.9 5.7 6.1 11.3 30.7 7.7 4.7 7.8 34.6 5.7 7.1 12.0 1.9 3.0 5.3 32.9 5.6 6.3 83.1 33.8 5.9 2.6 0.8 7.7 102.8 8.9 3.1 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavorable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favorable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.1 15.3 5.0 7.2 5.8 6.7 13.4 7.7 7.0 10.0 6.6 11.7 9.8 10.6 9.1 8.9 11.3 10.4 12.7 4.9 6.6 48.7 45.6 10.7 9.0 5.1 5.7 4.4 24.8 22.4 24.8 5.2 10.9 5.2 22.3 13.5 10.8 14.7 8.4 15.1 5.3 9.3 8.7 4.9 9.2 10.6 9.8 5.2 6.7 27.0 17.1 7.8 8.5 5.4 6.4 13.5 19.9 7.1 18.0 18.1 6.4 16.5 20.1 29.4 20.5 22.8 11.7 21.6 29.5 11.7 13.0 33.4 11.8 26.8 20.6 23.6 19.2 13.8 16.4 14.1 13.4 46.1 41.0 21.2 23.3 42.8 18.4 37.4 17.8 17.0 15.6 28.4 48.1 25.4 29.4 7.1 12.0 14.8 28.1 16.9 16.0 6.2 27.1 16.4 19.6 15.2 15.9 31.4 49.1 31.9 10.4 23.9 18.5 12.6 9.0 11.1 28.6 23.0 46.9 67.0 40.8 21.6 22.2 36.6 2.9 16.6 4.8 12.1 14.9 16.3 26.7 9.4 12.6 15.7 20.2 10.4 12.6 1.7 18.7 8.3 16.3 8.5 10.7 5.0 5.8 7.7 7.0 4.9 6.6 5.1 5.7 4.4 5.2 4.9 5.2 6.4 12.3 32.1 36.2 18.9 24.0 9.7 18.4 10.5 10.2 33.0 21.5 15.7 35.0 42.9 19.1 55.2 16.7 31.4 15.4 17.0 11.7 21.0 26.4 11.2 17.0 19.0 21.7 10.1 16.4 25.8 20.5 18.9 7.7 15.5 40.4 26.1 27.8 77.7 38.2 37.0 16.5 18.2 6.1 27.4 17.7 11.1 39.7 22.3 28.4 11.2 21.3 35.8 28.8 14.6 20.9 11.5 14.3 33.4 11.8 33.7 26.3 63.4 10.9 27.1 6.6 30.7 20.7 17.8 18.3 12.0 12.9 33.7 15.9 27.1 24.0 14.2 NSG2 "CALY3, HMP19" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045706-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 196.4" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "SCLC-21H: 39.5;SH-SY5Y: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 0.5 33.6 120.6 2.6 196.4 0.0 0.1 53.3 116.5 0.0 6.0 5.6 2.3 0.0 0.4 0.1 0.0 0.3 0.8 124.9 153.9 0.6 0.4 0.3 0.0 65.9 105.0 157.3 0.1 0.9 0.0 7.0 0.0 88.4 0.2 3.9 39.5 0.1 0.1 0.3 0.1 3.9 1.8 42.3 0.2 3.0 14.8 98.8 0.0 0.6 0.0 0.0 0.1 1.2 139.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 64.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.6 196.4 53.3 116.5 124.9 153.9 65.9 105.0 157.3 88.4 42.3 98.8 139.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SPDYE5 ENSG00000170092 "Speedy/RINGO cell cycle regulator family member E5" A6NIY4 7 75493625-75504304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.1" "Cell type enhanced" "Detected in some" "Early spermatids: 7.0;Excitatory neurons: 12.1;Horizontal cells: 5.0;Inhibitory neurons: 10.2;Late spermatids: 5.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 9.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.1;RT4: 1.9" HPA051750 Approved NA NA "HPA051750: AB_2681590" "unprognostic (2.22e-1)" "unprognostic (1.81e-1)" "unprognostic (7.87e-3)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (1.77e-2)" "unprognostic (7.25e-3)" "unprognostic (2.27e-2)" "unprognostic (6.34e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (9.10e-4)" "unprognostic (1.51e-10)" "unprognostic (4.21e-2)" "unprognostic (1.87e-1)" "unprognostic (6.63e-2)" "unprognostic (3.08e-4)" 0.4 0.5 0.2 0.5 0.2 0.9 0.5 0.4 0.7 0.5 0.1 0.5 0.3 0.4 0.0 0.5 0.4 0.4 0.4 0.2 0.0 0.6 0.7 0.5 0.6 0.4 0.1 0.0 0.7 0.7 0.0 0.7 0.2 0.7 0.7 0.0 1.2 0.6 0.0 0.5 1.7 0.7 0.0 0.0 0.8 0.5 3.1 0.1 0.0 0.8 0.0 0.0 0.4 0.5 0.4 0.5 0.5 0.6 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.3 0.3 0.7 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.3 0.2 3.1 0.3 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.8 0.7 0.0 0.8 0.4 1.1 0.4 0.1 0.4 0.4 0.2 0.0 0.0 1.9 0.5 0.4 0.5 0.4 0.1 0.5 0.8 0.1 0.6 1.0 0.3 0.6 0.6 0.6 0.2 1.1 0.1 0.6 0.6 1.3 0.5 0.3 0.9 0.3 0.4 0.5 0.4 0.4 0.2 0.8 0.4 0.4 0.9 0.2 0.5 0.6 0.1 0.2 0.2 0.2 0.4 0.7 0.2 0.0 0.4 0.1 0.0 0.7 0.0 0.1 0.4 0.3 0.0 0.0 3.6 0.4 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 7.0 1.2 1.2 0.7 0.0 0.4 12.1 0.0 0.0 0.4 0.0 1.2 0.0 0.2 0.4 0.4 0.1 5.0 10.2 0.0 0.0 0.6 0.0 5.5 0.0 0.4 0.0 3.7 0.6 0.4 1.0 5.5 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.6 0.5 1.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 SERPINA6 CBG ENSG00000170099 "Serpin family A member 6" P08185 14 94304248-94323389 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 782.8" "Group enriched" "Detected in some" 4 "Cholangiocytes: 204.5;Hepatocytes: 390.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 244.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "T-47d: 961.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA017864 Approved "Secreted to blood" NA NA 60800000000 37000000000 "HPA017864: AB_1856721" "unprognostic (2.82e-2)" "unprognostic (1.67e-1)" "unprognostic (1.02e-3)" "prognostic favorable (6.96e-5)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (4.43e-2)" "unprognostic (3.11e-1)" "unprognostic (4.80e-3)" "unprognostic (2.94e-1)" "unprognostic (2.47e-2)" "unprognostic (4.54e-2)" "unprognostic (1.43e-1)" "unprognostic (2.14e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 1.9 0.0 3.5 0.1 0.5 0.0 0.0 12.8 35.4 0.0 0.0 0.0 43.9 782.8 0.1 0.0 0.0 0.0 0.0 0.3 17.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 114.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.4 0.4 4.5 0.1 0.4 0.0 0.1 0.7 0.0 0.0 961.9 0.0 0.0 0.5 0.0 0.6 0.0 0.3 0.0 0.5 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.1 0.1 0.7 0.0 0.0 4.4 0.0 0.4 204.5 0.3 0.0 0.0 0.3 0.0 0.4 1.9 33.1 0.0 62.6 0.3 0.4 9.0 16.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.2 9.7 390.8 0.0 0.0 0.0 0.8 2.0 8.7 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.0 1.2 0.0 0.0 0.0 0.1 43.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.8 0.1 ZNF778 FLJ31875 ENSG00000170100 "Zinc finger protein 778" Q96MU6 16 89217703-89237141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA052057, HPA057151" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA052057: AB_2681710, HPA057151: AB_2683352" "unprognostic (3.63e-2)" "unprognostic (1.42e-1)" "unprognostic (4.75e-3)" "unprognostic (7.04e-2)" "unprognostic (2.43e-1)" "unprognostic (1.66e-3)" "unprognostic (5.34e-2)" "unprognostic (1.29e-2)" "unprognostic (1.91e-1)" "unprognostic (3.57e-1)" "unprognostic (3.53e-7)" "unprognostic (2.51e-1)" "unprognostic (2.85e-7)" "unprognostic (3.22e-2)" "unprognostic (3.67e-1)" "unprognostic (8.46e-2)" "unprognostic (3.63e-2)" 2.1 2.2 2.2 1.9 2.3 1.6 2.5 3.3 2.7 2.1 1.9 2.0 1.1 2.2 1.8 2.0 2.1 1.5 2.3 2.1 1.9 3.2 2.1 2.2 1.8 2.5 2.4 1.9 2.1 5.1 8.1 2.6 1.5 4.4 2.3 1.9 3.9 2.5 2.9 3.8 3.2 1.7 2.6 2.3 2.3 2.4 5.2 2.4 2.0 3.1 4.3 2.6 2.1 1.7 2.7 4.2 2.3 6.8 5.6 4.2 3.5 8.4 3.3 5.2 4.7 2.8 6.7 2.8 2.2 6.4 4.2 2.5 4.0 9.4 4.6 7.9 0.8 8.4 5.8 4.6 3.2 2.4 1.7 3.2 3.0 3.3 6.2 4.6 3.0 4.2 3.7 6.5 1.1 4.1 10.5 3.5 2.4 9.9 3.4 3.9 9.7 15.6 0.6 2.4 3.8 14.0 10.1 8.2 4.1 2.6 6.2 10.8 3.2 4.4 5.3 3.7 3.5 4.0 4.0 6.0 4.6 7.3 3.3 3.3 10.9 1.2 3.1 3.0 1.9 1.7 0.9 1.5 1.4 1.5 1.2 1.1 1.9 0.3 1.4 2.1 0.5 1.8 1.4 2.2 2.3 3.3 2.7 2.1 1.9 2.5 2.4 1.9 4.4 2.3 2.4 2.7 2.9 12.8 4.4 3.6 2.2 1.7 2.8 1.8 9.1 8.6 4.5 4.6 5.1 2.8 2.8 5.5 14.6 2.4 8.4 1.3 0.0 3.3 16.4 4.2 4.6 4.7 3.0 6.1 6.3 5.6 2.2 3.1 5.6 7.7 0.0 5.2 4.6 5.5 2.5 21.9 5.7 2.9 2.0 5.0 0.7 35.3 2.5 6.2 1.8 1.0 4.3 4.3 11.3 2.0 5.9 3.2 1.8 3.0 9.6 5.4 3.4 3.5 0.5 10.5 13.1 11.7 3.4 15.1 12.7 8.2 1.6 2.3 4.7 3.0 2.0 3.3 NIPA1 "MGC35570, SLC57A1, SPG6" ENSG00000170113 "NIPA magnesium transporter 1" Q7RTP0 15 22773063-22829789 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 36.2;Inhibitory neurons: 33.8;Oligodendrocytes: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023269 Uncertain NA NA "HPA023269: AB_1854485" "unprognostic (1.64e-2)" "unprognostic (7.60e-2)" "unprognostic (2.61e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (1.79e-1)" "unprognostic (3.31e-2)" "unprognostic (2.13e-2)" "unprognostic (2.77e-1)" "unprognostic (2.42e-2)" "unprognostic (6.25e-2)" "unprognostic (6.32e-2)" "unprognostic (6.95e-2)" "unprognostic (8.80e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.66e-2)" 3.1 4.2 35.3 3.7 39.4 1.2 2.9 40.3 35.8 3.7 21.7 4.5 6.5 2.3 2.1 4.3 2.6 4.8 3.1 27.7 33.6 6.2 5.7 4.7 5.3 40.2 42.2 24.6 1.5 5.8 8.8 3.6 3.5 43.4 6.7 4.4 6.2 3.7 3.4 2.5 4.9 6.7 2.6 42.8 4.2 6.4 4.3 39.4 8.3 7.4 3.5 5.5 3.3 3.5 44.9 14.9 17.4 5.4 12.4 6.9 5.6 3.8 17.6 12.7 8.5 7.1 13.3 7.4 6.9 13.5 7.3 17.4 9.7 16.0 4.6 10.1 40.2 9.8 10.8 10.8 11.4 8.3 0.1 20.8 1.7 15.2 5.5 9.2 13.6 8.2 15.2 8.4 11.3 4.8 5.6 5.9 9.7 5.9 15.9 18.2 12.1 7.7 5.4 13.0 14.9 15.2 15.4 13.2 1.6 16.7 7.0 10.3 13.8 15.4 23.9 12.2 10.1 27.2 12.7 13.6 12.4 12.3 0.0 15.6 0.4 0.1 0.2 0.6 0.0 0.6 0.9 0.7 0.6 0.5 1.1 0.4 0.3 0.3 0.3 0.0 3.9 0.8 0.3 35.3 39.4 40.3 35.8 27.7 33.6 40.2 42.2 24.6 43.4 42.8 39.4 44.9 5.9 12.8 5.9 14.4 7.4 8.8 4.0 5.9 2.2 4.1 4.4 3.0 4.3 15.7 5.2 5.5 6.2 2.6 10.5 9.9 3.9 5.7 3.3 3.6 2.4 5.9 3.0 4.0 36.2 11.6 2.1 4.5 10.2 5.7 0.0 4.1 4.6 6.0 4.1 5.0 33.8 7.1 2.0 4.4 6.9 4.2 2.1 2.9 5.4 4.7 3.8 4.7 4.1 15.6 65.2 17.7 6.8 3.0 7.2 8.6 11.8 5.8 6.2 6.6 19.7 3.0 3.6 3.4 8.5 4.2 14.9 1.5 7.1 1.6 7.5 7.3 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118417 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;monocytes: 2.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 4.3" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.1 0.4 0.4 0.1 0.4 0.0 0.1 0.9 0.7 0.2 0.3 0.2 0.0 0.3 0.0 0.2 0.2 0.0 0.1 0.5 0.4 0.6 0.2 0.3 0.1 0.5 0.4 0.4 0.2 0.5 0.2 0.5 0.0 0.5 0.5 0.0 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.4 0.4 0.3 1.1 0.5 0.1 0.2 0.0 0.0 0.2 0.2 0.6 0.3 0.2 0.0 0.2 0.6 0.1 1.8 0.1 0.1 0.0 0.1 0.4 0.0 1.8 0.3 0.0 0.0 0.0 0.4 0.1 0.1 1.8 1.5 0.0 0.2 0.2 0.1 1.5 0.9 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.6 0.8 0.0 0.6 0.1 1.0 0.0 0.2 0.8 0.1 0.5 0.2 0.4 1.0 0.9 0.7 0.5 0.3 0.0 0.1 0.5 4.3 0.3 0.5 0.5 0.3 0.6 0.1 0.2 0.5 0.4 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.9 0.7 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.6 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.6 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.2 0.1 0.3 0.0 GPR25 ENSG00000170128 "G protein-coupled receptor 25" O00155 1 200872981-200874178 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "stomach 1: 2.0" "Group enriched" "Detected in some" 7 "Plasma cells: 15.1;T-cells: 6.9" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 27.5;T-reg: 44.1" "Group enriched" "Detected in many" 57 "B-cells: 14.4;T-cells: 44.1" "Cell line enriched" "Detected in single" 6 "U-266/70: 1.3" "Low region specificity" "Detected in many" NA NA "unprognostic (2.80e-3)" "unprognostic (1.73e-2)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (2.21e-3)" "unprognostic (4.49e-5)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-2)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (1.29e-6)" "unprognostic (1.48e-2)" "unprognostic (3.71e-2)" "unprognostic (2.42e-2)" "unprognostic (3.22e-6)" 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 2.0 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 11.2 14.4 27.5 8.6 0.0 1.4 0.8 2.4 0.2 0.5 0.0 0.1 44.1 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.0 0.0 0.0 UBE2E1 UbcH6 ENSG00000170142 "Ubiquitin conjugating enzyme E2 E1" P51965 3 23805955-23891640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030445, CAB073413" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB073413: , HPA030445: AB_10669599" "unprognostic (7.50e-2)" "unprognostic (2.78e-2)" "unprognostic (7.91e-3)" "unprognostic (7.13e-2)" "unprognostic (6.74e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (9.97e-7)" "unprognostic (3.69e-2)" "unprognostic (3.53e-2)" "unprognostic (1.34e-2)" "unprognostic (5.36e-3)" "unprognostic (2.70e-2)" "unprognostic (2.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.94e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" 69.2 55.5 97.1 67.7 101.4 124.3 90.4 102.7 122.1 75.4 95.7 77.6 51.0 67.3 68.9 81.6 64.0 62.3 63.1 93.9 102.9 69.9 71.8 71.8 103.3 104.3 100.3 88.7 80.0 54.4 104.6 34.6 96.9 104.9 71.9 79.8 73.8 65.2 74.3 90.3 64.3 51.8 78.2 107.1 74.4 61.5 52.2 98.4 99.4 62.0 95.7 109.0 93.4 65.7 113.6 199.3 101.7 202.1 99.1 129.2 170.3 151.5 141.0 256.8 172.7 234.0 80.1 235.8 182.6 121.2 166.3 146.8 65.6 232.5 208.6 228.2 202.2 201.4 235.5 75.8 97.3 177.0 260.2 138.8 172.6 162.8 230.4 324.9 207.1 278.6 118.9 177.2 210.8 136.0 86.7 188.6 235.8 268.0 117.8 255.3 201.6 80.7 531.0 262.0 129.3 54.3 176.0 146.7 131.5 215.5 202.5 146.4 329.1 183.1 132.2 144.2 85.9 109.5 154.9 99.8 363.6 152.2 231.9 110.9 1.7 4.2 3.7 1.8 4.7 2.9 3.0 2.4 1.8 3.8 2.8 3.2 2.0 1.5 4.3 2.8 4.0 2.0 2.1 97.1 101.4 102.7 122.1 93.9 102.9 104.3 100.3 88.7 104.9 107.1 98.4 113.6 30.7 44.8 28.9 66.3 52.7 72.3 62.6 89.0 59.2 31.3 37.9 24.9 68.2 31.5 59.5 18.4 4.2 97.3 27.9 56.7 56.7 90.4 25.6 37.0 28.7 58.4 46.3 41.0 47.1 78.0 99.4 43.2 25.5 32.7 40.6 40.2 43.5 22.5 98.8 20.2 50.6 37.9 150.5 69.4 156.5 55.3 40.7 61.5 97.8 127.4 98.9 81.6 36.0 90.5 102.8 71.8 61.9 48.5 40.8 78.0 21.5 43.4 60.1 27.7 52.6 47.1 63.0 35.4 59.5 61.7 90.2 72.1 35.7 27.6 52.2 72.6 HNRNPA3 HNRPA3 ENSG00000170144 "Heterogeneous nuclear ribonucleoprotein A3" P51991 2 177212563-177223958 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, HPA066381" Supported Enhanced Nucleoplasm NA NA 1800000 Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666" "unprognostic (2.85e-2)" "prognostic favorable (4.87e-4)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (2.14e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-5)" "unprognostic (2.46e-1)" "unprognostic (3.15e-3)" "unprognostic (2.80e-3)" "unprognostic (3.65e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (9.57e-7)" "unprognostic (6.95e-2)" "unprognostic (3.04e-1)" "unprognostic (4.55e-2)" "unprognostic (1.10e-2)" 164.4 120.0 106.9 212.7 108.4 237.2 145.7 114.0 115.8 185.2 105.0 187.1 130.4 181.8 179.7 246.6 165.7 76.0 113.6 99.8 115.2 135.1 145.5 176.7 234.8 120.2 107.5 94.0 209.9 142.6 131.6 138.6 159.8 113.0 142.2 196.6 183.3 140.0 119.2 137.5 175.8 153.6 165.6 110.5 176.2 144.4 177.2 114.5 311.1 177.4 93.8 307.3 154.6 190.8 115.9 657.6 432.9 934.3 469.8 248.2 221.2 717.8 489.3 235.7 382.8 358.5 885.1 337.4 1315.9 366.5 388.4 518.3 370.6 944.2 616.7 712.9 609.6 556.2 996.1 620.3 1727.6 264.8 1064.7 584.0 249.8 288.3 569.9 422.1 217.9 537.3 587.4 723.1 414.3 492.1 891.1 746.9 444.4 507.3 762.5 405.0 947.2 790.1 414.2 547.9 1227.6 545.1 484.7 729.6 228.1 316.4 700.8 325.6 652.5 582.2 476.3 540.4 338.0 719.0 387.6 759.5 1117.2 305.4 699.5 320.0 8.9 21.2 10.8 25.0 22.6 20.2 21.2 20.0 22.0 23.4 20.4 17.5 18.1 8.2 23.5 23.0 37.8 25.9 14.5 106.9 108.4 114.0 115.8 99.8 115.2 120.2 107.5 94.0 113.0 110.5 114.5 115.9 274.8 166.7 255.1 84.5 277.4 351.8 429.6 442.1 224.8 192.8 155.2 135.1 64.2 114.4 302.7 160.0 98.0 512.7 368.9 200.7 121.3 257.2 47.2 296.5 387.2 289.7 275.0 288.6 56.9 273.8 563.0 231.4 184.0 343.0 278.1 222.6 196.7 165.0 342.7 148.0 70.5 315.0 193.3 221.0 372.5 44.0 204.7 258.3 192.1 73.1 311.1 187.1 232.8 65.9 88.6 276.1 184.0 209.5 336.6 288.9 136.8 156.7 257.8 164.4 151.2 319.3 461.9 362.8 208.3 331.1 330.5 496.0 307.9 214.1 310.7 382.6 SIK2 "DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2" ENSG00000170145 "Salt inducible kinase 2" Q9H0K1 11 111602449-111730855 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "ASC diff: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016026, HPA071049" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Vesicles" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA016026: AB_1857321, HPA071049: " "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.59e-2)" "unprognostic (4.81e-2)" "prognostic favorable (4.93e-4)" "unprognostic (6.41e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.72e-3)" "unprognostic (9.27e-2)" "prognostic favorable (1.17e-9)" "unprognostic (1.23e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-3)" "unprognostic (2.13e-2)" 30.0 9.4 8.1 5.3 11.1 3.1 20.8 7.4 11.8 7.3 9.3 7.5 6.0 7.4 5.0 6.0 8.2 10.1 11.1 9.2 14.0 11.5 22.9 11.8 4.4 11.8 8.7 7.8 15.0 32.1 21.5 16.7 5.8 9.5 6.8 6.3 30.9 13.9 6.2 33.4 8.3 7.6 6.0 5.0 4.6 17.8 3.1 8.8 5.4 8.8 23.4 4.4 7.8 6.2 11.3 9.2 6.0 10.3 11.1 50.3 14.8 6.1 7.9 11.2 5.9 6.7 20.5 9.6 7.2 10.7 9.2 6.9 12.7 8.2 5.9 7.6 5.4 3.4 7.9 5.2 10.1 10.9 7.7 4.9 14.5 8.6 8.7 11.1 11.7 7.1 7.1 7.4 10.3 9.4 4.3 8.0 7.0 3.5 7.6 5.9 10.6 11.0 8.7 13.1 8.2 4.8 11.3 11.6 4.7 4.5 9.4 11.5 6.2 9.9 12.9 7.7 8.3 10.9 2.9 2.4 14.8 4.2 10.6 8.8 0.3 0.7 0.6 0.7 0.7 0.3 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.3 0.5 0.6 0.3 0.5 0.5 8.1 11.1 7.4 11.8 9.2 14.0 11.8 8.7 7.8 9.5 5.0 8.8 11.3 22.1 19.2 24.8 113.3 14.1 14.7 6.2 5.2 18.2 15.7 10.5 9.9 21.3 27.1 10.0 16.5 66.7 4.4 11.4 15.6 5.9 10.4 16.5 27.7 14.9 18.8 18.0 12.4 217.6 7.9 4.6 20.1 27.5 45.3 9.5 24.3 9.3 38.7 5.4 32.0 132.4 11.3 4.1 12.4 16.9 14.1 11.5 13.3 19.6 73.1 6.0 14.5 4.1 86.0 191.9 8.4 10.3 14.7 8.9 6.9 8.3 23.1 13.4 60.9 0.0 19.1 19.0 3.9 6.4 10.3 11.9 5.2 12.6 5.0 11.5 7.1 AL391987.1 ENSG00000170152 9 61861848-61862567 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF150 KIAA1214 ENSG00000170153 "Ring finger protein 150" Q9ULK6 4 140859807-141212877 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Excitatory neurons: 184.5;Inhibitory neurons: 174.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 285.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 19.7;fHDF/TERT166: 27.1;SH-SY5Y: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037987 Uncertain "Intracellular and membrane" NA NA "HPA037987: AB_10669512" "prognostic favorable (1.41e-4)" "unprognostic (1.95e-2)" "unprognostic (8.26e-3)" "unprognostic (2.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.38e-2)" "unprognostic (2.38e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (9.32e-2)" "unprognostic (3.10e-3)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (3.88e-3)" "unprognostic (9.68e-2)" "unprognostic (1.32e-3)" "unprognostic (2.41e-2)" 11.4 12.5 5.8 1.8 13.1 0.3 3.1 7.9 6.8 8.0 0.0 11.7 1.0 12.0 10.9 6.8 12.5 3.5 15.0 7.6 6.7 8.4 0.9 1.3 3.3 3.7 2.3 7.9 10.9 2.0 0.5 7.9 2.0 5.0 8.4 3.8 32.1 31.9 11.2 18.9 0.9 3.8 12.4 1.2 5.5 4.0 1.4 4.2 2.0 6.3 12.6 3.1 6.5 3.9 4.9 0.3 0.5 4.8 4.2 19.7 1.4 0.2 6.8 3.5 2.5 1.2 0.0 0.1 0.0 0.9 27.1 0.1 0.1 9.8 0.1 1.3 0.1 4.6 0.0 8.9 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.2 1.6 0.0 4.8 0.0 0.1 0.9 0.1 4.7 0.2 2.2 0.0 1.8 2.6 12.4 0.1 2.8 0.0 2.0 37.0 0.7 0.3 1.9 2.5 0.1 0.1 0.1 12.6 5.2 8.7 3.1 0.3 0.1 0.0 0.2 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 13.1 7.9 6.8 7.6 6.7 3.7 2.3 7.9 5.0 1.2 4.2 4.9 0.8 0.0 0.5 65.6 0.0 1.1 0.7 0.3 3.4 53.9 3.1 7.4 72.5 1.5 2.2 11.0 112.6 1.3 0.0 0.1 1.9 0.4 4.6 17.8 43.9 2.7 1.8 0.0 184.5 0.5 0.1 10.0 0.0 22.8 0.0 11.4 2.2 0.2 0.7 26.9 174.3 0.0 0.0 0.6 2.9 2.7 28.6 2.0 0.0 114.3 0.0 13.4 0.0 285.5 5.7 0.1 0.0 18.0 0.0 1.1 0.0 1.0 0.2 69.1 13.1 34.5 17.4 0.0 2.0 0.5 0.6 0.4 0.4 47.6 0.0 0.1 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 9.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.5;TIME: 8.5" "HPA022996, HPA047220, HPA047851, HPA066260" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 1.3 1.3 0.8 2.1 2.8 4.2 1.5 6.7 4.8 1.1 0.0 1.5 0.8 3.6 2.5 0.8 1.6 1.2 1.1 4.5 5.9 0.5 1.1 1.3 1.7 2.8 2.2 0.3 4.6 2.8 0.4 1.6 2.7 6.8 1.5 0.9 7.4 1.2 1.0 1.1 2.5 1.0 1.6 2.1 1.8 1.5 9.2 1.2 3.4 0.8 2.3 1.2 1.7 0.9 4.8 0.5 3.4 0.8 2.1 3.0 9.5 0.4 0.2 0.0 0.2 0.2 4.4 0.1 0.5 2.8 6.2 0.2 5.3 4.4 0.3 0.2 3.2 0.2 0.4 0.5 0.3 0.2 0.7 2.7 1.7 0.1 2.1 0.2 0.9 0.1 0.1 0.4 0.3 2.0 0.1 0.0 1.1 0.6 0.9 0.4 1.4 0.2 0.1 0.1 4.1 1.1 1.2 0.6 0.2 1.2 1.5 3.4 0.1 8.5 0.7 0.4 4.6 1.4 5.7 6.3 0.2 0.3 6.2 1.6 0.2 0.1 0.0 0.5 0.1 0.3 0.2 0.5 0.3 0.1 0.1 0.9 0.5 0.2 0.2 0.4 0.2 0.5 0.0 0.8 2.8 6.7 4.8 4.5 5.9 2.8 2.2 0.3 6.8 2.1 1.2 4.8 5.9 0.0 14.9 15.7 3.1 4.0 6.4 1.9 0.0 40.8 4.5 2.5 2.8 2.8 2.9 0.0 54.2 4.9 6.4 1.7 0.0 1.8 59.1 8.0 25.8 9.1 1.2 1.7 21.2 0.0 7.1 9.7 2.0 10.4 26.0 6.2 3.6 2.0 4.2 33.7 19.8 2.4 2.0 6.8 7.7 6.5 7.2 6.3 5.4 1.0 3.6 7.1 6.2 17.1 4.0 1.7 3.8 9.1 1.7 8.6 1.2 1.1 3.9 49.4 6.6 11.7 10.2 165.9 36.1 0.2 3.7 1.9 6.9 22.2 2.1 4.6 VGLL2 ENSG00000170162 "Vestigial like family member 2" Q8N8G2 6 117265558-117273565 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 130.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.2;Hofbauer cells: 1.5;Skeletal myocytes: 7.7;Spermatogonia: 1.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Region enhanced" "Detected in some" "thalamus: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RH-30: 13.8;U-2 OS: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.02e-2)" "unprognostic (3.09e-2)" "unprognostic (1.75e-1)" "unprognostic (4.92e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.6 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.6 0.0 0.0 0.7 0.2 130.7 0.2 0.0 0.0 0.5 0.0 0.0 0.4 2.5 0.0 0.0 31.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 1.7 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 1.1 0.6 0.5 0.0 0.7 0.5 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151550-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 24.6;epididymis: 28.2" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Collecting duct cells: 16.5;Early spermatids: 3.7;Endothelial cells: 3.6;Leydig cells: 4.7;Proximal tubular cells: 6.5;Sertoli cells: 6.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Group enriched" "Detected in many" 4 "medulla oblongata: 9.9;pons: 5.6;spinal cord: 7.9;white matter: 7.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.6;HEK 293: 39.7;RPTEC TERT1: 29.6;SK-MEL-30: 11.0" "Region enriched" "Detected in single" 46 "pons and medulla: 4.5" "Group enriched" "Detected in some" 4 "medulla oblongata: 6.0;spinal cord: 7.8" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA054383: AB_2682470, HPA070349: AB_2686258" "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 6.9 8.4 1.2 1.6 1.6 0.0 7.4 0.0 0.7 6.0 0.0 6.1 1.0 24.6 28.2 1.1 14.4 1.5 0.4 0.0 0.3 16.2 0.0 0.4 1.7 9.9 1.0 0.0 15.2 0.6 0.1 0.0 0.4 5.6 2.9 2.0 0.0 0.7 11.2 2.8 2.5 6.3 9.8 7.9 7.3 1.0 3.0 1.8 0.2 1.2 0.5 0.4 2.7 4.1 7.4 0.5 0.3 0.0 0.0 2.0 3.0 0.0 0.2 0.9 0.1 1.1 0.9 0.0 0.0 16.6 3.4 0.7 0.2 2.6 0.0 0.4 0.0 39.7 0.5 0.0 0.0 0.5 0.0 0.1 9.3 2.6 0.0 0.5 0.2 6.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 29.6 4.1 2.5 4.2 0.6 0.0 11.0 0.6 0.0 0.0 5.0 0.5 0.2 2.9 2.1 0.0 0.1 0.0 2.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.7 0.0 0.3 9.9 1.0 0.0 5.6 7.9 1.8 7.4 5.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 16.5 0.0 0.0 0.0 0.9 0.0 0.0 3.7 0.1 1.1 3.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 2.6 4.7 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 3.0 0.0 0.1 0.3 6.5 0.0 0.0 6.6 0.6 0.9 0.3 0.4 0.0 0.6 0.0 0.1 3.0 1.3 0.0 CHRNB1 CHRNB ENSG00000170175 "Cholinergic receptor nicotinic beta 1 subunit" P11230 17 7445061-7457710 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.7;tongue: 58.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 34.6;RH-30: 71.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005822, CAB011200" Approved NA NA "CAB011200: AB_262151, HPA005822: AB_1079484" "unprognostic (2.89e-2)" "unprognostic (3.43e-1)" "unprognostic (1.08e-1)" "unprognostic (2.67e-2)" "unprognostic (4.19e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "unprognostic (3.56e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" "unprognostic (2.49e-1)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" 6.9 30.8 6.7 2.5 7.3 9.2 6.7 7.1 7.5 7.5 8.1 6.2 2.9 6.6 5.2 7.0 5.5 1.9 11.2 6.8 6.9 10.8 16.7 5.1 3.7 7.4 7.0 6.5 5.5 16.7 9.2 6.7 6.7 7.1 5.2 2.5 3.3 10.8 3.0 159.7 7.9 5.6 3.2 7.0 8.0 5.3 3.2 6.8 6.5 13.1 58.2 3.9 5.5 7.3 8.0 1.6 2.2 3.8 4.5 6.0 4.0 8.6 1.1 3.8 5.6 4.6 1.3 2.0 6.2 4.0 2.5 2.0 13.6 1.4 25.1 2.0 7.6 4.8 3.5 2.3 8.1 2.6 2.2 8.6 8.8 6.8 3.4 11.0 9.3 3.8 12.0 4.6 3.4 34.6 1.0 6.7 4.1 2.7 1.5 1.1 4.4 71.0 15.8 15.3 1.2 0.6 11.1 2.4 4.0 4.7 5.9 3.9 3.0 3.6 2.3 6.4 1.7 5.0 8.1 9.6 1.7 2.1 4.9 2.1 9.9 5.4 13.6 7.9 6.3 6.1 6.7 8.7 8.0 7.0 7.0 7.0 9.2 1.7 11.0 10.4 5.2 7.9 6.1 6.7 7.3 7.1 7.5 6.8 6.9 7.4 7.0 6.5 7.1 7.0 6.8 8.0 8.8 0.0 4.8 4.6 8.9 6.4 3.8 12.6 6.2 3.9 9.3 11.2 9.8 4.3 7.2 9.2 2.1 39.0 17.7 5.2 23.5 16.1 2.2 5.1 7.1 10.1 2.4 3.4 1.4 13.4 9.4 8.1 3.6 7.1 13.3 5.8 10.4 10.8 12.6 15.2 1.5 4.8 14.2 7.2 8.7 2.1 21.8 7.9 12.4 1.0 17.0 14.0 29.9 1.0 5.6 17.3 4.9 17.0 5.8 4.1 10.2 15.5 9.5 7.1 0.0 47.3 8.1 2.8 2.8 6.1 6.5 30.4 11.2 12.1 5.9 3.8 HOXD12 HOX4H ENSG00000170178 "Homeobox D12" P35452 2 176099795-176102489 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.5;seminal vesicle: 1.5" "Cell type enriched" "Detected in single" 12 "Cardiomyocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;REH: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA059444 Uncertain NA NA "HPA059444: AB_2684020" "unprognostic (1.00e-1)" "unprognostic (2.40e-3)" "unprognostic (1.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.71e-2)" "unprognostic (1.36e-2)" "unprognostic (7.11e-2)" "unprognostic (4.54e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140751 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "bone marrow: 157.6" "Cell type enriched" "Detected in some" 350 "Erythroid cells: 1995.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 203 "HEL: 149.1;K-562: 37.7" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 15000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.0 0.1 0.2 0.0 0.3 157.6 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.4 0.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 4.1 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.9 0.4 0.4 0.0 0.0 0.8 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.7 0.0 0.0 0.0 0.0 1995.6 2.4 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 1.7 0.0 0.0 0.9 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223874 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA036990: AB_2675419, HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favorable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 6.5 4.4 2.4 6.2 3.8 21.8 4.6 4.0 2.8 6.3 3.8 8.0 8.0 5.6 2.3 7.1 4.4 5.2 6.9 2.2 5.3 7.1 13.3 6.4 6.5 5.9 3.9 1.9 3.8 8.3 7.7 3.4 8.2 4.3 5.6 5.7 4.6 5.9 5.6 36.9 5.7 7.3 5.8 5.9 7.5 6.4 6.8 3.2 9.4 7.4 21.5 5.9 6.9 4.0 7.4 8.5 7.9 6.6 11.3 8.4 8.2 5.1 13.0 12.5 11.8 10.1 23.1 11.7 10.5 9.2 11.5 7.8 6.5 15.9 13.5 10.2 26.0 10.5 9.7 8.5 4.7 11.3 19.4 9.4 10.2 11.1 12.0 9.5 8.3 12.2 11.9 21.5 31.5 7.9 13.3 25.6 3.7 6.1 17.7 15.3 16.7 10.2 10.1 7.2 9.2 13.8 12.3 10.5 17.3 10.9 4.9 10.8 7.6 14.6 10.8 9.1 9.6 14.1 35.7 65.3 18.6 10.9 14.4 9.3 13.4 4.5 9.7 5.7 4.6 7.0 4.6 4.9 4.9 6.6 4.5 4.8 4.2 4.3 10.1 4.9 2.7 7.9 4.3 2.4 3.8 4.0 2.8 2.2 5.3 5.9 3.9 1.9 4.3 5.9 3.2 7.4 21.5 22.4 19.8 13.7 19.5 53.5 21.0 6.2 25.6 7.4 20.8 13.7 18.4 10.0 12.2 0.0 12.5 12.8 22.2 35.5 1.9 8.3 36.4 20.7 26.1 15.3 30.6 31.5 19.6 7.7 7.1 13.4 26.0 52.1 3.8 9.9 17.9 38.4 10.6 8.4 15.9 20.2 4.1 17.0 16.6 20.3 6.8 21.9 12.4 9.4 10.1 15.1 12.3 18.6 22.8 10.2 13.4 9.4 38.6 16.8 17.0 18.5 10.9 8.9 13.1 15.0 14.1 11.3 4.7 31.5 59.1 26.7 23.2 11.0 17.6 45.4 SLC16A5 "MCT5, MCT6" ENSG00000170190 "Solute carrier family 16 member 5" O15375 17 75087727-75106162 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Collecting duct cells: 88.3;Early spermatids: 42.2;Proximal enterocytes: 40.9;Respiratory ciliated cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 13.2;neutrophil: 34.9" "Group enriched" "Detected in all" 6 "granulocytes: 34.9;monocytes: 13.2" "Cell line enhanced" "Detected in many" "A549: 65.9;OE19: 71.5;RPTEC TERT1: 68.8;RT4: 139.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" "unprognostic (2.51e-2)" "unprognostic (2.90e-2)" "unprognostic (2.72e-1)" "unprognostic (6.30e-2)" "unprognostic (2.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (8.43e-3)" "unprognostic (8.07e-2)" "unprognostic (9.63e-2)" "unprognostic (3.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" 6.2 1.4 1.4 4.8 1.1 8.8 7.2 1.2 1.4 9.5 4.8 13.2 34.3 8.6 4.4 11.3 16.2 8.2 14.0 0.9 2.4 54.3 3.3 24.8 3.4 1.7 1.9 0.6 8.1 4.7 4.6 2.7 10.8 1.6 15.1 10.4 0.1 8.0 12.6 9.4 16.1 25.1 4.3 2.0 10.7 26.2 6.6 1.8 1.9 14.4 4.7 3.9 18.7 11.2 1.7 14.2 65.9 1.2 0.1 3.2 4.2 22.0 7.7 19.8 7.7 5.4 16.9 39.6 0.0 9.2 24.1 1.0 39.7 3.2 10.8 2.9 0.0 0.2 5.1 33.5 8.9 14.9 0.0 0.2 10.1 12.8 7.8 0.1 0.1 15.8 0.7 1.1 0.2 0.5 2.3 0.5 7.1 5.0 71.5 0.2 1.6 0.0 0.5 68.8 139.8 0.0 0.4 19.4 4.5 9.7 11.0 32.0 7.1 5.7 0.1 0.1 0.5 0.1 0.2 0.0 0.0 0.3 4.3 4.3 4.1 13.2 3.5 0.5 5.0 0.3 1.4 0.6 0.1 3.9 0.3 1.4 0.6 34.9 1.0 2.6 0.1 0.8 4.4 1.4 1.1 1.2 1.4 0.9 2.4 1.7 1.9 0.6 1.6 2.0 1.8 1.7 4.4 38.5 34.5 0.0 0.9 2.5 7.7 10.1 6.2 0.0 5.6 6.1 5.5 7.2 23.5 88.3 0.0 18.5 0.5 17.1 5.9 6.4 42.2 9.7 1.5 5.0 6.7 0.4 0.2 1.3 3.7 3.7 11.7 6.1 7.0 3.9 12.8 0.4 6.5 0.0 0.3 13.2 4.1 8.5 1.8 31.8 0.6 5.5 7.2 3.7 7.9 0.2 3.1 0.0 0.1 1.0 23.8 0.0 0.2 11.3 40.9 1.9 45.4 0.0 0.0 0.8 2.1 0.3 1.5 3.6 1.3 19.6 1.4 1.1 11.8 25.5 NANP "C20orf147, dJ694B14.3, HDHD4, MGC26833" ENSG00000170191 "N-acetylneuraminic acid phosphatase" Q8TBE9 20 25612935-25624014 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050342 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA050342: AB_2681098" "unprognostic (8.72e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (6.01e-2)" "unprognostic (5.59e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.01e-6)" "unprognostic (3.20e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-3)" "unprognostic (1.24e-1)" "unprognostic (3.46e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-1)" "unprognostic (1.71e-2)" "unprognostic (9.42e-2)" 3.3 3.8 1.5 2.6 1.5 3.5 3.0 2.7 1.5 2.3 1.7 2.1 2.9 2.3 2.4 2.8 2.1 2.5 2.5 1.3 1.6 4.4 4.8 2.4 2.0 1.5 1.4 1.3 2.7 3.2 2.8 1.5 2.6 1.7 2.3 2.5 2.9 2.1 1.9 1.8 2.0 2.0 2.9 1.2 1.9 2.3 2.8 1.7 4.9 3.1 3.7 2.4 3.0 2.0 1.6 14.2 8.5 6.7 9.4 10.7 11.0 9.5 7.1 13.9 9.3 11.8 7.4 9.7 4.9 7.9 13.6 11.0 8.9 10.6 10.7 17.9 1.7 5.9 13.3 3.8 20.1 9.1 10.0 3.7 9.9 5.1 10.7 13.6 5.1 8.2 17.8 11.1 8.5 11.7 8.0 19.4 4.8 4.8 12.6 12.6 9.3 14.1 6.4 5.7 7.7 12.6 5.2 8.0 12.7 8.7 6.6 5.3 8.5 6.8 14.5 10.9 13.6 10.2 4.3 4.1 12.4 4.3 22.7 9.1 0.3 2.3 0.9 1.3 2.4 2.0 0.6 0.9 1.0 3.3 0.6 0.8 1.4 0.3 2.2 1.4 0.7 0.8 1.1 1.5 1.5 2.7 1.5 1.3 1.6 1.5 1.4 1.3 1.7 1.2 1.7 1.6 3.6 3.2 1.5 4.2 1.9 5.9 5.8 4.6 2.8 4.5 3.0 2.3 2.8 5.7 3.6 7.3 0.0 4.1 5.2 1.7 13.7 5.2 0.3 2.0 4.7 4.4 3.0 16.0 3.3 4.2 2.1 4.9 4.6 2.0 5.7 3.4 3.6 5.3 4.6 6.7 3.6 2.3 6.1 4.1 4.8 0.8 3.1 2.8 5.4 1.9 2.4 5.5 9.2 2.5 2.3 4.8 2.0 2.6 3.5 5.1 1.8 8.2 2.1 7.3 0.0 4.6 3.4 5.5 11.3 2.6 5.1 1.9 1.9 7.4 2.2 3.1 ANKK1 X-kinase ENSG00000170209 "Ankyrin repeat and kinase domain containing 1" Q8NFD2 11 113387779-113400416 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 7.2;Club cells: 2.4;Ionocytes: 6.1;Respiratory ciliated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.1;RT4: 1.0" "Not detected" "Not detected" HPA012813 Uncertain NA NA "HPA012813: AB_1844832" "unprognostic (5.63e-3)" "unprognostic (6.67e-3)" "unprognostic (5.09e-3)" "unprognostic (6.27e-3)" "unprognostic (5.56e-4)" "unprognostic (7.02e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.50e-1)" "unprognostic (3.15e-1)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (5.39e-6)" "unprognostic (3.17e-2)" "unprognostic (3.83e-2)" "unprognostic (2.79e-1)" "unprognostic (4.65e-2)" 0.2 0.5 0.9 0.2 2.3 0.2 0.8 0.4 0.6 1.0 1.5 0.3 0.1 0.4 0.3 0.5 2.0 0.0 0.1 0.2 0.5 0.4 0.3 0.6 0.4 0.8 2.7 0.2 0.7 0.4 0.1 3.0 0.0 0.6 1.5 0.0 0.6 1.3 0.3 0.3 3.6 0.6 0.0 0.7 0.8 0.2 1.0 0.9 0.1 0.7 0.0 0.2 0.4 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 0.4 0.6 0.2 0.5 0.8 2.7 0.2 0.6 0.7 0.9 0.6 0.2 0.0 0.5 1.6 0.2 0.6 0.8 7.2 0.0 1.2 0.3 1.1 0.4 0.0 2.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 1.9 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.2 6.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.0 1.1 0.0 0.0 0.5 0.0 0.0 6.0 0.9 0.0 1.3 0.4 0.1 0.1 0.0 0.6 0.0 0.5 0.2 0.0 0.5 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159973012 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.5;liver: 11.5;lymphoid tissue: 11.7" "Group enriched" "Detected in some" 7 "Excitatory neurons: 41.5;Inhibitory neurons: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 11.9;HaCaT: 5.8;TIME: 9.8;U-2 OS: 7.9;U-251 MG: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA074416 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074416: AB_2686688" "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.00e-5)" "prognostic unfavorable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favorable (3.19e-5)" "unprognostic (1.59e-2)" 3.2 1.8 2.3 0.3 12.5 0.0 1.9 0.0 8.1 0.4 0.0 0.6 0.4 1.0 1.5 0.3 3.0 0.5 1.9 6.3 3.2 4.0 11.5 4.0 1.2 4.2 7.2 7.4 2.9 0.4 0.5 0.6 0.3 4.6 0.6 0.3 0.5 0.3 0.7 0.7 0.8 1.4 0.4 0.0 11.7 0.7 0.2 5.2 0.1 1.5 0.7 0.3 0.4 0.6 5.5 0.4 4.5 0.3 0.0 1.9 0.8 0.1 0.5 0.1 0.5 0.2 0.0 3.8 0.0 11.9 3.4 4.4 5.8 0.0 0.5 0.3 0.0 0.2 0.0 1.7 0.0 4.1 0.0 0.0 2.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 3.8 0.0 0.4 0.0 0.0 0.3 0.3 1.7 0.1 0.0 9.8 0.1 7.9 0.0 6.6 0.0 0.0 0.0 2.9 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.5 0.0 8.1 6.3 3.2 4.2 7.2 7.4 4.6 0.0 5.2 5.5 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADPRM "C17orf48, MDS006" ENSG00000170222 "ADP-ribose/CDP-alcohol diphosphatase, manganese dependent" Q3LIE5 17 10697594-10711558 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023265, HPA023820" Approved NA NA "HPA023265: AB_1845590, HPA023820: AB_1845591" "unprognostic (7.58e-3)" "prognostic favorable (1.69e-4)" "unprognostic (1.42e-1)" "prognostic favorable (2.38e-5)" "unprognostic (2.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (1.35e-1)" "unprognostic (1.43e-2)" "unprognostic (1.43e-1)" "unprognostic (6.26e-3)" "unprognostic (2.97e-1)" "unprognostic (6.53e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (4.77e-2)" "unprognostic (5.97e-2)" 6.2 4.6 1.5 5.0 1.8 6.6 6.7 1.6 2.2 6.8 1.2 4.9 3.1 6.5 3.7 4.4 4.9 4.7 3.6 1.5 1.6 4.0 6.9 3.9 6.9 1.6 1.6 1.3 7.9 7.0 3.2 3.9 2.6 1.9 7.7 3.2 10.0 4.7 3.6 9.3 5.4 6.0 2.8 1.6 5.8 8.0 4.0 1.6 7.1 6.6 6.5 5.6 4.8 5.2 1.9 3.8 2.8 3.9 5.0 8.8 11.1 1.9 7.2 7.7 5.2 7.5 1.5 1.7 7.1 3.3 7.5 2.2 3.0 1.8 5.2 6.4 4.4 5.4 3.5 2.9 4.3 14.7 2.6 4.3 13.7 7.5 5.6 7.8 8.0 9.6 7.8 3.4 0.6 6.8 1.1 2.8 4.5 4.2 2.5 1.5 3.1 2.7 1.9 9.1 2.5 0.7 5.2 3.5 1.3 8.2 4.7 3.6 5.0 9.8 2.9 2.3 3.6 4.2 1.6 1.1 1.1 6.9 3.6 6.1 2.6 2.5 4.7 2.4 2.6 3.5 5.9 6.2 4.1 3.1 7.2 13.0 8.5 2.3 4.1 2.3 1.7 5.9 3.9 1.5 1.8 1.6 2.2 1.5 1.6 1.6 1.6 1.3 1.9 1.6 1.6 1.9 5.8 3.2 2.0 6.5 17.6 5.2 11.7 17.4 8.0 11.7 5.9 6.0 2.7 4.3 8.9 1.8 18.8 7.2 6.4 3.8 3.9 8.4 10.2 1.9 3.9 5.7 4.8 6.7 6.0 8.3 7.3 6.6 4.6 2.4 14.0 4.4 7.1 9.8 6.7 3.3 6.9 7.5 2.0 9.5 5.1 5.2 15.8 6.0 10.6 1.9 11.1 13.5 6.2 8.0 8.1 8.1 4.6 8.2 3.6 12.7 14.9 8.5 4.1 34.3 6.6 6.6 14.0 12.5 10.2 4.4 4.7 8.2 13.0 4.4 5.6 11.4 FABP6 "I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP" ENSG00000170231 "Fatty acid binding protein 6" P51161 5 160187367-160238735 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 84 "intestine: 4570.5" "Cell type enriched" "Detected in some" 23 "Proximal enterocytes: 52213.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 31.6;EFO-21: 30.5;HDLM-2: 13.6;NB-4: 17.0;RPMI-8226: 17.2;RT4: 15.2;U-2197: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA012601, CAB024713" Enhanced "Intracellular and membrane" NA NA 890000 "CAB024713: , HPA012601: AB_1848435" "unprognostic (3.03e-2)" "unprognostic (7.55e-2)" "unprognostic (1.27e-1)" "unprognostic (5.00e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (5.35e-7)" "unprognostic (3.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.41e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.35e-9)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (2.48e-1)" "unprognostic (1.85e-3)" 0.0 14.5 8.2 2.5 8.4 0.1 0.2 9.0 11.7 1.8 8.5 2.5 5.0 1.9 0.0 1.2 54.3 0.2 1.3 7.7 11.7 0.2 0.1 5.4 4.2 9.0 9.3 7.2 0.1 0.1 0.0 0.7 0.1 10.1 0.2 0.0 0.9 0.2 0.2 0.0 0.4 4570.5 3.4 9.2 1.5 0.4 3.2 8.8 5.7 0.1 1.4 3.5 2.7 0.4 8.3 0.3 0.6 0.0 0.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 8.1 1.3 31.6 30.5 0.0 0.3 0.0 0.0 0.0 0.0 13.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 2.3 1.2 0.4 0.0 0.0 0.0 17.0 0.1 0.0 2.9 0.0 1.0 17.2 0.0 15.2 2.8 0.7 0.0 8.8 0.2 0.1 0.2 0.2 0.0 0.0 0.1 15.3 1.7 1.7 6.9 4.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 8.4 9.0 11.7 7.7 11.7 9.0 9.3 7.2 10.1 9.2 8.8 8.3 0.0 0.0 1.5 1.3 0.2 0.5 0.3 7.8 0.6 0.2 0.1 0.1 3.4 0.0 21.9 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.4 110.2 0.6 0.1 0.0 0.0 1.6 0.0 0.3 0.6 0.0 1.4 0.0 0.6 0.0 0.0 0.1 1.7 2.2 2244.4 2.0 0.0 4.2 0.2 0.3 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.9 0.3 2080.0 0.0 0.0 0.1 52213.9 0.1 134.9 0.7 0.0 0.0 1.2 0.1 2.1 2.0 0.1 0.0 0.1 1.7 1304.0 1.4 PWWP2A KIAA1935 ENSG00000170234 "PWWP domain containing 2A" Q96N64 5 160061801-160119450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046733, HPA058233" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA046733: AB_2679777, HPA058233: AB_2683647" "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (5.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.18e-2)" "unprognostic (7.86e-3)" "unprognostic (1.40e-3)" "unprognostic (6.24e-2)" "unprognostic (2.42e-2)" "unprognostic (7.08e-2)" "unprognostic (7.25e-2)" "unprognostic (8.24e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (3.88e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.51e-4)" 6.7 7.1 10.4 7.5 14.5 10.4 6.9 23.3 11.2 10.3 8.0 10.6 7.5 8.0 5.3 6.6 7.6 6.2 5.8 8.6 10.0 7.6 7.2 7.7 10.2 12.8 13.1 7.5 7.7 8.1 5.9 8.2 8.8 15.2 8.7 10.9 14.3 7.1 6.1 6.2 11.4 8.6 7.0 11.4 9.5 9.4 5.1 11.9 12.5 7.2 6.1 9.1 8.3 8.0 25.2 13.4 6.3 16.1 13.7 17.5 13.6 22.5 10.4 8.4 9.1 9.1 20.5 25.3 21.4 15.6 8.0 14.9 9.4 14.1 16.2 14.8 22.3 15.6 15.4 11.9 10.6 13.3 15.6 11.2 9.7 7.9 18.3 13.8 20.4 14.8 11.9 12.0 13.5 15.5 11.1 13.5 15.1 19.0 11.3 8.1 20.9 14.3 13.7 11.2 9.4 18.8 13.1 17.6 17.3 19.4 12.9 13.4 17.1 19.9 15.7 10.9 11.9 20.6 15.4 14.7 18.9 10.4 15.6 15.9 3.2 2.0 1.1 1.1 0.9 0.9 3.3 1.2 1.4 1.3 1.6 2.0 1.1 2.1 0.4 1.2 1.2 1.2 0.4 10.4 14.5 23.3 11.2 8.6 10.0 12.8 13.1 7.5 15.2 11.4 11.9 25.2 16.8 9.6 22.7 42.7 25.0 31.9 13.0 10.8 27.3 102.0 15.8 13.2 13.9 11.5 15.6 20.2 73.0 12.3 22.0 30.2 17.6 13.7 2.1 18.2 33.8 18.7 32.9 30.3 47.2 11.0 12.4 20.4 20.9 17.3 23.5 29.0 18.2 8.8 9.2 94.2 61.8 25.9 20.3 13.7 17.6 3.8 55.9 16.9 10.6 52.5 25.7 28.8 22.6 92.0 228.5 16.5 17.8 38.4 19.5 19.4 11.2 7.2 14.4 57.6 26.3 23.5 25.1 20.4 22.0 18.3 25.9 9.3 23.8 34.0 25.2 11.2 USP50 ENSG00000170236 "Ubiquitin specific peptidase 50" Q70EL3 15 50494018-50546708 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Group enriched" "Detected in some" 8 "Early spermatids: 107.8;Late spermatids: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039470 Uncertain NA NA "HPA039470: AB_10672964" "unprognostic (7.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.01e-2)" "unprognostic (4.04e-3)" "unprognostic (3.37e-1)" "unprognostic (2.53e-2)" "unprognostic (3.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.81e-2)" "unprognostic (4.65e-2)" "unprognostic (2.47e-1)" "unprognostic (7.49e-4)" "unprognostic (3.03e-1)" 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 107.8 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 3.2 0.0 0.0 0.0 0.0 58.0 0.3 0.2 0.0 2.8 0.0 0.0 0.0 3.0 9.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 3.8 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 USP47 ENSG00000170242 "Ubiquitin specific peptidase 47" Q96K76 11 11841423-11961887 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029286, HPA029289" Supported Approved "Vesicles,Intermediate filaments" NA NA "Intermediate filaments" Vesicles "HPA029286: AB_10599852, HPA029289: AB_10601675" "unprognostic (2.02e-1)" "unprognostic (2.72e-1)" "unprognostic (3.05e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.27e-2)" "unprognostic (7.39e-2)" "unprognostic (1.54e-2)" "unprognostic (7.05e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-1)" "unprognostic (1.51e-1)" "unprognostic (9.96e-3)" "unprognostic (1.90e-1)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" 14.8 14.4 12.2 11.5 16.1 19.2 15.3 17.8 13.2 14.2 10.7 17.5 10.4 17.4 15.7 16.2 13.6 12.4 23.8 12.9 15.0 13.3 23.5 16.3 13.4 14.3 13.4 10.7 16.1 17.1 22.4 13.9 16.8 15.2 16.8 12.4 26.0 14.2 15.6 60.3 17.7 14.2 17.9 15.1 11.9 16.7 15.2 13.6 19.3 15.0 33.9 13.9 16.9 14.3 21.1 26.8 15.7 30.3 13.1 21.8 23.2 12.6 31.6 22.3 20.1 22.1 16.5 22.2 29.6 13.3 28.0 23.7 17.8 23.7 15.3 30.3 27.5 20.4 18.6 30.3 12.6 21.5 25.0 23.9 22.3 22.5 12.3 29.0 26.1 21.8 21.7 35.8 23.7 25.4 10.6 21.7 14.3 7.9 28.1 12.7 21.4 30.3 9.4 24.6 29.1 9.8 21.0 25.8 19.6 19.3 18.4 14.4 20.6 24.9 27.8 16.2 22.3 19.6 7.9 18.1 25.9 19.9 15.2 20.3 14.7 5.9 11.9 11.0 7.4 14.5 7.4 10.3 11.4 7.9 6.7 13.1 11.4 2.8 18.5 11.5 4.8 8.3 7.9 12.2 16.1 17.8 13.2 12.9 15.0 14.3 13.4 10.7 15.2 15.1 13.6 21.1 41.1 70.5 63.1 116.5 46.9 71.0 68.8 28.8 45.5 67.5 41.1 30.9 222.5 40.0 56.0 23.9 47.9 69.6 57.2 30.4 25.4 39.5 40.1 49.8 63.0 44.8 59.3 34.3 122.7 38.9 33.2 69.7 44.4 134.5 54.3 52.6 32.5 53.9 28.0 63.9 136.5 32.9 24.4 27.7 39.7 30.0 44.1 41.8 24.9 96.5 40.5 79.7 68.0 171.4 315.9 44.8 31.5 50.0 55.2 65.5 29.7 21.9 48.2 52.4 52.6 85.0 68.2 92.8 55.1 46.6 87.9 125.7 65.0 41.8 35.0 58.9 PDCD6IP "AIP1, Alix, Hp95" ENSG00000170248 "Programmed cell death 6 interacting protein" Q8WUM4 3 33798571-33869707 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 299.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011905, CAB016212, HPA051604" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 4100000 Vesicles Centrosome "CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: " "unprognostic (1.53e-1)" "unprognostic (2.63e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.17e-1)" "unprognostic (2.75e-1)" "unprognostic (5.12e-2)" "unprognostic (7.76e-3)" "unprognostic (1.23e-2)" "unprognostic (3.29e-1)" "unprognostic (2.86e-1)" "unprognostic (3.88e-3)" "unprognostic (4.49e-2)" "prognostic favorable (3.90e-9)" "unprognostic (9.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.78e-1)" "unprognostic (1.11e-1)" 31.8 27.8 18.9 24.7 20.1 21.4 33.2 20.8 23.1 33.0 25.3 46.9 36.5 35.4 26.6 46.3 31.2 26.1 28.2 19.7 21.2 35.4 33.5 35.5 26.4 26.6 22.5 19.4 34.7 25.2 40.9 23.0 31.4 28.8 30.2 41.9 30.8 29.9 23.9 34.1 40.2 39.1 32.0 21.6 27.7 37.6 24.0 21.2 24.6 34.6 22.3 30.4 27.1 36.2 25.1 47.2 46.4 30.2 25.1 78.5 80.6 34.3 67.2 56.2 50.9 52.2 33.3 43.8 75.9 33.8 77.7 32.2 45.5 47.8 61.4 57.8 27.4 39.5 56.7 37.4 28.2 50.8 56.5 57.6 62.2 69.5 57.6 67.8 60.5 77.1 32.4 50.3 26.2 74.4 27.0 36.3 31.8 29.9 43.5 57.8 32.8 36.5 43.8 64.6 39.2 14.7 26.8 61.6 67.8 30.7 48.9 62.0 51.4 101.1 59.5 28.2 50.1 46.9 26.6 37.6 55.6 56.7 62.6 28.8 6.8 13.5 11.0 8.0 18.1 8.7 12.0 8.9 8.1 12.4 10.8 7.7 7.5 6.8 12.1 18.0 5.0 9.4 10.0 18.9 20.1 20.8 23.1 19.7 21.2 26.6 22.5 19.4 28.8 21.6 21.2 25.1 78.5 86.6 84.8 85.8 76.1 41.7 62.6 62.7 51.8 28.6 42.5 34.0 53.4 62.9 80.6 64.4 52.1 53.0 58.5 299.9 37.2 67.2 85.3 121.6 84.0 68.8 36.1 40.6 83.5 78.3 52.8 54.3 96.8 77.8 53.7 53.0 54.3 57.3 60.6 25.2 69.2 97.1 63.1 93.0 44.7 50.4 74.0 85.0 28.4 75.9 71.0 23.1 42.2 96.0 161.7 122.5 127.1 80.5 46.9 56.5 130.2 61.0 130.9 49.9 46.0 42.3 50.4 93.0 48.4 61.5 43.2 96.6 55.2 47.7 86.7 70.3 MRGPRX1 MRGX1 ENSG00000170255 "MAS related GPR family member X1" Q96LB2 11 18933813-18939507 "G-protein coupled receptors, Predicted membrane proteins" "Acute phase" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "SuSa: 2.8" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ZNF212 C2H2-150 ENSG00000170260 "Zinc finger protein 212" Q9UDV6 7 149239651-149255606 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049807, HPA054178" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA049807: AB_2680891, HPA054178: AB_2682406" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (6.77e-3)" "unprognostic (3.66e-3)" "unprognostic (6.48e-2)" "unprognostic (2.79e-3)" "unprognostic (5.55e-3)" "unprognostic (8.75e-3)" "unprognostic (1.37e-3)" "unprognostic (1.15e-1)" "unprognostic (4.32e-3)" "unprognostic (2.46e-1)" "unprognostic (2.30e-1)" "unprognostic (4.75e-2)" "unprognostic (2.99e-1)" "unprognostic (1.60e-2)" "unprognostic (1.59e-1)" 5.3 8.4 6.7 4.9 7.0 12.3 6.8 7.4 6.9 9.7 6.6 7.1 9.3 8.2 6.3 14.8 7.4 4.1 5.2 6.6 6.6 6.9 10.3 4.8 8.1 7.2 7.0 6.4 9.2 8.0 6.4 6.5 6.2 7.1 8.8 4.9 4.5 8.6 6.3 6.3 11.0 9.8 5.1 7.1 10.8 7.1 12.6 7.0 9.6 7.7 4.8 8.1 7.0 9.6 7.4 10.7 10.4 12.5 15.9 8.7 7.0 13.8 6.3 9.5 11.2 11.2 8.9 13.3 14.0 9.7 6.4 9.0 9.6 9.3 10.4 9.2 10.8 16.7 7.7 8.1 7.5 6.6 12.8 9.2 8.0 11.7 7.7 8.1 7.0 6.7 16.9 14.3 10.5 6.5 15.2 23.2 26.0 16.6 8.4 12.5 15.6 8.6 15.3 7.0 8.9 12.5 20.5 9.7 9.4 9.6 7.5 5.6 13.5 5.7 11.3 3.1 14.5 11.7 24.1 11.3 12.6 14.8 11.5 10.4 0.0 3.5 7.6 5.0 2.9 5.0 4.1 3.7 4.2 4.4 3.9 6.4 5.5 1.9 8.2 3.7 3.9 5.9 2.1 6.7 7.0 7.4 6.9 6.6 6.6 7.2 7.0 6.4 7.1 7.1 7.0 7.4 3.7 6.4 3.3 5.9 5.4 9.7 3.1 3.2 4.0 7.3 5.4 4.7 3.0 5.7 2.2 0.0 4.2 9.6 2.9 5.5 3.9 5.9 1.8 5.9 3.5 4.2 6.7 5.2 6.8 4.0 10.0 4.0 2.6 5.7 2.5 7.1 4.2 5.8 4.2 10.1 6.5 5.5 8.2 5.6 2.3 0.8 6.2 2.9 1.8 5.6 6.1 6.0 6.2 6.0 7.7 4.6 1.2 6.0 4.0 3.8 11.1 3.8 4.5 8.3 13.1 4.2 3.1 13.8 22.1 4.4 8.7 15.1 5.4 5.8 5.3 4.0 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "adipose tissue: 59.0;adrenal gland: 167.8;breast: 44.6" "Group enriched" "Detected in some" 5 "Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 1.5;HSkMC: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 59.0 167.8 0.1 1.8 0.1 0.0 44.6 0.1 0.5 0.1 0.6 0.9 0.2 0.0 0.0 0.1 0.0 0.6 1.3 0.2 0.1 0.3 2.4 1.0 0.1 0.3 0.1 0.0 2.1 0.7 0.0 0.1 1.7 0.2 0.0 0.2 1.0 2.0 0.0 0.2 1.2 3.5 0.1 0.1 0.0 0.6 0.5 0.1 0.1 0.7 0.2 0.0 1.4 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.7 0.2 0.4 0.2 0.8 0.2 0.5 0.0 1.9 0.1 0.5 0.7 0.0 0.1 0.1 0.1 0.5 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.1 0.2 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 1.3 0.0 0.0 0.0 43.7 0.0 1.7 0.1 43.7 0.6 0.0 0.0 0.0 0.0 6.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 1.6 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 FAM161A "FLJ13305, RP28" ENSG00000170264 "FAM161 centrosomal protein A" Q3B820 2 61824848-61854143 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 29.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 100.1;Early spermatids: 183.2;Late spermatids: 293.1;Rod photoreceptor cells: 417.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032119 Approved NA Yes "HPA032119: AB_10602806" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (4.23e-2)" "prognostic unfavorable (9.02e-4)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.56e-5)" "unprognostic (7.62e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (4.35e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (5.33e-2)" "unprognostic (3.93e-1)" "unprognostic (8.08e-3)" "unprognostic (7.04e-2)" 0.9 1.2 1.2 0.5 1.3 0.3 1.1 0.8 1.8 2.2 2.2 0.8 0.4 1.6 1.2 1.1 4.0 1.4 1.5 1.0 1.2 1.9 0.8 1.0 0.7 1.0 1.1 1.0 5.2 2.3 1.9 2.4 1.1 1.0 1.0 0.6 29.1 0.7 1.1 1.2 0.6 0.7 0.6 0.9 0.7 2.6 5.5 1.0 1.6 3.7 0.3 0.6 1.1 1.1 1.3 3.4 3.1 7.1 3.3 3.4 3.2 2.1 2.9 1.5 3.4 4.2 2.1 1.7 6.6 1.5 0.5 6.1 1.6 4.3 0.5 8.0 4.5 4.7 2.4 2.8 3.3 2.9 2.7 0.5 1.3 0.0 6.6 1.9 4.0 3.7 6.4 0.9 2.5 2.4 1.3 4.9 5.2 11.0 4.2 3.3 8.4 12.1 3.3 2.4 0.8 8.7 7.3 6.2 0.8 4.7 6.7 1.5 1.8 0.7 5.9 5.2 4.2 6.7 3.8 3.1 8.1 4.2 4.5 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 1.2 1.3 0.8 1.8 1.0 1.2 1.0 1.1 1.0 1.0 0.9 1.0 1.3 3.9 3.2 9.7 20.2 3.7 5.5 9.4 10.2 6.2 49.7 4.8 7.0 14.5 7.2 10.5 20.2 100.1 14.0 2.3 1.5 1.9 4.3 183.2 42.7 11.0 6.7 6.0 5.5 16.6 3.8 7.7 10.7 5.1 4.8 4.5 42.7 4.2 3.8 3.6 16.8 19.0 2.5 14.2 1.2 3.6 293.1 20.8 2.3 8.8 4.7 2.0 42.4 2.1 11.1 33.0 1.3 0.3 16.6 4.0 4.7 0.0 13.0 47.1 417.2 0.0 14.2 9.0 98.0 39.3 5.3 4.1 11.1 3.6 16.4 3.5 3.4 ZNF282 HUB1 ENSG00000170265 "Zinc finger protein 282" Q9UDV7 7 149195546-149226238 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 31.6;Late spermatids: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024374 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024374: AB_1851322" "unprognostic (1.79e-1)" "unprognostic (6.97e-2)" "unprognostic (1.19e-3)" "unprognostic (5.23e-3)" "unprognostic (3.11e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (2.73e-1)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" 9.8 10.2 7.4 6.7 7.0 11.1 11.1 9.4 9.1 13.8 4.7 13.0 10.0 14.4 2.5 15.7 12.5 6.1 10.9 6.9 6.4 10.3 13.2 8.8 6.9 7.3 7.0 6.5 14.1 17.1 6.8 10.0 8.1 7.4 18.5 4.0 3.8 12.8 7.1 17.0 17.0 10.9 5.8 6.2 12.7 12.6 5.3 6.8 7.3 11.5 9.2 4.7 14.1 12.2 7.9 20.6 20.3 11.5 27.7 10.0 11.6 17.0 18.4 13.4 15.8 15.7 18.8 21.9 20.7 27.1 11.6 14.0 22.2 13.6 17.6 6.0 31.3 49.1 17.2 13.1 16.0 15.0 22.0 18.8 13.6 23.4 15.2 16.5 11.9 16.7 13.6 33.8 15.6 8.6 24.6 46.4 33.0 37.3 12.0 25.3 29.9 11.2 28.8 8.7 19.6 26.1 25.1 20.3 24.2 16.9 6.1 15.6 21.3 20.9 22.5 5.1 27.2 27.0 22.4 14.4 15.5 18.8 19.0 19.7 0.0 0.5 1.1 0.5 0.5 0.6 0.2 0.7 0.6 0.3 1.7 0.3 0.4 0.5 0.6 0.6 0.7 1.0 0.3 7.4 7.0 9.4 9.1 6.9 6.4 7.3 7.0 6.5 7.4 6.2 6.8 7.9 8.2 3.2 4.5 5.2 3.9 7.1 2.7 4.7 5.2 11.4 9.0 8.3 4.8 7.2 3.6 1.8 4.2 11.7 3.8 10.2 0.0 4.9 31.6 7.0 6.2 6.8 13.1 3.0 6.1 4.4 5.4 5.4 4.6 9.3 5.7 13.3 7.5 8.7 6.0 15.2 6.7 11.5 2.0 6.8 2.7 32.6 6.2 4.5 1.8 9.4 4.2 6.9 3.1 6.0 9.3 6.3 11.9 5.7 4.4 4.9 9.9 3.2 2.9 7.7 13.1 7.5 6.3 11.8 1.3 6.0 6.5 5.1 5.3 9.6 10.1 4.4 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996609-33097202 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 857.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2700000 Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142" "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favorable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 22.2 36.4 11.8 28.0 12.3 22.1 20.7 12.1 14.9 33.7 14.9 43.9 43.3 22.1 104.5 15.5 28.5 32.3 15.6 12.2 14.2 46.4 48.6 43.1 26.0 13.3 12.4 11.9 21.6 31.1 59.9 18.6 54.2 14.0 23.4 46.1 15.1 25.5 29.6 7.7 15.2 31.3 30.9 12.8 24.6 35.8 13.7 13.1 17.6 53.3 10.8 23.2 32.1 16.3 13.9 37.4 63.6 39.8 48.3 241.9 123.7 857.2 59.1 157.6 73.7 95.1 91.3 86.5 17.9 50.9 120.9 53.9 35.1 38.1 75.5 53.7 104.9 33.0 69.9 35.3 47.4 124.3 50.5 69.9 144.9 70.2 67.0 39.2 144.1 116.5 24.7 64.3 67.0 81.8 44.6 29.6 31.6 26.4 78.0 27.0 24.7 26.4 86.6 78.4 54.4 12.0 40.3 75.0 120.2 74.4 69.3 80.3 130.2 67.7 46.8 32.2 65.2 50.1 53.2 87.9 5.9 99.6 71.2 36.7 43.9 146.2 86.4 29.2 125.8 40.4 37.9 34.3 31.8 166.5 35.6 17.9 21.8 56.6 26.0 92.1 35.1 77.1 91.9 11.8 12.3 12.1 14.9 12.2 14.2 13.3 12.4 11.9 14.0 12.8 13.1 13.9 8.7 19.2 25.3 39.2 18.6 6.0 13.6 60.1 10.8 11.3 11.5 7.5 9.1 34.3 43.3 27.6 6.2 100.1 14.1 41.9 27.4 53.5 24.8 18.7 16.0 17.4 16.9 20.6 46.7 35.4 55.3 29.2 26.0 27.1 26.6 20.6 19.6 39.7 79.5 5.0 46.0 23.5 40.7 43.9 13.9 5.0 15.2 41.7 14.2 23.4 64.6 16.5 10.3 27.2 24.2 28.1 43.4 21.1 19.8 9.9 36.2 33.1 31.0 16.2 13.1 12.9 16.3 1.0 6.6 10.1 3.4 49.1 18.7 51.0 32.0 12.1 GON7 C14orf142 ENSG00000170270 "GON7 subunit of KEOPS complex" Q9BXV9 14 93202894-93207065 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 68.4;Endometrial ciliated cells: 187.5;Proximal tubular cells: 51.8;Respiratory ciliated cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051832 Approved Supported "Nucleoplasm,Nucleoli rim" NA NA 41000 "Nucleoplasm, Nucleoli rim" "HPA051832: AB_2681628" "unprognostic (2.28e-2)" "unprognostic (1.96e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.53e-5)" "unprognostic (3.40e-3)" "unprognostic (8.82e-2)" "unprognostic (1.45e-3)" "unprognostic (2.47e-3)" "unprognostic (7.37e-2)" "prognostic favorable (3.08e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-1)" "unprognostic (2.67e-1)" "unprognostic (2.77e-1)" 6.6 13.3 10.5 5.9 9.3 0.4 8.4 9.3 11.6 12.2 14.8 14.0 13.3 5.5 23.5 6.8 35.7 7.2 12.3 9.5 11.9 15.3 13.0 8.9 1.9 10.2 9.8 8.9 5.6 10.5 12.7 12.9 5.6 9.8 8.0 12.2 13.6 8.0 5.8 13.5 4.7 10.3 5.3 9.3 8.9 9.1 8.8 9.5 3.8 8.8 13.0 10.0 7.0 5.7 9.6 11.6 9.2 13.3 8.9 9.2 21.4 9.3 11.0 6.2 21.6 17.5 9.1 18.1 4.7 7.2 7.0 12.6 18.2 18.3 9.2 25.1 0.1 0.0 4.6 22.5 22.6 4.7 9.7 19.6 4.1 11.9 15.1 9.7 6.0 13.3 5.5 16.7 1.5 9.3 26.8 11.3 23.4 3.4 49.6 4.3 20.0 12.9 21.4 23.4 12.9 15.8 19.8 8.2 20.4 24.8 11.8 16.8 19.9 13.6 7.6 15.1 16.5 6.2 10.0 29.6 3.1 23.2 10.8 13.2 6.2 0.9 0.4 0.8 1.7 0.1 0.0 0.5 0.6 1.5 0.7 0.2 0.4 0.9 0.3 0.8 0.2 0.8 0.5 10.5 9.3 9.3 11.6 9.5 11.9 10.2 9.8 8.9 9.8 9.3 9.5 9.6 17.2 6.4 13.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 19.7 23.9 0.0 0.0 9.9 14.7 0.0 19.6 12.7 0.0 68.4 27.7 0.0 187.5 15.8 7.3 0.0 0.0 0.0 21.7 18.1 5.8 0.0 27.4 10.1 9.4 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 17.5 0.0 0.0 1.4 0.0 0.0 51.8 94.7 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 7.7 7.0 21.3 0.0 0.0 FAXDC2 "C5orf4, FLJ13758" ENSG00000170271 "Fatty acid hydroxylase domain containing 2" Q96IV6 5 154818492-154859252 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 307.4" "Cell type enhanced" "Detected in many" "Astrocytes: 58.8;Erythroid cells: 93.5;Oligodendrocytes: 164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.8;ASC TERT1: 26.3;HSkMC: 23.2;hTERT-RPE1: 25.3;SK-MEL-30: 24.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.38e-3)" "unprognostic (2.88e-2)" "unprognostic (6.26e-2)" "unprognostic (5.11e-2)" "unprognostic (3.12e-2)" "unprognostic (2.70e-2)" "prognostic favorable (3.87e-5)" "unprognostic (8.29e-2)" "unprognostic (2.52e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (3.42e-2)" "prognostic favorable (9.71e-10)" "unprognostic (1.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.07e-3)" "unprognostic (3.94e-1)" 35.1 37.9 47.3 5.9 72.8 34.6 27.3 70.5 57.5 24.5 59.3 35.4 8.9 35.1 56.2 17.1 37.7 30.7 34.3 45.8 54.3 25.6 140.8 37.0 7.4 74.6 70.2 37.6 59.9 15.2 307.4 12.2 12.7 69.9 28.3 17.9 10.3 40.9 31.3 12.6 21.8 16.3 38.1 62.3 13.4 17.8 12.2 63.1 6.0 37.0 24.5 4.1 19.7 17.3 100.5 1.6 1.3 5.0 10.5 34.8 26.3 3.9 3.7 10.5 1.4 6.4 1.3 13.5 1.9 2.2 5.8 0.3 1.3 0.1 1.7 1.3 1.1 1.7 20.5 3.5 7.4 5.1 2.6 1.7 23.2 6.6 3.3 0.8 25.3 7.9 1.4 11.8 0.3 8.8 0.5 1.5 3.9 2.4 5.0 0.4 1.6 3.3 0.7 2.3 1.4 0.5 9.0 1.6 0.9 24.6 10.6 0.6 0.6 2.8 3.6 2.2 1.5 1.1 1.5 1.1 1.3 5.0 1.5 2.2 3.5 0.8 1.3 0.4 0.6 0.4 0.4 0.5 0.4 1.1 1.1 0.4 0.6 4.2 2.4 0.5 0.6 0.3 6.6 47.3 72.8 70.5 57.5 45.8 54.3 74.6 70.2 37.6 69.9 62.3 63.1 100.5 14.3 41.7 11.8 58.8 1.3 2.9 12.3 2.0 7.4 1.6 7.1 8.8 17.8 12.8 6.8 9.2 0.0 4.2 0.3 4.0 9.8 3.4 12.9 6.9 14.9 14.3 3.0 93.5 5.5 0.7 0.4 22.6 2.0 1.9 6.3 14.5 21.8 44.3 2.1 3.3 4.7 29.8 2.0 11.6 9.1 11.2 47.2 17.0 5.4 37.5 2.6 46.8 3.1 51.3 164.8 12.8 5.5 50.8 0.2 4.0 4.2 2.9 15.0 1.8 0.0 24.5 9.4 2.5 0.8 0.7 3.7 1.4 1.9 11.9 1.2 3.8 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33114014-33147773 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 377.6" "Group enriched" "Detected in all" 5 "dendritic cells: 306.9;monocytes: 377.6" "Cell line enhanced" "Detected in all" "ASC diff: 795.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" NA NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 155.8 107.4 64.9 39.1 65.4 43.6 125.0 54.9 54.5 193.8 57.7 118.0 35.3 171.5 57.6 59.2 139.5 81.2 71.1 51.5 67.8 67.5 45.0 93.1 37.6 69.2 62.9 44.7 132.5 36.3 46.1 22.9 70.5 63.6 91.5 52.1 19.5 54.5 107.5 54.8 81.3 66.1 116.0 68.4 48.5 79.5 25.2 79.2 23.9 77.9 69.5 38.4 143.9 137.0 65.5 64.1 123.3 37.8 119.2 795.0 516.6 219.0 136.1 294.0 160.6 151.9 42.1 35.1 44.4 147.6 259.3 129.9 80.2 68.0 103.9 115.5 110.1 106.0 69.2 87.6 43.7 237.4 45.4 54.8 415.3 208.5 145.0 183.2 311.7 172.0 27.0 60.3 82.1 164.6 54.7 16.5 46.3 45.5 67.5 165.7 59.4 111.0 86.1 127.8 42.0 7.9 61.0 92.0 79.8 201.1 87.3 85.9 109.3 113.0 209.1 89.1 115.4 145.9 59.0 214.3 6.7 164.3 89.7 117.1 13.4 377.6 28.5 35.8 147.7 52.5 39.9 51.4 40.2 306.9 39.2 29.2 27.8 30.5 42.1 46.0 82.5 74.0 200.5 64.9 65.4 54.9 54.5 51.5 67.8 69.2 62.9 44.7 63.6 68.4 79.2 65.5 74.0 9.6 42.8 15.3 29.0 60.4 41.1 39.5 150.8 17.9 32.7 43.7 34.7 25.8 22.0 38.6 8.4 49.0 37.1 14.8 11.7 25.0 1.2 17.4 135.7 72.7 6.0 46.0 10.0 32.0 81.6 142.3 29.0 31.2 48.1 58.4 122.4 53.2 107.0 35.3 14.5 26.0 10.2 181.1 91.1 6.3 142.9 108.6 80.0 10.3 134.1 15.9 22.6 17.1 11.6 18.4 16.3 144.8 58.1 24.5 24.4 52.7 6.8 10.1 111.7 78.4 120.9 1.6 15.9 95.1 46.7 28.0 26.5 89.9 36.1 30.0 HSPB2 "Hs.78846, MKBP" ENSG00000170276 "Heat shock protein family B (small) member 2" Q16082 11 111912734-111914093 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 154.6;skeletal muscle: 253.7;tongue: 319.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.7;Fibroblasts: 39.1;Leydig cells: 43.5;Melanocytes: 37.4;Smooth muscle cells: 39.8" "Cancer enhanced" "Detected in many" "melanoma: 5.1;renal cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 48.4;ASC TERT1: 23.4;fHDF/TERT166: 59.7;HSkMC: 23.3;LHCN-M2: 35.2;U-138 MG: 31.5" HPA079414 Approved NA NA "HPA079414: " "unprognostic (5.46e-2)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.69e-3)" "unprognostic (6.82e-2)" "unprognostic (1.51e-2)" "unprognostic (4.37e-2)" "unprognostic (3.25e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-2)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.69e-3)" "unprognostic (2.63e-1)" "unprognostic (1.99e-1)" "unprognostic (1.46e-2)" 40.2 5.3 23.9 4.4 24.4 0.0 21.7 33.8 32.7 25.5 21.9 16.6 3.4 25.2 5.8 15.5 22.4 18.6 154.6 22.5 25.0 13.4 2.3 17.5 5.5 25.6 24.4 19.9 14.1 1.4 1.4 3.8 12.3 23.8 13.2 4.1 1.8 7.2 13.1 253.7 12.9 9.2 19.3 24.1 7.4 9.7 2.4 25.1 1.4 9.7 319.7 2.1 16.3 19.2 24.4 0.0 0.0 0.0 7.0 48.4 23.4 0.2 5.6 0.0 0.0 0.3 0.0 0.0 0.0 0.5 59.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 23.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 35.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.2 31.5 3.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 24.4 33.8 32.7 22.5 25.0 25.6 24.4 19.9 23.8 24.1 25.1 24.4 8.5 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.2 0.4 5.1 16.4 115.7 1.5 0.6 1.8 0.0 0.8 0.1 0.0 1.9 0.4 0.1 0.1 7.9 3.5 0.0 0.0 0.0 0.0 0.7 39.1 0.0 0.2 0.0 0.4 4.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 10.3 1.1 43.5 0.6 37.4 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.3 0.0 23.5 0.0 0.5 13.1 22.8 39.8 0.8 0.6 0.6 5.8 1.5 1.0 0.4 0.0 0.0 C7orf33 ENSG00000170279 "Chromosome 7 open reading frame 33" Q8WU49 7 148590766-148615860 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "retina: 1.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Early spermatids: 1.1;Extravillous trophoblasts: 7.5;Late spermatids: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "SCLC-21H: 2.6" NA NA "unprognostic (4.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 CNGB3 "ACHM1, ACHM3, RMCH" ENSG00000170289 "Cyclic nucleotide gated channel subunit beta 3" Q9NQW8 8 86553977-86743675 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease variant, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.2;retina: 13.2" "Cell type enriched" "Detected in some" 13 "Cone photoreceptor cells: 158.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "SCLC-21H: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA057244 Enhanced NA NA "HPA057244: AB_2683380" "unprognostic (5.35e-1)" "unprognostic (1.68e-3)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (3.62e-2)" "unprognostic (2.58e-1)" "unprognostic (6.25e-2)" "unprognostic (1.18e-1)" "unprognostic (2.91e-1)" "unprognostic (2.17e-1)" "unprognostic (3.82e-1)" "unprognostic (9.28e-2)" "unprognostic (2.77e-4)" "unprognostic (1.40e-4)" "unprognostic (1.66e-2)" "unprognostic (8.76e-2)" "unprognostic (1.84e-1)" 0.0 0.0 0.0 0.3 0.2 4.2 0.0 1.0 0.3 0.1 1.2 0.1 0.5 0.2 0.1 0.0 0.9 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.1 2.0 0.0 0.4 0.6 0.0 0.0 0.1 0.4 0.1 0.0 13.2 0.3 0.0 0.1 1.2 0.1 0.0 0.0 0.1 0.3 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.3 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 1.0 18.9 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.3 0.1 0.1 0.1 2.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 158.4 0.1 1.3 0.0 0.0 0.0 5.6 0.1 0.6 0.2 0.0 0.0 2.4 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 11.4 0.0 0.1 0.0 1.0 0.2 1.5 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.1 1.6 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 8268.8;tongue: 3429.7" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 730.3;Muller glia cells: 462.5;Skeletal myocytes: 225.1" "Group enriched" "Detected in many" 5 "glioma: 21.6;head and neck cancer: 22.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HSkMC: 2.5;Karpas-707: 1.2;PC-3: 1.1;SuSa: 2.5;U-2 OS: 1.1" CAB011628 Approved Microtubules NA NA Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 4.8 8.4 2.6 0.0 3.7 0.0 2.1 4.1 7.9 0.2 1.5 3.3 0.3 0.2 0.8 150.5 0.7 0.3 496.9 2.5 2.2 0.7 0.7 6.4 0.2 1.7 2.3 2.3 0.6 1.8 0.2 0.7 1.3 2.6 37.3 0.1 61.2 59.9 0.3 8268.8 3.9 1.5 1.4 1.6 0.3 0.8 1.3 1.6 2.7 2.0 3429.7 1.0 0.4 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 4.1 7.9 2.5 2.2 1.7 2.3 2.3 2.6 1.6 1.6 2.3 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 2.4 0.0 0.0 730.3 0.0 0.0 0.0 2.1 1.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 10.5 0.0 0.0 0.3 0.4 1.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 1.1 8.8 0.0 1.0 0.0 0.0 0.0 462.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.4 0.0 19.9 0.0 225.1 40.5 0.1 0.0 0.0 1.4 5.7 1.0 0.0 0.0 0.1 ELP5 "C17orf81, DERP6" ENSG00000170291 "Elongator acetyltransferase complex subunit 5" Q8TE02 17 7251416-7259940 "Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 172.9" "Group enriched" "Detected in all" 4 "Early spermatids: 405.3;Late spermatids: 699.6;Spermatocytes: 226.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023279, HPA052411" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023279: AB_1847613, HPA052411: " "unprognostic (3.73e-2)" "unprognostic (9.21e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-3)" "unprognostic (7.72e-2)" "unprognostic (1.22e-1)" "unprognostic (7.70e-2)" "unprognostic (1.53e-1)" "unprognostic (7.83e-3)" "unprognostic (1.60e-2)" "prognostic favorable (2.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.83e-1)" "unprognostic (8.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.62e-1)" "unprognostic (2.30e-2)" 27.9 48.3 22.4 10.1 23.1 14.2 26.9 23.3 24.0 29.4 22.6 35.5 11.6 32.0 12.9 28.1 29.0 9.4 55.9 22.3 22.7 39.8 57.6 22.9 16.8 23.1 22.9 22.0 34.0 28.2 20.1 40.0 10.5 22.8 35.7 10.9 19.1 26.3 11.9 57.8 21.0 31.4 17.9 22.5 35.3 29.2 172.9 22.9 23.1 29.5 78.6 17.0 31.2 25.0 22.9 22.4 61.7 27.3 24.9 46.8 36.8 11.9 19.5 23.1 30.7 28.2 62.0 14.3 44.0 21.1 31.3 53.7 16.4 69.6 46.1 22.0 27.4 98.2 40.7 20.5 57.3 23.2 29.2 15.4 26.2 34.0 21.0 41.1 19.4 26.5 54.9 28.6 11.5 48.4 37.5 74.4 55.4 22.5 23.4 42.5 63.0 30.6 23.9 34.5 20.7 13.3 26.4 38.0 11.5 30.9 27.0 16.3 20.9 30.4 17.6 20.6 34.1 31.7 13.3 19.4 51.8 32.0 28.1 23.3 28.6 30.7 16.1 32.3 37.8 41.0 39.3 28.9 30.1 37.4 39.5 30.2 35.9 5.3 38.7 26.1 45.9 44.7 28.6 22.4 23.1 23.3 24.0 22.3 22.7 23.1 22.9 22.0 22.8 22.5 22.9 22.9 30.4 9.6 11.7 10.7 38.3 22.0 47.7 47.8 27.9 21.5 27.8 36.6 64.3 12.8 39.9 46.0 20.9 36.1 45.1 29.7 97.8 38.3 405.3 20.5 28.1 26.5 41.6 14.1 9.4 13.6 78.1 28.6 9.7 21.5 7.0 30.1 18.2 24.2 41.4 28.6 9.7 37.0 57.0 13.5 28.8 699.6 34.2 22.8 21.4 10.3 29.0 32.7 29.9 10.6 10.5 19.3 32.9 33.1 26.7 73.5 46.9 107.0 23.1 33.6 39.5 27.1 35.9 226.4 40.8 21.0 21.7 57.9 29.9 29.0 46.5 51.6 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370321 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.1" "Cell type enhanced" "Detected in many" "Adipocytes: 94.7;Cytotrophoblasts: 107.6;Granulosa cells: 129.9;Syncytiotrophoblasts: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "BEWO: 208.4;SK-BR-3: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 13.9 13.0 6.0 3.3 6.0 1.2 15.7 5.0 6.4 6.0 6.5 7.0 7.3 4.5 17.6 3.5 8.5 3.5 11.2 5.7 5.0 10.0 41.5 18.0 3.9 6.4 5.5 4.6 1.4 48.1 12.1 3.7 17.6 6.5 11.8 7.4 1.1 19.9 6.0 4.7 9.0 6.2 2.6 5.4 1.3 15.0 1.0 7.0 9.6 13.8 5.2 4.1 4.8 3.8 5.7 10.6 10.8 2.1 13.5 9.5 14.7 208.4 0.1 0.3 1.1 1.2 15.0 14.9 0.0 21.8 0.0 0.0 5.8 17.2 3.5 0.9 0.0 31.5 6.8 2.1 25.2 0.6 2.8 5.3 28.8 10.8 1.5 10.4 5.2 8.4 11.2 0.1 0.0 10.7 7.8 8.9 1.0 4.4 16.4 9.9 12.4 2.5 2.1 13.1 12.1 3.7 3.0 1.7 59.3 5.8 2.5 17.0 1.4 7.6 0.0 15.5 0.0 3.2 0.5 0.4 0.1 0.0 4.8 3.7 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 6.0 6.0 5.0 6.4 5.7 5.0 6.4 5.5 4.6 6.5 5.4 7.0 5.7 94.7 38.5 36.3 1.0 2.8 11.6 35.2 4.6 18.8 0.1 75.4 45.6 2.2 17.2 16.1 0.0 0.0 107.6 2.3 13.7 11.7 18.1 13.0 22.1 5.6 51.9 22.2 5.7 2.2 37.0 67.5 17.7 32.1 29.2 0.0 129.9 54.7 79.5 9.8 0.0 41.6 40.7 16.2 5.3 15.0 2.4 2.5 3.6 5.4 36.5 1.2 35.6 0.0 17.6 1.0 25.8 17.7 1.2 1.4 64.9 21.3 24.3 9.9 2.7 0.0 2.2 12.3 3.5 3.7 12.1 6.5 116.2 18.6 10.9 21.0 49.7 GABARAP "ATG8A, MM46" ENSG00000170296 "GABA type A receptor-associated protein" O95166 17 7240008-7242449 "Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 498.6;Ductal cells: 462.5;Plasma cells: 482.6;Squamous epithelial cells: 457.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065883 Approved Vesicles NA NA Vesicles "HPA065883: AB_2685574" "unprognostic (2.58e-1)" "unprognostic (4.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.08e-2)" "unprognostic (1.19e-1)" "unprognostic (4.30e-2)" "unprognostic (1.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "prognostic favorable (9.52e-5)" "unprognostic (1.85e-1)" "unprognostic (1.45e-2)" "unprognostic (2.09e-1)" "unprognostic (2.85e-2)" "unprognostic (1.22e-2)" "unprognostic (1.58e-1)" 612.9 855.2 778.7 347.8 796.0 483.1 616.1 829.6 1100.5 662.6 781.1 573.2 295.0 553.5 580.0 483.2 566.1 305.5 719.9 753.1 812.3 704.8 630.3 574.7 311.1 821.9 787.7 742.7 757.4 738.4 667.7 858.3 304.7 826.1 609.7 376.0 283.1 597.1 389.1 1009.3 650.9 501.0 344.4 831.8 656.9 664.3 609.2 797.1 392.8 556.8 924.5 414.4 538.6 552.1 874.4 233.5 342.1 598.0 404.5 887.1 999.5 227.0 377.1 645.5 330.1 491.2 141.9 200.6 233.9 233.2 672.0 430.6 206.9 428.1 329.7 441.7 421.8 474.4 182.8 301.3 377.3 858.3 118.7 369.6 1016.1 445.4 424.5 378.9 925.6 623.7 350.0 143.6 256.8 577.5 159.4 288.4 267.6 242.0 420.9 329.1 393.8 273.3 318.8 682.9 240.9 262.8 695.8 284.1 262.5 409.4 439.3 333.4 228.4 563.7 363.6 211.1 357.7 314.8 280.6 294.2 152.6 586.1 296.2 383.5 2968.2 4092.7 3746.6 766.9 3665.8 796.1 1262.2 906.3 810.4 3152.3 1156.6 812.9 765.5 7095.7 734.6 3213.5 2410.2 1132.5 4745.4 778.7 796.0 829.6 1100.5 753.1 812.3 821.9 787.7 742.7 826.1 831.8 797.1 874.4 24.0 89.8 120.1 44.4 183.6 20.8 3.9 21.3 498.6 2.4 64.1 31.9 0.5 54.3 81.3 27.6 0.0 24.3 35.8 302.0 43.0 462.5 24.1 25.5 32.4 61.5 396.5 179.3 36.7 309.6 31.1 124.2 264.6 24.8 150.0 6.9 45.0 39.9 78.2 1.7 37.7 314.3 34.6 147.0 60.8 71.3 21.1 397.4 33.8 43.1 399.2 15.1 32.0 21.1 87.8 375.2 374.3 13.9 482.6 6.0 384.7 72.0 166.4 3.0 6.6 5.2 74.2 22.1 5.8 457.2 23.2 52.9 105.2 5.2 237.1 4.9 LGALS9B ENSG00000170298 "Galectin 9B" Q3B8N2 17 20449395-20467539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.5;intestine: 11.2;stomach 1: 31.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 17.7;Gastric mucus-secreting cells: 109.1;Intestinal goblet cells: 32.6;NK-cells: 28.8;Paneth cells: 42.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 17 "NK-cell: 12.7" "Lineage enriched" "Detected in single" 17 "NK-cells: 12.7" "Group enriched" "Detected in some" 7 "CAPAN-2: 8.5;U-937: 2.8" "HPA046876, HPA047218" Approved Uncertain Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.69e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.05e-1)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (3.93e-3)" "unprognostic (2.72e-1)" "unprognostic (2.26e-2)" "unprognostic (6.85e-2)" "unprognostic (1.32e-2)" "unprognostic (3.20e-1)" "unprognostic (3.79e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (5.27e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.7 0.0 7.6 3.3 0.0 0.0 15.5 0.0 7.5 0.0 0.1 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 11.2 0.0 2.2 0.0 0.0 0.5 3.4 0.3 0.0 0.6 31.2 0.1 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.3 0.1 12.7 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 2.3 0.3 1.1 0.6 0.0 0.0 0.0 0.1 1.5 2.2 0.0 0.0 0.0 9.9 17.7 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 109.1 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 32.6 2.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 28.8 0.0 0.0 0.6 42.3 0.0 1.2 0.2 7.7 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 2.1 0.0 6.6 0.3 STX8 CARB ENSG00000170310 "Syntaxin 8" Q9UNK0 17 9250471-9576591 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 261.6;Late spermatids: 964.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001540 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA001540: AB_1080168" "unprognostic (8.68e-2)" "unprognostic (2.29e-2)" "unprognostic (2.53e-1)" "unprognostic (4.14e-3)" "unprognostic (3.36e-1)" "unprognostic (1.58e-2)" "unprognostic (6.91e-2)" "unprognostic (1.19e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (1.86e-3)" "unprognostic (2.54e-1)" "unprognostic (1.45e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" 48.3 43.3 51.3 21.9 51.9 43.3 46.0 52.7 73.5 44.1 53.8 51.0 23.3 41.8 64.8 35.8 39.1 28.8 54.4 51.6 53.1 46.7 48.3 35.7 33.1 52.9 51.3 50.2 42.9 45.6 43.2 33.9 29.3 53.1 40.5 39.1 32.5 43.1 41.4 64.5 39.9 34.3 42.8 52.5 36.0 43.7 76.8 52.2 43.9 43.2 62.1 39.8 49.0 42.3 54.5 35.1 65.9 54.6 28.9 86.2 107.7 24.6 40.3 69.4 55.6 73.5 22.5 27.6 42.3 34.6 79.7 48.0 37.7 35.5 76.6 86.2 66.6 59.2 26.7 19.0 52.5 117.4 20.3 47.1 87.9 120.9 43.8 65.7 66.5 67.2 44.8 13.2 18.8 62.5 18.5 39.9 41.6 14.2 41.5 34.2 56.2 46.6 25.9 71.8 32.6 7.3 34.7 30.8 16.3 48.2 73.8 21.3 32.3 61.0 42.8 26.6 24.5 54.3 17.5 17.3 16.3 64.1 47.4 39.6 117.0 142.5 159.3 124.3 128.0 113.5 117.0 133.3 139.5 142.6 108.8 85.6 100.7 40.9 167.4 132.6 123.1 198.8 197.8 51.3 51.9 52.7 73.5 51.6 53.1 52.9 51.3 50.2 53.1 52.5 52.2 54.5 39.2 32.1 27.0 65.3 37.0 45.8 52.8 83.8 23.3 15.2 32.8 36.2 61.5 31.5 58.5 29.5 12.5 55.9 49.8 34.6 103.7 62.3 261.6 31.4 33.2 33.9 25.0 25.2 79.7 82.8 55.3 49.3 23.0 27.7 54.5 33.5 29.3 38.6 87.1 6.7 63.0 41.2 85.5 46.3 84.0 964.1 46.3 43.6 78.2 89.9 70.4 58.4 107.1 91.0 86.9 69.9 58.1 47.4 23.5 23.8 66.2 93.5 45.0 24.3 13.1 33.9 59.7 58.6 23.8 29.4 44.6 43.4 54.2 20.1 31.2 38.7 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.6;lymphoid tissue: 74.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 3.2;T-reg: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003387, CAB003799, CAB079974" Enhanced Supported Nucleoplasm,Cytosol NA Yes 51000 "Nucleoplasm, Cytosol" "CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 3.9 1.8 1.0 17.2 1.0 53.6 7.4 0.9 1.5 5.2 1.0 17.7 16.5 7.1 12.3 17.7 3.7 4.3 1.3 0.9 1.3 3.2 3.2 4.7 40.9 1.2 1.1 0.8 2.3 0.8 2.5 4.1 19.6 1.0 1.8 21.0 1.3 3.2 5.3 1.4 13.3 14.6 8.0 0.9 9.1 10.2 25.4 1.3 74.7 3.7 2.2 47.9 7.1 6.9 2.1 249.9 93.5 241.1 96.0 15.4 23.6 99.0 183.8 132.7 218.8 209.0 218.9 213.7 226.2 69.6 50.6 79.6 149.9 166.2 106.8 225.8 162.3 121.1 119.4 84.4 128.1 2.8 184.5 117.6 4.7 10.4 142.1 137.0 49.6 133.3 146.2 185.1 270.3 246.9 66.3 234.0 131.1 106.6 149.3 193.1 199.7 224.5 111.3 84.3 81.4 112.7 98.7 123.5 184.9 96.3 130.0 199.9 111.5 55.4 92.8 197.9 99.1 255.8 104.9 180.8 205.6 79.9 203.5 117.6 0.0 0.0 0.0 0.3 0.1 0.2 0.5 0.7 1.3 0.3 0.4 0.2 0.7 0.0 3.2 0.1 0.9 3.4 0.9 1.0 1.0 0.9 1.5 0.9 1.3 1.2 1.1 0.8 1.0 0.9 1.3 2.1 7.7 0.0 3.2 0.3 7.1 39.8 5.4 29.9 2.8 1.1 5.3 6.1 0.8 0.0 10.2 18.4 0.0 80.9 3.6 8.9 3.9 0.8 18.7 10.8 6.2 10.5 3.0 209.6 0.4 0.0 144.6 13.3 13.3 9.4 0.0 51.5 7.5 1.3 57.2 0.0 0.2 14.6 30.5 20.5 18.1 10.4 2.1 16.5 1.8 1.9 1.0 1.0 3.1 0.0 0.1 0.4 0.7 0.7 32.1 4.3 2.2 3.0 17.6 0.7 0.0 0.5 24.6 110.0 39.6 33.8 18.6 22.0 10.3 2.1 26.6 10.4 UBB "FLJ25987, MGC8385" ENSG00000170315 "Ubiquitin B" P0CG47 17 16380798-16382745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013048, HPA041344, HPA049132" Supported NA NA "CAB013048: AB_2533002, HPA041344: AB_2677422, HPA049132: AB_2680646" "unprognostic (1.16e-1)" "unprognostic (2.98e-1)" "unprognostic (2.55e-1)" "unprognostic (7.34e-2)" "unprognostic (3.86e-1)" "unprognostic (9.32e-2)" "unprognostic (1.29e-3)" "unprognostic (2.48e-2)" "unprognostic (5.81e-2)" "unprognostic (2.15e-3)" "unprognostic (2.88e-2)" "unprognostic (1.45e-2)" "prognostic favorable (1.07e-4)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 844.2 1690.5 1540.5 680.8 1507.2 2397.2 777.0 1594.9 1979.8 819.7 1564.3 1064.4 1190.3 795.5 1379.0 661.5 662.5 820.2 1683.9 1613.5 1594.0 1600.2 3006.6 1055.3 1010.9 1624.8 1595.6 1428.5 732.3 1316.3 1691.3 1384.5 1020.7 1622.0 814.9 1108.3 570.9 1305.9 869.9 2682.1 680.2 1143.4 940.4 1644.9 1087.5 1255.8 1604.2 1602.2 1238.2 1192.3 2181.2 1001.1 982.9 694.9 1919.3 1646.5 3022.4 1559.8 1912.1 1530.0 963.9 1131.3 1609.5 2166.2 2855.8 2453.4 2916.5 1270.4 1662.3 2631.3 1916.6 1678.5 1295.4 0.8 1054.2 3076.0 2126.4 2231.3 1649.8 1653.1 2183.7 1022.3 6.6 2162.4 1468.9 1010.2 2183.4 848.2 1486.0 1582.3 1562.2 1888.9 1530.9 1743.0 3858.5 2354.7 2086.6 1288.4 4642.0 1177.2 2185.1 1984.7 1484.1 2312.8 1911.4 1179.0 1757.0 2109.6 1239.7 1454.4 3025.5 1392.6 1936.0 1152.7 1417.8 867.8 1087.6 2507.7 845.7 1238.7 1366.4 1688.3 1757.9 1356.3 5348.4 1684.4 3262.9 2632.2 2121.6 2131.1 3065.4 2048.1 2372.7 1501.1 2872.4 1787.4 2146.5 981.5 3290.2 1875.7 2799.7 2592.8 7841.1 1540.5 1507.2 1594.9 1979.8 1613.5 1594.0 1624.8 1595.6 1428.5 1622.0 1644.9 1602.2 1919.3 1607.0 1003.2 1168.4 46.7 786.3 979.5 1548.2 1890.9 796.2 426.2 763.6 1161.1 370.3 948.0 1262.5 551.8 120.9 1661.1 1082.7 1377.9 1829.3 1114.8 3648.2 961.6 510.0 870.9 922.4 4506.0 29.1 880.2 996.8 1202.3 1270.6 799.9 1800.7 412.4 669.3 1509.8 1168.9 233.9 37.3 1351.2 1310.2 589.0 1180.7 2126.9 592.4 826.6 1812.5 50.6 1001.9 912.0 1051.5 30.7 133.6 751.3 1879.5 775.2 700.4 974.6 1970.0 3101.7 2080.6 506.8 880.9 714.4 3554.9 3297.7 1090.7 739.1 1112.3 1815.4 1231.6 935.0 993.8 1036.2 NFRKB "DKFZp547B2013, INO80G" ENSG00000170322 "Nuclear factor related to kappaB binding protein" Q6P4R8 11 129863636-129895590 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007082, HPA007128" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA007082: AB_1079481, HPA007128: AB_1079482" "unprognostic (1.22e-1)" "unprognostic (3.42e-2)" "unprognostic (2.12e-1)" "unprognostic (9.41e-2)" "unprognostic (6.56e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (6.36e-3)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (2.00e-1)" "unprognostic (5.31e-2)" "unprognostic (9.22e-2)" "unprognostic (4.15e-2)" "unprognostic (6.57e-2)" "unprognostic (7.14e-2)" "unprognostic (3.93e-2)" 9.4 9.1 7.1 10.9 9.0 22.9 11.1 9.6 7.1 14.8 8.2 11.4 13.2 15.7 17.7 13.3 18.1 10.0 7.5 8.1 6.0 10.6 11.9 10.9 14.6 5.6 5.8 6.6 20.8 14.0 10.5 11.8 13.2 7.1 12.5 10.2 9.9 14.4 13.5 15.6 22.1 12.6 13.6 4.5 11.3 11.3 20.5 6.7 15.2 20.2 9.8 13.5 12.7 13.9 6.6 17.9 16.8 37.4 20.3 15.6 15.4 23.5 12.2 11.0 14.2 13.9 52.6 30.1 42.6 32.5 9.4 20.8 44.8 36.5 23.8 13.2 16.9 31.9 84.2 32.8 22.2 11.4 21.7 27.3 9.9 25.9 23.3 24.3 16.3 24.9 28.1 49.9 31.5 14.4 16.2 18.6 37.1 19.1 26.2 39.1 27.2 16.3 19.6 17.7 55.6 19.0 20.0 27.4 26.7 7.3 27.5 62.3 19.9 19.7 21.1 20.6 15.6 15.4 10.0 13.3 39.0 8.8 41.9 18.5 6.6 5.1 6.3 6.0 5.8 6.3 3.3 6.1 5.1 5.1 3.9 5.0 4.2 6.0 2.4 5.2 4.5 4.4 4.5 7.1 9.0 9.6 7.1 8.1 6.0 5.6 5.8 6.6 7.1 4.5 6.7 6.6 6.2 9.6 15.0 17.0 10.0 29.3 16.8 17.5 18.8 10.2 12.1 10.0 7.6 20.0 17.0 7.3 10.4 19.2 7.8 9.5 7.9 11.9 14.8 12.9 14.4 9.5 8.5 9.4 13.1 10.0 15.6 9.7 6.1 17.8 10.8 14.1 8.9 10.9 10.4 8.4 10.7 9.7 8.2 7.7 6.2 7.1 14.6 8.4 14.2 9.4 12.4 9.7 12.3 12.1 7.7 10.9 8.0 10.5 10.5 15.4 15.6 8.1 12.9 11.1 32.9 10.8 14.2 43.0 49.0 10.7 35.2 23.3 13.1 9.4 12.2 17.9 FABP4 "A-FABP, aP2" ENSG00000170323 "Fatty acid binding protein 4" P15090 8 81478419-81483236 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 3821.0;breast: 2214.1" "Cell type enriched" "Detected in many" 17 "Adipocytes: 24359.7" "Group enriched" "Detected in all" 7 "breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 171 "ASC diff: 4051.5;RT4: 2107.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA002188, CAB024961" Enhanced NA NA 22000000 "CAB024961: , HPA002188: AB_1078822" "unprognostic (4.81e-2)" "unprognostic (2.30e-3)" "unprognostic (1.64e-3)" "unprognostic (2.63e-2)" "unprognostic (2.58e-1)" "unprognostic (8.70e-3)" "unprognostic (1.78e-3)" "unprognostic (1.67e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" "unprognostic (8.76e-2)" "unprognostic (1.13e-3)" "unprognostic (4.48e-2)" "unprognostic (2.26e-2)" "unprognostic (1.39e-1)" 3821.0 42.6 0.8 47.1 0.9 2.8 2214.1 0.9 1.6 10.0 29.3 53.4 2.8 4.7 0.6 15.3 11.0 68.8 93.4 1.2 0.9 7.0 5.2 114.5 13.7 0.9 0.8 0.7 4.2 16.7 59.6 1.5 188.5 0.9 4.3 33.8 2.6 59.2 5.1 67.2 57.7 45.1 14.3 0.8 6.7 26.7 1.1 3.1 30.1 83.7 168.2 2.0 245.2 19.1 0.9 0.0 0.0 0.0 0.0 4051.5 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 17.9 0.0 0.1 1.3 0.0 0.4 0.0 0.0 2.0 0.7 0.0 0.0 0.0 0.8 1.2 0.1 3.0 0.0 9.4 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 2107.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.2 5.7 0.0 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.9 1.6 1.2 0.9 0.9 0.8 0.7 0.9 0.8 3.1 0.9 24359.7 35.3 64.3 0.0 19.4 14.4 1.1 0.9 4.6 0.5 71.7 196.2 42.1 0.0 26.7 0.0 0.0 0.5 73.6 0.0 0.0 0.2 1.6 0.4 8.8 1132.7 0.0 0.0 0.0 5.6 0.7 53.1 1.1 0.2 27.8 0.1 23.2 0.4 114.2 0.0 0.0 0.0 0.0 50.4 15.7 10.9 1.5 192.7 16.0 0.0 0.6 0.9 0.0 0.0 0.0 0.2 2.2 1.2 2.7 0.5 0.0 0.3 21.9 2.4 716.6 62.2 1364.8 0.0 0.1 1.2 13.9 0.7 18.7 2.3 0.0 55.3 FRMPD2 "MGC35285, PDZD5C, PDZK5C" ENSG00000170324 "FERM and PDZ domain containing 2" Q68DX3 10 48153088-48274696 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 25.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 50.0;Cone photoreceptor cells: 287.7;Early spermatids: 97.7;Endometrial ciliated cells: 70.6;Late spermatids: 118.5;Respiratory ciliated cells: 62.9;Rod photoreceptor cells: 90.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HBEC3-KT: 1.0;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.53e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-4)" "unprognostic (7.59e-2)" "unprognostic (2.37e-1)" "unprognostic (2.06e-1)" "unprognostic (6.54e-3)" "unprognostic (1.85e-1)" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (3.25e-12)" "unprognostic (3.48e-2)" "unprognostic (5.43e-2)" "unprognostic (1.54e-1)" "unprognostic (7.43e-5)" 0.0 0.0 5.4 0.0 1.9 0.0 0.4 3.9 1.9 0.2 4.5 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.9 1.8 4.9 0.1 0.0 0.2 0.0 4.4 5.0 0.8 0.0 0.0 0.0 0.1 0.0 4.2 0.3 0.1 25.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.3 3.1 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.9 3.9 1.9 1.8 4.9 4.4 5.0 0.8 4.2 4.8 3.1 3.5 0.0 0.0 0.5 36.6 0.0 0.1 0.4 1.6 0.0 50.0 1.1 0.4 5.0 0.0 4.6 3.7 287.7 0.2 0.0 0.1 0.0 0.1 97.7 70.6 0.5 0.3 3.0 0.0 2.0 0.0 0.3 0.8 0.0 1.6 0.0 0.0 0.0 0.2 0.1 3.3 0.9 0.6 6.1 0.0 0.0 118.5 0.3 0.2 0.0 0.0 0.0 5.2 0.0 0.5 0.3 0.2 0.1 0.4 0.0 0.4 4.2 0.5 62.9 90.8 0.0 0.2 0.6 2.1 1.0 0.0 0.3 0.0 0.1 0.1 0.7 0.4 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026997, HPA061749" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681, HPA061749: " "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 2.7 2.4 2.1 3.2 2.4 8.0 4.3 6.6 3.0 3.0 2.6 3.5 3.4 3.1 3.3 4.1 2.6 2.8 1.9 2.4 2.4 2.2 3.5 3.1 3.9 1.6 1.9 1.8 3.4 3.2 3.5 4.6 2.7 3.3 3.4 4.0 4.8 3.2 2.6 6.8 6.3 3.7 2.5 0.6 3.1 4.0 2.4 2.4 6.8 3.0 3.9 4.0 2.6 3.4 3.8 4.7 6.1 7.7 5.1 3.4 4.1 5.1 3.9 5.0 3.2 4.1 6.2 4.8 17.8 4.5 4.6 4.4 6.1 6.4 3.2 5.2 6.6 5.5 12.3 7.5 5.0 2.2 10.9 44.8 2.9 7.1 4.8 3.1 4.9 5.7 5.0 7.0 6.6 4.7 5.2 6.7 5.7 5.9 6.3 4.4 6.5 4.8 2.9 4.7 8.0 8.3 4.3 5.7 6.4 1.7 4.3 4.5 4.8 5.7 7.2 3.4 3.8 5.1 1.7 3.0 25.1 3.2 6.1 5.9 2.4 2.2 6.0 2.6 2.5 2.6 6.8 2.1 2.2 2.1 3.6 3.1 1.4 6.3 4.4 2.7 2.1 2.9 1.4 2.1 2.4 6.6 3.0 2.4 2.4 1.6 1.9 1.8 3.3 0.6 2.4 3.8 2.7 3.2 2.7 22.5 3.2 6.1 2.6 1.8 6.8 3.7 3.5 2.2 2.7 1.5 2.0 0.0 0.0 1.5 2.5 6.3 0.0 1.2 3.0 2.9 2.7 1.8 1.8 8.6 21.3 1.1 1.2 2.7 4.6 3.2 1.3 2.7 1.1 2.3 1.6 1.7 21.2 3.1 2.0 3.1 2.9 4.1 2.5 2.8 0.0 13.1 2.1 1.0 1.0 13.6 21.6 0.9 3.2 1.9 2.4 4.6 3.1 1.0 2.3 2.7 0.0 3.9 3.4 0.8 0.8 7.2 5.1 0.5 3.5 1.7 2.7 5.8 B3GNT2 "B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT" ENSG00000170340 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2" Q9NY97 2 62196115-62224731 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 115.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005997 Approved Approved Vesicles NA NA 99000000 Vesicles "HPA005997: AB_1845234" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (1.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.51e-1)" "unprognostic (1.55e-2)" "unprognostic (2.13e-2)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.63e-1)" "unprognostic (1.11e-2)" "unprognostic (9.55e-2)" "unprognostic (3.05e-2)" "unprognostic (3.18e-1)" "unprognostic (1.25e-1)" 17.5 21.0 7.5 13.5 12.8 73.4 26.3 6.9 9.9 26.1 9.9 19.6 28.0 24.9 6.3 25.3 12.8 27.6 19.1 7.4 9.1 33.7 22.0 34.5 24.3 7.8 9.0 7.2 5.9 40.0 7.7 13.3 30.9 9.5 10.9 24.5 5.2 15.6 8.2 3.2 10.3 14.5 24.3 7.0 15.0 18.4 7.6 8.9 25.8 19.7 9.1 18.5 20.3 12.9 7.9 20.7 14.0 20.9 9.3 22.5 10.0 60.0 19.8 21.8 15.4 20.5 29.2 32.5 22.3 17.8 18.5 21.6 19.4 13.3 16.6 26.5 46.8 10.8 55.1 6.4 17.2 16.8 33.2 23.8 12.3 30.7 29.6 10.5 11.0 23.4 15.3 30.4 13.7 18.9 15.7 63.7 49.6 20.0 37.4 5.8 115.0 14.4 12.3 29.2 20.1 20.1 14.9 14.1 29.9 23.5 33.4 8.6 38.7 26.7 18.6 16.4 31.7 19.9 38.2 14.4 96.2 14.6 56.5 18.4 14.9 9.0 56.2 20.0 8.6 28.0 14.8 14.7 34.6 10.6 16.6 17.3 26.0 21.3 41.0 11.7 13.3 26.2 17.6 7.5 12.8 6.9 9.9 7.4 9.1 7.8 9.0 7.2 9.5 7.0 8.9 7.9 40.3 64.1 9.8 2.0 31.4 71.5 30.9 20.8 92.2 15.6 40.0 20.7 9.2 18.6 21.9 18.4 0.0 40.9 43.8 42.7 23.5 24.0 0.1 51.1 30.3 31.8 9.5 61.6 11.2 57.2 38.3 19.5 36.7 97.3 3.8 9.7 37.5 21.3 60.4 0.0 3.4 22.7 87.5 20.5 58.5 0.7 2.5 34.4 35.6 14.0 19.7 8.6 18.6 2.5 7.2 36.3 24.8 2.2 25.8 25.5 14.2 19.0 19.1 2.1 65.7 8.1 68.2 0.3 1.6 77.4 64.8 65.3 45.9 10.6 13.9 41.1 FOS "AP-1, c-fos" ENSG00000170345 "Fos proto-oncogene, AP-1 transcription factor subunit" P01100 14 75278826-75282230 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 504.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 504.8" "Cell line enhanced" "Detected in many" "hTCEpi: 453.1;OE19: 170.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebellum: 80.9;spinal cord: 235.3" HPA018531 Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA018531: AB_1846576" "unprognostic (1.18e-2)" "unprognostic (8.70e-2)" "unprognostic (1.61e-1)" "unprognostic (3.80e-1)" "unprognostic (3.08e-2)" "unprognostic (4.82e-2)" "unprognostic (2.09e-1)" "unprognostic (3.30e-1)" "unprognostic (9.55e-3)" "unprognostic (4.20e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.81e-4)" "unprognostic (3.20e-2)" "unprognostic (1.52e-2)" "unprognostic (3.22e-1)" "unprognostic (1.43e-1)" "unprognostic (2.66e-2)" 1117.3 742.7 94.4 581.0 81.5 2290.9 482.5 178.6 126.2 706.6 102.1 429.2 237.4 414.3 58.9 1262.0 1793.4 1170.4 379.8 56.8 409.1 268.6 311.3 491.2 453.4 155.4 75.9 40.3 1199.1 300.8 266.5 455.8 420.9 90.5 798.2 633.2 235.3 560.4 466.6 99.9 1111.7 589.3 972.2 107.2 179.4 530.0 87.9 144.7 428.1 1017.3 1023.2 27.1 955.6 349.5 213.0 2.2 1.4 7.1 10.4 59.9 18.3 42.1 6.4 2.4 4.5 3.2 4.4 12.6 0.6 1.8 43.5 42.6 3.0 3.6 74.7 1.1 1.2 1.1 1.0 21.9 1.9 27.6 2.6 42.8 44.3 453.1 3.9 27.4 6.2 2.7 9.2 2.0 19.7 1.2 26.1 0.9 12.9 7.4 170.9 2.5 2.0 1.4 23.8 18.8 20.4 52.4 3.6 9.8 85.9 39.8 21.8 1.4 9.2 6.3 0.4 5.7 3.7 2.0 52.4 61.2 9.6 2.9 8.0 5.7 38.3 81.0 89.5 0.3 20.1 0.4 0.3 0.2 0.7 69.6 0.2 0.2 0.1 504.8 4.6 2.5 1.5 0.4 27.7 94.4 81.5 178.6 126.2 56.8 409.1 155.4 75.9 40.3 90.5 107.2 144.7 213.0 3911.0 1102.6 1859.4 137.1 1015.9 859.7 1644.7 1577.5 4336.7 106.1 3184.1 2874.6 1027.6 1416.9 752.7 191.3 129.3 1506.7 1323.5 1648.6 17.6 690.9 17.4 1834.4 3720.3 1624.0 1628.0 290.5 4.9 528.1 2694.6 4146.8 2049.5 3656.5 1630.6 751.3 1317.2 207.2 1693.8 35.3 3.0 1967.2 793.5 2600.2 1540.4 53.5 943.8 2910.7 855.6 58.1 269.5 1119.5 10.3 6.0 1.8 383.5 1507.8 178.3 1256.1 1115.7 1675.1 20.0 354.4 406.9 1209.6 3390.9 2705.7 10.0 10.5 2438.0 1092.4 2283.3 1497.0 417.4 1366.2 298.4 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131469-75176612 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" NA NA 220000 "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.06e-2)" 68.6 71.0 54.8 55.7 58.1 18.2 94.1 56.5 61.2 139.1 63.5 77.8 62.8 93.5 134.3 60.4 101.5 69.8 83.1 52.9 66.8 63.3 127.9 68.6 61.5 69.1 56.3 50.1 100.6 133.0 92.2 54.0 76.9 64.3 91.8 83.1 49.3 131.8 86.7 74.3 56.5 59.3 79.6 61.9 55.1 79.0 40.4 59.5 74.4 147.2 61.6 66.5 67.5 60.2 69.3 93.3 52.2 85.5 142.5 197.5 183.7 110.9 96.5 159.5 99.5 111.2 51.8 161.2 82.5 80.6 167.5 56.8 90.8 80.4 140.6 160.5 43.7 36.2 50.5 31.1 79.2 167.1 101.7 50.2 135.1 221.5 77.0 220.1 196.0 176.9 91.7 44.6 177.8 145.0 104.6 71.0 80.7 51.9 145.2 55.8 70.6 55.3 116.6 119.7 94.8 82.9 87.1 89.0 147.0 175.9 81.0 138.3 163.3 122.3 97.0 62.9 65.9 50.7 98.9 99.3 91.3 177.0 88.3 95.8 107.4 46.4 28.9 60.8 39.4 93.8 39.7 58.7 59.3 62.9 30.3 51.9 55.9 20.4 101.8 42.6 70.9 38.2 91.4 54.8 58.1 56.5 61.2 52.9 66.8 69.1 56.3 50.1 64.3 61.9 59.5 69.3 80.8 64.1 106.3 32.0 141.8 114.2 180.4 488.1 107.0 55.6 182.5 130.6 155.3 187.3 279.9 200.5 27.1 181.0 186.7 186.2 62.6 319.1 14.5 147.7 177.5 107.3 140.7 75.5 26.9 385.7 609.9 164.4 145.8 172.0 100.1 170.9 123.1 339.7 255.0 77.4 30.0 276.2 272.6 159.4 166.3 31.5 179.3 151.6 297.1 38.4 129.5 137.9 130.7 50.8 84.2 225.8 148.9 209.9 538.8 218.7 120.3 138.9 304.8 63.1 78.9 112.7 132.2 317.7 116.5 151.7 135.1 309.2 122.1 145.8 161.9 207.7 SETMAR metnase ENSG00000170364 "SET domain and mariner transposase fusion gene" Q53H47 3 4303304-4317567 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA057999 Supported Nucleoli NA NA Nucleoli "HPA057999: AB_2683574" "unprognostic (1.59e-1)" "unprognostic (1.22e-2)" "unprognostic (5.24e-3)" "unprognostic (4.89e-2)" "unprognostic (7.73e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.58e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-1)" "unprognostic (1.19e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.61e-6)" "unprognostic (5.42e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-3)" 6.5 3.7 2.6 2.2 4.2 2.7 8.6 4.1 3.3 8.3 1.8 3.8 2.7 10.4 4.7 4.6 8.6 5.3 3.4 2.9 2.4 6.4 3.3 2.7 3.0 3.4 2.6 2.5 12.2 5.2 3.4 3.8 3.7 3.5 8.0 4.4 2.1 5.8 6.2 3.9 4.8 3.1 10.5 1.9 2.8 3.7 4.2 3.3 6.1 7.4 5.2 2.8 5.6 5.2 6.4 3.7 3.2 9.8 2.1 23.1 7.6 9.9 4.1 1.2 3.9 3.7 3.5 2.9 9.9 4.2 2.3 7.2 3.1 8.9 6.1 4.3 6.8 7.6 12.5 6.1 5.6 2.7 5.9 5.1 9.1 4.7 3.0 0.9 3.6 5.7 11.2 8.3 3.6 6.2 5.2 8.9 3.7 9.5 2.4 5.7 10.3 9.6 4.1 3.6 5.1 7.8 11.4 4.9 6.1 5.3 6.2 5.9 3.4 3.8 5.8 8.0 4.9 5.4 4.9 12.3 24.1 2.1 6.7 4.9 0.7 0.4 0.5 0.8 1.2 0.7 1.0 1.0 1.1 0.4 1.3 1.6 2.0 0.0 0.2 0.8 0.6 0.7 0.6 2.6 4.2 4.1 3.3 2.9 2.4 3.4 2.6 2.5 3.5 1.9 3.3 6.4 4.8 0.0 5.0 4.9 2.4 2.4 8.0 12.0 10.8 5.8 6.6 13.7 6.6 2.8 10.8 0.0 0.0 25.5 1.9 2.7 13.7 11.2 0.7 3.8 6.3 5.6 3.6 5.5 6.4 13.4 12.1 8.9 5.6 4.4 1.3 13.9 4.2 2.6 5.7 0.0 6.9 2.8 10.2 2.1 1.5 1.9 9.6 2.7 0.0 4.7 4.1 4.6 2.1 7.1 11.7 6.6 4.4 13.2 1.8 4.4 2.0 6.0 6.7 2.8 6.6 7.0 8.1 7.5 6.4 6.0 0.6 16.3 2.8 16.9 5.6 3.6 SMAD1 "JV4-1, MADH1, MADR1" ENSG00000170365 "SMAD family member 1" Q15797 4 145481194-145559176 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 195.9;Endothelial cells: 76.3;Late spermatids: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 46.2;non-classical monocyte: 22.2" "Group enriched" "Detected in many" 5 "granulocytes: 46.2;monocytes: 22.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005389 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005389: AB_656608" "unprognostic (8.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-1)" "unprognostic (6.85e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (4.68e-2)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" "unprognostic (5.88e-2)" "unprognostic (1.14e-3)" "unprognostic (3.15e-2)" 19.8 5.3 19.2 11.0 20.9 5.9 16.1 16.6 20.1 20.5 9.0 20.6 15.5 29.3 33.0 16.5 24.6 17.3 13.3 20.9 20.8 12.7 20.3 12.4 17.8 20.4 19.0 14.9 11.8 13.4 29.3 6.1 11.5 14.8 12.6 21.0 6.6 13.1 17.3 20.9 24.6 15.8 30.6 14.2 14.1 10.7 14.1 18.4 18.4 17.5 18.0 13.8 18.1 9.0 26.3 9.6 12.6 23.5 27.3 8.7 12.8 11.5 13.9 32.6 22.0 16.4 6.2 34.0 9.8 8.0 31.8 9.7 14.1 26.6 30.2 12.8 0.0 13.5 0.0 10.0 13.1 23.2 15.8 2.4 17.6 35.2 11.8 22.9 17.9 110.7 20.7 11.1 0.4 27.0 9.6 24.4 0.3 21.8 15.3 14.6 47.0 21.1 28.5 25.9 17.1 35.3 17.6 18.8 40.3 9.6 14.1 14.0 0.2 32.4 10.5 14.5 11.3 8.6 31.1 0.0 56.1 16.7 0.3 11.1 46.2 3.6 1.5 0.0 9.4 0.0 0.0 0.6 0.0 6.8 0.1 0.3 0.0 0.0 2.4 22.2 0.0 1.3 1.3 19.2 20.9 16.6 20.1 20.9 20.8 20.4 19.0 14.9 14.8 14.2 18.4 26.3 62.9 9.6 10.9 54.9 0.1 11.5 17.5 22.0 45.5 6.6 8.6 9.3 3.6 12.8 16.3 14.7 14.6 5.2 0.8 13.2 7.9 12.6 195.9 19.5 12.1 76.3 9.1 8.4 47.7 18.5 2.7 11.5 12.2 24.8 0.0 10.0 10.4 12.0 2.5 10.1 43.2 10.4 28.5 6.5 2.7 80.7 4.4 4.5 1.8 26.2 3.2 5.3 0.0 66.9 22.0 12.0 10.2 5.7 0.3 17.5 6.6 11.5 12.7 5.9 0.0 19.0 10.6 8.3 16.8 19.9 12.6 2.2 1.2 6.9 8.8 17.2 CST5 ENSG00000170367 "Cystatin D" P28325 20 23875934-23879748 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 960 "salivary gland: 2175.7" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 9.6;Langerhans cells: 3.4" "Cancer enriched" "Detected in many" 5 "breast cancer: 17.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB024944, HPA061449" Enhanced "Secreted to digestive system" NA NA "CAB024944: , HPA061449: AB_2684523" "unprognostic (2.43e-1)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (4.73e-1)" "unprognostic (4.31e-2)" "unprognostic (1.76e-2)" "unprognostic (2.32e-1)" "unprognostic (1.35e-1)" "unprognostic (4.83e-3)" "unprognostic (5.14e-2)" "unprognostic (2.31e-1)" 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.3 0.4 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2175.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CST2 ENSG00000170369 "Cystatin SA" P09228 20 23823769-23826729 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 638 "salivary gland: 6041.2" "Group enriched" "Detected in some" 4 "Granulosa cells: 5.2;Melanocytes: 16.0" "Cancer enhanced" "Detected in many" "prostate cancer: 24.8" "Region enriched" "Detected in single" 13 "hypothalamus: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "RT4: 67.7" "CAB024963, HPA043706, HPA044763" Enhanced "Secreted to digestive system" NA NA "CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080" "unprognostic (1.57e-2)" "unprognostic (3.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.10e-1)" "unprognostic (1.64e-2)" "unprognostic (5.17e-3)" "unprognostic (1.28e-2)" "unprognostic (2.75e-3)" "unprognostic (2.73e-1)" "unprognostic (4.82e-3)" "unprognostic (6.43e-3)" "unprognostic (2.51e-1)" "unprognostic (4.58e-11)" "unprognostic (1.29e-3)" "unprognostic (3.22e-1)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" 0.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.1 0.2 0.1 0.0 0.2 4.8 2.4 0.0 1.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 1.6 9.4 0.1 2.0 1.0 0.0 2.5 0.0 0.0 6041.2 1.3 0.0 0.4 0.2 3.8 0.0 0.1 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 1.8 67.7 0.0 0.0 0.0 0.0 5.4 0.9 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 16.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542445-117549546 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 79.6;epididymis: 105.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 239.1;Distal tubular cells: 90.1;Endometrial ciliated cells: 75.6;Endometrial stromal cells: 126.5;Glandular and luminal cells: 68.6;Granulosa cells: 88.3;Proximal tubular cells: 185.0" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 25.4;fHDF/TERT166: 31.6;RPTEC TERT1: 31.1;RT4: 9.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 14.2;cerebral cortex: 17.8;hippocampal formation: 22.8;white matter: 8.1" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA003497: , HPA065294: AB_2685455" "unprognostic (1.53e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favorable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 6.3 0.1 22.0 0.2 20.8 0.2 2.8 15.8 31.6 50.0 15.8 0.4 0.1 79.6 105.2 0.4 53.4 1.5 0.5 26.0 18.1 39.5 0.1 0.1 0.6 15.7 16.4 19.9 12.0 0.0 0.1 1.8 0.4 17.6 1.1 0.1 0.3 2.4 53.1 10.9 8.8 0.1 45.3 13.2 0.2 0.1 1.2 17.3 0.1 0.3 5.3 0.4 4.8 4.5 21.8 0.0 0.0 0.0 2.6 0.0 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 25.4 31.6 0.0 0.1 0.6 0.0 0.0 0.1 2.8 0.8 0.1 0.2 0.0 0.1 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.2 31.1 9.4 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 2.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 22.0 20.8 15.8 31.6 26.0 18.1 15.7 16.4 19.9 17.6 13.2 17.3 21.8 4.6 0.0 0.0 43.4 1.0 10.7 2.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 239.1 0.0 0.2 0.0 0.1 90.1 0.0 1.4 75.6 126.5 3.1 0.0 0.0 0.1 0.0 0.3 18.0 0.0 68.6 0.0 88.3 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 8.0 2.6 60.3 2.5 21.4 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 41.0 0.0 2.5 0.1 185.0 0.0 0.1 52.6 8.6 32.1 0.3 0.3 0.0 7.5 0.1 2.2 2.2 0.3 1.7 CST1 ENSG00000170373 "Cystatin SN" P01037 20 23747562-23751268 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 119 "salivary gland: 28658.7" "Cell type enhanced" "Detected in some" "Cholangiocytes: 14.3;Collecting duct cells: 79.1;Glandular and luminal cells: 31.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 1142.2" "CAB026769, HPA043706, HPA044763" Enhanced "Secreted to digestive system" NA NA 6300000 "CAB026769: , HPA043706: AB_2678627, HPA044763: AB_2679080" "prognostic favorable (4.00e-4)" "unprognostic (2.47e-1)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (1.99e-1)" "unprognostic (5.27e-2)" "unprognostic (1.99e-1)" "unprognostic (1.56e-1)" "unprognostic (1.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.39e-1)" "unprognostic (8.26e-2)" "unprognostic (9.58e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.91e-3)" 0.0 0.3 0.1 1.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 3.7 0.4 0.1 0.2 241.0 8.1 0.1 0.6 0.0 0.0 0.1 0.0 0.8 0.6 0.1 7.2 37.6 0.0 0.1 4.1 0.8 13.1 0.2 0.0 28658.7 0.6 0.0 2.0 0.1 0.0 0.4 0.0 0.8 0.2 0.1 2.1 0.0 0.0 0.7 0.7 0.0 0.4 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 172.6 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.4 0.0 0.1 0.0 0.1 0.0 51.2 0.0 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 45.3 0.1 0.0 0.0 0.0 4.4 1142.2 0.7 0.0 0.1 0.0 0.3 5.6 0.0 0.0 223.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.6 0.8 0.6 0.1 0.8 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 14.3 0.0 79.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 5.7 2.2 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 31.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.5 SP7 "osterix, OSX" ENSG00000170374 "Sp7 transcription factor" Q8TDD2 12 53326575-53345315 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Cone photoreceptor cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory bulb: 28.1" "Low region specificity" "Detected in many" HPA063202 Enhanced NA NA "HPA063202: AB_2684961" "unprognostic (6.02e-1)" "unprognostic (6.28e-3)" "unprognostic (6.37e-2)" "unprognostic (2.49e-2)" "unprognostic (7.75e-2)" "unprognostic (3.02e-1)" "unprognostic (1.49e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-2)" "unprognostic (6.02e-1)" "unprognostic (3.93e-7)" "unprognostic (6.04e-2)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "unprognostic (1.95e-1)" 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.5 0.2 0.2 0.3 0.2 0.1 0.4 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCAF2 "FAM115C, FAM139A, FLJ40722, GATD9" ENSG00000170379 "TRPM8 channel associated factor 2" A6NFQ2 7 143620952-143730409 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 16.2;Hepatocytes: 12.3;Syncytiotrophoblasts: 15.7;T-cells: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 10.6;HUVEC TERT2: 11.6;TIME: 18.5;U-87 MG: 13.8" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" "unprognostic (6.59e-2)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (8.86e-3)" "prognostic unfavorable (9.53e-5)" "unprognostic (1.89e-1)" "unprognostic (3.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.36e-1)" "unprognostic (2.04e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.17e-6)" "unprognostic (7.19e-2)" "unprognostic (4.02e-2)" "unprognostic (5.41e-3)" "unprognostic (2.85e-2)" 1.9 1.9 1.3 4.1 1.6 4.1 5.8 4.5 3.4 3.3 0.0 1.1 1.1 1.7 0.8 9.2 1.9 2.2 1.0 1.6 1.8 2.3 4.5 3.7 4.2 2.3 1.8 1.4 2.6 2.0 2.1 2.6 5.3 3.0 2.8 1.1 3.2 3.7 1.2 0.7 4.2 2.4 1.5 0.5 2.8 2.0 1.6 3.1 3.3 1.3 0.7 3.5 2.8 5.9 5.6 5.5 0.3 0.1 0.2 1.0 1.0 2.0 1.5 3.1 0.7 2.2 0.1 0.3 0.2 2.1 1.3 0.5 0.8 0.1 3.0 2.3 10.6 0.5 0.8 0.6 0.1 1.2 0.3 0.4 2.9 1.3 0.3 0.9 2.1 11.6 0.7 3.0 5.1 4.3 0.8 0.6 0.8 0.2 5.0 2.7 0.4 2.1 2.4 0.0 1.9 0.1 0.1 0.5 4.3 0.2 0.8 1.9 0.2 18.5 1.3 0.9 5.5 0.4 7.7 2.6 0.1 13.8 0.4 3.2 5.7 0.2 0.2 2.9 0.2 3.1 1.9 4.8 3.1 0.2 1.8 4.2 3.3 0.9 2.2 0.2 0.7 5.6 1.2 1.3 1.6 4.5 3.4 1.6 1.8 2.3 1.8 1.4 3.0 0.5 3.1 5.6 0.5 0.0 1.8 0.0 4.5 0.0 1.3 0.0 3.4 0.7 5.6 3.4 0.4 0.0 1.8 0.0 0.0 16.2 5.6 0.2 0.0 0.9 1.0 0.8 1.4 3.5 0.0 0.4 3.7 0.4 4.9 2.4 2.6 1.3 2.5 0.3 0.7 12.3 2.0 0.0 3.6 0.2 0.0 1.6 0.0 1.1 1.8 1.8 0.0 0.0 0.4 2.1 7.2 1.5 0.1 1.3 0.1 0.7 5.0 2.1 2.1 0.4 0.0 0.1 0.0 2.3 1.1 3.5 2.0 4.9 0.0 15.7 9.1 0.8 0.4 1.1 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649139 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 176.3;Alveolar cells type 2: 110.2;Bipolar cells: 75.7;Excitatory neurons: 84.9;Oligodendrocyte precursor cells: 250.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.9;SK-BR-3: 19.9;U-2 OS: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: AB_2685127" "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 1.3 0.1 2.1 0.2 2.9 0.0 2.8 0.6 2.4 1.8 0.1 1.6 0.6 2.0 0.3 1.2 0.6 2.4 0.1 5.1 4.6 0.1 0.2 2.2 0.0 1.7 4.7 1.3 0.1 0.4 0.0 0.2 0.2 1.4 4.3 1.7 4.0 2.2 3.3 0.2 0.5 1.2 1.1 2.4 0.0 1.4 0.0 4.1 1.7 0.6 1.0 0.1 3.2 0.7 2.9 0.2 1.1 0.2 0.0 0.5 3.1 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 0.0 3.4 0.0 1.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 0.4 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 19.9 0.0 3.2 1.6 0.0 0.0 0.7 6.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.9 0.6 2.4 5.1 4.6 1.7 4.7 1.3 1.4 2.4 4.1 2.9 10.5 176.3 110.2 2.9 0.2 1.1 1.3 1.6 0.0 75.7 19.0 7.5 1.7 18.6 43.2 1.8 0.0 0.8 0.2 0.1 0.0 3.9 1.1 3.8 1.2 10.7 0.0 0.0 84.9 1.1 0.4 21.3 3.1 9.3 24.0 0.2 0.0 0.3 0.1 0.0 12.3 0.0 4.1 1.0 2.1 0.0 0.9 3.6 1.8 1.0 1.0 29.6 0.0 250.3 6.0 6.2 0.0 0.0 0.3 2.6 0.1 0.5 35.7 3.6 0.0 0.8 1.0 0.3 0.6 0.3 0.4 0.3 2.8 0.0 0.0 2.5 LRRN2 "FIGLER7, GAC1, LRANK1, LRRN5" ENSG00000170382 "Leucine rich repeat neuronal 2" O75325 1 204617170-204685738 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6" "Cell type enhanced" "Detected in many" "Astrocytes: 22.2;Distal enterocytes: 18.1;Excitatory neurons: 57.8;Horizontal cells: 52.2;Inhibitory neurons: 40.0;Oligodendrocyte precursor cells: 39.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 9.3;NTERA-2: 18.0;RPMI-8226: 29.0;SuSa: 9.8;T-47d: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029124 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029124: AB_10601545" "unprognostic (2.16e-2)" "unprognostic (1.93e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.59e-7)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" "unprognostic (1.21e-1)" "unprognostic (4.63e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (1.68e-2)" "unprognostic (1.43e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-1)" "unprognostic (1.59e-3)" 3.3 4.5 17.9 2.8 17.9 1.7 2.5 7.0 17.9 3.0 16.3 7.2 1.2 5.5 0.3 1.8 7.6 4.3 5.4 20.6 13.5 10.9 1.0 2.8 2.1 11.1 14.6 18.6 2.5 1.9 14.8 13.0 0.8 10.4 1.5 5.4 3.9 3.0 2.3 1.6 0.4 4.9 7.2 4.8 7.6 2.1 4.2 18.1 3.1 3.2 3.2 0.7 1.4 2.2 12.5 0.0 4.3 3.5 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.2 9.3 0.6 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.9 1.5 0.0 18.0 0.0 0.1 0.2 0.0 29.0 0.0 0.2 2.4 0.4 5.6 0.1 0.0 9.8 10.1 0.0 0.0 0.0 3.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 17.9 7.0 17.9 20.6 13.5 11.1 14.6 18.6 10.4 4.8 18.1 12.5 3.9 0.0 0.0 22.2 0.3 0.4 0.7 0.1 0.0 7.0 0.6 1.9 1.5 0.0 0.1 1.8 2.1 0.1 0.0 18.1 0.0 3.8 0.0 0.5 0.2 2.3 11.4 2.7 57.8 0.9 0.1 2.9 0.0 0.8 0.0 0.1 3.3 0.0 7.0 52.2 40.0 2.3 2.0 0.3 1.1 0.5 0.0 0.2 0.0 9.4 0.2 4.6 0.0 39.2 1.6 4.9 5.6 0.0 0.1 0.3 0.0 5.5 0.0 1.1 0.0 0.9 0.5 0.1 0.3 0.5 0.1 0.4 0.2 1.4 1.0 0.4 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211579161 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 86.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: AB_2680593" "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.3 18.1 18.3 11.0 17.7 30.0 8.6 17.1 19.5 18.8 25.7 15.5 28.4 10.9 9.9 8.1 12.6 12.5 10.1 18.4 16.3 20.7 86.8 7.3 6.2 18.8 17.9 13.4 7.9 11.4 10.3 4.6 10.2 17.4 7.8 13.7 6.1 9.4 8.0 1.9 16.0 20.1 11.7 16.8 15.5 9.6 13.5 18.2 4.5 17.1 4.9 7.2 12.3 7.5 17.0 10.3 15.0 7.7 9.9 32.4 14.9 70.5 27.3 19.3 13.8 13.6 6.4 46.6 5.8 24.1 24.4 19.3 17.2 11.5 15.4 16.4 15.0 9.3 4.7 28.8 14.7 18.1 15.8 10.0 22.5 37.5 17.7 28.4 20.5 8.6 3.4 18.7 25.5 17.2 9.1 3.2 9.9 24.2 10.6 12.0 10.0 3.7 20.4 42.5 26.4 7.8 13.7 26.7 13.6 62.7 14.2 7.0 20.2 14.6 10.4 24.8 35.4 22.1 11.9 19.0 4.5 9.8 15.7 9.3 1.4 1.3 0.5 0.4 1.5 0.5 0.2 0.3 0.2 0.9 0.1 0.3 0.4 0.1 0.4 1.2 0.5 0.3 0.4 18.3 17.7 17.1 19.5 18.4 16.3 18.8 17.9 13.4 17.4 16.8 18.2 17.0 29.7 9.6 9.8 3.9 8.8 28.6 8.2 3.0 16.5 11.0 24.9 14.7 21.0 18.6 4.2 36.8 6.2 11.6 19.9 54.5 1.9 6.9 44.0 37.0 19.1 27.3 9.5 26.1 0.6 12.5 32.7 15.9 8.6 66.4 5.1 7.5 17.9 94.9 32.0 6.7 0.6 22.8 2.0 27.2 14.5 6.8 9.9 25.5 21.4 3.7 18.8 29.0 1.0 1.0 0.1 9.5 41.7 7.5 8.6 13.9 49.2 29.8 6.4 9.4 6.6 15.9 11.7 37.9 17.4 24.2 46.2 24.5 14.2 14.8 23.3 13.7 DCLK2 "DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428" ENSG00000170390 "Doublecortin like kinase 2" Q8N568 4 150078445-150257438 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.7;retina: 18.6" "Group enriched" "Detected in many" 6 "Astrocytes: 501.1;Excitatory neurons: 189.8;Inhibitory neurons: 173.2;Oligodendrocyte precursor cells: 172.4" "Cancer enriched" "Detected in many" 17 "glioma: 53.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 23.6;BJ: 11.8;BJ hTERT+: 24.9;fHDF/TERT166: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015770 Enhanced Approved NA NA "HPA015770: AB_1847509" "unprognostic (7.37e-2)" "unprognostic (1.56e-3)" "unprognostic (9.30e-2)" "unprognostic (1.49e-2)" "unprognostic (4.06e-1)" "unprognostic (6.24e-3)" "unprognostic (1.90e-1)" "unprognostic (7.38e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.25e-4)" "prognostic favorable (2.48e-4)" "unprognostic (6.87e-2)" "unprognostic (3.93e-3)" "unprognostic (3.74e-3)" "unprognostic (4.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.45e-2)" 1.7 2.8 46.1 0.9 41.8 0.5 1.4 40.9 42.6 1.8 7.7 4.3 1.5 2.7 2.0 1.5 2.0 2.5 12.3 55.7 41.7 1.8 0.6 2.2 0.5 42.1 39.3 43.7 2.9 2.2 0.6 8.4 1.5 36.2 2.7 2.0 18.6 0.8 2.1 1.2 1.0 2.2 4.7 43.6 1.2 2.3 2.8 40.2 0.3 2.6 1.4 0.3 2.6 1.3 46.0 1.2 4.2 23.6 3.7 0.0 1.1 0.4 11.8 24.9 3.5 0.9 0.1 0.0 0.0 0.4 11.0 3.6 0.1 3.5 0.0 4.4 5.1 2.1 0.0 7.0 0.0 5.0 0.7 0.7 0.6 0.0 2.2 0.2 2.2 1.2 0.6 0.0 0.1 2.5 0.2 0.4 0.0 0.5 0.3 1.6 0.0 2.8 1.0 0.1 1.0 9.2 9.1 4.7 3.4 1.0 2.0 0.0 0.1 2.1 3.3 1.3 2.2 1.3 1.1 0.0 0.1 3.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 46.1 41.8 40.9 42.6 55.7 41.7 42.1 39.3 43.7 36.2 43.6 40.2 46.0 10.7 0.0 0.0 501.1 0.6 0.5 0.1 0.0 0.6 26.2 2.8 2.2 10.5 1.5 0.7 3.7 16.7 0.0 0.0 0.8 0.0 0.4 0.1 0.4 4.6 7.6 3.0 0.0 189.8 0.7 0.0 3.4 1.1 0.5 4.5 5.7 7.5 0.0 1.6 35.3 173.2 0.3 0.0 0.6 3.4 0.3 1.8 0.7 5.4 43.1 0.2 31.2 0.0 172.4 37.6 0.1 0.4 3.8 0.3 0.6 0.0 0.4 0.1 9.6 13.1 5.6 9.2 0.1 2.0 0.1 0.6 0.3 0.9 6.6 1.4 0.2 ZNF804A C2orf10 ENSG00000170396 "Zinc finger protein 804A" Q7Z570 2 184598529-184939492 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.2;retina: 3.8" "Group enriched" "Detected in many" 9 "Excitatory neurons: 267.9;Inhibitory neurons: 676.0;Oligodendrocyte precursor cells: 186.5" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 28.3;RH-30: 17.7;THP-1: 13.9;U-698: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029195 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029195: AB_10603011" "unprognostic (1.10e-1)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.08e-2)" "unprognostic (1.26e-2)" "unprognostic (1.50e-1)" "unprognostic (2.41e-1)" "unprognostic (4.45e-1)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (5.20e-2)" "unprognostic (4.98e-4)" "unprognostic (6.21e-2)" "unprognostic (4.04e-1)" "unprognostic (8.45e-2)" "unprognostic (4.93e-2)" 0.0 0.2 1.6 1.0 3.7 0.6 0.0 4.8 5.2 0.1 0.0 0.2 0.5 0.0 0.0 0.1 0.0 1.1 0.0 3.2 2.0 0.6 0.1 0.3 1.0 2.0 1.5 2.0 0.2 0.0 0.0 0.0 0.1 2.6 1.3 0.3 3.8 0.1 1.4 0.0 0.0 1.2 0.1 0.7 0.6 0.4 0.2 1.7 0.0 1.4 0.0 1.0 0.4 0.0 2.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.9 6.3 2.1 1.9 0.0 0.0 28.3 0.0 0.0 2.6 0.0 0.4 0.0 4.6 0.2 0.0 7.4 1.0 0.1 10.0 7.1 0.0 3.1 0.0 0.0 1.6 3.2 4.9 0.0 0.0 1.2 0.0 0.0 0.0 6.8 0.0 0.0 4.8 0.0 17.7 1.1 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.1 0.0 13.9 0.0 6.8 0.1 0.2 2.8 3.1 0.0 20.5 7.7 2.0 2.2 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.6 3.7 4.8 5.2 3.2 2.0 2.0 1.5 2.0 2.6 0.7 1.7 2.6 0.1 0.0 0.6 13.4 9.2 0.0 0.0 0.0 0.0 38.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 2.2 0.6 0.0 5.5 267.9 0.0 0.0 2.2 0.0 0.3 0.0 0.9 0.0 0.2 2.9 3.3 676.0 1.1 0.0 1.6 3.7 0.6 0.3 5.4 0.0 6.5 3.5 1.0 0.0 186.5 5.4 0.0 0.0 0.0 21.5 0.0 1.5 0.1 0.0 2.9 6.6 0.1 0.7 5.3 1.2 0.0 0.0 0.0 0.5 1.1 2.7 0.1 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 194.3;stomach 1: 232.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;monocytes: 3.7" "Cell line enhanced" "Detected in many" "Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0" "Region enriched" "Detected in all" 9 "cerebellum: 42.5" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA Yes 15000 "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 15.6 19.5 16.2 3.1 15.8 0.4 20.3 43.7 18.2 42.3 24.4 25.7 25.2 17.2 10.3 12.3 30.3 21.5 28.9 13.2 16.0 136.0 194.3 23.2 2.1 17.1 16.7 11.5 38.5 137.3 28.5 14.9 12.0 25.4 46.0 14.7 1.5 37.7 24.5 111.0 40.2 30.5 4.1 15.8 22.5 232.1 4.0 16.7 4.5 75.4 34.2 3.0 31.1 21.0 14.5 17.3 61.6 3.8 5.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 66.4 73.0 0.0 45.0 0.3 18.5 52.9 7.7 1.0 0.1 0.2 10.7 0.0 4.0 82.4 15.8 0.0 146.7 1.3 26.7 0.0 0.0 69.2 0.0 0.1 4.8 1.2 0.0 18.0 0.7 17.2 9.2 79.5 80.8 0.2 0.1 2.8 172.1 89.9 27.5 2.5 3.7 5.9 0.1 33.1 108.0 4.6 0.0 0.0 5.5 0.1 0.1 0.1 0.4 0.2 6.5 2.5 0.4 0.0 1.1 0.1 0.0 2.5 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.7 7.9 0.0 0.3 16.2 15.8 43.7 18.2 13.2 16.0 17.1 16.7 11.5 25.4 15.8 16.7 14.5 11.2 3.2 57.7 13.4 1.4 13.6 39.2 79.6 26.7 0.8 27.3 19.4 211.3 67.2 76.2 136.1 0.0 0.8 11.8 74.9 29.4 65.5 0.1 62.5 6.6 20.9 45.5 5.3 0.1 68.1 20.3 11.3 143.2 74.9 10.2 0.1 48.2 183.6 12.3 5.0 0.5 50.8 69.2 16.3 4.6 1.7 18.0 6.3 3.6 2.8 4.1 15.9 0.0 5.0 0.2 41.2 153.8 22.2 1.2 44.6 61.0 73.5 45.4 1.5 144.7 4.7 64.0 0.5 5.0 14.8 11.2 25.3 2.4 1.5 48.5 63.1 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 24 "heart muscle: 98.5;skeletal muscle: 152.1;tongue: 128.8" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 150.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045861 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA045861: AB_2679475" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.8 1.6 2.5 0.7 2.1 0.6 2.3 2.7 2.9 2.9 2.2 1.8 1.9 1.1 5.3 4.0 2.1 1.8 98.5 2.6 2.9 2.1 2.0 1.3 1.8 2.9 2.7 2.1 1.5 2.1 3.6 2.6 1.4 3.0 4.1 2.3 1.5 2.0 2.2 152.1 0.5 1.2 1.1 2.7 1.6 2.2 1.4 2.8 1.8 3.0 128.8 1.5 2.2 0.6 3.0 4.9 3.3 2.4 7.3 2.8 2.4 6.9 2.5 2.2 2.4 4.4 10.7 7.3 4.5 9.0 1.4 6.1 3.3 2.6 3.7 5.4 11.6 3.5 6.6 1.4 6.7 3.0 6.2 4.4 3.2 7.6 4.5 5.2 1.9 0.4 6.4 5.2 1.2 3.5 4.6 3.9 5.7 4.2 5.9 3.6 3.4 6.3 3.7 5.7 6.2 5.2 1.9 4.1 3.3 10.3 3.5 3.0 3.2 0.7 4.2 3.5 2.7 3.1 3.9 13.0 5.5 3.8 8.4 6.3 0.0 0.0 0.2 2.5 0.2 2.8 3.6 1.5 1.3 0.9 1.2 2.4 2.4 0.0 2.4 0.3 2.9 0.5 1.1 2.5 2.1 2.7 2.9 2.6 2.9 2.9 2.7 2.1 3.0 2.7 2.8 3.0 0.6 22.4 12.3 1.3 3.6 0.4 1.0 1.8 1.2 0.3 8.1 2.4 150.6 0.0 15.3 3.7 0.0 2.3 4.2 0.5 0.0 1.8 0.6 2.4 1.1 2.0 6.6 3.6 6.1 3.3 2.6 6.9 4.1 1.6 3.8 1.2 0.7 2.3 1.2 0.0 10.8 2.6 2.0 0.8 0.7 0.6 0.6 1.3 7.2 6.5 0.1 2.4 1.0 8.5 3.4 2.4 1.1 0.7 2.7 1.0 1.0 2.4 12.8 0.3 0.0 4.6 2.3 1.0 2.4 2.5 0.6 1.1 2.9 1.1 1.8 2.8 VSTM2A "MGC33530, VSTM2" ENSG00000170419 "V-set and transmembrane domain containing 2A" Q8TAG5 7 54542325-54571080 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.3;brain: 32.0;prostate: 9.8;retina: 14.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 42.0;Enteroendocrine cells: 7.3;Excitatory neurons: 12.5;Fibroblasts: 10.9;Inhibitory neurons: 30.1" "Cancer enhanced" "Detected in some" "breast cancer: 4.6;glioma: 3.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 4.2;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 31000 "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (4.66e-1)" "prognostic favorable (5.34e-4)" "unprognostic (4.34e-2)" "unprognostic (6.79e-2)" "unprognostic (7.15e-2)" 0.0 10.3 3.5 0.0 10.3 0.0 0.3 0.0 32.0 0.0 0.0 4.4 1.4 0.0 0.0 0.0 0.0 0.1 0.0 11.9 10.5 0.0 0.0 0.0 0.0 2.1 2.4 11.7 0.0 0.6 0.0 0.3 0.0 7.9 9.8 4.1 14.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.7 0.4 8.4 0.0 0.2 0.2 0.0 0.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 10.3 0.0 32.0 11.9 10.5 2.1 2.4 11.7 7.9 0.0 8.4 4.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 7.3 0.0 12.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 2.5 0.5 0.0 1.1 0.0 0.0 0.2 0.0 0.1 0.7 4.1 0.0 0.2 2.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.3 KRT8 "CARD2, CK8, CYK8, K2C8, K8, KO" ENSG00000170421 "Keratin 8" P05787 12 52897187-52949954 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1346.6;stomach 1: 807.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 10 "spinal cord: 44.0" "CAB000131, CAB001696, HPA049866" Enhanced Supported "Intermediate filaments" NA NA 1700000000 "Intermediate filaments" "CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923" "unprognostic (5.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "unprognostic (2.76e-2)" "unprognostic (4.86e-3)" "unprognostic (3.10e-2)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (8.99e-2)" "unprognostic (2.08e-2)" "unprognostic (2.83e-2)" "unprognostic (3.18e-1)" "unprognostic (3.68e-1)" "unprognostic (1.19e-2)" 65.2 43.9 2.1 160.1 1.4 1.0 114.8 2.1 2.4 184.9 17.5 1089.2 1122.1 35.0 67.0 48.6 135.5 219.5 124.2 2.0 1.6 242.0 467.7 174.0 8.0 7.8 2.2 1.2 10.4 659.6 60.4 280.9 371.8 9.0 152.9 569.4 0.4 320.6 74.3 1.5 45.0 1346.6 51.1 0.4 16.4 807.1 7.7 3.3 48.0 239.4 0.3 13.9 211.1 37.0 3.2 2787.7 6130.6 0.2 7.8 0.7 3.2 3998.7 11.1 47.9 6.1 6.3 7686.4 4774.8 1.1 1130.2 14.7 6.9 947.1 17.6 752.6 5.9 4.6 130.8 4.3 1184.4 2234.2 212.8 1.2 2.4 9.5 12.6 14.8 50.8 419.9 17.0 1.0 484.7 1.7 0.1 10521.8 6.5 10.6 418.5 2740.6 132.8 3.8 2.2 15.2 1198.1 1354.5 129.9 5.0 1063.2 5126.4 7.8 1263.8 4325.7 10.5 18.8 5.7 443.4 9.3 10.0 1.6 7.0 7.6 3.3 1.7 13.4 1.3 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.4 0.5 0.1 1.7 0.1 0.2 2.1 1.4 2.1 2.4 2.0 1.6 7.8 2.2 1.2 9.0 0.4 3.3 3.2 7.7 400.6 176.5 0.3 26.9 6.0 1948.0 684.7 303.3 2.3 521.6 342.8 30.2 1069.5 734.8 491.1 0.0 2208.2 8.5 4302.8 297.4 6037.3 13.9 419.2 41.0 42.3 942.5 8.6 0.5 5457.6 5323.4 94.7 1740.1 557.1 76.3 88.0 24.3 310.9 252.2 1.7 0.5 2876.3 1625.5 9.9 7.2 69.9 8.1 22.2 131.6 0.0 55.0 3.4 1.0 1.0 0.3 5278.1 4937.3 1.9 6.6 994.7 6802.6 569.1 594.8 4.3 0.0 2.2 167.4 2.0 11.4 258.9 1.7 5268.8 33.4 13.4 2337.3 1542.5 KRT78 K5B ENSG00000170423 "Keratin 78" Q8N1N4 12 52837804-52849092 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "esophagus: 980.5" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.4;Glandular and luminal cells: 1.9;Spermatocytes: 2.1;Spermatogonia: 8.0;Squamous epithelial cells: 6.7;Suprabasal keratinocytes: 4.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "EFO-21: 5.5;RT4: 1.6;SK-BR-3: 3.6;U-87 MG: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA039724 Enhanced NA NA 70000000 "HPA039724: AB_10795255" "unprognostic (5.36e-2)" "unprognostic (5.89e-2)" "unprognostic (2.95e-2)" "unprognostic (3.25e-2)" "unprognostic (1.88e-1)" "unprognostic (2.18e-2)" "unprognostic (3.01e-3)" "unprognostic (8.88e-16)" "unprognostic (3.50e-2)" "unprognostic (6.92e-1)" "unprognostic (7.55e-2)" "unprognostic (1.25e-1)" 0.4 0.2 0.0 0.0 0.0 0.1 3.5 0.0 0.5 108.6 0.0 0.1 0.0 0.1 0.0 980.5 0.1 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.7 0.0 0.0 0.1 0.0 0.0 142.9 0.0 0.3 114.3 0.2 0.0 0.0 0.1 1.0 1.5 0.2 0.5 0.3 0.0 135.4 0.4 222.9 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.5 0.6 0.0 0.8 2.4 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 8.0 6.7 4.4 0.3 0.0 0.0 0.2 0.5 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;urinary bladder: 14.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 73.5;Basal respiratory cells: 75.6;Langerhans cells: 31.9;Suprabasal keratinocytes: 64.4;Urothelial cells: 32.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9;myeloid DC: 9.0" "Group enriched" "Detected in many" 97 "dendritic cells: 9.0;granulocytes: 14.9;monocytes: 5.0" "Cell line enhanced" "Detected in many" "GAMG: 160.8;HMC-1: 162.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA Yes Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 0.5 1.1 7.0 1.7 8.8 0.8 0.7 6.5 11.8 1.3 8.1 8.7 0.2 0.7 0.5 9.2 0.9 1.1 1.0 8.5 6.8 0.1 0.1 1.9 0.3 7.1 7.1 7.7 0.0 1.3 0.0 1.4 5.0 6.9 1.3 6.7 2.8 1.4 0.1 0.1 7.8 1.4 1.3 5.5 0.2 1.2 0.3 7.6 0.4 0.1 0.5 1.3 14.3 5.3 7.7 34.1 18.3 0.6 0.7 5.8 11.1 0.7 6.4 28.4 18.3 22.6 8.8 34.6 4.4 7.8 5.7 160.8 51.9 7.9 47.8 24.2 9.7 18.0 32.7 5.8 13.0 22.3 0.0 162.6 6.5 20.1 26.0 60.4 31.3 9.3 5.1 1.6 0.1 18.2 8.9 2.2 6.6 1.9 72.0 25.5 0.1 0.4 0.0 19.1 9.1 0.8 1.2 14.3 3.4 9.0 13.4 0.1 5.1 7.7 6.5 17.1 18.3 30.3 2.8 0.0 0.0 25.8 0.0 9.2 14.9 4.2 2.8 0.0 5.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.0 1.7 7.0 8.8 6.5 11.8 8.5 6.8 7.1 7.1 7.7 6.9 5.5 7.6 7.7 0.1 3.2 4.2 18.9 0.2 73.5 21.0 75.6 27.3 0.2 1.3 1.9 0.9 1.5 20.2 0.0 0.0 10.9 0.1 10.8 0.0 6.6 0.9 0.9 0.6 1.7 2.4 3.4 0.9 0.9 3.2 4.9 2.0 1.2 0.0 0.1 2.2 0.0 4.5 0.0 1.1 1.7 2.0 1.4 31.9 0.4 0.0 6.7 7.2 3.7 1.3 7.9 0.0 1.0 1.0 1.0 7.2 0.0 0.0 15.6 0.2 0.0 8.3 0.5 0.0 0.7 2.1 0.5 1.4 23.0 64.4 6.2 0.3 0.3 5.7 32.4 SDR9C7 "RDHS, SDR-O" ENSG00000170426 "Short chain dehydrogenase/reductase family 9C member 7" Q8NEX9 12 56923133-56934408 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 14.7;skin 1: 56.8;vagina: 21.5" "Group enriched" "Detected in some" 5 "Early spermatids: 1.2;Suprabasal keratinocytes: 4.0" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.75e-2)" "unprognostic (1.42e-1)" "unprognostic (7.90e-5)" "unprognostic (7.93e-2)" "unprognostic (4.20e-3)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (9.31e-2)" "unprognostic (3.78e-2)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (3.27e-1)" "unprognostic (1.74e-3)" 0.1 0.0 0.1 0.0 0.1 0.0 2.7 0.2 0.3 5.6 0.0 0.2 0.0 0.4 0.0 14.7 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 4.1 0.0 0.8 56.8 0.1 0.0 0.0 0.2 0.1 0.9 0.0 0.5 0.0 0.0 7.5 0.2 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.0 0.0 0.0 0.0 0.0 0.0 MGMT ENSG00000170430 "O-6-methylguanine-DNA methyltransferase" P16455 10 129467190-129770983 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 465.7;Proximal tubular cells: 340.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 60.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002786, HPA032135, HPA032136, HPA069497, CAB069881" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134" "unprognostic (1.10e-1)" "prognostic favorable (9.42e-4)" "unprognostic (1.48e-1)" "unprognostic (5.81e-2)" "unprognostic (7.84e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-3)" "unprognostic (4.71e-2)" "unprognostic (2.03e-1)" "unprognostic (1.26e-1)" "unprognostic (6.32e-1)" "unprognostic (4.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" 21.3 17.2 13.2 10.3 13.1 12.8 20.6 13.2 18.8 13.1 14.6 14.2 17.0 13.4 8.1 16.0 23.9 19.8 17.9 12.3 12.6 23.6 90.0 11.8 19.6 14.1 13.1 11.9 17.1 26.8 12.4 9.5 6.9 14.4 15.2 5.0 4.0 22.9 7.9 25.7 17.0 15.4 8.1 12.8 14.4 18.3 15.3 13.9 23.4 16.4 16.1 11.2 18.6 14.0 14.9 0.0 7.0 7.1 35.2 14.9 30.9 27.1 15.6 17.0 10.9 10.7 44.0 45.6 33.0 24.6 20.2 0.0 20.8 4.5 16.4 4.6 0.0 2.7 6.6 16.2 28.6 22.7 0.7 17.8 19.7 0.0 6.6 0.0 0.0 0.1 53.5 0.1 22.0 14.0 60.0 26.1 34.0 1.6 29.9 27.8 29.3 0.1 12.7 20.7 16.0 7.2 18.0 18.3 7.7 0.0 5.5 29.8 25.3 0.0 14.6 7.1 0.1 0.0 0.0 0.0 17.1 0.0 10.8 0.0 9.6 37.2 17.1 43.9 39.2 43.6 49.7 40.4 42.0 39.0 48.2 39.6 42.8 4.6 49.5 37.2 43.7 54.0 42.1 13.2 13.1 13.2 18.8 12.3 12.6 14.1 13.1 11.9 14.4 12.8 13.9 14.9 106.0 12.8 19.0 32.0 59.2 51.2 80.6 91.5 49.5 17.4 69.0 112.9 49.3 94.4 48.7 103.0 8.4 51.3 51.1 55.6 127.2 50.0 107.6 138.0 29.6 70.4 54.5 48.2 28.5 58.7 67.0 59.2 31.1 34.1 64.7 93.9 108.1 465.7 89.7 15.2 16.9 73.1 50.8 75.0 48.7 140.6 67.4 44.6 65.8 62.8 56.4 37.2 78.2 23.1 30.7 82.4 57.9 55.3 37.0 47.1 108.4 340.3 102.5 45.6 46.0 48.6 70.6 45.3 81.4 46.9 42.6 26.8 52.5 87.4 63.8 75.2 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681678-55684611 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 134.3;liver: 286.6" "Cell type enhanced" "Detected in some" "Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6" "Cancer enhanced" "Detected in many" "glioma: 97.9;liver cancer: 97.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 45 "B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5" "Cell line enhanced" "Detected in many" "CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038644 Enhanced Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA038644: AB_2676130" "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favorable (2.37e-4)" "unprognostic (2.43e-1)" 2.1 1.7 6.0 1.8 6.6 1.2 0.9 5.7 11.3 0.3 6.5 28.8 60.2 0.4 134.3 0.1 3.1 11.9 72.8 13.8 11.8 52.6 286.6 1.6 2.4 8.9 6.0 5.4 0.1 2.9 0.2 3.1 11.0 6.0 0.3 23.8 1.3 0.5 0.8 7.5 0.6 55.8 2.1 6.9 4.3 4.3 0.7 10.4 0.2 3.3 10.1 0.5 1.3 0.1 8.4 0.4 21.8 0.1 0.5 4.3 15.3 0.3 0.8 3.2 0.2 1.4 28.4 56.6 11.6 41.3 1.2 1.1 0.1 4.1 0.3 0.8 0.0 5.4 1.2 3.2 28.7 0.0 0.6 0.0 4.0 0.0 1.0 0.0 4.2 0.0 0.0 0.2 0.0 47.0 20.2 0.0 0.4 5.7 32.5 2.7 0.0 1.5 2.7 0.5 0.1 0.1 0.3 2.2 0.0 3.9 0.2 3.8 42.2 0.0 3.1 3.5 0.4 2.9 0.0 0.6 3.5 41.9 9.9 0.2 0.0 0.8 0.0 0.0 4.5 0.0 0.5 0.0 0.0 7.0 1.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 6.0 6.6 5.7 11.3 13.8 11.8 8.9 6.0 5.4 6.0 6.9 10.4 8.4 0.0 0.0 1.5 0.7 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.1 26.5 22.8 0.6 0.0 0.0 0.5 0.0 29.0 3.9 3.9 0.0 0.1 0.0 0.5 1.2 4.0 0.7 5.1 0.5 2.0 2.6 0.2 0.0 0.8 1.1 83.9 72.7 0.0 0.1 14.0 0.0 17.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 4.6 20.7 1.2 0.0 0.1 192.4 55.6 0.0 0.0 0.0 7.8 0.6 0.0 0.1 0.0 0.0 0.7 0.3 0.1 22.2 0.1 KRT86 "Hb6, KRTHB6, MNX" ENSG00000170442 "Keratin 86" O43790 12 52249300-52309163 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "skin 1: 89.8" "Group enriched" "Detected in many" 4 "dendritic cells: 33.1;Early spermatids: 35.5;Late spermatids: 24.3;NK-cells: 11.3;T-cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 9 "basophil: 87.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 87.5" "Cell line enhanced" "Detected in many" "A-431: 24.9;A549: 25.7;MCF7: 51.6;RPMI-8226: 32.5;U-251 MG: 14.5" "HPA039798, HPA049778" Supported Approved Cytosol NA NA 160000000 Cytosol "HPA039798: AB_10674986, HPA049778: AB_2680877" "unprognostic (4.52e-2)" "unprognostic (6.83e-2)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (2.61e-2)" "unprognostic (6.49e-2)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.22e-2)" 0.7 0.5 0.5 0.2 0.7 2.6 0.6 0.2 0.4 0.2 0.0 0.3 0.4 0.4 0.5 0.1 0.7 0.4 0.1 0.8 0.2 0.2 0.1 0.7 0.0 1.0 0.2 0.5 0.1 2.1 0.1 0.1 0.4 0.3 0.3 0.0 0.1 3.9 0.3 0.3 89.8 0.3 0.1 0.2 0.1 0.2 4.1 0.3 0.2 4.1 0.0 0.1 0.8 0.2 1.2 24.9 25.7 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.3 0.1 0.3 1.3 0.0 1.1 0.0 0.5 1.5 0.0 4.5 0.1 10.9 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.5 12.7 0.0 0.0 0.0 1.8 0.0 51.6 0.0 3.0 0.1 0.2 6.1 0.0 0.0 32.5 0.4 3.2 2.9 0.0 4.5 2.0 2.0 0.0 1.4 0.0 0.8 0.0 1.3 0.1 14.5 0.0 0.0 0.0 0.0 5.3 0.0 87.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.5 0.5 0.7 0.2 0.4 0.8 0.2 1.0 0.2 0.5 0.3 0.2 0.3 1.2 0.1 0.0 0.6 0.0 0.3 0.6 2.9 2.0 0.0 0.4 2.8 3.4 0.4 2.8 3.1 0.0 0.0 0.1 33.1 0.2 0.0 2.1 35.5 3.6 0.8 0.2 0.0 0.0 0.5 5.1 1.6 0.3 1.1 4.9 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 2.0 0.0 1.1 24.3 0.3 0.3 1.8 0.0 0.0 0.2 11.3 0.0 0.5 2.9 0.0 0.0 2.1 2.7 0.0 0.6 1.9 0.3 0.0 1.0 0.4 0.8 0.4 0.0 0.1 1.2 14.2 0.0 0.0 3.5 HARS1 "HARS, HisRS, USH3B" ENSG00000170445 "Histidyl-tRNA synthetase 1" P12081 5 140673035-140691537 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 41.4;dendritic cells: 11.5;Extravillous trophoblasts: 48.6;Hofbauer cells: 35.7;Syncytiotrophoblasts: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036539 Approved Enhanced Cytosol NA NA 190000 Cytosol "HPA036539: AB_10669796" "unprognostic (9.35e-2)" "unprognostic (9.95e-2)" "unprognostic (1.62e-3)" "unprognostic (1.65e-2)" "unprognostic (2.33e-1)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.50e-2)" "unprognostic (1.46e-1)" "unprognostic (3.82e-2)" "unprognostic (1.28e-2)" "unprognostic (2.40e-1)" "unprognostic (3.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.36e-1)" 31.4 40.3 69.3 27.3 72.3 24.5 29.6 70.3 89.4 31.9 63.7 36.7 22.0 34.8 27.3 43.3 31.1 21.2 36.9 71.5 74.4 29.8 47.7 27.5 29.9 75.6 75.1 68.8 31.5 41.1 37.4 60.5 18.7 75.3 33.3 29.9 18.7 29.4 32.3 57.2 53.4 28.8 35.5 68.6 32.4 36.3 25.8 82.9 32.5 27.3 33.7 37.1 34.6 32.3 77.7 66.8 94.3 55.5 120.5 68.9 74.9 57.9 104.8 75.0 118.6 109.4 174.8 54.1 88.4 90.3 118.3 94.3 66.6 85.9 169.2 111.6 74.5 105.0 63.7 115.4 111.8 86.3 101.1 49.8 80.4 51.5 129.0 72.6 69.5 122.1 52.2 56.5 68.6 125.6 111.0 71.8 100.6 43.3 52.3 60.9 65.4 82.0 70.9 97.0 82.2 86.5 83.7 86.1 121.5 84.2 54.9 89.5 55.5 100.3 107.8 41.6 61.5 144.7 68.5 90.5 89.4 82.8 83.1 76.1 16.2 31.2 24.0 61.0 46.3 54.2 34.9 54.1 57.6 48.5 34.6 58.1 55.4 8.1 59.3 54.9 34.3 51.3 56.7 69.3 72.3 70.3 89.4 71.5 74.4 75.6 75.1 68.8 75.3 68.6 82.9 77.7 9.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 41.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 48.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 36.0 1.7 0.0 0.0 0.0 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 213.2;Spermatocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059132: AB_2683917" "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 2.7 2.3 2.1 4.5 2.2 4.3 6.5 3.7 2.4 5.5 1.4 3.7 4.7 5.4 11.0 3.9 5.5 3.3 1.6 1.7 2.3 4.1 3.9 3.0 4.1 2.2 2.6 2.0 6.2 4.7 6.6 3.3 3.9 2.4 5.0 4.9 3.7 5.3 4.4 2.7 3.9 3.9 5.0 2.4 3.8 4.8 13.9 2.4 4.3 10.1 2.9 4.6 4.3 3.6 2.2 7.0 4.4 4.8 9.9 8.9 14.6 16.2 4.7 6.7 7.6 9.3 7.4 15.6 5.5 8.8 3.1 14.6 7.1 12.4 9.4 8.9 4.3 4.8 6.0 8.7 13.6 11.5 14.8 11.5 9.6 12.3 5.2 30.7 8.9 6.6 11.5 10.8 6.7 7.8 7.0 11.7 6.9 11.6 9.7 6.7 10.3 9.2 9.3 9.6 13.2 15.1 7.3 3.5 9.8 6.8 9.1 6.8 4.2 5.5 9.8 6.2 4.6 10.6 10.8 7.0 11.2 5.7 8.2 8.8 0.0 0.5 0.6 0.7 0.7 0.9 0.8 1.0 0.8 0.5 0.8 1.1 1.0 1.9 0.4 0.4 0.6 0.7 0.6 2.1 2.2 3.7 2.4 1.7 2.3 2.2 2.6 2.0 2.4 2.4 2.4 2.2 6.9 6.4 8.7 15.0 6.3 5.4 4.0 5.2 7.4 19.6 10.0 7.0 213.2 11.5 9.9 7.3 10.4 5.6 10.5 6.2 11.7 9.2 36.9 15.7 16.7 7.8 11.4 6.9 35.6 7.1 11.5 27.3 7.1 18.4 2.5 10.9 7.9 7.5 4.8 8.4 35.0 11.2 12.2 6.5 4.3 20.2 12.8 9.9 1.8 17.8 7.3 11.0 8.2 33.7 30.7 7.4 4.7 10.1 13.8 7.0 6.5 4.2 9.9 16.5 0.0 8.1 9.1 81.1 27.2 9.9 4.3 6.7 6.8 5.5 8.1 5.2 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434371 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 19.5" "Cell type enriched" "Detected in some" 7 "Ductal cells: 20.4" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 38.5;U-2 OS: 50.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" NA NA 1500000000 Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: AB_2686786" "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 50.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.6 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 DENND5B MGC24039 ENSG00000170456 "DENN domain containing 5B" Q6ZUT9 12 31382226-31591136 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 152.8;Excitatory neurons: 217.3;Inhibitory neurons: 246.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 121.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SuSa: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038865 Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA038865: AB_2676245" "unprognostic (5.41e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (7.23e-2)" "unprognostic (2.13e-1)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (3.14e-1)" "unprognostic (8.27e-2)" "unprognostic (5.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-1)" "unprognostic (2.60e-2)" 4.0 6.5 5.0 5.4 7.5 2.2 3.2 20.9 13.2 4.5 2.7 4.3 9.2 6.9 2.1 2.5 3.9 4.3 11.0 6.3 8.8 7.6 12.6 2.7 7.4 7.8 7.0 5.6 21.9 5.7 2.8 4.7 4.9 8.6 3.0 4.3 16.0 2.0 3.1 7.1 1.2 10.5 7.3 1.5 6.8 5.0 16.2 8.3 2.5 3.0 13.2 8.5 3.7 3.1 8.4 2.8 27.9 20.1 7.7 7.1 8.8 3.0 6.8 7.4 16.9 12.1 18.9 11.1 10.4 11.1 14.8 18.5 0.8 4.0 1.9 16.7 0.0 8.5 0.1 21.2 11.3 6.5 9.6 0.2 5.5 6.0 11.3 18.5 15.5 15.7 5.7 4.0 20.6 10.6 2.6 5.7 10.0 20.4 6.5 4.9 5.4 27.8 0.2 14.2 3.6 6.4 9.5 17.0 1.9 15.0 57.3 2.8 5.2 16.5 6.3 16.0 11.4 14.4 10.9 13.0 10.5 10.7 1.1 10.7 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 5.0 7.5 20.9 13.2 6.3 8.8 7.8 7.0 5.6 8.6 1.5 8.3 8.4 6.7 3.2 0.5 152.8 43.9 2.9 3.5 0.9 2.8 42.4 5.3 4.1 44.0 17.2 2.1 7.3 31.3 0.6 7.0 13.3 3.9 1.8 19.6 6.1 10.1 7.4 8.4 6.3 217.3 9.3 2.9 13.0 4.6 4.4 0.0 45.0 25.0 34.2 4.5 28.6 246.4 3.1 2.0 4.5 5.8 8.3 8.4 3.8 23.2 74.9 2.5 12.9 1.0 144.3 121.0 7.9 3.6 10.5 72.6 2.4 33.2 12.0 2.2 26.8 6.6 12.9 10.0 32.0 18.2 0.2 1.4 0.7 2.3 15.5 4.4 1.2 CD14 ENSG00000170458 "CD14 molecule" P08571 5 140631728-140633701 "Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 406.7" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 2809.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 3697.0" "Group enriched" "Detected in all" 5 "granulocytes: 942.3;monocytes: 3697.0" "Cell line enhanced" "Detected in many" "A549: 10.1;CACO-2: 17.0;SiHa: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001887, HPA002127, CAB033631, CAB072865, CAB072866" Enhanced Approved Vesicles "Secreted to blood" NA NA 2750000000 10000000000 Vesicles "CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.42e-3)" "unprognostic (3.89e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" "unprognostic (4.71e-3)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.80e-5)" "unprognostic (1.20e-2)" "unprognostic (6.87e-3)" "unprognostic (8.12e-2)" "unprognostic (6.92e-2)" 135.7 152.8 14.5 238.1 20.3 69.4 51.0 14.6 38.9 28.1 29.7 56.4 31.7 23.8 21.2 24.1 40.9 80.5 31.6 13.1 63.4 27.2 406.7 92.4 108.8 33.8 20.5 12.6 21.6 27.2 16.8 35.8 184.5 26.6 18.4 48.0 4.0 122.9 30.7 10.7 12.3 38.4 112.8 23.9 88.3 34.2 26.9 28.8 21.1 23.2 17.6 23.2 103.4 12.7 37.2 0.1 10.1 0.1 0.8 1.3 0.3 0.5 0.9 4.7 1.9 2.1 17.0 3.1 0.4 1.0 5.9 1.4 4.9 0.0 2.6 0.5 0.1 1.4 0.3 1.1 2.0 5.1 1.1 0.3 4.8 0.3 0.3 1.5 0.4 0.0 0.3 0.3 0.3 1.7 0.3 0.1 1.2 0.4 0.3 0.3 0.4 0.6 1.8 0.2 0.1 3.6 1.3 21.1 0.5 0.5 0.2 0.3 2.1 0.6 0.4 0.4 1.9 2.1 0.8 1.6 0.8 0.4 0.5 0.1 13.5 3697.0 21.7 6.8 677.3 8.7 12.1 3.7 3.9 440.4 1.9 5.2 3.6 942.3 3.8 95.1 25.2 3.7 3034.0 14.5 20.3 14.6 38.9 13.1 63.4 33.8 20.5 12.6 26.6 23.9 28.8 37.2 17.9 9.6 27.6 0.7 9.0 5.1 3.4 5.2 6.2 7.2 164.9 23.4 2.6 22.8 18.3 1.8 0.0 18.1 5.3 77.2 1.9 5.1 2.3 0.6 1.7 46.5 7.2 29.5 0.7 1.8 16.3 19.7 1.1 1.0 8.8 0.6 340.2 348.0 2809.2 33.7 0.9 5.9 4.1 668.4 75.9 6.1 5.0 652.8 8.8 23.4 285.3 30.0 11.3 0.5 0.4 1.8 35.3 5.3 1.8 1.7 5.0 7.0 9.8 5.1 32.9 25.8 9.7 1.5 2.0 4.4 4.3 46.1 5.5 2.1 7.4 4.9 DNAJC18 MGC29463 ENSG00000170464 "DnaJ heat shock protein family (Hsp40) member C18" Q9H819 5 139408588-139444491 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 78.5" "Group enriched" "Detected in many" 21 "Early spermatids: 529.9;Late spermatids: 1332.4" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036538, HPA060154" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA036538: AB_10670802, HPA060154: AB_2684212" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (2.73e-3)" "unprognostic (8.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "prognostic favorable (5.89e-4)" "unprognostic (8.09e-2)" "unprognostic (1.69e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (6.96e-2)" "unprognostic (1.97e-2)" 5.5 3.1 7.2 1.5 7.6 0.9 5.3 8.1 9.6 6.8 4.6 4.8 0.7 6.6 2.3 2.4 6.6 2.2 6.3 7.2 8.3 3.7 1.0 6.8 1.7 8.4 7.7 7.4 7.5 1.9 3.6 8.1 2.1 9.0 4.6 1.3 7.7 3.0 2.9 7.5 2.3 3.5 3.6 6.6 2.8 3.5 78.5 7.7 1.6 4.4 4.4 1.2 5.4 4.7 9.1 1.2 1.2 7.9 7.4 4.3 4.5 0.9 2.4 5.3 4.2 7.6 2.9 0.9 5.4 6.4 3.8 9.2 2.1 4.5 7.3 4.4 12.5 5.9 3.7 2.6 1.3 3.4 0.4 1.7 6.1 0.9 7.0 4.3 7.1 5.8 2.0 1.7 5.1 6.3 0.6 1.6 1.7 5.4 0.4 1.8 4.5 8.5 0.9 2.5 1.3 7.3 7.6 2.5 0.9 5.8 10.1 1.1 2.7 7.5 5.5 0.0 1.7 5.2 6.0 8.6 2.8 2.9 2.7 2.4 0.5 0.4 0.5 0.5 0.3 0.7 0.8 0.7 0.9 0.3 0.9 0.7 0.4 0.1 1.4 0.2 0.5 1.7 0.3 7.2 7.6 8.1 9.6 7.2 8.3 8.4 7.7 7.4 9.0 6.6 7.7 9.1 14.9 3.2 3.9 12.7 5.0 1.5 8.3 9.4 7.4 29.4 2.2 5.5 11.0 2.8 5.8 1.8 10.4 4.7 7.0 0.7 1.9 4.9 529.9 2.1 11.0 15.2 12.6 1.7 33.1 1.1 3.4 11.3 2.0 2.3 9.5 14.4 13.6 0.2 2.9 16.8 39.0 2.1 0.0 3.5 2.4 1332.4 14.0 3.4 5.4 8.4 3.7 13.7 3.1 17.6 22.1 2.0 1.7 18.8 7.6 3.9 0.8 3.6 3.3 20.1 19.7 21.1 14.2 43.8 12.9 2.6 1.1 4.7 4.2 9.8 1.3 3.4 KRT6C KRT6E ENSG00000170465 "Keratin 6C" P48668 12 52468516-52473805 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 805.9;vagina: 336.2" "Cell type enriched" "Detected in some" 60 "Squamous epithelial cells: 234.3" "Group enriched" "Detected in many" 5 "head and neck cancer: 564.7;melanoma: 242.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 94.1" "HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (3.18e-2)" "unprognostic (6.26e-3)" "unprognostic (6.63e-2)" "unprognostic (1.54e-3)" "unprognostic (6.97e-2)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (2.84e-1)" "unprognostic (4.50e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 101.1 0.0 0.0 0.0 0.1 0.0 805.9 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 145.5 0.0 0.1 23.3 0.1 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 9.6 0.1 336.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 94.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.2 1.3 2.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 234.3 2.4 0.0 0.0 0.0 0.2 3.9 RIOX1 "C14orf169, FLJ21802, JMJD9, MAPJD, NO66" ENSG00000170468 "Ribosomal oxygenase 1" Q9H6W3 14 73490933-73493394 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 9.1;dendritic cells: 8.0;Extravillous trophoblasts: 6.9;Hofbauer cells: 8.2;monocytes: 7.2;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003730 Supported "Nucleoli rim" NA NA "Nucleoli rim" "HPA003730: AB_2667040" "unprognostic (4.70e-3)" "unprognostic (1.94e-2)" "unprognostic (2.45e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-3)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-2)" "unprognostic (5.36e-2)" "unprognostic (1.35e-3)" "unprognostic (4.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (7.97e-3)" "unprognostic (8.62e-2)" 3.8 4.3 5.1 5.1 4.7 7.9 3.7 6.6 5.0 3.5 4.1 4.5 3.9 5.4 4.9 5.6 4.4 2.4 5.0 4.6 4.5 3.7 6.8 3.9 6.7 4.4 3.8 4.9 3.9 6.5 5.4 3.5 2.8 4.7 3.4 3.7 1.9 4.7 3.8 3.6 3.8 5.1 4.1 3.5 5.6 5.0 13.7 4.7 9.5 3.4 3.0 6.9 4.6 3.3 5.2 17.5 15.5 9.9 15.3 12.5 7.0 19.0 11.7 8.5 11.8 10.6 13.5 8.8 29.7 8.4 10.1 9.9 20.4 19.1 11.6 9.8 19.0 21.0 18.7 9.0 9.0 6.9 0.0 24.1 7.6 10.6 11.4 5.2 7.5 10.8 17.0 13.8 10.7 10.7 27.6 33.1 21.4 10.8 15.1 26.0 26.1 15.4 9.0 11.8 12.9 20.5 14.8 19.4 34.4 12.7 9.8 34.4 18.6 15.6 0.0 19.5 10.2 0.1 14.6 16.9 10.2 5.2 15.3 11.8 0.1 1.3 3.4 3.7 2.3 4.3 2.3 3.6 2.9 1.8 1.6 3.3 2.5 0.5 3.2 1.4 3.1 1.7 0.8 5.1 4.7 6.6 5.0 4.6 4.5 4.4 3.8 4.9 4.7 3.5 4.7 5.2 2.9 3.2 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.4 3.2 0.0 0.0 3.1 5.5 0.0 9.1 8.0 0.0 5.9 3.8 0.0 4.2 4.0 2.1 0.0 0.0 0.0 5.7 6.9 1.5 0.0 4.7 2.5 5.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.4 3.4 3.5 0.0 0.0 SPATA24 "CCDC161, T6441" ENSG00000170469 "Spermatogenesis associated 24" Q86W54 5 139396563-139404089 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 148.2" "Group enriched" "Detected in many" 26 "Early spermatids: 1073.6;Late spermatids: 2829.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 85.6" HPA044000 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044000: AB_10959668" "unprognostic (2.19e-3)" "unprognostic (1.18e-1)" "unprognostic (2.09e-1)" "unprognostic (9.30e-2)" "unprognostic (3.82e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.36e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (3.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" 2.7 7.2 7.0 3.0 5.3 1.9 4.1 6.2 7.2 3.3 5.2 4.7 6.6 4.1 21.2 3.5 15.1 3.8 20.8 5.5 7.6 15.2 5.1 3.1 7.2 7.1 7.4 4.6 4.3 5.3 12.5 12.8 3.1 6.7 4.9 2.9 6.6 6.6 4.1 23.3 2.9 7.2 2.9 8.0 4.1 4.3 148.2 6.4 3.1 7.3 19.3 5.4 3.9 3.2 5.9 13.4 8.4 11.6 6.3 3.3 6.5 9.2 3.3 6.3 7.0 12.0 18.7 17.2 21.0 9.5 6.4 23.5 7.3 8.7 14.6 7.4 85.6 10.4 6.5 15.7 14.4 12.7 1.4 11.1 5.7 7.1 10.2 12.6 7.7 8.3 13.3 6.5 36.1 9.3 7.4 13.8 10.1 8.5 5.4 7.1 31.6 7.5 28.9 16.3 7.2 8.8 8.0 12.8 24.2 6.0 28.0 7.0 14.5 15.3 4.1 5.3 7.7 9.5 8.7 8.9 19.4 7.6 10.8 3.4 0.0 2.1 1.5 3.0 1.6 4.1 3.5 3.1 3.5 2.4 1.9 3.4 4.8 0.1 2.0 0.6 1.4 1.5 1.5 7.0 5.3 6.2 7.2 5.5 7.6 7.1 7.4 4.6 6.7 8.0 6.4 5.9 2.2 0.0 4.1 2.6 3.4 1.7 6.4 6.4 2.8 0.3 3.8 3.4 24.7 7.2 3.7 5.5 8.4 6.0 2.3 3.0 13.7 4.6 1073.6 14.9 1.6 4.1 0.0 0.8 1.0 1.8 3.2 2.2 2.0 2.4 0.0 3.6 4.2 3.7 5.2 1.7 1.3 1.5 2.0 2.7 1.4 2829.6 14.3 2.4 1.8 0.0 1.5 3.3 7.2 0.5 0.9 2.6 3.1 13.5 1.7 3.3 6.8 36.5 20.8 1.4 26.3 3.7 4.1 75.0 18.2 2.4 1.8 4.5 3.2 8.5 3.1 5.4 RALGAPB "DKFZp781M2411, KIAA1219, RalGAPbeta" ENSG00000170471 "Ral GTPase activating protein non-catalytic subunit beta" Q86X10 20 38472816-38578859 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051454 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA051454: AB_2681490" "unprognostic (1.06e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-2)" "unprognostic (3.42e-3)" "unprognostic (1.34e-1)" "unprognostic (1.06e-1)" "unprognostic (2.72e-3)" "unprognostic (7.28e-2)" "unprognostic (2.33e-1)" "unprognostic (8.93e-3)" "unprognostic (2.71e-1)" "unprognostic (9.51e-2)" "prognostic favorable (7.25e-4)" "unprognostic (3.03e-1)" "unprognostic (3.95e-1)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" 9.7 10.7 7.1 12.2 9.2 12.4 16.3 13.2 10.9 12.3 12.7 12.0 12.2 12.1 12.8 14.0 11.0 10.8 10.6 9.1 9.1 14.5 8.6 11.2 12.3 8.0 8.2 7.6 11.7 11.8 24.4 10.6 14.4 8.7 14.5 13.4 18.9 10.9 12.8 12.2 13.8 12.0 13.0 6.6 11.2 12.5 20.9 9.0 17.7 18.3 14.5 15.0 15.4 9.4 9.4 25.3 23.4 23.8 17.5 22.5 25.9 25.3 20.3 23.6 24.8 24.3 42.3 18.6 23.7 18.9 23.7 36.5 29.2 22.6 30.8 34.8 13.6 9.6 36.2 21.0 24.3 21.3 29.6 18.4 18.5 39.1 29.3 32.0 19.7 32.9 20.0 26.8 22.9 24.2 16.5 34.1 12.5 17.5 24.9 30.1 19.4 34.0 15.9 16.5 46.7 25.1 27.6 44.9 59.8 37.4 27.2 34.8 15.0 39.2 49.9 19.9 28.6 20.8 26.6 34.9 21.1 36.1 14.2 22.5 1.2 0.9 2.4 1.2 0.7 1.6 1.3 1.7 1.5 1.4 1.0 1.5 1.2 1.7 2.0 1.3 0.9 0.8 0.6 7.1 9.2 13.2 10.9 9.1 9.1 8.0 8.2 7.6 8.7 6.6 9.0 9.4 23.1 22.4 17.1 47.7 18.6 13.9 7.4 12.4 17.1 24.4 19.5 12.3 20.0 10.0 17.7 31.3 27.1 10.4 23.4 26.9 3.9 9.4 11.8 24.3 20.2 17.4 12.6 14.9 63.3 9.3 7.8 15.7 30.5 28.8 16.5 19.4 23.2 12.1 9.7 20.2 66.0 16.1 16.2 17.7 11.6 8.7 16.8 14.7 10.6 49.6 15.1 10.0 16.5 58.3 81.0 15.2 20.4 18.8 16.7 16.1 26.9 9.0 20.9 18.3 13.1 16.8 13.5 31.8 24.0 19.7 18.0 15.2 19.4 15.9 15.8 14.2 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 110.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" No No 27000 "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" 23.9 31.1 21.5 24.2 22.1 22.6 28.2 23.2 25.0 22.6 23.8 31.4 31.8 22.3 41.9 72.9 22.9 20.0 19.5 21.3 22.8 22.7 43.3 21.0 35.7 22.3 21.6 21.1 17.2 28.2 26.5 22.4 22.9 22.1 31.5 30.3 17.6 34.3 16.0 30.1 41.5 29.7 20.0 21.9 31.3 24.3 26.1 21.7 33.5 27.3 29.2 42.4 25.1 31.6 22.1 50.3 39.1 56.1 31.4 33.4 43.2 92.6 36.1 43.1 33.3 28.0 57.7 57.9 62.9 53.6 35.1 15.4 38.6 43.6 77.1 26.7 48.6 32.7 51.0 35.1 71.8 40.7 59.7 44.7 39.2 48.8 37.7 56.0 42.2 35.9 27.3 44.5 67.4 39.7 75.3 38.6 105.7 98.3 56.7 20.2 34.3 22.3 72.5 69.5 69.8 37.7 43.4 46.2 61.1 33.1 51.8 74.5 124.0 28.2 20.0 28.3 31.5 26.6 35.5 58.2 97.2 34.2 40.9 31.9 17.5 79.8 75.8 58.5 92.2 72.3 98.1 105.4 82.2 120.2 88.2 68.7 69.5 19.1 53.1 66.5 65.6 186.0 87.2 21.5 22.1 23.2 25.0 21.3 22.8 22.3 21.6 21.1 22.1 21.9 21.7 22.1 16.2 19.2 17.3 0.0 28.6 0.0 29.4 0.0 21.1 12.7 41.7 38.4 0.0 25.8 14.2 23.9 8.4 84.3 21.1 29.8 78.2 40.6 15.2 21.1 17.0 16.3 7.3 32.2 0.0 50.6 76.3 17.6 22.4 21.1 18.9 14.5 22.9 44.3 55.2 6.7 0.0 32.1 0.0 47.7 0.0 11.7 23.3 42.8 0.0 0.0 110.4 55.7 48.4 0.0 0.0 54.1 33.7 23.7 21.9 34.7 66.8 61.3 16.8 13.6 13.1 18.0 15.7 23.8 25.6 63.1 0.0 62.0 29.6 16.5 29.3 34.3 MZB1 "HSPC190, MEDA-7, MGC29506, PACAP, pERp1" ENSG00000170476 "Marginal zone B and B1 cell specific protein" Q8WU39 5 139387467-139390081 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 90.6;lymphoid tissue: 274.4" "Cell type enriched" "Detected in many" 6 "Plasma cells: 4000.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 160.4;plasmacytoid DC: 569.3" "Group enriched" "Detected in many" 116 "B-cells: 160.4;dendritic cells: 569.3" "Group enriched" "Detected in some" 5 "Karpas-707: 581.5;RPMI-8226: 2193.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043745, HPA052694" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 350000 "Golgi apparatus" "HPA043745: AB_10960359, HPA052694: AB_2681919" "unprognostic (4.97e-3)" "unprognostic (1.75e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.27e-4)" "unprognostic (2.21e-2)" "prognostic favorable (4.60e-5)" "unprognostic (6.57e-2)" "unprognostic (1.35e-1)" "unprognostic (6.45e-3)" "unprognostic (7.10e-3)" "unprognostic (2.57e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.15e-8)" "unprognostic (7.22e-2)" "unprognostic (3.14e-1)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" 3.7 9.2 0.1 88.2 0.1 33.3 21.2 0.1 0.7 18.5 0.3 70.8 90.6 1.8 0.4 10.2 5.8 14.4 2.3 0.1 0.1 5.9 5.8 16.0 124.2 0.2 0.4 0.1 5.0 1.3 0.0 0.7 0.0 0.2 5.1 40.2 0.0 57.2 4.9 0.1 0.4 48.2 2.1 0.4 274.4 67.2 2.4 0.2 148.6 9.1 0.0 118.7 59.2 3.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 256.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 144.6 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.5 581.5 0.0 0.0 227.8 2.2 0.0 0.0 0.0 90.1 0.3 2193.9 0.0 0.0 0.3 0.8 0.0 11.4 0.0 0.0 3.1 0.1 0.6 0.0 1.8 0.1 0.0 262.0 16.7 223.0 0.1 0.4 0.0 0.0 0.1 0.1 1.5 0.1 3.0 160.4 0.6 1.1 0.5 75.6 0.1 0.2 3.1 2.7 0.0 569.3 0.2 26.1 0.1 0.1 0.1 0.7 0.1 0.1 0.2 0.4 0.1 0.2 0.4 0.2 0.3 0.4 6.4 10.1 0.0 665.7 2.5 1.3 0.1 0.0 0.0 3.7 3.2 1.1 4.3 2.0 0.0 0.0 0.1 235.0 0.9 0.0 0.1 0.1 1.8 0.4 2.0 1.2 49.3 0.0 0.0 0.1 2.0 6.1 0.4 2.5 0.1 11.4 14.0 0.1 0.0 0.0 1.1 0.0 7.1 3.4 1.1 0.0 4.7 540.7 0.0 1.0 0.0 4.1 0.0 0.0 0.1 0.4 0.0 4000.1 3.0 1.2 1.9 1.2 0.0 0.0 1.7 2.1 0.1 0.1 0.4 2.4 2.2 100.7 0.5 9.7 0.4 KRT4 "CK4, CYK4, K4" ENSG00000170477 "Keratin 4" P19013 12 52806549-52814116 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "esophagus: 19918.5" "Cell type enriched" "Detected in some" 18 "Squamous epithelial cells: 5828.7" "Group enriched" "Detected in many" 5 "cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "HaCaT: 734.9;SK-BR-3: 361.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002154, HPA034881" Enhanced Supported "Intermediate filaments" NA NA 600000000 "Intermediate filaments" "CAB002154: AB_563803, HPA034881: AB_2674370" "unprognostic (4.04e-1)" "unprognostic (3.22e-3)" "unprognostic (5.16e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "unprognostic (2.64e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.85e-3)" "unprognostic (2.84e-2)" "unprognostic (2.58e-11)" "unprognostic (1.64e-1)" "unprognostic (6.97e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.26e-4)" 1.3 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 246.0 0.0 1.0 0.0 1.2 0.0 19918.5 9.6 3.2 7.2 0.0 0.0 0.9 2.6 17.5 0.0 0.0 0.0 0.0 1.8 2.8 0.0 8.9 0.0 0.0 4.4 0.0 0.0 2140.9 0.0 2.6 3.2 1.7 0.9 0.0 1.6 8.7 0.8 0.0 2.0 1.0 0.1 1430.5 4.4 1048.7 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.8 0.0 0.1 0.0 734.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.5 1.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 1.4 0.0 0.2 0.0 15.5 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 1.0 361.6 0.0 0.0 2.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 1.0 0.9 0.5 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 3.3 0.0 0.0 0.0 6.5 36.9 23.3 0.0 0.5 2.9 0.5 0.0 308.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.2 2.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.5 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.9 6.9 0.0 0.1 53.7 0.0 0.0 0.0 5.3 0.0 0.1 5828.7 0.0 0.0 2.0 0.0 0.0 54.4 SLC23A1 "SLC23A2, SVCT1, YSPL3" ENSG00000170482 "Solute carrier family 23 member 1" Q9UHI7 5 139367196-139384553 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 54.6;intestine: 65.8;kidney: 40.6;liver: 22.6" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0" "Group enriched" "Detected in many" 5 "endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047612 Enhanced NA NA "HPA047612: AB_2680102" "unprognostic (4.00e-3)" "unprognostic (2.66e-3)" "unprognostic (2.63e-2)" "unprognostic (1.75e-3)" "unprognostic (1.93e-1)" "unprognostic (6.36e-6)" "unprognostic (7.41e-2)" "unprognostic (6.55e-2)" "unprognostic (5.88e-2)" "unprognostic (3.90e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (4.16e-2)" "unprognostic (1.55e-2)" "unprognostic (3.65e-3)" 0.1 0.1 0.2 1.2 0.5 2.8 0.2 1.0 0.3 1.7 0.1 3.3 26.6 0.7 0.0 0.3 54.6 2.4 0.1 0.3 0.4 40.6 22.6 0.9 1.7 0.8 2.1 0.0 0.4 1.2 0.3 0.2 0.1 0.7 6.3 1.5 0.6 3.2 0.6 0.4 1.9 65.8 0.2 0.2 1.3 1.5 0.2 0.8 5.5 0.2 0.0 1.3 0.4 0.3 0.6 0.3 2.1 0.4 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.4 1.3 5.8 3.0 0.0 0.1 0.3 0.0 0.0 0.1 8.3 0.1 0.2 0.8 13.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 15.5 0.1 10.9 0.0 0.2 5.7 1.0 0.1 0.8 0.1 6.8 0.3 10.9 0.5 0.4 0.3 0.3 0.3 1.9 0.0 0.7 5.0 0.1 0.3 0.3 0.3 0.1 0.0 16.6 2.2 7.6 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.2 0.5 1.0 0.3 0.3 0.4 0.8 2.1 0.0 0.7 0.2 0.8 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.3 1.5 2.0 0.0 4.2 0.4 0.4 1.9 5.9 0.2 0.0 65.2 0.7 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 1.5 0.0 0.1 0.4 19.3 0.1 0.0 1.2 3.6 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.1 3.1 0.0 0.4 0.9 131.7 27.0 13.4 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.0 4.2 0.2 KRT74 "K6IRS4, KRT5C, KRT6IRS4" ENSG00000170484 "Keratin 74" Q7RTS7 12 52565782-52573843 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "epididymis: 5.6;skin 1: 10.0" "Cell type enriched" "Detected in some" 5 "Late spermatids: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040655, HPA048596" Enhanced Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 130000000 "Intermediate filaments" "Nucleoli, Cytosol" "HPA040655: , HPA048596: AB_2680457" "unprognostic (6.75e-3)" "unprognostic (3.93e-1)" "unprognostic (1.60e-1)" "unprognostic (2.49e-2)" "unprognostic (9.46e-2)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NPAS2 "bHLHe9, MOP4, PASD4" ENSG00000170485 "Neuronal PAS domain protein 2" Q99743 2 100820139-100996829 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 112.6;Early spermatids: 65.1;Excitatory neurons: 150.5;Inhibitory neurons: 58.5;Microglial cells: 69.3;Oligodendrocyte precursor cells: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 142.8;PC-3: 110.3;RT4: 90.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019674 Uncertain Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA019674: AB_10601275" "unprognostic (2.74e-1)" "unprognostic (8.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.06e-3)" "unprognostic (4.39e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (5.47e-3)" "unprognostic (4.48e-1)" "unprognostic (1.56e-1)" "unprognostic (1.59e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (3.55e-7)" "unprognostic (7.03e-2)" "unprognostic (6.58e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-3)" 8.5 12.6 18.2 6.0 16.6 0.1 9.6 2.3 17.7 12.8 3.1 13.7 21.1 13.6 2.9 50.7 11.0 10.0 26.2 17.0 9.1 17.9 23.8 8.0 2.3 7.7 10.3 14.5 3.9 39.9 1.2 15.1 5.3 9.1 17.4 11.2 6.2 18.3 4.5 22.1 27.1 17.5 9.2 4.9 6.0 24.2 11.2 18.8 1.2 9.7 7.8 5.1 28.6 22.4 11.6 13.4 74.1 0.1 0.9 69.9 30.1 10.6 24.4 72.2 9.8 21.1 1.3 6.0 0.0 28.5 4.0 142.8 0.6 10.8 18.1 10.2 0.9 4.2 0.0 13.7 34.6 33.1 0.0 3.0 25.6 28.7 23.9 38.3 39.8 41.0 7.8 0.3 0.2 8.0 27.1 5.1 0.6 1.3 21.8 110.3 0.3 1.6 0.8 51.0 90.4 0.2 1.4 0.1 4.4 54.8 0.8 0.7 0.8 15.8 7.3 9.6 14.6 10.7 0.0 0.0 0.1 77.3 0.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 18.2 16.6 2.3 17.7 17.0 9.1 7.7 10.3 14.5 9.1 4.9 18.8 11.6 1.2 0.0 11.4 112.6 0.4 3.8 8.6 12.0 3.4 6.4 9.0 10.2 16.0 21.5 8.8 12.9 0.0 0.8 0.2 32.6 0.0 12.9 65.1 10.1 5.7 7.1 9.1 0.0 150.5 15.6 1.0 5.7 24.5 22.0 0.0 3.7 21.4 14.4 0.1 28.6 58.5 8.9 6.1 0.3 1.0 14.0 7.2 0.7 3.6 69.3 0.8 3.2 0.0 58.3 4.2 14.3 15.5 5.3 0.1 27.3 30.5 11.3 6.0 0.6 0.0 4.8 3.9 0.6 3.5 9.6 6.5 0.3 1.3 5.5 12.4 39.1 KRT72 "K6irs, K6IRS2, KRT6, KRT6IRS2" ENSG00000170486 "Keratin 72" Q14CN4 12 52585589-52601538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 10.5;testis: 23.9" "Group enriched" "Detected in some" 4 "Early spermatids: 26.3;Late spermatids: 67.5;Spermatocytes: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065523 Enhanced NA NA "HPA065523: AB_2685504" "unprognostic (3.36e-1)" "unprognostic (7.20e-2)" "unprognostic (3.41e-2)" "unprognostic (1.02e-1)" "unprognostic (6.97e-2)" "unprognostic (4.38e-3)" "unprognostic (4.82e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" 0.1 0.1 0.0 0.7 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.5 2.2 0.0 0.0 2.3 0.0 23.9 0.0 0.5 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 26.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.5 1.5 0.1 0.0 0.0 0.1 0.0 12.3 0.0 0.1 0.0 2.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.2 0.0 0.4 0.0 0.3 0.0 0.1 0.0 KISS1 ENSG00000170498 "KiSS-1 metastasis suppressor" Q15726 1 204190341-204196491 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "placenta: 235.3" "Cell type enriched" "Detected in many" 26 "Syncytiotrophoblasts: 1336.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.2" "Region enriched" "Detected in some" 8 "hypothalamus: 9.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "BJ: 145.5;U-2 OS: 59.4" "Not detected" "Not detected" "CAB017775, HPA035542" Enhanced Approved Vesicles "Secreted in female reproductive system" NA NA 860000 Vesicles "CAB017775: , HPA035542: AB_2674677" "unprognostic (9.64e-2)" "unprognostic (1.78e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-1)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.63e-1)" "unprognostic (8.98e-12)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "prognostic favorable (6.29e-6)" 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.7 0.6 0.3 0.7 0.2 0.9 0.2 0.0 0.1 0.1 0.0 0.1 0.4 9.9 2.4 4.4 1.4 0.0 1.3 0.3 0.3 0.1 1.0 0.1 3.1 235.3 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.2 0.2 2.1 3.3 5.2 0.9 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 2.4 145.5 1.8 2.5 0.7 0.0 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.2 0.0 0.2 0.1 0.0 0.0 0.9 0.2 0.1 0.0 0.7 0.0 0.8 0.2 0.3 0.0 0.1 59.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.7 0.6 0.4 9.9 1.3 0.3 0.3 0.4 0.2 0.9 0.4 0.3 0.0 0.0 0.3 0.0 0.0 4.0 7.5 0.0 1.0 1.2 0.6 0.0 1.5 2.2 0.0 0.0 9.3 0.0 1.5 0.0 11.3 40.2 0.2 0.0 1.4 0.0 0.0 0.1 4.9 6.9 1.9 4.1 0.5 0.0 0.4 0.7 2.8 15.1 0.0 0.0 0.6 0.0 0.0 0.0 5.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.5 0.0 0.1 50.1 17.0 1.4 0.4 0.0 0.0 0.0 7.1 0.6 1.1 0.0 0.0 1336.6 0.1 0.1 2.1 14.3 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100271875-100322501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.2;fallopian tube: 46.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.6;Excitatory neurons: 166.8;Horizontal cells: 111.0;Inhibitory neurons: 126.2;Oligodendrocyte precursor cells: 58.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 15.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;GAMG: 7.3;HAP1: 5.8;HEK 293: 6.2;HMC-1: 5.1;PC-3: 5.3;SCLC-21H: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034595, HPA057366" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034595: , HPA057366: AB_2683420" "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 2.2 32.2 16.3 0.5 20.6 0.1 3.2 8.5 22.3 9.8 4.7 3.9 0.6 26.6 42.5 2.6 46.0 2.3 6.4 23.1 73.2 1.8 1.0 1.8 0.5 3.3 8.4 21.7 24.5 6.3 9.7 18.1 0.7 7.6 4.2 0.7 11.3 2.4 4.0 7.1 0.9 1.6 28.5 0.0 0.8 4.6 2.2 19.9 0.4 5.0 4.1 0.3 4.2 3.7 18.1 0.0 6.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 1.1 0.0 1.0 0.0 7.3 0.0 5.8 0.0 0.0 0.5 6.2 0.0 0.4 0.0 0.2 0.1 5.1 0.0 0.0 0.2 0.0 0.4 0.0 1.6 3.5 0.1 0.0 4.0 0.0 0.3 0.3 1.1 5.3 0.0 0.0 0.0 1.4 0.2 12.5 3.4 0.0 0.0 0.8 1.9 3.2 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 16.3 20.6 8.5 22.3 23.1 73.2 3.3 8.4 21.7 7.6 0.0 19.9 18.1 0.5 0.0 11.7 52.5 0.5 0.8 1.4 0.0 1.2 72.6 5.1 2.3 37.4 8.6 3.1 5.5 31.3 2.3 0.1 0.3 5.9 3.7 0.6 22.5 43.6 1.8 11.4 2.7 166.8 2.2 0.2 12.7 4.1 37.1 5.7 25.8 0.0 0.6 0.4 111.0 126.2 0.5 0.0 0.0 1.2 2.3 3.4 0.6 1.8 7.5 0.0 8.4 0.0 58.3 38.7 1.5 0.1 11.7 0.1 4.9 0.0 0.3 3.4 20.6 6.6 3.3 5.3 0.8 0.6 0.8 0.1 2.9 1.6 0.9 0.4 0.4 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422573-87459455 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 160.7" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9900 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 23.8 36.4 23.5 16.4 23.8 6.8 19.9 28.0 33.2 27.7 39.3 27.3 43.0 25.1 32.5 19.7 25.1 16.4 28.1 24.3 23.8 40.8 47.0 23.2 13.8 23.7 23.5 22.7 26.9 68.1 55.8 29.3 20.1 25.7 30.7 27.4 20.3 28.4 24.0 42.5 16.3 40.6 24.0 21.6 14.8 22.5 22.7 23.8 13.6 29.1 45.4 14.9 22.6 24.5 28.3 30.8 25.6 34.0 19.8 67.6 39.6 26.0 59.8 35.6 21.3 21.1 17.1 53.1 47.6 58.9 47.6 41.0 21.1 32.1 38.1 33.2 34.5 24.0 13.4 34.5 31.8 42.4 25.6 21.2 41.5 52.4 25.6 22.6 45.5 41.6 13.7 40.3 30.0 38.7 33.4 39.1 23.2 29.1 68.5 12.0 45.0 31.8 27.0 160.7 24.2 41.3 28.7 37.6 63.0 30.8 44.5 36.8 38.2 43.7 34.7 34.3 25.8 27.8 21.5 18.7 37.9 51.3 21.9 48.2 1.6 17.9 5.9 19.1 21.2 18.2 22.2 18.5 19.5 21.4 18.8 22.5 26.0 1.8 15.6 24.0 20.6 19.0 16.0 23.5 23.8 28.0 33.2 24.3 23.8 23.7 23.5 22.7 25.7 21.6 23.8 28.3 32.6 67.3 44.8 20.2 14.9 9.9 40.4 45.0 9.6 15.3 11.3 13.1 40.9 30.0 55.0 23.9 27.1 33.2 13.1 21.0 41.1 44.7 28.6 26.0 26.2 25.8 16.8 6.7 21.7 36.5 32.5 29.4 8.6 27.0 20.8 23.3 18.2 47.5 33.2 6.7 24.0 18.0 40.7 12.7 11.0 11.5 25.4 14.7 10.6 20.6 16.4 26.8 8.2 18.6 24.8 29.4 37.0 26.7 15.8 32.9 55.7 56.2 41.0 18.6 26.3 36.9 23.7 44.5 23.6 15.7 9.5 37.6 12.1 29.8 24.9 27.3 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322886 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "liver: 578.4" "Cell type enhanced" "Detected in many" "Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "NB-4: 1.4" "Not detected" "Not detected" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favorable (2.94e-4)" "prognostic favorable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 9.4 0.3 0.8 0.2 0.8 1.4 6.5 2.6 1.1 2.1 0.3 0.7 0.4 2.7 0.2 0.2 1.0 0.2 0.4 0.7 0.6 0.4 578.4 3.6 0.2 1.0 0.8 0.9 0.5 1.8 0.1 0.3 0.8 1.1 4.6 0.4 0.8 0.2 0.2 0.4 6.6 0.7 4.3 0.5 0.7 0.3 0.4 0.6 0.3 0.2 0.1 0.1 1.2 7.8 1.0 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.4 0.2 0.7 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.1 0.0 0.1 1.4 0.1 0.4 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.2 1.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.8 0.8 2.6 1.1 0.7 0.6 1.0 0.8 0.9 1.1 0.5 0.6 1.0 100.0 3.2 6.4 1.6 0.0 2.5 22.6 0.3 0.0 0.2 0.2 0.3 0.3 4.3 42.9 1.8 0.0 0.1 0.4 1.0 0.0 0.1 2.7 0.4 0.5 2.4 1.8 5.3 3.7 0.4 0.3 0.8 0.0 0.1 0.0 0.2 1.8 131.3 0.2 0.0 3.0 0.5 0.0 2.4 0.4 2.7 0.0 0.7 0.0 0.0 0.3 0.3 0.0 1.5 2.8 0.1 1.4 0.4 0.1 4.7 0.2 0.5 34.0 0.1 0.0 0.7 0.4 0.0 0.9 0.2 0.4 0.0 0.7 0.2 0.7 57.0 PA2G4 ENSG00000170515 "Proliferation-associated 2G4" Q9UQ80 12 56104537-56113910 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation, Translation regulation" "Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011711, CAB012428, HPA016484" Supported Approved Cytosol NA NA 2300000 Cytosol "CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912" "unprognostic (5.53e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-2)" "unprognostic (3.87e-1)" "unprognostic (6.03e-3)" "prognostic unfavorable (6.31e-7)" "unprognostic (4.25e-3)" "unprognostic (2.77e-1)" "unprognostic (3.79e-3)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (4.59e-7)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (1.32e-1)" "unprognostic (4.67e-2)" 78.2 60.1 48.7 90.1 52.6 134.1 77.0 52.9 58.5 59.1 46.3 79.5 74.8 65.2 48.6 133.6 65.3 44.1 73.7 50.3 51.8 62.4 73.4 63.1 97.4 51.9 50.5 47.6 71.8 75.8 84.3 36.5 69.7 53.1 53.7 91.4 38.6 64.5 55.9 145.2 105.6 70.3 69.0 52.3 61.8 66.0 63.6 50.9 124.5 61.9 93.4 121.7 106.4 77.5 59.1 429.6 374.8 248.9 275.5 112.5 169.8 499.6 441.3 209.7 530.9 293.8 464.7 307.5 850.8 291.2 209.6 155.9 343.5 574.2 493.1 510.9 243.9 517.6 659.1 242.5 400.4 219.7 898.8 232.4 172.5 247.2 460.2 410.8 218.1 327.3 292.0 812.8 380.7 294.7 383.5 700.8 496.2 410.9 264.5 460.9 569.3 449.8 577.2 272.0 315.7 372.8 225.6 290.5 451.6 275.0 183.1 488.7 343.5 264.8 256.3 364.7 300.3 495.5 234.4 345.1 822.1 232.3 532.6 340.9 34.3 87.0 54.6 129.9 96.0 174.7 98.0 136.8 141.3 102.1 81.3 129.7 131.2 13.8 151.5 82.0 98.6 170.9 155.9 48.7 52.6 52.9 58.5 50.3 51.8 51.9 50.5 47.6 53.1 52.3 50.9 59.1 135.7 54.5 91.2 9.8 136.3 368.5 244.7 187.4 224.8 56.2 151.9 165.7 37.3 118.7 161.3 130.6 18.8 232.0 163.1 123.4 193.7 235.8 530.6 127.1 218.4 154.2 93.3 552.1 12.8 249.1 321.7 139.5 112.7 142.2 170.9 103.7 107.8 197.5 208.6 33.7 13.0 159.0 99.7 124.2 127.8 238.9 132.0 126.2 129.9 6.5 155.4 117.1 178.2 10.6 14.8 269.3 100.8 126.7 163.5 360.7 118.6 264.7 103.6 48.8 144.7 188.1 191.7 344.6 110.9 295.2 362.7 193.5 176.2 132.2 254.1 242.7 COX7B2 ENSG00000170516 "Cytochrome c oxidase subunit 7B2" Q8TF08 4 46734827-46909245 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 70 "testis: 86.4" "Group enriched" "Detected in some" 9 "Early spermatids: 519.2;Late spermatids: 211.0;Spermatocytes: 391.5" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Karpas-707: 33.9" "Low region specificity" "Detected in many" NA NA "unprognostic (2.82e-1)" "unprognostic (2.42e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 86.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 519.2 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 211.0 9.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 391.5 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOVL6 "FLJ23378, LCE, MGC5487" ENSG00000170522 "ELOVL fatty acid elongase 6" Q9H5J4 4 110045846-110199199 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.4;Hepatocytes: 102.0;Inhibitory neurons: 78.5;Oligodendrocytes: 77.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.4;MAIT T-cell: 2.6;memory CD4 T-cell: 1.0;memory CD8 T-cell: 1.3;naive CD8 T-cell: 1.0;NK-cell: 3.3" "Group enriched" "Detected in many" 21 "NK-cells: 3.3;T-cells: 2.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042355 Uncertain NA NA "HPA042355: AB_10796577" "unprognostic (3.92e-2)" "unprognostic (9.47e-2)" "prognostic favorable (6.74e-4)" "unprognostic (8.09e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-3)" "unprognostic (4.16e-1)" "unprognostic (3.01e-3)" "unprognostic (4.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.33e-1)" "unprognostic (1.90e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (5.32e-2)" 8.7 8.8 4.4 3.0 5.5 4.0 7.5 5.2 8.0 2.8 1.7 11.6 8.6 3.1 2.2 18.1 2.2 3.2 4.3 4.8 5.4 3.2 36.5 3.1 0.7 5.8 5.2 4.7 1.5 2.0 6.4 4.1 1.7 7.2 1.9 10.3 12.2 4.1 2.3 1.0 14.7 6.3 3.7 5.6 1.7 13.7 0.9 6.5 1.8 1.9 0.5 2.4 6.9 5.7 8.0 24.1 14.5 57.8 12.9 31.6 32.6 24.6 16.8 9.5 6.4 16.4 7.6 45.5 2.5 1.3 13.3 22.0 21.5 46.8 52.2 13.6 9.5 14.8 33.9 17.3 17.9 19.6 30.4 18.8 30.0 10.2 34.9 13.5 21.5 11.9 3.4 33.8 57.0 12.6 10.5 7.1 2.6 25.0 15.3 7.2 4.3 24.1 7.2 37.2 20.3 11.0 23.3 9.9 57.9 9.1 24.3 10.0 0.3 5.9 13.2 15.5 20.4 21.4 2.7 11.3 57.9 20.8 0.0 2.8 0.1 0.0 0.0 2.4 0.0 2.6 0.0 1.0 1.3 0.0 0.0 0.3 1.0 0.1 3.3 0.0 0.0 0.1 0.4 4.4 5.5 5.2 8.0 4.8 5.4 5.8 5.2 4.7 7.2 5.6 6.5 8.0 2.1 0.0 7.8 51.2 1.6 1.8 3.0 8.6 2.8 24.4 3.8 2.8 3.2 8.6 9.8 11.0 37.5 2.5 8.9 38.1 5.9 13.0 7.6 3.5 11.1 2.2 3.0 34.9 83.4 8.2 26.8 6.9 30.5 6.3 6.3 8.3 4.2 102.0 1.9 26.9 78.5 14.4 8.2 3.0 0.3 3.9 1.2 0.7 0.0 18.7 0.1 5.5 18.6 56.3 77.3 16.6 24.8 1.2 2.9 2.5 7.1 6.9 2.9 16.3 6.6 6.4 7.5 0.2 1.5 19.9 7.0 2.1 9.6 11.8 22.4 5.1 KRT83 "Hb-3, KRTHB3" ENSG00000170523 "Keratin 83" P78385 12 52314301-52321398 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "skin 1: 40.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 13.3" HPA049778 Supported NA NA 130000000 "HPA049778: AB_2680877" "unprognostic (7.03e-2)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.30e-5)" "unprognostic (3.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-2)" "unprognostic (2.43e-1)" "unprognostic (1.12e-3)" "unprognostic (7.49e-3)" "unprognostic (2.16e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" 0.6 0.0 0.4 0.0 0.7 0.0 0.3 0.7 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 40.1 0.0 0.0 0.8 0.0 0.0 0.2 0.6 0.2 1.0 0.0 0.0 0.0 0.0 1.9 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.3 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.7 0.5 0.7 0.4 0.7 0.6 0.3 0.9 0.8 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PFKFB3 ENSG00000170525 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3" Q16875 10 6144934-6254644 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 337.6;skeletal muscle: 626.4" "Cell type enhanced" "Detected in many" "Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 26.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008266, CAB020795, HPA043889" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717" "unprognostic (1.61e-1)" "unprognostic (5.08e-3)" "unprognostic (2.89e-2)" "unprognostic (6.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (1.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (3.30e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.89e-2)" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" 337.6 23.0 63.4 72.9 69.7 248.2 155.1 76.5 70.3 22.9 23.3 20.5 19.6 24.2 11.2 51.7 38.0 60.5 20.0 62.7 146.2 72.7 33.1 68.3 24.7 139.4 78.7 48.3 24.4 21.2 10.2 39.9 20.1 92.5 20.3 9.0 31.7 40.7 50.0 626.4 50.0 23.1 17.1 86.2 50.6 26.3 14.0 80.9 15.3 11.0 30.6 28.4 64.5 40.6 101.7 22.0 296.2 23.1 18.8 85.2 10.5 12.2 31.6 22.5 22.9 35.5 14.1 78.0 37.2 20.2 13.8 18.0 69.0 24.9 50.2 26.3 44.6 17.3 22.1 16.2 5.2 7.2 21.6 32.2 7.6 16.4 39.5 9.5 58.3 44.9 25.6 16.6 13.6 18.6 35.7 15.3 20.3 22.5 31.1 20.5 34.3 11.3 14.7 181.8 11.1 21.9 8.9 22.9 24.7 45.8 39.5 192.0 25.2 57.0 23.9 22.0 3.1 38.7 27.8 10.4 33.7 65.8 25.0 37.4 2.9 7.5 7.7 2.2 9.2 5.7 1.8 4.2 2.9 4.7 1.6 3.0 3.0 26.4 1.2 5.5 2.9 4.3 4.3 63.4 69.7 76.5 70.3 62.7 146.2 139.4 78.7 48.3 92.5 86.2 80.9 101.7 37.1 76.9 55.1 153.8 27.2 102.6 16.7 21.5 37.5 6.4 37.1 36.8 19.5 22.8 32.1 195.0 52.1 0.4 37.0 14.9 0.0 54.7 5.0 41.1 18.9 32.9 8.5 1.3 42.8 25.7 6.9 30.8 33.1 64.3 44.2 72.5 8.9 15.8 20.6 6.7 19.4 6.6 18.3 88.0 132.3 9.5 2.8 122.2 46.2 41.2 19.6 0.3 4.1 14.1 31.9 59.6 5.2 7.2 25.3 4.2 5.4 2.4 19.2 1.9 0.0 58.5 24.4 0.6 2.5 20.9 63.9 1.0 61.7 12.4 8.1 14.7 TMC7 FLJ21240 ENSG00000170537 "Transmembrane channel like 7" Q7Z402 16 18983934-19063942 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;testis: 9.7" "Group enriched" "Detected in many" 6 "Early spermatids: 172.0;Late spermatids: 44.6;Oligodendrocytes: 96.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029465 Uncertain Approved Vesicles NA NA Vesicles "HPA029465: AB_10600914" "unprognostic (1.80e-4)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-3)" "unprognostic (1.25e-1)" "unprognostic (1.19e-3)" "unprognostic (7.60e-5)" "prognostic unfavorable (3.20e-4)" "unprognostic (7.60e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (3.39e-1)" "unprognostic (1.00e-1)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (5.66e-2)" "prognostic favorable (9.20e-4)" 2.1 0.2 6.3 1.0 14.2 0.3 1.7 11.5 9.6 0.4 1.2 3.8 2.5 0.8 0.6 0.5 0.4 1.4 1.0 6.5 10.1 0.4 0.3 2.9 0.3 12.6 13.5 4.6 0.2 0.4 0.4 0.4 4.4 15.5 1.5 4.5 1.1 0.4 0.9 0.9 1.1 2.7 1.1 8.9 0.6 3.1 9.7 12.5 0.2 0.8 0.9 0.2 8.2 0.8 24.0 1.9 3.5 1.0 1.9 0.2 1.6 4.8 0.6 1.0 0.7 1.5 1.2 8.5 0.2 7.9 0.7 1.8 6.8 2.9 2.8 0.9 0.1 2.0 0.1 3.6 5.5 0.2 0.2 0.1 0.3 4.1 6.5 7.2 2.2 2.6 3.8 2.2 0.2 2.8 3.9 0.3 0.3 3.1 11.1 5.1 0.2 3.1 0.2 1.3 8.7 0.6 1.9 2.1 5.4 0.6 4.9 1.7 0.6 2.3 1.1 1.8 1.3 3.3 0.4 0.9 0.2 5.4 0.3 1.0 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.3 0.1 0.2 0.1 0.0 6.3 14.2 11.5 9.6 6.5 10.1 12.6 13.5 4.6 15.5 8.9 12.5 24.0 12.6 3.2 6.2 3.9 0.1 0.4 4.4 3.2 0.0 0.6 1.3 0.4 0.7 1.5 2.0 0.0 0.0 0.2 0.0 13.4 0.0 4.1 172.0 1.4 0.4 4.9 1.2 2.7 7.5 11.0 2.3 0.6 9.2 2.4 0.0 1.2 4.6 0.2 0.2 0.0 12.1 6.0 4.1 0.0 1.2 44.6 1.2 0.6 0.0 6.5 0.2 0.3 2.1 6.6 96.5 14.0 8.0 0.4 0.1 2.3 3.6 0.3 0.9 2.7 0.0 1.6 2.2 6.9 12.1 1.9 1.0 0.3 0.4 0.1 7.6 17.3 ARL6IP1 "AIP1, ARL6IP, ARMER, KIAA0069, SPG61" ENSG00000170540 "ADP ribosylation factor like GTPase 6 interacting protein 1" Q15041 16 18791669-18801572 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045307 Uncertain Approved "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (2.42e-1)" "unprognostic (3.47e-2)" "unprognostic (4.07e-3)" "unprognostic (1.12e-1)" "unprognostic (1.54e-1)" "unprognostic (2.60e-3)" "unprognostic (2.58e-2)" "unprognostic (1.76e-2)" "unprognostic (3.88e-2)" "unprognostic (6.83e-2)" "unprognostic (1.91e-3)" "unprognostic (3.33e-2)" "unprognostic (1.13e-2)" "unprognostic (7.09e-2)" "unprognostic (4.60e-2)" "unprognostic (6.32e-3)" "unprognostic (5.36e-3)" 143.3 172.9 210.1 78.4 232.4 211.4 114.0 215.7 284.5 79.9 193.3 142.2 140.0 71.5 124.0 70.6 87.4 133.1 32.4 234.6 220.5 151.5 362.5 80.3 133.7 204.4 210.7 216.4 102.5 82.4 182.0 41.1 91.1 213.1 76.6 124.6 318.7 85.0 71.1 23.3 66.6 124.4 69.7 201.6 73.4 126.9 131.0 207.3 160.0 113.5 52.0 114.3 133.8 47.8 237.1 375.3 334.6 417.8 331.6 146.7 93.5 373.2 208.9 196.9 311.0 246.7 205.7 851.1 315.7 388.4 198.0 209.2 388.9 303.7 144.2 359.1 421.2 137.1 227.9 192.5 549.1 116.4 329.9 232.0 78.6 137.7 216.2 224.0 229.1 316.1 180.5 251.0 318.5 607.6 331.4 229.9 238.3 520.0 311.7 109.8 387.9 535.9 266.0 337.8 206.1 255.2 287.5 466.5 279.8 204.5 280.1 576.1 315.9 189.2 204.2 192.9 147.1 384.1 109.5 209.5 383.2 182.8 215.6 405.5 211.4 125.2 84.2 179.4 119.5 167.0 163.2 159.0 199.1 127.4 160.7 137.9 166.4 105.9 179.2 133.3 221.6 281.5 295.0 210.1 232.4 215.7 284.5 234.6 220.5 204.4 210.7 216.4 213.1 201.6 207.3 237.1 306.4 67.3 51.0 56.8 170.6 372.6 241.4 170.1 309.6 189.2 256.5 216.8 30.6 361.8 128.7 286.9 131.3 296.7 164.6 269.0 174.1 398.2 74.6 93.3 61.7 188.1 145.9 503.8 70.4 203.1 385.4 150.4 257.9 158.3 135.8 198.0 275.5 457.4 253.9 89.2 94.2 234.6 229.9 275.8 424.6 42.7 84.8 205.8 200.9 39.4 267.3 318.5 142.2 57.3 50.3 271.0 288.5 110.9 107.5 219.4 217.0 189.1 126.6 218.0 92.1 125.6 118.6 193.6 56.6 295.2 326.5 326.6 186.9 53.1 319.7 323.8 SERPINB9 "CAP3, PI9" ENSG00000170542 "Serpin family B member 9" P50453 6 2887270-2903309 "Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 41.4;placenta: 52.7" "Cell type enriched" "Detected in many" 5 "Langerhans cells: 1527.7" "Cancer enriched" "Detected in all" 5 "testis cancer: 46.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 225.3;SuSa: 227.6;U-698: 98.8" "Low region specificity" "Detected in all" HPA030067 Uncertain Approved Nucleoplasm,Cytosol NA NA 3400000 Nucleoplasm Cytosol "HPA030067: AB_2673295" "unprognostic (6.82e-3)" "unprognostic (8.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-1)" "unprognostic (4.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" "unprognostic (9.48e-2)" "unprognostic (2.12e-2)" "unprognostic (3.83e-3)" "unprognostic (1.06e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (9.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-2)" 9.6 11.1 6.0 35.7 7.0 19.1 5.3 7.3 8.0 6.4 5.9 5.3 4.4 4.5 3.1 9.3 8.3 11.4 7.5 6.3 11.2 5.3 16.5 26.6 41.3 8.6 7.6 4.9 3.0 2.4 6.8 8.9 52.7 9.2 5.2 6.5 4.8 4.4 2.8 2.4 2.4 10.8 5.9 8.0 28.4 5.0 8.7 7.8 13.9 7.7 1.8 41.4 17.1 7.5 8.5 0.2 9.8 0.3 0.1 0.7 0.3 225.3 1.9 0.5 2.3 3.4 2.9 18.8 38.2 22.8 2.1 0.1 0.1 27.6 0.0 2.0 12.4 2.7 3.8 3.3 5.5 12.9 0.0 0.1 10.1 0.1 4.1 0.0 0.2 50.2 3.4 17.8 0.3 1.9 0.9 0.0 0.3 31.7 0.1 0.1 3.7 0.1 0.4 1.6 0.1 1.5 0.5 22.7 0.1 0.0 227.6 0.1 0.6 52.5 0.0 0.4 0.1 0.1 0.2 49.5 98.8 0.0 0.1 0.1 4.7 48.6 0.3 43.6 100.8 36.3 22.4 31.3 41.7 16.1 24.9 28.7 41.4 7.6 51.3 62.7 17.0 35.7 37.9 6.0 7.0 7.3 8.0 6.3 11.2 8.6 7.6 4.9 9.2 8.0 7.8 8.5 26.2 19.2 17.6 12.1 105.1 35.3 2.2 4.2 1.8 1.5 13.8 6.7 5.3 1.5 12.1 5.5 0.0 83.1 100.8 4.7 0.0 15.8 1.0 68.0 10.8 44.1 15.5 11.6 21.4 0.2 143.7 35.6 3.6 82.2 46.3 2.2 66.4 7.1 17.9 8.4 23.1 2.7 2.0 59.6 1527.7 4.9 4.4 232.6 88.9 92.8 99.8 5.3 43.3 1.0 3.2 9.3 6.0 17.7 115.7 2.5 0.1 2.4 10.4 3.0 13.1 55.3 14.6 0.4 2.2 3.8 36.9 270.2 100.6 8.1 3.4 6.9 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 140.9;placenta: 103.0" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 131.2;OE19: 163.9" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 13.7 17.3 2.4 10.0 2.2 3.5 16.3 4.1 2.4 21.1 3.0 58.1 17.8 6.6 20.9 140.9 8.4 16.4 8.4 2.5 2.0 22.1 10.3 17.8 6.0 2.2 2.4 1.7 11.5 16.6 11.2 4.3 103.0 3.1 10.6 59.9 1.0 24.3 8.7 3.4 33.8 19.7 8.5 2.1 13.8 36.2 8.1 2.8 1.5 8.8 6.8 27.9 17.6 68.4 3.0 81.6 24.2 2.9 2.7 10.5 40.9 131.2 61.1 60.9 30.6 18.7 48.9 83.2 1.0 10.5 37.9 11.6 28.3 17.1 23.5 42.6 4.1 14.2 10.9 3.3 16.5 28.8 2.7 10.1 26.7 17.8 66.3 59.4 69.4 74.6 20.6 8.7 4.7 49.9 71.4 13.4 9.8 12.3 163.9 93.9 0.8 0.8 3.1 44.0 18.5 3.3 4.1 13.4 53.2 10.2 31.3 45.0 4.2 26.1 33.9 32.7 1.7 37.8 1.7 2.4 1.6 49.8 26.3 18.7 4.6 6.6 12.0 15.4 4.6 10.0 36.9 6.8 11.1 4.7 38.1 6.3 11.0 16.0 19.8 5.4 2.9 5.3 6.8 2.4 2.2 4.1 2.4 2.5 2.0 2.2 2.4 1.7 3.1 2.1 2.8 3.0 44.1 0.0 25.7 0.3 26.3 21.7 74.3 35.5 12.0 1.3 23.4 25.8 1.7 55.8 44.7 16.5 0.0 1219.9 21.7 85.0 49.0 43.6 11.7 4.8 2.3 60.9 20.4 8.6 0.6 108.7 108.0 11.4 47.9 8.7 12.7 19.7 51.4 6.7 96.8 1.7 0.5 121.5 26.4 6.3 11.2 3.2 13.1 6.1 14.2 6.5 7.9 4.1 38.1 0.0 0.5 142.5 88.1 9.8 5.7 73.7 35.0 22.6 17.4 1.7 26.3 4.8 11.1 6.2 31.3 80.7 29.7 842.5 13.8 9.8 121.7 105.2 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3595832-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;breast: 16.3;kidney: 12.5;salivary gland: 18.0" "Group enriched" "Detected in some" 4 "Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.8;REH: 37.8;U-251 MG: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 4.2 0.0 4.1 0.0 3.9 0.6 16.3 7.7 3.8 0.1 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.9 5.1 12.5 0.0 3.1 0.1 12.9 8.3 0.6 0.0 0.2 0.2 1.0 0.0 18.0 0.1 0.0 0.1 18.0 0.5 0.1 7.8 0.0 0.0 7.2 0.0 0.0 0.1 6.8 0.3 0.3 0.0 0.0 0.0 0.5 14.2 0.0 0.0 8.8 0.0 0.5 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 37.8 0.0 0.0 2.8 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 3.9 7.7 3.8 1.9 5.1 12.9 8.3 0.6 18.0 7.2 6.8 14.2 2.5 6.4 3.7 0.0 0.4 3.6 0.0 1.6 1.2 0.8 51.4 87.6 3.5 0.0 1.5 5.5 0.0 0.3 1.0 0.0 15.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.3 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 1.0 0.0 0.5 3.7 0.0 0.2 1.1 3.0 0.3 0.6 0.0 0.0 0.0 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27932879-28177946 "CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 197.8" "Cell type enhanced" "Detected in many" "Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9" "Cancer enhanced" "Detected in all" "glioma: 39.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.7;neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 160000000 "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760" "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 67.1 28.1 2.6 30.4 0.2 0.3 23.3 31.9 6.7 8.9 3.5 0.8 6.2 1.1 0.4 10.6 3.1 197.8 29.6 49.0 18.2 57.7 1.0 1.9 22.9 27.6 27.2 6.8 0.9 29.9 8.2 0.4 20.2 2.5 1.1 60.8 0.4 10.9 0.4 0.3 1.4 6.9 23.3 13.6 5.9 44.8 29.4 3.9 6.2 2.2 1.6 1.1 2.7 27.1 0.3 25.8 278.2 0.3 48.1 7.8 0.2 230.7 72.0 94.9 80.8 0.1 0.4 0.0 128.3 459.1 46.0 36.7 50.0 0.2 130.4 0.4 35.8 0.0 66.8 86.7 48.0 0.0 0.1 4.6 0.4 198.6 37.4 212.9 84.0 15.4 0.0 0.1 77.8 0.0 59.4 0.1 43.8 0.1 30.5 0.2 37.1 45.6 0.1 9.9 83.4 144.4 0.1 0.2 26.8 116.8 0.3 0.5 11.6 206.6 63.6 2.9 181.6 0.2 0.3 0.3 40.6 0.2 163.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 28.1 30.4 23.3 31.9 29.6 49.0 22.9 27.6 27.2 20.2 23.3 29.4 27.1 0.8 0.0 0.6 217.7 1.2 0.3 0.0 3.4 0.0 38.7 1.6 0.4 368.8 67.2 1.2 11.0 150.1 0.1 0.0 0.0 0.0 12.9 53.2 1.4 15.2 9.8 0.0 6.1 311.2 0.4 0.0 16.7 0.0 2.6 0.0 312.5 12.5 125.3 0.3 3.3 198.2 0.0 2.0 2.2 0.4 17.7 2.1 1.2 3.6 106.8 0.1 157.9 0.0 267.9 138.6 19.2 0.0 12.8 0.0 0.1 0.0 47.5 1.7 99.9 6.6 0.4 45.8 4.8 24.1 0.0 0.0 0.3 0.6 1.6 0.0 0.1 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751677 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9;breast: 24.3;salivary gland: 30.9;skin 1: 25.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3" "Cancer enhanced" "Detected in many" "breast cancer: 14.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1" "Group enriched" "Detected in many" 5 "midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2" "Region enhanced" "Detected in some" "pons: 5.1" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.5 0.1 2.8 0.0 2.5 0.0 24.3 5.3 5.3 0.3 0.4 0.7 0.0 0.0 3.1 4.5 0.2 0.0 1.6 0.8 3.3 8.6 0.0 18.2 0.2 16.0 7.7 0.3 0.0 2.0 3.0 1.6 5.6 22.9 3.6 0.3 1.1 30.9 0.9 0.3 25.6 0.0 0.0 3.6 0.0 15.8 2.1 5.7 0.5 1.9 0.7 0.2 0.2 2.0 18.2 10.7 0.0 93.2 0.0 5.4 3.9 56.4 5.4 3.4 5.0 4.0 11.8 0.0 0.0 0.0 11.5 0.0 32.0 0.1 24.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 68.9 2.4 20.1 0.0 0.0 0.0 0.0 0.0 3.6 19.1 0.0 0.1 10.2 25.7 0.0 0.0 5.7 0.0 22.7 0.0 3.5 0.0 18.6 39.1 0.0 14.3 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.5 5.3 5.3 0.8 3.3 16.0 7.7 0.3 22.9 3.6 5.7 18.2 5.5 109.0 74.2 0.0 0.2 202.1 17.6 33.1 31.9 1.4 147.4 159.8 2.7 0.0 23.9 7.3 0.0 27.8 1.2 3.0 27.4 0.1 5.0 0.1 0.4 2.9 0.0 0.0 0.0 0.0 18.6 15.0 15.3 0.0 1.3 0.1 0.0 0.0 3.3 0.0 0.0 2.5 14.2 0.0 15.4 10.4 0.0 0.7 19.6 0.0 0.0 0.3 0.0 1.5 0.0 0.3 2.9 0.0 0.1 23.5 0.2 0.6 13.0 2.5 0.0 3.6 14.6 9.4 9.4 20.1 131.3 15.2 0.9 0.0 2.8 8.3 EMB MGC71745 ENSG00000170571 Embigin Q6PCB8 5 50396192-50443248 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 154.0;intestine: 72.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 108.4;dendritic cells: 133.3;NK-cells: 153.5;Proximal enterocytes: 137.5;T-cells: 150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 281.5;U-937: 124.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.01e-3)" "unprognostic (8.65e-2)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (8.31e-2)" "unprognostic (2.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.76e-5)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (1.22e-2)" "unprognostic (8.86e-3)" 16.9 22.6 1.7 28.6 1.7 154.0 12.2 4.2 3.0 8.7 3.8 9.8 72.6 3.1 2.7 8.1 5.8 13.0 5.1 1.9 5.5 2.5 4.8 16.0 56.4 5.7 7.0 1.0 2.2 2.1 24.4 8.4 13.5 5.5 29.4 11.7 10.6 5.5 20.6 1.3 32.5 68.9 8.1 3.1 25.2 14.4 11.0 4.1 28.6 20.9 3.6 48.8 17.0 2.8 5.2 38.8 2.9 6.5 0.1 2.9 8.7 0.5 1.7 0.0 2.7 0.3 0.3 91.6 74.3 2.1 3.2 0.0 55.7 15.3 43.5 0.4 24.0 38.8 34.5 10.2 0.0 0.5 69.9 0.2 0.6 23.3 6.9 28.2 44.6 0.0 28.8 0.0 86.8 52.4 41.0 43.2 39.3 27.2 0.0 19.9 65.5 0.2 98.6 0.0 29.8 21.2 19.9 0.0 10.1 1.1 13.4 4.3 281.5 0.1 0.1 32.5 0.2 0.3 1.0 0.0 59.3 0.1 124.1 8.3 9.5 34.1 38.7 44.5 4.4 54.1 20.7 39.9 41.0 22.3 13.7 23.5 31.8 30.2 37.3 1.4 25.7 53.6 42.8 1.7 1.7 4.2 3.0 1.9 5.5 5.7 7.0 1.0 5.5 3.1 4.1 5.2 3.3 67.3 17.3 1.6 78.1 18.2 2.0 21.2 8.6 3.3 6.5 8.0 1.9 10.0 27.7 0.0 108.4 12.1 133.3 1.2 0.0 0.8 0.6 1.0 0.4 3.8 7.3 21.9 51.9 0.9 8.5 7.8 15.8 0.4 19.0 0.0 20.7 1.6 20.6 1.7 28.7 11.3 8.2 31.4 86.4 1.5 2.8 63.5 10.6 41.2 78.0 2.1 153.5 0.0 1.6 15.7 4.4 6.8 71.1 9.6 137.5 0.4 34.3 9.0 0.0 2.3 4.6 1.0 3.8 6.4 12.6 8.5 150.9 0.0 15.4 2.4 SIX2 ENSG00000170577 "SIX homeobox 2" Q9NPC8 2 45005182-45009452 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 21.3;skeletal muscle: 34.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 6.1;Cardiomyocytes: 3.3;Fibroblasts: 3.0;Ionocytes: 8.2;Skeletal myocytes: 8.5;Smooth muscle cells: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 48.8;LHCN-M2: 46.8;RH-30: 31.9;SCLC-21H: 54.3;U-2197: 35.3;U-698: 43.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA056958 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA056958: AB_2683287" "unprognostic (1.14e-3)" "unprognostic (2.73e-2)" "unprognostic (3.09e-6)" "unprognostic (1.28e-2)" "unprognostic (3.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.06e-3)" "unprognostic (9.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "unprognostic (1.07e-2)" "unprognostic (4.53e-9)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-5)" "unprognostic (1.05e-1)" 6.5 0.1 0.5 0.1 0.2 0.0 1.6 0.2 0.7 11.6 0.7 0.7 0.0 1.7 0.1 0.2 0.2 0.0 1.3 0.9 0.6 0.5 0.0 0.2 0.1 0.4 0.4 0.1 0.1 6.1 2.1 13.0 0.1 1.0 6.2 0.0 0.9 21.3 1.2 34.1 0.4 0.1 0.1 0.1 0.0 9.6 0.3 0.2 3.9 0.6 15.7 0.0 1.9 8.7 1.5 0.7 0.0 0.0 4.2 13.0 48.8 0.0 0.2 2.3 1.0 0.1 0.4 0.0 0.0 2.2 0.0 0.4 0.1 4.7 8.5 0.6 0.0 2.5 0.0 16.7 0.0 0.0 0.0 4.5 2.4 0.1 10.4 0.1 0.4 1.6 0.5 0.2 0.0 46.8 1.7 0.0 2.8 0.4 0.0 10.2 0.0 31.9 0.0 0.1 2.7 54.3 0.4 7.1 0.2 0.0 0.5 0.4 4.2 0.7 0.9 2.7 35.3 0.0 1.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.7 0.9 0.6 0.4 0.4 0.1 1.0 0.1 0.2 1.5 0.6 0.0 0.0 0.0 0.0 0.9 0.4 6.1 0.0 0.0 1.2 0.6 3.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.4 0.0 0.0 0.0 2.2 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.5 0.0 8.5 3.2 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.0 0.2 DLGAP1 "DAP-1, GKAP, SAPAP1" ENSG00000170579 "DLG associated protein 1" O14490 18 3496032-4455307 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.0" "Group enriched" "Detected in many" 7 "Excitatory neurons: 2145.5;Inhibitory neurons: 3599.2;Oligodendrocyte precursor cells: 1264.6" "Cancer enhanced" "Detected in many" "glioma: 2.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 10.7;HAP1: 3.7;U-2197: 3.3;U-87 MG: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078234 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA078234: " "unprognostic (2.50e-3)" "unprognostic (7.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-2)" "unprognostic (3.63e-3)" "unprognostic (2.73e-2)" "unprognostic (1.97e-2)" "unprognostic (2.93e-3)" "unprognostic (5.49e-3)" "unprognostic (5.87e-4)" "unprognostic (2.18e-1)" "unprognostic (2.78e-3)" "unprognostic (3.10e-2)" "unprognostic (4.93e-3)" "unprognostic (8.93e-2)" "unprognostic (9.68e-2)" 0.3 4.3 6.4 0.2 19.2 0.0 1.5 6.7 41.0 0.6 0.0 0.3 0.1 0.7 8.2 0.2 6.5 4.1 0.4 22.5 9.4 1.2 0.1 0.7 0.2 0.4 1.2 15.4 1.9 0.2 0.0 2.5 0.6 8.2 2.9 0.2 3.2 1.9 10.2 0.1 0.2 0.2 0.3 0.0 0.5 0.1 3.7 0.0 0.1 0.5 0.4 0.1 0.5 0.6 9.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.7 0.0 0.2 1.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 1.4 0.8 1.2 0.0 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.2 0.0 0.1 2.3 0.0 0.9 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 19.2 6.7 41.0 22.5 9.4 0.4 1.2 15.4 8.2 0.0 0.0 9.6 1.5 0.0 4.6 309.8 0.3 0.8 0.3 0.3 5.7 23.6 6.6 2.8 3.1 7.2 0.1 1.8 0.0 0.1 0.1 0.4 0.0 0.2 11.4 31.7 8.3 1.9 3.0 0.0 2145.5 0.2 0.1 1.8 0.5 94.6 0.0 0.0 2.2 0.0 0.2 0.0 3599.2 1.7 0.0 0.0 0.7 13.8 0.6 0.6 12.4 72.1 0.1 0.2 0.0 1264.6 31.0 0.2 0.1 0.4 0.0 3.5 0.0 5.4 4.4 1.4 0.0 0.7 2.2 12.9 4.8 1.6 0.1 0.3 0.8 0.1 0.1 0.1 STAT2 STAT113 ENSG00000170581 "Signal transducer and activator of transcription 2" P52630 12 56341597-56360167 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003858, HPA018888" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB003858: AB_562227, HPA018888: AB_1857550" "unprognostic (3.03e-1)" "unprognostic (8.59e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (7.27e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (4.12e-3)" "unprognostic (1.56e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.78e-13)" "unprognostic (1.88e-1)" "unprognostic (5.56e-2)" "unprognostic (2.77e-1)" "unprognostic (1.46e-3)" 17.5 6.4 1.7 19.3 1.2 7.9 10.4 1.6 2.6 18.8 1.6 10.8 10.8 11.4 5.6 11.2 13.0 20.3 8.2 4.5 2.3 8.5 20.8 23.0 19.8 2.6 1.5 0.4 17.5 10.0 12.5 8.7 16.1 1.9 10.4 12.7 5.7 18.3 10.0 4.0 7.9 13.1 22.0 2.2 25.4 10.4 4.1 3.5 20.1 10.8 8.5 20.3 18.5 5.6 9.1 15.5 8.5 11.8 12.5 98.3 58.6 26.1 19.4 94.0 92.4 93.1 8.7 16.4 17.9 22.6 38.6 24.2 14.9 21.0 15.1 18.0 13.8 4.7 27.2 7.6 9.3 58.8 5.0 20.2 86.8 13.4 19.5 22.8 70.5 25.6 14.3 15.2 44.7 35.1 9.4 7.3 3.5 5.2 15.1 9.8 6.9 22.1 17.1 21.3 18.1 4.2 10.1 31.5 18.8 43.1 22.7 16.4 17.7 11.2 22.2 10.7 8.0 3.1 32.5 32.9 9.8 30.3 7.2 9.9 14.8 17.2 11.3 7.7 22.8 7.9 5.2 7.4 7.7 11.6 7.5 5.2 5.1 6.8 4.8 18.3 10.2 9.8 13.1 1.7 1.2 1.6 2.6 4.5 2.3 2.6 1.5 0.4 1.9 2.2 3.5 9.1 36.0 12.8 41.7 40.5 24.0 14.3 10.3 13.7 17.1 17.0 17.4 15.0 11.1 15.7 24.4 18.4 20.9 11.2 28.1 23.8 1.9 14.0 13.8 20.7 36.4 26.5 15.5 8.6 29.8 10.7 24.5 27.6 19.9 26.6 10.1 24.6 27.8 64.8 25.9 3.3 28.6 16.8 6.1 50.9 25.6 43.7 19.6 45.2 32.0 24.4 42.3 10.4 18.6 27.6 111.8 11.9 21.9 17.3 24.4 11.4 24.0 10.7 24.2 21.8 26.3 20.3 22.5 3.2 5.0 12.5 14.5 11.1 20.1 13.7 14.8 13.2 NUDCD2 "DKFZp686E10109, NudCL2" ENSG00000170584 "NudC domain containing 2" Q8WVJ2 5 163446526-163460102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037384, HPA037385" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA 18000 Microtubules "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA037384: AB_2675447, HPA037385: AB_10673630" "unprognostic (3.96e-1)" "unprognostic (3.69e-2)" "prognostic favorable (2.80e-4)" "unprognostic (1.46e-1)" "unprognostic (9.12e-2)" "unprognostic (3.75e-3)" "unprognostic (1.84e-1)" "unprognostic (4.74e-1)" "unprognostic (3.47e-2)" "unprognostic (7.63e-3)" "unprognostic (1.81e-1)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" "unprognostic (6.86e-2)" "unprognostic (3.40e-2)" "unprognostic (7.85e-2)" 14.1 11.9 9.6 13.3 11.2 11.8 11.3 11.5 14.1 8.1 8.9 11.3 14.7 10.3 6.5 12.9 9.8 5.7 8.2 9.6 9.9 11.2 15.4 8.8 15.2 11.5 11.2 8.6 8.9 15.5 6.9 9.4 10.4 12.2 9.0 6.2 7.4 14.1 3.7 21.1 10.6 13.4 6.4 11.2 12.9 11.9 10.5 10.9 8.2 9.5 5.0 9.9 9.3 10.4 16.2 62.3 32.3 23.5 37.1 14.1 10.4 31.3 24.6 7.0 8.7 13.9 28.6 46.3 35.5 57.5 4.0 39.8 30.6 12.6 13.9 10.7 70.6 36.6 32.4 42.0 26.4 15.3 37.3 35.3 3.8 7.7 8.4 12.1 12.3 9.8 39.1 35.1 42.6 8.9 25.2 55.1 80.9 25.8 18.4 35.2 45.7 39.2 63.0 8.0 14.3 59.6 33.6 38.7 24.7 66.3 13.8 47.2 37.8 21.9 29.4 43.8 32.6 56.7 35.0 63.8 61.5 34.2 63.2 31.4 49.9 48.3 32.5 60.2 59.8 76.5 91.7 84.0 71.8 68.0 68.0 88.7 79.0 6.2 83.8 51.5 81.1 83.5 69.1 9.6 11.2 11.5 14.1 9.6 9.9 11.5 11.2 8.6 12.2 11.2 10.9 16.2 58.0 28.9 23.8 9.1 47.5 59.4 54.9 92.6 42.7 30.7 70.4 88.6 43.1 35.8 53.1 38.6 22.9 118.7 43.8 25.4 148.7 63.6 95.1 57.6 44.1 47.4 43.8 78.4 18.8 64.0 55.8 48.6 32.1 38.3 31.6 35.7 36.0 55.1 69.8 10.1 14.0 45.3 87.5 41.8 42.7 24.5 51.6 35.7 49.8 11.2 46.4 51.4 52.5 11.1 36.0 59.9 33.6 51.1 55.5 95.2 31.5 112.5 65.1 38.2 39.5 51.3 46.5 87.6 44.2 56.0 67.6 56.8 48.3 64.8 68.6 59.3 IRF2BP1 "DKFZP434M154, IRF-2BP1" ENSG00000170604 "Interferon regulatory factor 2 binding protein 1" Q8IU81 19 45883608-45886141 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "NB-4: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042164, HPA049480" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042164: AB_2677882, HPA049480: AB_2680785" "unprognostic (5.90e-2)" "unprognostic (1.34e-1)" "unprognostic (8.86e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-1)" "unprognostic (1.01e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.60e-1)" "prognostic favorable (3.85e-5)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (2.66e-1)" "unprognostic (5.07e-3)" 10.5 15.9 10.0 4.7 10.6 3.7 12.4 12.4 16.0 16.6 2.5 16.0 7.3 20.1 3.6 11.9 17.1 3.2 15.1 11.5 9.0 13.3 21.2 8.3 5.2 14.1 11.0 12.2 21.9 15.8 7.2 20.7 3.1 10.9 15.4 2.0 4.3 13.8 7.0 22.2 14.4 13.9 3.1 8.4 13.7 16.5 9.3 10.1 6.2 12.4 8.0 2.8 16.1 12.1 11.9 18.1 27.1 6.5 14.6 5.5 3.4 10.8 13.0 7.4 10.2 8.9 10.1 8.4 14.5 9.6 6.7 6.1 16.7 4.7 4.9 3.0 18.4 46.4 14.6 7.6 13.1 11.1 15.2 13.1 4.8 6.6 5.3 3.8 6.4 6.3 17.8 23.4 11.2 4.0 14.1 31.0 82.8 12.3 6.7 23.8 35.2 7.7 12.6 7.4 9.9 19.4 33.3 13.8 17.8 17.3 2.5 14.8 27.8 9.2 8.8 17.7 6.8 18.6 30.4 36.2 8.6 11.9 14.3 13.0 0.0 0.3 0.1 0.7 0.4 0.7 0.7 0.6 0.6 0.3 0.6 0.9 0.5 0.4 0.7 0.2 0.5 0.6 0.4 10.0 10.6 12.4 16.0 11.5 9.0 14.1 11.0 12.2 10.9 8.4 10.1 11.9 6.0 0.0 1.1 2.6 8.4 10.7 5.8 4.1 14.2 15.2 13.5 11.4 1.3 11.5 2.4 11.0 0.0 10.9 8.4 8.9 13.7 7.8 2.0 6.0 6.7 6.3 9.6 10.1 2.2 9.5 6.6 8.2 7.1 6.9 0.0 8.3 7.9 9.3 5.0 10.1 3.2 11.2 0.0 2.2 8.6 1.5 18.6 5.1 8.8 3.7 4.5 10.2 5.2 2.0 3.7 7.5 11.9 10.9 2.5 7.4 9.3 13.5 3.0 7.0 19.7 10.7 11.7 3.8 2.2 8.9 11.2 8.8 7.3 9.9 8.7 3.0 OR9K2 ENSG00000170605 "Olfactory receptor family 9 subfamily K member 2" Q8NGE7 12 55126406-55132750 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA015808 Uncertain NA NA "HPA015808: AB_2669306" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSPA4 "HS24/P52, HSPH2" ENSG00000170606 "Heat shock protein family A (Hsp70) member 4" P34932 5 133052013-133106449 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010023, CAB025529" Uncertain Approved Nucleoplasm,Cytosol NA NA 14000000 "Nucleoplasm, Cytosol" "CAB025529: , HPA010023: AB_1851206" "unprognostic (2.54e-2)" "unprognostic (3.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.62e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.31e-3)" "unprognostic (2.90e-1)" "unprognostic (2.40e-1)" "unprognostic (1.53e-1)" "unprognostic (2.85e-1)" "unprognostic (4.44e-3)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-1)" 31.6 37.3 41.2 41.4 38.4 35.9 27.1 39.2 58.9 26.8 53.4 32.1 26.8 27.8 29.5 62.6 27.1 28.1 51.3 49.2 41.2 44.7 47.6 26.5 47.8 43.2 37.4 32.0 21.5 29.9 43.8 24.2 38.0 44.7 26.5 35.1 104.9 28.1 27.2 58.1 26.3 26.2 35.6 44.2 29.0 26.8 63.3 47.0 40.6 40.0 42.0 61.4 48.9 23.9 59.7 160.8 215.8 147.6 241.7 137.5 114.6 267.3 171.0 127.8 162.1 199.2 408.0 163.2 264.4 175.2 165.8 382.6 138.9 259.4 282.9 232.7 122.9 148.3 195.4 136.5 225.7 109.6 122.6 163.8 115.1 117.3 209.7 136.3 92.9 157.2 126.5 207.9 79.6 179.8 141.4 173.5 91.0 202.4 123.8 98.7 156.6 180.4 140.2 146.7 207.4 117.0 96.0 163.4 84.4 234.6 273.5 124.3 118.5 139.0 146.8 210.8 127.1 206.1 90.7 215.2 199.9 125.5 198.7 149.2 29.5 22.6 24.9 18.1 35.8 21.5 34.2 16.6 19.0 27.7 42.0 17.1 16.2 14.7 22.9 27.1 10.5 18.0 18.5 41.2 38.4 39.2 58.9 49.2 41.2 43.2 37.4 32.0 44.7 44.2 47.0 59.7 30.5 64.1 47.0 12.4 74.8 41.8 116.8 25.5 52.9 58.9 30.3 26.8 113.1 28.6 47.3 22.0 54.2 67.3 38.5 42.9 27.4 48.4 68.7 54.7 48.5 40.8 47.2 46.9 24.2 49.9 66.1 45.3 38.2 46.1 54.6 66.9 19.6 32.9 64.3 35.3 24.8 34.4 36.7 28.2 40.9 31.9 23.3 50.7 30.2 21.5 55.0 60.1 22.6 18.6 24.2 50.1 24.9 25.9 66.5 61.5 27.7 49.7 60.7 152.4 26.3 41.8 85.1 107.4 101.0 71.7 41.8 87.2 58.2 68.0 39.4 69.7 FOXA3 HNF3G ENSG00000170608 "Forkhead box A3" P55318 19 45863989-45873797 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "intestine: 17.7;liver: 65.1;pancreas: 48.6;stomach 1: 37.2" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB015154, HPA054034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB015154: AB_647545, HPA054034: AB_2682349" "unprognostic (2.88e-1)" "unprognostic (6.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "unprognostic (2.27e-1)" "unprognostic (2.39e-2)" "unprognostic (1.42e-1)" "unprognostic (6.87e-3)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-2)" "unprognostic (2.57e-2)" "unprognostic (1.91e-2)" "unprognostic (3.55e-1)" "unprognostic (3.75e-1)" "unprognostic (2.11e-1)" 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 17.7 10.7 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 1.5 65.1 0.3 0.1 0.0 0.0 0.0 0.0 48.6 1.1 0.0 0.0 0.0 0.5 17.3 0.0 2.1 0.4 0.0 0.0 13.0 0.7 0.0 0.0 37.2 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.6 4.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 12.5 1.1 0.2 0.0 29.1 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.7 23.5 0.0 0.0 0.3 0.1 0.0 11.2 101.2 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 2.5 0.3 0.9 0.3 1.3 0.7 0.0 0.0 2.6 1.5 0.5 15.7 2.5 1.8 0.0 0.0 0.6 40.2 0.0 12.5 0.2 0.1 0.1 0.9 83.3 10.7 0.1 24.5 0.0 0.5 152.9 0.4 4.5 0.1 1.4 29.9 0.0 0.0 0.1 230.1 0.0 2.2 0.7 0.5 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.5 0.1 26.0 74.7 0.0 0.6 6.6 17.8 0.4 0.3 0.0 0.0 0.0 1.1 2.7 5.6 0.2 0.3 0.0 0.4 0.1 46.2 1.7 FAM71B MGC26988 ENSG00000170613 "Family with sequence similarity 71 member B" Q8TC56 5 157161846-157166264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 167 "Early spermatids: 871.3;Late spermatids: 401.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039478, HPA040771" Enhanced NA NA "HPA039478: AB_10795106, HPA040771: AB_10805829" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 871.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.4 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446207 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "cerebellum: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "basal ganglia: 10.4" NA NA "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 0.1 0.1 0.3 0.0 0.3 0.0 0.8 2.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.4 0.1 0.4 0.4 0.0 0.0 0.2 0.3 0.0 0.0 1.2 0.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.6 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.2 0.1 0.4 0.4 0.4 0.0 1.2 0.4 0.2 0.5 0.3 6.4 2.6 5.5 0.2 0.3 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.4 0.2 0.5 0.0 0.0 4.1 0.0 0.0 2.2 7.1 0.2 0.0 0.0 5.3 0.0 0.0 0.0 3.5 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.0 6.5 0.0 0.3 0.0 2.0 4.2 0.3 0.0 0.0 0.0 0.8 0.0 0.0 2.2 1.2 0.0 0.2 0.1 0.3 0.5 0.0 0.3 0.0 0.6 0.0 0.0 0.6 COMMD5 "FLJ13008, HCaRG, HT002" ENSG00000170619 "COMM domain containing 5" Q9GZQ3 8 144841042-144853736 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046905 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046905: AB_2732535" "unprognostic (2.95e-2)" "unprognostic (7.62e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (5.05e-3)" "unprognostic (6.82e-2)" "unprognostic (3.24e-1)" "unprognostic (9.35e-2)" "unprognostic (2.25e-1)" "unprognostic (7.97e-3)" "unprognostic (1.25e-2)" "unprognostic (8.58e-2)" "unprognostic (3.43e-1)" "unprognostic (2.02e-1)" "unprognostic (7.73e-3)" 16.3 23.1 15.6 12.0 15.8 21.4 15.9 17.2 19.8 14.8 14.9 15.4 12.3 16.3 9.8 20.2 14.3 11.4 17.8 15.2 15.5 18.8 23.4 15.2 16.4 17.0 16.0 15.0 12.9 16.8 14.6 17.9 11.1 16.5 16.6 6.9 3.9 15.6 10.8 18.4 16.9 15.1 8.9 16.9 22.1 16.5 11.3 16.4 11.4 16.5 11.5 10.7 16.0 14.5 17.7 32.8 38.3 17.9 24.2 21.8 17.4 16.0 18.5 19.7 30.9 24.2 23.0 25.1 22.3 40.4 22.6 17.9 21.7 22.5 30.6 13.2 29.6 31.7 47.1 35.3 38.8 28.8 16.0 39.6 23.1 27.6 21.2 15.7 15.0 24.2 7.9 34.2 39.8 25.2 59.4 14.6 16.8 27.1 45.6 75.3 18.8 20.4 34.8 30.2 28.3 41.6 36.6 30.9 18.5 27.4 11.9 36.3 29.7 22.4 23.1 45.9 33.3 36.8 16.6 19.2 21.3 32.5 29.7 30.5 66.1 84.3 76.6 55.8 72.4 49.8 60.7 42.4 54.9 74.2 54.1 41.6 46.7 52.3 69.2 47.0 26.8 71.2 70.1 15.6 15.8 17.2 19.8 15.2 15.5 17.0 16.0 15.0 16.5 16.9 16.4 17.7 27.8 12.8 15.0 8.5 27.5 27.8 20.4 46.4 11.4 12.3 22.8 23.9 10.9 21.5 25.0 16.5 12.5 35.8 39.0 26.4 39.2 46.4 3.5 19.6 16.4 27.6 19.9 14.1 6.2 40.1 23.8 22.7 13.7 18.6 24.8 15.6 25.7 19.0 70.0 11.8 7.7 16.8 34.6 31.4 27.6 2.5 18.6 34.2 26.6 5.6 37.2 22.3 38.1 6.6 9.5 50.0 18.4 23.3 20.3 42.7 29.8 44.6 28.2 15.2 13.1 16.0 24.6 12.1 17.2 18.4 30.0 33.1 27.0 28.7 18.9 28.5 SGCD "CMD1L, DAGD, LGMD2F" ENSG00000170624 "Sarcoglycan delta" Q92629 5 155870344-156767788 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.5;skeletal muscle: 43.3;tongue: 33.6" "Group enriched" "Detected in many" 4 "Astrocytes: 365.7;Cardiomyocytes: 107.8;Excitatory neurons: 193.0;Inhibitory neurons: 161.2;Microglial cells: 124.6;Oligodendrocyte precursor cells: 417.2;Oligodendrocytes: 196.4" "Cancer enriched" "Detected in many" 5 "melanoma: 10.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 16.1;fHDF/TERT166: 25.7;LHCN-M2: 12.7;RH-30: 18.2;SK-MEL-30: 27.0;U-138 MG: 24.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.23e-1)" "unprognostic (3.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (9.55e-2)" "unprognostic (2.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.53e-2)" "unprognostic (2.25e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-2)" "unprognostic (4.10e-2)" "unprognostic (9.65e-3)" "unprognostic (5.37e-2)" "unprognostic (5.60e-3)" "unprognostic (3.66e-3)" 5.4 4.2 3.3 2.1 2.2 0.0 3.4 1.8 3.7 6.8 0.3 6.0 2.0 8.2 2.5 6.3 3.0 9.3 39.5 2.9 3.3 1.3 2.1 5.0 0.4 4.3 3.5 2.7 8.9 1.0 9.9 1.6 0.6 4.0 6.1 3.6 1.6 1.9 5.2 43.3 1.6 2.7 13.6 3.9 1.4 2.9 1.3 2.6 0.7 17.9 33.6 0.5 6.6 3.1 7.2 0.0 6.4 0.0 0.0 5.8 9.2 0.0 16.1 5.5 0.0 0.2 0.0 0.0 0.0 0.0 25.7 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 3.0 0.1 0.0 0.0 27.0 0.0 0.0 0.0 0.0 24.1 0.0 4.3 0.0 0.1 0.1 0.0 4.1 0.0 9.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.2 1.8 3.7 2.9 3.3 4.3 3.5 2.7 4.0 3.9 2.6 7.2 0.7 0.0 0.5 365.7 0.0 3.6 0.0 0.0 0.0 3.5 4.0 2.2 107.8 0.0 0.0 0.0 54.2 0.0 1.6 0.1 0.0 0.1 6.9 6.1 1.5 1.7 1.8 0.0 193.0 0.0 0.0 27.4 0.0 16.3 0.0 11.3 3.3 1.6 0.2 21.9 161.2 0.0 0.0 0.0 2.5 13.3 19.0 0.8 24.9 124.6 0.0 0.3 0.0 417.2 196.4 0.0 0.0 15.4 0.7 0.8 0.0 0.3 0.0 1.2 0.0 38.5 5.9 0.0 0.4 0.5 3.1 0.1 1.0 9.4 0.0 0.2 GTSF1 "Cue110, FAM112B, FLJ32942" ENSG00000170627 "Gametocyte specific factor 1" Q8WW33 12 54455950-54473602 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 187.8" "Group enriched" "Detected in some" 11 "Early spermatids: 1181.4;Late spermatids: 1810.3;Spermatocytes: 531.1" "Cancer enriched" "Detected in many" 5 "testis cancer: 23.2" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 294.6;HMC-1: 207.5;K-562: 290.1;NB-4: 442.3;THP-1: 405.8;U-266/84: 337.6;U-937: 216.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038876, HPA038877" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038876: AB_10670911, HPA038877: AB_2676251" "unprognostic (1.17e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (1.59e-1)" "unprognostic (1.11e-2)" "unprognostic (6.74e-3)" "unprognostic (2.56e-2)" "unprognostic (3.94e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (7.59e-2)" "unprognostic (3.97e-5)" "unprognostic (4.16e-3)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (9.18e-2)" 0.5 0.6 0.3 2.4 0.5 6.4 0.4 0.5 0.5 0.1 0.1 0.9 1.4 0.3 0.5 0.2 0.1 1.1 0.9 0.2 0.6 0.4 1.3 1.9 5.7 0.5 0.3 0.3 0.3 0.2 0.1 0.2 14.2 0.5 0.4 2.0 0.3 0.3 0.1 0.4 0.5 1.4 0.3 0.2 3.6 0.7 187.8 0.4 6.1 0.4 0.1 11.0 1.0 0.2 1.0 1.1 0.0 0.3 0.0 0.0 0.0 146.3 0.2 0.0 0.0 0.0 0.3 0.1 114.1 52.2 0.0 0.1 0.4 151.3 0.0 0.0 59.7 0.1 0.1 0.0 0.1 0.0 294.6 207.5 0.0 0.0 0.0 0.1 0.1 0.0 85.3 290.1 113.6 0.0 0.0 0.2 442.3 0.1 0.0 0.0 0.2 0.0 158.8 0.0 0.2 0.2 0.9 0.0 5.7 0.3 2.5 0.1 405.8 1.4 0.1 10.3 0.1 0.7 113.1 337.6 0.7 0.0 216.5 0.1 28.3 9.4 18.9 23.5 9.8 28.3 33.4 26.3 33.1 16.9 33.7 24.3 25.4 4.5 32.2 11.2 33.6 31.0 16.7 0.3 0.5 0.5 0.5 0.2 0.6 0.5 0.3 0.3 0.5 0.2 0.4 1.0 0.1 0.0 0.6 0.3 4.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 48.1 6.3 0.4 0.0 0.0 1181.4 0.0 0.0 1.7 0.0 2.1 0.2 0.0 106.6 4.1 0.0 0.0 1.3 0.0 0.0 0.0 12.0 0.0 0.2 0.2 0.0 2.2 3.0 1810.3 15.8 4.0 3.6 0.0 10.3 0.0 6.2 0.0 0.1 0.0 0.0 10.1 6.5 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.1 531.1 105.5 0.0 0.3 27.0 5.0 0.2 0.5 0.0 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: AB_2684621" "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favorable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 4.3 3.6 4.7 2.5 4.7 2.6 6.4 4.6 5.1 6.0 5.6 5.7 4.8 6.2 6.9 6.0 7.1 5.7 4.5 4.6 4.5 5.4 3.9 3.8 3.2 4.4 4.3 4.4 11.1 7.6 8.7 4.0 4.0 4.4 5.5 4.7 5.2 4.6 5.6 8.4 9.1 4.8 5.5 4.5 3.4 5.0 7.6 4.8 4.5 7.1 8.4 3.9 5.7 6.1 4.7 4.5 3.9 7.7 4.2 6.4 9.0 5.5 4.0 8.9 8.0 7.2 3.1 4.5 7.1 5.2 5.2 4.3 3.5 5.4 8.9 7.2 3.1 4.5 8.2 4.4 4.5 10.7 3.0 4.6 10.9 8.8 5.1 13.2 7.9 4.4 5.3 5.7 4.7 6.4 6.2 6.1 3.0 4.7 6.9 8.8 7.5 4.5 4.5 6.8 6.7 6.4 4.7 8.5 5.1 6.9 5.8 9.5 5.6 4.7 3.6 7.5 4.3 4.5 3.4 3.1 6.4 4.1 4.0 5.8 2.6 3.0 2.2 4.9 2.9 5.6 2.8 3.8 4.5 4.8 4.4 3.8 3.5 0.4 9.2 3.0 2.5 5.8 3.2 4.7 4.7 4.6 5.1 4.6 4.5 4.4 4.3 4.4 4.4 4.5 4.8 4.7 3.6 3.2 4.4 4.9 3.4 2.7 6.9 6.8 5.2 11.4 4.3 2.9 3.7 5.7 3.1 9.2 12.5 5.9 7.0 3.2 1.9 7.3 10.3 2.0 3.5 3.7 4.2 3.0 6.8 4.4 3.6 3.8 5.1 3.9 7.0 9.4 5.0 4.5 3.6 6.7 6.3 5.6 6.1 3.5 2.4 3.7 6.2 2.1 1.8 6.5 5.4 6.2 7.2 6.6 7.2 3.6 4.9 6.4 3.2 4.2 10.6 4.8 3.4 25.1 0.0 3.4 4.0 13.6 18.1 4.5 4.5 5.5 5.1 6.6 5.4 5.5 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099759 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavorable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 19.9 23.0 11.9 9.4 12.2 7.3 18.3 11.0 12.9 21.8 12.2 18.2 9.9 18.0 17.1 21.2 18.7 11.4 16.7 11.5 12.7 22.4 24.6 15.6 10.9 11.3 12.0 12.2 24.6 24.6 17.3 12.0 10.9 11.7 18.2 12.9 13.9 16.5 15.8 18.6 25.1 12.2 14.5 12.7 12.4 19.9 12.3 11.7 13.7 17.8 8.7 11.6 21.5 19.6 16.3 30.1 25.5 16.1 28.8 30.0 28.4 15.1 19.3 22.2 14.7 17.4 13.7 34.8 57.3 42.4 18.0 43.4 25.6 20.9 23.3 20.9 19.2 22.3 19.4 10.9 7.8 31.9 55.8 21.3 19.3 40.4 18.8 30.2 45.7 33.6 29.6 45.9 32.8 26.5 58.8 38.8 43.9 36.2 54.5 26.8 22.9 15.5 69.2 37.7 20.8 16.3 25.1 30.3 43.8 35.3 26.9 17.6 26.9 23.4 22.9 23.6 52.0 31.8 47.8 77.6 42.9 25.5 50.1 30.2 0.0 2.3 3.8 1.4 3.1 2.2 2.2 2.2 2.2 3.4 3.0 2.3 2.4 0.5 2.1 1.6 3.1 2.4 1.1 11.9 12.2 11.0 12.9 11.5 12.7 11.3 12.0 12.2 11.7 12.7 11.7 16.3 30.1 25.6 17.9 12.1 31.8 78.8 60.2 7.9 54.7 24.4 53.3 56.1 17.4 34.3 12.4 27.6 14.6 45.3 41.1 17.6 66.5 19.7 12.6 31.4 32.3 28.4 15.0 51.5 20.7 15.5 52.2 35.4 33.6 23.8 17.2 37.9 30.4 37.6 46.7 8.4 18.5 32.6 6.1 38.8 39.5 8.3 33.8 32.7 46.2 14.0 28.7 38.3 25.7 20.6 44.0 23.2 20.5 34.3 41.9 87.1 21.9 97.4 10.5 28.6 32.9 28.6 37.5 15.6 35.1 67.2 104.3 45.0 31.4 31.9 41.3 71.9 RNF34 "FLJ21786, RIF, RIFF" ENSG00000170633 "Ring finger protein 34" Q969K3 12 121400041-121430623 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074151 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA074151: AB_2686668" "unprognostic (3.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.90e-1)" "unprognostic (6.10e-2)" "unprognostic (9.92e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (3.39e-1)" "unprognostic (9.99e-2)" "unprognostic (1.60e-2)" "unprognostic (5.87e-3)" "unprognostic (2.80e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.55e-3)" "prognostic favorable (3.02e-4)" 13.8 10.9 25.8 23.8 30.0 13.5 13.5 32.1 33.0 11.7 21.7 19.4 19.6 13.8 13.6 15.1 12.7 17.5 18.6 26.5 26.6 11.4 13.1 13.1 34.6 26.8 27.6 25.6 14.8 13.9 13.4 13.8 11.6 27.5 10.6 15.7 19.2 14.0 13.6 60.0 15.9 18.4 16.9 26.0 23.5 18.6 24.8 27.5 27.1 14.0 37.1 26.6 19.2 12.0 33.0 45.4 53.8 34.7 36.3 26.8 24.5 43.2 47.5 42.2 46.3 35.3 67.3 16.9 64.9 35.3 51.3 24.6 31.8 52.6 29.8 41.0 95.3 30.8 75.4 37.7 62.5 32.1 65.7 50.4 21.9 39.6 40.2 34.7 26.4 49.3 37.9 58.0 29.3 46.0 35.7 57.5 95.7 44.5 26.6 48.4 54.0 45.1 38.1 32.0 53.2 50.7 33.0 59.4 21.8 36.6 31.6 38.0 49.1 39.5 39.5 28.4 34.6 37.8 51.2 92.8 70.5 28.2 45.4 40.6 83.7 42.1 91.2 72.4 48.4 74.1 77.1 83.2 76.8 40.4 65.0 71.1 71.1 65.2 76.2 53.3 34.3 106.3 68.3 25.8 30.0 32.1 33.0 26.5 26.6 26.8 27.6 25.6 27.5 26.0 27.5 33.0 14.5 16.0 16.2 15.3 22.9 17.5 18.7 23.4 13.6 13.9 16.5 13.2 22.0 27.1 18.9 9.2 4.2 26.1 30.9 19.0 37.2 32.7 23.5 13.7 15.3 17.3 40.8 24.8 34.3 27.3 38.8 16.1 15.8 13.9 17.7 19.0 17.2 11.2 21.2 13.5 32.7 15.8 30.5 18.0 14.9 10.7 17.1 14.0 17.8 13.1 35.0 23.6 46.4 9.5 45.5 26.2 17.2 18.0 27.9 17.0 20.5 19.9 18.7 21.4 19.7 11.1 25.0 134.0 73.9 15.3 16.1 24.2 34.3 18.5 21.2 25.7 ACYP2 ENSG00000170634 "Acylphosphatase 2" P14621 2 53970838-54305300 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 209.4;tongue: 164.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 162.6;Excitatory neurons: 158.8;Oligodendrocytes: 180.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035301 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA035301: AB_10670291" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (6.90e-3)" "unprognostic (6.21e-2)" "unprognostic (2.03e-3)" "unprognostic (3.17e-1)" "unprognostic (5.22e-2)" "unprognostic (7.83e-3)" "unprognostic (3.64e-3)" "unprognostic (1.16e-1)" "unprognostic (6.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (3.24e-1)" "unprognostic (2.24e-2)" 19.7 43.2 71.3 5.4 78.5 7.2 15.8 80.9 86.1 10.5 67.8 12.4 7.5 11.6 12.9 10.5 11.7 8.6 64.0 70.6 79.1 14.6 28.2 10.7 11.0 76.6 75.6 68.3 9.4 12.8 13.7 26.5 6.6 76.9 14.5 5.4 24.3 15.3 9.3 209.4 9.6 9.1 8.0 76.9 12.8 13.1 10.3 76.7 10.8 12.7 164.7 8.5 14.1 10.8 83.4 11.7 5.9 6.0 4.4 23.7 17.3 3.7 11.5 9.7 8.3 7.3 1.5 7.1 21.5 33.0 12.6 7.8 8.5 3.3 10.8 7.4 14.4 13.1 13.4 6.3 16.3 8.5 12.7 6.3 13.6 19.3 5.6 9.5 15.2 3.9 9.8 5.5 11.5 17.9 7.6 7.5 17.0 5.9 8.4 6.7 5.4 4.7 12.2 18.8 10.6 17.6 10.0 17.4 10.0 5.7 1.9 3.4 13.2 10.9 11.5 10.6 3.5 11.1 21.4 12.5 10.2 16.3 24.3 12.4 41.2 14.0 26.1 16.9 13.0 15.4 29.0 16.6 16.1 20.3 26.9 20.1 16.4 11.5 18.6 13.5 33.4 16.3 11.3 71.3 78.5 80.9 86.1 70.6 79.1 76.6 75.6 68.3 76.9 76.9 76.7 83.4 21.7 16.0 17.9 84.9 30.6 20.5 41.9 52.8 18.8 15.5 49.7 65.7 162.6 34.3 32.0 18.4 10.4 13.6 27.9 24.5 62.6 24.3 86.8 29.5 23.6 23.1 30.6 14.5 158.8 38.1 6.1 21.0 26.0 19.5 19.7 17.6 30.7 74.2 31.9 28.6 134.1 21.9 36.7 40.0 28.5 64.7 13.4 25.4 23.2 59.0 26.1 90.1 24.7 67.8 180.1 29.9 18.8 30.9 36.4 27.4 29.1 55.6 32.2 31.6 52.6 30.8 30.0 22.9 9.8 28.9 21.3 10.3 22.7 29.7 18.6 45.0 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185913-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 17.8 20.9 5.3 28.0 5.6 61.4 18.7 8.4 10.7 23.1 4.3 21.0 18.5 17.0 3.8 40.7 18.9 11.1 20.6 5.5 7.2 26.7 41.2 26.2 33.1 6.9 5.0 5.6 19.0 73.3 7.6 22.0 8.5 5.4 29.3 6.3 3.2 29.2 9.7 29.5 23.4 30.9 5.3 4.9 37.2 27.7 20.9 5.5 16.8 25.0 5.1 15.8 22.8 27.2 5.6 62.8 40.9 14.5 24.7 7.8 9.0 35.9 21.4 14.0 17.6 14.9 26.2 29.6 38.3 20.5 10.1 13.7 38.6 18.8 38.1 3.5 27.1 87.1 22.5 71.2 46.0 30.5 45.4 42.7 14.6 22.9 12.9 17.7 10.3 17.9 37.3 27.8 61.7 7.6 70.5 32.5 51.2 21.3 21.3 38.0 87.6 19.7 83.0 13.4 61.5 16.8 28.0 18.4 66.2 31.3 6.1 28.0 47.0 19.4 14.6 36.2 19.2 24.4 73.9 14.1 46.7 18.0 31.5 23.5 16.9 30.5 51.4 21.2 26.5 20.3 13.6 19.1 19.5 32.5 6.7 12.6 15.3 40.6 32.1 16.7 68.7 29.5 22.4 5.3 5.6 8.4 10.7 5.5 7.2 6.9 5.0 5.6 5.4 4.9 5.5 5.6 22.2 9.6 19.3 12.1 80.3 42.1 57.4 48.9 33.6 32.6 38.8 30.1 12.0 17.2 31.8 33.1 18.8 25.5 151.7 66.2 27.4 52.3 20.7 17.1 25.1 27.2 18.0 17.4 11.6 62.9 54.5 27.2 77.5 32.4 27.3 31.6 12.8 24.0 46.4 43.7 12.9 55.3 46.8 46.9 59.4 8.8 32.3 69.6 42.7 9.4 111.4 22.5 117.4 14.1 15.3 80.6 67.7 32.4 133.1 125.9 55.0 28.9 19.7 32.8 19.7 20.5 23.7 49.9 31.5 34.3 45.6 30.6 84.3 31.2 71.0 92.5 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 141.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 25.6 13.3 12.1 18.2 17.6 15.5 24.1 24.5 17.5 20.0 11.3 19.9 12.7 24.7 14.6 22.6 17.9 18.2 20.1 13.3 14.4 17.6 14.7 20.4 13.3 20.5 16.0 8.2 24.8 18.6 14.3 11.6 18.5 19.9 19.1 21.3 15.5 24.4 14.7 30.8 24.5 14.1 26.2 15.5 14.4 18.2 12.7 15.5 16.6 16.5 22.4 15.8 20.0 21.1 28.6 16.6 32.1 16.6 18.2 30.8 39.1 10.8 19.6 20.1 21.3 14.2 23.0 25.2 25.8 25.4 24.2 8.7 20.2 13.0 21.7 19.2 25.2 16.7 22.6 37.4 24.8 20.7 29.0 16.1 30.7 28.1 26.5 29.9 35.3 42.6 14.0 26.0 23.2 32.1 30.9 17.6 20.2 16.3 18.7 17.4 22.9 19.7 24.9 32.3 21.2 13.8 14.6 29.9 21.7 30.8 16.0 29.2 17.6 31.4 25.2 17.7 20.2 17.9 11.4 14.6 16.2 20.6 27.1 23.6 15.3 13.8 13.8 7.4 19.1 7.6 10.5 10.1 7.5 10.8 11.5 7.2 8.6 8.6 14.2 14.1 7.5 10.4 8.8 12.1 17.6 24.5 17.5 13.3 14.4 20.5 16.0 8.2 19.9 15.5 15.5 28.6 30.5 12.8 17.3 83.2 16.3 22.2 24.0 35.9 25.6 9.4 33.3 31.1 18.2 22.8 23.4 14.7 25.0 22.2 14.0 21.4 37.2 30.3 32.2 16.5 23.1 25.4 18.6 13.2 29.0 31.6 25.0 23.8 17.3 22.5 28.6 25.0 28.9 14.7 25.3 10.1 29.7 20.3 24.4 24.1 23.1 35.8 27.1 24.9 24.9 55.3 24.0 23.9 17.5 40.7 141.9 27.5 13.8 24.5 12.5 25.0 17.9 46.0 17.0 10.9 26.3 25.6 27.5 9.9 17.9 34.1 28.8 27.9 17.3 20.2 18.4 28.9 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102479976-102517777 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 132.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Bipolar cells: 3.3;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 2.0;myeloid DC: 3.3;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 6 "dendritic cells: 3.3;monocytes: 2.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 15.1;U-138 MG: 17.0;U-2 OS: 14.9" "Low region specificity" "Detected in all" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 12.1 5.9 6.1 4.2 5.2 2.2 10.9 6.4 7.9 13.0 2.9 9.3 6.5 16.6 1.3 2.8 9.8 3.8 4.0 5.6 6.4 6.3 0.8 6.0 4.7 7.3 7.3 5.0 9.7 2.4 5.2 5.8 5.0 10.7 8.1 1.8 5.3 4.6 7.7 132.0 5.6 7.8 3.8 6.9 5.9 5.0 2.1 6.3 1.9 3.9 19.4 2.9 9.6 9.6 6.9 0.2 1.4 3.7 0.5 1.3 2.9 0.2 6.8 4.4 2.2 3.6 0.5 1.1 3.4 7.3 8.6 0.7 9.1 0.0 0.0 1.1 0.5 1.6 0.5 2.7 0.8 1.2 0.3 0.5 2.9 0.8 0.1 0.2 10.4 0.9 1.7 0.9 9.8 0.7 3.0 2.9 1.9 0.3 1.7 1.9 2.8 1.5 4.6 0.1 0.9 3.1 15.1 1.0 0.5 0.5 3.0 1.0 2.0 2.0 17.0 14.9 1.8 0.6 3.5 2.9 2.4 2.3 0.9 2.8 0.0 2.2 0.0 0.3 2.0 0.2 0.1 0.3 0.1 3.3 0.2 0.3 0.4 0.3 0.0 0.4 2.1 0.3 1.2 6.1 5.2 6.4 7.9 5.6 6.4 7.3 7.3 5.0 10.7 6.9 6.3 6.9 0.6 0.0 0.6 2.9 1.1 0.4 0.2 0.0 1.2 3.3 0.1 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.9 0.1 0.0 0.1 0.3 1.8 2.4 0.4 0.5 0.2 0.0 0.3 5.6 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.6 0.9 0.0 0.3 1.0 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.1 0.0 0.0 2.5 0.2 1.3 0.3 0.1 0.6 0.0 0.5 0.8 0.3 0.0 0.3 1.1 0.1 1.6 0.3 0.0 0.2 SOCS6 "CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4" ENSG00000170677 "Suppressor of cytokine signaling 6" O14544 18 70289045-70330199 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.6;myeloid DC: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010189 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB010189: AB_661195" "unprognostic (1.76e-3)" "unprognostic (6.83e-3)" "unprognostic (8.90e-3)" "unprognostic (4.52e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.07e-1)" "unprognostic (7.93e-2)" "unprognostic (5.83e-2)" "unprognostic (1.75e-1)" "unprognostic (6.90e-2)" "unprognostic (8.19e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (4.11e-2)" "unprognostic (1.80e-2)" 8.0 8.1 7.1 6.0 9.9 13.2 14.1 10.8 10.1 15.3 6.3 16.3 15.8 11.9 7.0 15.2 12.4 13.6 11.1 6.6 8.4 9.4 28.5 9.8 3.4 13.8 9.6 3.9 11.0 13.1 14.2 4.2 14.0 22.7 8.5 14.6 5.6 11.4 7.9 12.9 7.1 23.0 11.0 16.9 4.1 14.1 5.8 12.7 3.2 11.7 13.5 5.6 8.4 8.1 15.5 19.2 41.6 17.4 12.0 16.1 18.9 19.4 40.3 24.5 24.0 18.0 15.6 31.7 2.1 3.6 37.7 29.0 22.2 12.8 13.2 23.3 0.0 7.8 14.4 14.3 24.1 19.1 7.9 15.6 15.3 15.4 20.9 17.4 23.9 12.2 1.7 8.7 9.6 16.5 9.3 6.8 5.8 11.2 12.2 17.7 8.0 16.8 3.5 14.9 15.6 8.0 20.0 20.9 22.8 18.9 12.4 6.8 13.6 15.1 26.3 13.3 5.5 16.5 0.0 0.0 5.2 29.3 0.6 18.1 0.0 3.6 2.9 0.2 0.7 0.1 0.3 0.4 0.0 3.9 0.0 0.6 0.3 0.0 1.0 0.0 0.3 0.0 1.2 7.1 9.9 10.8 10.1 6.6 8.4 13.8 9.6 3.9 22.7 16.9 12.7 15.5 15.0 25.6 17.0 8.1 1.2 11.7 13.7 13.3 12.0 12.9 26.6 14.7 22.4 21.5 30.1 11.0 6.2 28.0 2.1 61.0 11.7 18.4 1.3 23.5 23.5 13.9 29.4 3.8 17.0 18.5 15.6 13.7 21.4 34.6 31.0 9.1 13.6 32.4 25.7 37.0 17.5 31.0 10.2 7.7 11.1 2.8 11.5 19.2 26.6 86.2 10.1 7.8 5.2 28.6 32.1 30.5 30.5 12.8 0.9 17.4 36.8 25.6 21.8 4.7 0.0 14.9 12.5 1.3 11.0 20.5 11.9 68.4 2.1 4.4 26.7 34.6 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100588389 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 278.6;tongue: 93.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.9;Granulosa cells: 1.8;Pancreatic endocrine cells: 1.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.9;SCLC-21H: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 0.2 0.1 2.8 0.2 3.9 0.1 0.1 2.9 5.1 0.4 1.5 0.3 0.0 0.5 0.1 4.4 0.1 0.3 46.4 2.8 3.0 0.2 0.2 0.4 0.1 3.7 3.7 2.5 0.2 0.1 0.1 0.2 0.3 4.0 4.6 0.1 0.3 2.4 0.1 278.6 0.2 0.1 0.3 3.0 0.1 0.3 3.7 3.5 0.4 0.5 93.2 0.1 0.3 0.2 4.5 0.5 0.3 6.1 2.2 1.4 2.0 4.3 1.1 0.9 0.8 1.0 0.0 0.4 0.2 0.3 0.6 2.1 0.3 3.1 0.1 1.7 1.4 2.0 0.1 1.0 0.0 0.4 0.2 0.4 5.0 0.3 0.8 0.5 1.5 1.1 1.5 0.2 0.2 3.9 0.1 1.8 0.3 8.9 1.0 0.7 2.6 5.8 0.0 0.8 0.3 13.2 3.4 0.2 0.2 1.1 4.1 0.1 0.2 1.1 1.5 1.2 1.0 1.0 0.3 1.1 0.6 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.9 2.9 5.1 2.8 3.0 3.7 3.7 2.5 4.0 3.0 3.5 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.4 0.5 0.0 1.9 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 OR10A3 "HSHTPCRX12, HTPCRX12" ENSG00000170683 "Olfactory receptor family 10 subfamily A member 3" P58181 11 7937171-7941708 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.53e-2)" "unprognostic (3.24e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF296 ZNF342 ENSG00000170684 "Zinc finger protein 296" Q8WUU4 19 45071500-45076587 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Cell type enhanced" "Detected in many" "B-cells: 53.3;Basal squamous epithelial cells: 94.4;Plasma cells: 48.2;Squamous epithelial cells: 107.3" "Cancer enhanced" "Detected in all" "testis cancer: 19.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 24.0;SK-BR-3: 15.6;U-698: 28.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA046940, HPA049576" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA046940: AB_2679871, HPA049576: AB_2680821" "unprognostic (1.32e-1)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.83e-3)" "unprognostic (1.67e-2)" "unprognostic (9.70e-2)" "unprognostic (9.55e-2)" "unprognostic (3.20e-3)" "unprognostic (1.12e-1)" "unprognostic (2.67e-5)" "unprognostic (7.14e-3)" "unprognostic (1.52e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-3)" 0.6 1.1 1.1 2.2 0.9 5.4 1.7 3.1 2.0 1.1 0.2 1.6 3.0 0.5 0.1 9.3 1.4 0.2 0.4 1.1 0.8 1.5 0.7 1.3 2.8 1.0 0.8 0.7 0.7 0.7 0.1 3.3 0.1 1.5 2.5 0.3 0.5 5.1 0.4 0.5 5.8 4.2 0.1 1.0 6.0 2.7 2.3 0.7 0.4 1.2 0.1 1.4 1.5 3.2 0.8 4.6 2.9 0.1 0.6 0.0 0.2 2.5 0.6 0.0 0.3 0.2 4.7 1.6 24.0 2.7 0.1 0.0 8.3 1.2 1.8 0.0 5.2 6.3 7.2 1.4 4.8 1.2 3.9 7.2 0.9 0.9 0.9 0.0 0.1 0.7 0.4 5.2 8.0 0.0 6.5 0.3 6.8 2.7 2.8 6.3 13.5 0.0 14.8 0.5 1.6 4.4 0.4 3.0 15.6 0.1 0.4 3.4 8.1 1.5 0.0 2.4 0.1 0.0 8.6 9.3 28.7 0.2 5.0 0.1 59.7 10.7 17.2 8.3 18.3 9.7 82.6 4.3 9.3 26.0 62.8 1.8 4.7 5.1 45.9 18.5 78.5 4.4 8.7 1.1 0.9 3.1 2.0 1.1 0.8 1.0 0.8 0.7 1.5 1.0 0.7 0.8 2.4 0.0 0.6 2.3 53.3 12.1 13.9 1.5 94.4 1.4 20.5 13.3 1.2 0.0 2.6 3.7 4.2 0.4 31.9 18.5 0.0 1.8 0.5 6.1 1.0 2.0 5.3 3.0 0.4 0.9 3.6 1.3 21.9 4.5 8.9 0.5 1.4 0.2 3.5 0.0 0.3 32.1 6.1 2.9 19.1 0.5 0.0 7.6 3.6 0.0 24.9 0.4 12.3 0.0 0.5 1.2 36.1 1.2 48.2 6.4 23.4 0.2 3.9 1.6 0.0 0.8 3.2 1.1 14.2 107.3 10.1 0.8 18.5 0.2 28.9 6.2 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621156-48626358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 88.6;intestine: 26.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5" "Group enriched" "Detected in many" 5 "colorectal cancer: 56.0;endometrial cancer: 26.4" "Group enriched" "Detected in some" 14 "spinal cord: 2.3;white matter: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 69 "spinal cord: 6.8" HPA004928 Supported Nucleoplasm NA No Nucleoplasm "HPA004928: " "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavorable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.4 1.0 0.0 4.7 0.0 0.0 0.5 0.0 0.0 11.5 0.0 26.5 0.0 0.9 88.6 0.0 0.3 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.6 0.0 0.4 22.5 0.0 0.0 16.0 0.1 0.1 13.5 1.3 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.3 1.0 18.0 5.8 0.0 32.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.6 7.0 0.1 34.6 0.9 3.9 0.1 5.5 0.0 0.0 339.3 126.4 59.1 2.3 0.0 2.3 1.1 127.7 0.1 0.2 0.1 3.3 9.8 0.0 2.7 145.7 0.1 5.5 0.3 0.0 0.4 0.0 8.0 5.4 0.3 21.9 1.9 57.1 0.2 0.0 0.0 4.4 0.0 37.4 0.5 0.6 0.3 0.4 0.1 32.1 0.2 10.4 0.2 0.4 0.2 0.1 0.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 1.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 58.8 0.0 0.0 0.5 30.4 39.2 0.0 0.1 5.5 0.4 3.0 176.7 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 0.0 0.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.3 0.0 0.0 0.3 6.0 0.9 0.0 0.0 0.0 0.0 0.3 0.5 1.2 0.0 0.0 0.0 0.4 0.0 45.5 0.2 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.0" "Group enriched" "Detected in some" 4 "Early spermatids: 49.7;Late spermatids: 176.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA052397: AB_2681812" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.6 0.1 0.6 0.0 0.1 0.5 1.0 0.1 1.3 2.9 1.3 0.1 0.0 0.0 3.7 0.5 0.0 0.6 0.5 2.4 0.0 0.6 0.0 0.7 0.7 0.5 0.0 0.6 0.0 0.4 0.0 0.7 0.1 3.9 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.5 0.0 0.2 19.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.0 0.6 0.5 0.7 0.7 0.5 0.7 0.5 0.7 0.6 0.1 3.2 2.6 5.2 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.6 0.0 3.8 1.8 0.0 0.0 0.0 7.4 1.9 0.3 49.7 2.6 0.1 0.5 4.2 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.1 0.1 0.0 1.0 2.6 0.0 0.0 0.0 176.1 1.2 0.1 0.0 0.0 0.0 0.4 0.0 13.0 0.7 0.0 2.2 0.0 0.0 0.4 4.1 3.2 23.8 0.7 0.0 0.0 0.0 11.2 0.4 0.0 0.0 0.0 0.0 0.4 3.5 0.1 POLH "RAD30A, XP-V" ENSG00000170734 "DNA polymerase eta" Q9Y253 6 43576185-43620523 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 91.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006721, HPA026762" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA006721: AB_1847785, HPA026762: AB_10601248" "unprognostic (1.79e-1)" "unprognostic (7.29e-2)" "unprognostic (2.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.61e-1)" "unprognostic (5.11e-3)" "unprognostic (9.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (7.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.24e-1)" "unprognostic (9.50e-2)" "unprognostic (6.73e-2)" "unprognostic (8.77e-2)" "unprognostic (7.91e-2)" "unprognostic (6.02e-2)" 5.0 3.9 2.3 7.0 2.6 4.2 4.9 4.8 2.9 6.0 4.6 7.0 4.6 4.2 3.6 5.5 5.6 4.4 3.7 2.2 2.1 4.7 5.6 5.8 13.0 2.4 2.1 2.6 4.7 5.5 3.7 3.2 4.0 2.9 4.8 7.2 7.5 4.0 3.8 8.6 8.5 4.4 6.3 2.1 5.6 4.6 10.7 2.9 13.0 6.9 4.7 14.4 4.9 4.3 3.5 46.7 9.7 13.5 19.9 17.6 29.1 33.0 48.6 13.9 26.2 29.2 12.0 7.9 48.9 12.0 17.6 7.6 11.4 13.1 28.6 31.5 25.9 10.0 15.3 31.6 35.5 13.4 26.8 19.2 19.5 33.4 21.5 11.3 10.6 24.3 14.5 24.0 29.6 33.0 15.0 23.9 6.4 4.2 33.2 7.2 25.1 14.3 11.8 9.9 34.6 15.1 5.4 14.5 12.9 7.3 15.4 17.9 10.8 36.2 23.6 24.4 12.2 25.2 28.0 21.3 91.1 11.8 14.5 27.3 4.1 1.7 2.7 4.2 1.6 3.8 5.0 3.5 3.1 1.3 4.9 2.8 3.0 1.7 4.2 1.6 2.6 4.6 2.0 2.3 2.6 4.8 2.9 2.2 2.1 2.4 2.1 2.6 2.9 2.1 2.9 3.5 3.1 12.8 8.2 12.1 15.1 4.7 3.2 4.8 19.4 6.3 3.4 3.3 2.3 5.7 6.5 3.7 10.4 2.4 5.2 6.3 5.9 2.1 11.4 10.2 4.8 2.8 5.4 5.7 14.8 0.9 2.8 5.3 8.2 9.0 0.0 6.1 1.4 2.4 1.7 0.0 15.3 2.2 4.1 2.2 2.2 7.3 3.4 3.0 1.8 6.5 3.2 2.6 2.1 10.1 13.4 1.9 4.5 3.0 12.7 2.2 3.1 2.3 5.4 9.4 0.0 7.0 5.0 25.9 6.7 13.0 3.0 1.9 8.8 5.6 3.0 2.3 SYT9 ENSG00000170743 "Synaptotagmin 9" Q86SS6 11 7238778-7469043 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;retina: 7.6" "Cell type enhanced" "Detected in some" "Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2" "Cancer enhanced" "Detected in some" "breast cancer: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.47e-1)" "unprognostic (9.41e-2)" "unprognostic (1.39e-5)" "unprognostic (1.63e-1)" "unprognostic (1.12e-1)" "unprognostic (5.50e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (3.31e-3)" "unprognostic (4.35e-2)" "unprognostic (1.92e-4)" "unprognostic (1.22e-4)" 0.0 2.0 8.0 0.0 7.8 0.0 0.8 11.0 5.3 0.4 0.8 0.1 0.0 1.3 0.0 0.0 0.1 0.1 0.3 4.3 6.5 2.1 3.6 0.0 0.0 9.4 11.4 3.8 0.1 1.4 0.9 1.5 0.0 9.3 1.0 0.0 7.6 0.0 3.6 0.0 0.1 0.1 0.1 7.5 0.0 0.1 0.9 13.2 0.0 1.1 0.0 0.0 0.2 0.3 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 17.9 3.2 13.2 0.0 0.0 0.0 0.4 0.0 0.0 20.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 7.8 11.0 5.3 4.3 6.5 9.4 11.4 3.8 9.3 7.5 13.2 11.4 0.0 0.0 0.0 48.6 0.5 0.0 0.1 0.0 0.0 13.6 0.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.9 0.0 0.2 0.0 0.0 0.0 15.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.2 0.0 3.3 9.8 0.0 0.0 0.3 0.0 23.5 0.0 0.0 0.0 5.6 0.0 2.0 0.0 55.3 139.2 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 3.5 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 86.8;tongue: 45.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Enteroendocrine cells: 32.5;Theca cells: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 69.2;RPMI-8226: 28.9;RT4: 48.2;U-266/84: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.7 1.1 4.0 3.8 3.3 0.0 6.3 4.2 4.6 6.9 8.5 11.4 3.8 3.2 2.7 6.0 4.0 5.4 6.2 3.3 4.2 5.1 3.8 23.7 0.7 9.7 8.1 2.9 1.0 9.9 2.9 1.2 11.1 13.0 6.6 5.0 0.4 11.3 3.1 86.8 5.4 5.4 3.4 6.3 1.0 9.6 4.0 5.2 1.4 2.4 45.9 2.1 6.8 6.3 10.7 8.5 1.4 0.7 0.0 1.6 0.8 3.8 2.8 8.5 1.7 2.0 0.1 17.1 0.0 0.9 3.0 1.9 2.7 20.7 0.1 1.8 0.0 5.7 0.0 0.2 0.1 8.1 0.2 0.7 0.7 12.9 0.1 1.2 15.5 0.4 3.9 0.4 0.0 1.0 2.2 0.0 0.0 10.2 11.5 0.2 2.4 69.2 28.9 1.8 48.2 20.3 0.7 0.0 5.3 6.1 4.8 2.8 0.0 0.2 2.7 0.0 0.2 21.6 0.1 34.9 0.1 15.2 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.3 4.2 4.6 3.3 4.2 9.7 8.1 2.9 13.0 6.3 5.2 10.7 3.8 28.9 8.2 0.0 0.0 13.9 16.8 6.9 21.1 0.2 11.5 7.0 0.5 18.6 6.8 11.0 0.0 0.6 0.0 10.9 0.0 21.5 0.3 0.9 0.6 5.9 32.5 0.0 0.3 0.4 3.5 12.1 8.2 0.9 1.3 4.3 2.5 5.4 0.5 0.0 16.9 5.6 14.2 0.0 4.5 1.2 1.5 0.4 21.4 1.9 0.7 0.1 0.0 7.1 2.5 2.4 4.9 3.8 1.2 13.6 4.1 5.5 1.7 0.2 6.6 13.5 10.6 0.3 3.4 8.0 5.8 0.8 0.6 30.6 10.3 7.1 RBMXL2 "HNRNPG-T, HNRPGT" ENSG00000170748 "RBMX like 2" O75526 11 7088998-7091148 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 168 "testis: 36.1" "Group enriched" "Detected in some" 8 "Early spermatids: 157.6;Late spermatids: 160.6;Spermatocytes: 205.3" "Cancer enriched" "Detected in single" 133 "testis cancer: 6.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038912, HPA051842" Enhanced NA NA "HPA038912: AB_10670913, HPA051842: AB_2681634" "unprognostic (3.73e-1)" "unprognostic (2.24e-1)" "unprognostic (5.47e-2)" "unprognostic (1.51e-2)" "unprognostic (3.24e-1)" "unprognostic (8.28e-2)" "unprognostic (3.77e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.6 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 205.3 20.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009015-32056425 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" NA Yes 97000 "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 60.2 42.2 138.5 47.1 138.2 85.7 45.8 125.2 129.1 47.7 93.3 61.6 52.5 54.6 30.6 53.2 39.5 60.4 88.3 104.7 118.3 45.1 32.2 53.0 40.2 136.5 140.2 93.5 27.9 42.2 92.3 23.1 54.9 140.3 66.5 64.2 45.5 39.4 52.5 65.5 39.3 55.2 82.0 147.2 48.5 51.9 64.9 128.7 44.4 50.9 67.9 36.9 61.3 30.1 162.2 115.8 96.4 127.3 89.9 89.2 97.7 54.4 155.6 73.3 117.6 99.6 106.6 124.0 78.7 65.8 185.8 66.9 93.3 117.6 99.4 156.4 68.4 64.1 100.2 87.9 104.5 102.5 70.5 105.6 79.9 138.0 135.8 94.0 93.4 152.8 68.2 122.9 80.5 164.7 69.7 74.0 39.7 20.7 110.1 43.4 95.7 237.2 32.6 90.6 79.5 123.3 89.9 120.4 47.5 117.3 88.0 57.5 99.4 128.4 118.7 111.0 139.3 117.2 24.2 29.8 90.9 113.2 142.2 114.1 41.8 25.9 44.0 19.1 33.0 18.7 23.7 24.0 20.6 24.7 24.3 21.1 20.8 51.1 24.3 35.7 47.9 29.4 18.4 138.5 138.2 125.2 129.1 104.7 118.3 136.5 140.2 93.5 140.3 147.2 128.7 162.2 160.3 182.7 206.8 49.3 86.3 213.1 177.7 200.6 66.0 181.9 119.0 103.8 396.0 115.8 198.4 104.8 100.1 121.0 125.5 145.0 45.0 209.4 185.5 167.8 171.4 181.0 132.3 69.2 44.6 176.0 134.9 141.2 85.6 158.9 91.2 159.7 88.5 46.2 132.7 151.4 56.0 227.3 213.6 111.8 129.1 51.8 59.0 137.2 101.4 84.3 169.3 160.5 82.4 61.9 83.3 202.2 164.9 130.9 84.2 254.1 120.2 59.5 206.1 123.8 85.5 176.0 244.8 566.0 195.6 87.6 236.7 331.9 116.0 137.4 208.1 246.8 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124743885-124765792 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 109.0;retina: 39.4" "Group enriched" "Detected in many" 8 "Muller glia cells: 616.6;Oligodendrocytes: 324.9" "Group enriched" "Detected in many" 4 "glioma: 19.2;liver cancer: 5.7;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" No No 900000 "Nuclear membrane, Cytosol" "HPA042903: AB_2678219, HPA068009: AB_2685940" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favorable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 0.5 0.1 28.9 0.1 59.6 0.0 0.5 51.2 46.3 0.3 7.1 0.5 0.0 1.6 0.2 3.7 0.6 0.3 0.0 30.3 44.0 0.3 10.1 0.2 0.1 60.7 58.2 22.4 0.0 1.5 0.1 0.2 5.2 57.6 0.5 0.3 39.4 0.9 0.5 0.6 2.2 0.6 1.2 51.5 2.1 1.3 10.7 47.3 0.0 0.0 0.1 0.0 1.4 0.6 109.0 0.1 1.4 7.5 0.0 0.0 0.0 2.1 0.5 1.9 1.9 0.4 0.3 0.7 0.0 0.0 17.7 0.2 0.1 2.2 0.0 0.4 0.3 1.0 0.1 4.4 0.0 2.2 0.0 0.3 0.0 7.7 0.0 0.1 0.0 3.6 0.0 0.0 3.4 0.0 0.4 0.0 0.0 1.1 0.0 3.5 0.0 0.0 0.0 0.0 0.1 1.7 2.7 0.0 6.8 2.6 8.0 1.7 0.0 12.7 1.5 0.6 0.0 0.0 1.1 0.0 0.0 0.7 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 59.6 51.2 46.3 30.3 44.0 60.7 58.2 22.4 57.6 51.5 47.3 109.0 0.1 0.0 0.0 5.9 0.0 4.6 0.5 4.4 6.8 55.8 4.6 3.0 0.6 7.2 1.8 1.8 6.2 10.1 0.0 0.1 0.0 5.1 0.4 2.0 0.4 0.7 0.0 0.0 6.0 0.6 19.7 1.9 0.0 3.4 0.0 0.3 0.4 22.4 1.2 18.5 1.1 1.1 2.0 0.3 0.7 1.7 2.8 0.2 3.6 1.0 0.6 616.6 0.0 1.5 324.9 0.4 0.2 0.7 0.0 3.2 0.0 0.0 1.4 22.5 0.0 4.8 0.7 0.6 2.2 4.6 10.2 3.0 0.5 0.1 0.0 0.4 AKAP13 "AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB" ENSG00000170776 "A-kinase anchoring protein 13" Q12802 15 85380571-85749358 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 161.8" "Low region specificity" "Detected in all" HPA019773 Approved Supported Cytosol NA NA 14000 Cytosol "HPA019773: AB_1844686" "unprognostic (4.61e-2)" "unprognostic (1.16e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (5.33e-2)" "unprognostic (7.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (3.99e-2)" "unprognostic (3.92e-1)" "unprognostic (6.69e-2)" "unprognostic (4.88e-2)" "unprognostic (4.80e-2)" "unprognostic (1.46e-1)" "unprognostic (3.81e-3)" 38.1 19.1 11.0 39.1 11.7 56.6 32.4 4.2 12.3 26.8 63.1 26.2 16.9 83.7 20.9 25.9 22.9 45.0 64.3 11.8 67.7 14.5 22.4 54.6 48.0 17.8 13.9 5.8 27.0 55.0 11.9 18.7 26.3 15.2 20.5 21.5 8.4 24.1 23.7 84.7 24.8 32.8 40.7 14.8 38.6 34.7 20.2 14.8 46.8 33.0 60.8 46.9 33.2 26.9 23.8 13.2 29.0 20.8 7.8 31.3 34.6 11.2 10.6 23.5 9.4 9.0 11.3 11.0 62.0 14.6 19.2 23.8 26.5 23.9 9.9 9.0 45.2 11.0 83.8 20.0 8.6 17.3 17.2 161.8 25.6 25.5 11.6 39.8 10.6 25.2 22.4 5.5 29.6 14.7 6.3 24.7 12.8 13.5 22.8 11.5 16.7 20.6 23.5 15.3 27.0 13.1 23.4 27.9 8.3 14.5 22.7 6.0 14.3 30.2 11.4 7.8 6.7 10.7 46.1 30.1 48.9 6.8 55.2 9.0 282.9 66.0 181.4 122.2 54.9 68.3 74.9 81.6 93.3 38.8 68.8 68.2 75.5 104.3 108.2 77.5 100.6 73.2 48.0 11.0 11.7 4.2 12.3 11.8 67.7 17.8 13.9 5.8 15.2 14.8 14.8 23.8 110.5 125.0 431.2 88.2 186.8 75.7 105.2 29.1 57.5 18.6 50.2 39.9 215.2 91.5 71.6 40.5 41.7 36.7 336.8 143.3 5.9 83.4 258.9 155.6 327.0 121.5 63.5 37.0 51.2 69.6 27.6 119.6 170.2 323.6 279.5 65.6 75.7 53.7 79.2 13.5 13.0 57.8 36.7 147.1 276.3 166.3 77.6 257.9 99.6 290.4 197.3 45.8 252.4 123.6 13.2 101.2 118.7 63.6 205.8 77.0 68.6 10.5 60.1 17.9 85.5 139.6 117.4 23.3 37.2 77.6 79.0 23.4 269.7 30.5 61.7 179.6 TPD52L3 "D55, NYD-SP25, TPD55" ENSG00000170777 "TPD52 like 3" Q96J77 9 6328375-6331900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1163 "testis: 156.4" "Cell type enhanced" "Detected in some" "Early spermatids: 648.0;Late spermatids: 1137.5;Spermatocytes: 283.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "BEWO: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 648.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1137.5 10.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 283.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 56.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 3.8 2.7 1.8 7.4 1.9 56.2 4.2 2.9 2.2 6.7 1.9 4.4 4.7 5.5 1.8 18.8 4.2 2.6 2.5 1.6 1.9 2.5 2.7 3.7 11.7 2.0 1.8 1.6 4.1 3.3 1.8 1.7 9.3 2.2 3.9 3.0 1.3 5.5 2.2 1.4 23.8 4.9 3.5 1.9 6.6 3.8 11.7 1.9 14.7 3.3 1.5 8.6 4.2 10.3 2.0 40.6 41.3 46.7 35.6 7.9 13.2 61.1 59.0 18.0 45.2 39.7 50.9 50.2 52.9 31.5 20.9 34.5 63.5 32.9 68.0 27.1 58.2 26.1 33.4 33.9 43.2 9.7 59.8 27.0 9.4 20.8 35.2 32.7 15.1 31.4 45.0 37.5 53.0 32.1 98.8 56.2 40.1 34.8 35.1 94.0 53.6 68.1 19.7 15.9 46.2 27.2 33.5 56.6 22.3 46.8 20.5 44.0 39.8 48.8 39.9 50.5 55.3 79.5 19.5 25.9 54.4 33.5 30.2 67.5 1.1 4.3 10.6 11.9 4.9 14.8 8.4 12.7 16.7 4.7 5.4 7.4 8.9 1.6 12.9 5.6 5.1 11.1 7.0 1.8 1.9 2.9 2.2 1.6 1.9 2.0 1.8 1.6 2.2 1.9 1.9 2.0 5.4 0.0 2.2 0.7 7.4 64.2 26.5 36.6 13.1 3.4 8.7 8.3 0.6 0.0 9.0 1.8 0.0 84.5 11.5 4.3 3.9 12.7 8.1 9.0 9.0 10.9 3.0 53.0 1.8 7.0 154.5 10.2 3.1 12.5 28.6 15.1 7.9 2.2 24.3 13.5 1.3 6.6 6.1 5.9 22.6 6.8 8.4 8.4 17.8 2.8 9.3 4.6 9.2 1.0 1.8 12.3 3.3 6.0 11.8 16.1 1.9 1.8 7.7 2.6 6.6 4.6 12.5 43.0 69.9 21.3 67.1 25.9 17.7 3.6 9.5 43.2 OR10A4 OR10A4P ENSG00000170782 "Olfactory receptor family 10 subfamily A member 4" Q9H209 11 6876625-6877619 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.16e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SDR16C5 "EPHD-2, RDH-E2, RDHE2" ENSG00000170786 "Short chain dehydrogenase/reductase family 16C member 5" Q8N3Y7 8 56300005-56320776 "Enzymes, Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 52.3;lung: 34.7;skin 1: 60.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 155.9;Basal respiratory cells: 325.1;Club cells: 141.9;Ionocytes: 120.1;Pancreatic endocrine cells: 99.5;Respiratory ciliated cells: 82.5;Suprabasal keratinocytes: 72.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 35 "memory B-cell: 4.7;naive B-cell: 2.3" "Lineage enriched" "Detected in single" 47 "B-cells: 4.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.8;HaCaT: 10.3;hTCEpi: 16.7;OE19: 24.8;T-47d: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA025224 Enhanced NA NA "HPA025224: AB_1856163" "unprognostic (1.66e-1)" "unprognostic (8.88e-2)" "unprognostic (9.46e-2)" "unprognostic (4.18e-4)" "unprognostic (8.83e-3)" "prognostic favorable (7.88e-4)" "unprognostic (1.66e-1)" "unprognostic (2.51e-1)" "unprognostic (2.42e-1)" "unprognostic (1.78e-3)" "unprognostic (2.39e-1)" "unprognostic (2.48e-5)" "unprognostic (2.55e-1)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" 0.3 0.2 2.0 3.0 2.2 0.0 9.2 1.9 3.8 7.6 0.9 2.2 2.3 0.0 0.0 52.3 0.2 0.4 0.1 2.4 2.0 0.0 0.0 34.7 0.5 4.7 2.5 1.9 0.2 0.4 0.0 0.5 0.0 5.3 0.3 4.0 1.1 17.0 0.0 0.3 60.8 15.8 0.2 1.3 0.0 18.3 0.8 3.6 0.3 0.0 0.2 22.1 6.3 25.2 4.7 4.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 10.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 24.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.2 1.9 3.8 2.4 2.0 4.7 2.5 1.9 5.3 1.3 3.6 4.7 1.7 48.1 155.9 0.0 1.7 51.1 6.2 325.1 4.6 0.3 5.5 2.4 0.2 5.7 141.9 0.0 0.0 0.0 0.0 7.1 0.0 0.7 0.4 0.0 0.1 2.3 0.0 0.0 4.3 1.4 0.0 0.9 10.2 0.1 3.8 0.0 0.0 0.0 0.0 0.0 1.1 19.7 120.1 0.0 3.6 0.4 0.6 0.4 3.6 0.0 0.6 12.3 0.0 0.0 0.3 99.5 3.4 0.0 0.0 9.5 0.3 0.0 82.5 1.6 0.0 0.1 4.9 0.3 5.5 36.6 72.2 0.0 0.6 0.0 5.3 26.0 DYDC1 "bA36D19.5, DPY30D1" ENSG00000170788 "DPY30 domain containing 1" Q8WWB3 10 80336105-80356755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 127.6" "Cell type enhanced" "Detected in some" "Early spermatids: 222.4;Late spermatids: 83.5;Spermatocytes: 349.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 2.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037790, HPA037791" Uncertain NA NA "HPA037790: AB_10805351, HPA037791: AB_10796215" "unprognostic (8.95e-2)" "unprognostic (8.28e-3)" "unprognostic (7.11e-2)" "unprognostic (3.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.90e-1)" "unprognostic (9.96e-2)" "unprognostic (7.95e-2)" 0.0 0.0 0.6 0.0 0.5 0.2 0.0 0.1 0.3 0.3 1.9 0.0 0.0 0.2 1.5 0.0 5.7 0.0 0.0 0.2 0.6 0.0 0.0 1.0 0.0 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 127.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.6 0.5 0.1 0.3 0.2 0.6 0.4 0.8 0.2 0.2 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.4 15.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 83.5 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.1 0.0 0.0 36.3 0.0 6.6 0.0 0.3 349.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A2 "OR10A2P, OST363" ENSG00000170790 "Olfactory receptor family 10 subfamily A member 2" Q9H208 11 6863057-6874717 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.04e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHCHD7 "COX23, MGC2217" ENSG00000170791 "Coiled-coil-helix-coiled-coil-helix domain containing 7" Q9BUK0 8 56211686-56218809 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050783 Approved Approved "Cell Junctions,Aggresome" NA NA "Cell Junctions" Aggresome "HPA050783: AB_2681236" "unprognostic (1.64e-2)" "unprognostic (3.23e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.46e-2)" "unprognostic (2.43e-1)" "unprognostic (5.04e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "prognostic favorable (9.47e-5)" "unprognostic (1.94e-1)" "unprognostic (5.07e-1)" "unprognostic (1.77e-2)" "unprognostic (2.50e-1)" 25.2 20.4 26.5 30.3 27.7 29.5 26.0 31.4 32.8 23.1 25.1 31.0 33.5 18.8 46.4 23.0 24.8 17.3 39.4 26.7 27.6 32.8 26.4 28.3 39.7 27.0 26.7 25.7 49.6 27.2 36.3 38.4 19.5 27.7 26.6 30.5 32.9 35.6 21.2 37.8 21.5 36.3 18.7 29.0 46.7 27.9 11.8 26.8 36.8 28.2 40.1 38.4 28.4 24.4 29.5 59.3 18.9 39.4 13.1 100.9 71.3 42.4 41.0 37.0 30.7 23.0 46.2 68.9 54.7 34.8 23.6 43.6 32.3 40.7 61.3 38.6 24.5 77.4 83.6 45.5 66.2 51.8 72.1 52.0 86.2 54.2 22.2 98.0 43.8 32.8 100.0 41.8 34.9 74.1 29.0 72.2 106.5 35.1 93.5 25.6 82.0 12.0 46.3 57.3 63.3 10.2 7.0 21.8 32.2 31.2 47.8 34.1 40.5 49.0 16.5 35.4 53.7 39.5 37.1 40.3 93.5 46.0 105.3 28.9 55.2 37.8 53.3 42.4 38.2 40.2 60.4 46.9 43.5 44.1 52.5 55.0 49.6 15.2 49.7 35.0 62.6 60.1 33.9 26.5 27.7 31.4 32.8 26.7 27.6 27.0 26.7 25.7 27.7 29.0 26.8 29.5 31.7 19.2 77.9 2.6 72.5 20.8 44.1 49.0 16.5 31.4 37.1 27.1 93.7 35.8 48.0 49.7 14.6 44.0 66.0 75.4 125.2 41.4 27.5 25.2 15.9 29.8 39.6 32.6 9.1 75.4 80.8 26.3 92.8 32.2 53.8 13.8 42.8 78.4 162.3 13.5 8.0 66.3 34.6 67.8 45.3 13.4 37.0 58.0 53.4 14.0 68.5 50.8 60.8 1.5 6.5 65.4 63.9 30.9 59.3 45.3 115.0 82.3 41.5 37.9 13.1 23.9 39.0 51.4 39.4 34.7 23.9 42.1 61.7 21.7 73.5 48.8 HTRA3 "Prsp, Tasp" ENSG00000170801 "HtrA serine peptidase 3" P83110 4 8269754-8307098 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 155.2" "Cell type enhanced" "Detected in some" "Fibroblasts: 158.8;Leydig cells: 43.5;Peritubular cells: 42.9;Skeletal myocytes: 99.0;Theca cells: 25.2" "Cancer enhanced" "Detected in all" "pancreatic cancer: 67.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "U-2197: 182.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "spinal cord: 10.3" "HPA021187, HPA063810" Approved Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA021187: AB_1851311, HPA063810: AB_2685129" "unprognostic (5.87e-2)" "unprognostic (1.40e-2)" "unprognostic (2.89e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-1)" "unprognostic (3.09e-2)" "unprognostic (1.12e-3)" "unprognostic (5.29e-2)" "unprognostic (3.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.95e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.61e-9)" "unprognostic (1.65e-3)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.34e-2)" 62.3 6.1 1.0 8.8 1.1 13.5 50.9 0.9 2.0 35.6 4.8 28.1 8.8 42.8 10.7 15.3 26.4 35.9 155.2 0.8 1.6 6.1 3.3 38.3 1.2 0.9 1.0 0.7 93.7 6.8 0.4 15.8 20.6 1.0 26.5 4.8 0.1 23.0 6.8 32.5 25.2 17.0 11.9 0.9 2.9 22.1 4.4 1.5 2.2 26.2 13.0 0.7 63.0 32.9 0.9 0.0 1.0 1.4 0.0 5.8 10.8 0.3 2.4 0.2 2.8 0.6 0.1 0.1 0.0 13.6 6.4 1.4 0.1 1.2 0.0 0.9 0.0 2.3 1.3 13.9 0.0 6.1 0.0 0.6 1.2 0.0 4.2 0.0 1.7 9.8 0.0 0.3 0.0 10.2 0.0 0.2 36.5 6.1 0.0 0.3 0.3 0.0 0.1 0.0 0.0 15.8 0.3 26.4 0.5 0.2 28.8 0.1 1.1 8.1 1.4 4.7 182.1 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.9 2.0 0.8 1.6 0.9 1.0 0.7 1.0 0.9 1.5 0.9 12.6 0.0 0.0 0.0 0.0 5.2 0.5 0.0 0.6 0.0 0.5 0.9 16.5 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.1 1.2 0.3 8.1 5.3 0.0 0.0 0.0 0.0 4.2 158.8 0.5 0.3 0.0 6.0 3.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 8.6 1.4 43.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.9 0.4 0.4 0.0 0.1 0.0 0.0 0.0 99.0 10.6 0.4 0.7 0.6 5.3 1.4 0.9 25.2 0.0 0.2 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379295 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.5;brain: 54.6" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 152.3;Oligodendrocytes: 282.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favorable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 18.1 5.6 14.8 15.5 28.6 54.5 8.1 25.7 18.6 7.7 6.5 7.8 8.4 6.8 4.3 9.3 5.6 9.8 8.7 13.4 18.6 6.7 20.0 9.6 19.6 22.0 22.0 9.9 5.9 9.0 9.5 3.0 13.5 23.0 5.0 8.1 3.4 5.6 4.2 4.8 3.7 10.4 9.9 22.5 18.3 8.0 6.3 19.9 15.1 7.0 6.5 17.2 10.7 3.9 54.6 13.1 19.5 22.2 19.6 17.2 12.7 24.3 14.4 15.8 11.9 13.2 17.3 15.9 28.4 18.7 17.0 14.5 16.2 13.7 16.5 17.2 22.3 11.7 56.1 13.3 17.4 30.0 30.9 42.1 11.4 6.9 12.9 22.3 9.6 12.8 11.6 26.6 32.7 19.5 10.1 34.4 20.3 16.8 9.8 10.2 17.0 46.5 23.2 10.2 16.5 12.4 12.6 6.9 13.2 24.9 7.5 5.7 18.0 15.0 16.0 16.1 15.2 15.2 17.8 14.2 40.5 13.9 27.5 22.2 120.9 32.4 129.6 24.0 26.2 27.4 21.2 23.1 22.4 33.6 20.6 17.2 17.7 40.8 25.7 36.4 20.8 28.8 17.2 14.8 28.6 25.7 18.6 13.4 18.6 22.0 22.0 9.9 23.0 22.5 19.9 54.6 22.1 0.0 7.4 66.6 31.3 15.6 27.5 10.0 15.4 6.7 5.4 5.6 11.1 14.3 6.1 1.8 0.0 6.7 28.3 7.0 5.9 6.0 4.8 8.9 17.2 21.8 2.4 22.5 28.1 5.4 32.1 13.3 14.3 13.3 22.8 1.2 20.7 19.7 17.9 13.5 25.2 8.0 8.2 39.5 47.3 4.7 12.2 44.4 12.4 35.6 44.1 7.8 26.8 152.3 282.0 11.0 7.1 11.3 31.0 35.2 11.3 4.8 3.3 3.6 6.6 17.8 27.4 22.7 13.1 11.9 21.2 16.6 38.3 2.8 8.9 35.9 LMOD2 ENSG00000170807 "Leiomodin 2" Q6P5Q4 7 123655866-123664290 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "heart muscle: 785.5;skeletal muscle: 942.6;tongue: 800.6" "Cell type enriched" "Detected in some" 26 "Cardiomyocytes: 1432.4" "Group enriched" "Detected in some" 20 "head and neck cancer: 3.5;prostate cancer: 1.4" "Region enhanced" "Detected in single" "midbrain: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA046370, HPA051039" Enhanced Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA046370: , HPA051039: AB_2681321" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-3)" "unprognostic (1.18e-1)" "unprognostic (5.50e-1)" "unprognostic (5.69e-2)" "unprognostic (6.98e-2)" "unprognostic (2.13e-2)" "unprognostic (1.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.82e-3)" 0.2 0.1 0.2 0.0 0.0 0.6 0.5 0.1 0.5 0.0 0.2 0.1 0.0 0.0 0.0 21.4 0.0 0.1 785.5 0.3 0.0 0.0 0.2 0.3 0.3 0.0 1.0 0.0 0.1 0.2 0.0 0.1 0.8 0.0 10.3 0.0 0.1 10.1 0.0 942.6 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.2 800.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1432.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.5 0.4 9.4 0.0 0.0 0.1 0.0 0.1 27.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 7.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133400056-133475222 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "T-reg: 13.4" "Lineage enriched" "Detected in single" 43 "T-cells: 13.4" "Group enriched" "Detected in some" 6 "Daudi: 2.4;U-698: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.1 5.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.6 0.0 1.0 0.1 0.1 0.0 FSHR "FSHRO, LGR1, ODG1" ENSG00000170820 "Follicle stimulating hormone receptor" P23945 2 48962157-49154527 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 2.0;testis: 2.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 10.1;Granulosa cells: 33.8;Late spermatids: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (5.94e-2)" "unprognostic (4.06e-3)" "unprognostic (5.78e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.8 0.7 0.8 0.0 0.3 0.2 0.5 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.1 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 USP32 "NY-REN-60, USP10" ENSG00000170832 "Ubiquitin specific peptidase 32" Q8NFA0 17 60177327-60422470 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.0" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 59.2" "Group enriched" "Detected in all" 10 "dendritic cells: 59.2;granulocytes: 29.4" "Cell line enhanced" "Detected in all" "MCF7: 171.4" "Low region specificity" "Detected in all" HPA044365 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA044365: AB_2678914" "unprognostic (4.10e-2)" "unprognostic (3.38e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.90e-3)" "unprognostic (2.33e-2)" "unprognostic (2.24e-1)" "unprognostic (3.93e-1)" "unprognostic (6.49e-2)" "unprognostic (2.78e-1)" "unprognostic (2.82e-1)" "unprognostic (1.97e-1)" "unprognostic (7.23e-2)" "unprognostic (8.35e-2)" "unprognostic (4.16e-2)" 16.2 21.9 13.8 15.1 24.7 32.3 14.2 20.9 21.3 11.2 22.3 12.3 9.6 10.4 6.8 21.8 10.8 11.9 17.2 14.8 21.4 20.4 26.9 20.9 10.6 22.8 23.2 11.4 10.1 12.6 19.4 12.0 13.3 23.8 10.9 11.5 59.3 13.0 11.3 41.2 20.8 10.6 13.8 19.3 18.6 12.3 103.0 20.9 14.5 20.8 29.5 11.7 13.2 14.8 43.1 32.6 38.2 19.0 30.8 44.8 45.3 17.2 26.4 41.9 34.5 45.8 18.6 20.0 19.4 21.5 50.0 56.1 16.3 33.1 36.9 61.5 16.8 13.9 39.7 31.8 19.5 44.1 31.7 33.6 39.6 24.6 49.9 45.2 33.5 38.6 24.4 42.9 17.1 41.1 171.4 32.3 21.3 21.7 29.6 18.8 15.8 51.6 11.5 33.1 24.5 13.1 19.1 22.9 6.0 33.8 32.1 27.4 41.3 32.6 49.7 54.9 33.1 23.5 16.2 37.4 19.6 24.6 23.6 33.4 14.5 4.3 16.5 2.0 3.7 1.4 3.0 1.4 1.7 8.5 2.2 1.0 1.9 29.4 1.3 4.6 59.2 2.6 2.1 13.8 24.7 20.9 21.3 14.8 21.4 22.8 23.2 11.4 23.8 19.3 20.9 43.1 8.0 6.4 16.4 58.8 12.5 26.9 13.3 5.8 11.4 17.3 9.2 7.6 8.2 10.0 10.1 5.5 241.8 5.1 12.6 8.5 3.9 11.3 95.0 9.0 9.9 9.8 8.3 44.2 92.3 7.5 8.4 12.6 15.8 11.6 11.4 18.5 12.5 12.0 18.5 13.5 113.1 5.6 6.1 29.7 41.3 33.3 13.1 25.1 5.4 101.2 28.0 10.4 24.7 70.4 268.9 9.6 11.4 5.7 8.3 10.3 7.4 4.6 7.0 136.4 26.3 11.9 9.1 92.7 14.9 11.2 21.9 4.9 10.9 8.5 5.5 8.2 CEL "BSSL, MODY8" ENSG00000170835 "Carboxyl ester lipase" P19835 9 133061981-133071861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 548 "pancreas: 111521.7" "Group enriched" "Detected in many" 10 "Breast glandular cells: 390.7;Exocrine glandular cells: 943.6" "Cancer enriched" "Detected in many" 29 "pancreatic cancer: 469.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008023, HPA052701" Enhanced "Secreted to digestive system" NA NA 110000 "HPA008023: AB_1846509, HPA052701: AB_2681921" "prognostic unfavorable (4.14e-4)" "unprognostic (2.30e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-1)" "unprognostic (2.48e-1)" "unprognostic (1.49e-1)" "unprognostic (6.27e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-3)" "unprognostic (2.98e-1)" "unprognostic (4.41e-1)" "unprognostic (4.37e-2)" "unprognostic (1.02e-1)" 8.1 3.1 3.1 2.2 3.2 0.9 10.5 4.7 4.5 4.5 11.2 2.7 21.8 3.2 202.6 7.2 11.2 0.4 22.2 4.0 2.7 7.4 6.5 2.1 4.1 3.0 2.9 2.9 57.7 111521.7 0.3 203.3 7.2 3.8 5.1 1.3 1.1 20.1 3.3 2.3 5.3 9.3 0.5 2.6 3.4 18.7 2.5 2.9 1.9 2.5 0.4 0.6 3.4 3.4 3.6 0.3 0.8 3.1 1.9 1.0 0.7 3.1 0.6 0.3 0.4 0.6 0.9 0.6 0.9 1.5 0.6 0.5 2.2 0.7 5.9 0.2 1.9 1.2 1.6 0.5 2.1 0.4 0.7 5.9 1.5 3.8 0.5 0.3 1.3 0.6 7.5 1.0 0.8 0.5 1.3 0.9 3.2 5.2 0.7 1.0 1.8 0.9 0.7 0.4 2.7 5.3 1.3 0.7 0.7 0.3 4.5 1.0 2.9 0.4 1.5 2.0 1.7 0.4 0.4 3.4 0.7 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.2 4.7 4.5 4.0 2.7 3.0 2.9 2.9 3.8 2.6 2.9 3.6 1.5 0.0 0.0 1.0 0.7 0.0 1.7 0.8 1.2 1.0 390.7 4.4 2.1 1.5 0.5 0.0 0.0 0.1 1.8 2.5 3.9 1.7 0.5 62.4 0.8 0.9 0.0 0.0 2.0 943.6 0.1 0.4 0.0 1.3 0.0 4.7 0.0 0.1 0.0 0.0 1.4 0.8 26.4 0.0 0.3 3.6 0.3 1.0 0.0 0.0 6.7 0.9 0.0 1.0 0.7 27.7 0.1 0.0 0.0 0.4 10.6 0.1 2.3 0.8 0.0 0.2 1.4 0.2 0.1 2.0 0.3 0.4 0.5 6.0 5.1 3.0 PPM1D "PP2C-DELTA, Wip1" ENSG00000170836 "Protein phosphatase, Mg2+/Mn2+ dependent 1D" O15297 17 60600183-60666280 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022277, HPA061848" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA022277: AB_1858839, HPA061848: " "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "prognostic favorable (3.52e-4)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (5.50e-2)" "unprognostic (1.70e-2)" "unprognostic (6.07e-2)" "unprognostic (2.52e-3)" "unprognostic (3.46e-2)" "unprognostic (1.95e-3)" "unprognostic (7.33e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (1.98e-1)" 4.2 2.5 3.2 2.2 5.3 5.9 3.9 15.2 4.8 4.4 6.1 3.1 2.9 4.4 3.0 3.5 3.7 3.1 2.6 3.5 7.0 2.8 2.8 3.6 2.8 4.1 4.2 2.7 6.3 3.3 2.3 2.4 5.9 7.3 3.1 3.5 6.4 3.1 2.2 4.0 2.8 2.7 3.0 4.0 3.8 2.8 5.5 4.3 4.5 2.9 3.1 2.3 2.8 4.0 9.4 3.8 6.9 7.5 6.4 5.0 3.1 10.7 5.8 3.6 3.4 4.9 7.1 2.0 9.9 4.5 3.7 1.3 3.4 4.9 2.2 4.6 1.9 11.1 7.4 6.7 8.1 4.2 2.9 5.3 2.7 3.6 5.1 3.0 2.8 7.9 4.1 5.4 4.0 3.7 34.4 8.1 4.4 3.5 3.4 5.2 9.5 9.6 6.6 3.1 4.2 10.5 7.4 7.1 2.4 1.6 8.0 2.8 3.9 5.7 4.7 12.5 3.5 3.3 6.7 7.7 7.3 1.7 2.9 3.8 9.9 16.1 18.0 7.6 12.5 6.8 8.9 6.3 7.0 16.0 6.2 6.8 7.0 24.7 8.6 8.1 7.0 10.6 9.8 3.2 5.3 15.2 4.8 3.5 7.0 4.1 4.2 2.7 7.3 4.0 4.3 9.4 40.9 32.1 7.7 15.0 23.1 21.0 6.2 3.3 52.3 13.1 14.2 9.8 6.3 8.6 4.6 5.5 4.2 17.6 19.4 15.0 3.9 6.6 68.9 14.0 15.5 25.2 14.4 14.1 19.6 6.6 6.4 14.7 10.2 15.6 1.3 7.2 23.6 4.2 8.8 3.3 20.8 11.4 6.1 21.4 19.2 12.8 13.7 16.1 3.6 28.1 12.3 7.0 6.2 20.6 38.6 5.4 10.2 7.5 24.5 7.8 8.7 5.1 3.6 10.4 0.0 12.1 14.0 43.8 15.0 34.4 18.0 38.6 18.1 6.0 11.5 7.7 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71753855-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "eosinophil: 2.8;neutrophil: 7.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.2" "Cell line enhanced" "Detected in some" "EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.4 4.0 23.5 1.5 26.1 15.8 3.9 16.2 21.9 3.4 10.5 1.3 0.3 5.0 2.8 3.8 6.9 1.0 3.3 22.5 24.4 3.2 0.2 1.4 0.2 21.4 20.4 21.3 4.4 3.1 17.4 9.3 1.3 19.9 5.2 0.5 1.9 1.4 4.4 0.7 1.8 0.7 2.9 22.9 3.4 2.0 4.8 24.6 0.5 6.2 1.9 0.2 2.0 2.4 21.9 0.0 1.1 1.9 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 17.9 0.0 0.8 0.1 4.3 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 17.5 0.9 0.0 2.9 0.0 1.2 0.0 0.0 3.7 0.0 0.0 0.0 14.6 1.2 0.2 28.9 0.0 0.0 0.0 0.0 0.0 13.6 7.8 3.0 10.9 3.8 0.0 0.0 3.6 9.9 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 7.2 0.0 0.1 0.0 0.0 0.1 23.5 26.1 16.2 21.9 22.5 24.4 21.4 20.4 21.3 19.9 22.9 24.6 21.9 0.2 0.0 1.1 0.0 0.1 1.9 4.2 0.0 4.0 10.3 6.5 7.5 3.5 2.8 1.3 12.9 4.2 1.4 0.4 0.2 1.9 0.7 0.2 2.1 4.9 0.4 1.2 1.7 0.0 0.0 1.3 1.2 1.1 8.1 0.0 2.4 0.4 0.0 0.9 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.9 3.2 0.0 0.0 8.6 0.5 1.0 0.0 0.0 0.3 0.1 1.2 0.0 5.6 0.0 0.1 1.5 0.4 0.0 2.3 1.7 0.2 4.8 4.7 1.7 0.3 0.7 0.5 0.3 2.0 AC093323.1 ENSG00000170846 "Novel protein, similar to Morf4 family associated protein 1" B2RBV5 4 6663396-6676755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 12.7;Cytotrophoblasts: 18.9;Distal tubular cells: 13.7;Glandular and luminal cells: 13.7;Granulosa cells: 12.2;Theca cells: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (9.08e-2)" "unprognostic (1.73e-3)" "unprognostic (2.10e-2)" "unprognostic (1.48e-1)" "unprognostic (1.81e-1)" "unprognostic (3.00e-2)" "unprognostic (2.33e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.59e-2)" "unprognostic (8.95e-3)" "unprognostic (2.77e-2)" "unprognostic (1.17e-2)" "unprognostic (3.20e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-3)" 1.7 3.1 3.3 2.5 3.7 3.6 3.9 2.6 3.8 1.9 2.5 3.2 1.5 3.6 3.7 2.2 2.3 2.2 2.3 3.6 3.9 2.8 2.9 2.7 4.1 2.5 2.7 3.4 4.0 2.1 3.2 2.5 2.7 3.6 4.2 2.0 3.3 2.5 4.3 7.0 2.4 2.5 2.7 4.2 4.2 2.7 4.2 3.2 2.0 4.4 4.4 2.2 3.1 4.0 5.0 7.4 7.6 3.5 4.5 7.0 6.0 2.6 4.7 3.8 5.8 5.7 3.8 3.1 2.9 4.8 5.1 5.8 4.2 8.0 1.6 8.2 16.5 7.6 4.4 1.2 17.6 10.0 2.0 3.8 4.6 4.2 6.6 3.1 7.3 12.3 1.3 4.0 7.9 12.0 16.1 7.7 6.0 7.6 5.6 4.9 1.9 1.6 2.8 16.6 5.8 5.1 3.2 2.6 2.6 16.1 5.4 4.2 3.5 0.0 2.6 8.3 2.5 5.8 1.3 1.0 19.3 5.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.3 3.7 2.6 3.8 3.6 3.9 2.5 2.7 3.4 2.7 2.7 4.2 3.1 4.3 6.4 12.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 10.6 9.8 0.0 0.0 4.3 5.5 0.0 18.9 7.2 0.0 13.7 2.1 0.0 9.8 11.0 2.2 0.0 0.0 0.0 3.2 7.0 3.4 0.0 13.7 1.3 12.2 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 5.3 3.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.6 5.2 19.5 0.0 0.0 PSG6 ENSG00000170848 "Pregnancy specific beta-1-glycoprotein 6" Q00889 19 42902086-42919563 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 49.9" "Cell type enriched" "Detected in some" 125 "Syncytiotrophoblasts: 363.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-2197: 144.6" HPA046327 Supported "Secreted in female reproductive system" NA NA 65000000 "HPA046327: AB_2679624" "unprognostic (4.23e-1)" 0.0 0.0 0.3 0.1 0.1 1.4 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 49.9 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.5 0.6 1.1 0.0 0.3 0.0 0.0 1.9 0.1 0.2 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.9 0.0 0.0 0.0 0.1 0.3 144.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.2 0.3 0.3 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 363.5 0.0 0.0 0.0 0.0 KBTBD2 "BKLHD1, DKFZP566C134" ENSG00000170852 "Kelch repeat and BTB domain containing 2" Q8IY47 7 32868172-32894131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021133 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA021133: AB_1852093" "unprognostic (1.01e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.17e-2)" "unprognostic (9.19e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (3.96e-3)" "unprognostic (1.05e-1)" "unprognostic (2.61e-1)" "unprognostic (2.80e-3)" "unprognostic (5.05e-1)" "unprognostic (6.79e-3)" "unprognostic (3.81e-3)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.96e-1)" 25.1 16.6 24.3 21.9 25.9 55.0 21.0 27.8 26.1 17.3 23.2 16.4 16.1 21.0 10.8 16.3 15.7 25.4 19.4 22.2 25.7 15.4 21.7 22.7 25.8 28.5 26.8 20.7 16.5 11.9 17.3 15.1 26.0 27.6 16.5 19.8 26.1 14.5 15.2 58.1 16.2 17.7 23.8 28.7 27.2 15.0 18.3 26.8 30.8 18.8 40.6 24.1 22.2 17.4 29.8 38.3 18.8 47.5 23.5 28.1 28.0 17.1 33.4 33.9 31.2 37.6 18.7 28.6 31.9 22.6 34.7 52.3 27.5 24.5 26.2 39.2 12.6 17.6 27.1 30.6 24.4 28.9 29.3 34.2 30.1 26.9 34.0 32.9 28.9 34.9 28.6 50.3 46.2 46.4 31.4 24.3 47.9 38.6 26.5 17.7 23.4 41.6 26.7 27.6 22.3 24.9 46.4 21.5 29.1 38.6 39.6 20.7 49.5 30.5 29.6 38.7 28.3 46.5 37.5 39.3 57.6 28.8 34.9 77.0 14.5 6.4 21.4 10.9 12.2 9.2 7.1 5.4 9.7 5.6 9.8 4.2 6.9 39.2 10.7 14.6 2.9 7.6 4.1 24.3 25.9 27.8 26.1 22.2 25.7 28.5 26.8 20.7 27.6 28.7 26.8 29.8 67.2 28.9 23.9 24.5 27.0 40.4 15.7 13.4 44.3 14.6 20.4 15.6 18.4 20.0 22.1 1.8 10.4 6.9 41.4 18.1 0.0 11.8 7.7 21.6 23.1 48.7 14.9 25.2 21.0 12.2 8.7 22.2 17.9 33.8 43.7 20.4 36.8 14.6 13.3 8.4 20.5 14.0 4.1 24.6 23.1 6.2 13.1 32.5 24.9 34.7 13.0 8.7 15.5 29.7 36.8 16.8 10.3 6.0 25.2 17.1 10.5 5.1 7.3 8.9 19.7 26.4 21.1 19.1 8.8 25.9 36.1 7.5 28.4 10.8 11.4 18.5 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 14.0 9.8 11.5 14.6 11.9 2.3 14.0 10.5 10.9 10.4 8.8 12.2 7.0 10.8 10.7 22.4 10.5 7.4 9.8 10.1 13.3 14.4 14.4 11.1 14.4 13.2 13.0 9.8 10.5 18.3 10.9 10.3 15.7 12.5 10.5 12.4 17.0 19.9 9.7 32.3 17.9 10.4 10.5 13.7 8.5 12.9 6.7 11.9 7.0 46.8 11.4 15.1 16.6 15.7 14.1 42.6 27.8 9.1 17.4 20.5 30.3 22.8 20.1 14.3 22.0 18.5 18.6 22.8 59.7 21.2 25.1 34.3 24.3 28.9 28.2 32.5 109.9 13.8 19.2 13.5 19.1 33.4 37.1 7.0 24.5 38.8 17.6 44.4 13.1 23.9 26.4 26.2 23.3 22.1 11.5 29.7 14.5 19.9 47.3 34.4 0.0 32.2 58.7 21.4 24.1 49.6 17.6 25.7 28.7 34.4 10.1 24.7 15.3 16.3 22.9 24.0 13.7 39.9 37.7 18.3 55.5 29.1 37.8 23.8 1.9 13.2 0.7 10.3 11.9 15.8 15.9 14.9 12.0 16.9 13.3 15.0 12.5 0.8 10.8 15.8 26.0 15.2 10.5 11.5 11.9 10.5 10.9 10.1 13.3 13.2 13.0 9.8 12.5 13.7 11.9 14.1 18.3 9.6 14.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 14.9 11.2 0.0 0.0 10.5 7.3 0.0 33.7 5.7 0.0 49.0 16.4 0.0 25.7 14.9 5.8 0.0 0.0 0.0 13.2 43.5 7.3 0.0 12.6 2.5 20.2 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.5 0.0 0.0 11.6 13.8 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 31.2 2.2 24.8 0.0 0.0 TRIAP1 "HSPC132, MDM35, P53CSV, WF-1" ENSG00000170855 "TP53 regulated inhibitor of apoptosis 1" O43715 12 120443964-120446384 "Predicted intracellular proteins, Transporters" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053640 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA053640: AB_2682213" "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (5.24e-2)" "unprognostic (4.06e-2)" "unprognostic (3.07e-1)" "unprognostic (1.40e-1)" "unprognostic (1.19e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (2.22e-4)" "unprognostic (9.87e-3)" "unprognostic (4.39e-2)" "unprognostic (9.93e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (8.81e-2)" "unprognostic (2.00e-1)" "unprognostic (6.44e-2)" "unprognostic (4.97e-2)" 22.0 24.8 18.2 19.0 18.4 33.2 28.7 18.5 23.2 16.7 19.4 24.8 19.4 14.2 21.0 23.1 17.4 15.6 16.4 18.1 18.9 20.3 66.9 17.0 25.0 18.5 18.3 17.8 12.2 53.0 14.9 12.4 29.4 18.4 20.3 30.8 8.9 25.5 15.4 61.0 26.7 18.7 21.1 19.0 16.4 19.8 13.3 18.3 26.0 15.8 39.5 27.7 24.3 15.7 19.6 56.2 75.1 67.4 46.3 57.5 88.1 161.0 71.8 51.2 62.5 51.6 63.2 30.4 110.0 59.6 59.2 25.0 37.4 79.3 118.6 65.8 49.1 88.5 66.9 48.7 167.9 85.4 113.6 49.6 91.6 146.7 61.4 87.0 62.3 131.1 59.8 109.3 27.7 92.1 70.3 86.0 152.7 96.5 67.9 60.4 70.4 63.5 114.4 81.1 62.0 66.3 43.2 82.7 28.1 64.6 105.7 93.9 65.6 74.8 40.0 60.7 40.7 44.1 70.6 120.6 118.5 61.5 86.9 71.2 26.7 47.1 18.2 41.0 52.7 48.8 35.1 39.2 39.0 59.1 31.8 48.3 43.1 4.0 49.6 36.5 53.1 37.3 45.0 18.2 18.4 18.5 23.2 18.1 18.9 18.5 18.3 17.8 18.4 19.0 18.3 19.6 25.8 3.2 15.2 3.6 30.5 51.2 28.5 108.2 44.3 10.6 35.9 44.1 12.1 45.8 36.0 7.3 6.2 128.5 29.4 16.9 66.5 48.4 8.3 22.4 27.7 34.3 22.1 23.7 3.9 50.4 91.2 23.1 15.3 16.4 17.2 34.9 24.3 63.3 52.0 3.3 2.9 22.6 40.7 23.3 27.6 5.7 16.4 19.1 39.2 1.0 48.0 15.4 44.3 3.0 4.7 43.2 20.7 18.4 19.8 37.7 30.1 49.4 25.4 9.5 19.7 18.9 27.3 34.5 31.4 45.6 71.3 75.4 28.3 47.0 39.5 28.9 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178817-14201122 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli NA NA 30000 Nucleoli Nucleoplasm "HPA044966: AB_2679159" "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 12.7 10.9 12.4 11.1 12.8 19.0 12.7 13.4 16.7 8.7 12.4 12.2 12.5 9.1 10.5 12.2 8.3 6.6 17.6 12.7 12.8 23.5 18.6 8.3 13.0 12.5 12.4 12.4 9.5 9.6 11.1 9.1 10.4 12.7 9.9 11.3 10.8 9.3 8.4 30.4 10.1 13.0 8.2 12.7 9.7 10.6 12.5 12.7 17.0 10.8 22.6 11.9 10.3 8.8 13.4 36.0 28.6 30.1 31.3 13.8 16.0 76.3 29.0 19.3 36.6 34.8 32.6 27.6 39.5 23.5 20.3 25.7 16.4 34.5 28.4 36.0 37.5 42.3 41.8 38.1 31.5 7.1 47.3 29.0 12.0 20.2 36.8 15.6 16.4 19.1 34.0 45.9 30.7 27.4 41.5 50.4 64.2 52.1 40.2 38.5 27.4 37.3 43.5 34.6 36.7 16.8 27.2 33.2 46.1 28.6 34.3 53.2 59.7 17.3 23.3 37.2 28.3 50.6 21.4 67.3 73.6 29.5 45.9 33.8 44.1 18.9 30.0 14.8 23.7 17.7 27.3 17.1 17.5 18.3 21.7 18.4 19.7 17.8 21.9 20.3 28.7 22.9 25.7 12.4 12.8 13.4 16.7 12.7 12.8 12.5 12.4 12.4 12.7 12.7 12.7 13.4 114.2 67.3 94.3 11.4 118.2 97.8 135.4 328.8 115.5 52.5 124.2 171.4 263.4 155.8 164.6 126.9 18.8 391.8 114.2 158.2 485.2 220.4 337.8 111.2 97.8 104.5 104.7 111.9 8.3 265.5 409.6 120.0 67.8 115.2 138.2 142.4 128.8 234.8 235.5 55.5 8.3 195.4 175.0 132.9 115.0 153.1 140.1 119.6 97.8 5.6 202.4 180.7 170.0 7.1 13.3 219.2 196.7 139.9 154.2 110.2 203.9 752.2 122.3 68.2 105.2 111.5 117.9 288.5 295.5 150.8 101.2 318.4 93.6 144.6 205.7 177.2 KIAA0232 ENSG00000170871 KIAA0232 Q92628 4 6781375-6884170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 10.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036891, HPA036892, HPA061498" Approved Approved Cytosol NA NA Cytosol "HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541" "unprognostic (6.88e-3)" "unprognostic (2.74e-1)" "unprognostic (8.98e-2)" "unprognostic (4.87e-2)" "unprognostic (2.43e-1)" "unprognostic (4.13e-2)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (1.85e-1)" "unprognostic (3.16e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "prognostic favorable (3.91e-10)" "unprognostic (1.21e-1)" "unprognostic (8.57e-2)" "unprognostic (2.04e-1)" "unprognostic (3.18e-2)" 13.1 12.1 20.3 8.5 20.9 16.3 13.4 21.7 21.7 12.1 18.3 14.1 8.6 15.6 12.7 20.8 15.4 12.5 33.5 19.6 23.3 19.0 15.2 12.1 7.6 20.8 24.3 17.4 13.2 10.7 24.1 10.3 10.5 21.4 14.9 12.4 24.9 8.9 14.7 32.8 7.7 11.6 13.2 22.0 13.0 11.0 12.1 25.0 11.8 15.3 51.5 8.7 10.5 9.9 22.5 13.7 13.0 26.7 16.7 18.8 20.2 14.0 17.4 18.1 12.0 10.1 8.2 11.3 9.0 5.8 19.7 18.5 7.0 13.7 7.7 15.5 5.1 5.6 26.7 11.1 11.0 9.9 11.6 33.6 13.6 17.7 13.4 7.4 15.4 12.6 8.9 20.3 7.6 15.4 6.7 22.3 11.7 14.1 10.2 14.3 15.7 27.3 4.2 20.3 12.8 20.2 13.1 12.9 11.4 12.1 18.3 14.5 21.1 16.0 11.0 12.8 9.8 15.2 13.1 14.1 7.0 13.5 12.2 30.3 2.0 2.0 5.7 2.1 1.4 2.9 1.3 1.6 2.5 1.3 1.3 1.5 1.6 10.6 1.8 2.1 2.0 1.6 0.9 20.3 20.9 21.7 21.7 19.6 23.3 20.8 24.3 17.4 21.4 22.0 25.0 22.5 27.6 32.1 39.2 62.3 19.1 12.7 27.4 12.9 24.5 77.2 29.0 20.6 132.1 10.0 29.0 12.9 37.5 14.7 23.6 47.9 41.1 23.4 45.0 74.4 28.0 20.6 25.1 49.9 123.8 11.7 7.7 27.7 44.9 38.7 12.6 16.3 15.0 42.9 11.2 99.3 120.7 20.9 30.5 23.9 11.8 64.2 24.8 28.4 7.2 73.1 34.8 49.7 27.8 90.0 138.0 21.8 24.8 33.1 24.2 28.0 29.6 24.6 58.0 44.6 26.3 39.4 31.6 31.6 22.4 19.2 11.1 22.4 27.4 27.0 17.5 35.7 MTSS1 "KIAA0429, MIM, MIMA, MIMB" ENSG00000170873 "MTSS I-BAR domain containing 1" O43312 8 124550784-124728473 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 168.3" "Group enriched" "Detected in all" 5 "B-cells: 50.3;monocytes: 168.3" "Cell line enhanced" "Detected in many" "ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019613, HPA064003, HPA075540" Approved Supported Approved "Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" "HPA019613: , HPA064003: , HPA075540: AB_2686756" "unprognostic (1.70e-1)" "unprognostic (4.13e-2)" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (3.87e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-1)" "unprognostic (2.50e-1)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (2.11e-7)" "unprognostic (6.74e-2)" "unprognostic (1.04e-1)" "unprognostic (2.41e-1)" "unprognostic (8.92e-3)" 23.9 36.6 20.0 13.3 22.4 12.6 14.1 46.2 23.6 9.4 21.2 11.1 6.5 8.5 10.0 45.6 12.6 9.3 17.2 16.5 22.2 24.4 73.5 16.6 16.1 27.1 25.1 12.9 10.5 28.7 3.7 11.1 36.0 23.6 10.2 9.2 15.2 14.0 6.4 32.6 29.6 8.0 9.7 20.4 34.7 12.1 22.5 22.5 18.6 6.1 24.6 17.3 15.7 24.5 40.2 3.6 1.1 51.6 1.0 81.4 41.7 0.1 2.1 14.2 1.1 0.5 4.8 0.4 1.6 4.9 0.2 0.4 0.8 0.4 29.2 1.1 98.7 1.2 337.8 0.9 27.0 18.4 0.0 34.5 66.4 65.4 15.9 41.0 2.1 31.5 0.3 0.5 0.3 5.6 2.7 0.8 4.0 1.8 54.8 0.4 0.4 0.1 0.5 11.6 11.3 36.3 2.8 7.9 6.3 26.6 2.5 1.3 1.1 16.7 2.7 1.0 0.2 0.7 0.5 0.3 5.4 29.1 0.4 10.7 3.1 13.1 0.1 22.7 88.1 2.6 44.9 4.8 8.7 11.8 50.3 2.2 6.8 2.2 2.2 168.3 0.2 0.5 29.2 20.0 22.4 46.2 23.6 16.5 22.2 27.1 25.1 12.9 23.6 20.4 22.5 40.2 33.0 0.0 26.9 15.7 92.0 35.8 81.4 41.2 9.6 0.0 8.0 19.9 34.9 22.8 30.9 66.2 0.0 36.0 51.4 10.7 21.5 17.6 54.2 25.5 0.9 32.2 44.2 17.2 40.4 5.2 2.3 30.5 26.5 9.7 46.3 0.9 70.3 78.1 74.2 0.0 208.2 17.1 61.1 167.1 116.2 62.1 3.7 96.7 26.6 114.3 90.2 0.0 78.2 360.4 178.4 32.6 15.9 4.5 12.6 71.9 1.2 19.9 42.0 0.0 39.5 25.2 17.3 2.5 10.7 86.1 63.4 94.4 22.7 1.8 15.8 59.2 TMEM43 "ARVD5, DKFZp586G1919, LUMA, MGC3222" ENSG00000170876 "Transmembrane protein 43" Q9BTV4 3 14125015-14143680 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 137.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019198 Approved NA NA 34000 "HPA019198: AB_1858118" "unprognostic (3.65e-3)" "unprognostic (2.52e-1)" "unprognostic (4.03e-2)" "unprognostic (4.66e-1)" "unprognostic (5.45e-3)" "unprognostic (1.72e-1)" "unprognostic (1.28e-3)" "unprognostic (1.08e-1)" "unprognostic (2.57e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.77e-2)" "unprognostic (5.45e-2)" "unprognostic (1.35e-3)" "unprognostic (2.19e-1)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" 71.6 34.6 25.1 37.1 24.1 21.1 61.8 23.3 25.5 66.7 24.8 50.0 23.7 89.8 31.3 70.2 64.5 47.6 56.7 23.3 40.7 27.8 19.8 58.7 30.4 28.2 25.2 23.1 83.4 27.5 25.8 30.8 58.0 25.9 43.7 29.7 16.1 38.2 65.8 61.3 109.6 40.3 83.3 24.1 31.5 35.1 15.3 25.1 26.2 47.4 46.2 34.0 56.6 67.0 25.2 41.5 45.7 44.1 58.3 173.4 180.6 104.6 80.1 164.8 129.9 93.0 37.5 54.1 19.5 55.7 201.3 64.3 88.3 47.1 70.9 92.9 48.7 38.0 35.3 45.6 53.8 109.3 51.4 40.4 136.0 173.6 107.9 133.0 103.6 94.8 36.2 56.1 47.8 76.6 54.3 23.4 43.2 48.4 62.8 75.3 32.2 46.8 78.2 59.4 70.4 12.9 35.5 101.0 59.3 66.5 37.3 37.5 74.3 86.4 118.7 63.7 120.6 76.0 32.1 54.3 25.1 89.3 68.4 108.7 81.3 51.5 100.3 68.7 45.5 64.0 36.8 66.8 62.7 67.4 31.6 44.5 49.0 157.2 79.9 49.2 42.6 65.7 69.7 25.1 24.1 23.3 25.5 23.3 40.7 28.2 25.2 23.1 25.9 24.1 25.1 25.2 44.2 137.8 46.8 17.9 16.8 43.7 32.2 31.0 39.9 6.2 19.9 29.7 13.4 15.7 52.9 18.4 14.6 31.2 43.2 9.3 0.0 34.9 0.6 17.3 58.1 37.4 4.9 22.5 24.1 10.0 65.6 68.0 20.9 34.4 28.4 16.1 23.6 8.9 17.8 6.7 20.6 8.3 8.2 16.1 33.5 3.9 43.2 19.8 30.2 15.9 26.8 8.4 16.5 30.2 23.9 22.4 9.7 70.7 15.6 35.8 8.8 9.0 16.2 8.6 32.9 43.6 39.3 5.6 12.0 44.1 45.5 37.5 32.1 17.6 11.5 30.2 RNF139 "HRCA1, RCA1, TRC8" ENSG00000170881 "Ring finger protein 139" Q8WU17 8 124474880-124488618 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 94.0" "Group enriched" "Detected in all" 10 "Early spermatids: 810.1;Late spermatids: 992.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001202 Approved NA NA "HPA001202: AB_1079824" "unprognostic (3.28e-3)" "unprognostic (2.92e-2)" "unprognostic (5.16e-2)" "unprognostic (5.43e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (2.71e-2)" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (9.85e-2)" "unprognostic (1.53e-2)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" "unprognostic (7.75e-2)" "unprognostic (1.45e-1)" 23.7 21.0 10.9 16.0 12.3 94.0 19.1 15.8 13.6 16.7 11.3 15.7 9.3 20.4 13.8 16.7 16.9 16.9 14.9 11.4 12.2 15.5 26.3 16.8 17.4 12.4 12.2 10.9 23.8 14.5 11.9 10.2 19.5 11.9 15.0 15.0 12.5 16.6 13.5 20.5 16.6 14.3 20.5 12.4 14.0 14.0 69.3 12.5 19.5 16.4 22.8 14.9 16.9 12.5 15.4 26.6 17.1 21.6 20.3 43.2 34.1 16.6 23.5 44.4 18.6 24.7 10.9 21.6 27.5 27.8 31.7 14.3 19.7 18.3 28.4 28.9 37.6 24.5 41.1 11.9 22.9 33.3 19.6 23.2 30.5 41.0 20.5 55.9 27.1 26.2 26.8 29.1 41.3 22.2 70.2 32.9 13.6 14.3 52.6 25.6 13.2 14.9 27.0 35.3 34.4 9.4 22.3 31.0 76.5 33.4 16.5 35.7 20.7 20.6 13.9 29.7 22.2 26.3 32.9 40.9 28.6 19.9 31.7 13.9 2.7 6.2 10.1 8.7 4.1 11.0 7.9 7.8 10.5 8.4 7.1 8.1 8.4 8.5 7.2 11.4 4.0 11.4 6.7 10.9 12.3 15.8 13.6 11.4 12.2 12.4 12.2 10.9 11.9 12.4 12.5 15.4 21.1 3.2 8.4 11.8 66.2 66.2 62.1 27.2 58.6 14.5 31.6 19.7 16.2 34.3 18.5 22.0 6.2 42.3 58.5 22.5 11.7 19.9 810.1 31.3 22.6 24.9 21.7 27.1 12.9 18.0 55.9 40.1 23.4 37.1 20.3 23.2 22.9 31.8 25.0 16.8 12.8 18.5 10.2 33.7 74.4 992.2 29.5 43.4 35.6 12.2 26.5 21.3 26.8 8.5 18.5 22.5 11.4 27.1 35.4 41.1 17.0 16.9 20.1 22.7 19.7 39.7 49.2 62.3 24.3 46.7 70.5 75.5 83.5 22.6 18.2 55.5 RPS9 S9 ENSG00000170889 "Ribosomal protein S9" P46781 19 54200809-54249003 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048746 Approved NA Yes 64000 "HPA048746: AB_2680510" "prognostic favorable (9.23e-4)" "unprognostic (1.11e-1)" "unprognostic (4.84e-2)" "unprognostic (1.15e-3)" "unprognostic (1.22e-2)" "unprognostic (2.82e-1)" "unprognostic (4.61e-2)" "unprognostic (3.12e-1)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (2.22e-1)" "unprognostic (9.45e-2)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" 1808.3 1593.9 589.1 523.7 583.9 1370.5 2008.6 580.8 983.0 1974.8 578.6 1524.2 570.0 1536.2 473.2 2144.0 1647.1 305.5 1329.5 582.5 581.2 1445.2 1661.0 1371.3 687.9 597.8 581.6 574.9 3487.7 3468.0 316.9 939.9 328.0 583.9 1676.5 358.7 79.8 1525.0 168.5 1694.4 2575.7 1466.7 371.6 579.7 1827.3 1624.1 459.0 589.3 977.4 1282.5 633.1 657.7 1596.0 1877.5 587.5 500.8 204.0 257.8 695.7 1424.1 1563.5 602.5 440.1 254.9 246.2 124.4 216.2 861.6 899.9 518.5 785.5 398.8 677.4 922.7 1119.2 196.3 505.5 310.3 328.7 42.2 221.0 1293.3 708.5 711.7 2154.8 1199.7 686.8 882.1 838.6 861.4 831.0 452.2 978.5 693.8 148.0 1452.1 2013.6 770.5 636.4 200.7 865.5 406.3 1507.6 1201.0 228.9 532.3 926.3 255.6 749.5 1308.2 304.6 1003.0 2054.0 249.1 425.4 652.4 545.4 725.2 748.9 663.0 773.2 638.7 752.2 525.7 178.8 847.5 163.1 533.1 712.2 877.4 1075.6 917.4 673.0 741.2 1129.0 1237.5 1060.6 534.1 658.8 677.2 1018.9 627.1 2882.7 589.1 583.9 580.8 983.0 582.5 581.2 597.8 581.6 574.9 583.9 579.7 589.3 587.5 1501.4 458.3 1166.6 22.2 3076.3 6471.6 6044.0 4452.4 2423.9 346.2 6390.8 6524.1 198.1 1996.0 1877.7 886.5 175.2 2267.8 2511.4 1539.2 2488.7 1954.7 794.3 1011.6 2061.6 2294.9 1974.5 1549.2 13.6 5626.0 4374.8 1874.4 911.8 1416.2 838.2 2875.5 2494.0 2045.6 2693.9 175.0 14.6 3345.8 1377.3 3888.3 5294.3 1889.2 2872.7 2675.0 3283.5 25.3 3499.1 1219.7 2250.3 16.6 45.8 2925.9 2828.6 1518.0 1474.4 5077.4 3010.2 3183.8 786.3 682.9 1051.8 3030.1 2744.3 526.5 484.2 2627.6 7500.0 2470.4 2489.3 2886.3 3908.4 5842.9 PLA2G1B "PLA2, PLA2A, PPLA2" ENSG00000170890 "Phospholipase A2 group IB" P04054 12 120322115-120327779 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1518 "pancreas: 118708.0" "Cell type enriched" "Detected in many" 17 "Exocrine glandular cells: 20351.4" "Cancer enriched" "Detected in many" 185 "pancreatic cancer: 763.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;U-2 OS: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047822, HPA060803" Enhanced "Secreted to digestive system" NA NA 3900000 "HPA047822: AB_2680169, HPA060803: AB_2684369" "unprognostic (1.28e-4)" "unprognostic (6.02e-2)" "unprognostic (1.84e-2)" "unprognostic (2.86e-2)" "unprognostic (2.74e-2)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (3.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (2.80e-4)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (3.60e-1)" "unprognostic (8.61e-4)" 8.8 6.5 0.2 1.7 0.1 3.0 5.8 0.2 0.6 3.4 0.0 2.1 16.0 2.3 0.0 3.3 1.8 0.9 21.7 0.2 0.3 2.7 7.2 32.4 4.0 0.1 0.1 0.1 78.2 118708.0 0.0 4.5 6.1 0.2 4.4 0.3 0.7 21.5 0.0 2.0 3.4 7.8 0.1 0.2 3.0 8.7 4.3 0.1 0.3 1.5 0.0 0.0 1.3 2.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 1.9 0.2 0.2 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.6 0.2 0.3 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.0 12.8 91.5 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.8 1.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.2 1.9 24.3 10.6 0.4 0.1 1.1 1.2 0.0 0.1 20351.4 0.0 0.3 0.0 0.0 0.0 8.6 0.0 1.9 0.0 0.0 0.1 1.2 0.0 0.0 0.0 41.0 3.1 1.5 0.0 1.0 43.9 0.0 2.1 0.0 0.0 1142.1 1.7 3.4 0.1 0.2 4.1 7.6 1.0 0.0 0.0 0.0 3.4 0.5 0.2 0.0 0.1 0.0 0.3 12.5 1.2 0.1 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019458 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 46.4" "Cell type enhanced" "Detected in some" "Adipocytes: 14.1;Endothelial cells: 32.0;Erythroid cells: 86.6;Fibroblasts: 16.8;Hofbauer cells: 15.5;Microglial cells: 23.4" "Group enriched" "Detected in many" 5 "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "NK-cell: 27.0" "Lineage enriched" "Detected in many" 11 "NK-cells: 27.0" "Cell line enhanced" "Detected in some" "HEL: 194.1;HUVEC TERT2: 152.3;NB-4: 382.2;WM-115: 89.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA 270000 "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.2 2.0 2.0 1.8 2.3 14.0 7.0 2.9 4.1 12.9 3.9 4.8 0.6 9.5 1.3 4.9 7.9 4.6 1.3 2.5 3.1 0.8 0.3 4.9 4.5 4.0 3.2 1.7 1.7 1.2 1.2 1.6 46.4 3.7 10.9 1.4 0.2 4.3 14.5 0.5 3.2 2.4 4.0 4.3 1.2 4.8 0.3 3.2 4.5 5.9 0.2 5.0 12.1 7.4 3.5 0.1 0.0 0.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.1 0.1 0.0 0.9 0.0 0.0 5.0 0.0 2.7 0.0 0.0 152.3 0.0 0.0 7.5 0.0 0.0 0.0 382.2 0.7 0.0 0.0 5.7 7.7 0.2 0.0 0.0 0.1 8.8 0.3 0.0 24.5 0.2 0.0 0.0 52.7 0.0 34.6 0.1 0.0 1.0 0.2 0.4 0.0 4.8 89.6 2.5 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.1 27.0 0.0 0.4 0.0 0.9 2.0 2.3 2.9 4.1 2.5 3.1 4.0 3.2 1.7 3.7 4.3 3.2 3.5 14.1 0.0 0.5 0.0 1.2 2.8 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.2 0.4 0.3 0.3 32.0 0.0 86.6 0.0 0.0 0.4 16.8 0.0 0.3 8.9 0.2 0.7 0.0 15.5 0.0 0.0 0.0 0.0 0.8 2.9 0.0 0.0 4.7 8.8 23.4 0.6 0.0 3.1 0.5 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 0.0 0.3 1.6 0.5 0.5 8.6 0.0 0.6 TSEN34 "LENG5, SEN34, SEN34L" ENSG00000170892 "TRNA splicing endonuclease subunit 34" Q9BSV6 19 54189938-54194536 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Disease variant, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 5.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041111, HPA048208" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA041111: AB_10794263, HPA048208: AB_2680313" "unprognostic (3.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (3.48e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.44e-7)" "unprognostic (2.38e-1)" "unprognostic (7.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.04e-3)" "unprognostic (8.98e-2)" "unprognostic (4.55e-3)" "unprognostic (2.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.81e-1)" "unprognostic (1.12e-1)" 28.7 68.8 2.0 1.3 1.9 1.3 29.8 2.4 2.3 38.6 1.7 34.9 1.1 37.4 1.9 41.4 38.1 1.5 26.0 1.8 1.6 38.8 41.7 31.8 1.4 1.7 1.6 2.0 48.3 43.3 1.8 36.3 1.3 1.8 36.5 1.3 2.0 34.3 1.9 26.9 40.6 27.9 1.2 1.1 44.5 34.6 45.3 1.7 0.5 31.2 1.8 0.7 39.3 34.5 2.9 3.3 1.7 2.5 3.1 1.3 2.0 3.9 0.6 1.0 0.9 1.7 2.1 1.1 1.1 0.0 0.9 2.5 2.5 2.6 2.3 1.4 1.1 6.2 1.0 1.1 2.0 0.5 1.1 1.1 1.9 1.1 2.0 1.3 0.9 1.3 0.0 1.7 0.9 2.4 1.4 0.4 0.2 1.5 2.9 1.1 1.4 2.6 0.7 3.4 2.4 0.1 1.7 0.0 3.5 3.0 2.5 2.6 3.1 1.1 0.2 2.8 2.7 3.4 1.4 1.9 0.9 2.6 1.3 1.2 5.0 0.6 1.9 0.2 0.5 0.4 0.1 0.3 0.1 0.3 0.4 0.4 0.2 4.8 0.0 0.3 0.4 0.0 0.2 2.0 1.9 2.4 2.3 1.8 1.6 1.7 1.6 2.0 1.8 1.1 1.7 2.9 33.1 12.8 27.7 6.8 28.2 73.5 92.0 137.7 67.2 35.4 62.9 60.8 11.8 52.9 60.9 44.1 29.2 102.5 45.4 58.8 95.9 68.7 24.0 39.4 37.0 32.5 76.8 13.7 3.8 59.7 98.2 47.5 19.9 35.3 26.6 47.7 35.7 40.6 57.8 16.8 4.9 103.7 122.1 37.0 53.6 17.2 67.7 45.0 46.2 1.0 51.8 81.9 18.6 6.0 5.9 50.4 55.9 66.5 27.6 79.8 57.8 110.5 70.0 48.9 59.2 38.7 60.8 40.1 77.2 56.7 70.2 111.0 32.8 100.3 66.5 62.3 TRH ENSG00000170893 "Thyrotropin releasing hormone" P20396 3 129974688-129977935 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 110.9;cervix: 26.2;retina: 35.5" "Cell type enriched" "Detected in some" 10 "Muller glia cells: 234.5" "Group enriched" "Detected in some" 5 "breast cancer: 13.3;endometrial cancer: 10.2;glioma: 4.3" "Group enriched" "Detected in many" 5 "hypothalamus: 28.6;medulla oblongata: 110.9;pons: 41.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.0" "Group enriched" "Detected in many" 5 "hypothalamus: 175.6;olfactory bulb: 148.0" "Low region specificity" "Detected in many" HPA035596 Enhanced "Secreted in other tissues" NA NA "HPA035596: AB_2674695" "unprognostic (1.22e-1)" "unprognostic (8.94e-2)" "unprognostic (5.82e-3)" "unprognostic (5.24e-2)" "unprognostic (2.82e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (4.44e-2)" "unprognostic (3.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" 0.2 0.0 11.2 0.1 3.1 3.8 1.9 1.9 0.9 26.2 0.2 0.0 0.1 18.9 0.0 0.0 2.5 0.0 0.3 2.2 28.6 0.1 0.0 0.6 0.0 110.9 4.5 0.6 3.9 0.0 0.0 0.2 0.2 41.3 0.1 0.0 35.5 0.5 0.1 0.1 0.5 0.0 0.3 1.7 0.1 0.0 1.3 10.1 0.4 0.0 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.2 3.1 1.9 0.9 2.2 28.6 110.9 4.5 0.6 41.3 1.7 10.1 2.7 0.3 0.0 0.0 0.3 0.2 0.8 0.7 0.0 0.0 10.4 1.6 1.4 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 9.0 0.8 0.7 0.0 0.0 0.2 0.0 0.1 0.2 0.0 22.5 0.0 0.1 0.0 0.0 0.1 5.0 0.3 0.0 0.0 0.0 11.5 2.7 0.0 2.0 0.0 0.0 0.0 234.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.2 0.0 0.0 0.2 0.7 1.6 0.0 0.1 0.1 0.2 0.1 0.0 4.3 GSTA4 ENSG00000170899 "Glutathione S-transferase alpha 4" O15217 6 52977948-52995304 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 298.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 280.0;Granulosa cells: 335.6;Syncytiotrophoblasts: 450.3;Theca cells: 415.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "non-classical monocyte: 20.0" "Lineage enriched" "Detected in many" 6 "monocytes: 20.0" "Cell line enhanced" "Detected in many" "AF22: 95.4;ASC TERT1: 93.1" "Low region specificity" "Detected in all" HPA048934 Approved NA NA "HPA048934: AB_2680563" "unprognostic (5.13e-3)" "unprognostic (2.75e-1)" "unprognostic (5.04e-2)" "unprognostic (1.38e-1)" "unprognostic (5.24e-2)" "unprognostic (3.63e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-2)" "unprognostic (5.05e-3)" "unprognostic (9.26e-2)" "unprognostic (3.31e-3)" "unprognostic (2.29e-2)" "unprognostic (1.34e-2)" "unprognostic (2.21e-1)" "unprognostic (4.07e-3)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 19.3 298.5 48.3 6.9 53.0 1.7 36.4 55.6 61.4 30.4 37.9 19.3 20.6 27.7 61.7 53.8 25.0 23.1 20.6 52.4 51.7 32.4 35.1 39.1 7.3 45.7 46.3 51.9 52.4 31.5 75.0 43.4 48.4 46.8 41.0 24.8 31.5 33.1 28.8 36.2 137.1 19.2 26.4 40.6 13.7 37.6 37.7 46.8 10.0 25.2 37.1 21.6 15.7 40.7 54.1 1.3 10.3 95.4 80.3 56.1 93.1 8.9 13.6 33.7 9.4 16.0 15.6 0.3 1.0 9.1 25.8 10.1 3.9 69.7 13.5 11.8 2.3 29.2 3.3 8.2 54.4 39.8 0.0 2.3 80.1 20.6 12.0 10.1 28.5 59.1 14.1 12.9 15.0 31.9 0.0 1.2 0.3 36.4 58.5 17.3 2.4 41.2 18.6 34.3 1.7 42.2 62.1 0.4 9.9 24.9 48.9 2.5 2.8 28.5 10.0 22.6 9.3 11.6 18.4 2.5 0.5 15.2 1.5 11.0 0.0 0.0 0.0 2.6 0.9 2.0 0.8 0.7 1.2 0.9 2.9 0.5 0.7 0.0 3.2 20.0 1.7 0.8 0.9 48.3 53.0 55.6 61.4 52.4 51.7 45.7 46.3 51.9 46.8 40.6 46.8 54.1 15.4 51.3 84.3 22.9 2.2 44.9 22.0 79.0 35.3 39.7 26.1 31.2 10.0 15.7 44.4 27.6 0.0 280.0 3.6 5.6 54.8 14.0 1.4 3.5 24.1 20.0 23.9 9.5 63.4 9.0 108.8 40.5 23.0 4.1 5.7 335.6 31.4 21.1 69.8 37.0 88.2 41.8 57.0 2.5 14.6 9.6 41.7 3.5 96.0 13.1 2.8 70.1 4.1 75.9 62.7 10.8 9.6 39.1 0.8 25.8 12.7 47.7 15.6 11.3 19.7 28.5 36.3 4.7 10.5 96.3 135.5 450.3 3.9 415.9 18.0 21.1 MSANTD4 KIAA1826 ENSG00000170903 "Myb/SANT DNA binding domain containing 4 with coiled-coils" Q8NCY6 11 105995623-106022403 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 48.3;Muller glia cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014411 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA014411: AB_2668995" "prognostic unfavorable (4.95e-4)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (1.30e-1)" "unprognostic (7.04e-3)" "unprognostic (8.21e-3)" "unprognostic (1.41e-2)" "unprognostic (2.13e-2)" "unprognostic (8.84e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.26e-5)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.78e-2)" "unprognostic (2.90e-1)" 8.4 10.2 12.5 8.5 14.0 3.2 8.4 16.1 16.9 11.8 7.3 6.4 5.3 11.7 6.9 8.8 7.5 7.2 16.0 12.8 11.7 9.6 7.1 8.6 9.9 13.5 13.3 9.9 10.9 9.7 8.3 9.8 7.4 12.0 9.6 6.3 33.6 7.4 12.1 12.0 4.5 5.8 10.7 11.1 8.5 7.3 10.4 12.9 8.4 13.5 16.7 10.1 8.8 5.6 16.2 8.3 12.0 26.6 0.2 28.4 31.2 0.2 23.1 31.7 17.7 22.5 21.2 15.9 18.1 38.3 19.6 19.5 21.0 30.1 14.8 22.0 33.3 14.5 35.5 14.3 13.2 42.6 28.0 26.9 21.3 17.8 24.0 47.2 22.1 16.0 19.2 16.8 11.4 26.3 3.4 26.4 14.0 10.3 12.3 24.3 17.7 34.4 26.1 24.3 10.2 17.5 33.5 6.1 20.8 16.8 16.4 16.5 14.2 23.0 26.1 20.3 13.8 23.5 11.3 13.9 9.5 12.1 11.0 19.4 2.4 5.7 3.2 8.7 8.7 8.6 6.5 7.8 6.2 7.2 7.5 9.2 8.0 1.4 8.5 5.2 6.1 6.4 5.4 12.5 14.0 16.1 16.9 12.8 11.7 13.5 13.3 9.9 12.0 11.1 12.9 16.2 5.8 16.0 15.4 16.6 6.9 5.4 3.3 6.4 6.2 48.3 6.2 6.3 25.1 10.0 14.4 3.7 20.9 1.6 6.2 2.4 1.9 6.7 39.0 6.6 16.8 8.3 8.4 2.5 8.6 5.8 1.3 13.0 5.6 7.2 6.3 11.9 6.1 6.2 5.3 37.0 10.3 3.3 8.2 9.5 5.3 16.0 14.0 6.2 12.4 5.6 8.8 140.7 8.2 31.7 17.3 6.5 1.0 9.8 6.4 2.0 1.8 10.2 9.0 20.1 0.0 15.0 8.2 12.3 6.9 6.1 5.8 0.3 7.4 10.8 3.2 1.5 NDUFA3 B9 ENSG00000170906 "NADH:ubiquinone oxidoreductase subunit A3" O95167 19 54102728-54109257 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 540.5;skeletal muscle: 496.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1133.8;Late spermatids: 2033.9;Proximal tubular cells: 1213.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 74.0" "Low region specificity" "Detected in all" HPA046976 Supported NA NA "HPA046976: AB_10960994" "unprognostic (3.04e-2)" "unprognostic (4.12e-3)" "unprognostic (9.53e-2)" "unprognostic (5.95e-2)" "unprognostic (6.73e-2)" "unprognostic (3.14e-2)" "unprognostic (3.91e-1)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.00e-2)" "prognostic favorable (9.65e-4)" "unprognostic (9.91e-2)" "unprognostic (3.24e-3)" "unprognostic (7.79e-2)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" "prognostic favorable (4.80e-4)" 113.7 194.1 17.9 3.2 19.4 6.6 108.9 24.3 28.2 94.0 20.5 142.8 11.3 103.4 5.3 128.7 96.6 5.4 540.5 19.1 19.1 260.2 250.2 103.3 5.1 19.2 18.2 16.7 105.4 125.0 4.8 227.7 3.3 22.0 123.5 8.2 6.6 114.4 3.7 496.5 80.5 118.5 4.1 14.8 134.6 162.1 165.6 18.8 3.6 153.6 10.9 5.4 98.4 93.1 24.6 9.1 9.7 8.4 11.6 10.3 10.7 5.2 7.6 9.3 6.5 7.3 10.1 7.2 8.2 5.3 7.4 6.1 6.6 6.9 16.7 3.5 11.5 32.0 9.5 9.6 11.9 7.6 9.2 2.3 6.2 15.1 5.2 8.5 3.1 11.7 7.3 4.9 3.5 6.9 32.3 7.3 10.5 7.4 74.0 15.2 4.3 5.0 17.7 4.9 23.2 14.1 6.9 6.9 17.7 4.3 10.3 23.4 9.6 8.7 7.4 4.5 4.0 13.2 6.9 5.7 3.9 9.1 10.5 4.5 25.2 12.9 20.9 12.6 15.3 13.0 18.4 13.0 12.9 14.3 16.1 13.5 13.6 12.5 18.0 12.3 23.7 14.5 22.3 17.9 19.4 24.3 28.2 19.1 19.1 19.2 18.2 16.7 22.0 14.8 18.8 24.6 146.9 96.1 117.4 4.6 168.1 39.8 53.5 266.5 58.6 37.7 196.2 212.6 1133.8 203.0 171.4 393.6 10.4 164.1 158.3 544.0 815.9 183.6 497.6 239.6 124.9 118.2 300.5 169.0 5.2 192.5 171.9 122.9 174.8 180.2 116.5 138.3 194.9 527.7 306.9 23.5 6.4 380.2 209.5 267.4 114.4 2033.9 163.1 181.6 218.7 1.9 300.4 146.3 265.7 3.0 7.7 204.2 448.8 141.4 232.7 67.5 705.7 1213.0 225.1 71.0 85.5 62.5 125.8 215.3 69.8 122.6 62.5 148.4 168.6 75.3 404.2 66.6 OSCAR ENSG00000170909 "Osteoclast associated Ig-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 13.7;lung: 28.6;lymphoid tissue: 30.0" "Cell type enhanced" "Detected in some" "Hofbauer cells: 35.6;Kupffer cells: 27.8;Macrophages: 42.9;monocytes: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 36 "classical monocyte: 43.0;eosinophil: 26.6;intermediate monocyte: 28.8;myeloid DC: 20.3;neutrophil: 40.0;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 79 "dendritic cells: 20.3;granulocytes: 40.0;monocytes: 43.0" "Cell line enhanced" "Detected in some" "EFO-21: 13.9;HHSteC: 9.4;hTERT-HME1: 5.0;NB-4: 5.9;U-937: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 84000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 3.5 1.8 0.4 2.4 0.6 13.7 1.9 0.0 1.4 2.2 0.1 1.4 0.0 1.4 0.0 1.5 3.3 1.3 1.9 0.2 0.8 1.5 2.5 28.6 0.3 1.1 0.6 0.2 1.1 1.3 0.2 1.0 0.6 0.7 1.7 0.3 0.0 2.2 0.3 0.5 2.0 1.6 1.8 0.6 30.0 1.2 0.9 0.9 0.2 1.1 0.6 0.6 2.2 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 13.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.4 0.6 0.0 0.0 0.2 0.6 5.0 0.8 0.0 0.0 0.0 0.4 0.1 0.1 0.0 5.9 0.3 0.1 1.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.5 17.9 0.0 0.0 43.0 26.6 0.3 28.8 0.1 0.0 0.2 0.4 20.3 0.0 0.1 0.0 40.0 0.0 27.0 0.8 0.2 16.8 0.4 0.6 0.0 1.4 0.2 0.8 1.1 0.6 0.2 0.7 0.6 0.9 0.9 0.2 3.2 5.9 0.3 0.3 0.8 0.6 0.7 0.6 0.0 0.7 0.4 0.3 1.5 2.1 0.0 0.0 0.3 0.6 0.1 0.0 0.3 0.0 0.1 0.3 0.9 0.0 1.7 1.9 0.0 0.4 0.6 0.0 0.1 1.3 0.3 0.0 0.0 35.6 0.0 1.0 0.3 0.0 27.8 11.6 0.2 0.0 42.9 0.0 1.0 66.4 0.0 1.0 0.0 0.3 0.4 0.0 0.0 0.4 0.3 0.1 0.2 3.7 0.4 0.0 0.2 0.1 0.6 0.5 0.4 0.1 0.3 0.7 0.4 0.1 0.3 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins, Transporters" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 148.8" "Cell type enhanced" "Detected in many" "Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 41.8;OE19: 87.9;SuSa: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA064625: AB_2685304" "prognostic favorable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favorable (6.40e-4)" 2.8 4.0 86.3 9.3 114.4 1.2 2.3 125.0 87.4 4.7 48.4 39.2 19.5 5.2 8.0 17.8 6.4 6.0 3.6 78.5 90.4 6.1 1.5 7.4 10.4 123.7 114.6 67.9 24.5 2.8 5.3 2.2 7.0 120.9 4.3 37.0 2.9 2.2 23.5 0.9 3.2 34.0 6.4 116.0 6.3 32.6 3.7 112.9 9.3 2.8 1.5 7.7 9.8 5.5 148.8 0.9 1.0 10.7 4.6 6.3 10.2 7.3 3.2 12.1 2.0 4.4 4.1 3.8 1.1 1.2 2.2 4.7 0.4 1.4 5.3 3.2 14.8 1.7 6.6 1.0 41.8 1.7 1.8 0.9 2.9 0.7 1.4 7.5 7.4 11.5 12.9 1.5 6.4 8.3 1.5 4.4 6.1 5.4 87.9 0.5 11.5 1.7 2.8 12.4 3.1 4.0 8.7 0.8 0.3 12.4 34.4 0.3 14.7 4.8 4.0 1.6 1.2 1.9 1.9 2.6 1.6 3.7 16.9 21.5 3.0 3.2 1.4 2.8 0.6 4.2 1.1 8.3 5.7 7.0 1.0 17.8 8.3 0.6 8.5 0.6 3.5 6.2 4.2 86.3 114.4 125.0 87.4 78.5 90.4 123.7 114.6 67.9 120.9 116.0 112.9 148.8 4.9 3.2 10.6 168.5 3.6 2.0 3.7 3.1 0.6 2.1 0.7 1.3 4.4 14.3 3.5 3.7 8.4 1.7 7.6 154.3 0.0 4.4 0.5 12.2 3.9 7.4 22.9 4.2 21.1 1.1 3.1 6.8 18.8 7.5 4.5 23.7 4.2 0.2 8.8 0.0 19.4 45.5 6.1 19.8 3.5 1.6 5.6 7.3 14.2 74.0 11.4 4.2 3.1 19.1 298.2 4.9 80.7 10.1 0.6 6.6 100.5 0.1 8.9 3.3 0.0 1.0 3.6 12.1 3.3 5.3 1.0 0.8 9.2 10.0 42.5 7.3 NUDT6 "FGF-AS, FGF2AS, gfg, gfg-1" ENSG00000170917 "Nudix hydrolase 6" P53370 4 122888697-122922968 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 27.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 37.2;Early spermatids: 36.7;Proximal tubular cells: 46.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039202, HPA066115" Uncertain NA NA "HPA039202: AB_10795032, HPA066115: AB_2685620" "unprognostic (7.51e-2)" "unprognostic (1.59e-1)" "unprognostic (1.46e-3)" "unprognostic (1.97e-2)" "unprognostic (3.11e-1)" "unprognostic (3.84e-2)" "unprognostic (4.23e-2)" "unprognostic (2.36e-1)" "unprognostic (3.79e-1)" "unprognostic (1.07e-1)" "unprognostic (6.29e-2)" "unprognostic (6.91e-6)" "unprognostic (1.13e-5)" "unprognostic (2.32e-1)" "unprognostic (7.60e-2)" "unprognostic (7.98e-2)" "unprognostic (2.16e-1)" 5.0 10.7 9.0 2.8 10.3 2.2 5.4 6.4 10.7 4.2 7.2 7.7 4.5 4.1 7.2 3.4 6.8 3.6 10.6 9.5 7.9 19.6 27.6 3.3 3.9 7.3 7.7 8.8 4.2 4.0 7.5 6.4 3.2 7.4 3.8 6.3 8.4 5.3 4.4 10.0 4.2 3.8 3.5 5.8 4.5 3.3 7.2 8.0 4.9 7.4 11.0 2.4 3.3 3.3 8.8 5.4 7.9 11.5 10.3 10.3 10.7 4.1 6.1 8.1 5.3 7.3 3.4 12.1 5.6 4.5 3.3 11.7 2.7 5.1 4.8 5.4 13.5 3.4 5.0 7.6 9.2 3.8 10.4 3.0 6.6 2.1 4.6 4.0 9.8 7.0 9.7 12.8 13.8 9.0 6.3 14.5 11.2 4.3 20.8 9.9 4.9 14.6 6.4 12.7 3.2 6.1 7.6 6.3 8.5 12.5 13.3 5.6 8.3 4.4 12.8 6.7 11.2 5.6 15.4 12.9 10.7 7.7 15.4 5.8 0.0 2.0 0.0 1.5 2.8 1.9 4.0 2.0 2.6 4.4 1.2 1.5 1.7 0.3 1.3 2.5 1.7 2.3 1.8 9.0 10.3 6.4 10.7 9.5 7.9 7.3 7.7 8.8 7.4 5.8 8.0 8.8 7.0 16.0 7.8 10.7 2.0 0.9 3.1 9.3 4.6 12.5 4.7 6.9 5.3 4.3 5.4 5.5 0.0 16.4 1.3 4.1 37.2 6.2 36.7 8.9 7.4 5.4 7.2 3.0 8.9 5.6 3.7 5.3 5.6 3.4 1.3 12.8 4.6 21.3 8.7 15.2 9.6 6.0 6.1 4.6 2.0 6.1 6.2 5.0 5.4 4.7 1.5 14.0 0.0 13.6 10.8 4.7 5.2 9.1 3.8 1.2 2.5 46.2 10.4 11.9 0.0 6.3 5.0 28.5 3.7 3.9 1.8 4.0 3.3 20.8 10.1 2.1 OR7G3 OST085 ENSG00000170920 "Olfactory receptor family 7 subfamily G member 3" Q8NG95 19 9126012-9126950 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TANC2 "DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA" ENSG00000170921 "Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2" Q9HCD6 17 63009556-63427699 "Disease related genes, Predicted intracellular proteins" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 597.7;Granulosa cells: 195.7;Inhibitory neurons: 394.9;Oligodendrocyte precursor cells: 641.4;Oligodendrocytes: 329.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023274 Uncertain Approved Cytosol NA NA Cytosol "HPA023274: AB_2199727" "unprognostic (8.37e-2)" "unprognostic (4.15e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-4)" "unprognostic (1.51e-1)" "unprognostic (4.09e-2)" "unprognostic (9.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.09e-2)" "unprognostic (5.52e-2)" "unprognostic (2.62e-1)" "unprognostic (2.69e-1)" "unprognostic (2.02e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-1)" "unprognostic (1.57e-1)" "unprognostic (2.01e-1)" 5.3 6.5 6.3 2.9 19.4 12.1 5.6 0.0 16.5 6.9 0.0 3.7 2.0 5.1 8.4 6.1 4.2 5.5 3.9 12.0 10.7 6.3 2.2 12.6 1.6 8.5 0.1 17.2 4.5 4.2 30.7 10.5 4.2 6.5 6.1 2.1 6.5 7.4 5.4 2.3 9.7 2.5 7.1 0.4 2.5 3.8 18.6 2.7 3.5 3.7 2.5 1.7 8.4 7.0 13.6 28.2 25.9 15.8 2.7 7.9 19.0 30.5 17.6 17.3 17.0 21.0 1.5 8.0 0.0 5.3 30.3 21.6 3.8 25.6 51.6 38.2 10.9 11.8 41.0 38.9 1.5 6.9 11.2 0.0 29.3 29.5 19.9 56.9 18.8 5.5 10.4 5.2 0.0 24.6 21.4 7.4 1.8 1.8 4.9 16.8 5.7 31.7 2.1 15.1 38.4 26.5 29.2 9.8 18.3 7.2 27.3 8.4 2.9 28.0 41.3 21.4 2.7 21.7 0.0 0.0 0.0 15.2 2.9 15.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.3 0.4 0.0 0.3 0.1 0.2 0.3 0.9 0.0 0.4 0.0 0.0 6.3 19.4 0.0 16.5 12.0 10.7 8.5 0.1 17.2 6.5 0.4 2.7 13.6 13.2 16.0 59.4 79.0 2.3 25.1 13.0 25.3 6.8 63.1 11.6 8.5 3.9 10.0 19.2 27.6 16.7 8.0 9.4 3.4 1.9 10.9 17.5 15.4 12.6 12.3 4.2 3.8 597.7 14.0 35.0 8.5 7.7 19.7 0.0 195.7 24.3 1.3 7.3 8.4 394.9 3.3 20.3 9.7 10.9 10.4 5.6 16.7 10.6 151.8 11.2 3.9 14.4 641.4 329.8 29.4 2.8 3.4 2.9 10.6 0.3 1.7 10.2 7.1 19.7 62.9 6.9 23.0 20.4 10.8 15.9 16.4 9.9 8.8 2.2 11.8 OR7G2 OST260 ENSG00000170923 "Olfactory receptor family 7 subfamily G member 2" Q8NG99 19 9100407-9107475 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.04e-1)" 0.0 0.1 0.2 0.1 0.2 0.3 0.0 0.6 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.1 1.5 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.3 0.1 0.1 1.2 0.4 0.1 0.2 0.1 0.0 0.2 0.2 0.6 0.3 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX13B "TGC3B, TSGA5" ENSG00000170925 "Testis expressed 13B" Q9BXU2 X 107980864-107982370 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.58e-2)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKHD1 "ARPKD, FCYT, FPC, TIGM1" ENSG00000170927 "PKHD1 ciliary IPT domain containing fibrocystin/polyductin" P08F94 6 51615299-52087613 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 4.8;kidney: 13.8;pancreas: 9.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 60.1;Collecting duct cells: 46.0;Early spermatids: 293.6;Late spermatids: 83.1" "Group enriched" "Detected in some" 5 "pancreatic cancer: 1.4;renal cancer: 5.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA031227 Enhanced "Intracellular and membrane" NA NA "HPA031227: AB_10602068" "unprognostic (6.34e-3)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" "unprognostic (1.35e-1)" "unprognostic (3.80e-2)" "unprognostic (1.29e-2)" "unprognostic (4.03e-2)" "unprognostic (6.42e-2)" "unprognostic (7.08e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (2.62e-2)" "prognostic favorable (9.74e-8)" "unprognostic (2.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.1 1.2 0.0 0.0 0.2 13.8 1.5 0.0 0.0 0.1 0.1 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.3 10.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.3 1.4 60.1 0.0 46.0 0.0 0.1 0.0 0.1 1.9 18.2 293.6 0.2 0.0 0.3 0.0 0.0 3.2 0.9 0.1 0.1 2.6 0.4 0.0 0.0 0.0 3.7 0.1 0.0 2.8 0.0 0.0 0.0 0.0 83.1 2.1 0.5 5.4 0.0 0.0 3.1 0.0 0.5 0.7 2.6 0.0 0.4 0.0 0.4 0.0 23.3 0.0 0.1 0.0 0.0 0.1 15.0 1.7 0.0 0.0 0.0 0.3 0.0 0.1 0.8 OR1M1 OR19-6 ENSG00000170929 "Olfactory receptor family 1 subfamily M member 1" Q8NGA1 19 9087061-9095669 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.29e-2)" 0.1 0.1 0.2 0.2 1.4 0.8 0.1 1.1 1.2 0.1 0.8 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.3 0.4 0.0 0.1 0.1 0.2 1.4 0.9 0.4 0.2 0.2 0.0 0.0 0.1 1.8 0.1 0.1 0.4 0.3 0.0 0.2 0.6 0.2 0.0 0.4 0.1 0.1 0.2 1.0 0.0 0.4 0.0 0.1 0.0 0.0 3.5 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.9 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.0 0.2 0.3 0.2 0.1 0.0 0.2 1.4 1.1 1.2 0.3 0.4 1.4 0.9 0.4 1.8 0.4 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NCBP2L ENSG00000170935 "Nuclear cap binding protein subunit 2 like" A6PVI3 X 107774899-107795829 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.1;testis: 2.6" "Cell type enriched" "Detected in some" 7 "Early spermatids: 40.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 79 "basophil: 8.3" "Lineage enriched" "Detected in single" 79 "granulocytes: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA010664 Uncertain NA NA "HPA010664: AB_1079451" "unprognostic (3.22e-1)" "unprognostic (8.00e-2)" "unprognostic (5.64e-2)" "unprognostic (7.29e-2)" "unprognostic (2.64e-1)" 0.0 1.1 0.2 0.0 0.1 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 2.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.1 1.3 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 DNAJC24 "DPH4, JJJ3, ZCSL3" ENSG00000170946 "DnaJ heat shock protein family (Hsp40) member C24" Q6P3W2 11 31369840-31432835 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 204.8;Late spermatids: 223.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020025, HPA025237" Approved Approved Cytosol NA NA Cytosol "HPA020025: AB_1847801, HPA025237: AB_1847802" "unprognostic (2.07e-1)" "unprognostic (3.73e-2)" "unprognostic (2.27e-2)" "unprognostic (9.74e-2)" "unprognostic (3.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (2.21e-2)" "unprognostic (1.49e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (3.56e-1)" "unprognostic (2.74e-1)" "unprognostic (9.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-1)" 7.3 6.4 8.2 5.4 8.1 1.9 6.8 9.7 8.5 4.8 7.4 4.3 4.5 5.9 6.5 5.4 3.1 4.9 11.9 8.1 8.5 6.4 6.1 4.4 6.8 8.1 8.3 7.9 4.6 7.4 4.8 4.6 5.1 8.0 5.8 4.4 8.3 5.9 6.0 17.2 8.9 4.5 6.3 7.6 5.9 5.1 4.5 8.6 5.2 6.6 11.4 5.7 5.7 3.4 8.4 4.8 6.4 11.2 8.2 8.7 10.9 4.9 12.7 8.0 7.0 7.3 5.2 4.5 6.3 6.7 8.6 10.4 6.2 6.4 8.2 12.2 14.8 11.9 6.9 10.2 5.3 11.1 14.0 10.9 10.3 10.4 4.3 13.8 10.2 9.5 10.7 13.3 10.9 14.0 5.0 10.8 9.4 5.7 7.0 6.7 6.7 18.8 6.5 10.3 4.5 4.9 6.9 11.0 7.5 11.0 6.3 10.5 9.1 10.0 13.1 8.9 16.3 15.8 13.3 11.3 7.6 19.3 6.6 14.9 4.5 1.0 0.9 2.2 1.8 3.1 1.5 2.2 1.9 0.8 1.6 2.8 2.9 0.7 1.3 1.1 1.6 1.5 1.3 8.2 8.1 9.7 8.5 8.1 8.5 8.1 8.3 7.9 8.0 7.6 8.6 8.4 7.5 3.2 7.4 14.0 14.4 12.1 7.0 9.2 6.8 11.9 9.1 7.2 20.3 1.5 9.3 3.7 10.4 8.6 15.5 5.6 3.9 9.1 204.8 6.4 11.0 7.7 7.2 5.2 40.7 9.1 9.4 10.4 7.1 6.3 5.1 5.3 9.3 10.5 8.2 23.5 28.9 5.1 4.1 6.9 10.3 223.9 9.0 8.5 12.4 25.3 7.1 26.2 9.2 41.2 29.9 11.7 6.2 9.4 18.5 7.2 5.2 11.4 4.4 14.6 0.0 9.6 8.3 28.2 18.2 9.5 8.2 6.3 13.5 7.1 5.9 9.1 MBD3L1 MBD3L ENSG00000170948 "Methyl-CpG binding domain protein 3 like 1" Q8WWY6 19 8832398-8843340 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 27.3" "Group enriched" "Detected in some" 24 "Early spermatids: 374.9;Late spermatids: 138.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043121, HPA046753" Supported NA NA "HPA043121: AB_2678327, HPA046753: AB_2679786" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 374.9 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 138.4 3.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 10.3 2.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 67.7;Theca cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 48.6" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.67e-5)" 18.7 29.2 8.6 7.9 10.3 7.5 17.7 11.3 11.7 19.4 5.4 15.0 8.0 19.0 13.8 11.1 18.0 14.1 15.2 7.3 10.1 20.1 13.9 15.1 11.7 9.4 11.0 4.4 21.0 12.8 18.3 10.3 13.8 10.5 15.4 10.8 14.3 14.3 13.6 8.4 12.3 12.6 14.2 7.9 33.6 13.8 15.0 9.3 13.6 29.5 9.1 10.5 17.3 15.6 19.2 9.8 8.6 11.6 17.8 19.1 13.4 19.7 10.4 13.9 8.3 13.2 7.4 6.0 11.1 8.8 9.7 11.0 7.0 11.1 10.7 16.4 8.3 13.4 17.2 6.6 4.2 10.5 0.0 11.3 16.7 10.8 8.9 12.5 20.9 9.0 12.9 8.8 0.0 15.8 6.7 14.5 10.6 10.9 2.6 13.7 9.1 12.2 8.6 13.0 48.6 9.8 12.8 0.0 8.2 1.6 37.0 8.8 10.0 17.3 23.0 8.2 6.9 7.7 6.1 27.4 15.9 4.0 4.2 11.1 10.9 3.1 11.4 6.7 4.2 10.0 8.6 6.9 9.2 4.4 9.9 10.4 8.3 6.6 17.6 6.6 4.2 7.9 5.5 8.6 10.3 11.3 11.7 7.3 10.1 9.4 11.0 4.4 10.5 7.9 9.3 19.2 46.5 22.4 30.5 23.8 18.5 4.0 10.0 14.7 9.6 23.2 9.4 9.5 20.6 15.7 14.1 9.2 29.2 8.3 16.8 8.0 5.9 8.2 31.0 12.4 21.6 29.8 8.4 9.9 17.1 6.8 9.5 15.4 20.4 16.0 18.3 67.7 34.2 5.0 6.4 47.1 18.8 8.3 8.2 11.3 6.4 10.2 10.8 13.0 1.8 15.9 7.1 13.8 19.6 21.6 29.4 8.1 6.3 14.3 12.7 12.6 11.1 5.9 12.7 19.1 13.1 13.9 18.4 8.3 8.3 8.1 4.0 10.4 18.5 66.0 5.7 13.0 PGK2 "PGK-2, PGKPS" ENSG00000170950 "Phosphoglycerate kinase 2" P07205 6 49785660-49787285 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 531 "testis: 201.7" "Group enriched" "Detected in some" 9 "Early spermatids: 1143.9;Late spermatids: 2784.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045385, HPA073644, HPA073656" Supported NA NA "HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235" "unprognostic (8.87e-3)" "unprognostic (5.02e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1143.9 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2784.5 14.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 204.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B12 ENSG00000170953 "Olfactory receptor family 8 subfamily B member 12" Q8NGG6 11 124539635-124545333 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF415 ENSG00000170954 "Zinc finger protein 415" Q09FC8 19 53107879-53133077 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 108.2;Late spermatids: 54.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 21.9" HPA005553 Approved Approved "Nucleoli fibrillar center,Microtubules" NA NA "Nucleoli fibrillar center, Microtubules" "HPA005553: AB_1859252" "unprognostic (2.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-3)" "unprognostic (2.18e-1)" "unprognostic (3.24e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-3)" "unprognostic (1.51e-1)" "unprognostic (1.06e-2)" "unprognostic (4.27e-2)" "unprognostic (1.28e-1)" "unprognostic (4.38e-2)" "unprognostic (2.84e-2)" 6.8 18.0 14.4 2.0 18.5 0.9 8.6 19.4 18.8 7.6 10.0 6.2 2.0 7.6 13.7 3.5 6.5 5.5 16.9 15.5 15.8 5.7 1.2 4.9 3.2 16.6 17.3 14.2 9.6 5.6 11.4 5.4 4.3 17.1 9.8 5.3 10.7 6.2 7.8 4.5 3.9 3.3 7.1 14.5 5.5 5.0 21.8 16.9 4.9 10.9 6.8 2.8 6.4 5.1 28.6 0.2 0.0 4.9 14.2 0.7 0.8 11.3 5.3 8.3 7.6 11.5 9.2 0.3 0.0 2.9 9.2 8.8 0.2 0.0 0.0 7.5 0.0 0.7 0.0 0.5 0.0 2.7 0.0 7.8 8.5 0.1 1.8 0.0 0.8 0.1 0.4 0.3 0.3 4.2 0.7 9.3 0.1 10.3 0.1 0.5 0.0 0.0 0.4 6.3 21.9 3.1 7.6 0.6 0.1 0.0 12.3 7.3 0.4 0.0 3.5 3.4 0.4 6.3 0.2 9.6 6.4 0.4 0.0 11.7 3.6 0.6 3.9 0.3 0.3 0.3 4.1 0.8 0.2 1.2 3.9 1.8 1.6 0.9 3.4 0.5 2.9 0.5 0.6 14.4 18.5 19.4 18.8 15.5 15.8 16.6 17.3 14.2 17.1 14.5 16.9 28.6 7.7 0.0 6.2 11.4 2.1 0.5 2.5 0.6 2.8 4.8 4.0 4.7 24.2 1.5 4.4 3.7 2.1 3.5 0.4 1.1 13.7 5.8 108.2 5.0 4.2 6.5 0.0 0.0 9.3 4.7 3.5 4.4 1.5 3.5 0.0 13.3 5.3 0.0 0.7 1.7 13.8 1.9 2.0 0.3 0.9 54.7 1.8 0.5 0.0 2.8 0.6 5.5 7.2 9.5 17.6 2.7 0.3 4.5 0.4 2.5 0.3 0.1 5.4 2.8 0.0 3.0 5.6 17.4 5.0 1.2 0.3 1.9 0.9 17.6 1.3 2.6 CAVIN3 "cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC" ENSG00000170955 "Caveolae associated protein 3" Q969G5 11 6318946-6320532 "Predicted intracellular proteins" "Biological rhythms" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 140.5;Exocrine glandular cells: 252.2;Extravillous trophoblasts: 88.9;Fibroblasts: 88.7;Pancreatic endocrine cells: 219.0;Smooth muscle cells: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 16.2;myeloid DC: 42.8" "Group enriched" "Detected in many" 5 "dendritic cells: 42.8;monocytes: 16.2" "Cell line enhanced" "Detected in many" "A-431: 120.7;BJ: 111.6;HaCaT: 91.7;TIME: 133.6;U-87 MG: 125.9;WM-115: 137.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055136, HPA073327" Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055136: AB_2682711, HPA073327: AB_2686595" "unprognostic (7.92e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.12e-2)" "unprognostic (2.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.69e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.37e-1)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.21e-6)" "unprognostic (3.85e-2)" "unprognostic (1.70e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-2)" 64.0 20.5 5.2 16.6 4.5 0.5 52.1 4.8 7.4 72.6 11.3 55.3 5.9 107.4 1.3 19.4 49.3 1.3 53.9 4.1 4.4 24.9 8.4 38.1 2.5 5.0 4.4 3.7 37.3 21.5 1.3 8.1 11.8 5.7 44.0 4.0 0.0 20.5 13.2 17.3 26.7 29.8 23.1 4.8 25.2 37.6 12.2 5.6 1.1 22.8 5.7 1.4 80.0 58.7 5.2 120.7 12.1 0.1 0.4 5.4 24.7 0.0 111.6 45.1 18.5 20.5 0.0 0.1 0.0 36.6 26.1 1.9 91.7 0.0 9.0 3.4 30.1 0.0 0.0 14.0 0.0 14.6 0.0 0.5 16.6 12.4 6.9 9.0 0.0 35.7 0.0 0.0 0.7 19.8 0.0 0.0 0.1 74.6 0.9 2.0 0.0 0.0 0.2 25.6 0.0 0.0 0.1 40.9 0.2 27.0 0.7 0.2 0.5 133.6 0.0 0.4 46.0 0.4 0.2 1.0 0.2 125.9 0.0 137.7 0.0 16.2 0.0 0.0 1.1 0.0 0.0 0.8 0.0 42.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 6.1 5.9 5.2 4.5 4.8 7.4 4.1 4.4 5.0 4.4 3.7 5.7 4.8 5.6 5.2 140.5 12.8 6.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.7 36.2 0.0 0.0 8.1 16.5 0.0 3.6 1.0 0.0 39.2 6.0 0.0 6.9 59.7 70.3 0.0 0.0 0.0 252.2 88.9 88.7 0.0 8.0 0.0 2.6 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 30.5 0.0 0.0 0.0 0.0 219.0 0.0 0.0 0.5 0.0 0.0 47.6 10.2 0.0 0.0 0.0 146.0 0.0 0.0 0.0 0.0 8.5 1.6 45.7 0.0 0.0 CEACAM3 "CD66d, CGM1" ENSG00000170956 "CEA cell adhesion molecule 3" P40198 19 41796587-41811554 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 44.7" "Cell type enriched" "Detected in some" 13 "Paneth cells: 56.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 6 "neutrophil: 289.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 289.3" "Not detected" "Not detected" HPA011041 Approved NA NA "HPA011041: AB_1078481" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (8.09e-3)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "unprognostic (1.62e-1)" "unprognostic (8.07e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (4.68e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-1)" 0.9 0.1 0.1 5.2 0.1 44.7 0.1 0.1 0.8 0.1 0.5 0.2 0.0 0.2 0.0 0.4 0.3 0.3 0.3 0.1 0.1 0.1 0.6 1.9 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.0 5.1 0.1 0.0 0.1 0.6 0.1 1.3 0.4 1.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.2 0.0 0.0 19.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 289.3 0.0 45.8 0.0 0.0 3.2 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.0 3.3 0.0 1.4 0.0 4.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 56.4 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.4 DCDC1 "DCDC5, FLJ46154" ENSG00000170959 "Doublecortin domain containing 1" M0R2J8 11 30830369-31369810 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 39.0;Endometrial ciliated cells: 47.7;Late spermatids: 18.0;Respiratory ciliated cells: 61.6;Rod photoreceptor cells: 19.0;Spermatocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.0 0.1 3.2 0.0 1.1 0.0 0.3 1.2 0.4 0.4 8.9 0.0 0.0 0.2 1.7 0.0 4.2 1.8 0.0 2.2 3.9 0.9 2.8 0.4 0.0 3.9 3.8 0.3 0.2 1.0 1.1 1.9 0.0 2.6 0.0 0.0 3.7 0.1 0.1 0.0 0.2 0.0 0.0 4.2 0.0 0.0 2.4 1.5 0.0 0.7 0.1 0.0 0.0 0.0 1.4 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.1 1.2 0.4 2.2 3.9 3.9 3.8 0.3 2.6 4.2 1.5 1.4 0.2 0.0 1.5 3.3 0.1 0.3 0.3 0.9 0.0 6.0 0.8 0.9 1.0 2.8 4.8 0.0 20.9 0.0 0.0 0.0 0.0 0.9 39.0 47.7 0.8 0.2 0.0 0.0 5.3 0.0 0.0 0.7 0.0 1.7 0.0 0.3 0.0 3.4 0.1 0.0 1.9 0.0 2.0 0.6 0.3 18.0 1.5 0.1 0.0 1.0 0.0 4.6 0.0 1.5 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 61.6 19.0 0.0 0.1 0.7 15.4 4.4 0.0 0.0 0.0 0.1 0.4 0.0 0.1 HAS2 ENSG00000170961 "Hyaluronan synthase 2" Q92819 8 121612116-121641440 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.9;urinary bladder: 20.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 54.1;Fibroblasts: 62.1;Langerhans cells: 28.9;Melanocytes: 30.2;Smooth muscle cells: 30.7;Urothelial cells: 89.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HBF TERT88: 157.8;hTEC/SVTERT24-B: 153.8;LHCN-M2: 206.5;U-138 MG: 396.9;U-251 MG: 123.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052060 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052060: AB_2681712" "unprognostic (7.01e-2)" "unprognostic (1.34e-2)" "unprognostic (4.07e-2)" "unprognostic (4.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.91e-2)" "unprognostic (5.33e-2)" "unprognostic (2.57e-3)" "unprognostic (3.44e-2)" "unprognostic (1.34e-1)" "unprognostic (8.19e-3)" "unprognostic (1.24e-1)" "unprognostic (1.66e-7)" "unprognostic (1.47e-3)" "unprognostic (3.67e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-3)" 22.9 0.3 0.8 9.1 0.5 0.1 5.3 0.7 0.5 0.7 0.1 4.1 2.8 0.8 1.2 1.6 1.7 7.8 3.0 0.4 2.0 0.8 2.9 3.7 1.6 1.6 1.4 0.4 0.2 0.9 0.2 0.3 2.3 1.2 1.2 5.7 0.0 1.0 0.2 0.5 2.3 5.2 4.0 1.1 0.1 2.1 1.8 1.1 0.8 0.7 0.9 0.9 20.7 0.6 1.2 0.3 2.8 0.0 0.4 4.7 11.8 0.0 23.5 17.3 29.9 51.2 0.2 0.4 0.1 0.0 20.8 0.0 4.2 0.0 0.0 157.8 0.1 0.6 0.0 0.6 0.0 19.9 0.0 0.0 31.0 0.0 153.8 14.1 0.7 0.0 0.0 0.0 0.0 206.5 0.3 0.0 0.0 0.4 0.0 3.4 0.0 26.6 0.0 0.0 2.0 0.0 0.4 10.0 0.0 5.6 9.0 0.2 0.3 0.0 396.9 1.4 37.7 123.7 0.0 0.0 0.0 8.5 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.7 0.5 0.4 2.0 1.6 1.4 0.4 1.2 1.1 1.1 1.2 2.2 0.0 0.0 0.0 0.0 16.3 54.1 1.8 0.6 0.0 0.1 0.4 1.2 0.0 0.2 3.7 0.0 0.2 0.2 1.6 0.0 0.9 19.0 0.1 3.5 7.2 1.2 0.0 0.1 0.0 0.0 62.1 1.1 0.1 13.4 0.0 0.7 0.0 0.3 0.0 0.2 2.3 0.0 0.0 28.9 3.4 1.8 0.7 30.2 0.0 0.0 0.0 0.0 16.1 0.2 1.6 1.9 0.0 0.0 11.0 0.0 0.1 0.0 0.0 0.0 6.9 30.7 0.3 0.1 0.6 11.9 0.1 1.5 0.0 3.9 89.3 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907189-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 107.6;ovary: 78.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4" "Cancer enhanced" "Detected in all" "renal cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1" "Group enriched" "Detected in many" 29 "granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4" "Group enriched" "Detected in many" 6 "ASC diff: 139.8;HHSteC: 42.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 39.4" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 95000 "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 20.4 107.6 0.6 3.5 0.8 0.9 21.9 0.7 2.5 25.4 7.6 8.9 4.2 11.9 7.1 1.9 9.4 34.3 23.4 0.7 1.7 7.7 2.3 3.2 7.5 4.8 4.2 0.7 78.7 25.9 17.2 13.5 7.1 8.6 10.1 9.9 1.5 8.7 37.8 2.2 6.5 4.9 9.8 2.7 2.8 23.6 3.3 2.2 3.7 18.4 8.9 5.4 16.0 15.5 3.1 0.0 7.8 4.0 0.0 139.8 4.2 0.1 0.9 0.8 0.7 0.8 0.0 1.3 7.4 1.4 7.3 5.2 0.4 0.0 0.2 0.3 0.0 3.2 0.2 1.6 0.3 42.6 0.0 0.1 14.7 0.0 0.1 0.0 0.2 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 1.4 0.0 2.1 0.0 6.7 0.0 0.1 9.6 0.0 13.8 3.2 1.8 0.0 2.0 1.0 0.1 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.6 0.0 9.5 16.4 0.0 1.4 0.4 1.7 7.2 0.0 0.0 0.2 6.0 0.2 17.1 0.1 0.0 0.1 4.2 0.6 0.8 0.7 2.5 0.7 1.7 4.8 4.2 0.7 8.6 2.7 2.2 3.1 15.6 0.0 0.0 1.0 1.6 3.1 7.7 0.2 1.8 2.3 1.7 9.4 4.5 32.9 0.6 5.5 0.0 0.2 30.0 0.2 0.0 30.6 8.2 0.8 1.8 10.3 1.8 1.3 13.9 4.4 0.2 44.3 0.0 1.4 0.0 8.1 2.9 0.0 0.3 26.9 95.0 1.0 0.0 1.3 3.7 13.3 0.3 0.8 0.0 28.1 0.9 1.5 46.4 2.0 2.8 3.0 0.5 2.2 8.4 1.6 0.0 0.3 0.0 0.5 6.6 1.9 3.7 0.4 4.3 0.3 2.0 0.0 10.2 5.2 0.6 3.2 PLAC1 "CT92, OOSP2B, OOSP2L" ENSG00000170965 "Placenta enriched 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "placenta: 28.1" "Cell type enhanced" "Detected in some" "Fibroblasts: 24.5;Leydig cells: 5.6;Peritubular cells: 7.9;Spermatocytes: 6.5;Spermatogonia: 11.0;Syncytiotrophoblasts: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 20.1;hTCEpi: 15.6;hTERT-HME1: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000163, HPA063425" Enhanced Approved Vesicles,Cytosol "Secreted in female reproductive system" NA NA Vesicles Cytosol "HPA000163: , HPA063425: AB_2685012" "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.9 0.0 1.2 0.0 0.2 1.2 0.3 0.4 1.1 0.0 2.0 0.3 0.1 1.8 0.3 0.5 20.1 0.0 0.1 0.3 2.3 0.0 0.0 0.9 15.6 0.1 6.3 0.1 2.4 0.2 0.1 1.7 0.1 1.0 0.0 0.3 0.0 1.3 2.6 0.0 0.3 3.7 0.0 0.0 3.0 0.0 0.0 3.7 0.7 2.2 0.1 0.0 0.0 0.5 0.8 0.2 0.0 0.4 0.1 0.3 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.3 0.0 2.8 24.5 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.9 0.0 0.0 0.0 0.0 0.7 5.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 11.0 0.0 0.0 10.7 0.0 2.1 0.0 0.0 DDI1 FLJ36017 ENSG00000170967 "DNA damage inducible 1 homolog 1" Q8WTU0 11 104036640-104039196 "Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 25.7" "Group enriched" "Detected in some" 74 "Early spermatids: 409.1;Late spermatids: 921.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA079511 Enhanced NA NA "HPA079511: " "unprognostic (2.98e-1)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 409.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 921.4 7.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S1PR1 "CD363, D1S3362, edg-1, EDG1" ENSG00000170989 "Sphingosine-1-phosphate receptor 1" P21453 1 101236865-101243713 "Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 1248.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010104, HPA075568" Supported Supported Vesicles No NA Vesicles "CAB010104: AB_2238920, HPA075568: AB_2686758" "unprognostic (1.41e-1)" "unprognostic (9.35e-2)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (9.78e-2)" "unprognostic (4.49e-3)" "unprognostic (1.34e-3)" "unprognostic (1.99e-1)" "unprognostic (1.36e-1)" "unprognostic (9.12e-2)" "unprognostic (2.34e-2)" "unprognostic (2.23e-1)" "unprognostic (5.82e-3)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.78e-4)" 107.4 14.5 57.1 30.1 55.7 18.7 92.7 59.4 59.6 18.7 29.0 19.3 9.5 24.9 3.9 27.0 23.1 28.2 61.6 50.8 62.0 14.5 31.6 79.0 46.7 66.5 66.3 42.4 8.2 20.5 23.5 8.8 48.5 60.6 13.8 10.2 14.7 15.1 7.9 28.1 15.7 22.5 31.5 51.8 63.6 17.3 2.6 64.7 21.6 36.2 52.0 27.1 34.7 19.3 56.4 15.6 0.2 14.2 0.0 1.4 32.7 0.1 73.0 13.5 47.9 16.6 0.1 0.7 0.0 17.8 25.2 0.4 0.0 1.8 0.8 27.0 6.1 1.2 6.8 0.3 0.0 6.6 0.0 3.5 45.0 0.3 0.1 3.7 1.7 198.9 5.8 0.2 14.4 13.5 0.0 20.6 0.0 3.9 0.4 4.8 0.0 13.4 0.5 0.1 0.0 0.0 0.1 0.7 0.0 0.2 0.9 0.0 0.2 113.3 6.8 2.9 2.0 147.1 1.3 0.0 1.0 0.7 0.0 0.4 1248.4 2.2 55.4 589.4 2.1 441.5 294.7 502.6 492.1 2.6 346.9 383.3 396.3 15.4 397.5 3.4 3.1 329.4 438.7 57.1 55.7 59.4 59.6 50.8 62.0 66.5 66.3 42.4 60.6 51.8 64.7 56.4 236.1 0.0 8.9 37.9 36.0 7.6 0.2 0.0 2.2 0.4 1.1 1.1 23.8 2.8 1.3 0.0 0.0 5.9 25.0 0.0 0.0 0.0 0.0 1.1 1.0 122.3 0.0 0.4 0.1 0.0 0.3 11.7 0.5 1.8 7.6 9.7 114.2 8.9 9.9 0.0 0.3 0.0 0.0 6.5 5.7 0.0 0.9 3.0 5.4 13.1 9.9 31.1 40.2 0.5 0.2 0.0 0.0 0.0 18.2 0.5 0.0 0.1 0.0 1.4 0.0 3.6 4.8 0.7 0.7 0.6 5.1 2.6 29.9 1.8 0.1 0.4 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;kidney: 14.0;ovary: 14.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034625 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA034625: AB_10612119" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.2 2.5 13.0 0.7 10.1 0.0 2.1 1.5 7.5 0.9 0.0 0.6 0.1 3.5 2.4 4.0 1.8 0.3 0.2 10.1 17.8 14.0 0.0 0.7 0.1 6.7 8.8 3.8 14.3 5.4 0.3 1.1 8.4 5.7 2.8 0.8 1.5 0.9 0.9 6.3 0.1 0.1 1.5 3.5 0.0 0.9 2.9 15.5 0.6 0.4 0.9 0.5 2.5 0.7 8.3 10.7 0.1 14.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.0 0.0 0.0 15.2 0.0 0.0 0.5 21.7 0.1 0.0 0.0 46.2 0.1 28.1 0.0 0.0 0.0 0.0 0.7 20.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 7.8 0.3 0.1 11.8 7.2 0.6 0.0 66.1 0.0 13.3 33.7 1.8 82.0 14.8 0.0 0.1 23.7 0.0 0.1 0.0 0.0 2.6 9.6 23.8 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.0 10.1 1.5 7.5 10.1 17.8 6.7 8.8 3.8 5.7 3.5 15.5 8.3 0.0 0.0 0.0 1.6 0.0 0.3 0.2 1.8 6.8 0.2 4.3 2.4 0.8 0.0 5.5 3.7 0.0 35.7 0.2 0.3 5.9 0.0 0.5 0.3 0.6 0.5 0.0 0.0 37.5 2.0 2.6 2.6 0.0 0.1 0.0 0.1 0.0 0.0 3.4 0.0 44.2 0.2 2.0 0.0 0.0 1.1 62.7 0.2 0.0 10.3 0.0 5.3 0.0 54.3 1.4 0.8 0.2 35.3 0.0 1.3 0.0 0.1 9.8 0.4 0.0 17.9 0.3 0.3 1.1 11.1 0.3 17.4 0.1 0.3 0.2 1.8 OR4D5 ENSG00000171014 "Olfactory receptor family 4 subfamily D member 5" Q8NGN0 11 123939543-123940637 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045005 Uncertain NA NA "HPA045005: AB_10959302" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538884-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-698: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 1.8 2.3 3.4 0.9 2.9 0.2 1.7 7.5 2.4 3.7 2.6 2.4 0.4 5.7 2.0 1.8 2.5 2.3 1.2 2.6 5.1 0.9 0.1 2.0 0.5 3.8 3.9 1.7 6.2 1.4 13.3 3.1 2.0 4.0 4.6 1.1 4.5 0.9 4.8 11.8 0.7 0.9 4.7 3.1 0.3 1.5 3.2 3.9 0.4 6.9 9.1 0.4 2.2 1.7 3.0 3.7 6.3 12.2 6.2 4.4 10.0 4.6 7.8 8.9 6.2 7.1 4.5 0.0 0.0 2.4 5.3 8.9 0.0 12.4 0.1 8.3 0.0 3.9 1.8 1.8 0.4 5.9 6.6 0.0 5.5 6.2 5.5 0.9 6.9 3.2 1.0 0.1 0.0 10.3 0.1 0.3 0.0 3.3 0.9 3.4 0.0 14.8 0.0 2.1 2.7 6.5 7.3 7.6 0.0 5.6 1.7 2.3 2.1 0.0 15.8 6.9 0.3 9.5 0.2 0.2 33.6 4.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.9 7.5 2.4 2.6 5.1 3.8 3.9 1.7 4.0 3.1 3.9 3.0 0.6 9.6 6.3 23.5 0.0 1.7 5.9 0.1 4.6 5.6 2.4 3.6 6.1 0.0 1.9 9.2 0.0 1.5 0.1 0.0 0.0 0.5 2.9 1.6 18.2 1.1 0.0 0.0 1.8 0.0 0.2 9.3 0.0 1.9 0.0 7.1 1.1 0.0 0.5 0.0 30.4 0.0 0.0 0.6 1.4 2.6 9.9 0.3 7.2 4.7 0.0 7.0 0.0 59.8 1.9 0.5 0.0 12.0 0.0 5.7 0.0 0.2 1.8 4.5 0.0 12.7 6.1 11.6 2.8 1.4 0.9 0.3 0.6 2.0 0.0 0.7 LRRC8E FLJ23420 ENSG00000171017 "Leucine rich repeat containing 8 VRAC subunit E" Q6NSJ5 19 7888505-7902021 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 9.6;Glandular and luminal cells: 13.0;Squamous epithelial cells: 11.6;Suprabasal keratinocytes: 11.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020466 Uncertain NA NA "HPA020466: AB_1853352" "unprognostic (3.79e-2)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-3)" "unprognostic (8.28e-3)" "unprognostic (7.64e-2)" "unprognostic (1.71e-2)" "unprognostic (3.36e-1)" "unprognostic (8.38e-2)" "unprognostic (3.98e-6)" "unprognostic (1.11e-1)" "unprognostic (2.30e-2)" "unprognostic (3.29e-2)" "unprognostic (3.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-1)" 0.5 4.9 0.5 0.8 0.6 1.9 4.7 0.9 0.7 2.3 0.7 1.0 0.9 1.4 6.3 6.4 2.1 2.3 0.9 0.6 0.2 1.4 4.1 4.4 0.7 0.5 0.4 0.6 0.3 7.3 3.3 0.5 1.3 0.7 3.5 1.1 0.4 7.8 2.1 0.5 10.2 0.5 0.4 0.0 0.3 3.6 0.7 0.4 0.1 2.0 0.4 2.8 2.9 4.7 1.6 23.5 6.0 0.2 0.6 1.1 5.6 3.5 10.1 8.7 15.8 12.3 7.7 5.3 0.6 7.5 9.8 22.5 18.3 7.7 9.8 14.9 0.4 8.5 0.3 3.1 8.2 4.1 0.3 0.5 9.1 13.9 10.5 7.8 21.2 2.0 4.1 6.5 0.8 1.9 11.9 0.1 0.5 1.7 4.3 21.9 1.4 0.2 0.6 12.0 21.3 0.5 0.4 7.6 9.6 0.3 1.7 12.8 0.5 2.6 4.8 8.7 13.2 5.8 1.5 2.9 0.3 36.4 0.8 1.7 1.7 0.4 0.5 0.5 0.3 0.6 0.6 0.4 0.4 0.1 0.8 0.5 0.6 1.5 1.1 0.4 0.5 0.4 0.2 0.5 0.6 0.9 0.7 0.6 0.2 0.5 0.4 0.6 0.7 0.0 0.4 1.6 0.1 3.2 5.5 0.0 0.1 9.6 5.0 1.5 6.2 0.0 8.2 5.7 0.2 1.5 5.4 1.8 0.0 0.7 0.0 1.1 0.0 6.2 0.0 7.7 2.4 0.5 0.0 0.0 0.1 6.0 1.0 1.0 3.6 13.0 1.3 0.4 0.0 3.2 0.1 0.0 0.1 1.2 4.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.0 5.0 0.1 0.5 6.5 0.0 0.0 0.8 0.9 0.0 0.3 11.6 11.2 1.9 0.5 0.1 1.3 5.9 PKIA PRKACN1 ENSG00000171033 "CAMP-dependent protein kinase inhibitor alpha" P61925 8 78516340-78605267 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 1171.4;tongue: 962.2" "Cell type enhanced" "Detected in many" "Astrocytes: 104.8;Cardiomyocytes: 367.0;Excitatory neurons: 103.3;Inhibitory neurons: 78.2;Muller glia cells: 82.8;Oligodendrocyte precursor cells: 82.9" "Cancer enhanced" "Detected in many" "glioma: 15.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 21.4" "Lineage enriched" "Detected in many" 9 "T-cells: 21.4" "Cell line enhanced" "Detected in many" "HDLM-2: 63.9;HUVEC TERT2: 104.0;RT4: 100.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042791 Uncertain NA NA "HPA042791: AB_10795761" "unprognostic (3.83e-3)" "unprognostic (1.89e-1)" "unprognostic (1.55e-2)" "unprognostic (5.59e-6)" "unprognostic (8.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.10e-3)" "unprognostic (1.65e-3)" "unprognostic (3.25e-2)" "unprognostic (2.58e-1)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (5.41e-4)" "unprognostic (3.14e-1)" "unprognostic (1.38e-1)" "unprognostic (7.52e-3)" 2.5 9.6 38.1 5.7 49.2 2.7 4.2 42.0 49.7 1.8 12.3 2.7 1.3 3.1 3.0 21.7 5.3 8.3 187.7 46.0 46.4 4.8 0.2 8.7 7.6 26.7 33.4 40.4 5.9 1.4 109.0 8.1 1.6 30.1 20.5 2.8 34.0 6.2 5.4 1171.4 9.3 2.5 2.6 30.3 4.1 1.7 1.4 40.8 26.5 34.5 962.2 11.1 9.5 3.6 38.2 0.6 0.3 34.2 0.0 18.5 4.8 0.2 32.1 6.3 3.4 7.2 0.0 5.3 14.8 0.2 4.8 3.3 0.5 11.3 10.3 22.3 63.9 24.6 18.5 3.7 0.2 1.2 0.0 10.3 7.7 1.5 0.0 9.6 45.5 104.0 19.8 0.0 15.8 51.4 5.4 28.3 0.0 8.1 0.0 35.3 0.0 29.3 0.0 18.7 100.2 16.6 32.5 4.1 26.4 0.0 8.9 0.0 0.1 41.2 7.8 6.4 1.8 19.2 6.5 6.9 4.9 36.9 0.1 9.8 0.0 0.0 0.0 0.5 0.1 0.4 2.3 9.1 1.8 0.1 2.2 7.7 4.6 0.4 1.7 0.1 0.2 21.4 2.5 38.1 49.2 42.0 49.7 46.0 46.4 26.7 33.4 40.4 30.1 30.3 40.8 38.2 0.6 3.2 2.8 104.8 9.8 5.9 8.8 4.5 19.9 40.2 2.6 6.5 367.0 0.0 2.0 1.8 2.1 3.1 2.7 0.4 1.9 0.0 13.9 0.9 0.2 9.1 10.2 4.2 103.3 0.2 2.8 12.3 0.0 1.3 5.7 18.6 2.5 0.0 0.7 58.9 78.2 0.8 6.1 0.0 1.1 5.9 0.0 3.9 3.6 15.0 0.5 82.8 0.0 82.9 17.9 1.5 0.1 0.4 2.3 6.1 0.0 0.1 1.0 6.9 0.0 22.9 4.8 0.4 0.6 13.9 13.8 3.4 8.0 0.1 0.3 3.6 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201833 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 12.7" "Cell type enhanced" "Detected in many" "Astrocytes: 90.1;Excitatory neurons: 419.0;Inhibitory neurons: 339.6;Microglial cells: 106.8;Oligodendrocyte precursor cells: 290.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 4.2;U-266/84: 7.1;U-698: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Approved "Actin filaments" NA NA "Actin filaments" "HPA024828: AB_2215165, HPA064769: AB_2732720" "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 0.2 0.6 2.2 0.3 3.4 0.7 0.3 12.7 3.7 0.4 0.0 0.4 0.3 0.5 0.1 1.0 0.5 0.2 0.3 3.1 3.7 0.4 0.1 0.6 0.8 2.1 2.2 2.0 0.1 1.3 0.3 0.5 0.1 4.7 0.6 0.3 0.4 1.0 0.3 0.1 0.8 0.8 0.2 0.2 0.8 0.7 2.2 3.9 0.2 0.6 0.0 0.5 0.5 0.6 2.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.4 0.4 1.1 0.0 0.3 3.4 0.0 0.6 1.8 0.1 1.6 1.9 0.6 0.1 0.5 1.0 0.1 0.0 0.5 0.0 2.6 0.3 1.1 0.0 1.4 1.3 0.6 0.0 0.1 4.2 0.5 0.4 0.0 0.0 2.0 0.2 0.8 0.0 0.0 0.9 1.4 1.4 1.9 1.2 0.6 0.1 0.0 1.6 0.0 0.7 0.0 1.6 0.8 0.0 0.5 1.1 7.1 3.6 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 3.4 12.7 3.7 3.1 3.7 2.1 2.2 2.0 4.7 0.2 3.9 2.5 1.7 6.4 0.5 90.1 9.7 1.8 4.0 1.2 6.2 37.7 4.2 3.0 2.2 5.7 1.6 3.7 14.6 0.0 3.9 1.0 1.9 2.1 10.2 4.6 2.8 2.1 4.2 2.1 419.0 5.3 0.0 1.2 4.6 3.8 0.0 4.3 3.6 0.1 0.5 26.9 339.6 0.7 2.0 1.3 1.5 2.5 0.0 1.4 1.8 106.8 0.5 9.0 3.1 290.0 39.6 3.5 1.4 0.0 10.1 3.0 1.7 0.8 1.8 6.1 0.0 5.6 3.3 6.6 6.1 4.4 1.3 0.0 3.6 3.7 1.3 3.9 TSNARE1 FLJ31164 ENSG00000171045 "T-SNARE domain containing 1" Q96NA8 8 142212080-142403182 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 26.7;Inhibitory neurons: 23.0;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 24.5" "Low region specificity" "Detected in all" HPA074249 Approved Approved Cytosol NA NA Cytosol "HPA074249: " "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.94e-3)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (1.09e-2)" "unprognostic (1.48e-2)" "unprognostic (3.72e-3)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.87e-3)" "unprognostic (1.66e-1)" "unprognostic (6.26e-2)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.33e-4)" 9.4 9.6 10.6 6.7 9.9 4.3 12.1 4.7 16.7 15.7 4.4 10.8 11.7 13.9 3.0 10.5 15.1 6.0 9.1 9.6 6.7 11.3 10.1 10.0 6.8 11.7 8.0 9.3 20.6 28.7 7.1 13.0 3.3 9.8 13.8 2.8 4.0 13.5 6.4 11.1 26.9 13.1 3.8 5.7 12.7 13.4 13.5 8.3 6.2 16.4 4.7 4.4 11.9 12.2 12.2 6.6 6.4 4.2 5.3 3.2 2.9 13.2 1.9 3.1 1.9 1.9 2.1 7.0 3.5 10.7 1.5 3.2 5.9 1.9 6.6 0.8 4.0 6.4 4.2 1.7 7.2 8.5 9.5 9.6 5.6 6.2 0.0 4.3 3.9 2.1 18.4 8.4 0.3 1.3 8.7 8.1 8.8 4.2 6.4 15.8 0.0 2.2 6.2 3.6 8.0 17.5 10.6 8.9 7.1 12.8 2.0 4.7 8.2 5.1 3.1 8.5 5.6 4.3 0.5 2.8 5.6 5.7 24.5 3.2 1.6 0.5 0.1 0.9 2.3 0.6 0.3 0.5 0.2 0.6 0.4 0.2 0.3 0.0 0.5 2.0 0.0 0.6 0.6 10.6 9.9 4.7 16.7 9.6 6.7 11.7 8.0 9.3 9.8 5.7 8.3 12.2 1.9 0.0 1.1 12.1 2.3 4.5 2.2 0.8 6.8 2.6 1.8 1.8 4.6 2.8 0.5 1.8 2.1 0.3 1.6 1.6 3.9 1.6 2.4 1.9 1.0 1.5 1.8 2.5 26.7 1.8 1.8 1.5 4.1 1.4 0.0 1.2 1.1 1.3 1.9 0.0 23.0 2.1 0.0 2.6 2.9 5.3 0.9 1.7 3.6 12.2 1.5 3.1 2.1 21.1 24.6 1.6 0.2 1.5 1.6 1.3 1.6 1.4 2.3 1.3 0.0 2.3 1.7 5.0 3.7 3.5 7.5 0.3 3.1 0.7 0.9 1.5 FPR2 "ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R" ENSG00000171049 "Formyl peptide receptor 2" P25090 19 51752026-51770531 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.5" "Cell type enhanced" "Detected in some" "Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 10 "neutrophil: 1187.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 1187.9" "Cell line enriched" "Detected in some" 20 "U-937: 32.7" "Not detected" "Not detected" HPA029154 Approved NA NA "HPA029154: AB_10602133" "unprognostic (3.11e-1)" "unprognostic (5.20e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (3.90e-4)" "unprognostic (3.41e-5)" "unprognostic (1.08e-2)" "unprognostic (4.69e-2)" "unprognostic (5.10e-2)" "unprognostic (1.90e-1)" 13.7 1.2 0.3 56.5 0.4 16.7 0.6 0.3 2.3 0.5 1.3 0.8 1.0 0.5 0.1 1.8 1.8 6.0 0.8 0.3 1.4 0.4 5.0 9.5 1.9 0.7 0.5 0.1 1.5 2.3 0.3 0.2 7.7 0.9 0.4 0.5 0.1 0.6 0.3 0.3 0.4 1.3 6.7 0.2 17.3 0.7 2.4 1.0 1.6 0.7 4.3 0.8 15.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.9 32.7 0.0 3.6 122.0 5.8 0.2 122.7 0.7 0.1 0.2 0.2 16.6 0.2 0.1 0.2 1187.9 0.2 85.0 3.3 0.1 46.0 0.3 0.4 0.3 2.3 0.3 1.4 0.7 0.5 0.1 0.9 0.2 1.0 0.7 0.0 0.0 5.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 9.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 5.1 0.0 0.4 0.4 12.7 0.0 0.0 0.0 0.0 18.8 0.8 26.8 0.0 61.3 0.0 0.0 23.3 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 197.2;lymphoid tissue: 167.4" "Group enriched" "Detected in many" 5 "Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 4199.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 4199.5" "Group enriched" "Detected in some" 5 "LHCN-M2: 17.2;U-87 MG: 67.1" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 70.2 10.1 4.0 167.4 6.3 197.2 5.4 4.7 8.1 8.2 8.5 4.7 3.1 3.7 0.5 9.0 15.6 28.9 6.5 3.8 22.5 4.5 21.6 51.2 12.8 16.0 6.7 4.2 2.4 11.3 5.1 3.5 45.5 10.9 3.1 3.3 2.6 4.1 2.3 1.8 1.2 5.2 43.3 8.1 130.2 5.4 2.2 9.1 8.5 3.1 23.0 10.4 67.5 2.7 20.0 0.5 0.8 0.3 0.4 1.0 2.1 0.5 0.2 0.0 0.5 2.0 0.3 0.7 1.2 0.6 0.0 3.9 0.4 0.0 0.0 0.1 0.1 0.0 0.7 0.9 1.0 6.0 0.3 0.5 4.8 0.2 1.8 1.8 9.2 0.0 0.3 0.1 0.6 17.2 0.9 0.1 0.3 0.4 0.3 0.7 0.3 0.7 0.0 1.5 0.5 0.2 0.3 0.6 0.1 0.5 0.2 1.0 1.1 1.0 2.0 0.4 0.1 3.5 0.2 0.0 0.5 67.1 1.7 0.1 317.1 759.9 204.9 1.6 319.7 1.5 0.7 1.0 0.7 174.1 1.0 1.0 1.2 4199.5 0.4 201.8 8.1 1.3 420.3 4.0 6.3 4.7 8.1 3.8 22.5 16.0 6.7 4.2 10.9 8.1 9.1 20.0 0.1 16.0 25.7 0.0 1.8 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.2 0.0 15.5 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.8 0.0 0.1 6.3 0.0 2.5 0.2 0.0 1.6 4.7 0.5 0.1 26.5 0.0 2.5 2.1 119.6 0.0 0.1 0.0 0.0 215.3 4.7 2.0 0.3 178.5 0.0 3.7 89.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.4 8.8 0.3 6.6 0.6 0.8 0.6 0.8 0.2 0.0 3.0 2.5 0.0 0.0 0.1 PATE1 PATE ENSG00000171053 "Prostate and testis expressed 1" Q8WXA2 11 125746279-125749867 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "epididymis: 1884.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA076587 Approved "Secreted in male reproductive system" NA NA "HPA076587: AB_2732316" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1884.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 211.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13H1 ENSG00000171054 "Olfactory receptor family 13 subfamily H member 1" Q8NG92 X 131543976-131545056 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FEZ2 ENSG00000171055 "Fasciculation and elongation protein zeta 2" Q9UHY8 2 36531805-36646087 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035978 Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Golgi apparatus, Cytosol" "HPA035978: AB_10672235" "unprognostic (1.42e-1)" "unprognostic (5.02e-3)" "unprognostic (2.89e-1)" "unprognostic (1.15e-2)" "unprognostic (2.91e-2)" "unprognostic (1.94e-3)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.09e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.65e-2)" "unprognostic (7.82e-3)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" 53.5 39.5 54.1 21.2 56.4 16.6 36.2 53.9 69.2 26.8 49.2 32.6 22.3 33.4 19.1 32.0 24.0 23.8 47.1 54.3 57.8 33.9 29.7 27.3 24.5 55.9 54.3 52.5 27.9 10.9 20.5 14.3 47.2 55.6 23.7 28.2 26.7 17.2 32.9 109.0 16.4 28.8 41.4 54.3 30.5 22.0 21.0 54.7 18.4 24.1 79.2 19.7 29.4 24.5 62.2 64.9 37.1 49.4 22.3 91.3 122.1 39.5 157.1 76.5 90.7 56.0 24.6 21.5 39.1 94.7 199.2 41.0 25.1 42.4 54.3 98.5 9.3 24.7 31.7 12.2 43.5 44.4 32.9 8.5 119.9 44.2 57.8 69.6 61.2 131.0 9.5 35.4 12.0 170.2 22.7 19.6 27.5 27.1 33.9 57.8 16.9 44.3 14.0 72.9 57.6 1.9 45.7 38.7 31.9 37.8 51.7 11.3 39.1 161.2 59.7 32.9 33.4 92.9 9.8 11.5 26.6 58.9 22.4 84.8 2.5 3.5 5.1 1.7 3.4 1.0 1.6 1.3 1.0 3.5 1.0 1.5 0.7 4.2 3.2 2.3 15.6 1.4 0.8 54.1 56.4 53.9 69.2 54.3 57.8 55.9 54.3 52.5 55.6 54.3 54.7 62.2 109.4 54.5 37.5 25.8 23.7 31.4 94.7 45.5 41.5 52.5 31.7 33.1 43.1 17.2 70.2 58.8 45.9 96.4 61.1 57.6 56.7 80.3 5.6 38.4 44.7 100.9 24.0 15.3 45.4 30.6 87.6 50.7 27.0 64.3 24.1 66.0 97.5 37.2 93.7 21.9 22.9 28.8 38.7 88.1 65.4 10.7 54.3 64.6 56.9 45.0 56.0 97.1 35.0 23.1 50.5 74.4 41.4 66.2 17.9 99.1 65.6 45.1 35.9 36.3 59.2 64.0 51.2 12.1 34.9 24.0 32.1 180.1 24.2 47.2 37.7 140.6 SOX7 ENSG00000171056 "SRY-box transcription factor 7" Q9BT81 8 10723768-10730511 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 42.7" "Cell type enhanced" "Detected in many" "Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 18.4 3.8 2.5 1.0 2.1 0.1 12.0 1.8 2.7 14.9 1.6 4.0 0.1 4.3 1.1 27.0 4.5 3.6 14.5 1.9 1.7 5.1 4.3 23.4 1.8 2.4 2.0 1.6 1.5 2.6 1.0 5.7 17.4 2.3 5.5 1.1 0.4 10.6 2.8 9.9 16.9 3.6 2.4 2.2 2.4 3.7 0.7 2.7 1.5 7.7 6.5 1.9 4.6 42.7 2.7 5.8 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.3 0.6 11.8 3.4 4.2 0.1 0.1 0.4 0.1 0.3 0.1 0.0 0.2 0.2 0.1 21.3 0.0 4.3 0.0 25.2 0.0 0.6 0.3 0.0 0.2 0.2 0.2 1.6 0.9 3.2 1.2 0.0 0.0 0.0 2.1 0.6 3.4 2.2 0.0 0.0 1.4 0.0 0.1 6.8 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.1 1.8 2.7 1.9 1.7 2.4 2.0 1.6 2.3 2.2 2.7 2.7 115.4 0.0 11.5 0.3 1.1 61.2 67.6 24.5 148.5 1.2 5.2 4.7 4.8 1.5 6.3 0.0 4.2 4.3 0.1 0.2 0.0 0.2 0.2 14.9 1.9 115.1 0.0 0.0 4.6 0.2 0.8 4.7 0.0 22.9 3.8 0.5 48.5 4.9 0.7 0.0 2.9 0.2 10.2 1.9 8.7 0.1 0.9 0.9 3.6 10.3 0.3 0.5 0.0 1.5 0.8 0.5 0.0 0.4 1.2 17.8 0.1 0.6 3.2 2.2 0.0 8.5 4.4 2.4 1.6 98.9 40.6 12.4 1.8 1.2 0.4 26.6 C8orf74 ENSG00000171060 "Chromosome 8 open reading frame 74" Q6P047 8 10672628-10700590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 172 "testis: 17.2" "Group enriched" "Detected in some" 90 "Early spermatids: 186.5;Late spermatids: 392.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027986 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA027986: AB_10600762" "unprognostic (4.24e-2)" "unprognostic (5.62e-2)" "unprognostic (4.68e-2)" "unprognostic (5.54e-2)" "unprognostic (2.37e-2)" "unprognostic (1.56e-4)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 186.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 392.8 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261338-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 107.7;Proximal enterocytes: 162.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 222.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 24.4 17.7 8.7 20.8 11.1 4.7 21.2 11.0 12.8 22.7 7.7 26.6 54.3 39.6 7.3 15.6 22.4 17.7 31.6 9.0 10.0 17.1 88.1 24.4 15.6 13.3 11.3 7.3 19.5 27.5 7.4 14.6 16.3 12.3 23.1 17.5 3.0 34.3 17.7 13.9 15.1 59.9 32.9 10.9 21.0 23.8 14.7 11.1 6.4 17.1 15.3 16.8 22.5 19.5 14.8 44.8 45.5 26.4 51.6 62.1 62.5 29.7 105.4 67.5 51.8 53.1 96.2 26.9 20.1 31.7 131.3 47.2 49.4 39.1 47.4 33.2 22.1 23.1 21.4 44.8 65.3 50.1 18.3 68.7 52.1 34.6 78.8 32.0 31.0 21.2 10.6 37.9 32.2 44.6 55.7 4.5 26.4 44.2 72.1 53.8 8.2 44.8 104.1 23.9 21.1 17.3 31.8 33.3 27.1 222.8 21.8 25.6 15.3 23.3 80.8 50.2 103.3 47.3 39.4 41.4 18.8 65.1 14.1 79.9 16.7 12.1 12.6 14.0 19.0 9.4 26.7 7.9 8.9 19.5 35.7 7.3 7.7 1.8 9.9 14.1 26.7 8.4 12.6 8.7 11.1 11.0 12.8 9.0 10.0 13.3 11.3 7.3 12.3 10.9 11.1 14.8 6.8 9.6 3.6 3.3 25.5 14.0 12.2 11.7 9.6 4.8 8.2 8.9 10.4 11.5 6.9 9.2 2.1 11.9 12.4 36.2 1.9 21.9 3.5 5.3 17.8 6.6 4.8 9.1 4.1 31.5 30.7 21.1 18.3 6.8 45.0 5.0 9.3 107.7 15.8 0.0 4.2 50.0 6.1 12.9 23.5 7.1 14.0 12.3 28.4 5.6 14.9 6.8 18.6 6.6 8.5 26.9 16.6 16.1 67.0 13.0 162.5 10.6 9.4 2.9 13.1 11.2 20.2 20.7 27.1 9.6 11.2 10.5 6.5 9.6 15.5 10.6 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921586 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 10.8" "Group enriched" "Detected in some" 5 "Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 31.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 0.3 0.6 2.2 0.2 2.2 0.0 0.1 0.7 2.8 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.3 10.8 0.0 0.0 0.1 0.0 3.8 5.2 1.6 0.0 0.0 0.0 1.3 0.0 7.2 0.0 0.2 0.7 0.1 0.1 0.0 0.1 0.3 0.1 2.2 0.0 0.1 1.2 2.2 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 4.3 0.0 0.0 0.1 0.4 31.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.2 0.7 2.8 1.3 10.8 3.8 5.2 1.6 7.2 2.2 2.2 2.3 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.5 0.1 0.2 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 274.2 0.0 0.0 0.0 0.0 41.2 0.0 0.5 0.0 7.5 0.0 0.6 0.0 433.8 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KYAT1 "CCBL1, GTK, KATI" ENSG00000171097 "Kynurenine aminotransferase 1" Q16773 9 128832942-128882494 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "Granulosa cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021176, HPA021177, HPA027736" Approved Supported Cytosol NA NA 22000 Cytosol "HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818" "unprognostic (6.51e-2)" "unprognostic (8.67e-3)" "unprognostic (1.05e-2)" "unprognostic (5.98e-3)" "unprognostic (2.15e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-2)" "unprognostic (2.47e-1)" "unprognostic (8.60e-3)" "unprognostic (1.43e-1)" "unprognostic (3.65e-2)" "unprognostic (3.10e-2)" "unprognostic (5.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" 3.2 4.7 13.7 3.6 14.3 2.4 4.1 13.9 15.7 6.6 11.4 4.0 2.6 5.9 3.0 5.3 6.5 2.7 9.6 13.2 13.4 7.8 12.8 3.7 5.0 14.3 13.5 13.3 6.3 3.1 5.5 8.8 2.5 13.9 7.5 1.3 7.5 4.2 4.4 12.8 7.8 4.2 3.1 13.5 5.4 4.9 5.6 14.0 8.9 6.2 8.8 4.8 7.3 6.7 19.0 4.8 9.8 9.3 10.6 6.9 11.4 3.0 5.5 8.0 6.2 8.0 3.9 9.7 8.3 2.9 4.6 7.0 14.9 13.9 11.1 9.3 10.0 7.3 5.7 27.7 9.6 7.7 5.0 1.9 4.5 7.1 7.1 7.7 21.8 11.3 22.7 8.2 9.0 8.5 3.1 14.0 3.4 15.2 18.3 7.6 16.4 6.4 18.9 8.7 1.7 10.5 7.4 9.9 2.9 6.2 12.8 6.6 1.6 7.0 4.6 7.9 7.1 5.0 15.2 11.0 11.6 9.6 8.3 3.2 0.1 1.4 2.9 5.1 1.8 4.5 7.7 5.7 6.0 5.5 3.3 5.9 6.7 0.9 3.3 2.9 2.4 7.0 3.3 13.7 14.3 13.9 15.7 13.2 13.4 14.3 13.5 13.3 13.9 13.5 14.0 19.0 2.6 0.0 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 2.0 1.5 0.0 0.0 0.6 0.0 0.0 5.0 0.9 0.0 3.9 1.6 0.0 2.6 3.3 0.7 0.0 0.0 0.0 0.2 2.4 0.7 0.0 4.2 0.0 45.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 7.3 2.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.3 1.3 0.0 0.0 MTM1 ENSG00000171100 "Myotubularin 1" Q13496 X 150568621-150673143 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 52.2;Oligodendrocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010008, HPA010665" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA010008: AB_1079426, HPA010665: AB_1079425" "unprognostic (3.66e-3)" "unprognostic (8.43e-3)" "unprognostic (3.52e-3)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (6.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.74e-1)" "unprognostic (2.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.59e-2)" "prognostic favorable (7.40e-7)" "unprognostic (4.46e-2)" "unprognostic (1.25e-1)" "unprognostic (4.99e-2)" "unprognostic (2.46e-1)" 6.9 11.2 7.3 9.8 7.9 11.4 7.7 8.1 8.5 5.8 5.9 20.0 11.8 6.6 8.5 7.6 9.6 7.2 7.4 6.8 11.0 13.1 18.5 11.3 12.5 7.5 8.0 5.6 11.8 5.0 16.2 3.8 6.3 7.8 8.1 19.4 5.5 6.3 10.8 11.9 8.2 12.2 7.0 7.1 12.0 7.9 11.6 8.0 8.5 11.3 10.2 9.8 7.2 4.7 8.7 14.3 6.1 8.5 3.1 7.5 7.3 5.4 6.1 8.5 7.0 7.9 4.7 7.3 22.2 11.4 8.3 21.9 9.9 6.1 11.5 8.6 6.4 5.2 5.6 5.4 15.0 5.8 25.2 19.1 4.5 14.3 5.7 11.9 6.9 9.4 9.3 3.9 19.8 8.8 4.5 6.9 25.2 4.3 13.4 7.4 8.0 4.9 4.5 11.7 6.9 2.2 2.4 5.5 11.3 8.5 11.9 4.1 35.2 8.2 5.0 3.1 12.4 7.1 4.2 10.0 20.3 6.0 14.8 8.0 34.8 9.5 27.9 2.0 10.8 6.8 8.0 9.6 7.3 12.0 10.6 9.0 5.4 11.6 14.6 9.8 7.4 12.2 7.1 7.3 7.9 8.1 8.5 6.8 11.0 7.5 8.0 5.6 7.8 7.1 8.0 8.7 9.9 9.6 20.0 52.2 13.9 15.2 8.3 5.8 2.2 0.0 5.8 3.9 15.0 4.3 6.0 3.7 0.0 2.1 8.4 33.0 1.9 3.4 35.6 7.7 5.0 11.5 9.6 7.4 44.0 4.3 2.8 6.6 8.2 4.8 8.8 3.3 16.4 13.2 8.0 0.0 41.5 17.7 2.0 16.3 10.4 18.8 6.2 13.0 5.4 24.4 12.0 0.0 0.0 27.6 47.7 4.7 9.5 12.8 8.0 6.8 11.2 14.7 13.4 0.0 0.0 5.2 6.9 5.1 4.1 4.9 19.0 7.3 12.8 4.8 13.8 9.7 OBP2B "hOBPIIb, LCN14" ENSG00000171102 "Odorant binding protein 2B" Q9NPH6 9 133205277-133209250 "Predicted secreted proteins" "Olfaction, Sensory transduction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.7;testis: 10.1" "Group enriched" "Detected in some" 9 "Breast glandular cells: 17.7;Breast myoepithelial cells: 29.1" "Group enriched" "Detected in many" 8 "breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.40e-1)" "unprognostic (5.70e-2)" "unprognostic (9.45e-3)" "unprognostic (6.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (7.03e-2)" "unprognostic (6.82e-6)" "unprognostic (2.00e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 17.7 29.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.5 1.2 0.1 1.8 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.2 1.2 0.1 0.1 TRMT61B FLJ20628 ENSG00000171103 "TRNA methyltransferase 61B" Q9BVS5 2 28849821-28870309 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026747, HPA026751" Enhanced Uncertain Cytosol NA NA Cytosol "HPA026747: AB_1848782, HPA026751: AB_1848784" "unprognostic (1.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.63e-3)" "unprognostic (2.05e-2)" "unprognostic (3.32e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.36e-2)" "unprognostic (2.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.52e-2)" "unprognostic (2.52e-2)" "prognostic favorable (9.61e-5)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (5.38e-2)" "unprognostic (2.34e-1)" 8.9 13.2 13.1 8.6 13.3 9.3 13.2 15.6 16.1 9.5 15.0 8.5 14.3 10.1 14.2 8.6 8.1 7.2 12.8 13.3 13.5 14.5 12.7 6.6 11.1 13.2 13.5 13.7 9.5 7.1 15.2 9.1 8.9 13.4 10.7 9.4 9.5 8.8 8.0 13.9 8.7 14.2 10.4 13.2 8.8 9.3 7.4 13.2 10.3 9.2 16.7 9.2 10.8 7.6 14.2 28.5 16.7 16.7 29.6 22.3 19.0 20.1 16.5 20.3 20.6 19.2 19.3 15.0 29.9 14.8 14.5 24.7 21.7 23.5 20.1 21.3 22.6 15.8 9.1 13.6 25.7 25.2 19.4 10.0 19.5 22.0 16.4 22.2 15.2 20.0 19.1 18.9 11.2 17.2 11.3 17.3 29.6 31.0 33.6 26.7 12.7 26.9 26.1 18.2 18.2 28.1 29.8 17.8 27.8 28.5 13.9 14.2 6.7 15.8 13.7 23.1 13.6 21.0 13.7 24.2 46.6 18.1 28.9 18.8 0.0 8.0 3.5 11.2 8.5 13.8 14.5 12.4 12.0 7.8 14.1 13.7 9.9 1.1 17.7 7.1 8.3 14.7 7.4 13.1 13.3 15.6 16.1 13.3 13.5 13.2 13.5 13.7 13.4 13.2 13.2 14.2 10.2 16.0 8.7 18.3 17.7 18.1 11.0 23.7 17.1 10.8 9.9 10.2 2.8 11.5 14.7 9.2 6.2 22.1 11.8 4.5 15.6 14.5 9.3 9.4 11.8 8.5 4.8 10.9 38.0 10.2 13.8 10.8 21.4 7.7 9.5 15.8 7.5 11.5 9.2 6.7 34.8 9.8 20.3 7.3 8.2 3.6 8.7 7.0 7.2 7.5 11.0 10.3 8.2 36.2 32.2 10.3 8.5 10.5 13.5 7.6 23.6 30.3 15.0 21.6 6.6 12.2 10.6 24.1 9.7 15.3 15.8 8.8 12.4 15.9 12.1 7.3 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294414 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5" "Cell line enhanced" "Detected in many" "Karpas-707: 54.9;U-266/70: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA Yes 190000 Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 12.5 22.7 13.5 2.8 16.1 5.7 13.1 16.3 13.1 13.8 17.8 14.6 10.1 18.6 6.4 4.2 17.0 8.3 21.9 9.6 13.9 22.0 33.3 7.3 2.3 18.1 16.3 8.7 40.2 64.7 13.1 16.5 7.4 18.0 15.3 10.5 6.6 17.0 10.0 23.7 11.3 12.3 11.6 14.8 48.6 12.7 5.5 16.1 2.7 14.6 13.4 3.5 12.4 9.3 22.1 6.2 3.2 3.6 5.7 18.8 6.1 11.1 3.5 2.9 1.6 1.6 8.4 7.0 9.0 8.2 6.8 4.0 1.6 8.9 1.4 1.2 0.0 6.4 0.0 2.3 22.6 8.2 4.3 6.7 10.0 4.5 0.2 4.9 4.2 3.8 4.8 9.5 54.9 1.8 3.2 3.1 7.8 3.3 3.8 5.2 29.0 2.1 7.6 0.1 27.8 6.6 5.2 6.5 3.8 3.3 6.4 1.4 21.6 3.6 3.4 2.1 8.2 5.1 40.4 23.9 20.2 4.3 7.3 0.0 2.7 8.6 5.9 0.2 8.8 0.3 0.8 0.3 0.1 9.8 1.1 0.7 0.1 1.9 1.0 12.5 8.2 0.0 1.6 13.5 16.1 16.3 13.1 9.6 13.9 18.1 16.3 8.7 18.0 14.8 16.1 22.1 75.6 48.1 34.7 64.9 10.6 64.9 63.6 34.7 8.0 40.4 134.0 76.2 92.1 137.2 83.3 62.5 79.2 17.8 6.7 124.1 15.6 55.1 4.7 26.8 106.8 123.9 163.6 25.0 68.3 78.7 53.7 43.7 20.4 42.1 3.8 168.4 255.2 246.0 9.2 38.7 100.8 97.3 32.6 49.0 31.1 9.0 96.3 35.0 51.6 62.8 24.2 31.6 0.0 62.8 183.5 50.7 68.8 245.3 21.8 107.9 122.9 114.1 65.3 23.6 59.2 37.6 44.2 5.2 3.6 3.2 68.8 38.3 4.7 81.4 65.2 130.0 MFN1 FLJ20693 ENSG00000171109 "Mitofusin 1" Q8IWA4 3 179347709-179394936 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 92.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033437, HPA059230" Approved Supported Mitochondria NA NA Mitochondria "CAB033437: AB_2250540, HPA059230: AB_2683952" "unprognostic (2.94e-2)" "unprognostic (5.56e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (6.70e-4)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (6.37e-2)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "unprognostic (3.76e-3)" "unprognostic (7.91e-2)" "unprognostic (7.90e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (9.79e-2)" 9.6 9.1 6.0 9.5 6.7 8.5 11.1 8.9 8.9 9.1 8.6 12.6 9.0 11.5 15.0 14.2 10.3 9.7 23.6 6.1 5.8 10.5 8.8 8.8 12.9 6.5 6.5 6.1 9.2 18.0 13.4 6.7 7.9 6.9 12.5 10.6 10.4 14.2 9.7 14.1 14.7 9.9 11.5 5.1 10.0 10.8 9.0 6.0 8.7 10.5 16.6 12.1 12.8 9.0 9.8 32.2 9.4 17.9 29.1 25.1 23.2 23.6 19.6 20.2 20.2 23.9 23.5 13.0 10.8 20.0 29.1 40.9 18.5 25.4 19.4 35.3 17.2 19.5 17.8 19.4 13.1 20.5 9.5 16.3 16.2 16.7 21.9 15.4 16.8 26.0 17.9 13.2 14.1 28.6 17.1 14.0 7.1 21.3 32.1 17.3 9.7 28.1 40.4 19.1 33.4 16.8 23.9 18.3 48.5 26.6 18.2 66.6 6.8 22.0 17.6 19.4 27.6 29.0 18.6 21.9 18.0 19.7 15.8 19.5 4.2 2.5 5.8 2.6 3.1 4.5 5.1 3.0 2.7 2.3 6.2 2.7 3.2 5.8 2.9 2.4 2.8 2.9 1.4 6.0 6.7 8.9 8.9 6.1 5.8 6.5 6.5 6.1 6.9 5.1 6.0 9.8 21.3 25.6 36.8 39.8 27.3 16.7 12.3 12.6 20.5 18.8 19.1 14.4 29.3 14.3 23.7 18.4 39.6 11.2 20.9 18.2 9.8 12.6 6.6 36.9 28.5 16.3 10.2 24.0 77.2 17.4 11.0 22.6 26.0 43.4 8.8 22.1 14.6 18.3 7.8 11.8 92.5 18.2 12.2 11.7 11.4 3.3 13.4 14.9 12.4 28.1 12.2 11.2 18.6 56.8 85.1 16.5 11.8 17.7 21.2 20.0 10.4 13.4 31.9 16.5 6.6 26.8 21.2 33.2 13.7 24.9 27.0 13.1 15.1 25.3 16.6 20.7 GIMAP8 "DKFZp667I133, hIAN6, IAN9" ENSG00000171115 "GTPase, IMAP family member 8" Q8ND71 7 150450630-150479393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" "Adipocytes: 67.4;Endothelial cells: 66.0;Hepatic stellate cells: 86.0;Kupffer cells: 75.1;Microglial cells: 32.8;monocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 59.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014474, HPA017765" Supported NA NA "HPA014474: AB_1849685, HPA017765: AB_1849683" "unprognostic (7.86e-2)" "unprognostic (7.87e-3)" "unprognostic (1.04e-1)" "unprognostic (4.42e-3)" "unprognostic (2.11e-1)" "unprognostic (8.09e-3)" "unprognostic (1.07e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (6.26e-3)" "unprognostic (2.15e-1)" "unprognostic (1.04e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (3.85e-1)" "unprognostic (1.31e-1)" 20.5 5.7 4.5 21.5 4.7 0.7 16.2 4.8 5.5 9.9 6.3 6.7 6.9 10.5 3.1 4.3 9.0 7.6 16.3 4.0 4.9 8.4 9.5 27.2 23.4 5.3 4.8 3.2 3.5 2.8 4.7 2.6 15.5 5.4 4.9 7.3 0.3 4.3 5.4 9.9 4.3 10.5 12.8 5.0 40.9 5.0 2.0 6.0 7.4 12.0 15.2 13.6 8.5 5.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 59.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.7 0.0 9.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.5 45.2 0.0 15.3 59.0 17.4 0.5 14.8 13.9 13.0 0.0 16.7 13.6 4.8 15.5 57.4 0.7 7.7 26.8 4.5 4.7 4.8 5.5 4.0 4.9 5.3 4.8 3.2 5.4 5.0 6.0 5.8 67.4 3.2 5.3 0.3 0.8 3.1 0.5 0.0 1.8 0.0 0.4 0.8 5.5 5.7 0.0 1.8 0.0 0.0 5.3 0.0 0.0 0.0 0.3 0.2 0.1 66.0 0.0 1.3 0.1 0.0 0.0 2.3 0.5 0.2 3.8 0.0 86.0 1.6 6.8 0.0 0.1 0.0 0.0 75.1 2.8 0.9 0.3 21.9 0.0 32.8 44.2 0.0 19.6 0.0 0.1 0.0 0.0 0.0 2.2 0.9 0.0 0.2 1.5 0.0 0.0 1.5 1.2 0.2 0.4 0.5 1.7 0.1 11.1 0.2 0.0 0.4 HSFX1 LW-1 ENSG00000171116 "Heat shock transcription factor family, X-linked 1" Q9UBD0 X 149774068-149776867 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "HPA051700, HPA063040" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA051700: AB_2681578, HPA063040: AB_2732695" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (2.30e-2)" "unprognostic (6.32e-2)" "unprognostic (3.38e-2)" "unprognostic (3.78e-1)" "unprognostic (5.03e-2)" "unprognostic (3.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.46e-1)" "unprognostic (3.10e-1)" 0.7 0.8 2.0 0.3 1.7 0.0 1.1 1.8 2.7 1.6 2.5 1.5 0.5 1.3 3.3 1.2 1.5 0.8 1.9 2.7 1.3 0.9 1.0 0.9 0.4 1.8 2.4 1.5 3.1 1.0 0.9 1.2 1.2 2.8 2.0 0.1 0.7 1.3 0.6 1.3 1.2 1.1 0.4 0.9 2.5 1.0 3.4 1.6 0.1 1.5 0.0 0.4 1.4 1.5 3.4 0.0 1.1 0.0 0.4 1.4 0.9 0.2 0.2 0.0 0.2 0.0 0.8 0.7 0.7 1.2 0.1 0.7 0.0 0.6 0.2 0.1 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.6 1.1 0.3 0.0 0.0 0.2 0.1 1.3 0.1 0.5 0.3 0.1 0.6 0.3 0.8 0.0 1.0 0.5 0.5 0.2 0.1 0.0 0.2 0.8 0.1 0.2 0.2 0.0 0.6 0.2 0.4 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 1.7 1.8 2.7 2.7 1.3 1.8 2.4 1.5 2.8 0.9 1.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRTN NTN ENSG00000171119 Neurturin Q99748 19 5823802-5828324 "Disease related genes, Predicted secreted proteins" "Growth factor" "Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.9;pancreas: 17.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.2;Cone photoreceptor cells: 12.5;Endometrial ciliated cells: 14.9;Hepatocytes: 12.3;Rod photoreceptor cells: 50.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 8.2;K-562: 8.1;REH: 21.0;SH-SY5Y: 10.8;U-266/70: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065260 Approved "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA065260: AB_2685448" "unprognostic (4.85e-2)" "unprognostic (1.66e-2)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (1.60e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.21e-3)" "unprognostic (5.60e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.38e-1)" "unprognostic (2.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.78e-3)" "unprognostic (3.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.32e-2)" 0.2 8.2 0.2 0.4 0.2 0.0 0.8 0.6 0.3 1.3 0.4 7.1 1.3 0.4 0.6 4.4 1.1 0.5 21.9 0.2 0.4 2.8 14.5 0.8 0.0 0.5 0.5 0.0 0.1 17.0 1.6 1.1 0.2 0.6 2.9 0.2 9.8 5.4 0.9 0.0 5.5 3.2 0.9 0.1 0.2 9.5 1.3 0.4 0.4 0.4 0.0 0.2 4.7 3.0 0.4 0.6 0.8 0.9 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.9 0.0 0.5 0.1 3.2 0.0 0.0 8.2 5.7 0.0 0.0 2.6 0.9 0.1 2.1 0.1 0.8 0.0 0.0 0.0 0.0 2.7 8.1 0.0 0.0 1.7 0.7 0.9 2.6 1.2 2.0 21.0 2.6 4.9 0.3 0.0 0.5 10.8 0.2 1.0 1.2 0.3 0.4 0.7 0.0 0.0 1.6 0.0 0.0 11.5 2.6 0.7 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.2 0.6 0.3 0.2 0.4 0.5 0.5 0.0 0.6 0.1 0.4 0.4 0.3 0.0 1.8 0.3 0.4 1.9 1.4 0.4 1.8 4.6 3.0 6.9 17.2 1.5 0.1 3.7 12.5 0.1 0.4 1.0 3.9 0.3 0.1 14.9 4.3 0.6 1.2 0.0 0.5 0.7 0.0 1.3 2.0 2.6 0.0 1.1 3.6 12.3 0.3 0.0 0.7 1.8 0.0 0.3 0.2 0.6 0.9 0.3 5.4 0.0 0.1 6.0 1.0 0.5 1.0 0.7 0.1 0.0 2.5 1.0 0.2 0.7 0.2 50.0 0.0 0.0 0.9 0.4 3.4 1.4 4.5 0.1 0.6 0.5 1.4 1.1 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 4.8;HEL: 8.1;NB-4: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 4.6 3.6 1.7 2.2 1.8 1.1 4.7 1.8 1.9 3.4 1.6 3.6 1.5 3.2 1.5 2.0 3.0 1.7 3.3 1.5 1.8 3.4 5.6 3.0 2.2 2.0 1.7 1.3 3.2 5.3 1.2 3.3 4.2 2.1 4.3 1.5 2.3 3.1 1.1 1.4 2.3 3.6 1.4 1.5 7.5 3.7 3.9 1.8 0.9 3.2 0.5 1.9 3.7 2.7 2.6 2.2 0.5 0.8 0.0 0.9 0.8 1.3 0.6 0.3 0.9 0.4 4.8 1.9 0.1 2.1 0.4 1.8 0.8 0.0 0.1 1.0 2.7 0.3 8.1 2.6 1.8 0.8 0.1 2.5 1.3 0.4 0.6 0.0 0.7 0.8 0.0 0.3 0.0 1.1 1.5 0.1 5.7 0.0 0.9 1.6 2.4 0.0 0.1 0.7 1.5 1.1 0.2 0.7 0.8 0.5 0.7 2.1 4.4 0.5 0.4 0.7 0.2 0.6 0.7 0.3 2.6 0.4 3.1 0.6 0.8 0.1 0.1 0.3 0.1 0.2 1.2 0.2 0.3 0.0 0.6 0.2 0.2 0.6 1.1 0.0 0.1 0.4 0.0 1.7 1.8 1.8 1.9 1.5 1.8 2.0 1.7 1.3 2.1 1.5 1.8 2.6 4.2 0.0 3.6 3.9 2.9 0.3 1.4 0.3 0.0 2.5 2.1 1.3 1.1 2.8 1.5 0.0 14.6 1.2 0.6 3.8 0.0 5.0 11.2 1.5 2.3 5.3 4.9 0.8 3.4 3.6 1.3 1.5 0.5 2.0 2.5 3.4 2.9 1.4 1.1 0.0 4.6 1.4 0.0 2.1 1.9 13.3 2.8 1.4 0.0 5.6 1.4 1.8 1.0 4.0 6.4 3.3 0.8 3.0 0.9 1.7 1.9 0.3 1.1 7.8 6.6 1.6 1.6 2.0 2.6 0.3 0.1 1.2 1.0 2.3 1.4 1.0 FUT3 "CD174, LE" ENSG00000171124 "Fucosyltransferase 3 (Lewis blood group)" P21217 19 5842888-5851474 "Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 159.9;intestine: 67.5;retina: 80.0;salivary gland: 84.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 154.7;Intestinal goblet cells: 78.7;Pancreatic endocrine cells: 49.0;Paneth cells: 88.9;Proximal enterocytes: 85.2;Undifferentiated cells: 65.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 46.3;hTCEpi: 6.9;OE19: 20.6;RH-30: 14.8;SK-BR-3: 7.1" HPA046966 Supported NA NA "HPA046966: AB_2679879" "prognostic unfavorable (6.86e-4)" "unprognostic (2.59e-1)" "unprognostic (1.06e-1)" "unprognostic (9.12e-2)" "unprognostic (8.58e-3)" "unprognostic (1.63e-3)" "unprognostic (3.88e-2)" "unprognostic (2.03e-2)" "unprognostic (4.02e-2)" "unprognostic (3.98e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "prognostic favorable (8.22e-7)" "unprognostic (5.66e-3)" "unprognostic (9.56e-2)" "unprognostic (4.30e-2)" "unprognostic (1.07e-1)" 0.5 0.0 0.7 12.7 0.6 0.7 1.2 0.5 0.7 13.9 0.4 67.5 48.2 0.3 0.0 159.9 1.4 22.6 0.2 0.5 0.5 9.8 2.3 5.3 0.1 1.0 0.4 0.1 0.1 9.2 0.0 0.6 0.1 0.7 2.3 44.9 80.0 84.8 8.6 0.1 3.2 56.8 2.8 0.3 0.2 21.0 4.1 0.5 0.2 0.0 0.0 16.1 3.0 53.7 1.1 46.3 0.0 0.2 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.6 0.0 0.0 2.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 20.6 0.0 0.0 14.8 1.6 0.0 0.6 0.0 0.2 0.0 7.1 0.2 0.1 0.1 0.4 0.0 0.2 0.1 0.1 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.6 0.5 0.7 0.5 0.5 1.0 0.4 0.1 0.7 0.3 0.5 1.1 0.1 0.0 4.8 0.3 1.1 0.0 3.0 23.6 0.0 1.8 1.7 0.3 0.3 11.5 36.4 0.0 0.0 0.1 0.0 154.7 0.0 43.2 4.9 1.1 0.1 0.5 13.8 0.0 0.1 14.2 0.4 0.0 18.3 0.6 8.9 0.1 0.0 0.4 0.0 0.0 0.0 78.7 14.2 0.0 0.0 8.7 0.0 0.2 0.0 1.0 0.0 1.9 0.0 0.0 0.1 49.0 88.9 0.0 0.1 0.9 85.2 16.5 22.8 34.9 0.0 0.0 1.5 0.5 0.2 6.5 0.0 0.3 0.5 0.0 65.6 27.3 KCNG3 Kv6.3 ENSG00000171126 "Potassium voltage-gated channel modifier subfamily G member 3" Q8TAE7 2 42442017-42493982 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 5.3" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 12.1;Excitatory neurons: 16.4;Glandular and luminal cells: 12.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 4.7;HMC-1: 16.2;NTERA-2: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041625 Approved "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA041625: " "unprognostic (1.56e-1)" "unprognostic (4.22e-3)" "unprognostic (2.48e-1)" "unprognostic (7.67e-3)" "unprognostic (7.95e-2)" "unprognostic (9.14e-3)" "unprognostic (4.83e-3)" "unprognostic (6.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (2.56e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-2)" "unprognostic (2.76e-1)" "unprognostic (6.47e-2)" "unprognostic (1.23e-1)" 0.0 0.9 2.0 0.1 2.5 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 1.0 0.1 0.0 0.1 0.0 0.6 1.2 3.5 0.2 0.5 0.0 0.4 0.0 0.9 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.6 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 4.7 0.0 0.0 0.0 2.5 0.0 0.5 0.9 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.9 0.0 10.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.6 1.0 1.6 0.4 1.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.5 0.0 3.3 5.3 1.0 0.6 1.2 3.5 0.9 0.0 0.2 1.0 0.1 3.2 1.1 0.7 0.0 1.3 0.3 0.0 0.0 1.6 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.6 12.1 1.5 0.2 1.8 0.0 16.4 0.0 0.0 0.5 0.0 12.8 0.0 0.3 0.0 0.0 0.1 0.0 1.4 0.4 0.0 0.0 0.3 0.2 1.8 0.1 0.0 0.0 0.0 2.0 0.0 1.5 0.4 0.2 0.2 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 1.1 0.0 1.1 0.1 0.1 1.8 0.3 0.3 ATP6V0E2 "ATP6V0E2L, C7orf32" ENSG00000171130 "ATPase H+ transporting V0 subunit e2" Q8NHE4 7 149872968-149891204 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 311.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 123.7;Horizontal cells: 114.4;Muller glia cells: 173.0;Proximal tubular cells: 102.9" "Cancer enhanced" "Detected in all" "glioma: 89.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 148.8;SCLC-21H: 169.4" "Low region specificity" "Detected in all" NA NA "unprognostic (8.72e-2)" "unprognostic (4.73e-2)" "unprognostic (3.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.23e-1)" "unprognostic (2.42e-2)" "unprognostic (5.84e-3)" "unprognostic (3.57e-2)" "prognostic favorable (5.80e-4)" "unprognostic (1.21e-1)" "prognostic favorable (8.26e-7)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.48e-3)" 22.0 30.2 255.5 11.5 254.3 5.7 17.8 225.1 311.8 9.5 128.4 27.6 7.6 9.4 9.3 10.5 22.1 9.4 101.5 308.1 241.0 56.3 119.0 13.0 23.5 272.6 276.6 242.3 10.5 22.9 41.8 135.9 4.2 308.4 44.7 8.1 50.9 66.7 31.0 16.5 14.3 19.1 10.0 207.1 24.2 34.1 8.1 285.9 31.2 55.9 15.7 13.6 12.2 8.9 267.6 26.2 72.2 29.6 96.3 11.9 1.9 18.5 13.4 18.2 36.0 36.8 25.7 32.1 53.5 55.2 17.9 37.5 22.9 63.2 22.6 15.4 69.4 70.2 16.7 21.0 148.8 17.8 12.3 35.3 4.1 23.1 39.8 2.4 27.9 30.2 66.3 18.3 25.5 2.6 45.0 8.8 28.2 25.7 33.7 50.6 57.8 1.2 24.7 28.4 28.0 169.4 96.0 17.4 60.0 41.9 7.2 33.9 8.1 5.7 10.4 11.0 109.6 50.3 35.4 49.2 26.5 65.9 21.4 34.4 4.4 9.0 2.2 45.9 17.5 41.7 19.6 56.5 53.4 18.5 17.8 71.9 66.6 1.5 38.6 22.2 8.5 92.9 31.6 255.5 254.3 225.1 311.8 308.1 241.0 272.6 276.6 242.3 308.4 207.1 285.9 267.6 3.7 16.0 11.3 35.6 14.1 4.2 4.1 3.4 0.6 123.7 31.1 23.5 29.6 21.5 8.5 27.6 25.0 19.5 23.2 1.9 54.8 45.5 0.4 13.6 1.9 6.7 22.2 9.5 39.9 12.8 4.8 8.8 10.2 20.9 10.8 21.9 11.4 65.1 24.7 114.4 62.3 26.2 22.4 10.2 4.1 1.6 5.3 9.9 44.4 14.0 6.4 173.0 27.8 34.7 34.2 5.6 0.7 11.3 4.5 15.0 0.9 102.9 6.7 78.9 6.6 8.7 10.0 0.9 13.2 6.9 4.4 5.1 38.1 6.6 2.5 5.6 PRKCE ENSG00000171132 "Protein kinase C epsilon" Q02156 2 45651345-46187990 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.0" "Cell type enhanced" "Detected in many" "Early spermatids: 206.5;Excitatory neurons: 394.4;Inhibitory neurons: 531.9;Late spermatids: 456.4;Oligodendrocyte precursor cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 27.0;TIME: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001948, HPA008236, HPA044496" Enhanced Supported Supported "Vesicles,Plasma membrane,Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "Vesicles, Plasma membrane" "CAB001948: , HPA008236: , HPA044496: AB_2678959" "unprognostic (1.10e-1)" "unprognostic (1.78e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (9.61e-2)" "unprognostic (5.70e-2)" "unprognostic (1.51e-1)" "prognostic favorable (9.62e-4)" "unprognostic (3.05e-1)" "unprognostic (6.72e-2)" "unprognostic (7.49e-3)" "unprognostic (9.99e-2)" "prognostic favorable (2.63e-7)" "unprognostic (1.21e-1)" "unprognostic (7.11e-2)" "unprognostic (6.43e-3)" "unprognostic (2.23e-2)" 4.3 5.6 11.3 3.7 20.9 8.1 4.2 7.4 36.0 4.7 0.0 4.8 2.6 4.5 2.3 4.2 5.7 3.0 6.3 35.5 10.8 10.1 12.6 20.3 5.8 7.9 0.7 20.9 2.8 3.4 9.5 5.2 8.4 9.5 2.9 3.4 15.5 2.7 3.0 7.7 2.6 3.6 4.2 0.0 3.9 4.1 7.6 2.9 3.1 5.0 5.4 4.2 4.9 3.5 18.0 7.7 2.7 3.8 3.8 5.8 6.7 3.1 4.9 9.5 4.3 4.5 0.7 7.0 11.3 4.8 5.5 6.1 1.8 2.5 2.8 6.1 6.9 4.4 0.1 1.8 1.5 6.5 0.9 3.8 5.8 3.0 6.5 4.7 3.6 16.0 2.4 1.6 2.6 5.0 3.8 3.8 0.5 1.3 4.2 1.4 27.0 18.3 12.4 3.9 5.1 2.6 5.7 2.4 7.6 17.1 1.4 6.1 2.6 26.8 8.2 8.5 6.1 5.1 0.0 0.0 9.3 6.7 6.3 8.4 0.0 0.5 0.7 0.3 0.1 0.4 1.5 0.2 0.2 0.8 1.8 0.5 0.1 0.1 0.4 0.6 0.3 0.0 0.3 11.3 20.9 7.4 36.0 35.5 10.8 7.9 0.7 20.9 9.5 0.0 2.9 18.0 12.6 6.4 9.2 90.4 20.7 5.0 8.4 5.0 9.1 55.3 6.4 5.7 11.9 8.6 17.2 11.0 14.6 0.5 9.3 6.1 3.9 3.7 206.5 6.8 7.0 13.8 7.7 0.4 394.4 3.8 7.2 8.7 11.2 6.9 7.0 2.9 13.2 12.5 2.8 11.8 531.9 5.8 0.0 19.0 10.7 456.4 5.3 11.5 14.2 70.3 9.4 6.5 1.0 147.8 96.0 3.6 2.9 6.0 4.2 5.3 4.1 30.2 19.3 7.6 13.1 2.9 6.4 2.8 2.3 9.0 4.8 2.9 6.8 1.2 6.2 8.8 OR2K2 "HSHTPCRH06, HTPCRH06, OR2AR1P" ENSG00000171133 "Olfactory receptor family 2 subfamily K member 2" Q8NGT1 9 111327483-111330183 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024261 Uncertain NA NA "HPA024261: AB_1854786" "unprognostic (1.03e-1)" 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.5 0.3 0.4 0.6 0.5 0.3 0.5 0.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JAGN1 "FLJ14602, GL009" ENSG00000171135 "Jagunal homolog 1" Q8N5M9 3 9890574-9894349 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067610 Approved Vesicles NA NA Vesicles "HPA067610: " "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-3)" "unprognostic (1.97e-2)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (2.37e-2)" "unprognostic (6.36e-3)" "unprognostic (9.93e-3)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.65e-2)" "unprognostic (2.49e-1)" 28.6 43.9 21.9 15.8 22.8 12.2 26.8 24.1 29.2 22.1 24.3 26.6 27.2 23.6 40.0 19.5 26.0 16.5 20.8 22.1 24.0 30.4 63.1 17.6 19.4 23.2 22.6 21.5 25.7 40.6 31.8 18.0 20.8 23.0 21.0 30.5 20.1 24.3 21.0 36.4 27.5 26.6 20.7 23.6 17.7 31.0 14.3 23.1 24.2 18.0 30.4 23.8 23.2 21.2 24.4 32.7 54.0 39.8 23.9 116.9 121.5 128.3 43.8 65.2 49.4 49.6 40.6 43.1 51.4 19.6 44.2 54.0 28.1 63.1 59.5 48.9 38.4 65.7 62.4 55.7 73.7 99.4 45.6 37.3 115.3 89.4 63.6 73.2 51.0 47.0 45.8 65.0 34.5 59.2 99.0 37.8 80.5 50.1 65.3 74.3 31.0 32.5 64.4 73.3 45.9 25.0 46.4 29.6 31.8 58.1 35.8 50.4 56.8 39.9 26.2 28.1 29.3 35.4 60.2 94.5 60.7 33.1 55.7 44.9 100.9 61.8 31.1 48.1 48.6 50.5 52.5 46.8 45.9 57.4 53.3 50.9 48.0 24.9 51.9 37.9 58.1 54.7 67.9 21.9 22.8 24.1 29.2 22.1 24.0 23.2 22.6 21.5 23.0 23.6 23.1 24.4 28.7 32.1 17.5 5.2 38.6 27.5 47.8 84.1 30.7 27.3 53.0 58.8 14.1 55.8 43.5 38.6 10.4 74.7 30.8 49.5 21.5 80.6 3.2 33.0 33.5 36.3 25.8 30.9 4.8 98.1 80.1 37.9 30.1 22.9 8.2 36.5 42.8 52.4 55.8 23.5 5.7 55.2 59.0 40.7 22.5 6.8 39.4 29.8 37.4 4.7 75.3 52.3 50.4 8.0 8.0 73.5 55.7 38.7 35.3 66.2 114.2 55.9 40.6 23.3 46.0 31.6 31.7 66.0 51.2 35.8 36.8 52.9 31.3 48.8 58.3 39.2 RLN3 "H3, RXN3, ZINS4" ENSG00000171136 "Relaxin 3" Q8WXF3 19 14028148-14031551 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "parathyroid gland: 1.6;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "midbrain: 11.7;pons and medulla: 27.2" "Region enriched" "Detected in many" 9 "pons: 23.6" "Secreted to blood" NA NA 60000000 "unprognostic (1.96e-2)" "unprognostic (2.54e-2)" "unprognostic (3.94e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TADA3 "ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L" ENSG00000171148 "Transcriptional adaptor 3" O75528 3 9779860-9793011 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042250 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042250: AB_10794043" "unprognostic (5.77e-2)" "unprognostic (1.72e-2)" "unprognostic (2.78e-1)" "unprognostic (2.00e-3)" "unprognostic (6.83e-2)" "unprognostic (4.70e-2)" "unprognostic (9.15e-3)" "unprognostic (2.71e-1)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.47e-2)" "unprognostic (6.56e-2)" "prognostic favorable (5.47e-5)" "unprognostic (1.10e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-3)" 32.6 60.6 45.8 37.3 44.9 35.1 32.8 44.2 57.4 37.7 38.2 42.4 31.7 44.6 23.4 34.4 44.5 32.3 45.8 45.3 46.9 41.8 51.3 34.3 46.7 48.7 48.5 41.8 57.3 29.3 35.8 45.3 22.4 45.1 50.1 27.3 18.2 35.9 41.2 60.2 28.4 34.1 32.7 46.5 39.2 39.7 54.9 51.0 33.1 39.6 40.4 38.2 42.0 32.2 43.3 48.0 49.7 78.2 44.2 67.1 61.3 167.6 50.0 83.6 64.3 80.3 50.7 55.1 52.8 59.1 107.7 84.3 28.4 43.9 65.3 29.2 66.0 53.7 118.0 60.6 55.3 95.5 44.6 185.5 62.6 83.3 91.5 65.8 85.0 43.3 75.0 80.6 63.4 80.0 136.0 43.2 44.5 73.5 62.8 47.8 22.2 39.6 67.2 66.3 47.6 30.5 88.5 42.9 23.1 81.5 43.2 80.6 106.2 62.9 88.0 70.4 47.1 70.0 50.3 61.3 92.4 126.0 76.5 74.0 62.8 44.0 126.0 58.2 68.4 30.6 33.8 40.7 48.1 49.6 30.4 35.9 39.2 51.6 53.0 88.9 31.5 54.5 55.2 45.8 44.9 44.2 57.4 45.3 46.9 48.7 48.5 41.8 45.1 46.5 51.0 43.3 26.1 12.8 12.8 22.5 37.0 16.8 88.3 66.2 32.5 28.6 43.4 45.7 8.6 41.5 30.2 33.1 14.6 47.3 59.1 80.2 66.5 65.2 93.3 28.7 32.9 24.4 35.5 41.6 9.9 64.2 53.5 34.4 32.1 22.6 47.0 31.9 35.0 43.1 65.0 25.2 10.9 63.0 44.7 50.3 25.4 75.6 36.7 48.8 32.0 6.5 92.8 96.9 146.2 5.0 10.0 67.1 68.2 42.9 31.9 43.1 64.9 70.3 25.2 29.3 72.3 33.9 42.2 86.9 81.2 32.7 16.6 36.8 50.2 41.0 52.7 53.0 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46780245 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 11.5 10.3 8.9 6.4 9.4 7.7 13.1 17.3 9.6 13.1 8.9 8.5 5.2 14.3 9.1 8.5 9.4 11.4 11.4 9.2 9.0 9.3 6.7 8.8 6.8 9.1 10.3 8.1 23.4 6.3 14.3 5.6 7.4 9.9 10.0 6.7 12.8 8.8 12.5 9.1 7.6 6.8 14.0 10.0 9.1 6.7 10.4 9.3 7.7 10.0 16.1 6.8 9.4 8.6 10.4 14.5 10.8 9.3 13.8 29.9 42.3 11.4 66.5 121.0 31.5 18.6 10.3 6.9 7.5 12.7 121.9 9.7 7.1 9.9 10.8 41.2 7.3 9.4 11.8 10.0 13.2 18.4 6.9 12.7 33.9 15.8 26.7 10.7 35.8 11.0 3.0 10.2 8.1 21.5 5.3 5.9 12.0 10.4 15.1 8.7 7.8 15.9 9.5 13.2 11.1 7.3 19.8 16.4 10.7 13.0 8.9 4.4 10.3 12.8 80.0 17.7 26.9 13.2 9.7 6.4 6.5 36.9 13.7 25.5 0.5 0.4 2.5 0.9 0.4 1.1 1.8 0.5 0.6 0.5 3.0 1.1 1.5 0.4 1.0 1.7 0.5 1.0 0.7 8.9 9.4 17.3 9.6 9.2 9.0 9.1 10.3 8.1 9.9 10.0 9.3 10.4 17.2 3.2 6.1 18.9 11.3 16.6 7.2 8.3 16.5 12.8 15.1 12.2 14.2 18.6 8.0 3.7 22.9 3.7 6.2 11.0 5.9 7.3 12.3 9.9 29.2 24.3 10.8 6.1 43.4 6.8 2.5 18.8 10.2 12.0 17.1 17.4 17.2 7.9 4.5 18.5 51.5 7.1 2.0 8.4 15.2 8.1 17.4 7.7 7.2 18.7 8.4 9.7 6.2 38.2 25.4 6.8 8.8 17.0 7.0 11.0 5.1 7.3 5.3 5.5 13.1 13.8 20.1 13.3 18.8 9.9 14.5 2.7 7.0 7.3 5.6 7.8 C1GALT1C1 "C1GALT2, COSMC" ENSG00000171155 "C1GALT1 specific chaperone 1" Q96EU7 X 120625674-120630054 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010666, HPA015632" Approved Approved Vesicles NA NA 21000 Vesicles "HPA010666: , HPA015632: AB_1845625" "prognostic unfavorable (5.66e-4)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (5.26e-3)" "unprognostic (4.34e-2)" "unprognostic (2.50e-1)" "unprognostic (2.18e-2)" "unprognostic (8.10e-2)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (3.98e-2)" "unprognostic (4.48e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (3.78e-2)" 15.0 28.1 4.5 8.8 4.8 2.9 14.6 5.1 5.7 15.4 6.4 13.4 10.1 12.3 16.9 14.9 13.8 8.4 17.1 4.5 6.7 12.9 21.1 12.1 8.8 5.1 5.1 4.2 9.7 16.0 16.4 34.2 9.2 5.2 10.6 14.7 6.3 20.1 11.2 7.9 5.8 13.3 9.6 5.0 13.1 13.6 6.2 4.9 7.5 13.3 7.1 9.7 11.6 12.9 5.6 15.9 15.1 8.2 14.2 126.7 24.0 13.0 28.4 39.9 14.7 27.7 9.9 49.8 10.3 13.9 57.6 28.4 21.9 16.2 13.9 23.4 17.6 19.6 6.6 13.1 14.7 19.7 11.7 10.1 21.0 12.1 18.3 6.1 36.9 47.0 5.1 4.2 11.8 17.5 21.6 3.9 11.0 9.3 53.3 15.1 1.8 6.4 28.5 29.9 10.6 9.0 8.6 27.0 18.4 14.6 15.0 15.9 11.2 43.4 6.7 8.3 27.2 26.9 5.1 7.9 8.2 24.6 22.7 15.0 12.1 12.3 20.4 12.0 16.4 13.3 12.3 15.4 13.0 14.6 7.6 15.6 12.5 22.7 12.3 13.6 16.7 15.8 12.2 4.5 4.8 5.1 5.7 4.5 6.7 5.1 5.1 4.2 5.2 5.0 4.9 5.6 27.1 6.4 10.4 6.5 16.3 6.8 22.7 107.9 15.4 8.3 17.6 10.0 17.6 14.3 75.9 38.6 2.1 56.9 16.3 18.7 15.6 40.3 2.7 30.5 20.2 27.6 13.8 5.9 4.7 44.3 51.7 34.7 10.7 25.3 2.5 14.5 21.4 22.3 24.1 20.2 6.5 20.8 77.3 16.2 11.4 6.4 22.7 19.6 30.2 3.7 20.7 17.5 15.5 5.5 10.1 30.0 20.8 19.2 50.1 10.7 16.9 20.3 71.0 10.5 6.6 18.1 24.4 6.5 8.4 14.1 7.2 20.0 15.2 25.8 21.5 20.5 C9orf16 "EST00098, FLJ12823, MGC4639" ENSG00000171159 "Chromosome 9 open reading frame 16" Q9BUW7 9 128160265-128163924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 327.8" "Cell type enhanced" "Detected in all" "Late spermatids: 869.5;Urothelial cells: 938.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020725 Uncertain Approved Microtubules NA NA Microtubules "HPA020725: AB_1845816" "unprognostic (8.85e-2)" "prognostic favorable (7.60e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (6.42e-3)" "unprognostic (3.98e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.13e-5)" "unprognostic (8.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-3)" "unprognostic (2.13e-1)" "unprognostic (3.09e-3)" "unprognostic (4.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.00e-3)" "unprognostic (2.48e-2)" 75.2 327.8 138.8 23.0 107.7 67.4 76.4 62.2 298.2 70.9 84.6 60.4 24.6 67.6 9.3 89.8 53.7 28.0 78.2 250.8 83.3 85.9 63.5 59.5 41.6 84.8 85.2 112.9 42.7 94.4 18.7 82.2 12.9 100.0 94.2 9.0 5.9 100.9 33.0 42.1 155.9 53.2 13.3 71.3 89.5 64.5 52.1 109.1 42.0 53.9 11.8 22.4 109.1 100.9 117.7 36.4 48.0 26.9 150.2 18.0 39.7 63.1 34.2 27.9 27.7 21.9 23.9 95.4 41.0 67.6 14.9 6.7 103.5 7.5 27.3 1.5 77.0 60.7 29.2 57.3 48.7 31.5 32.6 72.0 30.0 39.8 14.5 7.2 21.9 39.5 111.9 78.5 79.4 15.1 210.4 109.0 139.0 60.4 74.2 89.1 102.0 17.9 170.7 35.7 31.9 67.1 98.9 60.8 54.1 74.0 6.5 60.8 30.1 48.2 28.9 69.4 37.3 30.0 76.5 61.5 63.8 80.1 45.9 29.4 221.4 119.4 205.0 155.7 105.1 169.6 168.8 178.4 153.3 135.4 178.0 139.9 144.2 138.0 165.9 92.5 144.4 254.8 142.0 138.8 107.7 62.2 298.2 250.8 83.3 84.8 85.2 112.9 100.0 71.3 109.1 117.7 146.3 6.4 4.8 11.8 149.7 197.2 356.6 519.8 124.1 77.1 265.6 298.3 33.9 108.7 199.9 355.0 14.6 97.1 209.8 291.7 309.1 223.8 162.2 100.5 88.4 151.9 407.8 139.5 26.4 354.5 88.3 103.8 77.5 120.2 162.0 112.7 133.2 106.4 247.4 18.5 19.2 254.0 193.3 247.3 251.6 869.5 76.7 203.1 224.1 9.4 236.7 91.4 311.0 8.0 11.6 223.6 233.9 83.1 129.0 281.5 131.2 224.9 93.7 46.1 72.3 58.1 197.3 30.7 82.9 142.3 233.4 60.3 215.2 155.3 205.9 938.8 MORN4 "bA548K23.4, C10orf83, FLJ25925, rtp" ENSG00000171160 "MORN repeat containing 4" Q8NDC4 10 97614553-97633500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 51.5;Distal tubular cells: 90.1;Proximal tubular cells: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052718 Uncertain NA NA "HPA052718: AB_2681926" "unprognostic (7.24e-2)" "unprognostic (6.27e-2)" "unprognostic (1.78e-2)" "unprognostic (1.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.13e-2)" "unprognostic (1.11e-2)" "unprognostic (4.32e-1)" "unprognostic (3.14e-3)" "unprognostic (2.50e-1)" "unprognostic (6.15e-3)" "unprognostic (9.82e-2)" "unprognostic (1.07e-3)" "unprognostic (4.10e-1)" "unprognostic (1.89e-1)" "unprognostic (3.87e-1)" "unprognostic (1.32e-1)" 3.8 9.0 23.6 1.7 26.5 1.8 6.7 18.4 27.4 9.4 17.8 5.9 0.9 7.7 11.7 2.5 9.7 5.1 15.9 23.6 28.9 15.0 5.4 4.6 1.9 20.9 24.0 24.3 12.4 10.1 24.5 27.0 3.4 24.1 10.2 3.1 15.5 4.9 9.3 6.2 5.2 3.0 5.6 18.3 4.0 6.6 8.9 25.8 2.2 10.4 5.7 1.6 6.4 5.6 22.2 12.0 13.6 17.1 41.5 6.2 18.5 1.5 9.4 14.0 9.8 13.9 6.1 16.4 0.0 14.2 6.8 28.9 8.1 0.0 11.1 10.4 9.7 13.5 2.0 6.9 14.2 16.6 2.8 1.0 10.0 34.3 14.9 19.2 34.9 14.1 12.0 7.6 7.1 9.9 8.7 0.0 0.2 12.2 7.2 15.6 0.0 1.6 0.0 10.4 5.1 12.0 25.4 13.6 3.7 25.5 9.3 16.0 2.2 3.9 10.5 9.1 11.6 11.2 15.1 20.0 0.1 18.8 0.1 5.5 0.6 0.2 0.4 2.0 0.2 2.3 2.5 1.7 1.5 0.1 0.6 2.7 1.9 0.4 0.5 0.1 1.0 2.2 0.6 23.6 26.5 18.4 27.4 23.6 28.9 20.9 24.0 24.3 24.1 18.3 25.8 22.2 1.7 6.4 2.0 10.1 2.5 4.2 3.9 7.5 8.6 5.5 5.2 7.1 51.5 5.7 7.3 11.0 0.0 2.1 0.3 1.0 90.1 5.9 13.0 8.9 5.4 2.9 9.0 3.4 22.9 8.0 1.4 7.8 5.1 6.6 5.7 8.3 3.3 2.5 2.7 1.7 23.8 2.4 6.1 0.3 2.3 16.3 7.5 0.8 5.4 4.7 1.8 9.1 1.0 18.6 9.7 6.9 0.4 9.1 2.4 3.7 0.4 51.9 16.1 4.9 0.0 3.7 5.8 7.7 2.2 3.3 3.1 2.1 1.8 5.4 2.3 2.8 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 13.1 14.9 12.4 11.8 14.2 13.6 13.3 17.2 13.0 13.3 13.6 16.2 11.4 14.5 7.8 19.2 15.0 7.8 28.0 12.2 17.3 20.2 26.3 17.2 15.0 16.2 14.2 10.9 11.2 18.1 16.3 17.2 9.4 14.7 24.3 8.5 10.8 17.8 8.3 49.9 17.8 16.9 8.1 13.5 20.0 17.1 16.2 13.8 16.0 20.3 36.0 14.1 17.0 13.8 15.1 19.4 21.5 17.2 19.5 9.4 6.6 33.0 17.8 9.7 12.7 13.6 11.8 19.7 22.0 18.1 11.7 9.6 18.8 9.4 13.3 8.0 32.5 5.3 33.7 20.0 16.0 12.0 14.6 24.4 7.4 10.7 16.6 11.5 10.2 11.7 15.2 41.5 17.6 8.8 13.8 26.8 14.5 20.0 22.3 36.5 49.1 16.3 17.4 12.9 15.6 25.5 22.2 16.0 24.0 15.9 10.2 13.8 30.1 10.0 17.5 10.5 11.6 37.3 52.8 22.2 13.2 16.0 25.1 14.5 9.2 16.3 11.9 8.8 15.9 7.2 11.9 6.3 8.8 24.3 15.0 6.7 6.3 9.2 12.7 15.4 13.6 7.8 14.0 12.4 14.2 17.2 13.0 12.2 17.3 16.2 14.2 10.9 14.7 13.5 13.8 15.1 10.7 3.2 15.2 5.9 22.3 13.0 28.2 10.1 6.8 22.0 12.8 9.8 20.2 14.3 8.1 16.5 12.5 32.0 22.0 19.5 21.5 18.3 7.8 9.5 5.7 12.0 18.0 17.0 2.2 10.7 19.9 10.0 10.2 8.9 28.0 12.5 7.5 17.2 16.8 10.1 4.0 17.6 8.2 16.4 16.9 14.6 5.6 20.6 12.4 1.9 17.8 19.5 20.6 2.5 5.2 14.6 19.7 5.7 9.6 21.1 26.5 15.8 9.0 30.5 6.6 17.5 11.7 32.4 23.4 5.5 14.6 71.3 13.5 10.6 16.9 22.5 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059337: AB_2683984, HPA062792: AB_2684869" "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavorable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favorable (8.35e-5)" 11.5 16.6 33.4 4.8 34.2 7.5 16.4 34.6 48.9 26.3 32.3 18.5 5.2 17.2 8.3 23.4 25.5 5.0 16.4 33.3 33.1 24.0 21.9 12.6 6.2 35.0 33.9 33.6 27.8 28.4 7.5 29.3 4.2 36.0 35.2 3.6 8.6 17.9 5.4 17.8 17.1 16.8 3.9 32.8 23.7 19.8 39.2 33.8 7.0 24.9 4.7 4.5 21.4 21.0 35.0 7.1 6.4 6.1 14.7 4.7 2.5 26.4 6.1 1.9 6.2 4.0 8.2 9.8 8.8 11.7 2.3 2.5 9.5 9.1 8.8 3.9 12.6 5.7 9.9 17.8 2.2 3.5 11.4 8.3 3.2 10.2 6.8 17.5 5.8 5.9 11.1 21.1 6.2 2.9 3.8 5.9 23.7 12.2 17.1 13.1 19.3 3.6 16.9 11.9 4.5 11.7 8.8 6.3 10.1 12.2 2.3 13.1 18.5 4.5 2.7 5.0 2.7 8.0 17.0 11.3 5.8 6.2 14.9 4.7 0.0 1.5 1.4 3.6 1.1 3.3 3.0 2.9 4.0 3.1 2.3 4.1 3.0 3.3 8.1 1.0 2.5 3.5 2.0 33.4 34.2 34.6 48.9 33.3 33.1 35.0 33.9 33.6 36.0 32.8 33.8 35.0 7.8 9.6 8.6 27.1 10.7 9.6 12.5 19.0 11.4 15.3 16.8 18.7 5.4 7.2 10.8 11.0 22.9 12.8 10.3 10.0 5.9 7.6 14.3 6.1 7.0 6.7 8.3 22.7 20.6 4.0 10.4 8.1 15.8 6.8 5.7 15.9 2.9 6.2 6.5 11.8 19.7 12.3 12.2 6.0 5.5 7.8 10.2 5.4 16.0 10.3 6.1 8.3 9.2 8.5 23.5 5.7 5.2 7.2 6.6 17.3 11.6 4.1 10.8 13.6 0.0 8.4 8.0 52.7 15.4 11.0 8.0 6.2 11.3 9.5 14.3 10.0 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: AB_2682633, HPA064931: AB_2732725" "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favorable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favorable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 2.0 2.4 1.3 1.8 1.3 4.3 1.8 1.2 1.6 2.1 1.3 1.9 2.0 2.2 0.7 2.6 1.8 1.0 1.9 1.2 1.3 1.7 2.6 1.6 2.6 1.3 1.2 1.0 1.7 2.4 1.8 1.5 1.6 1.3 1.5 1.2 0.7 2.2 1.4 2.7 2.1 2.3 1.4 1.2 3.2 2.1 3.4 1.5 2.4 1.7 1.9 2.2 1.6 1.8 1.8 5.1 4.4 2.7 7.0 2.5 2.2 6.1 3.8 2.3 3.2 2.6 3.5 4.0 6.2 3.3 2.4 4.5 3.8 2.8 2.9 2.6 19.1 3.8 4.6 5.4 2.0 4.1 6.4 12.5 2.0 3.4 2.5 4.0 2.6 2.9 6.9 11.0 3.9 3.0 5.9 6.2 7.7 3.0 6.9 7.4 5.9 4.3 5.7 2.5 3.1 3.9 4.5 3.8 5.2 4.0 2.0 4.0 6.3 2.0 3.8 11.8 3.2 4.5 6.3 14.0 4.1 3.6 4.1 5.1 0.0 0.7 1.2 0.5 0.6 0.4 0.3 1.1 0.7 0.7 0.9 0.7 0.6 1.5 0.5 1.0 0.5 0.3 0.5 1.3 1.3 1.2 1.6 1.2 1.3 1.3 1.2 1.0 1.3 1.2 1.5 1.8 5.6 0.0 3.0 2.0 5.4 4.8 4.6 3.9 4.6 4.0 3.9 2.8 4.2 4.3 3.4 5.5 0.0 5.8 6.6 6.3 3.9 3.5 8.7 2.6 3.5 6.4 5.4 0.8 1.0 6.6 5.7 3.1 1.5 3.2 8.2 3.7 7.1 2.4 5.7 10.1 0.9 4.0 0.0 7.0 3.6 10.9 6.2 3.1 0.0 0.0 5.1 4.6 7.2 2.0 0.7 3.7 5.1 3.0 3.4 3.3 7.3 4.2 1.8 5.0 0.0 4.2 3.5 15.1 7.8 5.0 3.8 4.7 4.0 4.4 3.6 2.9 RBKS "DKFZp686G13268, RBSK" ENSG00000171174 Ribokinase Q9H477 2 27781379-27890681 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.8" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 79.0;Proximal tubular cells: 110.9;Respiratory ciliated cells: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 17.8;RPTEC TERT1: 40.8;U-266/84: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019725, HPA028285" Enhanced Approved Nucleoplasm,Cytosol No No 11000 Cytosol Nucleoplasm "HPA019725: AB_1856105, HPA028285: AB_10601480" "unprognostic (1.25e-1)" "unprognostic (2.16e-1)" "unprognostic (2.51e-2)" "unprognostic (5.54e-3)" "unprognostic (4.15e-3)" "unprognostic (2.44e-1)" "unprognostic (1.43e-2)" "unprognostic (4.77e-2)" "unprognostic (2.45e-1)" "unprognostic (5.35e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-1)" "unprognostic (1.20e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (9.27e-2)" 4.1 25.0 3.7 2.0 3.9 1.8 3.9 4.8 5.2 3.5 4.5 6.1 25.4 2.9 11.0 3.1 15.7 2.7 4.9 3.8 4.5 27.7 46.8 3.1 1.7 4.2 4.0 3.4 8.1 4.7 9.4 11.1 1.8 4.1 2.5 5.3 13.9 2.1 3.5 8.3 1.4 25.8 2.2 3.6 1.7 2.8 9.3 3.7 3.1 9.9 5.9 2.2 2.2 2.3 4.2 6.4 4.9 0.5 0.6 0.4 1.7 3.9 1.3 1.7 1.5 1.1 9.3 2.9 2.4 17.8 3.6 3.0 2.3 0.6 2.7 2.1 0.9 0.3 0.1 0.7 8.2 2.7 1.7 0.2 2.4 3.3 5.8 7.8 1.5 1.2 3.8 0.5 4.0 3.6 8.2 1.5 4.6 0.8 4.6 4.3 1.8 0.3 1.4 40.8 0.5 1.7 2.5 6.1 7.7 2.8 2.3 3.9 9.3 0.2 1.2 0.9 4.3 2.7 13.6 18.2 3.8 3.6 5.6 0.2 1.6 2.5 1.4 1.9 0.9 4.2 4.4 2.7 4.8 3.5 3.7 3.1 2.3 1.0 4.5 0.2 0.4 4.2 2.3 3.7 3.9 4.8 5.2 3.8 4.5 4.2 4.0 3.4 4.1 3.6 3.7 4.2 9.9 6.4 5.0 14.7 24.0 2.0 3.1 11.7 26.7 10.7 5.1 7.1 7.1 5.7 9.7 18.4 4.2 4.2 10.5 12.2 46.9 12.6 36.9 35.2 2.4 7.8 3.6 3.0 13.9 12.3 1.3 10.9 8.6 7.4 2.5 4.6 2.9 29.5 6.5 8.4 18.3 4.7 6.1 4.4 3.4 26.4 1.5 50.8 1.8 2.8 2.4 15.5 3.1 15.6 10.3 7.0 14.9 2.6 21.2 1.0 79.0 110.9 59.0 25.6 0.0 3.3 11.2 23.8 20.0 5.2 1.6 1.5 19.6 9.5 10.7 1.9 OR2M4 "HSHTPCRX18, HTPCRX18, OST710, TPCR100" ENSG00000171180 "Olfactory receptor family 2 subfamily M member 4" Q96R27 1 248231417-248244679 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051308 Uncertain NA NA "HPA051308: AB_2681435" 0.1 0.1 0.5 0.1 0.5 0.7 0.2 0.8 0.8 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.4 0.1 0.0 0.4 0.1 0.1 0.3 0.2 0.3 0.2 0.3 0.1 0.0 0.0 0.4 0.0 0.1 0.9 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.5 0.5 0.8 0.8 0.4 0.1 0.3 0.2 0.3 0.4 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIK1 "GluK1, GLUR5" ENSG00000171189 "Glutamate ionotropic receptor kainate type subunit 1" P39086 21 29536933-29940033 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "adrenal gland: 12.6;brain: 33.8;retina: 38.6" "Group enriched" "Detected in some" 10 "Inhibitory neurons: 2260.1;Oligodendrocyte precursor cells: 862.5" "Cancer enriched" "Detected in some" 5 "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014623, HPA073879" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA014623: AB_1850305, HPA073879: " "unprognostic (1.39e-1)" "unprognostic (6.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.12e-3)" "unprognostic (1.25e-1)" "unprognostic (8.77e-2)" "unprognostic (4.89e-3)" "unprognostic (1.20e-3)" "unprognostic (1.47e-8)" "unprognostic (2.09e-1)" "unprognostic (2.68e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-3)" 0.1 12.6 6.7 0.2 7.1 0.1 1.9 2.4 11.5 0.5 0.0 0.3 0.0 0.1 2.0 0.3 0.0 0.1 0.0 8.8 8.4 0.0 0.1 0.1 0.1 25.6 10.9 5.1 0.3 0.0 0.0 0.2 0.4 33.8 2.4 0.5 38.6 0.0 0.1 0.1 0.8 0.4 0.1 1.6 0.1 0.2 0.5 11.4 0.0 0.0 0.0 0.0 0.4 0.4 30.8 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.7 7.1 2.4 11.5 8.8 8.4 25.6 10.9 5.1 33.8 1.6 11.4 30.8 0.1 0.0 0.0 27.4 0.0 0.3 0.0 0.0 0.0 149.8 2.3 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.1 1.2 0.4 0.0 0.0 29.8 0.0 0.0 0.7 0.0 0.2 0.0 148.8 0.0 0.0 0.1 1.7 2260.1 0.0 0.0 0.0 0.4 13.2 0.3 0.2 3.6 10.3 0.0 2.5 0.0 862.5 8.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.9 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.1 33.8 0.1 0.0 MUC7 "FLJ27047, MG2" ENSG00000171195 "Mucin 7, secreted" Q8TAX7 4 70430492-70482997 "Disease related genes, Predicted secreted proteins" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 875 "salivary gland: 26231.5" "Cell type enriched" "Detected in some" 12 "Melanocytes: 12.4" "Group enriched" "Detected in some" 12 "head and neck cancer: 8.1;melanoma: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA006411 Enhanced "Secreted to digestive system" NA NA "HPA006411: AB_1854204" "unprognostic (5.49e-2)" "unprognostic (3.20e-1)" "unprognostic (1.06e-1)" 1.0 5.3 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 2.1 0.0 0.0 6.6 0.0 0.0 1.0 3.7 0.6 0.0 0.0 0.7 0.0 6.5 29.9 0.0 1.9 3.2 0.0 0.8 0.0 0.0 26231.5 0.0 2.6 3.3 1.5 0.0 0.0 1.0 1.1 1.5 0.2 0.0 1.4 0.1 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.4 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPRPN "BPLP, PRL1, PROL1" ENSG00000171199 "Opiorphin prepropeptide" Q99935 4 70397931-70410195 "Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "salivary gland: 147.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 12.5;Breast myoepithelial cells: 3.3;Glandular and luminal cells: 2.1" "Group enriched" "Detected in some" 5 "breast cancer: 7.4;liver cancer: 4.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065711 Approved "Secreted in other tissues" NA NA 63000 "HPA065711: AB_2685541" "unprognostic (3.11e-3)" "unprognostic (2.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMR3B "P-B, PRL3, PROL3" ENSG00000171201 "Submaxillary gland androgen regulated protein 3B" P02814 4 70370093-70390244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 946 "salivary gland: 219074.7" "Group enriched" "Detected in some" 55 "Breast glandular cells: 2.3;Early spermatids: 8.4;Late spermatids: 6.0" "Cancer enriched" "Detected in some" 22 "breast cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "EFO-21: 4.5" "Secreted to digestive system" NA NA 1900000 "unprognostic (3.72e-1)" 0.0 9.2 0.0 0.0 0.0 7.7 0.3 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.1 9.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 47.8 231.4 0.0 1.6 23.4 0.0 1.6 0.0 0.0 219074.7 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA046648: AB_2679737" "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 32.2 28.3 42.4 23.3 43.5 44.2 33.8 43.0 52.7 22.0 41.6 28.3 32.9 20.2 31.4 27.4 19.9 20.0 76.0 42.8 44.4 33.4 49.4 20.7 27.6 42.8 42.9 42.1 21.2 34.2 26.5 22.3 23.0 43.4 23.8 29.6 24.2 31.5 19.7 82.4 19.5 26.3 27.9 43.7 21.2 33.1 38.8 43.3 24.4 26.9 99.6 28.0 30.8 20.3 44.2 46.7 53.2 50.9 33.0 67.2 66.7 38.0 55.9 60.1 82.3 77.6 65.9 67.5 25.4 61.3 69.2 32.0 48.9 53.8 59.5 70.7 72.5 31.0 72.5 56.9 73.7 82.4 89.0 54.8 58.0 65.8 73.1 78.0 43.5 71.6 72.2 51.1 39.0 86.2 57.5 48.6 112.3 48.1 175.1 68.4 48.3 49.5 79.2 54.5 57.0 34.3 34.7 49.4 72.9 44.7 44.5 88.1 64.4 42.8 70.4 52.7 134.6 65.3 27.5 54.4 70.4 37.0 63.6 85.2 6.6 23.9 11.6 21.2 28.1 26.0 29.8 26.4 23.8 32.9 27.3 24.4 24.1 1.9 15.1 23.4 24.7 26.4 18.7 42.4 43.5 43.0 52.7 42.8 44.4 42.8 42.9 42.1 43.4 43.7 43.3 44.2 40.5 28.9 24.3 12.7 39.6 31.7 55.3 87.9 29.6 14.8 45.8 62.1 110.8 28.6 57.5 38.6 6.2 67.8 38.5 23.6 146.8 51.0 147.8 26.8 32.8 36.7 21.7 46.1 8.6 93.2 73.3 40.8 23.4 24.2 37.4 33.6 26.7 68.5 94.6 8.4 9.0 46.6 40.7 54.4 43.3 80.6 29.5 48.4 33.8 5.6 66.3 35.1 38.1 8.5 11.8 64.5 34.8 26.7 45.4 73.4 61.8 109.4 39.7 21.9 19.7 40.0 40.9 119.0 57.9 49.4 42.1 52.9 42.1 42.2 57.1 71.2 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria NA NA Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 13.5 16.8 33.7 13.1 34.1 6.5 19.5 32.9 37.0 17.6 30.9 20.4 19.7 19.5 31.0 14.5 16.0 17.4 25.0 34.2 35.5 15.1 17.3 15.9 18.8 34.8 34.3 32.8 16.6 16.1 11.1 21.0 13.4 35.0 17.1 17.7 18.7 15.9 14.3 16.4 14.0 20.0 21.6 34.8 16.6 17.7 11.0 35.0 16.1 17.0 20.3 17.7 18.8 14.9 36.7 37.9 29.8 33.1 16.0 60.2 49.6 10.6 33.1 36.1 25.6 38.1 84.8 37.1 39.9 72.2 27.1 28.6 45.0 53.2 33.0 23.8 56.5 49.7 30.1 49.1 36.1 35.6 75.4 34.7 37.9 38.3 38.6 47.0 41.1 38.6 49.5 72.5 31.2 58.8 47.9 29.4 91.3 36.1 129.6 50.1 25.0 25.4 33.6 49.5 42.1 30.8 19.1 31.2 24.9 31.9 42.5 50.1 45.4 20.5 38.2 26.5 96.9 35.4 14.6 91.1 47.7 19.4 60.4 20.6 21.5 15.6 7.9 19.0 18.2 24.8 18.3 23.4 23.5 20.1 17.7 23.3 23.4 5.9 23.4 14.5 18.4 25.9 15.9 33.7 34.1 32.9 37.0 34.2 35.5 34.8 34.3 32.8 35.0 34.8 35.0 36.7 44.9 22.4 40.7 16.6 34.6 26.1 32.2 80.8 22.8 32.5 36.8 31.1 87.3 54.3 57.2 40.5 14.6 41.0 54.2 33.6 168.3 76.0 5.4 27.2 39.2 46.1 34.6 34.5 19.3 49.0 54.5 45.1 15.8 25.8 42.5 27.8 42.5 43.6 84.1 23.5 20.1 41.3 81.4 47.4 44.6 8.3 66.5 43.5 72.9 9.4 48.8 79.0 80.3 20.6 29.7 51.5 52.8 88.4 22.4 35.3 56.5 162.9 51.3 31.2 39.5 30.0 43.8 34.4 46.8 23.1 36.9 25.2 49.7 45.4 52.0 45.4 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102644479-102658318 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 73.1 48.0 63.4 21.7 60.1 26.2 58.9 62.7 51.6 58.5 33.8 46.0 18.0 53.9 9.3 42.4 56.1 22.2 66.3 52.8 53.8 77.9 62.7 71.0 18.5 71.4 67.7 46.1 45.6 81.1 36.9 43.9 21.5 65.8 55.9 9.6 18.3 69.7 22.1 81.5 46.8 44.1 17.2 56.6 43.1 62.4 20.2 72.1 18.9 68.0 39.2 11.9 63.4 50.3 52.5 96.4 18.7 16.3 28.7 17.2 40.6 21.1 34.4 59.3 32.1 24.6 30.7 93.0 30.7 102.9 57.5 11.4 32.7 12.2 40.4 21.3 34.4 23.4 78.3 12.9 67.4 55.8 15.5 28.3 47.0 21.9 64.8 32.9 83.4 40.6 13.6 17.3 33.4 24.3 45.5 27.8 57.7 12.7 25.6 38.0 18.6 49.2 16.6 37.4 48.0 12.3 26.2 18.8 17.2 42.6 16.9 58.4 28.2 94.8 40.9 22.4 23.3 68.8 49.0 28.5 16.3 65.5 39.2 9.7 14.0 5.2 2.7 6.8 4.6 6.5 8.9 7.3 5.4 4.5 7.4 6.4 5.7 17.9 6.0 5.7 12.4 7.5 4.5 63.4 60.1 62.7 51.6 52.8 53.8 71.4 67.7 46.1 65.8 56.6 72.1 52.5 46.0 57.7 71.2 33.6 29.5 31.5 12.6 21.2 21.6 33.4 53.9 45.3 38.0 38.6 33.6 88.3 8.4 13.0 52.8 15.4 41.1 63.2 1.1 91.5 61.7 30.1 21.6 2.5 8.9 44.9 2.6 38.9 20.4 81.6 8.8 32.2 31.8 33.3 25.4 28.6 13.6 32.8 18.3 40.5 24.1 1.7 31.1 43.5 17.8 13.1 58.1 26.1 24.7 18.1 17.6 65.0 16.4 34.3 18.6 30.5 32.0 53.0 38.5 15.1 13.1 35.7 38.4 2.4 5.1 19.8 22.9 10.9 26.6 38.9 21.4 30.1 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143945 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 2.7 7.3 3.9 6.4 17.4 2.5 2.9 3.9 9.8 1.4 1.1 8.6 1.6 2.2 0.6 6.2 0.8 4.9 2.2 4.2 8.0 2.3 0.7 5.9 6.4 7.3 1.5 4.6 1.6 2.5 10.8 1.2 3.4 7.5 1.1 2.4 7.6 2.7 1.2 4.5 1.4 2.8 1.6 1.0 22.9 2.2 8.1 3.6 5.5 8.8 2.2 6.3 5.0 2.9 8.1 86.8 94.4 133.9 0.3 19.3 111.6 22.2 84.0 13.2 72.9 39.3 19.9 54.0 21.3 50.4 18.0 70.2 37.9 86.4 83.6 89.0 0.3 55.7 17.2 32.8 21.3 23.9 55.8 43.7 67.9 54.7 29.5 41.2 70.5 49.2 50.5 25.9 25.7 47.4 23.5 31.9 30.4 64.7 25.8 68.8 0.1 26.2 43.0 51.4 18.3 87.8 63.5 110.9 8.6 12.5 21.8 1.7 40.3 24.1 0.1 0.3 0.1 0.5 27.5 24.7 47.6 58.9 38.9 59.6 0.3 0.9 0.0 0.0 0.5 0.3 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.1 3.9 17.4 3.9 9.8 4.2 8.0 7.3 1.5 4.6 7.5 1.0 3.6 8.1 4.9 0.0 4.5 4.6 6.5 7.8 0.6 10.4 13.1 2.2 5.2 8.9 1.3 0.0 3.6 0.0 0.0 1.4 2.1 15.9 0.0 0.4 3.1 2.1 4.0 10.6 10.8 0.4 96.5 3.1 0.5 4.9 1.5 0.9 2.5 18.0 2.9 0.4 6.6 0.0 176.6 2.6 6.1 11.4 14.6 5.7 0.6 16.6 3.6 8.4 7.3 39.9 1.0 79.4 3.1 1.3 1.5 0.0 13.7 4.9 2.9 0.1 2.4 1.6 6.6 5.3 3.6 17.9 22.2 18.8 3.3 0.8 5.2 98.7 2.8 1.4 CSN3 CSN10 ENSG00000171209 "Casein kappa" P07498 4 70242588-70251428 "Predicted secreted proteins" "Milk protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 382.2" "Cell type enriched" "Detected in some" 48 "Breast glandular cells: 2554.0" "Cancer enriched" "Detected in some" 5 "breast cancer: 35.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035953, HPA035954" Enhanced "Secreted in female reproductive system" NA NA "HPA035953: AB_10673226, HPA035954: AB_2674884" 0.0 0.0 0.0 0.0 0.0 0.0 382.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 10.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 2554.0 52.2 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.1 3.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 CLDN20 ENSG00000171217 "Claudin 20" P56880 6 155264013-155276548 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.6;Excitatory neurons: 1.8;Inhibitory neurons: 1.7;Oligodendrocytes: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.2;WM-115: 1.2" NA NA "unprognostic (3.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-1)" "unprognostic (2.84e-1)" "unprognostic (4.04e-2)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (6.26e-2)" "unprognostic (6.40e-2)" "unprognostic (7.33e-3)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (3.29e-2)" "unprognostic (2.05e-1)" 0.1 0.3 0.2 0.1 0.8 0.8 0.1 1.1 1.0 0.1 0.4 0.1 0.1 0.4 0.0 0.2 0.1 0.3 0.1 0.4 0.5 0.3 0.2 0.1 0.3 0.9 0.6 0.3 0.2 0.2 0.0 0.1 0.0 0.9 0.1 0.0 1.0 0.3 0.0 0.2 0.8 0.2 0.5 0.2 0.3 0.2 0.3 0.7 0.0 0.4 0.0 0.0 0.1 0.3 1.1 0.1 0.5 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.9 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 0.3 0.8 1.2 0.1 0.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.8 0.0 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 1.1 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.6 0.4 0.2 0.2 0.6 0.2 0.1 0.6 0.2 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 1.1 1.0 0.4 0.5 0.9 0.6 0.3 0.9 0.2 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CDC42BPG "DMPK2, HSMDPKIN, kappa-200, MRCKgamma" ENSG00000171219 "CDC42 binding protein kinase gamma" Q6DT37 11 64823052-64844653 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.7;skin 1: 32.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 14.8;Gastric mucus-secreting cells: 23.0;Paneth cells: 18.3;Squamous epithelial cells: 19.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "cerebellum: 9.0;pons: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 29.3;HaCaT: 22.5;MCF7: 30.7;RT4: 18.4;SK-BR-3: 18.4;T-47d: 18.1" "Region enriched" "Detected in all" 4 "cerebellum: 10.5" "Low region specificity" "Detected in some" "HPA027382, HPA061836" Enhanced Supported Cytosol NA NA Cytosol "HPA027382: AB_1846378, HPA061836: AB_2684622" "unprognostic (3.26e-2)" "unprognostic (1.58e-1)" "unprognostic (6.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.21e-1)" "unprognostic (2.50e-1)" "unprognostic (4.68e-1)" "unprognostic (5.27e-2)" "unprognostic (3.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "prognostic favorable (5.99e-13)" "unprognostic (2.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.14e-2)" "unprognostic (3.99e-3)" 0.4 4.9 0.3 1.4 0.3 2.2 4.9 9.0 1.0 3.5 4.4 6.3 10.7 0.4 2.0 26.7 3.9 2.8 0.3 0.4 0.4 5.5 0.9 7.9 1.4 0.3 0.9 0.0 2.2 14.2 6.5 11.1 4.3 4.3 8.6 4.6 0.3 17.8 3.7 0.2 32.3 9.4 0.2 0.3 1.8 12.3 3.3 0.4 2.4 6.0 0.0 2.0 5.8 13.1 0.3 8.9 1.2 0.8 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 11.7 7.5 0.1 4.3 0.0 0.4 22.5 1.3 8.8 0.0 0.4 3.6 0.7 5.3 3.8 0.0 0.3 2.2 0.0 10.9 0.1 0.1 0.1 0.1 3.5 6.1 0.1 0.0 30.7 0.2 1.7 2.7 8.3 1.3 1.3 0.5 4.3 5.5 18.4 15.6 0.7 2.8 18.4 0.5 4.3 18.1 0.4 0.1 0.0 3.1 0.1 0.1 2.1 2.2 2.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 9.0 1.0 0.4 0.4 0.3 0.9 0.0 4.3 0.3 0.4 0.3 1.0 9.6 7.9 0.0 1.2 6.5 2.3 3.6 9.6 0.0 5.1 5.8 1.8 2.8 9.6 1.8 0.0 6.4 1.7 14.8 0.0 2.4 0.6 13.2 0.7 0.4 3.6 0.8 0.1 6.2 4.9 0.7 23.0 7.9 1.3 0.4 0.0 0.0 1.0 0.0 0.1 4.8 2.0 0.0 0.4 0.8 0.0 1.3 0.0 0.0 1.2 0.8 1.0 0.0 0.1 2.9 18.3 0.0 0.1 1.6 12.4 0.5 9.5 0.0 0.0 2.2 0.8 1.7 1.3 19.3 8.1 6.7 1.4 0.6 5.7 3.4 SCAND1 "RAZ1, SDP1" ENSG00000171222 "SCAN domain containing 1" P57086 20 35953617-35959472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 241.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071335 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA071335: " "unprognostic (3.88e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-2)" "unprognostic (4.09e-3)" "unprognostic (2.67e-2)" "unprognostic (1.56e-2)" "unprognostic (7.15e-3)" "unprognostic (3.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.48e-2)" 65.8 93.1 19.9 20.4 17.9 44.6 66.8 24.4 52.1 53.5 24.7 60.8 35.8 62.9 4.8 63.6 58.6 5.4 68.0 21.8 22.9 96.7 118.9 52.2 13.9 33.6 23.1 20.3 61.6 77.4 9.7 70.2 9.6 22.6 84.4 4.0 2.7 61.5 11.2 85.7 68.0 62.4 5.5 21.5 79.1 66.9 57.1 21.9 10.4 66.3 6.4 5.0 56.0 49.9 22.4 57.0 41.6 14.6 30.1 8.0 9.0 102.2 38.1 14.5 16.0 18.3 37.2 41.0 44.2 96.8 5.7 20.4 52.3 3.3 17.3 1.8 15.8 93.3 105.9 23.5 86.2 28.1 33.7 41.8 16.9 14.3 13.0 2.9 8.9 26.3 42.9 47.7 34.4 9.9 58.6 95.5 241.1 52.9 20.3 162.5 70.8 48.6 73.6 16.4 22.7 78.8 114.4 63.7 100.4 89.2 2.0 67.8 62.7 52.2 54.5 49.7 53.3 37.5 99.6 55.0 64.2 63.8 35.7 42.3 401.5 267.5 274.6 149.3 191.8 120.8 172.0 149.7 134.2 208.6 192.2 124.2 120.8 241.8 149.4 196.2 278.5 224.0 213.7 19.9 17.9 24.4 52.1 21.8 22.9 33.6 23.1 20.3 22.6 21.5 21.9 22.4 114.4 32.1 61.9 11.1 115.7 60.0 164.0 188.6 96.2 67.6 118.8 112.0 43.1 133.0 126.9 165.5 43.8 158.3 123.3 410.8 311.0 241.4 336.3 159.6 98.0 123.0 281.3 131.1 5.5 337.3 159.7 105.6 159.0 127.2 69.7 122.4 185.6 292.4 205.9 52.2 7.1 269.8 201.4 197.4 91.5 79.8 118.7 134.5 104.9 6.5 202.2 154.6 148.3 7.1 14.3 283.0 418.6 100.1 137.2 162.4 378.8 596.9 149.1 88.0 111.7 83.9 117.4 96.0 38.2 110.3 75.0 163.8 131.0 153.8 200.8 217.3 JUNB ENSG00000171223 "JunB proto-oncogene, AP-1 transcription factor subunit" P17275 19 12791486-12793315 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 257.6" "Immune cell enhanced" "Detected in all" "neutrophil: 679.4" "Group enriched" "Detected in all" 5 "granulocytes: 679.4;monocytes: 182.7" "Cell line enhanced" "Detected in all" "HDLM-2: 629.0;U-266/70: 256.4;U-266/84: 411.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004464, HPA019149" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004464: AB_2130023, HPA019149: AB_1852053" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.79e-1)" "unprognostic (9.78e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (7.20e-2)" "unprognostic (7.06e-2)" "unprognostic (3.77e-1)" "unprognostic (1.02e-1)" 481.9 261.6 31.8 111.3 25.6 459.1 250.7 76.5 67.0 183.1 41.3 259.5 53.3 131.1 2.2 452.7 882.8 93.4 306.5 24.4 257.6 170.3 281.3 402.7 65.5 84.9 26.5 13.7 654.9 151.3 21.0 354.7 39.7 28.3 196.7 22.2 32.3 132.7 56.6 145.8 502.1 146.3 58.7 49.5 154.6 312.4 30.3 36.0 79.5 200.3 73.9 13.0 335.8 333.4 58.5 52.9 10.4 2.8 6.4 11.3 27.4 10.2 22.8 19.2 11.0 10.0 6.8 30.4 18.2 77.4 8.4 33.5 98.5 2.5 34.3 1.2 629.0 9.9 18.0 42.2 9.0 15.1 24.3 80.5 34.9 97.6 10.0 7.5 22.0 5.3 12.9 48.1 32.6 3.6 158.8 16.8 147.5 1.7 36.1 40.0 22.4 7.7 38.8 7.5 65.5 23.7 36.0 98.4 59.5 30.5 1.7 10.5 27.0 17.6 32.2 18.7 64.3 28.9 256.4 411.4 17.1 37.7 62.7 8.9 29.1 132.2 132.2 33.4 182.7 33.4 30.6 36.8 42.0 87.1 25.4 25.5 28.5 679.4 18.6 177.2 7.9 38.7 124.1 31.8 25.6 76.5 67.0 24.4 257.6 84.9 26.5 13.7 28.3 49.5 36.0 58.5 3158.0 115.4 423.2 130.2 1751.7 1463.9 1778.3 2367.7 1985.1 81.0 1296.9 1693.1 374.0 474.7 707.4 154.5 39.6 129.7 1766.9 819.7 49.0 833.3 9.5 468.5 1091.4 1469.5 1502.1 244.8 8.7 546.7 224.7 2182.3 1060.1 627.8 510.5 310.0 852.4 84.6 1178.4 21.9 4.4 1029.3 740.6 674.1 2747.6 27.9 815.2 1583.3 894.6 20.6 379.3 634.6 115.4 4.5 2.4 1026.7 875.3 263.3 842.5 1036.7 701.0 84.2 337.3 168.8 1163.6 2566.6 2624.1 9.4 10.5 1164.3 1804.1 440.3 2362.6 417.0 687.7 472.6 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630247-69633596 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.4" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 19.4;Collecting duct cells: 16.5;Distal tubular cells: 11.7;Ductal cells: 24.3;Exocrine glandular cells: 18.4;Pancreatic endocrine cells: 20.7;Proximal tubular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "gdT-cell: 4.3;MAIT T-cell: 10.9;memory CD4 T-cell: 10.5;memory CD8 T-cell: 7.0;naive CD4 T-cell: 17.2;naive CD8 T-cell: 5.7;T-reg: 7.8" "Lineage enriched" "Detected in single" 25 "T-cells: 17.2" "Cell line enhanced" "Detected in many" "PC-3: 57.5" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.6 3.1 25.7 2.0 27.8 1.1 4.8 31.4 41.4 1.9 19.2 5.5 2.8 3.2 11.2 4.9 4.3 2.0 6.7 35.9 30.6 9.1 3.8 4.1 2.9 22.4 25.6 27.4 2.2 8.3 8.2 12.8 1.2 26.0 7.9 2.3 11.4 5.6 4.7 4.7 3.3 3.5 3.9 20.9 1.5 5.9 22.4 25.5 2.9 5.9 1.2 2.3 5.9 3.1 27.2 29.4 31.9 3.9 31.8 0.0 0.0 13.6 2.9 0.8 5.1 5.6 23.4 23.6 0.0 42.8 0.6 18.6 11.8 16.6 9.6 7.1 29.4 22.8 0.0 6.7 8.8 8.1 0.0 10.0 0.0 9.4 0.2 4.8 3.8 0.0 43.8 11.1 0.1 0.5 39.9 0.3 0.0 19.1 11.8 57.5 0.0 0.0 0.4 10.9 16.6 16.0 22.2 12.1 29.6 19.0 7.8 20.5 5.1 1.4 0.8 19.4 0.1 8.5 5.1 15.2 0.1 0.4 0.0 0.8 0.0 0.0 0.0 4.3 0.0 10.9 0.1 10.5 7.0 0.1 0.4 17.2 5.7 0.6 0.2 0.0 0.1 7.8 3.1 25.7 27.8 31.4 41.4 35.9 30.6 22.4 25.6 27.4 26.0 20.9 25.5 27.2 1.4 0.0 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.3 19.4 0.0 0.0 3.1 16.5 0.0 7.5 0.6 0.0 11.7 24.3 0.0 5.7 0.4 0.7 0.0 0.0 0.0 18.4 5.6 0.6 0.0 5.0 0.0 8.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.3 0.0 0.0 13.5 4.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.9 2.8 3.7 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438504 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 102.0;liver: 100.8;parathyroid gland: 125.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 179.9;Hepatocytes: 184.5;Muller glia cells: 146.8;Proximal enterocytes: 575.7;Proximal tubular cells: 188.1" "Cancer enhanced" "Detected in all" "renal cancer: 57.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "EFO-21: 26.9;Hep G2: 74.7;RPTEC TERT1: 60.0" "Low region specificity" "Detected in all" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 53.6 11.2 2.2 6.6 2.2 0.7 25.9 2.0 3.7 22.1 3.1 32.7 54.0 6.5 4.9 6.9 3.4 23.4 3.2 1.7 2.9 102.0 100.8 15.6 10.3 2.6 2.2 1.3 12.8 13.4 125.8 1.0 15.1 2.7 4.0 19.2 23.8 7.1 7.7 2.4 8.3 76.7 4.8 2.6 25.9 18.3 5.1 3.2 3.0 31.3 4.3 5.0 7.0 5.7 3.2 0.0 7.3 0.7 0.3 4.3 0.4 1.0 0.2 0.1 0.0 0.1 11.4 6.4 0.0 26.9 3.4 0.6 1.7 3.0 0.0 0.0 0.0 2.9 1.0 4.0 74.7 5.9 0.0 0.1 9.7 0.0 0.0 0.0 0.2 5.9 0.0 0.2 10.9 0.0 0.7 0.0 0.8 5.4 0.1 0.2 0.0 0.1 9.9 60.0 4.9 0.9 0.4 0.3 2.9 0.0 5.0 1.2 1.7 3.8 0.0 10.4 1.8 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.2 2.2 2.0 3.7 1.7 2.9 2.6 2.2 1.3 2.7 2.6 3.2 3.2 12.2 25.6 9.6 0.0 3.2 2.0 0.3 11.1 0.0 2.4 1.8 1.5 2.1 82.9 13.6 18.4 0.0 64.9 0.1 179.9 50.9 36.1 0.3 7.7 98.8 15.1 9.1 5.3 0.0 52.3 3.8 17.9 11.7 10.3 1.3 16.4 61.8 184.5 64.6 6.7 0.0 22.0 14.2 65.5 5.0 1.9 49.7 19.5 1.8 0.0 0.6 146.8 0.0 0.0 0.6 15.3 68.1 3.8 0.0 0.1 575.7 188.1 7.6 17.4 0.0 0.9 14.8 0.0 0.8 1.0 2.8 104.1 2.4 45.3 23.3 2.3 UGT2B7 UGT2B9 ENSG00000171234 "UDP glucuronosyltransferase family 2 member B7" P16662 4 69051363-69112987 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "kidney: 1311.9;liver: 1625.3" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5" "Group enriched" "Detected in many" 7 "liver cancer: 116.4;renal cancer: 101.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 310.8" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic favorable (7.65e-5)" "unprognostic (1.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-2)" "unprognostic (5.41e-3)" "unprognostic (1.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" "prognostic favorable (3.79e-4)" "unprognostic (1.08e-2)" "unprognostic (2.55e-1)" "unprognostic (6.23e-3)" "prognostic favorable (5.38e-4)" 0.3 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 32.3 0.0 3.8 69.3 9.0 24.4 0.2 50.4 10.5 0.0 0.0 0.0 1311.9 1625.3 0.4 0.0 0.0 0.0 0.0 0.1 10.0 0.0 0.0 0.1 0.0 0.3 7.0 0.0 3.6 27.8 0.0 0.3 67.1 0.3 0.0 0.0 0.9 0.1 0.0 0.9 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.3 0.0 0.0 77.6 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 41.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.1 0.6 0.1 310.8 2.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 43.2 0.0 0.0 0.0 0.2 0.3 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.6 1.6 0.0 0.0 1.2 0.6 0.1 38.6 2.1 125.0 0.0 0.0 0.0 5.7 97.8 6.6 0.3 150.6 14.0 1.0 3.5 2.7 0.4 10.6 0.0 0.1 0.0 234.7 0.0 0.0 8.9 550.8 0.1 0.0 0.3 37.3 0.0 13.8 0.0 0.0 1.8 7.6 3.6 0.0 0.0 0.0 0.0 1.5 0.4 13.0 10.7 0.0 0.0 0.6 70.6 1249.5 0.5 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 6.3 0.1 5.9 2.3 LRG1 LRG ENSG00000171236 "Leucine rich alpha-2-glycoprotein 1" P02750 19 4536402-4540036 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "liver: 952.0" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 793.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 160.9" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 19 "neutrophil: 285.2" "Lineage enriched" "Detected in many" 44 "granulocytes: 285.2" "Cell line enhanced" "Detected in many" "Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7" "Low region specificity" "Detected in single" "HPA001888, HPA001889" Enhanced Approved Vesicles "Secreted to blood" NA NA 21000000000 42000000000 Vesicles "HPA001888: AB_1079276, HPA001889: AB_1079275" "unprognostic (5.54e-3)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.46e-3)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.66e-6)" "unprognostic (4.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.49e-4)" "unprognostic (2.60e-2)" 5.5 4.6 0.6 17.9 0.5 31.7 4.3 1.1 2.3 8.7 1.2 7.4 6.8 1.9 5.9 22.9 10.1 15.6 1.1 0.6 0.6 7.9 952.0 7.9 0.8 0.7 0.6 0.5 1.6 44.5 0.1 1.6 1.9 1.9 4.4 4.7 0.2 21.1 6.2 1.0 4.3 3.4 2.2 0.4 16.4 13.8 0.3 0.8 1.2 1.3 1.4 6.5 13.4 3.8 1.3 10.8 0.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 1.0 8.0 3.6 13.3 0.0 0.5 1.4 0.0 1.7 0.1 13.4 0.4 0.3 0.2 15.4 0.0 0.4 13.9 4.1 0.0 0.0 0.0 0.0 0.1 0.0 9.6 0.2 0.0 0.6 0.0 11.3 0.2 8.2 0.0 0.1 0.3 11.3 1.0 2.0 0.0 0.0 0.1 15.7 0.1 1.3 4.8 26.2 0.3 0.0 0.2 0.1 0.2 0.1 0.1 0.2 0.0 48.7 0.0 2.4 6.4 15.0 0.1 2.0 0.1 0.4 0.3 0.1 1.6 0.4 0.1 0.1 285.2 0.2 1.3 0.2 1.1 2.2 0.6 0.5 1.1 2.3 0.6 0.6 0.7 0.6 0.5 1.9 0.4 0.8 1.3 13.4 12.8 54.3 0.0 3.3 8.0 33.1 56.8 18.2 0.1 14.2 2.5 0.5 60.1 50.2 14.7 0.0 0.8 0.5 44.7 1.9 112.7 0.0 38.0 1.8 24.7 4.9 13.2 0.0 64.1 12.4 3.0 31.6 17.3 12.0 0.2 38.2 793.0 6.7 1.7 0.0 26.3 32.6 19.9 5.0 0.0 0.0 14.7 1.8 0.0 7.3 0.1 0.0 0.0 0.0 40.6 11.9 0.0 1.7 4.5 10.8 4.9 76.1 0.1 0.0 2.3 3.3 0.0 0.2 9.0 5.8 1.4 1.9 3.4 27.6 30.2 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46578591-46621379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 0.7 0.5 0.5 5.2 0.6 17.6 0.9 1.3 0.6 0.4 0.5 1.9 1.2 0.6 0.6 3.5 0.2 0.6 0.9 0.5 0.4 3.5 0.2 1.0 9.9 0.4 0.4 0.6 0.4 0.2 0.2 0.2 2.4 0.8 0.3 2.2 0.2 0.8 0.2 1.6 3.3 1.5 1.7 0.2 4.4 0.9 5.2 0.5 8.9 0.3 0.2 10.7 1.2 1.2 0.8 33.8 30.8 11.9 15.3 3.1 6.2 16.2 60.7 24.6 59.2 26.8 14.6 20.8 28.0 30.2 28.8 26.8 21.0 29.3 21.7 73.8 17.7 17.2 28.2 25.8 30.3 0.1 28.5 35.4 1.2 1.6 45.9 18.1 5.9 33.0 14.9 12.7 28.3 69.7 21.5 24.0 23.7 10.0 17.2 31.6 45.4 89.9 44.8 13.7 9.4 5.0 7.2 46.0 23.7 11.1 11.4 13.0 23.4 16.1 43.9 28.7 43.5 54.0 24.9 36.7 46.7 21.4 31.3 45.8 0.2 0.3 0.6 0.2 0.5 0.0 1.7 0.3 0.1 0.3 1.2 0.0 0.1 0.4 0.1 2.4 0.7 1.2 1.1 0.5 0.6 1.3 0.6 0.5 0.4 0.4 0.4 0.6 0.8 0.2 0.5 0.8 0.2 0.0 1.1 1.3 7.1 1.7 0.7 1.2 0.0 0.3 0.6 1.1 1.9 1.5 1.4 0.0 0.0 11.3 0.8 1.9 0.0 0.2 8.4 0.7 1.7 1.7 0.0 36.2 2.1 0.0 28.7 3.7 4.1 1.5 0.0 7.6 1.8 0.3 12.6 0.0 0.7 2.2 2.0 4.5 3.3 2.3 0.6 4.0 1.8 2.8 2.8 0.8 0.0 1.0 0.5 0.1 0.1 0.4 38.3 0.5 0.4 0.1 0.1 0.3 0.0 0.5 6.3 33.7 23.7 3.6 0.6 3.7 2.2 0.8 3.4 1.1 SOSTDC1 "DAND7, DKFZp564D206, USAG1" ENSG00000171243 "Sclerostin domain containing 1" Q6X4U4 7 16461481-16530580 "Predicted secreted proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 91.8;lung: 39.5;stomach 1: 61.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 68.5;Distal tubular cells: 29.4;Gastric mucus-secreting cells: 76.5;Horizontal cells: 30.3;Ionocytes: 128.1;Melanocytes: 32.0" "Cancer enhanced" "Detected in many" "renal cancer: 25.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;EFO-21: 12.7;HEL: 4.8;NTERA-2: 4.9;RPTEC TERT1: 23.5" "Group enriched" "Detected in many" 5 "basal ganglia: 9.2;hippocampal formation: 18.4;pons and medulla: 15.1;thalamus: 11.9" "Low region specificity" "Detected in many" HPA042856 Uncertain "Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "Nucleoli, Nucleoli rim, Vesicles" "HPA042856: " "unprognostic (2.08e-2)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.17e-3)" "unprognostic (5.59e-3)" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.69e-4)" "unprognostic (2.59e-1)" "unprognostic (2.62e-1)" "prognostic favorable (3.22e-5)" "unprognostic (7.01e-2)" "unprognostic (1.23e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (8.72e-4)" 0.2 0.5 1.5 0.9 3.2 0.1 18.1 1.8 3.5 2.6 91.8 11.1 11.7 4.8 0.3 3.8 5.0 0.3 3.2 3.8 1.4 22.5 0.0 39.5 0.1 1.1 1.7 2.0 1.1 0.6 0.6 2.4 0.0 0.7 1.8 15.2 3.1 15.7 3.6 0.1 16.9 8.6 1.1 0.6 0.1 61.0 2.0 1.7 0.1 8.7 0.9 3.9 1.4 3.6 2.2 0.0 0.0 7.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 12.7 0.0 0.0 0.3 0.4 0.0 0.0 0.1 2.6 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.3 0.1 0.0 0.1 0.7 0.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 1.8 3.5 3.8 1.4 1.1 1.7 2.0 0.7 0.6 1.7 2.2 0.4 0.0 0.0 0.0 0.2 5.6 4.3 2.1 9.1 0.6 68.5 17.8 3.8 0.0 2.0 14.7 0.0 0.0 0.4 1.2 29.4 0.0 19.7 1.0 0.1 2.9 2.4 0.0 0.0 0.0 0.0 3.9 76.5 1.5 0.0 0.0 0.4 0.1 0.0 30.3 0.0 0.2 128.1 0.0 1.2 13.0 7.2 0.4 32.0 0.0 0.0 14.2 0.0 0.0 0.0 0.4 2.2 2.6 0.4 1.1 0.0 21.8 0.0 0.7 0.0 0.1 0.3 3.4 1.2 14.1 7.2 0.0 0.9 0.0 2.3 1.5 NPTX1 ENSG00000171246 "Neuronal pentraxin 1" Q15818 17 80466834-80477843 "Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 113.8" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 175.2;Excitatory neurons: 88.6;Late spermatids: 44.8" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 32.0;HeLa: 26.0;SiHa: 40.7;U-138 MG: 85.2;WM-115: 120.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 55.3;cerebellum: 128.1;cerebral cortex: 102.2;hippocampal formation: 131.3" HPA077062 Enhanced Approved "Secreted in brain" NA NA 1100000 "HPA077062: AB_2732329" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-2)" "unprognostic (6.95e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.63e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "unprognostic (9.63e-3)" "unprognostic (1.05e-6)" "unprognostic (1.41e-4)" "unprognostic (1.35e-1)" "unprognostic (8.86e-6)" "unprognostic (2.71e-3)" 0.4 5.2 99.5 1.0 90.2 0.1 0.4 90.1 81.8 0.1 0.0 23.7 0.7 0.8 2.2 0.8 0.8 1.2 0.0 113.8 15.5 0.2 0.0 1.3 0.9 26.0 8.4 88.9 0.6 0.2 0.0 2.4 1.2 31.8 0.7 2.1 13.1 0.0 2.5 2.7 3.3 4.2 0.8 3.9 2.1 3.9 1.3 11.8 12.0 0.2 0.7 0.1 0.6 0.1 85.3 0.0 2.0 0.5 0.2 0.4 0.5 0.0 2.0 0.0 0.1 0.0 0.7 0.2 0.0 0.3 0.2 3.5 0.1 32.0 0.0 0.0 0.0 20.2 0.0 26.0 0.1 0.1 0.0 1.4 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.0 6.5 0.0 0.0 8.3 0.0 0.0 21.4 0.0 40.7 0.1 0.0 0.3 0.1 0.6 0.3 85.2 0.0 4.2 0.2 0.0 0.0 0.0 0.2 0.0 120.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 99.5 90.2 90.1 81.8 113.8 15.5 26.0 8.4 88.9 31.8 3.9 11.8 85.3 1.3 0.0 0.0 8.1 0.3 1.5 0.1 0.0 0.0 12.8 0.7 2.2 3.0 0.0 0.6 0.0 175.2 0.1 0.6 0.3 0.0 0.0 8.2 0.3 0.4 1.2 0.0 0.0 88.6 0.0 0.2 0.9 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 11.0 0.7 0.0 0.0 0.0 44.8 0.9 0.6 0.0 6.5 0.0 0.8 0.0 5.0 5.8 0.6 0.0 2.2 0.1 0.5 0.0 0.0 0.0 4.1 0.0 1.6 1.1 1.6 0.4 0.1 3.0 0.1 0.1 0.5 0.1 0.0 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles NA NA 20000 "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 12.8 11.5 11.7 12.9 11.9 9.8 13.0 18.0 12.9 9.8 9.1 15.5 9.7 13.4 9.1 9.1 8.1 7.1 12.5 11.9 11.9 13.2 7.8 8.2 13.9 11.1 11.7 10.7 11.3 6.2 19.5 6.5 12.1 11.6 12.2 11.7 20.0 6.4 10.1 14.0 8.8 10.1 9.6 11.3 11.3 9.5 8.5 11.4 28.9 11.9 16.4 13.5 12.0 7.1 14.1 30.7 16.2 77.7 40.0 14.1 25.7 37.9 38.6 28.2 37.4 37.5 35.8 14.4 21.1 41.4 32.2 37.9 31.8 47.4 39.5 52.2 21.8 25.7 62.6 33.9 27.8 20.4 59.8 34.6 23.9 24.1 33.3 38.5 27.4 38.9 45.7 45.6 25.7 36.0 13.8 50.7 31.8 42.0 34.8 22.3 53.3 42.0 17.7 32.8 39.9 47.8 48.9 42.5 27.0 19.8 34.6 33.0 36.6 32.7 42.1 51.5 28.2 44.0 47.6 46.1 78.3 23.1 38.9 44.8 2.3 0.5 1.4 2.8 0.4 2.4 1.6 2.8 2.3 0.6 1.9 3.4 2.6 0.4 2.2 0.6 1.4 1.9 0.4 11.7 11.9 18.0 12.9 11.9 11.9 11.1 11.7 10.7 11.6 11.3 11.4 14.1 17.9 16.0 21.4 16.3 16.8 14.7 12.7 14.1 14.2 36.8 15.2 11.6 48.9 12.8 18.1 16.5 16.7 30.6 16.4 11.0 7.9 16.4 3.4 19.1 21.5 16.9 12.6 16.6 22.5 19.8 22.4 16.6 16.8 17.0 13.3 18.4 16.8 13.1 12.6 20.2 20.5 22.6 12.2 15.8 12.2 2.5 12.5 10.9 5.4 18.7 21.4 18.5 21.6 12.1 23.8 14.3 9.8 17.0 18.2 12.4 11.1 12.7 18.8 27.9 6.6 21.5 16.2 27.2 17.1 19.7 14.8 21.5 15.3 14.7 19.3 14.1 ZNF439 DKFZp571K0837 ENSG00000171291 "Zinc finger protein 439" Q8NDP4 19 11848726-11883750 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Rod photoreceptor cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 26.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.4;U-138 MG: 15.6" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (4.83e-2)" "unprognostic (3.55e-3)" "unprognostic (2.93e-2)" "unprognostic (1.19e-3)" "unprognostic (8.26e-3)" "unprognostic (7.54e-2)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "unprognostic (9.66e-4)" "unprognostic (1.00e-1)" "unprognostic (8.68e-2)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.29e-2)" 2.5 3.5 4.0 3.6 4.9 4.2 5.7 8.3 5.2 4.2 4.3 4.6 1.1 5.3 5.0 3.2 4.1 2.4 3.5 4.2 4.2 6.1 1.3 5.1 7.4 4.7 4.4 4.1 8.2 4.1 16.7 10.2 5.3 5.2 6.3 3.8 14.8 5.4 4.5 0.8 8.0 8.1 2.7 4.1 9.4 3.9 5.8 4.2 10.1 7.4 1.1 7.7 5.6 4.9 6.8 0.1 0.0 4.2 12.2 0.4 0.3 0.0 5.2 1.8 6.2 4.2 3.0 0.2 4.5 2.2 2.9 1.8 0.1 0.0 0.4 7.2 0.0 0.1 4.4 0.0 1.8 1.2 0.0 4.2 1.2 0.3 1.3 0.0 2.7 0.0 4.2 0.8 0.0 0.4 0.4 6.2 15.4 5.1 0.0 1.2 7.3 1.2 0.0 4.6 2.6 7.5 8.0 0.0 0.1 5.6 4.3 3.2 10.0 0.0 15.6 1.4 1.3 3.1 6.0 10.1 10.1 0.2 0.0 4.3 26.1 0.6 5.7 1.7 1.6 2.3 8.9 3.0 1.7 2.8 8.6 5.4 3.1 1.6 2.2 3.5 2.7 1.4 1.9 4.0 4.9 8.3 5.2 4.2 4.2 4.7 4.4 4.1 5.2 4.1 4.2 6.8 3.1 3.2 10.4 15.0 23.9 0.5 2.5 1.6 3.4 26.2 3.9 4.6 3.5 11.5 6.8 0.0 52.1 32.8 8.3 9.2 3.9 8.2 4.5 6.5 5.1 4.6 6.1 3.0 19.2 1.8 22.2 3.8 4.1 4.4 29.8 11.2 6.1 0.2 4.2 16.8 8.7 2.3 2.0 1.9 3.1 3.8 4.4 2.7 5.4 14.0 2.4 10.4 25.7 31.7 28.3 3.0 6.0 7.9 4.1 2.1 6.5 2.1 5.8 49.9 13.1 1.8 5.9 21.7 5.8 1.1 1.8 13.5 7.4 2.8 3.1 1.3 ZNF440 FLJ37933 ENSG00000171295 "Zinc finger protein 440" Q8IYI8 19 11814273-11835216 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 44.8;Respiratory ciliated cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 12.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "RT4: 25.5" HPA047845 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.48e-1)" "unprognostic (8.96e-3)" "unprognostic (1.34e-1)" "unprognostic (4.40e-2)" "unprognostic (2.45e-3)" "unprognostic (1.24e-3)" "unprognostic (1.03e-1)" "unprognostic (3.13e-2)" "unprognostic (9.05e-2)" "unprognostic (4.64e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.57e-4)" "prognostic favorable (1.18e-4)" "unprognostic (9.81e-3)" "unprognostic (2.22e-1)" "unprognostic (3.80e-2)" "prognostic favorable (9.88e-4)" 3.6 4.0 3.1 3.4 2.6 7.0 6.8 6.6 3.8 6.1 6.3 10.1 5.7 4.4 4.8 9.9 14.7 4.3 3.1 4.5 1.8 4.4 3.8 7.0 4.3 3.9 3.1 3.1 3.8 5.5 16.6 2.8 9.7 3.5 6.4 11.2 7.2 7.1 4.3 4.3 15.3 7.1 3.5 1.7 4.3 8.7 6.5 2.9 8.1 4.1 2.2 5.2 11.7 7.1 4.9 6.7 0.0 7.3 8.9 5.4 4.8 19.4 4.6 3.8 5.5 4.7 7.0 5.7 3.7 4.4 4.2 2.7 8.2 3.8 8.9 7.6 0.3 2.5 5.2 4.8 5.6 2.7 0.1 11.5 2.7 5.8 3.4 0.9 3.9 3.1 5.0 19.9 0.3 6.4 2.8 4.7 6.9 5.6 2.3 5.8 3.9 9.5 1.6 4.0 25.5 4.2 3.3 7.2 3.0 5.3 7.8 12.9 10.3 3.3 12.5 2.6 9.2 4.1 6.7 5.2 4.9 5.8 3.3 4.6 12.6 1.4 1.9 1.1 0.9 1.4 1.0 1.4 1.3 1.8 1.1 1.0 1.6 2.5 3.0 2.9 1.1 1.8 0.8 3.1 2.6 6.6 3.8 4.5 1.8 3.9 3.1 3.1 3.5 1.7 2.9 4.9 3.9 16.0 7.9 7.2 2.5 2.9 7.6 5.2 8.0 5.5 3.4 2.7 3.0 1.5 14.6 9.2 35.5 31.1 5.8 25.1 3.9 3.6 16.7 44.8 3.8 4.2 6.7 2.1 10.4 3.6 20.7 3.1 15.3 11.9 10.8 3.3 4.2 1.7 4.5 6.7 6.7 12.7 2.0 5.0 2.8 5.7 2.8 3.0 3.6 2.8 2.2 2.0 4.1 10.6 5.8 5.8 15.9 1.9 2.5 5.7 20.8 2.1 74.1 13.1 0.0 3.9 4.1 9.7 3.5 9.0 4.8 29.8 4.6 1.1 12.1 9.8 GAA ENSG00000171298 "Glucosidase alpha, acid" P10253 17 80101556-80119881 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 156.2;Extravillous trophoblasts: 143.9;Kupffer cells: 122.7;Syncytiotrophoblasts: 166.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 66.6;eosinophil: 22.8;intermediate monocyte: 50.3;myeloid DC: 39.7;neutrophil: 27.0;non-classical monocyte: 68.5" "Group enriched" "Detected in all" 10 "dendritic cells: 39.7;granulocytes: 27.0;monocytes: 68.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026970, HPA029126" Enhanced Approved Vesicles NA NA 3800000 Vesicles "HPA026970: AB_2672065, HPA029126: AB_2672918" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (2.94e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-2)" "unprognostic (2.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.29e-2)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (7.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.78e-2)" "unprognostic (1.18e-1)" 30.2 30.2 14.4 22.8 16.4 16.9 30.4 16.6 26.7 24.6 16.1 28.6 24.9 31.5 35.5 16.0 29.3 30.2 34.1 15.7 25.1 37.7 47.7 44.8 22.7 24.0 16.9 12.2 18.9 37.6 33.6 39.1 48.9 27.2 33.4 8.8 6.6 38.0 23.8 47.4 25.1 27.1 14.7 18.1 54.7 27.1 56.5 19.9 20.6 32.9 25.4 7.1 31.8 22.2 24.2 35.6 67.8 13.2 43.2 40.4 40.2 85.1 21.8 39.6 16.2 13.2 20.3 56.3 12.7 56.5 17.3 13.8 14.8 4.1 25.2 3.8 16.5 49.9 0.2 12.8 73.3 69.7 1.7 40.4 86.7 35.4 30.6 10.5 32.8 28.9 33.5 12.9 51.5 12.4 81.3 6.0 8.4 27.3 8.7 46.8 30.9 44.8 22.2 13.1 36.5 15.1 43.4 28.5 31.3 39.0 8.1 89.5 50.1 18.8 59.7 31.5 43.6 8.1 121.4 36.5 3.8 19.1 32.8 38.4 0.6 66.6 22.8 3.7 50.3 4.4 3.1 2.8 3.8 39.7 3.0 3.2 2.3 27.0 3.0 68.5 9.5 2.1 32.9 14.4 16.4 16.6 26.7 15.7 25.1 24.0 16.9 12.2 27.2 18.1 19.9 24.2 21.9 19.2 41.3 31.6 9.3 11.2 19.6 38.7 8.0 16.1 24.1 28.2 19.9 24.3 24.7 14.7 8.4 156.2 11.8 11.5 5.9 25.2 55.7 14.3 16.7 21.6 6.1 4.8 16.2 15.8 143.9 33.0 20.4 27.8 8.8 28.5 23.6 26.4 99.8 11.8 18.9 10.9 12.2 122.7 29.6 29.3 23.9 83.9 24.9 20.6 39.1 32.1 8.2 11.6 12.5 9.4 13.5 19.2 12.9 20.2 31.4 21.5 9.3 18.5 6.6 15.0 13.9 66.0 29.4 10.3 8.4 166.2 8.2 30.2 14.4 14.8 CANT1 "SCAN-1, SHAPY" ENSG00000171302 "Calcium activated nucleotidase 1" Q8WVQ1 17 78991716-79009867 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 445.4;T-47d: 282.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019627, HPA019639, HPA022818" Enhanced Supported "Golgi apparatus" NA Yes 3300000 "Golgi apparatus" "HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971" "unprognostic (1.98e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-2)" "unprognostic (5.36e-2)" "unprognostic (2.13e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.41e-4)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (7.04e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" 15.1 24.0 10.6 25.0 11.2 19.2 25.6 12.8 11.4 32.6 12.6 90.0 52.3 17.5 8.7 45.1 18.4 25.4 16.7 10.4 14.6 15.7 17.4 16.5 15.4 14.1 13.9 9.0 14.8 19.8 24.7 17.6 26.2 12.9 72.4 83.6 7.5 63.2 32.7 15.0 14.6 56.0 15.7 14.5 26.7 51.5 20.8 13.7 14.9 14.0 12.5 15.2 16.8 21.9 17.6 106.5 112.1 31.9 46.3 29.7 35.2 38.9 66.0 51.3 66.7 55.9 53.8 99.6 25.3 36.1 46.1 83.0 53.7 27.1 49.8 68.4 43.0 46.4 33.7 34.1 45.9 25.0 33.0 51.6 33.7 32.4 62.7 34.2 40.9 116.1 42.5 42.3 43.2 46.4 58.4 50.2 19.8 22.1 445.4 103.1 27.6 51.8 29.8 29.8 53.5 45.6 45.4 33.9 227.2 50.2 50.3 282.6 38.6 56.6 101.9 90.5 46.4 83.1 48.9 43.8 24.3 64.4 24.9 65.3 6.3 4.0 8.7 5.5 4.4 5.7 3.9 4.3 4.8 3.8 2.5 4.1 4.1 17.4 3.1 3.0 2.7 3.6 4.6 10.6 11.2 12.8 11.4 10.4 14.6 14.1 13.9 9.0 12.9 14.5 13.7 17.6 12.6 28.9 20.6 5.9 11.8 16.6 15.3 16.8 6.8 6.4 49.9 16.3 13.3 14.3 15.1 12.9 14.6 36.6 8.9 139.5 3.9 34.7 14.0 10.7 13.1 16.3 51.0 15.2 4.1 28.8 39.4 13.5 38.2 19.0 5.7 20.0 41.7 14.4 24.9 5.0 5.2 155.6 16.2 12.4 9.5 15.7 11.8 14.2 14.2 3.7 18.1 8.1 11.3 5.0 10.2 37.7 55.8 7.5 16.6 33.4 39.4 6.7 9.7 8.7 6.6 9.5 13.3 23.9 5.8 12.0 13.1 101.5 11.1 11.3 100.2 19.4 KCNK3 "K2p3.1, TASK, TASK-1, TASK1" ENSG00000171303 "Potassium two pore domain channel subfamily K member 3" O14649 2 26692690-26733420 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "adrenal gland: 183.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 82.1;Collecting duct cells: 103.0;Enteroendocrine cells: 23.4;Exocrine glandular cells: 95.2" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.1;EFO-21: 11.0;HeLa: 3.6;SCLC-21H: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-4)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (2.16e-1)" "unprognostic (3.31e-1)" "unprognostic (5.48e-2)" "unprognostic (3.77e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (3.09e-2)" "unprognostic (7.45e-2)" "unprognostic (1.44e-2)" "unprognostic (9.24e-3)" 3.5 183.1 5.2 1.4 4.8 0.1 2.9 4.7 9.4 7.5 0.0 5.2 1.2 6.4 1.5 2.1 4.0 1.2 7.7 3.4 7.9 2.7 0.5 25.9 0.1 22.0 15.0 5.7 2.1 35.8 12.2 8.4 25.0 26.9 6.4 0.9 3.3 0.5 3.3 0.8 0.5 2.5 2.7 4.8 1.1 4.2 0.6 17.6 0.2 3.6 0.0 0.0 4.2 2.8 34.6 0.0 0.7 0.2 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 11.0 0.0 1.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 0.0 25.9 2.3 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 5.2 4.8 4.7 9.4 3.4 7.9 22.0 15.0 5.7 26.9 4.8 17.6 34.6 0.3 0.0 2.8 0.3 0.1 0.0 0.2 0.3 0.0 82.1 0.2 3.6 12.7 0.0 0.0 103.0 0.0 0.2 0.1 0.0 0.0 1.0 0.4 0.3 7.7 1.2 23.4 0.0 2.1 95.2 0.2 2.7 0.0 0.2 0.0 1.2 0.4 0.0 0.4 1.7 14.5 1.8 0.0 0.0 0.9 1.9 0.9 0.3 0.0 0.0 0.6 1.4 0.0 1.5 0.3 19.2 0.0 0.0 0.3 1.6 0.1 0.1 0.0 4.1 6.6 0.6 4.9 0.0 1.5 0.0 0.1 0.5 0.4 11.5 0.1 0.4 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type palmitoyltransferase 16" Q969W1 10 97446170-97457370 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 13.9 15.0 17.5 10.3 18.1 6.8 16.5 19.5 22.0 15.1 15.7 17.0 14.5 16.5 18.6 20.1 12.3 10.0 20.7 17.9 17.2 23.1 30.5 20.9 11.4 17.4 17.7 17.4 16.1 23.0 25.7 16.9 21.8 17.1 18.4 17.5 17.6 24.4 12.3 26.0 13.3 14.8 16.7 15.8 14.6 24.3 17.4 18.4 12.7 16.1 28.2 15.2 17.3 15.4 16.8 50.7 57.4 37.9 47.1 58.7 40.4 38.7 54.6 72.1 61.2 58.4 45.7 43.6 44.4 60.1 79.8 53.4 58.0 48.2 76.7 54.2 43.7 56.0 28.5 39.8 44.3 47.4 34.0 39.7 45.7 49.8 71.6 51.3 66.3 63.9 40.4 23.1 32.8 79.0 48.4 51.8 46.0 29.9 45.8 49.5 34.0 38.6 40.9 51.9 23.2 18.4 25.9 33.2 33.7 30.6 37.7 44.6 32.9 39.6 38.2 35.0 25.0 64.7 29.2 53.0 26.9 44.1 51.7 20.7 0.3 11.1 11.1 7.2 11.9 8.1 9.0 12.5 11.5 15.7 10.6 10.0 10.1 0.5 14.5 11.8 12.0 11.1 6.8 17.5 18.1 19.5 22.0 17.9 17.2 17.4 17.7 17.4 17.1 15.8 18.4 16.8 6.2 19.2 23.1 3.9 9.0 5.2 18.9 31.8 14.8 15.8 13.6 9.3 10.1 14.3 27.6 12.9 4.2 39.8 10.3 11.5 25.4 35.5 24.8 7.0 13.3 11.3 7.2 11.6 8.2 32.3 67.2 13.7 10.2 10.9 7.0 13.3 7.5 19.5 24.6 13.5 9.2 18.9 28.5 7.3 5.9 7.6 8.7 9.3 3.6 9.4 18.4 14.9 15.5 11.1 8.4 31.5 12.1 3.8 17.1 20.0 18.9 22.2 8.3 13.0 6.6 5.2 12.2 20.1 12.9 13.8 4.3 37.9 7.2 10.9 20.9 19.3 CHST11 "C4ST, C4St-1, C4ST1, HSA269537" ENSG00000171310 "Carbohydrate sulfotransferase 11" Q9NPF2 12 104455295-104762014 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.4;choroid plexus: 50.2" "Group enriched" "Detected in many" 4 "Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052828 Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 55000 "Golgi apparatus" "HPA052828: AB_2681966" "unprognostic (6.35e-2)" "unprognostic (2.68e-3)" "unprognostic (2.28e-2)" "unprognostic (7.53e-2)" "unprognostic (3.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.64e-3)" "unprognostic (9.21e-3)" "unprognostic (3.12e-1)" "unprognostic (9.02e-2)" "unprognostic (1.22e-2)" "unprognostic (5.44e-2)" "prognostic unfavorable (7.59e-11)" "unprognostic (1.64e-2)" "unprognostic (5.60e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (8.42e-4)" 4.9 10.3 14.6 20.3 14.2 39.4 3.5 11.8 14.0 5.1 50.2 4.2 3.0 12.1 13.4 3.4 3.7 9.5 4.1 15.0 28.3 3.0 3.0 12.4 15.3 17.5 14.7 9.5 6.2 4.6 1.3 4.6 15.6 17.0 4.0 4.1 2.2 2.2 8.1 1.1 1.7 6.3 11.0 14.3 13.0 6.4 2.4 17.4 19.7 3.3 1.0 11.8 8.4 3.8 19.6 38.8 18.2 8.2 5.3 20.5 10.0 27.8 3.1 1.2 1.8 1.5 0.0 51.2 0.2 5.6 5.4 42.3 9.9 4.9 20.8 2.2 0.4 7.1 53.2 4.8 0.2 3.1 62.4 60.6 3.7 2.9 32.9 5.4 30.7 13.2 74.4 82.8 13.2 3.5 9.7 47.8 73.1 6.6 0.4 7.0 54.0 27.3 12.9 17.0 0.4 13.6 21.9 2.1 26.3 48.3 7.2 7.7 62.7 29.2 5.7 6.2 29.4 32.3 67.2 75.9 10.6 26.3 43.5 57.7 12.7 1.4 11.2 3.0 1.4 1.7 1.0 1.5 2.2 0.8 2.8 0.7 1.9 15.6 1.6 1.3 2.9 3.2 0.8 14.6 14.2 11.8 14.0 15.0 28.3 17.5 14.7 9.5 17.0 14.3 17.4 19.6 8.4 16.0 13.1 142.4 33.8 2.8 18.2 2.6 4.0 3.1 0.5 1.1 5.7 1.5 6.4 5.5 0.0 41.6 45.6 0.1 0.0 4.9 0.9 1.3 24.7 12.9 0.0 36.2 43.8 61.4 12.0 9.5 2.6 0.9 41.3 1.4 18.2 0.5 42.6 10.1 114.4 0.0 0.0 26.8 42.9 2.0 7.5 56.5 3.6 281.1 65.6 2.3 30.9 1012.8 3.5 28.6 0.0 17.0 64.0 3.9 0.0 6.0 8.1 0.6 6.6 1.8 12.8 0.6 2.5 0.9 2.8 26.5 49.0 15.5 0.3 3.7 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97435909-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 21.8 25.6 34.8 23.7 36.7 28.9 22.6 53.4 40.2 24.7 31.0 24.5 24.5 24.2 43.0 28.6 22.4 17.2 22.7 32.7 34.1 24.1 27.1 20.7 32.6 36.4 35.1 30.7 23.8 39.2 21.3 24.4 17.7 37.3 24.7 23.7 21.4 26.8 17.4 29.3 23.6 22.5 22.3 34.9 30.5 31.5 15.3 36.7 32.8 21.8 14.9 32.2 25.5 23.1 38.0 62.9 49.6 34.8 61.7 42.1 44.3 47.0 52.2 73.9 57.2 64.4 86.5 62.1 60.4 59.0 50.2 44.1 64.0 52.5 58.9 56.6 77.3 61.3 39.5 48.0 68.9 74.5 94.2 46.1 45.8 77.9 69.6 101.3 70.2 66.3 90.5 45.6 108.0 43.2 70.3 88.0 153.3 58.1 64.7 43.2 65.8 43.4 106.4 39.4 32.8 20.4 38.3 38.6 30.0 87.6 44.1 71.2 113.2 43.6 31.9 40.1 50.4 117.6 72.5 103.1 119.5 54.3 113.2 26.3 79.0 91.0 93.5 75.5 132.8 96.5 109.6 93.1 87.9 96.4 94.7 89.4 78.1 35.7 57.9 121.7 82.9 144.0 86.4 34.8 36.7 53.4 40.2 32.7 34.1 36.4 35.1 30.7 37.3 34.9 36.7 38.0 22.5 25.6 24.6 15.0 42.4 19.1 35.7 59.3 18.2 31.0 22.5 27.3 20.5 27.1 35.8 44.1 27.1 48.6 41.2 15.4 39.2 36.0 17.4 22.6 24.1 27.7 14.3 23.8 24.7 41.8 58.1 27.0 21.9 16.7 25.3 31.0 34.6 25.3 50.9 30.3 22.2 28.1 36.7 31.4 20.7 17.0 32.6 28.7 30.2 17.8 61.0 29.1 61.8 12.1 25.5 35.9 20.0 24.0 43.6 24.9 30.1 53.8 47.1 48.1 26.3 20.7 35.2 35.8 39.1 27.6 24.4 41.2 44.3 26.4 25.7 31.7 PGAM1 "PGAM-B, PGAMA" ENSG00000171314 "Phosphoglycerate mutase 1" P18669 10 97426191-97433444 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 791.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042528, HPA060483" Approved Supported Nucleoplasm NA NA 120000000 Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.64e-1)" "unprognostic (5.64e-2)" "unprognostic (1.16e-1)" "unprognostic (9.47e-3)" "unprognostic (7.60e-3)" "unprognostic (1.74e-3)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "unprognostic (2.48e-2)" "unprognostic (1.48e-1)" "unprognostic (5.74e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-1)" "unprognostic (2.61e-3)" 143.7 297.1 229.0 155.0 244.3 181.6 123.1 246.2 259.1 148.3 249.9 158.5 152.8 155.0 99.5 440.2 118.2 107.5 278.3 245.9 257.7 168.6 184.0 122.7 167.0 233.9 253.1 232.7 134.4 82.5 192.9 152.0 157.9 258.5 108.2 143.3 424.4 166.1 158.0 57.0 207.7 142.6 179.5 224.6 140.7 134.3 88.2 264.2 126.0 87.6 70.8 231.6 188.3 235.3 272.0 1160.6 538.9 364.0 697.9 336.7 307.7 494.1 722.4 938.4 830.2 1148.3 589.4 335.4 609.1 482.7 619.2 333.4 706.8 639.8 1051.4 998.1 567.2 611.7 393.6 386.4 667.5 248.4 570.0 503.9 303.2 422.5 552.7 408.7 1118.9 610.8 447.2 262.0 334.0 884.8 478.3 514.7 697.8 559.0 331.8 637.8 384.2 333.6 484.0 646.0 431.1 79.1 370.1 388.6 229.2 381.2 564.9 625.0 472.9 463.8 441.5 385.2 394.8 844.0 499.0 593.1 556.1 1023.3 937.5 209.3 242.5 433.5 572.7 217.0 366.6 192.3 134.8 183.8 216.9 309.7 114.7 117.5 164.9 312.6 149.4 422.7 110.5 265.6 580.2 229.0 244.3 246.2 259.1 245.9 257.7 233.9 253.1 232.7 258.5 224.6 264.2 272.0 92.9 44.8 44.4 23.8 122.2 187.0 173.1 394.2 124.1 403.5 77.8 76.7 22.9 85.8 140.8 106.7 77.2 495.8 122.3 233.9 358.1 321.8 15.1 50.2 113.7 145.9 48.1 71.1 29.4 205.8 791.9 146.0 68.8 72.0 103.4 109.5 96.8 193.7 395.1 387.0 35.7 116.7 152.5 170.0 129.1 27.0 149.5 174.6 131.6 16.9 376.9 404.4 174.0 14.1 19.9 295.7 132.9 234.3 254.9 175.2 283.0 274.8 72.1 300.5 203.8 73.1 199.9 38.0 114.7 253.3 204.7 372.6 138.0 257.8 176.4 269.6 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678740-60868028 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6" "Cell line enhanced" "Detected in many" "AF22: 51.5;SCLC-21H: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053075 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.4 1.9 10.0 3.9 15.1 22.3 3.5 62.0 8.0 2.0 2.1 4.3 4.6 2.2 2.2 4.9 2.3 1.9 3.7 7.7 11.6 3.1 3.2 4.7 5.9 15.1 17.0 3.7 1.0 4.4 5.3 6.1 4.4 28.5 2.7 4.1 23.9 3.9 1.7 10.5 5.0 6.4 1.7 11.5 5.7 3.5 3.0 13.7 2.6 4.2 4.2 5.8 3.5 3.2 16.6 8.0 4.0 51.5 9.2 0.1 0.0 16.2 0.4 0.1 1.8 1.6 10.0 7.3 15.5 0.9 0.1 2.3 4.8 26.7 7.9 1.6 5.9 14.3 36.5 7.0 13.2 2.1 11.1 6.5 1.0 5.9 0.0 8.5 3.1 7.7 12.5 2.7 13.4 1.2 8.3 17.5 12.7 35.4 8.1 1.8 36.0 12.1 5.0 4.1 9.1 46.9 23.2 1.4 5.9 14.9 18.0 10.5 10.5 9.0 0.5 8.3 0.5 4.3 14.2 8.7 23.7 3.0 1.2 13.4 14.9 0.4 17.6 3.2 0.2 4.1 10.1 3.6 1.1 0.1 14.9 6.6 2.4 9.3 0.0 0.8 0.8 0.3 0.6 10.0 15.1 62.0 8.0 7.7 11.6 15.1 17.0 3.7 28.5 11.5 13.7 16.6 35.9 32.1 17.5 68.6 64.3 30.3 35.9 10.8 9.6 36.3 16.6 14.6 35.8 27.1 20.7 16.5 241.8 8.2 17.4 31.8 1.9 17.7 15.9 34.0 4.1 40.5 87.3 3.8 6.8 11.3 8.6 6.4 28.5 37.6 41.0 39.8 21.4 12.6 14.9 70.7 17.8 39.9 32.6 10.8 10.4 8.9 0.9 13.6 21.4 118.0 13.9 121.3 15.5 298.6 255.7 16.9 27.4 0.4 29.1 42.9 17.4 5.4 20.4 198.5 0.0 49.7 9.8 8.0 12.9 25.5 32.4 6.2 21.4 3.0 34.1 35.8 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;intestine: 11.1;lymphoid tissue: 8.6;testis: 5.8" "Group enriched" "Detected in many" 4 "Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 0.5 0.4 0.0 2.7 0.2 6.0 1.2 0.3 0.2 0.3 0.0 3.8 11.1 0.6 0.0 2.5 0.2 0.6 0.3 0.0 0.0 0.1 0.7 0.5 4.6 0.0 0.0 0.1 0.1 1.0 0.3 0.0 1.1 0.1 0.3 4.3 0.5 0.3 0.1 0.0 1.1 7.9 0.7 0.0 0.8 2.6 5.8 0.0 8.6 0.3 0.2 5.8 0.8 0.5 0.2 54.6 39.9 17.9 22.0 2.3 3.9 10.2 31.6 12.9 27.8 32.5 14.2 10.7 21.0 16.6 8.3 24.7 29.2 22.0 8.5 43.6 15.8 9.2 24.4 16.2 15.3 0.3 12.5 21.4 0.7 0.9 17.0 4.2 3.0 11.6 15.2 20.0 30.0 17.7 10.5 49.8 5.9 12.2 29.9 13.4 21.7 53.0 14.8 9.6 31.9 8.0 11.7 15.5 19.6 7.9 6.5 13.2 14.1 5.2 17.9 37.0 36.2 25.7 4.0 11.1 25.2 10.2 20.5 25.2 0.0 0.2 0.1 0.0 0.4 0.0 0.4 0.2 0.2 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 1.3 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 4.7 0.0 2.4 2.3 0.6 2.1 1.8 1.2 1.5 1.7 1.2 0.0 3.3 0.0 4.2 4.6 1.3 8.2 0.0 0.4 5.4 1.3 2.6 1.0 1.2 44.6 0.3 0.0 6.6 3.2 5.6 3.1 1.3 11.4 1.4 1.5 5.4 0.0 0.4 4.4 2.0 2.5 3.5 0.8 1.8 3.2 0.0 1.0 0.5 0.1 4.1 1.0 0.9 0.1 1.5 0.0 11.5 0.6 15.1 0.1 1.6 2.0 6.6 0.8 2.3 62.0 80.0 6.8 0.6 1.0 3.1 1.8 8.0 1.4 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 896.1;intestine: 782.5;salivary gland: 817.3;urinary bladder: 788.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" NA NA 300000000 "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 44.8 18.9 1.7 62.2 2.2 0.3 407.1 6.7 2.5 252.1 2.3 495.5 351.5 58.4 72.7 896.1 177.7 301.3 8.0 1.4 1.7 142.5 7.8 205.8 0.4 1.7 2.0 1.4 75.0 49.2 14.4 15.7 176.6 3.4 210.1 362.5 0.1 817.3 195.9 1.3 119.7 782.5 46.8 1.3 1.2 637.1 3.4 1.7 129.0 28.6 1.6 99.1 788.7 319.7 1.6 2.6 343.4 0.0 6.3 0.7 1.8 1169.3 412.1 0.5 12.8 2.9 992.6 1945.3 0.4 393.3 199.0 1.5 1044.6 0.1 2945.0 2.5 0.8 10.4 0.2 213.4 692.3 30.3 0.0 82.0 0.7 524.9 9.0 0.4 0.2 26.2 0.0 148.4 2.5 0.1 2220.9 5.9 3.0 18.5 1323.5 492.7 2.9 0.1 5.8 1335.4 3146.7 40.0 1.7 3.3 5446.1 0.1 266.5 3674.2 0.3 1.7 3.6 6.1 7.7 0.7 1.1 0.8 2.0 1.5 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 2.2 6.7 2.5 1.4 1.7 1.7 2.0 1.4 3.4 1.3 1.7 1.6 10.5 673.1 185.5 0.0 17.8 5.2 4317.3 7444.0 1715.8 0.0 1393.0 867.5 2.9 662.0 5055.9 892.0 0.0 1160.8 20.5 3599.6 1.9 4717.9 0.1 737.2 102.8 41.9 362.5 0.0 0.1 2589.9 6919.3 171.8 1571.4 1010.7 94.6 1.0 1.1 0.7 179.0 0.0 0.1 1382.4 2720.0 2.6 2.5 2.6 37.9 25.5 190.3 1.0 30.0 0.8 0.0 0.0 0.0 7374.9 3399.6 88.8 19.9 2228.8 8623.3 26.7 1954.3 0.0 0.0 0.0 240.0 1.1 1.6 1302.6 1.1 2127.5 36.1 4.8 1619.0 5959.8 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513745-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 423.2;esophagus: 1166.0;skin 1: 1330.1;vagina: 426.8" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "HaCaT: 1156.8;hTCEpi: 1001.5" "Region enhanced" "Detected in single" "white matter: 1.9" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" No No 480000000 "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favorable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 2.8 0.3 0.1 0.2 0.1 0.7 423.2 0.1 0.1 71.7 0.1 1.1 1.5 0.3 2.3 1166.0 32.7 2.9 0.6 0.2 0.1 0.3 0.6 4.3 0.0 0.2 0.1 0.0 0.4 1.4 0.0 1.2 0.3 0.2 184.3 1.6 0.0 141.1 4.2 0.7 1330.1 2.3 0.1 0.1 0.3 1.6 8.0 0.1 94.6 0.5 0.0 78.3 9.5 426.8 0.1 56.4 7.4 0.0 0.0 0.0 0.0 0.7 5.3 1.3 0.3 0.2 5.9 20.2 0.0 1.8 0.6 14.0 1156.8 0.0 41.8 0.2 0.6 0.0 0.0 7.7 1.9 0.0 0.1 4.7 0.0 1001.5 2.2 6.9 2.7 3.4 0.0 0.3 0.5 0.2 3.5 0.1 0.5 0.0 3.9 6.2 0.0 0.0 104.9 3.3 5.9 2.6 0.1 1.1 15.0 1.2 0.3 20.3 0.0 18.6 0.3 2.8 0.3 2.2 0.1 0.1 0.0 8.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 6.1 12.8 10.3 0.0 2.7 1309.8 2789.9 1190.9 8290.4 0.6 577.7 670.3 0.8 5.7 287.5 1.8 0.0 0.7 16.9 18.3 1.9 8.5 117.6 4.1 0.7 22.9 4.8 0.0 0.1 7.5 7.7 21.7 4.6 8.2 2.5 0.0 0.0 0.0 0.4 0.0 0.1 10.3 189.2 0.0 61.7 44.4 1.5 17.2 320.2 0.0 0.0 0.2 0.0 0.0 0.1 14.1 10.5 0.4 88.7 872.9 8.6 0.1 57.7 0.6 0.0 0.4 32.1 0.6 0.8 4637.9 193.6 1.2 21.6 0.1 7.2 906.0 LURAP1 "C1orf190, FLJ25163, LRAP35a" ENSG00000171357 "Leucine rich adaptor protein 1" Q96LR2 1 46203334-46221256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Early spermatids: 140.9;Late spermatids: 335.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 5.4;RPTEC TERT1: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030060, HPA030061" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA030060: AB_10599997, HPA030061: AB_10601990" "unprognostic (3.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.22e-3)" "unprognostic (8.82e-2)" "unprognostic (1.91e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.47e-2)" "unprognostic (2.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.14e-2)" "unprognostic (1.33e-1)" "prognostic favorable (8.81e-8)" "unprognostic (1.32e-2)" "unprognostic (2.80e-1)" "unprognostic (3.11e-2)" "unprognostic (2.39e-2)" 1.9 3.5 1.9 0.9 7.5 1.7 2.1 6.2 5.9 4.4 2.6 2.5 0.8 3.2 2.2 2.0 3.3 1.7 4.9 3.1 3.6 4.8 0.4 1.6 0.5 7.8 5.6 1.9 3.9 0.3 9.6 2.1 0.9 6.7 4.7 1.0 1.4 2.6 4.8 1.1 2.1 1.3 2.7 5.4 1.7 2.7 8.9 5.7 1.2 10.6 1.0 0.8 3.8 4.1 13.6 0.1 0.1 2.1 0.1 2.8 3.8 2.1 1.5 3.8 2.0 2.3 0.1 0.1 0.2 0.1 3.6 0.7 0.2 2.2 4.8 1.6 0.4 1.0 0.2 0.5 0.2 0.8 0.1 0.1 1.8 3.0 4.0 1.8 5.4 3.0 0.5 1.9 0.3 1.1 0.2 0.2 0.2 0.8 0.0 0.3 0.7 1.0 0.0 5.3 0.0 0.3 0.8 0.0 0.1 3.4 0.8 1.1 0.2 0.2 1.2 1.5 1.0 0.3 0.1 0.1 0.2 1.2 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.3 0.3 0.2 0.8 0.3 0.1 0.2 0.0 0.1 1.9 7.5 6.2 5.9 3.1 3.6 7.8 5.6 1.9 6.7 5.4 5.7 13.6 2.2 0.0 0.0 6.8 0.0 5.0 15.6 4.5 8.0 0.2 2.7 4.1 3.1 0.0 1.3 11.0 0.0 4.1 0.1 0.2 15.6 0.1 140.9 1.3 1.6 2.9 1.2 0.0 10.0 0.4 2.3 4.0 0.0 1.3 0.0 2.5 3.3 0.1 4.4 0.0 5.5 0.3 0.0 0.3 3.3 335.2 9.3 1.2 14.2 5.6 0.7 2.0 1.0 1.0 25.3 0.0 0.1 9.8 0.0 8.6 0.1 5.3 3.3 0.2 6.6 2.6 4.7 36.3 2.2 2.7 3.4 7.7 0.2 2.7 0.1 5.5 KRT38 KRTHA8 ENSG00000171360 "Keratin 38" O76015 17 41436154-41440983 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "skin 1: 9.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "head and neck cancer: 1.1;urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 160000000 "unprognostic (1.37e-1)" "unprognostic (4.05e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922596-50099235 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "epididymis: 23.9;kidney: 46.6;liver: 17.0" "Cell type enriched" "Detected in many" 4 "Skeletal myocytes: 214.4" "Cancer enhanced" "Detected in all" "renal cancer: 9.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.6;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in all" 4 "CACO-2: 49.0;RH-30: 66.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 2.0 2.5 2.1 1.7 1.7 1.5 1.6 3.6 1.6 1.7 2.5 2.4 5.0 4.0 23.9 2.4 3.1 3.9 1.3 1.3 6.8 46.6 17.0 2.8 1.3 3.1 2.7 1.2 7.1 2.2 1.4 2.3 5.9 3.2 1.7 2.8 3.4 2.5 1.0 4.0 4.8 3.9 2.9 2.3 1.8 2.9 2.2 2.6 1.1 2.2 2.8 1.2 1.4 2.1 2.7 2.9 5.4 4.2 5.5 12.8 7.5 7.9 2.8 1.2 1.6 1.9 49.0 3.0 3.5 1.2 2.5 9.7 2.8 9.9 1.7 2.2 1.1 7.5 3.3 2.7 12.8 7.2 4.1 5.7 4.9 1.6 3.7 5.9 1.2 5.8 4.0 4.3 4.7 5.3 3.2 1.6 1.4 5.7 7.4 2.4 1.9 66.0 5.2 6.0 5.5 7.2 5.2 3.3 3.0 5.1 14.1 3.0 2.1 3.8 1.6 3.7 12.7 1.4 3.6 11.9 7.3 2.8 6.6 8.5 0.0 0.9 0.0 0.1 0.9 0.1 0.1 0.2 0.2 2.6 0.1 0.0 0.0 0.2 0.1 0.1 2.8 0.0 0.3 2.1 1.7 3.6 1.6 1.3 6.8 3.1 2.7 1.2 3.2 2.3 2.6 2.7 4.3 9.6 8.4 20.5 2.1 7.1 1.8 1.6 5.2 27.4 1.8 1.4 1.9 2.8 2.3 12.9 2.1 6.2 17.7 11.3 11.7 4.1 2.0 8.0 10.0 5.5 0.0 3.4 11.5 3.5 2.6 7.9 8.6 22.8 2.5 0.8 1.4 35.2 11.1 8.4 15.6 6.6 4.1 17.6 19.8 0.6 5.3 10.9 3.6 46.9 10.1 2.7 2.1 20.6 9.6 7.7 7.3 13.2 2.2 4.0 20.4 38.8 4.2 4.3 0.0 214.4 4.8 0.9 2.3 8.1 9.5 5.1 1.9 9.3 7.0 4.8 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693352 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 179.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Excitatory neurons: 45.2;Horizontal cells: 42.1;Inhibitory neurons: 32.6;Oligodendrocytes: 104.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.4;AN3-CA: 5.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favorable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.9 6.6 89.1 0.7 113.3 0.2 2.5 45.1 124.4 1.7 0.0 9.9 5.3 3.3 0.6 11.1 10.5 1.8 9.8 106.4 74.7 4.3 2.8 10.3 0.3 105.8 95.4 95.5 1.8 6.1 2.1 19.6 2.2 122.9 2.3 1.8 6.4 5.8 3.6 10.6 6.9 9.6 3.6 45.2 2.7 5.0 2.2 113.7 0.5 7.0 5.4 1.4 6.8 2.7 179.2 0.2 7.4 0.3 5.4 0.8 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.8 0.1 0.5 0.0 1.9 2.9 2.9 0.0 0.0 1.5 2.5 0.2 3.6 0.2 0.8 0.2 0.3 0.0 0.7 0.0 0.1 0.2 0.0 0.1 0.1 2.7 0.0 0.2 0.2 0.5 0.2 0.8 0.7 0.3 0.1 1.0 0.2 1.0 13.2 1.6 0.8 0.3 3.6 0.3 0.7 0.2 0.1 0.2 2.7 0.0 0.2 1.0 0.2 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 89.1 113.3 45.1 124.4 106.4 74.7 105.8 95.4 95.5 122.9 45.2 113.7 179.2 1.6 38.5 10.0 6.8 0.7 4.1 1.4 0.6 9.6 21.3 3.1 2.4 18.4 2.8 5.3 1.8 0.0 0.0 1.1 5.7 1.9 2.4 9.1 26.6 0.9 2.0 10.2 0.0 45.2 0.7 0.3 3.3 3.1 5.8 4.5 0.1 2.2 4.3 3.3 42.1 32.6 6.5 0.0 0.0 2.2 7.2 0.3 1.2 1.8 4.7 0.1 0.9 0.0 6.6 104.7 0.7 5.2 0.4 3.3 0.8 10.3 1.1 13.5 2.4 0.0 1.5 4.2 2.2 0.8 6.7 3.1 0.0 4.8 0.1 4.8 4.1 KCND3 "KSHIVB, Kv4.3, SCA19, SCA22" ENSG00000171385 "Potassium voltage-gated channel subfamily D member 3" Q9UK17 1 111770662-111989668 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 46.8;Cardiomyocytes: 38.1;Excitatory neurons: 105.7;Hepatocytes: 37.8;Inhibitory neurons: 88.4;Oligodendrocyte precursor cells: 45.8" "Cancer enhanced" "Detected in many" "prostate cancer: 8.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 4.8;SCLC-21H: 10.1;U-2 OS: 1.6;WM-115: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029452 Approved NA NA "HPA029452: AB_10602239" "unprognostic (1.11e-2)" "unprognostic (1.73e-3)" "unprognostic (1.71e-1)" "unprognostic (2.60e-2)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (1.41e-1)" "unprognostic (9.48e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-2)" "unprognostic (1.40e-1)" "unprognostic (7.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-3)" "unprognostic (6.64e-3)" 4.5 1.5 17.6 4.7 14.3 0.2 3.0 18.5 19.9 2.3 0.0 4.6 0.9 5.3 12.7 4.1 5.1 5.6 8.1 15.9 8.1 1.3 15.5 1.7 0.5 3.0 35.0 13.1 0.5 4.5 3.9 3.5 0.5 9.1 11.4 2.5 12.8 1.6 12.1 2.6 7.1 2.2 9.9 0.3 3.3 3.3 2.0 11.0 0.3 1.1 1.7 0.5 6.0 3.2 12.4 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.6 14.3 18.5 19.9 15.9 8.1 3.0 35.0 13.1 9.1 0.3 11.0 12.4 1.1 0.0 9.3 18.3 0.3 7.5 11.9 2.9 0.0 46.8 7.8 1.5 38.1 0.0 1.5 0.0 4.2 0.1 0.4 1.5 0.0 0.8 35.7 0.5 14.5 1.6 0.0 2.7 105.7 23.8 0.2 3.7 0.0 0.7 0.0 0.0 1.8 37.8 0.2 30.3 88.4 0.4 4.1 0.8 1.9 32.3 18.0 0.5 3.6 1.0 0.0 6.2 0.0 45.8 8.7 4.8 1.2 1.9 0.0 21.9 0.1 0.3 0.1 4.8 0.0 0.8 1.7 1.5 1.0 2.0 6.7 0.0 0.5 0.1 2.4 13.4 APLN "apelin, XNPEP2" ENSG00000171388 Apelin Q9ULZ1 X 129645259-129654956 "Predicted secreted proteins" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.6;placenta: 54.5" "Cell type enriched" "Detected in some" 7 "Endothelial cells: 68.2" "Group enriched" "Detected in all" 6 "glioma: 44.2;renal cancer: 21.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "HUVEC TERT2: 502.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.50e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (9.32e-4)" "prognostic unfavorable (6.09e-4)" "unprognostic (4.71e-2)" "unprognostic (2.25e-1)" "unprognostic (3.30e-1)" "unprognostic (9.12e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (2.26e-1)" "unprognostic (8.42e-2)" 4.0 9.3 19.8 2.3 19.0 0.0 3.0 20.6 20.5 0.4 7.3 1.0 0.8 0.7 0.3 0.6 1.2 0.4 10.2 15.8 22.0 7.3 1.4 13.6 0.1 29.5 25.2 12.6 2.4 0.3 1.0 5.5 54.5 33.6 1.1 0.3 0.3 0.6 0.5 3.8 1.2 0.8 2.0 29.4 0.7 1.2 1.2 29.9 0.3 0.9 1.1 0.2 3.4 0.4 37.6 0.2 0.6 58.5 0.5 1.9 3.6 0.0 0.2 0.0 1.1 1.8 0.0 0.0 0.0 6.2 0.2 2.5 0.0 1.4 14.1 1.0 0.0 0.1 0.0 0.6 0.1 0.2 3.3 1.4 7.7 0.1 7.2 0.0 0.0 502.1 1.7 0.1 1.9 2.6 0.0 0.2 0.7 1.5 0.0 26.8 0.3 0.5 0.9 0.0 0.0 2.0 6.2 0.2 0.1 0.0 0.1 0.1 0.9 86.2 2.1 0.2 36.5 2.1 0.8 0.0 0.0 34.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 19.0 20.6 20.5 15.8 22.0 29.5 25.2 12.6 33.6 29.4 29.9 37.6 3.0 0.0 1.3 8.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 9.4 6.8 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.1 0.1 68.2 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.2 1.3 0.0 0.0 0.3 0.3 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.2 1.8 1.9 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.4 0.6 0.0 0.2 0.0 0.1 1.2 0.2 2.9 0.0 0.0 KRTAP4-4 "KAP4.13, KAP4.4, KRTAP4-13" ENSG00000171396 "Keratin associated protein 4-4" Q9BYR3 17 41159649-41160748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 119 "skin 1: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1500000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT13 "CK13, K13, MGC161462, MGC3781" ENSG00000171401 "Keratin 13" P13646 17 41500981-41505705 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41253.5;vagina: 13518.8" "Cell type enriched" "Detected in many" 4 "Squamous epithelial cells: 16844.0" "Group enriched" "Detected in many" 5 "cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 93 "A-431: 2462.5;HaCaT: 1626.2" "CAB000133, HPA030877, HPA069771" Enhanced Enhanced "Intermediate filaments" NA NA 680000000 "Intermediate filaments" "CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141" "unprognostic (1.45e-1)" "unprognostic (6.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (9.30e-5)" "unprognostic (7.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (5.81e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.45e-6)" "unprognostic (1.80e-1)" "unprognostic (2.76e-1)" "unprognostic (3.04e-2)" "unprognostic (4.33e-1)" 6.8 7.5 0.0 0.0 0.1 6.9 5.2 0.0 0.0 3290.9 0.0 4.9 0.1 10.3 0.0 41253.5 7.1 8.9 9.3 0.0 0.1 5.5 12.9 6.0 0.3 0.0 0.0 0.0 9.9 17.3 0.0 27.1 0.0 0.0 116.2 0.0 0.0 6935.6 3.9 9.9 13.5 8.6 14.3 0.0 7.8 31.5 7.0 0.0 13.7 6.1 0.0 1871.4 933.9 13518.8 0.0 2462.5 0.6 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.6 0.8 7.1 0.6 0.0 0.0 1626.2 0.0 0.4 0.0 1.4 0.0 4.5 21.8 0.0 0.0 1.7 1.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 5.4 1.2 0.0 1.3 0.1 0.1 0.1 14.8 0.3 0.2 1.2 0.3 0.0 10.7 0.0 0.0 1.9 2.0 7.7 0.0 2.3 6.4 5.1 0.0 0.4 0.0 6.6 0.3 6.3 5.8 1.9 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.0 1.1 0.0 0.9 2.8 545.6 17.1 146.8 0.0 2.3 4.6 0.6 1.5 94.5 0.0 0.0 0.1 0.2 0.6 0.0 0.0 1.2 2.7 0.2 11.4 1.2 5.5 0.0 0.0 0.5 12.6 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 8.2 0.0 0.0 3.2 55.9 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 286.6 27.1 227.9 0.1 0.1 3.3 0.0 0.0 0.0 16.9 0.2 0.6 16844.0 1.6 0.4 8.8 0.0 0.4 3645.4 XAGE3 "CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3" ENSG00000171402 "X antigen family member 3" Q8WTP9 X 52862525-52868083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 121 "placenta: 385.3" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 2223.5;Extravillous trophoblasts: 1309.1;Syncytiotrophoblasts: 2678.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;U-266/70: 2.2;U-266/84: 2.1" "HPA052507, HPA060900" Supported Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (6.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.92e-1)" 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 385.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2223.5 0.0 0.1 0.0 0.2 0.3 0.1 0.0 4.5 0.0 0.0 0.0 0.4 1309.1 11.1 0.0 0.3 0.0 0.0 0.0 4.6 191.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 15.1 7.0 0.0 0.0 2678.1 0.0 0.0 0.1 0.0 KRT9 "CK-9, EPPK, K9" ENSG00000171403 "Keratin 9" P35527 17 41565836-41572059 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 12.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 3.4;Breast myoepithelial cells: 2.9;Extravillous trophoblasts: 2.2" "Cancer enriched" "Detected in some" 6 "melanoma: 21.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.0;HaCaT: 16.8;U-2197: 3.0;U-937: 5.3" "Region enhanced" "Detected in many" "basal ganglia: 25.1" "HPA007261, CAB037322" Supported NA NA 24000000000 "CAB037322: , HPA007261: AB_1079182" "unprognostic (2.13e-2)" "unprognostic (5.08e-2)" "unprognostic (4.97e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (5.92e-7)" "unprognostic (1.28e-1)" "unprognostic (3.02e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 12.2 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 7.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 0.0 0.0 0.0 0.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.2 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Cell type enhanced" "Detected in some" "Spermatocytes: 3.8;Spermatogonia: 9.0;Syncytiotrophoblasts: 1.9" "Cancer enriched" "Detected in single" 4 "liver cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "U-2 OS: 22.0" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA052507: AB_2681855, HPA055941: AB_2682978" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 9.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 PDE7B ENSG00000171408 "Phosphodiesterase 7B" Q9NP56 6 135851701-136195574 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell type enhanced" "Detected in many" "Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4" "Region enriched" "Detected in all" 5 "basal ganglia: 125.3" "Low region specificity" "Detected in all" HPA023967 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA023967: AB_1855128" "unprognostic (3.18e-1)" "unprognostic (3.47e-1)" "unprognostic (2.34e-1)" "unprognostic (1.79e-3)" "unprognostic (3.34e-1)" "unprognostic (3.22e-4)" "unprognostic (1.37e-2)" "unprognostic (3.00e-1)" "unprognostic (2.80e-1)" "unprognostic (6.73e-3)" "unprognostic (1.11e-2)" "unprognostic (7.85e-2)" "prognostic favorable (1.59e-4)" "unprognostic (3.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-2)" 4.5 2.3 6.8 2.3 19.8 0.1 2.7 3.9 7.1 3.9 2.4 2.4 1.9 7.9 2.2 1.3 2.8 3.4 5.8 3.1 33.0 5.5 3.7 1.7 1.5 7.5 8.9 3.9 13.1 0.8 6.2 4.8 1.0 9.9 4.3 2.7 2.4 3.0 10.4 4.8 0.7 2.2 7.7 3.6 1.1 3.6 1.5 11.3 3.9 4.8 8.9 0.8 6.1 3.7 7.8 0.0 5.7 0.2 0.0 8.7 10.2 0.1 0.5 2.9 2.1 1.1 0.0 0.1 0.1 16.2 3.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 9.6 0.0 3.7 0.1 0.0 22.4 0.0 4.2 0.0 0.9 10.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.8 0.7 3.9 3.7 0.1 0.2 0.0 0.0 1.8 0.0 2.3 0.0 11.4 0.0 0.1 0.0 0.0 0.6 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.8 1.3 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.1 6.8 19.8 3.9 7.1 3.1 33.0 7.5 8.9 3.9 9.9 3.6 11.3 7.8 8.3 0.0 0.5 346.4 11.9 0.4 0.3 0.5 0.0 4.4 0.9 0.4 8.4 2.8 0.2 22.0 0.0 0.1 0.7 0.1 0.0 0.2 0.5 3.1 1.4 23.1 7.3 0.8 136.7 1.6 0.0 9.8 4.6 2.1 10.2 31.1 35.3 3.8 0.3 6.7 166.0 0.0 0.0 1.9 4.8 0.9 12.2 3.2 0.0 70.3 0.7 11.5 0.0 343.8 10.4 0.1 0.0 7.9 0.2 0.4 0.0 1.6 1.6 0.9 13.1 30.6 9.1 0.3 0.1 0.2 1.4 0.0 2.9 4.4 0.0 0.3 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798385-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 472.3;Late spermatids: 471.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" No No "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 43.3 60.9 35.3 24.9 36.2 19.3 42.5 40.3 44.5 30.8 35.5 45.5 28.2 39.0 26.6 51.5 32.6 22.2 65.1 36.0 39.2 49.5 76.7 28.8 30.4 37.5 36.1 34.7 35.4 44.7 34.9 29.4 21.9 38.2 44.3 20.1 22.8 36.8 21.8 141.4 38.1 34.0 27.2 38.2 34.6 45.2 98.1 37.4 29.4 27.6 86.9 26.1 39.1 34.5 37.6 93.3 134.9 61.7 116.9 111.3 91.2 80.9 79.4 69.4 92.7 88.2 98.4 73.4 124.2 140.2 85.7 136.1 99.1 139.9 130.9 66.8 136.1 155.8 60.2 285.1 158.4 142.0 78.9 45.5 80.9 98.9 103.6 133.4 80.8 91.1 72.3 93.4 77.9 133.6 169.4 93.2 177.5 60.1 102.2 164.0 73.8 46.0 149.6 84.6 74.9 68.5 46.8 172.6 133.1 89.8 56.3 78.2 84.5 55.5 79.9 87.1 54.7 89.4 74.0 100.3 167.4 100.4 144.5 111.3 88.4 103.2 68.6 90.6 104.8 109.6 132.6 101.5 111.1 127.3 103.3 89.1 106.3 29.7 101.7 92.9 476.0 143.0 142.0 35.3 36.2 40.3 44.5 36.0 39.2 37.5 36.1 34.7 38.2 38.2 37.4 37.6 52.6 32.1 29.0 6.8 37.6 106.0 108.8 150.2 89.4 23.0 61.5 93.2 163.1 50.1 83.6 58.8 6.2 93.4 66.0 47.3 307.2 84.1 472.3 45.4 63.9 63.7 26.4 50.9 7.9 75.0 74.0 62.7 35.2 33.1 27.9 46.2 35.7 118.2 88.2 15.2 7.9 53.8 107.8 43.0 52.4 471.3 74.9 32.0 60.5 2.8 62.5 76.0 70.0 7.1 9.6 92.1 58.7 59.8 45.6 148.8 79.2 199.6 63.2 31.2 65.7 51.1 68.6 188.6 76.2 92.4 124.9 87.4 37.3 79.8 65.7 112.6 ZNF581 "FLJ22550, HSPC189" ENSG00000171425 "Zinc finger protein 581" Q9P0T4 19 55635459-55645623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 143.9" "Low region specificity" "Detected in all" HPA059657 Uncertain NA NA "HPA059657: AB_2684098" "unprognostic (1.15e-2)" "unprognostic (2.39e-2)" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-3)" "unprognostic (3.30e-2)" "prognostic unfavorable (5.74e-5)" "unprognostic (7.07e-2)" "unprognostic (6.81e-2)" "unprognostic (1.96e-1)" "unprognostic (7.50e-2)" "unprognostic (3.11e-1)" "unprognostic (5.70e-3)" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (4.07e-2)" "unprognostic (2.35e-1)" 17.6 20.1 11.0 10.4 11.1 16.9 17.1 11.3 14.4 23.7 11.1 20.1 9.4 19.2 9.5 23.3 19.1 7.1 11.6 11.1 11.7 16.4 13.1 14.8 15.7 11.5 10.6 9.8 34.8 34.8 7.2 12.1 6.7 11.2 16.2 5.8 4.4 16.7 7.4 20.9 26.6 19.9 6.8 11.1 27.5 20.9 10.7 11.2 13.0 15.4 8.2 18.3 18.8 19.6 14.7 16.6 24.9 15.6 14.8 22.1 53.8 23.6 10.4 28.0 19.3 21.8 18.9 20.9 75.2 11.5 15.5 10.0 15.3 27.1 35.6 10.8 12.7 143.9 22.2 17.8 30.4 34.0 20.6 15.5 69.4 38.8 12.3 24.1 64.4 25.9 30.6 33.8 9.2 16.8 13.6 34.0 26.1 21.3 17.2 58.8 33.2 16.9 37.3 33.5 23.5 30.7 30.0 10.8 26.6 36.4 14.5 13.0 20.7 24.5 23.5 20.5 5.8 18.8 31.6 21.9 36.0 16.4 15.2 11.6 32.6 42.0 27.7 20.1 50.9 22.3 81.1 29.9 21.9 41.9 84.0 34.9 33.8 21.4 22.4 35.9 24.9 40.4 26.3 11.0 11.1 11.3 14.4 11.1 11.7 11.5 10.6 9.8 11.2 11.1 11.2 14.7 12.4 16.0 7.0 3.3 50.7 71.0 20.4 32.7 55.8 6.2 35.5 30.1 5.8 20.0 15.8 7.3 0.0 24.5 20.3 16.7 7.9 22.2 1.5 12.9 20.8 21.3 19.7 14.7 1.3 30.7 31.2 19.1 10.2 15.1 21.6 31.0 30.0 7.1 34.6 3.3 1.4 23.0 20.3 84.1 64.8 3.7 31.4 29.5 33.8 0.0 46.5 6.1 9.2 1.0 2.0 29.4 21.6 15.1 21.5 24.8 53.8 24.8 9.2 5.8 6.6 10.4 15.4 8.6 21.1 37.1 77.0 25.9 24.6 29.3 28.9 21.2 NAT1 AAC1 ENSG00000171428 "N-acetyltransferase 1" P18440 8 18170477-18223689 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 24.2;Paneth cells: 32.7;Respiratory ciliated cells: 32.0" "Cancer enriched" "Detected in all" 14 "breast cancer: 47.9" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB017782, HPA043704" Approved NA NA "CAB017782: , HPA043704: AB_2678625" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.09e-1)" "unprognostic (2.53e-2)" "unprognostic (8.25e-2)" "unprognostic (5.20e-2)" "unprognostic (6.53e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-2)" "unprognostic (9.51e-2)" "unprognostic (6.60e-2)" "unprognostic (7.44e-2)" "unprognostic (2.30e-1)" "unprognostic (3.28e-2)" "unprognostic (8.15e-2)" 3.7 1.5 0.5 5.5 0.6 3.2 5.9 0.8 0.9 6.5 0.9 14.3 11.8 2.4 15.4 2.5 4.4 3.7 1.9 0.5 1.0 5.7 10.4 3.5 6.1 1.1 0.7 0.4 2.9 1.8 1.1 1.0 4.1 0.8 7.4 12.9 0.3 1.9 2.9 0.4 2.5 9.0 3.6 0.8 4.2 5.0 1.8 0.7 4.6 2.1 1.5 6.7 4.5 1.3 0.9 22.6 2.7 2.5 3.3 6.3 6.3 5.3 8.0 8.5 8.8 10.2 4.0 4.7 11.0 6.2 5.2 8.1 3.6 4.5 5.4 8.9 10.3 2.3 7.6 3.0 3.0 6.0 3.3 9.7 5.2 6.5 6.0 0.5 2.2 7.9 9.3 6.6 2.9 10.0 4.0 9.8 10.3 2.4 17.8 3.4 4.9 2.5 4.3 9.3 12.6 1.3 1.7 0.3 9.5 5.5 5.2 7.7 9.7 8.5 5.3 3.1 8.0 1.3 2.0 4.0 9.3 4.6 7.5 2.4 5.4 4.6 9.4 3.3 5.3 2.4 4.4 3.4 3.4 6.1 3.9 3.2 3.9 8.2 6.3 5.4 3.5 6.3 2.7 0.5 0.6 0.8 0.9 0.5 1.0 1.1 0.7 0.4 0.8 0.8 0.7 0.9 4.6 0.0 3.6 0.7 4.7 0.4 0.8 9.1 1.2 0.0 3.5 1.9 1.6 0.0 11.3 5.5 0.0 5.9 2.3 24.2 1.9 5.7 10.8 3.9 3.2 3.0 3.6 0.8 0.8 6.9 7.7 2.1 3.6 2.8 2.5 1.1 2.2 12.7 7.2 0.0 0.2 10.7 8.2 6.3 2.6 2.2 4.1 5.3 3.6 1.9 4.9 2.5 4.1 0.0 0.5 5.8 32.7 5.7 2.6 2.3 12.7 16.6 32.0 0.0 0.0 0.7 3.4 4.2 0.6 2.2 0.6 10.9 4.1 3.2 8.4 2.5 KRT20 "CK20, K20, MGC35423" ENSG00000171431 "Keratin 20" P35900 17 40875889-40885242 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 652.3" "Group enriched" "Detected in some" 6 "Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3" "Group enriched" "Detected in many" 6 "colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000032, HPA024309, HPA024684, HPA027236" Enhanced Supported Cytosol NA NA 30000000 Cytosol "CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224" "unprognostic (3.49e-1)" "unprognostic (3.13e-1)" "unprognostic (1.71e-1)" "unprognostic (6.38e-3)" "unprognostic (5.12e-2)" "unprognostic (2.66e-3)" "prognostic unfavorable (7.05e-4)" "unprognostic (2.63e-2)" "unprognostic (4.87e-3)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.71e-2)" "unprognostic (6.30e-2)" "unprognostic (7.27e-2)" 1.3 0.0 0.0 50.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 603.3 298.6 2.1 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 484.6 0.0 0.0 1.2 0.0 0.1 652.3 27.3 0.0 0.0 126.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.4 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1328.5 0.0 0.1 0.0 0.0 0.0 0.0 43.9 0.0 0.1 0.0 0.0 0.0 115.7 0.1 13.4 0.0 0.0 0.0 0.1 0.0 0.0 421.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1606.6 0.0 0.6 1.9 1107.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.6 0.0 160.4 1.4 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761747-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 5.8;intestine: 10.7;kidney: 11.3;liver: 8.2" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 45.2;Proximal tubular cells: 70.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA010667 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.3 0.0 4.7 10.7 0.0 5.8 0.1 1.9 0.8 0.0 0.0 0.0 11.3 8.2 1.3 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.2 6.1 1.9 0.3 0.3 0.0 0.0 10.1 0.1 0.0 0.0 1.4 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.2 2.6 1.3 0.5 0.0 0.3 0.2 0.0 0.6 8.3 1.0 0.0 4.3 0.3 7.3 0.0 0.1 0.0 14.4 13.7 0.6 0.2 3.0 0.1 0.0 1.2 2.7 0.2 0.9 0.1 0.0 0.0 1.1 0.0 0.1 0.0 8.0 0.0 0.0 0.3 7.3 0.0 0.3 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.5 0.0 0.5 0.5 0.8 13.9 0.0 0.1 0.3 45.2 70.5 2.7 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 8.9 0.7 KSR2 FLJ25965 ENSG00000171435 "Kinase suppressor of ras 2" Q6VAB6 12 117453012-117968990 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 9.7;pituitary gland: 8.0" "Cell type enhanced" "Detected in many" "Collecting duct cells: 161.8;Excitatory neurons: 284.7;Inhibitory neurons: 234.9;Oligodendrocyte precursor cells: 95.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 4.5;SCLC-21H: 3.2;TIME: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035536 Enhanced NA NA "HPA035536: AB_10673485" "unprognostic (1.74e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (2.29e-2)" "unprognostic (9.11e-2)" "unprognostic (8.42e-2)" "unprognostic (6.91e-3)" "unprognostic (1.10e-2)" "unprognostic (5.78e-2)" "unprognostic (5.80e-2)" "unprognostic (2.05e-4)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (5.02e-2)" "unprognostic (5.68e-2)" "unprognostic (8.14e-3)" "unprognostic (5.74e-2)" 0.0 0.9 1.1 0.0 2.7 0.0 0.2 1.2 9.7 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.0 8.2 2.1 0.6 0.0 0.0 0.2 1.0 0.2 2.9 0.0 0.5 0.6 8.0 0.0 1.3 0.1 0.3 1.9 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.4 0.0 0.7 0.0 0.1 0.2 0.0 3.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.4 0.9 3.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 6.9 0.0 0.5 0.0 0.1 0.5 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.7 1.2 9.7 8.2 2.1 1.0 0.2 2.9 1.3 0.0 0.4 3.7 0.9 0.0 0.0 17.6 0.5 0.3 1.2 0.1 0.0 55.2 2.8 2.4 2.2 5.7 0.2 161.8 39.6 0.9 0.0 1.3 0.0 2.3 10.8 4.0 0.3 0.5 20.4 5.3 284.7 1.5 0.4 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.1 47.1 234.9 10.3 2.0 0.3 0.4 12.5 0.0 0.0 0.0 5.6 0.0 2.4 0.0 95.0 4.2 0.4 1.5 0.0 0.0 1.4 0.1 0.8 0.3 28.2 0.0 0.3 0.1 0.6 3.1 0.0 0.3 0.3 0.6 0.0 3.0 1.3 ZNF524 MGC23143 ENSG00000171443 "Zinc finger protein 524" Q96C55 19 55600022-55603138 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 96.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050981 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050981: AB_2681298" "unprognostic (6.69e-2)" "unprognostic (1.23e-2)" "unprognostic (5.70e-2)" "unprognostic (4.27e-3)" "unprognostic (2.88e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.99e-1)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (2.13e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (3.84e-1)" "unprognostic (1.59e-2)" "prognostic favorable (4.98e-8)" 21.4 19.5 12.1 7.8 12.1 9.9 22.4 12.0 19.0 18.8 11.3 22.3 15.0 18.3 3.5 26.9 17.8 6.2 20.4 10.3 10.7 21.0 28.9 18.2 9.7 13.8 12.4 9.4 16.5 68.5 7.3 18.6 4.4 12.5 21.9 3.8 1.7 24.8 5.5 45.9 36.0 19.5 2.8 12.3 27.9 34.7 6.9 12.3 6.2 20.6 10.9 3.8 20.1 19.8 13.6 12.1 11.3 1.7 7.5 5.3 10.6 12.4 7.4 4.3 4.6 4.7 3.4 13.1 6.1 4.4 4.0 2.6 9.2 1.1 5.6 0.6 18.9 29.2 7.5 6.7 5.9 12.3 4.7 9.2 8.7 13.4 3.8 3.9 4.7 8.8 7.3 7.4 11.4 2.6 6.7 4.7 10.1 2.0 11.1 13.3 6.2 3.9 18.5 5.9 6.4 8.0 5.4 7.6 10.1 8.6 1.2 4.8 15.3 7.9 4.0 6.9 7.6 9.5 5.2 6.9 2.8 10.3 12.0 5.3 15.0 23.9 20.1 13.4 21.2 12.4 11.9 13.7 12.9 18.6 14.4 16.0 8.9 14.6 12.4 14.1 5.6 22.1 15.2 12.1 12.1 12.0 19.0 10.3 10.7 13.8 12.4 9.4 12.5 12.3 12.3 13.6 38.5 6.4 14.1 1.6 19.4 25.2 17.2 25.5 23.9 8.5 36.3 42.4 10.1 20.0 16.1 7.3 6.2 22.0 17.8 73.0 17.6 25.0 2.4 16.9 13.4 27.1 23.4 9.4 1.8 53.6 19.5 14.8 34.7 14.5 10.2 12.0 40.4 22.9 38.1 6.7 1.7 62.9 6.1 75.8 27.8 7.5 18.0 37.7 30.2 4.7 46.6 10.1 34.0 1.5 5.8 33.4 56.9 21.8 14.5 18.2 96.1 38.1 8.8 8.4 19.7 14.4 17.6 1.1 6.1 30.9 35.7 25.6 23.4 18.5 46.1 20.5 MCC ENSG00000171444 "MCC regulator of WNT signaling pathway" P23508 5 113022099-113488823 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 71.2" "Cell type enhanced" "Detected in many" "Astrocytes: 170.7;Bipolar cells: 115.5;Inhibitory neurons: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBEC3-KT: 52.9;hTCEpi: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 10.1 3.0 9.8 4.8 10.5 0.4 8.5 13.5 10.2 16.8 2.9 3.3 2.3 12.2 5.2 12.9 12.2 5.1 12.8 7.0 14.5 5.3 19.1 6.2 4.7 15.3 22.2 5.7 71.2 3.1 33.2 3.1 10.8 12.7 10.4 3.1 14.7 8.0 13.0 8.3 21.0 2.9 9.2 11.3 5.1 5.0 3.6 16.9 4.8 4.3 6.3 6.5 12.5 12.0 9.7 0.8 0.2 13.5 1.0 10.9 9.8 12.8 2.2 5.7 2.4 2.8 0.5 12.5 0.1 14.3 1.0 6.6 15.7 8.2 52.9 1.2 4.6 5.0 0.1 4.9 3.6 3.3 0.7 0.3 12.9 34.5 6.7 24.2 12.4 16.0 1.6 0.1 20.3 5.2 1.0 0.2 0.3 7.3 0.0 1.0 0.2 11.8 3.5 0.2 30.7 5.7 12.8 11.2 0.1 29.8 4.6 3.7 0.1 19.3 8.7 7.9 14.5 4.3 5.9 0.1 0.0 24.6 0.1 9.7 0.0 0.1 0.0 0.2 0.1 0.6 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.5 0.0 0.0 2.7 0.7 0.0 9.8 10.5 13.5 10.2 7.0 14.5 15.3 22.2 5.7 12.7 11.3 16.9 9.7 50.2 0.0 1.1 170.7 1.8 37.6 27.3 27.3 23.9 115.5 11.7 8.8 16.8 11.5 10.4 3.7 56.3 0.8 8.5 0.2 0.0 3.5 12.5 11.5 50.1 32.1 4.8 0.0 29.5 1.4 2.4 30.2 4.1 25.4 0.0 22.9 24.7 56.9 2.3 37.0 128.7 0.2 12.2 2.9 12.3 34.3 21.1 2.2 16.0 72.1 3.2 7.1 3.1 34.7 13.2 4.6 1.3 27.1 5.4 8.5 0.0 2.2 7.1 9.2 0.0 22.0 13.1 7.9 9.3 33.4 47.2 1.2 8.0 24.9 0.5 16.0 KRT27 KRT25C ENSG00000171446 "Keratin 27" Q7Z3Y8 17 40776808-40782550 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "skin 1: 44.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9;thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "hippocampal formation: 80.6" HPA055114 Enhanced NA NA "HPA055114: AB_2682700" "unprognostic (1.13e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (5.75e-4)" "unprognostic (5.11e-2)" "unprognostic (3.08e-2)" "unprognostic (8.41e-2)" "unprognostic (4.16e-1)" "unprognostic (1.53e-1)" "unprognostic (4.90e-1)" "unprognostic (1.56e-1)" "unprognostic (5.64e-3)" 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 8.8 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 ZBTB26 ZNF481 ENSG00000171448 "Zinc finger and BTB domain containing 26" Q9HCK0 9 122915566-122931512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 37.3;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021444 Uncertain NA NA "HPA021444: AB_1858948" "unprognostic (5.39e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (8.48e-2)" "unprognostic (1.46e-1)" "unprognostic (1.83e-3)" "unprognostic (5.67e-3)" "unprognostic (2.48e-2)" "unprognostic (2.75e-2)" "unprognostic (8.26e-2)" "unprognostic (7.34e-2)" "unprognostic (1.96e-2)" "unprognostic (1.47e-1)" "unprognostic (2.21e-1)" "unprognostic (6.26e-2)" "unprognostic (1.81e-2)" 3.0 3.1 4.1 4.1 4.5 5.7 6.3 5.2 5.1 6.0 3.5 5.9 3.9 8.1 4.9 3.7 5.6 3.8 3.2 3.6 4.0 3.8 2.6 3.7 6.0 4.1 4.2 3.6 9.4 4.6 7.6 4.7 5.6 4.3 6.3 5.1 11.3 4.6 6.1 4.1 3.7 5.4 6.3 4.1 5.9 4.6 10.0 4.0 5.5 7.1 4.1 5.5 5.6 4.7 6.0 3.6 3.7 13.9 6.6 4.1 7.7 5.4 4.0 4.4 4.6 4.3 7.2 5.8 7.1 3.8 4.0 10.7 13.3 6.1 3.0 6.8 7.3 4.8 9.0 12.7 5.3 5.1 8.3 8.8 5.6 8.8 3.9 5.2 8.7 5.1 11.1 8.7 11.1 4.6 6.3 8.6 6.3 5.4 11.9 4.8 7.5 12.8 8.3 4.9 4.8 10.7 9.2 7.3 4.0 5.1 6.7 9.9 3.0 4.6 6.5 6.2 5.5 3.6 8.3 13.9 7.7 4.0 3.4 7.1 1.5 0.6 0.7 0.2 1.4 0.5 0.3 0.6 0.4 0.9 0.7 0.5 0.6 0.6 1.0 0.5 0.4 0.3 0.4 4.1 4.5 5.2 5.1 3.6 4.0 4.1 4.2 3.6 4.3 4.1 4.0 6.0 2.0 3.2 1.1 5.9 3.9 0.3 2.0 2.2 4.6 4.0 3.2 2.0 2.3 1.5 2.5 1.8 0.0 2.6 4.1 1.4 5.9 1.4 37.3 1.9 2.8 2.9 6.0 5.7 8.3 0.6 0.8 2.3 1.5 1.5 4.5 5.3 3.3 1.9 1.4 3.3 9.0 1.7 2.0 2.5 1.6 57.7 2.1 1.4 0.0 2.8 2.8 2.5 2.1 8.0 12.2 1.0 2.5 6.0 2.7 2.1 1.5 1.7 4.5 3.1 6.6 1.6 3.2 14.1 5.6 3.0 0.4 2.1 2.6 2.1 2.2 1.8 CDK5R2 "NCK5AI, P39, p39nck5ai" ENSG00000171450 "Cyclin dependent kinase 5 regulatory subunit 2" Q13319 2 218959666-218962155 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 55.1;pituitary gland: 35.4;retina: 26.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 78.8;Cone photoreceptor cells: 20.9;Enteroendocrine cells: 22.8;Excitatory neurons: 17.7;Horizontal cells: 15.2;Rod photoreceptor cells: 50.9" "Cancer enhanced" "Detected in some" "glioma: 3.9;pancreatic cancer: 2.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 18.4;SH-SY5Y: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-1)" "unprognostic (6.53e-2)" "unprognostic (3.85e-5)" "unprognostic (1.73e-6)" "unprognostic (3.67e-2)" "unprognostic (2.83e-4)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.71e-3)" "unprognostic (3.53e-3)" "unprognostic (2.34e-10)" "unprognostic (1.54e-1)" "unprognostic (1.64e-4)" "unprognostic (6.46e-2)" 0.0 4.0 13.9 0.3 22.7 0.0 0.0 0.1 55.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 22.0 13.5 0.0 0.0 0.0 0.0 10.8 10.9 32.0 0.0 1.0 0.0 35.4 0.0 13.7 0.0 0.1 26.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.9 0.8 16.4 0.0 0.0 0.0 0.0 0.0 0.1 22.1 0.4 0.4 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 2.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 18.4 13.3 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.2 1.3 0.0 0.3 0.0 0.0 0.0 0.6 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 22.7 0.1 55.1 22.0 13.5 10.8 10.9 32.0 13.7 0.0 16.4 22.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 78.8 0.0 0.0 0.5 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 22.8 0.0 17.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.2 11.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 8.1 0.0 2.0 2.6 0.2 1.2 0.0 0.0 0.1 0.1 0.0 0.0 50.9 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase like" Q8IZU8 18 67506587-67516720 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.9" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 86.4;Extravillous trophoblasts: 72.5;Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 104.2;Theca cells: 83.9" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 70.7;BJ hTERT+: 43.0;fHDF/TERT166: 38.9;LHCN-M2: 92.1;U-138 MG: 95.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060942 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060942: AB_2684392" "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 4.1 1.3 4.8 1.3 8.0 0.3 2.6 6.7 5.4 5.1 1.2 1.8 0.6 2.6 1.6 1.1 3.3 4.1 1.8 4.8 6.5 4.4 3.6 2.7 0.6 8.7 7.5 4.5 3.6 1.5 3.2 0.3 6.2 8.8 2.0 1.4 0.8 0.8 2.1 0.7 1.2 1.1 3.7 6.4 2.0 1.2 1.3 7.0 0.9 1.0 1.8 0.3 1.7 1.4 11.9 0.0 0.3 8.7 0.1 16.5 24.3 0.9 70.7 43.0 19.2 8.3 0.1 0.2 0.0 0.1 38.9 4.7 0.4 1.7 3.5 18.5 0.0 0.1 0.0 8.5 0.1 14.6 0.0 0.1 25.3 5.1 11.7 26.0 6.8 3.8 0.0 0.0 1.1 92.1 0.0 0.0 0.0 1.3 0.0 3.7 0.8 19.3 0.1 8.7 0.1 3.1 4.0 4.8 0.2 0.0 3.7 0.1 0.0 6.2 95.6 2.4 6.2 8.6 0.3 0.0 0.0 20.0 0.0 8.1 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 4.8 8.0 6.7 5.4 4.8 6.5 8.7 7.5 4.5 8.8 6.4 7.0 11.9 15.9 6.4 16.2 3.3 2.6 11.6 9.9 8.6 19.4 10.1 14.5 12.3 13.3 47.1 5.2 11.0 4.2 2.8 1.4 1.0 0.0 9.7 1.8 3.9 86.4 10.9 6.6 0.0 10.3 2.3 72.5 44.3 8.2 4.2 4.5 9.5 13.2 15.6 2.6 3.3 25.5 1.1 0.0 2.2 9.3 1.7 24.5 3.5 7.2 2.8 0.0 12.6 1.0 112.6 104.2 6.6 0.1 36.9 0.3 8.5 0.4 26.4 1.3 4.2 13.1 43.3 20.9 31.6 21.9 7.1 13.2 8.9 4.9 83.9 0.7 5.2 POLR1C "AC40, RPA39, RPA40, RPA5, RPAC1, RPC40" ENSG00000171453 "RNA polymerase I and III subunit C" O15160 6 43509702-43562419 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 306.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031010 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA031010: AB_10603131" "unprognostic (2.84e-1)" "unprognostic (1.67e-1)" "unprognostic (3.15e-1)" "unprognostic (6.57e-2)" "unprognostic (7.01e-2)" "unprognostic (3.59e-1)" "unprognostic (6.69e-3)" "unprognostic (1.09e-3)" "unprognostic (2.00e-3)" "unprognostic (1.90e-2)" "unprognostic (2.05e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (1.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" 13.9 19.3 16.8 12.4 16.6 7.8 20.5 16.3 21.1 15.4 19.4 18.6 13.2 15.3 15.8 21.5 21.1 9.6 12.1 16.6 16.9 17.8 17.9 11.1 14.0 16.4 16.5 16.8 14.5 15.6 17.2 13.9 12.3 16.9 14.5 15.7 6.7 15.9 12.2 15.4 20.7 11.0 14.9 16.9 12.8 14.8 20.2 17.0 12.7 16.2 13.5 21.0 23.6 15.6 17.3 76.0 61.7 26.6 72.3 40.0 43.0 42.1 45.3 33.5 49.7 42.2 82.5 25.2 85.2 48.3 44.2 42.5 45.2 64.7 57.6 57.6 45.4 67.7 58.3 57.2 115.7 50.1 90.0 39.1 38.7 54.8 67.9 85.4 29.4 39.6 35.4 136.9 24.5 44.0 106.4 47.4 65.0 49.2 306.8 52.9 31.9 41.8 57.6 60.7 104.1 49.0 32.8 39.6 34.1 62.2 19.4 36.9 77.9 47.6 35.3 48.1 38.4 72.3 35.1 85.0 146.0 24.1 60.9 40.0 5.7 30.0 4.6 34.1 24.0 46.5 51.1 40.4 34.1 42.4 55.0 55.1 49.6 2.7 41.7 20.5 38.6 32.7 34.0 16.8 16.6 16.3 21.1 16.6 16.9 16.4 16.5 16.8 16.9 16.9 17.0 17.3 13.0 12.8 17.7 9.8 24.9 61.8 50.6 34.3 42.1 8.2 24.0 23.6 5.2 17.2 30.4 5.5 6.2 29.7 15.3 11.3 15.6 26.7 13.5 23.4 15.9 18.6 13.1 12.8 13.6 24.4 18.9 21.5 25.0 14.2 14.0 14.4 15.7 11.9 13.3 5.0 12.3 17.4 28.5 5.2 17.0 8.3 11.5 8.5 21.4 11.2 8.3 7.1 14.4 14.1 10.2 21.0 11.5 11.7 13.1 29.2 5.0 27.5 48.5 15.4 6.6 29.1 45.6 34.4 43.3 26.4 40.9 13.5 17.4 21.5 19.9 37.0 ASXL1 KIAA0978 ENSG00000171456 "ASXL transcriptional regulator 1" Q8IXJ9 20 32358330-32439319 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor" "Cancer-related genes, Craniosynostosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064156 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA064156: AB_2685200" "unprognostic (1.49e-1)" "unprognostic (5.97e-2)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (6.69e-2)" "prognostic favorable (9.16e-4)" "unprognostic (2.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-1)" "unprognostic (4.32e-2)" "unprognostic (3.21e-2)" "unprognostic (1.84e-3)" "unprognostic (5.47e-2)" "unprognostic (1.90e-1)" "unprognostic (4.82e-2)" "unprognostic (1.06e-1)" 31.8 24.8 15.1 18.3 14.8 37.3 30.8 15.6 14.6 30.6 19.8 27.7 12.3 27.0 15.8 17.4 28.8 13.8 21.3 14.7 16.2 28.3 33.1 36.3 24.2 16.4 14.0 12.7 32.6 33.2 13.2 19.3 17.4 14.6 25.0 13.3 19.9 21.2 13.5 30.4 23.3 28.1 18.6 14.6 35.3 24.9 37.5 15.3 27.7 32.3 16.6 25.2 26.7 24.4 17.7 59.2 33.6 52.7 28.2 23.6 28.6 45.6 35.4 33.0 64.1 48.6 99.8 35.2 54.4 24.5 47.3 62.2 39.5 45.3 37.8 53.2 70.6 24.1 88.9 53.6 55.7 21.6 38.5 36.1 32.4 25.1 46.1 35.6 33.3 37.4 45.3 45.2 29.1 31.9 18.4 51.7 30.3 12.9 27.7 38.9 30.8 62.1 24.8 27.1 28.4 23.7 38.2 68.9 23.5 31.7 27.9 32.7 27.0 39.9 69.1 59.4 32.3 43.2 33.9 38.6 39.3 34.0 100.2 27.8 0.1 0.6 1.0 2.6 0.5 2.5 4.8 3.6 3.9 0.8 3.3 3.5 4.0 0.5 1.5 0.6 2.7 9.0 1.5 15.1 14.8 15.6 14.6 14.7 16.2 16.4 14.0 12.7 14.6 14.6 15.3 17.7 92.3 51.3 35.5 54.9 63.3 40.0 51.8 8.6 50.7 21.4 52.9 48.6 19.8 15.7 17.9 27.6 52.1 18.0 55.2 18.8 25.4 13.5 97.8 59.4 80.1 65.6 7.2 40.8 61.4 12.6 16.5 49.8 30.5 86.2 18.3 57.7 41.0 34.7 21.3 18.5 80.3 14.1 16.2 21.2 42.2 84.9 25.4 33.5 78.2 75.9 16.7 11.6 20.6 78.4 125.9 15.6 13.7 14.7 94.6 49.6 29.9 31.7 20.8 30.7 6.6 96.7 62.7 31.0 16.1 34.6 30.5 5.9 67.2 36.4 17.5 40.5 OR1L6 OR1L7 ENSG00000171459 "Olfactory receptor family 1 subfamily L member 6" Q8NGR2 9 122742303-122750783 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.4;prostate: 13.0;skin 1: 12.8" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 96.9;Basal respiratory cells: 56.8;Basal squamous epithelial cells: 64.3;Breast myoepithelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 24.1;HBEC3-KT: 13.1;hTCEpi: 38.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 0.5 0.6 3.4 0.7 4.3 0.9 2.9 6.4 7.1 2.1 1.6 0.4 0.4 0.6 2.0 12.4 0.6 0.3 1.1 4.0 3.5 0.3 0.7 0.5 0.9 2.5 2.9 4.8 1.2 0.9 0.1 0.8 0.6 3.5 13.0 0.0 0.6 8.1 5.3 0.2 12.8 0.6 0.1 2.1 0.8 0.4 1.0 3.0 2.3 0.7 0.0 0.9 0.8 6.7 3.9 7.9 2.8 0.8 11.3 0.0 0.6 2.5 2.8 3.0 3.1 1.4 2.7 0.4 1.5 1.7 0.5 3.8 24.1 8.0 13.1 0.7 1.5 3.0 0.6 1.5 4.2 0.8 0.5 1.6 1.3 38.5 0.9 7.1 1.0 0.0 4.5 0.7 1.1 1.2 3.0 0.6 0.6 1.0 3.0 2.9 1.6 1.4 0.7 0.4 2.6 8.3 0.8 0.9 0.3 0.4 0.6 0.7 2.4 0.8 1.1 3.6 0.8 5.6 1.8 0.4 2.5 0.1 1.1 0.8 0.3 0.1 0.1 0.1 0.0 0.8 0.1 0.5 0.5 0.0 0.2 0.2 0.1 0.2 0.8 0.1 0.5 0.0 0.1 3.4 4.3 6.4 7.1 4.0 3.5 2.5 2.9 4.8 3.5 2.1 3.0 3.9 0.3 0.0 0.5 0.3 0.4 10.1 96.9 56.8 64.3 1.3 0.6 26.7 0.6 0.0 6.0 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.3 0.1 3.0 0.7 1.2 0.0 6.1 0.0 2.7 0.4 0.0 0.2 0.0 4.7 0.0 0.0 0.1 11.8 2.8 0.0 2.0 0.0 0.4 0.5 0.3 0.6 1.8 2.8 0.0 0.6 0.0 3.0 0.9 0.1 0.0 0.0 0.1 12.9 0.0 0.0 1.1 1.2 0.0 0.5 1.1 1.7 7.0 6.7 2.6 0.3 1.3 0.4 0.0 8.3 ZNF562 FLJ20079 ENSG00000171466 "Zinc finger protein 562" Q6V9R5 19 9641807-9675100 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (2.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (1.62e-1)" "unprognostic (2.02e-2)" "prognostic favorable (4.17e-4)" "unprognostic (4.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.88e-2)" "unprognostic (2.96e-3)" "unprognostic (1.81e-1)" "unprognostic (4.07e-2)" "unprognostic (1.81e-2)" "unprognostic (1.62e-3)" "unprognostic (9.44e-2)" "unprognostic (3.82e-2)" "unprognostic (1.13e-3)" 5.9 4.7 6.4 6.5 6.7 7.6 11.7 12.0 6.0 6.1 5.0 8.4 5.1 7.9 4.3 14.2 5.5 6.4 5.6 4.6 7.0 5.6 7.0 5.8 5.9 6.3 5.5 4.4 6.1 6.1 5.9 4.7 6.2 6.2 6.3 7.6 5.7 6.8 6.5 3.1 6.1 5.3 8.1 6.4 7.3 5.8 3.6 6.4 5.5 5.9 5.2 7.5 9.1 7.1 9.9 12.7 10.5 15.2 29.0 7.9 7.3 0.7 13.6 9.4 14.1 15.4 8.2 7.2 12.9 13.1 10.4 11.4 10.1 19.7 15.2 17.5 14.4 12.1 46.3 10.9 8.2 9.2 16.6 33.1 12.9 10.5 17.5 28.1 7.8 15.4 10.3 22.8 22.0 14.0 6.2 16.7 4.1 19.8 8.9 6.8 6.5 17.5 6.3 6.6 34.8 16.0 10.0 20.1 7.7 9.3 12.0 11.3 13.6 13.5 24.9 9.7 11.4 17.7 17.7 45.3 21.1 3.5 1.1 13.2 3.3 2.7 3.1 2.4 3.9 3.6 3.1 2.1 1.7 3.5 2.3 2.4 3.0 1.2 3.0 4.5 2.1 2.3 1.3 6.4 6.7 12.0 6.0 4.6 7.0 6.3 5.5 4.4 6.2 6.4 6.4 9.9 14.7 9.6 18.5 8.5 11.3 6.4 40.0 11.6 12.0 30.6 23.9 14.4 9.4 30.0 17.7 25.8 73.0 14.9 11.9 32.2 19.6 19.6 7.5 20.1 17.6 18.1 23.9 23.8 19.4 8.6 18.5 12.7 19.4 29.7 12.7 22.1 23.2 13.6 11.9 28.6 18.0 16.9 12.2 31.5 8.9 12.2 12.2 16.7 7.2 18.7 21.3 12.4 20.6 24.6 22.2 24.7 20.9 13.5 6.1 45.1 9.6 9.1 15.6 31.2 0.0 17.4 12.8 13.5 11.4 14.6 10.1 19.4 11.9 13.7 18.1 67.1 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369647 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.9;Spermatogonia: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.1" "Lineage enriched" "Detected in single" 4 "B-cells: 2.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 7.6 6.4 7.0 12.6 6.0 11.5 8.0 12.6 8.8 14.3 2.4 8.3 7.2 11.6 10.7 6.4 9.8 7.1 7.1 6.6 4.8 6.5 8.1 7.6 25.8 5.5 4.7 6.6 12.0 8.3 10.9 7.3 8.1 7.3 9.8 8.1 21.4 7.6 8.2 8.6 12.1 9.8 9.1 3.3 14.5 6.4 26.5 5.1 13.5 12.6 6.4 25.2 9.0 10.1 7.4 26.4 6.2 18.0 29.9 15.4 13.7 9.3 11.6 14.3 12.8 11.1 6.6 3.2 41.5 6.4 14.4 15.0 11.4 20.0 9.5 16.6 11.8 10.7 11.4 8.1 10.7 7.7 20.2 9.2 8.8 9.8 10.8 9.6 10.8 10.2 11.3 15.6 19.3 13.8 9.0 6.4 12.8 8.1 42.9 5.9 7.6 17.9 6.4 7.1 5.9 16.6 10.2 8.6 7.2 9.0 13.8 9.1 27.6 10.6 17.9 9.2 12.2 11.4 12.4 10.9 28.2 5.6 15.1 10.2 0.0 0.3 0.0 0.5 0.2 0.1 0.6 0.4 0.3 0.3 2.1 0.3 0.3 0.1 0.3 0.1 0.3 0.5 0.2 7.0 6.0 12.6 8.8 6.6 4.8 5.5 4.7 6.6 7.3 3.3 5.1 7.4 7.8 9.6 14.5 10.7 29.9 9.7 4.4 5.6 12.0 18.1 6.5 6.9 9.5 8.6 6.4 9.2 8.4 5.8 6.8 5.2 3.9 5.2 30.7 9.2 13.3 7.8 5.4 8.2 19.9 4.7 4.4 10.4 5.1 6.3 6.3 20.6 11.7 19.4 6.6 25.2 18.9 5.1 6.1 11.1 7.2 16.5 6.2 10.7 3.6 4.7 9.7 9.4 16.5 15.6 17.5 4.2 8.2 9.8 5.1 3.0 11.4 3.9 6.8 11.8 26.3 13.6 8.7 82.9 46.3 9.0 5.1 1.8 8.8 8.9 8.3 2.0 ZNF561 MGC45408 ENSG00000171469 "Zinc finger protein 561" Q8N587 19 9604680-9621236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055332: AB_2682786, HPA062397: AB_2684751" "unprognostic (6.68e-2)" "unprognostic (1.26e-1)" "unprognostic (6.86e-3)" "unprognostic (3.43e-2)" "unprognostic (1.18e-2)" "unprognostic (3.63e-3)" "unprognostic (9.92e-2)" "unprognostic (2.53e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.31e-4)" "unprognostic (9.21e-2)" "unprognostic (3.34e-2)" "prognostic favorable (1.16e-4)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (3.27e-3)" "unprognostic (2.85e-3)" 9.0 8.9 5.3 8.5 5.4 10.3 17.4 7.5 7.8 13.6 4.7 10.3 8.1 18.0 12.1 16.4 18.7 13.0 9.9 6.5 5.6 12.7 11.2 11.3 10.9 6.3 5.9 4.2 20.3 10.5 13.7 7.7 10.6 6.4 17.5 12.9 7.3 9.8 17.8 9.2 14.4 8.6 26.3 5.2 9.8 10.7 6.4 5.7 14.6 15.6 14.7 12.6 18.8 12.2 11.5 14.4 5.7 31.8 24.3 26.2 30.9 28.0 18.9 25.2 23.2 26.1 10.7 6.1 13.2 13.5 19.1 13.3 8.2 21.6 36.1 24.2 18.5 23.3 16.9 12.2 18.9 15.7 20.9 16.0 20.5 55.4 17.4 22.4 36.3 29.7 9.6 19.3 17.4 29.0 6.9 9.4 23.3 25.6 12.3 18.1 11.1 15.8 13.5 20.3 51.7 19.7 19.6 0.4 10.9 14.7 30.1 14.6 14.6 9.3 24.8 8.8 17.2 17.9 20.2 30.2 17.7 12.2 5.6 16.8 4.0 5.1 5.8 4.9 5.1 6.2 2.8 3.9 4.4 4.1 3.9 5.4 4.0 3.4 1.7 2.7 3.6 4.0 3.4 5.3 5.4 7.5 7.8 6.5 5.6 6.3 5.9 4.2 6.4 5.2 5.7 11.5 8.2 0.0 7.0 5.9 7.9 13.8 25.2 31.9 16.5 9.4 11.5 16.5 9.8 11.5 17.9 14.7 6.2 8.0 11.0 7.3 3.9 11.1 6.9 11.1 12.1 8.9 11.4 11.6 10.0 6.5 8.5 7.7 12.2 9.0 7.6 25.5 10.8 8.2 10.9 10.1 10.5 7.7 16.2 12.8 5.8 9.7 11.5 8.3 3.6 6.5 12.2 6.3 17.5 17.6 12.0 8.6 6.8 13.2 6.2 10.9 9.8 8.5 30.3 11.9 6.6 9.1 10.4 8.2 10.6 23.6 22.4 6.4 10.2 16.2 7.7 25.9 WIPF2 "WICH, WIRE" ENSG00000171475 "WAS/WASL interacting protein family member 2" Q8TF74 17 40219304-40284136 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 99.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024000, HPA024001, HPA024467" Enhanced NA NA "HPA024000: AB_1858840, HPA024001: AB_1858841, HPA024467: AB_1858842" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (2.59e-1)" "unprognostic (6.07e-2)" "unprognostic (2.63e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.92e-1)" "unprognostic (2.05e-1)" "unprognostic (8.51e-3)" "unprognostic (2.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.32e-3)" "unprognostic (4.12e-1)" "unprognostic (7.51e-2)" "unprognostic (5.28e-2)" "unprognostic (9.23e-2)" 11.0 7.1 11.5 10.1 11.2 17.6 8.5 10.7 19.0 9.6 2.7 14.5 12.1 10.4 9.4 15.0 9.4 10.1 6.1 13.4 7.4 12.3 7.6 12.9 8.6 10.7 8.6 9.6 7.8 10.4 12.5 7.5 12.1 10.0 8.6 13.7 9.5 9.0 10.4 7.0 15.5 13.4 11.9 4.0 12.0 12.9 6.6 10.6 7.9 9.1 6.9 11.4 9.4 10.3 11.5 23.4 36.0 15.3 14.5 15.6 16.4 15.1 20.5 14.1 18.5 19.8 17.7 20.1 13.7 22.8 24.8 23.0 39.4 13.1 15.7 24.3 24.7 15.9 14.8 17.6 21.3 15.9 19.7 16.1 13.2 19.3 19.3 21.8 19.9 18.2 14.6 14.3 12.5 18.0 15.3 19.5 9.9 9.2 17.5 11.1 12.5 18.6 13.6 19.8 38.2 18.8 13.1 37.3 99.2 13.6 26.0 33.5 12.1 26.5 12.5 18.7 24.0 23.8 13.9 23.3 13.9 27.5 10.3 18.9 5.2 2.0 2.4 3.3 1.8 2.7 3.0 1.9 2.0 1.5 2.2 2.2 1.9 7.1 2.6 2.1 2.5 2.4 1.0 11.5 11.2 10.7 19.0 13.4 7.4 10.7 8.6 9.6 10.0 4.0 10.6 11.5 28.4 67.3 39.5 71.2 32.5 43.1 33.8 28.7 29.6 38.0 35.7 23.6 11.8 41.5 25.2 46.0 45.9 50.7 29.4 102.5 13.7 29.0 3.9 31.8 27.8 35.5 47.3 17.2 71.8 36.6 31.5 24.5 35.2 54.9 38.1 23.6 43.2 25.3 30.3 42.1 52.7 33.9 26.4 48.3 31.7 3.4 20.2 27.9 16.0 37.5 32.2 20.8 33.0 36.2 36.5 52.0 57.5 25.9 15.9 44.6 60.3 26.4 22.3 17.2 39.5 26.9 23.3 20.6 34.2 54.9 69.0 67.5 31.1 15.9 36.4 70.7 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 722.4;skin 1: 1450.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8" "Cancer enhanced" "Detected in many" "glioma: 43.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 518.2;NK-cell: 781.6" "Group enriched" "Detected in all" 15 "NK-cells: 781.6;T-cells: 518.2" "Cell line enhanced" "Detected in many" "HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 8.9 34.0 202.4 27.9 218.8 12.2 113.5 198.4 324.7 123.8 213.8 21.7 17.3 19.3 546.1 722.4 10.6 35.4 44.8 220.3 200.4 17.6 2.9 376.0 18.6 219.9 193.6 209.6 9.5 5.3 13.4 11.8 60.1 202.1 27.1 7.0 22.3 173.4 65.3 19.4 1450.4 11.4 116.7 219.3 12.0 34.1 45.7 195.8 15.9 226.5 32.0 192.1 34.4 371.6 216.9 0.0 0.0 0.0 0.0 5.0 15.7 5.9 0.0 0.0 1.4 1.0 0.0 0.0 12.6 0.7 0.3 2.3 2.2 1.4 0.0 1.9 31.2 0.2 0.1 0.0 0.0 2.0 0.0 0.1 2.6 11.9 3.6 0.0 3.4 66.9 0.0 0.0 0.5 3.2 0.5 0.1 1.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 50.5 1.0 0.6 0.0 0.0 0.0 4.6 0.0 0.0 76.2 0.0 0.2 0.5 0.1 26.0 0.1 0.1 3.2 0.0 0.0 5.7 1.1 2.0 518.2 3.5 282.0 43.4 123.6 227.6 2.6 36.5 20.9 150.8 11.2 781.6 4.5 3.6 9.1 365.6 202.4 218.8 198.4 324.7 220.3 200.4 219.9 193.6 209.6 202.1 219.3 195.8 216.9 14.5 750.0 569.2 38.2 23.3 414.6 42.2 8.7 59.7 3.5 3.4 3.0 14.8 2.8 125.6 1.8 0.0 2.3 345.3 0.8 1.9 0.4 33.3 2.8 4.0 28.7 8.4 30.5 62.2 0.2 5.5 16.7 5.6 5.2 10.1 99.5 5.3 1.2 4.0 0.0 7.9 11.1 4.1 11.4 30.9 45.9 3.1 7.9 35.6 14.0 41.4 166.4 1150.4 7.1 6.7 1.7 0.0 3.0 9.6 31.3 1.2 0.6 12.5 5.6 32.9 3.7 104.8 3.3 15.3 31.6 377.2 321.8 219.9 0.1 1.4 28.8 SPACA5B LYZL5B ENSG00000171478 "Sperm acrosome associated 5B" Q96QH8 X 48130657-48132613 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 24.1" "Cell type enriched" "Detected in single" 16 "Early spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" NA NA "HPA044747: AB_2679071, HPA047149: AB_2679955" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.2 0.4 0.2 0.2 0.4 0.3 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L3 OR9-D ENSG00000171481 "Olfactory receptor family 1 subfamily L member 3" Q8NH93 9 122675036-122676153 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058878 Uncertain NA NA "HPA058878: AB_2683843" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP5 "CLR19.8, MATER, NALP5, PAN11, PYPAF8" ENSG00000171487 "NLR family pyrin domain containing 5" P59047 19 55999726-56061810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "parathyroid gland: 22.6" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "Karpas-707: 1.3;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047260, HPA056271" Uncertain Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus" Vesicles "HPA047260: , HPA056271: AB_2683083" "unprognostic (9.67e-2)" "unprognostic (2.22e-2)" "unprognostic (5.03e-1)" "unprognostic (7.78e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC8C AD158 ENSG00000171488 "Leucine rich repeat containing 8 VRAC subunit C" Q8TDW0 1 89633072-89769903 "Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3" "Cell line enhanced" "Detected in many" "THP-1: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029347 Uncertain Approved "Golgi apparatus" No No "Golgi apparatus" "HPA029347: AB_10601544" "unprognostic (2.61e-2)" "unprognostic (3.09e-2)" "unprognostic (3.83e-2)" "unprognostic (1.76e-2)" "unprognostic (3.32e-2)" "unprognostic (1.65e-2)" "unprognostic (5.02e-2)" "unprognostic (3.76e-3)" "unprognostic (4.28e-2)" "unprognostic (4.90e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.78e-2)" "unprognostic (4.42e-2)" "unprognostic (1.94e-2)" "unprognostic (3.38e-2)" 14.4 7.7 4.4 9.1 4.8 8.0 7.8 4.6 5.8 3.3 10.3 3.2 3.2 7.4 1.9 2.9 2.9 6.6 6.3 4.3 4.5 2.6 3.4 7.7 12.3 4.9 5.2 3.8 5.4 1.8 2.8 2.3 6.6 5.4 2.3 3.8 1.6 2.0 2.1 2.7 6.1 3.9 15.9 5.3 9.3 3.0 4.1 4.9 5.7 3.5 8.0 7.8 6.2 2.0 6.3 0.3 3.8 3.0 2.7 9.1 10.2 1.4 19.3 21.6 8.7 8.0 0.0 1.3 6.0 5.3 8.5 14.9 13.1 10.1 29.0 20.9 14.8 6.1 5.7 2.9 0.3 7.4 26.6 1.9 4.4 5.8 18.8 10.0 5.8 35.6 9.2 3.9 7.9 7.5 0.7 3.9 26.2 3.3 0.1 7.8 26.5 1.4 2.0 1.8 3.2 2.3 10.7 7.1 0.7 16.2 4.7 0.2 41.3 29.9 15.3 7.3 5.3 14.9 2.9 2.6 3.1 4.7 19.6 2.6 0.4 6.0 0.0 3.8 5.2 3.3 0.7 6.1 5.1 8.9 0.5 4.8 4.5 0.8 2.0 6.6 0.7 11.3 3.2 4.4 4.8 4.6 5.8 4.3 4.5 4.9 5.2 3.8 5.4 5.3 4.9 6.3 73.5 3.2 3.6 31.3 7.6 45.4 3.8 5.6 3.4 2.3 1.7 2.9 6.3 2.8 2.7 0.0 0.0 0.1 24.6 0.3 0.0 1.7 36.3 0.2 1.9 47.3 1.2 4.8 73.6 2.4 1.1 8.7 2.6 0.6 0.0 58.5 28.9 0.1 13.6 1.7 99.2 0.3 2.0 29.5 36.9 21.3 0.0 27.8 26.6 185.5 21.3 0.5 13.4 22.1 85.2 12.8 1.9 0.7 20.8 2.1 0.3 0.6 2.9 1.2 0.0 2.2 24.2 3.9 2.0 1.3 44.9 0.3 27.1 3.4 0.3 2.5 SPACA5 "dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288" ENSG00000171489 "Sperm acrosome associated 5" Q96QH8 X 48004336-48009729 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 14.2" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Early spermatids: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" NA NA "HPA044747: AB_2679071, HPA047149: AB_2679955" 0.0 0.0 0.7 0.0 0.7 0.1 0.1 1.0 0.9 0.0 0.3 0.1 0.0 0.2 0.5 0.0 0.2 0.1 0.0 0.4 0.6 0.1 0.0 0.1 0.4 0.9 0.5 0.4 0.2 0.9 0.0 0.0 0.0 0.7 0.2 0.1 0.3 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.1 14.2 0.6 0.0 0.8 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.7 1.0 0.9 0.4 0.6 0.9 0.5 0.4 0.7 0.1 0.6 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RSL1D1 "CSIG, DKFZP564M182, L12, PBK1, UTP30" ENSG00000171490 "Ribosomal L1 domain containing 1" O76021 16 11833850-11851580 "Predicted intracellular proteins, Ribosomal proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043483 Supported Enhanced "Nucleoli rim,Mitotic chromosome" Yes No 18000 "Nucleoli rim, Mitotic chromosome" "HPA043483: AB_2678504" "unprognostic (4.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.23e-2)" "unprognostic (8.88e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.95e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (6.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.28e-1)" "unprognostic (2.24e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (4.72e-2)" "unprognostic (1.36e-1)" "unprognostic (2.02e-2)" "unprognostic (2.68e-2)" 39.6 32.6 11.9 37.2 12.7 47.1 79.6 14.3 15.1 48.0 13.0 36.0 32.9 44.4 29.1 38.6 44.8 30.8 34.0 12.4 13.0 33.3 39.4 26.6 48.6 12.7 12.5 11.9 119.6 44.0 29.1 13.3 30.2 13.1 33.5 38.3 15.2 42.3 34.4 88.1 34.3 29.4 36.9 14.7 27.2 25.3 22.6 13.1 42.2 35.1 52.1 65.6 48.4 26.7 15.5 90.7 84.3 69.1 87.1 88.6 157.9 81.9 82.1 91.4 104.0 105.9 82.6 83.1 225.6 133.1 68.6 72.1 62.5 186.7 124.4 168.4 88.8 100.7 111.6 75.9 188.0 165.4 159.5 71.3 116.6 173.2 107.6 248.2 77.8 102.4 87.0 198.6 101.5 129.3 100.8 125.7 92.6 177.7 108.1 86.1 129.2 127.3 240.1 92.9 78.0 96.4 79.2 155.0 116.6 110.0 70.9 100.5 122.2 63.2 69.0 77.3 66.0 120.0 81.3 126.2 261.7 75.0 164.9 94.1 14.1 123.2 12.6 69.7 119.1 129.6 132.6 129.5 91.7 130.8 117.3 185.4 136.8 7.1 124.6 120.7 80.2 100.9 253.0 11.9 12.7 14.3 15.1 12.4 13.0 12.7 12.5 11.9 13.1 14.7 13.1 15.5 111.2 141.1 156.6 5.5 198.1 330.9 338.6 251.0 299.3 39.9 241.1 344.4 188.4 74.4 198.1 49.7 22.9 186.4 118.7 41.2 135.0 134.5 22.8 76.0 181.1 118.1 94.5 104.5 11.0 186.2 286.8 180.9 88.2 100.0 152.6 106.6 64.2 78.5 147.6 38.7 11.6 126.4 107.8 153.0 177.3 18.5 199.4 141.0 92.5 3.7 276.5 52.8 113.3 3.5 7.3 135.4 75.1 126.0 104.6 226.5 110.5 155.0 81.3 30.8 59.2 245.4 151.5 111.2 136.0 203.5 290.2 160.6 166.5 162.8 184.3 225.1 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 80.8;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 6.0 27.1 27.9 15.9 43.1 14.3 13.0 39.3 38.1 12.2 10.4 18.0 19.2 8.9 10.4 8.0 7.8 8.1 7.7 31.5 51.2 26.2 23.7 9.8 25.1 43.8 40.9 22.9 5.9 13.1 7.7 16.4 10.4 45.7 5.6 18.4 12.1 24.7 5.9 8.7 5.7 18.1 11.5 38.3 24.1 11.6 10.4 36.7 28.0 16.0 3.5 20.6 11.3 3.3 81.9 73.5 47.0 18.8 44.5 32.9 27.7 63.5 49.1 73.9 27.3 34.1 20.2 18.3 57.7 54.4 82.1 31.0 93.7 43.6 58.9 34.4 45.3 24.1 67.8 40.4 43.2 64.2 78.2 20.5 17.4 48.1 23.3 50.3 37.6 47.1 32.8 37.6 17.7 30.1 22.0 32.5 50.4 32.6 16.4 42.6 43.6 27.3 41.5 69.2 25.7 35.0 24.4 61.0 62.4 137.8 32.4 15.0 76.4 21.0 29.1 9.9 60.0 37.6 21.4 39.5 34.7 11.3 97.0 26.2 0.0 8.9 1.6 7.0 10.4 11.6 6.9 16.0 8.5 8.1 5.6 15.2 11.5 3.5 13.1 8.4 9.4 17.4 10.6 27.9 43.1 39.3 38.1 31.5 51.2 43.8 40.9 22.9 45.7 38.3 36.7 81.9 2.9 3.2 1.7 35.3 10.8 6.0 1.4 12.7 15.9 6.6 8.4 7.4 3.0 8.6 6.2 12.9 2.1 4.0 14.8 26.6 7.9 5.7 0.7 3.1 2.9 5.5 7.8 17.0 66.8 8.6 9.9 3.8 6.1 3.4 5.7 7.8 7.9 30.1 11.8 3.3 80.8 10.8 10.2 21.9 5.5 0.8 1.2 19.1 10.6 68.4 36.3 6.3 10.3 146.8 346.4 5.4 11.3 3.8 8.0 4.1 22.5 12.5 7.2 7.6 6.6 10.7 2.9 0.3 1.9 7.1 1.1 1.8 11.0 22.4 11.2 1.8 MROH2B "DKFZp781F0822, FLJ40243, HEATR7B2" ENSG00000171495 "Maestro heat like repeat family member 2B" Q7Z745 5 40998017-41071342 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 304 "testis: 30.4" "Group enriched" "Detected in some" 8 "Early spermatids: 21.0;Late spermatids: 40.2;Spermatocytes: 10.4" "Cancer enriched" "Detected in single" 6 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059457 Enhanced NA NA "HPA059457: AB_2684026" "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.41e-2)" "unprognostic (2.35e-1)" "unprognostic (8.91e-5)" "unprognostic (2.51e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 2.7 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 40.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L8 ENSG00000171496 "Olfactory receptor family 1 subfamily L member 8" Q8NGR8 9 122567117-122583384 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Excitatory neurons: 8.6;Inhibitory neurons: 5.1;Microglial cells: 1.9;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RT4: 4.9" "Not detected" "Not detected" NA NA "unprognostic (9.76e-2)" "unprognostic (1.11e-1)" "unprognostic (4.32e-2)" "unprognostic (3.86e-2)" "unprognostic (1.68e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-2)" "unprognostic (9.11e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-4)" "unprognostic (9.82e-3)" "unprognostic (3.33e-1)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.7 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709127-158723396 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA 480000 Cytosol "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 27.1 38.6 44.0 24.6 42.8 25.3 23.0 42.8 64.6 25.6 48.1 33.7 51.1 24.4 19.1 28.0 24.3 19.0 44.4 47.1 45.2 35.1 88.4 19.9 28.9 43.1 43.4 39.7 24.4 32.0 17.2 28.9 21.8 46.4 23.7 20.5 36.5 23.5 18.9 89.7 36.4 45.7 19.0 44.3 29.3 29.2 24.3 46.9 24.5 24.1 45.9 26.0 27.6 24.2 53.5 46.7 42.3 41.8 57.7 60.7 45.2 63.1 44.9 24.3 40.3 30.4 55.4 30.9 48.9 19.7 42.0 63.4 35.1 127.9 51.5 48.8 162.9 44.4 87.5 36.5 76.9 46.8 55.6 63.0 28.9 41.2 34.6 51.5 52.0 44.6 81.9 111.0 84.4 45.5 44.6 80.0 49.9 57.9 75.5 55.8 35.9 20.7 41.7 44.6 23.0 70.2 47.1 33.8 69.2 65.6 60.0 31.9 52.2 43.7 40.1 45.3 44.7 60.2 48.3 107.2 62.0 51.1 59.4 41.1 68.8 23.9 55.2 31.1 35.4 36.0 22.3 30.2 29.1 26.4 25.4 30.9 32.0 32.9 40.5 37.7 26.9 37.0 28.0 44.0 42.8 42.8 64.6 47.1 45.2 43.1 43.4 39.7 46.4 44.3 46.9 53.5 29.2 6.4 13.4 13.1 24.8 10.1 29.7 17.5 9.1 30.2 19.1 20.8 59.7 25.8 27.9 27.6 22.9 41.5 38.7 17.1 37.2 39.2 39.0 66.1 39.9 25.1 19.6 17.4 24.3 23.0 49.5 24.3 14.3 28.5 32.3 24.4 17.2 18.5 41.9 75.7 28.6 28.3 22.4 17.0 14.7 23.1 20.5 26.0 14.2 9.4 51.6 23.3 48.4 15.1 28.3 29.5 27.4 22.6 22.3 31.6 39.7 33.7 62.3 32.3 6.6 17.7 58.2 96.0 77.5 16.9 11.8 47.6 33.7 33.7 32.0 20.2 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122555173 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 3.0;Rod photoreceptor cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COL24A1 ENSG00000171502 "Collagen type XXIV alpha 1 chain" Q17RW2 1 85729233-86156943 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 167.1" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 9.3" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 2.7" "Lineage enriched" "Detected in single" 9 "dendritic cells: 2.7" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;Karpas-707: 3.7;NTERA-2: 1.9;RH-30: 2.7;SuSa: 2.8;U-266/70: 6.9" "Secreted to extracellular matrix" NA NA 52000 "unprognostic (3.00e-1)" "unprognostic (6.19e-2)" "unprognostic (2.21e-2)" "unprognostic (6.76e-3)" "unprognostic (1.82e-3)" "unprognostic (2.45e-2)" "unprognostic (2.44e-5)" "unprognostic (1.37e-1)" "unprognostic (4.08e-2)" "unprognostic (6.59e-2)" "unprognostic (3.89e-2)" "unprognostic (1.46e-1)" "unprognostic (3.48e-6)" "unprognostic (2.79e-5)" "unprognostic (5.07e-1)" "unprognostic (1.19e-1)" "unprognostic (9.90e-2)" 0.4 0.0 0.6 0.8 2.9 0.9 0.3 0.0 9.3 5.9 0.0 4.9 1.5 1.3 0.8 0.7 0.1 1.6 1.4 7.1 1.0 0.7 0.0 0.7 0.3 0.8 0.0 2.1 2.4 0.0 0.0 1.2 0.1 1.2 1.1 0.8 5.5 0.4 1.5 0.5 0.5 1.7 0.9 0.1 0.3 1.7 0.8 0.3 0.2 0.4 1.7 0.3 5.0 3.0 2.4 0.0 0.0 0.9 0.0 2.1 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.9 0.0 0.5 0.0 0.7 0.0 0.1 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.5 0.0 0.0 0.1 1.9 0.0 0.0 0.0 2.7 0.3 0.3 0.7 0.0 0.0 0.0 0.1 0.3 2.8 0.0 0.6 0.0 1.2 0.1 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.6 2.9 0.0 9.3 7.1 1.0 0.8 0.0 2.1 1.2 0.1 0.3 2.4 0.0 0.0 0.6 6.8 1.1 0.4 0.0 0.2 0.0 1.9 0.5 0.0 2.1 0.0 0.5 5.5 0.0 0.0 11.1 0.0 0.0 0.0 0.1 0.2 3.7 0.4 0.0 2.5 167.1 0.0 0.0 2.8 0.0 0.1 1.3 0.5 0.0 0.0 2.4 0.0 12.9 0.0 0.0 0.0 0.4 0.2 0.9 0.9 10.6 7.5 0.0 40.4 0.0 11.1 6.5 0.0 0.0 0.7 3.3 0.0 0.0 0.1 2.4 1.7 0.0 0.5 1.3 1.0 0.9 0.0 0.1 0.0 0.3 2.8 0.0 0.0 ETFDH ETFQO ENSG00000171503 "Electron transfer flavoprotein dehydrogenase" Q16134 4 158672125-158709623 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Disease variant, FDA approved drug targets, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 198.0;tongue: 188.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041978 Enhanced NA NA "HPA041978: AB_10795605" "unprognostic (7.19e-2)" "unprognostic (2.28e-1)" "unprognostic (2.90e-2)" "unprognostic (5.92e-3)" "unprognostic (1.91e-1)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (7.17e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-2)" "prognostic favorable (5.76e-10)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.85e-3)" "unprognostic (1.74e-1)" 34.9 38.3 13.1 10.8 14.5 9.5 16.1 13.8 15.3 10.0 23.1 32.9 64.3 10.5 8.5 25.2 9.4 11.2 76.4 12.8 14.0 47.0 198.0 9.3 8.8 13.0 13.7 11.9 10.9 20.6 33.0 9.9 13.1 13.2 13.8 27.1 15.9 22.0 13.3 112.1 18.9 51.8 14.9 12.4 9.6 27.1 11.3 15.0 9.5 13.3 188.6 14.4 13.0 12.9 15.2 13.2 9.2 12.2 21.4 47.2 28.8 6.6 21.3 19.4 13.9 14.3 3.7 24.6 27.8 4.6 24.1 15.8 13.8 22.1 20.9 19.2 51.5 20.3 26.5 17.3 8.0 20.8 24.0 23.4 26.5 23.8 15.8 12.8 20.8 27.3 20.7 15.6 53.8 22.2 14.7 22.7 11.0 5.0 33.2 19.4 18.4 4.3 21.9 21.2 10.6 18.7 8.0 21.0 39.5 21.8 10.0 30.4 17.6 13.6 11.9 6.7 18.5 12.2 31.3 42.1 20.3 24.6 19.2 13.5 3.7 21.5 41.5 10.1 22.6 12.7 10.3 9.8 10.4 18.3 9.6 11.6 9.9 7.8 10.5 20.9 13.1 16.1 9.5 13.1 14.5 13.8 15.3 12.8 14.0 13.0 13.7 11.9 13.2 12.4 15.0 15.2 18.1 12.8 10.3 55.2 18.5 33.0 46.0 27.2 29.6 29.2 12.6 13.8 146.6 14.3 22.8 18.4 64.6 24.9 18.0 34.4 29.4 14.4 4.2 12.5 12.5 17.7 18.0 30.7 43.2 11.7 9.9 23.9 44.4 14.2 5.1 19.2 12.8 85.7 13.4 25.2 71.9 22.5 30.5 14.4 15.8 4.7 23.0 13.3 8.8 15.0 12.2 13.9 10.3 55.8 58.0 11.7 29.4 23.7 30.1 21.3 58.3 26.8 13.1 43.9 32.9 27.4 30.4 43.2 29.8 32.7 36.9 43.0 19.7 15.7 26.2 38.7 OR1N1 "OR1-26, OR1N3" ENSG00000171505 "Olfactory receptor family 1 subfamily N member 1" Q8NGS0 9 122526358-122527296 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "endometrial cancer: 0.8;ovarian cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.63e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXFP1 "LGR7, RXFPR1" ENSG00000171509 "Relaxin family peptide receptor 1" Q9HBX9 4 158315311-158653372 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 6.8;endometrium 1: 6.3" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6" "Cancer enriched" "Detected in single" 9 "endometrial cancer: 3.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 11.8;hippocampal formation: 7.8" HPA027067 Approved NA NA "HPA027067: AB_10602127" "unprognostic (3.07e-3)" "unprognostic (3.02e-3)" "unprognostic (1.05e-1)" "unprognostic (2.53e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-3)" "unprognostic (6.13e-2)" "unprognostic (6.18e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-6)" "unprognostic (8.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.33e-4)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (6.22e-3)" 0.1 5.3 3.6 0.2 6.6 0.0 0.1 0.3 6.8 2.7 0.7 0.2 0.1 6.3 1.0 0.1 0.8 0.7 0.0 5.6 2.1 2.1 1.4 3.8 0.4 1.7 0.9 4.6 0.3 0.1 0.2 0.1 2.7 2.3 0.4 0.1 0.0 0.1 2.8 0.0 0.0 0.2 0.8 0.4 0.3 0.4 0.2 1.0 0.0 1.3 0.0 0.3 0.1 0.8 6.4 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 6.6 0.3 6.8 5.6 2.1 1.7 0.9 4.6 2.3 0.4 1.0 6.4 0.0 0.0 0.5 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 61.4 23.5 4.2 0.0 1.7 167.9 0.0 0.0 0.2 0.0 174.6 0.0 0.0 0.0 0.0 0.7 0.0 7.8 0.0 0.0 0.0 0.5 0.2 0.0 0.8 0.0 7.5 0.0 0.0 0.0 10.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.6 0.8 0.0 0.1 0.1 0.6 0.0 0.0 0.0 LPAR3 "Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3" ENSG00000171517 "Lysophosphatidic acid receptor 3" Q9UBY5 1 84811602-84893206 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 15.6;Cardiomyocytes: 31.2;Endometrial ciliated cells: 36.9;Glandular and luminal cells: 51.6;Respiratory ciliated cells: 18.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 24.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 19.0;HBEC3-KT: 22.2;hTCEpi: 25.0;NTERA-2: 20.3;PC-3: 19.0;SK-MEL-30: 24.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA013421 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA013421: AB_1847990" "unprognostic (2.85e-2)" "unprognostic (1.67e-1)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (2.72e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-1)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.31e-5)" "unprognostic (1.11e-2)" "unprognostic (7.52e-2)" "unprognostic (1.13e-4)" "unprognostic (4.11e-2)" "unprognostic (1.19e-1)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" 0.0 1.4 2.3 0.2 3.1 0.3 0.9 2.0 5.1 10.5 1.9 0.5 0.1 2.9 6.0 7.1 36.7 0.6 9.5 3.4 2.3 0.0 0.1 1.5 0.2 8.1 2.7 2.5 1.5 10.5 0.1 0.1 1.4 2.3 13.5 0.6 0.1 5.7 1.0 0.4 4.0 0.1 0.1 1.8 0.1 0.3 10.5 3.5 2.3 0.2 0.0 1.0 5.1 5.3 3.1 0.7 0.1 0.0 0.1 0.0 0.0 0.7 0.3 1.7 1.4 1.1 0.0 0.0 0.1 0.3 0.0 0.0 0.4 19.0 22.2 1.4 0.2 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 25.0 4.8 1.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 20.3 0.0 19.0 0.0 0.0 0.0 0.0 5.8 1.3 1.1 0.0 0.5 24.1 1.4 0.0 2.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.3 3.1 2.0 5.1 3.4 2.3 8.1 2.7 2.5 2.3 1.8 3.5 3.1 0.0 0.0 0.5 12.7 0.0 3.4 15.6 5.6 7.4 0.0 1.8 3.7 31.2 0.0 6.5 0.0 0.0 0.5 0.1 0.3 0.0 0.0 2.9 36.9 3.6 0.5 0.0 0.0 0.2 1.3 0.0 1.2 0.0 51.6 0.0 0.5 0.4 0.0 0.4 0.0 0.1 0.2 2.0 0.0 1.5 2.4 0.6 0.7 1.8 1.9 0.0 0.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 13.1 0.0 0.0 18.7 0.0 0.0 0.0 1.2 0.7 3.4 7.7 9.1 0.1 1.5 0.6 0.4 13.5 PTGER4 EP4 ENSG00000171522 "Prostaglandin E receptor 4" P35408 5 40679915-40693735 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 86.5;pancreas: 54.6" "Cell type enhanced" "Detected in many" "dendritic cells: 134.8;Langerhans cells: 130.7;Macrophages: 90.2;T-cells: 214.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 43.2;HUVEC TERT2: 28.7;LHCN-M2: 27.6;RT4: 43.1;THP-1: 27.4;TIME: 54.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011226, HPA012756" Approved NA NA "HPA011226: AB_1855885, HPA012756: AB_1855884" "unprognostic (1.79e-2)" "unprognostic (6.53e-3)" "unprognostic (9.43e-3)" "unprognostic (6.77e-3)" "unprognostic (1.44e-1)" "unprognostic (7.16e-2)" "unprognostic (7.28e-3)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "unprognostic (3.61e-2)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.48e-4)" 11.9 9.8 0.8 15.2 0.8 86.5 6.4 0.8 1.1 3.1 1.6 20.5 20.8 2.7 1.2 5.7 12.2 11.3 5.1 0.8 1.3 8.6 4.1 18.4 15.5 1.8 1.3 0.5 1.2 54.6 1.0 1.1 3.1 1.7 3.1 17.1 0.1 3.5 2.5 4.0 3.7 25.0 5.9 2.8 12.6 19.8 2.9 1.0 19.6 2.9 6.9 9.4 11.7 2.4 2.7 3.7 0.8 0.0 0.1 16.7 19.7 0.1 0.3 1.4 1.0 0.7 0.0 1.1 0.4 0.3 0.0 17.5 2.8 0.2 6.7 1.7 43.2 0.8 0.0 1.5 0.0 15.1 15.2 3.0 2.1 1.0 10.2 4.1 2.3 28.7 14.7 0.0 10.2 27.6 0.0 16.3 7.0 0.1 0.7 6.5 10.7 2.7 1.4 3.9 43.1 0.0 0.0 0.6 1.3 0.1 0.6 6.6 27.4 54.0 5.5 0.0 0.1 1.3 0.1 0.3 2.0 2.4 11.3 1.5 5.3 7.1 14.6 15.8 19.0 9.0 1.8 9.5 9.9 8.1 1.6 5.7 8.1 12.8 3.8 24.7 1.1 8.4 7.3 0.8 0.8 0.8 1.1 0.8 1.3 1.8 1.3 0.5 1.7 2.8 1.0 2.7 44.5 12.8 9.0 1.3 46.4 61.2 5.8 16.2 22.8 0.0 9.4 9.1 3.9 0.0 10.2 7.3 0.0 0.2 134.8 45.7 0.0 0.9 3.7 1.6 1.4 18.0 13.1 2.5 2.8 7.7 0.9 30.0 29.6 2.2 10.1 4.6 3.6 0.8 29.5 0.0 3.4 53.8 4.1 49.7 130.7 1.8 0.9 90.2 19.6 3.7 48.8 0.1 57.7 1.5 7.1 2.9 28.1 0.4 38.6 6.7 16.3 0.1 13.0 0.3 0.0 39.1 11.8 7.1 1.0 17.5 30.4 0.3 214.9 0.1 31.4 1.4 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules NA NA 1800000 Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 148.1 257.8 131.5 113.1 134.7 157.9 147.7 133.8 178.6 146.7 137.8 139.3 106.2 132.4 248.3 172.0 143.5 89.8 155.4 132.9 145.3 191.7 289.1 115.3 147.5 142.0 142.9 127.7 195.9 132.8 163.5 151.9 123.9 143.3 128.7 107.2 109.8 125.5 100.9 148.3 92.9 105.5 105.6 135.1 109.5 154.2 79.9 140.8 156.4 131.4 109.1 141.8 134.2 138.1 144.3 427.1 286.2 526.4 515.1 227.5 322.7 285.1 352.9 303.2 377.9 432.6 389.5 456.0 654.1 627.0 200.5 562.2 258.0 328.1 453.9 372.7 306.6 524.8 310.9 286.4 426.5 331.7 271.8 248.1 326.4 350.4 270.0 401.0 372.1 329.6 532.2 331.9 396.4 346.7 367.4 575.7 650.3 320.5 122.1 265.0 383.6 434.5 703.6 373.7 358.0 501.1 324.3 339.3 236.6 668.0 455.3 337.2 679.0 307.2 192.2 214.2 341.5 563.3 323.0 339.3 580.9 438.0 463.3 391.1 73.3 138.4 77.5 135.4 153.6 153.5 218.6 160.9 162.4 172.5 196.0 150.8 194.9 82.2 132.7 168.3 253.7 241.6 156.8 131.5 134.7 133.8 178.6 132.9 145.3 142.0 142.9 127.7 143.3 135.1 140.8 144.3 177.5 153.8 141.9 53.2 234.6 210.9 264.5 447.5 140.0 167.4 310.9 371.0 88.5 275.9 217.0 303.5 58.4 453.9 195.5 231.4 718.1 377.4 46.5 458.4 263.1 185.2 253.5 189.1 71.2 388.5 374.1 216.1 151.4 238.8 159.0 394.1 297.0 1298.8 411.2 148.0 73.9 300.7 252.3 495.5 401.4 42.7 306.6 226.3 225.9 40.3 394.9 231.3 254.3 66.9 126.8 476.2 283.1 258.8 182.6 406.3 256.6 1037.0 360.8 133.3 236.7 214.8 223.0 236.5 119.0 261.6 226.0 563.8 203.7 505.0 303.6 303.3 NEUROD2 "bHLHa1, NDRF" ENSG00000171532 "Neuronal differentiation 2" Q15784 17 39603536-39609777 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 77 "brain: 95.4;choroid plexus: 31.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 10.1;Cone photoreceptor cells: 4.2;Enteroendocrine cells: 23.8;Excitatory neurons: 14.9" "Cancer enhanced" "Detected in some" "cervical cancer: 0.7;glioma: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 139 "SCLC-21H: 29.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 68.0;hippocampal formation: 76.9" NA NA "unprognostic (5.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.87e-1)" "unprognostic (3.51e-3)" "unprognostic (2.44e-2)" "unprognostic (3.04e-1)" "unprognostic (4.69e-1)" "unprognostic (1.72e-1)" "unprognostic (2.16e-1)" "unprognostic (3.96e-1)" "unprognostic (6.15e-2)" "unprognostic (4.09e-2)" "unprognostic (3.21e-6)" "unprognostic (4.20e-1)" "unprognostic (2.66e-1)" "unprognostic (2.52e-2)" "unprognostic (2.57e-3)" 0.0 0.0 46.2 0.0 51.7 0.0 0.0 67.3 95.4 0.0 31.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 66.1 34.5 0.0 0.0 0.0 0.0 48.8 38.4 50.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.8 0.0 0.0 0.2 0.2 0.0 0.0 32.3 0.0 0.1 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 46.2 51.7 67.3 95.4 66.1 34.5 48.8 38.4 50.0 49.8 32.3 34.3 50.2 0.1 0.0 0.0 1.0 0.2 0.3 1.1 0.0 0.0 10.1 0.2 0.3 1.5 0.0 0.0 0.0 4.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 23.8 0.0 14.9 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.3 0.0 0.6 0.2 0.0 1.9 0.1 0.6 1.0 0.5 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 1.8 0.0 1.7 0.4 0.6 0.3 0.0 0.0 0.8 0.4 0.0 0.1 1.1 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669038 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.9;pituitary gland: 77.4;retina: 96.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 4.4 19.2 66.7 2.0 68.6 0.0 3.6 53.2 69.0 9.7 57.7 16.3 1.7 18.2 21.2 4.3 41.1 6.4 7.4 65.2 67.4 16.8 1.2 7.8 0.7 67.2 59.1 68.5 8.1 3.6 22.2 77.4 1.5 71.2 18.0 3.6 96.9 3.6 21.3 1.0 7.2 4.8 13.2 51.9 2.4 10.8 18.7 62.4 0.8 7.9 1.3 0.5 7.2 8.5 73.9 0.2 0.7 37.8 0.1 0.1 0.0 0.0 3.8 0.2 0.3 0.0 38.1 0.1 0.6 1.4 6.3 1.3 0.0 3.4 0.5 0.0 21.5 0.5 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.5 0.1 0.2 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.9 0.0 2.9 0.0 0.0 0.1 0.1 0.5 62.4 31.7 4.6 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.7 68.6 53.2 69.0 65.2 67.4 67.2 59.1 68.5 71.2 51.9 62.4 73.9 1.2 3.2 3.7 25.8 0.1 0.8 1.7 0.7 0.0 81.2 0.8 1.8 8.4 1.5 3.1 11.0 158.4 0.2 0.2 0.0 1.9 0.1 27.7 28.2 4.6 1.6 13.1 0.0 75.8 0.2 0.0 2.9 0.0 0.8 0.0 0.8 2.2 0.3 0.1 50.5 43.3 0.0 6.1 0.0 1.1 41.9 7.5 0.3 5.4 1.9 0.0 18.7 0.0 13.0 13.3 0.2 0.0 18.4 0.1 1.4 0.0 1.2 25.4 10.2 0.0 1.9 5.7 23.5 4.3 0.1 0.4 0.0 0.3 0.1 0.0 0.4 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77638713 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "brain: 19.8" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Region enhanced" "Detected in many" "hypothalamus: 19.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "hypothalamus: 20.0" "Region enhanced" "Detected in some" "hypothalamus: 15.5" HPA059342 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies" NA NA Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies" "HPA059342: AB_2732635" "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 7.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.5 0.0 19.8 7.7 2.8 0.0 4.8 0.7 5.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 2.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487834 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 75.6;ovary: 100.5;pituitary gland: 27.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 33.5;Muller glia cells: 100.3;Peritubular cells: 21.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Group enriched" "Detected in many" 4 "cerebral cortex: 23.8;hypothalamus: 75.6;medulla oblongata: 19.5;pons: 22.9;thalamus: 28.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 44.1;HeLa: 21.8" "Region enhanced" "Detected in many" "hypothalamus: 70.7" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 1.8 10.1 7.7 1.0 4.6 0.0 1.7 3.2 23.8 0.7 2.8 0.6 0.1 2.2 0.0 0.4 3.6 0.5 0.2 0.4 75.6 4.0 2.6 0.4 0.3 19.5 7.6 2.1 100.5 0.7 1.2 27.8 0.3 22.9 0.4 0.0 13.5 0.6 1.5 3.0 0.6 0.4 1.5 3.1 4.5 0.9 1.9 28.7 0.2 1.5 0.0 0.4 0.4 1.1 4.7 0.0 0.1 0.1 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.4 0.0 0.2 0.0 0.6 0.0 0.0 0.0 4.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 4.6 3.2 23.8 0.4 75.6 19.5 7.6 2.1 22.9 3.1 28.7 4.7 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 33.5 0.5 0.3 1.1 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.2 1.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.2 1.5 0.1 0.0 0.0 0.0 100.3 0.0 0.0 0.0 0.1 0.0 21.1 0.0 0.0 0.0 0.1 0.0 3.7 0.0 1.0 2.3 0.5 1.6 0.0 0.0 0.0 0.1 0.6 0.0 0.1 BCL2L1 "Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52" ENSG00000171552 "BCL2 like 1" Q07817 20 31664452-31723989 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Apoptosis, Endocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 160.0;Pancreatic endocrine cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035734, CAB072801" Approved Approved Mitochondria NA NA Mitochondria "CAB072801: , HPA035734: AB_2674757" "unprognostic (2.29e-1)" "unprognostic (5.40e-3)" "unprognostic (1.78e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (5.04e-2)" "unprognostic (7.82e-3)" "prognostic favorable (9.57e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (1.06e-1)" "prognostic favorable (8.89e-5)" "unprognostic (9.67e-2)" "unprognostic (3.03e-2)" "unprognostic (2.02e-2)" "unprognostic (3.32e-2)" 73.9 47.3 42.4 26.3 49.3 99.9 71.6 43.1 54.9 41.4 77.5 42.1 49.8 39.5 12.0 78.4 43.1 52.2 62.4 39.3 43.8 95.6 85.9 95.9 26.0 46.4 46.3 38.0 23.3 55.2 30.7 50.2 42.3 50.4 52.4 26.5 41.3 71.2 25.4 55.8 62.0 49.3 25.3 40.7 53.9 67.2 46.5 54.9 112.5 51.9 39.1 29.1 43.2 55.2 56.4 327.0 188.4 30.7 32.4 167.8 123.1 101.0 73.8 113.2 69.6 66.4 429.2 150.9 48.2 176.7 108.4 140.7 105.8 42.9 216.7 46.2 55.1 8.6 231.3 34.4 231.6 123.0 19.6 137.7 90.7 77.4 89.4 194.0 102.4 106.0 81.6 150.0 34.5 238.7 94.3 73.9 20.6 45.4 150.8 153.2 43.5 92.9 164.3 249.3 83.4 85.4 38.4 89.3 92.6 42.4 57.2 180.5 26.3 154.1 90.0 109.1 36.8 139.4 22.7 150.7 37.9 143.5 99.5 59.5 28.6 11.0 25.6 39.9 11.7 30.9 4.8 17.1 26.8 10.4 6.0 7.7 18.6 12.5 19.8 13.4 7.0 21.8 28.2 42.4 49.3 43.1 54.9 39.3 43.8 46.4 46.3 38.0 50.4 40.7 54.9 56.4 41.6 16.0 9.2 22.5 10.1 18.4 70.2 40.8 26.7 21.9 25.5 15.4 9.7 91.5 36.3 38.6 45.9 27.1 13.7 41.7 86.1 92.2 10.2 71.4 14.6 35.8 24.7 160.0 21.8 65.9 11.3 15.5 37.2 58.2 12.7 10.6 36.4 40.8 38.2 28.6 19.5 26.0 69.2 22.1 13.3 4.6 19.0 27.6 17.8 49.6 76.9 24.1 54.6 13.6 55.6 187.7 22.4 42.9 38.0 102.9 54.6 76.5 76.4 33.7 46.0 14.9 42.7 31.0 15.1 13.6 9.8 18.9 24.9 13.6 19.6 143.0 FGG ENSG00000171557 "Fibrinogen gamma chain" P02679 4 154604134-154612967 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 329 "liver: 16694.5" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 10221.7" "Cancer enriched" "Detected in many" 19 "liver cancer: 1503.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 56 "Hep G2: 735.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027529, CAB033120, HPA074638" Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 267000000000 73000000000 "Endoplasmic reticulum" "CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: " "unprognostic (1.26e-2)" "unprognostic (4.77e-3)" "unprognostic (6.33e-3)" "unprognostic (3.69e-3)" "unprognostic (2.18e-3)" "unprognostic (9.63e-2)" "unprognostic (7.57e-3)" "prognostic unfavorable (1.00e-6)" "unprognostic (1.75e-3)" "unprognostic (3.21e-1)" "unprognostic (1.14e-1)" 1.0 34.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.4 0.0 0.4 0.2 0.6 0.7 25.3 0.9 0.0 0.0 8.5 16694.5 50.6 0.1 0.0 0.0 0.0 1.4 15.9 0.0 0.4 6.4 0.0 0.4 0.0 0.0 0.4 0.3 0.5 0.5 0.6 0.0 0.0 9.1 8.7 3.1 0.1 0.3 0.4 0.0 0.0 0.5 0.6 0.1 0.0 13.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.5 0.4 735.3 0.2 8.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.3 6.4 0.0 0.0 0.6 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.1 0.1 1.7 0.0 3.6 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 19.2 214.4 0.0 31.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 633.4 2.5 0.0 0.0 0.0 0.0 0.1 0.0 21.9 4.3 0.0 0.1 9.2 0.0 157.7 0.0 48.5 0.2 0.5 0.0 0.1 11.4 1.1 202.4 10221.7 0.2 0.0 0.0 0.0 0.0 289.5 0.0 0.5 0.0 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 161.8 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.4 17.3 0.2 0.0 0.0 FGA ENSG00000171560 "Fibrinogen alpha chain" P02671 4 154583128-154590745 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 387 "liver: 18550.1" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 17365.8" "Cancer enriched" "Detected in many" 43 "liver cancer: 2431.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 429.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016776, HPA051370, HPA064755" Supported Enhanced "Endoplasmic reticulum" "Secreted to blood" NA NA 407000000 140000000000 "Endoplasmic reticulum" "CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345" "unprognostic (5.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "prognostic favorable (7.33e-4)" "unprognostic (1.29e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.23e-6)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" 1.2 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.5 0.0 0.6 0.6 0.7 0.9 13.4 1.1 0.0 0.0 18.3 18550.1 5.4 0.1 0.0 0.0 0.0 0.7 18.9 0.0 0.5 0.9 0.0 0.4 0.0 0.0 0.5 0.0 0.5 0.6 0.9 0.0 0.0 10.0 47.9 3.8 0.0 0.1 0.4 0.0 0.1 0.6 0.8 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 2.7 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.1 429.3 0.0 6.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.5 6.1 0.0 0.0 0.5 0.2 0.1 3.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 1.0 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 414.6 3.2 0.0 0.0 0.0 0.0 0.0 1.9 38.6 28.3 0.1 0.2 8.1 0.0 205.9 0.0 1.8 0.1 0.1 1.1 1.3 0.0 0.0 238.8 17365.8 0.1 0.0 0.0 0.0 0.0 328.3 0.0 46.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 1.2 0.0 0.0 0.0 2.3 9.5 0.0 0.0 0.0 0.1 17.4 0.7 0.0 0.0 0.1 17.6 0.0 0.0 0.0 OR2AT4 ENSG00000171561 "Olfactory receptor family 2 subfamily AT member 4" A6NND4 11 75081753-75096876 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;retina: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.3 0.2 0.8 0.3 1.0 1.4 0.2 3.4 2.3 0.1 0.0 0.2 0.2 0.2 0.6 0.2 0.1 0.3 0.2 0.8 0.3 0.2 0.4 0.2 0.4 0.5 0.3 0.4 0.4 0.2 0.2 0.0 0.2 1.5 0.2 0.2 1.8 0.3 0.1 0.3 0.7 0.3 0.1 0.0 0.4 0.2 0.5 0.2 0.2 0.3 0.0 0.2 0.2 0.0 2.4 0.3 0.2 0.3 0.3 0.1 0.2 0.3 0.1 0.1 0.0 0.1 0.3 0.3 0.6 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.5 0.7 0.3 0.1 0.5 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.4 2.1 0.8 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.3 0.4 0.5 0.1 0.5 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.4 0.3 0.3 0.3 0.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.8 1.0 3.4 2.3 0.8 0.3 0.5 0.3 0.4 1.5 0.0 0.2 2.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGB ENSG00000171564 "Fibrinogen beta chain" P02675 4 154563011-154572807 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 387 "liver: 18093.6" "Cell type enriched" "Detected in some" 40 "Hepatocytes: 17273.6" "Cancer enriched" "Detected in many" 42 "liver cancer: 2262.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "Hep G2: 249.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001900, HPA001901, CAB008624" Enhanced Enhanced "Endoplasmic reticulum" "Secreted to blood" NA NA 110000000000 "Endoplasmic reticulum" "CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864" "unprognostic (1.16e-1)" "unprognostic (3.89e-2)" "unprognostic (4.65e-2)" "unprognostic (3.44e-1)" "unprognostic (2.20e-3)" "unprognostic (1.42e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.48e-2)" "unprognostic (7.91e-2)" 1.1 0.8 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.8 0.0 0.5 0.0 0.6 0.3 0.6 0.8 0.4 1.1 0.0 0.0 46.7 18093.6 0.5 0.1 0.0 0.0 0.0 0.6 3.3 0.0 0.5 1.0 0.0 0.4 0.0 0.0 0.4 0.0 0.5 0.5 1.2 0.0 0.0 12.2 6.9 0.5 0.0 0.3 0.4 0.0 0.1 0.5 0.7 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 2.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.2 0.1 249.9 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.7 0.2 0.0 0.6 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.8 0.0 0.9 0.0 2.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 39.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 251.6 0.0 3.7 0.0 0.0 0.0 0.0 1.9 10.6 0.5 0.6 0.8 13.1 1.8 302.1 0.0 3.8 0.2 0.0 0.0 5.9 0.0 0.0 318.1 17273.6 0.3 0.0 0.0 0.0 0.0 421.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 0.0 0.0 0.0 PLRG1 "Cwc1, PRL1, Prp46, PRPF46, TANGO4" ENSG00000171566 "Pleiotropic regulator 1" O43660 4 154535005-154550400 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035931, HPA035932, HPA061486" Supported Enhanced "Nuclear membrane,Nuclear speckles" NA NA "Nuclear speckles" "Nuclear membrane" "HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536" "unprognostic (6.51e-2)" "unprognostic (5.66e-3)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.20e-5)" "unprognostic (2.92e-1)" "unprognostic (9.84e-3)" "unprognostic (1.64e-2)" "unprognostic (1.97e-1)" 29.7 22.1 24.5 25.1 28.8 31.4 39.1 28.1 25.3 33.1 22.2 31.2 25.0 34.3 28.9 34.2 34.5 25.1 26.2 24.1 49.2 38.5 44.2 27.5 35.4 31.4 28.1 23.3 34.3 19.8 41.4 16.2 28.5 31.4 27.6 34.6 26.6 26.0 34.0 32.0 26.6 26.0 45.0 34.2 28.0 26.7 21.6 27.6 40.8 38.4 39.8 51.7 35.2 22.9 41.8 73.2 58.6 73.7 79.4 85.1 73.5 62.3 91.6 111.2 121.9 98.9 69.3 62.7 79.1 45.7 109.1 80.3 52.4 97.2 122.1 134.5 80.2 48.7 95.1 45.1 67.8 87.0 96.0 76.4 79.7 110.8 144.6 112.6 73.0 106.1 85.3 98.9 98.2 107.2 52.3 73.9 45.7 56.1 57.5 62.7 72.2 38.5 48.2 84.8 46.1 43.0 48.6 55.9 59.3 91.7 69.4 57.1 66.4 69.3 72.4 81.9 64.6 82.9 50.9 72.0 100.6 68.1 45.6 98.8 53.0 37.0 29.7 41.6 43.3 49.9 47.0 43.5 45.7 47.6 36.2 45.9 43.2 9.4 67.6 63.9 46.4 55.7 49.4 24.5 28.8 28.1 25.3 24.1 49.2 31.4 28.1 23.3 31.4 34.2 27.6 41.8 26.9 25.6 18.1 29.0 26.9 16.3 31.2 98.7 18.2 26.2 19.6 22.9 24.7 20.0 50.7 22.0 12.5 49.1 23.6 18.0 15.6 48.0 31.7 22.7 33.0 27.5 27.1 30.5 23.6 34.7 37.9 30.9 17.9 20.3 45.7 27.0 16.1 26.8 34.2 62.2 21.7 15.9 73.2 19.3 12.0 5.8 28.0 17.2 14.2 17.8 36.8 31.2 28.8 14.1 25.0 32.6 20.9 35.0 21.8 14.9 33.7 35.0 45.2 21.4 19.7 31.2 40.8 36.4 30.2 25.0 17.3 44.3 26.9 36.8 22.3 20.6 ZNF584 FLJ39899 ENSG00000171574 "Zinc finger protein 584" Q8IVC4 19 58401504-58418327 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 49.8" "Low region specificity" "Detected in all" "HPA043408, HPA048075" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA043408: AB_2678466, HPA048075: AB_2680251" "unprognostic (6.06e-2)" "unprognostic (3.27e-3)" "unprognostic (3.76e-3)" "unprognostic (8.15e-3)" "unprognostic (5.50e-2)" "unprognostic (1.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-2)" "unprognostic (6.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.01e-3)" "unprognostic (1.90e-3)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.80e-1)" "unprognostic (3.27e-1)" "unprognostic (1.36e-2)" 5.4 6.8 4.6 2.9 4.5 1.8 5.1 5.3 5.3 5.6 4.9 5.7 3.6 7.0 3.8 5.9 6.8 2.3 8.9 5.1 4.4 4.8 6.6 4.4 2.5 5.2 4.5 4.1 6.2 4.9 8.5 6.7 2.7 4.9 5.1 2.6 5.1 4.7 5.8 9.9 8.8 3.5 5.2 3.8 3.3 5.6 4.7 4.9 3.2 4.7 11.0 3.5 6.1 5.1 5.4 11.7 16.7 11.2 14.7 10.8 10.7 4.5 8.9 15.8 5.4 6.7 2.7 3.5 5.8 7.0 14.7 14.2 6.5 12.1 14.6 6.1 7.5 49.8 15.7 9.6 3.5 18.3 17.3 4.3 11.1 10.4 16.5 22.8 11.9 10.9 9.5 15.8 5.4 8.9 8.3 14.4 5.4 2.8 7.6 23.2 10.4 8.4 9.0 7.6 13.7 9.0 9.5 19.5 5.6 7.4 2.9 3.7 8.6 7.0 21.2 6.5 8.9 14.3 5.0 9.5 1.3 15.2 6.0 7.1 0.0 2.2 0.8 3.2 2.1 5.2 2.1 4.3 4.5 3.4 3.3 2.3 3.6 0.7 3.2 3.5 2.9 5.1 2.7 4.6 4.5 5.3 5.3 5.1 4.4 5.2 4.5 4.1 4.9 3.8 4.9 5.4 4.2 3.2 3.9 1.0 2.3 11.2 3.2 5.6 6.2 4.1 4.8 4.3 12.8 5.7 2.1 9.2 4.2 1.0 5.9 1.6 13.7 5.6 9.6 8.1 6.1 4.6 6.7 9.5 2.0 5.1 1.5 5.6 3.6 1.8 2.5 5.5 6.8 4.7 2.6 3.3 2.2 2.3 4.1 2.4 3.3 7.8 5.3 2.1 1.8 0.0 1.3 6.1 2.1 0.5 1.6 4.9 2.8 6.4 2.6 4.2 2.1 5.5 10.2 9.2 6.6 4.4 6.3 8.1 3.7 4.3 15.9 0.4 4.0 12.3 3.2 2.0 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847158 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.9;pituitary gland: 4.2;retina: 1.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 4376.6" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.0 0.0 5.2 0.0 6.0 0.0 0.1 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.8 3.4 0.0 0.1 0.0 0.0 2.6 2.0 4.1 0.0 0.1 0.0 4.2 0.7 5.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.0 0.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 6.0 0.2 6.9 5.8 3.4 2.6 2.0 4.1 5.5 2.5 4.7 5.9 0.0 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 19.6 0.0 0.4 1.1 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 1083.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 16.8 649.1 0.0 0.0 2.4 0.0 4.2 0.0 0.0 0.0 200.5 0.0 0.7 0.0 4376.6 21.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.0 0.1 1.7 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 DNAI2 "CILD9, DIC2" ENSG00000171595 "Dynein axonemal intermediate chain 2" Q9GZS0 17 74274234-74314884 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 30.7;testis: 19.4" "Cell type enhanced" "Detected in some" "Early spermatids: 21.7;Endometrial ciliated cells: 51.3;Late spermatids: 16.4;Respiratory ciliated cells: 68.1;Spermatocytes: 41.7" "Group enriched" "Detected in some" 4 "endometrial cancer: 2.2;lung cancer: 0.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "NK-cell: 3.8" "Lineage enriched" "Detected in single" 7 "NK-cells: 3.8" "Cell line enriched" "Detected in single" 4 "HMC-1: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB006245, HPA050565" Enhanced NA NA "CAB006245: AB_426059, HPA050565: AB_2681177" "unprognostic (6.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.36e-1)" "unprognostic (3.04e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (1.16e-3)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (3.14e-2)" "unprognostic (1.61e-3)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "unprognostic (2.89e-2)" "unprognostic (1.96e-1)" "unprognostic (1.46e-1)" "unprognostic (4.62e-3)" 0.0 0.0 1.8 0.1 0.7 0.0 0.0 1.0 0.6 0.9 5.4 0.0 0.0 0.3 0.0 0.0 30.7 0.0 0.0 0.5 1.5 0.0 0.0 3.0 0.0 2.5 2.7 0.0 0.0 0.0 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 19.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 1.8 0.7 1.0 0.6 0.5 1.5 2.5 2.7 0.0 2.0 2.7 1.2 0.7 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.7 51.3 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.0 0.0 4.4 16.4 0.6 0.3 0.0 1.0 0.6 0.0 1.0 1.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 68.1 0.0 0.0 0.0 0.9 41.7 0.5 0.0 0.0 0.0 0.4 0.6 0.2 0.0 NMUR1 "FM-3, GPC-R, GPR66, NMU1R" ENSG00000171596 "Neuromedin U receptor 1" Q9HB89 2 231523187-231530445 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.3" "Cell type enhanced" "Detected in some" "dendritic cells: 13.7;Hepatic stellate cells: 7.9;NK-cells: 47.4;Rod photoreceptor cells: 17.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Group enriched" "Detected in many" 7 "gdT-cell: 18.1;MAIT T-cell: 4.6;memory CD8 T-cell: 8.8;naive CD8 T-cell: 5.2;NK-cell: 10.9" "Group enriched" "Detected in many" 19 "NK-cells: 10.9;T-cells: 18.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA027895 Uncertain NA NA "HPA027895: AB_10602713" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (6.74e-3)" "unprognostic (9.44e-3)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.22e-2)" "unprognostic (2.07e-1)" "unprognostic (4.08e-4)" "unprognostic (3.76e-3)" "unprognostic (2.26e-1)" "unprognostic (2.61e-1)" "unprognostic (5.25e-2)" 5.3 1.4 0.1 0.5 0.1 2.6 1.6 1.1 0.3 0.7 0.0 1.0 2.8 0.9 2.3 1.6 1.4 0.7 0.5 0.1 0.0 1.0 0.8 3.1 0.5 0.0 0.0 0.0 0.3 4.2 0.3 0.2 1.3 0.4 1.3 0.8 8.3 1.3 2.1 0.2 0.4 3.7 0.9 0.0 3.6 0.8 1.6 0.0 0.1 0.8 0.0 0.2 1.3 0.6 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.3 0.3 0.3 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.0 18.1 0.0 4.6 0.1 1.3 8.8 0.1 0.0 0.1 5.2 0.7 10.9 0.1 0.4 0.6 4.9 0.1 0.1 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.3 0.0 0.1 2.5 0.0 0.0 0.0 2.1 0.5 13.7 0.0 0.0 0.0 1.2 0.4 0.2 0.6 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.1 1.3 0.0 7.9 0.0 0.2 1.7 0.7 0.1 0.0 0.9 1.4 0.5 2.1 0.3 0.0 0.0 0.2 2.6 47.4 0.5 0.1 0.1 0.0 7.5 2.4 0.1 0.0 0.1 0.0 17.2 0.0 0.2 0.9 2.2 4.7 0.0 0.4 0.7 6.9 5.2 0.0 0.1 CLSTN1 "CDHR12, CSTN1, KIAA0911" ENSG00000171603 "Calsyntenin 1" O94985 1 9728926-9823984 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 437.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012412, HPA077705" Enhanced NA NA 86000000 "HPA012412: AB_1846981, HPA077705: " "unprognostic (4.63e-2)" "unprognostic (2.89e-1)" "unprognostic (9.76e-2)" "unprognostic (1.43e-1)" "unprognostic (9.79e-2)" "unprognostic (1.63e-1)" "unprognostic (2.44e-3)" "unprognostic (3.07e-2)" "unprognostic (2.54e-1)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (1.25e-1)" "prognostic favorable (4.10e-7)" "unprognostic (1.12e-1)" "unprognostic (2.65e-1)" "unprognostic (4.05e-2)" "unprognostic (4.72e-2)" 27.1 27.6 31.0 23.4 60.8 10.9 32.0 27.6 125.4 57.3 57.1 60.0 29.5 86.1 21.6 51.8 70.4 48.5 33.3 63.2 34.7 41.7 6.2 29.8 33.8 25.5 19.8 52.8 60.7 66.2 36.5 48.8 36.0 35.6 62.3 38.6 111.8 79.6 46.1 23.3 84.2 41.4 49.8 4.3 28.6 31.3 15.2 29.3 35.3 40.3 29.2 27.3 38.4 60.4 46.8 120.9 55.4 52.5 64.8 71.1 50.1 35.0 80.5 71.4 82.0 70.2 32.1 235.0 90.5 203.1 95.2 52.6 157.7 41.2 245.6 32.1 114.2 74.6 27.3 53.0 39.6 116.1 46.3 41.4 58.0 156.5 105.9 50.0 78.6 113.9 52.7 13.1 52.6 35.8 47.2 53.2 26.6 37.9 53.1 59.7 80.6 21.4 42.9 73.1 20.9 91.4 53.7 94.8 160.1 79.1 22.1 34.7 73.9 155.0 89.3 80.5 56.6 109.9 75.6 75.4 124.3 72.2 79.6 95.7 6.2 0.6 2.3 3.0 0.8 1.5 0.8 1.9 2.3 1.4 1.0 1.3 1.2 0.2 0.4 0.9 0.8 1.6 1.5 31.0 60.8 27.6 125.4 63.2 34.7 25.5 19.8 52.8 35.6 4.3 29.3 46.8 40.2 28.9 15.7 63.6 23.7 43.8 61.0 73.7 84.2 205.1 53.3 47.0 14.7 55.8 44.6 51.5 437.9 34.1 35.0 221.1 1.9 29.2 4.5 44.6 47.0 36.0 30.7 17.9 150.9 38.8 14.3 40.6 29.6 52.2 11.4 54.0 35.3 2.2 28.8 180.0 138.1 96.5 14.2 24.2 13.3 5.6 46.3 21.3 32.0 46.9 21.0 160.9 28.8 90.0 56.0 59.7 66.9 50.4 31.2 42.4 54.9 27.9 68.3 165.6 85.5 39.5 31.4 24.6 37.5 44.5 26.1 19.2 33.8 47.2 59.6 42.7 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 210.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 22.5 20.7 48.5 17.8 62.4 47.3 21.7 97.4 63.6 29.4 34.3 17.7 10.9 15.2 30.3 25.8 30.1 20.3 30.1 55.3 56.0 60.5 88.9 16.2 30.5 88.7 66.3 46.3 5.0 61.7 28.3 43.9 16.0 75.5 15.4 11.7 39.0 54.4 18.5 80.9 23.4 22.7 9.1 70.9 34.8 21.1 52.2 60.2 34.6 22.7 21.6 24.9 14.9 24.1 105.6 36.5 30.1 32.6 12.3 44.5 60.6 12.7 23.3 35.3 9.9 19.5 66.8 36.0 47.4 101.0 62.5 59.7 40.5 6.7 17.9 4.7 5.2 11.5 70.5 25.8 47.0 19.2 16.0 1.8 21.8 4.0 16.7 4.8 95.6 2.7 1.5 67.8 7.6 72.6 94.7 17.2 51.1 39.4 39.2 8.5 30.8 66.5 73.5 75.3 26.0 103.0 106.3 8.3 210.6 18.0 71.2 115.5 74.2 14.6 80.2 15.6 38.8 21.4 27.3 62.4 89.9 121.2 5.3 45.6 1.1 6.6 0.6 9.7 1.4 30.0 85.1 0.9 6.8 5.5 96.7 0.5 2.6 1.8 71.9 0.6 59.0 1.4 10.7 48.5 62.4 97.4 63.6 55.3 56.0 88.7 66.3 46.3 75.5 70.9 60.2 105.6 22.9 48.1 18.8 24.5 120.4 26.3 14.8 41.9 8.6 232.0 41.0 67.8 49.3 105.8 32.5 147.1 25.0 2.9 90.2 18.6 317.0 125.1 714.2 47.1 53.9 43.6 18.6 52.2 18.7 144.9 23.9 47.8 24.5 53.7 21.5 41.9 36.0 131.8 38.4 541.8 8.7 50.7 61.1 35.6 92.1 200.3 39.1 32.2 60.5 15.0 40.9 220.5 195.7 16.6 44.3 93.9 17.5 30.5 114.1 34.1 22.6 200.0 38.6 49.1 13.1 150.9 48.5 14.2 13.9 15.7 20.9 37.6 21.1 25.1 27.0 21.4 ZNF274 "ZKSCAN19, ZSCAN51" ENSG00000171606 "Zinc finger protein 274" Q96GC6 19 58183029-58213562 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 77.1" "Low region specificity" "Detected in all" HPA028880 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA028880: AB_10601929" "unprognostic (2.38e-3)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (3.84e-1)" "prognostic favorable (6.16e-4)" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (6.57e-2)" "unprognostic (2.19e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.58e-3)" 11.7 11.6 9.7 10.0 10.9 13.3 13.1 13.4 10.0 11.3 14.3 13.1 8.7 10.3 13.7 15.0 14.6 8.9 16.2 9.3 14.5 12.3 19.3 13.2 14.1 10.1 10.4 8.8 21.9 8.8 21.9 14.5 9.5 10.6 13.1 7.5 17.5 10.4 10.8 17.9 15.1 15.0 9.0 10.3 17.4 11.5 14.6 11.2 11.6 19.1 14.7 14.4 12.8 11.9 14.4 18.5 12.3 20.9 8.5 12.9 19.1 20.3 14.3 7.9 15.9 14.1 7.5 13.1 6.2 9.4 9.3 16.9 5.1 10.1 20.3 21.8 12.7 77.1 29.5 12.8 12.1 20.8 20.9 46.1 15.0 25.7 19.6 37.2 16.6 12.8 9.7 22.5 26.8 12.0 12.0 11.5 19.1 20.0 10.6 12.2 26.0 5.3 26.8 11.9 7.4 13.6 6.1 19.6 8.6 16.9 15.7 20.4 39.4 12.5 8.5 12.8 10.0 16.9 12.5 14.1 20.9 3.8 23.3 18.4 23.0 7.3 36.9 13.5 8.0 21.1 20.5 17.7 19.7 10.3 26.3 26.1 18.5 26.1 22.1 13.4 5.0 24.4 13.2 9.7 10.9 13.4 10.0 9.3 14.5 10.1 10.4 8.8 10.6 10.3 11.2 14.4 15.2 16.0 19.6 17.6 33.5 10.5 40.1 12.8 8.0 32.6 10.2 8.3 14.5 15.7 14.1 18.4 43.8 11.3 12.7 10.4 1.9 13.5 18.5 8.3 8.1 13.9 6.6 10.8 4.4 5.6 11.7 9.2 13.7 11.9 29.2 11.2 13.2 9.9 7.1 20.2 3.7 9.0 4.1 13.0 15.9 10.7 12.2 11.9 7.2 10.3 10.4 22.3 18.6 16.6 21.0 12.3 17.9 12.0 7.8 26.7 18.0 10.3 12.4 67.0 19.7 14.1 16.6 21.6 14.6 8.8 12.1 16.7 23.7 5.5 8.3 25.5 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651731-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 61.5;lymphoid tissue: 50.8" "Cell type enhanced" "Detected in many" "dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: AB_2679153" "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 6.0 3.2 6.4 33.7 6.6 61.5 4.0 5.7 7.6 5.5 6.9 5.2 5.2 4.9 1.8 4.9 6.1 7.0 3.2 6.8 6.4 6.4 3.5 12.1 47.3 6.9 6.4 5.7 7.1 3.0 2.9 2.8 4.2 7.6 4.7 3.4 0.6 5.2 2.7 1.2 3.0 17.3 4.7 6.9 50.8 5.8 4.0 8.4 24.5 5.6 3.5 32.2 7.5 5.2 7.8 8.1 5.2 0.4 1.4 1.3 1.1 0.7 12.1 24.5 26.0 21.1 0.3 3.3 21.5 4.9 9.8 12.4 2.4 2.0 11.0 16.2 153.3 0.4 2.4 1.3 9.0 5.1 56.0 18.7 4.3 4.5 29.2 9.8 11.4 3.8 14.9 8.0 0.1 15.0 0.6 5.4 65.9 2.2 0.3 1.4 68.9 13.0 0.7 10.9 0.0 1.7 1.5 2.7 4.9 11.9 6.8 0.8 65.4 9.8 7.7 7.9 0.2 11.5 4.9 4.9 30.1 16.7 78.6 4.4 18.0 23.5 40.2 21.6 23.0 22.6 12.8 16.3 19.9 22.5 13.6 20.9 23.1 63.2 25.9 29.2 25.7 13.3 38.3 6.4 6.6 5.7 7.6 6.8 6.4 6.9 6.4 5.7 7.6 6.9 8.4 7.8 1.7 9.6 13.4 2.0 22.2 1.5 2.2 1.8 4.0 0.7 2.0 1.7 3.1 0.0 1.1 0.0 2.1 0.3 44.0 0.1 1.9 3.9 3.0 2.0 1.7 2.7 0.0 10.3 6.7 2.0 0.5 2.9 0.0 1.0 25.3 4.2 3.6 0.0 14.7 0.0 13.4 0.1 0.0 35.2 6.0 2.8 1.2 23.1 3.6 29.0 19.3 2.5 29.9 1.0 1.1 11.3 0.0 1.5 8.2 4.1 0.2 3.8 3.3 1.3 6.6 2.0 4.7 1.5 3.4 2.9 1.1 0.3 37.1 1.5 0.2 2.1 PTCRA "PT-ALPHA, PTA" ENSG00000171611 "Pre T cell antigen receptor alpha" Q6ISU1 6 42915989-42925838 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "lymphoid tissue: 129.8" "Group enriched" "Detected in some" 6 "dendritic cells: 110.6;Macrophages: 152.8" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons: 3.9" "Immune cell enriched" "Detected in some" 46 "plasmacytoid DC: 410.7" "Lineage enriched" "Detected in many" 46 "dendritic cells: 410.7" "Group enriched" "Detected in some" 9 "MOLT-4: 42.8;SK-MEL-30: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.50e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-1)" "unprognostic (1.64e-1)" "unprognostic (2.83e-2)" "unprognostic (6.57e-4)" "unprognostic (7.18e-2)" "unprognostic (4.24e-2)" "unprognostic (8.16e-2)" "unprognostic (1.11e-2)" "unprognostic (2.73e-1)" "unprognostic (2.84e-4)" "unprognostic (1.16e-1)" "unprognostic (4.89e-1)" "unprognostic (3.22e-2)" "unprognostic (3.09e-2)" "unprognostic (1.45e-1)" 0.3 0.1 0.2 0.3 1.1 1.7 0.1 0.0 1.4 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.2 2.7 2.9 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.6 3.9 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 5.0 0.1 0.0 0.8 129.8 0.1 0.0 2.3 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 8.7 0.4 1.7 0.1 1.1 0.1 0.0 0.0 0.3 0.4 0.1 0.4 0.0 8.9 0.1 0.7 410.7 0.0 32.8 0.2 1.1 0.0 1.4 0.1 0.6 1.6 0.3 0.0 3.9 0.4 0.8 1.7 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 110.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 6.5 0.1 0.0 0.0 0.0 0.0 2.2 0.0 19.4 0.0 0.2 0.0 0.0 15.1 0.0 0.0 0.0 152.8 5.4 0.0 2.7 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 SLC25A33 "BMSC-MCP, MGC4399, PNC1" ENSG00000171612 "Solute carrier family 25 member 33" Q9BSK2 1 9539465-9585173 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 27.7" "Cell type enhanced" "Detected in all" "Early spermatids: 422.0;Late spermatids: 559.8;Spermatocytes: 358.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049982 Uncertain NA NA "HPA049982: AB_2680981" "unprognostic (1.61e-1)" "prognostic favorable (4.86e-4)" "unprognostic (2.94e-2)" "unprognostic (4.80e-2)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.18e-2)" "prognostic favorable (7.02e-4)" "unprognostic (1.88e-3)" "unprognostic (1.07e-1)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (4.55e-3)" "unprognostic (7.27e-2)" "unprognostic (1.19e-1)" "unprognostic (4.25e-2)" "unprognostic (3.77e-2)" 11.4 3.4 11.9 2.7 12.5 9.1 6.0 15.1 13.9 2.5 11.2 4.6 2.2 3.0 12.8 2.9 3.0 3.7 4.8 11.5 14.9 10.1 12.7 2.7 3.4 13.9 14.4 10.5 2.8 3.7 4.0 5.7 1.4 13.3 4.1 3.7 11.2 5.4 2.0 18.3 2.2 2.6 2.7 14.2 2.3 4.5 13.5 14.5 3.5 5.2 27.7 3.6 4.1 2.3 14.3 6.9 3.1 8.7 13.4 7.0 4.0 5.6 6.5 6.1 10.8 9.5 6.9 5.2 19.8 7.8 5.4 11.3 2.8 22.2 4.3 13.3 15.3 13.9 19.5 4.2 27.5 15.1 19.6 14.8 4.8 7.5 10.8 5.2 2.6 6.4 14.5 19.2 10.0 6.1 7.2 12.5 13.4 10.7 12.5 7.3 16.5 9.2 12.8 6.9 3.8 15.1 9.7 7.3 22.2 20.0 7.5 8.2 14.2 2.8 6.8 9.0 9.2 8.4 11.8 23.6 33.5 4.9 21.6 8.4 2.8 0.3 0.1 0.5 0.4 0.3 0.8 0.4 0.3 0.6 0.3 0.6 0.7 0.4 0.5 0.4 0.5 0.0 0.1 11.9 12.5 15.1 13.9 11.5 14.9 13.9 14.4 10.5 13.3 14.2 14.5 14.3 25.7 3.2 13.1 59.1 34.4 51.5 107.3 4.2 69.4 15.1 60.0 39.5 9.3 37.1 6.8 9.2 52.1 14.0 32.9 22.5 199.6 11.5 422.0 38.1 19.0 19.9 66.3 8.2 12.3 15.1 38.6 27.2 30.1 39.8 23.6 9.5 11.4 55.8 21.3 10.1 18.2 27.5 6.1 9.2 66.8 559.8 9.9 30.7 32.0 5.6 11.7 195.3 9.2 13.6 13.7 11.5 14.4 10.1 20.4 94.7 6.6 29.5 8.0 53.3 6.6 41.5 37.0 358.5 115.1 42.6 35.8 39.3 22.7 16.7 32.4 96.2 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 218.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 271.6;Theca cells: 210.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 263.2" HPA078061 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA078061: " "prognostic unfavorable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 5.6 2.0 82.5 13.7 156.0 18.1 4.4 0.0 181.8 10.0 0.0 14.8 18.0 7.0 3.9 5.7 2.4 19.3 8.3 218.4 67.2 5.4 19.0 12.8 5.8 8.9 10.5 194.3 15.1 33.0 25.0 6.8 11.5 42.8 11.9 21.4 2.3 15.7 19.4 4.7 4.3 21.8 7.7 0.0 11.5 27.2 12.1 5.7 7.2 2.7 3.9 5.0 20.5 3.1 123.3 40.0 47.9 45.8 22.1 20.1 4.5 109.6 27.7 27.6 27.8 19.9 74.0 60.0 0.0 30.9 21.5 46.0 29.9 0.7 46.7 60.0 0.8 3.4 43.6 9.5 36.8 1.9 4.9 0.4 7.6 3.3 72.3 7.3 102.2 23.2 9.5 9.9 23.4 81.5 10.4 4.2 6.4 51.2 39.1 40.4 4.8 31.0 4.0 17.3 27.5 60.3 26.9 4.5 20.5 2.4 58.3 9.7 6.6 59.2 46.3 75.3 30.4 87.7 0.5 0.1 0.8 53.8 4.0 73.9 0.0 2.7 2.6 1.2 2.3 0.0 0.0 0.2 1.4 1.2 0.1 0.1 1.3 0.6 1.4 0.6 0.0 0.0 0.8 82.5 156.0 0.0 181.8 218.4 67.2 8.9 10.5 194.3 42.8 0.0 5.7 123.3 10.6 0.0 17.0 18.9 11.7 2.5 14.0 20.2 1.2 1.1 9.1 14.7 2.3 17.2 22.6 11.0 2.1 14.6 51.9 15.3 3.9 69.6 16.2 12.8 7.0 13.9 15.5 0.4 271.6 31.7 5.7 40.4 31.6 11.0 21.5 26.4 41.4 18.0 26.5 0.0 25.4 20.9 57.0 8.2 4.9 20.4 37.6 10.2 0.0 25.3 6.2 0.6 0.0 20.6 15.7 67.0 10.1 33.4 23.2 17.6 12.3 4.4 12.9 1.2 6.6 4.4 41.9 0.5 1.0 3.2 1.1 2.6 15.9 210.4 33.4 18.3 SPSB1 SSB-1 ENSG00000171621 "SplA/ryanodine receptor domain and SOCS box containing 1" Q96BD6 1 9292894-9369532 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 79.5;Proximal enterocytes: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 81.5;SK-MEL-30: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.23e-2)" "unprognostic (8.91e-2)" "unprognostic (1.56e-1)" "unprognostic (2.85e-1)" "unprognostic (4.18e-2)" "unprognostic (2.88e-1)" "unprognostic (2.02e-2)" "unprognostic (1.24e-1)" "unprognostic (3.84e-2)" "unprognostic (2.54e-2)" "unprognostic (6.86e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.08e-6)" "unprognostic (3.95e-2)" "unprognostic (3.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" 53.8 9.8 10.1 14.5 14.7 1.5 25.3 12.9 10.1 28.4 8.0 22.4 19.8 47.4 3.9 26.9 23.6 29.4 16.7 9.1 17.3 16.6 48.5 29.0 9.4 22.6 15.0 6.3 24.3 30.9 20.6 10.3 10.8 14.1 18.2 8.8 2.0 15.8 10.1 44.6 24.2 30.2 26.3 13.8 3.6 18.1 8.4 13.8 10.4 20.4 32.6 12.2 33.3 21.9 19.9 16.2 14.6 1.1 3.2 42.4 20.2 26.6 10.7 35.4 21.0 16.6 15.8 23.2 0.4 21.5 16.4 25.0 23.9 4.8 19.4 13.8 58.2 3.8 0.0 19.6 17.5 27.1 0.1 1.4 21.1 38.3 81.5 10.4 20.8 30.9 3.2 1.9 42.1 17.3 6.0 9.0 0.6 2.3 11.1 15.5 3.1 6.4 5.1 17.9 10.9 3.9 1.1 17.1 45.8 71.4 28.4 1.2 5.3 25.8 15.2 18.9 24.0 9.9 17.7 27.3 5.6 27.5 2.0 16.7 1.2 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.8 0.2 10.1 14.7 12.9 10.1 9.1 17.3 22.6 15.0 6.3 14.1 13.8 13.8 19.9 19.4 19.2 5.3 2.6 6.5 69.0 47.0 11.8 25.6 0.6 26.9 17.8 4.1 24.3 11.5 3.7 2.1 1.1 3.2 19.9 3.9 25.0 0.8 42.2 30.3 20.6 6.6 0.4 2.1 32.0 12.0 67.0 4.1 79.5 14.0 30.7 13.2 21.6 3.1 11.8 1.7 7.7 2.0 0.9 27.7 1.8 11.8 8.2 49.8 3.7 3.3 2.2 0.0 18.1 22.8 33.7 15.6 8.2 8.4 28.4 83.1 5.5 20.7 0.6 6.6 40.7 22.9 0.4 3.2 57.0 70.8 2.2 8.1 0.5 11.4 63.1 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264498-73305103 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 32.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 124.3;Syncytiotrophoblasts: 272.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "myeloid DC: 27.2;plasmacytoid DC: 87.5" "Lineage enriched" "Detected in many" 19 "dendritic cells: 87.5" "Cell line enhanced" "Detected in many" "AN3-CA: 59.2;EFO-21: 18.1;MCF7: 30.4;SK-BR-3: 53.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074751 Enhanced NA NA "HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.1 1.5 1.0 7.1 1.3 0.8 1.3 0.7 1.9 1.6 1.1 1.9 2.4 0.8 0.5 2.5 1.1 1.6 2.6 1.6 1.6 7.1 1.0 2.9 3.1 1.3 0.9 1.3 0.3 1.4 0.2 2.4 10.7 1.1 2.0 1.8 0.8 1.4 0.6 2.7 0.7 4.0 2.7 0.5 32.8 1.8 0.5 1.2 1.5 5.0 0.3 1.3 3.2 1.4 1.7 1.3 12.9 0.1 59.2 0.0 0.1 13.7 0.2 0.0 0.2 0.1 11.6 0.2 0.1 18.1 0.4 0.1 3.0 0.1 0.1 0.1 0.3 0.1 0.1 1.2 8.1 0.0 0.2 0.3 0.2 0.0 0.7 0.0 1.0 0.1 0.1 0.1 0.4 0.2 30.4 0.1 2.8 0.2 0.4 0.2 0.1 0.1 1.4 11.0 0.2 0.2 0.7 1.7 53.4 0.1 1.2 13.4 2.7 0.3 2.0 0.1 1.8 0.1 0.5 0.2 0.1 2.7 4.0 0.1 2.3 2.7 0.2 0.1 4.6 0.3 0.1 0.1 0.1 27.2 0.2 0.1 0.1 0.6 3.4 1.5 87.5 0.1 2.2 1.0 1.3 0.7 1.9 1.6 1.6 1.3 0.9 1.3 1.1 0.5 1.2 1.7 0.3 0.0 0.6 0.3 1.5 0.1 0.4 0.4 0.6 0.0 0.6 1.0 0.8 0.0 0.7 9.2 0.0 124.3 16.9 0.1 3.9 2.7 0.4 0.3 0.1 8.9 0.0 2.7 0.7 14.4 11.6 1.8 0.0 0.4 0.0 0.2 1.1 0.1 19.8 0.0 0.1 0.3 0.0 9.2 9.8 2.3 0.0 12.9 0.0 13.1 13.4 1.1 0.0 0.5 0.0 14.9 0.0 0.0 12.6 0.3 2.9 12.0 0.9 0.1 0.0 2.4 0.8 0.0 0.1 0.2 0.4 272.5 0.6 0.5 0.2 0.5 BPTF "FAC1, FALZ, NURF301" ENSG00000171634 "Bromodomain PHD finger transcription factor" Q12830 17 67825503-67984378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029069, HPA048289" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029069: AB_10602597, HPA048289: AB_2680342" "unprognostic (1.22e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-2)" "unprognostic (3.74e-2)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (1.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (9.24e-2)" "prognostic favorable (8.46e-4)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" 25.5 23.9 28.2 25.6 30.7 32.3 25.7 82.4 26.5 30.0 10.6 26.8 15.9 28.1 28.9 26.8 29.8 19.2 20.7 21.7 22.1 22.1 20.8 22.8 44.0 32.5 22.8 12.3 38.4 23.1 27.6 34.9 22.4 32.8 25.4 22.4 44.4 25.4 16.8 26.2 37.8 28.7 19.8 19.1 31.6 23.8 32.4 23.4 53.4 27.6 22.5 39.5 24.6 28.0 31.6 42.2 52.8 76.3 38.7 41.6 39.0 42.2 32.0 29.4 37.1 31.8 49.6 29.0 167.7 22.4 35.4 28.5 32.2 74.4 34.5 60.0 24.2 72.5 64.9 50.4 68.8 19.8 97.3 49.9 28.6 37.3 36.9 27.6 34.0 70.2 52.9 75.1 46.1 32.3 64.0 99.1 47.3 58.9 37.9 47.8 70.3 91.0 33.6 32.5 50.6 56.5 65.6 42.8 117.4 46.4 91.4 49.1 53.7 49.6 56.2 43.7 20.7 39.7 39.3 42.0 97.9 26.9 45.1 22.0 20.3 4.2 8.5 7.2 2.4 5.7 6.2 5.9 5.7 3.0 11.8 6.1 6.3 9.2 10.7 5.7 10.9 4.5 1.6 28.2 30.7 82.4 26.5 21.7 22.1 32.5 22.8 12.3 32.8 19.1 23.4 31.6 118.7 115.4 148.2 192.3 130.9 75.2 55.3 37.8 87.0 216.8 76.2 78.5 136.0 61.5 92.0 58.8 143.9 39.4 170.3 64.1 7.9 63.8 26.6 147.7 174.5 108.1 126.1 114.6 124.4 63.1 30.8 94.8 88.2 165.9 121.4 124.9 71.0 46.4 42.2 198.5 136.4 68.9 48.8 56.3 54.4 25.7 108.7 84.7 64.0 109.6 88.0 129.3 146.2 231.8 262.7 65.4 64.5 111.3 129.2 62.1 37.7 17.4 80.8 202.6 65.7 167.3 92.3 144.9 101.3 82.6 75.6 38.7 128.8 126.6 85.8 60.7 S100Z "Gm625, S100-zeta" ENSG00000171643 "S100 calcium binding protein Z" Q8WXG8 5 76850001-76921650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.4;lymphoid tissue: 3.2" "Cell type enhanced" "Detected in some" "Hofbauer cells: 7.4;Kupffer cells: 8.7;Macrophages: 11.8;Microglial cells: 32.8;monocytes: 26.1" "Cancer enriched" "Detected in single" 4 "testis cancer: 1.1" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "classical monocyte: 35.0;eosinophil: 31.8;intermediate monocyte: 34.0;myeloid DC: 19.5;neutrophil: 11.8;non-classical monocyte: 39.6" "Group enriched" "Detected in many" 6 "dendritic cells: 19.5;granulocytes: 31.8;monocytes: 39.6" "Cell line enriched" "Detected in some" 6 "U-698: 81.9" "Region enriched" "Detected in single" 5 "olfactory bulb: 1.3" "Low region specificity" "Detected in all" HPA051929 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Centrosome, Cytosol" Nucleoplasm "HPA051929: AB_2732571" "unprognostic (4.17e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-4)" "unprognostic (1.86e-1)" "unprognostic (4.62e-2)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (8.89e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-3)" "unprognostic (1.32e-1)" "unprognostic (9.47e-5)" "unprognostic (3.39e-4)" "unprognostic (8.94e-2)" "unprognostic (6.85e-2)" "unprognostic (1.62e-1)" 0.3 0.2 1.0 2.0 0.7 2.4 0.2 0.4 0.9 0.0 0.2 0.3 0.4 0.1 0.1 0.3 0.1 0.7 0.1 0.5 1.0 0.1 0.3 0.7 0.9 0.5 0.5 0.5 0.0 0.9 0.1 0.1 1.2 0.7 0.2 0.5 0.0 0.2 0.1 0.2 0.0 0.8 0.6 0.7 3.2 0.4 0.2 0.9 0.8 0.1 0.0 2.5 0.5 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 2.7 0.1 0.2 0.1 0.0 0.0 0.0 14.5 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.1 1.0 0.1 81.9 3.3 0.0 0.0 2.5 35.0 31.8 0.8 34.0 0.2 4.7 0.5 0.1 19.5 2.1 0.0 0.0 11.8 0.7 39.6 0.1 0.7 10.5 1.0 0.7 0.4 0.9 0.5 1.0 0.5 0.5 0.5 0.7 0.7 0.9 0.7 0.2 0.0 0.0 0.3 2.7 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 2.1 2.1 0.0 0.2 0.2 0.5 0.2 0.0 0.5 0.4 0.0 7.4 0.0 2.0 0.0 0.0 8.7 1.1 0.0 0.0 11.8 3.6 32.8 26.1 0.0 0.0 0.5 0.7 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.1 1.4 0.0 0.0 0.0 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593890 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;NTERA-2: 34.3;REH: 25.6;U-266/84: 34.8" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA059975: AB_2684184" "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 1.9 2.0 2.2 2.7 2.2 4.6 3.2 5.7 2.2 2.9 1.8 1.7 0.6 2.4 4.3 1.3 4.9 1.9 3.1 1.9 2.1 2.2 0.8 2.5 5.9 1.5 1.8 2.0 6.1 1.1 6.7 2.6 3.4 2.6 3.3 1.4 7.0 1.7 4.1 1.8 2.1 2.2 2.7 1.6 4.7 1.6 5.3 2.3 7.2 5.7 2.4 6.4 2.0 1.1 2.3 0.1 0.0 22.5 0.1 0.9 0.9 0.0 7.9 7.4 11.3 10.2 0.1 0.2 0.0 5.6 4.0 8.9 0.6 0.0 12.6 16.0 0.0 28.8 4.6 0.1 2.5 2.6 0.1 8.5 4.6 0.0 8.7 0.0 1.0 0.8 1.8 0.2 0.0 3.7 0.0 17.8 2.4 34.3 0.0 2.8 25.6 0.1 5.6 3.2 0.0 16.4 16.5 0.1 0.0 0.7 17.4 0.1 0.3 0.1 10.2 5.2 0.0 9.3 0.2 34.8 8.8 0.1 0.0 10.1 1.8 1.6 8.1 1.8 1.9 3.5 6.8 3.5 2.2 2.6 9.4 6.5 3.2 0.3 4.1 1.7 2.8 4.4 2.6 2.2 2.2 5.7 2.2 1.9 2.1 1.5 1.8 2.0 2.6 1.6 2.3 2.3 1.4 0.0 0.0 3.3 4.5 1.0 1.4 1.8 1.2 3.7 1.7 1.4 3.0 5.7 1.9 5.5 0.0 2.0 1.1 0.0 3.9 3.0 2.9 0.3 1.5 1.8 0.0 4.2 2.3 0.2 1.0 1.7 2.0 0.3 3.8 5.4 2.9 0.3 1.9 3.3 1.9 0.1 4.1 0.8 1.8 3.4 2.1 1.2 0.0 1.0 1.0 4.8 0.0 4.0 0.7 0.2 0.1 2.2 2.6 0.7 0.0 0.5 0.9 5.0 6.6 1.5 1.9 1.0 5.6 0.7 0.9 1.2 2.3 1.7 0.1 1.1 GPR82 ENSG00000171657 "G protein-coupled receptor 82" Q96P67 X 41724181-41730130 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 2.7;lymphoid tissue: 7.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 16.5;Cone photoreceptor cells: 20.9;Kupffer cells: 37.0;Rod photoreceptor cells: 17.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 10 "eosinophil: 40.2;NK-cell: 10.9" "Group enriched" "Detected in many" 10 "granulocytes: 40.2;NK-cells: 10.9" "Cell line enriched" "Detected in single" 30 "HMC-1: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035914 Approved NA NA "HPA035914: AB_10670671" "unprognostic (5.62e-3)" "unprognostic (1.81e-2)" "unprognostic (4.65e-2)" "unprognostic (3.88e-3)" "unprognostic (1.15e-2)" "unprognostic (3.28e-2)" "unprognostic (4.62e-4)" "unprognostic (1.41e-3)" "unprognostic (2.12e-2)" "unprognostic (5.00e-2)" "unprognostic (1.39e-1)" "unprognostic (3.01e-1)" "unprognostic (7.45e-2)" "unprognostic (2.37e-2)" "unprognostic (2.26e-1)" "unprognostic (8.00e-3)" "unprognostic (1.18e-1)" 0.1 0.9 0.7 2.3 0.7 0.1 0.6 0.7 0.6 0.3 0.5 1.1 1.7 0.3 0.1 0.4 0.3 0.6 0.1 0.5 0.7 0.3 0.7 0.2 3.2 1.0 0.6 0.4 0.2 0.1 0.2 0.1 0.0 0.8 0.2 1.2 0.0 0.4 0.4 0.0 0.4 2.7 0.3 0.5 1.1 0.9 0.0 0.9 0.5 0.3 0.0 7.0 0.8 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 40.2 0.0 2.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.3 10.9 2.4 0.0 0.0 0.2 0.7 0.7 0.7 0.6 0.5 0.7 1.0 0.6 0.4 0.8 0.5 0.9 0.9 0.7 0.0 7.2 2.0 5.5 4.7 5.2 2.8 0.6 16.5 1.2 0.3 0.4 4.3 5.9 1.8 20.9 0.9 3.7 3.1 0.0 2.0 0.2 1.0 3.4 3.1 1.2 0.8 1.7 1.1 0.2 2.9 1.5 1.4 0.0 1.4 3.3 1.3 1.3 13.5 2.2 2.0 2.0 37.0 7.7 0.2 4.1 13.9 3.6 0.0 3.4 1.7 12.3 10.6 1.1 2.8 5.1 3.0 1.3 3.6 6.9 0.3 1.1 17.2 0.0 3.4 2.3 1.6 1.1 0.3 2.7 0.7 12.6 3.9 3.4 3.8 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697275 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 43.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "basophil: 339.6;eosinophil: 117.9" "Lineage enriched" "Detected in many" 24 "granulocytes: 339.6" "Cell line enhanced" "Detected in single" "HMC-1: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Approved Cytosol NA NA Cytosol "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 28.5 17.3 4.6 15.3 7.1 0.9 21.7 6.3 5.8 14.1 7.9 12.1 6.6 6.8 2.7 8.2 7.9 17.2 8.4 4.7 10.3 5.1 8.5 11.0 20.2 9.3 6.8 2.9 7.3 5.4 5.4 1.4 43.1 10.7 3.3 13.2 0.6 3.6 8.9 0.8 1.0 14.7 16.5 12.6 15.8 7.8 2.7 8.1 6.9 3.7 4.7 16.9 13.5 1.7 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 339.6 9.7 117.9 0.0 12.9 0.4 1.5 0.4 0.1 2.0 1.2 0.1 0.3 1.1 14.3 7.0 0.3 0.6 2.8 4.6 7.1 6.3 5.8 4.7 10.3 9.3 6.8 2.9 10.7 12.6 8.1 13.7 0.9 0.0 2.8 1.0 2.0 0.6 0.2 0.0 0.0 0.0 0.5 2.3 1.2 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.6 0.1 0.1 5.0 1.2 0.4 0.7 0.0 1.6 1.0 0.5 0.0 37.3 0.0 2.9 0.8 251.4 0.0 0.9 0.0 0.0 173.3 13.6 1.9 0.9 100.6 1.8 54.4 7.1 0.1 1.0 3.5 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.1 0.0 0.8 19.7 0.6 0.3 0.0 0.2 0.4 1.0 2.5 7.2 0.1 0.1 0.0 PLEKHG5 "GEF720, KIAA0720, Syx, Tech" ENSG00000171680 "Pleckstrin homology and RhoGEF domain containing G5" O94827 1 6467122-6520074 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 103.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 51.4;cerebral cortex: 19.4;hippocampal formation: 15.5;pons: 23.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 32.1;TIME: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049570: AB_2680818" "unprognostic (5.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.47e-1)" "unprognostic (2.81e-1)" "unprognostic (1.50e-3)" "unprognostic (5.10e-2)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.02e-2)" "unprognostic (4.85e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-3)" "unprognostic (4.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (4.85e-2)" 18.9 15.1 6.0 3.0 4.3 0.7 12.1 51.4 19.4 12.6 0.0 7.1 6.5 7.6 1.9 21.8 8.7 7.4 13.1 15.5 1.4 6.5 1.8 6.0 5.0 1.0 3.0 3.8 7.6 5.1 4.5 43.7 12.5 23.3 10.0 3.6 3.4 9.4 7.3 6.9 103.3 8.4 4.0 0.0 51.3 4.5 5.5 0.0 2.1 7.3 3.1 3.3 6.0 14.4 6.2 7.1 2.7 11.9 9.4 1.5 4.2 3.1 8.4 7.0 3.2 2.1 6.9 18.8 0.3 22.6 2.8 4.9 22.6 2.2 23.7 1.3 16.5 3.0 0.0 15.1 2.9 1.9 0.0 1.3 5.5 10.2 8.1 12.5 17.4 24.9 1.7 0.0 1.5 0.6 5.0 0.5 32.1 4.9 2.3 23.8 0.1 2.7 2.3 6.3 3.1 10.5 25.2 1.1 8.2 1.5 5.3 8.2 0.5 30.3 8.1 5.0 0.0 6.6 0.1 0.0 2.4 9.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 4.3 51.4 19.4 15.5 1.4 1.0 3.0 3.8 23.3 0.0 0.0 6.2 10.6 0.0 1.5 1.0 0.2 7.4 2.3 4.7 8.0 1.4 1.4 2.2 4.1 1.5 3.6 3.7 2.1 2.6 0.1 4.2 0.0 1.3 8.6 2.5 5.9 9.8 3.5 0.4 17.4 1.3 4.0 1.9 3.1 3.2 0.0 4.0 7.5 0.3 5.3 1.7 9.6 6.4 6.1 0.8 1.3 5.7 1.8 2.4 0.0 7.5 0.0 9.7 0.0 2.0 1.2 5.1 5.6 8.6 0.4 3.8 4.1 0.4 2.7 1.5 13.1 2.1 1.7 2.1 5.1 10.8 14.5 1.9 0.7 2.5 2.8 5.8 ATF7IP "FLJ10688, p621" ENSG00000171681 "Activating transcription factor 7 interacting protein" Q6VMQ6 12 14365632-14502935 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016578, HPA023505" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA016578: AB_1845147, HPA023505: AB_1845148" "unprognostic (2.06e-2)" "unprognostic (3.12e-2)" "unprognostic (1.25e-1)" "unprognostic (6.25e-3)" "unprognostic (1.20e-3)" "unprognostic (2.48e-2)" "unprognostic (5.84e-2)" "unprognostic (8.56e-3)" "unprognostic (7.36e-2)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (1.86e-1)" "unprognostic (7.90e-3)" "unprognostic (2.88e-1)" "unprognostic (7.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.78e-2)" 12.5 10.5 11.4 17.0 18.2 31.1 14.8 31.7 12.6 12.9 21.8 11.3 8.4 15.7 13.9 14.4 13.6 11.9 16.4 10.5 14.1 11.1 14.5 13.4 28.4 17.2 15.8 6.8 18.1 11.6 17.3 8.6 14.3 16.9 13.5 13.2 17.2 20.8 12.1 16.6 16.8 12.0 16.6 12.4 21.0 14.3 34.1 14.9 32.8 21.9 21.4 28.4 12.7 11.5 22.1 23.2 13.8 54.3 31.7 27.9 35.2 11.4 24.4 13.7 18.8 28.6 31.4 23.9 38.5 16.2 16.6 34.3 23.0 34.3 22.4 42.3 27.5 20.1 25.8 23.3 6.5 16.6 17.7 15.1 19.0 18.3 23.2 23.9 29.3 41.5 13.6 15.6 19.7 29.9 21.7 25.5 15.4 35.1 11.9 12.7 52.3 60.3 21.0 16.2 44.6 17.4 14.2 27.7 16.0 15.4 44.0 16.2 20.5 19.2 26.3 16.7 14.9 20.3 13.2 13.9 53.1 16.7 16.5 29.0 29.2 11.6 19.4 16.2 8.3 16.8 23.1 13.6 16.0 9.8 30.9 10.9 15.5 17.8 11.4 14.2 12.9 18.7 11.0 11.4 18.2 31.7 12.6 10.5 14.1 17.2 15.8 6.8 16.9 12.4 14.9 22.1 46.6 67.3 42.5 67.9 121.2 6.6 12.8 9.7 75.1 50.2 31.6 24.6 73.0 20.0 26.6 35.0 68.8 17.2 112.1 13.2 7.9 16.6 79.6 31.1 34.7 40.3 28.1 55.1 62.6 12.2 10.9 32.0 41.8 31.9 25.9 34.8 30.0 31.3 20.5 63.9 73.9 19.6 10.2 48.4 11.2 19.6 29.2 46.3 5.4 107.7 47.9 23.5 64.9 136.7 147.9 14.5 13.5 29.3 85.9 13.6 12.0 16.4 24.3 39.8 13.1 40.0 33.3 42.4 25.0 62.7 6.7 15.5 98.5 35.1 18.3 12.1 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 32.6" "Group enriched" "Detected in some" 14 "Early spermatids: 496.7;Late spermatids: 694.8" "Group enriched" "Detected in some" 4 "endometrial cancer: 0.8;glioma: 1.2;ovarian cancer: 1.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "intermediate monocyte: 8.6;non-classical monocyte: 13.5" "Lineage enriched" "Detected in many" 13 "monocytes: 13.5" "Group enriched" "Detected in some" 4 "REH: 5.6;SCLC-21H: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056463 Approved Nucleoplasm NA NA Nucleoplasm "HPA056463: AB_2683139" "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.1 0.1 1.5 0.0 0.8 0.1 0.1 0.3 1.9 0.2 0.0 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.1 1.1 1.5 0.0 0.0 0.6 0.0 1.2 0.9 1.5 0.0 0.2 0.0 0.7 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.0 32.6 1.4 0.0 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.4 0.2 0.0 0.9 5.6 0.0 0.1 0.0 0.0 5.5 1.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.1 8.6 0.6 0.1 0.6 0.1 1.0 0.0 0.7 0.2 0.0 0.0 13.5 0.2 0.0 0.9 1.5 0.8 0.3 1.9 1.1 1.5 1.2 0.9 1.5 0.9 0.5 1.4 1.4 0.5 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 1.1 0.6 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 496.7 40.3 1.3 0.5 0.0 0.8 1.1 0.0 0.0 0.6 0.0 0.5 0.0 0.1 1.4 0.1 1.6 0.0 0.9 0.0 0.0 1.8 0.0 694.8 3.7 2.2 0.0 0.0 1.4 0.7 0.0 1.0 0.5 0.1 0.0 3.0 0.4 0.2 0.0 0.2 0.0 1.0 13.1 0.3 0.4 24.0 6.6 0.1 0.0 0.1 0.8 0.1 0.0 0.2 RGS19 "GAIP, RGSGAIP" ENSG00000171700 "Regulator of G protein signaling 19" P49795 20 64073181-64079988 "Predicted intracellular proteins" Autophagy "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 57.7;lymphoid tissue: 78.1" "Cell type enhanced" "Detected in many" "B-cells: 97.8;dendritic cells: 82.0;Hofbauer cells: 135.0;Kupffer cells: 104.6;Macrophages: 101.6;monocytes: 86.3;NK-cells: 140.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 154.2;NB-4: 128.1;THP-1: 107.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056384, HPA069984" Enhanced Supported "Nucleoli fibrillar center,Cell Junctions" NA NA "Cell Junctions" "Nucleoli fibrillar center" "HPA056384: AB_2732602, HPA069984: AB_2732145" "unprognostic (3.98e-2)" "unprognostic (2.32e-1)" "unprognostic (4.26e-3)" "unprognostic (8.42e-2)" "unprognostic (2.03e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.25e-2)" "unprognostic (2.41e-2)" "unprognostic (3.91e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "prognostic unfavorable (2.06e-9)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (4.66e-3)" 11.7 8.8 6.0 28.7 6.6 57.7 9.1 6.6 7.9 5.9 6.5 5.6 7.6 5.1 2.0 8.2 7.0 6.1 6.3 5.8 8.8 6.4 5.9 19.8 35.5 9.5 7.8 4.8 2.4 7.1 2.7 4.3 7.3 8.6 7.4 2.2 0.3 8.6 2.5 2.5 8.2 21.3 4.3 10.8 78.1 8.3 1.8 10.5 14.0 6.9 2.2 17.4 8.4 7.0 9.6 16.1 24.1 6.8 12.2 3.0 4.9 11.5 10.0 6.9 20.2 8.4 36.0 21.8 28.1 27.0 6.2 21.6 15.4 7.0 12.8 4.8 14.0 13.2 40.3 12.3 14.8 4.0 83.0 154.2 3.3 7.7 8.6 3.0 4.0 13.3 18.4 15.5 14.5 6.2 28.6 61.6 128.1 7.0 13.8 30.3 51.1 4.0 20.4 5.7 7.8 12.9 12.1 10.3 6.3 13.6 3.4 8.3 107.3 14.0 18.9 9.5 3.3 9.8 9.1 7.6 34.7 10.5 62.6 12.8 289.5 273.2 760.9 96.6 396.0 99.2 125.7 91.1 92.6 228.8 125.7 62.4 64.9 606.5 75.1 458.3 130.8 107.1 204.7 6.0 6.6 6.6 7.9 5.8 8.8 9.5 7.8 4.8 8.6 10.8 10.5 9.6 19.0 3.2 4.1 2.0 97.8 9.7 6.4 8.0 4.0 0.1 10.4 13.3 3.9 2.8 5.7 1.8 0.0 3.0 82.0 0.5 0.0 12.0 0.5 2.8 8.3 17.2 0.0 14.7 1.4 14.3 8.1 6.5 4.6 2.2 48.8 4.5 15.0 0.8 135.0 0.0 1.0 0.5 4.1 104.6 50.0 1.1 4.4 101.6 5.4 17.8 86.3 0.3 140.1 2.5 0.2 16.9 3.8 1.2 25.0 14.5 0.1 2.4 3.3 0.2 13.1 2.4 8.8 0.3 7.0 5.2 8.9 1.8 57.1 3.7 0.9 8.8 TCEA2 TFIIS ENSG00000171703 "Transcription elongation factor A2" Q15560 20 64049836-64072347 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 173.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043836 Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA043836: AB_2678694" "unprognostic (6.51e-2)" "unprognostic (2.02e-1)" "unprognostic (3.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.80e-1)" "unprognostic (4.91e-3)" "unprognostic (2.38e-1)" "unprognostic (2.91e-1)" "unprognostic (1.65e-3)" "unprognostic (9.03e-3)" "unprognostic (2.49e-2)" "unprognostic (9.67e-2)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.70e-1)" "unprognostic (2.28e-1)" "unprognostic (3.79e-1)" 31.8 31.3 58.8 9.8 57.3 8.6 32.4 51.7 106.8 44.8 28.2 33.6 6.2 43.1 13.3 14.4 42.3 16.8 38.8 57.6 56.1 39.8 57.3 24.1 12.9 64.5 57.3 59.9 56.3 19.4 31.3 58.2 17.7 67.0 39.6 3.3 12.2 22.4 25.5 42.0 24.1 21.8 14.2 47.1 30.9 26.0 92.6 57.2 15.5 38.8 14.1 6.0 38.6 31.8 57.8 17.1 18.7 29.7 50.2 26.5 15.8 11.5 16.8 20.0 31.4 15.0 11.4 30.5 19.4 38.6 21.8 18.0 45.8 12.3 15.5 6.1 12.0 21.8 7.2 37.3 29.1 38.8 8.3 9.9 24.9 13.4 8.1 10.3 43.9 21.6 24.4 12.8 35.5 9.7 41.5 34.4 41.5 18.4 22.8 44.7 32.1 21.7 51.0 17.1 12.2 28.5 48.4 18.0 12.0 46.3 9.8 34.0 21.3 30.7 56.2 28.3 31.5 10.2 40.2 28.4 10.7 50.1 9.4 11.5 1.6 1.0 3.2 2.2 1.2 0.9 7.5 1.9 1.6 1.3 2.8 3.3 2.1 0.5 2.6 1.9 2.1 3.9 1.0 58.8 57.3 51.7 106.8 57.6 56.1 64.5 57.3 59.9 67.0 47.1 57.2 57.8 43.3 0.0 3.1 20.5 34.5 22.6 38.3 17.6 38.7 54.1 44.9 64.0 31.0 30.0 11.5 71.7 27.1 27.6 13.6 0.6 107.6 35.6 123.6 30.8 44.3 40.7 19.1 5.7 21.9 16.0 13.4 43.9 13.7 21.0 2.5 62.8 47.5 47.6 17.4 65.6 19.0 2.8 16.2 16.8 23.7 173.1 51.9 20.5 62.2 7.5 18.4 123.3 10.3 8.5 17.0 24.3 2.1 49.2 14.7 31.2 11.6 115.6 16.1 37.1 26.3 43.2 48.9 126.1 39.0 13.2 20.2 20.8 18.7 42.3 3.6 25.9 DEFB4A "DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1" ENSG00000171711 "Defensin beta 4A" O15263 8 7894677-7896716 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 125.1" "Group enriched" "Detected in some" 8 "Basal respiratory cells: 79.5;Club cells: 38.3;Exocrine glandular cells: 37.4;Pancreatic endocrine cells: 41.0" "Group enriched" "Detected in many" 6 "head and neck cancer: 32.2;melanoma: 9.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.4" "Secreted in other tissues" NA NA "unprognostic (6.96e-2)" "unprognostic (1.17e-2)" "unprognostic (2.72e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 125.1 0.1 3.6 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 3.1 0.4 0.0 0.0 0.0 7.3 0.0 0.0 5.0 0.0 0.0 7.7 0.2 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.5 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.1 0.0 5.6 0.0 4.3 0.0 5.3 0.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 3.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 1.1 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 ANO5 "GDD1, LGMD2L, TMEM16E" ENSG00000171714 "Anoctamin 5" Q75V66 11 21799934-22283357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Limb-girdle muscular dystrophy, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 25.1;parathyroid gland: 17.1;skeletal muscle: 66.1;tongue: 50.9" "Group enriched" "Detected in many" 7 "Astrocytes: 67.9;Cardiomyocytes: 86.2;Excitatory neurons: 166.6;Inhibitory neurons: 136.4;Oligodendrocyte precursor cells: 81.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.9;HAP1: 5.0;HEK 293: 6.6;NTERA-2: 3.5;RPTEC TERT1: 3.2;U-266/84: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058857 Uncertain NA NA "HPA058857: AB_2683835" "unprognostic (5.25e-3)" "unprognostic (1.36e-3)" "unprognostic (2.43e-1)" "unprognostic (7.67e-3)" "unprognostic (3.50e-2)" "unprognostic (5.85e-2)" "unprognostic (8.17e-3)" "unprognostic (2.30e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.54e-4)" "unprognostic (8.55e-2)" "prognostic favorable (2.50e-7)" "unprognostic (3.65e-3)" "unprognostic (2.84e-1)" "unprognostic (2.77e-4)" "unprognostic (7.94e-2)" 0.9 4.6 2.9 0.8 3.3 0.0 0.7 0.2 9.5 1.6 2.8 2.4 3.3 1.5 1.3 2.0 0.8 1.7 25.1 4.3 2.6 3.6 2.1 1.2 0.2 2.6 2.5 2.8 0.5 3.9 17.1 3.5 0.0 2.7 4.2 3.4 2.1 2.7 4.1 66.1 0.1 2.5 2.8 0.8 0.7 3.0 1.8 2.6 0.2 4.8 50.9 0.3 2.0 0.3 3.9 0.0 4.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 1.4 2.5 0.0 0.0 0.0 0.0 3.5 2.6 0.0 0.0 0.0 0.0 3.2 0.1 2.7 2.6 0.0 0.0 0.0 2.1 2.1 1.9 0.0 0.0 1.9 0.0 0.0 2.0 3.7 0.0 2.8 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.3 0.2 9.5 4.3 2.6 2.6 2.5 2.8 2.7 0.8 2.6 3.9 0.4 0.0 5.9 67.9 0.6 0.3 0.3 0.0 0.0 6.7 2.2 0.6 86.2 1.5 0.0 1.8 0.0 0.1 0.0 7.8 1.9 1.3 5.8 0.4 0.2 3.2 5.4 0.4 166.6 2.7 0.0 3.0 1.5 0.3 0.0 3.0 2.5 5.1 0.5 1.7 136.4 7.1 0.0 0.6 1.4 2.9 0.0 1.6 1.8 14.0 1.9 2.8 0.0 81.4 4.2 1.0 4.4 1.2 0.0 1.4 2.7 3.3 0.7 0.8 0.0 8.1 2.4 11.0 0.9 0.1 0.1 0.0 0.2 1.6 4.6 0.2 HDAC3 "HD3, KDAC3, RPD3, RPD3-2" ENSG00000171720 "Histone deacetylase 3" O15379 5 141620876-141636849 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005583, HPA052052, CAB072336" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708" "unprognostic (6.65e-2)" "unprognostic (1.96e-1)" "prognostic favorable (3.39e-4)" "unprognostic (1.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (5.56e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.65e-6)" "unprognostic (1.85e-1)" "unprognostic (1.63e-2)" "unprognostic (2.28e-3)" "unprognostic (2.17e-1)" 21.9 40.1 7.7 22.9 7.9 37.7 25.6 7.5 9.6 24.5 9.1 23.4 18.9 23.7 26.6 34.4 26.8 20.5 24.6 8.1 8.0 24.4 40.0 21.6 33.0 8.1 7.6 7.3 26.3 28.7 45.3 18.5 22.5 7.4 20.7 24.7 16.6 25.7 22.1 40.6 39.3 23.7 26.3 7.7 28.0 23.5 15.9 7.6 38.7 24.3 34.4 43.0 26.4 26.0 8.0 59.8 40.2 74.0 109.5 68.5 54.3 47.0 42.6 93.5 94.8 134.8 86.5 49.7 86.4 54.0 56.2 67.3 51.2 72.9 98.8 117.0 74.6 79.0 68.8 33.3 50.4 48.1 83.5 60.1 47.0 63.2 55.3 71.3 49.6 61.9 76.8 67.6 44.7 61.5 55.8 92.1 72.9 63.9 36.8 31.0 65.8 76.2 62.3 49.9 59.7 60.2 49.4 57.0 57.1 71.7 46.2 61.8 52.3 32.1 58.3 36.1 45.8 71.8 36.6 47.8 82.1 48.8 78.6 50.8 41.3 51.7 39.6 34.1 53.8 45.5 47.8 42.5 41.9 107.5 47.5 45.9 38.5 21.5 35.1 46.8 55.1 55.6 43.8 7.7 7.9 7.5 9.6 8.1 8.0 8.1 7.6 7.3 7.4 7.7 7.6 8.0 19.1 9.6 13.2 16.6 36.0 44.2 26.8 38.1 37.0 33.2 29.0 25.5 15.9 18.6 19.6 12.9 60.5 55.3 43.8 18.5 21.5 33.4 10.4 10.0 21.0 21.3 18.0 50.7 40.6 35.4 51.6 28.8 19.9 10.2 18.4 33.9 21.4 18.7 38.8 50.5 38.2 19.7 28.5 19.5 44.9 4.2 22.4 31.7 32.0 10.3 51.1 33.3 38.1 22.1 21.9 33.4 16.3 22.2 36.3 28.7 19.5 20.5 10.8 36.5 26.3 18.1 24.7 25.4 27.5 38.1 51.4 61.2 30.3 42.6 25.9 30.3 SPATA46 C1orf111 ENSG00000171722 "Spermatogenesis associated 46" Q5T0L3 1 162373203-162376854 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 31.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.71e-3)" "unprognostic (2.13e-2)" "unprognostic (1.40e-1)" "unprognostic (3.55e-1)" "unprognostic (1.10e-2)" "unprognostic (1.49e-3)" "unprognostic (6.42e-2)" "unprognostic (3.80e-2)" "unprognostic (1.32e-1)" "unprognostic (3.44e-1)" "unprognostic (2.38e-1)" "unprognostic (4.59e-4)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (5.22e-2)" "unprognostic (1.76e-2)" 0.0 3.2 0.6 0.0 0.7 0.1 0.2 0.5 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.0 1.1 0.1 0.4 0.0 0.0 0.8 1.0 0.6 0.0 0.3 0.0 0.6 0.0 0.4 0.1 0.0 2.4 0.3 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 31.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.0 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.4 1.0 1.1 0.8 1.0 0.6 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPHN KIAA1385 ENSG00000171723 Gephyrin Q9NQX3 14 66507407-67181803 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" "Multifunctional enzyme, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 63.0" "Group enriched" "Detected in many" 4 "Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003116, CAB004419, HPA024694" Enhanced Approved Vesicles,Cytosol NA NA 6900 Vesicles Cytosol "CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616" "unprognostic (8.37e-2)" "unprognostic (2.53e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (5.14e-2)" "unprognostic (4.89e-3)" "unprognostic (8.29e-2)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (2.23e-1)" "unprognostic (2.49e-2)" "unprognostic (8.54e-2)" "prognostic favorable (5.25e-12)" "unprognostic (9.81e-2)" "unprognostic (2.27e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (4.61e-5)" 13.0 11.2 37.5 3.5 39.6 2.7 13.5 51.9 54.6 9.3 25.3 11.9 7.5 10.0 11.7 12.3 11.2 6.2 14.5 39.4 38.9 25.1 63.0 9.3 3.8 37.7 38.8 38.9 8.9 24.1 11.8 13.7 3.6 39.8 11.4 10.2 23.3 9.5 6.7 24.7 14.4 9.1 6.3 32.3 6.8 14.8 6.3 38.2 5.8 12.0 13.9 4.3 11.5 10.8 43.0 39.9 8.8 13.7 15.9 14.2 17.5 9.5 11.1 5.7 12.7 12.2 2.8 17.9 0.0 1.8 7.7 5.5 13.1 17.0 19.9 18.9 15.0 14.9 15.8 9.4 22.3 7.8 9.1 15.8 13.3 13.8 2.9 16.0 4.8 11.8 13.8 9.3 14.2 7.1 19.2 11.9 22.2 5.0 28.3 17.0 0.0 32.5 13.2 16.7 7.5 25.8 10.3 10.2 31.6 12.4 3.3 18.5 11.5 6.7 14.1 24.8 11.3 13.0 22.8 9.1 0.3 10.5 0.8 11.2 0.0 0.7 0.3 2.0 1.2 3.2 1.2 2.5 1.7 1.1 1.9 1.7 1.6 0.0 1.3 1.0 1.5 3.0 0.7 37.5 39.6 51.9 54.6 39.4 38.9 37.7 38.8 38.9 39.8 32.3 38.2 43.0 11.5 6.4 13.1 493.0 11.8 4.7 9.2 5.8 27.9 34.3 12.4 6.7 12.7 8.6 10.8 1.8 52.1 3.9 3.5 8.6 13.7 4.0 3.8 7.2 13.5 10.7 6.0 7.6 686.5 5.3 2.3 8.7 19.9 13.6 0.0 3.9 15.7 47.6 3.7 43.7 866.7 15.0 8.2 5.8 1.7 5.0 11.1 4.5 1.8 148.0 1.3 8.9 1.0 576.1 597.5 3.1 7.8 5.7 15.1 11.5 7.1 20.1 2.4 34.9 0.0 12.5 11.8 11.8 8.9 26.7 5.8 2.1 7.9 9.0 10.4 6.5 VAT1L KIAA1576 ENSG00000171724 "Vesicle amine transport 1 like" Q9HCJ6 16 77788564-77980107 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "adrenal gland: 70.8;brain: 152.0;choroid plexus: 195.9;retina: 190.4" "Group enriched" "Detected in some" 4 "Horizontal cells: 297.8;Muller glia cells: 106.9" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044061, CAB046032, HPA061138" Enhanced Approved Cytosol NA NA Cytosol "CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: " "unprognostic (1.49e-2)" "unprognostic (8.74e-3)" "unprognostic (8.80e-3)" "unprognostic (3.39e-2)" "unprognostic (3.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (8.57e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.01e-6)" "unprognostic (2.50e-2)" "unprognostic (6.53e-2)" "unprognostic (1.19e-1)" "unprognostic (5.96e-2)" 1.3 70.8 34.3 3.3 40.3 0.8 0.5 48.2 24.3 0.7 195.9 3.6 2.4 5.4 6.9 1.7 0.9 4.0 15.3 21.2 152.0 5.4 1.0 0.3 0.4 61.9 67.9 19.7 0.3 1.8 0.7 4.5 1.9 62.4 0.3 5.7 190.4 1.4 0.4 0.2 0.1 3.3 2.6 39.1 0.0 1.9 1.9 66.3 0.1 2.4 0.3 2.4 1.5 1.2 67.1 0.0 0.0 23.1 0.0 7.8 0.0 0.0 2.8 68.7 0.9 0.7 0.0 0.0 0.0 0.0 38.1 0.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.5 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.4 79.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.0 3.7 0.0 1.1 0.0 14.1 0.1 18.6 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 82.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 40.3 48.2 24.3 21.2 152.0 61.9 67.9 19.7 62.4 39.1 66.3 67.1 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.5 9.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.2 4.4 0.0 0.2 0.9 3.0 0.0 20.7 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.4 0.0 0.2 297.8 31.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.0 0.6 106.9 0.0 44.7 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.3 0.1 0.1 0.0 0.0 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220478 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 87.0;Exocrine glandular cells: 74.1;Pancreatic endocrine cells: 71.0;Urothelial cells: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favorable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.4 20.7 8.7 8.9 7.8 0.8 5.5 16.2 10.7 12.7 7.1 18.9 23.0 5.4 7.3 17.8 11.4 21.4 5.1 8.0 8.4 34.4 4.0 14.3 4.8 8.5 7.7 6.7 21.5 45.5 13.0 7.1 10.9 10.3 15.8 10.8 0.4 10.5 15.5 1.7 7.3 20.2 7.9 8.4 7.1 30.4 2.6 8.8 2.2 4.8 3.1 5.1 30.6 18.3 12.8 42.7 22.4 12.5 3.0 2.1 4.5 0.0 4.8 20.1 14.5 19.6 29.6 46.8 0.0 15.4 3.2 20.7 40.2 4.3 15.7 8.2 0.1 11.1 1.0 1.2 29.8 17.8 0.0 39.7 1.4 13.7 18.9 20.6 9.3 13.6 1.7 6.5 0.1 7.5 14.7 0.0 0.1 2.3 33.7 8.4 5.9 8.0 7.4 37.0 43.3 1.9 37.0 4.0 16.2 40.6 7.5 2.3 4.5 9.5 15.0 13.2 6.6 15.2 0.4 0.6 0.1 14.8 0.6 18.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 8.7 7.8 16.2 10.7 8.0 8.4 8.5 7.7 6.7 10.3 8.4 8.8 12.8 2.7 0.0 2.6 19.9 1.5 18.2 53.8 9.4 15.4 0.1 9.7 6.7 3.0 34.3 10.7 49.7 0.0 6.3 0.1 20.3 5.9 87.0 0.5 10.0 1.9 10.5 19.2 0.0 0.7 74.1 0.9 10.3 26.0 15.7 0.0 0.3 8.6 0.4 48.1 0.0 8.1 18.7 57.0 31.4 19.2 0.4 2.8 22.1 14.2 23.4 13.1 0.0 0.0 11.6 0.4 71.0 27.2 13.9 0.3 53.7 14.3 12.1 11.7 0.1 32.9 1.6 30.3 0.5 3.6 20.7 21.2 1.4 1.1 1.0 15.4 117.9 CAMTA1 KIAA0833 ENSG00000171735 "Calmodulin binding transcription activator 1" Q9Y6Y1 1 6785454-7769706 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036342, HPA036343" Approved Supported Cytosol NA NA Cytosol "HPA036342: AB_2675072, HPA036343: AB_10671839" "unprognostic (1.11e-1)" "unprognostic (6.31e-2)" "unprognostic (5.80e-2)" "unprognostic (4.14e-3)" "unprognostic (3.10e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.10e-4)" "unprognostic (3.90e-3)" "unprognostic (8.84e-2)" "unprognostic (1.35e-3)" "unprognostic (2.17e-2)" "unprognostic (9.19e-3)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" 36.6 44.1 53.6 23.8 54.7 26.7 39.1 62.1 76.4 32.5 31.9 63.2 53.3 40.5 82.4 37.9 36.3 30.7 115.1 54.4 63.8 69.1 71.1 37.0 27.5 65.1 64.2 50.1 35.7 26.6 43.7 35.7 26.6 69.6 47.4 49.0 68.8 50.9 51.0 102.5 25.4 41.4 42.7 58.9 30.9 45.6 44.9 61.7 32.2 52.5 105.7 33.8 57.0 35.5 74.9 67.6 37.2 101.2 51.7 51.2 77.6 28.4 71.0 54.7 75.3 63.1 45.1 83.2 55.5 54.6 75.2 50.3 40.8 53.6 73.7 106.5 41.8 57.8 62.7 85.1 89.6 83.0 48.2 43.6 52.5 50.2 54.5 83.0 64.6 85.1 77.7 44.8 73.2 87.9 65.0 64.6 130.9 70.2 85.2 43.2 42.5 90.2 123.7 103.4 38.7 104.2 83.7 50.4 74.1 113.9 72.3 40.2 59.4 50.1 53.1 44.9 55.3 45.2 55.2 74.3 153.2 79.6 107.4 30.7 80.1 74.7 70.5 25.8 48.5 28.3 48.1 39.8 32.0 73.4 41.8 32.2 28.1 15.4 26.7 37.9 77.5 45.6 46.3 53.6 54.7 62.1 76.4 54.4 63.8 65.1 64.2 50.1 69.6 58.9 61.7 74.9 142.1 54.5 48.8 314.7 74.3 309.7 340.6 306.6 169.0 106.7 231.7 283.2 565.2 101.5 135.3 191.3 252.3 69.8 44.3 198.3 418.7 180.1 166.1 84.1 80.3 155.8 130.8 81.8 346.1 206.3 144.9 134.4 63.2 99.8 55.2 205.4 106.1 239.0 106.3 158.2 479.3 185.8 223.8 95.5 254.0 137.9 76.4 122.0 238.3 117.1 172.9 112.3 38.1 330.3 227.5 184.2 234.5 128.6 87.9 486.4 251.7 750.7 117.1 156.2 138.1 91.1 233.2 151.0 211.0 158.9 282.7 88.1 68.2 137.8 186.5 413.7 LGALS4 GAL4 ENSG00000171747 "Galectin 4" P56470 19 38801671-38812945 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 1127.6" "Group enriched" "Detected in many" 4 "Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6" "Group enriched" "Detected in many" 21 "colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 205 "OE19: 987.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB025653, HPA031184, HPA031185, HPA031186" Enhanced Uncertain "Plasma membrane" NA NA 200000 "Plasma membrane" "CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (2.57e-3)" "unprognostic (7.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.69e-1)" "unprognostic (3.38e-1)" "unprognostic (9.71e-2)" "prognostic favorable (3.21e-4)" 1.6 0.5 0.3 86.9 0.4 0.5 5.5 0.5 0.6 1.2 0.2 1127.6 819.5 3.2 0.2 1.5 2.4 138.4 0.9 0.3 0.3 3.0 80.1 1.2 1.2 0.3 0.3 0.3 1.7 31.8 0.0 0.8 0.2 0.3 2.3 941.8 0.2 1.1 2.3 1.6 1.4 697.8 55.7 0.2 4.0 136.4 1.0 0.3 0.3 1.8 0.2 0.4 11.3 1.5 0.4 0.0 0.4 0.1 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 1.3 0.1 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 2.2 0.0 987.1 0.0 0.1 0.0 2.5 0.1 4.8 0.2 1.4 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.2 1.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.4 1.7 3.2 6.5 0.7 10.3 1.1 3.0 0.6 3.4 1.1 3.6 3.0 1.3 770.7 1.0 0.0 0.0 0.8 0.9 4349.4 0.0 267.1 0.2 1.9 1.8 1.2 649.7 0.0 0.3 103.3 0.5 0.8 310.4 5.7 49.0 0.8 1.8 69.0 0.1 1.7 0.3 3767.6 0.0 1.9 0.3 0.0 0.0 1.2 0.0 1.0 3.0 0.8 1.0 0.0 0.7 492.7 3353.0 0.4 0.7 1.8 4572.2 9.3 0.4 2.3 0.0 3.9 1.1 0.3 0.9 0.9 2.7 0.5 11.1 1.1 2684.6 42.4 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793003-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 5.7;testis: 12.9" "Cell type enhanced" "Detected in many" "Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cell Junctions, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 1.3 0.4 2.1 0.6 2.3 1.4 1.2 1.9 2.7 0.8 2.5 0.4 0.2 0.7 0.3 0.2 5.5 0.3 0.8 1.3 2.3 0.8 0.2 1.0 0.8 2.1 2.3 1.3 0.8 0.2 0.3 2.8 0.2 2.2 0.6 0.1 5.7 0.3 0.8 0.4 0.5 0.4 0.2 2.1 0.7 0.4 12.9 2.0 0.6 0.9 0.4 0.3 0.4 0.4 1.9 2.3 0.4 0.5 0.0 0.9 3.0 0.0 0.9 1.9 2.4 2.1 0.1 0.0 1.5 0.1 0.6 3.1 0.0 1.8 0.0 0.8 0.4 5.6 8.1 0.2 0.0 0.6 8.9 1.8 0.9 0.4 0.8 0.0 0.1 1.6 7.1 0.2 0.0 0.9 0.0 0.8 1.1 7.7 0.0 2.6 4.0 0.0 0.4 2.1 0.2 4.0 3.1 0.5 0.3 0.0 0.2 0.0 4.2 0.5 0.4 0.0 0.3 0.1 0.1 0.1 1.9 3.5 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 2.1 2.3 1.9 2.7 1.3 2.3 2.1 2.3 1.3 2.2 2.1 2.0 1.9 3.9 3.2 2.6 8.5 1.5 0.4 0.9 5.3 0.0 6.9 0.4 0.9 3.2 0.0 12.9 5.5 37.5 0.2 1.6 0.1 1.9 0.5 137.9 33.8 5.8 3.0 4.2 4.2 15.1 0.2 0.3 5.0 0.5 1.0 1.3 1.0 10.4 0.3 2.4 11.8 12.5 0.4 6.1 0.8 1.2 36.3 10.5 1.2 0.0 3.7 3.8 7.4 0.0 9.5 3.6 0.3 0.0 10.5 0.7 0.4 0.0 3.6 129.6 18.8 0.0 3.6 3.7 104.4 9.2 0.1 0.3 0.5 0.9 1.9 0.2 0.4 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836889-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "kidney: 501.2;liver: 1419.9" "Group enriched" "Detected in some" 6 "Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "Hep G2: 238.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" No NA 40000 "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.1 6.4 2.1 0.0 1.7 0.0 0.2 1.9 3.4 0.1 0.9 0.3 0.1 0.1 0.5 0.0 0.1 80.1 0.0 2.0 3.3 501.2 1419.9 0.0 0.1 2.8 2.1 1.3 0.1 9.3 0.8 3.0 0.0 2.1 1.5 0.0 2.4 0.1 0.1 0.0 0.0 0.1 0.0 2.5 0.3 0.4 3.3 2.8 0.7 0.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 238.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.2 1.0 0.1 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.7 1.9 3.4 2.0 3.3 2.8 2.1 1.3 2.1 2.5 2.8 2.7 0.0 0.0 0.0 1.0 2.7 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.5 250.2 0.0 5.5 0.0 0.0 0.0 0.0 21.5 2.4 66.8 0.0 0.1 1.1 1.8 21.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 807.7 0.0 3.3 2.3 0.0 0.0 22.2 0.0 15.7 0.6 1.8 0.0 0.0 0.0 0.6 0.0 4.5 0.0 0.0 0.0 1.2 0.0 0.4 0.0 344.4 0.0 0.2 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.1 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402336-45421415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 4.6 4.9 5.1 4.7 5.2 6.4 4.6 5.7 6.3 5.3 4.6 5.1 6.0 4.5 3.9 10.1 5.0 2.7 5.0 5.0 5.1 5.4 7.6 3.3 4.7 5.0 5.1 4.7 6.1 5.9 4.4 3.2 5.3 5.1 4.3 4.9 4.7 4.4 4.0 9.0 7.4 5.5 4.5 5.2 4.5 4.6 3.4 5.2 4.9 5.4 5.5 5.0 5.5 6.1 5.7 10.0 6.3 9.9 7.3 8.0 7.8 12.0 8.7 7.9 9.3 9.0 17.3 6.3 7.3 9.5 5.8 16.9 22.5 14.8 10.9 10.3 10.0 8.4 9.5 11.2 13.6 9.0 12.8 4.0 6.2 12.2 7.7 10.1 10.6 7.4 9.4 15.6 11.4 10.5 6.7 8.9 24.5 7.1 24.8 9.7 9.8 13.9 6.8 11.7 9.8 13.5 6.9 7.2 15.5 8.4 11.7 13.7 23.1 4.7 4.5 6.9 27.8 18.8 9.7 20.8 11.3 11.6 20.8 8.3 0.0 0.9 1.2 1.1 0.7 0.4 0.6 0.7 1.5 0.9 0.7 0.6 0.9 1.1 1.1 1.9 1.0 0.8 0.2 5.1 5.2 5.7 6.3 5.0 5.1 5.0 5.1 4.7 5.1 5.2 5.2 5.7 4.7 0.0 1.1 7.2 8.9 5.0 8.9 4.6 5.2 7.9 3.7 2.4 6.9 7.2 5.2 3.7 16.7 12.2 7.3 5.4 3.9 6.2 20.6 6.2 5.4 6.3 3.6 2.5 11.0 7.3 11.9 5.2 9.2 8.4 4.5 8.6 1.1 5.7 8.0 6.7 10.1 6.3 0.0 3.7 7.6 7.1 7.8 7.7 3.6 6.5 7.7 5.0 2.1 16.6 14.6 5.5 3.1 3.8 8.5 6.2 9.2 5.7 2.4 6.5 0.0 4.1 4.1 6.2 5.6 10.4 6.8 6.7 5.8 6.1 7.3 8.2 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "kidney: 2119.1;liver: 2827.1;pancreas: 2960.4" "Group enriched" "Detected in many" 8 "Hepatocytes: 1495.2;Proximal tubular cells: 3703.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 11.0;dendritic cells: 6.8" "Group enriched" "Detected in many" 4 "RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria NA NA 600000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 14.6 21.6 146.8 12.5 149.1 1.8 25.7 166.1 218.4 10.0 112.0 16.7 177.1 8.5 10.6 25.3 11.7 48.2 57.8 144.0 163.3 2119.1 2827.1 7.4 18.6 160.5 148.2 131.6 166.7 2960.4 2.8 8.4 75.4 170.5 12.5 11.6 7.6 58.0 15.3 143.9 138.7 111.1 14.6 164.7 33.9 100.1 78.9 156.2 12.7 63.6 47.3 29.9 18.2 15.6 194.5 12.9 6.5 4.4 0.6 0.1 0.2 0.8 0.1 0.1 0.0 0.2 1.4 21.4 34.4 1.0 0.0 5.7 2.2 17.0 0.6 0.4 1.9 0.3 2.8 0.4 0.3 0.8 20.7 2.6 0.8 0.7 0.0 0.4 0.0 0.3 7.8 0.4 0.7 0.2 0.6 2.2 0.6 11.2 31.3 0.0 0.5 210.1 1.5 3.5 55.8 23.5 4.1 6.9 0.4 1.2 2.1 2.9 23.7 0.0 0.0 0.5 0.2 6.3 126.3 165.5 0.8 1.6 0.3 1.0 0.0 1.1 0.3 0.2 1.6 0.0 11.0 0.0 0.2 6.6 5.4 0.0 1.4 0.0 0.1 0.6 6.8 0.0 1.0 146.8 149.1 166.1 218.4 144.0 163.3 160.5 148.2 131.6 170.5 164.7 156.2 194.5 2.4 3.2 1.1 67.3 42.3 54.3 14.9 5.2 5.7 8.1 16.9 9.5 35.5 228.8 5.4 71.7 0.0 1.0 0.8 3.1 295.4 58.2 8.8 1.3 0.4 7.3 0.0 29.3 6.8 290.0 1.2 19.8 69.8 2.7 3.8 219.5 23.9 1495.2 89.6 8.4 3.3 3.1 2.0 80.3 80.3 18.3 4.4 50.6 23.2 20.6 3.1 19.1 2.1 57.3 196.3 97.3 3.9 3.4 7.2 6.4 98.4 3703.0 1.9 3.8 6.6 38.4 16.8 22.0 9.7 16.0 133.7 1.8 17.6 4.1 3.4 20.4 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 71.4" "Group enriched" "Detected in many" 6 "Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 18.5;U-2 OS: 15.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040208 Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.9 1.6 8.8 0.6 8.2 0.0 1.5 9.6 11.7 1.1 2.6 0.7 0.1 0.9 0.3 0.7 1.2 1.2 0.6 9.3 6.2 1.1 4.0 0.4 0.2 7.5 6.4 9.4 2.0 3.8 0.0 1.2 9.4 8.5 1.7 0.4 2.3 0.2 0.4 0.9 0.4 0.5 0.6 4.0 0.9 0.6 71.4 7.0 0.2 1.4 1.7 0.5 0.4 0.4 9.5 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.5 0.0 0.0 0.1 0.1 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 15.5 0.2 0.4 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.5 0.1 0.9 0.6 0.8 0.2 0.6 0.2 0.3 0.3 0.3 0.8 0.0 0.0 0.8 0.6 0.7 0.4 8.8 8.2 9.6 11.7 9.3 6.2 7.5 6.4 9.4 8.5 4.0 7.0 9.5 0.7 0.0 1.5 0.7 0.3 1.0 1.2 0.0 0.0 2.7 1.0 2.4 0.3 1.5 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 141.2 1.2 3.2 1.3 0.0 0.0 29.8 1.1 0.2 5.6 0.5 0.6 0.0 0.0 0.0 7.8 0.7 10.1 19.1 0.0 0.0 0.3 0.9 112.6 5.3 0.9 0.0 0.0 0.0 0.3 0.0 7.1 0.8 0.4 0.3 3.8 0.1 0.6 0.0 0.5 1.5 2.1 26.3 0.5 0.9 362.8 170.9 0.0 1.0 0.3 0.5 7.0 0.0 0.6 NXNL1 "RDCVF, TXNL6" ENSG00000171773 "Nucleoredoxin like 1" Q96CM4 19 17455425-17460926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 64.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.5;Cone photoreceptor cells: 52.1;Muller glia cells: 21.0;Rod photoreceptor cells: 109.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.62e-1)" "unprognostic (5.49e-1)" "unprognostic (1.81e-1)" "unprognostic (3.63e-1)" "unprognostic (1.13e-1)" 2.0 1.5 1.2 0.1 1.2 0.2 0.8 1.9 1.3 0.1 13.2 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.4 2.5 1.1 0.1 0.0 0.1 0.2 1.6 1.5 0.6 0.3 0.0 0.1 0.0 0.1 1.3 0.2 0.1 64.9 0.4 0.0 0.6 0.7 0.1 0.1 1.1 0.1 0.1 0.3 1.5 0.1 0.3 0.5 0.1 0.1 0.0 1.5 0.2 0.5 0.3 0.4 0.5 0.3 0.2 0.1 0.0 0.5 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.3 0.0 0.2 0.3 0.2 0.1 0.4 0.4 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.2 0.5 0.0 0.6 0.1 0.2 0.1 0.1 0.2 0.2 0.5 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.3 0.1 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.4 0.4 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.0 1.2 1.2 1.9 1.3 2.5 1.1 1.6 1.5 0.6 1.3 1.1 1.5 1.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.4 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 21.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 21.0;lymphoid tissue: 8.9" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "neutrophil: 39.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 25.7;HMC-1: 24.0;U-937: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 3.2 0.8 0.3 6.7 0.5 21.0 0.7 0.3 0.9 1.1 0.7 1.2 1.2 0.5 0.1 1.1 1.0 1.9 0.6 0.3 0.7 0.3 0.7 3.4 1.1 0.7 0.4 0.1 0.4 1.1 0.3 0.2 2.3 0.6 0.5 0.8 0.0 0.4 0.5 0.9 0.5 1.8 2.1 0.6 8.9 0.9 0.2 0.8 1.1 0.2 1.4 0.7 2.5 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 25.7 0.0 0.0 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 12.5 13.5 20.1 0.0 15.4 0.0 0.1 0.3 0.0 9.4 0.1 0.0 0.0 39.4 0.0 17.9 0.7 1.4 4.4 0.3 0.5 0.3 0.9 0.3 0.7 0.7 0.4 0.1 0.6 0.6 0.8 0.9 0.2 0.0 0.6 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.3 18.1 0.0 1.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.7 0.0 0.2 0.4 0.0 0.0 26.6 0.0 1.4 0.0 15.1 0.0 0.4 0.0 0.0 32.9 11.6 0.0 0.0 19.1 1.8 0.0 25.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.7 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.3 1.5 0.0 0.0 0.1 NHLH1 "bHLHa35, HEN1, NSCL, NSCL1" ENSG00000171786 "Nescient helix-loop-helix 1" Q02575 1 160367071-160372846 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.7" "Cell type enhanced" "Detected in some" "Astrocytes: 8.5;Excitatory neurons: 22.5;Inhibitory neurons: 18.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 48.6" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 26.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" "Region enriched" "Detected in some" 12 "cerebellum: 19.1" HPA017943 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA017943: AB_2732421" "unprognostic (6.95e-2)" "unprognostic (3.02e-1)" "unprognostic (3.81e-1)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-2)" "unprognostic (7.06e-2)" "unprognostic (1.96e-2)" "unprognostic (4.21e-8)" "unprognostic (4.09e-2)" "unprognostic (2.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.36e-1)" 0.2 0.1 1.5 0.1 1.7 0.0 0.1 1.5 1.7 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 1.6 1.2 0.1 0.2 0.2 0.0 2.3 2.7 1.2 0.1 0.1 0.0 0.3 0.0 1.7 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.2 0.0 2.7 0.6 0.1 0.3 1.7 0.6 0.1 0.0 0.0 0.1 0.1 2.0 0.0 0.1 2.6 0.0 0.6 0.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 1.2 0.5 0.2 0.6 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.4 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.0 26.3 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.3 0.0 1.9 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 1.5 1.7 1.6 1.2 2.3 2.7 1.2 1.7 2.7 1.7 2.0 0.5 0.0 0.0 8.5 0.5 0.3 0.0 0.1 0.6 0.9 0.5 0.8 0.7 0.0 0.1 0.0 2.1 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.3 0.3 1.8 0.0 22.5 0.2 0.1 0.2 0.0 0.5 0.0 0.2 0.4 0.0 0.2 3.3 18.6 0.6 0.0 1.9 0.6 0.0 0.3 1.1 0.0 9.4 0.4 0.2 0.0 16.6 48.6 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 1.4 0.0 0.5 0.1 1.1 0.6 0.3 0.0 0.3 0.2 0.2 0.0 0.1 SLFNL1 FLJ23878 ENSG00000171790 "Schlafen like 1" Q499Z3 1 41015597-41023237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "testis: 76.6" "Group enriched" "Detected in some" 76 "Early spermatids: 217.4;Late spermatids: 668.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054956 Approved Cytosol NA NA Cytosol "HPA054956: AB_2682649" "unprognostic (7.01e-3)" "unprognostic (1.62e-1)" "unprognostic (1.54e-3)" "unprognostic (4.35e-2)" "unprognostic (3.39e-1)" "unprognostic (4.11e-4)" "unprognostic (8.98e-3)" "unprognostic (1.02e-3)" "unprognostic (8.40e-3)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.71e-4)" "unprognostic (2.70e-3)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (3.26e-1)" "unprognostic (2.43e-1)" 0.2 0.3 1.1 0.2 1.0 0.5 0.2 1.4 1.6 1.0 2.3 0.7 0.3 1.0 0.0 0.3 1.1 0.2 0.4 1.0 0.9 0.7 1.6 2.0 0.3 1.0 0.8 1.0 1.4 0.7 0.0 0.9 0.1 1.2 1.4 0.0 0.6 4.2 0.2 0.3 0.3 1.1 0.0 0.7 0.4 0.4 76.6 0.8 0.0 0.7 0.0 0.0 0.7 0.6 1.0 0.5 0.8 0.4 0.6 0.0 0.1 2.5 1.1 0.0 0.0 0.0 5.4 0.5 0.9 0.9 0.0 0.2 0.9 0.0 0.0 0.0 0.7 1.5 0.7 1.5 0.7 0.3 1.0 0.6 0.1 0.1 0.0 0.0 0.2 0.1 0.8 0.6 1.1 0.0 0.4 0.6 1.1 0.9 0.1 1.3 1.3 0.6 0.6 0.0 1.4 0.6 0.3 0.2 0.5 0.4 0.4 0.3 0.6 0.4 1.0 1.2 0.5 0.8 0.6 0.3 1.1 0.1 1.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 1.4 1.6 1.0 0.9 1.0 0.8 1.0 1.2 0.7 0.8 1.0 0.1 0.0 5.1 0.3 0.0 0.3 0.1 0.0 0.0 0.7 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 217.4 0.1 0.2 0.2 0.0 0.0 2.2 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.3 668.9 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.4 0.0 0.0 2.2 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 5.8 2.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2 apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 271.6;Inhibitory neurons: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 18 "B-cells: 5.4;T-cells: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: AB_2682776" "unprognostic (1.11e-3)" "prognostic favorable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favorable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (2.63e-1)" 12.9 1.9 5.5 10.3 7.0 5.0 9.7 5.4 3.9 10.6 0.0 6.0 4.4 11.7 2.9 5.9 11.9 6.5 5.4 2.9 7.5 6.7 2.1 3.7 14.8 11.8 7.1 2.0 14.7 3.1 13.1 4.7 4.6 7.6 6.4 5.5 2.1 3.7 7.0 16.7 4.6 8.2 6.6 8.6 18.0 3.9 1.5 7.8 18.4 24.2 8.9 14.7 5.4 7.8 6.1 1.7 0.3 6.8 5.9 6.7 1.3 2.4 1.0 0.7 2.4 2.0 3.5 0.4 0.3 1.1 0.9 4.7 0.4 6.7 0.9 1.5 44.2 1.6 0.5 2.0 0.7 2.0 43.7 5.6 1.7 0.8 3.3 5.8 1.1 0.7 4.3 0.8 72.9 2.2 1.4 9.8 10.7 1.5 0.8 1.3 39.5 1.9 26.5 7.4 8.5 7.2 6.4 0.3 0.3 8.5 1.4 0.3 29.9 0.3 9.9 3.3 0.9 5.1 217.4 40.1 2.9 1.9 24.9 6.0 0.3 0.0 0.0 1.9 0.0 7.6 5.4 6.3 3.4 0.1 3.1 3.3 3.2 0.0 0.2 0.3 0.2 8.5 1.3 5.5 7.0 5.4 3.9 2.9 7.5 11.8 7.1 2.0 7.6 8.6 7.8 6.1 7.1 0.0 1.1 271.6 84.9 19.5 33.6 1.6 13.6 1.9 39.7 19.7 17.4 18.6 2.4 7.3 0.0 14.0 39.9 2.7 15.6 3.7 0.4 9.8 9.8 5.9 5.4 3.8 60.7 0.0 0.7 15.8 5.6 24.9 15.8 38.8 3.9 1.2 9.4 0.0 102.3 10.5 24.4 15.0 29.6 1.9 8.7 29.0 46.2 88.1 19.7 18.8 18.6 76.4 56.7 0.2 5.9 13.9 50.1 41.6 0.9 18.0 0.1 0.6 26.3 48.8 19.7 0.3 1.3 6.2 17.6 49.1 76.1 24.1 9.8 76.2 RHNO1 "C12orf32, HKMT1188, MGC13204, RHINO" ENSG00000171792 "RAD9-HUS1-RAD1 interacting nuclear orphan 1" Q9BSD3 12 2876258-2889524 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes "unprognostic (3.90e-2)" "unprognostic (4.86e-2)" "unprognostic (6.48e-3)" "unprognostic (1.86e-1)" "unprognostic (5.15e-2)" "unprognostic (3.59e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.15e-2)" "unprognostic (1.19e-2)" "unprognostic (1.12e-3)" "unprognostic (4.83e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (5.74e-13)" "unprognostic (1.97e-1)" "unprognostic (1.64e-1)" "unprognostic (2.54e-2)" "unprognostic (4.53e-2)" 5.5 8.9 12.1 13.2 10.6 17.2 12.3 11.2 13.0 13.2 14.3 14.2 11.1 11.7 22.9 17.6 12.3 10.8 7.2 11.8 13.1 9.1 5.2 9.3 19.7 9.6 11.0 9.6 15.8 8.7 13.7 12.1 11.7 12.3 13.5 14.6 13.1 12.2 12.8 6.6 13.8 10.2 11.6 7.3 12.9 10.7 11.4 12.0 25.9 16.7 4.0 21.1 12.5 10.7 16.4 42.3 54.2 64.5 32.9 14.8 18.6 67.7 40.7 43.3 51.0 50.1 66.3 91.4 34.5 22.8 42.4 64.2 32.4 43.0 50.9 62.4 138.6 28.2 45.0 25.3 39.6 20.0 50.8 33.4 18.4 32.4 50.3 104.8 36.7 52.5 71.8 41.1 81.2 61.3 60.9 92.8 28.5 149.7 52.8 32.4 61.6 77.7 26.8 41.2 52.3 21.6 32.0 56.1 35.6 30.0 117.7 69.3 47.2 37.1 55.1 83.6 62.6 85.3 18.5 37.9 90.6 25.3 41.8 51.7 23.7 23.3 34.9 23.8 22.0 31.2 27.7 36.4 31.9 26.5 41.9 36.8 24.7 4.8 26.5 23.9 15.8 54.7 25.9 12.1 10.6 11.2 13.0 11.8 13.1 9.6 11.0 9.6 12.3 7.3 12.0 16.4 3.8 0.0 5.9 3.3 14.0 7.8 10.0 27.7 6.2 6.8 11.9 13.3 7.6 7.2 10.4 11.0 8.4 40.1 6.5 7.2 23.5 13.9 6.5 8.1 7.0 8.7 10.3 33.2 6.6 8.4 34.0 8.2 7.1 9.0 14.0 17.4 12.5 3.9 31.7 10.1 6.4 16.3 14.2 15.5 8.0 14.6 12.2 10.2 3.6 2.8 32.3 20.4 10.3 3.0 6.5 6.9 9.6 8.6 11.4 18.1 13.2 15.4 6.4 9.8 0.0 3.1 7.5 67.1 46.0 18.8 7.1 21.8 17.3 8.4 17.3 12.5 CTPS1 "CTPS, GATD5" ENSG00000171793 "CTP synthase 1" P17812 1 40979688-41012565 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 74.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017111, HPA051322" Enhanced Approved "Actin filaments,Cytosol" NA Yes 150000 Cytosol "Actin filaments" "CAB017111: , HPA051322: AB_2681441" "unprognostic (6.60e-2)" "unprognostic (4.44e-2)" "unprognostic (3.21e-2)" "unprognostic (2.00e-3)" "unprognostic (2.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.42e-2)" "unprognostic (9.72e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (2.04e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-1)" "unprognostic (8.21e-3)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" "unprognostic (1.89e-2)" 9.2 8.1 5.0 11.2 5.1 6.8 6.8 4.5 5.9 9.3 7.8 8.8 4.4 23.8 5.8 15.0 11.2 10.7 5.3 5.1 5.4 12.5 74.0 7.7 12.5 5.0 5.3 5.1 3.4 4.7 48.0 0.0 7.8 5.6 13.7 12.1 2.4 51.0 25.0 7.8 4.6 8.4 52.3 4.7 5.0 4.1 14.9 5.6 17.5 4.8 7.6 17.9 17.9 0.3 6.4 77.8 68.5 95.3 60.5 22.9 30.9 138.5 138.8 57.0 141.2 92.0 131.5 66.6 149.8 55.6 61.7 39.4 38.6 91.5 97.0 139.5 66.5 78.0 87.3 72.3 43.3 87.8 128.0 56.8 34.0 49.2 148.5 103.0 23.0 64.1 102.2 84.7 51.5 99.4 42.9 125.0 38.1 126.8 66.4 81.3 100.9 120.0 93.7 71.4 69.4 118.4 61.7 79.2 77.7 33.9 90.8 30.1 152.9 53.5 78.2 119.6 61.7 167.2 36.8 50.8 134.5 59.8 84.5 97.4 0.0 3.5 0.0 3.6 6.5 5.7 5.2 4.1 4.3 11.0 4.0 3.7 6.1 0.0 6.9 5.9 11.9 6.3 3.4 5.0 5.1 4.5 5.9 5.1 5.4 5.0 5.3 5.1 5.6 4.7 5.6 6.4 5.4 6.4 18.4 4.9 10.9 8.0 14.3 9.1 9.6 12.5 4.6 4.7 5.7 21.5 7.0 5.5 6.2 15.4 26.4 2.2 1.9 19.2 32.4 4.7 10.8 8.5 3.0 22.5 14.1 17.2 26.4 8.7 7.1 7.3 1.3 15.8 2.2 29.0 11.0 11.8 18.7 3.4 6.1 2.8 6.2 27.9 10.8 6.8 1.8 7.5 8.7 5.4 7.2 7.1 10.3 19.3 1.1 24.8 15.1 19.3 25.2 12.8 2.8 4.3 39.5 9.3 17.5 11.1 40.6 11.8 7.4 5.6 9.9 20.7 5.8 7.3 UTF1 ENSG00000171794 "Undifferentiated embryonic cell transcription factor 1" Q5T230 10 133230217-133231558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 6.0" "Group enriched" "Detected in some" 5 "Langerhans cells: 42.1;Spermatogonia: 40.0" "Cancer enriched" "Detected in single" 243 "testis cancer: 49.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "NTERA-2: 5.5;RPMI-8226: 2.0" CAB022384 Enhanced NA NA "CAB022384: " "unprognostic (9.19e-2)" "unprognostic (1.95e-1)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-3)" "unprognostic (2.88e-1)" "unprognostic (3.82e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.9 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.0 42.1 1.1 0.3 7.0 0.0 0.0 4.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 40.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160219-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0;pituitary gland: 27.7" "Cell type enhanced" "Detected in many" "Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 0.7 13.8 31.4 0.1 17.5 0.0 0.2 7.2 45.0 2.0 0.0 0.2 0.0 2.8 0.7 0.2 9.0 0.2 0.2 17.1 7.5 0.8 6.6 2.8 0.0 18.7 13.3 21.8 8.6 0.5 0.4 27.7 0.4 12.5 1.1 0.0 0.9 0.6 0.9 0.0 0.2 0.2 0.4 1.9 0.5 0.3 1.8 24.9 0.0 2.5 0.0 0.0 0.3 1.0 13.3 0.2 0.3 0.2 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.2 0.0 1.2 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 31.4 17.5 7.2 45.0 17.1 7.5 18.7 13.3 21.8 12.5 1.9 24.9 13.3 0.0 0.0 9.0 93.4 0.2 0.0 0.1 0.4 0.0 1.6 0.2 0.0 2.4 1.5 4.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 14.2 1.5 0.2 3.0 0.0 41.9 0.0 0.1 1.4 0.0 0.3 0.0 1.5 0.4 4.6 0.2 1.7 36.3 0.0 0.0 1.0 0.4 1.0 3.7 1.2 0.0 5.6 0.3 4.5 0.0 6.6 2.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 25.9 1.0 0.0 0.1 0.5 0.0 1.7 0.0 0.3 0.1 0.4 1.2 0.0 0.0 WDR87 NYD-SP11 ENSG00000171804 "WD repeat domain 87" Q6ZQQ6 19 37884823-37906677 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "testis: 17.1" "Group enriched" "Detected in some" 5 "Early spermatids: 33.1;Spermatocytes: 114.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.37e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (1.89e-2)" "unprognostic (2.60e-1)" "unprognostic (4.22e-1)" "unprognostic (5.43e-2)" "unprognostic (2.58e-2)" "unprognostic (1.78e-8)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" "unprognostic (5.48e-2)" "unprognostic (4.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.1 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 114.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 METTL18 "AsTP2, C1orf156, HPM1, MGC9084" ENSG00000171806 "Methyltransferase like 18" O95568 1 169792529-169794963 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035314 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035314: AB_10601146" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (5.67e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (3.65e-1)" "unprognostic (3.06e-2)" "unprognostic (3.03e-2)" "prognostic favorable (3.28e-4)" 5.6 5.4 5.6 6.2 6.0 4.0 10.6 6.8 6.8 5.8 6.2 6.6 5.3 6.1 8.8 5.3 7.5 4.8 6.1 5.2 5.8 7.4 6.2 5.6 14.2 5.7 5.9 5.1 9.3 4.9 22.5 3.4 6.1 5.9 6.9 6.3 7.4 6.4 5.9 4.4 6.2 6.1 5.1 6.0 8.9 7.4 6.5 5.7 10.4 9.1 6.9 11.7 5.7 3.8 6.9 13.0 7.5 11.6 8.3 6.6 12.2 8.6 5.9 6.9 7.8 6.6 9.6 20.7 22.2 16.2 7.7 10.8 14.5 11.5 13.6 9.9 14.0 9.9 15.9 6.6 8.0 13.7 16.9 7.2 5.6 14.2 7.5 8.1 7.6 14.2 16.8 17.1 10.8 10.1 6.3 18.0 11.1 14.9 27.7 18.7 13.0 12.0 16.8 11.7 12.9 8.6 13.4 13.2 14.4 18.2 17.1 19.3 18.1 6.7 9.3 9.0 9.9 13.8 19.8 27.6 29.9 7.1 13.4 9.9 18.2 9.5 23.1 24.8 10.6 31.7 21.6 27.1 28.8 10.0 24.2 31.8 30.9 5.5 24.0 6.6 7.7 34.5 18.3 5.6 6.0 6.8 6.8 5.2 5.8 5.7 5.9 5.1 5.9 6.0 5.7 6.9 5.8 3.2 4.6 1.0 9.5 1.5 6.1 10.8 1.8 7.4 4.6 5.2 5.0 2.8 8.5 5.5 0.0 13.7 4.5 3.7 25.4 12.1 16.9 3.7 5.1 8.3 3.0 8.6 1.4 8.0 5.5 5.5 2.0 2.8 7.0 13.4 7.5 2.9 7.7 6.7 1.9 3.6 10.2 5.9 3.2 5.4 6.2 3.7 5.4 2.8 2.6 12.0 14.4 1.5 4.0 5.3 5.7 5.3 2.5 3.1 5.7 11.6 10.9 8.5 0.0 6.1 6.5 16.7 10.2 2.4 0.9 11.5 10.1 10.0 5.5 4.2 CFAP46 "bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40" ENSG00000171811 "Cilia and flagella associated protein 46" Q8IYW2 10 132808392-132942823 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 18.2;skeletal muscle: 33.8;testis: 42.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 95.9;Endometrial ciliated cells: 70.8;Excitatory neurons: 42.8;Respiratory ciliated cells: 59.0;Rod photoreceptor cells: 74.4;Spermatocytes: 53.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037786, HPA038034, HPA038867, HPA038868" Uncertain NA NA "HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247" "unprognostic (2.83e-2)" "unprognostic (4.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.83e-1)" "unprognostic (4.11e-1)" "unprognostic (5.40e-2)" "unprognostic (6.41e-3)" "unprognostic (1.39e-1)" "unprognostic (1.64e-4)" "unprognostic (1.21e-2)" "unprognostic (8.08e-2)" "unprognostic (4.56e-3)" "unprognostic (2.08e-2)" 0.0 0.2 12.9 0.0 6.6 0.0 0.1 5.9 10.1 0.9 18.2 0.0 0.1 0.1 1.3 0.2 16.3 0.1 0.6 5.3 5.5 1.0 0.2 3.4 0.0 10.2 12.8 4.7 0.2 0.4 1.1 2.2 0.0 7.4 0.2 0.0 3.9 0.4 0.4 33.8 0.1 0.1 0.0 11.2 0.1 2.4 42.1 6.7 0.0 4.2 10.8 0.0 0.0 0.0 4.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 12.9 6.6 5.9 10.1 5.3 5.5 10.2 12.8 4.7 7.4 11.2 6.7 4.4 0.2 0.0 4.8 9.8 0.3 0.0 0.5 0.0 0.6 6.3 1.3 1.1 3.7 0.0 9.3 7.3 95.9 0.0 0.0 0.0 5.9 4.8 18.0 70.8 0.9 0.9 0.0 0.0 42.8 0.2 0.0 1.5 5.1 1.5 3.8 4.3 5.0 0.2 0.6 1.7 22.0 0.0 0.0 0.6 0.0 11.3 1.2 0.3 0.0 1.0 0.0 4.7 0.0 2.0 0.9 1.6 0.0 2.2 0.2 0.7 0.0 5.6 59.0 74.4 0.0 0.4 0.4 53.7 7.2 0.7 0.0 0.0 0.3 7.3 0.0 0.6 COL8A2 "FECD, FECD1, PPCD, PPCD2" ENSG00000171812 "Collagen type VIII alpha 2 chain" P25067 1 36095239-36125222 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 10.2;Cardiomyocytes: 13.5;Fibroblasts: 13.4;Macrophages: 6.8;Melanocytes: 7.2;Microglial cells: 8.4;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.8;fHDF/TERT166: 4.3;HHSteC: 14.1;hTERT-RPE1: 18.2;THP-1: 4.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "spinal cord: 3.6" HPA049788 Uncertain Uncertain "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA049788: AB_2680882" "unprognostic (9.98e-2)" "unprognostic (3.26e-2)" "unprognostic (2.51e-2)" "unprognostic (8.41e-3)" "unprognostic (8.76e-2)" "prognostic favorable (9.44e-4)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (3.50e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.08e-2)" "unprognostic (6.77e-2)" "unprognostic (2.24e-2)" "unprognostic (1.16e-3)" 4.4 1.2 3.5 4.4 2.6 0.5 5.7 5.6 2.5 8.5 15.4 4.7 1.4 5.7 1.6 5.9 4.2 4.8 3.5 2.3 6.6 1.1 0.6 4.7 3.1 8.8 4.5 1.4 3.3 0.8 0.7 4.0 12.9 6.3 6.2 2.0 0.4 7.5 11.5 0.6 5.2 2.4 3.8 6.4 8.5 9.2 0.9 3.5 5.0 7.5 2.1 3.5 13.4 5.9 5.2 0.0 0.0 0.0 0.0 0.5 1.0 0.1 5.8 1.7 1.6 0.9 0.2 0.1 0.0 0.8 4.3 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 14.1 0.0 0.0 1.7 0.1 0.7 0.0 18.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.1 0.1 0.0 0.5 0.5 0.5 0.0 0.2 0.4 0.0 4.7 0.1 2.3 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.5 2.6 5.6 2.5 2.3 6.6 8.8 4.5 1.4 6.3 6.4 3.5 5.2 0.6 0.0 1.8 0.3 0.0 2.2 2.2 1.8 0.0 0.1 1.3 10.2 13.5 0.0 0.7 0.0 0.0 0.4 1.4 0.0 0.0 0.4 0.1 0.2 0.2 0.7 0.0 0.0 0.2 0.2 0.3 13.4 0.5 0.3 2.5 0.5 1.1 0.0 6.2 0.0 0.4 0.0 0.0 2.0 2.7 0.2 3.1 6.8 7.2 8.4 1.2 0.3 0.0 0.5 0.1 0.6 0.0 6.0 0.1 5.3 0.0 0.0 0.2 0.2 6.6 0.7 1.4 0.0 0.3 0.1 1.3 0.8 1.2 0.3 0.0 0.4 PWWP2B "bA432J24.1, FLJ46823, PWWP2" ENSG00000171813 "PWWP domain containing 2B" Q6NUJ5 10 132397168-132417859 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 56.2;MCF7: 44.5;SK-BR-3: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038056, HPA038502, HPA078118" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: " "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (1.11e-2)" "unprognostic (1.30e-2)" "unprognostic (5.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.67e-2)" "unprognostic (8.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-1)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "prognostic favorable (5.75e-4)" "unprognostic (4.77e-2)" "unprognostic (1.46e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" 9.7 31.2 9.1 3.3 12.8 2.4 10.2 3.5 10.2 9.3 7.9 15.5 4.8 10.4 1.0 22.3 9.4 2.0 10.5 10.2 6.3 9.9 5.9 11.1 2.9 8.1 6.6 7.5 8.4 38.4 6.5 14.6 4.2 7.1 11.4 2.3 1.9 15.5 3.9 22.5 15.1 10.7 1.2 4.4 27.4 16.5 17.5 8.1 1.0 13.6 5.2 1.7 12.2 12.3 6.3 21.9 12.9 1.6 8.2 1.2 1.0 56.2 2.6 2.6 1.5 1.4 5.8 12.4 0.0 8.8 1.6 3.2 22.9 2.3 3.1 0.2 16.5 6.4 2.5 12.4 5.7 5.8 7.2 9.3 0.8 8.0 0.9 2.3 1.3 1.2 2.9 4.3 1.8 1.0 44.5 0.2 27.0 2.5 8.5 9.5 5.2 0.1 5.0 0.7 16.3 10.4 12.9 1.7 33.1 6.9 1.6 10.2 17.5 4.3 0.8 4.4 4.0 1.8 0.4 0.2 4.5 5.0 6.4 1.6 0.0 1.6 2.6 1.3 3.5 1.0 0.9 0.7 0.8 1.5 3.3 0.5 0.5 0.3 5.4 5.3 0.9 0.0 0.8 9.1 12.8 3.5 10.2 10.2 6.3 8.1 6.6 7.5 7.1 4.4 8.1 6.3 5.8 22.4 11.0 2.3 18.0 17.6 14.0 5.8 9.1 7.3 13.5 11.0 5.4 14.3 10.2 9.2 8.4 31.8 12.1 33.5 13.7 15.0 33.0 29.5 4.7 7.1 25.3 2.1 4.3 22.0 47.4 4.1 16.3 19.9 2.5 13.6 13.2 1.6 13.1 15.2 3.8 29.1 10.2 12.6 17.2 70.8 3.7 13.3 14.2 5.6 7.3 3.1 6.2 2.0 0.2 10.6 25.5 2.2 2.2 16.3 5.5 1.5 29.4 14.9 0.0 3.9 5.0 1.2 1.6 8.8 20.3 52.9 7.8 17.4 19.4 31.8 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051374-141059346 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.2 0.5 0.1 0.5 0.4 0.0 0.8 0.6 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.1 0.5 0.3 0.3 0.1 0.1 0.2 0.5 0.4 0.5 0.1 0.4 0.3 0.5 0.1 0.7 0.1 0.0 0.5 0.2 0.0 1.4 0.3 0.2 0.0 0.2 0.2 0.3 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.5 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.5 0.5 0.8 0.6 0.5 0.3 0.5 0.4 0.5 0.7 0.2 0.3 0.5 0.0 0.0 1.1 0.0 0.4 0.0 0.9 0.0 0.0 0.3 0.1 0.0 2.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.2 0.4 0.0 1.2 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 26.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.3;Excitatory neurons: 47.7;Inhibitory neurons: 56.5;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 27.7;Rod photoreceptor cells: 22.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 3.0" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 1.5 5.0 9.9 2.3 10.8 0.6 3.2 14.6 11.6 4.9 7.3 3.6 2.2 3.3 4.8 1.7 3.9 1.9 5.3 9.7 11.8 4.4 2.2 2.6 3.8 8.9 9.4 10.1 8.5 2.5 5.3 14.8 1.2 10.0 5.6 1.8 26.0 3.5 4.6 2.0 3.2 4.2 1.8 7.4 4.7 3.3 2.9 11.1 2.1 7.9 1.6 3.4 3.7 3.5 10.6 0.1 0.0 1.1 1.3 3.0 1.8 0.1 0.4 0.4 0.5 0.9 0.1 0.0 0.5 0.1 1.1 0.3 0.4 0.8 0.4 0.4 1.7 1.2 0.4 0.8 0.0 0.8 0.5 0.9 0.9 1.1 0.3 0.0 0.2 0.0 2.4 0.2 0.0 0.7 0.0 0.8 0.3 0.4 0.1 0.2 0.7 0.7 0.4 0.2 0.1 1.2 1.4 0.4 0.1 0.1 0.8 0.6 0.5 0.0 0.4 1.4 0.5 0.4 1.6 1.0 1.3 0.0 0.2 0.2 0.0 0.0 0.8 2.7 0.0 2.6 1.9 2.7 3.0 0.1 2.2 4.4 4.8 0.1 2.4 0.0 0.2 3.1 1.2 9.9 10.8 14.6 11.6 9.7 11.8 8.9 9.4 10.1 10.0 7.4 11.1 10.6 2.3 3.2 2.6 15.3 6.3 1.7 1.3 0.8 3.4 23.3 2.4 2.2 10.4 0.0 1.7 1.8 6.2 0.3 3.3 0.2 7.9 0.3 18.6 1.1 1.0 2.2 0.0 0.0 47.7 0.4 0.4 2.8 1.5 0.6 3.8 1.7 2.2 1.1 0.8 18.5 56.5 0.3 0.0 0.8 1.0 5.5 2.5 1.0 3.6 11.2 0.5 5.5 8.2 23.1 27.7 0.2 1.1 5.7 2.5 0.4 2.3 2.7 0.4 22.3 6.6 3.1 2.9 5.7 3.3 1.8 1.3 0.1 3.9 1.2 0.3 0.2 ANGPTL7 "AngX, CDT6" ENSG00000171819 "Angiopoietin like 7" O43827 1 11189355-11195981 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 4.1;Enteroendocrine cells: 1.8;Fibroblasts: 6.9;Melanocytes: 3.6;Microglial cells: 1.9" "Cancer enriched" "Detected in some" 14 "melanoma: 18.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 65 "SCLC-21H: 41.4" "Not detected" "Not detected" "Region enriched" "Detected in all" 13 "spinal cord: 62.2" "Secreted in other tissues" NA NA 1100000 "unprognostic (3.23e-2)" "unprognostic (6.95e-2)" "unprognostic (1.22e-1)" "unprognostic (2.67e-3)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.89e-2)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (1.58e-2)" "unprognostic (3.41e-3)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" 11.6 2.3 0.2 1.3 0.2 0.0 5.3 1.8 1.0 3.9 0.1 6.1 0.8 0.5 2.2 2.3 2.2 3.8 7.2 0.1 0.3 2.6 0.1 1.3 0.0 0.3 0.5 0.1 0.4 0.4 0.0 4.2 0.6 0.6 4.3 1.5 0.2 2.4 6.7 7.9 5.0 1.8 1.9 0.0 0.3 2.3 0.2 2.2 0.3 0.7 5.8 0.2 4.2 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 1.0 0.1 0.3 0.3 0.5 0.1 0.6 0.0 2.2 0.3 0.1 3.2 0.0 0.3 0.0 0.1 0.1 0.0 1.2 0.1 0.2 0.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.3 0.0 0.0 6.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 1.9 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594581 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 47.4;Late spermatids: 103.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: AB_2682293" "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favorable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 5.1 4.3 9.2 5.9 9.0 5.9 4.6 8.4 21.8 3.6 6.6 7.9 4.9 4.5 1.6 6.0 5.8 4.9 4.9 13.0 7.5 4.6 4.0 5.7 7.6 9.3 7.9 8.1 4.8 11.4 7.1 8.8 4.2 8.4 3.7 3.5 4.2 6.3 4.1 3.4 3.4 6.3 2.1 7.1 6.5 9.7 21.3 8.9 8.4 6.4 2.5 3.3 4.7 4.4 9.4 11.8 16.3 4.8 8.4 4.0 4.1 14.3 2.6 4.7 2.4 2.7 17.1 14.8 15.8 3.1 2.9 4.0 8.1 3.9 6.0 0.4 27.2 19.0 19.6 4.7 5.5 5.3 15.0 14.4 6.5 2.7 4.4 3.7 4.3 4.3 13.4 8.3 43.2 2.9 12.4 15.9 7.4 21.2 6.4 6.7 13.5 7.8 9.9 3.8 10.3 9.2 9.1 6.3 9.5 9.8 4.9 7.5 12.1 6.4 5.3 17.5 6.8 9.5 5.3 6.1 19.7 11.3 8.7 8.2 0.7 0.1 0.0 0.1 0.1 0.1 0.2 0.4 0.4 0.2 1.7 0.4 0.2 0.3 0.6 0.2 0.2 1.6 0.1 9.2 9.0 8.4 21.8 13.0 7.5 9.3 7.9 8.1 8.4 7.1 8.9 9.4 1.9 0.0 0.0 11.4 1.1 0.0 0.3 0.5 1.8 4.2 1.1 0.9 0.9 0.0 0.3 0.0 0.0 0.2 0.5 1.6 0.0 0.2 47.4 1.7 0.8 2.3 0.0 0.4 12.3 0.5 0.1 1.3 1.5 0.9 0.0 0.5 2.9 1.1 0.6 10.1 13.4 0.7 2.0 0.8 0.8 103.7 0.3 1.2 0.0 12.2 0.8 2.7 0.0 10.6 17.1 0.1 0.7 1.5 1.8 0.8 1.4 0.8 1.0 3.0 0.0 1.7 1.1 10.4 0.5 2.9 0.0 0.1 1.8 0.9 1.2 0.3 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099869 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 29.5 21.6 18.0 26.2 17.8 39.8 31.0 22.6 22.3 31.5 14.2 27.1 20.8 28.9 24.1 27.6 26.6 19.4 20.2 17.8 16.2 21.9 20.2 24.5 31.4 17.3 16.2 16.5 36.1 24.2 25.4 26.3 26.4 18.0 25.5 27.9 35.7 25.6 21.2 33.5 37.3 26.3 27.7 12.6 27.6 26.3 23.7 16.3 33.0 23.5 22.8 34.5 24.8 28.6 18.4 66.4 41.5 84.9 33.0 44.3 48.7 48.5 63.8 46.8 109.8 99.1 61.6 94.1 66.3 40.3 61.0 48.8 64.2 95.0 71.2 100.1 74.9 95.0 96.5 80.5 63.2 43.4 79.5 73.7 38.4 60.2 108.1 63.1 40.9 69.4 58.0 103.2 59.3 61.4 37.4 78.5 73.1 56.5 50.3 49.1 79.8 72.2 58.1 64.8 33.3 54.5 53.3 68.8 58.9 77.0 59.4 51.5 72.1 63.6 58.2 60.4 53.0 76.2 35.7 60.0 130.0 59.4 116.2 71.5 57.7 32.0 26.6 36.2 41.5 43.0 36.4 37.7 36.7 37.9 36.5 31.9 35.4 6.2 49.3 51.2 19.3 39.4 43.3 18.0 17.8 22.6 22.3 17.8 16.2 17.3 16.2 16.5 18.0 12.6 16.3 18.4 18.4 28.9 18.3 17.0 26.1 13.3 14.3 19.8 26.2 14.9 11.0 23.6 6.4 12.8 29.2 5.5 47.9 26.5 18.8 16.4 9.8 25.0 16.4 14.3 21.0 20.1 9.0 28.0 20.3 31.9 34.3 17.2 31.1 19.2 20.2 26.2 13.9 11.1 24.7 21.9 24.3 16.5 22.4 15.1 14.1 7.1 29.5 18.7 12.4 9.4 24.0 6.1 28.8 30.2 15.2 30.2 9.4 23.0 26.8 8.5 12.7 8.8 27.3 34.8 13.1 18.4 17.6 21.9 20.8 28.7 13.4 22.7 21.2 19.7 20.1 10.0 ZNF570 FLJ30791 ENSG00000171827 "Zinc finger protein 570" Q96NI8 19 37467585-37488652 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 56.0;Horizontal cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028881 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA028881: AB_10603938" "unprognostic (2.93e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-2)" "unprognostic (1.24e-1)" "unprognostic (1.70e-2)" "unprognostic (1.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (6.54e-2)" "unprognostic (4.59e-2)" "prognostic favorable (4.06e-5)" "unprognostic (5.30e-2)" "unprognostic (2.85e-2)" "unprognostic (3.12e-2)" "unprognostic (2.20e-3)" 2.1 2.5 2.6 1.7 3.2 2.2 2.9 3.5 3.0 2.2 2.0 1.4 1.9 2.5 2.1 2.3 2.0 2.2 2.5 2.8 3.1 2.8 1.8 2.0 2.7 2.9 3.3 2.4 3.4 1.6 4.1 1.8 2.1 3.0 2.9 1.2 3.2 2.4 2.1 2.0 1.8 1.5 2.3 3.1 2.4 2.1 6.0 3.0 2.4 3.2 2.9 2.4 1.9 1.3 3.7 1.5 2.0 2.7 8.3 3.6 4.4 1.3 2.9 1.5 2.7 3.6 0.0 0.6 0.3 3.9 2.1 1.6 0.3 2.4 1.8 3.2 1.6 1.7 2.0 0.2 0.9 2.5 0.1 4.2 3.8 1.7 1.8 0.0 2.5 2.6 3.2 0.3 0.1 2.9 0.5 4.8 1.5 1.7 0.1 0.8 0.8 2.8 1.6 2.2 2.3 2.5 5.2 0.0 0.0 1.0 3.3 1.6 2.2 1.4 1.1 2.1 1.8 2.1 4.4 4.2 2.1 0.0 0.2 2.2 0.7 0.7 0.9 1.3 1.3 1.0 1.6 2.1 0.9 0.7 1.4 1.7 1.8 1.4 1.8 0.5 0.7 1.3 0.9 2.6 3.2 3.5 3.0 2.8 3.1 2.9 3.3 2.4 3.0 3.1 3.0 3.7 7.9 6.4 0.5 1.6 5.5 1.7 1.7 0.7 4.6 6.4 5.7 6.0 13.7 5.7 2.8 1.8 10.4 2.6 11.4 1.3 9.8 5.5 56.0 6.5 6.6 7.4 6.0 3.0 2.1 3.8 6.7 6.7 1.1 3.9 6.3 5.7 8.2 2.2 3.3 32.0 2.0 1.7 0.0 2.5 0.7 9.0 5.0 3.5 5.4 0.0 2.5 5.4 8.2 2.5 2.9 2.9 1.1 9.8 2.6 1.8 1.6 3.6 3.4 7.2 0.0 6.7 7.6 11.0 6.6 4.8 0.4 1.4 7.9 4.4 2.1 1.1 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.0" "Cell type enhanced" "Detected in many" "Adipocytes: 29.8;Alveolar cells type 2: 39.9;Erythroid cells: 35.4;Hofbauer cells: 30.7;Kupffer cells: 38.3;Oligodendrocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 153.5;MOLT-4: 263.8;THP-1: 54.4;U-698: 49.3" "Low region specificity" "Detected in all" "HPA058980, HPA067226" Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol" "HPA058980: AB_2683869, HPA067226: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favorable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 18.8 1.9 22.4 11.4 30.6 38.6 16.7 26.6 29.8 7.9 16.6 5.8 5.2 4.3 2.5 9.6 4.1 5.4 11.7 22.6 25.8 1.6 18.8 37.1 14.9 29.6 28.2 20.1 1.0 1.9 0.8 1.5 4.4 30.5 4.3 5.0 0.5 7.5 2.9 38.6 9.8 6.5 5.6 25.5 13.5 4.2 5.6 27.4 8.8 4.0 12.9 11.3 8.6 6.5 47.0 1.7 0.4 0.1 1.8 0.3 0.6 2.9 0.2 0.0 0.0 0.1 3.1 11.8 0.0 0.6 6.1 1.7 0.2 0.2 0.0 0.0 8.6 0.1 153.5 34.2 1.9 0.0 4.3 6.1 2.2 0.2 0.0 0.0 0.0 3.1 3.2 9.0 25.5 0.1 0.1 263.8 8.5 2.6 0.1 0.0 6.8 0.2 0.8 2.7 0.0 0.1 0.0 28.3 0.2 0.0 0.3 0.3 54.4 0.7 0.0 1.5 9.8 0.2 0.1 4.2 49.3 0.4 28.5 0.1 6.7 58.1 48.3 32.8 47.2 9.8 18.8 36.2 34.9 49.9 17.7 7.7 16.7 112.9 21.4 39.4 26.2 157.3 33.4 22.4 30.6 26.6 29.8 22.6 25.8 29.6 28.2 20.1 30.5 25.5 27.4 47.0 29.8 22.4 39.9 0.3 5.3 5.7 0.3 2.5 6.2 0.0 1.3 1.3 1.5 1.5 8.7 0.0 0.0 2.6 8.9 2.1 1.9 0.2 3.1 5.5 1.6 9.4 4.2 35.4 1.7 0.0 3.9 13.5 1.1 1.2 2.5 0.4 4.2 11.2 30.7 0.0 1.0 3.5 0.0 38.3 7.8 3.1 8.1 18.0 7.2 11.2 12.4 0.2 7.2 3.5 109.7 0.8 2.6 4.1 8.1 0.1 2.1 0.2 5.0 0.1 0.0 1.3 1.6 3.3 3.1 7.6 5.5 0.8 12.5 0.1 3.1 0.2 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3 super elongation complex subunit" P42568 9 20341669-20622499 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 5.1;T-cells: 16.3" "Cell line enriched" "Detected in many" 5 "HEL: 316.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 6.8 15.5 12.5 10.1 14.3 37.6 12.8 10.9 17.4 11.8 4.6 29.0 8.2 12.8 10.6 8.9 12.9 14.0 9.0 17.4 10.7 12.4 2.4 12.8 11.4 8.6 8.9 12.0 12.0 4.9 10.2 9.9 12.0 8.8 12.8 38.2 8.3 25.6 12.9 11.2 7.0 15.9 12.4 6.5 7.0 20.2 4.2 10.5 24.5 27.4 11.2 8.3 10.7 6.4 13.0 8.7 24.4 8.4 9.6 19.8 11.7 5.4 22.3 37.8 9.6 11.5 22.8 8.2 36.1 11.9 10.6 3.2 4.4 8.5 38.0 9.2 68.0 23.6 316.4 68.3 12.3 13.8 4.9 20.1 9.4 15.4 3.8 25.3 34.7 9.8 13.8 0.4 42.5 21.7 6.8 24.9 18.6 5.1 50.8 6.8 0.0 15.4 8.8 50.0 13.4 27.2 11.0 18.1 10.2 10.1 8.4 9.3 11.9 6.5 0.0 5.6 6.0 8.3 18.4 18.7 13.1 0.4 10.6 4.8 2.3 0.4 0.6 4.5 0.3 4.3 0.6 8.6 6.5 0.9 1.4 16.3 10.3 0.1 5.1 0.4 0.6 10.8 3.6 12.5 14.3 10.9 17.4 17.4 10.7 8.6 8.9 12.0 8.8 6.5 10.5 13.0 20.0 28.9 30.0 144.6 8.0 8.3 15.9 18.7 21.1 7.8 21.2 12.3 13.5 18.6 32.5 22.0 33.3 0.9 17.3 23.5 13.7 29.2 3.0 10.3 17.5 13.7 33.0 28.4 284.0 8.2 6.1 18.0 23.0 19.5 12.0 8.7 11.4 2.2 2.4 5.0 288.4 112.3 16.2 1.9 6.5 7.4 13.7 7.1 23.2 114.3 2.7 31.9 17.5 254.3 216.6 27.3 23.6 9.4 18.2 14.5 13.8 9.0 11.7 2.2 0.0 25.2 21.6 1.0 10.5 14.2 8.4 1.6 33.3 9.8 27.0 15.7 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.1;Muller glia cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;HDLM-2: 7.6;NTERA-2: 17.6" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.4 2.0 2.1 1.2 3.4 0.4 0.3 1.7 5.1 0.5 0.0 0.4 0.8 1.6 1.3 1.0 1.4 2.4 1.8 4.5 1.4 0.7 0.1 1.3 1.1 3.3 0.0 1.7 4.2 1.8 0.3 1.9 0.6 2.0 1.5 0.1 4.5 2.1 0.7 0.7 2.0 0.5 0.4 0.0 0.9 0.6 1.8 1.3 0.1 2.5 0.1 0.4 0.3 0.4 2.6 0.0 0.0 0.7 1.2 0.2 0.0 4.9 0.3 0.4 0.1 0.0 0.0 2.0 0.3 0.8 0.1 0.2 0.0 3.2 0.0 0.0 7.6 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.4 1.2 0.2 0.1 2.2 0.2 0.7 2.8 0.4 0.0 1.0 0.1 2.5 17.6 0.0 0.0 0.2 0.1 0.0 1.1 0.4 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.8 0.0 0.7 0.0 0.2 0.1 0.3 2.8 0.0 1.8 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 3.4 1.7 5.1 4.5 1.4 3.3 0.0 1.7 2.0 0.0 1.3 2.6 0.2 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.6 0.4 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.5 0.1 0.2 0.2 0.0 0.4 1.4 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.4 0.0 0.3 0.0 1.2 0.5 0.0 0.3 0.0 1.1 0.0 0.2 0.0 0.0 0.1 1.3 0.0 0.5 0.4 0.5 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.4 0.6 0.1 0.0 0.1 0.0 0.4 0.1 RRM2 "C2orf48, FLJ25102" ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10211725 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 44.6;esophagus: 18.5;intestine: 19.9;lymphoid tissue: 58.6" "Group enriched" "Detected in many" 4 "Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056994 Enhanced Supported Cytosol Yes Yes 13000 Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 1.5 1.3 0.5 12.5 0.3 44.6 2.9 0.5 0.4 2.2 1.5 14.4 9.5 2.2 0.7 18.5 0.8 1.1 0.5 0.3 0.5 0.9 3.2 2.4 35.8 0.4 0.4 0.3 0.3 1.1 0.4 0.2 4.6 0.4 0.9 19.9 0.2 2.2 0.5 0.1 3.7 7.6 6.2 0.5 11.2 6.0 2.9 0.7 58.6 0.9 0.1 37.9 6.1 4.6 0.8 110.2 25.0 127.1 49.9 7.4 22.5 116.8 209.2 128.6 170.2 187.9 70.8 59.1 114.4 9.5 88.6 151.1 55.0 188.0 136.6 198.0 210.7 41.8 146.3 52.1 105.1 0.8 146.7 87.4 8.1 3.4 234.6 16.2 27.7 103.3 110.4 63.4 328.6 214.3 57.1 167.3 90.9 83.0 133.3 103.6 87.6 187.0 67.8 87.1 62.7 67.7 56.2 198.0 116.6 17.3 51.8 69.2 31.4 57.6 93.1 125.1 66.9 289.6 212.1 184.9 195.9 51.0 134.4 107.7 0.3 0.1 0.1 1.2 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.1 0.4 0.4 0.8 0.0 0.1 0.2 0.2 0.5 0.3 0.5 0.4 0.3 0.5 0.4 0.4 0.3 0.4 0.5 0.7 0.8 0.2 3.2 1.5 0.0 25.0 10.5 3.0 9.2 1.2 0.0 3.9 4.4 1.4 1.5 2.3 0.0 0.0 42.3 5.6 12.9 1.9 1.2 3.9 2.2 3.5 4.2 0.0 214.0 0.1 0.0 254.1 11.2 11.7 3.6 5.7 12.2 3.9 3.7 47.9 0.0 0.0 26.9 2.0 7.2 8.8 6.8 0.3 5.0 0.0 1.0 0.0 0.0 7.2 0.0 0.0 0.5 0.3 0.4 248.0 1.5 2.4 2.1 4.6 0.0 0.0 0.2 14.6 22.9 34.0 51.5 1.6 48.7 11.9 1.2 36.7 5.6 TRAPPC12 "CGI-87, TTC-15, TTC15" ENSG00000171853 "Trafficking protein particle complex 12" Q8WVT3 2 3379675-3485094 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 97.4" "Cell type enhanced" "Detected in all" "Early spermatids: 293.9;Late spermatids: 504.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034799, HPA043196" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA034799: AB_10600920, HPA043196: " "prognostic favorable (1.80e-5)" "unprognostic (9.21e-2)" "unprognostic (1.01e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-2)" "unprognostic (1.32e-2)" "unprognostic (1.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.27e-1)" "prognostic favorable (9.15e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.53e-1)" "unprognostic (7.18e-2)" 21.7 26.2 12.9 11.0 12.4 10.2 22.0 13.3 23.4 20.2 11.2 25.0 10.2 23.9 6.4 23.2 22.4 10.4 44.5 13.8 13.5 22.8 28.2 17.3 16.2 14.2 12.9 13.4 21.6 26.4 18.5 27.0 6.6 15.6 20.8 4.8 9.2 26.0 10.1 46.2 34.0 21.4 5.3 11.6 22.3 28.7 97.4 12.9 15.8 24.9 6.5 5.0 26.3 19.1 15.2 16.4 28.0 9.1 10.4 19.9 24.5 23.9 26.6 6.5 7.6 4.2 17.5 13.6 18.8 28.6 9.0 6.7 20.8 10.5 11.9 3.1 22.8 39.5 16.2 8.1 60.8 9.0 20.4 28.0 18.1 9.0 8.5 21.2 5.8 6.7 21.5 25.5 10.0 13.5 22.5 20.6 34.9 22.1 7.3 39.4 15.4 12.4 15.3 8.1 13.5 23.2 37.8 10.6 11.8 18.5 4.0 13.9 16.3 17.2 18.6 10.6 18.7 23.6 28.5 22.4 15.0 21.8 15.9 10.5 0.7 1.0 3.8 0.8 2.5 2.0 0.5 1.3 2.2 1.4 0.5 0.8 1.0 1.0 0.9 3.6 4.3 2.5 0.8 12.9 12.4 13.3 23.4 13.8 13.5 14.2 12.9 13.4 15.6 11.6 12.9 15.2 18.8 9.6 12.8 59.4 20.7 11.5 16.2 15.1 14.2 31.8 13.7 16.0 68.4 21.5 11.2 12.9 33.3 21.3 16.9 17.1 58.7 21.7 293.9 20.3 16.4 18.5 3.5 19.1 56.2 18.0 15.2 23.7 23.0 14.5 5.7 22.3 11.0 16.0 25.9 26.9 62.5 17.7 14.2 17.9 10.0 504.5 26.4 20.7 16.0 30.0 28.5 42.6 15.5 52.3 56.4 23.9 11.9 24.0 19.6 16.0 20.3 30.0 19.4 42.0 26.3 20.9 21.7 125.2 26.3 18.8 17.8 17.6 14.4 33.8 15.7 12.2 IFNB1 "IFB, IFF, IFNB" ENSG00000171855 "Interferon beta 1" P01574 9 21077104-21077942 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "Hofbauer cells: 2.2;Macrophages: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+ SV40 Large T+ RasG12V: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073843 Supported "Secreted to blood" NA NA 3750 "HPA073843: " "unprognostic (2.38e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 RPS21 S21 ENSG00000171858 "Ribosomal protein S21" P63220 20 62387103-62388520 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003371 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 250000 "Endoplasmic reticulum, Cytosol" "HPA003371: AB_1079846" "unprognostic (1.92e-2)" "unprognostic (1.41e-1)" "unprognostic (1.31e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.46e-4)" "unprognostic (6.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "unprognostic (4.60e-1)" 1558.6 1428.5 1284.0 796.7 1289.9 2412.7 1893.4 1273.4 1786.4 2057.5 1264.9 1504.7 752.7 1471.9 555.6 2081.0 1818.6 469.6 991.6 1262.0 1294.0 1251.5 1097.1 1160.8 1526.3 1259.2 1268.3 1263.1 3207.8 2461.9 531.8 976.4 566.2 1282.1 1420.6 635.8 212.0 1483.7 514.5 2151.0 2844.3 1605.4 423.8 1317.9 1851.4 1594.4 480.1 1283.5 1524.5 1182.0 881.6 990.8 1515.7 1916.1 1321.7 2398.5 2358.8 1184.4 2320.2 1321.3 2309.7 1609.5 1472.3 1141.8 3554.0 1348.8 7961.3 3131.7 2835.0 3019.8 1156.5 1283.3 3239.7 1343.1 4099.0 1252.7 729.2 3445.4 4723.0 3120.5 6137.2 2650.8 3692.8 2066.1 2581.1 5669.7 1370.4 2496.5 1451.4 1705.6 3116.1 2436.0 2351.9 1269.6 3506.2 4242.3 5294.5 1862.4 4129.5 7157.1 2799.7 3043.3 4437.6 1745.8 2581.8 2240.7 2206.7 1508.4 6850.0 3365.8 753.9 2935.2 4792.0 1810.4 2182.4 2852.5 1853.4 2993.0 3660.0 4580.0 3219.1 2607.4 2209.6 1179.5 379.7 1000.3 242.1 1322.7 872.6 1890.4 2692.5 2242.4 1753.8 1447.0 2532.7 2648.9 2404.8 152.8 1251.1 707.2 2013.1 1578.6 3102.5 1284.0 1289.9 1273.4 1786.4 1262.0 1294.0 1259.2 1268.3 1263.1 1282.1 1317.9 1283.5 1321.7 1364.6 586.5 941.1 7.8 3935.3 2655.4 1626.1 981.0 3107.4 142.2 3889.4 5494.5 366.2 1229.6 931.4 489.2 223.1 1664.7 2299.9 1067.8 692.6 1619.1 132.9 556.3 999.9 1124.0 1212.9 2581.9 9.4 3548.5 2106.0 1019.6 1460.2 940.4 958.8 1067.6 1729.4 1728.5 1271.3 149.7 8.2 2684.6 321.4 2098.5 2590.7 133.6 1556.1 1493.7 974.7 5.6 1999.4 676.9 2139.1 4.0 6.5 2264.9 2168.9 802.3 2205.5 1561.5 1866.1 1305.7 429.3 305.3 558.8 1930.9 1036.6 265.6 853.2 3960.0 3136.3 1638.4 2731.0 645.0 3215.9 1523.2 C3AR1 "AZ3B, C3AR" ENSG00000171860 "Complement C3a receptor 1" Q16581 12 8056844-8066359 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.4" "Cell type enhanced" "Detected in some" "granulocytes: 36.8;Hofbauer cells: 161.5;Kupffer cells: 139.7;Macrophages: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 898.6;eosinophil: 450.8;intermediate monocyte: 273.6;non-classical monocyte: 371.3" "Group enriched" "Detected in many" 20 "granulocytes: 898.6;monocytes: 371.3" "Cell line enriched" "Detected in some" 9 "HMC-1: 148.0" "Low region specificity" "Detected in many" CAB009405 Enhanced NA NA "CAB009405: AB_2066739" "unprognostic (1.11e-2)" "unprognostic (5.67e-2)" "unprognostic (5.06e-2)" "unprognostic (4.14e-2)" "unprognostic (6.60e-2)" "unprognostic (1.50e-1)" "unprognostic (4.81e-2)" "unprognostic (2.78e-1)" "unprognostic (6.10e-2)" "unprognostic (8.04e-2)" "unprognostic (1.59e-1)" "unprognostic (3.50e-2)" "unprognostic (8.22e-2)" "unprognostic (4.96e-2)" "unprognostic (9.24e-3)" "unprognostic (2.09e-2)" "unprognostic (8.16e-2)" 18.1 10.7 3.3 40.4 5.0 23.1 6.8 4.7 5.8 6.8 6.0 7.5 6.6 3.8 1.5 4.0 5.9 16.3 3.8 3.4 10.2 3.1 10.8 18.7 12.5 9.4 4.6 2.3 3.8 6.0 3.3 2.5 22.2 8.0 3.3 6.9 0.8 5.7 4.4 1.4 1.8 9.7 15.7 10.7 21.5 5.4 2.1 6.0 4.9 2.4 2.6 5.2 15.3 2.7 10.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.9 0.5 3.8 0.0 0.0 1.6 0.0 0.0 2.2 0.1 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 1.4 15.6 148.0 0.7 0.0 0.2 0.4 0.3 0.7 1.2 4.0 8.2 0.7 0.0 0.7 5.2 0.1 0.0 0.0 0.1 3.1 15.1 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 6.6 0.6 0.5 0.4 0.1 0.3 0.3 0.0 0.4 8.5 6.4 0.4 898.6 105.0 450.8 21.8 273.6 26.9 0.2 10.6 14.5 31.1 0.3 2.0 7.8 14.0 4.1 371.3 2.8 11.0 76.0 3.3 5.0 4.7 5.8 3.4 10.2 9.4 4.6 2.3 8.0 10.7 6.0 10.0 0.7 0.0 3.0 0.3 1.1 0.5 0.1 0.1 0.0 0.1 0.3 0.9 0.6 1.5 2.5 0.0 2.1 0.7 5.9 0.0 0.0 0.0 3.0 0.0 0.1 6.6 0.0 0.8 0.4 0.2 1.0 0.6 0.0 0.0 36.8 0.0 1.8 0.8 161.5 0.0 0.3 0.0 0.0 139.7 19.8 4.2 1.2 105.7 0.0 8.4 16.2 0.0 8.2 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.7 0.4 19.7 0.7 1.0 0.0 0.2 0.0 0.6 1.5 8.6 0.1 0.0 0.0 MRM3 "FLJ10581, HC90, RMTL1, RNMTL1" ENSG00000171861 "Mitochondrial rRNA methyltransferase 3" Q9HC36 17 782353-792509 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 27.1;Distal tubular cells: 19.6;Ductal cells: 18.9;Exocrine glandular cells: 18.4;Extravillous trophoblasts: 24.6;Proximal tubular cells: 20.0;Syncytiotrophoblasts: 19.6;Theca cells: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022534, HPA023031, HPA023292" Enhanced Supported Mitochondria NA NA Mitochondria "HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388" "unprognostic (1.66e-1)" "unprognostic (5.83e-3)" "unprognostic (6.72e-2)" "prognostic favorable (2.81e-4)" "unprognostic (2.67e-1)" "unprognostic (1.83e-1)" "unprognostic (2.48e-1)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.20e-2)" "unprognostic (3.72e-3)" "unprognostic (8.47e-2)" "prognostic favorable (3.00e-4)" "unprognostic (3.82e-2)" "unprognostic (9.98e-2)" "unprognostic (1.05e-2)" "unprognostic (1.42e-2)" 9.4 13.0 8.0 6.9 8.5 17.8 8.8 10.0 9.3 6.5 9.4 9.6 7.9 7.7 5.2 11.7 8.1 4.8 14.9 8.3 8.3 9.8 20.7 6.1 10.5 8.2 8.3 8.2 8.8 19.8 9.2 6.3 6.9 8.7 7.6 7.6 4.3 9.6 6.0 29.6 14.7 8.2 6.7 7.8 10.0 13.1 18.7 8.3 8.4 7.1 18.9 9.4 8.7 7.3 8.5 26.4 53.9 11.3 19.8 16.2 13.8 22.5 13.6 12.8 27.3 22.8 31.8 12.0 47.3 14.1 10.6 13.1 21.7 33.0 12.0 24.8 16.2 55.9 18.3 30.6 27.9 16.7 15.8 16.0 16.7 16.2 29.0 23.9 13.6 20.7 28.3 31.3 20.1 14.5 28.5 27.5 20.8 16.9 19.3 28.2 33.1 7.9 25.3 18.2 14.2 15.1 17.6 19.8 16.6 26.5 9.0 20.6 14.2 16.6 14.6 11.2 21.0 38.3 8.0 11.8 18.9 18.3 22.1 20.0 12.5 24.6 14.7 25.0 20.6 27.0 38.2 27.1 30.8 25.8 38.4 32.8 28.4 1.8 32.7 21.1 20.8 31.9 26.8 8.0 8.5 10.0 9.3 8.3 8.3 8.2 8.3 8.2 8.7 7.8 8.3 8.5 11.3 6.4 1.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 9.8 10.4 0.0 0.0 1.3 5.5 0.0 27.1 7.6 0.0 19.6 18.9 0.0 8.3 8.0 5.1 0.0 0.0 0.0 18.4 24.6 4.1 0.0 8.8 3.8 15.6 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.5 0.0 0.0 20.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 19.6 4.4 28.9 0.0 0.0 PTEN "BZS, MHAM, MMAC1, PTEN1, TEP1" ENSG00000171862 "Phosphatase and tensin homolog" P60484 10 87863625-87971930 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Neurogenesis" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004076, HPA031335" Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "CAB004076: AB_390810, HPA031335: AB_2797221" "unprognostic (8.72e-2)" "unprognostic (2.45e-1)" "unprognostic (5.43e-1)" "unprognostic (1.50e-2)" "unprognostic (3.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (2.07e-1)" "unprognostic (6.87e-2)" "unprognostic (9.77e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (7.35e-4)" "unprognostic (1.57e-1)" "unprognostic (2.73e-1)" "unprognostic (6.54e-3)" "unprognostic (2.41e-1)" 59.5 25.6 19.3 18.8 20.9 13.1 48.0 36.3 23.5 47.9 17.7 27.2 13.0 27.6 18.7 28.5 35.5 15.8 28.2 20.7 19.7 22.7 39.6 39.8 21.6 18.7 21.2 19.2 28.3 33.5 12.0 17.4 30.7 21.6 26.5 14.7 30.3 19.7 16.7 23.9 25.4 24.7 22.4 16.3 40.4 25.8 28.4 19.7 32.1 26.3 14.1 16.6 28.3 38.7 19.0 23.5 10.8 12.3 11.2 28.5 19.7 10.9 12.5 28.0 14.5 20.4 10.9 28.0 28.1 8.0 20.9 8.3 14.1 16.6 14.3 22.8 14.1 4.7 9.3 28.5 13.8 30.1 31.9 15.3 13.5 38.7 18.0 23.7 60.3 20.8 17.7 7.0 72.6 13.5 18.1 17.8 56.3 4.6 19.9 0.0 27.6 6.4 20.8 22.9 13.4 4.5 19.9 16.6 7.9 23.0 9.7 21.9 45.2 17.9 44.6 10.8 18.3 10.1 23.9 32.9 30.7 14.6 29.2 2.9 21.3 14.2 25.8 6.8 21.8 7.2 7.9 7.2 6.6 10.3 6.8 8.3 8.3 60.5 8.9 15.6 8.2 7.0 4.5 19.3 20.9 36.3 23.5 20.7 19.7 18.7 21.2 19.2 21.6 16.3 19.7 19.0 67.2 35.3 63.3 83.6 48.3 56.1 57.4 31.5 47.3 113.0 49.4 41.9 46.5 57.2 31.2 29.5 39.6 25.8 64.4 57.7 33.2 24.7 70.1 40.0 114.5 56.0 31.2 52.0 141.0 30.0 62.2 79.3 39.8 33.6 25.4 39.6 53.9 64.1 35.0 45.4 132.4 44.7 12.2 206.1 97.2 92.1 56.8 105.2 62.2 196.8 101.5 61.6 44.3 139.2 95.7 30.6 39.7 54.5 39.3 45.1 50.1 38.0 31.2 61.2 92.1 66.4 170.7 33.5 25.4 45.2 60.1 57.3 46.3 44.7 46.1 64.0 RPS7 "eS7, S7" ENSG00000171863 "Ribosomal protein S7" P62081 2 3575260-3580920 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056586 Approved Approved "Endoplasmic reticulum,Cytosol" NA Yes 820000 "Endoplasmic reticulum, Cytosol" "HPA056586: AB_2683179" "unprognostic (3.28e-3)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.00e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.27e-4)" "unprognostic (6.41e-2)" "unprognostic (6.02e-3)" "unprognostic (7.08e-2)" "unprognostic (5.60e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.34e-8)" "unprognostic (3.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" 1036.8 771.0 777.2 781.8 781.3 2170.8 2216.4 774.3 1121.7 1088.6 806.5 1025.3 772.9 875.8 1320.4 1292.1 1162.2 648.2 736.2 756.9 785.2 931.6 1091.5 723.9 1635.7 788.0 770.4 756.5 2416.0 1637.7 731.2 691.6 947.5 783.8 895.4 1177.5 608.5 1224.3 703.9 915.1 1345.0 874.1 903.0 810.9 972.4 1019.6 399.9 796.2 1680.9 804.8 850.5 1857.0 1048.0 1072.0 800.2 1235.6 1178.5 1778.9 1923.5 1725.8 3754.0 2913.5 1458.3 2527.9 2370.8 1371.5 2053.4 1890.4 4081.0 2369.1 1697.7 1646.1 1321.0 2038.5 2370.0 2077.4 1289.4 2743.3 1496.8 758.2 2998.2 4156.0 2622.8 1489.1 3183.4 3497.5 1475.1 3176.3 2552.1 2816.8 3707.9 2356.3 2015.2 2433.4 1661.0 2930.2 5815.8 2638.6 3679.7 1810.5 2300.9 1812.6 3670.5 2725.7 1487.1 2016.6 3028.5 771.7 2931.1 4670.0 1487.2 1615.3 3727.3 1327.2 1415.1 931.1 987.9 2387.5 2240.1 4420.9 4079.3 1489.6 3113.0 1617.9 337.1 656.8 243.1 808.8 570.7 1192.3 1411.3 1159.2 1036.9 1063.6 1172.7 1254.6 1132.2 129.3 1032.8 553.2 1016.6 1083.5 2065.3 777.2 781.3 774.3 1121.7 756.9 785.2 788.0 770.4 756.5 783.8 810.9 796.2 800.2 2544.8 496.8 793.2 28.1 3845.5 3923.3 4252.7 2961.9 3989.5 401.5 4245.2 7977.4 154.5 1720.0 1620.6 647.4 325.2 3627.9 2815.0 730.8 2606.1 2129.9 1517.5 1255.0 3316.9 1997.7 1250.9 2352.4 33.5 3434.0 5702.2 1854.2 1378.2 1489.1 1171.5 2855.2 2067.5 1515.6 2338.1 141.3 37.2 2244.0 929.8 2534.9 3126.0 485.1 2927.6 2110.0 2001.1 50.6 3250.8 1257.2 2634.4 27.6 49.8 2878.9 1747.3 1748.6 2572.7 4420.1 1233.7 4372.3 847.1 741.6 1452.9 1699.5 3261.7 1248.6 775.4 4912.8 5050.7 3716.9 3078.6 3673.3 2604.1 4351.5 PRND "dJ1068H6.4, DOPPEL, DPL, PrPLP" ENSG00000171864 "Prion like protein doppel" Q9UKY0 20 4721909-4728460 "Predicted membrane proteins, Transporters" Fertilization Prion "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "choroid plexus: 25.3;testis: 71.5" "Cell type enhanced" "Detected in some" "Adipocytes: 5.3;Endothelial cells: 17.7;Late spermatids: 11.2;Spermatocytes: 4.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043373 Enhanced NA NA "HPA043373: AB_2678450" "unprognostic (1.69e-1)" "unprognostic (3.66e-2)" "unprognostic (2.24e-2)" "unprognostic (8.46e-2)" "unprognostic (3.40e-2)" "unprognostic (3.47e-3)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" "unprognostic (2.00e-2)" "unprognostic (1.56e-1)" "unprognostic (3.10e-1)" "unprognostic (5.85e-2)" "unprognostic (2.02e-3)" "unprognostic (6.11e-2)" "unprognostic (2.86e-1)" "unprognostic (2.45e-2)" "unprognostic (1.63e-3)" 0.2 0.0 0.1 0.1 0.2 0.1 0.2 0.8 0.2 0.1 25.3 1.0 0.1 4.1 0.0 0.1 0.0 1.2 0.2 1.0 0.1 0.0 0.0 0.1 0.3 0.3 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.0 0.0 0.1 0.2 0.0 1.3 0.0 0.1 0.1 71.5 0.6 0.1 0.1 0.1 0.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.2 1.0 0.1 0.3 0.4 0.1 0.2 0.0 0.6 0.2 5.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.1 0.2 17.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 11.2 2.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 4.7 1.9 0.0 0.0 0.0 0.1 1.3 0.0 0.2 RNASEH1 ENSG00000171865 "Ribonuclease H1" O60930 2 3541430-3558333 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA034817, HPA043037" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA034817: , HPA043037: AB_2678280" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "unprognostic (8.81e-3)" "unprognostic (4.32e-3)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.83e-6)" "unprognostic (9.43e-2)" "unprognostic (8.46e-3)" "unprognostic (6.38e-2)" "unprognostic (2.29e-3)" "unprognostic (2.67e-1)" "unprognostic (4.06e-2)" "unprognostic (2.34e-2)" "unprognostic (2.11e-1)" "unprognostic (3.06e-2)" "unprognostic (2.23e-3)" 10.6 8.8 10.4 9.6 11.5 11.5 9.8 9.1 12.3 8.6 7.5 7.9 7.3 11.8 11.4 9.7 7.9 7.6 13.1 12.2 11.5 7.2 8.1 7.9 10.3 11.1 10.2 10.9 8.2 8.8 9.2 3.3 8.0 11.2 9.4 9.6 8.8 7.8 11.9 15.5 10.0 7.8 13.4 9.9 9.0 7.0 7.0 12.1 10.4 9.6 15.1 11.0 8.5 4.8 11.8 11.9 21.4 22.1 22.5 24.9 23.2 17.2 29.0 30.6 24.8 16.5 19.4 13.0 33.6 13.7 31.5 18.8 14.7 32.6 23.2 30.9 12.4 17.5 33.1 18.9 27.5 35.5 42.0 23.3 23.5 24.9 24.2 29.3 18.5 21.5 54.8 33.0 19.4 31.1 9.3 32.7 27.3 34.7 20.6 17.0 26.9 32.0 34.3 21.0 19.7 33.3 48.9 17.8 15.9 27.5 16.7 10.3 22.9 24.8 24.1 11.5 24.7 40.7 36.1 37.5 43.9 43.2 35.1 37.5 0.1 0.6 1.3 1.3 1.2 2.2 1.1 1.0 1.7 0.7 0.6 1.0 2.1 0.5 0.4 1.2 1.5 0.4 0.7 10.4 11.5 9.1 12.3 12.2 11.5 11.1 10.2 10.9 11.2 9.9 12.1 11.8 15.6 22.4 6.9 9.1 30.7 7.5 26.1 21.0 13.6 25.7 14.9 12.6 25.9 11.5 14.7 3.7 20.9 32.7 25.4 14.4 37.2 44.3 5.1 9.6 20.8 20.1 15.0 13.5 11.8 48.7 44.3 20.2 17.9 11.0 27.3 17.9 16.8 18.0 30.8 35.3 10.7 16.4 14.2 18.8 8.9 3.4 13.7 16.2 10.6 10.3 32.3 17.5 30.9 7.5 9.8 48.3 9.9 26.4 41.7 50.2 16.6 28.6 14.1 18.8 19.7 23.6 23.4 21.0 27.5 17.8 12.1 36.5 18.9 27.7 15.9 37.9 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686350-4701590 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 9 "basophil: 875.9" "Lineage enriched" "Detected in all" 9 "granulocytes: 875.9" "Cell line enhanced" "Detected in many" "WM-115: 1039.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" NA Yes 5100000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: AB_2678461" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.96e-4)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 87.8 93.3 292.3 52.9 329.8 84.4 107.7 278.3 372.0 136.6 393.3 135.4 37.5 126.7 59.6 80.0 80.6 111.1 199.3 319.9 307.9 134.0 80.3 79.9 60.3 282.1 281.0 307.3 165.1 41.9 63.3 84.4 67.4 291.6 147.4 71.2 180.1 60.8 149.6 64.5 96.2 47.8 142.0 273.3 75.9 62.2 68.7 306.5 48.4 89.9 74.7 60.5 126.1 84.1 315.4 226.4 141.6 41.7 64.2 329.6 199.9 36.6 363.4 527.6 175.5 177.7 50.0 171.5 40.9 79.2 727.9 391.8 508.8 45.9 498.3 326.2 31.8 39.0 0.2 19.6 193.8 402.0 72.8 16.5 177.5 711.9 701.8 583.9 257.0 152.8 28.6 22.8 142.9 205.1 45.7 28.8 46.2 33.1 99.8 266.4 33.9 110.0 38.3 88.7 40.3 49.2 7.0 98.9 144.3 554.1 56.4 30.2 38.8 224.5 282.9 127.1 158.6 296.1 63.1 129.5 132.9 226.8 51.9 1039.0 875.9 74.1 5.4 67.3 60.9 100.7 25.1 56.9 55.8 62.9 25.6 33.5 40.1 4.6 23.6 50.4 24.6 72.8 72.7 292.3 329.8 278.3 372.0 319.9 307.9 282.1 281.0 307.3 291.6 273.3 306.5 315.4 44.9 80.1 45.4 120.2 85.3 412.6 211.8 132.5 369.3 265.4 60.8 103.0 257.7 32.9 68.2 33.1 116.7 7.7 71.8 2.6 11.7 58.1 6.0 14.1 73.2 66.7 29.9 31.8 125.5 14.7 6.3 177.4 14.8 18.2 173.0 25.5 41.0 36.2 63.6 45.4 170.8 5.4 40.7 219.1 200.4 13.6 143.2 126.3 168.9 59.0 54.5 142.4 42.2 95.0 158.8 18.7 4.5 170.0 47.0 120.3 2.2 84.0 38.1 99.0 13.1 73.0 82.3 36.6 4.5 81.6 284.4 14.4 107.2 10.3 8.8 122.6 KLF17 "FLJ40160, Zfp393, ZNF393" ENSG00000171872 "Kruppel like factor 17" Q5JT82 1 44118821-44135140 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 8.4" "Cell type enhanced" "Detected in some" "Early spermatids: 160.6;Late spermatids: 45.3;Oligodendrocyte precursor cells: 29.1" "Cancer enriched" "Detected in single" 25 "testis cancer: 4.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.2;HBF TERT88: 1.5;U-138 MG: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024629 Enhanced NA NA "HPA024629: AB_1668927" "unprognostic (1.73e-2)" "unprognostic (1.18e-4)" "unprognostic (4.02e-4)" "unprognostic (2.38e-1)" "unprognostic (4.64e-2)" "unprognostic (5.17e-2)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (9.70e-3)" "unprognostic (5.30e-3)" "unprognostic (8.35e-2)" "unprognostic (5.54e-2)" "unprognostic (6.60e-2)" "unprognostic (8.04e-3)" 0.0 0.6 0.2 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.7 0.1 0.6 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 1.1 0.1 0.0 0.1 8.4 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.5 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.3 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 160.6 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 45.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.1 4.9 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.3 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 ADRA1D "ADRA1, ADRA1A, ADRA1R" ENSG00000171873 "Adrenoceptor alpha 1D" P25100 20 4220630-4249287 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5;cervix: 6.3" "Cell type enhanced" "Detected in some" "Endothelial cells: 1.2;Excitatory neurons: 2.1;Inhibitory neurons: 2.4;Oligodendrocyte precursor cells: 1.0;Smooth muscle cells: 2.4" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.7;BJ: 7.5;CAPAN-2: 3.3;fHDF/TERT166: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038789 Uncertain NA NA "HPA038789: AB_10673475" "unprognostic (5.37e-2)" "unprognostic (4.65e-1)" "unprognostic (8.73e-2)" "unprognostic (7.75e-11)" "unprognostic (7.83e-3)" "unprognostic (1.54e-2)" "unprognostic (7.62e-2)" "unprognostic (7.82e-4)" "unprognostic (4.41e-3)" "unprognostic (8.37e-2)" "unprognostic (6.09e-2)" "unprognostic (7.24e-3)" "unprognostic (7.71e-7)" "unprognostic (5.21e-3)" "unprognostic (2.76e-1)" "unprognostic (6.01e-3)" "unprognostic (3.32e-5)" 1.1 0.4 4.3 0.0 0.5 0.0 0.8 0.4 4.8 6.3 0.0 1.4 0.0 3.5 0.3 0.2 2.0 0.2 0.2 6.3 4.0 0.3 0.1 2.4 0.1 2.5 4.7 0.7 0.6 0.3 0.2 0.0 0.1 2.4 3.4 0.2 0.0 0.2 1.7 0.5 0.3 0.2 0.3 1.2 1.4 1.6 0.7 9.5 0.0 0.8 0.4 0.0 2.4 2.9 3.8 0.0 1.7 0.1 0.0 0.0 0.0 0.0 7.5 1.3 0.4 0.1 0.3 3.3 0.0 0.0 4.4 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.5 0.4 4.8 6.3 4.0 2.5 4.7 0.7 2.4 1.2 9.5 3.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 2.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 FRMD5 MGC14161 ENSG00000171877 "FERM domain containing 5" Q7Z6J6 15 43870761-44195271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 40.0;heart muscle: 47.0;retina: 20.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 375.2;Inhibitory neurons: 646.2;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 2000.1" "Cancer enhanced" "Detected in many" "glioma: 6.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 26.4;U-251 MG: 21.8;WM-115: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.54e-2)" "unprognostic (2.16e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (7.26e-7)" "unprognostic (3.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" "unprognostic (5.00e-3)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.01e-2)" "unprognostic (2.92e-4)" "unprognostic (1.21e-1)" "unprognostic (7.31e-2)" "unprognostic (1.18e-1)" "unprognostic (3.31e-1)" 0.2 8.3 17.2 0.5 23.8 0.8 0.4 18.3 22.1 0.3 5.8 1.1 0.2 0.1 0.4 0.3 1.0 0.4 47.0 16.1 19.5 0.3 0.0 0.1 0.3 22.0 22.2 14.5 0.3 0.2 0.8 2.1 0.0 22.3 0.5 0.8 20.2 1.1 0.3 0.0 0.3 0.5 0.2 19.1 0.3 1.3 3.5 19.9 0.0 0.3 0.0 0.0 0.4 0.4 40.0 6.6 3.5 2.3 1.3 2.6 0.2 0.4 1.4 2.1 3.9 7.4 11.2 6.6 0.5 1.3 0.9 10.6 7.3 3.3 7.0 3.3 0.4 3.7 1.0 3.1 4.4 0.3 0.1 0.4 0.0 0.7 10.6 20.8 7.6 26.4 5.7 0.2 0.7 4.1 0.6 1.0 0.1 1.9 21.3 3.8 0.1 4.7 0.0 3.6 2.3 14.3 4.8 0.8 0.1 15.0 1.8 0.2 0.2 1.0 7.1 13.4 1.8 21.8 0.5 2.0 0.8 10.4 0.4 61.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 17.2 23.8 18.3 22.1 16.1 19.5 22.0 22.2 14.5 22.3 19.1 19.9 40.0 0.0 0.0 0.0 134.8 0.0 0.4 0.0 0.8 0.6 11.4 0.1 0.3 14.8 0.0 0.1 0.0 2.1 0.0 0.0 0.3 0.0 2.8 14.7 0.3 0.1 0.2 1.2 0.0 375.2 6.0 0.0 1.1 7.1 0.1 0.0 3.9 0.0 0.0 0.1 0.0 646.2 0.8 0.0 0.0 0.3 5.2 0.3 0.0 0.0 14.0 0.0 17.5 0.0 298.6 2000.1 8.6 0.3 0.0 0.3 0.4 0.0 1.0 0.1 4.4 0.0 0.1 0.7 6.6 3.9 0.2 0.0 0.0 0.1 0.0 1.3 0.1 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852043-26865771 "Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 459.0;lung: 115.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 1102.6;Alveolar cells type 2: 342.3;Astrocytes: 487.7;Muller glia cells: 227.2" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.4;RPTEC TERT1: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 0.1 0.1 275.2 0.0 271.6 0.0 0.3 318.4 248.5 0.6 71.1 0.3 0.0 0.0 0.8 0.9 1.1 0.1 2.8 290.5 459.0 2.3 0.9 115.8 0.3 297.6 289.7 204.0 2.5 0.3 2.2 3.7 0.0 318.7 0.4 0.0 60.7 0.7 0.2 60.7 0.1 0.1 0.0 337.9 0.5 11.5 0.5 393.7 0.2 14.9 21.1 0.1 0.1 0.1 372.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 275.2 271.6 318.4 248.5 290.5 459.0 297.6 289.7 204.0 318.7 337.9 393.7 372.6 0.0 1102.6 342.3 487.7 0.0 0.0 0.8 0.6 0.0 3.1 0.8 0.9 13.9 4.3 76.6 3.7 6.2 0.0 0.0 0.1 3.9 0.3 0.0 0.7 0.1 1.8 0.0 0.0 3.0 0.0 0.0 0.8 0.0 0.0 3.8 0.0 0.0 0.5 0.0 1.7 1.1 0.0 0.0 0.0 0.3 0.0 5.0 0.8 0.0 9.4 0.0 227.2 0.0 12.1 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 23.1 9.1 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 2.0 CYP4F11 ENSG00000171903 "Cytochrome P450 family 4 subfamily F member 11" Q9HBI6 19 15912367-15934867 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.1;liver: 72.9" "Cell type enhanced" "Detected in many" "Ductal cells: 15.6;Hepatocytes: 62.9;Prostatic glandular cells: 36.3;Urothelial cells: 26.1" "Cancer enhanced" "Detected in many" "liver cancer: 25.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 13.1;CAPAN-2: 50.4;EFO-21: 18.5;Hep G2: 25.0;RPMI-8226: 13.5;RT4: 15.2" "HPA017265, CAB033648, HPA058960" Enhanced "Intracellular and membrane" NA NA "CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862" "prognostic favorable (4.05e-4)" "unprognostic (4.12e-2)" "unprognostic (1.79e-1)" "unprognostic (5.99e-2)" "unprognostic (5.92e-3)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (2.33e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (9.28e-4)" "unprognostic (4.44e-2)" "unprognostic (9.50e-3)" "unprognostic (2.14e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-2)" "unprognostic (4.64e-2)" 0.2 2.9 5.3 0.6 4.6 0.6 2.2 5.9 6.5 1.3 0.0 3.5 10.8 0.5 16.5 13.1 3.1 18.9 0.2 4.6 5.3 6.5 72.9 0.6 0.4 8.7 7.3 3.2 0.1 5.2 0.1 0.5 0.1 6.1 3.8 2.6 1.6 3.8 4.3 0.5 1.0 24.1 0.1 4.4 1.0 4.1 1.1 6.5 0.0 3.0 0.0 0.9 5.8 3.4 5.0 13.1 2.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 50.4 0.1 18.5 0.0 10.5 1.5 0.0 6.6 0.0 0.0 0.1 0.1 4.2 25.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 10.0 0.0 1.9 0.1 0.3 0.1 11.4 0.0 0.1 0.1 13.5 3.4 15.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 1.8 0.2 0.2 0.1 0.6 0.2 0.4 1.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.6 5.9 6.5 4.6 5.3 8.7 7.3 3.2 6.1 4.4 6.5 5.0 0.1 0.0 0.0 9.1 0.2 0.1 7.7 5.3 0.0 0.0 1.4 1.7 0.4 10.0 4.4 9.2 0.0 0.0 0.0 6.9 1.9 15.6 0.0 2.8 0.6 0.3 1.2 2.7 0.0 11.5 0.0 0.3 0.0 4.4 0.0 0.3 0.4 62.9 0.0 0.0 0.0 2.0 2.0 2.4 0.0 0.1 0.3 0.4 0.0 0.0 0.0 3.0 0.0 0.0 0.8 9.2 3.2 0.0 0.0 36.3 11.7 8.3 7.6 0.1 0.0 0.6 0.6 0.0 0.0 0.5 0.3 0.0 0.1 0.1 2.7 26.1 TLN2 "ILWEQ, KIAA0320" ENSG00000171914 "Talin 2" Q9Y4G6 15 62390526-62844631 "Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 38.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.7;Inhibitory neurons: 127.2;Microglial cells: 139.6;Oligodendrocyte precursor cells: 108.6;Oligodendrocytes: 93.6;Skeletal myocytes: 135.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 59.3;hTERT-HME1: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017194, HPA051828, HPA054787" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 46000000 "Focal adhesion sites, Cytosol" "CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587" "prognostic favorable (6.53e-4)" "unprognostic (2.61e-1)" "unprognostic (9.47e-2)" "unprognostic (8.95e-2)" "unprognostic (3.74e-1)" "unprognostic (1.43e-1)" "unprognostic (8.24e-2)" "unprognostic (9.94e-2)" "unprognostic (1.68e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (1.91e-1)" "prognostic favorable (1.81e-6)" "prognostic favorable (7.74e-4)" "unprognostic (1.34e-1)" "unprognostic (5.79e-2)" "unprognostic (2.30e-1)" 19.1 4.1 14.7 2.2 16.4 3.8 10.5 3.6 14.0 7.9 16.4 9.4 4.7 3.7 2.1 2.1 4.3 1.9 12.2 17.2 12.1 38.7 4.9 2.4 0.6 8.4 8.5 15.5 4.7 4.7 2.4 5.5 1.3 8.1 2.3 7.4 7.7 7.8 2.1 26.4 3.4 5.1 3.0 6.6 1.3 5.5 5.5 5.6 3.1 13.1 12.3 0.5 4.2 4.2 13.9 1.8 5.6 8.0 9.4 59.3 5.6 9.0 13.7 10.8 12.4 12.2 15.1 1.9 4.8 6.2 24.0 20.5 2.4 10.3 2.2 10.8 15.2 1.0 0.6 22.8 10.1 2.0 1.6 0.4 10.3 5.6 16.6 48.9 7.1 0.5 5.7 0.6 0.2 21.0 7.5 0.7 0.6 14.2 26.3 4.1 5.8 20.3 5.8 6.5 11.6 1.9 9.3 10.6 1.1 3.5 17.1 2.9 3.6 3.9 22.2 30.0 36.3 35.6 0.3 0.9 3.1 10.1 3.4 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 16.4 3.6 14.0 17.2 12.1 8.4 8.5 15.5 8.1 6.6 5.6 13.9 11.5 0.0 3.2 50.6 1.1 2.4 1.8 0.7 1.2 18.6 16.5 10.2 41.1 5.7 0.9 27.6 37.5 1.2 0.7 39.0 11.7 3.5 4.3 10.9 14.3 9.0 2.4 37.7 153.7 3.9 29.7 21.5 40.8 17.4 0.0 9.3 3.3 12.6 4.9 48.8 127.2 20.0 6.1 6.2 3.1 5.2 11.8 5.5 0.0 139.6 0.8 11.1 1.0 108.6 93.6 3.7 21.0 15.8 0.7 1.5 14.6 35.1 0.1 48.3 0.0 135.6 12.3 6.7 24.5 3.1 1.6 1.4 1.3 25.8 37.7 1.7 LGALS9C ENSG00000171916 "Galectin 9C" Q6DKI2 17 18476737-18494945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 10.4;intestine: 5.3;stomach 1: 11.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 48.1;Gastric mucus-secreting cells: 194.2;Intestinal goblet cells: 37.9;Paneth cells: 58.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "neutrophil: 1.9;NK-cell: 5.5" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;NK-cells: 5.5" "Not detected" "Not detected" "HPA046876, HPA047218" Approved Approved Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.47e-2)" "unprognostic (1.43e-3)" "unprognostic (3.17e-2)" "unprognostic (4.30e-2)" "unprognostic (5.92e-1)" "unprognostic (3.02e-2)" "unprognostic (2.52e-1)" "unprognostic (5.16e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.04e-2)" "unprognostic (5.85e-2)" "unprognostic (4.27e-3)" "unprognostic (9.84e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 5.3 1.1 0.0 0.0 10.4 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 1.6 0.0 0.0 0.2 4.3 0.0 0.0 1.4 11.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.4 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 1.9 5.5 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.6 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.1 3.4 48.1 0.0 0.2 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.0 0.0 0.0 194.2 0.1 0.0 0.0 0.4 0.1 0.7 0.0 0.0 37.9 4.1 2.2 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.0 9.2 0.0 0.0 0.4 58.4 0.0 0.2 0.0 13.5 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.1 4.5 0.1 0.0 1.8 0.0 10.8 0.2 TVP23B "CGI-148, FAM18B, FAM18B1, YDR084C" ENSG00000171928 "Trans-golgi network vesicle protein 23 homolog B" Q9NYZ1 17 18781111-18806714 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (9.32e-3)" "unprognostic (1.13e-2)" "unprognostic (8.51e-2)" "unprognostic (2.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (2.30e-1)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (3.54e-1)" "unprognostic (5.27e-1)" "unprognostic (7.78e-2)" "unprognostic (8.55e-2)" 26.7 43.6 12.0 20.1 12.6 20.1 30.6 13.7 15.2 38.5 22.1 26.1 30.2 26.8 40.7 52.7 34.8 30.7 23.0 11.4 16.9 31.3 44.4 21.0 25.6 13.0 13.3 10.6 30.4 33.8 48.2 32.9 29.9 13.7 33.8 31.5 32.3 34.6 24.6 17.4 19.1 24.0 21.9 14.1 17.6 40.8 35.2 13.2 20.6 47.3 16.3 31.6 33.0 34.5 14.0 55.0 63.8 23.6 26.2 68.8 60.9 56.1 93.5 75.0 42.8 54.6 37.6 38.7 17.9 33.9 60.3 42.6 74.1 19.2 40.2 63.2 44.3 39.7 17.0 47.1 46.3 48.0 13.0 35.6 31.6 95.7 46.0 67.7 78.7 36.0 12.6 14.0 13.1 62.9 27.6 17.2 18.3 11.0 99.2 25.6 17.4 52.1 23.1 52.7 36.0 13.4 29.9 49.8 32.4 60.4 129.0 46.9 19.7 41.6 32.7 28.1 69.8 57.5 25.9 31.7 9.5 50.2 22.2 68.2 54.4 20.4 44.6 29.7 27.4 40.5 32.1 33.0 32.1 17.3 26.9 34.8 34.8 24.2 32.3 27.1 27.9 26.3 32.1 12.0 12.6 13.7 15.2 11.4 16.9 13.0 13.3 10.6 13.7 14.1 13.2 14.0 10.0 12.8 13.2 9.4 29.4 25.2 28.1 70.4 54.7 8.6 16.5 9.7 4.2 10.0 42.4 9.2 10.4 13.3 15.7 8.5 11.7 13.9 8.6 21.7 16.1 12.9 6.1 17.2 8.1 11.6 30.3 19.1 40.2 16.2 22.2 7.1 11.0 10.3 10.0 1.7 8.8 14.6 44.7 10.3 10.7 4.2 16.8 16.0 26.6 11.2 9.1 9.1 17.5 14.1 12.8 16.5 10.7 17.0 62.1 28.5 12.0 14.0 60.0 11.1 13.1 9.0 17.0 50.8 43.0 65.5 30.5 26.1 23.7 8.9 8.6 32.4 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744026-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 9.8" "Cell type enhanced" "Detected in some" "Early spermatids: 44.4;Late spermatids: 16.1;Respiratory ciliated cells: 5.3;Spermatocytes: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;CAPAN-2: 1.1;HaCaT: 1.5;HeLa: 1.4" "Low region specificity" "Detected in all" HPA047457 Approved Nucleoplasm NA NA Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.0 0.2 0.0 0.6 0.2 0.5 0.2 0.0 0.0 0.1 0.2 0.9 0.3 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 9.8 0.2 0.0 0.8 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.2 0.2 0.0 0.2 0.1 0.2 0.1 0.2 0.0 0.6 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.4 0.2 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 16.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.4 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.2 0.1 9.8 0.7 0.4 0.1 0.0 0.0 2.9 0.0 0.1 OR10H3 ENSG00000171936 "Olfactory receptor family 10 subfamily H member 3" O60404 19 15737985-15742343 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF217 ZABC1 ENSG00000171940 "Zinc finger protein 217" O75362 20 53567071-53609907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 129.1;Glandular and luminal cells: 154.8;Squamous epithelial cells: 118.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 148.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051857 Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA051857: AB_2681641" "unprognostic (4.17e-2)" "unprognostic (4.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (2.49e-3)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.13e-3)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.67e-1)" "unprognostic (2.52e-2)" 15.2 4.3 3.7 20.7 3.7 31.4 22.3 4.4 3.8 18.0 8.9 18.3 13.0 12.0 8.4 13.3 11.2 15.2 5.5 3.1 8.5 11.1 14.6 12.3 29.8 6.0 5.1 1.9 9.8 10.2 17.5 4.9 19.2 5.3 16.6 17.7 0.8 19.1 8.3 3.4 16.1 13.6 9.0 5.1 29.4 18.1 22.2 5.8 26.2 11.0 6.5 23.9 22.0 11.7 4.9 28.7 33.4 27.5 40.3 25.1 28.5 60.1 31.3 31.8 34.8 17.1 21.5 31.2 27.5 32.9 38.4 44.9 27.5 22.3 33.0 40.1 19.9 6.3 8.9 14.3 37.8 19.5 14.5 36.7 15.6 31.1 18.6 51.4 27.4 20.1 28.2 19.8 126.9 26.4 113.8 50.1 31.9 29.2 16.2 32.8 38.9 23.0 32.3 20.3 62.8 2.8 7.6 29.2 148.2 30.5 34.6 44.3 60.3 14.2 69.7 25.6 36.0 38.9 52.4 62.4 23.0 25.4 16.0 22.8 9.1 6.1 10.9 3.2 7.4 4.1 5.6 3.4 4.1 4.9 4.3 3.8 3.8 23.3 6.8 15.8 5.0 3.6 3.1 3.7 3.7 4.4 3.8 3.1 8.5 6.0 5.1 1.9 5.3 5.1 5.8 4.9 18.7 0.0 8.0 7.5 30.6 129.1 40.3 25.3 71.7 0.6 41.7 22.5 8.2 20.0 26.1 18.4 0.0 16.4 43.7 58.5 9.8 27.5 39.1 76.2 34.4 21.6 6.0 24.4 0.5 16.7 17.7 21.7 42.8 154.8 12.0 24.8 14.6 26.8 16.1 0.0 0.5 32.0 22.4 43.6 52.3 25.9 6.8 39.6 21.4 22.5 43.0 1.8 20.6 3.0 3.4 22.2 39.8 5.3 31.7 65.8 13.8 11.0 30.4 0.5 0.0 13.3 22.7 8.0 23.3 118.8 106.8 45.1 40.5 12.3 24.7 87.1 OR10H2 ENSG00000171942 "Olfactory receptor family 10 subfamily H member 2" O60403 19 15728024-15729052 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRGAP2C SRGAP2P1 ENSG00000171943 "SLIT-ROBO Rho GTPase activating protein 2C" P0DJJ0 1 121184811-121392874 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.9" "Cell type enhanced" "Detected in many" "Microglial cells: 180.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 80.0" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (7.65e-3)" "unprognostic (1.48e-6)" "unprognostic (2.40e-2)" "unprognostic (1.11e-1)" "unprognostic (7.18e-4)" "unprognostic (6.10e-2)" "unprognostic (7.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (2.89e-1)" "unprognostic (3.71e-7)" "unprognostic (4.90e-2)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" "unprognostic (7.66e-2)" 7.8 6.6 11.2 3.7 12.5 7.3 5.7 30.9 12.9 5.4 5.1 5.3 2.1 5.4 2.3 4.3 5.1 4.7 4.7 11.0 11.8 7.1 4.7 7.4 4.6 15.6 12.9 7.9 6.9 2.3 13.8 3.3 8.0 15.9 3.6 2.9 3.5 3.1 4.6 2.8 15.6 3.6 6.0 16.6 10.8 3.3 1.5 12.3 4.3 4.0 10.8 3.4 4.7 5.5 21.5 11.1 14.1 30.7 6.8 23.1 20.1 16.8 12.3 9.8 10.2 13.2 0.2 11.0 7.0 10.8 16.8 7.3 5.9 11.0 8.9 13.4 9.2 11.2 10.0 24.5 11.1 13.3 6.8 11.4 15.2 8.9 13.1 16.6 11.6 24.5 4.3 9.3 12.8 7.6 6.6 4.3 8.6 9.7 3.5 6.7 6.2 35.9 6.2 9.7 6.5 5.9 3.8 21.2 7.5 38.6 15.8 9.5 19.8 21.9 19.1 18.7 28.9 18.1 7.3 5.6 4.2 16.7 13.7 80.0 0.3 3.4 0.6 1.1 2.8 0.7 0.9 1.3 1.2 2.5 0.9 0.6 0.8 3.2 0.6 5.3 2.4 1.3 0.9 11.2 12.5 30.9 12.9 11.0 11.8 15.6 12.9 7.9 15.9 16.6 12.3 21.5 39.9 54.5 11.5 5.2 14.4 0.0 5.6 0.0 6.2 14.2 5.8 6.7 4.3 15.7 5.0 11.0 2.1 5.5 15.5 1.2 1.9 10.9 1.0 11.7 15.4 34.6 2.4 29.7 42.0 5.0 24.8 15.9 5.1 6.4 6.3 7.8 55.3 8.7 19.9 0.0 62.6 2.7 0.0 64.2 0.0 2.1 19.6 41.6 0.0 180.8 39.6 8.4 18.6 35.2 27.4 7.2 1.4 25.6 10.7 5.0 0.5 1.0 8.7 4.3 32.9 20.2 14.5 10.1 10.8 12.5 0.0 2.5 12.6 7.0 2.0 4.5 OR52A5 ENSG00000171944 "Olfactory receptor family 52 subfamily A member 5" Q9H2C5 11 5128776-5138356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602361 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 363.5;brain: 323.9;pituitary gland: 271.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 330000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favorable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 9.3 363.5 67.6 30.5 85.3 0.4 0.5 21.6 160.5 1.5 5.5 10.7 48.1 3.5 0.4 0.6 0.2 4.0 1.8 27.9 323.9 0.5 0.2 3.3 0.4 123.7 159.2 33.6 6.2 28.5 0.5 271.1 1.1 195.7 3.5 13.2 40.9 0.3 1.2 0.3 0.7 21.5 12.9 57.7 0.2 18.0 0.2 111.8 0.1 6.5 0.8 0.1 0.8 1.3 229.7 0.0 3.1 10.3 8.5 2.3 53.3 0.2 0.5 2.0 4.0 10.1 0.4 1.0 0.0 0.9 0.7 6.2 0.2 0.2 0.0 5.0 0.1 0.5 0.0 0.6 0.0 0.5 0.7 4.6 45.9 0.2 5.8 2.0 46.5 0.0 0.0 0.2 0.4 5.1 0.3 0.0 0.2 7.3 0.1 0.2 0.0 0.3 0.3 0.9 0.1 47.6 20.7 0.0 0.5 2.5 1.6 0.0 0.1 0.1 5.4 2.2 0.2 3.6 0.1 0.0 0.3 1.6 0.1 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 85.3 21.6 160.5 27.9 323.9 123.7 159.2 33.6 195.7 57.7 111.8 229.7 0.0 6.4 0.0 12.7 0.0 0.0 0.4 2.8 0.0 212.4 0.0 0.0 0.1 0.0 1.3 0.0 2.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 6.7 283.4 0.0 27.7 0.2 0.0 2.3 0.0 0.1 0.0 0.0 0.7 0.0 0.1 8.4 109.9 14.7 138.4 0.3 0.3 0.0 0.6 0.0 1.8 3.7 0.0 11.6 0.0 34.2 8.2 14.8 6.2 0.4 0.0 2.1 0.1 0.1 0.7 14.6 0.0 1.8 1.7 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.5 0.8 ATPAF2 "ATP12, Atp12p, LP3663, MGC29736" ENSG00000171953 "ATP synthase mitochondrial F1 complex assembly factor 2" Q8N5M1 17 17977409-18039209 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 104.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023329, HPA059422" Supported Enhanced Cytosol No No Cytosol "HPA023329: AB_1845209, HPA059422: AB_2684011" "unprognostic (3.16e-2)" "unprognostic (1.98e-2)" "unprognostic (4.40e-2)" "prognostic favorable (4.95e-4)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.70e-3)" "unprognostic (1.67e-2)" "prognostic favorable (6.00e-5)" "unprognostic (1.32e-1)" "unprognostic (2.53e-1)" "unprognostic (5.15e-1)" "unprognostic (2.62e-2)" 8.1 18.6 7.3 8.6 7.1 16.1 8.8 8.2 11.2 7.6 7.7 11.2 8.8 6.9 8.8 14.5 8.2 4.9 20.3 7.3 7.5 16.1 19.9 7.9 10.6 7.9 7.9 6.6 7.4 9.9 26.6 9.4 7.8 8.4 9.2 10.5 6.4 10.8 6.7 24.9 14.6 10.2 8.4 7.7 10.5 12.1 11.0 8.0 10.9 10.7 28.1 14.6 9.1 9.6 8.5 13.0 24.1 15.4 14.7 15.1 16.2 15.6 11.2 16.4 23.7 20.1 31.8 19.3 26.0 24.6 19.5 13.1 19.9 14.8 24.1 20.7 20.9 11.7 5.8 14.8 18.6 25.5 8.2 17.3 19.5 16.8 21.4 11.9 16.7 27.4 21.3 9.3 8.9 13.1 26.8 19.4 12.8 10.4 48.3 13.3 19.8 27.1 29.9 19.0 11.4 9.9 13.5 14.9 7.6 14.0 104.2 24.4 16.2 11.6 6.0 12.4 22.2 10.9 6.2 8.4 9.6 10.7 11.9 31.4 7.8 41.5 14.7 9.3 28.6 10.4 27.9 6.9 8.9 49.2 19.7 10.7 8.0 3.0 8.9 22.3 41.6 12.9 20.7 7.3 7.1 8.2 11.2 7.3 7.5 7.9 7.9 6.6 8.4 7.7 8.0 8.5 8.8 6.4 7.8 9.4 20.3 15.3 12.0 23.7 9.6 10.5 13.9 10.8 28.2 20.0 14.4 12.9 33.3 32.5 20.7 10.9 66.5 19.3 52.9 10.5 6.0 10.0 14.5 13.7 13.7 12.3 30.9 9.1 8.2 8.5 13.3 25.7 9.3 20.8 45.5 10.1 14.1 18.2 16.2 22.3 22.5 42.6 6.5 18.2 17.8 7.5 28.1 13.8 13.4 9.0 9.6 16.0 24.4 6.8 18.6 13.8 25.8 58.8 17.2 17.7 0.0 8.4 10.4 28.2 20.9 17.6 18.9 28.7 9.0 15.9 20.5 12.3 CYP4F22 FLJ39501 ENSG00000171954 "Cytochrome P450 family 4 subfamily F member 22" Q6NT55 19 15508525-15552317 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" Ichthyosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 19.0;skin 1: 55.3;vagina: 23.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.8;Breast myoepithelial cells: 5.5;granulocytes: 7.0;Prostatic glandular cells: 4.0;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in many" 7 "breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "intermediate monocyte: 6.1;MAIT T-cell: 4.3;non-classical monocyte: 14.1" "Group enriched" "Detected in many" 8 "monocytes: 14.1;T-cells: 4.3" "Cell line enhanced" "Detected in some" "MCF7: 1.7;T-47d: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA058960 Uncertain NA NA "HPA058960: AB_2683862" "unprognostic (2.32e-3)" "unprognostic (1.17e-2)" "unprognostic (6.81e-2)" "unprognostic (2.47e-2)" "unprognostic (1.03e-1)" "unprognostic (7.02e-2)" "unprognostic (1.30e-1)" "unprognostic (2.43e-1)" "unprognostic (3.33e-1)" "unprognostic (1.89e-2)" "unprognostic (9.33e-2)" "unprognostic (3.00e-2)" "unprognostic (2.21e-5)" "unprognostic (8.10e-2)" "unprognostic (3.16e-1)" "unprognostic (7.25e-3)" "unprognostic (2.03e-2)" 0.9 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 5.1 0.0 0.0 0.2 0.3 0.0 19.0 0.1 0.1 0.0 0.0 0.0 0.0 7.0 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 8.5 0.0 0.0 3.2 6.4 0.2 55.3 0.1 0.0 0.0 0.3 1.4 1.0 0.0 0.1 0.0 0.0 1.8 6.3 23.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 6.1 4.3 0.0 0.5 1.5 0.2 0.0 0.0 0.4 0.0 1.1 14.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 8.8 5.5 0.4 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.0 7.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 4.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 3.0 0.0 1.8 0.0 0.0 0.3 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004234-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "brain: 18.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 32.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 6.6;HDLM-2: 14.7;HEK 293: 10.7;JURKAT: 5.6" "Region enhanced" "Detected in many" "hypothalamus: 6.6" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073369: AB_2686597" "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 4.2 0.0 2.6 0.0 0.0 6.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 18.9 0.0 0.0 0.0 0.2 10.1 6.6 0.1 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.0 0.2 0.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 2.5 0.0 6.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.7 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 2.6 6.1 0.7 0.1 18.9 10.1 6.6 0.1 5.5 7.9 11.9 4.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 32.5 7.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.6 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PPIH "CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP" ENSG00000171960 "Peptidylprolyl isomerase H" O43447 1 42658335-42676758 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059019 Approved NA NA "HPA059019: AB_2683885" "unprognostic (7.93e-3)" "unprognostic (5.49e-3)" "unprognostic (2.53e-2)" "unprognostic (6.42e-2)" "unprognostic (3.79e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.09e-1)" "unprognostic (2.37e-2)" "unprognostic (1.82e-2)" "unprognostic (2.84e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.78e-9)" "unprognostic (6.59e-3)" "unprognostic (4.93e-1)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" 22.2 23.4 22.7 28.1 23.8 57.3 28.0 24.2 29.7 23.4 22.0 33.5 24.6 23.7 25.7 36.7 23.7 18.1 25.5 23.3 23.4 21.4 17.7 22.6 44.8 22.7 22.3 23.6 26.0 19.4 18.5 13.5 24.9 23.1 21.4 33.1 22.6 24.1 18.5 19.9 26.9 28.0 21.6 22.6 32.6 23.6 23.1 22.7 60.8 26.3 21.3 50.8 26.9 26.0 23.7 105.8 66.4 80.1 113.3 24.9 51.5 101.4 67.6 50.1 127.4 114.4 98.1 111.8 171.5 85.9 52.8 61.7 82.3 150.8 108.2 133.9 150.2 119.7 156.4 104.4 98.6 21.4 322.0 90.7 31.2 57.5 117.9 90.6 49.1 60.6 161.2 205.7 91.7 63.8 84.2 250.1 451.0 200.4 100.4 77.7 136.8 150.2 152.2 64.1 64.8 59.2 113.5 59.6 101.1 77.4 100.8 54.5 465.0 48.1 53.2 143.1 77.0 171.7 60.0 140.2 319.6 62.8 294.9 94.8 29.7 15.1 33.3 35.0 23.5 33.3 33.6 35.7 39.9 20.7 32.9 36.1 43.5 3.6 36.4 21.8 25.9 38.2 25.0 22.7 23.8 24.2 29.7 23.3 23.4 22.7 22.3 23.6 23.1 22.6 22.7 23.7 31.3 19.2 20.7 9.8 48.1 28.9 48.2 51.7 38.7 10.0 30.1 44.4 14.1 11.5 25.8 22.0 4.2 62.5 37.7 15.7 45.0 29.4 33.2 23.4 27.4 25.1 21.5 49.8 12.7 26.4 104.5 25.5 27.5 21.6 31.0 46.9 19.2 11.2 52.1 5.0 9.6 27.3 34.6 18.6 25.6 7.3 29.2 28.5 16.0 9.4 26.2 22.2 52.5 11.6 11.6 25.8 17.6 21.4 45.6 28.0 16.1 34.1 19.6 16.1 19.7 21.5 42.0 19.7 32.3 54.6 21.5 37.9 42.7 46.4 40.0 38.7 DRC3 "CFAP134, DKFZP586M1120, LRRC48" ENSG00000171962 "Dynein regulatory complex subunit 3" Q9H069 17 17972813-18016889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 125.1;Early spermatids: 41.8;Endometrial ciliated cells: 121.8;Respiratory ciliated cells: 130.4;Rod photoreceptor cells: 88.7;Spermatocytes: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036040, HPA036041" Approved NA NA "HPA036040: AB_10602349, HPA036041: AB_2674915" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-3)" "unprognostic (9.48e-2)" "prognostic favorable (4.05e-5)" "unprognostic (1.06e-1)" "unprognostic (7.64e-5)" "unprognostic (6.11e-2)" "unprognostic (5.47e-3)" "unprognostic (8.59e-2)" "unprognostic (3.67e-1)" "unprognostic (1.33e-4)" "unprognostic (1.62e-1)" "unprognostic (1.15e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.56e-2)" 0.8 1.0 4.7 0.2 2.6 0.1 2.4 3.7 2.2 3.5 15.5 0.7 0.9 4.5 12.0 0.6 61.9 2.4 1.1 2.5 8.6 4.5 1.1 5.3 0.5 7.6 7.9 0.9 3.3 4.1 6.6 10.0 0.4 5.4 2.1 0.5 9.2 1.5 2.1 1.5 1.2 0.3 1.3 8.2 0.8 0.7 12.0 3.3 1.0 8.6 0.7 0.4 0.8 1.1 3.2 0.5 2.1 0.3 1.0 0.2 0.7 0.1 0.5 0.2 1.0 1.0 0.3 2.2 0.0 1.7 0.3 0.6 1.8 0.6 0.2 0.5 0.1 1.5 0.1 0.1 0.0 0.7 0.3 0.1 0.6 0.6 1.6 0.2 1.1 0.3 0.2 0.0 0.2 1.2 0.6 0.1 0.0 0.4 0.1 0.4 0.1 0.6 0.0 3.1 0.6 0.6 1.7 0.8 0.0 1.9 1.2 2.0 0.0 0.5 0.5 0.4 0.1 0.2 0.3 0.1 0.1 2.7 0.0 1.7 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 4.7 2.6 3.7 2.2 2.5 8.6 7.6 7.9 0.9 5.4 8.2 3.3 3.2 1.9 3.2 3.1 0.0 0.6 0.0 3.6 0.0 1.8 10.7 6.6 7.2 0.0 2.8 13.6 11.0 125.1 0.5 1.5 0.1 5.9 3.0 41.8 121.8 5.3 3.4 0.0 0.0 0.0 0.8 2.7 3.1 3.6 5.4 0.0 3.3 4.6 0.2 0.4 20.2 0.0 0.3 0.0 3.5 0.0 11.1 5.0 0.8 0.0 0.0 0.8 8.6 0.0 0.0 0.0 1.1 1.1 4.5 0.0 1.7 0.5 10.6 130.4 88.7 0.0 8.2 1.3 48.7 13.3 0.9 0.0 0.8 1.4 2.7 0.5 1.1 ZNF57 ZNF424 ENSG00000171970 "Zinc finger protein 57" Q68EA5 19 2900898-2918473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.7;Early spermatids: 95.2;Late spermatids: 64.7;Squamous epithelial cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061915 Approved Nucleoli NA NA Nucleoli "HPA061915: AB_2684635" "unprognostic (3.59e-2)" "unprognostic (1.53e-3)" "unprognostic (1.91e-2)" "unprognostic (8.86e-3)" "unprognostic (3.32e-2)" "unprognostic (3.07e-2)" "unprognostic (7.66e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.35e-1)" "unprognostic (4.04e-2)" "prognostic favorable (7.72e-4)" "unprognostic (2.34e-3)" "prognostic favorable (4.11e-9)" "unprognostic (6.26e-3)" "unprognostic (2.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.49e-3)" 2.7 2.5 1.9 2.0 1.9 4.0 6.5 8.0 3.2 4.3 1.2 8.3 7.3 2.7 3.6 9.2 4.3 1.9 3.0 2.0 1.9 4.6 3.4 3.4 2.8 2.1 2.0 2.0 3.7 4.0 4.0 3.0 4.9 4.2 3.9 9.3 4.2 4.4 3.6 1.7 17.7 6.3 1.8 1.5 2.5 11.8 26.2 2.2 3.9 4.7 2.4 3.3 3.3 8.0 2.1 7.4 3.4 4.7 6.8 4.4 3.8 7.8 3.1 2.5 4.9 5.1 7.1 2.9 6.3 3.8 2.5 7.1 8.5 7.5 10.7 6.0 0.0 3.9 3.7 3.8 9.6 3.3 0.0 6.5 3.0 11.8 4.3 9.3 4.0 3.7 14.8 6.6 0.1 3.8 7.5 9.7 4.1 3.0 8.7 5.9 8.9 14.1 1.4 6.7 12.0 2.3 3.5 4.6 8.4 3.1 6.6 5.2 6.1 2.9 3.3 3.2 7.7 4.4 1.3 7.4 3.0 2.7 1.0 2.7 0.0 2.4 1.1 4.4 4.2 3.6 3.2 4.8 4.5 2.6 3.6 5.4 4.8 0.9 5.1 2.3 2.5 5.5 3.0 1.9 1.9 8.0 3.2 2.0 1.9 2.1 2.0 2.0 4.2 1.5 2.2 2.1 2.2 0.0 5.3 1.6 0.8 21.4 20.3 8.1 30.7 2.2 3.4 3.8 4.1 1.5 7.8 0.0 6.2 4.4 1.9 13.5 3.9 3.1 95.2 7.4 3.4 2.1 0.0 0.4 2.6 2.3 3.7 2.8 7.7 12.3 0.0 2.3 1.4 1.9 2.3 1.7 2.7 7.4 8.2 1.0 2.7 64.7 2.5 1.3 5.4 0.0 1.7 1.9 0.0 1.0 1.5 1.5 9.5 3.0 0.2 5.4 19.8 3.4 4.2 2.8 0.0 0.8 2.5 5.7 9.7 36.6 28.7 6.6 1.7 3.1 8.1 9.7 SHLD1 "C20orf196, FLJ25067, RINN3" ENSG00000171984 "Shieldin complex subunit 1" Q8IYI0 20 5750393-5864395 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;dendritic cells: 13.1;Distal tubular cells: 19.6;Exocrine glandular cells: 14.2;Hofbauer cells: 17.0;Pancreatic endocrine cells: 11.7;Proximal tubular cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 55.7;U-698: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favorable (4.05e-5)" 3.9 9.8 4.9 6.2 5.7 16.9 5.4 7.1 6.2 4.7 4.4 5.2 9.2 3.8 5.4 5.4 4.0 4.4 7.2 4.7 5.5 5.1 3.0 4.9 14.4 5.2 5.1 4.4 5.1 5.2 2.4 6.1 3.1 6.2 6.3 5.0 4.1 8.5 3.7 12.1 4.1 7.1 2.6 4.6 10.0 4.8 3.2 5.3 13.4 6.7 7.8 12.2 4.6 4.8 6.2 9.2 9.6 4.6 2.3 2.8 2.8 2.3 2.5 4.5 3.1 4.3 4.5 9.4 33.3 6.3 2.5 2.5 4.1 2.8 6.1 3.6 10.3 3.4 12.9 1.4 18.2 6.2 16.2 5.7 3.3 7.2 4.7 3.1 3.0 6.4 8.7 17.8 13.9 5.9 3.5 20.4 55.7 6.3 10.3 5.2 16.5 7.1 15.1 5.0 4.5 8.2 7.4 4.6 4.7 10.0 2.6 3.9 13.2 4.3 3.6 5.4 3.5 5.4 8.7 16.6 45.8 1.8 13.9 6.4 21.7 12.4 22.5 21.3 14.8 16.4 27.7 25.2 21.5 12.7 33.1 22.9 17.2 4.9 23.5 16.9 15.1 31.5 13.0 4.9 5.7 7.1 6.2 4.7 5.5 5.2 5.1 4.4 6.2 4.6 5.3 6.2 9.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 6.4 8.6 0.0 0.0 0.0 12.9 0.0 7.5 13.1 0.0 19.6 7.9 0.0 6.4 4.4 2.8 0.0 0.0 0.0 14.2 7.5 1.7 0.0 5.2 0.0 7.3 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.3 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 5.9 6.4 5.0 0.0 0.0 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 590.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 48.2" "Immune cell enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA056175: AB_2683057, HPA066195: AB_2685634" "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 16.4 12.6 3.9 19.1 5.3 40.6 22.5 48.2 7.4 20.0 6.6 11.4 17.1 24.3 11.4 12.9 12.6 24.8 12.2 4.6 7.4 15.7 22.5 16.1 22.2 5.6 7.9 2.4 24.9 13.2 22.1 6.9 14.5 15.6 14.2 12.4 41.8 13.2 11.6 11.1 11.2 19.1 15.7 3.9 21.0 14.7 15.8 5.4 20.6 21.0 13.9 21.5 16.2 9.5 7.9 23.2 11.5 26.5 20.4 13.8 25.2 9.3 15.8 32.5 13.9 19.0 19.8 24.2 31.3 9.4 14.9 12.6 18.6 7.6 15.2 24.7 8.5 9.6 11.9 11.9 14.4 16.8 25.8 4.3 25.3 15.3 24.7 71.3 31.5 25.4 22.0 21.4 23.0 33.1 6.2 19.8 13.8 28.3 5.2 40.0 34.0 57.5 15.0 14.1 16.5 14.4 23.5 23.8 14.7 22.8 19.3 14.6 46.0 30.6 12.9 18.1 11.3 20.0 20.4 17.4 29.1 15.7 15.1 11.7 0.6 2.7 3.2 1.8 1.8 2.7 4.4 1.9 1.9 2.3 4.2 2.7 2.3 14.1 1.7 1.6 4.0 1.8 1.1 3.9 5.3 48.2 7.4 4.6 7.4 5.6 7.9 2.4 15.6 3.9 5.4 7.9 256.1 112.2 93.3 214.5 184.4 151.9 369.2 46.6 93.9 88.7 106.7 92.7 69.4 55.8 96.9 55.2 152.2 34.7 117.4 80.7 13.7 63.3 38.3 155.8 179.7 176.7 86.0 75.3 590.1 47.0 27.7 141.1 119.8 210.1 93.1 79.1 118.2 37.2 57.9 117.8 416.5 66.8 38.7 89.8 185.0 42.3 103.8 206.8 76.5 355.1 96.6 61.2 58.7 419.2 378.8 76.7 88.4 89.5 124.8 161.0 90.6 32.4 104.1 170.9 72.3 214.4 112.6 158.6 146.5 56.4 134.0 33.2 145.6 76.0 52.3 286.7 LDHAL6B "LDH6B, LDHAL6, LDHL" ENSG00000171989 "Lactate dehydrogenase A like 6B" Q9BYZ2 15 59206843-59208588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 41.0" "Cell type enriched" "Detected in some" 13 "Spermatocytes: 101.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.1" "Region enriched" "Detected in single" 6 "olfactory bulb: 1.3" HPA053962 Enhanced NA NA "HPA053962: AB_2682324" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (2.37e-1)" "unprognostic (4.46e-2)" "unprognostic (6.59e-2)" "unprognostic (2.23e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (2.29e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-3)" "unprognostic (1.64e-1)" "unprognostic (3.12e-7)" "unprognostic (3.47e-2)" "unprognostic (1.49e-2)" "unprognostic (8.53e-2)" "unprognostic (7.80e-2)" 0.2 0.0 0.5 0.2 0.7 0.0 0.2 0.5 0.8 0.2 2.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.3 0.1 0.1 0.8 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.6 0.0 0.1 41.0 0.7 0.0 0.1 0.0 0.0 0.1 0.2 1.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.5 0.8 0.2 0.4 0.8 0.5 0.0 1.0 0.6 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659207 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 360.1;skeletal muscle: 1308.7;tongue: 506.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 264.7;Distal enterocytes: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Cell line enhanced" "Detected in many" "BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179" "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 92.6 113.0 104.8 21.5 65.5 0.3 49.0 0.0 84.6 21.0 17.0 37.1 31.7 39.0 21.1 31.3 31.1 32.5 360.1 98.8 28.1 60.1 38.8 72.7 10.7 25.8 12.9 73.4 34.8 33.2 17.2 21.8 24.0 32.8 46.4 17.7 10.1 21.7 29.4 1308.7 14.1 40.0 39.3 20.6 39.3 35.2 17.1 16.9 6.7 31.4 506.5 11.2 57.2 22.5 39.7 0.5 24.2 0.2 0.3 3.5 3.2 88.4 13.8 18.9 4.6 3.7 21.6 9.7 0.1 72.8 19.9 29.2 8.9 0.1 13.5 1.9 0.2 0.2 0.0 37.4 4.7 19.6 0.0 0.9 3.7 21.3 5.2 3.7 27.5 72.7 0.2 0.2 0.2 4.4 1.6 0.1 0.7 2.8 9.3 11.6 0.5 0.7 0.2 3.4 1.9 8.5 39.3 19.9 21.6 0.7 31.1 1.6 6.6 178.0 17.4 53.2 0.4 3.6 0.8 0.2 1.3 152.5 0.3 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.8 65.5 0.0 84.6 98.8 28.1 25.8 12.9 73.4 32.8 20.6 16.9 39.7 51.1 35.3 12.2 1.3 4.8 4.6 3.0 32.6 1.8 1.9 6.4 2.5 264.7 27.1 17.0 7.3 2.1 14.8 0.5 70.5 0.0 43.7 1.7 0.4 0.4 56.3 13.8 2.7 22.5 34.5 6.0 19.9 4.6 0.5 0.0 40.9 62.8 40.0 2.1 0.0 5.7 8.4 2.0 10.8 5.1 3.4 2.8 0.9 5.4 6.5 24.0 7.2 0.0 2.5 1.3 35.6 24.4 27.8 0.6 5.7 52.6 4.4 7.6 0.8 46.0 18.0 29.2 1.2 0.8 1.4 2.3 25.9 1.6 8.6 11.8 3.6 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.6;fallopian tube: 2.0;ovary: 5.4;skeletal muscle: 2.5;tongue: 3.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 7.9;granulocytes: 7.6;Skeletal myocytes: 7.5;Theca cells: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 9 "plasmacytoid DC: 14.9" "Lineage enriched" "Detected in many" 9 "dendritic cells: 14.9" "Cell line enhanced" "Detected in some" "CACO-2: 8.0;HBEC3-KT: 8.5;Hep G2: 13.4;RH-30: 19.3;THP-1: 7.1" HPA060593 Approved Nucleoplasm NA NA Nucleoplasm "HPA060593: AB_2684328" "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.0 0.0 0.5 0.1 0.4 0.5 0.2 1.6 0.5 0.1 0.2 0.0 0.0 0.4 0.3 0.7 2.0 0.1 0.1 0.3 0.2 0.5 0.1 0.1 0.1 0.3 0.2 0.4 5.4 0.5 0.4 0.0 0.1 0.8 0.2 0.1 0.2 0.3 0.0 2.5 0.3 0.1 0.1 0.0 0.2 0.1 0.6 0.2 0.2 0.1 3.4 0.1 0.0 0.0 0.9 2.1 0.3 0.0 3.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 8.0 0.1 2.7 1.3 0.2 0.0 0.1 0.0 8.5 0.0 0.1 0.1 0.1 3.4 13.4 0.1 0.1 4.1 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 2.5 0.1 0.1 0.2 0.0 0.2 0.1 0.0 19.3 1.7 0.0 0.3 0.1 3.1 0.0 0.3 0.0 0.1 4.0 7.1 0.0 0.1 0.1 5.1 0.1 2.3 4.5 0.1 0.2 0.2 0.1 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 1.0 0.5 0.1 14.9 0.1 0.2 0.5 0.4 1.6 0.5 0.3 0.2 0.3 0.2 0.4 0.8 0.0 0.2 0.9 0.6 3.2 7.9 0.0 0.3 0.4 2.9 1.5 4.6 2.7 1.1 2.2 0.4 0.0 5.6 3.7 2.1 0.5 1.9 0.1 0.0 0.1 2.1 2.2 4.1 1.0 0.0 0.0 0.5 0.0 0.3 2.7 0.0 4.5 7.6 1.0 1.1 0.2 0.2 3.3 0.6 0.0 0.0 1.3 1.4 0.0 0.6 1.8 0.0 1.0 0.4 0.5 0.0 0.5 0.4 0.1 0.2 0.4 0.3 2.2 0.0 0.7 4.6 5.4 0.0 7.5 1.5 5.0 5.0 4.8 0.1 0.3 1.3 12.9 0.1 2.0 MAL "MVP17, VIP17" ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053992 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 2840.5;vagina: 870.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 373.3;Distal tubular cells: 236.7;Muller glia cells: 91.5;Oligodendrocytes: 168.1;Skeletal myocytes: 82.3;Squamous epithelial cells: 90.9" "Cancer enhanced" "Detected in many" "renal cancer: 101.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 217.6;naive CD4 T-cell: 293.3;naive CD8 T-cell: 138.1;T-reg: 233.6" "Lineage enriched" "Detected in many" 38 "T-cells: 293.3" "Cell line enhanced" "Detected in some" "HDLM-2: 516.4;MOLT-4: 722.0;RPMI-8226: 256.7;RPTEC TERT1: 2531.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" NA NA "Golgi apparatus" Centrosome "HPA065691: AB_2685533" "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favorable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 4.6 1.9 294.6 10.9 372.1 12.8 4.4 309.1 366.1 221.6 228.6 38.7 2.2 2.7 8.4 2840.5 8.9 2.9 13.9 302.6 310.7 347.7 1.7 25.5 25.3 352.7 333.4 274.3 3.2 3.1 0.4 4.0 3.4 341.0 22.0 6.4 10.2 548.3 11.2 2.8 12.1 17.1 2.4 312.3 9.5 53.1 1.1 321.3 263.6 21.5 4.4 355.9 15.2 870.3 500.0 51.3 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 12.0 0.0 0.3 2.4 0.2 0.0 0.5 516.4 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 2.4 0.4 0.1 0.1 0.0 722.0 0.2 0.2 0.0 0.0 0.7 0.0 256.7 2531.4 65.3 0.6 0.0 0.1 9.4 1.6 2.1 0.3 0.9 0.8 0.0 0.2 0.1 0.5 0.4 0.3 0.3 0.3 0.4 0.1 0.7 0.6 0.1 4.7 0.3 2.1 3.1 217.6 38.4 0.5 3.5 293.3 138.1 2.6 7.7 0.6 1.2 233.6 71.0 294.6 372.1 309.1 366.1 302.6 310.7 352.7 333.4 274.3 341.0 312.3 321.3 500.0 0.9 0.0 0.0 12.1 3.1 1.1 0.2 0.0 1.8 1.5 1.2 0.9 11.3 0.0 1.3 373.3 4.2 0.2 0.9 0.0 236.7 0.1 5.3 4.3 0.6 0.5 0.0 46.1 0.5 0.0 0.0 4.7 24.5 8.2 1.3 3.2 2.5 0.0 0.1 5.0 0.5 0.0 14.2 0.0 1.3 19.5 0.9 1.0 17.8 1.9 2.5 91.5 4.1 6.6 168.1 0.1 0.0 0.0 8.9 0.2 0.0 3.2 0.0 2.7 6.6 82.3 5.3 0.0 0.6 90.9 1.0 0.3 35.8 0.0 0.1 0.8 ZNF554 FLJ34817 ENSG00000172006 "Zinc finger protein 554" Q86TJ5 19 2819868-2836735 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "HPA060247, HPA063358" Uncertain Enhanced Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA060247: AB_2684230, HPA063358: AB_2684995" "unprognostic (3.81e-1)" "unprognostic (1.89e-3)" "unprognostic (1.84e-1)" "unprognostic (3.58e-3)" "unprognostic (5.05e-2)" "unprognostic (7.36e-5)" "unprognostic (1.65e-1)" "prognostic favorable (9.31e-4)" "unprognostic (1.82e-1)" "unprognostic (3.37e-3)" "prognostic favorable (4.69e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.99e-5)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (1.79e-2)" "prognostic favorable (5.00e-4)" 1.9 2.0 2.8 0.6 2.8 0.5 2.5 2.7 4.1 2.9 1.4 2.5 1.3 2.7 1.2 2.5 2.4 0.6 3.2 2.7 2.5 2.9 3.2 1.4 0.6 2.9 2.3 2.9 3.8 3.1 1.5 2.9 1.1 3.0 2.8 0.8 2.5 2.8 0.9 5.2 3.4 2.3 0.6 1.8 1.9 2.5 2.5 3.0 0.9 2.6 2.1 0.7 2.7 2.6 2.6 1.2 0.2 0.9 1.3 0.7 0.9 1.3 0.7 0.6 1.0 0.7 0.1 0.3 1.5 0.6 0.4 1.1 0.7 0.2 0.7 0.8 0.0 0.5 0.5 0.8 0.4 0.6 0.2 0.5 0.7 1.0 0.4 0.7 0.9 0.3 1.1 1.1 0.8 0.5 0.6 1.1 0.3 0.7 0.2 0.1 1.3 0.6 0.3 0.5 1.1 1.5 1.8 0.5 0.3 1.1 0.9 0.4 0.8 0.2 0.4 0.4 0.6 0.4 2.3 2.8 0.4 0.6 0.7 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 0.0 0.6 0.3 0.1 0.1 0.2 0.2 0.9 0.1 0.2 2.8 2.8 2.7 4.1 2.7 2.5 2.9 2.3 2.9 3.0 1.8 3.0 2.6 2.2 12.8 12.5 2.9 3.5 1.3 2.8 1.0 4.0 4.9 2.3 2.2 4.6 1.5 4.6 0.0 8.4 2.8 1.5 3.4 3.9 2.6 0.8 2.1 1.9 3.1 3.6 3.4 4.0 1.4 1.3 3.4 1.5 2.7 0.0 4.4 3.3 2.9 1.5 3.3 4.8 2.0 2.0 2.4 2.5 0.7 3.1 1.6 0.0 1.0 1.4 4.7 5.2 3.5 2.7 1.7 1.0 2.6 3.3 3.3 5.9 3.0 5.5 4.9 0.0 3.8 2.3 7.0 12.2 2.7 1.4 8.8 2.7 3.7 2.2 2.1 RAB33B DKFZP434G099 ENSG00000172007 "RAB33B, member RAS oncogene family" Q9H082 4 139453232-139476609 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 22.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048367 Uncertain NA NA "HPA048367: AB_2680372" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.12e-1)" "unprognostic (3.11e-1)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-2)" "unprognostic (9.45e-2)" "unprognostic (2.36e-2)" "unprognostic (4.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.59e-1)" "unprognostic (8.06e-3)" "prognostic favorable (9.19e-4)" 8.5 5.2 4.4 5.2 5.0 12.9 7.2 7.6 5.3 8.1 3.4 4.1 3.9 9.5 4.2 6.6 5.6 6.0 6.6 4.0 5.2 5.1 16.8 6.9 6.5 6.1 5.8 4.0 10.0 10.1 4.1 2.9 9.1 6.2 6.8 4.1 4.1 4.2 5.7 4.2 4.9 4.2 8.4 5.6 7.5 5.5 3.6 5.5 5.5 6.4 5.2 5.9 5.6 3.1 8.2 5.1 1.9 5.6 7.7 12.6 12.3 9.4 6.1 8.5 5.2 6.4 5.5 8.0 10.7 3.0 7.0 2.6 4.8 6.1 5.4 6.2 10.1 4.0 3.7 4.5 6.4 12.6 6.8 8.4 9.5 5.9 6.6 6.2 9.4 15.3 6.7 4.1 20.6 3.9 3.5 5.8 6.0 3.9 8.5 3.2 7.3 8.4 4.7 7.3 3.4 7.4 7.6 4.3 8.5 10.1 6.2 3.9 4.7 10.7 6.2 4.5 10.6 3.4 10.9 13.3 6.9 6.2 7.3 5.6 4.3 3.4 8.7 3.6 3.5 5.8 4.3 4.5 4.0 2.3 3.6 5.6 5.1 22.6 4.3 3.4 2.8 5.2 3.5 4.4 5.0 7.6 5.3 4.0 5.2 6.1 5.8 4.0 6.2 5.6 5.5 8.2 13.9 6.4 7.7 5.2 15.1 9.9 7.2 3.4 18.2 5.0 10.0 6.3 10.1 5.7 4.1 3.7 0.0 6.3 9.1 5.3 1.9 5.3 34.1 13.7 11.3 12.0 8.4 3.8 5.9 4.7 5.7 10.7 7.1 10.6 6.3 3.3 11.4 19.7 6.6 3.3 7.5 8.2 2.0 9.4 8.9 72.1 10.5 7.1 1.8 10.3 8.6 5.9 3.1 10.1 8.9 6.2 5.2 12.8 10.9 6.8 6.3 4.5 6.4 8.5 6.6 12.8 9.9 4.6 4.3 12.9 11.6 16.8 13.2 3.4 6.5 5.9 THOP1 ENSG00000172009 "Thimet oligopeptidase 1" P52888 19 2785503-2815807 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 136.6;Paneth cells: 160.6;Proximal enterocytes: 312.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025497, HPA035262" Uncertain Supported Cytosol NA NA 2000000 Cytosol "CAB025497: , HPA035262: AB_2674541" "unprognostic (1.52e-2)" "unprognostic (1.73e-3)" "unprognostic (7.94e-2)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" "unprognostic (1.19e-1)" "unprognostic (4.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-3)" "unprognostic (3.00e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.90e-4)" "unprognostic (1.27e-1)" "unprognostic (2.64e-1)" "unprognostic (5.37e-2)" 13.1 19.8 25.6 11.9 27.1 19.8 15.4 24.5 48.8 15.3 20.3 20.7 22.8 18.8 6.4 31.2 17.8 3.3 34.8 28.7 24.4 19.1 73.6 13.8 11.7 29.2 27.8 28.8 18.9 17.6 6.0 32.3 7.8 26.2 37.9 7.0 9.4 15.8 5.3 41.0 20.0 21.7 6.2 22.3 23.2 16.2 70.7 24.6 13.9 18.1 11.1 8.4 18.9 16.0 27.0 91.4 66.3 25.1 54.6 12.8 12.5 89.9 55.4 20.4 53.8 43.4 78.4 28.3 81.3 26.4 21.7 37.7 72.4 37.8 45.6 22.5 0.3 79.7 28.9 75.9 94.4 13.7 56.3 43.1 13.9 16.0 44.8 20.0 15.5 31.0 54.0 68.2 38.7 23.1 70.5 63.1 105.0 74.7 27.2 90.2 51.7 33.8 77.5 22.8 51.9 68.5 54.6 48.5 42.9 27.6 13.1 41.8 53.8 35.5 41.2 35.5 88.6 95.4 67.1 60.7 55.7 46.0 93.3 50.1 9.3 2.5 1.2 3.7 2.9 3.0 3.8 2.7 5.2 3.6 5.3 3.4 3.0 1.0 3.0 6.0 7.0 7.6 2.5 25.6 27.1 24.5 48.8 28.7 24.4 29.2 27.8 28.8 26.2 22.3 24.6 27.0 5.1 3.2 10.6 15.0 12.0 6.8 10.3 15.6 11.4 20.3 12.6 10.8 9.0 5.7 9.7 11.0 35.5 27.6 8.7 136.6 9.8 18.7 17.6 11.1 8.3 7.4 40.8 13.7 12.1 15.1 55.9 11.1 9.2 10.1 5.7 23.1 7.1 85.9 23.0 6.7 10.5 59.9 6.1 9.8 6.0 23.4 11.5 9.1 3.6 3.7 8.3 13.5 4.1 4.0 7.1 21.3 160.6 6.0 17.2 16.6 312.2 10.8 9.7 32.4 13.1 10.6 15.0 55.6 19.2 13.4 5.8 33.8 8.0 15.9 48.2 8.4 ANKRD20A4P ANKRD20A4 ENSG00000172014 "Ankyrin repeat domain 20 family member A4, pseudogene" Q4UJ75 9 64369394-64413142 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 9.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.0;Karpas-707: 1.4" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753" Uncertain NA NA "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592" "unprognostic (3.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.69e-2)" "unprognostic (2.56e-1)" "unprognostic (9.24e-2)" "unprognostic (1.11e-2)" "unprognostic (3.97e-3)" "unprognostic (8.99e-2)" "unprognostic (2.88e-1)" "unprognostic (4.12e-1)" "unprognostic (4.01e-2)" "unprognostic (1.82e-2)" "unprognostic (1.16e-1)" "unprognostic (8.10e-2)" "unprognostic (5.84e-2)" 0.5 0.2 0.1 0.1 0.1 1.1 0.2 0.1 1.5 0.1 0.0 0.3 0.2 0.1 0.1 0.5 0.1 0.1 0.3 0.9 0.0 0.2 0.1 0.3 0.1 0.3 0.0 0.0 0.4 0.7 0.1 0.2 0.3 0.6 0.1 0.4 0.5 0.3 0.0 0.2 0.2 0.3 0.0 0.0 0.3 0.3 0.6 0.5 0.2 0.2 0.1 0.1 0.1 0.2 0.5 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.6 0.1 0.0 0.2 0.5 0.4 0.1 0.2 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.9 1.0 1.4 0.0 0.0 0.3 0.0 0.1 0.8 0.3 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.0 0.7 0.1 0.7 0.0 0.3 0.0 0.7 0.1 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 1.5 0.9 0.0 0.3 0.0 0.0 0.6 0.0 0.5 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 REG3A "HIP, PAP, PAP1, PBCGF, REG-III, REG3" ENSG00000172016 "Regenerating family member 3 alpha" Q06141 2 79157003-79159753 "Plasma proteins, Predicted secreted proteins, Transporters" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 61 "intestine: 6799.9;pancreas: 12313.8" "Group enriched" "Detected in some" 11 "Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 710.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1" "HPA047894, HPA048334, HPA060705" Supported Approved Cytosol "Secreted to digestive system" NA NA 23000000 Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (2.43e-2)" "unprognostic (2.12e-1)" "unprognostic (3.62e-2)" "unprognostic (1.42e-1)" 10.9 10.1 0.0 13.5 0.0 0.2 0.6 0.0 0.0 0.1 0.0 12.3 5226.9 2.9 0.0 1.4 0.2 25.2 0.9 0.0 0.0 2.6 2.1 0.6 5.0 0.0 0.0 0.0 0.9 12313.8 0.0 2.1 0.1 0.0 0.5 0.0 0.0 2.1 0.0 0.6 0.4 6799.9 0.2 0.0 1.3 157.8 0.9 0.0 0.0 0.6 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.4 0.0 0.0 0.0 24.6 0.0 0.0 1.8 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.5 5.4 11.0 0.0 15.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 152.8 7.7 0.0 0.0 3.0 0.0 0.0 0.0 1988.6 0.0 0.0 189.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 130.2 0.0 0.0 0.0 6.8 0.0 1.4 0.0 0.0 55.8 0.0 0.0 0.0 0.0 5382.1 32.5 0.0 0.2 0.0 215.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 315.9 0.0 GAP43 "B-50, GAP-43, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623510-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 289.7" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 270.2" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" NA NA 35000 "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 0.6 6.3 105.9 7.6 160.6 0.0 0.9 51.1 289.7 0.4 4.8 8.7 2.6 0.3 0.1 1.1 0.3 4.7 4.3 142.2 160.0 0.2 0.2 0.3 0.2 70.4 121.7 154.7 0.2 0.8 0.0 10.1 1.7 101.5 0.9 4.8 8.0 2.1 0.3 0.3 0.4 5.5 4.4 50.3 0.0 2.9 0.4 150.4 0.1 0.2 0.6 0.4 1.3 1.9 136.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.5 0.0 0.0 0.0 9.1 0.2 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.2 39.6 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.1 0.0 0.0 18.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 105.9 160.6 51.1 289.7 142.2 160.0 70.4 121.7 154.7 101.5 50.3 150.4 136.0 0.1 0.0 0.0 20.9 0.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.8 5.1 0.0 0.0 270.2 0.0 0.1 4.5 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.0 62.5 0.0 0.0 0.0 1.2 1.8 0.0 0.0 1.8 29.0 0.0 1.4 0.0 40.2 20.2 0.8 0.0 0.0 0.4 0.0 0.0 0.2 0.0 3.5 0.0 2.0 1.1 0.9 1.7 0.0 0.1 0.0 0.1 0.3 0.0 0.0 REG1B "PSPS2, REGH, REGI-BETA, REGL" ENSG00000172023 "Regenerating family member 1 beta" P48304 2 79085023-79088019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "pancreas: 40077.8" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 36125.0" "Cancer enriched" "Detected in some" 5 "pancreatic cancer: 201.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;HDLM-2: 4.1;RPMI-8226: 3.0;U-2 OS: 15.7;U-251 MG: 3.9;U-266/84: 3.8" "HPA045549, HPA045579" Supported "Secreted to digestive system" NA NA 32000000 "HPA045549: AB_2679365, HPA045579: AB_2679374" "unprognostic (4.08e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-3)" "unprognostic (9.20e-2)" 10.2 2.2 0.0 36.1 0.0 9.9 3.3 0.0 0.1 2.4 0.0 11.4 744.8 2.1 0.0 3.5 2.1 0.4 2.7 0.0 0.0 2.6 5.6 1.7 1.7 0.0 0.0 0.0 2.1 40077.8 0.0 3.1 0.1 0.0 2.0 109.3 0.0 3.1 0.0 1.6 16.2 2777.0 113.2 0.0 3.3 5.0 1.5 0.0 0.0 1.7 0.0 0.0 1.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.1 3.9 0.0 3.8 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 86.7 0.0 0.0 0.0 3.3 1.8 0.0 0.0 36125.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 178.3 0.0 0.0 0.0 0.0 7978.5 174.7 0.0 0.0 0.0 3101.3 0.1 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 178.8 0.0 EPHX4 "ABHD7, EH4, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029985-92063538 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;choroid plexus: 6.3" "Group enriched" "Detected in many" 5 "Excitatory neurons: 55.3;Inhibitory neurons: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 12.1" "Lineage enriched" "Detected in single" 21 "T-cells: 12.1" "Cell line enhanced" "Detected in some" "A-431: 15.4;CAPAN-2: 13.0;EFO-21: 25.9;RPTEC TERT1: 36.1;U-251 MG: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035067 Uncertain Approved Vesicles NA NA Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavorable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 0.4 0.5 5.1 0.5 8.8 0.0 1.4 3.4 11.1 0.9 6.3 0.4 0.6 0.7 0.5 0.8 0.4 0.4 0.5 7.7 5.5 0.4 0.0 0.6 0.2 4.7 4.3 7.4 0.1 0.0 0.4 1.1 0.8 5.4 0.9 0.5 2.2 0.2 1.8 0.1 0.4 0.4 1.1 3.0 0.0 0.3 1.2 4.1 0.0 1.8 0.1 0.2 0.7 0.2 6.8 15.4 0.5 2.9 0.0 0.0 0.0 0.7 0.3 5.5 0.5 0.3 0.0 13.0 0.0 25.9 0.0 3.9 0.2 0.5 1.2 0.5 0.0 8.0 0.0 0.1 0.0 0.2 1.1 0.0 0.9 0.7 0.0 0.0 9.4 4.5 0.0 0.1 0.0 0.4 0.9 2.2 0.6 2.8 0.0 5.2 0.5 0.3 0.0 36.1 3.0 1.8 2.2 9.1 0.0 2.9 0.2 0.0 2.2 0.2 0.0 0.1 0.0 10.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 2.0 0.1 1.4 3.0 0.0 0.0 0.3 2.8 0.0 0.5 0.0 0.0 0.0 1.5 5.1 8.8 3.4 11.1 7.7 5.5 4.7 4.3 7.4 5.4 3.0 4.1 6.8 2.0 0.0 0.0 4.9 0.0 0.1 0.1 2.0 0.0 2.0 6.7 4.6 1.0 0.0 1.5 0.0 2.1 0.4 3.2 0.1 0.0 0.4 1.7 1.0 0.1 6.2 0.0 0.0 55.3 0.9 0.7 0.3 0.0 1.3 0.0 0.3 0.4 0.0 0.2 1.7 32.5 0.0 0.0 0.0 0.4 0.1 0.0 0.2 3.6 4.7 0.1 8.6 0.0 5.5 2.7 5.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.6 0.0 0.1 0.8 6.0 0.7 0.1 0.4 0.0 1.1 0.2 0.3 0.3 LAMB2 "LAMS, NPHS5" ENSG00000172037 "Laminin subunit beta 2" P55268 3 49121114-49133118 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 151.8;Leydig cells: 146.3;Peritubular cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 299.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000053, HPA001895, HPA050033, CAB078160" Supported Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 25000000 Vesicles Cytosol "CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: " "unprognostic (1.12e-2)" "unprognostic (4.40e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" "unprognostic (4.08e-1)" "unprognostic (4.01e-1)" "unprognostic (5.59e-2)" "unprognostic (6.80e-2)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (1.26e-1)" "unprognostic (4.96e-2)" "unprognostic (1.21e-3)" "unprognostic (1.78e-1)" "unprognostic (4.38e-2)" "unprognostic (6.20e-2)" "unprognostic (1.24e-2)" 75.9 73.8 11.8 18.3 11.7 2.6 58.7 14.4 15.0 67.6 44.0 51.0 24.8 73.3 25.7 32.2 64.4 62.7 170.6 11.4 34.2 41.1 32.0 55.6 17.1 18.4 11.5 6.0 95.1 33.0 105.6 15.6 99.9 13.2 50.8 18.2 11.8 40.7 81.8 68.1 41.3 32.8 80.9 12.9 30.0 48.8 21.5 16.3 6.8 60.7 70.6 12.9 52.6 56.3 12.2 15.7 38.7 34.4 122.0 196.3 201.5 31.1 131.9 161.8 73.8 75.7 18.3 52.0 0.2 44.4 299.0 38.3 49.3 30.0 47.6 52.3 0.1 9.5 6.9 63.4 32.1 132.5 0.3 0.3 176.9 69.4 61.6 62.1 184.3 75.9 0.0 4.1 0.1 61.4 30.3 0.1 0.3 15.1 20.7 32.0 0.2 16.6 0.5 53.5 19.1 0.2 20.4 74.9 42.9 68.3 57.5 93.4 0.9 126.9 82.2 34.9 28.5 35.4 0.1 0.4 0.4 39.1 0.3 57.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 11.7 14.4 15.0 11.4 34.2 18.4 11.5 6.0 13.2 12.9 16.3 12.2 83.7 118.6 53.5 26.1 2.4 31.2 13.9 33.6 33.0 1.7 39.4 40.5 151.8 37.1 43.6 55.2 6.2 11.3 0.9 3.6 5.9 26.4 3.5 15.4 24.4 77.8 0.0 0.4 0.2 9.4 6.4 120.1 50.4 27.2 1.3 88.9 94.9 49.9 10.4 8.4 0.4 3.1 32.6 10.1 31.1 12.3 146.3 7.5 42.7 15.9 3.5 46.7 2.1 1.0 0.6 14.1 14.9 140.7 0.5 10.2 16.4 28.6 11.2 2.6 118.3 80.8 92.3 4.3 8.6 14.2 24.4 9.4 3.8 27.6 5.6 9.3 USP19 "KIAA0891, ZMYND9" ENSG00000172046 "Ubiquitin specific peptidase 19" O94966 3 49108046-49120938 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.23e-2)" "unprognostic (2.12e-1)" "unprognostic (5.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-2)" "unprognostic (3.90e-3)" "unprognostic (2.99e-2)" "unprognostic (3.00e-3)" "unprognostic (2.69e-1)" "unprognostic (3.65e-2)" "unprognostic (2.31e-2)" "unprognostic (1.26e-1)" "prognostic favorable (7.05e-9)" "unprognostic (2.99e-1)" "unprognostic (2.11e-1)" "unprognostic (1.72e-3)" "unprognostic (7.54e-2)" 19.6 25.7 16.2 19.6 16.7 27.1 19.7 17.7 18.7 22.0 20.7 24.8 22.6 24.5 19.3 19.8 24.5 15.6 27.0 16.1 15.4 19.0 18.7 17.9 21.7 17.5 16.4 14.3 23.0 21.3 31.2 17.6 16.6 17.9 19.6 16.1 14.4 29.9 24.6 76.3 26.7 22.1 19.1 15.5 23.1 21.8 21.0 16.8 27.7 23.8 45.4 16.9 23.5 19.8 18.0 20.2 26.3 28.6 42.1 36.8 24.1 38.7 23.1 26.1 35.1 28.7 28.7 27.3 41.6 22.2 24.4 36.2 24.1 40.3 29.1 16.0 32.7 32.1 42.5 56.4 22.8 36.1 45.7 40.5 33.8 22.7 36.9 24.1 25.9 24.2 33.8 30.8 28.4 18.9 23.9 42.6 43.0 58.2 27.4 44.1 19.4 24.3 45.7 22.3 37.4 16.5 51.4 33.3 38.1 34.9 26.1 26.0 55.4 21.8 24.5 30.5 36.7 33.7 77.7 97.1 38.0 32.8 34.3 32.6 9.7 3.7 5.3 4.5 3.6 4.2 2.8 3.7 5.2 4.6 2.9 3.3 3.9 7.5 2.9 4.4 1.9 2.7 4.3 16.2 16.7 17.7 18.7 16.1 15.4 17.5 16.4 14.3 17.9 15.5 16.8 18.0 7.8 12.8 14.5 10.4 7.2 6.2 3.8 8.5 8.6 12.7 8.7 7.4 13.1 5.7 9.9 7.3 18.8 9.6 9.2 17.1 5.9 7.7 3.6 14.8 8.7 7.6 9.1 10.3 8.4 7.8 5.3 7.7 14.3 9.5 2.5 8.1 7.9 13.6 9.0 13.5 8.0 11.6 10.2 8.7 4.7 4.9 13.1 6.8 3.6 2.8 6.5 8.7 3.1 8.0 7.7 11.5 13.9 12.4 7.4 4.2 16.3 7.7 14.9 11.4 13.1 12.3 11.1 16.2 13.2 9.1 5.4 13.5 8.0 9.8 13.4 3.1 QARS1 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase 1" P47897 3 49095932-49105130 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol No No 58000 Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favorable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favorable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 57.8 59.3 21.1 57.7 22.2 97.4 90.4 25.3 21.0 58.8 34.8 105.8 102.6 45.9 59.0 103.3 71.6 48.7 72.7 19.8 22.2 57.6 51.5 52.7 76.4 25.0 22.1 18.1 69.6 74.5 78.7 33.3 77.4 23.8 60.9 122.1 21.6 104.1 61.7 157.6 105.8 85.3 60.8 24.4 60.6 75.6 30.2 23.0 93.1 53.7 147.5 119.7 73.5 58.6 26.1 95.9 97.8 128.0 197.4 146.4 180.8 159.2 90.5 188.2 160.5 152.9 123.0 113.5 257.1 61.4 136.7 95.3 119.9 166.3 137.8 111.4 78.2 148.0 206.4 156.0 216.1 91.2 187.2 130.9 184.8 123.1 127.4 108.1 175.3 184.7 144.6 95.3 112.4 118.0 89.2 130.7 154.9 116.1 159.0 122.9 76.0 123.7 200.6 108.5 163.9 48.7 161.6 85.4 211.0 147.8 122.7 184.4 205.5 137.6 82.8 127.3 131.7 117.9 111.9 176.5 142.9 88.4 156.3 60.3 30.7 84.3 25.8 44.5 104.1 57.4 62.2 54.1 47.0 127.0 49.9 46.6 49.0 8.0 71.8 94.5 57.4 82.1 81.2 21.1 22.2 25.3 21.0 19.8 22.2 25.0 22.1 18.1 23.8 24.4 23.0 26.1 15.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 193.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 156.7 14.7 0.0 0.0 0.0 0.0 0.0 0.0 96.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 187.0 2.0 0.0 0.0 0.0 ORMDL3 ENSG00000172057 "ORMDL sphingolipid biosynthesis regulator 3" Q8N138 17 39921041-39927601 "Disease related genes, Predicted membrane proteins" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 236.4" "Cell type enhanced" "Detected in many" "Early spermatids: 251.6;Late spermatids: 328.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 427.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (3.31e-2)" "unprognostic (6.49e-2)" "unprognostic (4.11e-2)" "unprognostic (1.55e-1)" "unprognostic (2.96e-1)" "prognostic favorable (9.29e-4)" "unprognostic (1.26e-1)" "unprognostic (3.67e-1)" "unprognostic (5.68e-2)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (2.37e-1)" "unprognostic (4.55e-1)" "unprognostic (1.09e-3)" "prognostic favorable (5.18e-4)" 150.3 29.8 42.1 34.2 42.3 40.0 71.4 39.9 44.3 40.4 54.3 42.3 50.5 36.4 65.3 28.6 28.2 32.7 63.6 44.3 45.4 38.3 236.4 49.5 56.3 44.0 40.8 40.0 40.2 110.5 51.6 50.6 35.8 40.4 47.3 39.0 25.3 71.0 42.0 44.6 41.5 48.2 36.9 42.5 38.6 50.5 51.2 43.5 80.1 58.2 29.8 56.9 47.4 26.5 42.1 33.5 40.2 41.8 34.8 106.1 40.2 37.9 48.0 55.4 50.5 48.4 46.1 36.3 24.7 44.6 59.4 34.5 56.0 29.8 38.6 46.9 427.6 53.2 24.1 22.5 113.0 41.5 28.5 40.6 44.2 39.7 34.9 19.7 57.2 22.8 68.5 30.9 194.8 28.0 30.1 85.1 31.9 23.4 44.2 20.1 71.2 37.7 78.4 28.2 80.1 36.6 37.2 31.8 196.6 32.9 46.3 70.8 30.8 18.7 27.4 34.0 23.6 36.8 104.2 95.3 34.5 28.2 27.6 20.6 9.3 4.7 61.1 39.4 7.7 28.3 26.4 39.3 43.3 4.2 23.1 44.2 53.7 7.7 18.4 11.6 21.1 27.7 36.6 42.1 42.3 39.9 44.3 44.3 45.4 44.0 40.8 40.0 40.4 42.5 43.5 42.1 7.6 51.3 37.2 2.9 28.7 16.4 13.7 13.1 21.6 18.5 25.9 14.5 28.9 17.2 15.3 42.3 0.0 25.9 18.4 27.3 3.9 18.4 251.6 7.2 12.6 10.3 25.9 34.1 3.4 29.2 17.9 13.9 11.2 13.8 18.4 10.5 7.5 97.8 8.3 13.5 3.8 26.8 18.3 7.5 13.0 328.9 18.6 6.0 16.0 1.9 22.1 44.9 57.7 3.5 3.2 38.8 20.8 28.6 41.2 15.2 29.2 11.9 8.0 11.2 26.3 8.5 16.5 5.8 7.6 11.5 14.3 9.3 35.6 21.0 17.7 12.4 SERF1A "4F5, FAM2A, H4F5, SERF1, SMAM1" ENSG00000172058 "Small EDRK-rich factor 1A" O75920 5 70900669-70918530 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 65.3;testis: 44.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 92.1;Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 26.9;Smooth muscle cells: 17.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 111.9;SK-MEL-30: 80.5;WM-115: 59.8" HPA075271 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.14e-1)" "unprognostic (3.00e-2)" "unprognostic (9.58e-2)" "unprognostic (3.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.81e-3)" "unprognostic (1.29e-3)" "unprognostic (1.40e-2)" "unprognostic (2.55e-2)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (4.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.98e-2)" "unprognostic (1.22e-2)" "unprognostic (9.53e-2)" 3.9 2.6 10.9 3.3 11.2 5.8 3.3 10.4 30.6 2.2 10.3 3.4 0.5 5.6 38.6 7.5 2.4 11.0 3.3 11.2 11.4 16.4 5.7 6.2 5.8 11.7 12.1 11.0 6.4 13.5 13.8 3.7 3.2 12.8 6.2 8.1 65.3 9.6 5.6 3.4 5.5 2.6 10.5 10.1 5.4 8.5 44.1 11.4 0.6 9.6 0.1 0.4 12.6 2.7 11.2 35.9 0.2 5.5 5.6 32.6 22.0 28.3 10.3 14.7 5.0 2.1 1.0 0.3 1.8 57.9 16.4 1.1 9.7 0.8 0.4 24.9 1.3 1.3 17.4 2.2 1.0 0.3 5.6 0.6 1.1 30.6 0.2 0.5 23.5 1.0 0.3 0.2 6.3 0.2 1.6 32.8 28.8 19.7 0.0 0.2 0.2 18.4 13.9 7.1 2.6 38.5 17.3 111.9 17.2 80.5 0.4 50.0 10.6 53.8 28.4 4.3 1.8 0.5 0.5 0.5 27.4 0.5 0.1 59.8 0.1 0.8 10.2 2.9 1.6 2.8 3.5 2.5 5.0 0.2 2.8 2.0 2.1 2.6 3.2 2.6 1.5 3.5 0.6 10.9 11.2 10.4 30.6 11.2 11.4 11.7 12.1 11.0 12.8 10.1 11.4 11.2 1.7 0.0 4.2 0.3 1.9 1.9 2.7 2.4 0.6 3.9 1.8 1.3 92.1 2.8 3.2 3.7 25.0 0.3 1.5 2.4 3.9 1.7 2.8 0.8 1.2 8.2 5.4 0.0 0.5 0.5 0.4 6.2 0.0 0.7 2.5 1.5 1.4 0.2 0.5 0.0 0.4 1.0 0.0 0.3 2.1 1.2 2.1 0.5 0.0 0.0 1.3 2.4 0.0 0.0 0.4 1.0 3.2 3.8 1.2 2.3 3.1 1.5 4.2 26.9 0.0 3.1 17.1 3.0 2.0 0.3 2.3 0.1 1.9 1.4 1.8 1.0 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 135.0;Suprabasal keratinocytes: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: AB_2683664" "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 28.0 15.8 4.2 7.7 3.4 28.0 22.5 8.5 4.1 13.2 5.0 14.7 7.5 20.2 9.8 13.3 13.8 18.3 19.2 3.1 4.2 15.8 35.5 22.6 9.4 3.9 3.5 3.0 24.1 54.6 18.5 2.5 19.7 4.2 10.2 9.4 3.0 16.1 14.9 12.2 24.4 8.8 16.9 3.2 19.0 12.5 30.2 3.8 4.0 16.7 27.5 5.6 12.7 13.2 5.4 6.9 3.3 7.8 0.7 5.3 9.4 18.8 7.9 7.9 4.4 4.6 7.8 15.8 0.0 13.9 9.6 17.9 1.6 6.8 6.1 2.9 47.6 5.2 3.5 9.7 1.6 5.2 14.6 22.1 14.7 22.3 8.4 2.3 11.4 3.9 1.3 9.7 30.8 4.6 8.2 0.0 2.7 12.5 5.6 6.7 7.8 0.2 13.6 10.8 8.5 10.0 6.2 12.0 24.5 23.4 12.2 5.7 19.6 11.2 19.3 15.9 14.7 2.6 27.9 36.0 18.7 5.0 3.8 10.4 0.0 8.2 2.0 2.6 12.3 0.8 3.2 1.8 1.9 7.3 2.9 0.5 1.1 0.2 6.6 14.8 0.3 3.0 5.4 4.2 3.4 8.5 4.1 3.1 4.2 3.9 3.5 3.0 4.2 3.2 3.8 5.4 58.8 6.4 4.6 0.3 12.5 60.5 17.7 5.5 25.6 6.2 14.3 13.2 3.5 10.0 6.1 7.3 6.2 3.2 10.1 2.5 29.4 8.2 135.0 9.1 21.5 33.3 7.1 4.6 1.7 8.5 4.2 17.5 9.7 26.6 8.2 15.5 37.5 38.1 12.5 3.3 1.4 7.0 16.2 32.4 42.4 25.9 14.6 22.0 30.2 1.0 16.6 2.2 3.1 0.5 0.3 8.9 1.5 16.6 5.3 15.0 6.1 8.4 4.3 5.8 32.9 10.4 35.7 13.8 39.0 13.1 86.2 8.2 10.8 11.2 7.8 11.7 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355249-194369743 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 5.0;skin 1: 5.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "fHDF/TERT166: 120.6;U-87 MG: 62.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1700000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 1.1 0.1 0.0 1.4 0.0 0.0 3.7 0.0 0.1 2.9 0.1 1.7 0.5 1.9 0.0 0.5 1.1 1.6 0.1 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.1 0.0 0.2 0.1 0.1 0.0 2.3 0.0 0.1 3.1 0.0 1.0 0.0 0.1 5.3 0.4 0.6 0.0 1.3 1.5 0.0 0.0 0.2 1.3 0.2 5.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.7 0.1 0.1 0.4 0.0 0.0 1.0 120.6 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 22.5 3.7 3.0 0.0 0.0 0.0 0.0 62.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 SMN1 "BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A" ENSG00000172062 "Survival of motor neuron 1, telomeric" Q16637 5 70925030-70953942 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Club cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3" "CAB016324, HPA045271, CAB069888, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: " "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.18e-1)" "unprognostic (2.09e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-3)" "unprognostic (2.10e-2)" "unprognostic (2.43e-1)" "unprognostic (9.91e-3)" "unprognostic (1.13e-2)" "unprognostic (1.01e-1)" "unprognostic (4.41e-1)" "prognostic unfavorable (6.62e-13)" "unprognostic (2.04e-1)" "unprognostic (2.17e-1)" "unprognostic (8.06e-2)" "unprognostic (4.14e-2)" 26.5 22.0 5.5 5.0 6.1 22.0 27.0 7.8 7.5 32.5 5.1 24.3 2.1 24.9 12.9 26.0 31.8 7.5 20.2 6.4 8.1 21.0 37.9 22.2 15.7 7.8 6.8 5.6 37.1 27.8 7.0 26.6 5.2 7.0 25.8 7.9 12.2 21.7 3.8 31.7 23.4 19.7 8.2 6.5 22.8 20.5 25.0 5.8 2.4 24.4 1.6 2.0 26.3 27.8 6.6 11.3 2.1 3.5 4.0 19.3 23.0 62.8 3.5 4.9 5.3 3.8 4.1 4.1 4.6 69.5 9.9 5.8 7.4 5.4 3.7 4.2 1.0 5.2 65.4 6.2 6.2 1.3 7.9 5.8 1.5 29.8 1.8 1.8 31.4 3.0 4.1 2.7 6.4 2.7 3.2 120.5 77.9 4.4 0.9 2.1 6.0 15.9 58.0 2.4 5.2 11.4 16.2 6.5 23.4 69.4 2.4 88.9 21.2 32.7 33.8 3.8 3.1 7.5 4.2 3.0 60.0 4.9 4.8 120.3 9.8 7.4 4.3 6.4 12.2 17.6 13.2 10.2 7.7 11.2 7.2 13.1 14.5 2.1 8.7 13.5 13.1 16.1 6.3 5.5 6.1 7.8 7.5 6.4 8.1 7.8 6.8 5.6 7.0 6.5 5.8 6.6 5.0 9.6 11.5 0.0 5.6 13.9 4.6 10.7 0.6 4.7 4.1 4.3 22.4 7.2 29.9 1.8 10.4 7.9 7.0 2.3 5.9 6.8 18.2 5.6 5.5 6.8 6.0 9.9 1.3 4.6 8.4 11.8 4.1 4.4 19.6 4.0 5.0 2.9 4.8 3.3 1.1 4.2 10.2 3.4 4.4 12.9 9.3 5.2 5.4 0.0 6.1 1.4 12.3 1.0 1.3 6.5 1.8 6.4 5.1 2.9 3.8 4.5 28.1 7.8 13.1 7.4 8.5 16.0 17.2 6.9 12.5 8.8 7.2 5.6 4.2 4.1 EIF2AK3 "PEK, PERK" ENSG00000172071 "Eukaryotic translation initiation factor 2 alpha kinase 3" Q9NZJ5 2 88556741-88627464 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Stress response, Translation regulation, Unfolded protein response" "Kinase, Serine/threonine-protein kinase, Transferase" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.8" "Cell type enhanced" "Detected in many" "Plasma cells: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 46.8;U-266/70: 44.0;U-698: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009204, HPA015737" Approved NA NA "CAB009204: AB_2230863, HPA015737: AB_1848062" "unprognostic (7.25e-3)" "unprognostic (5.35e-2)" "unprognostic (3.03e-3)" "unprognostic (9.32e-2)" "unprognostic (9.39e-3)" "unprognostic (3.25e-2)" "unprognostic (2.27e-2)" "unprognostic (3.46e-3)" "unprognostic (9.84e-2)" "unprognostic (3.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (9.80e-2)" "unprognostic (3.60e-3)" "unprognostic (2.90e-3)" 3.3 3.2 1.1 4.0 1.1 2.6 1.7 1.6 1.4 2.3 1.4 4.8 6.2 1.9 1.0 1.6 1.3 1.4 1.3 0.7 6.0 2.1 1.9 1.8 3.3 1.1 1.2 0.5 1.9 19.8 3.4 1.2 3.3 1.0 4.0 1.8 0.1 9.7 1.2 2.0 1.5 5.1 0.9 1.7 3.1 12.5 1.0 1.2 1.3 3.5 0.0 2.3 1.9 1.9 2.1 8.7 3.3 1.2 4.3 2.8 2.0 15.9 12.4 1.1 0.7 2.1 3.5 2.9 46.8 8.0 1.3 3.1 7.2 1.6 1.3 1.1 25.3 7.1 4.6 1.7 2.0 1.1 3.9 12.3 0.1 1.5 0.7 2.0 0.8 1.4 4.9 3.0 8.7 0.6 4.4 5.5 2.2 6.2 2.7 7.2 25.1 7.0 8.2 1.3 5.0 5.6 9.9 6.3 6.5 8.2 1.7 2.2 4.4 3.9 2.5 5.5 10.8 7.1 44.0 24.4 31.0 4.6 4.2 6.2 0.0 0.1 0.1 0.3 0.0 0.2 1.0 0.2 0.8 0.1 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.1 1.1 1.6 1.4 0.7 6.0 1.1 1.2 0.5 1.0 1.7 1.2 2.1 9.2 9.6 7.5 14.7 43.8 20.3 8.9 7.2 26.7 8.4 14.7 8.9 8.2 17.2 7.2 12.9 8.4 4.1 13.4 14.0 0.0 3.7 0.1 18.4 18.3 7.6 13.7 1.7 31.3 6.5 6.9 15.2 40.2 39.2 1.3 4.4 8.9 11.8 4.6 1.7 39.0 30.1 14.2 5.1 41.2 0.7 7.5 27.7 32.0 21.5 3.9 3.0 9.2 20.1 26.2 7.0 7.7 5.7 121.3 13.0 5.4 2.9 7.7 2.3 0.0 13.4 9.4 3.1 3.6 23.8 18.3 6.7 12.8 3.5 6.8 16.6 TEX37 "C2orf51, FLJ25369, TSC21" ENSG00000172073 "Testis expressed 37" Q96LM6 2 88524649-88529585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 621 "testis: 85.7" "Group enriched" "Detected in some" 229 "Early spermatids: 846.6;Late spermatids: 3191.0" "Cancer enriched" "Detected in single" 17 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "BEWO: 50.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043987, HPA070239" Enhanced Supported Cytosol NA NA Cytosol "HPA043987: AB_10961125, HPA070239: " "unprognostic (1.08e-3)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 50.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 846.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3191.0 8.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.4 8.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071036-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 74.4;Langerhans cells: 91.3;monocytes: 81.1;NK-cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 24.4 15.4 19.6 50.2 17.9 54.2 21.1 18.5 40.8 25.1 23.1 31.2 13.0 32.5 9.4 22.6 27.6 17.7 14.2 18.7 22.0 15.9 9.8 25.4 73.9 25.9 19.3 14.6 20.6 13.7 8.7 12.3 16.0 21.9 26.2 15.1 6.8 17.3 20.3 14.2 21.2 31.9 28.9 19.2 60.9 20.5 8.8 22.9 35.2 16.1 14.5 66.2 27.3 23.0 27.7 45.6 18.4 21.5 20.6 49.7 54.7 16.7 28.1 17.7 18.7 14.9 7.4 16.1 116.4 10.1 48.8 15.2 18.9 12.0 62.2 15.0 41.2 6.2 25.3 12.3 10.1 49.2 40.0 125.7 32.4 40.4 51.5 21.7 21.6 35.5 22.1 13.4 113.4 27.6 18.1 20.9 40.6 6.6 5.5 13.1 12.6 6.4 91.2 23.5 11.3 13.7 18.3 14.3 14.9 15.9 15.9 16.0 64.3 60.8 22.6 12.4 42.5 16.9 22.1 86.8 90.4 61.0 26.7 27.7 80.8 87.0 100.7 62.3 83.8 52.9 43.6 45.8 51.9 58.7 39.1 34.1 44.1 274.5 54.2 96.3 33.4 60.3 85.6 19.6 17.9 18.5 40.8 18.7 22.0 25.9 19.3 14.6 21.9 19.2 22.9 27.7 8.6 3.2 4.5 8.8 50.6 15.0 10.9 11.7 8.6 3.7 9.4 7.4 3.7 4.3 9.7 11.0 20.9 11.1 50.8 18.9 3.9 10.8 1.6 6.1 12.7 11.7 14.9 11.8 6.5 9.5 53.5 12.0 8.2 9.6 27.9 8.1 18.5 4.7 33.3 1.7 5.8 12.2 14.2 74.4 91.3 4.8 18.3 50.1 16.0 6.5 81.1 6.9 77.2 4.0 6.0 10.1 12.6 17.0 38.0 11.9 16.0 9.0 10.1 6.6 6.6 10.5 11.2 9.4 6.6 7.2 15.9 27.5 37.3 7.7 9.5 10.8 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88064252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: AB_2681907" "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 26.6 21.2 21.6 29.0 24.1 10.1 38.8 23.4 28.2 33.3 22.8 46.3 32.3 24.1 42.0 32.5 27.4 22.4 32.0 21.6 23.3 32.2 44.0 22.1 38.3 24.6 23.5 20.1 24.8 28.9 34.4 15.8 22.1 25.1 25.5 44.2 14.7 25.0 26.3 29.4 26.0 36.0 23.1 24.1 30.9 27.5 15.4 23.3 31.8 33.5 34.9 32.6 24.6 25.1 26.8 29.4 17.8 27.4 20.1 64.1 75.3 20.2 45.5 50.3 23.7 23.1 1.6 38.5 41.4 16.0 28.9 36.1 14.8 6.3 9.4 26.7 43.7 8.7 8.0 4.4 2.8 46.7 12.2 5.5 38.0 46.3 15.9 33.7 61.9 27.1 32.9 11.5 20.2 51.7 25.0 14.1 16.9 20.9 42.3 11.8 28.3 5.0 4.5 36.0 15.8 21.1 21.3 17.3 23.7 54.8 20.1 16.7 49.2 38.2 28.0 2.1 46.5 14.5 45.3 33.6 32.5 30.1 32.0 67.5 59.4 21.6 77.7 18.8 23.8 21.7 36.6 23.0 23.2 25.7 32.5 25.8 21.0 35.8 31.6 21.5 22.5 34.3 16.8 21.6 24.1 23.4 28.2 21.6 23.3 24.6 23.5 20.1 25.1 24.1 23.3 26.8 24.2 35.3 41.7 29.4 61.8 33.0 32.6 49.9 53.5 11.9 50.9 50.9 41.3 40.0 49.0 35.0 2.1 46.1 24.8 109.1 60.7 50.5 16.7 34.4 37.8 31.6 41.6 28.2 14.5 70.9 16.3 42.5 17.3 30.9 43.1 28.4 37.9 59.5 48.6 10.1 13.9 56.8 26.4 40.3 39.8 5.3 47.8 38.8 28.4 44.0 53.6 35.9 58.7 34.7 53.5 51.4 79.6 43.2 29.6 62.6 60.4 76.0 62.6 5.4 19.7 40.3 29.7 41.0 20.7 45.4 42.6 41.9 37.2 32.2 72.4 26.4 NME6 "IPIA-ALPHA, NM23-H6" ENSG00000172113 "NME/NM23 nucleoside diphosphate kinase 6" O75414 3 48290722-48301685 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017909 Approved Approved Vesicles NA NA Vesicles "HPA017909: AB_1854530" "unprognostic (7.31e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-3)" "unprognostic (2.09e-2)" "unprognostic (8.52e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.00e-3)" "unprognostic (1.32e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.18e-5)" "unprognostic (1.98e-2)" "unprognostic (1.57e-2)" "unprognostic (1.23e-1)" "unprognostic (9.50e-2)" 8.8 7.8 6.9 10.5 6.4 8.2 12.2 9.2 6.3 9.2 7.8 11.7 13.3 9.4 8.6 12.2 14.9 9.0 13.6 7.1 6.4 11.2 10.4 10.3 12.3 6.2 5.9 6.3 12.5 11.7 12.5 6.1 14.3 7.1 9.6 11.6 7.7 11.0 8.8 17.9 10.1 10.5 12.5 4.9 9.7 11.7 6.3 6.1 9.5 12.3 17.3 13.8 9.6 9.1 6.3 30.0 19.1 24.3 18.3 18.2 23.4 22.1 27.2 18.3 37.5 27.3 30.5 26.5 30.1 14.0 20.5 36.5 10.1 21.9 27.2 24.1 36.1 21.3 17.9 24.1 26.6 25.7 24.3 20.7 19.7 33.8 34.4 42.9 19.3 19.8 21.1 33.9 23.6 14.0 13.9 21.4 11.3 22.3 19.5 23.3 12.7 22.9 25.3 21.2 23.6 7.7 12.7 19.8 21.0 26.1 17.8 23.9 22.5 22.1 8.3 33.0 21.2 39.4 27.0 40.9 26.1 16.3 31.9 18.4 47.3 33.4 76.4 40.9 36.0 36.6 43.5 37.4 35.2 39.9 38.0 28.1 27.2 37.3 40.4 42.1 34.5 33.5 25.1 6.9 6.4 9.2 6.3 7.1 6.4 6.2 5.9 6.3 7.1 4.9 6.1 6.3 13.1 28.9 20.7 2.3 16.4 5.0 8.5 18.2 9.6 11.9 14.1 13.6 10.4 15.7 19.4 9.2 14.6 49.5 18.4 8.2 39.2 24.8 2.6 16.1 17.5 12.8 4.2 8.0 2.5 30.1 41.6 12.4 11.7 11.8 10.1 22.8 7.9 7.9 34.4 10.1 3.2 10.8 12.2 9.3 9.7 1.7 11.8 13.7 16.0 1.9 23.4 17.6 18.6 2.5 2.7 31.3 8.3 7.2 10.8 12.8 16.6 16.4 30.6 11.5 13.1 7.7 12.2 9.3 15.0 12.4 4.1 19.7 14.7 15.1 12.8 7.1 CYCS "CYC, HCS" ENSG00000172115 "Cytochrome c, somatic" P99999 7 25118656-25125260 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Respiratory chain, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 806.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1663.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004222, CAB005126, CAB018597" Enhanced Supported Mitochondria NA NA 170000000 Mitochondria "CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383" "unprognostic (3.06e-2)" "unprognostic (3.39e-1)" "unprognostic (3.32e-2)" "unprognostic (4.11e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.81e-4)" "unprognostic (4.44e-2)" "unprognostic (7.04e-3)" "unprognostic (5.67e-2)" "unprognostic (6.22e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "prognostic favorable (1.30e-5)" "unprognostic (1.18e-1)" "unprognostic (4.94e-2)" "unprognostic (8.75e-3)" "unprognostic (7.04e-2)" 86.8 116.7 76.6 90.0 79.9 85.8 59.8 88.4 109.9 45.6 90.9 266.1 151.5 42.6 41.8 106.7 43.4 53.4 481.3 82.5 89.1 165.4 116.6 54.8 64.3 80.7 82.7 74.8 48.5 38.8 228.2 57.5 43.3 79.7 54.8 241.1 155.3 58.5 60.6 488.3 45.2 121.1 91.9 78.8 48.4 109.1 61.6 90.2 74.7 75.2 806.9 90.2 121.0 60.6 92.6 336.4 185.1 195.0 273.7 108.7 83.1 199.6 314.4 128.0 229.2 264.5 307.4 222.2 383.8 152.9 138.5 678.3 385.8 396.5 295.0 401.2 115.0 179.1 318.6 208.9 218.7 170.2 739.0 271.1 111.2 257.5 230.9 492.9 99.4 209.5 232.2 597.1 397.9 246.0 155.1 408.6 284.4 365.1 746.3 343.0 282.1 235.3 364.5 360.9 322.5 392.6 190.3 164.5 689.0 267.9 338.7 359.5 436.6 152.8 209.3 383.3 329.8 591.8 401.4 507.3 860.5 281.0 526.4 606.7 65.3 56.2 42.8 68.0 106.0 82.5 102.5 62.2 71.6 105.7 90.0 58.6 70.2 8.2 73.3 96.8 81.5 87.5 83.0 76.6 79.9 88.4 109.9 82.5 89.1 80.7 82.7 74.8 79.7 78.8 90.2 92.6 244.3 83.3 118.6 42.4 337.6 689.8 818.3 698.5 237.9 163.1 210.6 179.6 770.0 144.4 314.2 183.9 77.2 192.6 304.4 827.5 1663.0 278.3 496.4 154.8 120.2 183.3 384.9 162.6 53.2 216.0 351.0 257.3 287.5 197.5 212.6 68.7 81.0 210.8 353.0 132.9 64.6 522.5 502.5 141.5 715.2 161.8 90.1 329.2 590.5 16.9 245.8 220.9 197.8 17.1 24.2 303.8 570.5 93.6 358.7 551.9 392.8 638.6 146.1 195.2 138.1 294.7 962.3 423.1 211.1 402.7 715.2 349.3 349.7 146.9 600.2 884.1 CD8B CD8B1 ENSG00000172116 "CD8b molecule" P10966 2 86815339-86861924 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "lymphoid tissue: 463.9" "Group enriched" "Detected in many" 8 "dendritic cells: 53.2;T-cells: 162.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9" "Lineage enriched" "Detected in all" 25 "T-cells: 1053.9" "Cell line enriched" "Detected in some" 60 "RPMI-8226: 1113.4" "CAB004353, HPA029164" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB004353: AB_627211, HPA029164: AB_2672936" "unprognostic (1.83e-3)" "unprognostic (1.98e-3)" "unprognostic (2.22e-2)" "prognostic favorable (7.88e-7)" "unprognostic (6.23e-2)" "unprognostic (7.05e-3)" "unprognostic (1.11e-2)" "unprognostic (2.59e-2)" "unprognostic (5.50e-3)" "unprognostic (5.91e-2)" "unprognostic (9.25e-2)" "unprognostic (4.60e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (7.84e-2)" "unprognostic (3.00e-1)" "unprognostic (1.86e-2)" "unprognostic (4.33e-2)" 1.4 1.9 0.5 10.7 0.5 8.4 2.9 1.3 0.9 33.7 0.3 2.0 5.1 1.2 1.1 1.6 1.5 4.4 1.0 0.2 1.2 1.0 1.7 4.2 26.1 4.4 2.2 0.2 0.9 0.9 4.6 8.9 0.3 4.9 1.7 3.0 0.0 2.4 1.0 0.6 1.2 15.2 1.1 0.7 15.7 5.1 0.4 2.2 463.9 2.0 0.4 15.2 3.5 1.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.2 0.0 1113.4 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 6.6 0.0 0.0 0.0 42.0 1.0 0.8 15.7 1.1 79.3 0.7 1.9 601.8 0.6 1.2 4.6 1053.9 6.1 1.1 1.7 1.0 2.2 427.6 0.5 0.5 1.3 0.9 0.2 1.2 4.4 2.2 0.2 4.9 0.7 2.2 2.7 1.3 6.4 5.5 0.0 4.4 4.0 2.2 0.0 0.6 0.0 2.2 2.8 1.0 1.5 0.0 0.0 0.0 0.1 53.2 0.1 0.0 0.1 0.5 0.2 0.5 0.7 0.0 1.7 0.4 0.0 0.0 2.0 7.1 0.2 0.0 0.0 0.7 0.5 0.1 0.0 0.5 4.6 0.0 4.0 4.3 0.5 0.0 4.1 5.4 5.6 7.5 0.0 10.3 0.0 0.1 0.0 0.1 0.0 10.8 0.7 12.4 0.2 0.0 0.0 0.0 2.0 1.2 0.2 0.1 0.5 2.8 0.0 162.9 0.0 7.5 0.3 SLFN12 FLJ10260 ENSG00000172123 "Schlafen family member 12" Q8IYM2 17 35410922-35433283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 24.0;monocytes: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 54.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA022523 Uncertain NA NA "HPA022523: AB_2670945" "unprognostic (7.08e-2)" "unprognostic (1.87e-2)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (7.72e-2)" "unprognostic (9.31e-2)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.93e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (4.00e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (5.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" 6.6 4.5 2.0 4.7 2.5 2.3 5.4 1.8 1.8 6.7 4.6 2.9 3.4 5.5 2.7 2.6 5.2 7.0 4.1 1.6 3.2 3.8 1.9 8.0 6.0 3.1 2.0 0.5 6.1 1.9 2.6 0.9 6.2 3.0 3.0 3.6 0.8 3.6 4.4 1.0 2.3 3.6 5.9 2.1 10.6 3.2 1.8 2.7 3.4 7.2 2.1 4.6 5.9 2.1 3.3 0.2 0.3 22.2 0.1 5.5 9.2 0.1 19.1 10.7 42.1 42.2 0.0 0.0 0.1 36.8 16.0 30.3 12.3 0.4 11.6 40.3 1.0 3.3 6.7 20.0 0.1 7.1 9.3 5.0 15.1 4.1 18.2 3.7 10.5 31.6 0.3 0.0 2.6 32.9 0.0 0.0 12.3 0.5 0.0 0.1 0.9 29.8 0.0 15.9 21.1 0.1 0.0 0.0 4.9 14.6 0.7 9.4 8.6 35.3 20.8 28.9 6.6 24.4 7.0 1.8 0.3 7.8 8.6 26.7 54.5 16.1 12.8 3.2 9.5 2.9 2.9 1.7 2.9 11.1 2.3 0.8 2.5 7.6 10.1 5.0 1.8 3.8 3.5 2.0 2.5 1.8 1.8 1.6 3.2 3.1 2.0 0.5 3.0 2.1 2.7 3.3 24.0 6.4 3.1 0.3 4.1 0.8 1.4 8.2 5.2 0.0 7.0 5.3 3.0 4.3 8.5 12.9 0.0 0.9 17.2 0.5 3.9 5.9 0.1 12.7 18.4 15.8 0.0 3.0 0.0 1.4 2.1 11.4 6.6 14.9 14.0 6.8 11.7 0.5 8.1 0.0 0.0 1.4 4.1 11.6 3.5 0.7 1.8 13.1 0.0 9.4 31.2 1.2 15.5 0.0 0.0 3.5 0.2 3.0 4.0 0.8 0.3 9.0 4.9 0.0 19.7 3.6 9.9 0.2 0.2 3.5 0.9 0.3 8.8 16.0 0.8 0.4 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390436 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 82.8;brain: 129.7;breast: 53.9" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "thalamus: 449.0" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol NA NA 9600 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 82.8 36.9 34.3 4.2 16.0 0.0 53.9 16.7 32.4 1.9 4.2 12.4 0.7 0.7 0.5 7.8 7.8 1.1 4.4 13.2 67.8 0.3 0.2 3.6 0.1 81.9 49.0 13.9 11.5 0.7 0.0 14.4 0.0 95.4 0.9 4.7 23.9 11.2 0.4 0.5 4.5 6.2 1.7 15.9 0.1 1.0 13.1 85.5 0.1 0.2 0.2 0.9 2.0 2.7 129.7 19.1 2.0 17.0 0.0 0.6 0.1 3.3 0.6 0.3 0.5 0.1 0.1 21.5 0.0 0.3 0.2 2.7 3.7 0.0 0.0 0.2 0.1 0.1 63.9 0.0 0.6 0.1 0.0 133.0 0.0 0.0 1.3 0.2 0.3 0.0 1.6 0.0 0.5 0.1 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.1 0.2 0.1 0.6 0.0 0.1 0.0 3.1 38.0 0.3 3.8 0.0 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 16.0 16.7 32.4 13.2 67.8 81.9 49.0 13.9 95.4 15.9 85.5 129.7 0.5 9.6 7.2 0.3 0.0 0.3 0.1 0.2 0.0 12.5 10.3 2.3 0.4 1.5 0.0 0.0 6.2 0.0 0.0 0.0 0.0 1.8 2.6 0.3 10.8 0.7 0.0 0.0 0.4 97.8 0.1 29.6 0.0 0.1 251.5 44.1 0.0 0.1 0.1 30.3 17.4 0.0 0.0 0.0 0.4 2.4 6.2 1.2 5.4 1.0 0.0 2.5 0.0 0.0 0.6 16.5 0.0 0.0 0.1 0.1 0.0 0.0 1.5 10.3 0.0 0.2 1.9 1.8 5.0 0.0 0.0 0.1 3.5 70.2 0.0 0.2 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140898-112294227 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "skin 1: 2.1;testis: 8.1" "Cell type enhanced" "Detected in some" "Adipocytes: 4.1;Early spermatids: 3.3;Excitatory neurons: 4.3;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 5.1;Spermatocytes: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.3 1.0 0.1 2.5 0.0 0.0 4.3 0.0 0.3 0.2 1.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 5.0 5.1 0.1 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 15.2 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.1 OR1A1 OR17-7 ENSG00000172146 "Olfactory receptor family 1 subfamily A member 1" Q9P1Q5 17 3207539-3218896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 6.4" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 19.2;Alveolar cells type 2: 18.2;Club cells: 14.9;granulocytes: 11.4;Respiratory ciliated cells: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.0" NA NA 0.3 0.3 1.4 0.4 2.4 1.4 0.2 6.4 5.0 0.1 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.4 2.2 0.8 0.3 0.3 0.2 0.4 1.1 1.0 2.1 0.3 0.3 0.1 0.0 0.2 2.6 0.3 0.2 1.5 0.7 0.2 0.4 0.7 0.3 0.2 0.1 0.4 0.3 0.7 0.6 0.1 0.2 0.1 0.2 0.1 0.0 5.0 0.5 0.3 0.2 0.4 0.1 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.4 0.7 0.5 0.1 0.5 0.3 0.0 0.0 0.1 0.8 0.2 0.4 1.2 0.3 0.0 0.4 1.2 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 2.0 0.0 0.3 0.6 0.4 0.6 0.2 0.4 0.5 0.4 0.9 0.0 0.7 0.4 0.4 0.2 0.4 0.4 0.4 0.6 0.5 0.2 0.4 0.8 0.4 0.5 1.0 0.7 0.4 0.3 0.4 0.4 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.2 0.0 1.4 2.4 6.4 5.0 2.2 0.8 1.1 1.0 2.1 2.6 0.1 0.6 5.0 0.1 19.2 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 2.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 OR1A2 OR17-6 ENSG00000172150 "Olfactory receptor family 1 subfamily A member 2" Q9Y585 17 3197519-3198448 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8I2 ENSG00000172154 "Olfactory receptor family 8 subfamily I member 2" Q8N0Y5 11 56093277-56094286 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE1D LEP4 ENSG00000172155 "Late cornified envelope 1D" Q5T752 1 152796721-152798181 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "skin 1: 77.7" "Cell type enriched" "Detected in single" 42 "Suprabasal keratinocytes: 12.6" "Cancer enriched" "Detected in single" 8 "melanoma: 4.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 CCL11 "eotaxin, MGC22554, SCYA11" ENSG00000172156 "C-C motif chemokine ligand 11" P51671 17 34285742-34288334 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.1;lymphoid tissue: 31.7;stomach 1: 35.4;urinary bladder: 41.4" "Cell type enriched" "Detected in some" 15 "Fibroblasts: 38.9" "Cancer enhanced" "Detected in many" "stomach cancer: 12.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "BJ hTERT+: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 88500 "unprognostic (4.61e-2)" "unprognostic (1.45e-1)" "prognostic favorable (8.70e-4)" "unprognostic (8.18e-2)" "prognostic favorable (1.99e-4)" "unprognostic (9.91e-2)" "unprognostic (8.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (1.45e-1)" "unprognostic (9.64e-8)" "unprognostic (2.66e-2)" "unprognostic (1.05e-3)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" 1.7 0.8 0.0 31.7 0.0 0.0 0.2 0.0 0.0 2.4 0.0 32.1 33.5 1.7 0.0 12.5 0.7 4.8 9.8 0.0 0.0 4.2 0.6 9.2 0.0 0.0 0.0 0.0 0.3 2.9 1.7 1.0 0.0 0.0 2.7 14.9 0.0 0.1 1.0 0.0 0.0 36.1 20.7 0.0 2.8 35.4 0.0 0.0 0.3 0.0 0.0 0.7 41.4 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 9.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 1.9 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.1 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 85.8;skeletal muscle: 82.0;tongue: 75.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 27.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.5;monocytes: 3.4" "Cell line enhanced" "Detected in many" "HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 8.3 7.4 7.9 2.0 5.8 5.4 6.7 4.7 6.8 3.0 10.7 5.6 3.0 2.7 15.9 2.5 2.2 2.5 85.8 6.6 7.6 15.0 0.7 4.1 1.3 10.5 7.0 5.2 1.4 1.6 20.8 4.3 15.0 6.8 2.8 6.7 21.8 2.9 7.9 82.0 1.8 6.8 3.6 8.0 7.3 2.8 10.0 8.7 1.1 7.2 75.4 0.5 4.6 2.6 5.8 0.0 4.3 3.8 0.3 0.7 0.2 0.3 4.1 0.3 0.1 0.0 0.5 5.2 0.9 4.7 1.9 0.9 0.2 0.2 0.0 0.0 0.2 0.2 24.0 4.8 2.8 0.2 0.0 0.3 1.0 0.1 0.0 0.2 0.2 2.7 0.1 0.1 0.1 4.9 0.7 0.0 0.1 0.4 49.2 7.2 0.1 3.0 79.6 6.2 10.1 28.4 13.8 1.4 0.3 0.9 0.6 1.7 0.8 4.4 0.2 0.6 0.1 2.9 0.4 0.3 0.0 0.9 7.6 2.8 0.0 2.0 0.0 0.2 3.4 0.4 0.3 0.1 0.0 0.2 0.4 0.0 0.0 2.5 0.3 1.5 0.4 0.0 6.0 7.9 5.8 4.7 6.8 6.6 7.6 10.5 7.0 5.2 6.8 8.0 8.7 5.8 38.4 22.4 1.1 6.2 0.4 1.0 1.0 0.6 0.6 108.6 2.6 1.9 73.7 15.7 1.8 1.8 79.2 0.4 0.2 28.9 17.6 2.8 121.9 2.8 1.4 25.8 1.2 0.8 37.9 2.0 1.2 8.8 2.0 3.9 0.0 0.4 4.2 0.3 0.8 101.0 70.0 38.3 0.0 4.4 0.6 122.8 2.1 8.3 0.0 27.2 4.2 3.9 1.0 10.1 16.0 2.3 10.0 4.9 0.0 1.6 43.6 12.4 3.2 7.0 72.3 66.6 50.7 4.1 1.4 0.2 1.3 0.1 0.9 29.8 2.4 2.3 SNTB1 "59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43" ENSG00000172164 "Syntrophin beta 1" Q13884 8 120535745-120813273 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.1" "Cell type enhanced" "Detected in many" "Astrocytes: 70.2;Hepatocytes: 66.8;Microglial cells: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 84.9;OE19: 78.5;U-266/70: 77.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024659 Uncertain "Intracellular and membrane" NA NA 25000 "HPA024659: AB_1857713" "unprognostic (1.32e-1)" "unprognostic (2.77e-2)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (6.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.88e-1)" "unprognostic (1.31e-1)" "unprognostic (4.72e-1)" "unprognostic (2.00e-2)" "unprognostic (5.08e-2)" "unprognostic (5.88e-2)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" 7.3 66.9 8.1 5.5 6.2 19.0 8.1 6.7 6.0 5.6 37.2 6.2 5.8 4.4 2.7 8.5 6.1 4.3 5.0 6.4 24.4 12.8 90.1 15.6 7.3 7.7 9.8 4.3 2.5 45.4 1.4 2.7 8.7 9.4 4.8 6.5 4.9 35.1 3.5 28.4 9.3 6.4 3.1 6.3 12.0 24.3 9.9 9.2 3.4 61.9 32.7 3.6 3.9 3.6 6.8 0.1 1.8 0.7 0.0 11.3 22.9 0.1 6.0 36.7 1.8 2.7 12.0 1.6 0.0 10.7 6.8 0.0 0.1 2.0 0.0 1.3 5.6 6.5 0.0 0.3 84.9 1.2 16.9 0.0 11.4 0.0 10.1 0.0 14.9 0.4 10.4 0.0 32.3 5.9 3.3 0.0 13.7 2.1 78.5 8.7 0.0 43.8 0.1 34.4 2.0 0.1 0.4 2.4 12.5 30.2 0.7 1.5 30.5 0.0 23.7 1.4 0.0 2.0 77.2 33.0 34.8 18.4 49.0 26.7 1.8 0.8 2.7 2.2 0.4 0.5 0.5 0.4 1.1 0.6 0.2 1.1 1.1 0.1 1.6 0.3 0.0 0.0 0.6 8.1 6.2 6.7 6.0 6.4 24.4 7.7 9.8 4.3 9.4 6.3 9.2 6.8 1.9 12.8 27.2 70.2 4.7 0.4 0.7 0.9 1.8 2.4 8.5 6.0 2.0 2.8 9.0 5.5 2.1 0.8 8.4 1.3 9.8 1.5 9.3 2.4 5.8 4.2 0.0 14.1 2.4 10.9 2.2 9.8 11.2 6.2 1.3 8.8 13.2 66.8 11.3 0.0 3.1 3.9 16.2 29.9 4.3 4.2 4.7 18.1 1.8 45.9 12.1 16.0 18.6 2.5 12.2 4.3 1.9 13.2 2.8 1.1 0.1 3.3 13.8 0.7 13.1 3.9 14.3 1.1 0.2 10.1 1.0 0.3 12.0 11.0 4.1 0.6 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: AB_2681185" "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 1.2 1.1 1.0 2.6 1.3 4.1 2.6 3.6 1.7 1.5 0.8 1.7 1.5 2.1 2.4 1.4 1.7 1.2 0.6 1.1 1.0 1.0 0.8 1.3 4.3 1.2 1.3 1.1 2.4 0.9 1.0 0.8 2.1 1.8 1.5 2.6 4.3 1.1 1.1 0.7 3.0 1.3 2.0 1.0 1.8 1.1 5.0 1.1 4.6 0.8 0.8 4.0 1.0 1.3 1.5 15.3 4.5 14.6 6.0 2.1 3.5 7.1 11.4 6.5 16.4 21.0 4.9 8.3 13.8 11.2 3.8 4.9 13.0 13.9 6.8 20.3 11.5 10.6 11.6 6.7 5.6 1.1 12.4 8.6 1.3 2.9 12.7 8.1 2.5 7.3 12.6 7.6 10.2 9.7 6.9 19.8 7.6 6.5 12.0 9.0 11.3 15.0 9.8 3.9 5.3 7.4 8.6 7.7 44.8 7.0 7.9 8.5 8.9 4.5 7.0 12.7 9.0 18.6 3.9 8.9 8.0 6.6 15.1 8.3 0.0 0.1 0.1 0.3 0.6 0.5 0.7 0.5 0.7 0.2 0.5 0.8 0.7 0.0 0.5 0.3 0.0 0.7 0.3 1.0 1.3 3.6 1.7 1.1 1.0 1.2 1.3 1.1 1.8 1.0 1.1 1.5 1.6 0.0 1.5 7.5 2.9 0.8 1.7 1.5 1.8 0.0 1.4 1.3 1.1 0.0 1.1 1.8 0.0 2.3 2.5 0.5 0.0 0.9 0.8 1.3 2.6 1.1 0.0 12.8 14.7 1.8 3.0 2.5 2.6 1.5 2.5 5.0 1.8 0.9 1.6 0.0 9.1 0.9 0.0 0.3 1.8 0.4 1.5 1.7 1.8 3.7 1.0 0.0 2.1 9.0 16.1 0.6 0.1 1.2 2.3 1.2 0.3 0.3 2.4 0.0 0.0 5.6 2.6 16.2 10.2 1.4 0.6 0.7 3.3 1.5 0.8 0.8 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906238 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria No No Mitochondria "HPA023788: AB_1848818, HPA053044: AB_2682023" "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 4.9 6.1 4.4 6.0 4.6 2.2 6.7 5.7 6.1 4.0 5.2 5.8 5.7 5.0 4.1 5.2 4.8 4.2 9.0 4.6 4.6 9.6 8.8 4.1 7.4 4.4 4.5 4.2 4.9 3.4 6.6 3.2 6.8 4.7 5.1 6.7 6.9 5.5 4.9 6.8 5.4 4.6 5.2 4.3 5.8 5.2 4.2 4.5 5.4 5.5 11.8 6.8 5.4 2.9 5.1 12.8 19.2 10.7 14.9 12.7 12.4 10.1 13.1 9.5 23.7 21.4 15.6 7.2 17.4 12.7 8.1 15.5 21.6 18.6 9.1 22.4 5.5 23.9 8.8 15.1 15.5 8.5 18.7 11.2 7.9 11.7 13.4 6.9 7.2 11.9 12.4 19.1 14.3 13.9 11.7 16.0 24.3 8.9 19.6 12.1 10.5 22.9 17.6 19.2 14.4 16.3 7.5 9.8 11.7 15.4 10.9 23.7 14.1 7.8 10.9 14.7 11.2 13.8 7.9 14.0 16.2 7.3 13.8 13.2 2.6 7.7 6.5 6.4 12.2 8.8 9.8 8.2 6.5 8.1 6.3 9.9 9.2 2.3 8.6 9.9 7.0 10.0 7.1 4.4 4.6 5.7 6.1 4.6 4.6 4.4 4.5 4.2 4.7 4.3 4.5 5.1 10.1 16.0 10.6 13.7 11.3 4.1 8.0 22.6 9.1 17.8 6.8 6.9 5.8 11.5 13.6 9.2 8.4 26.0 11.5 5.4 25.4 13.4 10.4 12.6 15.3 9.6 5.4 6.9 27.1 8.5 17.3 10.2 5.1 7.8 5.1 17.2 10.4 10.1 20.4 16.8 27.3 7.4 22.4 7.8 3.0 6.3 8.1 9.6 7.2 21.5 14.0 15.0 16.5 27.2 32.2 12.5 5.6 7.5 7.1 5.2 9.4 17.7 17.8 19.4 19.7 11.0 11.6 27.7 17.8 8.7 4.3 17.8 10.0 18.9 7.9 4.7 MRPL13 "L13, L13A, L13mt, RPL13, RPML13" ENSG00000172172 "Mitochondrial ribosomal protein L13" Q9BYD1 8 120380761-120445402 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 264.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 497.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060899 Approved NA NA "HPA060899: AB_2684382" "prognostic unfavorable (1.37e-4)" "unprognostic (4.91e-2)" "unprognostic (8.50e-2)" "unprognostic (3.61e-2)" "unprognostic (1.81e-1)" "unprognostic (1.66e-1)" "unprognostic (7.28e-3)" "unprognostic (1.34e-3)" "unprognostic (1.18e-1)" "unprognostic (1.56e-2)" "unprognostic (1.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (7.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (1.84e-1)" 21.4 38.1 18.0 19.3 18.2 22.3 26.9 19.2 27.5 16.5 19.4 37.9 24.6 16.5 24.4 35.9 16.3 16.0 34.1 17.4 21.9 42.2 51.5 16.6 25.0 18.7 18.6 17.5 13.2 18.3 33.8 15.4 21.0 18.7 18.4 36.9 21.6 22.2 14.7 34.1 17.1 22.7 19.4 19.5 18.5 24.4 15.2 18.8 28.5 18.4 47.6 25.2 25.0 22.0 20.3 106.5 53.8 62.8 52.7 43.0 62.7 51.2 58.3 57.1 81.3 88.5 56.6 80.2 78.8 85.4 49.4 54.6 56.5 82.1 74.9 114.2 107.4 84.2 99.6 39.0 81.8 51.8 62.7 47.1 48.7 123.2 68.6 71.8 46.4 67.2 78.7 103.8 56.5 73.4 59.7 101.8 60.9 60.5 194.0 122.7 52.9 61.1 107.7 90.7 57.1 74.0 38.1 41.0 497.7 78.4 55.1 96.0 65.9 39.3 42.0 87.1 53.3 107.7 45.2 98.9 110.7 77.8 112.6 76.3 48.4 59.7 66.0 47.6 92.2 56.1 58.9 57.4 62.4 89.8 46.8 55.1 56.4 10.4 68.3 103.1 72.4 77.2 92.2 18.0 18.2 19.2 27.5 17.4 21.9 18.7 18.6 17.5 18.7 19.5 18.8 20.3 48.4 70.5 41.9 5.5 37.2 33.6 55.9 235.1 46.7 18.3 37.8 52.1 119.6 44.3 117.8 55.2 20.9 134.2 33.2 56.4 262.2 121.0 10.4 68.4 53.1 45.6 45.0 54.5 14.7 100.7 171.0 49.1 30.5 51.4 36.8 39.3 35.0 78.1 103.3 16.8 14.1 93.3 177.0 33.6 31.4 9.4 38.2 47.5 32.0 9.4 80.1 49.9 32.0 10.1 14.3 95.1 84.9 35.3 42.3 46.5 81.9 264.8 140.7 25.6 39.5 29.0 66.4 103.2 64.8 65.3 45.3 115.9 39.9 114.0 100.8 70.2 MALT1 "MLT, PCASP1" ENSG00000172175 "MALT1 paracaspase" Q9UDY8 18 58671465-58754477 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Immunity, Ubl conjugation pathway" "Hydrolase, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 88.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004494, HPA048432" Enhanced Approved "Nucleoli fibrillar center,Cytosol" No No "Nucleoli fibrillar center" Cytosol "CAB004494: AB_627909, HPA048432: AB_2680389" "unprognostic (3.25e-1)" "unprognostic (2.31e-1)" "unprognostic (3.64e-2)" "unprognostic (3.25e-2)" "unprognostic (1.65e-3)" "unprognostic (4.67e-2)" "unprognostic (6.46e-2)" "unprognostic (4.50e-2)" "unprognostic (3.33e-2)" "unprognostic (4.16e-3)" "unprognostic (3.74e-1)" "unprognostic (2.07e-1)" "unprognostic (2.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.97e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" 7.0 2.6 2.8 11.3 2.8 10.6 6.3 4.8 4.3 6.5 4.4 5.0 3.6 5.5 4.2 12.6 5.2 5.9 5.0 3.1 4.4 6.7 6.9 7.3 21.3 3.1 2.8 2.3 5.3 4.0 5.4 4.7 4.0 3.6 11.6 5.6 8.8 5.9 3.8 8.4 9.5 7.7 4.2 2.9 11.6 4.6 8.3 3.6 15.7 5.4 2.8 23.3 7.2 9.7 3.4 11.4 16.0 16.8 5.2 3.1 6.7 9.2 19.7 12.1 15.7 12.6 13.8 13.5 27.0 10.3 24.0 11.1 12.0 10.8 7.6 20.8 17.0 6.8 9.7 9.0 21.8 4.0 20.1 11.4 4.0 12.2 11.8 10.4 6.6 3.4 7.7 15.3 42.3 9.6 3.3 4.7 9.7 6.3 4.1 7.1 14.8 11.5 19.7 88.9 2.8 2.5 4.5 11.7 6.0 9.3 12.0 5.1 12.2 5.7 22.6 9.1 7.1 20.8 38.5 54.4 16.3 10.6 15.6 9.9 0.3 0.5 0.2 0.7 0.7 0.6 1.1 1.4 0.8 0.7 2.1 1.0 0.8 0.3 0.5 0.5 1.3 0.8 0.4 2.8 2.8 4.8 4.3 3.1 4.4 3.1 2.8 2.3 3.6 2.9 3.6 3.4 35.0 22.4 19.2 24.2 67.8 33.0 32.3 4.8 26.2 14.7 13.6 11.0 14.4 10.0 7.0 11.0 85.5 6.2 53.2 11.1 3.9 16.6 12.7 10.4 17.5 31.1 6.7 0.8 61.3 8.5 6.0 15.7 13.7 24.7 31.7 28.1 10.4 11.1 11.8 55.5 42.9 8.6 8.2 21.0 96.5 8.0 10.2 55.9 12.4 34.7 79.5 26.2 20.6 52.3 11.9 16.2 21.9 7.2 42.2 46.6 8.0 30.7 5.8 18.1 19.7 16.1 12.9 40.1 35.6 25.4 24.7 9.0 55.2 5.7 10.7 38.1 PRL ENSG00000172179 Prolactin P01236 6 22287244-22302826 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Lactation Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1022 "pituitary gland: 37798.5" "Group enriched" "Detected in some" 5 "Early spermatids: 13.8;Late spermatids: 28.4;Rod photoreceptor cells: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 31.0;SCLC-21H: 8.9;U-937: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB023353, HPA042416, HPA062017" Enhanced "Secreted to blood" NA NA 53900000 7200000 "CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (5.89e-3)" "unprognostic (4.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.11e-4)" "unprognostic (4.54e-1)" "unprognostic (1.57e-1)" "unprognostic (3.79e-2)" "unprognostic (4.29e-5)" "unprognostic (2.20e-1)" 2.6 11.3 0.3 1.4 0.0 0.0 1.2 0.5 0.1 0.6 0.1 2.2 0.1 11.6 0.0 11.8 1.6 0.1 3.2 0.0 0.4 2.4 9.7 2.1 0.0 0.9 0.7 0.0 4.1 5.5 0.0 37798.5 36.9 0.7 2.3 0.0 34.0 3.6 0.0 2.4 6.2 2.5 2.3 0.0 4.0 19.4 4.0 0.7 4.0 14.3 0.0 0.0 0.4 1.6 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.1 0.4 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.0 0.4 0.9 0.7 0.0 0.7 0.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.1 0.0 0.0 13.8 0.1 3.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.3 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 2.5 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ISG20 "CD25, HEM45" ENSG00000172183 "Interferon stimulated exonuclease gene 20" Q96AZ6 15 88635670-88656483 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 190.5" "Cell type enhanced" "Detected in many" "Langerhans cells: 500.2;Paneth cells: 476.1;Plasma cells: 663.4;Urothelial cells: 538.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 202.9;Karpas-707: 117.4;SK-MEL-30: 718.4;U-698: 123.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.55e-3)" "unprognostic (1.19e-3)" "unprognostic (2.00e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (4.54e-2)" "unprognostic (1.35e-3)" "prognostic favorable (1.85e-5)" "unprognostic (5.60e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.86e-8)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "unprognostic (3.39e-1)" "unprognostic (1.58e-2)" 18.6 8.1 7.0 79.0 7.6 41.7 21.9 7.3 9.9 12.9 6.2 28.7 77.9 7.5 9.6 30.4 15.4 39.0 13.6 5.8 17.2 15.1 28.5 63.3 190.5 9.9 7.3 5.2 19.3 10.6 2.7 28.9 12.6 8.9 18.9 9.6 0.2 25.3 11.3 5.1 10.3 66.2 3.4 7.1 149.7 69.7 6.7 8.0 88.0 31.2 3.1 64.5 27.6 13.6 10.5 9.1 15.0 0.6 0.2 0.2 0.6 2.4 0.4 7.0 41.4 56.7 4.5 20.8 202.9 10.5 0.6 20.2 3.1 1.1 4.2 1.7 65.1 0.6 0.7 6.3 9.6 26.8 0.3 0.2 3.7 9.3 13.3 10.3 1.2 6.5 15.1 0.8 117.4 0.0 16.4 0.7 1.7 2.1 34.2 30.1 8.8 1.0 39.7 3.3 2.3 0.7 1.0 2.4 84.9 718.4 0.4 3.8 4.7 8.6 1.6 5.0 0.3 3.0 81.2 22.4 123.2 1.8 4.0 8.7 141.9 37.4 75.9 303.2 63.5 402.9 1150.1 509.2 432.4 32.5 1184.0 365.5 390.7 1340.3 381.9 52.3 140.3 1244.0 369.5 7.0 7.6 7.3 9.9 5.8 17.2 9.9 7.3 5.2 8.9 7.1 8.0 10.5 70.4 48.1 46.7 0.0 424.2 178.7 152.3 98.5 3.4 0.2 84.3 58.8 1.9 51.5 97.0 3.7 0.0 2.3 378.8 213.5 1.9 66.1 23.7 318.8 29.4 86.6 37.6 108.2 0.6 148.9 71.5 63.5 130.0 254.1 7.6 2.9 21.8 13.3 8.2 0.0 1.9 144.1 168.9 34.4 500.2 5.2 2.1 72.2 225.9 5.6 195.4 0.0 224.6 1.5 3.1 307.1 476.1 1.9 663.4 318.7 131.8 8.6 118.4 0.2 26.3 14.6 26.9 1.1 2.9 9.9 287.0 52.0 318.4 4.9 19.7 538.6 OR4C11 OR4C11P ENSG00000172188 "Olfactory receptor family 4 subfamily C member 11" Q6IEV9 11 55602360-55607645 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBOAT1 "dJ434O11.1, LPEAT1, MGC44669, OACT1" ENSG00000172197 "Membrane bound O-acyltransferase domain containing 1" Q6ZNC8 6 20099684-20212469 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 18.8;Langerhans cells: 25.2;Oligodendrocytes: 41.5;Respiratory ciliated cells: 19.1;Suprabasal keratinocytes: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 42.2;HEL: 40.6;T-47d: 31.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.26e-2)" "unprognostic (4.18e-2)" "unprognostic (2.06e-2)" "unprognostic (5.85e-3)" "unprognostic (3.88e-2)" "unprognostic (5.31e-2)" "unprognostic (2.55e-2)" "unprognostic (6.57e-3)" "unprognostic (1.87e-1)" "unprognostic (1.62e-3)" "prognostic unfavorable (9.15e-4)" "unprognostic (2.90e-2)" "unprognostic (5.59e-2)" "unprognostic (5.17e-2)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (4.24e-2)" 6.5 3.3 2.2 6.0 3.4 11.2 12.6 4.6 2.4 12.1 2.1 18.2 13.9 14.4 5.8 10.5 21.9 8.5 5.3 1.3 3.4 5.8 4.5 7.5 5.4 6.5 3.9 1.1 12.6 5.8 5.8 2.5 4.0 5.7 9.4 19.1 1.2 8.2 5.4 2.0 6.8 16.5 8.5 6.5 7.3 15.3 1.4 4.1 2.8 7.7 2.3 5.2 8.7 11.0 10.6 4.5 4.7 8.3 6.6 0.9 2.7 0.6 7.1 2.0 4.4 5.1 2.3 19.0 0.0 14.5 6.8 3.9 42.2 7.6 3.6 6.3 11.3 4.5 40.6 7.9 0.1 5.5 10.6 11.9 1.2 3.6 1.9 8.1 2.3 2.4 7.1 5.4 7.2 1.0 4.7 6.3 10.1 2.1 4.4 2.3 2.0 9.1 25.0 5.9 8.7 0.4 5.3 1.4 8.6 9.0 15.9 31.2 5.3 2.0 6.0 4.2 3.6 3.4 9.7 20.9 0.1 0.6 7.9 7.9 39.9 27.6 66.8 3.9 33.3 20.2 2.6 9.1 7.2 15.1 1.6 2.6 2.6 34.4 4.4 41.1 18.5 13.5 7.9 2.2 3.4 4.6 2.4 1.3 3.4 6.5 3.9 1.1 5.7 6.5 4.1 10.6 1.3 3.2 0.5 0.3 1.7 11.0 0.9 3.5 4.6 0.0 2.4 1.3 0.4 0.0 6.6 0.0 0.0 0.1 3.7 3.5 1.9 2.7 0.0 4.7 3.1 2.5 0.0 8.4 1.1 1.2 0.1 6.4 18.8 7.5 0.0 1.9 1.1 0.0 1.5 0.0 0.5 2.0 2.0 1.0 25.2 0.0 0.3 4.4 8.8 6.5 4.5 1.3 0.0 0.0 41.5 1.5 7.7 0.0 1.5 0.8 5.5 0.0 19.1 0.1 0.0 1.0 3.6 0.0 0.1 5.4 15.5 0.3 6.4 10.4 3.0 1.8 OR8U1 ENSG00000172199 "Olfactory receptor family 8 subfamily U member 1" Q8NH10 11 56375624-56376553 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ID4 bHLHb27 ENSG00000172201 "Inhibitor of DNA binding 4, HLH protein" P47928 6 19837370-19842197 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 277.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 246.6;Endometrial ciliated cells: 438.4;Endometrial stromal cells: 362.6;Glandular and luminal cells: 335.3;Muller glia cells: 391.8;Smooth muscle cells: 368.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 111.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 45.0;AN3-CA: 50.7;EFO-21: 105.1;HEK 293: 66.0;SCLC-21H: 117.0;SuSa: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075639 Supported Nucleoplasm NA NA Nucleoplasm "HPA075639: " "unprognostic (3.25e-3)" "unprognostic (7.37e-3)" "unprognostic (1.80e-1)" "unprognostic (6.34e-3)" "unprognostic (4.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" "prognostic favorable (2.49e-4)" "unprognostic (7.26e-2)" "unprognostic (1.66e-3)" "unprognostic (2.41e-2)" "unprognostic (3.13e-2)" "unprognostic (1.03e-3)" "unprognostic (2.57e-3)" 61.7 5.1 51.9 7.5 46.3 0.2 42.1 41.4 55.9 39.0 26.5 9.5 7.3 30.3 9.5 21.9 70.9 10.3 41.3 51.0 69.0 19.7 4.4 28.0 5.0 46.8 57.1 36.9 48.8 19.2 2.5 36.7 22.4 49.6 30.0 6.7 19.6 27.4 44.4 3.6 106.4 12.0 21.1 43.3 20.4 20.0 23.1 52.5 2.0 277.3 3.1 2.1 31.6 33.3 43.2 0.0 0.6 45.0 50.7 1.2 0.1 0.1 5.8 0.1 0.4 0.0 0.0 0.0 0.0 105.1 14.1 0.2 20.3 0.0 0.0 0.4 0.0 66.0 0.0 0.0 0.5 0.3 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 8.1 6.3 0.0 0.0 0.0 0.2 7.6 14.2 117.0 1.5 0.0 1.8 7.2 37.6 3.2 0.0 0.0 0.2 5.6 0.1 1.6 0.0 0.1 1.1 1.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 46.3 41.4 55.9 51.0 69.0 46.8 57.1 36.9 49.6 43.3 52.5 43.2 31.8 96.1 53.0 229.9 1.9 83.1 190.8 16.7 232.8 11.2 143.8 246.6 42.5 7.2 19.6 68.0 2.1 9.9 2.9 15.6 50.9 18.0 2.1 438.4 362.6 19.9 91.6 0.0 1.8 3.3 9.5 83.9 118.3 335.3 0.0 17.6 23.9 0.0 2.7 3.3 1.2 23.4 22.4 0.6 24.8 7.9 8.1 5.3 88.9 2.8 0.0 391.8 0.0 0.5 0.3 1.4 27.1 0.0 1.4 93.6 8.2 76.0 8.4 13.7 0.0 76.3 368.8 1.2 44.9 119.6 78.6 5.9 6.1 0.7 7.8 42.4 OR4X2 ENSG00000172208 "Olfactory receptor family 4 subfamily X member 2" Q8NGF9 11 48245056-48246080 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475684 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.9;cervix: 2.1;heart muscle: 8.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 15.3;Cardiomyocytes: 57.9;Excitatory neurons: 49.9;Inhibitory neurons: 51.2;Oligodendrocyte precursor cells: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "SH-SY5Y: 2.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 60.4" NA NA "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.0 0.9 0.7 0.0 2.1 0.0 0.0 2.9 2.7 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.3 2.1 0.8 0.1 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.9 2.7 2.1 0.8 0.1 0.1 1.3 0.7 0.0 0.1 1.5 0.0 0.0 0.0 3.9 0.1 0.3 0.0 0.0 0.0 15.3 0.0 0.0 57.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.5 1.8 0.4 0.0 0.0 49.9 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.1 5.0 51.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 6.5 0.0 0.7 0.0 12.5 7.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 CXCR6 "BONZO, CD186, STRL33, TYMSTR" ENSG00000172215 "C-X-C motif chemokine receptor 6" O00574 3 45940933-45948351 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.2" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 74.1;T-cells: 58.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 445.8" "Lineage enriched" "Detected in many" 5 "T-cells: 445.8" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CAPAN-2: 11.2;JURKAT: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-3)" "prognostic favorable (4.92e-4)" "unprognostic (1.77e-3)" "prognostic favorable (6.74e-6)" "unprognostic (6.67e-2)" "prognostic favorable (2.16e-4)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.93e-2)" "unprognostic (3.65e-4)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (3.46e-2)" "unprognostic (1.57e-2)" 1.4 1.7 0.6 7.2 1.1 1.7 3.3 0.5 0.6 2.8 0.7 4.1 4.5 1.1 1.6 2.7 2.4 6.0 1.0 0.4 1.1 0.9 4.0 4.1 17.2 1.9 0.6 0.0 2.1 1.5 0.3 0.4 10.9 1.8 1.5 3.8 2.7 2.0 0.8 10.3 0.7 9.6 1.1 2.0 13.4 8.8 0.5 0.9 4.9 1.4 0.0 10.9 7.2 1.6 2.6 0.2 0.0 0.0 0.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.8 11.2 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.2 0.3 0.0 0.2 0.6 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.2 0.7 0.0 1.4 0.2 0.6 0.3 1.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.5 0.2 92.8 0.2 445.8 0.3 26.5 112.1 0.1 0.2 1.3 16.0 0.8 89.8 0.4 0.6 87.0 24.7 0.6 1.1 0.5 0.6 0.4 1.1 1.9 0.6 0.0 1.8 2.0 0.9 2.6 0.3 0.0 0.0 0.0 1.1 1.0 0.1 0.0 0.0 1.1 0.2 0.1 0.7 0.0 0.0 0.0 2.1 8.4 4.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 5.3 0.0 0.0 74.1 1.2 1.5 0.1 1.3 0.0 1.4 0.8 0.8 0.0 0.0 0.2 0.0 2.8 1.8 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.1 0.0 4.7 0.0 0.2 0.3 0.0 0.0 0.1 1.1 10.3 58.5 0.0 0.1 0.1 CEBPB "C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5" ENSG00000172216 "CCAAT enhancer binding protein beta" P17676 20 50190830-50192668 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.7" "Group enriched" "Detected in many" 8 "granulocytes: 16.7;monocytes: 7.7" "Cell line enhanced" "Detected in all" "SK-MEL-30: 169.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB004213, HPA061355, HPA062267" Supported Enhanced Nucleoplasm Yes No Nucleoplasm "CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (1.24e-2)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (1.40e-3)" "unprognostic (1.79e-2)" "unprognostic (9.85e-3)" "unprognostic (9.26e-3)" "unprognostic (6.55e-2)" "prognostic unfavorable (2.44e-12)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-2)" "unprognostic (7.63e-2)" 127.4 126.5 28.7 64.4 27.8 43.6 87.3 27.1 31.7 88.0 36.4 52.6 13.2 73.0 5.9 43.6 95.8 27.8 59.4 29.2 76.4 39.4 230.6 140.7 11.3 35.0 30.9 25.3 90.4 35.9 10.8 28.6 38.1 33.6 60.9 7.1 4.6 49.5 12.4 203.9 96.0 43.7 15.6 38.1 93.8 58.2 9.0 34.5 6.3 58.0 44.7 7.4 65.4 67.8 32.6 26.4 11.8 1.3 13.9 63.7 24.9 112.7 34.9 54.6 23.5 20.7 12.0 23.9 17.1 64.5 14.5 115.4 35.3 3.7 34.2 15.9 12.5 8.3 5.2 15.0 17.8 78.3 8.7 32.9 26.7 88.5 29.9 52.9 49.0 3.3 17.4 25.4 31.0 15.0 9.9 4.1 19.0 7.3 24.8 33.6 12.3 3.4 20.1 7.9 6.3 6.7 4.4 28.9 70.7 169.6 7.4 18.8 48.1 4.5 48.6 37.2 42.1 34.0 64.6 29.5 15.9 88.7 19.6 21.6 8.6 3.5 12.5 0.5 6.8 0.1 0.6 0.4 0.6 1.5 0.3 0.4 0.2 16.7 0.5 7.7 0.0 0.3 0.8 28.7 27.8 27.1 31.7 29.2 76.4 35.0 30.9 25.3 33.6 38.1 34.5 32.6 83.3 35.3 67.6 16.3 64.2 724.2 371.8 48.3 241.9 3.9 244.6 244.5 48.7 130.1 35.6 46.0 0.0 185.0 208.1 83.4 31.3 32.9 9.9 305.3 417.4 74.9 66.7 33.9 18.4 13.2 681.2 605.1 102.4 410.5 51.4 10.8 94.9 402.7 345.7 3.3 8.6 102.5 24.4 500.4 438.5 10.6 129.5 765.6 217.1 37.5 159.0 87.6 61.8 0.5 1.8 19.2 60.9 96.3 102.7 346.5 61.9 74.2 29.8 5.6 157.8 466.2 356.7 1.1 13.3 162.1 800.1 1409.9 159.3 68.2 63.4 359.6 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "bone marrow: 1592.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in some" 15 "THP-1: 659.5" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 320000 Vesicles "HPA055851: AB_2682943, HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.7 0.2 0.3 0.0 0.4 1592.0 1.5 0.2 0.9 0.2 0.1 0.2 0.0 0.5 0.0 0.1 1.5 0.0 1.5 0.4 0.3 0.4 2.8 16.0 0.6 0.3 0.3 0.4 0.2 0.2 0.0 0.9 0.9 0.3 0.4 0.0 0.0 2.6 0.0 0.5 0.6 0.2 0.0 0.2 33.3 0.2 2.4 0.3 3.1 0.6 0.0 0.0 0.3 0.2 0.2 1.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 44.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.6 659.5 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.6 0.0 34.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.2 0.9 0.4 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.2 3.5 0.0 0.0 0.0 0.6 0.0 0.1 1.2 0.0 0.0 4.5 4.6 0.7 0.0 0.5 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 8.9 1.2 1.0 0.0 8.8 0.8 0.0 0.3 0.8 0.0 2.3 0.0 0.1 0.0 0.4 3.2 0.0 1.4 0.4 0.0 3.7 0.4 0.7 0.0 3.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.0 4.5 0.0 0.0 5.7 1.2 0.1 6.4 0.9 0.1 0.0 1.0 0.0 0.6 0.0 TPSAB1 "TPS1, TPS2, TPSB1" ENSG00000172236 "Tryptase alpha/beta 1" Q15661 16 1240379-1242554 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 13 "granulocytes: 5873.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 893 "basophil: 89.3" "Lineage enriched" "Detected in single" 893 "granulocytes: 89.3" "Cell line enriched" "Detected in some" 166 "HMC-1: 3813.2" "CAB016369, CAB022175, HPA049153, HPA049554" Supported "Secreted to blood" NA NA "CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815" "unprognostic (2.06e-2)" "unprognostic (5.14e-2)" "unprognostic (2.02e-3)" "unprognostic (1.64e-2)" "unprognostic (9.31e-3)" "prognostic favorable (9.62e-6)" "unprognostic (1.02e-1)" "unprognostic (4.08e-2)" "unprognostic (1.80e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (2.83e-2)" "unprognostic (4.13e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.36e-2)" 78.4 2.9 0.6 23.8 0.5 2.4 47.6 0.4 0.9 47.1 0.8 67.8 72.2 73.9 6.0 64.9 26.8 130.9 12.7 0.5 0.4 13.7 12.3 129.6 21.4 0.6 0.4 0.4 3.2 19.0 2.3 3.6 1.2 0.9 66.5 35.0 0.0 60.7 22.7 10.1 106.0 150.0 18.1 0.4 6.0 104.9 9.0 0.5 14.3 4.7 13.2 13.4 114.4 53.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 1.3 3813.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 2.1 6.1 0.5 0.4 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 1.1 0.0 0.0 2.8 22.9 2.0 89.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.5 0.4 0.9 0.5 0.4 0.6 0.4 0.4 0.9 0.4 0.5 0.6 0.0 25.6 135.5 0.0 2.9 18.6 5.1 0.0 1.2 0.0 0.9 0.1 0.3 0.0 8.1 0.0 0.0 0.0 0.2 0.9 0.0 1.2 0.3 0.0 0.0 4.1 0.0 3.8 0.0 0.0 0.2 7.6 0.5 0.0 5873.9 0.0 0.0 0.3 5.2 0.0 0.0 0.0 0.0 0.3 25.6 0.2 0.0 7.7 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 11.7 4.0 0.4 0.1 5.1 0.0 0.0 0.3 3.2 0.0 0.1 0.1 9.9 0.3 440.9 0.0 0.5 5.6 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "intestine: 20.2" "Cell type enriched" "Detected in some" 30 "Intestinal goblet cells: 226.1" "Cancer enriched" "Detected in some" 4 "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.1 20.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 226.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 PAIP1 ENSG00000172239 "Poly(A) binding protein interacting protein 1" Q9H074 5 43526267-43557758 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073653, HPA076187" Approved Enhanced "Plasma membrane,Cytosol" No No 60000 "Plasma membrane, Cytosol" "HPA073653: AB_2732234, HPA076187: AB_2686784" "unprognostic (4.70e-2)" "unprognostic (4.30e-2)" "unprognostic (5.37e-2)" "unprognostic (2.65e-2)" "unprognostic (1.62e-2)" "unprognostic (4.74e-2)" "unprognostic (1.13e-3)" "unprognostic (2.98e-1)" "unprognostic (3.17e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (3.54e-1)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" 70.1 54.8 52.8 36.9 55.5 57.1 68.1 57.2 64.7 65.6 56.4 54.8 43.7 62.2 57.8 52.5 51.6 53.8 93.4 55.2 57.2 78.7 91.6 50.7 39.7 55.1 54.7 53.4 54.2 55.3 74.9 29.5 68.7 56.0 69.7 55.3 96.1 51.8 69.2 156.8 31.2 40.5 65.9 57.8 34.5 47.3 84.4 55.4 48.1 74.3 124.0 45.7 70.7 40.3 61.5 94.5 82.2 158.0 153.7 161.8 127.1 129.1 81.2 180.0 151.5 130.9 77.2 112.8 62.5 136.9 115.5 227.3 60.4 249.3 98.0 153.5 52.2 96.7 49.2 157.1 122.6 142.3 74.2 74.3 135.8 186.1 102.5 191.7 153.1 146.8 45.9 115.9 82.1 153.0 101.7 82.4 101.8 78.5 89.4 104.8 63.8 119.2 88.1 188.8 114.3 89.4 135.3 260.3 99.2 190.0 144.0 141.4 106.3 82.4 136.6 112.5 68.8 103.7 61.7 112.6 94.3 79.7 113.1 120.4 40.4 24.1 46.2 18.9 20.7 25.2 26.4 23.2 26.2 23.7 26.7 28.9 23.2 8.6 24.9 22.5 66.8 23.0 22.1 52.8 55.5 57.2 64.7 55.2 57.2 55.1 54.7 53.4 56.0 57.8 55.4 61.5 66.4 32.1 52.2 15.0 39.4 73.3 74.0 78.5 52.3 48.8 78.8 53.1 122.4 78.6 52.7 44.1 20.9 76.3 66.0 33.1 158.5 120.3 182.6 73.8 56.4 71.2 44.9 54.9 30.0 91.6 89.2 64.2 39.3 55.9 24.6 47.4 50.0 49.2 59.4 35.3 25.3 52.1 103.7 40.9 39.7 58.0 76.4 42.0 83.6 20.6 53.8 86.6 24.7 26.7 35.1 116.4 43.8 66.5 43.3 106.4 45.1 148.8 40.9 67.7 26.3 70.2 71.4 171.2 76.6 56.0 66.3 68.1 35.1 49.7 47.7 84.3 CLEC7A "CD369, CLECSF12, dectin-1, hDectin-1, SCARE2" ENSG00000172243 "C-type lectin domain containing 7A" Q9BXN2 12 10116777-10130258 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 84.8;lung: 31.2;lymphoid tissue: 44.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 87.2;Kupffer cells: 415.2;Langerhans cells: 291.5;Macrophages: 255.5;monocytes: 186.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 249.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "Karpas-707: 192.2;U-266/84: 168.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.79e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" "unprognostic (3.64e-1)" "unprognostic (3.03e-2)" "unprognostic (5.49e-2)" "unprognostic (5.19e-2)" "unprognostic (5.88e-3)" "unprognostic (2.10e-1)" "unprognostic (9.87e-2)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.83e-2)" "unprognostic (3.89e-2)" "unprognostic (5.13e-2)" "unprognostic (1.14e-1)" 9.4 6.0 1.9 44.9 2.4 84.8 4.6 2.4 6.4 3.5 3.5 7.5 5.7 3.3 3.7 9.7 5.9 11.2 4.2 1.7 2.8 3.5 11.1 31.2 14.5 4.1 2.3 1.4 2.4 3.0 2.0 2.7 7.3 3.7 3.3 7.4 1.7 7.3 3.2 1.3 3.8 8.6 8.8 3.4 34.4 4.6 1.5 2.7 10.1 2.6 2.0 12.0 9.2 4.9 5.6 0.3 0.4 0.1 0.2 0.0 0.0 1.1 0.0 0.5 0.2 0.1 0.1 0.4 0.1 0.1 0.0 1.1 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.9 0.7 0.1 0.8 0.1 0.0 0.2 0.1 0.2 0.0 192.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 4.3 0.0 5.2 0.3 0.2 0.3 0.6 0.0 1.4 0.4 0.1 0.3 0.1 0.2 0.2 0.2 11.4 168.1 0.1 0.3 1.0 0.2 1.4 122.9 2.2 0.3 137.2 0.5 0.3 0.3 0.2 60.6 0.3 0.3 0.2 249.6 0.4 148.1 1.0 0.4 40.4 1.9 2.4 2.4 6.4 1.7 2.8 4.1 2.3 1.4 3.7 3.4 2.7 5.6 2.0 12.8 15.1 0.3 5.9 3.7 0.2 0.9 8.6 0.0 3.1 2.8 0.9 0.0 9.7 0.0 0.0 1.5 2.1 0.2 0.0 0.1 1.7 0.2 0.1 9.3 0.0 0.0 0.1 0.0 14.1 2.4 0.0 0.1 6.3 0.0 6.1 2.1 87.2 0.0 0.1 0.0 4.1 415.2 291.5 2.2 0.3 255.5 3.6 27.2 186.1 0.0 8.2 0.0 0.0 0.0 1.1 0.0 1.1 0.1 0.0 1.3 2.4 0.4 13.1 1.1 1.0 0.1 0.5 13.2 3.0 5.3 4.1 0.0 0.0 0.5 C5orf34 FLJ32363 ENSG00000172244 "Chromosome 5 open reading frame 34" Q96MH7 5 43486709-43515148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 19.7;Spermatocytes: 18.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045386 Approved NA NA "HPA045386: AB_10965552" "unprognostic (2.67e-2)" "unprognostic (1.25e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (2.65e-6)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.66e-4)" "unprognostic (7.79e-3)" "unprognostic (6.51e-3)" "unprognostic (4.00e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-1)" "unprognostic (9.97e-6)" "unprognostic (9.87e-2)" "unprognostic (1.45e-1)" "unprognostic (1.39e-3)" "unprognostic (5.99e-2)" 0.8 0.5 0.7 1.3 0.8 1.1 1.6 0.4 0.8 1.2 0.4 1.0 0.6 0.9 0.4 1.0 0.8 0.6 0.5 0.7 0.7 0.8 0.4 0.7 2.8 0.9 0.6 0.6 0.8 0.3 0.4 0.3 1.1 0.8 2.4 1.3 0.5 1.0 1.2 0.4 1.3 0.8 1.2 0.8 1.0 0.7 4.2 0.5 3.7 1.2 0.4 2.4 1.4 1.1 0.9 5.6 6.5 9.3 11.1 1.4 3.1 10.5 8.3 7.6 13.3 10.5 4.0 5.7 14.7 8.5 2.7 18.1 5.4 11.3 3.9 14.7 6.9 13.4 3.0 24.0 3.5 0.6 8.1 1.7 2.4 1.3 13.5 7.3 2.1 6.4 7.9 9.5 3.9 10.6 4.3 4.4 11.3 6.6 2.4 7.3 8.2 18.5 9.2 3.6 2.6 6.5 8.0 14.1 6.8 5.8 5.6 11.4 8.5 4.1 10.5 12.9 11.0 8.8 4.1 6.0 8.9 6.0 10.3 11.4 0.0 0.0 0.0 0.5 0.2 0.8 0.7 0.5 0.5 0.3 0.4 0.7 1.4 0.3 0.9 0.1 2.5 0.2 0.3 0.7 0.8 0.4 0.8 0.7 0.7 0.9 0.6 0.6 0.8 0.8 0.5 0.9 1.7 3.2 0.5 0.7 2.6 1.7 1.8 1.4 1.2 0.3 1.2 1.7 0.7 0.0 0.5 1.8 0.0 3.7 3.1 0.2 1.9 1.0 1.3 0.9 1.1 1.3 0.0 7.0 8.6 1.5 4.4 1.5 2.0 1.4 5.1 5.0 2.5 0.0 1.7 0.0 3.0 0.4 2.0 1.2 1.4 1.3 1.2 1.2 1.8 1.0 2.7 0.1 0.0 0.5 2.4 0.8 0.3 0.7 2.0 1.6 0.3 0.5 0.5 0.6 19.7 0.6 3.6 18.9 6.9 2.3 2.0 0.4 1.6 1.9 1.6 2.2 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589667-47594411 "Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;ovary: 12.1;pituitary gland: 17.3" "Cell type enhanced" "Detected in many" "Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0" "Group enriched" "Detected in some" 4 "glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "REH: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041032 Approved Uncertain "Golgi apparatus,Vesicles" "Secreted in brain" NA NA "Golgi apparatus, Vesicles" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 1.7 1.5 6.8 0.0 28.4 1.1 2.2 13.2 14.5 4.9 0.0 2.9 0.1 5.9 0.0 0.5 4.3 0.0 0.9 5.7 3.0 1.1 0.9 0.7 0.0 17.2 5.8 12.0 12.1 0.4 0.7 17.3 0.0 11.1 2.8 0.0 0.1 1.2 0.1 0.9 1.7 1.5 0.1 0.4 1.0 1.5 5.9 8.5 0.0 1.5 0.0 0.0 1.3 2.0 4.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 28.4 13.2 14.5 5.7 3.0 17.2 5.8 12.0 11.1 0.4 8.5 4.4 2.4 0.0 0.0 18.9 0.0 2.4 6.5 0.2 0.0 15.8 1.3 25.8 0.7 1.5 0.3 3.7 16.7 1.3 0.1 0.2 3.9 0.1 11.3 0.8 21.2 4.5 0.0 2.5 15.5 0.2 2.7 20.7 0.5 0.6 0.0 31.3 2.5 0.2 3.3 5.0 17.8 0.1 0.0 0.3 3.0 51.7 46.0 0.7 10.6 4.7 0.0 54.5 0.0 5.0 8.0 0.1 0.1 38.4 0.0 4.3 0.1 0.6 0.6 24.7 26.3 12.8 8.5 13.5 44.5 0.3 1.8 3.6 0.6 39.0 0.2 2.4 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395943-72282539 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 30.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" NA NA 380000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 15.9 5.9 9.2 3.6 18.7 1.2 5.9 6.6 15.7 6.7 0.0 13.5 2.7 5.3 4.1 10.6 7.3 10.8 8.8 14.9 11.1 6.9 0.3 5.6 1.6 2.5 8.2 10.7 6.0 4.5 0.7 3.9 2.9 3.7 7.3 7.8 30.1 2.4 5.5 3.3 4.7 5.1 6.4 2.6 0.6 7.5 3.2 11.4 5.6 3.5 5.2 0.8 13.4 6.6 10.3 0.4 0.1 0.8 0.2 26.7 21.0 0.2 19.4 7.2 10.4 12.7 0.1 0.2 0.3 0.1 21.5 0.2 0.6 0.0 0.0 22.4 0.2 0.1 0.1 3.4 0.1 2.2 0.2 0.4 10.2 0.1 8.9 1.5 15.4 12.5 0.3 0.1 0.8 19.5 0.1 0.2 0.2 3.2 0.3 11.0 13.7 20.4 0.3 1.7 0.3 1.5 1.7 6.8 0.1 0.0 0.4 0.1 0.3 28.5 2.3 22.9 0.9 24.5 0.4 0.2 0.1 5.2 13.0 8.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 9.2 18.7 6.6 15.7 14.9 11.1 2.5 8.2 10.7 3.7 2.6 11.4 10.3 6.0 0.0 0.5 170.7 0.0 5.0 0.6 0.1 0.0 51.4 0.2 0.5 4.2 1.5 2.5 0.0 27.1 0.0 4.4 0.1 0.0 2.4 6.2 0.1 1.3 2.6 0.0 0.8 1968.8 0.0 0.0 88.7 0.5 0.1 0.0 0.2 0.0 0.0 0.2 1.7 1254.4 0.6 0.0 0.0 16.7 12.5 210.3 2.4 8.8 58.1 3.1 12.2 0.0 726.3 442.7 0.5 0.0 44.8 0.5 1.3 0.0 1.5 7.1 58.7 32.9 8.3 8.5 0.7 2.5 0.3 3.4 0.0 1.1 0.2 0.1 0.7 ZNF131 "pHZ-10, ZBTB35" ENSG00000172262 "Zinc finger protein 131" P52739 5 43065176-43192021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007023, HPA027748, HPA074630" Approved Enhanced "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705" "unprognostic (1.23e-1)" "unprognostic (8.24e-2)" "unprognostic (4.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.84e-2)" "unprognostic (7.18e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.52e-1)" "unprognostic (2.98e-3)" "unprognostic (1.94e-2)" "unprognostic (5.83e-2)" "unprognostic (8.07e-2)" "unprognostic (2.09e-2)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-3)" "unprognostic (1.46e-2)" 12.9 13.6 15.6 14.0 15.8 28.6 19.7 20.5 21.0 13.5 13.5 13.3 10.1 17.7 9.7 14.5 12.7 13.0 9.7 15.8 15.3 12.1 14.4 11.5 20.5 15.0 15.3 14.4 16.1 12.3 11.8 10.8 17.0 15.7 12.7 13.3 14.8 10.4 9.1 15.9 18.4 12.1 16.1 14.3 16.1 11.7 32.9 15.6 26.9 11.9 17.3 17.7 15.2 13.4 17.3 25.4 15.2 32.4 43.2 30.1 20.6 27.3 32.8 26.6 31.9 26.9 24.0 22.2 50.8 25.9 22.1 29.7 17.7 38.9 20.8 44.9 24.8 34.1 31.4 92.2 18.0 27.7 55.0 24.7 18.8 38.2 23.5 38.3 22.8 24.7 39.0 40.7 52.7 36.8 24.5 53.9 68.8 21.5 23.4 24.9 35.3 49.4 39.9 27.1 24.4 20.0 29.4 83.5 39.8 43.2 21.7 22.3 51.6 18.5 39.8 37.3 20.5 31.1 21.1 32.5 58.4 21.0 71.2 27.1 10.4 8.2 5.8 19.1 9.5 19.2 13.1 18.5 18.5 11.9 16.8 22.3 18.3 3.9 17.2 6.6 11.3 14.9 10.0 15.6 15.8 20.5 21.0 15.8 15.3 15.0 15.3 14.4 15.7 14.3 15.6 17.3 42.5 22.4 21.9 28.7 44.7 49.6 51.4 24.1 53.5 52.1 32.3 29.7 17.5 22.8 19.4 9.2 52.1 27.0 53.3 28.0 31.3 15.3 52.9 30.0 47.7 32.8 31.2 39.1 31.2 11.8 25.0 32.4 23.0 49.7 24.1 39.4 24.7 13.3 16.4 38.7 33.6 29.7 20.3 25.8 35.4 19.5 20.5 30.9 21.4 14.0 27.5 29.0 49.4 38.7 24.2 17.9 24.7 21.1 27.8 38.5 34.9 13.1 15.7 70.0 26.3 57.0 43.2 109.6 80.3 45.9 65.5 25.4 59.3 37.3 38.7 35.6 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "Mono-ADP ribosylhydrolase 2" A1Z1Q3 20 13995369-16053197 "Metabolic proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 13.2;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 1.9 3.2 3.8 2.2 8.8 1.2 2.8 2.5 4.6 3.2 0.1 1.4 0.7 5.0 2.3 1.5 7.3 2.8 1.1 4.5 3.1 3.9 1.8 11.0 4.1 3.0 3.6 4.5 2.9 2.9 2.6 2.2 1.1 3.9 4.7 1.3 4.9 1.3 10.0 1.5 2.7 0.9 4.0 1.8 5.0 2.3 5.2 5.4 1.8 2.6 0.6 5.4 4.6 1.3 4.6 1.0 0.4 3.0 1.2 0.8 0.7 0.5 0.3 2.1 1.2 0.7 0.4 0.7 2.0 15.5 1.4 2.6 1.5 0.3 0.7 1.9 1.0 0.9 1.2 1.2 2.4 3.4 0.3 0.3 1.9 1.3 0.0 0.5 1.1 1.1 0.2 1.4 19.1 3.1 0.5 0.5 0.8 0.9 7.1 0.6 1.2 0.5 4.0 2.2 8.4 10.6 1.9 1.6 0.2 0.6 1.1 1.0 1.8 0.7 1.4 3.2 0.3 0.0 0.7 0.3 2.1 0.9 1.0 1.7 0.1 0.5 0.5 0.2 1.2 0.2 8.9 0.2 0.2 0.4 13.2 0.2 0.3 3.4 0.1 1.6 0.2 0.0 0.5 3.8 8.8 2.5 4.6 4.5 3.1 3.0 3.6 4.5 3.9 1.8 5.4 4.6 1.6 51.3 203.8 349.7 18.3 4.5 49.8 1.4 5.2 94.0 7.6 6.9 5.9 11.5 37.5 12.9 39.6 7.1 0.1 1.8 9.8 11.9 35.4 8.6 2.5 3.0 1.2 0.4 752.7 1.6 0.4 4.6 9.2 6.7 1.3 7.6 7.1 4.8 0.9 8.4 1058.5 4.5 0.0 0.3 2.1 62.2 3.4 0.9 3.6 87.1 0.0 10.2 0.0 672.0 301.4 6.6 1.7 17.7 2.8 6.2 2.4 8.6 9.8 20.3 6.6 2.1 6.0 23.7 18.8 5.8 6.7 2.1 0.9 13.2 2.8 5.4 DPAGT1 "ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT" ENSG00000172269 "Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1" Q9H3H5 11 119096503-119108331 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053878 Approved NA NA "HPA053878: AB_2682288" "unprognostic (1.66e-2)" "unprognostic (3.14e-3)" "unprognostic (1.76e-1)" "unprognostic (7.83e-3)" "unprognostic (6.50e-2)" "unprognostic (8.53e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.52e-1)" "unprognostic (3.95e-1)" "unprognostic (9.05e-2)" "unprognostic (2.08e-2)" "unprognostic (7.12e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (1.08e-2)" "unprognostic (2.52e-2)" "unprognostic (4.57e-2)" 11.4 14.3 13.6 13.8 13.8 9.2 14.9 14.5 22.6 16.3 17.1 17.8 16.9 10.2 22.0 12.5 17.5 14.6 7.6 13.9 14.7 12.9 21.4 11.5 11.6 14.6 14.1 13.6 9.1 27.3 18.8 4.4 15.9 14.6 14.4 20.2 7.5 28.0 16.5 5.6 9.1 15.0 17.9 13.8 9.9 14.5 4.8 14.3 8.3 15.6 8.6 14.4 17.0 6.2 14.9 22.0 39.2 22.2 55.7 60.0 37.0 24.6 33.7 38.3 25.7 32.2 43.4 88.3 41.5 62.8 45.4 57.7 77.1 42.0 60.7 31.1 29.4 23.8 83.5 14.1 51.6 50.7 53.9 47.4 40.3 48.7 62.4 85.3 29.9 53.3 25.2 51.7 84.1 50.9 67.7 19.5 39.9 22.5 148.3 49.4 26.2 26.6 61.3 60.3 44.7 23.0 30.1 30.7 99.3 17.1 32.3 116.8 19.4 29.1 57.3 24.5 30.3 23.7 19.6 32.2 13.9 14.3 68.3 48.9 28.4 35.7 4.4 25.2 35.5 28.4 24.5 20.1 24.8 43.3 25.6 16.6 15.8 3.0 20.7 32.7 37.5 19.6 20.2 13.6 13.8 14.5 22.6 13.9 14.7 14.6 14.1 13.6 14.6 13.8 14.3 14.9 11.5 6.4 8.1 7.2 10.7 13.3 15.2 34.4 13.1 6.1 18.4 12.1 5.0 14.3 22.8 14.7 14.6 34.2 9.6 10.3 3.9 32.9 0.9 15.6 12.3 16.0 10.2 8.6 7.3 13.3 44.4 11.0 14.3 11.2 12.7 12.7 15.7 23.1 28.8 3.3 5.7 19.8 32.6 13.0 11.4 1.9 14.0 14.1 8.8 5.6 20.9 6.2 13.4 7.5 5.4 13.9 11.1 8.2 33.2 14.5 19.3 11.3 37.2 4.6 0.0 6.0 10.7 6.8 10.3 14.1 12.5 23.5 10.0 15.9 20.7 12.9 BSG "CD147, EMMPRIN, EMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583494 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 1408.0;Syncytiotrophoblasts: 1654.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles NA NA 340000 Vesicles "CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719" "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favorable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favorable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 352.3 523.0 572.8 155.9 551.8 434.9 316.4 516.9 854.2 303.6 832.3 500.7 233.4 416.7 261.8 247.1 325.8 177.8 1230.8 567.7 535.6 468.3 187.5 255.8 102.7 568.8 554.1 519.8 303.3 304.2 257.6 333.7 322.9 554.1 230.8 157.4 191.2 277.1 196.1 476.9 225.6 241.7 165.6 485.8 201.6 459.5 489.8 637.8 93.7 304.6 294.8 74.8 370.0 235.0 520.7 622.6 739.3 339.5 852.3 975.0 426.0 800.4 499.2 507.6 506.1 437.9 607.1 569.4 208.4 564.3 383.5 148.7 967.8 341.0 575.0 129.6 468.1 840.3 150.0 545.5 812.3 683.6 361.6 679.0 455.5 578.5 302.4 304.5 613.1 383.3 198.3 722.9 992.5 298.6 1015.8 261.6 706.6 901.9 353.7 408.3 522.8 301.2 745.2 655.9 412.1 561.0 539.1 984.4 408.1 769.7 257.9 432.3 1118.9 478.7 557.5 353.4 940.1 751.5 639.7 701.8 201.1 1066.9 510.2 712.8 189.0 324.7 348.9 226.4 245.9 200.5 115.0 150.7 218.4 209.6 93.2 114.0 144.7 474.8 173.5 284.2 235.2 192.0 434.0 572.8 551.8 516.9 854.2 567.7 535.6 568.8 554.1 519.8 554.1 485.8 637.8 520.7 313.5 22.4 31.5 75.1 101.5 208.6 176.8 668.0 91.0 157.7 202.8 187.6 80.6 128.7 253.4 286.9 204.3 1408.0 156.5 1140.1 146.8 580.9 261.6 156.6 296.6 246.7 255.1 1091.4 35.4 371.4 1095.5 279.8 192.1 190.1 116.2 181.1 132.1 96.9 416.7 139.7 31.4 337.2 510.6 137.8 179.6 600.2 300.4 139.8 506.9 122.7 264.5 495.5 221.4 20.6 30.7 458.0 929.1 336.7 192.4 172.8 450.7 306.7 178.8 269.2 203.8 74.3 235.6 347.9 604.4 127.7 156.7 1654.9 130.9 223.5 478.2 181.4 HINFP "DKFZP434F162, HiNF-P, MIZF, ZNF743" ENSG00000172273 "Histone H4 transcription factor" Q9BQA5 11 119121580-119136059 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061008 Uncertain NA NA "HPA061008: AB_2684414" "unprognostic (2.79e-1)" "unprognostic (2.63e-2)" "unprognostic (8.77e-2)" "unprognostic (8.41e-2)" "unprognostic (8.39e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (4.44e-8)" "unprognostic (4.17e-2)" "unprognostic (7.39e-2)" "unprognostic (3.78e-1)" "unprognostic (5.33e-2)" "unprognostic (2.95e-3)" "unprognostic (4.21e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "prognostic favorable (5.26e-4)" "unprognostic (1.25e-2)" 4.8 4.8 7.6 4.6 9.3 4.6 5.2 10.8 9.5 5.9 7.1 7.4 7.0 5.7 4.5 5.5 7.2 3.8 5.2 7.9 7.1 6.7 4.3 5.1 6.8 8.1 7.4 8.3 6.8 7.1 6.1 5.2 4.3 8.2 5.7 7.1 11.1 6.7 5.2 9.3 8.1 7.2 5.9 6.2 7.2 6.8 6.7 7.5 11.6 6.3 8.1 7.1 6.6 5.5 11.0 5.9 9.4 10.3 9.6 8.4 5.7 9.3 4.5 7.1 10.1 11.1 17.0 12.9 7.6 15.7 6.3 11.2 13.7 18.0 4.5 6.7 16.9 8.9 39.1 6.8 5.8 9.9 11.7 9.0 8.0 16.0 10.6 9.2 11.7 8.1 14.1 15.7 12.9 5.7 11.5 14.7 10.5 9.1 10.7 8.6 14.5 11.4 8.7 6.8 5.5 14.6 7.1 7.7 11.3 6.3 10.0 15.4 13.3 6.1 8.9 3.5 6.0 5.5 6.1 6.8 8.3 3.3 10.0 6.8 12.8 12.9 9.3 10.0 10.2 11.2 10.0 12.3 11.9 16.5 12.5 16.3 10.0 8.0 17.2 6.9 7.9 16.6 10.4 7.6 9.3 10.8 9.5 7.9 7.1 8.1 7.4 8.3 8.2 6.2 7.5 11.0 7.9 0.0 8.8 12.4 11.0 14.4 7.4 10.3 10.8 19.1 12.6 8.6 5.5 8.6 9.2 9.2 35.5 7.4 13.8 17.6 5.9 9.4 9.4 8.3 8.7 10.3 8.4 7.8 16.6 11.0 8.0 7.5 7.1 8.2 5.1 11.3 12.1 4.5 5.4 15.2 16.2 9.7 4.1 7.2 9.5 3.4 8.4 7.2 8.8 4.7 18.1 9.6 12.3 7.5 9.1 9.3 10.3 6.4 12.4 8.6 15.5 5.6 9.5 29.5 0.0 7.4 9.2 38.6 31.8 7.7 16.3 8.3 11.6 12.4 10.7 6.5 CDY1 CDY1A ENSG00000172288 "Chromodomain Y-linked 1" Q9Y6F8 Y 25622162-25624902 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10V1 ENSG00000172289 "Olfactory receptor family 10 subfamily V member 1" Q8NGI7 11 59712916-59713845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA060076 Uncertain NA NA "HPA060076: AB_2684198" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CERS6 LASS6 ENSG00000172292 "Ceramide synthase 6" Q6ZMG9 2 168456249-168775134 "Metabolic proteins, Predicted membrane proteins" "Inflammatory response, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 271.7;Inhibitory neurons: 293.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in many" 5 "dendritic cells: 5.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044683 Approved NA No "HPA044683: AB_10965059" "unprognostic (2.17e-2)" "unprognostic (1.87e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (3.24e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (9.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.93e-2)" "unprognostic (2.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-2)" "unprognostic (2.41e-1)" "unprognostic (4.80e-2)" 13.5 14.4 8.3 10.2 12.1 12.6 13.7 12.6 16.7 12.8 3.5 28.5 26.0 11.7 18.3 13.9 6.7 8.6 27.9 11.9 13.4 13.3 13.4 7.7 8.7 5.1 7.9 10.5 15.5 7.7 12.4 4.8 9.5 6.3 13.0 30.5 9.2 3.7 13.4 6.0 19.2 32.4 11.1 8.6 7.0 24.3 12.1 9.8 25.1 27.5 10.8 8.4 12.8 6.9 8.7 15.8 14.2 24.2 27.8 58.8 43.2 0.1 15.5 16.1 16.7 22.2 22.2 33.8 0.0 21.7 14.1 23.3 28.9 32.2 36.6 27.6 0.0 21.4 29.1 13.8 15.9 51.5 61.1 13.4 48.7 102.1 34.7 27.3 16.0 8.5 42.2 15.8 0.1 34.6 17.2 54.0 16.9 22.4 33.6 20.0 41.3 45.5 27.3 15.5 46.9 32.6 39.4 15.0 38.2 8.2 19.9 34.0 34.4 4.7 41.3 17.3 11.3 27.1 0.3 0.0 0.1 26.8 31.8 28.2 0.6 1.0 0.0 0.1 0.7 0.3 0.1 0.3 0.1 0.8 0.4 0.9 0.7 0.1 0.7 0.6 5.4 0.0 0.3 8.3 12.1 12.6 16.7 11.9 13.4 5.1 7.9 10.5 6.3 8.6 9.8 8.7 7.0 6.4 10.3 114.3 10.2 108.8 55.2 37.4 38.1 24.1 42.4 30.6 45.1 21.5 33.6 11.0 0.0 0.7 45.2 79.1 0.0 14.0 6.8 7.9 20.3 13.4 103.8 15.3 271.7 22.5 3.4 11.3 57.6 18.9 10.2 15.2 12.8 43.8 24.3 37.0 293.2 92.2 20.3 49.4 54.1 3.6 19.9 40.8 10.6 37.5 77.8 28.1 6.2 124.7 10.3 17.9 48.3 39.9 9.8 40.3 63.7 9.3 49.2 3.0 65.7 13.4 28.8 3.0 9.4 34.9 92.8 0.5 10.1 15.7 115.8 46.3 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008972-13169103 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 28.4;Early spermatids: 27.9;Glandular and luminal cells: 47.4;Microglial cells: 35.6;Syncytiotrophoblasts: 46.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "hypothalamus: 20.5" "Immune cell enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 33.3;RPTEC TERT1: 43.7;U-2197: 30.4;U-87 MG: 57.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA044247, HPA048079" Enhanced Approved Microtubules NA NA Microtubules "HPA044247: AB_2678872, HPA048079: AB_2680252" "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favorable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 4.6 4.3 1.3 1.4 1.3 0.6 8.4 1.4 1.3 7.5 7.7 6.2 15.8 4.7 16.9 6.0 6.8 11.0 6.4 1.6 20.5 18.4 20.1 7.9 1.4 2.5 1.9 0.7 7.2 5.6 11.1 2.8 21.1 3.2 6.0 7.5 2.8 6.7 3.6 0.5 25.8 16.4 3.9 1.8 2.9 4.6 6.4 2.5 5.1 24.6 2.1 1.7 5.7 5.1 2.4 1.5 2.4 1.8 0.0 14.1 20.2 11.4 0.0 3.2 2.1 8.2 18.6 9.3 0.0 1.2 0.6 18.2 25.0 0.0 7.0 3.0 0.0 0.1 0.0 5.6 26.4 1.3 0.0 0.2 11.5 21.4 8.4 2.8 7.7 1.4 4.4 0.0 33.3 23.7 0.5 0.1 0.0 0.1 2.2 2.9 2.3 4.2 15.1 43.7 18.2 0.0 0.3 0.2 2.3 0.1 3.1 18.6 0.5 3.3 9.2 3.1 30.4 2.2 0.2 0.0 0.0 57.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.3 1.3 1.4 1.3 1.6 20.5 2.5 1.9 0.7 3.2 1.8 2.5 2.4 3.6 6.4 22.3 5.2 0.1 2.4 5.3 2.3 4.6 0.1 5.4 5.0 17.9 4.3 4.9 9.2 0.0 28.4 1.0 3.4 7.9 3.0 27.9 18.7 5.2 4.6 0.0 2.1 0.5 4.4 13.0 5.4 4.6 47.4 1.3 5.6 1.8 20.7 2.8 0.0 0.9 5.7 6.1 2.6 0.4 11.6 3.7 2.4 0.0 35.6 0.0 12.3 3.1 0.0 0.1 3.2 6.7 2.6 0.1 2.3 10.9 18.6 3.5 0.4 0.0 6.1 0.8 1.2 0.1 4.9 2.3 46.1 1.2 2.9 7.3 2.6 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851871-31859291 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 243.3" "Cell type enhanced" "Detected in all" "Early spermatids: 253.2;Late spermatids: 288.9;Spermatocytes: 575.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: AB_2681868" "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 50.3 46.9 128.9 20.3 132.2 14.4 50.2 127.6 174.2 43.0 128.7 73.2 16.2 43.8 118.6 26.6 52.2 32.3 60.6 128.9 136.1 56.2 68.6 34.2 21.2 127.3 127.8 125.7 52.1 42.2 49.4 67.9 19.9 129.2 60.7 27.7 56.5 35.7 46.8 54.0 29.7 31.3 44.8 125.1 25.3 52.1 243.3 131.1 13.3 63.7 53.8 28.1 57.5 33.6 127.8 101.5 132.9 64.4 66.6 104.3 99.5 45.2 109.7 140.3 125.8 127.8 83.4 27.0 53.0 58.8 135.1 245.0 58.5 116.0 67.6 142.3 18.7 153.8 15.4 79.7 99.5 105.5 53.2 43.4 64.2 87.4 169.3 92.4 135.7 68.6 75.2 75.0 46.9 139.6 89.9 79.6 170.7 49.1 65.2 62.8 61.8 120.8 104.4 74.5 62.8 58.4 44.2 65.9 32.6 107.1 56.1 104.4 57.9 37.0 327.8 85.9 116.6 156.3 76.2 77.2 58.3 170.8 50.1 44.9 1.8 2.0 0.0 0.6 2.0 1.6 1.9 0.5 0.1 2.6 3.6 0.3 0.3 0.6 0.0 0.9 1.0 0.8 0.3 128.9 132.2 127.6 174.2 128.9 136.1 127.3 127.8 125.7 129.2 125.1 131.1 127.8 54.2 22.4 8.3 13.7 20.9 34.4 69.0 15.3 29.6 43.1 79.2 88.4 78.9 68.6 13.4 86.5 10.4 31.9 10.7 12.1 225.0 99.6 253.2 142.2 38.5 53.5 19.7 18.7 14.6 80.8 54.9 65.7 14.3 40.5 3.8 39.9 62.4 95.4 87.6 26.9 14.8 15.9 40.7 30.3 34.7 288.9 62.4 36.5 58.7 7.5 47.9 136.3 9.2 3.5 9.2 70.7 8.4 65.1 27.4 127.4 6.4 212.0 55.8 43.0 19.7 46.9 63.5 575.6 63.8 21.4 31.7 27.4 11.2 49.6 21.3 39.6 TP53RK "BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk, TPRKB" ENSG00000172315 "TP53 regulating kinase" Q96S44 20 46684365-46689444 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 214.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 212.4;SK-MEL-30: 90.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004688, HPA015837" Approved NA NA "CAB004688: AB_426116, HPA015837: AB_1855776" "unprognostic (9.45e-2)" "unprognostic (3.73e-1)" "unprognostic (9.76e-2)" "prognostic unfavorable (6.70e-5)" "unprognostic (4.41e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (9.16e-3)" "unprognostic (6.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.72e-2)" "unprognostic (1.25e-2)" "unprognostic (3.37e-2)" "unprognostic (1.75e-1)" "unprognostic (1.59e-1)" "unprognostic (1.74e-2)" 6.2 7.8 5.9 7.4 5.6 6.4 9.0 4.9 6.2 7.0 2.9 6.6 4.8 7.1 4.7 8.9 6.4 5.7 5.0 5.2 5.8 6.9 7.0 5.8 11.3 5.4 5.7 5.3 6.3 5.5 7.5 6.2 6.0 5.4 8.0 6.1 6.5 7.1 6.2 6.8 9.0 5.9 6.9 4.4 7.1 7.0 12.2 6.5 13.4 8.1 5.3 12.0 10.7 6.8 6.8 12.7 8.7 17.9 15.9 18.5 15.1 16.6 17.7 16.3 22.7 16.4 24.7 8.0 32.2 26.1 14.6 20.3 19.6 23.1 20.3 19.6 7.9 12.0 31.0 8.4 22.4 24.3 20.2 212.4 20.3 24.2 15.8 15.4 10.6 15.3 12.7 21.5 13.1 19.6 19.1 31.0 35.5 14.6 18.1 29.8 17.9 16.2 19.1 15.2 14.1 21.6 11.5 21.3 42.1 90.7 9.3 15.4 21.8 15.7 26.3 15.5 17.5 19.8 14.5 19.6 24.7 15.2 15.2 12.6 36.6 16.1 28.4 16.9 15.8 19.5 19.9 18.2 19.4 16.7 19.3 19.9 17.1 2.7 22.5 14.6 25.4 25.5 17.4 5.9 5.6 4.9 6.2 5.2 5.8 5.4 5.7 5.3 5.4 4.4 6.5 6.8 12.6 9.6 13.1 5.2 14.3 50.7 54.8 45.9 39.9 9.4 22.8 21.2 7.0 18.6 27.7 9.2 12.5 42.6 23.9 10.4 27.4 28.9 214.7 13.3 25.6 17.5 13.1 16.2 5.0 23.8 73.6 29.1 23.4 14.2 22.9 14.6 11.0 12.2 25.8 15.2 4.7 16.5 32.6 14.4 28.5 49.9 22.1 13.1 37.4 4.7 17.9 8.1 21.6 6.0 6.0 34.7 4.9 16.1 8.4 62.6 15.5 31.1 18.0 10.4 6.6 8.8 26.1 87.6 15.6 35.2 61.8 88.7 19.4 26.8 13.1 59.9 B3GALT1 beta3Gal-T1 ENSG00000172318 "Beta-1,3-galactosyltransferase 1" Q9Y5Z6 2 167868948-167874041 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.1;tongue: 18.0" "Group enriched" "Detected in some" 6 "Astrocytes: 920.7;Excitatory neurons: 519.3;Inhibitory neurons: 723.8" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "AN3-CA: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.22e-2)" "unprognostic (1.67e-1)" "unprognostic (4.23e-3)" "unprognostic (2.49e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.94e-2)" "unprognostic (8.72e-2)" "unprognostic (6.44e-2)" "unprognostic (2.30e-3)" "unprognostic (8.34e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (3.79e-1)" 0.2 0.5 4.2 0.2 5.2 0.1 0.4 2.3 6.0 0.3 0.1 3.7 0.0 0.2 0.4 0.1 0.6 0.0 0.0 6.1 10.1 0.1 0.0 0.1 0.0 2.3 3.2 3.8 0.2 0.3 0.0 1.8 0.0 2.4 0.2 3.7 2.4 0.2 0.7 5.2 0.2 0.2 0.2 1.6 0.2 0.0 0.5 3.1 0.0 0.2 18.0 0.0 0.0 0.2 3.6 0.0 0.0 2.8 35.7 0.3 0.0 0.0 0.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 4.6 0.0 1.2 0.0 0.2 0.0 0.5 0.0 2.3 0.4 0.0 0.0 0.7 1.6 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.0 0.8 0.0 0.7 0.0 3.3 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.3 0.2 0.2 0.1 0.0 0.1 0.1 0.0 4.2 5.2 2.3 6.0 6.1 10.1 2.3 3.2 3.8 2.4 1.6 3.1 3.6 0.2 0.0 1.3 920.7 0.2 0.1 0.0 0.0 0.0 3.0 0.1 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 18.3 0.0 0.1 0.5 0.1 0.6 0.7 0.0 0.0 519.3 0.2 0.0 0.5 0.0 0.4 1.3 0.0 0.0 0.0 0.1 1.7 723.8 3.8 0.0 0.0 0.3 0.0 0.6 0.3 1.8 39.4 0.0 2.4 0.0 108.0 30.3 0.0 3.4 1.5 0.0 0.4 0.0 0.4 0.0 1.3 0.0 1.1 0.6 0.0 1.7 0.0 0.0 0.0 0.1 0.1 7.4 0.1 OR5A1 "OR5A1P, OST181" ENSG00000172320 "Olfactory receptor family 5 subfamily A member 1" Q8NGJ0 11 59436469-59451380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.73e-2)" 0.1 0.2 0.6 0.2 1.0 0.7 0.1 2.0 1.8 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.9 0.4 0.0 0.1 0.1 0.2 0.4 0.3 0.8 0.2 0.2 0.0 0.0 0.1 0.9 0.1 0.1 0.9 0.2 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 1.0 2.0 1.8 0.9 0.4 0.4 0.3 0.8 0.9 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CLEC12A "CD371, CLL-1, DCAL-2, MICL" ENSG00000172322 "C-type lectin domain family 12 member A" Q5QGZ9 12 9951316-9995694 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 80.6;lymphoid tissue: 22.3" "Group enriched" "Detected in some" 4 "Kupffer cells: 121.9;Macrophages: 141.6;monocytes: 154.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 37 "dendritic cells: 72.6;granulocytes: 202.6;monocytes: 136.6" "Group enriched" "Detected in some" 6 "HL-60: 21.8;U-937: 66.5" "Region enriched" "Detected in single" 7 "basal ganglia: 6.2" "Not detected" "Not detected" HPA048515 Enhanced NA NA "HPA048515: AB_2680425" "unprognostic (4.74e-2)" "unprognostic (6.06e-3)" "unprognostic (7.76e-2)" "unprognostic (6.88e-2)" "unprognostic (2.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (3.29e-1)" "unprognostic (1.44e-2)" "unprognostic (1.70e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-3)" "unprognostic (9.67e-3)" "unprognostic (7.43e-2)" "unprognostic (3.78e-2)" "prognostic favorable (9.33e-4)" 6.5 2.7 0.4 14.1 0.2 80.6 1.1 0.3 1.0 2.0 1.1 2.8 1.0 1.1 1.2 1.2 1.0 5.2 1.7 0.2 0.3 0.7 6.5 16.8 6.6 0.4 0.2 0.2 0.4 0.7 0.6 0.4 2.5 0.3 0.9 3.1 0.3 1.3 0.4 1.3 1.4 4.5 7.8 0.1 22.3 1.8 0.6 0.3 2.6 1.1 0.7 2.1 4.9 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 21.8 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 66.5 0.0 23.9 136.6 202.6 0.2 114.6 0.5 0.2 0.1 0.1 72.6 0.1 0.4 0.5 47.2 3.7 130.2 6.4 0.2 61.6 0.4 0.2 0.3 1.0 0.2 0.3 0.4 0.2 0.2 0.3 0.1 0.3 0.3 0.7 3.2 5.0 0.0 2.8 0.4 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 3.1 0.0 0.0 0.2 6.9 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 7.2 0.3 0.0 1.0 1.5 0.5 0.1 30.3 0.0 0.7 0.8 19.2 0.0 0.3 0.0 0.0 121.9 16.9 0.0 0.0 141.6 0.0 0.0 154.0 0.0 9.2 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.1 0.9 0.9 0.2 0.6 1.4 4.2 0.0 0.0 0.0 OR5A2 ENSG00000172324 "Olfactory receptor family 5 subfamily A member 2" Q8NGI9 11 59416969-59426413 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047135, HPA049575" Uncertain NA NA "HPA047135: AB_2679948, HPA049575: AB_2680820" 0.2 0.2 0.9 0.3 0.7 0.8 0.2 1.9 1.3 0.1 0.0 0.2 0.3 0.4 0.4 0.1 0.2 0.2 0.2 0.9 0.6 0.2 0.3 0.2 0.4 0.7 0.4 0.5 0.2 0.3 0.1 0.0 0.1 0.9 0.2 0.2 1.1 0.3 0.2 0.4 0.5 0.4 0.1 0.1 0.5 0.2 0.5 0.8 0.2 0.3 0.2 0.2 0.1 0.0 1.3 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.2 0.3 0.4 0.0 0.2 1.4 0.2 0.3 0.7 0.3 0.0 0.2 0.6 0.1 0.1 0.0 0.1 0.2 0.0 0.5 0.3 0.7 0.0 0.2 0.2 0.3 0.5 0.1 0.1 0.5 0.3 0.2 0.1 0.3 0.3 0.1 0.2 0.1 0.4 0.4 0.2 0.2 0.3 0.1 0.3 0.4 0.1 0.6 0.4 0.2 0.2 0.6 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.0 0.9 0.7 1.9 1.3 0.9 0.6 0.7 0.4 0.5 0.9 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646811-134679816 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.0" "Group enriched" "Detected in all" 4 "Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 118.2;RT4: 186.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 81000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 11.5 12.7 18.4 9.2 19.1 88.0 12.5 19.8 20.2 12.6 19.2 11.3 8.5 9.7 18.6 27.2 8.5 13.0 13.6 18.4 21.0 35.5 13.2 14.1 11.2 20.1 20.3 17.6 7.2 8.5 35.6 18.3 47.4 20.4 13.7 10.1 20.1 17.9 18.0 38.1 10.8 8.1 12.2 20.6 12.6 12.0 14.8 19.8 16.5 12.0 27.3 26.4 39.4 17.3 21.0 14.0 16.3 21.7 29.6 24.3 14.4 21.9 41.3 49.9 15.7 23.2 6.5 18.5 17.1 12.0 23.2 30.9 11.2 23.3 22.7 27.6 118.2 19.9 9.8 15.4 7.8 16.7 18.8 12.4 14.2 20.0 29.7 16.0 24.0 58.0 20.8 28.8 20.9 37.8 6.6 30.7 26.0 22.7 27.7 15.3 23.2 15.5 12.4 36.1 186.8 18.7 31.1 19.3 23.1 21.7 23.1 15.1 11.8 44.7 25.1 6.0 33.7 33.9 33.9 41.2 21.5 43.3 17.7 43.7 61.1 16.4 48.9 23.3 22.2 16.7 19.3 15.0 20.7 17.5 18.9 20.7 21.1 30.2 18.5 23.0 11.4 21.1 23.6 18.4 19.1 19.8 20.2 18.4 21.0 20.1 20.3 17.6 20.4 20.6 19.8 21.0 17.6 9.6 25.5 6.5 15.7 39.0 18.5 60.6 10.8 19.2 15.9 18.7 25.0 18.6 52.3 27.6 2.1 44.5 43.0 5.0 129.1 45.9 3.4 10.0 7.0 18.8 13.1 456.6 8.0 18.2 32.7 17.0 4.1 8.5 24.7 6.6 10.0 4.7 15.1 20.2 9.3 4.6 36.7 11.7 10.5 7.2 10.2 11.8 23.2 5.6 15.7 25.6 47.4 7.5 11.6 49.0 4.6 12.0 14.2 26.0 5.5 68.8 50.5 13.5 6.6 12.0 22.1 33.9 21.8 13.5 13.2 368.9 25.0 7.8 4.8 19.2 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706121-100707486 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 24.6 32.0 28.8 18.3 31.2 34.2 26.9 32.9 38.9 23.5 23.4 27.3 19.4 28.0 11.1 34.3 21.5 9.9 32.0 31.0 30.6 26.0 67.7 18.4 17.4 30.0 27.8 30.5 18.3 31.6 16.7 23.0 16.8 30.7 22.7 9.3 9.7 29.2 13.6 69.6 50.5 22.5 12.3 28.6 22.8 26.6 12.6 28.5 15.8 17.0 32.2 12.1 25.6 25.1 34.0 115.7 115.3 47.2 78.4 25.1 23.9 92.0 65.6 32.4 73.7 73.1 159.8 71.0 97.5 105.1 30.0 81.4 70.4 70.1 79.5 36.8 82.7 212.4 44.9 75.0 166.5 42.1 69.2 49.8 27.6 30.2 76.2 74.8 20.9 41.6 68.9 157.4 77.8 39.8 330.4 158.0 232.9 135.2 77.8 164.4 123.6 50.0 159.4 45.3 65.2 90.4 92.3 54.5 156.2 78.7 42.0 50.0 66.2 41.3 92.0 117.7 191.0 127.6 34.0 99.4 175.8 61.0 115.1 104.6 106.3 63.2 72.4 54.7 64.7 50.7 60.3 54.6 54.3 55.3 47.7 49.5 52.0 39.0 78.9 70.3 51.2 69.8 62.5 28.8 31.2 32.9 38.9 31.0 30.6 30.0 27.8 30.5 30.7 28.6 28.5 34.0 30.5 19.2 17.0 2.9 29.7 105.0 32.0 57.2 56.3 26.1 61.6 64.1 27.9 37.1 31.5 35.0 6.2 148.2 25.8 51.8 93.9 75.4 2.1 31.2 32.3 37.2 40.2 50.1 5.2 87.4 181.3 37.3 25.0 35.1 17.7 32.4 33.5 99.0 66.1 32.0 6.0 61.7 67.1 27.3 40.7 7.9 42.0 22.4 56.9 2.8 38.7 41.8 41.2 4.0 5.8 92.2 47.6 37.2 55.1 75.6 69.8 86.1 27.8 21.3 46.0 29.8 52.2 9.2 45.5 74.7 119.2 139.3 27.2 39.9 55.8 43.5 ALG14 MGC19780 ENSG00000172339 "ALG14 UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974405-95072951 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA031829: AB_2674062" "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 1.2 2.5 1.6 0.8 1.7 0.9 1.3 2.2 2.0 1.0 1.6 1.6 1.8 0.8 2.3 1.0 0.9 1.2 0.9 1.6 1.5 1.5 2.1 0.8 0.8 1.6 1.5 1.6 0.9 1.8 1.6 1.0 0.8 1.6 0.9 1.8 1.5 1.8 0.8 1.5 0.9 1.3 0.8 1.3 0.8 1.1 1.1 1.5 0.7 1.7 0.5 0.8 0.9 0.7 2.2 2.5 1.6 1.3 1.2 1.0 1.7 1.1 1.8 1.9 1.8 1.5 1.8 0.8 1.3 1.8 2.2 2.2 1.7 1.5 1.7 2.2 2.8 2.5 0.7 1.6 2.9 1.6 1.7 0.4 1.9 1.7 1.4 1.3 1.4 1.6 1.7 1.4 1.6 1.8 1.2 1.9 1.1 0.8 2.5 2.2 1.2 2.6 1.4 2.1 1.4 1.1 1.5 1.0 3.4 3.2 0.9 1.5 1.5 1.2 1.1 1.3 2.0 3.9 1.0 1.0 1.1 0.8 0.8 0.9 1.3 1.0 0.3 0.8 1.3 0.7 1.6 0.9 1.0 1.5 1.4 0.8 0.9 0.8 0.9 0.6 1.9 1.3 0.6 1.6 1.7 2.2 2.0 1.6 1.5 1.6 1.5 1.6 1.6 1.3 1.5 2.2 11.8 0.0 12.2 14.0 13.1 11.7 11.4 30.5 19.4 16.9 13.8 15.2 7.7 10.0 20.3 16.5 6.2 34.6 10.5 25.7 19.6 24.9 10.0 12.2 19.6 10.1 4.2 13.0 24.6 53.7 25.9 18.9 11.2 13.3 1.3 14.7 11.7 32.4 18.9 8.4 22.4 12.9 18.3 8.4 8.9 8.4 14.3 8.6 32.0 14.0 10.3 30.9 3.1 14.6 35.4 23.6 22.6 10.1 41.6 8.9 22.1 40.0 12.7 14.4 32.9 17.1 15.2 36.1 23.0 19.0 8.7 25.2 5.6 39.9 26.9 12.9 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming subunit beta" Q96I99 3 67360460-67654612 "Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 280.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Approved "Plasma membrane,Mitochondria" NA NA 300000 Mitochondria "Plasma membrane" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favorable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 67.3 45.3 16.2 37.0 17.9 18.7 49.2 17.8 19.8 42.4 22.7 171.3 137.8 32.9 32.4 50.9 39.5 48.8 86.3 14.7 19.2 148.7 280.3 34.3 39.6 19.3 17.7 12.9 39.3 48.3 34.9 10.2 28.4 19.2 49.7 147.5 7.3 47.2 42.7 155.5 26.3 133.3 40.3 18.1 45.2 111.6 10.5 18.6 24.9 49.8 131.7 35.8 39.7 24.2 20.3 43.8 37.4 36.3 44.6 59.7 102.5 44.2 51.3 74.4 58.9 65.4 41.7 95.1 55.7 16.3 72.5 38.8 22.0 28.5 70.8 75.9 23.8 19.5 50.5 31.2 65.5 76.8 67.2 33.9 77.3 60.3 46.2 105.2 73.0 63.6 41.8 39.1 49.5 129.9 30.6 25.5 21.2 34.1 199.2 23.0 17.6 56.1 83.8 100.0 66.9 7.1 24.5 81.5 92.7 68.8 24.3 71.6 42.5 55.9 58.2 38.2 64.5 61.8 33.4 52.2 39.0 85.5 51.6 70.0 17.3 36.3 13.0 30.8 44.3 37.6 45.5 44.6 39.5 24.6 42.5 68.4 53.1 1.6 68.0 37.4 9.8 45.4 48.5 16.2 17.9 17.8 19.8 14.7 19.2 19.3 17.7 12.9 19.2 18.1 18.6 20.3 40.2 35.3 50.8 66.6 48.5 37.1 44.7 38.9 21.1 2.9 54.1 29.1 172.0 84.4 51.7 80.9 8.4 55.4 31.7 223.5 244.6 85.1 3.2 49.6 43.4 40.1 58.2 17.2 6.2 80.9 44.9 47.5 90.7 46.8 30.4 31.4 45.0 402.3 56.5 5.0 5.3 212.1 40.7 68.6 49.2 5.4 41.3 36.3 42.7 90.9 35.5 29.2 36.0 72.4 60.0 59.2 164.0 47.4 30.3 41.2 222.2 354.4 58.7 4.5 32.9 41.6 50.5 1.6 6.3 55.6 49.3 38.0 48.6 78.5 306.6 50.9 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 28.0;Plasma cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 1.0 0.6 0.6 6.1 0.8 4.3 0.7 3.3 1.5 7.2 2.4 2.6 2.2 4.6 5.0 3.4 1.9 1.4 0.7 0.7 1.2 0.6 5.1 1.1 7.8 1.0 0.9 0.4 1.2 0.6 0.6 0.4 1.6 1.9 3.7 3.7 0.4 1.6 2.1 0.6 8.0 4.2 1.9 1.0 6.2 2.1 0.7 0.8 0.5 0.9 0.3 1.6 2.6 5.5 2.4 0.3 0.0 0.0 0.9 2.3 2.3 0.1 0.3 0.3 0.8 1.2 0.1 0.1 4.8 0.0 1.5 0.2 4.0 1.1 1.0 0.6 0.1 0.4 1.8 0.3 0.4 0.5 2.8 5.8 2.0 2.0 0.3 0.6 1.5 0.1 1.9 0.6 1.3 0.5 0.1 0.5 4.0 0.3 0.2 0.0 0.1 0.7 6.2 0.3 1.4 0.3 0.1 0.1 0.5 0.6 0.3 0.6 0.6 0.2 1.3 0.6 1.3 0.1 7.1 1.5 1.8 0.9 6.8 0.4 5.0 1.8 2.3 3.0 2.4 2.5 1.0 2.7 3.2 2.6 0.7 3.9 3.9 1.3 2.6 2.3 1.4 3.6 3.7 0.6 0.8 3.3 1.5 0.7 1.2 1.0 0.9 0.4 1.9 1.0 0.8 2.4 3.8 0.0 1.1 0.0 11.4 13.3 12.0 28.0 10.8 1.8 2.7 4.2 0.3 0.0 4.9 0.0 6.2 2.5 4.2 22.1 3.9 1.3 15.2 2.5 14.4 2.5 11.4 2.5 2.2 1.4 4.0 8.5 15.8 2.3 10.2 1.0 3.6 25.4 5.2 1.7 2.0 24.3 2.0 7.9 10.9 1.5 5.0 8.0 1.8 1.9 0.7 1.2 2.1 0.0 0.4 1.8 14.4 9.8 31.5 3.3 23.9 0.7 4.0 0.9 0.0 3.8 2.8 0.9 0.7 19.6 16.3 4.9 4.2 6.3 19.9 9.6 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41561010-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 145.0;heart muscle: 249.4;ovary: 134.7" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 75.0;Distal tubular cells: 19.6;Granulosa cells: 30.7;Muller glia cells: 51.7;Proximal tubular cells: 42.5;Sertoli cells: 72.3;Smooth muscle cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 12.4;U-2 OS: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: AB_2686807" "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favorable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 6.1 145.0 29.1 1.6 20.3 0.1 3.2 55.2 32.4 68.2 2.9 11.2 0.8 84.1 1.4 3.2 24.3 2.3 249.4 26.7 26.6 39.9 2.7 11.6 0.2 42.1 37.1 11.3 134.7 51.5 0.0 20.6 0.4 35.1 26.4 0.5 5.2 1.1 10.5 2.8 2.0 3.2 11.0 24.2 1.1 4.5 31.5 41.8 0.0 2.5 2.8 0.0 27.6 29.2 27.8 0.0 0.2 1.5 0.2 0.0 0.0 0.1 3.4 0.2 0.1 0.1 0.9 0.0 0.0 0.5 4.7 0.5 0.1 0.0 0.0 0.0 0.0 2.9 0.0 12.4 1.5 3.5 0.0 0.0 1.9 0.1 0.0 0.0 3.5 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.1 1.1 0.2 0.0 0.1 0.1 1.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.1 41.8 0.3 0.1 0.2 0.2 0.0 0.8 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 29.1 20.3 55.2 32.4 26.7 26.6 42.1 37.1 11.3 35.1 24.2 41.8 27.8 0.1 0.0 0.0 4.6 0.5 0.3 0.2 0.3 0.6 9.9 0.1 0.6 75.0 0.0 0.0 7.3 2.1 0.1 0.0 0.0 19.6 0.3 1.5 0.2 6.0 0.9 0.0 0.0 6.8 10.4 0.1 5.1 0.0 0.1 0.0 30.7 0.4 0.2 0.2 6.7 11.0 0.0 0.0 0.0 0.0 5.1 5.3 0.3 1.8 0.0 0.0 51.7 0.0 1.0 0.6 2.4 0.0 2.6 0.0 0.2 0.0 42.5 0.7 3.2 72.3 0.4 19.9 2.1 0.3 0.0 0.1 0.3 0.2 0.3 0.0 0.0 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 201.3;tongue: 181.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 255.4;Excitatory neurons: 261.4;Inhibitory neurons: 254.4;Muller glia cells: 183.1;Oligodendrocytes: 294.6;Smooth muscle cells: 138.4" "Cancer enhanced" "Detected in all" "renal cancer: 25.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "gdT-cell: 1.8;memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 63.3;HDLM-2: 129.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053880: AB_2682290" "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 28.2 12.7 32.3 7.7 45.7 0.0 17.2 32.6 109.5 18.7 4.6 20.3 9.9 17.7 51.9 26.2 17.1 35.4 201.3 34.9 61.8 32.7 4.9 16.4 4.2 69.4 79.9 38.9 24.2 11.2 86.2 17.6 0.6 77.2 25.5 22.8 62.2 9.7 27.3 73.9 14.4 19.2 14.2 28.6 7.1 36.9 5.7 82.6 4.7 20.3 181.7 7.1 44.4 21.6 118.8 0.0 0.0 1.6 0.0 0.7 0.2 0.1 1.1 15.1 1.1 0.1 0.0 0.0 0.0 0.8 63.3 0.0 0.1 0.0 0.0 0.3 129.7 0.8 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.1 5.1 0.0 0.0 0.2 2.7 0.4 0.4 0.4 13.6 0.1 0.2 0.3 4.9 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.1 1.8 0.1 0.2 6.8 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.1 2.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 32.3 45.7 32.6 109.5 34.9 61.8 69.4 79.9 38.9 77.2 28.6 82.6 118.8 7.6 6.4 5.8 13.7 0.6 6.2 4.6 0.0 0.0 24.8 1.8 1.4 255.4 8.6 0.0 3.7 4.2 0.1 0.8 1.0 70.5 5.5 40.2 0.8 0.4 17.1 25.1 0.0 261.4 2.5 0.0 22.2 1.5 0.8 0.0 0.3 0.4 1.2 0.1 30.3 254.4 1.5 34.6 0.3 8.0 14.2 29.2 0.9 32.0 46.9 0.0 183.1 0.0 76.9 294.6 2.9 0.3 50.4 0.4 3.3 0.0 1.9 0.0 9.7 98.6 16.4 138.4 1.5 1.4 0.5 7.4 0.0 4.0 0.8 0.3 1.4 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 136.5" "Cell type enhanced" "Detected in many" "B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 57.3;pons: 20.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1" "Group enriched" "Detected in all" 11 "cerebellum: 54.5;hippocampal formation: 27.0" "Region enriched" "Detected in many" 12 "cerebellum: 48.8" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 208000 7300 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 18.4 6.3 5.2 63.9 3.7 62.6 15.6 57.3 7.2 9.7 13.4 14.5 11.4 10.0 7.7 7.5 17.9 16.3 6.0 2.9 6.4 3.2 9.8 23.9 133.6 6.1 8.1 1.8 6.1 2.6 2.3 2.1 9.0 20.8 5.9 17.0 0.5 11.3 4.6 3.3 12.1 40.2 9.9 7.3 86.9 15.8 4.3 5.2 131.6 7.0 8.6 136.5 19.1 10.5 7.5 0.0 0.0 0.0 0.1 17.5 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 27.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 29.4 0.0 0.0 0.9 21.0 50.6 0.9 0.0 0.1 0.6 0.0 0.4 3.5 3.2 10.7 0.1 0.0 1.7 22.2 0.0 0.1 0.0 0.1 0.1 51.0 0.0 0.2 0.1 0.1 0.1 0.0 9.9 0.0 0.0 4.6 0.2 0.3 0.2 1.0 0.0 60.3 5.5 25.8 1.8 35.1 1.5 252.8 116.2 321.3 164.5 142.7 185.9 166.0 170.6 180.6 150.9 157.2 224.9 185.6 282.5 213.2 149.1 113.7 197.0 338.0 5.2 3.7 57.3 7.2 2.9 6.4 6.1 8.1 1.8 20.8 7.3 5.2 7.5 9.4 3.2 6.6 0.0 135.3 8.2 0.2 0.8 1.2 0.2 0.8 1.4 2.7 8.6 1.9 1.8 0.0 0.3 78.1 0.3 0.0 0.1 1.4 3.1 6.6 7.5 0.0 20.2 3.4 0.2 0.3 15.9 1.1 0.7 27.1 0.0 26.7 9.2 19.0 0.0 4.9 0.3 0.0 59.2 94.4 1.4 10.8 33.1 28.4 18.7 30.2 0.3 121.5 0.0 0.3 0.0 1.2 18.0 55.6 0.1 0.1 0.4 7.7 0.7 6.6 1.1 3.2 2.1 7.5 1.2 3.7 0.4 76.3 0.2 0.7 0.2 ABCG4 WHITE2 ENSG00000172350 "ATP binding cassette subfamily G member 4" Q9H172 11 119149052-119162653 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 52.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 13.8;Cone photoreceptor cells: 58.4;Inhibitory neurons: 9.8;Rod photoreceptor cells: 46.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.9;HAP1: 1.0;U-2 OS: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057635 Enhanced NA NA "HPA057635: " "unprognostic (3.26e-2)" "unprognostic (4.75e-4)" "unprognostic (6.31e-2)" "unprognostic (1.83e-3)" "unprognostic (3.76e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (9.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (8.78e-2)" "unprognostic (2.25e-1)" "unprognostic (4.15e-4)" "unprognostic (2.26e-1)" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" 0.2 0.4 4.0 0.1 4.6 0.0 0.1 7.8 11.7 0.3 0.0 0.3 0.2 0.5 0.3 0.9 0.2 0.3 0.8 4.3 5.6 0.3 0.1 0.1 0.0 6.4 5.0 5.0 0.1 0.3 1.8 0.3 0.1 8.1 0.3 0.1 52.4 0.2 0.6 0.1 0.3 0.2 0.4 1.6 0.1 0.2 5.9 5.8 3.0 0.8 0.2 0.5 0.1 0.6 9.3 0.1 0.4 0.4 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.8 0.1 1.0 0.1 0.2 0.1 0.3 0.3 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.3 0.0 0.2 0.4 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.6 7.8 11.7 4.3 5.6 6.4 5.0 5.0 8.1 1.6 5.8 9.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.9 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 6.7 9.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 2.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.3 2.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CDY1B ENSG00000172352 "Chromodomain Y-linked 1B" Q9Y6F8 Y 24045229-24048019 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "testis: 2.2" "Cell type enhanced" "Detected in single" "Early spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNB2 ENSG00000172354 "G protein subunit beta 2" P62879 7 100673567-100679174 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010032, HPA040736" Approved Supported "Plasma membrane" NA NA 940000 "Plasma membrane" "CAB010032: AB_2263466, HPA040736: AB_2677106" "unprognostic (1.55e-1)" "unprognostic (5.76e-2)" "unprognostic (1.01e-3)" "unprognostic (2.76e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (3.68e-3)" "unprognostic (3.52e-1)" "unprognostic (6.58e-2)" "unprognostic (2.54e-1)" "unprognostic (9.79e-3)" "unprognostic (1.70e-1)" "unprognostic (3.75e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-1)" "unprognostic (5.29e-2)" "unprognostic (2.98e-1)" 199.8 212.7 113.9 129.4 114.4 209.4 189.6 97.9 181.0 196.6 90.0 164.2 104.1 184.0 64.2 331.0 181.4 106.4 173.3 109.9 130.4 180.8 187.3 211.9 108.8 119.9 113.5 110.6 176.8 186.3 99.7 204.9 108.3 101.3 184.6 84.4 20.3 192.3 114.7 177.3 287.5 144.7 114.5 108.1 227.7 173.8 93.7 115.7 91.0 146.0 91.0 106.6 166.6 219.6 102.8 358.6 268.6 222.7 272.5 169.8 199.9 194.3 208.4 288.4 294.3 241.7 205.3 333.7 157.7 216.0 311.3 332.2 243.0 177.7 312.6 103.0 216.9 152.1 120.8 198.7 171.3 282.4 157.7 254.5 259.5 291.1 304.2 244.6 237.6 343.6 132.5 228.6 303.3 270.4 980.0 249.5 450.3 173.5 225.1 290.1 234.3 136.3 253.8 235.4 291.3 241.0 380.1 278.0 449.2 201.3 125.3 192.4 192.1 325.8 313.8 346.8 619.2 266.6 88.8 111.9 240.9 237.1 349.7 443.6 27.6 28.6 70.9 17.5 42.7 16.2 13.6 17.9 15.4 28.1 18.1 11.8 12.4 117.2 15.4 35.9 23.8 23.5 12.5 113.9 114.4 97.9 181.0 109.9 130.4 119.9 113.5 110.6 101.3 108.1 115.7 102.8 138.1 57.7 97.0 16.0 104.1 151.8 159.3 72.9 148.0 10.4 105.4 106.0 35.0 100.1 55.5 84.6 4.2 172.4 89.4 285.4 162.4 163.7 32.6 133.5 106.8 136.5 180.4 127.7 12.7 218.7 312.1 117.6 135.1 127.2 44.4 97.6 126.0 69.9 264.4 72.3 10.8 211.2 75.3 198.6 198.8 20.1 144.8 193.5 140.5 15.9 160.8 128.2 96.8 5.0 6.9 257.1 285.6 130.1 122.5 226.5 162.3 107.0 68.3 8.5 65.7 62.0 162.2 34.3 69.6 240.7 194.8 293.9 117.8 88.1 192.2 259.5 CFAP53 "CCDC11, FLJ32743" ENSG00000172361 "Cilia and flagella associated protein 53" Q96M91 18 50227193-50266495 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "fallopian tube: 28.7;testis: 80.2" "Group enriched" "Detected in many" 14 "Early spermatids: 809.6;Endometrial ciliated cells: 331.5;Late spermatids: 528.4;Respiratory ciliated cells: 216.5;Spermatocytes: 481.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 4.7" "HPA041069, HPA066142" Enhanced Approved Midbody Yes No Midbody "HPA041069: AB_10805835, HPA066142: AB_2732739" "unprognostic (1.73e-2)" "unprognostic (1.13e-2)" "unprognostic (5.83e-2)" "unprognostic (3.12e-3)" "unprognostic (3.31e-2)" "unprognostic (1.19e-1)" "unprognostic (3.64e-4)" "unprognostic (2.90e-2)" "unprognostic (3.68e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "prognostic favorable (5.85e-4)" "unprognostic (3.22e-1)" "unprognostic (1.17e-2)" "unprognostic (4.34e-3)" "unprognostic (4.61e-3)" 0.3 1.2 6.1 0.4 3.6 0.7 1.1 5.3 3.2 2.0 7.3 0.4 0.2 1.2 5.8 0.4 28.7 0.7 0.4 3.0 5.3 2.7 0.5 3.4 0.3 6.0 6.3 2.2 1.0 1.1 2.6 3.3 0.3 5.7 0.9 0.2 3.5 0.6 1.2 2.3 1.0 0.4 0.3 6.3 0.4 0.5 80.2 4.3 0.6 3.9 0.4 0.2 0.6 0.7 5.2 1.2 0.8 0.5 1.0 0.7 1.3 0.9 0.2 0.1 0.1 0.2 0.1 1.0 0.7 0.7 0.3 0.3 0.5 0.3 0.5 0.2 0.5 0.7 0.3 0.3 0.1 0.3 0.5 0.4 0.4 2.0 0.5 4.7 1.1 0.3 1.9 1.4 0.4 0.3 1.2 1.2 0.2 0.2 0.2 0.5 0.1 0.2 1.0 1.4 0.0 0.8 0.6 0.1 0.0 0.4 1.3 0.6 0.1 0.0 0.7 0.5 0.4 0.4 2.1 0.8 0.1 0.7 0.5 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.2 0.0 6.1 3.6 5.3 3.2 3.0 5.3 6.0 6.3 2.2 5.7 6.3 4.3 5.2 0.6 6.4 4.2 2.6 0.6 0.0 2.0 0.0 1.8 4.3 4.7 3.8 0.4 0.0 21.1 9.2 8.4 1.7 0.2 0.3 9.8 3.4 809.6 331.5 3.8 1.4 0.0 0.4 3.8 0.6 0.5 2.2 2.6 7.9 1.3 1.4 1.8 1.0 0.4 1.7 4.4 0.2 0.0 0.0 0.0 528.4 8.4 1.3 0.0 2.8 1.0 2.7 1.0 3.0 6.5 0.8 0.1 5.7 0.9 1.3 0.8 20.5 216.5 10.5 6.6 2.1 0.7 481.5 32.5 1.3 0.0 0.7 1.0 1.7 0.4 1.1 OR5B12 "OR5B12P, OR5B16, OST743" ENSG00000172362 "Olfactory receptor family 5 subfamily B member 12" Q96R08 11 58439077-58442758 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B2 OST073 ENSG00000172365 "Olfactory receptor family 5 subfamily B member 2" Q96R09 11 58421238-58428121 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCRIP2 "C16orf14, FAM195A, MGC15416" ENSG00000172366 "MAPK regulated corepressor interacting protein 2" Q9BUT9 16 636817-648474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 56.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 189.2;Distal tubular cells: 183.9;Hofbauer cells: 133.9;Proximal tubular cells: 310.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060363 Uncertain NA NA "HPA060363: AB_2684263" "unprognostic (7.14e-2)" "unprognostic (3.85e-2)" "unprognostic (8.25e-2)" "unprognostic (2.49e-2)" "unprognostic (2.72e-1)" "unprognostic (4.18e-2)" "unprognostic (1.60e-1)" "unprognostic (2.96e-3)" "unprognostic (7.82e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.06e-2)" "unprognostic (4.00e-2)" "unprognostic (2.10e-2)" "prognostic favorable (7.23e-4)" 6.5 31.6 4.8 2.1 4.1 1.7 5.2 6.9 8.7 3.3 13.5 16.5 6.9 4.0 0.0 8.7 4.3 0.5 39.0 4.4 4.1 25.4 56.5 5.7 0.8 5.3 4.0 3.7 4.4 12.6 2.7 12.8 2.2 5.9 8.2 0.9 0.1 8.9 1.5 39.6 2.5 10.8 0.3 3.9 9.6 14.8 5.6 7.1 0.3 7.4 3.3 0.6 9.5 4.3 4.6 14.7 3.4 0.4 6.0 1.3 3.7 7.1 7.8 2.4 3.8 2.1 3.9 6.8 23.9 18.8 0.7 2.2 15.0 2.4 6.0 0.1 19.0 30.4 10.6 3.5 3.1 6.8 18.2 14.4 2.2 5.4 1.7 2.0 1.4 1.3 6.3 23.6 3.0 0.7 4.4 1.7 30.0 9.2 7.5 37.1 25.9 0.1 34.5 3.1 1.1 15.3 7.7 13.9 9.9 26.0 0.3 8.8 14.4 6.1 0.3 7.8 8.6 10.9 37.6 47.0 35.9 1.4 15.8 0.9 0.0 11.3 3.1 1.2 12.9 3.1 10.5 3.3 3.7 10.0 6.8 4.2 2.8 0.2 2.5 14.5 0.3 3.9 3.5 4.8 4.1 6.9 8.7 4.4 4.1 5.3 4.0 3.7 5.9 3.9 7.1 4.6 11.3 3.2 12.4 0.0 10.0 0.0 0.0 0.0 0.0 0.0 55.5 53.8 0.0 0.0 1.8 64.4 0.0 189.2 7.9 0.0 183.9 62.7 0.0 17.3 13.1 4.6 0.0 0.0 0.0 70.8 27.6 7.5 0.0 16.9 5.1 51.1 0.0 0.0 133.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 40.3 0.0 0.0 0.0 0.0 67.4 0.0 0.0 1.7 0.0 0.0 310.2 0.7 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 79.6 6.3 50.3 0.0 0.0 PDZD3 "FLJ22756, IKEPP, PDZK2" ENSG00000172367 "PDZ domain containing 3" Q86UT5 11 119185457-119190223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 19.5;kidney: 16.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.3;renal cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA077887 Enhanced NA NA "HPA077887: " "unprognostic (2.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.39e-2)" "unprognostic (6.07e-2)" "unprognostic (3.22e-1)" "unprognostic (1.86e-2)" "unprognostic (6.58e-3)" "unprognostic (9.00e-2)" "unprognostic (6.08e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (3.41e-3)" 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 17.3 0.0 0.0 0.0 1.0 2.8 0.0 0.0 0.0 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.3 8.6 0.0 0.0 6.2 0.0 0.0 93.4 3.9 0.1 0.0 0.2 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.4 30.5 0.1 0.0 0.1 1.1 0.1 0.2 0.0 0.0 8.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 74.8 0.0 0.2 0.1 79.1 29.5 0.7 0.7 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.1 21.0 0.1 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 50.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011044, HPA075369" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA011044: AB_2668414, HPA075369: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 6.4 8.3 26.8 6.6 25.1 13.8 5.8 15.6 29.1 6.4 14.7 9.5 16.3 6.3 4.9 10.9 8.9 5.3 9.4 25.6 20.9 11.6 13.2 10.4 8.2 18.0 18.9 25.9 6.0 11.1 5.7 24.1 4.0 19.2 7.2 7.3 14.2 9.6 5.3 15.4 15.4 17.2 5.2 14.7 15.1 8.1 4.4 20.6 8.6 6.8 7.4 5.7 7.0 6.6 23.3 6.1 4.5 6.0 12.5 7.7 3.2 3.9 9.0 7.8 8.7 7.2 7.3 6.3 9.1 23.1 6.3 9.1 13.4 7.6 3.9 3.4 14.3 6.2 35.7 5.9 5.3 10.2 10.5 50.5 3.7 7.9 16.4 6.1 9.8 5.4 13.5 15.1 16.1 8.3 16.2 11.9 24.9 2.2 15.0 11.8 7.4 5.3 10.5 8.7 3.8 18.7 10.5 3.8 20.1 5.9 2.3 35.3 13.9 6.7 8.1 2.8 9.9 16.1 6.8 4.5 3.5 4.9 17.6 9.1 0.5 1.3 2.7 0.2 1.4 0.4 0.1 0.6 0.6 0.5 0.0 0.6 0.3 0.4 0.8 2.0 0.3 0.6 0.5 26.8 25.1 15.6 29.1 25.6 20.9 18.0 18.9 25.9 19.2 14.7 20.6 23.3 5.1 6.4 4.2 9.4 3.7 10.7 1.6 2.3 10.2 15.6 6.8 5.0 2.4 2.8 4.3 1.8 37.5 0.9 7.4 40.6 3.9 3.4 5.4 12.1 2.6 5.7 1.2 7.0 15.1 2.8 1.7 2.5 3.6 4.6 2.5 2.2 11.4 5.4 9.4 21.9 15.0 8.0 0.0 13.9 16.1 1.3 2.1 11.4 7.2 5.6 15.3 5.9 7.2 4.5 8.4 5.1 10.4 1.5 7.2 3.2 33.0 4.0 21.9 29.9 6.6 2.1 3.6 3.7 2.0 10.3 10.9 1.1 8.6 3.6 5.5 1.9 OR9I1 ENSG00000172377 "Olfactory receptor family 9 subfamily I member 1" Q8NGQ6 11 58116742-58125530 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597933 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 119.9;choroid plexus: 32.3" "Group enriched" "Detected in many" 4 "Astrocytes: 209.6;Excitatory neurons: 204.7;Inhibitory neurons: 301.5;Microglial cells: 98.4;Oligodendrocyte precursor cells: 232.7;Oligodendrocytes: 136.9" "Cancer enhanced" "Detected in all" "glioma: 27.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.2;hTERT-RPE1: 29.7;LHCN-M2: 26.0;SK-MEL-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favorable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favorable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 1.9 2.1 95.7 2.2 95.4 0.4 1.4 53.7 111.9 4.6 32.3 4.4 1.7 6.0 8.3 2.1 5.4 2.6 4.1 119.9 66.2 13.8 0.4 5.0 2.3 72.2 73.3 85.0 10.8 3.5 6.4 11.6 1.2 64.7 5.6 2.2 8.2 1.2 5.1 9.8 2.1 2.7 3.9 57.5 3.6 4.1 10.0 69.7 2.2 7.0 6.1 3.0 4.4 2.0 76.3 0.4 16.1 28.4 0.0 0.1 3.6 0.1 12.2 17.3 13.9 28.2 0.0 0.0 0.0 3.0 14.7 7.2 0.4 10.5 0.6 17.7 0.0 2.9 0.5 0.0 1.0 0.9 0.0 7.2 13.2 0.5 6.1 0.3 29.7 0.0 0.0 0.0 0.1 26.0 14.0 0.0 0.0 5.7 0.0 0.2 0.0 0.3 0.0 6.0 20.5 14.9 20.6 1.5 0.2 30.8 1.8 0.6 0.0 0.0 22.2 4.4 0.6 14.7 0.0 0.0 0.0 8.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.7 95.4 53.7 111.9 119.9 66.2 72.2 73.3 85.0 64.7 57.5 69.7 76.3 0.1 0.0 2.3 209.6 0.0 1.3 1.2 1.5 4.0 17.0 3.2 3.4 7.6 2.8 4.7 3.7 8.4 0.2 0.1 0.2 13.7 6.0 36.7 8.5 2.7 1.8 22.9 0.0 204.7 0.2 3.6 2.7 3.1 4.4 2.5 5.7 0.4 0.0 0.2 1.7 301.5 2.6 8.2 0.0 1.6 39.8 0.6 0.4 7.2 98.4 0.1 5.9 2.1 232.7 136.9 2.4 2.3 3.0 0.0 2.2 0.3 1.0 1.6 9.3 6.6 2.6 2.5 2.1 3.0 0.5 0.3 2.7 0.6 1.9 1.3 1.4 GNG12 ENSG00000172380 "G protein subunit gamma 12" Q9UBI6 1 67701475-67833467 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 243.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057790, HPA062208" Enhanced Supported Approved Mitochondria NA NA 550000 Mitochondria "HPA057790: AB_2683527, HPA062208: AB_2684711" "unprognostic (5.18e-2)" "unprognostic (1.76e-3)" "unprognostic (4.46e-3)" "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (4.71e-2)" "unprognostic (5.29e-2)" "unprognostic (5.84e-3)" "unprognostic (5.50e-2)" "unprognostic (3.41e-2)" "unprognostic (4.46e-3)" "unprognostic (8.13e-2)" "unprognostic (4.12e-3)" "unprognostic (2.33e-2)" "unprognostic (9.33e-2)" "unprognostic (7.78e-2)" "unprognostic (2.14e-3)" 64.0 57.5 14.3 28.7 12.4 0.3 50.6 11.5 14.2 59.8 14.4 69.0 123.1 60.3 27.9 82.8 43.8 59.8 34.8 14.0 20.0 79.9 45.2 34.6 12.1 21.1 28.9 10.2 48.3 25.4 55.2 13.2 60.7 17.7 38.6 66.3 6.7 26.8 48.1 13.0 81.1 111.7 74.6 19.9 56.7 43.1 17.9 14.8 16.1 60.3 19.9 22.9 57.0 46.9 19.5 60.5 55.5 58.0 31.5 241.2 207.9 59.5 182.9 237.2 157.9 141.0 26.5 58.2 0.1 75.9 258.0 98.8 44.2 36.6 150.0 275.7 0.5 28.1 1.0 46.0 0.1 96.0 0.1 3.0 125.7 87.8 168.7 221.8 221.1 251.9 0.0 3.6 0.3 175.6 10.2 0.1 0.5 44.1 65.7 68.3 0.3 119.6 0.9 151.8 53.5 13.2 26.8 126.8 52.1 248.4 48.8 26.9 1.1 326.7 182.5 118.8 332.0 114.5 3.0 0.3 0.5 115.3 7.1 252.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 12.4 11.5 14.2 14.0 20.0 21.1 28.9 10.2 17.7 19.9 14.8 19.5 49.7 54.5 32.2 54.5 2.1 201.3 78.8 53.3 78.6 2.1 52.4 37.1 26.7 35.8 42.8 58.8 6.2 61.8 0.9 243.1 74.3 96.2 14.6 51.8 20.6 67.0 34.7 5.3 0.5 138.5 105.6 82.6 45.3 49.3 3.8 21.3 76.1 45.6 27.9 3.3 15.3 56.3 30.5 18.2 32.4 16.6 71.4 6.2 78.2 21.5 3.6 3.0 0.0 63.3 1.3 143.7 99.9 75.6 0.2 119.9 227.3 177.9 79.2 18.9 52.6 54.8 71.7 1.8 18.8 83.1 216.8 175.9 4.5 107.1 61.8 109.1 PRSS27 "CAPH2, MPN" ENSG00000172382 "Serine protease 27" Q9BQR3 16 2712419-2720551 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 391.7;vagina: 135.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Horizontal cells: 11.8;Squamous epithelial cells: 9.6;Urothelial cells: 11.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;SK-BR-3: 24.4;T-47d: 14.6;U-266/70: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB024920, HPA028848" Approved Approved Vesicles "Secreted to digestive system" NA NA 8700000 Vesicles "CAB024920: , HPA028848: " "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (3.46e-3)" "unprognostic (5.35e-2)" "unprognostic (5.25e-2)" "unprognostic (2.48e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (4.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.79e-2)" "unprognostic (4.40e-3)" "unprognostic (4.03e-3)" "unprognostic (2.40e-1)" "unprognostic (2.26e-1)" "unprognostic (2.04e-2)" "unprognostic (1.28e-2)" 0.8 0.4 1.0 0.2 1.0 0.3 1.3 1.1 2.0 40.6 0.8 0.8 0.0 1.0 0.0 391.7 0.7 0.2 0.4 0.9 1.5 0.9 0.6 0.6 0.3 1.3 1.6 0.9 0.5 0.8 0.7 1.5 0.1 1.3 1.0 0.0 0.2 52.9 0.4 0.3 3.1 0.6 0.0 1.0 0.6 0.8 2.6 1.4 0.6 0.9 0.0 30.2 0.9 135.2 1.0 0.1 0.3 0.4 2.1 0.3 0.7 6.1 0.0 0.2 0.2 0.2 0.1 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.1 0.1 0.0 1.0 0.0 0.3 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.6 0.0 2.0 0.0 1.1 1.4 0.2 0.0 1.0 0.2 0.1 0.2 0.3 0.7 2.8 0.0 24.4 0.6 0.1 14.6 1.8 0.0 0.4 0.0 0.1 0.0 5.2 3.7 0.5 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 1.1 2.0 0.9 1.5 1.3 1.6 0.9 1.3 1.0 1.4 1.0 1.5 9.6 5.8 0.0 0.5 1.8 2.5 1.3 0.6 5.2 5.1 6.2 1.2 1.5 5.6 1.8 4.2 0.7 0.5 1.2 0.0 1.5 3.3 0.6 1.4 1.8 0.0 0.0 0.4 1.4 0.6 1.4 1.1 1.6 3.8 1.1 0.4 0.7 0.3 11.8 0.8 0.5 0.0 0.3 3.1 1.0 0.3 0.8 1.8 1.9 0.9 2.6 0.0 0.0 0.3 1.1 1.2 0.0 0.2 1.7 0.1 0.7 3.4 6.6 0.0 2.7 1.5 3.0 3.9 9.6 2.4 3.3 1.3 0.6 1.4 11.1 MYOZ2 "C4orf5, CS-1, FATZ-2" ENSG00000172399 "Myozenin 2" Q9NPC6 4 119135832-119187789 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 778.5;skeletal muscle: 227.3;tongue: 175.0" "Cell type enriched" "Detected in some" 51 "Cardiomyocytes: 2275.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA035763, HPA035764" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035763: AB_2674770, HPA035764: AB_10696509" "unprognostic (2.53e-1)" "unprognostic (9.20e-2)" "unprognostic (6.94e-2)" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.34e-2)" "unprognostic (5.71e-1)" "unprognostic (2.18e-1)" "unprognostic (4.77e-2)" "unprognostic (4.04e-1)" "unprognostic (8.25e-2)" "unprognostic (5.07e-2)" "unprognostic (6.19e-7)" "unprognostic (6.66e-4)" "unprognostic (2.43e-1)" "unprognostic (3.06e-1)" "unprognostic (2.83e-2)" 0.5 0.3 0.2 0.0 0.3 0.0 2.1 0.1 0.5 0.6 0.1 0.7 0.0 2.0 0.3 1.0 1.0 0.3 778.5 0.3 0.3 0.7 0.1 0.9 0.3 0.2 0.2 0.1 0.6 0.1 0.0 0.2 0.2 0.1 4.8 0.1 0.0 1.8 0.3 227.3 0.3 0.4 0.8 0.3 0.6 0.6 1.0 0.3 0.3 0.3 175.0 0.1 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.2 1.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 6.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.5 0.3 0.3 0.2 0.2 0.1 0.1 0.3 0.3 0.3 0.1 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 2275.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.4 20.8 0.0 0.0 3.4 2.2 0.0 44.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.7 0.0 0.2 0.0 2.9 0.0 0.0 6.6 6.9 22.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYNPO2 MYOPODIN ENSG00000172403 "Synaptopodin 2" Q9UMS6 4 118850688-119061247 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 999.7;tongue: 497.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1" "Group enriched" "Detected in all" 5 "prostate cancer: 25.7;stomach cancer: 27.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2" "Region enriched" "Detected in all" 4 "thalamus: 27.1" "Low region specificity" "Detected in all" "HPA030665, CAB037231, HPA049707, HPA068563" Enhanced Enhanced "Vesicles,Actin filaments" NA NA "Vesicles, Actin filaments" "CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006" "unprognostic (1.50e-2)" "unprognostic (1.73e-2)" "unprognostic (5.32e-2)" "unprognostic (1.50e-2)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (5.71e-4)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (1.39e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (1.82e-2)" "unprognostic (1.35e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.91e-4)" 51.6 10.9 6.8 47.8 5.9 0.3 36.2 5.9 8.8 54.7 8.5 253.5 34.6 138.2 33.6 199.0 90.2 50.4 66.8 11.0 36.5 8.8 7.1 16.3 10.6 7.8 4.8 1.4 39.3 3.9 3.6 7.5 21.0 6.0 182.1 58.5 1.2 16.1 270.0 999.7 14.5 76.1 246.6 10.5 10.3 127.3 6.7 6.7 14.4 16.1 497.9 6.6 228.4 54.5 11.7 0.2 4.2 0.2 0.0 10.5 3.5 0.7 13.4 14.1 0.4 0.5 0.0 0.7 1.5 0.1 57.8 0.9 0.2 0.4 0.3 0.7 5.9 0.1 0.8 1.3 0.0 2.4 0.1 0.2 14.5 0.3 4.0 0.2 3.7 0.2 0.2 0.0 0.7 18.5 0.3 0.7 7.2 1.4 0.0 0.0 0.5 1.5 0.4 0.2 0.3 0.4 83.2 0.4 0.3 0.1 3.3 0.0 7.0 0.4 0.6 0.1 0.2 0.1 0.1 0.3 0.1 1.1 0.6 0.2 0.8 0.1 0.5 0.2 0.0 0.4 0.3 0.4 0.2 0.0 0.4 0.4 0.3 0.2 0.3 0.1 0.0 0.5 0.1 6.8 5.9 5.9 8.8 11.0 36.5 7.8 4.8 1.4 6.0 10.5 6.7 11.7 25.5 3.2 1.1 42.7 1.1 13.5 17.9 3.7 46.1 2.5 6.3 30.7 135.4 0.0 0.3 1.8 0.0 1.4 0.5 0.1 0.0 0.1 2.2 6.9 130.0 11.3 0.0 1.7 149.6 1.8 0.5 41.5 0.5 10.6 0.0 16.1 13.9 0.4 1.4 0.0 31.5 0.2 0.0 0.9 11.4 7.0 27.1 3.8 5.4 76.8 12.9 0.0 0.0 6.0 3.0 0.2 0.4 101.5 0.8 24.9 0.1 0.3 2.5 0.5 131.5 93.4 206.1 1.3 0.5 5.3 8.1 0.8 2.6 33.4 0.2 4.0 DNAJB7 HSC3 ENSG00000172404 "DnaJ heat shock protein family (Hsp40) member B7" Q7Z6W7 22 40859549-40862113 "Predicted intracellular proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 10.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 553.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000534 Approved NA NA "HPA000534: AB_1078693" "unprognostic (3.89e-2)" "unprognostic (1.12e-2)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (2.66e-2)" "unprognostic (1.16e-2)" "unprognostic (5.56e-3)" "unprognostic (1.62e-1)" "unprognostic (7.42e-2)" "unprognostic (1.22e-3)" "unprognostic (2.81e-2)" "unprognostic (4.46e-4)" "unprognostic (3.32e-3)" "unprognostic (3.06e-2)" "unprognostic (7.05e-2)" "unprognostic (2.45e-2)" 0.1 0.1 0.2 0.1 0.2 0.5 0.1 0.7 0.7 0.3 0.3 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.0 0.4 0.2 0.1 0.8 0.2 0.0 0.4 0.1 0.5 0.0 0.0 0.1 0.1 10.4 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.4 0.4 0.2 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.3 0.3 0.1 0.3 0.2 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.7 0.7 0.1 0.1 0.2 0.2 0.2 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.1 0.4 0.8 0.0 0.0 553.5 1.5 0.8 0.4 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.4 4.5 0.2 0.0 0.0 0.1 1.7 0.5 0.4 0.0 0.0 0.0 98.5 2.8 0.2 0.0 0.0 0.0 0.9 0.0 1.0 0.7 0.0 0.0 2.6 0.1 0.1 6.0 0.0 0.0 11.2 0.0 0.3 0.1 2.9 1.5 0.0 0.0 0.3 0.2 0.2 0.9 0.1 CLP1 "hClp1, HEAB" ENSG00000172409 "Cleavage factor polyribonucleotide kinase subunit 1" Q92989 11 57648188-57661865 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Kinase, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057770 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA057770: AB_2683523" "unprognostic (1.33e-1)" "unprognostic (7.90e-2)" "unprognostic (1.11e-3)" "unprognostic (2.13e-2)" "unprognostic (4.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.82e-2)" "unprognostic (7.58e-2)" "unprognostic (8.31e-3)" "unprognostic (3.71e-2)" "unprognostic (1.75e-1)" "unprognostic (8.78e-2)" "unprognostic (3.07e-1)" 9.0 7.4 3.3 10.2 3.7 26.3 9.3 4.1 4.5 7.1 4.3 9.0 8.8 7.7 7.7 9.2 7.4 6.0 5.7 3.5 3.4 8.1 10.2 7.4 10.9 3.4 3.4 3.5 6.9 7.5 6.8 4.4 9.3 3.9 5.6 8.7 3.2 6.8 7.2 8.2 8.7 8.4 8.9 3.7 10.0 8.1 8.5 3.5 11.3 7.3 9.4 13.2 8.7 5.0 3.9 21.2 22.2 21.0 21.6 22.3 14.4 19.7 21.4 23.2 30.1 25.8 21.4 18.4 35.1 24.3 18.9 24.2 25.9 29.2 34.5 34.2 24.3 18.0 19.4 13.5 21.7 17.7 28.5 22.2 17.4 24.0 26.9 18.6 11.9 27.7 17.4 30.4 11.9 24.9 14.8 21.8 32.9 31.8 24.3 22.2 21.7 32.1 37.5 16.5 15.0 11.1 22.3 19.1 17.2 28.7 21.7 32.7 23.2 20.0 16.0 21.7 27.7 15.9 18.6 26.4 39.3 17.3 16.3 17.3 31.2 19.0 20.0 15.9 16.4 18.9 15.6 14.1 16.4 19.0 14.3 16.4 14.9 21.7 13.6 15.9 10.8 16.2 12.3 3.3 3.7 4.1 4.5 3.5 3.4 3.4 3.4 3.5 3.9 3.7 3.5 3.9 6.1 9.6 5.1 1.0 8.5 19.4 10.7 13.4 16.5 4.3 6.0 6.2 2.4 7.2 10.5 0.0 6.2 16.5 12.7 4.8 9.8 12.9 32.5 6.7 5.7 7.3 2.4 12.2 1.9 11.7 13.9 7.4 3.1 7.1 8.2 4.9 4.2 3.5 11.0 5.0 1.8 3.2 8.2 6.0 6.9 4.1 5.6 5.8 8.8 1.0 15.0 3.3 7.2 2.5 1.4 9.8 4.7 8.6 5.9 4.7 6.2 10.1 6.4 3.1 6.6 10.4 6.9 9.4 12.0 9.3 14.5 13.5 9.7 6.5 4.6 7.8 INSL5 ENSG00000172410 "Insulin like 5" Q9Y5Q6 1 66797741-66801256 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 104 "intestine: 130.1" "Cell type enriched" "Detected in some" 365 "Enteroendocrine cells: 8836.2" "Group enriched" "Detected in some" 5 "colorectal cancer: 1.2;prostate cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA030100, CAB033849" Enhanced "Secreted to blood" NA NA 38500000 "CAB033849: AB_2264904, HPA030100: AB_10601915" "unprognostic (2.48e-1)" "unprognostic (4.41e-2)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (2.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.62e-2)" "unprognostic (7.53e-2)" 0.0 0.0 1.0 0.0 0.9 0.0 0.1 0.8 1.1 0.0 1.0 76.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.9 0.3 0.0 0.0 0.0 0.9 0.8 0.8 0.0 0.0 0.0 0.2 0.0 0.8 0.1 130.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.8 1.1 0.8 0.9 0.9 0.8 0.8 0.8 1.2 0.9 0.8 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.2 0.3 0.0 0.0 8836.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 22.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 11.4 0.0 EFCAB3 FLJ25818 ENSG00000172421 "EF-hand calcium binding domain 3" Q8N7B9 17 62343941-62416480 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.0" "Cell type enriched" "Detected in some" 8 "Early spermatids: 74.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046862 Uncertain NA NA "HPA046862: AB_2679844" "unprognostic (2.99e-6)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.4 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 74.6 0.2 0.4 0.4 0.0 0.0 1.3 0.0 0.2 0.4 0.0 0.3 1.3 0.3 0.4 0.3 0.0 1.7 0.9 0.0 0.0 0.0 1.1 8.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.4 0.0 0.1 0.0 0.1 3.1 0.3 0.0 0.2 0.1 0.1 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 172.9" "Group enriched" "Detected in many" 13 "Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 100000 Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 8.1 1.3 0.7 0.1 0.6 0.0 11.2 0.8 0.7 0.3 0.5 0.5 5.9 0.4 18.6 0.5 0.5 0.1 1.0 0.3 0.5 8.7 172.9 0.3 0.1 1.2 0.7 0.4 0.6 1.2 0.0 1.6 0.1 1.1 1.0 0.0 0.3 0.9 0.0 1.4 0.5 4.2 0.0 0.6 0.3 0.7 0.8 0.5 0.0 0.7 0.4 0.0 0.5 0.3 1.0 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.2 0.7 0.0 0.0 0.2 0.0 0.0 9.7 0.0 0.0 0.8 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.6 0.8 0.7 0.3 0.5 1.2 0.7 0.4 1.1 0.6 0.5 1.0 0.3 0.0 0.0 0.3 2.4 0.3 0.6 0.2 0.6 0.1 21.2 11.3 0.3 11.5 0.1 12.9 0.0 1.5 0.1 0.8 17.6 0.2 0.1 1.2 0.6 1.1 2.4 16.4 0.2 0.5 0.2 0.3 2.0 1.7 0.0 0.4 9.7 492.9 0.1 0.0 0.3 9.3 0.0 14.2 0.3 0.2 0.3 0.9 0.0 0.0 0.6 1.1 0.0 0.0 0.1 0.2 7.6 0.0 0.3 1.9 185.5 172.9 0.2 0.8 0.0 0.2 0.2 0.3 0.3 0.3 0.1 2.1 1.1 0.4 11.7 1.3 RSPH9 "C6orf206, CILD12, FLJ30845, MRPS18AL1" ENSG00000172426 "Radial spoke head component 9" Q9H1X1 6 43645036-43672600 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.4;testis: 15.3" "Group enriched" "Detected in many" 4 "Early spermatids: 195.6;Endometrial ciliated cells: 96.3;Respiratory ciliated cells: 327.5;Spermatocytes: 89.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-87 MG: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031703 Enhanced NA NA "HPA031703: AB_10602126" "unprognostic (2.54e-2)" "unprognostic (1.85e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" "unprognostic (7.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.81e-3)" "unprognostic (2.78e-3)" "unprognostic (6.42e-2)" "unprognostic (7.27e-2)" "unprognostic (6.89e-3)" "unprognostic (1.33e-1)" "unprognostic (2.62e-4)" "unprognostic (1.48e-1)" "unprognostic (2.42e-2)" "unprognostic (1.16e-2)" "unprognostic (3.73e-2)" 0.5 0.7 1.9 0.3 0.9 0.6 0.6 1.8 1.0 1.4 3.1 0.7 0.2 1.3 0.2 0.6 8.4 0.3 0.6 0.8 1.5 0.8 0.5 2.2 0.2 1.4 1.2 0.8 0.7 0.4 0.2 3.4 0.4 0.9 1.1 0.1 1.0 0.5 0.3 0.6 0.5 0.5 0.4 1.0 0.7 0.8 15.3 1.3 0.1 0.6 0.1 0.1 0.7 0.8 0.6 0.3 0.1 0.5 0.5 0.1 1.6 0.5 0.7 0.2 0.0 0.0 0.8 0.1 0.1 0.2 0.3 0.3 0.3 0.1 0.0 0.0 0.2 0.4 0.4 0.2 0.2 1.3 0.5 0.2 0.5 0.0 0.5 0.0 0.2 0.1 0.3 0.5 0.5 0.0 0.4 0.3 0.6 0.2 1.7 0.4 0.2 0.4 0.4 0.0 0.5 0.6 0.8 0.0 0.4 0.5 0.6 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.6 1.0 0.5 2.0 0.4 0.6 0.1 0.6 0.3 0.6 0.2 0.5 0.7 0.4 0.3 0.5 1.5 0.5 0.4 1.0 0.6 0.1 0.3 0.5 0.8 1.9 0.9 1.8 1.0 0.8 1.5 1.4 1.2 0.8 0.9 1.0 1.3 0.6 0.4 0.0 4.8 0.3 0.4 0.5 0.6 24.0 0.0 0.4 0.3 2.7 1.0 2.8 28.9 0.0 2.1 0.5 0.0 0.3 0.0 0.6 195.6 96.3 2.3 1.9 1.2 0.0 1.4 0.0 3.0 3.4 0.0 1.5 3.8 0.6 0.4 0.2 0.6 1.7 1.5 0.2 38.7 0.3 0.3 26.4 2.8 4.2 7.2 1.0 1.2 6.4 0.0 0.5 0.5 0.4 0.1 1.5 0.0 0.4 0.4 0.3 327.5 1.7 0.0 1.8 8.4 89.9 2.3 0.0 0.3 0.5 0.4 1.1 0.3 0.1 COPS9 "CSNAP, MYEOV2" ENSG00000172428 "COP9 signalosome subunit 9" Q8WXC6 2 240126563-240136807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 340.8;Breast myoepithelial cells: 395.6;Distal tubular cells: 498.9;Exocrine glandular cells: 383.2;Pancreatic endocrine cells: 347.0;Proximal tubular cells: 720.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044845 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044845: AB_10962975" "unprognostic (6.05e-3)" "unprognostic (1.44e-1)" "unprognostic (7.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (1.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.25e-3)" "unprognostic (9.02e-2)" "unprognostic (3.02e-1)" "unprognostic (3.71e-1)" "unprognostic (2.26e-2)" "unprognostic (3.03e-1)" "unprognostic (4.37e-2)" 133.4 130.4 363.9 62.7 360.9 81.2 140.8 377.5 489.1 110.8 356.5 143.2 74.2 97.8 143.7 168.7 94.1 59.8 227.7 371.3 359.2 177.5 94.0 92.9 89.1 366.2 361.8 348.6 106.6 185.5 73.0 169.6 50.6 364.5 131.1 52.5 50.7 125.7 69.9 284.9 136.6 100.3 59.9 369.5 114.6 150.9 106.0 376.7 75.6 120.2 132.4 58.4 116.3 126.4 386.0 151.7 200.3 154.5 162.4 209.0 169.6 142.0 213.7 147.0 136.5 173.9 146.2 131.7 41.4 62.5 196.0 218.1 118.9 138.4 197.5 94.0 177.6 510.6 125.0 182.8 458.8 166.1 126.7 112.4 201.1 159.9 102.0 126.3 126.1 203.2 207.8 147.3 87.0 201.8 324.3 204.2 391.0 235.5 188.5 433.3 158.3 207.2 129.3 172.4 256.1 178.7 178.8 112.1 150.7 243.1 118.5 139.0 242.2 165.7 179.5 203.1 231.3 206.9 177.4 166.2 220.1 223.8 148.6 180.9 514.1 298.1 415.1 292.3 315.9 293.1 322.9 298.6 301.0 287.2 237.6 260.5 294.1 106.3 259.4 330.2 364.2 386.0 415.1 363.9 360.9 377.5 489.1 371.3 359.2 366.2 361.8 348.6 364.5 369.5 376.7 386.0 187.9 128.2 121.1 0.0 41.2 0.0 0.0 0.0 0.0 0.0 340.8 395.6 0.0 0.0 55.7 275.8 0.0 175.1 117.0 0.0 498.9 220.7 0.0 182.6 190.7 75.6 0.0 0.0 0.0 383.2 193.7 82.8 0.0 193.1 61.8 174.9 0.0 0.0 322.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.4 0.0 0.0 145.3 0.0 0.0 0.0 0.0 347.0 0.0 0.0 18.6 0.0 0.0 720.0 67.1 0.0 0.0 0.0 93.1 0.0 0.0 0.0 0.0 132.4 69.8 129.2 0.0 0.0 GTPBP2 ENSG00000172432 "GTP binding protein 2" Q9BX10 6 43605316-43629264 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 5.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.4" "Cell line enhanced" "Detected in all" "hTERT-HME1: 181.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031418, HPA031419" Approved Approved Vesicles NA Yes Vesicles "HPA031418: AB_2673872, HPA031419: AB_10600709" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (8.94e-2)" "unprognostic (1.08e-3)" "unprognostic (2.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.71e-2)" "unprognostic (2.58e-3)" "unprognostic (6.47e-2)" "unprognostic (8.31e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (1.44e-15)" "unprognostic (1.13e-1)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" 38.7 30.0 16.8 15.5 17.4 28.9 37.8 18.4 18.0 35.7 17.6 30.7 20.1 27.0 15.6 61.8 25.3 12.6 33.6 16.1 18.5 33.2 33.6 47.1 17.0 19.8 17.1 16.3 29.3 40.3 24.3 40.3 18.1 18.4 31.8 17.2 19.1 42.9 11.7 31.9 26.3 35.0 15.5 16.2 44.8 36.2 27.4 18.8 16.9 44.5 10.5 17.2 34.2 40.7 19.3 59.2 10.9 37.7 24.0 28.3 30.6 45.6 56.3 55.2 52.6 70.1 12.0 19.9 18.8 23.5 26.9 53.8 31.6 9.8 14.5 45.6 60.9 31.6 44.1 33.0 13.9 126.0 35.6 50.1 35.1 160.5 72.5 181.4 35.1 20.5 25.7 77.1 107.8 26.2 13.9 23.4 45.1 10.6 41.2 14.8 19.4 29.5 17.5 24.0 25.8 33.1 32.4 19.5 14.0 72.5 19.0 30.3 37.3 34.8 27.2 33.2 20.5 38.3 70.8 38.2 26.7 45.4 26.0 27.5 5.4 0.8 2.1 1.2 0.7 0.9 0.6 0.2 1.1 0.4 1.0 0.7 1.0 1.3 0.6 0.9 1.1 0.6 1.2 16.8 17.4 18.4 18.0 16.1 18.5 19.8 17.1 16.3 18.4 16.2 18.8 19.3 19.6 3.2 5.5 6.8 5.1 5.2 2.3 4.3 1.2 5.9 7.5 5.0 11.4 5.7 5.7 1.8 8.4 2.8 5.3 24.0 0.0 10.1 17.0 8.5 8.2 9.7 1.2 14.3 7.2 10.1 9.8 6.8 11.7 13.3 1.3 5.7 6.8 5.5 8.2 1.7 6.3 8.8 2.0 12.6 6.5 47.6 5.3 16.0 7.2 5.6 10.1 3.4 1.0 5.5 9.1 20.7 13.4 4.1 2.4 5.8 6.8 1.8 4.1 9.2 13.1 5.3 7.8 7.1 8.1 4.4 5.3 2.5 3.8 4.7 6.0 12.6 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 77.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 191.7;Cholangiocytes: 343.1;Hepatocytes: 142.3" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;RH-30: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054971, HPA075137" Approved "Nucleoplasm,Nuclear bodies" NA NA 220000 Nucleoplasm "Nuclear bodies" "HPA054971: , HPA075137: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.2 14.7 10.1 2.0 10.7 2.3 6.6 20.9 8.7 6.3 3.7 7.2 7.2 4.8 36.9 5.5 10.0 5.5 11.5 6.0 10.2 19.3 77.7 4.7 3.4 11.8 11.2 5.1 4.9 12.1 10.6 9.8 3.1 11.4 7.9 6.7 9.7 7.5 10.4 42.2 5.2 8.1 4.2 8.4 2.8 6.2 4.3 12.4 4.2 7.7 17.3 3.6 7.0 5.2 11.7 4.8 1.4 9.2 3.9 4.7 16.6 0.8 4.1 6.8 2.3 3.4 0.0 3.8 5.4 13.0 11.0 4.1 2.0 1.6 11.9 4.9 42.9 1.1 3.8 2.9 8.6 12.3 2.3 2.4 23.2 10.2 5.0 7.9 10.0 4.6 6.0 2.7 3.4 15.3 5.2 3.0 3.2 5.8 13.0 5.3 6.5 28.3 2.1 12.9 8.8 7.2 3.2 5.6 3.3 12.0 8.0 2.8 2.3 4.7 4.0 2.6 4.7 2.8 7.5 2.9 4.6 12.9 9.2 3.8 1.5 1.3 1.4 3.0 1.3 2.7 5.1 1.4 3.8 2.2 3.6 2.7 4.3 2.2 2.9 3.4 1.1 2.8 1.8 10.1 10.7 20.9 8.7 6.0 10.2 11.8 11.2 5.1 11.4 8.4 12.4 11.7 3.7 54.5 191.7 83.2 7.9 20.9 23.8 45.2 14.2 10.1 33.1 66.9 29.9 343.1 40.4 12.9 12.5 9.3 3.7 4.2 17.6 62.6 14.0 33.2 7.5 6.9 2.4 12.2 20.4 42.5 4.5 7.6 7.1 20.4 10.1 5.3 5.3 142.3 11.4 8.4 33.7 11.3 22.4 8.8 7.6 11.4 1.8 6.7 35.6 17.8 11.2 12.2 3.1 39.2 36.0 17.7 7.7 3.0 3.4 19.1 14.9 47.9 91.2 16.4 0.0 31.4 8.9 4.6 11.5 13.5 31.5 4.5 5.1 5.9 17.1 35.5 OR9G4 ENSG00000172457 "Olfactory receptor family 9 subfamily G member 4" 11 56741223-56748697 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL17D "FLJ30846, IL-17D, IL-27, IL27" ENSG00000172458 "Interleukin 17D" Q8TAD2 13 20702127-20723098 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 92.7;skeletal muscle: 132.3" "Cell type enhanced" "Detected in many" "Astrocytes: 64.0;Early spermatids: 19.3;Excitatory neurons: 17.5;Late spermatids: 35.0;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 20.6" "Group enriched" "Detected in many" 9 "glioma: 10.8;melanoma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 25000 "unprognostic (1.76e-2)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.26e-2)" "unprognostic (3.86e-2)" "unprognostic (5.96e-2)" "unprognostic (1.37e-2)" "unprognostic (4.00e-2)" "unprognostic (3.28e-2)" "unprognostic (1.35e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (5.97e-2)" 7.0 5.8 68.6 1.6 69.6 0.4 6.4 69.4 58.7 14.0 20.3 5.3 9.5 6.6 1.1 9.0 5.0 5.1 8.7 62.2 64.0 1.5 0.8 6.2 1.2 92.7 58.5 49.1 9.3 5.9 0.4 9.0 1.7 68.4 5.5 0.5 10.7 4.4 1.6 132.3 4.7 5.8 1.3 74.8 1.0 4.4 3.9 63.3 0.2 7.7 24.7 0.3 5.4 10.0 80.0 16.5 2.2 3.5 7.6 8.1 4.6 18.3 4.5 1.1 0.4 0.8 7.6 8.7 11.0 0.8 0.4 5.3 8.5 1.5 0.1 0.2 4.0 12.2 0.8 0.7 9.1 1.0 12.2 2.4 6.3 0.1 0.6 0.0 6.9 5.0 15.3 4.5 0.0 3.0 15.9 13.6 10.0 10.7 19.2 2.6 17.8 8.6 1.3 0.2 14.1 20.7 6.7 2.6 3.8 18.3 6.1 9.6 10.4 27.1 1.7 3.0 1.4 5.7 2.0 1.7 2.9 4.0 5.7 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 68.6 69.6 69.4 58.7 62.2 64.0 92.7 58.5 49.1 68.4 74.8 63.3 80.0 0.7 0.0 0.0 64.0 0.2 2.4 0.3 0.0 1.2 1.2 0.4 0.4 1.0 0.0 0.0 0.0 0.0 1.1 0.3 0.7 0.0 0.1 19.3 0.2 1.6 0.6 0.0 0.4 17.5 0.2 7.4 7.6 0.0 0.7 0.0 0.9 1.4 0.0 0.4 0.0 12.2 0.1 0.0 0.3 1.9 35.0 11.5 0.2 8.8 2.8 0.0 20.2 0.0 20.6 12.5 0.2 0.1 1.2 0.0 0.5 0.2 0.2 0.0 4.9 0.0 9.4 2.0 8.6 0.6 0.0 2.0 1.1 0.3 0.1 0.3 0.2 OR5AR1 ENSG00000172459 "Olfactory receptor family 5 subfamily AR member 1" Q8NGP9 11 56663662-56664687 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015974-96215612 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 20.6;stomach 1: 23.4" "Cell type enhanced" "Detected in some" "Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 0.0 0.4 12.0 0.0 13.7 0.0 0.6 16.1 11.8 0.0 0.0 0.1 2.1 0.2 0.0 0.0 0.2 0.0 0.0 13.2 14.5 0.1 0.0 0.0 0.0 6.3 20.6 8.5 0.0 4.9 0.0 0.4 0.4 7.8 0.2 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 5.9 0.0 23.4 0.0 14.0 0.0 0.1 0.0 0.0 1.0 0.0 10.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.0 0.0 6.5 6.3 0.1 0.0 3.6 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 13.7 16.1 11.8 13.2 14.5 6.3 20.6 8.5 7.8 5.9 14.0 10.3 0.0 0.0 0.0 776.4 0.2 0.0 0.6 0.0 0.0 4.2 1.4 1.7 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.5 0.1 1.3 0.0 0.0 333.5 2.0 0.0 0.1 56.1 1.4 0.0 0.4 0.0 0.0 0.1 0.0 238.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.2 0.0 168.9 224.7 0.5 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 OR5AP2 ENSG00000172464 "Olfactory receptor family 5 subfamily AP member 2" Q8NGF4 11 56641466-56642471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCEAL1 "p21, pp21, SIIR, WEX9" ENSG00000172465 "Transcription elongation factor A like 1" Q15170 X 103628704-103630953 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057345, HPA060384, HPA076762" Approved Enhanced Nucleoplasm No No Nucleoplasm "HPA057345: , HPA060384: AB_2732648, HPA076762: " "unprognostic (1.98e-2)" "unprognostic (2.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.60e-3)" "unprognostic (6.09e-2)" "unprognostic (2.03e-2)" "unprognostic (9.85e-3)" "unprognostic (6.54e-2)" "unprognostic (4.80e-2)" "unprognostic (2.62e-1)" "unprognostic (2.56e-1)" "unprognostic (5.56e-2)" "unprognostic (8.76e-2)" 33.2 55.2 36.5 13.9 39.7 10.0 39.8 37.6 47.5 105.6 36.3 48.8 15.3 141.9 40.7 38.2 115.3 35.2 29.3 38.9 39.6 25.1 19.2 30.8 14.2 35.9 35.6 37.3 176.3 20.5 32.2 34.2 17.9 36.9 63.8 16.9 14.9 16.2 80.1 55.6 17.3 29.5 95.7 34.6 26.4 40.6 20.3 38.2 12.3 32.2 33.9 9.9 98.7 58.8 40.0 21.8 20.6 11.4 15.8 48.2 33.2 15.2 30.2 30.3 28.9 31.2 9.1 21.1 10.0 30.4 39.3 43.9 21.2 19.2 16.0 21.4 0.0 23.9 13.6 27.2 17.8 21.7 0.1 19.7 40.9 30.4 22.4 12.3 47.7 30.1 11.4 5.1 5.5 58.7 24.1 12.1 0.3 3.8 19.3 32.9 12.4 36.8 0.1 40.4 21.3 15.7 13.2 30.6 14.4 35.4 8.3 13.5 12.7 24.0 20.9 7.7 49.3 15.7 5.4 18.6 0.3 27.4 0.1 21.3 26.8 13.2 0.8 15.3 9.4 22.5 31.9 13.7 12.9 26.4 24.9 18.2 20.8 1.4 22.6 4.0 20.9 13.2 12.8 36.5 39.7 37.6 47.5 38.9 39.6 35.9 35.6 37.3 36.9 34.6 38.2 40.0 26.5 16.0 31.2 9.4 10.4 29.7 52.7 38.4 24.5 21.8 47.3 42.8 32.9 28.6 37.2 25.8 2.1 30.0 8.9 6.2 56.7 22.9 2.5 27.5 50.0 32.2 27.6 9.1 22.1 24.6 29.8 37.4 7.7 21.9 26.6 22.7 46.1 19.7 34.7 21.9 20.4 13.2 30.5 21.0 23.1 11.7 283.6 16.5 19.6 6.5 19.7 38.6 19.6 16.6 10.3 11.7 17.5 387.8 5.1 18.4 15.0 52.8 48.0 12.3 151.2 32.6 45.3 6.0 8.5 15.5 21.3 7.3 11.3 32.5 19.4 17.6 ZNF24 "KOX17, Zfp191, ZNF191, ZSCAN3" ENSG00000172466 "Zinc finger protein 24" P17028 18 35332227-35345482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024062, CAB025642" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB025642: , HPA024062: AB_1859150" "unprognostic (1.19e-1)" "unprognostic (3.25e-1)" "unprognostic (1.16e-3)" "unprognostic (2.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.49e-2)" "unprognostic (3.12e-2)" "unprognostic (2.79e-2)" "unprognostic (6.01e-2)" "unprognostic (7.69e-2)" "unprognostic (5.68e-2)" "unprognostic (2.44e-2)" "prognostic favorable (1.44e-4)" "unprognostic (5.25e-2)" "unprognostic (1.74e-2)" "unprognostic (9.27e-2)" "unprognostic (5.30e-3)" 19.6 22.1 32.2 22.6 40.0 25.2 35.6 36.1 34.1 21.8 30.0 19.8 20.7 24.0 22.4 18.0 18.4 18.3 21.1 29.9 34.1 24.0 31.1 21.7 29.0 36.2 38.2 27.4 26.4 26.0 32.6 12.6 23.6 37.3 25.7 21.6 38.4 23.9 18.4 23.9 15.5 21.6 18.3 37.3 25.8 25.3 20.1 36.1 34.4 33.6 27.8 26.7 19.4 12.7 55.9 19.3 19.1 60.0 31.5 24.9 26.7 16.9 25.9 29.1 31.3 35.7 12.4 15.5 43.7 28.4 21.7 25.0 34.8 44.7 24.3 53.5 40.1 24.3 31.3 40.2 26.7 26.2 66.9 48.6 22.6 41.0 28.0 30.2 36.0 30.2 27.2 48.2 27.6 32.8 22.8 51.3 28.5 31.2 12.8 12.8 38.0 38.8 35.1 31.5 44.0 51.0 43.7 31.6 29.2 54.7 31.0 27.4 50.3 25.7 44.8 20.1 10.8 26.1 69.7 60.6 44.4 25.0 27.0 41.8 30.2 21.0 24.8 24.4 20.3 23.5 30.5 24.1 20.8 19.3 30.2 23.0 21.4 40.9 22.4 30.3 29.7 20.0 15.2 32.2 40.0 36.1 34.1 29.9 34.1 36.2 38.2 27.4 37.3 37.3 36.1 55.9 49.0 57.7 63.0 30.0 66.1 32.9 65.9 44.2 29.0 57.2 62.6 55.4 46.9 52.9 60.7 25.8 43.8 41.4 52.7 37.7 27.4 46.4 126.1 47.6 37.6 50.2 55.6 43.1 26.9 41.1 33.6 47.5 29.6 41.1 43.6 40.0 42.8 48.3 35.3 79.1 26.4 39.2 44.7 38.2 25.4 33.8 54.3 38.6 23.2 33.7 43.1 101.3 56.7 33.2 71.7 42.3 37.8 50.0 34.0 67.2 29.8 30.4 59.1 85.5 46.0 50.1 53.9 59.0 51.6 32.7 32.5 70.7 45.6 50.9 32.2 76.5 HSFY1 "HSF2L, HSFY" ENSG00000172468 "Heat shock transcription factor Y-linked 1" Q96LI6 Y 18546691-18588963 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074968 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA074968: " 0.0 0.0 0.7 0.0 0.7 0.1 0.0 0.7 0.8 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.8 0.2 0.1 0.0 0.0 0.7 0.7 0.6 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 10.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.7 0.8 0.6 0.8 0.7 0.7 0.6 0.8 0.5 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577535-95609452 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 59.8;Plasma cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" NA NA 140000 "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favorable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 12.0 7.0 3.1 8.0 3.7 3.3 9.0 3.9 3.7 8.4 4.3 8.2 8.9 6.9 6.3 8.1 6.5 8.0 5.7 2.7 4.4 12.1 24.2 7.3 9.3 4.5 3.9 2.2 9.8 8.5 11.2 2.1 6.4 4.4 7.0 8.8 6.1 5.7 8.0 1.4 6.9 8.9 6.8 3.9 9.7 12.2 6.2 4.0 9.2 11.7 3.5 11.3 9.1 3.5 5.8 6.5 5.3 20.4 16.6 33.1 38.5 7.7 17.7 16.2 10.1 14.8 6.1 16.0 12.3 21.7 11.7 14.9 10.4 14.1 12.0 23.2 20.9 12.6 16.6 4.7 10.2 11.5 22.3 14.4 38.4 13.7 12.0 8.5 14.6 24.3 12.1 26.2 28.1 22.0 4.5 13.1 9.5 3.0 17.1 5.5 15.4 19.9 18.8 15.5 11.2 16.3 8.8 10.0 7.2 6.5 14.3 11.4 20.7 22.0 10.1 7.1 18.4 17.8 20.9 12.9 15.2 18.2 19.1 23.6 8.5 2.3 1.3 3.2 4.1 4.6 4.5 3.9 3.8 2.5 2.3 4.5 3.1 0.5 2.9 3.7 1.0 7.7 2.4 3.1 3.7 3.9 3.7 2.7 4.4 4.5 3.9 2.2 4.4 3.9 4.0 5.8 11.6 12.8 8.4 7.8 15.5 7.4 4.4 6.4 8.6 8.1 8.4 7.4 4.5 10.0 7.4 12.9 4.2 5.4 5.4 1.8 5.9 4.1 16.7 7.3 14.4 10.7 1.8 8.2 6.0 7.3 5.6 12.0 8.2 8.1 2.5 17.8 28.2 59.8 11.0 11.8 7.3 4.6 0.0 12.0 5.8 11.7 5.9 7.9 8.8 8.4 6.8 10.5 3.1 16.1 18.7 3.4 2.8 15.8 113.4 3.4 4.8 8.5 8.5 5.3 13.1 9.8 17.1 7.1 12.1 11.8 7.0 1.4 9.2 13.5 5.0 3.5 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 8.1" "Group enriched" "Detected in some" 5 "Astrocytes: 4.9;Excitatory neurons: 7.4;Inhibitory neurons: 7.3;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.6;Oligodendrocytes: 3.3;Peritubular cells: 6.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;NTERA-2: 3.7" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 1.2 1.2 1.1 0.2 3.2 0.1 0.9 0.7 1.4 2.7 5.2 0.6 0.4 4.5 8.1 7.2 2.4 0.6 0.5 1.7 0.7 0.9 0.3 1.3 0.2 1.0 0.3 0.9 4.6 0.5 0.2 2.4 0.6 0.6 3.6 0.3 1.3 0.4 2.1 0.2 0.5 0.5 0.9 0.0 0.6 0.8 3.8 0.6 0.1 0.7 0.2 0.1 2.3 1.6 1.3 0.2 0.9 3.3 0.1 0.7 0.9 1.6 1.0 0.2 0.1 0.3 0.7 0.5 0.8 1.2 0.2 1.0 0.0 0.2 0.0 0.1 0.0 2.0 0.2 1.8 0.2 0.3 0.0 0.1 0.7 0.1 0.3 0.2 1.2 0.2 0.3 1.2 0.5 0.3 0.2 0.2 0.1 3.7 0.0 0.5 0.0 0.2 0.0 0.0 0.3 1.4 1.7 0.3 0.0 0.7 0.9 0.0 0.1 1.7 1.3 0.8 2.1 0.9 0.6 0.4 0.6 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.2 0.7 1.4 1.7 0.7 1.0 0.3 0.9 0.6 0.0 0.6 1.3 0.3 0.0 0.0 4.9 0.0 0.0 0.7 0.1 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 7.4 0.0 0.2 0.2 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.0 0.7 0.9 0.0 0.0 5.6 0.0 0.2 0.0 6.6 3.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.0 0.0 MAB21L4 "C2orf54, FLJ22671" ENSG00000172478 "Mab-21 like 4" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 264.7;vagina: 81.1" "Cell type enriched" "Detected in single" 7 "Cytotrophoblasts: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.2 0.1 0.4 1.0 0.6 0.0 1.8 0.6 1.4 17.5 0.0 3.0 11.6 0.2 0.1 264.7 0.9 0.5 0.1 0.9 0.2 13.2 13.1 10.1 0.3 0.4 0.0 0.5 0.1 1.2 0.0 0.2 0.8 0.7 1.5 2.5 0.3 29.4 0.2 0.3 59.5 5.0 0.1 0.0 0.2 5.8 0.3 0.2 1.1 0.1 0.0 23.7 2.0 81.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 45.9 2.7 0.3 0.3 0.0 0.0 34.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 5.7 0.1 0.1 0.2 7.3 0.0 0.1 0.0 11.4 0.3 5.9 2.3 0.0 0.0 117.0 0.0 0.2 0.9 0.7 0.0 0.0 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.6 0.6 1.4 0.9 0.2 0.4 0.0 0.5 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 AGXT "AGT, AGT1, AGXT1, PH1, SPAT, SPT" ENSG00000172482 "Alanine--glyoxylate and serine--pyruvate aminotransferase" P21549 2 240868824-240880502 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 322 "liver: 2217.2" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 2037.9" "Cancer enriched" "Detected in some" 425 "liver cancer: 253.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035370, HPA035371" Enhanced Supported Vesicles NA NA 4700000 Vesicles "HPA035370: AB_10673218, HPA035371: AB_2674593" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (3.37e-4)" "unprognostic (1.04e-1)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "prognostic favorable (5.92e-5)" "unprognostic (8.28e-2)" "unprognostic (2.77e-1)" "unprognostic (5.39e-2)" "unprognostic (1.55e-1)" "unprognostic (7.57e-3)" "unprognostic (2.54e-1)" "unprognostic (9.22e-2)" "unprognostic (1.37e-1)" "unprognostic (3.26e-2)" 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.8 2217.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 44.3 0.1 7.3 0.0 0.7 0.0 7.6 23.5 0.1 0.1 0.2 0.0 2.8 9.0 128.4 0.0 1.7 26.7 0.4 0.0 0.4 0.0 0.0 52.5 2037.9 0.2 0.0 0.0 8.1 4.1 53.5 0.0 1.6 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.8 0.4 0.0 0.8 1.9 343.9 0.1 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.0 1.9 5.2 0.1 1.5 0.4 OR8J1 ENSG00000172487 "Olfactory receptor family 8 subfamily J member 1" Q8NGP2 11 56354291-56361511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T3 OR5T3Q ENSG00000172489 "Olfactory receptor family 5 subfamily T member 3" 11 56252254-56253222 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 225.2;Microglial cells: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.5 18.2 10.5 18.2 10.7 35.3 22.9 8.6 12.5 25.0 46.7 23.6 18.4 25.9 11.9 19.3 21.6 19.7 19.7 10.2 23.4 33.1 25.0 20.8 16.5 18.0 9.3 1.5 29.0 28.4 32.1 12.6 27.1 12.6 18.3 22.7 64.1 24.2 23.1 56.0 23.6 19.5 32.2 9.5 19.6 19.2 7.0 13.7 23.0 55.4 42.2 13.5 18.7 19.2 23.3 15.3 13.5 11.3 12.0 18.3 21.6 15.9 15.1 22.2 11.3 16.7 14.7 27.8 17.3 20.2 18.7 14.4 6.8 18.0 22.8 15.7 29.8 7.2 36.0 38.3 12.3 14.1 35.0 27.4 17.7 16.1 19.4 17.0 16.4 42.1 14.1 22.5 47.5 4.8 4.1 31.6 10.1 15.0 25.6 4.8 24.7 6.7 22.2 33.1 14.5 25.6 4.7 23.1 15.0 7.2 23.5 9.0 28.9 21.3 20.9 18.8 12.9 8.5 41.0 24.8 29.6 17.1 39.5 7.7 5.4 7.4 17.6 8.8 5.4 9.8 12.0 11.8 8.9 8.5 14.5 6.0 5.8 28.4 7.7 3.3 20.7 11.3 4.2 10.5 10.7 8.6 12.5 10.2 23.4 18.0 9.3 1.5 12.6 9.5 13.7 23.3 88.0 41.7 55.6 125.7 29.3 24.1 20.2 17.8 33.6 41.7 20.6 11.6 119.8 40.0 28.4 92.0 225.2 1.4 29.1 40.7 3.9 11.9 7.2 32.4 39.1 50.2 32.3 54.5 69.2 12.6 4.2 36.3 42.8 46.2 25.2 40.3 65.0 34.2 13.0 18.5 47.5 35.8 16.2 41.7 32.8 9.3 29.2 34.8 23.2 202.4 16.5 21.4 16.5 74.4 84.0 13.1 31.4 28.6 53.9 21.9 29.8 50.3 36.0 147.2 26.3 41.9 31.2 3.8 11.3 45.3 31.7 32.8 26.4 13.3 29.0 15.8 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81329996-81394179 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "liver: 101.5" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 36.2" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA037723 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoplasm, Cytokinetic bridge" "HPA037723: AB_10672606" "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.6 2.7 101.5 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.4 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 8.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 36.2 0.5 0.0 1.2 0.0 0.0 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 3.4 4.2 0.0 0.0 0.0 0.4 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 FIBP FGFIBP ENSG00000172500 "FGF1 intracellular binding protein" O43427 11 65883740-65888531 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011729 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA011729: AB_1848579" "unprognostic (1.70e-1)" "unprognostic (6.06e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-1)" "unprognostic (1.37e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.23e-1)" "unprognostic (2.95e-1)" "unprognostic (3.10e-3)" "unprognostic (2.13e-1)" "unprognostic (1.29e-1)" "unprognostic (5.50e-2)" "unprognostic (2.39e-1)" "unprognostic (3.18e-1)" "unprognostic (1.83e-2)" "unprognostic (4.89e-2)" 34.3 48.8 44.1 27.1 46.6 32.4 33.3 45.5 55.5 31.3 38.9 29.8 30.7 36.3 29.6 35.9 37.5 22.5 50.6 47.5 46.6 48.5 37.4 31.9 35.9 49.9 45.6 45.3 28.8 39.3 33.1 31.5 25.3 52.2 30.9 27.6 20.0 28.1 24.9 54.1 45.3 35.6 31.2 43.3 43.7 38.0 65.4 47.2 40.6 36.1 56.6 43.3 30.0 28.5 47.9 61.0 86.9 48.3 118.6 72.8 91.2 35.9 54.8 110.9 74.3 62.0 36.1 83.1 79.7 98.2 124.1 35.9 65.2 48.5 121.0 48.1 93.7 62.2 77.3 84.1 54.7 99.8 100.7 64.4 73.8 68.3 54.1 114.4 60.0 93.7 61.5 27.4 139.4 98.9 198.2 78.9 88.0 47.8 61.5 130.7 104.9 45.6 196.3 88.5 79.6 87.8 80.4 60.3 110.6 110.5 32.5 113.0 58.1 86.3 79.7 66.4 130.9 40.3 73.8 87.6 48.4 101.1 73.6 30.7 123.5 121.2 98.9 71.1 136.9 74.4 100.7 67.2 64.9 164.7 83.1 52.7 57.0 20.4 101.1 150.0 84.1 100.6 109.4 44.1 46.6 45.5 55.5 47.5 46.6 49.9 45.6 45.3 52.2 43.3 47.2 47.9 55.8 12.8 28.0 4.9 57.0 47.3 51.7 105.7 38.7 47.7 66.9 85.6 44.7 42.9 55.7 44.1 31.3 79.4 41.1 61.6 93.9 114.2 176.7 45.3 59.8 52.6 93.5 39.1 7.1 149.3 125.7 50.3 37.2 39.6 67.2 68.6 45.3 36.5 115.0 42.1 7.3 49.2 57.0 75.3 75.9 608.0 36.1 67.9 51.6 3.7 129.3 47.1 101.0 3.5 5.6 98.9 68.8 39.5 60.1 56.1 185.8 150.1 54.9 52.8 19.7 39.2 77.2 100.5 84.0 51.5 52.1 71.8 54.6 79.6 58.8 61.5 CARNS1 "ATPGD1, KIAA1394" ENSG00000172508 "Carnosine synthase 1" A5YM72 11 67414968-67425607 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 295.2;skeletal muscle: 76.3" "Cell type enriched" "Detected in some" 19 "Oligodendrocytes: 447.9" "Group enriched" "Detected in many" 5 "glioma: 4.1;thyroid cancer: 10.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "RPMI-8226: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038569 Enhanced "Intracellular and membrane" NA NA "HPA038569: AB_2676089" "unprognostic (1.07e-4)" "unprognostic (4.33e-3)" "unprognostic (2.00e-2)" "unprognostic (6.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.05e-1)" "unprognostic (7.28e-2)" "unprognostic (7.54e-3)" "unprognostic (1.29e-1)" "unprognostic (1.82e-1)" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (6.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.83e-3)" "unprognostic (8.33e-2)" 5.7 0.3 81.2 0.4 155.2 0.5 0.7 139.2 116.3 0.6 39.9 0.7 0.4 0.5 1.4 0.9 1.3 0.5 8.6 78.7 109.4 0.8 0.5 0.9 1.2 215.4 158.7 59.8 0.9 1.3 0.9 0.6 0.0 208.2 0.7 0.2 0.0 1.3 0.2 76.3 0.5 0.9 0.2 134.6 2.1 7.6 0.2 128.8 0.4 5.6 30.3 0.5 0.5 0.6 295.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.5 0.3 1.0 0.0 0.6 0.4 1.0 0.0 0.5 0.0 0.0 0.2 0.3 81.2 155.2 139.2 116.3 78.7 109.4 215.4 158.7 59.8 208.2 134.6 128.8 295.2 0.6 3.2 0.5 1.0 3.5 0.3 0.2 0.2 0.0 0.0 0.3 0.4 13.5 7.2 0.7 0.0 0.0 0.1 6.1 0.6 0.0 0.5 0.0 0.3 0.2 1.0 3.0 0.0 1.2 0.0 0.1 1.5 23.0 0.5 0.0 0.1 0.4 0.4 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 4.1 2.5 447.9 0.1 0.1 0.4 4.0 0.2 0.2 0.3 0.9 0.5 0.0 3.5 3.0 0.0 0.3 0.1 0.9 0.0 2.3 0.3 0.2 0.1 OR10H5 ENSG00000172519 "Olfactory receptor family 10 subfamily H member 5" Q8NGA6 19 15787661-15800357 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA 0.0 0.1 1.1 0.1 0.6 0.7 0.1 1.0 1.2 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.8 0.2 0.1 0.0 0.1 0.2 0.5 0.4 0.8 0.1 0.1 0.0 0.0 0.1 0.9 0.0 0.2 0.4 0.1 0.0 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.1 1.4 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.1 0.2 1.0 0.3 0.1 0.3 0.1 0.0 1.1 0.6 1.0 1.2 0.8 0.2 0.5 0.4 0.8 0.9 0.1 0.5 1.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BANP "BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1" ENSG00000172530 "BTG3 associated nuclear protein" Q8N9N5 16 87949244-88077318 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047164 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA047164: AB_2679964" "unprognostic (1.82e-1)" "unprognostic (7.84e-3)" "unprognostic (4.73e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.35e-2)" "unprognostic (4.95e-2)" "unprognostic (1.47e-1)" "unprognostic (1.19e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.68e-3)" "unprognostic (4.98e-2)" "unprognostic (2.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (5.89e-2)" 8.0 9.3 9.2 9.6 8.4 12.2 7.8 13.7 10.5 9.9 10.2 8.4 5.2 9.7 3.4 7.6 9.7 4.9 7.8 10.1 11.3 7.6 14.0 7.5 9.7 9.8 8.3 6.2 12.4 8.8 6.2 10.0 7.7 10.6 8.2 3.6 6.4 8.0 5.1 10.3 8.0 8.8 4.4 7.1 12.2 7.6 11.1 9.4 10.5 8.1 5.1 6.5 9.4 8.3 16.3 12.5 19.7 9.6 14.4 8.4 10.1 32.2 14.8 7.4 14.3 9.7 21.6 17.0 16.8 19.6 3.5 13.0 14.2 14.4 6.7 5.2 13.1 15.5 10.5 12.9 18.0 7.1 11.2 8.3 3.0 10.7 8.8 6.3 12.9 8.9 10.9 17.9 9.3 8.8 14.5 15.5 14.6 16.5 9.7 23.6 16.4 11.1 12.4 8.5 5.9 14.2 11.7 18.8 11.0 13.8 14.1 13.5 14.3 11.0 15.4 10.7 9.1 14.8 7.6 13.9 25.7 9.2 17.2 15.1 22.9 19.9 40.7 22.2 18.2 18.7 25.1 23.5 19.9 24.7 21.5 24.9 22.3 64.5 24.5 22.5 29.7 23.0 19.5 9.2 8.4 13.7 10.5 10.1 11.3 9.8 8.3 6.2 10.6 7.1 9.4 16.3 12.0 9.6 8.3 15.0 28.6 14.9 11.8 7.4 6.2 14.2 14.1 13.2 5.8 10.0 5.1 16.5 4.2 19.4 42.2 9.2 3.9 12.5 5.8 10.7 9.7 13.6 12.1 4.4 32.7 8.0 27.3 16.3 4.1 13.4 8.2 17.9 5.3 10.3 12.4 26.9 28.3 8.9 2.0 11.1 48.3 8.2 10.8 22.6 19.6 20.6 16.0 11.6 22.6 23.1 28.6 11.0 8.6 10.9 21.2 16.2 10.0 7.8 6.3 17.2 13.1 10.8 22.7 33.7 22.7 6.2 21.3 56.6 19.1 10.2 8.9 17.2 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398181-67421183 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 65.6 103.2 59.9 103.6 66.0 129.0 64.0 62.1 71.2 62.7 58.7 111.9 96.7 50.9 67.4 185.5 61.6 51.7 99.8 62.0 63.5 122.3 129.2 79.6 149.0 65.8 60.7 59.3 33.4 105.9 64.7 60.3 84.2 62.0 81.8 90.5 21.8 101.3 51.5 124.2 106.3 108.0 56.6 62.5 149.9 103.6 34.9 61.9 114.8 89.4 82.1 156.8 75.6 81.2 64.4 283.1 305.6 181.1 270.3 88.4 108.9 185.6 136.1 158.4 267.4 202.3 445.8 328.5 237.2 227.3 208.1 198.4 238.7 213.9 280.2 169.6 256.3 139.9 227.5 129.3 232.7 195.2 295.2 281.1 123.3 181.1 225.7 130.7 125.4 272.2 226.0 217.4 191.1 220.5 619.4 378.2 562.2 303.5 526.7 241.1 262.7 254.0 209.8 262.2 220.7 142.5 236.7 159.2 283.0 439.8 135.3 338.5 201.2 196.4 208.5 208.9 245.3 179.0 190.1 193.2 271.8 244.6 199.9 224.3 921.6 735.9 1234.1 779.2 962.9 604.3 733.4 679.9 792.5 705.3 779.6 412.6 584.2 853.8 688.8 1186.1 500.4 1098.7 2042.5 59.9 66.0 62.1 71.2 62.0 63.5 65.8 60.7 59.3 62.0 62.5 61.9 64.4 49.2 76.9 92.2 8.8 165.8 99.9 143.5 305.9 64.3 35.5 81.7 79.1 8.4 102.9 157.8 86.5 10.4 360.4 151.2 377.5 213.2 265.6 2.5 63.1 67.2 101.6 96.9 108.8 8.8 311.1 507.0 68.8 132.0 107.1 109.6 87.1 89.3 113.9 377.1 43.7 7.7 241.3 181.0 219.8 138.5 7.7 49.0 186.5 136.9 9.4 353.0 53.8 408.8 6.0 13.1 318.4 308.4 28.6 206.5 139.0 341.3 297.4 70.5 30.5 98.6 67.1 100.7 13.6 94.6 142.0 121.6 427.3 176.3 100.1 231.7 205.4 HCFC1 "CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF" ENSG00000172534 "Host cell factor C1" P51610 X 153947557-153971818 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078588 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA078588: " "unprognostic (2.05e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (2.64e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.62e-5)" "unprognostic (1.45e-1)" "unprognostic (1.29e-3)" "unprognostic (1.99e-2)" "unprognostic (2.12e-1)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" 17.2 25.8 16.8 15.6 15.4 40.6 17.2 13.5 22.7 21.4 8.7 27.2 11.5 33.9 8.6 25.3 24.6 7.7 21.5 17.7 11.9 20.3 24.0 21.8 19.1 15.7 15.1 14.7 25.7 21.2 11.5 34.1 8.7 15.1 23.7 7.1 7.2 19.4 12.9 28.6 17.9 25.5 11.2 11.2 33.1 25.0 18.0 14.7 26.3 21.3 10.6 12.2 23.8 20.0 15.6 45.3 57.7 38.4 48.9 15.8 11.2 56.3 18.2 14.0 21.1 19.1 61.5 29.8 81.6 45.3 23.6 34.6 36.4 41.8 29.7 11.0 43.6 49.2 49.0 47.7 48.8 10.8 60.9 77.8 17.6 19.1 36.8 15.9 12.7 22.7 58.2 69.4 50.2 15.0 63.0 84.6 78.2 50.0 29.4 35.1 97.5 31.6 49.3 16.0 41.4 42.5 46.2 33.7 34.4 19.4 18.4 31.7 54.4 30.2 39.9 49.0 35.0 59.4 79.1 117.0 100.2 32.5 58.6 38.6 0.9 2.1 0.9 3.0 3.1 2.1 2.4 2.4 2.3 2.4 2.4 2.4 3.4 0.4 1.5 2.2 4.2 1.7 2.3 16.8 15.4 13.5 22.7 17.7 11.9 15.7 15.1 14.7 15.1 11.2 14.7 15.6 19.1 19.2 17.8 7.5 21.9 16.6 13.4 15.5 20.5 21.0 24.6 18.7 35.9 20.0 13.6 12.9 14.6 16.5 26.8 20.1 3.9 17.4 0.6 16.7 18.4 21.2 19.2 39.9 8.4 16.5 21.3 17.7 19.9 21.6 3.8 25.0 15.7 29.5 21.3 20.2 8.3 23.2 8.2 35.2 13.8 1.8 17.4 26.0 5.4 9.4 28.6 13.6 17.5 8.0 7.2 19.5 13.3 21.8 32.0 25.7 12.6 8.8 13.4 12.4 6.6 21.8 21.2 11.3 25.0 28.9 13.9 15.9 22.8 14.3 23.9 20.5 FAM170B "AC084727.4, C10orf73" ENSG00000172538 "Family with sequence similarity 170 member B" A6NMN3 10 49131154-49134021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 6.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 80.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 20 "eosinophil: 1.9" "Lineage enriched" "Detected in single" 20 "granulocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043899, HPA050610" Uncertain NA NA "HPA043899: AB_2678721, HPA050610: AB_2681189" "unprognostic (8.01e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 19.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTSW ENSG00000172543 "Cathepsin W" P56202 11 65879809-65883741 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 117.2;lymphoid tissue: 42.8" "Group enriched" "Detected in many" 9 "dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 8 "gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1" "Group enriched" "Detected in all" 39 "NK-cells: 2276.1;T-cells: 1376.3" "Group enriched" "Detected in some" 22 "HEL: 156.7;NB-4: 363.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB016345, HPA066903" Enhanced "Intracellular and membrane" NA NA 270000 "CAB016345: AB_626813, HPA066903: " "prognostic favorable (3.06e-4)" "unprognostic (2.06e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.36e-6)" "unprognostic (1.21e-1)" "prognostic favorable (9.89e-4)" "unprognostic (5.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (5.14e-3)" "unprognostic (2.83e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (8.84e-6)" "unprognostic (3.86e-2)" "unprognostic (3.78e-1)" "unprognostic (1.26e-1)" "unprognostic (4.01e-3)" 5.1 3.0 0.9 13.0 1.1 117.2 3.7 1.8 1.7 2.6 0.9 5.7 6.1 6.8 2.9 3.2 4.0 6.3 3.0 0.8 1.0 2.1 6.6 24.2 29.7 1.5 1.1 0.6 2.4 1.8 0.5 1.1 3.4 1.3 2.1 6.4 0.0 9.2 3.9 1.3 2.7 6.2 2.8 1.3 42.8 8.4 1.2 1.0 7.9 3.2 0.4 14.0 8.7 2.5 1.3 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 156.7 0.3 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 9.1 0.2 0.2 1.9 363.4 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.0 0.0 5.6 0.1 0.0 0.1 0.4 0.1 0.3 0.5 0.0 0.2 9.9 0.3 46.4 3.4 4.8 1376.3 4.0 869.4 5.1 145.3 892.8 37.6 3.7 86.0 636.3 25.7 2276.1 5.4 23.3 23.7 809.3 0.9 1.1 1.8 1.7 0.8 1.0 1.5 1.1 0.6 1.3 1.3 1.0 1.3 5.1 0.0 4.2 0.0 9.7 4.6 0.4 0.0 1.8 0.0 2.3 2.2 0.4 2.8 1.4 0.0 0.0 0.4 717.8 0.3 0.0 0.3 2.0 0.9 0.9 1.9 0.0 44.1 0.0 0.0 0.2 4.0 12.8 1.1 71.7 0.1 5.7 1.6 1.9 0.0 0.0 0.2 0.0 5.6 34.1 11.1 0.0 9.9 17.8 0.0 6.1 0.0 867.2 0.0 0.2 0.0 0.0 0.0 57.7 0.3 0.0 1.1 0.8 0.0 0.0 1.6 1.9 0.3 1.2 0.8 6.3 0.3 352.6 0.1 0.3 0.3 NIPAL4 ICHYN ENSG00000172548 "NIPA like domain containing 4" Q0D2K0 5 157460213-157474722 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" Receptor "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5;skin 1: 60.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 29.7;Basal prostatic cells: 9.8;Oligodendrocytes: 21.0;Squamous epithelial cells: 9.8;Suprabasal keratinocytes: 42.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.0;urothelial cancer: 11.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 1.6;naive B-cell: 4.8" "Lineage enriched" "Detected in single" 37 "B-cells: 4.8" "Group enriched" "Detected in some" 8 "hTCEpi: 31.7;RT4: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038259 Approved NA NA "HPA038259: AB_10672510" "unprognostic (6.74e-4)" "unprognostic (9.54e-2)" "unprognostic (2.63e-2)" "unprognostic (1.49e-1)" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (3.55e-2)" "unprognostic (5.20e-2)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (5.28e-9)" "unprognostic (3.12e-2)" "unprognostic (8.66e-3)" "unprognostic (1.18e-2)" "prognostic favorable (6.82e-4)" 0.3 0.0 4.5 2.0 9.6 3.5 2.2 8.8 7.9 2.9 2.1 2.9 0.3 1.2 0.1 15.3 0.1 0.5 0.8 4.5 6.7 0.0 0.0 0.7 0.4 12.8 9.5 3.5 0.0 0.0 0.0 0.5 0.6 10.3 1.5 0.6 0.1 1.9 1.4 0.2 60.2 1.0 1.1 9.8 0.2 2.6 0.1 8.5 0.4 0.3 0.0 5.8 11.6 15.2 19.5 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 0.1 1.1 0.0 0.0 0.7 0.4 0.0 6.3 0.3 2.7 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.3 31.7 0.0 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 108.1 0.0 0.4 0.0 0.0 0.0 8.5 1.6 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 9.6 8.8 7.9 4.5 6.7 12.8 9.5 3.5 10.3 9.8 8.5 19.5 0.0 0.0 0.5 0.0 2.4 29.7 9.8 0.6 2.2 0.6 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.7 0.3 0.0 1.1 1.8 0.0 0.0 0.0 0.0 0.0 21.0 0.1 0.0 0.0 0.3 3.8 0.0 0.0 0.1 1.1 0.0 5.2 0.3 0.0 0.1 9.8 42.1 0.0 0.2 0.0 0.0 4.4 MUCL1 SBEM ENSG00000172551 "Mucin like 1" Q96DR8 12 54830518-54896008 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "breast: 3274.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4494.5;Breast myoepithelial cells: 1273.2;Melanocytes: 1060.1" "Cancer enriched" "Detected in many" 30 "breast cancer: 298.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;hTCEpi: 1.3;MCF7: 2.1;SK-BR-3: 4.8;SuSa: 3.3" HPA039093 Enhanced "Secreted in other tissues" NA NA "HPA039093: AB_10795577" "unprognostic (2.26e-1)" "unprognostic (3.38e-1)" "unprognostic (1.90e-1)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (8.34e-3)" "unprognostic (5.55e-2)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (9.90e-2)" 19.9 0.4 0.2 1.1 0.4 0.0 3274.7 0.1 0.6 1.3 0.1 1.8 0.0 0.2 1.5 0.4 2.2 0.2 1.5 0.2 0.2 2.4 1.0 1.1 0.1 0.2 0.2 0.2 0.3 0.3 0.0 0.3 0.4 0.2 1.1 0.0 0.0 209.2 0.0 2.0 710.5 0.3 0.1 0.2 0.2 0.7 1.2 0.2 2.4 0.2 0.0 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.8 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 10.4 0.0 1.1 0.0 3.8 188.4 0.4 2.1 0.0 0.0 4494.5 1273.2 0.1 0.0 3.4 0.0 0.0 0.0 12.9 0.0 3.9 0.0 0.0 1.8 0.0 3.4 0.0 0.0 1.4 0.2 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 2.0 0.0 14.1 0.2 0.0 45.5 1060.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 5.9 0.0 0.1 2.6 0.0 0.0 0.0 6.1 0.2 0.6 0.0 10.1 0.0 2.5 0.1 0.0 3.8 SNTG2 "G2SYN, SYN5" ENSG00000172554 "Syntrophin gamma 2" Q9NY99 2 950849-1367613 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Early spermatids: 68.2;Excitatory neurons: 24.4;Horizontal cells: 90.9;Late spermatids: 44.7;Spermatocytes: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HAP1: 1.7;JURKAT: 1.6;MOLT-4: 1.1;NTERA-2: 2.0;SCLC-21H: 2.0" "Low region specificity" "Detected in many" "HPA065258, HPA077904" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA065258: , HPA077904: " "unprognostic (7.52e-3)" "unprognostic (7.52e-4)" "unprognostic (4.15e-1)" "unprognostic (3.50e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-3)" "unprognostic (2.05e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (7.87e-3)" "unprognostic (3.58e-3)" "unprognostic (3.64e-1)" "unprognostic (2.52e-1)" "unprognostic (1.77e-2)" "unprognostic (5.05e-2)" 1.9 0.3 0.5 0.0 0.6 0.0 1.9 0.9 0.6 0.9 1.0 0.5 0.1 1.2 0.2 0.5 1.2 0.2 0.3 1.7 0.9 0.1 0.0 0.4 0.0 1.7 0.9 0.3 0.2 0.9 0.0 2.9 0.0 1.4 0.6 0.2 2.1 0.5 0.0 0.4 1.1 0.6 0.7 0.4 3.3 0.3 1.8 0.8 0.2 0.7 0.9 0.1 0.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.9 0.6 1.7 0.9 1.7 0.9 0.3 1.4 0.4 0.8 0.7 6.8 0.0 0.0 0.7 0.4 0.9 0.1 0.0 0.6 0.8 0.2 0.3 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 68.2 0.1 0.9 7.3 0.0 0.0 24.4 0.2 0.5 0.8 0.0 0.0 0.0 3.0 0.0 0.0 0.1 90.9 10.7 0.0 0.0 0.0 1.2 44.7 0.3 0.0 1.8 9.4 0.0 0.6 0.0 1.5 1.3 0.0 0.0 4.1 0.0 0.3 0.0 0.5 0.0 4.6 0.0 0.3 0.4 22.0 5.4 0.1 0.1 0.0 0.2 0.2 0.0 0.2 FNDC9 "C5orf40, MGC27121" ENSG00000172568 "Fibronectin type III domain containing 9" Q8TBE3 5 157341598-157345677 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 27.6;pituitary gland: 11.8" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 5.8" "Cancer enriched" "Detected in single" 16 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.35e-3)" "unprognostic (3.80e-2)" "unprognostic (2.93e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-3)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.68e-1)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (6.35e-6)" "unprognostic (3.63e-2)" "unprognostic (6.39e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" 0.0 4.8 5.3 0.3 5.8 0.7 0.0 6.5 14.6 0.0 0.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 27.6 0.1 0.1 0.1 0.1 6.7 6.1 4.7 0.0 0.0 0.0 11.8 0.0 4.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.1 0.1 0.0 14.8 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.8 6.5 14.6 5.0 27.6 6.7 6.1 4.7 4.0 1.2 14.8 5.7 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20368537-20688583 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 33.4" "Cell type enhanced" "Detected in many" "Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 18.8" "HPA014492, HPA074258" Approved Approved "Plasma membrane" NA NA 37000000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 5.9 1.0 1.5 3.1 1.2 0.2 3.9 3.0 1.2 6.3 2.0 14.8 1.9 4.2 1.4 2.2 4.1 4.7 33.4 1.2 7.9 3.3 1.3 4.0 1.0 1.9 2.3 0.9 3.5 6.2 0.6 2.2 11.4 1.4 5.5 7.6 5.7 2.7 3.5 2.2 1.0 9.7 5.3 1.5 2.2 5.1 0.4 2.4 0.6 2.9 1.9 0.5 2.5 3.1 1.4 0.0 0.2 8.6 0.0 1.9 1.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.3 42.5 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.1 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 1.1 0.0 0.0 0.0 2.7 0.0 0.1 17.9 0.0 0.0 0.1 3.3 0.0 0.0 0.3 11.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 3.0 1.2 1.2 7.9 1.9 2.3 0.9 1.4 1.5 2.4 1.4 2.7 0.0 0.0 98.2 0.0 0.3 0.2 0.0 0.6 38.4 0.2 0.3 131.3 4.3 0.6 0.0 0.0 0.0 0.0 28.4 0.0 5.8 0.7 0.5 1.6 3.9 4.2 0.0 4.1 0.5 0.0 11.3 0.0 1.4 17.1 0.0 2.2 0.0 0.7 52.2 78.8 7.0 0.0 0.0 0.7 0.6 1.5 3.1 1.8 27.2 0.5 4.4 0.0 27.6 3.9 0.4 26.9 0.7 0.0 0.5 33.4 3.1 0.0 2.8 6.6 3.6 49.9 0.3 0.9 0.9 0.3 0.0 0.6 0.5 16.4 0.2 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Disease variant, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8;lymphoid tissue: 46.1;retina: 30.0" "Cell type enhanced" "Detected in many" "dendritic cells: 71.4;Excitatory neurons: 54.1;Muller glia cells: 86.9;Plasma cells: 43.0;T-cells: 84.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 10.3" "Lineage enriched" "Detected in many" 4 "T-cells: 10.3" "Group enriched" "Detected in many" 4 "HDLM-2: 54.5;JURKAT: 70.2;MOLT-4: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039389: AB_2732481" "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 0.8 0.8 3.9 10.6 13.7 8.6 1.7 23.8 12.1 0.7 0.0 1.5 2.4 1.4 0.4 5.9 4.5 2.5 1.2 11.8 4.2 5.5 1.1 4.1 21.5 13.4 5.3 8.2 0.4 1.8 0.5 0.5 0.9 19.1 0.7 2.1 30.0 1.7 0.7 0.4 6.7 3.7 0.6 0.0 8.9 4.6 2.1 8.1 46.1 0.6 0.7 16.5 3.4 2.0 16.9 0.0 0.4 1.0 0.3 0.0 0.0 0.1 4.1 1.2 2.0 1.7 4.5 0.0 11.6 0.9 0.1 0.2 0.2 2.4 0.0 1.9 54.5 2.2 0.9 0.5 0.0 0.6 0.5 0.8 0.0 0.1 1.1 0.0 0.0 0.0 70.2 0.5 3.6 0.0 1.7 52.3 0.1 0.7 0.0 0.0 14.4 0.3 0.0 2.0 0.1 4.7 1.7 2.6 0.1 0.2 1.5 1.2 0.0 0.2 0.4 1.6 5.6 0.8 8.7 4.6 13.6 0.2 0.1 0.6 0.0 0.0 0.9 5.2 0.0 3.7 1.1 5.7 5.2 0.0 0.6 5.2 5.3 0.2 2.4 0.0 0.0 10.3 1.4 3.9 13.7 23.8 12.1 11.8 4.2 13.4 5.3 8.2 19.1 0.0 8.1 16.9 0.9 6.4 10.7 6.5 26.5 2.4 0.4 6.8 4.6 9.6 3.4 2.0 4.5 5.7 2.7 33.1 10.4 0.3 71.4 0.1 3.9 18.4 1.5 7.6 1.6 0.8 0.0 0.0 54.1 10.0 0.2 1.2 1.1 6.6 3.8 0.4 1.1 0.5 0.7 6.7 16.5 1.3 0.0 0.8 6.1 0.7 0.0 3.0 7.2 9.4 3.0 86.9 34.0 2.5 3.9 34.1 0.0 0.0 43.0 0.7 0.3 7.8 0.4 21.3 0.0 1.9 1.3 1.2 3.8 4.0 8.2 0.0 84.7 0.3 0.9 0.5 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487551-183555706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 31.3" "Cell type enhanced" "Detected in many" "B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" Yes NA "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 1.5 0.7 1.1 11.9 1.0 3.5 1.0 1.1 3.2 0.8 1.8 2.5 2.5 0.6 0.2 0.6 4.9 2.1 0.7 0.7 2.1 0.4 1.0 4.2 29.5 2.0 1.0 0.2 0.3 0.6 0.2 0.2 1.9 1.9 0.5 2.3 0.1 1.3 0.1 0.2 0.1 4.8 0.7 1.9 6.3 4.1 0.2 2.6 10.1 0.6 0.3 31.3 1.8 0.3 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 21.9 0.0 26.6 0.0 0.0 0.0 7.3 26.7 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.4 18.4 0.0 0.0 8.8 4.1 0.0 0.0 0.0 14.8 0.1 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.5 0.0 0.1 0.0 0.1 82.1 45.5 121.3 0.0 8.0 0.0 7.8 2.8 11.8 0.6 2.2 0.7 3.6 2.4 1.0 2.0 2.4 2.9 1.8 2.4 2.2 2.7 4.6 4.2 2.6 1.1 1.0 1.1 3.2 0.7 2.1 2.0 1.0 0.2 1.9 1.9 2.6 3.6 4.0 6.4 6.5 0.7 35.7 1.1 1.7 0.6 0.6 0.6 0.3 0.4 4.8 0.0 5.4 0.0 2.1 0.2 16.6 0.2 0.0 0.1 2.0 28.3 0.5 4.6 0.0 7.6 0.3 0.0 0.3 1.7 2.0 0.8 51.1 8.1 1.1 0.2 24.1 0.0 0.3 0.0 0.0 20.7 22.4 0.8 0.3 33.3 8.8 14.0 10.1 0.3 5.2 1.0 0.3 0.0 0.1 0.0 63.6 1.2 0.0 0.4 24.4 0.7 0.0 1.8 1.5 0.3 0.4 0.1 0.6 0.5 16.8 0.0 0.2 1.2 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 561.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favorable (5.42e-4)" 27.4 53.7 39.9 29.6 40.2 26.9 34.8 41.0 45.5 24.5 42.3 36.1 40.4 26.1 52.4 50.2 25.8 18.7 45.2 39.8 40.4 51.3 55.1 25.8 36.7 39.9 39.9 39.3 24.3 31.6 43.2 31.3 29.4 40.3 37.1 29.3 22.1 46.0 22.1 64.9 28.9 35.4 19.3 40.3 40.7 37.9 25.0 40.4 34.9 32.2 51.1 31.1 28.0 30.3 41.1 115.8 87.6 70.8 98.3 57.0 56.6 71.1 58.3 70.7 59.8 80.0 78.6 99.3 56.9 63.3 52.9 60.1 77.9 69.8 79.8 46.9 87.6 132.4 42.7 73.2 119.6 68.6 65.8 65.7 52.3 96.3 51.5 33.0 87.4 83.9 78.8 67.0 61.7 78.3 117.3 82.1 146.5 66.3 109.6 561.7 77.3 53.9 72.6 97.5 63.0 34.2 67.4 36.0 246.2 127.3 56.8 138.0 92.5 47.2 35.7 79.7 60.2 102.4 61.5 70.7 91.2 83.4 133.7 28.5 44.2 51.3 32.5 36.1 54.9 43.9 62.6 43.7 43.5 52.5 50.8 36.1 36.9 21.2 36.6 45.6 75.1 65.2 35.8 39.9 40.2 41.0 45.5 39.8 40.4 39.9 39.9 39.3 40.3 40.3 40.4 41.1 45.0 41.7 48.4 5.2 50.7 35.1 34.4 117.2 29.0 27.0 68.7 74.4 77.3 47.1 84.4 60.7 22.9 151.6 49.3 112.1 199.6 80.8 73.3 99.0 64.1 44.5 61.8 61.2 8.6 88.3 166.3 38.2 41.8 75.8 29.8 63.9 51.4 132.5 139.7 20.2 8.0 106.2 122.1 61.2 35.6 16.3 56.5 52.7 40.9 5.6 82.5 76.8 51.5 5.5 9.6 96.4 96.4 55.3 53.3 55.3 101.0 243.3 99.0 35.3 52.6 36.1 52.4 70.1 48.7 71.2 43.5 128.1 41.6 83.9 98.4 54.9 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 549.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 69.6 106.4 95.9 54.1 97.0 52.4 73.1 100.9 131.9 64.6 95.6 87.7 70.7 73.4 31.1 142.7 61.5 20.8 168.4 96.1 98.9 131.8 155.4 74.1 42.0 100.3 95.9 91.4 60.5 109.6 71.2 70.7 33.2 100.7 84.2 34.3 15.4 80.2 35.9 156.4 94.3 78.4 25.8 100.9 97.1 114.3 68.2 101.0 62.5 83.9 55.9 41.6 85.7 78.8 103.1 237.5 181.4 97.4 121.4 59.3 69.1 236.8 161.2 115.0 140.8 133.4 224.1 321.9 178.8 172.5 111.3 143.4 210.8 79.8 223.4 105.6 190.8 132.6 133.6 65.6 518.5 180.3 211.9 183.6 104.8 150.4 182.7 154.5 111.2 226.6 222.7 139.4 172.8 104.6 329.2 172.5 320.0 180.1 292.5 397.5 210.2 121.5 210.4 149.9 138.7 96.8 125.1 124.5 120.6 178.3 68.9 116.0 198.9 176.5 146.4 172.0 185.1 249.2 169.4 219.1 228.0 133.3 143.3 239.6 101.5 111.2 60.2 74.5 128.9 69.5 140.9 82.2 68.2 159.1 111.6 75.9 74.2 19.1 74.5 96.4 131.3 100.7 98.5 95.9 97.0 100.9 131.9 96.1 98.9 100.3 95.9 91.4 100.7 100.9 101.0 103.1 105.5 73.7 85.4 5.2 132.5 121.2 88.0 169.2 98.4 23.2 131.2 145.2 103.4 167.3 118.0 136.1 18.8 177.3 82.5 220.9 277.8 245.2 72.4 106.5 89.8 104.4 138.0 112.5 5.7 314.5 287.7 65.8 165.1 116.3 123.0 70.5 106.4 291.0 236.2 20.2 6.2 268.0 107.8 140.2 125.1 58.3 55.9 120.1 124.5 6.5 221.5 80.4 107.1 5.5 9.1 396.9 215.6 49.2 156.4 111.8 313.7 549.8 99.9 33.7 65.7 70.7 147.7 135.4 105.3 190.8 149.2 126.0 85.0 80.3 233.8 98.8 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "basophil: 80.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 80.9" "Cell line enhanced" "Detected in many" "ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" No No 26000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 15.1 23.5 5.2 18.9 5.8 23.1 23.9 8.8 9.5 58.4 8.7 61.2 45.9 13.4 6.6 13.7 7.9 17.3 5.5 5.7 6.2 47.8 80.7 14.2 21.6 6.3 5.8 5.3 9.1 21.0 32.6 7.6 44.3 6.6 22.0 66.3 6.1 13.8 16.8 40.1 65.0 78.0 8.5 6.2 27.2 30.8 2.9 5.9 5.2 9.2 56.3 16.3 35.9 31.1 8.1 0.3 2.6 6.1 2.8 44.2 19.9 19.5 10.4 27.8 3.1 6.6 3.3 2.7 0.0 1.4 6.6 8.2 4.9 1.7 5.3 2.6 0.0 5.4 2.5 9.8 9.0 28.3 0.0 0.1 24.4 36.9 3.0 5.3 12.0 5.5 0.0 3.8 0.0 12.7 9.3 0.0 0.2 1.1 58.8 8.0 0.0 10.8 0.4 15.1 4.2 4.4 0.1 1.5 18.5 27.9 3.9 3.1 1.4 11.0 5.9 3.5 0.6 6.8 0.0 0.0 0.0 8.7 4.9 13.7 80.9 4.0 1.1 0.0 4.3 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 7.5 0.0 0.0 1.4 5.2 5.8 8.8 9.5 5.7 6.2 6.3 5.8 5.3 6.6 6.2 5.9 8.1 11.8 3.2 17.8 5.2 2.4 53.7 24.5 13.7 15.9 3.0 12.2 6.6 4.0 25.8 9.7 5.5 4.2 156.3 0.4 291.5 56.7 24.6 0.2 4.2 12.6 7.1 48.7 5.7 7.4 25.7 40.4 46.3 34.7 5.2 10.1 0.8 18.9 77.8 62.7 3.3 10.5 61.7 59.0 126.3 10.0 1.2 15.5 33.4 35.6 11.2 9.9 11.5 2.1 11.1 11.0 19.5 157.5 14.3 0.9 16.7 383.1 129.3 7.5 6.2 13.1 12.8 9.9 1.1 3.7 15.5 76.0 115.1 2.0 11.4 38.9 16.6 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 132.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 205.5;Ductal cells: 220.6;Exocrine glandular cells: 147.1;Pancreatic endocrine cells: 350.9" "Cancer enhanced" "Detected in many" "liver cancer: 16.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SK-BR-3: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" NA NA "Vesicles, Plasma membrane, Actin filaments" "HPA077800: AB_2686854" "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 6.7 0.8 23.6 2.6 28.9 1.8 5.7 21.0 36.1 1.1 17.9 4.7 2.4 3.9 1.0 3.1 2.7 14.6 5.2 27.4 25.4 4.0 132.9 38.2 1.0 23.3 23.6 25.6 1.2 2.8 2.4 8.1 1.2 26.1 6.5 1.9 1.7 4.0 0.8 1.0 1.4 2.7 2.4 21.3 0.8 23.6 1.0 22.7 2.4 15.5 0.7 2.3 14.1 2.7 26.8 1.1 7.9 3.8 2.0 0.8 0.0 0.6 0.0 0.4 1.2 1.3 4.9 1.7 6.0 1.4 0.0 0.4 0.1 3.1 0.3 0.7 1.8 1.9 0.8 0.0 3.0 0.4 1.8 1.1 0.0 0.2 0.6 0.8 0.0 2.0 3.9 0.2 6.0 0.0 10.2 0.9 0.5 8.9 13.6 0.5 1.9 0.4 2.6 1.1 1.5 0.0 1.0 0.2 67.7 0.3 9.1 6.9 0.4 0.2 0.0 0.7 0.0 0.9 2.9 5.4 10.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.6 28.9 21.0 36.1 27.4 25.4 23.3 23.6 25.6 26.1 21.3 22.7 26.8 28.9 28.9 205.5 5.9 8.5 11.5 8.4 14.1 9.1 2.5 37.5 25.4 3.8 18.6 27.5 1.8 8.4 1.1 9.0 21.7 0.0 220.6 0.4 4.5 2.0 87.3 31.5 2.7 10.6 147.1 0.7 10.5 55.5 12.6 15.2 0.8 6.1 10.9 1.2 0.0 2.7 11.4 18.3 0.8 24.1 0.0 0.0 6.6 14.2 1.0 6.4 3.0 0.0 7.1 1.0 350.9 42.2 0.4 6.5 19.5 11.1 1.7 7.7 3.6 0.0 5.8 16.7 0.8 1.6 4.3 10.5 1.5 9.9 0.6 5.4 8.6 RAD9A RAD9 ENSG00000172613 "RAD9 checkpoint clamp component A" Q99638 11 67317871-67398410 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006725, HPA048155, CAB079979" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290" "unprognostic (7.64e-2)" "prognostic favorable (6.95e-4)" "unprognostic (8.83e-3)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (2.12e-3)" "unprognostic (9.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (9.19e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (2.82e-5)" "unprognostic (6.16e-2)" "unprognostic (3.72e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.52e-6)" 5.3 5.1 3.2 7.0 3.0 10.3 7.0 1.6 6.0 9.1 2.0 6.7 11.0 7.5 2.2 9.0 11.0 5.8 4.1 3.3 3.0 7.1 6.7 6.7 8.3 2.1 2.2 2.7 8.1 8.1 3.4 10.2 4.4 1.8 10.9 3.0 1.8 9.9 6.1 5.2 11.2 11.2 2.5 1.7 9.5 8.4 8.7 2.0 6.2 9.8 2.1 3.7 6.5 8.5 2.3 10.8 15.8 9.5 13.8 2.8 1.1 12.0 5.7 4.9 8.0 7.1 23.2 20.9 11.1 12.4 1.8 13.0 18.7 6.0 5.5 0.9 13.0 16.3 16.8 8.5 10.4 3.8 12.3 20.3 3.2 5.3 7.2 3.5 6.1 5.5 23.2 14.7 15.6 2.3 33.2 21.9 21.8 13.2 15.9 12.1 18.8 12.5 13.6 2.2 9.0 9.8 10.6 9.9 27.2 21.1 2.4 19.1 10.9 4.2 11.7 14.3 23.3 8.7 14.6 14.2 11.5 7.5 11.6 9.6 5.3 1.8 6.0 5.2 2.3 3.8 4.3 4.1 4.3 1.2 3.1 2.9 3.2 2.8 3.1 2.5 3.4 2.4 1.5 3.2 3.0 1.6 6.0 3.3 3.0 2.1 2.2 2.7 1.8 1.7 2.0 2.3 16.0 22.4 17.1 10.1 31.0 17.1 17.7 17.9 23.3 19.6 19.7 18.4 1.1 12.8 22.2 20.2 70.9 27.9 31.3 54.2 13.7 11.3 27.3 32.1 13.4 16.3 14.3 17.7 8.5 13.1 22.4 13.8 27.0 14.9 20.3 26.0 11.0 6.6 15.1 21.9 6.0 48.9 10.2 10.3 31.4 13.2 10.5 14.0 19.6 11.2 8.9 15.0 56.7 2.5 5.3 11.6 31.6 12.4 38.5 16.6 61.8 10.9 44.0 32.1 13.1 10.5 14.5 32.0 17.6 18.3 17.3 40.6 30.3 15.3 38.7 18.0 EFEMP2 "FBLN4, UPH1" ENSG00000172638 "EGF containing fibulin extracellular matrix protein 2" O95967 11 65866441-65873592 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 122.8;Leydig cells: 93.5;Muller glia cells: 84.8;Peritubular cells: 107.2;Smooth muscle cells: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 125.8;BJ hTERT+: 159.7;fHDF/TERT166: 232.6;HSkMC: 155.3;hTERT-RPE1: 159.1;LHCN-M2: 134.5;U-138 MG: 114.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023270 Approved "Secreted to extracellular matrix" NA NA 2600000 "HPA023270: AB_1848019" "unprognostic (3.13e-1)" "unprognostic (2.15e-3)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (8.57e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.89e-2)" "unprognostic (9.12e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (8.33e-3)" "unprognostic (6.35e-2)" "unprognostic (2.37e-1)" "unprognostic (2.58e-2)" 38.8 18.1 19.1 13.9 19.6 2.8 29.7 18.9 26.9 46.8 21.6 31.0 9.4 55.7 8.4 12.9 36.1 33.8 56.5 19.0 26.0 27.0 7.1 32.3 9.1 25.2 19.3 16.5 47.4 20.0 27.0 15.3 22.6 21.1 31.4 6.6 6.0 17.5 35.5 21.4 14.1 16.3 32.6 19.8 16.2 20.8 8.2 20.1 5.7 39.4 22.2 5.1 33.3 31.0 19.2 0.5 0.2 2.1 47.3 54.3 108.0 0.8 125.8 159.7 48.1 44.8 0.0 4.3 0.7 9.3 232.6 0.7 0.9 0.0 1.3 12.1 5.4 0.1 1.1 3.2 8.0 89.1 0.0 0.4 155.3 0.4 18.9 1.0 159.1 28.5 1.0 0.3 8.0 134.5 0.4 0.2 20.7 1.6 0.2 0.6 0.4 0.3 3.2 1.6 0.6 0.7 14.1 0.2 1.3 1.5 6.6 1.5 10.0 64.6 114.2 24.7 52.6 0.6 10.9 0.7 0.3 42.6 0.8 19.7 0.0 0.1 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.2 19.1 19.6 18.9 26.9 19.0 26.0 25.2 19.3 16.5 21.1 19.8 20.1 19.2 30.8 35.3 7.4 29.0 1.5 13.5 38.9 33.9 8.6 7.7 10.2 27.6 46.0 15.7 11.4 18.4 0.0 2.4 2.3 0.3 7.9 28.7 15.6 3.4 57.1 27.9 0.0 0.4 1.1 0.2 3.9 122.8 2.6 4.1 0.0 74.3 42.8 1.8 9.8 6.7 2.9 0.3 4.1 3.5 19.1 33.3 93.5 3.0 24.9 9.4 0.7 84.8 2.1 9.5 1.6 2.6 0.1 107.2 1.4 30.1 0.2 21.2 9.0 4.8 39.5 41.1 113.2 35.9 3.3 1.1 10.1 5.9 2.4 78.5 0.3 14.2 OR10AD1 OR10AD1P ENSG00000172640 "Olfactory receptor family 10 subfamily AD member 1" Q8NGE0 12 48202083-48203387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4;retina: 2.4" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049913 Uncertain NA NA "HPA049913: AB_2680950" "unprognostic (2.90e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-2)" "unprognostic (1.70e-2)" "unprognostic (6.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-2)" "unprognostic (1.74e-1)" 0.0 0.4 0.5 0.3 0.3 0.0 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.3 0.4 0.4 0.0 0.3 0.1 0.0 0.9 0.1 0.5 0.3 0.0 2.4 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.1 0.9 0.2 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.2 0.2 0.3 0.4 0.4 0.0 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGAP5 "CTGLF2, Em:AC073389.1" ENSG00000172650 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 5" A6NIR3 10 73674287-73697881 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 79.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (1.84e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (4.45e-3)" "unprognostic (1.40e-1)" "unprognostic (4.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (4.04e-3)" "unprognostic (4.33e-3)" "unprognostic (5.83e-5)" "unprognostic (3.33e-2)" "unprognostic (2.87e-1)" "unprognostic (7.29e-2)" "unprognostic (1.17e-2)" 3.2 5.1 2.7 3.8 3.0 3.2 4.4 4.1 3.8 3.9 4.0 3.3 3.6 3.4 4.2 3.3 3.4 2.6 5.2 2.6 3.0 4.5 6.9 3.6 4.4 3.0 2.9 2.3 4.9 9.9 1.9 4.8 2.7 3.3 4.7 3.1 5.4 6.4 2.5 8.8 6.6 4.0 2.2 2.1 5.0 4.3 8.4 3.0 3.1 4.0 2.2 2.8 3.4 3.5 4.5 2.4 2.9 3.8 4.2 3.0 2.3 5.7 2.9 2.1 2.0 1.7 3.9 3.3 2.9 2.4 2.3 0.8 5.9 2.8 2.4 1.3 3.4 3.3 2.3 6.7 4.5 2.5 5.9 3.7 2.4 2.6 2.3 6.2 5.2 1.6 4.2 3.0 5.8 1.8 2.3 2.3 7.7 1.1 2.6 7.9 3.1 1.6 2.2 2.0 2.3 1.7 1.5 1.7 6.2 3.5 2.7 3.5 4.7 2.9 2.5 3.4 2.5 3.8 6.9 3.7 1.7 2.6 6.7 1.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 2.7 3.0 4.1 3.8 2.6 3.0 3.0 2.9 2.3 3.3 2.1 3.0 4.5 2.1 0.0 9.0 4.2 1.5 1.9 0.3 0.8 0.0 2.4 2.4 1.7 0.0 1.5 3.7 3.7 6.2 1.7 2.1 1.0 0.0 1.6 79.9 2.6 2.3 2.1 0.0 2.7 6.4 2.2 0.7 1.7 4.6 1.5 3.8 2.5 3.9 3.5 1.5 3.3 6.3 2.0 0.0 1.3 2.2 18.9 1.2 1.9 1.8 1.9 2.4 1.7 2.1 4.5 8.4 2.7 0.5 3.8 1.6 1.1 3.2 0.6 6.6 2.7 0.0 0.9 0.9 4.2 2.4 0.9 1.3 0.7 1.8 1.3 2.1 0.7 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 18.0 15.9 11.3 17.4 12.2 42.8 17.7 15.3 14.7 19.3 14.2 20.0 15.4 16.9 12.6 13.6 15.0 16.7 19.0 11.6 12.4 18.2 16.1 17.9 20.3 13.0 12.6 10.6 21.8 11.7 21.6 14.0 13.9 13.1 15.7 22.2 14.4 15.4 14.7 17.3 17.0 19.8 19.1 10.7 19.5 15.1 13.1 13.6 21.4 17.3 9.9 18.8 17.9 14.8 14.4 24.5 25.9 20.7 23.5 52.1 45.8 12.4 28.4 45.8 32.4 30.8 16.0 23.3 20.1 18.8 41.7 30.8 21.6 23.2 13.0 32.6 18.9 19.2 20.9 32.3 12.3 55.0 21.4 24.6 43.4 30.4 35.4 26.1 31.6 33.7 16.5 33.9 15.7 40.1 12.8 14.0 35.9 14.8 14.7 3.9 17.4 30.5 10.5 23.8 38.2 10.0 22.3 32.8 16.1 39.4 21.0 22.1 20.6 58.1 16.8 18.0 44.7 19.1 21.5 36.3 19.6 23.5 49.4 9.2 14.1 17.1 11.7 12.2 17.9 11.8 9.9 10.1 12.7 11.7 9.2 10.0 8.9 16.8 12.5 22.8 8.1 10.4 13.3 11.3 12.2 15.3 14.7 11.6 12.4 13.0 12.6 10.6 13.1 10.7 13.6 14.4 16.2 35.3 35.2 0.0 3.0 0.0 0.0 0.0 0.0 0.0 11.3 8.8 0.0 0.0 11.8 23.9 0.0 6.8 11.8 0.0 3.9 13.5 0.0 11.3 17.9 6.1 0.0 0.0 0.0 14.0 6.4 7.9 0.0 13.9 30.3 13.7 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 3.8 0.0 0.0 12.8 24.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 7.8 7.0 12.1 0.0 0.0 TMEM134 FLJ21749 ENSG00000172663 "Transmembrane protein 134" Q9H6X4 11 67461710-67469272 "Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043744 Approved Supported Cytosol NA NA Cytosol "HPA043744: AB_10794773" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (4.67e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (7.22e-2)" "unprognostic (3.85e-1)" "unprognostic (1.39e-2)" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (1.75e-1)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-2)" "unprognostic (4.43e-3)" 12.5 24.5 19.3 8.6 19.7 4.7 14.9 18.2 30.1 13.2 17.1 13.6 8.4 9.7 11.1 56.0 10.3 6.6 38.8 18.7 19.3 25.2 34.1 11.3 12.0 19.7 19.6 18.4 8.7 43.2 7.9 8.7 5.4 20.8 25.9 4.5 2.9 20.8 7.4 57.8 55.6 14.7 4.4 19.1 16.3 22.5 26.7 19.2 6.7 13.6 26.2 8.8 16.1 25.6 19.4 12.3 4.6 6.5 14.0 4.3 7.3 7.2 2.5 4.6 2.9 1.2 5.8 14.3 11.7 27.2 6.2 9.2 10.0 2.9 10.7 1.8 11.3 4.9 2.2 4.5 5.9 6.6 2.3 3.2 7.3 13.4 2.3 7.7 12.7 3.0 7.9 3.0 6.6 6.3 29.0 13.3 8.6 11.0 20.4 16.3 6.5 3.8 38.5 11.3 12.5 6.0 13.3 9.1 14.2 28.6 4.4 34.5 2.3 5.8 10.4 9.0 12.5 3.3 27.8 19.4 8.2 15.6 3.0 8.5 58.2 54.3 98.5 71.4 132.7 78.8 203.7 84.2 80.6 66.6 195.7 85.6 80.6 25.7 90.2 176.0 87.3 123.9 73.3 19.3 19.7 18.2 30.1 18.7 19.3 19.7 19.6 18.4 20.8 19.1 19.2 19.4 43.3 16.0 41.5 11.8 83.0 90.0 87.7 177.7 99.0 29.3 139.9 173.4 53.4 60.1 93.5 68.0 10.4 69.5 46.5 64.7 133.1 95.0 50.2 53.0 35.3 36.6 71.4 22.3 9.4 126.0 147.9 31.3 120.3 73.4 23.4 52.5 29.3 69.6 84.0 11.8 8.2 100.3 97.6 43.6 49.3 46.2 20.8 49.0 110.3 2.8 61.2 39.5 63.8 9.5 14.1 189.9 81.7 24.8 47.2 142.6 150.8 148.9 75.0 29.5 6.6 24.4 45.9 105.8 80.1 185.1 180.1 72.8 53.3 37.6 73.5 152.2 ZMAT3 "FLJ12296, MGC10613, PAG608, WIG-1, WIG1" ENSG00000172667 "Zinc finger matrin-type 3" Q9HA38 3 178960121-179072215 "Predicted intracellular proteins" "Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HSkMC: 76.0;LHCN-M2: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027569, HPA028671, HPA054356" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460" "unprognostic (3.53e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.46e-1)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.81e-2)" "unprognostic (3.57e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (6.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.85e-2)" "unprognostic (7.09e-2)" "unprognostic (2.51e-1)" "unprognostic (3.91e-2)" "unprognostic (1.46e-2)" 5.3 8.0 11.6 5.3 12.1 3.4 6.0 5.9 15.4 5.8 3.3 6.4 3.5 5.2 6.3 6.8 5.8 8.9 6.2 12.8 12.2 6.3 12.8 5.9 7.4 11.1 13.4 10.5 4.5 4.2 8.9 4.9 5.6 12.2 5.9 8.6 6.2 4.4 7.8 3.1 6.1 3.4 11.3 11.3 7.0 5.1 4.2 12.6 10.3 7.6 4.4 6.4 6.2 3.7 16.7 5.9 4.0 12.8 8.4 57.4 64.2 28.3 23.1 33.9 3.3 4.3 5.1 3.5 24.2 11.1 36.2 5.1 5.4 4.6 24.6 7.6 20.7 7.0 10.7 7.8 16.2 45.7 11.7 16.0 76.0 45.2 8.1 16.7 51.2 48.5 6.8 5.7 3.3 87.7 5.8 9.3 2.1 5.7 8.3 3.3 10.7 11.1 5.2 19.2 11.3 3.0 12.7 7.1 6.4 7.7 23.8 8.0 4.9 53.2 49.9 19.2 8.3 11.0 3.2 2.9 10.2 29.6 1.7 34.9 2.1 0.7 1.7 1.8 0.6 1.0 0.9 1.3 1.4 0.7 1.8 2.2 1.5 0.8 1.6 1.4 0.8 1.0 0.6 11.6 12.1 5.9 15.4 12.8 12.2 11.1 13.4 10.5 12.2 11.3 12.6 16.7 11.2 54.5 105.8 38.2 24.6 39.6 10.6 26.1 34.1 19.5 22.2 22.9 21.0 24.3 53.8 35.0 25.0 10.7 25.1 14.0 7.9 16.1 1.1 12.0 15.7 14.6 20.9 14.5 40.7 20.7 2.9 28.2 19.9 12.2 39.8 19.8 17.2 32.1 18.2 62.2 36.7 9.5 30.5 40.2 16.6 2.2 20.2 24.4 51.6 41.2 49.7 15.5 32.0 87.4 18.9 28.6 11.9 29.0 11.1 17.3 14.0 20.2 45.1 11.1 39.5 25.0 23.8 9.5 13.1 25.2 36.7 4.4 29.8 42.8 10.4 11.1 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615500-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 37.7" "Group enriched" "Detected in many" 6 "Early spermatids: 414.6;Late spermatids: 689.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "Daudi: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.1 3.3 2.1 2.0 2.3 2.3 3.0 4.3 2.1 2.6 2.2 2.1 2.1 2.4 1.5 1.6 2.7 1.4 2.4 1.9 2.6 2.1 3.9 2.3 5.0 2.7 2.8 1.6 2.5 2.5 1.5 3.0 1.2 3.1 2.6 2.2 2.2 2.3 1.7 2.2 3.1 2.1 1.8 2.5 2.6 1.9 37.7 2.6 3.2 3.4 1.6 4.7 2.1 2.2 2.8 1.0 0.7 1.4 2.1 3.2 2.5 0.0 1.4 2.4 1.3 1.4 0.0 1.0 34.6 1.7 0.9 1.9 0.3 1.1 0.9 1.6 5.6 1.7 1.0 1.1 0.8 2.4 0.0 6.8 2.2 1.7 0.5 1.3 1.0 1.2 4.5 0.9 5.8 1.5 0.1 3.3 0.7 1.4 1.1 0.9 0.5 1.1 0.0 1.1 0.9 2.7 1.8 1.1 1.3 1.1 1.5 2.9 1.9 1.1 0.5 2.5 2.1 1.7 4.6 8.2 0.0 1.0 3.4 0.6 0.3 0.2 0.0 0.4 0.1 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.4 0.0 0.7 0.4 0.1 0.3 0.1 2.1 2.3 4.3 2.1 1.9 2.6 2.7 2.8 1.6 3.1 2.5 2.6 2.8 2.5 6.4 3.1 22.5 7.6 0.8 3.3 1.0 5.7 7.9 4.0 2.2 3.9 4.3 0.7 1.8 27.1 0.3 7.1 3.7 1.9 1.1 414.6 6.5 3.4 2.8 1.8 5.7 3.3 1.8 0.4 3.1 4.6 1.8 2.5 3.0 3.3 5.6 2.2 3.3 23.2 2.5 0.0 2.5 1.0 689.8 6.5 2.3 3.6 13.1 2.2 4.1 1.0 47.3 39.7 1.3 0.5 3.0 10.3 3.9 1.6 3.7 8.9 8.7 6.6 4.5 2.2 86.3 13.5 3.2 2.3 0.1 7.0 4.0 2.7 1.9 THEMIS "bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA" ENSG00000172673 "Thymocyte selection associated" Q8N1K5 6 127708072-127918631 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 33.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 22 "gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3" "Lineage enriched" "Detected in single" 88 "T-cells: 58.3" "Group enriched" "Detected in some" 4 "HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031422, HPA031425" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031422: AB_2673874, HPA031425: AB_10670129" "unprognostic (1.47e-4)" "unprognostic (2.50e-3)" "unprognostic (1.31e-2)" "unprognostic (1.41e-4)" "unprognostic (1.41e-1)" "unprognostic (5.20e-3)" "unprognostic (7.48e-3)" "unprognostic (9.01e-3)" "unprognostic (1.47e-1)" "unprognostic (7.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (2.65e-4)" "unprognostic (2.04e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-2)" 0.3 0.5 0.6 3.3 2.9 1.7 0.6 0.4 2.4 0.5 1.1 0.7 1.6 0.2 0.4 0.6 0.2 1.4 0.1 1.1 0.6 0.2 0.7 1.4 7.5 1.7 0.7 0.9 0.1 0.3 0.0 0.0 0.1 1.1 0.4 0.9 0.0 0.9 0.1 0.1 0.2 2.3 0.3 0.6 3.2 1.5 0.1 0.8 33.2 0.4 0.1 4.0 1.1 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 51.6 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 26.7 0.1 34.0 0.1 33.5 48.9 0.2 0.2 30.0 58.3 0.6 0.1 0.2 0.2 1.7 20.3 0.6 2.9 0.4 2.4 1.1 0.6 1.7 0.7 0.9 1.1 0.6 0.8 2.2 0.5 0.0 3.0 2.9 2.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.9 0.1 0.2 0.4 0.0 1.7 47.1 0.0 0.0 0.7 5.1 0.1 1.3 0.0 1.1 0.1 0.1 0.0 0.9 0.0 0.0 0.8 0.8 0.2 0.0 1.5 7.2 15.0 1.4 0.0 0.0 0.0 9.7 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.1 1.4 0.0 59.9 0.0 0.0 0.1 MOS ENSG00000172680 "MOS proto-oncogene, serine/threonine kinase" P00540 8 56112942-56113982 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Early spermatids: 6.5;Spermatocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.28e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF738 ENSG00000172687 "Zinc finger protein 738" Q8NE65 19 21358930-21379302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 38.6;Sertoli cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 49.5;NTERA-2: 51.6" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (1.00e-1)" "unprognostic (1.59e-1)" "unprognostic (4.48e-2)" "unprognostic (4.35e-3)" "unprognostic (4.47e-2)" "unprognostic (1.37e-1)" "unprognostic (1.55e-2)" "unprognostic (6.22e-2)" "unprognostic (4.27e-3)" "prognostic favorable (2.27e-4)" "unprognostic (2.10e-1)" "unprognostic (3.51e-2)" "unprognostic (7.39e-5)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.20e-2)" 3.4 2.7 5.3 3.7 7.2 13.4 3.7 7.5 6.9 4.7 4.5 3.0 3.2 5.9 4.2 3.7 4.0 2.9 2.7 5.2 6.2 2.6 0.7 3.3 6.9 6.8 6.9 5.2 9.4 2.8 2.3 2.6 7.1 7.2 3.9 4.1 5.5 3.8 3.1 1.6 3.5 3.6 4.1 6.0 4.2 3.4 5.1 6.5 7.0 3.9 1.4 6.6 3.5 4.0 9.5 3.2 1.7 49.5 18.7 5.9 4.7 33.2 11.8 4.8 23.1 23.7 3.8 14.7 10.6 12.1 4.5 13.8 8.5 17.8 5.8 31.4 14.0 13.2 7.9 3.6 3.1 3.3 0.2 2.8 4.2 3.4 13.2 7.1 8.0 10.2 29.0 0.1 0.4 14.2 3.3 41.4 14.4 51.6 0.0 8.5 42.4 19.3 6.4 5.9 7.6 22.0 10.9 4.1 0.2 6.4 34.7 5.3 30.5 6.4 2.6 2.8 14.3 10.7 1.1 17.7 28.4 0.2 0.2 5.0 5.6 3.4 4.7 2.0 3.8 1.8 4.0 2.5 2.5 3.0 4.4 2.4 2.4 5.2 4.5 4.8 3.0 4.3 1.7 5.3 7.2 7.5 6.9 5.2 6.2 6.8 6.9 5.2 7.2 6.0 6.5 9.5 5.3 9.6 1.1 5.2 8.9 3.4 6.2 7.8 4.0 10.4 7.1 6.7 1.6 4.3 4.6 14.7 14.6 24.2 8.7 1.4 7.9 6.1 2.3 5.3 7.6 7.9 4.2 10.1 5.7 7.6 24.3 8.4 4.6 5.2 2.5 38.6 5.7 0.1 11.1 0.0 8.8 2.5 6.1 10.6 5.1 2.2 5.3 8.1 5.4 5.6 2.0 4.2 6.2 13.6 23.7 6.5 0.6 4.1 6.3 3.8 1.4 1.5 3.5 15.1 32.9 3.7 8.5 17.2 20.0 7.7 1.8 15.6 5.5 19.7 4.8 5.7 MS4A10 "CD20L7, MS4A9" ENSG00000172689 "Membrane spanning 4-domains A10" Q96PG2 11 60785333-60801305 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 101 "intestine: 86.5" "Cell type enriched" "Detected in some" 25 "Proximal enterocytes: 319.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014778 Uncertain NA NA "HPA014778: AB_2669089" "unprognostic (7.67e-3)" "unprognostic (1.28e-1)" "unprognostic (8.73e-3)" "unprognostic (1.27e-1)" "unprognostic (5.21e-2)" 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.1 0.2 73.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 86.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.2 319.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.3 0.3 SLFN11 FLJ34922 ENSG00000172716 "Schlafen family member 11" Q7Z7L1 17 35350305-35373701 "Predicted intracellular proteins" "Antiviral defense, DNA damage, Immunity" "Helicase, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 118.2" "Low region specificity" "Detected in many" "HPA023030, HPA062062" Uncertain Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA023030: AB_1856613, HPA062062: AB_2684673" "unprognostic (1.93e-2)" "unprognostic (2.56e-1)" "unprognostic (3.04e-2)" "unprognostic (1.03e-2)" "unprognostic (3.48e-3)" "unprognostic (1.01e-1)" "unprognostic (5.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (9.93e-10)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (6.33e-2)" "unprognostic (8.81e-3)" 28.5 8.3 6.2 20.1 5.6 12.9 17.3 6.3 6.2 19.6 9.2 10.3 6.3 12.3 42.6 8.5 20.8 18.5 18.6 5.4 10.1 6.5 6.9 38.1 21.3 8.2 6.5 3.0 23.3 5.4 6.2 6.6 10.6 9.3 9.2 11.2 1.4 11.9 12.5 7.3 4.8 14.0 19.2 7.1 23.5 9.1 2.7 8.8 23.1 24.3 19.2 21.1 18.0 12.7 10.2 29.3 25.6 0.1 0.0 25.4 72.0 0.4 35.3 25.2 59.9 103.9 0.0 0.0 0.2 0.6 46.4 18.8 13.9 78.8 0.0 72.1 16.6 94.2 63.0 0.3 0.0 33.0 82.4 0.1 29.5 0.9 66.5 0.2 0.0 99.4 46.8 0.1 0.3 10.1 0.0 118.2 66.4 0.6 0.0 0.1 98.9 73.3 0.2 0.7 13.8 0.2 0.1 0.0 13.0 0.1 0.0 20.7 58.6 52.1 16.3 0.4 61.9 53.7 2.3 1.0 0.2 12.2 70.3 36.0 0.5 18.2 2.1 6.1 27.6 8.4 4.6 3.8 5.5 14.0 1.5 2.8 4.1 1.4 3.1 18.2 19.4 6.3 8.7 6.2 5.6 6.3 6.2 5.4 10.1 8.2 6.5 3.0 9.3 7.1 8.8 10.2 70.6 0.0 5.2 0.3 19.5 7.5 1.1 1.1 5.7 0.4 6.7 2.8 9.2 1.5 2.7 1.8 0.0 1.4 39.9 0.1 0.0 0.0 1.4 5.9 16.0 38.8 0.0 9.9 0.3 0.6 0.5 29.2 6.6 2.2 3.8 0.3 15.0 0.4 32.8 0.0 2.6 0.1 0.0 36.5 53.0 1.7 10.2 47.0 12.4 17.8 17.2 0.3 3.1 0.0 0.1 0.1 1.2 3.0 24.7 1.3 0.1 0.2 13.3 0.1 6.6 7.9 38.8 0.0 0.2 1.9 8.5 0.8 37.3 7.7 0.1 0.7 FAM71D C14orf54 ENSG00000172717 "Family with sequence similarity 71 member D" Q8N9W8 14 67189393-67228550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 14.3" "Group enriched" "Detected in many" 21 "Early spermatids: 199.1;Late spermatids: 257.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.58e-2)" "unprognostic (8.05e-4)" "unprognostic (2.34e-2)" "unprognostic (2.86e-1)" "unprognostic (5.80e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (6.62e-2)" "unprognostic (5.01e-1)" "unprognostic (6.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.96e-5)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (8.85e-2)" "unprognostic (5.01e-5)" 0.0 0.0 0.1 0.1 0.5 0.3 0.1 1.4 0.7 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.4 0.5 0.0 0.1 0.0 0.1 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 14.3 0.3 0.1 0.2 0.2 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 1.0 0.1 0.1 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.5 1.4 0.7 0.4 0.5 0.2 0.3 0.4 0.3 0.0 0.3 1.0 0.4 0.0 3.0 1.3 1.8 3.2 0.3 2.2 0.0 0.2 0.5 0.6 2.3 0.0 4.2 0.0 0.0 4.2 5.7 10.1 0.0 8.2 199.1 0.5 0.4 1.6 10.3 0.0 2.8 7.4 3.6 1.2 0.0 0.6 10.8 0.2 0.7 1.0 3.0 0.0 3.6 8.5 2.0 1.0 2.5 257.6 3.7 2.2 0.0 0.0 6.3 0.5 1.0 2.5 2.1 9.5 8.2 0.7 0.1 0.6 5.8 0.5 7.2 0.7 0.0 0.2 1.8 2.2 2.1 0.0 2.3 4.4 1.7 0.1 8.3 0.3 CCL19 "CKb11, ELC, exodus-3, MIP-3b, SCYA19" ENSG00000172724 "C-C motif chemokine ligand 19" Q99731 9 34689570-34691276 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 637.6" "Group enriched" "Detected in some" 12 "Basal keratinocytes: 74.7;Basal respiratory cells: 56.9;Fibroblasts: 59.6;Langerhans cells: 111.9;Melanocytes: 92.5;monocytes: 107.1;Smooth muscle cells: 150.9;Suprabasal keratinocytes: 54.0" "Cancer enhanced" "Detected in all" "testis cancer: 118.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HDLM-2: 3.2;TIME: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067758 Enhanced "Secreted to blood" NA NA 195000 63000 "HPA067758: AB_2685897" "prognostic favorable (2.88e-5)" "prognostic favorable (9.91e-6)" "unprognostic (8.25e-3)" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (1.67e-2)" "unprognostic (1.30e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (8.36e-3)" "unprognostic (8.31e-2)" "unprognostic (2.43e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (7.98e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-1)" "unprognostic (1.87e-1)" 134.4 3.4 2.8 615.1 3.1 0.0 44.0 2.6 8.3 20.0 7.0 34.6 7.9 5.5 3.8 56.0 14.2 70.0 23.5 2.4 5.0 28.5 49.5 49.1 637.6 4.8 3.5 2.3 2.4 4.9 0.3 8.0 0.0 4.6 34.6 70.9 0.1 50.0 2.0 0.4 43.2 147.6 32.8 2.9 60.2 69.4 4.1 3.3 531.3 52.1 2.2 608.0 109.4 9.2 6.5 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.1 2.6 8.3 2.4 5.0 4.8 3.5 2.3 4.6 2.9 3.3 6.5 3.3 0.0 0.0 0.0 0.8 74.7 0.0 56.9 0.0 0.0 0.4 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.3 0.0 0.0 0.0 0.2 0.0 59.6 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 1.3 111.9 0.2 0.0 3.7 92.5 1.0 107.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 150.9 0.7 0.6 0.9 54.0 0.0 6.6 0.0 0.0 0.5 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 301.4;Paneth cells: 324.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 221.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Supported "Plasma membrane,Cytosol" NA NA 960000 "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268" "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 52.3 56.8 17.3 30.0 19.5 20.4 53.9 20.0 27.2 55.1 18.7 59.0 63.5 73.4 14.7 80.8 54.7 44.5 25.3 15.6 22.3 48.2 47.6 54.1 42.2 24.2 19.9 13.4 43.1 53.0 24.8 35.4 31.5 20.8 71.6 34.8 6.6 73.8 40.0 13.1 42.2 62.8 37.0 21.1 66.5 77.7 14.0 20.4 21.3 56.2 10.0 18.5 58.8 54.0 22.4 80.9 81.4 37.5 76.0 94.1 81.3 56.6 58.5 118.0 94.2 70.8 134.1 116.0 6.4 111.3 80.8 95.8 67.9 41.9 74.9 16.8 19.4 40.7 54.9 47.3 57.9 148.1 2.3 120.8 110.6 66.3 80.1 37.2 59.7 120.7 49.4 42.7 9.2 54.2 238.4 14.4 11.2 47.7 198.2 73.4 11.2 41.0 14.9 62.6 104.3 40.7 50.8 52.4 139.6 181.6 26.0 178.5 63.0 92.2 63.4 47.4 87.4 35.2 1.6 3.3 14.6 103.4 8.2 66.4 57.3 102.8 8.0 10.9 212.9 8.3 20.0 37.6 14.6 79.0 11.0 21.2 11.4 47.8 11.9 221.8 60.8 55.2 57.8 17.3 19.5 20.0 27.2 15.6 22.3 24.2 19.9 13.4 20.8 21.1 20.4 22.4 58.7 3.2 2.2 4.6 53.4 27.9 60.1 90.8 40.9 13.0 53.8 39.0 1.6 50.1 66.4 47.8 8.4 87.8 39.2 301.4 60.7 111.4 8.9 43.6 32.9 52.0 99.0 19.8 1.8 105.0 229.8 35.8 111.1 64.8 28.0 46.7 47.8 22.4 251.8 15.2 2.4 188.6 81.4 138.6 66.4 5.0 39.4 96.3 71.2 10.3 195.3 30.0 41.2 4.5 6.8 136.9 324.9 34.6 64.3 55.6 263.5 84.0 41.2 14.6 52.6 22.1 55.1 8.1 6.6 47.6 31.0 150.5 100.3 54.8 128.0 74.5 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473146 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: AB_2682327, HPA058655: AB_2683789" "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 1.9 2.2 4.2 1.0 4.4 0.8 3.5 4.2 4.1 4.1 2.2 2.5 2.5 3.1 1.2 1.9 3.3 1.8 1.7 3.0 3.2 3.1 2.0 2.4 1.8 4.6 4.5 3.1 5.3 2.6 5.1 1.3 3.5 3.2 2.2 2.8 5.2 2.7 2.2 0.6 3.2 2.6 3.0 2.5 1.5 2.3 1.5 3.7 2.9 2.8 1.3 2.2 2.2 2.2 2.5 2.4 4.5 6.8 8.3 10.8 10.8 3.4 4.3 7.1 4.2 5.4 6.3 3.6 2.7 5.1 5.8 3.5 5.9 10.4 4.1 4.1 5.8 3.8 8.6 3.6 7.0 4.9 1.9 2.9 8.0 7.0 1.1 5.4 8.8 8.6 4.4 8.0 3.2 3.9 1.4 6.6 2.8 9.1 6.4 3.0 4.8 5.1 1.4 6.1 5.4 2.4 2.3 2.5 3.7 5.1 7.0 3.8 1.9 6.6 3.2 1.4 8.1 3.6 1.3 2.2 1.8 2.0 5.4 3.4 0.4 0.6 0.7 1.3 0.2 1.4 1.0 0.7 1.2 1.3 0.3 0.8 0.8 0.4 1.6 0.2 0.7 1.7 0.6 4.2 4.4 4.2 4.1 3.0 3.2 4.6 4.5 3.1 3.2 2.5 3.7 2.5 4.5 3.2 2.0 140.0 2.5 2.7 2.7 3.4 4.0 2.9 3.7 3.8 2.5 2.8 3.2 3.7 10.4 12.0 3.0 1.5 1.9 4.5 248.8 2.8 5.7 3.8 3.6 3.8 16.3 4.0 7.0 5.8 6.1 3.0 5.7 10.1 5.3 3.6 3.4 3.3 20.2 3.2 4.1 2.2 1.8 334.2 6.8 2.2 1.8 29.0 3.0 29.9 5.2 44.2 16.4 4.0 1.0 4.9 5.0 1.4 5.3 3.0 2.0 11.0 0.0 5.7 4.6 7.0 2.7 5.5 1.7 6.0 2.6 6.5 3.6 1.3 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 308.5;tongue: 126.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-2 OS: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 2.8 5.9 18.0 2.6 18.5 3.3 2.4 14.7 22.5 9.7 11.0 10.5 2.8 6.5 3.1 14.9 4.3 3.2 33.3 18.7 16.6 3.7 32.3 4.5 3.2 17.9 17.1 18.6 4.3 3.4 3.3 13.3 1.4 19.3 4.7 4.0 4.4 6.4 4.2 308.5 3.2 4.1 6.9 14.4 3.3 5.1 12.6 19.3 7.4 4.4 126.2 5.3 6.3 20.0 18.4 26.1 18.1 16.2 29.7 9.3 6.5 0.1 4.0 14.5 9.2 8.6 17.2 27.7 5.9 13.2 2.4 31.1 9.8 14.3 18.1 8.1 14.7 3.6 3.2 4.6 53.3 8.6 8.2 2.7 2.6 7.0 11.3 5.4 11.2 18.7 34.6 4.0 7.6 8.4 3.6 31.0 8.4 5.3 26.0 46.3 23.8 8.2 14.8 15.1 2.7 32.4 16.2 2.0 2.5 10.9 4.1 3.4 9.2 10.6 6.3 64.7 10.7 8.9 13.6 22.3 9.3 12.6 32.7 1.7 0.0 0.2 0.0 0.4 0.3 0.4 0.1 0.3 0.4 0.6 0.0 1.0 0.4 0.0 0.4 0.1 0.1 0.0 0.3 18.0 18.5 14.7 22.5 18.7 16.6 17.9 17.1 18.6 19.3 14.4 19.3 18.4 1.9 0.0 4.6 9.4 1.1 1.5 0.5 0.6 0.0 8.5 1.5 0.6 31.0 2.8 1.3 0.0 4.2 0.1 0.8 0.8 0.0 3.9 25.4 1.1 1.3 2.4 5.4 1.7 10.0 4.7 0.2 2.8 1.5 0.7 0.0 2.5 2.2 17.5 0.5 1.7 10.1 2.0 0.0 0.6 0.7 50.1 3.1 0.8 1.8 1.9 1.2 7.5 1.0 6.6 3.9 5.8 3.1 1.5 1.7 0.8 0.3 1.6 0.6 2.0 0.0 5.2 1.9 8.5 4.8 0.1 0.6 0.0 1.3 1.8 2.1 0.6 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA059530: AB_2684052" "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 20.0 18.2 13.2 13.5 13.4 11.4 20.5 13.5 20.2 30.9 11.5 28.6 17.1 35.7 7.8 17.0 31.1 11.0 23.9 12.4 11.8 24.3 19.6 21.8 18.7 14.3 13.5 11.9 30.1 20.0 10.3 22.6 11.1 13.6 26.4 7.2 8.2 16.8 16.1 24.5 14.0 23.9 12.5 12.7 29.2 22.7 16.8 13.4 16.2 23.7 17.1 13.7 30.0 22.7 16.1 21.6 13.3 22.1 22.0 9.5 11.5 28.2 22.7 17.9 28.2 18.8 17.7 34.4 20.4 30.0 17.8 35.2 20.6 19.9 19.9 6.3 44.5 14.7 37.3 39.8 10.8 29.0 26.9 38.2 18.3 36.2 35.8 28.0 20.7 24.0 36.5 22.9 55.4 18.7 14.2 38.1 41.0 16.1 14.1 29.2 37.2 10.6 39.7 21.5 13.3 22.1 25.3 15.5 27.7 48.7 13.5 32.6 27.3 21.5 21.2 18.0 27.3 24.9 37.6 26.9 29.7 24.1 17.5 36.3 22.6 13.7 27.4 21.0 16.3 21.0 13.1 15.9 18.4 14.7 10.4 12.3 15.4 9.4 13.3 18.5 14.7 15.1 13.0 13.2 13.4 13.5 20.2 12.4 11.8 14.3 13.5 11.9 13.6 12.7 13.4 16.1 19.3 12.8 18.4 15.0 17.2 8.0 21.5 13.5 10.2 19.2 11.8 15.6 10.0 11.5 16.0 7.3 20.9 20.8 22.0 27.0 5.9 24.7 62.8 12.2 22.0 16.1 16.8 25.7 9.0 22.2 23.6 13.5 27.0 13.0 14.0 15.0 16.8 9.2 19.6 23.5 8.8 23.9 10.2 13.3 8.8 130.0 21.8 14.3 10.6 9.4 27.1 15.0 32.0 8.5 12.9 26.6 24.5 27.1 12.6 11.0 36.1 12.4 16.0 24.7 39.5 11.5 21.9 27.9 16.7 8.4 7.4 19.7 19.9 15.0 21.4 10.2 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 18.5" "Cell type enhanced" "Detected in some" "Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 0.2 0.4 8.1 0.2 8.1 0.0 0.2 11.0 9.5 1.2 1.1 0.3 0.1 2.1 0.6 0.2 0.4 0.8 0.3 9.3 18.5 0.3 0.0 0.2 0.2 7.2 7.9 8.6 0.5 0.0 0.0 3.0 0.2 7.5 0.6 0.1 4.1 0.3 0.6 0.1 0.0 0.2 1.3 6.2 0.7 0.2 2.6 7.9 0.1 0.2 0.2 0.1 0.2 0.8 7.0 0.0 0.0 6.1 0.1 0.0 0.0 0.0 0.1 0.3 0.5 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 2.0 0.0 0.7 0.0 3.1 1.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.9 0.0 0.7 3.0 4.3 0.3 0.4 0.1 0.0 0.6 0.0 4.8 0.0 0.2 1.6 0.8 0.0 0.0 0.0 0.8 5.7 0.0 0.0 0.0 2.2 0.0 0.0 1.9 2.0 2.5 0.0 0.3 0.2 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 8.1 11.0 9.5 9.3 18.5 7.2 7.9 8.6 7.5 6.2 7.9 7.0 0.5 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 13.3 0.1 0.3 0.6 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 17.3 0.2 3.2 0.5 0.0 0.0 57.2 0.0 0.0 1.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 20.2 69.5 0.0 0.0 0.0 0.3 22.0 0.6 0.1 0.0 12.2 0.0 10.8 0.0 49.3 27.8 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.3 1.3 4.2 1.5 0.0 0.0 0.0 0.1 1.8 0.0 0.0 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212178-37258155 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.2" "Cell type enhanced" "Detected in many" "Early spermatids: 20.5;Exocrine glandular cells: 16.0;Pancreatic endocrine cells: 15.9;Spermatocytes: 55.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 7.7;HUVEC TERT2: 6.4;TIME: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.7 3.1 0.9 0.7 1.0 2.8 0.5 1.1 1.7 0.3 0.9 0.3 1.1 0.3 1.6 1.6 0.7 1.2 0.3 0.9 1.2 0.6 1.0 0.7 0.4 0.9 0.9 1.0 0.3 2.7 1.3 0.1 0.3 1.0 0.3 0.4 0.7 1.2 0.1 0.1 1.0 0.4 0.4 0.9 0.2 0.2 9.2 1.0 0.7 0.7 0.0 0.3 2.2 0.1 1.1 0.7 0.0 0.5 0.4 0.3 2.1 0.3 2.2 3.9 1.9 5.5 1.7 1.3 0.1 0.8 0.5 2.4 1.2 0.7 0.6 2.0 0.7 1.1 7.7 1.7 0.9 0.9 0.2 3.7 1.4 1.7 5.0 0.5 1.0 6.4 0.8 2.5 0.0 0.9 0.9 0.5 3.2 0.6 0.0 0.3 1.0 0.2 0.2 2.1 0.8 0.6 0.3 0.4 0.4 1.0 0.9 0.1 0.4 17.6 1.8 0.5 0.2 0.4 0.5 0.7 1.9 0.3 1.7 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.9 1.0 1.1 1.7 0.9 1.2 0.9 0.9 1.0 1.0 0.9 1.0 1.1 2.6 0.0 0.6 2.9 0.7 2.5 8.9 2.6 0.6 0.8 3.9 1.8 0.2 1.5 3.9 1.8 0.0 0.8 1.3 3.4 3.9 15.0 20.5 8.3 1.3 3.3 1.8 0.0 2.9 16.0 0.6 3.8 2.0 5.6 5.7 1.4 0.4 0.1 0.9 3.3 2.1 0.4 2.0 0.6 6.3 14.9 0.6 2.8 1.8 0.0 0.0 6.4 0.0 1.5 3.0 15.9 1.1 0.0 0.5 6.9 0.8 1.1 5.0 0.5 0.0 4.1 1.8 55.0 0.8 3.4 3.0 1.1 1.1 1.5 1.0 13.9 OR4D9 ENSG00000172742 "Olfactory receptor family 4 subfamily D member 9" Q8NGE8 11 59511368-59520703 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;Collecting duct cells: 1.8;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA 0.0 0.1 0.4 0.2 0.5 0.9 0.1 1.8 0.7 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.7 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.5 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 1.4 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.2 1.2 0.4 0.1 0.2 0.1 0.2 0.4 0.5 1.8 0.7 0.4 0.1 0.2 0.1 0.5 0.8 0.0 0.2 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 ZNF596 ENSG00000172748 "Zinc finger protein 596" Q8TC21 8 232137-264703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 18.8" "Cell type enhanced" "Detected in many" "Early spermatids: 60.1;Late spermatids: 20.4;Oligodendrocytes: 20.7;Spermatocytes: 63.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4" "Low region specificity" "Detected in all" HPA055463 Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA055463: AB_2682821" "unprognostic (3.30e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.90e-1)" "unprognostic (9.07e-3)" "unprognostic (9.68e-3)" "unprognostic (2.10e-3)" "unprognostic (1.74e-1)" "unprognostic (4.84e-1)" "unprognostic (1.70e-5)" "unprognostic (6.37e-2)" "unprognostic (1.20e-1)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "unprognostic (3.51e-1)" "unprognostic (4.53e-1)" 2.6 3.6 4.2 2.0 4.6 1.8 5.2 8.0 5.4 3.6 4.6 2.7 2.7 7.2 7.1 2.3 4.1 2.2 3.4 4.2 4.9 3.8 3.0 3.1 3.8 4.4 4.4 4.2 5.1 3.4 5.0 4.7 3.6 5.6 3.9 3.3 18.8 2.4 4.0 2.9 4.5 2.6 3.2 3.2 5.0 3.7 15.7 4.8 3.5 5.8 1.9 2.8 2.7 2.6 6.6 1.6 1.1 4.5 11.4 2.1 2.3 3.6 3.6 1.5 1.3 2.4 1.1 2.0 1.6 1.3 2.7 1.9 3.3 1.2 2.6 1.7 1.2 1.9 3.3 3.3 1.3 2.4 1.4 1.8 4.8 0.4 1.5 2.4 2.2 1.0 5.7 2.4 5.4 7.8 5.6 4.0 1.8 2.4 3.0 1.1 1.6 1.0 2.7 4.4 2.7 2.7 6.7 2.3 1.2 1.8 2.3 3.6 4.1 2.6 3.3 0.9 0.3 1.8 1.7 5.1 2.2 4.1 1.4 2.4 4.6 1.5 2.3 2.4 1.2 3.1 3.2 2.5 2.2 1.7 3.6 2.9 3.4 1.4 1.5 2.9 2.3 2.9 1.3 4.2 4.6 8.0 5.4 4.2 4.9 4.4 4.4 4.2 5.6 3.2 4.8 6.6 2.3 3.2 2.7 10.1 2.2 0.4 0.7 2.6 2.2 8.3 1.3 1.8 2.9 1.5 2.4 1.8 2.1 2.1 0.8 1.6 3.9 2.1 60.1 1.5 2.7 2.5 0.0 1.7 14.1 1.7 1.4 2.1 5.1 1.3 5.1 2.9 2.2 0.9 1.1 11.8 15.7 1.5 4.1 0.8 0.3 20.4 4.1 0.9 0.0 9.4 0.5 5.4 1.0 15.6 20.7 1.3 0.5 1.2 2.9 0.7 1.6 1.9 3.8 9.0 0.0 2.6 1.8 63.7 4.5 3.1 0.4 1.5 1.8 2.9 1.5 0.5 COL6A5 "COL29A1, FLJ35880, VWA4" ENSG00000172752 "Collagen type VI alpha 5 chain" 3 130345516-130484844 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lung: 5.7;skin 1: 6.3" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 3.4;Early spermatids: 5.6;Erythroid cells: 3.8;Fibroblasts: 5.5;Langerhans cells: 5.2;Late spermatids: 3.0;Suprabasal keratinocytes: 3.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "midbrain: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 64 "HDLM-2: 15.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA043138 Uncertain "Secreted in other tissues" NA NA "HPA043138: AB_10796687" "unprognostic (3.45e-2)" "unprognostic (4.08e-2)" "unprognostic (6.01e-3)" "unprognostic (2.32e-1)" "unprognostic (3.42e-2)" "unprognostic (1.46e-6)" "unprognostic (8.44e-2)" "unprognostic (2.07e-3)" "unprognostic (2.47e-1)" "unprognostic (1.71e-1)" "unprognostic (7.58e-8)" "unprognostic (3.85e-2)" "unprognostic (4.51e-1)" "unprognostic (1.54e-1)" "unprognostic (2.79e-2)" 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.7 0.0 0.0 0.0 1.0 0.8 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.3 0.0 3.8 0.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.2 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 3.4 0.0 0.2 0.0 0.0 0.0 CFL1 CFL ENSG00000172757 "Cofilin 1" P23528 11 65823022-65862026 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013086, CAB033687, CAB037077, HPA053761" Approved Supported Cytosol NA NA 290000000 Cytosol "CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251" "unprognostic (1.14e-1)" "unprognostic (2.37e-2)" "unprognostic (7.69e-3)" "unprognostic (4.32e-3)" "unprognostic (3.14e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.88e-3)" "unprognostic (6.57e-3)" "unprognostic (2.09e-1)" "unprognostic (6.19e-3)" "unprognostic (1.72e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" 575.9 438.9 569.6 941.1 598.6 1333.8 518.9 584.2 666.6 438.5 488.0 1156.0 1179.8 719.0 346.2 711.7 485.7 417.3 480.8 654.3 622.3 568.2 474.9 689.4 995.7 624.5 571.5 590.8 347.5 266.8 304.2 343.2 483.2 618.3 444.4 999.7 210.7 456.8 461.9 264.1 507.1 1130.1 854.7 618.2 781.4 639.4 269.5 598.0 948.3 373.9 232.7 1109.4 689.4 475.1 669.2 2284.3 1783.6 1908.5 1529.8 1142.6 1157.0 1031.6 2309.7 1942.4 2457.5 1460.7 1012.4 1815.2 1700.8 1755.3 2925.7 1780.5 1623.2 1389.2 2103.8 1824.9 1869.0 718.2 2185.8 1271.2 1162.1 1222.6 1890.2 2854.6 1339.3 1412.4 2166.7 1108.0 1494.0 2663.1 1099.4 1037.6 1648.5 2635.7 2133.0 2739.4 2965.4 2095.8 1985.4 1432.7 2050.3 941.1 2181.9 1847.8 1468.6 952.7 2106.6 1250.6 1733.6 1682.2 1053.4 2104.1 1427.8 2330.5 2087.3 1603.5 2672.6 2194.0 1193.1 2065.2 2251.0 2146.2 1161.7 2004.4 1690.2 2720.0 2973.1 2534.0 2955.4 1964.6 1561.4 1992.5 2296.2 3343.8 1527.0 1459.3 1905.2 2946.2 1961.1 3255.3 2558.6 2696.1 6842.2 569.6 598.6 584.2 666.6 654.3 622.3 624.5 571.5 590.8 618.3 618.2 598.0 669.2 805.5 246.8 223.0 24.5 890.8 1349.3 1253.3 1197.1 598.8 198.5 655.2 646.0 74.8 459.0 595.7 520.5 58.4 1239.8 1439.8 2052.9 892.1 2114.0 459.4 376.6 648.1 918.4 779.0 557.7 38.8 1965.0 2470.6 579.0 642.8 603.3 598.2 527.4 698.2 436.3 2911.0 203.6 30.3 1448.8 891.1 1185.5 1706.6 373.2 352.2 1474.2 985.4 38.4 2903.8 478.3 2075.2 22.6 62.0 3082.4 1894.7 502.9 639.1 991.2 2279.4 1246.5 295.5 118.0 420.7 448.2 1184.3 177.4 412.8 703.8 1267.4 1732.4 1276.2 621.7 1315.3 1383.3 TMCC1 KIAA0779 ENSG00000172765 "Transmembrane and coiled-coil domain family 1" O94876 3 129647792-129893606 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Alveolar cells type 1: 54.5;Astrocytes: 119.1;Excitatory neurons: 206.7;Inhibitory neurons: 201.5;Microglial cells: 127.4;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 209.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053894 Uncertain NA NA "HPA053894: AB_2682295" "unprognostic (4.26e-2)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (2.60e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (7.75e-3)" "unprognostic (1.13e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.50e-2)" "prognostic unfavorable (1.77e-6)" "unprognostic (6.82e-3)" "unprognostic (2.90e-1)" "unprognostic (1.20e-1)" "unprognostic (2.32e-1)" 7.6 6.9 13.1 4.9 13.1 3.2 7.4 24.4 15.1 9.9 1.3 5.8 4.2 7.8 6.7 7.7 7.0 8.7 8.3 11.1 10.9 6.7 34.8 6.8 5.1 10.3 12.9 8.6 8.1 4.8 7.9 6.6 9.9 11.7 7.6 5.2 15.3 5.5 6.3 30.4 7.4 4.4 6.9 10.1 6.9 4.1 13.6 15.0 8.4 6.9 21.3 5.5 7.9 7.0 15.3 10.6 11.3 8.8 7.2 12.9 9.1 8.9 4.1 5.4 3.6 3.7 7.3 5.7 6.5 11.4 7.9 4.2 9.6 5.0 8.2 2.6 8.6 1.6 4.3 3.4 26.7 4.4 3.2 2.6 5.3 15.1 2.8 6.7 7.7 11.0 3.9 2.2 4.7 8.2 11.6 5.7 1.9 6.7 7.7 3.6 5.2 7.4 5.5 8.4 12.9 8.2 5.7 14.0 4.8 4.1 8.5 9.2 3.5 9.6 5.7 9.2 5.3 8.5 6.9 5.1 4.8 4.2 3.8 3.0 0.6 0.9 2.1 1.1 0.9 1.2 0.7 0.9 0.9 0.5 1.1 1.1 1.4 9.6 0.8 2.0 1.4 1.9 0.8 13.1 13.1 24.4 15.1 11.1 10.9 10.3 12.9 8.6 11.7 10.1 15.0 15.3 14.1 54.5 7.4 119.1 9.4 6.6 12.6 9.9 12.5 37.1 17.4 12.1 23.0 7.2 16.0 22.0 31.3 10.6 8.3 9.0 7.9 15.8 9.6 30.5 14.6 13.2 12.6 4.6 206.7 8.1 20.7 10.9 10.2 38.3 3.8 12.0 9.7 36.8 9.9 35.3 201.5 12.2 10.2 18.6 6.6 10.5 13.1 13.5 1.8 127.4 6.8 27.0 12.3 181.0 209.2 24.9 22.8 8.6 14.5 20.4 4.7 13.1 19.6 29.5 6.6 18.1 12.2 33.5 19.4 15.8 7.0 23.9 8.9 9.6 8.3 25.2 NAA16 "FLJ22054, MGC40612, NARG1L, PRO2435" ENSG00000172766 "N-alpha-acetyltransferase 16, NatA auxiliary subunit" Q6N069 13 41311267-41377030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 23.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039761, HPA040157" Approved Enhanced Cytosol NA NA Cytosol "HPA039761: AB_10795112, HPA040157: AB_10793917" "unprognostic (2.09e-2)" "unprognostic (2.86e-2)" "unprognostic (2.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.66e-2)" "unprognostic (4.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.90e-1)" "unprognostic (3.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.94e-2)" "unprognostic (5.81e-2)" "unprognostic (1.58e-1)" "unprognostic (3.34e-2)" 3.2 2.7 2.1 5.0 2.1 23.7 3.9 5.1 2.7 5.1 1.8 2.8 4.3 6.3 2.7 4.2 4.3 3.5 2.5 1.8 2.0 3.1 2.9 3.7 6.6 2.0 1.8 0.4 6.0 20.7 3.5 1.9 3.9 2.3 4.8 3.2 6.0 3.9 3.9 4.4 4.2 4.1 3.8 1.6 4.5 4.8 7.5 2.2 6.0 3.8 4.5 4.1 3.9 3.5 3.5 7.3 6.0 14.9 10.8 5.1 6.5 5.7 8.9 7.4 8.6 7.5 7.1 5.6 12.1 4.1 7.2 3.5 10.0 7.7 5.7 10.5 7.5 15.5 15.0 6.3 7.2 5.5 16.8 9.7 4.5 4.2 3.6 6.8 5.8 8.6 11.7 6.8 6.5 5.6 6.0 17.5 4.8 12.6 10.1 8.1 12.9 6.1 10.1 6.8 6.6 5.0 11.6 8.0 7.7 3.3 8.6 4.7 9.3 6.2 5.8 4.9 9.3 7.0 4.5 5.4 14.0 7.5 7.2 7.1 4.4 1.5 3.1 2.3 0.8 2.1 1.0 2.6 2.4 0.8 1.6 4.5 4.7 0.8 3.4 1.2 1.6 2.0 1.3 2.1 2.1 5.1 2.7 1.8 2.0 2.0 1.8 0.4 2.3 1.6 2.2 3.5 15.0 9.6 16.7 34.0 19.6 17.7 21.9 9.5 18.8 27.9 10.3 10.2 12.0 10.0 12.4 9.2 14.6 8.8 20.2 5.6 1.9 12.5 17.9 17.2 26.7 16.7 7.7 15.4 53.5 20.5 7.8 18.8 19.9 22.1 3.8 18.9 13.6 8.7 19.1 38.7 66.9 5.5 4.1 8.5 11.7 26.3 30.1 14.3 14.2 45.0 12.0 11.3 21.6 68.9 57.1 13.1 6.9 19.9 28.3 20.0 7.3 7.0 17.3 33.6 19.7 17.0 24.7 39.2 28.8 17.0 14.6 2.9 31.7 17.1 9.7 21.2 OR5B3 "OR5B13, OST129" ENSG00000172769 "Olfactory receptor family 5 subfamily B member 3" Q8NH48 11 58402464-58406874 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 10.3;fallopian tube: 19.9" "Group enriched" "Detected in some" 4 "Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPTEC TERT1: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.2 0.4 4.9 0.1 1.2 0.8 0.3 1.8 1.0 0.7 10.3 0.1 0.0 0.3 0.8 0.0 19.9 0.2 0.2 1.5 2.6 0.8 1.2 1.7 0.1 3.6 4.7 0.1 1.0 0.6 1.7 3.7 0.1 2.8 3.0 0.0 1.6 0.2 0.2 0.0 0.1 0.3 0.0 4.4 0.4 0.7 7.0 1.4 0.2 1.2 0.0 0.2 0.0 0.1 1.1 0.1 0.7 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 1.5 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 1.2 1.8 1.0 1.5 2.6 3.6 4.7 0.1 2.8 4.4 1.4 1.1 0.2 3.2 1.7 0.3 0.5 0.5 0.1 0.8 0.0 0.4 0.7 0.4 1.3 1.5 1.8 0.0 2.1 0.0 0.3 0.1 0.0 0.2 29.6 31.9 0.7 0.5 0.0 0.0 2.7 0.2 0.1 0.5 3.1 1.9 0.0 0.1 0.0 1.1 0.1 5.0 0.8 0.3 2.0 0.0 0.0 20.1 0.3 0.3 0.0 0.0 0.1 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.9 46.0 5.6 0.0 0.5 0.6 6.8 2.7 0.7 0.3 0.0 0.3 0.3 0.0 0.2 OR10W1 OR10W1P ENSG00000172772 "Olfactory receptor family 10 subfamily W member 1" Q8NGF6 11 58266792-58268260 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.61e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSME3IP1 "C16orf94, FAM192A, NIP30, PIP30" ENSG00000172775 "Proteasome activator subunit 3 interacting protein 1" Q9GZU8 16 57152466-57186116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054382, HPA059652" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA054382: AB_2682469, HPA059652: AB_2684095" "unprognostic (1.69e-2)" "unprognostic (5.20e-2)" "unprognostic (1.36e-1)" "unprognostic (9.20e-3)" "unprognostic (4.69e-3)" "unprognostic (2.45e-2)" "unprognostic (1.01e-2)" "unprognostic (2.22e-1)" "unprognostic (6.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.41e-1)" "unprognostic (4.19e-1)" "unprognostic (3.00e-1)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-3)" 48.7 50.7 85.9 73.6 96.7 152.5 67.4 90.1 99.8 51.8 86.3 76.1 68.2 54.6 65.3 64.0 54.6 47.7 56.8 82.9 88.3 61.7 63.1 58.1 95.6 93.0 91.2 79.8 55.0 55.8 77.3 65.8 56.4 94.1 65.2 88.4 75.9 55.7 50.7 79.7 91.0 76.8 52.8 92.8 94.1 63.2 97.7 91.8 85.8 72.1 66.5 97.3 53.8 56.6 101.1 119.3 148.6 163.6 109.8 70.3 86.2 153.4 138.3 102.3 166.3 107.1 141.3 122.5 179.2 150.6 105.8 84.2 155.9 114.4 137.9 167.1 80.3 92.1 125.0 141.6 148.3 101.0 154.8 170.8 86.6 134.8 158.2 127.4 101.8 121.0 134.4 170.1 56.5 110.8 88.2 169.4 143.2 105.1 88.0 111.3 205.6 236.9 174.5 113.1 96.4 116.3 133.9 250.2 105.2 92.7 113.0 87.1 105.9 120.2 122.0 102.3 90.2 103.7 133.2 113.1 228.6 125.0 109.7 119.6 170.3 78.3 124.1 47.6 93.0 46.8 83.1 45.8 44.7 90.0 77.8 47.0 49.1 107.6 57.1 123.4 62.4 69.2 68.1 85.9 96.7 90.1 99.8 82.9 88.3 93.0 91.2 79.8 94.1 92.8 91.8 101.1 16.9 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.3 0.0 0.0 0.0 0.0 56.7 10.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 59.5 16.8 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 53.1 1.5 0.0 0.0 0.0 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 47.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 12.0;Gastric mucus-secreting cells: 5.6;Plasma cells: 9.2;Squamous epithelial cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 11.2" "Group enriched" "Detected in many" 5 "granulocytes: 11.2;T-cells: 2.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA046840: , HPA060085: AB_2684199" "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 7.7 8.3 9.2 10.5 9.7 22.5 7.1 11.3 8.2 7.4 8.6 7.9 8.1 6.6 2.9 5.9 7.3 9.5 3.8 7.6 6.7 10.4 47.3 14.9 17.5 9.4 7.3 6.9 10.0 10.3 5.3 6.7 4.0 8.1 10.0 2.7 0.7 10.3 5.1 1.8 3.7 7.0 2.7 6.3 11.0 8.2 7.6 7.3 13.0 22.9 1.4 4.7 7.3 4.0 9.2 22.4 6.0 1.4 5.7 2.7 1.2 8.3 7.6 5.1 4.4 3.5 9.4 9.4 0.6 17.1 5.7 5.9 9.2 0.5 8.8 1.0 11.2 5.6 1.5 1.1 12.5 25.9 5.1 12.7 7.1 5.4 2.2 0.5 1.9 8.7 13.0 2.5 10.8 6.1 9.7 5.0 9.8 7.0 5.2 10.5 10.8 3.2 6.6 14.1 18.7 0.4 2.7 3.3 7.0 14.4 2.2 3.0 5.3 12.5 9.3 6.4 7.6 2.9 16.9 9.8 3.6 8.5 1.0 10.3 0.4 1.2 2.3 1.5 1.5 0.7 0.5 1.5 1.2 0.6 1.0 2.8 2.4 11.2 1.4 0.7 0.9 2.4 1.0 9.2 9.7 11.3 8.2 7.6 6.7 9.4 7.3 6.9 8.1 6.3 7.3 9.2 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 12.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.3 0.6 0.4 0.0 0.0 0.0 0.2 0.1 0.5 5.6 0.5 0.0 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 9.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 2.5 0.1 0.1 1.2 0.2 0.3 0.1 FADS6 ENSG00000172782 "Fatty acid desaturase 6" 17 74877302-74893781 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.9;epididymis: 18.3;intestine: 14.9" "Cell type enriched" "Detected in some" 13 "Proximal enterocytes: 72.2" "Cancer enhanced" "Detected in some" "liver cancer: 2.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016802 Uncertain NA NA "HPA016802: AB_2669448" "unprognostic (2.41e-2)" "unprognostic (6.80e-3)" "unprognostic (2.64e-1)" "unprognostic (4.68e-3)" "unprognostic (4.73e-2)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (1.07e-1)" "unprognostic (6.41e-2)" "unprognostic (6.98e-4)" "unprognostic (3.38e-2)" "unprognostic (7.53e-2)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (2.27e-1)" "unprognostic (8.45e-2)" "unprognostic (1.79e-1)" 0.2 7.1 3.2 0.5 3.5 1.5 0.5 5.4 9.0 0.2 0.0 0.6 7.6 0.2 18.3 3.2 0.1 0.0 0.2 2.1 2.3 1.1 6.2 0.2 0.6 8.8 2.5 3.5 0.3 0.4 0.6 0.1 0.2 10.9 0.1 0.7 1.2 0.3 0.3 0.5 7.5 14.9 0.2 0.8 4.2 0.2 0.7 6.4 0.4 0.4 0.2 0.8 1.2 1.1 10.7 0.2 0.3 0.5 0.4 0.0 1.0 0.7 0.5 0.0 0.1 0.2 0.8 0.3 0.3 0.1 0.5 0.3 0.3 0.7 0.0 0.2 0.1 0.0 0.5 1.6 0.6 0.3 0.4 0.4 0.3 0.0 1.1 0.4 0.2 0.0 0.4 0.4 1.4 0.6 0.6 0.3 1.1 0.3 0.2 0.5 0.2 0.1 0.5 0.3 0.3 0.4 0.4 0.5 0.2 0.1 0.5 0.2 0.5 0.3 0.3 0.7 0.6 0.5 0.5 0.2 0.3 1.0 0.3 0.5 1.1 0.6 0.4 0.2 0.6 0.2 0.3 0.3 0.3 0.1 0.5 0.3 0.4 2.0 0.8 1.5 0.5 0.2 0.0 3.2 3.5 5.4 9.0 2.1 2.3 8.8 2.5 3.5 10.9 0.8 6.4 10.7 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 1.8 1.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.0 3.7 0.0 0.0 0.8 0.0 0.1 0.3 0.0 0.0 5.2 0.2 0.1 0.3 0.0 0.2 0.0 1.1 0.4 4.0 0.3 1.7 5.4 1.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.2 0.0 5.1 0.0 0.0 1.1 72.2 1.9 0.0 0.5 0.0 1.1 0.4 0.0 2.0 1.7 0.6 3.8 0.2 0.4 0.7 1.3 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 185.1" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 18.8 34.7 10.4 15.4 11.1 13.1 20.1 12.3 11.2 14.3 13.9 16.6 13.4 13.8 21.0 27.0 14.8 10.6 20.6 10.8 11.6 40.4 27.0 16.3 13.5 10.8 11.3 10.2 15.5 30.3 38.7 19.6 22.4 11.0 20.0 15.3 27.7 23.9 12.3 22.0 22.4 14.2 12.3 11.3 17.0 19.3 16.5 10.8 13.3 25.6 17.8 20.3 23.6 17.2 12.5 43.3 16.1 22.7 12.2 29.1 26.2 50.3 22.2 14.6 30.4 23.0 23.4 16.1 39.4 28.3 8.2 18.4 7.3 11.3 21.1 32.4 67.8 38.9 0.4 39.1 72.6 31.5 115.1 17.2 23.5 9.9 7.3 59.0 19.5 32.9 19.7 13.6 84.3 25.2 52.1 25.1 185.1 22.9 37.6 34.6 47.7 34.6 75.8 39.4 120.7 40.8 24.8 45.8 16.8 17.8 55.5 35.6 109.2 34.4 16.0 22.9 20.8 19.7 10.1 14.6 44.6 39.6 60.6 19.2 3.6 65.7 19.3 10.3 75.6 16.9 21.1 18.6 16.8 74.1 15.7 16.2 17.7 10.2 12.8 60.8 19.6 18.1 48.3 10.4 11.1 12.3 11.2 10.8 11.6 10.8 11.3 10.2 11.0 11.3 10.8 12.5 19.5 54.5 50.1 8.1 41.2 47.7 29.9 47.6 97.9 50.8 49.4 37.6 51.8 30.0 49.8 35.0 108.4 96.3 17.7 20.4 35.2 79.9 51.7 14.9 10.1 23.0 31.2 44.6 17.0 118.5 41.2 23.0 34.7 11.9 32.8 26.7 20.7 19.0 32.0 38.7 17.1 39.0 50.8 25.1 38.0 16.4 18.0 37.9 32.0 18.7 81.5 32.2 18.6 5.5 16.7 66.9 38.2 13.2 90.0 32.0 49.5 73.6 31.0 63.5 32.9 20.2 27.8 48.6 28.1 83.8 50.6 124.8 23.5 24.1 62.3 24.9 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54033050-54035361 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;fallopian tube: 4.2" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Fibroblasts: 2.6;Granulosa cells: 2.5;Leydig cells: 2.5;Peritubular cells: 2.6;Skeletal myocytes: 2.6;Smooth muscle cells: 2.5;Spermatocytes: 3.2;Squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "gdT-cell: 3.0" "Lineage enriched" "Detected in single" 31 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 7.1;ASC TERT1: 4.8;HSkMC: 4.5;SH-SY5Y: 7.6" "Region enriched" "Detected in single" 46 "pons and medulla: 4.6" "Group enriched" "Detected in some" 5 "medulla oblongata: 1.5;spinal cord: 2.1" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.0 0.9 0.0 0.1 0.3 0.0 1.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 2.8 0.9 4.2 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.2 2.8 0.6 0.0 2.6 0.0 0.0 0.0 0.8 3.5 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.7 1.5 1.9 0.0 2.1 1.4 0.4 0.0 0.2 0.0 0.0 0.1 0.1 1.3 0.8 1.9 0.0 7.1 4.0 4.8 0.0 0.4 0.3 0.8 0.6 3.0 0.4 0.0 0.5 2.1 0.0 1.1 0.1 0.0 0.3 2.4 2.4 0.0 1.0 0.1 0.1 0.0 0.1 4.5 0.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 7.6 0.5 0.2 3.9 0.9 1.4 0.0 0.0 1.2 0.7 2.6 0.2 0.0 0.0 0.0 0.1 0.1 2.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.0 0.1 2.8 0.6 0.0 3.5 1.9 0.4 1.3 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.2 0.0 0.3 0.9 0.1 0.0 0.0 1.8 0.0 0.1 0.8 0.0 1.9 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 2.5 3.2 1.0 2.2 0.9 0.3 0.1 1.0 0.1 0.0 RAB37 ENSG00000172794 "RAB37, member RAS oncogene family" Q96AX2 17 74670578-74747335 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.7;brain: 19.6;lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" "dendritic cells: 33.4;Excitatory neurons: 33.2;granulocytes: 50.7;Inhibitory neurons: 29.6;NK-cells: 87.6;T-cells: 31.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 269.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 269.7" "Cell line enhanced" "Detected in some" "HEL: 50.6;HMC-1: 58.7;OE19: 25.4;U-266/70: 84.9;U-937: 34.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.10e-2)" "unprognostic (7.04e-4)" "unprognostic (5.95e-2)" "unprognostic (9.80e-4)" "unprognostic (3.49e-1)" "unprognostic (7.04e-5)" "unprognostic (1.74e-1)" "unprognostic (1.48e-2)" "unprognostic (7.62e-3)" "unprognostic (9.47e-3)" "unprognostic (3.05e-2)" "unprognostic (2.02e-2)" "prognostic unfavorable (8.80e-6)" "unprognostic (7.30e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (7.80e-2)" "unprognostic (4.01e-2)" 1.4 1.9 1.5 10.6 2.2 24.7 1.0 19.6 10.3 1.8 0.0 5.4 5.2 1.3 1.8 2.0 1.6 4.8 1.4 1.7 2.3 1.0 12.3 6.8 19.4 10.2 5.7 1.0 0.5 0.7 1.7 0.6 1.8 11.3 3.9 5.2 3.3 2.3 0.9 0.6 0.8 8.4 1.9 0.6 17.2 6.8 0.8 12.3 21.5 0.6 2.7 15.0 4.2 1.9 11.1 0.0 7.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 50.6 0.2 0.3 0.1 3.9 58.7 0.5 0.0 0.0 0.0 0.0 0.0 7.3 0.0 18.3 0.0 0.2 15.3 13.0 0.0 25.4 0.0 2.8 0.0 0.0 0.1 0.0 0.8 0.0 0.0 3.6 0.0 2.9 0.2 11.4 0.0 0.0 0.3 0.0 0.0 84.9 3.6 1.1 0.1 34.3 0.0 269.7 13.6 201.5 51.1 28.9 12.9 12.3 22.4 37.8 7.3 12.2 12.5 28.3 63.2 54.0 50.3 1.4 42.8 48.9 1.5 2.2 19.6 10.3 1.7 2.3 10.2 5.7 1.0 11.3 0.6 12.3 11.1 0.9 3.2 3.2 1.6 23.1 0.1 0.2 0.3 0.0 7.6 0.8 0.4 1.8 5.7 1.8 0.0 6.2 0.1 33.4 1.3 0.0 1.3 0.0 0.1 0.1 0.9 5.4 16.0 33.2 0.9 0.1 2.0 8.2 0.5 50.7 0.0 2.2 12.6 0.6 3.3 29.6 7.7 14.2 2.2 0.0 0.4 0.6 18.5 0.0 1.9 11.8 1.3 87.6 2.0 1.6 0.4 2.8 1.2 6.3 0.1 0.2 1.5 2.3 1.0 6.6 3.0 1.1 0.0 1.5 0.3 0.1 0.0 31.0 0.5 0.5 0.3 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113022195 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: AB_2683500" "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavorable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 4.7 4.1 5.0 8.2 6.2 14.2 7.0 10.0 5.8 6.0 6.5 3.7 3.7 4.3 3.5 4.1 4.7 3.5 3.3 5.7 6.3 4.6 4.7 6.9 12.7 5.4 5.2 4.6 6.8 3.3 3.1 3.7 12.2 6.0 4.4 4.1 7.5 5.3 3.5 4.9 5.8 5.2 3.3 4.5 10.3 4.0 3.9 7.9 18.1 3.7 4.0 12.4 4.4 5.2 5.5 6.4 5.6 24.1 19.0 4.5 5.3 37.0 6.7 4.3 7.2 9.8 25.0 13.1 32.2 8.5 3.2 5.6 7.9 27.6 7.1 8.8 9.0 11.0 29.5 4.6 9.9 5.4 20.1 15.3 4.8 5.3 8.4 9.0 6.9 12.5 24.8 22.7 12.0 6.1 8.1 29.6 19.6 20.8 4.0 2.9 27.0 22.7 12.2 10.5 15.4 5.6 11.4 8.3 8.8 11.3 24.1 25.3 24.4 7.7 7.8 13.9 4.4 8.8 8.8 19.8 23.6 4.7 26.0 6.3 14.0 4.9 3.7 3.0 6.1 4.2 3.8 3.7 3.0 5.1 2.5 3.4 3.7 9.4 3.5 7.3 2.9 4.3 2.6 5.0 6.2 10.0 5.8 5.7 6.3 5.4 5.2 4.6 6.0 4.5 7.9 5.5 30.0 19.2 16.8 16.0 50.7 27.8 19.9 22.3 31.9 24.7 43.5 26.4 12.4 8.6 24.1 20.2 79.2 66.7 65.0 11.6 19.6 11.2 24.3 21.7 38.1 28.9 16.2 41.9 25.5 11.8 49.6 25.7 17.3 25.7 19.6 66.7 28.5 7.0 31.7 28.6 34.1 8.9 20.3 78.1 41.5 53.8 19.0 57.4 26.6 56.2 90.7 36.9 35.0 26.7 28.8 17.3 10.6 10.9 27.1 33.3 13.8 14.4 22.7 34.6 6.6 16.5 32.3 36.6 29.5 20.0 26.6 64.4 50.1 52.0 13.1 48.8 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833834-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 38.1;choroid plexus: 14.2" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Early spermatids: 11.3;Excitatory neurons: 48.4;Inhibitory neurons: 34.2;Late spermatids: 12.3;Oligodendrocyte precursor cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.5;HSkMC: 5.8;REH: 1.9;SH-SY5Y: 2.3;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.2 0.1 21.4 0.1 23.0 0.3 0.3 15.8 38.1 0.6 14.2 0.8 1.0 0.7 0.2 0.1 0.7 0.8 0.2 22.8 18.0 0.2 0.0 0.1 0.1 18.5 17.1 23.3 0.7 0.1 0.2 0.4 0.0 18.6 0.2 0.4 1.1 0.0 0.1 0.0 0.3 0.5 0.5 15.3 0.2 0.2 2.2 17.5 0.4 0.1 0.2 0.2 0.4 0.2 22.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.5 5.8 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.0 1.9 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 7.0 1.2 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.3 0.2 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 21.4 23.0 15.8 38.1 22.8 18.0 18.5 17.1 23.3 18.6 15.3 17.5 22.2 0.3 0.0 0.6 25.5 0.6 0.4 0.3 0.0 1.2 2.4 0.7 1.0 0.8 0.0 0.6 0.0 0.0 0.1 0.1 0.6 0.0 0.1 11.3 0.3 3.6 0.6 0.0 0.8 48.4 0.0 0.4 0.9 1.1 0.5 3.8 2.8 0.4 0.0 0.3 0.0 34.2 0.8 0.0 0.3 0.3 12.3 0.3 0.2 1.8 3.7 0.0 0.9 1.0 12.1 10.2 0.2 0.5 1.2 0.5 0.2 3.9 0.4 0.7 0.6 0.0 1.0 0.8 6.1 1.7 0.5 0.4 0.0 0.7 1.3 1.7 0.1 RPL38 L38 ENSG00000172809 "Ribosomal protein L38" P63173 17 74203582-74210655 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052543 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 180000 "Endoplasmic reticulum, Cytosol" "HPA052543: AB_2681864" "unprognostic (1.68e-3)" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.99e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (7.71e-3)" "unprognostic (4.95e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.17e-8)" "unprognostic (1.89e-1)" "unprognostic (6.00e-2)" "unprognostic (1.18e-1)" "unprognostic (3.39e-2)" 1516.2 1184.0 1453.7 829.7 1459.1 1462.0 1581.8 1425.4 1862.9 1803.6 1396.7 1385.8 654.4 1267.3 852.3 1508.0 1447.5 273.8 1410.6 1407.8 1494.5 1121.0 1118.5 1075.0 1019.3 1476.0 1441.1 1375.4 3189.6 2008.8 761.0 948.9 550.6 1499.5 1278.3 666.4 383.0 1199.7 538.6 2871.4 1917.3 1255.3 540.3 1527.7 1431.2 1242.0 790.9 1494.6 1465.8 1092.8 1917.1 1207.4 1384.9 1582.9 1565.3 1720.7 1654.5 1568.1 1609.4 2096.5 2459.6 1552.1 1818.4 1160.9 1622.8 1130.0 1870.1 1274.6 3002.4 1237.3 1565.8 1504.9 1512.7 1888.2 2361.4 1266.0 844.7 3028.3 1724.1 1374.6 2467.9 2443.9 3251.8 1474.0 4777.2 3230.5 1527.0 2469.4 2179.8 2416.1 2387.7 2155.9 1622.2 1375.7 1793.0 3170.7 3903.4 1837.0 3823.2 2488.8 2259.2 3321.0 2695.8 1971.0 1317.5 1415.6 2630.5 757.0 3129.9 4282.5 1942.0 2389.2 3316.1 1592.2 1347.1 2210.4 1254.4 2416.6 2187.4 3677.2 3159.9 1104.9 2101.7 1314.4 1192.1 1841.8 676.2 1819.2 1524.9 2176.5 2904.1 3073.8 2304.5 2001.8 2772.2 3429.7 3037.1 575.3 1491.2 1383.9 2455.1 2101.1 4458.5 1453.7 1459.1 1425.4 1862.9 1407.8 1494.5 1476.0 1441.1 1375.4 1499.5 1527.7 1494.6 1565.3 863.9 451.9 901.6 12.7 2204.9 2331.7 1278.1 1084.7 961.2 186.6 2059.8 1364.6 753.8 1509.9 820.1 614.3 73.0 1330.3 1639.9 1230.1 1441.9 1518.1 1413.7 1051.3 1657.7 1158.2 1469.3 1411.7 9.9 2875.9 2467.6 981.1 490.8 1223.8 1223.7 933.3 2189.2 2371.8 1800.6 87.5 9.1 3044.0 413.0 2925.5 2553.8 3689.8 3016.5 1394.9 1213.1 7.5 2817.4 751.3 2063.9 7.1 15.2 2380.8 2171.4 1509.4 769.1 1476.4 2127.6 2377.0 565.8 266.1 959.8 1959.8 1054.6 956.0 1132.1 1084.0 2690.5 1450.3 1884.0 684.7 2643.7 1293.5 CYP7B1 SPG5A ENSG00000172817 "Cytochrome P450 family 7 subfamily B member 1" O75881 8 64587763-64798737 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease variant, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5" "Cell type enhanced" "Detected in many" "Astrocytes: 93.7;Oligodendrocyte precursor cells: 94.5;Oligodendrocytes: 119.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 2.5;eosinophil: 1.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Group enriched" "Detected in some" 4 "HSkMC: 16.5;SH-SY5Y: 5.5;WM-115: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017761 Uncertain NA NA "HPA017761: AB_1847455" "unprognostic (3.19e-2)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (6.89e-3)" "unprognostic (1.07e-1)" "unprognostic (5.80e-3)" "unprognostic (3.80e-1)" "unprognostic (5.50e-2)" "unprognostic (6.11e-3)" "unprognostic (2.46e-1)" "unprognostic (1.61e-1)" "unprognostic (3.19e-2)" "unprognostic (1.87e-2)" "unprognostic (2.38e-3)" "unprognostic (4.00e-1)" "unprognostic (3.04e-3)" "unprognostic (6.75e-3)" 8.5 5.4 5.4 5.7 11.3 0.3 6.3 8.2 7.1 5.8 7.8 2.4 1.8 2.9 2.0 7.3 2.7 5.8 3.6 5.2 9.8 8.0 21.7 4.6 2.4 10.6 8.9 2.9 4.2 6.7 11.5 0.8 0.5 10.8 4.5 3.5 1.9 4.7 5.6 0.2 5.9 1.9 4.4 8.0 9.3 2.4 1.8 8.7 2.1 12.3 1.7 2.9 7.9 3.0 27.5 1.5 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 5.5 0.0 0.0 2.2 0.8 0.0 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 2.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 11.3 8.2 7.1 5.2 9.8 10.6 8.9 2.9 10.8 8.0 8.7 27.5 3.3 0.0 3.4 93.7 0.1 10.6 6.6 1.0 7.4 4.9 4.2 5.5 3.0 2.8 0.9 7.3 2.1 0.1 0.4 0.0 3.9 4.4 7.4 0.2 6.9 2.1 1.8 1.3 29.3 4.9 0.2 15.9 0.5 0.1 12.7 0.6 2.5 8.2 0.2 3.3 30.6 0.5 0.0 0.3 4.9 8.6 5.9 0.5 17.8 30.0 1.0 6.9 0.0 94.5 119.2 1.2 0.0 4.9 0.0 4.2 0.0 2.9 0.8 0.5 13.1 1.1 16.8 4.1 3.4 6.2 12.6 0.0 1.3 7.6 0.0 3.1 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787063-65797214 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 57.6;skin 1: 47.1;testis: 35.8" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.1 0.0 0.0 1.1 0.1 0.1 2.8 0.1 0.1 6.5 0.0 10.4 15.7 0.5 0.1 57.6 0.6 0.9 0.0 0.0 0.0 5.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 9.2 15.1 0.1 6.9 0.0 1.4 8.4 0.1 8.9 1.0 0.1 47.1 9.2 0.3 0.0 0.1 1.7 35.8 0.1 0.4 1.4 0.0 5.5 27.7 21.4 0.1 19.0 0.0 0.0 0.0 0.0 0.0 52.2 0.0 0.0 0.0 0.0 13.6 5.0 0.0 0.1 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 9.7 0.1 0.3 0.0 0.1 1.4 31.2 0.2 0.1 0.0 24.0 0.2 5.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 3.3 0.3 2.3 26.6 62.6 14.5 54.1 0.0 59.4 25.4 0.5 7.2 13.0 3.7 0.0 19.5 1.3 57.6 0.0 2.5 81.9 76.2 11.7 1.8 31.6 0.0 0.1 3.8 14.0 0.9 0.0 113.2 2.5 0.0 0.0 0.1 2.1 0.0 0.1 54.9 20.3 0.0 1.4 87.2 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 44.5 1.9 3.0 34.1 39.1 6.7 11.3 0.0 0.0 0.0 1.1 83.9 4.8 130.8 57.4 348.9 1.7 0.0 52.0 114.9 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 142.8;skin 1: 122.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.8" "Group enriched" "Detected in all" 4 "dendritic cells: 6.7;T-cells: 18.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 101.0;MCF7: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 15.7 16.3 9.2 5.8 8.8 3.7 19.6 12.4 11.0 48.0 9.7 19.1 2.5 23.5 6.1 142.8 27.4 15.8 16.4 8.7 9.6 11.3 3.2 15.3 5.9 10.0 8.6 7.7 20.7 8.5 7.2 8.8 9.5 9.3 27.1 7.9 4.0 30.8 16.3 6.9 122.3 10.4 13.1 9.1 10.3 14.6 4.9 9.2 5.1 22.8 10.7 22.7 26.4 69.9 9.4 22.8 24.7 5.5 50.9 55.0 46.8 1.7 23.2 50.0 29.7 23.3 8.3 101.0 0.5 12.5 93.6 16.2 74.3 18.4 44.6 7.4 5.7 9.4 3.3 18.6 7.4 23.2 0.0 9.1 34.8 63.9 28.5 6.4 74.7 12.7 4.6 0.8 9.8 11.9 110.3 1.3 1.1 16.3 30.4 42.7 7.3 1.9 18.1 8.9 37.1 4.4 22.9 47.0 50.6 32.1 6.8 43.9 1.4 13.8 35.4 16.5 23.6 1.5 4.2 2.6 1.8 43.4 3.8 51.3 1.8 3.1 0.9 7.4 0.9 18.8 2.0 6.5 5.4 6.7 0.6 5.2 4.7 0.0 2.3 0.0 0.6 1.8 4.0 9.2 8.8 12.4 11.0 8.7 9.6 10.0 8.6 7.7 9.3 9.1 9.2 9.4 10.7 3.2 7.0 21.2 2.5 34.2 24.1 21.6 42.7 0.5 18.0 15.6 3.7 11.5 11.1 3.7 2.1 7.5 6.2 3.2 0.0 10.5 0.1 3.6 14.4 11.0 1.8 0.8 2.5 5.1 1.2 19.6 13.7 3.4 1.3 0.3 20.3 0.1 2.7 0.0 3.0 2.1 12.2 4.1 13.3 0.5 5.3 4.9 8.8 6.5 1.8 3.6 5.2 7.1 0.7 14.3 4.4 5.3 3.0 19.2 0.2 0.5 3.9 5.2 6.6 9.5 22.0 0.8 5.6 69.9 55.8 1.8 7.2 0.4 5.5 45.7 CES4A "CES8, FLJ37464" ENSG00000172824 "Carboxylesterase 4A" Q5XG92 16 66988589-67009758 "Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.1;skin 1: 13.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 44.4;Excitatory neurons: 53.6;Oligodendrocytes: 37.6;Respiratory ciliated cells: 47.1" "Cancer enhanced" "Detected in many" "renal cancer: 5.3" "Region enhanced" "Detected in many" "white matter: 10.1" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 19.1;HMC-1: 5.2;PC-3: 4.5;SiHa: 7.8;SK-BR-3: 5.7;U-266/70: 5.9" "Not detected" "Not detected" HPA035701 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA035701: AB_10696357" "unprognostic (6.34e-2)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-1)" "unprognostic (6.20e-2)" "unprognostic (2.12e-2)" "unprognostic (2.04e-2)" "unprognostic (5.78e-3)" "unprognostic (3.93e-2)" "unprognostic (2.02e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-3)" 2.3 1.5 0.6 0.9 1.6 1.2 2.5 0.0 2.4 1.0 0.0 0.6 0.8 0.5 3.9 1.1 17.1 0.8 2.5 2.1 1.0 2.5 8.5 1.5 0.7 1.7 1.2 2.1 1.0 1.1 3.1 3.6 1.0 2.7 0.9 0.7 0.8 4.4 2.1 4.9 13.7 0.8 0.3 0.0 0.5 1.4 0.8 0.8 0.7 2.8 0.2 0.9 1.2 0.7 10.1 0.2 1.5 0.1 0.0 0.9 0.8 0.0 0.4 0.7 0.1 0.0 0.0 2.3 0.0 0.0 1.5 0.0 0.7 0.0 0.2 0.0 19.1 0.0 0.0 1.2 0.0 0.1 0.0 5.2 1.8 3.5 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 4.5 0.2 0.0 1.1 0.0 0.3 1.4 0.9 7.8 5.7 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 5.9 2.2 0.0 1.4 0.0 0.0 0.0 1.4 0.0 0.5 2.5 0.5 0.6 1.0 0.5 0.8 0.0 0.9 0.2 0.0 0.0 3.5 1.2 0.3 0.7 0.6 1.6 0.0 2.4 2.1 1.0 1.7 1.2 2.1 2.7 0.0 0.8 10.1 0.4 0.0 11.4 2.0 3.5 5.4 5.7 5.0 3.4 23.1 44.4 7.7 2.8 4.3 7.3 5.5 14.6 4.7 3.9 4.1 1.9 0.9 1.7 9.9 1.4 1.0 9.0 0.0 53.6 1.6 0.9 3.9 3.1 11.1 9.5 4.9 1.1 22.1 5.6 0.0 29.7 1.8 4.1 4.1 2.1 1.2 13.7 3.2 0.0 4.7 5.7 8.3 4.1 6.6 37.6 0.9 9.7 12.8 1.3 3.5 5.8 1.5 47.1 15.3 0.0 1.5 1.8 32.1 11.8 4.1 5.3 4.5 3.3 13.5 3.5 7.5 CES3 "ES31, FLJ21736" ENSG00000172828 "Carboxylesterase 3" Q6UWW8 16 66961245-66975149 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.9;liver: 52.9;skeletal muscle: 24.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041008, HPA041307" Approved Approved "Nuclear membrane,Endoplasmic reticulum" "Intracellular and membrane" NA NA 1200000 "Nuclear membrane, Endoplasmic reticulum" "HPA041008: AB_2677247, HPA041307: AB_2677400" "unprognostic (3.91e-3)" "unprognostic (1.22e-1)" "unprognostic (1.94e-2)" "unprognostic (8.99e-3)" "unprognostic (9.32e-2)" "unprognostic (7.84e-4)" "prognostic favorable (7.26e-5)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.43e-2)" "unprognostic (1.84e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-2)" 0.6 0.5 3.0 3.2 2.8 0.9 2.3 2.6 3.3 1.3 1.2 36.9 30.3 0.7 0.2 4.2 2.9 0.9 0.6 3.8 2.1 12.3 52.9 0.7 0.3 3.3 2.3 2.8 0.6 4.1 1.0 1.9 0.6 3.6 0.5 31.6 0.6 12.1 0.3 24.9 1.3 23.9 1.2 1.4 0.4 7.8 1.1 2.1 0.2 0.4 1.5 0.2 0.1 0.8 2.6 0.4 3.1 0.3 7.4 0.2 0.2 1.2 0.2 0.2 0.3 0.5 0.5 3.8 8.5 2.4 0.0 0.2 0.6 1.1 0.5 0.1 1.5 5.5 4.3 1.3 2.6 0.0 0.9 0.7 0.3 0.9 0.8 0.1 0.2 0.0 13.5 2.8 1.7 0.3 1.1 1.4 1.4 1.5 2.6 0.4 1.3 0.7 1.3 0.1 0.4 0.4 0.8 0.2 5.8 0.2 0.6 5.0 6.5 0.3 0.4 2.4 0.7 0.2 0.9 3.6 1.3 0.3 7.2 0.2 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 3.0 2.8 2.6 3.3 3.8 2.1 3.3 2.3 2.8 3.6 1.4 2.1 2.6 0.1 3.2 6.7 0.7 0.4 0.5 0.0 1.3 1.2 0.2 9.1 5.7 1.4 2.8 0.9 0.0 0.0 0.0 0.0 120.1 0.0 0.2 0.5 3.2 0.3 0.2 19.7 0.0 1.8 0.9 0.0 0.2 11.7 4.4 1.3 58.5 0.4 53.4 0.3 0.0 2.9 32.0 0.0 3.2 0.9 5.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 1.5 0.1 1.0 67.0 1.2 0.1 0.1 66.0 9.9 4.8 0.2 0.0 0.6 0.2 2.3 2.9 1.1 0.3 0.0 0.4 0.1 44.3 0.2 SSH3 "FLJ10928, FLJ20515" ENSG00000172830 "Slingshot protein phosphatase 3" Q8TE77 11 67303478-67312607 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 11.6;eosinophil: 11.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.6" "Cell line enhanced" "Detected in many" "HaCaT: 64.9;MCF7: 64.1;RT4: 111.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019949, HPA019957" Approved Approved "Nuclear speckles,Plasma membrane,Actin filaments,Cytosol" NA NA "Nuclear speckles, Cytosol" "Plasma membrane, Actin filaments" "HPA019949: AB_1857498, HPA019957: AB_1857499" "unprognostic (4.38e-2)" "unprognostic (1.37e-1)" "unprognostic (3.50e-3)" "unprognostic (3.73e-2)" "unprognostic (2.61e-3)" "unprognostic (9.30e-2)" "unprognostic (2.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.89e-4)" "unprognostic (1.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (6.78e-3)" 13.1 7.8 8.5 4.1 10.9 9.4 16.3 12.9 11.7 22.5 8.9 17.8 13.4 16.1 7.6 42.2 18.5 11.6 11.2 8.1 9.5 13.2 11.0 12.9 3.1 13.8 11.1 7.3 23.7 15.4 9.8 9.8 6.5 12.5 30.2 9.4 1.2 26.5 29.0 6.9 25.3 15.1 6.2 12.3 9.5 20.2 2.3 10.2 1.9 16.4 3.9 4.8 37.7 32.8 14.3 17.3 18.7 0.4 0.6 11.4 11.8 18.8 10.3 13.7 5.6 5.1 21.2 46.8 1.0 32.5 10.5 11.9 64.9 6.0 46.4 2.8 3.6 6.3 4.3 32.2 9.9 8.2 0.9 16.0 12.2 40.5 8.3 8.3 12.9 6.3 0.4 0.1 1.5 6.2 64.1 0.8 7.3 4.2 48.9 13.8 20.6 0.6 3.1 18.2 111.2 3.7 5.8 24.8 41.0 12.8 6.3 57.1 15.3 10.4 4.5 9.8 12.7 2.7 1.5 0.9 0.5 12.7 6.9 4.9 11.6 1.5 11.1 2.0 2.3 1.7 0.2 1.9 1.7 1.7 0.1 0.8 0.8 4.4 1.5 1.1 1.1 1.8 1.1 8.5 10.9 12.9 11.7 8.1 9.5 13.8 11.1 7.3 12.5 12.3 10.2 14.3 7.6 3.2 8.7 8.5 0.9 7.0 20.8 25.2 11.4 0.8 21.3 17.3 3.8 20.0 23.4 16.5 0.0 15.1 3.3 28.3 3.9 19.4 0.1 8.3 5.6 4.7 3.6 5.2 4.2 21.6 24.9 8.0 20.9 17.8 3.8 8.1 3.9 5.0 7.7 1.7 5.3 14.4 24.4 6.2 3.1 0.6 13.1 4.8 8.8 2.8 9.2 4.8 7.2 0.0 15.9 20.0 21.0 12.0 0.7 15.4 20.2 7.4 11.6 0.5 0.0 4.9 9.2 0.5 0.4 27.0 10.4 15.7 4.4 5.3 21.4 26.8 CES2 "CE-2, CES2A1, iCE" ENSG00000172831 "Carboxylesterase 2" O00748 16 66934444-66945096 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 709.6;liver: 348.6" "Cell type enhanced" "Detected in all" "Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5" "Cancer enhanced" "Detected in all" "liver cancer: 104.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA018897, HPA074629" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 6400000 "Golgi apparatus" "Endoplasmic reticulum, Cytosol" "HPA018897: AB_1846558, HPA074629: " "unprognostic (8.15e-3)" "unprognostic (1.82e-2)" "unprognostic (1.32e-1)" "unprognostic (2.67e-3)" "unprognostic (2.74e-2)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (1.31e-1)" "unprognostic (6.93e-2)" "unprognostic (7.99e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-2)" "prognostic favorable (1.50e-5)" "unprognostic (8.01e-2)" "unprognostic (1.53e-1)" "unprognostic (4.14e-2)" "unprognostic (1.38e-1)" 18.9 38.4 21.2 18.2 20.5 6.3 13.6 23.8 23.1 17.5 24.2 193.0 709.6 14.8 14.5 133.8 18.1 19.7 37.2 22.4 20.8 97.3 348.6 15.7 12.0 22.2 21.2 19.6 17.1 14.5 38.3 15.8 10.2 21.9 16.8 180.5 16.3 33.1 15.1 34.0 32.9 581.3 19.9 19.8 12.5 42.0 9.3 20.9 13.2 28.1 14.5 21.0 13.9 33.8 21.6 11.6 16.6 18.4 25.9 19.5 17.9 14.5 15.9 25.8 17.6 22.1 17.3 23.5 15.7 14.3 20.9 13.3 35.4 14.2 39.8 15.3 10.7 18.9 14.4 9.6 44.2 26.3 21.6 26.3 25.4 82.5 26.0 46.7 24.6 14.1 11.3 22.2 10.9 35.7 9.1 17.7 21.4 10.8 16.3 18.8 20.9 19.1 19.8 60.7 18.6 11.6 16.0 50.9 12.6 14.5 8.1 21.0 26.5 17.5 22.4 12.6 15.3 11.1 23.3 24.0 18.4 36.7 17.3 17.4 4.1 5.4 1.6 5.1 3.8 4.5 3.0 4.1 5.8 4.5 3.1 4.8 4.5 1.6 4.3 4.1 4.3 3.2 3.1 21.2 20.5 23.8 23.1 22.4 20.8 22.2 21.2 19.6 21.9 19.8 20.9 21.6 13.2 32.1 24.6 8.8 18.8 19.5 13.5 32.8 39.3 31.2 12.4 18.3 33.6 115.8 19.8 53.3 20.9 16.1 12.9 794.4 37.2 24.6 2.1 26.9 15.0 14.1 24.1 7.8 7.0 33.8 5.7 15.3 60.6 33.7 27.3 80.7 28.5 518.5 19.6 28.6 9.7 196.0 18.3 37.0 9.6 2.3 18.6 15.3 10.6 10.3 19.5 19.0 21.6 8.0 5.9 51.8 519.2 18.0 8.5 19.1 2529.8 176.0 85.4 24.2 32.9 19.5 15.2 47.2 19.7 116.1 20.5 13.5 13.0 22.1 499.5 16.7 PDP2 "KIAA1348, PPM2B, PPM2C2" ENSG00000172840 "Pyruvate dehyrogenase phosphatase catalytic subunit 2" Q9P2J9 16 66878589-66895754 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019950, HPA062059" Approved Approved Mitochondria NA NA Mitochondria "HPA019950: AB_1855156, HPA062059: AB_2684671" "unprognostic (8.42e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.31e-2)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (4.90e-3)" "unprognostic (1.57e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" "unprognostic (1.39e-1)" "prognostic favorable (9.75e-7)" "unprognostic (1.89e-1)" "unprognostic (5.10e-1)" "unprognostic (3.20e-1)" "unprognostic (6.15e-2)" 6.1 2.6 3.6 1.8 4.1 1.5 3.7 6.8 5.2 2.0 6.4 3.9 5.5 2.7 3.4 3.7 3.4 2.0 1.8 3.7 3.9 9.3 8.6 3.4 2.6 5.9 4.5 3.6 7.5 4.5 6.1 3.0 4.0 6.8 3.8 4.1 5.0 3.6 2.7 2.6 2.1 3.3 2.1 3.5 2.0 3.0 3.8 5.9 2.5 9.4 4.1 3.0 2.1 2.2 5.9 9.8 11.7 7.1 14.1 18.7 9.6 8.9 5.0 19.2 11.3 17.0 23.9 6.7 13.5 6.9 6.9 10.8 12.1 20.8 11.3 10.9 3.2 10.5 6.8 5.9 15.9 10.1 8.8 11.5 7.4 8.3 16.1 16.6 12.3 4.9 14.9 13.3 9.5 10.3 6.3 17.1 6.2 8.4 6.5 14.7 16.7 9.9 21.4 6.0 10.3 14.3 8.0 15.9 6.5 6.0 5.5 8.7 4.3 4.6 7.0 9.2 4.2 7.5 16.6 16.9 13.4 9.5 6.9 7.0 1.1 0.2 1.2 3.8 0.1 3.1 1.0 1.8 3.2 0.8 2.1 2.6 3.0 0.7 4.2 0.1 0.5 0.6 1.3 3.6 4.1 6.8 5.2 3.7 3.9 5.9 4.5 3.6 6.8 3.5 5.9 5.9 2.5 9.6 22.9 8.1 3.1 5.2 6.4 1.3 6.2 9.6 5.8 4.2 5.1 8.6 3.1 9.2 14.6 12.8 3.3 13.3 7.9 3.4 0.2 3.5 3.2 3.3 3.6 0.8 8.8 2.9 2.2 4.1 3.1 4.3 6.3 14.4 7.1 20.5 2.4 5.0 7.6 4.2 2.0 1.3 0.4 2.4 3.1 1.2 3.6 3.7 0.4 8.1 7.2 4.5 4.3 3.4 6.6 4.5 4.5 8.9 7.4 9.9 1.2 6.7 0.0 5.9 2.7 12.6 5.7 8.0 2.4 3.6 3.4 4.0 5.5 6.5 SP3 SPR-2 ENSG00000172845 "Sp3 transcription factor" Q02447 2 173880850-173965702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004580, HPA032145, HPA032146" Supported Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (2.39e-3)" "unprognostic (2.50e-1)" "unprognostic (4.92e-2)" "unprognostic (5.54e-3)" "unprognostic (6.36e-2)" "unprognostic (2.76e-3)" "unprognostic (3.27e-1)" "unprognostic (5.01e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.46e-5)" "unprognostic (2.78e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.69e-1)" 30.1 20.0 17.0 35.5 17.1 53.6 43.6 22.7 20.0 51.4 17.9 34.6 27.1 45.5 34.9 32.4 37.4 29.2 24.0 15.4 19.9 29.9 40.4 30.2 46.5 18.0 17.4 14.3 40.6 25.1 43.4 13.3 49.5 17.2 32.2 39.2 21.1 26.3 30.7 22.7 38.8 29.9 36.6 18.0 38.9 27.2 25.5 16.5 68.6 47.9 34.0 54.2 34.1 28.2 19.8 41.6 34.5 74.6 45.8 91.8 82.3 83.5 47.5 67.1 62.2 66.1 56.8 59.7 65.1 39.3 65.0 46.3 41.0 57.8 46.0 91.7 55.2 21.2 65.9 33.9 54.0 45.5 60.4 48.9 60.6 53.2 72.9 63.6 48.4 49.4 51.3 51.4 86.8 65.7 44.4 84.0 49.9 66.1 60.1 37.8 74.2 68.5 53.0 48.4 55.8 67.8 48.1 67.1 38.1 52.4 81.7 30.0 80.0 44.1 70.6 61.8 47.5 50.4 58.8 46.7 85.8 53.0 41.6 67.2 8.9 9.4 13.0 11.6 7.0 12.9 9.5 12.3 12.3 9.9 7.4 13.8 12.8 27.3 21.9 10.3 6.2 13.8 9.9 17.0 17.1 22.7 20.0 15.4 19.9 18.0 17.4 14.3 17.2 18.0 16.5 19.8 36.1 19.2 22.9 44.7 55.2 57.6 31.7 25.7 64.9 29.1 36.8 23.4 18.8 14.3 23.3 20.2 27.1 30.9 67.9 37.9 11.7 18.6 4.3 22.3 57.8 33.9 30.5 31.7 52.7 19.3 42.7 43.9 17.9 29.5 23.5 31.3 32.2 43.8 24.6 23.5 50.7 28.8 20.3 54.1 72.8 7.1 45.4 55.6 42.7 81.5 39.0 30.5 46.4 60.3 74.7 30.8 22.9 36.9 63.7 34.2 22.1 24.4 26.6 20.2 19.7 40.4 53.4 10.5 20.4 48.6 57.0 34.6 50.8 26.0 29.0 59.0 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652211 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 39 "skin 1: 3251.0" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 265.4" "Cancer enriched" "Detected in some" 5 "melanoma: 23.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "HEL: 2.0" "Group enriched" "Detected in some" 6 "amygdala: 1.7;hippocampal formation: 2.7" "Not detected" "Not detected" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" NA NA 9700000000 "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 2.1 0.5 0.0 0.1 0.0 1.0 82.9 0.0 0.0 0.8 0.0 0.7 1.6 0.4 0.3 1.1 0.1 0.0 1.5 0.0 0.0 0.5 1.2 1.0 0.5 0.0 0.0 0.0 0.5 1.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 1.6 0.0 48.3 3251.0 0.8 0.0 0.0 0.5 0.7 1.0 0.0 6.9 0.8 0.0 6.1 0.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 9.5 0.0 0.0 0.1 8.8 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 265.4 0.1 1.0 0.0 0.6 0.1 DMXL1 ENSG00000172869 "Dmx like 1" Q9Y485 5 119037772-119249138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.3;Inhibitory neurons: 147.3;Oligodendrocytes: 224.0" "Cancer enhanced" "Detected in all" "prostate cancer: 14.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036431, HPA036432" Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA036431: AB_10669791, HPA036432: AB_2675120" "unprognostic (2.47e-1)" "unprognostic (4.84e-2)" "unprognostic (7.87e-3)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-1)" "unprognostic (6.77e-2)" "unprognostic (1.40e-1)" "unprognostic (4.88e-2)" "unprognostic (5.93e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.16e-5)" "unprognostic (4.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-2)" "unprognostic (5.18e-2)" 7.0 4.8 2.3 7.3 5.8 26.1 9.3 7.2 5.9 7.5 10.2 6.9 6.2 8.8 5.7 8.3 6.7 7.6 6.2 2.6 4.3 14.0 7.2 6.6 10.2 6.6 5.2 2.3 10.5 12.1 11.9 2.6 7.2 7.3 27.4 7.1 9.1 8.0 5.9 4.1 8.3 6.1 8.2 5.7 8.2 8.0 5.9 4.7 10.4 13.5 7.3 9.8 6.2 4.6 14.8 10.4 8.0 8.8 9.0 9.3 12.2 9.4 8.4 8.4 8.3 9.6 9.6 6.2 20.2 8.5 10.8 12.9 6.1 9.9 10.0 10.7 15.6 9.9 14.2 14.0 3.4 7.8 9.4 11.8 9.8 5.5 9.6 7.9 8.5 11.0 12.4 12.1 13.3 6.7 6.5 12.6 5.3 4.8 3.6 4.7 9.8 16.3 7.9 6.4 11.9 8.2 8.3 14.5 5.2 12.6 9.4 8.6 10.7 10.7 9.8 8.2 9.9 9.0 12.4 9.4 17.6 12.2 9.1 8.0 4.1 4.9 3.6 2.4 4.4 3.0 8.8 1.9 2.0 3.4 9.1 3.0 1.8 3.8 1.3 8.9 8.3 2.6 2.7 2.3 5.8 7.2 5.9 2.6 4.3 6.6 5.2 2.3 7.3 5.7 4.7 14.8 23.7 28.9 20.1 93.4 56.5 13.6 16.5 17.7 22.8 36.8 22.8 15.4 25.7 7.2 17.6 16.5 25.0 12.6 27.5 16.2 17.6 12.0 10.2 19.8 21.1 16.7 6.0 19.1 122.3 20.1 10.3 20.4 27.5 25.0 14.0 15.6 11.0 15.6 16.6 21.9 147.3 12.2 10.2 21.9 19.9 12.1 15.2 31.0 33.8 68.4 29.1 16.9 25.7 111.6 224.0 14.1 11.6 15.4 27.2 36.0 15.8 32.5 13.9 22.6 13.1 28.6 24.7 28.0 23.2 35.0 18.8 16.3 24.3 17.8 11.3 15.0 METAP1D "MAP1D, Metap1l" ENSG00000172878 "Methionyl aminopeptidase type 1D, mitochondrial" Q6UB28 2 171999943-172082430 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.5;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030298, HPA030299, HPA077742" Uncertain Uncertain Vesicles NA NA Vesicles "HPA030298: AB_2673419, HPA030299: AB_10602421, HPA077742: " "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (5.83e-2)" "unprognostic (2.54e-2)" "unprognostic (7.90e-3)" "unprognostic (1.92e-3)" "unprognostic (1.07e-2)" "unprognostic (4.55e-1)" "unprognostic (7.07e-2)" "unprognostic (2.64e-2)" "unprognostic (8.19e-2)" "unprognostic (2.53e-3)" "unprognostic (3.44e-3)" "unprognostic (3.06e-2)" "unprognostic (5.48e-3)" "unprognostic (2.92e-2)" 4.0 5.0 4.1 2.4 4.4 3.5 4.0 3.6 5.0 5.3 3.6 4.5 2.3 4.6 2.8 3.5 6.7 2.0 4.4 4.0 4.3 3.6 6.0 2.3 2.9 4.2 4.1 4.0 12.0 8.2 2.2 4.4 1.8 4.5 5.7 3.2 2.5 4.2 3.7 7.9 3.4 4.1 2.8 3.7 5.9 4.7 2.8 4.1 1.2 3.6 5.7 2.1 4.2 3.8 4.9 3.6 2.8 4.1 13.5 5.9 7.7 8.3 4.1 4.1 6.4 4.1 6.4 4.7 1.8 7.2 4.3 6.6 6.4 9.1 7.2 6.5 6.3 10.6 10.2 7.8 8.6 6.2 6.1 2.6 5.8 10.9 6.4 10.2 5.5 3.6 6.9 14.8 5.1 4.9 4.4 3.5 8.2 7.4 10.4 3.4 7.7 3.5 3.3 4.5 5.0 8.4 3.2 2.9 5.8 10.2 3.6 6.7 8.1 4.4 8.1 6.4 5.0 4.0 6.3 6.1 4.0 5.8 11.9 7.9 0.0 0.0 0.0 0.4 0.4 0.2 0.3 0.5 0.2 0.1 0.7 0.5 1.1 0.0 0.4 0.0 0.0 0.4 0.2 4.1 4.4 3.6 5.0 4.0 4.3 4.2 4.1 4.0 4.5 3.7 4.1 4.9 6.1 0.0 4.6 23.8 15.4 5.6 10.3 7.5 22.8 5.8 9.2 8.9 4.5 7.2 3.5 3.7 2.1 4.1 2.7 1.3 7.9 2.5 1.2 2.7 14.7 5.4 0.0 16.8 19.6 3.5 4.7 10.9 8.2 2.5 4.5 17.9 6.4 6.4 3.9 5.0 39.5 2.9 2.0 2.5 2.2 2.3 33.5 2.2 5.4 14.0 1.0 3.7 9.2 35.7 35.5 1.4 1.3 26.4 9.9 4.3 0.6 5.7 2.0 6.1 13.1 18.1 9.5 9.8 12.2 11.6 5.7 1.9 7.5 14.5 5.7 5.1 ZNF621 FLJ45246 ENSG00000172888 "Zinc finger protein 621" Q6ZSS3 3 40524878-40574685 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065518, HPA071440" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA065518: AB_2685501, HPA071440: AB_2686395" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (9.50e-3)" "unprognostic (3.06e-2)" "unprognostic (3.14e-2)" "unprognostic (2.62e-1)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.19e-1)" "unprognostic (5.33e-2)" "unprognostic (8.76e-2)" "unprognostic (2.50e-2)" "unprognostic (2.01e-3)" 12.6 10.1 16.3 6.0 19.5 7.2 13.0 16.4 16.1 12.5 14.4 10.8 5.3 11.2 8.2 9.6 11.6 5.7 9.3 14.2 18.3 12.8 12.5 13.3 6.3 20.7 17.5 13.1 12.1 12.3 7.7 14.8 5.5 21.4 14.5 5.8 7.4 12.2 6.9 7.2 10.0 11.7 6.1 18.9 12.8 10.8 7.6 18.4 5.5 13.3 5.6 6.1 11.1 11.6 20.0 8.9 5.0 12.2 12.0 7.8 13.4 6.9 9.5 11.1 11.7 11.6 11.1 4.8 3.7 6.9 12.4 8.8 3.1 12.2 7.2 13.7 14.9 15.1 12.4 20.8 10.1 13.6 11.6 11.8 10.4 14.9 12.2 19.0 12.7 9.9 4.4 13.3 10.8 10.1 5.6 2.9 13.8 7.7 3.5 10.2 1.1 8.2 4.4 6.1 11.0 4.3 10.9 10.2 6.9 12.0 11.7 11.4 9.4 13.1 20.2 9.8 10.2 13.4 16.1 17.4 8.3 9.9 8.6 12.5 2.5 1.0 0.9 1.3 1.3 0.8 2.3 1.3 1.8 0.9 3.3 1.6 1.2 1.2 1.8 0.7 1.3 1.3 0.7 16.3 19.5 16.4 16.1 14.2 18.3 20.7 17.5 13.1 21.4 18.9 18.4 20.0 13.2 9.6 12.3 22.5 9.6 1.5 5.2 2.3 9.1 13.8 6.3 5.0 12.1 10.0 7.7 11.0 12.5 5.5 9.5 4.9 5.9 7.7 10.8 11.1 16.4 12.0 10.2 12.4 4.1 5.6 3.5 9.0 7.7 12.2 3.8 15.0 5.0 5.6 3.7 15.2 4.2 7.1 4.1 8.1 3.0 7.9 7.5 6.9 3.6 11.2 9.4 7.1 10.3 19.1 26.1 7.5 4.9 12.0 8.8 6.6 6.7 3.2 4.6 16.7 0.0 13.6 9.1 10.6 6.3 7.5 1.8 5.5 8.1 12.9 5.8 4.4 EGFL7 ZNEU1 ENSG00000172889 "EGF like domain multiple 7" Q9UHF1 9 136658856-136672678 "Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 806.1;Endothelial cells: 436.5;Hepatic stellate cells: 511.5;Hofbauer cells: 290.3;Spermatogonia: 179.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.1;eosinophil: 3.5;intermediate monocyte: 6.2;non-classical monocyte: 5.5;plasmacytoid DC: 5.9" "Group enriched" "Detected in many" 20 "dendritic cells: 5.9;granulocytes: 3.5;monocytes: 6.2" "Cell line enhanced" "Detected in many" "EFO-21: 183.9;HUVEC TERT2: 329.0;RPMI-8226: 136.8;TIME: 312.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050716 Approved "Secreted to extracellular matrix" NA NA "HPA050716: AB_2732562" "unprognostic (1.72e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (9.76e-3)" "unprognostic (5.03e-1)" "unprognostic (1.03e-1)" "unprognostic (4.31e-3)" "unprognostic (4.39e-2)" "unprognostic (1.14e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (4.09e-2)" "unprognostic (4.49e-2)" 193.0 50.6 95.7 13.6 70.1 14.5 193.9 64.9 145.4 109.3 63.0 48.6 13.5 105.1 9.9 40.1 99.4 27.7 188.7 69.7 67.2 145.4 56.6 205.9 21.0 82.4 76.0 63.4 38.2 28.4 18.6 51.7 183.1 78.0 75.6 3.5 1.0 39.7 13.3 61.0 46.2 51.8 13.6 67.8 193.2 41.0 43.6 85.0 5.6 106.3 25.5 2.9 88.2 87.1 87.5 0.1 45.7 14.6 52.7 1.2 1.0 33.4 12.9 2.3 7.3 2.3 16.2 42.4 0.3 183.9 4.3 11.9 6.5 3.7 8.3 0.3 77.2 14.1 28.8 3.4 1.3 11.4 0.0 40.1 1.5 3.2 3.7 0.0 2.5 329.0 2.1 104.9 0.1 2.5 83.5 0.5 0.7 21.1 64.3 2.6 91.4 5.9 136.8 4.6 1.1 9.3 31.0 6.3 5.9 12.2 4.2 15.5 43.6 312.6 1.8 37.2 4.4 2.5 0.4 0.1 0.5 0.2 0.1 38.4 0.0 2.1 3.5 0.0 6.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.8 0.2 5.5 5.9 0.0 2.4 95.7 70.1 64.9 145.4 69.7 67.2 82.4 76.0 63.4 78.0 67.8 85.0 87.5 806.1 0.0 26.5 2.3 6.2 11.9 5.6 5.5 9.6 2.0 5.9 6.7 23.7 5.7 4.2 3.7 0.0 3.1 5.9 1.4 7.9 19.4 2.7 1.4 3.4 436.5 1.2 58.9 15.0 2.0 17.8 18.5 0.5 1.9 20.3 2.0 511.5 20.5 290.3 3.3 10.1 4.6 2.0 24.5 14.2 9.2 8.7 18.7 19.6 102.1 1.2 1.9 0.0 3.5 1.8 5.8 3.7 6.0 4.0 19.1 22.5 25.2 0.2 2.3 13.1 13.0 18.4 18.9 179.8 2.7 9.5 6.0 2.9 4.8 0.5 3.5 NADSYN1 FLJ10631 ENSG00000172890 "NAD synthetase 1" Q6IA69 11 71453109-71524107 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017798, HPA038523, HPA038524" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Golgi apparatus, Cytosol" "CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" "unprognostic (7.30e-2)" "unprognostic (2.63e-3)" "unprognostic (1.75e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.17e-6)" "unprognostic (1.19e-2)" "unprognostic (4.38e-2)" "unprognostic (1.41e-1)" "unprognostic (9.41e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (1.54e-2)" "prognostic favorable (5.10e-4)" 26.4 34.4 18.7 24.3 20.3 68.2 26.4 18.7 21.3 30.5 20.6 39.6 39.9 26.2 24.4 56.7 31.5 26.0 20.2 17.7 19.7 33.3 50.2 35.6 33.6 22.4 19.9 17.3 27.8 29.8 13.5 36.3 16.7 21.8 45.7 36.4 7.0 33.1 23.0 11.1 30.2 51.5 19.5 19.0 58.9 34.6 25.8 21.0 28.1 32.1 5.1 28.4 43.8 33.7 24.5 15.9 37.8 12.0 21.6 35.0 50.6 32.4 29.7 27.2 15.4 17.0 32.4 25.7 13.4 33.1 35.3 20.7 55.2 15.9 42.6 8.2 27.9 12.8 22.2 27.6 36.3 43.3 45.1 40.9 72.0 65.8 19.9 17.8 34.9 54.6 24.2 11.9 18.5 21.9 49.7 22.4 29.9 7.0 69.6 21.3 27.5 37.2 13.5 37.8 72.1 8.9 12.7 21.2 27.9 56.0 17.9 24.9 24.4 66.2 16.7 14.2 30.9 11.8 24.3 11.0 11.7 29.9 25.6 12.0 6.1 28.0 17.3 15.3 25.0 12.7 12.2 13.5 13.8 31.1 9.2 8.8 11.4 17.7 16.3 22.6 23.0 17.7 21.4 18.7 20.3 18.7 21.3 17.7 19.7 22.4 19.9 17.3 21.8 19.0 21.0 24.5 12.6 22.4 32.3 4.2 24.0 6.2 17.8 18.4 26.2 7.8 13.5 10.9 8.3 12.8 19.8 11.0 4.2 17.4 27.3 65.3 3.9 16.5 22.6 21.1 11.1 15.6 23.4 20.2 5.1 17.3 14.5 12.8 51.0 19.7 22.1 23.1 13.9 16.7 20.1 13.5 5.8 30.3 16.2 23.2 18.5 60.9 9.3 25.4 8.8 8.4 25.8 5.9 29.9 7.5 18.5 20.0 55.8 10.1 18.0 17.9 73.3 16.2 16.5 7.3 13.1 9.6 9.8 15.9 5.0 38.3 12.8 17.2 22.3 17.1 43.7 24.2 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 162.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 77.9;Granulosa cells: 81.3;Hepatocytes: 156.1;Theca cells: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favorable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (5.67e-4)" 19.7 98.0 28.8 13.1 36.4 47.1 36.7 41.6 37.7 11.5 16.5 21.3 48.5 10.7 59.8 42.6 12.6 9.0 24.3 29.7 42.2 16.4 162.4 22.0 6.1 52.6 44.5 29.3 54.8 16.7 24.6 18.5 8.4 57.4 21.8 14.5 8.7 28.0 7.2 13.7 68.3 19.5 10.0 36.5 9.6 19.2 31.3 38.5 4.8 12.0 13.3 9.5 7.9 22.9 64.9 126.4 112.3 106.7 118.9 49.0 75.8 33.7 50.9 134.1 43.1 114.5 419.8 401.5 87.1 79.0 48.6 376.2 235.9 128.8 276.7 44.5 33.5 98.7 33.4 89.3 183.1 127.8 63.7 15.6 89.2 122.1 159.3 108.4 34.6 63.8 112.7 159.6 180.7 43.2 341.1 52.4 72.6 154.1 124.9 67.4 46.9 150.6 377.3 162.3 187.3 144.7 53.9 48.4 157.6 113.9 51.4 153.2 34.5 60.4 11.5 62.4 3.7 61.5 59.3 78.7 95.8 33.8 110.9 48.9 5.6 2.1 1.9 10.5 1.4 12.6 6.5 8.9 9.8 2.8 5.4 11.0 13.0 1.1 5.8 1.5 7.1 6.0 6.9 28.8 36.4 41.6 37.7 29.7 42.2 52.6 44.5 29.3 57.4 36.5 38.5 64.9 7.1 3.2 19.1 7.2 7.1 0.8 10.1 77.9 3.4 8.4 21.8 14.9 13.1 15.7 39.2 22.0 12.5 15.5 11.9 9.9 7.9 36.9 0.1 3.9 1.5 11.8 9.5 5.2 3.2 49.9 27.6 12.8 11.7 9.3 0.0 81.3 7.9 156.1 11.9 0.0 4.5 12.3 54.9 3.8 3.3 1.7 8.4 5.6 5.4 1.0 5.8 21.2 4.1 5.0 14.7 26.7 11.5 4.9 10.0 16.5 8.9 3.8 7.6 8.7 13.1 3.9 9.0 0.5 7.0 11.9 1.1 54.2 13.8 103.6 15.0 9.5 LVRN "APQ, AQPEP, FLJ90650, TAQPEP" ENSG00000172901 Laeverin Q6Q4G3 5 115962454-116027619 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 11.2;placenta: 22.0" "Group enriched" "Detected in some" 4 "Early spermatids: 29.3;Extravillous trophoblasts: 33.1;Late spermatids: 68.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "spinal cord: 2.5" HPA053254 Enhanced "Intracellular and membrane" NA NA "HPA053254: AB_2682092" "unprognostic (1.47e-1)" "unprognostic (3.38e-3)" "unprognostic (5.81e-2)" "unprognostic (2.97e-3)" "unprognostic (5.38e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-3)" "unprognostic (1.88e-2)" "unprognostic (2.23e-1)" "unprognostic (2.23e-2)" "unprognostic (3.83e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-7)" "unprognostic (1.05e-2)" "unprognostic (5.94e-2)" "unprognostic (6.53e-2)" "unprognostic (3.31e-2)" 11.2 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.4 0.8 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 29.3 0.0 0.1 0.1 0.0 0.0 2.1 0.0 33.1 7.9 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 0.0 0.0 68.1 4.7 0.3 0.0 1.9 0.0 0.0 0.0 3.0 1.5 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.3 0.3 0.1 0.0 10.7 0.0 1.0 0.0 0.1 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942270-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.4;retina: 66.3" "Group enriched" "Detected in many" 4 "Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.1;SH-SY5Y: 80.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favorable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 2.4 7.3 5.7 1.6 11.4 0.3 5.0 20.5 24.4 3.6 2.7 4.5 1.4 6.1 2.3 3.3 5.5 3.4 6.9 17.0 7.4 4.2 0.6 2.0 1.6 5.1 1.3 9.3 6.2 3.1 7.1 8.4 0.6 6.1 6.7 2.6 66.3 4.7 8.4 5.6 1.5 2.5 6.5 0.0 3.2 2.7 3.6 1.4 5.6 6.3 5.8 1.2 3.7 2.8 8.8 0.0 4.5 10.9 6.1 0.7 0.1 0.3 7.0 10.8 7.9 6.6 0.1 1.0 3.0 0.0 12.9 4.7 0.3 3.7 1.5 16.3 1.4 3.6 0.0 3.4 1.2 0.5 1.9 4.7 2.1 1.2 0.1 0.7 33.1 1.8 1.2 0.1 17.6 1.1 1.9 1.1 0.0 4.6 6.2 2.0 1.1 4.7 0.9 9.3 2.1 6.2 80.1 5.4 0.1 3.6 8.1 2.0 0.4 0.1 2.0 1.2 0.0 1.6 1.9 0.5 1.3 5.4 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 5.7 11.4 20.5 24.4 17.0 7.4 5.1 1.3 9.3 6.1 0.0 1.4 8.8 19.7 28.9 9.2 132.9 5.2 1.0 5.3 2.7 1.2 124.8 5.0 6.5 51.8 11.5 14.1 9.2 146.0 0.1 4.4 0.3 1.9 9.2 19.3 5.6 18.4 10.1 22.9 0.8 1016.1 1.8 0.1 12.3 2.0 0.6 25.2 20.7 11.0 0.3 0.9 47.1 953.0 2.1 6.1 3.5 3.9 13.6 17.7 3.5 7.2 150.9 1.2 69.1 0.0 466.9 163.7 2.3 0.1 19.2 5.8 8.5 0.2 7.6 56.5 87.0 6.6 22.2 13.1 8.5 8.0 0.3 0.9 0.0 1.2 11.9 1.1 13.5 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 388.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA065375: AB_2685481" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 16.1 24.0 15.6 9.7 16.1 19.8 17.0 16.6 19.5 29.8 15.8 29.0 8.6 27.5 6.5 14.7 28.4 6.3 18.6 16.0 14.5 23.3 16.9 16.5 14.0 16.0 15.7 15.6 34.2 17.1 7.6 32.6 5.6 17.6 34.7 3.9 7.7 16.6 9.7 10.2 11.1 25.3 6.2 14.8 33.3 23.3 13.4 15.5 9.9 22.3 3.7 8.0 28.1 22.4 16.9 13.5 12.9 16.6 13.1 13.3 6.3 5.4 7.4 4.6 18.6 15.4 15.8 15.4 19.9 7.7 6.8 24.1 19.5 14.0 10.3 12.2 13.5 30.2 20.2 40.9 7.4 2.3 3.5 17.7 7.3 3.6 16.7 4.7 11.0 8.0 21.4 10.9 22.7 7.8 19.9 33.9 19.0 10.3 6.4 15.6 27.1 11.3 27.4 4.9 7.8 20.6 20.4 3.5 14.5 8.1 5.1 17.6 7.1 8.2 17.9 15.7 18.3 11.7 20.6 6.3 6.7 26.6 16.8 14.8 3.3 14.6 3.7 9.2 10.7 9.9 12.7 6.2 6.8 9.2 12.8 7.6 5.7 3.0 11.2 8.0 23.3 6.9 9.8 15.6 16.1 16.6 19.5 16.0 14.5 16.0 15.7 15.6 17.6 14.8 15.5 16.9 94.0 25.6 39.9 8.5 90.6 31.6 109.5 59.8 23.9 26.7 82.2 102.7 69.8 94.4 44.5 68.0 8.4 73.5 89.5 64.6 105.7 62.6 40.0 34.1 75.5 77.7 128.4 124.2 14.3 46.6 107.8 89.5 32.6 36.7 65.4 168.7 104.6 103.6 128.0 23.5 12.5 52.7 42.7 93.6 51.4 138.2 135.8 73.1 64.0 7.5 90.7 47.5 145.2 8.5 16.9 43.4 83.1 100.1 119.0 74.5 132.5 271.4 37.5 23.5 111.7 66.1 101.7 66.5 68.5 44.1 36.9 208.0 68.6 388.0 53.9 95.9 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294151-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 5.3;esophagus: 9.7;stomach 1: 6.1" "Cell type enriched" "Detected in many" 5 "Pancreatic endocrine cells: 199.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 3.8 0.1 0.0 0.6 0.0 0.1 5.3 0.0 0.0 0.9 0.0 0.5 0.3 0.0 0.7 9.7 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.0 3.8 0.2 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.1 0.0 1.0 0.1 4.0 0.0 172.8 83.5 0.0 0.0 0.0 0.0 2.5 0.2 0.1 0.0 0.0 0.5 24.3 0.5 6.3 0.0 0.1 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.1 8.5 0.0 2.4 0.2 0.1 3.8 0.1 0.1 0.2 3.4 6.8 0.0 0.1 3.5 0.6 0.2 0.0 0.0 0.0 2.4 0.6 0.0 2.9 0.7 1.6 0.1 36.1 0.0 1.4 0.3 1.7 0.2 0.2 0.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.0 0.8 0.8 3.8 0.0 0.0 30.7 37.7 0.4 0.0 17.6 3.7 0.0 0.0 0.9 7.8 0.0 12.6 12.7 1.2 0.1 0.5 0.0 0.0 0.0 9.4 0.4 3.4 23.9 1.5 0.0 0.1 0.0 0.2 2.4 0.0 0.0 1.3 2.0 0.0 0.0 6.9 0.3 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 199.3 22.3 0.0 3.9 1.4 0.0 0.0 1.5 0.0 0.0 0.1 2.9 0.0 0.4 3.4 1.3 0.1 0.4 0.0 2.7 8.5 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67289300-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 63.9;SK-MEL-30: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 11.4 14.8 12.9 6.9 13.5 0.3 11.5 10.3 20.2 19.0 10.0 12.3 3.1 12.6 2.9 24.6 15.5 8.0 11.3 15.9 11.2 15.4 9.0 13.9 15.2 13.4 10.8 14.1 14.2 9.6 6.1 29.1 5.2 14.7 24.0 2.3 2.0 14.5 7.3 3.7 14.8 14.0 6.6 9.7 39.5 12.9 12.2 15.8 10.1 11.3 3.8 5.7 17.6 20.7 19.1 9.7 7.2 5.8 12.3 10.9 10.1 3.8 7.0 8.4 7.2 5.6 6.4 10.1 11.6 12.4 5.6 10.7 12.4 4.5 8.6 1.0 19.9 5.3 11.6 11.3 4.3 16.8 14.0 27.8 10.4 11.8 6.2 6.8 14.1 9.5 9.2 6.3 12.4 8.0 14.1 18.0 63.9 2.5 19.8 10.1 28.5 4.9 9.9 13.6 6.0 6.0 9.8 7.0 16.7 57.0 4.5 14.3 33.1 7.7 7.1 6.1 7.9 8.2 9.8 9.4 5.6 17.4 21.4 8.2 6.6 0.6 5.7 2.0 2.1 1.3 0.8 1.5 2.8 1.2 0.5 0.5 3.2 1.9 3.1 1.4 1.8 1.6 1.2 12.9 13.5 10.3 20.2 15.9 11.2 13.4 10.8 14.1 14.7 9.7 15.8 19.1 23.2 0.0 18.8 18.9 22.2 14.1 11.7 15.4 17.6 61.1 21.5 20.8 7.0 8.6 14.5 16.5 75.0 8.3 73.6 7.5 1.9 8.3 18.0 27.7 19.7 17.9 10.8 8.2 29.8 6.9 9.0 15.7 20.4 18.0 25.3 25.7 22.1 3.0 20.0 42.1 29.7 7.9 18.3 52.0 21.4 6.0 22.1 45.8 12.4 18.7 49.7 20.8 49.4 17.6 18.4 9.9 4.6 17.0 30.7 19.9 2.3 2.6 30.4 51.7 13.1 13.6 18.5 3.1 8.1 19.3 25.1 7.5 49.9 28.9 8.4 19.8 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013382 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 172.6" "Cell type enhanced" "Detected in many" "Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8" "Region enriched" "Detected in many" 5 "cerebellum: 14.8" "Region enhanced" "Detected in some" "spinal cord: 4.8" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 41.3 3.8 2.4 12.9 2.2 0.0 32.8 11.5 4.0 103.8 5.0 114.7 9.4 172.6 14.3 16.3 98.8 16.9 11.2 2.1 3.2 16.9 7.0 18.8 4.5 4.5 2.9 1.8 37.3 3.4 0.5 4.1 11.7 5.5 48.7 9.0 0.2 10.9 46.0 5.1 14.1 38.6 59.9 2.5 13.5 44.5 7.3 2.7 0.7 10.8 3.1 1.3 75.8 66.2 2.5 0.0 0.1 0.1 0.0 67.6 30.0 1.4 39.5 99.1 36.8 24.3 0.0 1.8 0.0 0.8 30.8 0.1 0.1 0.1 0.0 6.8 0.0 0.0 0.0 2.8 0.0 8.5 0.0 0.0 22.1 0.0 23.5 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.9 1.5 0.8 0.1 0.0 3.4 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 2.5 0.0 0.0 0.0 22.4 0.0 46.8 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 11.5 4.0 2.1 3.2 4.5 2.9 1.8 5.5 2.5 2.7 2.5 3.2 0.0 0.0 0.0 0.6 5.0 0.2 0.0 1.2 0.0 0.3 2.3 0.6 2.8 0.0 11.0 0.0 0.7 0.1 0.0 0.0 0.0 4.9 1.1 20.6 2.3 0.0 0.0 1.1 0.0 0.6 33.3 0.5 0.8 0.0 0.0 3.9 3.8 1.1 0.0 0.2 0.0 0.0 0.0 7.3 7.9 66.2 0.2 7.2 3.7 0.0 3.0 0.0 0.0 0.2 0.1 0.0 100.8 0.1 0.3 0.0 0.9 0.0 0.3 52.6 19.1 63.7 1.3 0.5 0.4 3.8 1.1 0.6 0.6 0.0 0.4 MYD88 ENSG00000172936 "MYD88 innate immune signal transduction adaptor" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 172.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favorable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 20.3 14.3 6.6 43.9 7.4 52.2 15.2 7.0 7.5 13.1 8.2 30.6 32.5 12.2 18.8 36.9 14.5 23.7 9.1 6.3 10.8 13.9 61.6 42.9 35.5 9.1 7.1 5.8 11.5 11.7 11.7 9.2 22.8 7.7 14.5 32.0 2.1 18.1 12.2 3.3 17.0 32.5 24.7 8.0 41.0 27.9 7.8 8.3 38.6 9.4 8.9 42.0 47.8 20.5 9.9 25.1 34.2 5.9 33.2 25.0 32.0 10.8 23.6 39.0 68.1 72.9 22.7 30.9 52.8 13.8 44.7 15.8 30.9 43.2 24.2 22.1 39.5 8.7 28.5 16.6 36.6 21.4 36.2 72.0 38.4 26.6 39.2 15.3 13.2 39.9 40.3 13.3 22.3 36.8 25.7 61.3 12.2 22.1 52.8 35.7 24.8 7.0 23.1 37.6 58.9 3.0 12.0 33.4 172.1 22.3 4.8 25.8 40.8 35.5 13.8 7.9 60.6 24.0 28.9 32.9 38.5 25.0 63.0 28.9 288.5 236.9 296.9 67.2 333.6 58.1 43.7 60.6 69.3 203.6 35.2 42.1 59.5 284.7 54.6 436.1 99.9 87.4 257.3 6.6 7.4 7.0 7.5 6.3 10.8 9.1 7.1 5.8 7.7 8.0 8.3 9.9 13.4 6.4 15.2 2.0 19.5 14.4 13.5 12.7 14.2 1.0 11.3 10.8 1.6 5.7 16.4 5.5 0.0 14.6 35.3 40.8 7.9 24.5 1.4 10.9 30.2 15.9 9.6 9.7 0.2 27.3 24.4 10.8 23.9 18.6 24.1 10.0 10.4 33.2 32.2 0.0 0.4 14.9 10.2 75.4 40.5 0.9 13.7 61.5 3.6 1.9 58.1 4.1 28.8 2.5 0.3 64.0 34.8 10.5 12.9 16.0 28.0 12.2 12.1 0.1 13.1 4.3 7.2 8.6 0.6 15.1 17.2 12.0 19.6 10.2 15.9 49.4 MRGPRD mrgD ENSG00000172938 "MAS related GPR family member D" Q8TDS7 11 68980021-68980986 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031346 Uncertain NA NA "HPA031346: AB_10602710" "unprognostic (1.92e-1)" "unprognostic (7.14e-2)" "unprognostic (1.72e-1)" 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.2 0.0 0.5 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OXSR1 "KIAA1101, OSR1" ENSG00000172939 "Oxidative stress responsive kinase 1" O95747 3 38165089-38255484 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008237, CAB017181" Supported Enhanced Cytosol NA NA 300000 Cytosol "CAB017181: , HPA008237: AB_1079540" "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (1.79e-2)" "unprognostic (4.55e-3)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (3.53e-3)" "unprognostic (4.05e-2)" "unprognostic (4.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.95e-3)" "unprognostic (1.88e-2)" "unprognostic (1.87e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.71e-1)" "unprognostic (6.99e-3)" 18.5 17.3 10.3 15.8 10.8 34.1 15.7 14.3 12.8 15.8 13.0 18.4 15.3 14.9 15.7 34.4 12.9 15.2 16.4 10.5 11.5 21.7 18.7 15.6 18.7 11.4 11.2 9.8 16.3 12.2 26.5 11.6 16.7 11.7 16.6 19.8 13.2 15.3 16.5 37.0 19.2 15.8 17.7 11.3 15.1 17.0 14.2 11.2 25.3 14.9 35.7 23.6 27.0 21.3 12.2 48.5 21.9 42.5 29.8 29.0 33.3 48.2 41.9 57.1 59.2 63.8 28.3 30.8 53.4 20.8 50.5 25.4 29.4 57.8 43.1 77.5 57.6 24.5 58.6 46.1 31.1 34.6 36.6 34.2 26.6 49.6 54.8 87.8 55.7 37.5 67.7 45.2 29.9 102.7 13.7 71.1 26.4 44.8 31.2 26.1 24.2 35.7 41.4 36.4 36.4 22.0 34.0 45.9 114.2 29.0 46.3 37.7 23.7 34.4 37.0 36.6 56.8 63.0 22.7 29.0 38.7 50.7 44.6 75.3 6.8 1.6 3.9 1.8 2.8 1.9 1.0 2.2 1.7 2.6 1.2 1.7 2.1 3.2 3.1 2.5 1.4 2.8 0.9 10.3 10.8 14.3 12.8 10.5 11.5 11.4 11.2 9.8 11.7 11.3 11.2 12.2 19.0 12.8 25.8 46.7 27.3 44.1 35.5 25.3 26.7 13.3 19.4 16.5 32.6 4.3 27.6 27.6 20.9 12.1 27.4 44.0 19.6 28.4 3.9 39.9 32.1 19.0 24.1 29.7 59.6 14.5 21.0 18.4 90.7 91.2 15.8 24.9 14.6 20.5 14.9 21.9 51.9 24.5 10.2 29.8 79.0 2.3 9.6 58.0 7.2 29.0 35.2 8.0 18.6 44.7 42.8 46.5 29.4 12.8 19.5 56.5 27.0 22.5 16.1 7.0 13.1 23.7 22.6 15.1 18.5 41.9 51.9 33.0 29.6 19.6 21.6 115.3 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278757 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 9.1" "Group enriched" "Detected in some" 12 "Excitatory neurons: 2.3;Inhibitory neurons: 1.8;Proximal tubular cells: 7.1" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035603, HPA035962" Enhanced NA NA "HPA035603: AB_10672869, HPA035962: AB_2674890" "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.5 1.0 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHF8 "JHDM1F, KDM7B, KIAA1111, ZNF422" ENSG00000172943 "PHD finger protein 8" Q9UPP1 X 53936676-54048958 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 71.2" "Cell type enhanced" "Detected in many" "Spermatocytes: 57.9;Spermatogonia: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038779, HPA062015" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038779: AB_10675950, HPA062015: AB_2684658" "unprognostic (6.35e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-2)" "unprognostic (1.04e-1)" "unprognostic (8.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.66e-3)" "unprognostic (1.97e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (5.17e-2)" "unprognostic (1.22e-1)" "unprognostic (9.94e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.74e-5)" 11.4 8.1 9.4 13.4 11.1 16.3 13.9 9.5 10.8 13.9 19.2 11.3 10.4 14.3 71.2 13.5 14.2 9.2 9.6 7.7 11.2 9.8 28.9 13.6 16.5 10.5 9.5 7.0 19.5 17.9 10.9 14.0 13.3 11.1 16.1 9.7 14.8 12.9 18.5 11.1 12.9 14.3 9.5 8.4 14.1 12.8 40.5 10.1 18.8 13.3 7.9 16.0 14.2 13.6 13.2 16.1 14.0 20.4 19.9 12.2 9.6 33.3 12.0 10.4 12.9 11.4 15.7 12.8 23.4 6.9 10.8 13.9 16.5 51.1 10.3 13.7 36.4 23.8 14.2 18.1 15.8 9.6 22.4 25.6 10.9 14.0 15.0 20.2 9.7 12.0 24.3 18.7 33.2 7.6 16.1 30.6 16.9 37.2 11.0 19.6 29.7 22.5 22.9 8.9 19.2 29.2 14.5 31.6 20.5 10.5 31.2 20.5 15.5 14.3 10.3 14.5 19.2 10.0 25.1 25.4 28.3 12.2 27.9 11.3 6.1 2.7 4.4 3.2 4.8 5.1 2.3 3.3 3.9 2.9 3.1 2.5 2.8 4.4 3.5 3.2 2.3 5.3 3.4 9.4 11.1 9.5 10.8 7.7 11.2 10.5 9.5 7.0 11.1 8.4 10.1 13.2 9.5 9.6 10.3 17.3 11.2 8.9 9.4 4.5 15.4 13.7 13.9 8.1 7.8 5.7 5.4 9.2 12.5 13.9 14.1 8.3 0.0 5.1 54.9 34.5 11.3 11.3 5.4 5.2 19.7 4.6 4.7 6.9 10.7 40.2 14.0 15.0 7.9 39.4 6.8 8.4 22.0 8.8 10.2 11.8 6.4 31.4 9.3 11.6 3.6 20.6 9.2 6.1 9.2 27.2 30.0 4.4 9.4 6.4 14.4 10.9 9.2 3.7 16.5 15.3 6.6 11.6 9.2 57.9 58.7 15.2 9.8 12.2 13.5 6.3 8.3 14.7 LCLAT1 "AGPAT8, ALCAT1, FLJ37965, LYCAT" ENSG00000172954 "Lysocardiolipin acyltransferase 1" Q6UWP7 2 30447226-30644225 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 67.3;Inhibitory neurons: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031880, HPA049217" Uncertain Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "HPA031880: AB_10610002, HPA049217: AB_2680678" "unprognostic (6.60e-2)" "unprognostic (2.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.52e-3)" "unprognostic (4.10e-1)" "prognostic unfavorable (9.67e-4)" "prognostic unfavorable (8.72e-4)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-2)" "unprognostic (7.11e-3)" "unprognostic (2.85e-2)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (3.93e-3)" "unprognostic (1.10e-1)" 4.3 5.0 6.3 5.0 7.4 10.0 5.4 11.4 9.8 6.7 2.9 7.9 12.4 7.3 9.9 5.1 6.2 6.2 11.4 5.8 5.3 9.6 8.7 5.2 5.5 3.9 4.4 4.9 5.0 6.0 6.3 3.3 4.4 5.8 7.9 8.0 10.7 4.6 7.1 9.7 6.7 9.6 8.7 1.8 5.4 5.4 8.4 5.1 6.4 11.0 4.2 5.5 5.0 3.7 11.7 16.9 21.6 11.3 19.3 2.6 5.7 16.3 11.8 11.7 12.3 10.3 21.8 19.0 10.5 10.7 18.4 15.2 18.3 38.8 16.0 12.1 13.6 13.0 19.4 12.8 21.6 12.0 28.1 14.3 4.6 12.4 13.0 18.0 8.0 8.7 6.0 18.3 9.5 9.6 12.8 16.1 16.5 12.5 13.6 12.4 15.6 22.9 21.8 9.7 24.7 13.1 20.5 26.4 17.4 15.7 7.7 12.6 9.5 10.0 22.1 18.2 12.4 18.9 7.0 16.2 23.2 22.7 20.1 17.3 15.9 2.3 5.0 5.2 3.8 6.2 7.5 8.3 6.7 2.8 9.7 11.7 11.5 7.2 4.6 3.6 2.0 4.2 3.0 6.3 7.4 11.4 9.8 5.8 5.3 3.9 4.4 4.9 5.8 1.8 5.1 11.7 6.5 9.6 6.9 27.1 11.4 7.1 5.0 8.4 6.8 15.5 6.9 5.3 20.1 18.6 8.7 14.7 27.1 5.2 6.7 10.4 0.0 7.7 3.9 12.0 7.0 7.7 13.1 10.3 67.3 16.4 5.3 6.7 3.1 9.4 3.8 11.6 8.6 21.5 6.1 15.2 86.8 14.3 0.0 5.7 3.9 1.4 5.6 3.4 5.4 45.0 2.4 7.9 5.2 50.8 37.3 12.9 8.6 9.1 5.2 5.4 21.4 12.1 16.6 18.2 6.6 10.9 16.3 13.9 21.0 7.9 6.7 1.9 9.1 10.9 17.0 4.7 ADH6 ADH-5 ENSG00000172955 "Alcohol dehydrogenase 6 (class V)" P28332 4 99202638-99219537 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 709.5" "Group enriched" "Detected in some" 6 "Hepatocytes: 325.5;Proximal tubular cells: 92.4" "Cancer enriched" "Detected in many" 18 "liver cancer: 46.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Hep G2: 44.7" "Not detected" "Not detected" "HPA067946, HPA069081" Enhanced NA NA 3400000 "HPA067946: AB_2732776, HPA069081: AB_2732127" "unprognostic (1.38e-2)" "unprognostic (1.83e-2)" "unprognostic (5.82e-2)" "unprognostic (1.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.08e-1)" "unprognostic (5.11e-3)" "unprognostic (2.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.35e-1)" "unprognostic (9.72e-3)" "unprognostic (1.67e-1)" "unprognostic (3.66e-3)" "unprognostic (1.35e-1)" "unprognostic (2.43e-1)" "unprognostic (8.74e-3)" "unprognostic (3.86e-3)" 0.2 0.0 0.3 0.6 0.1 0.0 0.1 0.1 0.1 0.2 0.1 8.3 41.9 0.3 0.0 0.3 9.3 7.8 0.0 0.1 0.2 52.8 709.5 0.2 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 8.7 0.0 0.0 0.1 0.0 1.4 22.8 0.4 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 44.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 9.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.5 0.0 0.7 0.5 0.1 0.5 0.0 0.0 0.0 0.0 0.3 15.7 1.1 5.5 0.0 0.0 0.0 7.8 7.9 0.3 0.0 11.2 0.3 0.4 12.1 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.0 7.1 325.5 0.0 0.0 0.1 8.9 8.2 5.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 31.1 92.4 15.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 12.7 0.1 XKR3 "MGC57211, XTES" ENSG00000172967 "XK related 3" Q5GH77 22 16783412-16821699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 8.2" "Cell type enriched" "Detected in some" 10 "Early spermatids: 159.6" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 15 "Karpas-707: 230.8" "HPA003379, HPA035081" Uncertain NA NA "HPA003379: AB_10602682, HPA035081: AB_2674451" "unprognostic (4.57e-1)" "unprognostic (3.37e-1)" "unprognostic (3.11e-2)" "unprognostic (3.13e-2)" "unprognostic (5.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.5 0.0 0.0 15.2 230.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.9 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FRG2C ENSG00000172969 "FSHD region gene 2 family member C" A6NGY1 3 75664330-75667220 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Distal tubular cells: 27.4;Early spermatids: 13.9;Late spermatids: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HDLM-2: 12.7" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" "unprognostic (3.47e-2)" "unprognostic (8.28e-2)" "unprognostic (9.57e-2)" "unprognostic (2.59e-1)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "unprognostic (4.56e-2)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.4 0.0 13.9 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 30.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KAT5 "cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5" ENSG00000172977 "Lysine acetyltransferase 5" Q92993 11 65711996-65719604 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016953, HPA074328" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA016953: AB_1851277, HPA074328: " "unprognostic (2.20e-1)" "unprognostic (3.58e-1)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (7.16e-2)" "unprognostic (1.29e-3)" "unprognostic (1.20e-1)" "unprognostic (2.01e-1)" "unprognostic (2.74e-1)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "prognostic favorable (1.10e-13)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.54e-2)" 29.7 30.3 37.5 24.0 39.1 53.3 32.3 40.2 49.2 39.3 36.5 40.2 21.8 45.5 34.0 35.2 45.3 20.6 32.3 36.6 37.3 33.0 26.5 29.7 28.2 38.9 38.9 37.1 39.6 33.0 46.0 34.0 30.2 39.8 33.3 27.3 31.3 29.8 36.6 43.1 47.6 32.5 35.5 38.1 34.5 36.2 45.5 38.9 39.6 38.5 34.9 30.4 39.8 35.1 42.4 37.2 44.1 40.1 29.6 31.3 32.7 41.1 26.7 43.6 44.0 38.0 32.6 42.2 34.3 36.2 47.4 47.5 30.8 50.8 45.1 26.4 44.4 32.5 50.6 36.3 38.9 44.6 55.7 56.4 35.2 49.7 28.9 59.0 33.7 28.1 39.1 52.5 51.1 42.0 68.2 45.7 62.3 33.9 26.8 28.4 38.2 26.5 63.3 40.6 56.2 37.1 38.9 25.4 46.5 51.2 20.8 45.9 34.2 36.3 33.9 30.4 27.6 28.0 38.7 43.7 50.4 29.7 27.0 29.3 42.7 33.6 58.8 33.4 32.0 29.6 28.2 28.8 34.2 34.1 30.4 36.5 29.8 34.8 35.8 34.6 20.9 31.0 36.4 37.5 39.1 40.2 49.2 36.6 37.3 38.9 38.9 37.1 39.8 38.1 38.9 42.4 17.6 12.8 17.5 10.7 26.0 21.2 44.2 60.2 17.6 44.9 17.3 15.0 1.0 25.8 33.8 29.5 31.3 51.3 25.6 27.1 35.2 42.2 11.1 20.2 14.2 18.7 30.4 12.4 7.5 51.5 42.6 21.1 20.4 19.8 33.7 27.0 18.2 10.9 36.3 38.7 8.7 25.1 42.7 17.6 15.2 11.1 28.0 20.4 42.7 3.7 38.8 40.3 33.0 7.1 13.8 39.4 30.6 38.7 10.4 24.2 23.3 32.6 30.0 44.8 46.0 27.6 27.0 61.1 27.8 14.6 21.3 102.5 21.6 29.2 26.2 31.0 SH3RF3 "FLJ00204, POSH2, SH3MD4" ENSG00000172985 "SH3 domain containing ring finger 3" Q8TEJ3 2 109129205-109504634 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044822, HPA048444" Approved Supported Nucleoplasm Yes No Nucleoplasm "HPA044822: AB_2679103, HPA048444: AB_2680396" "unprognostic (1.97e-1)" "unprognostic (8.84e-3)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (2.55e-1)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.57e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-2)" 6.0 6.8 4.2 3.1 6.2 0.8 4.3 1.5 6.7 5.2 2.3 4.6 1.1 3.7 0.7 2.8 4.8 4.5 5.5 6.1 3.2 4.2 1.1 7.3 2.1 2.9 3.4 4.5 3.2 2.0 0.5 2.0 5.2 3.2 4.7 1.4 0.6 1.6 4.4 5.8 2.7 3.3 3.8 2.7 2.1 2.9 4.2 2.9 3.2 2.6 7.3 1.3 5.5 4.2 3.5 0.0 0.1 0.1 2.2 9.0 6.9 0.0 4.2 12.2 3.1 1.1 1.1 0.0 0.0 3.1 3.1 0.7 0.0 0.2 1.8 1.3 0.0 4.2 0.0 0.2 0.0 19.8 0.1 0.0 12.0 2.9 14.1 6.3 1.8 11.4 2.2 0.0 11.7 7.3 0.0 0.0 6.5 1.1 0.0 12.0 2.6 0.0 20.5 0.0 0.0 0.7 2.5 0.0 0.0 0.4 0.1 0.2 0.0 23.2 4.0 12.0 11.5 5.5 4.0 28.6 0.0 0.0 6.3 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 6.2 1.5 6.7 6.1 3.2 2.9 3.4 4.5 3.2 2.7 2.9 3.5 5.3 0.0 0.0 47.0 0.2 1.9 0.4 0.2 1.8 0.5 0.6 0.5 10.7 0.0 0.7 0.0 0.0 0.0 1.5 0.1 0.0 1.1 2.6 9.4 9.6 6.7 1.8 0.0 108.3 0.2 0.2 4.8 0.0 1.1 0.0 0.2 7.5 0.0 4.7 10.1 160.9 0.8 0.0 2.5 1.5 5.2 2.1 1.2 5.4 164.9 0.0 1.7 0.0 42.3 1.9 0.1 0.0 3.0 1.6 0.2 0.0 0.6 2.1 0.0 13.1 3.2 6.8 0.7 9.6 0.8 0.9 0.1 0.5 2.3 0.1 0.0 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888046-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 5.7 3.9 1.9 5.3 4.6 1.8 4.1 3.8 3.2 5.8 3.2 3.7 0.6 5.7 2.5 3.2 5.1 10.2 13.7 1.5 4.8 1.0 0.3 3.8 1.6 5.6 5.3 2.1 16.6 4.2 2.4 2.0 4.0 5.1 3.3 2.1 0.4 5.3 4.0 0.8 1.7 1.2 5.5 4.9 0.7 1.3 5.8 3.7 6.8 8.8 1.5 1.0 5.8 3.6 6.4 0.2 1.8 0.1 11.2 9.9 19.3 1.7 1.8 4.2 4.0 9.8 0.5 1.2 0.0 3.1 4.9 22.3 0.1 1.0 2.2 3.8 0.0 1.3 0.0 7.2 12.4 12.6 4.9 0.0 18.8 1.1 9.7 1.6 6.0 0.0 22.1 5.8 0.1 2.4 2.7 36.5 0.1 6.6 0.1 2.2 0.2 9.5 0.0 1.3 1.7 1.1 5.0 9.8 0.5 1.3 2.0 3.7 1.5 0.1 4.3 13.5 13.3 6.5 1.0 0.1 0.2 11.1 2.3 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.3 0.0 1.9 4.6 3.8 3.2 1.5 4.8 5.6 5.3 2.1 5.1 4.9 3.7 6.4 1.6 3.2 2.6 7.2 0.1 1.9 1.9 5.3 0.0 0.6 1.5 7.6 14.6 2.8 2.3 0.0 0.0 0.2 1.5 1.4 0.0 0.1 47.9 5.7 45.4 0.6 3.5 0.0 8.3 1.1 0.3 23.0 0.0 7.5 0.0 8.0 0.7 0.0 0.4 0.0 9.0 2.9 0.0 0.0 4.0 27.1 8.1 0.5 0.0 12.2 0.0 2.5 0.0 3.0 61.3 0.8 0.4 7.2 0.0 2.0 0.6 0.5 2.1 0.4 0.0 40.0 3.9 2.5 4.2 0.2 0.4 0.8 0.4 22.9 1.6 0.4 HPSE2 "HPA2, HPR2, UFS" ENSG00000172987 "Heparanase 2 (inactive)" Q8WWQ2 10 98457077-99235862 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5;cervix: 33.3;vagina: 27.8" "Cell type enriched" "Detected in some" 9 "Astrocytes: 900.7" "Cancer enhanced" "Detected in some" "prostate cancer: 4.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "BJ hTERT+: 10.2;HEL: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA044603 Uncertain "Secreted to extracellular matrix" NA NA "HPA044603: AB_10794051" "unprognostic (2.44e-1)" "unprognostic (4.28e-3)" "unprognostic (4.83e-3)" "unprognostic (6.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.05e-2)" "unprognostic (1.82e-2)" "unprognostic (4.03e-2)" "unprognostic (7.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-4)" "unprognostic (5.79e-2)" "unprognostic (2.51e-1)" "unprognostic (9.39e-3)" "unprognostic (6.13e-3)" 1.8 0.0 10.6 2.0 19.2 0.0 5.2 17.1 9.1 33.3 3.4 2.9 2.8 4.5 0.0 14.4 1.8 1.4 0.0 5.8 19.8 1.1 0.0 2.2 0.0 23.6 24.3 4.1 0.2 0.0 0.0 0.3 1.5 23.0 11.2 3.0 0.0 2.4 4.3 0.3 3.0 5.3 1.7 15.1 0.0 4.6 2.7 27.5 0.1 0.1 3.1 0.4 18.5 27.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.6 19.2 17.1 9.1 5.8 19.8 23.6 24.3 4.1 23.0 15.1 27.5 13.8 0.3 0.0 0.0 900.7 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.4 24.8 0.3 0.0 0.0 6.4 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 97.3 0.2 0.0 0.0 0.0 48.6 0.3 0.0 0.0 40.3 0.0 0.0 0.0 16.6 4.6 0.0 0.0 0.4 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.9 1.9 11.5 2.1 0.0 0.1 0.0 0.2 0.8 0.0 0.7 DCAKD FLJ22955 ENSG00000172992 "Dephospho-CoA kinase domain containing" Q8WVC6 17 45023340-45061109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060997 Approved Nucleoplasm NA NA Nucleoplasm "HPA060997: AB_2797262" "unprognostic (1.32e-2)" "unprognostic (4.79e-3)" "unprognostic (9.71e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.13e-1)" "unprognostic (8.24e-3)" "unprognostic (7.57e-2)" "unprognostic (6.05e-3)" "unprognostic (4.10e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-3)" "unprognostic (4.00e-2)" "unprognostic (6.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "unprognostic (1.82e-2)" 17.4 36.3 47.6 9.8 47.7 6.5 22.1 53.4 47.4 24.3 41.0 19.2 8.9 21.7 20.7 24.6 25.1 12.3 27.6 42.2 60.9 18.5 23.6 13.3 11.2 60.8 55.6 40.3 27.1 15.1 24.2 37.6 10.6 50.7 27.6 9.0 15.9 35.5 19.0 13.2 25.3 14.6 12.7 57.2 13.9 15.3 17.4 58.6 17.5 25.3 9.4 10.6 26.6 24.8 63.7 17.5 32.9 31.2 47.8 26.1 27.5 17.0 15.1 10.3 19.1 19.1 7.9 18.3 30.3 31.8 14.9 16.6 21.9 21.8 15.0 16.3 99.1 41.5 32.3 15.5 40.1 31.5 13.6 18.0 34.3 34.3 21.3 6.4 17.8 16.5 47.2 30.7 21.2 22.8 39.2 43.1 15.4 16.5 31.5 26.2 25.7 24.6 25.8 17.6 22.9 38.7 48.9 10.1 8.2 18.5 26.8 24.5 19.8 24.8 24.7 16.3 35.8 16.2 26.1 13.5 14.1 43.3 13.8 29.7 1.0 4.0 2.1 6.2 5.7 7.8 4.7 6.2 5.6 6.2 4.0 5.7 6.0 0.7 4.3 4.2 11.6 6.2 4.2 47.6 47.7 53.4 47.4 42.2 60.9 60.8 55.6 40.3 50.7 57.2 58.6 63.7 7.1 6.4 9.2 31.3 8.3 7.6 14.0 9.9 21.6 11.0 17.3 10.5 16.3 11.5 6.1 20.2 4.2 18.3 5.1 6.5 23.5 4.4 2.0 13.1 11.1 6.1 12.1 11.3 15.6 4.9 12.0 11.5 6.6 12.0 0.0 11.0 7.9 11.9 7.5 16.8 20.6 9.6 8.2 4.7 4.1 3.8 9.3 5.5 16.0 6.5 17.0 28.1 5.2 20.6 12.2 3.2 8.1 10.9 10.7 10.3 4.0 14.3 8.2 11.4 13.1 11.4 9.3 4.5 5.7 17.1 8.0 11.2 7.2 18.5 14.0 10.2 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 250.5;lymphoid tissue: 171.6;skeletal muscle: 86.3" "Group enriched" "Detected in some" 6 "Excitatory neurons: 861.9;Oligodendrocyte precursor cells: 624.8" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Region enhanced" "Detected in many" "basal ganglia: 250.5" "Immune cell enriched" "Detected in single" 30 "plasmacytoid DC: 10.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 10.1" "Cell line enhanced" "Detected in some" "JURKAT: 111.4;MOLT-4: 68.4;REH: 37.3;RH-30: 20.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 254.3" HPA017303 Enhanced Supported Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 0.2 0.2 21.8 0.4 250.5 4.5 0.1 80.7 84.9 0.0 0.0 0.4 0.2 0.0 0.0 2.6 0.0 0.0 0.1 46.8 30.7 1.1 2.3 0.1 0.1 33.6 22.1 45.3 0.0 0.1 0.0 12.7 0.0 69.1 1.2 0.4 2.9 2.1 0.2 86.3 0.2 0.3 0.0 0.0 0.2 0.2 0.0 27.9 171.6 0.5 49.0 0.4 0.0 0.0 49.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.6 0.0 5.2 0.0 0.0 0.0 0.6 0.0 111.4 0.0 0.2 2.6 0.0 68.4 0.0 0.1 0.0 2.7 37.3 20.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 21.8 250.5 80.7 84.9 46.8 30.7 33.6 22.1 45.3 69.1 0.0 27.9 49.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 861.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 108.2 0.0 0.0 0.0 0.0 3.5 0.3 0.1 0.0 21.5 0.1 0.0 0.0 624.8 85.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.5 0.0 21.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TADA2B MGC21874 ENSG00000173011 "Transcriptional adaptor 2B" Q86TJ2 4 7041899-7057952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 40.4;Rod photoreceptor cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035770 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035770: AB_10603993" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "unprognostic (6.61e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (2.99e-1)" "unprognostic (6.03e-2)" "unprognostic (8.91e-3)" "unprognostic (1.72e-1)" "prognostic favorable (7.17e-11)" "unprognostic (5.00e-2)" "unprognostic (1.58e-1)" "unprognostic (2.59e-2)" "prognostic favorable (1.59e-4)" 11.0 16.4 7.6 13.3 8.1 35.7 10.6 9.3 10.3 10.6 7.7 12.2 13.6 11.9 8.2 14.7 12.3 10.3 20.8 10.9 6.3 12.5 15.8 11.8 18.0 8.6 7.0 7.3 19.4 30.4 16.9 9.2 10.9 8.6 12.9 10.4 20.4 24.7 13.1 52.4 11.7 13.1 11.7 6.1 15.5 14.7 15.6 7.9 12.1 16.5 42.7 12.7 11.6 9.3 8.2 11.5 17.2 11.8 14.0 12.8 14.5 11.3 16.5 16.9 20.9 12.8 17.0 16.8 15.2 9.6 18.4 27.8 9.2 16.3 8.7 13.4 9.0 12.5 15.5 10.5 12.9 15.6 17.9 24.3 10.5 18.2 13.9 16.1 14.4 9.8 13.9 17.6 23.9 15.8 11.0 21.8 15.3 14.0 15.3 26.4 14.0 24.1 8.0 19.1 15.9 19.2 13.8 14.2 12.6 16.6 9.5 19.0 26.6 15.3 13.2 10.2 16.1 22.9 21.6 19.5 19.7 10.9 9.7 13.7 0.7 1.3 6.9 2.7 1.7 1.9 2.5 1.7 2.6 1.2 1.7 2.3 1.7 4.4 1.5 2.1 1.3 2.0 1.2 7.6 8.1 9.3 10.3 10.9 6.3 8.6 7.0 7.3 8.6 6.1 7.9 8.2 7.1 9.6 15.0 7.2 9.0 4.6 2.7 3.3 0.6 27.1 12.4 8.0 12.7 4.3 9.1 7.3 31.3 3.6 14.2 10.6 5.9 4.5 2.9 8.6 9.0 6.4 7.2 2.1 5.0 9.3 2.9 8.0 8.2 8.7 9.5 6.3 4.2 16.7 5.7 40.4 5.2 9.5 4.1 8.8 4.2 4.8 16.8 7.0 7.2 1.9 8.1 10.4 6.2 5.0 3.7 7.9 7.8 12.8 5.1 5.8 8.7 7.6 7.1 38.3 0.0 12.4 5.2 6.1 4.5 3.6 5.8 4.4 10.1 12.5 6.9 5.4 CCDC96 FLJ90575 ENSG00000173013 "Coiled-coil domain containing 96" Q2M329 4 7040849-7043001 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 65.9" "Cell type enhanced" "Detected in many" "Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 5.3" HPA047546 Enhanced NA NA "HPA047546: AB_2680082" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "unprognostic (7.95e-2)" "prognostic favorable (4.05e-4)" "unprognostic (1.22e-2)" "unprognostic (3.51e-3)" "unprognostic (1.77e-1)" "unprognostic (9.24e-3)" "unprognostic (1.01e-2)" "unprognostic (3.92e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.43e-1)" "prognostic favorable (3.80e-5)" "unprognostic (4.37e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 0.8 2.1 3.1 0.5 2.2 1.3 1.2 2.9 2.1 0.9 5.1 0.7 0.9 0.8 0.7 1.3 10.7 0.8 0.6 2.4 2.3 1.4 0.6 1.7 0.8 3.0 2.8 1.5 0.8 1.3 1.0 3.3 0.5 3.0 1.0 0.6 1.8 1.0 1.1 1.1 1.7 0.8 0.6 3.0 0.8 1.1 65.9 2.1 0.7 1.5 0.7 0.7 0.8 0.9 2.1 1.0 2.7 1.4 1.1 1.8 1.2 0.3 2.7 1.6 3.0 1.8 0.9 2.4 0.6 0.7 1.5 3.9 1.2 0.5 1.2 0.9 0.1 0.4 0.6 1.1 0.7 0.9 0.8 1.5 1.1 1.3 1.8 0.2 0.3 1.2 1.9 0.4 0.2 1.9 2.4 1.6 1.0 0.5 0.9 1.6 0.6 0.9 0.1 5.3 1.0 3.8 0.8 2.2 1.0 0.5 1.3 1.0 1.5 1.3 2.5 0.7 1.5 2.1 0.0 0.1 0.5 1.9 0.0 0.8 0.0 0.4 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.5 0.0 0.0 0.5 0.1 0.1 1.0 0.0 0.0 0.1 3.1 2.2 2.9 2.1 2.4 2.3 3.0 2.8 1.5 3.0 3.0 2.1 2.1 3.1 0.0 4.8 0.0 1.0 0.6 0.8 2.8 0.6 4.0 3.7 3.2 0.9 0.0 6.9 3.7 12.5 0.6 0.7 2.5 1.9 2.2 76.7 59.7 4.0 2.3 5.4 0.0 0.0 1.1 0.6 1.5 0.5 2.4 0.0 0.6 2.9 0.9 1.2 0.0 0.0 1.9 4.1 2.2 0.9 93.4 3.1 1.7 1.8 0.0 1.1 6.9 0.0 0.0 0.0 1.7 2.7 4.1 0.1 1.2 0.2 4.5 53.4 19.6 0.0 4.6 2.3 30.6 3.6 1.2 1.0 0.5 0.8 2.7 0.8 0.9 GRK2 "ADRBK1, BARK1" ENSG00000173020 "G protein-coupled receptor kinase 2" P25098 11 67266473-67286556 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 198.9" "Cell type enhanced" "Detected in many" "Adipocytes: 33.4;dendritic cells: 80.2;Hofbauer cells: 35.8;Macrophages: 37.6;Pancreatic endocrine cells: 32.4;T-cells: 31.0;Theca cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 318.0;REH: 417.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005021, CAB037248, HPA060707" Enhanced Approved Cytosol NA NA Cytosol "CAB005021: AB_562360, CAB037248: AB_1078280, HPA060707: " "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (2.01e-2)" "unprognostic (5.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.29e-3)" "unprognostic (3.31e-2)" "unprognostic (6.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-2)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (3.66e-1)" "unprognostic (2.40e-1)" "unprognostic (4.04e-2)" "unprognostic (5.19e-3)" 41.3 35.9 36.8 73.6 37.0 198.9 38.4 26.4 64.3 41.5 15.7 47.1 38.6 35.0 10.4 68.6 41.9 29.1 44.7 38.8 27.4 38.9 47.8 64.6 103.3 30.7 26.7 37.1 30.3 33.4 16.4 37.8 25.7 33.7 59.6 33.6 8.0 47.5 23.0 56.0 68.8 89.4 25.3 25.5 188.3 45.7 24.3 27.9 75.4 32.5 41.3 78.4 41.7 47.8 35.7 43.1 29.8 28.1 48.0 22.2 19.9 28.7 24.7 23.4 33.0 27.4 67.1 69.0 215.3 39.5 23.0 44.0 56.7 41.3 33.5 17.2 264.4 26.3 122.5 35.4 30.8 27.9 259.5 238.3 18.0 38.2 26.5 34.8 24.4 42.8 87.7 45.3 107.7 29.0 80.7 147.5 318.0 35.3 125.8 44.4 417.0 55.3 65.2 34.0 54.6 57.0 30.8 36.9 52.9 90.5 16.9 49.7 283.0 24.5 26.7 34.8 33.6 28.4 69.2 67.5 195.3 34.0 153.6 24.6 12.6 17.8 19.2 8.4 27.6 6.3 6.1 6.3 7.0 10.2 6.4 5.0 4.9 35.7 6.9 33.7 9.0 4.4 15.9 36.8 37.0 26.4 64.3 38.8 27.4 30.7 26.7 37.1 33.7 25.5 27.9 35.7 33.4 3.2 17.9 0.0 16.7 0.0 0.0 0.0 0.0 0.0 24.5 19.7 0.0 0.0 4.3 5.5 0.0 8.9 80.2 0.0 1.9 10.3 0.0 16.6 14.7 9.0 0.0 0.0 0.0 12.6 5.9 6.1 0.0 18.9 21.5 22.3 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 32.4 0.0 0.0 17.7 0.0 0.0 5.6 0.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 9.6 31.0 36.3 0.0 0.0 RELA "NFKB3, p65" ENSG00000173039 "RELA proto-oncogene, NF-kB subunit" Q04206 11 65653597-65663090 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004264, CAB005030, HPA063461" Supported Enhanced Cytosol NA NA Cytosol "CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016" "unprognostic (9.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.04e-1)" "unprognostic (3.22e-1)" "unprognostic (7.67e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.30e-3)" "unprognostic (1.69e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (5.66e-4)" "unprognostic (2.78e-1)" "unprognostic (1.46e-1)" "unprognostic (9.81e-2)" "unprognostic (2.53e-1)" 66.0 43.1 25.3 38.8 26.2 80.4 63.7 26.0 35.3 61.2 24.5 57.1 31.5 61.5 23.2 61.3 62.8 35.0 49.1 23.8 30.4 48.5 67.2 70.9 40.0 33.9 27.9 21.2 65.9 49.4 26.1 32.6 28.1 28.8 56.1 24.0 9.8 54.8 35.7 75.5 65.6 49.5 40.2 27.1 60.2 57.2 24.3 28.8 30.6 45.3 27.1 37.0 60.8 59.9 31.4 66.9 68.4 31.4 45.2 49.1 49.6 32.2 52.9 65.6 62.3 49.9 33.0 71.1 53.0 85.5 75.4 72.0 63.9 36.8 66.6 35.5 62.1 53.2 57.5 50.1 47.5 56.7 43.8 78.8 55.4 65.3 70.4 79.2 58.9 76.6 43.7 56.6 61.4 48.5 90.3 74.1 38.5 20.9 43.6 64.6 61.5 29.6 80.6 50.7 60.9 26.6 59.5 47.1 72.7 72.4 22.2 82.3 29.4 100.3 65.8 55.3 103.3 50.9 86.0 80.5 53.6 71.7 30.8 65.4 12.5 14.0 18.6 22.7 17.1 25.5 17.3 19.8 22.4 15.4 14.0 18.4 20.0 21.2 25.2 15.4 15.3 21.4 16.5 25.3 26.2 26.0 35.3 23.8 30.4 33.9 27.9 21.2 28.8 27.1 28.8 31.4 43.2 32.1 25.5 9.1 33.9 47.3 54.4 41.3 33.0 9.4 31.6 27.9 23.1 17.2 30.9 11.0 8.4 24.0 40.7 30.9 29.4 41.4 5.1 32.8 25.7 43.9 19.7 19.0 5.5 45.1 24.8 30.1 33.1 50.0 44.3 26.2 32.9 20.3 24.3 15.2 5.9 25.0 32.6 24.9 40.4 7.7 28.9 28.0 32.0 10.3 35.2 14.5 28.8 7.5 13.8 65.4 20.8 26.4 30.7 66.8 22.2 17.4 23.4 9.5 13.1 30.5 34.7 14.3 20.3 29.2 43.2 43.6 37.9 21.0 21.6 75.1 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Microtubules, Cytokinetic bridge" "Nucleoplasm, Cytosol" "HPA040910: AB_2677195, HPA048122: AB_2680272" "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favorable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 4.4 0.7 1.7 1.5 1.3 0.1 3.6 1.2 1.9 5.9 2.3 3.0 0.6 4.7 1.7 2.2 4.8 2.7 2.4 1.4 2.3 2.5 0.7 2.1 2.0 1.6 1.3 0.7 7.8 1.7 3.1 1.1 1.3 1.2 3.3 0.6 0.3 2.8 2.0 1.1 3.6 2.0 2.4 1.5 1.0 2.1 1.6 1.3 1.0 3.9 1.9 1.7 4.1 4.4 1.7 0.0 2.7 0.0 6.6 8.4 9.3 0.0 4.1 9.7 3.6 6.0 0.0 0.0 5.2 0.0 3.3 2.0 2.8 0.0 1.7 3.4 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 5.9 4.6 4.6 10.6 0.0 3.9 0.0 0.0 0.2 5.3 0.0 0.0 0.0 3.9 0.0 0.0 8.6 8.2 0.0 0.4 0.0 0.4 0.6 0.0 0.0 0.0 1.6 0.0 0.5 6.7 0.0 0.0 2.4 0.0 4.1 4.7 1.2 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.3 1.2 1.9 1.4 2.3 1.6 1.3 0.7 1.2 1.5 1.3 1.7 0.6 0.0 0.5 17.6 0.8 2.2 4.9 2.3 12.0 0.0 0.9 2.2 1.0 1.5 1.3 0.0 0.0 8.3 1.7 0.0 0.0 1.9 2.2 0.7 5.6 1.2 0.0 0.4 0.3 0.5 0.3 8.9 0.5 1.7 2.5 4.7 1.4 0.1 0.5 0.0 0.3 0.0 0.0 0.3 1.2 0.9 11.5 0.8 0.0 6.5 0.0 1.9 1.0 1.0 0.3 0.6 0.0 7.9 1.7 2.8 0.0 0.9 1.0 0.1 0.0 14.7 3.2 1.8 2.1 4.4 0.9 1.4 2.8 3.4 0.0 1.4 ZNF680 FLJ90430 ENSG00000173041 "Zinc finger protein 680" Q8NEM1 7 64519878-64563075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 116.9;Oligodendrocytes: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.65e-1)" "unprognostic (3.21e-2)" "unprognostic (6.88e-2)" "unprognostic (7.41e-2)" "unprognostic (1.52e-3)" "unprognostic (3.62e-2)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (1.07e-2)" "unprognostic (1.20e-1)" "unprognostic (2.46e-1)" "unprognostic (5.72e-2)" "unprognostic (1.35e-1)" "unprognostic (8.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (8.05e-3)" 5.9 13.8 9.7 3.8 11.8 2.5 13.2 16.3 15.7 6.2 4.8 3.8 2.8 4.9 5.8 3.6 5.1 5.3 11.4 9.8 9.6 8.5 20.3 4.9 6.6 10.1 11.6 6.7 11.0 4.9 3.7 4.0 4.6 11.4 10.2 5.2 4.9 4.2 5.4 11.7 5.8 3.3 4.6 10.5 6.7 6.4 4.2 12.1 6.7 25.2 15.4 5.4 4.5 4.2 13.9 5.6 3.2 12.8 15.3 6.2 6.9 8.0 4.4 3.6 7.9 9.8 4.4 10.6 10.6 10.7 4.2 9.0 3.8 10.5 4.9 12.9 2.0 7.4 8.1 6.7 4.0 2.6 10.8 7.1 4.6 5.8 7.0 7.9 9.9 7.5 14.6 14.8 0.0 11.1 4.4 16.8 17.1 15.0 5.0 3.9 13.0 12.7 32.1 10.8 17.6 10.1 13.8 13.5 12.7 4.9 23.5 12.7 4.6 4.0 9.6 4.8 4.5 7.8 9.1 12.3 29.9 0.5 9.8 8.6 2.8 0.5 0.6 1.5 0.7 1.2 2.2 2.1 1.8 0.9 1.5 2.2 2.1 0.2 4.6 0.6 0.7 0.6 0.8 9.7 11.8 16.3 15.7 9.8 9.6 10.1 11.6 6.7 11.4 10.5 12.1 13.9 10.2 12.8 5.1 116.9 15.4 4.2 10.7 9.4 19.9 12.5 17.5 9.5 13.3 14.3 11.6 25.8 4.2 12.0 11.5 2.8 9.8 8.9 0.9 8.9 9.1 11.0 0.0 7.2 57.7 9.1 10.7 13.4 11.7 6.4 7.0 34.0 23.9 21.5 5.3 1.7 60.5 4.4 16.2 10.1 6.4 2.4 27.7 6.2 7.2 41.2 7.3 23.8 23.7 59.8 89.2 5.8 3.1 22.2 6.3 9.5 3.1 7.1 6.8 9.3 19.7 15.2 9.7 13.7 15.1 6.5 5.3 7.1 11.2 16.5 5.3 9.4 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 141.8;Excitatory neurons: 190.4;Inhibitory neurons: 180.0;Oligodendrocyte precursor cells: 109.1;Oligodendrocytes: 138.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA041062: AB_2677281, HPA045473: AB_2679338" "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.5 6.6 3.0 3.1 5.5 14.3 6.9 13.8 5.7 9.5 2.2 10.0 2.1 9.6 4.0 11.1 8.4 3.2 6.8 4.2 3.8 7.5 7.7 7.8 3.8 1.4 2.2 5.0 8.6 8.9 6.2 11.8 4.2 4.9 10.6 3.6 10.9 8.0 4.1 8.1 10.5 7.6 4.2 0.5 7.6 10.1 6.9 2.0 6.6 13.6 5.6 4.1 8.8 9.8 5.5 5.1 9.2 7.7 6.1 8.7 7.4 3.2 3.2 3.6 4.8 4.0 8.6 1.3 5.2 3.2 6.7 5.4 4.6 10.8 4.3 3.9 7.0 9.4 8.6 10.7 3.8 2.6 6.1 6.3 4.7 4.8 7.3 5.1 8.7 7.7 9.6 10.2 3.9 4.5 4.4 6.7 7.7 3.3 5.7 7.1 8.3 4.2 3.3 2.4 8.8 12.8 8.0 9.2 7.5 2.8 7.2 5.3 6.7 11.0 5.2 4.0 5.7 4.6 11.8 5.7 6.5 4.1 3.3 2.9 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.0 0.0 3.0 5.5 13.8 5.7 4.2 3.8 1.4 2.2 5.0 4.9 0.5 2.0 5.5 14.7 19.2 20.8 96.9 15.7 11.5 8.4 8.3 18.8 54.3 15.1 11.7 20.1 12.8 9.4 12.9 141.8 10.9 15.2 14.6 0.0 8.0 7.0 23.9 25.9 14.2 27.6 47.4 190.4 8.7 5.2 11.2 23.9 32.2 8.2 17.9 15.7 15.2 6.6 80.8 180.0 14.2 8.2 11.1 6.7 6.3 11.5 12.6 7.2 66.5 11.1 17.7 14.4 109.1 138.8 10.3 9.0 15.8 15.8 12.8 9.2 5.6 16.0 53.8 0.0 19.3 14.6 25.0 7.8 22.1 14.9 8.9 12.9 12.4 14.0 9.0 FAM222B "C17orf63, FLJ10700" ENSG00000173065 "Family with sequence similarity 222 member B" Q8WU58 17 28755978-28855232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.8;Inhibitory neurons: 84.7;Oligodendrocytes: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051840, HPA062239" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051840: AB_2681633, HPA062239: AB_2684722" "unprognostic (4.11e-2)" "unprognostic (9.72e-2)" "unprognostic (9.12e-2)" "unprognostic (2.40e-3)" "unprognostic (1.57e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.18e-2)" "unprognostic (1.05e-1)" "unprognostic (8.28e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (3.70e-2)" "unprognostic (2.37e-2)" "unprognostic (1.46e-1)" "unprognostic (3.61e-2)" "unprognostic (7.18e-2)" 8.5 6.4 6.5 7.0 6.5 7.1 8.4 13.0 9.6 8.6 14.7 11.3 12.4 7.6 7.8 11.1 7.1 8.7 9.9 6.3 4.2 10.5 7.8 8.1 6.6 8.3 6.4 3.6 8.5 8.1 10.6 10.3 9.9 8.0 9.4 10.1 10.0 14.3 8.9 43.8 7.8 11.1 7.1 2.7 6.7 8.5 27.7 8.9 7.9 8.6 16.3 7.2 10.8 9.9 10.2 13.1 25.1 21.2 24.4 17.7 12.3 23.2 9.1 8.5 12.5 12.6 32.4 12.6 13.3 17.9 10.2 16.0 16.2 17.7 20.4 10.4 18.7 24.1 15.0 12.9 24.9 20.4 9.9 23.1 12.9 19.8 17.7 15.7 12.6 25.2 15.5 29.1 9.2 26.4 16.5 16.9 7.9 24.3 17.5 9.4 7.9 20.1 13.4 22.4 16.4 23.0 16.1 12.9 24.8 31.8 44.0 18.9 9.3 28.8 8.3 17.1 9.4 14.5 18.5 24.9 8.8 11.4 6.8 15.5 15.9 3.9 9.5 6.4 5.0 7.6 6.2 5.4 6.6 5.4 4.6 7.3 6.3 4.5 3.9 7.9 4.9 5.2 4.2 6.5 6.5 13.0 9.6 6.3 4.2 8.3 6.4 3.6 8.0 2.7 8.9 10.2 10.3 3.2 7.3 49.3 12.0 9.4 7.7 14.7 9.1 14.8 14.7 10.3 13.6 31.5 9.1 7.3 27.1 7.9 6.5 22.9 3.9 18.1 56.9 11.0 10.8 13.7 25.9 14.7 73.8 13.3 10.6 7.9 11.7 17.1 10.1 8.1 31.4 11.4 8.7 25.2 84.7 17.3 20.3 8.4 5.7 45.3 12.5 6.8 7.2 41.2 8.3 6.2 8.2 64.3 79.0 24.1 12.7 7.9 8.6 14.0 18.3 11.2 10.0 8.0 0.0 9.5 6.5 51.9 34.8 9.2 6.7 6.0 10.7 8.1 19.0 10.4 BNC2 "BSN2, FLJ20043" ENSG00000173068 "Basonuclin 2" Q6ZN30 9 16409503-16870843 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.2;ovary: 32.0;smooth muscle: 32.0" "Cell type enhanced" "Detected in many" "Astrocytes: 46.7;Leydig cells: 90.1;Microglial cells: 230.5;Peritubular cells: 67.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "gdT-cell: 2.5" "Lineage enriched" "Detected in single" 5 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HSkMC: 31.9;Karpas-707: 40.4;RPMI-8226: 28.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA018525, HPA059419" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018525: AB_1845402, HPA059419: AB_2732637" "unprognostic (2.68e-1)" "unprognostic (2.89e-1)" "unprognostic (3.64e-2)" "unprognostic (1.14e-2)" "unprognostic (1.56e-2)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (2.50e-1)" "unprognostic (1.94e-2)" "unprognostic (6.05e-2)" "unprognostic (5.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (6.74e-2)" "unprognostic (1.14e-3)" 5.4 1.0 1.6 3.7 2.0 0.8 3.3 2.5 4.6 11.9 7.9 7.4 1.3 27.2 2.2 4.6 18.6 7.3 2.0 2.6 3.6 6.5 0.3 3.1 0.8 4.7 4.7 0.5 32.0 0.5 2.9 1.7 3.4 4.4 3.8 3.0 0.9 1.3 4.8 3.5 2.8 3.4 32.0 4.4 0.7 3.0 7.0 3.6 2.5 2.1 1.9 1.1 6.4 5.9 5.1 0.3 1.7 1.2 0.1 17.5 21.1 2.7 11.4 19.5 7.8 6.4 0.1 0.0 0.0 3.7 7.8 5.8 0.1 5.1 0.0 7.9 0.2 2.0 0.1 5.3 0.0 13.4 0.1 0.5 31.9 0.0 16.6 0.1 13.7 18.0 0.0 0.0 40.4 11.1 0.0 0.0 2.8 6.6 0.1 10.2 0.0 12.5 28.0 6.0 0.3 0.2 1.0 0.1 0.1 18.6 8.3 0.1 0.0 17.7 18.6 13.5 15.1 20.9 0.2 0.0 0.1 7.6 2.5 2.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 1.5 1.6 2.0 2.5 4.6 2.6 3.6 4.7 4.7 0.5 4.4 4.4 3.6 5.1 5.5 0.0 2.2 46.7 0.0 10.1 0.6 0.0 33.6 8.2 0.2 0.4 4.8 0.0 0.6 0.0 0.0 3.2 10.7 0.1 0.0 1.0 7.2 2.2 9.1 10.5 0.0 0.0 1.6 0.4 1.2 38.6 3.1 2.0 22.2 25.1 10.4 0.3 7.3 0.0 1.9 1.1 6.1 1.6 2.3 4.5 90.1 4.2 10.6 230.5 0.1 2.6 30.9 1.0 1.6 0.1 0.0 67.7 3.9 0.7 5.7 35.5 0.7 0.3 6.6 31.5 5.1 0.9 13.5 5.7 5.5 1.2 3.1 36.5 1.8 0.1 RXFP4 "GPCR142, GPR100, RLN3R2, RXFPR4" ENSG00000173080 "Relaxin family peptide/INSL5 receptor 4" Q8TDU9 1 155941638-155943087 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;intestine: 1.8" "Cell type enriched" "Detected in some" 21 "Enteroendocrine cells: 58.3" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.4" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (3.64e-2)" "unprognostic (1.84e-3)" "unprognostic (2.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.17e-2)" "unprognostic (4.73e-2)" "unprognostic (2.87e-1)" "unprognostic (8.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (3.86e-2)" 0.0 0.0 0.0 0.2 0.2 0.6 0.0 1.9 0.2 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 1.9 0.2 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 HPSE "HPA, HPSE1, HSE1" ENSG00000173083 Heparanase Q9Y251 4 83292461-83335153 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Cell adhesion" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "classical monocyte: 27.2;neutrophil: 18.5" "Group enriched" "Detected in many" 4 "granulocytes: 18.5;monocytes: 27.2" "Cell line enhanced" "Detected in many" "Karpas-707: 39.8;OE19: 40.1;TIME: 25.8" "Region enhanced" "Detected in some" "olfactory bulb: 3.7" "Low region specificity" "Detected in all" "CAB009813, HPA055344" Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" No No 6500000 Nucleoplasm Vesicles "CAB009813: AB_2120854, HPA055344: " "unprognostic (6.57e-2)" "unprognostic (1.22e-2)" "unprognostic (9.13e-2)" "unprognostic (5.92e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.24e-2)" "unprognostic (5.65e-2)" "unprognostic (7.06e-2)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (9.62e-3)" "unprognostic (3.27e-1)" "unprognostic (2.78e-1)" "unprognostic (3.04e-3)" "unprognostic (4.15e-2)" "unprognostic (3.70e-3)" 2.2 4.6 0.7 6.6 1.0 2.3 1.0 0.6 2.0 1.6 0.4 6.0 2.2 2.7 0.2 10.0 4.0 2.7 0.6 0.9 0.9 1.6 2.4 3.3 4.6 1.4 1.0 0.6 4.5 0.8 5.6 1.2 2.1 1.8 0.6 6.5 0.2 9.8 0.6 0.3 5.3 2.8 1.9 1.2 6.1 2.0 5.7 1.7 2.0 0.7 0.3 3.9 3.1 3.3 3.7 13.5 0.6 0.1 1.7 3.2 0.9 0.1 1.5 8.2 3.6 16.5 0.0 11.0 0.4 2.3 4.2 20.8 12.3 16.8 2.5 6.5 1.4 1.7 4.2 9.0 0.2 1.4 2.5 8.4 1.8 5.1 2.4 15.4 1.4 18.1 2.4 0.1 39.8 1.5 2.8 0.2 0.3 0.7 40.1 2.6 0.0 0.4 0.6 10.2 0.3 9.3 0.0 17.7 9.8 1.4 2.6 1.5 3.8 25.8 1.5 4.6 1.4 1.7 0.5 6.2 0.2 9.9 11.4 2.7 0.4 27.2 0.0 1.4 10.1 1.0 0.2 2.7 1.0 3.0 0.3 1.7 1.6 18.5 2.3 1.5 0.1 5.2 7.9 0.7 1.0 0.6 2.0 0.9 0.9 1.4 1.0 0.6 1.8 1.2 1.7 3.7 0.3 6.4 4.4 0.0 0.7 3.4 3.0 3.3 2.8 0.0 0.3 0.5 0.6 0.0 5.6 1.8 0.0 0.5 2.4 10.1 0.0 1.9 0.6 2.3 3.7 1.0 6.6 2.7 0.8 1.3 2.9 1.4 4.1 13.2 0.0 0.4 2.9 0.6 16.4 0.0 3.8 2.8 0.0 41.5 3.0 0.3 0.6 20.2 0.0 7.5 33.9 0.0 3.1 0.0 0.1 1.1 6.7 0.0 0.7 1.7 4.1 0.0 2.8 0.0 0.0 0.1 1.2 0.2 1.0 4.0 3.7 1.5 6.2 1.4 4.6 3.7 COQ2 "CL640, FLJ26072" ENSG00000173085 "Coenzyme Q2, polyprenyltransferase" Q96H96 4 83261536-83284914 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 37.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 50.7;Kupffer cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056599, HPA068727" Approved Approved Cytosol NA NA Cytosol "HPA056599: AB_2683184, HPA068727: AB_2686022" "unprognostic (8.26e-2)" "unprognostic (7.40e-3)" "unprognostic (3.95e-3)" "unprognostic (1.55e-1)" "unprognostic (9.22e-2)" "unprognostic (5.59e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (4.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.56e-2)" "unprognostic (3.73e-1)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (2.46e-1)" 6.1 17.1 2.9 8.1 3.4 11.9 5.8 3.7 3.7 7.9 3.6 14.3 9.6 6.4 7.6 10.5 4.5 4.3 15.2 3.0 7.1 5.6 13.7 8.0 6.4 3.7 3.5 2.7 6.6 6.6 6.1 4.0 8.5 3.8 6.6 14.4 4.0 7.8 5.1 29.4 10.2 9.2 6.9 3.8 10.1 5.5 3.5 3.7 3.7 5.8 37.8 7.1 8.0 6.5 5.3 26.1 14.7 14.1 27.4 10.5 11.9 9.7 16.1 27.0 29.7 34.4 10.5 38.7 17.2 11.7 28.4 24.6 18.6 23.9 26.0 38.7 17.2 14.8 15.3 22.3 15.4 11.7 31.3 73.5 15.9 16.3 14.2 24.8 8.9 30.7 9.7 10.0 21.4 29.3 27.4 8.6 21.7 10.9 30.6 19.9 14.1 11.4 22.1 45.4 13.8 10.3 6.3 19.0 24.5 9.2 6.7 15.4 18.8 21.0 14.6 14.6 11.1 23.4 5.7 5.2 10.2 29.5 36.8 20.2 2.1 28.8 4.0 2.7 26.8 1.9 6.2 3.0 2.5 21.1 6.9 2.1 3.2 9.8 6.7 33.5 11.2 4.1 13.6 2.9 3.4 3.7 3.7 3.0 7.1 3.7 3.5 2.7 3.8 3.8 3.7 5.3 5.4 0.0 4.2 15.7 11.5 6.6 12.4 9.8 4.6 5.9 6.3 5.6 19.5 2.8 10.7 9.2 0.0 25.4 7.1 14.0 31.3 6.7 0.8 7.6 19.5 6.1 4.8 14.1 12.8 10.8 30.0 9.0 6.6 9.2 0.0 17.2 9.3 15.0 50.7 1.7 20.1 15.3 8.2 53.2 7.9 0.8 3.7 25.2 7.2 33.7 21.8 12.6 6.2 25.6 15.6 5.4 15.4 4.9 4.3 12.6 11.0 9.9 6.2 4.8 0.0 7.3 9.7 18.1 19.7 16.7 12.6 12.4 9.6 35.5 26.7 12.9 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.5" "Group enriched" "Detected in some" 32 "Early spermatids: 305.6;Late spermatids: 241.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "MCF7: 4.4" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 241.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 4.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526894 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 511.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebral cortex: 511.3" "Immune cell enriched" "Detected in many" 7 "neutrophil: 317.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 317.9" "Cell line enriched" "Detected in some" 7 "Karpas-707: 50.7" "Low region specificity" "Detected in all" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854" "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 15.0 15.8 26.6 9.9 17.3 3.7 3.6 23.5 511.3 2.3 24.3 8.7 1.7 1.7 0.7 7.3 3.8 8.7 24.8 86.3 18.2 26.9 33.2 95.3 2.4 28.7 14.1 10.5 47.2 6.0 1.1 24.0 20.6 32.8 3.4 1.7 1.8 3.3 5.0 3.9 6.7 5.2 2.4 16.5 64.1 34.7 2.4 22.6 1.3 12.9 3.7 1.8 18.6 11.0 52.3 0.8 1.5 0.0 0.3 0.0 1.1 1.0 0.6 0.5 0.2 0.4 0.5 0.7 0.2 2.2 0.2 0.8 0.4 0.5 0.4 0.3 0.5 0.1 0.3 1.4 0.0 0.0 0.1 3.3 0.2 1.0 0.5 0.0 0.0 0.0 0.2 0.6 50.7 0.0 0.0 0.3 1.3 0.1 0.3 5.4 0.0 0.1 0.7 0.0 0.3 0.1 0.0 0.2 0.9 3.1 0.1 0.4 0.7 0.2 0.1 0.5 0.4 3.6 6.9 0.4 0.0 1.3 1.3 2.3 6.5 35.1 13.4 6.4 44.1 1.0 0.2 0.7 3.4 12.2 0.0 0.0 1.6 317.9 8.3 37.7 0.2 0.0 11.8 26.6 17.3 23.5 511.3 86.3 18.2 28.7 14.1 10.5 32.8 16.5 22.6 52.3 14.0 9.6 9.3 0.3 23.8 29.3 335.3 4.4 5.2 42.5 8.7 36.2 11.1 0.0 12.2 5.5 127.2 1.8 12.8 25.3 0.0 0.4 3.2 16.2 16.4 36.7 71.0 24.0 0.0 0.0 11.2 98.8 30.1 26.2 2.5 0.0 3.9 0.3 76.0 10.1 0.0 71.0 4.1 47.8 478.8 1.1 5.6 213.7 103.2 1.0 15.8 36.1 5.2 0.0 0.1 0.3 16.5 0.0 104.1 180.1 0.0 1.5 17.1 36.9 0.0 11.1 235.6 2.9 0.6 16.5 21.7 18.3 391.3 3.6 67.3 92.7 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64317559 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules NA NA 17000 Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 152.5 275.9 157.5 110.5 156.2 150.9 153.8 157.3 183.8 176.6 170.6 127.9 69.1 174.5 141.9 169.1 169.0 91.8 134.1 154.2 168.5 176.5 166.0 130.7 172.3 164.8 161.9 151.8 240.2 146.7 110.8 183.5 113.1 165.0 138.9 66.0 64.9 117.5 97.3 160.7 145.7 110.9 106.5 160.9 148.0 130.5 131.7 166.1 153.7 143.2 82.5 154.7 147.1 151.5 174.3 411.4 590.3 203.2 298.9 238.0 195.8 199.9 195.3 245.2 231.2 188.3 308.0 401.7 320.5 575.6 204.5 353.1 338.8 367.8 430.1 157.7 373.0 340.1 359.7 503.6 708.9 264.3 282.2 225.2 227.1 401.0 205.5 409.7 241.4 239.7 218.3 298.2 394.5 220.0 1070.4 414.0 527.9 543.0 279.2 511.0 249.6 233.0 451.3 270.6 416.8 133.3 599.3 278.1 322.8 571.4 178.1 503.8 249.7 197.0 241.7 297.2 408.7 365.7 338.7 591.5 512.8 330.2 276.3 255.4 780.9 377.7 573.3 428.7 331.8 444.1 956.3 559.0 481.0 404.8 808.8 617.8 534.8 459.0 392.8 303.5 671.5 551.1 883.6 157.5 156.2 157.3 183.8 154.2 168.5 164.8 161.9 151.8 165.0 160.9 166.1 174.3 234.8 160.3 164.3 8.1 269.6 349.9 421.7 465.9 299.9 89.4 219.5 323.8 137.4 135.8 255.8 274.0 22.9 561.1 239.3 96.1 491.0 232.1 71.3 270.9 200.4 236.0 154.4 251.8 10.0 224.4 469.8 249.8 96.8 257.8 217.4 251.8 189.5 196.0 395.2 52.2 10.9 160.6 205.4 174.6 312.3 63.1 299.5 179.1 336.2 12.2 321.2 177.2 247.2 9.0 24.5 221.2 126.4 218.6 296.7 304.4 111.0 610.2 305.0 88.1 216.9 196.2 246.6 230.6 531.2 276.6 396.4 412.1 261.6 258.2 155.3 386.8 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.4;thyroid gland: 19.8" "Cell type enhanced" "Detected in many" "Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9" "Lineage enriched" "Detected in single" 70 "T-cells: 32.5" "Cell line enhanced" "Detected in some" "AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.3 23.4 10.4 1.2 13.6 0.6 1.8 11.1 15.3 2.5 5.2 0.9 0.4 0.5 2.3 1.3 0.7 1.0 8.0 12.0 11.3 0.4 2.2 7.6 3.0 7.3 9.5 12.1 6.4 0.9 0.2 3.1 5.8 9.0 2.6 1.0 6.4 1.2 5.0 4.1 0.3 1.4 0.4 7.3 1.4 0.4 15.1 11.5 10.6 19.8 0.5 3.6 0.8 0.9 11.1 0.0 0.1 24.7 3.1 11.2 4.8 0.1 14.7 31.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 15.6 0.1 1.5 0.0 3.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.3 0.1 0.0 0.1 0.1 6.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.0 43.9 0.0 0.0 0.0 13.6 24.3 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 2.7 2.0 0.0 0.1 32.5 30.9 0.2 0.0 0.1 0.0 0.4 6.1 10.4 13.6 11.1 15.3 12.0 11.3 7.3 9.5 12.1 9.0 7.3 11.5 11.1 0.8 0.0 4.3 47.0 0.8 0.0 0.0 0.0 0.0 29.2 0.6 0.8 24.8 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 1.1 0.3 0.5 1.2 1.8 0.0 81.2 0.0 0.5 13.3 1.5 0.5 1.3 0.0 1.1 0.0 0.8 3.3 46.5 0.0 0.0 0.0 0.4 4.4 56.2 0.2 1.8 7.5 0.8 11.0 1.0 61.3 7.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 3.8 0.0 1.6 1.7 1.1 0.4 0.0 0.1 0.4 10.3 0.5 0.0 0.2 KDM2A "CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA" ENSG00000173120 "Lysine demethylase 2A" Q9Y2K7 11 67119263-67258082 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012272, HPA044251" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012272: , HPA044251: " "unprognostic (7.43e-2)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (8.66e-2)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (6.05e-2)" "unprognostic (2.84e-1)" "unprognostic (4.46e-1)" "unprognostic (2.04e-3)" "unprognostic (3.27e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-2)" "unprognostic (3.30e-1)" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "unprognostic (9.45e-3)" 19.6 13.3 12.1 27.5 11.7 47.6 19.9 18.2 13.1 24.0 14.5 21.0 14.8 29.3 17.5 32.1 19.5 19.2 16.9 11.8 12.1 14.2 20.0 24.2 27.8 13.0 11.2 10.2 24.7 13.1 16.3 13.2 18.2 13.3 21.8 17.2 18.7 21.5 19.4 34.1 29.0 24.1 24.2 10.3 27.2 19.0 29.3 12.2 28.1 19.2 24.8 29.0 24.1 26.1 15.0 49.9 31.8 17.6 27.7 17.1 27.0 13.5 21.5 26.6 41.0 27.9 48.7 25.4 38.8 37.5 33.3 23.8 48.2 31.3 22.5 33.1 66.4 13.4 28.9 39.2 11.7 16.9 24.5 38.1 21.7 23.9 39.4 25.7 20.7 29.9 22.7 27.4 54.4 18.6 35.4 32.5 18.1 36.1 29.8 25.6 39.9 29.4 21.4 14.7 33.7 24.2 18.9 71.0 38.6 39.0 21.6 59.9 23.9 38.7 25.0 16.7 34.5 18.8 29.3 35.4 25.4 22.0 17.2 17.8 0.4 1.1 0.3 2.5 0.8 2.7 3.6 1.9 2.3 0.6 3.6 1.9 1.9 2.7 2.7 0.5 0.9 2.6 1.9 12.1 11.7 18.2 13.1 11.8 12.1 13.0 11.2 10.2 13.3 10.3 12.2 15.0 41.4 38.5 35.8 75.1 56.6 41.2 23.3 23.4 75.7 75.3 40.3 30.9 31.1 34.3 31.0 16.5 137.6 23.9 77.5 43.2 0.0 17.3 20.6 84.8 63.0 38.4 31.8 22.1 89.4 14.5 13.4 32.4 42.8 112.3 27.3 42.1 29.3 35.5 21.5 95.9 89.8 27.5 24.4 46.5 59.6 11.2 21.5 49.1 19.6 104.0 43.3 19.8 33.0 96.0 99.5 25.9 25.5 23.0 72.5 37.2 21.2 10.3 40.0 111.7 19.7 40.2 32.3 52.0 38.1 78.7 47.7 32.3 66.9 33.8 29.5 48.7 ACSM6 "bA310E22.3, C10orf129" ENSG00000173124 "Acyl-CoA synthetase medium chain family member 6" Q6P461 10 95194200-95228928 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 3.6;pancreas: 4.1;skin 1: 1.2;stomach 1: 1.9;urinary bladder: 1.1" "Cell type enhanced" "Detected in some" "Astrocytes: 2.0;Cone photoreceptor cells: 2.1;Early spermatids: 2.4;Excitatory neurons: 3.8;Inhibitory neurons: 3.4;Oligodendrocytes: 2.1;Rod photoreceptor cells: 5.3" "Cancer enriched" "Detected in single" 7 "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "RT4: 3.7" HPA044593 Uncertain NA NA "HPA044593: AB_10960261" "unprognostic (2.91e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (5.73e-2)" "unprognostic (2.48e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (3.75e-3)" "unprognostic (2.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.71e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.9 0.1 0.1 3.6 0.4 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.4 0.0 0.0 2.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.4 0.6 1.2 0.6 0.0 0.0 3.8 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 61.7;Theca cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 3.2 9.2 0.9 1.5 1.0 0.9 3.5 0.8 2.6 4.3 0.6 5.4 4.9 3.8 0.2 6.4 3.8 0.6 3.4 1.0 0.9 4.3 6.4 2.8 1.1 1.1 0.8 1.1 4.5 5.0 0.8 3.5 0.6 1.0 4.1 0.7 0.5 4.2 0.8 4.1 4.8 8.5 0.4 0.6 5.8 4.4 6.8 0.9 1.1 3.6 0.8 0.5 4.1 4.2 0.9 2.5 3.1 0.7 2.1 0.5 0.5 3.7 2.2 1.2 1.8 0.7 3.6 2.7 1.1 1.5 0.5 0.6 3.2 0.1 2.2 0.1 2.8 1.0 2.9 2.6 3.9 1.6 0.7 2.2 1.0 1.4 0.6 0.7 0.9 1.2 2.1 1.9 1.9 0.9 6.9 2.2 2.9 0.4 2.3 2.3 2.8 1.0 2.0 1.2 2.3 0.4 1.1 3.1 2.4 1.8 0.5 2.1 1.9 0.8 0.8 3.2 2.2 1.5 0.9 0.3 1.0 1.9 2.5 1.3 0.9 2.0 1.2 1.1 2.7 1.3 0.9 1.3 0.8 3.2 2.7 1.3 0.7 0.4 1.0 2.7 2.0 2.1 1.3 0.9 1.0 0.8 2.6 1.0 0.9 1.1 0.8 1.1 1.0 0.6 0.9 0.9 5.8 3.2 1.7 4.9 6.5 4.1 3.3 10.2 2.2 10.3 5.0 6.1 2.3 7.2 6.9 5.5 16.7 4.3 6.6 33.5 3.9 9.3 8.2 3.7 4.2 5.0 8.4 3.0 7.6 7.1 11.2 4.5 20.4 4.8 8.9 16.2 2.5 8.2 8.0 3.3 8.3 31.2 12.2 5.5 4.3 11.3 5.9 5.0 3.6 2.8 9.1 6.4 7.2 4.0 2.4 9.5 16.8 7.2 3.7 2.7 61.7 6.9 9.5 16.3 13.1 2.5 4.4 26.5 19.2 4.7 5.1 2.5 4.8 42.3 25.4 3.1 MRPL57 MRP63 ENSG00000173141 "Mitochondrial ribosomal protein L57" Q9BQC6 13 21176658-21179084 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 719.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039779, HPA059370" Supported Supported Mitochondria NA NA Mitochondria "HPA039779: AB_10673362, HPA059370: AB_2683993" "unprognostic (1.00e-1)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (9.57e-3)" "unprognostic (1.51e-1)" "unprognostic (5.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.68e-2)" "prognostic favorable (8.35e-4)" "unprognostic (7.65e-2)" "unprognostic (2.01e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (6.78e-2)" 12.4 27.2 15.2 8.5 15.3 11.0 14.0 16.0 18.4 12.2 14.3 16.5 10.9 13.0 11.8 17.7 13.5 5.2 25.7 16.0 18.5 24.8 29.4 11.8 8.8 16.5 16.0 14.6 16.3 17.0 15.4 28.1 7.1 16.2 18.0 6.8 15.6 15.0 8.5 39.2 14.4 13.8 5.7 15.5 14.9 16.3 11.9 16.0 17.2 16.5 18.5 6.6 15.0 12.5 16.5 16.9 30.3 20.8 19.0 15.6 12.8 21.9 20.0 12.4 18.5 13.9 39.6 30.6 9.7 22.7 12.5 14.5 28.7 18.3 19.0 13.9 25.8 30.8 44.2 21.3 45.3 23.2 24.6 21.3 13.2 20.8 14.8 13.9 11.2 17.9 39.0 19.5 12.4 13.2 59.3 53.7 64.8 15.1 54.8 35.0 32.1 31.4 17.2 23.1 20.3 41.4 19.4 16.2 20.1 31.2 14.0 20.2 22.8 12.6 9.6 17.9 20.5 17.9 17.2 14.9 17.7 8.6 28.5 24.6 51.1 70.4 56.3 49.8 59.0 56.4 63.1 62.4 53.2 64.0 60.5 69.6 55.6 10.4 54.5 50.4 102.2 70.2 72.4 15.2 15.3 16.0 18.4 16.0 18.5 16.5 16.0 14.6 16.2 15.5 16.0 16.5 93.3 80.1 124.4 12.1 95.4 0.0 107.2 0.0 84.2 88.3 172.1 195.7 495.7 140.2 56.3 176.6 45.9 233.6 118.8 171.7 508.7 159.8 256.0 188.6 98.8 91.6 149.5 165.6 16.8 245.1 205.0 94.2 116.2 107.6 72.2 104.5 117.8 478.4 231.4 77.4 21.3 218.9 0.0 126.6 0.0 341.6 115.2 104.1 0.0 8.4 166.2 181.4 109.2 6.6 17.9 171.6 190.7 98.9 141.9 160.4 266.5 719.5 80.9 100.7 52.6 69.0 74.0 83.6 48.9 175.7 0.0 223.1 99.0 179.5 204.1 112.2 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331" "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 8.7 9.1 5.8 9.5 6.9 3.6 11.3 6.5 5.9 6.7 6.6 5.3 5.5 8.5 6.4 9.1 6.2 5.7 5.4 5.3 7.2 7.3 10.0 5.2 13.2 7.2 7.0 4.7 8.3 5.4 9.1 4.3 9.0 7.1 7.5 6.4 6.2 5.4 6.6 9.5 9.4 5.4 7.1 7.2 11.5 5.5 10.5 6.5 7.6 11.2 10.5 13.3 10.4 6.4 7.8 38.4 20.6 13.6 44.1 13.9 22.4 16.1 29.9 23.6 40.2 46.3 35.1 26.4 41.3 21.4 15.0 20.6 26.9 39.2 18.0 64.6 28.3 29.3 28.1 16.6 22.6 27.8 45.0 12.2 13.0 17.3 42.5 42.2 26.2 18.1 15.1 44.2 20.3 40.0 12.9 28.5 33.2 28.9 22.3 22.4 12.5 31.3 22.8 23.7 11.7 9.7 24.1 21.4 10.7 33.9 15.2 27.6 17.1 17.7 25.6 25.9 23.4 50.9 19.1 40.8 56.8 23.4 42.6 19.5 0.1 2.6 0.6 4.3 4.3 5.4 14.4 4.4 5.5 4.6 12.8 5.7 5.2 0.1 8.2 5.0 4.1 4.3 3.3 5.8 6.9 6.5 5.9 5.3 7.2 7.2 7.0 4.7 7.1 7.2 6.5 7.8 33.5 19.2 13.7 11.4 38.0 23.7 32.7 17.0 33.0 20.7 16.4 20.7 22.5 14.3 31.8 22.0 8.4 21.1 17.7 5.1 25.4 20.6 3.9 20.3 50.1 26.1 5.4 26.7 11.7 13.8 15.1 27.0 10.2 17.0 29.2 26.9 11.7 12.9 13.2 13.5 15.5 8.1 12.2 17.0 11.9 5.0 18.3 15.0 12.4 11.2 23.3 20.5 20.6 19.6 23.6 15.3 3.4 24.8 26.3 34.1 1.7 22.7 21.1 20.9 13.1 37.8 23.7 64.0 64.5 25.5 21.7 15.2 17.3 44.5 10.7 19.1 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305497-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 196.9" "Cell type enhanced" "Detected in all" "Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053785, HPA077297" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: AB_2682260, HPA077297: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 26.4 35.8 24.3 16.0 25.3 16.5 23.8 34.6 29.1 15.8 28.7 50.6 82.5 15.6 4.7 63.2 14.7 10.3 128.2 21.4 28.2 70.7 92.2 31.1 11.1 28.7 29.8 17.7 8.2 56.8 24.1 16.0 15.5 28.4 26.7 23.1 5.2 48.8 12.7 196.9 35.7 65.9 7.2 23.9 32.3 52.9 8.5 33.9 8.4 28.6 89.6 12.5 31.3 29.0 27.2 25.9 40.2 9.8 23.6 13.0 12.7 54.2 25.0 11.9 9.2 9.0 37.4 30.3 34.9 45.1 12.8 23.7 66.0 16.9 33.0 3.5 23.0 21.0 22.9 51.7 30.1 18.0 39.3 55.3 17.4 49.8 20.7 27.0 12.8 12.8 18.1 37.9 18.7 15.3 57.9 19.4 55.9 27.9 30.4 74.4 20.4 19.7 79.6 31.1 52.4 20.6 26.2 12.8 81.2 83.8 5.5 25.8 38.2 28.9 16.6 20.4 47.4 25.6 28.6 25.5 23.6 26.9 38.2 13.4 0.2 2.9 4.8 2.7 5.4 2.6 1.7 2.3 1.9 2.7 2.3 2.3 3.3 5.3 1.8 5.1 2.1 3.6 1.7 24.3 25.3 34.6 29.1 21.4 28.2 28.7 29.8 17.7 28.4 23.9 33.9 27.2 20.8 9.6 22.7 21.2 14.7 18.6 41.0 29.7 18.8 28.8 30.9 24.3 9.2 100.1 21.3 20.2 33.3 103.8 20.9 159.2 54.8 51.3 3.4 18.7 17.4 15.3 37.8 19.4 13.6 80.2 61.3 12.4 39.8 20.3 7.6 9.3 35.0 266.3 33.6 33.7 16.6 82.5 28.5 82.7 11.7 1.1 6.5 22.2 17.8 11.2 28.8 20.1 27.8 9.0 6.4 81.1 103.1 12.0 8.2 42.8 199.7 82.2 19.8 20.4 13.1 18.7 21.7 3.5 7.1 26.3 18.5 134.2 14.5 22.2 113.7 65.0 RHOD "ARHD, Rho, RhoHP1" ENSG00000173156 "Ras homolog family member D" O00212 11 67056847-67072017 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 183.7;liver: 123.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 124.7;Ductal cells: 102.8;Exocrine glandular cells: 141.6;Pancreatic endocrine cells: 271.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 156.0;CAPAN-2: 109.2;HaCaT: 135.9;HBEC3-KT: 179.8;hTCEpi: 208.6;MCF7: 101.0;T-47d: 148.7" "Group enriched" "Detected in many" 4 "cerebellum: 14.9;pons and medulla: 5.1" "Low region specificity" "Detected in some" NA NA "unprognostic (2.12e-2)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.89e-3)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (3.10e-4)" "unprognostic (5.85e-2)" "unprognostic (4.39e-2)" "unprognostic (1.38e-3)" "unprognostic (8.89e-2)" "unprognostic (2.56e-2)" "unprognostic (2.24e-1)" "unprognostic (5.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-2)" 10.5 2.5 2.5 2.5 2.4 0.0 14.1 3.3 4.7 23.8 15.1 7.3 9.2 12.6 1.1 183.7 11.5 6.7 44.1 3.0 6.4 19.5 123.9 9.0 1.1 2.8 2.2 2.1 11.9 36.5 25.0 15.7 7.4 2.8 18.2 1.3 0.8 35.2 7.2 28.4 57.6 7.3 3.3 2.2 2.7 15.7 4.9 2.0 1.4 23.2 5.0 6.0 7.8 60.6 3.2 156.0 12.2 0.8 15.8 2.3 1.7 23.1 13.7 22.5 8.2 8.1 11.4 109.2 0.0 24.6 16.1 0.0 135.9 1.6 179.8 1.5 0.0 0.5 0.0 62.6 1.3 21.7 0.1 0.2 21.4 208.6 2.5 54.2 10.1 8.3 0.0 0.0 10.6 2.5 101.0 0.2 0.1 17.8 16.6 62.6 0.0 0.0 0.3 76.3 11.2 1.0 0.0 70.9 4.0 6.1 2.9 148.7 0.5 5.1 0.1 0.4 2.2 0.8 0.0 3.5 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.4 3.3 4.7 3.0 6.4 2.8 2.2 2.1 2.8 2.2 2.0 3.2 6.6 16.0 4.4 0.7 1.3 32.9 34.6 124.7 56.9 0.2 38.8 57.7 28.2 28.6 29.0 16.5 0.0 29.9 0.6 67.7 45.0 102.8 16.7 6.5 8.1 7.2 4.2 3.6 0.4 141.6 34.1 14.8 24.5 9.7 0.0 8.0 5.7 46.3 3.6 0.0 0.3 4.5 10.2 1.0 4.0 9.4 11.8 1.0 8.8 1.0 0.6 13.6 0.0 0.5 0.2 271.3 66.1 22.2 1.7 61.0 90.8 24.7 19.3 0.6 0.0 2.1 9.1 0.9 4.7 55.4 57.7 36.0 2.8 1.5 6.6 71.8 ADAMTS20 GON-1 ENSG00000173157 "ADAM metallopeptidase with thrombospondin type 1 motif 20" P59510 12 43353866-43552203 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 3.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 5.1;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "medulla oblongata: 2.4;midbrain: 1.0;pons: 3.2;white matter: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.6;NB-4: 1.6;NTERA-2: 2.8;SuSa: 2.2;U-266/70: 4.0;U-266/84: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027608, HPA027609" Uncertain "Secreted to extracellular matrix" NA NA "HPA027608: AB_10600098, HPA027609: AB_10599024" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (1.91e-2)" "unprognostic (2.04e-1)" "unprognostic (9.61e-2)" "unprognostic (3.29e-1)" "unprognostic (6.67e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-4)" "unprognostic (7.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.81e-3)" "unprognostic (2.57e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.0 0.0 0.0 0.0 0.0 0.0 0.5 3.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 0.1 0.0 0.0 1.6 2.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 4.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.4 2.4 1.0 0.0 3.2 0.0 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 COMMD1 "C2orf5, MGC27155, MURR1" ENSG00000173163 "Copper metabolism domain containing 1" Q8N668 2 61888724-62147247 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034633, HPA049223" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034633: AB_10601800, HPA049223: AB_2680680" "unprognostic (6.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.83e-1)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.22e-2)" "unprognostic (5.58e-2)" "unprognostic (1.07e-1)" "unprognostic (4.93e-1)" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (2.07e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (1.27e-1)" "unprognostic (5.51e-2)" "unprognostic (2.77e-1)" 21.0 26.6 22.5 22.1 24.0 20.6 27.2 25.7 33.2 23.2 23.3 18.2 22.8 20.2 30.4 25.0 21.0 20.4 55.2 23.6 23.1 31.5 36.2 18.9 23.7 22.9 22.5 23.6 21.5 24.3 24.6 14.9 26.7 23.4 22.4 22.8 20.2 33.8 20.3 35.5 22.3 15.0 30.1 22.3 20.7 19.4 24.6 22.7 20.9 28.4 38.4 25.7 24.1 20.0 25.2 23.2 29.1 32.0 25.4 41.2 41.2 27.4 27.2 45.6 53.7 37.9 50.1 20.4 40.4 22.3 50.8 45.8 17.6 18.0 33.1 55.8 43.9 21.1 31.5 16.3 56.0 35.1 49.6 23.8 34.6 37.7 26.1 30.8 39.2 54.6 23.2 19.6 64.3 56.7 43.6 38.6 87.4 27.9 19.0 39.0 27.1 42.4 46.7 49.3 25.0 19.5 21.7 30.7 50.9 28.6 31.8 32.4 21.4 25.9 48.1 41.5 30.2 42.4 26.6 22.9 48.6 26.5 42.8 42.8 62.4 96.2 48.4 63.0 86.5 63.4 91.8 71.5 72.0 117.3 84.7 68.1 73.8 8.1 91.1 78.4 109.5 88.8 110.8 22.5 24.0 25.7 33.2 23.6 23.1 22.9 22.5 23.6 23.4 22.3 22.7 25.2 53.0 35.3 33.8 56.8 38.2 54.4 73.8 98.7 47.8 35.4 47.0 72.4 176.7 41.5 57.3 35.0 10.4 127.3 37.3 27.4 129.1 71.5 195.6 50.6 52.1 53.2 21.6 43.1 91.9 65.1 75.5 67.6 32.1 47.2 57.7 60.4 52.5 72.4 101.7 28.6 78.4 29.8 63.1 36.0 81.3 163.5 41.3 46.3 83.6 71.2 118.6 45.3 30.9 89.5 109.7 57.1 37.1 49.7 71.5 48.9 49.0 192.3 49.1 33.2 32.9 57.6 97.2 124.5 58.7 49.6 61.7 147.2 38.6 81.6 30.1 64.0 RAPH1 "ALS2CR18, ALS2CR9, KIAA1681" ENSG00000173166 "Ras association (RalGDS/AF-6) and pleckstrin homology domains 1" Q70E73 2 203394345-203535335 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 62.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 84.0;Hepatic stellate cells: 103.5;Microglial cells: 92.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016744, HPA020027" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 69000000 "Nuclear bodies, Plasma membrane" Cytosol "HPA016744: AB_1844781, HPA020027: AB_1844782" "unprognostic (9.78e-2)" "unprognostic (9.05e-2)" "unprognostic (7.17e-4)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (8.32e-2)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.24e-4)" "unprognostic (1.92e-1)" "unprognostic (1.40e-2)" "unprognostic (5.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (2.79e-1)" 11.2 6.6 1.5 5.3 4.9 3.2 13.5 1.7 8.4 9.4 0.6 7.1 7.9 5.7 4.6 8.9 5.1 8.9 5.9 5.0 7.3 7.3 62.1 14.4 3.8 2.7 6.9 4.5 2.0 6.4 5.6 3.7 13.1 2.8 6.7 7.4 7.4 8.7 4.4 6.6 8.2 8.0 7.9 1.6 17.1 8.8 9.5 2.8 2.6 30.3 6.2 4.9 7.8 6.7 0.4 11.1 7.5 15.6 9.0 12.0 15.4 14.7 15.1 11.0 15.3 19.1 35.0 11.4 0.0 3.7 23.1 11.2 5.8 8.2 12.9 31.7 2.2 4.6 0.0 17.9 6.2 30.0 0.1 0.2 21.5 10.7 28.1 29.4 16.8 24.2 1.7 0.8 8.2 31.0 6.2 0.1 0.0 9.2 5.7 10.0 0.2 22.0 6.9 11.2 34.9 5.5 7.5 10.3 9.8 12.5 20.4 5.5 0.5 29.0 37.5 12.5 18.2 16.1 3.8 7.7 0.1 30.9 0.2 8.4 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.1 0.0 1.5 4.9 1.7 8.4 5.0 7.3 2.7 6.9 4.5 2.8 1.6 2.8 0.4 36.3 16.0 8.4 12.7 1.2 49.1 20.7 10.3 16.5 11.3 21.6 9.4 1.1 15.7 9.7 14.7 14.6 8.9 0.8 32.9 7.9 6.3 14.4 24.4 17.7 29.0 2.4 3.2 84.0 9.3 7.6 23.4 47.9 65.7 1.3 6.2 103.5 79.6 18.1 10.1 56.7 8.6 4.1 17.8 51.1 4.9 4.7 28.8 12.4 92.8 3.3 18.6 0.0 41.2 9.1 20.5 21.3 4.9 0.1 19.0 22.4 2.8 5.2 4.4 19.7 26.8 33.4 29.3 19.6 26.9 40.9 10.9 2.8 0.9 13.3 28.4 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208695-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 601.3;Late spermatids: 1473.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Approved Mitochondria NA NA Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 29.3 33.5 23.0 16.2 23.0 39.4 28.5 24.4 29.5 22.5 27.0 23.4 19.1 25.5 18.0 33.3 31.3 13.2 20.8 22.1 25.8 34.0 45.1 23.1 19.8 23.7 23.2 21.8 17.7 27.9 38.1 20.5 20.9 23.3 22.3 19.0 3.8 31.9 21.9 17.6 25.1 23.2 18.8 24.0 29.5 28.3 91.0 23.6 21.1 24.6 16.9 21.3 20.9 21.4 24.0 54.3 87.6 27.3 39.3 49.9 44.8 86.4 27.4 55.0 79.4 55.1 109.5 88.2 44.3 88.2 63.4 25.2 52.8 40.6 77.4 28.8 32.9 95.4 28.3 64.0 107.1 78.8 52.5 38.0 57.5 71.2 82.2 54.9 30.4 71.2 64.4 58.1 21.5 47.9 131.7 59.6 65.9 54.7 76.5 100.2 48.3 17.2 105.4 73.1 46.2 44.5 55.3 34.0 106.3 31.0 41.6 86.2 84.1 30.0 37.8 42.6 25.4 46.9 41.1 37.3 46.2 50.1 26.8 41.3 32.8 69.0 17.4 24.2 38.3 23.2 41.6 29.6 25.7 60.8 37.7 29.3 26.5 114.2 34.6 22.2 32.9 39.0 40.6 23.0 23.0 24.4 29.5 22.1 25.8 23.7 23.2 21.8 23.3 24.0 23.6 24.0 26.0 9.6 17.0 4.9 28.9 20.3 42.0 91.3 26.7 0.0 41.8 42.4 1.1 27.1 45.1 35.0 0.0 107.5 17.1 36.5 97.8 80.1 601.3 56.6 35.1 24.7 19.8 14.7 2.8 84.7 130.7 33.6 40.8 30.1 26.6 42.2 23.9 54.4 97.3 0.0 3.6 42.3 54.9 37.1 23.3 1473.9 43.2 38.9 49.8 1.0 65.1 0.0 37.0 3.0 4.8 72.7 48.4 39.5 39.3 41.6 44.3 144.6 61.2 0.0 46.0 29.2 58.4 105.2 52.9 34.9 21.0 88.7 22.5 43.9 54.6 42.6 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449090 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.3;heart muscle: 106.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2" "Region enriched" "Detected in all" 5 "basal ganglia: 388.0" "Region enriched" "Detected in all" 6 "basal ganglia: 155.9" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 19.0 3.3 22.8 4.9 81.3 0.0 10.7 13.1 39.1 9.4 1.5 26.1 5.3 14.8 5.7 19.0 12.8 10.1 106.1 25.4 22.6 7.4 3.3 4.2 2.3 27.3 18.1 28.3 13.3 7.6 0.8 14.4 6.2 34.0 20.0 5.7 4.6 4.0 21.7 2.8 2.1 13.1 18.3 11.2 6.6 21.3 8.3 25.6 1.3 1.9 5.9 3.1 23.4 7.9 28.3 0.0 0.6 1.3 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.2 2.3 0.5 0.6 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 15.5 0.0 0.0 0.8 0.0 0.1 0.0 0.3 2.7 5.2 0.5 1.8 1.6 0.0 0.5 0.1 1.7 0.0 0.1 0.0 0.1 1.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 81.3 13.1 39.1 25.4 22.6 27.3 18.1 28.3 34.0 11.2 25.6 28.3 0.3 0.0 0.0 8.1 0.1 0.3 0.1 0.2 0.0 21.8 0.4 5.8 75.5 8.6 0.0 7.3 0.0 1.4 0.0 2.6 0.0 15.9 0.9 1.5 7.1 1.8 0.0 0.0 34.0 6.9 4.0 5.2 0.0 4.0 0.0 4.6 3.9 0.1 0.3 0.0 44.0 0.3 0.0 0.0 0.3 3.0 20.5 0.1 0.0 6.5 1.0 1.0 0.0 19.1 89.7 0.4 59.6 73.7 0.0 0.1 0.3 0.8 0.0 2.2 65.7 0.6 21.4 0.8 6.3 0.2 0.9 12.4 0.2 1.0 2.0 0.1 PARP14 "ARTD8, KIAA1268, pART8" ENSG00000173193 "Poly(ADP-ribose) polymerase family member 14" Q460N5 3 122680839-122730840 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 246.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008846, HPA012063" Supported Supported Cytosol NA NA Cytosol "HPA008846: AB_1854982, HPA012063: AB_1854981" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-1)" "unprognostic (2.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (1.44e-1)" "unprognostic (4.20e-2)" "unprognostic (1.74e-3)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-3)" "unprognostic (1.71e-2)" 13.8 12.7 5.5 24.5 6.7 20.3 11.4 3.8 3.9 10.6 7.2 11.1 15.4 8.3 2.4 9.1 10.8 15.3 9.5 2.6 10.0 15.0 24.7 33.8 24.2 10.0 4.7 0.7 9.2 7.8 7.4 7.6 18.0 8.3 13.2 8.8 1.1 11.8 7.3 5.1 5.3 17.6 10.3 6.1 37.7 11.8 2.2 7.7 15.5 14.9 8.4 27.0 13.8 9.5 16.9 15.6 13.0 8.0 8.3 9.1 26.2 0.0 6.1 40.1 74.7 113.1 6.9 28.7 0.0 24.2 13.4 41.8 11.5 11.9 11.6 15.0 24.0 1.5 14.6 5.8 8.7 20.4 6.4 6.8 14.7 4.7 13.0 4.8 16.4 32.2 12.3 7.0 22.7 2.1 7.9 24.8 1.5 1.1 2.1 11.1 34.2 8.3 4.3 9.5 16.2 0.6 0.0 15.3 3.1 14.1 0.8 5.7 9.3 22.0 4.0 9.4 2.3 5.5 8.7 1.6 2.7 12.0 13.8 7.2 13.1 10.8 5.8 8.6 13.7 7.2 12.8 4.5 5.6 5.6 20.3 3.6 4.1 29.5 9.5 14.7 0.7 9.9 4.3 5.5 6.7 3.8 3.9 2.6 10.0 10.0 4.7 0.7 8.3 6.1 7.7 16.9 111.5 246.8 98.4 17.3 115.3 16.8 17.0 35.9 13.1 2.1 19.6 15.6 14.6 24.3 65.9 25.8 4.2 14.1 64.9 43.0 3.9 36.0 0.3 118.8 59.8 94.7 10.7 18.5 0.5 41.2 28.4 37.2 24.5 149.8 32.2 69.6 67.1 32.5 36.5 0.0 3.0 18.2 26.4 61.6 39.9 2.1 28.0 83.9 16.0 124.6 132.2 15.1 58.7 47.3 1.1 44.0 20.2 17.3 50.9 31.8 29.5 11.5 73.0 1.0 13.1 32.7 30.3 1.9 1.1 13.7 10.5 4.8 51.4 42.8 16.0 25.9 CYSLTR1 "CysLT(1), CysLT1, CYSLT1R" ENSG00000173198 "Cysteinyl leukotriene receptor 1" Q9Y271 X 78271468-78327691 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 67.3;Alveolar cells type 2: 68.4;B-cells: 64.1;dendritic cells: 44.7;granulocytes: 78.6;Plasma cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "eosinophil: 85.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 19.8;Karpas-707: 12.4;NB-4: 27.1;RPMI-8226: 41.9;THP-1: 25.2;U-937: 28.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010546 Approved NA NA "HPA010546: AB_1078268" "unprognostic (9.48e-2)" "unprognostic (6.01e-5)" "unprognostic (4.72e-3)" "unprognostic (3.04e-1)" "unprognostic (6.30e-2)" "unprognostic (2.80e-3)" "unprognostic (2.52e-1)" "unprognostic (8.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.53e-2)" "unprognostic (4.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.41e-4)" "unprognostic (5.82e-2)" "unprognostic (3.56e-2)" "unprognostic (9.87e-2)" "unprognostic (8.94e-2)" 4.7 1.7 0.6 7.6 0.6 3.5 2.4 0.7 0.8 2.6 1.0 3.6 2.5 1.7 0.7 7.4 1.7 5.6 1.7 0.6 1.1 1.0 1.6 7.3 9.6 0.9 0.8 0.4 0.4 0.6 1.4 0.3 3.6 1.0 2.3 4.9 0.3 1.9 1.0 0.5 3.3 3.9 4.5 0.9 10.7 2.9 0.3 0.9 4.1 2.0 1.8 11.7 7.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 19.8 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 27.1 0.1 0.0 0.0 5.7 0.0 41.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 28.1 0.0 19.5 15.1 85.8 0.0 26.5 0.1 19.1 5.5 0.2 11.7 15.2 8.3 0.1 45.2 10.6 31.2 18.0 1.4 6.9 0.6 0.6 0.7 0.8 0.6 1.1 0.9 0.8 0.4 1.0 0.9 0.9 1.0 20.4 67.3 68.4 0.7 64.1 3.7 3.7 0.6 5.2 3.7 1.6 0.9 1.4 0.0 36.7 0.0 6.2 0.3 44.7 1.1 0.0 0.2 0.0 0.3 0.3 21.5 0.0 3.8 0.5 0.2 0.3 7.6 0.0 0.3 78.6 1.3 5.7 0.3 29.8 0.0 0.3 0.3 2.0 39.3 14.7 0.0 0.6 37.5 7.2 16.9 21.4 0.5 23.7 0.0 0.0 0.2 0.0 0.0 44.9 1.4 1.7 0.5 35.9 0.7 0.0 0.7 3.2 0.1 0.3 1.4 3.7 0.8 20.6 0.2 0.5 3.4 PARP15 "ARTD7, FLJ40597, pART7" ENSG00000173200 "Poly(ADP-ribose) polymerase family member 15" Q460N3 3 122577628-122639047 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 23.3;intestine: 42.5;lymphoid tissue: 67.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 19.2;B-cells: 88.4;dendritic cells: 38.6;granulocytes: 19.6;NK-cells: 21.6;Plasma cells: 18.6;T-cells: 31.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.6;JURKAT: 5.1;REH: 3.5;THP-1: 3.7;TIME: 8.9" "Low region specificity" "Detected in single" HPA035757 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035757: AB_10669656" "unprognostic (8.19e-3)" "unprognostic (2.88e-3)" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (9.01e-5)" "unprognostic (4.79e-2)" "unprognostic (1.83e-2)" "unprognostic (3.91e-2)" "unprognostic (5.40e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "unprognostic (9.24e-7)" "unprognostic (9.03e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (1.22e-2)" 3.4 1.2 2.5 26.0 2.6 23.3 1.8 4.3 3.9 1.5 0.9 2.8 2.6 1.9 1.4 2.0 2.0 4.4 1.7 2.0 1.0 1.7 3.2 9.1 44.7 2.1 1.3 2.0 0.7 0.8 0.2 0.7 2.5 2.7 1.8 4.8 2.3 2.2 1.1 6.0 1.2 42.5 1.9 0.8 67.7 4.1 2.5 2.0 8.4 3.1 1.9 50.7 4.5 1.6 4.4 0.3 0.2 0.3 0.3 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.2 0.7 0.3 0.4 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.1 7.6 0.5 0.3 0.1 0.5 0.3 1.5 0.1 0.3 0.1 0.2 1.7 5.1 0.2 1.3 0.0 0.3 2.3 0.4 0.4 0.1 0.1 3.5 0.2 0.3 0.0 0.6 0.5 0.3 0.1 0.1 0.1 0.3 0.5 3.7 8.9 0.2 0.6 0.3 0.2 0.6 0.4 1.6 0.4 0.2 0.1 1.8 0.2 0.1 7.2 0.3 5.8 9.4 4.4 5.4 0.8 9.3 3.8 4.8 0.5 3.9 0.7 1.0 4.2 2.2 2.5 2.6 4.3 3.9 2.0 1.0 2.1 1.3 2.0 2.7 0.8 2.0 4.4 0.8 19.2 15.9 0.0 88.4 0.5 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.0 2.1 0.0 0.0 0.1 38.6 0.1 0.0 0.0 0.2 0.3 0.1 1.2 0.0 7.4 0.1 0.0 0.1 2.7 2.6 0.3 19.6 0.0 2.2 0.6 8.3 0.0 0.2 0.0 0.0 5.1 1.4 0.2 0.0 6.4 1.8 6.5 4.7 0.0 21.6 0.0 0.1 0.1 0.0 0.0 18.6 0.0 0.0 0.1 10.5 0.0 0.0 0.7 0.4 0.1 1.6 0.4 0.0 0.3 31.1 0.0 0.0 0.0 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 651.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavorable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.37e-1)" 55.0 32.2 15.4 33.9 15.7 118.7 68.4 16.4 19.9 40.2 15.3 49.9 41.2 35.4 37.2 62.1 41.2 22.4 30.2 15.2 18.1 33.1 73.9 29.2 71.9 17.3 16.9 14.8 31.9 22.6 35.8 18.5 51.0 17.5 26.3 51.0 6.1 28.6 33.2 14.7 51.6 44.7 35.1 18.0 37.3 35.8 49.0 15.7 89.5 30.4 23.8 74.7 30.3 43.0 18.7 459.2 616.5 455.9 245.3 66.9 68.1 361.4 209.1 166.8 463.4 367.8 599.9 653.4 433.8 345.9 143.2 251.2 410.6 468.0 305.2 428.7 392.9 293.9 294.6 249.9 426.5 19.4 359.7 257.9 39.8 132.2 391.4 532.8 91.5 232.5 298.2 486.6 566.8 353.9 452.8 337.3 273.9 575.3 442.1 547.6 334.8 373.6 554.3 165.6 164.2 184.3 463.9 313.6 292.0 347.3 530.2 391.6 492.9 126.0 282.5 292.4 237.0 505.3 348.9 734.7 617.0 179.6 300.1 399.8 2.2 13.0 6.9 19.8 82.0 24.4 74.2 28.0 27.1 22.1 70.4 34.0 32.8 1.7 28.7 105.4 92.6 33.3 28.1 15.4 15.7 16.4 19.9 15.2 18.1 17.3 16.9 14.8 17.5 18.0 15.7 18.7 31.7 12.8 33.3 1.3 46.5 217.6 101.3 170.6 74.0 3.4 90.6 140.5 9.2 87.2 63.1 29.5 0.0 224.0 40.7 48.3 80.3 93.0 15.8 43.1 24.6 51.9 20.4 140.1 0.8 112.1 651.8 84.6 20.9 28.3 21.0 66.7 29.6 89.8 132.1 1.7 0.8 57.4 120.1 46.0 121.0 21.7 76.1 37.4 113.8 0.0 41.3 20.7 20.6 0.5 3.5 119.0 41.7 45.9 38.4 130.2 63.1 87.5 52.1 3.0 19.7 50.6 53.0 124.7 151.0 74.9 203.6 131.9 40.7 27.2 80.0 99.5 ABCD2 "ALDL1, ALDR, ALDRP" ENSG00000173208 "ATP binding cassette subfamily D member 2" Q9UBJ2 12 39550033-39619803 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 15.9;brain: 9.1" "Cell type enhanced" "Detected in some" "Astrocytes: 71.5;Bipolar cells: 57.2;Excitatory neurons: 33.2;Inhibitory neurons: 34.2" "Cancer enriched" "Detected in single" 7 "glioma: 1.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in single" 4 "T-cells: 4.2" "Group enriched" "Detected in some" 6 "ASC diff: 11.6;HDLM-2: 16.9;Karpas-707: 29.0;SH-SY5Y: 17.3;U-266/70: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (4.06e-4)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (2.06e-1)" "unprognostic (7.31e-5)" "unprognostic (3.42e-2)" "unprognostic (2.90e-2)" "unprognostic (8.06e-3)" "unprognostic (3.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-4)" "unprognostic (5.04e-2)" "unprognostic (8.04e-2)" "unprognostic (1.13e-1)" "unprognostic (6.74e-2)" 15.9 1.7 2.0 1.7 2.3 0.2 2.8 9.1 5.7 5.4 0.0 0.7 0.5 2.7 0.2 0.4 2.7 0.5 4.3 2.1 2.3 0.5 0.1 0.5 2.9 2.4 4.0 1.7 0.1 0.1 0.0 0.5 0.0 3.6 0.4 0.7 6.0 2.6 0.6 0.1 0.1 0.7 2.6 1.4 1.6 0.7 0.2 4.0 1.4 0.2 0.3 1.7 0.9 0.6 2.0 0.0 0.0 0.1 0.0 11.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 0.0 0.1 0.0 0.0 0.6 0.2 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 9.8 1.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 1.2 0.5 2.8 3.7 0.1 0.3 3.2 4.2 0.1 0.9 0.0 0.6 3.6 1.2 2.0 2.3 9.1 5.7 2.1 2.3 2.4 4.0 1.7 3.6 1.4 4.0 2.0 0.4 0.0 0.0 71.5 2.6 0.0 0.0 0.0 0.0 57.2 0.3 0.3 10.9 0.0 0.0 0.0 6.2 0.0 3.8 0.1 0.0 0.0 0.3 0.2 0.5 0.2 0.0 0.0 33.2 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.1 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.5 1.1 2.2 0.0 13.0 1.3 0.0 0.0 0.7 5.9 0.0 0.0 0.9 2.4 2.3 0.0 0.4 2.5 0.2 0.1 0.0 0.0 0.0 7.8 0.6 0.1 0.0 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 116.8" "Cell type enhanced" "Detected in many" "Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 30000 "Nucleoplasm, Plasma membrane" "Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 64.8 7.4 21.1 3.8 18.9 0.5 58.0 45.0 18.8 11.2 8.3 9.6 2.8 10.5 6.4 33.5 14.6 7.1 84.9 20.4 25.7 19.4 116.8 20.1 5.3 34.5 24.1 16.1 3.9 2.7 60.1 6.8 34.7 29.7 9.2 5.0 28.8 6.5 8.3 46.2 7.8 7.8 10.7 34.7 8.8 5.5 2.0 27.5 2.3 9.3 39.0 4.6 14.2 17.9 32.3 23.6 4.8 0.0 0.2 39.6 75.3 0.1 16.1 44.8 9.1 15.8 0.1 16.2 0.0 2.7 20.5 47.9 0.5 0.1 18.9 17.7 0.1 0.2 0.0 1.4 0.6 77.6 0.0 0.1 89.4 5.1 32.5 90.9 76.2 41.1 0.0 0.0 7.2 54.8 9.2 0.0 0.0 0.2 1.5 63.0 0.0 0.1 0.0 50.3 16.0 6.3 0.1 3.3 1.1 8.7 1.2 1.5 0.1 103.9 18.9 4.2 19.9 27.7 0.1 0.0 0.0 33.5 0.0 55.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 2.7 21.1 18.9 45.0 18.8 20.4 25.7 34.5 24.1 16.1 29.7 34.7 27.5 32.3 197.6 0.0 3.7 21.5 1.3 1.5 1.2 2.6 0.6 2.5 7.6 3.9 61.7 18.6 5.3 0.0 0.0 0.2 0.3 0.0 5.9 8.7 3.0 0.5 2.5 39.6 0.0 0.0 31.0 3.5 0.7 9.4 3.6 2.5 1.3 0.0 34.2 116.0 12.3 28.6 33.7 0.0 8.2 13.5 1.1 0.5 0.3 8.5 5.4 21.5 0.9 19.3 0.0 63.8 25.6 22.5 0.0 0.7 0.1 2.5 0.0 23.5 4.9 25.1 0.0 7.4 7.7 1.7 2.7 2.0 1.6 0.4 0.7 0.5 0.0 22.2 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.9;esophagus: 7.0;skin 1: 6.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Alveolar cells type 2: 48.3;Club cells: 18.5;granulocytes: 17.7;Oligodendrocytes: 31.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.6;EFO-21: 13.4;RT4: 14.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "cerebellum: 6.2" HPA039551 Approved Nucleoplasm NA NA Nucleoplasm "HPA039551: AB_2676565" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.1 0.0 0.9 0.1 1.4 0.6 0.3 2.2 5.9 0.8 0.0 1.6 0.2 0.2 0.1 7.0 0.0 0.0 0.0 1.2 1.3 1.3 1.7 0.2 0.1 2.6 2.5 0.2 0.1 0.0 0.0 0.0 0.7 2.6 0.8 1.3 1.3 0.8 0.6 0.3 6.3 0.3 0.0 0.2 0.2 0.2 0.4 1.7 0.2 0.1 0.1 0.6 0.6 2.9 4.8 2.6 0.0 0.4 0.2 0.0 0.0 4.6 0.2 0.1 0.0 0.0 0.3 0.7 1.8 13.4 0.0 0.1 2.5 0.1 0.1 0.0 0.4 0.0 0.4 0.2 2.7 0.0 0.5 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.5 1.3 0.0 0.2 0.2 0.2 1.1 0.4 0.9 0.4 0.5 0.2 0.5 14.4 0.3 0.3 2.0 1.4 0.3 1.4 1.6 0.3 0.2 0.6 1.1 0.3 0.2 1.2 2.2 0.7 0.3 0.2 0.7 0.9 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.6 0.1 0.1 1.5 1.2 0.1 0.3 0.0 0.0 0.9 1.4 2.2 5.9 1.2 1.3 2.6 2.5 0.2 2.6 0.2 1.7 4.8 0.1 44.8 48.3 2.0 0.0 0.6 2.5 0.4 0.6 0.1 0.1 0.0 0.4 0.0 18.5 3.7 0.0 6.3 0.0 5.3 1.9 0.1 0.6 3.1 0.3 2.9 0.0 0.0 13.2 0.2 0.6 4.4 0.0 4.8 17.7 0.0 0.0 0.5 0.3 0.0 10.1 1.2 6.1 0.3 0.0 0.0 0.0 3.2 0.0 1.0 0.0 0.2 0.0 6.0 31.6 0.0 1.1 0.0 0.0 0.8 1.2 0.9 13.2 0.3 0.0 0.1 0.2 0.0 0.2 3.7 1.7 13.7 2.6 0.1 1.4 0.5 TUBB8B TUBB8P12 ENSG00000173213 "Tubulin beta 8B" A6NNZ2 18 47390-49557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 2.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043640, HPA046280" Uncertain Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.29e-1)" "unprognostic (6.73e-2)" "unprognostic (1.76e-1)" "unprognostic (6.91e-2)" "unprognostic (1.92e-1)" "unprognostic (4.36e-2)" "unprognostic (1.29e-1)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (7.42e-4)" "unprognostic (3.96e-2)" "unprognostic (5.98e-2)" "unprognostic (4.88e-2)" "unprognostic (3.21e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MFSD4B "KIAA1919, MGC33953" ENSG00000173214 "Major facilitator superfamily domain containing 4B" Q5TF39 6 111259327-111445354 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 30.7;Cytotrophoblasts: 24.5;Glandular and luminal cells: 22.4;granulocytes: 20.2;Granulosa cells: 34.4;Syncytiotrophoblasts: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031784 Approved "Intracellular and membrane" NA NA "HPA031784: AB_10603775" "unprognostic (2.98e-2)" "unprognostic (1.64e-2)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (7.50e-5)" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (6.84e-2)" "unprognostic (2.94e-2)" "unprognostic (3.41e-1)" "unprognostic (6.04e-3)" "unprognostic (9.27e-2)" "unprognostic (3.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.98e-4)" 1.3 1.8 1.5 1.8 1.7 2.2 2.1 2.0 1.6 2.3 5.9 1.4 3.6 1.5 2.4 1.4 1.7 1.3 1.0 1.2 1.0 2.9 2.6 1.4 1.6 1.1 0.8 1.5 1.1 1.3 1.8 1.6 4.7 0.9 1.3 1.7 3.1 1.7 1.8 2.0 2.5 3.4 1.6 0.4 1.6 1.6 4.4 1.2 1.4 2.0 0.9 1.3 1.5 1.1 1.5 1.5 3.3 2.8 7.1 2.8 1.7 4.4 2.1 3.1 3.2 4.2 5.5 2.7 3.9 3.3 2.7 3.1 3.4 5.5 2.2 5.1 2.6 1.4 5.0 5.4 3.6 3.9 3.9 8.3 1.2 3.8 3.7 3.0 4.2 2.7 4.9 5.5 5.9 3.5 2.7 3.5 2.4 2.2 3.5 0.9 3.9 2.4 1.6 4.1 4.0 2.0 2.5 2.2 2.7 1.3 3.0 2.2 5.4 2.1 3.3 1.8 16.7 4.0 2.0 2.9 3.9 4.5 3.2 4.0 4.4 1.4 1.9 1.7 1.7 2.0 2.1 1.1 1.1 1.5 1.2 1.5 1.7 1.9 1.7 1.6 1.8 0.9 1.0 1.5 1.7 2.0 1.6 1.2 1.0 1.1 0.8 1.5 0.9 0.4 1.2 1.5 4.2 9.6 30.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.7 2.2 0.0 0.0 13.6 5.5 0.0 24.5 5.3 0.0 1.9 5.6 0.0 15.0 9.4 4.1 0.0 0.0 0.0 3.6 11.5 4.9 0.0 22.4 20.2 34.4 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.8 0.0 0.0 6.6 10.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 31.1 2.8 5.7 0.0 0.0 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641970-115698224 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 6.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB076375: AB_2665604, HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favorable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 5.0 3.9 1.9 3.8 1.1 2.5 3.2 1.0 1.1 9.2 2.8 6.9 3.9 5.6 4.9 10.5 12.2 3.8 5.4 1.2 1.5 5.4 3.0 4.1 2.1 1.2 2.7 0.5 4.5 5.1 5.2 0.5 3.6 1.3 4.4 6.4 1.6 6.5 4.5 0.9 6.8 3.9 7.4 1.2 2.2 5.6 5.0 4.2 7.4 7.7 2.4 2.5 6.5 4.4 1.1 49.6 20.7 6.6 8.9 24.1 21.5 13.1 18.8 13.5 24.1 19.1 12.0 24.1 0.0 31.5 21.9 22.7 60.9 11.2 33.3 15.8 57.9 13.7 27.4 18.4 9.8 8.8 8.2 11.4 11.4 23.1 17.2 18.2 12.8 24.1 45.9 16.8 14.8 24.5 65.7 41.0 3.4 16.7 28.8 19.5 0.1 19.1 14.3 11.0 32.8 5.9 8.0 33.9 22.2 15.4 12.4 11.3 8.8 26.2 16.5 25.7 36.3 34.6 2.1 2.3 0.2 22.3 14.3 41.1 0.0 0.5 0.0 1.9 0.3 0.5 0.2 1.2 1.9 2.3 0.0 0.4 2.0 0.0 6.2 0.5 2.0 3.0 1.0 1.9 1.1 1.0 1.1 1.2 1.5 1.2 2.7 0.5 1.3 1.2 4.2 1.1 9.2 3.2 3.2 5.5 0.5 7.4 7.4 16.8 11.4 5.2 4.6 4.6 7.9 2.8 9.6 9.2 39.6 5.0 3.4 11.2 0.0 15.7 6.1 25.1 7.7 10.5 6.7 13.2 0.9 13.8 7.3 10.1 8.2 17.0 0.0 5.1 28.9 2.5 4.3 0.0 0.7 8.6 10.2 1.9 1.4 3.0 5.9 2.9 0.0 4.7 11.1 4.7 9.2 2.0 0.1 20.8 6.1 8.2 1.8 8.3 2.6 5.6 12.8 0.9 6.6 4.3 8.5 5.5 7.0 20.0 6.5 0.4 3.1 3.2 10.3 6.5 GLRX "GRX, GRX1" ENSG00000173221 Glutaredoxin P35754 5 95751319-95822726 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 783.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008634, HPA046431, CAB069419" Approved Supported "Plasma membrane,Cytosol" NA NA 6300000 "Plasma membrane, Cytosol" "CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (1.94e-2)" "unprognostic (4.81e-2)" "unprognostic (2.01e-2)" "unprognostic (2.22e-2)" "unprognostic (8.62e-3)" "unprognostic (9.31e-3)" "unprognostic (1.99e-2)" "unprognostic (1.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (2.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.61e-1)" 82.8 102.2 39.0 80.8 41.7 175.3 37.5 52.9 48.8 28.4 37.8 57.8 196.4 12.8 10.2 13.7 17.4 51.2 97.9 51.7 65.7 249.7 144.8 72.6 62.0 59.5 41.9 40.7 11.0 11.0 83.1 23.9 102.9 49.2 28.7 47.8 7.0 59.6 25.8 783.7 33.0 171.7 25.9 43.5 65.4 40.5 5.0 47.4 76.3 19.1 56.4 81.1 53.6 21.1 51.1 22.2 97.1 8.4 18.0 211.3 310.4 1.6 326.5 569.0 35.9 62.9 31.2 10.2 86.2 45.7 99.0 83.0 9.7 12.9 156.4 100.5 75.7 24.1 62.8 63.5 248.1 386.6 67.2 182.8 184.4 23.2 219.7 21.3 81.1 75.3 179.3 8.2 51.3 262.3 7.9 121.4 133.0 22.2 3.3 111.6 186.1 66.8 107.9 462.1 16.8 23.6 12.5 85.3 47.8 39.4 22.0 13.0 66.0 78.0 91.9 101.9 74.6 14.4 37.1 202.0 70.4 441.3 170.6 19.7 48.9 727.2 901.6 222.9 483.8 313.6 142.9 205.0 166.7 459.8 107.8 201.4 186.1 783.8 113.4 411.2 166.6 457.7 781.7 39.0 41.7 52.9 48.8 51.7 65.7 59.5 41.9 40.7 49.2 43.5 47.4 51.1 77.5 22.4 28.4 3.6 74.1 17.2 62.9 330.5 8.6 2.2 57.9 31.5 154.9 65.8 183.6 93.8 0.0 47.4 130.0 173.8 723.9 60.4 0.3 83.4 49.0 47.1 31.7 63.1 8.7 96.0 751.2 63.1 35.7 118.0 31.6 3.5 46.4 206.9 271.5 0.0 8.0 89.9 65.1 304.9 276.1 2.3 19.0 232.3 69.4 12.2 340.0 7.8 302.8 2.0 2.4 113.5 291.3 13.9 200.2 89.5 968.3 1165.9 124.1 3.9 19.7 22.1 67.0 0.6 1.6 4.1 20.6 285.3 97.7 11.7 85.4 214.6 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769761-121835079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 155.3;Spermatogonia: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 131.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: AB_2677806" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (3.08e-5)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.5 11.3 10.0 14.8 10.3 20.6 23.4 11.3 10.7 15.7 10.9 13.1 12.1 15.6 19.9 12.6 16.8 12.2 9.0 10.1 10.3 11.4 8.9 12.4 24.5 9.8 9.8 9.9 18.0 18.5 14.0 15.5 11.6 9.7 16.0 16.3 19.1 15.7 15.7 11.5 15.6 14.2 11.9 9.9 18.5 12.4 29.2 10.2 22.3 10.6 5.8 26.0 14.3 13.8 11.1 38.3 10.1 48.9 55.5 7.5 11.6 57.2 17.4 10.8 19.7 23.8 33.6 18.1 76.8 23.9 10.1 30.2 28.7 30.5 14.5 29.3 15.1 23.8 51.2 22.2 28.7 20.0 64.1 14.8 7.4 27.2 13.7 30.3 10.2 15.2 32.4 31.0 27.9 22.3 19.3 41.7 44.5 40.1 22.6 18.1 40.4 23.4 24.9 11.4 16.9 26.0 20.9 17.3 12.2 31.3 16.0 10.8 49.4 12.9 18.5 22.4 9.1 23.4 66.4 44.9 131.2 17.9 29.0 17.1 3.2 6.6 11.7 7.2 12.3 10.5 22.8 9.8 9.0 9.6 21.6 11.5 7.2 2.8 12.2 14.1 8.7 11.7 6.4 10.0 10.3 11.3 10.7 10.1 10.3 9.8 9.8 9.9 9.7 9.9 10.2 11.1 15.8 6.4 15.0 48.3 28.4 18.9 19.2 20.0 19.9 15.2 19.6 17.3 8.4 11.5 26.5 11.0 27.1 26.6 21.9 7.7 3.9 11.1 3.7 31.1 12.7 11.2 7.2 21.5 60.1 12.9 8.2 15.4 11.7 12.6 8.8 21.9 6.8 6.2 10.5 13.5 66.8 8.6 20.3 9.8 14.1 7.4 15.5 11.3 14.2 51.5 15.8 12.8 17.5 49.3 59.5 13.9 8.2 13.5 45.2 15.7 7.9 7.5 69.2 27.7 13.1 17.8 15.9 155.3 96.5 16.2 20.6 14.1 19.9 8.4 11.9 16.3 SYT12 SRG1 ENSG00000173227 "Synaptotagmin 12" Q8IV01 11 67006778-67050863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.4;liver: 17.8;parathyroid gland: 64.3" "Cell type enhanced" "Detected in many" "Astrocytes: 8.8;Basal respiratory cells: 10.9;Excitatory neurons: 39.3;Inhibitory neurons: 21.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 49.8;MCF7: 38.0;SiHa: 44.3;SK-BR-3: 20.9;T-47d: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011006, HPA074255" Enhanced NA NA "HPA011006: AB_2286996, HPA074255: " "unprognostic (2.72e-2)" "unprognostic (2.77e-2)" "unprognostic (2.23e-2)" "unprognostic (1.12e-3)" "unprognostic (4.47e-3)" "unprognostic (3.88e-2)" "unprognostic (1.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.04e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.75e-1)" "unprognostic (9.86e-4)" "unprognostic (4.21e-2)" "unprognostic (7.38e-2)" "unprognostic (2.42e-2)" "unprognostic (9.85e-2)" 0.6 6.9 7.8 0.2 10.9 0.0 4.6 21.4 18.7 0.1 2.6 0.0 0.7 0.1 5.1 0.4 3.8 0.6 0.4 9.8 15.7 0.3 17.8 0.1 0.1 10.2 12.0 9.5 0.1 0.3 64.3 5.7 0.8 12.3 1.7 0.0 0.4 1.6 0.8 0.3 0.8 0.3 0.0 4.7 0.0 0.3 1.4 8.2 0.0 0.4 0.0 0.1 1.2 0.2 11.3 0.0 2.0 0.3 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 8.1 1.5 3.4 1.3 0.3 1.5 0.2 4.5 0.0 0.0 0.4 0.0 49.8 0.1 0.0 0.0 0.1 0.5 0.3 0.1 0.0 4.6 0.0 0.0 0.1 0.1 0.0 38.0 0.0 0.1 0.9 0.2 1.7 0.0 0.0 0.0 0.6 0.0 0.3 0.0 44.3 20.9 0.1 0.1 19.3 0.2 0.0 0.0 7.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.9 21.4 18.7 9.8 15.7 10.2 12.0 9.5 12.3 4.7 8.2 11.3 0.2 0.0 0.0 8.8 0.1 1.3 3.8 10.9 0.0 2.2 6.9 6.6 1.2 1.5 3.1 1.8 0.0 0.4 0.1 0.5 0.0 2.9 0.5 0.8 0.3 0.4 0.0 0.0 39.3 0.0 1.5 1.1 0.0 0.5 0.0 0.3 0.0 5.8 0.1 0.0 21.6 0.0 0.0 0.0 1.2 0.2 0.0 0.1 0.0 4.7 0.0 0.1 0.0 3.0 2.3 0.4 0.0 0.4 0.1 1.2 0.2 0.1 1.6 1.2 0.0 1.2 1.6 0.8 1.2 0.0 1.1 1.9 0.5 0.0 0.4 1.3 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 18.4 25.4 10.8 7.1 13.3 14.2 24.4 15.5 13.0 22.1 24.0 18.6 12.3 17.5 32.4 15.2 15.9 13.4 17.6 14.0 12.4 18.6 18.0 15.4 8.4 10.2 10.2 8.9 22.1 27.3 20.9 25.2 13.5 10.3 26.0 17.3 31.3 25.4 20.1 14.3 20.2 19.1 10.1 11.2 16.7 19.9 14.7 9.9 11.4 21.2 11.2 9.9 16.4 15.9 12.0 19.9 15.7 15.3 9.9 28.8 31.0 9.6 12.6 27.5 11.9 13.4 13.8 7.1 4.3 10.4 23.6 11.9 9.0 9.2 13.7 14.1 6.3 17.5 12.2 20.1 19.2 17.2 13.7 16.0 25.4 31.9 7.5 18.7 25.8 15.3 7.3 5.8 9.6 12.7 14.3 4.1 9.9 9.9 19.1 16.4 5.4 12.0 10.3 17.7 20.2 10.8 12.0 15.5 11.0 16.7 17.3 13.6 15.2 21.5 11.4 6.9 4.9 9.2 17.8 11.4 7.2 15.3 6.6 4.3 1.6 4.1 4.3 4.3 2.2 3.5 3.4 3.5 3.3 2.6 2.8 3.3 3.6 15.4 3.9 1.7 5.5 3.9 1.6 10.8 13.3 15.5 13.0 14.0 12.4 10.2 10.2 8.9 10.3 11.2 9.9 12.0 118.9 291.7 233.9 101.2 97.3 51.6 89.1 62.1 96.8 101.4 110.2 130.3 274.8 74.4 179.2 53.3 123.0 78.7 134.7 148.6 11.7 104.3 56.0 247.9 186.4 102.7 91.9 36.8 72.9 111.0 53.0 135.5 144.8 284.0 115.6 220.7 74.3 68.9 34.5 69.0 80.2 176.8 65.1 47.2 48.3 23.8 198.5 82.1 33.8 68.4 76.8 82.1 54.6 50.3 72.8 100.2 95.7 199.0 176.0 74.9 79.9 29.3 165.7 193.6 85.5 165.9 120.5 155.0 66.8 70.2 45.7 150.8 102.6 197.7 101.7 88.3 C11orf86 FLJ22675 ENSG00000173237 "Chromosome 11 open reading frame 86" A6NJI1 11 66975277-66977004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 68.6" "Group enriched" "Detected in some" 20 "Distal enterocytes: 212.2;Paneth cells: 132.8;Proximal enterocytes: 506.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "hypothalamus: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 7.2;SiHa: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA039348 Uncertain NA NA "HPA039348: AB_10673421" "unprognostic (1.54e-2)" "unprognostic (7.67e-3)" "unprognostic (3.02e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "prognostic unfavorable (8.97e-4)" "unprognostic (4.17e-1)" "prognostic unfavorable (6.97e-5)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.69e-2)" "unprognostic (3.58e-3)" 0.1 15.5 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.0 0.0 10.5 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.7 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.0 64.7 0.7 0.1 0.0 2.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 24.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 1.5 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 212.2 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 132.8 0.0 0.0 0.0 506.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 8.4 0.2 LIPM "bA304I5.1, LIPL3" ENSG00000173239 "Lipase family member M" Q5VYY2 10 88802730-88820546 "Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 28.2" "Cell type enriched" "Detected in single" 11 "Suprabasal keratinocytes: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071276 Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "HPA071276: " "unprognostic (7.72e-2)" "unprognostic (8.49e-4)" "unprognostic (1.42e-2)" "unprognostic (2.23e-4)" "unprognostic (6.70e-3)" "unprognostic (3.01e-3)" "unprognostic (5.75e-2)" "unprognostic (6.63e-2)" "unprognostic (5.61e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.59e-2)" "unprognostic (5.93e-2)" "unprognostic (7.05e-3)" "unprognostic (4.17e-2)" "unprognostic (9.02e-2)" "unprognostic (9.70e-6)" 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 28.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 GPR151 "GALR4, PGR7" ENSG00000173250 "G protein-coupled receptor 151" Q8TDV0 5 146513103-146516190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "brain: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 37 "midbrain: 9.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 19 "thalamus: 30.6" "Region enriched" "Detected in single" 9 "thalamus: 4.7" HPA065728 Supported NA NA "HPA065728: " "unprognostic (2.09e-1)" "unprognostic (2.30e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DMRT2 ENSG00000173253 "Doublesex and mab-3 related transcription factor 2" Q9Y5R5 9 1049858-1057552 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 40.5;lymphoid tissue: 21.0;parathyroid gland: 46.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 115.4;Ionocytes: 46.8;Skeletal myocytes: 22.7" "Group enriched" "Detected in many" 4 "lung cancer: 3.0;renal cancer: 9.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.8;RH-30: 5.0;RPMI-8226: 19.4;SK-MEL-30: 5.2;THP-1: 3.6;WM-115: 3.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "HPA003498, HPA029297" Uncertain Approved "Nucleoplasm,Nucleoli,Vesicles,Centriolar satellite" NA NA "Nucleoplasm, Nucleoli" "Vesicles, Centriolar satellite" "HPA003498: , HPA029297: AB_10600905" "unprognostic (5.67e-2)" "unprognostic (2.20e-3)" "unprognostic (3.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (7.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.43e-3)" "unprognostic (8.93e-2)" "unprognostic (8.62e-2)" "unprognostic (4.93e-2)" "unprognostic (1.27e-3)" 3.3 0.1 1.8 0.1 3.0 0.0 5.4 2.8 3.1 0.1 0.2 1.6 0.0 0.1 1.1 0.3 0.6 0.0 0.1 1.7 2.0 40.5 0.0 3.1 0.2 2.9 3.1 1.0 0.0 0.0 46.8 0.5 0.2 3.6 0.3 0.9 0.4 1.3 1.4 13.4 0.3 0.1 0.0 1.8 0.0 0.0 0.8 2.5 21.0 0.2 2.5 0.1 0.0 0.2 8.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.8 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.0 19.4 0.0 0.8 2.9 0.0 0.0 0.0 5.2 0.3 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.0 2.8 3.1 1.7 2.0 2.9 3.1 1.0 3.6 1.8 2.5 8.5 0.5 0.0 0.0 0.3 0.2 0.5 0.6 1.8 0.0 0.1 0.1 0.3 0.5 0.0 0.5 0.0 0.0 0.1 0.1 1.8 115.4 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 4.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 46.8 0.0 1.1 0.4 0.6 0.2 3.6 0.0 0.0 0.3 0.0 0.5 11.1 0.0 1.9 0.0 0.4 0.2 0.0 0.4 0.6 2.4 0.0 22.7 0.7 4.0 3.0 0.2 0.1 0.1 0.1 0.0 1.8 0.4 ZNF483 "KIAA1962, ZKSCAN16, ZSCAN48" ENSG00000173258 "Zinc finger protein 483" Q8TF39 9 111525159-111577844 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 46.5;Excitatory neurons: 118.2;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 86.8" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055041 Approved Nucleoli NA NA Nucleoli "HPA055041: AB_2682681" "unprognostic (4.33e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (2.34e-1)" "unprognostic (4.11e-2)" "unprognostic (5.95e-3)" "unprognostic (9.18e-5)" "unprognostic (2.02e-1)" "unprognostic (9.50e-2)" "unprognostic (4.44e-3)" "unprognostic (5.49e-2)" "unprognostic (5.19e-4)" "unprognostic (7.19e-3)" "unprognostic (1.74e-1)" "unprognostic (4.30e-2)" "unprognostic (6.17e-2)" 1.1 6.1 17.7 0.7 25.8 3.6 2.7 45.4 20.4 2.3 1.3 1.2 0.9 5.1 8.3 0.9 3.0 2.2 2.1 19.3 30.8 2.2 0.8 1.7 1.5 5.5 15.4 18.2 5.7 1.8 4.0 6.0 0.5 12.8 3.7 0.8 11.8 1.5 3.8 1.4 1.8 1.2 2.3 2.0 2.3 1.4 5.3 27.0 1.0 6.1 0.7 1.1 1.4 1.7 19.9 0.2 2.0 2.1 3.4 0.5 0.5 0.6 0.4 1.0 2.0 1.7 0.2 0.9 0.3 0.3 0.8 1.5 0.7 1.1 0.9 1.2 0.1 1.3 1.0 3.2 2.3 0.6 0.4 0.2 0.8 0.5 1.1 0.5 1.7 1.8 1.4 0.8 0.5 0.5 2.2 0.1 0.4 9.7 1.3 0.7 0.2 2.9 0.3 1.1 0.8 4.8 2.2 1.0 0.5 0.4 2.1 1.2 0.3 0.5 0.6 1.0 1.1 1.5 0.4 1.3 0.2 0.8 0.3 0.3 3.1 0.4 0.3 2.7 0.2 1.6 0.8 1.7 1.3 0.1 1.2 3.3 3.6 1.5 1.1 0.4 0.5 1.1 0.8 17.7 25.8 45.4 20.4 19.3 30.8 5.5 15.4 18.2 12.8 2.0 27.0 19.9 1.6 0.0 6.3 33.0 1.4 0.8 6.3 1.5 2.2 46.5 2.0 7.6 4.0 1.5 4.0 7.3 20.9 1.1 3.0 0.2 5.9 1.0 20.3 2.6 1.9 2.0 3.0 0.0 118.2 2.0 0.5 6.1 1.5 3.5 0.0 4.9 1.4 2.1 0.3 35.3 122.4 0.1 0.0 0.9 1.9 8.6 4.7 0.6 1.8 13.1 0.4 19.1 5.2 54.3 86.8 1.0 1.1 10.1 0.2 4.2 0.8 0.2 1.6 26.8 6.6 5.5 3.5 11.0 4.1 0.6 1.4 0.7 2.6 6.3 0.2 3.7 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084313-146105577 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 18.5" "Group enriched" "Detected in some" 35 "Early spermatids: 456.8;Late spermatids: 300.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074266 Approved Nucleoplasm NA NA Nucleoplasm "HPA074266: AB_2686676" "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.3 0.3 1.4 0.1 1.7 0.1 0.3 2.1 1.9 0.5 0.7 0.3 0.1 0.6 0.1 0.2 0.6 0.0 0.3 1.6 1.5 0.4 0.9 0.2 0.1 1.4 1.3 1.6 0.4 0.5 0.0 0.7 0.0 1.8 0.8 0.1 0.7 0.3 0.1 0.5 0.8 0.3 0.1 1.2 0.6 0.2 18.5 1.4 0.1 0.4 0.1 0.0 0.4 0.3 1.9 0.2 0.5 0.7 2.3 0.1 0.4 0.3 0.3 0.2 0.5 0.6 0.1 0.1 0.4 0.5 0.2 0.2 0.3 1.3 0.1 0.6 0.7 1.0 0.3 0.4 0.2 0.2 0.3 0.5 0.1 1.3 0.7 0.6 0.1 0.2 0.8 0.1 0.4 0.1 0.0 0.4 0.6 0.2 0.0 0.8 0.3 0.3 0.0 0.0 0.0 0.7 0.3 0.1 0.2 0.8 0.2 0.0 0.5 0.2 0.1 0.8 0.3 0.6 0.4 0.7 0.3 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.4 1.7 2.1 1.9 1.6 1.5 1.4 1.3 1.6 1.8 1.2 1.4 1.9 0.2 0.0 0.0 2.3 0.3 0.0 0.3 0.1 0.0 0.6 0.3 0.5 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 456.8 0.1 0.3 0.3 0.0 0.0 10.7 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.1 1.7 7.2 0.0 2.0 0.0 0.4 300.4 4.4 0.3 0.0 3.7 0.5 0.4 0.0 5.0 10.4 0.0 0.0 1.5 0.0 0.3 0.0 0.1 0.1 0.6 0.0 0.8 0.3 5.7 2.3 0.0 0.0 0.1 0.1 0.3 0.4 0.0 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 82.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 65.7" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 3.7;neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5" HPA006539 Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.6 5.7 0.8 0.3 1.1 6.3 0.9 4.2 1.2 0.2 1.5 0.9 0.2 0.3 0.2 1.5 0.4 0.9 0.7 1.7 0.7 0.6 3.0 0.5 0.6 0.3 0.4 1.0 2.7 6.7 0.0 0.4 1.1 1.8 1.3 0.5 1.4 0.1 0.1 0.5 0.7 0.5 0.5 0.0 0.3 0.2 82.0 1.1 0.2 0.2 0.1 0.2 1.0 0.3 1.0 0.4 1.5 0.7 0.4 0.3 0.8 18.4 0.2 0.0 0.0 0.5 31.0 0.2 0.1 0.8 0.0 0.3 0.2 0.1 0.0 0.0 0.7 0.2 3.3 1.2 8.1 0.1 2.0 4.5 0.0 0.2 0.2 0.0 0.1 0.0 1.1 3.6 0.8 0.0 0.7 0.4 1.6 3.6 0.1 0.0 0.2 0.1 1.1 0.0 0.5 0.6 0.2 0.5 0.7 0.1 35.5 0.1 2.7 0.5 0.1 3.0 0.5 0.5 3.0 1.3 0.6 0.9 0.1 0.6 3.7 0.4 1.0 0.6 0.1 0.6 0.3 0.5 0.4 0.2 0.3 0.3 0.4 3.4 0.6 0.1 0.2 1.0 0.2 0.8 1.1 4.2 1.2 1.7 0.7 0.3 0.4 1.0 1.8 0.0 1.1 1.0 2.1 0.0 1.1 0.0 0.9 0.6 0.0 0.0 0.0 0.1 0.1 0.3 2.4 0.0 0.0 0.0 4.2 0.4 0.5 0.1 0.0 0.0 8.9 0.1 1.3 3.2 0.0 6.9 1.9 1.5 1.5 1.9 0.0 0.2 9.5 6.4 5.3 0.5 0.2 0.0 2.2 0.0 0.0 2.5 12.2 5.4 0.3 1.4 1.8 1.9 0.0 0.1 0.0 0.5 0.4 0.3 5.7 2.6 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.2 2.7 65.7 3.1 0.0 0.1 0.4 3.6 4.2 0.1 0.0 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 205.4" "Cell type enhanced" "Detected in all" "Early spermatids: 193.1;Late spermatids: 573.0;Spermatocytes: 175.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 20.4 32.9 49.2 16.6 45.1 13.8 19.8 44.0 64.3 23.9 34.8 22.4 12.4 23.8 12.7 29.1 22.5 15.1 28.2 47.9 38.4 34.1 34.2 19.5 15.1 48.4 44.9 41.5 18.9 16.4 23.4 26.8 15.7 56.1 29.3 7.6 11.9 23.9 14.9 16.9 21.9 19.7 10.5 40.8 24.7 27.6 205.4 48.5 10.7 31.0 16.0 12.9 26.9 21.6 47.1 22.0 50.2 18.6 49.5 34.9 19.9 69.6 25.5 24.3 31.0 18.4 38.0 31.6 22.7 42.4 24.1 51.9 44.3 28.8 17.1 9.7 73.0 27.9 22.7 53.7 22.5 21.6 15.0 40.9 24.8 25.0 27.5 19.0 20.8 16.3 28.4 20.6 56.2 19.1 56.9 16.8 40.5 22.5 20.4 49.9 31.0 18.0 37.5 20.0 30.3 27.2 32.6 30.0 44.6 30.6 21.4 46.0 6.3 23.1 69.1 46.8 53.3 18.7 41.9 84.9 20.5 50.0 12.3 44.9 1.9 2.8 5.1 2.3 2.5 2.9 2.7 2.0 1.7 3.0 3.8 2.1 1.8 14.0 1.9 2.1 3.0 1.6 1.4 49.2 45.1 44.0 64.3 47.9 38.4 48.4 44.9 41.5 56.1 40.8 48.5 47.1 13.0 3.2 11.2 12.7 15.0 14.4 18.5 21.8 19.4 14.1 16.2 13.3 5.3 20.0 13.7 12.9 12.5 49.6 9.5 26.2 15.6 39.0 193.1 14.4 14.8 15.8 16.2 14.7 9.3 26.6 69.7 13.4 15.3 10.0 2.5 10.3 11.4 10.8 23.2 20.2 9.0 16.8 14.2 15.4 14.5 573.0 19.3 11.5 14.2 6.5 16.4 38.9 11.3 4.5 11.2 30.8 14.6 16.1 13.4 26.7 31.5 19.6 18.6 9.1 26.3 8.7 14.1 175.0 55.9 16.9 15.2 119.6 10.8 16.6 15.1 23.3 SNCG "BCSG1, persyn, SR" ENSG00000173267 "Synuclein gamma" O76070 10 86958599-86963258 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 270.5;brain: 577.0" "Cell type enhanced" "Detected in many" "Adipocytes: 164.9;Breast myoepithelial cells: 156.1;Endothelial cells: 143.3;Hepatic stellate cells: 206.0;Smooth muscle cells: 234.3;Urothelial cells: 358.3" "Group enriched" "Detected in all" 8 "ovarian cancer: 84.1;urothelial cancer: 301.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 748.2;RT4: 483.5;T-47d: 151.7;TIME: 160.9" "Region enhanced" "Detected in all" "pons and medulla: 279.9" "Low region specificity" "Detected in many" "CAB001452, HPA014404, CAB040581, CAB080022" Enhanced Supported NA NA 23000 "CAB001452: AB_564020, CAB040581: , CAB080022: , HPA014404: AB_1857715" "unprognostic (2.06e-1)" "unprognostic (2.58e-1)" "unprognostic (6.87e-3)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (4.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-3)" "unprognostic (3.75e-1)" "prognostic unfavorable (2.29e-8)" "prognostic unfavorable (7.15e-4)" "unprognostic (2.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.77e-3)" 210.0 270.5 237.3 12.1 145.0 0.0 99.0 193.6 316.0 32.3 42.1 24.3 9.3 23.1 15.2 25.7 65.1 12.8 26.1 179.2 224.3 17.1 4.4 14.0 11.7 344.4 277.1 167.5 42.5 5.3 3.4 11.2 12.0 354.5 36.9 4.9 53.2 23.1 102.6 14.7 27.9 19.0 10.2 160.2 64.7 16.5 5.4 328.5 9.1 20.4 13.8 25.8 206.6 39.2 577.0 2.6 6.8 0.7 1.1 0.3 3.9 0.7 0.8 0.0 0.0 0.0 1.1 748.2 0.0 22.6 1.4 0.0 71.0 0.0 3.4 0.0 0.1 1.4 3.6 109.6 2.0 1.4 0.0 1.8 2.8 55.5 0.0 0.6 0.2 49.8 0.0 5.3 0.0 0.0 0.6 0.2 0.4 11.3 0.0 0.4 0.0 0.4 0.3 0.2 483.5 0.1 0.0 6.5 8.7 0.9 1.0 151.7 0.3 160.9 1.1 3.7 0.3 0.0 0.2 0.0 0.0 0.8 3.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 237.3 145.0 193.6 316.0 179.2 224.3 344.4 277.1 167.5 354.5 160.2 328.5 577.0 164.9 0.0 0.0 7.5 1.5 28.8 65.9 16.3 11.4 32.2 61.1 156.1 1.9 8.6 14.6 55.2 6.2 19.4 2.8 0.1 125.2 3.6 0.6 0.4 0.8 143.3 0.0 2.7 9.9 1.1 0.6 14.2 0.5 0.6 0.0 0.1 206.0 0.8 5.5 87.5 28.0 0.0 20.3 1.8 27.3 3.7 59.0 2.2 23.2 6.5 0.9 66.4 0.0 4.5 7.5 4.7 2.2 9.8 0.0 14.2 0.3 1.3 2.4 109.3 92.1 2.5 234.3 0.6 0.7 2.6 19.7 6.2 2.7 16.9 0.0 358.3 MMRN2 "EMILIN3, EndoGlyx-1, FLJ13465" ENSG00000173269 "Multimerin 2" Q9H8L6 10 86935540-86969481 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020741 Approved Vesicles "Secreted to extracellular matrix" NA NA 84000000 Vesicles "HPA020741: AB_1848154" "unprognostic (4.17e-1)" "unprognostic (7.87e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.08e-2)" "unprognostic (1.75e-3)" "unprognostic (1.43e-1)" "unprognostic (2.09e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (6.17e-3)" "unprognostic (1.54e-3)" "unprognostic (1.25e-1)" "unprognostic (6.44e-2)" "unprognostic (1.66e-1)" 60.6 14.0 14.2 10.2 11.3 1.5 54.9 10.8 19.2 19.9 16.1 13.8 10.6 28.4 13.9 17.1 22.9 16.7 33.7 10.5 10.9 17.6 8.7 32.4 9.8 12.7 11.3 8.4 23.3 10.6 10.7 7.6 74.4 12.3 14.2 9.0 3.0 26.8 29.0 27.0 39.3 14.0 27.6 11.9 34.9 12.0 15.4 15.8 6.5 26.0 32.7 13.4 32.5 19.3 11.6 11.4 2.9 0.4 0.2 1.2 6.3 7.1 4.1 11.1 4.8 6.8 6.4 89.2 0.1 39.5 7.6 11.6 21.9 0.0 5.2 6.4 8.1 0.0 2.3 10.2 0.2 0.9 0.0 4.6 1.5 26.4 5.7 38.6 13.0 196.6 2.4 2.1 35.0 1.8 7.1 0.4 4.4 2.0 0.4 4.9 0.2 0.1 0.1 2.0 17.5 4.8 0.0 3.1 3.7 1.4 0.9 14.9 1.2 237.1 1.9 11.0 1.9 0.1 2.6 4.0 0.1 5.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.2 11.3 10.8 19.2 10.5 10.9 12.7 11.3 8.4 12.3 11.9 15.8 11.6 229.3 0.0 5.8 1.6 0.3 9.4 0.9 0.0 4.6 0.2 1.4 2.0 13.2 5.7 0.7 1.8 0.0 0.7 0.4 0.0 0.0 0.1 1.0 0.3 0.4 127.1 0.0 2.7 0.9 0.0 0.1 8.1 0.0 0.5 0.0 0.2 182.0 4.1 1.7 0.0 1.2 0.0 0.0 6.5 4.4 2.8 2.5 0.7 3.6 15.9 0.0 0.7 0.0 1.0 0.1 0.0 0.0 3.0 0.1 0.6 0.5 0.2 0.0 0.6 6.6 3.9 9.4 1.8 2.3 2.2 7.7 0.3 0.8 3.6 0.2 1.0 MZT2A "FAM128A, MOZART2A" ENSG00000173272 "Mitotic spindle organizing protein 2A" Q6P582 2 131464900-131492743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 79.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 421.1" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA051758: , HPA052623: AB_2681888" "prognostic favorable (3.04e-4)" "unprognostic (3.82e-2)" "unprognostic (7.14e-2)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-2)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (3.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (3.04e-11)" "unprognostic (1.51e-2)" "unprognostic (5.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.66e-1)" 37.4 69.2 28.7 11.7 25.0 40.8 44.8 12.9 75.3 79.7 17.8 56.0 32.0 61.2 2.5 103.5 86.6 6.6 165.6 29.4 21.4 51.1 81.8 28.6 19.4 19.6 21.0 24.5 88.7 95.5 14.6 38.5 4.7 20.8 75.0 2.6 0.7 53.0 9.2 48.4 51.3 46.2 2.1 13.4 38.1 65.4 37.1 20.8 7.2 55.5 5.7 4.2 55.5 70.4 21.8 212.0 115.2 3.0 40.9 3.3 7.7 44.1 70.6 17.3 27.8 28.2 286.2 71.3 136.7 88.3 3.4 2.8 94.6 7.2 49.8 1.0 54.5 346.6 56.8 135.3 353.8 17.3 100.7 20.4 22.3 27.8 18.7 8.8 6.4 23.8 122.7 114.1 138.7 6.9 196.1 137.1 421.1 73.0 28.1 259.8 114.5 37.3 317.5 18.7 102.2 160.1 20.4 71.6 46.5 135.2 2.1 74.7 177.8 61.6 70.2 168.9 28.3 68.6 128.9 105.6 116.9 97.2 64.3 41.3 22.1 2.0 79.5 8.5 1.4 9.4 32.4 18.9 10.9 7.7 18.8 20.7 10.2 1.1 7.1 0.8 12.0 21.7 4.9 28.7 25.0 12.9 75.3 29.4 21.4 19.6 21.0 24.5 20.8 13.4 20.8 21.8 60.4 16.0 13.8 11.8 126.6 148.1 138.9 81.9 124.1 55.6 196.7 284.6 305.6 111.5 47.3 71.7 20.9 88.7 101.1 159.7 170.2 210.3 25.5 42.2 89.7 68.7 108.8 75.7 15.8 167.8 223.9 100.4 115.2 70.4 23.6 189.2 99.2 128.0 123.1 26.9 16.4 240.7 54.9 79.4 138.1 89.8 152.8 71.4 103.2 4.7 105.2 112.9 114.4 10.1 13.0 269.2 167.0 205.4 140.8 163.1 240.1 255.6 28.9 41.9 92.1 83.2 85.9 44.4 166.3 269.5 142.9 42.4 155.8 156.7 270.4 133.6 TNKS "ARTD5, PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555912-9782346 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 149.9;Excitatory neurons: 203.2;Inhibitory neurons: 230.6;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 285.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 6.7 9.4 15.0 6.5 20.5 12.3 10.0 20.6 17.6 12.2 7.2 7.1 6.1 10.6 17.7 5.9 8.3 6.3 7.1 14.5 18.1 6.1 7.6 6.7 8.6 22.2 20.0 13.0 13.2 7.6 12.6 12.7 8.0 23.0 7.9 6.9 21.1 7.2 7.8 18.6 11.5 7.9 7.2 17.0 6.6 7.3 20.5 19.0 10.6 9.7 11.9 8.7 7.9 6.9 33.0 8.8 11.5 28.8 17.4 17.8 23.7 10.7 13.4 15.1 10.7 12.0 6.9 6.9 18.9 5.4 13.2 14.3 9.2 16.5 12.5 15.4 4.9 8.6 13.3 10.7 15.6 16.0 6.9 7.9 16.9 14.8 11.1 21.6 17.3 14.6 14.5 12.7 19.6 19.9 5.8 17.5 10.4 18.9 9.7 6.7 13.9 17.8 5.5 12.8 17.8 29.1 21.4 10.5 9.9 19.3 17.3 6.6 10.2 19.7 17.4 10.6 11.9 10.0 6.7 11.8 13.3 18.7 9.5 17.1 2.4 1.1 0.9 2.0 1.1 1.0 1.9 1.6 1.9 1.4 3.2 1.8 2.2 3.5 1.5 1.4 1.8 0.8 0.7 15.0 20.5 20.6 17.6 14.5 18.1 22.2 20.0 13.0 23.0 17.0 19.0 33.0 19.7 16.0 11.7 130.9 23.1 11.5 12.8 11.4 12.0 34.1 15.8 13.6 17.0 15.7 12.0 9.2 14.6 11.2 14.9 9.2 1.9 12.4 149.9 19.9 30.6 15.5 13.8 14.5 203.2 8.5 10.9 20.3 19.9 20.9 10.1 33.7 18.9 18.0 7.1 42.1 230.6 10.8 16.2 9.4 8.5 76.3 16.8 10.3 12.4 92.8 8.4 15.1 5.2 313.1 285.7 13.4 12.8 18.0 20.7 12.8 17.2 6.9 28.1 37.0 0.0 28.7 16.6 37.7 15.4 12.9 15.5 12.3 18.1 39.5 12.2 12.8 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 15.8;Inhibitory neurons: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 6.2 10.4 2.9 4.5 3.2 1.4 6.1 2.7 4.4 5.2 2.9 4.9 3.2 6.5 5.3 3.6 4.4 5.4 5.3 3.2 3.4 3.7 3.5 5.1 3.9 4.0 3.3 3.5 4.6 8.3 5.8 4.3 6.8 4.2 5.7 3.4 4.9 4.8 4.4 5.3 3.6 3.8 4.9 2.6 6.1 4.9 2.8 3.3 2.8 7.0 5.5 3.5 4.6 4.7 3.0 2.7 3.8 7.7 6.3 6.8 13.5 3.7 5.1 3.9 3.2 7.8 1.3 3.6 1.7 6.4 4.0 4.3 3.1 5.4 2.3 5.1 2.3 4.6 2.2 4.3 2.0 5.2 1.8 3.2 5.3 6.6 2.7 7.9 4.5 6.2 4.2 2.2 1.8 9.2 1.5 2.3 2.0 2.7 2.6 4.2 1.9 5.1 2.5 4.7 1.6 1.8 4.5 1.2 3.7 3.8 4.9 2.7 2.0 6.1 7.4 2.7 5.0 4.6 1.4 1.8 1.3 2.9 3.0 4.8 0.7 1.2 1.7 1.2 1.5 2.4 0.7 1.1 1.7 1.1 0.4 1.1 1.1 0.3 2.6 3.3 0.7 1.1 1.0 2.9 3.2 2.7 4.4 3.2 3.4 4.0 3.3 3.5 4.2 2.6 3.3 3.0 6.7 0.0 2.2 7.8 2.4 0.9 0.9 1.1 1.2 6.0 2.5 2.5 10.2 1.5 1.3 1.8 0.0 2.5 1.3 0.8 0.0 1.7 0.3 1.2 3.4 6.4 3.0 0.8 15.8 0.6 2.1 3.7 3.1 1.1 1.3 6.4 6.8 0.6 4.2 10.1 12.5 0.8 0.0 3.2 1.9 0.5 5.3 2.4 3.6 8.4 5.0 3.9 0.0 9.5 7.2 1.2 1.4 4.1 1.1 1.1 0.6 0.6 2.2 2.8 0.0 2.4 4.0 2.8 2.3 1.0 2.3 1.2 1.9 11.5 0.6 0.6 ZBTB21 "KIAA1227, ZNF295" ENSG00000173276 "Zinc finger and BTB domain containing 21" Q9ULJ3 21 41986831-42010387 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.6" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 60.4;U-266/84: 57.0" "Low region specificity" "Detected in all" "HPA024655, HPA031757, HPA031758" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032" "unprognostic (1.16e-2)" "unprognostic (3.51e-2)" "unprognostic (8.79e-2)" "unprognostic (1.79e-1)" "unprognostic (5.88e-2)" "unprognostic (4.61e-2)" "unprognostic (6.03e-3)" "unprognostic (2.19e-2)" "unprognostic (2.67e-1)" "unprognostic (6.21e-3)" "unprognostic (2.67e-2)" "unprognostic (4.59e-2)" "unprognostic (1.35e-3)" "unprognostic (1.81e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-3)" "unprognostic (4.02e-1)" 9.0 35.9 5.4 6.0 4.2 41.6 8.2 4.4 8.8 8.0 2.9 5.8 4.0 13.8 7.1 6.5 6.6 12.0 4.0 5.0 16.1 6.6 11.3 7.0 5.1 6.6 5.9 2.6 8.6 9.5 14.1 4.9 6.9 7.4 7.9 4.9 14.3 4.1 4.3 2.5 8.8 4.7 8.5 3.0 6.6 6.6 12.3 5.8 6.4 9.5 3.1 5.5 9.7 5.1 6.5 12.8 10.0 9.6 10.9 13.3 10.2 9.3 11.6 16.6 10.9 16.5 12.0 6.2 22.5 5.1 11.6 19.6 9.5 14.1 8.2 17.6 11.9 13.9 2.6 10.3 7.3 10.2 8.9 5.2 5.9 17.2 15.2 19.9 4.8 6.2 12.2 15.1 38.0 7.8 18.6 24.0 4.3 9.5 9.3 12.3 10.1 10.7 26.4 4.8 10.1 13.6 7.9 16.1 23.8 11.2 4.8 8.5 4.2 7.0 16.0 8.9 11.3 11.5 60.4 57.0 20.9 21.0 14.5 10.6 0.1 2.4 1.2 1.6 2.8 1.9 2.6 1.8 1.3 2.4 1.9 2.6 1.9 2.3 0.5 3.2 2.1 1.3 1.2 5.4 4.2 4.4 8.8 5.0 16.1 6.6 5.9 2.6 7.4 3.0 5.8 6.5 19.0 6.4 41.1 8.1 24.7 60.0 32.9 6.2 26.2 14.5 15.6 15.9 4.9 12.8 12.4 7.3 2.1 6.7 20.8 7.1 11.7 5.4 14.0 20.8 34.8 19.6 4.2 2.1 13.8 5.0 5.5 31.9 10.2 27.1 16.5 6.7 9.3 20.4 6.1 32.0 15.5 10.2 10.2 6.3 24.8 5.3 4.1 14.5 35.6 5.6 7.2 10.1 5.2 4.5 8.1 3.9 6.0 10.5 20.3 24.7 5.4 4.8 13.5 13.6 6.6 36.1 21.0 21.5 14.1 19.3 63.2 9.7 20.8 7.3 5.6 20.9 PPP1R3B "FLJ14005, GL, PPP1R4" ENSG00000173281 "Protein phosphatase 1 regulatory subunit 3B" Q86XI6 8 9136255-9151574 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 146.1;skeletal muscle: 96.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 69.9;Hepatocytes: 184.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "hypothalamus: 26.2" "Group enriched" "Detected in many" 14 "basophil: 53.6;eosinophil: 15.8;neutrophil: 50.4" "Lineage enriched" "Detected in all" 19 "granulocytes: 53.6" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 47.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028731 Enhanced Approved Cytosol NA NA Cytosol "HPA028731: AB_10602120" "unprognostic (4.97e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.46e-2)" "unprognostic (2.39e-1)" "unprognostic (5.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.08e-7)" "prognostic unfavorable (6.03e-5)" "unprognostic (3.33e-1)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" 19.3 7.5 2.6 8.3 2.7 12.4 16.0 3.4 3.5 19.7 7.2 12.5 4.7 19.9 4.5 17.4 13.0 9.1 28.9 1.7 26.2 7.5 146.1 9.3 4.3 5.0 2.9 1.2 10.5 5.2 50.5 3.4 10.5 3.9 21.9 9.6 7.2 14.0 18.8 96.3 11.5 7.3 12.1 3.1 7.8 12.1 7.2 3.6 4.6 11.8 17.8 3.6 26.7 15.1 6.3 6.7 2.5 7.3 2.5 17.9 15.1 26.3 2.4 7.9 2.9 3.5 10.0 3.1 2.3 3.9 5.0 16.1 1.2 1.3 1.9 3.1 7.2 1.1 4.0 1.0 0.0 8.0 2.0 17.1 12.4 5.9 2.5 14.6 22.0 47.3 11.6 3.1 5.6 1.1 4.1 11.2 3.8 10.6 15.2 2.2 4.5 9.2 4.0 28.6 26.9 0.0 13.6 4.4 0.1 18.6 11.6 3.4 4.1 32.9 8.5 2.9 1.7 3.1 3.1 7.5 0.0 14.8 6.2 2.6 53.6 1.6 15.8 2.2 1.1 1.8 1.6 2.0 1.2 0.9 1.2 2.7 1.5 50.4 2.2 0.7 1.8 1.5 1.6 2.6 2.7 3.4 3.5 1.7 26.2 5.0 2.9 1.2 3.9 3.1 3.6 6.3 16.7 12.8 34.5 0.7 5.5 10.7 18.8 7.2 3.4 3.7 19.4 12.7 69.9 24.3 21.8 9.2 6.2 12.9 7.6 26.7 3.9 8.8 20.3 29.5 21.9 21.0 0.0 0.8 0.8 12.7 38.3 12.7 9.7 51.7 33.6 10.4 31.1 184.7 6.9 6.7 0.4 11.5 8.2 9.8 27.9 5.2 9.6 15.6 5.4 3.7 3.1 3.9 4.1 3.5 1.4 18.4 7.5 18.0 4.5 8.0 7.4 6.8 30.8 13.0 13.1 10.9 17.9 1.7 5.7 0.6 12.1 18.3 10.8 9.4 5.5 2.2 OR10K1 ENSG00000173285 "Olfactory receptor family 10 subfamily K member 1" Q8NGX5 1 158461574-158470857 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 14.2;Club cells: 5.0;granulocytes: 8.8;Respiratory ciliated cells: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.1 0.2 1.8 0.3 1.8 0.6 0.1 4.4 4.6 0.0 0.2 0.1 0.1 0.1 0.3 0.8 0.0 0.1 0.0 1.7 0.7 0.1 0.2 0.1 0.1 1.9 2.4 1.6 0.1 0.1 0.0 0.0 0.1 3.7 0.1 0.1 0.8 0.1 0.0 0.6 0.2 0.1 0.1 0.2 0.2 0.1 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 3.4 0.2 0.2 0.2 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.8 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 0.2 0.0 0.2 0.4 0.3 0.2 0.4 0.3 0.2 0.1 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.8 1.8 4.4 4.6 1.7 0.7 1.9 2.4 1.6 3.7 0.2 1.1 3.4 0.0 22.4 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 GPR148 PGR6 ENSG00000173302 "G protein-coupled receptor 148" Q8TDV2 2 130729070-130730336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046655, HPA060527" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA046655: , HPA060527: AB_2684307" "unprognostic (7.16e-4)" "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.2 0.3 0.1 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STOX2 DKFZp762K222 ENSG00000173320 "Storkhead box 2" Q9P2F5 4 183797692-184023526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049776, HPA065002" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA049776: AB_2680875, HPA065002: " "unprognostic (9.79e-3)" "unprognostic (3.46e-1)" "unprognostic (2.10e-1)" "unprognostic (6.57e-3)" "unprognostic (3.33e-1)" "unprognostic (6.41e-2)" "unprognostic (4.57e-4)" "unprognostic (8.97e-3)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-3)" "unprognostic (2.49e-1)" 1.9 1.6 5.8 0.7 8.1 6.0 1.8 3.7 12.9 2.1 1.6 1.6 0.9 1.9 3.4 5.0 2.8 1.3 3.2 10.8 4.2 2.2 2.0 2.1 0.6 3.2 4.3 8.4 3.3 5.0 4.0 7.1 1.4 5.8 2.4 0.9 3.8 7.4 2.4 2.1 3.9 1.3 1.9 2.0 4.1 2.3 0.9 5.2 4.2 5.9 2.1 1.1 2.6 3.3 10.9 2.1 4.3 13.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.3 1.7 0.0 2.6 0.0 2.7 0.2 7.4 1.2 0.0 0.0 5.9 0.0 12.7 0.1 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.5 0.0 1.8 0.0 0.6 0.0 0.1 16.8 0.0 0.6 0.1 4.8 0.0 3.1 4.1 6.8 15.8 3.2 0.0 0.0 4.7 0.2 0.4 0.0 0.0 2.8 0.0 0.1 0.1 3.8 2.1 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 8.1 3.7 12.9 10.8 4.2 3.2 4.3 8.4 5.8 2.0 5.2 10.9 12.7 12.8 22.1 39.2 0.4 4.2 6.0 3.7 8.6 28.2 3.8 4.6 20.7 5.7 8.7 7.3 0.0 2.7 0.0 0.2 3.9 5.4 1.2 7.2 0.7 18.5 1.8 0.0 181.7 3.1 2.1 5.8 3.1 3.7 0.0 0.3 21.4 5.6 1.1 33.7 192.3 0.4 2.0 2.2 1.5 2.6 0.6 0.8 1.8 72.1 0.0 12.4 0.0 91.0 153.5 2.1 0.0 4.5 1.3 5.2 0.0 4.0 16.8 3.4 0.0 4.8 4.5 0.6 2.0 17.8 3.3 0.7 0.7 3.6 0.4 3.4 MAP3K11 "MEKK11, MLK3, PTK1, SPRK" ENSG00000173327 "Mitogen-activated protein kinase kinase kinase 11" Q16584 11 65597756-65615382 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010165 Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "CAB010165: AB_631936" "unprognostic (8.36e-2)" "unprognostic (1.17e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-1)" "unprognostic (7.56e-3)" "unprognostic (3.10e-2)" "unprognostic (4.50e-2)" "unprognostic (4.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.77e-2)" "unprognostic (3.13e-2)" "unprognostic (2.01e-2)" "unprognostic (7.62e-2)" "unprognostic (1.95e-1)" "unprognostic (8.27e-3)" 46.4 32.9 42.5 37.3 45.9 24.6 43.3 40.8 48.8 26.6 28.0 34.5 48.7 29.9 7.5 35.9 31.5 13.6 40.6 31.3 34.4 48.5 96.1 63.2 23.9 44.7 46.5 26.3 21.1 36.1 12.2 28.1 21.8 55.0 39.5 11.9 2.8 29.3 12.8 20.3 35.5 51.4 10.1 39.1 79.0 36.6 21.4 41.6 19.5 37.6 10.5 11.4 29.4 28.6 56.1 48.0 43.4 23.1 22.6 7.0 8.0 21.7 19.3 11.9 19.9 14.9 43.4 43.9 16.4 65.5 13.0 33.0 40.9 12.2 19.5 7.1 40.2 15.5 50.0 28.2 50.9 18.6 28.9 71.2 12.4 19.1 14.5 13.3 21.6 57.4 21.5 21.6 32.7 10.9 58.2 34.0 50.9 24.2 31.0 48.1 56.1 13.3 36.2 19.2 43.1 19.6 22.9 22.0 58.1 107.7 10.4 46.6 45.8 68.8 31.3 35.8 48.1 32.4 23.3 27.5 15.8 35.3 33.1 75.1 7.5 10.5 13.1 3.1 15.3 3.0 2.7 3.2 4.5 10.1 3.0 2.4 1.8 17.3 2.4 15.4 3.0 1.8 9.5 42.5 45.9 40.8 48.8 31.3 34.4 44.7 46.5 26.3 55.0 39.1 41.6 56.1 70.0 22.4 21.1 4.2 22.1 21.0 25.3 18.4 20.5 24.4 28.9 23.4 8.7 31.5 14.1 11.0 25.0 24.7 26.4 123.5 19.6 21.9 13.5 15.4 11.3 78.9 41.9 13.0 4.1 27.5 17.7 11.4 44.4 26.1 26.0 19.6 58.5 56.2 53.3 18.5 3.5 54.9 20.3 50.6 65.5 68.5 9.6 48.3 21.4 21.5 50.2 16.1 23.7 3.0 29.5 33.7 99.0 6.4 15.5 28.1 113.1 27.6 10.3 54.7 32.9 10.5 12.8 12.2 18.3 24.8 30.0 34.3 24.0 28.9 55.2 34.6 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430358-125438403 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 368.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 242.7;Distal enterocytes: 281.6;Endometrial stromal cells: 240.1;Plasma cells: 283.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 9.9;neutrophil: 4.7;non-classical monocyte: 3.5;T-reg: 2.8" "Group enriched" "Detected in many" 12 "granulocytes: 9.9;monocytes: 3.5;T-cells: 2.8" "Cell line enhanced" "Detected in many" "HEL: 193.9;U-266/70: 114.2;U-266/84: 123.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA063982: AB_2685165" "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 83.3 25.8 7.4 41.3 8.0 368.9 28.3 10.8 16.3 36.2 7.5 45.5 20.6 25.7 13.7 33.8 15.9 80.9 18.0 7.6 15.6 24.2 140.8 54.2 17.4 9.2 7.9 5.8 4.1 43.4 79.6 12.1 29.1 8.0 45.8 52.4 16.4 19.4 7.2 44.4 15.7 32.3 43.6 8.3 22.5 38.3 7.0 10.3 36.4 108.5 19.3 18.2 100.1 5.4 10.4 14.7 16.4 2.2 4.6 4.6 8.8 25.4 9.4 13.2 6.8 2.3 22.1 18.9 26.5 8.5 6.9 40.6 11.0 7.0 9.1 5.8 11.8 34.3 193.9 7.3 43.6 11.6 98.3 17.0 8.5 13.5 27.8 62.8 33.0 20.0 0.3 17.5 81.6 0.9 15.8 9.2 15.3 15.8 35.1 31.6 18.5 3.3 29.2 54.6 55.1 13.7 5.0 22.9 24.6 93.1 14.0 6.4 4.6 10.4 7.3 9.5 7.3 11.7 114.2 123.2 36.6 13.1 0.7 17.7 0.0 0.7 9.9 0.0 1.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 4.7 0.0 3.5 0.3 2.8 0.1 7.4 8.0 10.8 16.3 7.6 15.6 9.2 7.9 5.8 8.0 8.3 10.3 10.4 69.6 134.6 168.5 13.7 19.8 100.1 242.7 68.6 77.4 25.5 100.8 71.9 16.6 31.5 67.9 16.5 0.0 12.3 2.8 281.6 11.7 45.3 0.4 96.6 240.1 62.0 112.0 5.3 2.1 24.7 19.1 54.6 58.6 222.5 29.9 0.5 8.2 131.7 35.3 21.9 0.7 129.6 32.6 72.0 59.7 1.7 0.3 85.9 56.9 4.7 27.5 20.1 0.0 4.5 0.2 45.5 130.9 0.4 283.6 139.0 117.4 24.9 39.7 3.8 0.0 36.6 45.1 0.3 2.2 88.2 64.2 30.6 14.8 1.5 106.9 128.7 CST9 "CLM, CTES7A" ENSG00000173335 "Cystatin 9" Q5W186 20 23602410-23605917 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "breast: 1.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 37 "breast cancer: 9.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029190 Uncertain "Secreted in female reproductive system" NA NA "HPA029190: AB_10602804" "unprognostic (2.06e-2)" "unprognostic (2.21e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592836-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 85.8" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 103.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 2.1;naive B-cell: 2.2;neutrophil: 1.5" "Group enriched" "Detected in many" 16 "B-cells: 2.2;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA077577 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 1.7 0.7 3.4 0.2 3.3 5.5 3.0 3.8 5.7 3.1 2.3 1.7 0.4 1.4 0.1 18.1 2.3 0.3 1.3 3.4 2.9 0.7 0.9 1.7 0.3 3.3 3.3 2.8 1.8 0.4 0.0 1.3 0.4 3.5 1.5 0.0 0.7 2.5 0.3 2.6 85.8 1.2 0.2 3.4 2.0 1.3 1.1 3.2 0.4 0.6 0.5 1.0 1.7 9.6 3.9 0.3 1.6 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.4 0.4 0.1 0.2 2.2 0.0 0.0 0.0 0.5 1.1 0.5 0.9 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.6 1.3 0.4 1.0 0.5 0.4 0.6 0.6 0.6 0.9 0.0 0.2 0.6 0.1 6.8 1.5 0.3 0.4 0.7 0.0 0.4 1.1 0.0 0.3 1.1 1.0 0.1 0.9 0.7 0.2 0.5 0.6 0.6 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.0 3.4 3.3 3.8 5.7 3.4 2.9 3.3 3.3 2.8 3.5 3.4 3.2 3.9 1.1 0.0 0.5 0.3 0.8 19.1 0.4 0.7 0.6 2.1 0.7 1.8 0.2 0.0 0.7 0.0 0.0 0.1 1.6 1.0 0.0 0.1 0.7 0.7 0.3 1.2 1.2 0.0 0.9 0.0 0.1 0.4 0.0 1.7 0.0 0.2 0.7 0.3 0.5 0.0 0.9 0.4 0.0 1.3 4.0 1.8 0.6 0.7 3.6 0.0 0.4 0.1 0.0 1.0 1.8 0.1 4.8 0.0 0.0 0.3 0.3 0.1 1.1 1.1 6.6 0.4 0.8 0.1 1.3 16.3 103.7 0.0 0.6 0.1 0.8 1.3 SFT2D3 MGC5391 ENSG00000173349 "SFT2 domain containing 3" Q587I9 2 127701497-127705242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.4;ASC TERT1: 4.2;BJ hTERT+: 4.2;HHSteC: 5.0;hTCEpi: 7.0;hTERT-HME1: 5.2;RPTEC TERT1: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 0.9 0.0 2.5 0.0 2.5 0.0 5.2 2.5 3.0 3.8 2.5 3.3 0.0 1.3 6.2 0.0 4.2 0.0 0.0 2.5 2.5 3.2 6.0 1.6 0.0 2.6 2.7 2.5 1.4 1.0 5.0 0.0 1.6 2.6 2.9 5.5 0.0 0.0 3.5 0.0 0.0 0.0 2.9 2.5 1.1 1.5 1.3 2.8 4.8 1.0 2.6 4.9 1.1 0.0 2.6 0.0 0.0 0.0 0.0 7.4 4.2 0.0 0.0 4.2 4.1 3.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 3.5 2.9 3.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.8 7.0 2.0 5.2 0.0 4.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 2.5 2.5 3.0 2.5 2.5 2.6 2.7 2.5 2.6 2.5 2.8 2.6 6.9 3.2 6.8 1.6 7.6 1.3 8.2 1.6 5.7 7.9 7.1 7.0 0.0 2.8 1.5 7.3 16.7 4.2 9.5 6.4 9.8 2.8 4.9 9.3 8.7 5.2 5.4 5.5 1.8 6.2 4.4 6.4 7.7 7.4 1.3 7.5 4.2 9.5 4.1 8.4 2.5 10.5 0.0 8.4 3.0 2.7 5.6 10.5 3.6 3.7 5.1 10.0 8.2 3.0 5.1 3.1 7.0 7.5 5.6 9.3 5.6 6.4 3.4 10.1 0.0 5.2 5.2 18.3 3.8 7.1 2.7 2.9 6.5 9.7 8.7 5.9 AC097637.1 ENSG00000173366 "Novel twinfilin, actin-binding protein, homolog 2 (Drosophila) (TWF2) and toll-like receptor 9 (TLR9) protein" 3 52221081-52231190 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.8;lymphoid tissue: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.08e-2)" "unprognostic (9.63e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.7 0.1 1.8 0.0 0.0 2.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QB ENSG00000173369 "Complement C1q B chain" 1 22652762-22661637 "Human disease related genes, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lung: 551.1;lymphoid tissue: 998.9" "Group enriched" "Detected in many" 28 "Hofbauer cells: 1451.0;Kupffer cells: 4559.7;Macrophages: 1747.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 71 "intermediate monocyte: 140.6;non-classical monocyte: 101.2" "Lineage enriched" "Detected in many" 85 "monocytes: 140.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052116 Approved "Secreted to blood" NA NA "HPA052116: AB_2681735" "unprognostic (1.42e-1)" "unprognostic (3.36e-2)" "unprognostic (5.61e-3)" "unprognostic (8.20e-2)" "unprognostic (5.93e-2)" "unprognostic (4.09e-1)" "unprognostic (1.25e-1)" "unprognostic (2.35e-1)" "unprognostic (2.87e-2)" "unprognostic (2.21e-1)" "unprognostic (2.63e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (4.14e-2)" "unprognostic (7.76e-3)" "unprognostic (4.83e-2)" "unprognostic (2.35e-2)" 443.2 231.2 90.6 150.8 116.6 54.0 87.9 97.1 149.9 65.9 158.4 163.5 187.7 28.0 26.7 63.6 51.0 196.6 63.1 85.5 184.7 18.5 245.3 551.1 519.1 163.0 111.8 79.7 39.9 40.3 28.7 1.8 251.3 134.4 28.3 147.4 7.9 45.3 51.7 5.4 6.2 187.7 263.9 141.5 998.9 88.8 40.3 144.1 72.7 23.8 38.9 58.9 258.2 1.1 197.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.4 0.0 0.0 0.5 0.3 0.6 0.0 0.0 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.8 0.0 0.1 0.1 0.0 0.2 0.0 1.7 0.0 0.0 140.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.8 101.2 0.0 0.0 5.3 90.6 116.6 97.1 149.9 85.5 184.7 163.0 111.8 79.7 134.4 141.5 144.1 197.4 13.8 12.8 22.1 0.0 17.1 6.2 2.1 0.0 1.8 1.2 4.9 23.1 5.5 24.3 10.5 3.7 0.0 6.6 2.7 0.6 0.0 0.0 3.3 0.1 0.2 65.9 0.0 32.8 0.1 0.0 9.6 5.9 0.0 0.1 11.4 0.1 52.1 26.0 1451.0 0.0 0.1 0.0 0.0 4559.7 92.1 7.8 8.4 1747.2 0.0 34.7 5.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 2.3 1.0 0.3 1.1 3.6 3.9 59.2 4.0 3.2 0.4 0.9 5.7 4.5 9.6 6.1 0.2 0.0 1.5 C1QA ENSG00000173372 "Complement C1q A chain" P02745 1 22636628-22639678 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 1101.4" "Group enriched" "Detected in many" 9 "Hofbauer cells: 1663.2;Kupffer cells: 5007.4;Macrophages: 1874.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 39 "intermediate monocyte: 226.1;non-classical monocyte: 181.7" "Lineage enriched" "Detected in many" 60 "monocytes: 226.1" "Cell line enhanced" "Detected in some" "HMC-1: 2.3;NB-4: 1.4;RPMI-8226: 7.1;SCLC-21H: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002350, CAB009823" Supported "Secreted to blood" NA NA 2700000000 "CAB009823: AB_2228238, HPA002350: AB_1078552" "unprognostic (1.97e-1)" "unprognostic (1.14e-2)" "unprognostic (1.98e-3)" "unprognostic (3.07e-2)" "unprognostic (6.10e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" "unprognostic (1.99e-1)" "unprognostic (4.42e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (1.58e-6)" "unprognostic (1.54e-1)" "unprognostic (2.11e-3)" "unprognostic (2.75e-2)" "unprognostic (7.30e-2)" 378.5 237.9 79.7 135.3 91.5 54.3 96.9 81.7 136.4 76.5 126.9 144.2 173.9 43.5 26.2 58.8 76.3 173.9 75.4 76.3 149.3 55.6 210.5 407.8 536.9 122.9 90.4 75.9 37.9 34.5 26.4 46.7 258.5 97.9 47.5 121.3 4.2 48.5 55.1 15.0 20.7 191.7 196.9 102.0 1101.4 91.6 38.5 106.5 101.2 36.8 49.7 68.6 259.9 30.6 125.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.0 0.5 0.2 7.1 0.0 0.0 3.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.4 0.1 0.8 0.0 0.0 0.1 0.1 0.0 0.1 5.2 0.1 0.1 226.1 0.0 0.0 0.1 0.1 3.7 0.0 0.0 0.0 0.5 0.3 181.7 0.0 0.0 9.7 79.7 91.5 81.7 136.4 76.3 149.3 122.9 90.4 75.9 97.9 102.0 106.5 125.2 17.4 35.3 55.8 0.0 19.0 18.4 2.3 0.0 2.2 0.4 5.1 24.6 8.9 37.1 18.0 0.0 0.0 8.7 2.7 0.5 0.0 0.0 4.5 0.2 0.5 46.0 1.8 41.0 0.0 0.2 11.3 9.6 0.0 0.2 21.5 0.2 76.1 26.2 1663.2 0.0 0.0 0.1 0.0 5007.4 291.4 9.9 13.1 1874.2 26.6 20.6 16.7 0.3 0.0 0.0 0.1 0.0 0.1 0.4 2.8 1.3 0.1 1.1 15.3 0.8 78.9 7.4 4.6 0.7 2.1 4.2 16.8 18.2 11.8 0.0 0.2 1.3 NDNF "C4orf31, FLJ23191" ENSG00000173376 "Neuron derived neurotrophic factor" Q8TB73 4 121035613-121073021 "Disease related genes, Predicted secreted proteins" Neurogenesis "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 107.5;placenta: 60.6;retina: 57.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 246.8;Bipolar cells: 69.8;Early spermatids: 217.1;Late spermatids: 221.7" "Cancer enriched" "Detected in many" 4 "lung cancer: 12.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.5;U-266/70: 20.8;U-266/84: 85.8" "Group enriched" "Detected in all" 4 "basal ganglia: 11.1;olfactory bulb: 34.0" "Low region specificity" "Detected in all" HPA048881 Supported Vesicles "Secreted in other tissues" NA NA Vesicles "HPA048881: " "unprognostic (2.84e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" "unprognostic (6.65e-4)" "unprognostic (2.18e-3)" "unprognostic (6.27e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.38e-3)" "unprognostic (1.20e-1)" "unprognostic (1.18e-4)" "unprognostic (1.74e-1)" 4.8 2.6 2.0 0.9 1.4 0.0 3.3 5.0 1.7 14.3 7.9 6.6 2.9 6.0 4.3 7.8 20.6 9.5 4.8 1.8 7.4 27.4 0.4 107.5 0.3 7.6 9.5 0.7 42.9 0.5 0.7 5.3 60.6 7.5 16.8 8.3 57.9 2.2 4.4 4.4 1.6 4.8 3.5 8.0 0.4 4.1 10.5 3.3 2.5 1.3 14.2 0.2 9.1 1.9 5.9 0.2 0.0 10.6 0.0 13.9 11.3 0.2 0.2 0.5 0.2 0.5 1.6 0.0 0.0 0.0 48.5 0.8 0.0 0.0 0.0 1.1 0.9 1.7 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.2 0.6 0.0 0.0 0.0 14.3 1.0 0.0 0.2 0.1 0.9 7.4 2.1 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.6 0.2 0.0 0.0 11.5 0.0 0.2 0.5 20.8 85.8 0.0 3.9 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 5.0 1.7 1.8 7.4 7.6 9.5 0.7 7.5 8.0 3.3 5.9 10.9 246.8 48.3 1.6 0.0 1.1 0.0 0.0 0.0 69.8 0.2 0.1 1.6 8.6 28.6 12.9 18.8 0.3 0.0 5.3 0.0 0.0 217.1 0.9 4.7 11.7 1.8 0.0 0.0 0.2 0.0 14.9 0.0 0.1 2.5 0.1 2.9 0.0 0.1 1.7 8.0 0.8 0.0 0.0 0.8 221.7 3.4 0.4 5.4 6.5 0.0 12.2 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.0 12.5 20.0 0.0 1.2 3.6 6.4 5.0 0.3 0.9 0.5 0.3 13.0 1.2 0.1 IQCF1 MGC39725 ENSG00000173389 "IQ motif containing F1" Q8N6M8 3 51894876-51903353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 242 "testis: 71.3" "Group enriched" "Detected in some" 170 "Early spermatids: 1222.4;Late spermatids: 3277.3" "Cancer enriched" "Detected in single" 30 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1222.4 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3277.3 10.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 101.1;placenta: 115.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 399.0;Hofbauer cells: 202.1;Macrophages: 202.6;Syncytiotrophoblasts: 463.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 125.4;HaCaT: 64.9;HHSteC: 125.1;hTCEpi: 58.4;SiHa: 248.8;SK-BR-3: 96.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.3 3.4 11.5 29.3 13.4 24.0 3.7 18.3 22.2 3.3 8.0 0.7 1.3 1.6 1.3 0.5 2.1 7.4 1.0 8.0 23.6 8.3 3.2 101.1 0.7 22.0 13.5 3.7 0.3 2.2 4.2 2.7 115.5 37.2 2.3 1.0 5.1 3.8 1.0 0.5 0.6 1.2 2.1 35.9 0.8 2.4 4.7 15.5 2.8 2.6 0.0 0.8 6.0 0.3 38.1 7.3 0.5 0.1 0.3 0.3 0.0 16.8 12.1 2.2 7.3 2.6 125.4 0.1 1.6 0.0 15.8 0.5 64.9 0.0 0.7 4.9 0.0 0.0 0.0 6.1 0.0 125.1 0.1 0.3 1.0 58.4 0.3 0.0 0.0 0.3 0.1 0.1 0.7 0.0 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.3 0.2 13.3 0.4 0.2 248.8 96.9 0.0 17.4 27.1 0.0 0.1 0.2 1.4 0.0 0.0 0.4 0.3 0.4 0.1 0.1 0.1 0.6 0.6 1.3 0.1 0.1 0.1 0.1 0.1 0.0 2.8 0.2 0.1 0.1 1.4 0.1 0.1 0.3 0.1 0.6 11.5 13.4 18.3 22.2 8.0 23.6 22.0 13.5 3.7 37.2 35.9 15.5 38.1 1.9 28.9 27.4 0.0 4.0 1.5 0.4 0.5 0.0 0.4 1.1 4.6 0.1 1.5 4.4 0.0 0.0 399.0 0.3 0.0 0.0 0.1 13.4 0.1 0.0 10.8 0.0 0.4 2.3 0.0 14.6 10.9 0.5 0.1 15.2 0.0 0.0 0.5 202.1 0.0 0.2 0.0 0.0 18.9 79.5 11.6 0.3 202.6 0.0 40.3 21.3 0.1 0.0 0.5 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.2 6.6 0.2 0.0 0.2 0.4 0.1 0.2 0.8 0.6 463.1 1.6 0.1 0.0 0.3 GLIPR1L1 MGC26856 ENSG00000173401 "GLIPR1 like 1" Q6UWM5 12 75334670-75370560 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 34.0" "Group enriched" "Detected in some" 7 "Early spermatids: 226.7;Spermatocytes: 179.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "NTERA-2: 109.1" "Low region specificity" "Detected in many" HPA042095 Enhanced "Secreted in male reproductive system" NA NA "HPA042095: AB_10796898" "unprognostic (2.45e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (3.04e-1)" "unprognostic (2.70e-1)" "unprognostic (4.79e-2)" "unprognostic (3.01e-1)" "unprognostic (2.89e-1)" "unprognostic (7.90e-3)" "unprognostic (1.08e-1)" "unprognostic (9.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-1)" "unprognostic (2.11e-2)" 0.2 0.9 0.3 0.1 1.5 0.3 0.1 3.5 1.1 0.1 0.3 0.1 0.2 0.5 0.0 0.8 0.2 0.8 1.4 0.3 1.3 0.6 0.1 0.4 0.4 1.4 1.1 0.1 0.6 0.2 0.0 0.5 0.0 1.4 0.3 0.0 1.1 0.6 0.0 0.5 1.1 0.3 0.0 0.6 0.4 0.3 34.0 1.9 0.0 0.3 0.0 0.0 0.2 0.1 1.7 0.5 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 109.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.2 14.5 0.1 0.2 0.0 0.4 0.2 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 1.5 3.5 1.1 0.3 1.3 1.4 1.1 0.1 1.4 0.6 1.9 1.7 0.1 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.6 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 226.7 0.1 0.3 0.5 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 28.3 5.3 0.3 0.0 1.9 0.0 0.3 0.0 5.0 5.1 0.0 0.0 2.6 0.0 0.0 0.0 0.3 0.0 0.3 6.6 0.2 0.2 179.3 2.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 207.9;Skeletal myocytes: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 280.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353, HPA070563" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 84000000 "Vesicles, Plasma membrane" Nucleoplasm "CAB001960: , CAB016353: AB_627292, HPA070563: " "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 25.4 22.2 30.2 18.1 29.7 5.4 26.8 30.1 30.9 26.4 23.9 35.2 24.2 32.4 16.3 28.6 32.1 26.7 69.6 28.9 29.1 27.9 43.4 32.0 9.5 32.2 29.9 24.7 24.9 51.8 44.6 18.8 77.6 27.1 29.8 30.9 9.9 32.1 38.3 94.7 28.7 24.2 46.3 28.2 12.7 32.3 27.2 31.7 10.6 25.7 96.6 14.4 28.0 22.2 29.4 92.3 92.4 61.9 152.3 80.3 38.8 280.9 63.9 93.7 108.0 69.0 74.2 96.0 13.0 62.2 103.2 87.6 168.4 55.6 81.2 67.2 12.7 18.6 9.6 84.3 87.2 35.5 11.2 17.4 33.3 72.5 100.3 33.3 96.7 97.1 15.3 14.5 9.8 31.2 75.5 10.1 8.1 66.4 110.0 31.2 5.5 60.5 22.3 82.5 126.4 21.8 45.2 74.8 206.0 105.5 170.3 171.6 22.8 51.8 39.1 63.9 76.0 91.4 11.0 24.2 8.1 50.4 12.6 245.9 2.3 1.2 0.7 1.1 1.3 1.2 1.2 0.9 0.9 0.7 1.0 1.0 1.0 2.2 1.1 2.5 1.3 0.7 1.4 30.2 29.7 30.1 30.9 28.9 29.1 32.2 29.9 24.7 27.1 28.2 31.7 29.4 19.0 54.5 18.4 32.0 4.0 14.3 8.0 31.7 17.1 7.4 36.1 46.4 56.6 30.0 20.6 35.0 4.2 116.4 5.8 37.3 1.9 32.4 30.0 30.2 17.3 20.9 33.0 14.3 15.6 79.6 118.4 26.1 37.8 37.9 7.0 207.9 16.8 59.9 21.2 3.3 16.5 29.7 14.2 8.6 7.0 20.0 21.5 6.3 33.8 9.4 5.6 27.1 5.2 19.6 10.7 57.2 21.4 36.9 5.1 14.4 18.9 7.6 23.2 8.7 46.0 326.1 36.2 7.1 19.9 19.0 17.0 95.9 5.9 10.0 29.2 10.2 INSM1 "IA-1, IA1" ENSG00000173404 "INSM transcriptional repressor 1" Q01101 20 20368104-20370949 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.3;pituitary gland: 29.5" "Cell type enriched" "Detected in some" 42 "Enteroendocrine cells: 506.7" "Cancer enhanced" "Detected in many" "glioma: 9.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 370.4" "Low region specificity" "Detected in many" NA NA "unprognostic (1.86e-2)" "unprognostic (5.25e-4)" "unprognostic (7.59e-2)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (1.07e-3)" "unprognostic (4.34e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" "unprognostic (1.33e-1)" "unprognostic (1.52e-1)" "unprognostic (2.77e-1)" "unprognostic (1.33e-1)" "unprognostic (5.23e-1)" "unprognostic (1.22e-1)" 0.2 7.2 2.1 0.6 4.7 0.0 0.0 13.3 3.2 0.0 0.1 1.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.5 0.0 0.0 0.0 0.5 3.1 2.5 2.5 0.0 3.0 0.0 29.5 0.0 4.1 0.2 1.9 0.1 0.0 0.2 0.0 0.1 2.1 0.0 0.5 0.2 5.2 0.4 2.9 2.8 0.0 0.0 0.3 0.1 0.0 2.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.1 3.2 19.4 0.0 0.0 370.4 0.3 0.0 0.3 0.0 1.1 0.9 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 4.7 13.3 3.2 2.5 4.5 3.1 2.5 2.5 4.1 0.5 2.9 2.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.9 0.0 0.0 0.2 0.1 0.1 506.7 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 1.4 10.8 0.0 0.0 0.7 0.0 0.0 0.2 3.6 0.0 11.9 0.0 0.0 0.5 3.1 1.5 2.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 DAB1 ENSG00000173406 "DAB adaptor protein 1" O75553 1 56994778-58546734 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.1;intestine: 22.5;seminal vesicle: 10.0" "Group enriched" "Detected in some" 8 "Excitatory neurons: 460.3;Inhibitory neurons: 1170.3;Oligodendrocyte precursor cells: 814.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 54.0;HeLa: 18.6;NTERA-2: 23.4;RT4: 32.0;WM-115: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032329, HPA052033, HPA067495" Enhanced Enhanced Vesicles NA NA Vesicles "CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (8.54e-2)" "unprognostic (2.09e-4)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (7.30e-4)" "unprognostic (3.90e-1)" "unprognostic (3.07e-2)" "unprognostic (1.47e-2)" "unprognostic (2.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.00e-3)" "unprognostic (1.78e-1)" "unprognostic (2.01e-1)" "unprognostic (1.44e-2)" "unprognostic (5.67e-2)" 2.0 1.7 4.3 0.4 5.4 0.0 0.3 17.1 8.9 1.6 0.0 0.7 15.9 0.5 0.4 0.6 1.6 0.7 1.7 10.3 4.9 0.3 7.8 0.4 0.2 2.3 4.1 4.8 1.2 0.4 0.0 0.2 0.0 6.2 3.9 0.3 5.5 0.9 10.0 0.1 0.1 22.5 0.3 2.4 0.2 1.0 0.4 4.2 0.1 0.3 0.1 0.1 1.2 0.9 4.0 0.0 0.0 10.6 0.0 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.1 23.4 0.0 0.0 6.0 0.0 0.2 0.0 32.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.6 0.1 0.0 2.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 4.3 5.4 17.1 8.9 10.3 4.9 2.3 4.1 4.8 6.2 2.4 4.2 4.0 0.7 0.0 0.0 30.0 0.1 0.0 0.1 0.1 0.0 23.7 0.1 0.3 3.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 8.6 8.2 0.6 0.3 0.0 0.0 460.3 0.0 0.0 0.4 4.6 12.8 0.0 0.0 0.7 5.1 0.1 21.9 1170.3 1.9 6.1 0.3 0.0 4.7 3.4 0.1 0.0 22.5 0.0 1.0 1.0 814.8 26.5 0.0 0.0 2.6 0.0 0.1 101.1 0.2 0.0 0.8 0.0 0.1 0.9 0.2 0.5 0.0 0.0 0.7 0.6 0.0 2.1 0.0 ARV1 ENSG00000173409 "ARV1 homolog, fatty acid homeostasis modulator" Q9H2C2 1 230978981-231000733 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035709 Approved Uncertain Vesicles NA NA Vesicles "HPA035709: AB_2674744" "unprognostic (2.32e-1)" "unprognostic (4.69e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-1)" "unprognostic (1.42e-1)" "unprognostic (9.95e-2)" "unprognostic (5.66e-2)" "prognostic favorable (3.27e-5)" "unprognostic (1.37e-1)" "unprognostic (1.12e-2)" "unprognostic (9.57e-2)" "unprognostic (9.82e-2)" "unprognostic (2.31e-1)" "unprognostic (4.82e-1)" "unprognostic (5.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.12e-3)" 10.7 18.6 24.9 10.3 26.3 14.0 19.2 27.5 33.0 12.4 26.3 24.9 16.6 9.8 23.1 15.9 14.5 16.5 30.4 25.9 26.8 25.4 26.4 15.2 14.9 26.6 26.0 25.1 11.3 17.6 33.6 20.3 11.8 26.6 16.4 26.1 29.2 22.2 15.4 21.9 17.9 17.5 13.2 27.4 13.7 17.3 31.6 26.5 15.2 22.1 25.0 15.4 15.4 11.3 29.2 40.8 43.6 20.8 25.1 29.6 26.4 20.1 19.0 34.0 33.5 38.3 16.3 31.4 11.4 22.7 21.3 20.5 32.3 40.6 25.5 39.2 30.4 55.7 36.8 28.9 22.1 30.5 53.6 27.9 28.0 25.8 18.1 20.9 21.9 22.5 34.7 53.7 30.7 22.2 14.3 22.3 16.4 27.1 43.0 27.1 25.2 32.1 33.1 47.1 33.0 21.2 32.6 22.6 26.6 57.9 5.3 46.6 46.6 13.9 13.4 8.7 23.6 45.9 47.4 44.6 28.9 36.8 45.9 36.7 9.1 8.1 8.5 10.0 12.2 13.9 18.1 11.2 12.4 10.1 11.2 13.7 13.0 2.0 12.7 21.2 14.9 15.4 9.0 24.9 26.3 27.5 33.0 25.9 26.8 26.6 26.0 25.1 26.6 27.4 26.5 29.2 13.6 16.0 31.7 10.7 12.6 12.9 22.0 75.8 11.4 18.9 14.8 15.6 32.2 21.5 38.9 29.5 2.1 37.9 12.7 15.8 60.7 24.1 52.6 12.7 10.9 12.7 7.7 58.1 20.2 40.8 14.5 14.5 11.7 9.7 17.1 14.4 15.0 17.3 24.9 38.7 25.6 18.5 34.6 13.3 5.5 22.9 9.3 13.5 24.9 8.4 9.8 33.6 7.2 8.5 19.3 21.5 11.5 16.6 14.7 11.6 17.9 32.5 27.3 20.0 0.0 11.4 15.6 116.7 21.0 20.3 15.2 15.6 11.4 22.0 26.4 20.9 NAA20 "dJ1002M8.1, NAT3, NAT5" ENSG00000173418 "N-alpha-acetyltransferase 20, NatB catalytic subunit" P61599 20 20017310-20033655 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 399.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063344 Supported Cytosol NA NA Cytosol "HPA063344: AB_2684991" "unprognostic (2.94e-2)" "unprognostic (1.14e-1)" "unprognostic (7.14e-2)" "unprognostic (2.59e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (6.18e-2)" "unprognostic (9.30e-2)" "unprognostic (3.85e-1)" "unprognostic (2.93e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" 50.8 53.8 41.4 35.2 43.0 46.9 66.0 43.5 52.0 41.2 53.1 42.3 28.2 42.1 54.7 114.5 42.0 32.9 62.3 41.8 46.5 86.0 83.2 40.5 37.6 43.1 43.3 41.3 33.3 63.2 104.8 26.9 53.5 43.6 43.9 43.2 50.1 47.6 47.3 85.7 38.5 34.2 46.6 43.9 32.1 42.5 67.2 43.6 37.5 60.3 74.3 51.4 51.8 44.5 45.9 212.7 139.9 50.1 69.4 95.0 116.6 67.7 149.2 100.3 132.1 123.8 67.0 137.7 108.4 80.6 113.6 125.5 156.3 85.8 233.2 153.2 51.4 75.7 79.4 49.6 132.6 141.2 102.2 65.9 122.4 182.1 132.8 153.9 93.2 139.7 80.4 126.7 115.7 157.6 177.2 128.6 149.9 37.9 181.5 180.7 69.8 191.9 148.3 190.0 70.4 84.1 62.2 81.9 254.1 170.7 42.5 145.4 171.1 113.7 106.6 75.4 137.8 153.8 130.0 171.9 116.9 66.5 76.2 76.7 39.7 86.2 70.1 55.5 97.5 83.6 63.3 65.9 65.4 92.9 56.6 63.5 75.0 12.5 70.3 81.8 77.7 75.6 100.6 41.4 43.0 43.5 52.0 41.8 46.5 43.1 43.3 41.3 43.6 43.9 43.6 45.9 60.5 67.3 42.2 17.0 44.9 108.7 113.6 312.4 45.5 52.9 62.9 75.2 73.1 77.2 147.8 104.8 25.0 111.8 51.4 32.6 230.9 194.0 399.9 99.5 87.6 77.4 41.3 28.8 18.0 169.0 102.2 66.4 31.1 75.8 51.3 46.5 50.3 72.9 255.9 69.0 22.7 43.8 164.8 66.8 56.1 60.5 69.9 68.6 71.2 31.9 100.1 91.5 58.7 16.1 25.2 198.0 37.1 74.9 44.2 184.5 45.7 242.6 199.9 60.7 39.5 75.8 90.8 354.2 58.3 122.5 118.8 85.5 40.8 99.5 54.2 141.7 IHO1 "CCDC36, CT74, FLJ25320, LELA1" ENSG00000173421 "Interactor of HORMAD1 1" Q8IYA8 3 49198428-49258106 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 26.7" "Cell type enhanced" "Detected in some" "Adipocytes: 1.7;Cardiomyocytes: 1.4;Fibroblasts: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.9;hTEC/SVTERT24-B: 9.2;LHCN-M2: 4.0;NTERA-2: 2.5;U-2197: 5.1;WM-115: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA045690, HPA069534" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045690: AB_10964634, HPA069534: AB_2686146" "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 3.2 1.4 0.6 0.3 0.2 0.2 1.8 0.9 0.8 1.1 6.1 0.8 0.2 1.2 0.4 0.4 1.3 0.7 1.1 0.5 0.1 0.2 0.1 0.6 0.3 0.3 0.4 0.0 3.8 0.2 0.1 0.2 0.9 0.7 0.4 0.1 0.7 0.3 0.5 0.9 0.5 0.4 1.0 0.2 0.5 0.3 26.7 0.5 0.1 1.0 0.9 0.1 0.8 0.6 1.5 0.0 0.1 0.0 0.0 1.9 2.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.1 1.7 0.0 9.2 0.0 0.0 1.2 0.0 0.0 0.1 4.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 5.1 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.9 0.8 0.5 0.1 0.3 0.4 0.0 0.7 0.2 0.5 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 RNASE8 RAE2 ENSG00000173431 "Ribonuclease A family member 8" Q8TDE3 14 21057822-21058455 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 229 "salivary gland: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAA1 "PIG4, SAA, TP53I4" ENSG00000173432 "Serum amyloid A1" P0DJI8 11 18266260-18269977 "Disease related genes, Predicted secreted proteins" "Acute phase" Heparin-binding Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 48539.6" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 99298.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 1249.6" "Group enriched" "Detected in some" 6 "hypothalamus: 41.8;white matter: 12.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "HBEC3-KT: 716.4" "Secreted to blood" NA NA 300000000 11000000000 "unprognostic (2.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (1.50e-1)" "unprognostic (4.54e-3)" "unprognostic (1.79e-2)" "unprognostic (1.63e-2)" "unprognostic (7.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-2)" "unprognostic (8.95e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.57e-12)" "unprognostic (5.15e-2)" "unprognostic (9.78e-2)" "unprognostic (9.23e-3)" "unprognostic (1.64e-1)" 2058.8 54.9 0.1 163.1 0.1 0.0 1394.3 0.1 0.6 260.1 1.4 31.8 1.4 2.2 0.2 51.5 57.1 34.0 17.0 0.2 41.8 28.5 48539.6 99.4 1.2 0.8 3.0 0.1 3.3 47.1 0.5 67.1 7.2 0.3 67.1 6.5 0.0 2387.4 4.4 515.8 81.3 75.6 19.0 0.1 39.1 42.4 1.7 4.5 52.6 18.3 0.2 15.9 64.4 29.3 12.5 49.2 0.3 0.0 0.3 34.4 0.2 18.9 1.3 1.1 0.2 0.3 0.1 17.2 0.0 38.3 0.0 11.7 45.5 0.0 716.4 0.3 0.6 0.0 0.8 0.0 0.1 148.4 1.1 0.0 60.9 66.7 0.2 76.7 0.1 0.0 0.0 0.1 0.0 9.3 0.1 0.0 0.1 0.0 0.0 0.0 0.2 1.7 0.0 28.5 0.9 0.0 0.1 4.2 5.5 0.2 0.0 0.5 0.0 0.0 0.2 5.5 0.0 1.3 0.0 1.3 1.3 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.2 41.8 0.8 3.0 0.1 0.3 0.1 4.5 12.5 107.2 6.4 2.8 0.0 259.8 9.3 64.9 10039.5 10.2 0.0 210.6 1010.4 0.1 1701.5 7604.7 55.2 0.0 1.3 3.0 44.5 0.0 250.4 0.0 12.6 1.6 114.9 1.8 3543.7 0.1 81.1 34.4 8.3 0.0 14.3 2.5 0.0 2568.6 99298.7 1.0 0.0 0.1 5.2 2012.1 2454.9 0.3 0.0 0.0 2.6 51.6 0.0 2.6 0.0 1.0 0.0 0.1 68.8 5.5 0.0 0.1 185.5 3.1 0.2 15716.2 0.0 0.0 31.5 736.1 0.0 0.0 34.1 0.1 2.1 214.7 0.0 36.7 178.8 MICOS10 "C1orf151, FLJ36999, Mic10, MINOS1, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial contact site and cristae organizing system subunit 10" Q5TGZ0 1 19484403-19629821 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 453.9;Cytotrophoblasts: 283.4;Extravillous trophoblasts: 279.7;Hofbauer cells: 531.0;Syncytiotrophoblasts: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria NA NA Mitochondria "HPA059930: AB_2684167" "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favorable (8.11e-4)" 5.0 5.0 12.5 3.1 12.7 2.6 6.0 12.8 13.5 8.4 11.8 8.8 5.1 7.1 6.3 7.3 7.4 4.2 12.4 12.5 14.2 9.7 4.0 4.7 4.3 13.6 12.8 12.1 6.5 5.2 11.2 9.5 4.0 14.2 8.6 8.9 5.9 5.1 8.3 14.4 4.8 6.0 7.1 12.1 3.7 6.7 3.4 14.1 4.1 6.6 17.0 5.9 7.1 6.3 14.2 10.0 13.3 7.3 8.4 13.7 13.6 4.5 8.3 9.6 9.5 10.1 9.3 8.7 8.1 6.8 11.0 7.7 6.9 12.8 10.9 15.2 12.7 9.1 7.1 21.2 13.0 6.0 11.6 5.1 10.7 17.5 9.5 11.6 7.4 14.1 6.0 15.8 5.9 14.4 17.2 5.8 15.0 6.2 12.5 16.7 5.7 9.3 10.8 23.3 5.9 15.4 6.7 9.6 7.4 7.1 5.7 7.1 6.7 9.3 7.4 5.7 9.5 8.3 3.8 6.8 8.4 5.8 21.3 7.1 3.8 4.8 5.7 3.6 6.6 3.3 4.3 4.9 4.1 5.1 4.1 6.3 4.5 3.2 2.3 7.0 5.0 4.9 5.9 12.5 12.7 12.8 13.5 12.5 14.2 13.6 12.8 12.1 14.2 12.1 14.1 14.2 63.3 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 453.9 0.0 0.0 0.0 0.0 283.4 25.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 279.7 52.8 0.0 0.0 0.0 0.0 0.0 0.0 531.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 183.5 5.3 0.0 0.0 0.0 EHBP1L1 "DKFZp762C186, TANGERIN" ENSG00000173442 "EH domain binding protein 1 like 1" Q8N3D4 11 65576046-65592650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 258.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 79.1;Kupffer cells: 79.7;Macrophages: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039479, HPA073476" Enhanced Approved "Vesicles,Plasma membrane" NA NA 110000 "Vesicles, Plasma membrane" "HPA039479: AB_10795678, HPA073476: " "unprognostic (1.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.84e-1)" "unprognostic (2.41e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.36e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.10e-3)" "unprognostic (5.02e-2)" "unprognostic (3.50e-2)" "unprognostic (1.10e-1)" 27.2 10.0 6.3 52.4 6.3 60.2 21.7 5.4 9.4 36.1 7.7 83.4 26.2 56.6 5.8 45.8 48.5 18.2 39.6 6.0 6.9 15.9 10.9 39.9 31.0 6.7 6.6 4.4 19.8 8.1 4.1 9.9 16.4 6.9 45.6 12.3 0.4 23.1 39.9 258.2 22.7 47.0 33.1 7.5 73.9 41.4 7.3 7.9 14.7 13.1 71.3 16.7 71.9 41.1 7.6 40.6 41.0 1.3 21.8 10.5 26.4 8.2 31.4 22.9 14.8 7.8 13.7 34.9 14.0 52.4 45.8 41.2 55.9 7.6 29.7 3.4 39.3 1.2 32.4 51.0 12.0 10.0 7.1 30.1 22.7 19.8 37.2 6.8 26.9 15.2 20.8 50.5 55.9 13.8 34.5 12.4 27.5 1.8 15.1 34.8 33.6 0.2 46.8 13.7 20.0 0.9 17.2 17.4 15.2 32.9 3.0 21.9 33.7 26.3 40.3 42.9 57.3 0.6 98.5 66.6 7.3 60.2 18.8 23.9 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 6.3 6.3 5.4 9.4 6.0 6.9 6.7 6.6 4.4 6.9 7.5 7.9 7.6 33.1 0.0 6.9 6.2 23.9 10.1 8.5 2.9 15.9 1.4 12.2 14.2 22.0 7.2 7.4 1.8 0.0 3.4 27.3 79.1 0.0 3.6 0.2 11.9 12.2 26.0 4.2 61.6 4.4 5.1 1.4 13.8 61.2 14.2 2.5 5.3 18.9 5.7 32.6 0.0 2.2 16.3 2.0 79.7 33.9 1.7 11.5 67.6 7.2 15.0 49.1 0.7 20.6 1.5 1.3 27.8 53.0 38.0 19.5 11.6 19.5 0.4 8.6 1.1 26.3 27.3 30.7 2.7 5.9 15.3 14.8 2.6 23.2 23.0 21.9 17.0 THAP2 DKFZP564I0422 ENSG00000173451 "THAP domain containing 2" Q9H0W7 12 71664301-71680644 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 367.4;Late spermatids: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039790 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA039790: AB_10795157" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" "unprognostic (5.55e-2)" "unprognostic (2.90e-2)" "unprognostic (1.80e-2)" "unprognostic (1.51e-4)" "unprognostic (1.24e-4)" "unprognostic (7.00e-2)" "unprognostic (1.02e-1)" "unprognostic (7.20e-2)" "unprognostic (3.73e-3)" "unprognostic (6.83e-2)" "unprognostic (3.13e-2)" "unprognostic (7.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (4.80e-2)" 16.3 26.3 6.9 9.2 7.8 14.9 4.3 12.5 9.3 4.8 4.3 4.2 5.8 6.3 17.1 6.6 4.6 8.7 5.0 6.7 6.9 5.6 4.5 4.7 7.9 7.7 8.4 6.1 8.6 3.8 3.4 11.1 6.9 8.0 4.8 5.8 11.4 4.8 4.1 5.0 5.7 4.3 4.5 7.4 5.2 6.4 18.3 7.3 5.5 4.6 5.7 7.1 28.5 4.2 11.7 3.9 4.9 11.2 8.6 8.2 7.2 5.6 6.0 5.5 5.7 4.8 5.1 5.1 2.7 4.0 4.0 6.9 6.8 10.9 3.4 7.4 11.5 6.0 7.8 8.6 8.0 7.4 4.8 3.4 5.1 15.1 5.4 12.0 11.9 9.0 13.2 5.7 5.6 7.9 1.3 3.9 4.7 5.7 7.9 8.2 5.5 3.8 13.3 7.1 6.0 7.9 12.4 6.6 3.8 5.8 7.8 7.1 5.4 4.0 5.9 2.8 5.1 4.1 6.9 9.4 6.2 3.4 5.7 3.6 1.4 2.2 2.2 3.7 3.0 6.0 4.1 5.1 3.6 3.0 4.8 8.1 5.5 1.9 6.4 3.7 1.4 5.5 2.1 6.9 7.8 12.5 9.3 6.7 6.9 7.7 8.4 6.1 8.0 7.4 7.3 11.7 15.1 0.0 11.0 11.1 36.2 19.6 27.7 13.7 20.5 11.5 9.9 13.6 12.4 4.3 7.9 3.7 4.2 4.0 24.4 8.1 9.8 7.7 367.4 12.2 13.5 10.6 5.4 3.4 14.8 5.4 7.3 47.1 12.8 20.2 58.3 9.4 6.1 4.3 12.3 13.5 20.8 8.1 2.0 11.3 93.2 183.7 11.5 75.2 78.2 5.6 9.9 10.2 9.2 14.1 24.3 7.0 9.4 5.7 44.3 16.7 15.6 19.2 10.5 7.5 0.0 22.2 64.1 26.1 7.2 44.8 29.5 3.0 20.0 6.7 9.5 25.7 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719315-19773617 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 11.3;retina: 21.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 4.8;ASC TERT1: 4.5" "Low region specificity" "Detected in many" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.2 1.3 3.0 0.0 5.0 0.0 0.0 0.1 4.5 0.3 0.0 0.1 0.0 1.4 0.4 0.0 0.3 0.0 0.0 2.6 11.3 0.0 0.0 0.0 0.0 4.2 5.6 4.2 0.0 1.2 0.0 3.7 0.0 3.9 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.7 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.4 0.0 4.8 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 5.0 0.1 4.5 2.6 11.3 4.2 5.6 4.2 3.9 1.3 6.5 2.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 116.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 90.9 0.4 0.0 0.0 45.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 3.3 23.9 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.9 0.0 2.6 0.0 127.6 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337309 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 14.2 15.9 12.2 11.6 11.9 22.2 13.5 13.2 14.7 14.9 10.0 18.5 14.6 23.7 10.4 21.1 16.7 10.6 12.2 12.5 11.8 13.7 23.8 12.5 11.8 14.3 12.7 12.2 17.3 13.9 18.6 10.5 14.3 15.2 14.9 12.7 8.5 15.0 18.8 8.6 15.5 17.2 19.2 12.5 14.7 19.3 15.3 14.0 13.4 13.3 7.2 12.9 19.0 14.4 13.5 43.8 47.4 43.4 51.4 41.8 32.8 46.0 46.3 49.7 52.8 41.5 80.6 88.9 38.3 62.5 55.5 80.1 77.2 61.9 69.8 33.0 46.0 34.2 101.0 21.8 67.3 31.9 42.8 40.4 34.3 35.2 66.1 59.0 34.7 40.8 58.1 50.0 58.4 36.9 94.9 39.5 44.3 43.5 50.2 59.8 40.5 44.5 30.4 32.7 31.1 30.8 29.9 37.4 46.8 12.5 41.4 106.1 35.4 27.0 63.5 41.8 33.7 43.0 14.0 24.6 0.4 21.3 71.0 50.6 9.5 21.6 5.6 20.8 19.2 13.4 11.1 15.7 18.4 19.0 16.7 17.5 15.5 1.5 14.0 20.2 11.0 8.7 24.9 12.2 11.9 13.2 14.7 12.5 11.8 14.3 12.7 12.2 15.2 12.5 14.0 13.5 5.1 3.2 9.4 1.0 9.1 6.9 13.3 15.4 12.5 9.2 10.9 9.8 0.8 22.8 11.1 11.0 2.1 44.0 6.2 9.3 5.9 20.8 6.6 5.9 7.9 8.6 13.8 18.5 3.2 17.0 66.0 11.5 9.2 5.9 7.6 16.9 11.4 23.4 21.5 5.0 2.9 13.0 8.2 14.8 5.9 8.6 14.0 6.6 1.8 1.0 11.6 11.6 15.5 4.5 2.7 14.1 7.5 17.7 4.3 14.2 15.6 12.5 4.8 9.4 6.6 6.5 10.6 19.9 10.5 14.3 8.5 24.4 8.3 8.8 18.6 9.8 PPP1R14B "PHI-1, PLCB3N, PNG, SOM172" ENSG00000173457 "Protein phosphatase 1 regulatory inhibitor subunit 14B" Q96C90 11 64244479-64246943 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 653.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 75 "plasmacytoid DC: 382.3" "Lineage enriched" "Detected in all" 75 "dendritic cells: 382.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053882 Approved NA NA 190000 "HPA053882: AB_2682291" "unprognostic (1.36e-1)" "unprognostic (7.12e-3)" "unprognostic (1.74e-2)" "unprognostic (1.20e-2)" "unprognostic (3.74e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (1.75e-6)" "unprognostic (1.14e-1)" "unprognostic (9.87e-2)" "unprognostic (3.04e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (6.86e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.77e-3)" "unprognostic (3.43e-1)" 84.1 108.3 28.0 50.0 27.7 49.4 72.2 30.5 38.5 68.3 30.7 66.3 52.1 54.7 14.6 240.7 49.3 19.3 115.5 27.0 33.1 93.6 140.6 64.9 32.9 32.7 29.7 24.6 40.7 249.9 20.0 39.6 38.4 29.0 50.0 24.4 3.9 84.3 18.4 219.1 164.2 65.5 22.3 29.7 84.5 75.2 61.7 32.8 31.3 53.3 53.6 36.7 93.1 108.8 28.8 409.8 236.0 147.4 237.1 69.9 93.6 224.7 211.4 130.8 215.4 95.2 138.6 351.1 204.0 369.8 198.0 181.1 264.8 112.2 214.0 80.6 178.7 176.0 145.3 260.5 218.4 126.8 227.7 137.3 86.4 223.9 165.5 283.4 189.5 194.1 149.3 201.2 108.4 240.2 483.3 246.2 341.4 416.4 209.3 520.0 236.8 475.2 540.3 191.4 190.8 220.3 319.0 165.2 227.3 314.3 72.5 156.3 138.4 180.0 311.1 291.1 614.7 320.2 102.2 70.2 204.7 269.0 189.7 362.2 0.0 2.3 1.9 1.5 3.1 3.1 5.0 2.4 1.7 4.0 3.8 1.3 1.2 4.8 3.0 2.8 382.3 0.7 2.7 28.0 27.7 30.5 38.5 27.0 33.1 32.7 29.7 24.6 29.0 29.7 32.8 28.8 107.4 9.6 11.7 6.5 49.3 228.5 90.0 66.2 41.5 21.9 211.7 273.7 38.7 41.5 32.2 79.1 8.4 58.4 333.8 69.9 76.3 131.9 6.3 60.8 180.6 81.8 83.0 37.6 3.0 234.2 653.6 77.5 45.3 126.1 27.3 273.4 46.8 101.4 87.4 20.2 4.6 109.8 44.7 33.0 119.5 9.0 9.3 75.2 60.5 2.8 72.8 38.7 12.3 6.6 1.8 306.8 51.2 11.7 55.0 365.5 129.8 63.1 10.2 19.3 26.3 332.6 136.6 5.9 14.8 169.1 259.0 132.8 37.4 179.6 107.4 258.3 RNASE11 "C14orf6, RAJ1" ENSG00000173464 "Ribonuclease A family member 11 (inactive)" Q8TAA1 14 20583559-20609884 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 448.3" "Group enriched" "Detected in some" 63 "Early spermatids: 32.1;Late spermatids: 57.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003724 Uncertain "Secreted in male reproductive system" NA NA "HPA003724: AB_1079817" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 448.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNRD2 "p27, SSSCA1" ENSG00000173465 "Zinc ribbon domain containing 2" O60232 11 65570460-65573942 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 44.9;Cytotrophoblasts: 81.1;Extravillous trophoblasts: 84.5;Hofbauer cells: 57.9;Syncytiotrophoblasts: 79.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039789, HPA064670" Uncertain Approved Cytosol NA NA Cytosol "HPA039789: AB_2676680, HPA064670: AB_2732718" "unprognostic (9.32e-2)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.35e-3)" "unprognostic (3.03e-2)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (1.36e-2)" "unprognostic (1.20e-1)" "unprognostic (3.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (5.86e-2)" "unprognostic (9.34e-2)" 39.3 46.4 12.2 33.1 16.3 48.6 39.3 9.8 28.8 38.2 5.4 43.3 22.7 46.3 8.9 41.9 42.9 20.4 49.7 18.0 10.5 38.4 48.0 39.1 33.0 12.1 12.6 14.3 39.1 62.3 20.1 31.4 23.5 14.2 42.2 9.2 7.3 45.6 20.8 105.0 42.7 31.2 16.3 5.6 41.7 41.6 51.0 10.7 25.9 36.2 37.4 16.6 43.4 36.0 15.2 79.4 61.5 39.2 72.0 23.5 20.1 61.0 55.0 31.2 50.8 35.5 59.1 79.9 75.3 93.4 30.8 37.0 68.9 29.5 59.2 18.1 54.7 45.8 67.7 61.0 48.0 32.8 81.6 53.8 31.5 40.2 39.4 40.2 39.2 40.6 68.0 79.8 97.0 28.8 110.0 100.1 72.1 63.9 28.2 104.7 77.4 29.0 142.1 30.3 40.2 78.2 81.3 33.4 82.3 79.8 15.9 111.4 41.3 47.3 92.1 50.5 111.1 69.0 69.0 102.8 66.1 74.3 57.1 83.5 15.4 62.8 27.1 56.5 55.5 59.1 103.5 57.2 57.4 51.5 89.5 66.1 57.7 20.1 85.4 37.5 85.9 69.8 50.7 12.2 16.3 9.8 28.8 18.0 10.5 12.1 12.6 14.3 14.2 5.6 10.7 15.2 16.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 81.1 16.2 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 84.5 13.5 0.0 0.0 0.0 0.0 0.0 0.0 57.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 79.9 2.3 0.0 0.0 0.0 AGR3 "BCMP11, hAG-3, HAG3, PDIA18" ENSG00000173467 "Anterior gradient 3, protein disulphide isomerase family member" Q8TD06 7 16859412-16881987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 227.1;intestine: 239.5;lung: 154.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 861.1;Intestinal goblet cells: 701.9;Paneth cells: 744.5;Proximal enterocytes: 1051.2;Respiratory ciliated cells: 1771.2;Undifferentiated cells: 495.4" "Cancer enhanced" "Detected in many" "breast cancer: 104.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "OE19: 109.8;T-47d: 339.3" "Region enriched" "Detected in some" 5 "olfactory bulb: 4.6" HPA053942 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 67000 "Endoplasmic reticulum" Vesicles "HPA053942: AB_2682317" "unprognostic (2.18e-2)" "unprognostic (2.02e-1)" "unprognostic (2.13e-1)" "unprognostic (9.59e-2)" "unprognostic (3.32e-3)" "unprognostic (3.08e-2)" "unprognostic (1.49e-1)" "unprognostic (1.46e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.96e-1)" "unprognostic (6.66e-2)" "unprognostic (1.57e-1)" 0.6 0.1 0.1 11.1 0.4 0.0 70.3 0.4 0.2 25.2 0.0 222.0 168.7 8.7 0.0 1.5 227.1 48.7 0.0 0.1 0.8 2.5 0.3 154.1 0.2 2.0 0.9 0.0 0.3 10.7 0.0 21.4 0.8 1.0 4.8 217.0 0.0 31.1 0.9 0.0 1.5 239.5 8.7 0.9 0.3 100.8 0.2 0.4 0.0 7.4 0.0 0.8 27.9 0.2 0.4 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 109.8 0.0 0.0 0.0 2.3 8.1 0.0 1.3 0.4 0.0 0.6 0.0 0.0 339.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.2 0.1 0.8 2.0 0.9 0.0 1.0 0.9 0.4 0.4 0.7 333.3 408.1 0.3 1.4 2.7 12.5 108.5 0.0 0.0 105.1 51.9 0.1 31.5 319.9 29.5 0.0 3.4 0.7 380.0 1.9 30.4 0.0 861.1 7.4 1.9 112.7 0.0 0.2 71.4 3.3 5.3 71.4 39.2 20.8 0.0 0.0 0.0 0.5 0.0 0.2 701.9 134.3 0.0 0.3 0.0 0.3 2.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 16.6 744.5 0.0 0.4 7.1 1051.2 0.0 1771.2 0.0 0.0 0.0 27.9 0.0 0.1 0.0 9.8 2.2 4.1 0.0 495.4 117.9 SMARCC1 "BAF155, CRACC1, Rsc8, SRG3" ENSG00000173473 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1" Q92922 3 47585269-47782106 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011576, CAB016336, HPA024352, HPA026853" Supported Enhanced Nucleoplasm NA NA 31000 Nucleoplasm "CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030" "unprognostic (3.47e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.34e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.33e-2)" "unprognostic (4.28e-3)" "unprognostic (6.92e-2)" "unprognostic (5.53e-2)" "unprognostic (2.78e-2)" "unprognostic (1.66e-2)" "unprognostic (7.99e-2)" "unprognostic (3.84e-1)" "unprognostic (2.31e-2)" "unprognostic (2.45e-1)" 12.1 8.2 21.2 18.8 21.5 21.4 23.7 17.7 18.7 19.5 17.9 20.4 14.8 18.5 15.7 20.3 13.2 11.9 9.5 17.3 18.5 20.2 13.9 13.2 22.3 19.8 21.0 15.7 17.9 19.6 14.5 8.3 22.4 20.1 22.6 22.1 9.7 17.2 17.3 19.2 24.0 17.0 16.4 21.1 16.4 17.1 16.9 19.8 35.1 17.9 10.4 30.5 21.2 16.1 20.8 45.1 23.4 95.7 74.9 21.0 35.7 64.3 35.1 32.7 44.5 45.1 42.3 46.6 104.3 27.7 44.4 25.8 37.7 91.2 54.3 64.6 50.3 54.1 102.4 38.4 57.7 31.4 94.8 45.3 30.1 47.0 50.1 55.2 33.1 52.8 68.7 87.5 34.4 48.4 33.4 124.4 48.9 126.8 43.2 35.4 55.1 55.5 92.0 47.2 58.0 42.6 85.5 54.5 52.7 38.9 66.5 45.8 87.1 42.7 29.6 41.7 33.9 58.0 41.9 57.1 122.0 21.6 88.1 42.5 1.9 1.6 1.7 2.7 2.6 2.4 3.9 3.0 3.7 2.1 2.6 2.8 3.3 1.9 2.0 1.9 2.2 3.1 1.9 21.2 21.5 17.7 18.7 17.3 18.5 19.8 21.0 15.7 20.1 21.1 19.8 20.8 30.4 41.7 45.9 56.5 61.7 53.0 60.5 37.4 71.7 29.3 60.3 45.5 31.5 34.3 58.9 57.0 37.5 79.7 43.7 30.1 13.7 67.9 88.9 60.2 72.3 38.3 91.6 76.9 47.3 46.7 113.0 32.7 49.5 115.7 24.6 103.8 22.1 37.8 30.2 20.2 52.2 64.5 34.6 32.3 36.9 113.1 25.4 41.6 23.2 42.2 57.7 18.9 52.5 98.0 104.9 58.8 29.0 28.6 65.3 83.7 24.1 38.0 34.0 33.0 39.5 44.7 60.1 59.4 108.3 86.0 66.8 72.5 52.4 77.6 61.8 62.4 ZNF417 MGC34079 ENSG00000173480 "Zinc finger protein 417" Q8TAU3 19 57900296-57916610 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 57.4" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.74e-2)" "unprognostic (8.93e-2)" "unprognostic (1.63e-2)" "unprognostic (1.85e-1)" "unprognostic (5.76e-2)" "unprognostic (2.59e-3)" "unprognostic (2.34e-1)" "unprognostic (7.65e-3)" "unprognostic (5.33e-2)" "unprognostic (7.63e-2)" "unprognostic (1.01e-1)" "unprognostic (1.93e-2)" "unprognostic (8.75e-2)" "prognostic favorable (3.48e-4)" 7.7 9.8 32.9 9.8 33.1 15.8 21.5 41.2 38.4 18.5 33.9 10.6 9.5 13.5 49.3 8.4 13.1 15.2 11.4 32.6 32.1 11.8 15.0 10.6 19.1 32.0 32.0 30.9 12.2 8.5 15.5 10.6 10.1 34.4 16.0 13.6 26.0 12.7 17.5 7.3 29.2 10.8 10.5 29.1 18.0 14.6 9.6 33.1 21.8 21.3 6.3 22.4 9.4 4.9 39.0 7.1 10.8 17.2 11.9 17.0 16.2 14.6 8.8 12.7 8.0 6.7 11.6 4.1 15.1 4.8 12.9 6.1 4.9 10.9 11.9 22.4 2.6 57.4 16.2 26.5 10.7 11.5 15.0 16.7 11.9 11.9 7.9 10.5 14.9 10.3 12.0 5.1 0.9 16.7 6.9 16.3 7.2 9.9 4.9 10.6 12.8 20.7 10.8 8.6 32.1 15.7 10.2 11.6 7.8 3.0 17.7 8.3 12.0 7.1 20.2 8.6 4.6 8.9 16.1 27.8 12.5 8.7 6.0 9.8 5.9 2.0 5.1 2.6 2.4 3.3 2.6 3.0 2.6 1.5 3.6 4.0 3.0 3.3 2.1 1.7 3.3 2.7 1.5 32.9 33.1 41.2 38.4 32.6 32.1 32.0 32.0 30.9 34.4 29.1 33.1 39.0 1.5 6.4 1.1 5.5 1.7 0.8 1.2 0.7 1.8 4.0 2.5 1.9 3.0 2.8 4.8 0.0 0.0 1.0 1.5 1.7 0.0 1.2 0.5 1.2 1.2 2.6 6.0 6.1 3.9 1.4 0.8 2.0 2.0 1.6 4.5 2.0 2.9 2.2 1.0 1.7 3.8 2.1 0.0 2.5 1.5 0.1 2.5 1.7 0.0 1.9 1.0 0.9 2.1 2.5 5.7 0.4 0.5 1.5 5.0 1.4 1.5 1.5 2.2 3.9 6.6 1.9 1.7 1.3 2.1 1.0 1.3 0.8 2.0 1.2 1.7 1.6 PTPRM "hR-PTPu, PTPRL1, RPTPU" ENSG00000173482 "Protein tyrosine phosphatase receptor type M" P28827 18 7566782-8406861 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 142.0;Astrocytes: 188.1;Inhibitory neurons: 751.6;Microglial cells: 263.3;Oligodendrocyte precursor cells: 224.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory CD8 T-cell: 4.7" "Group enriched" "Detected in many" 33 "dendritic cells: 1.8;T-cells: 4.7" "Cell line enhanced" "Detected in many" "ASC diff: 98.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003891, CAB022442, CAB022443" Supported Approved "Plasma membrane" NA Yes 130000000 "Plasma membrane" "CAB022442: , CAB022443: , HPA003891: AB_2667073" "unprognostic (2.59e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (4.89e-2)" "unprognostic (1.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.41e-2)" "unprognostic (7.62e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-2)" "unprognostic (9.64e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-3)" "unprognostic (9.41e-2)" "unprognostic (2.63e-2)" "prognostic favorable (1.07e-4)" 53.6 24.3 18.1 12.0 29.6 1.2 42.2 12.2 26.3 18.5 46.3 20.7 8.7 24.4 12.0 14.3 23.5 32.7 61.8 9.5 29.7 29.7 11.9 39.2 15.6 21.0 27.0 10.4 26.7 13.3 23.6 16.3 33.4 28.2 16.8 11.6 19.5 11.0 36.3 53.0 11.2 15.2 25.0 2.4 23.3 18.6 23.0 46.7 16.9 55.3 64.0 12.0 24.1 12.4 25.6 4.6 33.4 15.7 0.2 98.0 67.4 38.7 41.1 35.6 26.9 39.5 30.9 7.1 0.0 39.0 49.1 0.5 0.3 0.2 14.3 36.9 0.5 7.2 0.0 22.2 15.2 27.9 0.0 0.4 77.1 29.3 14.9 42.1 51.1 27.2 0.0 0.0 13.8 21.8 0.7 13.7 0.3 2.6 9.9 7.3 0.5 13.5 63.9 64.9 57.6 1.4 8.6 1.1 0.2 34.6 24.9 0.2 0.0 28.2 54.9 34.6 26.4 7.2 1.1 0.4 0.3 46.8 0.2 10.4 0.0 0.0 0.0 2.8 0.0 1.1 0.0 3.8 4.7 0.0 0.0 1.0 2.0 0.0 0.0 0.0 1.8 0.7 1.1 18.1 29.6 12.2 26.3 9.5 29.7 21.0 27.0 10.4 28.2 2.4 46.7 25.6 142.0 44.8 36.0 188.1 1.1 6.0 7.3 3.0 2.8 28.3 2.5 3.2 26.7 14.3 7.1 5.5 2.1 11.4 5.4 0.9 1.9 17.6 25.9 28.9 15.6 68.9 1.8 0.4 70.1 8.3 3.4 14.0 8.2 59.6 2.5 13.0 47.2 25.3 9.9 0.0 751.6 1.4 0.0 8.0 5.7 42.0 2.8 5.1 30.2 263.3 0.6 2.9 3.1 224.7 50.3 14.3 1.2 5.3 2.3 8.3 3.0 13.3 15.6 2.2 6.6 7.4 9.9 8.6 9.9 0.9 2.8 12.6 5.7 3.7 0.8 8.6 FKBP2 "FKBP-13, FKBP13, PPIase" ENSG00000173486 "FKBP prolyl isomerase 2" P26885 11 64241003-64244132 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 929.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025561, HPA049405" Enhanced Approved "Plasma membrane" "Intracellular and membrane" No No 510000 "Plasma membrane" "CAB025561: , HPA049405: AB_2680749" "unprognostic (4.94e-2)" "unprognostic (1.12e-1)" "unprognostic (5.77e-2)" "unprognostic (2.66e-3)" "unprognostic (7.40e-2)" "unprognostic (1.92e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.23e-1)" "unprognostic (5.91e-3)" "unprognostic (5.86e-2)" "unprognostic (7.18e-2)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (5.23e-1)" "unprognostic (2.30e-1)" "unprognostic (3.57e-2)" 62.3 128.8 176.1 78.2 177.1 50.5 58.9 179.5 236.5 114.1 192.6 106.7 137.5 81.8 401.1 69.0 95.3 77.9 118.5 171.8 178.0 112.1 199.0 63.3 71.3 185.2 178.0 166.5 76.0 282.5 161.7 202.5 73.8 183.2 93.3 85.0 37.4 210.7 148.1 33.6 61.4 108.2 73.2 171.0 68.1 114.4 75.3 182.9 59.6 189.3 48.8 71.0 86.5 62.1 195.6 101.2 144.8 82.8 165.9 178.5 98.2 94.6 132.9 146.4 108.8 101.4 148.1 257.0 80.8 195.4 186.5 148.2 134.7 70.5 121.0 51.3 101.4 54.5 90.0 196.5 158.3 231.6 74.5 125.5 116.0 169.3 145.4 163.5 156.9 86.9 76.6 61.0 253.6 138.1 186.7 85.1 112.6 92.6 211.1 130.0 70.8 70.9 299.2 198.9 120.7 110.0 91.3 85.4 263.2 147.9 59.5 98.1 69.5 68.9 123.8 100.9 182.8 72.6 128.5 48.6 69.0 156.7 80.6 142.8 276.8 173.1 25.9 178.9 191.2 230.8 170.1 139.2 176.4 172.2 165.0 90.4 131.5 68.6 162.9 162.7 929.1 55.9 126.7 176.1 177.1 179.5 236.5 171.8 178.0 185.2 178.0 166.5 183.2 171.0 182.9 195.6 129.5 147.4 168.0 20.9 179.7 164.4 251.0 447.2 125.2 86.4 205.0 185.4 134.7 275.9 270.6 389.9 22.9 279.8 174.4 534.1 412.8 270.8 126.4 212.5 206.3 138.6 342.6 41.4 11.3 254.2 386.9 167.0 179.4 258.5 144.0 146.5 148.5 754.4 228.4 32.0 14.8 508.2 305.2 100.1 201.7 99.0 230.2 140.7 300.6 16.9 151.7 181.7 111.2 11.1 20.6 292.2 424.7 255.1 765.2 315.5 594.7 792.2 241.9 83.3 184.1 138.4 221.3 327.1 282.1 136.6 168.1 620.5 123.6 138.8 339.4 312.0 VEGFB "VEGFL, VRF" ENSG00000173511 "Vascular endothelial growth factor B" P49765 11 64234584-64239264 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 204.9;Muller glia cells: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 30.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 30.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 186000 "unprognostic (4.88e-2)" "unprognostic (6.04e-2)" "unprognostic (1.33e-2)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.38e-2)" "unprognostic (2.45e-1)" "unprognostic (4.68e-1)" "unprognostic (5.01e-3)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (1.67e-2)" "unprognostic (8.08e-3)" "unprognostic (2.00e-1)" "unprognostic (4.15e-2)" "unprognostic (4.31e-3)" 205.9 82.7 43.3 12.1 39.3 3.9 152.6 37.3 53.5 99.4 38.4 115.6 12.2 100.8 7.2 51.3 73.1 19.4 244.9 32.8 37.9 84.2 44.4 83.2 14.6 51.6 40.2 25.8 83.3 85.6 18.5 105.0 9.9 44.6 93.5 4.8 12.8 58.1 28.8 145.0 75.1 60.0 10.3 37.4 56.4 89.9 17.6 42.0 6.6 84.4 52.0 9.2 119.0 78.2 33.1 15.4 25.9 9.9 28.1 49.7 36.8 12.7 14.7 27.8 13.1 16.0 13.8 31.7 19.8 28.6 14.0 28.8 20.8 15.8 11.5 2.3 20.6 15.1 16.7 33.9 13.3 45.4 4.8 20.1 39.6 12.0 19.6 12.2 33.9 18.4 20.6 20.2 32.5 22.2 31.8 27.4 12.6 7.0 10.9 22.3 32.1 20.5 46.5 11.0 19.5 14.0 46.4 12.4 38.1 57.4 7.6 25.1 5.6 13.0 50.8 30.2 23.1 8.7 90.5 45.5 15.4 41.6 5.3 25.1 0.3 0.2 0.6 0.9 0.0 0.8 3.0 0.8 0.9 0.4 2.4 0.9 1.6 0.0 0.4 0.0 30.5 0.5 0.4 43.3 39.3 37.3 53.5 32.8 37.9 51.6 40.2 25.8 44.6 37.4 42.0 33.1 54.1 19.2 32.6 43.8 27.6 12.7 6.7 10.1 2.2 47.9 32.8 65.7 204.9 10.0 7.6 14.7 33.3 9.6 68.3 11.9 39.2 14.8 1.1 24.2 47.7 21.9 53.3 4.4 7.3 12.9 16.8 68.6 5.1 31.6 18.4 62.7 19.6 9.8 51.4 65.6 26.6 12.2 20.3 31.5 21.5 3.5 60.9 50.0 35.6 19.7 17.7 130.6 12.3 29.1 11.8 14.5 7.3 109.1 12.3 11.5 20.3 31.6 8.9 39.6 6.6 47.4 53.7 0.5 1.2 6.4 13.9 8.9 19.0 34.3 12.8 7.5 PEAK1 "KIAA2002, sgk269" ENSG00000173517 "Pseudopodium enriched atypical kinase 1" Q9H792 15 77100656-77420144 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Excitatory neurons: 162.1;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 338.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.8" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.8" "Cell line enhanced" "Detected in all" "TIME: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026313, HPA026517" Approved NA NA "HPA026313: AB_1856801, HPA026517: AB_1856802" "unprognostic (1.15e-1)" "unprognostic (2.89e-1)" "unprognostic (1.05e-1)" "unprognostic (4.20e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (6.63e-3)" "unprognostic (1.90e-1)" "unprognostic (2.42e-2)" "unprognostic (6.00e-3)" "unprognostic (1.06e-1)" "unprognostic (9.75e-2)" "unprognostic (2.25e-3)" "unprognostic (5.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.33e-1)" "unprognostic (5.65e-3)" 12.2 4.5 9.0 5.8 12.2 9.2 9.6 5.6 9.0 11.4 3.7 7.9 6.0 7.4 6.5 5.2 5.8 10.1 16.3 8.0 7.3 5.0 3.8 18.2 6.9 7.7 7.8 6.4 7.6 4.8 5.5 2.9 16.8 7.2 6.1 8.2 13.8 5.5 7.4 6.8 6.5 7.3 10.0 4.6 29.7 4.9 10.0 10.4 4.7 6.3 8.5 4.7 9.1 7.6 12.0 5.4 7.8 18.1 4.3 33.4 35.7 6.3 28.6 19.7 14.9 14.9 6.3 4.7 4.1 5.0 41.4 5.7 2.6 14.6 4.5 16.9 4.2 7.6 7.7 12.2 3.8 12.2 4.6 3.9 27.6 4.3 28.8 4.8 16.3 42.3 6.6 10.0 4.0 16.1 2.2 2.6 4.9 8.4 3.7 2.1 5.3 10.8 3.0 4.4 9.6 4.0 4.9 11.2 2.3 18.6 19.7 1.7 3.2 52.1 31.5 15.2 13.2 12.2 6.3 9.5 5.9 5.5 10.5 17.3 0.1 0.2 0.4 0.2 0.0 0.4 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.1 1.8 0.1 0.2 0.0 0.2 9.0 12.2 5.6 9.0 8.0 7.3 7.7 7.8 6.4 7.2 4.6 10.4 12.0 48.3 147.4 46.8 101.9 12.6 21.9 7.5 5.6 2.2 18.4 6.1 5.8 46.9 10.0 29.2 1.8 12.5 3.1 12.3 23.9 0.0 6.9 15.1 22.9 19.5 41.2 3.0 10.8 162.1 5.4 2.0 35.6 15.8 10.1 17.7 6.3 31.8 6.0 18.9 20.2 84.4 11.9 2.0 21.3 34.7 13.6 19.9 20.2 12.4 124.6 8.5 28.1 10.3 513.2 338.1 9.8 10.7 16.1 7.0 8.3 15.7 3.7 41.6 20.1 13.1 23.0 37.7 13.6 13.7 5.8 18.0 6.3 8.2 22.6 12.3 7.2 TNFRSF10D "CD264, DcR2, TRAILR4, TRUNDD" ENSG00000173530 "TNF receptor superfamily member 10d" Q9UBN6 8 23135588-23164027 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 114.4;Endothelial cells: 52.3;Gastric mucus-secreting cells: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 99.5;LHCN-M2: 250.4;WM-115: 238.4" HPA070971 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA070971: AB_2686330" "unprognostic (1.49e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.69e-1)" "unprognostic (7.06e-2)" "unprognostic (3.56e-2)" "unprognostic (1.66e-1)" "unprognostic (1.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.12e-2)" "unprognostic (2.70e-1)" "unprognostic (1.35e-2)" "unprognostic (6.32e-2)" "unprognostic (1.72e-1)" 7.4 2.3 5.3 5.3 4.4 9.0 4.8 4.3 6.6 3.2 6.2 6.1 4.4 4.8 3.8 2.6 6.0 8.0 5.6 4.8 5.8 9.2 17.8 10.1 3.5 4.8 4.5 3.5 7.2 3.6 1.9 2.8 2.9 5.0 4.6 7.4 0.5 2.2 2.9 1.4 1.9 7.0 7.7 4.8 5.0 5.5 3.0 6.3 1.8 3.8 1.0 4.2 4.0 3.1 5.9 15.1 12.7 16.3 9.4 12.2 47.7 0.3 78.2 29.5 5.8 7.9 24.4 12.2 0.0 16.1 47.1 0.0 5.0 13.7 68.6 50.3 0.1 12.1 4.2 7.7 21.2 52.7 2.7 5.3 60.1 75.0 20.6 14.0 71.4 99.5 0.6 0.0 0.1 250.4 0.0 0.0 8.2 13.2 44.1 0.1 3.0 0.1 3.8 19.0 6.8 0.3 0.1 8.4 0.0 0.0 36.1 0.1 9.9 59.4 0.1 0.0 4.7 0.1 0.0 0.0 0.0 63.3 4.0 238.4 2.5 2.1 0.9 0.0 0.8 0.1 1.3 1.9 0.6 2.9 0.4 5.2 2.1 1.4 0.2 1.4 0.0 0.6 1.5 5.3 4.4 4.3 6.6 4.8 5.8 4.8 4.5 3.5 5.0 4.8 6.3 5.9 114.4 0.0 9.8 0.3 7.0 5.0 4.1 11.3 14.8 0.0 6.0 12.8 3.5 1.5 10.2 1.8 0.0 0.1 1.2 6.8 0.0 5.7 0.4 6.4 5.8 52.3 1.8 0.0 0.1 2.2 0.3 19.2 83.6 9.5 7.6 1.5 16.1 8.2 2.9 0.0 0.1 5.6 6.1 6.1 9.8 0.1 0.3 13.0 8.8 19.7 3.5 0.3 0.0 0.5 0.1 12.3 3.1 0.4 6.8 4.9 6.8 2.8 6.4 0.2 0.0 11.9 14.3 0.8 2.3 4.5 2.4 0.1 5.9 2.1 6.9 3.7 MST1 "D3F15S2, DNF15S2, HGFL, MSP, NF15S2" ENSG00000173531 "Macrophage stimulating 1" 3 49683947-49689501 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "liver: 935.5" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 362.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 42.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024036 Approved "Secreted to blood" NA NA "HPA024036: AB_1854147" "unprognostic (5.13e-3)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (1.16e-2)" "unprognostic (9.42e-3)" "unprognostic (8.24e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.14e-4)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 16.7 28.2 11.2 1.1 11.2 6.3 8.2 11.7 13.0 10.7 11.0 4.7 51.0 8.9 11.4 7.4 10.6 7.5 4.6 11.0 11.9 95.4 935.5 5.9 3.7 11.2 11.3 11.1 12.6 16.6 9.5 29.5 5.9 11.3 13.0 2.1 5.3 8.1 5.2 3.6 15.0 31.4 2.2 11.2 14.0 8.8 35.1 11.1 2.2 36.7 2.9 1.7 6.1 6.9 11.2 0.2 0.4 1.2 2.0 3.7 7.6 3.7 1.1 1.4 0.6 0.8 3.9 1.2 0.3 2.6 1.3 0.5 0.8 0.6 1.5 0.6 1.3 0.7 0.6 2.6 84.6 5.8 0.0 1.6 10.2 2.6 0.7 2.1 14.1 1.4 3.5 0.7 9.9 1.9 0.6 0.5 17.3 0.2 1.1 1.0 0.4 0.5 2.2 4.2 0.6 0.2 2.8 0.0 1.6 0.4 2.5 1.5 5.7 0.9 1.9 0.6 0.1 0.2 21.8 2.9 0.5 2.2 3.2 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 11.2 11.7 13.0 11.0 11.9 11.2 11.3 11.1 11.3 11.2 11.1 11.2 3.1 6.4 3.9 10.1 3.5 2.9 4.6 5.8 6.8 8.2 6.1 10.2 2.2 45.8 5.4 27.6 8.4 4.8 1.0 5.1 62.6 6.9 7.6 2.3 3.5 3.4 8.3 29.7 1.1 3.9 19.7 5.2 9.2 3.2 1.3 36.9 10.0 362.8 1.4 1.7 2.0 8.9 6.1 10.7 1.4 2.6 3.1 1.2 3.6 2.8 0.1 8.9 0.0 3.0 2.9 2.1 7.2 1.9 1.6 1.3 57.0 61.9 6.7 6.9 0.0 2.3 10.9 21.8 9.2 2.6 4.7 5.1 2.1 22.8 13.7 3.4 TNFRSF10C "CD263, DcR1, LIT, TRAILR3, TRID" ENSG00000173535 "TNF receptor superfamily member 10c" O14798 8 23102921-23117445 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.2;lymphoid tissue: 24.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.9;Endothelial cells: 5.3;Gastric mucus-secreting cells: 13.7;granulocytes: 8.8;Proximal enterocytes: 6.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 6 "neutrophil: 3195.8" "Lineage enriched" "Detected in many" 120 "granulocytes: 3195.8" "Group enriched" "Detected in many" 5 "BEWO: 108.8;HUVEC TERT2: 91.2" CAB025635 Enhanced NA NA 14600000 "CAB025635: " "unprognostic (2.63e-1)" "unprognostic (4.49e-3)" "unprognostic (7.21e-3)" "unprognostic (2.07e-2)" "unprognostic (3.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.81e-2)" "unprognostic (2.11e-3)" "unprognostic (5.56e-2)" "unprognostic (4.37e-2)" "unprognostic (8.98e-2)" "unprognostic (1.94e-3)" "unprognostic (2.74e-3)" "unprognostic (4.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.34e-3)" "unprognostic (6.54e-2)" 8.4 1.8 1.3 24.0 1.0 21.2 1.0 0.9 2.1 4.1 2.3 2.8 2.1 1.1 0.7 2.3 4.8 12.8 1.6 0.7 1.9 1.3 2.7 7.5 1.6 1.4 1.3 0.3 0.5 2.5 1.8 1.1 8.4 1.6 1.8 3.1 0.1 1.1 1.5 0.5 0.4 2.4 3.2 1.1 18.5 2.6 0.8 1.8 2.9 3.6 7.2 1.3 6.9 0.4 1.5 0.7 3.6 1.3 3.4 0.0 0.7 108.8 4.4 0.0 0.3 0.4 0.0 4.1 0.2 1.4 3.9 0.3 0.6 0.2 0.4 0.2 4.4 1.1 0.4 1.1 1.2 11.2 0.5 2.0 12.1 0.8 2.0 0.8 1.6 91.2 0.2 0.0 0.0 0.8 3.2 0.0 2.6 4.2 0.2 0.1 0.2 0.1 0.0 19.4 0.4 0.0 0.2 0.2 0.2 1.0 9.7 14.7 0.6 18.0 1.0 2.3 3.3 0.3 3.4 1.3 0.0 4.9 0.9 1.7 57.8 26.7 511.0 0.1 14.4 0.3 1.4 0.5 0.1 6.0 0.4 0.6 0.3 3195.8 1.4 21.5 0.4 0.4 9.2 1.3 1.0 0.9 2.1 0.7 1.9 1.4 1.3 0.3 1.6 1.1 1.8 1.5 1.0 6.4 7.9 0.3 0.2 0.3 0.3 1.5 0.6 0.0 0.1 0.0 0.4 2.8 4.7 3.7 0.0 1.1 0.0 0.3 0.0 0.4 1.0 0.5 0.1 5.3 1.8 0.0 0.1 0.4 0.9 0.8 13.7 0.2 8.8 0.0 1.8 0.0 2.4 0.0 0.0 0.5 0.0 1.6 0.6 0.4 0.0 2.5 0.0 1.0 1.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 6.2 0.0 1.8 0.1 0.0 0.4 0.3 0.6 1.5 0.2 0.1 1.1 0.9 0.3 0.4 0.4 GMPPB KIAA1851 ENSG00000173540 "GDP-mannose pyrophosphorylase B" Q9Y5P6 3 49716844-49723973 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 130.2;Syncytiotrophoblasts: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014657 Uncertain NA NA 38000 "HPA014657: AB_1849852" "unprognostic (3.48e-2)" "unprognostic (9.84e-2)" "unprognostic (2.77e-2)" "prognostic favorable (6.19e-6)" "unprognostic (1.01e-2)" "unprognostic (5.11e-3)" "unprognostic (1.54e-2)" "unprognostic (4.01e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-2)" "unprognostic (5.01e-3)" "unprognostic (5.73e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" 13.4 30.4 6.1 16.2 5.9 11.9 15.5 5.8 6.7 19.6 8.2 17.2 14.6 18.8 14.7 26.6 19.6 9.6 16.9 5.9 6.9 17.6 44.6 21.6 13.1 6.5 6.5 5.8 14.1 57.9 10.1 39.7 7.6 6.1 28.2 12.3 4.1 35.7 14.8 13.5 14.9 22.0 9.5 5.8 28.2 26.4 9.7 7.1 9.4 26.5 5.8 13.1 16.0 16.9 6.0 31.8 27.0 21.0 12.3 15.6 10.8 21.7 36.1 17.1 29.0 26.1 18.7 21.5 17.6 15.8 18.1 22.2 16.7 18.6 29.0 10.6 17.2 14.5 13.5 27.2 21.5 31.1 19.0 19.6 8.2 15.1 40.0 34.8 11.3 24.8 20.2 10.4 32.0 16.3 20.3 27.3 11.7 12.2 22.5 34.3 9.2 12.5 30.4 16.3 24.0 13.8 16.0 15.7 36.5 12.5 10.6 20.6 13.9 21.9 25.7 25.0 33.4 38.8 33.7 11.1 13.6 25.4 14.7 28.6 22.1 15.6 6.7 18.3 21.3 18.6 22.7 15.9 19.3 14.7 22.5 11.8 14.6 4.0 11.3 21.8 61.8 12.0 14.8 6.1 5.9 5.8 6.7 5.9 6.9 6.5 6.5 5.8 6.1 5.8 7.1 6.0 7.3 9.6 17.2 1.6 35.4 0.8 22.8 0.7 2.8 3.7 34.1 14.1 4.5 15.7 3.8 18.4 2.1 28.5 28.5 43.6 29.4 39.8 10.0 18.3 14.3 10.7 16.7 9.9 0.8 50.6 67.2 15.5 34.7 17.8 0.0 11.2 9.3 28.4 39.0 6.7 0.8 55.9 0.0 10.7 1.7 10.0 15.5 13.7 1.8 1.0 40.9 5.8 19.6 1.0 0.4 31.9 27.1 7.5 130.2 40.9 29.2 25.7 14.4 6.2 0.0 5.3 12.2 22.9 12.6 14.7 1.7 79.5 14.7 13.1 32.8 37.1 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 7.4 7.6 10.8 9.7 13.1 30.2 8.5 7.8 13.4 7.5 17.9 5.9 4.8 7.9 5.1 7.5 8.9 6.9 8.6 19.9 19.4 22.7 6.6 9.7 11.4 11.0 11.5 8.7 7.8 8.7 12.6 4.0 8.9 10.5 9.7 6.3 4.9 8.6 5.5 6.1 8.9 5.5 7.7 14.7 8.8 8.1 6.1 10.4 20.2 11.1 6.4 10.4 7.0 5.3 16.8 8.2 6.6 24.2 19.9 12.9 16.2 20.2 24.2 13.2 13.3 11.5 8.8 15.3 45.6 11.5 21.6 9.1 5.7 15.2 20.3 31.9 25.1 5.5 71.5 7.4 6.8 12.9 15.6 13.8 13.5 10.9 14.9 12.0 14.8 15.9 23.4 45.0 14.5 21.3 8.9 49.2 9.7 8.0 5.3 8.5 15.6 23.5 6.1 22.1 14.1 8.4 16.5 10.6 4.7 32.9 12.9 10.9 10.0 19.3 36.6 18.9 16.8 10.0 9.2 3.4 19.1 12.8 11.5 17.2 0.3 1.2 1.1 0.5 0.6 0.4 0.1 0.2 0.2 1.7 0.2 0.3 0.2 0.1 0.2 0.4 2.1 0.6 0.5 10.8 13.1 7.8 13.4 19.9 19.4 11.0 11.5 8.7 10.5 14.7 10.4 16.8 11.1 25.6 19.1 42.4 8.9 17.8 6.0 6.1 18.8 3.3 13.7 8.8 17.4 5.7 10.2 44.1 18.8 5.6 31.5 2.6 9.8 5.4 0.8 27.2 16.0 12.8 37.8 99.1 38.4 4.6 5.6 12.1 7.1 25.6 10.8 24.5 9.7 7.1 11.2 6.7 36.5 8.9 4.1 29.2 39.7 1.6 4.4 33.5 10.6 65.6 45.6 6.0 8.2 41.7 12.1 9.4 2.1 8.6 6.9 11.5 1.4 17.1 16.9 4.5 26.3 8.7 23.0 6.4 9.0 15.1 17.0 5.7 10.3 23.4 6.6 9.4 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA036514: AB_2675167, HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 18.7 13.6 21.5 14.0 21.9 36.3 18.5 18.5 22.7 16.2 15.8 21.7 17.1 18.0 17.4 18.0 15.4 12.2 45.2 19.5 21.2 14.6 22.1 16.7 17.9 20.9 21.9 17.7 15.8 54.7 15.8 15.2 17.0 22.5 15.7 20.9 10.9 18.5 12.8 42.0 24.8 20.5 12.6 20.9 15.6 22.6 20.7 20.8 16.2 15.7 25.4 15.8 17.7 17.1 22.2 25.7 55.2 16.9 35.2 40.4 34.3 61.4 45.2 33.9 36.0 45.6 66.0 23.2 30.0 59.6 36.0 48.4 33.3 27.5 35.3 28.9 40.6 37.3 27.4 92.8 47.7 58.1 53.8 31.5 53.3 43.7 33.6 31.5 28.0 25.6 17.6 37.6 28.9 40.1 43.2 28.4 52.3 30.0 24.2 53.8 22.1 20.6 25.8 33.6 38.0 23.4 26.2 63.1 46.8 78.2 29.4 26.0 41.1 35.3 40.0 30.5 39.3 29.1 41.3 39.7 41.9 34.9 45.8 28.5 89.3 65.6 88.6 73.8 71.3 77.8 85.4 73.7 82.0 73.3 81.9 84.2 70.3 87.9 67.9 79.6 59.2 85.0 82.6 21.5 21.9 18.5 22.7 19.5 21.2 20.9 21.9 17.7 22.5 20.9 20.8 22.2 14.8 22.4 24.2 2.9 33.2 60.7 43.1 48.6 34.1 22.8 19.8 16.4 73.8 24.3 34.4 14.7 10.4 64.0 39.5 77.5 27.4 55.2 111.5 35.0 36.8 22.3 98.7 20.0 7.6 66.7 57.2 34.1 31.1 71.3 52.0 13.3 15.0 25.1 50.0 16.8 7.9 60.6 48.8 19.3 35.1 62.8 18.0 29.7 33.8 4.7 43.3 22.6 37.0 6.6 9.0 51.2 127.1 19.9 26.6 28.3 84.5 39.2 29.7 19.3 19.7 31.7 46.9 63.2 37.8 21.8 43.2 40.6 41.6 20.5 55.5 33.5 CSPG4 "CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA 48000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991" "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (4.93e-5)" 28.1 1.8 8.8 7.3 6.6 0.0 18.7 6.3 9.4 14.7 3.2 41.4 2.8 34.8 1.4 8.4 15.1 5.7 14.6 7.3 7.4 4.9 0.9 19.6 0.4 11.2 7.3 6.4 9.0 2.2 1.2 2.2 15.7 9.4 14.5 2.2 0.1 4.7 11.3 39.9 7.5 15.4 22.9 6.8 5.6 19.2 1.3 7.4 0.6 5.6 10.1 0.3 30.6 12.7 11.2 11.9 0.1 1.0 7.1 1.6 9.8 0.1 64.7 28.6 44.4 28.8 0.1 45.0 0.0 1.5 45.4 6.2 0.6 0.1 0.3 13.6 0.6 0.2 0.0 19.2 0.0 10.0 0.0 0.1 4.8 0.1 13.5 1.5 16.5 0.0 0.0 0.1 0.1 7.6 0.1 0.0 0.2 1.2 0.0 0.3 0.1 4.0 0.1 0.0 0.0 0.1 0.2 1.7 0.1 146.1 1.2 0.9 1.2 0.1 92.1 17.9 3.6 0.8 0.0 0.2 0.0 20.3 0.5 138.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.8 6.6 6.3 9.4 7.3 7.4 11.2 7.3 6.4 9.4 6.8 7.4 11.2 4.9 0.0 0.0 1.0 0.0 2.8 0.7 4.7 0.0 1.4 0.1 0.8 11.4 0.0 0.8 1.8 0.0 0.2 0.5 0.1 0.0 0.0 0.6 0.7 0.7 2.7 0.0 0.0 0.4 0.0 0.6 5.9 1.5 0.4 0.0 1.8 1.1 0.2 1.1 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.3 0.3 12.4 3.7 0.0 0.0 0.0 57.3 0.1 0.0 0.0 0.4 0.0 4.3 0.0 0.1 1.0 0.2 118.3 3.1 47.1 0.0 1.3 0.1 1.8 0.3 0.3 0.1 0.0 0.4 SNX33 "MGC32065, SH3PX3, SH3PXD3C, SNX30" ENSG00000173548 "Sorting nexin 33" Q8WV41 15 75647912-75662301 "Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040988 Approved NA NA "HPA040988: AB_10794983" "unprognostic (1.83e-2)" "unprognostic (2.75e-2)" "unprognostic (1.09e-2)" "unprognostic (1.94e-3)" "unprognostic (1.73e-1)" "unprognostic (3.18e-1)" "unprognostic (2.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (5.00e-3)" "unprognostic (3.00e-2)" "unprognostic (5.23e-3)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" 24.8 17.3 10.2 7.2 10.3 0.5 21.5 9.0 9.9 27.5 11.0 18.8 12.2 23.8 8.5 42.9 22.1 14.4 17.6 9.2 10.7 12.6 29.3 19.5 8.3 13.6 9.8 7.4 25.8 27.4 11.2 7.0 12.0 9.2 23.7 10.1 1.6 20.8 16.7 5.9 29.4 15.6 14.7 9.0 11.9 19.0 3.6 12.0 7.7 16.9 9.2 10.7 20.4 30.5 9.7 14.9 13.1 12.6 13.5 48.7 31.5 13.9 14.3 29.8 15.6 14.2 8.3 15.3 0.4 10.3 31.7 22.3 35.1 15.7 37.4 8.3 16.4 5.3 4.6 15.5 15.2 32.3 0.4 4.7 32.6 44.5 15.2 21.2 37.4 10.0 1.4 11.0 2.0 18.4 2.9 0.1 9.4 12.1 9.3 7.3 2.3 9.9 0.7 15.9 22.1 1.1 8.6 21.1 22.7 17.4 23.4 13.6 10.5 14.6 22.1 10.4 16.6 7.7 0.3 0.4 0.1 22.3 5.4 6.0 0.0 0.5 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 10.2 10.3 9.0 9.9 9.2 10.7 13.6 9.8 7.4 9.2 9.0 12.0 9.7 8.3 6.4 5.6 2.9 0.2 12.1 3.4 9.3 6.2 0.0 6.8 5.7 3.8 2.8 8.2 7.3 2.1 3.1 1.2 13.5 0.0 7.5 0.3 4.8 7.5 5.7 9.1 0.4 0.5 6.5 4.1 13.3 14.3 4.8 1.3 6.8 10.0 12.6 5.1 0.0 0.1 8.1 8.2 2.8 7.8 0.6 13.1 2.9 3.6 2.8 3.0 3.8 0.0 2.5 0.2 15.9 7.6 15.1 1.1 7.5 12.4 3.7 9.5 0.2 19.7 8.5 9.5 0.1 0.6 5.5 11.2 1.4 1.8 2.5 7.3 11.3 FAM166C "C2orf70, LOC339778" ENSG00000173557 "Family with sequence similarity 166 member C" A6NJV1 2 26562585-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.7;testis: 26.8" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA062453: AB_2684769" "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.0 0.1 2.3 0.1 0.7 0.0 0.2 0.7 0.6 0.2 3.4 0.6 0.1 0.2 0.3 0.1 7.7 0.0 0.3 0.8 2.1 0.5 0.0 0.4 0.0 1.5 1.6 0.5 0.0 0.7 0.1 0.7 0.0 1.1 0.2 0.4 0.1 1.9 0.2 0.1 0.1 0.1 0.1 1.7 0.0 4.8 26.8 2.1 0.0 1.1 0.0 0.0 0.1 0.0 1.1 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 3.7 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.6 0.8 2.1 1.5 1.6 0.5 1.1 1.7 2.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191741097 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.0" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 452.0;Langerhans cells: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054978: AB_2682660, HPA067802: AB_2685899" "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 19.0 5.3 2.6 23.4 2.0 5.6 9.9 1.7 3.5 4.5 5.2 4.4 10.1 4.6 0.6 13.3 5.5 7.4 3.2 2.4 7.2 9.9 9.8 21.3 12.5 2.7 2.8 2.0 4.5 3.9 0.8 4.3 7.7 3.1 4.4 3.8 1.0 5.2 3.3 2.9 4.4 18.9 3.8 2.6 37.0 4.7 9.3 4.4 6.3 3.3 3.3 11.7 18.6 7.7 4.2 36.2 5.5 1.5 1.6 15.7 16.4 10.2 53.4 31.3 28.6 15.1 30.9 18.7 2.6 43.1 26.3 23.9 11.5 5.7 22.1 29.0 21.2 5.5 18.4 10.8 5.6 14.3 9.8 16.5 22.5 20.3 47.9 23.4 13.8 8.3 4.8 28.7 76.3 31.8 3.3 3.5 10.8 3.6 6.8 31.4 7.1 6.1 16.8 30.2 22.2 2.0 1.3 21.3 7.7 14.1 18.7 2.7 4.7 31.4 28.2 24.6 15.4 33.6 25.2 12.7 9.1 25.1 9.7 6.4 20.0 10.4 8.8 13.2 17.1 19.1 10.8 17.3 13.7 7.3 3.5 8.0 10.7 38.8 6.6 21.5 6.9 28.5 8.5 2.6 2.0 1.7 3.5 2.4 7.2 2.7 2.8 2.0 3.1 2.6 4.4 4.2 42.2 214.7 452.0 2.0 66.5 53.0 141.0 15.7 32.5 3.3 33.1 34.3 9.3 8.6 106.2 11.0 2.1 23.6 46.9 79.0 3.9 16.7 212.8 64.9 28.1 34.0 4.2 9.1 3.5 5.7 43.5 62.2 32.1 179.6 139.6 2.2 10.8 8.6 54.9 3.3 3.6 20.2 8.2 113.8 301.8 69.9 10.2 151.3 40.9 18.7 108.8 1.9 18.6 1.5 1.7 30.7 85.7 3.8 43.9 44.8 109.2 22.4 57.6 3.6 6.6 101.5 46.3 25.7 18.4 35.6 45.3 146.3 111.6 12.2 31.7 112.8 ADGRF3 "GPR113, hGPCR37, PGR23" ENSG00000173567 "Adhesion G protein-coupled receptor F3" Q8IZF5 2 26308173-26346817 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 1.4;U-937: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044500 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA044500: AB_10794290" "unprognostic (9.58e-3)" "unprognostic (2.13e-2)" "unprognostic (4.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (6.68e-4)" "unprognostic (8.98e-3)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" "unprognostic (9.66e-4)" "unprognostic (2.29e-1)" "unprognostic (8.09e-2)" "unprognostic (3.53e-2)" "unprognostic (2.58e-1)" "unprognostic (4.08e-2)" "unprognostic (8.70e-5)" 0.0 0.1 0.5 0.4 0.3 0.4 0.0 0.9 0.9 0.0 0.6 0.1 0.5 0.1 0.0 0.2 0.1 0.1 0.0 0.7 0.6 0.8 0.1 0.1 0.5 0.5 0.4 0.2 0.2 0.8 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.2 0.5 0.5 0.4 0.2 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.2 0.0 1.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.7 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 1.4 0.4 0.9 0.0 0.0 0.8 0.7 0.3 0.0 1.1 0.8 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.7 0.7 1.2 0.0 1.4 0.1 0.0 0.0 0.4 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.3 0.9 0.9 0.7 0.6 0.5 0.4 0.2 0.5 0.2 0.5 0.6 0.4 0.0 0.0 11.4 1.3 0.0 0.3 0.0 0.0 0.9 0.3 0.4 0.7 0.0 0.0 0.0 2.1 0.1 0.8 0.0 0.0 0.1 12.0 0.9 1.1 0.2 0.0 0.0 3.4 0.0 0.1 0.2 0.5 0.8 0.0 0.2 0.0 0.2 0.1 1.7 4.1 0.1 0.0 0.0 0.0 28.0 0.0 0.5 0.0 5.6 0.3 0.2 0.0 3.0 6.3 0.1 0.0 0.0 2.7 0.1 0.4 0.1 0.0 1.2 0.0 0.2 0.3 1.5 0.4 0.1 0.0 0.1 0.9 0.2 0.2 0.1 NLRP13 "CLR19.7, NALP13, NOD14, PAN13" ENSG00000173572 "NLR family pyrin domain containing 13" Q86W25 19 55891699-55932336 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060459 Uncertain NA NA "HPA060459: AB_2684284" "unprognostic (2.16e-1)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHD2 "DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614" ENSG00000173575 "Chromodomain helicase DNA binding protein 2" O14647 15 92900189-93027996 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060744, HPA060960" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060744: AB_2684353, HPA060960: AB_2684398" "unprognostic (1.65e-2)" "unprognostic (2.43e-1)" "unprognostic (2.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.12e-2)" "unprognostic (3.10e-2)" "unprognostic (2.67e-2)" "unprognostic (7.85e-2)" "unprognostic (7.51e-3)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (1.79e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-1)" "unprognostic (1.70e-2)" 14.0 12.4 25.9 20.9 27.8 74.1 20.6 42.2 30.9 15.6 31.8 14.5 14.9 19.6 29.4 14.7 16.4 15.7 12.0 23.6 35.9 15.2 15.5 21.8 26.6 32.1 25.7 19.9 26.3 19.7 18.3 16.7 20.6 28.9 20.6 15.0 31.0 21.4 13.5 17.5 19.0 18.9 13.4 25.5 23.5 17.9 20.9 26.5 27.2 26.5 14.8 25.6 13.9 16.3 36.8 21.3 11.6 30.6 13.6 17.9 45.3 23.0 19.4 20.0 13.0 16.1 14.5 27.4 5.2 16.1 17.3 22.1 31.1 17.6 19.5 18.0 0.1 10.6 25.3 26.1 12.9 24.6 27.1 19.0 28.7 23.0 15.5 31.1 26.8 22.4 36.7 26.8 57.1 19.9 13.1 14.2 14.0 19.5 10.5 12.6 19.9 27.6 28.4 13.3 28.5 16.8 18.1 34.2 12.3 25.9 30.6 14.1 22.6 36.2 10.7 13.9 9.3 12.8 53.4 23.2 21.6 15.9 15.9 9.4 35.9 10.8 27.7 22.1 6.6 21.8 48.7 21.5 20.5 7.4 39.6 30.1 22.1 53.7 20.6 13.4 27.9 24.9 10.9 25.9 27.8 42.2 30.9 23.6 35.9 32.1 25.7 19.9 28.9 25.5 26.5 36.8 59.3 70.5 176.3 182.2 137.8 164.3 112.3 102.3 153.7 71.4 62.6 46.5 42.3 37.1 137.3 46.0 91.8 30.7 116.3 59.6 3.9 36.1 56.5 96.9 61.7 58.6 59.3 65.4 161.5 38.3 28.5 64.5 96.4 189.8 99.3 70.7 25.0 34.9 24.8 57.2 146.2 54.9 91.6 55.1 297.4 39.2 34.8 89.5 96.0 119.9 50.7 34.2 48.4 140.8 155.9 64.2 61.6 37.6 133.0 110.0 39.9 11.5 93.9 82.2 32.9 52.7 64.4 15.3 14.7 125.2 180.7 60.5 153.2 42.9 51.5 143.6 XCR1 "CCXCR1, GPR5" ENSG00000173578 "X-C motif chemokine receptor 1" P46094 3 46017007-46027487 "G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.3" "Cell type enriched" "Detected in some" 5 "Langerhans cells: 10.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "myeloid DC: 3.8" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.8" "Cell line enhanced" "Detected in some" "HEL: 1.6;Karpas-707: 2.5;RT4: 2.0;U-266/84: 2.2;U-87 MG: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA013169 Uncertain NA NA "HPA013169: AB_1846211" "unprognostic (3.49e-3)" "unprognostic (4.23e-3)" "unprognostic (1.15e-2)" "unprognostic (5.91e-3)" "unprognostic (7.91e-2)" "unprognostic (8.53e-6)" "unprognostic (3.89e-6)" "unprognostic (9.27e-3)" "unprognostic (4.41e-3)" "unprognostic (3.40e-3)" "unprognostic (2.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.87e-1)" "unprognostic (5.98e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.80e-1)" 0.9 0.1 0.3 3.9 0.3 3.0 0.6 0.7 0.8 0.7 0.5 1.1 1.7 0.5 4.5 1.9 0.6 3.0 0.5 0.5 0.4 0.3 1.1 1.4 11.3 0.4 0.2 0.3 0.9 0.1 0.1 0.0 4.3 0.4 0.6 1.1 0.7 0.2 0.6 0.1 2.8 1.7 1.5 0.1 7.2 1.2 0.4 0.3 8.9 0.5 0.4 4.6 1.6 0.2 0.8 0.0 0.8 0.3 0.0 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.7 0.0 0.7 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.4 0.3 0.5 2.5 0.0 0.8 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.3 2.0 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.4 0.9 0.2 0.1 1.2 2.2 0.7 1.7 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.3 0.3 0.7 0.8 0.5 0.4 0.4 0.2 0.3 0.4 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 10.2 1.5 0.0 2.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 CCDC106 HSU79303 ENSG00000173581 "Coiled-coil domain containing 106" Q9BWC9 19 55641062-55653161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 9.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 82.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041925, HPA043219" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041925: AB_2677750, HPA043219: AB_2678368" "unprognostic (5.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "unprognostic (5.16e-2)" "unprognostic (9.19e-2)" "unprognostic (2.82e-1)" "unprognostic (8.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.88e-2)" "unprognostic (8.74e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.28e-1)" "prognostic favorable (7.54e-11)" "unprognostic (5.03e-2)" "unprognostic (7.88e-2)" "unprognostic (3.26e-1)" "unprognostic (8.69e-2)" 11.9 21.9 25.9 5.2 28.1 2.6 12.0 18.5 37.9 10.4 14.5 15.1 4.1 13.5 6.4 8.1 13.4 6.5 21.1 31.3 20.6 29.3 24.5 9.5 10.4 20.3 21.7 23.2 12.8 9.9 13.7 27.5 5.2 21.4 15.3 2.7 6.5 11.2 11.3 24.8 9.0 13.8 7.1 16.4 18.3 13.9 21.0 21.9 4.7 16.8 20.4 9.0 12.9 8.4 22.8 8.7 33.6 14.4 25.3 10.1 9.6 2.0 7.4 12.9 25.0 21.0 7.3 13.2 25.6 5.6 13.8 0.7 7.3 24.6 16.0 7.1 1.3 82.2 26.7 23.4 13.3 30.1 1.8 14.3 15.6 1.9 5.9 1.4 17.4 8.0 16.0 20.1 15.7 12.5 2.3 16.3 10.8 6.9 0.8 18.3 25.5 7.3 17.7 25.9 0.8 15.8 29.4 5.9 41.3 14.7 8.5 17.9 17.3 9.0 7.7 7.9 0.7 5.5 9.3 3.5 33.0 20.7 8.4 0.6 0.0 2.3 0.0 0.4 1.5 1.4 7.2 0.4 0.6 2.9 9.6 3.1 1.9 0.0 0.8 0.1 8.9 0.3 1.7 25.9 28.1 18.5 37.9 31.3 20.6 20.3 21.7 23.2 21.4 16.4 21.9 22.8 12.0 0.0 1.3 8.8 18.1 2.5 6.0 14.0 12.0 22.3 16.0 17.1 23.8 11.5 6.5 20.2 4.2 13.5 6.8 4.6 41.1 19.6 4.0 3.9 7.2 10.8 4.9 4.2 6.4 7.2 15.0 9.7 11.7 3.3 8.9 10.5 10.0 17.5 17.5 37.0 6.4 8.7 8.2 9.4 6.4 2.7 14.0 7.9 3.6 3.7 11.7 34.1 3.1 4.5 3.6 8.7 8.0 18.8 7.0 6.0 10.6 69.4 3.2 9.7 13.1 9.3 9.0 4.7 30.2 10.3 3.7 8.8 3.9 18.9 6.0 5.7 CCR9 "CDw199, GPR-9-6, GPR28" ENSG00000173585 "C-C motif chemokine receptor 9" P51686 3 45886504-45903175 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "lymphoid tissue: 125.5" "Cell type enhanced" "Detected in some" "B-cells: 1.0;T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 24.0;naive B-cell: 15.6;T-reg: 8.1" "Group enriched" "Detected in many" 42 "B-cells: 24.0;T-cells: 8.1" "Cell line enriched" "Detected in some" 54 "MOLT-4: 112.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB006839 Uncertain NA NA "CAB006839: " "unprognostic (3.08e-3)" "unprognostic (3.37e-1)" "unprognostic (5.56e-2)" "unprognostic (1.78e-1)" "unprognostic (8.65e-3)" "unprognostic (7.88e-3)" "unprognostic (4.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.00e-1)" "unprognostic (1.77e-1)" "unprognostic (8.06e-2)" "unprognostic (1.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.88e-1)" "unprognostic (4.34e-1)" "unprognostic (2.27e-1)" "unprognostic (7.20e-3)" 0.0 0.0 0.0 1.1 0.1 0.5 0.0 0.0 0.1 0.0 0.3 0.2 3.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 5.5 0.0 0.2 1.0 0.2 0.0 0.1 125.5 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 24.0 2.8 2.4 0.3 15.6 0.4 0.1 0.0 0.0 0.0 0.3 8.1 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 CEP83 "CCDC41, NPHP18, NY-REN-58" ENSG00000173588 "Centrosomal protein 83" Q9Y592 12 94306449-94459988 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 109.1;Oligodendrocyte precursor cells: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038161 Approved NA NA "HPA038161: AB_10674547" "unprognostic (4.98e-2)" "unprognostic (1.64e-2)" "unprognostic (7.22e-2)" "unprognostic (1.75e-2)" "unprognostic (4.76e-3)" "unprognostic (3.59e-2)" "unprognostic (5.44e-3)" "unprognostic (1.70e-1)" "unprognostic (2.24e-2)" "unprognostic (1.92e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (5.00e-10)" "unprognostic (1.29e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-2)" 5.4 8.0 6.5 5.3 5.3 7.0 6.9 5.8 5.4 5.9 7.2 5.4 4.0 6.2 6.1 5.1 11.6 3.9 14.0 5.6 7.0 5.1 5.1 5.5 6.1 6.0 5.9 5.0 7.8 9.7 5.5 5.1 4.6 5.7 5.2 7.2 5.3 4.2 2.8 5.2 4.7 4.3 4.6 6.7 5.4 5.1 18.8 5.1 5.4 7.2 3.3 6.0 4.6 5.5 6.7 8.2 9.1 15.1 14.2 6.5 8.7 12.9 14.2 4.5 10.1 10.3 11.3 6.7 21.3 3.0 4.3 6.4 11.4 18.3 10.9 15.5 12.5 13.3 12.7 9.2 11.5 6.5 20.9 8.3 5.7 8.9 8.4 25.6 5.9 9.6 17.1 16.6 8.5 10.6 8.3 14.3 34.5 17.2 14.0 16.6 19.4 14.2 21.6 9.1 10.2 15.6 6.5 11.9 13.9 9.9 13.3 9.5 13.0 5.7 11.8 7.3 5.9 11.3 11.1 13.3 19.3 4.9 21.8 11.4 0.6 2.5 1.5 3.8 2.5 3.6 4.7 3.9 3.1 5.7 4.8 4.0 3.6 1.0 4.6 1.2 6.1 5.2 1.5 6.5 5.3 5.8 5.4 5.6 7.0 6.0 5.9 5.0 5.7 6.7 5.1 6.7 10.3 16.0 10.7 37.5 17.9 0.0 15.3 0.0 23.9 12.9 12.7 11.7 39.0 1.5 11.8 3.7 14.6 6.8 9.4 8.9 1.9 4.7 55.4 109.1 26.3 8.0 14.9 14.9 51.7 3.5 9.6 13.3 17.3 17.0 26.6 17.8 2.9 5.2 5.7 5.0 45.6 11.9 0.0 4.6 0.0 16.6 10.8 11.6 0.0 46.9 15.1 4.9 11.3 74.4 55.0 3.5 5.2 6.4 17.4 15.0 1.9 5.5 48.1 12.0 0.0 24.9 7.8 45.4 24.0 18.4 0.0 3.3 10.5 15.2 12.5 13.2 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721167-69787961 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.3;stomach 1: 45.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 10.7;neutrophil: 32.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA002107: AB_2666542" "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 3.0 0.7 2.2 10.8 4.7 5.6 2.1 8.1 7.3 1.6 2.6 70.6 100.3 2.0 2.4 2.0 1.5 1.5 2.0 3.0 2.6 1.9 24.0 2.5 4.3 1.8 1.8 2.7 3.1 0.8 1.0 0.1 1.3 3.6 2.5 62.8 4.0 0.8 1.5 1.2 1.3 96.1 5.1 0.3 9.8 45.3 1.2 1.5 3.0 2.7 2.3 7.6 1.6 0.9 5.9 0.7 0.6 0.8 0.8 1.8 1.9 1.2 0.8 0.4 0.3 0.3 0.7 0.7 1.3 0.7 0.8 1.0 1.1 0.1 0.2 0.7 1.5 1.0 1.0 1.2 0.5 2.7 1.3 1.3 12.3 0.2 0.3 0.5 1.1 110.9 1.6 0.6 2.5 1.0 0.7 0.6 1.0 0.8 26.3 0.4 0.6 3.7 0.8 0.2 1.8 1.3 0.8 0.5 0.3 0.5 0.7 1.6 0.6 36.2 1.0 1.7 31.5 0.6 1.9 1.0 0.6 0.4 3.3 1.3 10.7 4.8 1.4 1.0 2.7 0.3 0.1 1.5 0.4 2.7 0.2 4.9 2.5 32.0 2.9 3.4 0.2 0.9 2.6 2.2 4.7 8.1 7.3 3.0 2.6 1.8 1.8 2.7 3.6 0.3 1.5 5.9 1.3 19.2 20.8 0.3 0.9 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 8.4 0.0 0.0 0.0 4.9 298.2 0.0 0.3 0.1 1.2 0.1 2.2 33.7 2.7 0.1 4.4 0.2 1.8 61.7 0.2 16.4 0.2 2.9 45.1 0.3 0.0 0.1 42.6 0.0 24.9 1.8 0.0 0.0 9.4 0.0 3.7 15.4 0.0 11.3 0.0 0.1 18.2 153.4 0.0 1.0 0.2 234.3 1.5 12.8 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.3 6.7 0.1 76.4 0.1 NUDT4 "DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487" ENSG00000173598 "Nudix hydrolase 4" Q9NZJ9 12 93377883-93408146 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 361.9;Erythroid cells: 520.6;Muller glia cells: 485.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.44e-2)" "unprognostic (2.15e-1)" "unprognostic (4.40e-3)" "unprognostic (4.25e-1)" "unprognostic (3.08e-3)" "unprognostic (1.42e-1)" "unprognostic (8.12e-2)" "unprognostic (9.09e-3)" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (5.01e-1)" "unprognostic (8.32e-3)" 61.7 72.5 50.6 32.2 63.7 170.7 49.2 40.6 70.4 52.5 58.1 57.9 26.8 31.2 63.1 35.2 44.9 90.6 121.9 60.2 166.7 131.7 45.5 29.2 34.5 52.8 56.6 57.0 151.5 63.4 42.0 26.7 60.7 50.4 79.4 63.5 102.9 130.9 38.6 88.0 19.0 35.7 38.2 44.3 25.9 34.9 32.5 49.5 35.1 58.0 116.6 36.6 79.3 26.3 54.8 24.1 20.4 36.4 41.1 132.5 54.3 45.5 66.0 52.4 37.0 27.2 188.4 58.6 33.7 14.0 53.1 24.3 29.5 102.4 33.2 56.5 51.9 21.6 126.9 17.1 99.3 126.8 66.8 29.3 118.5 109.2 38.3 85.0 186.1 212.9 59.7 130.7 46.0 42.9 24.6 61.9 63.7 57.2 59.4 47.7 50.7 32.5 36.5 45.0 171.7 29.1 37.5 53.6 103.3 153.2 58.2 75.2 85.6 81.6 31.6 18.0 47.9 42.5 25.6 34.2 49.4 16.6 51.8 98.3 9.5 2.2 11.3 2.8 2.8 5.1 4.5 4.2 2.9 2.0 3.8 4.4 4.4 1.9 6.0 2.5 3.2 4.2 1.9 50.6 63.7 40.6 70.4 60.2 166.7 52.8 56.6 57.0 50.4 44.3 49.5 54.8 44.0 19.2 42.8 8.1 74.8 116.8 123.1 22.5 178.7 66.9 58.3 39.1 243.9 114.4 31.8 62.5 62.6 188.7 49.8 226.9 361.9 21.8 125.6 45.7 38.2 66.4 152.2 520.6 16.6 16.5 32.9 99.2 36.2 60.6 25.4 54.2 41.7 53.4 43.7 42.1 7.5 89.3 12.2 35.1 81.0 26.2 39.1 47.2 106.7 5.6 34.3 485.7 34.0 10.6 1.3 55.1 92.8 46.6 113.9 137.8 68.2 52.8 86.1 44.5 72.3 184.4 204.4 115.7 17.3 119.2 96.7 163.8 80.2 37.3 90.4 178.4 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848417-66958386 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 61.4;liver: 149.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 201.9;Late spermatids: 53.2" "Cancer enhanced" "Detected in all" "liver cancer: 37.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria Yes No 200000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 61.4 23.9 31.7 2.9 31.8 3.5 28.7 34.6 36.1 3.2 14.0 4.2 6.5 3.8 1.9 9.4 3.2 2.8 4.3 29.3 41.3 23.5 149.2 2.7 1.3 40.9 36.0 22.6 5.1 5.0 18.3 8.6 4.4 34.9 7.3 2.8 2.5 35.6 9.4 12.2 4.6 7.7 1.4 33.9 1.5 9.2 10.8 40.5 2.0 4.7 6.6 2.0 2.9 4.5 34.2 6.1 19.3 6.5 17.2 25.4 8.9 6.6 3.4 15.5 6.9 7.5 8.8 6.0 0.0 7.4 6.0 9.6 6.8 7.7 39.5 1.5 2.8 11.0 10.3 57.4 41.2 21.0 0.1 10.8 40.2 10.1 5.8 12.4 4.4 5.7 14.3 17.4 0.0 2.1 44.6 9.2 4.6 12.0 15.1 16.2 8.3 13.0 3.2 5.7 1.9 15.2 21.0 33.6 18.0 15.5 4.8 14.6 2.7 6.3 7.8 6.6 8.8 4.7 3.5 4.8 0.1 7.7 5.7 6.7 0.0 1.3 0.0 0.5 0.3 0.5 0.0 0.1 0.5 0.9 0.2 0.9 0.5 0.1 0.1 0.1 0.3 0.5 0.7 31.7 31.8 34.6 36.1 29.3 41.3 40.9 36.0 22.6 34.9 33.9 40.5 34.2 0.9 0.0 3.0 26.4 1.4 1.3 1.6 9.1 2.8 5.6 4.8 5.8 4.4 11.5 3.0 3.7 2.1 17.4 0.6 27.6 1.9 3.1 18.4 2.3 7.1 1.5 9.0 28.0 18.5 1.8 4.2 3.2 5.6 3.0 8.9 16.0 4.6 201.9 12.3 0.0 18.6 5.0 0.0 7.0 1.8 53.2 0.6 1.8 5.4 7.5 18.9 9.4 2.1 10.1 16.7 2.3 8.5 4.1 0.1 3.1 23.6 39.0 1.5 4.8 0.0 2.2 2.2 11.2 4.7 4.1 0.6 25.4 1.2 6.0 6.4 1.3 UGT2A1 ENSG00000173610 "UDP glucuronosyltransferase family 2 member A1 complex locus" P0DTE4 4 69588417-69653249 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 2.9;kidney: 2.2;liver: 3.7;pituitary gland: 5.6" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 107.9" "Cancer enhanced" "Detected in some" "liver cancer: 0.7;lung cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017261, HPA045108" Uncertain NA NA "HPA017261: AB_10963582, HPA045108: AB_2679218" "unprognostic (3.93e-3)" "unprognostic (5.62e-1)" "unprognostic (1.28e-4)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 3.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SCAI "C9orf126, FLJ36664, NET40" ENSG00000173611 "Suppressor of cancer cell invasion" Q8N9R8 9 124942608-125143528 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 200.1;Excitatory neurons: 327.4;Inhibitory neurons: 171.6;Rod photoreceptor cells: 136.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020632 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA020632: AB_1845804" "unprognostic (1.93e-1)" "unprognostic (1.88e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (6.90e-2)" "unprognostic (3.34e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-3)" "unprognostic (5.69e-2)" "unprognostic (2.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-2)" "unprognostic (3.57e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (1.26e-3)" 1.7 2.6 2.1 1.8 4.2 2.9 1.9 0.4 4.3 2.0 4.3 1.7 1.1 2.1 1.5 1.4 2.1 1.2 1.3 2.4 2.3 1.5 1.5 3.2 2.9 0.0 0.6 3.0 2.7 1.7 1.5 1.7 0.9 0.9 1.9 1.8 7.5 1.4 1.0 1.7 2.4 1.6 1.4 0.0 1.9 1.5 2.0 0.9 11.3 1.9 1.0 2.3 1.6 1.7 3.3 3.2 2.4 3.2 3.1 1.7 4.2 5.4 2.0 4.1 2.1 2.9 3.1 3.0 5.7 1.5 2.0 2.4 5.3 4.2 2.2 4.2 4.1 1.5 3.8 4.4 2.8 2.4 4.0 2.8 1.6 1.8 3.2 2.1 3.5 3.0 10.2 5.4 6.6 3.2 3.5 13.0 2.8 3.2 6.1 2.6 8.1 5.1 5.0 1.4 4.3 3.3 2.1 4.7 2.5 2.4 3.5 6.3 1.8 3.1 1.9 3.5 3.2 3.5 3.6 7.3 5.5 2.2 3.3 2.8 0.2 0.3 0.0 0.2 0.4 0.3 0.5 0.4 0.3 0.2 0.6 0.6 0.4 0.2 0.6 0.1 0.8 0.7 0.3 2.1 4.2 0.4 4.3 2.4 2.3 0.0 0.6 3.0 0.9 0.0 0.9 3.3 7.3 70.5 28.2 49.0 19.7 2.8 7.9 6.0 10.2 46.4 8.7 5.6 4.8 14.3 9.4 18.4 200.1 6.6 14.6 6.3 1.9 4.1 14.5 9.4 8.5 8.0 13.1 23.3 327.4 2.0 4.7 7.5 8.2 14.2 5.1 74.5 12.5 8.7 4.2 16.8 171.6 8.4 16.2 6.6 5.5 5.9 9.6 5.4 3.6 55.3 5.4 25.8 22.6 72.9 61.0 2.9 7.3 6.0 14.3 9.6 8.3 3.1 10.3 136.5 0.0 11.3 8.3 34.7 21.5 12.4 4.3 2.6 14.8 28.9 11.2 4.4 GPRC6A bA86F4.3 ENSG00000173612 "G protein-coupled receptor class C group 6 member A" Q5T6X5 6 116792085-116829083 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Enteroendocrine cells: 1.8" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (9.16e-2)" "unprognostic (2.48e-1)" "unprognostic (4.38e-3)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMNAT1 "LCA9, NMNAT, PNAT1" ENSG00000173614 "Nicotinamide nucleotide adenylyltransferase 1" Q9HAN9 1 9943428-9985501 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059447 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA059447: AB_2684022" "unprognostic (1.94e-1)" "unprognostic (3.81e-3)" "unprognostic (7.54e-3)" "unprognostic (1.01e-1)" "unprognostic (3.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (4.45e-3)" "unprognostic (4.55e-2)" "unprognostic (1.12e-1)" "unprognostic (3.57e-1)" "prognostic favorable (3.85e-14)" "unprognostic (3.11e-3)" "unprognostic (1.17e-1)" "unprognostic (1.47e-3)" "unprognostic (5.16e-2)" 5.2 7.4 5.4 4.4 6.0 2.5 5.7 5.0 7.8 5.4 8.4 9.1 6.1 3.8 5.8 5.2 4.8 3.4 9.6 5.0 5.9 8.0 7.9 3.3 4.3 5.3 5.4 4.9 3.0 5.0 8.2 3.8 3.8 5.5 4.5 9.1 5.3 5.3 5.4 23.6 5.7 6.1 5.1 4.4 5.1 4.5 4.3 5.3 4.3 7.3 17.0 4.7 4.0 3.7 7.2 4.6 5.4 7.5 7.1 13.4 12.2 1.8 9.1 7.2 10.3 6.7 2.4 7.7 4.8 5.7 12.9 4.5 4.6 9.4 12.4 11.0 10.4 4.8 7.6 3.0 7.6 11.4 6.7 7.7 13.3 14.2 12.1 17.4 9.5 10.2 10.4 9.7 3.1 10.9 8.0 3.8 4.4 0.9 10.2 10.2 4.2 4.7 2.7 11.9 2.5 5.4 2.8 11.8 9.7 10.4 3.8 3.5 7.2 10.2 4.1 3.3 8.7 4.2 4.5 4.3 4.5 7.1 13.8 8.6 7.5 3.7 3.2 1.6 2.6 0.8 4.9 1.6 1.9 3.3 2.3 1.4 1.8 9.1 2.5 3.9 3.2 1.5 1.8 5.4 6.0 5.0 7.8 5.0 5.9 5.3 5.4 4.9 5.5 4.4 5.3 7.2 5.6 3.2 4.4 10.1 3.7 2.3 5.6 14.3 2.2 7.7 6.1 5.1 14.4 4.3 7.3 7.3 6.2 10.1 3.7 18.8 23.5 9.1 7.8 5.5 8.1 7.9 3.0 2.1 13.0 6.9 4.7 5.7 4.1 6.1 4.5 9.2 7.5 9.0 12.9 10.1 14.3 7.6 12.2 10.3 2.7 3.7 6.5 7.2 5.4 4.7 13.5 9.6 12.3 6.0 13.2 6.0 6.2 6.4 0.9 5.9 19.0 14.3 8.6 7.1 6.6 5.9 5.1 17.3 8.3 3.6 1.8 9.0 3.6 13.1 14.5 4.8 LRFN4 "FIGLER6, MGC3103, SALM3." ENSG00000173621 "Leucine rich repeat and fibronectin type III domain containing 4" Q6PJG9 11 66856647-66860475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077570 Enhanced NA NA "HPA077570: " "unprognostic (2.25e-2)" "unprognostic (5.90e-3)" "unprognostic (7.51e-2)" "unprognostic (2.01e-2)" "unprognostic (4.35e-2)" "unprognostic (6.73e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-3)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (5.69e-2)" "unprognostic (9.45e-2)" "unprognostic (1.93e-1)" "unprognostic (6.80e-3)" "unprognostic (1.81e-1)" "unprognostic (2.85e-1)" "unprognostic (3.53e-1)" 13.9 13.5 9.3 2.2 6.8 3.9 12.8 8.3 14.3 10.8 0.0 11.8 1.5 13.5 0.1 8.0 11.7 0.7 11.3 9.1 2.6 9.3 2.6 8.5 1.6 3.6 3.5 9.0 6.3 3.0 1.2 7.9 0.9 5.6 8.9 1.3 0.5 9.3 2.3 9.7 9.4 5.9 1.0 0.8 7.7 8.4 23.0 4.4 1.2 5.9 2.0 0.6 9.3 10.8 6.4 22.5 18.9 3.0 8.7 2.3 4.5 0.2 14.5 4.7 8.7 4.7 12.0 10.8 10.6 17.1 5.4 9.6 13.2 5.2 5.0 1.0 5.2 16.7 7.8 51.3 4.6 14.6 16.5 19.8 6.6 7.8 4.0 4.0 5.3 6.4 14.4 21.0 0.4 1.3 47.2 30.5 55.0 25.0 10.2 32.4 22.0 11.8 35.0 3.8 0.1 16.6 16.0 21.1 17.5 51.1 0.6 24.0 12.7 15.1 12.1 23.0 35.0 14.0 10.2 10.1 2.3 7.6 18.2 9.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 9.3 6.8 8.3 14.3 9.1 2.6 3.6 3.5 9.0 5.6 0.8 4.4 6.4 4.8 0.0 1.1 10.7 1.1 2.2 2.5 7.1 0.0 18.7 3.6 5.7 0.7 0.0 2.9 3.7 4.2 0.2 1.9 15.9 0.0 1.6 17.1 7.6 18.4 4.0 1.8 1.3 9.1 0.8 1.2 4.9 4.1 10.2 1.3 9.5 2.2 0.2 5.3 13.5 9.5 12.3 6.1 3.1 2.2 29.6 3.7 4.3 5.4 1.9 7.6 2.0 3.1 5.0 6.8 4.3 9.6 1.5 1.9 5.9 0.3 0.5 2.6 8.6 0.0 3.8 6.0 5.5 2.2 2.1 1.7 0.3 2.1 11.8 16.2 1.8 TRAPPC3L "bA259P20.2, BET3L, FLJ11180" ENSG00000173626 "Trafficking protein particle complex 3 like" Q5T215 6 116494989-116545684 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.9" "Cell type enhanced" "Detected in some" "Adipocytes: 1.6;Early spermatids: 1.8;Endothelial cells: 1.5;Hepatic stellate cells: 6.1;Kupffer cells: 4.2;Macrophages: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA060912 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA060912: " "unprognostic (1.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.93e-2)" "unprognostic (2.91e-1)" "unprognostic (5.25e-2)" "unprognostic (1.15e-2)" "unprognostic (8.98e-2)" "unprognostic (9.09e-4)" "unprognostic (8.41e-2)" "unprognostic (3.23e-2)" "unprognostic (1.96e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (8.11e-2)" "unprognostic (7.47e-3)" 0.7 0.7 1.9 0.9 2.0 3.8 1.0 8.9 5.4 0.4 0.3 0.7 1.0 1.2 1.8 0.7 0.5 1.1 0.9 2.2 0.9 0.8 1.4 1.2 1.7 1.6 0.6 1.1 1.0 0.7 3.1 0.0 3.9 3.8 0.7 0.5 4.3 1.2 0.7 1.3 2.3 1.0 0.5 0.1 4.7 1.1 1.5 1.1 0.5 1.8 0.2 0.6 0.5 0.0 5.7 0.8 0.4 1.0 1.5 0.3 1.0 1.1 0.5 0.5 0.4 0.5 0.5 0.7 1.3 0.6 0.2 0.8 1.0 0.3 0.6 0.5 0.6 0.6 1.4 1.9 0.6 0.5 0.9 0.6 0.4 0.3 0.2 0.3 1.5 0.8 1.0 0.8 6.6 0.3 1.5 0.9 1.0 0.9 0.3 0.6 0.8 0.7 2.2 0.7 1.3 1.0 0.7 0.8 0.4 0.5 1.2 0.7 0.8 1.0 1.2 0.9 1.2 0.6 1.2 0.8 0.8 0.8 0.9 0.7 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.3 0.1 2.8 1.9 2.0 8.9 5.4 2.2 0.9 1.6 0.6 1.1 3.8 0.1 1.1 5.7 1.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 6.1 0.1 1.1 0.0 0.1 0.0 0.0 4.2 0.0 0.4 0.3 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 APOBEC4 "C1orf169, FLJ25691, MGC26594, RP1-127C7.4" ENSG00000173627 "Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4" Q8WW27 1 183646275-183653316 "Metabolic proteins, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 11.7;testis: 10.1" "Cell type enhanced" "Detected in some" "Early spermatids: 131.4;Endometrial ciliated cells: 31.0;Late spermatids: 86.7;Respiratory ciliated cells: 63.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.27e-1)" "prognostic favorable (2.65e-4)" "unprognostic (2.61e-1)" "unprognostic (3.84e-2)" "unprognostic (1.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.10e-2)" "unprognostic (4.00e-2)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.1 0.7 0.1 0.8 0.0 0.1 0.2 0.0 0.0 11.7 0.0 0.0 0.6 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.7 0.6 0.1 0.0 0.1 0.2 0.4 0.0 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 11.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 131.4 31.0 0.2 0.1 3.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 86.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.2 0.0 63.3 0.0 0.0 0.0 0.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45573365 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 66.7" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 158.0;Syncytiotrophoblasts: 362.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 102.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 102.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 6.9 9.5 7.0 5.7 4.7 8.1 6.0 5.2 11.2 9.3 66.7 5.8 22.7 6.5 0.9 3.2 7.0 1.9 4.0 11.8 2.4 8.0 21.1 15.8 4.3 5.2 4.9 2.6 11.9 6.9 0.8 5.4 13.7 7.4 5.9 0.8 2.3 3.3 0.9 2.6 4.0 8.0 1.1 2.5 15.2 7.4 4.6 4.9 2.2 13.9 0.5 0.7 4.4 5.2 4.4 28.9 23.7 4.9 19.4 1.5 2.1 40.2 12.5 1.9 11.1 7.0 55.1 26.1 26.8 24.9 2.8 9.1 14.1 9.0 8.5 2.7 25.2 51.2 54.7 12.4 38.8 6.1 37.2 8.5 2.7 6.3 11.6 3.3 3.3 9.1 27.3 67.6 11.8 3.5 29.3 49.6 29.9 28.5 11.2 30.0 66.5 5.4 79.2 4.6 16.9 29.7 26.7 14.9 23.5 11.2 6.7 18.4 41.4 10.7 14.6 18.8 4.3 21.1 4.8 18.5 23.5 6.7 56.4 11.9 1.6 18.5 24.1 0.9 16.3 2.8 2.5 1.4 2.0 13.4 0.8 2.0 1.5 102.9 1.1 10.8 4.1 3.2 7.9 7.0 4.7 5.2 11.2 11.8 2.4 5.2 4.9 2.6 7.4 2.5 4.9 4.4 1.4 48.1 6.3 13.7 2.9 2.4 2.0 2.6 1.8 23.6 3.9 3.4 2.5 1.5 6.2 0.0 0.0 158.0 0.5 8.2 0.0 8.0 3.7 2.2 5.8 3.4 0.0 6.7 3.4 4.9 21.5 3.7 4.1 4.5 1.3 12.7 1.1 16.2 27.3 8.4 4.0 4.1 8.2 11.1 5.0 6.6 6.5 8.6 3.6 23.4 8.3 5.7 0.0 2.0 1.7 7.6 5.4 11.3 9.4 4.6 20.5 2.4 0.9 3.6 0.0 3.3 4.1 1.5 4.8 1.8 1.6 362.4 2.6 5.1 8.5 0.9 HSPB7 cvHSP ENSG00000173641 "Heat shock protein family B (small) member 7" Q9UBY9 1 16014028-16019594 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 2988.1;skeletal muscle: 2437.7;tongue: 1240.4" "Cell type enriched" "Detected in some" 32 "Cardiomyocytes: 2389.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "fHDF/TERT166: 315.1" "Not detected" "Not detected" HPA027639 Approved Approved Nucleoplasm NA NA 130000 Nucleoplasm "HPA027639: AB_10601756" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.28e-3)" "unprognostic (7.44e-3)" "unprognostic (8.35e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (1.02e-1)" "unprognostic (5.32e-2)" "unprognostic (2.47e-3)" "unprognostic (3.19e-3)" "unprognostic (6.94e-2)" "unprognostic (1.55e-1)" "unprognostic (1.20e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (1.26e-4)" 309.6 124.4 4.5 32.4 3.7 0.2 120.7 8.5 5.1 49.8 8.6 101.7 5.2 181.0 7.6 44.5 65.4 18.8 2988.1 3.6 8.5 13.4 3.2 22.3 1.7 10.2 5.6 2.5 25.6 9.3 39.1 5.4 7.1 14.1 43.3 8.1 3.1 35.4 24.6 2437.7 14.5 34.3 191.0 4.9 4.5 72.0 20.3 4.6 0.6 14.2 1240.4 0.7 100.0 30.8 6.5 0.0 0.0 0.0 1.5 70.7 3.2 1.8 18.4 1.1 0.0 0.2 0.0 0.1 0.0 0.0 315.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 3.4 0.0 0.0 2.1 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.6 0.1 0.1 0.0 0.1 5.3 3.3 0.0 0.0 0.0 1.3 0.0 11.8 0.0 1.3 0.1 1.1 0.0 14.1 0.6 1.9 0.0 10.3 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 3.7 8.5 5.1 3.6 8.5 10.2 5.6 2.5 14.1 4.9 4.6 6.5 0.5 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.8 0.2 0.4 2389.7 0.0 0.0 3.7 0.0 2.8 0.0 0.0 13.7 1.4 55.5 0.1 0.7 26.6 0.0 0.0 0.0 0.2 1.4 46.3 0.0 0.1 0.0 0.4 0.0 0.0 1.6 1.7 0.1 0.0 0.0 0.0 4.6 74.2 14.3 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.5 0.0 0.2 0.0 0.6 0.0 20.2 42.6 1.9 0.9 0.1 2.6 3.3 0.5 3.0 0.0 0.1 RCE1 "FACE-2, FACE2, hRCE1, RCE1A, RCE1B" ENSG00000173653 "Ras converting CAAX endopeptidase 1" Q9Y256 11 66842835-66846552 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074124 Approved NA NA "HPA074124: " "unprognostic (1.11e-1)" "unprognostic (7.23e-2)" "unprognostic (1.15e-1)" "unprognostic (8.16e-3)" "unprognostic (3.11e-1)" "unprognostic (6.40e-3)" "unprognostic (1.98e-3)" "unprognostic (7.69e-3)" "unprognostic (1.39e-1)" "unprognostic (9.14e-3)" "unprognostic (2.35e-3)" "unprognostic (5.31e-3)" "unprognostic (1.06e-1)" "unprognostic (4.48e-3)" "unprognostic (2.17e-2)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" 8.9 11.0 13.5 7.3 13.8 21.0 9.3 16.6 18.4 10.7 12.5 10.7 10.2 8.5 5.9 20.0 9.0 8.7 7.3 13.7 13.7 16.8 8.0 9.0 10.0 13.3 12.9 14.1 10.9 15.7 9.6 14.0 11.9 14.2 12.1 8.3 10.1 12.7 6.1 4.4 20.1 12.5 5.9 12.6 12.1 12.1 13.6 13.9 9.6 7.1 4.3 6.1 12.0 13.0 13.6 22.7 24.5 14.7 13.8 9.0 7.8 32.3 11.6 11.2 17.7 15.8 46.6 47.2 17.2 21.8 11.1 29.3 39.6 17.1 17.4 10.2 20.7 19.3 15.5 17.0 18.0 31.7 20.3 22.0 12.6 32.7 19.9 17.6 13.7 14.6 23.5 21.7 26.0 9.0 42.8 28.2 38.3 43.5 43.1 24.0 22.9 11.0 34.1 19.5 12.0 18.3 16.5 16.8 22.3 74.1 14.3 26.2 16.3 9.7 24.2 18.7 26.4 18.5 14.6 15.2 19.6 16.4 20.8 18.4 23.1 21.1 14.6 17.1 24.0 15.6 15.3 14.7 22.1 18.9 12.0 11.8 17.8 7.2 14.3 21.5 29.1 6.7 17.8 13.5 13.8 16.6 18.4 13.7 13.7 13.3 12.9 14.1 14.2 12.6 13.9 13.6 12.5 0.0 4.8 4.2 16.9 31.2 26.6 46.2 14.2 9.2 16.4 20.6 1.8 10.0 20.3 16.5 29.2 54.6 24.9 12.4 3.9 24.3 10.1 11.3 12.5 12.2 10.7 10.7 7.7 27.4 65.0 12.0 11.7 17.1 8.2 13.3 8.2 3.0 22.8 3.3 6.2 16.0 26.4 8.9 15.1 20.2 6.8 13.3 14.2 3.7 12.9 6.4 9.2 6.0 4.0 30.0 18.0 6.4 14.5 19.6 23.2 7.4 8.9 18.0 13.1 5.6 32.1 9.7 25.7 17.1 24.9 58.6 19.1 10.3 16.2 23.9 UQCRH "QCR6, UQCR8" ENSG00000173660 "Ubiquinol-cytochrome c reductase hinge protein" P07919 1 46303698-46316776 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2099.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042574 Supported NA NA "HPA042574: AB_10960998" "unprognostic (2.24e-2)" "unprognostic (6.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.06e-3)" "unprognostic (6.34e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (4.63e-5)" "unprognostic (1.31e-1)" "unprognostic (3.15e-2)" "unprognostic (2.56e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-3)" "unprognostic (2.07e-2)" "unprognostic (3.77e-1)" "unprognostic (5.14e-2)" "unprognostic (1.04e-1)" 216.9 161.2 425.1 202.2 427.7 418.0 243.9 438.3 537.4 178.1 439.5 437.2 400.2 155.1 217.6 295.2 122.1 136.1 1022.4 426.2 438.3 355.0 263.6 122.7 259.7 437.2 425.9 416.8 229.9 217.7 406.9 145.9 143.6 433.3 149.1 422.5 440.4 281.0 178.9 941.6 160.3 293.4 148.2 428.4 144.3 258.4 78.4 434.3 315.3 139.3 1042.4 352.5 239.8 190.5 438.6 766.7 456.4 514.3 945.2 529.0 720.3 1070.8 501.7 311.3 435.2 372.5 883.1 416.1 750.2 653.2 474.0 777.9 537.8 742.2 778.7 650.8 563.1 1262.1 1854.5 1320.9 1215.3 313.6 1832.0 508.1 810.8 466.3 706.7 363.4 643.0 622.6 907.5 1803.3 814.1 675.1 613.9 830.6 1884.9 3043.4 950.6 917.8 858.9 840.5 2386.6 974.1 1679.4 1008.3 1180.4 806.7 1519.3 1628.1 1346.7 507.4 2232.3 541.3 410.8 528.9 589.2 935.7 546.9 1230.5 1185.4 593.1 1432.2 625.9 171.5 372.6 249.0 214.4 332.7 281.9 544.6 307.8 283.6 481.5 433.1 346.2 313.0 69.3 221.4 297.8 318.2 340.7 620.8 425.1 427.7 438.3 537.4 426.2 438.3 437.2 425.9 416.8 433.3 428.4 434.3 438.6 249.6 105.8 148.5 26.4 523.3 457.8 703.8 1298.7 544.7 269.7 669.2 942.3 1897.2 479.0 505.3 393.6 166.8 651.5 273.8 761.5 2099.3 479.4 65.2 239.0 321.1 293.0 502.5 453.8 49.7 350.6 816.2 285.8 452.1 341.1 283.6 432.7 355.6 612.9 724.5 102.6 53.9 1148.6 612.3 711.1 410.1 69.1 308.8 516.2 489.2 12.2 606.2 408.1 365.6 22.1 22.2 419.9 789.0 284.4 703.3 710.0 944.4 1521.9 213.3 454.0 328.7 358.3 372.6 184.3 337.8 935.4 526.9 650.2 318.0 396.5 1298.2 866.4 TAS1R1 "GPR70, T1R1, TR1" ENSG00000173662 "Taste 1 receptor member 1" Q7RTX1 1 6555307-6579755 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 4.4" "Group enriched" "Detected in some" 6 "Early spermatids: 6.1;Late spermatids: 18.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;Hep G2: 1.6;LHCN-M2: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034579, HPA034580" Approved NA NA "HPA034579: AB_2674232, HPA034580: AB_10671504" "unprognostic (2.03e-2)" "unprognostic (9.29e-3)" "unprognostic (5.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (4.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.53e-4)" "unprognostic (3.89e-2)" "unprognostic (3.15e-1)" "unprognostic (3.26e-2)" "unprognostic (3.17e-1)" "unprognostic (5.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.26e-2)" "unprognostic (8.28e-2)" "unprognostic (6.22e-2)" 0.1 0.3 0.3 0.1 0.2 0.6 0.1 0.2 0.4 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.0 0.1 0.3 0.1 0.3 0.3 0.1 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.8 0.0 0.2 0.5 0.1 0.1 0.2 0.6 0.2 4.4 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 1.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.8 1.9 0.0 0.1 0.0 0.0 1.5 0.0 0.1 HES3 bHLHb43 ENSG00000173673 "Hes family bHLH transcription factor 3" Q5TGS1 1 6244179-6245578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 11.0" "Region enriched" "Detected in some" 30 "cerebellum: 34.8" "Low region specificity" "Detected in some" "HPA047927, HPA072697" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047927: AB_2680213, HPA072697: " "unprognostic (7.42e-2)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EIF1AX "eIF-1A, eIF-4C, EIF1A, EIF4C" ENSG00000173674 "Eukaryotic translation initiation factor 1A X-linked" P47813 X 20124525-20141838 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "unprognostic (9.69e-2)" "unprognostic (1.43e-2)" "unprognostic (1.26e-3)" "unprognostic (7.13e-3)" "unprognostic (2.22e-1)" "unprognostic (8.28e-2)" "unprognostic (1.02e-3)" "unprognostic (2.82e-2)" "unprognostic (4.73e-2)" "unprognostic (8.66e-2)" "unprognostic (2.23e-3)" "unprognostic (7.81e-2)" "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" 61.8 43.3 31.8 48.4 32.3 62.1 58.7 40.8 37.9 45.5 27.9 46.9 44.3 58.4 28.7 50.2 42.6 26.9 47.8 30.9 38.4 58.5 62.5 35.3 44.9 33.3 36.1 29.9 67.5 51.1 46.9 19.9 40.4 32.7 36.5 31.9 45.7 50.4 31.1 80.8 42.4 37.7 50.0 36.9 34.0 46.1 30.6 33.4 41.8 48.9 50.8 34.2 43.0 49.6 39.6 233.3 128.4 96.9 129.8 92.5 124.8 78.8 202.6 73.9 108.3 84.9 186.2 108.2 215.5 132.2 134.9 101.4 97.6 172.8 175.9 167.8 88.8 284.5 95.7 148.9 160.1 64.5 257.8 129.5 59.1 105.2 167.4 260.2 71.4 153.3 68.9 252.3 117.6 107.9 113.2 160.3 160.6 252.1 97.5 211.0 129.8 222.3 232.0 85.1 127.7 112.1 124.9 215.0 165.8 139.0 138.8 134.6 108.0 88.3 130.8 81.6 430.8 153.6 79.9 163.3 255.7 89.5 116.1 101.2 36.3 41.0 27.4 47.8 46.5 64.1 69.0 54.4 57.2 41.2 66.4 62.6 52.8 10.7 64.5 47.1 68.1 47.6 52.6 31.8 32.3 40.8 37.9 30.9 38.4 33.3 36.1 29.9 32.7 36.9 33.4 39.6 205.4 105.8 116.7 22.2 167.5 474.9 354.9 172.6 178.2 164.0 226.5 212.2 100.2 161.5 154.5 115.8 93.8 191.4 231.5 131.6 187.9 213.6 450.5 210.5 310.1 161.2 167.2 135.2 40.5 230.4 453.8 208.6 107.6 321.9 164.0 140.7 137.4 329.9 196.3 102.6 43.2 213.5 120.1 137.9 230.1 132.2 144.1 157.3 154.7 35.6 118.2 181.3 68.0 23.6 48.0 251.0 140.1 145.2 176.7 469.7 152.2 301.4 93.2 140.4 144.7 288.6 213.9 52.9 101.1 245.4 570.1 227.0 170.5 149.6 288.5 377.0 SPDYE2B ENSG00000173678 "Speedy/RINGO cell cycle regulator family member E2B" A6NHP3 7 102650325-102661398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.2;testis: 2.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.8;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 4.1;Karpas-707: 5.4" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (2.67e-1)" "unprognostic (4.29e-1)" "unprognostic (2.29e-1)" "unprognostic (2.09e-3)" "unprognostic (2.68e-3)" "unprognostic (1.48e-1)" 0.2 0.4 0.7 0.9 0.4 1.0 0.2 0.3 0.8 0.1 0.1 0.5 0.3 0.3 0.0 0.4 0.2 0.4 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.7 0.1 0.0 0.2 0.9 0.0 0.3 0.2 1.9 0.3 0.0 0.5 0.8 0.0 3.2 0.9 1.3 0.0 0.0 0.9 0.3 2.8 0.3 0.0 0.3 0.0 0.0 0.2 0.3 1.1 1.0 1.1 0.4 0.7 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.7 0.6 1.1 0.5 0.0 0.2 1.3 0.0 0.0 0.0 0.8 0.7 0.4 4.1 0.3 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.1 5.4 0.0 0.9 0.7 1.4 0.9 0.1 0.2 1.2 0.2 1.6 0.0 0.8 1.8 1.2 2.0 1.6 0.5 1.2 0.4 0.1 0.0 1.6 1.8 1.4 0.7 0.6 0.6 1.3 1.3 1.0 0.7 0.9 0.1 0.4 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.5 0.1 0.3 0.4 0.1 0.2 0.2 0.1 0.1 0.7 0.4 0.3 0.8 0.3 0.0 0.7 0.1 0.0 1.9 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR1L1 "OR1L2, OR9-C" ENSG00000173679 "Olfactory receptor family 1 subfamily L member 1" Q8NH94 9 122661566-122662648 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BCLAF3 CXorf23 ENSG00000173681 "BCLAF1 and THRAP3 family member 3" A2AJT9 X 19912860-19970298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 17.0;Granulosa cells: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027215 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027215: AB_1847358" "unprognostic (2.46e-1)" "unprognostic (1.96e-1)" "unprognostic (3.15e-1)" "unprognostic (2.24e-1)" "unprognostic (2.27e-2)" "unprognostic (2.48e-2)" "unprognostic (3.72e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (1.43e-1)" "unprognostic (4.83e-2)" "unprognostic (2.03e-2)" "unprognostic (2.21e-1)" "unprognostic (9.38e-2)" "unprognostic (2.30e-2)" "prognostic favorable (5.56e-4)" 4.2 3.0 3.9 3.8 4.1 3.6 5.2 9.7 4.2 4.6 2.2 5.3 3.4 5.5 8.3 3.5 4.1 4.3 3.5 4.3 3.1 4.3 2.7 4.5 4.4 4.1 4.1 2.8 5.0 3.5 5.7 3.4 3.3 4.8 5.0 5.9 6.5 3.4 5.2 4.5 6.0 4.4 4.0 2.8 4.1 4.0 2.6 4.7 5.4 4.8 5.2 4.2 4.2 4.2 5.2 4.8 3.8 5.1 8.7 4.5 6.3 2.8 4.4 3.7 2.8 3.9 3.4 5.0 4.9 2.6 5.2 4.9 3.5 4.6 3.3 5.3 3.2 3.7 3.1 4.3 3.4 6.3 4.4 5.3 5.7 5.0 3.1 4.2 6.5 3.2 3.9 2.3 11.5 3.2 3.6 3.1 2.9 4.5 4.5 4.8 1.3 5.1 6.7 7.3 4.7 3.1 4.8 5.6 4.6 4.5 9.5 5.5 3.9 6.0 4.7 2.3 11.4 3.3 3.6 3.0 4.0 4.0 2.4 4.1 1.8 0.3 0.6 0.4 0.4 0.5 0.4 0.3 0.4 0.2 0.8 0.3 0.4 1.5 0.4 0.4 0.7 0.2 0.1 3.9 4.1 9.7 4.2 4.3 3.1 4.1 4.1 2.8 4.8 2.8 4.7 5.2 10.8 16.0 17.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 8.8 8.1 0.0 0.0 7.4 9.2 0.0 4.5 8.9 0.0 1.9 6.1 0.0 8.2 9.4 3.4 0.0 0.0 0.0 3.6 3.5 5.0 0.0 10.9 6.3 12.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 6.1 0.0 0.0 3.6 0.0 0.0 6.2 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 4.5 3.9 7.4 0.0 0.0 PSMD1 "P112, Rpn2, S1" ENSG00000173692 "Proteasome 26S subunit, non-ATPase 1" Q99460 2 231056845-231173116 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021092, HPA036736, HPA036737" Enhanced Approved "Nucleoplasm,Actin filaments" NA NA 230000 Nucleoplasm "Actin filaments" "CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279" "unprognostic (9.32e-3)" "unprognostic (2.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (2.71e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (8.63e-12)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (3.09e-3)" "unprognostic (2.49e-1)" "unprognostic (8.91e-3)" "unprognostic (1.10e-2)" "unprognostic (6.26e-2)" "unprognostic (4.16e-2)" "unprognostic (1.70e-3)" 37.6 38.6 21.8 32.0 26.0 20.2 29.3 21.0 33.9 26.6 19.9 35.1 35.8 37.7 25.8 41.8 24.5 20.5 47.1 27.6 27.1 34.4 42.5 27.2 29.0 26.2 24.1 22.2 19.3 17.4 73.2 33.1 37.1 27.1 30.0 37.2 25.6 26.0 33.7 137.4 34.1 29.5 45.3 22.5 25.4 28.1 29.3 24.1 36.9 27.6 82.3 38.7 37.6 28.0 29.3 103.9 113.1 120.6 93.8 122.2 88.7 115.4 135.3 139.4 133.4 134.0 136.5 97.6 80.0 123.3 150.5 138.0 95.0 169.4 125.0 174.3 124.3 93.3 148.7 81.6 155.5 62.9 133.3 119.4 76.5 57.8 142.4 73.9 73.4 159.6 70.3 212.1 56.8 158.7 100.3 103.0 68.3 157.8 100.1 89.3 86.0 190.4 77.7 96.5 104.0 78.8 74.1 108.7 94.1 65.7 120.6 75.3 74.7 152.3 101.4 110.8 126.0 129.8 48.6 80.2 140.4 162.7 100.0 123.4 34.6 27.8 18.8 25.1 39.0 27.3 21.0 25.8 23.8 30.9 17.2 19.2 22.9 12.5 35.9 42.5 18.9 32.3 25.7 21.8 26.0 21.0 33.9 27.6 27.1 26.2 24.1 22.2 27.1 22.5 24.1 29.3 51.9 51.3 48.5 77.7 32.9 33.1 37.7 57.0 19.9 46.4 23.0 25.8 125.4 31.5 53.0 33.1 41.7 119.2 27.0 63.6 17.6 83.9 6.2 51.2 67.5 51.7 39.4 61.6 100.0 102.2 101.4 54.6 42.3 60.9 103.9 67.8 30.0 86.9 72.3 90.9 96.0 30.0 57.0 44.2 23.5 9.9 34.8 49.8 17.8 54.4 62.6 46.6 29.9 67.3 93.1 98.6 26.2 45.9 49.4 46.5 46.9 32.1 66.9 53.2 72.3 54.6 128.2 247.9 158.8 39.2 33.1 167.5 36.6 65.5 42.9 38.8 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989307-19122637 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 1238.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" NA NA 22000000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 3.9 0.3 0.1 0.9 0.1 0.0 2.0 0.0 1.1 1.0 0.0 0.4 0.5 1.1 1238.4 0.5 16.6 1.7 0.9 0.7 0.6 0.4 0.7 1.3 5.0 0.3 0.9 0.0 0.2 1.2 164.7 1.1 0.5 0.3 2.2 0.4 0.9 8.6 3.7 0.2 0.3 1.2 0.4 0.1 2.4 9.1 1.9 0.3 6.6 1.6 1.1 3.7 0.8 1.0 0.1 0.2 6.0 0.0 0.0 0.1 0.9 7.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.4 0.0 5.9 0.2 0.8 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 2.2 6.4 0.0 2.0 0.0 0.0 4.5 0.0 1.2 2.2 6.6 1.5 0.1 0.0 1.1 0.1 0.1 0.1 0.2 0.4 14.6 2.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.7 0.6 0.3 0.9 0.0 0.3 0.1 0.3 0.1 0.6 0.0 0.0 3.6 0.1 0.0 0.1 0.0 0.0 0.6 1.2 1.1 1.0 7.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 1.1 5.4 0.6 0.0 0.0 4.4 0.2 0.3 5.3 9.2 3.2 0.0 0.2 1.4 0.4 0.0 3.3 5.0 0.1 0.0 0.0 0.0 0.2 1.2 0.1 0.0 4.7 0.0 4.8 0.0 10.1 7.0 3.1 0.0 1.5 0.0 3.4 0.0 0.1 2.2 0.7 0.0 1.6 0.6 0.1 1.4 0.1 0.0 0.0 0.3 0.3 0.0 0.3 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 174 "testis: 178.1" "Cell type enriched" "Detected in some" 6 "Late spermatids: 5258.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018254 Enhanced NA NA "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.5 0.0 0.5 0.1 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.5 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 178.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.4 0.5 0.5 0.5 0.7 0.2 0.5 0.2 1.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 783.7 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5258.5 22.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 23.9 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC13 DRCC1 ENSG00000173702 "Mucin 13, cell surface associated" Q9H3R2 3 124905442-124953819 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 620.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 198.4;stomach cancer: 152.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "OE19: 220.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045163, HPA079663" Enhanced "Secreted to digestive system" NA NA "HPA045163: AB_10960396, HPA079663: " "unprognostic (8.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.55e-3)" "unprognostic (2.93e-1)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.48e-2)" "unprognostic (2.94e-1)" "unprognostic (5.10e-2)" "unprognostic (2.02e-1)" "unprognostic (9.64e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (2.05e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.42e-1)" 0.8 0.8 0.0 62.6 0.0 0.1 0.5 0.0 0.1 0.8 0.0 307.4 620.2 1.5 0.0 0.8 2.8 48.3 0.0 0.0 0.0 17.7 3.7 0.3 0.4 0.2 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.3 2.1 304.2 0.0 0.0 0.8 0.0 0.2 507.9 11.0 0.0 0.1 35.7 0.3 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.1 6.4 13.6 0.0 0.8 0.2 0.1 1.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.1 0.0 0.0 1.0 0.0 220.9 1.1 0.0 0.1 2.7 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 3.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 25.8 0.8 0.0 0.0 0.0 0.0 853.2 0.0 24.7 0.9 120.0 1.5 0.4 153.8 0.0 0.1 31.4 0.0 0.0 36.7 6.1 8.9 0.0 0.0 0.0 0.0 0.0 0.2 418.5 0.0 0.3 0.0 4.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.8 641.9 0.7 0.0 1.5 422.5 7.7 10.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 1.5 0.0 207.9 1.4 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150043-33218810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA 17000000 "Golgi apparatus, Vesicles" "HPA052788: AB_2681948" "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 4.6 1.4 3.1 0.9 3.3 0.1 2.0 2.5 4.6 6.4 5.2 1.6 0.8 4.6 2.3 1.3 5.2 5.5 1.6 3.4 4.2 1.5 0.5 1.8 2.4 3.8 3.5 3.2 3.8 0.6 1.0 0.8 0.2 4.0 1.3 1.2 0.6 0.7 6.4 1.6 1.7 1.9 4.9 3.3 2.5 1.8 2.1 4.2 0.1 3.2 3.4 5.3 1.5 2.4 3.8 0.0 1.1 1.2 0.7 1.7 0.2 0.1 9.6 3.4 31.1 10.5 0.1 0.0 0.0 8.8 2.5 9.5 0.1 13.7 4.5 12.9 0.3 15.3 0.0 2.0 0.0 0.2 0.1 0.1 1.3 2.4 19.9 3.9 15.2 78.5 0.0 0.0 0.1 30.4 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.0 1.0 0.1 0.1 2.5 0.7 1.8 1.9 31.3 0.0 14.4 1.2 4.7 0.0 0.7 0.0 0.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.1 3.3 2.5 4.6 3.4 4.2 3.8 3.5 3.2 4.0 3.3 4.2 3.8 0.1 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 2.2 0.5 0.0 0.0 15.4 0.0 0.1 1.4 0.0 0.9 0.0 0.2 0.4 0.0 0.0 3.3 10.5 0.0 0.0 2.1 2.0 0.3 0.0 0.1 1.8 0.0 0.0 0.5 0.0 61.3 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 32.9 3.6 29.0 0.1 2.6 0.1 1.0 0.0 0.2 0.1 0.0 0.1 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055997 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 510000000 Vesicles "Plasma membrane" "HPA010952: AB_2668389, HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.16e-4)" 26.1 10.0 22.1 19.4 22.6 1.9 14.9 26.6 17.1 20.9 30.0 11.6 8.0 19.4 6.2 16.3 13.3 39.2 67.9 13.5 20.7 15.3 7.5 55.6 16.7 31.9 27.1 8.1 12.6 31.8 16.3 3.6 33.7 26.9 14.1 12.3 47.2 7.7 14.8 14.5 5.2 9.5 25.6 27.0 18.0 9.9 13.6 28.4 8.6 52.7 24.4 15.8 30.2 10.1 29.9 7.0 7.1 54.7 4.2 73.2 58.7 21.1 64.9 90.1 72.6 83.5 58.5 1.0 2.8 43.8 174.1 52.3 15.3 7.4 31.6 97.9 6.5 3.7 1.3 42.3 8.4 241.5 1.8 80.6 77.8 10.1 87.4 21.5 351.3 69.3 5.0 0.1 1.0 25.7 1.3 2.8 0.1 10.1 0.1 5.5 4.8 41.0 0.2 14.6 1.2 1.0 5.6 134.8 10.6 6.4 55.1 24.2 4.3 93.9 37.7 41.3 150.5 29.1 6.9 19.7 0.4 76.8 6.5 82.4 1.1 0.1 0.0 1.9 1.7 1.1 0.5 0.6 1.7 0.4 0.3 1.2 0.8 0.0 3.9 1.9 0.4 0.2 0.5 22.1 22.6 26.6 17.1 13.5 20.7 31.9 27.1 8.1 26.9 27.0 28.4 29.9 90.1 86.6 5.8 28.7 4.9 5.0 8.0 25.4 6.8 6.1 2.4 5.7 90.5 7.2 6.5 27.6 264.8 1.8 19.2 0.5 0.0 32.0 7.0 4.0 20.1 121.5 0.0 6.1 0.9 6.4 65.3 44.8 1.1 2.2 26.6 24.9 130.3 3.5 6.8 1.7 14.9 0.5 4.1 18.4 7.3 9.4 5.0 7.1 7.2 92.8 4.0 6.0 35.0 13.0 57.6 6.4 0.1 13.9 8.6 5.2 0.8 1.3 1.0 66.8 0.0 24.0 28.7 1.0 1.1 2.7 4.4 3.3 14.2 3.1 0.1 1.3 WFIKKN2 "WFDC20B, WFIKKNRP" ENSG00000173714 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2" Q8TEU8 17 50834650-50842353 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "choroid plexus: 472.1;ovary: 147.4" "Group enriched" "Detected in some" 11 "Leydig cells: 9.0;Peritubular cells: 24.0" "Group enriched" "Detected in some" 5 "glioma: 0.7;testis cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "medulla oblongata: 12.6;midbrain: 5.1;thalamus: 6.1" "Secreted in other tissues" NA NA 4500000 "unprognostic (7.31e-2)" "unprognostic (7.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.80e-2)" "unprognostic (3.46e-2)" "unprognostic (5.72e-2)" "unprognostic (5.42e-3)" "unprognostic (2.54e-3)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (1.42e-3)" "unprognostic (2.17e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-1)" 0.0 1.3 2.4 0.0 1.6 0.0 0.1 5.0 3.6 0.3 472.1 0.7 0.0 1.1 0.5 0.2 0.8 0.2 0.5 9.0 1.2 0.0 0.0 0.2 0.0 1.4 2.2 0.6 147.4 0.3 0.0 2.2 0.0 3.8 0.4 0.0 0.3 0.1 0.6 2.2 0.9 0.2 0.3 0.7 0.0 0.2 2.4 5.2 0.5 0.0 1.0 0.0 0.1 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.6 5.0 3.6 9.0 1.2 1.4 2.2 0.6 3.8 0.7 5.2 1.6 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.0 0.1 0.0 0.0 0.0 1.5 0.0 0.5 0.1 0.0 0.0 24.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 C11orf80 "FLJ22531, TOPOVIBL" ENSG00000173715 "Chromosome 11 open reading frame 80" Q8N6T0 11 66744451-66843516 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 41.4" "Cell type enhanced" "Detected in many" "Early spermatids: 66.0;Excitatory neurons: 101.2;Inhibitory neurons: 73.8;Late spermatids: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038932, HPA038933" Approved Approved Centrosome NA NA Centrosome "HPA038932: AB_2676275, HPA038933: AB_10671867" "unprognostic (2.81e-1)" "unprognostic (4.39e-2)" "unprognostic (1.71e-2)" "unprognostic (6.69e-2)" "unprognostic (3.30e-1)" "unprognostic (2.09e-1)" "unprognostic (5.54e-3)" "unprognostic (4.16e-1)" "unprognostic (4.26e-2)" "unprognostic (6.59e-2)" "unprognostic (4.04e-2)" "unprognostic (2.53e-2)" "unprognostic (6.31e-2)" "unprognostic (1.23e-1)" "unprognostic (4.98e-1)" "unprognostic (3.72e-2)" "unprognostic (1.26e-1)" 3.7 10.9 6.0 6.0 7.1 5.5 11.2 14.5 7.9 7.7 2.2 9.4 9.1 4.1 14.1 24.0 5.5 2.9 4.3 5.5 4.7 20.4 3.2 6.1 6.8 3.1 3.1 8.1 4.1 5.9 10.2 12.3 3.3 6.1 13.9 9.4 12.3 14.5 7.1 1.2 41.4 14.3 4.4 0.5 10.0 5.7 24.0 4.5 13.1 4.3 1.4 15.1 5.1 13.5 4.8 16.1 8.7 17.1 11.7 0.9 5.3 3.2 6.8 7.9 7.8 9.8 28.7 19.5 26.4 3.8 5.8 5.2 28.8 7.8 9.8 7.7 6.9 4.5 4.7 12.0 7.3 2.1 3.2 4.7 1.4 35.0 6.1 11.0 11.9 25.2 9.6 7.7 10.0 4.7 17.9 10.8 9.7 26.9 46.4 11.6 6.5 8.1 20.4 33.6 5.8 12.8 12.6 11.2 30.0 24.2 15.1 21.3 2.0 11.7 5.5 9.9 6.0 9.9 7.2 16.2 19.1 6.2 5.5 6.9 2.2 0.8 3.0 1.8 0.4 3.6 10.7 3.3 2.6 0.5 7.4 3.5 3.0 1.6 1.5 0.9 9.1 4.1 0.7 6.0 7.1 14.5 7.9 5.5 4.7 3.1 3.1 8.1 6.1 0.5 4.5 4.8 2.8 19.2 3.6 9.8 17.0 11.6 3.2 11.9 4.6 3.6 9.4 7.6 0.5 4.3 8.0 35.0 18.8 1.7 6.0 10.7 9.8 17.0 66.0 5.0 2.1 3.0 13.8 5.7 101.2 11.7 2.3 2.5 5.6 4.4 4.5 3.2 2.2 2.7 3.3 0.0 73.8 12.4 14.2 1.0 5.2 125.5 2.5 1.3 3.6 14.0 4.3 2.0 8.2 9.5 8.5 14.6 12.1 0.4 43.6 2.8 46.2 4.1 4.8 8.7 6.6 2.3 3.0 22.0 22.9 20.4 20.0 1.5 5.9 0.8 10.3 3.2 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109341-235128837 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria NA NA Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 72.1 84.3 87.7 39.5 103.8 97.4 132.1 75.7 108.8 83.6 76.0 64.9 61.6 84.3 92.4 68.5 96.5 48.7 87.2 101.2 102.0 101.3 89.0 60.7 54.2 89.9 89.3 92.1 120.5 104.0 112.6 54.7 68.7 93.9 81.2 68.6 51.8 126.2 70.7 83.8 83.1 54.9 59.8 96.6 47.6 70.0 33.1 97.8 57.6 144.2 83.1 57.1 67.0 57.2 104.8 198.7 102.4 131.6 111.6 101.4 202.6 203.5 138.8 119.3 127.9 92.5 133.1 135.6 239.3 180.1 121.0 36.1 154.0 147.8 135.0 166.9 57.9 314.8 146.2 126.2 253.9 169.2 331.3 84.2 182.3 180.8 128.6 175.4 173.0 140.7 92.2 312.1 85.9 141.9 58.2 141.9 149.4 296.6 131.2 54.9 170.9 100.3 312.6 144.5 140.2 172.5 402.8 108.0 149.2 306.7 53.6 230.9 358.6 125.6 111.5 67.5 143.0 299.6 201.2 203.1 172.4 131.2 155.4 193.1 37.7 18.8 6.5 19.4 19.7 23.6 23.0 24.8 24.3 22.7 18.2 30.1 24.2 5.6 15.8 22.9 30.6 23.7 21.5 87.7 103.8 75.7 108.8 101.2 102.0 89.9 89.3 92.1 93.9 96.6 97.8 104.8 167.2 137.8 163.5 25.1 201.9 267.4 254.9 158.5 251.6 49.9 299.2 307.0 137.8 160.2 151.3 49.7 29.2 171.3 195.5 98.3 160.4 161.6 318.4 180.2 254.3 156.8 160.5 127.0 69.0 211.2 462.5 139.9 121.3 216.9 157.7 146.4 129.9 160.1 159.9 50.5 61.1 273.4 99.7 197.7 164.6 354.0 155.0 175.7 149.4 28.1 187.5 145.4 116.4 26.2 55.8 220.1 172.3 153.4 176.7 340.4 247.0 223.5 99.7 60.9 105.2 201.4 207.5 186.5 71.1 273.3 286.1 199.5 179.5 196.1 272.6 333.4 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 35.3" "Group enriched" "Detected in some" 151 "Early spermatids: 1207.7;Late spermatids: 851.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 41 "K-562: 5.9" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 35.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1207.7 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 851.9 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGFG1 "HRB, RAB, RIP" ENSG00000173744 "ArfGAP with FG repeats 1" P52594 2 227472152-227561217 "Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Transport" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 333.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008741 Approved Supported Vesicles NA NA 120000 Vesicles "HPA008741: AB_1850752" "unprognostic (5.76e-2)" "prognostic unfavorable (7.13e-4)" "unprognostic (8.73e-3)" "unprognostic (6.31e-3)" "prognostic favorable (6.10e-4)" "unprognostic (9.30e-3)" "prognostic unfavorable (7.31e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (2.03e-2)" "unprognostic (5.78e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (1.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-1)" "unprognostic (4.24e-3)" 68.0 39.7 30.6 48.8 31.7 157.0 51.5 28.6 36.3 25.4 24.7 32.5 43.8 25.9 20.2 47.6 27.5 39.3 36.5 30.5 33.2 32.9 36.5 55.0 47.5 33.5 29.4 28.7 26.3 35.3 41.9 18.1 76.5 31.6 21.2 33.4 48.1 28.1 23.6 34.2 35.8 36.5 39.7 36.1 46.9 33.5 93.6 32.9 49.0 34.6 38.9 53.7 66.3 32.5 46.6 60.5 97.9 50.8 49.6 84.8 62.1 191.6 78.4 74.6 92.0 81.2 77.4 67.6 42.7 58.3 86.8 123.8 62.2 87.9 101.7 118.6 72.3 48.9 94.1 80.8 144.3 90.9 64.7 57.0 38.3 106.4 116.7 109.5 70.3 93.7 43.3 100.3 112.0 111.8 85.8 77.8 58.0 79.3 80.4 50.4 70.8 83.6 30.3 91.7 81.5 47.0 36.7 64.1 82.5 74.7 87.6 35.3 72.4 92.7 78.8 63.0 114.7 70.0 64.5 46.9 59.6 85.6 54.4 92.5 4.1 5.3 1.9 1.6 4.3 3.2 2.0 1.8 1.5 3.3 3.5 1.5 2.8 5.6 1.1 4.2 2.3 2.3 1.6 30.6 31.7 28.6 36.3 30.5 33.2 33.5 29.4 28.7 31.6 36.1 32.9 46.6 36.6 25.6 23.6 45.7 27.2 33.1 37.5 18.0 18.2 37.7 29.3 22.1 23.3 17.2 19.6 22.0 25.0 31.0 26.5 28.2 15.6 17.5 162.3 32.7 34.9 29.1 34.1 13.3 114.2 21.5 17.5 26.8 39.8 65.8 12.7 30.4 23.6 22.9 24.1 43.7 74.9 20.4 12.2 92.8 33.6 333.2 15.5 67.3 19.6 119.9 48.4 43.3 19.6 109.6 116.0 32.6 18.0 11.7 22.7 39.4 31.3 27.4 15.5 35.4 19.7 83.8 21.7 72.6 18.4 25.0 32.1 39.7 24.0 20.6 22.2 57.9 STAT5B ENSG00000173757 "Signal transducer and activator of transcription 5B" P51692 17 42199177-42276707 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 100.5;Late spermatids: 188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 121.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004298, CAB005418, HPA042128, HPA049883, HPA051156" Approved Approved Cytosol NA NA Cytosol "CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366" "unprognostic (1.49e-1)" "unprognostic (3.60e-2)" "unprognostic (4.06e-2)" "prognostic favorable (9.37e-4)" "unprognostic (2.68e-1)" "unprognostic (4.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.03e-1)" "unprognostic (3.06e-2)" "unprognostic (7.98e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.36e-1)" "prognostic favorable (2.39e-5)" "unprognostic (9.19e-2)" "unprognostic (2.95e-1)" "unprognostic (1.54e-1)" "unprognostic (2.13e-1)" 46.3 46.1 28.2 35.5 25.3 42.8 37.0 32.5 26.9 42.5 24.6 38.3 15.0 59.6 19.5 19.4 51.2 23.8 24.0 22.8 38.2 24.3 24.6 32.8 44.0 32.3 30.8 22.2 56.3 23.0 21.3 41.2 31.8 30.0 29.4 17.2 18.8 23.0 34.5 74.0 24.9 31.0 43.1 26.5 42.6 27.8 23.7 42.5 38.0 22.8 46.9 35.0 43.7 31.8 27.1 15.0 22.9 33.3 9.0 40.6 20.4 15.9 15.0 26.5 21.0 18.2 10.1 12.3 48.1 21.8 17.2 41.3 18.7 19.9 13.0 16.6 121.8 23.0 47.1 44.5 15.6 22.3 20.9 72.7 25.1 19.6 15.9 19.9 18.0 33.6 31.9 86.5 10.1 8.8 14.6 99.2 54.9 8.3 34.3 0.2 42.0 20.9 16.8 13.3 23.5 24.5 14.4 27.3 34.4 21.2 7.4 24.3 24.3 26.0 29.2 10.2 15.2 21.2 19.8 9.8 23.9 11.6 21.7 15.5 11.5 3.3 5.9 6.6 3.0 7.1 2.9 9.3 7.6 2.9 2.9 6.5 5.5 22.5 4.2 3.7 2.1 8.4 4.7 28.2 25.3 32.5 26.9 22.8 38.2 32.3 30.8 22.2 30.0 26.5 42.5 27.1 30.2 6.4 19.5 41.8 12.9 8.9 5.7 4.5 2.8 21.2 25.1 22.7 20.7 5.7 7.8 3.7 20.9 8.0 31.2 8.4 5.9 8.2 100.5 10.1 22.4 26.0 10.2 12.4 23.7 11.8 6.1 18.8 13.3 15.0 16.4 16.1 20.0 11.2 9.4 10.1 61.2 6.1 8.2 13.3 17.1 188.5 47.2 16.9 10.6 51.5 23.7 9.5 26.8 69.4 60.8 12.2 6.2 74.4 13.6 11.9 7.9 9.8 6.3 13.3 39.5 20.0 23.0 4.3 7.3 5.9 9.8 12.7 34.4 15.5 7.5 7.7 CD7 "GP40, LEU-9, Tp40, TP41" ENSG00000173762 "CD7 molecule" P09564 17 82314868-82317608 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.8;lymphoid tissue: 54.2" "Group enriched" "Detected in many" 9 "dendritic cells: 625.0;NK-cells: 1299.7;T-cells: 527.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 231.5" "Group enriched" "Detected in many" 22 "NK-cells: 231.5;T-cells: 71.5" "Cell line enhanced" "Detected in some" "Hep G2: 52.0;JURKAT: 26.7;MOLT-4: 119.2" "Region enhanced" "Detected in some" "cerebral cortex: 3.2" "Not detected" "Not detected" "CAB002594, HPA039079" Enhanced NA NA "CAB002594: , HPA039079: AB_2676337" "unprognostic (3.14e-3)" "prognostic favorable (5.51e-4)" "unprognostic (1.89e-2)" "prognostic favorable (2.03e-5)" "unprognostic (7.69e-3)" "unprognostic (1.09e-3)" "unprognostic (3.28e-2)" "unprognostic (1.34e-1)" "prognostic favorable (2.69e-4)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.75e-11)" "unprognostic (4.69e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (1.55e-3)" 5.3 1.3 0.6 33.2 0.7 28.8 2.6 0.7 1.2 2.3 1.4 5.7 12.5 3.0 0.4 4.0 3.9 3.2 1.6 0.5 0.9 3.7 7.8 17.3 37.1 1.4 1.0 0.4 0.9 1.2 0.1 1.4 3.3 1.1 4.4 1.9 0.0 3.1 1.0 0.8 1.6 21.3 1.1 1.1 54.2 8.2 0.6 1.2 49.2 3.6 0.1 14.9 3.9 3.9 1.1 0.0 0.0 0.0 0.0 0.1 0.4 12.9 0.0 0.2 0.1 0.2 0.6 0.1 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.7 52.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 26.7 0.1 0.0 0.1 0.0 119.2 0.0 0.0 0.0 0.2 0.1 0.1 2.3 0.2 0.0 0.4 0.3 1.8 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.3 1.0 0.0 1.2 0.2 0.0 0.2 0.0 0.0 0.5 0.4 0.5 66.6 0.2 57.6 0.4 29.8 49.0 0.3 0.2 69.4 71.5 2.3 231.5 0.6 6.9 28.7 30.9 0.6 0.7 0.7 1.2 0.5 0.9 1.4 1.0 0.4 1.1 1.1 1.2 1.1 5.3 0.0 0.0 0.0 12.1 7.5 0.6 0.1 1.8 0.0 4.2 3.7 0.5 4.3 0.3 0.0 0.0 0.7 625.0 9.4 0.0 1.3 0.1 2.8 2.0 4.5 0.0 47.7 0.0 0.5 10.3 12.4 43.8 5.3 8.2 0.0 16.8 3.3 3.6 1.7 0.0 1.5 0.0 18.5 8.8 0.0 0.0 19.2 12.4 0.0 11.6 0.0 1299.7 0.0 0.0 0.1 5.8 0.0 82.7 3.8 8.1 1.4 0.5 0.0 0.0 0.5 3.9 0.0 1.3 1.0 4.4 1.9 527.4 0.0 2.1 3.8 TOPAZ1 "C3orf77, FLJ36157" ENSG00000173769 "Testis and ovary specific PAZ domain containing 1" Q8N9V7 3 44241886-44332098 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 3.5" "Group enriched" "Detected in some" 5 "Spermatocytes: 122.4;Spermatogonia: 75.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047431, HPA051034" Uncertain NA NA "HPA047431: AB_2680045, HPA051034: AB_2681318" "unprognostic (1.68e-1)" "unprognostic (8.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 19.7 0.0 0.0 122.4 75.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNP ENSG00000173786 "2',3'-cyclic nucleotide 3' phosphodiesterase" P09543 17 41966763-41977740 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 1435.7" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 555.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 149.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Region enriched" "Detected in all" 4 "white matter: 1789.4" "Low region specificity" "Detected in all" "CAB002672, HPA023266, HPA023278, HPA023280, HPA023338" Enhanced Supported Supported "Plasma membrane" NA NA 46000 "Plasma membrane" "CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062" "unprognostic (2.17e-1)" "unprognostic (4.48e-2)" "unprognostic (3.85e-3)" "unprognostic (1.41e-1)" "unprognostic (3.09e-1)" "unprognostic (9.71e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.87e-1)" "unprognostic (2.99e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (8.86e-2)" "unprognostic (1.10e-3)" 32.2 33.8 516.4 31.5 867.4 23.6 29.8 717.0 656.9 38.7 236.8 46.4 21.6 33.8 37.0 63.9 29.2 32.9 24.6 510.3 646.1 42.9 45.2 21.9 36.0 983.4 801.8 404.4 32.5 28.1 23.9 28.3 23.7 889.5 41.9 18.6 20.7 47.6 37.5 26.6 34.6 31.7 30.5 735.6 26.0 30.1 16.8 717.3 31.4 24.9 22.4 35.4 37.6 40.8 1435.7 56.9 92.4 85.8 106.6 71.7 67.2 38.5 70.1 102.5 171.1 191.5 73.0 49.6 59.0 54.3 88.5 88.1 95.0 58.3 44.6 59.0 59.7 76.8 56.7 59.3 127.7 76.9 56.7 49.6 111.0 31.5 94.1 22.8 61.9 79.4 58.0 42.4 46.4 60.6 35.1 148.5 50.9 20.7 29.8 66.5 91.4 126.7 58.7 45.7 55.7 50.9 69.5 85.7 127.0 155.5 41.6 57.2 82.3 80.2 66.6 73.7 92.3 81.9 53.4 66.6 47.5 66.1 42.9 266.4 18.7 38.2 23.4 21.5 40.7 17.2 28.0 18.8 17.4 33.8 19.2 16.6 19.6 7.7 23.5 34.0 149.4 22.4 33.0 516.4 867.4 717.0 656.9 510.3 646.1 983.4 801.8 404.4 889.5 735.6 717.3 1435.7 26.6 16.0 12.7 14.4 19.0 16.7 17.5 10.4 16.5 22.0 29.5 24.0 13.0 20.0 19.5 35.0 6.2 30.6 53.2 39.9 125.2 46.3 1.3 19.1 27.1 24.8 19.7 25.2 6.8 41.7 50.2 27.7 17.9 21.3 9.5 20.2 20.3 32.3 39.8 50.5 9.5 16.2 18.3 17.0 14.5 4.0 38.8 20.3 55.2 14.0 25.0 84.7 23.7 45.2 555.6 35.5 19.0 36.1 27.8 21.7 19.0 80.5 12.8 25.4 32.9 36.6 29.4 5.1 16.0 30.9 18.9 13.0 16.9 33.3 20.6 17.4 JUP "CTNNG, DP3, DPIII, PDGB, PKGB" ENSG00000173801 "Junction plakoglobin" P14923 17 41754604-41786931 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 959.9;skin 1: 915.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 1090.1;OE19: 3919.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002139, HPA032047" Supported Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 64000000 "Plasma membrane, Cell Junctions" Vesicles "CAB002139: AB_563468, HPA032047: AB_2674124" "unprognostic (3.96e-3)" "unprognostic (3.40e-1)" "unprognostic (2.32e-1)" "unprognostic (4.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (8.11e-3)" "unprognostic (1.41e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-3)" "unprognostic (9.60e-2)" "prognostic favorable (2.06e-10)" "unprognostic (2.50e-1)" "unprognostic (9.49e-2)" "unprognostic (9.05e-2)" "unprognostic (1.51e-2)" 41.3 16.2 11.7 23.8 19.1 20.9 69.2 19.3 16.4 136.8 22.3 85.1 88.9 57.5 15.4 959.9 70.6 40.2 132.2 12.5 48.6 111.7 71.5 57.6 15.9 20.3 15.2 11.4 46.6 60.1 20.0 37.6 51.9 18.8 68.5 49.4 4.8 228.2 42.2 111.8 915.2 96.5 23.3 13.6 22.9 87.1 12.5 14.2 29.9 87.1 62.7 92.8 69.4 436.2 32.4 268.8 217.8 21.7 18.5 0.2 0.1 330.6 15.3 89.2 5.9 5.2 332.6 289.0 5.4 157.8 9.7 7.5 1090.1 31.6 242.4 1.0 0.6 74.2 11.6 165.1 74.4 34.7 7.3 113.6 0.5 538.6 0.9 43.9 64.2 96.1 7.0 99.6 94.0 0.0 342.6 1.9 96.5 42.3 3919.9 36.2 313.5 0.2 202.5 165.8 674.0 52.2 38.6 33.8 652.1 1.9 98.6 545.9 8.0 152.4 0.3 14.8 6.8 5.1 8.2 31.2 5.5 1.5 12.7 2.6 3.9 13.1 28.7 0.0 22.6 0.0 13.5 0.0 0.2 14.5 11.7 0.2 0.1 0.6 0.8 43.8 4.5 0.1 5.7 11.7 19.1 19.3 16.4 12.5 48.6 20.3 15.2 11.4 18.8 13.6 14.2 32.4 56.9 60.9 36.8 4.6 10.6 196.9 218.5 104.5 100.2 1.9 87.3 77.0 87.8 48.6 80.9 132.4 4.2 98.9 1.1 315.9 27.4 212.2 28.5 112.6 21.1 55.2 66.8 3.4 0.5 135.4 167.3 25.6 136.1 247.0 11.4 16.5 41.4 34.1 14.4 0.0 1.6 125.0 81.4 7.7 32.7 8.3 5.0 10.9 12.4 2.8 6.3 18.2 0.0 7.1 13.6 356.2 223.7 0.0 3.9 220.1 141.1 35.6 45.7 4.3 6.6 37.4 18.8 2.5 4.5 318.3 383.3 185.7 6.1 3.2 129.2 301.6 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 53.1" "Cell type enriched" "Detected in many" 4 "Glandular and luminal cells: 66.5" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "REH: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023394, HPA076992" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA023394: AB_1850492, HPA076992: AB_2686822" "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.3 1.5 27.3 0.3 18.5 0.1 1.0 14.2 21.8 10.3 9.6 1.7 2.8 3.5 1.6 1.1 2.6 1.5 0.0 17.8 42.2 1.9 0.4 1.0 0.2 26.3 21.8 16.1 1.2 1.0 0.0 11.6 1.5 23.1 1.9 0.5 0.8 1.5 1.3 0.2 1.3 1.5 0.6 20.1 3.5 11.1 2.2 53.1 2.8 5.1 0.1 0.2 0.5 1.9 26.4 0.2 3.1 1.4 3.1 0.0 0.0 0.3 0.3 0.1 0.6 0.1 1.9 0.2 0.2 1.1 0.2 0.5 13.1 6.7 0.5 0.0 0.0 3.4 0.0 1.8 0.1 0.3 0.0 0.6 0.0 1.6 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.2 1.6 18.7 0.8 96.0 0.0 3.7 0.6 1.0 0.4 0.1 0.7 0.4 0.1 1.5 2.4 0.0 0.0 0.0 1.3 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 27.3 18.5 14.2 21.8 17.8 42.2 26.3 21.8 16.1 23.1 20.1 53.1 26.4 1.1 0.0 1.7 3.3 0.3 3.1 7.3 1.0 6.8 1.6 1.6 6.7 3.6 0.0 1.9 0.0 2.1 1.5 0.5 1.1 0.0 0.3 0.5 11.5 7.6 3.2 0.0 0.0 1.0 0.9 0.7 3.4 7.7 66.5 0.0 0.2 1.4 0.8 0.5 0.0 5.4 0.6 4.1 0.6 2.2 0.6 0.3 1.2 0.0 0.0 0.4 0.6 2.1 14.6 0.3 1.5 0.2 0.7 0.3 5.3 0.2 0.2 1.7 1.8 0.0 10.6 2.3 0.1 4.7 8.4 3.1 15.7 0.9 0.1 1.1 3.5 TDRD12 "ECAT8, FLJ13072" ENSG00000173809 "Tudor domain containing 12" Q587J7 19 32719753-32829580 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "epididymis: 7.4;testis: 16.9" "Cell type enhanced" "Detected in some" "Early spermatids: 24.0;Late spermatids: 12.0;Spermatocytes: 65.0;Spermatogonia: 43.5" "Cancer enriched" "Detected in many" 9 "testis cancer: 10.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HDLM-2: 25.5;NTERA-2: 81.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.43e-2)" "unprognostic (3.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.87e-7)" "unprognostic (5.44e-2)" "unprognostic (1.78e-1)" "unprognostic (6.79e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.40e-1)" "unprognostic (9.69e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-4)" "unprognostic (2.09e-1)" "unprognostic (4.75e-2)" "unprognostic (3.08e-2)" "unprognostic (2.69e-2)" 0.2 0.8 0.2 0.1 0.2 0.1 0.2 0.2 0.3 0.7 0.0 0.1 0.0 1.1 7.4 0.3 0.8 0.1 0.1 0.2 0.5 0.1 0.0 0.1 0.2 0.5 0.2 0.0 1.6 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.4 0.1 0.3 0.1 1.7 1.3 0.1 0.1 0.3 0.1 16.9 0.6 0.5 0.5 0.0 0.2 0.2 0.2 0.2 0.0 1.1 0.2 1.3 0.1 0.1 1.7 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 25.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.0 81.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.1 0.0 0.0 0.4 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.5 0.5 0.2 0.0 0.2 0.1 0.6 0.2 0.3 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.4 0.6 0.3 0.9 0.0 0.0 1.8 0.0 0.4 0.2 0.1 0.0 0.0 24.0 0.3 1.2 0.4 0.0 0.0 2.2 0.0 1.3 0.2 0.0 1.1 0.0 0.2 0.4 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.3 12.0 2.1 0.1 0.0 1.0 0.0 0.2 0.0 0.0 1.4 0.1 0.2 1.5 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.4 0.3 65.0 43.5 0.0 0.1 0.3 0.2 2.9 0.4 0.2 EIF1 "A121, EIF-1, EIF1A, ISO1, SUI1" ENSG00000173812 "Eukaryotic translation initiation factor 1" P41567 17 41688885-41692668 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 2792.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 210000 "unprognostic (1.43e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (1.62e-1)" "unprognostic (7.13e-2)" "unprognostic (4.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.39e-1)" "unprognostic (5.01e-2)" "unprognostic (1.09e-1)" "unprognostic (4.23e-3)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (2.62e-1)" "unprognostic (3.63e-3)" 467.7 276.8 212.8 152.4 245.2 761.8 406.7 244.6 259.9 318.8 166.6 341.8 180.4 320.2 77.1 346.9 320.8 151.7 483.2 193.0 253.2 334.1 270.1 333.1 161.8 256.9 235.2 175.2 405.6 491.5 215.1 255.3 145.1 257.8 218.1 100.1 186.6 307.4 137.5 1251.3 363.1 252.5 146.0 252.8 268.8 406.8 161.2 253.5 215.3 214.3 487.2 118.5 338.0 325.6 285.5 337.2 171.6 195.0 184.8 384.8 354.8 187.7 436.7 310.0 234.8 229.0 101.2 234.3 451.1 339.9 332.1 243.6 416.3 263.7 296.2 226.3 484.8 224.2 236.8 82.7 150.2 796.8 379.4 452.6 430.2 561.0 320.0 779.6 344.4 233.5 354.9 383.9 674.5 223.1 92.7 447.8 239.5 167.9 2792.4 326.7 224.6 419.6 453.7 207.4 157.9 240.4 307.6 263.5 485.0 1017.9 185.0 342.5 273.6 370.0 230.8 354.5 483.5 441.4 993.5 895.6 358.8 326.5 235.0 296.7 1141.9 365.4 462.9 250.5 438.7 310.3 328.3 337.8 293.8 293.8 309.3 347.0 306.8 358.7 220.9 455.7 291.3 428.9 590.8 212.8 245.2 244.6 259.9 193.0 253.2 256.9 235.2 175.2 257.8 252.8 253.5 285.5 3115.6 810.9 974.8 63.0 2362.0 3078.5 4610.8 3421.0 1812.6 838.1 1828.6 2567.4 1099.6 1512.7 1918.4 776.1 310.6 1507.4 2857.7 1521.7 4188.9 2108.4 2701.8 1405.1 1228.6 2033.0 963.1 1790.4 66.7 3096.1 2381.2 2059.4 889.4 1606.5 1287.6 948.4 1680.6 1403.6 2488.3 804.2 70.2 1539.7 2063.0 3165.8 3449.2 6637.8 1358.8 2644.2 2440.4 85.3 3560.1 1514.7 1829.0 35.2 153.8 2423.6 2131.0 961.4 1762.7 3063.8 3025.9 3169.3 1107.9 958.4 959.8 3290.6 3039.9 1114.0 825.4 1521.7 2932.9 3955.5 2533.0 1059.7 1428.5 5190.4 ENDOV FLJ35220 ENSG00000173818 "Endonuclease V" Q8N8Q3 17 80415165-80438086 "Predicted intracellular proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (4.24e-5)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.40e-4)" "unprognostic (1.27e-1)" "unprognostic (2.08e-1)" "unprognostic (9.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (7.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.10e-2)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (3.09e-3)" 8.6 8.4 11.2 5.5 10.9 5.0 10.2 12.1 13.3 13.3 7.6 10.1 6.4 11.2 11.7 9.3 11.7 6.5 6.3 11.1 9.1 15.5 15.1 9.8 5.3 9.3 9.1 10.4 10.6 10.6 5.9 9.4 4.3 10.1 13.1 4.7 26.5 10.5 6.6 12.7 14.3 9.2 5.1 7.6 13.6 9.6 24.0 9.5 5.3 9.2 5.6 3.8 9.4 10.6 10.6 18.9 25.2 7.9 13.3 13.2 12.2 7.2 8.2 9.1 4.8 10.5 5.8 21.4 0.9 4.7 8.7 13.6 12.2 2.1 3.8 3.9 8.8 18.7 1.8 8.8 10.0 13.6 2.8 3.8 13.5 8.5 9.4 9.5 11.2 8.1 13.1 2.9 15.8 4.0 36.2 5.4 4.4 8.6 11.7 20.3 6.2 7.8 11.1 10.7 9.0 8.6 28.0 9.6 9.3 23.9 9.2 33.4 24.2 8.2 33.5 17.8 22.8 3.6 19.7 3.6 2.0 18.1 7.6 6.4 15.2 12.5 11.0 4.8 12.9 6.0 11.8 5.2 5.1 20.1 18.6 4.4 5.4 8.3 9.5 5.8 26.5 5.6 6.5 11.2 10.9 12.1 13.3 11.1 9.1 9.3 9.1 10.4 10.1 7.6 9.5 10.6 15.8 16.0 13.4 13.7 18.1 11.6 23.8 28.0 6.2 35.1 21.7 18.5 7.9 24.3 18.7 27.6 79.2 18.8 22.1 38.2 29.4 26.7 15.3 15.6 15.0 21.9 29.9 3.0 11.5 19.6 13.2 15.9 29.0 12.9 8.9 43.6 27.8 13.5 12.9 37.0 10.8 26.6 26.4 23.6 17.1 15.0 30.1 14.8 14.2 2.8 23.6 28.4 17.5 7.5 11.9 22.4 22.6 21.4 8.2 21.9 59.4 28.9 26.3 87.9 39.5 21.3 18.0 46.3 49.5 9.7 15.2 23.4 14.9 29.9 27.7 19.4 RNF213 "ALO17, C17orf27, KIAA1554, KIAA1618, MYMY2, NET57" ENSG00000173821 "Ring finger protein 213" Q63HN8 17 80260866-80398786 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Ubl conjugation pathway" "Hydrolase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 396.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003347, HPA026790" Approved Supported Cytosol NA NA 3500 Cytosol "HPA003347: AB_1079204, HPA026790: AB_10602296" "unprognostic (8.98e-2)" "unprognostic (1.60e-1)" "unprognostic (8.97e-3)" "prognostic unfavorable (4.65e-5)" "unprognostic (7.39e-2)" "unprognostic (3.99e-2)" "unprognostic (2.23e-2)" "unprognostic (1.52e-1)" "unprognostic (4.57e-2)" "unprognostic (3.85e-1)" "unprognostic (1.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-3)" "unprognostic (8.92e-2)" "unprognostic (1.13e-2)" "unprognostic (1.40e-1)" "unprognostic (4.56e-2)" 7.4 10.0 6.8 18.8 11.3 25.9 7.0 8.3 9.1 8.1 12.6 9.0 8.8 7.9 8.8 7.2 8.7 10.7 6.6 3.4 12.9 10.4 6.2 13.3 18.1 17.0 10.1 1.8 9.0 7.8 34.4 6.6 10.1 14.5 7.1 7.9 12.2 10.9 6.9 6.7 8.9 10.7 9.2 10.2 18.9 11.2 3.5 12.6 20.3 11.1 7.6 14.6 11.1 7.1 22.7 40.1 69.7 6.9 4.9 24.4 37.0 5.1 9.9 21.4 43.7 37.1 7.5 18.1 2.6 8.3 20.8 46.6 22.7 9.3 12.9 14.7 90.8 4.3 6.3 29.9 13.3 10.5 6.7 6.2 20.5 8.6 24.6 10.6 13.7 34.3 28.3 11.8 14.5 16.5 9.7 26.7 2.8 5.1 7.5 16.0 18.0 15.9 3.1 12.1 34.1 6.6 9.2 24.1 50.3 17.3 15.3 11.6 8.2 44.5 24.2 19.0 14.4 10.3 6.3 6.3 7.0 18.2 7.6 8.9 19.5 20.8 10.4 26.2 18.5 17.5 15.3 18.6 21.6 5.4 15.5 14.6 18.2 84.5 26.1 17.1 32.0 15.4 4.8 6.8 11.3 8.3 9.1 3.4 12.9 17.0 10.1 1.8 14.5 10.2 12.6 22.7 76.1 89.8 56.9 56.8 89.9 35.8 37.2 39.2 43.3 21.2 59.9 41.7 32.6 75.8 50.3 101.2 50.1 21.0 240.8 117.4 13.7 120.3 1.4 58.7 58.9 90.7 46.0 30.3 23.6 162.4 31.5 50.8 158.0 93.4 46.7 140.7 74.3 56.4 98.0 23.5 15.5 68.2 32.6 136.5 94.9 3.7 60.9 128.9 30.2 87.1 194.6 26.1 396.5 32.2 70.4 166.1 76.2 51.6 167.6 100.8 116.3 92.2 66.2 68.5 65.7 52.3 53.7 1.4 8.2 43.0 34.4 21.8 211.6 84.7 54.9 66.5 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354751-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;intestine: 2.5;testis: 5.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 9.6;Spermatocytes: 40.5;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basophil: 7.7;eosinophil: 10.9;neutrophil: 17.5" "Lineage enriched" "Detected in many" 11 "granulocytes: 17.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.2 1.0 0.2 1.4 0.5 0.1 2.5 2.1 0.1 0.4 0.1 0.8 0.1 0.2 0.2 0.1 0.1 0.3 1.2 1.1 0.3 0.2 0.2 0.4 1.0 1.4 1.1 0.3 0.5 0.4 1.2 0.1 1.4 0.2 0.1 0.9 0.3 0.1 0.2 0.1 2.5 0.0 0.9 1.0 0.3 5.1 1.0 1.3 0.1 0.3 0.2 0.1 0.1 1.1 0.8 1.6 1.3 3.5 0.0 0.0 0.5 0.0 0.1 0.3 0.4 1.2 0.2 0.6 0.5 0.1 0.6 0.8 1.3 0.0 0.1 1.1 1.4 0.2 0.9 2.8 0.0 0.5 2.6 0.0 0.1 0.1 0.0 0.0 0.2 1.3 0.9 1.8 0.0 2.1 1.7 1.1 0.7 0.7 0.6 2.5 0.6 2.4 0.0 0.8 3.9 2.4 1.0 1.5 0.6 0.1 2.5 0.8 0.0 0.1 0.6 0.9 0.6 3.7 2.5 0.8 0.0 1.1 0.4 7.7 0.6 10.9 0.0 0.3 0.0 0.4 0.0 0.0 1.0 0.2 0.2 0.0 17.5 0.1 1.5 1.5 0.0 0.2 1.0 1.4 2.5 2.1 1.2 1.1 1.0 1.4 1.1 1.4 0.9 1.0 1.1 1.0 0.0 1.1 0.7 4.5 1.5 0.4 0.5 5.7 4.0 1.7 0.9 2.6 0.0 0.3 0.0 0.0 0.4 4.0 0.4 0.0 1.1 4.3 1.0 0.3 0.6 0.0 2.7 0.7 0.6 0.3 0.4 1.1 1.1 0.0 2.9 0.0 0.4 0.3 0.0 1.0 0.6 0.0 0.6 5.7 2.2 0.0 1.3 1.8 1.0 1.9 1.1 0.0 1.0 0.4 0.4 0.1 0.4 3.0 0.8 9.6 0.9 0.6 3.4 0.0 1.2 0.8 40.5 13.5 3.5 1.6 0.8 1.0 0.7 1.1 0.1 KCNH6 "erg2, HERG2, Kv11.2" ENSG00000173826 "Potassium voltage-gated channel subfamily H member 6" Q9H252 17 63523334-63548977 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.8;kidney: 6.8;pituitary gland: 5.4;prostate: 3.9;retina: 4.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 44.8;Cardiomyocytes: 25.6;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 34.6;Proximal enterocytes: 40.3;Proximal tubular cells: 14.1" "Cancer enhanced" "Detected in some" "prostate cancer: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 3.3;SH-SY5Y: 1.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "medulla oblongata: 1.1;olfactory bulb: 2.4;spinal cord: 2.5" HPA061704 Approved NA NA "HPA061704: " "unprognostic (8.00e-2)" "unprognostic (1.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.68e-2)" "unprognostic (5.98e-5)" "unprognostic (3.39e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-1)" "unprognostic (1.28e-2)" "unprognostic (3.25e-1)" "unprognostic (1.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.19e-1)" "unprognostic (9.80e-2)" "unprognostic (3.66e-1)" "unprognostic (8.05e-2)" "unprognostic (9.15e-2)" 0.0 0.1 1.4 0.0 1.0 0.2 0.0 0.9 1.1 0.0 0.3 0.2 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.3 6.8 0.0 0.3 0.0 1.6 2.1 0.7 0.0 1.3 0.0 5.4 0.1 1.6 3.9 0.2 4.5 0.0 0.0 0.1 0.1 4.8 0.0 1.0 0.1 0.8 1.2 1.5 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.9 1.1 0.6 1.3 1.6 2.1 0.7 1.6 1.0 1.5 1.6 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 44.8 0.0 0.3 25.6 0.0 0.0 0.0 31.3 0.0 0.0 0.1 0.0 0.0 3.0 0.6 0.1 1.3 34.6 0.0 1.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 3.8 0.0 0.0 0.0 3.4 0.0 0.1 1.8 0.0 0.0 1.1 0.0 0.5 0.1 0.1 1.2 0.0 0.0 1.4 40.3 14.1 0.0 3.1 0.0 0.2 1.0 0.0 0.7 0.0 0.1 0.1 0.1 0.0 0.8 0.1 MARCHF10 "FLJ35757, MARCH-X, MARCH10, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 138.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;EFO-21: 4.7;HSkMC: 2.1;SCLC-21H: 8.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.1 0.2 4.7 0.2 1.8 0.0 0.1 1.8 1.2 0.8 8.8 0.8 0.0 0.4 7.5 0.1 12.9 0.1 0.0 1.0 1.7 1.0 0.0 2.7 0.0 3.2 4.3 0.6 0.1 0.2 0.3 12.8 0.0 2.7 0.6 0.0 0.1 0.3 0.1 0.0 0.2 0.4 0.0 5.2 0.1 0.4 138.7 2.1 0.2 0.1 0.0 0.0 0.1 0.2 2.2 0.1 0.0 0.1 0.0 0.0 0.1 2.5 1.1 0.1 0.8 0.2 0.0 0.0 0.0 4.7 0.3 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.8 0.6 0.0 1.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.0 8.3 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.1 4.7 1.8 1.8 1.2 1.0 1.7 3.2 4.3 0.6 2.7 5.2 2.1 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PLK3 "CNK, FNK, PRK" ENSG00000173846 "Polo like kinase 3" Q9H4B4 1 44800377-44805990 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Paneth cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060318 Enhanced NA NA "HPA060318: AB_2684252" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" "unprognostic (3.69e-2)" "unprognostic (3.51e-3)" "unprognostic (3.09e-2)" "unprognostic (4.72e-2)" "unprognostic (1.02e-1)" "unprognostic (1.59e-1)" "unprognostic (5.12e-3)" "unprognostic (6.78e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (1.35e-1)" 11.0 6.5 3.9 10.8 3.9 13.9 9.0 4.4 4.8 7.0 7.6 4.8 3.3 8.2 2.9 19.3 7.4 17.5 6.3 3.3 9.3 5.8 7.1 13.0 9.1 9.4 6.0 2.9 6.6 9.0 7.2 7.6 6.7 6.1 5.7 2.9 0.4 6.8 3.3 2.8 16.1 6.5 4.9 5.6 7.7 5.4 2.1 5.2 5.4 7.4 2.4 5.8 18.2 8.7 7.4 7.2 4.1 6.6 3.4 4.7 15.0 12.3 15.7 20.8 5.9 5.8 2.5 9.9 8.1 6.5 12.9 18.7 6.5 3.7 21.4 3.2 13.5 0.7 9.1 2.6 6.2 22.5 2.9 11.7 11.8 12.3 17.4 16.1 20.0 17.8 3.0 4.9 3.6 13.0 4.6 6.2 2.7 4.5 4.0 5.5 7.8 4.3 13.3 20.3 2.4 5.0 3.2 4.5 8.3 17.6 10.1 0.6 2.8 23.3 3.6 9.4 7.5 9.7 9.5 4.7 2.8 8.0 5.2 7.2 0.0 4.0 1.0 1.9 5.9 2.1 1.4 11.6 4.7 5.0 1.2 12.4 5.8 4.7 0.8 6.3 2.0 14.0 4.4 3.9 3.9 4.4 4.8 3.3 9.3 9.4 6.0 2.9 6.1 5.6 5.2 7.4 55.7 12.8 35.1 1.3 32.2 44.1 60.5 23.3 32.5 7.1 58.4 33.7 3.4 32.9 15.8 5.5 2.1 19.0 32.2 77.7 0.0 18.3 0.8 41.9 27.6 43.5 53.0 2.7 3.6 13.0 22.9 36.7 109.6 67.5 78.7 12.0 32.5 6.7 36.9 6.7 6.3 53.0 2.0 37.7 60.3 0.7 9.9 72.5 12.4 10.3 9.8 7.4 1.0 1.5 2.0 24.3 116.8 5.3 31.4 25.8 47.3 3.3 14.7 10.2 26.3 58.5 30.5 2.5 4.5 37.2 33.5 59.2 65.2 17.0 46.3 58.9 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412557-5459056 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 252.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Yes Yes Nucleoplasm Vesicles "HPA020068: AB_2670348" "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 49.2 10.9 43.5 23.6 37.5 40.8 53.3 43.4 47.8 44.1 52.7 93.1 56.7 42.2 56.7 69.0 46.6 36.2 13.4 34.7 37.8 49.8 45.5 22.4 26.9 47.2 41.3 28.6 28.7 38.2 5.5 10.7 66.3 47.9 41.7 89.0 6.6 93.9 24.5 25.2 38.4 75.4 37.2 42.4 8.2 78.5 14.5 43.5 30.7 26.4 28.2 33.2 61.3 59.8 44.3 115.9 67.7 45.2 51.0 26.8 11.9 252.9 69.1 37.6 53.4 50.4 36.4 215.2 40.6 27.7 42.4 11.4 185.5 54.9 104.3 63.9 38.1 38.5 77.5 22.9 84.0 7.2 21.5 31.1 18.2 61.0 54.0 12.3 47.6 31.1 42.6 138.5 64.4 30.0 54.3 74.3 30.6 61.5 158.6 51.0 45.0 85.0 32.4 33.4 57.6 38.5 20.6 60.7 110.9 20.3 76.2 36.7 65.3 29.5 20.3 30.9 30.7 56.0 39.3 23.1 53.4 18.1 33.1 43.4 2.0 0.6 1.4 0.6 1.0 0.0 1.4 1.2 0.4 4.9 0.6 8.7 1.7 0.1 0.8 0.4 2.0 4.0 2.2 43.5 37.5 43.4 47.8 34.7 37.8 47.2 41.3 28.6 47.9 42.4 43.5 44.3 18.4 32.1 55.8 2.6 12.7 40.3 127.2 49.0 103.0 11.0 52.6 28.3 12.1 41.5 84.3 12.9 4.2 110.2 8.4 242.2 5.9 13.1 2.4 97.7 30.6 42.7 80.8 54.1 5.1 24.4 109.1 33.2 107.0 131.4 15.2 16.9 12.5 55.7 14.5 3.3 7.7 145.3 34.6 10.5 59.8 2.4 21.8 31.2 35.6 44.0 48.7 3.8 0.0 8.5 5.7 62.1 148.3 87.6 39.2 67.8 123.6 29.2 85.7 3.5 111.7 183.0 185.0 26.3 16.0 158.1 32.4 117.5 9.3 2.9 145.0 186.5 DPY19L1 KIAA0877 ENSG00000173852 "Dpy-19 like C-mannosyltransferase 1" Q2PZI1 7 34928876-35038271 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 206.2;Excitatory neurons: 132.8;Late spermatids: 72.0;Oligodendrocytes: 95.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059139 Uncertain Approved Vesicles NA NA Vesicles "HPA059139: AB_2683921" "unprognostic (4.66e-2)" "unprognostic (1.11e-3)" "unprognostic (8.53e-3)" "unprognostic (2.47e-3)" "unprognostic (2.50e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (3.57e-2)" "unprognostic (1.14e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.21e-1)" "unprognostic (1.88e-2)" "unprognostic (3.99e-1)" "unprognostic (2.69e-2)" "unprognostic (1.37e-1)" "unprognostic (4.12e-2)" 10.9 13.3 17.9 12.2 20.8 11.3 6.5 24.2 24.4 16.0 13.6 10.7 5.4 19.1 4.2 7.7 10.8 15.3 15.1 19.0 24.4 7.1 19.7 14.8 10.8 26.2 25.3 14.0 9.0 5.6 4.1 6.3 21.8 23.8 9.1 12.2 28.1 7.2 8.5 3.5 4.6 6.3 19.5 30.3 15.8 10.2 38.5 22.6 4.8 11.5 6.2 9.8 16.7 5.5 37.7 16.7 64.6 36.2 46.3 69.7 55.3 7.5 36.6 30.7 22.4 29.3 15.5 42.4 24.2 52.1 38.2 92.4 29.1 27.2 20.1 50.1 12.4 22.2 35.3 40.2 25.7 24.5 33.6 31.6 27.3 16.5 29.7 20.1 63.1 93.5 11.9 26.9 95.8 79.3 8.1 0.3 33.3 23.3 39.2 28.9 24.7 47.8 34.8 85.0 57.4 16.7 43.4 32.8 4.2 19.4 56.5 32.6 38.6 109.1 44.3 53.1 30.9 50.2 42.3 99.9 27.6 54.9 30.5 126.2 0.9 0.5 0.0 1.2 0.7 1.3 0.4 0.5 1.0 0.5 0.7 0.1 0.5 0.1 0.6 0.2 0.5 0.3 0.3 17.9 20.8 24.2 24.4 19.0 24.4 26.2 25.3 14.0 23.8 30.3 22.6 37.7 12.1 28.9 16.4 42.7 3.9 7.1 5.6 4.4 2.2 8.4 7.4 5.8 13.3 5.7 10.0 7.3 18.8 14.5 10.2 11.2 0.0 7.7 206.2 17.0 23.4 13.9 14.9 8.2 132.8 16.4 4.1 11.3 10.7 16.9 27.3 6.5 20.3 15.4 8.7 11.8 35.1 5.1 4.1 11.1 7.5 72.0 9.3 8.0 5.4 30.0 4.4 8.6 3.1 30.2 95.5 24.0 4.5 10.1 8.0 9.5 1.0 1.9 12.4 12.8 0.0 7.5 8.5 9.1 4.6 3.2 4.8 21.2 6.9 4.4 8.5 13.7 AC013489.1 ENSG00000173867 "Novel transcript" 15 88459501-88546585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "granulocytes: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (3.32e-2)" "unprognostic (9.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (6.56e-3)" "unprognostic (4.03e-1)" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.02e-2)" "unprognostic (2.29e-2)" "unprognostic (1.10e-2)" "unprognostic (2.62e-3)" "unprognostic (1.79e-1)" "unprognostic (4.47e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" 0.4 0.4 0.7 0.2 0.7 0.4 1.1 0.8 0.7 0.4 0.8 0.5 0.3 2.2 1.0 0.3 1.0 0.5 0.8 0.6 0.7 0.8 0.8 0.5 0.4 0.7 0.6 0.5 2.2 1.0 0.7 0.5 0.8 0.6 0.6 1.3 0.4 0.7 1.4 0.3 0.4 0.9 0.6 0.7 0.4 0.4 0.7 0.5 0.7 1.2 0.5 0.3 0.8 0.3 0.6 0.5 0.8 1.2 0.6 0.6 1.0 0.7 1.0 0.7 0.6 1.1 0.9 0.7 1.2 0.7 0.6 2.1 0.6 0.9 0.3 1.0 1.0 0.5 0.8 0.4 0.8 0.7 1.0 1.1 0.7 0.8 0.4 0.5 1.2 1.0 0.9 0.1 0.4 1.0 0.5 0.6 0.7 0.2 0.4 0.7 1.2 0.6 0.8 0.6 0.4 0.9 0.4 1.4 1.0 0.7 1.5 0.8 0.7 0.5 0.9 0.9 0.5 0.9 0.6 0.9 0.7 0.5 0.0 0.5 0.3 0.7 0.9 0.8 0.9 0.9 0.8 0.8 0.7 1.0 1.1 0.0 0.9 0.6 0.6 0.8 0.9 0.7 0.7 0.8 0.7 0.6 0.7 0.7 0.6 0.5 0.8 0.6 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHOSPHO1 ENSG00000173868 "Phosphoethanolamine/phosphocholine phosphatase 1" Q8TCT1 17 49223366-49230787 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Mineral balance" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 103.8" "Cell type enriched" "Detected in some" 6 "Late spermatids: 1499.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 160 "eosinophil: 171.1;neutrophil: 426.7" "Lineage enriched" "Detected in many" 228 "granulocytes: 426.7" "Cell line enhanced" "Detected in some" "Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065025 Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA065025: AB_2732727" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (7.53e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-1)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-2)" "unprognostic (2.04e-1)" "unprognostic (6.88e-2)" "unprognostic (1.02e-2)" "unprognostic (2.88e-1)" "unprognostic (2.03e-1)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" 2.5 1.3 2.3 3.4 3.1 19.1 0.5 6.4 4.3 0.4 1.1 0.7 2.9 0.7 0.2 1.0 1.3 2.2 1.4 2.1 6.1 1.3 1.0 2.3 1.6 9.1 5.6 0.4 0.3 1.2 0.2 0.6 6.4 8.9 0.8 0.0 0.7 1.2 0.3 3.4 1.3 3.0 0.4 5.4 14.3 0.9 103.8 4.9 0.3 0.7 3.3 0.2 0.9 0.5 10.0 0.0 1.0 0.0 0.8 0.1 0.1 0.0 0.2 0.2 0.0 0.1 1.5 0.0 5.7 3.2 0.0 2.1 0.0 0.9 0.3 0.1 4.1 0.1 0.7 0.7 0.2 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.4 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.7 1.2 2.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 5.4 0.1 0.1 2.2 0.3 1.7 1.1 0.0 0.1 0.2 0.3 1.5 2.0 0.1 0.2 0.6 171.1 0.4 1.5 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.2 426.7 0.5 1.8 0.0 0.1 1.1 2.3 3.1 6.4 4.3 2.1 6.1 9.1 5.6 0.4 8.9 5.4 4.9 10.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.1 0.3 0.0 0.0 0.0 205.8 0.0 0.0 1.4 0.0 8.6 0.7 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.0 1.4 0.0 0.0 0.3 0.0 1499.6 7.8 0.6 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 11.2 4.5 0.0 0.0 237.6 0.1 0.0 0.1 0.1 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021537: AB_2670741" "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favorable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favorable (1.39e-5)" 7.7 6.0 5.2 7.5 5.9 13.4 9.4 11.8 6.4 8.3 6.7 6.9 5.7 8.3 7.6 7.0 7.8 5.1 6.3 5.0 6.1 6.4 6.8 8.7 8.7 5.9 6.4 5.0 10.3 7.2 9.7 7.4 6.5 6.5 7.3 6.4 13.7 7.3 6.8 7.0 8.6 7.8 5.7 5.2 7.9 6.8 2.7 5.6 5.2 12.2 8.2 10.2 8.2 8.2 8.5 7.2 4.0 7.6 7.7 8.6 11.3 6.4 9.7 10.1 5.8 8.3 5.0 4.5 1.6 9.1 9.8 3.8 6.7 7.1 8.7 10.6 4.8 7.7 7.6 10.0 6.9 6.9 9.7 6.7 9.9 9.6 8.5 11.4 10.4 7.3 4.4 8.6 11.2 7.2 10.9 6.2 3.5 8.2 4.3 11.9 4.4 13.0 6.2 5.9 14.3 8.5 10.3 7.9 6.6 8.5 8.9 6.5 8.1 7.5 13.2 5.3 11.8 7.3 15.6 22.8 5.0 8.9 6.8 8.3 9.9 2.6 4.7 5.5 1.9 5.5 6.2 4.8 5.6 2.4 8.6 5.4 6.6 4.6 9.2 3.5 8.3 4.2 2.2 5.2 5.9 11.8 6.4 5.0 6.1 5.9 6.4 5.0 6.5 5.2 5.6 8.5 34.2 12.8 28.2 4.9 56.1 29.2 31.2 18.1 35.9 75.5 28.3 25.7 21.8 27.1 22.6 18.4 98.0 30.5 56.7 29.0 19.6 23.8 5.5 35.6 29.3 41.2 37.1 16.8 9.1 17.6 19.4 31.6 15.8 34.2 9.5 58.7 48.9 26.5 14.0 35.3 9.4 26.3 16.2 21.8 33.5 3.9 39.1 24.9 14.2 1.0 19.8 36.2 49.4 3.0 10.9 26.3 15.4 39.1 69.5 37.6 33.0 13.3 27.9 98.0 39.5 34.8 34.6 13.4 12.7 22.1 27.7 39.1 41.5 33.2 24.1 36.8 PHC3 "EDR3, FLJ12729, FLJ12967, HPH3" ENSG00000173889 "Polyhomeotic homolog 3" Q8NDX5 3 170086732-170181749 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039162, HPA062031" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039162: AB_10671038, HPA062031: AB_2684666" "unprognostic (4.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (8.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-3)" "unprognostic (3.26e-2)" "unprognostic (3.70e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (9.58e-3)" "unprognostic (2.76e-2)" 9.2 7.5 4.0 12.8 9.9 51.2 10.6 27.3 8.9 9.1 6.4 10.6 11.3 12.3 8.2 12.5 10.3 13.0 8.2 2.5 7.7 9.8 8.8 9.8 18.2 8.5 5.7 0.0 15.0 11.4 15.2 5.5 8.5 7.8 11.7 11.4 42.4 9.0 8.7 8.8 8.6 12.4 13.6 0.1 14.1 11.9 11.6 5.6 16.9 16.8 14.1 14.2 11.9 7.4 13.1 35.0 32.3 6.9 11.6 19.2 19.4 12.8 14.6 16.5 14.8 18.2 21.6 17.0 16.5 34.8 20.5 19.7 17.1 15.3 14.1 26.6 38.3 14.2 28.5 30.2 10.0 11.3 35.4 14.8 14.0 8.1 22.1 31.0 10.9 11.1 12.7 6.9 45.0 14.6 32.3 16.2 7.4 7.2 11.3 11.9 12.0 29.5 24.0 7.4 38.7 7.5 4.6 48.1 29.8 9.8 4.5 34.6 27.0 22.3 20.5 12.1 17.1 25.4 43.0 37.6 48.1 12.8 13.1 12.6 9.5 7.0 25.7 16.2 11.2 13.8 16.8 15.2 14.1 7.8 21.6 15.6 13.8 10.2 13.3 7.3 26.0 20.2 7.5 4.0 9.9 27.3 8.9 2.5 7.7 8.5 5.7 0.0 7.8 0.1 5.6 13.1 26.8 22.4 31.9 77.4 46.2 14.1 16.9 16.1 19.9 36.3 16.4 12.1 22.7 18.6 18.7 27.6 60.5 15.5 45.9 11.1 0.0 8.9 5.5 18.7 34.5 21.3 7.8 28.8 108.2 7.5 9.6 25.1 25.0 19.0 12.7 35.9 19.6 17.8 11.1 53.8 103.2 14.1 16.2 21.6 22.6 3.8 29.5 22.5 19.6 105.9 25.5 21.9 32.0 103.0 156.5 10.4 16.7 27.8 45.6 22.8 16.4 10.7 24.1 126.2 6.6 29.8 26.4 21.0 19.3 17.8 15.9 18.3 40.4 25.7 14.4 19.6 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037995-170085392 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 108.9;parathyroid gland: 218.3" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006970 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 12.3 1.7 0.9 16.0 1.2 108.9 22.7 1.2 1.5 11.3 1.0 72.7 74.5 5.8 58.4 2.9 5.4 18.7 1.0 0.8 0.9 60.3 4.1 15.2 28.2 1.5 0.7 0.7 0.6 18.6 218.3 1.4 4.2 1.2 26.9 73.3 105.6 19.5 6.4 1.3 1.2 99.4 4.5 1.0 25.5 43.4 5.3 0.9 9.6 6.8 2.7 30.6 27.0 1.0 1.3 64.2 1.5 0.3 0.5 0.3 0.4 15.6 0.4 0.5 0.4 1.9 11.7 8.1 29.4 12.9 0.6 4.0 0.7 8.8 0.5 1.0 45.9 17.7 19.1 1.0 24.3 0.2 38.2 24.8 0.2 0.9 2.0 2.3 2.8 1.4 13.7 6.4 73.9 0.4 41.5 2.9 8.4 10.3 39.1 2.4 5.3 1.1 123.9 32.3 86.8 6.1 1.8 0.8 95.8 4.5 8.2 55.9 197.2 1.9 0.2 0.4 7.1 4.8 206.2 127.9 51.4 0.8 40.3 2.8 2.9 1.1 9.3 0.5 0.4 1.0 8.0 1.0 0.4 2.4 12.3 3.0 1.1 11.3 0.4 0.2 3.2 0.3 1.2 0.9 1.2 1.2 1.5 0.8 0.9 1.5 0.7 0.7 1.2 1.0 0.9 1.3 35.2 9.6 51.1 0.7 25.9 0.4 3.2 4.1 0.0 9.5 48.5 18.3 1.0 28.6 22.7 62.5 39.6 3.1 11.6 88.9 54.8 10.3 33.7 20.6 4.4 8.7 194.8 0.4 1.5 72.0 21.1 1.0 50.0 54.0 1.3 0.1 20.0 0.9 7.4 15.2 0.6 133.9 18.3 11.7 11.2 36.3 0.6 17.0 28.4 7.5 62.3 16.6 0.0 1.0 0.9 60.3 118.6 0.4 56.8 25.4 362.1 151.4 27.9 153.2 0.0 0.8 1.4 7.4 13.1 0.9 0.9 27.2 4.2 1.2 199.7 35.5 CBX2 "CDCA6, MGC10561" ENSG00000173894 "Chromobox 2" Q14781 17 79778148-79787983 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.4;testis: 12.9" "Cell type enhanced" "Detected in many" "Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 96.4;SK-BR-3: 134.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023083 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023083: AB_2671063" "unprognostic (1.37e-2)" "unprognostic (1.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.72e-2)" "unprognostic (2.25e-11)" "unprognostic (1.05e-1)" "unprognostic (7.77e-2)" "unprognostic (6.34e-3)" "unprognostic (1.86e-3)" "unprognostic (1.66e-1)" "unprognostic (1.25e-8)" "unprognostic (1.34e-1)" "unprognostic (3.33e-2)" "unprognostic (2.37e-3)" "unprognostic (2.07e-1)" 1.3 0.3 1.1 0.8 0.9 2.2 1.2 0.7 0.9 1.1 0.6 0.5 0.4 1.2 1.8 4.2 1.0 0.6 1.6 0.7 0.7 0.7 0.4 1.2 1.3 1.0 0.8 0.6 2.1 1.4 0.5 0.2 2.2 1.0 0.6 0.2 0.5 0.9 0.5 0.7 2.0 0.7 0.7 0.7 1.6 0.5 12.9 1.0 7.4 0.5 1.1 1.4 1.0 1.6 1.0 7.5 20.5 37.0 67.4 0.4 0.5 13.2 2.7 1.2 1.3 2.4 21.2 1.7 29.7 5.8 0.3 4.7 3.8 43.0 1.2 0.9 4.3 23.3 1.5 24.0 14.2 1.4 9.0 6.1 0.7 2.6 0.7 1.7 1.6 7.5 31.3 20.8 2.3 1.4 31.3 47.3 22.1 36.8 10.3 23.4 96.4 27.7 18.0 1.5 10.5 45.1 69.8 11.7 134.7 8.0 17.6 24.5 13.4 5.4 13.1 38.4 4.0 5.3 8.7 4.8 18.3 0.5 24.1 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.7 0.9 0.7 0.7 1.0 0.8 0.6 1.0 0.7 1.0 1.0 5.3 0.0 0.0 0.3 0.1 1.0 0.3 0.4 0.0 1.0 0.6 1.8 2.5 0.0 0.3 1.8 2.1 0.4 2.9 0.4 1.9 3.6 32.5 0.9 1.8 8.6 0.0 5.9 0.1 0.9 1.4 0.8 1.1 1.8 0.0 10.4 3.6 1.1 1.2 0.0 0.0 0.8 0.0 0.6 0.9 39.1 0.6 0.5 3.6 0.0 0.8 4.3 0.0 0.0 0.3 1.1 0.0 0.7 0.5 0.7 0.0 0.8 0.1 0.4 0.0 0.3 1.0 1.6 14.3 4.1 1.4 0.3 1.2 0.9 0.5 0.9 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66682497-66729226 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.7;skin 1: 86.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531" "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 1.0 14.5 27.4 1.0 32.9 2.3 7.8 31.5 75.7 14.4 0.0 0.8 0.9 1.7 1.2 40.1 3.8 1.7 1.0 40.3 21.1 27.5 23.5 1.1 0.2 6.6 7.2 37.0 0.9 16.8 13.2 16.6 0.4 10.6 12.5 0.7 14.9 29.8 4.7 0.5 86.1 1.0 1.1 0.0 0.9 2.9 53.2 7.2 1.0 0.3 0.1 6.7 1.6 16.6 25.9 20.5 7.4 3.4 0.3 0.1 0.0 0.6 0.3 0.1 0.1 0.0 4.8 28.2 0.2 3.7 0.0 0.7 16.9 25.2 2.4 0.0 0.1 10.4 0.1 45.6 3.0 0.8 7.3 0.6 0.2 11.5 0.0 7.4 4.2 6.3 5.2 7.3 0.1 0.1 35.2 6.3 3.5 49.1 28.7 21.1 23.8 2.8 14.7 9.6 4.8 49.9 29.4 14.0 52.3 3.2 2.7 67.2 2.4 1.4 0.1 8.6 1.3 11.5 0.7 3.0 14.7 0.1 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 27.4 32.9 31.5 75.7 40.3 21.1 6.6 7.2 37.0 10.6 0.0 7.2 25.9 0.7 3.2 1.1 4.9 0.3 3.7 2.7 3.2 2.8 11.0 4.7 4.6 1.8 1.5 4.6 86.5 104.3 0.9 0.0 0.6 0.0 2.6 30.9 3.6 1.8 1.1 3.0 7.2 29.3 10.0 0.3 0.8 1.5 3.6 0.0 1.4 1.4 24.7 0.1 0.0 20.7 1.6 0.0 0.3 0.7 77.6 1.8 0.1 0.0 2.8 0.6 1.6 0.0 7.5 4.6 7.5 0.2 1.5 0.8 3.2 0.2 1.3 3.5 21.3 0.0 0.2 0.5 8.5 9.4 14.6 12.5 0.3 0.2 0.1 0.8 1.7 GOLIM4 "GIMPC, GOLPH4, GPP130, P138" ENSG00000173905 "Golgi integral membrane protein 4" O00461 3 168008689-168095924 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 370.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001677, HPA002315" Enhanced Enhanced "Golgi apparatus" NA NA 1000000 "Golgi apparatus" "HPA001677: AB_1079017, HPA002315: AB_1079018" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (6.27e-2)" "unprognostic (2.11e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-1)" "unprognostic (5.17e-2)" "unprognostic (1.39e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.84e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-3)" 25.0 12.7 26.6 21.6 25.4 9.1 13.0 27.9 32.4 17.0 16.2 53.9 66.4 22.1 9.0 15.9 15.8 28.8 55.1 29.8 36.6 31.6 59.6 29.4 11.4 44.6 28.4 16.8 20.0 12.0 12.9 9.7 22.6 41.1 15.3 51.6 53.4 17.5 13.7 32.7 9.4 85.9 26.9 37.1 23.2 24.5 9.1 33.7 6.5 19.2 31.0 9.6 16.9 10.8 37.9 23.7 34.5 47.8 30.4 79.7 58.6 14.5 135.8 72.4 36.3 33.2 38.7 28.4 51.6 159.1 82.4 58.4 42.5 44.4 39.9 54.9 81.3 57.0 83.8 100.2 48.1 32.1 80.5 45.8 61.5 20.9 33.4 32.8 32.2 42.1 0.0 43.7 146.2 41.9 39.2 0.1 21.8 46.9 44.2 36.6 0.1 48.1 72.2 20.6 8.5 42.9 55.5 83.5 25.1 28.4 31.7 30.9 36.1 79.0 114.9 44.2 81.3 110.1 56.4 43.4 109.4 57.1 47.4 52.4 3.2 2.5 10.8 0.6 2.8 0.2 1.2 0.1 0.5 3.3 2.0 0.0 0.2 0.0 5.5 2.3 4.0 0.0 0.7 26.6 25.4 27.9 32.4 29.8 36.6 44.6 28.4 16.8 41.1 37.1 33.7 37.9 74.9 48.1 124.8 141.0 11.1 41.4 24.4 18.3 41.5 16.2 21.3 20.6 157.3 67.2 23.3 36.8 37.5 11.4 33.5 184.5 17.6 21.8 1.7 20.6 51.5 70.9 63.3 33.9 18.1 29.6 17.2 119.2 34.1 30.9 58.3 23.3 45.3 178.8 39.1 16.8 84.2 136.5 12.2 50.7 57.5 3.3 39.7 42.2 37.4 38.4 22.0 370.3 14.4 145.8 44.7 23.6 181.2 51.1 28.9 26.0 195.2 31.6 9.2 62.8 46.0 108.2 82.5 5.5 37.6 20.1 35.9 5.5 16.5 20.4 167.6 8.4 KRT28 KRT25D ENSG00000173908 "Keratin 28" Q7Z3Y7 17 40792196-40799959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "skin 1: 7.6" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.3" "Cancer enhanced" "Detected in some" "cervical cancer: 0.6;endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 3.2" "Not detected" "Not detected" HPA066890 Enhanced NA NA "HPA066890: AB_2685742" 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBM4B "MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B" ENSG00000173914 "RNA binding motif protein 4B" Q9BQ04 11 66664998-66677887 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (3.32e-2)" "unprognostic (1.98e-3)" "unprognostic (3.57e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (6.22e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (1.71e-2)" 7.8 16.3 24.7 11.2 24.8 5.0 10.8 35.0 31.3 20.4 20.9 14.2 10.1 20.0 20.6 13.9 18.9 10.5 10.4 24.6 24.1 13.6 14.4 9.5 16.3 24.4 23.9 24.0 30.2 13.7 13.2 23.7 13.3 26.7 18.8 12.1 34.8 15.4 15.0 16.5 18.9 14.6 14.6 22.9 15.7 12.7 16.4 24.3 13.4 16.2 15.4 17.4 14.1 15.7 28.6 21.3 21.0 45.1 37.7 21.7 22.3 15.3 19.9 20.0 21.9 22.3 29.5 21.9 23.8 27.9 25.5 21.5 27.2 30.1 27.7 23.2 23.0 20.4 25.7 26.6 31.9 15.9 26.4 24.4 23.3 18.6 22.5 19.1 25.1 21.5 19.0 20.0 23.1 29.8 34.3 16.5 20.4 26.7 47.8 27.9 33.4 35.8 24.4 20.2 21.1 27.7 25.2 23.9 12.1 47.3 28.8 32.3 24.7 20.1 24.1 24.6 23.7 18.3 11.2 20.5 24.2 22.2 18.4 21.7 26.4 15.1 43.9 16.1 22.6 15.7 34.6 14.9 15.8 18.2 28.9 18.1 13.5 9.8 22.6 25.9 15.1 12.2 13.8 24.7 24.8 35.0 31.3 24.6 24.1 24.4 23.9 24.0 26.7 22.9 24.3 28.6 7.5 12.8 5.9 15.3 25.9 8.0 14.7 29.8 24.5 36.3 14.4 13.6 6.9 12.8 15.9 18.4 33.3 36.5 11.5 8.1 11.7 11.9 26.5 13.4 12.8 9.5 19.2 12.0 20.0 5.8 16.5 14.9 11.2 11.7 8.9 17.0 12.8 9.0 13.0 25.2 25.8 11.7 26.4 9.8 6.1 53.9 18.3 9.8 16.0 11.2 10.5 23.3 13.4 29.1 31.1 4.7 12.4 13.5 13.4 7.0 21.2 13.4 22.6 60.4 6.6 12.0 14.2 50.8 42.8 13.6 7.1 22.2 14.6 12.2 10.9 5.7 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396492 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1340.2;Ductal cells: 705.9;Exocrine glandular cells: 723.1;Pancreatic endocrine cells: 884.5;Proximal tubular cells: 1879.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA 55000 Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 322.3 345.8 537.8 156.5 547.7 194.7 327.9 542.1 727.8 216.9 541.1 489.2 276.0 178.4 413.8 429.5 196.0 142.1 1068.4 547.8 564.6 531.1 592.0 217.1 181.8 532.7 533.4 534.6 158.9 324.0 523.9 311.6 158.7 537.0 256.3 453.9 247.5 236.9 238.6 1028.9 193.9 263.9 231.9 544.3 186.9 372.8 143.6 539.8 322.0 192.8 1337.3 253.1 287.4 261.0 556.6 557.8 559.4 528.4 648.2 570.2 696.0 348.3 523.2 612.7 501.0 556.6 925.2 605.3 312.4 288.9 575.3 398.6 559.4 502.2 522.7 697.9 414.7 887.3 331.8 682.1 1057.7 545.7 688.3 491.3 569.2 801.1 456.4 715.7 849.2 661.5 470.0 441.5 517.5 849.4 842.0 552.0 1167.5 397.8 830.1 959.1 355.8 326.0 495.3 1218.4 878.4 203.7 464.8 269.4 419.7 824.9 723.5 373.4 619.9 388.6 255.2 394.2 394.0 692.8 537.2 958.4 543.5 545.2 678.2 200.3 575.3 271.2 395.8 214.7 384.0 248.0 301.6 296.3 259.8 314.1 219.1 251.4 256.7 231.1 230.5 375.3 456.3 307.9 304.4 537.8 547.7 542.1 727.8 547.8 564.6 532.7 533.4 534.6 537.0 544.3 539.8 556.6 169.1 211.5 173.2 0.0 40.9 0.0 0.0 0.0 0.0 0.0 323.4 417.6 0.0 0.0 91.0 388.1 0.0 298.0 76.3 0.0 1340.2 705.9 0.0 406.0 245.4 114.5 0.0 0.0 0.0 723.1 439.4 81.8 0.0 424.5 118.6 176.9 0.0 0.0 543.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.4 0.0 0.0 432.6 0.0 0.0 0.0 0.0 884.5 0.0 0.0 0.0 0.0 0.0 1879.7 121.0 0.0 0.0 0.0 127.9 0.0 0.0 0.0 0.0 305.8 69.4 209.9 0.0 0.0 HOXB2 "HOX2, HOX2H" ENSG00000173917 "Homeobox B2" P14652 17 48540894-48545109 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 156.5;Endometrial ciliated cells: 69.2;NK-cells: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 54.5;EFO-21: 52.2;HEK 293: 59.1;HMC-1: 116.8;WM-115: 52.6" "Region enriched" "Detected in single" 34 "pons and medulla: 4.4" "Group enriched" "Detected in some" 4 "medulla oblongata: 4.9;spinal cord: 7.0" HPA047857 Supported Nucleoplasm NA NA Nucleoplasm "HPA047857: AB_2680184" "unprognostic (8.58e-3)" "unprognostic (4.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (7.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.75e-2)" "unprognostic (2.60e-1)" "unprognostic (3.24e-1)" "unprognostic (3.04e-3)" "unprognostic (4.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (2.89e-1)" 19.6 29.2 3.6 6.6 2.6 3.6 21.9 0.4 1.3 19.8 0.5 33.9 3.6 17.6 43.1 24.2 33.9 5.3 10.9 0.2 0.6 41.1 5.0 15.7 7.2 15.8 1.4 0.0 3.4 3.7 19.8 0.4 2.4 10.6 13.8 2.4 0.0 0.8 12.1 10.0 8.8 17.4 5.4 10.3 16.6 16.6 3.4 4.5 4.2 6.7 7.9 2.0 11.2 18.9 10.8 0.3 1.9 54.5 0.1 12.1 14.0 0.2 5.1 0.0 0.1 0.0 0.7 0.4 0.0 52.2 15.3 0.0 0.0 8.2 0.0 0.1 0.2 59.1 21.4 2.7 0.0 21.3 0.0 116.8 8.9 0.0 23.3 9.2 0.5 8.6 0.2 42.3 0.1 31.9 0.1 0.1 0.1 0.0 1.3 0.2 0.0 26.9 0.1 38.9 4.9 0.0 0.0 4.0 0.0 34.3 3.8 28.9 0.0 0.3 0.0 3.5 0.6 0.1 0.0 0.1 0.1 20.8 0.0 52.6 3.9 0.3 0.0 3.0 0.4 1.0 0.2 4.6 3.4 1.5 0.5 6.8 2.9 0.0 1.8 0.3 4.8 6.1 1.0 3.6 2.6 0.4 1.3 0.2 0.6 15.8 1.4 0.0 10.6 10.3 4.5 10.8 27.9 3.2 1.1 0.0 4.9 7.0 7.3 0.5 53.5 0.0 18.5 18.7 2.5 0.0 2.0 53.3 0.0 15.9 26.9 1.0 156.5 1.4 0.5 69.2 9.9 21.4 2.4 21.9 0.0 0.2 30.2 19.4 0.0 42.4 21.0 0.0 31.1 0.3 7.6 0.0 0.0 1.6 24.4 10.4 21.2 1.7 0.0 11.4 12.4 2.8 7.5 0.0 58.7 0.0 0.1 0.1 1.7 0.0 3.7 8.8 0.1 26.1 0.9 0.0 0.0 9.6 31.6 7.4 6.6 36.6 5.7 24.9 28.6 0.1 0.9 28.0 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 213.8;heart muscle: 261.5" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 120.0;Sertoli cells: 105.2;Smooth muscle cells: 105.8;Syncytiotrophoblasts: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 313.5;BJ hTERT+: 72.9;HHSteC: 112.3;HSkMC: 61.3;U-87 MG: 66.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 314000000 40000 "Nucleoplasm, Cytosol" "CAB025429: , HPA051101: AB_2681343" "unprognostic (2.58e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 213.8 76.0 11.0 15.0 14.0 0.5 157.3 16.2 13.5 50.0 41.0 34.5 4.6 45.4 6.6 19.0 64.1 24.5 261.5 9.1 17.5 25.3 46.1 44.8 14.1 18.0 25.3 6.2 71.1 15.0 13.6 17.6 42.6 18.1 57.5 6.4 0.9 35.2 44.4 27.2 36.2 29.6 13.4 13.2 36.0 25.2 5.4 20.6 5.1 116.0 21.5 6.6 35.0 42.7 18.8 0.1 32.3 0.3 0.1 313.5 27.1 0.2 13.6 72.9 7.0 11.9 2.7 14.0 0.1 1.5 5.1 18.1 0.7 1.0 0.5 5.0 0.1 3.5 0.2 11.7 1.5 112.3 0.1 0.2 61.3 0.2 14.5 0.8 9.3 8.8 1.6 0.1 0.3 1.6 0.1 0.3 0.2 3.0 3.7 27.9 0.1 22.3 0.4 0.0 0.4 1.3 5.3 9.2 1.8 32.7 1.2 0.0 0.0 1.4 32.6 0.8 4.0 4.8 0.3 0.1 0.1 66.2 0.2 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.0 14.0 16.2 13.5 9.1 17.5 18.0 25.3 6.2 18.1 13.2 20.6 18.8 36.1 0.0 0.6 4.9 0.4 6.5 0.7 12.3 0.6 0.1 9.2 1.8 10.8 5.7 0.5 1.8 0.0 21.5 0.4 3.2 0.0 19.5 0.1 0.6 17.9 38.3 4.8 2.7 0.2 5.9 1.5 23.6 2.6 0.6 0.0 25.3 120.0 1.9 2.6 0.0 0.9 6.3 2.0 7.5 11.3 0.7 10.5 1.1 3.6 5.6 10.9 0.5 0.0 0.5 0.3 3.7 3.1 3.4 0.1 1.8 0.9 0.2 0.3 0.5 105.2 12.7 105.8 0.0 0.7 0.4 4.5 47.3 0.8 18.1 5.2 0.6 MARCHF3 "MARCH-III, MARCH3, MGC48332, RNF173" ENSG00000173926 "Membrane associated ring-CH-type finger 3" Q86UD3 5 126867714-127030558 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 43.8;Syncytiotrophoblasts: 98.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 10.5;naive B-cell: 12.1" "Lineage enriched" "Detected in many" 4 "B-cells: 12.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.4;HUVEC TERT2: 27.4;TIME: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043406 Uncertain Supported Vesicles NA NA Vesicles "HPA043406: AB_10793947" "unprognostic (5.96e-3)" "unprognostic (1.46e-2)" "unprognostic (1.91e-2)" "unprognostic (4.21e-2)" "unprognostic (9.00e-3)" "unprognostic (1.17e-2)" "unprognostic (7.75e-3)" "unprognostic (9.41e-2)" "unprognostic (8.93e-2)" "unprognostic (2.05e-3)" "unprognostic (3.15e-2)" "unprognostic (1.82e-1)" "unprognostic (5.60e-6)" "unprognostic (7.74e-2)" "unprognostic (7.64e-2)" "unprognostic (1.05e-1)" "unprognostic (3.64e-1)" 5.4 2.8 5.9 3.0 5.9 3.7 2.6 5.4 3.5 0.7 1.7 5.3 0.9 1.4 0.0 1.4 1.5 5.2 7.8 3.8 6.3 0.8 0.7 2.4 2.5 10.8 6.8 2.5 1.1 2.4 0.4 2.4 1.7 9.0 0.6 5.7 7.5 4.6 0.2 6.6 5.6 2.4 3.0 8.0 1.6 2.4 5.6 9.5 1.3 1.4 3.3 2.1 7.6 0.7 10.4 0.4 1.8 3.9 2.1 3.4 3.2 1.2 14.2 5.9 11.1 16.3 1.9 0.8 3.8 1.3 1.9 2.4 1.1 4.9 2.5 15.3 0.8 4.7 12.2 3.2 1.9 5.6 5.0 3.0 2.4 0.7 40.4 4.8 2.6 27.4 0.6 5.1 0.7 9.3 1.3 0.5 2.3 3.3 3.0 4.6 1.5 15.5 1.2 0.9 2.0 1.3 0.9 3.3 0.5 1.6 1.9 2.9 5.0 33.5 2.2 1.8 12.6 1.6 1.9 2.3 2.3 8.3 3.8 2.0 0.0 0.2 2.8 0.5 0.4 0.1 10.5 0.6 0.3 0.1 12.1 2.3 0.5 0.8 2.3 0.3 0.7 2.9 0.8 5.9 5.9 5.4 3.5 3.8 6.3 10.8 6.8 2.5 9.0 8.0 9.5 10.4 3.8 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 43.8 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 98.6 0.6 0.0 0.0 0.0 SWSAP1 "C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1" ENSG00000173928 "SWIM-type zinc finger 7 associated protein 1" Q6NVH7 19 11374666-11376951 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052712 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA052712: AB_2681925" "unprognostic (6.45e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.75e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (5.03e-1)" "unprognostic (1.34e-2)" "unprognostic (4.65e-2)" "unprognostic (8.62e-3)" "unprognostic (1.40e-3)" "unprognostic (2.53e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.18e-3)" 2.4 3.6 1.7 3.9 1.7 5.2 4.0 3.4 2.0 3.7 2.2 4.4 4.6 3.0 3.6 3.7 4.8 3.9 3.1 1.9 1.4 3.3 5.4 3.7 7.2 1.6 1.4 1.9 5.3 4.5 2.7 2.0 4.1 2.0 4.1 3.2 0.7 5.1 4.4 3.7 5.0 3.8 2.2 1.3 6.5 4.6 3.6 1.5 4.2 5.1 3.0 4.2 3.4 1.6 2.5 8.1 6.8 3.6 2.2 3.6 3.0 5.3 2.0 2.2 4.6 4.2 7.1 5.5 14.9 10.0 1.9 3.2 5.7 3.4 8.6 0.5 4.8 8.5 6.9 3.0 10.3 3.3 11.3 12.0 4.7 7.4 2.6 1.7 2.7 5.5 6.9 8.4 6.4 2.5 17.6 6.6 15.0 9.0 6.0 9.0 5.5 1.7 16.2 8.6 5.5 7.4 5.5 2.6 8.7 5.5 1.9 11.9 12.9 5.7 3.8 2.7 5.4 4.0 9.5 14.8 10.6 2.1 13.2 3.0 3.2 31.4 7.9 12.5 30.5 12.1 20.9 13.1 13.6 24.3 19.4 16.1 13.9 20.2 16.7 29.5 15.3 13.8 12.3 1.7 1.7 3.4 2.0 1.9 1.4 1.6 1.4 1.9 2.0 1.3 1.5 2.5 4.9 3.2 2.0 2.3 10.3 2.7 8.5 16.7 4.0 7.2 9.8 9.3 3.2 2.8 10.6 16.5 8.4 17.8 11.3 10.5 41.1 7.1 10.8 4.5 3.7 6.7 2.4 7.0 1.1 10.7 10.5 4.0 3.1 4.1 1.3 3.7 6.8 13.5 12.1 10.1 1.0 14.2 22.4 9.8 5.4 1.9 11.8 6.5 7.2 0.0 9.6 8.8 19.6 0.0 2.7 6.1 12.2 7.9 3.4 5.6 11.2 17.2 14.6 10.2 6.6 3.2 6.3 10.7 15.0 4.1 3.1 31.7 8.8 13.7 8.9 5.5 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296284 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 41.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 9.5;neutrophil: 9.8" "Group enriched" "Detected in many" 5 "granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8" "Cell line enhanced" "Detected in some" "Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.8 0.1 0.7 0.4 8.7 0.5 0.0 0.4 0.3 0.0 1.0 2.2 0.1 0.2 0.1 0.2 2.3 0.3 0.2 0.0 41.9 7.6 7.9 0.5 0.3 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.5 0.0 0.8 0.1 2.0 3.7 0.1 0.3 1.5 0.1 0.0 1.3 0.6 0.8 0.3 1.0 1.6 0.1 0.2 0.2 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.7 1.1 0.0 1.0 0.2 1.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 17.5 0.0 1.3 0.1 0.3 0.8 0.0 0.0 0.0 0.0 1.2 98.8 0.1 0.7 0.5 0.0 0.3 0.0 2.3 0.0 2.4 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.0 25.8 0.1 9.5 1.0 7.3 3.8 0.0 0.3 0.0 0.6 2.1 0.4 0.1 0.2 1.3 9.8 2.6 0.0 0.2 0.0 1.0 0.1 0.4 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.5 0.0 0.3 0.5 0.1 6.4 49.7 0.3 0.6 0.0 0.1 1.2 0.0 0.0 1.8 0.3 0.3 1.5 6.4 5.5 0.0 0.0 9.6 1.4 1.9 0.2 21.6 0.0 0.1 0.3 0.0 5.7 9.1 0.8 0.0 0.3 0.0 1.6 5.7 0.0 0.4 11.0 0.2 0.0 6.6 0.1 2.0 0.6 0.3 2.6 0.3 2.4 0.0 1.0 3.2 0.0 26.8 1.5 0.3 0.3 0.1 0.0 1.4 0.0 1.8 32.8 3.1 0.0 0.0 0.1 0.1 2.5 2.4 0.0 0.0 0.0 3.4 0.1 1.1 0.4 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638667-66668374 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 77.5 112.4 59.4 71.6 62.5 132.7 76.4 79.6 67.3 90.3 65.7 91.0 68.4 87.8 91.1 101.1 80.1 59.5 74.4 60.5 63.8 93.6 83.0 78.1 98.3 58.2 58.4 62.1 104.5 116.5 77.8 86.7 73.4 66.7 96.7 63.2 75.0 89.9 60.6 97.4 78.9 84.3 69.7 60.6 105.6 99.2 74.9 64.8 110.8 86.4 73.1 99.9 84.9 84.8 64.5 127.2 163.6 246.5 136.4 90.1 95.6 153.9 128.6 106.1 134.1 97.3 281.5 160.9 161.1 174.4 132.3 120.5 136.4 263.5 159.1 142.9 162.1 138.4 220.7 163.5 170.3 173.1 152.8 91.9 138.8 134.3 158.6 213.9 136.4 184.3 155.0 180.1 115.0 147.3 263.3 252.9 157.9 309.7 246.8 176.0 234.2 224.6 181.7 180.7 199.5 204.5 149.5 227.1 168.6 379.9 163.8 315.3 154.4 180.9 140.4 124.0 86.5 107.3 143.9 162.5 258.8 109.9 118.3 205.8 210.0 119.4 131.3 135.5 123.2 122.3 119.3 139.8 149.9 116.2 130.4 147.5 149.8 137.5 155.4 144.0 103.6 194.3 159.1 59.4 62.5 79.6 67.3 60.5 63.8 58.2 58.4 62.1 66.7 60.6 64.8 64.5 19.7 28.9 42.2 8.1 64.0 17.8 61.4 36.3 112.7 58.2 24.2 12.7 4.6 15.7 36.5 20.2 93.8 36.2 48.7 16.6 15.6 25.1 39.8 26.6 28.0 28.5 34.7 42.5 23.9 23.1 30.1 33.6 53.0 30.7 36.8 38.1 25.7 11.1 14.5 62.2 21.4 15.5 32.6 18.8 29.2 9.3 27.4 27.5 19.6 7.5 28.8 15.9 69.0 15.1 18.8 19.6 23.6 20.3 60.2 62.6 32.9 10.6 41.1 90.0 19.7 29.7 28.3 41.1 40.1 68.6 22.3 43.8 66.3 42.4 24.8 65.5 PIFO "C1orf88, FLJ23853, pitchfork" ENSG00000173947 "Primary cilia formation" Q8TCI5 1 111346600-111353013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "fallopian tube: 175.7" "Group enriched" "Detected in many" 4 "Early spermatids: 430.6;Endometrial ciliated cells: 495.3;Late spermatids: 458.1;Respiratory ciliated cells: 990.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.4;RPTEC TERT1: 4.7;RT4: 5.9;SuSa: 7.9;T-47d: 3.8;U-87 MG: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.18e-3)" "unprognostic (3.23e-2)" "unprognostic (7.33e-2)" "unprognostic (3.03e-3)" "unprognostic (6.00e-2)" "unprognostic (7.43e-4)" "unprognostic (8.78e-7)" "unprognostic (6.43e-3)" "unprognostic (7.28e-2)" "unprognostic (9.07e-3)" "prognostic favorable (2.48e-4)" "unprognostic (3.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.03e-3)" "unprognostic (4.73e-2)" "unprognostic (6.37e-2)" "unprognostic (6.83e-2)" 0.9 2.8 11.9 0.8 8.4 0.1 5.7 9.7 9.2 3.6 31.4 3.7 0.6 7.5 12.6 3.6 175.7 3.6 9.4 7.7 19.2 8.4 0.0 13.0 0.3 13.0 11.5 5.8 3.3 6.4 15.2 9.8 2.9 12.4 12.3 1.1 5.2 3.1 6.1 0.1 1.4 1.1 4.8 14.4 0.4 4.4 25.0 10.0 1.7 15.1 0.9 0.6 5.5 0.9 13.8 0.0 0.0 0.5 0.6 0.6 0.7 1.0 0.0 1.2 0.2 0.0 0.8 1.1 0.0 0.2 0.0 1.1 0.0 0.8 0.2 0.0 1.4 0.2 0.0 0.1 0.9 0.4 0.0 0.0 0.4 3.2 0.0 0.0 3.4 0.0 0.2 0.2 0.1 2.0 0.3 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 4.7 5.9 2.2 0.2 0.0 0.1 0.1 7.9 3.8 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.4 3.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 8.4 9.7 9.2 7.7 19.2 13.0 11.5 5.8 12.4 14.4 10.0 13.8 0.3 3.2 18.5 3.3 0.5 4.2 9.1 71.5 1.8 0.7 6.0 12.6 17.3 0.0 83.2 5.5 4.2 11.6 0.1 0.0 21.5 13.0 430.6 495.3 5.8 1.6 3.0 0.0 0.5 2.0 4.4 3.7 1.5 9.0 0.0 3.8 0.7 0.1 1.2 0.0 1.4 0.0 77.3 0.0 0.7 458.1 5.9 1.5 8.8 0.0 0.0 11.8 0.0 0.5 0.6 1.2 0.0 3.4 0.4 6.2 0.0 36.3 990.5 5.4 6.6 4.6 22.8 127.1 10.5 0.5 2.8 7.0 1.0 8.4 0.1 4.3 XXYLT1 "C3orf21, FLJ35155" ENSG00000173950 "Xyloside xylosyltransferase 1" Q8NBI6 3 195068284-195271159 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 110000 "unprognostic (1.39e-2)" "unprognostic (2.31e-2)" "unprognostic (3.42e-2)" "unprognostic (2.32e-3)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "unprognostic (6.29e-3)" "unprognostic (5.67e-2)" "unprognostic (5.50e-2)" "unprognostic (6.57e-2)" "unprognostic (3.13e-2)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.07e-1)" "unprognostic (2.23e-2)" "unprognostic (8.20e-2)" "unprognostic (1.07e-2)" 6.4 4.4 5.1 6.9 4.8 5.9 5.5 4.2 5.6 7.3 5.1 5.8 4.4 9.3 3.7 11.4 5.9 5.5 4.5 4.4 5.4 4.3 1.9 5.1 6.3 5.6 4.4 5.2 4.4 2.9 5.9 5.8 10.5 6.2 5.4 4.7 2.7 4.6 5.6 1.9 9.2 4.4 8.7 3.9 5.3 4.2 2.5 5.7 5.3 4.4 1.7 5.1 6.2 8.2 6.6 16.1 13.5 39.7 65.2 22.1 19.2 14.1 24.9 17.0 24.1 20.8 14.3 11.0 18.9 26.1 19.7 18.5 18.8 16.8 14.7 12.7 10.7 26.6 18.9 10.7 15.5 10.2 23.9 29.2 13.8 19.0 8.6 9.4 13.4 51.3 12.4 23.5 5.4 8.3 40.0 16.0 30.6 30.7 15.1 23.5 27.0 16.2 20.5 17.8 5.3 36.4 33.6 15.5 12.1 15.5 21.0 36.6 13.2 34.2 14.0 3.5 13.7 25.8 4.6 14.8 45.9 9.1 30.4 15.2 0.9 3.8 1.8 1.5 2.6 1.2 1.4 1.3 1.4 2.6 2.2 1.3 1.3 1.2 1.5 2.3 10.0 0.7 1.2 5.1 4.8 4.2 5.6 4.4 5.4 5.6 4.4 5.2 6.2 3.9 5.7 6.6 11.8 3.2 4.4 15.0 4.0 4.2 4.8 5.6 4.0 6.8 4.1 6.2 3.9 2.8 5.8 7.3 4.2 10.9 7.8 2.2 3.9 10.3 0.3 4.2 11.6 10.8 8.4 9.7 25.1 5.3 13.9 11.9 3.1 4.5 2.5 15.9 11.7 1.6 8.3 0.0 30.9 4.0 8.2 13.8 3.2 1.9 6.5 11.8 0.0 26.2 9.9 4.4 10.3 20.6 17.4 8.4 0.5 10.5 2.6 6.6 1.4 5.3 4.8 3.2 6.6 5.0 8.6 1.0 6.1 13.0 7.1 4.8 4.4 10.3 4.3 4.9 UBXN2A UBXD4 ENSG00000173960 "UBX domain protein 2A" P68543 2 23927285-24004909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065482, HPA069096" Supported Approved Centrosome NA NA Centrosome "HPA065482: AB_2685495, HPA069096: AB_2686084" "unprognostic (5.29e-2)" "unprognostic (1.93e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.86e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (9.26e-2)" "unprognostic (2.76e-1)" "unprognostic (1.15e-2)" "unprognostic (1.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (8.85e-2)" "unprognostic (2.14e-1)" "unprognostic (4.60e-2)" "unprognostic (6.75e-2)" 6.2 3.8 3.6 3.5 4.2 5.0 5.1 6.1 3.8 3.1 2.5 4.9 5.7 5.2 3.9 5.1 3.6 3.7 7.9 3.0 3.8 4.1 5.7 4.7 3.9 4.3 4.3 2.5 4.0 3.1 7.4 1.5 5.3 4.5 3.8 4.2 5.6 4.5 4.7 11.0 4.8 5.4 6.9 4.3 3.0 3.0 3.2 4.0 4.5 3.9 7.9 4.4 4.1 2.4 6.1 14.8 9.6 13.1 8.8 14.8 12.9 6.6 14.8 9.9 14.1 9.8 7.2 6.5 12.7 4.5 9.5 9.9 6.2 12.7 10.5 12.5 25.7 12.0 14.9 6.4 10.9 10.9 9.5 6.4 15.8 8.3 12.4 9.4 10.0 8.5 9.6 17.0 12.3 12.4 11.2 12.6 6.0 10.4 9.5 6.8 16.9 32.7 5.6 5.9 11.3 6.5 15.6 14.2 6.9 18.6 9.2 4.1 5.3 14.2 10.1 10.5 9.3 9.6 17.7 20.3 18.0 7.9 8.7 10.4 4.8 2.1 2.5 3.2 1.2 3.5 3.7 3.3 3.1 1.7 2.9 3.6 3.3 1.9 4.7 1.6 4.1 2.7 1.6 3.6 4.2 6.1 3.8 3.0 3.8 4.3 4.3 2.5 4.5 4.3 4.0 6.1 26.9 25.6 19.2 27.1 29.3 25.5 26.9 13.6 35.9 17.1 29.7 35.2 54.9 15.7 13.6 16.5 43.8 33.9 38.9 23.1 17.6 27.4 2.3 28.9 38.7 23.5 4.2 19.6 22.0 27.2 34.4 33.4 26.5 30.6 17.7 25.2 25.4 16.3 15.6 42.1 35.5 18.3 18.3 15.4 17.5 2.9 26.4 28.2 35.6 13.1 26.7 25.6 27.8 26.7 53.6 38.4 29.9 26.7 28.7 32.8 32.3 17.7 14.7 28.4 32.9 27.6 34.7 25.0 15.6 27.5 31.3 37.4 29.0 10.2 19.5 36.3 RAX2 "ARMD6, CORD11, MGC15631, RAXL1" ENSG00000173976 "Retina and anterior neural fold homeobox 2" Q96IS3 19 3769089-3772228 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" DNA-binding "Age-related macular degeneration, Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "retina: 65.0" "Group enriched" "Detected in some" 9 "Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 217.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052533 Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA052533: AB_2681862" "unprognostic (5.53e-2)" "unprognostic (1.39e-2)" "unprognostic (4.48e-1)" 0.0 0.0 0.2 0.1 0.4 0.4 0.0 0.5 0.6 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 1.3 0.2 0.0 0.0 0.3 1.6 0.0 0.6 0.0 0.0 65.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.6 0.4 0.3 0.3 1.3 0.2 0.6 0.1 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 14.3 0.0 0.1 0.6 0.0 0.0 0.0 123.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 217.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LRRC63 RP11-139H14.4 ENSG00000173988 "Leucine rich repeat containing 63" 13 46211940-46277366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;testis: 3.4" "Cell type enriched" "Detected in some" 7 "Oligodendrocytes: 255.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 1.7;JURKAT: 3.0;Karpas-707: 1.6;U-87 MG: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039318, HPA039763" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA039318: AB_10796224, HPA039763: AB_10795408" "unprognostic (3.40e-2)" "unprognostic (2.81e-1)" "unprognostic (5.33e-1)" "unprognostic (2.12e-3)" "unprognostic (1.96e-1)" "unprognostic (3.99e-1)" "unprognostic (1.06e-2)" "unprognostic (7.28e-2)" "unprognostic (3.05e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-2)" "unprognostic (7.61e-2)" "unprognostic (1.18e-6)" "unprognostic (1.27e-1)" "unprognostic (2.98e-1)" "unprognostic (4.57e-2)" "unprognostic (7.31e-2)" 0.1 0.3 2.1 0.1 4.6 0.3 0.1 4.9 3.4 0.2 1.0 0.1 0.0 0.0 2.4 0.0 1.1 0.1 0.1 1.8 3.0 0.1 0.1 0.4 0.2 6.7 4.1 1.4 0.0 0.0 0.1 0.0 0.1 5.8 0.5 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.1 5.9 0.1 0.1 3.4 4.3 1.3 0.0 0.1 0.1 0.0 0.0 10.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.4 0.7 0.6 0.0 2.1 0.0 0.2 0.0 0.1 1.7 0.5 0.7 0.0 0.0 0.1 0.4 1.1 0.4 0.0 0.2 0.0 0.0 0.0 3.0 0.0 1.6 0.0 0.0 1.0 0.3 0.1 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.5 0.6 0.0 0.0 0.7 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.3 0.6 1.3 0.1 2.0 1.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.1 0.1 2.1 4.6 4.9 3.4 1.8 3.0 6.7 4.1 1.4 5.8 5.9 4.3 10.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 34.1 3.1 0.1 0.1 0.0 1.3 0.9 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.5 0.0 5.2 0.0 0.0 0.8 0.3 8.4 0.0 0.2 0.0 1.9 0.0 0.1 0.0 4.0 255.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 2.8 0.0 0.0 0.2 3.8 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TCAP "CMD1N, LGMD2G, T-cap, TELE, telethonin" ENSG00000173991 Titin-cap O15273 17 39665349-39666554 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 45 "heart muscle: 4049.4;skeletal muscle: 15979.8;tongue: 5883.1" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 2473.2" "Group enriched" "Detected in many" 8 "head and neck cancer: 20.2;prostate cancer: 11.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 5.3;SK-BR-3: 8.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.8" "Low region specificity" "Detected in some" "CAB004591, HPA026477" Enhanced NA NA 36000 "CAB004591: AB_628340, HPA026477: AB_1857888" "unprognostic (5.29e-2)" "unprognostic (9.29e-2)" "unprognostic (2.40e-3)" "unprognostic (4.32e-3)" "unprognostic (8.79e-2)" "unprognostic (3.68e-2)" "unprognostic (1.61e-1)" "unprognostic (3.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.12e-4)" "unprognostic (2.62e-1)" "unprognostic (4.51e-2)" "unprognostic (8.59e-2)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "prognostic favorable (4.55e-4)" 3.5 4.2 11.9 0.8 14.2 2.9 5.8 12.8 16.2 2.9 10.2 2.6 0.7 2.2 0.0 190.5 2.6 1.9 4049.4 11.0 11.8 3.1 3.4 8.5 3.3 12.4 12.8 10.9 3.6 2.7 0.9 5.4 0.9 12.6 108.0 0.1 1.1 138.7 1.6 15979.8 4.3 2.5 0.8 11.2 3.2 2.7 3.5 12.2 1.0 5.0 5883.1 0.9 1.7 3.0 12.0 0.1 2.5 1.7 2.2 0.2 0.3 0.6 0.4 0.2 0.4 0.5 0.9 1.5 1.0 1.6 0.3 1.7 0.9 0.3 0.0 0.0 0.9 2.6 0.7 2.0 0.4 0.1 0.6 0.3 0.7 0.3 1.0 0.1 1.0 0.2 1.1 1.6 0.3 0.0 1.1 0.7 5.3 1.0 0.9 0.6 0.7 1.5 0.7 0.8 0.2 1.0 1.7 1.3 8.4 1.1 0.9 0.6 1.1 1.1 0.8 1.0 1.4 0.5 3.7 2.0 0.5 0.6 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.9 14.2 12.8 16.2 11.0 11.8 12.4 12.8 10.9 12.6 11.2 12.2 12.0 3.3 0.0 0.0 8.1 0.7 1.7 0.5 0.3 0.0 1.5 1.5 0.9 2473.2 5.7 0.3 1.8 0.0 0.1 0.3 0.4 1.9 0.3 0.4 0.9 0.5 29.0 3.0 1.3 2.2 0.0 0.0 68.5 1.5 0.6 0.0 0.8 2.2 0.0 0.4 10.1 2.7 1.1 0.0 0.6 2.0 0.1 0.3 2.9 1.8 1.0 0.1 0.8 0.0 1.0 2.6 0.5 0.6 0.4 0.9 0.7 0.5 0.3 0.6 1.7 6.6 336.9 25.4 1.0 1.2 0.0 2.0 0.4 1.9 0.5 1.2 0.7 CCS ENSG00000173992 "Copper chaperone for superoxide dismutase" O14618 11 66593153-66606019 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008672, HPA040026, HPA044090" Approved NA NA 190000 "CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805" "unprognostic (1.19e-1)" "unprognostic (8.46e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.57e-2)" "unprognostic (3.22e-2)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.01e-1)" "unprognostic (3.00e-1)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-3)" 21.3 26.9 28.1 18.6 27.9 34.7 14.3 30.2 40.8 18.5 29.2 20.0 28.1 20.0 18.4 16.7 17.9 21.3 21.6 30.0 28.3 21.5 56.7 15.8 24.0 29.8 28.0 26.5 23.8 31.4 22.7 17.4 18.0 27.9 22.8 14.8 25.1 37.1 20.2 19.3 22.1 30.3 17.3 27.5 22.0 23.5 17.0 28.8 16.0 17.4 14.3 17.5 17.9 14.8 32.3 24.6 34.1 24.4 26.9 22.0 21.4 29.9 22.4 18.7 15.9 10.7 38.8 26.5 14.4 31.3 19.9 23.8 24.6 7.2 25.8 5.3 26.8 10.9 23.3 30.5 51.1 42.3 6.0 18.3 35.8 18.9 16.9 11.1 33.6 26.0 16.5 12.3 19.2 16.5 55.0 9.5 30.1 22.7 40.2 23.9 17.4 23.3 29.8 25.0 25.6 19.9 12.9 37.2 25.4 49.7 14.4 38.9 17.4 23.6 10.8 17.7 24.4 10.8 32.1 19.2 7.6 29.7 9.2 26.5 23.6 26.4 60.0 19.7 21.0 17.0 32.5 16.9 16.0 31.1 25.3 17.7 17.9 17.8 19.1 13.0 83.7 18.4 17.3 28.1 27.9 30.2 40.8 30.0 28.3 29.8 28.0 26.5 27.9 27.5 28.8 32.3 37.8 19.2 33.7 58.8 56.1 24.2 52.9 44.7 31.3 42.4 33.6 37.5 29.9 45.8 30.4 36.8 25.0 55.2 59.3 49.7 82.2 34.1 25.4 16.5 38.0 28.7 73.0 204.4 20.2 59.8 43.8 60.4 44.4 27.2 21.5 63.9 39.3 163.5 64.9 11.8 19.1 41.1 26.4 35.8 32.3 12.6 71.4 43.8 44.4 23.4 38.5 65.4 44.3 15.1 20.6 40.5 44.9 57.2 50.6 31.2 90.4 132.9 19.7 104.2 19.7 31.8 67.1 46.7 31.4 30.1 20.3 51.6 41.0 191.3 46.7 37.2 NRROS "ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030" ENSG00000174004 "Negative regulator of reactive oxygen species" Q86YC3 3 196639694-196662004 "Disease related genes, Predicted membrane proteins" "Growth factor binding" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.0" "Cell type enhanced" "Detected in many" "B-cells: 40.2;Erythroid cells: 27.5;Hofbauer cells: 76.9;Kupffer cells: 35.5;Langerhans cells: 59.9;Macrophages: 33.3;Microglial cells: 31.9;NK-cells: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;granulocytes: 4.2;monocytes: 1.1" "Cell line enhanced" "Detected in many" "HEL: 53.1;HMC-1: 106.4;Karpas-707: 66.7;MOLT-4: 59.8;NB-4: 138.5;RPMI-8226: 68.9;THP-1: 60.5;U-937: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031586 Uncertain NA NA "HPA031586: AB_10601543" "unprognostic (5.28e-2)" "unprognostic (8.92e-3)" "unprognostic (1.02e-1)" "unprognostic (3.05e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-3)" "unprognostic (1.05e-1)" "unprognostic (9.67e-2)" "unprognostic (3.20e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (6.73e-3)" "unprognostic (1.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" 7.5 2.7 1.6 8.6 1.4 33.0 5.1 1.5 1.9 2.4 1.8 2.5 2.4 2.9 0.5 2.1 2.8 4.2 2.6 1.4 2.9 2.4 2.5 7.7 10.6 2.1 1.8 0.8 1.2 1.1 0.9 1.2 10.0 2.3 2.0 1.6 0.3 2.5 1.6 1.3 1.9 5.1 4.2 2.9 15.8 2.3 1.3 2.9 7.7 2.2 2.5 3.7 4.5 2.2 3.1 0.1 0.0 0.3 0.0 0.4 1.0 0.1 0.4 2.1 0.4 0.3 0.1 0.2 0.0 6.7 0.4 0.3 0.1 1.1 0.0 0.1 4.0 0.1 53.1 0.0 0.0 0.5 43.7 106.4 0.4 0.0 1.7 0.7 2.1 4.3 48.6 5.5 66.7 1.2 0.1 59.8 138.5 4.4 0.0 0.1 15.7 0.1 68.9 0.1 0.4 0.3 0.0 0.1 0.1 28.0 0.9 0.1 60.5 0.5 0.5 0.2 1.9 0.1 26.5 43.1 12.1 3.4 76.1 0.7 4.2 1.0 1.8 0.3 1.0 0.1 0.3 0.2 0.2 1.3 0.2 0.1 0.2 0.0 0.3 1.1 0.2 0.3 0.7 1.6 1.4 1.5 1.9 1.4 2.9 2.1 1.8 0.8 2.3 2.9 2.9 3.1 5.6 0.0 0.5 0.0 40.2 1.5 0.1 0.0 2.2 0.4 0.4 0.3 0.3 0.0 0.6 0.0 4.2 0.3 15.5 0.0 0.0 0.0 1.4 0.0 0.4 10.1 0.0 27.5 1.8 0.0 0.7 0.7 0.5 0.1 14.5 0.1 15.4 0.2 76.9 0.0 2.7 0.0 0.0 35.5 59.9 0.4 0.6 33.3 8.8 31.9 24.1 0.1 33.0 1.0 0.3 0.0 0.0 0.7 25.7 0.0 0.0 0.1 0.0 0.4 6.6 0.3 0.3 2.7 0.4 0.2 0.9 0.5 10.8 0.5 0.0 0.0 CEP19 "C3orf34, MGC14126" ENSG00000174007 "Centrosomal protein 19" Q96LK0 3 196706277-196712250 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 54.8;Spermatocytes: 66.3;Spermatogonia: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 51.5;eosinophil: 59.0;neutrophil: 144.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 144.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047614, HPA071138" Enhanced Supported Centrosome NA NA Centrosome "HPA047614: AB_2680103, HPA071138: AB_2686348" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (5.11e-2)" "unprognostic (9.31e-2)" "unprognostic (5.51e-3)" "unprognostic (4.66e-2)" "unprognostic (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (2.36e-2)" "unprognostic (1.91e-1)" "unprognostic (3.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.33e-2)" 1.7 2.6 5.4 3.1 5.2 1.2 1.1 4.7 6.4 1.7 5.3 1.2 0.9 1.6 3.1 1.6 4.2 1.9 1.3 5.6 5.6 2.7 1.1 1.6 2.9 5.1 5.3 5.1 1.8 0.7 3.4 3.9 2.0 5.5 1.7 1.0 6.6 1.2 2.1 0.6 1.6 1.2 1.4 5.1 3.4 0.9 10.0 5.2 7.7 2.3 1.8 3.5 1.8 1.5 5.5 6.0 4.1 5.6 3.5 12.6 9.6 1.6 4.8 9.0 5.1 6.6 2.1 3.9 4.4 13.3 2.4 11.1 2.6 3.8 1.1 5.9 6.2 3.8 6.8 2.0 0.6 5.0 3.1 8.3 4.4 5.5 6.6 1.8 9.3 2.0 5.4 3.8 5.4 5.2 3.1 7.8 5.6 2.9 2.6 6.9 9.0 3.4 2.9 5.4 0.5 5.6 4.0 6.4 0.8 7.6 4.7 5.0 5.9 1.7 5.8 1.3 9.1 3.2 16.2 16.6 9.1 8.4 7.9 5.8 51.5 4.0 59.0 5.4 3.2 6.0 3.8 8.0 7.3 2.6 4.4 10.3 6.6 144.2 7.3 3.7 11.0 4.8 3.9 5.4 5.2 4.7 6.4 5.6 5.6 5.1 5.3 5.1 5.5 5.1 5.2 5.5 2.6 0.0 2.0 3.6 4.5 2.0 1.3 2.2 5.2 5.8 2.7 3.0 2.0 2.8 2.1 1.8 0.0 1.8 5.1 0.6 5.9 2.0 54.8 14.8 5.2 3.7 0.0 1.3 8.4 0.8 1.5 3.4 0.0 1.3 1.3 5.0 5.0 0.3 3.1 5.0 6.6 0.4 4.1 2.2 4.7 6.3 6.5 2.4 0.0 1.0 15.3 9.5 14.4 1.5 1.4 0.8 0.0 5.3 7.1 0.8 0.1 4.9 21.4 8.3 0.0 2.9 2.2 66.3 39.6 2.1 0.9 0.4 3.9 8.8 0.4 0.5 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol NA NA Cytosol Aggresome "HPA065730: AB_2685547" "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 4.9 9.6 3.2 3.7 3.6 53.6 3.3 4.2 3.8 4.1 3.9 3.2 2.9 5.1 8.1 8.8 4.2 4.6 3.3 3.5 6.2 5.0 12.9 3.4 4.0 3.1 3.5 2.8 5.9 6.5 7.3 3.3 3.4 3.0 5.9 3.1 5.6 2.5 4.0 3.6 2.1 3.0 5.1 3.1 4.1 4.0 18.4 3.5 6.2 5.2 3.2 3.5 3.5 1.8 3.3 5.0 4.8 5.2 7.7 7.6 5.4 5.4 7.9 6.9 3.6 4.3 4.4 4.4 13.2 2.7 5.2 5.6 3.7 8.4 4.3 8.7 5.2 17.2 8.4 13.4 2.3 4.8 11.0 5.6 5.7 2.2 6.2 6.0 3.2 2.6 7.7 5.4 18.0 6.7 1.7 9.9 10.7 9.9 2.5 5.8 7.8 9.5 8.2 3.3 4.4 13.7 6.5 11.0 2.6 9.2 6.5 3.6 9.7 3.3 5.4 3.3 10.9 5.2 9.9 10.6 14.8 4.3 7.0 4.4 0.2 0.2 0.5 0.3 0.4 0.4 0.1 0.3 0.3 0.3 0.2 0.4 0.4 0.2 0.2 0.4 0.3 0.3 0.2 3.2 3.6 4.2 3.8 3.5 6.2 3.1 3.5 2.8 3.0 3.1 3.5 3.3 20.1 6.4 7.9 4.2 10.4 18.0 4.5 4.0 18.8 8.1 18.7 16.9 11.5 5.7 5.4 3.7 12.5 0.5 12.2 3.9 0.0 1.4 3.1 15.5 20.7 10.5 8.4 6.9 7.0 1.4 1.3 12.7 6.6 31.4 8.2 6.3 8.9 11.9 3.6 20.2 9.1 5.0 2.0 9.1 14.1 2.8 3.4 19.8 12.4 3.7 3.9 7.9 3.1 6.0 5.4 1.6 0.7 4.1 8.8 5.6 3.8 2.4 2.8 7.6 0.0 22.6 16.4 2.8 17.7 15.3 9.9 1.4 11.7 13.3 4.8 3.3 FBXO45 Fbx45 ENSG00000174013 "F-box protein 45" P0C2W1 3 196568611-196589059 "Predicted intracellular proteins" "Neurogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040730 Uncertain Approved Cytosol NA NA Cytosol "HPA040730: AB_10959311" "unprognostic (7.17e-3)" "unprognostic (1.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.01e-2)" "unprognostic (8.14e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.61e-5)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.13e-2)" "unprognostic (9.48e-3)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.16e-5)" "prognostic unfavorable (4.93e-5)" "unprognostic (5.18e-2)" "unprognostic (1.66e-1)" "unprognostic (6.93e-2)" "unprognostic (1.65e-1)" 5.1 4.3 12.0 6.1 12.7 14.0 7.4 13.1 14.2 4.5 8.1 6.9 5.4 4.8 3.1 9.0 3.6 4.5 3.7 12.0 12.3 3.8 6.9 4.6 6.8 12.0 12.3 11.0 5.1 4.7 7.3 3.2 5.4 11.7 5.1 7.1 8.3 4.1 4.3 13.9 12.8 5.1 5.0 13.0 5.1 5.6 12.3 12.5 8.9 3.7 11.6 10.1 6.9 5.1 12.6 45.5 8.5 17.6 22.4 11.6 11.4 20.9 19.7 9.0 15.3 15.6 23.9 15.1 19.1 33.1 12.8 22.8 19.0 33.9 22.5 28.1 27.7 15.3 34.8 15.5 15.1 11.1 46.9 17.1 5.8 24.9 17.3 31.8 8.0 16.9 30.5 42.4 39.2 17.2 45.3 27.5 21.9 27.4 40.3 32.5 23.1 23.0 46.2 12.9 18.3 35.6 24.4 21.4 36.8 23.5 15.4 63.3 31.1 16.8 17.7 19.1 25.7 53.8 38.3 68.5 52.6 15.4 59.6 17.3 1.3 0.9 1.1 0.8 0.9 1.4 0.5 0.8 0.5 1.2 0.8 0.8 0.9 0.4 0.6 1.1 1.4 1.6 0.4 12.0 12.7 13.1 14.2 12.0 12.3 12.0 12.3 11.0 11.7 13.0 12.5 12.6 10.2 12.8 4.1 6.5 6.6 9.8 10.2 5.6 4.6 20.1 10.5 7.7 10.8 4.3 4.2 3.7 14.6 2.6 11.5 7.9 0.0 4.4 15.5 8.0 12.9 8.0 17.4 6.1 13.8 7.7 4.6 7.8 10.7 8.8 1.3 6.9 7.9 9.9 5.8 13.5 15.0 8.2 4.1 9.1 11.0 18.9 5.6 7.6 5.4 8.4 8.3 9.3 4.1 6.6 12.4 8.3 4.8 6.4 8.0 14.8 4.0 3.4 6.8 10.7 0.0 10.5 7.5 32.4 24.4 9.4 13.5 1.9 8.2 7.1 9.8 14.5 CBY2 "NURIT, SPERT" ENSG00000174015 "Chibby family member 2" Q8NA61 13 45702320-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 579 "testis: 99.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 99.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TENT5D "CT1.26, CT112, FAM46D, MGC26999" ENSG00000174016 "Terminal nucleotidyltransferase 5D" Q8NEK8 X 80335504-80445311 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA059362 Uncertain NA NA "HPA059362: AB_2683991" "unprognostic (3.49e-1)" "unprognostic (1.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.59e-1)" "unprognostic (4.64e-1)" "unprognostic (4.28e-2)" "unprognostic (8.21e-3)" "unprognostic (2.95e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 GNG5 ENSG00000174021 "G protein subunit gamma 5" P63218 1 84498325-84506581 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB032623, HPA043651" Approved NA NA 37000 "CAB032623: AB_2109919, HPA043651: AB_2678600" "unprognostic (1.82e-2)" "unprognostic (9.27e-2)" "unprognostic (2.87e-2)" "unprognostic (2.75e-3)" "unprognostic (6.19e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (3.23e-5)" "unprognostic (1.59e-1)" "unprognostic (9.28e-2)" "unprognostic (8.93e-3)" "unprognostic (2.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.72e-3)" "unprognostic (1.64e-1)" "unprognostic (6.51e-2)" "unprognostic (3.44e-2)" "unprognostic (4.22e-2)" 125.3 94.2 44.3 78.0 49.1 178.2 115.2 47.7 76.7 104.0 52.5 126.9 111.4 100.7 69.8 150.1 97.9 56.9 256.7 44.2 67.2 163.8 166.8 161.2 78.2 51.1 47.1 41.3 78.8 119.5 63.2 72.5 76.1 50.4 97.3 101.2 19.2 109.4 56.8 268.7 103.7 113.6 67.8 48.6 150.1 143.4 97.2 50.9 103.7 107.7 165.6 94.8 101.4 103.5 54.4 205.2 82.4 218.6 189.3 143.5 161.9 263.4 194.6 130.3 230.2 241.5 107.4 123.8 127.8 179.9 184.6 346.3 105.2 127.3 183.3 195.1 165.2 200.7 264.4 83.9 213.9 245.7 184.7 96.9 148.0 223.5 228.0 139.9 132.3 247.1 146.8 249.0 194.2 222.9 55.5 268.7 405.3 287.7 139.7 255.2 171.0 271.4 151.2 301.7 100.2 66.2 212.6 141.0 186.6 395.0 169.1 133.6 240.4 193.7 179.0 213.3 264.5 250.4 213.0 157.3 192.4 104.8 240.5 169.2 512.9 447.6 425.3 192.8 568.4 154.7 286.4 204.1 190.5 428.5 226.8 163.6 177.5 879.6 218.7 655.9 461.8 269.9 426.7 44.3 49.1 47.7 76.7 44.2 67.2 51.1 47.1 41.3 50.4 48.6 50.9 54.4 327.9 266.0 231.9 15.7 150.2 278.6 316.7 478.4 224.8 3.4 286.2 398.1 1037.7 303.1 364.7 277.7 6.2 405.2 248.3 668.3 716.1 413.6 777.6 344.8 218.5 296.1 210.0 277.0 2.0 486.0 486.6 213.9 209.5 342.8 174.8 216.1 280.6 382.0 599.6 18.5 1.2 405.6 319.4 371.5 463.1 122.3 181.1 417.2 249.1 15.9 564.4 430.9 241.0 3.0 4.0 631.1 639.7 195.6 322.0 496.2 571.6 724.9 312.3 16.7 131.5 195.4 271.3 206.8 133.7 367.5 261.0 311.7 171.1 134.1 421.0 541.2 SLC25A30 ENSG00000174032 "Solute carrier family 25 member 30" Q5SVS4 13 45393316-45418455 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 72.3;skeletal muscle: 87.1;tongue: 63.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 38.8;Hepatocytes: 43.6;Proximal tubular cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045260 Approved Nucleoplasm NA NA Nucleoplasm "HPA045260: AB_10962505" "unprognostic (9.23e-2)" "unprognostic (9.92e-2)" "unprognostic (1.05e-1)" "unprognostic (4.28e-2)" "unprognostic (1.96e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-2)" "unprognostic (3.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (5.69e-2)" "unprognostic (1.58e-1)" "prognostic favorable (9.91e-8)" "unprognostic (2.24e-1)" "unprognostic (5.19e-2)" "unprognostic (4.12e-1)" "unprognostic (6.19e-3)" 9.6 10.0 5.2 6.0 6.3 10.6 8.4 5.2 6.1 9.8 8.8 5.5 4.3 9.2 6.9 7.1 6.6 7.6 72.3 4.8 8.1 42.3 32.5 7.8 8.4 5.6 5.4 4.5 18.7 5.5 5.1 4.3 4.3 5.9 13.7 6.0 1.7 8.3 12.8 87.1 5.9 4.5 10.2 5.6 11.6 5.1 6.2 5.4 5.2 11.5 63.9 8.0 6.4 6.3 5.5 3.9 8.4 5.0 21.4 24.4 15.5 1.7 18.2 10.5 15.3 9.2 8.8 10.4 0.0 15.5 18.6 11.4 7.4 11.6 18.2 18.1 12.8 9.4 14.6 5.5 23.8 14.4 20.9 18.9 10.1 12.1 22.6 16.7 18.0 26.9 14.3 8.9 0.0 31.3 4.6 7.7 14.6 7.3 4.5 10.7 19.1 8.3 7.8 33.3 3.2 1.0 5.0 10.2 16.1 14.7 8.6 12.0 28.0 10.0 14.2 8.0 16.0 12.6 3.7 8.0 0.3 15.6 19.5 22.3 0.0 1.2 1.9 0.8 1.3 0.6 0.6 0.9 0.9 1.7 0.6 1.0 0.4 0.0 0.7 0.6 2.2 0.3 0.5 5.2 6.3 5.2 6.1 4.8 8.1 5.6 5.4 4.5 5.9 5.6 5.4 5.5 6.2 6.4 2.2 4.2 4.5 12.9 2.0 4.2 1.2 1.9 8.6 4.4 38.8 8.6 2.5 14.7 4.2 0.8 5.6 1.6 23.5 3.2 10.1 7.4 3.5 6.0 2.4 3.0 3.6 1.4 0.9 2.6 1.1 7.8 5.1 7.7 9.3 43.6 4.1 0.0 4.2 3.4 6.1 10.0 7.7 7.7 5.0 6.5 5.4 5.6 6.6 0.9 3.1 4.0 0.8 2.2 1.6 6.4 3.9 3.9 2.1 29.5 3.4 1.0 6.6 3.6 3.3 0.3 1.8 3.8 6.1 0.5 6.6 8.6 3.3 1.5 C9orf131 MGC41945 ENSG00000174038 "Chromosome 9 open reading frame 131" Q5VYM1 9 35041095-35045986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 36.1" "Group enriched" "Detected in some" 18 "Early spermatids: 129.6;Late spermatids: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA022029 Approved Mitochondria NA NA Mitochondria "HPA022029: AB_10960628" "unprognostic (1.10e-2)" "unprognostic (8.99e-2)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-3)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.66e-1)" "unprognostic (9.45e-2)" "unprognostic (4.63e-2)" "unprognostic (1.75e-2)" "unprognostic (2.37e-2)" "unprognostic (9.34e-2)" "unprognostic (1.82e-1)" "unprognostic (9.90e-4)" "unprognostic (4.19e-3)" 0.3 0.2 0.9 0.6 1.2 2.7 0.7 6.8 2.7 1.3 0.3 0.6 0.3 2.7 1.3 0.2 0.1 2.1 0.4 1.8 0.9 0.4 0.7 0.2 0.8 1.7 0.9 0.3 0.2 0.2 0.4 0.1 0.5 2.9 0.2 0.7 1.4 0.1 0.1 1.3 1.1 0.3 0.2 0.3 0.6 0.4 36.1 1.0 0.1 0.7 0.0 0.2 0.5 0.0 2.2 2.0 0.3 0.2 0.1 0.4 0.0 0.8 0.4 0.0 0.0 0.0 0.6 1.2 0.4 0.2 0.0 0.7 1.4 0.0 0.0 0.2 0.3 0.3 0.8 2.0 0.5 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.0 0.3 0.7 1.8 1.6 0.0 0.4 0.3 0.8 0.4 0.5 0.0 0.0 0.2 0.0 0.2 9.1 0.2 0.0 0.5 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.8 0.0 0.1 0.8 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.9 1.2 6.8 2.7 1.8 0.9 1.7 0.9 0.3 2.9 0.3 1.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 129.6 0.5 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 35.7 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 4.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Adipocytes: 298.7;Endothelial cells: 292.4;Fibroblasts: 121.9;Hepatic stellate cells: 136.0;Leydig cells: 146.3;Peritubular cells: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 64.3;MOLT-4: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 93000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272" "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 189.3 28.8 31.0 14.0 27.5 5.8 123.4 26.8 32.2 96.2 23.1 49.4 13.6 72.2 42.7 29.2 83.5 54.8 145.0 24.8 26.7 49.7 5.7 69.7 18.2 31.8 29.0 21.8 35.7 19.1 22.0 10.2 221.4 29.3 36.5 19.5 2.3 37.7 33.5 59.0 58.6 39.6 76.1 23.8 21.9 34.7 20.4 30.5 19.2 80.2 68.8 17.2 74.6 62.1 27.9 0.0 0.0 0.2 0.0 3.2 0.3 0.2 0.4 2.4 0.7 1.7 0.0 0.0 0.0 6.2 0.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.7 64.3 1.1 0.0 0.0 1.7 0.0 66.5 0.3 0.5 0.0 0.0 0.1 3.7 0.0 0.3 0.0 0.1 0.2 0.0 0.6 0.1 0.4 2.3 0.0 9.9 0.2 2.8 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 31.0 27.5 26.8 32.2 24.8 26.7 31.8 29.0 21.8 29.3 23.8 30.5 27.9 298.7 3.2 7.8 1.6 1.0 16.7 0.2 0.3 4.6 0.6 2.1 3.0 21.9 2.8 0.1 3.7 2.1 0.2 1.5 0.0 0.0 0.5 11.6 1.0 5.2 292.4 0.0 22.3 0.2 0.2 0.3 121.9 0.5 1.0 1.3 0.1 136.0 0.6 0.4 0.0 0.1 0.0 0.0 1.2 21.8 5.0 146.3 2.4 17.8 33.7 0.3 0.2 0.0 0.5 0.3 0.2 0.0 123.0 1.6 0.3 0.0 0.1 0.0 0.2 6.6 7.7 15.2 1.0 2.0 1.5 12.9 0.1 2.2 4.0 0.0 0.3 CTSF "CATSF, CLN13" ENSG00000174080 "Cathepsin F" Q9UBX1 11 66563464-66568879 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 320.9;Muller glia cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 23.1;SK-MEL-30: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002141, HPA031431" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 5800000 Vesicles "Endoplasmic reticulum, Plasma membrane" "CAB002141: AB_563471, HPA031431: " "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (7.22e-3)" "unprognostic (2.25e-2)" "unprognostic (6.72e-2)" "unprognostic (2.67e-2)" "unprognostic (2.76e-2)" "unprognostic (3.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.69e-2)" "unprognostic (9.12e-2)" "prognostic favorable (8.92e-7)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (2.42e-1)" 57.2 70.5 67.0 0.8 70.8 0.3 62.8 71.0 74.6 78.6 81.3 58.6 3.1 89.9 22.1 15.7 71.4 10.1 78.3 60.6 67.6 46.7 66.5 33.2 3.6 72.2 70.8 56.1 99.9 32.0 20.2 43.7 3.8 69.1 54.0 3.6 26.4 56.2 17.3 92.6 43.4 29.8 12.3 71.7 25.2 54.7 110.5 66.1 3.1 40.9 27.8 3.0 57.1 59.2 84.9 0.0 17.0 3.1 5.4 14.2 8.6 3.4 13.0 11.4 6.3 2.3 0.0 2.2 0.0 21.3 10.4 0.0 1.2 6.8 2.6 4.8 3.7 0.0 0.5 7.0 0.0 9.9 0.3 4.4 22.3 9.1 0.8 1.6 13.7 3.8 2.0 5.4 1.6 5.2 4.6 0.1 1.7 0.9 3.7 9.7 0.0 0.0 1.5 7.1 0.3 4.3 6.9 23.1 0.3 59.5 0.3 7.4 0.6 3.3 1.8 2.9 1.5 1.2 21.2 0.2 0.0 2.2 0.0 2.9 0.0 0.4 0.3 3.9 0.6 4.1 1.5 3.5 4.6 0.6 1.4 6.4 4.1 0.1 4.6 0.2 0.9 1.3 2.2 67.0 70.8 71.0 74.6 60.6 67.6 72.2 70.8 56.1 69.1 71.7 66.1 84.9 36.6 12.8 15.6 31.3 5.9 39.8 62.4 8.5 37.5 107.9 45.3 80.6 57.9 41.5 7.4 36.8 41.7 31.6 9.6 0.6 15.6 13.1 163.3 1.7 22.8 27.2 12.0 11.4 26.5 7.5 9.5 118.1 8.2 5.3 9.5 52.1 56.0 67.8 14.9 134.6 31.3 3.1 18.3 21.5 32.8 320.9 145.7 13.1 156.5 12.2 3.1 196.6 17.5 21.6 29.4 5.9 3.2 121.9 12.9 50.5 1.3 44.7 3.3 77.9 78.9 62.0 45.9 169.6 43.3 3.6 25.3 23.7 9.5 30.7 4.3 32.9 MSRB3 "DFNB74, DKFZp686C1178, FLJ36866" ENSG00000174099 "Methionine sulfoxide reductase B3" Q8IXL7 12 65278643-65491430 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 2801.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 41.6" "Lineage enhanced" "Detected in many" "granulocytes: 41.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014432 Enhanced "Intracellular and membrane" NA NA "HPA014432: AB_1854146" "unprognostic (1.40e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (2.86e-3)" "unprognostic (1.94e-1)" "unprognostic (2.74e-2)" "unprognostic (1.74e-2)" "unprognostic (2.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-2)" "unprognostic (5.33e-2)" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.85e-8)" "unprognostic (3.29e-3)" "unprognostic (7.80e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (2.17e-4)" 45.3 10.8 12.9 21.1 12.9 21.4 26.5 12.0 13.5 28.9 20.1 79.1 12.0 86.5 20.3 63.5 41.8 33.5 91.7 11.8 22.7 10.0 3.9 30.9 5.7 16.3 14.3 9.9 17.1 5.9 3.2 6.8 25.4 13.4 53.2 28.0 12.6 10.9 104.0 105.0 8.9 25.8 124.9 14.2 13.7 36.5 5.9 17.4 4.1 14.6 69.8 4.0 61.4 23.9 13.4 8.8 19.2 16.4 75.9 71.6 63.0 0.5 87.0 92.9 33.2 19.8 0.7 1.0 0.0 18.3 126.1 10.5 1.9 7.7 22.1 30.0 0.2 15.9 0.0 16.7 0.9 46.6 47.1 0.3 33.4 11.9 28.1 39.0 110.6 68.2 0.1 0.3 0.3 76.8 2.9 0.0 11.0 5.4 0.2 10.4 0.2 22.0 0.5 7.5 1.0 0.4 7.9 30.0 1.8 21.9 16.8 14.1 44.5 78.9 42.3 22.8 19.5 34.2 8.0 6.7 0.2 11.5 106.7 26.9 15.0 0.6 41.6 0.2 0.9 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 6.8 8.3 0.4 10.8 0.1 1.4 12.9 12.9 12.0 13.5 11.8 22.7 16.3 14.3 9.9 13.4 14.2 17.4 13.4 55.3 12.8 3.4 76.7 0.8 6.4 16.4 11.4 4.0 22.7 2.2 45.3 2801.7 4.3 1.2 3.7 0.0 0.4 8.3 0.0 0.0 9.3 5.7 0.9 16.7 154.2 0.0 17.4 37.1 1.0 0.4 108.8 1.1 0.4 2.5 7.4 28.2 0.2 0.5 21.9 56.6 0.0 0.0 0.0 13.7 2.2 12.5 4.0 10.6 62.8 1.6 44.4 2.1 37.7 1.4 1.6 0.0 116.6 0.3 14.8 0.0 0.4 6.8 10.6 105.2 37.7 218.7 4.2 4.7 0.8 4.5 0.7 2.4 10.3 0.0 2.9 LEMD3 MAN1 ENSG00000174106 "LEM domain containing 3" Q9Y2U8 12 65169583-65248355 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025078, HPA076986" Uncertain Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA025078: AB_10601908, HPA076986: AB_2686821" "unprognostic (2.10e-2)" "unprognostic (6.83e-3)" "unprognostic (1.63e-3)" "unprognostic (1.76e-3)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (1.68e-3)" "unprognostic (7.22e-2)" "unprognostic (3.06e-2)" "unprognostic (4.16e-2)" "unprognostic (8.89e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.30e-4)" "unprognostic (4.37e-2)" "unprognostic (3.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.72e-1)" 9.4 7.4 7.5 10.6 8.6 21.0 10.7 13.2 9.4 8.5 7.6 10.5 9.7 12.3 8.8 8.1 9.3 7.0 7.2 9.1 7.7 9.7 9.6 9.4 13.6 7.1 8.1 7.7 12.0 9.9 14.8 5.4 7.3 7.7 9.5 10.1 16.7 9.4 7.8 8.8 8.1 9.5 8.4 7.2 11.5 9.8 15.7 7.6 13.7 10.7 9.7 12.4 8.9 8.1 8.4 19.7 10.9 17.1 17.2 11.8 13.6 11.7 22.4 12.0 11.0 9.5 13.7 12.4 53.2 14.1 13.9 8.5 25.8 18.5 16.0 15.9 12.8 21.4 21.7 10.2 10.5 9.0 33.4 15.1 9.9 16.9 13.1 17.6 15.5 13.1 14.6 28.9 24.6 15.6 11.5 17.5 17.3 23.5 8.9 11.1 40.6 16.8 26.8 13.8 21.4 17.8 10.9 22.5 22.7 14.0 16.4 22.6 26.0 18.1 13.4 14.3 12.7 15.7 17.5 17.7 32.3 11.2 16.1 16.8 1.0 0.7 1.4 1.5 0.6 2.0 1.8 2.0 2.0 1.0 1.9 1.9 2.1 0.8 1.6 0.9 2.1 1.9 0.7 7.5 8.6 13.2 9.4 9.1 7.7 7.1 8.1 7.7 7.7 7.2 7.6 8.4 21.7 38.5 21.0 29.7 29.0 32.1 19.4 10.4 14.8 20.1 15.3 11.3 14.7 8.6 13.5 11.0 18.8 8.0 32.7 20.2 0.0 10.3 2.1 16.3 18.0 17.4 14.9 16.8 50.0 13.1 4.6 18.5 13.3 19.8 22.2 12.5 14.6 13.3 6.5 16.8 58.2 13.7 12.2 13.7 16.4 3.2 15.8 16.4 17.8 49.6 16.1 20.3 17.5 53.3 52.7 14.6 14.5 12.4 23.6 18.9 7.8 4.3 19.3 21.5 6.6 23.5 19.2 43.3 35.3 17.6 39.1 14.4 21.9 13.7 11.8 22.9 C16orf91 "CCSMST1, gs103, URLC5" ENSG00000174109 "Chromosome 16 open reading frame 91" Q4G0I0 16 1419752-1420756 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.97e-2)" "unprognostic (4.62e-2)" "unprognostic (4.11e-3)" "unprognostic (6.35e-2)" "unprognostic (2.11e-1)" "unprognostic (2.10e-1)" "unprognostic (5.47e-3)" "unprognostic (5.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.26e-1)" "unprognostic (4.33e-1)" "unprognostic (7.12e-2)" "prognostic favorable (1.11e-4)" "unprognostic (9.81e-3)" "unprognostic (5.67e-2)" "unprognostic (4.19e-2)" "unprognostic (9.97e-2)" 6.7 14.5 13.2 4.4 13.3 8.1 7.7 13.2 14.6 6.1 13.6 8.6 7.8 7.2 5.9 10.0 8.0 4.7 10.9 13.6 13.2 8.9 12.5 5.2 8.1 13.2 13.0 13.1 6.5 8.4 7.8 5.2 7.0 13.5 6.6 6.3 5.9 6.3 7.6 14.1 10.3 7.6 6.4 12.9 8.0 8.2 7.9 13.3 10.2 5.7 16.1 7.7 7.9 6.7 13.3 16.6 31.4 11.3 11.9 18.1 13.6 13.4 12.9 13.8 23.3 19.4 30.3 26.2 15.7 18.8 15.1 17.4 16.6 20.6 21.5 12.9 15.7 29.6 8.9 31.3 24.3 24.7 24.3 12.0 14.9 35.1 22.2 23.5 11.1 19.4 27.1 27.4 25.2 13.8 42.3 20.7 21.3 19.4 26.4 23.0 32.6 11.1 39.1 19.5 8.8 13.9 19.4 16.6 26.1 17.4 7.5 23.8 46.6 12.2 12.1 9.3 9.5 14.6 17.5 20.8 31.2 10.3 15.8 14.6 27.1 23.5 12.5 31.7 23.2 34.0 42.9 28.8 24.5 26.9 32.9 33.6 26.6 12.8 40.2 15.8 37.6 25.2 18.1 13.2 13.3 13.2 14.6 13.6 13.2 13.2 13.0 13.1 13.5 12.9 13.3 13.3 20.5 6.4 6.7 3.3 21.8 44.4 26.8 36.7 25.0 13.8 30.8 34.7 13.8 21.5 21.1 7.3 12.5 33.8 27.0 22.3 45.0 23.4 3.9 21.4 20.5 21.0 15.6 21.2 5.8 20.7 26.9 16.6 13.7 19.6 15.2 23.2 13.9 21.6 21.6 13.5 5.4 23.5 26.4 10.9 15.7 2.0 13.1 11.2 16.0 1.0 23.7 26.3 25.7 4.0 5.0 22.6 16.6 11.3 21.3 39.8 21.0 25.0 29.6 25.2 13.1 21.9 18.5 20.7 22.5 35.8 61.1 36.9 22.3 30.8 29.1 30.1 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772238-38782990 "CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 48.3" "Cell type enhanced" "Detected in some" "B-cells: 57.2;dendritic cells: 9.4;Microglial cells: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 39.0;naive B-cell: 24.0" "Lineage enriched" "Detected in many" 5 "B-cells: 39.0" "Group enriched" "Detected in some" 53 "Daudi: 68.6;REH: 22.9;U-698: 24.7" "Low region specificity" "Detected in many" HPA066755 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.9 0.3 1.1 15.9 1.1 1.4 0.8 0.9 1.2 0.2 0.6 1.4 1.2 0.4 0.4 0.5 0.5 1.4 0.1 0.9 1.6 0.2 0.4 0.8 42.6 1.7 1.6 1.0 0.0 0.1 0.1 0.2 0.2 2.0 1.0 1.9 0.1 1.4 0.4 0.2 0.5 10.1 0.3 2.2 24.5 2.9 0.1 1.4 5.2 0.4 0.1 48.3 2.7 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 22.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.4 0.0 0.1 0.0 24.7 0.0 0.1 0.0 0.3 0.4 0.9 0.0 2.8 0.0 39.0 0.0 0.0 6.4 24.0 0.1 0.1 1.3 0.1 3.6 7.2 0.0 1.8 1.1 1.1 0.9 1.2 0.9 1.6 1.7 1.6 1.0 2.0 2.2 1.4 2.1 0.2 0.0 1.1 0.0 57.2 0.4 0.2 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.1 0.1 0.6 1.2 2.7 0.3 0.0 0.0 0.9 0.0 0.2 1.3 0.0 0.4 0.3 0.8 0.0 0.3 0.2 0.0 1.9 0.8 0.0 0.0 4.5 0.0 16.9 1.0 0.2 0.0 4.5 0.1 0.0 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 TLR1 "CD281, KIAA0012, rsc786" ENSG00000174125 "Toll like receptor 1" Q15399 4 38790677-38856817 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.7;lymphoid tissue: 27.2" "Cell type enhanced" "Detected in many" "B-cells: 15.4;Hofbauer cells: 14.9;Kupffer cells: 34.9;Macrophages: 32.7;Microglial cells: 29.0;monocytes: 19.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 128.5" "Group enriched" "Detected in all" 6 "granulocytes: 128.5;monocytes: 42.7" "Cell line enhanced" "Detected in many" "Daudi: 11.3;HUVEC TERT2: 12.6;RPMI-8226: 14.4;U-698: 20.6;U-937: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (7.82e-2)" "unprognostic (3.35e-3)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (3.88e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-2)" "unprognostic (1.76e-1)" "unprognostic (7.25e-3)" "unprognostic (4.08e-2)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (3.97e-2)" 8.9 4.2 1.7 27.2 2.6 34.7 7.4 2.5 2.4 4.6 3.3 4.9 6.6 6.1 2.1 3.3 6.1 9.7 2.3 1.7 4.6 4.4 8.9 10.9 16.3 4.9 2.7 0.7 10.3 5.1 1.6 1.0 10.1 4.7 3.6 6.9 1.4 9.0 3.7 0.5 1.8 6.2 9.9 4.9 25.1 6.5 1.3 3.3 8.2 1.6 3.4 19.9 8.1 1.1 5.5 0.2 2.0 0.1 0.0 0.3 1.5 0.0 0.0 0.5 0.1 1.1 0.2 5.4 11.3 1.1 0.0 5.3 0.3 0.1 1.4 0.3 1.3 0.5 1.4 0.5 0.0 0.1 2.1 0.6 0.4 0.3 0.5 0.0 0.4 12.6 0.2 1.6 3.3 1.7 0.0 0.5 4.6 0.0 0.0 0.0 7.7 0.1 14.4 1.3 0.0 0.0 1.5 0.0 0.1 0.5 0.1 0.1 2.7 3.3 1.1 0.5 0.1 0.7 1.2 0.2 20.6 2.8 7.7 0.3 0.1 22.0 8.3 3.0 30.8 2.3 6.5 3.2 2.5 13.8 5.6 3.1 1.8 128.5 5.6 42.7 4.5 1.3 9.0 1.7 2.6 2.5 2.4 1.7 4.6 4.9 2.7 0.7 4.7 4.9 3.3 5.5 1.0 0.0 1.5 1.0 15.4 0.3 0.6 3.0 1.8 0.3 2.9 1.1 0.2 0.0 4.4 1.8 0.0 0.1 8.6 0.6 1.9 5.5 0.0 6.1 0.7 2.6 0.0 0.8 0.7 4.4 0.2 3.1 2.0 4.7 3.8 0.1 0.4 2.5 14.9 0.0 1.6 0.4 2.0 34.9 14.6 0.2 0.0 32.7 0.0 29.0 19.2 1.9 6.2 3.5 2.2 2.0 0.3 2.6 2.1 1.1 0.6 1.1 7.8 0.2 0.0 3.9 0.5 0.1 0.3 0.8 0.6 0.1 6.1 2.6 1.4 1.4 TLR6 CD286 ENSG00000174130 "Toll like receptor 6" Q9Y2C9 4 38823715-38856817 "CD markers, Enzymes, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.9" "Cell type enhanced" "Detected in some" "B-cells: 13.6;Hofbauer cells: 7.2;Kupffer cells: 12.2;Langerhans cells: 6.6;Macrophages: 11.6;Microglial cells: 20.6;monocytes: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "neutrophil: 13.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.3;GAMG: 13.5;RPMI-8226: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062733 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA062733: AB_2684853" "unprognostic (9.82e-2)" "unprognostic (4.76e-2)" "unprognostic (3.30e-2)" "unprognostic (3.05e-2)" "unprognostic (1.91e-1)" "unprognostic (1.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.45e-2)" "unprognostic (9.26e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (7.62e-7)" "unprognostic (4.89e-2)" "unprognostic (1.02e-2)" "unprognostic (7.78e-2)" "unprognostic (2.12e-2)" 1.6 1.6 1.0 10.4 1.3 6.6 1.5 1.4 1.5 1.0 1.6 1.6 1.6 1.0 0.5 1.4 1.2 3.6 0.5 1.0 2.2 0.4 2.0 2.6 10.9 2.3 1.6 0.3 1.3 0.4 0.5 0.4 2.7 2.6 0.9 2.1 0.1 2.0 0.5 0.3 0.7 4.5 2.0 3.5 9.8 2.2 0.3 2.2 2.0 0.6 1.3 13.9 3.2 0.8 3.2 1.6 6.1 0.2 0.1 0.3 6.8 0.0 1.7 7.3 0.7 2.4 0.0 13.3 7.5 2.8 0.3 13.5 0.7 0.1 1.3 1.1 0.0 0.5 3.4 7.3 0.2 0.4 3.9 5.5 2.9 1.4 2.9 1.6 0.2 1.5 1.1 3.9 2.3 3.3 0.0 0.0 6.7 0.2 0.0 1.0 3.7 3.2 10.8 0.4 0.1 0.0 0.1 0.2 0.0 1.0 0.3 0.3 2.0 2.1 2.3 7.8 0.9 2.7 0.1 0.0 6.1 5.3 4.4 1.7 0.0 2.6 0.8 0.2 2.5 0.0 1.7 0.1 0.1 1.8 1.0 0.2 0.1 13.4 0.3 1.3 1.2 0.3 0.7 1.0 1.3 1.4 1.5 1.0 2.2 2.3 1.6 0.3 2.6 3.5 2.2 3.2 0.6 0.0 0.0 0.3 13.6 0.6 1.2 0.3 0.0 0.6 1.2 0.8 1.2 0.0 0.2 0.0 0.0 0.0 2.2 0.2 0.0 0.5 0.0 0.5 0.7 1.1 0.0 0.4 0.2 0.2 0.2 0.9 0.0 1.2 2.5 0.3 0.4 0.2 7.2 0.0 0.9 0.1 0.0 12.2 6.6 0.0 0.6 11.6 0.0 20.6 14.0 0.2 1.0 0.5 0.3 0.3 0.1 0.7 3.7 0.9 0.2 0.0 1.3 0.8 0.0 0.9 0.5 0.2 0.0 0.2 0.9 0.3 1.7 1.4 0.1 0.8 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535374-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 154.5;Respiratory ciliated cells: 222.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 55.8" "Lineage enriched" "Detected in all" 10 "granulocytes: 55.8" "Cell line enhanced" "Detected in all" "U-266/84: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 16.3 23.3 16.0 8.2 16.0 2.8 15.4 15.1 16.8 11.1 22.5 12.4 11.3 12.2 12.2 24.5 35.1 7.6 18.7 15.4 18.8 17.4 15.9 17.4 5.7 15.8 14.8 14.3 10.2 22.8 29.5 27.6 15.3 15.9 18.4 8.6 16.9 17.5 11.9 43.2 29.3 10.4 8.0 16.3 10.3 15.6 22.2 15.3 5.3 13.8 25.0 5.5 13.1 17.0 17.2 10.3 10.7 4.3 13.6 10.3 8.4 15.1 23.1 12.9 9.3 12.7 2.2 13.1 1.8 46.2 10.1 16.2 8.6 3.6 15.1 7.0 12.8 10.9 1.3 18.6 6.4 13.9 5.3 12.4 10.7 35.4 7.2 5.5 21.3 14.3 5.3 3.8 13.7 15.9 20.7 1.6 11.1 2.4 1.2 29.1 3.6 16.2 18.2 17.0 12.3 8.6 23.4 16.2 14.5 13.7 5.0 13.9 11.5 16.1 11.7 7.4 19.0 18.5 44.3 61.5 2.4 14.5 7.1 10.4 7.9 4.9 7.1 3.3 5.5 5.1 2.8 3.3 4.0 4.4 3.3 2.9 3.8 55.8 5.5 5.7 4.4 4.4 3.3 16.0 16.0 15.1 16.8 15.4 18.8 15.8 14.8 14.3 15.9 16.3 15.3 17.2 40.8 32.1 31.8 13.1 13.8 88.1 31.4 80.3 43.3 29.7 57.3 31.2 17.4 34.3 54.7 29.5 4.2 44.5 10.0 17.8 43.0 30.6 33.2 154.5 13.8 27.1 34.8 20.6 26.0 30.0 40.3 26.9 18.8 25.3 13.3 8.1 35.0 30.6 23.5 30.3 38.3 32.3 85.5 16.8 22.1 10.1 18.0 14.1 49.8 15.9 17.1 75.4 6.2 19.1 25.1 30.2 23.3 24.5 60.7 28.1 23.2 40.0 222.5 42.3 13.1 48.7 24.3 91.5 20.7 59.6 115.1 50.3 13.8 18.4 18.9 43.1 RGMB "DRAGON, FLJ90406" ENSG00000174136 "Repulsive guidance molecule BMP co-receptor b" Q6NW40 5 98768650-98798643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 63.9;Undifferentiated cells: 88.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 12 "B-cells: 1.6;T-cells: 3.3" "Cell line enhanced" "Detected in many" "BJ: 285.8;BJ hTERT+: 142.9;fHDF/TERT166: 178.0;HBF TERT88: 222.5;LHCN-M2: 167.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016993 Approved Nucleoplasm NA NA 560000 Nucleoplasm "HPA016993: AB_1856216" "unprognostic (1.50e-2)" "unprognostic (3.77e-2)" "unprognostic (9.03e-2)" "unprognostic (8.92e-2)" "unprognostic (2.88e-1)" "unprognostic (5.27e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (8.24e-2)" "unprognostic (2.19e-1)" "unprognostic (3.60e-3)" "unprognostic (9.00e-2)" "unprognostic (3.88e-2)" "unprognostic (3.90e-2)" "unprognostic (6.40e-2)" "unprognostic (4.20e-2)" "unprognostic (3.78e-3)" 8.9 7.7 14.1 7.2 18.8 0.4 9.2 11.9 15.5 9.4 5.8 20.7 21.6 9.3 6.1 11.9 11.2 7.6 10.3 16.3 17.6 3.7 6.1 8.2 3.8 13.2 18.6 16.6 22.0 11.3 9.3 11.4 5.5 19.4 20.9 33.6 3.8 22.0 14.0 25.0 34.0 26.4 11.0 12.1 6.0 42.1 10.5 18.7 2.6 11.6 16.3 4.5 10.9 9.6 16.0 7.3 5.2 87.8 8.1 26.2 44.5 9.1 285.8 142.9 138.5 97.6 4.4 3.5 4.2 10.2 178.0 9.7 7.5 10.4 26.0 222.5 12.5 10.2 0.0 7.1 4.9 12.6 0.9 0.1 37.1 9.4 71.1 28.2 37.6 26.3 13.6 0.0 3.5 167.1 8.1 0.1 0.1 6.0 3.3 14.0 11.4 50.7 7.9 5.4 8.4 35.6 18.0 3.9 9.4 14.1 4.4 7.5 0.4 57.4 86.7 14.2 54.1 133.5 6.0 9.1 5.8 31.9 0.1 19.1 0.0 0.0 0.2 0.1 0.0 0.7 1.1 1.5 0.6 0.0 1.6 3.3 1.5 0.1 0.1 0.0 0.0 2.4 0.8 14.1 18.8 11.9 15.5 16.3 17.6 13.2 18.6 16.6 19.4 12.1 18.7 16.0 8.6 16.0 4.1 7.5 12.7 31.0 15.3 6.0 44.3 5.7 17.8 12.4 14.3 7.2 5.3 9.2 16.7 4.5 0.4 12.8 1.9 5.0 63.9 10.2 12.7 10.3 21.8 0.0 20.8 5.3 6.2 19.1 18.8 18.0 0.0 4.0 9.3 8.2 2.1 0.0 23.6 44.6 4.1 1.0 7.2 16.9 9.0 2.4 12.4 5.6 0.7 1.7 0.0 35.2 6.6 8.4 16.3 7.2 1.7 16.1 11.9 1.6 6.1 4.0 0.0 20.3 13.1 7.4 17.5 27.0 24.4 1.8 2.9 5.4 88.9 17.4 FAM53A DNTNP ENSG00000174137 "Family with sequence similarity 53 member A" Q6NSI3 4 1617915-1684261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.9" "Cell type enhanced" "Detected in some" "Early spermatids: 12.8;Oligodendrocytes: 14.8;Spermatocytes: 14.6;Spermatogonia: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "PC-3: 3.8;SCLC-21H: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036452, HPA058138" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA036452: AB_10671841, HPA058138: AB_2683619" "unprognostic (8.78e-2)" "unprognostic (1.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.52e-1)" "unprognostic (7.59e-2)" "unprognostic (3.45e-2)" "unprognostic (5.27e-2)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (5.33e-3)" "unprognostic (7.80e-2)" "unprognostic (2.14e-3)" "unprognostic (3.73e-2)" "unprognostic (1.03e-1)" "unprognostic (5.26e-3)" "unprognostic (1.15e-3)" 1.2 1.1 1.2 0.4 1.9 0.6 1.1 1.4 1.6 1.1 0.5 1.0 0.2 1.3 1.7 0.8 1.2 0.5 0.8 0.9 1.3 1.0 1.8 0.6 0.5 2.7 2.3 0.5 1.3 1.5 0.5 5.7 0.2 3.2 0.9 0.0 0.0 1.2 0.4 1.1 1.4 0.8 0.4 1.8 1.0 1.2 12.9 1.6 0.3 3.8 0.2 0.2 1.1 0.8 3.7 0.6 0.1 0.7 1.4 0.2 0.9 0.5 2.5 1.5 1.7 1.3 0.4 0.8 1.8 1.4 0.5 0.7 0.2 0.0 0.3 0.5 0.3 0.6 0.4 0.2 0.4 1.7 0.0 0.6 0.8 1.5 0.6 1.9 0.4 0.4 2.8 1.1 0.2 0.6 0.5 0.5 1.7 0.6 0.3 3.8 0.5 0.2 0.0 0.5 0.5 4.4 2.4 1.2 0.1 2.1 0.4 1.8 0.7 0.4 0.2 0.1 0.8 0.4 0.3 1.0 0.5 0.0 0.6 3.2 0.0 0.3 0.3 0.1 0.9 0.3 0.5 0.2 0.2 0.7 0.5 1.1 0.0 0.0 0.2 0.4 1.7 0.3 0.3 1.2 1.9 1.4 1.6 0.9 1.3 2.7 2.3 0.5 3.2 1.8 1.6 3.7 1.0 0.0 0.0 0.7 0.5 1.3 0.4 0.5 1.2 0.7 0.9 0.5 3.6 1.5 0.2 1.8 0.0 0.1 0.1 0.4 1.9 0.6 12.8 0.3 0.7 0.7 0.0 1.3 2.0 1.0 0.0 0.8 1.1 0.8 0.0 0.9 1.1 0.7 0.2 0.0 1.9 0.1 0.0 0.6 0.7 2.0 0.6 0.6 0.0 1.0 0.6 0.2 0.0 2.5 14.8 0.5 0.1 0.4 0.2 0.4 0.0 0.5 0.3 0.4 0.0 1.3 1.9 14.6 11.0 1.6 0.4 0.0 0.7 1.2 0.4 0.2 NWD2 KIAA1239 ENSG00000174145 "NACHT and WD repeat domain containing 2" Q9ULI1 4 37244743-37449463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.4;brain: 5.0" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 91.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046911 Uncertain NA NA "HPA046911: AB_2679861" "unprognostic (1.14e-2)" "unprognostic (3.12e-2)" "unprognostic (2.53e-1)" "unprognostic (5.47e-2)" "unprognostic (9.42e-2)" "unprognostic (2.55e-1)" "unprognostic (5.15e-2)" "unprognostic (1.63e-2)" "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (7.00e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (7.65e-2)" "unprognostic (4.36e-2)" "unprognostic (1.26e-2)" 1.4 0.0 0.6 0.0 5.0 0.0 1.1 0.2 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 0.1 0.0 0.0 1.2 4.7 2.4 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.9 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.0 0.2 3.0 1.6 0.9 1.2 4.7 2.4 2.3 0.0 0.2 2.3 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.1 0.0 4.5 1.9 0.1 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 CYB561D1 "FLJ39035, FLJ44753" ENSG00000174151 "Cytochrome b561 family member D1" Q8N8Q1 1 109494052-109502932 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027028 Uncertain NA NA "HPA027028: AB_1847365" "unprognostic (2.15e-2)" "unprognostic (3.49e-1)" "unprognostic (1.04e-2)" "unprognostic (1.98e-1)" "unprognostic (2.27e-1)" "prognostic favorable (4.68e-4)" "unprognostic (4.53e-4)" "unprognostic (1.32e-1)" "unprognostic (3.45e-1)" "unprognostic (5.29e-2)" "prognostic favorable (5.16e-6)" "unprognostic (4.30e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.20e-3)" "unprognostic (2.75e-1)" "unprognostic (4.95e-3)" "unprognostic (5.82e-2)" 4.8 7.4 6.1 8.0 6.0 8.5 5.3 7.9 7.0 3.4 4.1 5.8 5.7 4.7 11.2 7.2 5.1 4.0 3.6 6.9 4.8 5.6 2.9 5.8 11.0 5.0 5.5 6.4 6.9 11.2 8.6 8.0 3.2 5.7 4.6 5.9 4.4 6.2 6.0 6.9 18.0 9.1 5.2 4.5 8.8 7.3 2.8 5.7 7.8 7.9 3.7 10.4 4.7 3.5 6.1 9.4 5.4 3.9 4.5 13.1 9.4 9.9 8.0 6.1 9.0 6.4 5.2 4.0 8.3 8.2 10.3 5.7 10.4 5.1 6.4 5.8 6.9 4.7 5.4 8.6 4.3 6.2 11.6 16.8 10.2 15.8 8.7 4.5 5.5 6.3 8.1 3.6 3.7 5.8 11.7 4.1 6.2 1.8 6.9 8.2 6.9 15.6 3.3 8.2 15.6 5.7 5.1 9.1 8.9 8.6 5.4 5.9 6.3 8.5 8.8 10.2 12.0 6.6 4.3 3.3 4.0 8.9 9.4 9.9 2.5 2.4 3.6 3.7 2.6 3.3 2.5 3.9 3.4 1.7 2.5 4.9 3.4 6.7 5.6 2.9 1.9 3.1 2.5 6.1 6.0 7.9 7.0 6.9 4.8 5.0 5.5 6.4 5.7 4.5 5.7 6.1 2.5 0.0 4.7 2.3 7.1 2.3 1.7 2.9 1.8 7.7 4.2 2.3 3.7 7.2 4.4 3.7 2.1 2.5 5.3 10.6 0.0 3.3 0.0 2.6 3.0 2.6 4.2 0.4 10.4 8.0 1.1 2.9 4.6 3.0 1.3 3.7 0.7 2.2 1.3 3.3 6.4 2.9 2.0 4.1 3.2 0.4 2.5 2.5 1.8 3.7 3.7 2.4 28.8 3.5 9.1 5.8 0.8 4.1 3.5 1.9 10.2 2.6 4.3 6.4 0.0 5.6 2.2 0.9 2.0 3.4 3.0 1.1 8.3 1.9 3.5 2.5 GSTA3 ENSG00000174156 "Glutathione S-transferase alpha 3" Q16772 6 52896639-52909698 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 67.8;fallopian tube: 65.9;placenta: 22.9;skin 1: 26.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.5;testis cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "HPA004342, HPA048934, HPA053817" Approved Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (7.51e-2)" "unprognostic (7.06e-3)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (4.38e-3)" "unprognostic (2.86e-3)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (9.35e-2)" 0.0 67.8 0.2 0.1 0.1 0.0 1.8 0.1 0.0 0.7 0.4 0.0 0.3 0.8 0.9 0.0 65.9 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.9 0.1 3.0 0.0 22.9 0.1 0.1 0.0 0.0 0.3 0.2 0.0 26.2 0.4 0.1 0.0 0.0 2.4 11.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 6.2 0.0 0.0 194.9 0.0 0.0 0.0 0.0 1.3 47.0 0.5 0.5 0.0 0.0 0.0 0.0 7.5 1.1 0.0 0.7 1.3 7.4 0.0 0.4 15.7 0.0 0.0 0.0 2.0 0.0 0.4 2.1 1.5 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 24.8 0.0 0.0 0.0 0.8 0.5 0.5 0.0 9.8 515.3 0.1 91.3 0.0 0.0 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546235 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 4.8 6.9 6.0 3.4 4.7 5.0 4.8 4.2 5.4 3.4 5.0 3.1 2.8 4.3 5.1 4.3 3.9 2.3 3.5 5.0 4.6 6.2 4.6 4.6 4.3 5.5 5.2 5.0 2.8 7.2 6.1 4.7 2.5 5.1 4.6 2.1 2.6 5.1 2.7 2.9 5.0 4.7 1.9 4.1 7.2 4.9 3.7 5.7 3.1 6.0 1.1 3.0 4.0 3.4 5.4 5.2 7.4 2.4 6.5 5.8 4.7 6.2 3.9 3.4 3.1 2.1 6.5 7.7 1.6 11.5 3.3 8.3 11.9 1.9 3.4 2.1 7.6 4.9 2.9 3.7 4.1 5.5 3.4 6.9 5.6 6.2 2.5 3.6 3.7 5.1 13.0 4.2 4.3 4.0 10.4 7.4 8.6 5.3 12.2 7.6 8.8 5.3 9.3 3.9 3.6 3.5 5.6 6.7 6.5 11.6 2.7 9.5 2.4 8.0 7.1 2.4 8.3 3.1 6.9 2.2 2.1 6.2 1.5 8.2 3.0 5.9 1.0 7.3 5.7 6.6 6.4 6.0 8.4 7.2 7.5 3.8 5.9 2.2 8.0 5.0 23.1 6.6 6.1 6.0 4.7 4.2 5.4 5.0 4.6 5.5 5.2 5.0 5.1 4.1 5.7 5.4 21.7 12.8 8.3 7.8 21.9 8.0 15.2 26.8 10.8 9.6 21.5 15.2 4.5 22.8 17.3 23.9 10.4 33.0 49.9 29.0 9.8 50.3 13.5 15.1 14.4 23.3 14.4 6.3 7.6 49.4 37.2 15.0 17.9 19.8 8.9 18.5 23.2 14.9 63.9 23.5 7.0 17.8 20.3 42.8 14.8 12.1 7.5 27.9 17.8 5.6 36.4 16.9 46.4 4.0 8.5 42.8 40.6 9.8 15.8 24.9 54.8 35.2 14.7 10.3 19.7 11.2 15.1 29.6 4.1 21.6 8.1 24.1 23.3 18.5 21.8 23.1 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561868-101566446 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favorable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 16.8 17.6 7.8 15.0 8.7 18.4 21.0 9.8 9.8 12.3 9.1 15.6 12.8 14.2 13.5 19.1 14.6 11.5 21.8 8.5 9.0 19.4 25.4 10.4 20.7 8.0 8.2 7.9 15.8 10.5 15.8 6.4 14.1 8.6 12.0 14.8 7.9 13.1 10.0 27.8 12.8 13.3 16.2 8.1 12.6 12.2 11.9 8.1 17.6 15.5 30.5 20.9 26.8 8.7 9.7 58.9 28.2 36.6 37.1 33.0 28.0 34.1 34.2 33.3 43.6 48.5 43.2 38.6 121.3 43.4 21.6 35.4 57.9 71.5 52.5 59.7 43.8 35.3 81.6 20.5 31.6 25.4 72.5 33.1 32.9 53.3 38.3 35.4 23.2 43.1 45.4 70.3 26.3 47.6 40.4 58.2 52.9 68.2 75.9 60.4 42.9 29.8 54.3 56.2 49.0 90.9 51.8 26.7 56.0 78.1 31.9 74.0 78.9 28.7 23.6 45.0 15.8 36.5 30.4 59.4 117.5 40.0 51.5 36.2 56.6 18.2 12.8 21.1 24.7 29.8 35.7 26.2 25.1 22.7 34.2 35.0 33.2 8.1 21.4 27.4 25.8 26.2 19.5 7.8 8.7 9.8 9.8 8.5 9.0 8.0 8.2 7.9 8.6 8.1 8.1 9.7 33.3 22.4 24.0 4.9 47.9 94.3 153.4 106.8 63.7 30.6 39.9 52.7 51.5 21.5 69.2 29.5 14.6 65.7 50.3 21.5 52.8 48.5 49.7 54.7 54.0 39.5 35.8 65.0 8.8 33.8 47.0 38.8 28.1 63.5 46.3 47.3 31.4 56.9 31.1 21.9 8.5 31.5 69.2 27.3 31.9 13.7 37.3 23.7 14.2 1.9 42.1 29.8 37.0 6.6 7.6 37.2 17.9 37.6 21.5 85.3 17.3 72.0 53.3 33.9 32.9 58.1 41.3 77.7 55.0 55.2 105.0 65.5 46.4 57.1 47.0 127.4 SELP "CD62, CD62P, GMP140, GRMP, PADGEM, PSEL" ENSG00000174175 "Selectin P" P16109 1 169588849-169630193 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 14.7;Endothelial cells: 51.8;Hepatic stellate cells: 33.9;Macrophages: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 11 "cerebral cortex: 6.5" "Group enriched" "Detected in some" 4 "basophil: 8.3;T-reg: 8.8" "Group enriched" "Detected in many" 7 "granulocytes: 8.3;T-cells: 8.8" "Group enriched" "Detected in some" 38 "EFO-21: 36.0;HEL: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002145, HPA002655, HPA005990" Enhanced NA NA 520000000 "CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479" "unprognostic (3.37e-2)" "unprognostic (2.98e-4)" "unprognostic (4.11e-1)" "unprognostic (1.46e-1)" "unprognostic (9.26e-2)" "prognostic favorable (3.12e-4)" "unprognostic (5.30e-4)" "unprognostic (4.14e-2)" "unprognostic (3.59e-1)" "unprognostic (1.74e-1)" "unprognostic (1.93e-2)" "unprognostic (6.61e-2)" "unprognostic (1.19e-1)" "unprognostic (8.24e-3)" "unprognostic (1.74e-2)" "unprognostic (7.85e-3)" "unprognostic (1.66e-1)" 11.1 2.4 0.2 12.0 0.3 2.3 10.7 0.0 6.5 9.0 11.0 3.3 5.1 6.5 4.2 5.2 6.8 9.6 6.8 0.2 0.2 4.9 2.5 12.7 7.0 0.2 0.1 0.2 1.8 1.2 3.1 2.2 6.4 0.1 6.2 4.2 0.0 2.7 5.7 1.0 3.7 4.8 14.3 0.1 1.0 2.8 0.8 0.5 2.6 4.0 1.8 12.7 14.5 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.3 0.4 0.6 0.0 0.2 0.0 1.1 0.5 0.2 0.0 0.1 0.2 0.1 2.1 0.3 0.0 0.1 8.8 7.8 0.2 0.3 0.0 6.5 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.5 0.3 14.7 0.0 3.6 0.3 0.4 3.7 0.1 0.0 0.6 0.0 0.2 0.1 1.9 1.5 0.0 1.8 0.0 2.6 0.1 0.0 0.0 0.0 2.0 0.1 0.1 51.8 0.0 5.2 0.5 0.2 0.0 1.5 0.0 0.0 0.0 0.0 33.9 0.4 0.2 0.0 0.2 0.0 0.0 1.5 3.6 0.1 0.3 10.1 3.6 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 3.4 4.1 0.5 0.0 0.0 0.3 CTU2 "C16orf84, NCS2" ENSG00000174177 "Cytosolic thiouridylase subunit 2" Q2VPK5 16 88706483-88715396 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041135, HPA041894" Uncertain Supported Mitochondria NA NA Mitochondria "HPA041135: AB_10794543, HPA041894: AB_10796463" "unprognostic (4.19e-1)" "unprognostic (3.62e-2)" "unprognostic (5.19e-2)" "unprognostic (5.77e-2)" "unprognostic (3.00e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (4.83e-2)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (1.19e-3)" "unprognostic (2.90e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" 8.9 9.7 7.4 5.1 7.3 6.3 8.8 6.7 13.9 10.1 5.4 9.0 4.2 11.7 2.0 8.7 9.6 3.5 11.0 7.9 6.8 7.6 12.6 7.9 6.1 8.4 7.1 7.7 10.6 11.4 3.7 11.4 3.2 7.3 8.9 1.6 1.4 8.1 3.7 19.2 8.7 7.7 3.4 6.5 9.5 9.7 11.0 7.1 4.0 10.4 5.4 3.4 10.0 8.2 9.3 14.9 22.9 8.8 19.4 7.3 7.5 21.8 15.2 11.4 16.6 8.1 27.2 14.0 21.7 19.8 9.8 7.8 14.7 14.8 14.9 4.5 6.8 44.6 14.9 9.8 27.8 12.4 15.1 10.8 8.5 10.8 13.1 13.9 6.0 14.1 13.1 56.5 6.3 6.3 40.0 42.0 34.9 13.7 12.9 36.9 33.0 6.6 23.4 5.8 5.8 29.0 14.0 24.2 4.6 9.7 5.3 13.8 15.6 15.9 17.5 22.1 19.2 16.8 19.4 10.5 61.7 15.1 32.1 19.6 1.1 5.5 0.0 7.3 6.9 6.0 5.5 6.6 7.3 6.8 5.8 6.4 5.5 0.4 7.5 6.0 6.4 4.1 4.2 7.4 7.3 6.7 13.9 7.9 6.8 8.4 7.1 7.7 7.3 6.5 7.1 9.3 6.5 0.0 4.4 2.3 10.0 13.8 12.2 7.8 5.2 12.5 7.3 7.2 2.5 10.0 7.8 1.8 6.2 11.0 15.7 8.4 11.7 8.8 12.1 4.0 7.1 6.6 5.4 3.8 2.9 13.6 16.2 8.6 11.2 4.9 0.0 9.9 3.6 6.7 9.9 13.5 2.3 7.1 4.1 1.9 4.0 7.0 8.1 6.7 5.4 1.0 5.0 4.4 7.2 0.5 2.7 8.9 8.2 9.8 15.5 17.2 9.6 7.8 4.7 8.7 0.0 8.9 11.1 25.6 25.7 6.5 10.7 8.1 9.5 10.8 10.5 8.9 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MAX dimerization protein MGA" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: AB_2683632" "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 3.9 5.2 6.6 5.5 11.5 8.8 7.2 33.9 8.0 7.4 0.0 4.5 3.7 7.5 6.1 4.5 5.8 4.2 4.5 5.0 8.3 5.3 4.7 4.3 7.7 6.6 7.2 3.7 12.1 5.1 6.1 3.9 6.9 11.8 5.7 5.2 7.0 5.2 5.6 5.2 6.2 4.0 5.8 5.3 6.8 4.6 8.8 8.1 11.7 7.6 7.9 7.6 5.5 3.9 17.4 2.4 13.5 16.6 10.9 12.8 10.1 13.3 6.7 6.8 7.8 7.7 14.5 7.8 16.2 11.8 7.8 14.2 9.3 25.9 5.9 10.7 7.7 8.5 34.3 22.1 12.8 11.3 31.9 16.4 7.7 7.2 10.9 10.7 3.2 10.3 15.5 40.7 7.2 7.1 6.7 19.4 12.3 10.3 7.0 6.9 21.7 16.9 8.5 4.1 9.8 15.7 15.3 24.0 8.2 4.3 12.1 6.6 20.1 11.0 9.5 13.3 9.8 8.0 9.8 15.7 15.3 6.0 11.9 4.8 3.6 1.4 1.6 2.5 1.0 2.5 2.8 2.1 2.9 1.4 3.0 2.1 2.4 0.6 5.8 3.3 2.4 1.1 1.0 6.6 11.5 33.9 8.0 5.0 8.3 6.6 7.2 3.7 11.8 5.3 8.1 17.4 18.5 22.4 19.8 56.5 28.1 7.9 10.9 7.2 13.6 25.5 11.1 8.9 29.5 5.7 16.2 12.9 33.3 18.1 23.6 9.7 7.9 11.8 16.7 16.8 35.4 18.6 7.8 28.6 62.4 5.3 12.0 20.5 18.8 24.9 14.5 32.9 15.0 9.3 11.8 13.5 60.1 10.0 8.2 11.9 8.8 7.0 20.8 17.1 8.8 44.0 13.2 16.0 25.7 64.8 122.6 8.1 13.5 20.7 16.4 16.2 7.6 5.2 14.9 23.6 39.5 35.6 19.2 45.4 40.4 11.7 11.2 26.0 27.5 23.5 11.3 10.7 C12orf66 FLJ32549 ENSG00000174206 "Chromosome 12 open reading frame 66" Q96MD2 12 64186316-64222296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046743, HPA052855" Uncertain Supported "Lysosomes,Cytokinetic bridge" Yes No Lysosomes "Cytokinetic bridge" "HPA046743: AB_2679782, HPA052855: AB_2681973" "unprognostic (7.44e-3)" "unprognostic (2.38e-1)" "unprognostic (6.20e-2)" "unprognostic (2.70e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (7.46e-2)" "unprognostic (4.07e-2)" 2.7 4.2 3.8 3.4 5.6 1.7 5.5 4.2 5.0 2.8 2.3 2.8 3.2 2.6 4.9 4.2 4.0 2.5 2.3 3.7 4.5 5.5 8.7 2.8 4.9 4.4 4.7 3.8 3.9 5.2 5.7 2.6 2.1 5.2 2.4 3.1 1.6 2.9 2.3 4.5 5.6 2.5 2.3 3.8 5.0 3.1 3.4 4.6 3.3 5.7 3.3 4.9 2.6 3.0 7.1 5.5 8.7 1.6 4.7 4.3 7.2 4.5 3.0 3.7 4.4 2.7 2.7 4.3 17.4 4.1 2.4 7.1 6.3 6.9 5.3 4.7 13.3 4.6 6.3 2.1 2.5 5.6 6.9 3.6 5.6 9.0 5.7 10.3 5.0 3.2 12.0 8.8 11.3 4.4 10.6 7.9 6.0 7.7 6.5 6.8 4.0 4.9 13.4 6.6 6.4 3.8 3.8 4.9 6.7 4.8 4.2 10.8 4.4 2.5 4.4 2.9 4.4 2.9 14.9 13.2 9.7 6.6 5.9 5.0 0.5 2.6 0.2 3.3 2.6 5.7 8.5 6.4 5.0 4.3 7.2 8.7 8.4 0.2 4.0 1.8 3.1 10.8 4.2 3.8 5.6 4.2 5.0 3.7 4.5 4.4 4.7 3.8 5.2 3.8 4.6 7.1 3.4 3.2 2.7 5.5 9.3 2.4 8.8 3.4 7.4 2.1 5.9 4.1 2.7 7.2 5.5 9.2 2.1 6.3 4.0 1.9 9.8 4.1 9.2 3.3 4.0 3.9 4.2 3.4 7.1 5.2 3.9 3.5 7.1 3.6 1.3 3.6 1.8 10.8 4.9 0.0 5.5 2.7 4.1 6.3 2.6 7.3 4.7 4.3 1.8 1.0 2.1 2.5 1.0 3.5 17.4 2.6 2.6 1.9 2.8 4.7 2.1 12.9 2.4 1.6 0.0 7.4 2.8 4.4 8.8 6.9 4.3 1.8 5.8 4.3 3.7 4.3 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 5.1" "Group enriched" "Detected in some" 29 "Early spermatids: 69.8;Late spermatids: 55.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037377, HPA037378" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA037377: AB_2675442, HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.2 5.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 55.5 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572889-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 6.6;urinary bladder: 16.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 81.8" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 49 "RT4: 80.7" "Region enriched" "Detected in single" 5 "thalamus: 2.6" "Not detected" "Not detected" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: AB_2682161" "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favorable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.1 1.5 0.0 1.4 0.2 0.4 0.9 3.3 0.4 0.4 0.2 0.0 0.3 0.2 6.6 0.3 1.1 1.7 2.3 0.8 0.2 0.5 0.1 0.4 1.6 0.1 0.9 0.4 0.3 0.3 0.2 0.0 1.8 1.4 0.1 0.2 1.2 0.2 0.6 0.6 0.1 0.5 0.3 0.1 0.7 4.0 1.6 0.3 0.5 0.5 3.6 16.5 1.7 1.7 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.0 80.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.5 1.4 0.9 3.3 2.3 0.8 1.6 0.1 0.9 1.8 0.3 1.6 1.7 0.5 0.0 0.0 6.2 0.1 0.4 3.3 0.2 9.6 0.0 0.2 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.9 0.0 81.8 0.2 0.1 0.4 0.0 0.0 12.8 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 19.7 0.6 0.2 0.0 1.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 1.2 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.3 3.7 0.3 0.5 9.7 0.4 0.0 0.1 0.0 0.0 6.0 PIGG "FLJ20265, GPI7, LAS21" ENSG00000174227 "Phosphatidylinositol glycan anchor biosynthesis class G" Q5H8A4 4 499210-540200 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015997 Uncertain NA NA "HPA015997: AB_2164679" "unprognostic (3.87e-2)" "unprognostic (5.32e-2)" "unprognostic (5.78e-3)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (3.48e-2)" "unprognostic (4.68e-1)" "unprognostic (2.64e-1)" "unprognostic (7.01e-3)" "unprognostic (6.61e-3)" "unprognostic (9.09e-2)" "unprognostic (1.83e-2)" "unprognostic (1.51e-1)" "unprognostic (4.27e-3)" "unprognostic (2.97e-2)" 12.1 13.8 5.8 11.5 6.5 9.5 12.9 5.7 6.7 10.5 7.6 12.9 14.3 11.6 20.7 11.5 11.7 13.0 7.7 6.9 7.3 9.6 9.0 11.8 13.5 6.3 5.9 6.4 15.6 14.2 17.7 15.3 12.7 6.7 12.2 12.2 10.8 14.8 11.3 8.2 20.5 13.6 9.9 6.5 13.3 13.3 8.8 6.5 10.9 15.0 4.2 11.4 13.0 11.6 9.9 18.7 20.2 18.2 15.2 33.0 23.1 28.7 24.0 28.8 25.1 29.7 21.5 42.4 7.8 17.4 30.8 46.0 25.0 17.2 23.5 23.1 7.3 19.1 19.4 24.7 17.0 22.6 27.3 27.6 26.2 38.9 23.2 12.7 27.4 19.4 14.9 21.4 16.5 22.6 11.6 15.3 23.9 29.6 20.2 28.2 16.9 11.2 11.5 24.2 25.4 18.2 23.2 17.7 18.3 17.6 17.3 29.2 24.1 30.0 25.6 12.0 13.3 37.7 13.5 19.4 12.3 21.7 19.9 32.7 20.5 5.1 4.2 5.9 6.5 6.7 3.5 4.5 5.7 8.1 2.8 4.8 3.9 3.8 7.8 4.9 7.2 8.3 3.9 5.8 6.5 5.7 6.7 6.9 7.3 6.3 5.9 6.4 6.7 6.5 6.5 9.9 14.4 16.0 12.6 21.9 12.6 8.9 10.9 17.7 12.5 10.8 11.4 9.3 8.6 7.2 23.0 9.2 4.2 16.7 14.8 14.9 0.0 15.8 2.4 16.4 15.4 13.1 10.8 11.2 23.2 17.8 14.8 10.2 22.4 20.2 12.7 19.8 8.9 10.1 9.1 8.4 15.1 8.5 16.2 11.5 6.5 0.7 13.7 9.5 8.8 24.4 13.6 11.6 17.5 16.6 26.0 18.4 12.8 12.8 14.9 13.7 13.1 5.6 19.9 10.5 19.7 10.4 11.5 9.9 8.2 10.1 6.3 23.1 14.2 13.0 9.7 14.2 PRPF8 "hPrp8, Prp8, PRPC8, RP13, SNRNP220" ENSG00000174231 "Pre-mRNA processing factor 8" Q6P2Q9 17 1650629-1684867 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 252.3;Rod photoreceptor cells: 293.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009941, CAB015457" Supported Enhanced Nucleoplasm NA NA 120000 Nucleoplasm "CAB009941: AB_2171185, CAB015457: AB_831685" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.94e-2)" "unprognostic (6.58e-2)" "unprognostic (1.56e-1)" "unprognostic (4.19e-2)" "unprognostic (1.77e-1)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" "unprognostic (2.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" 77.0 129.7 75.2 46.1 78.4 71.1 79.3 86.6 122.2 98.2 88.3 86.7 33.3 95.3 44.5 86.0 95.0 31.1 92.1 77.6 80.9 70.9 91.9 84.9 53.2 76.6 74.8 74.4 132.7 79.0 83.3 131.4 45.1 80.0 90.5 44.9 116.6 78.7 49.5 147.9 92.0 84.9 52.2 73.4 99.0 81.2 100.8 75.0 84.6 89.7 80.8 62.1 97.8 85.0 81.1 104.0 240.7 149.0 116.1 120.8 90.4 107.9 78.2 109.5 160.3 122.4 208.2 50.0 150.0 73.2 150.5 113.4 152.9 356.3 139.5 181.6 99.4 170.0 124.3 187.1 161.0 73.5 145.4 138.9 86.0 91.2 194.8 146.7 84.5 146.1 106.2 121.1 126.6 117.9 112.7 114.4 117.4 97.0 97.7 74.4 218.4 82.3 80.7 63.1 121.1 71.0 103.8 145.0 61.5 69.3 121.6 87.4 91.3 122.1 91.7 78.3 130.2 176.1 46.6 46.7 101.9 81.6 108.1 121.6 23.1 8.9 10.1 19.1 14.4 23.6 17.5 17.7 20.9 15.7 18.3 16.7 20.0 9.0 14.2 21.7 25.2 23.2 11.2 75.2 78.4 86.6 122.2 77.6 80.9 76.6 74.8 74.4 80.0 73.4 75.0 81.1 45.7 60.9 84.3 24.5 72.8 30.1 30.0 42.5 56.9 128.0 31.8 34.4 39.4 42.9 53.9 47.8 252.3 43.3 66.6 42.9 7.9 35.5 11.8 45.4 38.8 46.3 36.5 73.0 23.6 40.9 26.7 48.3 56.1 40.3 52.6 55.9 37.9 38.7 39.8 72.3 29.3 40.2 32.6 40.1 26.5 11.2 73.3 42.6 19.6 19.7 48.3 55.9 46.4 21.6 19.0 42.7 36.5 52.3 70.0 31.4 48.7 18.3 51.3 293.2 72.3 65.4 44.8 100.4 99.1 57.3 27.8 39.5 62.8 50.2 50.3 31.5 ADCY6 AC6 ENSG00000174233 "Adenylate cyclase 6" O43306 12 48766194-48789089 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018365 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB018365: AB_2257941" "unprognostic (1.18e-2)" "unprognostic (2.20e-2)" "unprognostic (6.89e-2)" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (3.68e-2)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-3)" "unprognostic (5.10e-3)" "unprognostic (1.09e-1)" "unprognostic (3.09e-1)" "unprognostic (2.48e-2)" 43.6 15.2 7.1 6.1 7.8 1.3 23.9 4.8 9.2 18.9 8.4 23.7 18.9 20.9 19.2 10.4 17.3 14.0 57.7 7.8 8.0 17.4 9.7 13.6 4.0 5.6 4.3 7.7 22.5 22.5 20.9 14.7 14.6 7.7 16.5 20.5 5.8 33.8 16.6 12.3 15.5 21.6 13.7 1.3 4.9 25.3 4.1 10.9 2.9 18.0 12.8 3.3 12.4 12.9 6.4 14.0 25.9 30.2 18.9 32.0 15.9 32.0 16.7 17.1 19.8 13.8 45.7 45.3 0.0 37.2 15.3 8.2 10.9 9.2 11.6 7.9 0.1 13.4 12.5 37.8 8.4 17.6 0.0 10.1 20.0 13.6 17.1 6.5 37.9 18.7 0.8 1.7 4.5 15.6 23.1 0.0 0.5 10.3 21.6 12.3 4.6 11.4 7.7 23.4 41.5 4.5 18.4 17.2 68.0 15.2 13.3 53.3 3.5 21.1 18.3 13.1 9.7 7.4 7.0 3.7 0.4 16.9 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 7.8 4.8 9.2 7.8 8.0 5.6 4.3 7.7 7.7 1.3 10.9 6.4 11.6 0.0 6.4 18.3 0.6 2.7 3.3 7.5 4.0 10.1 22.7 15.0 8.2 7.2 9.8 18.4 20.9 7.4 0.4 38.8 0.0 5.8 0.8 6.8 8.0 8.1 8.4 0.0 17.5 4.0 2.7 7.6 14.3 11.3 1.3 14.6 5.0 7.7 2.5 10.1 18.8 24.9 8.2 0.6 2.8 1.1 11.5 0.7 7.2 7.5 0.6 3.4 0.0 15.1 7.0 9.5 30.3 9.4 0.3 6.3 26.0 2.8 5.8 9.3 19.7 9.5 26.6 1.9 1.7 3.6 2.0 5.1 0.8 13.9 23.7 9.3 REP15 RAB15EP ENSG00000174236 "RAB15 effector protein" Q6BDI9 12 27696447-27697596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "intestine: 59.9;stomach 1: 77.8" "Group enriched" "Detected in many" 20 "Gastric mucus-secreting cells: 132.5;Intestinal goblet cells: 440.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 12.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040448, HPA059868" Approved NA NA "HPA040448: AB_10964206, HPA059868: AB_2684148" "unprognostic (4.13e-2)" "unprognostic (4.32e-3)" "prognostic favorable (9.43e-5)" "unprognostic (7.29e-2)" "unprognostic (7.42e-5)" "unprognostic (4.63e-2)" "unprognostic (2.31e-1)" "unprognostic (1.87e-3)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (5.13e-3)" "unprognostic (3.00e-1)" "unprognostic (5.30e-2)" "unprognostic (3.52e-1)" "unprognostic (2.76e-1)" "unprognostic (5.27e-5)" "unprognostic (1.77e-1)" 1.2 1.4 2.8 3.2 2.7 0.0 1.2 2.0 4.3 0.9 2.4 37.2 14.1 0.9 0.9 1.2 1.0 0.4 3.7 3.0 2.2 1.9 2.7 2.0 0.3 2.4 2.3 2.3 2.6 0.8 0.5 1.4 1.6 3.0 1.5 59.9 0.1 1.4 0.8 0.9 1.3 32.3 1.7 2.1 2.7 77.8 2.2 3.0 0.5 1.9 1.9 0.2 1.2 1.1 2.7 0.5 1.0 0.9 2.0 1.9 2.7 1.6 3.0 1.5 1.2 1.1 4.2 0.8 0.6 1.0 3.9 1.3 1.1 1.0 2.0 3.1 1.5 0.7 1.2 1.3 1.1 0.3 0.5 0.7 1.5 1.9 3.9 1.1 1.8 4.0 0.4 0.5 0.1 5.5 0.5 2.0 0.2 2.9 0.7 2.6 0.3 2.0 4.2 3.6 0.5 0.1 0.2 1.0 0.5 1.6 12.6 0.2 0.7 3.8 6.7 3.1 0.8 2.7 0.0 0.0 0.0 4.9 0.6 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.7 2.0 4.3 3.0 2.2 2.4 2.3 2.3 3.0 2.1 3.0 2.7 3.7 3.2 0.5 0.0 0.2 1.1 3.0 0.7 2.8 0.3 0.6 1.8 0.5 2.8 0.2 0.0 0.0 0.6 0.1 8.7 0.0 0.6 0.1 1.0 0.3 3.9 9.1 0.0 1.7 0.5 0.6 1.6 132.5 1.8 0.0 3.7 6.4 0.6 0.1 0.0 0.5 440.4 0.0 0.3 0.4 0.0 0.3 0.5 1.8 1.9 0.1 0.1 0.0 1.0 1.0 0.4 9.1 0.7 0.5 1.2 13.9 0.8 0.2 0.0 0.0 2.9 1.0 0.0 0.2 0.7 0.3 1.4 0.3 0.3 10.2 3.5 PITPNA "PITPN, VIB1A" ENSG00000174238 "Phosphatidylinositol transfer protein alpha" Q00169 17 1517718-1562792 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol NA NA 190000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (1.54e-1)" "unprognostic (6.63e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.29e-4)" "unprognostic (7.88e-2)" "unprognostic (8.89e-3)" "unprognostic (2.37e-1)" "unprognostic (1.37e-1)" "unprognostic (7.33e-2)" "unprognostic (3.17e-2)" "prognostic favorable (1.80e-6)" "unprognostic (7.41e-2)" "prognostic favorable (9.35e-4)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-2)" "unprognostic (6.81e-3)" 42.9 37.2 38.8 61.5 44.3 94.5 42.2 45.9 54.7 51.2 44.7 47.7 57.2 55.9 59.3 77.3 66.5 45.8 39.5 41.5 46.8 40.4 39.3 47.3 40.7 57.8 43.6 36.3 32.4 34.2 61.3 33.3 50.6 64.4 54.7 56.2 48.0 84.9 62.2 25.0 93.9 89.7 54.8 39.8 42.7 40.9 45.2 50.3 33.5 65.3 22.9 57.5 52.4 42.1 52.4 64.9 70.5 70.5 61.0 72.1 78.8 110.7 68.9 75.8 70.6 50.9 78.7 25.7 81.8 62.4 94.0 45.4 79.5 64.2 68.4 97.0 68.3 69.2 44.7 61.4 37.0 70.6 31.1 51.6 58.9 90.6 70.5 73.1 74.4 118.4 67.1 63.3 44.9 74.8 36.5 80.1 28.5 49.3 103.4 34.1 63.8 27.2 46.9 70.5 73.5 25.2 55.2 83.2 59.1 51.4 70.5 52.2 24.7 113.8 44.8 39.5 126.4 95.5 27.2 49.8 28.8 77.4 47.9 58.4 3.7 2.4 3.2 2.1 2.7 4.0 4.3 3.1 2.8 3.5 3.1 2.9 2.6 8.0 3.7 1.9 2.7 5.2 1.7 38.8 44.3 45.9 54.7 41.5 46.8 57.8 43.6 36.3 64.4 39.8 50.3 52.4 29.3 35.3 35.0 28.7 14.1 31.0 17.5 12.0 12.0 36.4 30.0 30.2 23.9 17.2 17.1 25.8 8.4 43.4 26.9 41.2 13.7 16.0 12.0 50.5 48.4 31.4 22.1 15.6 42.4 18.5 47.3 19.1 13.3 36.5 19.0 16.8 34.6 30.2 40.5 40.4 46.3 27.7 10.2 29.9 49.7 16.8 12.5 36.4 19.6 36.5 36.6 40.2 13.4 12.1 16.0 26.0 22.9 21.8 15.7 33.0 78.0 16.3 21.7 18.4 6.6 18.8 45.1 35.8 34.7 37.8 41.8 120.0 14.9 24.7 25.3 27.0 DDX23 "prp28, PRPF28, SNRNP100, U5-100K" ENSG00000174243 "DEAD-box helicase 23" Q9BUQ8 12 48829756-48852842 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038680, HPA039037" Approved Supported Nucleoplasm,Nucleoli NA NA 21000 "Nucleoplasm, Nucleoli" "HPA038680: AB_10795401, HPA039037: AB_2676317" "unprognostic (1.32e-3)" "unprognostic (8.90e-2)" "unprognostic (8.92e-2)" "unprognostic (7.12e-2)" "unprognostic (5.34e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.03e-5)" "unprognostic (3.54e-2)" "unprognostic (5.68e-2)" "unprognostic (2.19e-2)" "unprognostic (1.69e-1)" "unprognostic (8.34e-2)" "unprognostic (5.94e-2)" "unprognostic (9.78e-2)" "unprognostic (6.88e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-1)" 32.6 30.9 29.6 37.3 31.0 26.8 33.4 30.2 29.9 35.6 33.0 39.4 33.8 35.4 25.3 37.8 35.7 25.6 27.7 28.5 30.9 30.3 43.3 34.1 46.9 31.2 30.5 27.2 40.9 37.0 34.8 28.6 33.9 31.0 36.4 38.0 28.0 37.6 30.0 54.8 39.3 41.6 34.3 30.6 47.9 38.6 26.9 31.7 63.9 33.1 36.1 48.5 36.4 35.0 31.0 74.0 165.1 76.6 81.5 74.7 51.4 81.3 89.1 68.1 98.9 62.5 162.0 95.7 92.5 95.6 74.4 93.3 64.9 168.1 81.1 84.0 146.1 89.2 122.7 139.0 73.8 40.3 125.3 106.9 49.9 71.7 105.1 62.6 67.6 82.4 80.4 165.6 80.3 72.9 102.1 119.8 118.2 114.4 104.0 77.4 125.9 90.7 73.5 58.3 101.9 94.1 54.9 89.4 101.0 38.4 78.0 99.0 113.7 74.5 74.4 54.1 37.2 71.8 60.1 89.8 109.5 63.3 86.8 41.8 20.9 11.8 21.9 19.3 13.6 19.6 12.6 14.1 17.5 11.3 10.5 13.5 16.6 12.2 12.8 9.8 11.9 14.3 12.0 29.6 31.0 30.2 29.9 28.5 30.9 31.2 30.5 27.2 31.0 30.6 31.7 31.0 22.7 25.6 36.5 11.8 25.5 12.9 13.7 12.7 25.6 17.5 18.6 19.4 20.0 22.8 25.8 12.9 25.0 25.9 30.7 33.0 15.6 25.9 14.4 24.4 25.2 27.2 13.9 21.7 6.9 38.9 29.1 19.2 25.5 26.6 18.3 29.8 17.9 18.7 19.1 15.2 8.7 26.6 16.2 13.2 10.3 6.3 24.5 16.5 14.2 9.4 25.5 26.2 35.0 7.5 8.4 33.9 32.3 22.2 32.0 26.7 24.3 12.5 34.4 26.1 19.7 20.8 20.0 43.8 33.1 24.4 15.2 26.5 28.6 21.1 27.3 21.6 ZNF80 pT17 ENSG00000174255 "Zinc finger protein 80" P51504 3 114234631-114237578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "lymphoid tissue: 3.1" "Cell type enhanced" "Detected in some" "dendritic cells: 3.2;granulocytes: 1.3;NK-cells: 2.1;Plasma cells: 1.4;T-cells: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 4 "T-cells: 1.2" "Not detected" "Not detected" HPA065484 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA065484: AB_2685496" "unprognostic (6.27e-3)" "unprognostic (3.00e-2)" "unprognostic (4.42e-2)" "unprognostic (1.26e-1)" "unprognostic (4.52e-2)" "unprognostic (9.68e-5)" "unprognostic (5.36e-1)" "unprognostic (6.52e-3)" "unprognostic (2.80e-2)" "unprognostic (1.27e-2)" "unprognostic (6.25e-2)" "unprognostic (1.49e-1)" "unprognostic (6.69e-12)" "unprognostic (1.85e-1)" "unprognostic (3.10e-1)" "unprognostic (1.16e-1)" "unprognostic (1.34e-2)" 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.7 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.7 0.0 0.4 0.0 5.2 0.1 0.1 0.0 ZNHIT2 "C11orf5, FON" ENSG00000174276 "Zinc finger HIT-type containing 2" Q9UHR6 11 65116403-65117701 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 68.0" "Group enriched" "Detected in many" 8 "Early spermatids: 356.7;Late spermatids: 720.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058066 Uncertain NA NA "HPA058066: AB_2683593" "unprognostic (1.73e-2)" "unprognostic (2.93e-1)" "unprognostic (3.11e-1)" "unprognostic (7.74e-3)" "unprognostic (3.07e-1)" "unprognostic (3.26e-2)" "unprognostic (4.55e-3)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (1.61e-2)" "unprognostic (2.13e-2)" "unprognostic (1.41e-1)" "unprognostic (2.16e-3)" "unprognostic (3.53e-3)" "unprognostic (2.00e-1)" "unprognostic (3.64e-1)" "unprognostic (7.53e-2)" 7.7 25.5 4.2 2.1 3.6 3.5 9.2 4.1 6.3 7.2 7.6 8.1 3.3 10.4 0.9 10.7 13.0 0.8 8.5 4.0 3.8 10.2 15.8 6.7 2.1 4.7 4.3 3.5 8.1 14.7 2.3 16.4 1.2 4.5 10.6 0.6 0.8 9.4 2.4 14.3 12.9 7.7 0.8 4.1 9.6 10.5 68.0 3.7 1.5 11.3 1.1 1.0 8.2 6.6 4.5 17.4 13.0 1.9 5.5 1.5 2.6 13.1 6.6 2.6 4.5 2.8 6.2 8.9 5.5 13.4 1.4 4.4 18.4 0.9 5.0 0.5 12.4 17.7 5.5 10.5 5.4 4.6 12.4 8.9 3.1 6.7 3.0 2.5 2.0 2.8 5.1 14.5 4.8 2.0 18.1 10.2 19.5 14.9 3.9 25.4 8.4 2.5 35.7 3.3 4.5 16.2 15.5 6.7 11.0 18.6 0.6 17.0 10.6 6.3 5.1 6.8 10.1 7.1 20.9 15.5 3.5 8.3 4.2 5.9 11.7 20.5 11.5 25.1 15.2 25.1 19.0 19.6 23.5 18.7 27.3 20.6 23.1 3.4 16.8 10.1 26.3 11.3 17.4 4.2 3.6 4.1 6.3 4.0 3.8 4.7 4.3 3.5 4.5 4.1 3.7 4.5 4.2 16.0 9.3 0.7 9.5 11.1 14.6 16.0 6.8 13.6 11.4 11.4 3.0 10.0 13.0 12.9 6.2 12.5 11.6 13.9 31.3 22.4 356.7 36.0 5.6 6.1 13.8 6.9 1.2 18.9 9.8 7.3 9.7 7.6 2.5 2.7 7.5 17.1 10.6 11.8 1.3 11.0 20.3 5.7 5.2 720.1 14.9 5.5 7.2 1.9 10.7 13.5 23.7 1.5 1.5 17.7 15.9 12.0 11.0 12.5 13.6 40.5 41.7 15.8 19.7 6.3 12.1 61.2 26.0 8.1 8.7 11.4 9.0 14.4 14.8 11.1 EVX2 ENSG00000174279 "Even-skipped homeobox 2" Q03828 2 176077472-176083913 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.2;prostate: 1.3;seminal vesicle: 1.6;testis: 3.1;vagina: 1.1" "Cell type enhanced" "Detected in some" "Early spermatids: 8.7;Enteroendocrine cells: 2.4;Late spermatids: 4.7;Paneth cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "midbrain: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" HPA041576 Uncertain NA NA "HPA041576: AB_10796347" "unprognostic (2.27e-1)" "unprognostic (1.68e-3)" "unprognostic (1.83e-1)" "unprognostic (3.41e-1)" "unprognostic (5.75e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-3)" "unprognostic (2.32e-1)" "unprognostic (4.93e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.5 0.7 0.0 1.2 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 8.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.3 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 32.7 36.4 24.6 7.5 21.4 3.1 31.7 19.9 24.1 42.1 12.3 37.5 6.4 40.7 16.4 26.6 40.8 9.7 37.1 22.2 21.0 24.3 7.8 30.2 8.3 27.7 23.1 19.1 48.8 23.3 36.4 28.8 10.9 28.1 33.3 6.6 23.3 28.3 21.6 32.7 26.1 23.2 16.5 20.2 22.2 27.5 16.0 23.6 9.6 44.3 14.9 9.0 42.6 34.1 22.5 10.7 14.4 3.6 6.9 37.1 19.1 6.5 14.7 21.0 13.0 12.9 4.8 5.1 1.1 11.4 28.0 9.5 16.7 3.6 20.6 9.5 17.0 6.2 5.3 12.3 3.4 10.4 1.0 12.2 13.4 21.1 12.5 15.9 30.6 11.5 4.0 1.8 3.4 14.5 7.1 3.7 2.2 1.5 4.3 6.8 6.8 6.2 1.6 15.9 8.9 2.1 5.3 6.5 4.6 6.9 6.3 8.6 2.4 16.1 14.6 5.7 13.9 12.3 6.1 4.5 0.7 15.7 3.3 7.7 0.4 0.3 0.5 1.0 0.5 1.0 0.5 0.8 0.8 0.2 0.5 1.0 1.0 0.2 0.6 1.7 0.4 0.4 0.6 24.6 21.4 19.9 24.1 22.2 21.0 27.7 23.1 19.1 28.1 20.2 23.6 22.5 27.4 51.3 53.1 33.6 14.6 30.7 16.3 18.4 18.8 86.6 23.6 20.6 92.6 20.0 24.8 20.2 68.8 10.3 24.5 4.6 3.9 14.4 40.8 21.1 25.2 26.1 17.4 9.5 36.9 14.4 2.2 24.8 7.1 26.0 13.9 25.7 23.9 8.1 13.5 74.0 37.3 10.1 14.2 30.0 34.6 57.0 51.9 18.6 17.8 15.9 12.0 27.0 24.7 21.6 26.7 19.0 5.3 70.0 9.5 16.2 8.2 11.2 32.2 39.9 32.9 37.8 27.4 7.3 4.3 17.3 23.4 5.2 21.1 16.3 9.0 14.7 TNK1 KOS1 ENSG00000174292 "Tyrosine kinase non receptor 1" Q13470 17 7380534-7389774 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 13.1;Distal enterocytes: 13.9;Gastric mucus-secreting cells: 16.8;Proximal enterocytes: 11.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 5.7;HaCaT: 9.1;HBEC3-KT: 6.0;hTCEpi: 6.6;T-47d: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012065, HPA056452" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA012065: AB_1858165, HPA056452: " "unprognostic (4.90e-2)" "unprognostic (1.93e-1)" "unprognostic (2.95e-1)" "prognostic favorable (4.28e-4)" "unprognostic (2.84e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-1)" "unprognostic (2.20e-1)" "unprognostic (2.52e-2)" "unprognostic (2.43e-1)" "unprognostic (3.10e-1)" "prognostic favorable (6.40e-4)" "unprognostic (1.77e-3)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.52e-4)" 2.8 0.9 0.4 1.2 0.6 0.2 5.6 1.9 0.5 3.7 0.4 5.5 3.7 2.4 0.8 7.2 3.1 1.0 1.6 0.2 0.2 4.2 5.1 2.6 1.5 0.1 0.2 0.0 3.3 7.9 3.0 3.0 0.2 0.7 7.0 2.3 1.3 8.1 1.5 0.5 8.8 7.7 0.5 0.1 3.1 7.7 1.9 0.1 0.5 4.8 0.2 1.8 4.2 5.7 0.4 5.7 0.9 0.1 0.4 0.0 0.0 3.7 0.2 0.0 0.3 0.4 2.9 2.6 0.0 2.2 0.3 0.1 9.1 0.0 6.0 0.1 0.6 1.3 0.0 3.5 1.6 0.3 0.0 0.2 0.1 6.6 0.0 1.0 0.1 0.0 2.4 0.7 0.0 0.0 4.4 0.6 0.0 0.7 4.9 0.7 0.2 0.1 0.6 4.1 2.6 0.1 0.4 3.1 4.5 0.8 0.2 7.4 0.1 1.5 0.2 0.7 0.2 0.0 0.4 0.9 0.1 0.1 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.6 0.5 0.6 0.4 0.0 0.4 1.1 1.3 0.1 0.0 0.0 0.0 0.2 0.2 0.4 0.6 1.9 0.5 0.2 0.2 0.1 0.2 0.0 0.7 0.1 0.1 0.4 2.6 6.4 3.4 0.0 2.9 2.5 2.6 5.1 13.1 1.8 9.1 7.4 1.1 2.8 3.5 1.8 0.0 0.2 0.3 13.9 0.0 5.2 1.5 2.8 1.0 1.5 3.0 0.4 0.5 6.9 0.6 1.0 16.8 4.6 0.0 0.1 1.1 2.9 0.1 0.0 0.4 7.0 2.0 0.0 0.5 1.5 1.2 0.4 0.0 0.0 0.4 0.2 2.1 0.0 0.1 8.5 8.0 0.4 0.4 3.9 11.6 1.6 1.9 2.9 0.0 0.8 1.8 1.5 0.6 11.0 2.4 0.7 2.4 0.1 7.2 2.2 ZHX3 "KIAA0395, TIX1" ENSG00000174306 "Zinc fingers and homeoboxes 3" Q9H4I2 20 41178448-41317672 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046498 Supported Nucleoplasm NA NA Nucleoplasm "HPA046498: AB_2679676" "unprognostic (6.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.50e-2)" "unprognostic (2.29e-1)" "unprognostic (3.88e-1)" "unprognostic (3.42e-1)" "unprognostic (7.25e-3)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.53e-5)" "unprognostic (3.06e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (7.52e-4)" "prognostic unfavorable (1.84e-5)" 14.4 15.5 30.9 6.5 32.1 3.4 13.4 30.2 26.8 11.0 13.1 16.6 8.6 15.9 5.8 13.7 15.8 8.5 11.9 29.0 33.0 26.7 17.3 11.7 4.5 40.5 28.9 21.0 16.4 12.0 15.6 7.9 4.9 29.9 10.7 8.1 10.9 5.7 12.0 28.7 10.8 11.5 12.2 27.3 4.3 15.6 35.3 30.4 7.1 19.1 20.2 4.8 18.3 11.1 26.5 22.5 6.3 6.6 14.2 52.6 56.3 7.6 31.0 35.4 28.3 19.1 11.4 2.9 15.6 14.7 58.5 7.6 7.0 7.9 39.2 30.0 4.3 7.1 6.6 8.6 8.8 21.6 7.6 7.9 34.6 18.7 21.3 27.3 19.2 12.3 11.7 6.2 10.6 38.3 45.0 11.9 4.5 2.9 10.4 23.0 5.8 18.6 6.2 38.6 6.7 23.0 8.3 20.7 12.0 7.4 5.7 11.6 10.5 19.9 70.2 10.8 25.0 15.5 12.2 8.0 6.9 28.9 11.0 11.4 0.1 0.1 0.4 0.2 0.1 0.4 0.6 0.2 0.1 0.2 0.6 0.4 0.3 0.1 0.6 0.2 0.1 0.2 0.1 30.9 32.1 30.2 26.8 29.0 33.0 40.5 28.9 21.0 29.9 27.3 30.4 26.5 29.8 19.2 16.4 370.5 4.7 2.9 3.9 2.6 2.8 19.5 6.3 4.7 12.7 17.2 5.8 22.0 4.2 0.6 3.8 5.5 11.7 3.7 106.3 12.3 33.2 15.1 14.9 3.8 99.0 2.7 2.7 20.5 6.6 26.3 1.3 3.7 16.4 31.6 3.0 40.4 96.5 5.6 4.1 3.5 1.7 32.3 18.6 3.5 1.8 52.5 1.9 28.6 1.0 139.7 142.4 4.6 1.3 24.5 2.7 2.6 12.6 27.0 3.2 7.1 26.3 41.2 10.9 11.0 5.2 6.3 3.7 0.4 2.7 19.7 4.7 2.3 PHLDA3 TIH1 ENSG00000174307 "Pleckstrin homology like domain family A member 3" Q9Y5J5 1 201464278-201469237 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 269.3;Prostatic glandular cells: 188.7;Urothelial cells: 556.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 284.8;WM-115: 164.3" "Low region specificity" "Detected in all" HPA027601 Approved NA NA "HPA027601: AB_10601389" "unprognostic (1.51e-1)" "unprognostic (7.48e-2)" "unprognostic (5.65e-2)" "prognostic favorable (1.77e-4)" "unprognostic (8.55e-3)" "unprognostic (4.34e-3)" "unprognostic (5.55e-3)" "unprognostic (1.42e-1)" "unprognostic (2.16e-3)" "unprognostic (8.65e-2)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (9.32e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" "unprognostic (7.45e-2)" 137.9 30.2 36.8 8.5 46.1 0.3 120.3 49.3 38.4 52.9 19.9 99.1 4.1 53.3 11.7 90.1 41.1 15.4 39.6 31.4 41.0 18.1 8.1 42.0 2.5 73.1 48.7 29.1 23.7 23.6 10.8 28.7 8.9 56.6 65.3 5.6 3.0 39.6 27.0 76.5 66.5 29.2 17.9 47.6 10.5 35.4 9.0 46.7 10.2 31.8 11.7 4.9 76.1 68.9 69.6 52.4 60.8 11.1 33.5 50.6 47.7 284.8 75.6 57.3 18.2 21.0 4.0 39.5 0.1 3.1 37.6 15.7 90.0 1.0 61.0 3.6 0.0 22.4 0.0 26.2 47.6 57.4 0.0 1.0 66.7 90.6 29.4 25.8 53.5 26.3 4.5 0.0 0.1 36.7 37.5 8.0 0.8 19.1 0.0 3.8 2.5 51.9 0.0 16.9 115.1 0.7 11.7 26.5 0.8 62.7 42.5 25.0 3.6 39.4 42.2 69.6 36.1 16.2 1.4 0.2 0.1 102.4 0.1 164.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.6 0.0 36.8 46.1 49.3 38.4 31.4 41.0 73.1 48.7 29.1 56.6 47.6 46.7 69.6 83.3 9.6 9.1 8.8 0.9 78.1 269.3 48.8 93.9 5.2 29.8 42.4 6.2 2.8 30.7 49.7 0.0 84.9 1.8 2.2 11.7 42.0 36.8 42.7 15.2 22.2 5.3 2.7 5.7 18.9 24.4 43.3 7.1 31.8 0.0 11.2 10.4 1.4 18.1 0.0 8.3 2.1 10.2 0.6 28.5 136.5 26.8 7.9 32.0 1.0 18.2 105.4 1.0 4.5 37.1 71.4 2.9 41.8 2.1 188.7 1.2 8.5 22.3 5.2 0.0 38.0 55.8 0.8 4.0 92.1 102.0 37.5 5.7 46.5 3.6 556.5 SLC16A11 "FLJ90193, MCT11" ENSG00000174326 "Solute carrier family 16 member 11" Q8NCK7 17 7041621-7044092 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid metabolism, Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.9;thyroid gland: 13.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Muller glia cells: 32.0" "Cancer enhanced" "Detected in many" "liver cancer: 12.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 8 "B-cells: 1.0;T-cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.65e-4)" "unprognostic (9.40e-3)" "unprognostic (6.10e-2)" "unprognostic (8.85e-2)" "unprognostic (6.97e-5)" "unprognostic (5.22e-3)" "prognostic favorable (2.56e-4)" "unprognostic (2.22e-3)" "unprognostic (5.38e-2)" "unprognostic (2.58e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.30e-2)" "prognostic favorable (3.19e-7)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-1)" "unprognostic (5.83e-2)" 1.4 0.7 1.2 0.3 1.3 0.0 3.7 2.1 1.9 1.8 5.8 1.2 0.4 1.3 1.4 2.3 12.9 0.4 2.1 1.2 2.9 4.1 9.7 2.8 0.4 1.4 1.4 0.8 2.6 4.0 5.5 4.9 0.0 1.8 3.1 0.0 0.2 10.5 1.9 0.5 6.1 1.8 0.0 1.9 1.8 1.3 0.8 1.1 0.2 13.6 0.1 0.2 0.9 1.8 1.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.6 0.3 1.4 0.0 1.0 0.7 1.3 0.0 0.1 0.0 0.0 0.0 0.2 1.2 1.3 2.1 1.9 1.2 2.9 1.4 1.4 0.8 1.8 1.9 1.1 1.6 9.8 12.8 8.4 2.6 5.9 1.8 5.4 4.0 4.6 0.4 7.0 8.8 2.6 8.6 8.3 7.3 0.0 0.0 3.0 0.2 1.9 3.9 0.3 0.4 0.1 4.0 9.6 0.0 0.6 1.3 0.0 1.7 0.0 0.2 0.0 0.0 1.4 5.0 0.0 0.0 0.3 1.2 6.1 0.3 0.4 0.7 6.8 0.4 3.6 0.0 0.4 32.0 9.2 2.0 0.1 0.1 0.1 4.9 1.1 3.1 0.0 1.5 6.5 1.9 0.0 1.2 1.3 1.5 1.2 5.9 3.1 0.1 3.9 0.4 1.4 7.9 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036015-7040117 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 22.8;GAMG: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA065245: AB_2685443" "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 1.3 1.0 1.0 2.2 0.8 0.4 1.5 1.8 1.1 1.2 0.9 2.2 9.3 0.8 1.3 5.3 1.8 3.8 1.1 0.9 1.0 6.9 36.4 2.4 2.8 1.2 0.9 0.7 0.5 1.2 2.9 0.8 1.5 1.0 1.5 1.6 0.3 3.3 0.8 0.4 5.3 5.5 1.0 1.0 3.5 1.9 0.5 1.3 1.8 3.3 0.2 2.5 1.3 2.6 1.1 13.1 22.8 5.3 3.2 3.2 1.8 2.2 1.3 3.3 2.9 6.5 7.4 14.3 8.3 2.2 2.1 26.2 20.1 4.1 7.0 1.2 10.3 2.9 3.4 1.8 18.0 3.6 1.2 7.6 2.1 7.8 4.3 3.5 3.9 11.9 7.4 4.0 2.3 3.1 6.5 5.1 2.1 2.2 6.6 1.8 2.4 1.8 1.4 2.7 3.6 0.2 1.4 4.0 2.2 1.8 7.8 6.1 1.8 4.5 1.8 4.1 3.0 1.9 4.0 8.9 0.5 5.4 3.0 0.8 0.0 0.8 1.0 1.2 0.8 0.9 1.1 1.0 1.5 0.8 2.5 1.1 1.1 0.9 1.2 0.9 1.1 1.2 0.5 1.0 0.8 1.8 1.1 0.9 1.0 1.2 0.9 0.7 1.0 1.0 1.3 1.1 2.3 0.0 1.5 0.7 5.1 0.5 0.9 1.3 4.0 0.4 1.6 0.9 0.4 1.5 0.8 5.5 0.0 1.9 2.4 1.1 0.0 1.0 0.0 0.5 0.5 2.8 0.0 0.4 1.8 0.2 0.4 0.6 4.1 0.7 3.8 1.1 2.2 8.2 0.5 3.3 1.1 1.2 2.0 0.6 3.1 0.0 0.9 1.6 0.0 1.0 1.4 0.9 6.2 0.5 0.0 0.5 0.1 0.0 2.9 0.9 2.4 1.9 1.4 0.5 0.0 0.3 1.1 0.0 0.0 7.4 1.6 2.5 4.7 0.5 1.0 1.0 GLIS1 FLJ36155 ENSG00000174332 "GLIS family zinc finger 1" Q8NBF1 1 53506237-53738106 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 8.2;seminal vesicle: 7.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.6;Excitatory neurons: 28.0;Inhibitory neurons: 13.3;Proximal tubular cells: 4.8" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;GAMG: 5.9;hTERT-RPE1: 4.7;PC-3: 7.3;U-138 MG: 5.1" "Not detected" "Not detected" HPA001409 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA001409: AB_1078974" "unprognostic (1.30e-1)" "unprognostic (1.46e-1)" "unprognostic (2.07e-1)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (1.54e-2)" "unprognostic (8.91e-3)" "unprognostic (1.92e-1)" "unprognostic (2.27e-3)" "unprognostic (2.30e-1)" "unprognostic (3.03e-2)" "unprognostic (1.15e-2)" "unprognostic (1.93e-1)" "unprognostic (4.06e-2)" "unprognostic (1.55e-1)" "unprognostic (6.37e-4)" "unprognostic (1.98e-4)" 0.9 0.1 0.4 0.4 0.6 0.0 1.2 0.1 2.2 4.1 0.0 0.3 0.4 0.9 0.6 0.8 0.8 0.6 0.7 2.3 0.0 4.2 0.0 0.2 0.1 0.2 0.0 0.4 0.6 0.0 0.1 0.1 0.0 2.4 8.2 0.0 0.0 0.8 7.7 0.1 1.8 0.6 0.2 0.0 0.2 0.8 2.3 0.0 0.2 0.4 0.0 0.0 2.6 4.6 1.3 0.0 0.0 0.0 0.4 2.8 3.7 0.0 2.0 4.5 1.7 1.3 0.0 0.0 0.0 0.1 2.1 5.9 0.0 0.0 0.0 0.5 0.0 1.3 0.0 1.4 0.1 1.0 0.0 0.0 2.5 0.2 2.1 2.0 4.7 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 7.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.9 0.1 1.3 0.0 0.0 3.1 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 2.2 2.3 0.0 0.2 0.0 0.4 2.4 0.0 0.0 1.3 0.2 0.0 0.0 1.3 0.1 6.6 0.0 0.0 4.0 1.3 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.2 0.1 0.0 0.0 28.0 0.0 0.0 3.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 1.0 2.9 0.3 0.0 3.6 1.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 1.2 0.1 0.1 0.0 4.8 0.0 0.0 0.0 0.4 0.8 1.8 2.8 0.3 1.7 0.1 0.1 0.1 0.0 0.1 OR2Y1 ENSG00000174339 "Olfactory receptor family 2 subfamily Y member 1" Q8NGV0 5 180739042-180740099 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA9 NACHRA9 ENSG00000174343 "Cholinergic receptor nicotinic alpha 9 subunit" Q9UGM1 4 40335333-40355217 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "breast cancer: 2.5;glioma: 3.5;lung cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "U-87 MG: 15.9" "Region enriched" "Detected in single" 6 "basal ganglia: 1.0" "Not detected" "Not detected" NA NA "unprognostic (6.20e-3)" "unprognostic (9.18e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "unprognostic (3.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "unprognostic (7.30e-2)" "unprognostic (1.94e-1)" "unprognostic (8.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.76e-1)" "unprognostic (5.01e-2)" "unprognostic (9.18e-3)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.1 0.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PODN "MGC24995, PCAN, PODOCAN, SLRR5A" ENSG00000174348 Podocan Q7Z5L7 1 53062052-53085501 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Fibroblasts: 123.5;Leydig cells: 268.7;Peritubular cells: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "gdT-cell: 5.1;memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 52 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;BJ: 39.2;fHDF/TERT166: 23.9;HHSteC: 94.1;U-2197: 46.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 910000 "unprognostic (8.69e-2)" "unprognostic (4.73e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.65e-1)" "unprognostic (1.90e-3)" "unprognostic (1.71e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (2.02e-5)" "unprognostic (5.91e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (5.02e-2)" 156.9 14.4 8.5 13.4 7.0 0.2 117.3 5.6 8.8 107.0 8.1 64.4 11.7 106.0 19.9 36.4 128.7 104.7 67.1 5.9 24.6 5.1 12.6 66.9 3.8 6.9 8.9 4.6 179.5 21.0 2.9 19.6 18.3 6.9 70.4 8.3 0.6 49.2 34.8 20.4 40.8 26.3 45.1 5.7 3.4 76.1 27.1 9.3 10.9 72.1 30.8 2.7 102.1 88.6 8.5 0.0 0.0 0.0 0.0 23.0 3.1 0.1 39.2 5.3 0.4 0.3 0.0 0.0 0.0 0.6 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.1 0.0 0.0 14.9 0.0 0.9 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 8.5 7.0 5.6 8.8 5.9 24.6 6.9 8.9 4.6 6.9 5.7 9.3 8.5 8.5 0.0 3.3 0.0 0.0 6.4 0.4 0.0 0.6 0.5 0.8 0.9 1.7 1.5 0.6 0.0 0.0 0.4 1.3 0.0 0.0 0.0 1.6 0.3 11.2 3.8 0.0 0.0 0.0 0.0 0.4 123.5 2.6 0.3 0.0 0.7 4.2 0.1 0.6 0.0 1.9 0.0 0.0 0.3 8.8 9.2 268.7 1.3 5.4 6.5 0.0 0.3 3.1 5.5 0.2 0.0 0.0 261.1 1.6 0.5 0.1 0.0 0.0 0.5 0.0 4.4 16.0 0.7 0.6 0.7 6.0 0.5 1.6 0.0 0.0 0.2 SLC6A19 ENSG00000174358 "Solute carrier family 6 member 19" Q695T7 5 1201595-1225111 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "intestine: 143.6;kidney: 89.5" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 561.5" "Group enriched" "Detected in many" 4 "renal cancer: 7.9;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 14.3;HEL: 18.3;OE19: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037415, HPA043207" Enhanced NA NA "HPA037415: AB_10672346, HPA043207: AB_2678363" "unprognostic (1.26e-1)" "unprognostic (1.01e-3)" "unprognostic (6.04e-2)" "unprognostic (3.64e-1)" "prognostic favorable (4.14e-6)" "unprognostic (1.37e-1)" "unprognostic (7.36e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 141.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 89.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 5.6 0.0 0.0 0.0 0.0 0.0 143.6 0.3 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.0 5.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 64.3 0.6 1.8 0.0 0.0 0.0 104.4 1.9 0.1 0.1 0.0 0.0 0.1 4.8 2.7 0.0 0.0 14.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 561.5 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 8.7 0.0 C11orf45 "FLJ43646, MGC35558" ENSG00000174370 "Chromosome 11 open reading frame 45" Q8TAV5 11 128899565-128906035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.7;Hofbauer cells: 8.7;Kupffer cells: 5.9;Late spermatids: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 11.2;U-937: 8.9" HPA039716 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039716: AB_10672892" "unprognostic (8.32e-2)" "unprognostic (3.93e-2)" "unprognostic (5.99e-3)" "unprognostic (1.35e-3)" "unprognostic (1.01e-1)" "unprognostic (9.93e-2)" "unprognostic (4.50e-5)" "unprognostic (1.97e-2)" "unprognostic (4.78e-2)" "unprognostic (3.10e-1)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "unprognostic (2.55e-9)" "unprognostic (2.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.87e-2)" "unprognostic (7.22e-2)" 0.6 3.4 1.7 0.7 3.8 0.8 0.9 0.6 1.6 1.0 0.9 0.7 1.4 0.5 0.6 2.9 1.0 2.0 4.5 1.1 1.7 1.1 0.5 2.6 0.8 1.7 1.6 1.0 0.9 2.6 3.9 2.4 2.1 2.6 1.1 0.9 0.2 1.6 2.9 0.1 6.7 0.9 0.5 1.2 1.6 1.8 1.1 1.5 2.4 1.8 0.2 0.9 1.2 1.3 1.7 2.4 4.5 0.0 0.0 0.3 0.4 1.6 0.8 4.7 1.7 4.2 6.3 5.8 0.0 3.2 0.5 4.2 2.3 2.4 11.2 0.8 0.0 1.1 0.3 2.7 0.0 0.2 0.0 0.0 0.3 1.5 1.3 0.9 3.8 1.0 3.5 0.0 0.2 2.0 1.2 2.6 2.4 1.8 1.0 3.9 1.1 4.6 0.5 3.9 1.1 0.0 0.2 1.8 5.0 0.3 1.2 0.8 4.4 0.5 0.0 6.2 0.0 0.8 0.1 0.0 0.0 0.8 8.9 0.2 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 1.7 3.8 0.6 1.6 1.1 1.7 1.7 1.6 1.0 2.6 1.2 1.5 1.7 0.1 0.0 0.5 0.0 0.0 2.8 1.3 0.9 5.7 0.0 0.3 0.4 1.7 0.0 0.2 0.0 0.0 2.0 0.0 0.1 1.9 1.0 2.0 0.3 0.1 0.2 0.0 0.0 0.3 0.8 2.1 0.3 0.0 0.5 1.3 0.3 0.4 0.0 8.7 0.0 0.2 0.1 0.0 5.9 0.8 8.2 0.0 2.2 0.0 2.8 0.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 1.5 1.7 3.0 0.9 1.2 0.2 0.1 0.2 1.1 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.4;lymphoid tissue: 11.2" "Cell type enhanced" "Detected in some" "Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 0.5 0.3 0.2 3.3 0.2 17.4 1.3 0.2 0.7 0.4 0.1 3.2 3.0 0.8 0.0 2.5 0.3 0.4 0.2 0.2 0.2 0.3 0.6 0.6 5.9 0.1 0.2 0.1 0.2 0.3 0.8 0.1 3.3 0.2 0.3 3.7 0.0 0.5 0.2 0.1 1.8 2.5 1.2 0.1 1.5 1.6 5.8 0.3 11.2 0.4 0.0 6.5 1.2 0.8 0.4 41.3 26.8 43.4 28.6 2.7 6.7 36.5 53.4 17.7 46.7 50.5 33.9 22.5 44.3 25.3 12.6 25.1 40.0 55.5 22.5 54.8 69.5 48.4 41.5 28.8 17.3 1.0 59.8 29.4 1.7 1.1 46.8 12.5 5.7 14.7 43.4 84.6 57.0 37.8 19.0 65.9 33.6 60.4 49.7 26.0 46.2 40.5 47.5 9.6 25.6 48.1 60.9 34.8 27.9 19.5 20.2 25.8 36.6 5.5 44.9 39.5 42.7 72.9 41.5 59.0 71.3 15.6 48.1 54.9 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.3 0.2 0.2 0.2 0.7 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.4 0.2 0.0 0.0 0.3 0.7 0.8 0.1 0.7 0.0 0.0 0.3 0.5 2.3 0.0 0.1 0.0 0.0 5.3 0.2 1.2 0.0 0.1 9.3 0.3 0.4 0.7 0.0 7.4 1.0 0.0 16.7 0.9 1.1 0.5 0.0 4.6 0.4 0.0 3.3 0.0 2.9 0.5 0.0 0.3 0.8 2.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 11.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 9.3 9.8 2.7 0.1 4.0 0.8 0.8 1.9 0.3 RALGAPA1 "DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1" ENSG00000174373 "Ral GTPase activating protein catalytic subunit alpha 1" Q6GYQ0 14 35538352-35809304 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 394.0;Inhibitory neurons: 233.9;Oligodendrocyte precursor cells: 239.3;Oligodendrocytes: 412.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000851 Approved Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA000851: AB_1078945" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (8.90e-2)" "unprognostic (6.76e-2)" "unprognostic (1.85e-1)" "unprognostic (1.19e-2)" "unprognostic (7.65e-2)" "unprognostic (1.17e-2)" "unprognostic (2.88e-1)" "unprognostic (3.38e-2)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "prognostic favorable (9.76e-5)" "unprognostic (2.75e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" "unprognostic (1.46e-1)" 13.3 18.6 25.8 9.1 28.8 7.2 16.1 37.5 29.3 20.1 19.9 17.6 7.7 16.6 13.9 16.0 18.0 9.4 12.8 24.8 27.8 12.3 13.1 14.2 9.7 28.0 27.6 22.9 24.1 16.4 25.7 23.6 7.5 27.4 17.6 14.6 39.8 13.1 10.6 18.6 20.3 14.8 12.8 28.2 12.1 15.9 10.7 27.5 9.8 16.5 11.0 9.1 16.1 18.4 34.9 7.4 8.7 11.0 9.6 16.4 11.4 7.0 5.2 5.4 6.7 6.0 5.2 6.4 7.2 7.2 7.1 8.8 12.0 13.4 10.2 6.2 16.1 5.1 6.7 11.0 26.3 8.4 11.4 10.4 8.6 18.3 5.8 14.1 11.0 9.5 14.2 6.7 17.9 5.9 11.8 8.5 5.4 5.0 18.2 12.9 6.9 6.7 4.6 13.8 11.9 10.2 16.7 11.0 18.9 9.6 10.6 18.0 5.3 8.7 6.5 5.0 7.6 6.5 14.6 14.4 9.3 3.0 7.3 7.2 0.0 0.2 0.0 0.7 0.3 0.9 0.5 0.7 0.9 0.3 0.3 0.4 0.7 0.0 0.7 0.3 0.4 0.8 0.1 25.8 28.8 37.5 29.3 24.8 27.8 28.0 27.6 22.9 27.4 28.2 27.5 34.9 40.2 16.0 30.9 162.6 63.9 38.1 28.3 13.9 62.0 86.1 27.7 21.5 19.4 15.7 25.2 23.9 394.0 10.9 105.8 31.0 0.0 12.8 19.5 47.0 38.5 31.4 31.1 14.9 215.3 15.8 5.5 34.6 54.0 50.8 53.4 41.6 18.5 14.8 9.2 52.2 233.9 23.3 16.2 10.0 39.9 8.7 34.2 35.4 19.6 173.3 16.8 30.5 16.5 239.3 412.8 15.9 25.9 29.0 86.3 36.0 26.6 10.4 25.2 119.1 39.5 59.0 37.8 47.0 38.0 55.9 46.2 15.2 80.7 24.0 28.7 27.1 LIG4 ENSG00000174405 "DNA ligase 4" P49917 13 108207439-108218368 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001334, HPA057325" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA001334: AB_1078689, HPA057325: AB_2732608" "unprognostic (9.93e-2)" "unprognostic (1.56e-1)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (1.40e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.21e-3)" "unprognostic (1.94e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (1.50e-2)" "unprognostic (9.03e-3)" 7.2 8.4 7.5 8.7 7.7 4.0 5.6 7.2 9.1 4.0 9.2 5.8 7.2 4.5 8.5 4.3 4.5 6.8 6.7 8.5 9.9 8.3 12.1 7.0 11.1 7.9 7.7 7.3 5.9 3.8 11.4 5.3 5.8 8.2 5.7 6.7 23.3 4.7 5.3 7.2 5.3 7.1 6.6 7.1 8.4 7.9 9.8 9.3 22.0 7.8 6.6 8.4 7.0 2.3 9.0 15.5 5.8 15.3 10.2 12.4 13.3 5.4 14.9 11.2 11.2 13.3 6.9 6.7 26.0 11.9 9.8 13.7 6.3 10.2 9.9 19.2 15.4 9.8 12.3 13.8 3.6 14.8 16.6 12.5 12.3 16.3 10.8 9.6 10.7 13.5 47.0 4.4 4.7 17.4 8.3 27.7 12.1 3.9 12.6 3.6 25.1 6.0 4.2 14.6 9.7 9.6 9.9 3.3 9.0 11.7 11.7 7.7 25.4 20.1 6.6 7.2 7.5 13.5 12.4 8.7 41.7 25.4 9.4 15.2 0.6 1.6 4.8 1.1 2.5 1.6 1.6 1.2 1.2 1.4 2.2 1.2 1.7 2.2 1.9 8.3 1.0 1.8 1.0 7.5 7.7 7.2 9.1 8.5 9.9 7.9 7.7 7.3 8.2 7.1 9.3 9.0 5.6 9.6 9.5 13.4 9.2 2.7 2.8 4.9 3.4 10.7 4.9 2.8 11.6 1.5 10.0 1.8 8.4 2.3 7.3 7.9 9.8 5.3 11.6 8.3 5.7 4.3 9.6 0.4 16.6 7.5 1.0 4.2 7.7 6.0 3.8 3.6 4.6 9.8 5.8 18.5 16.1 5.3 2.0 7.5 3.9 5.1 2.8 7.4 1.8 10.3 9.3 7.3 4.1 13.6 24.9 8.9 6.3 6.0 6.2 2.5 3.5 6.3 21.9 13.6 13.1 4.6 3.8 19.1 4.4 4.0 5.7 1.8 4.1 8.7 2.9 3.7 TRHR ENSG00000174417 "Thyrotropin releasing hormone receptor" P34981 8 109086585-109121565 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Congenital hypothyroidism, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "brain: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055162 Approved NA NA "HPA055162: AB_2732592" "unprognostic (1.92e-2)" "unprognostic (8.58e-2)" "unprognostic (1.17e-1)" 0.0 0.0 3.4 0.0 0.8 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.0 0.0 0.0 1.0 0.8 0.8 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.8 0.0 5.5 3.6 1.3 1.0 0.8 0.8 1.2 1.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTF2IRD2B ENSG00000174428 "GTF2I repeat domain containing 2B" Q6EKJ0 7 75092573-75149817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 14.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056679, HPA056680" Supported Nucleoplasm NA NA Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "prognostic favorable (3.27e-4)" "unprognostic (1.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-2)" "unprognostic (2.19e-2)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-1)" "unprognostic (8.90e-4)" "unprognostic (1.54e-2)" "unprognostic (7.21e-3)" "unprognostic (2.31e-1)" "unprognostic (3.61e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-5)" 11.6 9.6 7.7 5.7 9.8 14.1 13.7 7.8 6.8 13.7 8.9 12.5 5.1 16.1 5.5 8.2 17.5 9.5 12.8 6.2 6.8 13.9 15.8 10.8 5.3 9.0 8.7 4.7 33.1 17.1 13.9 7.6 7.3 13.1 13.1 9.3 10.9 13.4 13.0 36.3 5.9 8.0 13.6 8.2 8.1 15.6 4.6 8.6 17.3 12.4 28.9 7.9 14.0 8.6 19.8 19.0 7.4 12.4 12.9 9.8 13.4 9.4 9.7 14.5 4.4 11.5 3.5 14.2 11.4 9.4 9.7 17.3 6.3 6.1 6.3 5.3 14.7 5.5 8.4 9.5 7.9 19.0 13.5 12.5 12.4 12.7 3.7 15.5 15.9 6.1 4.1 11.7 24.4 14.4 12.4 9.1 31.6 12.6 16.3 11.5 18.0 3.8 17.6 13.2 13.8 11.5 21.6 20.4 20.9 22.7 3.4 20.8 13.0 10.8 11.4 7.7 10.4 12.8 10.1 6.3 31.4 5.3 12.9 25.6 0.5 1.3 5.0 1.0 1.8 1.5 14.8 1.7 2.2 1.0 6.6 2.9 1.3 1.3 1.1 1.1 1.4 2.6 0.7 7.7 9.8 7.8 6.8 6.2 6.8 9.0 8.7 4.7 13.1 8.2 8.6 19.8 4.6 0.0 10.8 20.5 22.1 4.5 4.5 10.3 27.3 7.2 11.9 9.5 21.1 14.3 5.5 7.3 12.5 2.4 8.1 9.1 0.0 12.9 13.5 9.9 7.8 6.1 19.2 8.6 4.1 12.9 2.7 13.2 35.2 5.6 3.8 13.3 11.0 12.0 2.6 13.5 7.2 15.1 10.2 8.1 5.4 4.4 27.4 4.0 21.4 5.6 6.0 6.5 9.2 15.6 27.0 14.8 14.6 17.0 23.4 4.6 10.2 3.4 13.8 13.4 13.1 11.3 10.7 2.5 1.5 22.2 4.3 3.0 13.0 6.0 14.3 3.6 ABRA STARS ENSG00000174429 "Actin binding Rho activating protein" Q8N0Z2 8 106759483-106770244 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Actin-binding, Activator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 30.0;skeletal muscle: 146.3;tongue: 64.3" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 206.4;Early spermatids: 132.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (9.08e-3)" "unprognostic (1.61e-2)" "unprognostic (3.26e-1)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "unprognostic (2.64e-2)" "unprognostic (1.35e-2)" "unprognostic (6.84e-2)" "unprognostic (2.69e-1)" "unprognostic (2.09e-1)" "unprognostic (2.69e-1)" "unprognostic (1.15e-2)" "unprognostic (4.34e-1)" "unprognostic (6.21e-3)" 0.4 0.3 0.0 0.1 0.1 0.0 0.1 1.5 0.3 0.4 0.0 0.1 0.0 1.1 0.1 3.0 0.4 0.1 30.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 1.2 0.1 146.3 0.1 0.0 0.9 0.0 0.1 0.1 2.2 0.0 0.0 0.1 64.3 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.1 0.2 0.3 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 206.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 132.8 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 14.8 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 22.5 3.6 3.3 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ATP2A2 "ATP2B, DAR, SERCA2" ENSG00000174437 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2" P16615 12 110280756-110351093 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "heart muscle: 1015.1;skeletal muscle: 2883.7;tongue: 2793.4" "Cell type enriched" "Detected in all" 7 "Cardiomyocytes: 2119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062605 Enhanced NA NA 2500000 "HPA062605: AB_2684805" "unprognostic (4.81e-2)" "unprognostic (2.16e-2)" "unprognostic (1.87e-1)" "unprognostic (3.41e-3)" "unprognostic (2.50e-1)" "unprognostic (3.98e-3)" "unprognostic (1.91e-2)" "unprognostic (6.20e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-3)" "unprognostic (2.26e-1)" "unprognostic (5.62e-2)" "unprognostic (9.93e-2)" 61.0 50.1 27.9 58.3 29.2 46.4 34.4 34.9 24.9 43.7 18.3 64.8 48.0 47.0 39.4 182.8 67.6 61.1 1015.1 33.7 26.8 34.8 55.2 49.4 36.3 29.6 42.4 20.6 42.4 38.5 56.5 24.7 55.8 29.4 94.2 69.7 19.2 93.0 70.7 2883.7 46.2 56.9 75.0 30.2 30.8 47.6 74.8 51.1 36.6 74.0 2793.4 48.5 91.8 58.4 34.2 129.7 305.7 135.4 106.5 95.3 111.7 185.1 154.9 197.2 163.6 102.1 229.1 131.3 155.4 129.2 165.4 115.4 185.0 215.9 264.4 157.3 130.0 127.2 148.0 115.6 121.5 164.7 151.1 130.6 130.3 170.7 202.3 190.1 165.4 134.9 82.6 162.9 74.9 118.6 131.3 76.0 53.2 139.7 126.6 134.8 96.8 130.2 128.6 59.5 279.2 138.2 101.5 207.8 151.1 87.0 113.9 213.7 95.6 159.8 147.8 69.3 93.9 127.4 140.6 189.5 169.0 152.3 70.9 168.8 0.0 0.6 0.0 0.5 1.3 0.2 0.1 0.3 0.2 0.5 0.2 0.3 0.3 0.0 0.3 0.6 0.5 0.3 0.2 27.9 29.2 34.9 24.9 33.7 26.8 29.6 42.4 20.6 29.4 30.2 51.1 34.2 48.9 44.8 57.5 85.5 26.3 114.5 95.2 134.5 68.9 63.6 70.2 64.6 2119.9 41.5 103.5 51.5 64.6 33.4 37.4 155.1 1.9 43.7 14.8 291.6 90.8 59.7 137.3 14.1 161.0 71.0 37.6 104.2 49.5 258.1 45.0 47.3 40.7 122.2 64.3 84.1 146.1 109.6 65.1 54.6 64.9 13.4 30.4 65.3 67.6 63.7 33.8 27.5 15.5 119.6 96.4 98.0 89.4 83.1 56.8 117.4 78.0 25.3 176.4 42.9 52.6 88.0 110.2 80.3 47.7 142.3 109.0 30.6 32.7 40.0 97.7 126.4 ZWILCH "FLJ10036, KNTC1AP" ENSG00000174442 "Zwilch kinetochore protein" Q9H900 15 66504959-66550130 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.4" "Cell type enhanced" "Detected in many" "Early spermatids: 97.3;Late spermatids: 74.5;Spermatocytes: 167.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-1)" "unprognostic (9.99e-2)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-1)" "unprognostic (4.83e-3)" "unprognostic (3.32e-2)" "unprognostic (1.31e-2)" "unprognostic (2.17e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (7.34e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.81e-2)" "unprognostic (4.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-1)" 3.8 2.2 3.2 8.5 2.9 10.4 6.7 2.7 3.1 4.9 3.9 8.8 5.5 6.3 6.3 6.7 4.0 5.9 2.7 3.1 3.2 4.7 5.4 5.3 11.7 3.6 2.7 2.4 6.0 3.2 2.6 2.4 7.3 3.1 4.6 10.0 3.8 3.4 3.7 3.3 7.9 5.5 6.3 3.4 5.6 5.6 54.4 3.2 14.3 3.9 3.1 14.2 5.5 4.1 3.9 38.1 48.5 58.0 51.5 13.6 24.0 31.3 58.8 35.6 69.4 76.5 39.4 32.2 81.6 26.3 38.6 57.7 92.6 156.4 42.2 83.9 41.7 31.9 59.5 63.9 31.3 4.9 41.4 32.0 9.9 10.7 71.2 51.8 21.4 44.8 34.3 57.4 43.2 54.7 38.2 36.7 25.2 111.7 75.2 31.0 41.9 72.1 59.6 24.9 42.6 34.5 37.5 32.1 41.4 50.6 66.1 32.9 27.6 30.0 63.2 68.7 37.6 87.2 21.6 92.6 85.0 42.9 94.5 53.5 4.0 2.1 3.6 4.3 4.2 3.7 4.3 4.3 4.1 2.1 4.1 2.8 4.0 2.5 5.0 5.4 2.2 4.5 2.2 3.2 2.9 2.7 3.1 3.1 3.2 3.6 2.7 2.4 3.1 3.4 3.2 3.9 6.1 3.2 4.6 1.3 7.5 11.1 6.4 8.4 4.0 5.1 5.8 4.2 1.5 5.7 8.7 1.8 0.0 14.1 7.0 5.3 3.9 8.2 97.3 5.9 6.6 6.5 4.8 31.5 5.2 6.5 25.1 6.7 10.7 7.8 15.2 9.6 3.9 4.7 12.5 0.0 4.3 10.3 12.2 4.1 8.4 74.5 7.5 7.4 5.4 2.8 7.4 1.5 7.2 2.5 2.7 8.1 2.1 5.3 15.0 4.6 2.0 2.8 5.2 3.7 26.3 3.1 6.4 167.9 43.1 11.2 8.5 12.9 8.3 4.8 10.1 6.9 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Approved "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" Yes No 1300000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 824.3 571.1 353.0 745.4 389.5 1944.4 2051.1 367.8 550.1 1397.4 372.9 980.2 455.3 1288.1 1097.7 1301.2 1467.0 783.7 922.5 370.5 401.3 758.5 922.5 672.2 1643.4 362.1 361.3 331.0 3049.0 1755.2 961.9 507.9 752.3 371.9 715.4 1154.5 353.6 1245.4 1102.3 1325.6 1337.8 512.2 1365.2 370.5 783.6 649.7 299.0 386.3 1900.8 1300.8 1938.7 2471.4 1334.8 789.1 397.1 1192.9 2343.4 973.0 1646.3 4272.4 7697.6 1710.1 1416.1 2899.7 2143.0 1648.1 2611.3 2025.2 4676.6 1572.3 3396.6 1011.9 2105.0 7026.5 5476.3 2352.2 1301.4 4208.3 2872.9 1955.7 2201.2 6007.7 3042.0 1376.1 7627.4 6980.3 2334.4 9237.8 2620.8 3489.1 2180.2 2682.6 1785.2 3252.1 1956.0 2044.2 1348.1 2136.9 2634.2 1661.9 2256.2 2213.4 4588.3 2958.1 2321.4 1718.4 1794.6 872.3 2447.5 3515.4 2022.2 1812.5 4303.4 2059.2 1111.1 1662.1 1048.4 2297.9 1736.5 2937.8 3118.9 1368.2 4015.4 1281.7 46.4 455.3 62.2 359.4 370.9 668.1 711.1 698.6 506.5 586.8 644.5 888.5 721.6 26.9 478.1 361.3 372.8 589.8 1758.0 353.0 389.5 367.8 550.1 370.5 401.3 362.1 361.3 331.0 371.9 370.5 386.3 397.1 393.9 451.9 1004.9 28.1 1553.4 2423.4 2769.6 2082.8 1295.3 122.6 1594.0 1140.4 403.3 760.7 1165.2 342.1 81.3 2059.9 1055.8 364.9 1651.3 1162.8 672.5 337.9 821.0 840.2 761.1 1195.8 26.2 2141.0 3735.7 879.7 467.9 430.0 945.5 899.2 711.0 715.5 1211.2 40.4 23.9 1089.8 636.8 1281.3 2031.3 1392.4 1334.0 991.6 1088.5 27.2 1920.9 417.7 1196.8 15.1 30.0 1239.9 737.1 996.0 1019.5 2031.3 370.6 1572.3 603.9 169.9 460.2 1196.4 934.7 376.4 454.9 1632.1 2583.2 2398.3 1289.5 1184.6 1371.2 2628.6 SNAPC5 SNAP19 ENSG00000174446 "Small nuclear RNA activating complex polypeptide 5" O75971 15 66490135-66497780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 118.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024379 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024379: AB_2671552" "unprognostic (4.43e-2)" "unprognostic (1.53e-3)" "unprognostic (4.39e-3)" "unprognostic (4.56e-2)" "unprognostic (3.49e-2)" "unprognostic (2.31e-1)" "unprognostic (1.06e-1)" "unprognostic (8.07e-2)" "unprognostic (1.12e-2)" "unprognostic (3.39e-2)" "unprognostic (3.13e-1)" "unprognostic (6.28e-2)" "unprognostic (1.64e-2)" "unprognostic (1.25e-1)" "unprognostic (2.21e-1)" "unprognostic (9.40e-2)" "unprognostic (5.69e-2)" 22.1 26.2 34.1 17.5 34.3 15.1 22.0 35.5 40.8 20.1 36.5 27.9 15.8 25.3 41.5 15.9 23.1 14.1 39.8 34.5 36.0 30.1 35.4 19.6 23.9 34.1 34.6 34.0 21.0 22.5 33.2 27.6 18.4 35.3 24.6 18.9 28.8 18.7 22.3 60.6 15.2 19.9 20.4 33.6 23.0 23.4 32.9 35.3 21.5 27.2 27.7 22.5 27.6 17.9 35.4 17.3 54.2 23.4 50.4 27.8 26.5 26.3 19.4 27.1 24.5 17.2 31.1 40.3 21.2 44.6 22.6 22.4 35.5 62.6 27.0 27.3 37.7 34.6 28.5 56.2 47.0 33.0 72.8 30.2 22.4 33.2 20.2 49.9 16.5 17.0 38.6 92.8 43.3 18.2 37.7 35.0 28.5 24.3 72.2 23.0 33.8 23.0 79.5 30.2 24.9 30.1 24.3 22.1 44.0 86.5 49.4 40.5 48.7 17.8 23.0 43.2 25.1 33.3 30.2 56.5 36.3 23.7 93.2 47.9 32.5 26.7 34.7 33.6 43.3 42.3 43.8 40.4 45.2 22.6 32.7 53.5 45.3 13.0 49.2 47.0 39.1 50.7 32.3 34.1 34.3 35.5 40.8 34.5 36.0 34.1 34.6 34.0 35.3 33.6 35.3 35.4 24.2 22.4 19.2 13.1 20.1 9.4 16.2 33.0 8.6 13.7 19.1 24.5 53.1 18.6 27.9 27.6 10.4 33.4 23.9 13.9 84.1 27.1 118.4 28.4 18.1 23.3 13.9 17.9 8.6 47.6 26.6 22.5 11.7 14.0 19.6 25.1 12.5 48.2 47.2 18.5 10.2 18.1 38.7 18.2 11.8 98.3 26.8 20.3 26.6 8.4 33.2 22.2 43.3 8.5 13.6 27.9 11.1 27.8 19.2 28.7 17.1 79.7 46.4 19.7 0.0 21.3 25.5 92.3 40.7 15.7 9.7 22.3 26.0 30.0 18.6 19.2 STARD6 ENSG00000174448 "StAR related lipid transfer domain containing 6" P59095 18 54324358-54357964 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 26.8" "Group enriched" "Detected in some" 53 "Early spermatids: 189.8;Late spermatids: 271.2;Spermatocytes: 103.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;Karpas-707: 2.7;U-266/70: 3.2;U-266/84: 1.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (7.81e-2)" "unprognostic (1.50e-1)" "unprognostic (5.56e-3)" "unprognostic (1.70e-1)" "unprognostic (3.25e-1)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (8.98e-3)" "unprognostic (6.98e-5)" "unprognostic (1.90e-1)" "unprognostic (2.33e-3)" "unprognostic (2.68e-1)" "unprognostic (9.97e-2)" "unprognostic (1.91e-3)" "unprognostic (1.16e-3)" 0.1 0.3 0.2 0.0 0.5 0.1 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 26.8 0.3 0.3 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.3 0.2 0.1 0.0 0.4 0.1 0.0 0.7 0.1 2.0 0.3 0.1 0.0 0.0 0.2 0.7 0.3 0.5 0.1 0.2 0.1 0.2 0.3 0.7 0.1 2.7 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.7 0.3 0.7 0.7 0.4 0.0 0.1 0.2 0.0 0.2 0.7 0.2 0.5 0.3 0.2 3.2 1.6 0.3 0.9 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.5 0.4 0.6 0.3 0.4 0.3 0.3 0.2 0.4 0.0 0.3 0.5 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 189.8 0.0 0.1 0.2 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.4 271.2 2.5 0.2 0.0 0.0 0.0 1.3 0.0 2.0 1.6 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 103.9 3.5 0.0 0.0 0.3 0.2 0.0 0.0 0.1 GOLGA6L2 "CT105, FLJ36144" ENSG00000174450 "Golgin A6 family like 2" Q8N9W4 15 23439038-23447243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "testis: 54.2" "Cell type enriched" "Detected in some" 8 "Early spermatids: 567.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-266/70: 5.0;U-266/84: 1.2" NA NA "unprognostic (1.45e-1)" "unprognostic (4.86e-2)" "unprognostic (4.12e-1)" "unprognostic (1.92e-2)" "unprognostic (1.24e-1)" "unprognostic (5.52e-2)" "unprognostic (8.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 54.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 567.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 64.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 VWC2L ENSG00000174453 "Von Willebrand factor C domain containing 2 like" B2RUY7 2 214411054-214578976 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 2.9;retina: 1.4" "Group enriched" "Detected in some" 21 "Excitatory neurons: 67.4;Inhibitory neurons: 132.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044815, HPA059414" Uncertain "Secreted - unknown location" NA NA "HPA044815: AB_10962359, HPA059414: AB_2684007" "unprognostic (8.77e-2)" "unprognostic (2.83e-3)" "unprognostic (2.05e-2)" "unprognostic (8.49e-2)" "unprognostic (1.51e-3)" "unprognostic (4.36e-1)" "unprognostic (2.56e-2)" "unprognostic (2.05e-1)" "unprognostic (3.89e-1)" 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.0 0.9 1.3 1.2 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 0.2 1.9 2.9 1.9 0.9 1.3 1.2 1.8 0.1 2.8 2.5 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 67.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 132.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.1 0.0 4.5 2.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" 12 110027028-110073634 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 80.8;choroid plexus: 50.2" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 174.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 60.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA039713 Uncertain Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640" "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favorable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 3.8 5.0 62.7 5.5 66.7 2.4 7.5 71.6 74.7 6.3 50.2 5.6 3.6 5.7 9.9 3.9 10.4 3.7 3.8 64.8 68.5 7.9 10.1 8.0 8.6 71.7 70.5 63.5 8.5 6.5 4.0 10.3 8.1 71.8 6.8 4.7 16.7 5.0 5.1 6.8 4.7 5.7 3.4 70.0 9.3 4.7 8.3 67.6 7.1 9.7 4.2 6.2 5.5 5.4 80.8 3.8 7.5 10.7 8.8 5.2 12.2 10.9 3.4 3.0 7.3 5.0 4.8 4.3 8.1 4.6 1.8 5.0 8.8 4.2 5.4 5.0 9.8 9.9 8.5 7.2 13.3 7.2 13.6 16.2 13.7 14.9 4.7 11.3 19.7 10.7 13.4 13.0 3.0 5.4 4.1 4.3 25.2 9.4 5.1 6.1 10.5 7.0 12.5 11.2 4.1 26.4 12.5 5.3 2.8 11.1 13.3 8.4 6.2 6.2 3.5 4.9 3.4 1.5 8.4 12.8 4.4 8.2 6.3 3.5 60.0 10.2 11.0 6.4 7.8 9.2 18.6 12.7 7.1 10.9 11.6 17.4 10.2 5.8 18.8 5.2 9.7 12.8 12.0 62.7 66.7 71.6 74.7 64.8 68.5 71.7 70.5 63.5 71.8 70.0 67.6 80.8 22.5 32.1 17.0 13.4 15.2 7.9 16.2 18.7 13.6 26.4 24.9 39.8 7.1 18.6 10.5 16.5 2.1 30.2 13.3 6.4 35.2 11.6 31.0 42.3 18.7 18.3 6.1 14.5 32.0 15.1 10.5 17.7 6.6 17.4 5.1 22.8 21.8 22.4 26.4 32.0 28.5 10.7 16.2 24.2 13.1 13.5 26.1 35.9 19.6 15.0 25.3 39.4 24.7 53.3 174.6 11.8 7.5 33.8 10.2 11.7 13.3 38.6 33.9 20.9 6.6 16.4 16.5 25.2 11.3 9.0 8.5 12.0 21.8 15.4 9.5 9.8 ZCCHC12 "FLJ16123, PNMA7A, SIZN, SIZN1" ENSG00000174460 "Zinc finger CCHC-type containing 12" Q6PEW1 X 118823824-118826968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 221.3;endometrium 1: 102.3;fallopian tube: 133.3;smooth muscle: 142.7" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 4.6;Spermatogonia: 5.6" "Cancer enriched" "Detected in many" 76 "thyroid cancer: 256.3" "Group enriched" "Detected in all" 4 "hypothalamus: 221.3;thalamus: 114.6" "Immune cell enriched" "Detected in single" 6 "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 7 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 3.9;HEK 293: 10.1;NTERA-2: 3.2;SH-SY5Y: 2.5;SuSa: 2.0" "HPA031016, HPA034940" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA031016: AB_2673698, HPA034940: AB_10671098" "unprognostic (1.29e-1)" "unprognostic (7.48e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.66e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (3.44e-1)" "unprognostic (8.36e-3)" "unprognostic (5.34e-4)" "unprognostic (9.18e-13)" "unprognostic (4.14e-3)" "unprognostic (1.63e-1)" "prognostic favorable (3.42e-5)" "unprognostic (1.18e-1)" 0.2 7.8 39.0 0.8 26.3 0.0 0.5 22.1 24.0 25.0 1.2 0.9 0.3 102.3 8.7 0.0 133.3 0.4 0.1 24.5 221.3 0.1 0.1 0.5 0.6 26.6 34.5 30.2 3.1 0.1 0.0 27.1 0.0 27.8 0.4 0.4 4.2 0.0 0.5 0.0 0.0 0.9 142.7 10.1 0.2 0.9 0.6 114.6 0.6 3.1 0.0 0.7 0.0 6.1 32.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 3.9 0.0 0.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 2.5 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 39.0 26.3 22.1 24.0 24.5 221.3 26.6 34.5 30.2 27.8 10.1 114.6 32.7 0.2 0.0 0.0 0.7 0.6 0.0 0.1 0.0 0.6 0.9 0.2 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 1.2 0.2 1.2 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.0 0.5 0.0 0.0 0.1 0.0 4.6 0.5 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.5 1.4 1.2 5.6 0.1 0.1 0.0 0.7 0.5 0.1 0.0 CNTNAP2 "Caspr2, KIAA0868, NRXN4" ENSG00000174469 "Contactin associated protein 2" Q9UHC6 7 146116002-148420998 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Autism, Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 35.9;retina: 14.5" "Group enriched" "Detected in many" 4 "Excitatory neurons: 3383.0;Inhibitory neurons: 6845.7" "Cancer enhanced" "Detected in many" "prostate cancer: 10.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 25 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "AF22: 8.0;CACO-2: 6.7;NTERA-2: 12.0;SCLC-21H: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002739 Enhanced NA NA "HPA002739: AB_1078545" "unprognostic (2.49e-2)" "unprognostic (1.49e-2)" "unprognostic (4.05e-1)" "unprognostic (3.08e-3)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (2.51e-2)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (3.67e-2)" "unprognostic (2.68e-1)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.00e-3)" 0.1 0.8 4.6 0.2 11.5 0.0 0.6 1.1 18.4 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.6 0.0 0.1 5.2 10.8 0.1 1.9 0.0 0.4 5.6 3.4 16.7 1.1 0.2 0.3 3.9 0.5 4.1 4.1 0.4 14.5 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.5 6.7 3.8 0.3 0.0 0.2 0.1 0.1 35.9 0.0 0.0 8.0 3.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.7 0.1 0.0 0.0 0.2 0.0 2.0 1.7 0.6 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.0 1.4 0.0 0.0 0.0 2.2 0.0 0.0 21.5 1.4 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 11.5 1.1 18.4 5.2 10.8 5.6 3.4 16.7 4.1 0.0 6.7 35.9 0.1 0.0 0.0 65.6 9.3 0.1 0.3 15.5 1.8 33.9 0.3 0.0 1.2 7.2 4.1 0.0 2.1 40.8 0.0 1.8 0.0 1.4 7.2 0.6 0.0 0.6 2.4 0.0 3383.0 0.7 6.8 1.1 0.5 0.7 0.0 0.2 0.0 8.9 3.3 1031.4 6845.7 3.9 0.0 0.6 2.0 2.7 1.2 0.4 0.0 180.8 0.2 8.2 1.0 429.3 914.7 4.1 2.1 0.0 0.3 7.4 4.7 0.5 0.9 16.7 0.0 0.0 0.9 2.4 12.0 9.1 0.0 6.3 0.0 1.2 6.8 0.2 GALNTL6 "GalNAc-T6L, GALNT17" ENSG00000174473 "Polypeptide N-acetylgalactosaminyltransferase like 6" Q49A17 4 171812254-173041559 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.9;lymphoid tissue: 2.6" "Group enriched" "Detected in some" 17 "Excitatory neurons: 424.4;Inhibitory neurons: 1567.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 8 "B-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031019 Uncertain "Intracellular and membrane" NA NA "HPA031019: AB_10601653" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-2)" "unprognostic (5.73e-2)" "unprognostic (7.50e-2)" "unprognostic (8.32e-2)" "unprognostic (3.25e-1)" "unprognostic (9.55e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (2.80e-1)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-2)" "unprognostic (4.84e-3)" "unprognostic (1.73e-2)" 0.0 0.2 2.4 0.4 3.0 0.4 0.2 0.4 4.2 1.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.1 6.6 7.9 0.0 0.1 0.1 0.3 0.7 4.5 4.5 0.0 0.1 0.0 0.0 0.0 1.1 0.7 0.2 1.3 0.3 0.0 0.3 0.1 0.5 0.0 0.2 2.6 1.0 2.5 3.8 0.0 0.1 1.4 0.1 0.1 0.4 2.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.0 0.4 4.2 6.6 7.9 0.7 4.5 4.5 1.1 0.2 3.8 2.2 0.0 0.0 1.5 10.4 2.4 0.3 0.1 0.0 0.0 1.6 0.3 0.0 1.2 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.5 0.0 0.0 0.1 0.0 0.0 424.4 4.1 0.0 0.3 2.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 1567.9 2.6 0.0 1.6 0.0 21.1 0.3 0.9 5.4 13.1 0.0 0.1 0.0 57.3 9.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 1.2 0.2 1.6 1.6 0.0 0.3 0.0 0.0 0.1 0.4 0.1 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 7.5;smooth muscle: 8.8" "Group enriched" "Detected in some" 29 "Excitatory neurons: 1591.2;Inhibitory neurons: 988.0" "Cancer enhanced" "Detected in single" "melanoma: 0.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "NK-cell: 1.0" "Lineage enriched" "Detected in single" 9 "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;hTERT-HME1: 1.5;SH-SY5Y: 9.1;U-87 MG: 1.6;WM-115: 4.1" "Low region specificity" "Detected in all" "HPA016633, CAB025361" Approved NA NA "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.4 0.5 0.0 1.1 0.2 0.0 0.0 3.6 0.5 0.0 0.1 0.0 7.5 0.9 0.0 0.4 1.0 0.0 2.8 3.2 0.7 0.0 0.0 0.0 0.0 0.1 2.6 0.1 0.1 0.8 0.6 1.7 0.8 0.6 0.0 2.5 0.0 1.5 0.0 0.1 0.0 8.8 0.0 0.1 0.6 1.7 0.5 0.2 3.0 0.0 0.0 0.2 0.3 1.1 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 9.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 1.1 0.0 3.6 2.8 3.2 0.0 0.1 2.6 0.8 0.0 0.5 1.1 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 17.5 0.4 4.6 0.2 1.8 0.0 1591.2 0.0 0.1 1.4 0.0 0.9 1.3 29.6 0.0 0.0 0.2 0.0 988.0 0.0 0.0 0.0 0.0 16.4 0.0 0.1 0.0 43.1 0.1 0.9 5.2 17.6 20.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.3 2.8 1.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 BBS1 FLJ23590 ENSG00000174483 "Bardet-Biedl syndrome 1" Q8NFJ9 11 66510606-66533613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 19.9;Excitatory neurons: 28.5;Inhibitory neurons: 28.4;Microglial cells: 14.0;Oligodendrocyte precursor cells: 13.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058283 Uncertain Uncertain Midbody Yes NA Midbody "HPA058283: AB_2683667" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (1.08e-3)" "unprognostic (1.40e-2)" "unprognostic (6.68e-2)" "unprognostic (1.72e-2)" "unprognostic (2.76e-1)" "unprognostic (1.19e-3)" "unprognostic (2.61e-2)" "unprognostic (6.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.20e-1)" "unprognostic (2.38e-1)" "unprognostic (4.87e-4)" 9.9 15.4 11.5 4.9 12.4 2.9 12.0 10.4 18.0 19.1 11.2 15.2 6.6 20.8 17.9 9.0 28.3 12.7 10.0 11.1 15.8 24.4 7.1 10.5 5.1 9.7 12.4 10.6 27.8 13.6 38.3 18.1 8.3 9.3 15.9 7.4 21.6 16.9 22.2 8.2 9.3 9.4 14.2 9.0 6.1 13.9 10.6 11.7 8.0 27.4 8.3 5.0 15.5 11.0 10.4 5.7 6.0 13.7 5.4 24.9 17.2 6.3 4.8 9.6 6.3 6.0 9.5 10.1 0.8 10.0 11.5 5.6 10.6 10.1 10.6 6.8 5.2 5.8 2.5 8.9 5.3 11.7 4.7 1.8 17.7 9.7 9.7 7.1 17.8 8.9 8.5 5.5 4.3 7.8 5.1 3.7 4.1 10.4 18.0 10.5 9.2 9.0 7.4 19.3 6.4 14.0 9.3 8.1 8.7 18.6 6.6 18.7 2.5 8.7 5.0 5.7 6.0 1.6 3.1 1.5 1.4 16.3 1.3 5.4 0.0 1.5 0.2 1.8 1.6 2.6 2.2 2.5 2.0 1.2 1.1 1.7 2.2 0.9 3.1 3.0 0.5 0.8 1.9 11.5 12.4 10.4 18.0 11.1 15.8 9.7 12.4 10.6 9.3 9.0 11.7 10.4 0.5 0.0 2.2 19.9 2.5 0.5 1.3 1.6 0.6 3.9 0.9 1.0 0.5 1.5 1.1 0.0 8.4 1.6 0.5 0.6 0.0 0.8 4.1 2.3 1.8 1.3 1.2 3.0 28.5 0.4 0.6 3.1 7.1 0.9 0.0 2.9 0.7 0.3 0.6 0.0 28.4 0.7 2.0 0.9 0.7 2.6 0.9 0.5 0.0 14.0 0.8 1.7 1.0 13.6 9.0 0.4 0.5 1.5 2.5 0.8 0.4 1.7 9.2 10.8 0.0 1.5 1.6 4.9 2.6 2.2 1.0 1.0 1.4 2.0 0.9 0.9 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 59.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 195.4;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 180.2;Rod photoreceptor cells: 155.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA065343: AB_2685476" "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 6.2 9.9 4.2 11.5 6.7 34.1 6.9 30.8 8.3 7.5 10.0 6.7 5.9 8.9 5.2 6.7 7.3 11.3 5.2 5.4 5.4 8.0 17.0 9.6 19.9 4.1 6.2 4.4 12.9 15.6 10.2 8.4 8.6 9.4 6.1 6.8 59.8 6.2 5.6 9.3 6.5 6.4 7.4 5.2 12.5 9.0 8.0 4.1 12.8 9.4 7.8 18.3 10.3 4.5 8.6 9.9 9.6 4.9 5.1 14.3 15.9 5.9 10.1 13.9 6.8 9.9 5.5 7.8 52.0 6.8 15.1 8.4 18.1 9.7 9.2 12.0 56.7 11.2 49.4 11.7 10.4 8.3 16.8 16.7 10.6 10.3 9.5 20.0 12.0 18.5 11.4 15.2 31.5 7.9 5.2 8.1 9.1 1.5 30.5 6.9 3.9 17.2 45.1 8.0 19.0 7.7 7.0 9.8 6.9 8.9 5.8 6.7 43.1 19.6 9.3 10.3 16.7 14.2 16.8 20.1 19.3 13.1 36.2 7.8 3.2 2.6 5.2 3.6 1.0 5.5 5.4 3.1 4.6 2.3 6.1 3.2 3.1 1.4 3.5 0.9 0.9 3.3 1.5 4.2 6.7 30.8 8.3 5.4 5.4 4.1 6.2 4.4 9.4 5.2 4.1 8.6 22.7 16.0 23.1 126.7 81.5 27.9 29.8 7.9 36.5 73.8 23.9 12.2 12.3 20.0 15.2 9.2 60.5 5.6 47.8 5.8 0.0 10.1 2.4 29.3 22.2 23.7 17.4 83.1 195.4 13.0 6.8 22.4 25.0 46.1 48.8 10.5 21.0 25.9 20.4 111.0 140.3 9.7 0.0 19.0 47.5 3.0 13.1 42.2 24.9 145.2 24.5 26.9 20.6 176.5 180.2 12.0 10.1 12.4 55.1 20.2 6.4 9.8 18.1 155.9 6.6 37.9 15.7 11.3 10.9 18.7 17.0 12.6 56.5 13.2 10.0 17.3 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;parathyroid gland: 5.2;placenta: 6.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3" "Group enriched" "Detected in many" 5 "glioma: 2.2;testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.0 0.2 2.3 0.0 2.0 0.0 0.8 3.9 3.2 1.0 0.0 0.3 0.0 0.8 0.1 0.0 0.6 0.1 0.1 2.6 1.8 0.2 0.0 0.0 0.0 2.4 2.8 1.7 0.8 0.0 5.2 1.9 6.1 3.6 0.1 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.0 0.2 2.8 3.1 1.4 0.9 0.0 0.0 0.1 0.4 3.1 0.0 0.0 105.8 4.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 27.4 0.2 0.0 0.3 0.0 0.0 0.0 7.2 0.0 0.0 0.0 1.0 0.0 0.2 87.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.2 1.5 0.1 0.1 0.0 41.9 3.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 3.9 3.2 2.6 1.8 2.4 2.8 1.7 3.6 1.3 3.1 3.1 0.1 0.0 0.0 15.3 0.0 0.0 0.2 0.0 0.0 4.1 2.2 1.0 0.6 0.0 0.0 1.8 33.3 104.8 0.0 0.4 0.0 0.0 37.6 0.4 4.8 1.0 0.0 0.0 2.8 0.0 4.3 3.0 0.0 0.6 0.0 0.1 0.0 0.0 7.2 0.0 7.0 0.0 0.0 0.0 0.0 98.6 0.6 0.1 0.0 1.0 0.0 3.7 0.0 16.1 8.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.7 0.4 1.3 11.0 0.0 0.0 41.3 0.1 0.1 0.2 0.0 GCSAM "GCET2, HGAL, MGC40441" ENSG00000174500 "Germinal center associated signaling and motility" Q8N6F7 3 112120839-112133270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 29.5;skin 1: 15.4" "Cell type enhanced" "Detected in some" "B-cells: 10.9;dendritic cells: 6.7;Langerhans cells: 5.3;monocytes: 23.3;T-cells: 9.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Daudi: 132.8;U-698: 76.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA002473 Approved NA NA "HPA002473: AB_1078960" "unprognostic (8.23e-4)" "unprognostic (1.64e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (2.33e-1)" "unprognostic (4.17e-3)" "unprognostic (9.20e-2)" "unprognostic (8.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.69e-3)" "unprognostic (1.97e-1)" "unprognostic (5.78e-2)" "unprognostic (3.32e-2)" "unprognostic (3.77e-1)" "unprognostic (3.43e-2)" "unprognostic (2.35e-2)" "unprognostic (2.38e-2)" 0.4 0.2 0.0 6.5 0.1 1.7 0.6 0.0 0.2 0.3 0.3 1.5 2.1 0.2 0.2 1.8 0.4 1.6 0.6 0.0 0.5 1.2 0.5 2.2 22.3 0.0 0.1 0.0 0.1 4.0 0.0 0.7 0.3 0.0 0.9 0.9 0.0 1.3 0.3 0.2 15.4 3.6 0.3 0.0 5.0 2.8 0.4 0.0 17.9 3.3 0.1 29.5 1.3 1.0 0.0 1.9 0.3 0.5 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 3.6 0.2 132.8 0.1 0.0 0.8 3.5 0.0 2.4 0.0 2.7 0.8 0.9 0.8 0.6 0.0 0.6 0.0 0.0 2.4 0.0 0.2 0.8 0.0 1.0 0.2 7.5 0.0 0.1 12.6 0.0 1.0 0.7 0.7 14.6 1.1 0.0 0.0 1.3 0.1 0.2 0.8 0.7 0.3 0.9 1.8 0.0 1.0 1.2 0.6 0.0 0.0 0.7 0.0 76.4 0.2 0.2 0.3 9.0 0.0 0.0 2.2 0.1 0.5 10.2 11.3 5.8 6.7 12.1 10.4 5.7 0.4 0.6 0.0 3.7 1.9 3.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.9 0.1 0.8 0.3 0.0 0.0 0.1 1.8 0.4 0.0 0.2 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.5 1.2 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 1.6 5.3 0.0 0.0 1.6 0.0 0.0 23.3 0.0 1.0 0.0 0.0 0.0 0.1 0.0 3.2 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.0 2.0 0.4 0.1 9.6 0.0 0.0 0.7 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.4" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 615.1;Gastric mucus-secreting cells: 498.9;Inhibitory neurons: 290.7;Pancreatic endocrine cells: 311.5;Urothelial cells: 411.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 30.9" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 1.8 1.5 6.3 2.2 8.7 16.4 6.2 24.1 9.5 2.3 1.2 2.8 1.2 3.8 2.4 2.3 3.1 4.8 1.2 4.5 5.3 1.2 0.6 2.6 3.6 11.3 9.7 3.6 6.1 1.9 1.6 1.6 1.5 11.4 1.9 2.6 10.7 14.7 1.5 0.7 3.6 1.6 2.0 4.4 2.9 5.5 12.1 7.9 6.6 1.6 0.9 2.9 3.3 1.9 26.4 8.4 1.6 3.3 2.3 2.1 5.7 1.3 1.9 1.4 2.5 3.3 1.9 1.9 8.3 2.5 1.4 2.5 1.9 3.0 1.5 3.2 4.8 4.1 3.2 4.5 2.4 0.5 9.9 2.4 1.7 1.2 2.0 1.0 2.5 4.3 11.7 3.3 10.2 2.8 1.2 7.7 3.7 0.7 0.4 30.9 4.0 2.5 3.3 1.3 1.6 3.0 2.7 1.3 2.1 1.3 1.2 1.0 2.3 4.8 3.1 3.4 2.4 2.4 3.8 3.4 8.9 0.9 6.7 1.3 48.0 3.3 2.8 20.8 0.5 13.4 17.1 16.7 13.9 2.5 19.5 14.5 14.2 0.2 12.6 1.0 35.0 15.6 1.3 6.3 8.7 24.1 9.5 4.5 5.3 11.3 9.7 3.6 11.4 4.4 7.9 26.4 32.3 38.5 19.9 123.1 26.9 10.7 53.4 33.6 11.4 84.4 38.4 20.8 29.1 4.3 91.0 9.2 79.2 0.3 47.2 23.5 0.0 226.3 118.4 42.6 28.7 25.8 21.0 27.1 227.9 615.1 0.8 26.3 498.9 25.8 34.1 41.3 15.4 1.5 8.3 33.7 290.7 70.2 12.2 7.0 14.7 17.7 32.6 15.9 14.2 46.9 27.4 15.8 50.4 147.8 177.7 311.5 8.4 36.5 48.7 145.8 7.7 0.9 82.3 72.9 19.7 56.1 31.0 178.7 22.4 7.7 7.4 0.3 47.5 13.1 22.0 411.9 SLC26A9 ENSG00000174502 "Solute carrier family 26 member 9" Q7LBE3 1 205913048-205943460 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "salivary gland: 73.1;stomach 1: 34.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051485 Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA051485: AB_2681503" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-1)" "unprognostic (1.83e-2)" "prognostic favorable (8.55e-5)" "unprognostic (1.26e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (8.85e-2)" "unprognostic (3.41e-1)" "unprognostic (2.43e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (7.45e-3)" "unprognostic (2.01e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 1.3 0.2 0.0 0.0 0.1 0.0 7.8 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.2 0.0 0.5 0.0 0.0 0.0 73.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 34.2 0.0 0.2 0.0 0.4 0.3 5.3 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.2 0.1 0.0 3.2 50.1 1.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.2 0.0 2.7 1.8 0.0 0.0 0.0 0.0 1.9 4.3 0.5 0.2 0.0 0.3 0.0 0.0 0.1 2.2 0.0 1.7 29.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.4 0.0 25.4 2.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 1.5 0.0 0.4 MFSD4A "DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064" ENSG00000174514 "Major facilitator superfamily domain containing 4A" Q8N468 1 205568885-205602918 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 67.3;stomach 1: 133.9" "Cell type enhanced" "Detected in some" "Adipocytes: 11.3;Collecting duct cells: 9.2;Distal tubular cells: 13.7;Endometrial ciliated cells: 9.9;Glandular and luminal cells: 40.5;Proximal tubular cells: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 59.8" HPA055407 Approved NA NA "HPA055407: " "unprognostic (7.15e-4)" "prognostic favorable (7.54e-4)" "unprognostic (5.60e-2)" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic favorable (4.59e-4)" "unprognostic (2.73e-2)" "unprognostic (1.65e-2)" "unprognostic (3.20e-2)" "unprognostic (6.97e-3)" "prognostic favorable (2.27e-13)" "unprognostic (1.58e-1)" "unprognostic (4.44e-2)" "unprognostic (5.75e-3)" "unprognostic (8.78e-2)" 1.9 0.4 15.3 1.1 12.7 0.0 2.7 1.6 17.1 8.5 0.0 13.9 1.9 1.1 9.3 1.4 2.6 17.0 0.9 17.8 5.4 67.3 0.2 6.8 0.4 2.1 0.4 19.2 0.6 1.5 0.4 1.5 6.3 7.7 1.4 18.3 14.2 17.2 0.6 0.3 4.4 1.4 0.8 0.0 0.6 133.9 0.5 1.0 0.6 0.4 0.7 1.3 0.7 0.9 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 12.7 1.6 17.1 17.8 5.4 2.1 0.4 19.2 7.7 0.0 1.0 10.0 11.3 6.4 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 2.9 0.0 0.0 6.2 9.2 0.0 0.5 0.7 0.0 13.7 1.4 0.0 9.9 6.0 2.5 0.0 0.0 0.0 6.2 0.1 0.5 0.0 40.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 7.7 2.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.8 0.2 0.0 0.0 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 26.5;Horizontal cells: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735" "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favorable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 7.2 10.2 21.0 2.6 18.8 1.2 7.7 20.3 33.4 12.3 4.7 11.7 3.3 14.1 5.6 6.9 11.3 6.9 8.6 21.3 16.5 6.3 4.3 5.6 3.3 22.4 17.8 18.4 13.7 8.2 11.8 13.5 2.4 24.2 14.8 1.7 5.6 8.8 15.0 18.5 7.7 6.3 5.6 13.0 5.2 9.5 7.6 20.6 1.1 6.3 4.6 1.5 14.8 9.2 23.6 20.2 8.1 6.5 5.0 10.2 4.0 5.6 6.2 8.0 5.7 4.9 11.8 4.3 5.0 6.1 6.9 10.3 10.2 4.0 7.8 2.4 9.6 4.1 1.3 7.2 3.5 6.4 1.0 9.2 3.8 8.6 5.8 2.1 8.3 1.2 6.4 2.3 7.2 2.5 11.5 4.2 3.0 3.9 10.2 8.4 13.6 4.7 5.2 3.2 6.3 7.9 4.4 3.2 8.8 21.6 2.8 10.3 5.3 3.4 5.0 7.6 21.7 5.4 6.9 4.2 2.7 10.6 3.1 4.1 0.5 1.0 0.2 1.0 0.8 0.8 1.2 0.8 1.2 1.4 1.5 0.9 0.7 0.0 0.5 3.4 0.4 1.0 0.6 21.0 18.8 20.3 33.4 21.3 16.5 22.4 17.8 18.4 24.2 13.0 20.6 23.6 5.0 6.4 2.0 2.0 0.7 1.7 3.8 0.9 4.0 13.3 3.0 4.4 8.1 4.3 0.6 0.0 10.4 2.5 0.4 0.6 1.9 3.2 5.0 0.4 2.6 2.7 26.5 0.0 7.1 2.5 2.1 4.2 2.0 1.1 0.0 2.9 3.3 2.8 3.3 21.9 7.7 1.4 2.0 1.9 1.4 10.4 7.5 2.9 0.0 1.9 2.8 7.5 0.0 2.0 2.5 1.8 1.4 9.8 1.0 2.5 0.9 2.9 0.2 9.7 6.6 3.1 4.9 3.0 3.5 1.8 0.3 0.3 1.3 1.5 0.8 1.5 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 111.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 39.1;Excitatory neurons: 39.3;Horizontal cells: 18.5;Inhibitory neurons: 19.7;Oligodendrocyte precursor cells: 27.2" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 0.0 0.6 60.2 0.3 67.2 0.0 0.0 43.2 111.6 0.0 26.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 77.4 51.4 0.0 0.0 0.0 0.0 40.8 40.2 77.9 0.0 0.0 0.0 0.9 0.0 51.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.1 34.2 0.0 0.2 0.3 48.9 0.0 0.0 0.0 0.0 0.0 0.1 67.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 26.8 1.4 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.4 0.1 0.0 0.3 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 60.2 67.2 43.2 111.6 77.4 51.4 40.8 40.2 77.9 51.9 34.2 48.9 67.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 39.1 0.2 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.8 0.2 0.2 1.8 0.0 39.3 0.5 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 18.5 19.7 0.1 0.0 0.0 0.0 1.0 0.3 0.0 0.0 4.7 0.0 1.7 0.0 27.2 5.0 0.1 1.2 0.7 0.0 0.1 0.0 0.0 1.2 8.4 0.0 0.0 0.1 7.0 8.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 MYO1H FLJ37587 ENSG00000174527 "Myosin IH" 12 109347903-109455523 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 3.8;Early spermatids: 5.0;Endometrial ciliated cells: 1.6;Late spermatids: 3.5;Skeletal myocytes: 1.4;Spermatogonia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA039516 Uncertain NA NA "HPA039516: AB_10794198" "unprognostic (1.92e-1)" "unprognostic (8.00e-3)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (4.07e-7)" "unprognostic (7.13e-2)" "unprognostic (6.26e-4)" "unprognostic (1.51e-1)" "unprognostic (2.09e-1)" "unprognostic (7.90e-2)" "unprognostic (2.88e-1)" "unprognostic (1.12e-3)" "unprognostic (2.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (1.52e-1)" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 5.0 1.6 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.5 1.6 0.0 0.0 0.0 0.1 0.0 0.2 0.1 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052515 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA052515: AB_2681858" "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.67e-4)" 1.9 3.8 9.4 1.2 9.6 1.5 1.8 12.0 12.4 4.0 8.8 2.5 0.9 2.4 2.0 2.8 2.7 0.8 3.7 9.6 9.5 4.5 6.1 2.9 1.7 9.2 9.5 9.3 4.0 2.5 1.5 3.9 1.3 9.9 3.7 1.1 4.3 2.1 1.3 6.7 3.3 2.6 1.1 9.3 5.5 2.6 5.9 9.7 3.2 2.8 2.4 1.7 2.7 3.3 10.1 1.8 2.8 4.6 6.0 6.6 2.6 2.3 3.4 2.0 1.7 1.0 5.0 1.2 3.4 2.4 1.9 2.5 1.6 7.5 2.8 3.0 3.0 2.9 2.9 3.8 2.5 4.5 1.5 1.5 2.6 5.1 2.7 1.3 4.5 3.4 4.0 6.5 1.4 2.2 3.6 3.4 6.3 3.5 2.3 4.0 2.3 5.3 3.6 4.0 1.8 2.9 4.5 2.1 2.5 5.6 7.1 1.9 6.2 1.6 3.2 1.6 4.1 3.7 3.2 4.2 2.7 4.5 2.2 5.5 1.7 0.4 0.0 1.8 0.6 0.0 0.6 0.8 0.4 0.6 0.5 0.8 1.4 1.0 0.0 0.6 0.6 1.1 0.4 9.4 9.6 12.0 12.4 9.6 9.5 9.2 9.5 9.3 9.9 9.3 9.7 10.1 0.5 0.0 0.0 2.0 0.7 2.3 0.5 0.6 0.0 0.8 1.6 1.4 2.0 1.5 0.4 3.7 0.0 0.2 1.6 0.8 0.0 0.7 15.6 1.1 0.6 0.9 0.0 0.0 2.0 0.6 0.5 0.6 0.0 1.3 0.0 2.3 0.4 1.0 0.6 1.7 1.5 0.5 2.0 0.3 2.1 3.1 0.0 0.9 1.8 1.0 0.4 1.4 3.1 1.0 1.3 0.8 0.1 0.4 1.3 1.2 0.4 1.3 0.5 1.1 0.0 1.0 0.6 0.9 1.1 0.5 2.6 0.1 0.9 0.4 0.6 1.0 MRPL11 ENSG00000174547 "Mitochondrial ribosomal protein L11" Q9Y3B7 11 66435075-66466738 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057685 Approved Supported Mitochondria NA NA Mitochondria "HPA057685: AB_2683502" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.21e-2)" "unprognostic (1.79e-2)" "unprognostic (9.30e-2)" "unprognostic (1.12e-2)" "unprognostic (1.81e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-1)" "unprognostic (8.32e-3)" "unprognostic (2.85e-2)" "unprognostic (3.21e-1)" "unprognostic (1.31e-2)" "unprognostic (9.34e-2)" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" 13.8 11.1 12.9 11.9 13.2 23.2 17.4 13.5 22.0 12.3 14.9 22.0 16.7 13.9 16.2 19.6 16.7 8.1 19.1 13.0 13.3 16.8 22.2 10.4 19.2 13.0 12.8 12.2 17.8 19.1 17.2 7.9 12.3 13.2 11.7 24.0 11.2 18.1 13.2 49.8 13.1 17.4 14.6 12.5 14.4 17.5 9.8 13.7 18.6 11.7 36.3 20.7 14.9 12.8 13.6 62.1 48.3 44.9 43.3 22.0 24.5 64.2 35.2 40.0 65.8 50.2 135.8 74.7 77.3 59.8 33.6 73.0 52.9 66.5 69.1 46.2 35.8 44.1 48.6 42.6 72.9 26.4 81.4 31.4 29.3 40.6 40.6 49.9 31.7 49.5 73.1 72.1 32.9 28.9 105.6 94.1 129.5 82.3 165.7 69.8 59.2 89.5 97.6 29.1 42.0 47.0 40.8 38.9 58.0 127.4 37.9 66.0 42.4 28.1 39.3 53.1 37.6 42.1 24.1 40.3 87.0 40.7 51.8 27.1 2.1 34.3 7.7 35.9 44.9 38.1 51.6 39.1 35.3 54.5 40.3 40.9 37.8 2.3 37.9 40.7 32.9 43.8 42.5 12.9 13.2 13.5 22.0 13.0 13.3 13.0 12.8 12.2 13.2 12.5 13.7 13.6 45.7 12.8 28.3 3.6 61.9 49.8 94.2 80.8 58.1 21.8 69.4 96.3 66.6 60.1 49.0 33.1 8.4 139.6 46.5 66.3 123.3 67.7 40.7 38.0 47.3 51.8 51.0 63.9 4.5 85.6 196.6 54.2 47.4 35.2 31.6 93.9 50.7 82.9 126.2 20.2 4.7 97.3 30.5 60.6 60.3 11.1 50.7 59.5 67.6 1.9 77.6 32.3 66.9 2.5 4.5 59.6 69.4 45.9 61.4 75.0 94.4 124.5 43.7 22.1 26.3 48.9 77.1 78.9 60.5 95.7 49.0 77.4 51.7 68.5 165.2 91.4 KLK15 "ACO, HSRNASPH, prostinogen" ENSG00000174562 "Kallikrein related peptidase 15" Q9H2R5 19 50825289-50837213 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.3;salivary gland: 5.7" "Cell type enhanced" "Detected in some" "Early spermatids: 5.5;Intestinal goblet cells: 34.6;Late spermatids: 8.8;Spermatocytes: 15.0;Spermatogonia: 9.5" "Group enriched" "Detected in some" 4 "prostate cancer: 3.5;renal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA019802 Uncertain "Secreted to blood" NA NA "HPA019802: AB_1852601" "unprognostic (6.06e-2)" "unprognostic (2.85e-1)" "unprognostic (8.13e-2)" "unprognostic (2.90e-1)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 1.2 0.0 5.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 0.0 0.0 0.1 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 34.6 0.0 0.0 0.0 8.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 9.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "esophagus: 111.6;skin 1: 164.6;vagina: 66.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.7 0.2 0.1 0.0 0.2 0.0 10.4 0.2 0.6 11.8 0.5 0.5 0.0 0.2 0.0 111.6 0.4 0.0 0.5 0.2 0.1 0.2 5.4 0.5 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.3 0.4 0.2 2.2 0.5 0.0 13.8 0.2 1.0 164.6 0.4 0.0 0.2 0.3 0.5 3.8 0.3 2.0 0.5 0.9 9.6 1.3 66.7 0.2 27.2 0.0 0.1 0.4 15.4 64.9 2.6 0.6 1.8 0.3 1.2 2.7 3.4 0.2 14.9 9.7 1.0 86.0 0.0 140.0 0.7 0.4 0.0 0.3 19.5 0.0 91.8 0.2 0.2 11.5 555.6 4.5 102.6 0.7 0.1 0.1 0.3 0.1 0.0 0.0 0.6 0.0 0.4 2.4 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 54.6 0.0 2.8 4.7 0.5 0.9 0.0 0.2 1.8 0.5 0.5 0.1 0.2 0.2 8.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.6 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.7 0.0 0.0 0.7 0.0 36.8 1.7 115.8 60.9 0.0 0.3 0.5 0.4 0.0 43.0 0.0 0.0 1.7 0.8 0.8 0.0 0.9 57.0 0.7 0.4 0.9 0.0 0.0 1.0 0.2 1.4 3.9 0.0 0.8 0.0 0.2 0.0 2.2 0.4 0.0 1.2 0.7 10.2 0.3 6.6 28.8 0.3 0.6 3.6 1.0 1.7 0.0 1.0 1.0 0.2 1.0 0.1 0.7 0.4 1.3 0.2 0.3 5.5 0.0 0.0 0.6 3.6 1.7 1.9 56.5 38.1 1.6 0.6 0.2 0.5 5.3 GOLT1A "CGI-141, FLJ42654, GOT1, MGC62027, YMR292W" ENSG00000174567 "Golgi transport 1A" Q6ZVE7 1 204198163-204213988 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 192.3" "Group enriched" "Detected in many" 4 "Hepatocytes: 131.3;Proximal enterocytes: 206.8" "Cancer enriched" "Detected in many" 6 "liver cancer: 80.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 18.0;CAPAN-2: 20.0;Hep G2: 25.9;MCF7: 43.5;OE19: 16.1;RT4: 27.7;SK-BR-3: 27.2" "Region enhanced" "Detected in many" "cerebral cortex: 9.0" NA NA "unprognostic (3.43e-1)" "unprognostic (1.13e-1)" "unprognostic (2.22e-3)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (6.20e-3)" "unprognostic (2.14e-1)" "unprognostic (8.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.26e-2)" "unprognostic (7.33e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.35e-5)" "unprognostic (1.37e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-3)" "prognostic favorable (1.51e-4)" 0.1 0.1 6.0 0.4 8.7 0.0 5.4 7.0 5.3 11.0 3.4 5.7 47.9 0.3 10.8 0.5 3.3 1.6 0.1 4.2 9.2 15.8 192.3 8.4 0.1 4.6 5.0 4.3 0.1 22.5 18.5 30.7 3.5 4.3 5.4 5.0 1.5 3.4 2.1 0.3 0.5 45.9 0.3 3.5 0.1 8.3 2.7 8.4 0.8 0.7 0.0 0.2 13.2 0.4 4.9 0.5 8.2 0.0 0.0 0.0 0.0 5.5 0.1 0.1 0.1 0.0 18.0 20.0 0.0 0.7 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.3 0.1 0.0 25.9 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.1 4.0 16.1 0.2 0.0 0.1 0.4 8.5 27.7 1.3 1.8 0.8 27.2 0.1 0.7 8.9 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.0 8.7 7.0 5.3 4.2 9.2 4.6 5.0 4.3 4.3 3.5 8.4 4.9 0.1 0.0 19.5 0.3 0.1 0.0 12.7 2.6 2.8 1.7 7.2 4.7 0.2 40.0 5.1 16.5 0.0 13.3 0.1 7.0 13.7 29.2 0.9 0.5 0.1 0.3 10.3 0.0 2.2 19.1 0.5 1.1 8.2 2.0 1.3 1.4 1.8 131.3 1.3 1.7 0.7 7.8 2.0 1.6 0.0 0.4 0.0 0.2 1.8 0.0 0.0 0.0 0.0 4.5 0.1 18.7 5.6 0.0 0.0 15.0 206.8 14.7 0.3 0.2 0.0 0.3 0.3 2.9 0.9 1.4 0.1 26.4 0.5 0.2 12.5 20.5 AKIRIN1 "C1orf108, FLJ12666" ENSG00000174574 "Akirin 1" Q9H9L7 1 38991276-39006059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 1546.1;Late spermatids: 1455.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051871 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA051871: AB_2681646" "unprognostic (1.16e-1)" "unprognostic (2.13e-2)" "unprognostic (1.05e-1)" "unprognostic (5.35e-3)" "unprognostic (1.40e-1)" "unprognostic (1.39e-3)" "prognostic unfavorable (5.39e-7)" "unprognostic (3.53e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-2)" "unprognostic (9.49e-3)" "unprognostic (1.47e-2)" "unprognostic (3.89e-2)" "unprognostic (1.22e-1)" "unprognostic (7.13e-2)" "unprognostic (3.77e-3)" "unprognostic (5.17e-2)" 46.5 30.2 40.0 33.8 42.7 77.9 23.3 43.2 46.4 22.0 40.0 34.4 24.4 28.9 42.7 29.4 25.3 42.2 38.7 41.3 48.6 43.3 53.7 30.3 42.7 48.8 45.4 40.9 19.7 28.0 43.5 40.3 26.8 48.5 36.6 36.5 37.8 24.6 36.1 30.3 16.3 27.0 42.3 44.3 32.0 33.6 83.9 52.3 41.8 36.5 30.6 42.4 41.6 18.7 50.7 61.4 28.0 117.3 96.9 56.3 66.2 83.8 70.0 73.1 69.2 70.1 73.2 49.5 48.3 63.3 67.1 49.6 41.8 114.7 62.8 110.8 72.2 58.3 142.7 41.6 92.5 74.2 137.5 75.3 68.5 80.5 90.4 73.6 61.6 64.9 61.8 99.0 46.6 87.8 25.2 58.5 60.2 248.2 45.9 47.1 92.4 85.4 48.2 77.7 73.9 81.3 55.2 77.8 41.4 160.1 182.8 37.9 70.6 58.3 42.3 68.4 46.2 72.1 67.1 92.5 102.6 72.7 80.4 73.3 35.7 39.3 83.7 33.4 33.9 50.6 33.7 54.4 51.7 55.4 30.2 63.3 42.0 102.8 72.0 38.8 41.7 54.7 53.1 40.0 42.7 43.2 46.4 41.3 48.6 48.8 45.4 40.9 48.5 44.3 52.3 50.7 48.5 64.1 43.9 25.1 83.8 137.9 77.1 34.0 56.9 48.1 69.0 48.6 45.1 31.5 40.1 38.6 47.9 72.9 111.6 48.6 93.9 45.6 1546.1 108.2 56.7 43.5 94.8 57.9 32.9 40.5 76.9 49.9 37.2 93.9 47.6 55.1 35.0 37.3 45.5 55.5 26.6 49.6 36.7 39.9 109.9 1455.5 44.1 65.2 42.7 16.9 85.1 52.1 42.2 23.6 73.2 50.5 37.2 45.5 53.2 67.8 23.9 41.8 38.9 45.0 52.6 61.3 77.5 77.3 103.9 43.4 138.5 167.5 99.9 34.0 41.8 81.4 NPAS4 "bHLHe79, Le-PAS, NXF, PASD10" ENSG00000174576 "Neuronal PAS domain protein 4" Q8IUM7 11 66421004-66426707 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 137.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.2;Horizontal cells: 11.8;Rod photoreceptor cells: 5.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 13 "cerebellum: 137.0;cerebral cortex: 89.0;white matter: 35.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 4.9;cerebellum: 5.0;cerebral cortex: 7.5;hippocampal formation: 4.6;olfactory bulb: 3.8" HPA039255 Uncertain NA NA "HPA039255: AB_10674282" "unprognostic (7.81e-2)" "unprognostic (9.93e-2)" "unprognostic (1.55e-2)" "unprognostic (1.24e-1)" "unprognostic (2.51e-1)" "unprognostic (1.78e-3)" "unprognostic (4.97e-1)" "unprognostic (7.84e-2)" "unprognostic (1.85e-2)" "unprognostic (3.29e-2)" "unprognostic (3.96e-2)" "unprognostic (1.12e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-1)" "unprognostic (4.24e-1)" "unprognostic (3.21e-2)" 0.2 0.2 0.9 0.4 2.3 0.0 0.1 137.0 89.0 0.6 2.4 1.9 0.1 3.4 0.1 0.3 1.3 0.1 0.1 3.5 6.9 0.1 0.1 0.1 0.0 1.6 2.3 0.8 0.3 0.3 0.0 19.4 0.0 3.3 1.3 0.1 0.1 0.1 0.7 0.0 0.1 0.5 1.3 0.3 0.0 1.1 0.1 1.0 0.0 0.1 0.2 0.0 1.1 0.5 35.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 137.0 89.0 3.5 6.9 1.6 2.3 0.8 3.3 0.3 1.0 35.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.2 0.1 0.4 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.8 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSL2 "FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184" ENSG00000174579 "MSL complex subunit 2" Q9HCI7 3 136148917-136197241 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003413 Uncertain Approved Nucleoplasm,Cytosol NA No "Nucleoplasm, Cytosol" "HPA003413: AB_1848659" "unprognostic (9.86e-2)" "prognostic favorable (4.80e-4)" "unprognostic (1.30e-1)" "unprognostic (2.32e-1)" "unprognostic (4.41e-2)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (4.62e-2)" "unprognostic (7.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.71e-1)" "unprognostic (2.54e-2)" "unprognostic (2.23e-1)" "unprognostic (5.79e-3)" "unprognostic (4.54e-2)" "unprognostic (3.52e-2)" "unprognostic (1.76e-3)" 12.0 9.5 6.5 21.5 9.1 58.4 14.0 19.5 8.6 14.8 5.4 13.0 13.4 15.3 9.3 12.9 15.6 12.9 9.5 6.9 7.5 11.4 14.2 14.6 33.3 7.4 8.6 5.4 21.1 11.6 15.5 8.1 13.2 9.7 12.1 12.8 14.9 13.1 11.7 12.8 11.4 15.0 12.2 6.7 26.0 14.9 17.5 7.8 60.8 17.1 17.4 32.0 13.4 10.2 12.6 26.5 7.5 20.8 23.2 14.4 15.6 33.1 16.1 16.0 14.9 14.9 19.4 15.0 52.1 21.2 14.3 17.0 20.4 24.6 16.2 23.5 25.3 11.9 59.6 19.8 11.0 14.8 51.7 26.1 12.6 17.7 11.7 34.0 14.2 15.1 48.1 22.0 47.7 12.5 15.8 93.8 26.7 25.3 14.7 13.1 40.5 33.5 35.3 7.1 21.2 25.2 16.8 37.7 16.1 26.5 16.2 14.7 28.5 20.6 19.0 15.0 17.4 15.1 47.5 28.0 78.7 15.9 20.2 13.2 5.1 2.5 4.1 5.1 2.9 6.2 3.1 4.7 6.0 2.7 5.4 9.6 6.4 5.9 5.1 2.2 1.5 3.9 4.2 6.5 9.1 19.5 8.6 6.9 7.5 7.4 8.6 5.4 9.7 6.7 7.8 12.6 15.0 19.2 11.2 18.9 30.4 28.0 15.6 5.6 23.3 12.9 15.8 9.5 15.2 8.6 7.0 12.9 4.2 8.9 47.1 9.3 3.9 5.1 4.1 9.6 15.3 13.9 18.0 23.1 28.0 5.6 6.3 14.7 9.2 12.9 7.0 12.6 16.8 23.4 8.5 16.8 31.6 14.1 2.0 24.2 25.4 3.7 9.3 18.9 21.4 37.5 21.4 8.0 30.9 39.2 55.1 6.4 5.6 8.6 27.8 14.5 7.7 7.4 5.7 9.7 6.6 18.6 12.3 16.0 12.5 22.8 26.7 4.8 36.2 8.5 12.2 14.0 ZNF497 FLJ44773 ENSG00000174586 "Zinc finger protein 497" Q6ZNH5 19 58354357-58362848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Respiratory ciliated cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 20.2" HPA047872 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA047872: AB_2680196" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (2.17e-1)" "unprognostic (1.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.42e-2)" "unprognostic (2.30e-2)" "unprognostic (8.53e-2)" "unprognostic (9.45e-2)" "unprognostic (9.29e-2)" "unprognostic (4.16e-3)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.58e-2)" "unprognostic (7.28e-2)" "unprognostic (1.24e-1)" 0.7 1.4 3.2 1.8 3.0 1.6 1.8 6.1 3.5 2.5 3.0 0.9 1.3 2.4 1.9 2.1 5.7 1.2 1.4 2.8 0.8 2.3 3.2 1.9 2.5 1.6 1.1 2.4 2.5 2.6 1.4 4.5 0.9 2.1 2.4 0.8 1.8 2.8 1.1 0.7 2.8 1.2 0.4 1.1 2.3 1.6 1.6 0.9 0.5 3.8 0.0 0.4 0.9 1.7 4.0 2.0 6.8 6.0 5.8 0.2 0.1 7.9 3.7 0.0 0.0 0.0 0.5 2.2 4.0 1.9 0.0 3.3 0.9 0.7 0.4 0.0 4.2 20.2 3.6 2.2 1.2 0.3 1.5 9.2 0.5 0.9 0.1 0.7 6.6 0.0 9.8 3.1 0.6 0.1 7.1 5.1 5.1 3.7 1.7 2.1 12.6 4.4 2.1 0.6 1.6 4.6 6.6 2.0 5.9 3.3 3.0 8.1 4.1 0.6 6.6 3.4 0.6 1.2 8.7 11.1 3.5 1.8 4.1 3.6 1.3 1.1 0.3 0.8 0.4 0.9 1.3 1.0 1.0 1.0 1.5 0.9 1.7 0.3 0.8 0.3 1.8 1.2 0.7 3.2 3.0 6.1 3.5 2.8 0.8 1.6 1.1 2.4 2.1 1.1 0.9 4.0 0.3 6.4 0.5 3.9 0.9 0.3 0.4 1.0 1.2 1.4 2.1 1.3 0.7 0.0 1.0 0.0 0.0 2.0 0.1 0.5 1.9 1.4 1.7 3.6 0.6 0.6 0.0 1.3 3.1 0.2 0.5 0.5 1.5 1.2 0.0 1.9 0.0 1.9 0.5 0.0 3.0 1.4 0.0 0.0 0.4 0.9 0.0 0.2 0.0 1.9 0.1 1.3 0.0 3.0 3.5 0.3 1.2 0.0 0.7 0.3 0.4 0.7 5.2 1.6 0.0 0.4 0.4 0.3 1.7 0.8 0.3 0.3 0.5 0.3 1.2 0.1 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 6.8;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 13.5;Spermatogonia: 6.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.0;U-138 MG: 11.0;U-266/70: 9.1" "Low region specificity" "Detected in all" HPA044560 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 1.2 2.4 5.6 0.5 7.0 0.0 4.2 5.9 7.0 2.5 3.7 1.0 0.4 1.9 6.0 0.8 3.9 1.7 1.0 5.8 6.9 6.9 0.1 1.6 0.5 6.7 6.7 5.5 2.2 2.9 2.4 3.3 0.6 6.9 4.4 1.1 5.6 1.4 2.5 0.3 2.4 0.6 2.1 5.7 0.6 1.9 3.7 6.7 0.2 5.0 0.6 0.4 1.2 0.8 7.4 1.4 0.9 4.2 2.1 0.0 0.0 0.0 0.6 0.4 0.9 2.5 0.1 5.0 0.0 0.5 1.1 5.4 0.1 2.0 2.3 3.4 0.0 0.1 1.2 1.2 0.5 1.2 1.3 0.0 4.5 1.9 1.1 0.0 3.5 0.0 0.0 0.0 2.6 7.0 0.3 2.3 0.0 0.3 0.0 1.1 0.0 5.5 0.0 0.7 0.3 2.4 9.0 0.0 3.6 4.5 2.2 6.2 1.3 3.0 11.0 4.8 0.1 1.7 9.1 2.1 0.0 4.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 7.0 5.9 7.0 5.8 6.9 6.7 6.7 5.5 6.9 5.7 6.7 7.4 0.6 0.0 1.5 2.6 0.5 0.9 0.3 0.3 1.8 6.8 2.8 2.0 0.7 0.0 1.6 1.8 4.2 1.9 0.0 0.0 1.9 2.3 0.3 0.5 2.2 2.0 0.0 0.0 3.0 0.7 0.4 2.5 0.0 0.5 0.0 1.5 0.0 0.0 0.3 5.0 3.8 0.3 2.0 0.0 0.4 0.1 0.9 0.1 3.6 0.0 0.0 3.3 0.0 8.0 13.5 0.6 0.0 1.9 0.0 0.9 0.0 2.1 2.3 3.1 0.0 1.7 0.8 1.9 6.2 1.5 1.4 0.3 0.1 1.8 0.1 0.1 CMKLR1 RVER1 ENSG00000174600 "Chemerin chemokine-like receptor 1" Q99788 12 108288044-108339317 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.6" "Cell type enhanced" "Detected in some" "dendritic cells: 17.3;Hofbauer cells: 32.4;Kupffer cells: 69.6;Macrophages: 27.1;Microglial cells: 39.4;NK-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 14.5;plasmacytoid DC: 18.1" "Group enriched" "Detected in many" 22 "dendritic cells: 18.1;monocytes: 14.5;T-cells: 7.0" "Cell line enhanced" "Detected in some" "ASC diff: 11.9;ASC TERT1: 45.3;BJ hTERT+: 34.9;hTERT-RPE1: 13.6;LHCN-M2: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047865 Uncertain NA NA "HPA047865: AB_2680191" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (8.83e-3)" "unprognostic (7.39e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-3)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (1.69e-1)" "unprognostic (6.83e-2)" "unprognostic (1.06e-1)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "unprognostic (1.83e-2)" "unprognostic (5.19e-2)" "unprognostic (1.14e-1)" 10.5 5.9 2.8 11.8 3.1 0.9 5.0 2.8 6.8 4.1 8.2 7.5 4.5 8.4 1.6 3.1 4.4 5.5 6.4 2.5 7.1 3.3 6.9 12.9 17.8 5.8 3.5 1.2 1.9 3.2 1.7 3.4 22.4 5.0 3.8 9.0 0.3 4.8 4.5 2.4 3.6 5.1 14.8 3.9 34.6 2.9 2.7 5.5 4.2 8.8 5.1 8.2 8.2 2.5 6.7 0.0 0.0 0.1 0.0 11.9 45.3 0.2 0.0 34.9 0.1 0.0 0.0 0.0 0.2 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.2 13.6 0.7 0.0 0.0 0.0 10.6 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 4.1 0.0 7.0 14.5 0.0 0.0 1.1 5.1 1.1 0.0 0.4 3.5 0.3 0.6 2.8 18.1 0.3 5.1 2.8 3.1 2.8 6.8 2.5 7.1 5.8 3.5 1.2 5.0 3.9 5.5 6.7 1.9 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.1 0.3 2.2 1.5 0.6 0.0 0.0 0.4 17.3 0.0 0.0 0.0 0.1 0.0 0.7 5.8 0.0 2.7 0.5 0.0 0.5 7.8 0.0 0.0 0.0 0.0 11.4 0.6 32.4 0.0 0.4 0.0 0.0 69.6 2.5 0.3 0.3 27.1 3.6 39.4 7.6 0.0 30.9 1.0 0.0 0.0 0.0 5.3 0.8 0.0 0.0 0.0 0.7 0.1 6.6 4.1 5.1 0.0 0.0 0.1 0.6 0.5 2.2 0.5 0.0 0.0 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015867 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" NA NA Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavorable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.20e-4)" 6.9 6.7 14.8 7.0 15.7 6.5 10.5 12.8 13.9 8.0 10.7 6.2 5.2 8.7 8.2 6.0 7.4 6.1 5.7 14.5 12.3 7.8 8.1 6.7 10.6 12.3 12.5 13.4 10.9 6.8 7.8 6.3 6.6 13.1 8.3 6.5 9.3 6.0 6.3 7.4 9.2 7.3 7.2 11.6 9.9 6.3 5.6 13.7 10.3 8.2 7.2 9.3 7.1 6.3 13.2 12.2 9.6 15.2 13.2 11.5 16.8 13.6 9.8 16.3 15.4 15.3 6.3 8.9 11.8 8.8 9.7 8.5 9.4 17.8 9.4 15.5 22.3 10.6 11.9 7.4 6.3 12.5 11.8 13.6 10.4 11.9 12.1 12.2 13.1 13.2 10.4 13.9 11.8 18.0 4.0 13.6 7.9 36.4 6.6 6.8 6.9 27.4 12.4 12.1 8.2 7.5 21.7 11.9 15.7 18.3 16.2 12.2 8.6 9.8 12.7 6.7 15.7 15.1 8.6 8.9 7.9 14.2 8.7 11.9 6.6 4.4 5.9 5.1 4.3 6.5 5.7 6.4 5.4 5.5 3.5 6.7 5.7 2.7 10.9 3.5 3.3 8.9 5.2 14.8 15.7 12.8 13.9 14.5 12.3 12.3 12.5 13.4 13.1 11.6 13.7 13.2 23.1 48.1 9.8 26.8 23.8 6.9 8.5 11.7 12.5 21.2 14.6 10.2 15.2 17.2 14.5 12.9 10.4 14.8 26.2 7.6 11.7 10.3 1.5 11.3 19.8 15.9 6.7 18.1 33.2 10.5 15.0 18.0 14.3 11.7 17.1 28.8 16.1 12.5 11.8 28.6 26.3 8.4 14.2 20.4 10.5 2.6 15.5 17.1 3.6 30.0 17.3 11.6 16.5 30.2 49.3 10.2 6.4 13.9 24.2 10.8 10.7 16.9 22.5 17.8 19.7 21.7 16.1 9.5 16.6 12.7 7.0 10.9 25.8 17.9 8.0 7.4 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598770-114678225 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 263.0" "Cell type enriched" "Detected in many" 8 "Oligodendrocytes: 821.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 6.9;naive B-cell: 10.7" "Lineage enriched" "Detected in single" 12 "B-cells: 10.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria No No Mitochondria "HPA014405: AB_1858606, HPA065785: AB_2685559" "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favorable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.6 0.6 67.4 4.7 134.5 1.1 4.7 153.4 106.2 7.0 9.3 27.1 30.6 3.8 0.3 1.5 4.4 11.1 0.3 60.4 99.0 31.3 0.2 1.1 5.0 194.5 130.6 40.1 0.4 8.6 0.2 0.2 0.2 178.3 0.5 28.0 2.2 7.3 0.7 0.5 2.2 27.9 1.6 161.8 1.7 16.9 5.1 119.8 0.6 13.6 0.4 5.1 0.6 0.6 263.0 0.6 0.2 4.4 0.6 0.3 0.0 0.7 0.2 0.0 0.1 3.4 17.7 58.4 17.6 1.2 0.2 13.8 25.8 0.0 0.1 0.1 0.3 14.3 0.3 24.6 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 5.4 0.1 0.2 16.1 3.0 0.1 0.3 0.3 1.7 6.4 123.7 8.8 1.6 28.9 0.3 55.2 0.6 31.4 4.6 0.2 5.4 0.8 1.1 0.9 5.4 1.0 1.1 19.2 0.7 19.6 6.3 0.8 0.6 29.2 0.9 17.9 0.2 0.0 0.8 0.0 0.0 0.6 6.9 0.0 0.0 0.0 10.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.3 67.4 134.5 153.4 106.2 60.4 99.0 194.5 130.6 40.1 178.3 161.8 119.8 263.0 0.1 6.4 1.5 1.0 22.0 0.0 1.8 0.3 6.8 0.0 5.7 6.1 0.8 8.6 3.9 25.8 0.0 0.0 0.1 19.0 9.8 1.4 9.2 9.6 1.7 0.5 48.4 0.0 1.0 13.1 0.0 0.6 19.4 21.4 0.0 0.2 0.0 0.0 0.0 0.0 3.7 27.9 0.0 0.0 0.0 3.5 1.2 0.5 1.8 2.8 0.0 0.0 0.0 98.5 821.1 10.8 14.6 0.0 4.0 0.7 24.2 1.4 1.5 0.0 0.0 0.0 0.4 20.9 34.0 5.9 0.1 0.0 0.4 0.1 26.9 0.9 KY FLJ33207 ENSG00000174611 "Kyphoscoliosis peptidase" Q8NBH2 3 134599923-134651636 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 16.4;skin 1: 9.6;tongue: 27.9" "Cell type enhanced" "Detected in some" "Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 5.7" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.7" "Cell line enhanced" "Detected in some" "Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 9.2" "HPA036492, HPA036668" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036492: AB_10672222, HPA036668: AB_2675239" "unprognostic (1.40e-2)" "unprognostic (2.05e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-2)" "unprognostic (2.72e-2)" "unprognostic (1.65e-2)" "unprognostic (2.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-1)" "unprognostic (3.86e-2)" "unprognostic (9.87e-2)" "unprognostic (2.83e-2)" "unprognostic (3.82e-1)" "unprognostic (4.62e-2)" "unprognostic (2.29e-1)" "unprognostic (8.98e-2)" "unprognostic (1.47e-1)" 0.1 2.7 2.7 0.2 1.8 0.3 0.8 1.5 2.9 0.6 0.1 0.6 0.4 2.0 0.8 2.0 2.0 0.5 1.8 1.9 1.5 0.3 0.0 0.1 0.0 1.9 2.0 1.4 0.9 0.0 2.2 3.3 0.0 2.7 2.2 0.2 1.7 0.8 1.8 16.4 9.6 0.2 4.2 2.1 0.1 0.7 0.3 2.0 0.9 3.1 27.9 0.0 0.6 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 8.1 0.7 0.0 5.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.7 1.8 1.5 2.9 1.9 1.5 1.9 2.0 1.4 2.7 2.1 2.0 1.8 0.0 0.0 0.0 15.0 0.0 0.6 0.1 0.0 0.0 0.4 0.1 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 10.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.0 0.0 2.5 0.0 24.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 128.3;Cone photoreceptor cells: 114.7;Respiratory ciliated cells: 98.7;Rod photoreceptor cells: 107.4;Spermatocytes: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 3.5 2.7 6.3 1.3 4.9 0.5 5.9 5.7 6.8 7.6 7.7 2.6 3.9 4.7 15.5 1.6 20.4 5.7 3.5 4.6 10.2 8.7 2.1 4.1 1.5 5.7 5.7 3.4 6.5 3.6 19.5 6.3 3.2 5.4 3.5 2.9 11.1 6.5 7.7 3.1 1.9 1.6 3.8 7.0 1.8 4.0 18.3 5.4 1.6 16.9 2.9 1.1 4.2 2.1 7.8 2.6 6.8 8.7 5.7 2.6 8.1 0.5 0.0 4.4 4.0 3.1 0.4 4.8 0.3 4.7 2.4 2.5 3.0 1.9 3.3 2.8 1.1 1.8 0.1 1.9 3.4 8.2 1.6 0.0 4.7 2.7 5.4 1.2 4.5 4.4 4.2 2.8 0.8 2.5 8.5 1.6 0.9 2.6 2.8 6.4 5.3 0.8 0.4 10.0 1.8 8.1 3.4 3.9 1.2 5.3 1.6 3.6 0.9 3.1 1.1 0.9 4.6 0.9 0.1 0.6 0.0 5.4 0.2 1.9 0.0 0.3 0.0 0.5 1.3 0.9 0.5 0.5 0.8 0.1 0.2 1.0 0.5 0.0 0.0 1.3 0.3 0.5 0.3 6.3 4.9 5.7 6.8 4.6 10.2 5.7 5.7 3.4 5.4 7.0 5.4 7.8 42.4 16.0 5.1 128.3 1.7 6.1 9.7 16.4 9.6 54.1 18.3 16.5 0.7 24.3 17.8 46.0 114.7 4.9 1.3 8.6 46.9 47.2 57.2 76.9 19.0 22.1 5.4 0.8 31.9 29.6 2.8 11.8 12.8 14.9 0.0 6.2 11.7 2.1 6.0 3.3 45.9 4.3 32.6 2.4 3.9 34.8 18.0 3.7 17.8 15.0 1.5 26.3 0.0 37.2 53.4 29.8 2.2 18.0 2.3 7.3 2.0 32.5 98.7 107.4 6.6 7.5 15.6 101.7 35.8 3.9 5.1 4.1 3.0 18.1 6.7 5.1 SLCO2A1 "MATR1, OATP2A1, PGT, SLC21A2" ENSG00000174640 "Solute carrier organic anion transporter family member 2A1" Q92959 3 133932701-134052184 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 124.8" "Group enriched" "Detected in many" 4 "Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 90.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA013742 Enhanced NA NA "HPA013742: AB_2668877" "unprognostic (4.39e-3)" "unprognostic (2.84e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.69e-4)" "unprognostic (8.53e-2)" "unprognostic (2.32e-3)" "prognostic favorable (9.24e-5)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (7.60e-2)" "unprognostic (2.04e-2)" "unprognostic (6.87e-2)" "unprognostic (5.63e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (3.07e-2)" 20.7 42.8 1.8 16.9 1.6 0.0 18.2 1.2 2.5 29.9 8.7 19.7 10.3 46.7 6.2 18.9 28.6 18.9 23.3 1.5 4.2 52.1 2.4 124.8 9.3 2.1 1.6 1.1 5.2 21.0 28.9 15.9 23.6 2.2 36.8 18.2 0.0 21.0 85.5 2.1 12.3 29.6 33.8 1.8 24.4 23.8 1.3 2.0 8.5 90.1 3.4 9.6 21.5 20.4 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 4.3 0.5 0.0 0.1 0.1 0.0 90.6 0.9 0.0 11.2 0.1 0.0 0.1 0.1 0.1 0.0 5.8 0.0 2.4 0.0 0.0 3.4 0.2 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.6 6.0 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 4.6 1.5 0.0 3.7 0.1 0.0 22.1 0.0 4.5 0.1 0.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 1.6 1.2 2.5 1.5 4.2 2.1 1.6 1.1 2.2 1.8 2.0 2.6 19.8 0.0 2.5 0.0 2.1 5.1 9.1 0.5 8.6 0.0 0.8 3.9 4.6 1.5 1.6 3.7 0.0 1.5 0.0 47.1 0.0 2.8 1.0 0.9 0.2 65.2 1.2 0.0 8.1 3.3 4.0 8.7 18.8 1.6 1.3 0.1 146.7 0.6 0.2 0.0 1.7 4.1 0.0 2.2 0.4 0.8 0.3 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.1 14.0 15.8 0.0 0.0 1.5 3.2 2.1 0.8 0.0 0.0 0.4 1.1 0.4 0.2 2.0 1.7 0.8 1.1 0.1 0.6 2.2 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412461-9435571 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 74.2" "Low region specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" NA NA Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: AB_2672018, HPA054110: AB_2682383" "unprognostic (2.50e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favorable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favorable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favorable (9.15e-5)" 19.9 17.8 9.2 12.9 9.6 17.6 23.0 11.1 10.8 23.9 10.6 22.2 10.3 20.8 53.7 17.6 21.9 9.8 14.1 9.0 10.3 16.4 15.5 22.0 24.0 9.3 10.0 8.7 24.4 15.2 15.9 20.3 15.1 9.9 31.8 16.0 12.7 19.2 14.7 11.5 24.6 29.7 14.1 9.2 44.4 19.5 16.9 9.6 27.9 26.5 8.7 28.2 20.2 20.5 10.5 21.5 5.4 13.0 26.6 10.8 15.3 10.3 19.4 18.9 19.1 27.5 10.1 7.1 22.5 12.6 10.7 7.4 6.3 19.3 10.8 22.1 6.8 29.6 27.1 21.8 13.9 9.2 16.9 17.3 16.4 16.0 9.6 14.3 15.5 14.2 25.7 18.0 0.0 16.7 2.1 25.8 74.2 16.6 9.9 16.5 9.6 16.4 16.9 13.6 22.2 13.0 19.5 10.5 11.0 14.0 14.0 8.8 14.2 13.7 16.6 6.9 23.1 11.8 32.1 55.6 28.0 4.5 14.8 11.3 4.0 3.5 4.9 9.6 4.1 6.8 4.8 5.7 7.4 2.9 5.3 7.5 8.1 2.0 11.1 5.4 2.7 7.5 4.8 9.2 9.6 11.1 10.8 9.0 10.3 9.3 10.0 8.7 9.9 9.2 9.6 10.5 8.8 0.0 14.3 10.4 15.3 4.0 5.9 5.3 11.4 8.0 9.0 8.8 5.5 4.3 8.7 3.7 12.5 4.8 22.4 7.2 3.9 5.5 0.7 5.0 5.4 7.5 9.5 14.3 12.5 3.7 3.3 6.6 11.2 6.5 12.0 12.9 10.8 3.1 4.8 8.4 12.0 7.1 6.1 11.4 7.2 1.4 6.2 9.1 5.4 14.0 11.3 4.2 20.6 14.1 15.1 4.7 5.2 4.5 10.5 5.6 7.6 1.4 6.6 9.5 6.6 7.2 6.2 5.5 8.7 6.4 4.7 4.7 17.1 6.5 7.4 6.4 OR7D4 "hg105, OR19-B, OR7D4P" ENSG00000174667 "Olfactory receptor family 7 subfamily D member 4" Q8NG98 19 9210276-9219589 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.30e-1)" 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.6 0.3 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 91.6;tongue: 47.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA Yes Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.6 0.9 3.7 2.5 4.1 0.8 7.4 8.6 5.6 1.8 3.0 5.7 7.8 1.0 3.1 3.3 3.6 1.4 11.4 3.6 3.3 4.5 1.5 4.5 2.8 6.0 6.3 2.6 0.7 8.8 13.0 6.2 4.1 6.9 5.3 4.2 3.2 7.3 2.4 91.6 2.8 7.4 0.3 2.9 2.1 9.5 0.5 5.5 2.3 5.4 47.7 1.9 1.2 2.6 5.1 14.2 11.4 8.2 1.8 1.2 0.3 44.3 0.6 0.0 0.4 0.6 20.2 53.5 6.1 10.4 0.1 3.1 12.9 11.4 9.7 0.0 0.5 18.6 11.7 12.4 1.5 1.3 21.9 0.4 0.7 4.3 1.5 4.1 5.2 0.5 5.1 33.0 0.0 0.0 34.5 1.6 31.9 21.8 35.1 8.1 1.3 0.3 26.4 22.2 10.4 16.1 6.6 1.0 18.4 1.2 2.4 55.2 4.1 0.0 0.3 11.2 0.4 0.0 0.3 0.8 0.5 0.9 0.5 0.7 0.0 0.0 0.0 1.3 0.0 0.4 0.2 0.7 1.7 0.3 0.7 1.7 1.7 0.1 0.0 0.0 0.6 0.1 0.5 3.7 4.1 8.6 5.6 3.6 3.3 6.0 6.3 2.6 6.9 2.9 5.5 5.1 0.6 3.2 6.3 9.4 2.2 0.6 4.7 5.4 1.2 2.5 7.6 5.8 12.3 4.3 6.5 14.7 12.5 46.4 0.7 6.0 3.9 5.0 0.1 2.1 0.5 0.9 2.4 2.1 11.2 6.7 16.5 1.7 11.2 5.4 4.5 1.8 0.4 0.9 4.4 5.0 10.8 9.2 4.1 0.8 0.4 0.0 0.0 0.5 0.0 2.8 0.9 2.3 0.0 7.5 0.8 3.5 4.7 0.4 1.5 4.7 1.6 0.5 3.8 3.7 0.0 4.4 2.1 0.4 0.5 3.5 0.0 13.5 2.1 0.4 10.6 3.4 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 38.1;pancreas: 105.1" "Cell type enhanced" "Detected in some" "Astrocytes: 22.9;Bipolar cells: 87.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 35.5;Horizontal cells: 69.0;Inhibitory neurons: 23.5;Rod photoreceptor cells: 28.6" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;AN3-CA: 17.3;CACO-2: 14.4;HAP1: 13.3;NTERA-2: 27.2;SCLC-21H: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 0.8 2.4 10.5 0.2 16.4 0.1 0.7 25.7 38.1 1.8 0.0 2.3 0.5 1.0 0.0 0.8 2.0 0.7 1.0 21.0 4.9 0.4 0.2 0.4 0.1 10.2 5.4 16.1 1.0 105.1 2.2 15.7 0.6 14.1 1.4 0.1 17.6 0.4 0.2 0.4 0.3 1.5 0.1 0.4 0.6 1.9 9.0 6.7 0.1 1.0 0.2 0.0 0.9 1.1 18.1 0.1 7.2 15.8 17.3 0.3 0.5 0.0 0.2 0.2 1.3 0.5 14.4 0.9 0.0 2.4 0.2 0.2 0.0 13.3 0.1 1.0 1.7 6.2 0.0 0.0 0.2 0.7 0.0 0.6 0.2 0.0 0.0 1.6 0.3 0.0 0.5 0.2 0.1 0.3 1.7 0.0 0.0 27.2 5.1 2.2 0.0 0.0 0.0 0.2 0.2 62.0 9.0 3.3 0.2 4.7 0.3 0.3 0.8 0.3 1.4 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 16.4 25.7 38.1 21.0 4.9 10.2 5.4 16.1 14.1 0.4 6.7 18.1 0.4 0.0 0.0 22.9 0.1 0.3 0.1 0.0 0.0 87.9 0.1 0.1 2.1 0.0 0.0 0.0 35.5 0.0 0.2 0.1 0.0 0.1 0.5 0.2 0.4 0.6 0.0 0.0 35.5 1.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.2 69.0 23.5 0.2 0.0 0.0 0.0 0.7 0.9 0.1 0.0 6.5 0.0 20.7 0.0 20.1 20.6 0.3 0.0 1.2 0.0 0.2 0.0 0.1 0.0 28.6 6.6 0.9 6.0 0.9 1.7 0.1 0.0 0.0 0.6 0.1 0.1 0.0 B4GAT1 "B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT" ENSG00000174684 "Beta-1,4-glucuronyltransferase 1" O43505 11 66345374-66347629 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 187.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.3;Horizontal cells: 158.2;Muller glia cells: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015484 Uncertain "Intracellular and membrane" NA NA 57000000 "HPA015484: AB_1845235" "unprognostic (1.80e-1)" "unprognostic (7.20e-2)" "unprognostic (1.70e-1)" "unprognostic (3.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.45e-1)" "unprognostic (9.23e-2)" "unprognostic (1.59e-1)" "unprognostic (2.65e-2)" "unprognostic (3.43e-3)" "prognostic favorable (3.55e-5)" "unprognostic (2.20e-1)" "unprognostic (3.50e-1)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-1)" "unprognostic (2.76e-3)" 16.1 41.8 122.1 6.2 137.4 1.3 16.1 81.6 118.2 22.6 73.3 25.1 16.3 28.7 15.3 8.4 23.6 10.0 42.4 125.1 187.8 25.5 19.0 17.4 6.7 99.3 116.0 127.8 34.6 25.7 22.8 62.8 22.6 104.0 17.4 7.8 46.4 15.9 22.7 27.9 11.9 14.7 14.1 91.9 10.3 26.0 8.3 142.3 6.6 21.2 19.4 4.3 20.4 16.5 153.1 10.8 26.7 29.7 36.5 32.6 29.3 39.4 18.4 42.5 28.1 22.9 20.1 14.9 8.9 76.1 16.9 24.1 16.8 32.0 20.6 13.5 17.6 58.2 1.3 20.4 77.6 19.3 7.0 2.7 28.6 15.6 17.5 7.4 92.8 33.5 14.8 8.6 13.7 13.6 18.1 16.7 19.1 20.2 10.6 28.0 24.0 23.2 15.9 29.6 2.7 17.8 33.7 15.8 10.4 74.8 18.4 42.6 6.8 19.7 21.8 15.9 28.0 9.6 26.1 19.2 5.3 36.8 5.8 26.0 0.0 1.2 0.0 7.1 0.4 9.9 5.7 7.8 7.6 3.0 3.2 9.0 8.3 0.4 4.6 0.3 7.4 5.7 4.4 122.1 137.4 81.6 118.2 125.1 187.8 99.3 116.0 127.8 104.0 91.9 142.3 153.1 13.5 22.4 10.8 25.8 2.9 0.0 1.6 0.0 14.2 72.3 6.2 12.7 45.9 25.8 1.8 20.2 58.4 57.8 8.6 8.0 5.9 7.4 0.5 3.9 9.7 17.1 4.9 0.8 22.1 6.0 22.6 23.4 6.6 2.6 1.3 22.5 30.4 24.4 12.7 158.2 35.0 8.0 0.0 2.4 0.0 2.4 32.6 2.6 0.0 10.3 1.3 70.1 2.1 22.6 14.2 4.3 4.9 40.6 6.1 2.0 13.3 17.5 2.9 47.4 26.3 21.2 11.8 1.4 2.8 5.8 0.0 18.1 2.6 28.0 7.2 0.3 TMEM167A "FLJ30508, MGC23909, TMEM167" ENSG00000174695 "Transmembrane protein 167A" Q8TBQ9 5 83052846-83077863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077278 Approved Vesicles NA NA Vesicles "HPA077278: " "unprognostic (5.38e-3)" "unprognostic (2.84e-3)" "unprognostic (3.78e-2)" "unprognostic (4.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (4.06e-3)" "unprognostic (7.74e-2)" "unprognostic (9.94e-3)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.09e-2)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.51e-1)" "unprognostic (1.13e-3)" "unprognostic (1.29e-2)" 31.8 49.0 33.9 29.8 34.1 31.1 30.3 37.4 34.0 30.2 30.7 25.5 28.1 21.7 26.0 19.2 15.1 27.8 27.5 34.3 41.7 34.5 33.5 26.8 23.0 36.3 37.5 30.3 16.2 23.1 32.2 23.0 35.4 37.0 23.0 29.8 35.6 26.5 19.7 17.5 21.8 24.7 22.9 36.2 22.2 24.4 12.4 38.2 26.7 29.2 21.4 24.2 25.5 15.8 37.1 35.4 21.1 77.7 70.4 111.9 77.6 71.2 54.5 42.6 34.5 44.9 31.8 45.1 22.3 33.4 64.6 45.9 29.1 52.0 70.5 57.1 31.4 32.1 61.2 39.5 49.7 43.5 31.4 38.8 61.0 48.5 44.3 41.4 56.4 43.1 32.7 34.1 44.7 50.9 30.8 38.9 34.4 80.9 18.5 35.4 34.2 50.2 62.5 48.5 27.8 36.8 48.0 36.7 38.2 56.1 70.6 69.2 73.5 59.7 21.8 21.3 63.5 49.2 25.7 77.5 22.3 40.6 56.1 53.0 26.0 21.6 10.3 3.4 20.4 4.0 3.9 4.7 4.3 12.0 3.2 5.0 4.0 12.3 6.0 24.2 5.7 6.2 10.7 33.9 34.1 37.4 34.0 34.3 41.7 36.3 37.5 30.3 37.0 36.2 38.2 37.1 56.5 35.3 26.2 21.2 62.8 47.9 60.4 160.3 39.9 47.8 76.2 58.4 53.3 55.8 104.8 49.7 41.7 102.9 63.1 100.0 170.2 86.6 16.7 49.0 135.7 57.2 50.8 56.4 22.7 121.4 306.2 90.6 47.9 71.1 32.4 41.2 50.3 121.6 158.7 33.7 30.2 101.6 103.7 181.4 117.6 20.8 47.2 154.7 94.3 15.0 188.0 68.8 66.9 61.3 50.6 130.7 81.8 49.7 129.3 126.4 84.4 223.3 72.9 31.6 32.9 41.8 79.2 64.1 57.6 79.8 67.2 179.4 64.8 57.1 73.6 125.2 LEP "OB, OBS" ENSG00000174697 Leptin P41159 7 128241278-128257629 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "adipose tissue: 310.3;breast: 90.9" "Group enriched" "Detected in some" 44 "Extravillous trophoblasts: 124.2;Syncytiotrophoblasts: 432.2" "Cancer enhanced" "Detected in some" "breast cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;SuSa: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" CAB010490 Approved "Secreted to blood" NA NA 17000000 19000000 "CAB010490: AB_2296951" "unprognostic (8.19e-3)" "unprognostic (5.33e-1)" "unprognostic (1.60e-4)" "unprognostic (1.19e-1)" "unprognostic (7.99e-3)" "unprognostic (1.83e-1)" "unprognostic (6.56e-3)" "unprognostic (1.98e-2)" "unprognostic (1.42e-2)" "unprognostic (2.45e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.23e-2)" "unprognostic (6.84e-2)" 310.3 0.9 0.2 5.1 0.1 0.1 90.9 0.5 0.3 0.1 0.2 2.0 0.1 0.0 0.0 0.2 0.1 1.3 0.7 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 2.4 0.0 0.0 4.6 0.2 0.0 0.4 0.0 1.1 0.0 0.7 2.9 1.2 0.1 0.0 0.2 0.5 0.2 0.1 0.3 0.2 1.2 0.0 1.0 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.3 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.8 0.1 0.6 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 124.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.1 432.2 0.1 0.1 0.0 0.1 SH3PXD2B "FLJ20831, KIAA1295" ENSG00000174705 "SH3 and PX domains 2B" A1X283 5 172325000-172454525 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 91.1;Leydig cells: 39.7;Oligodendrocytes: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 95.2;ASC TERT1: 79.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036471 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA036471: AB_10670799" "unprognostic (3.32e-1)" "unprognostic (1.95e-2)" "unprognostic (4.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.84e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.51e-5)" "unprognostic (5.38e-3)" "unprognostic (3.11e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.87e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (8.45e-4)" 21.0 25.6 9.2 11.3 11.2 0.1 19.1 12.3 10.5 31.4 8.4 13.0 2.3 32.8 5.4 10.6 18.1 19.1 6.7 9.1 18.2 2.4 3.0 17.7 3.6 14.0 12.2 7.0 18.6 9.9 6.6 5.1 9.0 17.4 12.9 5.7 3.6 18.5 14.1 3.5 18.3 11.6 23.4 10.0 6.6 13.2 6.3 11.0 4.2 8.0 3.4 3.4 18.5 18.2 15.0 1.0 14.3 52.3 34.6 95.2 79.9 44.3 8.6 29.7 5.4 10.7 4.0 1.3 0.1 11.5 33.4 16.7 8.1 18.7 9.8 5.3 0.8 3.5 0.1 13.3 2.9 30.6 0.0 36.5 51.5 15.1 22.4 6.4 5.2 37.9 3.8 0.1 0.2 24.1 3.1 0.1 4.6 20.1 8.1 3.3 17.3 8.5 5.1 5.7 1.5 4.6 29.2 6.0 3.8 10.7 16.5 1.4 2.1 40.9 33.4 13.2 20.7 3.8 0.0 0.0 0.2 22.6 2.2 27.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.2 12.3 10.5 9.1 18.2 14.0 12.2 7.0 17.4 10.0 11.0 15.0 11.3 0.0 1.1 91.1 0.4 10.1 3.2 13.9 8.6 0.6 6.2 6.5 1.8 5.7 12.0 0.0 0.0 4.5 0.2 1.3 0.0 9.9 0.9 5.5 30.8 6.4 2.4 0.0 5.0 16.0 31.0 29.8 6.1 13.4 0.0 5.8 3.3 1.8 3.1 1.7 11.2 2.1 18.3 28.4 9.4 2.0 39.7 13.6 14.2 13.1 1.3 6.3 0.0 25.1 63.0 21.8 1.0 27.1 0.0 6.9 0.2 1.9 3.8 0.3 13.1 6.0 10.5 0.8 4.2 4.7 8.1 2.2 0.5 22.3 2.7 5.7 RESF1 "C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1" ENSG00000174718 "Retroelement silencing factor 1" Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 74.6" "Cell type enhanced" "Detected in some" "Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 212.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 212.8" "Cell line enhanced" "Detected in all" "SuSa: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 14.4 7.1 2.6 51.2 3.2 22.0 14.0 7.5 9.9 29.2 3.5 14.1 24.0 23.4 9.1 10.7 38.4 19.4 8.2 2.0 3.0 9.2 25.1 17.2 70.7 3.5 2.5 1.2 74.6 6.8 9.9 4.0 38.2 5.1 9.3 13.9 7.1 8.3 11.3 4.1 9.2 27.6 16.2 2.9 45.7 20.7 13.3 3.6 61.2 12.7 12.0 63.1 17.9 8.7 5.2 7.6 13.3 22.5 8.6 10.1 12.0 33.6 9.1 9.0 6.0 6.9 50.6 48.9 36.4 21.9 7.6 21.5 9.6 31.3 6.0 8.4 27.1 4.4 51.1 6.7 6.7 19.7 37.0 79.2 6.5 9.0 7.1 11.6 25.4 50.3 24.0 29.5 56.1 6.8 3.7 52.6 15.6 48.3 28.4 5.5 24.1 21.4 16.0 6.3 14.0 9.0 8.1 11.7 6.0 6.0 112.9 20.8 40.5 32.0 6.7 10.4 11.5 9.6 33.9 38.1 44.8 3.6 20.6 7.4 55.5 14.7 15.4 42.2 16.1 40.3 33.6 38.0 40.7 12.3 26.8 44.1 43.8 212.8 30.6 18.1 7.7 38.9 20.4 2.6 3.2 7.5 9.9 2.0 3.0 3.5 2.5 1.2 5.1 2.9 3.6 5.2 35.8 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 15.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 2.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 5.1 21.5 0.0 0.0 0.0 LARP7 "DKFZP564K112, HDCMA18P, PIP7S" ENSG00000174720 "La ribonucleoprotein 7, transcriptional regulator" Q4G0J3 4 112637107-112657592 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" RNA-binding "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026842, HPA027930" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026842: AB_10611116, HPA027930: AB_10601233" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (5.72e-2)" "unprognostic (2.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.82e-2)" "unprognostic (1.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 37.5 31.9 27.6 33.1 30.0 45.0 36.0 30.5 34.9 28.3 30.1 36.6 34.1 33.6 30.1 32.0 26.0 30.8 60.1 27.0 34.6 40.6 44.5 28.3 45.3 32.4 30.6 23.9 34.5 18.5 30.2 20.2 34.4 33.1 32.4 37.1 31.8 23.4 27.5 47.0 30.9 33.5 29.8 30.4 37.2 31.8 24.8 30.4 42.6 39.1 45.7 40.6 33.3 22.0 33.0 42.9 34.9 77.7 44.3 50.7 61.6 44.0 55.3 40.6 45.3 42.0 27.9 62.0 95.4 43.7 46.9 42.2 29.6 75.1 45.2 60.2 86.8 52.1 56.4 35.2 41.9 41.0 131.6 84.6 49.3 50.7 40.4 25.1 62.6 40.4 47.6 71.4 51.1 55.3 35.2 107.4 56.7 182.2 67.5 28.2 62.9 66.2 44.3 68.8 44.8 46.5 64.4 32.0 83.4 55.4 131.4 35.1 61.0 43.7 42.4 49.5 47.7 57.6 34.7 62.5 97.6 57.7 52.4 49.2 70.1 28.1 49.9 32.8 43.1 30.3 48.1 33.9 34.2 25.3 47.4 32.3 31.3 33.2 38.7 60.7 64.0 37.9 20.8 27.6 30.0 30.5 34.9 27.0 34.6 32.4 30.6 23.9 33.1 30.4 30.4 33.0 66.1 96.1 79.2 45.1 68.8 24.9 66.5 102.6 34.1 61.3 48.3 50.4 113.2 95.8 91.6 47.8 29.2 79.0 88.7 83.2 111.6 69.3 17.6 78.7 70.5 63.2 38.9 43.6 18.0 64.4 70.2 60.6 32.1 58.8 104.4 51.5 81.4 160.9 70.4 58.9 19.9 79.7 61.1 93.7 27.1 14.9 94.4 67.2 24.9 32.8 96.0 107.1 107.1 20.6 43.1 62.0 85.6 100.1 39.1 38.8 73.1 117.0 109.8 54.1 118.3 74.5 68.3 83.5 87.8 33.3 20.9 100.4 65.9 74.2 75.6 47.9 FGFBP3 "C10orf13, MGC39320" ENSG00000174721 "Fibroblast growth factor binding protein 3" Q8TAT2 10 91906584-91909486 "Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 19.6;Enteroendocrine cells: 46.2;Muller glia cells: 28.2" "Cancer enhanced" "Detected in many" "glioma: 4.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 9 "AF22: 315.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA053943 Uncertain "Secreted in brain" NA NA "HPA053943: AB_2682318" "unprognostic (8.66e-2)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (2.88e-1)" "unprognostic (9.98e-3)" "unprognostic (7.76e-2)" "unprognostic (1.43e-1)" "unprognostic (1.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.39e-3)" "unprognostic (2.61e-1)" "unprognostic (3.90e-1)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "unprognostic (2.63e-1)" "unprognostic (6.76e-3)" 0.9 1.4 4.0 0.8 3.9 0.6 1.1 3.1 3.9 1.4 2.3 1.0 0.6 1.4 1.5 0.9 1.1 0.3 0.8 3.5 4.4 1.0 0.6 0.7 0.8 4.3 3.8 3.5 1.4 1.9 0.9 2.2 0.4 4.3 1.7 1.0 4.6 1.6 0.6 2.1 1.3 1.1 0.4 3.6 1.3 1.2 0.5 4.0 0.8 2.3 0.6 0.6 1.5 1.1 4.3 0.3 2.5 315.8 4.7 1.3 0.4 1.1 0.2 0.2 0.6 1.0 0.8 1.2 0.4 0.4 0.6 0.1 1.3 2.2 0.3 0.8 1.2 3.4 6.5 2.6 3.8 0.7 35.5 0.9 0.9 0.4 1.6 1.5 1.0 0.2 4.1 3.4 1.2 0.1 2.7 4.1 14.2 23.4 1.3 1.1 10.5 2.0 0.5 0.5 0.8 3.3 4.3 0.8 0.1 5.7 1.8 1.3 0.7 0.3 0.3 2.3 0.4 1.1 0.8 2.0 1.3 0.3 4.1 0.6 0.6 0.1 0.0 0.5 0.0 0.1 0.8 0.3 0.2 0.1 1.7 0.5 0.4 0.0 0.3 0.0 0.1 0.0 0.0 4.0 3.9 3.1 3.9 3.5 4.4 4.3 3.8 3.5 4.3 3.6 4.0 4.3 2.8 0.0 2.0 2.6 2.9 1.3 5.1 0.3 1.2 13.0 5.4 5.1 3.2 4.3 2.9 5.5 2.1 2.9 4.4 1.7 19.6 2.0 0.3 1.4 1.9 2.6 46.2 2.1 1.9 3.4 1.1 3.8 5.1 1.3 0.0 3.2 3.3 1.5 1.4 6.7 2.7 7.6 0.0 3.4 2.6 0.5 5.9 2.5 3.6 1.0 2.5 28.2 10.3 5.5 2.6 0.6 2.4 3.8 3.1 3.2 1.0 3.2 4.9 15.9 0.0 4.6 3.1 0.3 1.0 4.7 2.7 1.0 6.4 2.6 3.8 4.3 NR1D2 "BD73, EAR-1r, Hs.37288, HZF2, REVERBB, REVERBbeta, RVR" ENSG00000174738 "Nuclear receptor subfamily 1 group D member 2" Q14995 3 23945286-23980617 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053868, HPA054798" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053868: AB_2682284, HPA054798: AB_2616453" "unprognostic (8.64e-2)" "unprognostic (9.96e-3)" "unprognostic (2.27e-1)" "unprognostic (2.46e-1)" "unprognostic (8.67e-2)" "unprognostic (2.09e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (2.60e-1)" "unprognostic (6.79e-3)" "unprognostic (2.21e-1)" "unprognostic (5.73e-2)" "prognostic favorable (4.47e-7)" "unprognostic (2.36e-3)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 15.5 16.1 16.0 11.0 15.3 15.4 21.1 29.0 21.7 13.0 11.0 11.6 13.7 25.1 13.9 15.9 16.9 14.6 32.0 15.3 16.2 22.0 29.7 14.2 14.8 14.8 18.5 12.9 31.4 17.2 53.2 12.0 8.7 18.1 17.7 11.4 34.7 32.7 25.0 55.0 14.1 14.0 13.4 15.6 18.9 15.0 7.4 18.6 12.3 54.7 50.8 14.3 10.7 12.5 20.6 22.5 5.0 11.5 10.9 11.8 12.6 7.1 32.7 42.7 17.8 19.7 3.7 21.6 16.0 10.7 46.0 27.8 14.7 14.6 21.4 36.9 5.8 16.9 2.6 11.3 4.5 24.6 8.6 2.3 16.9 22.1 21.7 55.4 32.9 12.3 9.3 5.8 56.3 14.2 12.9 4.7 2.7 12.5 18.2 24.8 4.1 18.6 11.1 9.9 30.6 11.8 26.2 23.9 13.6 29.2 18.5 11.9 7.4 24.5 46.2 47.0 30.2 37.6 27.4 39.4 7.4 26.3 12.6 27.5 0.0 0.3 0.0 1.4 1.1 2.6 1.0 1.6 1.3 0.4 0.7 1.1 1.1 0.1 0.5 0.6 0.4 1.0 0.4 16.0 15.3 29.0 21.7 15.3 16.2 14.8 18.5 12.9 18.1 15.6 18.6 20.6 51.8 12.8 7.5 51.6 39.6 33.3 34.7 14.5 59.2 82.5 29.7 23.9 39.5 17.2 17.5 20.2 39.6 11.1 43.0 17.1 7.9 11.3 10.0 77.5 49.8 38.9 28.5 3.8 58.6 15.1 2.5 47.7 35.7 135.2 8.2 33.2 15.4 33.1 9.6 95.9 62.0 18.2 26.4 12.8 32.0 11.3 34.2 26.8 28.4 32.8 12.6 62.8 11.3 44.2 57.5 19.8 10.3 42.5 28.5 41.4 17.9 11.9 16.0 53.6 32.9 46.8 45.5 7.6 10.9 42.0 33.5 6.8 44.4 37.0 12.1 31.1 PABPC5 PABP5 ENSG00000174740 "Poly(A) binding protein cytoplasmic 5" Q96DU9 X 91434595-91438584 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.4;ovary: 11.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.8;Endometrial stromal cells: 8.3;Horizontal cells: 8.4;Oligodendrocyte precursor cells: 7.5;Peritubular cells: 11.7;Sertoli cells: 13.1;Skeletal myocytes: 11.2;Theca cells: 12.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.0;HSkMC: 2.8;LHCN-M2: 1.9;RH-30: 8.4;U-2 OS: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000164, HPA000165" Approved NA NA "HPA000164: AB_1079551, HPA000165: AB_1079552" "unprognostic (1.05e-1)" "unprognostic (2.98e-1)" "unprognostic (3.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.37e-1)" "unprognostic (1.56e-2)" "unprognostic (1.23e-1)" "unprognostic (3.52e-1)" "unprognostic (2.89e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "unprognostic (2.46e-1)" "unprognostic (1.26e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.55e-2)" "unprognostic (8.07e-2)" 2.1 7.4 1.3 0.7 1.4 0.0 0.9 1.2 1.4 2.4 0.7 1.2 0.4 3.1 2.5 1.2 1.8 1.3 1.6 1.1 1.4 0.8 0.3 0.9 0.8 1.6 1.5 1.0 11.2 0.4 1.2 1.3 0.7 1.5 2.3 0.8 1.2 0.8 2.0 0.5 0.4 0.7 2.9 1.2 1.8 0.7 1.6 1.3 0.2 2.0 0.9 0.5 1.3 1.0 1.8 0.0 0.0 7.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 1.2 1.4 1.1 1.4 1.6 1.5 1.0 1.5 1.2 1.3 1.8 1.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 12.8 0.1 1.1 0.7 0.0 0.0 1.8 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 8.3 1.3 0.0 0.0 1.7 0.0 0.0 5.0 0.0 0.1 0.0 6.6 1.1 0.0 0.1 8.4 1.8 0.0 0.0 0.0 0.4 0.7 5.9 0.1 3.6 1.0 0.0 4.1 0.0 7.5 3.6 0.0 0.0 11.7 0.0 0.3 0.0 0.1 0.0 3.4 13.1 11.2 4.4 0.2 0.3 0.1 0.3 0.0 0.1 12.0 0.0 0.0 BRMS1 DKFZP564A063 ENSG00000174744 "BRMS1 transcriptional repressor and anoikis regulator" Q9HCU9 11 66337333-66345125 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010824, HPA019637" Approved Approved Centrosome NA NA Centrosome "CAB010824: , HPA019637: AB_1845448" "unprognostic (1.75e-1)" "unprognostic (2.64e-2)" "unprognostic (2.01e-1)" "unprognostic (4.31e-2)" "unprognostic (1.72e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (5.67e-3)" "unprognostic (2.54e-1)" "unprognostic (6.32e-2)" "unprognostic (1.61e-1)" 27.0 28.3 24.0 24.3 25.1 52.6 27.3 25.4 28.7 21.6 24.9 26.2 26.2 20.7 17.7 37.0 20.2 18.1 23.4 24.8 24.0 34.3 29.3 25.2 32.5 25.5 25.4 22.6 20.0 41.2 19.5 18.0 19.6 26.1 34.2 19.4 9.2 30.7 18.4 38.4 41.5 29.9 13.2 25.0 38.6 31.9 31.8 24.6 29.0 26.7 13.9 25.8 25.3 26.0 26.2 80.3 102.4 33.8 56.6 35.1 36.1 47.8 54.4 58.9 95.9 63.9 84.1 51.2 53.5 78.9 53.8 82.5 91.7 64.9 99.2 45.0 63.9 53.9 49.2 54.2 62.1 65.1 71.3 54.9 41.2 104.5 97.0 72.2 29.1 59.9 60.1 59.0 24.3 58.0 128.9 87.5 169.1 73.3 61.2 95.3 73.2 62.2 100.0 60.1 45.6 70.8 57.0 67.2 68.6 180.9 24.6 83.5 43.7 58.2 71.9 68.2 117.1 68.8 50.2 53.8 85.3 93.0 46.2 78.8 45.6 79.4 80.8 61.1 77.3 65.1 79.2 65.2 58.6 62.4 75.6 56.3 54.3 104.2 51.3 69.9 67.3 79.9 67.3 24.0 25.1 25.4 28.7 24.8 24.0 25.5 25.4 22.6 26.1 25.0 24.6 26.2 27.2 16.0 26.9 4.2 42.7 58.1 28.5 45.0 33.6 12.3 31.7 27.6 11.7 40.0 22.6 22.0 6.2 61.5 37.1 109.0 54.8 72.6 7.4 25.6 16.6 30.8 32.3 33.7 2.9 117.9 68.5 22.9 33.1 18.6 27.8 21.4 28.2 21.5 67.6 11.8 2.2 54.0 32.6 51.3 41.7 9.9 22.4 39.1 28.4 5.6 68.3 31.7 56.7 3.0 5.1 85.7 85.6 14.7 30.5 40.6 80.5 51.1 22.2 14.9 6.6 23.1 27.3 35.8 39.4 32.2 60.0 71.7 42.5 21.1 61.3 29.8 RPL15 "EC45, L15, RPL10, RPLY10, RPYL10" ENSG00000174748 "Ribosomal protein L15" P61313 3 23916591-23924374 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 290000 "unprognostic (8.73e-3)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" "unprognostic (5.77e-3)" "unprognostic (1.16e-2)" "unprognostic (8.40e-2)" "unprognostic (1.76e-3)" "unprognostic (4.43e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-1)" "unprognostic (3.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.53e-2)" "unprognostic (1.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (2.17e-2)" 1208.2 982.6 878.8 997.6 887.1 3200.4 2004.8 862.7 1025.9 1461.0 854.7 1268.2 924.5 1245.0 1376.2 1604.7 1699.4 1041.9 1074.6 841.5 910.7 926.5 971.7 889.4 2156.4 911.7 885.2 822.8 3539.9 2333.7 1141.7 882.1 1007.6 898.8 1065.4 1092.5 496.5 2563.6 942.4 1214.1 1611.3 952.6 1156.3 987.5 1145.5 1199.5 548.2 942.6 2165.1 1433.1 1483.7 1983.7 1637.3 1309.2 926.3 1884.4 1672.6 1865.3 2205.4 2938.4 4771.0 2306.5 1735.1 3111.2 2614.8 2272.5 1911.8 2160.2 3773.1 1663.6 2599.8 1395.8 1246.8 2257.1 3847.8 1873.7 1781.3 3198.5 1482.3 1665.5 2318.9 3919.5 2624.0 1883.9 4784.3 5359.8 2903.6 4909.4 3783.5 3360.8 2616.7 1920.5 3044.4 2731.4 2598.3 3423.7 3345.9 3254.1 2354.3 2745.2 2980.8 1645.5 4025.3 2762.8 2203.8 987.6 2402.2 1020.5 4416.6 3791.8 1655.3 2958.9 5102.2 1849.1 1569.5 2056.3 1645.1 3196.8 2579.1 3758.6 3500.8 1570.9 3483.4 1852.3 897.2 2250.3 454.1 1698.4 1878.9 2960.6 3476.6 2599.4 2357.9 2917.1 3310.7 3182.8 2831.7 263.1 2346.0 1602.6 2369.7 2475.9 6597.8 878.8 887.1 862.7 1025.9 841.5 910.7 911.7 885.2 822.8 898.8 987.5 942.6 926.3 1499.2 746.8 1100.3 44.7 3602.1 7074.5 6959.4 8223.9 3122.1 541.8 6066.8 6379.1 385.1 2546.4 3484.1 1029.9 181.4 4812.5 2798.4 1007.2 4187.0 3163.6 3239.1 1167.3 1989.0 2798.6 1720.1 2338.9 63.9 4491.5 6879.4 2261.8 1083.6 1607.8 1478.8 2969.2 2682.2 1755.9 3583.6 277.6 77.7 2855.1 3013.0 3552.7 6451.3 4965.7 3662.3 2601.6 3966.5 50.6 4609.7 1412.2 2856.9 45.8 91.3 3499.5 2558.2 2337.3 2291.1 7001.0 1750.8 3801.2 1422.6 570.1 1360.8 2679.8 4368.3 1786.6 962.8 4001.9 8678.9 5061.5 2967.3 3017.0 3549.9 7926.6 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145454-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 41.3;HUVEC TERT2: 28.0" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 16.9 4.2 6.5 5.4 9.7 7.3 11.3 17.8 17.1 2.9 0.5 2.8 2.9 3.9 3.9 4.4 2.3 5.1 7.3 7.7 3.6 4.6 4.6 5.1 5.2 4.8 5.0 8.6 2.8 2.2 3.9 1.5 10.9 9.4 3.8 2.8 10.6 8.9 2.9 6.1 6.4 3.4 5.1 0.5 5.0 7.3 6.1 2.7 3.2 4.3 5.0 4.2 5.1 2.5 16.1 6.3 2.4 2.5 2.1 12.5 7.1 3.7 5.3 1.2 1.0 1.6 1.9 7.9 41.3 4.9 2.9 3.5 3.1 3.9 5.5 1.8 19.7 6.6 4.4 6.4 3.4 7.4 10.3 2.7 7.8 8.7 1.5 9.1 2.0 28.0 5.8 8.4 19.6 3.1 6.5 3.8 7.4 3.2 10.3 5.9 8.6 4.2 8.5 4.2 6.1 4.6 3.8 5.0 9.0 2.7 3.6 6.5 4.4 17.9 3.2 9.7 2.1 1.9 8.2 11.3 19.1 7.3 5.1 4.1 2.8 0.6 0.6 0.5 0.5 0.4 0.6 0.5 0.4 0.3 0.9 0.5 0.6 1.5 0.6 0.6 1.0 0.6 0.3 6.5 9.7 17.8 17.1 7.7 3.6 4.8 5.0 8.6 9.4 0.5 2.7 16.1 272.0 60.9 69.9 0.0 4.9 0.0 0.0 0.0 0.0 0.0 87.0 42.2 0.0 0.0 36.5 33.1 0.0 1.6 9.2 0.0 7.9 12.0 0.0 4.6 3.9 44.0 0.0 0.0 0.0 17.3 2.8 13.8 0.0 12.0 32.8 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 28.2 0.0 0.0 4.0 0.0 0.0 3.5 42.3 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 2.5 9.8 1.3 0.0 0.0 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: AB_2680903, HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 27.6 24.8 63.9 3.5 62.8 2.9 27.2 59.4 87.5 25.7 54.3 30.1 2.8 23.7 12.6 80.7 19.1 3.6 49.3 60.6 60.8 34.0 22.0 27.3 4.4 62.5 61.8 58.9 20.2 20.7 13.2 38.5 9.0 63.0 38.6 6.9 10.3 27.6 12.4 59.5 67.1 19.7 9.0 61.1 20.7 24.4 16.7 62.6 9.3 20.7 25.4 10.3 34.8 44.6 65.4 59.0 105.6 44.2 25.6 22.2 17.5 39.6 49.9 25.1 64.5 29.5 62.4 29.7 20.4 10.9 63.2 60.7 43.7 46.0 114.1 19.3 19.5 108.4 6.6 43.7 56.1 38.5 13.9 12.0 28.3 118.0 42.0 51.5 19.6 31.5 34.3 29.7 32.3 40.9 110.6 34.0 50.5 26.5 39.9 94.5 31.6 40.7 18.2 47.0 33.2 87.6 43.7 25.5 55.4 17.9 31.5 43.3 14.8 35.4 47.3 44.7 16.4 39.7 20.3 17.7 15.4 39.1 17.0 38.3 0.0 0.5 0.6 0.8 0.7 0.4 0.3 0.9 0.8 0.7 2.0 0.9 0.3 0.0 0.1 4.0 0.9 1.5 0.2 63.9 62.8 59.4 87.5 60.6 60.8 62.5 61.8 58.9 63.0 61.1 62.6 65.4 51.3 12.8 10.7 9.1 18.0 131.2 101.7 25.4 82.0 46.0 38.8 75.7 25.2 22.8 11.2 35.0 18.8 78.8 21.5 72.2 74.3 35.2 1.6 36.1 28.6 32.0 29.3 11.2 9.8 37.4 63.4 25.9 33.6 34.1 2.5 26.8 22.9 17.4 39.9 48.8 10.6 26.5 4.1 11.7 38.4 7.9 17.1 21.3 64.0 10.3 12.8 50.8 11.3 4.0 12.3 48.2 30.9 23.0 26.5 61.2 30.8 54.6 20.0 37.6 32.9 20.3 40.3 5.4 21.4 118.1 145.9 78.1 22.0 18.8 26.2 106.4 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 34.5;choroid plexus: 24.7;fallopian tube: 10.1" "Group enriched" "Detected in some" 5 "Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 24 "dendritic cells: 2.9;monocytes: 2.7" "Cell line enhanced" "Detected in some" "AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.5" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.1 0.1 16.5 0.4 7.1 2.0 0.1 20.6 5.4 0.3 24.7 0.1 2.0 0.4 0.0 0.9 10.1 0.2 1.1 7.0 27.8 0.3 0.0 1.9 0.3 26.3 22.9 1.8 0.1 0.3 0.0 0.5 0.0 23.1 0.2 0.1 0.0 0.2 0.0 0.0 0.1 4.6 0.1 34.5 0.4 0.2 0.6 14.4 0.4 0.1 0.2 0.3 0.2 0.2 23.8 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.5 16.5 7.1 20.6 5.4 7.0 27.8 26.3 22.9 1.8 23.1 34.5 14.4 23.8 0.2 0.0 0.6 79.0 0.1 0.0 0.9 1.7 9.1 0.0 0.1 0.1 1.1 0.0 10.9 0.0 0.0 0.0 1.6 0.1 0.0 0.1 2.4 43.4 0.3 0.2 0.0 1.7 4.5 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 4.1 1.6 2.5 0.8 0.0 1.8 0.0 0.0 4.0 0.0 0.0 2.5 3.0 0.0 0.0 0.0 0.1 0.4 3.3 0.0 47.7 0.0 6.6 0.3 0.6 0.1 0.2 1.0 0.1 0.0 0.1 0.0 0.2 0.8 SRP72 ENSG00000174780 "Signal recognition particle 72" O76094 4 56467617-56503681 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Ribonucleoprotein "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034621 Approved NA NA 23000 "HPA034621: AB_10601593" "unprognostic (1.96e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.75e-1)" "unprognostic (1.76e-2)" "unprognostic (9.40e-2)" "prognostic unfavorable (3.25e-6)" "unprognostic (7.76e-3)" "unprognostic (2.88e-2)" "unprognostic (4.09e-3)" "unprognostic (4.60e-3)" "unprognostic (9.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (1.13e-2)" "unprognostic (3.35e-1)" 38.0 31.9 14.6 41.6 15.6 74.2 50.3 15.7 18.2 41.8 20.9 39.4 29.6 41.2 29.8 42.7 33.3 33.8 25.4 14.2 18.2 33.7 45.8 32.3 49.9 16.4 16.7 13.1 45.4 48.1 43.7 16.5 48.7 17.2 31.4 41.5 27.6 44.2 33.0 33.5 34.6 31.8 45.0 14.7 39.5 34.0 27.5 15.2 53.3 54.8 36.1 56.1 47.1 23.9 19.3 109.1 82.0 101.6 98.7 63.2 90.0 98.0 157.2 125.0 129.3 102.7 91.2 120.5 167.6 105.6 132.2 68.2 61.1 126.9 133.4 152.3 44.3 74.0 146.4 90.3 86.0 115.7 284.4 116.3 85.8 175.9 138.0 243.3 112.1 117.1 126.4 216.1 157.0 124.9 84.2 168.6 73.9 88.2 135.1 86.1 149.2 81.9 127.0 88.5 101.7 62.9 104.5 99.8 193.4 88.5 81.3 77.0 102.3 142.7 106.8 143.3 110.4 165.2 111.8 56.9 181.2 114.9 148.3 132.2 43.0 64.3 38.7 50.4 70.8 65.1 52.8 50.9 51.1 82.1 48.5 49.4 49.9 8.4 59.5 57.5 61.4 60.8 58.7 14.6 15.6 15.7 18.2 14.2 18.2 16.4 16.7 13.1 17.2 14.7 15.2 19.3 78.5 73.7 72.5 17.0 84.7 97.3 93.7 103.5 47.3 61.6 65.8 80.4 45.2 54.3 87.9 27.6 18.8 120.8 97.0 30.5 66.5 121.1 86.3 38.9 87.2 83.7 53.2 113.8 30.2 131.2 197.3 84.0 39.3 73.3 101.9 94.5 63.9 80.1 100.4 57.2 32.4 94.8 69.2 109.4 78.9 116.1 65.3 83.4 58.7 28.1 122.4 54.5 72.1 29.1 35.6 111.8 48.7 66.5 156.6 131.7 43.5 71.1 54.6 37.7 39.5 92.9 106.7 48.2 86.5 73.2 100.9 166.5 71.1 111.0 89.0 115.2 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.8;retina: 33.6;testis: 113.3" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4139.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 52.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7" "Region enriched" "Detected in many" 44 "cerebellum: 2160.4" "Region enriched" "Detected in all" 28 "cerebellum: 552.9" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.3 1.7 0.4 1.1 0.6 3.8 5.6 52.8 1.9 2.1 0.0 0.5 1.4 0.9 3.3 2.1 2.4 2.3 1.3 0.5 0.1 8.0 3.7 2.3 3.0 0.3 2.6 0.0 0.1 5.4 1.1 1.4 0.4 12.9 5.9 0.3 33.6 16.5 1.9 0.2 7.1 1.6 0.0 0.1 3.0 3.1 113.3 0.1 3.1 5.7 0.0 1.5 0.9 1.6 16.6 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.6 2.8 0.1 0.0 0.3 8.4 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.2 0.0 0.3 0.3 17.7 0.4 0.3 0.0 0.8 0.2 0.7 0.8 0.1 0.1 0.0 1.4 1.4 0.0 0.4 3.7 3.4 0.2 0.0 0.5 0.4 0.0 1.4 0.7 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.8 0.2 0.0 0.6 0.0 1.7 0.4 0.6 52.8 1.9 0.5 0.1 0.3 2.6 0.0 12.9 0.1 0.1 16.6 0.1 0.0 2.3 0.0 0.2 0.8 1.1 1.4 0.0 734.7 7.7 5.8 0.0 2.8 1.8 5.5 22.9 0.2 2.7 0.7 9.8 0.8 836.5 1.0 0.1 2.6 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.5 1.3 1.3 0.0 0.5 0.4 23.5 0.0 0.4 0.0 0.8 1.3 4139.3 10.5 7.1 1.8 1.0 1.5 40.7 2.1 0.0 0.0 0.4 0.1 13.2 0.3 1.0 1.3 0.5 0.4 100.3 19.7 0.0 0.1 14.5 9.0 0.0 1.1 0.0 1.0 0.0 0.6 0.6 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330241-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.6;skin 1: 26.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 9.7" "Lineage enriched" "Detected in many" 6 "monocytes: 9.7" "Cell line enhanced" "Detected in many" "hTCEpi: 44.3;U-2197: 40.7" "Low region specificity" "Detected in many" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favorable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.7 4.3 3.5 2.3 4.0 1.1 4.5 3.1 5.4 7.4 1.3 4.0 2.7 4.4 0.2 20.6 5.7 1.5 3.2 6.1 1.8 3.3 1.3 4.9 0.5 1.7 1.3 3.0 3.7 5.3 0.4 7.3 1.5 2.0 7.2 1.0 0.2 5.2 0.8 7.6 26.2 4.4 0.6 0.6 6.1 6.9 3.7 1.5 0.5 2.4 0.5 0.4 5.5 11.4 2.5 2.3 5.7 2.3 5.3 2.8 14.5 1.2 13.7 18.0 14.4 6.8 3.3 9.3 0.5 5.0 13.6 5.2 12.9 0.0 24.3 1.8 1.1 0.0 0.8 4.4 4.1 5.5 0.1 4.2 15.9 44.3 12.4 8.0 17.1 2.8 0.6 0.3 0.1 6.1 0.5 0.3 11.0 0.6 3.9 12.6 0.1 5.4 0.1 3.9 3.0 10.9 2.3 3.2 2.5 20.5 0.6 1.8 1.3 6.5 18.7 7.9 40.7 3.3 0.3 0.9 0.0 26.9 3.5 6.3 0.1 2.7 0.0 0.2 4.7 0.6 0.1 0.4 0.2 1.7 0.0 0.5 0.2 0.0 0.1 9.7 0.0 0.1 1.8 3.5 4.0 3.1 5.4 6.1 1.8 1.7 1.3 3.0 2.0 0.6 1.5 2.5 3.9 0.0 0.5 1.3 0.8 13.4 9.3 25.7 23.3 3.8 3.5 4.3 0.8 4.3 4.8 0.0 0.0 0.8 0.5 9.6 0.0 4.1 0.5 2.4 5.1 5.3 3.0 0.0 6.0 6.9 4.8 5.6 5.6 1.8 4.5 0.1 7.9 0.2 4.7 0.0 2.3 4.5 2.0 8.7 6.5 2.0 4.4 6.4 1.8 1.0 8.1 0.7 1.0 0.5 0.5 8.9 7.8 1.9 1.4 4.0 9.1 0.1 3.4 1.2 0.0 4.2 3.4 1.2 0.9 18.6 15.2 0.3 2.2 1.6 9.2 5.8 ODAPH "AI2A4, C4orf26, FLJ23657" ENSG00000174792 "Odontogenesis associated phosphoprotein" Q17RF5 4 75556048-75565871 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;placenta: 5.9" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 9.2;Syncytiotrophoblasts: 27.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1;urothelial cancer: 0.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 33 "basophil: 10.7" "Lineage enriched" "Detected in single" 33 "granulocytes: 10.7" "Cell line enriched" "Detected in some" 6 "HDLM-2: 61.3" "Secreted in other tissues" NA NA "unprognostic (1.13e-1)" "unprognostic (4.45e-3)" "unprognostic (3.78e-1)" "unprognostic (1.66e-1)" "unprognostic (6.12e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (2.44e-1)" "unprognostic (3.87e-2)" "unprognostic (5.30e-2)" "unprognostic (3.43e-1)" "unprognostic (1.17e-7)" "unprognostic (8.31e-2)" "unprognostic (2.70e-2)" "unprognostic (8.40e-4)" "unprognostic (6.53e-3)" 0.1 0.1 1.0 0.2 1.0 0.3 0.1 1.1 1.5 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.8 0.1 0.1 0.1 0.2 1.1 1.0 0.8 0.1 0.0 0.0 0.4 5.9 1.1 0.1 0.2 0.5 0.1 0.1 0.9 0.3 0.2 0.0 0.8 0.1 0.1 0.4 0.9 0.1 0.0 0.0 0.3 0.1 0.1 1.8 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 1.3 0.5 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.3 61.3 0.0 0.2 0.2 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.0 2.8 0.0 2.1 0.3 0.1 0.0 0.1 2.6 0.1 0.9 9.6 0.1 0.1 0.6 0.2 0.0 10.7 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.1 1.0 1.0 1.1 1.5 0.9 0.8 1.1 1.0 0.8 1.1 0.8 0.9 1.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 1.8 0.0 1.9 0.1 0.0 0.0 3.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 9.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 27.0 0.1 0.1 0.0 0.0 THAP6 MGC30052 ENSG00000174796 "THAP domain containing 6" Q8TBB0 4 75513946-75550473 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035767 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA035767: AB_10696510" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.52e-1)" "unprognostic (6.89e-2)" "unprognostic (8.96e-2)" "unprognostic (3.37e-3)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (9.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.47e-2)" "unprognostic (8.54e-2)" "unprognostic (2.38e-2)" 9.9 11.4 6.4 12.7 12.0 12.8 15.5 13.8 10.8 10.0 8.3 10.0 12.5 16.7 12.8 9.4 10.7 9.1 14.7 7.4 9.4 9.9 12.6 9.4 15.9 10.1 9.4 6.0 14.9 8.6 12.5 9.5 9.7 11.0 13.6 11.8 21.9 13.4 10.3 15.4 16.8 13.3 10.8 6.5 12.6 11.1 23.7 9.4 9.2 15.6 13.8 12.2 9.3 8.6 20.9 8.5 6.2 13.4 9.2 14.8 14.9 6.9 19.8 10.1 10.5 10.8 7.3 20.7 11.5 10.0 6.6 11.8 8.8 12.4 8.8 12.8 14.1 8.5 8.8 10.5 9.3 20.0 12.8 9.5 12.3 16.9 11.7 18.3 16.5 5.9 14.8 16.2 25.0 11.3 10.4 11.1 8.2 6.8 12.2 5.8 11.0 14.5 8.5 9.9 6.5 10.0 10.3 9.6 12.6 11.8 11.0 14.1 10.2 6.8 17.5 11.6 20.8 9.8 22.4 12.3 11.5 11.9 9.5 14.9 17.2 8.4 12.7 9.0 7.4 12.2 8.6 10.9 8.6 7.0 10.2 12.2 9.5 18.2 6.9 8.3 5.7 13.3 6.6 6.4 12.0 13.8 10.8 7.4 9.4 10.1 9.4 6.0 11.0 6.5 9.4 20.9 11.0 12.8 11.0 21.9 19.8 8.3 14.7 12.7 14.8 20.2 13.0 10.5 17.0 18.6 11.5 22.0 31.3 10.8 13.5 8.9 15.6 8.3 131.8 13.1 13.5 8.5 12.6 12.6 11.0 6.4 8.8 16.0 8.6 8.4 10.8 18.0 9.3 9.8 7.2 16.8 15.6 12.8 6.1 14.0 6.5 23.0 14.0 9.6 7.2 13.1 11.5 13.3 8.2 18.6 35.9 8.0 11.5 11.3 17.5 11.4 16.7 15.7 20.6 18.9 0.0 10.0 13.7 56.0 16.6 12.2 6.8 7.7 18.1 15.5 7.5 7.7 CEP135 "CEP4, FLJ13621, KIAA0635" ENSG00000174799 "Centrosomal protein 135" Q66GS9 4 55948871-56033361 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 92.3;monocytes: 64.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.75e-1)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.06e-2)" "unprognostic (3.63e-1)" "unprognostic (3.42e-2)" "unprognostic (4.65e-3)" "unprognostic (4.78e-3)" "unprognostic (1.83e-3)" "unprognostic (9.89e-3)" "unprognostic (9.50e-2)" "unprognostic (2.27e-1)" "unprognostic (6.02e-9)" "unprognostic (7.55e-2)" "unprognostic (5.54e-2)" "unprognostic (1.95e-1)" "prognostic favorable (6.11e-5)" 2.6 1.7 1.2 7.2 1.4 10.2 2.9 2.0 1.6 3.3 2.2 2.4 3.1 7.7 2.1 2.0 3.3 3.1 1.4 1.1 1.6 4.0 1.3 3.2 10.3 1.7 1.5 0.8 5.1 1.7 2.0 1.2 6.0 1.7 2.3 3.2 3.7 1.5 1.6 0.8 3.9 3.3 5.0 1.2 5.7 2.2 6.5 1.7 9.6 2.6 1.3 7.7 2.9 2.2 1.9 8.9 4.8 13.0 12.3 2.6 5.0 5.5 8.6 6.1 7.7 9.0 5.2 9.0 23.7 6.4 3.8 6.0 4.0 13.8 5.2 14.6 6.5 8.4 8.3 7.6 4.9 2.9 15.2 12.6 3.9 4.1 9.9 7.0 3.4 6.5 11.9 15.4 11.0 8.1 5.2 21.3 9.5 8.3 4.4 4.9 15.4 6.1 4.8 5.6 6.4 9.3 9.6 7.7 5.2 6.4 7.8 6.9 9.7 6.5 10.4 17.0 12.5 15.1 5.9 4.4 15.7 5.2 11.8 13.1 9.9 2.1 2.9 3.0 2.8 2.8 3.0 3.9 2.9 1.5 5.6 5.0 3.1 4.3 4.7 3.2 5.6 2.7 1.4 1.2 1.4 2.0 1.6 1.1 1.6 1.7 1.5 0.8 1.7 1.2 1.7 1.9 16.3 6.4 12.4 7.8 30.2 9.1 8.2 6.3 7.4 12.6 5.6 6.6 8.5 2.8 9.4 7.3 10.4 20.0 27.3 5.2 3.9 9.4 92.3 23.1 14.6 18.2 5.4 28.2 10.0 5.4 16.3 11.5 3.1 13.0 14.5 38.2 12.5 1.7 10.4 26.9 10.4 5.5 6.1 12.9 11.3 19.4 5.9 19.2 5.4 19.7 64.5 4.3 32.0 8.0 13.9 15.6 6.7 8.2 16.7 5.2 3.0 10.0 17.4 24.5 6.6 16.2 11.2 57.3 38.7 6.8 6.7 9.6 20.0 34.6 5.7 6.3 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955395 "CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 121.1" "Cell type enhanced" "Detected in many" "Adipocytes: 83.0;Collecting duct cells: 36.8;Endothelial cells: 51.2;Hepatic stellate cells: 99.6;Sertoli cells: 32.9" "Cancer enhanced" "Detected in all" "renal cancer: 22.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 63.6;Hep G2: 85.2;HSkMC: 46.0;HUVEC TERT2: 93.6;TIME: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 121.1 9.6 6.5 5.9 5.8 0.3 56.0 5.0 7.4 11.9 7.7 13.1 2.8 12.3 7.6 6.6 16.5 11.6 24.0 5.4 5.7 27.4 14.7 33.2 6.3 6.4 6.2 4.9 13.1 9.6 6.5 8.8 11.8 6.5 12.6 6.4 1.1 12.3 30.5 31.7 5.6 8.9 13.5 5.0 14.2 14.3 5.1 7.0 3.9 18.2 41.0 4.6 10.6 9.6 6.7 1.3 1.1 2.7 5.2 63.6 16.5 3.7 8.4 7.6 3.2 3.3 7.1 0.9 0.0 1.8 2.6 4.4 2.8 3.1 1.3 2.5 0.2 2.1 2.8 2.3 85.2 18.9 0.0 0.1 46.0 0.5 2.8 0.5 7.5 93.6 0.1 3.9 0.4 2.2 2.2 0.0 0.0 3.9 7.5 18.8 0.1 4.8 0.2 9.0 13.7 0.6 0.8 3.5 1.0 1.4 5.6 12.0 0.0 46.3 7.8 5.1 9.2 1.7 0.4 1.3 0.0 1.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 5.8 5.0 7.4 5.4 5.7 6.4 6.2 4.9 6.5 5.0 7.0 6.7 83.0 0.0 1.3 9.8 0.5 1.5 0.5 1.3 2.2 0.7 5.5 3.2 8.3 7.2 2.0 36.8 10.4 0.2 0.5 1.0 3.9 0.5 0.7 0.4 2.7 51.2 0.0 2.7 8.1 1.6 0.2 17.7 4.1 0.5 0.0 9.1 99.6 14.1 0.2 0.0 3.4 1.3 0.0 6.7 1.8 2.2 9.3 0.6 0.0 10.3 0.0 0.2 2.1 3.0 0.7 1.0 0.1 6.8 0.3 1.4 0.7 9.4 2.1 0.2 32.9 14.4 26.6 0.3 3.2 1.3 0.6 0.3 0.4 16.6 1.1 0.2 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314494-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 206.1;breast: 156.8" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "naive CD8 T-cell: 21.8" "Lineage enriched" "Detected in single" 144 "T-cells: 21.8" "Cell line enhanced" "Detected in many" "ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 43000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 206.1 13.0 2.7 39.7 2.7 0.4 156.8 2.2 4.0 81.4 2.3 31.6 7.9 52.6 7.0 19.8 61.3 32.6 29.0 2.1 2.5 18.4 3.6 36.8 6.2 3.1 2.6 1.6 24.1 11.8 3.4 8.9 68.0 2.4 18.0 7.5 0.4 18.3 19.5 15.9 46.3 27.5 26.8 1.9 7.2 26.6 5.0 3.5 5.4 35.3 6.5 2.6 63.9 62.0 3.1 0.0 0.0 4.9 0.0 492.4 481.9 0.3 222.2 330.1 16.3 15.1 0.1 0.0 0.0 5.8 451.1 0.0 0.0 0.2 0.2 3.5 0.0 0.0 0.0 0.1 3.3 97.5 0.0 0.0 516.8 0.0 21.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.4 3.2 2.5 0.0 1.4 9.5 0.0 0.2 0.0 0.0 2.8 7.6 0.0 1.2 0.0 13.4 0.5 0.4 0.1 0.0 0.8 794.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 2.6 0.0 0.1 3.1 21.8 0.0 0.0 0.0 0.0 0.0 2.5 2.7 2.7 2.2 4.0 2.1 2.5 3.1 2.6 1.6 2.4 1.9 3.5 3.1 15.0 0.0 0.0 1.3 1.3 12.5 0.0 0.0 0.6 0.1 1.2 1.5 2.2 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.2 0.3 5.3 155.4 5.8 0.0 0.0 0.0 0.0 2.5 166.9 13.3 3.1 0.0 0.0 2.5 0.0 6.0 0.0 0.0 0.0 0.0 0.3 14.4 2.3 74.9 1.6 12.4 1.9 0.6 2.9 1.0 0.0 0.0 0.3 0.0 20.3 0.1 0.0 0.0 0.1 0.0 0.1 32.9 5.5 59.3 0.1 0.1 0.8 8.2 4.4 6.9 1.1 0.0 0.1 BTC ENSG00000174808 Betacellulin P35070 4 74744759-74794523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 18.5;Respiratory ciliated cells: 43.1;Skeletal myocytes: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.1;MCF7: 5.8;RPTEC TERT1: 9.5;SK-BR-3: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 314000 "unprognostic (7.36e-2)" "unprognostic (4.99e-2)" "unprognostic (7.04e-2)" "unprognostic (7.76e-3)" "unprognostic (3.87e-3)" "unprognostic (1.01e-3)" "unprognostic (1.05e-1)" "unprognostic (7.17e-3)" "unprognostic (2.68e-2)" "unprognostic (8.81e-2)" "unprognostic (1.50e-2)" "unprognostic (5.35e-1)" "prognostic favorable (6.10e-5)" "unprognostic (2.33e-1)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (2.31e-3)" 2.5 1.7 1.5 1.9 0.9 0.0 4.1 0.4 0.9 2.7 3.4 18.4 4.3 3.3 7.0 11.1 7.7 6.2 0.4 0.9 1.1 4.5 1.1 4.7 0.1 1.0 1.0 0.9 0.9 3.0 7.4 1.6 0.4 0.8 4.6 7.5 4.2 6.9 4.5 0.4 13.8 6.9 10.1 1.1 0.1 6.2 0.6 0.6 0.2 5.9 1.0 0.5 4.7 2.0 0.8 3.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.1 0.0 16.1 0.0 3.3 0.0 2.3 0.5 0.0 0.1 0.0 0.0 0.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.2 0.3 0.1 2.6 0.1 0.0 0.0 0.1 0.4 5.8 0.1 0.0 0.0 1.7 2.4 0.0 0.0 0.0 9.5 4.6 0.2 0.0 2.4 6.4 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.3 2.8 0.3 0.0 0.0 2.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.9 0.4 0.9 0.9 1.1 1.0 1.0 0.9 0.8 1.1 0.6 0.8 2.9 9.6 10.8 0.0 0.0 0.6 3.9 3.7 0.0 2.4 3.9 1.4 0.9 4.3 12.2 11.0 2.1 0.5 0.0 6.1 0.0 4.1 2.0 18.5 1.3 0.7 12.0 0.0 7.7 5.9 0.0 0.7 8.6 10.7 0.0 6.7 2.9 0.4 0.1 0.0 3.2 9.9 10.2 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 10.4 0.0 2.5 0.3 3.3 4.9 0.0 0.0 4.3 1.7 1.1 43.1 5.7 0.0 18.5 5.6 0.0 0.2 8.4 3.0 0.3 0.2 1.2 7.3 7.6 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 601.3" "Group enriched" "Detected in many" 5 "Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8" "Group enriched" "Detected in many" 4 "liver cancer: 27.6;renal cancer: 44.3" "Group enriched" "Detected in many" 4 "cerebellum: 13.5;pons: 4.7" "Immune cell enriched" "Detected in single" 5 "NK-cell: 4.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 4.2" "Group enriched" "Detected in many" 4 "RPTEC TERT1: 250.0;T-47d: 653.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.6 3.5 0.8 0.5 1.0 0.6 19.8 13.5 2.1 2.4 1.5 4.8 75.5 0.7 15.9 0.2 1.0 22.2 0.4 1.1 0.7 601.3 129.2 0.3 0.7 1.5 1.9 0.6 0.3 16.7 0.0 0.6 0.5 4.7 0.3 8.3 3.0 0.4 0.8 0.3 1.7 125.9 0.8 0.6 0.7 2.8 0.6 1.0 0.3 0.3 0.1 0.2 0.3 0.3 1.6 7.6 1.2 0.8 0.8 0.3 0.4 3.0 1.2 0.3 0.2 1.0 106.6 1.0 0.7 1.3 5.9 0.5 3.4 0.2 0.6 0.6 10.3 2.0 0.9 2.8 45.7 0.0 1.1 0.9 0.3 0.7 0.4 0.2 0.8 0.0 0.4 0.8 1.6 0.8 6.0 0.7 1.4 1.2 1.5 3.6 0.4 7.3 1.6 250.0 0.3 0.6 6.7 1.7 1.8 0.2 6.4 653.8 0.9 0.5 1.3 1.3 0.9 1.1 8.8 1.2 0.6 1.0 0.6 0.5 0.1 0.1 0.0 0.7 0.1 0.2 0.6 0.2 0.8 0.0 0.4 0.2 0.3 0.1 4.2 0.0 0.5 0.0 0.3 0.8 1.0 13.5 2.1 1.1 0.7 1.5 1.9 0.6 4.7 0.6 1.0 1.6 0.2 0.0 0.0 2.0 4.1 0.1 0.0 0.1 0.0 0.4 20.2 3.3 0.5 72.9 0.0 57.0 0.0 0.0 0.9 27.4 138.9 1.2 8.6 1.1 0.5 0.4 6.6 0.0 2.8 2.0 0.1 0.5 0.5 4.9 0.0 0.2 1.1 47.9 0.2 0.0 1.9 7.8 0.0 0.9 0.3 9.0 0.0 4.9 0.0 1.9 0.0 0.3 2.1 3.0 0.7 1.5 7.4 0.0 0.0 0.1 280.0 1113.8 0.1 0.5 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.1 4.1 4.3 6.5 0.1 ADGRE1 "EMR1, TM7LN3" ENSG00000174837 "Adhesion G protein-coupled receptor E1" Q14246 19 6887566-6940459 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 6.8;lymphoid tissue: 14.9" "Group enriched" "Detected in some" 6 "Kupffer cells: 31.5;Macrophages: 13.2;monocytes: 13.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 166.4;eosinophil: 324.9" "Group enriched" "Detected in many" 18 "granulocytes: 324.9;monocytes: 105.0" "Cell line enhanced" "Detected in some" "A549: 7.9;BJ hTERT+: 10.5;GAMG: 10.9;HDLM-2: 26.5;HMC-1: 18.1;Karpas-707: 22.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA052809 Uncertain NA NA "HPA052809: AB_2681959" "unprognostic (2.06e-2)" "unprognostic (3.45e-1)" "unprognostic (1.32e-1)" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (6.93e-5)" "unprognostic (6.77e-2)" "unprognostic (1.18e-1)" "unprognostic (5.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-7)" "unprognostic (6.69e-2)" "unprognostic (3.33e-4)" "unprognostic (1.11e-2)" "unprognostic (1.35e-1)" 1.9 0.1 0.3 7.4 0.3 6.8 0.2 0.2 0.6 0.1 0.6 0.9 2.9 0.2 1.1 0.2 0.2 1.0 0.2 0.2 1.5 0.1 2.7 4.7 1.5 1.4 0.7 0.2 0.0 0.1 0.2 0.1 1.3 0.7 0.2 0.7 0.0 0.2 0.1 0.1 0.0 2.9 2.0 0.4 14.9 1.0 1.0 0.5 3.5 0.1 0.1 1.5 4.1 0.0 1.8 2.8 7.9 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 10.9 0.0 0.0 0.0 0.0 26.5 0.0 0.1 0.0 0.0 0.0 0.6 18.1 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 22.3 0.0 0.2 0.7 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.4 0.3 0.4 0.2 1.1 4.2 0.1 5.1 5.2 0.0 166.4 21.1 324.9 0.1 58.6 0.3 0.1 7.2 0.9 12.0 0.1 8.9 0.6 7.9 0.9 105.0 0.5 2.2 10.0 0.3 0.3 0.2 0.6 0.2 1.5 1.4 0.7 0.2 0.7 0.4 0.5 1.8 0.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.8 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.3 1.8 0.0 0.6 0.0 0.0 31.5 0.0 0.4 0.0 13.2 0.0 0.0 13.2 0.0 1.0 0.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 1.3 0.0 0.0 0.1 0.8 0.1 0.0 0.1 DENND6A "AFI1A, FAM116A, FLJ34969" ENSG00000174839 "DENN domain containing 6A" Q8IWF6 3 57625454-57693077 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 66.9;Inhibitory neurons: 65.4;Oligodendrocytes: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 18.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 18.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062618, HPA069725, HPA071711" Approved Supported Vesicles NA NA Vesicles "HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435" "unprognostic (6.20e-2)" "unprognostic (3.86e-2)" "prognostic favorable (9.21e-4)" "unprognostic (1.76e-1)" "unprognostic (7.75e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.36e-4)" "unprognostic (7.16e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-3)" "unprognostic (5.97e-3)" "unprognostic (1.12e-1)" "prognostic favorable (7.77e-6)" "unprognostic (3.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.61e-3)" "unprognostic (2.94e-1)" 11.6 7.4 3.6 8.9 5.3 12.8 13.1 13.5 7.1 11.0 4.1 9.4 7.2 12.9 10.0 11.5 10.3 8.4 8.1 3.4 9.0 9.0 7.7 10.6 12.7 5.2 5.3 2.9 21.1 5.3 11.5 6.7 11.9 6.4 10.0 9.3 10.1 8.5 11.8 7.1 8.7 9.3 11.4 4.5 13.0 9.8 8.0 5.1 12.0 14.1 9.9 10.5 10.8 10.6 8.9 16.8 13.5 18.0 11.0 9.4 10.6 10.2 8.6 11.0 10.5 8.2 8.7 18.4 19.9 3.6 8.9 9.2 8.8 14.4 18.2 8.9 5.1 12.9 15.7 15.1 6.7 9.0 12.1 8.9 11.3 13.0 7.2 18.7 10.6 15.2 21.1 10.8 21.1 7.6 7.3 26.2 14.9 10.2 10.6 9.3 10.9 10.7 14.8 12.8 28.1 6.1 22.0 17.1 13.9 12.5 7.7 9.1 14.7 16.7 12.7 6.8 13.6 22.8 15.7 22.2 20.7 14.8 19.9 18.9 18.7 1.0 1.4 2.4 1.1 2.9 0.8 2.3 2.4 1.3 1.2 3.4 2.6 1.5 1.9 1.4 1.0 1.3 1.0 3.6 5.3 13.5 7.1 3.4 9.0 5.2 5.3 2.9 6.4 4.5 5.1 8.9 28.8 19.2 8.2 31.3 14.5 12.9 11.8 10.6 12.0 16.2 9.9 9.1 20.8 11.5 10.0 5.5 8.4 6.4 21.4 5.7 3.9 8.1 22.2 10.1 25.6 16.0 3.0 16.2 66.9 10.9 4.4 15.7 10.2 17.1 2.5 24.1 20.7 11.1 11.1 10.1 65.4 5.5 12.2 34.3 9.9 11.3 11.8 16.8 3.6 47.8 16.8 10.2 20.6 42.3 74.3 18.9 3.5 14.3 9.5 8.4 6.5 8.9 8.0 14.5 6.6 19.2 18.3 13.3 5.0 14.1 10.7 2.3 19.6 16.7 6.1 13.0 PDE12 "2'-PDE, 3635, DKFZp667B1218" ENSG00000174840 "Phosphodiesterase 12" Q6L8Q7 3 57556274-57566848 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043171 Approved NA NA "HPA043171: AB_10794654" "unprognostic (2.79e-1)" "unprognostic (3.18e-1)" "prognostic favorable (2.85e-5)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (8.43e-3)" "unprognostic (1.27e-1)" "unprognostic (6.45e-2)" "unprognostic (2.10e-1)" "unprognostic (9.88e-3)" "prognostic favorable (3.63e-8)" "unprognostic (6.97e-3)" "unprognostic (1.32e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-1)" 7.7 8.7 4.0 8.4 4.9 14.0 6.1 5.4 4.7 5.3 4.4 7.3 9.2 5.7 3.9 9.1 4.2 7.1 5.8 4.7 5.7 8.1 10.7 5.6 9.0 4.2 4.1 4.5 4.8 9.9 9.2 4.4 7.3 4.3 6.4 6.8 7.3 6.0 6.5 8.5 5.0 7.2 6.9 4.4 7.1 7.3 4.2 4.2 7.0 7.2 8.0 8.2 8.7 4.9 6.3 19.5 18.8 11.5 21.3 14.6 10.3 20.8 16.1 15.3 17.8 15.8 24.9 12.9 31.6 5.9 14.6 23.7 12.5 24.8 16.8 14.5 14.7 12.7 23.5 15.4 19.3 16.6 31.1 23.5 14.2 11.3 21.5 19.0 9.3 15.6 16.1 19.4 22.3 16.3 15.0 28.0 10.2 17.8 15.1 32.0 10.5 9.4 23.0 14.4 22.3 10.2 16.0 17.3 20.2 17.4 9.1 15.0 17.6 19.3 14.7 13.7 28.1 26.4 21.9 34.2 27.4 17.3 24.1 22.2 20.6 9.3 8.7 10.9 12.7 12.3 6.7 10.2 11.3 10.2 11.4 12.4 12.4 2.3 14.9 13.8 5.3 13.5 10.2 4.0 4.9 5.4 4.7 4.7 5.7 4.2 4.1 4.5 4.3 4.4 4.2 6.3 15.9 25.6 21.9 32.0 20.0 36.8 18.5 13.2 14.8 21.0 17.9 10.0 10.8 22.8 14.8 31.3 12.5 19.0 23.9 17.9 5.9 10.0 1.3 15.5 19.3 14.6 12.5 20.4 50.8 9.8 11.3 14.6 12.8 21.7 19.7 12.8 13.6 27.8 15.0 26.9 49.0 10.8 10.2 18.5 16.8 1.3 10.5 16.1 12.4 26.2 15.8 18.3 17.5 47.7 56.6 9.0 9.8 12.4 20.4 18.6 14.8 16.5 8.9 31.1 6.6 32.7 15.1 18.6 10.3 21.7 39.6 20.5 19.2 19.7 19.5 19.1 GLMN "FAP48, FKBPAP, GLML, GVM, VMGLOM" ENSG00000174842 "Glomulin, FKBP associated protein" Q92990 1 92246402-92298987 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 39.4" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 102.2;Excitatory neurons: 97.8;Inhibitory neurons: 91.5;Oligodendrocyte precursor cells: 72.9;Rod photoreceptor cells: 148.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031446, HPA031448" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA031446: AB_2797222, HPA031448: AB_2673888" "unprognostic (4.20e-2)" "unprognostic (3.47e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.37e-2)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (7.32e-2)" "unprognostic (2.07e-3)" "unprognostic (4.59e-2)" "unprognostic (9.88e-2)" "unprognostic (1.81e-2)" "prognostic unfavorable (5.89e-8)" "unprognostic (7.33e-2)" "unprognostic (5.21e-2)" "unprognostic (1.89e-1)" "unprognostic (3.58e-1)" 3.5 4.6 4.2 6.2 5.7 7.6 7.1 7.8 6.3 4.7 4.8 4.7 3.7 6.0 5.7 6.5 3.8 4.1 5.3 5.4 4.8 4.5 3.9 3.9 8.4 3.5 4.6 5.4 5.0 3.0 5.3 3.8 5.6 4.8 5.1 4.9 39.4 2.7 3.8 5.2 9.4 4.5 4.7 3.9 4.4 3.9 8.2 4.0 8.7 6.2 4.5 8.8 5.4 4.3 5.6 21.5 8.8 26.7 14.6 9.1 14.2 25.0 15.0 12.5 18.6 16.2 16.2 8.3 22.1 23.4 8.9 27.1 16.2 14.3 13.5 25.4 16.8 20.7 29.1 16.5 16.5 9.0 38.7 14.7 11.2 7.5 21.1 9.3 7.3 19.7 19.6 24.9 12.9 23.7 4.8 23.7 27.8 40.2 10.9 17.4 19.1 36.7 14.9 20.6 20.9 24.3 12.7 25.3 24.1 15.6 15.4 11.5 34.9 13.9 12.8 12.5 22.3 22.4 11.7 18.1 28.6 4.8 36.8 7.7 0.0 0.6 1.2 3.0 1.4 5.5 2.6 3.0 3.6 2.1 1.8 2.8 3.2 0.1 7.4 0.7 1.6 2.6 1.5 4.2 5.7 7.8 6.3 5.4 4.8 3.5 4.6 5.4 4.8 3.9 4.0 5.6 6.8 9.6 8.3 29.7 16.7 8.9 13.7 16.2 12.0 28.3 7.6 6.7 10.0 7.2 8.5 12.9 102.2 15.1 31.6 2.9 1.9 5.9 1.7 4.9 13.6 7.9 10.7 12.8 97.8 5.2 12.1 10.5 9.2 5.4 8.2 10.7 5.7 2.1 8.3 26.9 91.5 4.4 10.2 3.9 7.7 1.1 12.5 7.1 8.8 28.1 6.8 14.2 37.0 72.9 46.0 5.3 3.3 7.9 12.2 9.6 2.3 9.7 4.0 148.1 6.6 10.5 18.9 19.8 30.1 9.4 8.9 15.7 28.3 15.0 5.5 7.7 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 3.9;choroid plexus: 5.9;fallopian tube: 10.4;lung: 3.5;testis: 8.9" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 230.5;Respiratory ciliated cells: 318.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.6" "HPA037493, HPA058203, HPA061365" Enhanced NA NA "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493" "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.0 0.2 3.1 0.0 1.2 0.0 0.2 1.7 0.7 0.5 5.9 0.0 0.0 0.3 0.1 0.0 10.4 0.2 0.0 1.2 2.1 0.1 0.1 3.5 0.0 3.9 3.5 0.4 0.1 0.7 0.0 0.9 0.0 2.8 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.1 8.9 1.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.2 1.7 0.7 1.2 2.1 3.9 3.5 0.4 2.8 3.7 1.5 1.6 0.2 3.2 1.1 13.7 0.2 0.0 0.2 5.4 0.0 0.3 0.8 0.6 1.1 0.0 42.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 49.8 230.5 1.3 0.1 1.8 0.0 3.9 0.0 0.0 1.2 0.0 4.6 1.3 0.3 0.0 0.0 0.1 0.0 3.8 0.0 6.1 0.0 0.0 9.8 0.9 0.7 0.0 2.8 0.1 1.7 0.0 5.0 15.8 0.1 0.0 0.4 0.0 0.1 0.0 0.5 318.9 0.2 0.0 0.7 1.6 28.4 2.7 0.0 0.0 0.0 0.5 5.4 0.1 0.1 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289145 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 49.2 55.2 28.4 28.7 30.7 16.8 47.9 34.0 41.7 42.6 35.0 49.0 57.1 53.9 34.8 51.4 46.1 25.7 57.6 28.6 34.2 51.1 150.7 45.3 23.0 33.7 31.3 25.7 42.4 86.7 40.9 74.7 34.8 33.0 47.7 38.0 12.4 51.5 29.9 97.0 43.2 47.8 41.5 33.5 36.2 56.5 36.7 32.3 21.8 50.4 59.8 24.9 45.7 41.0 37.1 80.7 131.3 39.4 72.6 130.0 138.7 73.8 114.4 122.3 95.5 94.3 126.0 95.5 67.9 111.5 161.4 107.8 119.9 60.7 107.9 75.6 77.7 72.0 42.5 93.3 158.7 147.4 59.3 61.5 97.4 144.4 98.6 158.9 76.6 91.3 67.0 80.7 114.8 84.3 199.3 71.3 64.4 40.3 147.4 136.6 54.9 61.2 203.9 81.9 70.9 58.5 57.9 62.5 106.7 103.4 49.6 155.5 43.5 81.0 80.8 69.0 165.3 54.1 78.1 86.0 63.0 125.4 56.2 90.2 19.4 95.6 20.6 71.3 141.4 78.4 95.9 60.6 67.2 116.4 82.4 48.0 55.3 9.4 51.2 140.0 141.6 54.9 99.8 28.4 30.7 34.0 41.7 28.6 34.2 33.7 31.3 25.7 33.0 33.5 32.3 37.1 63.4 38.5 48.0 6.2 52.2 36.1 88.1 170.4 38.1 27.1 84.4 92.7 34.5 82.9 115.5 46.0 22.9 114.3 42.6 66.8 64.6 137.9 28.1 42.1 84.8 53.6 87.4 21.0 1.9 149.4 248.5 90.4 55.0 42.8 29.9 38.8 49.2 172.0 105.4 26.9 3.9 140.9 116.0 38.4 44.9 48.6 75.5 45.0 72.9 8.4 40.8 73.7 28.8 10.1 10.4 132.1 93.3 82.4 92.4 195.2 202.2 135.2 101.4 34.0 39.5 60.8 150.0 61.0 56.8 63.3 46.3 154.3 36.5 88.1 107.2 112.1 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278175-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 293.8" "Cell type enhanced" "Detected in some" "Early spermatids: 75.7;Enteroendocrine cells: 49.6;Excitatory neurons: 17.7;Horizontal cells: 16.8;Late spermatids: 28.1" "Cancer enriched" "Detected in many" 5 "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.8;AN3-CA: 13.9;MCF7: 13.9;NTERA-2: 15.1;SCLC-21H: 61.5;SH-SY5Y: 28.5;T-47d: 13.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 0.4 3.4 86.3 0.2 71.3 1.6 0.3 24.4 293.8 0.6 6.0 0.9 0.6 0.4 0.0 0.8 0.6 0.2 0.3 220.8 45.5 0.5 0.4 0.7 0.1 26.6 30.4 70.9 0.4 3.4 0.1 46.3 0.5 34.9 0.6 0.2 1.1 0.3 0.0 0.1 1.3 0.6 0.2 15.4 0.6 1.0 5.1 37.8 1.3 0.4 0.0 0.0 0.3 0.5 47.9 0.4 0.8 15.8 13.9 0.2 0.3 2.0 1.0 1.1 2.0 0.1 0.4 0.0 0.1 0.3 0.2 0.9 0.2 3.6 0.0 0.3 1.5 1.4 0.0 0.5 0.0 0.0 0.1 1.1 0.0 0.3 0.1 0.0 0.3 0.0 1.6 0.2 2.1 0.9 13.9 2.1 0.3 15.1 0.0 1.0 6.8 0.0 0.1 0.1 0.8 61.5 28.5 0.1 7.6 0.6 0.7 13.3 0.2 0.0 1.8 0.7 0.5 0.6 0.3 0.4 0.6 4.2 0.4 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.3 71.3 24.4 293.8 220.8 45.5 26.6 30.4 70.9 34.9 15.4 37.8 47.9 0.8 0.0 0.5 2.9 0.2 0.6 0.3 1.4 0.6 2.3 1.6 1.3 0.7 1.5 0.8 0.0 0.0 1.4 0.7 0.1 0.0 0.2 75.7 5.7 0.6 0.4 49.6 0.0 17.7 0.2 1.6 0.7 2.0 0.6 0.0 0.5 0.4 0.1 0.2 16.8 11.7 1.5 0.0 0.0 0.3 28.1 0.6 0.4 0.0 1.9 0.1 0.7 0.0 1.5 2.7 0.6 0.1 0.4 0.9 0.3 0.2 0.2 6.8 2.6 0.0 0.9 0.7 6.0 0.9 0.6 0.4 1.2 1.4 0.1 0.4 0.3 AMY1B AMY1 ENSG00000174876 "Amylase alpha 1B" P04745 1 103687415-103696680 "Metabolic proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "salivary gland: 4644.3" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 19.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 70000000 "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (7.34e-2)" "unprognostic (2.59e-1)" "unprognostic (6.05e-2)" "unprognostic (6.08e-2)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 87.2 0.0 0.0 0.0 0.1 0.0 0.6 56.8 0.0 0.9 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.4 32.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4644.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 1.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.8 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NLRP6 "CLR11.4, NALP6, PAN3, PYPAF5" ENSG00000174885 "NLR family pyrin domain containing 6" P59044 11 278407-285388 "Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 40.2" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 9.9;T-cells: 2.6" "Group enriched" "Detected in some" 4 "colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8" "Region enhanced" "Detected in some" "cerebral cortex: 3.1" "Group enriched" "Detected in many" 4 "neutrophil: 15.4;non-classical monocyte: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 15.4;monocytes: 4.6" "Cell line enhanced" "Detected in some" "REH: 2.0;U-266/70: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043681, HPA048500" Supported NA NA "HPA043681: AB_2678614, HPA048500: AB_2680422" "unprognostic (6.37e-3)" "unprognostic (4.69e-2)" "unprognostic (4.26e-2)" "unprognostic (3.42e-2)" "unprognostic (6.40e-2)" "unprognostic (1.18e-2)" "prognostic favorable (4.23e-5)" "unprognostic (8.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (2.19e-1)" "unprognostic (3.11e-3)" "unprognostic (4.96e-2)" "unprognostic (2.14e-2)" "unprognostic (6.90e-3)" "unprognostic (3.69e-2)" 0.7 0.0 0.1 2.2 0.2 0.6 0.2 0.2 3.1 0.1 0.6 0.4 40.2 0.2 0.1 0.1 0.6 0.3 0.1 0.1 0.9 1.3 2.6 0.9 1.2 0.9 0.3 0.0 0.0 0.5 0.0 0.1 0.1 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 38.4 0.1 0.3 3.6 0.3 0.2 0.2 0.3 0.1 0.1 0.3 0.3 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.2 0.2 0.4 0.1 0.0 0.0 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 1.4 0.3 1.6 1.1 0.1 0.1 1.8 2.3 15.4 1.0 4.6 0.0 0.0 0.7 0.1 0.2 0.2 3.1 0.1 0.9 0.9 0.3 0.0 1.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.7 0.0 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.24e-1)" "prognostic favorable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favorable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 189.0 433.3 173.7 94.3 174.2 159.4 190.5 191.4 308.1 196.5 168.4 272.9 126.1 221.4 53.6 285.7 203.3 107.6 685.9 173.2 183.7 292.1 383.6 156.4 146.5 182.8 180.7 161.0 202.4 207.5 139.9 207.5 97.7 180.9 230.2 56.6 32.0 233.3 106.3 429.0 185.6 187.2 90.3 185.6 198.0 252.5 97.1 187.2 121.8 190.4 333.6 63.3 211.2 217.3 191.3 315.2 227.6 168.7 273.1 138.9 231.5 191.2 209.8 243.9 369.4 341.5 271.9 155.5 300.4 320.0 209.6 163.9 195.4 118.6 250.8 85.7 271.2 466.9 124.4 194.5 434.4 374.3 188.8 174.4 317.3 221.9 219.9 106.6 147.6 250.7 284.5 257.3 316.4 192.4 228.2 484.1 325.0 249.9 249.1 609.2 325.0 214.2 427.9 238.3 194.9 236.2 254.3 163.5 254.3 381.5 72.9 196.1 395.0 224.9 202.8 194.7 410.1 340.1 493.5 460.1 400.6 341.0 443.1 263.7 421.2 526.8 313.4 313.2 440.5 323.9 394.4 341.2 314.6 461.1 343.7 321.0 281.1 239.0 303.9 387.8 550.1 474.0 870.2 173.7 174.2 191.4 308.1 173.2 183.7 182.8 180.7 161.0 180.9 185.6 187.2 191.3 189.9 144.2 198.0 22.5 179.2 205.6 236.8 306.8 99.6 60.1 279.3 430.3 436.9 267.4 202.9 292.4 25.0 585.4 164.2 429.9 841.2 286.0 157.4 199.8 146.9 175.6 351.5 208.9 12.9 301.6 595.6 224.3 114.7 137.6 213.0 135.5 272.7 735.4 423.7 50.5 16.6 477.0 207.5 347.7 234.1 452.4 194.8 197.7 286.4 14.0 403.3 198.0 220.4 5.5 31.2 287.1 446.6 167.3 208.5 283.5 606.9 1107.9 176.7 89.6 118.3 174.3 210.0 97.2 91.8 162.5 243.5 593.4 156.9 159.0 451.1 241.3 RSRC1 "BM-011, MGC12197, SFRS21, SRrp53" ENSG00000174891 "Arginine and serine rich coiled-coil 1" Q96IZ7 3 158105855-158545730 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044792 Supported Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044792: AB_10794502" "unprognostic (1.06e-2)" "unprognostic (8.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (7.40e-5)" "unprognostic (5.18e-1)" "unprognostic (1.17e-1)" "unprognostic (3.60e-3)" "unprognostic (2.91e-2)" "unprognostic (2.86e-2)" "unprognostic (5.71e-2)" "unprognostic (2.53e-3)" "unprognostic (8.84e-2)" "unprognostic (7.98e-3)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (2.71e-1)" "unprognostic (2.15e-1)" 17.8 17.3 13.4 11.9 12.5 15.3 16.6 17.5 17.9 15.2 7.9 13.3 8.8 14.3 11.7 12.8 10.8 10.3 13.8 9.7 12.9 16.1 16.6 10.7 13.8 15.2 16.1 7.1 13.0 15.7 15.7 11.7 11.9 13.3 13.3 13.6 18.9 13.6 12.4 19.5 12.6 10.3 13.9 12.2 11.9 12.2 11.4 18.3 13.3 17.1 11.1 14.3 13.7 13.5 13.4 73.6 37.3 24.1 32.1 60.7 41.4 34.1 36.2 29.3 37.8 41.5 51.8 56.8 68.6 66.9 42.9 47.2 32.8 48.4 31.8 58.3 107.6 40.4 71.0 30.4 41.3 9.3 61.5 43.2 32.3 30.0 32.4 29.1 43.4 17.7 38.8 45.4 50.2 31.6 63.7 43.2 41.5 21.4 44.3 33.4 54.7 45.4 86.1 29.5 23.8 47.4 51.7 40.7 26.6 44.6 27.1 59.2 51.7 20.3 52.6 31.6 63.3 69.4 41.0 51.0 72.6 48.5 79.5 61.2 40.4 36.3 20.3 25.1 38.6 25.9 49.5 25.6 24.3 22.0 45.5 23.9 25.7 25.4 17.7 37.2 62.3 22.4 12.9 13.4 12.5 17.5 17.9 9.7 12.9 15.2 16.1 7.1 13.3 12.2 18.3 13.4 36.0 32.1 23.1 51.6 51.1 37.3 36.1 32.3 15.4 78.1 39.4 28.7 44.9 45.8 27.0 82.8 33.3 37.5 41.1 33.2 74.3 52.6 49.9 32.8 48.4 35.5 33.0 68.8 71.3 60.5 52.8 47.5 26.0 29.9 76.5 44.0 32.2 74.5 38.3 63.9 82.4 54.9 40.7 45.6 67.6 11.0 46.3 42.4 44.4 80.6 50.0 52.2 44.3 46.3 142.2 45.8 34.2 35.7 35.4 27.7 21.8 67.8 29.7 95.6 19.7 34.8 49.5 39.5 40.4 27.4 27.4 29.6 37.4 39.8 35.9 29.3 CATSPERD "MGC39581, TMEM146" ENSG00000174898 "Cation channel sperm associated auxiliary subunit delta" Q86XM0 19 5720637-5778734 "Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 120.2;Endometrial ciliated cells: 67.5;Late spermatids: 165.8;Respiratory ciliated cells: 149.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "HEL: 7.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA024056 Enhanced NA NA "HPA024056: AB_1858093" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (3.77e-3)" "unprognostic (9.91e-2)" "unprognostic (3.74e-2)" "unprognostic (6.85e-2)" "unprognostic (2.63e-3)" "unprognostic (2.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.50e-1)" "unprognostic (5.95e-8)" "unprognostic (2.54e-2)" "unprognostic (9.92e-2)" "unprognostic (2.83e-1)" "unprognostic (3.74e-2)" 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.0 2.2 0.7 0.0 0.4 0.2 4.7 0.0 0.0 0.3 0.6 0.5 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 120.2 67.5 0.7 0.5 0.0 0.0 1.3 0.2 0.1 0.4 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 8.2 0.3 0.0 165.8 0.6 0.2 0.0 1.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.4 0.1 0.2 0.0 0.0 149.9 0.0 0.0 0.5 2.0 18.7 1.2 0.0 1.4 0.3 0.1 0.0 0.0 0.1 RAB1B ENSG00000174903 "RAB1B, member RAS oncogene family" Q9H0U4 11 66268590-66277492 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010225, HPA056141" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "CAB010225: AB_2284660, HPA056141: AB_2683051" "unprognostic (6.07e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (2.90e-1)" "unprognostic (9.91e-2)" "unprognostic (2.61e-2)" "unprognostic (2.04e-3)" "unprognostic (2.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.09e-5)" "unprognostic (2.41e-2)" "unprognostic (9.45e-2)" "unprognostic (9.42e-2)" "unprognostic (5.85e-2)" 123.2 130.8 112.2 84.8 107.0 91.9 122.0 108.7 138.9 107.5 95.0 128.8 113.5 112.1 83.0 182.4 106.6 83.8 134.7 108.1 106.0 127.5 127.4 117.5 91.0 115.1 111.8 102.4 104.3 97.0 134.0 113.5 89.1 109.8 141.8 91.1 46.9 129.1 106.1 235.4 145.5 113.8 87.6 109.9 126.3 126.5 80.5 113.5 106.5 112.4 154.1 86.8 114.5 120.2 109.8 226.5 248.0 126.2 166.1 205.6 150.9 113.8 182.7 212.8 232.2 163.4 141.4 223.7 91.7 235.7 263.1 172.1 209.0 140.7 253.9 125.9 190.3 128.0 144.7 156.0 124.2 135.0 124.3 258.2 158.7 212.4 199.6 102.4 163.2 221.1 144.9 153.1 158.8 223.6 434.5 219.1 197.1 131.5 196.1 230.8 133.0 101.8 237.2 234.7 204.5 122.9 137.1 132.7 319.2 133.7 91.4 487.5 141.6 228.1 221.4 152.9 267.9 164.9 89.9 77.9 121.5 251.2 104.3 207.8 173.1 199.8 329.3 227.5 211.9 171.7 109.8 135.5 188.1 163.0 130.2 115.3 140.6 420.5 203.5 243.9 188.3 165.5 375.6 112.2 107.0 108.7 138.9 108.1 106.0 115.1 111.8 102.4 109.8 109.9 113.5 109.8 56.3 38.5 59.6 7.8 41.7 33.6 31.4 42.4 53.5 22.0 55.0 53.1 1.1 40.0 47.9 36.8 29.2 56.2 50.8 137.1 50.9 49.3 13.4 41.3 38.6 50.6 54.0 27.1 7.2 71.3 84.2 36.5 58.1 44.9 53.8 24.6 48.9 47.8 54.2 16.8 8.0 85.0 36.7 55.2 26.4 27.2 35.8 51.4 24.9 5.6 47.7 37.8 43.3 5.5 13.1 71.6 80.6 42.2 61.0 41.4 79.6 49.5 36.0 18.2 39.5 36.2 39.7 23.8 17.4 64.5 42.1 80.2 57.4 28.1 64.9 43.5 OR9G1 OR9G5 ENSG00000174914 "Olfactory receptor family 9 subfamily G member 1" Q8NH87 11 56699095-56703884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTDSS2 PSS2 ENSG00000174915 "Phosphatidylserine synthase 2" Q9BVG9 11 448268-491399 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 144.6;Late spermatids: 347.6;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEK 293: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038928, HPA038929" Approved NA NA "HPA038928: AB_10672832, HPA038929: AB_2676274" "unprognostic (3.41e-1)" "unprognostic (2.52e-1)" "unprognostic (2.07e-1)" "unprognostic (5.75e-3)" "unprognostic (3.19e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.12e-9)" "unprognostic (6.18e-2)" "unprognostic (1.09e-1)" "unprognostic (1.89e-2)" "unprognostic (1.41e-3)" "unprognostic (6.41e-2)" "unprognostic (1.11e-2)" "unprognostic (3.39e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" 13.0 21.5 6.6 2.3 8.7 2.3 12.6 8.3 8.3 16.1 7.1 14.0 1.6 15.5 3.8 12.1 14.8 4.0 23.9 6.0 6.2 21.1 13.7 12.9 2.3 10.3 9.2 5.3 22.1 19.1 13.7 13.8 5.8 8.6 17.2 2.3 3.2 11.5 5.2 17.9 11.7 10.5 4.9 7.3 12.7 15.6 47.6 8.2 3.3 17.5 5.6 2.0 14.3 12.1 12.5 15.7 15.6 12.8 18.5 11.0 18.2 15.9 13.1 15.5 16.7 14.7 4.1 10.5 8.3 11.0 17.0 15.1 25.4 15.7 20.8 8.0 13.9 67.2 10.5 11.9 9.6 21.3 13.9 8.8 20.8 15.2 5.8 10.1 14.6 13.2 9.8 30.9 2.5 13.3 2.2 13.9 13.3 18.1 12.4 36.8 14.7 14.4 4.1 11.9 3.1 19.3 10.6 18.4 11.9 15.2 13.9 4.3 8.1 16.1 7.7 5.1 3.9 8.5 10.3 4.8 3.6 13.5 6.4 5.6 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 6.6 8.7 8.3 8.3 6.0 6.2 10.3 9.2 5.3 8.6 7.3 8.2 12.5 10.3 0.0 6.1 18.6 6.2 4.8 8.3 6.1 6.2 36.9 11.1 11.0 20.1 5.7 6.7 7.3 29.2 19.6 3.0 12.5 5.9 13.3 144.6 7.1 11.1 11.4 16.1 8.2 21.1 13.1 21.3 12.9 9.7 7.5 0.0 30.1 9.3 6.0 17.2 21.9 17.8 7.6 8.2 4.7 4.2 347.6 17.1 6.9 5.4 5.6 5.8 22.7 2.1 18.6 26.8 11.7 6.9 15.4 9.5 10.5 7.0 17.7 4.9 29.8 6.6 11.3 12.9 98.2 24.7 8.2 5.1 17.4 4.9 34.1 9.0 6.1 MICOS13 "C19orf70, MIC13, P117, QIL1" ENSG00000174917 "Mitochondrial contact site and cristae organizing system subunit 13" Q5XKP0 19 5678421-5680516 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 344.8;Cytotrophoblasts: 154.4;Extravillous trophoblasts: 196.7;Hofbauer cells: 242.2;Syncytiotrophoblasts: 125.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favorable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 71.6 69.5 122.8 48.9 125.1 54.6 59.8 137.2 181.6 44.2 116.7 77.3 79.3 47.3 44.4 87.7 67.9 54.2 273.8 122.3 135.6 94.0 78.9 44.6 60.9 133.4 125.9 120.8 45.1 87.4 98.3 60.3 38.2 129.9 50.5 41.1 18.8 96.2 61.2 282.0 59.3 67.3 44.2 125.9 45.4 62.3 150.4 133.8 39.2 58.4 188.1 35.4 61.8 49.7 130.9 175.7 167.9 43.4 87.6 98.3 117.1 58.7 100.7 121.0 142.6 120.3 132.6 85.2 82.0 157.6 105.2 65.3 124.7 25.8 175.5 34.6 128.9 311.9 76.1 101.2 153.4 162.5 105.8 79.2 133.0 157.9 71.5 92.6 68.0 104.9 112.5 120.5 220.6 101.2 186.3 145.7 129.2 45.1 118.5 474.3 79.5 57.8 286.7 145.3 126.1 111.5 134.8 37.8 198.1 152.2 25.2 128.3 123.8 87.4 121.9 50.5 217.4 169.2 315.8 280.6 66.9 174.5 183.6 126.0 76.8 214.3 77.8 198.9 274.7 237.5 291.6 228.5 225.8 261.4 235.7 222.8 211.3 29.6 192.1 238.8 302.5 211.1 278.1 122.8 125.1 137.2 181.6 122.3 135.6 133.4 125.9 120.8 129.9 125.9 133.8 130.9 44.6 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 344.8 0.0 0.0 0.0 0.0 154.4 24.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 196.7 46.9 0.0 0.0 0.0 0.0 0.0 0.0 242.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 125.9 5.8 0.0 0.0 0.0 C3orf33 "AC3-33, FLJ31139" ENSG00000174928 "Chromosome 3 open reading frame 33" Q6P1S2 3 155762617-155806278 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037663 Uncertain "Secreted in other tissues" NA NA "HPA037663: AB_10672610" "unprognostic (1.18e-1)" "unprognostic (9.39e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-3)" "unprognostic (1.31e-1)" "unprognostic (7.27e-2)" "unprognostic (6.31e-3)" "unprognostic (3.28e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic favorable (6.48e-7)" "unprognostic (3.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (1.56e-1)" 2.8 10.8 5.2 1.3 5.6 2.0 4.3 5.3 7.8 3.9 5.9 2.9 2.6 3.8 5.8 1.7 3.9 2.3 6.2 5.6 5.4 6.3 3.2 3.3 1.6 5.4 5.4 5.1 4.6 6.7 7.5 5.0 1.3 5.5 4.5 2.3 2.8 3.3 3.9 5.0 1.3 2.3 3.3 5.4 2.3 3.2 4.2 5.6 1.5 8.7 4.4 1.0 2.8 2.5 5.6 5.5 7.5 3.6 4.9 0.3 4.4 1.5 2.4 3.5 2.2 5.2 2.6 6.9 0.9 5.3 2.3 3.3 0.8 3.7 0.0 3.9 2.7 5.4 3.3 1.0 7.0 6.0 4.8 1.1 3.4 4.0 2.4 4.6 2.8 3.8 5.5 5.4 2.4 3.8 4.1 4.9 4.0 4.6 5.2 1.8 4.8 1.8 5.2 12.2 2.7 2.6 3.6 5.3 6.7 4.6 1.8 9.8 5.7 2.3 2.5 1.8 5.5 5.9 4.1 4.3 0.0 1.8 4.4 2.6 2.1 1.2 0.2 4.0 1.1 5.1 1.8 3.1 3.6 2.1 1.4 3.9 4.1 0.1 4.0 0.8 1.7 2.2 2.1 5.2 5.6 5.3 7.8 5.6 5.4 5.4 5.4 5.1 5.5 5.4 5.6 5.6 1.6 3.2 6.7 13.7 1.5 1.3 5.2 4.7 5.2 8.5 3.1 2.7 11.9 5.7 6.7 0.0 6.2 4.2 0.9 1.8 5.9 3.7 6.6 1.5 2.7 2.3 3.6 3.8 14.9 3.3 3.1 4.8 1.1 1.4 7.0 2.8 2.5 3.3 2.4 6.7 14.9 3.8 4.1 0.3 2.0 5.4 6.2 1.4 1.8 3.7 0.6 15.6 6.2 11.6 10.7 1.4 2.5 7.9 2.2 5.1 1.0 7.0 3.5 7.6 0.0 8.4 4.1 14.5 14.8 2.7 1.4 3.7 2.8 3.8 3.7 2.5 OR5M3 ENSG00000174937 "Olfactory receptor family 5 subfamily M member 3" Q8NGP4 11 56469274-56473352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEZ6L2 "FLJ90517, PSK-1" ENSG00000174938 "Seizure related 6 homolog like 2" Q6UXD5 16 29871159-29899547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 139.2;pituitary gland: 92.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 236.6;Cone photoreceptor cells: 185.6;Enteroendocrine cells: 132.5;Horizontal cells: 188.4;Rod photoreceptor cells: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064471 Enhanced NA NA 5600000 "HPA064471: AB_2685271" "unprognostic (2.56e-2)" "prognostic unfavorable (7.46e-4)" "prognostic unfavorable (1.31e-4)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.27e-1)" "unprognostic (1.67e-2)" "unprognostic (2.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.85e-1)" "unprognostic (1.43e-3)" "unprognostic (8.31e-2)" "unprognostic (1.04e-1)" "unprognostic (8.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.08e-1)" 2.9 23.4 37.9 1.4 46.4 0.1 4.5 39.3 99.5 11.9 0.0 4.5 10.4 9.0 0.7 1.1 4.0 9.7 1.6 46.2 73.7 7.6 0.6 4.5 0.9 64.8 39.5 46.3 5.5 41.5 21.4 92.6 3.0 69.7 14.6 3.4 26.0 22.3 4.3 1.0 2.1 5.8 4.1 19.7 1.9 16.7 11.3 69.3 0.4 1.0 0.1 1.4 3.1 1.8 139.2 1.4 11.6 0.9 11.0 0.1 0.5 7.7 14.4 6.7 13.3 7.3 17.2 53.8 5.8 76.7 17.5 11.1 4.9 4.4 3.4 4.0 0.1 9.6 0.9 9.2 35.7 28.7 0.0 33.9 32.3 6.5 15.8 4.3 48.1 1.0 5.1 1.8 34.5 6.7 59.4 0.2 0.1 17.2 19.6 19.8 0.0 0.0 1.6 12.1 5.1 51.3 41.2 4.9 36.5 2.3 9.1 34.3 51.3 0.6 44.3 21.6 0.3 0.9 3.9 3.6 0.3 53.8 9.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 46.4 39.3 99.5 46.2 73.7 64.8 39.5 46.3 69.7 19.7 69.3 139.2 3.2 3.2 16.4 4.2 0.8 2.9 9.4 6.2 2.8 236.6 49.6 30.6 8.6 77.2 5.5 3.7 185.6 0.3 0.5 19.9 0.0 61.7 2.8 25.1 48.2 4.9 132.5 0.0 28.6 39.4 2.7 12.2 34.7 33.4 1.3 3.5 2.5 0.2 1.3 188.4 46.3 32.9 10.2 0.3 0.0 5.4 1.2 1.0 12.4 3.7 0.6 20.8 0.0 5.5 13.1 45.2 22.1 1.9 1.4 23.5 15.3 5.0 3.4 230.3 13.1 0.9 15.2 8.2 4.7 1.0 1.4 1.4 0.7 26.8 29.0 9.1 ASPHD1 ENSG00000174939 "Aspartate beta-hydroxylase domain containing 1" Q5U4P2 16 29900375-29919864 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 139.7;choroid plexus: 78.1;pituitary gland: 36.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 27.1;Enteroendocrine cells: 29.4;Excitatory neurons: 25.1;Gastric mucus-secreting cells: 32.1;Inhibitory neurons: 22.6;Oligodendrocytes: 29.3;Pancreatic endocrine cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 61.7;Hep G2: 79.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045175 Uncertain NA NA "HPA045175: AB_10959899" "unprognostic (1.58e-1)" "unprognostic (5.50e-2)" "unprognostic (4.74e-3)" "unprognostic (2.20e-3)" "unprognostic (1.34e-3)" "unprognostic (6.96e-2)" "unprognostic (5.75e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (8.37e-2)" "prognostic favorable (7.38e-4)" "unprognostic (5.55e-2)" "unprognostic (6.17e-2)" "unprognostic (1.97e-2)" "unprognostic (1.90e-1)" "unprognostic (2.97e-1)" "unprognostic (9.03e-2)" 2.7 5.2 111.1 0.7 114.5 0.1 0.8 102.0 139.7 0.9 78.1 1.1 2.5 3.1 0.1 0.4 1.3 15.0 0.6 106.0 100.4 4.4 0.7 1.2 0.2 110.7 112.1 98.5 1.3 9.2 0.8 36.7 0.3 128.7 1.5 0.9 2.3 4.9 0.5 0.2 0.3 1.8 1.4 107.2 0.3 21.1 6.0 109.4 0.0 0.1 0.2 0.2 0.8 0.4 112.0 3.3 14.5 0.0 16.7 0.0 2.4 0.9 15.8 5.1 18.0 12.9 35.1 61.7 6.2 39.4 10.5 13.0 2.4 2.0 4.2 3.4 1.0 2.4 3.1 50.9 79.1 29.1 0.7 40.5 18.3 3.9 26.7 2.7 19.4 0.7 11.3 0.2 13.1 4.3 32.1 0.9 0.6 23.0 13.7 13.8 1.2 0.0 2.5 18.4 0.4 47.3 19.3 0.2 26.1 5.2 0.3 10.0 11.9 1.2 7.5 13.2 0.4 4.5 1.1 0.4 0.6 23.7 41.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 111.1 114.5 102.0 139.7 106.0 100.4 110.7 112.1 98.5 128.7 107.2 109.4 112.0 0.7 0.0 5.1 4.9 0.1 0.6 4.8 2.5 0.0 19.2 4.3 3.9 0.3 27.1 0.5 1.8 4.2 0.0 0.0 2.6 1.9 17.3 1.9 0.7 9.4 0.9 29.4 0.0 25.1 20.2 0.4 7.8 32.1 1.4 1.3 0.5 0.0 0.2 4.0 6.7 22.6 4.2 6.1 0.0 0.3 1.2 0.3 0.9 1.8 5.6 0.0 1.7 0.0 9.0 29.3 29.3 0.3 0.7 0.1 8.1 1.7 3.7 0.3 10.2 0.0 0.2 2.5 1.2 1.0 0.0 0.6 0.3 0.2 4.8 4.2 2.8 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29926236 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA043524: AB_2678528" "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavorable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favorable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 6.0 7.6 24.7 7.9 26.5 8.6 5.5 14.9 35.1 5.0 14.9 6.3 7.4 5.1 9.9 6.0 8.4 7.8 4.4 32.5 22.2 3.9 3.5 4.6 9.8 19.7 18.2 26.7 7.6 7.6 8.0 3.7 4.5 19.3 6.7 6.6 9.4 6.6 8.0 2.7 12.3 7.1 5.2 17.5 7.7 5.9 36.7 19.6 9.6 5.8 2.4 7.1 6.1 2.7 26.1 9.7 12.4 6.2 15.5 10.0 8.1 12.5 5.8 7.2 5.7 8.9 3.5 12.6 17.4 11.3 8.5 9.6 14.4 6.8 5.5 4.4 26.5 17.0 3.7 7.1 6.0 13.7 9.2 15.9 10.2 15.3 11.6 8.7 6.1 4.7 19.9 9.1 14.8 7.9 28.1 18.7 14.2 3.6 5.0 6.0 13.9 4.5 9.0 7.8 9.1 15.5 15.4 2.4 7.0 31.7 5.8 10.1 7.2 10.0 5.0 5.1 15.3 10.6 12.4 5.3 3.9 12.0 10.4 14.4 7.2 3.3 8.0 2.9 2.6 3.0 3.0 5.4 5.0 3.5 2.4 5.0 4.7 11.1 3.1 4.4 3.8 4.4 1.9 24.7 26.5 14.9 35.1 32.5 22.2 19.7 18.2 26.7 19.3 17.5 19.6 26.1 7.1 0.0 9.7 20.9 10.6 6.0 5.7 10.4 12.5 9.9 8.5 8.0 3.4 5.7 5.8 0.0 8.4 5.3 7.9 5.2 3.9 6.9 17.9 9.1 6.8 4.7 7.7 3.0 15.4 4.2 5.1 6.5 4.6 8.7 2.5 10.9 6.4 2.4 7.6 5.0 20.5 7.2 10.2 4.4 5.6 9.0 6.2 6.3 8.8 12.2 5.7 5.0 11.3 17.6 28.9 11.0 7.4 6.4 3.6 8.7 6.5 2.9 6.3 6.5 0.0 5.0 7.8 20.6 26.5 12.4 9.1 6.7 10.6 5.8 6.1 7.0 P2RY14 "GPR105, KIAA0001" ENSG00000174944 "Purinergic receptor P2Y14" Q15391 3 151212117-151278542 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 32.0" "Cell type enhanced" "Detected in many" "Astrocytes: 31.0;dendritic cells: 54.4;Endometrial stromal cells: 35.5;Excitatory neurons: 41.2;granulocytes: 45.7;Langerhans cells: 61.3;Oligodendrocyte precursor cells: 29.1;Sertoli cells: 26.3;Smooth muscle cells: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "eosinophil: 230.1;plasmacytoid DC: 98.0" "Group enriched" "Detected in many" 9 "dendritic cells: 98.0;granulocytes: 230.1" "Cell line enriched" "Detected in single" 68 "HMC-1: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022646 Uncertain NA NA "CAB022646: " "unprognostic (9.78e-2)" "unprognostic (7.47e-4)" "unprognostic (3.89e-2)" "unprognostic (4.52e-4)" "unprognostic (1.69e-2)" "unprognostic (2.57e-5)" "unprognostic (2.68e-2)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (1.64e-3)" "unprognostic (6.30e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.72e-5)" "unprognostic (3.79e-2)" "unprognostic (6.89e-2)" "unprognostic (1.58e-1)" "unprognostic (2.58e-2)" 7.9 0.8 3.7 10.9 4.3 0.7 7.1 4.1 6.0 5.9 20.8 11.8 7.0 8.1 0.6 20.4 1.1 5.3 5.3 3.7 2.6 2.0 1.0 7.2 9.7 2.7 2.9 3.7 1.5 0.7 2.5 0.9 32.0 3.6 0.7 9.8 0.4 1.2 1.3 2.6 1.9 12.1 4.1 1.7 5.7 11.3 0.5 3.5 4.8 2.6 6.4 6.8 9.3 1.2 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 67.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 10.3 0.4 230.1 1.1 0.3 19.0 3.7 0.6 2.2 13.8 17.0 0.1 0.0 8.9 11.7 0.1 98.0 1.1 2.0 3.7 4.3 4.1 6.0 3.7 2.6 2.7 2.9 3.7 3.6 1.7 3.5 4.1 5.8 3.2 0.5 31.0 13.9 2.3 0.0 0.0 0.0 2.1 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.1 54.4 0.0 0.0 0.0 0.4 1.0 35.5 5.9 0.0 0.4 41.2 0.0 0.2 3.9 0.0 0.7 45.7 0.0 0.0 0.0 0.6 0.0 16.4 0.0 0.0 0.8 61.3 0.5 0.0 22.7 3.6 5.6 1.2 0.4 1.0 29.1 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.4 26.3 1.6 29.3 0.0 0.1 0.2 1.7 0.3 4.8 1.5 0.1 0.1 AMZ1 KIAA1950 ENSG00000174945 "Archaelysin family metallopeptidase 1" Q400G9 7 2679522-2775500 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "brain: 7.8" "Cell type enriched" "Detected in some" 5 "Oligodendrocyte precursor cells: 104.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 7.0;MCF7: 7.5;SK-BR-3: 5.2;T-47d: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020233 Uncertain NA NA "HPA020233: AB_1844818" "unprognostic (9.08e-3)" "unprognostic (1.66e-1)" "unprognostic (3.23e-3)" "unprognostic (1.81e-1)" "unprognostic (5.72e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-2)" "unprognostic (3.42e-1)" "unprognostic (1.98e-1)" "unprognostic (7.16e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (3.64e-9)" "unprognostic (1.60e-3)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" 0.0 0.0 7.8 0.2 6.3 0.4 0.1 3.7 4.8 0.9 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.1 0.1 3.9 2.0 0.0 0.8 0.5 0.2 3.9 3.9 5.4 0.2 0.1 0.0 0.6 0.8 4.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.8 0.4 0.0 0.6 6.5 0.0 0.0 0.0 0.3 0.1 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 7.0 2.3 3.4 1.6 2.2 0.0 1.0 0.6 0.2 2.2 0.2 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.5 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 5.2 0.0 0.1 27.7 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.2 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.8 6.3 3.7 4.8 3.9 2.0 3.9 3.9 5.4 4.2 0.8 6.5 2.1 0.1 0.0 0.5 14.4 0.9 0.0 0.1 0.0 0.0 0.8 0.3 0.3 3.3 0.0 0.0 0.0 4.2 0.3 1.6 0.0 0.0 0.0 18.8 0.5 1.6 0.4 0.0 0.0 6.1 0.0 9.8 0.3 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 10.6 0.2 0.0 0.0 1.9 9.9 0.0 1.7 1.8 5.6 0.0 0.0 0.0 104.5 20.7 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.1 0.8 0.0 0.0 0.1 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203216 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enriched" "Detected in some" 4 "T-cells: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 110.3" "Lineage enriched" "Detected in many" 15 "T-cells: 110.3" "Cell line enriched" "Detected in some" 25 "U-266/70: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 2.8 1.6 0.6 21.5 1.5 1.2 1.9 1.6 3.8 4.4 9.9 4.4 4.6 1.5 0.5 2.5 3.0 6.3 0.7 1.1 1.3 1.3 4.4 6.5 17.6 2.6 0.6 1.1 0.9 0.7 0.2 0.5 0.5 0.8 1.9 4.6 0.0 1.8 0.8 0.2 0.9 13.0 1.1 0.0 13.1 6.0 0.3 1.2 13.2 1.8 0.1 11.4 9.4 2.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 3.5 27.9 0.2 110.3 0.0 40.2 53.5 2.3 0.5 24.1 21.1 0.8 7.3 0.5 2.2 21.4 9.4 0.6 1.5 1.6 3.8 1.1 1.3 2.6 0.6 1.1 0.8 0.0 1.2 2.4 0.4 0.0 2.2 0.3 2.3 1.1 0.4 0.0 0.6 4.8 0.3 0.3 1.0 0.0 1.3 0.0 2.1 0.4 25.8 0.1 0.0 0.0 0.2 0.1 0.6 0.5 0.0 2.7 0.8 0.0 0.0 2.3 4.6 0.1 2.5 0.0 1.8 1.6 0.1 21.9 0.3 0.5 0.0 2.2 8.1 0.1 0.0 4.8 0.0 0.0 14.0 5.7 6.2 0.5 0.0 0.0 0.0 0.0 14.9 0.2 0.0 0.5 0.0 0.1 0.0 0.5 1.2 0.8 0.7 0.1 0.6 0.7 107.6 0.1 0.0 0.3 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154334943-154430190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.6" "Cell type enriched" "Detected in some" 22 "Inhibitory neurons: 48.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in many" HPA018020 Uncertain NA NA "HPA018020: AB_1849334" 0.0 0.0 0.6 0.0 6.6 0.0 0.0 1.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.5 1.4 0.7 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.6 1.2 1.9 0.1 2.0 1.5 1.4 0.7 2.6 0.4 4.8 2.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383333 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 20.1;fallopian tube: 30.3;salivary gland: 13.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 28.5;Endometrial ciliated cells: 53.6;Respiratory ciliated cells: 146.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.2;CAPAN-2: 4.1;HaCaT: 1.9;HBEC3-KT: 2.2;hTCEpi: 2.8;SK-BR-3: 2.6;T-47d: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.0 0.1 0.3 0.0 0.6 0.0 2.5 0.4 0.4 3.3 0.8 0.1 0.0 0.3 0.5 20.1 30.3 0.1 0.0 0.3 0.7 0.7 0.2 5.2 0.0 1.7 1.5 0.2 0.0 0.8 0.8 3.4 0.0 0.6 4.2 0.2 0.0 13.6 0.3 0.0 10.6 0.1 0.0 1.0 0.0 0.7 0.5 0.4 1.0 0.4 0.0 1.8 0.0 9.4 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.9 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.1 0.1 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 2.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.4 0.4 0.3 0.7 1.7 1.5 0.2 0.6 1.0 0.4 0.3 0.2 0.0 3.7 0.0 0.2 2.9 9.6 12.9 28.5 0.0 5.7 14.4 0.9 0.0 10.1 0.0 0.0 0.0 0.3 0.8 0.0 0.1 0.2 53.6 0.5 1.5 0.0 0.0 0.2 0.2 0.1 0.5 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.3 0.5 12.2 0.0 0.4 1.6 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.2 3.4 0.0 0.1 146.1 0.0 0.0 0.1 2.8 0.1 1.0 9.3 2.8 0.0 0.4 0.0 0.5 4.4 FUT1 "H, HSC" ENSG00000174951 "Fucosyltransferase 1 (H blood group)" P19526 19 48748011-48755390 "Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.7;stomach 1: 13.7" "Cell type enhanced" "Detected in many" "Adipocytes: 13.8;Endothelial cells: 8.5;Langerhans cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 9.3;HEL: 11.5;RT4: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 15000 "unprognostic (2.90e-2)" "unprognostic (3.09e-2)" "unprognostic (8.05e-3)" "unprognostic (4.65e-3)" "unprognostic (2.92e-3)" "unprognostic (8.73e-2)" "unprognostic (2.58e-2)" "unprognostic (3.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.99e-4)" "unprognostic (1.33e-1)" "unprognostic (3.22e-2)" "unprognostic (8.67e-3)" "unprognostic (3.98e-2)" 3.8 1.6 2.1 0.6 3.6 2.9 3.1 5.4 3.2 1.2 1.2 0.6 1.9 0.9 0.9 2.8 2.1 1.0 3.3 3.0 2.2 2.6 1.0 10.7 0.7 1.9 1.9 3.2 0.3 27.7 3.4 2.8 4.3 2.7 1.4 0.5 0.3 1.5 1.0 1.7 1.6 0.7 0.9 1.3 5.4 13.7 1.6 2.1 0.7 1.9 2.9 1.5 1.3 1.4 2.2 3.8 0.1 0.2 0.2 0.0 0.0 1.8 0.2 0.1 0.2 0.2 9.3 5.4 0.4 0.4 0.3 0.8 6.2 1.9 5.8 0.2 0.1 0.9 11.5 0.4 0.2 2.6 0.4 4.9 0.0 9.1 0.4 4.1 0.1 4.1 2.0 0.6 1.8 0.0 4.4 0.2 7.3 1.1 7.5 0.5 0.3 0.0 1.9 0.3 11.2 8.5 0.5 0.5 8.0 0.2 0.4 5.2 0.3 4.0 0.4 2.6 0.2 0.4 1.5 4.3 1.1 0.1 0.3 0.4 1.3 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.3 0.0 0.2 0.0 0.0 2.1 3.6 5.4 3.2 3.0 2.2 1.9 1.9 3.2 2.7 1.3 2.1 2.2 13.8 3.2 1.7 0.0 0.0 2.5 0.7 4.1 1.2 0.4 1.2 0.9 1.1 2.8 2.3 0.0 2.1 0.4 0.0 0.1 1.9 1.7 0.0 1.3 0.3 8.5 1.2 6.5 1.3 2.4 0.3 0.8 4.1 3.4 1.3 0.0 6.8 0.0 0.3 0.0 0.4 1.2 2.0 0.8 41.9 0.1 0.9 1.9 5.4 1.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.9 0.1 0.0 0.9 0.2 0.0 0.6 0.9 0.1 0.1 2.4 1.7 0.4 0.3 0.0 0.1 0.6 DHX36 "DDX36, KIAA1488, MLEL1, RHAU" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324487 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 547.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035398, HPA035399" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA035398: , HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 17.8 14.5 5.5 17.5 8.7 16.4 16.5 8.6 7.2 14.0 6.1 12.2 12.7 18.5 11.7 14.9 14.5 15.6 17.1 5.2 7.3 18.7 20.1 13.8 21.9 6.7 7.0 4.1 19.2 16.1 29.3 15.0 19.1 6.7 17.5 13.8 17.1 11.8 16.6 59.4 11.7 12.9 17.3 6.4 15.3 16.1 34.7 7.1 21.9 23.3 31.9 20.7 17.4 11.1 9.6 63.8 42.6 56.6 32.7 26.1 36.3 28.1 40.6 40.5 45.2 53.5 43.7 49.7 61.3 64.0 35.8 41.7 40.1 53.8 34.4 70.6 59.3 35.6 44.5 34.8 25.0 44.2 62.7 37.4 41.3 28.5 48.6 59.1 24.5 39.4 37.3 42.6 34.3 42.2 31.0 52.2 13.7 75.4 33.6 40.5 53.4 47.6 88.8 32.1 44.4 52.7 56.1 42.3 44.4 59.7 38.3 45.5 31.5 44.9 47.1 29.6 44.6 82.1 63.6 43.9 87.5 38.1 32.2 51.1 1.2 1.5 1.8 3.7 1.5 2.3 2.6 3.2 2.5 1.3 3.1 2.9 3.1 0.6 2.6 3.5 3.3 3.1 0.6 5.5 8.7 8.6 7.2 5.2 7.3 6.7 7.0 4.1 6.7 6.4 7.1 9.6 95.6 57.7 92.9 45.4 123.6 92.9 146.6 56.6 81.4 152.2 61.8 62.6 60.8 67.2 83.5 60.7 129.3 138.0 179.3 43.8 39.2 71.2 547.0 73.4 147.9 82.0 92.0 68.5 53.5 62.8 69.9 97.6 66.8 104.2 103.8 86.7 72.8 80.5 62.0 154.8 60.2 57.4 73.2 73.7 85.2 335.5 110.6 83.0 53.4 37.5 88.5 86.4 113.3 59.3 55.4 66.5 49.9 121.5 97.6 132.2 40.4 54.4 52.3 128.6 78.9 130.6 88.8 197.4 135.1 65.3 83.1 370.1 152.0 114.2 58.1 128.4 OR5J2 ENSG00000174957 "Olfactory receptor family 5 subfamily J member 2" Q8NH18 11 56176618-56177556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059466 Uncertain NA NA "HPA059466: AB_2684029" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406809 "Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 66.3" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Late spermatids: 13.5;Microglial cells: 6.5;Muller glia cells: 5.5;Oligodendrocytes: 6.9;Skeletal myocytes: 6.2" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Region enhanced" "Detected in many" "cerebellum: 66.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.5;ASC diff: 4.7;BEWO: 3.5;MCF7: 4.7;SH-SY5Y: 4.9;U-2197: 3.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 8 "cerebellum: 67.3" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.3 0.0 6.7 0.0 5.8 0.0 0.0 66.3 3.1 0.0 4.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.5 4.3 0.0 0.3 0.0 0.0 9.5 6.4 0.4 0.0 0.0 0.0 0.1 0.0 17.1 0.0 0.0 4.9 0.0 0.0 1.3 1.2 0.1 0.0 1.6 0.0 0.0 0.5 7.5 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 16.5 0.0 4.7 1.9 3.5 1.8 0.4 0.2 0.5 0.0 0.0 0.0 2.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.1 0.0 3.9 1.8 0.0 0.0 0.0 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 5.8 66.3 3.1 1.5 4.3 9.5 6.4 0.4 17.1 1.6 7.5 14.4 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 6.5 0.0 5.5 0.0 0.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.2 0.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10AG1 ENSG00000174970 "Olfactory receptor family 10 subfamily AG member 1" Q8NH19 11 55965755-55969945 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4S2 "OR4S2P, OST725" ENSG00000174982 "Olfactory receptor family 4 subfamily S member 2" Q8NH73 11 55648327-55652854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBXW8 "FBW6, FBW8, FBX29, FBXO29" ENSG00000174989 "F-box and WD repeat domain containing 8" Q8N3Y1 12 116910950-117031148 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.5;Excitatory neurons: 40.6;Inhibitory neurons: 38.9;Late spermatids: 84.1;Oligodendrocyte precursor cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038850, HPA038851" Supported Supported Cytosol NA NA Cytosol "HPA038850: AB_2676238, HPA038851: AB_10673479" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (9.03e-2)" "unprognostic (1.48e-2)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (3.35e-2)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "unprognostic (4.30e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (6.20e-2)" "unprognostic (6.34e-2)" "unprognostic (2.55e-1)" 5.0 4.9 2.5 4.7 8.2 3.6 6.0 1.5 2.8 5.8 8.3 4.7 3.6 6.6 4.0 5.3 6.4 4.1 4.8 4.1 2.4 3.6 4.0 4.6 5.6 3.0 2.2 2.2 8.7 7.1 8.6 8.3 7.7 3.5 4.9 5.0 4.5 6.6 5.3 5.4 5.9 4.3 5.8 1.2 4.1 5.9 5.0 3.0 5.5 9.5 3.4 6.6 5.2 5.0 2.6 8.6 15.5 13.4 10.8 12.1 16.9 8.8 16.0 16.6 11.8 11.4 4.9 5.9 13.0 5.9 21.1 6.3 9.1 10.1 6.3 9.5 20.6 7.3 6.3 7.1 5.0 20.7 8.1 4.7 17.6 5.4 11.0 24.7 16.7 13.2 11.7 8.2 6.0 10.7 22.3 6.4 5.5 15.7 3.9 9.4 10.0 6.1 11.2 9.5 14.6 12.0 33.4 11.5 4.1 7.9 11.3 15.2 7.1 16.7 10.4 4.3 10.8 5.0 19.0 12.6 12.2 14.2 4.9 17.2 0.2 0.8 2.0 1.4 0.8 1.3 2.4 0.8 0.9 1.1 1.9 0.5 0.8 0.0 3.9 1.0 1.1 1.2 0.7 2.5 8.2 1.5 2.8 4.1 2.4 3.0 2.2 2.2 3.5 1.2 3.0 2.6 3.2 0.0 6.4 21.9 5.4 1.9 3.0 1.4 5.2 9.1 3.5 4.2 3.1 4.3 5.6 1.8 25.0 9.4 5.5 1.4 1.9 4.2 53.5 4.1 6.6 3.6 9.1 3.8 40.6 4.5 6.5 5.4 8.6 3.6 2.5 11.1 0.7 3.0 4.3 1.7 38.9 4.2 0.0 3.5 0.8 84.1 9.3 2.6 0.0 33.7 2.3 3.1 5.2 38.2 28.3 2.4 3.3 5.3 7.7 5.4 1.0 2.2 4.7 15.2 0.0 7.2 4.2 4.6 6.7 3.5 1.4 6.7 4.5 11.6 3.7 3.2 CA5A "CA5, CAV, CAVA" ENSG00000174990 "Carbonic anhydrase 5A" P35218 16 87881546-87936580 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Lyase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "liver: 24.4" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 39.0" "Cancer enriched" "Detected in single" 26 "liver cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "Hep G2: 25.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.91e-1)" "unprognostic (8.64e-3)" "unprognostic (3.36e-2)" "unprognostic (6.11e-2)" "unprognostic (2.49e-2)" "unprognostic (2.96e-1)" "unprognostic (8.39e-3)" "unprognostic (3.50e-3)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (6.55e-2)" "unprognostic (4.23e-2)" "unprognostic (7.99e-3)" "unprognostic (1.77e-1)" "unprognostic (5.03e-3)" "unprognostic (3.37e-2)" "unprognostic (2.76e-2)" 0.0 0.0 0.5 0.1 0.4 0.1 0.1 0.5 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 24.4 0.1 0.1 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.7 0.4 0.4 0.5 0.4 0.3 0.5 0.4 0.6 0.5 0.2 0.0 3.4 0.3 0.3 0.4 2.5 0.0 0.0 1.7 0.2 0.3 2.1 0.0 1.3 1.8 4.2 0.4 0.5 0.1 0.0 0.0 0.3 0.6 0.4 5.4 0.0 2.7 0.8 0.0 0.3 1.0 0.0 0.8 6.3 0.2 1.1 39.0 0.1 3.3 0.6 0.2 0.0 1.4 1.6 0.8 0.3 1.5 0.0 2.8 0.2 0.8 2.1 0.0 0.5 0.0 0.0 1.2 0.1 1.9 0.2 0.3 1.5 3.8 0.0 4.1 1.1 0.4 0.4 0.0 0.3 0.3 1.2 1.7 0.1 1.8 ZG16 "hZG16, JCLN, JCLN1, ZG16A" ENSG00000174992 "Zymogen granule protein 16" O60844 16 29778256-29782973 "Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "intestine: 484.1" "Cell type enriched" "Detected in some" 10 "Intestinal goblet cells: 20216.0" "Cancer enriched" "Detected in some" 6 "colorectal cancer: 21.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 2.3" "Not detected" "Not detected" "HPA052066, HPA052512" Enhanced "Secreted to digestive system" NA NA 1300000 "HPA052066: AB_2681716, HPA052512: AB_2681857" "unprognostic (1.64e-2)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (8.20e-2)" "unprognostic (3.50e-2)" "unprognostic (1.93e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-1)" "unprognostic (7.77e-2)" "unprognostic (3.27e-1)" "unprognostic (2.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" 0.5 0.0 0.0 7.9 0.1 0.1 0.7 0.1 0.1 0.0 0.0 366.3 58.3 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 22.4 0.0 0.2 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.1 484.1 0.1 0.0 0.5 0.0 0.1 138.0 13.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 1107.2 0.0 0.0 0.0 0.1 0.0 0.1 145.5 0.0 0.1 11.9 0.0 0.1 0.0 0.2 40.1 0.0 0.4 44.6 0.0 0.0 0.1 20216.0 0.0 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 484.8 0.0 0.0 0.2 1950.6 1.6 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.5 7.1 0.0 306.7 0.3 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 14.9 18.2 17.8 9.6 25.9 3.6 16.1 34.3 77.2 27.5 0.0 23.4 9.9 27.3 6.4 18.4 21.8 9.0 28.0 29.8 14.4 21.7 8.3 19.1 9.1 37.4 13.2 24.5 24.8 15.7 15.3 48.7 7.2 40.1 29.0 4.8 28.7 16.1 16.1 58.2 18.0 16.5 11.3 5.1 13.8 20.3 32.5 25.7 25.3 17.8 14.3 6.4 27.4 21.9 42.4 49.4 58.2 28.3 16.9 16.9 13.5 21.9 34.1 24.2 34.2 26.1 31.9 14.3 21.3 31.9 25.6 43.9 40.7 29.3 33.2 11.4 35.7 37.2 4.4 48.0 22.4 32.1 9.9 22.7 13.5 42.7 40.1 32.8 22.0 16.1 26.2 24.1 29.0 27.8 69.2 56.8 15.0 27.8 14.2 49.2 21.4 14.6 30.1 27.2 27.4 76.3 37.5 24.6 22.1 41.3 15.7 36.3 6.7 26.8 55.5 49.8 68.2 45.5 30.7 27.4 11.9 39.3 6.7 22.9 0.0 0.2 0.5 2.4 0.1 3.1 1.9 1.1 1.6 0.3 3.2 1.1 1.4 0.3 1.3 0.2 2.1 0.3 1.1 17.8 25.9 34.3 77.2 29.8 14.4 37.4 13.2 24.5 40.1 5.1 25.7 42.4 4.0 3.2 1.5 8.8 8.9 8.9 9.2 11.1 7.4 34.4 10.1 7.2 2.4 7.2 5.5 12.9 12.5 9.9 5.1 3.1 13.7 14.8 10.1 7.7 6.2 5.2 37.1 0.8 20.7 8.2 18.2 6.5 13.7 9.7 0.0 8.6 3.9 2.3 3.1 55.5 19.0 7.2 18.3 3.2 4.0 4.6 8.7 2.8 12.4 5.6 6.3 14.6 4.1 4.0 6.2 19.1 4.9 13.9 9.1 18.2 3.9 10.3 7.3 35.2 0.0 9.5 13.3 26.2 29.8 8.9 9.7 12.7 8.2 3.4 4.9 8.5 SLC22A1 OCT1 ENSG00000175003 "Solute carrier family 22 member 1" O15245 6 160121815-160158718 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 381 "liver: 614.5" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 966.3" "Cancer enriched" "Detected in some" 81 "liver cancer: 83.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029846 Approved NA NA "HPA029846: AB_10603026" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "unprognostic (7.80e-2)" "unprognostic (2.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.35e-5)" "unprognostic (2.28e-1)" "unprognostic (8.61e-2)" "unprognostic (3.35e-1)" "unprognostic (9.11e-2)" "unprognostic (9.94e-2)" "unprognostic (1.46e-7)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (4.72e-2)" "unprognostic (8.07e-4)" 0.3 0.3 0.2 0.1 0.2 0.4 0.3 0.0 0.8 0.3 0.2 0.2 0.0 0.3 0.1 0.2 0.3 0.7 0.1 0.5 0.0 0.9 614.5 0.4 0.2 0.2 0.1 0.2 0.4 0.4 0.0 0.3 0.0 0.3 0.4 0.1 0.1 0.4 0.1 1.0 0.4 0.3 0.0 0.0 1.6 0.3 0.3 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.4 0.0 0.2 0.2 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.8 0.0 0.0 0.4 0.1 0.4 0.2 0.1 0.2 0.6 0.0 0.3 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.6 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.3 0.3 0.7 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.8 0.5 0.0 0.2 0.1 0.2 0.3 0.0 0.1 0.4 0.2 0.0 1.3 2.0 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.5 47.1 0.0 0.0 2.1 0.0 0.4 0.1 0.0 0.5 0.3 0.5 0.1 0.9 0.0 13.5 6.1 0.2 0.1 0.2 0.0 0.7 0.0 0.2 11.4 966.3 0.1 0.0 3.7 0.1 0.0 16.3 0.0 0.2 0.3 0.4 0.0 1.0 0.0 0.9 0.0 0.0 0.9 0.1 0.0 0.7 0.1 0.3 0.1 1.8 0.1 0.0 0.0 0.7 0.3 0.0 0.4 0.0 0.3 0.1 1.2 0.3 0.1 0.2 TEX36 "bA383C5.1, C10orf122" ENSG00000175018 "Testis expressed 36" Q5VZQ5 10 125576522-125683163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 27.1" "Group enriched" "Detected in some" 53 "Early spermatids: 358.7;Late spermatids: 347.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2197: 8.3" "Region enriched" "Detected in single" 15 "cerebellum: 2.3" "Low region specificity" "Detected in some" NA NA "unprognostic (7.72e-3)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.7 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 347.6 1.8 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 3.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTBP2 ribeye ENSG00000175029 "C-terminal binding protein 2" P56545 10 124984317-125161170 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023559, HPA023564, CAB031916, HPA044971, CAB079018" Approved Approved Approved Nucleoplasm NA NA 10000 Nucleoplasm "CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161" "unprognostic (8.69e-2)" "unprognostic (1.27e-2)" "unprognostic (4.14e-2)" "unprognostic (1.41e-2)" "unprognostic (6.84e-3)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (5.60e-3)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (3.24e-2)" "unprognostic (3.99e-3)" "prognostic favorable (1.70e-4)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.62e-1)" 27.0 25.6 21.6 17.2 22.1 17.3 30.9 30.7 19.0 46.0 42.0 35.6 33.6 47.2 21.2 30.7 37.6 22.3 19.9 21.7 32.6 28.4 5.8 33.3 9.5 23.3 22.4 16.7 42.1 41.0 22.1 23.8 24.9 22.9 38.9 29.5 55.9 37.0 24.2 23.0 16.2 33.7 30.3 21.5 21.8 37.2 19.9 25.3 9.1 54.4 19.9 9.2 30.1 31.1 25.5 87.3 96.5 83.6 70.2 43.9 43.0 46.1 66.4 77.0 61.2 69.3 60.4 99.7 0.1 33.6 66.9 38.6 67.2 83.8 106.5 45.8 0.3 63.8 63.8 61.6 1.3 91.7 27.2 48.9 37.1 82.7 63.5 125.5 80.9 79.1 4.9 2.6 0.5 38.7 96.5 3.0 27.8 63.0 90.3 61.3 77.4 35.0 0.8 72.5 38.8 25.5 73.1 64.7 56.0 86.5 64.7 39.7 43.9 64.4 36.8 46.2 53.0 57.9 1.4 5.3 0.3 46.1 0.3 37.1 30.8 8.5 16.4 8.5 9.0 1.1 0.5 0.4 2.3 11.2 0.3 0.5 3.6 14.3 34.6 22.4 9.4 0.3 4.7 21.6 22.1 30.7 19.0 21.7 32.6 23.3 22.4 16.7 22.9 21.5 25.3 25.5 64.7 32.1 27.2 72.1 4.0 47.2 83.4 41.5 33.6 182.5 75.8 59.8 32.7 55.8 53.2 38.6 158.4 22.3 50.7 81.7 68.4 69.3 29.9 125.0 65.1 63.0 55.0 42.3 41.8 60.8 70.5 42.3 40.2 163.0 17.7 43.1 61.4 1.2 29.6 107.7 35.0 93.9 50.8 49.3 46.9 38.1 60.3 47.0 58.7 127.4 60.6 63.2 124.6 44.2 87.1 83.8 61.6 77.8 6.9 89.3 45.1 31.6 94.1 107.5 59.2 59.6 67.0 12.7 45.5 42.1 39.8 19.3 15.3 81.3 106.1 102.7 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119771-143124014 "Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3" "Cell type enhanced" "Detected in many" "Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4" "Group enriched" "Detected in many" 5 "monocytes: 11.4;NK-cells: 4.9" "Cell line enhanced" "Detected in many" "ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 7.6 2.7 18.0 8.2 17.7 16.9 6.3 16.3 13.8 5.3 5.5 2.6 2.1 8.5 1.4 1.1 2.1 1.7 4.5 10.2 13.7 8.4 1.3 7.6 7.8 29.6 19.4 12.3 4.9 1.3 0.9 6.9 10.4 25.5 7.5 1.1 11.1 2.7 10.0 1.6 3.4 7.5 3.7 28.4 18.3 3.5 1.7 26.4 14.6 6.7 0.8 5.4 7.2 7.7 51.3 0.0 0.3 3.1 2.6 57.7 58.8 0.2 3.3 9.5 2.3 2.1 0.0 0.0 0.6 2.0 2.3 3.1 0.1 2.3 8.2 1.2 0.8 1.5 48.2 0.1 0.0 118.4 1.2 55.4 62.3 9.7 3.1 10.1 3.6 3.6 7.2 5.5 2.9 15.4 0.0 9.1 12.2 16.5 0.0 8.0 0.5 1.0 0.1 1.7 2.2 3.7 0.0 0.7 0.0 5.6 2.9 0.0 1.9 12.3 7.0 4.1 9.5 13.9 52.4 0.8 3.3 13.8 9.3 37.4 0.7 0.5 0.7 0.3 4.3 0.0 1.1 0.1 0.2 1.6 0.8 0.6 0.5 0.3 4.9 11.4 0.1 0.5 0.9 18.0 17.7 16.3 13.8 10.2 13.7 29.6 19.4 12.3 25.5 28.4 26.4 51.3 11.3 0.0 0.0 3.6 17.7 2.4 7.3 2.5 0.0 25.0 2.8 2.7 1.4 0.0 1.8 3.7 2.1 0.6 41.9 0.0 0.0 0.4 0.2 5.7 29.8 9.4 0.0 39.1 6.8 0.2 0.6 14.4 2.0 6.5 11.4 12.5 3.6 0.4 2.8 1.7 8.1 0.0 0.0 10.3 32.2 1.3 12.8 20.2 17.8 1.0 13.6 114.4 233.8 2.5 6.1 5.9 0.0 2.2 79.3 13.1 0.0 0.0 0.1 23.8 92.1 0.8 20.2 0.0 2.2 0.1 0.6 1.0 9.8 58.1 1.3 14.8 ZDHHC14 "FLJ20984, NEW1CP" ENSG00000175048 "Zinc finger DHHC-type palmitoyltransferase 14" Q8IZN3 6 157381133-157678157 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 161.7;Horizontal cells: 122.8;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 315.2;Oligodendrocytes: 221.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 4 "HDLM-2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013437, HPA063754" Approved Uncertain Vesicles NA NA Vesicles "HPA013437: , HPA063754: AB_2685113" "unprognostic (1.66e-2)" "unprognostic (1.27e-2)" "unprognostic (1.58e-2)" "unprognostic (3.98e-2)" "unprognostic (1.59e-1)" "unprognostic (6.78e-3)" "unprognostic (1.84e-1)" "unprognostic (6.02e-2)" "unprognostic (2.87e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.93e-4)" "unprognostic (3.94e-2)" "unprognostic (5.01e-3)" "unprognostic (1.89e-1)" "unprognostic (7.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.63e-1)" 2.9 1.6 7.4 1.8 7.7 2.5 1.6 9.7 6.7 4.3 1.4 2.4 2.8 12.5 0.5 1.8 2.0 2.3 5.3 7.4 6.1 2.9 4.4 3.0 2.4 11.8 9.5 6.3 1.4 2.6 5.7 1.6 2.3 11.2 3.5 1.7 1.3 2.2 1.5 2.3 1.4 4.1 6.2 15.2 3.2 3.8 3.3 10.3 0.9 1.7 3.9 2.5 2.5 1.9 23.8 2.6 2.7 0.8 3.8 2.0 1.5 8.7 4.1 3.7 2.8 2.5 3.3 1.9 6.4 1.4 3.3 5.4 1.3 2.2 2.2 2.5 50.9 3.2 12.7 1.0 1.5 2.7 1.7 2.8 1.1 2.3 2.9 1.2 2.4 4.3 2.8 10.4 4.7 1.6 1.7 1.1 4.2 1.6 5.1 3.2 0.2 0.4 3.9 5.8 1.1 6.3 1.9 4.8 3.1 3.5 1.6 0.4 2.0 6.0 4.2 3.1 8.3 5.2 1.1 1.3 0.9 1.5 4.5 4.7 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 7.4 7.7 9.7 6.7 7.4 6.1 11.8 9.5 6.3 11.2 15.2 10.3 23.8 23.4 3.2 0.0 45.4 9.8 12.9 2.1 3.0 4.0 25.3 5.8 8.0 18.3 12.8 1.4 7.3 6.2 12.5 11.2 7.4 11.7 7.5 10.7 5.0 16.6 15.1 2.4 4.2 161.7 3.1 2.2 11.4 6.1 9.4 0.0 7.7 22.5 23.1 11.4 122.8 108.1 9.8 6.1 15.5 6.7 5.9 8.1 8.8 10.6 65.6 3.8 5.4 7.2 315.2 221.0 2.7 8.5 10.1 4.5 14.2 6.0 3.8 0.4 6.0 0.0 6.2 8.4 7.2 10.0 1.5 8.4 21.1 6.6 4.6 11.5 2.7 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449007-142578733 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" No No Nucleoplasm "Golgi apparatus" "HPA054320: AB_2682448" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavorable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 3.0 8.6 0.6 4.1 1.1 1.2 3.2 1.0 1.4 3.8 3.2 2.7 1.7 3.4 2.3 3.1 3.3 3.4 2.3 1.0 1.9 3.7 3.6 2.9 4.8 1.4 1.1 1.3 2.8 3.8 5.3 3.7 3.1 1.4 3.1 2.9 2.9 3.5 2.5 2.9 2.6 3.1 3.3 0.9 4.2 2.8 5.2 1.1 5.0 5.1 1.4 4.7 4.1 2.7 1.4 28.6 13.2 7.1 7.0 9.6 13.6 8.8 14.8 8.4 10.1 9.7 6.4 6.8 19.9 14.6 10.1 14.6 16.1 10.9 12.8 15.0 7.5 7.9 11.9 8.2 4.1 4.2 20.5 5.3 9.8 4.8 9.5 10.3 5.8 11.6 8.7 8.2 7.5 9.6 7.5 13.9 2.6 7.3 15.6 9.6 11.8 12.5 13.5 6.3 11.1 5.2 5.1 28.6 8.3 8.0 7.8 12.0 5.4 14.6 10.5 4.9 12.3 15.2 10.8 7.4 18.5 13.8 6.5 8.5 0.0 0.3 0.0 0.5 0.4 1.0 0.1 0.3 0.5 0.7 0.3 0.4 0.4 0.0 1.3 0.2 0.2 0.4 0.2 0.6 1.1 1.0 1.4 1.0 1.9 1.4 1.1 1.3 1.4 0.9 1.1 1.4 11.5 6.4 10.6 39.2 22.4 4.0 7.2 8.8 14.2 14.1 9.2 6.5 7.6 5.7 10.1 3.7 37.5 7.7 14.9 3.5 0.0 5.9 16.4 18.8 18.6 10.2 7.7 14.5 93.0 4.9 3.6 8.3 14.8 10.3 1.3 16.3 7.9 7.3 6.4 8.4 94.4 4.8 14.2 9.4 4.0 8.7 6.5 12.8 10.6 73.1 12.0 6.0 9.2 65.4 71.9 6.4 1.8 7.2 23.1 8.1 1.9 6.5 25.4 23.6 0.0 14.6 9.8 50.1 18.5 14.7 4.5 5.1 15.1 13.8 7.6 6.1 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 79.1;lymphoid tissue: 114.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 8.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 4.3;white matter: 11.4" "Low region specificity" "Detected in some" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Approved "Plasma membrane,Cytosol" Yes Yes "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 2.6 2.9 0.7 21.7 0.3 79.1 4.3 1.0 0.6 3.6 0.7 27.0 21.6 5.7 0.6 37.5 1.9 2.7 1.3 0.4 1.3 1.9 2.9 5.4 45.6 0.4 0.9 0.1 1.3 1.0 0.4 0.4 20.6 0.6 1.5 31.2 0.2 5.1 0.9 1.0 18.6 20.8 10.6 0.6 15.9 13.1 16.5 1.4 114.5 1.1 0.2 70.1 6.9 12.4 3.2 312.8 223.9 390.9 188.3 10.4 24.0 225.2 238.5 121.6 390.7 278.4 743.8 345.4 327.6 233.2 115.5 475.6 294.9 2.2 260.5 395.8 141.7 213.7 101.5 168.5 196.0 3.0 145.4 241.6 7.6 27.8 265.7 257.3 57.4 193.4 206.4 1.8 261.6 325.4 516.2 243.5 41.1 237.1 350.8 529.4 256.0 354.8 1.4 134.9 105.9 226.1 188.7 378.3 271.7 154.4 196.2 276.6 209.4 70.1 341.2 298.4 236.2 473.4 84.3 2.9 369.4 208.0 103.4 328.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 1.7 0.6 0.1 0.1 0.1 2.1 2.1 0.5 0.3 8.2 3.2 0.7 0.3 1.0 0.6 0.4 1.3 0.4 0.9 0.1 0.6 0.6 1.4 3.2 0.9 0.0 3.7 0.0 17.9 17.3 7.8 39.0 5.7 0.0 8.6 14.6 0.0 1.5 9.3 0.0 0.0 129.6 3.6 27.4 0.0 1.3 12.0 5.8 5.9 9.5 1.2 182.1 0.0 0.5 449.1 28.5 25.5 9.6 5.7 119.0 18.2 3.6 92.6 0.0 0.1 41.1 50.8 20.8 18.1 6.4 0.9 24.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 7.2 0.0 37.0 12.6 6.2 0.6 1.8 0.0 0.0 0.5 19.2 52.2 50.7 83.2 11.6 31.2 13.7 2.5 68.4 18.4 DSG4 "CDHF13, LAH" ENSG00000175065 "Desmoglein 4" Q86SJ6 18 31376777-31414912 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skin 1: 1.8" "Cell type enhanced" "Detected in some" "Early spermatids: 1.4;Squamous epithelial cells: 1.0;Urothelial cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 133 "HaCaT: 37.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059456, HPA079244" Enhanced NA NA 320000 "HPA059456: AB_2684025, HPA079244: " "unprognostic (9.86e-2)" "unprognostic (8.61e-2)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "unprognostic (5.55e-2)" "unprognostic (5.61e-2)" "unprognostic (2.11e-2)" "unprognostic (6.00e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "unprognostic (2.14e-1)" "unprognostic (1.79e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.0 0.0 0.2 1.3 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5" Q6ZS86 3 142157527-142225592 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: AB_2683573" "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 4.2 7.1 2.4 3.8 2.5 7.8 6.9 4.8 3.3 4.5 6.0 6.8 9.5 5.5 9.1 4.3 6.1 3.2 2.4 2.4 3.2 3.3 2.1 3.8 2.2 4.2 3.2 2.2 8.7 4.0 3.1 5.8 1.7 3.5 8.4 7.4 4.7 11.1 4.1 2.5 5.7 8.0 3.4 3.3 2.2 5.3 3.2 2.9 2.1 4.6 1.5 2.4 4.2 4.4 4.7 11.2 2.7 3.9 2.6 8.0 15.2 6.7 3.6 2.5 3.9 2.5 4.2 6.0 7.9 3.2 3.5 4.3 4.6 4.5 3.5 5.2 2.9 4.3 5.2 7.1 3.1 4.3 6.1 6.7 6.2 3.0 2.6 3.4 2.5 2.3 9.1 4.6 4.7 7.2 7.2 5.3 5.0 2.5 7.5 3.1 4.9 4.2 2.9 4.1 6.8 3.8 2.8 10.1 10.5 3.3 2.3 14.8 4.0 2.5 3.1 2.6 6.9 4.1 4.9 5.1 8.1 5.6 3.8 5.3 2.0 0.4 0.3 1.5 0.3 0.7 0.2 0.5 0.5 0.3 0.4 0.3 0.6 1.1 1.5 2.6 0.4 0.2 0.2 2.4 2.5 4.8 3.3 2.4 3.2 4.2 3.2 2.2 3.5 3.3 2.9 4.7 13.7 38.5 30.7 31.6 6.8 4.0 12.3 3.7 15.9 30.6 26.6 13.6 10.5 17.2 17.3 27.6 29.2 13.1 80.5 37.4 7.9 14.9 2.8 32.7 22.5 9.7 27.9 8.8 37.6 20.4 7.3 15.2 25.0 39.2 8.8 23.2 5.0 11.8 5.6 15.2 44.1 42.0 0.0 10.0 3.9 5.2 33.8 20.2 3.6 15.9 9.3 10.2 127.7 27.6 75.6 19.3 31.6 46.6 34.6 21.5 69.5 6.1 14.1 33.0 26.3 16.0 9.0 4.0 5.9 19.4 4.0 6.8 21.0 21.1 34.5 17.3 VCPIP1 "DUBA3, FLJ23132, KIAA1850, VCIP135" ENSG00000175073 "Valosin containing protein interacting protein 1" Q96JH7 8 66628487-66667231 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 20.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023932 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA023932: AB_2671373" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (4.01e-2)" "unprognostic (5.56e-2)" "unprognostic (5.23e-2)" "unprognostic (7.21e-2)" "unprognostic (2.80e-1)" "unprognostic (3.96e-1)" "unprognostic (5.23e-3)" "unprognostic (7.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-2)" "unprognostic (8.58e-3)" 4.6 3.6 4.1 6.1 4.2 20.4 4.8 4.7 5.5 3.7 2.7 4.5 3.8 3.0 4.5 3.5 3.0 3.7 2.9 4.4 5.1 4.4 7.1 4.2 8.6 4.6 4.3 3.5 4.0 4.1 5.6 1.6 4.4 4.8 3.6 4.1 4.6 4.2 3.2 5.3 3.3 3.7 3.3 4.3 8.9 4.5 5.7 5.0 5.4 4.3 5.3 7.8 4.2 2.4 5.2 8.5 7.6 3.8 5.1 11.5 8.1 3.7 6.7 6.7 5.0 5.8 4.5 7.8 11.5 1.9 9.0 6.2 7.4 6.2 5.6 7.2 8.6 4.5 12.8 7.5 5.6 6.9 4.3 13.2 8.7 8.1 5.5 9.9 6.1 5.5 6.1 8.8 10.8 7.5 4.1 9.4 7.4 7.3 7.1 5.2 5.9 6.0 5.8 7.3 6.6 2.2 4.3 5.2 7.8 6.0 4.8 8.0 7.0 11.1 6.6 4.9 5.9 4.5 9.5 5.0 11.9 6.6 6.0 5.1 10.0 2.7 5.9 3.4 4.3 2.8 1.7 2.1 2.5 2.9 2.2 1.7 2.2 9.7 2.4 8.3 1.1 2.8 1.7 4.1 4.2 4.7 5.5 4.4 5.1 4.6 4.3 3.5 4.8 4.3 5.0 5.2 18.6 19.2 15.2 9.8 18.5 17.0 9.3 10.3 12.5 11.0 12.6 9.4 20.3 11.5 12.8 7.3 22.9 10.4 38.9 18.4 3.9 10.2 7.5 16.7 17.1 14.2 6.0 23.4 17.6 13.6 5.5 15.0 15.3 16.4 19.0 12.4 17.2 22.9 14.9 11.8 18.1 15.5 8.2 47.3 20.4 5.2 8.1 25.6 10.6 14.0 28.6 11.9 39.1 13.6 21.1 13.0 16.6 15.8 21.8 14.2 14.7 12.8 18.6 12.1 6.6 21.7 20.2 32.9 16.6 16.3 20.6 9.9 28.6 11.8 13.2 16.9 RTP1 "MGC35450, Z3CXXC1" ENSG00000175077 "Receptor transporter protein 1" P59025 3 187197486-187201462 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.3" "Cell type enhanced" "Detected in some" "Early spermatids: 3.3;Late spermatids: 1.9;Spermatocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "SuSa: 4.0;T-47d: 2.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (2.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.29e-1)" "unprognostic (1.91e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-1)" 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.3 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 2.3 0.0 0.0 0.0 0.0 0.5 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.3 1.1 0.9 2.3 0.5 1.0 0.8 0.4 0.4 2.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DES "CMD1I, CSM1, CSM2" ENSG00000175084 Desmin P17661 2 219418377-219426734 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 9831.5;skeletal muscle: 16668.0" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2531.9" "Cancer enhanced" "Detected in all" "prostate cancer: 562.1;stomach cancer: 400.2" "Region enhanced" "Detected in all" "cerebral cortex: 13.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "midbrain: 29.5" "CAB000034, HPA018803" Enhanced Supported "Intermediate filaments" NA NA 1600000 "Intermediate filaments" "CAB000034: , HPA018803: AB_1847616" "unprognostic (1.75e-1)" "unprognostic (1.95e-3)" "unprognostic (3.43e-2)" "unprognostic (8.76e-2)" "unprognostic (7.75e-3)" "unprognostic (6.61e-3)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (4.67e-1)" "unprognostic (3.84e-2)" "unprognostic (2.57e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (3.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (9.25e-3)" 170.8 57.6 1.7 440.0 3.3 1.1 51.7 1.8 13.7 490.7 19.3 5828.2 293.9 3040.5 86.7 1494.9 1094.5 456.2 9831.5 2.0 2.0 17.0 15.6 175.5 7.3 4.2 2.6 1.8 173.3 14.7 0.5 8.5 53.2 2.0 2237.7 247.9 0.0 257.4 2274.3 16668.0 123.2 1355.1 2581.7 2.0 25.4 1982.2 16.2 2.0 3.2 66.7 5804.8 1.2 4801.7 675.1 2.5 0.0 0.0 0.1 0.0 0.0 2.2 5.3 0.2 0.0 0.1 0.1 0.5 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 17.0 0.1 1.3 70.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 145.3 0.0 0.0 39.5 0.5 0.0 0.0 0.0 333.1 2.1 0.0 0.0 0.2 1.2 0.0 0.0 0.0 9.2 0.0 5.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.7 3.3 1.8 13.7 2.0 2.0 4.2 2.6 1.8 2.0 2.0 2.0 2.5 0.4 0.0 0.0 0.0 0.0 4.1 2.7 0.0 0.0 0.0 0.1 0.0 2531.9 1.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 90.6 0.5 6.7 22.7 0.0 0.0 0.1 0.0 5.2 104.6 0.0 0.1 0.0 0.0 1.8 0.0 5.6 0.0 0.0 0.9 0.0 0.0 10.7 71.6 28.9 2.8 12.4 0.0 0.6 0.0 0.0 0.5 0.0 0.5 0.0 50.4 0.0 8.7 0.0 0.1 0.0 0.0 46.0 497.8 210.5 5.0 5.1 0.1 9.8 8.5 2.4 0.0 0.2 2.9 PDIK1L CLIK1L ENSG00000175087 "PDLIM1 interacting kinase 1 like" Q8N165 1 26111165-26125555 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064157 Supported Nucleoplasm NA NA Nucleoplasm "HPA064157: " "unprognostic (1.09e-1)" "unprognostic (1.81e-3)" "unprognostic (2.99e-3)" "unprognostic (2.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.34e-3)" "unprognostic (3.93e-2)" "unprognostic (1.72e-3)" "unprognostic (7.29e-3)" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (3.59e-1)" "unprognostic (1.34e-2)" "unprognostic (4.24e-3)" "unprognostic (2.94e-1)" "unprognostic (4.47e-1)" "unprognostic (1.78e-2)" 3.2 3.4 3.8 4.5 4.1 16.7 8.3 6.7 5.3 5.9 2.6 6.9 7.2 4.4 4.6 5.0 5.5 4.0 3.3 4.0 4.6 6.1 8.2 4.7 6.6 3.9 4.0 3.7 6.5 7.8 7.0 2.6 3.5 4.9 4.7 7.4 8.3 6.3 5.1 4.8 5.5 5.6 3.7 3.3 4.7 7.4 5.1 4.1 8.7 15.5 5.3 6.4 4.7 3.2 4.9 7.9 2.9 7.5 9.8 2.7 3.8 2.6 2.3 2.7 5.2 3.3 2.0 11.2 17.8 6.3 2.6 4.0 5.6 11.2 4.0 4.4 6.1 7.7 15.3 4.3 2.2 4.7 15.6 9.0 2.2 5.9 4.6 8.5 3.5 4.8 15.3 18.0 16.8 1.8 4.8 23.5 7.4 3.5 9.5 4.7 12.7 7.3 19.2 3.7 6.1 13.3 10.8 8.2 10.0 10.5 2.0 5.4 5.4 4.4 5.5 5.2 7.0 6.9 23.8 26.5 12.0 5.9 19.2 5.0 10.5 3.8 3.3 4.8 3.6 4.5 4.9 6.6 5.3 7.3 4.2 7.0 5.6 0.3 4.4 5.1 2.8 7.9 4.0 3.8 4.1 6.7 5.3 4.0 4.6 3.9 4.0 3.7 4.9 3.3 4.1 4.9 6.4 9.6 4.2 5.9 6.2 3.2 1.7 3.5 7.4 18.6 8.6 3.9 2.3 7.2 7.0 1.8 0.0 3.9 2.7 6.5 0.0 3.7 1.3 3.2 5.7 5.0 13.1 6.3 13.7 4.0 0.7 3.8 7.1 4.9 7.0 6.3 5.0 11.1 4.1 23.5 15.4 8.0 4.1 6.3 5.9 0.5 2.5 4.6 3.6 5.6 3.1 11.0 0.0 10.1 12.1 2.9 3.3 3.0 14.0 3.5 4.5 7.5 8.4 11.7 0.0 2.9 3.6 14.0 11.7 14.5 7.4 1.6 5.4 3.0 8.7 3.0 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051347-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8;pancreas: 7.1;pituitary gland: 3.0;testis: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062793 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA062793: AB_2732689" "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.3 0.3 1.1 0.0 0.9 0.0 0.1 0.8 1.3 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 1.9 0.3 0.0 0.4 0.0 2.8 2.0 0.2 0.0 7.1 0.2 3.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 1.6 1.1 0.0 2.9 1.1 0.2 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 12.5 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.9 0.0 3.5 0.0 0.0 0.0 4.2 0.6 0.0 0.0 1.1 3.6 0.0 0.0 0.0 2.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.8 1.3 0.3 1.9 2.8 2.0 0.2 1.6 1.6 1.1 1.1 0.4 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.6 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.0 3.2 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.0 5.6 0.0 0.0 5.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.4 22.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease variant, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 153.8" "Group enriched" "Detected in some" 19 "Astrocytes: 1.3;Early spermatids: 2.3;Excitatory neurons: 2.9;Inhibitory neurons: 1.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.3;Spermatocytes: 1.5" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 40.0;MOLT-4: 46.8;REH: 183.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065704 Approved Nucleoplasm NA NA Nucleoplasm "HPA065704: AB_2732737" "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 153.8 24.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 46.8 0.0 0.1 0.0 0.0 183.8 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36483769-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favorable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 6.3 5.1 4.4 5.3 5.2 23.5 5.9 4.8 6.1 5.9 5.3 5.6 6.1 6.5 5.8 6.5 6.2 5.7 7.6 4.6 4.7 6.8 7.9 8.0 6.3 4.9 5.0 4.6 7.9 7.2 6.0 4.1 6.2 4.7 5.1 6.4 5.4 6.0 5.4 7.0 6.4 7.6 7.5 3.8 8.5 5.8 7.8 4.6 9.6 9.7 8.0 7.1 5.5 6.2 6.5 5.1 6.3 12.0 6.8 11.0 7.9 5.1 7.5 8.0 6.8 8.8 5.6 3.3 6.7 4.5 8.0 7.8 9.4 9.6 7.6 11.2 11.0 11.1 6.4 5.0 5.0 7.1 7.2 7.5 7.5 10.5 3.6 11.1 6.6 9.7 8.7 9.7 7.1 8.7 6.2 11.6 4.0 6.5 5.8 5.7 7.5 16.2 3.8 8.2 10.4 1.9 10.4 7.5 7.1 5.3 8.0 8.3 6.9 7.7 9.6 8.5 8.9 9.2 8.2 7.4 7.1 5.4 5.0 7.3 59.5 12.4 34.6 17.8 17.9 17.4 17.1 15.0 17.5 12.3 13.6 14.5 19.0 17.5 16.2 13.7 7.2 13.2 14.5 4.4 5.2 4.8 6.1 4.6 4.7 4.9 5.0 4.6 4.7 3.8 4.6 6.5 9.1 9.6 5.1 13.1 12.1 12.7 13.8 6.5 6.8 2.7 5.3 3.6 7.0 7.2 4.0 3.7 6.2 6.6 12.3 8.1 5.9 8.7 7.3 6.3 6.3 12.1 4.2 7.4 29.0 7.2 6.2 6.5 6.6 10.4 19.0 5.5 19.2 6.0 7.2 8.4 24.0 5.8 8.2 8.5 13.6 3.4 2.5 7.8 7.2 17.8 9.1 4.6 8.2 11.1 29.1 7.9 8.2 4.1 10.8 10.4 10.0 5.5 3.1 2.9 13.1 6.6 9.5 15.2 9.3 8.0 12.5 6.4 10.9 4.4 3.9 11.6 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" 3 88059255-88144660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364" "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavorable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 5.0 3.8 3.1 4.2 3.1 8.1 5.5 5.5 3.6 5.1 2.6 4.4 4.6 4.7 4.8 5.7 3.4 4.9 3.4 3.0 3.5 4.8 7.0 4.5 6.1 3.3 3.6 2.5 6.4 4.1 4.3 1.2 5.0 3.7 5.5 4.2 11.9 4.6 4.1 3.0 6.5 4.8 4.1 3.8 5.0 4.7 6.0 3.3 7.7 6.0 5.0 5.7 5.1 2.3 4.5 7.2 3.0 5.0 6.9 9.9 8.6 4.6 9.3 8.4 6.1 8.4 4.4 4.3 11.3 6.2 7.4 4.4 4.7 5.3 8.6 11.8 7.0 3.0 7.0 3.9 3.2 7.5 8.0 7.6 8.4 7.4 6.7 7.8 12.1 8.1 6.6 4.9 9.0 13.6 5.3 8.0 6.5 2.7 5.7 4.8 5.7 3.4 5.4 5.4 9.0 3.7 3.3 6.8 5.2 17.0 6.0 7.3 5.7 9.5 13.6 8.7 51.8 6.6 10.1 7.6 7.9 10.8 7.5 8.6 9.7 1.2 1.8 1.7 1.2 2.0 1.1 1.8 2.4 1.5 1.7 2.2 1.5 1.7 4.0 1.0 0.7 1.4 1.0 3.1 3.1 5.5 3.6 3.0 3.5 3.3 3.6 2.5 3.7 3.8 3.3 4.5 18.2 9.6 13.1 10.1 12.8 22.4 10.1 7.9 9.1 14.0 17.4 10.2 11.8 5.7 10.8 5.5 12.5 4.8 14.5 11.9 1.9 7.6 1.4 9.4 16.0 12.4 5.3 5.2 11.7 5.3 4.2 11.7 5.1 12.2 15.8 14.5 8.9 14.0 6.3 16.8 11.3 7.1 10.2 12.3 19.5 1.5 7.5 14.8 8.8 7.5 10.9 9.9 9.2 9.0 13.3 8.4 8.2 12.4 9.2 12.0 9.0 6.0 10.7 14.3 6.6 13.9 11.5 12.1 10.4 11.4 18.6 8.2 14.0 9.0 7.8 14.4 TVP23C "FAM18B2, MGC8763" ENSG00000175106 "Trans-golgi network vesicle protein 23 homolog C" Q96ET8 17 15502264-15563595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (2.87e-3)" "unprognostic (5.35e-3)" "unprognostic (1.01e-1)" "unprognostic (8.39e-3)" "unprognostic (1.33e-3)" "unprognostic (3.00e-1)" "unprognostic (6.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-3)" "unprognostic (3.43e-1)" "unprognostic (8.09e-5)" "unprognostic (2.42e-2)" "unprognostic (1.61e-1)" "unprognostic (3.50e-1)" "unprognostic (2.45e-2)" 3.8 6.7 4.8 2.3 4.0 11.0 4.6 7.2 4.5 7.1 7.3 3.2 2.1 4.6 3.3 5.9 4.2 2.4 3.7 3.6 4.4 4.3 4.0 4.6 2.8 5.2 4.7 3.5 8.8 5.2 3.8 10.2 4.0 5.7 6.5 2.1 4.1 6.0 2.0 3.0 4.4 3.8 2.2 3.6 4.8 3.9 5.2 5.2 1.9 6.9 1.5 2.4 3.9 5.7 7.1 8.3 7.3 2.7 3.9 3.5 1.8 4.2 6.9 11.6 12.1 14.2 9.3 3.3 0.0 3.7 5.8 6.6 3.5 8.4 5.2 8.6 5.2 4.5 5.5 6.7 13.2 3.2 2.0 5.0 2.4 2.0 12.2 7.2 10.2 11.1 2.9 6.7 3.5 5.3 2.7 3.5 5.6 3.0 3.3 2.5 0.6 0.3 0.4 3.3 4.8 0.9 2.3 8.7 1.0 1.8 11.3 4.8 1.1 7.9 2.0 2.8 2.9 2.2 2.2 2.1 0.0 2.3 0.0 1.8 11.3 1.8 8.4 3.3 4.1 4.5 6.4 4.5 5.0 3.0 4.6 5.5 5.1 2.9 5.0 2.9 3.3 4.7 4.3 4.8 4.0 7.2 4.5 3.6 4.4 5.2 4.7 3.5 5.7 3.6 5.2 7.1 3.5 3.2 8.2 0.0 2.9 4.0 5.4 4.3 4.6 5.9 4.2 2.7 17.2 0.0 7.0 0.0 14.6 5.9 5.5 3.8 1.9 2.9 1.3 6.6 4.4 5.8 1.8 3.0 0.0 0.6 11.7 5.6 6.6 6.5 2.5 6.2 1.8 0.7 3.2 6.7 0.0 4.0 6.1 1.9 3.3 0.9 3.4 2.3 1.8 0.0 2.4 2.6 4.1 0.0 0.0 1.6 2.9 2.2 9.2 5.2 4.3 0.8 4.3 10.5 0.0 3.3 5.6 10.0 7.9 5.5 2.8 5.5 4.7 7.2 4.9 7.0 MRPS22 "C3orf5, GIBT, GK002, MRP-S22" ENSG00000175110 "Mitochondrial ribosomal protein S22" P82650 3 139005806-139357223 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006083, HPA007830" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA006083: AB_1854122, HPA007830: AB_1854123" "unprognostic (8.38e-2)" "unprognostic (1.52e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (5.22e-3)" "unprognostic (5.45e-3)" "unprognostic (4.85e-2)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" "unprognostic (4.49e-3)" "prognostic unfavorable (1.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.22e-3)" "unprognostic (2.56e-2)" "unprognostic (1.49e-1)" "unprognostic (1.77e-1)" "unprognostic (3.40e-1)" 25.7 56.1 23.8 20.8 24.3 38.2 25.4 27.1 31.7 22.1 22.7 35.3 37.3 20.4 19.5 37.8 20.7 17.5 61.9 23.6 26.9 38.3 57.8 17.1 23.0 25.9 24.8 22.2 22.8 32.2 32.0 13.8 25.8 25.8 17.2 32.2 18.1 22.2 20.4 83.8 22.0 33.4 24.1 25.2 17.2 25.2 35.7 24.9 23.7 23.0 78.0 24.6 27.6 21.8 27.6 101.2 40.4 40.0 44.5 49.1 41.7 79.1 58.9 72.3 97.1 80.7 130.0 68.3 66.5 106.9 67.1 98.9 109.9 64.6 76.5 96.4 39.0 64.1 105.2 35.8 97.2 56.2 99.3 58.1 45.2 59.6 58.3 61.8 49.2 61.0 76.2 149.2 41.7 61.2 72.4 51.9 85.9 64.4 102.3 73.3 65.0 61.3 98.9 75.0 61.4 43.4 40.4 94.2 141.4 154.6 37.0 97.1 93.7 47.5 42.4 42.3 82.4 55.9 66.3 38.5 119.5 56.9 70.6 42.3 42.8 38.4 36.1 34.9 53.4 43.0 40.3 37.5 39.4 45.8 36.1 41.0 38.9 9.2 38.1 53.6 29.7 47.6 36.3 23.8 24.3 27.1 31.7 23.6 26.9 25.9 24.8 22.2 25.8 25.2 24.9 27.6 30.7 19.2 13.4 8.8 21.8 22.8 29.7 63.3 19.4 19.9 15.3 18.0 50.3 25.8 33.3 18.4 14.6 62.9 24.9 26.5 68.4 47.5 84.3 19.9 30.5 26.6 15.6 31.2 8.7 60.3 48.0 27.7 16.3 22.0 27.3 24.9 18.2 38.9 48.6 20.2 13.8 26.5 32.6 21.9 16.1 14.3 23.3 22.5 16.0 4.7 38.0 21.8 24.7 10.1 10.1 42.0 27.1 23.7 38.4 16.6 45.4 59.4 35.5 26.2 39.5 32.2 39.1 102.2 51.4 34.8 20.5 75.4 24.7 74.1 46.5 31.2 PACS1 "FLJ10209, KIAA1175" ENSG00000175115 "Phosphofurin acidic cluster sorting protein 1" Q6VY07 11 66070272-66244744 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038914 Approved Approved Microtubules,Cytosol NA NA 17000 "Microtubules, Cytosol" "HPA038914: AB_10672831" "unprognostic (7.03e-2)" "unprognostic (3.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.40e-1)" "unprognostic (3.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.80e-3)" "unprognostic (1.40e-2)" "unprognostic (3.55e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (5.31e-2)" "unprognostic (5.23e-2)" "unprognostic (3.46e-1)" 28.5 24.2 26.0 34.0 26.2 26.2 26.6 27.2 29.2 29.6 11.9 24.2 13.5 26.9 17.9 32.4 22.4 23.8 45.8 26.8 18.3 28.1 11.5 30.5 50.2 19.2 17.8 22.9 32.7 27.1 18.9 21.8 19.0 19.7 34.9 10.3 35.4 93.6 22.4 22.6 25.7 25.8 30.5 12.3 35.2 25.1 42.6 19.0 35.4 34.2 17.3 46.6 34.2 29.8 18.8 44.1 45.6 21.1 13.3 38.5 46.1 23.7 59.3 41.9 40.6 25.2 28.4 34.3 27.6 38.2 102.5 37.7 27.9 15.6 42.7 54.4 43.7 18.3 45.0 41.7 41.2 45.8 6.5 34.6 46.8 19.8 37.0 47.2 78.1 39.8 18.2 16.7 52.2 44.7 83.3 48.1 16.8 9.8 12.0 21.2 31.6 21.5 47.9 28.9 43.4 29.8 33.6 61.5 34.5 29.1 33.9 39.7 8.3 54.4 52.2 23.1 71.9 25.6 26.2 19.1 7.4 45.0 10.4 26.0 3.7 1.3 2.8 3.4 1.0 2.2 2.9 3.1 2.9 1.3 4.8 3.5 3.1 7.4 2.0 2.9 0.8 4.0 3.0 26.0 26.2 27.2 29.2 26.8 18.3 19.2 17.8 22.9 19.7 12.3 19.0 18.8 19.9 3.2 3.0 93.7 41.3 10.1 17.6 8.8 16.5 31.4 16.5 16.3 16.9 8.6 12.1 12.9 50.1 8.1 31.9 2.8 5.9 20.5 17.0 11.1 17.3 18.2 6.1 14.1 113.5 62.7 10.9 15.8 13.7 16.3 23.5 80.3 26.0 4.6 13.1 92.5 90.0 2.2 6.1 14.5 14.7 27.6 18.6 22.7 10.6 96.5 33.4 13.9 38.1 87.4 49.2 54.7 1.2 18.0 13.5 23.3 1.0 13.1 11.8 41.2 13.1 12.3 16.5 20.6 21.8 16.5 9.9 5.7 36.3 16.5 3.6 17.0 WFDC5 "dJ211D12.5, WAP1" ENSG00000175121 "WAP four-disulfide core domain 5" Q8TCV5 20 45109452-45115172 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "skin 1: 397.1" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 55.8;Early spermatids: 17.6;Late spermatids: 10.4;Suprabasal keratinocytes: 43.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.32e-1)" "unprognostic (3.22e-2)" "unprognostic (3.05e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-4)" "unprognostic (6.59e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.32e-5)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.96e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 1.5 1.2 397.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.6 0.0 0.0 13.4 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 55.8 0.4 2.5 0.6 0.0 0.1 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.1 0.0 0.0 17.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 10.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 3.0 43.2 0.0 0.1 0.0 0.1 0.2 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333839-32336233 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 743.2" "Cell type enhanced" "Detected in many" "monocytes: 941.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 8 "eosinophil: 252.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 252.7" "Cell line enhanced" "Detected in many" "AF22: 1016.3;NTERA-2: 984.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" NA Yes 170000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: AB_2673514" "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavorable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 43.1 60.4 388.1 82.8 511.5 50.5 103.9 549.6 431.8 81.9 240.7 109.1 62.3 94.3 157.1 15.2 72.9 98.1 44.4 360.6 427.5 32.6 39.0 40.3 177.4 592.0 532.7 319.4 361.0 23.9 6.5 23.1 43.3 586.9 85.4 117.6 38.2 76.6 50.3 8.8 26.6 56.6 43.1 555.0 63.6 133.9 140.3 479.0 167.5 111.3 11.1 201.1 78.5 27.3 743.2 82.9 73.3 1016.3 418.6 22.5 8.3 181.0 34.0 21.2 99.9 66.0 176.0 59.9 185.7 124.4 23.2 0.3 43.0 333.1 3.8 73.3 4.5 246.5 10.0 27.0 392.4 68.7 48.8 0.9 114.8 13.7 75.0 2.1 154.2 295.0 312.6 291.5 2.2 135.7 197.5 613.5 205.9 984.3 267.4 168.1 754.8 109.4 87.7 152.1 163.1 629.0 597.8 178.8 194.2 587.8 411.9 135.4 85.8 87.8 41.8 241.3 3.9 66.1 27.8 2.3 489.8 4.7 73.6 225.7 3.1 4.0 252.7 3.8 23.1 1.4 20.0 7.4 4.9 6.6 27.7 15.3 6.4 18.2 1.1 30.3 9.0 4.8 4.9 388.1 511.5 549.6 431.8 360.6 427.5 592.0 532.7 319.4 586.9 555.0 479.0 743.2 242.5 0.0 1.3 27.1 191.1 93.7 114.7 43.5 40.5 27.7 465.7 385.8 8.5 178.7 68.8 60.7 6.2 16.1 110.1 194.1 82.2 389.7 37.4 68.7 190.3 326.9 746.2 74.4 4.2 307.2 116.4 124.3 246.2 115.2 22.3 378.6 462.3 5.3 21.2 10.1 21.9 514.2 236.0 61.0 365.3 66.7 613.3 82.0 300.6 9.4 941.4 464.3 46.4 93.0 428.3 751.6 292.8 641.3 39.5 418.8 30.2 9.8 15.6 14.8 131.5 40.3 210.0 14.8 102.7 22.5 83.1 13.4 89.8 172.0 447.1 586.9 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248825915 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.7;eosinophil: 4.1;neutrophil: 4.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 9.7 10.6 18.2 10.2 17.9 9.1 7.7 17.1 21.1 8.9 13.8 11.6 13.6 10.6 7.8 16.0 10.0 8.1 14.2 19.0 15.9 9.5 10.6 9.3 11.4 17.2 16.9 18.4 8.7 10.1 12.1 6.0 11.5 19.2 9.2 7.4 5.3 12.0 11.7 30.9 18.6 12.5 10.0 16.5 12.5 10.0 9.6 17.0 13.9 8.2 18.0 10.3 9.1 9.2 17.9 23.2 14.7 18.5 21.2 25.7 17.1 24.6 51.1 17.4 29.2 21.8 14.3 20.0 11.6 29.7 44.1 7.3 24.6 17.9 22.1 15.0 25.4 6.3 18.6 16.4 11.9 15.8 20.4 21.9 14.4 23.4 33.0 12.9 20.7 19.6 21.4 33.0 12.0 20.2 7.9 19.7 16.5 32.4 25.5 36.9 21.9 13.0 23.5 20.5 10.6 21.1 29.2 15.6 19.3 17.9 14.0 21.0 42.4 27.5 36.9 15.7 14.7 80.2 30.5 34.3 10.5 26.8 23.5 15.4 7.7 1.2 4.1 0.7 0.8 0.7 0.6 1.0 0.6 1.1 0.6 0.3 0.3 4.6 0.3 0.3 0.4 0.2 0.8 18.2 17.9 17.1 21.1 19.0 15.9 17.2 16.9 18.4 19.2 16.5 17.0 17.9 5.2 0.0 2.0 5.9 4.3 4.6 2.1 2.9 4.0 8.3 6.1 5.0 9.4 1.5 2.3 11.0 0.0 9.6 4.7 15.1 1.9 8.8 1.3 10.5 5.4 6.0 7.7 6.9 6.5 6.0 5.2 4.9 7.7 6.1 0.0 9.0 6.1 10.0 6.0 8.4 5.7 8.4 2.0 5.3 4.5 1.0 4.4 5.6 3.6 3.7 7.1 4.7 6.2 6.0 6.4 10.6 8.1 5.7 5.4 3.0 13.8 9.2 5.1 3.5 0.0 3.7 5.8 8.8 7.0 7.0 4.7 11.4 6.3 5.4 7.3 3.3 OR2T1 OR1-25 ENSG00000175143 "Olfactory receptor family 2 subfamily T member 1" 1 248403048-248408020 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YPEL2 FKSG4 ENSG00000175155 "Yippee like 2" Q96QA6 17 59331655-59401729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 84.0" "Cell type enhanced" "Detected in all" "Horizontal cells: 489.6;Oligodendrocytes: 237.8;Rod photoreceptor cells: 862.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 28.2;HSkMC: 20.0;SuSa: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030501, HPA045621" Uncertain NA NA "HPA030501: AB_10602683, HPA045621: " "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (5.73e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "unprognostic (1.53e-1)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "unprognostic (3.00e-1)" "unprognostic (1.85e-1)" "unprognostic (3.04e-1)" 17.6 9.9 12.7 11.1 17.7 28.6 12.0 14.6 19.0 8.8 5.3 10.6 9.7 9.3 10.3 11.6 11.7 15.2 24.9 12.4 13.0 13.6 19.8 12.5 10.7 17.2 14.5 11.7 7.0 10.9 13.4 9.3 15.2 15.8 7.6 10.4 84.0 10.7 11.4 31.3 11.9 9.6 16.9 10.7 12.4 9.7 8.6 14.0 7.9 11.6 22.9 9.8 10.5 9.0 30.8 0.2 3.0 3.2 1.9 18.4 17.3 6.5 1.5 6.3 1.5 2.5 1.0 3.4 2.8 15.8 3.5 1.9 0.2 1.5 1.9 2.0 28.2 4.2 0.7 2.1 3.2 3.7 4.3 0.7 20.0 4.2 2.8 3.0 5.9 17.3 3.6 1.1 3.3 1.3 2.5 1.2 5.5 1.2 6.2 0.4 1.3 1.0 5.9 5.5 2.6 2.6 10.4 1.6 1.5 4.5 35.5 2.9 6.2 12.0 1.6 4.8 1.2 0.4 4.6 1.5 0.9 3.6 3.2 2.1 13.5 12.6 7.0 3.4 17.2 2.1 6.2 5.5 4.2 7.1 8.6 10.4 7.3 10.5 13.0 17.5 2.5 10.3 7.6 12.7 17.7 14.6 19.0 12.4 13.0 17.2 14.5 11.7 15.8 10.7 14.0 30.8 44.0 22.4 15.5 18.3 20.0 19.8 6.8 7.5 27.9 75.9 59.8 23.6 43.2 44.3 15.8 27.6 196.0 1.3 17.5 32.1 7.9 46.0 2.5 29.5 15.0 64.4 30.5 10.3 40.0 16.2 11.1 40.2 43.3 52.8 4.5 130.8 29.3 31.2 9.2 489.6 35.4 42.9 14.2 58.5 37.4 6.2 19.3 40.6 24.9 37.5 34.4 25.1 12.3 13.6 237.8 15.9 25.2 15.8 8.7 21.5 17.9 27.3 25.5 862.6 39.5 17.6 56.8 2.3 14.0 13.6 26.6 2.2 20.2 75.6 17.4 13.3 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958989-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "brain: 47.5;retina: 95.7" "Group enriched" "Detected in many" 6 "Astrocytes: 1985.3;Excitatory neurons: 4097.4;Inhibitory neurons: 3632.5;Oligodendrocyte precursor cells: 3613.6;Oligodendrocytes: 5060.4" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 6.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "AF22: 10.9;AN3-CA: 31.4;U-266/70: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced NA NA 250000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 4.8 4.7 17.8 0.4 24.7 0.0 1.7 18.1 47.5 0.6 0.0 2.5 0.3 0.2 0.5 1.0 3.0 0.9 2.8 25.5 17.2 0.1 0.9 0.5 0.1 20.7 25.1 22.7 0.6 0.7 0.4 2.9 0.2 22.8 1.7 1.0 95.7 0.6 4.5 3.9 0.2 0.9 0.4 8.5 0.2 1.8 0.5 25.2 0.2 0.4 4.1 0.1 0.9 1.0 36.5 0.0 0.1 10.9 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.5 0.0 0.0 0.0 0.0 3.6 2.3 0.9 0.0 0.0 0.0 0.0 0.0 1.1 3.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 24.7 18.1 47.5 25.5 17.2 20.7 25.1 22.7 22.8 8.5 25.2 36.5 57.3 0.0 1.1 1985.3 0.0 1.0 0.7 0.1 5.7 230.3 2.2 3.4 13.2 0.0 0.8 0.0 519.1 0.3 0.2 0.7 0.0 0.2 3.0 0.1 0.5 3.5 1.8 0.0 4097.4 0.2 0.2 3.6 0.0 0.1 0.0 0.3 2.9 0.0 0.4 94.2 3632.5 0.5 0.0 0.0 0.8 2.1 1.8 1.4 3.6 145.2 0.0 60.8 0.0 3613.6 5060.4 0.2 0.0 0.4 0.0 0.7 0.1 0.1 0.0 576.3 0.0 265.0 0.9 0.4 6.4 1.6 1.0 0.0 0.3 0.5 0.1 0.3 ABO "A3GALNT, A3GALT1" ENSG00000175164 "ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase" 9 133233278-133276024 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 13.5" "Cell type enhanced" "Detected in many" "Granulosa cells: 54.6;Intestinal goblet cells: 55.3;Proximal enterocytes: 194.0;Undifferentiated cells: 60.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0;naive B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 22.4;HaCaT: 15.4;K-562: 16.5;OE19: 20.6;RT4: 7.2" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.78e-3)" "unprognostic (2.56e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (1.39e-1)" "unprognostic (3.10e-2)" "unprognostic (1.84e-3)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (8.51e-2)" "unprognostic (9.30e-3)" "unprognostic (7.23e-2)" "unprognostic (2.67e-2)" "unprognostic (4.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (9.04e-2)" 1.2 3.3 4.1 5.2 4.7 1.7 1.3 3.2 3.8 0.5 5.2 7.2 3.2 1.3 1.4 6.2 9.6 3.3 0.3 4.3 3.9 3.8 0.6 3.4 0.5 2.1 2.2 3.4 10.4 3.3 3.7 0.5 0.4 2.2 1.3 0.9 1.5 1.3 1.9 1.8 1.1 13.5 0.9 1.7 0.5 6.1 2.7 3.9 0.1 5.3 0.5 0.5 1.4 2.4 4.2 4.8 0.0 0.2 0.2 0.5 0.0 0.5 0.0 0.6 0.3 0.0 0.0 22.4 0.2 1.0 0.0 0.0 15.4 0.0 0.0 0.0 0.2 0.0 2.5 1.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.1 16.5 2.2 0.4 0.0 1.8 0.3 1.5 20.6 0.0 0.1 0.0 0.0 0.0 7.2 0.1 0.8 0.9 0.6 0.0 0.0 0.7 0.1 0.1 0.3 0.2 0.2 0.0 0.3 0.6 0.5 0.1 0.0 0.2 0.8 0.1 2.0 0.1 0.5 0.0 0.1 0.5 0.0 0.0 2.1 0.4 0.3 0.5 0.0 0.0 0.2 0.2 1.5 4.1 4.7 3.2 3.8 4.3 3.9 2.1 2.2 3.4 2.2 1.7 3.9 4.2 10.0 32.1 32.2 1.0 1.5 0.0 3.8 0.0 11.4 0.0 4.5 2.5 3.2 11.5 14.9 47.8 0.0 1.3 0.3 38.1 0.0 5.0 5.7 14.8 1.1 9.2 25.5 11.8 3.8 0.4 0.3 5.2 22.4 10.6 0.0 54.6 3.3 0.2 0.3 0.0 0.4 55.3 0.0 1.0 0.0 10.0 15.2 9.2 0.0 4.7 0.9 0.0 0.0 0.0 0.1 6.1 42.0 6.8 0.1 7.0 194.0 24.1 30.6 0.3 6.6 0.2 5.9 0.9 2.5 25.9 0.0 0.7 3.1 42.0 60.5 16.5 PSMD2 "MGC14274, P97, Rpn1, S2, TRAP2" ENSG00000175166 "Proteasome 26S subunit, non-ATPase 2" Q13200 3 184299198-184309050 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 335.6" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 349.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045192, HPA062363" Enhanced NA NA 430000 "HPA045192: AB_10961324, HPA062363: " "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (6.82e-2)" "unprognostic (2.43e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (9.98e-4)" "prognostic unfavorable (6.63e-7)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.69e-1)" "unprognostic (4.68e-2)" "unprognostic (1.51e-2)" "unprognostic (1.32e-1)" "unprognostic (4.25e-3)" "unprognostic (1.53e-1)" "unprognostic (9.12e-2)" "unprognostic (1.13e-2)" "unprognostic (2.74e-3)" 64.7 103.4 66.3 62.5 67.4 78.4 53.7 68.4 72.3 54.2 62.7 70.3 49.8 69.7 45.9 84.9 54.0 41.7 102.3 66.7 71.2 63.3 69.3 59.8 58.3 73.0 80.1 63.8 50.7 48.4 83.6 59.2 58.9 79.2 52.7 63.8 47.3 61.1 60.3 335.6 78.7 56.2 77.4 68.0 59.6 63.9 102.7 72.4 74.1 55.8 184.9 77.8 65.0 59.3 74.5 800.0 248.6 194.3 328.7 226.2 129.6 238.8 478.3 363.6 580.3 327.6 349.1 163.4 251.5 643.4 393.8 467.1 254.3 290.3 516.4 725.0 383.6 234.1 268.4 229.6 211.9 123.7 191.9 211.8 147.3 156.8 549.5 339.0 219.1 353.6 188.9 201.1 226.9 476.0 310.7 199.4 110.1 279.4 290.8 438.1 217.6 287.8 262.9 240.4 248.7 174.5 134.7 376.2 321.3 174.7 208.4 446.5 145.1 463.6 361.2 383.9 293.3 1049.9 219.7 501.3 412.9 438.7 204.2 256.7 48.8 86.0 82.2 61.9 74.5 56.7 59.0 60.1 68.0 103.1 53.5 58.5 56.3 26.6 76.7 79.6 48.3 66.9 96.3 66.3 67.4 68.4 72.3 66.7 71.2 73.0 80.1 63.8 79.2 68.0 72.4 74.5 49.0 67.3 61.7 13.4 53.4 71.1 66.2 101.1 58.1 66.9 38.7 31.5 113.3 38.6 81.8 57.0 20.9 153.8 60.6 67.3 90.1 183.2 161.8 56.1 55.0 63.0 79.6 105.9 21.0 130.8 117.9 60.3 45.3 61.3 40.5 111.3 35.0 60.5 83.8 72.3 20.0 40.0 79.3 38.8 54.0 90.3 48.7 58.5 53.4 15.9 94.1 117.1 51.5 12.5 16.6 349.2 33.3 65.8 84.4 63.1 59.1 97.0 71.5 60.5 32.9 48.2 183.0 184.6 138.9 65.2 67.1 222.9 53.0 94.3 55.8 57.7 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755854-58985179 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 34.7;retina: 22.5" "Group enriched" "Detected in some" 4 "Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1" "Cancer enhanced" "Detected in some" "glioma: 2.7;prostate cancer: 3.0" "Group enriched" "Detected in many" 5 "cerebral cortex: 32.8;hippocampal formation: 34.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.1 5.5 5.6 0.1 5.2 0.0 0.1 1.3 32.8 0.2 0.0 0.1 0.1 0.3 0.9 0.0 1.5 0.1 1.0 34.7 6.3 0.7 1.0 0.2 0.2 2.0 4.3 4.6 0.2 0.6 0.3 1.3 0.0 2.8 1.4 0.0 22.5 0.2 0.0 0.0 0.0 0.2 0.4 0.3 0.2 0.5 6.7 6.7 0.2 0.1 0.1 0.2 0.1 0.1 6.3 0.0 0.1 12.2 0.6 0.0 0.0 0.9 0.0 0.0 0.9 1.4 0.0 0.0 8.0 0.1 0.1 2.7 0.0 19.9 0.0 0.5 0.2 5.9 0.0 0.2 0.0 1.3 0.6 2.6 0.3 1.6 0.1 0.0 0.6 0.0 4.9 2.1 0.0 0.0 3.6 9.9 0.0 3.5 0.0 1.0 0.0 1.5 0.0 0.0 0.0 9.1 18.7 0.3 0.0 1.3 0.1 0.0 8.7 0.0 0.0 2.2 0.0 2.9 0.1 0.1 5.4 0.3 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 5.2 1.3 32.8 34.7 6.3 2.0 4.3 4.6 2.8 0.3 6.7 6.3 0.1 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.4 3.3 0.0 1.8 0.0 31.3 0.0 0.0 0.1 0.0 0.0 30.8 3.9 0.1 0.3 3.0 0.0 220.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.4 0.1 77.4 288.4 0.0 0.0 0.3 0.0 17.6 0.0 0.1 0.0 5.6 0.0 4.2 0.0 109.1 38.4 0.0 0.2 0.4 0.0 1.3 0.0 0.1 0.0 13.8 0.0 0.0 0.5 12.1 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042800 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 14.0 22.9 40.4 5.5 51.8 3.3 13.6 23.9 52.3 17.3 19.6 22.1 7.6 19.3 5.1 13.3 20.8 10.3 28.3 66.9 37.5 13.2 5.6 17.0 4.4 30.2 28.9 53.0 24.4 13.9 14.6 55.2 5.9 29.5 17.2 3.8 4.9 10.9 12.4 17.4 30.0 13.9 10.1 21.5 10.8 16.8 16.5 34.1 3.2 12.9 18.2 2.9 17.2 15.3 43.7 14.5 6.1 9.5 16.3 12.1 10.2 8.8 6.5 13.7 9.6 7.5 4.7 5.1 2.1 25.9 6.0 20.7 13.5 0.0 11.8 5.8 15.7 16.0 0.1 9.4 10.2 12.4 0.3 10.8 7.3 1.9 8.4 19.2 9.2 19.4 9.7 3.2 2.1 3.3 11.3 5.6 0.3 16.1 8.7 11.8 10.4 4.0 14.0 9.8 0.5 28.2 29.3 4.1 10.5 14.7 5.9 31.9 3.3 20.2 12.1 9.3 9.9 20.0 22.9 15.4 1.5 38.5 2.1 8.3 1.5 3.8 4.8 1.1 4.9 1.2 1.4 0.8 1.1 4.2 1.4 0.9 1.1 8.3 1.2 2.7 1.7 1.7 2.2 40.4 51.8 23.9 52.3 66.9 37.5 30.2 28.9 53.0 29.5 21.5 34.1 43.7 15.5 6.4 5.0 13.7 5.5 11.1 20.0 6.1 5.7 24.0 8.0 11.0 7.6 14.3 4.1 14.7 14.6 9.0 4.6 11.6 1.9 6.0 4.4 6.5 10.5 11.5 9.6 6.1 30.8 3.5 3.5 9.7 5.1 11.0 7.0 55.9 13.6 1.4 7.9 23.5 16.6 7.5 6.1 5.7 14.2 2.5 18.6 7.7 1.8 11.2 9.6 13.1 6.2 6.6 11.9 10.7 9.6 20.7 2.5 15.2 15.7 3.4 15.8 15.9 6.6 13.0 14.4 12.9 7.1 3.5 14.6 33.2 5.0 20.0 8.7 15.9 CSRP2 "CRP2, LMO5, SmLIM" ENSG00000175183 "Cysteine and glycine rich protein 2" Q16527 12 76858709-76879023 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 275.3;Muller glia cells: 625.9;Smooth muscle cells: 268.4;Squamous epithelial cells: 271.2" "Cancer enhanced" "Detected in all" "glioma: 24.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 336.2;BEWO: 177.9;fHDF/TERT166: 184.9;HEK 293: 186.4;NTERA-2: 181.4;WM-115: 188.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045617 Uncertain NA NA 63000 "HPA045617: AB_2679391" "unprognostic (9.06e-2)" "unprognostic (4.32e-2)" "unprognostic (5.18e-3)" "unprognostic (1.58e-1)" "unprognostic (5.40e-1)" "unprognostic (2.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.18e-1)" "unprognostic (3.54e-2)" "unprognostic (2.67e-1)" "prognostic favorable (8.52e-4)" "prognostic unfavorable (4.48e-5)" "unprognostic (3.55e-2)" "unprognostic (4.41e-1)" "unprognostic (3.08e-1)" "unprognostic (3.45e-1)" 60.4 8.2 51.9 32.9 51.8 0.3 52.6 55.9 70.6 67.5 51.4 33.5 17.3 54.7 27.4 98.9 56.3 62.1 27.9 49.1 94.1 64.8 45.6 58.2 28.1 53.1 53.4 45.7 30.4 16.8 11.7 28.9 84.7 54.3 48.9 16.4 65.4 30.1 16.1 15.4 22.5 39.4 37.5 54.1 19.6 46.1 23.9 55.6 27.1 50.4 34.8 37.8 47.8 63.1 59.2 26.0 23.0 336.2 67.7 15.0 3.3 177.9 43.7 52.5 39.3 108.2 15.3 1.1 0.3 17.5 184.9 30.9 31.4 75.3 44.5 63.0 3.2 186.4 0.3 46.4 14.9 3.7 0.0 0.7 18.0 29.5 31.8 5.6 67.8 8.1 12.9 1.2 1.0 68.8 8.3 3.8 0.3 181.4 1.6 39.1 39.5 90.9 0.3 130.3 61.7 17.4 111.8 74.3 2.7 17.9 92.5 0.1 0.8 1.9 34.3 44.4 8.5 32.6 2.2 1.9 3.7 10.5 0.6 188.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 51.9 51.8 55.9 70.6 49.1 94.1 53.1 53.4 45.7 54.3 54.1 55.6 59.2 93.8 0.0 1.7 6.2 1.8 78.5 105.5 24.3 133.7 16.7 12.7 57.0 14.4 20.0 8.5 14.7 10.4 275.3 2.7 0.8 215.2 28.5 35.3 107.1 16.1 119.1 0.0 0.0 4.7 4.4 156.7 116.6 7.7 82.4 0.0 61.7 13.2 25.7 28.8 0.0 2.1 2.5 2.0 1.0 43.7 21.0 3.7 5.3 49.8 13.1 76.1 625.9 0.0 2.5 0.6 5.5 1.4 9.1 8.1 72.7 0.4 140.8 2.7 19.4 210.4 138.0 268.4 81.2 44.8 271.2 61.9 117.9 5.9 25.1 3.8 55.0 INHBC ENSG00000175189 "Inhibin subunit beta C" P55103 12 57434784-57452062 "Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 172 "liver: 166.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Hepatocytes: 5.7;Microglial cells: 1.0" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 6.4;Karpas-707: 6.3;RH-30: 2.8;U-266/70: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050755 Approved Cytosol "Secreted to blood" NA NA 21000000 Cytosol "HPA050755: " "unprognostic (5.26e-2)" "unprognostic (4.58e-1)" "unprognostic (3.43e-3)" "unprognostic (4.08e-3)" "unprognostic (3.76e-1)" "unprognostic (1.98e-2)" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-4)" "unprognostic (2.90e-2)" "unprognostic (1.52e-1)" "unprognostic (3.55e-3)" "unprognostic (5.05e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 166.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 6.4 0.0 0.4 0.0 0.1 0.0 0.1 0.4 0.0 0.0 1.6 0.0 6.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 2.8 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.7 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019545 Approved Approved Mitochondria NA NA Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favorable (9.11e-5)" 36.5 36.1 52.3 26.9 53.3 34.1 40.7 52.5 66.8 32.2 55.4 45.1 29.5 32.2 58.2 37.0 30.5 19.8 51.3 51.8 53.8 39.9 45.4 28.6 32.3 53.1 53.9 51.5 32.0 50.3 40.0 32.2 25.7 53.9 37.4 42.3 33.0 40.9 30.6 55.3 37.1 35.0 29.9 52.8 36.5 43.0 26.9 53.4 34.8 31.7 52.1 34.1 39.2 31.8 53.8 115.1 55.6 39.7 33.0 38.8 42.1 80.2 39.2 59.4 80.5 65.0 172.0 59.0 47.8 90.0 56.7 73.5 49.2 64.1 68.0 90.0 71.6 76.1 73.9 35.5 96.9 57.3 73.9 61.6 60.0 85.4 58.0 70.7 38.5 59.0 82.4 42.6 45.0 69.2 131.0 148.3 194.3 105.5 100.6 53.3 64.7 72.8 92.0 79.0 97.6 37.9 52.0 47.6 162.9 107.8 48.1 159.2 143.5 31.8 29.3 63.0 60.9 108.2 89.2 65.7 116.0 56.6 75.1 35.5 97.5 143.1 133.4 51.3 107.8 60.9 62.4 57.3 59.9 132.4 59.1 68.7 54.2 41.3 67.1 83.3 79.7 73.7 116.1 52.3 53.3 52.5 66.8 51.8 53.8 53.1 53.9 51.5 53.9 52.8 53.4 53.8 30.3 22.4 19.7 17.9 37.6 30.3 54.9 93.5 26.7 35.9 31.8 31.5 41.2 35.8 44.5 31.3 31.3 58.9 38.4 24.4 117.4 63.9 24.0 15.2 18.3 30.2 33.7 23.3 23.4 84.7 49.0 35.1 28.1 13.7 69.8 33.1 33.2 30.4 77.7 33.7 24.1 42.0 77.3 56.2 55.7 9.7 28.9 57.5 42.7 33.7 79.3 55.9 50.4 17.1 28.0 60.3 35.1 27.1 42.3 55.4 47.3 86.0 30.5 51.1 6.6 44.8 96.6 47.8 47.4 40.2 30.0 42.1 40.9 49.0 49.2 58.8 DDIT3 "CHOP, CHOP10, GADD153" ENSG00000175197 "DNA damage inducible transcript 3" P35638 12 57516588-57521737 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Growth arrest, Stress response, Transcription, Transcription regulation, Unfolded protein response, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 170.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 784.2;hTERT-HME1: 399.9;SK-MEL-30: 409.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058416, HPA068416" Uncertain Supported Nucleoplasm No No Nucleoplasm "HPA058416: AB_2683712, HPA068416: AB_2685985" "unprognostic (1.12e-1)" "unprognostic (5.33e-2)" "unprognostic (2.20e-3)" "unprognostic (4.92e-2)" "unprognostic (7.86e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.55e-4)" "unprognostic (8.55e-2)" "unprognostic (1.26e-3)" "unprognostic (9.40e-3)" "unprognostic (4.92e-2)" "unprognostic (4.16e-2)" "unprognostic (3.52e-2)" "unprognostic (3.70e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" 59.4 66.7 106.9 16.3 110.1 198.3 64.9 101.6 127.2 50.3 96.9 44.4 20.9 39.5 110.2 31.8 41.6 32.4 69.2 95.7 109.4 106.4 82.4 55.9 19.0 109.9 102.6 90.4 57.9 37.6 81.2 82.0 37.9 106.5 45.9 26.8 124.2 43.6 26.0 45.2 46.4 28.2 29.5 101.8 34.5 44.8 41.2 121.4 17.9 183.7 55.9 17.6 56.6 49.9 135.0 17.8 16.1 10.1 34.5 90.7 61.0 53.8 48.2 106.0 70.1 65.4 57.2 45.7 25.3 46.9 14.3 186.7 21.4 38.5 7.3 72.2 21.0 15.5 19.9 19.9 42.3 784.2 31.8 29.3 175.7 152.7 118.6 399.9 81.7 16.9 26.5 86.4 94.0 31.2 10.8 21.1 41.5 19.7 37.3 37.5 11.8 220.7 22.3 25.0 22.3 20.9 15.3 14.2 16.2 409.0 37.2 34.4 82.8 9.9 47.5 20.2 45.4 42.0 164.4 60.3 26.8 57.4 29.1 85.8 121.1 17.9 48.8 25.1 16.6 22.7 48.3 17.9 23.6 12.8 44.8 34.1 31.1 170.7 35.6 19.4 15.9 23.8 18.0 106.9 110.1 101.6 127.2 95.7 109.4 109.9 102.6 90.4 106.5 101.8 121.4 135.0 237.9 19.2 55.1 17.0 96.6 56.3 176.5 93.1 177.0 114.9 86.3 265.7 177.9 37.1 56.7 22.0 91.8 42.3 101.8 265.7 115.4 43.3 9.5 111.3 39.4 62.3 230.7 12.8 9.6 16.0 17.5 115.7 74.5 82.4 204.0 26.3 27.5 20.1 45.7 55.5 14.5 218.4 101.7 30.4 81.6 6.3 28.0 81.5 88.9 6.5 8.2 156.1 17.5 14.1 23.0 33.0 300.0 38.0 43.2 115.1 61.7 61.6 38.1 160.0 13.1 56.9 122.2 77.7 15.6 91.5 45.7 107.8 89.7 37.2 127.2 65.1 PCCA ENSG00000175198 "Propionyl-CoA carboxylase subunit alpha" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 220.1" "Cell type enhanced" "Detected in all" "Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria NA NA 290000 Mitochondria "HPA041716: AB_2677635, HPA047792: AB_2680156" "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favorable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 35.8 56.7 28.3 12.5 29.3 6.2 26.0 55.7 34.9 22.5 40.4 37.8 13.3 15.0 220.1 19.5 17.6 11.7 31.6 27.9 26.3 112.7 105.2 12.1 8.1 28.6 29.3 20.7 20.1 27.8 26.0 12.4 21.5 32.2 26.1 27.9 25.4 27.1 17.0 17.7 17.8 18.1 13.8 31.9 17.3 41.2 9.3 31.6 11.5 20.6 27.4 6.5 21.5 17.7 39.0 10.6 18.5 29.8 9.9 27.9 24.2 16.6 10.2 15.4 9.5 9.0 23.0 13.9 0.8 15.2 10.1 12.0 11.8 9.1 14.1 15.6 17.5 10.1 24.6 12.7 49.7 15.4 1.2 11.3 22.4 15.2 8.8 14.6 23.0 19.6 13.0 9.8 13.4 17.1 11.6 2.6 54.8 18.6 37.2 8.1 21.4 12.9 17.3 167.0 20.5 91.1 10.9 7.0 38.4 17.9 31.9 27.9 43.1 14.3 9.6 8.0 6.7 7.3 13.1 12.9 0.4 18.4 131.6 6.9 1.6 9.1 1.7 4.5 11.2 5.9 3.6 2.8 4.2 13.5 2.3 3.9 4.9 1.1 8.7 12.3 1.1 6.5 5.2 28.3 29.3 55.7 34.9 27.9 26.3 28.6 29.3 20.7 32.2 31.9 31.6 39.0 11.3 3.2 8.7 152.8 6.6 1.9 29.1 12.7 8.6 15.5 13.5 8.8 10.5 52.9 14.8 20.2 29.2 25.7 4.3 20.7 99.7 19.7 17.6 76.5 22.4 12.0 3.6 3.4 152.8 8.4 6.9 12.9 12.2 72.9 14.0 20.7 12.1 48.8 11.8 28.6 166.5 12.4 12.2 14.2 2.2 12.0 8.7 8.2 5.4 217.4 6.0 11.5 10.3 200.6 182.5 5.8 17.5 13.5 9.4 11.2 13.2 86.9 13.2 31.7 13.1 12.3 10.1 7.2 6.2 10.6 3.8 30.2 6.4 17.6 27.6 19.2 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675798-72686182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 3.6" "Group enriched" "Detected in some" 10 "Early spermatids: 18.3;Late spermatids: 8.6;Spermatocytes: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.3 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 8.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.1 0.0 20.1 1.5 0.0 0.1 0.1 0.1 0.0 0.1 0.2 DCTN2 "DCTN-50, RBP50" ENSG00000175203 "Dynactin subunit 2" Q13561 12 57529633-57547224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039715, HPA040040" Enhanced Supported Centrosome,Cytosol NA NA 630000 Centrosome Cytosol "HPA039715: AB_10795154, HPA040040: AB_10794870" "unprognostic (1.70e-2)" "unprognostic (1.82e-1)" "unprognostic (1.54e-1)" "unprognostic (6.88e-2)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.38e-7)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" "unprognostic (1.71e-1)" "unprognostic (4.26e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-2)" "unprognostic (9.50e-3)" "unprognostic (2.09e-1)" "unprognostic (1.52e-3)" "unprognostic (3.41e-3)" 81.4 100.5 77.0 41.0 78.8 45.0 77.4 85.9 83.6 88.9 62.2 102.0 45.0 99.1 62.3 121.1 72.5 44.0 99.8 77.9 84.9 85.4 51.1 72.3 43.7 89.0 83.5 76.3 76.5 117.0 78.9 76.3 52.8 93.0 66.9 74.2 61.9 83.6 66.0 156.5 100.6 76.5 94.1 81.8 64.8 95.7 52.3 80.0 61.9 70.5 103.6 72.0 80.3 90.6 91.6 94.9 109.4 129.1 90.3 194.7 200.0 69.4 104.7 191.7 205.0 149.6 87.2 79.0 95.5 114.1 172.5 83.8 70.8 106.0 136.4 162.0 108.7 119.1 84.8 48.4 69.9 139.3 58.7 60.0 186.3 213.8 131.5 225.1 245.6 201.9 102.0 127.7 126.6 189.5 107.4 89.3 71.8 62.4 56.2 124.0 77.2 101.0 91.4 158.1 92.3 173.2 125.8 98.3 85.2 96.7 104.0 138.5 54.4 153.5 110.6 95.6 69.1 66.7 94.6 91.6 93.8 106.4 73.8 121.2 47.9 48.5 43.7 38.0 54.2 39.3 32.9 37.9 38.0 49.2 30.3 28.1 34.3 22.5 35.1 50.3 37.5 45.5 62.8 77.0 78.8 85.9 83.6 77.9 84.9 89.0 83.5 76.3 93.0 81.8 80.0 91.6 82.6 48.1 30.2 20.2 47.5 64.9 87.2 105.1 58.6 84.3 64.7 76.7 70.9 65.8 60.0 35.0 31.3 118.2 53.5 83.4 80.3 162.7 105.5 42.9 58.6 74.0 49.1 53.6 27.9 227.5 122.1 73.6 80.5 52.4 36.2 70.8 69.9 31.7 102.6 72.3 32.6 70.3 83.4 51.8 54.2 265.5 77.9 52.8 76.5 15.0 153.5 141.9 57.7 23.1 28.2 200.4 85.5 73.0 60.9 85.3 121.1 115.8 40.9 67.8 92.1 59.4 107.6 122.7 37.1 93.6 68.5 163.4 52.6 92.3 94.5 89.5 NPPA "ANP, PND" ENSG00000175206 "Natriuretic peptide A" P01160 1 11845709-11848345 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 537 "heart muscle: 37245.5" "Cell type enriched" "Detected in some" 23 "Cardiomyocytes: 62235.0" "Cancer enriched" "Detected in some" 9 "glioma: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 9.6;SH-SY5Y: 9.5" "Region enriched" "Detected in some" 7 "olfactory bulb: 22.8" "Low region specificity" "Detected in all" "HPA058269, HPA064007" Enhanced "Secreted to blood" NA NA 1200000 "HPA058269: AB_2683660, HPA064007: " "unprognostic (1.27e-3)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (9.72e-3)" "unprognostic (2.21e-1)" "unprognostic (5.93e-4)" "unprognostic (2.31e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" 7.0 3.0 1.3 0.7 1.6 0.6 18.1 1.3 2.3 1.1 1.9 4.3 0.2 3.3 13.0 2.9 1.3 0.9 37245.5 1.7 1.2 2.5 5.1 58.6 1.2 1.3 1.3 1.6 12.2 69.3 0.9 4.0 5.9 1.1 5.1 0.0 0.4 28.8 0.0 9.0 5.7 6.1 0.7 1.1 3.1 3.6 3.9 1.2 0.5 7.1 0.0 0.0 1.2 3.9 1.7 0.5 0.2 0.3 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.6 0.8 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.4 1.0 0.3 1.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 1.2 0.0 0.3 0.3 1.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.6 9.6 9.5 0.0 0.0 0.5 0.3 0.3 0.1 0.0 0.4 0.7 0.6 0.1 0.4 0.8 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 1.6 1.3 2.3 1.7 1.2 1.3 1.3 1.6 1.1 1.1 1.2 1.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62235.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 339.1 0.0 0.0 0.3 0.0 0.0 2684.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 636.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF408 FLJ12827 ENSG00000175213 "Zinc finger protein 408" Q9H9D4 11 46701030-46705912 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017892 Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA017892: AB_1859248" "unprognostic (7.54e-2)" "unprognostic (2.41e-1)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (3.01e-2)" "unprognostic (6.89e-2)" "unprognostic (1.42e-1)" "unprognostic (7.13e-3)" "unprognostic (5.77e-2)" "unprognostic (3.38e-2)" "unprognostic (9.99e-3)" "unprognostic (9.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-2)" 5.5 5.1 5.2 4.0 5.6 14.6 5.7 5.8 7.9 6.0 3.7 6.4 5.1 7.9 1.6 8.6 5.8 4.0 6.3 4.8 4.8 5.2 12.8 4.0 5.3 5.7 5.4 4.5 5.7 6.6 3.2 5.4 3.7 5.3 7.3 2.9 1.3 5.8 4.3 10.4 9.8 6.6 3.5 5.2 7.6 7.5 6.0 5.8 5.4 5.3 6.3 3.4 7.2 6.0 5.8 4.8 11.4 5.2 9.4 6.5 5.7 13.5 6.3 8.8 12.5 9.1 10.3 5.3 7.4 5.7 7.6 9.0 12.2 6.7 12.4 4.4 5.9 13.5 7.1 8.0 12.7 12.2 7.4 9.7 11.2 12.0 6.3 9.0 6.7 6.2 11.1 11.4 6.5 5.2 15.5 9.0 15.1 21.8 15.9 13.8 9.8 7.8 11.7 6.7 12.5 7.3 9.8 12.1 15.0 10.0 4.8 13.1 12.9 7.1 12.2 8.1 10.2 12.4 9.4 8.8 10.9 7.9 8.5 9.9 3.9 7.6 7.8 8.5 8.3 6.6 6.3 8.3 10.2 7.2 7.6 9.2 7.0 7.1 5.8 6.3 5.7 8.1 7.3 5.2 5.6 5.8 7.9 4.8 4.8 5.7 5.4 4.5 5.3 5.2 5.8 5.8 4.6 6.4 2.2 1.6 7.5 6.6 5.5 12.0 7.4 5.1 6.4 5.5 5.3 4.3 5.7 1.8 0.0 10.1 8.5 9.6 11.7 7.8 5.6 7.0 7.2 4.8 8.4 11.4 1.4 4.8 7.7 4.5 6.6 14.9 0.0 8.2 5.3 9.2 5.5 3.3 1.6 9.4 2.0 7.1 2.8 3.2 6.2 3.2 10.6 1.9 6.6 7.9 8.2 1.5 2.1 5.9 3.2 6.4 5.2 4.5 9.0 5.8 4.3 3.5 13.1 3.7 7.2 11.2 9.0 7.5 4.1 10.5 4.8 5.7 7.1 6.0 CTDSP2 "OS4, PSR2, SCP2" ENSG00000175215 "CTD small phosphatase 2" O14595 12 57819927-57846729 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "RH-30: 1208.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052607 Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052607: AB_2681883" "unprognostic (7.09e-2)" "unprognostic (2.45e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (4.39e-1)" "unprognostic (5.57e-2)" "unprognostic (1.05e-3)" "unprognostic (2.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" "unprognostic (1.12e-1)" "unprognostic (4.15e-1)" "unprognostic (7.38e-3)" "unprognostic (5.50e-2)" "unprognostic (6.50e-2)" "unprognostic (2.18e-1)" "unprognostic (3.11e-1)" 91.7 83.1 66.6 66.0 75.2 46.1 82.5 75.8 63.5 78.5 59.1 99.4 54.8 97.2 51.9 67.5 90.7 65.3 68.1 62.0 62.7 66.8 59.2 114.9 66.7 89.3 77.7 55.2 108.2 120.4 68.7 40.6 95.0 71.6 70.7 84.0 30.4 110.0 83.6 123.5 89.6 77.6 95.6 70.8 76.1 90.6 32.5 69.5 105.8 68.7 103.7 78.1 85.9 72.4 81.1 83.1 35.4 165.6 105.8 145.6 248.8 55.0 87.4 165.1 85.2 75.4 45.6 131.5 101.3 98.1 187.5 33.2 64.8 70.0 85.3 88.8 34.2 29.7 140.3 54.4 37.0 135.4 64.3 78.3 239.7 88.9 77.3 65.1 181.9 135.0 60.6 74.5 172.9 43.4 38.2 69.1 38.3 84.3 52.5 44.4 91.0 1208.7 133.2 66.2 118.6 31.1 68.3 122.1 69.4 105.3 100.2 125.8 110.4 109.3 75.0 80.8 85.6 31.5 51.4 59.6 120.3 84.4 58.5 59.7 12.6 9.1 14.4 6.1 8.5 7.2 6.6 8.6 7.1 8.7 6.0 9.8 7.6 17.2 8.2 7.6 7.2 6.2 7.4 66.6 75.2 75.8 63.5 62.0 62.7 89.3 77.7 55.2 71.6 70.8 69.5 81.1 50.9 73.7 42.7 31.3 28.5 67.6 45.2 34.6 51.8 19.0 51.2 36.6 34.0 78.6 27.6 47.8 16.7 43.7 48.8 151.1 15.6 72.9 52.2 33.4 51.2 59.3 48.7 50.1 15.8 135.0 41.4 51.0 20.4 50.1 24.7 44.2 86.4 59.1 42.3 20.2 11.0 39.4 16.2 76.1 43.5 151.9 51.9 39.5 42.7 16.9 81.9 44.4 42.2 17.6 27.9 105.8 49.3 48.5 30.3 70.4 57.5 30.6 18.4 11.2 72.3 49.2 53.3 6.3 25.1 39.6 76.1 56.2 34.3 34.8 37.3 99.2 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 119.7;Spermatocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 360000 "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 12.9 30.9 15.5 15.3 19.3 26.1 15.0 30.6 24.5 11.8 4.4 18.7 12.7 15.8 12.3 13.1 11.6 12.3 21.5 19.5 19.8 11.6 45.9 10.5 18.6 20.9 16.4 17.0 28.1 9.1 21.4 12.6 17.5 22.0 16.1 17.4 57.5 9.2 13.3 38.2 13.8 12.4 19.5 15.2 12.0 16.2 33.3 18.7 36.8 9.7 29.1 18.7 13.6 10.9 24.0 104.7 95.8 212.6 90.8 48.7 73.0 48.3 117.1 69.4 107.8 114.6 76.8 33.3 104.5 41.0 76.0 117.0 116.2 144.0 62.7 134.3 102.0 107.6 176.6 80.2 78.4 35.0 139.6 76.7 37.0 34.0 60.3 125.6 56.1 79.3 97.9 129.5 103.8 89.2 71.2 127.9 39.2 114.7 78.8 73.0 131.2 210.0 98.3 34.7 63.3 96.8 83.9 149.8 56.9 57.3 88.9 103.9 39.1 64.0 106.2 92.9 180.8 176.2 59.2 137.3 158.6 66.5 64.9 105.9 4.6 4.2 4.6 6.1 6.2 5.9 6.5 4.5 6.9 6.1 6.2 5.4 5.8 0.7 8.6 6.2 3.9 5.6 3.1 15.5 19.3 30.6 24.5 19.5 19.8 20.9 16.4 17.0 22.0 15.2 18.7 24.0 13.4 25.6 23.6 32.3 17.4 8.5 11.0 17.9 16.5 19.3 11.6 12.3 65.2 12.8 18.8 9.2 37.5 19.4 11.2 13.3 9.8 12.2 119.7 19.7 21.0 16.5 12.1 32.6 61.9 7.8 15.0 27.8 29.0 18.8 37.9 55.5 11.7 8.1 18.7 13.5 63.1 16.9 16.2 17.6 5.6 50.7 19.6 19.6 7.2 30.9 16.5 16.2 16.5 32.6 51.7 13.7 15.2 29.0 26.4 14.2 9.1 9.3 30.7 25.6 19.7 18.0 21.4 107.4 59.3 24.3 11.6 11.5 16.1 83.3 19.8 9.7 ARHGAP1 "CDC42GAP, p50rhoGAP, RhoGAP" ENSG00000175220 "Rho GTPase activating protein 1" Q07960 11 46677080-46700619 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004689, HPA008285" Approved Approved Approved Vesicles NA NA 11000000 Vesicles "HPA004689: AB_1078194, HPA008285: AB_1078195" "unprognostic (1.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.05e-3)" "unprognostic (5.19e-2)" "unprognostic (2.48e-2)" "unprognostic (9.07e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.34e-3)" "unprognostic (1.24e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.94e-1)" "unprognostic (4.79e-2)" "unprognostic (4.13e-2)" "unprognostic (3.49e-2)" "unprognostic (2.55e-1)" "unprognostic (9.24e-2)" 72.1 49.6 37.5 38.3 44.9 33.7 62.3 32.3 42.1 68.9 30.4 56.6 25.9 94.5 21.7 75.6 69.0 51.1 113.4 38.3 42.1 41.5 46.5 38.7 31.0 44.7 42.3 35.5 46.8 36.8 24.9 37.1 39.4 41.7 65.4 32.9 9.7 46.5 63.2 30.3 61.6 47.1 81.3 36.7 58.9 49.4 16.0 40.0 23.4 44.9 20.7 34.9 108.8 63.9 52.8 23.0 56.7 27.9 39.8 135.4 99.6 32.9 50.3 50.7 45.3 41.2 34.2 29.5 33.1 26.7 102.3 40.7 55.8 22.4 76.0 33.5 23.3 24.6 36.8 27.7 40.4 44.5 31.3 52.3 131.9 46.7 34.5 42.9 46.8 39.1 27.1 24.3 30.3 55.9 82.6 21.2 30.9 72.1 78.5 29.4 25.0 39.9 49.3 42.3 85.2 10.0 31.6 45.8 69.8 19.1 40.1 88.0 35.4 49.1 82.1 25.5 98.7 51.0 32.0 38.2 24.8 77.4 52.0 39.3 27.6 33.0 33.1 26.7 56.9 19.3 14.3 20.8 22.8 32.3 14.7 17.9 20.8 37.3 23.7 72.0 34.1 27.4 24.9 37.5 44.9 32.3 42.1 38.3 42.1 44.7 42.3 35.5 41.7 36.7 40.0 52.8 25.2 19.2 18.7 16.6 18.3 8.5 13.4 24.6 10.8 11.9 22.3 24.6 50.2 10.0 18.1 29.5 27.1 25.1 35.2 35.2 3.9 22.2 0.4 17.9 26.9 19.6 19.4 15.3 13.0 27.9 31.0 29.2 31.6 27.6 19.6 21.3 25.7 32.1 30.4 16.8 15.3 36.0 14.2 30.7 8.4 1.7 23.6 19.1 8.8 11.2 28.2 11.0 36.0 23.1 92.3 27.3 19.2 35.3 10.1 11.4 22.4 13.3 10.9 14.2 59.2 28.0 55.9 3.1 3.5 24.7 13.1 16.6 19.9 9.4 21.5 18.7 MED16 "DRIP92, THRAP5, TRAP95" ENSG00000175221 "Mediator complex subunit 16" Q9Y2X0 19 867630-893218 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030685, HPA046495" Uncertain Approved Nucleoli NA NA Nucleoli "HPA030685: AB_10601872, HPA046495: AB_2679674" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "prognostic favorable (5.46e-4)" "unprognostic (1.90e-1)" "unprognostic (5.25e-3)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-1)" "unprognostic (3.15e-2)" "unprognostic (4.93e-3)" "unprognostic (3.28e-1)" "prognostic favorable (1.11e-5)" "unprognostic (4.83e-2)" "unprognostic (5.52e-1)" "unprognostic (1.57e-1)" "unprognostic (5.17e-2)" 43.7 38.5 27.1 19.5 26.2 14.0 41.5 19.9 57.9 46.9 17.5 38.5 15.5 34.9 1.9 44.6 35.3 11.9 32.0 26.4 22.9 44.3 69.2 32.9 16.3 26.2 25.7 29.6 44.6 55.7 12.9 39.6 13.6 23.5 54.6 5.8 5.0 36.4 10.2 44.9 42.6 36.0 8.7 21.5 46.4 40.0 36.7 24.6 10.6 38.5 10.0 7.6 45.4 41.6 23.6 29.4 25.1 24.7 17.0 10.2 10.8 27.5 20.3 19.1 29.7 22.4 32.6 27.3 29.8 23.6 18.1 9.9 23.4 9.3 24.3 5.0 37.8 29.6 29.9 18.5 30.4 20.3 29.0 26.6 18.9 12.1 18.2 11.7 17.4 23.1 31.5 36.3 69.8 17.9 44.5 47.3 34.1 38.3 11.0 33.5 48.1 17.9 38.3 20.5 45.3 30.6 29.5 27.2 18.3 22.5 9.2 21.4 22.3 22.4 30.1 30.2 46.3 23.6 50.6 19.8 28.4 39.2 27.2 22.7 53.0 31.5 40.7 50.2 34.2 45.4 53.7 56.0 57.8 40.7 44.0 46.2 43.8 44.1 40.4 36.6 27.3 82.3 52.7 27.1 26.2 19.9 57.9 26.4 22.9 26.2 25.7 29.6 23.5 21.5 24.6 23.6 15.5 35.3 24.8 6.5 19.0 11.6 11.3 15.6 12.0 15.9 16.9 17.7 7.1 15.7 15.2 22.0 6.2 62.6 11.9 57.5 17.6 24.4 3.6 15.5 16.9 15.2 25.7 14.1 3.2 24.3 32.3 19.4 44.9 27.3 14.5 32.4 14.6 24.0 25.3 15.2 2.6 34.8 18.3 16.1 5.7 6.5 13.7 14.6 10.6 4.7 23.8 15.8 12.3 3.0 4.7 23.0 29.4 14.7 23.2 11.3 34.6 17.4 12.9 20.4 6.6 12.3 16.4 13.9 28.8 12.0 16.1 63.8 19.7 30.4 34.1 15.0 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 30.9 40.0 57.7 26.3 69.8 61.1 30.4 50.1 64.3 29.2 46.9 26.8 29.6 28.5 32.5 32.3 32.4 29.9 37.2 57.0 58.9 28.8 44.2 25.5 31.8 62.1 61.9 58.5 30.0 45.0 37.8 58.2 22.1 63.8 31.4 24.3 48.8 36.2 25.7 34.8 37.4 28.2 25.0 54.0 36.7 36.7 82.6 60.7 41.0 37.1 33.7 33.8 27.6 29.4 89.7 32.8 58.5 44.1 26.1 60.2 70.0 44.5 37.5 65.4 45.0 57.0 40.2 31.7 30.2 25.6 56.5 58.1 38.8 42.7 50.3 45.2 57.9 81.1 32.8 39.7 71.2 67.4 44.1 54.1 84.9 59.0 31.0 67.9 63.9 45.0 69.4 57.8 66.8 40.8 48.8 44.0 65.1 55.0 59.5 49.9 41.4 57.0 53.7 29.9 34.5 41.6 42.1 51.2 40.6 55.4 42.1 58.0 89.5 44.6 54.7 33.3 51.1 41.2 61.1 73.8 38.6 67.8 39.3 40.9 41.7 36.1 48.5 35.1 42.6 27.9 27.1 31.2 27.8 35.0 21.7 26.4 29.2 67.7 31.5 35.1 25.6 44.7 39.9 57.7 69.8 50.1 64.3 57.0 58.9 62.1 61.9 58.5 63.8 54.0 60.7 89.7 10.6 16.0 16.2 14.7 16.9 9.3 12.0 9.0 13.1 22.7 16.7 12.3 13.2 8.6 12.0 12.9 39.6 9.9 25.4 24.5 7.9 18.9 42.7 30.0 17.3 12.7 18.0 28.2 23.4 32.3 22.4 14.8 20.9 46.1 8.8 22.5 13.2 22.5 15.1 33.7 25.7 22.6 14.2 19.1 9.8 46.8 11.5 15.7 12.4 15.0 22.8 16.3 19.6 25.1 61.0 30.4 12.9 11.3 36.6 19.9 19.5 13.5 9.4 32.2 13.1 16.9 19.9 46.3 16.3 15.8 11.5 26.4 18.0 9.8 11.9 24.3 GAL3ST3 GAL3ST2 ENSG00000175229 "Galactose-3-O-sulfotransferase 3" Q96A11 11 66040765-66049161 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 17.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.9;Cardiomyocytes: 3.6;Cone photoreceptor cells: 10.4;Excitatory neurons: 3.7;Horizontal cells: 5.0;Inhibitory neurons: 4.7;Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 15.4" "Group enriched" "Detected in many" 5 "glioma: 4.7;ovarian cancer: 5.5;thyroid cancer: 10.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 6.5;SH-SY5Y: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "prognostic unfavorable (6.53e-6)" "unprognostic (1.24e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-2)" "unprognostic (2.01e-3)" "unprognostic (7.26e-2)" "unprognostic (2.07e-2)" "unprognostic (1.40e-1)" "unprognostic (5.29e-1)" 0.0 0.0 3.3 0.0 5.4 0.0 0.0 4.6 5.1 2.5 0.0 0.0 0.0 3.9 0.1 0.0 2.6 0.0 4.3 4.6 2.0 2.3 0.0 0.0 0.0 2.1 2.3 4.7 0.2 0.6 0.3 4.1 0.0 3.2 0.8 0.0 5.7 0.0 1.6 0.3 0.1 0.0 2.8 0.6 0.0 0.0 2.1 2.1 0.0 17.2 0.3 0.0 0.0 0.3 3.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.4 4.6 5.1 4.6 2.0 2.1 2.3 4.7 3.2 0.6 2.1 3.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 5.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 7.5 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 15.4 0.0 0.0 0.3 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf127 FLJ37118 ENSG00000175262 "Chromosome 1 open reading frame 127" 1 10946471-10982037 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 4.4;skeletal muscle: 16.7" "Cell type enriched" "Detected in some" 9 "Enteroendocrine cells: 20.4" "Cancer enriched" "Detected in single" 9 "pancreatic cancer: 2.8" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.3" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Cell line enriched" "Detected in single" 4 "THP-1: 2.6" "Not detected" "Not detected" HPA027654 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA027654: AB_10611814" "unprognostic (1.82e-2)" "unprognostic (8.57e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-2)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-2)" "unprognostic (8.47e-2)" "unprognostic (1.59e-2)" "unprognostic (3.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.04e-1)" "unprognostic (4.03e-1)" 0.2 0.6 0.3 0.1 0.3 0.1 0.1 1.2 0.7 0.1 0.3 0.3 0.7 0.0 0.1 0.6 0.0 0.3 0.6 0.2 0.3 0.0 0.2 0.4 0.6 0.2 0.5 0.2 0.0 4.4 0.1 0.2 0.2 0.3 0.1 0.6 0.0 0.2 0.0 16.7 0.0 0.4 0.0 0.2 0.6 1.9 0.5 0.6 0.1 0.2 3.8 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 1.2 0.7 0.2 0.3 0.2 0.5 0.2 0.3 0.2 0.6 0.3 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.8 0.0 0.8 0.6 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST1 "C6ST, KSGal6ST" ENSG00000175264 "Carbohydrate sulfotransferase 1" O43916 11 45647689-45665622 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;thyroid gland: 20.7" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Early spermatids: 75.9;Granulosa cells: 138.1;Spermatocytes: 96.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.3;TIME: 9.2;WM-115: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 10000 "unprognostic (1.77e-2)" "unprognostic (1.67e-1)" "unprognostic (6.37e-3)" "unprognostic (1.32e-1)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (6.22e-2)" "unprognostic (1.64e-1)" "unprognostic (1.39e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.64e-7)" "unprognostic (5.37e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" 2.2 3.8 31.4 0.5 27.5 0.3 1.9 0.3 31.6 2.2 0.0 1.7 0.5 2.3 0.1 1.0 5.5 0.6 4.7 30.3 8.9 3.7 2.1 4.5 0.7 11.3 12.3 31.7 5.4 1.3 3.3 12.0 0.4 10.7 2.0 0.1 1.0 6.5 0.3 8.8 1.0 1.6 0.5 0.4 7.7 1.6 4.0 18.8 0.5 20.7 1.1 0.4 2.1 2.1 15.8 0.0 0.3 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.0 0.0 0.2 0.3 9.3 0.1 0.0 0.1 0.8 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.5 0.7 0.2 0.0 9.2 1.8 2.6 0.0 0.0 0.0 0.0 0.0 3.8 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 31.4 27.5 0.3 31.6 30.3 8.9 11.3 12.3 31.7 10.7 0.4 18.8 15.8 4.4 0.0 0.0 38.5 0.0 0.1 2.9 0.4 0.0 10.0 1.4 0.4 2.1 0.0 0.3 1.8 0.0 0.0 0.2 0.0 0.0 2.6 75.9 0.7 1.1 21.1 0.0 0.0 23.9 0.2 0.1 2.3 0.5 2.5 0.0 138.1 10.4 0.3 0.2 0.0 10.2 0.0 0.0 0.9 1.7 15.0 5.6 0.9 0.0 4.7 0.0 4.5 0.0 3.0 3.9 0.3 0.0 4.9 0.0 2.4 0.0 0.1 0.2 0.5 26.3 0.7 2.6 96.8 1.4 0.2 0.0 0.0 0.5 2.3 0.0 0.9 GOLGA8A "CFAP286, FAP286, GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.0;HeLa: 80.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 23.4 18.8 22.0 10.5 17.8 8.0 32.7 23.1 27.3 52.9 15.2 30.2 10.6 31.9 32.1 31.4 37.9 7.3 20.4 19.0 13.0 23.5 6.9 22.6 14.1 19.5 16.1 12.6 63.0 23.1 6.4 22.9 2.2 20.5 38.1 2.2 26.6 27.1 10.3 7.6 34.8 38.5 3.2 11.0 48.5 30.5 40.3 16.2 1.2 57.3 1.0 2.1 33.2 40.6 31.9 2.4 13.4 3.7 12.5 0.1 0.0 2.8 20.3 0.1 3.4 1.5 23.3 0.0 0.1 3.6 2.4 6.9 21.7 9.5 6.8 5.3 20.1 7.6 48.0 80.1 15.0 1.3 18.4 12.6 0.0 19.5 2.3 0.5 2.3 0.3 7.0 46.0 40.0 9.2 4.3 4.7 34.6 6.9 6.4 7.2 19.6 11.2 16.2 7.7 13.8 17.1 8.2 13.6 9.2 2.2 0.1 3.6 11.4 10.5 15.7 3.5 0.0 3.6 37.5 13.4 5.5 4.7 38.9 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 22.0 17.8 23.1 27.3 19.0 13.0 19.5 16.1 12.6 20.5 11.0 16.2 31.9 37.3 211.5 71.6 82.9 16.1 26.1 10.9 13.4 7.4 95.3 36.1 41.9 35.0 5.7 127.6 1.8 100.1 2.9 21.1 6.5 0.0 4.2 37.5 17.6 83.9 18.4 16.1 2.5 114.4 2.6 5.0 17.4 13.7 52.3 13.9 39.3 14.6 1.5 2.4 84.1 91.8 11.9 14.2 6.8 20.1 8.4 31.4 8.5 23.2 38.4 1.7 14.8 6.2 146.8 62.5 4.7 6.9 21.1 19.3 8.5 6.6 0.9 52.0 117.6 0.0 26.7 22.4 33.0 23.5 7.8 21.6 3.3 32.9 39.9 11.7 9.4 VWA3A "FLJ40941, FLJ46765" ENSG00000175267 "Von Willebrand factor A domain containing 3A" A6NCI4 16 22092538-22156964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 24.8;choroid plexus: 45.1;fallopian tube: 40.0" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Club cells: 16.7;Endometrial ciliated cells: 45.6;Excitatory neurons: 33.8;Late spermatids: 15.2;Respiratory ciliated cells: 88.0" "Group enriched" "Detected in some" 4 "endometrial cancer: 3.2;glioma: 1.4;ovarian cancer: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041696, HPA042044" Uncertain "Secreted - unknown location" NA NA "HPA041696: AB_10964202, HPA042044: AB_10968997" "unprognostic (2.69e-2)" "unprognostic (1.54e-1)" "unprognostic (9.75e-4)" "prognostic favorable (8.15e-4)" "unprognostic (2.70e-1)" "unprognostic (4.46e-2)" "unprognostic (1.65e-2)" "unprognostic (6.79e-3)" "unprognostic (5.55e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (1.40e-1)" "unprognostic (2.16e-5)" "unprognostic (1.08e-1)" "unprognostic (2.97e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-4)" 0.3 0.3 24.8 0.0 11.8 0.4 0.4 8.2 13.3 6.2 45.1 0.3 0.1 2.5 0.1 0.1 40.0 0.0 0.5 6.8 14.5 0.5 0.1 8.9 0.1 17.3 23.3 6.5 0.5 0.4 0.1 16.7 0.1 13.0 0.4 0.1 0.3 0.1 0.1 0.1 2.0 0.3 0.1 20.5 0.3 0.2 8.3 9.9 0.1 0.5 0.2 0.2 0.1 0.1 10.8 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 11.8 8.2 13.3 6.8 14.5 17.3 23.3 6.5 13.0 20.5 9.9 10.8 0.3 0.0 1.1 25.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 45.6 0.3 0.0 0.0 0.0 33.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 15.2 0.3 0.2 0.0 3.7 0.0 0.0 0.0 4.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 88.0 0.0 0.0 0.0 1.2 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 461.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 41.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA059727: AB_2684113, HPA061276: AB_2684461" "prognostic unfavorable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 66.5 18.7 41.0 20.6 17.6 29.9 64.2 37.0 25.8 30.0 18.3 34.0 20.4 36.3 4.9 24.7 45.9 24.9 62.0 23.2 19.1 28.0 10.6 46.1 12.8 16.3 32.3 24.4 20.1 38.0 5.7 20.4 24.1 22.2 48.2 27.7 2.2 43.0 11.8 15.1 30.3 39.1 33.1 21.5 61.7 30.1 16.3 17.4 9.2 41.4 10.4 12.4 29.5 32.2 12.9 0.0 82.0 27.3 38.2 28.0 2.2 0.5 23.9 46.3 8.5 10.7 5.1 0.5 14.3 20.5 6.9 21.7 14.5 14.6 0.5 2.8 28.0 12.3 1.3 0.8 0.0 52.5 0.8 101.1 118.0 1.9 11.5 4.9 2.0 29.6 31.6 2.2 0.1 11.3 73.0 1.4 133.9 48.9 53.4 26.9 60.3 16.1 7.2 0.0 5.2 357.9 13.0 44.2 96.8 0.1 33.9 209.9 7.5 6.8 55.8 39.3 87.3 0.1 0.5 0.5 0.3 0.1 7.8 16.1 0.0 5.9 0.0 5.2 5.8 7.0 8.0 1.0 5.1 4.7 8.4 0.0 1.7 41.2 8.1 21.2 25.3 0.9 4.8 41.0 17.6 37.0 25.8 23.2 19.1 16.3 32.3 24.4 22.2 21.5 17.4 12.9 52.2 22.4 30.9 0.3 13.2 10.8 36.9 12.9 13.6 1.7 29.5 22.7 10.3 24.3 23.7 42.3 0.0 57.8 8.7 31.0 1.9 32.0 96.5 9.0 6.3 45.1 36.0 3.2 2.7 21.3 22.0 15.0 23.0 9.7 0.0 7.8 76.8 1.6 35.7 0.0 10.2 30.1 38.7 7.5 20.3 461.2 12.2 9.3 10.6 5.6 11.5 0.8 0.0 0.0 0.5 28.5 16.0 7.5 2.1 28.6 17.7 0.1 14.5 0.8 13.1 1.4 22.4 3.4 6.3 4.4 4.4 68.3 8.7 5.1 54.0 45.7 CENPS "APITD1, CENP-S, FAAP16, MHF1" ENSG00000175279 "Centromere protein S" Q8N2Z9 1 10430433-10442808 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.7;Distal tubular cells: 37.2;Proximal tubular cells: 86.1;Respiratory ciliated cells: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-1)" "prognostic favorable (1.24e-4)" "unprognostic (3.06e-3)" "unprognostic (2.21e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (4.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.26e-3)" "unprognostic (2.95e-2)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.04e-3)" "unprognostic (4.23e-2)" "unprognostic (4.66e-2)" "unprognostic (1.87e-1)" "unprognostic (9.21e-2)" 3.5 9.0 5.1 5.8 5.1 9.1 5.2 4.8 6.7 5.7 5.8 6.9 12.6 4.6 12.4 7.5 10.0 7.7 4.5 5.0 5.0 28.3 8.3 5.1 6.4 5.0 4.9 4.7 4.0 7.9 14.6 14.2 4.5 4.9 6.6 7.5 8.9 6.9 4.8 3.6 4.4 9.6 4.2 5.0 3.9 6.4 49.0 5.0 9.6 12.1 3.7 6.5 5.7 4.3 4.8 38.9 25.1 17.4 25.2 13.6 11.3 9.1 21.2 22.4 27.8 21.4 11.5 26.4 29.3 19.3 19.0 15.6 29.5 16.1 24.0 30.0 25.1 17.4 17.2 21.0 24.2 8.7 58.5 21.5 7.0 12.0 29.5 18.3 10.8 16.6 31.2 24.3 24.9 27.0 29.6 27.7 35.1 24.5 33.0 26.6 29.7 19.9 34.5 34.1 13.6 22.0 20.1 23.1 25.4 25.7 14.4 30.9 31.6 9.9 29.2 35.6 26.6 37.1 6.6 16.8 35.5 27.3 65.4 38.5 0.0 1.4 0.8 2.8 2.3 3.8 6.9 4.1 3.1 1.8 6.1 4.5 3.8 0.8 2.1 6.0 5.0 4.5 1.8 5.1 5.1 4.8 6.7 5.0 5.0 5.0 4.9 4.7 4.9 5.0 5.0 4.8 2.5 6.4 13.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.6 6.5 0.0 0.0 8.1 5.5 0.0 23.7 2.3 0.0 37.2 16.5 0.0 15.0 3.7 3.6 0.0 0.0 0.0 10.9 12.0 3.5 0.0 3.6 3.8 7.4 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.5 0.0 0.0 86.1 27.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 6.7 2.0 9.3 0.0 0.0 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947603 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 9.7 14.4 7.7 6.3 6.3 1.5 7.8 7.2 6.8 7.5 8.1 7.6 7.7 9.4 13.6 8.6 9.0 7.9 10.6 6.4 7.9 9.2 10.6 9.2 6.8 7.4 7.0 5.9 6.7 14.6 17.0 5.9 9.4 7.0 10.1 6.7 4.5 12.1 10.1 6.8 10.0 7.6 9.5 6.5 8.1 10.6 14.6 7.3 5.1 7.9 7.2 6.6 8.6 5.9 7.2 11.7 42.5 14.8 22.0 42.6 22.2 20.0 23.7 38.1 28.5 21.0 33.7 17.9 6.4 12.3 34.6 40.3 80.3 20.3 29.6 14.7 10.7 17.8 8.0 27.4 24.5 43.0 8.8 13.5 31.1 27.0 30.8 16.8 16.7 28.1 9.1 19.7 10.0 31.3 56.9 7.3 7.3 19.0 33.0 26.0 7.2 19.5 25.1 25.7 17.3 13.5 15.1 31.4 25.6 14.1 13.7 44.8 11.4 23.6 25.6 9.2 32.5 19.8 9.4 25.0 6.4 24.2 8.0 19.9 2.7 15.4 6.9 11.2 15.3 10.1 11.8 9.9 12.3 16.6 12.5 12.8 13.2 2.2 13.0 21.2 9.3 16.8 10.5 7.7 6.3 7.2 6.8 6.4 7.9 7.4 7.0 5.9 7.0 6.5 7.3 7.2 8.5 6.4 4.1 2.9 2.6 1.8 3.6 13.9 4.6 9.1 4.4 4.3 3.5 10.0 10.9 7.3 8.4 25.6 3.5 5.2 0.0 15.7 15.1 5.9 7.2 9.2 1.2 3.6 1.2 14.2 16.4 8.1 5.1 3.6 1.3 7.5 16.1 9.2 13.5 5.0 2.2 3.5 12.2 5.2 2.7 3.7 12.2 2.9 3.6 1.9 2.8 10.7 5.2 2.5 1.7 11.1 7.5 6.0 1.5 4.4 7.5 9.0 11.4 7.1 0.0 7.0 15.7 33.8 15.1 3.3 1.3 18.2 2.3 15.8 5.7 2.1 PHYHD1 MGC16638 ENSG00000175287 "Phytanoyl-CoA dioxygenase domain containing 1" Q5SRE7 9 128920966-128942041 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Muller glia cells: 139.3;Proximal tubular cells: 161.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 13.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 13.0" "Cell line enhanced" "Detected in many" "ASC diff: 46.5;ASC TERT1: 32.7;BEWO: 50.6;HSkMC: 28.3;RPTEC TERT1: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012115 Approved "Nuclear speckles" NA NA 36000 "Nuclear speckles" "HPA012115: AB_1859448" "unprognostic (1.18e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (2.16e-1)" "unprognostic (1.17e-2)" "unprognostic (4.49e-2)" "unprognostic (5.37e-3)" "unprognostic (1.35e-1)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "prognostic favorable (6.38e-10)" "unprognostic (1.10e-2)" "unprognostic (3.09e-1)" "unprognostic (2.14e-1)" "unprognostic (9.83e-3)" 27.4 25.9 41.9 3.3 40.6 8.5 34.9 41.3 41.1 40.1 41.0 19.4 2.3 34.1 38.7 25.8 28.8 13.3 33.3 38.0 51.3 50.0 79.3 23.3 4.6 48.1 45.8 33.2 39.4 70.7 15.7 15.6 9.7 46.2 37.1 3.8 42.2 40.4 30.3 29.5 41.3 12.5 15.5 48.6 14.9 33.7 7.2 48.9 6.9 43.4 12.9 4.7 26.2 25.8 51.1 0.2 0.5 0.4 0.8 46.5 32.7 50.6 3.7 0.0 3.4 6.0 1.8 0.5 0.7 0.4 3.0 0.3 0.7 0.4 0.3 2.9 0.5 5.4 0.1 6.7 18.0 15.1 0.8 0.6 28.3 1.0 0.4 0.2 0.2 0.3 0.3 0.3 1.2 24.3 0.4 0.5 0.7 17.0 0.2 0.2 20.5 9.7 0.3 78.9 0.7 1.1 0.4 0.5 0.3 0.3 11.4 4.7 0.6 1.3 0.7 2.1 0.7 0.5 0.4 0.9 20.7 0.3 0.4 0.7 1.3 0.2 0.2 1.3 0.3 0.3 2.8 0.4 0.5 1.7 0.7 1.8 1.9 0.8 2.2 0.4 13.0 0.3 0.5 41.9 40.6 41.3 41.1 38.0 51.3 48.1 45.8 33.2 46.2 48.6 48.9 51.1 8.5 32.1 34.3 51.6 3.7 22.0 63.2 26.8 57.5 9.4 40.0 46.9 19.8 10.0 31.0 33.1 29.2 58.8 3.4 0.7 119.3 11.4 0.4 27.0 26.0 9.5 1.2 12.0 1.2 15.8 30.0 34.5 7.7 53.8 0.0 42.8 31.8 82.2 10.7 3.3 0.8 2.4 4.1 3.2 5.5 4.2 68.6 3.1 12.4 5.6 0.1 139.3 4.1 1.0 0.7 14.2 0.5 66.2 2.6 19.3 0.0 161.5 14.6 67.5 52.6 48.1 17.8 0.9 3.9 32.7 24.3 30.9 2.7 44.6 1.4 35.0 CATSPER1 CATSPER ENSG00000175294 "Cation channel sperm associated 1" Q8NEC5 11 66016752-66026479 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 17.5" "Cell type enhanced" "Detected in some" "Early spermatids: 44.0;granulocytes: 99.6;Hofbauer cells: 19.9;monocytes: 27.3;NK-cells: 42.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.4;EFO-21: 4.0;HEL: 2.8;HMC-1: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.21e-2)" "unprognostic (3.00e-2)" "unprognostic (2.67e-2)" "unprognostic (1.91e-1)" "unprognostic (3.96e-3)" "unprognostic (1.71e-1)" "unprognostic (6.09e-3)" "unprognostic (1.88e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-3)" "unprognostic (5.99e-3)" "unprognostic (1.61e-2)" "unprognostic (2.12e-8)" "unprognostic (8.79e-3)" "unprognostic (9.02e-3)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.3 0.0 4.4 0.0 4.0 0.8 1.4 0.0 0.0 0.8 0.4 0.0 0.0 2.8 0.1 0.0 0.0 0.0 5.1 0.0 0.0 0.3 0.5 0.9 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 1.1 2.2 0.1 0.2 0.0 0.0 0.0 0.8 0.3 0.6 16.9 5.8 0.1 0.2 0.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.6 3.7 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 9.6 0.0 0.0 0.4 44.0 0.1 0.1 0.4 0.0 0.8 0.1 0.7 6.0 0.2 0.0 0.0 99.6 0.0 1.4 0.1 19.9 0.0 0.2 0.0 0.0 17.0 12.2 4.3 0.9 15.4 1.8 0.0 27.3 0.0 42.2 0.5 0.0 3.7 0.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 1.9 1.2 0.0 0.3 0.4 4.5 0.0 0.0 0.3 CCNE2 CYCE2 ENSG00000175305 "Cyclin E2" O96020 8 94879770-94896678 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 33.6;Oligodendrocytes: 34.5;Spermatocytes: 77.7;Spermatogonia: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 101.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007825, CAB019374" Enhanced NA Yes "CAB007825: AB_598148, CAB019374: " "unprognostic (1.80e-2)" "unprognostic (4.81e-2)" "unprognostic (7.49e-2)" "unprognostic (2.08e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.87e-4)" "unprognostic (8.37e-4)" "prognostic unfavorable (8.77e-4)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.64e-2)" "unprognostic (1.04e-2)" "unprognostic (7.01e-12)" "unprognostic (1.81e-2)" "unprognostic (1.50e-1)" "unprognostic (1.06e-2)" "unprognostic (3.03e-1)" 2.0 0.6 4.7 6.9 9.1 37.3 2.2 9.3 7.1 1.3 1.2 5.5 3.7 1.8 0.1 4.7 0.6 2.4 1.4 4.2 6.1 0.5 2.3 1.8 11.0 13.8 9.3 2.8 1.5 1.8 0.5 0.6 4.3 10.2 1.2 5.7 5.2 1.9 0.2 0.7 5.9 4.3 2.2 8.8 2.4 4.1 14.6 7.8 15.2 1.7 0.7 9.7 2.1 1.5 14.6 47.2 6.2 24.0 15.0 2.9 5.4 16.5 47.3 16.6 29.4 28.9 11.3 20.6 24.5 31.4 20.3 9.1 24.4 19.4 17.5 39.5 17.4 17.5 49.5 26.6 4.2 0.2 20.2 29.0 1.4 1.1 21.4 2.1 6.4 15.5 30.1 21.7 101.5 42.5 14.2 77.8 9.7 8.1 37.4 14.1 54.1 41.7 11.7 8.1 26.4 34.8 14.5 31.8 8.4 5.9 3.0 42.0 21.2 13.0 30.7 20.2 22.9 42.8 19.1 21.1 59.3 24.8 36.1 23.1 0.0 0.2 0.1 0.8 0.2 0.3 0.3 1.1 1.3 0.7 1.0 0.3 0.6 0.6 1.5 0.1 0.0 5.2 0.6 4.7 9.1 9.3 7.1 4.2 6.1 13.8 9.3 2.8 10.2 8.8 7.8 14.6 7.5 6.4 1.7 0.7 3.0 4.2 1.6 2.3 6.8 2.9 5.9 8.9 2.5 0.0 1.9 1.8 6.2 7.2 7.2 12.3 0.0 0.2 6.9 1.3 2.7 3.5 0.0 33.6 2.3 0.2 7.8 2.6 4.1 2.9 0.0 2.1 2.5 1.3 4.4 8.4 2.6 4.0 0.0 2.5 1.9 9.0 1.2 4.8 0.0 0.0 0.0 1.0 1.0 1.5 34.5 0.2 2.4 0.4 14.6 1.1 6.3 0.1 1.1 4.7 6.6 2.6 4.3 77.7 26.2 9.5 3.8 1.9 7.5 1.2 3.3 0.8 PHYKPL "AGXT2L2, MGC15875" ENSG00000175309 "5-phosphohydroxy-L-lysine phospho-lyase" Q8IUZ5 5 178208471-178232802 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036461, HPA063608" Approved Approved Mitochondria Yes No 160000 Mitochondria "HPA036461: AB_10670717, HPA063608: AB_2685059" "unprognostic (3.29e-3)" "unprognostic (2.60e-1)" "unprognostic (5.51e-2)" "unprognostic (9.75e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-2)" "unprognostic (3.29e-1)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "prognostic unfavorable (3.82e-5)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.41e-3)" 23.4 10.6 7.2 16.6 7.8 15.0 14.1 6.8 7.7 12.4 8.0 24.1 20.8 14.5 16.0 11.2 14.0 14.5 15.2 6.3 9.5 17.3 42.5 15.9 24.7 11.1 7.7 4.9 12.6 15.7 13.8 5.3 16.4 9.3 13.8 31.1 3.4 13.9 12.1 19.8 10.8 25.0 18.7 7.5 17.4 15.6 6.0 8.7 25.4 19.9 18.9 23.8 13.9 9.7 10.1 9.6 3.8 9.0 3.6 21.6 17.4 13.9 5.6 6.2 7.6 11.8 9.7 11.7 13.0 18.4 17.6 9.7 6.2 7.7 14.3 8.5 24.0 8.7 15.6 18.0 7.1 35.1 9.2 11.4 19.6 15.0 9.3 22.4 14.9 24.9 18.6 11.8 26.7 11.3 13.1 13.1 5.5 1.9 11.5 12.4 9.1 4.3 25.0 13.4 8.3 5.7 5.4 9.2 5.2 9.4 10.2 5.5 7.4 9.9 7.8 7.0 5.1 6.2 18.8 5.5 7.2 2.2 9.2 5.2 16.7 41.7 36.9 20.3 46.8 20.4 28.4 22.2 22.9 53.4 26.3 27.3 22.2 9.2 23.7 47.2 70.9 28.6 33.2 7.2 7.8 6.8 7.7 6.3 9.5 11.1 7.7 4.9 9.3 7.5 8.7 10.1 23.1 19.2 14.3 31.6 63.0 10.7 43.1 16.1 25.0 21.9 17.2 14.5 17.4 37.1 13.0 23.9 25.0 18.4 72.5 96.1 19.6 24.6 21.7 13.2 27.7 26.2 19.2 30.7 20.7 18.6 20.2 33.4 76.9 13.8 12.7 38.4 31.1 30.1 31.7 15.2 17.9 40.8 6.1 37.1 22.9 55.3 42.6 43.3 24.9 36.5 61.1 25.0 70.0 29.1 45.2 15.1 64.5 25.2 51.4 30.3 119.2 43.1 13.6 26.4 13.1 34.5 23.6 37.2 25.9 14.6 10.4 22.0 58.9 36.3 39.2 36.6 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233699-21253850 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 12.4;kidney: 5.9;liver: 13.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Region enhanced" "Detected in single" "cerebellum: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043523, HPA061125" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043523: AB_10966687, HPA061125: " "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.0 0.0 0.1 0.6 0.2 0.1 0.0 1.8 0.2 0.0 0.0 6.9 9.1 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 5.9 13.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.0 7.2 0.2 0.0 0.0 0.7 0.1 12.4 0.2 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.2 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.8 2.8 0.6 1.8 0.0 0.0 0.0 63.4 0.0 0.2 0.8 0.3 0.1 0.3 25.1 0.0 1.3 1.7 0.0 0.2 0.0 0.1 1.3 0.0 0.4 28.0 0.0 0.0 0.2 40.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.1 1.3 38.2 0.0 0.0 0.5 113.0 37.5 0.0 0.3 0.0 1.5 0.3 0.2 0.0 0.0 0.0 0.1 0.6 0.0 24.7 0.4 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66012008-66013505 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "skin 1: 599.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0" "Group enriched" "Detected in many" 5 "thyroid cancer: 171.0;urothelial cancer: 43.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 130.2;CAPAN-2: 364.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 82000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 1.7 0.3 0.1 0.3 0.2 0.2 28.8 0.8 0.4 4.1 0.9 0.4 0.0 0.3 0.6 34.9 15.0 0.5 1.9 0.1 0.7 2.3 0.3 18.5 0.0 0.2 0.2 0.0 0.7 0.7 2.1 1.6 8.2 0.5 0.9 0.0 0.0 7.5 4.9 2.0 599.0 0.3 0.1 0.1 0.2 0.6 1.9 0.3 2.7 21.6 0.0 2.3 1.2 22.7 0.2 130.2 0.0 0.0 0.6 0.0 0.0 37.6 1.4 0.0 0.3 0.2 1.0 364.6 0.0 1.8 5.1 0.1 4.5 0.0 32.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.6 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.8 0.2 0.7 0.0 0.0 35.8 0.4 0.1 0.8 0.1 0.0 0.2 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.8 0.4 0.1 0.7 0.2 0.2 0.0 0.5 0.1 0.3 0.2 0.1 93.0 6.1 0.0 0.6 1.1 1.7 41.4 0.6 0.0 5.3 7.1 1.2 0.0 115.2 58.8 0.0 33.3 0.0 0.1 0.0 57.4 0.2 7.7 0.1 0.9 0.0 0.0 0.0 21.6 24.4 2.0 0.0 0.6 21.6 0.1 0.4 0.1 41.1 0.0 0.0 0.0 24.4 1.4 10.0 0.8 0.0 5.3 5.4 0.0 1.1 1.3 0.0 0.0 0.0 368.1 1.1 0.4 9.8 1.9 0.0 0.5 404.0 0.1 0.0 0.3 16.0 5.2 17.6 1.0 27.6 64.2 0.7 0.0 0.4 6.1 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159806-72197787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.2;placenta: 49.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 70.5;Cytotrophoblasts: 106.2;Extravillous trophoblasts: 29.5;Syncytiotrophoblasts: 147.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 165.5;SK-BR-3: 75.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.0 0.0 3.9 0.5 1.9 0.0 10.3 4.9 2.7 1.2 1.8 1.2 1.0 0.4 36.2 1.1 5.9 0.3 0.1 1.4 5.8 2.7 0.0 15.2 0.4 5.4 5.8 0.6 0.1 0.5 0.1 0.8 49.1 9.9 1.3 0.8 0.9 2.1 5.3 0.0 2.5 3.4 0.2 3.1 0.2 0.8 0.4 6.8 0.2 9.0 0.0 0.4 0.3 0.7 2.1 2.1 0.0 0.1 0.0 0.0 0.0 165.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.6 0.0 0.0 1.2 0.0 10.0 0.2 0.0 0.2 0.3 0.1 0.0 1.2 0.0 0.0 0.1 2.1 0.0 7.5 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.5 0.6 0.0 0.1 0.0 0.1 0.2 0.1 1.7 0.1 0.3 75.8 0.1 5.5 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.9 4.9 2.7 1.4 5.8 5.4 5.8 0.6 9.9 3.1 6.8 2.1 0.1 70.5 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.3 0.0 0.0 7.4 3.7 0.0 106.2 0.1 0.0 0.0 0.1 0.0 14.0 0.2 0.2 0.0 0.0 0.0 0.0 29.5 0.8 0.0 0.7 1.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 10.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 147.1 0.3 0.1 0.0 0.0 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.3;Inhibitory neurons: 64.3;Oligodendrocyte precursor cells: 30.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 5.5;SCLC-21H: 6.6" HPA028982 Uncertain Approved Nucleoli NA NA Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 0.8 0.5 0.4 0.3 0.5 0.3 0.9 1.6 0.9 2.3 0.2 1.8 0.1 1.9 0.3 1.7 1.5 0.4 0.8 0.5 0.5 0.3 0.4 0.5 0.6 0.4 0.5 0.5 2.1 0.6 0.2 0.8 0.2 0.7 1.2 0.5 0.4 0.8 0.4 0.4 0.9 1.0 0.7 0.4 0.9 0.7 0.8 0.4 0.6 0.9 0.3 0.4 1.6 1.7 0.6 0.6 0.0 2.3 2.2 0.0 0.5 0.9 0.4 0.3 1.7 1.6 0.7 0.6 1.2 0.8 0.2 0.5 0.6 2.3 0.3 2.5 1.0 1.4 2.7 1.3 0.4 0.0 5.5 0.8 0.1 0.6 1.2 0.3 0.3 0.2 1.9 0.9 1.8 0.7 0.3 3.7 0.8 0.9 1.2 0.7 3.3 2.9 1.6 0.3 0.4 6.6 1.2 1.2 0.1 0.8 1.8 0.4 0.8 0.2 2.7 2.5 1.1 0.9 0.3 0.6 1.3 0.7 1.8 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.5 1.6 0.9 0.5 0.5 0.4 0.5 0.5 0.7 0.4 0.4 0.6 4.6 6.4 9.5 17.6 7.6 2.0 2.4 2.5 11.4 15.0 2.8 3.8 4.9 1.5 1.3 0.0 2.1 3.2 3.3 0.6 1.9 2.5 1.1 0.6 11.2 3.2 1.2 8.0 83.3 2.0 4.2 7.6 3.1 1.1 3.8 18.2 2.9 0.7 1.7 3.3 64.3 1.9 4.1 3.1 1.9 1.8 6.5 2.3 1.8 23.4 1.6 5.9 6.2 30.2 15.9 1.0 0.4 9.1 6.0 1.2 0.3 0.7 2.0 7.4 0.0 8.4 4.2 10.7 12.2 18.3 1.3 0.8 6.4 3.6 2.4 1.4 LSM1 "CASM, YJL124C" ENSG00000175324 "LSM1 homolog, mRNA degradation associated" O15116 8 38163335-38176730 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024601 Approved "Cytosol,Cytoplasmic bodies" NA NA 22000 "Cytoplasmic bodies" Cytosol "HPA024601: AB_1853379" "unprognostic (1.19e-2)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" "unprognostic (9.59e-2)" "unprognostic (7.26e-2)" "unprognostic (1.69e-1)" "unprognostic (2.08e-3)" "unprognostic (2.18e-2)" "unprognostic (1.95e-2)" "unprognostic (2.48e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (3.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (2.97e-1)" 30.3 32.2 41.9 27.8 42.5 34.7 28.3 44.0 49.6 25.3 43.1 28.4 25.5 27.7 39.9 27.7 23.1 27.0 61.6 41.4 43.4 36.4 37.0 20.6 34.2 43.3 42.8 40.8 20.1 28.6 29.7 22.2 34.9 42.5 27.6 29.7 21.6 32.7 34.4 35.1 24.9 25.6 32.0 43.0 22.6 27.2 21.1 43.1 35.2 29.0 35.3 32.0 38.2 22.7 43.9 66.8 72.1 47.6 54.2 78.1 71.8 41.2 78.6 81.9 74.9 78.3 51.3 45.7 32.2 69.4 96.9 75.3 33.1 61.2 67.0 83.7 49.0 71.8 102.9 52.2 65.4 68.1 36.4 65.3 70.1 60.9 62.0 51.2 57.1 66.1 65.0 83.2 78.7 94.7 66.7 110.7 70.4 68.7 100.9 73.9 53.2 49.2 38.1 102.9 78.8 80.3 67.1 34.3 51.0 98.7 48.3 43.3 76.2 65.1 63.9 77.1 96.0 65.0 82.2 123.2 66.2 74.8 73.7 67.3 161.5 65.7 105.0 58.6 75.0 61.1 59.8 64.6 64.9 66.0 52.4 58.4 67.2 50.5 62.9 78.8 111.1 82.1 78.8 41.9 42.5 44.0 49.6 41.4 43.4 43.3 42.8 40.8 42.5 43.0 43.1 43.9 40.8 12.8 24.6 5.2 49.5 66.3 45.6 101.7 26.2 26.6 58.5 42.4 5.9 48.6 61.7 68.0 10.4 109.3 78.4 40.7 180.0 90.6 9.0 65.0 47.1 42.9 46.7 36.2 9.3 119.2 138.9 40.7 25.5 53.0 24.1 29.5 42.5 58.5 84.9 13.5 11.6 48.8 75.3 51.5 46.9 8.4 61.5 58.6 48.0 12.2 104.8 55.0 125.7 7.5 12.4 120.0 54.5 56.8 57.1 92.1 59.8 121.4 51.1 24.1 52.6 39.0 58.0 64.7 129.3 40.8 70.3 102.2 57.8 67.3 49.9 87.3 PROP1 ENSG00000175325 "PROP paired-like homeobox 1" O75360 5 177992235-177996242 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "pituitary gland: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049839 Enhanced NA NA "HPA049839: AB_2732557" "unprognostic (2.90e-1)" "unprognostic (4.90e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ISX RAXLX ENSG00000175329 "Intestine specific homeobox" Q2M1V0 22 35066136-35087387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "intestine: 37.8" "Group enriched" "Detected in some" 32 "Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "CACO-2: 1.6;Hep G2: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060328 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA060328: AB_2684254" "unprognostic (5.02e-2)" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "unprognostic (3.33e-1)" "unprognostic (3.86e-1)" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 26.2 0.0 0.0 0.0 0.0 0.0 27.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.2 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.8 0.0 BANF1 BAF ENSG00000175334 "BAF nuclear assembly factor 1" O75531 11 66002228-66004149 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB032896, HPA039242" Enhanced Supported Nucleoplasm,Cytosol NA NA 690000 Nucleoplasm Cytosol "CAB032896: AB_2061090, HPA039242: AB_2676409" "unprognostic (1.69e-1)" "unprognostic (4.46e-3)" "unprognostic (2.04e-1)" "unprognostic (9.59e-3)" "unprognostic (1.23e-1)" "unprognostic (3.70e-3)" "unprognostic (6.16e-3)" "unprognostic (8.39e-3)" "unprognostic (2.31e-1)" "unprognostic (5.07e-2)" "unprognostic (1.76e-2)" "unprognostic (4.57e-1)" "unprognostic (7.36e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" 117.4 150.5 255.4 146.2 256.7 128.3 152.9 262.8 309.3 136.5 251.3 155.2 108.2 169.6 250.7 137.3 282.1 101.8 274.8 251.9 257.4 116.7 175.4 112.3 179.9 263.5 257.7 247.4 209.5 133.6 150.0 69.6 121.8 261.7 140.4 157.4 99.6 149.5 171.3 587.7 122.0 105.8 191.6 265.2 117.0 93.5 112.1 263.9 222.8 166.1 398.3 213.6 142.0 83.1 275.5 665.5 712.0 452.8 427.9 237.7 306.5 220.5 364.7 349.4 715.9 447.0 415.3 496.1 606.5 651.8 503.3 544.0 433.5 641.7 600.1 559.1 476.4 411.5 699.5 431.3 537.0 296.0 503.4 480.4 292.5 404.6 453.8 418.1 404.6 494.6 526.5 552.5 459.6 687.5 1196.3 607.7 1023.8 494.7 410.4 525.6 507.0 447.1 1297.4 647.9 361.7 362.9 458.0 399.1 636.4 469.4 352.9 698.8 378.6 350.4 535.8 574.2 601.8 515.8 313.6 680.4 771.1 442.7 420.2 485.5 112.7 231.7 82.2 165.2 239.1 159.1 243.7 139.0 160.5 252.9 234.6 166.0 174.4 28.7 219.7 266.2 238.2 125.5 324.0 255.4 256.7 262.8 309.3 251.9 257.4 263.5 257.7 247.4 261.7 265.2 263.9 275.5 135.8 54.5 41.9 11.4 112.7 126.8 154.6 301.2 142.9 52.8 164.8 230.0 32.1 102.9 153.6 196.8 25.0 296.5 101.4 70.7 326.8 196.8 17.1 164.8 147.2 126.5 142.8 144.5 12.3 177.3 346.6 126.6 86.6 116.2 140.2 199.7 79.9 130.8 324.5 50.5 13.4 171.4 223.8 80.6 169.8 41.9 142.0 124.7 186.7 8.4 155.9 123.8 186.4 9.0 22.2 170.3 107.1 123.8 110.8 126.8 77.4 251.5 187.7 57.8 72.3 123.9 145.5 250.2 325.1 227.0 118.1 174.7 104.9 172.6 196.2 148.9 APOF ENSG00000175336 "Apolipoprotein F" Q13790 12 56360568-56362857 "Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 333 "liver: 420.1" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 341.9" "Cancer enriched" "Detected in some" 6 "liver cancer: 34.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "Hep G2: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 18000000000 2200000000 "unprognostic (3.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.48e-2)" "unprognostic (8.99e-3)" "unprognostic (9.84e-2)" "unprognostic (3.29e-2)" "unprognostic (2.08e-3)" "unprognostic (7.84e-2)" "unprognostic (4.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.68e-3)" "unprognostic (8.55e-2)" "unprognostic (2.42e-2)" "unprognostic (2.77e-1)" "unprognostic (5.57e-2)" "unprognostic (2.87e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.4 0.1 0.3 0.2 0.1 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 420.1 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.4 4.3 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.6 0.3 0.2 0.1 0.4 0.2 0.1 0.3 0.0 0.3 1.2 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.3 8.6 0.0 0.0 2.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.4 0.0 16.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 5.0 341.9 0.0 0.0 0.0 0.1 0.0 10.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.1 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 CHRNA7 ENSG00000175344 "Cholinergic receptor nicotinic alpha 7 subunit" P36544 15 31923438-32173018 "FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.9;intestine: 9.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8" "HPA029422, CAB033624" Enhanced NA NA "CAB033624: AB_784835, HPA029422: AB_10600863" "unprognostic (3.43e-2)" "unprognostic (8.44e-2)" "unprognostic (2.02e-1)" "unprognostic (4.61e-4)" "unprognostic (6.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.14e-2)" "unprognostic (5.08e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-2)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (2.40e-2)" "unprognostic (4.36e-3)" "unprognostic (5.44e-2)" "unprognostic (7.41e-3)" "unprognostic (2.43e-1)" 0.3 7.9 1.9 0.5 1.0 0.9 1.0 1.7 1.9 0.4 1.8 1.5 4.4 0.5 0.3 0.3 0.4 0.9 0.4 1.0 4.8 0.4 0.1 0.5 0.7 3.7 2.7 0.9 1.6 2.4 6.4 1.0 0.0 5.0 1.2 2.3 2.6 0.5 0.7 0.5 0.3 9.7 0.4 1.2 1.2 6.7 2.6 2.8 0.4 2.2 0.8 0.7 1.5 0.8 2.7 0.0 1.3 2.7 6.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 3.1 0.0 0.0 0.0 1.7 0.6 0.0 2.2 0.0 0.4 1.0 0.0 0.0 0.2 0.0 0.1 0.4 2.5 0.0 0.2 0.3 0.2 0.0 0.2 1.5 3.7 0.0 0.0 4.2 0.3 0.5 12.9 0.5 8.3 0.2 13.3 0.0 0.7 0.0 0.5 1.2 0.0 10.8 0.3 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.9 1.0 1.7 1.9 1.0 4.8 3.7 2.7 0.9 5.0 1.2 2.8 2.7 0.5 0.0 0.0 1.0 0.0 0.3 3.0 0.0 7.4 1.8 1.1 1.3 1.1 2.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.1 0.2 0.3 1.5 3.0 0.0 9.0 2.5 0.0 0.4 26.0 0.6 1.3 4.6 0.7 0.0 0.1 16.8 30.7 8.9 0.0 0.0 0.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.5 1.1 1.6 2.9 0.0 0.2 0.7 14.4 0.2 0.0 0.0 0.0 0.4 0.3 0.2 5.9 3.2 0.0 0.0 0.1 0.2 2.0 1.2 TMEM9B C11orf15 ENSG00000175348 "TMEM9 domain family member B" Q9NQ34 11 8947202-8965011 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037784 Approved NA NA "HPA037784: AB_10671886" "unprognostic (3.18e-1)" "unprognostic (4.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.84e-3)" "unprognostic (1.13e-1)" "unprognostic (8.48e-3)" "unprognostic (2.56e-2)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" "unprognostic (3.78e-2)" "unprognostic (1.89e-2)" "unprognostic (5.06e-1)" "prognostic favorable (4.26e-5)" "unprognostic (1.83e-1)" "unprognostic (1.82e-1)" "unprognostic (5.51e-3)" "unprognostic (9.56e-2)" 34.6 40.4 71.3 34.1 74.0 78.7 48.3 74.6 81.6 37.4 65.7 64.2 55.1 22.4 59.6 62.9 31.7 39.9 53.8 69.1 72.8 60.7 40.1 51.2 40.8 74.7 74.1 65.8 24.3 41.7 64.4 38.8 45.6 74.7 34.5 67.7 42.6 51.9 26.3 47.8 45.8 55.2 22.4 74.6 42.1 59.8 27.7 75.4 35.9 75.7 43.3 43.7 47.7 36.2 79.8 63.0 42.4 23.7 46.0 117.1 65.9 41.1 78.4 69.3 45.2 46.3 32.4 96.7 39.1 40.3 81.6 53.2 81.9 22.3 57.5 47.3 72.7 45.0 26.2 36.8 31.0 66.3 53.2 79.5 61.1 94.6 27.9 56.0 61.7 54.5 26.4 21.0 58.0 87.2 43.9 16.6 33.9 7.4 90.1 49.5 18.8 30.4 31.6 67.7 72.4 26.4 22.5 44.8 92.3 40.6 29.7 55.7 35.1 59.4 55.0 24.9 93.7 48.6 24.1 44.7 27.8 69.0 35.0 47.5 178.7 104.5 151.8 98.5 134.7 101.7 103.2 94.3 109.8 112.6 89.3 77.7 109.0 50.5 93.3 150.2 80.7 136.8 159.8 71.3 74.0 74.6 81.6 69.1 72.8 74.7 74.1 65.8 74.7 74.6 75.4 79.8 61.5 41.7 52.0 17.9 65.7 65.0 65.5 155.5 58.6 61.0 67.5 35.9 28.6 70.1 104.1 95.6 20.9 104.8 69.6 124.0 70.5 84.5 16.4 29.2 28.0 49.3 31.2 111.6 21.9 80.7 112.9 48.0 34.7 43.8 88.1 21.1 55.0 30.5 109.3 43.7 23.2 78.8 213.6 79.0 109.8 13.4 38.2 70.1 60.5 15.9 58.1 82.6 77.2 24.1 33.8 70.9 103.9 28.6 53.6 59.2 114.7 45.7 53.2 49.2 19.7 41.6 26.2 56.4 58.2 83.7 87.4 160.8 66.8 40.3 82.8 80.6 NRIP3 C11orf14 ENSG00000175352 "Nuclear receptor interacting protein 3" Q9NQ35 11 8980576-9004049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2;retina: 24.7;testis: 43.8" "Cell type enhanced" "Detected in many" "Early spermatids: 545.3;Horizontal cells: 242.3;Late spermatids: 478.6;Spermatocytes: 189.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 13.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 13.1" "Cell line enhanced" "Detected in many" "HMC-1: 51.4;SiHa: 34.3;U-87 MG: 47.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058827, HPA072961" Approved Approved Cytosol NA NA Cytosol "HPA058827: AB_2683829, HPA072961: " "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.84e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-1)" "unprognostic (2.68e-1)" "unprognostic (2.03e-4)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (3.63e-2)" "unprognostic (1.04e-2)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.41e-1)" "unprognostic (5.88e-3)" "unprognostic (1.30e-1)" 0.9 10.3 17.0 1.6 14.5 13.9 3.9 24.6 44.6 2.9 0.0 1.3 0.5 3.2 3.1 0.9 2.2 1.6 0.9 69.2 14.4 0.9 0.2 0.8 0.8 19.0 21.8 13.2 0.5 0.4 5.4 1.5 0.8 18.9 0.7 0.6 24.7 0.6 0.9 0.3 0.5 0.6 2.3 17.0 0.5 2.5 43.8 38.1 0.9 0.9 0.2 0.6 1.3 0.7 33.0 0.0 0.9 1.9 0.3 0.7 2.7 0.1 20.3 8.0 16.2 16.9 3.1 1.8 0.1 3.0 5.9 9.6 0.2 5.5 0.5 28.0 1.7 8.5 2.2 1.2 0.2 1.4 26.5 51.4 3.7 0.3 16.7 0.1 17.1 13.3 4.4 4.2 0.2 15.0 0.0 1.3 8.6 6.6 0.1 0.0 0.0 2.8 0.0 0.3 1.2 5.4 1.7 34.3 0.9 5.3 1.4 3.5 2.5 16.6 24.7 11.8 1.4 0.1 0.1 0.0 0.0 47.9 3.1 12.3 13.1 0.1 2.0 0.1 0.3 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.1 0.3 17.0 14.5 24.6 44.6 69.2 14.4 19.0 21.8 13.2 18.9 17.0 38.1 33.0 4.0 0.0 1.3 1.0 1.7 2.2 5.7 0.5 0.0 19.6 12.1 8.9 1.6 0.0 0.4 0.0 10.4 0.4 7.4 0.6 5.9 0.4 545.3 3.7 4.1 2.5 5.3 2.7 11.5 1.1 0.5 2.5 7.1 6.6 15.8 2.4 0.0 0.0 12.1 242.3 96.3 0.5 8.2 3.1 17.2 478.6 6.8 12.8 3.6 0.0 0.6 4.4 0.0 4.5 1.6 8.2 0.1 5.7 1.2 3.5 0.1 0.0 0.1 10.6 0.0 6.0 3.6 189.8 44.0 0.9 1.0 1.0 5.5 5.6 0.2 4.2 PTPN2 "PTPT, TC-PTP, TCELLPTP, TCPTP" ENSG00000175354 "Protein tyrosine phosphatase non-receptor type 2" P17706 18 12785478-12929643 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015004, HPA046176" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015004: AB_2669131, HPA046176: AB_2679569" "unprognostic (5.83e-3)" "unprognostic (8.50e-2)" "unprognostic (5.85e-2)" "unprognostic (7.21e-3)" "unprognostic (8.94e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (1.68e-1)" "unprognostic (2.37e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.06e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.20e-8)" "unprognostic (3.19e-1)" "unprognostic (6.84e-3)" "unprognostic (2.17e-1)" "unprognostic (4.61e-3)" 20.2 15.3 12.3 33.1 12.3 57.7 24.0 22.4 17.3 20.0 15.9 22.4 19.1 16.2 20.6 20.2 17.5 22.6 13.4 12.9 16.4 17.0 26.0 26.5 44.7 13.9 11.9 11.2 27.1 33.4 14.2 18.4 19.7 16.2 17.7 24.3 20.4 29.6 13.6 16.8 19.9 19.7 17.0 11.8 28.7 18.2 13.7 11.6 100.7 17.6 12.0 43.9 37.5 20.1 15.5 34.8 20.7 23.7 7.9 26.5 47.4 23.0 22.7 50.2 47.5 42.2 45.4 48.8 54.3 37.2 23.6 53.2 20.4 39.0 62.2 62.1 21.2 23.5 38.4 17.7 47.6 36.4 91.1 35.1 40.2 57.6 43.3 85.1 29.2 24.6 58.1 37.9 71.6 38.6 39.9 91.3 74.5 28.5 141.7 24.0 30.4 37.3 61.9 40.2 54.6 42.3 22.0 46.0 26.7 41.8 25.1 22.4 51.5 18.8 59.8 58.0 45.1 49.8 22.6 24.5 77.8 28.3 49.3 25.7 23.7 52.6 39.2 37.0 47.7 50.4 54.4 43.7 41.4 62.5 39.5 31.6 34.9 19.0 64.1 46.7 53.0 57.3 40.7 12.3 12.3 22.4 17.3 12.9 16.4 13.9 11.9 11.2 16.2 11.8 11.6 15.5 25.8 35.3 77.0 38.5 82.4 59.9 106.0 88.0 61.5 44.1 37.0 50.5 15.0 47.1 84.4 14.7 104.3 54.1 130.4 32.2 13.7 55.1 24.3 51.0 44.8 32.0 32.3 40.8 81.1 68.8 52.5 38.1 24.5 78.7 56.4 53.1 20.3 27.9 51.3 15.2 60.5 35.0 69.2 99.2 92.5 23.2 29.2 93.4 23.2 44.0 137.0 17.6 128.8 22.6 55.0 40.0 45.1 25.6 120.2 126.4 29.9 23.1 55.4 84.5 19.7 35.4 33.8 23.3 61.3 40.0 50.2 81.1 84.2 65.2 39.5 152.4 SCUBE2 "Cegb1, Cegf1, FLJ16792" ENSG00000175356 "Signal peptide, CUB domain and EGF like domain containing 2" Q9NQ36 11 9019476-9138114 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 49.2" "Cell type enhanced" "Detected in many" "Adipocytes: 30.3;Basal prostatic cells: 51.4;Breast glandular cells: 45.0;Breast myoepithelial cells: 31.5;Prostatic glandular cells: 39.8" "Cancer enhanced" "Detected in all" "breast cancer: 54.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 6 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "HAP1: 5.7;SK-MEL-30: 8.1;T-47d: 28.4" "Group enriched" "Detected in some" 4 "olfactory bulb: 4.6;thalamus: 2.7" "Low region specificity" "Detected in all" "HPA006353, HPA029871" Uncertain "Secreted to blood" NA NA 1100000 "HPA006353: AB_1856642, HPA029871: AB_10602299" "prognostic favorable (2.41e-4)" "unprognostic (5.72e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "unprognostic (2.73e-1)" "unprognostic (6.12e-4)" "unprognostic (3.11e-1)" "unprognostic (6.39e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (1.54e-2)" "unprognostic (3.04e-1)" "unprognostic (1.94e-2)" "unprognostic (9.12e-4)" "unprognostic (4.35e-1)" "unprognostic (5.94e-2)" "unprognostic (2.88e-1)" 14.9 2.0 3.3 3.7 3.4 0.0 32.5 13.4 3.1 17.8 0.2 10.2 3.7 13.6 49.2 4.5 18.4 8.0 4.3 3.5 4.1 1.2 0.9 4.7 3.9 2.8 3.6 2.5 0.9 22.2 19.6 9.7 22.6 6.1 33.5 4.5 1.9 2.4 8.8 9.1 12.4 16.5 13.1 3.3 5.1 21.5 2.3 3.6 2.4 5.2 6.3 7.7 28.9 7.0 4.4 0.0 0.1 1.5 0.9 0.5 0.6 0.2 1.6 0.8 0.9 0.6 0.3 0.0 0.0 0.6 3.9 0.1 0.0 5.7 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.6 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.9 0.0 0.0 0.1 0.0 0.2 0.4 3.1 0.7 1.0 1.1 0.1 8.1 1.3 28.4 0.0 0.0 0.6 0.4 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.3 3.4 13.4 3.1 3.5 4.1 2.8 3.6 2.5 6.1 3.3 3.6 4.4 30.3 16.0 9.2 1.6 0.0 7.4 51.4 0.3 1.2 0.4 45.0 31.5 0.6 0.0 5.6 1.8 0.0 0.2 0.1 1.0 0.0 0.1 3.4 2.2 8.8 3.3 1.2 0.0 3.1 1.8 0.2 9.4 0.0 6.4 0.0 0.3 1.1 0.1 0.8 13.5 14.9 5.2 6.1 0.3 1.5 2.5 0.3 0.7 19.6 5.6 0.1 0.0 0.0 13.6 4.6 0.1 4.3 0.7 0.0 39.8 0.6 0.0 1.5 0.3 0.0 5.2 1.5 0.6 0.7 0.1 1.8 0.4 0.3 6.6 9.6 15.6 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA054991: AB_2682664, HPA058735: AB_2683802" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 15.1 17.8 16.6 20.1 16.1 45.0 16.1 19.0 19.4 13.2 15.0 15.9 15.2 16.0 16.4 21.2 15.5 13.1 15.9 17.9 16.8 13.6 17.4 15.1 23.6 16.5 16.3 16.4 20.6 19.4 17.2 16.7 21.3 17.6 13.5 14.9 16.7 16.9 15.0 27.4 23.1 17.1 14.9 16.0 20.2 16.2 19.5 17.3 20.1 13.9 23.5 27.9 17.2 14.6 18.7 51.0 43.9 35.0 35.9 27.6 28.8 32.8 36.4 34.6 44.2 37.7 44.8 47.5 38.2 62.6 41.2 38.0 34.9 42.2 48.8 41.5 35.1 21.7 54.4 52.0 46.4 33.7 50.3 41.8 24.1 41.9 65.3 44.1 31.2 31.0 40.9 81.1 54.4 64.7 68.7 46.6 55.1 25.9 23.3 47.5 50.3 35.9 75.0 25.6 31.8 26.5 31.2 39.3 54.7 41.5 28.1 53.1 31.0 36.5 59.7 39.9 47.8 36.1 66.7 85.5 79.8 42.9 33.8 39.5 52.6 20.5 13.5 17.7 16.6 13.6 19.4 15.0 13.0 21.3 19.0 14.1 13.5 13.1 16.4 21.3 12.7 15.3 13.3 16.6 16.1 19.0 19.4 17.9 16.8 16.5 16.3 16.4 17.6 16.0 17.3 18.7 8.2 3.2 5.4 3.3 16.2 37.7 12.2 13.4 12.5 7.2 14.2 9.1 16.2 14.3 7.3 5.5 14.6 16.3 17.7 11.6 15.6 12.7 18.3 9.0 8.3 11.6 2.4 21.0 3.0 13.1 23.0 11.4 7.1 10.5 12.7 31.7 16.4 16.5 24.5 11.8 2.8 11.2 6.1 10.4 29.5 14.3 12.2 14.4 12.4 1.0 17.6 10.5 17.5 5.5 4.5 29.0 15.2 5.7 22.6 13.2 13.8 15.7 10.6 18.5 6.6 9.8 27.0 31.3 23.2 15.7 48.9 25.3 16.2 7.4 10.9 13.2 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 49.1 53.1 37.4 39.0 40.7 37.9 47.0 46.7 37.0 43.6 37.4 47.9 37.1 39.0 41.4 55.5 47.2 40.0 54.3 33.2 46.6 43.7 35.8 47.1 44.9 50.6 41.7 28.6 53.0 40.7 44.9 20.5 43.1 50.6 36.7 49.2 71.1 37.0 45.2 58.0 33.3 37.7 48.3 53.2 47.9 45.6 52.0 42.8 73.1 76.4 56.0 55.6 54.3 31.4 62.8 81.1 113.7 68.0 66.2 106.1 128.5 77.4 86.1 102.7 87.9 101.8 43.8 75.6 124.8 60.3 110.0 123.0 86.6 77.2 96.1 116.9 136.4 39.3 106.4 164.4 71.9 123.2 149.6 104.1 95.8 121.4 75.5 172.9 102.1 98.6 99.7 50.3 101.6 109.6 52.7 103.4 71.6 33.6 4.4 26.7 74.4 98.9 85.9 197.8 137.2 62.8 73.3 103.7 70.1 85.7 65.8 53.5 97.7 111.4 129.5 74.2 35.6 63.6 99.0 102.7 108.3 89.6 99.9 97.1 58.8 33.6 38.7 23.8 38.5 29.8 16.7 32.3 29.9 32.8 13.9 35.3 27.6 34.1 38.6 33.0 23.3 40.5 31.6 37.4 40.7 46.7 37.0 33.2 46.6 50.6 41.7 28.6 50.6 53.2 42.8 62.8 55.0 44.8 36.1 55.8 36.3 54.4 44.1 38.3 54.1 48.0 44.2 30.2 49.2 41.5 45.5 77.3 212.7 48.2 53.0 42.8 39.2 36.5 68.1 58.6 53.0 53.1 51.0 36.4 63.4 43.5 40.3 40.5 44.4 68.1 21.5 80.0 56.4 29.6 43.9 35.3 50.5 46.1 38.7 57.3 41.8 131.9 41.7 48.7 51.6 104.9 63.9 44.8 72.1 96.0 130.0 44.0 31.6 53.4 34.5 66.1 37.9 39.5 41.8 88.1 32.9 53.5 39.6 37.2 39.4 59.2 61.8 69.5 47.4 41.7 42.3 77.2 EIF3F "eIF3-epsilon, eIF3-p47, EIF3S5" ENSG00000175390 "Eukaryotic translation initiation factor 3 subunit F" O00303 11 7970251-8001862 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Ubl conjugation pathway" "Hydrolase, Initiation factor, Protease, Thiol protease" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049250 Approved NA NA 83000 "HPA049250: AB_2680692" "unprognostic (1.11e-2)" "unprognostic (1.42e-1)" "unprognostic (8.46e-2)" "unprognostic (1.15e-2)" "unprognostic (8.50e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.16e-1)" "unprognostic (1.97e-1)" "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-1)" "unprognostic (5.66e-2)" "unprognostic (2.61e-1)" "unprognostic (8.36e-2)" "unprognostic (8.78e-2)" 222.8 162.1 8.4 10.3 7.9 21.9 218.7 8.9 7.6 245.8 6.0 231.0 10.6 208.6 10.2 229.2 215.2 16.9 183.7 7.7 7.5 166.1 161.6 158.4 24.9 9.3 7.9 6.4 356.8 364.3 8.0 127.6 11.8 8.2 171.5 12.7 15.6 177.0 13.0 377.1 332.0 190.1 21.4 7.3 203.2 240.9 133.7 8.0 11.9 155.0 12.9 25.6 220.6 214.7 8.6 23.6 9.3 12.7 11.3 23.5 52.6 39.9 16.1 28.1 20.3 19.4 9.6 23.0 70.4 6.7 15.7 9.1 12.5 9.9 27.7 20.4 23.1 32.4 24.8 9.5 11.1 38.7 26.9 10.0 32.2 32.7 7.9 18.7 18.6 20.7 12.6 21.5 16.1 22.2 9.6 15.8 25.5 13.1 9.5 22.6 17.7 17.3 22.4 11.0 15.8 29.2 50.6 15.2 6.7 19.3 7.7 11.9 18.6 19.3 9.5 11.0 6.9 11.7 11.8 21.1 29.0 6.4 16.8 12.6 37.5 92.4 41.7 81.5 99.7 112.1 174.6 130.5 96.4 130.9 161.6 155.4 114.5 11.7 95.8 93.6 87.7 177.6 246.5 8.4 7.9 8.9 7.6 7.7 7.5 9.3 7.9 6.4 8.2 7.3 8.0 8.6 179.9 109.0 145.4 11.1 355.2 349.1 364.1 411.0 266.9 72.2 271.6 285.6 96.8 264.5 197.2 79.1 52.1 631.3 283.7 121.1 293.5 277.0 424.5 113.8 204.9 218.3 210.2 221.7 11.5 442.8 670.6 216.3 139.7 112.1 164.8 335.7 256.6 170.6 344.2 45.4 10.9 262.0 140.4 423.1 398.1 913.3 246.0 263.4 247.3 8.4 471.1 141.5 362.5 7.5 18.8 322.2 242.2 196.7 237.6 247.4 312.9 286.9 115.1 87.1 98.6 222.4 374.3 197.0 124.8 358.3 440.4 563.4 319.3 264.8 392.2 426.0 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949573-37976647 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" No No "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 9.0 10.2 12.4 3.6 13.8 2.7 8.3 13.8 20.3 9.6 6.0 9.7 2.3 10.0 6.2 5.5 9.3 6.2 10.1 12.9 15.5 5.8 3.0 6.5 4.8 13.1 12.4 12.1 11.2 5.4 7.7 14.4 4.8 14.4 7.4 4.4 10.7 4.6 9.0 22.5 4.7 5.3 9.0 9.9 6.5 5.9 4.7 14.5 4.6 6.0 21.7 4.4 8.9 7.2 18.5 1.6 3.0 3.3 6.7 12.1 9.2 0.6 3.6 4.9 2.8 4.2 0.5 2.3 3.1 1.0 6.4 1.0 0.4 0.9 1.5 4.5 7.3 1.6 5.0 0.0 1.0 7.7 3.3 3.1 6.5 6.6 3.1 3.6 11.1 4.9 4.0 0.4 2.3 6.9 1.0 1.1 2.6 0.6 0.6 2.2 1.2 3.7 0.6 3.3 0.6 1.2 7.6 1.2 0.2 4.7 1.2 2.9 5.3 7.1 4.3 0.8 7.1 2.2 2.8 1.4 1.3 8.2 6.3 2.9 1.3 1.5 3.4 1.6 2.5 1.7 1.0 1.4 1.3 1.9 1.3 1.8 1.5 0.2 1.0 5.2 0.3 1.2 1.2 12.4 13.8 13.8 20.3 12.9 15.5 13.1 12.4 12.1 14.4 9.9 14.5 18.5 10.0 3.2 3.2 17.9 4.8 3.4 2.5 2.5 3.4 17.3 3.8 3.6 23.6 4.3 2.9 7.3 6.2 1.2 3.5 1.0 1.9 2.0 27.9 2.4 7.0 7.6 0.0 2.1 46.7 2.5 0.5 10.6 4.1 2.7 8.2 8.2 10.4 2.9 5.7 16.8 44.6 1.2 4.1 13.2 6.8 41.9 12.2 9.5 3.6 14.0 8.1 13.7 5.2 38.2 36.7 1.8 0.3 16.1 1.5 2.6 1.3 3.1 8.1 7.1 0.0 11.4 10.4 4.4 6.4 2.4 4.0 0.3 5.2 4.8 0.8 1.3 OR10P1 "OR10P1P, OR10P2P, OR10P3P, OST701" ENSG00000175398 "Olfactory receptor family 10 subfamily P member 1" Q8NGE3 12 55636860-55637854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA074114 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074114: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARL10 ARL10A ENSG00000175414 "ADP ribosylation factor like GTPase 10" Q8N8L6 5 176365487-176401865 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 22.0;Oligodendrocyte precursor cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047044 Approved NA NA "HPA047044: AB_2679915" "unprognostic (2.50e-2)" "unprognostic (4.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (6.00e-3)" "unprognostic (2.78e-1)" "unprognostic (9.29e-2)" "unprognostic (5.92e-3)" "unprognostic (7.96e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-2)" "unprognostic (4.33e-2)" 3.0 1.5 6.3 2.4 6.7 4.2 2.7 7.5 7.9 6.0 1.2 4.3 1.2 4.6 2.8 4.5 3.5 3.7 4.0 6.2 3.3 2.1 1.3 2.5 3.2 2.8 2.3 6.0 7.5 1.9 2.2 3.9 3.0 4.0 3.9 1.2 5.3 1.9 3.0 6.8 14.3 3.3 3.3 1.2 2.9 2.5 2.0 6.7 1.8 1.9 1.8 2.3 4.6 5.3 5.4 0.4 0.1 13.5 6.3 7.1 8.6 0.7 4.0 1.7 5.4 5.7 0.4 1.0 1.4 0.8 7.1 0.3 9.0 0.1 1.1 8.1 0.1 5.5 1.2 13.1 1.4 4.3 0.2 1.6 5.1 0.5 7.0 0.0 2.9 9.0 2.6 0.4 1.3 7.3 8.4 2.4 0.3 2.4 1.0 1.5 4.0 3.3 2.6 3.3 4.7 12.5 13.3 3.2 1.8 2.6 5.9 0.4 1.6 6.9 5.1 4.2 3.7 0.7 0.5 3.7 0.4 4.1 0.2 1.7 0.2 0.0 0.0 0.3 0.1 0.5 1.6 1.1 0.7 0.1 1.2 0.7 0.7 0.2 1.5 0.1 0.6 0.5 0.1 6.3 6.7 7.5 7.9 6.2 3.3 2.8 2.3 6.0 4.0 1.2 6.7 5.4 2.7 3.2 22.0 15.0 4.5 4.0 4.3 3.8 2.8 13.1 2.1 2.0 11.1 1.5 7.1 7.3 6.2 0.5 1.0 0.6 0.0 2.0 0.8 1.2 8.7 5.6 0.0 0.0 17.5 0.2 0.7 8.5 2.0 2.4 17.1 11.7 4.2 0.6 1.2 20.2 18.2 0.4 4.1 1.9 3.1 0.5 6.5 2.9 3.6 7.5 0.9 3.6 6.2 26.2 20.3 0.9 0.0 7.2 2.9 6.5 0.4 2.0 5.5 4.5 0.0 8.1 7.6 1.5 1.1 6.2 7.5 0.4 3.9 1.9 0.3 2.9 CLTB Lcb ENSG00000175416 "Clathrin light chain B" P09497 5 176392501-176416539 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 1839.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 704.2;MCF7: 641.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003692, HPA036458" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "CAB003692: AB_425372, HPA036458: AB_2675136" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (4.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (1.83e-2)" "unprognostic (1.74e-2)" "unprognostic (1.93e-1)" "unprognostic (7.42e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.89e-5)" "unprognostic (3.55e-1)" "unprognostic (7.50e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-2)" 97.0 134.7 115.5 50.5 115.4 40.9 83.6 107.1 178.0 128.0 115.1 132.4 93.1 86.6 23.4 477.5 83.1 34.4 279.4 118.8 114.4 91.0 83.2 97.4 33.1 123.0 113.6 116.4 108.1 68.8 70.7 113.6 58.0 124.6 88.9 45.9 38.2 129.6 44.8 325.1 431.0 100.5 41.6 103.1 69.2 124.4 39.2 122.5 44.1 70.1 121.9 58.9 107.1 303.3 134.5 229.1 107.6 29.9 128.2 65.7 49.2 244.4 286.3 110.9 178.6 127.0 140.3 103.9 49.6 165.0 130.2 71.8 213.3 51.4 704.2 69.7 341.7 95.3 33.6 163.3 87.7 102.9 53.2 85.6 52.6 241.5 98.1 114.7 36.0 84.7 39.2 65.2 123.4 100.3 641.9 84.5 81.1 24.4 189.5 158.2 91.3 52.9 165.2 95.6 92.0 127.7 43.7 136.6 148.0 103.6 34.7 61.4 101.9 185.2 64.0 96.3 117.5 165.1 96.5 73.3 68.5 51.4 112.7 74.4 6.6 19.7 61.7 13.6 15.8 7.0 5.9 11.9 13.2 20.0 10.1 10.0 10.0 36.6 15.0 20.8 16.1 24.9 8.1 115.5 115.4 107.1 178.0 118.8 114.4 123.0 113.6 116.4 124.6 103.1 122.5 134.5 113.7 57.7 19.8 8.5 54.7 634.0 238.7 155.7 180.4 310.5 105.5 124.6 208.5 72.9 93.4 82.8 64.6 141.1 82.3 794.5 135.0 324.7 9.5 58.4 72.7 102.2 151.8 43.6 25.4 453.1 586.9 136.7 193.2 85.2 48.2 40.8 70.3 96.3 111.9 336.5 24.1 348.5 114.0 80.7 226.1 13.7 122.1 88.4 220.5 6.5 85.7 136.1 107.1 8.0 15.2 1839.9 786.9 129.8 76.4 391.4 545.7 269.7 49.6 64.3 78.9 79.6 161.4 15.9 29.1 415.6 803.0 386.5 81.3 151.2 289.7 436.0 PCSK1 "NEC1, PC1, PC3, SPC3" ENSG00000175426 "Proprotein convertase subtilisin/kexin type 1" P29120 5 96390333-96434143 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease variant, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.8" "Cell type enriched" "Detected in some" 4 "Enteroendocrine cells: 224.6" "Cancer enhanced" "Detected in many" "breast cancer: 12.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048564, HPA079656" Approved "Secreted in other tissues" NA NA "HPA048564: AB_2680444, HPA079656: " "unprognostic (1.86e-2)" "unprognostic (2.13e-2)" "unprognostic (4.66e-3)" "unprognostic (8.20e-5)" "prognostic unfavorable (9.13e-5)" "unprognostic (8.47e-4)" "unprognostic (1.46e-1)" "unprognostic (5.84e-3)" "unprognostic (4.71e-1)" "unprognostic (3.07e-3)" "unprognostic (1.89e-3)" "unprognostic (1.01e-1)" "unprognostic (7.90e-6)" "unprognostic (5.25e-2)" "unprognostic (9.96e-2)" "unprognostic (1.33e-3)" "unprognostic (9.37e-3)" 1.6 6.3 8.8 4.7 4.1 0.1 1.5 1.0 36.9 0.8 0.0 2.4 5.3 0.1 0.0 0.1 0.2 0.2 0.5 4.7 44.8 0.2 0.0 0.4 0.1 4.8 6.6 2.9 0.4 7.7 0.0 12.2 0.0 20.0 0.4 2.4 8.8 2.7 0.1 0.3 1.1 3.6 0.6 1.6 0.1 5.8 0.1 8.9 0.2 1.9 0.0 0.0 2.1 0.5 16.0 0.0 0.0 0.3 0.0 2.3 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.0 3.8 0.0 0.0 0.1 0.0 0.1 0.1 0.8 2.4 0.0 0.0 0.0 0.0 2.0 1.0 0.4 0.1 0.2 0.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 3.3 0.0 0.0 0.4 0.0 0.0 1.2 19.0 0.6 0.3 0.2 0.0 0.0 0.1 15.8 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 4.1 1.0 36.9 4.7 44.8 4.8 6.6 2.9 20.0 1.6 8.9 16.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 1.8 13.2 0.0 0.0 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.2 224.6 0.0 54.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 4.0 10.7 2.0 0.0 0.4 1.6 0.0 0.0 0.0 4.7 0.0 0.5 0.0 3.5 4.9 1.5 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.9 0.0 1.7 1.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.7 0.0 LPL LIPD ENSG00000175445 "Lipoprotein lipase" P06858 8 19901717-19967259 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant, FDA approved drug targets, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 945.8;heart muscle: 353.7" "Cell type enhanced" "Detected in many" "Adipocytes: 453.0;Cardiomyocytes: 489.0;Granulosa cells: 495.2;Horizontal cells: 206.9;Sertoli cells: 236.7" "Cancer enhanced" "Detected in all" "glioma: 39.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 6 "monocytes: 4.2" "Cell line enriched" "Detected in some" 5 "AF22: 391.6" "Region enhanced" "Detected in many" "basal ganglia: 45.3" "Group enriched" "Detected in all" 5 "basal ganglia: 79.2;spinal cord: 59.3" HPA048749 Supported Vesicles "Secreted to blood" NA NA 4200000 Vesicles "HPA048749: AB_2680511" "unprognostic (5.52e-2)" "unprognostic (3.16e-1)" "unprognostic (6.41e-2)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-4)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (8.20e-2)" "unprognostic (2.54e-2)" "unprognostic (5.28e-1)" "unprognostic (1.18e-1)" "unprognostic (4.20e-3)" "unprognostic (4.16e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.07e-4)" 945.8 16.1 7.8 9.2 43.4 0.9 257.6 21.2 11.1 2.4 8.6 11.0 1.5 3.8 0.5 2.9 2.7 8.7 353.7 10.4 16.7 19.3 0.8 62.7 8.6 13.2 7.7 7.1 10.7 6.4 183.1 4.1 14.8 18.9 3.9 5.9 11.2 24.6 65.2 87.2 7.4 13.4 4.1 6.6 1.6 8.5 1.0 12.5 4.3 10.7 128.4 2.8 6.2 4.7 9.4 0.0 0.0 391.6 0.1 8.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.8 0.0 0.0 0.1 0.3 0.0 71.5 0.0 0.2 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.1 0.7 9.6 0.0 0.0 0.0 0.0 68.4 0.0 0.0 8.4 0.2 0.0 0.0 0.1 13.5 0.0 1.8 0.0 0.0 8.1 0.0 3.5 0.0 0.1 0.1 0.1 0.1 32.6 0.0 0.9 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 7.8 43.4 21.2 11.1 10.4 16.7 13.2 7.7 7.1 18.9 6.6 12.5 9.4 453.0 12.8 104.9 1.0 0.4 1.5 0.1 0.0 0.6 2.8 114.7 5.7 489.0 0.0 0.6 0.0 2.1 0.4 0.9 0.1 15.6 0.0 0.8 0.2 2.5 56.1 0.0 0.0 1.9 0.0 0.7 13.6 0.0 0.3 6.3 495.2 2.9 0.0 108.5 206.9 0.4 1.0 0.0 14.8 4.2 1.3 1.2 38.2 14.2 1.9 2.0 2.3 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.4 2.9 2.7 236.7 91.4 68.1 0.4 0.2 0.2 0.6 0.4 2.3 4.3 2.8 0.1 RFESD ENSG00000175449 "Rieske Fe-S domain containing" Q8TAC1 5 95646754-95684773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 27.1" "Cell type enriched" "Detected in many" 7 "Erythroid cells: 278.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 41.3;K-562: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016546 Uncertain Approved Nucleoplasm NA NA 48000 Nucleoplasm "CAB016546: AB_630417" "unprognostic (1.15e-1)" "unprognostic (5.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.37e-2)" "unprognostic (6.07e-3)" "unprognostic (2.72e-1)" "unprognostic (1.33e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (9.91e-2)" "unprognostic (8.24e-3)" "unprognostic (4.89e-2)" "unprognostic (5.83e-3)" "unprognostic (6.78e-2)" "unprognostic (9.03e-2)" "unprognostic (9.35e-2)" "unprognostic (1.09e-1)" 1.6 2.3 1.5 1.2 1.8 27.1 2.9 2.2 3.4 2.2 1.8 1.5 1.2 2.0 4.5 2.4 2.0 1.2 3.2 1.6 2.0 2.4 2.5 1.5 3.1 1.9 1.8 1.5 2.9 3.6 3.9 2.8 1.6 1.9 3.1 1.5 3.6 4.8 1.5 5.8 7.7 1.4 1.4 1.7 2.4 2.5 12.3 1.8 4.9 3.3 3.5 3.3 2.3 1.9 2.3 3.6 5.5 1.0 3.5 3.4 6.2 0.0 1.9 2.9 3.1 3.1 4.4 3.8 5.8 3.8 1.6 7.3 5.2 3.8 3.0 3.3 8.7 3.3 41.3 5.2 1.6 4.3 3.8 4.2 2.8 5.5 4.0 3.6 2.8 3.1 17.1 78.3 4.5 4.9 2.4 12.4 16.4 4.4 1.6 5.2 6.0 0.7 2.6 1.1 2.1 5.3 3.8 5.4 2.4 0.0 0.3 2.8 2.0 1.6 3.9 3.1 2.9 3.4 3.9 10.1 4.7 3.4 4.5 2.1 0.0 0.7 0.4 3.6 0.9 9.6 3.9 8.7 6.2 1.6 3.3 12.7 7.5 0.0 6.1 0.9 1.9 5.4 2.7 1.5 1.8 2.2 3.4 1.6 2.0 1.9 1.8 1.5 1.9 1.7 1.8 2.3 2.0 12.8 3.3 1.6 2.8 3.2 4.5 6.0 3.4 2.1 2.3 3.4 7.8 0.0 5.5 1.8 0.0 3.5 4.2 0.5 1.9 2.4 18.2 2.3 2.4 1.4 0.0 278.7 1.6 1.8 12.1 3.2 2.0 1.8 3.8 2.0 2.9 2.1 3.8 1.7 1.9 1.1 14.2 1.6 0.8 8.5 1.8 1.2 0.0 2.8 2.3 3.8 3.1 0.0 1.7 1.7 0.3 1.2 1.0 2.5 0.9 2.9 5.3 1.9 6.6 2.8 2.7 37.2 14.3 4.5 6.8 2.1 4.6 2.5 1.2 2.5 CCDC14 "DKFZp434L1050, FLJ12892" ENSG00000175455 "Coiled-coil domain containing 14" Q49A88 3 123897305-123961408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035278, HPA035279" Uncertain Enhanced "Centriolar satellite" NA Yes "Centriolar satellite" "HPA035278: AB_2674548, HPA035279: AB_10601253" "unprognostic (7.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.86e-1)" "unprognostic (1.41e-1)" "unprognostic (9.45e-2)" "prognostic favorable (5.27e-4)" "prognostic unfavorable (4.82e-4)" "unprognostic (6.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.76e-1)" "prognostic unfavorable (4.76e-4)" "prognostic unfavorable (3.50e-8)" "unprognostic (2.14e-2)" "unprognostic (2.86e-1)" "unprognostic (9.37e-2)" "prognostic favorable (2.72e-5)" 10.9 9.7 7.9 12.9 9.2 36.9 21.6 8.0 8.4 16.5 6.0 19.4 12.9 22.3 35.8 10.1 14.6 13.7 8.2 6.4 11.6 11.9 15.5 13.8 16.7 10.0 8.8 6.0 17.5 16.9 5.6 13.8 10.7 12.1 16.4 35.1 43.6 15.0 7.9 6.2 24.0 15.5 14.3 8.7 12.5 14.1 23.9 8.0 20.7 13.3 2.9 15.1 12.1 12.5 11.0 42.6 22.5 72.1 28.0 10.6 16.1 34.0 79.9 26.2 41.6 45.2 17.5 28.5 12.4 19.9 19.1 30.1 44.5 27.1 14.8 55.9 10.5 20.0 49.9 50.7 17.7 9.0 31.2 29.9 15.1 9.7 20.7 21.9 49.0 19.7 48.9 25.8 21.0 28.1 18.3 26.4 17.3 22.2 19.0 28.0 47.2 29.0 15.2 23.3 34.1 25.4 28.3 45.2 13.0 33.4 46.5 27.5 31.2 22.9 91.1 45.8 28.5 26.5 20.0 15.8 32.8 32.2 25.6 31.5 1.1 0.6 1.3 1.4 0.9 1.0 0.8 1.2 1.2 0.3 0.7 1.3 1.1 0.1 2.5 0.2 1.8 2.6 0.7 7.9 9.2 8.0 8.4 6.4 11.6 10.0 8.8 6.0 12.1 8.7 8.0 11.0 22.1 22.4 71.5 72.8 21.3 21.9 36.4 31.2 25.6 35.9 48.9 37.7 14.6 38.6 29.4 36.8 60.5 27.5 27.6 67.9 0.0 26.1 38.6 33.7 44.0 23.8 89.7 72.1 83.8 13.8 22.9 32.3 26.0 29.9 25.9 67.9 28.5 22.3 20.9 28.6 67.7 85.6 67.1 19.7 29.9 17.3 32.6 21.0 24.9 41.2 20.1 18.6 49.4 91.0 77.1 22.8 63.7 31.2 25.3 20.4 41.6 12.6 18.9 75.5 19.7 39.2 29.4 144.0 49.6 18.2 16.1 11.6 30.3 33.5 77.7 22.9 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 40.7;intestine: 25.8;lymphoid tissue: 59.1" "Group enriched" "Detected in many" 4 "B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA069743 Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA069743: AB_2686186" "prognostic favorable (3.83e-4)" "prognostic favorable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favorable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 1.9 0.7 0.7 26.0 1.2 40.7 1.1 0.5 1.2 1.3 1.1 3.0 5.5 0.9 0.1 2.3 1.9 3.2 0.9 0.6 0.8 2.4 2.6 9.0 57.1 0.8 0.5 0.7 0.5 0.8 0.2 0.5 0.8 0.9 1.9 1.5 0.0 3.8 0.8 0.9 1.4 25.8 0.5 0.9 59.1 7.6 0.5 0.9 46.4 7.7 0.6 22.0 3.3 1.7 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.1 1.2 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.1 0.0 0.0 0.3 47.1 64.7 0.0 0.0 0.0 6.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 4.5 0.0 0.0 0.1 0.2 0.0 0.4 0.5 12.2 0.0 24.6 0.0 191.0 46.0 270.4 237.7 120.4 169.7 177.3 201.5 208.3 65.6 184.2 206.7 192.0 237.6 148.0 167.0 55.8 286.6 261.6 0.7 1.2 0.5 1.2 0.6 0.8 0.8 0.5 0.7 0.9 0.9 0.9 0.9 2.5 6.4 19.5 0.0 109.6 1.1 0.1 0.1 0.6 1.0 1.4 1.9 1.5 2.8 2.5 0.0 0.0 0.2 144.4 0.2 0.0 0.2 0.2 2.4 0.4 1.9 1.2 12.6 0.2 0.0 0.3 2.0 2.0 1.1 23.4 0.1 5.0 1.4 23.7 0.0 0.1 0.0 0.0 16.0 6.9 0.6 0.0 23.1 3.6 1.0 24.5 0.3 284.2 0.0 0.5 0.0 0.0 0.0 40.2 0.1 0.1 1.1 1.3 0.5 0.0 1.3 1.1 0.1 0.2 0.0 1.0 0.4 147.7 0.1 0.1 0.1 SART1 "Ara1, HAF, SNRNP110, Snu66" ENSG00000175467 "Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP" O43290 11 65961728-65980137 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Allergen, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031188, HPA031189, HPA031190" Supported Enhanced "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289" "unprognostic (2.93e-2)" "unprognostic (1.13e-2)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "unprognostic (6.99e-2)" "unprognostic (2.52e-3)" "unprognostic (8.15e-2)" "unprognostic (8.97e-2)" "unprognostic (2.10e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" 23.6 18.4 15.7 18.5 15.6 42.0 23.3 14.4 17.5 29.0 13.4 24.9 15.7 29.3 8.1 22.9 25.8 8.7 22.5 14.0 13.8 19.1 22.0 23.1 20.5 15.7 15.2 12.8 29.4 26.1 11.8 21.6 14.1 15.3 21.8 7.8 8.1 22.3 14.5 38.4 31.5 24.5 11.0 13.9 33.0 25.1 23.7 15.5 21.1 23.7 13.1 13.4 26.4 24.8 17.1 50.4 60.8 27.2 36.8 26.1 20.7 40.8 37.5 27.2 43.8 28.6 44.2 34.3 56.9 42.4 33.8 52.9 48.7 34.6 35.6 22.0 45.8 33.5 65.6 43.6 41.4 39.0 57.4 52.7 26.2 26.4 40.8 36.3 17.4 27.6 42.3 42.2 39.8 25.6 92.6 74.0 83.5 45.7 27.3 55.9 80.8 39.0 60.7 18.4 33.7 30.5 43.0 35.6 37.2 45.5 12.6 41.7 47.0 40.6 54.5 53.0 53.9 54.1 59.6 49.4 48.3 45.0 28.8 47.0 1.4 2.8 8.1 4.3 3.5 3.6 3.9 4.8 4.4 3.6 3.5 3.5 3.9 4.1 2.8 2.0 3.2 5.4 1.8 15.7 15.6 14.4 17.5 14.0 13.8 15.7 15.2 12.8 15.3 13.9 15.5 17.1 17.5 6.4 9.1 7.8 27.8 22.7 24.0 12.2 17.6 19.2 12.2 9.1 9.4 21.5 11.3 16.5 10.4 34.1 27.2 30.5 5.9 23.7 9.0 14.2 16.3 19.8 12.5 32.8 5.1 29.3 31.9 17.6 21.9 16.8 32.4 21.8 21.0 15.6 29.4 16.8 4.8 26.5 16.2 22.5 23.6 8.7 37.0 22.9 17.8 6.5 35.7 23.8 34.0 7.1 7.8 26.3 20.1 33.1 31.2 20.5 28.3 18.5 17.5 26.0 32.9 27.6 34.9 26.7 29.7 18.3 21.7 45.3 28.4 15.5 27.5 18.2 PPP2R2D "B55D, B55delta, MDS026" ENSG00000175470 "Protein phosphatase 2 regulatory subunit Bdelta" Q66LE6 10 131901008-131959834 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 16.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042122, HPA042770" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (7.75e-3)" "unprognostic (7.11e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.40e-1)" "unprognostic (3.57e-1)" "unprognostic (9.64e-3)" "unprognostic (1.83e-1)" "unprognostic (3.13e-2)" "unprognostic (1.76e-2)" "unprognostic (8.74e-2)" "unprognostic (8.46e-2)" "unprognostic (8.04e-2)" "unprognostic (4.41e-3)" "unprognostic (1.10e-1)" "unprognostic (6.57e-2)" "unprognostic (6.66e-2)" "unprognostic (1.90e-2)" 1.5 3.1 4.0 1.2 4.3 0.0 1.5 6.5 5.7 1.9 3.2 2.6 2.1 1.6 2.0 1.6 1.6 1.6 3.3 4.2 3.7 1.8 1.6 2.4 2.4 3.7 3.8 3.9 3.6 16.1 3.2 2.4 1.9 3.9 1.8 1.9 2.8 3.3 1.9 2.8 2.7 2.4 1.3 2.9 1.9 2.2 1.3 5.7 1.7 2.3 2.9 1.5 2.4 2.0 4.5 4.4 3.8 2.4 1.8 3.3 2.6 3.4 1.5 3.1 2.9 3.1 3.1 3.6 1.8 1.0 1.8 1.8 7.9 3.2 0.7 3.1 4.5 4.2 3.0 3.7 1.8 1.1 3.2 3.4 0.9 6.7 3.2 4.5 4.6 2.0 2.6 3.9 0.8 3.2 2.1 1.5 7.3 1.5 1.5 3.4 2.0 1.6 0.5 2.3 0.6 1.9 2.6 1.9 1.6 1.8 2.5 1.4 2.4 2.8 1.6 0.7 2.3 8.1 2.8 1.6 2.3 1.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.3 6.5 5.7 4.2 3.7 3.7 3.8 3.9 3.9 2.9 5.7 4.5 26.8 19.2 14.3 22.2 20.0 37.3 37.4 6.4 20.5 55.0 25.8 23.6 36.3 14.3 10.2 9.2 10.4 10.6 36.1 27.6 19.6 9.8 12.7 21.5 24.8 19.0 10.7 18.7 43.0 17.7 13.6 21.8 19.9 32.3 6.3 33.1 13.2 23.2 14.1 52.2 37.5 18.2 8.2 12.0 17.6 6.4 17.4 23.3 12.4 26.2 10.5 28.3 18.6 29.7 38.1 16.8 18.0 20.7 20.3 39.1 20.0 29.6 5.7 32.6 26.3 29.2 23.2 14.3 20.1 18.8 34.0 11.8 24.4 39.5 19.1 39.6 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.8" "Cell type enhanced" "Detected in many" "Adipocytes: 113.3;Excitatory neurons: 510.6;Inhibitory neurons: 412.2;Oligodendrocyte precursor cells: 263.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 37.0;classical monocyte: 28.6;eosinophil: 13.2;intermediate monocyte: 41.4;myeloid DC: 22.3;neutrophil: 40.5;non-classical monocyte: 40.6;plasmacytoid DC: 11.4" "Group enriched" "Detected in many" 54 "dendritic cells: 22.3;granulocytes: 40.5;monocytes: 41.4" "Cell line enhanced" "Detected in many" "Karpas-707: 71.4;RPMI-8226: 73.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 20.7 2.3 7.3 12.6 26.2 45.8 16.0 30.0 19.2 6.0 5.7 7.8 5.1 5.9 2.0 6.5 4.9 17.6 3.9 20.8 17.0 2.7 3.7 13.0 6.2 7.6 2.7 8.5 1.7 3.2 1.9 4.0 7.4 12.2 3.5 7.3 1.7 3.7 2.2 3.2 4.4 4.9 11.3 0.7 8.9 5.6 2.1 4.0 8.0 4.6 8.0 4.4 21.5 6.1 14.2 0.3 5.2 3.3 0.1 49.0 19.6 0.2 0.3 25.1 2.3 8.1 0.1 13.3 18.7 19.2 0.0 51.1 0.2 0.4 0.2 2.8 0.0 3.6 11.4 13.3 0.2 6.4 23.6 14.6 7.3 0.0 9.0 32.5 21.2 52.7 7.6 0.3 71.4 18.7 0.6 1.4 17.9 4.1 0.3 20.7 0.9 0.2 73.7 52.7 29.0 10.0 0.5 1.7 0.1 37.1 1.4 0.0 21.8 0.3 9.0 13.9 0.4 4.2 5.0 0.1 0.2 41.8 38.5 9.1 37.0 28.6 13.2 0.1 41.4 0.0 0.6 0.1 0.2 22.3 0.3 0.4 0.0 40.5 0.3 40.6 11.4 0.0 8.5 7.3 26.2 30.0 19.2 20.8 17.0 7.6 2.7 8.5 12.2 0.7 4.0 14.2 113.3 3.2 10.8 15.3 3.2 18.1 0.2 6.9 3.4 2.2 1.7 1.1 3.1 0.0 6.6 3.7 0.0 0.3 9.8 0.1 0.0 0.0 27.8 5.5 1.2 97.9 0.0 5.0 510.6 0.2 0.2 18.5 5.6 11.6 63.3 0.1 2.2 0.3 12.2 3.3 412.2 0.0 4.1 42.4 76.5 16.2 0.6 63.5 12.4 67.5 32.9 3.2 2.1 263.4 9.0 1.3 0.0 0.0 2.4 0.8 0.0 0.5 3.5 3.5 0.0 1.8 2.0 1.8 1.4 0.7 13.4 0.3 3.7 0.3 0.0 0.6 POLD4 "p12, POLDS" ENSG00000175482 "DNA polymerase delta 4, accessory subunit" Q9HCU8 11 67350772-67356972 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 274.2" "Cell type enhanced" "Detected in all" "Distal enterocytes: 538.2;Paneth cells: 572.5;Proximal enterocytes: 403.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 177.0" "Low region specificity" "Detected in all" HPA078008 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA078008: " "unprognostic (7.55e-3)" "unprognostic (2.71e-1)" "unprognostic (3.93e-2)" "unprognostic (2.75e-1)" "unprognostic (1.19e-2)" "unprognostic (1.03e-1)" "unprognostic (8.25e-2)" "unprognostic (1.43e-2)" "unprognostic (4.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.39e-3)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (1.95e-1)" "unprognostic (9.36e-2)" 78.9 78.8 8.3 60.9 8.0 37.4 67.1 7.0 19.7 56.5 7.9 84.2 86.8 53.5 5.6 119.3 47.7 19.3 92.0 7.3 14.0 106.9 274.2 74.1 83.8 10.8 8.2 6.5 48.8 105.7 4.0 40.0 17.3 8.5 87.8 14.9 3.0 73.3 9.6 92.4 55.9 119.8 9.9 7.2 112.4 82.4 28.2 9.0 8.7 49.7 9.3 25.6 82.8 76.1 16.6 48.0 125.5 2.0 13.6 14.4 27.8 7.6 58.3 12.1 8.5 6.0 21.9 147.7 126.4 177.0 16.9 31.1 64.2 0.4 39.5 1.1 53.4 7.2 29.1 29.6 29.2 31.9 10.3 142.1 31.4 19.7 15.4 13.1 42.6 25.4 19.5 27.1 42.2 14.3 79.4 13.2 22.7 10.1 94.7 83.7 21.6 23.4 34.7 19.9 33.1 1.0 13.2 29.7 21.9 95.8 6.9 51.8 37.5 82.5 28.7 20.2 75.2 19.8 52.9 19.1 72.4 95.8 24.3 34.3 129.3 147.8 258.6 63.2 192.4 59.1 333.3 72.5 65.6 143.8 354.7 78.9 71.0 143.4 50.7 376.9 101.1 115.6 128.9 8.3 8.0 7.0 19.7 7.3 14.0 10.8 8.2 6.5 8.5 7.2 9.0 16.6 8.0 19.2 44.9 12.4 115.3 43.3 3.1 152.6 47.8 2.6 14.8 8.6 2.3 12.8 86.1 7.3 6.2 8.6 15.5 538.2 15.6 144.7 7.8 4.8 7.8 19.1 83.1 26.1 6.5 188.5 10.5 25.3 180.4 11.9 68.5 5.6 22.1 40.7 31.3 3.3 4.9 226.0 105.8 31.3 92.5 18.7 6.8 66.9 60.5 34.7 114.1 4.2 36.0 5.5 12.6 220.3 572.5 3.8 66.8 4.5 403.3 30.2 18.7 4.2 6.6 5.8 26.8 4.7 3.0 96.4 68.9 12.4 49.4 2.2 130.8 4.5 OR52W1 OR52W1P ENSG00000175485 "Olfactory receptor family 52 subfamily W member 1" Q6IF63 11 6199146-6200259 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.4 0.5 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC25 "FLJ38116, MAPA" ENSG00000175489 "Leucine rich repeat containing 25" Q8N386 19 18391137-18397622 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 32.7;lymphoid tissue: 61.7" "Group enriched" "Detected in some" 6 "Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7" "Group enriched" "Detected in all" 60 "dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029459 Approved Approved "Endoplasmic reticulum,Microtubules,Cytosol" NA NA 630000 "Endoplasmic reticulum, Microtubules, Cytosol" "HPA029459: AB_10610005" "unprognostic (2.72e-2)" "unprognostic (6.08e-2)" "unprognostic (1.76e-2)" "unprognostic (2.07e-1)" "unprognostic (3.77e-2)" "unprognostic (9.15e-2)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-3)" "unprognostic (5.77e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.74e-1)" "unprognostic (1.14e-1)" 9.5 9.5 2.2 22.0 2.3 32.7 3.1 2.9 3.5 1.7 3.6 3.3 3.7 1.7 0.8 2.3 4.0 5.4 2.4 2.0 7.3 2.3 6.0 11.6 10.0 4.2 2.9 1.7 1.5 2.1 0.7 1.2 5.4 3.3 2.0 2.8 0.3 2.6 1.2 3.7 0.9 4.9 6.7 3.0 61.7 2.4 1.2 4.4 3.0 1.2 8.7 4.0 7.1 1.3 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.3 1.0 0.8 0.4 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.7 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.2 1.5 0.1 55.4 320.6 356.2 0.9 512.1 1.9 7.3 0.6 0.7 229.3 8.4 0.5 0.6 573.0 4.6 706.7 32.1 1.3 229.2 2.2 2.3 2.9 3.5 2.0 7.3 4.2 2.9 1.7 3.3 3.0 4.4 7.7 0.7 0.0 1.3 0.0 5.0 0.0 0.1 0.1 0.0 0.1 0.3 1.0 0.3 0.0 0.7 0.0 0.0 0.1 2.9 0.1 5.9 0.1 1.9 0.2 0.1 0.9 0.0 2.1 0.1 0.0 0.4 0.5 0.0 0.4 10.2 0.0 1.8 0.5 47.0 0.0 0.1 0.0 0.0 123.6 12.5 0.5 0.0 90.0 1.8 1.0 74.9 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 2.4 0.2 0.0 0.2 0.0 0.1 0.4 1.1 0.2 0.1 0.1 DPP10 "DPL2, DPPY, DPRP3" ENSG00000175497 "Dipeptidyl peptidase like 10" Q8N608 2 114442299-115845780 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.8;brain: 20.1;pancreas: 17.4" "Cell type enhanced" "Detected in many" "Astrocytes: 4634.9;Excitatory neurons: 3067.4;Inhibitory neurons: 3258.7;Oligodendrocyte precursor cells: 990.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.1;HAP1: 6.2;HMC-1: 4.3;JURKAT: 3.4;NTERA-2: 3.7;RT4: 6.7;SCLC-21H: 9.7;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048767 Uncertain NA NA "HPA048767: AB_2680515" "unprognostic (1.19e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (6.59e-2)" "unprognostic (2.92e-1)" "unprognostic (5.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (8.33e-2)" "unprognostic (7.61e-2)" "unprognostic (4.22e-2)" 0.1 10.8 7.2 0.3 20.1 0.1 0.0 0.7 16.0 0.3 0.0 2.2 1.2 0.4 0.0 0.0 0.1 0.8 0.1 19.1 6.5 0.2 0.1 0.2 0.0 2.5 2.9 16.3 0.0 17.4 0.0 0.8 0.8 5.4 0.0 2.8 4.1 0.2 0.0 0.0 0.1 1.2 0.9 2.7 0.0 1.0 1.0 4.6 0.0 0.6 0.0 0.0 0.3 0.0 17.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 6.7 9.7 3.9 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 20.1 0.7 16.0 19.1 6.5 2.5 2.9 16.3 5.4 2.7 4.6 17.2 0.0 0.0 0.0 4634.9 0.0 0.0 0.0 0.0 0.6 21.7 0.0 0.0 1.5 4.3 0.6 0.0 0.0 1.5 0.0 2.3 0.0 0.0 12.4 0.1 0.1 0.1 4.2 2.1 3067.4 2.7 10.2 0.5 0.0 0.3 0.0 5.8 0.7 0.0 0.3 5.0 3258.7 1.4 0.0 0.0 0.0 5.7 0.3 0.0 1.8 58.1 0.0 1.4 0.0 990.7 48.3 0.8 1.9 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.0 0.1 1.6 2.6 0.3 0.0 4.4 0.0 0.4 3.2 0.0 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 41.8;Glandular and luminal cells: 104.9;Pancreatic endocrine cells: 56.2;Prostatic glandular cells: 56.4;Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "hypothalamus: 7.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" NA NA "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 11.4 6.1 1.6 8.1 0.7 13.8 5.3 0.1 1.9 11.4 1.1 11.4 1.4 16.7 1.0 4.4 17.2 17.9 7.3 1.2 7.7 16.1 4.2 9.4 5.4 1.7 0.7 0.7 6.8 6.6 0.2 6.6 4.3 0.5 7.3 1.7 1.4 9.2 1.8 1.5 2.6 9.4 8.4 0.1 8.2 11.3 1.9 2.1 0.7 9.8 2.0 4.4 18.3 7.7 1.4 15.1 31.4 2.2 9.7 4.2 5.8 0.0 20.9 11.6 14.4 7.0 5.1 40.3 9.1 17.1 26.8 17.5 10.3 0.4 10.7 6.3 0.5 0.3 0.1 23.9 4.0 13.6 1.9 2.4 7.6 2.6 15.0 6.5 27.4 3.1 0.0 3.5 0.4 15.0 12.0 0.1 6.8 8.1 18.9 28.8 0.9 4.8 0.5 22.7 0.8 0.1 1.6 57.8 2.2 1.3 4.4 1.3 2.5 12.5 27.6 11.6 35.4 31.5 2.0 0.1 1.0 35.4 1.8 11.1 0.0 0.9 15.2 10.5 3.4 6.2 10.8 4.8 8.3 1.3 13.8 0.1 3.5 0.3 0.2 10.5 0.0 1.1 3.2 1.6 0.7 0.1 1.9 1.2 7.7 1.7 0.7 0.7 0.5 0.1 2.1 1.4 4.2 16.0 4.8 1.3 10.6 3.7 25.9 6.5 1.8 0.0 14.5 2.4 0.8 25.8 9.6 7.3 0.0 0.4 10.0 3.8 1.9 24.0 1.8 41.8 19.4 6.2 1.2 0.0 0.7 11.8 0.6 14.0 5.1 104.9 3.8 2.1 2.9 1.0 1.2 0.0 0.5 2.3 6.1 0.3 10.7 4.7 3.4 6.7 8.8 1.0 6.5 1.7 3.1 0.5 0.1 56.2 14.3 0.0 9.5 56.4 0.2 5.2 1.7 0.3 0.0 32.6 10.4 0.3 0.9 1.6 4.4 0.1 9.7 0.1 1.5 65.2 TSGA10IP "FAM161C, FLJ32880" ENSG00000175513 "Testis specific 10 interacting protein" Q3SY00 11 65945445-65959963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 10.0" "Group enriched" "Detected in some" 5 "Early spermatids: 54.6;Late spermatids: 59.8" "Group enriched" "Detected in some" 7 "testis cancer: 1.5;thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.69e-1)" "unprognostic (8.39e-3)" "unprognostic (3.84e-1)" "unprognostic (6.76e-2)" "unprognostic (2.31e-1)" "unprognostic (3.57e-4)" "unprognostic (8.66e-2)" "unprognostic (8.53e-3)" "unprognostic (1.69e-1)" "unprognostic (1.11e-1)" "unprognostic (5.47e-2)" "unprognostic (5.61e-1)" "unprognostic (1.62e-4)" "unprognostic (8.96e-2)" "unprognostic (2.31e-1)" "unprognostic (7.35e-2)" "unprognostic (6.66e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 59.8 0.9 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 GPR152 PGR5 ENSG00000175514 "G protein-coupled receptor 152" Q8TDT2 11 67451301-67452729 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035078 Uncertain NA NA "HPA035078: AB_10670286" "unprognostic (3.81e-2)" "unprognostic (1.69e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.76e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBQLNL "MGC20470, MGC26958" ENSG00000175518 "Ubiquilin like" Q8IYU4 11 5514393-5518431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 32.0" "Group enriched" "Detected in some" 76 "Early spermatids: 169.6;Late spermatids: 637.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-4)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.60e-2)" "unprognostic (7.69e-2)" "unprognostic (2.22e-2)" "unprognostic (3.64e-1)" "unprognostic (1.17e-3)" "unprognostic (1.73e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-8)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (1.17e-1)" "unprognostic (9.69e-5)" 0.5 0.7 0.7 0.1 0.4 0.3 0.5 0.3 0.5 1.4 0.6 0.6 0.1 0.9 1.2 0.4 1.2 0.2 0.6 0.4 0.9 0.9 0.9 0.8 0.3 0.6 0.5 0.4 2.4 0.7 0.1 0.6 0.2 0.6 1.5 0.1 0.0 0.4 0.1 0.1 0.5 0.8 0.3 0.5 1.5 0.5 32.0 0.4 0.4 1.1 0.0 0.1 0.7 0.8 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.5 0.4 0.9 0.6 0.5 0.4 0.6 0.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 169.6 0.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 637.7 5.3 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.2 2.6 0.1 0.3 0.0 0.4 0.5 0.0 0.0 0.3 0.2 4.0 2.6 0.0 0.1 0.3 0.1 0.3 0.2 0.2 UBQLN3 TUP-1 ENSG00000175520 "Ubiquilin 3" Q9H347 11 5507300-5509958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 234 "testis: 160.0" "Group enriched" "Detected in some" 70 "Early spermatids: 709.6;Late spermatids: 1878.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020547, HPA062018" Enhanced NA NA "HPA020547: AB_1858577, HPA062018: AB_2684661" "unprognostic (3.79e-3)" 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 160.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.1 0.6 0.4 0.2 0.1 0.4 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 709.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1878.4 9.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 18.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNLIP PL ENSG00000175535 "Pancreatic lipase" P16233 10 116545931-116567855 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2057 "pancreas: 448477.5" "Cell type enriched" "Detected in some" 8 "Exocrine glandular cells: 4086.8" "Cancer enriched" "Detected in some" 4854 "pancreatic cancer: 2731.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA062430, HPA062494" Enhanced "Secreted to digestive system" NA NA 14000000 "HPA062430: AB_2684761, HPA062494: AB_2684782" "unprognostic (2.05e-2)" "unprognostic (4.46e-2)" 13.1 3.1 0.0 10.6 0.0 1.1 8.9 0.0 0.0 4.1 0.0 3.1 65.3 9.1 0.4 4.8 1.5 0.0 78.9 0.0 0.0 3.0 10.2 2.1 17.1 0.0 0.0 0.0 218.0 448477.5 0.0 2.5 24.6 0.0 4.6 0.0 0.0 72.3 0.0 2.9 3.7 34.2 0.0 0.0 3.8 28.5 2.3 0.0 0.0 2.0 0.0 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.5 0.0 0.0 0.3 0.0 0.0 0.1 4086.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 14.5 0.0 0.0 0.5 0.1 507.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 LIPT2 ENSG00000175536 "Lipoyl(octanoyl) transferase 2" A6NK58 11 74490519-74493724 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Ligase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.4" "Cell type enhanced" "Detected in many" "Early spermatids: 55.4;Late spermatids: 29.4;Proximal tubular cells: 17.7;Spermatocytes: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040249 Approved NA NA "HPA040249: AB_10795275" "unprognostic (8.80e-2)" "unprognostic (9.67e-2)" "unprognostic (5.12e-3)" "unprognostic (1.09e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-2)" "unprognostic (8.96e-2)" "unprognostic (1.11e-2)" "prognostic favorable (1.63e-4)" "unprognostic (6.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (9.45e-2)" "unprognostic (1.01e-1)" "unprognostic (1.51e-2)" "unprognostic (1.35e-1)" 1.3 2.0 1.9 1.6 2.0 2.1 2.5 2.0 1.8 1.5 1.2 2.1 3.7 1.6 3.2 1.8 3.2 1.9 1.5 1.9 2.1 4.7 3.2 1.7 2.2 2.6 1.8 1.6 3.4 2.9 2.1 2.1 2.2 2.9 1.9 2.3 1.9 2.1 2.8 8.1 1.6 3.6 0.6 1.9 2.1 3.5 12.4 2.7 2.8 3.1 7.1 2.3 1.7 1.2 2.9 2.1 3.3 6.6 3.1 2.1 0.4 6.9 0.8 1.5 3.3 2.3 9.8 3.0 11.5 4.0 0.6 8.0 3.2 2.8 1.9 1.2 2.2 2.6 4.0 3.2 2.9 2.9 4.4 5.0 1.4 2.2 2.2 2.2 1.5 0.2 12.7 3.0 4.1 1.3 4.0 6.6 6.1 4.9 13.0 2.6 4.3 7.0 3.7 2.6 7.3 5.5 3.6 5.6 2.0 8.1 6.2 5.6 3.2 0.6 1.0 2.1 1.5 1.8 5.7 5.8 9.3 0.6 2.7 2.9 0.1 4.7 7.5 5.5 3.0 7.6 10.6 7.3 6.6 5.3 10.5 13.3 10.9 1.1 8.4 3.4 6.3 3.7 4.8 1.9 2.0 2.0 1.8 1.9 2.1 2.6 1.8 1.6 2.9 1.9 2.7 2.9 0.6 0.0 0.0 1.0 2.5 0.8 1.1 2.9 4.0 0.9 1.7 1.9 1.1 2.8 1.4 3.7 0.0 13.2 0.7 0.9 5.9 2.6 55.4 1.5 0.7 1.0 0.0 4.0 0.3 4.4 14.1 1.4 2.0 1.1 0.0 1.9 2.2 4.2 5.4 3.3 0.2 3.1 4.1 1.3 0.0 29.4 1.8 2.3 1.8 0.0 0.7 9.8 2.1 0.5 1.1 2.8 0.5 1.2 0.8 1.0 4.3 17.7 1.9 1.6 0.0 1.3 0.9 46.7 10.7 2.9 0.6 8.1 1.4 3.0 3.1 0.3 KCNE3 "HOKPP, MiRP2" ENSG00000175538 "Potassium voltage-gated channel subfamily E regulatory subunit 3" Q9Y6H6 11 74454841-74467729 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 71.1;stomach 1: 56.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 48 "basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6" "Group enriched" "Detected in many" 115 "dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8" "Cell line enhanced" "Detected in some" "HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014849 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014849: AB_1852112" "unprognostic (1.61e-2)" "unprognostic (2.94e-1)" "unprognostic (1.11e-1)" "unprognostic (8.69e-2)" "unprognostic (3.58e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (4.67e-3)" "unprognostic (4.89e-4)" "unprognostic (4.12e-3)" "unprognostic (2.56e-2)" "unprognostic (2.97e-2)" "unprognostic (1.45e-3)" "unprognostic (7.86e-2)" "unprognostic (1.33e-2)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" 7.4 2.8 2.7 20.9 3.0 8.3 5.3 2.4 4.0 10.0 7.8 35.2 71.1 8.9 2.0 4.7 9.5 24.8 5.1 2.9 5.1 20.3 5.0 14.0 5.1 3.5 3.1 2.1 14.1 10.9 3.6 3.1 12.8 3.1 8.1 47.7 8.1 15.5 3.4 1.3 1.3 40.3 11.2 3.0 12.7 56.7 1.8 3.7 1.9 33.8 3.1 3.2 6.3 4.5 5.4 0.1 0.1 0.1 0.2 8.1 2.1 7.1 0.1 0.0 1.0 0.8 23.0 2.0 0.3 21.3 0.1 0.1 0.3 1.8 0.0 0.7 0.0 0.2 70.3 0.4 4.7 2.9 0.6 12.0 7.1 0.0 0.6 0.0 0.3 0.3 0.1 1.9 0.3 0.8 0.1 0.1 44.7 0.9 155.3 0.1 7.6 0.3 0.5 1.7 0.0 0.0 0.4 0.1 0.0 0.0 5.4 0.1 32.7 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.4 0.1 12.9 0.1 51.4 38.5 23.4 0.1 41.8 0.2 0.2 0.1 0.1 18.3 0.3 0.1 0.1 53.1 0.2 36.6 0.7 0.0 13.2 2.7 3.0 2.4 4.0 2.9 5.1 3.5 3.1 2.1 3.1 3.0 3.7 5.4 4.4 0.0 6.8 0.3 0.7 0.3 0.6 1.1 3.4 0.2 0.2 0.3 0.7 8.6 5.6 1.8 0.0 0.4 0.0 8.6 3.9 0.5 0.1 3.1 3.4 8.9 2.4 2.1 0.2 7.3 7.4 4.5 41.8 5.0 33.7 0.2 5.7 2.0 40.6 0.0 0.3 27.9 4.1 104.0 2.9 0.3 3.7 37.8 0.0 8.4 59.0 22.7 1.0 0.0 0.0 3.3 8.9 2.6 0.2 0.4 8.6 23.4 4.6 1.2 0.0 4.7 0.7 0.0 0.4 2.7 0.1 2.1 1.0 8.8 44.3 0.6 CABP4 CSNB2B ENSG00000175544 "Calcium binding protein 4" P57796 11 67452406-67461752 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "retina: 68.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 141.8;Rod photoreceptor cells: 254.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 12.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.24e-1)" "unprognostic (1.26e-1)" "unprognostic (4.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.78e-3)" "unprognostic (2.91e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (1.44e-2)" "unprognostic (2.32e-3)" "unprognostic (2.57e-1)" "unprognostic (7.10e-4)" "unprognostic (5.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.10e-1)" "unprognostic (3.44e-3)" 1.2 0.6 1.1 0.5 1.2 0.7 1.4 1.8 1.5 1.0 1.3 0.5 0.6 0.5 1.7 0.3 0.4 0.8 0.5 1.1 1.1 0.6 0.7 1.7 1.1 1.3 1.1 1.0 0.2 0.8 0.1 0.1 1.4 1.5 1.4 0.4 68.8 0.9 0.6 0.9 0.7 1.2 0.3 0.8 7.3 1.4 0.2 1.2 0.3 0.5 0.2 0.4 0.6 0.3 2.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 4.5 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.1 4.1 0.1 0.0 0.1 19.4 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.6 1.0 0.3 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 1.9 0.1 0.1 0.3 0.1 0.2 0.0 0.6 0.1 0.2 0.1 4.0 3.3 0.8 0.7 1.7 0.5 0.6 0.6 0.5 2.5 1.1 0.6 0.7 2.7 1.3 12.1 0.9 0.4 3.5 1.1 1.2 1.8 1.5 1.1 1.1 1.3 1.1 1.0 1.5 0.8 1.2 2.3 2.2 0.0 0.5 0.3 1.9 0.9 1.2 0.0 0.6 17.0 2.2 2.0 2.0 2.8 0.0 5.5 141.8 0.1 0.9 0.4 0.0 1.6 0.4 3.8 0.6 3.6 0.0 0.0 0.2 1.5 0.2 0.7 2.6 2.8 0.0 0.1 3.9 0.2 3.9 13.5 0.3 0.7 0.0 9.5 1.9 0.2 0.3 1.9 1.8 2.8 0.3 28.9 5.2 0.0 0.4 1.7 0.1 0.0 1.5 1.5 0.1 1.2 0.7 254.4 0.0 4.8 0.6 0.0 0.3 0.2 0.3 0.8 1.4 0.0 0.2 1.0 ALG10B KCR1 ENSG00000175548 "ALG10 alpha-1,2-glucosyltransferase B" Q5I7T1 12 38316762-38329721 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (4.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "unprognostic (1.25e-1)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (4.43e-2)" "unprognostic (8.58e-2)" "unprognostic (7.40e-2)" "unprognostic (8.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.30e-3)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" 2.9 3.6 2.4 3.1 2.6 4.4 5.2 3.4 2.5 2.9 2.2 2.1 2.5 3.7 3.7 1.8 3.4 2.7 2.2 2.2 2.5 3.3 3.8 2.5 4.6 2.8 2.8 1.9 5.0 2.9 3.7 1.1 5.0 2.8 3.5 2.6 9.2 2.8 2.2 1.5 4.4 2.6 2.5 2.9 4.7 3.8 2.6 2.4 4.0 4.2 2.4 3.8 1.5 1.4 3.4 5.1 4.6 6.1 6.2 3.0 5.5 6.3 4.0 2.0 5.3 4.6 1.7 15.2 8.0 7.2 2.3 4.1 5.3 5.7 4.4 7.6 5.2 6.8 8.4 8.4 3.5 3.5 11.3 6.1 3.1 5.7 7.5 5.5 4.7 4.2 10.4 9.6 4.6 4.8 3.9 7.5 8.9 7.8 0.5 4.6 2.5 13.2 6.3 4.4 6.4 1.8 6.3 7.1 2.3 5.0 6.6 10.6 4.6 3.3 5.5 6.6 4.9 5.2 3.6 10.1 12.5 4.7 7.7 7.3 0.3 0.4 0.6 0.3 0.5 0.5 0.4 0.3 0.4 0.3 1.3 0.5 0.7 0.1 0.4 0.4 0.7 1.2 0.3 2.4 2.6 3.4 2.5 2.2 2.5 2.8 2.8 1.9 2.8 2.9 2.4 3.4 7.1 6.4 13.9 9.1 2.6 2.0 3.4 3.3 4.0 14.9 5.0 3.8 3.9 0.0 7.0 3.7 33.3 16.1 2.1 0.9 7.9 4.3 0.3 6.5 6.2 5.7 0.0 2.5 4.8 5.8 9.6 4.8 2.0 4.6 1.3 9.5 6.8 7.1 4.8 10.1 5.7 1.9 4.1 1.6 2.0 1.8 4.1 3.1 1.8 10.3 2.5 8.0 1.0 9.0 9.1 4.5 2.0 5.7 1.6 2.0 2.6 2.6 5.2 14.5 6.6 6.5 3.2 10.7 4.7 3.1 1.8 8.1 3.0 4.6 2.3 2.3 DRAP1 NC2-alpha ENSG00000175550 "DR1 associated protein 1" Q14919 11 65919274-65921563 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 813.2;Suprabasal keratinocytes: 1015.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 1032.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006790 Uncertain Approved Cytosol NA NA Cytosol "HPA006790: AB_1078702" "unprognostic (1.69e-2)" "unprognostic (1.02e-2)" "unprognostic (1.01e-1)" "unprognostic (3.01e-2)" "unprognostic (1.84e-2)" "unprognostic (4.06e-2)" "unprognostic (4.89e-3)" "unprognostic (5.58e-2)" "unprognostic (8.47e-2)" "unprognostic (4.23e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.96e-5)" "unprognostic (1.62e-1)" 84.5 87.1 106.2 71.7 107.7 97.7 81.0 107.5 164.1 85.4 91.8 89.7 56.6 90.1 28.2 108.4 74.6 35.2 117.9 109.1 112.1 75.5 76.9 75.7 71.6 108.4 105.3 102.6 68.0 73.9 63.1 81.9 43.5 109.4 73.7 21.3 25.3 58.8 48.5 199.0 110.5 63.4 40.5 104.4 86.2 70.5 174.5 108.9 97.5 119.9 79.2 39.5 84.9 84.1 119.0 578.7 226.8 108.3 200.0 99.9 195.3 75.9 634.9 273.2 344.1 223.6 85.6 302.7 142.2 277.3 420.3 395.5 222.7 42.7 292.0 138.2 187.7 70.1 173.4 103.8 85.4 186.0 145.8 228.2 123.7 126.6 365.8 246.7 191.4 142.2 138.9 78.5 223.6 377.4 301.9 255.0 263.6 167.5 73.1 575.9 216.3 107.1 305.4 113.6 82.3 122.2 137.7 149.6 137.8 348.9 46.1 188.2 104.8 413.0 470.1 461.4 1032.4 556.2 201.8 186.6 149.9 490.1 91.4 650.8 146.5 118.9 290.5 131.0 311.9 117.5 139.5 116.3 136.6 183.2 124.2 114.6 123.3 164.6 194.6 538.9 136.8 148.5 112.7 106.2 107.7 107.5 164.1 109.1 112.1 108.4 105.3 102.6 109.4 104.4 108.9 119.0 116.7 6.4 30.5 9.1 131.8 813.2 199.3 238.8 139.5 56.9 122.9 189.0 32.9 64.3 89.8 130.6 35.5 136.6 166.9 111.7 283.7 202.8 128.9 78.6 142.8 110.6 151.9 195.7 11.5 170.7 161.9 130.2 58.1 98.9 238.0 78.9 92.1 96.4 298.5 63.9 10.8 120.4 142.4 152.4 462.0 85.7 179.3 208.1 247.3 14.0 241.9 79.9 286.3 11.6 22.9 289.9 126.2 173.0 131.7 423.3 144.8 257.8 54.4 47.9 92.1 90.1 194.1 131.0 171.1 163.8 1015.8 174.4 197.2 107.1 125.0 425.3 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 7 "T-cells: 3.8" "Cell line enhanced" "Detected in many" "GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050422: AB_2681122, HPA061162: AB_2732658" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavorable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.3 3.3 1.1 1.9 0.8 4.5 1.4 6.1 2.7 1.5 0.0 3.5 2.3 2.0 1.2 1.4 2.0 2.4 1.7 3.2 3.1 2.9 12.8 6.4 0.8 1.1 2.1 0.6 1.6 7.1 0.7 0.9 0.8 2.6 1.9 4.3 2.8 4.9 2.4 8.9 0.6 2.0 1.6 1.9 0.6 4.0 1.7 1.8 0.3 8.2 3.9 1.0 3.6 0.7 1.1 5.0 6.9 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 6.0 0.0 3.5 0.0 12.2 0.0 1.3 0.0 0.1 0.1 3.7 6.6 11.8 6.9 3.7 5.7 0.7 0.0 0.0 0.0 0.0 2.1 1.7 0.5 13.8 0.0 0.9 5.5 0.0 2.3 0.0 15.2 16.0 0.0 3.1 0.0 4.2 2.1 0.2 0.0 14.5 0.4 11.8 0.1 0.0 4.5 0.3 0.1 0.2 0.0 7.9 1.4 6.3 0.0 3.2 5.4 3.4 0.0 0.4 0.0 2.4 0.0 3.8 0.0 1.1 0.8 0.0 0.0 0.5 0.8 0.5 0.0 0.0 0.0 0.4 0.3 1.1 0.8 6.1 2.7 3.2 3.1 1.1 2.1 0.6 2.6 1.9 1.8 1.1 2.2 6.4 13.4 7.8 0.4 1.5 16.9 0.2 1.8 3.3 0.8 1.9 4.4 0.0 6.1 1.8 0.0 0.5 5.3 11.2 1.9 3.0 1.6 4.4 6.4 3.3 1.2 0.4 1.8 4.3 0.0 8.0 17.3 13.0 6.3 0.1 2.2 4.1 2.7 1.7 6.0 4.6 0.0 4.7 7.7 1.0 0.9 9.5 3.6 9.4 0.5 3.7 2.1 3.5 0.2 5.2 8.8 1.5 1.3 7.2 1.6 1.5 0.3 0.3 0.0 9.9 2.0 2.4 4.6 1.6 0.1 0.4 2.7 0.2 3.7 12.5 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000277-74009085 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 80 "skeletal muscle: 396.4;tongue: 265.4" "Cell type enhanced" "Detected in some" "Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "HDLM-2: 15.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 1.2 1.7 3.0 1.3 2.7 2.3 1.3 4.1 3.1 1.2 2.3 1.5 0.7 1.4 2.1 2.9 1.5 0.9 2.0 2.9 2.2 1.4 1.3 1.4 1.3 2.5 2.6 2.4 1.1 1.2 0.9 2.7 0.5 3.4 1.8 0.8 4.1 3.7 0.7 396.4 1.3 1.7 0.8 2.0 3.1 1.2 4.0 2.5 1.6 2.6 265.4 0.7 1.4 0.9 3.0 0.2 1.8 1.7 1.5 0.7 0.3 0.3 0.5 0.4 0.4 0.2 0.4 0.4 0.9 0.2 0.3 0.2 1.9 0.7 0.3 0.7 15.8 0.5 0.3 2.4 0.2 0.5 1.1 1.4 0.4 1.1 1.1 0.1 0.3 0.5 0.9 0.4 1.2 0.6 1.0 0.7 1.4 0.9 1.4 1.1 1.4 3.6 0.5 0.9 0.5 0.9 1.0 0.4 0.7 0.6 0.3 0.2 1.0 0.3 0.2 1.1 0.6 1.1 1.4 1.5 0.7 0.2 1.0 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.0 2.7 4.1 3.1 2.9 2.2 2.5 2.6 2.4 3.4 2.0 2.5 3.0 0.8 0.0 0.0 1.6 0.8 0.1 0.1 0.5 0.6 2.3 1.0 1.1 0.7 0.0 1.1 0.0 0.0 0.3 2.0 0.3 0.0 0.3 15.4 1.2 1.1 0.6 0.0 0.4 1.6 0.5 0.2 0.4 0.0 0.8 0.0 0.7 1.1 0.3 0.7 0.0 1.6 0.5 2.0 0.8 0.0 14.0 0.0 0.6 0.0 1.0 0.7 0.8 6.2 0.5 0.6 0.4 0.1 0.7 0.5 0.2 0.3 0.1 3.0 2.1 0.0 6.5 0.5 1.5 0.8 0.4 0.3 0.3 1.5 0.3 0.6 0.1 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974672-73982843 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 280.4" "Cell type enhanced" "Detected in many" "dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria NA NA Mitochondria "CAB025583: , HPA075202: AB_2732284" "unprognostic (1.13e-1)" "prognostic favorable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 71.6 20.7 14.0 144.2 14.9 133.9 38.0 14.1 24.3 41.6 22.7 33.5 53.9 17.6 7.7 17.9 177.2 42.7 14.1 12.3 27.7 22.2 26.4 69.9 280.4 19.2 17.0 11.3 5.0 12.7 8.2 13.9 27.5 19.4 19.9 45.2 7.0 43.0 23.2 100.0 9.3 57.1 30.7 18.9 184.8 55.7 14.6 20.2 219.3 45.5 143.0 242.1 74.3 5.0 36.9 0.9 78.7 20.2 43.5 9.5 0.0 11.6 14.1 9.3 54.9 14.8 153.1 59.0 360.2 165.1 19.5 5.5 3.5 13.3 0.0 28.6 97.1 5.6 241.5 26.4 28.3 32.2 123.9 77.5 8.9 0.0 43.9 0.0 11.0 5.7 144.6 101.5 119.0 9.5 147.5 108.5 55.8 12.8 9.0 21.7 99.7 120.7 202.0 150.4 211.0 23.6 32.3 68.2 395.6 26.6 55.9 123.3 79.3 10.0 0.2 59.7 14.4 21.5 48.4 24.4 293.8 7.2 45.0 0.4 809.1 1116.7 1465.3 1462.8 1945.8 925.0 1914.8 1176.3 1233.5 1228.7 1851.8 1092.9 1143.1 154.2 1816.8 1692.3 3009.5 2589.5 2966.6 14.0 14.9 14.1 24.3 12.3 27.7 19.2 17.0 11.3 19.4 18.9 20.2 36.9 4.7 3.2 27.6 0.3 287.4 3.4 2.7 20.2 0.6 0.9 30.9 19.8 5.2 5.7 43.9 92.0 8.4 8.3 404.4 6.2 7.9 1.9 18.7 122.1 10.5 8.9 297.3 695.6 0.0 7.5 12.1 9.9 46.4 102.4 86.2 12.4 9.7 5.0 442.2 0.0 0.1 31.5 89.5 326.6 146.2 46.0 0.9 232.3 26.6 1.9 533.6 4.3 509.8 1.0 1.0 1.8 45.9 0.4 117.9 12.8 4.5 2.7 137.6 8.1 6.6 6.1 11.2 15.2 14.5 1.9 4.5 11.2 189.9 13.5 21.7 43.4 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916810-65919062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 33.8 29.6 68.4 15.0 71.1 10.1 33.8 75.5 82.9 50.4 59.9 42.6 17.3 56.6 39.4 30.0 40.9 20.9 46.6 71.2 67.0 31.3 28.2 32.1 25.0 70.0 68.8 70.8 43.7 27.4 25.8 24.2 23.6 70.0 43.0 15.8 12.6 31.2 32.0 81.8 32.8 31.2 27.3 66.7 41.9 33.0 54.3 68.3 29.4 32.9 51.9 21.5 46.3 39.9 71.9 76.4 33.6 20.4 22.2 70.0 67.3 17.6 59.7 90.2 74.3 45.2 12.6 83.9 15.6 40.6 89.5 118.6 24.0 15.9 36.6 39.8 24.2 16.1 18.5 23.4 33.2 55.7 14.9 23.7 62.9 53.8 53.9 58.9 76.6 56.1 26.1 25.1 37.7 136.2 34.5 19.7 35.9 20.5 16.5 165.8 28.8 23.1 44.4 39.6 14.5 13.9 21.6 23.1 30.1 59.8 21.0 39.0 14.0 61.4 118.0 57.9 162.1 30.9 25.3 11.9 13.1 69.8 11.1 94.1 6.8 2.5 3.7 5.3 3.9 3.8 3.0 3.4 4.4 2.0 5.3 5.2 5.2 9.1 3.8 2.1 2.7 4.2 2.2 68.4 71.1 75.5 82.9 71.2 67.0 70.0 68.8 70.8 70.0 66.7 68.3 71.9 17.8 16.0 5.1 6.5 7.3 15.3 32.9 4.2 6.8 11.4 14.7 22.5 16.6 14.3 2.3 16.5 10.4 16.4 14.5 10.8 7.9 14.5 7.9 8.1 17.8 13.8 4.8 2.1 7.9 11.7 16.5 18.5 7.1 11.8 3.8 12.9 18.2 10.5 14.2 16.8 7.5 13.1 4.1 13.9 7.5 24.5 21.5 8.7 10.6 7.5 14.1 26.7 22.6 4.5 8.6 19.3 3.4 35.3 3.6 23.2 11.8 5.4 1.9 9.9 19.7 13.5 16.4 15.0 17.1 6.2 12.8 21.9 8.3 23.3 9.2 31.3 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931114 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.9" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: AB_2676802" "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 16.3 29.2 100.7 11.4 106.9 9.0 17.8 98.5 117.7 19.5 85.2 21.2 11.9 16.8 24.0 14.5 19.7 12.1 22.5 96.8 100.4 24.1 22.1 12.7 12.7 103.6 104.5 94.8 24.8 22.3 19.3 26.0 11.8 106.2 22.2 16.4 46.8 15.6 20.0 20.0 19.2 14.4 15.7 103.6 16.4 18.6 30.5 101.6 16.0 18.9 7.6 17.4 21.9 16.5 117.9 13.5 30.6 27.2 21.3 28.9 29.6 15.5 22.6 25.9 35.3 25.0 60.2 10.4 40.4 34.4 23.2 32.8 30.2 33.5 27.2 52.2 30.4 20.8 41.4 28.0 50.3 34.6 39.1 15.3 30.5 41.7 38.8 47.2 28.4 27.0 32.1 50.7 33.7 33.2 26.3 34.5 40.5 12.7 71.0 23.7 31.6 72.6 66.5 26.5 22.9 28.8 33.8 26.8 17.7 70.6 25.4 53.1 21.8 19.7 24.8 15.7 35.3 22.3 41.3 50.3 82.2 17.4 25.0 26.5 53.4 26.2 32.3 26.8 17.2 29.5 40.8 28.7 27.3 34.4 36.1 37.0 31.7 2.2 32.4 6.3 24.8 36.8 27.9 100.7 106.9 98.5 117.7 96.8 100.4 103.6 104.5 94.8 106.2 103.6 101.6 117.9 9.0 3.2 12.5 40.1 11.5 4.7 11.6 27.3 6.8 50.4 6.8 9.1 19.6 8.6 15.6 16.5 112.6 33.5 9.5 5.5 13.7 15.9 38.4 10.7 12.2 9.8 3.6 20.2 17.4 13.8 4.8 11.5 6.6 9.4 19.6 30.1 11.7 13.6 18.8 47.1 23.7 7.7 20.3 9.5 6.6 22.6 16.8 9.5 14.2 14.0 16.3 37.6 18.6 24.6 55.5 7.3 5.7 18.0 15.3 9.6 12.0 53.5 14.1 51.7 6.6 18.2 12.5 48.9 28.6 9.6 8.1 18.3 9.8 29.9 10.3 8.0 MRPL48 CGI-118 ENSG00000175581 "Mitochondrial ribosomal protein L48" Q96GC5 11 73787872-73865133 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040241, HPA040864" Approved Supported Mitochondria NA NA Mitochondria "HPA040241: AB_2676899, HPA040864: AB_2677175" "unprognostic (2.41e-1)" "unprognostic (1.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-3)" "unprognostic (1.99e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (8.89e-2)" "unprognostic (4.41e-2)" "unprognostic (3.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.85e-2)" "unprognostic (4.61e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (3.30e-1)" 9.3 17.5 35.3 10.3 37.6 12.2 13.4 37.5 50.4 15.2 34.2 17.7 14.2 12.4 15.0 16.7 13.7 5.6 20.3 34.4 35.4 20.4 21.4 10.3 12.9 39.1 37.5 33.0 14.3 19.5 21.4 11.0 10.7 40.4 14.7 16.0 11.6 14.0 10.1 28.9 11.6 14.9 8.2 37.3 14.6 15.2 5.8 36.0 23.4 14.2 27.2 14.5 12.4 14.8 45.5 29.6 33.2 36.7 20.8 20.9 16.8 16.2 18.0 20.3 27.9 23.0 63.9 26.6 71.0 35.7 25.6 18.7 35.6 37.3 37.7 24.6 28.3 40.9 36.3 33.3 45.4 24.5 61.5 24.9 14.1 41.0 23.8 33.0 24.5 39.1 40.5 46.9 37.7 28.1 47.1 72.9 58.9 27.5 95.5 35.0 32.1 43.8 81.3 31.0 35.3 28.9 28.0 14.2 48.8 156.9 17.0 31.4 38.5 13.6 21.6 27.9 15.3 24.2 18.1 39.3 103.1 9.5 39.8 18.0 40.7 23.6 12.5 25.8 30.4 27.3 27.5 30.1 31.6 33.6 29.8 32.3 31.3 4.1 28.1 28.1 37.6 35.3 29.5 35.3 37.6 37.5 50.4 34.4 35.4 39.1 37.5 33.0 40.4 37.3 36.0 45.5 17.3 9.6 20.5 11.1 29.4 19.2 35.3 66.7 25.6 10.2 28.5 35.1 33.0 21.5 33.9 25.8 4.2 92.0 27.6 28.3 88.0 37.1 6.3 31.0 21.0 18.9 24.1 36.6 16.1 39.7 73.5 22.5 19.9 22.9 21.0 32.5 16.4 28.0 42.9 15.2 22.6 38.0 42.7 25.4 19.4 16.5 18.3 20.5 44.4 3.7 29.4 16.6 22.6 24.6 45.2 30.9 36.1 18.0 30.0 22.0 63.4 76.5 39.1 8.5 0.0 22.5 29.7 18.6 26.3 38.2 19.7 59.8 26.8 26.6 49.1 37.1 RAB6A RAB6 ENSG00000175582 "RAB6A, member RAS oncogene family" P20340 11 73675638-73761137 "Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009936, HPA059131" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB009936: AB_2175466, HPA059131: AB_2683916" "unprognostic (2.84e-1)" "unprognostic (7.18e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (8.18e-5)" "unprognostic (1.79e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (8.67e-3)" "unprognostic (1.16e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-1)" "unprognostic (4.93e-2)" "unprognostic (2.36e-1)" 71.9 70.5 97.2 53.5 106.0 38.7 51.1 93.1 111.7 64.9 85.7 66.8 72.3 67.5 53.4 101.1 54.5 56.1 100.4 111.2 106.2 75.8 86.0 69.1 46.1 110.1 102.3 108.5 65.1 49.4 68.0 36.7 92.2 120.6 64.5 71.3 56.6 48.2 65.5 108.6 55.5 84.1 80.4 93.3 57.4 55.4 36.5 107.0 54.7 99.5 102.6 61.3 79.6 62.9 132.8 86.2 66.3 105.8 68.5 135.9 154.3 141.7 130.4 124.6 111.1 100.8 131.5 146.4 73.2 136.6 174.0 94.9 94.6 68.4 135.3 142.5 84.6 25.6 118.2 68.6 110.9 114.2 78.1 113.1 114.7 246.8 113.5 165.0 124.4 135.9 75.7 71.3 111.5 133.3 99.6 85.7 54.7 42.2 192.0 62.3 64.8 193.9 132.5 135.2 146.6 83.0 70.5 136.1 136.7 290.9 104.7 107.2 71.0 165.0 113.3 56.9 193.5 56.6 71.9 89.5 149.5 46.3 63.2 104.6 227.9 81.8 133.2 84.2 87.6 76.2 56.1 70.3 75.5 62.9 50.7 52.0 61.8 61.9 78.6 88.6 33.7 86.3 111.1 97.2 106.0 93.1 111.7 111.2 106.2 110.1 102.3 108.5 120.6 93.3 107.0 132.8 66.3 32.1 51.0 79.7 59.2 83.5 49.4 57.2 88.2 53.9 45.8 30.4 64.2 35.8 42.7 68.0 87.6 109.9 55.3 85.2 43.0 66.0 8.8 51.5 41.3 78.7 52.0 47.5 133.6 49.5 162.3 60.5 52.5 51.2 48.8 83.7 72.5 63.7 65.7 40.4 119.0 61.8 75.3 58.4 85.7 9.5 52.8 58.3 72.9 49.6 74.2 47.7 52.5 130.7 109.4 79.0 61.7 61.7 86.3 57.8 102.7 54.1 47.2 54.2 26.3 47.4 65.5 74.2 53.4 106.5 112.7 173.6 63.8 45.0 50.8 69.8 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218281-73242427 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.0;skeletal muscle: 50.6;tongue: 31.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 16.5;Distal enterocytes: 18.0;Pancreatic endocrine cells: 18.9;Proximal enterocytes: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 57.6" "Group enriched" "Detected in many" 12 "granulocytes: 57.6;monocytes: 20.2" "Cell line enhanced" "Detected in many" "HaCaT: 32.8;HL-60: 30.8;MCF7: 25.1;NB-4: 26.1;PC-3: 24.5;SK-BR-3: 29.6;THP-1: 76.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.6 3.9 1.3 1.8 1.8 16.0 1.7 1.3 0.9 3.9 1.4 3.4 2.8 0.5 0.3 30.0 1.4 0.7 7.4 1.2 2.2 1.4 4.0 3.5 0.1 1.9 1.9 0.4 0.4 0.7 4.9 1.6 2.0 1.8 2.1 2.8 1.2 6.3 1.2 50.6 5.3 5.9 0.5 1.2 3.9 1.1 1.2 2.5 0.2 8.8 31.6 2.9 2.2 19.1 1.4 7.2 6.7 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 17.2 5.4 0.0 10.4 0.4 0.0 32.8 0.9 15.2 0.0 0.0 0.6 2.3 0.6 3.2 0.1 30.8 0.0 0.0 6.8 2.3 0.5 0.0 1.4 0.0 1.4 0.0 0.0 25.1 0.1 26.1 0.4 6.8 24.5 0.0 0.0 1.1 2.4 17.9 0.0 0.0 0.5 29.6 0.0 0.2 12.9 76.5 10.2 0.0 0.3 0.0 0.0 1.0 0.4 0.0 0.0 5.6 0.0 0.5 6.6 57.6 0.0 20.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 13.5 0.0 0.0 2.5 1.3 1.8 1.3 0.9 1.2 2.2 1.9 1.9 0.4 1.8 1.2 2.5 1.4 0.7 3.2 0.5 0.0 0.2 3.7 8.6 13.2 1.2 0.7 2.8 0.5 6.1 5.7 10.3 0.0 0.0 16.5 0.0 18.0 1.9 5.8 6.0 1.4 0.1 1.5 0.0 0.8 0.0 6.3 1.3 0.7 0.5 0.8 0.0 1.2 0.0 5.2 2.6 0.0 0.0 5.1 0.0 3.7 0.7 8.8 0.0 4.5 0.0 0.0 2.8 6.0 0.0 0.0 0.1 18.9 10.9 0.0 0.2 5.3 14.2 0.3 2.8 0.4 0.0 0.8 1.4 0.1 0.1 12.6 7.2 10.9 0.1 0.1 3.0 11.7 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.3;urinary bladder: 85.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 51.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "myeloid DC: 3.4" "Lineage enriched" "Detected in single" 4 "dendritic cells: 3.4" "Cell line enhanced" "Detected in many" "PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 32.0 11.3 1.4 7.7 1.4 27.0 10.6 2.4 4.4 3.7 1.3 7.1 1.0 3.5 0.1 49.3 8.5 29.8 11.7 1.6 4.4 7.8 5.7 16.8 0.3 2.1 1.2 1.1 1.7 13.0 0.5 4.9 2.7 2.3 6.4 1.9 0.6 11.1 0.8 4.1 16.4 5.5 4.8 2.0 1.7 21.1 0.9 2.0 2.7 5.3 0.3 2.1 85.1 13.9 2.3 324.3 43.8 5.4 20.4 45.7 44.4 45.0 288.5 257.2 239.7 131.7 14.2 252.6 0.5 65.1 199.7 379.6 60.6 19.6 227.4 210.8 9.7 0.7 20.6 4.5 34.9 57.0 13.3 6.9 18.8 23.1 191.1 297.1 117.9 80.4 0.2 48.8 1.7 320.9 12.3 0.3 26.5 21.5 27.0 829.4 1.5 25.7 1.3 116.7 20.4 0.4 0.5 18.2 0.8 229.0 13.0 1.0 12.1 200.6 282.5 62.7 520.1 423.8 0.3 1.4 0.9 389.7 4.9 1123.6 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.2 0.1 3.4 0.0 0.2 0.0 0.5 0.0 0.3 0.4 0.0 0.5 1.4 1.4 2.4 4.4 1.6 4.4 2.1 1.2 1.1 2.3 2.0 2.0 2.3 15.2 6.4 4.4 0.3 2.0 338.0 398.5 56.2 281.1 0.0 27.6 12.2 1.0 4.3 26.2 0.0 0.0 1.3 4.3 11.8 0.0 25.1 0.3 24.4 12.2 30.1 11.3 0.8 0.1 3.5 4.3 45.8 74.9 56.3 9.5 0.3 6.1 0.4 1.9 0.0 0.1 6.8 10.2 1.0 46.6 0.0 0.3 15.5 44.4 1.0 1.1 0.1 0.0 0.5 0.2 39.0 11.1 0.0 6.2 196.9 1.2 0.2 10.7 0.0 0.0 32.4 26.1 0.4 0.7 210.4 339.5 17.6 6.8 0.1 4.2 456.4 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920154-13952348 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.7" "Cell type enhanced" "Detected in many" "Early spermatids: 140.7;Late spermatids: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB000156: , HPA045828: AB_2679463" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 2.7 3.9 4.9 3.3 5.2 2.5 2.8 6.6 5.5 3.3 4.4 2.0 1.7 3.3 2.8 2.9 3.6 3.0 3.7 4.3 4.6 2.9 3.2 2.7 3.3 5.0 5.0 4.8 4.4 2.7 3.9 1.6 2.6 5.3 3.6 2.2 4.1 2.8 2.9 18.7 3.1 1.9 3.6 4.3 3.8 2.6 5.6 4.6 4.2 4.4 3.4 2.9 2.6 1.5 6.8 4.7 5.5 5.3 7.5 8.7 8.1 4.0 6.1 6.4 5.4 6.8 2.1 4.5 7.8 8.6 5.4 4.8 5.8 8.0 4.1 8.3 10.7 4.7 3.8 6.7 5.2 7.9 5.2 4.2 6.1 5.7 7.1 6.0 5.3 7.2 4.6 6.1 8.8 7.6 3.9 7.0 3.4 3.9 2.4 3.1 7.8 10.8 9.7 3.3 3.2 4.3 5.1 7.5 6.0 5.8 4.2 7.5 3.9 7.9 7.8 5.7 7.0 5.4 7.9 9.9 5.2 7.6 6.2 8.1 4.9 2.3 2.3 2.6 2.7 2.9 2.5 2.4 2.0 2.3 3.1 2.4 2.6 2.7 3.6 2.4 3.2 2.5 1.1 4.9 5.2 6.6 5.5 4.3 4.6 5.0 5.0 4.8 5.3 4.3 4.6 6.8 14.0 19.2 13.5 16.6 11.3 4.8 6.1 18.3 10.2 0.0 10.0 9.5 8.6 14.3 12.7 5.5 0.0 17.3 9.7 3.3 9.8 11.6 140.7 18.6 19.0 13.5 9.6 12.0 20.4 8.4 6.2 13.0 5.1 7.4 1.3 17.8 17.2 17.7 11.7 0.0 21.2 4.8 10.2 13.6 6.5 117.9 14.9 11.4 10.6 8.4 14.4 0.0 17.5 12.1 20.1 9.9 1.7 21.1 14.4 10.2 4.4 13.3 26.1 0.0 26.3 17.3 12.2 49.4 28.9 9.2 5.5 12.3 11.8 18.0 6.0 4.7 SUGCT "C7orf10, DERP13, FLJ11808, ORF19" ENSG00000175600 "Succinyl-CoA:glutarate-CoA transferase" Q9HAC7 7 40135005-40860763 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 44.8;liver: 28.7" "Cell type enhanced" "Detected in many" "Astrocytes: 76.0;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 58.3;Proximal tubular cells: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBEC3-KT: 43.9;LHCN-M2: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026698, HPA026704, HPA026705" Enhanced NA NA "HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003" "unprognostic (4.66e-3)" "unprognostic (3.45e-2)" "unprognostic (2.06e-2)" "unprognostic (3.32e-3)" "unprognostic (5.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.14e-3)" "unprognostic (1.75e-2)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (5.27e-3)" "unprognostic (7.65e-2)" "prognostic favorable (3.93e-7)" "unprognostic (2.62e-2)" "unprognostic (3.38e-1)" "unprognostic (3.41e-3)" "prognostic unfavorable (2.53e-4)" 2.5 9.0 1.7 0.9 1.9 0.1 2.3 1.9 2.2 2.2 4.1 4.5 0.7 2.2 1.0 2.1 1.7 2.8 3.9 1.7 2.2 44.8 28.7 0.6 0.8 2.0 2.0 1.4 4.1 2.3 4.1 0.9 0.6 1.8 2.0 2.4 2.0 1.4 1.8 10.4 0.8 5.3 2.2 1.8 0.8 1.0 2.9 1.8 0.8 1.8 8.3 1.0 2.0 1.6 1.8 0.8 0.1 4.8 3.4 5.0 11.5 1.8 2.5 4.6 3.2 3.8 2.0 1.0 3.1 1.2 3.5 3.4 0.2 1.4 43.9 5.3 0.0 2.1 2.8 0.3 7.3 6.2 0.4 0.3 14.6 9.7 3.7 2.2 6.9 0.9 1.2 3.9 0.3 26.2 0.0 0.1 0.4 8.1 0.1 3.7 2.9 0.4 0.0 7.4 0.0 0.3 2.7 4.0 1.8 5.8 7.9 0.1 0.7 3.7 14.6 4.2 0.2 1.0 0.3 0.0 0.2 2.8 1.2 3.3 0.0 0.0 0.1 0.2 0.0 0.4 0.5 0.7 0.3 0.0 0.3 1.4 0.9 0.3 0.0 0.0 0.0 0.0 0.2 1.7 1.9 1.9 2.2 1.7 2.2 2.0 2.0 1.4 1.8 1.8 1.8 1.8 0.6 3.2 0.5 76.0 1.9 2.0 2.1 26.0 10.2 1.0 1.3 23.0 5.1 1.5 4.4 1.8 8.4 1.5 0.0 10.1 17.6 1.2 31.0 0.9 2.5 0.7 3.6 0.4 19.8 0.8 2.4 3.5 0.0 1.3 0.0 2.2 0.0 21.1 0.3 0.0 38.5 1.5 0.0 1.3 1.0 16.7 6.2 0.7 3.6 14.0 0.1 5.3 0.0 58.3 22.8 0.6 5.6 3.0 0.1 0.8 13.9 81.6 0.8 4.5 6.6 1.4 15.3 2.7 3.1 3.2 0.6 0.8 0.7 7.4 5.3 0.7 CCDC85B DIPA ENSG00000175602 "Coiled-coil domain containing 85B" Q15834 11 65890673-65891635 "Predicted intracellular proteins" "Differentiation, Growth regulation, Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 437.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 251.3;WM-115: 244.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054415 Uncertain NA NA "HPA054415: AB_2682481" "unprognostic (4.58e-2)" "unprognostic (1.64e-2)" "unprognostic (9.74e-2)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (8.01e-2)" "unprognostic (3.99e-2)" "unprognostic (2.43e-2)" "unprognostic (3.02e-2)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (5.33e-2)" "prognostic unfavorable (3.78e-5)" "unprognostic (4.44e-1)" "unprognostic (1.69e-1)" "unprognostic (1.60e-1)" "unprognostic (9.87e-2)" 52.1 48.9 51.6 8.8 36.4 12.3 42.8 16.1 120.8 35.6 0.0 36.9 7.6 45.9 1.2 31.0 45.0 2.0 77.1 72.1 12.9 26.2 23.2 53.8 5.2 43.6 23.1 47.4 43.3 25.9 1.8 27.2 5.9 30.9 38.2 0.8 1.4 17.0 5.0 50.2 39.8 26.2 2.2 18.5 58.1 32.4 23.1 64.6 1.4 32.0 1.9 1.9 50.5 35.7 35.6 136.2 19.9 4.6 19.6 6.7 12.4 17.4 123.9 16.9 5.9 7.1 5.8 45.9 87.0 118.0 9.0 34.0 61.7 2.4 9.4 0.6 94.2 43.6 63.8 12.7 20.3 10.1 56.2 30.3 11.0 3.5 5.2 8.3 15.1 20.3 12.2 50.0 29.2 4.3 50.9 37.2 180.7 59.1 3.2 251.3 98.5 37.5 79.2 3.4 4.1 42.2 46.1 34.7 21.1 128.4 0.8 16.0 17.8 134.6 50.4 77.7 131.0 86.4 32.3 38.8 22.1 90.8 47.3 244.8 1.8 9.0 20.7 15.9 6.5 21.6 23.3 18.7 22.0 8.3 19.5 24.8 19.9 1.6 16.0 10.8 16.3 16.1 5.1 51.6 36.4 16.1 120.8 72.1 12.9 43.6 23.1 47.4 30.9 18.5 64.6 35.6 382.8 0.0 4.2 13.7 126.0 275.6 173.8 59.7 171.4 181.4 103.4 171.8 27.5 35.8 17.5 36.8 150.1 18.4 177.2 47.8 33.2 41.6 6.5 30.5 159.9 362.1 57.6 64.1 33.7 70.6 53.1 112.9 38.2 36.1 85.2 90.6 437.6 38.5 99.5 101.0 30.2 46.7 28.5 152.9 188.6 17.8 84.5 150.3 156.5 22.5 168.9 121.9 346.1 19.1 16.3 49.8 12.6 100.8 91.7 177.0 24.3 32.9 17.8 102.3 164.3 71.4 143.0 3.9 20.5 111.8 212.1 19.0 167.0 121.0 54.9 95.4 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 101.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 78.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Approved Supported Nucleoplasm,Mitochondria NA Yes Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 14.5 18.4 10.0 9.9 10.8 10.5 11.4 11.5 12.2 7.5 10.6 12.5 5.8 9.0 10.7 9.4 11.4 9.0 16.7 11.3 11.5 12.1 24.6 9.0 10.1 10.7 10.3 10.9 10.6 25.2 8.4 7.6 10.3 11.2 7.5 9.8 6.1 10.0 6.0 101.5 7.5 9.5 9.2 10.5 9.7 17.9 9.9 10.5 11.1 6.1 20.6 10.4 11.4 7.5 11.0 21.2 16.4 13.1 13.8 14.9 12.7 13.6 17.6 15.8 19.4 15.3 15.8 11.9 28.4 15.0 12.0 16.4 19.1 24.9 16.8 21.4 18.9 17.5 28.3 10.0 21.2 14.7 15.5 14.5 11.8 15.3 12.2 6.4 7.3 16.4 14.2 22.0 13.5 20.5 15.9 35.8 29.6 12.3 26.6 20.6 25.4 12.8 24.2 20.5 20.0 29.7 13.1 11.0 78.0 23.3 10.2 16.0 14.1 10.6 11.1 13.7 20.7 16.9 19.9 18.7 28.1 16.4 12.1 12.5 6.3 9.1 6.7 8.0 10.2 9.1 17.7 9.0 9.3 9.6 10.9 10.3 9.6 6.7 5.8 7.9 11.0 7.9 12.0 10.0 10.8 11.5 12.2 11.3 11.5 10.7 10.3 10.9 11.2 10.5 10.5 11.0 136.2 16.0 30.1 5.5 37.1 67.3 43.7 54.8 24.5 23.9 26.2 22.2 46.3 14.3 35.7 22.0 8.4 71.2 48.1 69.0 66.5 36.6 20.3 40.8 26.2 96.4 13.8 26.5 12.8 63.5 59.6 50.2 17.3 17.1 39.9 17.0 28.5 50.3 132.4 10.1 11.4 31.7 42.7 70.0 74.5 12.1 29.8 73.2 40.9 5.6 38.9 23.1 22.6 3.5 8.1 43.6 37.9 29.0 68.6 42.1 28.8 75.4 58.7 17.5 39.5 61.9 40.8 70.6 29.5 21.5 59.7 70.3 39.8 52.6 34.1 26.2 OR4B1 OST208 ENSG00000175619 "Olfactory receptor family 4 subfamily B member 1" Q8NGF8 11 48216810-48217739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059443 Uncertain NA NA "HPA059443: AB_2684019" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPS6KB2 "KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B" ENSG00000175634 "Ribosomal protein S6 kinase B2" Q9UBS0 11 67428460-67435401 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010010, CAB019404" Approved Supported Cytosol NA NA Cytosol "CAB019404: AB_331355, HPA010010: AB_1856469" "unprognostic (1.38e-1)" "unprognostic (2.36e-3)" "unprognostic (8.50e-2)" "unprognostic (2.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (9.01e-3)" "unprognostic (5.10e-2)" "unprognostic (1.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.66e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.28e-2)" "unprognostic (1.55e-1)" "unprognostic (2.12e-1)" "unprognostic (2.66e-1)" 15.9 28.2 8.9 13.9 9.8 28.5 17.2 9.2 12.5 19.8 11.8 21.0 26.8 17.9 6.0 72.5 20.2 10.7 20.7 8.3 9.8 21.3 50.6 19.7 18.6 9.7 9.7 7.8 16.4 35.7 17.7 20.8 13.7 10.5 31.8 13.0 4.3 31.7 10.0 38.2 80.6 25.6 10.2 9.7 33.9 35.5 9.7 9.0 24.2 20.3 26.2 20.3 19.5 31.6 10.6 58.2 42.7 22.8 39.0 10.4 20.0 30.0 27.4 33.9 49.7 34.2 67.2 37.5 21.1 46.3 26.9 31.0 41.8 25.9 41.4 19.9 36.9 70.0 34.5 54.2 55.5 35.2 43.7 40.4 25.5 42.8 26.3 26.9 12.5 37.5 54.8 55.8 54.8 25.4 88.5 68.1 68.4 24.9 83.7 54.6 50.0 31.8 100.5 23.0 32.6 34.4 37.1 28.0 76.8 59.8 13.2 90.4 35.7 15.8 25.8 27.6 63.1 31.1 48.8 43.9 34.4 42.4 27.3 33.1 18.8 37.2 28.5 23.8 42.6 24.5 23.4 22.9 23.9 44.1 21.9 16.1 17.9 24.7 29.6 49.9 30.4 34.5 37.3 8.9 9.8 9.2 12.5 8.3 9.8 9.7 9.7 7.8 10.5 9.7 9.0 10.6 22.0 9.6 20.5 6.8 48.1 49.8 28.0 48.9 19.9 25.3 32.6 27.8 1.3 28.6 31.2 7.3 10.4 71.8 45.0 66.9 43.0 44.5 14.9 16.0 16.9 17.9 46.2 65.0 7.7 64.8 89.1 21.9 48.9 19.3 27.9 23.2 18.2 57.4 61.3 33.7 7.1 67.7 34.6 45.8 29.1 29.4 20.2 36.9 19.6 3.7 56.6 28.5 73.2 5.0 12.1 46.6 70.4 17.3 82.1 43.7 115.0 42.2 16.0 27.6 19.7 16.7 26.9 15.8 16.0 52.5 63.6 103.6 41.7 27.5 58.3 39.4 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11381662 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 123.8;Erythroid cells: 38.5;Extravillous trophoblasts: 34.1;Peritubular cells: 42.5;Spermatocytes: 36.6;Spermatogonia: 51.8;Syncytiotrophoblasts: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 4.2" "Group enriched" "Detected in many" 6 "B-cells: 4.2;T-cells: 1.4" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.4 1.5 2.2 12.4 1.9 10.0 5.1 1.0 2.2 4.8 1.0 12.6 7.5 2.9 4.0 10.8 2.1 2.2 1.6 2.2 1.6 3.5 4.4 1.9 31.7 1.3 1.3 2.0 3.0 1.8 1.4 0.6 19.4 1.3 3.2 14.5 0.5 2.5 2.1 0.9 10.3 8.9 2.3 1.0 3.6 7.1 14.1 1.5 37.2 1.5 0.6 35.2 4.6 4.4 1.9 60.3 39.5 75.2 32.6 3.3 15.8 33.0 35.9 26.8 31.6 51.8 15.4 69.2 83.8 29.1 15.8 35.3 34.4 32.4 32.5 50.5 16.6 30.5 45.3 22.6 102.5 1.3 17.6 19.5 3.7 6.1 14.5 13.3 12.3 17.4 36.2 65.3 63.2 16.5 70.3 60.9 83.1 64.1 82.6 15.7 73.1 81.1 89.3 18.7 38.0 44.1 35.0 28.5 47.4 26.1 43.5 80.4 25.8 5.6 25.1 23.3 49.3 5.0 18.1 30.9 99.3 23.3 57.4 47.2 0.0 0.0 0.4 0.3 0.0 0.0 4.2 0.1 0.0 0.2 1.1 0.8 0.3 0.1 0.1 0.0 0.2 1.4 0.1 2.2 1.9 1.0 2.2 2.2 1.6 1.3 1.3 2.0 1.3 1.0 1.5 1.9 1.3 0.0 0.5 0.0 4.5 6.8 5.4 1.4 6.2 0.2 3.4 3.2 1.0 4.3 1.6 7.3 0.0 123.8 0.5 3.3 5.9 2.6 3.0 0.8 2.1 2.8 2.4 38.5 0.0 0.5 34.1 6.4 4.1 2.2 0.0 19.7 1.1 1.1 18.5 0.0 0.0 7.7 0.0 0.8 6.5 5.9 15.8 3.7 3.6 0.0 1.1 0.2 1.0 0.0 0.0 1.0 4.0 42.5 2.4 2.1 1.3 0.4 0.1 0.6 32.9 0.0 2.2 36.6 51.8 11.3 5.4 47.7 1.9 6.5 10.3 7.5 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280841-11281330 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1098 "testis: 14225.7" "Cell type enriched" "Detected in some" 6 "Late spermatids: 776887.9" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.4;U-2197: 1.7" "Not detected" "Not detected" "HPA055150, HPA059371" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 2.2 2.2 0.0 0.5 0.0 0.0 10.0 0.0 0.0 1.8 0.0 2.1 1.5 1.0 0.0 2.0 1.2 0.0 1.7 0.0 0.0 2.6 4.4 1.4 0.4 0.0 0.0 0.0 1.6 3.1 0.0 1.9 0.0 0.1 12.9 0.0 0.0 2.1 1.3 5.8 3.6 4.1 0.0 0.0 1.4 2.4 14225.7 0.0 0.0 4.4 0.0 0.1 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126844.3 0.0 0.0 80.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 776887.9 1855.9 161.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1689.6 0.0 0.0 0.0 0.0 0.0 0.0 1157.0 0.0 0.0 2054.0 1211.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TOM1L2 ENSG00000175662 "Target of myb1 like 2 membrane trafficking protein" Q6ZVM7 17 17843511-17972422 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 180.5;Cone photoreceptor cells: 158.4;Oligodendrocytes: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022541, HPA023304" Enhanced Approved "Golgi apparatus,Intermediate filaments" NA NA 73000 "Intermediate filaments" "Golgi apparatus" "HPA022541: AB_1858182, HPA023304: AB_1858183" "unprognostic (2.32e-1)" "unprognostic (7.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.25e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "prognostic unfavorable (2.58e-4)" "prognostic favorable (1.92e-4)" "unprognostic (3.19e-2)" "prognostic favorable (6.21e-9)" "unprognostic (7.11e-2)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (4.51e-2)" 19.8 30.7 59.3 9.6 60.9 6.1 20.5 49.3 68.0 29.6 18.2 37.2 14.2 33.5 11.1 64.9 26.8 13.2 142.3 64.3 51.7 31.5 14.0 23.4 7.7 86.1 75.9 56.2 33.1 19.8 40.6 42.5 9.1 92.5 37.6 13.9 50.7 21.5 28.9 67.7 58.1 21.0 23.5 45.0 16.8 35.1 39.7 71.0 8.9 48.9 55.9 13.0 31.6 35.4 69.9 27.1 29.0 8.2 6.2 19.1 19.3 14.2 43.3 20.1 22.9 19.3 28.2 17.6 5.0 52.9 40.8 13.3 104.3 6.8 24.1 14.0 7.2 12.7 8.0 28.0 6.0 12.2 2.0 5.2 22.9 16.6 20.5 15.2 19.6 23.3 7.3 3.0 6.9 30.3 27.1 3.6 4.6 1.5 34.4 19.5 4.7 20.7 12.0 32.4 48.1 8.7 8.4 19.5 25.2 15.3 55.9 13.4 3.6 31.8 21.9 6.5 46.0 16.8 6.1 5.1 2.3 26.4 2.7 55.2 10.0 3.3 4.8 2.8 1.0 2.0 1.6 2.6 2.4 1.6 2.2 4.3 3.2 12.8 1.4 3.3 1.9 1.3 1.7 59.3 60.9 49.3 68.0 64.3 51.7 86.1 75.9 56.2 92.5 45.0 71.0 69.9 10.1 32.1 17.0 180.5 9.5 10.8 14.6 13.9 7.4 74.5 20.9 14.1 73.7 15.7 16.6 11.0 158.4 8.5 10.2 43.3 5.9 12.2 30.8 14.1 9.4 12.4 20.4 4.8 63.2 8.7 17.4 12.7 13.3 15.7 2.5 28.1 16.4 13.4 9.2 95.9 74.2 19.2 18.3 8.5 7.6 64.2 26.4 6.4 12.4 35.6 11.8 28.1 10.3 66.9 123.2 16.1 41.0 25.6 8.4 39.1 22.4 11.1 22.9 78.3 19.7 18.0 13.0 16.7 12.1 37.2 17.2 32.2 10.0 30.8 15.4 64.5 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932656-30975500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 21.7" "Group enriched" "Detected in some" 19 "Early spermatids: 847.1;Late spermatids: 1640.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA079709 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA079709: " "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.1 0.4 2.1 0.0 1.2 0.0 0.0 1.1 1.3 0.8 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.9 3.9 0.0 0.1 0.2 0.0 2.1 1.8 0.8 0.0 0.0 0.0 1.3 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 21.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.2 1.1 1.3 0.9 3.9 2.1 1.8 0.8 1.8 2.3 3.1 1.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 28.6 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 847.1 19.0 0.1 0.4 0.0 0.0 4.3 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.0 6.1 0.0 0.0 1640.3 8.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 65.4 0.0 0.0 1.1 1.1 15.5 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favorable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favorable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 2.6 2.7 2.2 1.3 2.1 2.3 4.6 4.3 2.6 3.2 1.9 2.5 1.4 3.0 2.8 3.1 2.9 1.4 2.5 2.1 2.1 2.6 2.7 2.8 2.5 2.1 2.2 2.0 3.4 3.0 3.3 3.1 2.9 3.0 2.8 2.1 4.1 2.6 2.2 2.6 3.2 2.1 2.9 1.9 2.6 3.2 3.6 2.1 3.4 3.0 4.1 3.5 2.6 2.9 2.6 4.3 2.1 9.4 5.5 1.9 2.5 4.2 2.5 3.8 5.0 5.9 6.5 1.7 4.8 2.1 2.8 2.7 3.4 6.1 4.1 8.3 0.7 4.7 5.9 3.4 7.3 4.8 0.2 4.6 3.9 5.6 3.9 5.7 6.2 7.0 9.2 7.7 0.0 3.4 4.7 7.2 4.2 2.1 3.7 2.8 8.1 7.3 3.3 4.1 6.5 3.8 7.2 3.9 3.6 4.6 4.5 3.5 10.0 3.5 2.1 2.7 6.0 4.7 4.8 4.9 2.2 5.4 0.1 3.9 0.0 1.6 0.8 3.0 1.7 3.5 3.7 3.1 3.2 2.2 3.5 2.3 3.4 0.1 2.4 1.8 1.7 1.6 1.9 2.2 2.1 4.3 2.6 2.1 2.1 2.1 2.2 2.0 3.0 1.9 2.1 2.6 4.2 3.2 3.9 3.6 2.2 11.6 4.7 3.3 14.2 2.8 4.6 5.3 2.2 1.5 3.4 1.8 2.1 3.6 5.7 1.9 0.0 2.1 2.1 3.3 3.6 3.7 7.2 1.3 2.9 1.8 3.0 2.9 4.6 4.0 2.5 4.0 4.2 2.2 1.7 0.0 3.2 2.5 2.0 1.6 2.8 0.3 2.8 1.7 1.8 0.0 0.7 3.3 4.1 1.0 2.6 2.4 1.9 1.5 2.0 2.8 1.5 1.4 2.0 5.6 0.0 2.5 2.3 9.7 8.1 6.8 10.9 6.2 3.3 5.4 3.4 1.8 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285222 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 2.7" "Group enriched" "Detected in some" 4 "Astrocytes: 15.0;Early spermatids: 8.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.3;PC-3: 1.3;SiHa: 3.5;U-2 OS: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.0 0.0 0.4 0.1 0.3 0.0 0.3 0.1 0.3 0.2 0.1 0.0 0.0 0.4 0.0 0.2 1.0 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.3 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.7 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.7 0.1 0.3 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.5 0.0 0.2 0.0 0.3 1.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 3.5 0.0 0.4 0.1 0.4 0.0 0.1 0.1 1.9 0.0 0.1 0.4 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.3 0.3 0.2 0.3 0.4 0.1 0.2 0.4 0.1 0.4 0.0 0.0 0.0 15.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.3 0.3 0.2 0.0 0.0 0.0 1.5 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.0 1.0 0.0 1.3 0.0 13.0 2.9 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.1 0.6 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 CCDC197 "C14orf48, LINC00521" ENSG00000175699 "Coiled-coil domain containing 197" 14 93987225-94008863 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "Not detected" "Not detected" NA NA "unprognostic (5.01e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.4 0.2 0.1 0.5 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTLN "LEMP, LINC00116, MOXI, MPM, NCRNA00116, SMIM37" ENSG00000175701 Mitoregulin Q8NCU8 2 110211529-110245420 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 792.3" "Cell type enhanced" "Detected in some" "Adipocytes: 27.4;Cytotrophoblasts: 43.7;Extravillous trophoblasts: 32.8;Hofbauer cells: 78.4;Syncytiotrophoblasts: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.74e-2)" "unprognostic (1.86e-1)" "unprognostic (7.68e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "unprognostic (3.49e-3)" "unprognostic (8.20e-2)" "unprognostic (9.10e-2)" "unprognostic (6.08e-2)" "unprognostic (5.08e-3)" "unprognostic (8.27e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (8.80e-2)" "unprognostic (1.95e-2)" 57.4 69.4 61.6 22.4 57.6 10.2 51.6 67.6 104.7 42.2 51.3 65.2 42.0 58.4 52.6 64.0 42.0 9.3 190.1 58.4 64.0 70.1 78.6 40.6 16.1 64.0 59.5 54.4 33.9 46.6 37.3 41.6 13.0 65.1 49.0 12.5 11.1 44.2 34.3 792.3 42.9 47.2 16.8 59.8 44.8 57.8 25.9 66.6 18.7 48.4 282.8 12.1 56.2 46.5 68.8 0.4 125.0 13.3 15.3 14.7 17.5 81.1 49.9 38.6 58.7 39.2 86.0 39.7 16.9 95.0 13.8 81.4 52.9 13.2 57.5 9.6 72.0 51.4 10.1 30.5 73.3 61.2 35.6 50.3 45.6 67.8 48.8 0.0 31.8 52.9 50.2 28.6 40.6 28.1 130.0 49.8 121.6 34.1 39.9 36.9 5.5 28.0 51.9 37.2 77.9 29.5 19.4 27.7 95.2 57.1 8.9 26.4 59.2 41.0 57.7 81.3 56.9 75.9 67.8 48.0 5.3 60.0 56.1 42.1 9.6 101.9 13.8 109.6 112.1 125.1 104.0 123.5 118.7 110.6 115.0 129.1 129.1 5.6 85.9 67.6 150.2 119.0 77.4 61.6 57.6 67.6 104.7 58.4 64.0 64.0 59.5 54.4 65.1 59.8 66.6 68.8 27.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 8.7 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 32.8 11.8 0.0 0.0 0.0 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 20.2 1.5 0.0 0.0 0.0 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960468 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 32.6;Ductal cells: 29.4;Syncytiotrophoblasts: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 36 "B-cells: 3.4;T-cells: 6.2" "Cell line enhanced" "Detected in some" "A-431: 24.9;BEWO: 20.8;CAPAN-2: 22.7;HaCaT: 21.4;HBEC3-KT: 30.3;hTCEpi: 38.5;OE19: 39.3;SK-BR-3: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA028634, HPA028639" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA028634: , HPA028639: AB_10599191" "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favorable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.40e-4)" 0.1 1.1 0.6 1.3 0.4 0.1 10.4 1.6 1.4 4.1 0.4 9.0 12.5 0.9 19.9 20.3 7.5 3.0 0.3 1.0 0.3 9.5 4.7 4.5 0.8 0.5 0.8 0.3 0.1 16.4 12.6 10.4 3.9 0.6 7.3 7.2 1.3 12.9 4.6 0.0 17.4 10.5 0.3 0.3 0.6 10.7 2.6 0.4 2.4 10.1 0.0 3.4 4.8 8.3 0.9 24.9 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 12.1 22.7 0.0 0.9 0.0 0.0 21.4 0.0 30.3 0.0 0.1 0.4 0.0 0.0 4.4 0.3 0.0 0.0 0.1 38.5 0.0 3.1 0.0 0.0 0.0 1.4 0.0 0.0 14.7 0.0 0.1 1.7 39.3 0.1 0.0 0.0 3.7 5.5 11.7 14.9 0.0 0.2 25.2 0.1 2.7 16.1 0.4 0.2 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.2 2.5 4.3 3.0 0.1 3.4 6.2 3.8 0.0 0.0 0.0 0.0 0.2 1.7 0.6 0.4 1.6 1.4 1.0 0.3 0.5 0.8 0.3 0.6 0.3 0.4 0.9 0.2 12.8 8.8 0.0 0.8 0.0 14.3 0.0 10.8 0.6 15.1 16.3 0.3 12.8 2.5 14.7 0.0 32.6 1.5 17.2 25.4 29.4 0.4 7.3 0.8 0.7 7.8 0.0 0.2 23.2 26.5 0.6 13.7 8.0 0.0 0.1 0.0 4.4 2.7 0.0 0.1 13.1 0.0 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.2 1.1 0.0 0.0 0.1 21.8 25.2 0.0 0.4 16.8 26.2 10.1 5.1 2.5 0.0 0.0 0.3 6.3 7.5 14.4 0.0 29.7 1.2 0.0 16.9 19.0 B3GNTL1 B3GNT8 ENSG00000175711 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1" Q67FW5 17 82942155-83051810 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 19.9;Respiratory ciliated cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.1;HL-60: 27.0;THP-1: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023585, HPA024547" Supported Approved "Nucleoli,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli, Nucleoli fibrillar center" Vesicles "HPA023585: AB_2061075, HPA024547: AB_1845240" "unprognostic (1.51e-2)" "unprognostic (9.84e-2)" "unprognostic (4.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (8.11e-2)" "unprognostic (2.61e-7)" "unprognostic (9.95e-2)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (8.74e-2)" "unprognostic (2.80e-2)" "unprognostic (4.17e-9)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (3.39e-3)" 2.5 2.8 1.7 2.9 1.9 7.8 2.4 1.2 1.8 3.4 3.4 2.0 1.7 3.8 1.2 2.4 3.8 1.4 3.0 1.8 1.5 1.9 2.4 3.0 2.4 1.3 1.4 2.1 4.0 2.3 0.8 2.6 1.4 1.7 2.6 0.9 0.5 2.1 1.5 3.8 2.1 2.2 1.9 1.1 4.2 2.0 3.0 1.9 2.3 2.4 1.4 1.1 3.1 2.6 1.7 11.9 7.8 0.2 3.7 2.1 6.6 4.7 4.2 3.7 4.8 3.7 4.7 25.1 5.8 8.1 5.2 11.7 2.2 1.9 0.0 4.1 8.9 5.1 12.2 12.6 16.0 7.5 27.0 0.5 2.4 2.1 2.9 4.8 2.4 5.9 8.9 5.4 5.5 3.9 2.7 7.6 10.3 1.8 8.1 5.6 9.8 0.9 0.4 2.7 2.5 2.4 0.9 3.6 2.7 3.7 3.4 0.0 25.5 9.7 9.2 6.2 1.4 7.6 1.1 2.9 4.4 10.3 3.6 1.3 3.0 6.0 1.0 2.8 5.9 4.4 3.0 4.4 3.3 10.4 5.5 3.9 4.7 19.0 3.2 3.2 4.1 13.5 4.0 1.7 1.9 1.2 1.8 1.8 1.5 1.3 1.4 2.1 1.7 1.1 1.9 1.7 2.6 3.2 4.5 4.6 2.9 1.0 2.0 4.4 3.4 3.5 3.0 3.0 2.8 1.5 6.4 5.5 4.2 5.7 3.6 1.3 1.9 1.9 15.3 6.8 4.2 2.3 1.2 7.6 11.3 1.0 3.1 4.0 3.1 1.9 7.0 7.6 1.4 2.0 7.7 3.3 9.2 1.5 6.1 7.3 2.8 19.9 3.1 8.9 1.8 6.5 5.5 1.3 8.2 5.0 4.7 2.1 2.7 4.9 5.2 2.8 0.2 2.4 20.7 3.5 0.0 2.5 2.3 0.9 5.0 5.6 1.7 1.9 6.8 4.8 3.5 2.1 RBMXL3 "CXorf55, FLJ40249" ENSG00000175718 "RBMX like 3" Q8N7X1 X 115189410-115192868 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 2.7" "Group enriched" "Detected in some" 9 "Spermatocytes: 17.9;Spermatogonia: 16.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051842 Supported NA NA "HPA051842: AB_2681634" "unprognostic (1.05e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MLXIP "bHLHe36, KIAA0867, MIR, MONDOA" ENSG00000175727 "MLX interacting protein" Q9HAP2 12 122078756-122147344 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 131.0" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 769.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023084 Approved NA NA "HPA023084: AB_1854005" "unprognostic (4.49e-1)" "unprognostic (8.89e-2)" "unprognostic (8.48e-2)" "unprognostic (3.60e-1)" "unprognostic (3.06e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (2.72e-1)" "unprognostic (6.19e-2)" "unprognostic (3.53e-2)" "unprognostic (1.71e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.92e-4)" "unprognostic (3.04e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (7.40e-2)" 24.6 28.7 10.1 29.9 9.1 36.2 21.1 12.1 12.0 22.2 9.4 70.3 26.9 30.7 25.5 15.6 33.6 21.5 23.0 9.1 13.7 23.3 31.4 30.2 17.3 9.5 8.1 10.4 47.6 62.0 12.9 21.6 12.6 10.5 27.4 44.6 11.1 32.3 19.1 131.0 25.3 39.2 32.5 6.3 35.4 41.1 16.5 9.3 14.3 41.8 42.4 13.7 46.3 17.4 12.0 25.1 21.6 12.5 26.3 20.1 16.8 4.7 13.8 8.3 6.3 5.3 23.2 9.8 8.4 16.5 13.3 9.3 28.2 24.0 31.8 7.9 16.4 24.9 28.1 15.8 18.3 33.7 12.5 18.4 29.5 24.9 16.2 20.2 17.0 33.1 22.4 54.8 8.0 13.8 16.9 17.5 30.5 12.0 17.8 14.6 26.1 27.4 11.5 19.3 28.2 21.0 12.0 35.3 17.0 18.3 11.2 17.6 27.9 49.1 14.4 13.9 25.6 20.4 18.6 13.6 11.7 18.6 17.2 22.8 2.5 3.7 1.2 1.9 1.4 1.4 1.8 1.9 1.6 2.3 2.3 2.7 3.3 2.9 2.1 2.4 3.1 1.7 1.9 10.1 9.1 12.1 12.0 9.1 13.7 9.5 8.1 10.4 10.5 6.3 9.3 12.0 66.7 25.6 31.2 18.6 31.2 57.2 36.5 19.0 25.0 52.0 37.2 26.0 17.4 54.3 29.8 31.3 769.4 2.8 32.9 195.2 13.7 56.7 22.7 58.5 71.1 44.4 180.6 59.1 31.7 149.6 2.8 44.4 29.6 60.6 8.8 23.2 72.5 32.9 28.0 28.6 32.1 128.9 32.6 65.7 65.7 39.8 50.7 39.4 32.0 28.1 57.2 8.1 30.9 26.2 29.3 127.5 105.3 88.8 35.0 59.0 36.2 14.3 58.0 33.5 19.7 66.2 39.9 20.7 25.0 20.0 61.1 5.3 29.8 42.9 231.2 47.7 NR2F1 "COUP-TFI, COUPTF1, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1" ENSG00000175745 "Nuclear receptor subfamily 2 group F member 1" P10589 5 93583222-93594611 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 294.1;Hepatic stellate cells: 171.4;Leydig cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 232.4;AN3-CA: 92.9;HHSteC: 174.1;hTERT-RPE1: 155.1;PC-3: 194.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019281, HPA058974" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB019281: , HPA058974: AB_2732629" "unprognostic (8.07e-2)" "unprognostic (1.06e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-1)" "unprognostic (4.75e-1)" "unprognostic (7.68e-3)" "unprognostic (3.18e-3)" "unprognostic (3.07e-2)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (5.24e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.28e-2)" "prognostic unfavorable (1.47e-4)" 21.8 40.7 43.3 5.0 35.6 0.2 20.6 33.2 43.2 62.4 14.7 9.2 2.6 29.7 25.5 10.5 78.6 34.6 8.5 42.0 24.7 32.8 13.1 44.8 8.4 34.5 39.1 34.8 63.2 7.7 1.6 21.7 53.0 24.0 45.3 3.1 8.8 6.9 40.6 0.3 1.9 7.5 11.9 31.1 7.3 29.0 3.9 47.4 2.1 17.1 3.7 3.8 49.5 41.0 31.1 20.1 9.5 232.4 92.9 48.3 14.8 11.0 11.6 4.7 6.9 7.1 1.3 3.6 0.1 0.7 4.7 2.8 5.0 5.7 0.4 3.0 24.7 45.2 9.2 61.9 15.1 174.1 1.9 0.9 69.7 0.1 3.3 1.3 155.1 26.3 0.1 0.1 0.1 21.4 0.1 0.0 2.7 0.1 1.4 194.2 2.8 1.9 0.1 1.4 0.8 23.9 48.4 5.2 0.0 0.6 4.0 1.9 3.7 26.7 39.3 1.8 20.6 29.4 0.0 0.0 0.1 64.2 0.8 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 35.6 33.2 43.2 42.0 24.7 34.5 39.1 34.8 24.0 31.1 47.4 31.1 16.1 0.0 1.7 68.2 1.5 1.3 0.2 0.4 1.8 32.8 3.8 2.4 37.3 1.5 3.5 14.7 54.2 0.6 0.0 0.2 7.9 4.0 3.8 10.1 294.1 70.1 0.0 0.0 23.3 1.6 0.6 69.1 0.5 5.7 0.0 29.7 171.4 5.0 1.3 0.0 47.1 0.0 0.0 15.8 0.4 5.9 93.5 1.9 0.0 59.0 0.0 69.0 0.0 13.0 1.7 3.6 0.0 10.5 0.0 0.5 0.1 37.3 10.8 3.7 13.1 2.9 51.6 4.8 4.4 2.8 0.6 1.1 2.2 11.8 0.0 0.6 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1314.3;Late spermatids: 3668.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 92.6 130.2 105.2 43.8 102.7 52.0 90.7 113.6 143.5 64.1 112.0 109.5 72.3 70.6 23.7 118.9 64.6 26.3 224.3 101.4 103.1 153.1 217.6 67.8 41.7 114.6 104.3 100.3 58.7 121.1 74.0 93.0 36.1 105.2 86.7 27.8 23.8 89.0 39.1 283.9 91.1 86.3 22.6 104.6 86.5 122.4 302.9 113.1 38.3 83.8 172.8 27.4 88.0 73.5 104.9 197.8 116.9 62.9 113.6 54.6 68.2 115.7 116.8 76.8 180.7 127.6 206.3 177.5 103.2 169.3 79.6 90.7 142.4 86.5 154.6 51.9 124.7 245.8 83.6 156.1 194.0 106.7 109.0 109.0 90.4 68.6 127.1 51.3 52.8 99.2 96.3 167.2 138.5 106.6 150.3 134.7 386.9 119.1 123.2 329.1 154.8 77.5 222.7 145.9 51.6 200.7 150.6 83.7 288.4 295.1 38.1 125.0 250.7 75.5 111.3 144.4 134.1 175.7 179.1 177.0 223.4 155.3 159.2 77.1 279.1 231.8 266.6 171.6 200.3 162.7 190.6 178.4 181.7 207.4 202.7 166.6 161.1 291.7 142.4 177.7 294.0 230.1 225.6 105.2 102.7 113.6 143.5 101.4 103.1 114.6 104.3 100.3 105.2 104.6 113.1 104.9 118.9 48.1 73.5 18.9 137.4 162.3 166.4 271.4 87.0 109.8 228.1 240.2 231.3 180.1 149.6 165.5 64.6 384.1 134.7 642.0 677.0 310.2 1314.3 145.6 119.3 127.6 203.9 125.2 11.2 418.4 458.6 121.0 178.4 141.8 87.5 144.6 121.1 390.5 294.6 104.3 12.8 415.1 238.0 154.8 175.5 3668.5 136.1 149.7 217.1 5.6 208.1 299.8 166.9 13.0 17.9 425.2 484.3 118.5 240.5 272.5 607.4 780.2 142.2 124.5 157.8 104.4 152.4 572.4 149.2 190.4 197.6 438.1 116.3 181.0 414.3 270.1 TTLL11 "bA244O19.1, C9orf20" ENSG00000175764 "Tubulin tyrosine ligase like 11" Q8NHH1 9 121821928-122093606 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 24.5" "Group enriched" "Detected in many" 4 "Excitatory neurons: 201.7;Inhibitory neurons: 157.5;Oligodendrocytes: 412.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021828 Approved NA NA "HPA021828: AB_2670841" "unprognostic (2.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (5.56e-3)" "unprognostic (7.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.59e-3)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (3.71e-2)" "unprognostic (5.27e-3)" "unprognostic (3.88e-2)" "unprognostic (3.61e-6)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (3.53e-2)" 3.8 5.5 11.0 2.7 13.8 1.3 3.6 11.3 15.6 4.2 0.0 7.9 2.6 5.2 3.0 7.0 5.0 3.4 5.1 6.4 7.1 2.8 5.5 3.9 2.5 12.4 12.0 4.5 4.3 4.9 4.3 3.0 4.4 14.2 4.4 4.0 6.0 4.7 5.2 24.5 4.1 3.2 9.4 12.7 3.2 4.2 12.2 11.3 2.7 3.5 8.7 2.6 5.8 4.2 19.9 2.4 1.2 3.9 5.3 5.4 6.5 1.6 4.5 5.5 7.7 4.4 3.6 1.4 5.4 1.4 9.3 2.5 5.8 6.8 5.4 4.7 3.7 5.6 2.6 5.2 3.7 6.2 4.7 2.9 4.7 7.6 3.1 4.9 2.9 2.8 4.6 8.1 5.3 2.7 3.8 3.3 3.8 2.1 8.2 8.3 3.4 6.8 8.4 4.0 1.9 8.2 3.4 2.7 5.0 3.6 2.1 4.0 4.0 3.2 3.6 0.7 6.5 6.1 5.8 7.9 2.3 3.3 5.2 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 11.0 13.8 11.3 15.6 6.4 7.1 12.4 12.0 4.5 14.2 12.7 11.3 19.9 2.1 0.0 1.5 18.3 1.6 2.5 0.9 0.8 6.2 3.0 2.2 2.4 1.4 1.5 0.4 1.8 10.4 1.7 1.2 1.1 1.9 1.9 22.3 2.8 2.7 1.5 1.2 3.4 201.7 1.8 0.7 2.2 1.1 1.3 1.3 1.0 0.7 1.8 1.6 6.7 157.5 1.6 0.0 0.9 1.2 23.1 3.7 0.9 3.6 22.5 0.9 2.4 2.1 58.8 412.6 1.9 0.1 3.0 2.2 0.8 0.5 2.0 1.8 2.6 0.0 5.5 2.6 13.3 2.5 4.2 4.1 1.0 1.8 2.7 1.0 0.9 EIF4E1B FLJ36951 ENSG00000175766 "Eukaryotic translation initiation factor 4E family member 1B" A6NMX2 5 176630618-176646644 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.2;epididymis: 1.1;retina: 2.8" "Group enriched" "Detected in some" 6 "Bipolar cells: 8.5;Cardiomyocytes: 12.8;Cone photoreceptor cells: 16.7;Excitatory neurons: 7.1;Horizontal cells: 11.8;Inhibitory neurons: 8.4;Rod photoreceptor cells: 17.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "T-47d: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA045045 Approved NA NA "HPA045045: AB_2679197" "unprognostic (6.54e-2)" "unprognostic (1.53e-2)" "unprognostic (7.44e-2)" "unprognostic (5.26e-2)" "unprognostic (1.86e-1)" 0.0 0.2 1.2 0.0 1.5 0.2 0.0 1.7 3.2 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.1 1.2 1.0 1.4 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 1.5 1.7 3.2 1.4 1.0 1.2 1.0 1.4 1.3 0.7 0.8 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 12.8 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 7.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 8.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TOMM5 "bA613M10.3, C9orf105, Tom5" ENSG00000175768 "Translocase of outer mitochondrial membrane 5" Q8N4H5 9 37582646-37592604 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048712 Approved Supported Mitochondria NA NA Mitochondria "HPA048712: AB_2680499" "unprognostic (1.81e-2)" "unprognostic (1.96e-1)" "unprognostic (3.37e-2)" "unprognostic (3.34e-2)" "unprognostic (2.02e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (9.89e-3)" "prognostic unfavorable (5.49e-4)" "prognostic favorable (2.37e-4)" "unprognostic (7.80e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.37e-1)" "unprognostic (9.09e-2)" 80.0 93.4 69.9 63.4 72.5 67.0 72.5 71.9 85.5 61.3 70.2 80.4 74.6 65.4 62.5 89.8 59.2 47.6 80.1 71.0 75.3 115.3 88.2 57.5 83.6 72.0 73.8 69.9 64.2 91.1 52.9 66.8 39.5 75.1 59.4 60.7 40.5 70.7 46.4 130.5 59.8 62.7 56.4 73.2 76.1 73.3 65.7 72.9 72.6 65.8 90.4 79.4 80.6 65.8 75.4 353.2 400.4 234.3 211.2 265.7 258.9 128.9 262.5 169.4 252.1 268.6 431.4 142.2 240.3 208.4 253.7 254.4 119.0 212.0 316.2 262.6 338.5 329.0 212.1 535.7 630.0 216.1 350.6 133.7 224.9 170.4 277.4 273.5 118.7 293.5 264.1 524.9 261.5 261.1 282.3 297.2 306.9 407.7 296.2 249.0 247.9 195.2 353.3 294.0 218.7 202.4 184.7 134.9 181.6 201.5 198.2 127.0 405.4 198.8 173.3 369.7 273.9 411.8 97.5 312.3 407.8 211.4 300.9 272.0 77.3 155.2 74.5 202.0 177.4 252.1 309.9 246.7 227.8 196.8 260.6 251.9 232.8 17.8 216.5 154.3 218.4 221.2 279.7 69.9 72.5 71.9 85.5 71.0 75.3 72.0 73.8 69.9 75.1 73.2 72.9 75.4 31.7 28.9 33.4 16.0 95.5 112.3 49.9 72.8 138.3 5.0 51.2 66.5 20.8 47.1 54.3 46.0 12.5 24.5 41.6 36.5 80.3 55.6 218.3 43.3 49.1 49.8 18.1 120.5 14.2 127.2 55.6 45.9 122.9 46.2 46.2 22.1 50.0 159.2 66.6 1.7 14.9 50.8 52.9 52.7 48.6 181.2 35.1 55.0 62.2 6.5 58.3 10.5 32.0 6.6 11.0 109.2 32.6 31.2 178.3 67.7 75.3 215.0 51.7 8.8 0.0 40.5 42.2 87.4 24.2 235.4 146.3 25.2 73.3 20.8 53.6 55.9 SLC35E3 BLOV1 ENSG00000175782 "Solute carrier family 35 member E3" Q7Z769 12 68746125-68793964 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049403 Uncertain NA NA "HPA049403: AB_2680747" "unprognostic (1.49e-1)" "unprognostic (6.47e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.61e-2)" "unprognostic (2.49e-1)" "unprognostic (1.26e-4)" "unprognostic (2.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-2)" "unprognostic (6.98e-2)" "unprognostic (6.85e-3)" "unprognostic (1.48e-1)" "unprognostic (3.22e-2)" "unprognostic (2.89e-3)" "unprognostic (1.80e-1)" 0.7 1.3 1.3 0.6 1.3 1.5 0.7 2.4 1.8 0.7 0.4 0.6 0.4 0.6 0.8 0.9 0.5 0.5 0.6 1.1 0.6 0.7 1.1 0.8 0.7 1.5 1.0 1.3 0.7 1.0 0.3 0.6 0.3 1.8 0.8 0.3 1.4 1.0 0.2 0.9 1.5 0.7 0.3 0.3 0.9 0.7 0.4 1.3 0.5 0.6 0.3 0.4 0.8 0.8 2.7 0.4 0.4 0.6 0.5 0.5 0.4 0.7 0.4 0.2 0.3 0.1 0.8 0.4 1.6 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.5 0.5 0.7 1.0 0.9 0.2 0.6 0.5 0.5 0.4 0.4 0.3 0.5 0.3 0.6 0.5 0.9 0.3 0.4 0.3 1.1 0.5 0.2 0.6 2.1 0.8 0.3 0.2 0.7 0.5 0.7 0.6 0.6 0.3 0.3 0.6 0.4 0.5 0.9 0.4 0.7 0.5 1.0 0.5 2.2 0.9 0.6 0.4 2.0 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.3 0.1 0.7 0.3 0.4 1.9 0.6 0.3 0.5 0.4 0.1 1.3 1.3 2.4 1.8 1.1 0.6 1.5 1.0 1.3 1.8 0.3 1.3 2.7 15.1 12.8 22.4 10.7 21.5 7.9 23.7 20.7 8.6 72.0 16.9 17.3 18.4 12.8 19.7 18.4 39.6 24.8 22.7 5.0 5.9 18.8 7.8 17.7 15.7 16.2 13.1 15.6 16.0 22.7 23.9 20.7 6.1 15.2 18.3 32.9 16.8 23.7 15.7 43.7 19.1 10.2 12.2 29.6 6.6 2.0 15.2 30.2 7.2 4.7 27.4 29.2 28.8 17.6 40.4 18.9 6.7 23.0 24.3 17.1 11.2 11.7 19.4 68.2 26.3 31.0 16.3 8.8 14.3 19.0 7.5 12.4 20.9 30.3 12.6 17.9 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788485 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.6" "Group enriched" "Detected in some" 9 "Muller glia cells: 35.5;Oligodendrocytes: 54.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2" "Region enhanced" "Detected in many" "basal ganglia: 18.1" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.0 3.0 7.7 3.0 10.2 0.0 3.8 10.5 9.5 17.5 2.9 40.6 2.1 14.0 2.1 8.1 18.4 1.6 7.1 5.1 10.7 1.1 0.8 1.0 0.1 16.0 12.9 4.0 5.4 1.4 0.0 0.7 1.0 13.8 15.7 3.7 5.7 5.1 5.0 0.9 3.3 21.8 8.2 13.8 0.2 20.2 1.7 8.9 0.2 1.7 1.4 2.3 11.1 14.5 18.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.2 0.0 0.0 0.1 0.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.3 8.2 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 10.2 10.5 9.5 5.1 10.7 16.0 12.9 4.0 13.8 13.8 8.9 18.3 0.2 0.0 0.0 1.3 0.0 0.5 1.0 0.3 0.6 2.6 0.4 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 3.4 2.6 0.6 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.2 2.8 0.1 0.0 0.0 0.0 35.5 0.0 2.0 54.7 0.1 0.0 0.0 1.2 0.7 0.0 0.1 0.0 0.3 0.0 4.9 0.3 0.7 1.4 0.6 0.3 0.0 0.0 0.0 0.0 0.1 ZNF169 MGC51961 ENSG00000175787 "Zinc finger protein 169" Q14929 9 94259298-94301829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.4;Inhibitory neurons: 16.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041769, HPA061185" Uncertain Approved "Nucleoplasm,Nuclear speckles,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Vesicles, Cytosol" "HPA041769: AB_2677662, HPA061185: " "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (3.27e-2)" "unprognostic (9.08e-3)" "unprognostic (1.18e-3)" "unprognostic (7.33e-2)" "unprognostic (2.27e-1)" "unprognostic (7.45e-2)" "unprognostic (6.79e-2)" "unprognostic (1.69e-2)" "unprognostic (1.49e-4)" "unprognostic (6.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (2.15e-4)" 2.7 2.7 4.1 4.4 4.4 3.2 3.9 4.4 5.0 5.3 3.5 4.0 2.9 3.9 4.2 2.6 4.8 1.7 2.6 4.4 3.1 3.3 2.1 3.2 6.0 4.3 3.4 4.5 5.5 3.3 2.3 2.7 2.1 4.9 4.2 5.5 4.2 3.9 2.6 4.6 5.3 5.7 2.8 2.3 6.1 4.1 2.6 3.6 3.8 4.9 1.8 5.2 4.1 4.1 5.8 3.0 2.6 2.8 4.9 1.5 3.4 3.1 1.1 2.0 2.2 2.3 1.8 4.3 7.3 1.4 1.7 2.2 5.8 5.7 2.7 2.9 4.0 6.3 5.1 6.5 3.3 1.8 7.8 5.0 3.0 2.9 1.8 2.8 2.8 2.7 6.8 4.6 2.1 2.8 2.9 3.7 4.4 4.6 6.2 3.2 3.1 2.0 2.3 1.9 2.5 2.9 3.5 1.9 3.5 1.4 2.7 2.2 3.2 3.1 2.0 2.6 2.6 2.2 3.9 1.5 1.4 1.9 5.2 1.9 2.2 3.0 3.2 2.4 3.4 3.1 3.0 2.9 1.7 2.1 4.0 3.0 4.1 2.5 3.3 2.6 2.0 3.1 1.7 4.1 4.4 4.4 5.0 4.4 3.1 4.3 3.4 4.5 4.9 2.3 3.6 5.8 2.0 3.2 0.5 10.4 8.0 0.3 2.2 1.3 1.2 4.8 1.0 1.3 1.2 1.5 2.6 1.8 4.2 0.5 3.9 2.5 0.0 1.1 1.0 0.6 1.4 2.3 1.2 3.8 18.4 0.9 0.8 1.8 2.6 0.5 0.0 6.3 2.5 0.8 0.7 5.0 16.7 4.1 0.0 4.4 1.6 1.0 5.9 4.1 0.0 7.5 7.8 2.3 15.5 14.1 19.9 1.2 3.1 3.4 2.6 2.6 4.3 1.0 2.4 4.5 0.0 2.9 1.7 5.2 3.6 0.7 0.4 0.4 4.7 3.7 2.1 2.4 RUVBL1 "ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a" ENSG00000175792 "RuvB like AAA ATPase 1" Q9Y265 3 128064778-128153914 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019947, HPA019948" Enhanced Supported Nucleoplasm,Cytosol NA NA 81000 "Nucleoplasm, Cytosol" "HPA019947: AB_1856516, HPA019948: AB_1856514" "unprognostic (7.40e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (4.73e-2)" "unprognostic (3.55e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (2.43e-2)" "unprognostic (3.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (7.39e-2)" "unprognostic (2.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 18.7 18.8 7.1 10.2 5.9 8.7 18.7 6.6 7.1 17.5 8.9 15.9 5.1 23.3 5.8 26.2 27.7 5.0 24.9 6.0 6.7 20.0 17.4 17.3 13.2 6.5 7.0 5.8 15.5 14.1 14.7 17.5 12.8 7.1 13.2 8.6 7.4 14.1 7.0 19.2 17.5 15.3 10.1 6.7 22.5 15.0 29.7 6.6 15.9 15.5 6.1 16.3 19.4 18.7 6.3 75.1 66.2 40.1 65.6 30.5 29.4 52.2 35.8 30.5 67.3 45.9 69.7 43.2 105.0 34.8 34.2 52.2 58.4 107.2 75.6 77.6 43.4 52.3 87.8 36.3 47.4 31.4 82.9 27.0 30.2 39.1 56.5 72.1 25.6 45.6 39.4 72.9 24.4 38.7 105.9 89.7 64.6 101.1 83.5 55.8 72.4 48.4 73.4 40.7 27.6 66.8 60.1 39.6 32.4 55.9 36.8 58.5 61.8 29.8 30.5 37.2 46.4 55.2 24.3 41.6 103.0 37.4 50.2 39.2 1.3 7.3 2.5 15.6 11.9 20.1 15.6 18.7 19.6 11.3 15.7 15.6 17.6 0.3 15.9 11.9 12.6 30.5 11.0 7.1 5.9 6.6 7.1 6.0 6.7 6.5 7.0 5.8 7.1 6.7 6.6 6.3 26.1 22.4 15.3 12.7 22.7 20.0 23.7 61.6 25.0 17.4 17.4 21.8 20.9 21.5 37.3 22.0 2.1 53.7 31.3 7.8 46.9 40.9 21.2 147.0 50.8 27.4 16.9 20.4 12.6 30.1 65.4 22.9 17.3 23.8 26.0 35.7 12.8 14.6 29.9 23.5 14.6 14.0 28.5 8.8 8.2 67.1 15.2 14.6 10.6 4.7 13.3 28.1 11.3 9.0 10.0 27.1 11.1 18.4 27.3 34.5 4.6 59.2 221.3 19.7 13.1 16.1 32.3 94.8 75.0 27.9 16.9 24.1 29.1 84.7 23.4 15.6 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863149-26864456 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 2481.3;skin 1: 1140.9;vagina: 697.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0" "Cancer enhanced" "Detected in all" "cervical cancer: 1510.8;head and neck cancer: 2526.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 17 "basophil: 5.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 5.9" "Cell line enhanced" "Detected in many" "A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7" "Low region specificity" "Detected in many" "CAB006268, HPA011105, CAB040552" Enhanced Supported Cytosol "Secreted in other tissues" NA Yes 29000000 Cytosol "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339" "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favorable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 2.3 0.8 2.0 11.7 1.7 2.0 29.4 1.7 7.9 169.6 0.5 89.5 49.2 8.1 0.7 2481.3 2.2 21.6 1.2 2.0 2.8 15.8 3.7 56.6 0.2 9.0 1.8 1.3 0.9 2.2 0.1 2.7 1.6 6.0 77.9 32.8 0.6 335.5 3.2 5.0 1140.9 41.1 3.3 2.1 0.9 67.1 0.7 4.3 22.3 2.0 0.1 149.1 169.3 697.7 3.3 770.8 126.9 0.1 1.1 0.3 0.1 37.2 0.5 0.0 0.1 0.3 46.6 393.6 6.7 32.2 0.2 0.6 1181.6 0.3 1819.0 0.0 183.4 5.4 0.9 119.6 138.4 0.1 0.4 1.4 0.4 1196.7 0.6 310.1 0.2 0.2 0.7 1.8 4.5 0.1 163.8 0.7 0.3 2.3 132.6 208.7 0.5 0.4 43.1 281.3 173.9 0.7 0.7 181.2 31.9 1.8 2.9 83.6 1.5 0.5 0.5 337.2 0.3 4.9 1.0 5.8 3.8 1.5 0.7 0.7 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.0 1.7 1.7 7.9 2.0 2.8 9.0 1.8 1.3 6.0 2.1 4.3 3.3 1.6 179.5 162.2 0.0 5.0 7750.0 2119.7 1374.7 1714.2 0.0 72.6 119.9 0.8 24.3 285.6 16.5 0.0 18.6 0.7 972.0 3.9 48.8 0.0 138.0 20.1 45.3 67.4 0.0 0.0 76.2 59.9 46.2 221.2 251.8 32.3 0.0 0.4 4.5 1.9 0.0 0.1 140.7 114.0 0.6 479.7 0.0 0.0 9.7 533.6 0.0 1.0 0.0 0.0 0.0 0.1 524.8 933.0 0.0 21.2 1030.2 318.5 0.6 158.2 0.0 0.0 0.7 55.2 0.0 0.6 3587.1 10714.0 6.0 23.4 0.1 292.4 2780.0 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054292-10428891 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 84.7;liver: 64.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 28.1" "Immune cell enhanced" "Detected in some" "eosinophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 12.3" "Low region specificity" "Detected in all" "HPA023804, HPA075766" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" No No 55000 "Nucleoplasm, Cytosol" "Plasma membrane, Actin filaments" "HPA023804: AB_1853826, HPA075766: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 17.1 20.5 2.8 1.1 3.6 13.6 16.3 28.1 6.1 8.5 0.0 13.9 1.1 10.8 0.1 11.7 7.5 0.4 25.8 4.6 0.8 84.7 64.5 12.3 0.6 0.3 1.7 2.7 6.4 14.6 0.7 9.3 0.8 10.2 9.3 0.6 0.6 10.6 1.0 14.6 9.3 20.3 0.8 0.3 18.8 14.3 15.3 0.4 1.5 9.7 1.3 0.6 11.7 8.3 3.7 0.1 0.9 1.3 4.3 1.2 1.4 0.5 2.5 0.2 0.3 1.7 0.6 2.1 0.0 0.6 2.5 5.8 2.3 0.4 0.1 1.3 0.2 0.0 0.3 1.5 2.2 4.3 0.8 12.3 0.4 3.2 0.3 0.0 1.4 0.6 0.3 0.4 0.2 4.9 0.1 0.0 0.3 0.6 3.3 0.8 1.6 1.3 2.0 1.1 1.1 2.5 1.5 4.6 0.2 0.5 0.4 2.3 2.8 2.6 1.7 2.0 0.4 1.2 0.2 0.1 0.7 4.8 0.8 3.1 0.5 1.9 5.6 0.4 1.2 0.3 0.6 0.4 0.3 1.2 0.1 0.3 0.2 2.2 0.7 0.9 0.2 0.3 0.2 2.8 3.6 28.1 6.1 4.6 0.8 0.3 1.7 2.7 10.2 0.3 0.4 3.7 44.1 0.0 7.4 152.8 21.4 16.4 29.3 10.8 14.2 10.1 21.2 21.8 21.6 25.8 7.2 25.8 31.3 7.7 12.4 26.4 92.0 32.3 80.6 13.6 8.7 30.3 9.6 3.4 625.8 47.1 4.6 13.1 14.8 11.8 80.7 13.7 19.6 97.2 47.0 16.8 318.6 20.8 4.1 33.6 48.3 167.9 9.3 38.0 30.2 85.3 22.3 14.6 11.3 268.9 60.7 51.1 37.8 9.8 16.2 33.8 195.5 666.1 5.6 6.2 13.1 11.3 16.9 39.3 26.5 20.1 14.1 8.3 18.0 14.1 24.5 31.1 CBLL2 "CT138, FLJ25735, HAKAIL, ZNF645" ENSG00000175809 "Cbl proto-oncogene like 2" Q8N7E2 X 22272913-22274461 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729367-102759072 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 8.9" "Cell type enriched" "Detected in some" 11 "Early spermatids: 1011.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 3.2 0.0 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.7 1.8 4.5 0.0 1.8 0.0 0.0 0.3 2.3 0.1 0.0 0.3 1011.0 0.2 1.2 0.6 0.0 0.0 1.1 0.4 0.5 0.4 0.0 0.4 0.0 0.4 0.4 0.0 0.3 0.0 0.9 0.0 0.0 0.6 0.0 91.3 2.1 0.6 0.0 1.0 1.6 0.0 0.0 0.5 0.6 0.4 0.0 0.7 1.4 0.5 0.0 0.2 0.0 0.0 0.0 2.9 0.7 3.1 1.5 0.0 0.0 0.4 0.9 0.2 0.2 0.2 CTDNEP1 "DULLARD, HSA011916, NET56" ENSG00000175826 "CTD nuclear envelope phosphatase 1" O95476 17 7243591-7252491 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 413.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037439, HPA066466" Uncertain Approved "Lipid droplets" NA NA "Lipid droplets" "HPA037439: AB_10601264, HPA066466: AB_2732745" "unprognostic (7.11e-2)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "prognostic favorable (6.45e-4)" "unprognostic (3.12e-1)" "unprognostic (2.13e-1)" "unprognostic (4.61e-2)" "unprognostic (1.50e-2)" "unprognostic (2.98e-1)" "unprognostic (9.90e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.37e-1)" "unprognostic (2.77e-3)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (9.97e-2)" "unprognostic (2.02e-2)" 98.3 95.0 52.8 41.8 51.8 49.2 92.2 49.6 55.5 102.0 50.5 90.5 36.7 98.4 37.4 106.1 88.9 32.4 114.3 50.0 50.1 86.0 69.7 92.3 46.3 56.6 52.9 47.1 104.3 99.3 44.8 84.4 41.4 53.4 82.5 47.1 30.0 83.3 33.9 413.4 114.4 94.6 45.4 50.6 116.8 96.1 67.0 54.8 56.7 81.9 180.8 62.3 89.0 87.7 52.8 86.2 123.9 68.4 73.7 105.0 128.0 52.5 62.4 102.8 97.4 83.1 59.6 57.7 80.6 65.6 111.5 68.6 70.5 90.8 95.4 108.6 118.5 74.6 55.2 79.7 104.1 96.5 63.3 100.3 103.4 113.8 111.9 118.3 99.9 105.2 76.2 50.9 56.3 93.3 53.4 77.3 67.0 48.3 75.7 50.9 85.3 61.3 62.6 77.9 44.1 26.3 75.5 49.8 48.9 69.8 67.6 46.3 51.5 61.6 70.9 61.3 57.5 119.4 49.2 46.0 40.6 91.5 85.8 75.1 4.2 6.3 11.0 5.5 6.7 4.4 7.8 5.2 5.9 4.6 7.4 4.0 5.9 8.4 4.1 4.5 9.7 5.7 2.3 52.8 51.8 49.6 55.5 50.0 50.1 56.6 52.9 47.1 53.4 50.6 54.8 52.8 48.0 25.6 23.2 12.7 47.1 47.2 42.4 36.1 19.9 44.8 73.9 70.1 13.1 37.1 33.5 40.5 22.9 66.1 68.3 84.5 11.7 63.7 4.8 50.0 59.9 47.2 73.7 18.5 14.7 85.2 129.9 43.5 22.4 68.5 20.3 71.3 44.6 35.6 90.6 30.3 17.0 79.6 22.4 104.4 62.2 7.9 57.8 69.8 28.4 14.0 69.2 47.9 59.8 11.6 21.9 84.5 52.1 47.0 41.3 58.3 62.8 34.8 25.8 35.4 26.3 42.5 51.4 23.7 35.5 32.5 67.1 83.2 41.3 68.3 69.6 61.8 ETV4 "E1A-F, E1AF, PEA3" ENSG00000175832 "ETS variant transcription factor 4" P43268 17 43527844-43579620 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 23.3;Cholangiocytes: 17.2;Distal tubular cells: 17.6;Enteroendocrine cells: 14.9;Extravillous trophoblasts: 19.8;Syncytiotrophoblasts: 14.9" "Cancer enhanced" "Detected in all" "testis cancer: 80.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 177.7;Hep G2: 173.0;SK-MEL-30: 197.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005768 Approved Supported "Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA005768: AB_1848294" "unprognostic (2.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.14e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.58e-2)" "unprognostic (5.34e-2)" "unprognostic (8.13e-2)" "unprognostic (7.05e-2)" "unprognostic (3.01e-1)" "unprognostic (7.79e-2)" "unprognostic (2.03e-1)" "unprognostic (7.08e-2)" "prognostic favorable (7.60e-4)" "unprognostic (1.69e-1)" 0.5 2.5 1.3 1.0 1.6 0.0 7.1 0.9 2.2 3.0 0.0 2.0 6.1 2.5 1.0 9.2 2.5 6.4 3.1 1.4 1.4 5.4 1.2 2.3 0.6 1.1 0.9 0.8 0.4 7.9 7.9 14.9 5.3 1.1 4.6 1.8 3.0 4.7 3.6 1.3 6.4 4.2 1.4 0.3 0.4 3.8 1.2 0.7 0.3 7.0 2.5 4.8 2.2 5.3 0.9 24.5 67.0 80.4 177.7 3.1 20.1 17.9 7.9 21.1 14.9 15.2 38.1 33.9 0.1 4.3 4.1 36.6 43.6 2.7 40.2 13.2 0.8 0.5 2.3 10.7 173.0 4.3 47.0 20.9 3.6 1.4 56.8 35.0 16.8 32.1 0.3 48.9 0.1 31.0 9.8 0.2 82.9 116.9 123.1 110.9 99.8 9.8 58.9 33.0 17.3 0.1 71.4 2.1 4.5 197.0 43.8 0.8 13.9 15.1 10.6 52.0 15.7 22.1 7.3 47.8 0.1 18.9 8.9 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.6 0.9 2.2 1.4 1.4 1.1 0.9 0.8 1.1 0.3 0.7 0.9 0.2 0.0 0.0 1.3 0.0 1.9 2.5 3.6 23.3 3.2 10.4 12.3 1.1 17.2 2.4 0.0 0.0 2.3 0.1 1.1 17.6 6.5 3.1 0.7 0.3 1.5 14.9 0.0 1.6 1.0 19.8 1.9 3.1 1.6 0.0 0.2 0.7 0.0 0.8 0.0 1.0 4.0 2.0 0.3 0.3 6.0 0.3 0.2 3.6 1.0 0.0 10.9 0.0 1.0 0.0 3.7 3.3 0.4 0.0 0.9 1.9 0.1 1.0 0.3 0.0 2.1 1.7 0.0 1.3 3.6 1.1 14.9 0.3 0.1 7.7 4.3 SWI5 "bA395P17.9, C9orf119, SAE3" ENSG00000175854 "SWI5 homologous recombination repair protein" 9 128275379-128316123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 143.6" "Group enriched" "Detected in all" 9 "Early spermatids: 1180.8;Late spermatids: 1131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052032 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052032: AB_2681702" "unprognostic (1.27e-2)" "unprognostic (1.74e-2)" "unprognostic (3.56e-3)" "unprognostic (3.21e-2)" "unprognostic (1.42e-3)" "unprognostic (3.28e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (4.58e-3)" "unprognostic (1.15e-1)" "prognostic favorable (9.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (7.38e-2)" 26.3 26.7 28.9 11.4 30.6 11.1 28.4 30.9 41.2 37.2 31.7 21.5 16.1 27.7 69.4 33.5 32.0 17.9 33.2 28.3 31.5 36.6 42.7 20.7 12.6 30.0 30.2 27.4 41.2 21.4 72.0 54.9 17.8 30.3 33.1 12.8 21.3 25.8 37.5 25.4 26.0 18.7 20.4 29.5 18.1 23.2 143.6 29.8 17.2 44.4 25.8 17.9 26.7 31.7 31.4 29.2 51.4 29.7 34.8 79.2 71.8 33.7 50.6 66.7 64.2 42.6 66.6 33.5 27.7 65.7 82.6 39.5 47.8 48.1 67.5 42.6 41.4 35.7 21.0 97.5 52.9 101.9 13.6 18.6 60.8 31.7 107.4 57.8 55.9 62.5 96.8 50.5 42.8 66.5 119.9 29.6 19.6 20.3 67.8 105.3 27.1 41.0 44.4 43.6 15.2 34.0 18.9 63.0 39.8 63.0 32.9 66.2 14.5 39.0 46.4 38.0 90.9 43.3 45.6 75.0 37.0 61.8 20.9 50.7 54.3 14.2 25.8 14.5 8.7 17.0 17.6 14.1 14.4 14.7 20.2 16.7 21.6 9.0 22.2 9.1 21.4 15.6 15.3 28.9 30.6 30.9 41.2 28.3 31.5 30.0 30.2 27.4 30.3 29.5 29.8 31.4 33.8 6.4 17.4 5.2 18.0 24.5 35.1 54.0 31.3 13.7 33.6 38.9 36.2 31.5 33.5 36.8 12.5 65.7 13.7 15.7 66.5 25.5 1180.8 30.7 29.1 31.3 25.6 17.2 2.9 38.5 41.1 40.7 19.9 30.7 9.5 27.9 35.7 82.4 33.2 1.7 3.3 27.5 28.5 20.8 13.0 1131.1 43.2 31.5 37.4 2.8 23.8 50.7 20.6 4.5 7.8 29.8 27.1 31.6 17.9 34.9 68.4 84.1 29.5 21.1 32.9 25.7 31.3 93.7 44.3 33.5 21.9 117.0 18.6 32.8 23.4 36.6 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 17.1;lymphoid tissue: 43.0" "Cell type enhanced" "Detected in some" "B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "eosinophil: 1000.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 1000.3" "Cell line enhanced" "Detected in some" "HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA011048, HPA011070" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA011048: , HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.8 0.8 0.7 28.8 0.9 17.1 2.3 0.8 1.1 2.7 1.4 2.7 3.7 1.3 1.1 2.2 1.6 5.8 0.7 0.7 1.2 0.8 2.0 4.2 25.5 1.4 1.1 0.6 0.4 1.1 1.1 0.6 1.0 1.2 1.8 3.8 0.5 1.9 1.2 0.2 0.8 6.7 4.8 1.2 18.3 3.8 0.7 1.3 7.0 0.6 0.7 43.0 6.1 0.5 1.6 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 71.5 0.2 0.0 0.0 41.8 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 43.3 0.0 0.0 0.0 17.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 33.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 118.4 0.0 125.5 66.7 1000.3 0.4 46.5 0.5 97.0 0.4 0.4 76.8 97.4 0.3 0.3 82.0 1.4 59.3 205.4 0.3 32.0 0.7 0.9 0.8 1.1 0.7 1.2 1.4 1.1 0.6 1.2 1.2 1.3 1.6 0.4 3.2 1.9 0.0 84.8 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.2 0.0 0.6 0.0 0.0 0.0 160.1 0.0 0.0 0.0 1.6 0.0 0.1 0.9 0.0 8.8 0.0 0.0 0.1 0.4 0.5 0.0 55.0 0.0 0.4 0.0 14.3 0.0 0.0 0.0 0.0 19.4 6.0 0.5 0.0 43.0 0.0 1.9 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 BAIAP2 "BAP2, IRSp53, WAML" ENSG00000175866 "BAR/IMD domain containing adaptor protein 2" Q9UQB8 17 81035122-81117432 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 185.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 19.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023310, HPA027421" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 18000 "Plasma membrane, Cytosol" "HPA023310: AB_1845264, HPA027421: AB_10602392" "unprognostic (2.20e-1)" "unprognostic (1.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (6.97e-3)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (6.77e-2)" "unprognostic (1.45e-2)" "unprognostic (4.23e-2)" "unprognostic (2.94e-1)" "unprognostic (7.04e-2)" "unprognostic (6.77e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (7.58e-6)" 23.3 18.4 127.9 7.5 138.4 2.7 27.3 90.4 177.5 37.0 96.4 33.7 6.8 31.1 46.9 134.0 37.9 29.5 23.2 164.0 112.8 38.3 86.4 49.5 6.9 86.1 73.0 138.0 13.8 13.5 20.1 56.8 32.1 87.4 61.9 12.2 16.4 58.0 27.9 13.2 125.0 14.8 19.5 68.4 11.9 62.8 26.5 101.3 11.9 27.3 9.9 25.5 23.6 73.8 119.8 99.9 45.1 28.1 36.6 22.2 29.0 32.8 40.2 26.1 35.7 15.8 60.9 49.1 0.5 28.3 35.8 73.5 93.6 26.1 46.1 13.7 0.4 32.8 20.2 41.3 46.4 20.7 0.0 28.2 12.5 53.0 29.5 15.4 32.7 19.5 1.1 26.4 0.6 20.6 51.2 4.0 22.3 11.8 65.6 38.1 6.0 6.6 81.3 108.5 34.5 36.8 39.9 64.2 91.3 110.1 23.1 80.4 22.6 23.8 81.6 78.4 13.8 43.4 1.4 0.3 1.4 72.0 3.3 18.3 0.0 7.9 0.5 3.2 9.4 1.0 0.1 1.2 1.0 10.3 0.1 1.3 1.8 5.4 1.9 9.2 19.5 0.5 3.2 127.9 138.4 90.4 177.5 164.0 112.8 86.1 73.0 138.0 87.4 68.4 101.3 119.8 74.1 76.9 39.0 13.4 6.2 63.7 138.4 42.3 94.4 37.1 49.4 37.1 22.5 25.8 47.2 22.0 79.2 77.1 16.6 18.8 7.9 9.8 10.5 80.8 10.4 35.7 49.3 0.8 65.3 5.1 9.2 28.0 88.2 79.7 13.4 3.1 45.0 78.6 43.2 11.8 13.6 29.1 24.4 18.3 58.2 29.4 6.8 31.2 40.9 13.1 18.6 18.5 0.0 4.5 5.9 14.8 8.0 3.8 3.1 77.0 3.7 25.4 110.8 19.1 0.0 10.4 13.3 7.6 33.0 103.6 75.3 101.0 13.9 8.2 14.7 185.1 CALCB "CALC2, CGRP-II, FLJ30166" ENSG00000175868 "Calcitonin related polypeptide beta" P10092 11 14904997-15082342 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Hormone "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 18.7;thyroid gland: 20.9" "Group enriched" "Detected in some" 4 "Melanocytes: 5.4;Spermatogonia: 5.1" "Group enriched" "Detected in some" 5 "colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9" "Region enhanced" "Detected in many" "pons: 18.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0" "Region enriched" "Detected in some" 7 "pons and medulla: 9.6" "Group enriched" "Detected in many" 5 "amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7" HPA059886 Supported "Secreted to blood" NA NA "HPA059886: " "unprognostic (7.84e-2)" "unprognostic (4.07e-1)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.02e-1)" "unprognostic (8.40e-2)" "unprognostic (1.75e-1)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "unprognostic (3.32e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" 0.2 0.0 0.9 0.3 0.8 0.1 0.2 0.5 2.5 0.1 0.1 1.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.3 9.8 0.3 0.8 0.1 0.1 7.3 7.6 0.0 0.1 1.5 0.3 2.2 0.1 18.7 0.1 0.2 0.1 0.3 0.0 0.8 0.1 0.4 0.1 2.1 0.1 0.1 0.3 1.4 0.0 20.9 0.1 0.1 0.0 0.1 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.2 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 1.9 0.0 0.4 0.1 0.0 10.4 0.0 0.0 0.0 0.6 2.9 0.1 0.1 0.4 0.0 0.2 0.0 0.0 1.1 3.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.0 0.6 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.8 0.5 2.5 0.3 9.8 7.3 7.6 0.0 18.7 2.1 1.4 4.7 0.0 0.0 0.0 0.3 0.2 1.3 0.1 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.4 0.2 0.9 0.5 0.2 0.5 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 5.4 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 5.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 CREG2 ENSG00000175874 "Cellular repressor of E1A stimulated genes 2" Q8IUH2 2 101345550-101387503 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "brain: 29.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 66.0;Inhibitory neurons: 27.6;Oligodendrocytes: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;HaCaT: 6.3;HeLa: 2.5;OE19: 7.1;PC-3: 2.4;RT4: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038224 Enhanced "Secreted in brain" NA NA "HPA038224: AB_10673167" "unprognostic (5.09e-2)" "unprognostic (3.78e-3)" "unprognostic (4.10e-3)" "unprognostic (8.15e-3)" "unprognostic (5.63e-3)" "unprognostic (9.68e-3)" "unprognostic (4.52e-8)" "unprognostic (3.86e-4)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (7.69e-2)" "unprognostic (5.41e-3)" "unprognostic (4.44e-2)" "unprognostic (2.91e-1)" "unprognostic (8.26e-3)" "unprognostic (7.77e-2)" 0.0 0.1 10.4 0.0 17.1 0.1 0.0 0.0 27.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 29.8 6.2 0.0 0.0 0.0 0.0 3.8 0.9 17.8 0.0 0.0 0.2 0.2 0.0 5.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.7 15.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 2.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 10.4 17.1 0.0 27.0 29.8 6.2 3.8 0.9 17.8 5.6 0.0 2.1 15.3 0.0 0.0 0.0 2.9 0.0 0.0 0.6 0.5 0.0 0.8 0.1 0.1 0.9 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.5 0.0 0.0 66.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.1 2.0 0.0 0.0 6.5 0.0 0.2 0.0 6.5 0.0 0.8 0.0 2.5 12.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.5 0.0 0.2 0.1 1.5 5.6 0.5 0.0 0.1 0.0 0.2 0.0 1.5 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865890 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 215 "testis: 78.2" "Cell type enriched" "Detected in single" 7 "Endometrial ciliated cells: 2.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOXD8 "HOX4, HOX4E" ENSG00000175879 "Homeobox D8" P13378 2 176129694-176132695 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 100.5;kidney: 76.9" "Cell type enhanced" "Detected in many" "Adipocytes: 51.8;Collecting duct cells: 60.7;Distal tubular cells: 213.2;Early spermatids: 124.6;Leydig cells: 51.3;Peritubular cells: 53.8;Spermatocytes: 82.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "white matter: 6.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 45.4;RPTEC TERT1: 74.8;TIME: 32.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 70 "spinal cord: 34.6" NA NA "unprognostic (1.22e-1)" "unprognostic (6.31e-2)" "unprognostic (2.19e-3)" "unprognostic (2.68e-2)" "unprognostic (3.35e-1)" "unprognostic (3.49e-1)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.78e-4)" "unprognostic (2.79e-1)" "unprognostic (1.40e-2)" "unprognostic (3.93e-1)" "unprognostic (3.05e-1)" "unprognostic (3.63e-2)" "unprognostic (4.80e-2)" "unprognostic (5.21e-2)" "unprognostic (8.31e-2)" "unprognostic (2.80e-2)" 15.0 20.8 0.1 4.8 0.2 0.0 19.0 0.0 0.0 12.2 0.0 10.2 1.2 19.6 100.5 2.7 17.4 3.1 0.8 0.0 0.0 76.9 0.3 0.9 4.9 1.2 0.0 0.0 34.5 1.4 1.1 0.0 0.7 0.7 6.1 5.0 0.0 1.7 24.2 7.8 4.7 8.7 13.2 4.0 10.6 1.6 20.3 0.2 1.0 3.5 1.5 1.4 6.6 9.2 6.1 13.7 2.1 0.0 0.0 8.8 14.1 0.3 1.7 7.2 2.2 0.2 0.1 0.1 0.0 16.7 10.8 1.7 0.1 4.7 0.5 5.4 0.0 6.4 2.3 0.8 0.0 2.9 1.3 0.8 24.7 45.4 0.3 6.7 0.0 22.9 4.4 0.2 0.1 3.7 0.1 0.1 0.4 0.2 0.0 2.6 0.0 4.9 0.2 74.8 9.6 14.2 26.4 4.3 0.0 28.4 1.2 0.0 0.1 32.5 1.1 8.9 15.4 9.1 0.0 0.0 0.0 21.1 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 4.0 0.2 6.1 51.8 0.0 1.1 0.0 0.5 2.7 2.1 0.0 0.6 0.0 0.7 0.6 2.3 0.0 0.0 60.7 0.0 0.0 0.2 2.7 213.2 0.0 124.6 0.7 9.4 36.4 4.8 0.0 0.0 0.0 0.0 14.9 0.0 0.3 0.0 0.0 2.5 0.0 0.1 0.0 0.0 1.8 0.0 0.0 3.4 29.9 51.3 0.5 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 53.8 0.0 1.3 0.5 25.1 0.7 0.0 32.9 14.1 9.8 82.1 20.4 0.2 2.8 0.1 1.0 31.9 3.4 1.1 ZDHHC21 "DHHC21, DNZ1, HSPC097" ENSG00000175893 "Zinc finger DHHC-type palmitoyltransferase 21" Q8IVQ6 9 14611071-14693432 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 219.4;Inhibitory neurons: 201.6;Oligodendrocyte precursor cells: 268.9;Oligodendrocytes: 158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065254 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA065254: AB_2685446" "unprognostic (2.95e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-2)" "unprognostic (2.01e-1)" "unprognostic (4.19e-2)" "unprognostic (2.58e-2)" "unprognostic (2.81e-2)" "unprognostic (1.13e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (9.79e-3)" "unprognostic (3.97e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (8.87e-2)" "prognostic favorable (9.28e-6)" 3.7 5.7 4.7 4.6 6.8 2.6 6.2 13.8 7.3 5.4 2.9 4.7 6.9 5.0 6.1 8.6 4.6 3.6 4.7 6.3 5.6 5.0 2.6 5.2 6.7 4.7 5.1 5.0 5.3 4.7 4.9 6.6 4.3 6.1 5.2 5.3 10.7 4.6 3.7 4.6 8.8 7.3 4.1 3.7 5.5 4.4 4.2 4.4 2.6 6.1 3.4 6.1 4.2 6.8 6.5 7.1 3.6 6.9 4.6 1.1 1.2 5.3 8.9 2.7 3.1 3.5 1.8 3.3 7.0 2.1 6.2 3.9 4.5 4.8 2.9 4.4 14.1 3.7 29.9 8.3 3.5 3.6 5.3 9.5 2.3 6.6 3.6 2.3 5.7 18.4 2.8 2.5 0.8 5.5 3.9 1.2 5.1 4.8 3.0 6.7 0.0 3.3 3.5 9.6 7.8 4.2 11.3 4.1 5.0 2.8 5.3 6.3 8.6 13.2 2.2 3.3 2.2 8.3 2.8 5.6 0.0 4.6 0.3 2.3 0.2 0.1 0.0 0.4 0.3 0.4 2.0 0.4 0.4 0.0 1.4 0.3 0.4 0.0 1.1 0.2 0.5 0.6 0.2 4.7 6.8 13.8 7.3 6.3 5.6 4.7 5.1 5.0 6.1 3.7 4.4 6.5 18.0 22.4 24.1 132.9 46.6 9.6 9.3 8.1 13.1 45.1 23.0 14.1 23.2 24.3 18.2 44.1 43.8 8.8 27.7 31.9 5.9 16.0 5.3 18.1 23.5 18.4 15.6 7.2 219.4 17.9 7.1 14.0 26.5 24.6 10.8 36.7 32.9 10.1 11.1 37.0 201.6 14.6 10.2 15.5 8.2 7.7 19.3 11.8 1.8 107.7 17.7 65.7 41.2 268.9 158.2 35.9 14.1 31.2 20.8 12.4 46.7 11.3 12.7 49.4 6.6 19.7 15.3 22.3 26.6 24.4 20.0 7.7 14.4 10.5 13.9 16.1 TSPEAR "C21orf29, DFNB98, MGC11251, TSP-EAR" ENSG00000175894 "Thrombospondin type laminin G domain and EAR repeats" Q8WU66 21 44497893-44711572 "Disease related genes, Human disease related genes, Predicted secreted proteins" Hearing "Deafness, Disease variant, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 1.0;skin 1: 1.0;testis: 1.0" "Cell type enhanced" "Detected in some" "Astrocytes: 1.3;Early spermatids: 3.3;Excitatory neurons: 1.1;Oligodendrocytes: 1.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.7;U-2 OS: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory bulb: 1.0" "CAB034203, CAB034204, HPA052995" Uncertain "Secreted in other tissues" NA NA "CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008" "unprognostic (8.61e-3)" "unprognostic (2.45e-1)" "unprognostic (1.86e-4)" "unprognostic (7.87e-3)" "unprognostic (4.08e-2)" "unprognostic (1.00e-3)" "unprognostic (7.92e-3)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-2)" "unprognostic (3.86e-4)" "unprognostic (2.13e-2)" "unprognostic (4.80e-7)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 PLEKHF2 "FLJ13187, PHAFIN2, ZFYVE18" ENSG00000175895 "Pleckstrin homology and FYVE domain containing 2" Q9H8W4 8 95133785-95156685 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 85.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 102.6;U-698: 109.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024829 Uncertain NA NA "HPA024829: AB_10603127" "unprognostic (4.08e-2)" "unprognostic (2.98e-2)" "unprognostic (5.72e-2)" "unprognostic (2.06e-1)" "unprognostic (1.18e-3)" "unprognostic (9.67e-2)" "unprognostic (4.83e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-1)" "unprognostic (1.44e-1)" "unprognostic (3.16e-2)" "unprognostic (5.94e-2)" "prognostic favorable (1.49e-4)" "unprognostic (2.55e-2)" "unprognostic (1.32e-1)" "unprognostic (3.01e-1)" "unprognostic (4.61e-3)" 12.5 6.2 5.5 21.5 5.6 85.5 21.9 6.4 7.0 9.2 7.5 16.1 12.7 7.5 14.7 15.5 9.0 11.3 9.0 5.3 6.1 22.4 14.9 17.7 53.5 5.9 6.1 4.8 7.3 11.9 7.0 3.7 15.2 6.0 9.4 14.1 14.9 11.9 7.5 10.8 19.6 13.9 7.2 7.2 22.8 22.1 12.4 5.6 24.0 9.8 9.4 56.6 12.8 7.6 8.5 27.5 4.5 7.0 4.2 10.0 11.1 37.6 14.9 20.0 12.7 13.6 11.3 29.7 102.6 12.6 10.5 6.6 33.1 10.9 18.1 18.3 19.2 7.4 49.4 10.0 8.8 9.9 9.9 68.7 7.1 25.0 10.0 18.8 14.9 14.1 32.9 32.6 13.0 13.6 16.8 29.0 12.8 4.2 50.1 20.6 11.5 7.1 14.0 10.4 24.2 9.3 5.4 11.3 13.5 27.8 9.7 36.2 16.0 9.0 9.8 6.7 8.6 8.7 17.2 14.9 109.4 7.5 22.8 14.1 107.2 21.6 43.0 9.0 18.6 10.8 69.7 11.2 13.9 24.3 78.6 12.9 12.7 29.8 12.4 16.0 10.1 13.7 19.4 5.5 5.6 6.4 7.0 5.3 6.1 5.9 6.1 4.8 6.0 7.2 5.6 8.5 29.3 12.8 14.1 7.2 88.8 61.4 73.4 29.7 56.3 17.0 49.0 22.7 7.0 31.5 26.1 5.5 14.6 51.6 17.8 46.7 29.4 13.6 59.5 47.1 12.0 18.5 33.6 34.5 5.0 22.0 36.1 11.9 31.1 59.5 60.4 14.4 25.0 11.0 29.6 6.7 2.4 14.6 57.0 22.6 54.0 19.8 8.7 34.7 21.4 14.0 31.9 19.1 13.4 10.6 4.7 14.6 39.0 3.8 21.3 42.4 20.7 95.9 26.2 31.7 13.1 10.8 14.5 55.2 16.0 47.2 57.7 50.9 27.4 6.0 17.7 75.4 A2M "CPAMD5, FWP007, S863-7" ENSG00000175899 Alpha-2-macroglobulin P01023 12 9067664-9116229 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 1692.9" "Cell type enhanced" "Detected in many" "Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.5" "Lineage enhanced" "Detected in single" "T-cells: 1.5" "Group enriched" "Detected in some" 5 "AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002265, CAB017621" Supported "Secreted to blood" NA NA 1630000000000 170000000000 "CAB017621: AB_1118894, HPA002265: AB_1078142" "unprognostic (1.73e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (2.29e-2)" "unprognostic (7.36e-2)" "unprognostic (3.91e-2)" "unprognostic (7.95e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.19e-2)" "unprognostic (4.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (2.32e-2)" "unprognostic (8.58e-2)" "unprognostic (9.03e-3)" 455.6 184.0 166.1 151.1 145.4 5.6 297.8 154.8 225.4 204.0 166.7 259.4 142.5 309.0 246.3 220.4 230.4 456.3 315.6 138.6 180.6 308.6 1260.4 1692.9 99.0 187.2 149.9 113.5 102.5 92.3 155.0 136.4 448.9 178.4 296.4 319.4 131.0 132.9 228.8 149.2 63.1 184.3 524.4 171.7 242.7 173.1 59.4 178.5 54.4 204.4 288.1 59.7 855.2 161.6 210.6 0.3 0.0 772.0 0.0 223.5 16.2 2.0 93.1 25.5 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.4 10.1 649.8 0.0 0.8 0.8 36.9 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.2 0.0 0.0 0.2 2.0 3.3 0.0 0.1 1.8 0.9 0.8 0.0 0.3 0.3 0.7 1.8 0.0 230.1 3.2 0.0 0.3 0.3 0.1 6.7 1.5 0.5 0.7 0.3 0.7 0.2 0.5 15.4 0.0 0.1 0.0 1.5 0.0 0.8 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 166.1 145.4 154.8 225.4 138.6 180.6 187.2 149.9 113.5 178.4 171.7 178.5 210.6 1319.0 12.8 85.6 5.2 9.0 19.5 2.3 0.0 12.0 5.5 10.8 95.5 106.1 22.8 6.8 1.8 8.4 2.5 8.1 0.0 0.0 0.2 18.8 8.3 54.7 797.7 0.0 45.9 3.2 5.5 2.9 241.3 9.2 14.7 27.8 2.5 526.1 910.1 233.0 681.4 2.9 0.0 0.0 123.1 41.4 36.8 77.3 130.7 23.2 355.1 37.8 6.1 1.0 5.5 4.7 0.2 0.0 141.4 11.2 4.7 0.0 0.3 4.4 21.2 335.2 22.1 328.0 2.7 8.8 8.2 14.1 4.1 13.0 73.3 0.0 3.6 ARL4D ARF4L ENSG00000175906 "ADP ribosylation factor like GTPase 4D" P49703 17 43398993-43401137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 85.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 32.3;naive B-cell: 36.1" "Lineage enriched" "Detected in all" 4 "B-cells: 36.1" "Cell line enhanced" "Detected in many" "HHSteC: 57.1;hTCEpi: 76.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4" HPA060379 Uncertain Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA060379: AB_2684269" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (2.34e-2)" "prognostic favorable (1.16e-5)" "unprognostic (7.71e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.47e-1)" "unprognostic (4.59e-2)" "unprognostic (4.45e-1)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (7.87e-2)" "unprognostic (2.00e-3)" "unprognostic (3.49e-2)" "unprognostic (6.48e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (9.25e-4)" 14.0 4.4 6.9 2.3 8.3 0.9 7.3 8.5 11.9 29.6 12.0 20.6 2.0 20.4 4.7 82.8 22.3 7.3 10.7 8.3 7.2 30.7 56.8 16.3 1.6 6.4 6.4 7.8 9.8 2.2 8.1 21.8 7.8 6.8 11.1 3.5 85.8 17.0 15.3 2.0 42.2 6.1 14.9 5.3 16.8 7.7 32.4 6.4 1.7 38.7 3.4 3.0 28.8 39.8 9.3 8.7 10.9 6.7 5.2 12.5 17.2 3.1 21.0 21.5 14.6 18.8 9.7 37.7 0.1 10.3 22.6 10.0 23.4 4.5 32.0 10.0 1.9 7.5 0.7 8.7 22.5 57.1 2.4 2.1 19.2 76.1 21.3 45.8 13.2 6.3 2.3 1.4 0.4 14.3 0.5 5.4 5.0 7.1 0.8 10.1 9.1 1.5 1.0 24.9 18.8 7.9 5.6 16.5 0.4 15.8 14.4 30.6 8.5 1.3 21.0 6.7 27.2 6.4 2.1 1.1 0.0 25.8 1.9 7.1 0.1 2.8 2.1 5.1 4.3 3.2 32.3 4.2 4.7 8.4 36.1 4.6 5.2 0.0 2.1 1.4 2.5 1.0 4.6 6.9 8.3 8.5 11.9 8.3 7.2 6.4 6.4 7.8 6.8 5.3 6.4 9.3 28.8 0.0 1.7 0.7 37.9 224.3 41.4 142.2 132.1 155.5 35.3 60.6 12.7 5.7 49.5 132.4 116.7 39.9 37.4 1.5 76.3 2.3 220.8 55.5 33.3 32.2 11.9 4.0 9.1 1.8 24.1 52.3 5.6 69.6 0.0 20.7 22.9 29.7 8.1 16.8 9.3 5.4 26.4 4.1 77.9 55.3 15.8 16.6 26.6 1.0 1.4 70.1 2.1 2.5 1.3 3.7 0.9 22.6 1.4 9.5 0.3 17.6 7.6 259.6 13.1 11.1 45.1 25.0 9.2 223.4 254.6 105.5 31.7 19.3 4.6 78.1 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463306-3501473 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 38.8;skeletal muscle: 29.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9" "Group enriched" "Detected in many" 16 "B-cells: 3.4;NK-cells: 1.9" "Cell line enriched" "Detected in some" 4 "MCF7: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 0.1 0.9 1.3 0.2 3.3 0.2 0.4 7.4 3.0 1.4 9.0 0.2 0.1 1.0 1.7 0.3 5.9 0.3 38.8 1.4 1.1 2.7 1.2 1.6 0.7 3.5 2.0 0.2 0.3 5.9 0.1 15.8 0.0 4.8 1.8 0.1 0.0 1.9 1.0 29.8 1.1 1.4 0.0 0.4 1.9 2.7 4.8 2.3 0.0 0.7 8.8 0.4 1.2 0.6 3.0 2.7 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.6 0.0 1.2 0.0 0.1 1.3 0.0 4.4 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 36.2 0.0 1.4 0.3 1.6 0.1 0.0 6.7 0.3 2.3 3.0 0.6 0.1 3.0 0.0 0.0 0.0 8.3 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 2.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 1.3 3.3 7.4 3.0 1.4 1.1 3.5 2.0 0.2 4.8 0.4 2.3 3.0 0.1 0.0 1.5 1.3 5.3 0.0 3.9 3.7 0.0 0.3 0.7 0.9 17.1 0.0 3.0 5.5 0.0 0.0 0.4 0.5 0.0 2.3 5.8 2.6 0.7 0.1 6.0 2.7 0.4 4.4 0.0 1.4 4.1 2.8 0.0 3.0 0.0 0.1 0.1 0.0 0.9 3.0 2.0 0.0 0.0 9.9 0.9 0.1 0.0 0.0 0.1 0.0 3.1 1.0 0.0 1.8 0.0 0.0 0.0 2.0 0.1 0.3 1.8 0.5 0.0 1.0 0.3 0.2 0.4 0.0 0.0 0.0 0.4 0.1 0.4 1.2 LRRN1 FIGLER3 ENSG00000175928 "Leucine rich repeat neuronal 1" Q6UXK5 3 3799431-3849834 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Cell type enriched" "Detected in many" 6 "Oligodendrocyte precursor cells: 418.2" "Cancer enhanced" "Detected in many" "glioma: 20.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 106.6;CAPAN-2: 37.9;HAP1: 32.3;NTERA-2: 62.7;SuSa: 104.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011071 Enhanced NA NA 2400000 "HPA011071: AB_1853355" "unprognostic (1.27e-2)" "unprognostic (4.87e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-3)" "unprognostic (2.01e-2)" "unprognostic (3.02e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.34e-1)" "unprognostic (2.96e-1)" "unprognostic (2.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-3)" "unprognostic (1.86e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (7.25e-2)" 0.4 0.1 7.4 0.4 10.7 1.2 4.2 6.4 6.6 3.6 0.0 0.2 0.9 2.4 1.1 0.8 1.3 2.4 0.1 6.4 4.7 0.5 0.2 1.0 0.3 12.9 13.9 5.6 5.4 1.9 4.5 2.0 0.2 13.2 4.0 0.3 1.3 5.2 4.2 5.8 1.2 1.3 1.5 5.7 1.2 1.3 6.1 13.1 2.9 2.4 2.8 0.8 3.7 0.8 16.3 0.0 0.0 106.6 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 32.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 19.9 0.0 4.7 0.0 8.1 0.0 0.0 1.1 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 7.0 0.0 0.0 0.0 104.4 4.0 0.0 0.0 0.0 12.5 0.0 1.2 11.1 23.3 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.4 10.7 6.4 6.6 6.4 4.7 12.9 13.9 5.6 13.2 5.7 13.1 16.3 0.4 3.2 0.0 63.0 3.5 2.2 1.8 8.7 1.8 3.0 7.6 13.3 0.4 10.0 6.6 0.0 0.0 0.1 0.7 0.4 0.0 1.6 3.2 0.5 1.5 1.0 0.0 0.4 52.7 2.2 0.2 3.0 2.0 1.2 2.5 1.1 0.0 0.0 0.1 0.0 48.1 1.0 0.0 0.0 0.8 1.1 2.5 0.3 1.8 1.9 0.0 3.4 1.0 418.2 5.3 9.9 2.5 0.7 2.9 2.4 0.3 0.7 3.0 0.5 0.0 14.9 0.9 0.0 0.9 0.5 0.3 0.0 0.6 0.1 1.4 1.0 UBE2O E2-230K ENSG00000175931 "Ubiquitin conjugating enzyme E2 O" Q9C0C9 17 76389456-76453152 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.7;Inhibitory neurons: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023605 Uncertain Supported "Nucleoplasm,Nuclear bodies" No No 220000 "Nuclear bodies" Nucleoplasm "HPA023605: AB_2671257" "unprognostic (8.75e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (8.68e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (6.84e-8)" "unprognostic (3.54e-1)" "unprognostic (2.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.34e-9)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" 9.1 9.7 9.0 10.2 13.7 21.4 9.8 7.4 24.2 12.7 1.0 10.2 9.4 11.6 7.1 12.9 11.1 6.6 20.4 13.6 12.9 8.5 10.6 8.8 13.2 19.3 9.4 15.9 15.2 17.6 11.0 18.3 9.2 21.7 11.7 5.3 10.6 13.0 8.8 28.5 16.2 10.7 7.2 3.8 14.0 11.1 16.7 13.8 12.1 16.3 13.6 8.7 10.9 12.6 26.5 25.8 29.2 29.1 35.5 17.7 11.3 25.2 11.8 12.8 18.9 18.3 25.6 12.7 36.4 8.3 14.8 29.7 25.2 34.2 20.4 13.2 10.5 42.2 36.9 20.6 42.9 14.7 22.6 22.0 11.4 16.2 18.1 15.3 16.2 25.7 19.9 31.5 31.4 9.6 21.3 44.7 26.0 27.0 15.5 38.9 43.3 37.6 40.2 8.5 22.1 43.0 38.5 17.4 43.9 23.6 26.3 25.4 16.1 15.4 21.9 20.5 18.8 19.9 25.8 9.2 30.8 24.1 18.8 14.6 0.0 0.7 1.0 1.4 0.3 0.8 0.9 0.9 0.7 0.4 1.6 0.7 1.1 0.1 0.5 0.4 1.5 0.9 0.8 9.0 13.7 7.4 24.2 13.6 12.9 19.3 9.4 15.9 21.7 3.8 13.8 26.5 7.9 3.2 7.7 24.8 19.6 8.7 6.1 7.2 13.1 45.8 9.7 9.1 23.2 5.7 7.3 7.3 41.7 6.4 15.2 6.5 0.0 6.0 1.8 8.6 13.7 8.3 23.4 33.2 54.7 9.4 7.4 8.3 17.9 10.1 7.0 18.9 7.1 8.5 8.1 45.4 63.0 9.3 2.0 5.3 11.0 1.8 9.6 11.6 5.4 19.7 10.0 7.3 18.6 27.2 24.7 7.2 5.7 7.9 22.9 9.8 5.2 3.3 5.6 23.8 6.6 12.2 10.9 19.6 23.2 12.9 12.4 5.2 14.7 13.3 8.7 6.2 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949068-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 77.3;Hofbauer cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 94.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 17.1 34.4 16.9 8.3 15.5 17.8 15.3 16.4 17.2 24.3 23.9 19.3 9.3 18.4 16.4 15.5 19.4 10.0 15.2 14.4 17.4 19.3 70.8 14.3 12.0 17.9 17.1 13.2 19.1 17.8 19.0 18.1 15.0 16.2 26.5 8.7 4.0 14.7 17.2 7.9 14.2 16.3 9.9 17.6 22.7 17.2 15.8 20.3 11.3 16.6 8.2 10.7 27.4 20.4 18.4 2.8 15.8 8.1 10.7 68.1 60.7 0.6 9.3 62.3 6.8 17.2 1.5 26.1 3.9 20.7 17.9 27.5 12.7 1.4 17.6 4.6 12.3 5.2 10.2 4.9 16.1 94.9 11.2 30.5 65.5 45.9 13.1 25.5 63.8 11.7 2.2 11.7 20.6 22.1 10.8 0.7 42.6 6.6 9.1 4.3 8.6 6.3 30.8 26.2 6.8 2.0 13.5 8.4 2.6 14.9 19.5 19.7 45.5 8.5 5.1 3.5 11.4 2.2 50.4 4.0 3.1 25.3 26.4 7.9 23.2 8.7 26.6 3.4 9.2 3.6 7.1 1.8 2.7 8.5 6.7 2.2 2.9 15.3 11.7 12.6 9.5 2.7 3.3 16.9 15.5 16.4 17.2 14.4 17.4 17.9 17.1 13.2 16.2 17.6 20.3 18.4 12.1 6.4 10.8 0.0 23.9 7.9 24.5 25.6 32.5 1.5 11.1 19.6 6.9 5.7 11.6 16.5 2.1 28.1 25.9 11.1 13.7 21.4 61.1 16.5 21.8 16.5 15.0 16.2 0.0 11.4 2.7 25.9 4.1 10.5 7.0 17.9 23.6 77.3 93.8 35.3 0.0 11.3 10.2 43.7 11.5 36.7 53.1 31.4 21.4 0.0 39.1 24.4 17.5 0.0 0.0 9.5 18.4 43.2 18.1 14.0 9.5 48.2 14.7 3.6 26.3 11.0 14.0 26.5 2.5 17.0 4.5 4.4 9.7 61.0 5.8 20.4 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 57.2;skeletal muscle: 270.9;tongue: 77.6" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Group enriched" "Detected in some" 5 "breast cancer: 1.3;melanoma: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.5 0.2 0.1 0.7 0.1 1.3 0.0 2.5 0.7 0.7 57.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.5 0.1 1.3 0.0 1.5 0.2 0.8 0.1 0.0 0.7 0.1 270.9 0.2 0.2 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 77.6 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.9 0.0 0.5 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UNC119B "MGC5139, POC7B" ENSG00000175970 "Unc-119 lipid binding chaperone B" A6NIH7 12 120710458-120723640 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077812 Enhanced NA No "HPA077812: " "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.86e-3)" "unprognostic (6.71e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.26e-4)" "unprognostic (9.35e-2)" "prognostic favorable (6.69e-10)" "unprognostic (2.52e-2)" "unprognostic (7.73e-2)" "unprognostic (2.20e-1)" "unprognostic (5.42e-2)" 14.7 35.0 22.9 10.7 19.5 12.3 17.9 19.4 18.4 14.2 25.4 13.8 9.3 20.2 15.8 12.0 47.5 10.0 11.1 18.8 26.3 30.0 10.9 15.6 11.2 25.1 25.0 17.3 36.0 18.6 40.5 26.2 11.5 21.5 19.0 13.2 20.3 13.1 25.0 8.0 15.2 13.2 19.1 25.6 14.7 17.2 18.5 25.7 22.5 31.6 11.3 15.8 11.4 10.0 18.7 27.0 25.8 52.3 45.0 51.2 37.8 44.3 32.7 38.0 36.5 16.3 31.1 10.9 27.1 12.7 36.8 17.5 28.1 55.9 36.6 37.4 21.2 28.3 12.5 19.5 19.4 34.6 34.9 19.1 29.9 37.1 27.2 41.6 58.7 41.7 40.3 31.1 2.9 31.1 23.7 32.2 28.5 64.8 30.6 31.5 38.0 34.8 14.0 43.3 55.7 31.4 39.5 78.5 15.3 27.5 36.7 60.2 23.6 26.2 33.7 22.9 14.6 22.3 21.1 19.7 16.6 40.1 17.4 37.4 0.0 0.4 0.5 1.3 0.2 0.7 0.6 1.1 1.4 0.5 0.7 1.5 1.2 0.8 1.1 2.7 1.0 1.2 0.6 22.9 19.5 19.4 18.4 18.8 26.3 25.1 25.0 17.3 21.5 25.6 25.7 18.7 10.1 3.2 7.5 7.8 3.4 2.9 7.6 5.8 6.8 8.1 11.9 11.7 4.6 7.2 5.9 18.4 10.4 11.4 6.3 7.0 15.6 7.1 17.2 30.7 9.6 9.9 14.3 8.2 6.8 7.7 5.3 7.3 1.1 7.2 2.5 8.3 6.1 6.0 3.0 8.4 8.6 5.3 4.1 3.8 1.4 4.0 13.1 3.3 5.4 7.5 3.3 12.8 1.0 4.5 4.7 8.6 4.5 16.1 3.5 11.4 4.8 14.0 33.0 10.4 13.1 7.6 7.3 15.6 13.6 6.3 3.3 5.2 5.9 9.0 8.0 8.1 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.8;skeletal muscle: 42.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "basophil: 3.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "U-2197: 11.8;U-266/70: 25.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 0.9 0.5 0.8 0.3 0.8 1.0 1.9 0.9 0.9 2.4 1.9 0.6 0.7 1.6 0.8 17.8 0.9 1.2 1.1 1.1 0.5 0.6 2.0 1.5 0.4 0.7 0.6 0.6 1.1 1.2 1.7 0.6 0.1 0.7 1.4 0.6 1.6 2.7 1.4 42.0 12.5 0.6 1.1 0.3 0.4 0.9 5.5 0.6 0.4 1.4 1.7 3.4 2.6 7.1 0.8 2.1 0.0 0.1 1.4 1.7 1.8 0.4 0.6 1.1 0.7 1.1 0.3 0.0 0.1 0.9 4.1 1.4 7.4 1.4 4.6 0.7 0.1 1.8 1.2 0.4 0.1 0.5 0.0 1.8 1.8 4.4 2.7 2.3 0.1 0.2 0.5 0.2 0.3 2.4 6.0 0.2 0.1 0.9 0.0 1.1 0.0 6.2 0.1 0.1 5.7 0.0 0.0 4.5 0.1 0.5 1.1 0.9 0.3 0.3 1.0 1.5 11.8 0.2 25.4 4.8 0.0 1.0 0.0 0.8 3.0 0.0 0.9 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.8 0.8 0.9 0.9 1.1 0.5 0.7 0.6 0.6 0.7 0.3 0.6 0.8 6.6 28.9 2.2 3.3 3.3 109.1 138.2 32.5 60.3 20.4 5.2 5.3 8.7 11.5 21.3 7.3 20.9 0.1 1.9 1.1 0.0 7.2 29.5 100.3 15.7 8.6 0.0 0.0 2.8 7.5 0.1 6.9 5.6 192.7 2.5 8.1 15.4 11.7 0.3 0.0 0.8 0.9 4.1 2.2 9.3 12.9 5.0 14.0 7.2 9.4 1.1 2.3 1.0 5.0 3.5 33.0 0.2 2.2 17.6 79.5 0.1 0.8 46.8 10.3 0.0 21.7 6.6 47.9 59.7 114.9 171.8 0.0 3.7 1.3 1.5 340.4 PLEKHD1 UPF0639 ENSG00000175985 "Pleckstrin homology and coiled-coil domain containing D1" A6NEE1 14 69484692-69531551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0;parathyroid gland: 6.1;retina: 8.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 60.9;Horizontal cells: 230.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 3.7" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.7" "Cell line enhanced" "Detected in some" "OE19: 1.1;SK-BR-3: 2.4;T-47d: 2.3;U-266/70: 1.0" "Region enhanced" "Detected in many" "cerebellum: 30.0" "Low region specificity" "Detected in many" HPA051875 Uncertain NA NA "HPA051875: AB_2681648" "unprognostic (8.73e-2)" "unprognostic (4.64e-3)" "unprognostic (3.73e-2)" "unprognostic (4.03e-2)" "unprognostic (7.58e-2)" "unprognostic (3.15e-3)" "unprognostic (1.44e-1)" "unprognostic (1.64e-3)" "unprognostic (3.28e-1)" "unprognostic (1.83e-1)" "unprognostic (4.56e-3)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.42e-2)" 0.1 0.2 1.0 0.1 0.4 0.5 0.6 8.0 2.3 0.3 0.0 0.0 0.2 0.1 1.6 0.1 0.1 0.1 0.1 0.4 1.3 1.4 0.0 0.2 0.9 1.3 3.4 0.4 0.1 0.2 6.1 0.3 0.1 2.4 0.1 0.0 8.8 1.6 0.3 0.1 1.4 0.1 0.0 0.4 0.2 0.2 1.2 5.1 0.1 2.2 0.0 0.2 0.0 0.0 1.0 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.4 0.1 0.1 0.2 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.3 0.7 0.0 2.4 0.0 0.0 2.3 0.0 0.0 0.1 0.3 0.1 0.1 1.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 1.0 0.4 8.0 2.3 0.4 1.3 1.3 3.4 0.4 2.4 0.4 5.1 1.0 0.5 0.0 7.3 0.3 0.0 0.4 1.8 0.1 0.0 60.9 0.6 0.4 1.3 0.0 2.0 0.0 4.2 0.1 11.2 0.1 3.9 0.1 0.5 0.4 0.2 1.0 0.0 0.0 6.3 0.2 0.1 0.6 0.0 0.6 1.3 0.1 0.4 0.0 0.1 230.5 3.3 0.0 0.0 0.0 0.6 0.1 0.0 1.0 0.0 0.0 0.6 1.7 1.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.2 0.5 0.9 5.9 0.0 1.4 0.6 0.8 0.3 0.0 0.3 0.1 2.3 0.2 0.1 0.7 ASCL3 "bHLHa42, HASH3, Sgn1" ENSG00000176009 "Achaete-scute family bHLH transcription factor 3" Q9NQ33 11 8937579-8938211 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "salivary gland: 8.8" "Cell type enriched" "Detected in single" 923 "Ionocytes: 461.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027032 Uncertain NA NA "HPA027032: AB_10602434" "unprognostic (8.91e-2)" "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 8.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 461.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUBB6 "HsT1601, MGC4083" ENSG00000176014 "Tubulin beta 6 class V" Q9BUF5 18 12307669-12344320 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 157.3" "Group enriched" "Detected in many" 6 "B-cells: 58.7;dendritic cells: 157.3" "Cell line enhanced" "Detected in many" "TIME: 821.6" "Region enriched" "Detected in many" 6 "olfactory bulb: 19.9" "Region enhanced" "Detected in all" "spinal cord: 10.3" "HPA043640, HPA046280" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes 52000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.40e-2)" "unprognostic (8.28e-3)" "unprognostic (1.22e-2)" "unprognostic (5.20e-3)" "unprognostic (8.42e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-2)" "unprognostic (4.95e-2)" "unprognostic (4.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (5.83e-3)" "unprognostic (1.99e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (9.69e-4)" 187.4 38.3 12.0 82.8 11.1 35.1 135.7 13.9 14.7 94.4 28.4 152.5 31.7 174.9 25.1 219.3 122.3 67.0 161.1 11.2 17.1 49.5 41.1 93.7 31.8 18.5 16.4 9.3 81.9 53.2 5.6 33.3 60.2 15.8 84.9 29.1 3.6 70.2 92.2 37.7 78.8 76.4 153.3 13.2 34.3 89.9 28.5 17.6 12.3 52.6 20.4 31.6 131.0 125.2 12.8 211.8 142.3 149.5 76.1 149.0 208.8 108.1 648.5 424.2 492.0 459.1 113.0 65.2 1.3 281.7 440.8 148.6 99.5 84.7 653.6 380.6 1.8 46.1 32.3 159.2 73.6 151.0 2.7 59.5 219.1 146.0 429.4 222.7 148.8 366.1 12.5 159.7 2.5 432.5 216.1 0.8 162.4 79.1 3.3 70.0 1.6 260.0 2.2 99.7 5.8 19.3 27.2 360.3 34.8 113.9 153.7 76.5 203.8 821.6 600.0 510.6 565.7 574.2 11.5 3.8 3.8 458.9 46.9 219.8 2.0 19.4 0.3 0.6 7.6 0.3 42.0 0.1 0.2 25.5 58.7 0.2 0.3 0.4 0.9 7.5 157.3 0.2 13.2 12.0 11.1 13.9 14.7 11.2 17.1 18.5 16.4 9.3 15.8 13.2 17.6 12.8 67.0 83.3 7.9 0.7 16.1 69.6 42.7 151.4 16.5 1.2 30.4 44.8 54.3 8.6 37.4 7.3 0.0 53.8 23.6 0.6 1.9 167.6 190.2 6.4 76.9 128.9 0.0 12.2 0.8 104.9 494.3 112.8 1.5 7.1 45.6 7.4 82.5 0.4 69.4 0.0 0.6 0.4 42.7 13.2 85.2 114.9 70.2 36.5 33.8 12.2 65.9 0.2 0.0 0.5 0.4 221.1 0.1 91.4 1.0 51.5 0.1 1.2 18.2 1.6 26.3 89.2 130.5 4.3 6.3 55.7 66.9 22.2 3.6 9.5 0.5 65.2 LYSMD3 FLJ13542 ENSG00000176018 "LysM domain containing 3" Q7Z3D4 5 90515611-90529584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018024 Approved Approved Cytosol NA NA Cytosol "HPA018024: AB_2138525" "unprognostic (4.50e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.83e-4)" "unprognostic (5.59e-2)" "unprognostic (5.61e-2)" "unprognostic (9.80e-3)" "unprognostic (3.99e-2)" "unprognostic (4.66e-2)" "unprognostic (6.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (2.02e-1)" "prognostic favorable (9.25e-4)" "unprognostic (1.81e-1)" "unprognostic (8.48e-2)" "unprognostic (4.97e-3)" "unprognostic (9.46e-2)" 10.5 14.4 4.6 12.7 4.9 11.8 11.8 8.4 6.4 14.3 10.3 12.4 12.9 12.3 5.2 10.3 7.5 13.5 12.1 4.8 6.7 13.7 24.3 13.5 12.7 5.1 5.1 3.9 15.2 9.1 18.3 7.6 17.2 5.3 13.2 11.4 11.5 11.6 10.3 9.8 6.4 12.0 11.1 4.7 11.5 9.7 6.1 5.6 12.6 18.2 16.4 12.7 10.7 5.6 6.6 17.5 11.6 14.5 15.4 22.2 22.4 14.3 27.3 29.5 18.6 30.2 9.9 17.6 21.6 11.5 24.1 29.1 8.7 22.5 26.6 36.3 16.0 14.2 16.4 14.2 16.2 23.0 13.9 26.5 16.6 18.4 17.1 28.5 19.9 27.1 13.6 15.9 32.1 21.1 15.5 16.1 8.1 7.1 4.4 19.4 14.8 24.5 31.0 20.5 11.9 4.4 8.8 16.2 12.1 22.6 11.4 14.0 12.9 34.1 11.2 15.8 24.8 20.1 36.2 24.7 18.2 18.9 23.3 17.9 53.7 11.5 18.1 9.2 14.4 14.7 9.6 10.5 11.4 11.2 8.4 14.1 12.3 17.2 18.5 15.3 5.3 12.7 11.4 4.6 4.9 8.4 6.4 4.8 6.7 5.1 5.1 3.9 5.3 4.7 5.6 6.6 18.6 35.3 27.1 8.8 22.0 14.3 10.1 9.7 11.4 10.3 20.3 14.6 25.0 7.2 18.0 12.9 4.2 10.2 27.3 16.6 1.9 7.1 1.2 17.1 21.7 15.7 21.6 12.6 13.4 8.1 10.8 20.0 15.8 24.6 26.0 10.6 21.4 32.9 8.7 20.2 13.5 17.3 10.2 16.7 23.5 1.9 16.8 19.2 7.2 10.3 13.5 21.5 11.3 14.6 18.8 7.7 9.2 13.2 41.5 16.4 14.5 12.9 14.5 13.7 19.7 15.9 16.7 7.5 5.5 13.4 16.6 14.0 21.5 10.9 12.0 13.0 AMIGO3 ENSG00000176020 "Adhesion molecule with Ig like domain 3" Q86WK7 3 49716829-49719684 "Metabolic proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 1.3;Enteroendocrine cells: 1.2;Microglial cells: 1.0;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 11.0" "Lineage enriched" "Detected in many" 10 "dendritic cells: 11.0" "Cell line enhanced" "Detected in many" "CACO-2: 3.4;HeLa: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (5.33e-2)" "unprognostic (5.15e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-1)" "unprognostic (2.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.92e-3)" "unprognostic (3.75e-3)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (7.56e-2)" "unprognostic (7.85e-3)" "unprognostic (3.10e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-1)" "unprognostic (3.58e-3)" 0.6 0.8 0.5 0.2 0.4 1.5 0.5 1.3 0.9 0.6 0.1 0.4 0.4 0.7 0.5 1.0 0.9 0.2 0.9 0.4 0.6 0.6 1.9 0.9 0.5 1.0 0.3 0.2 1.0 1.6 0.0 3.2 0.1 0.8 1.1 0.0 0.1 0.9 0.4 3.5 2.9 0.8 0.0 0.1 1.1 1.0 1.7 0.3 0.3 0.9 0.0 0.1 0.5 0.7 0.9 0.4 0.4 0.3 0.6 1.9 0.2 1.3 0.3 0.0 0.2 0.1 3.4 0.5 0.0 0.4 0.7 0.1 1.8 0.0 0.2 0.0 1.9 1.0 0.0 4.2 2.2 0.0 1.0 2.7 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.6 0.6 0.0 1.7 1.6 1.7 0.4 0.5 0.5 0.4 0.6 0.4 0.0 1.9 1.5 2.5 1.0 0.2 0.5 0.0 0.2 0.5 1.1 0.3 1.8 1.2 0.3 2.2 1.4 0.5 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.9 0.1 0.1 0.3 0.6 0.0 1.0 0.0 11.0 0.5 0.3 0.5 0.4 1.3 0.9 0.4 0.6 1.0 0.3 0.2 0.8 0.1 0.3 0.9 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 B3GALT6 beta3GalT6 ENSG00000176022 "Beta-1,3-galactosyltransferase 6" Q96L58 1 1232237-1235041 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 14000 "unprognostic (9.76e-2)" "unprognostic (6.97e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-1)" "unprognostic (4.62e-2)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "unprognostic (1.37e-1)" "unprognostic (2.66e-1)" "unprognostic (3.08e-2)" "unprognostic (2.40e-2)" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-2)" 8.2 8.8 9.1 5.7 9.0 1.8 8.5 7.5 9.0 7.7 7.1 6.4 3.9 10.8 3.9 7.3 7.8 3.7 9.2 9.7 9.3 8.1 13.6 6.8 6.2 10.7 9.4 9.7 7.0 12.0 7.9 9.4 5.2 9.2 8.0 3.1 2.5 6.4 4.3 9.4 8.9 6.5 4.9 8.6 10.4 7.8 5.5 8.9 5.8 7.8 4.9 3.8 7.6 6.4 9.4 20.4 10.2 17.0 17.9 16.8 11.3 13.2 21.2 17.9 17.4 14.1 9.1 20.3 15.1 12.4 12.7 15.2 17.9 7.4 11.4 10.6 26.8 28.2 28.2 10.1 8.7 17.3 17.6 17.1 10.6 8.3 11.6 11.3 10.5 13.3 17.2 20.0 13.2 18.0 11.6 24.0 31.6 21.9 21.2 37.9 22.8 6.7 12.5 17.4 6.1 69.6 28.6 15.8 18.4 11.4 9.9 15.4 24.9 14.4 17.9 7.9 11.3 30.9 8.2 7.6 14.0 14.1 38.9 20.8 1.3 1.2 0.4 1.6 1.6 2.8 1.4 1.6 1.9 1.7 2.3 1.4 1.7 0.6 2.9 2.0 2.3 0.7 1.0 9.1 9.0 7.5 9.0 9.7 9.3 10.7 9.4 9.7 9.2 8.6 8.9 9.4 15.6 12.8 9.9 3.9 13.7 8.4 31.1 3.8 2.2 13.1 15.4 17.5 8.4 11.5 3.4 12.9 4.2 1.7 20.9 3.8 7.9 8.1 0.6 7.6 16.0 12.5 6.0 5.9 3.8 12.7 3.4 10.8 5.1 9.4 0.0 24.7 11.4 13.6 7.3 20.2 5.0 3.7 4.1 12.2 10.3 2.2 2.8 10.5 1.8 1.9 6.9 11.0 18.6 5.5 3.8 11.9 1.0 4.1 9.6 24.5 1.6 10.9 3.0 9.4 0.0 13.6 10.8 1.7 4.1 3.7 12.6 1.4 11.1 33.2 5.3 14.8 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 19.6" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "prostate cancer: 10.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 3.1 3.3 3.2 2.7 3.5 1.4 7.1 4.4 4.2 3.0 3.0 5.2 2.3 3.5 3.9 3.4 3.2 2.8 3.3 3.3 4.1 4.9 2.9 3.8 4.2 3.9 3.9 2.9 3.8 2.5 6.1 3.2 6.6 3.9 19.6 5.1 7.2 2.9 4.0 2.8 3.6 2.9 4.2 3.4 4.3 2.9 2.9 3.9 5.6 4.3 3.5 4.3 3.6 2.8 4.0 2.9 3.8 6.2 6.3 5.5 5.7 1.5 5.0 7.8 6.4 8.1 1.3 3.5 2.7 2.6 6.1 5.8 3.2 6.3 6.1 6.9 0.1 8.2 5.4 2.8 3.7 5.5 0.3 7.2 4.6 7.1 6.2 5.0 7.7 7.1 6.2 2.5 0.0 6.6 0.5 8.9 4.1 4.5 1.3 5.9 4.7 7.0 2.8 6.5 9.9 4.2 4.0 8.0 5.8 4.6 9.8 6.3 6.4 4.6 2.7 5.3 2.2 5.3 5.5 0.0 4.9 0.1 0.0 8.5 5.7 5.2 10.5 7.1 5.3 6.5 6.0 7.4 8.3 7.0 9.0 7.6 9.9 5.4 7.7 9.4 3.5 7.7 5.4 3.2 3.5 4.4 4.2 3.3 4.1 3.9 3.9 2.9 3.9 3.4 3.9 4.0 2.0 3.2 2.6 2.0 0.9 0.5 0.6 0.8 0.6 2.4 1.6 1.0 4.6 1.5 2.7 3.7 0.0 6.1 1.5 1.9 3.9 2.5 2.3 1.2 1.2 3.0 1.2 0.0 2.4 2.2 1.7 1.2 1.5 1.6 1.3 4.9 3.3 1.5 3.2 0.0 2.0 3.7 6.1 1.6 1.5 1.2 1.2 1.2 0.0 4.7 3.0 2.3 3.1 4.5 4.6 1.8 2.1 1.5 0.5 1.6 1.0 1.4 0.5 4.0 0.0 1.6 1.5 1.9 2.1 1.5 0.6 7.1 1.4 2.3 2.1 0.7 C11orf16 ENSG00000176029 "Chromosome 11 open reading frame 16" Q9NQ32 11 8920076-8933006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.0;fallopian tube: 13.0;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 40.8;Ionocytes: 28.5;Respiratory ciliated cells: 110.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA040644 Uncertain "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA040644: " "unprognostic (5.32e-3)" "unprognostic (1.03e-2)" "unprognostic (4.09e-3)" "prognostic favorable (3.32e-4)" "unprognostic (1.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.94e-5)" "unprognostic (6.40e-4)" "unprognostic (1.58e-2)" "unprognostic (9.99e-2)" "unprognostic (4.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.71e-1)" "unprognostic (1.13e-3)" 0.0 0.1 1.1 0.0 0.3 0.0 0.1 0.5 0.2 0.5 5.0 0.0 0.0 0.3 0.0 0.0 13.0 0.0 0.0 0.3 0.8 0.2 0.0 2.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 2.2 0.4 6.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.3 0.5 0.2 0.3 0.8 1.0 1.3 0.0 0.8 1.2 0.4 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.1 0.0 0.0 7.1 5.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 40.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 28.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 110.8 0.0 0.0 0.0 1.5 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TMPRSS7 ENSG00000176040 "Transmembrane serine protease 7" Q7RTY8 3 112034843-112081269 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 4.3;Early spermatids: 6.0;Excitatory neurons: 4.0;Respiratory ciliated cells: 8.1;Urothelial cells: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA040630 Uncertain NA NA "HPA040630: AB_10796124" "unprognostic (4.02e-2)" "unprognostic (9.87e-2)" "unprognostic (9.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.24e-1)" "unprognostic (4.64e-3)" "unprognostic (6.63e-2)" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.94e-1)" "unprognostic (7.23e-2)" "unprognostic (2.96e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.3 1.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.5 4.3 0.6 0.0 0.0 0.5 0.0 0.3 0.0 1.9 0.0 0.0 0.6 0.0 1.6 0.0 0.2 6.0 1.3 0.1 0.4 0.0 0.0 4.0 0.2 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.7 2.2 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.4 2.2 0.0 0.0 1.6 2.6 0.0 8.1 0.0 0.0 0.3 0.5 0.7 0.2 0.0 0.9 0.8 0.4 0.1 0.2 3.0 NUPR1 "COM1, p8" ENSG00000176046 "Nuclear protein 1, transcriptional regulator" O60356 16 28532708-28539008 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 1167.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 14.3" "Lineage enriched" "Detected in single" 16 "granulocytes: 14.3" "Cell line enhanced" "Detected in many" "HHSteC: 280.6;hTCEpi: 446.5;SK-MEL-30: 344.9;T-47d: 199.1;U-87 MG: 173.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006349 Supported "Nucleoplasm,Cytokinetic bridge" Yes NA Nucleoplasm "Cytokinetic bridge" "HPA006349: " "unprognostic (2.64e-2)" "unprognostic (2.77e-2)" "unprognostic (3.76e-2)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (7.72e-3)" "unprognostic (5.77e-3)" "unprognostic (3.61e-2)" "unprognostic (2.77e-1)" "unprognostic (1.04e-2)" "unprognostic (2.32e-2)" "unprognostic (3.27e-2)" "unprognostic (1.51e-1)" "unprognostic (6.14e-2)" "unprognostic (6.36e-3)" "unprognostic (2.80e-2)" 185.9 273.0 77.3 32.5 64.5 1.2 187.3 65.0 84.3 146.6 50.4 175.0 12.4 138.9 82.5 111.0 147.6 71.4 88.2 59.1 77.4 81.2 348.2 165.8 30.1 84.5 65.9 51.3 190.4 1167.1 26.6 39.8 54.9 80.5 205.9 60.5 9.1 257.4 125.4 88.6 203.9 71.9 64.0 70.9 36.1 131.7 68.4 79.3 23.5 357.5 17.4 14.0 179.5 153.7 104.3 1.4 10.5 0.0 73.3 108.0 94.7 58.6 66.5 57.3 2.3 54.6 0.2 0.2 0.2 37.2 101.2 8.8 1.9 0.4 2.1 2.3 0.4 3.7 0.1 6.2 52.1 280.6 0.3 0.5 90.2 446.5 31.2 148.5 76.8 0.4 0.1 0.1 3.5 34.0 13.7 0.3 1.4 0.4 0.2 38.7 0.2 0.2 3.1 0.0 6.9 0.6 0.5 19.6 78.5 344.9 1.5 199.1 12.0 0.2 21.3 51.7 55.2 10.5 0.5 0.6 0.6 173.1 0.3 2.6 14.3 0.4 3.6 0.3 0.3 0.3 0.3 0.3 0.2 0.1 0.5 0.3 0.3 2.4 0.8 0.4 0.6 0.2 0.1 77.3 64.5 65.0 84.3 59.1 77.4 84.5 65.9 51.3 80.5 70.9 79.3 104.3 179.9 288.4 336.2 11.1 9.7 316.9 318.4 1162.8 253.8 3.5 379.6 348.1 146.1 121.5 639.3 323.7 2.1 142.3 5.2 276.3 21.5 242.0 14.8 186.4 291.8 165.4 61.1 53.5 0.2 567.2 73.6 407.5 58.6 597.3 20.3 198.3 262.3 734.9 296.8 1.7 0.5 464.9 225.9 45.2 115.2 61.0 528.8 100.6 154.7 3.7 6.3 200.2 1.0 0.5 4.7 222.5 71.1 704.5 7.7 374.2 0.9 272.6 514.1 5.3 203.8 129.5 368.3 9.8 4.9 211.2 531.8 707.8 20.0 66.3 376.1 483.8 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585438-147782775 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Group enriched" "Detected in many" 6 "Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0" "Group enriched" "Detected in many" 6 "NK-cells: 7.0;T-cells: 7.3" "Cell line enhanced" "Detected in many" "AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA046929: AB_2679867, HPA065023: AB_2685407" "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.2 3.3 12.2 1.0 12.6 0.5 0.1 26.0 13.8 0.5 1.2 1.4 0.4 1.0 0.3 1.3 0.1 1.4 0.3 12.7 12.3 0.3 2.6 2.1 0.9 12.5 12.9 10.9 0.1 0.8 1.0 8.4 0.1 15.0 0.6 0.5 5.4 0.2 0.4 0.0 0.2 0.6 1.5 11.1 0.8 1.8 2.9 13.0 7.1 0.1 1.6 0.9 0.7 0.2 17.5 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.1 0.0 0.0 4.8 0.1 0.0 0.0 0.0 3.1 6.9 2.0 0.0 0.0 0.3 0.0 5.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 47.5 0.0 0.1 5.1 0.0 11.4 0.1 0.1 2.0 47.8 16.0 0.0 0.1 22.4 15.4 0.0 0.3 0.1 2.5 0.0 0.0 0.0 3.5 4.0 0.0 1.1 3.3 2.0 4.6 8.9 0.0 0.0 0.0 0.0 0.4 7.3 0.0 5.3 0.7 2.8 5.5 0.1 0.3 0.7 4.6 0.5 7.0 0.2 1.1 1.3 1.5 12.2 12.6 26.0 13.8 12.7 12.3 12.5 12.9 10.9 15.0 11.1 13.0 17.5 0.2 0.0 1.5 195.5 1.5 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.7 0.0 1.3 0.0 2.1 0.0 13.3 0.0 0.0 0.8 11.3 0.2 0.5 0.3 1.2 3.0 250.7 0.0 0.0 1.2 0.5 0.1 29.1 10.3 0.7 3.1 1.3 85.8 229.4 0.8 0.0 0.9 0.0 8.4 0.0 4.2 0.0 11.2 0.4 24.4 23.7 159.3 198.5 0.2 0.0 0.0 3.1 0.0 0.1 0.1 1.5 7.9 0.0 0.4 0.7 7.8 2.0 0.1 0.1 0.3 13.8 18.9 0.0 0.3 MBLAC2 "DKFZp686P15118, MGC46734" ENSG00000176055 "Metallo-beta-lactamase domain containing 2" Q68D91 5 90458209-90474771 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037757, HPA037758" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037757: AB_10670528, HPA037758: " "unprognostic (6.32e-2)" "unprognostic (2.48e-1)" "unprognostic (9.22e-3)" "unprognostic (1.21e-2)" "unprognostic (9.27e-2)" "unprognostic (1.96e-3)" "unprognostic (9.98e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.00e-3)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (3.34e-1)" "unprognostic (6.31e-2)" "unprognostic (1.63e-2)" 2.6 3.9 4.2 3.3 5.1 1.5 5.2 5.4 5.5 4.4 1.8 3.1 3.3 5.1 3.4 3.8 3.9 2.4 2.9 5.2 5.0 5.0 6.3 2.3 4.2 4.1 4.1 5.0 8.7 3.2 8.1 2.4 2.9 4.2 4.5 3.2 3.5 4.6 3.9 2.3 5.3 3.0 3.7 3.1 3.8 2.6 3.1 6.2 4.4 5.3 2.2 4.0 2.5 2.9 4.9 6.4 2.7 4.6 5.9 6.0 8.0 5.6 5.0 4.5 4.2 4.4 2.1 4.7 14.9 2.9 4.4 5.8 6.4 6.0 7.5 6.6 8.5 4.1 6.7 4.6 4.8 6.3 6.7 2.8 7.0 9.9 3.0 11.6 4.9 5.4 7.9 10.2 8.0 7.2 3.9 6.5 9.1 3.0 1.3 13.1 6.9 7.7 20.5 6.3 2.3 7.9 9.3 4.5 6.5 12.1 2.7 5.4 4.9 6.7 5.2 3.6 6.4 6.5 5.6 6.8 6.5 4.5 13.8 7.2 0.0 0.7 0.5 1.4 1.8 1.6 1.3 1.5 1.5 1.3 2.4 2.0 1.6 0.0 1.6 0.9 0.4 0.6 1.1 4.2 5.1 5.4 5.5 5.2 5.0 4.1 4.1 5.0 4.2 3.1 6.2 4.9 3.8 3.2 3.6 2.9 4.7 2.7 1.2 2.8 8.6 8.1 4.6 5.0 4.9 2.8 1.7 1.8 8.4 3.9 3.9 1.9 1.9 1.6 0.3 2.0 5.0 4.2 4.2 6.3 14.4 1.3 3.1 3.5 3.1 2.0 0.0 5.3 3.6 5.8 2.6 3.3 16.4 2.9 4.1 5.1 1.0 0.6 4.1 2.1 1.8 6.5 2.1 5.5 3.1 8.5 15.6 1.8 1.8 5.3 2.1 1.2 3.0 5.5 2.4 6.7 0.0 4.3 4.9 2.5 6.1 7.3 3.3 0.8 3.7 12.6 3.9 0.7 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.5;pancreas: 92.2" "Cell type enhanced" "Detected in all" "Distal enterocytes: 177.7;Proximal enterocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 61.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 23.6" "HPA020899, HPA076667" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favorable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.5 5.1 23.0 4.4 34.2 2.7 4.8 29.0 28.4 5.1 13.7 17.4 22.2 4.7 0.9 20.6 5.1 3.2 7.3 22.1 24.5 19.1 24.5 8.2 2.4 31.8 32.2 19.8 6.4 92.2 2.5 6.0 3.4 39.7 8.0 7.0 1.7 11.9 3.4 6.2 15.0 26.2 1.5 22.1 5.0 29.6 9.3 30.6 2.0 5.6 3.1 1.5 7.8 7.0 55.5 10.2 11.4 3.8 17.0 5.2 5.5 30.1 7.0 4.3 7.0 3.9 38.5 12.1 18.6 10.1 3.6 9.2 30.4 7.9 3.9 0.9 11.9 11.1 8.7 17.5 25.5 7.9 13.5 10.8 4.7 7.5 6.2 4.3 4.6 4.5 8.2 16.1 6.4 2.1 61.9 8.9 29.0 13.5 55.5 14.8 26.3 9.1 28.4 15.9 21.0 24.4 8.9 10.8 49.6 13.0 2.9 57.8 21.0 5.0 12.7 6.0 20.1 15.1 5.3 11.0 9.7 9.1 12.1 7.2 0.0 0.8 0.0 0.3 0.8 0.1 0.3 0.3 0.5 0.6 0.3 0.1 0.3 0.0 0.8 0.4 0.6 0.6 0.2 23.0 34.2 29.0 28.4 22.1 24.5 31.8 32.2 19.8 39.7 22.1 30.6 55.5 4.6 19.2 5.5 6.2 3.5 1.8 1.3 2.6 2.2 19.3 13.2 9.5 7.6 15.7 2.6 16.5 6.2 5.4 8.4 177.7 7.9 8.0 3.1 7.6 4.1 2.9 9.0 7.4 3.3 45.4 1.3 3.0 15.3 9.6 1.3 8.7 3.9 19.5 3.6 11.8 3.8 46.0 6.1 2.8 1.6 5.3 3.4 5.2 5.4 1.0 2.8 12.4 1.0 2.5 30.4 15.3 39.7 4.5 1.9 3.3 95.9 20.0 2.3 7.3 6.6 3.2 4.5 2.7 4.4 5.8 2.8 1.9 4.5 10.3 36.7 1.7 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;skeletal muscle: 4.0;tongue: 4.9" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;hTEC/SVTERT24-B: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 1.1 0.8 4.1 0.1 4.7 1.6 0.5 9.1 2.9 0.2 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.6 2.4 5.1 0.5 0.2 0.4 0.0 7.1 9.5 1.1 0.5 0.1 0.0 0.3 0.2 5.9 0.3 0.0 0.2 0.2 0.3 4.0 0.1 0.1 0.1 3.7 0.9 0.1 0.3 7.9 2.3 0.1 4.9 0.0 0.3 0.2 11.8 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.8 0.3 0.0 0.1 1.0 1.1 0.7 0.0 0.0 1.5 0.2 0.5 2.0 0.5 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.4 0.5 0.0 0.9 0.4 0.7 0.3 0.3 0.9 0.2 0.2 0.1 0.4 0.4 0.1 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 4.1 4.7 9.1 2.9 2.4 5.1 7.1 9.5 1.1 5.9 3.7 7.9 11.8 0.1 0.0 1.1 4.6 0.1 0.0 0.0 0.0 1.2 0.0 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.3 0.0 0.5 0.1 0.2 0.0 3.8 0.1 0.4 1.2 1.4 0.0 0.5 1.3 0.7 1.1 0.0 0.6 0.0 0.1 0.0 0.0 2.0 0.0 0.0 1.2 2.1 0.0 1.0 9.4 5.3 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.4 0.0 0.0 0.1 0.0 0.8 0.2 0.1 0.0 0.1 ZNF683 "Hobit, MGC33414" ENSG00000176083 "Zinc finger protein 683" Q8IZ20 1 26361634-26374522 "Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 82.5" "Group enriched" "Detected in some" 12 "Early spermatids: 473.7;Late spermatids: 482.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "gdT-cell: 172.4;memory CD8 T-cell: 113.1" "Lineage enriched" "Detected in many" 15 "T-cells: 172.4" "Group enriched" "Detected in some" 8 "NB-4: 2.2;OE19: 4.8" "Not detected" "Not detected" HPA023865 Uncertain NA NA "HPA023865: AB_2671333" "unprognostic (3.95e-3)" "unprognostic (5.58e-3)" "unprognostic (5.83e-2)" "prognostic favorable (2.90e-5)" "unprognostic (9.17e-2)" "unprognostic (8.98e-4)" "unprognostic (7.90e-2)" "unprognostic (5.05e-3)" "unprognostic (5.81e-3)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.30e-2)" "unprognostic (3.54e-8)" "unprognostic (5.90e-3)" "unprognostic (1.63e-1)" "unprognostic (1.14e-2)" "prognostic favorable (3.45e-5)" 0.2 0.4 0.2 0.6 0.6 1.9 0.8 0.3 0.4 0.9 0.3 0.3 0.3 0.6 0.1 0.7 1.7 1.8 0.8 0.8 0.9 0.3 0.6 4.8 1.9 1.0 0.4 0.2 1.0 0.4 0.2 0.3 0.4 0.5 0.9 0.5 0.0 10.2 0.8 0.1 0.5 0.6 0.3 0.5 2.2 3.4 82.5 0.6 2.9 1.1 0.0 0.4 0.9 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.2 0.1 172.4 0.1 0.4 0.2 35.4 113.1 0.0 0.0 13.4 63.2 0.9 11.8 3.8 0.3 1.1 24.2 0.2 0.6 0.3 0.4 0.8 0.9 1.0 0.4 0.2 0.5 0.5 0.6 0.9 0.9 3.2 0.6 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 473.7 0.2 0.5 0.8 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 482.4 1.8 1.8 0.0 0.0 0.3 0.0 6.2 0.0 0.1 0.0 0.0 1.2 1.7 0.1 0.0 0.2 0.7 0.0 0.0 0.4 0.7 3.3 2.2 0.2 0.0 0.0 39.8 0.0 0.0 0.0 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564446-140569100 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 45.4 62.6 32.9 40.1 34.7 23.4 42.5 37.1 35.8 37.1 28.5 52.1 46.0 38.3 31.6 69.7 39.7 34.2 62.4 29.8 34.4 58.8 54.3 46.7 42.3 37.5 37.1 27.6 33.0 44.7 59.9 24.3 33.4 39.0 41.4 48.0 19.7 66.6 33.9 139.7 61.8 44.4 36.4 35.1 47.9 46.8 45.5 36.1 44.7 45.0 94.9 44.8 42.6 41.9 33.3 43.9 134.2 57.5 124.6 77.5 43.0 92.4 60.8 45.5 84.3 91.3 186.2 57.0 115.7 80.0 65.7 105.2 55.2 0.0 107.7 59.3 155.0 96.7 91.3 109.1 1.3 74.7 91.7 83.7 65.5 92.6 83.3 71.0 38.2 74.2 73.0 83.6 136.4 80.5 98.3 110.5 62.7 43.5 74.2 92.1 82.5 93.5 129.2 69.1 79.5 66.6 91.1 79.8 157.1 84.0 50.4 131.4 52.7 69.3 78.2 52.9 70.0 78.7 57.8 127.8 53.9 54.0 127.6 91.9 16.6 65.0 37.0 56.5 83.1 54.4 29.9 45.5 52.1 75.5 32.7 53.5 49.3 24.5 63.4 79.4 28.3 33.7 83.4 32.9 34.7 37.1 35.8 29.8 34.4 37.5 37.1 27.6 39.0 35.1 36.1 33.3 13.0 12.8 22.4 4.9 17.0 10.5 23.2 20.3 15.4 13.7 21.1 15.4 30.0 32.9 21.8 16.5 4.2 32.1 13.2 56.4 45.0 33.3 71.3 9.4 11.8 18.1 25.2 19.0 3.3 35.1 50.2 16.2 24.5 15.5 21.0 14.3 25.4 25.0 32.9 13.5 3.5 27.9 20.3 24.2 13.3 127.2 12.5 18.9 17.8 5.6 27.6 28.6 44.3 3.5 5.7 39.5 26.4 12.4 15.7 22.1 33.5 39.9 10.5 10.3 32.9 11.8 15.0 9.7 17.5 20.4 11.6 30.5 17.6 18.1 38.5 28.8 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 48.6;skin 1: 19.1;vagina: 20.7" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 48.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 11.4;BEWO: 23.2;CACO-2: 39.3;CAPAN-2: 25.7;HaCaT: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 4.9 0.0 2.7 6.6 0.0 0.9 48.6 0.3 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 6.0 0.0 0.4 1.9 0.0 6.2 0.0 0.0 19.1 5.9 0.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 4.2 8.5 20.7 0.0 11.4 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.1 0.1 39.3 25.7 0.3 7.7 0.0 0.1 9.7 0.1 6.9 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.0 0.0 8.6 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 1.9 6.3 0.0 0.0 0.0 0.2 0.4 2.5 0.4 0.0 0.0 4.5 0.0 1.7 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 1.8 0.0 6.7 0.9 0.0 1.9 2.1 0.0 2.4 0.1 0.1 0.0 0.0 0.0 1.4 4.4 0.1 0.0 2.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 48.6 1.2 0.0 0.0 0.0 IP6K1 "IHPK1, KIAA0263" ENSG00000176095 "Inositol hexakisphosphate kinase 1" Q92551 3 49724294-49786542 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040825 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040825: AB_10960426" "unprognostic (6.18e-2)" "unprognostic (1.33e-1)" "unprognostic (3.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.08e-4)" "unprognostic (9.97e-3)" "unprognostic (8.45e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic favorable (6.85e-4)" "unprognostic (1.29e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.75e-2)" "unprognostic (1.67e-1)" "unprognostic (9.24e-2)" "unprognostic (1.64e-2)" 17.0 20.4 29.0 12.2 34.0 12.6 17.4 27.8 32.9 20.1 17.2 21.6 12.2 25.8 12.3 20.2 19.6 13.1 14.5 34.0 30.3 19.9 14.8 17.7 13.4 26.4 29.2 33.1 25.7 20.0 23.0 21.7 16.5 28.3 18.3 11.4 18.4 17.5 17.4 12.7 21.7 17.9 17.1 23.6 22.1 18.7 32.5 29.8 17.4 16.3 11.5 13.3 19.2 16.2 30.9 20.6 24.5 27.9 33.1 28.6 21.8 22.5 26.6 27.8 42.7 37.3 31.9 20.9 17.3 16.8 29.7 28.8 14.9 39.8 24.2 24.0 35.6 30.6 40.5 36.1 21.8 31.4 25.0 26.7 25.6 29.4 46.4 27.8 24.0 36.1 20.3 26.7 20.3 21.4 18.2 30.6 25.6 30.2 16.1 37.6 19.1 19.8 35.7 27.7 30.8 15.0 29.8 33.4 21.8 30.6 16.0 17.6 36.2 32.8 23.9 23.6 33.1 31.0 24.3 35.6 18.8 21.9 28.4 24.9 4.7 7.3 12.1 11.7 5.4 11.4 6.0 10.4 12.8 5.6 8.4 12.6 12.7 33.3 10.3 7.0 4.1 11.8 9.5 29.0 34.0 27.8 32.9 34.0 30.3 26.4 29.2 33.1 28.3 23.6 29.8 30.9 17.1 25.6 12.3 24.5 25.0 15.6 14.7 7.4 11.4 38.4 19.7 15.0 8.8 18.6 10.1 12.9 89.6 19.2 27.6 22.0 5.9 14.5 88.2 24.9 19.9 19.0 27.6 24.2 42.3 13.0 16.1 14.7 14.8 17.3 19.7 19.6 19.6 12.2 12.8 30.3 46.6 14.1 10.2 15.0 14.2 23.7 21.1 17.8 19.6 31.9 15.9 19.6 35.0 43.7 39.8 19.2 8.8 16.6 28.9 19.6 14.6 12.5 21.8 78.3 19.7 16.2 18.3 24.6 21.9 13.7 18.8 27.5 27.6 30.5 12.8 20.4 SSNA1 "N14, NA14" ENSG00000176101 "SS nuclear autoantigen 1" O43805 9 137188660-137190370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.70e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-2)" "prognostic favorable (8.94e-4)" "unprognostic (1.73e-1)" "unprognostic (4.44e-1)" "unprognostic (1.12e-3)" "unprognostic (2.15e-1)" "unprognostic (2.10e-2)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (9.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.68e-2)" "unprognostic (1.67e-2)" "unprognostic (7.72e-2)" "unprognostic (1.66e-1)" 44.4 48.6 59.1 42.0 61.7 62.2 45.7 60.5 89.7 39.0 56.8 50.9 42.4 39.9 18.6 78.2 39.2 24.7 65.9 58.2 60.3 60.7 67.0 39.0 55.1 62.6 61.5 57.2 30.5 76.5 30.5 28.1 29.3 61.1 49.0 19.4 10.2 62.0 28.1 79.4 61.1 46.3 26.2 59.3 52.6 68.9 125.8 61.7 49.0 37.7 42.3 35.2 49.2 44.2 66.8 79.1 167.4 54.9 86.6 52.0 45.8 56.8 71.8 63.9 96.9 53.5 82.6 108.2 77.0 89.3 60.8 84.2 128.2 65.6 99.2 14.7 140.7 44.9 62.7 128.8 89.0 70.8 104.6 64.5 46.2 86.2 64.5 56.3 45.7 87.8 112.5 69.4 141.9 66.7 225.2 138.8 107.0 86.5 167.7 73.6 91.6 75.2 223.0 83.1 67.5 96.7 54.8 56.9 156.0 82.3 21.3 167.2 122.3 63.8 94.3 53.5 141.6 98.2 34.9 140.3 76.7 103.6 103.3 79.0 117.4 96.7 161.1 99.6 143.8 90.3 118.0 91.6 100.9 90.6 117.9 84.0 85.1 85.0 107.7 136.9 146.1 140.6 93.7 59.1 61.7 60.5 89.7 58.2 60.3 62.6 61.5 57.2 61.1 59.3 61.7 66.8 72.4 41.7 44.2 7.5 83.7 63.7 58.0 78.3 63.2 39.1 96.1 115.6 49.9 94.4 59.4 62.5 16.7 150.7 109.9 200.5 113.5 144.6 76.3 80.3 54.4 64.8 77.7 97.4 14.2 233.1 170.5 51.5 65.2 75.0 57.2 57.8 49.6 84.0 156.3 40.4 13.6 131.0 71.2 78.0 82.8 56.6 60.3 82.6 119.2 7.5 186.1 86.7 107.1 8.0 39.7 207.0 166.2 50.8 83.4 88.6 210.2 194.3 52.7 40.3 32.9 27.8 67.1 320.6 114.2 113.5 84.0 111.1 89.9 67.0 130.2 72.7 CSTF3 CstF-77 ENSG00000176102 "Cleavage stimulation factor subunit 3" Q12996 11 33077188-33162371 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039743, HPA040168" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039743: AB_10795682, HPA040168: AB_10794025" "unprognostic (2.38e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.63e-4)" "unprognostic (3.77e-1)" "unprognostic (4.04e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (8.20e-6)" "unprognostic (1.47e-1)" "unprognostic (1.67e-2)" "unprognostic (6.42e-3)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.64e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-3)" 13.8 21.4 33.6 21.0 35.3 12.8 19.7 39.0 37.5 23.3 33.9 20.0 19.3 20.0 61.6 26.9 21.4 15.1 16.4 34.7 36.3 24.9 34.9 21.5 26.8 30.8 32.1 33.1 26.1 21.2 18.4 58.0 19.3 33.4 30.7 20.2 32.2 20.8 15.2 17.0 26.3 20.4 13.8 29.8 25.7 18.7 33.1 34.4 24.0 30.0 11.9 21.7 22.2 24.9 37.4 45.8 43.3 82.8 56.4 22.0 38.7 59.8 44.2 28.5 48.5 66.2 31.7 34.9 49.3 31.2 28.5 32.4 58.5 73.8 42.9 77.5 52.7 128.3 50.6 109.1 58.2 24.9 66.5 30.9 28.2 30.6 37.6 36.7 39.1 64.4 39.2 67.9 34.2 66.4 32.3 66.8 35.7 40.3 34.6 54.0 52.2 80.5 39.7 54.6 58.2 61.4 34.9 50.9 29.9 37.6 52.7 54.4 44.1 39.5 40.3 49.7 64.5 59.7 32.3 46.8 41.9 47.4 68.9 40.2 4.6 4.8 7.0 5.8 6.9 6.8 6.5 7.2 5.8 7.7 5.0 7.5 7.9 1.9 6.9 8.3 5.7 9.1 3.7 33.6 35.3 39.0 37.5 34.7 36.3 30.8 32.1 33.1 33.4 29.8 34.4 37.4 12.8 19.2 18.7 38.5 19.0 18.9 50.6 50.1 10.2 33.3 22.3 19.9 21.8 17.2 43.5 58.8 6.2 63.0 12.7 15.1 62.6 24.3 37.6 31.4 20.7 21.2 31.8 34.9 75.2 16.9 32.0 23.1 15.3 18.9 14.5 29.0 11.0 57.3 28.4 13.5 59.1 30.0 77.3 22.0 21.1 10.3 29.8 17.0 28.4 42.2 28.1 35.7 14.4 62.4 56.9 20.8 18.6 29.7 14.0 33.0 20.6 47.0 68.0 25.2 26.3 26.1 25.4 77.3 57.6 19.1 19.5 33.8 18.3 25.3 29.6 55.6 YES1 "c-yes, HsT441, Yes" ENSG00000176105 "YES proto-oncogene 1, Src family tyrosine kinase" P07947 18 721588-812546 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "basophil: 20.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 20.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004370, HPA026480" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004370: AB_627370, HPA026480: AB_1858921" "unprognostic (3.28e-1)" "unprognostic (1.62e-2)" "unprognostic (5.87e-2)" "unprognostic (2.47e-2)" "unprognostic (6.24e-2)" "unprognostic (4.24e-2)" "unprognostic (6.01e-2)" "unprognostic (1.03e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.14e-1)" "unprognostic (8.12e-2)" "unprognostic (4.65e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (4.11e-1)" 25.4 13.6 12.6 10.6 13.2 4.2 22.0 13.6 14.4 17.6 12.8 22.0 25.0 16.2 18.0 22.9 14.0 19.0 13.2 12.4 13.9 28.2 51.1 17.4 6.3 14.7 13.3 10.0 12.6 26.7 20.1 6.2 42.0 13.9 15.1 22.9 8.4 21.1 12.0 8.3 16.9 23.9 16.0 14.5 27.6 21.5 19.1 14.5 10.6 22.2 14.7 8.9 20.5 11.6 14.9 42.7 20.8 64.3 50.6 37.8 46.5 75.6 27.9 56.2 32.0 43.7 49.9 30.7 0.1 28.8 47.3 41.0 24.3 60.8 49.1 62.3 0.2 20.7 12.6 19.4 35.1 30.6 9.9 21.7 35.7 51.7 48.5 53.6 39.8 109.8 7.0 56.1 18.4 46.1 29.3 6.0 13.0 40.9 26.0 26.4 7.4 50.6 3.6 46.8 49.6 13.1 15.3 57.5 42.9 37.1 42.3 29.7 20.5 95.6 78.4 86.2 59.9 75.8 15.7 8.3 2.6 29.7 13.8 47.6 20.2 0.0 1.0 2.2 0.0 1.5 0.1 0.4 1.2 0.0 0.0 1.0 1.7 0.0 1.1 0.0 0.0 0.1 0.6 12.6 13.2 13.6 14.4 12.4 13.9 14.7 13.3 10.0 13.9 14.5 14.5 14.9 120.3 25.6 36.8 18.9 3.3 60.2 46.8 21.4 50.1 6.0 38.1 26.7 18.2 24.3 31.3 29.5 6.2 37.1 52.9 40.3 3.9 29.6 29.4 32.8 35.0 91.0 22.8 12.0 0.4 39.2 26.6 35.4 57.6 43.6 13.9 35.9 39.7 44.9 4.9 3.3 10.3 37.2 14.2 5.4 14.7 11.7 18.3 5.0 24.9 46.9 2.0 16.8 16.5 31.7 30.2 51.0 28.8 12.8 28.9 65.4 33.1 45.6 29.0 8.6 19.7 35.9 23.8 20.3 13.6 53.1 49.7 45.6 27.5 42.4 36.7 66.6 CHMP6 "FLJ11749, VPS20" ENSG00000176108 "Charged multivesicular body protein 6" Q96FZ7 17 80991598-81009517 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023001, HPA024460" Approved NA NA 17000 "HPA023001: AB_1848689, HPA024460: AB_1848691" "unprognostic (6.05e-3)" "unprognostic (2.25e-2)" "unprognostic (7.21e-3)" "unprognostic (2.26e-1)" "unprognostic (3.54e-2)" "unprognostic (3.41e-1)" "unprognostic (5.96e-2)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.99e-4)" "unprognostic (5.67e-2)" "unprognostic (3.74e-2)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-2)" "unprognostic (2.40e-3)" 17.8 18.3 14.6 13.6 12.8 9.0 19.4 12.7 13.9 20.8 10.3 20.3 13.3 20.0 9.6 24.9 16.4 8.9 21.8 12.7 10.6 21.6 35.7 18.0 14.2 14.2 12.4 12.0 15.8 19.4 19.2 16.3 13.7 14.6 20.1 15.7 18.7 17.3 12.7 45.5 21.8 19.0 17.3 12.4 25.8 17.7 10.6 12.4 17.3 18.4 29.5 14.8 18.9 18.2 16.2 27.6 43.5 32.1 19.5 16.8 17.2 22.2 26.6 29.8 44.2 32.3 10.9 14.8 28.0 20.7 42.2 27.4 18.5 7.0 30.5 31.3 13.5 23.8 23.1 9.0 38.0 25.0 28.1 28.0 18.4 20.7 27.5 29.7 27.5 62.4 28.1 24.4 22.9 23.0 25.8 34.9 28.8 10.4 7.4 26.9 27.3 28.5 19.0 25.2 37.1 10.5 31.9 19.9 30.8 29.9 25.6 27.5 21.4 35.7 61.1 34.5 18.1 36.3 13.8 3.6 14.4 26.1 17.0 29.0 66.9 40.6 84.1 37.2 42.7 23.9 26.2 22.4 30.5 32.5 19.8 24.6 22.0 25.9 43.7 52.6 30.9 19.0 39.2 14.6 12.8 12.7 13.9 12.7 10.6 14.2 12.4 12.0 14.6 12.4 12.4 16.2 19.1 6.4 9.3 5.9 12.8 6.1 8.9 16.3 8.0 20.2 14.7 16.6 1.0 17.2 14.5 14.7 4.2 39.9 20.1 36.8 13.7 37.4 1.5 8.2 11.2 17.4 21.1 8.8 1.7 43.9 31.6 16.6 20.4 9.9 21.0 23.8 18.2 17.3 41.6 10.1 1.9 19.7 18.3 24.2 6.5 2.5 10.2 20.1 16.0 1.0 37.1 26.7 35.0 3.0 4.4 33.9 35.5 12.8 11.5 9.5 36.7 23.2 8.6 44.3 13.1 15.8 14.1 9.0 12.2 14.0 5.8 50.3 16.7 18.9 22.2 8.8 UFSP1 UFSP ENSG00000176125 "UFM1 specific peptidase 1 (inactive)" Q6NVU6 7 100888721-100889715 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 7.9;Proximal tubular cells: 7.4;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027099 Uncertain NA NA "HPA027099: AB_2214069" "unprognostic (8.56e-2)" "unprognostic (2.62e-2)" "unprognostic (2.23e-1)" "unprognostic (1.94e-1)" "unprognostic (7.21e-3)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (2.11e-1)" "unprognostic (3.55e-3)" "unprognostic (5.71e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-1)" "unprognostic (2.48e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" 1.8 2.7 1.2 0.9 1.3 0.6 1.6 2.2 1.5 1.3 0.2 1.8 1.0 2.4 1.3 1.9 1.8 0.1 1.6 1.0 1.1 1.8 3.1 1.0 0.6 1.4 1.5 0.9 0.9 3.1 1.0 2.3 0.4 1.5 1.8 0.5 0.3 1.7 1.0 3.8 1.1 1.5 0.9 1.2 1.6 1.9 0.7 1.0 0.8 1.4 1.2 0.4 2.2 1.1 1.6 2.9 3.7 0.8 3.8 3.6 2.1 2.3 2.2 0.7 0.9 0.6 1.5 2.0 0.7 1.7 1.8 1.4 5.6 1.1 1.3 0.5 2.6 8.2 2.4 3.2 1.8 3.6 1.0 1.1 2.4 1.6 1.2 4.6 1.0 0.3 1.4 3.7 1.7 1.4 7.3 2.4 6.0 2.8 3.0 5.1 1.2 1.1 5.8 1.6 1.3 2.6 4.3 4.4 5.6 2.7 1.1 1.4 0.9 0.9 2.4 2.5 2.6 1.7 1.7 2.2 0.2 0.8 2.0 2.8 0.0 2.4 1.5 3.1 2.1 3.5 1.0 2.6 1.7 2.9 3.9 2.9 3.6 0.4 3.0 2.2 4.4 1.2 1.7 1.2 1.3 2.2 1.5 1.0 1.1 1.4 1.5 0.9 1.5 1.2 1.0 1.6 0.7 0.0 0.0 0.0 0.8 0.6 2.3 1.3 1.8 0.4 1.4 1.3 0.8 1.5 0.7 1.8 0.0 2.4 0.8 2.5 7.9 2.2 0.3 2.2 3.6 0.8 3.0 0.8 0.3 2.1 1.2 1.2 1.1 1.2 0.0 0.6 1.8 4.7 1.9 0.0 0.3 2.2 0.0 0.8 0.7 0.4 1.8 0.6 0.0 1.0 0.5 2.5 0.0 1.0 0.2 1.8 5.0 1.9 1.3 3.2 1.6 7.4 0.7 1.0 6.6 1.5 1.5 0.2 0.3 2.4 1.0 1.6 0.8 4.4 2.5 2.2 MC5R ENSG00000176136 "Melanocortin 5 receptor" P33032 18 13824149-13827323 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.4;lymphoid tissue: 1.0" "Cell type enriched" "Detected in single" 17 "Squamous epithelial cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA042365, HPA058088" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA042365: AB_2677961, HPA058088: " "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (7.10e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 TMEM39A "FLJ10902, SUSR2" ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119428949-119468830 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 11.5 10.6 1.7 14.5 3.7 13.0 10.3 3.8 3.0 19.7 10.0 9.1 10.1 13.3 11.0 9.1 11.8 12.7 9.5 1.7 5.6 6.5 13.1 12.5 10.1 3.4 3.1 1.3 13.2 28.7 12.9 15.5 18.2 3.9 9.2 9.4 5.1 13.4 14.5 7.3 8.2 8.0 9.8 3.5 9.3 9.9 7.9 3.7 12.2 16.7 12.0 13.7 14.6 10.5 5.8 28.3 15.1 24.1 17.4 56.1 54.2 24.1 26.4 54.3 37.2 50.0 26.1 21.2 12.0 27.4 28.7 37.9 28.7 29.3 12.1 38.0 12.6 11.2 15.5 13.5 25.4 37.9 27.1 23.4 29.7 20.5 25.9 61.5 37.5 23.6 18.5 16.1 35.5 19.6 14.1 13.7 7.0 20.5 29.8 31.5 16.5 11.3 25.7 9.2 10.7 10.7 15.8 26.6 15.2 33.4 17.3 14.8 23.8 18.5 20.2 17.2 13.8 17.3 39.5 12.5 28.5 27.6 18.2 26.8 12.7 10.9 7.3 11.7 5.8 11.9 7.7 7.1 9.6 12.3 9.0 5.6 6.1 3.8 11.9 4.6 17.3 8.9 9.4 1.7 3.7 3.8 3.0 1.7 5.6 3.4 3.1 1.3 3.9 3.5 3.7 5.8 8.5 9.6 15.8 9.8 14.3 22.8 16.0 21.8 8.6 4.7 14.6 10.8 10.8 7.2 16.2 7.3 6.2 26.5 24.7 7.4 5.9 11.6 22.8 8.2 26.3 10.8 10.8 9.0 12.4 14.2 57.6 28.9 13.3 17.9 1.3 13.5 7.9 12.0 13.3 1.7 14.0 18.3 6.1 15.0 54.9 6.8 17.1 17.8 10.6 12.2 31.0 3.9 9.2 25.1 21.8 10.2 6.6 13.2 57.8 20.6 8.0 3.0 14.9 6.4 6.6 15.9 25.2 26.1 18.5 9.6 21.7 59.8 17.4 9.4 11.1 20.4 TCP11L1 FLJ11336 ENSG00000176148 "T-complex 11 like 1" Q9NUJ3 11 33039417-33105943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005769 Approved Approved "Golgi apparatus,Cytosol" NA Yes Cytosol "Golgi apparatus" "HPA005769: AB_2202398" "unprognostic (5.22e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (3.73e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "unprognostic (6.99e-2)" "unprognostic (9.10e-2)" "unprognostic (1.42e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.50e-3)" 6.4 5.1 2.8 5.5 7.1 7.5 4.6 0.3 6.3 4.9 0.0 7.0 6.1 5.1 3.4 4.9 4.0 8.2 4.4 7.3 4.7 6.0 4.0 4.7 4.9 4.4 8.2 4.7 5.4 5.7 4.0 5.1 7.0 7.0 5.0 7.3 6.1 5.0 7.1 3.0 5.4 9.0 8.8 1.1 5.4 4.2 5.6 3.1 7.6 3.2 4.1 5.7 5.9 4.6 6.5 11.9 21.3 10.7 10.2 18.3 20.3 7.2 16.9 14.4 12.8 17.3 11.0 5.6 12.3 4.6 33.1 19.0 18.7 14.5 13.2 18.2 16.1 13.0 8.3 23.1 8.1 12.0 8.2 10.8 16.4 16.2 13.2 25.0 14.6 12.8 17.4 5.2 14.3 32.4 17.6 8.1 3.2 8.0 8.8 8.2 9.4 22.4 2.2 11.6 4.6 9.1 18.3 43.3 27.5 7.9 13.5 7.0 3.4 20.0 22.7 32.5 25.7 18.1 17.5 19.7 13.9 16.5 4.0 18.1 18.6 6.1 8.8 3.4 3.9 3.4 2.1 1.8 3.8 5.9 2.8 1.8 2.4 3.6 4.8 1.1 11.1 5.9 3.5 2.8 7.1 0.3 6.3 7.3 4.7 4.4 8.2 4.7 7.0 1.1 3.1 6.5 4.9 9.6 1.1 12.7 5.0 2.3 10.7 4.2 12.0 5.6 1.7 2.0 3.1 2.8 1.8 0.0 4.2 3.8 4.6 3.5 1.9 4.6 11.6 1.8 4.4 4.5 1.8 2.1 22.5 4.0 19.2 6.3 3.1 2.3 4.5 2.4 4.2 1.6 6.8 8.4 23.7 1.2 2.0 5.7 5.2 6.3 1.8 6.9 0.0 18.7 20.2 1.6 8.2 23.1 29.6 5.7 1.6 2.6 11.6 8.9 13.3 5.0 0.7 5.7 0.0 7.0 6.4 10.4 5.4 6.1 2.6 4.7 6.7 2.8 1.4 3.9 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 502.3;intestine: 458.2;liver: 639.2;stomach 1: 378.0;urinary bladder: 353.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 493.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 4748.8" "Region enhanced" "Detected in single" "pons and medulla: 1.2" "Low region specificity" "Detected in some" HPA003545 Enhanced Approved Nucleoplasm,Cytosol NA NA 82000 Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 1.9 0.2 0.1 54.3 0.2 0.3 5.3 0.4 0.3 12.0 0.1 336.7 97.6 0.7 1.8 189.2 4.9 502.3 0.2 0.1 0.2 30.2 639.2 2.6 0.1 0.3 0.1 0.0 0.2 24.8 0.0 1.2 0.2 0.3 43.7 458.2 0.1 72.4 25.2 0.3 21.8 177.2 9.8 0.0 0.6 378.0 2.6 0.1 3.4 0.5 0.0 1.2 353.8 109.1 0.7 0.0 1152.6 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 36.9 9.6 0.0 6.0 0.0 1.9 303.7 0.6 4.8 0.0 0.2 0.1 0.1 1.1 1048.6 0.0 0.1 0.4 0.0 9.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 5.6 0.6 0.3 1.3 4748.8 0.2 0.5 0.2 0.2 0.1 727.5 324.2 0.2 0.1 13.4 0.0 0.6 0.5 0.0 0.0 0.0 0.8 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.2 0.3 0.1 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.0 0.3 6.9 9.9 169.4 104.5 42.1 0.2 0.6 4.1 0.4 386.1 17.1 23.9 0.0 0.1 0.0 436.6 11.7 272.8 13.8 3.8 0.5 3.5 115.2 50.8 0.2 260.6 0.1 2.1 912.3 2.8 13.4 0.1 17.5 753.4 0.0 0.0 0.2 438.6 36.7 26.1 0.8 66.6 0.9 3.5 0.0 1.9 3.2 0.0 0.0 0.0 0.4 163.7 463.0 0.0 2.4 100.7 68.1 31.4 9.0 0.7 0.0 0.0 3.6 0.4 0.0 315.5 9.7 0.0 5.9 0.1 776.8 1062.0 CCDC57 "FLJ00130, FLJ23754" ENSG00000176155 "Coiled-coil domain containing 57" Q2TAC2 17 82101460-82212830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Late spermatids: 729.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 3.7;naive CD8 T-cell: 7.6" "Lineage enriched" "Detected in many" 6 "T-cells: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023315, HPA023326, HPA023342, HPA023344" Approved Approved "Microtubules,Centriolar satellite,Cytosol" NA NA Microtubules "Centriolar satellite, Cytosol" "HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162" "unprognostic (2.51e-3)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (9.92e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-3)" "unprognostic (1.33e-1)" "unprognostic (1.56e-2)" "unprognostic (3.19e-2)" "unprognostic (2.16e-1)" "prognostic favorable (5.55e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.28e-6)" "unprognostic (5.19e-2)" "unprognostic (1.53e-1)" "unprognostic (2.04e-1)" "unprognostic (3.80e-3)" 5.3 8.5 3.7 5.8 4.7 8.4 8.4 6.0 8.7 10.4 5.6 7.6 7.3 9.5 6.5 3.5 11.1 6.7 3.9 4.3 1.6 12.4 7.4 8.2 5.4 2.9 1.7 3.4 12.4 10.6 7.9 17.0 3.5 3.7 14.5 3.0 9.1 9.1 5.9 4.0 5.6 6.7 3.6 0.0 6.3 7.8 12.3 1.5 8.2 17.8 1.1 2.9 7.0 6.6 3.7 5.2 10.4 5.4 6.9 3.1 5.8 6.0 3.9 3.9 2.8 2.5 3.0 7.9 2.7 3.7 3.2 2.9 12.0 1.6 7.2 1.6 2.8 10.6 4.5 20.3 6.7 4.0 4.5 5.6 5.9 5.5 5.3 6.9 6.5 3.4 3.9 5.8 1.5 2.0 7.5 8.8 8.5 1.7 3.0 4.1 4.7 2.4 3.8 5.5 6.2 18.5 11.3 3.4 17.3 6.7 3.4 9.9 5.3 3.7 11.0 10.0 4.8 8.2 11.0 1.2 0.9 8.5 5.1 4.5 0.5 0.4 0.5 0.6 0.1 0.2 0.4 0.5 0.8 0.4 0.3 3.7 7.6 1.3 0.3 0.1 1.2 0.2 1.0 3.7 4.7 6.0 8.7 4.3 1.6 2.9 1.7 3.4 3.7 0.0 1.5 3.7 5.9 25.6 62.7 19.6 35.8 11.7 22.7 23.7 19.4 22.5 82.3 66.2 5.3 17.2 41.9 29.5 41.7 36.2 45.4 27.6 9.8 15.8 116.1 44.9 15.9 6.9 42.7 14.1 72.8 17.1 34.2 9.8 36.2 19.2 34.9 33.2 7.1 101.0 29.9 25.2 54.4 46.9 30.5 42.1 35.8 729.3 8.1 28.7 33.8 13.1 39.6 10.0 48.4 16.1 10.6 18.1 26.9 10.1 36.5 20.4 31.6 13.2 52.3 66.3 6.6 14.3 9.9 13.6 6.9 21.2 18.3 12.4 40.2 10.5 37.2 23.1 HSF5 FLJ40311 ENSG00000176160 "Heat shock transcription factor 5" Q4G112 17 58420167-58488408 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 49.2" "Group enriched" "Detected in some" 4 "Early spermatids: 53.8;Spermatocytes: 68.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.3;T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016440, HPA063613" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA016440: AB_1851142, HPA063613: AB_2685060" "unprognostic (2.13e-1)" "unprognostic (1.21e-4)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (7.48e-3)" "unprognostic (7.40e-2)" "unprognostic (8.85e-3)" "unprognostic (2.13e-3)" "unprognostic (2.58e-2)" "unprognostic (6.65e-4)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (8.75e-2)" "unprognostic (3.64e-2)" 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 49.2 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.1 0.6 0.5 0.0 1.3 1.1 0.8 0.0 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 3.9 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 53.8 0.0 0.0 0.1 0.0 0.4 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 14.6 3.1 0.1 0.0 0.0 0.0 0.2 2.1 0.5 2.4 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 68.8 3.3 0.0 0.0 0.0 1.3 0.1 0.0 0.0 FOXG1 "BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN" ENSG00000176165 "Forkhead box G1" P55316 14 28766787-28770277 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 25.6" "Cell type enhanced" "Detected in some" "Astrocytes: 69.5;Excitatory neurons: 35.9;Inhibitory neurons: 33.2;Oligodendrocyte precursor cells: 31.2;Spermatocytes: 15.4" "Cancer enriched" "Detected in some" 10 "glioma: 15.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 15.6;SCLC-21H: 39.0;U-138 MG: 25.2;U-251 MG: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (3.49e-1)" "unprognostic (1.17e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-11)" "unprognostic (4.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-2)" 0.0 0.0 12.5 0.0 23.5 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 22.4 4.5 0.0 0.0 0.0 0.6 6.1 1.5 18.2 0.4 0.0 0.1 2.8 0.0 9.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.0 3.2 0.2 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 7.6 6.0 4.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 3.4 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.1 25.2 0.0 2.0 25.2 0.0 0.0 0.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 23.5 0.0 25.6 22.4 4.5 6.1 1.5 18.2 9.2 0.0 1.0 11.7 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.0 35.9 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 33.2 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.0 4.7 0.0 1.4 0.0 31.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 9.5 15.4 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "olfactory bulb: 5.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 18.0 4.1 3.9 10.5 4.5 17.5 18.2 2.8 3.9 8.8 2.6 6.5 1.9 6.7 4.0 24.0 9.5 12.0 16.7 2.7 5.8 8.1 3.8 24.5 8.1 4.1 4.0 1.9 4.4 14.6 4.9 4.9 2.5 5.1 7.4 1.1 8.5 20.1 1.5 3.3 14.7 7.0 3.2 3.0 5.0 6.8 5.9 6.8 3.5 10.7 0.8 4.1 11.4 13.2 4.4 36.9 3.7 15.2 0.8 7.6 7.0 15.8 82.6 54.0 67.8 40.8 19.4 3.9 1.8 7.4 61.0 28.9 7.7 11.7 105.4 16.4 1.6 6.2 0.5 28.3 127.6 16.6 1.3 2.9 13.6 2.1 105.9 41.3 28.8 66.0 3.7 17.3 0.2 13.5 46.6 3.5 0.6 0.9 8.2 29.7 2.5 4.1 2.8 3.7 0.5 2.0 3.6 8.3 0.9 74.4 9.1 3.0 5.1 108.9 105.8 20.8 82.3 142.1 1.7 0.4 1.6 80.5 6.5 16.1 1.5 1.9 0.0 0.7 0.9 0.2 0.0 0.1 0.2 0.5 0.1 0.0 0.1 0.2 0.0 0.2 4.8 0.0 0.8 3.9 4.5 2.8 3.9 2.7 5.8 4.1 4.0 1.9 5.1 3.0 6.8 4.4 22.0 0.0 0.0 1.0 2.8 12.6 57.0 18.6 2.8 1.5 31.1 29.1 5.3 47.1 6.6 1.8 0.0 1.2 9.1 1.0 0.0 105.4 0.2 15.3 13.5 51.2 0.0 22.3 0.5 12.7 16.9 27.5 3.1 60.7 7.0 0.4 4.2 0.2 30.1 33.7 1.6 2.4 6.1 8.9 45.4 1.4 3.7 39.9 12.4 1.0 61.5 165.1 3.1 0.0 0.1 101.8 1.2 19.9 3.5 68.9 0.8 2.5 2.0 3.9 0.0 17.3 54.3 0.0 9.5 6.7 10.7 1.4 4.2 0.8 0.4 27.0 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 364.6;skeletal muscle: 216.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 544.1;Hepatocytes: 437.4;Proximal tubular cells: 714.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 390.1;hTERT-RPE1: 286.7;U-87 MG: 347.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported NA NA "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 49.6 35.3 58.5 8.2 59.4 5.9 36.0 66.1 65.4 25.8 41.1 20.9 7.7 17.5 24.0 30.2 20.7 16.9 79.0 75.3 57.9 64.5 127.5 26.2 10.1 68.2 63.8 56.2 82.9 364.6 20.5 37.0 30.3 68.2 40.9 4.9 82.1 47.3 12.9 216.2 34.2 15.0 12.2 58.6 13.9 28.1 15.8 79.0 10.1 23.4 92.3 8.0 28.5 39.7 71.8 390.1 30.7 21.6 60.9 56.7 59.5 110.9 92.7 85.3 68.3 193.2 6.4 8.4 0.7 146.5 53.6 79.5 23.3 46.2 131.4 254.7 20.7 34.9 13.8 19.2 90.1 75.4 17.9 10.6 41.4 32.7 66.6 66.8 286.7 48.1 23.6 36.0 1.4 112.9 31.0 9.2 99.3 18.5 2.7 91.1 21.8 11.0 33.3 75.1 6.4 28.5 66.3 18.9 38.7 54.3 91.1 23.7 24.7 55.4 96.0 32.3 36.4 74.4 63.5 58.1 54.0 347.4 0.9 16.8 4.2 6.3 9.8 16.6 4.2 17.7 11.4 23.4 17.7 5.6 11.6 39.1 26.3 1.5 4.3 6.2 4.3 25.4 16.5 58.5 59.4 66.1 65.4 75.3 57.9 68.2 63.8 56.2 68.2 58.6 79.0 71.8 49.3 48.1 56.5 34.3 22.5 29.8 98.3 101.0 34.7 98.2 75.8 63.1 159.2 137.2 43.6 84.6 39.6 173.8 24.7 2.6 301.3 185.1 110.3 84.7 64.4 53.6 81.0 21.5 39.6 87.9 544.1 64.6 27.5 98.1 0.0 107.4 61.4 437.4 79.1 333.1 30.0 10.3 59.0 28.4 20.4 112.1 70.2 28.2 33.8 7.5 28.1 169.2 27.8 16.1 22.8 133.8 9.5 103.4 37.5 140.5 63.5 714.8 72.7 64.6 39.5 53.1 60.0 35.3 100.2 6.5 13.1 247.4 38.4 47.3 5.3 48.9 ENTHD1 FLJ25421 ENSG00000176177 "ENTH domain containing 1" Q8IYW4 22 39743044-39893864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.1" "Cell type enhanced" "Detected in some" "Early spermatids: 21.2;granulocytes: 8.9;Late spermatids: 17.5;Spermatocytes: 37.4;Spermatogonia: 6.7" "Cancer enriched" "Detected in single" 30 "melanoma: 7.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-MEL-30: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA019800 Uncertain NA NA "HPA019800: AB_1848842" "unprognostic (5.28e-3)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (9.84e-3)" "unprognostic (2.97e-4)" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (2.17e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-4)" "unprognostic (3.60e-2)" "unprognostic (7.75e-10)" "unprognostic (3.68e-2)" "unprognostic (8.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 11.1 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 17.5 0.6 1.1 0.0 0.0 0.7 0.0 0.0 1.5 0.2 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 37.4 6.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 MYPOP P42pop ENSG00000176182 "Myb related transcription factor, partner of profilin" Q86VE0 19 45890023-45902613 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HDLM-2: 27.7;NB-4: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065307 Approved Nucleoplasm NA NA Nucleoplasm "HPA065307: AB_2685460" "unprognostic (5.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.87e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.94e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.67e-5)" "unprognostic (1.28e-3)" "unprognostic (1.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.19e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-3)" 5.7 7.8 15.7 3.1 14.8 1.4 5.7 9.9 23.3 8.4 4.2 8.0 4.4 7.6 2.3 8.5 8.9 1.5 10.8 17.3 9.9 10.1 8.5 5.4 3.4 13.7 10.4 15.2 6.6 8.0 3.0 13.0 2.1 15.9 9.1 1.9 5.3 7.4 2.7 17.5 7.5 7.2 2.1 8.9 10.8 7.4 7.7 13.0 4.1 6.2 7.8 2.5 7.8 8.3 16.0 6.2 9.7 3.6 7.4 4.5 2.9 7.2 4.4 4.5 4.8 6.2 3.9 3.8 5.9 4.2 2.2 4.7 5.1 2.7 2.0 3.4 27.7 15.5 2.8 5.8 6.3 5.0 2.8 8.5 2.8 5.6 2.7 2.5 5.1 4.0 9.7 3.8 5.1 3.1 2.6 14.7 37.8 4.0 7.9 9.6 11.6 1.5 3.4 2.8 3.4 7.4 5.6 4.3 4.7 5.0 2.6 3.2 10.2 5.1 4.4 7.4 4.2 7.1 15.0 11.6 3.8 6.5 7.4 5.4 0.0 0.2 0.5 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 15.7 14.8 9.9 23.3 17.3 9.9 13.7 10.4 15.2 15.9 8.9 13.0 16.0 4.6 3.2 2.0 3.3 5.8 11.5 5.2 7.5 9.6 10.9 4.4 5.5 16.0 4.3 3.3 5.5 8.4 5.4 3.5 8.1 23.5 8.2 7.3 2.6 5.4 4.9 9.0 5.2 9.4 8.9 19.4 6.6 3.1 3.6 0.0 4.8 4.2 3.4 5.6 6.7 10.2 5.1 4.1 5.7 9.8 2.3 7.2 5.5 3.6 7.5 7.6 4.9 8.2 6.0 7.7 6.1 5.5 7.5 10.5 4.2 15.8 8.5 2.1 11.7 19.7 4.2 5.5 7.0 5.1 6.6 9.8 5.3 4.8 4.8 5.2 3.1 CIDEA CIDE-A ENSG00000176194 "Cell death inducing DFFA like effector a" O60543 18 12254361-12277595 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "adipose tissue: 223.3;breast: 108.9" "Cell type enriched" "Detected in some" 78 "Breast glandular cells: 330.6" "Cancer enhanced" "Detected in some" "breast cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "hTEC/SVTERT24-B: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-2)" "unprognostic (2.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (8.93e-3)" "unprognostic (3.20e-2)" "unprognostic (7.00e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-3)" "unprognostic (3.17e-2)" "unprognostic (7.67e-3)" "unprognostic (1.96e-1)" 223.3 3.8 2.7 0.2 3.5 0.0 108.9 3.5 4.6 1.7 2.4 1.2 0.0 0.0 0.0 4.9 0.0 1.2 1.9 3.3 2.5 0.2 0.2 0.0 0.3 3.0 2.8 3.0 0.0 0.9 0.0 0.0 0.0 3.5 0.1 0.9 0.1 4.3 0.0 1.1 7.3 2.1 0.2 2.8 0.0 1.0 0.1 2.6 0.2 0.5 4.7 0.2 1.1 5.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.5 3.5 4.6 3.3 2.5 3.0 2.8 3.0 3.5 2.8 2.6 3.7 1.9 0.0 0.0 0.7 0.5 0.1 0.1 0.3 0.0 0.2 330.6 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.3 1.0 0.0 0.2 0.3 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 4.2 0.6 0.6 1.8 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.4 0.3 0.7 1.0 0.0 0.3 0.5 0.0 0.8 OR11H4 ENSG00000176198 "Olfactory receptor family 11 subfamily H member 4" Q8NGC9 14 20239286-20244349 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052790 Uncertain NA NA "HPA052790: AB_2681950" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D11 OR4D11P ENSG00000176200 "Olfactory receptor family 4 subfamily D member 11" Q8NGI4 11 59503576-59504511 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRTM4 FLJ12568 ENSG00000176204 "Leucine rich repeat transmembrane neuronal 4" Q86VH4 2 76747685-77593319 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 18.7;retina: 6.8" "Group enriched" "Detected in some" 16 "Excitatory neurons: 3972.6;Inhibitory neurons: 2310.6;Oligodendrocyte precursor cells: 3758.4" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 10 "Karpas-707: 125.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (3.13e-1)" "unprognostic (4.72e-4)" "unprognostic (7.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-1)" "unprognostic (5.84e-2)" "unprognostic (4.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (5.77e-3)" "unprognostic (3.54e-2)" "unprognostic (7.99e-2)" 0.4 0.6 6.2 0.3 11.9 1.8 0.2 0.2 18.7 0.4 0.0 0.5 0.8 0.4 1.5 0.8 0.2 0.7 0.2 12.1 3.5 0.2 1.3 0.8 0.4 2.3 4.0 9.6 0.6 0.5 0.0 1.0 0.9 5.3 0.6 0.5 6.8 0.9 1.6 1.6 0.8 0.6 0.3 0.0 0.5 0.6 0.3 0.8 0.1 0.7 0.3 0.2 0.3 0.5 15.5 1.4 1.7 0.9 0.8 0.0 0.0 0.9 0.3 0.0 0.0 0.0 2.1 0.5 1.0 2.2 0.8 0.7 0.8 0.2 0.0 0.3 0.8 2.5 0.5 4.8 3.1 0.4 1.3 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 125.8 0.0 2.8 0.5 0.7 12.2 0.2 1.2 0.5 0.1 2.6 0.0 4.1 3.7 1.4 0.8 0.7 0.8 2.0 1.4 0.9 0.0 2.9 3.7 0.1 0.2 0.0 2.4 0.1 2.8 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.5 0.2 0.1 0.0 0.1 0.0 6.2 11.9 0.2 18.7 12.1 3.5 2.3 4.0 9.6 5.3 0.0 0.8 15.5 0.0 0.0 0.5 208.6 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.3 0.3 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 1.1 0.4 0.2 0.4 0.0 0.0 3972.6 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 2310.6 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 84.3 0.0 2.8 0.0 3758.4 176.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.7 2.3 6.6 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family AAA domain containing 5" Q96QE3 17 30831966-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 59.3;Spermatocytes: 73.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Yes No Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 0.6 0.4 0.3 2.2 0.3 12.4 1.2 2.6 0.4 0.7 0.1 1.2 1.5 1.0 0.4 1.3 0.7 0.5 0.4 0.3 0.1 0.4 0.5 0.8 3.6 0.3 0.2 0.2 0.9 0.5 0.3 0.5 1.4 1.0 0.6 1.6 2.5 0.7 0.4 0.4 2.5 1.4 0.6 0.1 1.4 1.1 2.0 0.2 5.3 0.6 0.1 3.0 0.6 1.0 0.5 7.2 6.0 14.0 13.3 0.3 1.4 5.5 6.3 3.2 6.9 9.8 6.6 5.1 19.5 5.9 2.9 4.7 13.0 9.1 4.7 12.4 4.4 7.9 11.7 8.0 4.6 0.2 23.1 9.2 0.6 0.6 10.1 3.5 1.4 3.6 18.7 18.7 15.9 4.6 4.2 26.1 11.5 8.2 5.3 2.9 17.6 26.4 9.3 1.8 7.6 8.1 7.2 7.0 4.0 3.7 7.6 7.6 10.2 2.8 8.3 11.3 12.0 11.4 5.2 5.9 24.0 3.6 10.7 8.4 0.4 0.2 0.3 0.3 0.3 0.2 0.3 0.1 0.2 0.1 0.4 0.2 0.2 0.6 0.6 0.1 0.5 0.3 0.1 0.3 0.3 2.6 0.4 0.3 0.1 0.3 0.2 0.2 1.0 0.1 0.2 0.5 4.3 3.2 4.1 6.8 9.9 4.7 3.1 2.6 3.4 19.3 4.7 5.1 2.7 0.0 2.6 3.7 0.0 21.7 10.7 6.6 0.0 4.1 13.9 4.4 8.5 5.4 0.0 59.3 20.4 2.9 21.1 5.4 9.7 5.1 3.8 32.6 2.9 0.7 8.7 11.8 17.4 8.6 2.0 2.8 7.4 7.8 3.7 5.7 7.2 11.2 10.0 2.9 12.3 16.6 14.9 4.0 2.4 2.2 24.4 2.4 2.3 0.5 2.7 21.3 0.0 7.4 6.5 73.3 34.5 9.3 4.5 7.9 10.5 8.4 13.0 2.3 SMIM19 C8orf40 ENSG00000176209 "Small integral membrane protein 19" Q96E16 8 42541155-42555195 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011145, HPA074830" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA011145: AB_1078360, HPA074830: " "unprognostic (2.12e-2)" "unprognostic (2.33e-3)" "unprognostic (4.01e-2)" "unprognostic (1.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (7.04e-3)" "unprognostic (1.76e-2)" "unprognostic (4.84e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.67e-2)" "prognostic favorable (1.74e-6)" "unprognostic (5.10e-2)" "unprognostic (9.70e-3)" "unprognostic (9.64e-2)" "unprognostic (2.93e-3)" 48.9 57.5 37.4 18.6 37.8 32.7 65.5 38.3 44.6 30.0 38.0 42.1 30.3 32.8 80.7 33.5 57.5 28.1 58.4 38.0 38.6 77.6 138.0 31.7 37.2 36.9 37.8 37.2 42.5 69.1 36.5 27.1 23.5 37.2 32.2 35.0 21.3 63.2 30.4 122.9 44.8 39.2 25.3 38.2 33.5 46.6 44.3 37.4 37.0 74.1 74.8 34.2 36.7 30.2 39.9 38.9 28.5 61.0 52.6 35.9 43.2 19.9 29.9 40.2 23.4 27.8 6.8 84.4 42.4 12.2 25.1 57.0 27.2 31.8 19.2 24.3 33.8 26.3 35.9 17.9 15.5 73.9 25.7 9.0 35.4 16.1 19.6 62.7 45.3 21.5 49.1 28.8 94.5 23.7 38.0 18.8 39.0 72.1 90.4 19.5 21.1 43.4 72.4 60.7 28.5 12.7 46.0 30.0 32.2 93.1 32.6 68.0 48.2 27.3 14.7 12.5 40.8 19.6 88.7 53.8 56.9 62.2 40.9 39.6 92.2 42.3 31.4 46.3 34.0 56.5 71.3 59.6 57.0 65.1 68.3 55.6 54.3 15.3 80.7 28.8 107.2 78.2 40.0 37.4 37.8 38.3 44.6 38.0 38.6 36.9 37.8 37.2 37.2 38.2 37.4 39.9 53.1 22.4 45.9 5.9 43.0 45.8 63.5 89.8 70.6 25.2 89.9 108.8 75.7 88.6 66.2 33.1 6.2 90.1 58.6 36.2 201.5 67.9 183.9 109.6 26.0 43.9 16.3 45.6 12.7 126.8 62.9 65.5 43.3 54.8 40.0 52.3 47.8 142.5 78.3 23.5 13.4 74.4 61.1 45.9 51.0 77.5 69.0 47.3 92.5 11.2 64.0 66.7 42.2 10.6 14.6 85.5 69.5 59.5 29.0 53.3 161.9 228.2 110.9 14.3 26.3 67.6 50.7 131.3 48.6 58.4 49.6 47.2 43.3 76.4 74.8 63.2 OR11H6 ENSG00000176219 "Olfactory receptor family 11 subfamily H member 6" Q8NGC7 14 20223710-20224702 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872365-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 21.5;Oligodendrocytes: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2 OS: 43.7" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Nucleoli rim,Intermediate filaments" NA Yes "Nucleoli, Nucleoli rim" "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: AB_2732705" "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 2.0 3.2 9.8 1.1 10.9 0.6 2.7 10.1 11.4 3.5 8.6 4.4 0.6 2.5 9.7 2.0 6.5 2.4 8.3 9.3 9.5 3.9 2.4 2.1 3.6 10.4 10.2 9.1 6.8 2.4 2.5 14.4 2.9 10.4 6.1 1.8 18.1 2.8 2.3 2.6 3.1 2.7 2.0 10.1 5.5 3.2 4.7 10.7 2.3 4.2 1.9 1.6 4.6 2.9 12.7 3.4 0.5 3.4 0.4 8.4 11.8 2.0 4.6 2.2 2.9 4.0 0.3 1.2 0.0 4.7 2.2 0.1 0.4 0.6 2.3 3.9 0.5 3.3 1.2 0.1 1.3 3.0 0.3 0.9 7.1 5.5 2.1 2.0 9.8 2.5 0.0 0.1 0.0 2.7 0.3 0.0 0.1 2.8 0.1 0.7 0.0 1.8 0.7 2.8 2.2 1.8 1.4 1.9 0.8 2.4 6.1 0.1 1.3 1.1 4.1 43.7 3.7 2.7 5.8 8.1 0.0 5.8 0.0 2.4 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.3 0.3 0.0 0.5 0.0 0.2 0.3 0.1 9.8 10.9 10.1 11.4 9.3 9.5 10.4 10.2 9.1 10.4 10.1 10.7 12.7 1.3 0.0 3.2 21.5 1.5 0.0 0.7 1.1 0.6 3.6 1.3 1.9 7.0 0.0 0.9 0.0 0.0 1.5 0.3 0.2 0.0 0.7 1.5 1.6 3.2 1.5 2.4 0.4 6.9 0.2 1.1 1.6 0.5 1.1 7.0 2.9 1.1 0.5 0.7 5.0 6.9 0.6 4.1 0.3 0.3 0.3 0.9 0.7 0.0 1.9 0.4 3.8 2.1 3.0 19.4 0.2 0.5 3.4 0.1 0.8 0.7 0.4 1.9 3.3 0.0 0.4 1.3 1.7 3.2 0.4 0.0 1.0 1.5 0.5 0.9 0.5 RTTN DKFZP434G145 ENSG00000176225 Rotatin Q86VV8 18 70003031-70205726 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Microglial cells: 69.3;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "hTERT-HME1: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041343, HPA041967, HPA075089" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA041343: AB_10794409, HPA041967: AB_10796790, HPA075089: " "unprognostic (1.76e-1)" "unprognostic (2.13e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-2)" "unprognostic (3.44e-2)" "unprognostic (6.16e-3)" "unprognostic (4.63e-3)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (4.66e-2)" "unprognostic (1.90e-1)" "unprognostic (8.25e-2)" "unprognostic (6.94e-3)" "unprognostic (1.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" 1.4 1.2 3.5 1.6 4.8 3.2 2.1 3.7 3.5 1.4 2.2 1.3 1.1 1.8 1.5 1.1 1.6 1.2 2.3 2.6 3.1 2.4 2.8 1.6 2.2 4.1 4.2 2.4 2.7 1.8 1.8 0.8 1.6 4.6 1.1 1.5 4.1 1.4 0.6 1.9 1.3 1.3 1.0 4.2 2.0 1.3 3.3 5.6 3.7 0.9 1.1 1.9 0.9 1.1 7.2 4.4 6.6 9.4 2.7 1.8 2.0 3.9 7.5 3.4 6.8 7.0 2.5 2.5 3.8 1.0 4.7 6.0 5.4 6.9 11.0 11.1 13.1 3.0 4.1 5.9 3.1 1.3 7.7 4.0 1.6 10.9 7.2 21.2 3.1 4.2 5.8 4.3 8.4 6.1 2.0 7.4 2.1 1.8 1.0 5.8 6.0 8.6 3.9 1.1 3.2 4.0 4.3 4.6 2.6 2.8 6.2 2.8 4.4 3.4 8.8 2.3 3.1 5.7 4.1 3.8 7.8 5.1 4.9 6.0 0.2 0.2 0.1 0.2 0.0 0.4 0.6 0.4 0.3 0.0 0.2 0.6 0.3 0.1 0.3 0.0 0.2 0.3 0.1 3.5 4.8 3.7 3.5 2.6 3.1 4.1 4.2 2.4 4.6 4.2 5.6 7.2 6.1 0.0 8.6 19.6 7.1 1.5 1.7 10.1 1.8 8.2 3.9 3.9 5.0 1.5 5.7 0.0 0.0 4.0 4.9 2.9 0.0 1.1 10.6 6.0 5.2 3.4 0.0 4.2 25.4 1.6 1.9 4.0 6.1 6.0 5.1 10.9 1.8 3.7 2.3 16.8 25.8 1.5 2.0 1.3 1.4 3.2 2.1 3.3 0.0 69.3 1.3 1.9 3.1 48.7 110.8 2.0 2.4 1.9 14.7 1.1 2.2 4.1 1.7 9.7 13.1 5.1 4.0 10.6 6.7 3.5 1.7 3.0 5.8 2.5 2.6 2.3 OR4K17 ENSG00000176230 "Olfactory receptor family 4 subfamily K member 17" Q8NGC6 14 20110739-20122199 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.2;liver: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.2 0.3 0.2 0.4 0.1 2.2 0.1 1.7 1.0 0.0 0.0 0.1 0.6 0.2 0.3 0.2 0.1 0.3 0.2 0.3 0.1 0.4 4.7 0.2 0.5 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.7 0.3 0.1 1.4 0.4 0.0 1.0 0.6 0.3 0.1 0.0 0.4 0.3 0.4 0.1 0.1 0.3 0.0 0.1 0.1 1.6 0.2 0.3 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.4 0.5 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.5 0.2 0.6 0.5 0.1 0.0 0.6 0.4 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.5 0.5 0.0 0.4 0.3 0.7 0.4 0.4 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.2 0.3 0.1 0.3 0.2 0.5 0.3 0.6 0.3 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.0 0.2 0.1 1.7 1.0 0.3 0.1 0.3 0.0 0.0 0.7 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H4 ENSG00000176231 "Olfactory receptor family 10 subfamily H member 4" Q8NGA5 19 15944299-15950350 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B6 ENSG00000176239 "Olfactory receptor family 51 subfamily B member 6" Q9H340 11 5351508-5352446 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15075475-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 42.6;choroid plexus: 16.3" "Cell type enriched" "Detected in some" 5 "Astrocytes: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 28.7;MOLT-4: 29.2;U-698: 21.8" "Region enriched" "Detected in all" 5 "olfactory bulb: 17.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043326: AB_2678429, HPA062478: AB_2684777" "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 0.3 0.3 34.5 0.4 33.1 1.4 4.3 29.0 35.7 0.2 16.3 0.4 0.9 0.3 0.8 0.4 1.9 0.4 0.2 31.8 28.4 0.4 0.4 0.4 0.7 42.6 32.8 26.3 0.4 0.4 0.3 0.6 0.3 38.0 0.4 0.4 7.8 2.4 0.5 0.9 1.3 0.5 0.2 22.9 0.4 0.5 3.0 32.6 6.8 1.7 0.0 0.5 0.3 0.1 25.9 3.4 0.8 12.7 7.0 1.0 0.6 1.8 0.8 0.7 1.9 3.0 3.8 4.2 2.9 4.3 2.5 2.6 0.6 6.9 1.8 2.9 6.0 10.2 3.4 1.1 2.3 0.1 0.4 1.3 0.3 0.1 1.0 0.1 3.2 2.9 28.7 2.4 3.6 2.5 10.5 29.2 4.5 6.3 1.0 2.0 16.4 4.3 6.9 1.6 1.0 9.7 6.6 2.7 8.6 1.1 4.7 10.9 0.6 1.6 0.7 6.6 1.3 2.8 10.4 19.1 21.8 2.1 0.5 0.7 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.3 0.1 0.0 34.5 33.1 29.0 35.7 31.8 28.4 42.6 32.8 26.3 38.0 22.9 32.6 25.9 0.1 0.0 0.6 28.1 0.1 0.1 0.1 0.0 0.6 0.2 0.5 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.2 0.0 0.0 5.3 2.6 0.1 0.4 1.8 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.0 0.0 0.6 0.0 1.5 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.1 1.6 0.8 0.0 0.3 0.3 2.9 0.4 0.5 0.0 0.1 0.2 0.1 0.1 0.1 OR4L1 OR4L2P ENSG00000176246 "Olfactory receptor family 4 subfamily L member 1" Q8NH43 14 20060045-20060983 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANAPC2 "APC2, KIAA1406" ENSG00000176248 "Anaphase promoting complex subunit 2" Q9UJX6 9 137174784-137188560 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 58.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018692, HPA066539" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB018692: AB_2258285, HPA066539: AB_2685688" "unprognostic (5.20e-2)" "unprognostic (8.86e-3)" "unprognostic (1.43e-2)" "prognostic favorable (8.91e-5)" "unprognostic (2.29e-1)" "unprognostic (2.38e-2)" "unprognostic (4.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.36e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.41e-2)" "prognostic favorable (3.67e-4)" "prognostic favorable (2.87e-4)" "unprognostic (1.35e-1)" "unprognostic (8.46e-2)" "unprognostic (9.88e-2)" 14.0 17.8 7.6 11.4 8.6 15.1 16.0 7.8 13.5 14.9 7.4 14.4 12.0 16.0 3.1 15.9 14.8 8.7 14.2 8.9 7.7 14.2 20.4 13.3 14.6 10.6 8.5 8.4 15.4 20.9 7.4 13.9 7.3 9.9 17.7 3.2 4.4 18.4 9.0 19.1 19.3 16.6 5.3 7.7 20.1 17.1 25.7 7.8 10.3 15.7 8.4 6.1 14.0 13.6 12.1 20.9 45.6 10.7 17.5 12.6 7.5 33.5 18.5 11.5 16.9 12.8 27.8 20.9 22.4 21.3 12.3 15.8 41.9 12.9 13.8 2.5 28.9 22.5 13.3 55.1 24.9 14.9 20.7 22.1 15.0 10.9 11.3 6.1 8.3 20.8 20.7 20.3 26.4 8.0 58.2 24.7 28.7 21.6 27.4 34.6 29.3 26.5 41.4 13.1 18.1 14.1 21.3 28.2 36.5 11.9 5.1 39.2 27.8 22.4 24.8 19.8 30.1 16.7 12.9 20.5 24.5 20.1 14.1 18.3 0.3 0.6 0.1 0.5 0.6 0.3 0.3 0.3 0.4 0.5 0.2 0.3 0.4 0.2 0.3 0.9 0.6 0.3 1.1 7.6 8.6 7.8 13.5 8.9 7.7 10.6 8.5 8.4 9.9 7.7 7.8 12.1 9.3 0.0 0.5 6.2 12.2 9.3 7.9 14.2 6.2 5.7 13.0 12.6 3.2 11.5 11.5 11.0 4.2 25.9 11.1 19.0 13.7 10.0 40.5 4.2 4.0 9.0 10.2 9.5 2.4 10.9 11.1 9.0 27.0 5.0 11.4 8.5 12.1 11.1 15.6 1.7 2.5 19.1 12.2 8.8 7.8 58.4 11.1 7.6 14.2 1.0 13.9 3.7 6.2 1.5 4.3 8.6 8.0 9.4 15.3 6.8 21.2 15.8 10.2 4.7 0.0 9.8 17.4 40.5 26.4 11.9 9.5 24.5 9.4 5.9 15.4 7.1 OR4K13 ENSG00000176253 "Olfactory receptor family 4 subfamily K member 13" Q8NH42 14 20029399-20036038 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HMGB4 FLJ40388 ENSG00000176256 "High mobility group box 4" Q8WW32 1 33860475-33864791 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1033 "testis: 375.6" "Group enriched" "Detected in some" 117 "Early spermatids: 11656.4;Late spermatids: 21015.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA035699 Enhanced NA NA "HPA035699: AB_10960531" "unprognostic (1.33e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 375.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11656.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21015.5 100.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 138.7 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB8OS ARCH ENSG00000176261 "Zinc finger and BTB domain containing 8 opposite strand" Q8IWT0 1 32600172-32650903 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046315 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046315: AB_2679623" "unprognostic (3.41e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "unprognostic (9.08e-2)" "unprognostic (1.82e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (9.63e-2)" "prognostic unfavorable (8.56e-4)" "unprognostic (5.18e-2)" "unprognostic (3.84e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (7.11e-8)" "unprognostic (1.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.68e-1)" "unprognostic (1.42e-1)" 21.6 25.7 23.8 29.0 23.6 21.7 20.8 25.9 34.7 16.2 22.5 34.1 32.5 16.4 35.9 27.4 18.5 14.8 30.3 23.6 24.2 28.5 34.7 20.5 37.2 23.6 23.2 22.7 12.5 27.6 21.7 27.9 15.0 23.7 21.8 33.6 27.9 23.0 16.0 44.0 16.1 29.4 20.4 22.9 27.4 28.7 16.7 24.0 17.1 18.5 35.8 44.2 21.6 18.4 24.9 56.1 31.8 27.9 47.2 47.7 43.3 38.1 62.1 62.3 48.5 49.0 75.5 60.9 62.0 55.9 45.6 53.5 41.1 48.7 48.5 64.4 83.2 44.8 50.5 67.4 127.0 39.2 73.2 44.9 43.4 52.3 42.7 51.2 30.3 53.6 74.6 50.8 81.6 62.9 44.3 56.2 42.4 86.1 86.5 48.7 44.9 59.8 60.7 58.7 65.7 55.9 43.0 50.1 49.9 83.3 74.8 34.2 59.8 38.4 67.2 40.8 55.0 78.9 123.1 130.8 177.0 48.1 89.6 68.1 37.5 57.7 71.5 46.3 71.0 44.8 73.0 50.5 56.0 41.6 54.0 41.9 45.1 66.3 48.0 78.0 53.6 86.1 37.8 23.8 23.6 25.9 34.7 23.6 24.2 23.6 23.2 22.7 23.7 22.9 24.0 24.9 39.4 22.4 53.7 32.0 56.3 17.2 31.2 69.5 18.2 46.9 28.5 34.7 69.3 30.0 53.3 38.6 43.8 49.3 54.5 68.8 90.1 60.5 38.1 42.5 38.1 34.4 37.7 46.1 58.3 52.7 61.8 35.9 35.2 45.3 44.2 24.0 33.2 82.5 72.3 16.8 60.5 53.2 71.2 61.9 19.8 30.5 36.7 47.4 51.6 21.5 82.2 35.7 75.2 35.7 46.8 68.4 71.6 46.3 79.9 32.8 115.9 139.4 42.0 56.5 32.9 27.3 51.7 52.9 30.0 28.1 15.6 65.1 50.3 31.2 49.7 37.8 OR4F21 OR4F21P ENSG00000176269 "Olfactory receptor family 4 subfamily F member 21" O95013 8 166086-167024 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "BEWO: 1.0" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G1 "C10orf60, FLJ33990, TMEM20" ENSG00000176273 "Solute carrier family 35 member G1" Q2M3R5 10 93893973-93956062 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 69.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 26.9;Peritubular cells: 36.5;Proximal enterocytes: 47.4;Theca cells: 59.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.94e-2)" "unprognostic (1.90e-1)" "unprognostic (9.48e-2)" "unprognostic (1.65e-1)" "unprognostic (7.90e-4)" "unprognostic (8.89e-2)" "unprognostic (9.01e-3)" "unprognostic (1.15e-2)" "unprognostic (9.47e-2)" "unprognostic (7.90e-2)" "unprognostic (2.09e-1)" "unprognostic (4.30e-2)" "unprognostic (1.65e-2)" "unprognostic (2.29e-3)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" "unprognostic (2.30e-1)" 0.7 0.8 0.1 1.0 0.1 0.3 0.7 0.2 0.1 0.5 0.9 6.1 69.0 0.8 0.8 1.1 0.4 0.6 1.5 0.1 0.8 0.5 3.7 0.8 0.8 0.3 0.2 0.0 1.0 9.6 2.1 1.1 0.8 0.4 0.7 5.9 0.2 1.4 0.8 0.6 1.6 33.7 0.9 0.1 0.6 2.0 3.4 0.2 0.4 1.4 0.2 0.6 1.1 0.7 0.3 6.2 6.1 2.9 3.3 0.9 2.5 3.8 5.4 6.2 5.2 6.5 4.8 4.2 3.9 2.1 3.6 3.4 11.1 6.7 2.1 7.9 4.8 7.0 3.2 3.7 3.6 1.3 6.1 6.1 2.4 2.1 3.9 2.3 1.7 2.3 3.5 3.0 2.2 3.1 2.2 2.9 1.3 3.7 2.2 7.1 0.0 4.6 1.5 2.5 5.3 3.7 3.4 7.2 3.5 4.6 2.4 3.7 2.0 2.9 3.8 6.1 6.8 5.6 2.5 2.4 1.3 2.8 0.0 2.7 0.0 0.1 0.7 0.1 0.1 0.4 0.1 0.8 0.5 0.1 0.1 0.8 0.5 0.0 0.0 0.0 0.1 1.1 0.2 0.1 0.1 0.2 0.1 0.1 0.8 0.3 0.2 0.0 0.4 0.1 0.2 0.3 3.2 3.2 3.9 1.0 2.4 3.1 2.1 2.2 2.2 4.3 1.5 2.7 4.7 5.7 1.6 7.3 4.2 3.0 0.6 26.9 3.9 2.3 20.3 1.8 5.0 4.7 4.2 3.0 2.6 9.7 6.1 4.4 3.1 1.3 0.0 19.9 5.0 5.8 2.3 1.7 6.4 5.0 2.0 3.3 1.2 9.2 17.1 0.9 5.4 1.0 3.1 4.8 0.0 5.0 0.9 3.1 18.3 36.5 2.2 1.3 47.4 1.2 1.3 2.7 0.0 3.6 2.4 19.1 9.2 4.1 1.8 0.8 3.6 59.2 8.3 2.3 OR4K5 ENSG00000176281 "Olfactory receptor family 4 subfamily K member 5" Q8NGD3 14 19920582-19921659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF135 "pHZ-17, ZNF61, ZNF78L1" ENSG00000176293 "Zinc finger protein 135" P52742 19 58059239-58086310 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 21.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 5.5;HSkMC: 5.5;MOLT-4: 6.3;NTERA-2: 5.5;T-47d: 7.0" "Low region specificity" "Detected in all" HPA006961 Approved Approved Cytosol NA NA Cytosol "HPA006961: AB_1080670" "unprognostic (4.87e-2)" "unprognostic (7.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.96e-1)" "unprognostic (1.01e-1)" "unprognostic (6.54e-2)" "unprognostic (1.70e-1)" "unprognostic (5.85e-2)" "unprognostic (9.18e-3)" "unprognostic (1.20e-2)" "unprognostic (1.01e-3)" "unprognostic (2.34e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (1.25e-1)" 3.6 2.5 4.8 2.1 4.8 1.3 6.3 3.3 5.0 6.1 3.5 3.6 1.3 8.8 8.0 2.7 6.2 4.2 3.4 4.1 3.2 4.5 0.8 2.7 2.3 4.4 4.2 3.0 11.5 2.3 10.7 8.3 3.9 4.6 6.0 2.1 10.0 2.4 5.3 2.0 4.6 2.1 6.8 2.4 3.9 2.6 6.5 3.9 7.1 8.1 1.8 2.3 4.8 3.8 7.5 0.0 0.0 1.4 0.0 0.1 0.0 0.0 3.3 0.0 4.3 0.2 0.0 0.2 0.0 3.6 4.7 2.6 0.2 0.0 0.0 4.7 0.0 5.1 0.0 0.0 0.0 1.9 0.0 5.5 5.5 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 6.3 0.0 5.5 0.0 0.0 0.0 0.0 0.0 2.2 3.8 5.2 0.1 0.0 0.0 0.0 4.8 7.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 2.3 0.0 0.0 0.0 2.6 0.0 0.0 1.9 0.0 0.1 0.0 0.4 0.1 0.1 0.8 1.7 1.7 1.0 0.0 2.6 0.0 2.0 0.1 0.4 4.8 4.8 3.3 5.0 4.1 3.2 4.4 4.2 3.0 4.6 2.4 3.9 7.5 2.7 0.0 1.1 5.5 3.2 2.3 2.5 0.8 2.8 11.9 7.9 7.6 5.3 11.5 1.2 9.2 16.7 0.9 0.8 0.1 21.5 6.4 13.3 7.8 5.6 3.3 2.4 1.7 8.1 0.7 0.2 4.1 0.0 3.6 5.1 12.3 4.2 0.3 0.6 15.2 9.3 1.2 2.0 0.3 0.3 11.5 7.8 0.5 1.8 1.9 0.3 8.0 1.0 6.0 13.7 0.6 0.3 6.8 0.0 2.1 0.2 2.5 4.2 14.0 0.0 3.3 5.3 12.7 11.5 1.0 3.1 0.7 1.0 4.6 0.9 1.6 OR4N2 ENSG00000176294 "Olfactory receptor family 4 subfamily N member 2" Q8NGD1 14 19719015-19830253 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 3.8" "Group enriched" "Detected in some" 18 "Early spermatids: 30.9;Late spermatids: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 2.0" "Not detected" "Not detected" NA NA "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M1 ENSG00000176299 "Olfactory receptor family 4 subfamily M member 1" Q8NGD0 14 19773504-19783696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "Early spermatids: 48.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXR1 "DLNB13, FOXN5" ENSG00000176302 "Forkhead box R1" Q6PIV2 11 118971712-118981287 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 4.2" "Group enriched" "Detected in some" 19 "Spermatocytes: 13.1;Spermatogonia: 33.5" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038124 Approved Nucleoplasm NA NA Nucleoplasm "HPA038124: " "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.1 33.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974620-63976543 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055942 Supported NA NA "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 292.5 447.5 396.9 135.3 393.2 294.5 289.3 437.7 548.9 239.1 465.2 461.3 340.9 238.0 122.2 617.4 248.9 79.1 1166.5 376.4 430.1 776.5 453.6 267.7 120.9 390.1 388.5 366.0 250.1 278.0 369.4 376.8 106.6 382.5 318.6 252.5 150.8 365.1 225.9 1538.4 350.9 384.6 133.5 396.5 279.2 471.2 97.4 427.1 208.5 345.7 1014.2 177.3 309.7 334.0 397.2 613.9 803.9 505.6 505.2 213.8 260.8 365.3 317.0 355.2 621.2 480.1 543.1 489.1 290.1 680.8 447.1 581.6 597.7 395.7 550.9 212.5 427.6 687.8 423.2 621.8 650.3 341.4 431.0 527.7 336.7 412.4 497.3 398.6 274.1 391.9 676.2 503.9 613.3 397.7 1600.5 613.8 1461.1 460.7 726.4 1401.4 473.9 406.3 1234.3 512.9 512.7 457.8 645.0 377.1 541.2 816.1 215.0 796.1 459.8 240.7 356.1 481.0 769.2 374.2 760.8 662.4 461.7 462.0 420.9 436.9 764.9 743.9 692.9 407.0 848.8 301.5 398.5 441.6 403.5 867.0 347.3 337.1 369.6 530.6 418.3 794.1 851.2 589.5 723.9 396.9 393.2 437.7 548.9 376.4 430.1 390.1 388.5 366.0 382.5 396.5 427.1 397.2 236.7 224.4 259.8 13.7 255.3 294.6 392.2 640.4 385.3 196.8 394.3 458.2 1263.1 424.7 396.1 437.7 73.0 451.2 305.9 1382.7 2341.9 453.1 9.6 271.6 217.2 215.7 721.6 272.9 12.5 483.1 559.6 246.1 395.0 305.1 224.5 209.3 227.4 811.5 927.5 107.7 16.8 1011.7 592.0 535.2 427.0 25.6 239.6 455.4 627.9 11.2 508.9 429.3 416.1 7.5 15.2 562.9 1103.8 221.2 393.2 419.8 1417.0 1658.2 345.2 187.5 157.8 256.0 339.9 74.0 55.5 844.0 370.9 366.9 290.4 203.7 1088.7 593.4 TAC4 "HK-1, PPT-C, Pptc" ENSG00000176358 "Tachykinin precursor 4" Q86UU9 17 49838309-49848017 "Predicted secreted proteins" "Hypotensive agent" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 5.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Excitatory neurons: 2.3;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;BEWO: 5.9;CACO-2: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (8.95e-2)" "unprognostic (1.71e-1)" "unprognostic (6.24e-2)" "unprognostic (8.15e-2)" "unprognostic (5.61e-2)" "unprognostic (6.05e-3)" "unprognostic (3.19e-1)" "unprognostic (2.00e-1)" "unprognostic (4.52e-2)" "unprognostic (4.69e-3)" "unprognostic (8.19e-5)" "unprognostic (8.69e-2)" "unprognostic (2.23e-1)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 0.2 0.3 0.7 0.3 0.5 0.7 0.1 1.5 1.4 0.2 0.8 0.1 0.2 0.2 0.0 0.6 0.0 0.3 1.0 0.5 0.0 0.1 1.7 0.3 0.4 0.3 0.2 0.2 0.1 0.1 0.1 5.1 0.2 0.9 0.3 0.0 0.3 0.4 0.0 0.2 1.7 0.2 0.3 0.0 0.7 0.3 0.3 0.1 0.0 0.5 0.0 0.0 0.4 0.1 0.7 0.0 2.5 0.0 0.4 0.0 0.0 5.9 0.0 0.0 0.0 0.0 3.5 0.2 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.7 0.1 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.2 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.9 0.3 0.3 0.0 0.5 0.2 0.1 0.1 0.2 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.5 1.4 0.5 0.0 0.3 0.2 0.2 0.9 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 18.0;Proximal tubular cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 7.6 5.8 2.8 4.3 3.8 8.8 7.3 4.2 3.2 6.2 2.0 4.3 3.2 6.4 2.3 2.4 4.0 3.5 6.1 2.9 3.0 7.5 8.8 3.0 4.1 2.9 3.0 2.5 6.0 16.7 4.2 4.1 2.1 3.6 5.2 3.0 6.3 6.9 3.0 8.3 2.6 4.5 3.3 2.7 5.9 8.2 11.9 3.2 10.2 4.1 3.2 3.2 4.6 3.5 4.6 2.2 13.4 9.0 14.6 5.7 3.5 8.5 2.5 6.2 5.3 6.4 10.4 5.2 4.9 6.9 3.5 9.8 5.6 6.9 5.0 4.6 10.4 13.0 6.2 8.4 22.0 4.9 3.9 4.4 5.6 4.9 7.0 6.6 7.0 15.5 24.0 8.4 3.9 5.6 6.7 16.8 9.6 16.9 4.5 7.9 16.8 5.6 9.2 5.3 16.7 13.5 23.1 7.6 4.1 11.7 14.5 9.1 9.8 10.8 6.3 12.4 3.2 3.3 6.3 9.5 16.8 4.3 8.7 3.7 6.4 5.8 5.0 5.7 6.4 2.8 3.9 5.2 4.3 6.6 3.5 3.8 4.3 3.1 5.6 8.4 5.9 7.8 3.9 2.8 3.8 4.2 3.2 2.9 3.0 2.9 3.0 2.5 3.6 2.7 3.2 4.6 9.1 0.0 2.0 1.6 3.9 0.9 1.2 2.6 2.2 3.1 3.5 3.2 2.5 4.3 1.7 7.3 2.1 1.6 2.5 1.3 5.9 6.9 18.0 5.7 3.3 3.0 3.0 3.0 1.6 8.6 5.1 2.3 4.6 6.9 1.3 8.0 1.1 7.5 3.6 0.0 1.6 3.2 4.1 2.8 2.3 12.3 0.9 2.9 1.8 1.0 5.5 2.3 2.1 4.0 2.5 9.9 4.2 1.5 11.1 2.6 1.9 22.6 1.8 3.1 6.6 2.3 3.9 7.1 8.2 0.9 0.4 1.4 3.7 3.6 2.6 1.5 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 126.7" "Cell type enriched" "Detected in some" 5 "Oligodendrocytes: 27.3" "Group enriched" "Detected in some" 5 "glioma: 3.1;liver cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 4.3;SH-SY5Y: 2.5" "Low region specificity" "Detected in all" HPA077250 Enhanced NA NA "HPA077250: AB_2732336" "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 0.3 0.0 28.4 0.0 73.4 0.0 0.1 35.0 71.3 0.1 7.2 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 29.4 37.1 0.0 3.4 0.2 0.0 90.4 59.1 17.8 0.0 0.2 1.2 0.9 0.0 101.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 31.2 0.0 0.1 0.0 54.7 0.0 0.1 0.0 0.0 0.0 0.0 126.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 73.4 35.0 71.3 29.4 37.1 90.4 59.1 17.8 101.1 31.2 54.7 126.7 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.6 2.8 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 27.3 0.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203681-122208952 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;skin 1: 3.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 3.3;Excitatory neurons: 3.2;Proximal tubular cells: 9.7;Spermatogonia: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.1;hTCEpi: 4.0;T-47d: 4.2;U-266/84: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA055261: AB_2682765" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.2 0.7 2.6 0.1 3.0 1.5 0.2 4.4 3.1 0.2 0.0 0.3 0.2 0.1 0.0 1.3 0.6 0.2 0.1 4.2 1.0 2.6 0.4 0.3 0.1 0.6 0.3 3.1 0.2 0.3 0.3 1.5 0.1 2.1 0.4 0.0 0.5 0.5 0.0 0.2 3.1 0.3 0.0 0.0 0.5 0.3 1.6 1.0 0.0 0.4 0.0 0.1 0.1 0.5 1.8 3.4 0.6 0.2 1.4 0.1 0.1 0.6 0.1 0.0 0.2 0.3 2.2 0.3 0.3 0.5 0.0 0.2 1.3 1.7 1.2 0.1 5.1 1.9 0.1 1.3 0.2 0.4 0.5 0.7 0.3 4.0 0.1 0.2 0.5 0.0 1.3 1.0 0.4 0.0 3.2 0.0 0.5 0.4 0.1 1.4 0.2 0.4 0.7 0.5 0.4 0.8 1.1 0.9 0.7 0.4 0.5 4.2 0.1 0.1 0.3 1.7 0.4 0.2 0.4 3.6 0.8 0.3 0.5 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.6 3.0 4.4 3.1 4.2 1.0 0.6 0.3 3.1 2.1 0.0 1.0 1.8 0.4 0.0 1.8 0.7 0.3 1.3 0.7 3.3 0.6 0.2 0.7 0.8 0.5 0.0 1.1 0.0 0.0 0.5 0.5 0.6 1.9 1.0 0.4 0.6 0.3 0.3 0.0 0.0 3.2 0.2 1.1 0.3 0.0 0.8 0.0 0.1 0.4 0.0 0.2 0.0 1.4 0.0 2.0 0.6 0.6 0.1 0.3 0.3 0.0 1.9 0.0 0.2 0.0 0.5 0.6 0.4 1.3 0.0 0.4 0.3 0.1 9.7 1.1 0.2 0.0 0.5 0.2 0.8 2.9 0.8 1.4 0.5 0.4 0.1 0.3 0.4 CDC26 "ANAPC12, APC12, C9orf17" ENSG00000176386 "Cell division cycle 26" Q8NHZ8 9 113255835-113275572 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044130 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044130: AB_10963690" "unprognostic (9.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "unprognostic (2.60e-1)" "unprognostic (1.48e-1)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (7.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.27e-1)" "unprognostic (6.26e-2)" "unprognostic (3.79e-2)" 39.4 33.3 28.8 34.4 29.1 29.2 39.3 29.4 39.8 34.3 34.5 36.5 31.1 28.4 42.1 34.5 31.2 25.5 47.0 27.9 32.9 45.3 53.6 34.5 42.9 30.0 28.7 26.3 34.1 30.2 59.3 29.8 28.0 30.8 37.2 34.5 42.0 32.8 32.1 47.9 35.4 37.5 26.8 30.9 42.3 34.6 22.5 31.2 46.4 35.5 52.8 47.3 40.7 33.0 30.9 47.0 73.3 62.5 32.2 104.4 89.3 29.0 67.1 100.7 67.6 66.3 78.0 53.9 84.1 56.6 58.3 77.2 88.8 53.2 99.1 66.8 80.3 38.9 55.7 71.4 73.1 50.8 99.6 55.0 62.2 68.9 62.5 92.2 70.3 91.7 67.2 85.3 63.7 51.8 94.7 86.2 62.9 102.7 213.1 65.1 73.1 134.3 42.9 71.1 78.2 48.1 45.7 88.4 63.7 51.4 68.2 57.9 43.4 62.1 40.5 37.9 61.4 87.5 43.5 79.5 67.4 57.1 58.3 41.0 239.6 116.9 274.2 177.6 127.3 220.0 233.4 222.3 195.9 122.2 201.0 253.5 195.2 182.8 192.8 122.9 103.8 241.6 171.5 28.8 29.1 29.4 39.8 27.9 32.9 30.0 28.7 26.3 30.8 30.9 31.2 30.9 91.9 35.3 40.9 3.3 58.5 77.9 79.3 111.8 68.3 20.3 58.2 79.8 5.3 45.8 61.2 22.0 22.9 45.7 59.6 51.1 113.5 64.4 22.2 53.4 67.4 65.7 31.8 55.2 5.0 59.5 68.6 54.3 21.4 43.3 27.3 48.6 63.1 83.3 58.4 15.2 5.5 50.7 73.2 51.6 92.0 13.9 80.2 49.6 51.6 2.8 67.9 76.7 72.1 5.0 6.7 58.0 62.7 43.6 51.7 91.4 88.9 169.2 68.1 36.4 26.3 54.2 43.7 35.3 16.8 55.0 90.8 47.9 75.4 50.0 47.2 97.7 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 156.0;kidney: 332.7;salivary gland: 262.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9" "Cancer enhanced" "Detected in all" "renal cancer: 62.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB032443, HPA042186, HPA056385" Enhanced Approved "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favorable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 2.1 5.4 1.5 13.5 3.9 0.1 14.2 2.8 3.0 13.8 0.9 156.0 40.4 11.9 4.0 11.0 10.5 6.9 1.9 1.8 1.4 332.7 5.6 3.2 1.0 2.7 1.7 1.4 9.4 7.5 3.6 0.5 13.1 3.6 13.0 103.1 0.0 262.5 6.3 0.9 60.0 143.0 18.4 1.4 7.1 9.9 2.6 2.6 0.4 11.2 0.2 0.9 5.4 23.8 2.5 3.6 1.1 0.4 1.4 0.1 1.7 3.6 0.0 0.0 0.1 0.1 6.1 1.3 0.0 2.7 0.1 0.1 7.8 5.1 0.5 0.0 0.0 1.8 0.0 0.7 6.6 0.6 0.7 0.0 1.7 3.0 0.3 0.1 0.0 0.0 4.6 0.4 0.0 0.0 3.8 0.2 0.2 11.4 29.0 1.0 0.0 0.2 13.9 0.5 13.9 14.9 1.0 0.8 13.4 0.6 1.3 6.5 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.9 2.8 3.0 1.8 1.4 2.7 1.7 1.4 3.6 1.4 2.6 2.5 0.7 0.0 0.5 0.0 1.1 1.5 7.2 1.3 1.2 0.0 4.8 2.2 0.5 30.0 2.3 191.3 0.0 1.2 0.3 476.1 45.0 2.1 0.2 17.4 25.2 0.5 26.9 0.0 1.1 3.0 0.7 7.1 7.1 43.5 8.9 43.4 1.1 1.2 1.4 0.0 0.8 288.8 4.1 0.3 0.5 0.5 25.4 0.7 1.8 0.0 0.0 0.0 0.0 0.5 0.3 0.6 226.2 6.8 0.2 13.5 270.2 16.3 0.4 0.0 13.1 0.3 3.9 0.2 1.6 3.5 3.4 114.5 1.2 16.7 170.9 10.5 CRLF3 "CREME9, CYTOR4" ENSG00000176390 "Cytokine receptor like factor 3" Q8IUI8 17 30769388-30824692 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007596 Enhanced Approved "Plasma membrane,Cytosol" NA NA 210000 "Plasma membrane, Cytosol" "HPA007596: AB_1847241" "unprognostic (1.02e-1)" "unprognostic (9.79e-2)" "unprognostic (7.12e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-2)" "unprognostic (9.22e-2)" "unprognostic (1.00e-2)" "unprognostic (3.10e-2)" "unprognostic (5.81e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.31e-7)" "unprognostic (3.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (6.51e-2)" 7.6 4.9 3.6 21.7 3.4 20.8 7.0 9.3 4.7 6.5 0.6 7.9 6.2 5.3 2.8 12.9 4.9 7.6 4.1 4.3 3.0 4.2 5.5 9.2 35.8 2.2 2.5 3.9 4.3 4.4 8.0 4.7 12.7 4.5 4.7 7.9 9.6 5.9 3.8 3.9 11.2 9.8 6.6 1.5 23.6 6.7 10.4 3.2 33.8 4.4 4.4 33.0 11.1 8.0 4.2 11.3 12.2 7.5 15.6 13.4 10.3 11.1 10.4 10.1 19.8 20.6 13.5 7.4 36.8 15.2 13.0 19.3 19.2 12.8 8.6 23.6 17.6 23.3 15.7 9.9 10.3 7.4 21.0 11.2 6.1 11.8 16.0 13.4 7.4 19.4 32.9 40.1 37.6 12.6 6.8 46.6 21.8 14.9 18.7 7.4 20.0 24.2 22.2 13.1 9.4 5.3 12.5 10.6 16.1 11.6 15.6 12.5 10.3 10.4 11.4 13.9 18.5 25.8 15.7 14.2 24.9 10.9 16.6 12.9 53.7 57.9 139.9 37.0 59.5 39.3 46.7 52.2 42.4 43.0 46.8 99.9 75.6 117.3 40.3 72.1 22.0 63.7 84.5 3.6 3.4 9.3 4.7 4.3 3.0 2.2 2.5 3.9 4.5 1.5 3.2 4.2 10.4 0.0 12.5 17.6 50.9 22.6 8.0 5.4 16.5 17.9 7.0 4.3 4.5 2.8 4.6 7.3 14.6 18.7 36.2 9.2 5.9 5.1 13.5 6.1 8.4 10.6 3.6 46.9 54.8 5.3 17.6 7.7 13.3 9.1 22.8 5.5 8.9 4.2 16.8 6.7 56.5 3.9 8.2 26.1 25.0 21.3 6.5 26.7 5.4 42.2 39.9 4.7 47.4 38.7 38.0 9.1 3.4 4.1 25.7 8.4 2.6 5.3 8.9 25.2 13.1 9.2 7.5 27.5 27.3 11.4 27.8 45.8 47.1 5.3 4.2 7.8 RNPEP APB ENSG00000176393 "Arginyl aminopeptidase" Q9H4A4 1 201982372-202006147 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036074, HPA036075, HPA061487" Approved Approved "Golgi apparatus" "Secreted - unknown location" NA NA 7800000 "Golgi apparatus" "HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537" "unprognostic (8.57e-2)" "unprognostic (3.43e-2)" "unprognostic (2.81e-1)" "unprognostic (5.45e-2)" "unprognostic (2.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-3)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-1)" "unprognostic (3.50e-3)" "unprognostic (1.91e-1)" "unprognostic (6.00e-2)" "unprognostic (1.97e-2)" "unprognostic (1.68e-1)" 25.4 31.4 7.3 23.0 7.4 25.5 26.1 7.9 8.6 25.0 14.3 54.1 69.1 25.9 39.4 54.3 40.9 22.5 14.7 7.9 10.3 26.1 32.6 30.8 22.2 9.1 8.0 6.1 23.6 34.4 25.6 13.4 27.7 8.7 26.2 57.5 4.3 38.6 27.8 19.0 37.3 58.6 28.3 9.0 33.7 28.8 18.1 9.4 21.9 33.5 12.8 26.7 23.5 29.0 10.2 66.2 71.0 40.8 62.7 65.1 61.3 102.1 49.5 95.6 60.9 67.6 51.8 83.1 14.3 61.8 87.8 38.0 117.4 52.5 97.2 42.4 39.1 67.6 35.5 32.5 48.7 55.1 92.3 121.3 55.9 97.9 54.1 62.0 74.7 110.6 34.8 82.5 21.6 62.1 61.0 12.8 40.2 58.4 105.4 34.4 48.3 57.5 101.6 128.7 61.2 46.9 39.9 122.2 155.9 52.1 78.9 116.6 52.4 79.9 28.9 38.0 28.7 61.3 45.3 39.6 12.9 27.8 77.3 58.1 22.9 14.9 22.1 3.0 25.9 4.1 2.5 3.2 3.4 19.8 4.6 2.8 3.2 11.0 2.9 29.9 7.2 5.4 4.0 7.3 7.4 7.9 8.6 7.9 10.3 9.1 8.0 6.1 8.7 9.0 9.4 10.2 26.7 9.6 21.5 8.5 19.7 28.8 40.5 31.2 40.5 15.5 32.8 33.1 12.2 38.6 26.7 25.8 10.4 116.6 21.4 136.6 19.6 71.1 5.4 35.9 17.7 26.1 44.9 19.0 12.7 51.2 91.1 26.1 45.3 21.5 15.2 23.2 27.1 51.4 103.7 11.8 11.1 71.9 14.2 81.0 39.4 4.9 25.4 72.9 24.9 15.0 86.7 12.6 17.5 5.5 8.1 47.8 83.4 23.0 23.6 25.0 201.7 65.8 39.1 8.0 26.3 11.4 28.2 22.7 9.5 53.6 21.6 87.6 17.7 33.2 86.6 34.8 EID2 "CRI2, EID-2, MGC20452" ENSG00000176396 "EP300 interacting inhibitor of differentiation 2" Q8N6I1 19 39538707-39540161 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045477 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA045477: AB_10959785" "unprognostic (5.91e-2)" "unprognostic (6.37e-3)" "prognostic favorable (9.73e-4)" "unprognostic (5.93e-2)" "unprognostic (6.50e-2)" "unprognostic (1.39e-1)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-1)" "unprognostic (6.88e-3)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" 10.5 18.0 14.2 8.9 16.6 6.5 8.6 15.2 21.5 7.8 13.5 8.7 6.9 11.0 8.2 9.2 8.5 6.2 9.3 15.9 16.9 12.7 10.9 8.5 9.2 15.4 14.5 16.1 8.5 7.9 12.7 13.1 14.5 16.2 9.1 6.7 15.9 7.8 8.1 11.2 7.3 9.1 9.9 13.9 9.5 8.8 9.1 14.5 14.4 8.4 10.4 8.5 7.9 6.6 18.6 25.0 33.4 31.1 21.2 24.7 15.3 4.6 29.3 22.0 22.5 23.2 21.2 7.7 25.4 23.5 20.6 15.1 10.5 29.0 21.3 29.0 24.6 36.5 11.4 19.1 25.5 24.5 19.9 16.1 18.0 13.3 18.7 14.4 17.8 26.6 49.0 18.8 17.2 19.8 16.5 29.0 17.5 17.4 30.1 14.0 26.6 29.7 11.9 28.9 22.8 29.0 20.6 31.8 12.6 21.0 20.9 17.1 12.9 19.2 14.3 51.0 19.1 22.3 26.9 33.8 32.1 13.3 18.5 11.8 0.0 0.4 0.7 0.8 0.5 0.8 0.5 1.0 1.0 0.5 0.5 1.0 1.4 0.1 0.3 0.5 0.5 0.2 0.4 14.2 16.6 15.2 21.5 15.9 16.9 15.4 14.5 16.1 16.2 13.9 14.5 18.6 16.4 19.2 9.2 2.6 7.3 10.1 4.5 2.4 6.2 23.9 11.2 15.6 19.1 17.2 4.0 14.7 10.4 48.9 14.0 6.5 1.9 5.2 3.2 18.3 23.3 14.4 7.2 4.2 7.4 5.0 5.3 10.0 5.1 12.4 1.3 14.4 13.2 12.9 10.8 26.9 8.0 5.3 0.0 8.1 6.5 1.3 10.2 7.8 8.8 3.7 7.5 31.1 12.3 5.0 8.6 6.2 7.4 13.2 7.2 5.3 5.9 9.5 5.5 20.7 6.6 9.7 12.7 11.3 8.8 5.2 7.5 19.4 11.3 25.2 7.5 2.6 DMRTA1 ENSG00000176399 "DMRT like family A1" Q5VZB9 9 22446824-22455740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 8.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 19.4;Distal tubular cells: 15.6;Glandular and luminal cells: 14.5;Hepatocytes: 30.8;Proximal tubular cells: 29.2;Squamous epithelial cells: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.3;hTERT-RPE1: 7.4;LHCN-M2: 2.9;RPTEC TERT1: 3.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.2" "HPA044764, HPA062253" Uncertain Approved Vesicles NA NA Vesicles "HPA044764: AB_10959788, HPA062253: AB_2684726" "unprognostic (1.47e-1)" "unprognostic (2.48e-2)" "unprognostic (2.86e-1)" "unprognostic (7.74e-4)" "unprognostic (3.81e-2)" "unprognostic (2.67e-3)" "unprognostic (4.36e-2)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (9.64e-2)" "unprognostic (3.65e-3)" "unprognostic (2.92e-1)" "prognostic favorable (1.14e-6)" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (8.53e-3)" 1.8 0.0 0.3 0.2 0.4 0.0 0.5 0.3 0.3 1.6 2.0 0.4 0.6 0.3 1.2 1.7 0.3 1.0 0.3 0.6 0.3 3.5 8.5 0.9 0.4 0.3 1.5 0.2 0.2 1.4 2.2 0.7 0.0 0.4 1.4 0.4 0.1 3.5 0.4 0.7 0.2 0.5 0.1 0.4 0.2 2.1 0.1 0.6 0.5 1.8 1.1 0.8 0.4 0.1 0.4 0.2 0.3 0.0 0.0 0.2 0.1 0.1 0.0 6.3 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.2 1.2 1.7 0.2 0.0 0.4 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.1 7.4 0.4 0.0 0.0 2.3 2.9 0.6 0.0 0.0 1.2 0.3 2.1 0.0 0.1 0.9 3.0 0.0 0.1 0.0 0.8 0.5 1.4 1.4 0.0 0.0 2.1 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.3 0.6 0.3 0.3 1.5 0.2 0.4 0.4 0.6 0.4 0.1 0.0 2.7 2.0 0.1 0.0 4.8 7.2 19.4 0.5 1.9 1.0 1.9 5.7 5.6 5.5 0.0 0.0 0.0 1.1 15.6 6.9 0.1 10.7 1.4 0.3 2.4 0.0 0.0 6.7 0.0 0.8 10.2 14.5 0.0 0.6 0.0 30.8 0.3 0.0 0.0 0.7 8.2 0.3 0.3 0.1 0.3 0.4 0.0 1.0 0.0 5.4 0.0 0.0 0.0 7.8 0.2 0.0 0.1 6.3 4.1 29.2 5.9 0.1 0.0 2.9 0.6 0.2 1.2 26.5 0.4 0.1 0.3 0.0 1.9 8.2 EID2B "EID-3, FLJ38944" ENSG00000176401 "EP300 interacting inhibitor of differentiation 2B" Q96D98 19 39530987-39532852 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.1;Horizontal cells: 32.0;NK-cells: 27.8;Rod photoreceptor cells: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064185 Approved NA NA "HPA064185: AB_2685207" "unprognostic (1.15e-1)" "unprognostic (8.53e-3)" "unprognostic (6.41e-3)" "unprognostic (1.08e-3)" "unprognostic (4.00e-1)" "unprognostic (7.08e-2)" "unprognostic (9.92e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.57e-4)" "unprognostic (6.80e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-2)" "unprognostic (1.78e-1)" "unprognostic (2.77e-1)" "unprognostic (4.20e-2)" 2.0 3.6 7.2 2.0 7.4 1.2 2.1 8.4 7.1 3.6 4.8 2.9 1.3 4.1 2.6 1.2 4.2 1.2 3.0 6.6 8.7 2.4 1.0 2.2 3.2 5.7 6.3 7.4 5.2 1.4 1.9 10.3 1.1 6.2 2.9 0.9 9.5 1.3 2.0 2.1 0.9 2.5 1.5 5.0 3.4 1.9 5.2 7.8 2.6 3.6 1.2 1.5 3.0 2.4 7.4 2.0 4.1 4.6 5.1 2.9 2.7 1.0 3.1 2.4 5.0 4.5 0.6 1.3 4.0 1.7 1.9 2.5 0.6 2.3 2.1 3.7 6.3 6.3 1.8 5.3 2.5 2.5 1.8 3.1 2.7 1.5 2.8 1.4 1.9 2.2 8.9 2.0 5.6 2.5 1.8 3.6 3.1 1.2 0.7 2.2 4.6 4.2 2.0 2.5 0.6 6.3 3.9 6.1 0.2 2.5 1.8 0.5 1.0 1.5 3.7 6.6 3.6 4.1 4.0 6.1 3.0 2.0 4.3 2.0 0.4 1.9 3.9 2.8 2.1 2.7 3.6 3.5 4.1 2.4 3.1 6.5 4.3 0.6 4.6 2.2 2.4 2.4 2.1 7.2 7.4 8.4 7.1 6.6 8.7 5.7 6.3 7.4 6.2 5.0 7.8 7.4 3.9 6.4 1.1 3.9 8.5 1.5 1.3 3.5 1.8 30.1 1.6 2.7 5.5 7.2 6.3 9.2 25.0 3.0 6.4 0.2 11.7 4.0 1.8 5.3 6.0 4.3 6.1 4.6 9.0 3.0 1.2 6.3 2.0 0.7 4.5 9.1 3.3 1.8 3.7 32.0 9.2 0.5 4.1 4.1 5.3 1.2 15.2 4.6 8.8 4.7 5.5 23.2 27.8 3.0 5.5 1.8 1.3 11.3 5.6 0.6 0.2 4.9 10.8 30.2 13.1 3.5 5.3 22.1 8.8 0.5 0.6 0.8 7.8 8.0 0.1 0.4 GJC3 "CX30.2, GJE1" ENSG00000176402 "Gap junction protein gamma 3" Q8NFK1 7 99923266-99929620 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 8.7;pancreas: 11.1;salivary gland: 11.8" "Cell type enhanced" "Detected in some" "Breast glandular cells: 36.3;Breast myoepithelial cells: 26.9;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 12.8;Prostatic glandular cells: 13.0" "Group enriched" "Detected in many" 5 "breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.3;SK-MEL-30: 2.3;U-2197: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015024 Uncertain NA NA "HPA015024: AB_1847132" "unprognostic (9.31e-2)" "unprognostic (6.43e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-2)" "unprognostic (2.54e-1)" "unprognostic (2.88e-2)" "unprognostic (7.68e-2)" "unprognostic (9.14e-2)" "unprognostic (6.71e-2)" "unprognostic (4.78e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (1.14e-1)" "unprognostic (4.17e-1)" "unprognostic (3.49e-1)" "unprognostic (5.81e-3)" 1.3 0.5 0.9 0.1 1.0 0.1 8.7 0.2 1.5 0.3 0.0 0.4 0.4 0.2 0.0 0.2 0.3 0.3 0.4 1.2 0.4 1.0 2.8 0.2 0.2 0.4 0.5 1.0 0.4 11.1 0.0 0.4 1.0 0.6 4.7 0.0 1.0 11.8 0.1 0.2 2.2 0.3 0.2 0.0 0.3 1.4 1.8 0.7 0.1 0.3 0.2 0.0 0.3 0.3 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.4 0.7 0.5 0.6 0.1 0.5 0.2 0.4 1.1 1.3 0.0 0.0 0.4 0.3 0.0 0.4 0.1 0.2 0.1 0.3 2.3 0.5 0.7 0.0 0.3 0.1 0.4 1.8 0.1 0.1 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.9 1.0 0.2 1.5 1.2 0.4 0.4 0.5 1.0 0.6 0.0 0.7 1.5 1.1 3.2 3.7 0.0 0.4 0.3 4.9 1.4 0.0 0.0 36.3 26.9 0.0 4.3 2.1 1.8 0.0 0.0 0.6 0.0 1.9 0.4 0.4 0.0 0.0 1.5 1.2 0.0 0.7 24.0 0.0 0.2 0.0 0.0 4.5 0.2 1.1 5.0 0.1 0.0 0.4 0.1 8.2 0.0 0.3 1.1 0.3 0.1 0.0 0.0 0.6 4.0 0.0 0.0 0.6 12.8 0.0 0.0 0.0 13.0 0.0 9.7 0.3 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 9.4 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500696-104256094 "Human disease related genes, Predicted intracellular proteins" Differentiation "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 51.1;brain: 52.7;retina: 103.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 383.6;Cone photoreceptor cells: 706.8;Excitatory neurons: 1589.3;Inhibitory neurons: 1234.9;Oligodendrocyte precursor cells: 577.0;Rod photoreceptor cells: 1088.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 9.2;RT4: 7.3;SCLC-21H: 16.5;SuSa: 8.8;U-2 OS: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: AB_2685678" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.2 51.1 17.3 0.2 30.6 0.4 0.7 40.7 52.7 7.6 0.0 0.1 0.4 0.6 0.9 0.3 5.9 0.9 0.0 20.2 17.3 0.3 0.1 0.1 0.3 10.9 16.5 27.9 2.1 0.8 0.0 15.1 0.4 17.3 1.8 0.1 103.2 0.8 1.0 0.2 0.2 0.5 1.4 2.0 0.1 0.6 2.9 23.2 0.8 1.4 0.1 0.2 1.7 2.5 33.7 4.6 0.0 4.8 0.0 0.0 0.1 0.0 0.4 0.3 1.0 1.3 0.1 0.3 9.2 0.1 0.1 1.4 0.3 1.9 0.8 2.2 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 1.0 1.5 0.0 1.2 0.0 0.5 0.0 0.4 0.9 0.0 4.0 0.0 0.5 0.0 0.0 0.0 0.0 7.3 16.5 3.3 0.0 0.1 0.7 8.8 0.4 0.2 0.0 0.0 6.5 0.1 0.1 1.2 0.0 0.1 0.4 0.3 0.3 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 17.3 30.6 40.7 52.7 20.2 17.3 10.9 16.5 27.9 17.3 2.0 23.2 33.7 0.4 28.9 22.5 38.5 0.2 0.3 1.8 2.8 1.8 383.6 0.7 0.6 0.9 1.5 16.9 0.0 706.8 0.5 0.1 0.2 1.9 0.1 34.2 2.1 0.4 4.9 8.4 0.0 1589.3 0.0 0.3 3.7 0.0 3.7 16.4 18.0 0.7 0.3 0.3 67.3 1234.9 0.9 0.0 0.6 0.8 20.1 72.1 2.5 1.8 63.7 0.6 86.6 1.0 577.0 27.0 0.3 1.2 29.3 0.3 4.1 2.0 0.2 10.6 1088.7 0.0 0.8 1.0 34.8 15.7 0.8 0.4 0.1 2.1 0.1 1.5 1.1 KCMF1 "DEBT91, DKFZP434L1021, PCMF, ZZZ1" ENSG00000176407 "Potassium channel modulatory factor 1" Q9P0J7 2 84971093-85059472 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030383, HPA030384" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA030383: AB_10599977, HPA030384: AB_10601230" "unprognostic (8.01e-2)" "unprognostic (1.98e-2)" "unprognostic (9.95e-2)" "unprognostic (7.42e-3)" "unprognostic (1.24e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (5.68e-3)" "unprognostic (1.43e-1)" "unprognostic (9.81e-2)" "prognostic unfavorable (6.10e-5)" "unprognostic (4.98e-2)" "prognostic unfavorable (4.18e-6)" "unprognostic (6.11e-2)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (1.01e-1)" 40.1 24.2 25.4 34.3 22.8 61.4 34.2 22.2 30.5 28.3 21.7 47.1 35.1 29.5 40.0 58.9 27.8 29.8 44.5 25.9 24.4 33.4 45.4 32.1 36.3 24.0 27.0 23.4 24.9 80.7 39.5 21.0 33.3 25.6 28.1 46.8 32.7 37.1 32.1 141.2 34.7 36.5 40.9 24.3 28.6 33.7 69.6 27.9 37.3 40.8 72.4 52.8 38.1 36.4 26.1 102.3 76.4 66.7 51.8 69.0 66.2 114.5 106.0 96.0 97.4 64.6 93.8 104.5 110.9 107.2 141.6 97.0 65.1 52.7 100.6 127.8 87.6 37.9 69.8 55.9 97.3 134.7 77.9 63.9 69.0 155.7 95.7 262.5 86.4 74.7 57.2 71.3 83.1 98.4 91.5 76.9 42.6 74.9 125.5 64.1 55.4 94.7 68.5 88.3 85.8 64.8 48.9 61.0 76.0 101.8 76.4 35.3 48.1 66.2 98.9 99.2 93.5 111.8 99.1 130.9 110.4 74.5 55.7 75.8 3.1 1.6 5.4 2.7 1.4 2.1 2.3 1.9 2.0 1.4 3.1 1.6 1.8 4.5 1.9 2.2 2.6 6.0 1.0 25.4 22.8 22.2 30.5 25.9 24.4 24.0 27.0 23.4 25.6 24.3 27.9 26.1 45.5 32.1 26.6 25.5 29.6 70.9 92.9 32.7 24.5 31.8 42.8 34.3 51.4 21.5 33.2 12.9 14.6 23.6 42.0 56.2 25.4 34.8 85.2 55.3 33.8 33.1 19.2 29.0 47.9 53.4 32.0 31.9 18.8 80.5 17.7 30.9 24.3 32.9 20.1 72.3 47.4 29.0 20.3 33.3 61.1 127.7 25.7 34.7 26.6 51.5 36.8 37.5 21.6 45.8 36.6 61.2 40.8 29.0 27.6 107.6 44.8 30.7 22.5 27.5 26.3 48.2 47.2 44.9 24.6 34.4 79.0 40.8 32.1 27.1 33.7 135.5 DNAJC30 WBSCR18 ENSG00000176410 "DnaJ heat shock protein family (Hsp40) member C30" Q96LL9 7 73680918-73683453 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" Chaperone "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 120.1;Late spermatids: 230.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017318 Supported NA NA "HPA017318: AB_1858788" "unprognostic (1.86e-2)" "unprognostic (1.85e-1)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (2.66e-2)" "unprognostic (4.53e-1)" "unprognostic (3.93e-2)" "unprognostic (2.85e-3)" "unprognostic (4.60e-2)" "prognostic favorable (4.91e-8)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" 6.2 14.8 6.2 3.1 7.2 2.9 6.3 6.1 8.3 5.3 4.3 5.9 3.8 7.2 4.6 5.5 6.4 2.0 11.3 6.9 6.1 9.5 12.0 4.0 3.5 6.5 5.8 7.3 6.3 8.0 6.6 10.6 2.8 7.1 6.7 3.2 3.8 6.1 4.7 9.3 4.9 5.3 2.9 4.1 6.0 6.4 12.6 6.0 3.8 8.7 4.9 3.0 6.3 4.4 6.5 6.5 6.3 4.6 9.2 7.0 4.9 4.8 10.0 7.3 7.6 7.4 6.1 6.6 5.7 2.5 8.0 11.2 9.0 4.1 5.6 4.3 6.7 8.4 3.3 6.0 6.5 7.2 5.6 4.5 5.5 4.6 6.9 5.9 5.3 6.6 7.3 6.8 5.0 7.5 13.0 9.1 11.3 3.9 6.0 10.6 6.2 3.6 14.1 9.9 7.5 12.3 6.6 10.2 17.7 7.9 4.6 16.1 3.7 6.5 8.0 5.8 8.4 7.2 5.3 3.9 5.4 6.4 3.8 10.0 5.4 6.2 3.9 6.3 5.7 7.7 7.4 7.7 7.6 6.0 9.8 9.1 7.8 0.8 6.0 4.4 6.3 5.6 5.2 6.2 7.2 6.1 8.3 6.9 6.1 6.5 5.8 7.3 7.1 4.1 6.0 6.5 10.0 19.2 6.2 2.3 14.7 5.9 16.6 19.9 12.5 34.9 13.9 11.9 19.7 14.3 15.8 18.4 14.6 43.6 18.6 7.2 56.7 30.2 120.1 15.9 13.3 10.6 17.4 6.9 5.6 28.0 16.2 13.9 16.3 11.3 12.7 20.8 15.0 25.3 22.3 20.2 6.1 12.8 12.2 13.2 5.3 230.1 24.5 9.3 14.2 2.8 26.9 24.6 32.0 2.5 8.9 19.2 8.4 18.4 9.4 13.3 15.4 81.8 10.0 29.5 19.7 12.6 12.4 69.6 16.5 16.9 8.2 36.0 11.2 56.0 17.1 12.6 SPRYD4 DKFZp686N0877 ENSG00000176422 "SPRY domain containing 4" Q8WW59 12 56468578-56479708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 20.7" "Cell type enhanced" "Detected in many" "Hepatocytes: 147.2;Proximal tubular cells: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053469 Uncertain Approved Nucleoplasm NA NA 7500 Nucleoplasm "HPA053469: AB_2682162" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (3.06e-3)" "prognostic favorable (4.52e-4)" "unprognostic (5.59e-3)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (9.98e-2)" "unprognostic (1.27e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-1)" "unprognostic (3.44e-1)" "unprognostic (1.14e-1)" 1.4 3.7 1.5 1.6 1.5 2.8 3.1 3.1 2.0 2.0 0.6 2.5 2.0 2.0 3.0 3.1 2.1 1.5 3.0 1.4 1.2 3.7 20.7 1.4 1.8 1.1 0.8 1.7 2.4 6.0 2.5 3.8 1.2 1.9 2.6 3.2 3.4 2.7 1.7 4.2 2.3 2.2 1.7 0.5 2.4 2.5 1.5 1.2 1.4 2.7 5.2 1.7 2.3 2.1 1.7 2.1 2.7 2.3 1.8 2.0 1.3 3.1 1.7 1.7 3.5 2.1 2.5 3.6 2.6 2.2 2.2 2.4 3.5 2.0 2.9 2.2 1.3 4.1 3.8 3.1 3.8 1.9 2.6 3.7 2.9 1.9 2.5 2.1 1.9 3.6 1.8 2.1 11.0 3.0 3.4 1.3 1.9 1.5 2.4 3.1 1.6 1.7 5.4 3.8 2.6 2.3 1.1 3.3 3.9 2.6 1.4 6.6 0.8 1.7 1.5 2.8 2.2 1.4 1.8 1.1 0.9 1.2 2.2 1.9 1.0 1.0 0.5 0.7 0.7 0.8 1.0 0.7 0.7 0.9 1.0 0.7 0.7 0.7 1.2 0.9 1.3 0.3 0.7 1.5 1.5 3.1 2.0 1.4 1.2 1.1 0.8 1.7 1.9 0.5 1.2 1.7 4.4 0.0 7.4 2.0 7.9 4.8 16.2 24.8 10.2 13.2 14.1 12.7 17.7 18.6 16.2 22.0 16.7 38.3 5.8 17.3 54.8 26.6 1.4 4.0 7.5 8.9 17.5 19.1 0.9 21.4 24.3 8.1 14.8 9.8 10.2 10.7 10.0 147.2 20.8 16.8 1.6 14.6 28.5 12.2 2.3 1.1 9.0 6.4 5.4 1.9 11.1 10.2 8.2 2.0 2.2 18.5 10.1 10.5 6.3 10.8 19.5 101.5 5.9 17.8 0.0 8.1 8.6 5.1 10.2 22.2 5.3 36.0 4.4 30.2 16.4 19.8 VPS37D "MGC35352, WBSCR24" ENSG00000176428 "VPS37D subunit of ESCRT-I" Q86XT2 7 73667831-73672112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.0;Collecting duct cells: 11.0;Distal tubular cells: 9.8;Muller glia cells: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040978 Uncertain Approved Vesicles NA NA Vesicles "HPA040978: AB_10805833" "unprognostic (2.98e-2)" "unprognostic (2.17e-1)" "unprognostic (1.13e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-1)" "unprognostic (3.85e-2)" "unprognostic (2.54e-1)" "unprognostic (3.94e-1)" "unprognostic (8.80e-2)" "unprognostic (1.97e-1)" "prognostic favorable (2.07e-5)" "unprognostic (4.19e-2)" "prognostic favorable (5.80e-9)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" 1.6 1.3 7.3 0.3 7.7 0.2 2.4 7.0 12.2 5.5 2.6 2.4 1.8 3.8 2.9 0.8 3.6 1.4 2.1 7.9 7.0 11.4 9.7 1.0 0.3 6.9 6.5 7.4 4.3 4.0 2.7 3.3 0.3 6.5 3.7 0.2 1.6 3.2 2.0 1.4 2.5 1.9 0.7 5.2 0.9 2.1 7.2 7.1 0.3 3.4 0.5 0.1 2.2 2.8 6.1 0.5 2.3 1.8 3.8 1.2 2.4 1.1 1.0 1.5 0.8 1.0 0.2 0.7 0.8 0.9 1.3 2.1 0.3 1.9 0.9 0.2 0.3 2.0 0.0 0.2 2.6 3.2 0.0 1.1 1.9 0.5 1.1 0.3 3.5 0.9 3.2 1.1 0.2 1.1 2.8 0.6 0.0 1.2 0.7 3.3 0.1 0.0 0.1 3.0 0.2 3.7 11.8 0.0 1.6 2.3 0.3 3.8 0.1 1.3 2.2 3.0 1.3 0.8 1.4 0.1 1.1 5.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 7.7 7.0 12.2 7.9 7.0 6.9 6.5 7.4 6.5 5.2 7.1 6.1 2.4 0.0 0.0 1.3 0.2 1.0 0.8 0.3 0.6 13.0 3.4 3.8 1.8 1.5 0.1 11.0 0.0 0.2 0.1 0.2 9.8 4.0 1.1 3.6 3.1 1.1 4.9 0.0 1.6 0.8 0.4 1.6 0.0 5.1 0.0 5.9 1.8 5.3 0.1 0.0 2.7 0.4 2.0 0.0 0.4 0.9 1.8 0.2 5.4 1.0 0.6 13.9 0.0 1.0 0.9 1.8 1.4 2.6 0.3 1.0 2.0 8.3 0.2 5.3 0.0 0.9 2.7 0.6 8.3 0.1 1.1 0.3 0.2 0.9 0.7 0.4 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254000-38256093 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 4100000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: AB_2680270" "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 60.2 9.6 14.3 7.9 13.0 0.1 51.0 13.7 13.8 22.8 13.4 14.9 10.2 31.4 7.7 11.2 22.8 19.1 53.1 11.4 13.2 15.9 9.5 56.0 6.7 15.1 13.8 10.7 9.6 7.8 10.6 6.2 25.2 14.8 14.6 7.3 0.8 13.7 9.9 33.5 13.9 19.0 19.9 13.2 16.8 14.0 3.5 14.1 4.7 31.7 43.7 4.2 19.4 16.9 15.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 451.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 13.0 13.7 13.8 11.4 13.2 15.1 13.8 10.7 14.8 13.2 14.1 15.6 396.6 0.0 3.2 0.0 0.9 3.4 0.2 0.0 1.8 0.1 1.5 2.5 6.4 1.5 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.1 0.2 0.5 272.8 0.0 0.0 0.4 0.2 0.1 31.0 0.0 0.3 1.3 0.1 567.2 2.1 0.4 0.0 0.2 0.0 0.0 6.4 3.1 1.0 0.6 1.1 5.4 15.0 0.0 0.2 0.0 4.0 2.9 0.0 0.0 0.4 1.4 0.2 0.0 0.0 0.0 0.5 0.0 14.1 7.5 1.6 0.9 0.9 3.1 0.1 1.3 6.7 0.0 0.3 SYNE3 "C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53" ENSG00000176438 "Spectrin repeat containing nuclear envelope family member 3" Q6ZMZ3 14 95407266-95475836 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 70.2;Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 103.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.5;ASC TERT1: 36.2;Karpas-707: 42.3;REH: 34.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055227, HPA077140" Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA055227: AB_2682747, HPA077140: AB_2686826" "unprognostic (4.63e-2)" "unprognostic (6.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.48e-3)" "unprognostic (7.15e-2)" "unprognostic (2.12e-3)" "unprognostic (2.45e-1)" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.87e-1)" "unprognostic (8.50e-2)" "unprognostic (3.32e-1)" "unprognostic (7.41e-6)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.19e-2)" 15.5 3.4 5.6 4.3 8.3 13.9 12.7 6.0 5.3 3.6 8.2 2.6 1.6 2.3 1.4 2.1 4.6 2.1 4.0 3.9 5.5 1.1 3.0 4.4 6.0 9.3 7.5 2.5 4.0 0.9 0.4 1.8 3.4 8.1 1.6 2.6 12.0 3.2 1.2 2.3 4.1 3.8 2.2 6.2 5.1 2.1 2.7 7.3 2.4 2.9 3.3 6.0 3.2 4.2 12.4 1.2 0.1 0.7 1.1 46.5 36.2 14.3 5.4 9.4 5.1 4.0 7.8 1.3 6.3 0.9 2.6 1.6 0.3 1.1 4.0 2.3 20.9 0.9 4.3 0.9 2.1 6.0 6.6 10.4 10.2 1.4 6.4 3.7 0.4 9.0 1.9 0.3 42.3 3.9 1.5 3.9 7.3 0.1 0.2 2.6 34.8 23.2 13.5 0.6 0.7 1.0 5.1 0.2 0.1 2.5 0.6 2.0 9.6 8.2 3.7 2.2 5.0 0.7 5.0 11.1 5.9 7.4 14.6 28.2 2.2 1.9 0.1 0.7 1.5 0.9 1.2 1.0 0.8 0.8 1.0 1.2 1.0 0.9 0.3 1.6 1.0 0.9 1.0 5.6 8.3 6.0 5.3 3.9 5.5 9.3 7.5 2.5 8.1 6.2 7.3 12.4 12.4 9.6 18.3 3.3 19.7 2.3 0.4 0.1 0.6 5.1 1.0 1.3 70.2 0.0 0.7 0.0 62.6 2.2 16.1 4.9 0.0 0.0 3.9 6.5 5.1 14.7 1.2 4.0 2.5 0.4 15.0 22.3 1.1 1.4 12.0 0.2 5.0 6.8 4.3 6.7 3.3 5.0 0.0 17.6 14.8 2.4 13.1 20.3 5.4 3.7 27.8 5.3 9.2 14.1 20.8 0.5 6.2 0.4 20.6 1.9 2.9 0.4 6.6 103.7 6.6 19.1 12.1 0.6 1.1 0.3 1.0 1.9 14.0 0.0 1.9 0.5 CLK2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA055366: AB_2682795, HPA059507: AB_2684044" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.43e-4)" 23.3 25.8 12.3 10.8 12.3 11.5 24.6 14.4 14.5 38.7 14.3 22.2 11.8 30.0 12.9 22.8 29.0 9.7 18.0 12.4 13.2 26.8 29.2 22.2 19.8 12.6 12.1 12.1 34.2 24.1 14.1 31.7 13.9 12.7 33.3 8.7 9.5 23.5 11.4 16.3 27.2 24.2 11.0 12.1 40.5 20.9 16.3 12.4 18.8 33.5 8.6 16.1 28.3 30.1 13.6 10.8 10.5 29.8 11.4 17.3 9.1 22.5 8.1 12.3 8.2 7.8 13.1 8.7 23.3 9.7 6.6 4.0 17.0 16.8 13.5 6.3 11.4 17.7 20.4 12.9 15.4 14.6 26.8 20.5 7.6 10.7 11.3 20.3 19.0 13.6 16.9 29.6 15.4 10.5 22.2 12.1 11.3 21.2 27.2 17.6 17.7 21.6 28.0 17.9 25.8 11.8 25.1 4.5 10.9 9.9 21.4 15.9 24.9 9.3 4.3 12.1 9.1 9.1 31.6 28.6 22.9 9.9 19.1 5.9 0.5 0.8 1.9 0.8 0.4 1.6 1.2 1.5 0.8 0.9 0.9 1.6 1.6 0.8 0.5 0.4 0.8 0.9 0.6 12.3 12.3 14.4 14.5 12.4 13.2 12.6 12.1 12.1 12.7 12.1 12.4 13.6 9.2 16.0 24.3 9.8 13.7 4.6 5.7 4.2 17.6 5.7 7.8 7.5 14.9 12.8 12.6 7.3 4.2 8.0 7.1 5.4 0.0 6.5 6.5 6.9 15.2 11.1 6.7 8.4 8.3 4.4 8.0 11.3 25.0 9.5 10.1 12.1 7.5 8.4 6.9 5.0 6.8 9.1 2.0 11.4 4.5 6.6 7.8 10.4 3.6 9.4 9.5 5.4 8.2 9.5 8.0 4.9 4.8 3.0 17.1 5.7 5.1 3.2 5.1 7.2 6.6 6.4 12.6 8.6 4.3 14.3 4.5 12.4 11.0 7.4 7.2 5.1 LPCAT4 "AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2" ENSG00000176454 "Lysophosphatidylcholine acyltransferase 4" Q643R3 15 34358633-34367196 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 85.2;Gastric mucus-secreting cells: 131.5;Urothelial cells: 129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 108.5;OE19: 113.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057321 Supported NA NA "HPA057321: " "unprognostic (2.79e-2)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (4.64e-3)" "unprognostic (1.29e-2)" "unprognostic (2.15e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (7.47e-2)" "unprognostic (1.13e-1)" "unprognostic (2.90e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.69e-2)" "unprognostic (3.44e-3)" 19.1 6.3 18.2 12.3 22.1 6.8 17.9 16.5 41.7 18.6 8.4 37.6 31.2 14.5 9.5 36.4 18.8 17.2 21.9 21.1 22.8 9.3 3.4 10.1 9.8 27.9 18.9 24.1 11.9 10.3 7.2 11.9 5.2 30.4 11.2 36.2 4.9 11.8 8.9 8.3 18.7 31.5 16.9 13.1 16.4 40.1 3.4 26.6 8.8 8.5 8.0 11.3 22.4 29.1 38.2 13.7 31.9 15.7 12.6 41.4 41.9 7.5 18.8 31.5 17.6 24.0 11.6 36.0 12.4 38.4 26.3 41.3 108.5 13.8 35.5 7.8 25.2 8.2 12.5 13.6 11.3 8.5 13.5 12.3 31.3 15.8 16.6 21.4 40.6 29.0 22.1 8.3 23.6 33.1 13.3 11.9 26.1 15.7 113.7 26.0 14.7 17.6 25.1 38.7 32.4 12.6 9.5 11.3 14.9 7.3 18.2 11.5 17.9 36.4 32.5 19.6 51.8 18.3 28.5 23.9 4.3 24.3 37.0 7.6 0.1 0.8 3.6 2.7 1.1 6.6 1.6 3.2 4.2 1.3 2.3 1.8 1.7 3.5 1.7 1.4 4.6 5.6 0.8 18.2 22.1 16.5 41.7 21.1 22.8 27.9 18.9 24.1 30.4 13.1 26.6 38.2 31.0 25.6 5.9 8.8 13.1 4.8 7.8 35.5 15.4 15.5 5.8 8.3 12.8 25.8 63.1 9.2 4.2 4.9 15.7 85.2 1.9 11.6 0.0 7.1 7.8 31.9 25.3 9.2 57.5 9.8 17.1 9.6 131.5 10.1 12.0 5.5 23.6 0.7 7.9 10.1 53.3 58.0 24.4 8.1 9.7 1.2 15.5 6.3 8.8 9.4 5.7 1.7 9.2 12.5 7.2 43.1 83.4 6.8 29.1 9.7 58.7 2.8 40.7 5.9 13.1 5.1 11.9 2.5 8.1 20.3 6.1 2.5 19.9 8.6 71.8 129.9 SLCO3A1 "OATP-D, OATP3A1, SLC21A11" ENSG00000176463 "Solute carrier organic anion transporter family member 3A1" Q9UIG8 15 91853708-92172435 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 625.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 63.1;HaCaT: 95.5;HMC-1: 55.3;RPMI-8226: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066327 Approved NA NA "HPA066327: AB_2732743" "unprognostic (1.05e-3)" "prognostic favorable (8.61e-4)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.57e-6)" "unprognostic (1.03e-1)" "unprognostic (7.39e-2)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-2)" "unprognostic (1.49e-2)" "unprognostic (2.64e-2)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (7.17e-2)" "unprognostic (1.62e-2)" 11.4 6.2 21.3 6.9 27.2 9.7 8.7 32.4 24.0 7.3 21.6 3.8 1.8 5.3 3.3 10.7 7.0 6.3 23.8 20.2 21.3 6.3 2.9 13.9 6.4 29.8 29.9 15.2 4.2 3.0 15.8 6.7 1.0 29.3 4.3 3.5 1.6 4.7 6.3 5.9 15.3 4.2 5.0 26.3 11.2 4.7 18.0 25.5 2.6 10.7 9.7 6.2 8.7 10.9 39.4 10.1 12.3 13.9 0.2 20.9 12.6 0.2 4.0 3.4 1.6 0.4 0.0 63.1 12.1 5.3 1.3 9.1 95.5 2.7 6.3 0.2 8.8 0.4 27.8 20.9 0.0 0.9 0.6 55.3 5.7 6.7 2.9 7.3 5.4 0.0 3.6 0.0 0.1 0.0 1.8 0.0 5.1 3.7 0.2 1.7 0.0 1.1 44.0 13.4 10.0 2.0 3.3 10.5 0.9 0.1 2.0 0.1 8.5 0.0 3.3 4.7 0.0 10.3 25.5 16.0 11.7 4.2 16.9 6.0 4.3 2.4 6.9 1.4 2.0 1.1 0.2 1.5 1.7 1.6 0.0 0.5 0.6 7.5 0.3 1.7 0.0 2.7 0.6 21.3 27.2 32.4 24.0 20.2 21.3 29.8 29.9 15.2 29.3 26.3 25.5 39.4 53.5 48.1 32.0 17.0 4.3 39.0 29.3 14.2 22.8 28.1 3.1 13.0 44.0 24.3 16.4 51.5 4.2 0.0 33.1 6.2 1.9 26.6 105.6 15.8 29.0 26.2 37.8 6.1 89.5 8.7 0.1 22.9 0.5 36.2 22.8 94.9 34.6 0.8 4.6 0.0 149.4 7.2 8.2 24.7 95.2 38.5 5.0 34.0 10.6 56.2 43.6 5.2 25.7 20.6 625.8 8.4 11.1 3.0 17.3 41.5 0.0 0.4 22.1 3.1 39.5 17.4 62.0 69.5 11.9 22.6 60.1 0.0 23.3 0.8 7.9 38.2 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 18.9;Paneth cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: AB_2681643" "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 2.9 1.6 1.7 1.1 2.0 0.6 2.1 2.0 4.7 2.9 0.0 4.3 1.6 2.9 1.0 1.6 2.3 0.7 2.2 2.2 0.3 2.1 2.2 1.6 1.1 2.1 0.5 0.8 3.1 1.5 0.5 3.2 0.4 1.6 2.1 2.0 0.6 1.7 1.0 4.6 2.0 2.2 0.8 0.0 2.2 1.6 0.8 0.3 1.1 2.1 0.5 0.6 2.2 2.3 1.7 1.9 1.7 0.4 0.5 2.4 2.0 0.1 1.2 0.8 0.4 0.6 0.4 0.7 0.4 0.8 0.9 0.2 1.0 0.0 0.2 0.2 2.7 0.3 1.4 0.7 0.3 0.5 0.6 1.7 1.2 0.7 0.6 0.1 1.3 0.3 2.6 0.5 2.6 0.7 1.3 7.7 0.2 0.1 1.3 0.8 4.1 0.0 1.0 0.4 1.1 0.3 0.6 0.9 1.2 1.3 0.3 0.3 0.7 1.3 2.3 1.5 0.5 0.9 1.3 2.2 1.2 1.4 1.7 2.4 0.0 0.4 0.3 1.4 0.2 0.5 0.7 1.3 1.4 0.6 1.8 2.1 1.5 0.4 3.3 0.2 0.9 1.4 0.7 1.7 2.0 2.0 4.7 2.2 0.3 2.1 0.5 0.8 1.6 0.0 0.3 1.7 1.5 6.4 1.1 1.6 1.3 0.1 0.6 1.2 1.8 1.2 1.1 1.9 2.0 0.0 0.9 0.0 4.2 1.3 1.9 18.9 3.9 0.4 0.1 0.5 1.6 1.8 1.2 1.3 0.9 0.6 0.9 3.5 1.1 1.1 0.0 1.5 2.5 2.3 1.6 0.0 1.1 2.3 0.0 2.7 1.0 0.4 2.5 1.8 1.8 0.0 0.8 0.8 4.1 0.0 1.3 0.2 8.7 3.4 2.6 0.3 2.0 2.5 0.2 0.1 0.0 2.0 2.6 0.1 1.1 2.6 1.7 0.3 3.1 0.7 2.7 0.5 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.1 10.1 8.0 2.5 7.5 4.1 6.5 7.8 9.6 7.7 7.5 6.3 3.2 8.0 4.2 4.5 6.9 3.0 6.0 7.2 7.3 7.0 8.7 5.9 3.7 7.3 7.6 7.6 6.6 13.0 3.5 11.4 3.4 7.8 8.0 2.6 4.5 5.8 3.6 10.8 5.5 4.8 2.7 6.9 5.8 6.6 7.5 7.2 5.6 9.2 4.5 2.4 8.0 5.4 7.6 3.5 6.1 4.2 15.6 6.7 6.2 3.5 6.4 10.2 7.3 7.4 2.9 6.5 5.1 7.9 5.0 2.0 6.2 4.0 7.8 3.8 5.0 2.9 3.4 6.9 4.9 12.2 4.0 3.8 9.3 9.2 5.3 7.9 6.4 5.3 5.9 4.2 7.3 4.8 13.5 6.0 4.4 3.2 4.2 10.7 4.3 5.9 3.6 5.6 2.8 9.8 10.3 5.2 1.9 9.0 4.0 7.2 1.4 9.2 2.8 3.2 10.8 3.7 4.9 2.6 2.5 9.7 3.0 5.4 34.0 16.4 24.6 8.6 14.6 8.7 13.0 11.1 9.1 14.3 8.5 11.7 8.6 8.7 5.6 16.3 11.0 12.0 12.2 8.0 7.5 7.8 9.6 7.2 7.3 7.3 7.6 7.6 7.8 6.9 7.2 7.6 7.1 0.0 6.4 12.1 5.1 3.2 4.3 8.6 0.6 8.8 5.5 6.1 2.6 0.0 6.9 3.7 10.4 8.4 6.7 6.3 9.8 12.7 9.2 13.8 6.7 8.8 5.4 11.0 17.8 33.6 4.7 6.2 8.2 8.5 3.8 3.9 5.0 8.7 6.9 5.0 16.9 9.0 14.2 5.6 4.0 6.3 6.8 3.7 5.4 16.9 5.4 14.0 5.2 14.6 19.1 13.3 3.8 11.3 6.3 3.3 7.5 17.9 11.8 16.2 13.1 4.5 7.2 15.6 17.0 2.8 3.0 7.0 5.0 9.2 7.1 3.0 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 222.2;Late spermatids: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA052590: AB_2681875, HPA053608: AB_2682205" "unprognostic (1.38e-2)" "prognostic favorable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favorable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 15.7 16.3 13.6 11.3 15.1 12.5 16.6 16.6 14.7 25.6 14.1 24.0 12.9 29.3 9.6 12.1 27.9 9.2 14.4 13.2 16.3 11.2 20.0 14.1 17.0 15.0 14.2 12.6 33.6 25.8 10.8 10.4 7.2 15.1 16.5 7.3 7.9 16.7 16.8 51.6 16.1 19.0 12.1 14.7 16.3 20.0 43.3 14.4 14.2 17.7 20.0 10.3 23.7 16.5 16.6 13.1 21.3 16.3 10.5 10.6 10.9 29.5 8.5 9.6 21.7 20.2 24.6 11.5 39.1 21.1 6.7 13.2 15.0 12.4 15.4 6.1 12.8 24.0 24.3 12.9 33.7 27.1 22.1 26.1 11.5 20.0 13.1 13.2 11.7 8.3 24.5 20.8 19.4 7.9 43.4 25.5 43.2 22.7 9.6 20.5 38.9 10.6 34.2 11.3 19.5 26.3 12.2 13.3 25.3 15.0 5.8 20.7 18.4 5.9 15.4 12.9 9.2 15.3 22.4 35.7 22.7 10.9 36.9 12.5 20.6 47.0 50.0 53.6 41.8 65.2 57.9 74.2 65.8 47.6 65.9 84.1 66.3 13.4 55.1 33.7 71.4 78.3 58.7 13.6 15.1 16.6 14.7 13.2 16.3 15.0 14.2 12.6 15.1 14.7 14.4 16.6 11.2 16.0 16.7 0.0 20.0 0.0 18.1 0.0 32.5 5.5 12.5 21.1 0.0 12.8 7.4 18.4 14.6 17.3 27.1 7.9 9.8 12.6 222.2 8.5 10.1 8.7 3.6 17.1 0.0 12.9 11.8 12.7 10.2 7.7 6.3 16.9 11.0 17.3 14.2 0.0 0.0 8.8 0.0 12.9 0.0 384.4 30.7 13.5 0.0 0.0 17.1 11.8 22.6 0.0 0.0 10.1 15.7 21.8 16.7 9.5 40.1 23.7 6.6 14.1 19.7 18.3 13.0 10.5 30.9 17.0 0.0 21.1 21.0 14.8 11.9 12.0 PLAAT3 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754., PLA2G16, PLAAT-3" ENSG00000176485 "Phospholipase A and acyltransferase 3" P53816 11 63573195-63616883 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 321.6;brain: 417.2" "Cell type enhanced" "Detected in some" "Adipocytes: 80.5;Cardiomyocytes: 151.9;Cytotrophoblasts: 137.4;Extravillous trophoblasts: 365.5;Hofbauer cells: 71.0;Syncytiotrophoblasts: 290.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 187.8" "Group enriched" "Detected in all" 6 "dendritic cells: 187.8;T-cells: 55.0" "Cell line enhanced" "Detected in many" "A549: 135.1;ASC diff: 148.2;CAPAN-2: 247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011749, HPA058997" Approved Supported Mitochondria NA NA Mitochondria "HPA011749: , HPA058997: AB_2683874" "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favorable (2.54e-5)" "unprognostic (2.35e-1)" 321.6 36.6 237.3 10.3 292.4 3.1 168.2 254.6 238.6 13.4 165.1 27.1 8.7 17.7 26.8 13.4 33.3 29.4 103.9 212.5 237.5 64.6 77.1 38.0 11.7 286.5 270.0 188.5 74.0 32.7 28.9 33.6 40.7 295.8 16.6 7.7 26.9 29.1 30.2 110.0 10.0 22.0 16.0 283.5 16.0 32.2 55.2 257.5 7.2 41.6 119.7 4.5 27.0 9.7 417.2 87.7 135.1 3.7 0.2 148.2 25.1 24.1 3.2 26.9 22.3 11.2 30.8 247.1 0.0 55.3 6.9 72.4 4.4 127.4 6.8 16.9 108.0 5.0 1.3 33.3 5.4 87.8 0.0 1.3 15.2 0.7 55.4 2.2 88.1 35.4 0.0 1.6 9.6 24.0 15.3 0.2 0.6 10.8 55.0 43.0 0.0 0.0 8.7 71.2 12.3 1.7 9.7 18.0 51.5 28.7 54.6 111.6 4.5 52.2 10.0 0.7 34.0 7.7 39.6 28.0 0.3 40.1 0.0 1.0 0.1 21.1 0.1 55.0 9.1 30.3 7.4 12.1 40.5 6.4 1.2 3.9 30.0 1.3 21.0 0.6 187.8 9.3 27.2 237.3 292.4 254.6 238.6 212.5 237.5 286.5 270.0 188.5 295.8 283.5 257.5 417.2 80.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.9 0.0 0.0 0.0 0.0 137.4 18.6 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 365.5 14.7 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 290.6 2.0 0.0 0.0 0.0 DIRAS1 "Di-Ras1, GBTS1, RIG" ENSG00000176490 "DIRAS family GTPase 1" O95057 19 2714567-2721372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.2;heart muscle: 91.5;tongue: 52.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 18.0;Distal tubular cells: 31.3;Excitatory neurons: 20.4;Horizontal cells: 89.2;Inhibitory neurons: 25.9" "Cancer enhanced" "Detected in many" "glioma: 17.4;melanoma: 13.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 43.4;REH: 49.2;SH-SY5Y: 27.8;THP-1: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050164 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA050164: " "unprognostic (7.43e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (4.19e-3)" "unprognostic (8.01e-3)" "unprognostic (2.68e-1)" "unprognostic (5.62e-2)" "unprognostic (3.60e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.00e-1)" "unprognostic (1.79e-3)" "unprognostic (5.47e-3)" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (6.91e-4)" 1.2 2.5 14.8 1.2 20.2 0.7 1.9 17.0 81.2 6.2 0.0 1.4 1.2 12.8 2.5 5.5 6.6 0.7 91.5 21.0 13.9 3.4 0.1 0.6 0.7 17.6 18.9 23.3 2.8 6.8 17.1 22.6 0.3 33.6 3.3 1.1 11.6 6.7 1.8 2.7 1.8 2.3 7.4 0.5 4.2 3.5 6.0 54.9 0.1 0.5 52.3 0.7 4.0 2.4 33.2 0.1 2.2 7.0 24.1 0.9 3.1 0.1 8.2 2.8 0.4 0.1 1.4 0.4 0.0 1.0 21.9 12.2 0.1 10.1 0.0 0.0 0.0 15.6 0.5 0.8 0.9 1.0 0.0 43.4 1.4 5.1 0.1 0.1 4.6 0.0 0.2 15.0 7.2 2.8 3.6 0.2 0.4 15.2 0.0 3.3 49.2 0.0 11.7 0.0 0.0 3.1 27.8 0.3 1.1 15.6 1.2 1.1 34.2 0.0 5.3 6.6 0.2 2.6 16.4 12.4 8.9 11.8 0.5 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 20.2 17.0 81.2 21.0 13.9 17.6 18.9 23.3 33.6 0.5 54.9 33.2 0.0 0.0 0.0 1.6 6.9 1.1 0.8 0.2 2.2 7.9 2.6 2.8 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 31.3 1.4 0.4 0.1 2.2 0.3 0.0 1.3 20.4 2.0 0.5 0.9 0.0 0.3 0.0 2.3 0.0 0.0 5.7 89.2 25.9 0.0 0.0 0.0 3.6 1.1 1.2 0.5 3.6 4.7 0.1 4.6 0.0 2.0 3.4 1.5 0.0 0.0 0.6 0.9 0.0 0.1 0.0 6.1 0.0 0.7 2.1 0.7 0.4 0.3 0.4 0.3 0.1 0.0 0.0 0.2 OR5AN1 ENSG00000176495 "Olfactory receptor family 5 subfamily AN member 1" Q8NGI8 11 59358895-59371714 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.4 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHLDB3 FLJ40193 ENSG00000176531 "Pleckstrin homology like domain family B member 3" Q6NSJ2 19 43474954-43504935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.4;skin 1: 42.8" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 58.0;Urothelial cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043425 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles" "Plasma membrane, Cytosol" "HPA043425: AB_10797142" "unprognostic (2.50e-2)" "unprognostic (4.22e-3)" "unprognostic (3.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "unprognostic (4.43e-1)" "unprognostic (1.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.60e-2)" "prognostic favorable (6.36e-6)" "unprognostic (4.62e-2)" "prognostic unfavorable (4.11e-5)" "prognostic unfavorable (5.77e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (2.37e-1)" 3.7 9.3 5.9 5.7 4.9 3.5 6.4 3.7 5.4 11.3 9.3 6.1 5.0 5.3 1.1 42.4 8.0 6.2 4.6 4.6 8.3 6.0 14.0 5.6 7.8 4.2 3.9 3.0 12.8 8.1 4.3 10.6 3.1 5.4 14.9 1.7 0.8 15.7 3.7 3.7 42.8 6.7 1.9 2.2 6.7 6.3 30.3 4.5 6.3 5.1 1.0 6.9 8.3 22.6 11.1 6.9 7.2 3.0 7.4 2.6 5.3 19.1 4.9 4.3 4.8 3.3 7.3 7.2 4.1 15.2 3.0 3.8 8.0 2.1 8.6 0.9 9.9 6.8 4.6 7.4 8.8 6.5 1.8 8.5 4.5 10.7 5.1 3.1 3.7 4.3 10.2 8.3 6.1 2.4 11.0 7.2 0.4 1.8 16.6 5.8 8.3 3.9 2.8 2.3 23.3 0.1 6.4 6.3 13.5 6.2 1.8 9.7 5.8 5.4 3.1 8.2 3.8 4.7 15.8 18.8 4.7 2.9 3.4 5.3 0.2 2.3 0.3 2.4 1.4 1.8 2.2 2.2 1.8 4.4 2.4 3.2 3.0 0.5 1.8 0.1 5.1 2.3 1.7 5.9 4.9 3.7 5.4 4.6 8.3 4.2 3.9 3.0 5.4 2.2 4.5 11.1 2.7 0.0 1.7 2.6 17.1 29.1 27.2 11.6 31.9 1.0 10.0 8.0 1.9 8.6 7.6 9.2 0.0 18.5 7.6 7.1 1.9 5.5 11.3 12.9 9.6 4.6 3.0 1.7 5.1 2.4 4.5 7.3 4.6 9.8 5.7 3.2 4.6 12.6 3.6 0.0 7.0 4.3 8.2 2.8 34.7 8.9 3.7 11.2 5.4 11.2 6.7 4.1 7.2 4.0 2.0 2.1 4.7 3.4 11.6 22.0 10.5 8.5 12.7 1.9 6.6 8.6 10.9 28.2 4.8 37.7 38.4 58.0 14.3 4.6 3.7 45.1 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563835-29567293 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 63.1;intestine: 82.1;stomach 1: 49.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA040996: AB_2677241, HPA048121: AB_2680271" "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favorable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favorable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 3.3 0.7 0.5 4.8 0.3 1.1 9.2 0.1 0.7 63.1 0.3 82.1 72.9 18.3 21.7 1.0 9.1 7.9 1.0 0.2 0.6 17.0 0.3 2.4 0.4 0.7 0.4 0.1 6.0 3.1 1.4 3.0 4.8 1.1 2.5 53.1 0.0 7.5 3.1 0.2 0.3 73.0 2.3 0.5 0.2 49.7 0.9 0.7 0.1 1.2 0.0 0.7 16.7 0.5 0.5 16.8 23.3 0.0 0.0 8.7 10.7 29.3 0.7 1.1 0.4 0.2 20.5 38.7 0.0 4.1 5.5 0.6 45.1 4.9 0.0 0.0 0.0 3.3 1.3 4.5 22.7 2.8 0.0 0.1 0.1 7.3 0.0 1.7 0.0 0.1 1.5 0.0 0.0 0.0 3.9 0.6 3.2 3.5 97.7 18.5 0.1 0.0 21.4 26.5 34.5 0.5 0.3 2.3 74.9 0.0 12.8 5.4 0.0 19.9 0.5 0.0 0.1 0.9 1.8 3.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.7 0.2 0.6 0.7 0.4 0.1 1.1 0.5 0.7 0.5 1.8 0.0 0.5 0.0 0.4 0.1 1.2 11.0 0.0 0.0 10.0 7.1 0.5 12.8 16.4 38.6 0.0 14.2 0.2 263.0 29.4 6.9 0.8 31.3 2.3 1.2 8.4 0.0 0.1 21.8 9.9 1.3 16.8 34.7 0.0 194.2 0.4 0.2 2.7 0.0 0.0 45.3 26.4 0.0 0.3 0.1 1.5 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 14.4 58.5 2.2 0.1 3.0 122.4 14.4 63.1 0.0 0.0 0.0 7.8 0.0 0.4 1.2 0.0 6.3 0.6 0.4 56.9 23.3 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702694 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "brain: 298.2" "Cell type enhanced" "Detected in many" "B-cells: 145.4;Distal tubular cells: 123.3;Horizontal cells: 169.9;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 206.1;Plasma cells: 169.7" "Cancer enhanced" "Detected in all" "glioma: 21.9;melanoma: 20.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0" "Group enriched" "Detected in many" 4 "B-cells: 57.2;dendritic cells: 48.0" "Cell line enhanced" "Detected in many" "Daudi: 22.3;REH: 66.5;SK-MEL-30: 31.2;U-266/70: 61.0;U-266/84: 30.0" "Region enriched" "Detected in all" 6 "basal ganglia: 1277.2" HPA057790 Supported Supported NA NA 72000 "HPA057790: AB_2683527" "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favorable (3.05e-4)" "prognostic favorable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favorable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favorable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.5 5.8 64.0 5.3 298.2 6.6 4.4 79.8 100.6 4.9 14.5 6.4 5.2 7.2 5.1 12.1 8.2 3.6 26.6 67.0 81.9 9.0 4.3 4.0 10.0 153.9 86.6 67.3 12.3 8.1 6.2 17.6 1.4 166.1 9.5 3.2 15.2 26.2 5.7 3.5 2.6 14.3 3.5 74.3 19.5 6.8 8.9 93.2 2.7 5.8 8.1 9.5 7.9 3.3 81.3 0.2 0.0 3.2 7.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.7 22.3 1.0 0.3 0.3 0.2 3.5 0.0 0.1 0.0 3.1 0.6 0.1 2.7 1.6 0.0 12.9 0.4 0.5 0.0 0.2 0.2 0.0 2.7 0.3 14.2 0.0 2.2 0.6 1.4 2.6 0.4 1.4 66.5 0.0 6.2 0.3 0.0 0.1 9.2 0.1 0.1 31.2 2.1 0.4 5.6 0.1 0.1 3.0 0.2 0.2 61.0 30.0 4.7 0.2 7.0 16.5 3.5 1.5 8.0 0.4 0.5 1.1 57.2 0.5 0.4 6.0 50.1 1.2 0.7 11.8 0.2 0.1 48.0 0.0 3.0 64.0 298.2 79.8 100.6 67.0 81.9 153.9 86.6 67.3 166.1 74.3 93.2 81.3 14.5 6.4 4.2 40.8 145.4 2.5 13.0 0.3 5.2 10.5 22.9 30.1 55.1 15.7 3.3 9.2 8.4 0.6 56.1 0.9 123.3 17.0 5.4 2.1 2.3 11.7 6.1 8.6 26.5 4.8 1.1 6.6 5.6 3.5 12.7 8.6 19.2 11.4 63.2 169.9 38.8 2.0 0.0 8.5 15.0 11.4 2.5 12.3 51.6 45.9 11.2 84.7 3.1 102.5 206.1 2.7 1.8 2.6 169.7 7.5 0.7 22.6 2.9 11.1 6.6 7.1 5.4 2.7 2.6 1.5 2.0 3.4 6.9 2.1 2.2 7.2 OR4C5 "OR4C5P, OR4C5Q" ENSG00000176540 "Olfactory receptor family 4 subfamily C member 5" Q8NGB2 11 48365485-48366465 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049516 Uncertain NA NA "HPA049516: AB_2680800" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 6.8 5.0 6.4 3.0 6.8 10.3 6.8 9.6 8.0 5.3 7.7 7.3 2.8 5.4 7.9 6.9 6.2 2.5 6.5 7.2 6.0 8.1 16.6 6.0 5.4 6.2 6.3 6.6 5.9 8.5 6.1 6.8 2.8 6.6 5.9 3.9 5.7 6.4 2.8 18.9 7.4 8.4 2.4 6.2 8.8 7.6 4.9 6.2 6.7 6.3 8.6 4.7 6.0 6.1 7.6 4.6 3.4 4.1 3.9 9.8 3.7 2.8 1.8 2.9 1.7 1.6 3.2 1.9 8.0 3.2 4.6 2.8 2.8 4.5 3.6 3.3 2.7 1.9 5.7 2.2 5.3 2.9 10.5 6.2 5.5 6.4 3.2 3.6 2.6 4.2 5.9 2.7 4.1 3.7 6.4 5.9 5.8 3.0 6.1 3.4 2.5 3.2 3.2 6.3 6.3 1.9 3.0 4.3 2.4 5.5 2.8 3.3 7.7 5.7 2.7 6.0 1.5 2.6 4.8 2.9 9.2 3.1 4.3 2.0 2.2 1.0 1.7 1.3 1.3 1.0 1.0 0.9 1.0 0.8 2.3 1.1 1.2 3.2 1.2 1.8 2.3 0.5 0.7 6.4 6.8 9.6 8.0 7.2 6.0 6.2 6.3 6.6 6.6 6.2 6.2 7.6 27.1 22.4 15.1 0.0 30.1 0.0 11.2 0.0 15.9 19.5 19.7 12.6 0.0 14.3 6.2 25.8 14.6 8.1 42.7 13.1 25.4 8.4 6.7 28.3 18.6 15.6 6.1 17.0 0.0 11.8 4.2 13.3 18.3 22.8 5.1 6.7 20.3 46.3 7.8 13.5 0.0 10.2 0.0 22.6 0.0 10.9 13.1 17.0 0.0 0.0 16.4 12.4 29.9 0.0 0.0 12.5 12.4 13.9 17.5 18.4 23.6 29.2 12.4 18.8 6.6 27.6 13.8 13.1 6.0 15.8 0.0 14.5 20.0 12.2 10.9 19.5 OR4C3 ENSG00000176547 "Olfactory receptor family 4 subfamily C member 3" Q8NH37 11 48324920-48328471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4S1 ENSG00000176555 "Olfactory receptor family 4 subfamily S member 1" Q8NGB4 11 48306223-48307152 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798800-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 42.8" "Group enriched" "Detected in many" 5 "Early spermatids: 70.5;Late spermatids: 124.8;Respiratory ciliated cells: 47.0;Spermatocytes: 150.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;ASC diff: 1.6;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA072363 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA072363: " "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.3 0.2 1.1 0.0 1.1 0.1 1.9 1.3 1.9 0.1 0.4 0.9 0.1 0.1 1.4 0.0 0.7 0.0 0.1 1.1 1.6 1.5 0.0 0.5 0.0 1.2 1.1 1.1 0.4 1.1 0.3 0.0 0.1 1.2 1.3 1.9 0.2 0.1 0.1 0.1 0.1 0.2 0.1 1.1 0.1 3.4 42.8 1.1 0.0 0.3 0.6 0.0 0.2 0.0 2.1 2.9 0.3 0.2 0.5 1.6 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.8 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.3 1.9 1.1 1.6 1.2 1.1 1.1 1.2 1.1 1.1 2.1 1.2 3.2 4.6 2.3 1.0 0.4 0.5 0.4 0.0 1.7 5.5 2.2 1.1 1.5 2.1 0.0 0.0 0.3 1.2 1.4 5.9 0.2 70.5 5.4 1.7 0.8 0.0 2.7 1.9 0.4 0.4 1.9 4.1 1.6 6.3 0.2 0.4 1.1 0.3 6.7 1.6 5.3 4.1 1.0 0.7 124.8 2.5 1.1 0.0 0.0 0.2 1.0 0.0 2.0 1.1 0.4 0.4 1.2 0.7 5.6 0.9 0.5 47.0 0.7 6.6 1.0 1.7 150.2 17.1 0.0 0.6 0.3 0.9 0.5 2.7 2.3 DCAF4L2 WDR21C ENSG00000176566 "DDB1 and CUL4 associated factor 4 like 2" Q8NA75 8 87870747-87874015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 215 "testis: 21.5" "Group enriched" "Detected in some" 4 "Spermatocytes: 68.6;Spermatogonia: 75.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 20.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "U-266/84: 7.5" HPA067584 Uncertain NA NA "HPA067584: AB_2685868" "unprognostic (4.25e-1)" "unprognostic (4.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4X1 ENSG00000176567 "Olfactory receptor family 4 subfamily X member 1" Q8NH49 11 48263861-48264778 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNBD1 FLJ35802 ENSG00000176571 "Cyclic nucleotide binding domain containing 1" Q8NA66 8 86866415-87615219 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 6.6" "Group enriched" "Detected in some" 33 "Early spermatids: 155.4;Late spermatids: 92.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Karpas-707: 4.4;U-266/70: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025037, HPA027469, HPA027786" Uncertain "Secreted in male reproductive system" NA NA "HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 155.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 92.3 1.2 0.0 0.0 1.0 0.0 0.0 0.0 2.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KBTBD11 "KIAA0711, KLHDC7C" ENSG00000176595 "Kelch repeat and BTB domain containing 11" O94819 8 1973677-2006936 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Proximal enterocytes: 58.0;Proximal tubular cells: 32.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;HEK 293: 2.0;MOLT-4: 1.4;REH: 1.8;SCLC-21H: 2.0;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051159 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA051159: AB_2681367" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (1.20e-3)" "unprognostic (2.70e-2)" "unprognostic (2.03e-1)" "unprognostic (6.84e-2)" "unprognostic (2.76e-4)" "unprognostic (2.50e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.75e-2)" "unprognostic (9.53e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-2)" 2.9 6.7 6.4 0.2 4.8 0.0 2.8 3.9 9.2 1.4 0.0 5.2 0.1 0.9 0.0 1.2 2.7 0.0 2.0 8.8 1.7 8.9 7.9 2.7 0.0 6.6 3.4 6.6 1.3 3.7 0.1 3.7 0.0 6.2 2.9 0.0 0.0 1.2 0.1 1.1 1.5 9.9 0.0 4.6 7.5 2.0 1.2 1.9 0.0 4.0 0.0 0.0 1.9 1.1 9.7 0.5 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.8 3.9 9.2 8.8 1.7 6.6 3.4 6.6 6.2 4.6 1.9 9.7 6.1 0.0 8.1 17.6 0.6 1.0 0.4 0.0 0.0 24.3 1.0 0.6 5.2 8.6 0.1 12.9 35.5 0.0 0.6 25.6 25.4 2.0 0.8 0.6 0.4 7.9 6.0 3.6 29.2 3.8 0.2 2.0 1.1 0.7 0.0 1.3 4.2 18.2 3.6 20.2 12.6 13.0 0.0 13.5 1.9 0.3 5.0 8.0 1.8 9.4 15.7 9.6 2.1 9.5 16.3 11.9 10.7 10.5 1.5 3.1 58.0 32.2 1.7 31.3 0.0 15.1 1.3 0.3 3.7 0.0 0.9 0.3 1.0 0.1 19.7 1.4 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253253-183298504 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.3" "Cell type enhanced" "Detected in many" "Adipocytes: 151.2;Distal enterocytes: 150.4;Squamous epithelial cells: 169.9;Syncytiotrophoblasts: 157.9;Urothelial cells: 144.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 5.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.6" "Cell line enhanced" "Detected in many" "GAMG: 82.4;HBEC3-KT: 70.3;hTCEpi: 83.5" "Region enriched" "Detected in many" 4 "cerebellum: 14.7" "Low region specificity" "Detected in all" HPA017292 Uncertain Approved Nucleoli NA NA 28000 Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 11.2 2.4 3.6 13.9 3.9 77.3 5.5 3.0 3.4 5.9 1.9 22.8 38.5 5.1 9.2 37.9 9.6 21.5 2.9 3.9 11.4 3.8 3.4 15.1 1.1 5.2 3.7 3.1 4.6 7.5 3.6 5.8 14.0 4.3 7.9 19.7 1.2 10.2 3.3 7.5 8.5 42.3 6.8 5.7 1.6 11.4 7.4 2.9 7.7 5.3 4.5 5.3 24.4 13.9 5.9 46.2 4.4 23.8 14.7 19.5 57.0 21.5 0.7 1.1 4.6 3.8 9.0 23.6 0.0 2.7 0.1 82.4 20.6 24.7 70.3 3.9 0.1 15.3 2.4 1.9 0.0 24.8 23.4 10.9 27.0 83.5 3.7 62.1 6.2 43.4 0.1 26.6 0.1 38.1 0.0 0.1 7.6 10.1 26.9 38.5 7.3 12.0 0.1 14.4 12.7 1.0 22.6 12.7 0.1 5.3 10.6 0.0 28.0 64.6 1.1 9.0 1.4 11.0 0.0 0.0 0.0 8.8 54.1 23.8 0.0 1.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.2 0.3 3.6 3.9 3.0 3.4 3.9 11.4 5.2 3.7 3.1 4.3 5.7 2.9 5.9 151.2 6.4 17.5 2.3 1.2 65.1 70.2 35.8 101.3 10.0 18.4 10.4 2.2 21.5 40.5 5.5 22.9 31.0 1.9 150.4 1.9 18.0 13.4 58.0 13.1 26.3 38.2 6.3 1.8 11.8 10.7 9.2 70.3 55.3 14.0 2.4 2.2 0.6 29.6 3.3 1.5 88.2 34.6 15.6 123.2 26.5 1.5 76.8 12.4 80.6 9.4 3.1 0.0 4.5 0.8 35.7 126.4 0.4 1.4 43.1 74.9 4.8 118.5 13.1 0.0 23.6 5.4 7.9 0.8 169.9 84.8 157.9 4.3 0.2 36.2 144.4 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964485-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.2;choroid plexus: 7.8;fallopian tube: 18.4;testis: 5.4" "Group enriched" "Detected in some" 8 "Early spermatids: 59.7;Endometrial ciliated cells: 73.7;Late spermatids: 148.4;Respiratory ciliated cells: 121.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011388 Uncertain Cytosol NA NA Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.0 0.1 3.3 0.0 1.3 0.0 0.0 1.4 0.8 0.4 7.8 0.0 0.0 0.6 0.0 0.0 18.4 0.0 0.1 0.8 3.2 0.0 0.0 1.5 0.1 4.5 3.5 0.2 0.0 0.0 0.0 0.3 0.0 2.9 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.0 5.2 0.0 0.0 5.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.3 1.4 0.8 0.8 3.2 4.5 3.5 0.2 2.9 5.2 1.9 3.2 0.1 0.0 1.1 2.3 0.1 0.0 0.1 2.6 0.0 0.3 0.0 0.0 0.4 0.0 11.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 59.7 73.7 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 2.0 0.0 0.0 148.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 121.0 0.2 0.0 0.0 0.8 7.5 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LMNB2 LMN2 ENSG00000176619 "Lamin B2" Q03252 19 2427638-2456959 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 220.2;Extravillous trophoblasts: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022593, HPA047863, HPA062477" Enhanced Supported "Nuclear membrane" NA NA 110000 "Nuclear membrane" "CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776" "unprognostic (3.92e-2)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (4.05e-2)" "unprognostic (9.65e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.53e-3)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.96e-1)" "unprognostic (3.09e-3)" "prognostic unfavorable (9.53e-5)" "prognostic unfavorable (9.34e-5)" "prognostic favorable (3.98e-4)" "unprognostic (4.03e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-2)" 8.2 10.2 8.1 15.5 7.5 17.4 7.7 10.2 9.9 10.8 5.5 11.0 11.0 12.0 2.4 32.4 10.8 3.4 10.0 7.4 8.4 9.3 6.1 11.3 12.9 7.5 7.9 7.1 13.5 8.2 3.6 12.4 14.8 8.4 9.9 6.3 3.5 9.1 5.0 15.0 10.4 12.3 5.6 6.9 12.4 10.5 11.0 8.7 23.3 8.8 5.2 10.6 10.1 12.5 8.0 181.5 114.0 80.8 105.7 17.3 27.2 107.5 119.2 57.7 117.7 88.8 152.0 75.6 83.5 47.8 55.9 68.1 185.6 72.4 84.8 60.0 102.4 86.3 66.4 40.3 119.8 20.9 93.5 64.6 24.5 21.4 63.4 49.7 22.0 60.9 76.2 117.8 51.9 56.4 105.4 107.9 51.8 154.0 97.8 98.6 150.1 102.4 70.0 33.7 89.8 118.7 68.8 99.6 65.6 39.6 44.7 65.9 95.7 85.1 112.5 116.6 174.8 180.6 45.6 41.8 83.5 91.3 88.5 148.3 0.0 0.6 0.8 1.0 0.6 1.6 0.4 1.1 1.0 0.8 0.9 1.1 1.3 0.0 0.9 2.1 3.5 0.4 0.6 8.1 7.5 10.2 9.9 7.4 8.4 7.5 7.9 7.1 8.4 6.9 8.7 8.0 8.6 3.2 4.2 2.6 9.4 20.6 14.8 7.9 10.2 8.2 8.8 8.1 5.7 2.8 5.3 5.5 8.4 30.4 9.7 17.5 9.8 7.0 220.2 7.7 14.9 12.7 6.0 19.6 3.0 11.8 81.6 14.3 14.3 11.7 4.5 31.4 8.2 2.7 21.2 13.5 3.9 15.1 6.1 6.8 18.2 31.4 9.3 10.3 1.8 3.7 12.2 9.4 11.3 2.0 3.3 12.7 9.1 7.9 25.5 24.4 12.7 4.9 5.7 10.8 13.1 14.3 11.2 8.6 15.0 30.0 20.0 13.8 11.4 12.0 23.1 19.2 RMDN1 "CGI-90, FAM82B, FLJ20665, RMD1" ENSG00000176623 "Regulator of microtubule dynamics 1" Q96DB5 8 86468257-86514357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026495 Approved Supported "Actin filaments,Centrosome" NA NA Centrosome "Actin filaments" "HPA026495: AB_1848414" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.02e-1)" "unprognostic (2.09e-1)" "unprognostic (1.60e-1)" "prognostic favorable (8.51e-4)" "unprognostic (2.08e-1)" "unprognostic (7.15e-2)" "unprognostic (4.71e-3)" "unprognostic (3.47e-1)" 35.9 26.3 28.7 21.0 31.8 24.9 24.5 32.9 28.0 15.6 26.4 27.0 29.0 17.8 20.0 29.7 21.3 22.7 63.5 24.8 30.8 52.2 57.2 23.6 30.5 32.4 31.7 21.3 17.2 17.6 26.5 13.0 19.1 31.2 21.4 29.3 31.2 16.5 20.9 72.4 33.1 29.5 20.4 30.2 25.4 30.9 26.6 30.7 23.2 50.9 71.1 31.8 20.3 16.5 32.5 64.0 27.1 31.3 17.8 60.3 97.8 38.5 45.9 41.1 35.8 34.6 32.2 39.9 76.2 38.1 38.2 33.2 61.0 39.8 46.0 42.1 64.6 31.9 40.2 32.8 82.1 32.1 18.4 1.0 53.3 42.6 47.6 72.9 63.9 81.6 44.3 42.4 40.7 57.5 57.3 65.1 8.6 15.9 111.3 67.5 36.6 43.6 78.9 42.5 39.3 14.8 32.8 38.2 149.2 67.6 32.5 83.9 33.6 44.6 39.5 64.0 50.8 28.2 52.4 46.5 59.7 51.2 28.7 54.4 16.4 38.5 94.2 26.6 50.7 31.1 42.2 27.1 31.3 45.2 30.8 22.3 29.0 15.5 39.0 70.3 51.3 43.2 30.7 28.7 31.8 32.9 28.0 24.8 30.8 32.4 31.7 21.3 31.2 30.2 30.7 32.5 24.0 41.7 39.0 38.8 23.8 13.5 13.2 40.1 22.2 14.5 16.8 15.0 117.3 20.0 42.4 20.2 16.7 42.5 29.9 22.2 49.0 42.9 97.8 28.3 26.6 24.3 10.2 27.3 22.5 53.0 57.1 24.0 32.1 24.8 1.3 18.9 21.8 57.7 53.7 20.2 29.9 20.6 18.3 40.1 14.8 77.1 13.1 28.3 16.0 33.7 48.5 27.4 21.6 42.3 51.9 45.8 17.2 9.1 21.8 9.2 45.7 73.0 34.4 21.5 0.0 19.9 32.9 65.7 33.5 31.0 15.5 28.5 21.6 53.1 26.9 15.2 MEX3C "FLJ38871, RKHD2, RNF194" ENSG00000176624 "Mex-3 RNA binding family member C" Q5U5Q3 18 51174550-51218333 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 119.4" "Group enriched" "Detected in many" 6 "Early spermatids: 555.3;Late spermatids: 514.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040603 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA040603: AB_10805714" "unprognostic (1.09e-1)" "unprognostic (2.90e-2)" "unprognostic (8.88e-2)" "unprognostic (8.88e-3)" "unprognostic (2.04e-1)" "unprognostic (7.30e-2)" "prognostic unfavorable (8.49e-5)" "unprognostic (4.34e-2)" "unprognostic (4.43e-1)" "unprognostic (1.05e-2)" "unprognostic (1.03e-2)" "unprognostic (6.75e-2)" "unprognostic (7.99e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (8.01e-2)" "unprognostic (3.17e-1)" 17.8 13.7 9.8 17.1 10.9 49.8 17.6 13.6 12.1 16.5 9.9 13.6 12.7 17.8 10.4 15.7 14.2 18.8 10.9 11.4 11.5 12.0 14.1 13.8 23.8 11.3 11.0 8.7 23.8 14.8 18.1 1.8 16.2 11.2 11.6 14.2 14.9 9.7 12.3 9.8 9.3 13.5 20.3 11.1 22.5 13.4 119.4 10.4 41.3 16.2 17.2 26.8 20.4 2.4 12.7 23.8 19.6 71.2 26.8 27.7 36.8 49.6 32.8 37.4 18.9 22.2 33.6 17.3 53.0 13.2 44.2 30.4 44.6 27.9 42.7 31.0 43.0 12.5 10.7 19.1 29.0 44.5 75.2 22.3 28.2 46.5 26.9 76.4 47.0 41.8 36.0 11.3 95.7 40.0 18.0 63.8 24.3 32.1 13.3 15.0 61.7 36.5 46.7 31.1 9.5 34.8 39.1 30.4 12.4 117.7 54.3 13.5 34.3 43.2 46.3 30.9 15.1 28.1 64.5 12.4 87.2 32.9 31.3 110.7 9.7 1.2 1.5 2.3 1.0 2.0 1.9 2.4 2.4 1.4 1.1 0.9 2.3 0.4 3.4 0.7 1.1 2.0 1.4 9.8 10.9 13.6 12.1 11.4 11.5 11.3 11.0 8.7 11.2 11.1 10.4 12.7 25.2 19.2 5.0 6.8 18.6 38.2 10.3 12.4 11.4 12.6 25.9 23.2 14.5 14.3 11.2 3.7 20.9 5.2 56.6 9.0 5.9 12.1 555.3 18.9 22.7 30.0 6.7 7.4 8.0 8.5 7.0 18.2 6.1 34.9 12.7 79.3 10.4 7.6 7.7 11.8 7.9 9.4 12.2 10.9 20.5 514.0 16.1 13.8 19.6 5.6 8.2 10.0 34.0 14.1 13.3 16.5 3.9 15.1 20.6 15.4 9.1 9.3 6.4 14.8 0.0 30.2 17.7 14.4 14.2 18.1 45.9 4.2 24.2 14.9 11.5 19.6 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080464-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 23.0" "Group enriched" "Detected in some" 7 "Early spermatids: 52.8;Spermatocytes: 133.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 3.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 23.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.3 0.2 0.4 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.1 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.2 0.0 133.0 12.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RNF152 FLJ39176 ENSG00000176641 "Ring finger protein 152" Q8N8N0 18 61808067-61894247 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.2;choroid plexus: 51.3;kidney: 57.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 96.4;Proximal tubular cells: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 21.5;SH-SY5Y: 13.4;TIME: 14.2;U-138 MG: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.64e-1)" "unprognostic (8.55e-3)" "unprognostic (2.05e-1)" "unprognostic (2.09e-1)" "unprognostic (2.96e-3)" "unprognostic (3.62e-1)" "unprognostic (1.51e-2)" "unprognostic (8.13e-2)" "unprognostic (5.14e-2)" "unprognostic (6.73e-2)" "prognostic favorable (1.13e-8)" "prognostic unfavorable (2.85e-5)" "unprognostic (3.26e-2)" "unprognostic (2.82e-2)" "unprognostic (4.83e-2)" 7.2 3.4 11.1 0.9 12.3 0.9 6.7 46.2 7.0 7.9 51.3 7.3 1.7 6.4 3.6 4.5 5.3 3.8 6.6 5.9 9.7 57.0 22.3 7.0 0.6 21.0 14.3 2.1 4.0 2.5 2.4 2.9 6.6 28.0 5.3 6.7 5.0 14.1 2.8 2.3 11.4 5.6 4.2 9.8 0.6 6.3 1.3 19.6 0.6 5.5 2.3 0.9 4.3 7.6 17.4 0.0 0.0 4.8 1.0 4.4 0.6 0.0 3.1 9.4 0.7 0.5 0.0 0.1 0.1 0.9 4.9 0.1 21.5 5.9 11.4 1.3 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.1 0.7 8.1 3.6 2.4 2.1 8.7 0.1 0.0 0.1 1.4 0.9 0.8 0.0 0.3 0.7 0.0 0.3 3.1 0.0 0.5 3.7 3.9 13.4 0.0 8.7 1.5 4.2 5.1 0.0 14.2 21.6 2.2 0.0 0.5 0.1 0.0 0.0 0.7 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.1 12.3 46.2 7.0 5.9 9.7 21.0 14.3 2.1 28.0 9.8 19.6 17.4 26.8 0.0 0.0 9.4 0.2 42.3 28.1 11.1 11.4 19.1 16.2 10.3 4.8 12.8 10.5 20.2 0.0 0.4 0.9 58.1 46.9 2.5 0.4 16.8 18.5 17.1 16.2 8.0 9.9 2.7 0.1 9.5 18.3 29.9 0.0 0.1 10.8 96.4 0.1 21.9 20.0 5.6 32.6 1.8 7.7 1.4 8.7 2.2 28.4 2.8 0.0 3.5 0.0 16.6 27.5 1.7 34.9 18.4 0.3 8.7 46.6 159.0 1.8 3.6 65.7 2.8 59.7 0.2 0.5 28.0 32.5 0.3 1.7 18.7 16.2 21.2 MYO1D "KIAA0727, myr4, PPP1R108" ENSG00000176658 "Myosin ID" O94832 17 32492522-32877177 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 112.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 193.1;Excitatory neurons: 201.4;Oligodendrocytes: 578.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 105.7;CACO-2: 148.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054744 Uncertain Approved Cytosol NA NA Cytosol "HPA054744: AB_2682589" "unprognostic (3.83e-3)" "unprognostic (1.53e-1)" "unprognostic (9.70e-3)" "unprognostic (3.95e-2)" "unprognostic (6.68e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-1)" "unprognostic (2.04e-1)" "unprognostic (8.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "prognostic favorable (5.01e-6)" "unprognostic (1.73e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.53e-6)" 29.7 27.7 10.6 15.8 24.1 3.7 21.2 22.3 17.6 21.4 14.5 112.2 85.2 21.2 22.4 36.3 16.7 31.6 11.1 9.8 15.8 26.9 14.4 32.2 6.4 22.9 22.3 7.4 24.8 26.4 27.4 12.4 14.1 22.6 17.9 92.4 1.7 33.4 13.1 5.5 36.2 84.3 18.4 22.6 9.6 26.9 9.9 18.9 7.1 41.4 3.6 14.4 24.8 26.0 52.1 32.3 1.5 0.9 0.3 105.7 60.0 1.2 18.9 36.5 3.4 20.9 148.0 50.0 18.2 3.9 83.7 0.8 29.6 3.8 47.0 5.3 2.3 38.6 16.5 0.1 10.5 6.8 0.0 8.6 17.3 29.3 26.7 24.0 0.4 45.8 9.5 28.2 28.9 16.3 38.6 0.1 0.5 5.8 36.2 28.0 0.0 21.1 21.0 14.6 61.8 36.3 6.2 6.4 11.4 93.2 9.1 50.1 0.2 57.2 16.3 8.2 0.6 0.4 35.2 43.4 0.2 21.6 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 10.6 24.1 22.3 17.6 9.8 15.8 22.9 22.3 7.4 22.6 22.6 18.9 52.1 14.3 22.4 13.1 5.5 8.4 8.0 10.1 11.7 26.2 0.9 8.8 8.4 5.0 20.0 12.9 23.9 18.8 19.4 2.7 193.1 5.9 20.8 126.0 7.2 2.8 12.3 26.5 8.2 201.4 23.8 3.1 11.4 30.1 21.3 1.3 24.5 3.9 11.0 8.8 0.0 28.9 93.4 10.2 1.6 8.2 37.6 5.9 4.4 16.0 18.7 0.3 1.2 4.1 9.0 578.3 46.4 94.4 18.4 42.8 18.7 126.5 2.5 25.2 0.9 6.6 5.3 22.8 20.5 7.2 25.4 11.2 12.4 5.7 9.8 81.7 23.3 FOXL1 "FKH6, FKHL11, FREAC7" ENSG00000176678 "Forkhead box L1" Q12952 16 86576368-86583478 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 4.3" "Group enriched" "Detected in some" 4 "Pancreatic endocrine cells: 10.4;Peritubular cells: 7.9;Sertoli cells: 6.6;Smooth muscle cells: 4.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 8.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.4;CAPAN-2: 31.9;hTEC/SVTERT24-B: 21.2;PC-3: 46.7;REH: 27.9;U-87 MG: 86.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "spinal cord: 5.0" NA NA "unprognostic (3.21e-1)" "unprognostic (3.31e-3)" "unprognostic (2.98e-1)" "unprognostic (1.12e-2)" "unprognostic (3.79e-1)" "unprognostic (4.62e-2)" "unprognostic (1.43e-3)" "unprognostic (1.79e-2)" "unprognostic (1.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.33e-3)" "unprognostic (1.35e-1)" "unprognostic (2.36e-8)" "unprognostic (1.50e-1)" "unprognostic (9.77e-2)" "unprognostic (3.16e-2)" "unprognostic (5.17e-3)" 1.2 0.4 0.5 0.7 0.5 0.0 0.7 0.4 0.6 0.8 1.3 2.0 2.5 0.6 0.3 0.2 1.0 4.3 1.8 0.4 0.4 1.0 0.2 1.5 0.1 0.5 0.4 0.2 0.5 0.1 0.0 0.6 0.0 0.6 1.1 1.9 0.0 0.6 0.3 2.8 0.4 2.6 0.3 0.3 0.0 2.8 1.0 0.5 0.1 0.6 1.3 0.1 3.6 0.9 0.5 2.0 0.2 0.1 0.0 3.1 10.5 0.0 7.9 24.4 6.2 2.3 0.0 31.9 0.0 1.9 2.0 3.0 0.9 0.0 2.3 7.4 0.0 0.1 0.0 7.5 0.0 3.0 0.0 0.0 2.5 0.8 21.2 5.3 2.5 3.1 0.0 0.0 0.1 3.1 0.0 0.1 0.0 0.3 0.7 46.7 27.9 1.7 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 5.7 11.3 0.0 17.6 4.7 0.0 0.0 2.2 86.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.6 0.4 0.4 0.5 0.4 0.2 0.6 0.3 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 7.9 0.0 0.2 0.0 0.0 0.1 0.0 6.6 0.4 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 TGIF2LY ENSG00000176679 "TGFB induced factor homeobox 2 like Y-linked" Q8IUE0 Y 3579067-3580041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "testis: 4.0" "Group enriched" "Detected in some" 9 "Early spermatids: 16.8;Late spermatids: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.2" "Cell type enhanced" "Detected in some" "Astrocytes: 55.5;Excitatory neurons: 86.9;Inhibitory neurons: 82.8;Microglial cells: 49.6;Oligodendrocyte precursor cells: 60.8;Oligodendrocytes: 48.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.7;HeLa: 2.0" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 2.0 1.7 1.6 0.7 1.7 0.5 2.2 1.8 2.8 3.0 1.5 2.2 0.0 2.1 0.0 2.0 3.3 0.1 1.5 1.6 1.6 2.0 1.7 2.3 0.5 1.8 1.6 1.6 2.3 2.2 0.3 3.7 0.2 1.9 2.9 0.3 1.6 2.4 0.2 4.8 3.6 2.4 0.1 1.4 2.6 2.0 11.2 1.7 0.4 2.5 0.4 0.3 2.5 2.6 3.1 0.1 0.1 0.7 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.7 0.1 3.7 0.1 0.1 1.2 0.1 0.0 0.0 0.0 0.2 0.5 0.2 2.0 1.3 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.0 0.1 0.3 0.5 0.0 0.0 1.3 1.3 0.8 0.0 0.8 0.2 0.4 0.1 0.3 0.0 0.0 0.2 1.7 0.6 0.6 1.0 0.1 0.1 1.5 1.2 0.2 0.6 1.1 1.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.6 1.7 1.8 2.8 1.6 1.6 1.8 1.6 1.6 1.9 1.4 1.7 3.1 0.7 3.2 0.5 55.5 1.0 0.1 0.4 0.0 0.6 0.5 0.2 0.0 4.3 0.0 0.2 0.0 0.0 0.1 0.9 1.4 1.9 0.1 21.0 0.3 0.7 0.4 1.2 0.0 86.9 0.4 0.0 0.6 2.0 0.4 1.3 0.4 0.4 0.1 0.3 0.0 82.8 1.1 0.0 2.2 0.8 2.8 0.0 0.6 0.0 49.6 0.1 0.2 0.0 60.8 48.1 0.2 0.8 0.4 0.4 0.1 1.9 0.2 0.9 0.9 0.0 0.7 0.6 1.3 1.1 0.4 0.1 0.1 1.4 0.1 1.1 0.1 FOXC2 "FKHL14, MFH-1" ENSG00000176692 "Forkhead box C2" Q99958 16 86566829-86569728 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 6 "spinal cord: 42.7" HPA056302 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA056302: AB_2683093" "unprognostic (3.17e-2)" "unprognostic (1.76e-3)" "unprognostic (4.87e-2)" "unprognostic (4.32e-1)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (4.49e-2)" "unprognostic (1.15e-2)" "unprognostic (4.71e-2)" "unprognostic (8.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (1.12e-2)" "unprognostic (3.47e-2)" "unprognostic (2.43e-1)" "unprognostic (1.84e-4)" 2.3 1.6 0.8 0.3 0.8 0.0 1.8 0.9 1.6 1.9 4.6 0.5 0.1 0.8 0.6 0.5 2.0 1.3 4.7 0.5 0.8 5.5 0.1 2.1 0.4 0.6 0.8 0.3 1.2 0.2 0.1 2.4 0.1 0.7 1.0 0.1 0.1 2.4 0.6 0.7 0.7 0.4 0.4 0.7 0.0 0.4 2.0 0.7 0.1 2.0 0.5 0.1 0.8 1.5 0.5 0.0 0.0 0.0 0.0 5.8 7.8 0.0 11.3 14.3 8.0 1.5 0.0 0.0 0.0 1.5 1.4 11.2 0.0 0.2 3.3 7.0 0.0 0.6 0.0 7.9 0.0 2.7 0.0 0.0 1.3 3.4 25.2 7.9 14.5 19.5 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 1.7 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 5.9 0.0 0.0 36.0 18.4 0.0 31.5 0.0 0.0 0.0 0.0 24.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.9 1.6 0.5 0.8 0.6 0.8 0.3 0.7 0.7 0.7 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.8 2.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 1.5 0.1 1.8 1.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 30.9 1.2 0.8 0.0 0.0 0.0 0.1 19.7 0.6 33.2 0.2 5.0 0.5 0.0 0.0 0.0 0.0 0.1 1.4 OR4F17 "OR4F11P, OR4F18, OR4F19" ENSG00000176695 "Olfactory receptor family 4 subfamily F member 17" Q8NGA8 19 107104-117102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 76.9;Alveolar cells type 2: 59.5;Club cells: 26.0;granulocytes: 27.8;Respiratory ciliated cells: 24.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.9 59.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 38.5;Bipolar cells: 13.8;Cardiomyocytes: 9.1;Excitatory neurons: 22.3;Smooth muscle cells: 25.8;Theca cells: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 36.6;BJ hTERT+ SV40 Large T+: 28.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;HBF TERT88: 26.5;U-138 MG: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA Yes 16000000 24000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.3 0.5 2.0 0.2 2.3 0.2 0.2 2.8 8.4 0.6 0.1 0.3 0.3 0.2 3.3 0.6 0.1 0.7 3.3 8.0 1.9 0.3 0.1 2.0 0.1 3.1 1.1 0.9 0.5 0.4 0.0 1.2 1.6 1.9 2.0 0.1 0.7 0.3 1.8 0.4 0.9 0.1 0.1 0.4 0.1 0.3 0.6 1.5 0.3 1.0 0.0 0.1 2.1 0.6 3.0 2.9 12.2 0.3 0.0 3.7 2.2 0.0 36.6 7.9 28.0 20.9 0.1 4.0 0.0 3.7 11.8 0.5 1.4 0.1 0.2 26.5 0.2 0.1 0.0 3.5 0.0 17.4 0.2 0.2 9.2 4.2 6.8 3.7 18.1 1.3 0.1 0.0 0.1 4.8 0.0 0.0 0.0 4.0 0.1 2.9 0.0 2.0 0.0 4.5 0.0 0.2 1.1 7.8 0.1 0.1 1.7 0.2 0.0 11.0 37.6 6.9 14.4 9.2 0.5 0.1 0.0 14.1 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 2.8 8.4 8.0 1.9 3.1 1.1 0.9 1.9 0.4 1.5 3.0 0.2 38.5 0.5 1.6 0.0 0.6 0.4 0.5 1.8 13.8 0.5 0.9 9.1 0.0 0.4 1.8 4.2 0.4 0.0 0.1 0.0 0.8 1.8 0.3 0.3 0.2 0.0 0.0 22.3 0.0 0.5 6.1 0.0 0.1 1.3 1.9 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.4 1.5 0.3 0.9 1.8 0.0 0.0 0.2 0.0 2.0 2.2 0.2 0.0 0.0 0.0 0.8 0.0 1.5 0.1 1.8 0.0 1.8 25.8 3.7 0.8 2.3 0.0 0.7 0.0 9.3 0.1 0.1 CCDC121 "FLJ13646, FLJ43364" ENSG00000176714 "Coiled-coil domain containing 121" Q6ZUS5 2 27625638-27629012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.6" "Cell type enriched" "Detected in many" 4 "Early spermatids: 186.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 10.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051791 Uncertain Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA051791: AB_2681611" "unprognostic (1.52e-1)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (3.93e-1)" "unprognostic (1.28e-1)" "unprognostic (4.71e-3)" "prognostic favorable (4.12e-4)" "unprognostic (4.03e-2)" "unprognostic (1.23e-1)" "unprognostic (5.65e-4)" "unprognostic (7.78e-2)" "prognostic favorable (1.87e-5)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (7.86e-2)" "unprognostic (5.42e-2)" 4.0 3.1 6.5 1.8 5.6 1.3 5.2 6.4 6.5 3.9 4.7 3.1 2.4 4.9 4.5 2.8 7.2 2.6 6.0 5.6 10.0 5.4 3.0 4.0 2.3 8.6 5.6 4.1 10.0 2.4 7.8 2.5 3.4 6.0 4.3 3.0 7.3 5.3 5.7 3.6 3.0 2.2 3.5 8.4 4.1 3.5 25.6 7.6 2.4 7.2 5.7 2.3 2.3 1.9 8.0 3.3 3.8 5.1 5.7 9.1 4.0 6.4 1.7 0.8 1.7 0.8 2.9 3.0 1.7 2.6 1.1 4.9 3.1 3.8 1.4 1.8 2.4 4.1 1.0 2.1 3.8 1.7 1.5 2.9 1.3 4.5 0.9 2.4 2.8 3.4 0.8 4.6 2.3 2.4 2.8 1.2 1.6 5.3 4.2 1.9 5.7 12.4 3.0 3.5 2.6 6.6 7.6 1.4 6.3 2.2 4.1 5.2 3.6 1.8 1.5 5.5 1.3 4.7 1.4 1.5 2.5 3.6 2.1 1.8 1.8 1.9 10.8 0.4 2.9 1.3 2.3 1.4 0.5 1.4 1.9 2.3 1.6 4.2 2.3 3.4 0.4 0.3 1.0 6.5 5.6 6.4 6.5 5.6 10.0 8.6 5.6 4.1 6.0 8.4 7.6 8.0 7.3 6.4 2.6 1.6 2.9 0.6 1.7 0.8 0.6 5.1 2.4 3.2 3.2 4.3 1.9 0.0 20.9 3.1 1.3 1.9 7.9 3.6 186.5 17.1 5.2 5.8 1.2 1.7 0.7 1.1 2.0 4.2 2.6 7.6 0.0 2.8 5.3 2.0 1.9 3.3 1.1 1.3 2.0 1.6 2.1 44.7 8.7 2.2 1.8 0.0 0.8 12.7 0.0 1.5 2.9 2.0 0.8 6.8 0.3 1.2 1.4 3.9 21.2 12.4 13.1 5.6 3.2 31.0 10.0 1.4 1.1 1.8 1.7 4.9 2.1 0.8 ACSF3 ENSG00000176715 "Acyl-CoA synthetase family member 3" Q4G176 16 89088375-89164121 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 242.9;U-698: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008322 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA008322: AB_1845294" "unprognostic (1.94e-1)" "unprognostic (3.35e-1)" "unprognostic (4.66e-2)" "unprognostic (1.56e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (5.68e-2)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.96e-1)" "prognostic favorable (3.76e-5)" "unprognostic (3.36e-2)" "prognostic favorable (5.97e-6)" "unprognostic (2.33e-1)" "unprognostic (5.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.00e-3)" 9.0 20.7 6.3 16.0 7.1 11.7 9.4 8.5 9.2 8.7 8.1 17.2 31.0 9.7 9.8 10.6 9.6 9.8 8.8 6.8 6.9 11.7 19.4 8.0 21.9 7.9 6.7 6.5 9.0 15.7 18.7 7.8 6.2 8.5 8.6 11.5 5.9 13.3 6.6 13.2 10.4 26.6 7.9 5.8 13.4 12.7 7.9 8.3 37.9 9.9 16.7 14.0 10.3 8.8 10.9 12.8 17.8 8.4 14.4 14.5 13.3 19.6 16.5 6.1 16.2 10.4 16.2 20.9 33.2 21.5 14.2 10.5 20.9 8.6 19.4 10.0 12.3 20.6 25.8 16.6 23.8 35.2 8.1 13.3 19.4 22.0 12.4 18.1 18.5 11.7 242.9 36.4 10.1 9.0 32.7 45.6 25.7 9.8 24.8 30.0 53.2 7.2 14.1 15.9 17.2 20.6 15.3 26.6 6.8 26.2 13.5 23.1 28.6 11.6 17.3 12.8 10.2 12.5 11.7 17.3 113.0 15.4 29.8 14.5 7.0 23.0 17.2 22.7 22.8 25.2 29.8 18.5 16.5 21.7 20.6 19.5 17.4 9.0 10.8 21.3 24.6 19.6 17.9 6.3 7.1 8.5 9.2 6.8 6.9 7.9 6.7 6.5 8.5 5.8 8.3 10.9 9.2 0.0 11.4 9.4 22.5 3.2 7.6 11.9 4.0 20.2 8.5 7.5 9.1 11.5 15.5 5.5 31.3 11.9 17.5 29.9 15.6 16.1 13.8 10.3 9.3 10.3 16.8 14.3 10.1 10.7 3.8 9.3 17.3 8.1 2.5 44.7 7.9 12.5 18.6 21.9 9.5 19.4 28.5 19.5 14.2 20.4 12.2 14.0 7.2 14.0 18.6 9.3 13.4 9.0 11.2 16.3 20.8 10.1 21.2 8.9 54.7 13.5 10.0 19.0 39.5 11.1 9.7 8.8 8.5 8.2 4.5 7.3 17.0 20.1 31.1 7.4 BOK "BCL2L9, BOKL, MGC4631" ENSG00000176720 "BCL2 family apoptosis regulator BOK" Q9UMX3 2 241551424-241574131 "Plasma proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 213.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 100.8;Oligodendrocytes: 47.0;Proximal tubular cells: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.3" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Cell line enhanced" "Detected in many" "TIME: 65.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.16e-2)" "unprognostic (3.01e-2)" "unprognostic (1.24e-3)" "unprognostic (6.30e-2)" "unprognostic (8.63e-2)" "unprognostic (1.33e-1)" "unprognostic (2.24e-3)" "unprognostic (1.16e-2)" "unprognostic (8.45e-2)" "unprognostic (2.33e-1)" "unprognostic (2.47e-2)" "unprognostic (2.27e-1)" "prognostic favorable (1.09e-9)" "unprognostic (9.48e-3)" "unprognostic (6.81e-2)" "unprognostic (2.46e-1)" "unprognostic (1.09e-1)" 91.4 7.1 101.0 6.3 125.2 0.4 38.0 101.5 95.0 15.3 46.3 26.9 8.2 34.5 16.4 29.7 18.3 22.9 6.3 67.6 89.6 20.5 97.8 20.2 3.7 136.9 114.1 62.2 9.9 16.4 3.8 4.7 5.7 130.2 28.8 5.0 1.2 12.0 25.8 2.6 19.2 9.5 20.5 107.4 6.5 21.7 7.8 103.6 1.1 11.1 3.3 3.4 35.2 18.7 213.6 36.0 8.8 15.7 36.2 26.3 15.6 4.4 28.6 11.3 36.9 37.9 16.2 14.6 0.1 9.7 51.0 9.0 32.9 1.7 28.9 13.8 0.1 0.3 0.1 9.3 42.2 21.8 0.2 1.3 15.9 29.2 15.5 4.4 27.8 44.6 2.4 6.4 0.1 36.7 46.0 0.2 0.2 9.9 40.0 26.8 0.4 25.9 0.2 24.2 0.9 14.0 5.4 13.2 8.5 23.3 18.3 24.4 1.3 65.0 0.1 52.8 0.7 3.2 0.1 0.1 0.1 0.1 0.0 2.1 0.0 0.0 0.0 2.3 0.0 0.2 0.0 0.7 1.0 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.6 101.0 125.2 101.5 95.0 67.6 89.6 136.9 114.1 62.2 130.2 107.4 103.6 213.6 22.5 6.4 32.1 0.3 0.5 7.1 11.5 8.6 5.2 0.2 19.4 10.5 10.2 32.9 6.3 11.0 0.0 2.0 2.5 5.8 15.6 23.2 0.2 6.6 17.6 15.6 11.4 5.3 0.8 11.1 10.5 10.9 5.6 14.4 0.0 2.6 12.5 100.8 0.7 0.0 1.5 3.7 2.0 4.7 1.2 1.5 6.2 0.7 1.8 4.7 0.0 3.9 6.2 7.5 47.0 27.7 2.8 10.5 0.9 26.3 7.1 41.9 1.5 1.3 0.0 11.7 11.2 0.3 8.2 19.8 12.8 6.2 1.6 3.4 6.1 15.1 ZNF843 MGC46336 ENSG00000176723 "Zinc finger protein 843" Q8N446 16 31432593-31443160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 4.6;Cardiomyocytes: 5.3;Prostatic glandular cells: 3.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;EFO-21: 1.8;HMC-1: 1.6" "HPA030911, HPA030912, HPA077945" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: " "unprognostic (9.27e-2)" "unprognostic (1.32e-1)" "unprognostic (3.43e-3)" "unprognostic (9.24e-2)" "unprognostic (1.33e-1)" "unprognostic (6.25e-3)" "unprognostic (2.86e-1)" "unprognostic (8.30e-3)" "unprognostic (3.55e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-3)" "unprognostic (2.93e-3)" "unprognostic (5.96e-3)" "unprognostic (1.23e-2)" "unprognostic (7.66e-2)" "unprognostic (1.28e-5)" "unprognostic (1.17e-1)" 0.5 0.5 1.5 0.3 1.2 0.3 0.6 2.4 1.3 1.0 0.1 0.4 0.2 1.0 0.7 0.4 1.1 0.7 1.8 1.5 1.5 0.6 0.4 0.3 0.3 1.1 1.3 1.3 3.0 2.1 0.9 1.5 0.4 1.4 0.6 0.1 1.1 1.6 0.8 2.2 0.9 0.3 0.5 1.0 0.4 0.4 0.5 1.3 0.2 1.0 0.8 0.2 0.5 0.6 1.0 0.1 0.3 0.2 1.2 2.3 0.6 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.0 1.8 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.6 0.2 1.6 1.2 0.3 0.0 0.1 0.8 0.0 0.2 0.2 0.2 0.6 0.8 0.1 0.4 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.2 0.8 0.0 0.2 0.1 0.1 0.0 0.1 0.4 1.0 0.2 0.2 0.7 0.1 0.4 0.2 0.2 0.7 0.1 0.2 0.1 0.4 0.7 1.7 0.1 0.2 0.1 1.0 1.5 1.2 2.4 1.3 1.5 1.5 1.1 1.3 1.3 1.4 1.0 1.3 1.0 0.5 0.0 0.5 2.9 0.3 0.8 4.6 0.1 0.0 2.2 0.9 1.3 5.3 0.0 0.7 0.0 2.1 0.3 0.1 0.3 0.0 0.3 0.2 0.4 2.0 1.0 1.2 0.0 1.4 0.2 0.1 1.4 0.0 0.4 1.3 1.4 1.8 0.3 0.6 0.0 1.7 0.0 0.0 0.3 2.1 0.0 1.5 0.9 0.0 0.0 0.1 1.4 2.1 1.0 1.3 0.1 0.1 1.5 0.1 3.6 0.0 0.4 0.0 1.9 0.0 2.8 1.3 0.4 0.7 0.1 1.4 0.3 1.2 0.8 0.1 1.9 RBIS C8orf59 ENSG00000176731 "Ribosomal biogenesis factor" Q8N0T1 8 85214048-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 56.0;Cytotrophoblasts: 105.8;dendritic cells: 39.1;Extravillous trophoblasts: 123.8;Hofbauer cells: 102.1;Syncytiotrophoblasts: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 73.0 69.9 61.9 51.5 62.0 83.9 96.2 63.8 73.0 84.8 64.6 75.2 61.2 67.6 91.9 91.0 72.9 43.2 91.2 60.4 65.9 75.1 86.9 52.8 71.3 63.3 62.3 59.7 83.4 104.0 61.1 69.5 46.0 63.6 72.2 57.4 46.2 75.9 41.8 78.6 61.3 66.9 49.2 64.5 76.0 99.8 41.8 63.4 75.7 61.8 69.2 71.9 74.5 74.2 66.2 166.6 83.1 122.6 79.4 73.4 140.2 94.8 107.6 102.7 123.1 120.5 97.2 140.0 42.1 86.8 71.8 116.2 112.9 84.8 118.2 138.1 116.6 92.5 242.1 74.2 145.8 87.0 92.5 105.7 120.0 137.0 79.4 99.7 133.3 106.4 145.3 111.9 97.8 103.7 131.0 205.8 173.1 36.1 372.8 143.3 86.9 100.6 188.2 121.2 104.7 40.7 87.1 81.7 132.8 161.0 145.5 154.4 135.9 81.8 78.1 164.9 87.5 104.2 114.1 144.8 197.4 155.8 116.8 88.9 76.6 55.2 39.2 63.5 71.7 76.7 89.3 83.7 78.9 96.9 77.7 95.8 95.0 14.1 104.7 64.4 118.7 90.8 71.0 61.9 62.0 63.8 73.0 60.4 65.9 63.3 62.3 59.7 63.6 64.5 63.4 66.2 56.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 105.8 39.1 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 123.8 27.8 0.0 0.0 0.0 0.0 0.0 0.0 102.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 76.9 7.6 0.0 0.0 0.0 PFN4 ENSG00000176732 "Profilin family member 4" Q8NHR9 2 24114809-24123464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "testis: 81.7" "Group enriched" "Detected in some" 6 "Early spermatids: 491.1;Spermatocytes: 319.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (3.52e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-4)" "unprognostic (1.25e-1)" "unprognostic (3.82e-2)" "unprognostic (2.21e-2)" "unprognostic (2.74e-2)" "unprognostic (8.97e-3)" "unprognostic (1.77e-5)" "unprognostic (2.55e-2)" "unprognostic (1.52e-1)" "unprognostic (1.16e-1)" "unprognostic (9.10e-2)" 0.8 0.6 1.5 0.2 1.0 0.3 1.3 1.2 1.6 0.7 0.9 0.4 0.2 0.9 2.0 0.8 1.7 0.6 1.2 0.9 0.8 1.2 0.3 0.8 0.5 1.2 1.0 1.0 1.9 0.4 1.0 1.2 0.5 1.9 0.9 0.6 3.0 0.7 0.7 1.0 0.6 0.4 0.4 0.4 0.7 0.3 81.7 0.8 0.4 2.0 0.5 0.7 0.4 0.6 1.0 2.0 1.0 0.4 1.8 1.9 1.9 0.7 0.6 0.3 0.6 0.4 0.4 2.1 1.2 0.3 0.0 2.3 0.2 0.0 0.2 0.2 1.5 0.0 0.1 0.5 0.0 1.1 0.3 0.1 2.4 1.2 0.5 1.2 0.4 0.3 1.3 0.4 1.1 1.0 1.4 0.3 0.6 0.4 0.0 1.3 0.4 1.0 0.0 1.0 0.2 1.1 1.6 0.7 0.2 0.6 0.7 2.1 0.4 0.9 0.9 0.7 0.1 0.7 1.7 1.7 1.1 1.6 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.0 1.2 1.6 0.9 0.8 1.2 1.0 1.0 1.9 0.4 0.8 1.0 0.3 0.0 1.1 0.7 0.2 0.3 0.6 0.4 0.0 0.8 0.9 0.6 2.4 0.0 0.3 0.0 0.0 0.4 0.2 0.1 3.9 0.5 491.1 4.6 0.9 1.1 0.0 0.0 1.3 1.4 0.7 0.7 0.0 0.7 0.0 1.7 0.4 0.8 1.0 1.7 1.7 0.2 0.0 0.0 0.0 66.9 6.5 0.7 0.0 0.0 0.0 1.1 0.0 0.5 1.4 0.8 0.0 1.9 0.1 0.3 0.1 2.0 4.3 1.0 0.0 0.5 0.5 319.1 3.6 0.0 0.6 0.3 0.1 0.8 0.2 0.4 OR51V1 OR51A12 ENSG00000176742 "Olfactory receptor family 51 subfamily V member 1" 11 5199735-5200682 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB6 "CT3.4, FLJ40242, MAGE-B6, MAGEB6A" ENSG00000176746 "MAGE family member B6" Q8N7X4 X 26192440-26195646 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "testis: 3.2" "Group enriched" "Detected in some" 6 "Spermatocytes: 23.5;Spermatogonia: 16.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "K-562: 4.6" "HPA041853, HPA076711" Enhanced NA NA "HPA041853: AB_10796785, HPA076711: " "unprognostic (2.05e-1)" "unprognostic (1.31e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486993-32491253 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 64.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Early spermatids: 21.2;Excitatory neurons: 36.6;Inhibitory neurons: 31.6;Late spermatids: 18.9" "Cancer enhanced" "Detected in many" "melanoma: 14.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "SCLC-21H: 58.1;SH-SY5Y: 15.6;SK-MEL-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000252: AB_2665953" "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 0.8 2.8 36.2 7.2 55.1 5.4 1.2 16.0 64.0 1.0 0.0 0.9 1.4 0.9 0.2 7.6 0.7 0.9 1.0 54.7 32.5 0.8 1.0 0.8 14.0 10.5 16.5 61.6 2.7 1.4 0.7 6.9 0.7 23.5 0.6 0.8 10.5 1.2 0.5 2.3 1.8 3.7 0.6 1.9 12.2 1.6 7.3 21.6 4.3 0.5 0.8 14.2 0.8 3.1 39.5 3.9 2.2 9.8 3.1 1.1 1.8 1.1 2.4 1.4 2.9 3.7 5.7 0.9 1.9 2.2 2.0 2.4 1.8 3.8 2.4 3.8 0.7 7.3 0.7 1.1 2.3 0.5 1.3 1.9 1.1 5.8 2.9 2.4 1.1 2.1 6.9 3.9 2.2 6.2 1.6 3.4 1.5 6.2 1.4 2.1 2.9 5.9 7.1 1.4 1.7 58.1 15.6 2.3 1.3 43.8 1.4 2.5 4.4 2.2 4.0 5.9 1.6 6.3 1.1 1.5 1.9 3.4 5.6 9.7 0.0 0.3 0.4 0.8 0.3 0.6 0.2 1.1 0.4 0.0 0.1 1.5 0.9 1.2 0.2 0.1 0.6 0.1 0.6 36.2 55.1 16.0 64.0 54.7 32.5 10.5 16.5 61.6 23.5 1.9 21.6 39.5 1.7 0.0 1.5 6.5 13.1 1.5 0.5 1.0 7.4 15.9 3.7 2.3 3.6 0.0 0.8 0.0 45.9 0.6 10.1 0.3 0.0 0.2 21.2 1.1 1.3 1.2 0.0 0.0 36.6 0.6 0.3 1.2 0.5 1.5 0.0 1.6 0.7 0.7 0.9 1.7 31.6 1.4 2.0 3.5 0.5 18.9 0.0 1.3 3.6 2.8 2.0 18.4 10.3 9.5 11.9 1.2 1.2 0.7 0.9 1.2 0.4 1.5 1.0 6.3 0.0 2.9 3.1 6.7 4.3 8.8 1.3 1.1 7.1 1.9 1.1 0.5 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;retina: 6.2;thyroid gland: 15.1" "Group enriched" "Detected in some" 5 "Excitatory neurons: 69.9;Horizontal cells: 102.6" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.3;RPMI-8226: 1.1;SuSa: 1.9;U-2 OS: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.0 0.9 1.2 0.0 3.9 0.0 0.1 0.6 5.7 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 2.3 2.2 0.0 0.0 0.0 0.0 2.4 1.4 3.2 3.1 0.3 0.5 1.3 0.0 1.2 0.6 0.0 6.2 0.0 0.6 0.0 0.5 0.0 0.0 1.2 0.2 0.0 1.6 1.8 0.6 15.1 0.0 0.1 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.9 0.6 5.7 2.3 2.2 2.4 1.4 3.2 1.2 1.2 1.8 2.6 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.0 2.2 5.9 0.5 0.1 1.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 69.9 0.0 0.7 0.9 0.5 0.1 0.0 0.1 0.0 0.0 0.0 102.6 14.5 0.0 0.0 0.0 0.0 0.1 4.7 0.2 10.6 1.0 0.0 0.9 0.0 3.0 2.3 0.1 0.0 4.5 0.0 0.7 0.0 0.0 0.0 4.3 0.0 0.3 0.2 0.4 3.7 2.8 0.6 0.1 0.1 2.5 0.0 0.1 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671788-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 39.0;lung: 11.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 262.8;Astrocytes: 478.6;Oligodendrocyte precursor cells: 774.6;Oligodendrocytes: 2156.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 1.5 1.0 9.8 0.5 27.1 0.0 3.0 17.0 10.3 0.8 1.9 1.2 2.2 0.4 0.6 4.0 0.4 0.8 2.6 7.8 13.6 4.1 3.9 11.5 1.3 21.3 27.5 3.1 2.5 0.9 0.6 0.6 2.6 39.0 0.8 1.0 4.7 2.1 0.3 0.5 2.1 3.2 0.4 13.3 1.7 1.7 1.1 27.3 0.8 1.1 0.6 1.1 0.5 2.0 34.0 0.0 2.2 46.2 0.0 0.1 0.4 0.2 0.7 8.3 0.7 0.8 0.0 0.1 3.6 0.0 0.5 0.5 0.2 0.3 0.7 2.5 0.0 0.3 0.0 7.1 0.0 0.0 0.0 0.0 0.5 3.8 4.4 0.6 7.2 0.8 0.0 0.0 0.0 1.3 0.5 0.0 0.0 1.1 0.3 1.4 0.4 0.0 1.9 1.1 1.1 0.2 1.4 0.0 1.7 2.4 0.4 0.7 0.0 2.4 0.3 0.4 6.7 0.1 0.2 0.0 1.3 0.4 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 27.1 17.0 10.3 7.8 13.6 21.3 27.5 3.1 39.0 13.3 27.3 34.0 6.0 262.8 13.3 478.6 0.6 8.9 0.7 1.4 15.4 179.6 14.5 10.8 16.8 0.0 28.6 1.8 41.7 0.1 0.1 5.3 3.9 0.3 6.8 1.1 1.1 2.9 3.6 0.0 16.4 0.2 0.2 6.8 7.7 1.4 1.3 0.0 0.7 6.3 0.6 33.7 41.3 5.4 10.2 7.9 32.2 3.3 26.4 6.2 1.8 147.1 4.1 56.9 0.0 774.6 2156.8 1.0 5.2 7.5 0.0 0.5 20.7 14.0 1.2 7.8 6.6 8.7 24.7 0.1 1.3 15.5 2.8 0.0 0.7 0.0 1.6 1.5 MAGEB18 MGC33889 ENSG00000176774 "MAGE family member B18" Q96M61 X 26138343-26140736 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "Spermatocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "Karpas-707: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA046141 Enhanced NA NA "HPA046141: AB_2679554" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB104A "DEFB-4, DEFB104, DEFB4" ENSG00000176782 "Defensin beta 104A" Q8WTQ1 8 7836436-7841242 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 763 "epididymis: 1320.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045292 Supported "Secreted in male reproductive system" NA NA "HPA045292: AB_2679288" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1320.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RUFY1 "FLJ22251, RABIP4, ZFYVE12" ENSG00000176783 "RUN and FYVE domain containing 1" Q96T51 5 179550554-179610012 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Macrophages: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038804 Approved Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 25000 "Vesicles, Cytosol" "Nuclear speckles" "HPA038804: AB_10673290" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.50e-1)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (9.74e-2)" "unprognostic (1.31e-1)" "unprognostic (2.73e-2)" "unprognostic (3.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" 27.1 33.4 9.7 13.6 10.0 13.4 26.3 9.7 10.2 26.6 11.2 27.2 9.4 27.7 8.2 34.2 24.8 8.9 19.9 9.4 10.5 24.2 21.5 26.9 14.3 10.2 10.0 8.8 24.1 24.6 13.6 22.9 9.0 10.0 22.6 8.3 7.4 26.0 8.7 34.1 33.0 26.1 7.9 9.9 35.5 24.4 11.0 10.1 13.7 24.9 10.2 11.6 26.5 27.5 12.7 13.9 22.5 11.8 15.7 22.3 18.2 13.4 24.2 17.2 14.1 16.3 22.0 31.6 22.4 13.4 29.6 16.2 12.6 21.9 31.6 16.4 71.2 16.6 39.2 17.1 16.0 22.8 22.0 20.7 18.5 17.1 9.5 27.0 24.6 15.5 12.5 16.2 20.8 12.7 42.0 23.5 15.2 12.6 15.0 10.5 20.9 8.4 20.9 23.5 22.4 11.7 16.7 35.4 22.5 13.2 14.8 18.0 26.6 18.8 18.3 6.2 10.0 19.3 12.8 21.2 39.8 16.9 39.0 17.2 14.9 4.8 11.9 2.2 5.1 1.3 3.8 2.7 2.3 4.2 5.7 1.9 2.4 7.9 1.8 7.1 4.8 4.5 29.8 9.7 10.0 9.7 10.2 9.4 10.5 10.2 10.0 8.8 10.0 9.9 10.1 12.7 19.8 35.3 30.8 30.0 23.6 10.3 11.5 11.7 16.5 9.3 17.8 17.5 22.8 28.6 23.1 14.7 20.9 21.7 15.7 20.0 9.8 19.7 8.0 28.2 21.9 20.9 10.8 27.7 31.8 14.4 15.8 19.7 19.9 20.0 29.8 20.4 12.5 14.1 31.1 11.8 28.4 17.5 8.2 30.7 21.0 3.4 23.0 137.2 10.6 21.5 43.7 11.9 15.5 23.1 33.9 22.1 18.5 27.1 18.3 14.2 14.1 34.0 32.8 12.0 6.6 20.8 17.8 11.1 8.4 21.9 11.4 21.2 19.5 25.0 15.3 10.2 OR52E2 ENSG00000176787 "Olfactory receptor family 52 subfamily E member 2" Q8NGJ4 11 5058650-5059627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045748 Uncertain NA NA "HPA045748: AB_10959665" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 483.6;epididymis: 306.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 128.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 128.5" "Cell line enhanced" "Detected in many" "GAMG: 467.0;HeLa: 800.8;SiHa: 830.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" NA NA 63000000 "Plasma membrane" "HPA045218: AB_2679263, HPA050333: AB_2681090" "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 29.8 13.9 186.2 74.3 256.6 88.4 14.1 100.4 483.6 57.1 79.8 11.1 7.4 37.6 306.0 11.0 11.5 29.4 9.5 241.6 195.9 11.6 17.3 36.8 81.6 133.7 140.7 247.2 36.9 3.7 3.4 21.3 92.9 167.5 80.4 10.9 74.9 13.3 21.8 2.3 21.3 22.4 33.7 104.0 77.1 22.9 2.9 159.3 24.3 11.4 6.8 92.3 58.4 27.6 277.9 0.1 125.6 152.7 0.2 71.7 76.1 227.1 161.7 50.9 127.9 135.0 6.1 0.1 51.3 22.4 112.0 467.0 10.6 98.2 109.2 164.8 21.3 57.9 0.4 800.8 0.3 158.9 101.3 1.4 131.2 132.7 145.6 121.0 163.9 140.1 0.2 0.4 0.5 138.2 183.7 0.3 92.5 115.7 0.3 39.6 0.1 0.5 28.0 46.5 31.3 99.3 21.3 830.7 72.3 0.2 336.5 0.3 101.9 187.7 169.3 0.6 14.2 26.1 1.7 0.2 27.1 171.2 123.0 23.1 25.0 3.1 25.3 0.0 1.5 0.0 5.4 0.0 0.0 4.9 7.9 0.0 0.0 128.5 1.8 2.1 0.5 0.3 0.8 186.2 256.6 100.4 483.6 241.6 195.9 133.7 140.7 247.2 167.5 104.0 159.3 277.9 8.0 9.6 4.8 22.2 158.7 215.9 88.0 21.3 58.1 54.8 9.8 10.2 1.6 0.0 15.8 9.2 12.5 155.0 3.8 0.6 0.0 0.6 0.9 98.4 345.6 30.2 0.0 18.1 254.0 3.4 362.9 102.6 23.4 156.4 27.3 18.1 35.7 2.5 53.8 244.0 125.3 0.7 12.2 227.9 489.4 0.0 0.6 298.5 28.4 53.4 275.1 796.9 1.0 115.1 23.7 1.0 0.2 0.0 173.0 121.0 0.0 0.3 93.5 58.4 0.0 2.0 66.2 0.4 3.4 21.0 58.8 738.5 11.9 8.3 1.8 13.2 DEFB103A "DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3" ENSG00000176797 "Defensin beta 103A" P81534 8 7881392-7882663 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.6;salivary gland: 3.2;vagina: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 5.8;LHCN-M2: 1.7;U-2197: 3.0" "Secreted in other tissues" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.6 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51L1 ENSG00000176798 "Olfactory receptor family 51 subfamily L member 1" Q8NGJ5 11 4994851-5005536 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC37A3 "FLJ34306, KIAA0563" ENSG00000176809 "Leucine rich repeat containing 37 member A3" O60309 17 64854312-64919480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.1" "Cell type enhanced" "Detected in many" "Astrocytes: 82.6;Excitatory neurons: 143.1;Inhibitory neurons: 161.3;Microglial cells: 75.9;Oligodendrocyte precursor cells: 110.1;Oligodendrocytes: 99.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA042121, HPA043056, HPA045090" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211" "unprognostic (2.28e-1)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.84e-2)" "unprognostic (2.27e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-2)" "unprognostic (5.31e-6)" "unprognostic (1.83e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (2.26e-1)" "unprognostic (4.89e-2)" "unprognostic (5.18e-2)" "unprognostic (7.43e-3)" 4.1 4.3 12.7 2.1 11.4 4.1 5.1 15.3 16.3 6.2 10.7 3.4 1.5 4.2 9.4 3.4 7.6 3.9 3.4 11.3 12.4 15.0 4.4 4.2 2.6 11.7 11.4 10.6 7.8 4.8 2.8 22.5 2.6 12.1 8.2 2.1 19.0 3.2 3.3 4.3 4.3 3.0 2.3 10.1 4.4 3.1 29.1 12.9 2.0 17.2 1.0 1.6 3.6 4.5 11.8 2.2 4.4 4.1 9.3 4.6 2.8 2.9 3.0 2.5 2.0 2.3 1.9 3.3 2.2 1.4 1.6 3.6 1.9 1.1 0.9 0.9 2.9 4.2 7.0 3.1 1.3 1.8 2.5 1.6 1.9 1.9 1.5 0.6 9.2 1.4 2.8 1.4 1.2 1.5 6.0 1.3 4.5 3.1 0.5 1.2 1.5 2.2 1.0 4.3 2.0 2.7 10.2 1.2 5.3 1.3 11.6 2.4 4.7 5.1 3.7 1.1 1.5 1.7 1.8 1.9 1.7 2.6 10.7 6.3 2.7 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.6 0.3 0.3 0.7 1.1 0.4 0.8 0.3 0.1 12.7 11.4 15.3 16.3 11.3 12.4 11.7 11.4 10.6 12.1 10.1 12.9 11.8 2.0 0.0 2.2 82.6 1.8 1.8 1.6 0.5 1.8 11.4 1.6 1.5 2.8 1.5 1.9 1.8 4.2 1.3 1.9 1.5 1.9 3.0 37.9 4.9 2.7 3.6 1.2 0.4 143.1 1.3 0.2 1.9 1.1 2.3 2.5 4.6 4.6 1.0 1.5 25.2 161.3 1.1 0.0 0.9 0.7 8.6 2.1 1.4 1.8 75.9 1.4 3.7 2.1 110.1 99.3 0.7 1.7 3.0 1.8 1.2 0.7 6.9 6.9 4.1 6.6 4.1 1.7 7.3 1.8 1.0 1.0 1.0 1.4 1.3 1.1 1.4 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 69.3;Proximal enterocytes: 106.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 33.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA062022: AB_2732675" "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 6.0 11.4 4.6 2.4 5.2 0.8 6.0 5.5 4.6 6.8 4.5 13.5 14.0 4.3 3.1 8.8 4.7 3.8 3.4 3.8 4.3 4.4 5.8 8.5 1.5 5.9 4.8 3.4 6.4 7.1 8.2 4.4 8.7 4.8 5.9 16.0 1.9 7.1 5.2 17.2 5.0 24.7 3.2 5.3 3.9 6.6 2.6 5.0 0.9 12.2 10.9 2.1 6.0 6.9 4.9 7.9 11.4 4.8 16.1 19.4 8.8 12.4 13.3 8.5 6.4 5.3 3.3 18.2 1.1 5.3 9.8 12.0 18.9 33.8 3.4 7.6 4.0 5.1 1.8 11.0 5.0 3.9 1.1 2.7 4.0 9.8 4.9 3.1 18.6 14.2 3.8 2.3 0.1 6.1 8.3 0.0 1.1 14.9 22.8 7.5 2.8 13.2 0.0 9.4 25.1 4.1 5.3 13.0 5.4 3.4 10.2 11.9 5.3 16.8 7.4 4.7 9.2 6.8 0.1 0.1 0.1 10.7 5.5 15.0 0.2 0.5 0.6 0.1 0.1 0.1 0.0 0.1 0.0 0.6 0.1 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.1 4.6 5.2 5.5 4.6 3.8 4.3 5.9 4.8 3.4 4.8 5.3 5.0 4.9 23.6 19.2 28.6 14.0 3.3 2.4 13.0 1.8 6.8 9.9 15.1 11.7 11.4 31.5 5.0 29.5 12.5 38.0 2.2 69.3 19.6 26.2 6.1 10.3 13.0 19.1 50.4 9.9 4.7 20.3 41.0 11.9 16.8 13.6 2.5 33.3 21.0 27.5 11.2 5.0 5.1 40.4 2.0 6.7 9.4 9.9 18.0 5.6 3.6 3.7 7.4 18.9 2.1 9.0 3.1 26.7 45.3 14.7 3.1 10.4 106.6 13.7 2.7 7.9 0.0 12.9 8.6 4.0 6.1 12.4 3.1 14.0 4.0 24.7 48.2 15.3 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930865-54934485 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.2;salivary gland: 10.2;skin 1: 15.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 40.3;Breast myoepithelial cells: 55.5;Granulosa cells: 43.8;Muller glia cells: 43.1;Squamous epithelial cells: 33.9" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.1;T-47d: 36.6;THP-1: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" No NA "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favorable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 1.0 0.6 1.4 0.0 1.3 0.0 14.2 4.5 0.5 1.0 0.2 0.2 0.0 0.1 0.0 7.3 0.2 0.1 5.3 0.2 1.9 3.2 0.0 6.4 0.0 3.3 3.8 0.0 0.3 0.1 0.3 0.4 0.0 3.0 3.5 0.0 1.3 10.2 0.2 1.4 15.4 0.0 0.0 3.5 0.0 2.6 0.8 4.5 0.3 0.1 1.1 0.0 0.6 5.9 3.8 0.8 0.5 8.6 3.2 3.1 0.6 0.4 3.3 8.2 1.1 0.8 1.9 0.8 0.0 0.7 4.5 0.3 8.4 3.0 3.6 0.6 6.0 4.1 0.9 3.4 0.0 0.1 2.0 3.3 0.8 15.1 5.4 2.3 1.5 0.0 4.8 0.5 0.0 6.2 3.3 9.6 12.3 0.1 1.3 2.4 5.0 4.4 0.5 27.1 0.2 2.9 3.0 1.4 7.3 3.9 0.0 36.6 20.2 0.5 5.9 0.2 4.2 1.3 3.6 2.3 2.9 9.6 3.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 4.5 0.5 0.2 1.9 3.3 3.8 0.0 3.0 3.5 4.5 3.8 2.4 9.6 21.9 0.0 0.1 8.3 9.7 6.7 15.9 8.6 40.3 55.5 11.1 0.0 15.4 0.0 0.0 0.2 1.0 0.2 0.0 0.3 1.0 9.6 1.2 1.6 0.0 0.0 0.0 0.6 0.0 5.3 7.7 12.2 0.0 43.8 0.0 0.0 0.2 1.7 0.0 0.8 4.1 0.0 2.7 2.4 0.0 0.6 5.4 0.0 0.0 43.1 0.0 0.0 0.0 2.9 0.3 0.0 0.3 4.8 0.0 1.5 13.0 1.9 0.0 8.3 5.2 0.7 2.8 33.9 8.0 0.0 0.4 0.0 0.5 8.5 METRNL ENSG00000176845 "Meteorin like, glial cell differentiation regulator" Q641Q3 17 83079609-83095122 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 239.1" "Cell type enhanced" "Detected in many" "dendritic cells: 640.2;Macrophages: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 119.5;U-2197: 162.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023792 Uncertain "Secreted to blood" NA NA 445000 1300000 "HPA023792: AB_2144182" "unprognostic (7.99e-2)" "unprognostic (2.32e-1)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (6.41e-3)" "unprognostic (7.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (1.01e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-3)" "unprognostic (4.43e-1)" "unprognostic (2.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.61e-2)" 102.2 24.2 7.9 13.3 6.9 22.1 67.4 7.0 9.9 69.6 30.5 48.4 26.8 34.1 2.1 185.6 39.7 12.3 91.9 7.1 12.6 71.9 19.3 81.0 5.2 9.5 9.1 5.4 23.2 24.6 25.3 36.8 14.7 8.2 26.6 4.1 3.4 53.4 3.8 15.4 239.1 50.4 4.3 7.0 41.3 41.4 32.6 12.2 3.2 61.8 1.5 4.7 47.8 104.3 8.8 11.4 0.3 5.4 7.3 5.9 21.8 26.7 11.7 5.1 8.4 9.6 1.4 7.8 0.7 4.6 9.1 6.4 29.8 1.9 0.7 5.6 8.6 4.4 26.8 32.0 3.3 14.1 7.8 49.5 10.5 2.2 36.1 2.4 5.3 4.2 0.0 17.1 0.0 7.2 19.0 0.7 23.9 1.1 16.6 16.6 8.2 11.4 3.9 1.3 4.3 0.5 3.6 16.0 29.5 14.2 5.3 27.3 8.2 10.9 119.5 12.5 162.6 3.6 0.0 0.0 0.4 28.1 3.1 7.5 6.8 3.2 10.5 1.8 6.0 0.1 1.4 0.3 1.3 4.5 0.1 0.0 0.5 5.5 3.2 8.1 1.7 1.8 1.5 7.9 6.9 7.0 9.9 7.1 12.6 9.5 9.1 5.4 8.2 7.0 12.2 8.8 39.0 25.6 31.1 6.5 28.0 22.9 19.9 4.7 1.2 3.3 19.7 16.5 40.5 14.3 12.3 49.7 6.2 12.4 640.2 110.2 3.9 11.5 9.5 72.6 27.1 16.8 6.0 3.2 0.7 13.9 5.1 56.1 18.3 103.4 32.9 41.5 25.0 1.0 53.8 1.7 2.1 41.4 6.1 62.2 133.6 1.5 7.8 162.0 16.0 1.9 13.7 90.6 25.7 4.0 0.3 19.7 64.9 3.4 95.8 18.4 53.4 8.3 7.4 22.2 0.0 75.4 35.5 5.9 3.4 13.5 49.2 19.2 98.8 0.5 35.1 62.2 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768439-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 13.0 11.8 8.0 16.0 8.3 43.3 14.2 9.2 8.4 12.9 12.8 13.1 14.6 13.9 12.0 13.2 10.4 16.1 6.7 7.3 13.2 18.5 26.8 13.2 18.8 10.0 9.0 6.7 12.9 14.1 21.2 9.4 20.4 9.1 11.7 15.0 11.8 11.5 11.1 6.1 11.6 14.3 11.8 9.9 19.8 14.0 11.0 9.8 14.4 18.5 6.3 17.1 17.3 10.7 11.9 63.9 42.4 12.9 22.4 24.4 26.3 20.8 36.2 39.4 33.7 42.5 21.3 25.8 29.9 39.2 29.9 26.7 30.4 30.8 39.2 60.0 57.5 29.8 47.2 21.9 25.6 38.0 21.7 58.9 25.0 31.1 44.1 54.3 23.0 31.0 18.4 17.1 41.3 30.7 75.8 37.7 14.4 12.7 51.8 37.3 20.4 21.5 22.4 28.4 64.7 15.5 21.6 48.1 102.4 49.8 18.8 31.5 22.9 31.5 32.0 57.4 35.7 53.1 31.9 65.8 28.4 50.2 38.7 39.9 7.0 8.0 11.3 3.2 9.5 2.9 5.1 3.2 2.7 8.2 4.2 2.7 3.7 10.1 5.9 8.5 3.1 3.1 4.3 8.0 8.3 9.2 8.4 7.3 13.2 10.0 9.0 6.7 9.1 9.9 9.8 11.9 31.9 25.6 13.2 17.6 30.6 39.6 21.9 19.0 20.5 15.0 24.0 17.7 8.4 22.8 19.3 25.8 22.9 10.4 25.3 21.3 5.9 12.1 22.4 20.8 22.9 27.5 27.5 10.3 21.0 15.5 12.7 19.3 26.5 33.0 8.8 18.2 18.5 59.3 27.1 23.5 22.0 22.0 16.2 73.6 43.5 26.0 14.0 45.9 21.4 24.4 40.1 17.6 19.6 23.6 45.8 35.1 21.7 14.7 25.8 34.8 18.7 20.8 16.5 21.7 13.1 26.5 22.4 14.2 10.7 27.0 46.7 19.2 19.6 16.0 14.5 45.3 WSB2 "MGC10210, SBA2" ENSG00000176871 "WD repeat and SOCS box containing 2" Q9NYS7 12 118032687-118062430 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 164.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052606 Uncertain NA NA "HPA052606: AB_2681882" "unprognostic (5.02e-3)" "unprognostic (4.57e-2)" "unprognostic (4.85e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.91e-2)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.42e-3)" "unprognostic (4.66e-3)" "unprognostic (7.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.93e-1)" "unprognostic (4.05e-1)" "unprognostic (2.92e-1)" "unprognostic (2.66e-1)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" 34.1 47.2 109.5 30.1 106.5 17.7 20.5 92.0 116.6 19.7 59.5 45.1 35.6 18.9 24.0 53.5 18.1 25.5 56.3 108.5 90.8 35.9 36.9 31.8 24.3 105.9 115.6 96.1 14.0 37.0 43.4 36.4 19.3 99.9 26.8 45.8 39.2 21.1 26.6 103.7 22.0 39.3 36.0 102.6 17.9 33.3 18.8 102.0 21.0 46.9 164.7 28.5 46.0 21.2 105.6 49.3 78.2 55.2 93.5 81.1 46.7 39.1 129.3 95.9 138.6 82.8 41.5 66.4 7.1 42.6 168.7 77.4 25.8 46.6 78.6 98.7 90.7 29.6 27.5 36.7 39.0 85.7 16.2 71.5 62.7 77.7 75.0 51.6 148.7 72.3 48.5 83.2 12.5 143.8 73.2 10.3 9.9 32.2 110.7 48.2 29.3 57.5 2.2 81.9 211.5 58.5 87.3 100.1 21.8 69.9 54.7 75.0 37.3 113.7 164.6 68.7 53.1 158.8 21.6 14.6 13.4 148.8 20.3 266.9 9.7 5.0 11.5 4.5 7.5 4.0 0.7 4.4 4.7 3.5 1.8 1.9 3.4 5.4 3.4 5.2 4.1 5.1 1.8 109.5 106.5 92.0 116.6 108.5 90.8 105.9 115.6 96.1 99.9 102.6 102.0 105.6 17.1 25.6 15.7 14.7 5.9 16.6 39.4 16.4 5.2 21.0 20.2 10.3 33.7 24.3 14.1 20.2 4.2 10.0 11.8 75.1 21.5 37.4 2.0 19.5 23.6 16.7 72.7 7.4 45.9 85.1 24.3 19.6 23.0 31.5 7.0 13.1 17.2 36.4 34.7 57.2 31.9 40.7 22.4 51.8 18.4 4.7 7.5 23.5 28.4 18.7 34.8 34.1 11.3 18.1 30.7 89.6 44.5 17.3 6.2 53.4 47.7 35.6 7.2 14.1 13.1 21.8 26.0 3.2 5.1 17.8 18.6 17.2 13.1 44.8 25.8 86.9 GRIN1 "GluN1, NMDAR1" ENSG00000176884 "Glutamate ionotropic receptor NMDA type subunit 1" Q05586 9 137139154-137168756 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "brain: 196.5" "Group enriched" "Detected in some" 4 "Excitatory neurons: 132.6;Inhibitory neurons: 134.4" "Cancer enhanced" "Detected in some" "glioma: 1.9;prostate cancer: 1.8" "Region enriched" "Detected in many" 4 "cerebral cortex: 196.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067773 Enhanced NA NA "HPA067773: " "unprognostic (3.58e-2)" "unprognostic (4.51e-1)" "unprognostic (2.68e-2)" "unprognostic (5.48e-4)" "unprognostic (5.20e-2)" "unprognostic (1.25e-1)" "unprognostic (2.34e-2)" "unprognostic (2.81e-2)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (4.47e-2)" "unprognostic (1.44e-1)" "unprognostic (3.56e-3)" "unprognostic (4.72e-2)" 0.0 0.1 13.1 0.2 46.8 0.0 0.2 0.0 196.5 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.1 37.7 18.4 0.0 0.0 0.1 0.1 12.1 27.3 36.7 0.0 0.1 0.2 0.7 0.0 22.0 0.7 0.0 3.8 1.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 42.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.4 0.0 1.9 0.0 2.5 0.0 0.0 5.2 3.1 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 46.8 0.0 196.5 37.7 18.4 12.1 27.3 36.7 22.0 0.0 1.8 42.0 0.0 0.0 0.0 8.5 0.0 0.0 0.3 0.1 0.0 28.0 1.2 0.9 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.9 0.2 0.1 0.2 1.8 0.0 132.6 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.7 134.4 1.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 9.4 2.0 1.7 0.0 10.1 7.6 0.2 0.1 0.0 0.0 0.7 0.5 0.1 0.3 7.8 0.0 0.0 0.1 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 SOX11 ENSG00000176887 "SRY-box transcription factor 11" P35716 2 5692384-5701385 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 4.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8" "Cancer enhanced" "Detected in many" "glioma: 8.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.0 0.0 2.4 0.0 3.0 0.0 0.0 1.5 2.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 4.4 0.0 0.0 0.0 0.0 2.3 3.1 1.2 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.2 3.2 0.1 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 47.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 2.3 0.0 0.0 4.4 0.0 0.0 0.0 23.6 0.0 0.0 17.9 18.2 0.7 0.0 0.0 29.1 44.0 0.0 0.3 0.0 8.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 3.3 0.6 1.2 0.0 0.0 11.1 0.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 2.4 3.0 1.5 2.0 1.3 4.4 2.3 3.1 1.2 1.9 3.2 3.5 3.1 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 6.4 8.6 13.9 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 5.7 0.9 0.0 0.8 1.2 0.0 0.0 0.4 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 1.0 0.0 0.5 0.0 21.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 38.8 1.1 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 TYMS "HsT422, TMS, TS, Tsase" ENSG00000176890 "Thymidylate synthetase" P04818 18 657653-673578 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 89.2;lymphoid tissue: 114.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 14.1" "Group enriched" "Detected in many" 6 "NK-cells: 6.7;T-cells: 14.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002784, HPA074922" Enhanced NA Yes "CAB002784: , HPA074922: " "unprognostic (7.58e-2)" "unprognostic (2.06e-3)" "unprognostic (9.31e-2)" "unprognostic (2.34e-2)" "unprognostic (7.35e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.10e-6)" "unprognostic (1.62e-3)" "unprognostic (1.68e-2)" "unprognostic (9.82e-2)" "unprognostic (1.07e-3)" "unprognostic (3.28e-2)" "unprognostic (1.23e-2)" "unprognostic (6.34e-2)" "unprognostic (1.66e-1)" "unprognostic (5.65e-3)" "unprognostic (2.47e-1)" 4.5 3.1 4.5 24.4 7.5 89.2 6.8 4.4 6.5 3.7 3.3 23.1 10.6 5.2 1.3 14.9 5.7 3.8 2.2 5.2 5.4 6.5 11.9 5.0 36.4 6.7 5.7 4.0 2.1 3.6 1.8 1.7 22.5 6.9 3.2 27.4 4.2 3.9 2.0 0.4 6.2 14.9 12.8 4.8 10.6 8.9 34.6 5.8 114.7 2.1 0.4 44.8 8.5 5.5 10.9 102.7 156.6 320.4 154.9 35.1 57.9 159.9 238.9 141.1 251.7 299.9 132.8 80.1 160.0 91.5 129.9 143.2 45.1 225.3 89.7 216.1 152.3 244.9 273.1 135.8 229.4 8.2 564.8 286.5 51.5 20.7 159.6 49.6 48.4 214.4 334.0 222.0 249.6 321.8 118.1 687.7 311.4 114.7 124.3 114.0 446.8 287.0 191.3 95.6 88.9 106.0 175.7 201.4 91.6 61.1 197.3 63.5 253.5 85.0 289.7 569.5 267.3 474.2 305.9 405.2 367.3 75.2 240.6 339.2 0.0 0.0 1.3 1.1 0.1 0.0 1.1 2.8 2.2 1.8 0.0 0.0 0.6 0.7 6.7 0.1 0.3 14.1 2.9 4.5 7.5 4.4 6.5 5.2 5.4 6.7 5.7 4.0 6.9 4.8 5.8 10.9 2.1 0.0 2.3 1.6 15.7 14.4 15.9 13.0 27.9 0.5 7.8 11.7 3.6 2.8 6.7 0.0 0.0 105.8 14.5 15.5 1.9 2.3 34.4 5.6 8.4 12.5 1.2 189.3 0.4 0.8 115.3 28.3 14.3 7.4 7.0 76.2 6.8 4.3 71.4 0.0 0.6 20.9 10.2 15.6 19.4 31.9 6.2 10.7 10.6 1.0 3.9 45.0 5.2 0.5 15.6 1.5 8.9 3.8 112.7 5.0 13.8 36.6 1.0 2.4 13.1 1.3 32.6 180.8 30.7 48.0 7.2 27.0 21.3 10.5 54.9 18.7 OR51G2 ENSG00000176893 "Olfactory receptor family 51 subfamily G member 2" Q8NGK0 11 4912588-4919350 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PXMP2 "MPV17L3, PMP22" ENSG00000176894 "Peroxisomal membrane protein 2" Q9NR77 12 132687587-132704985 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 314.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 187.3;Hepatocytes: 577.4;Proximal enterocytes: 333.3;Proximal tubular cells: 303.7" "Cancer enhanced" "Detected in all" "liver cancer: 43.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-2)" "unprognostic (7.96e-2)" "unprognostic (4.70e-3)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (7.39e-3)" "unprognostic (2.83e-1)" "unprognostic (2.44e-2)" "unprognostic (3.02e-1)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.75e-4)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.71e-3)" "unprognostic (3.04e-1)" 20.5 14.8 22.1 7.6 22.3 23.6 18.9 23.0 30.0 13.7 33.0 46.8 52.6 15.0 22.5 16.3 18.8 15.5 47.1 26.9 22.0 57.8 314.6 13.0 11.6 22.3 22.1 22.3 23.2 42.9 14.6 9.3 8.1 22.1 20.0 39.5 7.6 18.8 9.8 42.7 14.6 55.6 9.6 20.9 13.2 99.0 9.2 22.9 26.1 14.8 30.8 10.8 16.1 12.9 22.2 60.5 24.8 36.6 34.1 21.5 16.6 21.4 21.0 19.4 44.7 39.6 30.3 22.4 37.2 24.9 30.0 15.7 42.0 49.1 26.6 24.3 21.3 77.8 33.2 43.9 33.8 41.7 24.8 14.4 21.7 21.8 18.6 14.7 31.2 12.1 56.2 58.2 28.4 23.8 54.2 78.9 39.2 35.7 70.0 33.9 80.1 39.2 30.6 32.9 25.2 69.0 22.5 45.6 23.6 29.6 28.1 63.2 56.0 14.3 21.9 51.1 19.1 35.6 25.7 26.7 60.6 24.6 34.9 17.7 0.0 1.2 2.9 2.3 0.6 2.1 2.5 1.8 2.4 2.1 2.7 1.8 1.5 0.7 1.5 0.6 6.3 3.1 1.2 22.1 22.3 23.0 30.0 26.9 22.0 22.3 22.1 22.3 22.1 20.9 22.9 22.2 10.9 3.2 7.2 8.1 8.2 8.4 20.0 10.6 15.4 6.1 50.3 51.1 35.8 138.7 6.0 25.8 4.2 60.1 7.3 187.3 166.3 16.5 18.7 11.8 16.9 14.1 18.7 55.9 5.9 10.3 36.6 17.0 65.7 17.4 4.5 32.4 46.8 577.4 34.9 0.0 7.1 85.1 2.0 19.2 9.4 38.8 31.1 8.1 12.4 5.6 2.7 45.5 13.4 4.5 1.0 10.2 143.4 35.0 20.9 28.1 333.3 303.7 2.1 7.3 19.7 7.5 14.8 44.9 30.2 31.2 10.7 28.5 8.1 12.4 158.6 23.2 OR51A7 ENSG00000176895 "Olfactory receptor family 51 subfamily A member 7" Q8NH64 11 4903783-4909462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061356 Uncertain NA NA "HPA061356: AB_2684488" "unprognostic (4.57e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCEANC MGC17403 ENSG00000176896 "Transcription elongation factor A N-terminal and central domain containing" Q8N8B7 X 13653189-13681964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000337, HPA001013" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000337: , HPA001013: AB_1079371" "unprognostic (1.44e-1)" "unprognostic (2.21e-3)" "unprognostic (1.74e-2)" "unprognostic (4.45e-2)" "unprognostic (2.21e-3)" "unprognostic (2.29e-3)" "unprognostic (4.03e-2)" "unprognostic (4.29e-6)" "unprognostic (3.82e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-5)" "unprognostic (1.68e-1)" "unprognostic (1.25e-3)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (5.10e-3)" "unprognostic (1.11e-4)" 1.3 1.2 1.5 1.0 1.6 4.5 2.5 2.2 1.9 1.4 1.5 1.2 1.1 1.5 3.0 0.8 1.8 1.0 1.6 1.6 1.6 1.6 1.8 1.8 2.7 1.7 1.7 1.6 2.6 1.5 1.2 1.3 1.2 1.7 1.5 1.5 2.9 1.8 1.2 1.7 1.5 1.4 1.5 1.5 2.5 1.2 1.0 1.7 3.0 2.1 1.5 2.0 1.1 1.1 2.1 0.4 1.1 1.2 2.1 2.5 3.0 0.4 0.3 1.0 1.0 0.4 0.4 0.8 1.3 1.1 0.8 0.6 0.6 1.1 0.6 0.2 1.4 1.5 0.7 0.6 0.6 1.4 1.1 1.3 2.6 1.0 0.6 4.2 1.5 0.3 1.3 1.4 2.2 1.4 0.9 1.8 1.1 1.6 0.6 0.3 1.4 1.1 2.8 0.5 0.7 1.2 1.1 1.1 1.2 1.6 1.5 1.2 1.0 0.5 0.9 0.4 0.8 0.1 1.8 1.1 1.0 1.2 0.6 0.4 7.2 1.6 4.2 2.6 1.4 3.0 3.5 2.8 3.5 1.3 3.6 3.4 3.1 2.1 1.6 1.5 2.3 3.7 1.9 1.5 1.6 2.2 1.9 1.6 1.6 1.7 1.7 1.6 1.7 1.5 1.7 2.1 2.9 0.0 1.1 1.6 3.8 0.3 1.0 1.2 1.8 3.5 2.3 2.0 2.6 1.5 2.3 3.7 2.1 2.2 7.3 1.3 3.9 1.5 0.0 2.2 2.6 1.5 2.4 19.0 1.7 0.9 0.8 1.8 1.1 2.0 5.1 2.1 1.8 3.9 2.0 1.7 2.2 2.5 2.0 2.8 2.0 0.2 3.4 1.8 0.0 2.8 3.1 4.9 6.2 0.5 2.5 0.5 1.8 2.2 7.3 1.2 2.7 3.2 2.0 2.3 0.0 1.7 2.6 1.1 1.2 0.9 0.3 3.3 4.8 2.1 1.3 0.9 OR51T1 ENSG00000176900 "Olfactory receptor family 51 subfamily T member 1" Q8NGJ9 11 4881819-4882883 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046877 Uncertain NA NA "HPA046877: AB_2679853" "unprognostic (2.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMA1 MA1 ENSG00000176903 "PNMA family member 1" Q8ND90 14 73711783-73714384 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003817, HPA015007" Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA Cytosol "Nucleoplasm, Focal adhesion sites" "HPA003817: AB_1079646, HPA015007: AB_1855502" "unprognostic (2.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (7.49e-5)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.90e-1)" "unprognostic (5.35e-2)" "unprognostic (3.63e-1)" "unprognostic (5.58e-2)" "unprognostic (4.58e-2)" "unprognostic (1.67e-3)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (2.23e-3)" "prognostic unfavorable (4.51e-5)" 35.8 30.5 72.4 20.5 85.1 8.9 20.8 61.2 89.8 36.0 37.7 44.5 14.1 46.7 55.1 23.6 38.5 24.8 23.5 78.2 86.3 28.1 4.9 15.6 16.6 67.6 65.4 78.4 53.9 9.3 8.0 53.5 21.6 67.0 49.2 16.7 60.5 11.0 90.1 12.1 9.6 25.1 52.7 66.5 19.3 26.2 71.6 74.7 19.1 18.7 10.5 12.6 42.0 26.8 74.2 48.2 42.8 72.3 54.1 53.1 56.0 29.9 49.8 27.8 44.5 32.5 40.6 29.2 1.1 33.8 60.7 42.4 31.6 56.0 29.4 45.7 45.7 34.7 27.2 35.8 30.7 56.8 15.3 41.6 49.8 35.1 53.4 33.5 87.4 68.1 28.7 23.9 29.3 61.2 117.6 30.5 37.1 21.8 24.6 149.0 47.5 45.0 1.1 58.8 1.5 85.4 65.5 87.5 19.9 40.4 43.6 97.0 25.6 66.5 89.3 71.7 54.9 41.1 25.7 42.9 14.2 88.3 21.4 30.3 2.9 1.8 4.7 8.5 3.5 5.8 2.8 10.9 8.7 3.9 3.1 10.4 10.0 1.6 5.6 5.3 0.6 14.2 7.3 72.4 85.1 61.2 89.8 78.2 86.3 67.6 65.4 78.4 67.0 66.5 74.7 74.2 13.1 6.4 3.0 21.9 8.8 3.8 6.8 5.0 6.2 48.6 7.0 7.5 19.9 2.8 4.1 14.7 12.5 7.5 10.4 6.7 15.6 10.1 84.2 32.2 30.6 13.5 18.7 3.0 31.4 6.7 11.3 20.5 14.3 10.2 16.5 16.6 20.0 1.6 15.6 58.9 28.9 5.4 14.2 6.8 25.9 57.6 32.6 18.8 19.6 12.2 14.1 65.2 10.3 17.1 21.7 30.2 1.4 84.7 10.9 7.4 1.6 26.6 23.1 49.1 72.3 31.2 44.1 87.2 44.4 4.7 3.8 6.0 20.0 43.8 2.5 3.7 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153482-40155310 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 209.5;Alveolar cells type 2: 882.5;Collecting duct cells: 200.5;Distal tubular cells: 193.7;Ductal cells: 331.6;Glandular and luminal cells: 397.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 48.5;AF22: 134.4;BJ: 51.5;BJ hTERT+: 134.4;EFO-21: 87.5;HeLa: 94.8;RPTEC TERT1: 67.2;SuSa: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 85.5 24.4 6.8 43.3 7.6 0.0 64.6 6.4 10.9 135.3 11.8 62.5 31.2 68.3 18.4 22.5 20.4 106.1 116.8 7.0 14.3 115.3 211.8 166.8 18.2 6.9 7.0 6.7 45.0 51.9 70.8 19.1 166.5 7.7 68.3 71.8 4.5 177.5 28.5 38.1 11.1 102.2 43.9 7.2 84.0 56.7 4.8 8.5 3.9 54.4 48.3 4.1 257.8 26.4 9.4 0.0 48.5 134.4 0.0 0.0 0.0 0.3 51.5 134.4 0.2 0.6 0.7 0.0 0.0 87.5 1.0 0.5 0.1 0.0 0.0 0.5 0.1 0.0 0.0 94.8 21.4 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.3 1.0 0.0 0.5 0.6 0.0 0.0 0.1 0.0 0.2 67.2 0.1 0.1 0.2 0.2 4.6 0.0 50.4 0.0 0.0 43.6 0.0 1.2 0.4 0.8 1.2 1.7 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 7.6 6.4 10.9 7.0 14.3 6.9 7.0 6.7 7.7 7.2 8.5 9.4 209.5 99.3 882.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 124.9 62.0 0.0 0.0 77.4 200.5 0.0 12.3 1.5 0.0 193.7 331.6 0.0 152.6 90.7 103.2 0.0 0.0 0.0 111.2 26.5 13.5 0.0 397.4 26.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 102.4 0.0 0.0 0.1 0.0 0.0 2.5 8.7 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 4.5 8.1 22.7 0.0 0.0 MAMSTR "FLJ36070, MASTR" ENSG00000176909 "MEF2 activating motif and SAP domain containing transcriptional regulator" Q6ZN01 19 48712725-48719725 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 32.7;skeletal muscle: 89.8;tongue: 22.8" "Cell type enhanced" "Detected in many" "Theca cells: 10.1" "Cancer enhanced" "Detected in all" "ovarian cancer: 7.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 7.2;RH-30: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049765 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049765: AB_2680870" "unprognostic (6.00e-2)" "unprognostic (3.20e-2)" "unprognostic (5.98e-2)" "unprognostic (6.07e-2)" "unprognostic (1.65e-1)" "unprognostic (6.50e-3)" "unprognostic (4.34e-4)" "unprognostic (2.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (4.65e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (2.79e-1)" "unprognostic (4.84e-2)" "unprognostic (1.39e-2)" 2.9 32.7 1.6 0.8 1.5 0.3 1.8 7.3 3.7 5.6 0.0 2.0 0.6 8.1 1.5 3.6 8.0 1.0 3.9 2.0 0.2 1.5 0.4 1.5 0.6 0.8 0.7 1.8 8.8 1.9 3.0 3.9 1.6 3.2 2.4 0.8 0.5 2.9 1.9 89.8 2.1 1.3 4.7 0.1 6.2 1.6 9.3 0.6 0.5 1.2 22.8 0.6 2.1 4.6 1.1 0.5 1.3 1.4 3.5 2.7 4.5 1.3 4.8 3.8 2.3 3.6 1.4 0.9 0.7 0.2 4.4 1.3 1.0 0.1 0.8 0.9 0.5 1.6 0.3 0.6 7.2 1.4 0.1 0.9 2.8 0.9 3.2 0.4 3.1 0.8 1.3 0.3 0.9 1.5 0.6 1.1 0.5 0.1 1.1 1.0 1.3 16.6 0.4 0.2 0.3 1.5 2.8 0.7 0.3 0.3 0.3 0.5 0.0 0.3 4.7 0.8 3.8 0.6 1.0 0.6 0.5 1.7 0.5 0.9 0.0 0.2 0.5 1.6 0.4 1.0 1.3 1.7 1.6 0.4 2.1 1.6 1.5 0.2 0.3 0.4 1.3 0.8 0.3 1.6 1.5 7.3 3.7 2.0 0.2 0.8 0.7 1.8 3.2 0.1 0.6 1.1 2.4 0.0 0.0 2.6 1.3 0.9 1.8 1.5 4.6 1.8 1.4 2.2 2.9 0.0 2.3 1.8 2.1 0.8 0.5 0.6 5.9 1.7 0.8 0.8 3.5 3.8 0.0 1.3 2.9 1.0 2.9 4.9 1.1 1.6 0.0 6.1 4.6 0.3 1.1 0.0 2.0 0.7 2.0 0.3 2.2 1.7 5.6 1.6 7.2 0.0 1.2 5.3 2.1 1.5 1.2 0.5 0.0 6.0 1.5 0.6 1.1 0.6 0.4 2.9 0.0 5.1 4.7 0.7 1.6 2.4 0.9 1.0 1.8 10.1 0.8 1.6 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761832 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 215.7;Urothelial cells: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 29.8 37.9 12.3 27.3 13.5 38.7 28.1 15.5 16.7 25.5 20.2 23.9 18.0 25.1 19.2 33.9 25.5 17.6 20.6 13.9 13.9 22.0 23.1 31.5 31.8 13.0 12.6 12.5 27.3 24.9 18.0 23.3 20.5 14.2 24.1 16.3 12.4 26.3 15.8 29.6 36.2 33.6 22.1 12.4 38.2 24.3 56.2 14.1 26.5 23.5 18.4 31.4 25.3 27.8 12.7 50.7 46.4 47.3 29.5 26.9 42.1 59.1 60.2 44.7 59.0 45.0 53.2 33.6 39.5 30.7 53.1 39.5 59.2 41.8 54.8 56.2 17.0 51.6 50.1 84.0 25.2 29.9 54.6 34.0 39.1 54.9 56.2 41.3 108.8 42.8 32.0 46.1 15.1 61.2 36.4 51.1 89.4 40.1 24.8 43.9 58.0 31.1 16.7 42.6 64.9 57.9 35.6 77.7 32.4 27.1 44.1 56.9 39.1 61.5 70.5 50.9 38.0 68.1 27.9 29.5 47.9 54.7 35.8 40.5 0.9 1.2 4.4 1.8 1.1 2.4 2.7 2.6 2.8 1.7 2.8 2.4 2.0 0.7 2.7 1.3 1.7 2.6 0.7 12.3 13.5 15.5 16.7 13.9 13.9 13.0 12.6 12.5 14.2 12.4 14.1 12.7 38.0 73.7 31.2 18.3 43.2 67.3 92.0 38.2 32.5 32.3 31.2 27.1 24.6 27.1 51.3 31.3 45.9 29.2 41.1 33.8 1.9 33.2 109.1 58.6 52.4 36.3 20.8 23.1 21.0 32.7 35.5 35.7 35.2 119.2 18.4 38.3 22.9 12.9 20.1 32.0 17.8 18.0 24.4 19.7 47.6 24.5 25.1 35.5 33.8 16.9 40.6 21.9 47.4 18.1 18.4 101.9 24.8 28.2 47.6 116.9 18.8 8.5 32.3 39.7 26.3 39.2 40.5 215.7 61.8 44.8 72.9 36.5 44.7 31.6 24.0 168.7 C8G ENSG00000176919 "Complement C8 gamma chain" P07360 9 136945185-136946975 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 569.1" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 1134.7" "Cancer enriched" "Detected in all" 58 "liver cancer: 260.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HMC-1: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046269 Approved "Secreted to blood" NA NA 2800000000 "HPA046269: AB_2679606" "unprognostic (5.00e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.94e-1)" "unprognostic (4.53e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-3)" "unprognostic (2.79e-1)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (2.96e-2)" "unprognostic (3.00e-1)" "unprognostic (5.02e-3)" "unprognostic (2.16e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" 0.3 1.5 0.1 0.0 0.1 0.0 0.3 0.2 0.3 0.3 0.0 1.3 31.5 0.4 0.9 0.6 0.4 2.5 1.0 0.1 0.0 2.3 569.1 0.3 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.6 0.0 0.1 0.4 0.3 0.0 0.4 0.1 3.2 0.3 17.9 0.0 0.1 2.1 1.3 2.3 0.1 0.2 0.7 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.4 0.0 0.0 41.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.3 2.3 0.4 0.2 0.4 0.0 0.0 0.4 0.9 0.7 28.6 0.3 0.0 2.1 0.4 1.1 25.0 0.0 0.2 0.9 0.1 0.1 0.7 1.8 8.0 0.2 0.8 1.0 0.1 0.0 0.3 8.9 1.2 17.5 1134.7 0.3 0.0 0.2 5.0 0.0 25.3 0.2 1.5 0.0 0.2 0.0 0.0 0.0 1.1 4.1 0.5 0.1 0.5 4.7 0.7 0.0 0.4 122.3 6.7 0.1 0.5 0.0 0.3 0.3 0.7 0.6 0.5 0.4 3.4 1.8 0.2 2.0 0.2 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705951 "Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.9;salivary gland: 66.8;stomach 1: 29.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 56.4;Club cells: 69.4;Distal enterocytes: 110.0;Gastric mucus-secreting cells: 83.6;Ionocytes: 57.0;Paneth cells: 75.5;Proximal enterocytes: 182.4;Undifferentiated cells: 62.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.2" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CAPAN-2: 63.6;OE19: 76.1" "Region enhanced" "Detected in some" "cerebellum: 2.3" "Low region specificity" "Detected in all" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.2 0.7 1.0 6.3 1.1 0.3 1.7 5.2 1.4 16.1 0.0 23.7 44.9 1.1 0.1 26.2 2.7 13.6 0.5 1.1 0.1 0.6 0.3 1.0 0.5 0.6 0.4 0.5 1.1 5.2 0.1 2.0 0.1 2.0 1.4 20.0 0.9 66.8 3.0 0.8 4.8 22.0 0.8 0.0 0.6 29.1 0.8 0.4 0.6 0.7 0.0 6.6 6.4 9.8 0.8 2.0 1.5 0.3 0.9 0.0 0.0 0.2 0.2 0.0 0.0 0.0 7.2 63.6 0.7 0.5 0.0 0.3 10.6 0.0 0.0 0.0 0.5 0.5 0.6 0.6 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 1.0 0.0 1.2 0.1 0.8 0.1 0.5 0.7 1.5 0.4 76.1 0.3 0.5 0.2 3.0 0.0 0.6 3.4 0.5 0.3 0.6 0.1 0.4 9.5 0.1 0.3 0.4 0.4 0.5 0.2 0.7 0.5 0.1 0.3 0.4 0.2 1.1 0.1 0.1 0.4 0.1 0.2 0.3 0.5 0.2 0.1 0.3 0.4 0.1 0.5 0.2 0.1 0.4 0.6 0.2 1.0 1.1 5.2 1.4 1.1 0.1 0.6 0.4 0.5 2.0 0.0 0.4 0.8 0.5 0.0 0.6 0.7 0.6 0.9 2.3 56.4 5.7 2.5 6.1 3.0 0.8 32.9 69.4 20.2 2.1 0.1 0.4 110.0 1.9 4.7 0.5 8.4 2.7 0.7 11.4 0.0 2.3 46.5 0.0 0.5 83.6 23.9 0.0 0.1 0.0 0.1 0.1 0.0 1.4 42.1 57.0 0.3 0.3 0.2 0.0 0.3 1.8 0.0 0.3 0.5 2.1 0.5 1.2 31.8 75.5 0.0 0.2 2.9 182.4 0.1 37.8 4.2 0.0 1.2 2.4 0.3 0.2 9.9 1.4 0.1 0.8 0.3 62.9 19.4 OR51S1 ENSG00000176922 "Olfactory receptor family 51 subfamily S member 1" Q8NGJ8 11 4847489-4849238 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51F2 ENSG00000176925 "Olfactory receptor family 51 subfamily F member 2" Q8NH61 11 4821321-4822456 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EFCAB5 FLJ46247 ENSG00000176927 "EF-hand calcium binding domain 5" A4FU69 17 29929200-30108452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 8.6" "Group enriched" "Detected in some" 4 "Early spermatids: 136.5;Late spermatids: 101.0;Spermatocytes: 65.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.4;eosinophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MOLT-4: 2.1;RPTEC TERT1: 2.9;SK-MEL-30: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (2.30e-1)" "unprognostic (3.74e-1)" "unprognostic (8.52e-2)" "unprognostic (2.40e-1)" "unprognostic (5.08e-4)" "unprognostic (3.13e-1)" "unprognostic (3.22e-2)" "unprognostic (6.77e-3)" "unprognostic (9.86e-4)" "unprognostic (7.93e-2)" "unprognostic (2.11e-1)" "unprognostic (6.74e-2)" "unprognostic (3.11e-5)" 0.0 0.1 0.2 0.2 0.0 1.3 0.0 0.9 0.4 0.0 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.4 0.4 0.0 0.1 0.4 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.3 0.4 0.2 0.0 0.1 0.3 8.6 0.3 0.1 0.2 0.0 0.4 0.0 0.0 0.8 0.3 0.4 0.3 0.0 0.4 0.6 0.0 0.6 0.1 0.0 0.4 0.0 0.9 0.5 0.3 0.9 0.3 0.4 0.1 0.6 0.5 0.2 1.7 0.0 1.1 0.4 0.2 0.5 0.3 0.0 0.0 0.1 0.0 0.7 0.2 0.7 0.0 0.1 0.0 0.0 2.1 1.0 0.1 0.4 0.0 0.7 0.8 0.8 2.9 1.2 1.3 0.2 0.8 0.5 2.3 0.3 0.0 0.2 0.6 0.1 0.3 0.4 0.0 0.0 0.0 0.8 0.2 0.2 1.1 2.4 0.0 3.2 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.9 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.4 0.1 0.4 0.2 0.3 0.0 0.3 0.0 0.3 0.8 0.3 0.0 2.0 0.7 1.5 0.3 0.2 0.1 0.0 0.8 0.7 0.6 0.7 1.5 0.1 3.7 0.0 0.3 1.7 1.4 1.9 0.0 136.5 1.7 0.2 0.4 0.0 0.4 23.3 0.2 0.2 0.3 0.5 1.1 5.1 0.2 1.4 0.4 0.2 0.0 15.0 0.8 0.0 0.0 0.2 101.0 1.8 0.6 7.2 2.8 0.1 0.0 0.0 10.6 11.1 0.3 0.2 0.7 0.2 0.2 1.3 1.4 0.6 0.2 0.0 3.1 0.8 65.9 5.0 0.4 0.0 0.0 0.7 0.5 0.8 0.3 GCNT4 "C2GNT3, LINC01336" ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4" Q9P109 5 75025346-75052558 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.2;lymphoid tissue: 15.6;stomach 1: 18.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 22.4" "Group enriched" "Detected in many" 53 "granulocytes: 22.4;T-cells: 18.2" "Cell line enriched" "Detected in some" 5 "RT4: 37.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.9 0.8 1.0 2.9 2.0 0.7 1.4 0.0 3.6 1.4 0.1 1.4 24.2 1.2 2.0 2.2 2.1 5.3 0.3 2.1 0.5 4.1 1.1 1.7 4.4 0.8 0.2 1.5 1.0 4.6 9.7 0.2 6.4 0.8 1.7 1.3 0.1 0.5 4.8 1.0 2.1 20.4 2.3 0.1 1.7 18.7 1.6 0.2 15.6 0.5 1.5 3.0 4.1 1.8 1.8 0.3 0.2 1.4 2.3 2.5 0.8 0.1 2.8 7.2 1.5 1.2 3.7 0.2 0.0 0.4 2.2 0.8 1.0 1.4 2.5 0.3 0.0 0.1 1.2 0.3 0.3 1.1 0.0 0.0 0.4 3.9 0.1 0.5 0.0 0.0 2.2 0.0 0.5 0.2 0.0 2.1 0.1 0.6 8.0 0.0 0.0 0.0 3.6 0.3 37.1 0.0 0.1 0.3 0.0 0.1 7.0 0.0 0.0 0.0 0.8 0.2 1.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 22.4 0.0 0.0 1.2 0.0 5.0 0.0 11.4 3.7 0.0 0.0 11.1 8.1 0.2 0.3 0.2 0.1 18.2 2.3 1.0 2.0 0.0 3.6 2.1 0.5 0.8 0.2 1.5 0.8 0.1 0.2 1.8 1.2 3.2 5.0 0.7 0.3 0.6 8.7 0.5 0.0 0.0 0.9 2.3 0.5 32.9 2.7 12.9 0.0 39.6 0.8 4.9 9.8 7.1 0.1 11.9 2.4 1.8 0.0 0.0 1.3 4.4 0.9 2.5 14.8 16.7 7.6 2.0 3.3 0.7 2.3 0.0 0.0 2.7 0.0 0.3 0.0 0.3 4.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 6.9 2.6 0.5 3.0 28.0 0.7 0.6 0.0 6.6 1.6 2.5 0.2 1.7 0.6 0.1 24.4 3.7 0.0 4.4 4.2 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720884-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.0;kidney: 69.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 170000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 6.0 5.1 3.6 1.3 4.5 0.9 8.0 7.0 7.5 16.9 2.2 20.1 3.0 5.1 4.5 59.0 20.1 6.4 5.9 3.5 1.7 69.2 21.3 8.0 0.8 3.9 4.0 3.2 11.9 16.2 2.1 16.6 0.5 4.7 21.0 7.2 8.1 40.6 1.1 7.1 7.5 14.9 0.8 1.3 6.1 9.9 8.5 3.3 0.8 16.4 1.0 1.5 21.2 26.3 4.9 0.9 0.0 0.2 0.7 0.4 0.0 0.7 0.0 0.2 0.0 0.1 0.0 3.7 0.1 0.7 0.0 0.2 1.5 0.1 0.0 0.1 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.4 0.1 0.7 3.9 0.1 1.0 0.1 1.1 0.1 3.6 1.3 0.4 0.0 28.1 0.2 0.5 0.2 0.0 0.0 0.2 0.8 1.0 0.1 1.3 1.7 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.5 7.0 7.5 3.5 1.7 3.9 4.0 3.2 4.7 1.3 3.3 4.9 0.9 35.3 16.7 16.6 0.5 1.8 10.0 6.4 0.6 19.9 3.2 1.5 0.7 14.3 43.7 22.0 35.5 0.1 0.2 53.2 1.9 55.5 0.1 3.5 1.3 1.7 13.8 5.3 7.5 9.9 0.1 1.8 13.3 6.2 1.3 5.3 3.3 7.3 0.5 11.8 7.7 7.3 152.5 1.0 0.8 0.4 5.3 1.1 3.6 1.0 0.0 4.7 0.0 5.0 3.0 12.2 16.9 6.4 1.7 14.2 16.9 3.3 66.5 20.5 0.0 8.8 3.3 1.3 1.3 4.3 1.8 0.0 1.7 1.0 15.2 84.4 THAP4 "CGI-36, Nb(III)" ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637158 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "DNA-binding, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 223.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: AB_2682154" "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favorable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 34.1 32.0 53.7 19.2 52.9 28.3 36.0 50.7 79.1 34.0 51.3 46.1 42.5 31.2 29.0 53.5 29.3 25.3 98.7 51.5 53.0 85.9 54.4 29.5 22.2 52.6 54.2 52.3 33.4 48.8 107.9 38.0 16.2 52.8 44.1 27.3 9.1 42.5 24.3 119.8 47.2 35.2 17.4 48.6 26.8 52.4 41.1 54.7 23.6 32.2 92.4 19.1 41.9 39.2 54.7 47.6 53.4 31.5 58.9 41.5 43.1 53.7 32.1 42.5 46.6 41.4 48.6 41.1 40.5 16.4 50.1 53.8 53.4 63.8 71.4 17.6 33.3 76.9 42.5 35.7 138.7 55.0 48.6 28.5 44.8 55.4 50.2 69.2 32.5 43.9 62.4 76.9 13.1 36.4 84.5 51.1 110.1 57.1 43.9 45.2 55.9 44.1 52.6 100.2 57.0 76.4 50.1 24.7 76.9 65.1 19.4 38.7 52.3 40.0 55.5 36.6 50.7 58.3 32.4 19.9 42.6 40.2 40.4 40.9 31.0 15.7 40.3 27.4 18.0 29.4 21.6 30.3 25.5 16.4 25.0 28.6 23.3 10.2 22.7 24.1 23.2 53.6 16.1 53.7 52.9 50.7 79.1 51.5 53.0 52.6 54.2 52.3 52.8 48.6 54.7 54.7 16.6 19.2 21.7 15.7 16.4 20.0 42.1 31.9 21.1 9.9 21.2 17.1 55.9 35.8 28.3 40.5 4.2 23.4 13.2 64.6 223.0 48.0 17.7 37.5 19.6 17.7 28.8 21.5 12.2 27.8 24.6 19.9 35.2 58.9 7.0 16.6 13.6 38.0 17.7 8.4 12.8 52.3 32.6 11.4 10.6 7.7 18.0 14.2 12.4 7.5 15.3 11.1 22.6 11.1 11.5 27.6 44.2 19.5 21.3 38.1 79.0 90.0 21.3 6.8 32.9 16.3 23.3 25.3 29.1 40.0 25.9 27.5 15.1 17.5 60.2 53.4 NFATC2IP "ESC2, FLJ14639, NIP45, RAD60" ENSG00000176953 "Nuclear factor of activated T cells 2 interacting protein" Q8NCF5 16 28950807-28967097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053587 Approved Nucleoplasm NA NA Nucleoplasm "HPA053587: AB_2682202" "unprognostic (6.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.48e-2)" "unprognostic (1.33e-1)" "unprognostic (4.90e-1)" "unprognostic (7.09e-2)" "unprognostic (8.82e-3)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (5.80e-2)" "unprognostic (5.32e-2)" "prognostic unfavorable (5.23e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (8.00e-2)" "unprognostic (3.85e-2)" "unprognostic (3.25e-1)" "unprognostic (5.94e-2)" 21.0 16.7 10.6 27.8 10.5 49.1 21.9 15.3 10.9 24.9 10.0 27.6 21.3 23.5 14.5 29.2 24.7 14.4 19.3 11.2 9.2 22.9 28.1 26.0 36.9 11.6 11.3 10.1 24.4 22.9 20.1 15.2 15.6 12.6 24.1 32.5 26.8 24.5 15.7 25.9 32.7 37.2 23.0 9.5 45.7 26.1 30.5 11.4 34.6 22.2 15.9 38.8 26.2 23.7 11.8 38.6 27.2 36.5 36.7 21.7 22.8 46.0 36.7 27.6 42.1 53.7 32.0 47.0 41.1 27.0 26.4 25.6 44.8 44.3 40.3 56.9 35.0 32.4 37.5 81.2 39.8 13.9 34.1 55.0 16.1 32.1 45.9 27.6 20.8 34.3 40.9 34.4 49.5 37.8 47.9 44.9 60.2 35.9 30.9 32.0 77.0 32.4 37.5 30.2 34.2 28.0 20.0 24.7 37.7 14.4 29.6 39.1 25.2 38.1 46.3 26.1 36.5 28.1 36.5 51.5 49.7 25.6 55.5 27.8 5.0 1.5 1.8 1.9 2.0 1.8 1.5 1.4 2.3 0.9 1.5 2.3 2.0 1.1 2.8 1.2 3.2 2.4 0.7 10.6 10.5 15.3 10.9 11.2 9.2 11.6 11.3 10.1 12.6 9.5 11.4 11.8 40.9 35.3 52.2 15.7 43.1 31.7 23.0 19.1 33.0 63.1 29.4 25.7 17.4 21.5 29.8 29.5 100.1 30.1 69.8 51.3 19.6 21.9 6.3 28.3 43.6 35.1 40.9 77.2 21.3 22.9 30.5 23.3 50.0 37.6 36.7 69.5 38.9 26.0 23.2 43.7 27.0 63.1 18.3 38.8 32.2 7.6 29.5 37.8 23.2 26.2 56.7 15.3 57.7 19.6 18.2 44.6 31.6 20.3 55.4 40.4 40.7 17.8 21.7 84.5 39.5 26.7 26.6 95.0 92.2 35.7 30.3 26.1 51.4 38.3 53.0 42.1 LY6H NMLY6 ENSG00000176956 "Lymphocyte antigen 6 family member H" O94772 8 143157914-143160711 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 115.6;pituitary gland: 55.9" "Cell type enhanced" "Detected in some" "Adipocytes: 20.0;Endothelial cells: 18.7;Enteroendocrine cells: 54.9;Excitatory neurons: 24.8;Inhibitory neurons: 47.8;Ionocytes: 22.4;Oligodendrocyte precursor cells: 22.6;Spermatogonia: 22.4" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MOLT-4: 2.9;SCLC-21H: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077218 Enhanced "Intracellular and membrane" NA NA 12000 "HPA077218: " "unprognostic (8.76e-2)" "unprognostic (2.76e-1)" "unprognostic (1.41e-2)" "unprognostic (9.45e-4)" "unprognostic (3.34e-3)" "unprognostic (1.82e-1)" "unprognostic (1.71e-4)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-3)" "unprognostic (3.76e-3)" "unprognostic (5.97e-2)" "unprognostic (2.20e-5)" "unprognostic (6.43e-3)" "unprognostic (1.54e-1)" "unprognostic (8.98e-2)" "unprognostic (9.89e-3)" 1.5 0.5 62.2 0.2 84.4 0.0 0.8 27.6 115.6 0.9 27.7 16.2 2.5 1.6 0.0 1.3 2.0 0.0 0.3 86.5 84.9 0.6 0.1 1.4 0.1 39.7 46.9 76.9 1.0 1.1 0.0 55.9 0.0 35.8 0.9 0.0 0.5 0.1 0.0 0.2 0.4 6.7 0.4 33.3 0.2 11.9 5.8 67.4 0.0 0.9 0.0 0.0 0.6 0.4 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.2 84.4 27.6 115.6 86.5 84.9 39.7 46.9 76.9 35.8 33.3 67.4 64.6 20.0 0.0 0.0 9.1 0.0 0.6 0.2 0.3 0.0 5.8 0.6 0.0 6.2 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.8 0.1 18.7 54.9 0.0 24.8 0.0 0.1 3.7 12.2 0.0 0.0 2.7 0.0 0.0 0.1 0.0 47.8 0.9 22.4 0.0 0.0 2.2 0.0 0.1 0.0 13.1 0.0 2.3 0.0 22.6 5.9 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.2 3.5 0.0 0.1 0.4 1.9 22.4 0.3 0.0 0.0 0.0 2.5 0.2 0.5 FIBIN MGC24932 ENSG00000176971 "Fin bud initiation factor homolog" Q8TAL6 11 26994112-26997087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 33.0;Fibroblasts: 80.8;Granulosa cells: 42.4;Leydig cells: 37.9;Oligodendrocyte precursor cells: 32.2;Peritubular cells: 35.0" "Cancer enhanced" "Detected in all" "glioma: 48.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 65.2;ASC TERT1: 41.8;fHDF/TERT166: 22.1;HHSteC: 88.2;HSkMC: 89.5;hTCEpi: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040120 Uncertain "Intracellular and membrane" NA NA "HPA040120: AB_10795243" "unprognostic (1.72e-1)" "unprognostic (2.61e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (1.62e-2)" "unprognostic (5.42e-2)" "unprognostic (7.28e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.93e-5)" "prognostic unfavorable (6.72e-4)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.02e-2)" 26.1 4.9 10.7 7.7 9.9 0.0 25.3 11.6 10.9 30.2 6.9 21.5 2.2 26.3 8.1 11.4 36.0 8.0 27.5 10.7 9.8 15.1 2.0 27.4 2.9 10.6 11.5 8.2 18.7 3.8 0.3 2.6 12.7 11.5 17.1 2.7 0.6 17.8 61.9 17.2 14.9 12.1 17.2 10.9 14.3 21.3 1.3 11.0 2.1 13.6 14.6 0.9 16.4 58.8 11.5 0.0 0.0 1.0 0.0 65.2 41.8 0.1 2.1 5.7 0.2 0.9 0.0 0.0 0.0 0.0 22.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 88.2 0.0 0.0 89.5 24.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 4.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 9.9 11.6 10.9 10.7 9.8 10.6 11.5 8.2 11.5 10.9 11.0 11.5 2.5 0.0 0.0 17.9 0.0 6.6 1.6 33.0 1.8 0.3 1.9 0.9 1.2 11.5 4.0 11.0 0.0 1.2 0.0 0.1 11.7 0.6 0.1 0.0 0.1 1.0 0.0 0.0 0.5 0.0 0.9 80.8 0.0 0.0 0.0 42.4 6.1 0.5 1.8 0.0 0.1 0.0 12.2 0.0 10.3 0.3 37.9 0.8 7.2 0.0 0.0 19.8 0.0 32.2 0.1 0.1 0.0 35.0 0.1 0.2 0.0 4.3 0.9 0.6 0.0 3.7 7.4 0.1 0.3 0.8 5.1 1.9 0.5 3.9 0.0 0.0 FAM89B "LRAP25, MTVR1" ENSG00000176973 "Family with sequence similarity 89 member B" Q8N5H3 11 65572349-65574198 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046895 Approved NA NA "HPA046895: AB_2679858" "unprognostic (1.16e-1)" "unprognostic (9.46e-3)" "unprognostic (1.02e-1)" "unprognostic (5.11e-2)" "unprognostic (4.09e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (8.32e-2)" "unprognostic (1.51e-1)" "prognostic favorable (6.00e-4)" "unprognostic (1.69e-1)" "unprognostic (4.07e-3)" "prognostic unfavorable (9.48e-5)" "unprognostic (3.59e-2)" "unprognostic (2.63e-1)" "unprognostic (3.27e-2)" "unprognostic (1.12e-2)" 38.6 34.0 54.5 20.0 50.6 22.7 34.5 49.7 85.4 45.5 38.5 56.7 13.8 48.1 13.1 46.5 43.1 25.0 49.7 55.5 43.8 31.2 36.3 40.1 26.0 48.5 48.1 53.6 44.2 76.8 23.4 23.0 14.8 49.8 50.7 11.0 3.2 47.4 24.5 130.8 43.0 34.7 23.2 45.9 48.7 45.4 18.6 48.7 31.5 26.4 95.9 19.6 54.5 43.4 51.6 16.6 26.3 38.4 47.8 45.7 52.5 12.5 29.3 26.2 21.4 12.7 15.8 18.2 11.2 38.7 45.9 23.7 28.1 16.3 17.5 5.0 38.0 43.6 21.3 18.8 9.0 27.8 10.5 38.7 41.1 34.8 17.7 12.2 68.3 57.5 26.2 24.2 73.3 30.7 24.6 48.1 37.1 17.2 16.1 61.2 59.2 5.9 49.6 24.1 15.2 43.5 57.6 21.5 30.8 50.0 11.7 31.1 15.7 37.9 45.6 23.9 44.6 15.5 36.3 61.3 7.4 39.9 15.7 33.2 7.8 5.7 11.6 5.0 10.5 6.8 2.6 6.3 6.4 5.0 2.3 5.3 5.4 8.5 5.8 14.0 5.5 10.1 3.5 54.5 50.6 49.7 85.4 55.5 43.8 48.5 48.1 53.6 49.8 45.9 48.7 51.6 45.3 9.6 3.9 9.8 33.4 47.4 32.8 4.3 18.8 10.1 67.0 57.8 10.7 21.5 5.3 23.9 2.1 27.7 63.9 27.2 13.7 23.6 10.4 19.7 33.3 39.7 29.2 36.7 13.6 27.5 19.9 32.8 10.7 20.3 4.5 26.5 43.5 27.6 32.5 16.8 10.9 15.2 2.0 40.6 48.8 27.8 26.4 47.1 44.4 13.1 27.1 29.1 73.2 9.0 10.6 33.3 21.7 30.1 43.6 31.8 16.1 14.9 4.2 8.7 46.0 22.3 48.8 2.9 13.1 19.1 57.4 22.3 46.5 26.2 16.6 48.5 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 170.1;liver: 401.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 307.7;Proximal tubular cells: 435.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023314, HPA078682" Enhanced Supported Nucleoplasm,Cytosol NA NA 1500000 Cytosol Nucleoplasm "HPA023314: AB_1856830, HPA078682: " "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favorable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favorable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 37.0 9.5 7.3 4.0 8.5 9.5 36.6 10.7 7.8 12.1 6.3 14.5 14.0 7.7 5.0 59.7 13.3 7.7 5.6 7.4 8.9 170.1 401.9 10.4 9.1 9.4 8.7 5.4 11.8 8.9 86.5 4.2 7.8 9.2 10.1 6.1 3.2 30.3 10.1 19.0 22.5 24.6 3.7 7.6 21.9 13.4 12.9 7.5 21.3 23.7 18.8 17.8 11.6 19.4 15.1 39.6 28.9 5.5 34.5 29.9 15.8 63.0 11.3 10.3 30.8 31.2 22.1 22.5 26.8 27.8 3.6 16.4 18.8 32.4 39.7 24.3 17.3 30.6 13.0 39.9 21.6 7.2 4.4 11.0 21.1 13.6 23.1 7.2 10.9 9.7 32.3 10.0 10.9 11.3 12.4 46.0 13.9 17.4 43.6 5.1 29.7 48.5 34.7 69.3 17.0 24.0 5.3 82.7 14.9 21.4 50.2 64.5 19.4 2.6 5.7 14.0 71.4 17.6 10.7 20.5 7.1 10.3 12.7 16.5 10.2 4.7 5.2 5.3 5.9 8.1 4.4 6.6 5.5 3.5 3.7 6.8 6.4 0.2 8.5 5.2 1.1 11.2 4.3 7.3 8.5 10.7 7.8 7.4 8.9 9.4 8.7 5.4 9.2 7.6 7.5 15.1 11.2 12.8 31.0 3.3 10.4 10.3 21.7 16.5 18.8 3.1 22.7 13.8 2.7 42.9 11.2 36.8 4.2 23.7 5.2 8.9 82.2 13.7 10.9 6.2 1.9 7.4 1.2 28.0 5.2 7.7 76.1 8.0 9.2 10.1 8.2 9.9 13.6 307.7 39.6 0.0 4.8 12.9 4.1 36.8 3.5 5.5 5.9 17.2 12.4 9.4 4.4 33.8 5.2 2.0 11.4 5.3 9.7 3.0 20.3 5.9 53.7 435.7 3.5 4.2 19.7 8.1 4.4 30.0 21.4 35.4 10.5 8.5 10.1 4.9 32.2 10.9 DPP7 "DPP2, DPPII" ENSG00000176978 "Dipeptidyl peptidase 7" Q9UHL4 9 137110546-137115177 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 997.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.0;THP-1: 218.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021282, CAB025541, HPA059381" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted - unknown location" NA NA 1600000 "Golgi apparatus, Vesicles" "CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999" "unprognostic (1.15e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (6.78e-3)" "unprognostic (1.25e-1)" "unprognostic (8.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.10e-2)" "unprognostic (2.28e-2)" "unprognostic (5.71e-3)" "prognostic favorable (8.31e-5)" "unprognostic (7.99e-2)" "unprognostic (1.46e-2)" "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (2.15e-1)" "unprognostic (1.02e-1)" 56.8 99.6 37.9 28.2 36.8 46.2 57.3 38.0 65.4 43.5 69.4 56.0 28.6 46.7 16.9 46.3 54.1 31.5 106.7 36.8 49.5 58.8 70.6 57.8 42.0 46.2 40.5 33.4 38.0 83.5 54.8 113.1 27.0 38.3 81.8 7.4 8.1 93.1 46.6 53.2 54.3 52.2 13.0 40.1 79.6 70.0 75.9 39.9 20.0 84.4 21.6 14.6 59.8 48.4 39.8 28.0 43.1 3.5 3.6 51.1 40.5 5.7 42.2 66.2 26.6 17.4 41.0 22.2 56.2 44.4 27.2 1.2 60.3 30.7 8.2 1.3 54.8 2.1 26.4 63.6 1.3 113.5 69.1 135.5 50.0 31.7 11.6 24.1 38.3 35.1 65.8 57.5 41.2 18.0 76.4 35.7 65.7 14.8 99.9 42.8 52.8 0.5 232.0 43.3 30.5 67.7 46.7 47.8 122.6 118.9 0.8 43.5 218.1 44.1 67.4 23.5 43.4 29.5 51.7 31.8 14.9 80.9 41.1 31.1 40.2 194.8 59.2 148.8 176.2 151.8 86.6 131.4 127.9 190.6 83.4 117.1 106.2 12.0 95.0 110.6 276.6 173.6 204.1 37.9 36.8 38.0 65.4 36.8 49.5 46.2 40.5 33.4 38.3 40.1 39.9 39.8 80.5 54.5 80.9 54.9 96.8 67.0 103.2 109.2 59.7 74.5 90.3 82.2 66.5 94.4 76.8 53.3 35.5 55.2 129.2 28.2 37.2 121.0 288.7 35.9 40.7 58.2 88.1 35.9 31.4 68.1 115.3 97.2 33.6 47.3 74.3 178.7 64.6 77.1 315.7 121.1 27.9 32.3 107.8 171.7 106.2 997.8 155.4 150.1 167.2 9.4 165.5 123.9 122.6 16.6 26.4 58.2 54.3 169.2 190.2 108.5 97.3 84.9 75.4 83.6 52.6 57.4 58.4 106.2 46.2 47.3 64.9 51.4 115.4 19.0 43.1 90.4 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165016458-165041749 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 1.5;testis: 1.5" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 5.1;Early spermatids: 3.0;Extravillous trophoblasts: 10.6;Spermatocytes: 9.6;Spermatogonia: 8.2;Syncytiotrophoblasts: 5.6" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "BEWO: 14.2" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.3 0.2 0.3 0.2 0.3 0.0 0.4 0.5 0.9 0.7 0.0 0.1 0.0 0.0 5.1 0.6 0.0 0.0 0.0 3.0 0.8 0.9 0.7 0.0 0.0 0.2 0.0 10.6 0.3 0.0 1.5 0.0 0.2 0.0 1.1 0.5 0.0 0.3 0.0 0.0 1.3 0.0 0.5 0.9 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.7 0.3 0.0 0.1 0.8 0.5 0.0 0.0 0.3 9.6 8.2 0.0 0.3 5.6 0.7 0.2 0.0 0.1 SEC24C KIAA0079 ENSG00000176986 "SEC24 homolog C, COPII coat complex component" P53992 10 73744372-73772161 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040196, HPA040213" Supported Supported Vesicles NA NA Vesicles "HPA040196: AB_10796449, HPA040213: AB_10796451" "unprognostic (5.06e-2)" "unprognostic (1.00e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-1)" "unprognostic (8.46e-2)" "unprognostic (7.23e-2)" "unprognostic (9.06e-2)" "unprognostic (4.55e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (7.71e-2)" "unprognostic (8.34e-3)" "unprognostic (2.11e-1)" "unprognostic (3.35e-2)" "unprognostic (1.77e-2)" 27.8 43.2 18.8 31.9 19.1 16.4 27.6 21.6 26.7 39.7 18.3 33.6 27.6 36.7 33.5 69.6 30.9 24.2 32.8 19.5 18.0 29.9 46.1 30.8 31.7 22.4 19.3 17.2 33.5 35.2 50.9 45.7 36.7 20.9 38.1 27.9 29.4 37.2 31.4 50.1 34.5 31.9 32.4 16.7 37.4 34.4 27.9 20.8 35.5 34.3 34.2 43.7 35.8 39.1 24.0 72.7 71.8 55.6 99.9 59.2 48.3 45.6 53.6 90.4 70.4 65.7 67.2 47.9 57.3 43.3 72.0 48.1 61.4 78.3 70.7 60.4 76.6 55.6 53.1 50.5 71.2 47.0 80.7 71.1 41.5 76.8 61.8 76.4 89.2 73.6 44.6 64.1 80.8 69.9 64.7 60.4 55.3 34.8 68.3 259.2 65.2 45.0 47.0 46.5 40.8 20.0 51.7 41.9 144.6 60.1 51.7 106.3 70.6 72.7 29.5 53.1 57.7 62.5 82.0 85.9 84.0 84.0 80.8 35.0 28.2 15.8 13.6 27.4 21.4 35.5 12.6 16.2 21.6 18.1 9.4 11.7 15.8 11.5 22.4 19.1 14.8 10.9 22.7 18.8 19.1 21.6 26.7 19.5 18.0 22.4 19.3 17.2 20.9 16.7 20.8 24.0 12.1 35.3 28.6 16.3 11.6 8.7 4.7 11.5 6.2 15.1 17.0 14.9 2.3 14.3 17.6 14.7 16.7 17.8 18.6 24.7 3.9 15.1 8.8 10.9 13.0 11.0 19.2 5.9 14.6 19.4 16.4 9.7 19.9 17.0 22.2 20.1 16.4 19.9 17.1 15.2 15.7 18.4 8.2 11.7 8.4 6.0 11.8 12.4 5.4 6.5 12.3 10.3 17.5 14.1 16.8 23.8 14.4 11.7 21.9 10.8 20.0 10.4 8.2 14.7 6.6 10.0 9.7 10.3 8.3 11.5 11.4 25.2 16.9 14.7 16.1 10.9 FMR1NB "CT37, FLJ25736, NY-SAR-35" ENSG00000176988 "FMR1 neighbor" Q8N0W7 X 147981337-148026665 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 333 "testis: 58.6" "Group enriched" "Detected in some" 10 "Spermatocytes: 502.2;Spermatogonia: 296.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "U-266/70: 67.5;U-266/84: 57.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA011284, CAB026403" Enhanced NA NA "CAB026403: , HPA011284: AB_1078898" "unprognostic (2.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (4.38e-2)" "unprognostic (4.11e-3)" "unprognostic (2.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 67.5 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.1 0.1 0.0 0.5 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 18.4 5.6 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 39.5 0.0 0.0 502.2 296.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 SMCR8 "DENND8A, FLJ34716" ENSG00000176994 "SMCR8-C9orf72 complex subunit" Q8TEV9 17 18315293-18328056 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021557, HPA024646" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021557: AB_1857283, HPA024646: AB_1857284" "unprognostic (1.69e-1)" "unprognostic (2.25e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.07e-1)" "unprognostic (4.34e-3)" "unprognostic (2.11e-3)" "unprognostic (3.02e-2)" "unprognostic (3.18e-1)" "unprognostic (1.48e-2)" "unprognostic (5.09e-3)" "unprognostic (7.11e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.41e-3)" "unprognostic (4.35e-2)" "unprognostic (1.55e-2)" "unprognostic (9.27e-2)" 4.8 5.1 1.8 5.0 1.9 12.6 5.1 2.1 2.0 4.3 2.5 5.7 3.3 5.3 2.6 5.3 4.8 2.7 4.1 1.7 2.1 4.7 4.1 5.6 5.8 1.8 1.7 1.5 4.9 5.2 5.9 5.3 3.0 1.9 4.8 3.8 2.8 6.5 3.0 6.5 5.7 7.2 3.0 2.1 8.5 6.2 4.9 2.2 5.4 4.7 3.5 5.7 5.3 3.9 2.7 7.0 9.6 4.7 5.5 6.5 4.3 8.6 4.9 6.6 8.5 8.1 14.8 2.9 4.1 3.6 6.1 9.6 9.1 9.4 5.8 7.8 8.4 7.9 7.7 10.0 4.2 7.0 3.0 18.1 5.5 7.3 9.8 6.1 5.6 6.1 5.9 6.5 3.8 5.1 4.3 5.1 4.4 4.5 9.0 4.0 5.6 12.1 6.5 3.9 7.9 2.5 5.8 5.6 7.1 10.5 24.7 14.4 6.1 6.1 4.8 5.8 12.8 6.6 5.7 7.0 2.1 6.7 4.7 5.0 2.5 0.5 0.4 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.2 0.3 0.3 0.5 0.3 0.7 0.3 0.2 0.3 1.8 1.9 2.1 2.0 1.7 2.1 1.8 1.7 1.5 1.9 2.1 2.2 2.7 5.6 6.4 11.0 2.3 7.0 0.4 3.4 0.0 4.6 6.7 8.2 6.1 3.3 5.7 5.6 11.0 2.1 3.8 6.4 8.2 0.0 5.4 3.3 8.9 9.0 6.3 3.6 5.2 5.1 5.4 2.9 4.6 7.7 13.9 8.8 7.4 10.4 5.3 8.7 6.7 5.5 6.0 0.0 23.5 0.3 2.0 4.1 15.1 0.0 5.6 18.7 2.9 4.1 2.5 3.7 6.9 4.5 4.1 3.5 6.8 6.3 6.4 2.2 5.9 0.0 5.4 4.3 9.3 7.8 3.9 0.6 6.0 6.3 6.2 6.1 7.5 MTHFR ENSG00000177000 "Methylenetetrahydrofolate reductase" P42898 1 11785723-11806455 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 44.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063389, HPA076180, HPA077255" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA063389: AB_2685001, HPA076180: , HPA077255: " "unprognostic (3.25e-2)" "unprognostic (8.19e-2)" "unprognostic (4.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.97e-5)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.75e-2)" "unprognostic (2.85e-1)" "unprognostic (8.69e-2)" "prognostic favorable (4.81e-5)" "unprognostic (3.10e-1)" "prognostic favorable (2.12e-4)" "unprognostic (2.35e-3)" "unprognostic (2.94e-1)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" 11.6 11.4 6.4 10.9 9.0 29.2 10.3 10.9 8.0 8.8 5.2 11.1 10.9 9.0 54.0 10.4 12.5 10.2 23.5 9.7 6.0 12.7 13.2 17.0 12.4 8.9 6.2 7.6 19.8 11.5 6.6 17.9 7.1 8.5 10.3 8.7 12.7 6.9 6.7 18.1 13.5 14.8 10.9 3.8 18.5 14.7 11.0 6.8 8.0 16.5 17.0 12.3 10.4 7.9 8.4 2.2 9.4 10.9 12.3 10.2 15.1 2.0 5.2 14.6 6.0 5.1 8.1 13.2 18.0 3.6 7.5 16.3 4.1 8.1 7.7 2.4 9.3 6.8 13.4 13.3 3.2 13.7 7.4 16.4 13.6 6.1 8.0 6.4 10.0 10.7 17.2 44.1 11.0 6.7 3.3 8.2 3.5 3.6 9.5 3.0 8.9 6.0 20.3 8.8 11.7 10.5 17.6 8.1 7.8 10.9 6.2 12.9 11.7 8.5 6.0 4.9 7.2 1.6 6.4 9.4 32.8 7.6 16.8 5.6 0.7 2.3 1.1 2.7 4.3 0.9 1.6 0.8 1.4 1.7 2.3 1.2 1.4 2.5 2.0 6.1 0.9 0.6 1.6 6.4 9.0 10.9 8.0 9.7 6.0 8.9 6.2 7.6 8.5 3.8 6.8 8.4 15.9 25.6 48.0 8.1 18.3 8.4 6.8 11.9 15.9 0.0 17.9 10.8 37.0 11.5 13.0 27.6 0.0 5.1 6.0 44.2 1.9 8.9 18.2 32.0 25.8 16.9 12.1 29.5 15.8 25.3 3.3 21.0 52.5 55.5 8.2 10.7 37.5 23.4 22.2 0.0 15.2 18.0 6.1 39.3 39.9 42.4 18.3 32.1 12.4 16.9 26.5 0.0 20.6 9.0 13.3 21.9 20.6 9.1 10.3 10.2 36.0 17.2 12.3 0.0 19.7 22.8 23.3 6.8 5.2 15.0 9.2 2.9 10.6 21.3 18.6 9.6 DEFB104B ENSG00000177023 "Defensin beta 104B" Q8WTQ1 8 7470308-7475082 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045292 Supported "Secreted in male reproductive system" NA NA "HPA045292: AB_2679288" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.5" "Cell type enriched" "Detected in many" 5 "Early spermatids: 131.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;HEK 293: 3.0;RT4: 2.0;U-266/84: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014527, HPA079195" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014527: AB_1845612, HPA079195: " "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favorable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.2 1.9 4.9 0.4 5.1 0.6 2.7 4.5 6.9 1.3 7.3 1.6 0.8 1.3 4.0 0.6 2.3 1.2 4.0 4.5 7.1 1.5 1.8 1.0 0.6 6.5 4.9 3.7 1.8 1.1 0.9 3.9 0.8 5.8 3.4 0.8 5.2 1.2 1.3 3.6 1.3 1.2 0.9 5.2 1.3 1.1 12.5 4.8 0.6 1.7 0.6 0.7 1.6 0.9 5.0 0.1 0.0 0.8 2.0 0.4 0.6 0.6 1.0 0.2 0.2 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 3.0 0.1 0.0 0.7 0.7 0.0 0.5 0.7 1.2 0.0 0.2 0.7 0.1 0.4 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.0 0.5 0.5 2.0 0.8 0.2 0.4 0.0 0.3 0.6 0.7 0.6 0.4 0.1 0.2 0.2 0.2 0.4 1.8 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 4.9 5.1 4.5 6.9 4.5 7.1 6.5 4.9 3.7 5.8 5.2 4.8 5.0 1.9 3.2 2.2 17.9 0.8 0.4 0.3 0.6 0.0 0.9 2.2 1.8 3.6 1.5 2.1 0.0 0.0 0.5 0.6 0.8 0.0 2.0 131.6 5.7 0.9 2.1 0.0 2.7 2.5 0.2 0.6 0.7 0.0 1.4 0.0 0.7 4.6 1.9 0.4 0.0 3.2 1.9 0.0 0.8 1.4 24.2 2.1 0.4 1.8 1.0 0.6 1.5 0.0 8.5 8.0 1.0 0.3 0.7 0.2 0.6 0.5 0.3 4.0 3.4 6.6 0.9 1.2 5.3 2.2 0.2 0.6 0.3 0.6 1.2 1.1 0.5 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1 transcription factor" O75398 11 644233-706715 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA030302: AB_2673421" "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 10.8 19.8 49.3 6.5 48.0 9.3 12.6 29.1 67.5 12.6 14.6 10.9 7.8 13.4 10.1 20.0 14.8 9.5 10.9 57.7 30.6 15.5 8.1 9.2 8.8 30.6 34.8 48.0 12.5 16.3 11.4 17.1 7.0 34.1 14.7 4.1 4.6 21.6 7.3 16.7 17.4 10.2 8.0 21.4 11.2 20.2 15.2 36.0 9.8 25.5 14.0 6.4 10.7 12.9 43.9 14.1 13.6 22.9 13.1 18.4 22.8 13.5 14.1 18.2 28.3 20.6 9.7 18.6 5.4 14.8 14.0 9.0 14.4 18.1 12.9 4.3 24.2 108.1 13.5 8.5 13.0 32.8 28.0 22.3 20.4 18.1 5.1 15.4 20.1 22.4 15.5 29.0 28.8 11.3 10.9 11.7 31.9 49.9 20.3 24.0 28.1 6.8 24.2 21.9 3.0 27.3 31.8 10.4 18.2 12.9 5.8 8.4 9.7 26.6 10.5 4.7 4.5 13.7 24.5 9.3 10.2 13.4 21.2 22.9 0.0 2.0 2.3 1.6 1.3 1.7 0.6 3.4 1.7 2.8 0.4 3.9 2.0 0.8 2.0 1.2 0.1 1.4 1.1 49.3 48.0 29.1 67.5 57.7 30.6 30.6 34.8 48.0 34.1 21.4 36.0 43.9 20.1 0.0 3.9 12.7 8.7 13.3 27.1 11.8 11.4 20.0 35.8 25.7 8.2 18.6 8.0 35.0 10.4 14.9 12.3 10.0 52.8 19.5 3.6 19.6 15.0 19.3 10.9 25.0 33.8 11.1 6.4 20.1 10.7 26.2 0.0 40.1 10.8 12.4 10.0 60.6 35.2 9.3 12.2 12.9 10.2 6.5 19.9 11.2 17.8 17.8 13.7 39.9 7.2 19.1 17.4 15.4 10.6 30.1 9.0 36.0 16.9 34.2 10.0 19.9 13.1 11.4 16.8 7.5 22.1 17.3 15.5 15.5 12.4 42.2 9.1 32.4 MTX3 ENSG00000177034 "Metaxin 3" Q5HYI7 5 79976716-79991262 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047858, HPA062061" Approved Approved Mitochondria NA NA Mitochondria "HPA047858: AB_2680185, HPA062061: AB_2684672" "unprognostic (2.56e-2)" "unprognostic (2.32e-1)" "unprognostic (2.47e-2)" "unprognostic (4.21e-2)" "unprognostic (4.59e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (5.08e-5)" "unprognostic (4.02e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (8.58e-2)" "unprognostic (8.46e-2)" "unprognostic (5.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-2)" "unprognostic (3.09e-2)" "unprognostic (2.28e-1)" 6.6 10.1 6.8 6.3 7.7 6.5 8.2 6.9 7.8 8.3 5.3 7.7 4.4 9.2 6.7 8.0 8.3 3.9 7.1 7.4 6.9 7.0 5.7 5.6 8.4 6.9 6.9 6.9 12.6 7.2 11.9 7.4 4.6 7.6 7.9 5.0 12.0 8.3 6.9 8.8 7.6 9.7 6.2 6.2 8.4 7.5 5.2 6.9 3.9 8.9 5.6 7.9 8.0 7.7 6.9 8.6 4.9 13.1 7.1 6.3 11.3 3.3 8.2 5.9 6.6 7.3 2.1 9.1 13.6 2.4 7.7 11.0 9.9 0.0 18.1 12.4 3.6 8.0 5.7 14.7 6.8 11.8 0.0 6.7 9.0 18.0 11.4 20.1 9.3 4.6 0.0 3.0 7.5 11.3 9.2 0.0 0.1 13.4 2.8 5.1 0.0 19.7 5.8 6.0 9.7 17.1 13.2 10.8 7.4 15.9 10.1 12.1 9.7 5.3 11.9 9.7 9.2 18.0 10.5 10.8 11.9 17.8 0.0 15.0 0.3 0.2 0.2 0.6 0.2 0.4 0.8 0.6 0.5 0.1 0.5 0.8 0.6 0.2 0.4 0.1 0.2 0.4 0.2 6.8 7.7 6.9 7.8 7.4 6.9 6.9 6.9 6.9 7.6 6.2 6.9 6.9 7.6 28.9 5.3 18.9 8.4 1.5 4.9 2.7 9.6 0.0 9.8 6.7 9.4 15.7 8.0 12.9 0.0 5.1 6.2 2.5 5.9 3.9 2.7 9.2 16.4 7.2 0.0 3.8 27.1 2.5 3.2 9.9 5.1 8.6 1.3 20.6 10.8 7.9 3.2 0.0 24.5 4.4 4.1 3.5 1.7 4.1 12.8 3.4 0.0 5.6 2.8 0.0 5.2 23.6 25.0 5.3 5.3 12.4 5.1 8.7 3.9 8.6 12.5 0.0 13.1 13.4 9.8 8.8 7.5 11.5 3.4 1.8 8.1 15.5 6.0 5.8 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.2;Spermatogonia: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 18.8 23.2 19.3 14.8 19.1 6.5 24.0 20.7 22.2 29.7 17.2 29.9 23.9 28.0 25.0 42.9 30.4 8.5 14.5 20.3 17.8 29.5 20.4 17.7 21.4 22.5 19.0 17.9 29.9 29.9 18.0 34.6 8.8 19.4 30.1 17.7 9.2 31.8 19.6 19.9 31.1 31.4 12.8 20.7 34.6 31.0 25.0 18.6 19.9 48.0 11.9 21.5 28.1 30.8 21.6 37.8 17.5 11.0 14.3 23.6 11.1 19.0 8.5 4.7 8.9 9.6 23.9 42.0 16.0 7.3 13.2 15.8 26.8 16.2 9.7 6.3 11.0 41.7 9.7 19.0 14.5 13.9 12.8 16.8 25.7 19.9 4.0 6.2 17.5 10.5 18.9 12.1 17.7 11.4 12.2 16.8 8.7 10.4 29.9 8.4 12.2 7.6 31.5 12.7 5.7 31.1 9.8 12.8 23.5 12.3 7.3 18.2 11.9 15.0 14.9 7.8 3.4 6.4 8.4 3.2 14.8 15.6 15.9 6.5 8.3 26.5 35.4 21.0 25.9 18.4 26.7 15.7 16.0 21.8 30.1 22.3 20.0 12.8 21.4 32.0 22.0 21.4 20.7 19.3 19.1 20.7 22.2 20.3 17.8 22.5 19.0 17.9 19.4 20.7 18.6 21.6 15.1 6.4 20.7 13.7 24.0 15.3 15.9 25.6 17.6 22.7 31.7 36.8 19.3 15.7 20.2 20.2 8.4 33.9 19.4 15.4 11.7 13.0 9.2 17.1 15.8 14.4 12.1 8.6 13.9 17.1 9.8 20.8 9.7 19.9 7.0 15.9 12.8 6.2 17.6 55.5 13.1 22.7 28.5 13.2 13.6 9.5 42.6 12.7 12.4 11.2 19.7 23.2 26.8 16.6 16.7 10.6 10.3 28.6 11.5 12.3 22.1 8.1 19.4 9.1 32.9 23.4 21.2 82.2 87.2 13.7 17.2 15.2 16.7 21.6 19.5 12.3 SIX5 DMAHP ENSG00000177045 "SIX homeobox 5" Q8N196 19 45764785-45769252 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042068 Approved NA NA "HPA042068: AB_10795390" "unprognostic (3.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (9.60e-3)" "unprognostic (2.11e-1)" "unprognostic (2.96e-3)" "unprognostic (1.00e-3)" "unprognostic (1.02e-3)" "unprognostic (3.90e-2)" "unprognostic (8.60e-2)" "unprognostic (3.82e-1)" "unprognostic (3.30e-1)" "unprognostic (1.69e-3)" "unprognostic (5.59e-2)" "unprognostic (1.95e-1)" "unprognostic (1.08e-2)" "unprognostic (8.99e-2)" 19.0 23.7 8.4 5.9 6.7 0.6 20.7 7.7 10.1 35.7 11.3 28.3 6.8 34.9 8.8 14.8 38.1 8.2 22.8 6.8 9.7 16.5 24.8 12.7 4.3 9.9 8.7 5.3 46.2 41.4 9.3 16.0 8.5 7.1 34.3 4.4 0.6 28.3 16.0 16.2 12.6 14.4 12.7 8.9 12.2 25.6 8.0 8.0 2.3 29.6 5.7 3.0 31.1 22.7 7.1 3.3 19.3 25.6 39.2 16.0 15.9 13.2 7.3 15.5 11.1 9.7 4.8 12.4 1.8 7.0 11.9 13.6 7.5 7.7 8.4 3.7 9.3 11.6 2.1 18.7 13.8 14.1 0.5 11.9 15.6 13.1 7.2 9.2 16.8 9.4 7.6 9.0 3.9 3.2 10.6 2.6 18.2 17.4 10.4 10.9 9.7 2.3 7.9 12.1 4.1 1.6 10.5 21.7 10.7 16.8 10.1 10.0 18.8 5.7 11.0 10.3 10.0 8.1 4.7 5.1 1.9 15.9 0.9 12.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 6.7 7.7 10.1 6.8 9.7 9.9 8.7 5.3 7.1 8.9 8.0 7.1 5.2 0.0 7.2 7.5 1.0 3.2 5.4 7.9 4.6 0.1 11.6 14.7 0.3 11.5 3.4 5.5 0.0 6.1 0.3 2.1 3.9 6.2 0.4 7.3 14.9 5.2 3.0 0.0 0.0 6.0 13.1 9.1 4.1 8.3 0.0 11.0 6.8 7.0 1.1 5.0 0.0 8.6 2.0 0.8 1.4 1.2 15.8 0.9 0.0 3.7 0.0 3.1 0.0 0.0 0.1 5.0 2.1 12.8 5.5 6.1 0.7 1.9 4.0 0.5 0.0 8.2 8.8 0.5 3.5 4.2 2.6 4.0 0.8 4.5 5.0 1.4 IFNW1 ENSG00000177047 "Interferon omega 1" P05000 9 21140214-21142145 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730896 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HeLa: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA049390: AB_2680742" "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favorable (5.44e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favorable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (5.09e-6)" 7.5 7.3 10.2 11.2 10.1 9.3 8.9 9.5 11.6 12.5 18.2 11.0 7.6 13.7 7.5 21.6 10.4 5.2 8.2 8.6 11.3 7.2 10.6 7.5 14.8 8.7 10.8 7.5 14.2 9.6 5.9 9.5 6.6 11.4 9.9 7.6 10.0 10.2 5.4 11.5 13.4 11.1 6.4 5.8 14.6 10.9 12.4 9.4 11.2 10.5 5.5 14.0 9.4 13.1 20.7 14.0 21.5 16.2 18.9 4.1 7.3 18.3 7.1 4.0 5.6 6.5 17.8 17.9 24.1 9.5 4.0 7.9 19.9 12.1 9.1 4.2 30.0 25.5 19.6 84.1 9.8 6.2 8.7 24.2 6.1 8.1 9.5 5.9 14.0 8.4 29.4 15.6 28.4 4.6 13.2 20.3 10.2 10.2 13.0 7.3 27.3 9.0 22.6 6.7 16.3 16.1 14.1 11.4 23.7 9.4 15.3 20.1 10.7 9.6 11.8 10.6 6.5 12.0 27.2 41.0 16.1 13.1 12.3 9.8 4.6 1.1 1.2 1.8 0.9 1.2 2.1 1.3 1.3 0.8 3.8 1.2 1.4 3.3 0.6 1.2 1.3 1.4 0.7 10.2 10.1 9.5 11.6 8.6 11.3 8.7 10.8 7.5 11.4 5.8 9.4 20.7 4.8 9.6 4.8 6.2 6.5 26.0 10.0 5.7 9.1 3.3 12.7 8.5 5.4 10.0 6.1 7.3 2.1 7.9 3.4 16.3 1.9 6.5 2.9 8.0 5.1 5.2 7.3 5.9 6.5 4.9 19.0 3.6 6.1 9.2 3.8 11.4 4.2 21.1 3.7 11.8 5.5 12.7 0.0 5.7 8.8 3.1 5.6 3.3 5.4 5.6 5.6 4.0 7.2 4.0 6.1 6.9 12.2 1.9 5.5 8.0 6.3 2.2 7.2 3.4 0.0 3.6 4.7 6.5 4.6 13.3 35.8 12.4 5.1 4.9 9.3 11.1 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type palmitoyltransferase 13" Q8IUH4 11 19117099-19176422 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Urothelial cells: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 136.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.2 5.8 5.6 7.8 5.9 9.8 9.0 7.3 7.1 8.6 6.9 17.1 11.3 6.8 5.2 37.6 13.0 8.8 9.2 5.9 6.4 9.2 2.2 6.1 9.6 6.1 5.9 6.0 5.4 11.3 15.1 11.8 6.3 6.4 8.2 18.3 16.2 10.3 5.5 1.6 19.0 11.4 6.2 5.9 5.7 18.7 14.6 5.8 11.9 8.8 2.9 22.6 22.6 15.5 6.6 41.6 19.3 18.0 15.5 6.3 7.2 17.3 19.4 17.8 21.3 24.4 11.7 9.7 21.1 13.1 16.3 47.9 61.3 26.0 12.8 23.3 26.4 22.6 11.1 12.6 9.7 14.6 15.2 18.5 8.3 14.7 9.0 12.5 19.9 136.8 28.9 10.7 10.3 22.1 13.5 19.6 12.2 15.1 38.7 17.6 21.3 25.0 5.0 21.9 27.0 31.3 23.0 23.2 28.0 10.7 17.3 13.2 17.6 39.6 18.9 13.2 29.2 15.8 8.7 28.5 19.2 22.6 15.5 33.6 11.6 4.7 32.7 8.5 7.9 7.8 8.7 6.6 9.6 5.9 5.5 6.2 8.3 6.0 6.3 6.4 5.6 9.4 4.6 5.6 5.9 7.3 7.1 5.9 6.4 6.1 5.9 6.0 6.4 5.9 5.8 6.6 8.1 9.6 10.7 28.7 9.6 24.2 22.3 27.2 14.2 12.0 7.5 4.8 34.1 12.8 41.3 16.5 10.4 8.7 10.6 20.1 5.9 25.1 120.5 21.5 6.6 11.3 15.6 11.6 27.2 19.2 18.8 9.2 24.5 30.8 12.0 16.2 12.8 0.9 6.1 16.8 34.9 24.7 36.7 6.8 8.3 46.6 7.8 6.2 3.6 9.4 20.8 52.8 18.6 19.6 20.9 20.4 16.4 2.2 10.4 47.4 15.5 3.5 57.0 8.8 0.0 5.4 7.4 58.1 31.7 21.3 36.2 6.3 11.4 7.7 21.4 103.0 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 58.3" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 182.5;Early spermatids: 262.6;Syncytiotrophoblasts: 619.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 110.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles NA NA Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 6.1 4.9 5.5 8.9 7.4 7.2 8.3 8.5 6.3 6.6 4.7 9.5 8.1 6.7 6.7 8.5 5.0 8.3 3.8 4.7 6.9 7.5 16.7 8.1 11.3 6.4 6.2 4.3 5.4 12.2 10.7 3.3 58.3 6.9 6.1 9.9 10.0 6.4 6.0 4.4 7.7 6.7 8.6 6.2 8.4 8.2 19.4 6.3 8.9 7.7 3.9 14.7 8.5 4.8 9.1 17.9 17.3 17.1 20.0 22.0 20.4 110.0 16.5 21.3 18.3 30.4 29.5 27.2 31.6 28.6 12.7 32.1 22.5 20.2 18.2 22.8 15.4 18.4 10.8 16.4 18.7 31.1 18.9 10.8 26.3 21.0 20.2 25.7 13.7 20.0 21.3 20.9 18.6 16.5 15.0 23.6 16.4 29.4 7.2 15.6 17.6 28.6 32.2 24.7 14.0 8.1 14.5 17.3 9.3 25.4 24.0 20.1 34.4 29.6 3.6 11.7 26.8 16.6 20.5 47.6 20.8 10.9 17.4 11.4 3.3 9.3 5.5 5.2 8.7 7.5 7.4 4.5 6.1 8.4 4.2 6.2 5.3 2.0 7.7 6.9 8.0 5.9 4.9 5.5 7.4 8.5 6.3 4.7 6.9 6.4 6.2 4.3 6.9 6.2 6.3 9.1 7.3 6.4 3.1 21.9 14.2 3.2 4.2 8.5 2.8 6.6 5.7 3.9 2.8 11.5 9.8 9.2 8.4 182.5 10.4 8.9 1.9 8.9 262.6 4.4 9.2 8.1 4.2 8.4 56.2 11.4 71.5 7.2 8.6 7.3 2.5 8.0 10.4 22.1 26.3 1.7 57.3 4.3 8.2 10.0 8.0 82.4 7.5 11.7 5.4 38.4 11.0 5.6 4.1 55.8 103.2 10.9 9.7 4.9 8.4 4.6 4.4 7.2 6.3 7.4 6.6 3.3 7.0 15.8 6.5 8.1 3.4 619.9 8.7 4.0 5.2 4.7 ACER2 "ALKCDase2, ASAH3L, FLJ41587" ENSG00000177076 "Alkaline ceramidase 2" Q5QJU3 9 19409009-19452505 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "stomach 1: 62.3;urinary bladder: 39.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 19.7;Gastric mucus-secreting cells: 21.9;Inhibitory neurons: 10.3;Microglial cells: 26.2;Oligodendrocytes: 7.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "BEWO: 29.7;RT4: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.94e-1)" "unprognostic (2.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (2.03e-1)" "unprognostic (3.90e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (7.42e-2)" "unprognostic (8.46e-3)" 6.5 1.4 5.4 1.1 3.2 0.6 5.0 2.5 5.3 1.8 2.4 3.3 4.5 1.4 4.2 2.2 3.7 1.7 2.7 4.6 3.0 1.9 2.4 2.2 1.1 3.4 2.9 2.3 1.0 6.9 2.5 1.2 9.8 3.5 3.7 4.3 3.8 2.0 4.6 1.2 5.9 2.7 1.3 2.5 1.4 62.3 1.9 4.3 2.4 2.6 1.0 1.3 39.6 1.8 5.1 1.2 2.0 3.9 2.0 6.2 0.5 29.7 2.1 1.4 0.7 1.0 0.6 1.9 1.3 0.7 0.3 0.4 4.5 0.8 5.8 1.5 2.4 1.1 2.1 1.6 3.0 1.3 0.5 2.0 1.8 5.6 2.2 2.4 0.6 6.2 2.1 3.1 3.8 2.0 1.7 3.6 1.8 3.1 11.1 0.9 3.2 1.0 0.7 0.6 73.6 6.9 1.8 0.4 2.2 0.5 9.3 2.7 2.5 3.1 0.5 1.5 0.6 0.9 1.4 1.7 1.4 0.6 1.5 1.3 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 5.4 3.2 2.5 5.3 4.6 3.0 3.4 2.9 2.3 3.5 2.5 4.3 5.1 3.2 0.0 0.0 1.0 0.7 0.3 0.4 0.1 0.6 1.0 0.3 0.4 0.1 0.0 0.1 0.0 2.1 0.5 0.4 0.0 0.0 0.1 2.6 0.3 0.2 0.8 0.0 0.8 19.7 0.0 0.6 0.3 21.9 0.4 0.0 0.0 1.4 0.0 0.1 0.0 10.3 0.0 0.0 0.0 0.0 4.0 0.3 0.2 0.0 26.2 0.0 0.6 0.0 5.5 7.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.6 0.0 0.6 0.4 0.4 0.4 0.8 0.0 4.0 0.3 0.0 0.0 1.1 WDR73 "FLJ14888, HSPC264" ENSG00000177082 "WD repeat domain 73" Q6P4I2 15 84639285-84654343 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039357 Uncertain NA NA "HPA039357: AB_10673242" "unprognostic (8.49e-2)" "unprognostic (2.16e-1)" "unprognostic (4.77e-2)" "unprognostic (6.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.48e-1)" "unprognostic (1.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.02e-1)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.19e-4)" "unprognostic (9.21e-4)" "unprognostic (4.12e-1)" "unprognostic (3.16e-2)" "unprognostic (8.58e-2)" "unprognostic (4.02e-2)" 2.2 3.6 2.1 2.2 2.2 2.8 3.3 3.1 2.4 3.1 2.7 3.0 2.3 3.5 4.2 2.7 3.4 1.5 2.1 2.4 2.4 3.2 2.3 2.4 2.3 2.0 2.0 2.1 3.3 3.1 3.8 3.3 1.7 2.4 3.5 2.7 3.5 3.0 2.4 2.3 3.0 3.1 3.0 1.9 3.3 3.0 1.8 2.2 3.0 3.9 1.8 2.9 3.0 2.8 2.9 2.8 4.6 5.5 2.7 2.7 3.1 2.8 1.4 2.7 2.4 1.8 4.3 4.7 3.2 1.5 4.7 2.5 6.6 6.4 4.3 2.6 1.7 3.4 2.3 5.5 2.5 3.7 3.4 3.2 5.6 4.0 3.9 5.5 4.5 2.2 3.9 3.9 1.8 1.4 4.7 4.0 5.1 4.7 2.9 1.9 4.2 4.1 2.4 3.7 7.0 3.5 5.8 3.6 5.1 5.8 3.0 8.4 6.5 2.4 2.9 3.3 3.1 4.2 3.4 6.0 2.6 5.1 5.7 4.2 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.2 0.4 0.1 0.6 0.3 0.3 0.8 0.4 0.2 0.3 0.1 0.4 2.1 2.2 3.1 2.4 2.4 2.4 2.0 2.0 2.1 2.4 1.9 2.2 2.9 17.0 25.6 32.8 21.9 17.5 5.4 18.9 18.6 12.5 48.4 16.9 20.1 1.1 27.1 25.9 29.5 73.0 33.6 14.4 13.9 23.5 27.6 4.8 32.2 26.3 14.9 18.0 14.3 13.6 14.0 16.1 18.2 16.3 21.8 17.1 38.0 18.9 9.5 13.2 40.4 15.2 13.8 22.4 10.7 5.1 2.3 22.7 9.8 5.4 15.0 17.4 36.8 21.6 13.6 12.2 17.3 11.5 16.1 8.4 17.7 10.1 20.7 70.1 98.5 6.6 27.2 17.7 44.9 18.0 8.7 5.3 25.7 17.1 44.5 15.0 13.9 POLE POLE1 ENSG00000177084 "DNA polymerase epsilon, catalytic subunit" Q07864 12 132623753-132687376 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 46.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebellum: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA058210, HPA067385" Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058210: AB_2683639, HPA067385: AB_2685830" "unprognostic (1.60e-1)" "unprognostic (1.77e-3)" "unprognostic (2.00e-1)" "unprognostic (9.17e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-2)" "unprognostic (3.96e-3)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (7.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.19e-8)" "unprognostic (8.60e-2)" "unprognostic (3.18e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" 5.4 2.9 0.2 6.2 0.1 24.9 6.1 3.9 1.0 6.4 0.3 6.7 6.6 5.4 2.1 7.1 6.3 3.2 4.1 1.6 0.1 3.0 8.7 5.1 7.2 0.3 0.2 0.0 7.8 6.5 2.6 2.7 5.3 2.7 6.5 6.4 2.4 6.2 3.3 7.6 13.3 8.6 3.7 0.1 16.4 8.0 16.3 0.3 15.9 4.7 3.0 7.2 6.2 6.3 0.8 25.3 33.3 48.7 22.0 10.2 7.6 39.9 26.0 11.7 30.3 21.8 38.3 14.5 28.7 10.2 14.1 11.6 33.6 35.4 16.7 18.8 13.3 41.2 45.4 45.7 15.2 1.9 37.2 24.9 5.5 6.0 31.8 10.5 8.1 10.8 35.1 53.4 15.7 14.9 33.3 61.8 46.8 36.9 9.3 18.5 48.0 27.6 13.0 6.9 40.8 40.6 22.0 30.0 22.7 4.7 23.4 35.0 19.1 9.9 26.5 24.7 20.6 25.9 20.3 14.5 44.8 14.7 26.3 19.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 3.9 1.0 1.6 0.1 0.3 0.2 0.0 2.7 0.1 0.3 0.8 3.2 0.0 6.7 7.5 4.0 5.7 3.8 3.0 4.0 8.7 7.8 6.7 6.9 1.5 1.6 1.8 0.0 8.8 5.6 18.8 0.0 2.3 8.2 3.2 3.8 4.9 7.2 14.9 13.6 3.3 10.8 5.1 11.2 6.8 2.5 16.2 8.9 10.5 13.2 0.0 7.6 9.1 2.0 6.9 5.4 9.7 6.8 2.9 5.4 4.7 1.6 2.6 2.1 3.5 2.9 2.6 6.0 3.4 6.3 4.0 4.1 1.0 1.9 6.1 26.3 7.0 6.1 46.6 18.2 5.8 7.7 4.0 5.8 2.9 10.9 2.8 PHETA2 "DKFZp686J07229, FAM109B, IPIP27B, SES2" ENSG00000177096 "PH domain containing endocytic trafficking adaptor 2" Q6ICB4 22 42074248-42079438 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 14.1;Endometrial stromal cells: 10.3;Extravillous trophoblasts: 27.4;Syncytiotrophoblasts: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 20.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.8;fHDF/TERT166: 33.7;HSkMC: 32.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA000647 Uncertain NA NA "HPA000647: AB_1078800" "unprognostic (4.96e-2)" "unprognostic (3.28e-2)" "unprognostic (5.90e-2)" "unprognostic (6.66e-3)" "unprognostic (1.56e-2)" "unprognostic (9.61e-3)" "unprognostic (2.40e-1)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (8.80e-2)" "unprognostic (7.52e-2)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" 10.4 4.3 2.7 6.7 2.5 4.6 9.8 2.4 2.8 11.9 4.0 11.5 6.0 15.5 2.9 9.7 9.9 8.3 8.3 2.3 2.7 5.6 1.9 9.8 4.2 2.9 2.5 2.2 5.2 18.4 4.8 5.8 15.7 2.6 10.0 8.5 0.4 12.8 7.7 2.5 7.7 9.5 13.1 2.8 7.9 13.5 2.5 2.6 2.4 5.9 3.2 4.2 11.4 9.2 2.8 0.1 0.0 0.0 0.2 30.9 36.8 0.2 21.4 17.5 13.0 12.9 22.6 20.5 0.1 13.1 33.7 0.0 3.7 0.1 0.2 6.9 0.0 0.0 0.0 29.1 0.2 17.6 0.0 17.1 32.3 9.5 20.1 2.5 0.0 29.3 0.3 0.2 0.0 14.1 0.4 0.1 0.2 2.4 1.1 0.0 0.2 0.1 0.3 5.9 0.0 0.2 0.2 9.2 0.1 0.1 0.2 14.1 0.0 30.0 0.2 13.8 31.5 0.1 0.5 0.5 0.3 0.0 0.4 24.0 20.0 4.3 1.7 1.3 4.9 0.2 0.5 0.8 1.0 8.4 0.2 0.6 1.2 0.3 0.7 2.8 3.9 0.6 3.2 2.7 2.5 2.4 2.8 2.3 2.7 2.9 2.5 2.2 2.6 2.8 2.6 2.8 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 2.4 0.0 0.0 0.0 0.0 0.0 14.1 0.2 0.0 3.9 5.7 0.0 1.1 10.3 3.0 0.0 0.0 0.0 7.0 27.4 6.6 0.0 2.8 0.0 3.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 22.2 0.2 3.6 0.0 0.0 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.9;tongue: 57.3" "Cell type enhanced" "Detected in many" "Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2" "Region enriched" "Detected in all" 11 "basal ganglia: 816.3" "Region enriched" "Detected in many" 4 "basal ganglia: 134.6" HPA017293 Approved NA NA "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 23.7 5.4 7.5 1.2 66.9 0.0 9.3 41.1 99.9 2.1 0.0 2.7 2.4 3.2 1.6 5.4 5.4 3.2 11.7 5.1 12.5 1.1 0.4 9.0 2.1 48.7 15.2 0.0 0.5 5.2 6.9 2.7 1.8 43.1 2.2 2.1 0.9 2.5 2.3 30.7 3.9 4.7 7.1 13.5 0.0 2.9 0.7 19.7 8.7 14.6 57.3 0.7 3.0 1.5 47.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 66.9 41.1 99.9 5.1 12.5 48.7 15.2 0.0 43.1 13.5 19.7 47.3 12.3 0.0 0.0 2.9 0.0 1.3 0.6 2.0 2.8 1.7 0.5 5.7 4.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.1 3.0 0.0 0.0 18.2 0.0 0.1 3.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 2.0 1.2 1.4 8.7 2.1 1.1 0.0 1.9 0.0 0.5 0.0 1.5 1.4 0.0 0.0 1.5 0.0 0.1 0.0 0.1 5.8 0.8 46.0 0.6 38.8 0.1 0.6 0.5 1.1 0.0 0.1 0.0 0.0 0.2 DSCAML1 KIAA1132 ENSG00000177103 "DS cell adhesion molecule like 1" Q8TD84 11 117427772-117817525 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.5;retina: 20.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 87.9;Excitatory neurons: 178.8;Inhibitory neurons: 232.4;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 465.3;Rod photoreceptor cells: 137.7" "Cancer enhanced" "Detected in some" "glioma: 1.9;renal cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;HDLM-2: 1.7;RPTEC TERT1: 4.8;T-47d: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035230 Uncertain NA NA "HPA035230: AB_2674527" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.07e-2)" "unprognostic (6.27e-5)" "unprognostic (8.48e-2)" "unprognostic (1.56e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (7.96e-2)" "unprognostic (2.89e-2)" "unprognostic (2.39e-3)" "unprognostic (8.37e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-2)" 0.9 0.4 4.9 0.1 10.3 0.2 0.4 3.0 10.9 1.0 0.0 1.5 0.4 2.0 0.5 0.2 2.7 1.2 0.9 10.5 6.3 3.0 0.4 0.7 0.3 11.6 11.4 3.5 5.0 0.9 0.0 4.4 0.1 17.2 0.8 0.6 20.3 1.1 0.3 0.5 0.2 0.7 0.8 5.3 1.1 0.7 2.2 12.2 0.5 0.8 0.3 0.4 1.2 0.7 26.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.6 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.9 0.1 0.0 0.0 0.0 0.3 9.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.9 10.3 3.0 10.9 10.5 6.3 11.6 11.4 3.5 17.2 5.3 12.2 26.5 0.4 0.0 0.0 23.8 0.1 0.1 0.1 0.1 0.6 87.9 0.0 0.0 2.7 4.3 0.1 0.0 41.7 0.0 0.0 0.3 0.0 0.4 6.1 2.1 0.3 0.7 6.7 0.0 178.8 0.0 0.0 1.3 0.0 0.4 0.0 0.2 0.7 0.0 0.1 3.3 232.4 3.7 0.0 0.0 1.2 10.5 1.2 0.2 0.0 3.7 0.0 4.0 0.0 352.8 465.3 0.0 0.1 1.9 0.0 0.2 0.0 1.8 5.5 137.7 0.0 1.2 1.2 0.3 0.8 0.0 0.0 0.1 0.3 0.1 0.9 0.1 RHOG "ARHG, MGC125835, MGC125836" ENSG00000177105 "Ras homolog family member G" P84095 11 3826978-3840959 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 275.6" "Cell type enhanced" "Detected in many" "Kupffer cells: 365.2;Langerhans cells: 356.6;monocytes: 391.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 625.4" "Low region specificity" "Detected in all" HPA039871 Enhanced NA NA 86000 "HPA039871: AB_10673428" "unprognostic (2.39e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.26e-2)" "unprognostic (1.35e-1)" "unprognostic (4.21e-2)" "unprognostic (4.27e-3)" "unprognostic (7.28e-2)" "unprognostic (1.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (9.49e-8)" "unprognostic (9.38e-2)" "unprognostic (8.98e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" 58.5 39.8 62.8 83.3 84.5 275.6 46.1 82.4 69.8 45.2 61.5 48.4 45.1 47.1 19.7 83.3 45.0 34.7 41.1 58.6 82.3 35.9 39.6 88.3 85.9 90.5 83.9 51.0 38.3 30.7 18.5 25.6 43.9 87.4 37.2 28.6 4.3 39.5 28.7 53.4 49.9 64.8 39.5 82.6 169.8 42.6 15.4 81.2 68.6 29.2 27.2 67.9 57.0 49.0 107.2 74.1 99.0 19.8 34.1 74.8 84.1 21.4 48.1 59.6 73.7 77.8 61.0 78.7 74.9 24.9 89.2 74.9 85.3 31.2 68.0 47.6 66.6 75.3 170.3 44.7 57.9 75.3 150.0 625.4 82.0 61.1 46.1 44.4 42.6 85.8 99.5 101.3 80.8 61.0 86.5 126.5 206.8 31.5 53.4 78.8 63.7 21.4 44.4 53.1 50.9 10.6 26.7 34.0 77.7 39.4 22.5 41.0 111.6 67.2 88.8 44.5 95.3 57.2 44.8 66.4 42.5 81.0 135.8 50.6 441.3 351.1 739.9 114.8 468.1 101.8 79.8 125.6 128.7 310.8 78.1 87.4 101.6 981.2 97.9 561.9 77.2 206.6 346.7 62.8 84.5 82.4 69.8 58.6 82.3 90.5 83.9 51.0 87.4 82.6 81.2 107.2 38.4 19.2 21.5 2.9 109.0 68.7 62.4 35.3 22.8 0.9 24.0 26.3 6.6 20.0 26.9 20.2 0.0 100.4 105.2 99.1 15.6 67.2 1.6 10.2 20.6 58.5 16.2 71.9 1.9 56.6 82.1 38.2 22.4 19.1 200.0 62.8 43.5 19.5 247.7 3.3 1.9 26.7 14.2 365.2 356.6 3.6 38.5 250.6 53.4 8.4 391.7 18.0 166.9 3.0 45.9 86.6 143.6 36.1 45.1 70.4 135.4 24.8 9.7 3.0 19.7 21.6 34.0 10.2 23.9 45.1 59.5 124.2 124.8 11.2 28.9 95.7 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 190.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 211.4;Paneth cells: 175.3;Proximal enterocytes: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 3.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.1" "Cell line enhanced" "Detected in many" "A-431: 234.3;BEWO: 220.8;CAPAN-2: 206.6;SK-BR-3: 257.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 9.2" HPA041143 Approved Supported Cytosol NA NA Cytosol "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 7.4 11.3 5.4 5.7 4.9 0.0 27.2 8.7 4.3 36.7 3.7 39.3 101.7 11.5 3.5 190.0 19.4 13.4 3.1 4.3 4.9 82.8 102.6 32.7 0.7 10.8 7.2 2.7 11.9 44.0 3.8 11.6 17.8 6.9 29.5 15.6 1.0 95.3 15.3 1.3 75.2 105.9 2.9 7.0 1.4 48.6 3.2 6.1 2.1 70.8 0.4 11.0 17.7 80.8 6.7 234.3 68.6 0.2 1.6 2.7 14.4 220.8 20.1 20.3 29.2 12.5 51.4 206.6 0.4 81.6 21.4 5.4 122.4 0.6 117.8 6.4 0.6 5.4 0.0 27.7 94.7 16.3 0.3 0.4 8.1 77.8 8.0 18.7 12.3 0.2 0.1 1.8 1.1 3.2 72.1 0.5 1.3 2.7 71.5 24.0 0.5 0.8 1.8 103.8 55.2 0.8 0.8 75.9 257.5 0.5 14.3 94.9 0.2 1.5 11.2 27.3 7.2 1.6 0.9 1.0 0.8 6.1 0.6 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.1 5.4 4.9 8.7 4.3 4.3 4.9 10.8 7.2 2.7 6.9 7.0 6.1 6.7 1.8 141.1 51.8 3.9 11.2 19.8 26.2 48.8 51.8 0.6 39.1 37.0 4.5 57.2 62.4 90.1 0.0 47.9 21.6 211.4 27.4 55.2 1.0 47.3 7.1 4.7 43.8 1.3 3.1 80.0 33.4 11.5 131.0 60.8 7.0 0.4 0.7 59.4 4.7 0.0 3.8 76.8 32.6 2.1 7.8 2.3 18.0 2.7 14.2 2.8 3.1 10.0 16.5 2.0 0.7 83.2 175.3 11.7 7.6 33.6 235.9 108.2 60.9 1.5 0.0 0.9 7.5 1.1 4.8 74.9 24.4 92.5 18.6 0.9 77.2 32.1 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type palmitoyltransferase 22" Q8N966 14 77131270-77142734 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 40.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 17.3;Excitatory neurons: 8.8;Inhibitory neurons: 13.4;Late spermatids: 5.0;Oligodendrocyte precursor cells: 24.6" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 3.6;NTERA-2: 3.8;RH-30: 6.4;SCLC-21H: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA049471: AB_2732553, HPA072213: AB_2686496" "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 0.0 0.2 10.7 0.0 14.5 0.0 0.0 24.1 33.9 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 22.1 7.6 0.0 0.0 0.0 0.0 2.1 26.2 10.9 0.0 0.0 0.0 4.7 0.0 10.5 0.0 0.1 7.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.5 40.8 0.0 0.1 0.4 0.0 0.1 0.0 14.5 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 3.8 0.0 0.5 0.0 6.4 0.0 0.0 0.0 7.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 14.5 24.1 33.9 22.1 7.6 2.1 26.2 10.9 10.5 0.0 40.8 14.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 24.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45482280 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" NA NA 47000 "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 87.1 26.1 6.8 16.9 7.1 9.9 27.7 7.7 8.4 29.1 14.2 23.1 36.5 39.3 25.8 25.2 27.5 31.9 28.0 6.7 15.6 36.6 57.4 40.6 13.5 9.9 7.8 5.3 57.1 25.5 59.3 7.0 50.9 10.7 30.1 15.1 3.6 25.6 37.4 56.5 12.1 51.8 48.8 8.7 16.1 13.9 11.9 8.8 25.2 13.3 46.7 12.9 35.3 16.1 9.1 41.5 44.3 25.7 35.4 119.1 61.7 97.4 57.4 72.5 38.4 36.3 71.9 61.5 21.1 52.2 92.0 34.9 54.0 24.1 32.3 45.6 31.4 16.9 25.0 17.8 62.1 37.8 39.5 19.4 51.7 31.9 33.0 48.7 95.4 52.6 44.5 19.3 34.0 42.7 11.2 41.5 13.2 28.6 0.0 18.0 23.4 33.3 24.4 36.9 63.1 11.7 39.9 59.9 36.8 27.9 67.7 43.3 62.8 70.6 41.2 26.1 41.8 29.3 18.3 21.5 25.8 37.3 122.8 33.4 3.1 5.9 1.4 2.4 6.9 2.5 1.4 2.2 2.0 5.5 1.2 2.0 1.3 0.6 2.3 7.1 2.7 3.0 4.2 6.8 7.1 7.7 8.4 6.7 15.6 9.9 7.8 5.3 10.7 8.7 8.8 9.1 65.1 60.9 11.8 54.9 10.0 30.5 20.3 27.7 23.3 1.1 23.0 18.7 23.4 30.0 21.5 18.4 0.0 34.0 14.5 2.5 3.9 38.4 1.3 13.3 32.1 37.5 8.4 8.0 49.8 37.4 28.0 44.2 21.4 26.0 12.7 20.2 52.5 88.3 19.9 0.0 49.0 11.5 12.2 56.3 22.9 3.5 51.3 46.0 17.8 68.4 29.1 8.2 15.5 110.6 3.0 73.3 10.0 40.6 12.2 29.5 70.3 23.4 16.5 0.3 39.5 45.9 52.1 3.5 4.3 25.1 22.0 24.6 17.3 6.7 14.6 30.5 ZBTB34 "KIAA1993, MGC24652, ZNF918" ENSG00000177125 "Zinc finger and BTB domain containing 34" Q8NCN2 9 126860665-126885878 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023893 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023893: AB_2219180" "unprognostic (2.96e-2)" "unprognostic (1.83e-1)" "unprognostic (2.72e-3)" "unprognostic (6.59e-3)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.96e-2)" "unprognostic (5.15e-2)" "unprognostic (9.32e-3)" "unprognostic (3.94e-2)" "unprognostic (2.55e-2)" "unprognostic (3.23e-2)" "unprognostic (9.71e-2)" "unprognostic (3.69e-2)" "unprognostic (2.01e-2)" 3.8 2.8 5.0 4.4 6.1 14.9 3.8 7.9 5.6 3.1 3.3 3.5 3.1 3.6 3.2 3.2 3.3 3.9 2.8 4.5 5.2 3.4 3.0 5.3 4.9 6.1 6.6 4.0 3.6 3.2 3.7 3.5 6.8 5.7 3.0 3.0 12.8 4.4 2.9 3.3 4.1 3.7 3.1 6.2 5.4 3.9 3.0 6.2 4.9 3.6 4.9 4.6 3.3 3.1 7.1 2.6 3.5 9.9 4.1 7.6 7.6 13.8 3.1 4.6 3.6 4.0 8.3 4.8 5.0 3.3 3.3 3.3 7.9 12.1 3.1 3.6 5.2 5.0 5.7 9.8 4.4 5.3 7.9 9.1 6.7 4.9 4.2 4.8 4.7 4.8 8.6 12.3 3.9 3.4 3.7 5.1 6.6 8.7 4.9 2.6 9.5 11.5 5.2 4.7 3.8 3.1 10.7 4.1 3.6 5.6 8.9 3.6 11.6 5.2 3.3 6.0 4.7 3.4 6.8 8.5 4.2 3.0 6.4 3.2 0.7 0.3 1.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.1 1.4 0.4 0.2 0.3 0.0 0.1 5.0 6.1 7.9 5.6 4.5 5.2 6.1 6.6 4.0 5.7 6.2 6.2 7.1 5.6 3.2 4.6 5.2 1.3 5.4 2.5 1.6 2.8 6.8 5.9 3.9 2.2 2.8 3.5 1.8 6.2 3.8 3.8 5.6 1.9 2.4 8.4 2.1 4.0 5.4 1.8 3.0 6.9 1.6 3.1 4.7 4.1 4.8 0.0 3.7 6.8 4.1 7.8 8.4 8.1 4.1 2.0 13.6 8.4 31.8 6.8 7.2 5.4 7.5 8.3 2.1 2.1 7.1 12.4 3.2 5.0 0.7 1.7 4.4 4.0 2.5 2.3 12.7 0.0 4.5 5.6 4.0 2.5 3.8 8.2 3.3 2.2 2.1 2.4 4.7 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9295682 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 3.1;testis: 5.9" "Group enriched" "Detected in some" 16 "Spermatocytes: 114.8;Spermatogonia: 96.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "U-266/70: 27.8;U-266/84: 32.1" HPA035135 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.0 0.1 0.4 0.0 0.2 0.3 0.0 0.3 0.4 0.0 0.2 0.1 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 3.1 0.1 0.0 0.3 0.2 0.3 0.3 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.7 0.1 0.1 0.3 0.9 0.1 0.4 0.2 5.9 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 27.8 32.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.1 0.3 0.5 0.1 0.0 1.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 4.9 0.2 1.7 0.4 0.0 0.0 0.3 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 6.6 0.6 0.2 114.8 96.5 0.0 0.3 0.0 0.2 0.0 0.0 0.2 CETN1 "CEN1, CETN" ENSG00000177143 "Centrin 1" Q12798 18 580380-582114 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1083 "testis: 135.4" "Group enriched" "Detected in some" 34 "Early spermatids: 930.9;Late spermatids: 435.6;Spermatocytes: 675.9" "Cancer enriched" "Detected in single" 10 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001470, HPA028956, CAB037244, HPA069157" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Nucleoplasm, Centriolar satellite, Cytosol" "CAB037244: AB_476871, HPA001470: , HPA028956: AB_10601798, HPA069157: " "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 930.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 435.6 12.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 675.9 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUDT4B NUDT4P1 ENSG00000177144 "Nudix hydrolase 4B" A0A024RBG1 1 148748894-148750099 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 5.8" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Cell line enhanced" "Detected in all" "CACO-2: 42.1;RT4: 34.5" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.24e-1)" "unprognostic (4.01e-2)" 4.9 6.9 0.4 3.7 0.4 23.8 1.8 0.0 1.5 4.5 1.3 5.7 5.3 3.8 2.6 8.2 7.0 17.8 20.9 0.4 5.8 9.8 3.9 2.6 6.9 1.3 0.4 0.2 16.2 12.0 4.7 0.3 7.8 0.7 7.6 6.2 0.7 23.8 3.2 5.3 1.3 5.2 3.6 0.3 3.0 4.1 7.7 0.4 3.2 8.0 8.2 3.7 11.2 0.6 0.5 3.5 3.8 1.5 4.7 6.3 5.1 9.3 4.1 6.2 4.4 4.2 42.1 14.8 3.5 1.7 3.7 4.2 5.7 6.8 3.0 2.2 11.0 3.3 8.5 2.3 5.4 8.4 5.8 2.6 10.6 9.7 5.5 5.1 5.3 16.5 4.3 17.6 13.8 4.2 3.0 7.9 1.1 8.3 3.4 6.2 9.7 2.2 10.0 3.2 34.5 3.0 4.4 3.5 8.6 23.7 1.0 11.7 11.0 9.1 5.8 4.5 9.6 6.3 3.2 5.2 4.5 2.7 8.7 17.4 0.0 0.1 2.8 0.0 0.3 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.2 0.2 0.4 0.4 0.0 1.5 0.4 5.8 1.3 0.4 0.2 0.7 0.3 0.4 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 33.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" NA NA "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 6.0 4.7 5.1 5.6 4.8 3.5 4.8 6.0 7.0 3.8 7.4 6.9 9.4 3.9 2.9 8.9 4.2 4.0 22.0 4.8 5.8 9.5 13.3 4.1 6.4 5.5 5.8 4.5 5.7 3.4 6.4 2.6 7.5 5.8 4.5 6.4 11.6 5.2 4.7 25.8 3.4 6.3 6.3 5.4 3.7 4.7 8.5 7.1 5.4 6.4 33.4 7.3 6.4 5.1 6.0 24.6 13.6 9.4 8.8 10.9 11.2 13.6 16.5 15.3 18.2 21.1 18.4 11.6 24.9 20.2 11.8 33.6 11.5 18.2 20.6 29.5 17.4 8.4 17.7 9.7 13.0 12.9 30.3 15.9 9.7 15.9 17.5 61.6 12.7 11.9 14.8 24.2 13.4 21.2 16.8 18.7 19.5 10.6 47.7 13.5 15.2 22.3 29.1 15.1 15.3 6.0 10.1 14.5 21.1 40.0 13.4 10.8 14.2 13.2 46.4 45.7 29.1 20.6 15.1 20.1 28.8 24.6 15.6 18.9 3.5 5.3 3.3 6.2 8.0 6.8 5.7 5.2 5.4 6.4 6.3 6.4 6.2 0.8 6.0 4.2 4.0 5.4 3.8 5.1 4.8 6.0 7.0 4.8 5.8 5.5 5.8 4.5 5.8 5.4 7.1 6.0 14.9 9.6 8.3 13.7 29.8 55.3 14.8 28.3 12.5 63.2 11.0 11.2 66.4 12.8 14.6 7.3 20.9 20.6 11.6 9.1 21.5 18.6 20.5 16.7 21.6 18.3 11.4 5.9 18.0 8.8 39.0 17.4 10.2 32.7 7.0 36.7 6.8 20.7 20.0 30.3 23.5 10.0 10.2 9.5 43.4 6.1 9.3 26.5 8.8 15.0 11.4 19.0 15.5 18.6 24.8 12.6 4.1 10.1 14.2 19.9 12.1 29.8 5.0 29.9 6.6 16.3 15.4 31.4 32.3 20.6 57.3 25.7 16.8 45.6 20.5 14.8 OR2T35 ENSG00000177151 "Olfactory receptor family 2 subfamily T member 35" Q8NGX2 1 248636356-248645278 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747415-765012 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 820.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 2870.4;neutrophil: 3726.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol NA NA 29000000 Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 139.9 81.3 109.7 122.9 126.0 468.9 122.1 129.4 120.2 88.6 109.1 100.5 117.1 68.9 67.0 333.2 79.8 100.9 96.4 111.2 123.6 111.7 137.3 110.0 108.7 137.1 121.5 106.0 77.6 108.4 49.7 53.4 88.7 129.2 92.7 79.2 34.5 133.9 60.7 121.7 133.8 101.9 61.3 130.1 153.9 133.5 40.7 122.5 110.9 141.5 108.0 116.8 162.1 143.3 150.3 331.0 405.5 115.4 218.1 235.8 136.5 338.0 242.2 313.8 238.2 194.5 176.6 694.8 179.5 323.1 324.7 181.9 345.5 185.6 263.5 122.8 238.9 372.5 310.9 146.0 616.4 250.3 498.4 449.0 112.0 210.6 159.6 129.0 170.4 331.6 224.0 413.5 294.3 224.5 318.0 296.4 601.2 183.9 478.9 326.0 243.5 131.5 656.4 437.9 185.4 284.2 100.1 224.9 466.1 243.3 102.4 220.0 383.9 434.1 107.9 99.5 86.0 232.9 122.9 132.1 223.5 238.5 440.5 444.7 1456.7 1203.5 2870.4 94.1 432.7 102.3 145.5 125.7 115.5 654.2 127.2 100.9 94.9 3726.6 112.2 457.8 267.0 192.7 1066.0 109.7 126.0 129.4 120.2 111.2 123.6 137.1 121.5 106.0 129.2 130.1 122.5 150.3 90.2 141.1 117.2 10.7 91.1 73.5 199.8 354.0 61.5 50.3 113.0 122.2 46.4 100.1 253.4 150.8 14.6 419.8 83.8 151.0 250.5 230.4 82.1 156.5 85.4 85.6 101.5 507.0 13.1 272.1 427.6 97.3 144.3 216.7 161.4 86.0 93.5 149.7 418.3 50.5 11.6 186.0 268.5 271.8 169.4 21.2 117.8 352.8 140.5 7.5 820.0 142.1 84.5 10.6 54.8 257.6 200.3 104.2 129.4 361.9 197.7 309.1 232.6 61.7 72.3 59.6 115.0 143.2 140.6 257.6 83.1 526.6 86.8 77.5 215.1 342.6 ULK1 "ATG1, ATG1A" ENSG00000177169 "Unc-51 like autophagy activating kinase 1" O75385 12 131894622-131923150 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 4.0;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;granulocytes: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063990 Approved Cytosol NA NA Cytosol "HPA063990: AB_2685167" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (2.52e-3)" "unprognostic (2.21e-3)" "unprognostic (8.01e-3)" "unprognostic (5.48e-2)" "unprognostic (2.74e-2)" "unprognostic (5.04e-3)" "unprognostic (3.94e-3)" "unprognostic (2.03e-2)" "unprognostic (9.09e-3)" "unprognostic (8.19e-2)" "unprognostic (6.25e-2)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.82e-2)" "unprognostic (3.16e-1)" 18.5 30.3 19.7 7.3 36.6 31.7 21.1 5.4 26.7 30.3 3.9 25.9 9.1 27.4 6.5 21.7 27.5 9.3 30.9 23.2 5.8 21.8 36.7 21.0 6.8 9.6 8.1 14.0 40.2 56.1 12.2 47.6 7.1 13.0 28.1 2.3 14.6 21.6 9.5 82.3 40.8 19.7 4.9 0.5 29.5 28.0 17.9 7.0 8.0 24.7 13.9 2.9 23.3 27.1 10.7 9.1 28.8 13.1 16.4 5.8 4.7 17.8 14.1 10.1 5.9 4.8 6.3 9.2 2.4 14.5 10.0 12.0 8.9 3.0 5.6 1.7 9.8 17.2 6.1 25.2 8.6 10.8 4.4 12.9 8.6 15.1 6.6 2.7 16.4 7.3 18.2 8.1 7.0 4.0 20.6 27.5 25.6 14.4 4.3 27.2 20.5 4.7 12.2 3.5 11.1 33.1 18.2 15.1 15.3 7.9 13.1 23.4 29.5 14.2 14.1 8.3 24.8 6.6 30.9 12.0 3.3 23.8 7.6 16.6 0.2 0.9 1.4 0.4 0.4 0.1 0.1 0.3 0.4 0.2 0.3 0.2 0.3 4.0 0.1 0.4 3.8 0.3 0.4 19.7 36.6 5.4 26.7 23.2 5.8 9.6 8.1 14.0 13.0 0.5 7.0 10.7 15.6 16.0 17.4 17.9 7.8 14.4 6.1 11.6 9.6 25.0 19.6 14.4 22.0 15.7 15.6 7.3 39.6 5.7 23.7 10.5 1.9 8.5 0.8 19.1 35.7 14.9 19.2 12.0 27.0 12.7 4.2 13.1 13.3 28.0 3.8 24.4 8.6 33.8 5.4 53.8 21.9 14.6 18.3 12.0 6.7 3.0 12.5 13.1 5.4 11.2 12.3 14.7 5.2 20.1 13.9 24.5 7.7 15.8 11.9 15.0 9.9 3.2 13.9 84.3 13.1 19.5 16.9 6.8 7.5 9.7 19.5 17.2 9.1 8.8 7.7 9.5 OR14C36 OR5BF1 ENSG00000177174 "Olfactory receptor family 14 subfamily C member 36" Q8NHC7 1 248348775-248349713 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMKLA "FAM80A, MGC47816, NAAGS-II, RP11-157D18.1" ENSG00000177181 "Ribosomal modification protein rimK like family member A" Q8IXN7 1 42380792-42424232 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;retina: 11.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 25.9;Cone photoreceptor cells: 43.8;Distal enterocytes: 46.3;Excitatory neurons: 39.1;Horizontal cells: 35.3;Inhibitory neurons: 35.9;Rod photoreceptor cells: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.4;JURKAT: 5.8;Karpas-707: 8.3;SCLC-21H: 9.9;U-266/70: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027826 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027826: AB_10603992" "unprognostic (4.04e-2)" "unprognostic (1.61e-1)" "unprognostic (3.68e-3)" "unprognostic (9.84e-2)" "unprognostic (2.49e-2)" "unprognostic (1.06e-1)" "unprognostic (2.63e-3)" "prognostic favorable (1.43e-4)" "unprognostic (8.89e-2)" "unprognostic (3.76e-1)" "unprognostic (9.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" "unprognostic (7.07e-2)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" 0.2 0.2 2.7 0.4 3.6 0.0 0.2 3.8 14.9 0.1 0.0 3.1 0.3 0.1 0.0 0.1 0.2 0.5 3.2 5.2 3.0 0.7 0.1 1.9 0.1 5.7 2.5 4.6 0.0 1.0 2.3 1.2 0.2 6.6 0.5 3.2 11.3 0.5 0.2 0.7 0.2 0.4 0.7 1.1 0.2 1.0 0.7 7.8 0.0 0.6 1.0 0.0 0.4 0.2 8.4 0.0 0.7 0.1 6.4 0.1 0.0 1.3 0.0 0.0 0.2 0.5 0.3 0.2 0.0 1.4 0.0 1.2 0.0 4.2 0.0 0.3 3.7 2.5 0.3 0.1 1.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 8.3 0.0 0.3 2.0 0.0 3.5 0.5 5.1 0.0 0.2 0.3 0.6 1.7 9.9 4.2 0.3 0.3 0.1 0.7 0.3 1.9 0.0 0.0 0.4 0.0 0.7 7.4 4.4 5.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2.7 3.6 3.8 14.9 5.2 3.0 5.7 2.5 4.6 6.6 1.1 7.8 8.4 0.9 16.0 3.9 1.3 0.2 0.6 1.1 1.0 0.0 25.9 0.9 1.0 14.4 1.5 1.1 1.8 43.8 1.4 0.3 46.3 1.9 3.3 5.3 0.4 0.0 2.2 11.4 0.0 39.1 4.8 20.1 0.5 0.5 0.1 0.0 0.3 0.7 0.0 1.0 35.3 35.9 8.0 2.0 0.3 1.4 10.5 0.3 0.3 5.4 2.8 0.0 5.1 0.0 7.1 3.9 9.4 14.2 0.0 0.1 1.7 0.3 3.7 0.2 24.6 0.0 0.8 0.6 1.1 4.8 0.0 0.1 1.6 0.7 0.3 5.2 1.0 CLVS1 "C6orf212L, CRALBPL, MGC34646, RLBP1L1" ENSG00000177182 "Clavesin 1" Q8IUQ0 8 61057158-61501645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.7;retina: 5.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 113.1;Inhibitory neurons: 158.1;Oligodendrocyte precursor cells: 90.0;Oligodendrocytes: 37.3" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.5;SCLC-21H: 3.7;SH-SY5Y: 1.6;U-266/70: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076650 Approved NA NA "HPA076650: " "unprognostic (1.86e-2)" "unprognostic (3.09e-4)" "unprognostic (2.79e-1)" "unprognostic (2.96e-7)" "unprognostic (1.11e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-1)" "unprognostic (8.02e-4)" "unprognostic (2.23e-1)" "unprognostic (8.44e-3)" "unprognostic (7.25e-3)" "unprognostic (2.94e-1)" "unprognostic (5.79e-8)" "unprognostic (2.49e-1)" "unprognostic (3.19e-2)" "unprognostic (9.71e-2)" "unprognostic (1.14e-2)" 1.5 0.4 3.9 0.3 5.2 0.2 0.5 10.7 7.2 0.1 0.0 0.2 0.1 0.0 0.1 1.5 0.5 0.3 0.3 5.0 5.2 0.2 0.6 0.1 0.5 3.9 2.6 4.9 0.1 0.1 0.0 2.5 0.1 5.2 0.2 0.1 5.2 1.2 0.0 0.5 1.5 0.2 0.0 1.5 0.4 0.2 2.0 3.7 0.7 1.2 0.0 0.9 0.1 0.3 6.7 0.2 0.4 0.1 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.4 0.8 0.2 0.2 1.2 1.0 0.1 0.4 0.0 3.7 1.6 0.1 0.2 0.0 0.2 0.2 0.5 0.3 0.1 0.2 0.1 0.1 1.6 0.8 0.2 0.9 0.0 0.0 1.1 0.3 0.2 0.2 0.2 0.1 0.3 0.3 0.1 0.0 0.5 0.2 0.3 0.8 0.5 0.1 0.3 0.0 0.3 3.9 5.2 10.7 7.2 5.0 5.2 3.9 2.6 4.9 5.2 1.5 3.7 6.7 6.1 6.4 0.5 9.8 0.3 0.0 0.1 0.1 0.0 2.0 0.1 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.4 0.0 0.0 113.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 158.1 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 19.7 0.0 11.2 0.0 90.0 37.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.0 1.8 0.0 1.0 0.2 0.4 0.6 0.3 0.1 0.8 0.0 0.0 0.0 0.2 OR2M7 ENSG00000177186 "Olfactory receptor family 2 subfamily M member 7" Q8NG81 1 248323630-248324568 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPS6KA3 "CLS, HU-3, MRX19, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 236.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 21.3 19.0 7.2 34.0 9.3 16.3 15.0 12.2 13.2 16.2 11.5 33.2 24.4 17.7 8.5 18.9 15.3 27.1 21.3 8.6 10.1 19.7 45.4 32.6 31.5 8.3 8.8 7.1 10.7 17.3 59.9 5.9 19.6 8.3 20.1 32.1 15.9 13.3 18.1 52.3 15.1 27.8 28.1 8.8 29.4 21.3 5.5 11.7 33.2 21.4 40.7 32.9 34.5 8.6 7.7 44.9 77.0 28.4 14.8 27.1 47.3 8.6 38.0 57.4 27.8 37.7 87.7 56.2 29.3 12.8 40.0 40.5 30.9 32.8 32.2 51.1 24.8 26.1 34.6 46.2 236.8 27.7 67.8 34.2 30.3 25.1 43.5 54.4 24.3 101.9 30.4 23.1 81.0 29.4 21.2 44.2 20.7 20.6 57.8 45.9 23.3 60.0 33.8 23.9 36.9 13.1 12.8 51.1 15.3 54.4 35.3 0.1 20.0 57.3 30.1 20.8 96.3 21.7 64.3 42.1 32.1 56.9 33.1 72.6 11.9 3.8 7.9 4.7 5.3 8.3 2.4 5.4 5.2 5.6 3.2 3.7 4.5 5.8 6.6 6.0 6.7 2.9 2.2 7.2 9.3 12.2 13.2 8.6 10.1 8.3 8.8 7.1 8.3 8.8 11.7 7.7 60.6 44.8 67.5 31.6 34.8 54.4 37.0 21.2 10.2 37.8 20.4 10.8 22.9 34.3 41.1 16.5 22.9 4.0 70.0 63.5 3.9 26.3 0.4 10.8 24.0 61.1 25.0 19.1 142.2 30.5 6.7 31.6 24.5 26.1 44.3 8.3 34.6 65.4 22.6 13.5 108.4 59.1 28.5 40.8 104.3 1.5 13.1 62.6 37.4 126.5 53.7 27.5 46.4 116.6 27.0 37.4 57.9 21.1 25.5 56.6 33.5 25.1 23.3 9.7 19.7 41.5 21.3 6.4 8.7 13.8 55.5 3.6 66.0 14.2 61.1 63.8 B3GNT8 "B3GALT7, beta3Gn-T8, BGALT15" ENSG00000177191 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8" Q7Z7M8 19 41425359-41428730 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.9;vagina: 19.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 37.2;Distal enterocytes: 58.1;Ionocytes: 44.7;Paneth cells: 45.0;Proximal enterocytes: 68.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "basophil: 95.0;eosinophil: 117.5;neutrophil: 159.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 159.0" "Cell line enhanced" "Detected in some" "HMC-1: 6.5;HUVEC TERT2: 3.5;K-562: 3.1;THP-1: 3.4;U-937: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043669 Enhanced "Intracellular and membrane" NA NA 57000000 "HPA043669: AB_2678608" "unprognostic (6.89e-2)" "unprognostic (2.46e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (6.44e-3)" "unprognostic (6.51e-3)" "unprognostic (1.84e-2)" "unprognostic (9.92e-3)" "unprognostic (7.30e-2)" "unprognostic (2.56e-2)" "prognostic favorable (9.31e-6)" "unprognostic (5.04e-2)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" 2.2 1.2 0.2 1.6 0.3 3.9 2.1 1.1 0.5 6.5 0.3 9.1 15.7 2.4 0.3 44.9 1.8 0.5 4.5 0.1 0.2 3.7 0.5 9.1 0.7 0.4 0.2 0.0 0.8 1.5 0.5 1.9 0.5 0.5 3.4 2.7 0.1 6.4 2.6 0.8 5.0 15.4 0.8 0.0 8.6 2.0 0.2 0.2 0.3 1.2 0.9 1.6 2.8 19.6 0.7 0.2 0.0 0.2 0.0 0.3 1.4 0.3 0.4 0.1 0.0 0.0 2.1 0.0 0.1 0.5 1.0 0.0 1.4 0.0 0.3 0.0 0.1 0.2 0.0 0.1 1.1 0.5 0.5 6.5 1.7 1.2 0.0 0.0 0.0 3.5 0.1 3.1 0.2 0.0 0.5 0.0 2.0 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.7 0.9 0.6 0.0 0.1 0.0 0.2 0.0 3.4 1.3 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 5.5 0.0 95.0 16.3 117.5 2.4 12.3 28.4 0.0 1.2 5.2 6.0 0.0 0.1 0.6 159.0 1.5 26.5 0.5 0.6 7.1 0.2 0.3 1.1 0.5 0.1 0.2 0.4 0.2 0.0 0.5 0.0 0.2 0.7 0.9 6.4 37.2 0.0 0.0 1.8 5.2 16.3 2.2 0.4 1.4 2.2 0.5 0.0 10.6 23.9 0.0 0.9 0.3 58.1 3.9 5.8 0.0 0.8 0.5 1.7 15.0 1.3 0.1 0.6 2.1 3.0 0.5 1.8 5.1 0.1 2.5 0.0 11.2 0.0 0.1 23.8 44.7 8.8 0.6 0.0 1.5 5.6 0.0 0.0 3.8 0.1 1.0 0.0 0.1 2.9 45.0 0.7 0.1 7.4 68.7 0.3 3.5 0.4 0.0 0.6 2.7 0.0 0.1 20.5 1.7 2.3 1.2 0.0 18.5 13.4 PUS1 ENSG00000177192 "Pseudouridine synthase 1" Q9Y606 12 131929200-131945896 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051636, HPA057593" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051636: AB_2681560, HPA057593: AB_2683479" "unprognostic (2.72e-1)" "unprognostic (9.13e-2)" "unprognostic (1.81e-1)" "unprognostic (2.69e-2)" "unprognostic (8.12e-3)" "unprognostic (8.07e-2)" "unprognostic (4.57e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (2.06e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (3.49e-8)" "unprognostic (1.80e-3)" "unprognostic (8.06e-2)" "unprognostic (8.59e-2)" "unprognostic (1.56e-2)" 10.9 15.0 10.2 15.0 8.1 23.2 10.5 7.8 9.7 9.8 6.9 11.5 9.8 12.6 14.1 16.6 11.3 7.2 8.3 9.0 5.8 10.4 21.8 9.1 18.6 7.0 5.3 10.0 8.7 15.0 5.4 8.8 6.4 7.4 11.0 7.9 5.0 9.4 6.8 14.3 13.5 14.1 7.5 4.6 15.9 12.8 13.1 6.3 8.7 9.6 4.8 10.7 14.3 10.8 9.2 45.3 58.1 13.7 24.0 13.0 21.5 82.2 34.5 14.2 25.4 16.3 64.5 28.7 53.2 38.3 18.6 19.9 56.0 44.4 32.2 16.3 24.0 90.6 54.0 30.9 56.9 34.0 93.5 47.4 21.7 25.6 28.9 24.8 12.3 25.0 36.8 68.0 15.6 14.9 77.9 61.9 83.4 71.5 36.7 87.3 57.8 19.2 55.4 20.8 61.7 37.5 20.8 28.6 38.9 32.5 13.1 42.5 99.3 22.7 20.2 43.3 43.1 50.0 43.5 35.5 64.5 20.7 73.6 28.4 1.0 1.3 0.2 2.0 1.0 1.5 4.6 1.7 2.1 1.1 4.2 2.4 1.3 1.1 5.6 0.9 3.0 1.8 0.9 10.2 8.1 7.8 9.7 9.0 5.8 7.0 5.3 10.0 7.4 4.6 6.3 9.2 7.0 0.0 6.1 9.8 10.7 29.6 22.3 8.4 6.2 6.2 10.7 10.5 5.3 8.6 6.2 5.5 22.9 13.9 11.7 10.9 5.9 12.3 0.9 6.6 10.1 11.1 14.4 13.2 11.9 9.6 19.1 8.3 15.3 7.7 16.5 11.7 6.1 12.9 15.2 0.0 8.4 20.1 10.2 7.3 8.1 3.0 7.8 7.2 7.2 9.4 8.8 4.4 6.2 5.0 7.1 16.3 6.9 9.4 8.8 35.4 4.0 13.7 4.9 10.0 6.6 15.9 9.3 18.5 19.7 14.7 22.7 8.6 9.5 14.3 18.8 21.4 CHD9 "BC022889, FLJ12178, KIAA0308" ENSG00000177200 "Chromodomain helicase DNA binding protein 9" Q3L8U1 16 53055033-53329150 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042053, HPA049420, HPA066155" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: " "unprognostic (3.57e-2)" "unprognostic (3.73e-2)" "unprognostic (3.44e-3)" "unprognostic (2.42e-1)" "unprognostic (4.34e-2)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "unprognostic (7.75e-3)" "unprognostic (2.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.35e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (5.09e-2)" "unprognostic (2.87e-1)" 7.5 6.7 16.2 6.0 18.6 21.9 11.6 31.5 13.8 10.2 1.9 8.2 5.5 9.8 6.2 7.8 9.1 8.2 7.2 6.0 13.0 11.2 6.9 7.0 6.9 13.3 16.2 2.0 12.8 6.4 10.3 5.0 8.8 16.4 8.4 7.9 29.1 8.6 8.8 7.2 6.2 5.8 8.0 7.9 7.8 9.7 4.9 16.5 10.0 12.4 12.9 6.7 7.2 6.3 18.3 10.4 12.0 25.0 20.8 20.0 28.6 4.4 18.0 13.8 9.9 4.3 6.8 9.1 14.0 11.3 16.8 6.9 12.5 14.0 10.4 14.0 5.0 10.2 18.4 12.0 4.6 13.5 25.3 15.8 19.9 9.5 15.2 18.3 12.9 14.7 8.3 22.2 4.5 13.0 4.2 13.1 5.9 9.6 3.1 8.7 46.2 28.8 5.8 6.4 9.7 10.4 11.7 16.6 5.4 12.3 9.7 6.0 12.0 28.3 18.1 8.9 6.6 12.0 13.1 9.7 21.9 13.2 11.3 17.9 102.0 25.5 27.5 15.7 21.9 24.5 38.9 10.7 17.6 16.2 46.6 8.5 12.0 8.6 38.3 39.4 126.7 6.1 5.4 16.2 18.6 31.5 13.8 6.0 13.0 13.3 16.2 2.0 16.4 7.9 16.5 18.3 146.3 70.5 74.7 426.4 111.5 57.2 123.4 107.7 96.8 318.9 81.3 89.9 39.0 55.8 81.5 90.1 502.5 17.4 112.1 80.8 46.9 60.4 16.4 71.8 109.3 97.5 87.6 67.7 272.9 36.7 31.2 117.2 109.1 69.9 96.7 121.8 107.4 66.4 69.0 220.4 297.3 89.7 69.2 67.8 50.7 19.1 108.4 88.6 67.6 319.5 89.3 153.3 98.9 462.4 312.0 39.0 100.5 123.4 70.3 98.2 76.1 60.8 72.3 766.6 59.2 157.2 106.1 105.7 50.9 75.4 75.0 24.9 60.5 89.3 72.1 83.4 OR2T12 ENSG00000177201 "Olfactory receptor family 2 subfamily T member 12" Q8NG77 1 248290139-248303424 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.2" NA NA 0.0 0.1 0.3 0.1 1.0 0.4 0.0 1.4 1.6 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.2 0.3 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.3 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.8 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 1.0 1.4 1.6 0.6 0.6 0.2 0.3 0.5 0.5 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA4 SAMP14 ENSG00000177202 "Sperm acrosome associated 4" Q8TDM5 19 48606742-48607714 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 118.7" "Cell type enriched" "Detected in some" 5 "Early spermatids: 1014.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041927, HPA061302" Enhanced NA NA "HPA041927: AB_10794162, HPA061302: AB_2684475" "unprognostic (2.48e-2)" "unprognostic (6.37e-4)" "unprognostic (6.59e-2)" "unprognostic (4.52e-2)" "unprognostic (2.09e-3)" "unprognostic (9.43e-6)" "unprognostic (6.67e-3)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (2.78e-1)" "unprognostic (3.43e-1)" "unprognostic (2.88e-1)" "unprognostic (4.47e-1)" "unprognostic (2.01e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.3 0.4 0.0 2.1 3.1 0.0 0.0 2.0 0.3 1.1 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.9 0.0 0.1 1.4 3.1 0.0 0.0 0.0 3.5 118.7 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.2 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1014.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 185.9 4.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 9.8 3.3 0.0 1.6 0.0 0.0 0.0 0.0 0.2 OR2T33 ENSG00000177212 "Olfactory receptor family 2 subfamily T member 33" Q8NG76 1 248269917-248277976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.79e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GATD1 "FLJ34283, PDDC1" ENSG00000177225 "Glutamine amidotransferase like class 1 domain containing 1" Q8NB37 11 767220-777488 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 120.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008812 Uncertain Supported Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA008812: AB_10962724" "unprognostic (3.39e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (3.50e-2)" "unprognostic (2.19e-1)" "unprognostic (5.67e-2)" "unprognostic (5.23e-3)" "unprognostic (4.89e-3)" "prognostic favorable (3.79e-5)" "unprognostic (2.84e-2)" "unprognostic (8.40e-2)" "unprognostic (6.11e-2)" "unprognostic (6.61e-3)" 16.0 37.8 32.8 11.4 29.9 7.9 16.9 31.1 38.1 22.3 29.0 22.1 15.6 25.1 12.7 23.9 22.9 7.4 16.1 32.9 31.4 24.1 19.5 15.5 11.3 40.2 36.7 28.7 26.1 16.1 10.6 30.3 9.2 35.0 23.1 6.5 9.8 17.7 12.4 14.6 20.3 18.3 8.0 32.8 19.7 18.0 18.7 38.3 8.9 22.2 6.6 6.8 19.9 20.6 32.8 41.3 22.3 22.2 23.9 10.2 15.6 20.9 24.2 10.5 22.0 19.3 15.8 62.5 22.1 8.6 16.0 23.2 42.7 16.7 21.6 11.0 28.1 120.5 13.0 38.8 36.0 17.5 25.4 27.8 22.4 23.2 9.3 14.2 19.9 17.1 25.8 34.2 20.0 12.4 11.0 29.3 27.5 21.3 13.4 42.8 31.4 15.1 28.0 19.2 9.1 56.9 22.3 22.9 32.0 16.6 5.7 28.5 16.8 31.3 23.2 17.5 12.7 18.8 23.4 12.9 28.4 35.4 33.9 19.6 1.0 5.2 0.9 2.9 6.6 2.1 2.7 3.0 2.9 6.9 2.3 2.4 1.7 0.5 1.2 2.6 4.0 1.4 2.0 32.8 29.9 31.1 38.1 32.9 31.4 40.2 36.7 28.7 35.0 32.8 38.3 32.8 8.7 44.8 22.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 11.9 10.4 0.0 0.0 7.4 22.0 0.0 13.8 5.2 0.0 5.9 10.3 0.0 11.8 15.2 3.8 0.0 0.0 0.0 7.6 7.9 8.5 0.0 9.6 6.3 19.2 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.6 0.0 0.0 1.3 0.0 0.0 14.7 7.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 9.6 3.9 25.8 0.0 0.0 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214091-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 153.3;tongue: 43.4" "Cell type enriched" "Detected in many" 5 "Skeletal myocytes: 45.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.9" "Group enriched" "Detected in many" 5 "cerebellum: 9.4;pons: 3.2" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054909: AB_2682639" "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 0.2 0.2 0.9 0.2 0.8 0.8 0.2 9.4 1.1 0.1 0.4 0.2 0.2 0.2 0.3 1.0 0.1 0.2 0.7 0.7 0.5 0.1 0.1 0.2 0.3 1.1 0.8 0.6 0.2 0.3 0.1 0.0 0.2 3.2 1.9 0.1 0.8 2.5 0.1 153.3 0.5 0.2 0.1 0.2 0.3 0.3 0.3 0.6 0.1 0.2 43.4 0.2 0.1 0.0 1.3 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.3 0.1 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.3 0.1 0.2 0.7 0.2 0.2 7.2 0.3 1.2 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.8 12.6 0.1 0.1 0.5 0.2 0.2 0.2 0.3 29.7 4.1 0.0 0.2 2.6 0.2 0.1 0.3 0.1 0.3 0.2 2.6 0.1 0.2 0.2 0.2 0.1 17.9 1.7 0.2 0.2 0.4 0.2 1.9 0.3 0.5 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.6 0.4 0.3 1.5 0.6 0.4 0.6 0.2 0.1 0.9 0.8 9.4 1.1 0.7 0.5 1.1 0.8 0.6 3.2 0.2 0.6 1.3 4.7 3.2 3.8 0.0 0.8 0.1 3.1 0.0 0.0 1.0 3.1 8.0 3.0 0.0 2.5 0.0 2.1 0.3 2.4 0.0 0.0 0.0 0.3 1.5 4.7 1.5 0.0 0.0 0.2 0.0 0.3 2.5 0.0 4.0 1.3 0.8 0.4 0.0 0.2 0.0 0.1 0.2 0.0 1.2 0.3 0.0 0.0 3.1 0.0 0.0 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.1 0.1 0.0 0.9 0.0 45.6 2.2 0.1 0.2 0.8 0.3 0.1 2.2 1.2 0.9 1.5 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086985-137109183 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles NA NA 940000 Vesicles "HPA051516: AB_2681518" "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 23.8 32.5 20.4 12.2 20.3 9.2 25.3 20.4 33.2 22.7 24.2 21.6 15.7 20.9 20.6 32.4 22.2 20.2 27.3 21.2 21.7 31.7 40.0 23.2 15.5 21.8 21.9 21.2 28.3 36.3 20.1 32.9 21.6 22.7 26.3 10.0 3.7 34.5 15.4 17.8 32.7 23.1 12.2 20.6 29.0 25.8 28.5 21.4 13.9 27.3 10.0 10.2 22.2 22.1 22.4 22.8 50.7 18.2 49.9 67.0 57.7 57.0 37.9 78.4 48.6 43.7 24.9 67.4 20.0 118.8 64.7 69.2 74.3 11.0 36.3 9.1 27.7 17.3 8.7 41.2 33.2 59.6 16.0 33.1 65.1 66.9 29.1 25.1 67.1 32.4 26.5 24.5 32.7 36.4 45.0 16.7 37.8 23.5 67.3 50.0 9.7 30.6 63.9 41.6 11.3 20.4 18.3 55.2 55.9 38.7 9.6 63.5 31.5 46.5 69.6 25.9 52.9 43.6 13.0 11.1 13.3 84.6 19.9 61.6 17.9 31.2 27.0 32.4 34.4 30.2 19.1 25.1 30.4 36.0 16.4 24.3 25.0 9.0 31.0 42.2 26.6 34.5 32.1 20.4 20.3 20.4 33.2 21.2 21.7 21.8 21.9 21.2 22.7 20.6 21.4 22.4 18.8 19.2 27.3 23.5 18.3 11.6 12.6 33.0 12.0 20.7 23.5 21.7 10.3 14.3 21.5 25.8 16.7 53.2 24.3 39.1 7.9 32.0 5.8 21.5 16.4 19.7 30.5 14.3 13.0 32.0 72.4 26.9 23.4 20.3 21.0 47.8 25.0 25.2 32.1 30.3 10.2 28.1 22.4 22.9 17.4 6.8 21.1 21.8 23.2 11.2 29.3 16.0 16.5 6.6 12.8 27.6 25.0 21.8 25.4 9.0 35.9 15.9 24.9 19.3 13.1 19.4 20.2 16.1 28.4 16.3 16.2 45.4 21.5 41.1 25.6 8.2 DEFB103B ENSG00000177243 "Defensin beta 103B" P81534 8 7428888-7430348 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB4B DEFB4P ENSG00000177257 "Defensin beta 4B" O15263 8 7414855-7416863 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 12.0;lymphoid tissue: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA3 "HLK3, HPCN3, Kv1.3, MK3" ENSG00000177272 "Potassium voltage-gated channel subfamily A member 3" P22001 1 110672465-110674940 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 13.1;Inhibitory neurons: 60.2;Plasma cells: 61.6;T-cells: 20.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 4.9;T-cells: 14.3" "Cell line enhanced" "Detected in some" "HDLM-2: 23.1;Karpas-707: 45.6;U-266/70: 32.6;U-266/84: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016625 Approved NA NA "HPA016625: AB_2669407" "unprognostic (2.17e-2)" "unprognostic (5.07e-3)" "unprognostic (3.92e-3)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (1.76e-5)" "unprognostic (1.70e-4)" "unprognostic (8.48e-2)" "unprognostic (1.49e-2)" "unprognostic (5.92e-4)" "unprognostic (1.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" 0.5 0.9 2.2 6.5 1.9 4.6 0.9 1.4 4.0 1.1 0.0 2.4 2.5 0.5 0.0 0.5 0.3 1.3 0.4 5.2 4.7 0.2 0.8 6.0 9.5 0.9 3.2 4.6 0.7 0.4 0.4 0.4 0.7 3.1 0.5 1.9 0.6 1.4 0.2 0.1 0.2 2.6 0.6 0.0 6.0 4.3 0.6 4.4 25.6 0.8 0.1 7.6 2.6 0.2 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 45.6 0.0 0.0 10.0 0.0 0.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 6.3 0.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.7 0.0 0.0 32.6 31.9 11.6 0.0 2.7 0.0 0.0 1.1 0.0 8.9 0.0 10.0 2.8 13.4 14.3 1.4 4.9 10.4 7.9 0.0 1.3 0.1 0.6 13.4 4.4 2.2 1.9 1.4 4.0 5.2 4.7 0.9 3.2 4.6 3.1 0.0 4.4 1.8 0.2 0.0 1.9 1.3 11.5 0.4 0.0 0.0 0.0 2.5 0.1 0.0 0.6 0.0 0.0 1.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.3 13.1 0.0 0.0 0.7 1.5 0.0 0.0 0.0 1.8 0.0 0.4 0.0 60.2 0.0 0.0 1.6 2.4 0.0 0.0 3.1 3.6 2.8 2.4 0.3 3.1 7.5 1.3 0.0 0.0 0.0 61.6 0.0 0.0 0.1 0.0 0.2 6.6 0.0 0.1 4.3 0.9 0.1 0.6 0.0 20.3 0.0 0.0 0.1 OR2AJ1 "OR2AJ1P, OR2AJ1Q" ENSG00000177275 "Olfactory receptor family 2 subfamily AJ member 1" Q8NGZ0 1 247924889-247935339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FZD8 ENSG00000177283 "Frizzled class receptor 8" Q9H461 10 35638247-35642296 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 32.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Gastric mucus-secreting cells: 13.7;Muller glia cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.6;PC-3: 40.3;U-138 MG: 14.8;U-251 MG: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045025, HPA071142" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045025: AB_10795888, HPA071142: AB_2686349" "unprognostic (1.20e-1)" "unprognostic (4.42e-3)" "unprognostic (1.85e-2)" "unprognostic (1.97e-1)" "unprognostic (2.21e-2)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "prognostic favorable (8.21e-4)" "unprognostic (4.92e-2)" "unprognostic (2.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.68e-1)" "unprognostic (7.34e-3)" "unprognostic (1.19e-1)" 4.6 1.4 4.3 1.2 5.6 0.1 3.8 1.8 6.1 2.3 32.5 7.1 0.6 2.5 0.5 0.9 5.4 1.3 7.6 5.6 6.4 6.4 3.1 4.4 1.3 2.3 3.0 4.8 1.8 4.7 2.5 2.8 0.4 2.9 1.3 2.0 3.9 3.3 1.4 3.1 3.6 2.0 1.6 1.4 11.8 7.3 2.5 4.3 1.4 6.7 2.5 0.6 1.8 1.6 4.7 0.0 4.4 0.7 0.0 1.7 0.1 2.6 4.8 0.2 0.2 0.2 0.5 0.7 0.0 0.7 2.1 4.8 1.5 0.5 1.5 0.0 0.0 12.4 0.0 0.5 0.2 0.8 0.0 0.3 1.5 6.0 9.7 3.8 15.6 3.4 0.0 0.3 0.0 1.3 1.9 0.0 0.0 4.0 0.3 40.3 4.1 2.5 0.0 7.7 0.3 12.0 0.4 0.9 0.2 0.0 5.5 0.1 0.7 8.1 14.8 2.2 7.3 13.4 0.0 0.0 0.0 8.5 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.6 1.8 6.1 5.6 6.4 2.3 3.0 4.8 2.9 1.4 4.3 4.7 12.2 19.2 3.3 12.4 0.0 0.3 1.0 4.2 2.2 0.6 4.1 10.8 10.2 1.5 3.1 0.0 2.1 0.1 0.5 11.2 0.0 3.4 0.0 4.2 2.7 7.2 1.2 0.0 0.4 3.1 0.3 6.1 13.7 9.3 0.0 1.6 10.4 4.5 0.6 0.0 0.5 2.7 0.0 0.8 1.3 0.1 1.2 1.2 0.0 1.9 0.2 27.2 0.0 1.0 0.3 3.5 1.5 2.2 0.1 0.8 0.5 4.2 2.1 1.3 6.6 2.7 5.8 0.2 1.4 1.2 1.1 0.1 0.4 0.7 4.8 0.2 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605341-35608935 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Paneth cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in single" "RH-30: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038266 Uncertain NA NA "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.5 0.0 0.3 0.2 0.2 0.2 0.1 0.5 0.2 1.4 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.6 0.2 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.7 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 FBXO39 "CT144, Fbx39, MGC35179" ENSG00000177294 "F-box protein 39" Q8N4B4 17 6776215-6797101 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "testis: 30.6" "Group enriched" "Detected in some" 160 "Early spermatids: 346.2;Late spermatids: 553.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (6.73e-2)" "unprognostic (1.69e-2)" "unprognostic (1.78e-2)" "unprognostic (2.15e-2)" "unprognostic (7.19e-2)" "unprognostic (7.93e-2)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-3)" "unprognostic (2.36e-1)" "unprognostic (3.73e-9)" "unprognostic (5.11e-2)" "unprognostic (2.67e-1)" "unprognostic (5.93e-2)" "unprognostic (3.79e-2)" 0.3 0.0 0.3 0.0 0.3 0.2 0.2 0.1 0.4 0.4 0.1 0.0 0.1 0.2 0.2 0.2 0.3 0.2 0.1 0.3 0.2 0.1 0.8 0.2 0.1 0.5 0.2 0.1 1.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.3 0.3 0.0 30.6 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.4 0.3 0.2 0.5 0.2 0.1 0.2 0.3 0.3 0.5 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.2 0.1 0.2 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 553.7 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 CLDN22 CLDN21 ENSG00000177300 "Claudin 22" Q8N7P3 4 183318100-183320276 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 4.9" "Group enriched" "Detected in some" 14 "Endometrial ciliated cells: 34.1;Glandular and luminal cells: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 0.0 0.2 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 KCNA2 "HK4, Kv1.2" ENSG00000177301 "Potassium voltage-gated channel subfamily A member 2" P16389 1 110519837-110631474 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 77.2" "Group enriched" "Detected in some" 4 "Astrocytes: 49.9;Excitatory neurons: 36.7;Inhibitory neurons: 37.1;Muller glia cells: 19.8;Oligodendrocyte precursor cells: 36.2" "Cancer enhanced" "Detected in some" "glioma: 1.2;testis cancer: 1.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "T-reg: 1.3" "Lineage enriched" "Detected in single" 8 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "Karpas-707: 4.8;SCLC-21H: 1.4;U-2 OS: 1.2;U-266/70: 1.9;U-266/84: 3.1;WM-115: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001976 Enhanced NA NA "CAB001976: " "unprognostic (1.84e-2)" "unprognostic (9.70e-3)" "unprognostic (1.97e-1)" "unprognostic (2.98e-1)" "unprognostic (7.17e-3)" "unprognostic (6.68e-3)" "unprognostic (5.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (4.50e-3)" "unprognostic (3.08e-3)" "unprognostic (2.93e-4)" "unprognostic (2.15e-1)" "unprognostic (3.55e-1)" "unprognostic (6.41e-2)" "unprognostic (2.83e-1)" 1.3 0.3 6.8 0.7 5.9 0.0 0.6 10.6 77.2 0.2 0.0 1.2 0.4 0.1 0.3 0.4 0.1 0.4 0.6 10.2 9.7 0.1 0.0 0.2 0.6 24.8 8.0 2.8 0.1 0.8 0.0 2.2 0.0 32.0 0.5 0.5 9.7 0.5 0.8 1.0 0.5 0.6 0.4 0.0 0.3 0.7 0.9 27.0 3.0 2.3 2.1 1.5 0.3 0.3 41.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.9 3.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 6.8 5.9 10.6 77.2 10.2 9.7 24.8 8.0 2.8 32.0 0.0 27.0 41.3 0.1 0.0 0.0 49.9 0.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.5 0.2 0.0 0.0 36.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 37.1 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 8.4 0.0 19.8 0.0 36.2 6.8 0.0 0.0 5.3 1.6 0.0 0.0 0.0 0.0 4.2 0.0 0.4 1.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TOP3A "TOP3, ZGRF7" ENSG00000177302 "DNA topoisomerase III alpha" Q13472 17 18271428-18315007 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, Disease variant, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002449 Approved NA NA "CAB002449: AB_564037" "unprognostic (5.49e-2)" "unprognostic (9.04e-2)" "unprognostic (8.99e-2)" "unprognostic (7.24e-3)" "unprognostic (4.01e-2)" "unprognostic (1.95e-2)" "unprognostic (2.33e-3)" "unprognostic (6.54e-2)" "unprognostic (2.34e-1)" "unprognostic (2.74e-1)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (4.59e-4)" "unprognostic (5.58e-2)" "unprognostic (8.80e-2)" "unprognostic (3.53e-2)" "unprognostic (5.05e-2)" "unprognostic (6.05e-2)" 9.0 8.1 1.9 3.3 1.9 5.8 8.7 3.1 2.7 8.5 2.1 7.9 2.4 8.4 1.6 8.6 8.6 2.1 6.0 1.9 1.9 6.3 11.2 7.8 3.6 1.9 1.9 2.0 7.6 7.8 2.7 9.0 2.5 2.3 7.8 2.4 2.1 8.1 1.7 10.1 11.1 8.2 2.7 1.7 11.5 7.7 11.8 2.0 4.2 6.7 2.5 3.4 8.5 7.9 2.2 9.3 14.2 9.4 11.1 3.8 4.6 10.9 9.4 4.9 14.2 12.8 22.4 3.4 13.7 6.0 6.5 6.6 11.7 12.6 6.7 11.5 11.6 11.4 13.1 15.2 7.9 4.3 5.8 11.9 2.9 4.6 15.0 8.7 2.9 7.3 11.5 11.3 5.7 6.1 6.4 15.2 5.9 8.7 13.8 6.8 17.4 22.6 14.8 3.2 8.1 7.7 13.6 12.6 8.3 8.4 24.5 16.1 6.5 6.5 10.6 8.1 18.2 15.4 5.8 13.7 10.4 6.6 8.0 10.5 1.1 3.1 3.4 1.8 2.7 1.3 0.7 1.3 1.6 1.3 0.8 1.1 1.2 4.2 2.2 1.5 1.2 1.2 2.0 1.9 1.9 3.1 2.7 1.9 1.9 1.9 1.9 2.0 2.3 1.7 2.0 2.2 5.3 6.4 4.8 6.5 9.7 2.0 4.5 4.5 6.8 20.8 6.2 3.9 3.1 5.7 7.4 11.0 39.6 7.4 11.8 4.6 3.9 4.2 7.2 5.0 8.7 6.2 0.0 9.9 16.4 3.7 6.9 6.3 6.6 6.3 5.1 12.1 6.4 7.0 5.4 21.9 17.2 4.2 4.1 12.4 6.3 7.9 8.1 11.6 1.8 12.2 13.9 6.4 15.5 11.6 11.2 3.6 2.8 6.4 12.0 5.8 3.8 2.1 6.5 22.2 13.1 9.3 6.6 26.7 25.5 5.2 3.4 4.4 9.0 13.1 5.9 5.0 CASKIN2 "ANKS5B, FLJ21609, KIAA1139" ENSG00000177303 "CASK interacting protein 2" Q8WXE0 17 75500261-75515537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 75.5;Endothelial cells: 42.2;Hepatic stellate cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071906, HPA075184" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA071906: AB_2732191, HPA075184: AB_2732281" "unprognostic (1.60e-1)" "unprognostic (4.54e-2)" "unprognostic (9.12e-3)" "unprognostic (5.27e-3)" "unprognostic (9.32e-2)" "unprognostic (5.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.10e-2)" "unprognostic (7.67e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.47e-5)" "unprognostic (1.82e-2)" "prognostic favorable (4.83e-8)" "unprognostic (1.43e-1)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.95e-2)" 30.3 22.9 16.1 5.0 18.8 0.4 30.2 16.3 18.8 15.0 3.0 14.9 9.1 21.2 2.7 10.8 21.8 11.3 23.6 12.6 13.7 25.2 11.4 42.7 2.9 19.8 18.9 7.9 12.1 10.8 9.4 13.7 11.9 20.1 15.0 2.9 4.8 11.6 8.8 15.5 12.5 11.5 10.5 15.3 31.1 15.1 5.7 16.9 2.9 22.8 10.0 1.5 16.2 14.4 19.8 13.3 17.2 10.2 14.4 6.6 4.1 11.2 6.6 8.7 15.8 10.2 19.0 5.6 0.5 7.4 7.7 10.5 12.0 8.2 7.7 3.9 4.7 10.8 9.4 17.2 7.5 7.7 0.5 12.6 3.5 10.4 8.2 5.9 5.3 16.2 13.3 6.9 1.6 5.0 31.1 24.3 0.7 7.5 10.3 17.5 12.8 21.8 2.1 10.2 13.4 10.4 10.2 13.9 18.7 11.0 8.7 13.7 4.0 13.9 16.1 14.6 7.9 8.7 1.2 5.9 1.5 5.6 0.3 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 18.8 16.3 18.8 12.6 13.7 19.8 18.9 7.9 20.1 15.3 16.9 19.8 75.5 3.2 2.2 11.1 1.3 8.0 2.5 3.5 6.8 6.5 5.8 5.0 11.4 2.8 1.8 9.2 10.4 2.2 0.6 11.7 3.9 5.1 0.5 2.8 4.4 42.2 7.7 8.0 1.3 5.3 1.9 6.0 8.2 5.7 0.0 14.9 56.7 6.8 2.7 3.3 1.7 4.3 8.2 4.1 3.1 2.3 8.1 1.2 1.8 7.5 2.0 28.2 0.0 15.1 8.3 6.0 6.0 11.3 1.6 2.5 8.4 3.1 1.4 6.8 0.0 5.5 6.4 2.7 4.4 4.5 7.0 2.2 0.5 5.7 4.6 2.2 ZBTB38 "CIBZ, FLJ35036, PPP1R171, ZNF921" ENSG00000177311 "Zinc finger and BTB domain containing 38" Q8NAP3 3 141324213-141449792 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 284.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 261.2;RPMI-8226: 395.1;U-266/70: 259.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014865, HPA059378" Enhanced Nucleoplasm No No Nucleoplasm "HPA014865: AB_2732412, HPA059378: AB_2683998" "unprognostic (1.78e-1)" "unprognostic (3.18e-1)" "unprognostic (2.97e-3)" "unprognostic (1.93e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-2)" "unprognostic (4.01e-2)" "unprognostic (7.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.38e-1)" "unprognostic (2.01e-3)" "unprognostic (4.53e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" 27.3 42.7 9.2 30.7 14.3 11.4 25.7 34.7 20.9 48.2 14.6 39.5 29.0 66.1 20.4 27.1 32.6 47.7 42.5 11.1 13.3 34.4 24.4 32.0 34.7 12.6 14.2 7.6 38.5 33.9 53.9 8.4 35.1 14.6 28.3 41.2 39.4 33.3 34.3 55.5 16.8 31.7 56.5 8.7 24.1 29.4 30.3 14.7 14.4 38.3 31.3 39.0 35.3 11.7 28.6 56.4 82.0 9.3 18.7 84.8 79.4 12.5 89.0 106.7 84.6 122.8 43.0 32.4 1.9 36.1 78.1 65.7 15.5 10.8 75.4 191.5 54.5 15.2 15.8 74.4 25.2 94.0 1.0 22.4 60.1 43.8 89.9 180.6 137.8 65.6 1.5 16.9 261.2 96.9 6.0 1.0 3.5 9.7 15.7 10.1 1.1 27.5 395.1 54.3 34.3 3.6 13.7 130.7 12.4 46.0 16.4 26.8 13.8 159.5 68.5 17.5 134.9 42.2 259.7 163.4 19.8 116.7 1.8 38.5 27.9 5.5 15.2 25.9 8.2 19.3 16.6 16.7 26.4 8.1 7.2 12.9 21.0 6.3 24.1 7.2 3.9 24.4 11.5 9.2 14.3 34.7 20.9 11.1 13.3 12.6 14.2 7.6 14.6 8.7 14.7 28.6 70.7 76.9 64.6 38.2 48.0 20.4 33.8 36.3 24.5 89.8 44.0 41.1 114.8 64.3 61.2 58.8 75.0 32.6 66.5 57.8 29.4 39.3 284.2 63.4 107.9 81.2 36.0 17.7 115.4 31.8 17.0 59.3 35.2 125.9 68.9 40.0 59.3 34.9 32.6 141.3 107.9 37.0 24.4 23.4 43.1 118.6 70.5 37.9 39.2 65.6 70.8 59.3 55.6 56.8 105.3 69.6 37.0 103.0 221.9 36.8 38.9 51.1 46.6 73.3 118.3 71.9 106.9 9.4 11.4 19.0 18.6 124.9 88.4 35.6 82.5 43.5 BEND2 "CXorf20, MGC33653" ENSG00000177324 "BEN domain containing 2" Q8NDZ0 X 18162931-18220886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 5.4" "Cell type enhanced" "Detected in some" "Leydig cells: 18.6;Peritubular cells: 13.2;Spermatocytes: 84.5;Spermatogonia: 29.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "basophil: 2.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 2.9" "Not detected" "Not detected" "HPA009420, HPA013142" Enhanced NA NA "HPA009420: AB_2064489, HPA013142: AB_2668784" "unprognostic (2.23e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.0 0.1 0.0 1.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 1.3 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 18.6 5.7 0.0 0.0 0.7 0.0 1.0 0.0 0.1 0.0 0.0 13.2 0.0 0.6 0.0 0.0 0.7 0.0 6.6 0.3 0.2 84.5 29.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 CCDC71 FLJ12800 ENSG00000177352 "Coiled-coil domain containing 71" Q8IV32 3 49162535-49166331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047547 Uncertain Approved "Nuclear membrane" No No "Nuclear membrane" "HPA047547: AB_2680083" "unprognostic (1.06e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-3)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (3.68e-2)" "unprognostic (6.71e-3)" "unprognostic (7.20e-3)" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (9.03e-3)" "unprognostic (7.20e-2)" "prognostic favorable (9.65e-9)" "unprognostic (3.53e-2)" "unprognostic (1.53e-1)" "unprognostic (2.00e-2)" "unprognostic (7.14e-2)" 12.4 15.5 4.5 9.7 4.8 7.3 14.6 4.8 6.2 13.7 4.1 9.3 8.3 15.0 9.7 13.9 16.5 9.2 12.3 4.4 4.9 10.1 12.7 11.2 13.6 4.7 4.7 4.1 18.4 9.6 13.7 9.7 10.1 4.9 12.1 7.7 3.4 12.6 10.6 14.9 13.1 10.8 10.1 4.7 13.4 10.6 12.3 4.4 13.2 16.3 9.6 9.5 13.0 12.0 4.9 12.6 16.9 19.4 18.8 21.8 15.8 18.6 15.2 21.8 26.1 22.9 17.6 19.8 11.2 13.0 26.2 20.9 13.0 19.3 40.7 9.3 24.9 14.0 22.7 22.0 17.9 25.7 18.3 16.5 26.9 31.4 31.0 23.7 19.4 25.8 26.7 23.1 4.6 21.1 26.9 31.8 11.2 30.2 18.8 18.1 11.5 10.8 10.5 24.8 24.0 9.8 21.3 15.5 16.3 18.5 15.6 21.7 30.2 17.1 18.3 19.4 18.3 20.0 17.5 8.2 15.6 13.3 17.2 20.7 0.0 1.0 0.4 0.9 1.7 1.4 0.5 0.8 1.2 0.9 1.3 1.2 0.8 0.9 4.8 1.3 0.3 1.0 0.6 4.5 4.8 4.8 6.2 4.4 4.9 4.7 4.7 4.1 4.9 4.7 4.4 4.9 5.1 6.4 1.5 1.6 7.9 2.7 12.5 23.8 6.8 1.5 7.5 8.5 1.4 5.7 11.2 7.3 0.0 23.3 4.1 8.3 25.4 21.3 9.3 2.4 3.5 8.0 8.4 11.8 2.1 11.8 16.5 7.7 7.1 1.8 2.5 6.5 16.1 9.3 20.1 0.0 2.0 8.4 24.4 5.6 2.1 10.2 11.8 5.3 5.4 6.5 8.8 3.6 12.3 1.0 1.0 15.2 9.3 13.5 9.3 10.8 10.4 14.1 7.1 1.2 13.1 4.1 7.0 10.6 18.4 9.2 2.7 22.4 5.8 6.6 8.2 11.5 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299170-49327492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 282.8;tongue: 82.7" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 56.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "K-562: 6.9;RH-30: 9.9" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA057556: AB_2683467" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 44.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 22.1 0.0 0.0 0.1 1.3 0.0 0.0 1.2 0.0 282.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686406-62689530 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4" "Low region specificity" "Detected in many" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 23.3 6.7 0.4 2.5 0.4 0.5 16.2 1.4 1.3 21.6 2.3 12.6 1.9 30.0 3.8 4.5 18.4 3.6 6.3 0.6 1.0 1.0 0.1 3.5 0.5 0.4 0.3 0.3 21.2 1.1 0.3 1.7 0.7 0.5 6.1 2.1 0.4 5.5 5.8 4.8 9.1 7.3 9.2 0.2 0.2 8.3 1.5 0.4 0.4 4.2 5.7 0.3 9.8 16.2 0.6 0.0 0.1 0.2 0.3 7.7 25.3 0.3 2.8 4.0 0.3 1.4 0.2 0.1 0.2 0.3 4.6 0.1 0.3 0.1 0.0 0.4 0.2 0.2 0.5 0.2 0.2 19.8 0.2 0.2 10.6 0.1 0.6 0.0 0.2 0.1 0.4 0.3 0.1 13.4 0.1 0.3 0.6 0.6 0.1 0.1 0.1 1.7 0.3 0.0 0.2 0.8 0.3 0.4 0.3 0.8 0.1 0.2 0.3 0.3 2.4 0.2 2.7 0.1 0.2 0.2 0.3 1.5 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.0 0.4 0.4 1.4 1.3 0.6 1.0 0.4 0.3 0.3 0.5 0.2 0.4 0.6 4.0 0.0 1.8 0.0 0.1 6.6 2.1 0.0 0.0 2.1 0.5 0.8 1.5 0.0 0.6 0.0 2.1 0.1 0.2 0.0 0.0 0.0 1.0 0.5 11.0 3.7 1.2 0.0 0.1 0.0 0.2 62.1 0.5 0.4 1.3 0.2 1.4 0.1 0.4 1.7 0.3 0.3 0.0 0.6 8.3 0.5 27.1 1.1 33.8 1.9 0.1 0.2 1.0 0.0 0.1 0.0 0.1 17.3 0.4 1.4 0.1 0.3 0.0 1.0 0.0 33.0 2.8 0.4 0.3 0.5 7.0 0.1 1.1 1.2 0.1 1.3 TIMM22 "TEX4, TIM22" ENSG00000177370 "Translocase of inner mitochondrial membrane 22" Q9Y584 17 997129-1003671 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 40 "basophil: 4.0" "Lineage enriched" "Detected in single" 40 "granulocytes: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045138 Uncertain NA NA "HPA045138: AB_10962055" "unprognostic (2.69e-1)" "unprognostic (3.42e-1)" "unprognostic (2.57e-1)" "unprognostic (8.69e-3)" "unprognostic (3.00e-2)" "unprognostic (2.75e-2)" "unprognostic (2.16e-2)" "unprognostic (9.36e-2)" "unprognostic (2.37e-1)" "unprognostic (1.80e-1)" "prognostic favorable (3.42e-4)" "unprognostic (1.27e-1)" "prognostic favorable (1.41e-4)" "unprognostic (2.45e-1)" "unprognostic (3.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.70e-3)" 7.7 10.0 6.2 3.9 6.9 6.8 7.6 9.0 8.6 6.6 7.7 8.0 2.8 7.6 8.9 8.9 6.4 1.6 13.5 6.1 9.1 9.1 6.4 6.3 3.8 7.2 6.7 5.8 7.4 7.1 10.4 9.1 7.0 7.3 7.1 4.4 4.5 7.2 1.8 12.4 8.5 6.2 5.3 6.7 7.3 8.5 7.0 6.7 6.3 6.7 12.3 6.0 8.0 6.8 7.8 3.9 0.2 13.0 12.6 19.0 8.8 4.0 12.8 8.5 10.6 13.1 8.4 4.8 4.7 2.5 21.2 9.1 3.6 26.0 14.2 21.0 0.0 0.0 9.5 1.8 0.1 18.6 5.6 1.5 11.3 9.0 13.4 20.6 10.6 17.2 0.3 1.8 13.1 12.9 0.0 17.2 6.6 9.0 11.5 17.0 8.9 6.5 6.5 17.1 0.2 4.6 10.7 4.9 5.3 10.3 12.3 8.1 10.0 18.7 12.5 9.5 10.2 15.7 2.9 0.0 4.2 10.2 8.6 12.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 6.9 9.0 8.6 6.1 9.1 7.2 6.7 5.8 7.3 6.7 6.7 7.8 20.2 3.2 15.9 2.0 21.7 43.6 10.7 31.5 17.1 26.4 21.4 18.5 25.3 18.6 17.8 7.3 33.3 62.8 16.3 11.8 37.2 36.2 5.9 14.9 21.2 28.2 20.4 16.8 6.9 28.2 60.8 26.9 17.3 15.8 3.8 27.1 13.9 12.1 40.4 26.9 7.1 11.9 30.5 9.7 18.9 9.7 20.2 14.6 16.0 7.5 26.9 19.1 24.7 4.0 2.8 29.0 8.6 21.4 13.2 17.0 14.2 26.7 10.2 43.7 13.1 17.4 21.4 42.7 47.2 19.5 54.1 61.6 19.0 42.7 16.8 12.9 HIC1 "ZBTB29, ZNF901" ENSG00000177374 "HIC ZBTB transcriptional repressor 1" Q14526 17 2054154-2063241 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 38.6;Fibroblasts: 44.3;Leydig cells: 57.5;Peritubular cells: 48.2;Sertoli cells: 46.0;Smooth muscle cells: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.9" "Lineage enhanced" "Detected in single" "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.9;BJ: 11.9;HSkMC: 7.1;TIME: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043372 Uncertain NA NA "HPA043372: AB_10795614" "unprognostic (1.93e-1)" "unprognostic (9.27e-2)" "unprognostic (6.63e-2)" "unprognostic (4.27e-3)" "unprognostic (2.06e-1)" "unprognostic (1.87e-2)" "unprognostic (3.08e-1)" "unprognostic (6.45e-2)" "unprognostic (8.58e-2)" "unprognostic (2.06e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (9.36e-6)" "unprognostic (2.20e-2)" "unprognostic (3.92e-2)" "unprognostic (1.00e-1)" "unprognostic (5.14e-2)" 21.1 8.7 7.5 5.7 3.5 1.3 16.7 3.0 3.7 21.5 2.4 13.8 6.6 27.2 1.5 5.8 21.7 4.4 22.6 2.8 4.5 12.4 5.9 15.3 2.1 5.2 3.6 1.1 30.2 3.8 0.9 19.8 1.4 4.5 20.2 1.7 0.5 5.2 4.5 8.6 4.9 11.8 3.2 3.4 9.0 9.9 5.0 5.8 2.3 12.7 1.2 0.5 18.0 14.0 9.1 0.6 0.7 0.8 0.6 4.7 6.9 1.4 11.9 6.4 1.6 2.3 0.6 0.3 0.1 0.2 6.2 0.6 1.1 0.7 0.2 0.5 0.4 1.5 0.3 0.8 0.3 4.0 0.2 0.5 7.1 0.8 2.4 0.1 3.3 6.2 0.6 1.8 2.8 0.4 0.0 0.1 0.4 0.2 0.0 0.4 0.7 0.3 0.3 0.2 0.4 0.4 0.7 0.2 0.1 0.0 0.2 0.0 0.1 12.4 4.3 0.1 4.2 6.2 0.4 0.4 0.2 0.4 0.4 1.1 0.0 0.0 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.5 3.5 3.0 3.7 2.8 4.5 5.2 3.6 1.1 4.5 3.4 5.8 9.1 25.6 0.0 1.8 1.0 3.9 4.0 2.1 1.5 1.2 2.1 1.9 1.8 5.8 0.0 1.0 1.8 0.0 0.1 19.2 0.1 0.0 0.5 0.5 2.0 38.6 26.9 1.8 0.4 0.2 1.1 0.7 44.3 1.1 1.6 2.5 0.2 23.9 0.3 0.5 0.0 0.3 0.1 2.0 8.5 6.0 1.6 57.5 15.5 3.6 6.5 0.2 0.3 12.3 0.0 0.0 0.2 0.1 48.2 2.3 1.1 0.2 0.1 1.0 1.6 46.0 12.5 30.1 0.8 2.9 1.1 4.1 0.1 13.0 13.3 0.0 2.6 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119544-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8;pituitary gland: 45.3;skin 1: 39.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 40.8;Horizontal cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center, Vesicles" "HPA043567: AB_2678558, HPA050340: AB_2681096" "prognostic unfavorable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favorable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favorable (6.46e-7)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 1.8 4.5 13.1 0.8 18.4 0.2 2.7 11.0 28.8 3.0 0.0 4.5 3.1 2.2 0.3 14.2 1.9 0.6 3.0 18.0 10.9 2.7 2.7 2.9 0.8 10.8 9.3 19.3 1.3 4.7 2.1 45.3 0.4 12.4 5.7 1.0 3.7 5.3 0.6 1.4 39.9 3.7 0.4 1.7 2.2 2.4 4.2 12.0 2.4 2.8 0.2 1.2 1.4 8.2 16.7 3.3 3.3 3.3 8.0 0.1 0.0 6.0 0.4 0.4 1.5 2.2 2.2 1.3 7.3 4.3 0.4 2.4 1.7 5.0 0.7 0.4 7.9 10.8 4.6 3.5 1.7 0.4 1.9 11.4 0.4 1.8 1.0 0.5 0.7 0.0 12.1 9.0 11.2 0.1 14.2 2.3 3.2 1.4 23.1 36.1 7.6 6.5 3.6 0.5 1.6 7.2 9.5 1.3 29.7 3.3 0.0 16.5 4.4 0.7 1.7 6.1 1.1 0.2 21.0 18.2 5.4 1.7 7.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 18.4 11.0 28.8 18.0 10.9 10.8 9.3 19.3 12.4 1.7 12.0 16.7 15.7 0.0 0.6 8.5 0.8 7.1 8.0 3.5 11.4 40.8 10.4 6.1 4.2 8.6 3.0 5.5 14.6 0.5 3.6 19.3 19.6 2.7 1.2 1.3 3.6 15.2 26.5 2.7 19.9 4.4 2.1 3.4 3.6 2.4 0.0 2.7 23.2 8.6 2.5 43.7 21.5 26.3 8.2 2.2 2.4 1.7 5.6 2.7 16.0 2.8 0.0 16.2 0.0 10.6 2.7 1.9 13.7 3.8 1.2 18.2 15.0 4.6 0.9 17.9 0.0 0.6 5.5 2.5 5.9 8.7 11.8 0.5 0.7 13.2 20.4 6.3 MAGEF1 ENSG00000177383 "MAGE family member F1" Q9HAY2 3 184710364-184712064 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046899, HPA054190" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA046899: AB_2679859, HPA054190: AB_2682411" "unprognostic (7.36e-3)" "unprognostic (3.79e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.46e-3)" "unprognostic (2.34e-3)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (2.80e-3)" "unprognostic (1.82e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.59e-4)" "unprognostic (7.65e-2)" "unprognostic (8.97e-2)" "unprognostic (3.15e-3)" "unprognostic (1.19e-1)" 15.1 27.1 29.5 16.5 30.3 2.7 24.3 30.6 33.6 31.7 30.4 26.0 17.6 32.7 36.2 20.9 26.3 15.7 23.9 29.7 35.4 25.9 25.7 20.4 21.4 29.1 29.5 28.8 27.6 29.5 35.8 56.7 23.3 30.9 30.6 17.3 27.2 26.2 27.0 32.9 21.2 20.5 19.3 29.6 19.3 27.2 12.4 31.0 21.9 29.9 21.9 17.8 27.6 21.8 32.8 86.3 22.3 89.8 56.1 32.0 12.9 61.8 32.1 34.9 53.2 53.3 54.8 31.3 59.1 65.2 29.2 88.1 60.0 46.2 27.7 49.0 96.2 65.1 17.3 32.9 77.4 31.5 27.4 27.4 29.7 34.4 33.9 10.7 25.4 13.0 19.3 30.3 40.0 31.5 108.8 10.4 60.8 56.9 54.6 38.4 29.9 72.6 18.4 39.5 56.4 99.0 94.6 49.5 83.1 77.4 50.0 132.4 10.1 9.1 35.0 61.6 41.1 62.9 82.9 65.6 78.7 27.6 9.8 46.3 0.1 1.4 2.5 1.6 0.3 0.6 2.8 2.2 1.8 5.7 4.7 6.1 3.1 0.2 1.2 0.2 0.4 2.3 0.9 29.5 30.3 30.6 33.6 29.7 35.4 29.1 29.5 28.8 30.9 29.6 31.0 32.8 6.5 32.1 25.8 10.4 22.1 18.7 52.7 56.9 30.1 60.3 37.5 33.7 19.2 48.6 33.0 42.3 10.4 103.2 6.0 9.2 146.8 54.3 1.2 27.0 22.3 16.0 49.3 13.2 14.6 41.3 56.4 37.3 27.5 19.0 5.7 36.1 20.3 26.2 68.6 63.9 15.1 46.1 71.2 8.1 36.3 3.9 55.3 10.1 24.9 6.5 32.3 67.3 20.6 13.6 12.6 30.0 22.4 57.2 26.5 44.3 11.2 64.8 30.1 49.2 32.9 30.7 33.4 21.3 8.9 29.6 13.8 60.5 11.4 56.8 32.5 72.3 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;fallopian tube: 1.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.4;Early spermatids: 4.3;Endometrial ciliated cells: 3.9;Ionocytes: 2.0;Late spermatids: 2.4;Spermatocytes: 2.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 1.6;U-266/70: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA067245 Uncertain NA NA "HPA067245: AB_2685810" "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 3.9 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 2.0 0.0 0.0 2.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.1 SAMD9L "C7orf6, FLJ39885, KIAA2005" ENSG00000177409 "Sterile alpha motif domain containing 9 like" Q8IVG5 7 93130056-93148385 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.6" "Cell type enhanced" "Detected in many" "monocytes: 64.8;NK-cells: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 54.0;GAMG: 44.1;HDLM-2: 51.2;Karpas-707: 131.4" "Low region specificity" "Detected in all" "HPA019461, HPA019465, HPA019488" Enhanced Approved Cytosol NA NA Cytosol "HPA019461: AB_1856555, HPA019465: AB_2183384, HPA019488: AB_1856557" "unprognostic (6.93e-3)" "unprognostic (6.12e-2)" "unprognostic (5.00e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (5.03e-2)" "unprognostic (7.10e-2)" "unprognostic (4.21e-2)" "unprognostic (2.32e-1)" "unprognostic (6.18e-3)" "unprognostic (1.05e-3)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (1.36e-1)" "unprognostic (2.07e-2)" "unprognostic (1.85e-2)" "unprognostic (1.22e-1)" 10.3 6.1 4.2 24.6 5.0 10.1 7.6 3.5 4.5 7.3 4.1 10.6 11.6 7.4 4.5 6.4 6.6 14.0 6.2 3.4 6.4 6.0 6.1 22.1 27.4 6.8 3.7 2.3 9.2 3.3 1.9 3.9 12.7 5.2 4.3 11.6 2.4 13.0 4.2 2.9 4.1 11.8 9.1 5.1 38.6 14.5 2.9 5.2 23.1 6.8 4.7 16.3 12.0 6.3 11.0 7.2 0.4 0.0 0.4 9.3 18.7 0.2 6.2 25.7 34.5 54.0 0.0 15.9 4.7 7.7 16.7 44.1 3.1 0.0 2.2 5.5 51.2 0.0 4.3 1.9 0.0 7.5 9.6 7.0 7.2 0.8 6.9 1.0 6.4 15.1 7.1 0.0 131.4 14.6 0.0 15.3 8.5 0.5 0.0 1.8 6.3 2.2 11.0 1.8 0.6 0.0 0.3 1.3 0.2 9.8 0.1 0.4 5.0 35.8 10.1 2.2 29.6 3.8 36.4 13.0 1.3 10.6 8.6 10.1 30.1 6.7 16.7 13.4 13.3 11.6 15.1 7.4 10.0 6.3 10.3 4.3 7.7 29.2 8.2 12.8 4.7 11.8 4.0 4.2 5.0 3.5 4.5 3.4 6.4 6.8 3.7 2.3 5.2 5.1 5.2 11.0 37.4 35.3 11.2 15.7 28.5 2.3 2.3 6.0 4.6 0.0 8.0 5.5 1.8 2.8 9.6 11.0 0.0 0.3 34.2 18.8 9.8 12.7 0.1 4.9 16.3 28.0 1.2 10.1 0.2 5.7 1.0 14.3 20.4 2.4 34.2 12.2 27.5 0.4 24.4 0.0 0.1 12.6 6.1 20.4 12.9 1.1 9.6 36.5 7.2 44.0 64.8 14.1 91.6 0.0 0.2 16.2 50.2 11.7 28.1 3.1 5.1 4.2 18.6 0.4 6.6 15.0 7.7 0.3 0.2 4.1 2.3 0.1 34.0 12.2 4.1 8.0 UBE2U MGC35130 ENSG00000177414 "Ubiquitin conjugating enzyme E2 U" Q5VVX9 1 64203627-64267368 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 45.1" "Group enriched" "Detected in some" 4 "Early spermatids: 154.3;Late spermatids: 214.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.1" NA NA "unprognostic (9.44e-4)" "unprognostic (5.52e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-1)" "unprognostic (4.01e-2)" "unprognostic (3.63e-1)" "unprognostic (7.69e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 2.4 45.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 1.2 154.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 214.5 1.8 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.5 0.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 40.9 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 PAWR "par-4, PAR4" ENSG00000177425 "Pro-apoptotic WT1 regulator" Q96IZ0 12 79574979-79690964 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.7;naive B-cell: 2.8;NK-cell: 1.4" "Group enriched" "Detected in many" 5 "B-cells: 2.8;NK-cells: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012640, CAB020779" Approved Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "CAB020779: , HPA012640: AB_1855748" "unprognostic (2.42e-1)" "unprognostic (5.58e-2)" "unprognostic (9.77e-3)" "unprognostic (5.39e-2)" "unprognostic (9.44e-3)" "unprognostic (4.21e-3)" "unprognostic (9.21e-2)" "unprognostic (1.37e-1)" "unprognostic (4.78e-1)" "unprognostic (3.03e-1)" "unprognostic (2.42e-3)" "unprognostic (4.97e-3)" "unprognostic (2.22e-2)" "unprognostic (2.58e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-1)" "unprognostic (4.23e-2)" 11.1 6.2 7.0 9.0 7.8 3.2 13.5 6.9 5.0 20.2 20.0 16.9 11.9 28.2 16.1 14.4 24.9 8.5 4.6 4.9 10.3 12.6 13.4 11.7 6.9 7.4 11.4 2.0 20.5 11.7 13.4 8.8 6.3 6.9 15.1 15.4 0.7 14.4 22.0 1.7 16.6 12.2 16.9 5.9 6.3 13.7 11.0 12.4 4.4 16.4 1.9 6.6 16.3 16.6 5.9 54.5 49.1 8.8 0.3 4.4 1.9 58.6 34.1 9.9 17.0 10.3 61.5 20.2 36.2 61.2 19.0 12.2 59.2 31.0 25.7 24.3 14.7 42.2 0.0 28.7 27.1 23.6 0.5 1.0 4.1 53.4 13.4 76.0 63.0 28.7 14.8 2.1 4.9 18.8 41.0 8.8 0.2 42.6 15.7 27.7 0.0 20.2 23.5 32.4 40.4 25.4 0.1 60.8 31.8 5.7 29.4 28.5 0.3 43.2 25.4 22.8 0.9 23.1 15.3 21.6 26.8 4.2 0.1 11.2 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.1 0.2 2.8 0.2 0.2 0.2 1.4 0.0 0.1 0.0 0.0 7.0 7.8 6.9 5.0 4.9 10.3 7.4 11.4 2.0 6.9 5.9 12.4 5.9 51.3 80.1 40.7 16.6 33.1 200.1 170.3 42.0 63.2 6.4 93.6 77.3 21.0 60.1 59.2 66.2 0.0 57.1 4.6 103.9 17.6 57.3 62.6 75.7 50.9 31.0 68.8 4.6 1.5 38.5 81.4 41.7 32.1 157.5 1.3 87.4 13.6 54.5 6.5 16.8 50.9 120.9 32.6 1.6 19.2 96.3 84.8 5.3 17.8 23.4 0.4 2.5 4.1 30.7 0.9 83.2 72.0 91.0 11.4 273.4 44.3 47.2 49.9 1.4 85.5 18.3 109.7 98.4 62.1 76.6 179.6 76.9 6.7 62.9 92.7 169.5 TGIF1 "HPE4, TGIF" ENSG00000177426 "TGFB induced factor homeobox 1" Q15583 18 3411608-3459978 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 783.4;Basal respiratory cells: 419.8;Basal squamous epithelial cells: 483.2;Urothelial cells: 426.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062160 Supported Nucleoplasm NA Yes Nucleoplasm "HPA062160: AB_2684701" "unprognostic (1.11e-2)" "unprognostic (5.20e-2)" "unprognostic (2.40e-1)" "unprognostic (1.97e-1)" "unprognostic (3.57e-3)" "unprognostic (3.10e-2)" "unprognostic (2.75e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-2)" "unprognostic (1.96e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (9.60e-2)" "unprognostic (1.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.60e-1)" "unprognostic (7.07e-2)" "unprognostic (2.48e-3)" 46.9 40.4 21.8 43.7 20.5 41.9 58.1 22.8 25.9 69.5 27.7 52.0 31.9 51.7 134.9 47.1 75.4 65.8 27.2 19.5 84.1 53.5 62.0 48.0 26.6 29.1 23.1 15.3 67.9 47.3 27.1 22.2 64.4 23.4 55.1 66.3 8.1 57.0 56.6 34.7 56.6 38.2 37.8 28.1 35.8 49.5 26.1 24.4 40.4 67.3 27.2 27.2 113.2 40.3 27.6 33.6 148.5 92.7 29.3 90.0 121.7 235.7 63.1 236.6 49.9 62.1 61.0 142.6 1.9 20.9 49.8 165.7 33.7 35.0 73.8 61.6 13.9 16.8 4.3 73.2 110.5 178.8 47.6 38.3 89.5 291.7 89.7 233.7 131.3 104.4 22.3 36.0 0.4 95.6 65.8 31.1 58.8 240.8 119.0 34.8 32.8 43.2 10.3 198.1 156.7 27.1 26.5 166.2 123.0 92.5 151.3 28.1 43.7 49.6 77.5 65.6 92.7 41.1 5.0 0.6 15.7 78.5 18.6 98.2 65.4 42.8 7.6 62.9 16.6 67.8 46.5 52.5 61.9 35.1 32.2 37.1 43.5 19.8 21.5 16.7 3.3 32.1 36.3 21.8 20.5 22.8 25.9 19.5 84.1 29.1 23.1 15.3 23.4 28.1 24.4 27.6 41.0 35.3 40.2 8.1 106.5 359.6 783.4 419.8 483.2 0.0 114.1 72.1 5.6 100.1 128.3 123.2 0.0 161.6 60.1 30.0 49.0 117.1 41.5 167.2 58.5 66.6 46.4 25.7 2.7 75.0 220.9 102.8 79.0 240.2 68.0 71.5 29.3 35.7 71.8 1.7 0.6 99.4 136.3 44.9 221.1 9.7 28.6 126.8 76.5 7.5 71.9 6.7 11.3 4.0 1.7 106.0 53.0 15.4 15.1 308.1 24.9 113.1 93.3 0.1 32.9 90.9 86.6 7.9 15.4 223.9 257.1 150.4 103.7 8.0 91.8 426.2 MIEF2 "MGC23130, MiD49, SMCR7" ENSG00000177427 "Mitochondrial elongation factor 2" Q96C03 17 18260597-18266552 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042334 Uncertain NA NA "HPA042334: AB_10794418" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (7.56e-3)" "unprognostic (1.30e-1)" "unprognostic (8.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-2)" "prognostic favorable (1.75e-7)" "unprognostic (4.68e-2)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" 4.2 10.0 3.7 1.5 3.7 1.6 6.0 4.8 4.2 8.8 3.8 6.3 3.6 7.7 4.1 11.5 8.3 2.1 13.9 3.5 3.2 10.8 6.6 5.7 2.4 4.5 3.2 4.2 10.3 7.7 6.0 10.6 2.4 3.8 7.9 1.5 2.1 10.7 3.3 24.8 9.5 5.8 1.9 3.0 5.7 6.6 5.0 3.7 1.9 9.9 12.1 1.7 6.2 8.1 4.0 24.0 7.0 2.5 5.5 1.8 2.1 4.4 8.1 4.7 6.6 3.3 9.8 7.4 3.4 8.6 4.0 3.1 17.4 1.8 6.1 3.3 3.3 10.6 1.2 12.0 4.6 3.3 0.6 2.9 2.0 6.3 3.3 2.3 5.4 2.8 4.6 2.9 0.9 2.5 6.8 3.0 2.3 2.1 5.6 3.4 4.2 7.4 4.5 9.2 4.4 1.9 4.3 6.0 7.4 3.4 16.0 18.0 2.1 3.4 4.6 7.5 7.3 3.7 3.6 2.3 1.0 6.6 1.2 2.5 1.6 1.9 6.4 3.5 1.8 3.3 2.1 2.8 2.9 2.0 3.3 3.2 3.4 3.2 7.7 4.7 3.0 3.7 2.1 3.7 3.7 4.8 4.2 3.5 3.2 4.5 3.2 4.2 3.8 3.0 3.7 4.0 2.9 16.0 6.0 2.6 4.6 1.9 3.9 6.8 2.8 16.9 5.2 5.5 16.2 1.5 5.6 11.0 16.7 12.0 3.4 6.4 9.8 15.1 14.6 11.4 2.7 4.0 4.2 2.5 2.5 6.0 5.5 4.6 1.5 8.4 2.5 7.0 3.9 3.8 4.1 38.7 3.7 5.4 6.1 2.5 1.1 2.3 8.1 1.6 0.0 1.0 1.9 11.2 6.2 1.5 1.4 21.8 8.6 10.1 3.4 4.2 5.8 5.6 12.5 20.6 6.6 5.2 5.5 2.0 3.8 2.1 1.7 7.7 2.8 10.6 4.6 2.9 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695913-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.5" "Cell type enhanced" "Detected in many" "Muller glia cells: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SH-SY5Y: 49.6" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058227: AB_2683644" "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 9.4 28.0 38.6 4.6 40.0 7.3 6.0 28.1 58.4 7.1 15.7 4.7 2.1 7.9 13.0 4.8 5.8 6.7 7.3 35.6 63.7 7.6 6.2 3.6 3.8 42.8 49.1 35.8 9.9 3.3 9.1 23.2 6.0 50.0 8.2 3.5 21.2 2.8 10.5 2.9 2.1 2.9 8.1 28.3 4.4 3.9 6.2 43.0 3.8 11.8 4.0 2.8 7.7 3.5 77.5 0.0 1.9 12.4 7.6 17.7 11.3 0.0 13.5 8.2 6.8 10.5 0.0 1.6 0.0 5.4 7.9 3.0 2.6 22.2 5.4 12.2 4.3 0.0 23.8 7.9 1.9 15.4 12.4 15.0 18.0 1.7 8.0 1.2 8.7 12.2 13.1 6.8 0.1 20.1 0.2 15.3 0.9 5.1 6.6 0.0 8.2 3.6 1.4 4.5 5.7 16.4 49.6 0.0 2.4 10.4 13.2 0.0 3.5 8.8 7.7 1.9 4.9 6.8 3.4 0.0 0.0 16.4 0.0 6.1 0.0 0.1 0.1 1.4 0.1 0.9 0.0 0.6 1.0 0.3 0.2 1.2 1.1 0.2 0.5 0.3 0.3 0.7 0.3 38.6 40.0 28.1 58.4 35.6 63.7 42.8 49.1 35.8 50.0 28.3 43.0 77.5 6.4 3.2 6.7 8.5 4.2 1.8 3.8 2.2 5.2 32.4 3.0 5.2 5.3 1.5 4.7 5.5 14.6 16.0 12.2 0.6 15.6 1.8 1.0 2.8 13.0 7.2 17.3 10.5 21.2 2.6 2.2 12.8 4.6 3.3 31.1 5.6 16.8 3.0 5.6 15.2 30.8 2.2 2.0 0.9 3.1 0.7 10.8 2.9 5.4 3.7 1.8 36.8 8.2 5.5 7.6 1.0 1.3 18.0 4.3 2.0 0.1 5.9 1.4 16.1 19.7 9.2 14.5 8.6 3.0 2.2 1.4 22.2 9.0 16.3 0.9 2.2 NIM1K "MGC42105, NIM1" ENSG00000177453 "NIM1 serine/threonine protein kinase" Q8IY84 5 43192071-43280850 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 13.8;choroid plexus: 7.4;pituitary gland: 6.6;retina: 10.4" "Cell type enhanced" "Detected in some" "Astrocytes: 29.7;Excitatory neurons: 56.0;Horizontal cells: 18.5;Inhibitory neurons: 44.2;Oligodendrocyte precursor cells: 43.7;Oligodendrocytes: 20.3" "Cancer enriched" "Detected in some" 11 "glioma: 6.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HDLM-2: 2.3;PC-3: 2.5;U-87 MG: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007695 Approved Cytosol NA NA Cytosol "HPA007695: AB_2667897" "unprognostic (7.97e-2)" "unprognostic (9.79e-2)" "unprognostic (8.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (4.35e-2)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (8.84e-4)" "unprognostic (1.25e-1)" "unprognostic (1.55e-5)" "unprognostic (2.18e-1)" "unprognostic (2.66e-1)" "unprognostic (6.46e-3)" "unprognostic (4.98e-3)" 0.4 1.2 11.3 0.4 12.2 0.0 0.4 8.8 13.8 0.8 7.4 1.3 0.1 0.2 0.3 0.4 0.5 0.3 0.5 11.9 12.0 0.3 0.3 1.3 0.2 9.7 10.4 11.8 0.2 0.3 1.2 6.6 0.4 9.6 0.8 0.4 10.4 0.8 0.6 0.8 0.5 0.5 0.2 9.3 0.2 1.2 0.5 10.6 0.2 0.9 0.6 0.1 0.6 0.8 11.7 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.4 1.5 0.5 2.0 0.0 0.0 0.2 0.2 0.4 0.7 0.1 0.3 0.0 1.2 2.3 0.1 0.0 0.3 0.0 0.7 0.1 0.3 0.8 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 2.5 0.1 0.1 0.2 0.0 0.3 0.4 0.0 0.8 0.2 0.1 0.1 0.2 0.7 0.0 0.4 0.3 0.3 0.3 0.7 0.2 0.1 2.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 11.3 12.2 8.8 13.8 11.9 12.0 9.7 10.4 11.8 9.6 9.3 10.6 11.7 0.4 0.0 4.4 29.7 0.0 0.5 0.1 0.4 1.8 7.6 0.1 0.0 0.3 0.0 0.1 0.0 6.2 0.1 0.1 0.0 0.0 0.0 1.3 0.0 1.0 0.2 0.0 0.0 56.0 0.0 1.4 1.0 0.5 0.3 0.0 0.1 0.0 0.1 0.1 18.5 44.2 0.0 0.0 0.3 0.0 1.8 0.0 0.2 0.0 1.0 0.6 9.9 0.0 43.7 20.3 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 6.6 0.0 1.2 0.6 0.4 0.4 0.2 0.4 0.0 0.4 0.4 0.0 0.1 CD19 ENSG00000177455 "CD19 molecule" P15391 16 28931965-28939342 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 33.3;lymphoid tissue: 75.9" "Cell type enhanced" "Detected in some" "B-cells: 135.3;Early spermatids: 38.2;Plasma cells: 30.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 80 "memory B-cell: 138.2;naive B-cell: 172.1" "Lineage enriched" "Detected in many" 89 "B-cells: 172.1" "Cell line enhanced" "Detected in some" "Daudi: 143.3;REH: 77.1;U-698: 33.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB016110 Enhanced NA NA "CAB016110: AB_626952" "unprognostic (3.27e-3)" "unprognostic (1.19e-3)" "unprognostic (6.63e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-3)" "unprognostic (3.11e-5)" "unprognostic (2.61e-1)" "unprognostic (6.96e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (5.41e-6)" "unprognostic (2.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (2.07e-1)" 0.6 0.1 0.0 28.8 0.1 6.3 0.1 0.9 0.4 0.1 0.0 1.9 0.9 0.2 0.1 0.9 0.2 0.9 0.1 0.1 0.7 0.6 0.3 0.5 72.7 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 1.6 0.1 1.2 0.1 0.0 0.0 33.3 0.2 0.0 73.3 3.9 3.9 0.1 5.8 1.2 0.0 75.9 2.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 77.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 33.0 0.0 0.1 0.0 1.9 0.2 0.2 0.0 0.3 0.0 138.2 0.1 0.0 0.3 172.1 0.4 0.1 1.3 0.3 0.4 0.2 0.0 7.2 0.0 0.1 0.9 0.4 0.1 0.7 0.2 0.1 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.6 0.0 135.3 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.0 0.0 38.2 1.5 0.0 1.0 0.0 0.8 0.0 0.0 0.8 0.8 0.5 0.1 0.0 0.4 1.4 0.3 1.7 0.0 0.0 0.1 0.0 0.8 0.6 7.9 0.3 1.1 3.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.7 30.5 0.2 0.3 0.1 0.5 0.1 0.0 0.1 0.1 7.4 4.2 0.0 0.0 0.7 2.4 0.6 0.5 0.1 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064522-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "myeloid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2" "Not detected" "Not detected" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.2 0.1 1.3 0.3 2.2 0.0 1.0 0.8 1.3 2.5 1.0 1.9 5.3 1.4 0.6 0.7 11.2 12.4 2.9 1.0 2.0 5.6 10.3 1.0 1.0 1.6 1.7 0.9 0.9 34.4 2.2 1.3 0.2 1.8 2.7 3.3 2.3 1.3 2.4 0.0 0.7 1.5 0.5 1.1 0.2 12.7 2.4 3.4 0.7 0.7 0.0 0.7 1.9 0.5 1.7 0.0 7.3 0.0 0.0 0.1 0.0 4.7 4.6 1.8 2.3 1.8 0.1 2.4 0.0 6.0 1.2 3.6 0.4 8.0 0.2 2.8 0.0 11.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 14.7 0.0 0.0 0.1 0.2 0.0 0.8 1.6 0.2 2.8 0.0 0.0 0.2 7.5 18.2 4.1 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 2.2 0.8 1.3 1.0 2.0 1.6 1.7 0.9 1.8 1.1 3.4 1.7 0.0 3.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 2.1 1.3 8.0 100.1 3.1 7.3 0.0 0.3 0.0 1.6 0.0 57.6 0.3 27.8 0.6 0.8 18.0 0.0 1.1 18.4 1.8 0.2 7.7 7.7 0.0 4.3 0.4 2.6 0.1 0.0 1.6 2.4 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.1 8.0 0.0 0.5 0.1 14.8 1.6 0.0 0.0 2.5 0.7 24.5 39.4 0.1 0.0 0.2 1.0 0.2 4.7 1.1 0.0 0.1 0.2 0.7 3.6 2.6 OR2T8 OR2T8P ENSG00000177462 "Olfactory receptor family 2 subfamily T member 8" A6NH00 1 247920252-247923152 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.9;Inhibitory neurons: 1.3;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "GAMG: 1.1" NA NA "unprognostic (7.26e-2)" "unprognostic (4.16e-1)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (2.83e-2)" 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.3 0.2 0.2 0.1 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NR2C2 "hTAK1, TAK1, TR2R1, TR4" ENSG00000177463 "Nuclear receptor subfamily 2 group C member 2" P49116 3 14947584-15053600 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006313 Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006313: AB_1079503" "unprognostic (1.32e-1)" "unprognostic (3.87e-1)" "unprognostic (3.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.51e-5)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-1)" "unprognostic (1.29e-1)" "unprognostic (5.95e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-1)" "unprognostic (1.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.82e-3)" 14.2 12.5 12.1 18.2 12.1 19.3 13.8 23.3 14.2 15.4 3.2 16.5 18.6 17.3 9.9 12.5 15.4 11.4 14.7 13.3 5.2 12.4 13.1 16.9 18.1 12.7 7.5 8.4 18.8 14.3 14.3 19.4 9.8 8.7 13.8 11.8 36.5 13.6 11.6 20.3 19.7 19.0 12.9 3.3 20.0 14.9 20.9 7.7 22.6 24.5 18.0 15.9 14.5 13.8 14.4 18.3 20.2 22.8 17.7 15.8 18.8 52.0 25.8 20.7 20.5 21.0 13.0 17.4 28.0 13.2 23.3 17.9 17.9 21.2 13.3 21.2 37.1 30.0 36.8 45.8 12.0 13.4 27.3 27.3 15.0 17.2 25.9 13.4 17.1 23.5 27.2 26.6 18.7 18.3 16.2 41.9 21.3 15.1 8.6 20.7 33.4 27.1 18.8 9.9 27.1 14.5 36.1 23.5 19.4 23.2 17.9 19.5 26.7 30.5 31.6 37.2 29.1 35.6 28.4 40.0 30.4 22.7 25.6 28.2 2.7 0.9 0.7 1.6 1.2 1.5 0.8 0.9 1.0 0.9 1.8 1.2 1.1 1.2 1.0 1.1 1.5 0.9 0.6 12.1 12.1 23.3 14.2 13.3 5.2 12.7 7.5 8.4 8.7 3.3 7.7 14.4 14.0 22.4 12.2 35.9 15.7 3.7 11.1 1.0 17.1 17.4 15.1 9.7 6.2 11.5 4.7 7.3 14.6 7.8 15.2 16.5 5.9 6.6 58.8 8.0 10.3 13.4 25.1 20.4 35.5 7.2 7.3 11.5 14.3 9.1 9.5 17.2 18.9 8.2 7.8 13.5 39.9 10.2 0.0 20.1 2.3 65.4 19.3 14.2 5.4 52.5 13.6 13.9 9.2 50.8 92.2 12.3 12.4 20.7 14.2 19.6 13.0 6.8 13.7 17.2 0.0 18.8 10.3 33.9 22.2 13.3 3.1 14.9 15.3 17.0 10.4 18.4 GPR4 ENSG00000177464 "G protein-coupled receptor 4" P46093 19 45589764-45602212 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.8;lung: 28.9" "Cell type enhanced" "Detected in some" "Adipocytes: 26.7;Endothelial cells: 26.4;Hepatic stellate cells: 24.7;Sertoli cells: 6.6;Smooth muscle cells: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "HUVEC TERT2: 18.7;TIME: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014278 Uncertain NA NA "HPA014278: AB_1849300" "unprognostic (2.49e-2)" "unprognostic (6.62e-3)" "unprognostic (1.33e-2)" "unprognostic (2.93e-2)" "unprognostic (2.70e-1)" "unprognostic (1.31e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (1.29e-1)" "unprognostic (6.23e-2)" "unprognostic (1.70e-1)" "unprognostic (4.66e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (6.46e-3)" "unprognostic (1.93e-1)" "unprognostic (9.18e-2)" "unprognostic (2.49e-3)" 28.8 7.0 8.4 3.3 5.8 0.5 22.3 5.7 8.9 4.6 6.4 4.1 0.9 7.5 0.7 2.7 6.0 3.3 19.6 5.8 5.8 13.5 3.6 28.9 0.9 7.7 7.8 3.9 3.6 3.7 1.4 6.0 4.1 7.9 5.9 0.7 0.9 2.9 0.9 5.7 2.8 5.1 2.6 6.0 4.2 5.7 1.7 10.7 0.5 18.4 2.5 0.6 7.1 4.9 8.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.1 0.0 0.1 0.0 2.0 0.1 0.0 0.1 0.0 0.1 1.3 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.0 0.3 0.3 0.0 18.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 31.3 0.1 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.4 5.8 5.7 8.9 5.8 5.8 7.7 7.8 3.9 7.9 6.0 10.7 8.6 26.7 0.0 0.5 0.7 0.1 2.4 0.2 0.0 1.2 0.1 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 0.3 26.4 0.0 0.0 0.1 0.0 0.0 1.5 2.0 0.2 0.0 0.0 24.7 0.1 0.3 0.0 0.2 0.0 0.0 1.2 1.6 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 6.6 0.6 16.8 0.0 0.2 0.1 1.3 0.0 0.1 0.3 0.0 0.3 ACOT4 "FLJ31235, PTE-Ib, PTE2B" ENSG00000177465 "Acyl-CoA thioesterase 4" Q8N9L9 14 73591873-73595766 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 15.1;liver: 16.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 26.4;Proximal tubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.6;MCF7: 14.1;SK-BR-3: 27.9;T-47d: 69.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA000779 Enhanced NA NA "HPA000779: AB_1078093" "unprognostic (2.29e-3)" "unprognostic (2.53e-3)" "unprognostic (2.30e-1)" "unprognostic (2.29e-3)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (2.25e-2)" "unprognostic (3.10e-2)" "unprognostic (1.72e-2)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.77e-4)" "unprognostic (3.95e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" 4.9 1.4 3.4 1.1 3.7 0.6 4.7 4.0 4.2 3.9 2.2 3.0 4.3 0.9 2.6 1.5 0.9 0.9 1.0 3.5 3.1 15.1 16.9 3.6 1.4 3.0 2.7 3.4 0.9 1.5 1.1 0.4 1.8 3.3 1.4 3.5 0.9 1.7 1.8 0.6 0.6 3.3 1.5 2.4 1.5 2.0 2.2 2.8 1.0 1.3 0.6 1.3 1.2 0.9 3.1 10.7 2.9 0.3 0.1 1.3 0.6 0.0 0.6 0.0 0.7 1.2 0.3 17.6 0.0 0.6 1.0 0.0 1.1 0.0 0.1 0.1 5.8 0.1 0.0 3.5 0.0 2.0 0.0 9.5 0.8 1.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.6 14.1 0.3 1.9 0.9 3.7 2.8 0.0 0.0 0.0 0.4 5.2 1.5 0.3 6.9 27.9 2.1 0.1 69.7 10.5 0.2 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 11.5 0.0 1.4 14.7 0.6 7.3 2.1 6.9 8.4 0.4 3.3 4.0 8.5 0.0 7.2 0.2 0.9 7.2 5.3 3.4 3.7 4.0 4.2 3.5 3.1 3.0 2.7 3.4 3.3 2.4 2.8 3.1 0.4 0.0 2.7 1.0 1.0 0.3 1.1 3.8 1.2 0.2 5.5 4.2 1.7 7.2 2.8 11.0 0.0 15.9 3.6 8.3 15.6 4.2 1.8 4.1 1.1 0.5 0.0 0.0 1.4 9.2 13.8 1.5 3.1 5.6 5.7 4.1 0.0 26.4 11.2 1.7 0.8 3.2 8.2 3.0 0.3 5.3 0.3 2.1 0.0 1.9 1.0 0.7 11.3 0.5 0.3 6.2 2.6 0.4 1.5 1.1 15.7 59.8 2.9 0.5 0.0 1.5 1.1 3.2 15.8 2.6 0.3 4.5 5.1 0.4 2.6 1.3 OLIG3 "Bhlhb7, bHLHe20" ENSG00000177468 "Oligodendrocyte transcription factor 3" Q7RTU3 6 137492199-137494394 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018303, CAB024865" Uncertain NA NA "CAB024865: , HPA018303: AB_1854796" "unprognostic (1.07e-3)" "unprognostic (1.44e-1)" "unprognostic (2.77e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CAVIN1 "cavin-1, CGL4, PTRF" ENSG00000177469 "Caveolae associated protein 1" Q6NZI2 17 42402449-42423256 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "RNA-binding, rRNA-binding" "Congenital generalized lipodystrophy, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049838, HPA074213" Supported Supported "Vesicles,Plasma membrane" NA NA 440000 "Plasma membrane" Vesicles "HPA049838: AB_2680907, HPA074213: AB_2686674" "unprognostic (1.59e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.36e-4)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (6.33e-3)" "unprognostic (1.72e-1)" "unprognostic (1.04e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (7.18e-3)" "unprognostic (2.36e-1)" "unprognostic (3.44e-3)" "unprognostic (4.24e-3)" "unprognostic (3.21e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (5.87e-4)" 358.0 65.8 48.2 69.8 47.2 3.7 297.9 58.0 45.9 216.9 62.6 236.8 31.1 347.2 57.3 101.9 209.3 78.8 198.0 36.9 63.1 59.2 21.2 204.6 30.2 65.8 55.8 28.4 163.8 28.6 26.7 35.1 152.6 58.1 183.1 51.2 3.6 84.9 217.4 146.2 154.1 105.0 244.4 58.0 110.0 133.9 22.8 54.2 16.7 113.3 93.5 24.2 257.6 193.9 62.4 315.9 264.8 5.5 69.8 342.3 409.6 6.9 1105.9 477.8 432.2 340.5 134.6 20.1 0.5 216.3 796.6 177.4 509.7 46.8 331.6 351.0 1.1 9.5 137.5 154.8 66.1 215.8 0.3 1.2 283.0 120.5 340.8 115.8 230.2 592.3 0.4 95.5 1.3 187.9 5.0 7.4 1.6 25.8 48.1 1.8 0.6 173.3 0.6 186.1 1.6 0.4 2.0 371.9 6.4 91.7 145.2 29.8 2.0 920.9 912.0 429.5 330.9 407.9 0.8 0.9 1.6 270.7 0.5 104.8 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 48.2 47.2 58.0 45.9 36.9 63.1 65.8 55.8 28.4 58.1 58.0 54.2 62.4 575.1 429.5 117.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 55.4 154.9 0.0 0.0 50.8 23.9 0.0 159.8 3.4 0.0 3.9 45.6 0.0 11.7 130.4 217.4 0.0 0.0 0.0 4.4 11.3 114.2 0.0 16.9 63.1 116.3 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.5 0.0 0.0 0.5 0.0 0.0 1.1 3.6 0.0 0.0 0.0 211.7 0.0 0.0 0.0 0.0 77.2 4.5 6.6 0.0 0.0 OR2G3 ENSG00000177476 "Olfactory receptor family 2 subfamily G member 3" Q8NGZ4 1 247605586-247606515 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARIH2 TRIAD1 ENSG00000177479 "Ariadne RBR E3 ubiquitin protein ligase 2" O95376 3 48918821-48986382 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067381, HPA069715, HPA070963" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329" "unprognostic (7.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-1)" "unprognostic (2.74e-1)" "unprognostic (2.55e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.90e-2)" "unprognostic (4.01e-2)" "unprognostic (5.01e-2)" "prognostic favorable (7.31e-4)" "unprognostic (5.01e-3)" "prognostic favorable (6.60e-4)" "unprognostic (1.15e-1)" "unprognostic (7.04e-2)" "unprognostic (1.27e-2)" "unprognostic (1.39e-2)" 20.5 23.1 22.0 16.1 25.1 23.2 20.0 25.0 23.9 20.5 25.0 25.9 11.8 24.7 34.1 19.6 21.5 15.1 48.8 22.1 23.7 19.5 21.5 19.9 20.8 23.6 23.9 22.0 20.9 24.4 24.6 26.3 18.6 24.5 23.3 17.9 32.7 18.8 22.1 101.4 16.6 21.4 24.6 23.1 24.5 22.7 27.2 23.4 26.3 22.2 80.3 21.6 23.8 17.5 28.5 40.4 39.6 37.6 53.2 54.3 29.7 52.4 46.3 53.5 56.5 62.1 42.0 35.0 84.1 21.4 49.8 82.0 23.5 77.9 47.2 68.7 57.0 48.1 85.3 51.7 34.5 48.9 63.4 39.5 31.9 70.2 70.9 94.9 32.2 43.1 38.3 68.4 54.6 50.7 27.8 65.4 25.8 64.3 43.3 59.5 23.5 42.8 70.2 32.9 54.1 16.4 44.8 47.7 56.1 45.0 44.1 28.6 43.8 41.4 34.1 49.4 52.5 74.0 72.8 148.1 103.3 37.3 51.9 43.7 53.1 34.6 39.9 44.2 32.2 30.5 28.8 28.2 37.1 32.3 34.2 29.2 37.3 25.6 25.8 20.9 29.9 35.5 39.3 22.0 25.1 25.0 23.9 22.1 23.7 23.6 23.9 22.0 24.5 23.1 23.4 28.5 37.0 35.3 31.4 54.9 50.2 50.9 51.5 27.3 68.3 57.0 35.5 35.3 74.6 32.9 44.0 29.5 87.6 36.4 76.0 31.3 29.4 33.8 15.3 33.5 48.3 38.4 16.7 76.2 50.0 43.2 36.2 40.1 42.3 38.1 45.5 42.3 28.5 44.6 26.6 57.2 59.1 26.2 14.2 32.8 35.7 11.3 41.7 44.6 30.2 38.4 45.2 42.2 95.8 42.3 128.6 42.1 23.0 43.2 85.0 78.9 20.8 34.3 30.6 82.5 26.3 51.5 48.6 165.7 89.7 59.4 54.0 53.4 66.8 37.7 31.6 67.0 RBM44 FLJ40411 ENSG00000177483 "RNA binding motif protein 44" Q6ZP01 2 237798389-237842808 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 15.9" "Group enriched" "Detected in many" 4 "Spermatocytes: 104.7;Spermatogonia: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 13 "basophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003298 Enhanced NA NA "HPA003298: AB_2284846" "unprognostic (1.29e-1)" "unprognostic (2.66e-1)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "unprognostic (8.47e-3)" "unprognostic (3.15e-2)" "unprognostic (2.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.83e-2)" "unprognostic (8.12e-2)" "unprognostic (4.10e-2)" "unprognostic (4.57e-2)" "unprognostic (5.01e-5)" "unprognostic (1.90e-1)" "unprognostic (4.27e-2)" "unprognostic (6.85e-3)" "unprognostic (7.89e-3)" 0.3 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.1 15.9 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 1.1 1.6 0.4 0.8 0.7 0.3 0.6 0.0 0.8 0.3 0.7 1.5 1.5 1.8 0.0 0.1 2.2 0.0 0.0 0.1 16.8 2.0 0.5 2.4 0.0 0.0 2.4 0.2 0.3 1.0 0.0 4.6 0.0 0.3 0.0 0.2 0.3 0.0 3.3 0.0 0.0 0.8 2.3 16.1 2.8 1.5 1.8 1.9 1.4 0.0 1.0 3.0 0.4 0.6 0.0 1.5 1.0 2.0 0.1 0.1 1.8 0.0 6.6 2.6 0.7 104.7 59.8 0.2 0.6 0.0 0.8 0.7 0.0 1.6 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 6.5 7.1 7.8 8.6 7.3 19.7 15.6 8.0 9.1 6.9 5.3 6.9 7.8 6.2 9.5 10.0 8.2 7.3 4.9 6.8 9.1 6.5 19.2 8.7 13.3 7.8 8.5 5.6 9.8 8.5 13.8 4.8 8.9 8.4 7.4 6.6 5.8 10.5 6.0 5.5 19.0 6.5 4.9 9.1 11.6 8.6 5.8 8.6 16.4 10.2 7.7 12.9 8.1 4.9 10.1 13.6 12.9 19.6 18.1 15.9 17.8 23.4 10.3 13.5 11.7 14.5 9.0 11.7 19.5 18.8 10.4 15.7 20.7 31.9 15.7 15.3 22.0 21.6 20.3 20.3 12.7 11.6 21.2 22.7 12.7 19.9 11.2 17.6 17.1 20.9 18.7 13.5 23.2 14.6 15.6 19.2 14.1 24.3 20.9 15.3 21.9 14.9 32.0 12.5 22.2 35.6 15.2 20.9 21.3 25.3 14.9 11.5 29.6 19.6 9.5 6.9 14.3 18.5 12.7 13.1 24.7 12.6 29.4 11.9 11.5 4.2 5.6 2.9 6.4 5.0 2.4 3.8 3.9 6.2 2.2 4.6 3.4 0.9 4.0 4.2 6.7 3.5 3.6 7.8 7.3 8.0 9.1 6.8 9.1 7.8 8.5 5.6 8.4 9.1 8.6 10.1 15.7 16.0 7.0 3.9 7.9 12.7 7.8 5.1 12.5 4.5 11.5 13.1 5.2 8.6 11.9 1.8 0.0 7.7 21.7 5.3 1.9 5.5 0.1 12.9 8.7 8.5 8.4 10.3 3.4 6.7 8.7 7.9 7.1 10.3 0.0 16.0 7.9 16.6 7.6 3.3 4.6 7.0 6.1 12.8 10.3 0.4 4.4 8.2 3.6 3.7 14.6 7.0 14.4 5.0 4.6 6.9 5.7 2.6 5.4 9.5 6.8 4.0 15.3 1.6 6.6 6.9 4.1 5.0 10.0 12.7 13.1 9.3 8.7 11.2 6.0 11.9 OR2G2 ENSG00000177489 "Olfactory receptor family 2 subfamily G member 2" Q8NGZ5 1 247588360-247589313 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 45 "granulocytes: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 48.0;thyroid gland: 71.7" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 44.8" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" No No "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.1 0.0 0.0 1.8 0.5 0.3 0.2 0.0 0.1 2.6 0.1 0.1 0.1 0.1 0.2 12.9 20.1 0.3 0.1 0.0 0.0 0.2 0.0 10.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.1 0.0 2.8 0.4 0.0 1.7 0.5 0.0 0.0 0.3 0.5 0.0 0.0 48.0 71.7 0.0 13.0 0.4 10.0 0.0 15.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 54.8 0.5 37.4 0.0 0.0 53.1 0.0 119.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.3 1.2 0.2 0.1 0.0 2.1 0.6 0.8 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 44.8 1.1 0.0 0.6 4.5 0.3 3.1 4.6 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 3.8 0.0 4.5 0.0 0.1 0.2 VCX2 VCX-2r ENSG00000177504 "Variable charge X-linked 2" Q9H322 X 8169944-8171267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 283 "testis: 28.2" "Group enriched" "Detected in some" 5 "Spermatocytes: 306.0;Spermatogonia: 414.0" "Cancer enhanced" "Detected in some" "stomach cancer: 0.8;testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044642, HPA044996, HPA049357" Enhanced NA NA "HPA044642: AB_2679033, HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.0 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 306.0 414.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRX3 IRX-1 ENSG00000177508 "Iroquois homeobox 3" P78415 16 54283304-54286787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 76.4;skin 1: 72.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 66.7;Breast glandular cells: 133.8;Breast myoepithelial cells: 84.6;Endometrial ciliated cells: 73.0;Glandular and luminal cells: 88.2;Respiratory ciliated cells: 67.3;Squamous epithelial cells: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 119.4;NB-4: 204.4;RPTEC TERT1: 236.4;T-47d: 122.9;THP-1: 201.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA066576 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066576: " "unprognostic (4.21e-3)" "unprognostic (4.50e-2)" "unprognostic (2.34e-2)" "unprognostic (1.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.35e-2)" "unprognostic (1.52e-1)" "unprognostic (9.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (3.15e-2)" "unprognostic (5.40e-2)" "unprognostic (2.39e-1)" "unprognostic (8.20e-2)" "unprognostic (1.25e-1)" 5.1 6.9 3.0 0.4 2.7 0.1 76.4 7.0 1.6 30.0 2.4 0.3 0.4 2.2 36.8 33.3 11.0 0.3 38.7 1.1 5.9 20.4 2.2 36.8 2.0 6.2 7.1 0.3 1.0 4.0 27.4 7.3 2.0 5.5 23.4 0.0 1.2 43.5 31.6 22.9 72.6 0.6 1.2 6.3 0.1 22.7 0.5 6.8 1.0 9.4 8.9 4.6 4.8 17.7 5.1 1.1 1.1 15.6 15.1 8.4 3.3 1.7 6.6 14.5 13.9 3.4 4.2 6.8 0.0 2.2 10.0 5.5 29.0 12.6 3.6 18.5 14.3 9.8 0.0 22.2 14.6 0.6 16.7 4.1 2.5 59.7 26.5 12.0 9.8 0.0 19.1 0.0 0.0 119.4 7.7 30.9 204.4 1.1 0.0 0.0 23.2 19.2 0.0 236.4 6.2 10.6 1.9 20.4 51.3 2.6 1.7 122.9 201.8 3.4 57.9 6.4 10.6 5.3 0.0 0.0 0.1 38.0 53.7 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.7 7.0 1.6 1.1 5.9 6.2 7.1 0.3 5.5 6.3 6.8 5.1 2.6 19.2 66.7 0.0 0.4 25.0 47.4 25.3 45.5 1.3 133.8 84.6 14.1 0.0 43.2 5.5 0.0 0.1 1.3 0.1 1.9 5.2 0.0 73.0 8.1 5.8 0.0 0.0 0.0 0.2 0.1 18.3 2.0 88.2 0.0 5.5 8.2 7.1 0.3 0.0 0.0 0.0 36.7 1.2 2.7 0.0 0.0 9.0 10.6 0.0 0.2 10.4 0.0 0.0 0.0 0.1 0.0 0.0 1.7 25.8 0.0 6.5 67.3 1.2 0.0 32.1 6.4 0.4 1.0 72.8 41.3 0.0 1.1 0.1 0.0 34.0 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57352557-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.2;pituitary gland: 8.2;retina: 7.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.0 4.3 4.9 0.0 18.2 0.0 0.0 8.2 15.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.9 0.0 11.4 12.0 0.0 0.1 0.0 0.0 3.6 1.1 14.6 0.0 3.7 0.0 8.2 0.0 5.2 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 18.2 8.2 15.6 11.4 12.0 3.6 1.1 14.6 5.2 0.0 2.5 8.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 1.6 5.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 63.9 56.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 1.2 0.0 22.1 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPRM "FLJ90327, REPRIMO" ENSG00000177519 "Reprimo, TP53 dependent G2 arrest mediator homolog" Q9NS64 2 153477338-153478762 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 13.7;Endometrial stromal cells: 63.3;Fibroblasts: 16.3;Sertoli cells: 13.1;Theca cells: 50.4" "Cancer enriched" "Detected in many" 4 "testis cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 25.9;MCF7: 29.8;NTERA-2: 20.5;SCLC-21H: 7.5;SH-SY5Y: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.66e-2)" "unprognostic (2.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-1)" "unprognostic (1.62e-2)" "unprognostic (5.19e-1)" "unprognostic (5.51e-2)" "unprognostic (3.09e-3)" "unprognostic (2.58e-1)" "unprognostic (6.19e-2)" "unprognostic (6.38e-4)" "unprognostic (5.21e-2)" "unprognostic (1.25e-2)" "unprognostic (8.61e-2)" 2.7 16.4 12.6 0.1 8.4 0.0 0.4 2.5 8.1 18.8 10.4 11.2 0.1 23.0 2.0 0.5 4.0 0.0 0.2 6.1 23.1 0.8 0.0 0.7 0.0 9.6 7.8 8.4 18.0 0.0 1.0 19.8 0.1 6.3 12.8 0.4 1.3 11.3 6.5 0.2 0.9 0.6 12.3 4.4 2.0 9.4 1.1 7.3 0.1 1.2 0.2 0.1 3.1 3.2 6.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 25.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 29.8 0.0 0.0 20.5 0.0 1.1 0.0 0.0 0.1 0.0 0.2 7.5 8.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.6 8.4 2.5 8.1 6.1 23.1 9.6 7.8 8.4 6.3 4.4 7.3 6.6 0.9 3.2 0.0 0.0 0.0 0.1 0.8 1.3 1.2 7.8 0.8 2.2 0.5 2.8 1.6 1.8 0.0 0.3 0.0 0.0 13.7 0.0 0.5 2.2 63.3 0.9 1.8 0.0 3.2 1.7 0.4 16.3 1.1 1.0 0.0 2.9 0.0 0.0 0.6 0.0 3.1 0.0 10.2 0.0 0.3 0.8 0.9 0.5 0.0 1.0 0.0 0.8 0.0 3.0 0.3 0.4 0.0 0.7 0.0 1.6 0.0 0.5 1.1 1.8 13.1 0.7 4.0 0.6 5.2 2.2 0.3 0.8 0.3 50.4 0.0 1.4 OR2B11 ENSG00000177535 "Olfactory receptor family 2 subfamily B member 11" Q5JQS5 1 247449118-247458105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "Alveolar cells type 2: 2.2;Club cells: 5.0;granulocytes: 3.8;Macrophages: 2.2;Respiratory ciliated cells: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "THP-1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047459 Uncertain NA NA "HPA047459: AB_10963692" "unprognostic (1.83e-1)" 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798281 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.8;pancreas: 84.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 12.0 13.7 29.0 11.1 56.0 7.6 11.3 13.4 83.8 8.6 0.0 8.5 13.0 9.7 2.1 15.3 10.5 4.2 7.6 72.4 15.8 15.2 40.6 15.2 10.2 20.5 8.9 54.2 12.8 84.1 4.0 49.1 5.0 23.7 14.0 3.0 16.2 14.5 4.3 2.1 13.8 12.3 3.7 0.0 14.0 13.6 19.2 11.3 6.4 9.5 0.5 6.3 10.4 10.4 36.8 56.2 35.7 20.4 18.6 8.3 14.8 19.4 26.3 21.3 28.0 17.7 34.9 37.1 16.8 19.2 21.6 31.9 48.8 22.4 31.1 6.3 31.9 41.4 15.4 18.2 21.9 35.8 24.7 25.0 14.9 18.6 21.4 22.6 8.8 13.0 19.3 31.8 25.3 12.7 33.9 26.3 23.5 44.8 33.9 53.7 30.9 11.2 38.9 16.8 9.2 100.3 45.3 15.0 35.9 18.7 3.1 17.4 12.5 13.0 32.1 21.5 14.8 25.0 22.1 14.3 21.5 37.8 22.2 19.3 0.0 1.6 2.5 3.7 3.3 2.2 1.3 2.3 3.9 1.8 1.0 1.3 2.3 0.9 2.0 3.4 0.5 1.3 1.6 29.0 56.0 13.4 83.8 72.4 15.8 20.5 8.9 54.2 23.7 0.0 11.3 36.8 5.7 6.4 8.6 7.8 8.4 12.6 8.7 9.5 9.1 143.2 9.1 7.5 2.5 8.6 5.0 9.2 33.3 7.1 8.8 3.9 3.9 22.0 12.4 9.5 9.0 7.0 13.1 2.5 11.8 19.3 10.3 5.1 12.8 11.2 2.5 7.2 3.3 17.6 4.3 43.7 10.0 7.6 2.0 2.8 4.6 7.7 4.7 4.1 3.6 3.7 6.6 16.0 13.4 2.5 1.4 14.1 7.8 4.9 13.7 23.8 13.0 7.1 5.8 32.0 0.0 2.8 6.7 1.8 10.4 7.4 13.4 3.1 8.2 13.7 5.9 8.8 RABEP2 "FLJ23282, FRA" ENSG00000177548 "Rabaptin, RAB GTPase binding effector protein 2" Q9H5N1 16 28904421-28936526 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047641 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047641: AB_2680111" "unprognostic (4.93e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-2)" "unprognostic (7.06e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.84e-4)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (1.26e-3)" "unprognostic (5.86e-2)" "prognostic favorable (1.24e-6)" "unprognostic (7.50e-2)" "unprognostic (8.20e-2)" "unprognostic (1.08e-1)" "unprognostic (5.92e-3)" 7.3 21.7 6.8 25.3 7.4 11.6 9.4 7.3 9.3 10.5 8.9 12.6 17.0 8.5 2.7 18.8 7.0 6.6 15.4 5.6 6.7 17.3 10.7 10.2 47.1 9.7 7.5 5.4 6.3 18.1 11.5 16.5 5.3 9.5 28.8 4.7 3.5 17.7 7.0 6.6 23.4 28.5 3.4 6.7 48.3 14.6 6.3 7.1 5.3 14.0 3.3 9.5 12.6 12.4 7.7 13.5 21.1 5.6 10.5 3.3 4.7 10.1 15.5 9.2 10.9 10.7 15.9 12.0 27.7 23.7 6.5 4.4 17.8 2.2 9.9 2.1 9.5 9.9 10.5 17.0 21.7 6.5 7.7 32.1 7.9 8.0 13.5 2.4 6.3 15.5 7.4 4.9 9.7 8.5 31.9 9.5 17.8 7.3 5.4 11.4 33.6 5.1 17.4 7.5 17.5 8.6 11.1 7.6 34.8 7.0 1.2 27.6 15.9 27.5 16.4 8.4 12.1 15.6 15.3 5.0 20.7 17.3 18.2 12.6 0.9 2.8 2.4 3.5 2.9 2.4 12.1 2.5 3.2 3.7 15.0 2.2 2.1 0.7 5.5 3.3 2.2 2.2 2.8 6.8 7.4 7.3 9.3 5.6 6.7 9.7 7.5 5.4 9.5 6.7 7.1 7.7 11.5 3.2 10.0 4.9 42.4 5.1 14.7 14.6 17.6 11.1 13.3 11.0 1.9 11.5 12.9 20.2 35.5 26.1 21.0 35.0 17.6 16.0 0.7 9.2 8.2 14.2 17.3 6.5 4.8 20.9 7.1 9.0 23.0 10.0 18.4 12.1 7.9 4.2 12.4 15.2 6.5 33.7 18.3 8.4 11.3 1.3 4.1 10.5 10.6 9.4 11.6 8.6 22.6 5.0 8.4 20.0 44.1 6.4 21.4 15.4 32.3 11.6 8.0 43.4 13.1 7.9 9.6 4.3 6.0 16.6 8.4 22.0 14.5 22.6 26.7 19.0 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.2;esophagus: 2.3;retina: 2.1;skin 1: 3.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 58.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nuclear bodies" Nucleoplasm "HPA055238: AB_2682752" "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.0 0.0 2.6 0.0 1.9 0.0 0.1 5.5 2.3 0.1 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 3.0 4.5 0.0 0.0 0.2 0.0 3.3 5.4 1.1 0.0 0.0 0.0 0.2 0.0 5.7 0.2 0.0 2.1 0.4 0.1 0.2 3.3 0.0 0.0 2.3 0.0 0.2 0.4 6.2 0.0 0.0 0.0 0.0 0.0 0.7 4.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.9 5.5 2.3 3.0 4.5 3.3 5.4 1.1 5.7 2.3 6.2 4.4 0.0 0.0 0.0 0.3 0.0 2.8 2.8 3.3 14.8 3.9 0.0 0.6 3.4 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 1.8 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 4.5 7.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.4 0.0 3.5 0.3 5.1 3.4 7.0 2.3 0.0 0.0 0.0 0.0 0.4 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 932.7;Proximal tubular cells: 1449.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" NA NA 790000 Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 101.3 138.0 170.4 66.5 178.3 74.5 100.9 176.7 202.7 77.9 177.7 77.6 82.5 74.4 98.9 113.0 65.1 64.2 106.3 167.5 187.9 216.2 263.1 81.0 144.1 180.6 176.8 166.0 58.2 57.6 182.1 81.8 70.4 181.0 101.0 65.0 25.1 93.7 75.3 54.0 103.4 83.7 76.6 180.2 125.4 76.7 73.5 181.5 83.3 120.3 39.9 129.2 92.5 84.9 189.7 112.0 181.9 104.4 73.1 275.1 224.2 136.6 197.7 225.8 197.2 267.3 248.2 235.8 224.9 233.3 345.7 437.1 102.4 129.2 502.5 161.3 143.9 220.3 98.7 118.4 255.1 254.1 137.5 108.5 291.3 105.0 246.0 161.1 144.7 295.3 138.5 83.4 642.7 305.1 276.6 102.3 304.0 59.8 249.8 382.3 61.4 120.0 350.0 190.6 98.1 136.2 80.0 169.3 476.6 763.4 117.2 234.2 165.3 328.5 201.0 159.4 246.9 345.9 522.6 513.4 136.2 271.7 92.3 846.1 154.6 207.9 199.4 75.1 247.6 69.0 98.6 67.3 66.2 171.3 68.3 53.0 58.0 155.3 97.0 177.2 217.8 103.5 117.3 170.4 178.3 176.7 202.7 167.5 187.9 180.6 176.8 166.0 181.0 180.2 181.5 189.7 209.1 57.7 56.6 8.1 93.2 67.7 79.8 204.5 70.0 22.7 250.1 246.5 112.1 165.8 102.2 211.5 14.6 146.0 65.6 213.6 541.9 207.6 178.9 121.1 171.1 183.2 150.7 104.1 6.4 159.1 218.7 127.3 96.8 135.3 73.0 117.8 236.7 932.7 671.2 25.2 9.1 171.1 164.8 221.4 166.0 321.1 83.0 230.4 238.3 4.7 436.7 185.7 88.6 5.5 22.7 318.1 238.7 103.4 170.4 124.2 727.0 1449.1 108.5 24.9 92.1 69.0 235.2 81.9 156.0 153.1 106.4 118.8 55.4 96.6 152.7 122.2 FAM187B "FLJ25660, TMEM162" ENSG00000177558 "Family with sequence similarity 187 member B" Q17R55 19 35224800-35228729 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "testis: 69.3" "Cell type enriched" "Detected in some" 4 "Late spermatids: 2682.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079535 Enhanced NA NA "HPA079535: " "unprognostic (3.34e-1)" "unprognostic (4.96e-1)" "unprognostic (2.40e-1)" "unprognostic (2.84e-1)" "unprognostic (2.72e-1)" "unprognostic (2.12e-1)" "unprognostic (1.25e-3)" "unprognostic (2.71e-1)" "unprognostic (2.49e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 69.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 548.1 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2682.3 7.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBL1XR1 "C21, DC42, FLJ12894, IRA1, TBLR1" ENSG00000177565 "TBL1X receptor 1" Q9BZK7 3 177019340-177228000 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 280.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019182 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA019182: AB_1857800" "unprognostic (4.11e-2)" "unprognostic (3.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.27e-3)" "prognostic favorable (5.16e-5)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (3.75e-1)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (3.13e-3)" "unprognostic (2.50e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (5.83e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" 19.0 20.5 7.1 24.6 10.7 30.5 21.9 11.1 10.3 25.1 6.8 31.3 24.8 17.0 9.3 21.4 22.6 23.4 32.9 12.0 3.7 22.5 24.7 19.8 31.6 6.5 7.4 5.4 21.1 12.2 27.5 2.9 21.2 3.0 25.8 24.6 43.1 16.2 14.9 13.0 17.3 18.8 19.6 4.5 23.1 22.5 19.2 5.7 45.9 47.5 25.6 36.6 25.5 10.3 12.8 96.8 41.2 61.1 39.7 56.2 65.8 44.2 26.1 52.3 30.3 36.3 48.9 76.2 98.9 132.9 43.6 58.4 61.2 42.9 63.2 58.7 97.5 14.5 56.2 66.8 30.3 49.7 91.0 29.6 95.3 35.9 37.3 90.6 53.8 48.5 68.5 44.8 189.9 42.8 31.0 81.7 14.0 38.1 59.8 32.2 53.9 72.6 124.6 33.1 119.5 24.8 38.7 43.3 35.9 49.8 37.3 113.0 74.3 60.5 48.9 35.3 28.8 65.6 89.8 117.6 280.7 32.9 66.2 56.1 14.3 3.7 3.8 5.6 6.2 5.9 7.5 6.9 7.3 4.6 7.3 5.9 7.4 12.9 7.4 5.5 12.4 8.3 5.3 7.1 10.7 11.1 10.3 12.0 3.7 6.5 7.4 5.4 3.0 4.5 5.7 12.8 55.1 73.7 60.7 128.0 56.5 91.5 55.1 90.6 62.0 113.6 69.2 42.2 101.9 47.1 80.3 104.8 125.1 28.9 70.0 84.7 29.4 52.2 7.4 90.9 59.0 65.5 85.3 60.4 228.9 43.8 35.1 81.8 44.4 134.5 25.3 65.9 48.5 66.6 37.8 116.1 167.6 72.6 59.0 91.1 75.0 9.0 64.0 69.4 65.8 184.6 55.8 47.6 41.2 241.8 269.4 66.7 43.7 73.0 75.1 144.9 41.5 67.3 83.9 81.6 46.0 76.3 54.4 12.9 61.4 88.1 111.8 27.5 66.0 41.6 84.6 83.6 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189455-118622112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.6;U-266/70: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favorable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 0.5 1.4 2.3 1.1 5.3 0.4 3.1 1.6 8.8 2.3 0.0 4.0 3.7 1.2 4.0 4.2 5.3 3.6 7.0 6.8 3.1 5.3 1.7 4.2 0.7 2.1 2.1 4.5 0.9 2.0 9.7 3.3 0.1 3.5 3.7 4.7 5.9 2.4 5.0 0.9 0.8 2.1 0.7 1.4 2.7 5.8 1.3 1.7 1.0 10.3 0.1 2.0 4.4 1.1 8.4 10.2 0.7 0.9 0.0 0.0 0.0 2.1 3.4 10.4 7.8 4.3 1.1 12.1 3.4 0.8 8.2 1.6 1.9 2.0 4.7 11.9 0.1 1.1 0.0 5.7 0.0 0.0 0.0 0.2 0.0 2.3 4.6 0.4 2.8 0.2 5.9 0.0 6.0 6.0 2.0 1.6 0.0 0.8 13.2 1.3 0.0 0.0 9.7 5.4 13.5 4.0 0.0 2.8 34.6 0.0 2.1 0.5 0.0 0.0 0.1 3.8 1.4 1.2 14.9 10.2 0.4 1.8 0.0 1.1 0.1 0.0 0.0 0.1 0.0 1.0 1.5 0.8 0.5 0.0 1.0 1.0 0.6 0.1 0.6 0.0 0.3 0.8 0.2 2.3 5.3 1.6 8.8 6.8 3.1 2.1 2.1 4.5 3.5 1.4 1.7 8.4 4.7 112.2 95.0 53.5 8.0 1.7 10.1 10.3 13.1 16.8 10.9 5.1 12.1 12.8 57.5 29.5 43.8 0.0 3.3 10.5 19.6 12.9 5.2 12.1 1.5 13.0 14.3 2.1 537.6 12.4 0.1 9.1 26.5 16.4 56.8 4.4 7.5 5.2 0.1 30.3 531.7 11.2 14.2 0.3 0.0 6.1 0.3 6.5 7.2 163.0 0.7 4.5 4.1 122.6 1158.0 13.0 3.5 0.4 16.9 5.0 8.6 17.4 68.0 26.9 0.0 0.5 0.9 0.5 2.4 15.9 1.7 0.0 8.9 4.5 11.9 13.6 CD163 "M130, MM130, SCARI1" ENSG00000177575 "CD163 molecule" Q86VB7 12 7470811-7503893 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Acute phase, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 242.4" "Cell type enriched" "Detected in many" 4 "Kupffer cells: 1756.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "classical monocyte: 76.1;myeloid DC: 65.2" "Group enriched" "Detected in many" 40 "dendritic cells: 65.2;monocytes: 76.1" "Cell line enhanced" "Detected in some" "GAMG: 1.8;HSkMC: 1.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002432, HPA046404, HPA051974" Enhanced Supported "Plasma membrane" "Secreted to blood" NA NA 903000000 1600000000 "Plasma membrane" "CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (5.02e-3)" "unprognostic (2.72e-1)" "unprognostic (6.17e-3)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.84e-2)" "unprognostic (8.77e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (1.20e-2)" 173.4 86.3 5.9 153.8 11.0 17.8 51.3 5.2 23.0 25.0 30.7 45.6 12.5 27.5 3.7 16.6 68.8 43.9 40.7 5.1 50.8 26.7 90.4 132.8 54.8 15.8 8.1 4.4 23.3 21.6 8.9 11.5 110.4 7.7 15.6 21.8 4.4 26.2 7.2 11.5 13.9 53.4 131.7 6.7 242.4 35.9 9.8 38.9 18.8 17.4 17.8 7.3 69.2 16.4 11.8 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 76.1 0.5 0.1 6.4 0.0 0.0 0.0 0.1 65.2 0.0 0.0 0.0 1.7 0.0 0.0 1.0 0.1 20.1 5.9 11.0 5.2 23.0 5.1 50.8 15.8 8.1 4.4 7.7 6.7 38.9 11.8 2.7 3.2 8.3 0.0 3.8 1.5 0.2 0.0 0.0 0.1 0.1 0.3 4.6 7.2 5.0 0.0 2.1 1.5 0.5 0.0 0.0 0.0 4.3 0.0 0.1 13.9 0.0 3.6 0.4 0.0 1.9 3.0 0.5 0.0 5.1 0.1 17.9 13.9 269.9 0.0 0.5 0.0 0.0 1756.1 30.9 6.4 5.0 387.9 0.0 2.8 41.1 0.9 1.0 0.0 0.0 0.0 0.0 1.2 1.0 0.1 0.0 0.2 1.6 0.2 118.3 1.7 4.0 3.9 2.6 0.5 1.0 3.0 1.3 0.0 0.0 0.1 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477243-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 238.5;Late spermatids: 233.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favorable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 41.7 67.2 12.8 5.6 15.9 6.9 40.1 16.0 20.2 34.4 9.5 44.7 6.2 35.9 5.6 32.6 34.8 6.7 58.1 12.3 14.7 79.9 87.6 46.9 7.9 15.1 14.3 12.5 39.2 47.4 18.6 68.4 6.9 15.1 39.7 10.3 24.8 44.1 8.5 38.2 27.2 40.3 7.4 15.4 39.5 58.6 41.2 14.6 8.6 44.2 7.3 10.5 39.1 32.9 20.1 4.3 3.2 14.4 13.3 12.3 8.8 8.6 5.5 7.6 6.0 6.8 0.5 3.7 4.9 8.6 7.9 9.0 11.1 5.1 10.6 12.6 11.3 4.1 4.2 2.3 5.4 11.2 5.1 11.2 9.9 21.0 5.0 6.1 16.0 12.2 10.1 4.1 11.4 9.9 1.9 4.6 2.5 4.7 4.9 5.9 4.0 3.6 3.8 7.1 5.0 10.7 12.3 5.1 3.4 4.4 19.8 3.1 2.3 13.1 9.6 5.0 1.7 6.9 13.4 24.1 9.1 5.2 5.9 7.1 27.4 8.4 25.8 8.4 8.8 8.7 8.9 6.9 7.7 6.6 7.4 6.6 8.4 41.4 6.2 11.3 9.5 8.2 10.3 12.8 15.9 16.0 20.2 12.3 14.7 15.1 14.3 12.5 15.1 15.4 14.6 20.1 20.2 44.8 29.2 0.0 50.8 5.5 4.6 21.2 39.3 35.0 26.2 15.0 5.5 31.5 22.4 23.9 43.8 22.9 33.8 92.9 39.2 87.5 238.5 38.1 21.0 17.5 95.5 20.2 0.0 82.7 17.7 28.7 63.2 30.3 45.6 5.3 23.6 40.4 22.1 18.5 0.0 57.3 32.6 38.0 12.0 233.1 17.1 48.1 23.2 0.0 73.9 41.4 34.0 0.0 0.0 92.3 77.5 10.1 83.0 5.6 92.7 57.2 42.4 36.3 19.7 10.3 22.7 12.7 13.9 58.4 7.7 38.7 43.4 4.5 40.8 5.2 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012647, HPA055473, HPA066948" Supported Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: AB_2682827, HPA066948: " "unprognostic (1.38e-1)" "prognostic favorable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favorable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.0 3.1 1.7 2.3 2.2 7.5 3.3 1.9 4.2 3.4 2.0 3.4 3.0 3.0 0.1 4.1 3.3 1.1 2.7 1.6 1.8 3.2 5.6 2.7 3.2 3.0 2.2 1.5 2.9 3.8 0.9 2.8 1.9 3.0 4.4 0.7 0.2 3.2 1.0 6.6 5.5 4.6 0.7 2.1 5.0 4.1 2.4 2.2 3.2 3.9 0.8 1.0 3.2 3.1 3.9 5.4 6.2 2.9 6.2 0.6 2.2 26.6 7.5 2.0 2.7 3.6 5.7 10.2 4.4 2.3 1.1 2.5 7.9 2.1 3.0 0.5 9.0 12.3 3.8 5.0 12.0 6.8 4.3 9.4 8.4 5.3 1.4 0.3 0.5 5.0 10.3 4.5 3.3 1.1 2.6 12.0 7.2 4.0 5.8 4.3 19.4 4.2 8.6 1.1 1.9 5.1 6.8 3.1 8.2 2.0 1.6 6.0 7.3 2.7 3.4 7.6 2.5 4.9 10.5 6.4 8.5 4.4 3.5 5.6 0.0 0.5 0.0 0.4 0.4 0.4 0.3 0.3 0.4 0.8 0.4 0.4 0.4 0.0 0.1 0.4 0.2 0.9 0.4 1.7 2.2 1.9 4.2 1.6 1.8 3.0 2.2 1.5 3.0 2.1 2.2 3.9 4.9 3.2 8.8 25.8 7.2 0.0 3.6 0.0 6.2 14.9 7.3 8.1 4.2 5.7 5.6 3.7 10.4 29.2 8.9 12.0 1.9 2.5 1.4 6.7 4.2 3.7 9.0 5.7 12.8 4.6 7.5 4.4 10.7 4.2 1.3 14.0 2.2 10.3 5.5 1.7 14.2 8.1 0.0 3.5 0.0 1.9 7.2 3.8 0.0 7.5 4.1 7.0 2.1 6.6 26.9 3.5 9.9 4.1 6.0 4.4 10.0 3.8 0.0 15.4 0.0 5.7 3.5 25.2 20.8 6.7 0.0 9.7 6.3 7.5 10.5 3.6 ZNF491 FLJ34791 ENSG00000177599 "Zinc finger protein 491" Q8N8L2 19 11797667-11809622 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 9.7" "Cell type enhanced" "Detected in some" "Astrocytes: 4.9;Early spermatids: 6.0;Excitatory neurons: 4.2;Late spermatids: 6.9;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 4.3;Rod photoreceptor cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3" NA NA "unprognostic (1.33e-1)" "unprognostic (6.05e-2)" "unprognostic (6.76e-2)" "unprognostic (1.58e-2)" "unprognostic (5.59e-2)" "unprognostic (1.83e-3)" "unprognostic (1.03e-1)" "unprognostic (5.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-4)" "unprognostic (8.72e-5)" "unprognostic (1.43e-2)" "unprognostic (9.55e-2)" "unprognostic (6.14e-2)" "unprognostic (3.75e-2)" "unprognostic (2.71e-1)" 0.9 2.0 1.3 0.6 1.5 0.6 1.7 3.5 1.6 1.5 1.8 1.5 0.9 1.5 1.3 0.7 1.2 0.8 1.5 1.3 0.9 1.0 1.2 1.1 1.1 1.2 1.3 1.2 2.1 1.9 2.1 2.3 0.9 1.9 1.8 1.5 9.7 1.6 1.1 1.5 1.3 1.1 1.3 0.6 1.2 1.4 0.5 1.1 2.6 1.3 1.4 0.7 1.1 1.1 1.5 0.2 0.1 2.1 3.3 0.8 1.3 0.6 1.1 0.9 0.6 0.7 0.4 0.0 1.1 0.8 1.4 0.5 0.0 0.0 0.7 0.8 0.0 0.3 0.5 0.4 0.4 0.5 0.0 0.5 1.1 0.7 0.4 0.0 0.7 0.3 2.7 0.0 0.1 1.2 0.0 2.9 0.9 0.4 0.0 0.3 0.0 1.9 0.2 0.9 0.4 2.0 1.8 0.1 0.2 0.7 1.2 1.0 0.6 0.2 1.1 0.1 1.4 0.7 1.8 2.2 0.0 0.0 0.0 0.6 0.6 0.2 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.2 0.2 0.5 0.2 0.4 0.4 0.1 0.3 0.0 0.1 1.3 1.5 3.5 1.6 1.3 0.9 1.2 1.3 1.2 1.9 0.6 1.1 1.5 0.4 0.0 1.1 4.9 0.6 0.0 0.1 0.0 1.2 1.8 0.4 0.8 0.7 0.0 0.6 0.0 2.1 0.5 0.4 0.3 0.0 0.2 6.0 1.2 0.5 0.1 2.4 1.7 4.2 0.7 0.2 0.5 0.5 0.4 0.0 0.9 1.4 0.6 0.1 0.0 1.3 0.1 0.0 0.3 0.4 6.9 0.3 0.4 0.0 0.0 0.0 2.0 1.0 7.5 4.3 0.1 1.2 0.0 0.5 0.3 0.0 0.3 0.0 6.3 0.0 0.3 0.8 0.6 0.6 0.9 0.0 0.3 0.4 0.2 0.1 0.1 RPLP2 "D11S2243E, LP2, MGC71408, P2, RPP2" ENSG00000177600 "Ribosomal protein lateral stalk subunit P2" P05387 11 809965-812880 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053635, HPA075365" Approved Approved "Nuclear speckles,Mitotic spindle,Cytosol" "Intracellular and membrane" Yes NA 2900000 "Nuclear speckles, Cytosol" "Mitotic spindle" "HPA053635: AB_2682212, HPA075365: " "unprognostic (6.98e-3)" "unprognostic (2.21e-1)" "unprognostic (4.57e-2)" "unprognostic (8.63e-2)" "unprognostic (2.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (1.63e-1)" "unprognostic (2.98e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (2.19e-6)" "unprognostic (6.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-2)" 2031.6 838.1 1009.5 1002.3 1020.8 2185.7 1670.8 984.9 1379.8 1204.5 1009.1 1289.0 1026.0 937.9 707.7 1251.3 1251.2 569.2 872.2 935.4 1036.8 796.9 662.4 858.4 1940.9 1027.0 992.3 905.1 2111.8 2105.5 550.4 600.1 837.8 1022.8 933.7 896.1 182.4 1925.0 782.9 1819.8 1733.7 1201.6 630.0 1116.8 1557.4 1014.3 380.6 1056.8 1560.0 791.5 944.4 1729.7 1084.6 1147.5 1084.7 2773.5 2229.6 1070.4 1864.1 2343.2 2458.2 2389.5 1728.2 1285.0 2090.8 1638.4 3307.6 2218.5 3851.6 1225.0 1629.9 1107.9 2546.7 1786.2 2778.3 836.3 1713.6 8117.9 1901.7 1416.9 3996.4 2837.3 3540.8 1905.4 3393.9 4684.6 764.1 2182.7 1860.8 2111.9 2798.2 3432.2 2040.5 1317.9 2656.6 2969.5 6002.3 3188.8 3394.5 6045.3 3345.1 1465.6 4369.9 1759.0 1281.0 2222.2 3142.1 1118.5 2825.8 3582.4 885.1 1198.9 3577.2 1881.2 1142.3 1393.9 964.1 1981.6 3838.4 3778.8 3419.3 1790.5 2952.3 1340.6 1565.3 3908.1 1299.1 4402.2 3129.1 6208.3 10718.3 8296.0 6323.4 4273.6 9867.1 10158.6 8083.9 529.9 4310.4 2525.7 5882.9 5140.5 13330.7 1009.5 1020.8 984.9 1379.8 935.4 1036.8 1027.0 992.3 905.1 1022.8 1116.8 1056.8 1084.7 1311.8 1067.3 1685.0 16.3 5889.9 6113.3 6658.4 2808.0 2619.1 206.2 5955.7 4736.9 638.4 2505.0 1972.2 1601.9 79.2 5046.4 3469.2 2296.4 2592.4 3688.3 1403.0 1105.9 2434.1 2724.8 2370.2 3482.2 18.6 7413.9 8045.8 2074.3 1401.2 1787.6 1721.9 1543.2 4028.6 3068.9 4514.0 146.4 17.8 5925.5 870.8 5458.4 6404.8 3133.4 6393.4 3169.4 2986.4 27.2 5854.8 1052.2 5787.9 6.0 19.0 5201.1 4547.7 2821.7 2403.4 6640.3 4473.8 4234.1 900.4 235.5 1991.9 3688.9 2346.3 1123.1 2093.1 4264.4 7887.4 5841.1 4889.3 1629.7 6189.1 7014.0 HASPIN GSG2 ENSG00000177602 "Histone H3 associated protein kinase" Q8TF76 17 3723903-3726699 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.1;lymphoid tissue: 5.4;testis: 7.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA027422, HPA030698" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027422: AB_10601812, HPA030698: AB_2673575" "unprognostic (1.15e-2)" "unprognostic (2.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.14e-2)" "unprognostic (8.05e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (6.60e-2)" "unprognostic (1.77e-1)" "unprognostic (2.75e-3)" "unprognostic (3.82e-3)" "unprognostic (0.00e+0)" "unprognostic (5.65e-3)" "unprognostic (3.09e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" 0.2 0.1 0.0 1.9 0.2 6.1 0.4 0.0 0.1 0.1 0.2 1.1 1.6 0.2 0.1 1.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 1.4 4.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.3 1.1 0.0 0.4 0.0 0.6 0.7 1.9 0.4 0.1 1.7 0.9 7.3 0.1 5.4 0.3 0.1 5.2 0.4 0.6 0.2 11.3 12.2 11.1 12.5 0.7 1.4 9.3 10.2 7.8 19.7 19.3 9.6 4.6 27.7 5.7 5.7 7.9 18.0 20.1 9.9 18.7 0.1 16.7 13.8 9.9 5.8 0.5 8.1 13.7 0.9 0.8 14.9 9.2 2.4 9.1 21.6 12.4 23.7 10.1 5.9 16.4 4.8 9.8 8.7 8.3 16.8 13.9 7.4 3.0 7.8 4.4 6.5 8.9 6.1 3.5 9.6 6.1 7.5 4.7 8.7 9.9 9.8 18.1 4.5 5.4 13.4 5.1 11.5 10.7 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.2 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 JUN "AP-1, c-Jun" ENSG00000177606 "Jun proto-oncogene, AP-1 transcription factor subunit" P05412 1 58776845-58784048 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 295.6" "Low region specificity" "Detected in all" "CAB003801, CAB007780, HPA031174, HPA059474" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030" "unprognostic (2.06e-2)" "unprognostic (1.76e-2)" "unprognostic (1.34e-1)" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (5.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "unprognostic (2.82e-1)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.83e-1)" "unprognostic (2.37e-1)" "unprognostic (2.81e-3)" 311.4 93.6 33.0 36.6 33.5 130.3 310.9 36.9 38.3 151.7 25.7 143.7 35.0 117.3 15.9 101.0 317.0 90.4 143.0 34.0 57.6 93.8 206.9 204.6 52.5 30.7 28.0 29.9 198.6 193.8 60.3 75.6 40.4 28.3 154.8 55.5 30.0 155.8 72.3 115.2 237.9 79.8 114.2 31.9 62.6 241.5 20.4 29.8 72.2 191.3 160.2 5.5 157.7 165.9 40.1 49.8 2.8 22.4 2.6 35.3 40.0 0.2 69.4 27.0 57.1 34.3 10.1 3.5 1.7 23.8 57.4 133.6 12.9 2.0 27.7 40.6 29.8 128.9 0.5 1.9 16.9 29.4 5.3 10.2 42.0 74.0 78.1 34.0 27.7 47.2 2.4 15.6 29.6 24.9 8.0 2.5 32.5 13.5 34.6 32.2 1.1 295.6 7.0 60.7 5.8 43.7 12.8 49.9 62.3 26.4 24.5 17.2 3.0 61.6 127.5 37.3 35.3 96.8 37.9 9.8 4.4 133.9 8.4 35.2 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.6 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 33.0 33.5 36.9 38.3 34.0 57.6 30.7 28.0 29.9 28.3 31.9 29.8 40.1 2721.4 538.5 543.8 187.7 1018.8 1235.5 2850.5 772.6 2825.1 103.4 1647.1 2067.3 1487.5 1315.4 449.3 104.8 262.7 675.8 651.1 1653.6 50.9 987.0 49.3 1337.1 2845.2 1443.8 1497.4 174.3 12.2 516.4 93.9 2730.7 2663.1 1822.2 541.9 333.4 737.2 158.6 650.5 87.5 4.9 1909.1 836.2 584.9 632.0 48.2 1227.4 1034.9 757.7 65.6 140.1 1234.2 8.2 17.6 10.0 562.8 1529.6 258.8 1540.3 1489.1 1654.1 48.6 216.3 453.5 1538.3 1892.9 2392.5 17.4 20.9 2146.3 964.4 415.6 1065.5 846.5 1199.5 545.7 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695486-51699595 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: AB_2684662" "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 13.7 13.3 11.2 17.6 13.6 13.7 11.8 13.6 13.0 11.1 11.4 10.5 11.9 11.8 10.4 9.0 15.0 10.3 14.6 11.2 12.3 12.1 12.7 9.7 19.7 13.4 13.3 10.9 18.1 12.4 18.1 6.0 12.0 13.8 12.0 10.7 14.0 10.8 9.4 22.4 10.9 11.7 12.3 14.1 17.7 11.2 9.6 12.8 21.7 11.6 23.0 19.5 12.5 6.4 19.0 16.2 18.9 27.9 29.4 38.5 26.2 1.9 22.5 20.7 25.4 24.7 25.3 23.2 46.5 12.7 19.7 15.4 24.8 21.2 23.6 22.9 27.1 24.0 26.8 19.9 4.7 18.6 10.5 23.6 38.0 18.0 22.4 25.8 16.1 19.3 26.9 29.3 25.6 22.2 13.9 42.9 16.8 10.3 19.7 40.3 33.7 56.2 9.9 19.6 13.4 23.3 30.1 18.8 19.4 20.4 28.9 36.2 19.2 20.7 16.2 22.1 15.1 28.5 32.5 13.0 32.9 33.7 24.1 14.3 2.8 4.1 4.5 3.5 3.8 4.9 1.7 2.6 2.8 4.3 3.0 4.4 4.0 1.1 10.9 2.8 2.7 4.6 2.9 11.2 13.6 13.6 13.0 11.2 12.3 13.4 13.3 10.9 13.8 14.1 12.8 19.0 13.4 9.6 7.5 2.9 15.8 9.1 7.1 15.7 12.5 18.2 8.7 5.6 14.3 8.6 11.1 9.2 8.4 24.1 13.7 7.5 23.5 16.4 1.7 9.2 13.5 17.7 6.1 17.7 4.6 15.3 14.6 12.4 9.7 7.8 20.3 10.9 17.9 16.7 15.4 20.2 5.7 8.7 10.2 14.8 8.3 2.7 23.9 8.9 0.0 3.7 22.5 13.2 33.0 3.0 19.3 13.9 6.1 19.9 7.1 4.1 9.3 13.6 17.8 13.7 6.6 16.1 9.1 37.0 15.7 8.5 6.5 6.2 17.2 12.0 11.2 5.1 PGBD5 "DKFZp761A0620, FLJ11413" ENSG00000177614 "PiggyBac transposable element derived 5" Q8N414 1 230314490-230426332 "Disease related genes, Predicted intracellular proteins" Transposition "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8;pancreas: 20.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 26.6;Excitatory neurons: 83.3;Inhibitory neurons: 78.4;Oligodendrocytes: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 30.7;GAMG: 15.0;NTERA-2: 30.3;RH-30: 16.4;SCLC-21H: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065010 Supported Nucleoplasm NA NA Nucleoplasm "HPA065010: AB_2685402" "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (4.91e-2)" "unprognostic (3.97e-1)" "unprognostic (1.15e-1)" "unprognostic (7.48e-3)" "unprognostic (2.57e-1)" "unprognostic (3.29e-2)" "unprognostic (6.69e-2)" "unprognostic (2.12e-1)" "unprognostic (3.13e-3)" "unprognostic (2.51e-1)" 0.4 9.5 18.5 0.4 20.6 0.1 0.4 2.1 37.2 18.3 0.0 1.0 0.5 4.6 0.0 1.2 4.9 1.7 13.2 38.8 7.8 1.0 3.2 1.3 0.5 2.3 0.9 22.1 0.3 20.5 1.3 5.8 2.1 8.3 0.9 0.7 6.9 5.3 0.7 2.6 0.6 0.5 2.4 0.0 2.2 1.1 5.2 1.7 3.0 5.3 5.2 4.7 0.9 2.6 11.3 0.0 0.0 7.6 0.1 0.1 0.0 0.6 0.5 0.0 0.2 0.0 6.8 0.0 30.7 2.8 0.1 15.0 5.7 2.4 0.0 0.0 0.1 2.6 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 1.5 0.3 6.2 30.3 0.0 0.2 0.0 16.4 4.9 3.5 0.0 41.4 7.7 1.0 0.1 0.4 0.6 0.4 10.5 0.0 0.0 2.5 0.0 2.5 12.7 10.3 0.0 0.1 2.6 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.5 20.6 2.1 37.2 38.8 7.8 2.3 0.9 22.1 8.3 0.0 1.7 11.3 0.3 0.0 1.9 18.9 0.3 0.1 0.7 0.1 0.0 26.6 1.3 0.6 9.0 4.3 0.4 0.0 20.9 0.1 0.3 0.4 0.0 10.3 0.9 1.4 3.0 0.3 9.1 0.0 83.3 5.8 0.2 0.8 0.0 2.9 10.8 1.9 0.4 4.1 11.5 21.9 78.4 0.4 0.0 3.8 0.3 0.9 0.0 0.9 1.8 4.7 0.1 2.8 0.0 16.1 48.0 5.5 0.3 0.0 0.0 2.1 0.0 0.8 0.9 10.8 0.0 6.4 0.8 0.7 1.8 0.0 0.0 0.3 0.5 2.8 0.6 1.9 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482498-48496524 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 39 "testis: 40.7" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2541.6" "Cancer enhanced" "Detected in some" "cervical cancer: 2.9;head and neck cancer: 2.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 2.7" "Not detected" "Not detected" HPA073090 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.0 0.4 0.4 0.0 0.5 0.0 0.2 0.3 1.0 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.4 0.1 0.0 40.7 0.3 0.0 0.0 0.2 0.6 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 1.0 0.4 0.3 0.6 0.5 0.4 0.6 0.4 0.3 0.6 0.0 0.0 2.6 8.1 0.0 5.1 38.6 19.5 1.2 0.2 0.2 0.1 0.7 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.9 0.1 543.1 0.0 0.0 1.2 0.0 0.0 5.3 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 9.1 0.0 2.0 0.0 1.8 2541.6 10.8 1.4 0.0 2.8 0.0 0.3 0.0 4.5 2.5 0.0 0.0 13.2 0.0 6.4 0.0 1.9 1.9 0.2 6.6 4.3 1.0 11.5 6.5 5.9 2.3 0.0 0.5 0.4 0.0 10.8 GBA "GBA1, GLUC" ENSG00000177628 "Glucosylceramidase beta" P04062 1 155234452-155244699 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease variant, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 65.2;Syncytiotrophoblasts: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006667, CAB037171, CAB037289" Supported "Intracellular and membrane" NA NA 470000 "CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979" "unprognostic (6.03e-2)" "unprognostic (6.02e-2)" "unprognostic (3.41e-1)" "unprognostic (2.42e-1)" "unprognostic (6.00e-3)" "unprognostic (2.97e-1)" "unprognostic (1.04e-3)" "unprognostic (4.76e-2)" "unprognostic (1.22e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-1)" "unprognostic (2.94e-2)" 24.1 38.2 22.0 25.1 23.1 42.1 25.3 24.9 24.0 23.6 24.9 35.5 24.2 23.1 50.6 27.8 20.6 28.5 16.7 24.1 27.6 33.9 34.0 28.6 20.1 26.4 26.0 22.3 17.1 33.6 103.8 44.1 39.6 31.5 23.5 40.1 12.5 27.1 34.0 9.2 33.2 22.7 30.0 23.8 29.2 22.9 8.9 25.5 19.9 38.0 13.8 28.2 27.3 22.1 28.4 38.0 72.2 25.1 34.2 254.8 55.8 29.3 65.4 230.4 95.3 119.0 43.2 135.7 26.3 70.4 153.7 152.0 76.2 35.9 46.4 50.3 55.5 25.1 21.8 45.1 23.2 73.6 25.8 87.0 73.4 38.2 199.7 30.2 100.2 85.6 22.2 23.4 42.9 113.5 82.6 32.5 11.9 16.3 61.9 51.2 26.8 41.9 108.1 63.9 29.0 23.9 33.5 57.4 136.4 145.3 45.6 102.6 63.3 65.7 71.7 31.7 91.9 53.7 86.2 78.6 20.4 126.6 23.4 56.4 21.4 36.0 15.3 20.8 35.8 13.2 11.1 15.7 13.8 22.4 7.8 11.0 11.7 28.9 11.6 37.2 12.5 23.4 23.3 22.0 23.1 24.9 24.0 24.1 27.6 26.4 26.0 22.3 31.5 23.8 25.5 28.4 6.8 3.2 5.1 3.3 8.8 6.0 5.8 9.5 4.6 4.0 12.7 6.5 8.8 17.2 8.1 12.9 2.1 30.7 6.2 36.1 3.9 30.5 1.4 12.3 9.7 12.2 14.6 7.4 3.4 32.4 27.9 18.6 20.9 17.9 7.0 7.9 17.2 23.2 65.2 5.0 2.7 11.6 4.1 33.3 9.9 2.8 9.9 26.8 26.6 1.0 22.8 11.7 12.3 0.5 3.3 29.5 15.8 9.1 19.8 6.7 28.6 20.6 8.5 6.0 0.0 9.4 21.6 22.5 12.5 8.6 4.4 59.4 8.5 6.0 10.4 6.5 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128924003 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria No No Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favorable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 16.8 20.7 8.1 6.2 8.1 4.7 14.7 8.9 10.3 14.3 8.2 13.7 9.1 14.7 7.7 23.4 13.0 7.4 20.7 7.8 8.0 15.7 20.8 11.1 6.6 7.7 8.1 8.2 13.1 14.5 28.0 14.7 8.5 8.3 12.2 9.5 4.1 14.3 12.1 30.6 43.4 11.3 11.2 6.8 12.3 16.0 12.6 7.9 12.2 13.7 28.9 11.3 13.0 14.7 8.5 46.2 22.6 18.0 12.6 28.7 20.7 17.5 22.4 26.2 43.6 36.8 33.3 27.1 33.3 21.1 29.5 29.0 35.5 33.8 45.9 32.8 21.2 23.1 29.3 46.8 24.4 21.6 23.9 10.6 22.5 16.8 23.6 26.7 25.1 35.8 25.2 14.4 11.4 29.5 46.5 36.7 19.0 9.9 49.3 33.8 25.5 17.4 35.1 30.9 25.1 19.0 11.6 37.0 32.9 23.2 17.4 44.5 54.8 18.2 13.2 13.4 14.2 20.3 14.5 5.8 28.3 28.3 21.4 22.7 2.4 15.1 4.9 8.3 18.3 7.8 8.1 7.6 7.3 17.5 5.4 6.2 8.0 0.7 6.8 25.2 9.9 8.3 12.1 8.1 8.1 8.9 10.3 7.8 8.0 7.7 8.1 8.2 8.3 6.8 7.9 8.5 10.4 16.0 21.7 13.1 9.3 6.2 11.4 16.7 8.6 14.1 11.9 9.5 30.5 15.7 14.8 14.7 10.4 26.2 10.5 11.7 21.5 20.6 20.2 10.4 11.5 11.2 5.4 14.3 14.3 17.8 18.8 12.9 16.8 12.9 16.5 12.0 15.7 26.7 31.5 10.1 17.7 7.4 16.2 9.5 4.0 17.3 10.2 10.8 16.0 7.5 13.4 15.0 12.3 6.0 12.2 14.1 8.7 14.7 9.5 8.1 9.4 26.3 12.0 11.9 13.1 12.7 14.9 22.6 9.6 13.5 14.2 30.6 8.2 18.1 14.3 8.4 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32.1" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 59.9;NB-4: 52.5;THP-1: 74.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 62000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favorable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 8.7 5.6 5.5 9.7 10.5 32.1 7.0 5.8 6.4 5.2 7.5 4.1 3.9 5.4 5.0 5.2 6.0 3.7 4.6 5.9 8.7 3.6 5.7 10.1 7.0 8.5 6.4 3.7 4.5 5.3 3.9 3.8 3.6 8.8 5.0 3.4 1.5 5.3 2.8 1.8 6.8 6.2 5.4 8.2 16.7 5.6 2.0 8.9 15.6 4.2 2.6 5.7 4.6 4.8 9.5 7.9 4.5 4.1 5.1 8.0 4.6 5.1 11.5 7.4 5.3 6.8 4.4 5.1 7.1 4.6 11.6 6.9 12.4 5.6 5.4 3.7 11.6 6.6 0.0 2.6 2.8 9.2 59.9 17.8 6.8 7.9 4.7 3.7 5.2 5.7 5.6 3.0 7.3 5.5 6.7 7.2 52.5 2.2 10.1 4.3 1.6 0.8 1.3 5.1 5.8 2.8 0.1 8.0 6.7 5.7 4.6 5.3 74.7 15.9 4.1 5.8 6.1 4.3 5.8 3.4 3.3 6.0 28.3 4.5 8.5 7.4 7.2 1.1 3.4 0.9 0.5 1.5 1.2 3.9 0.4 2.4 1.8 16.5 1.5 3.5 1.8 1.0 2.6 5.5 10.5 5.8 6.4 5.9 8.7 8.5 6.4 3.7 8.8 8.2 8.9 9.5 14.0 12.8 14.1 2.9 13.8 8.8 6.6 10.2 10.8 3.9 7.2 5.8 6.1 10.0 8.6 5.5 8.4 6.1 18.7 23.6 0.0 8.7 4.0 7.2 8.1 13.7 13.2 9.2 8.3 12.6 11.9 13.6 29.0 9.7 7.6 58.9 17.5 11.1 34.0 3.3 6.4 13.9 6.1 81.4 16.2 2.1 9.0 61.4 8.8 41.2 114.2 4.3 28.8 12.5 11.4 12.2 12.4 4.5 10.3 9.1 14.7 3.4 8.0 2.9 13.1 10.4 10.0 3.0 13.4 9.0 6.8 6.4 25.4 8.1 12.4 9.6 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818914-825573 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 483.3;breast: 364.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 194.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 483.3 76.0 9.7 9.3 10.8 43.5 364.4 11.1 18.9 42.5 11.7 54.4 19.5 49.6 2.8 40.2 51.2 9.6 141.7 9.7 10.7 61.5 58.9 57.8 8.2 15.4 10.8 6.6 50.9 76.1 9.7 46.6 8.4 15.4 47.0 4.8 1.3 81.7 16.9 196.2 67.6 75.3 6.4 10.6 51.6 71.9 32.3 10.3 11.0 55.8 64.9 4.1 65.3 44.8 13.3 33.9 26.0 5.3 14.0 194.4 17.2 34.1 35.3 28.1 21.6 19.1 22.3 33.3 19.9 20.4 26.7 13.6 30.0 8.1 14.6 6.6 25.9 71.5 27.6 11.2 36.3 63.3 19.2 33.4 33.9 18.7 14.5 16.7 22.3 17.7 14.5 23.8 19.9 19.5 20.0 25.8 42.3 15.2 34.3 55.1 24.6 11.5 45.7 21.4 7.7 19.6 26.0 65.3 55.0 21.9 3.4 23.7 22.0 32.5 19.3 15.0 12.7 16.3 75.2 49.8 16.7 48.4 27.0 13.8 11.5 9.5 22.1 3.7 6.1 3.6 4.7 4.8 5.4 6.1 4.1 5.4 4.4 8.2 4.0 7.1 7.0 4.2 4.7 9.7 10.8 11.1 18.9 9.7 10.7 15.4 10.8 6.6 15.4 10.6 10.3 13.3 78.1 6.4 11.8 12.7 63.5 44.2 69.2 34.2 42.1 14.0 79.5 67.1 45.5 61.5 65.2 51.5 8.4 70.2 50.8 151.8 33.2 65.1 22.1 58.0 31.8 51.8 51.5 52.6 8.9 65.3 32.0 37.4 204.4 114.3 11.4 42.2 100.6 50.6 29.2 11.8 7.5 96.1 20.3 27.6 29.0 6.2 48.4 46.6 42.7 16.9 29.6 32.2 21.6 5.5 13.8 142.2 170.7 39.1 92.0 78.5 166.8 45.0 31.3 9.0 65.7 64.4 50.7 33.5 23.9 53.7 41.2 169.4 53.3 182.2 43.6 195.5 MBOAT4 "FKSG89, GOAT, OACT4" ENSG00000177669 "Membrane bound O-acyltransferase domain containing 4" Q96T53 8 30131671-30144665 "Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 1.7;gallbladder: 1.0;pancreas: 3.6;stomach 1: 3.7" "Cell type enhanced" "Detected in some" "Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;OE19: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044509 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA044509: AB_2678966" "unprognostic (4.35e-3)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (3.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.76e-2)" "unprognostic (1.85e-3)" "unprognostic (4.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (6.30e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-6)" "unprognostic (9.87e-3)" "unprognostic (1.58e-1)" "unprognostic (2.18e-1)" "unprognostic (3.66e-2)" 0.1 0.5 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 1.7 1.0 0.2 0.1 0.1 0.1 0.4 0.3 0.4 0.1 0.0 0.0 0.1 3.6 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.4 3.7 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.1 0.1 0.6 0.1 0.4 0.7 0.0 0.4 0.6 0.2 1.0 0.7 1.2 0.8 0.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 1.1 0.0 0.0 0.0 3.5 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.0 3.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TEX44 "C2orf57, MGC35154" ENSG00000177673 "Testis expressed 44" Q53QW1 2 231592864-231594276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 692 "testis: 153.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049917, HPA056433" Enhanced NA NA "HPA049917: AB_2680951, HPA056433: AB_2683131" "unprognostic (5.42e-2)" "unprognostic (3.90e-1)" "unprognostic (6.21e-2)" 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 153.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 196.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Enhanced Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 44.3 50.7 23.8 30.5 24.5 133.5 44.7 24.8 32.7 32.6 38.2 28.1 11.3 24.9 48.1 54.1 48.7 25.4 35.9 21.4 38.4 65.9 29.7 62.8 23.6 34.4 24.1 19.5 27.2 67.8 25.9 31.4 22.2 26.9 79.7 9.4 3.4 39.3 21.1 54.8 38.2 26.0 20.5 26.3 84.0 34.0 24.9 27.1 11.4 41.1 12.6 13.5 44.2 43.7 32.7 55.9 66.7 16.7 36.9 27.5 34.9 30.5 28.6 49.0 34.8 30.2 42.0 129.7 5.4 126.7 35.4 87.3 45.8 27.9 135.3 10.7 3.1 61.5 1.6 38.4 51.8 84.9 27.6 64.3 34.6 105.4 112.9 59.2 42.4 46.9 17.3 73.8 52.8 19.8 44.6 13.7 80.9 29.7 24.0 67.3 4.6 15.0 27.5 56.7 5.2 14.6 22.0 52.5 26.4 48.4 22.3 59.8 57.4 26.0 44.1 30.8 70.3 30.9 19.6 24.2 33.3 111.7 196.1 20.7 483.4 844.2 694.6 185.7 442.7 90.4 47.0 66.9 109.8 312.2 38.2 72.0 93.5 756.8 73.0 385.2 25.5 90.8 577.4 23.8 24.5 24.8 32.7 21.4 38.4 34.4 24.1 19.5 26.9 26.3 27.1 32.7 46.2 22.4 27.4 3.9 12.1 11.6 30.7 112.4 16.5 1.0 54.8 56.0 12.0 32.9 41.6 36.8 6.2 15.7 60.1 6.9 9.8 95.5 20.6 75.3 30.8 36.1 7.2 21.0 0.2 446.7 92.4 45.3 11.2 41.1 88.0 19.1 42.1 7.7 118.3 3.3 0.2 12.3 20.3 143.5 18.9 23.4 37.9 97.8 28.4 1.9 107.4 19.4 122.6 0.5 7.0 96.9 22.5 27.1 8.6 66.5 8.6 55.3 78.5 5.6 13.1 13.0 23.8 3.5 36.1 34.4 13.5 13.1 45.0 50.4 18.2 25.2 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.2;lymphoid tissue: 32.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 27.5;Breast myoepithelial cells: 20.3;Excitatory neurons: 18.9;Inhibitory neurons: 16.6;Melanocytes: 14.2;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 10.8;HDLM-2: 10.1;HUVEC TERT2: 10.6;TIME: 10.1;U-87 MG: 22.7" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 660000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 7.6 2.0 0.7 6.5 0.9 0.2 3.7 0.6 1.7 2.1 2.1 14.7 8.6 0.9 0.6 3.0 0.7 4.3 1.3 0.9 2.4 0.7 2.6 2.7 8.1 1.7 1.1 0.9 0.3 0.4 0.3 0.5 10.7 2.0 0.5 22.2 1.8 0.9 1.2 0.4 0.6 18.6 3.2 1.3 32.1 4.5 4.1 3.0 4.7 0.7 0.9 6.3 6.2 0.3 1.8 0.2 0.5 0.3 0.0 1.1 0.4 0.0 1.0 2.1 0.2 0.9 0.0 1.7 0.0 0.4 1.0 10.8 0.0 0.0 1.4 1.6 10.1 0.0 0.0 0.6 1.6 0.0 0.7 0.1 0.3 0.0 0.3 3.9 0.7 10.6 0.0 0.2 5.6 6.3 0.0 0.0 8.1 0.2 0.0 0.0 1.9 1.8 2.2 0.0 0.0 1.4 6.5 5.1 8.0 0.0 0.4 0.0 6.6 10.1 3.5 3.2 0.3 0.0 0.1 0.1 0.0 22.7 0.5 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.6 1.7 0.9 2.4 1.7 1.1 0.9 2.0 1.3 3.0 1.8 4.1 0.0 0.0 2.6 0.3 1.3 0.0 1.1 0.0 2.5 27.5 20.3 0.7 0.0 2.1 0.0 4.2 0.1 0.5 0.4 0.0 0.0 3.1 0.0 0.1 2.5 0.0 0.0 18.9 1.4 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.4 9.1 0.0 16.6 0.1 4.1 4.1 5.2 1.5 0.0 6.4 14.2 7.5 0.2 1.1 0.0 4.5 2.4 3.3 2.6 0.0 1.2 0.0 0.0 0.1 1.2 2.1 19.7 2.1 10.5 3.4 0.8 0.1 1.3 0.3 0.3 0.0 0.1 0.1 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201896-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 53.0;retina: 27.4" "Group enriched" "Detected in many" 7 "Bipolar cells: 153.1;Cone photoreceptor cells: 479.6;Excitatory neurons: 139.1;Horizontal cells: 171.6;Inhibitory neurons: 144.4;Rod photoreceptor cells: 421.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 10.9;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" NA NA "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.0 2.1 8.5 0.1 12.0 0.0 0.0 53.0 32.8 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.0 0.1 6.1 8.2 0.0 0.0 0.0 0.0 34.3 7.7 5.8 0.2 0.3 0.3 9.0 0.0 43.7 0.1 0.1 27.4 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.4 2.1 8.4 0.0 0.0 0.0 0.0 0.0 0.2 45.6 0.3 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 12.0 53.0 32.8 6.1 8.2 34.3 7.7 5.8 43.7 0.6 8.4 45.6 0.3 0.0 0.0 8.1 0.0 2.0 6.4 1.9 7.4 153.1 1.8 0.5 6.9 1.5 1.2 0.0 479.6 0.4 0.0 0.2 0.0 2.0 22.2 0.5 4.2 1.2 12.1 0.0 139.1 2.4 8.1 4.8 0.5 1.0 0.0 12.0 1.8 0.0 0.5 171.6 144.4 0.1 2.0 0.0 0.8 32.2 2.1 0.2 3.6 5.6 0.0 15.9 0.0 18.6 4.9 0.9 0.1 2.2 0.0 2.2 0.0 0.4 0.2 421.8 0.0 1.2 2.0 8.6 3.1 4.9 1.1 2.2 0.1 0.2 0.0 4.9 THAP5 DKFZp313O1132 ENSG00000177683 "THAP domain containing 5" Q7Z6K1 7 108554543-108569750 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 9 "Early spermatids: 398.3;Late spermatids: 537.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043170, HPA051488" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA043170: AB_10964500, HPA051488: AB_2681504" "unprognostic (2.53e-2)" "unprognostic (1.91e-1)" "unprognostic (2.88e-1)" "unprognostic (2.05e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (1.79e-1)" "unprognostic (5.84e-2)" "unprognostic (3.33e-2)" "unprognostic (3.94e-1)" "unprognostic (3.67e-2)" "unprognostic (3.20e-1)" "prognostic favorable (8.99e-4)" "unprognostic (6.00e-2)" "unprognostic (3.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.79e-2)" 9.0 13.3 11.1 11.4 12.8 4.7 12.9 14.7 14.4 12.2 10.9 9.3 9.9 13.0 12.7 7.8 10.0 7.9 13.9 10.7 12.1 16.0 19.9 10.4 14.7 12.3 13.1 10.3 17.5 10.0 18.2 10.7 10.1 12.5 13.2 8.3 17.9 10.0 11.5 13.1 8.4 9.9 8.7 12.4 12.8 10.3 26.9 12.3 13.2 22.5 15.4 13.4 7.9 6.0 16.5 19.4 14.8 18.6 42.3 11.8 16.7 9.7 17.5 19.8 19.0 20.1 7.5 15.9 23.4 31.0 12.1 24.8 8.0 19.3 13.8 24.5 30.5 15.2 17.6 14.4 7.1 25.1 31.7 22.4 10.4 26.1 11.6 27.4 20.2 11.8 26.3 27.9 49.3 19.4 19.5 48.6 13.7 21.9 11.5 14.4 15.0 26.6 54.8 11.6 11.2 21.8 38.2 25.0 29.2 35.1 14.5 12.2 11.9 11.8 35.7 19.7 28.3 21.8 57.0 52.6 43.0 19.8 19.1 33.0 19.2 8.0 15.0 11.7 10.6 15.2 17.8 13.2 11.1 8.0 19.5 17.2 14.6 25.7 11.2 15.5 12.7 11.9 8.3 11.1 12.8 14.7 14.4 10.7 12.1 12.3 13.1 10.3 12.5 12.4 12.3 16.5 30.6 16.0 20.9 9.4 31.0 12.2 12.0 9.0 9.1 40.9 23.6 20.4 30.1 32.9 12.6 25.8 8.4 13.2 26.6 14.7 46.9 15.5 398.3 14.9 18.9 20.7 15.7 39.5 12.9 16.9 9.3 21.3 7.7 12.1 32.2 18.6 21.8 26.5 9.6 47.1 15.1 16.3 12.2 15.2 19.8 537.3 28.3 15.0 35.6 6.5 16.1 49.5 15.5 12.5 21.6 13.6 15.6 28.2 20.8 14.9 16.6 32.8 23.7 40.7 26.3 24.4 21.8 44.6 25.9 8.4 18.0 14.4 22.5 18.0 12.4 8.1 DEFB114 DEFB-14 ENSG00000177684 "Defensin beta 114" Q30KQ6 6 49960249-49964164 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 500 "epididymis: 49.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRACR2B "EFCAB4A, MGC45840" ENSG00000177685 "Calcium release activated channel regulator 2B" Q8N4Y2 11 826144-831991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 210.5;salivary gland: 225.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 180.4;Breast myoepithelial cells: 116.3;Gastric mucus-secreting cells: 178.9;Hepatic stellate cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 3.4;eosinophil: 3.7;memory B-cell: 3.9;naive B-cell: 3.0;NK-cell: 1.7" "Group enriched" "Detected in many" 6 "B-cells: 3.9;granulocytes: 3.7;NK-cells: 1.7" "Cell line enhanced" "Detected in many" "NB-4: 35.2;OE19: 29.6;SK-BR-3: 111.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046217 Approved NA NA "HPA046217: AB_10960833" "unprognostic (8.87e-2)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.81e-5)" "unprognostic (4.47e-3)" "unprognostic (8.20e-3)" "unprognostic (5.27e-3)" "unprognostic (7.31e-2)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (5.61e-3)" "unprognostic (3.49e-3)" "unprognostic (9.25e-3)" "unprognostic (5.28e-2)" "unprognostic (4.29e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-1)" "unprognostic (5.15e-3)" 11.3 8.4 1.4 3.3 1.5 13.5 66.3 3.3 2.1 8.4 3.1 26.6 22.6 4.6 1.0 6.8 6.5 6.9 19.9 1.3 1.4 14.5 3.4 15.0 2.5 1.8 1.4 1.6 1.4 210.5 6.9 23.5 2.7 1.7 45.3 13.7 1.0 225.5 5.3 4.3 21.3 28.7 1.2 1.1 14.0 81.7 2.4 1.6 0.6 6.4 1.7 2.0 19.8 3.9 1.5 3.6 3.1 0.6 1.5 0.2 0.0 11.5 0.3 0.0 0.1 0.0 3.8 12.0 0.0 4.7 0.0 0.3 3.2 2.1 0.1 0.0 26.2 1.1 13.3 3.1 8.8 0.0 10.9 0.5 0.2 0.5 0.0 0.0 2.2 0.5 1.4 17.3 10.7 0.0 8.0 0.3 35.2 0.9 29.6 0.4 2.4 0.6 22.5 8.7 2.8 2.8 1.5 0.4 111.6 0.0 0.6 17.5 9.0 0.3 1.7 0.6 0.4 0.2 26.3 2.4 3.8 5.5 14.4 0.1 3.4 0.5 3.7 0.1 0.0 0.0 3.9 0.0 0.3 0.0 3.0 0.0 0.0 0.1 1.7 0.3 0.5 0.0 0.2 1.4 1.5 3.3 2.1 1.3 1.4 1.8 1.4 1.6 1.7 1.1 1.6 1.5 61.5 6.4 19.8 3.3 16.8 0.0 6.6 0.0 1.8 2.4 180.4 116.3 8.8 22.8 27.2 12.9 0.0 3.8 6.4 18.8 15.6 15.0 2.6 11.6 1.9 34.8 12.2 6.1 0.1 37.1 1.7 2.5 178.9 16.2 1.3 0.6 85.3 2.0 3.5 0.0 0.1 71.9 0.0 5.0 0.0 5.0 2.5 3.8 0.0 3.7 1.2 11.4 0.0 0.0 0.0 25.8 40.5 1.9 24.2 29.6 46.2 4.3 13.1 7.2 13.1 2.4 4.4 2.1 6.5 4.2 0.0 1.8 5.0 1.8 43.6 66.5 SUMO4 "dJ281H8.4, IDDM5, SMT3H4" ENSG00000177688 "Small ubiquitin like modifier 4" Q6EEV6 6 149400262-149401278 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 11.1;Glandular and luminal cells: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "HPA042123, HPA048064" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-1)" "unprognostic (7.75e-2)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-2)" "unprognostic (2.44e-11)" "unprognostic (4.94e-3)" "unprognostic (5.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" 0.4 0.3 1.1 0.3 0.8 0.7 0.3 1.7 1.1 0.9 1.2 0.3 0.2 0.2 0.1 0.6 0.5 0.2 0.6 0.6 0.8 0.8 1.3 1.0 0.5 2.0 0.7 0.4 0.9 0.4 0.0 0.8 0.3 1.1 1.0 0.2 0.7 0.4 0.1 0.2 0.3 0.3 0.1 1.6 0.6 0.3 0.6 1.1 0.1 0.6 0.0 0.2 0.6 1.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.5 0.2 0.2 0.4 1.0 0.7 0.2 0.6 0.6 0.9 2.2 1.0 0.5 0.2 1.1 0.2 1.1 0.8 1.7 1.1 0.6 0.8 2.0 0.7 0.4 1.1 1.6 1.1 1.9 2.0 3.2 1.5 0.0 3.1 2.9 1.8 0.9 0.0 4.3 2.5 1.8 11.1 1.5 0.9 1.8 4.2 0.7 6.4 1.3 0.0 0.7 0.1 4.5 4.0 2.7 1.8 0.8 0.0 0.9 0.4 2.9 2.0 8.4 1.3 7.2 1.4 1.6 1.1 0.0 0.0 0.5 0.0 1.3 4.7 0.9 2.1 5.1 0.0 0.0 3.9 1.7 1.0 0.0 0.0 1.1 1.2 1.2 3.5 3.5 1.0 0.4 1.0 3.9 6.6 1.8 3.6 1.9 0.8 0.5 0.9 0.3 4.3 2.7 0.4 3.9 MAGEB10 FLJ32965 ENSG00000177689 "MAGE family member B10" Q96LZ2 X 27807990-27823014 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 2.5" "Group enriched" "Detected in some" 12 "Spermatocytes: 7.5;Spermatogonia: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000611 Uncertain NA NA "HPA000611: AB_2138307" "unprognostic (2.77e-1)" 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.5 10.4 0.0 0.4 0.0 0.1 0.0 0.0 0.1 DNAJC28 "C21orf55, C21orf78" ENSG00000177692 "DnaJ heat shock protein family (Hsp40) member C28" Q9NX36 21 33485530-33491716 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 7.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 14.0;Early spermatids: 33.3;Proximal tubular cells: 10.4;Spermatocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018003, HPA030076" Approved NA NA "HPA018003: AB_1845695, HPA030076: AB_10602218" "unprognostic (9.63e-3)" "unprognostic (4.44e-1)" "unprognostic (5.66e-3)" "unprognostic (2.05e-1)" "unprognostic (4.00e-2)" "unprognostic (4.92e-3)" "unprognostic (2.89e-2)" "unprognostic (6.61e-3)" "unprognostic (1.45e-1)" "unprognostic (7.23e-4)" "unprognostic (1.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.14e-9)" "unprognostic (1.84e-1)" "unprognostic (1.71e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-2)" 0.6 2.2 0.9 0.1 0.9 0.4 0.7 1.0 1.2 0.5 0.7 0.9 0.3 0.5 1.2 1.1 0.3 0.5 2.1 0.9 0.8 2.6 2.6 0.6 0.2 0.9 0.8 0.9 0.4 1.4 1.4 1.5 0.6 1.0 0.8 0.7 1.7 1.4 0.6 2.8 0.6 1.1 0.3 0.6 1.2 1.5 7.0 0.8 0.1 2.5 2.0 0.1 0.7 0.6 1.0 0.3 0.1 1.2 0.4 3.1 0.8 0.3 0.6 0.6 1.2 0.5 0.1 0.5 0.3 0.1 0.0 0.6 0.1 0.1 0.1 0.3 0.1 1.3 0.7 0.2 0.8 0.7 0.0 1.2 0.6 0.6 0.6 0.1 1.0 0.7 0.6 0.4 0.1 0.4 0.4 0.1 0.3 0.6 0.4 0.0 0.3 1.3 0.1 0.6 0.1 0.9 0.6 0.1 0.0 0.3 0.4 1.1 0.2 0.2 0.5 0.2 0.1 0.1 0.5 0.5 0.1 1.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.9 0.9 1.0 1.2 0.9 0.8 0.9 0.8 0.9 1.0 0.6 0.8 1.0 1.3 0.0 2.2 0.3 0.7 0.4 0.3 1.1 1.8 1.7 1.2 0.9 14.0 1.5 0.5 3.7 0.0 1.3 0.9 1.3 3.9 2.2 33.3 0.7 0.8 1.4 1.2 4.0 2.5 1.3 0.4 1.1 1.1 0.9 3.8 0.8 1.4 4.7 1.0 1.7 2.3 1.1 0.0 2.4 0.3 7.6 0.6 0.9 0.0 1.9 1.3 0.9 0.0 1.0 1.2 1.7 1.2 1.2 2.0 0.6 1.8 10.4 2.4 2.2 0.0 1.1 1.2 13.4 2.0 0.6 0.0 2.3 0.8 3.0 0.6 0.2 OR4F4 OR4F18 ENSG00000177693 "Olfactory receptor family 4 subfamily F member 4" Q96R69 15 101922042-101923113 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810548 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 311.5;Inhibitory neurons: 135.1;Microglial cells: 155.5;Oligodendrocyte precursor cells: 468.0;Oligodendrocytes: 532.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.5;BJ hTERT+: 5.4;fHDF/TERT166: 6.4;WM-115: 5.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 2.5 1.1 1.0 1.0 2.3 0.2 5.9 1.1 1.1 6.4 1.2 3.1 1.7 3.7 5.5 1.5 3.9 4.3 2.6 1.2 1.8 3.4 2.9 2.0 0.5 2.0 1.2 0.8 3.9 2.2 10.3 0.5 1.2 2.0 5.0 2.4 1.6 5.8 3.8 1.0 0.8 1.6 3.5 1.3 1.9 2.7 1.0 1.5 1.2 2.3 1.7 0.5 3.8 1.3 3.4 0.0 0.0 0.3 0.0 4.4 14.5 0.1 3.1 5.4 0.7 0.9 0.2 1.7 0.0 0.6 6.4 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 4.1 0.8 0.1 0.0 3.8 0.5 0.0 0.0 0.1 3.1 0.6 0.2 0.0 0.0 2.2 0.0 0.0 0.2 0.1 2.2 0.3 0.1 0.1 0.3 0.3 1.2 0.3 4.0 0.2 0.7 2.9 0.1 0.1 0.6 0.0 0.0 0.0 1.9 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 2.3 1.1 1.1 1.2 1.8 2.0 1.2 0.8 2.0 1.3 1.5 3.4 5.1 0.0 11.5 311.5 0.1 2.3 8.9 2.7 1.2 7.7 35.1 13.7 3.0 12.8 9.1 12.9 12.5 19.6 0.3 11.1 7.9 10.1 74.9 23.7 8.7 2.8 9.0 2.7 113.4 2.5 1.4 15.0 23.9 30.2 4.5 3.4 2.9 4.5 1.8 0.0 135.1 2.6 10.2 0.3 3.0 39.6 15.2 1.1 3.6 155.5 0.0 6.7 0.0 468.0 532.9 3.6 4.4 12.0 0.0 13.6 13.2 2.4 21.9 6.2 0.0 23.4 4.9 3.2 2.8 5.3 1.8 12.3 0.8 5.7 16.4 16.0 CD151 "PETA-3, RAPH, SFA-1, TSPAN24" ENSG00000177697 "CD151 molecule (Raph blood group)" P48509 11 832887-839831 "Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Blood group antigen" "Deafness, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002428, HPA011906" Supported NA NA "CAB002428: AB_564129, HPA011906: AB_1846245" "unprognostic (1.50e-1)" "unprognostic (1.12e-2)" "unprognostic (5.47e-2)" "unprognostic (5.45e-3)" "unprognostic (4.10e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (5.58e-4)" "prognostic unfavorable (9.46e-4)" "unprognostic (5.47e-2)" "unprognostic (2.41e-1)" "unprognostic (1.02e-3)" "unprognostic (3.31e-1)" "unprognostic (4.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.24e-1)" "prognostic favorable (6.92e-4)" "unprognostic (7.83e-2)" 330.4 160.9 47.9 80.4 45.9 25.2 280.2 46.3 68.1 179.4 64.7 214.3 141.9 266.8 103.9 98.2 185.9 133.6 337.9 47.5 58.6 194.0 146.5 242.2 35.7 57.4 49.4 43.2 117.1 280.6 86.5 81.7 111.0 53.8 184.4 100.7 9.7 245.5 196.0 114.0 104.0 150.7 257.5 52.5 95.6 188.9 45.1 52.5 15.1 134.6 77.7 30.9 204.8 152.6 53.2 380.0 475.3 71.8 256.3 1088.7 422.8 110.4 587.1 400.4 285.0 241.2 252.6 677.2 0.2 224.0 943.5 388.4 358.4 71.1 498.4 96.1 135.0 236.6 112.8 139.1 193.4 366.7 90.2 157.4 388.6 328.2 164.5 367.8 1089.2 348.8 16.4 135.1 56.3 485.9 196.1 1.9 99.5 48.0 232.9 569.4 20.0 173.7 106.4 642.8 102.1 99.5 111.8 578.9 371.5 121.5 81.6 145.8 102.4 600.0 462.6 209.3 147.5 352.9 62.0 66.5 4.5 437.5 89.7 265.8 24.6 19.1 15.2 5.7 19.3 6.8 3.0 4.7 5.0 11.9 2.0 1.9 3.0 7.3 8.2 24.1 1.8 2.9 10.8 47.9 45.9 46.3 68.1 47.5 58.6 57.4 49.4 43.2 53.8 52.5 52.5 53.2 294.4 208.3 79.1 13.1 12.8 70.6 143.2 328.2 60.9 16.6 180.9 203.7 180.0 133.0 159.8 248.3 4.2 222.6 15.6 542.3 19.6 716.2 2.6 60.8 114.6 214.8 127.6 28.6 10.0 636.7 423.8 173.8 236.5 143.7 81.3 103.7 265.2 54.0 130.0 37.0 5.5 388.5 138.4 59.3 70.4 11.3 123.6 81.8 128.1 15.9 75.6 94.8 23.7 3.5 0.7 736.6 477.9 283.2 26.6 307.1 440.6 124.6 52.2 17.0 210.4 96.6 310.3 5.6 13.6 73.4 54.4 185.7 29.7 61.1 289.8 199.6 POLR2L "hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6" ENSG00000177700 "RNA polymerase II, I and III subunit L" P62875 11 837356-842529 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1813.6;Proximal tubular cells: 1989.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 569.0;PC-3: 706.8" "Low region specificity" "Detected in all" HPA073614 Supported Nucleoplasm NA NA Nucleoplasm "HPA073614: " "unprognostic (2.65e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (5.71e-2)" "unprognostic (3.49e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (6.17e-3)" "unprognostic (1.34e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (6.77e-2)" "prognostic favorable (5.56e-4)" "unprognostic (3.60e-2)" "unprognostic (1.32e-1)" "unprognostic (4.03e-3)" "unprognostic (1.73e-1)" 105.3 102.1 54.6 21.7 55.5 27.4 91.7 55.5 99.0 45.2 72.0 60.1 26.3 49.3 16.6 87.8 43.7 16.6 143.2 58.4 62.9 113.1 108.5 68.9 20.6 57.2 54.8 52.2 37.7 112.4 30.7 72.3 21.3 56.1 68.5 15.5 12.0 63.1 31.6 101.8 65.4 46.6 25.2 54.8 69.0 63.9 34.6 57.8 21.2 73.1 43.5 17.7 63.9 54.6 60.4 106.4 569.0 52.9 66.5 150.1 107.8 45.6 134.5 94.1 129.6 86.5 166.2 97.6 64.4 35.6 166.6 110.4 69.5 79.7 160.8 39.9 59.9 381.6 63.4 160.7 216.6 88.3 62.3 49.3 178.9 71.6 74.2 36.6 79.2 101.7 63.9 67.0 71.3 156.1 268.4 59.7 63.1 82.6 124.7 706.8 58.8 41.9 99.3 160.7 81.1 104.1 32.1 133.3 135.2 107.3 28.2 81.2 36.7 117.9 87.5 69.1 48.3 83.8 40.0 50.0 62.3 130.8 58.3 78.2 93.3 119.5 121.7 92.9 109.0 100.1 75.5 86.0 92.0 114.0 73.6 71.8 89.3 32.1 123.7 76.6 141.1 92.5 134.7 54.6 55.5 55.5 99.0 58.4 62.9 57.2 54.8 52.2 56.1 54.8 57.8 60.4 364.4 410.3 390.2 9.8 265.9 611.8 245.0 767.6 279.4 68.1 491.1 412.0 500.6 584.8 415.4 526.0 25.0 625.4 305.0 669.3 1287.4 444.0 84.2 388.4 377.2 400.3 501.7 363.4 5.0 684.1 467.7 392.3 283.4 301.7 266.2 194.4 649.6 1813.6 700.2 50.5 5.3 641.6 323.5 434.5 582.0 235.7 305.7 307.3 658.1 11.2 493.6 368.5 389.3 3.5 9.0 751.1 589.2 255.1 382.8 300.0 813.6 1989.1 329.9 82.5 157.8 195.2 340.8 182.6 268.6 459.8 696.6 449.6 286.1 284.9 553.1 289.7 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C golgi associated secretory pathway kinase" Q8IXL6 7 192571-260772 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 55.2;Hepatocytes: 94.0;Hofbauer cells: 54.9;Peritubular cells: 56.4;Proximal tubular cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 55.3;hTERT-RPE1: 39.9;U-87 MG: 36.0;WM-115: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" NA NA 240000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 30.5 14.9 6.6 7.4 5.6 1.5 33.1 4.7 6.1 17.6 1.0 35.6 4.5 19.6 2.1 14.4 20.3 5.9 26.3 3.8 7.0 34.4 57.0 28.1 1.1 11.6 9.1 3.1 20.5 13.5 1.7 18.5 2.6 6.5 30.2 1.4 1.1 20.5 3.6 31.0 14.2 23.5 6.8 6.1 8.9 39.2 7.9 10.1 0.6 19.8 6.3 0.6 37.1 15.3 6.9 19.6 6.4 0.3 10.3 11.8 20.3 0.0 17.4 23.2 7.9 5.9 0.9 10.1 0.0 9.3 21.8 10.4 14.9 1.1 0.6 1.6 4.5 0.6 0.0 3.1 3.4 8.8 0.0 1.0 55.3 1.6 0.3 0.7 39.9 5.0 0.0 0.0 0.0 1.8 1.9 0.0 0.7 8.9 0.1 0.3 2.3 0.5 0.0 4.9 0.0 4.4 0.2 17.2 0.0 2.3 1.1 9.7 6.5 14.6 10.3 5.3 7.7 5.3 0.0 0.0 0.0 36.0 1.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.6 4.7 6.1 3.8 7.0 11.6 9.1 3.1 6.5 6.1 10.1 6.9 5.0 6.4 5.1 11.8 1.2 10.1 2.3 4.5 1.8 26.9 27.6 18.7 9.9 21.5 1.0 55.2 0.0 0.5 4.6 3.4 5.9 1.8 0.0 4.1 19.0 4.5 11.9 0.4 7.4 4.8 0.5 22.6 13.7 9.5 3.8 3.1 9.3 94.0 54.9 1.7 17.0 5.3 2.0 24.4 9.8 2.6 16.1 34.5 1.8 5.6 10.8 17.1 0.0 8.5 15.3 6.3 3.7 56.4 0.1 6.6 33.7 48.7 3.4 9.0 13.1 8.7 17.3 0.3 1.0 3.5 8.1 0.5 0.9 0.6 9.0 1.9 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Syncytiotrophoblasts: 117.3;Theca cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 117.4;TIME: 170.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 41000000 Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 9.0 4.9 5.4 4.7 6.2 0.2 4.3 7.5 6.9 7.4 0.8 23.2 33.2 7.7 1.5 4.7 9.8 8.3 5.4 7.9 5.5 12.1 29.7 10.5 3.0 10.5 6.0 4.0 16.3 7.2 4.6 1.2 22.9 7.7 11.8 23.3 7.3 5.7 8.5 1.8 1.4 21.3 13.7 8.1 4.0 24.8 55.1 10.8 1.5 42.9 7.2 3.1 6.1 3.0 10.2 0.2 36.2 117.4 7.7 45.7 85.3 7.2 78.6 82.7 47.8 39.7 33.4 16.7 0.0 25.4 112.4 26.6 0.6 33.2 11.4 87.4 0.9 8.8 0.1 12.1 2.4 77.2 5.9 1.1 43.6 4.6 31.7 30.3 42.5 40.8 1.5 0.0 30.2 104.2 0.2 7.8 0.0 33.0 11.0 12.9 0.0 58.2 0.2 26.9 19.2 2.9 20.8 1.6 0.0 15.7 38.9 1.3 0.5 170.4 58.8 24.9 11.1 47.2 17.2 0.0 0.2 37.9 0.1 56.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 6.2 7.5 6.9 7.9 5.5 10.5 6.0 4.0 7.7 8.1 10.8 10.2 8.3 25.6 11.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.6 3.0 0.0 0.0 3.1 12.9 0.0 3.9 4.5 0.0 0.0 6.5 0.0 9.0 11.4 4.4 0.0 0.0 0.0 18.9 9.4 9.5 0.0 13.7 1.3 6.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.8 0.0 0.0 7.1 0.7 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 117.3 5.3 31.5 0.0 0.0 SLC35G5 "AMAC, AMAC1L2" ENSG00000177710 "Solute carrier family 35 member G5" Q96KT7 8 11331012-11332360 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.4" "Cell type enriched" "Detected in some" 4 "Early spermatids: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (9.67e-2)" "unprognostic (2.60e-4)" "unprognostic (6.48e-3)" "unprognostic (4.09e-1)" "unprognostic (5.79e-2)" "unprognostic (1.06e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-2)" "unprognostic (3.44e-1)" "unprognostic (2.06e-6)" "unprognostic (7.88e-2)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (2.04e-3)" 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.6 0.1 2.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.7 0.1 0.2 0.2 0.0 1.7 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.2 13.8 0.2 0.3 0.4 0.0 0.0 0.3 0.4 0.3 0.2 0.0 0.2 0.0 0.2 2.2 0.1 0.5 1.7 0.3 0.3 2.0 0.3 0.3 1.8 0.0 0.2 0.0 1.0 0.1 0.2 0.0 1.0 0.6 0.4 0.0 0.4 0.1 0.5 0.1 0.0 0.4 3.1 0.0 1.3 0.1 2.3 0.3 0.0 0.1 0.0 0.6 0.1 0.4 0.3 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039233-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.9;lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" "Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5" "Group enriched" "Detected in all" 6 "B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3" "Cell line enhanced" "Detected in many" "HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: AB_2681500" "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 4.5 1.3 3.1 12.2 2.8 19.9 3.9 2.7 3.8 3.5 3.3 2.4 3.3 2.4 1.7 1.8 3.3 3.6 2.6 2.5 2.9 2.0 1.3 4.7 26.3 2.9 2.9 2.2 1.2 0.8 0.6 1.1 3.3 2.9 2.8 2.7 0.1 1.7 1.2 2.6 2.1 8.2 2.1 3.3 16.0 3.4 1.6 3.4 25.5 2.7 3.0 17.3 3.2 3.9 3.5 2.1 2.1 1.6 1.2 2.6 8.0 0.4 0.5 0.3 0.5 0.6 3.9 1.9 6.8 6.5 1.6 2.2 0.8 5.0 0.5 0.5 13.3 4.0 2.2 5.9 1.8 4.1 2.6 0.8 27.7 0.2 2.4 0.2 0.1 16.2 33.1 1.5 8.9 2.1 3.1 30.0 4.1 0.0 1.7 14.8 30.9 3.6 3.9 0.7 1.1 5.7 0.0 2.7 0.7 0.7 0.2 0.7 4.9 9.9 0.5 0.0 0.8 2.5 4.4 6.7 3.3 3.6 117.7 1.4 5.6 3.5 1.7 53.9 2.5 63.5 34.3 56.1 59.9 3.5 32.9 96.3 72.1 3.2 24.8 8.1 5.2 66.5 26.6 3.1 2.8 2.7 3.8 2.5 2.9 2.9 2.9 2.2 2.9 3.3 3.4 3.5 32.2 0.0 9.9 0.0 23.8 3.7 1.4 0.3 2.2 0.1 1.9 2.2 1.3 4.3 1.5 0.0 0.0 0.4 36.4 0.5 0.0 0.1 4.0 1.1 5.0 24.8 1.8 8.2 0.0 0.0 1.1 7.2 1.5 0.8 15.2 4.1 38.2 1.4 8.7 0.0 0.0 0.1 2.0 18.2 5.6 1.5 1.5 7.5 7.2 0.0 7.1 0.2 47.4 0.0 0.0 0.1 0.0 0.4 7.8 1.2 1.0 0.4 2.0 0.0 0.0 3.4 3.7 0.7 1.6 1.2 2.3 0.4 66.0 0.3 0.5 1.4 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500452 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 43.0;Granulosa cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: AB_2681207" "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 21.3 56.3 46.3 14.0 41.0 18.5 21.9 23.1 55.3 20.1 22.7 23.5 19.0 24.6 5.4 21.2 31.0 15.9 25.9 36.1 26.7 29.6 20.3 25.8 14.2 41.2 31.9 29.3 28.0 23.9 20.5 30.4 14.3 43.5 20.1 13.7 28.0 21.3 13.3 64.0 23.0 28.4 10.8 25.5 29.9 25.2 27.3 39.7 18.2 27.7 26.1 8.6 20.6 15.5 31.1 15.3 40.7 33.6 52.6 16.1 18.8 45.6 9.2 20.0 15.4 15.4 13.7 22.6 20.6 30.3 15.9 23.6 19.9 15.8 25.6 8.8 19.4 23.1 22.0 18.4 22.9 21.2 23.7 45.2 30.9 14.5 15.0 13.4 13.9 28.1 18.3 22.6 24.4 20.7 19.1 53.3 18.8 14.4 19.3 16.2 36.2 37.2 19.2 16.0 40.7 28.1 30.5 10.2 47.4 28.7 25.3 29.8 29.3 16.0 16.5 19.0 16.5 13.8 53.2 17.2 12.2 17.2 23.8 20.8 0.1 2.6 3.0 3.5 1.6 2.6 1.0 1.6 2.5 2.5 2.5 1.3 2.2 0.7 2.4 1.4 3.3 2.1 2.9 46.3 41.0 23.1 55.3 36.1 26.7 41.2 31.9 29.3 43.5 25.5 39.7 31.1 12.8 12.8 11.1 0.0 5.8 0.0 3.3 0.0 6.2 43.0 10.9 9.1 0.0 12.8 6.2 9.2 31.3 16.1 8.8 18.0 0.0 8.1 4.7 10.1 6.8 8.2 7.3 10.7 0.0 9.5 11.0 4.4 28.1 8.6 6.3 41.5 13.9 8.9 15.4 20.2 0.0 10.5 0.0 12.4 0.0 1.9 6.8 8.9 0.0 0.0 5.6 15.2 4.1 0.0 0.0 6.0 9.1 9.1 8.1 3.3 19.6 3.4 2.9 33.6 6.6 7.5 6.0 14.9 8.8 9.7 0.0 20.1 6.9 19.0 9.3 3.1 FLII "FLI, Fli1, FLIL, MGC39265" ENSG00000177731 "FLII actin remodeling protein" Q13045 17 18244815-18258738 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 247.4" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 198.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007084, HPA008903, CAB016132" Enhanced Enhanced "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Nucleoplasm, Centriolar satellite, Cytosol" "CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640" "unprognostic (8.09e-2)" "unprognostic (1.09e-2)" "unprognostic (6.89e-2)" "unprognostic (2.53e-2)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-3)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" 54.9 50.4 10.4 23.1 10.1 26.7 55.5 11.4 10.4 48.8 12.0 55.0 19.6 50.0 7.4 66.2 41.7 13.8 62.9 8.5 11.8 42.2 30.9 53.7 20.1 13.8 11.3 7.2 39.4 58.1 17.0 39.3 17.1 14.1 41.8 13.0 4.7 64.1 17.6 247.4 46.7 51.2 19.1 11.0 58.5 46.0 35.6 11.9 17.6 44.5 73.8 15.9 61.8 50.8 14.4 198.0 73.5 18.4 30.0 44.2 38.9 29.4 53.7 64.1 59.0 36.4 93.5 45.2 39.7 56.3 61.1 33.7 89.0 26.2 90.1 34.4 32.6 42.6 20.5 54.9 36.9 50.0 23.6 44.3 36.4 53.3 47.9 71.8 36.2 58.0 35.3 18.0 15.0 34.9 61.3 34.9 20.5 20.5 85.1 37.8 34.3 87.2 48.7 43.5 58.4 7.2 10.9 63.1 51.0 28.7 117.2 90.8 17.8 73.3 53.6 54.4 104.0 64.4 15.9 12.5 11.5 50.8 23.5 28.7 10.0 27.5 25.6 12.8 39.3 12.5 9.3 9.9 13.0 30.2 6.0 7.3 8.2 22.6 10.5 51.1 8.6 12.7 24.2 10.4 10.1 11.4 10.4 8.5 11.8 13.8 11.3 7.2 14.1 11.0 11.9 14.4 44.9 60.9 36.9 12.7 23.3 22.7 24.9 35.1 26.7 15.4 29.6 23.9 37.4 22.8 47.3 25.8 18.8 25.9 24.8 62.8 15.6 53.5 45.2 37.5 27.9 38.7 23.9 21.7 7.2 56.9 28.7 28.4 42.3 56.6 46.9 28.8 27.5 19.4 48.9 26.9 7.4 26.0 24.4 46.2 39.7 9.2 32.3 52.2 16.0 14.0 55.7 11.4 12.3 3.5 14.2 134.4 49.8 35.0 31.8 40.7 48.8 21.3 50.3 12.7 32.9 28.0 30.7 40.0 20.0 33.8 19.6 25.4 32.1 33.3 40.9 38.6 SOX12 SOX22 ENSG00000177732 "SRY-box transcription factor 12" O15370 20 325552-330224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 52.3;Cone photoreceptor cells: 41.7;Horizontal cells: 32.0;Rod photoreceptor cells: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055052, HPA061627" Enhanced Nucleoplasm No No Nucleoplasm "HPA055052: AB_2682685, HPA061627: AB_2684571" "unprognostic (1.02e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-3)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.64e-5)" "unprognostic (1.90e-1)" "unprognostic (1.49e-3)" "unprognostic (3.55e-1)" "unprognostic (5.02e-3)" "unprognostic (4.66e-1)" "unprognostic (3.12e-3)" "unprognostic (7.91e-2)" "unprognostic (1.55e-1)" "unprognostic (8.36e-2)" "unprognostic (2.20e-2)" 3.5 8.3 9.0 2.4 8.5 3.0 3.9 12.1 11.5 9.2 5.4 8.3 1.8 10.0 5.1 4.8 8.6 2.1 5.8 8.7 6.4 9.8 4.9 3.9 2.6 10.1 7.6 8.1 11.8 6.6 3.7 6.9 2.3 10.1 8.2 1.2 8.6 4.2 6.1 1.1 4.4 5.4 3.7 6.5 6.1 5.5 9.0 7.8 4.0 9.9 1.3 1.7 7.3 6.5 9.6 7.9 27.1 26.0 17.7 12.3 9.0 7.8 10.6 9.2 9.5 9.4 5.5 8.0 17.5 8.0 12.3 19.9 9.2 18.9 3.5 5.4 8.8 13.3 11.3 10.9 55.3 15.8 15.7 2.9 12.4 10.9 8.0 3.2 15.4 12.6 11.8 26.9 9.0 6.2 19.2 5.4 38.4 42.3 4.4 35.3 27.7 6.6 14.2 13.5 1.0 31.7 36.9 7.1 30.9 41.0 10.6 29.4 21.7 14.3 36.5 36.0 1.0 9.5 25.5 28.8 18.1 6.8 15.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 9.0 8.5 12.1 11.5 8.7 6.4 10.1 7.6 8.1 10.1 6.5 7.8 9.6 3.8 0.0 3.2 15.3 2.6 3.4 2.5 2.7 15.4 52.3 8.5 6.2 11.3 5.7 0.8 7.3 41.7 1.4 1.6 2.3 15.6 1.3 0.9 12.1 16.2 8.6 9.1 5.5 6.5 0.4 0.4 5.3 0.5 6.6 0.0 22.8 8.9 8.7 2.3 32.0 9.2 4.5 2.0 1.3 4.5 2.0 10.2 1.7 5.4 6.5 0.8 9.9 1.0 10.6 10.1 0.4 0.8 12.4 0.8 3.3 1.1 5.1 1.2 39.1 0.0 3.2 7.6 1.3 6.9 3.9 1.1 0.7 2.9 18.4 3.9 0.5 HNRNPA0 HNRPA0 ENSG00000177733 "Heterogeneous nuclear ribonucleoprotein A0" Q13151 5 137745651-137754363 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036569, HPA059404" Enhanced Enhanced Nucleoplasm No No 150000 Nucleoplasm "HPA036569: AB_10670840, HPA059404: AB_2684004" "unprognostic (5.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.00e-2)" "unprognostic (3.78e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (2.34e-1)" "unprognostic (4.57e-1)" "unprognostic (2.66e-2)" "unprognostic (7.39e-2)" 21.3 24.0 11.3 14.6 11.5 32.4 19.4 15.4 12.5 22.3 9.1 19.1 13.9 28.7 10.7 20.3 23.4 10.3 17.2 11.3 13.1 13.7 14.9 19.3 15.9 11.3 11.2 11.2 30.6 17.6 12.4 15.6 15.7 12.2 15.4 10.8 11.0 14.6 12.0 18.2 19.2 19.3 16.2 10.8 18.1 19.6 13.0 12.5 28.9 17.8 12.9 14.7 19.2 19.2 12.6 36.9 36.2 68.6 69.7 33.1 20.9 70.3 27.6 22.7 24.2 27.8 67.8 28.3 66.3 38.9 23.7 26.6 33.1 37.4 42.8 29.4 33.6 52.1 42.9 22.5 41.6 30.4 39.8 43.9 34.0 29.6 19.2 22.0 26.6 34.0 59.0 35.7 43.2 24.7 47.8 75.0 53.2 53.7 17.3 26.1 88.6 50.0 33.8 24.2 41.7 86.6 70.5 35.6 24.5 49.1 74.8 31.1 45.6 33.4 38.6 32.8 21.6 53.3 43.4 37.6 46.8 25.0 45.4 38.9 2.7 1.4 4.6 2.9 2.1 3.4 2.1 2.8 3.0 2.3 2.5 3.0 3.2 1.3 4.4 2.5 3.2 1.7 1.1 11.3 11.5 15.4 12.5 11.3 13.1 11.3 11.2 11.2 12.2 10.8 12.5 12.6 151.5 86.6 53.6 7.2 251.2 550.9 436.4 290.2 390.9 85.1 197.5 136.1 36.1 155.8 138.6 101.2 37.5 347.9 234.6 88.8 172.1 257.5 25.5 108.6 172.1 204.4 236.4 179.6 11.3 146.5 478.1 237.2 141.7 126.8 95.8 162.4 192.1 77.0 191.7 84.1 11.5 181.2 229.9 142.3 416.4 44.9 157.8 142.4 281.1 11.2 228.6 137.1 213.1 15.6 16.8 201.6 157.2 150.8 138.9 313.1 147.3 146.9 65.3 62.9 85.5 271.8 221.9 144.0 72.8 247.6 484.3 365.7 267.5 155.8 242.0 401.0 YIPF7 "FinGER9, FLJ39576" ENSG00000177752 "Yip1 domain family member 7" Q8N8F6 4 44622065-44678556 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 85.7;tongue: 28.1" "Cell type enhanced" "Detected in some" "Astrocytes: 1.6;Cardiomyocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 4.8;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.0;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030642 Uncertain NA NA "HPA030642: AB_10601027" "unprognostic (9.41e-4)" "unprognostic (2.27e-1)" "unprognostic (2.90e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.46e-2)" "unprognostic (9.81e-2)" "unprognostic (2.32e-2)" "unprognostic (3.05e-2)" "unprognostic (1.52e-2)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.98e-2)" 0.0 0.1 0.8 0.0 1.0 0.0 0.1 5.4 1.3 0.1 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.0 0.8 0.9 1.1 0.1 0.0 0.0 0.1 0.8 1.1 0.9 0.2 0.3 0.0 0.2 0.0 1.7 0.3 0.0 0.3 0.3 0.2 85.7 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.9 0.0 0.1 28.1 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 1.0 5.4 1.3 0.9 1.1 0.8 1.1 0.9 1.7 0.7 0.9 1.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.1 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MYOZ1 "CS-2, FATZ, MYOZ" ENSG00000177791 "Myozenin 1" Q9NP98 10 73631612-73641474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 82 "skeletal muscle: 7201.9;tongue: 3337.4" "Cell type enriched" "Detected in some" 11 "Skeletal myocytes: 144.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BEWO: 44.6" "Region enriched" "Detected in single" 17 "olfactory bulb: 3.9" "Low region specificity" "Detected in all" "HPA037848, HPA038437" Enhanced NA NA 71000 "HPA037848: AB_10670156, HPA038437: AB_2676009" "unprognostic (4.55e-2)" "unprognostic (2.23e-1)" "unprognostic (4.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.14e-1)" "unprognostic (5.08e-2)" "unprognostic (2.76e-2)" "unprognostic (1.22e-4)" "unprognostic (1.18e-1)" "unprognostic (9.25e-2)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (5.14e-2)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" "unprognostic (7.17e-2)" "unprognostic (1.09e-1)" 2.6 0.7 2.7 0.2 2.8 0.0 2.7 2.7 3.9 1.4 2.7 0.7 0.0 1.0 23.4 64.4 1.5 1.4 23.9 2.4 3.9 2.6 0.6 5.1 0.4 2.8 2.6 2.1 1.8 0.6 0.2 2.7 2.2 2.7 22.3 0.3 1.2 37.2 3.5 7201.9 1.5 0.5 0.9 2.7 1.6 0.6 2.1 2.7 0.9 4.4 3337.4 0.4 0.9 1.6 2.8 0.0 0.0 0.3 0.0 0.0 0.0 44.6 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.2 7.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.8 2.7 3.9 2.4 3.9 2.8 2.6 2.1 2.7 2.7 2.7 2.8 0.2 0.0 0.0 0.3 0.0 0.3 1.6 0.3 0.6 2.7 1.0 1.9 9.3 0.0 1.3 5.5 0.0 0.4 0.0 0.0 7.9 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.2 2.5 1.5 0.0 0.0 0.0 0.9 0.0 0.0 6.3 0.0 0.1 0.0 2.0 0.0 0.8 1.2 0.9 0.7 0.0 0.0 0.0 6.1 0.0 0.5 0.1 0.0 0.0 7.5 0.0 0.3 0.0 0.4 0.1 0.6 13.1 144.4 11.6 0.4 2.2 0.1 0.3 0.1 0.6 3.0 0.0 0.3 KCNJ10 "Kir1.2, Kir4.1" ENSG00000177807 "Potassium inwardly rectifying channel subfamily J member 10" P78508 1 159998651-160070160 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 99.8;kidney: 28.2;retina: 37.0" "Group enriched" "Detected in some" 5 "Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7" "Cancer enriched" "Detected in some" 6 "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078302 Enhanced NA NA "HPA078302: AB_2732378" "unprognostic (2.64e-2)" "unprognostic (3.54e-3)" "unprognostic (6.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (6.98e-4)" "unprognostic (1.96e-1)" "unprognostic (7.13e-2)" "unprognostic (3.43e-1)" "unprognostic (1.28e-3)" "unprognostic (5.80e-4)" "unprognostic (9.52e-2)" "unprognostic (2.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "unprognostic (6.70e-3)" 0.1 0.3 54.1 2.1 80.3 0.0 0.1 98.7 61.5 0.2 10.8 0.5 0.2 0.1 0.0 0.1 0.1 0.1 0.1 51.2 72.3 28.2 2.1 0.1 7.3 88.7 93.5 37.9 0.1 0.1 0.1 0.4 0.0 81.7 0.2 0.2 37.0 0.3 0.2 0.1 0.4 0.5 0.0 80.5 10.5 0.9 0.6 87.5 0.4 0.2 0.1 1.9 0.1 0.1 99.8 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 1.0 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 2.1 0.5 0.0 0.3 0.1 0.0 0.2 0.5 0.0 2.0 1.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.6 0.0 54.1 80.3 98.7 61.5 51.2 72.3 88.7 93.5 37.9 81.7 80.5 87.5 99.8 0.1 0.0 0.0 93.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.5 0.0 0.0 3.7 4.2 0.0 0.0 0.0 11.7 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 13.0 0.0 1.1 0.0 1.1 0.0 3.7 0.0 75.7 0.0 35.7 93.7 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 3.5 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHID1 "FLJ42707, MGC3234, SI-CLP" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867859-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 404.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" No No 1500000 "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favorable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 44.3 63.8 39.2 22.9 40.3 46.6 40.6 37.4 52.1 44.9 53.3 34.5 31.2 38.3 90.3 35.1 64.0 41.7 49.9 39.7 41.7 52.5 86.5 31.2 27.5 38.7 38.6 39.8 58.6 151.1 46.4 63.2 43.0 38.3 42.6 30.0 25.4 82.9 41.6 37.3 33.7 28.0 36.1 40.4 72.2 47.5 74.7 41.8 20.3 47.7 31.3 20.4 34.6 35.6 43.3 75.6 71.7 53.2 131.6 203.3 107.5 90.1 83.2 97.0 78.8 76.7 78.7 214.6 61.1 75.1 121.7 78.4 145.2 53.1 95.9 57.3 53.7 131.9 44.1 25.9 75.1 92.6 102.9 37.4 104.1 59.2 53.9 77.2 130.3 67.2 76.6 81.2 152.6 55.8 52.9 58.4 134.0 47.2 141.6 107.3 49.0 50.9 111.8 57.5 21.5 101.8 84.5 90.3 124.0 78.4 53.0 50.4 156.8 66.6 89.6 38.9 25.3 68.3 88.9 81.4 36.0 100.2 88.6 71.7 21.1 50.4 19.2 34.7 45.0 37.1 45.7 33.2 36.8 74.0 32.1 34.9 35.3 6.2 43.4 45.6 69.6 32.4 46.0 39.2 40.3 37.4 52.1 39.7 41.7 38.7 38.6 39.8 38.3 40.4 41.8 43.3 33.0 41.7 36.7 4.2 28.6 22.8 62.2 78.9 22.2 38.5 69.9 75.7 25.6 51.5 49.0 53.3 18.8 121.3 34.4 25.2 72.4 62.3 120.9 44.0 44.4 31.5 53.3 56.4 7.8 58.3 79.7 69.6 20.9 36.8 29.2 107.6 50.0 91.2 81.1 30.3 7.8 42.8 57.0 66.6 24.7 404.8 62.7 34.0 55.2 1.9 35.2 60.6 20.6 6.0 6.8 38.0 43.2 58.3 123.7 86.5 71.5 85.1 45.7 53.2 52.6 45.9 41.7 208.3 139.9 37.2 23.3 91.5 19.2 85.4 59.9 62.6 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Bipolar cells: 20.2;Horizontal cells: 10.1;Skeletal myocytes: 6.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;ASC diff: 10.3;ASC TERT1: 9.4;SH-SY5Y: 14.3" HPA013445 Uncertain NA NA "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 0.9 0.8 0.6 0.1 1.1 0.1 1.2 1.1 1.9 1.5 0.0 0.8 0.1 2.0 1.8 0.3 1.3 0.7 1.0 1.5 0.2 0.5 0.2 1.1 0.1 0.3 0.5 0.2 2.0 0.7 1.2 2.4 0.5 0.4 0.6 0.3 1.2 1.0 0.4 0.4 0.8 0.4 1.2 0.3 0.3 0.5 0.8 1.1 0.2 0.6 1.0 0.1 0.8 0.9 0.9 0.0 0.0 0.9 6.0 10.3 9.4 0.2 0.1 3.5 0.4 0.5 0.0 1.0 0.4 3.9 0.2 2.8 0.0 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 1.8 0.0 0.1 0.0 2.7 3.1 0.9 0.6 0.7 0.3 0.0 0.4 2.8 5.4 0.0 0.6 0.1 2.1 14.3 0.6 0.1 1.0 0.4 2.6 0.2 0.9 5.2 0.5 4.7 1.2 0.0 0.0 0.0 3.1 0.2 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 1.1 1.1 1.9 1.5 0.2 0.3 0.5 0.2 0.4 0.3 1.1 0.9 1.8 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 20.2 0.5 1.4 0.2 1.5 1.3 1.8 0.0 0.0 0.0 0.2 0.0 0.4 1.0 0.2 2.8 1.3 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.1 0.0 0.0 1.8 0.2 0.1 10.1 0.0 0.1 0.0 0.3 0.0 0.4 1.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 1.9 0.0 0.2 0.0 0.3 0.0 0.7 0.0 6.3 1.8 1.0 0.2 0.3 0.0 0.0 0.1 0.3 0.0 0.1 ZNF620 MGC50836 ENSG00000177842 "Zinc finger protein 620" Q6ZNG0 3 40477131-40518736 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA031452, HPA059383" Uncertain Approved Centrosome NA NA Centrosome "HPA031452: AB_10603939, HPA059383: AB_2732636" "unprognostic (1.42e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-3)" "unprognostic (2.15e-2)" "unprognostic (7.73e-2)" "unprognostic (3.78e-2)" "unprognostic (1.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.21e-5)" "unprognostic (1.28e-1)" "unprognostic (4.78e-1)" "unprognostic (2.61e-2)" "unprognostic (9.19e-4)" 1.4 1.9 1.9 1.0 3.0 3.3 2.1 4.4 2.4 1.3 2.4 1.9 1.7 1.3 1.6 1.1 1.9 1.1 1.7 1.5 2.7 2.2 1.4 2.2 1.3 2.3 2.4 1.2 1.5 2.5 2.7 2.5 2.3 2.7 1.8 2.1 4.3 1.0 1.9 2.6 0.7 1.5 1.6 2.1 1.8 2.7 1.1 2.5 1.6 3.4 2.3 1.0 1.4 0.9 3.4 2.4 3.1 8.8 3.3 0.7 0.9 3.6 0.6 1.0 3.8 6.0 9.0 5.2 0.0 2.7 0.5 3.5 0.6 13.3 1.3 3.1 8.0 10.4 6.6 9.8 4.9 1.5 2.4 1.0 0.6 0.9 2.6 1.2 1.0 3.0 0.1 3.5 0.8 0.5 4.5 0.5 2.0 10.4 5.0 2.0 3.6 3.5 1.2 3.9 8.7 10.4 8.0 0.7 6.3 4.2 7.9 8.1 2.4 2.0 0.4 5.8 0.8 2.9 1.3 2.3 0.1 1.4 1.2 1.5 7.7 0.5 1.0 2.1 0.9 2.4 0.4 0.8 2.0 0.5 1.6 1.6 2.2 0.6 3.0 0.3 1.2 3.5 0.9 1.9 3.0 4.4 2.4 1.5 2.7 2.3 2.4 1.2 2.7 2.1 2.5 3.4 5.4 6.4 4.1 2.6 1.7 0.5 3.4 1.6 0.6 10.5 3.3 2.9 2.1 4.3 3.2 0.0 4.2 8.5 3.6 2.3 5.9 6.1 0.1 4.3 2.0 5.4 9.0 8.6 1.6 2.9 1.8 2.1 3.1 9.2 7.0 7.8 5.0 2.1 1.4 3.3 2.2 4.2 8.2 1.9 1.2 0.7 0.3 1.6 0.0 0.0 11.0 9.0 7.2 3.0 6.2 2.2 4.8 0.4 0.5 2.8 2.3 3.5 2.1 11.6 0.0 4.5 4.6 7.8 6.7 0.8 0.1 1.9 2.7 5.0 4.3 1.4 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Yes No Nucleoplasm "HPA029049: AB_2672885" "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 4.2 3.3 3.9 4.4 4.7 7.6 7.4 5.8 5.0 4.2 2.6 7.1 5.1 5.6 7.9 4.3 4.4 4.1 3.5 3.7 4.6 5.1 4.6 4.6 6.1 5.1 5.8 2.8 7.4 4.6 4.1 4.1 4.5 5.5 4.8 7.0 9.4 4.1 4.2 2.0 6.0 6.4 4.4 4.0 5.5 6.8 16.3 4.3 8.2 7.8 2.3 6.1 3.8 2.8 6.9 4.2 9.4 10.3 0.0 5.1 5.8 12.4 4.4 2.5 4.7 4.8 8.9 10.0 15.5 4.1 2.8 6.7 5.9 11.8 4.2 4.3 7.1 6.3 23.2 3.2 14.5 4.5 25.3 13.5 3.8 10.1 4.9 7.8 3.4 5.7 17.8 20.1 10.1 4.7 4.2 15.0 15.3 15.9 4.7 0.6 16.7 11.8 6.2 5.6 8.5 3.0 7.2 6.2 5.8 4.5 17.0 6.9 16.0 3.7 2.2 8.5 3.0 4.8 9.3 24.9 8.8 1.5 19.0 2.4 9.8 2.6 3.2 1.8 2.8 2.7 2.5 2.1 1.8 1.7 2.2 3.0 2.1 2.5 2.3 5.3 2.9 2.5 1.4 3.9 4.7 5.8 5.0 3.7 4.6 5.1 5.8 2.8 5.5 4.0 4.3 6.9 31.1 57.7 28.2 136.8 26.1 0.0 17.1 0.0 13.1 65.0 32.5 21.2 26.5 30.0 14.9 40.5 43.8 49.1 31.6 51.0 19.6 24.1 23.6 42.6 38.8 24.0 61.2 17.1 63.9 25.5 30.8 21.6 32.6 41.3 9.5 57.9 35.3 28.3 28.1 75.7 90.5 35.8 0.0 32.8 0.0 15.0 35.1 31.3 0.0 81.5 48.7 29.1 47.4 150.3 173.0 32.9 52.4 25.2 18.3 20.8 39.5 20.4 10.2 56.9 19.7 33.8 23.2 73.1 131.2 16.2 0.0 43.8 23.3 40.9 35.2 17.6 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972754-153983194 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038134 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favorable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 6.1 9.2 5.7 4.9 6.2 2.7 6.5 6.4 6.6 6.6 8.2 6.2 5.0 5.8 7.1 5.2 7.5 4.3 6.2 5.4 7.9 5.7 8.3 4.8 7.8 6.4 6.0 5.0 7.2 12.5 5.6 6.8 3.6 6.2 6.7 3.3 2.7 10.8 6.3 6.5 8.1 6.9 4.4 7.0 7.0 6.5 4.0 5.6 5.4 5.1 3.3 4.7 6.0 5.6 7.7 11.9 13.1 2.9 11.6 12.1 10.0 1.8 4.7 2.9 1.4 4.7 2.8 20.7 1.8 27.5 5.2 7.7 11.3 3.9 7.4 1.1 15.8 6.4 3.2 8.3 4.8 10.4 1.9 3.5 12.8 12.1 4.0 7.6 7.4 4.2 7.4 2.9 15.0 6.7 14.7 6.8 2.6 2.1 14.2 18.4 6.5 2.0 20.1 9.2 3.9 4.4 4.1 8.2 6.9 5.8 3.2 11.9 4.0 7.3 2.4 2.6 10.1 2.9 10.9 7.7 2.5 6.9 7.7 1.7 31.5 15.2 19.6 21.5 11.7 21.8 14.6 25.9 23.1 11.4 18.8 31.6 19.5 14.1 17.0 11.4 30.6 29.3 17.7 5.7 6.2 6.4 6.6 5.4 7.9 6.4 6.0 5.0 6.2 7.0 5.6 7.7 6.7 0.0 6.3 3.9 4.7 2.8 6.1 11.7 5.2 4.8 9.4 9.8 5.2 12.8 5.1 7.3 6.2 13.3 8.5 5.9 1.9 10.1 0.3 9.4 5.4 7.0 2.4 4.0 1.5 8.7 10.8 6.8 3.6 7.9 3.8 9.0 7.9 16.1 12.4 1.7 1.8 8.2 12.2 7.0 3.3 0.6 14.6 7.1 10.6 0.0 7.0 14.6 5.2 0.5 3.7 9.9 3.8 14.3 3.6 5.9 12.0 8.7 6.5 6.0 6.6 7.8 5.5 1.7 9.4 4.3 4.7 9.9 6.9 14.7 8.1 3.8 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817397 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 31.9 15.2 36.4 13.8 37.2 43.5 30.2 39.1 50.3 30.0 34.3 26.1 11.7 25.1 26.4 17.9 27.4 15.3 22.9 36.9 38.1 23.2 19.3 17.5 23.1 38.2 37.3 35.6 36.6 12.2 22.3 30.8 20.7 37.6 20.5 15.8 22.8 16.0 15.6 28.2 17.7 20.1 19.4 38.0 22.3 19.2 53.3 37.9 48.8 19.1 23.7 23.7 24.1 25.0 40.1 25.9 12.9 75.2 26.9 30.9 48.3 37.2 21.5 18.1 28.8 29.7 22.8 20.2 29.1 23.5 28.6 22.6 18.3 14.3 23.7 35.2 53.6 23.7 54.5 12.1 43.9 25.6 41.3 35.2 31.2 37.4 16.2 15.4 29.7 29.1 56.0 46.2 14.3 35.3 12.0 41.5 50.8 40.8 23.7 14.5 30.9 55.8 19.2 29.9 25.3 45.5 40.4 26.8 14.9 31.7 76.9 11.3 120.1 22.7 25.4 28.1 19.6 35.6 14.9 19.1 20.7 16.1 27.5 24.4 60.5 40.2 76.5 26.8 40.8 23.5 56.4 46.5 32.3 39.2 59.8 42.8 37.2 70.3 37.3 43.8 33.0 115.7 24.7 36.4 37.2 39.1 50.3 36.9 38.1 38.2 37.3 35.6 37.6 38.0 37.9 40.1 46.2 9.6 6.3 0.0 25.0 0.0 33.0 0.0 23.9 6.2 33.1 53.1 0.0 28.6 9.3 20.2 2.1 53.8 20.0 19.5 54.8 51.7 149.0 32.2 34.6 32.3 18.2 135.4 0.0 24.5 66.0 36.6 14.3 18.2 11.4 22.8 42.8 45.6 70.4 6.7 0.0 19.6 0.0 51.8 0.0 61.6 42.9 48.4 0.0 0.0 70.2 33.1 29.9 0.0 0.0 43.1 21.7 53.8 16.9 21.9 20.5 43.2 7.3 15.5 59.2 28.1 28.4 158.0 153.8 21.4 0.0 61.6 21.4 24.1 23.6 31.1 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40491053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 1.5 1.7 2.0 2.0 3.2 3.1 3.0 2.9 2.4 2.0 2.3 2.1 2.3 2.0 2.1 1.4 2.5 1.3 1.8 1.9 2.7 2.2 2.4 2.0 2.4 2.6 2.8 1.6 2.6 2.5 3.1 1.2 2.1 3.0 2.1 2.6 4.2 2.7 2.2 2.6 2.4 2.0 2.3 2.1 3.0 2.4 1.1 2.7 1.5 3.0 2.2 2.9 1.7 1.5 4.5 1.9 2.5 2.9 2.8 4.5 4.3 1.3 2.7 3.1 4.5 3.9 0.9 2.6 0.2 1.4 2.2 2.2 2.1 3.2 5.0 4.8 3.6 1.1 6.1 2.2 1.4 4.6 4.2 5.0 3.4 3.9 4.7 6.6 3.9 3.8 0.2 3.9 2.9 2.9 2.3 0.1 2.1 1.6 2.2 2.8 1.2 3.0 3.3 2.1 4.2 2.1 2.2 2.4 4.1 2.0 2.9 3.4 2.7 3.6 3.3 2.7 2.0 2.8 1.6 2.2 0.2 2.1 2.6 3.7 0.8 0.7 1.1 0.7 0.9 0.7 0.7 0.6 0.8 1.0 0.8 0.6 0.9 0.8 1.3 1.0 0.6 1.2 0.7 2.0 3.2 2.9 2.4 1.9 2.7 2.6 2.8 1.6 3.0 2.1 2.7 4.5 1.5 0.0 1.1 1.0 2.3 0.3 0.8 0.6 1.2 3.6 1.0 1.0 1.3 0.0 0.3 3.7 2.1 1.4 1.0 0.7 0.0 1.4 0.1 1.4 1.6 1.6 0.0 2.1 0.5 1.5 0.9 1.2 1.5 1.1 0.0 2.4 1.8 0.9 1.1 0.0 1.0 1.3 0.0 1.6 0.4 0.0 1.2 1.2 0.0 2.8 1.6 2.5 2.1 1.0 2.3 0.6 0.2 0.4 1.7 0.5 1.6 1.3 1.0 3.6 0.0 2.0 1.1 1.2 1.4 1.7 0.1 0.4 1.5 2.5 0.8 0.6 CCDC184 "C12orf68, LOC387856" ENSG00000177875 "Coiled-coil domain containing 184" Q52MB2 12 48183644-48185926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Cell type enhanced" "Detected in many" "Early spermatids: 62.5;Late spermatids: 15.1;Sertoli cells: 46.0" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.7;AF22: 6.3;hTERT-RPE1: 2.4;SH-SY5Y: 4.3;U-2 OS: 2.5;U-87 MG: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039947, HPA041715" Uncertain Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA039947: AB_2676764, HPA041715: AB_2677634" "unprognostic (2.02e-1)" "unprognostic (1.16e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.61e-2)" "unprognostic (4.59e-1)" "unprognostic (1.33e-2)" "unprognostic (6.65e-2)" "unprognostic (9.79e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (1.07e-1)" "unprognostic (5.87e-4)" "unprognostic (1.08e-2)" "unprognostic (2.39e-2)" "unprognostic (2.55e-1)" "unprognostic (2.36e-2)" 0.9 5.3 11.6 0.9 12.2 0.1 1.0 11.6 21.4 2.4 1.5 1.6 0.2 5.5 0.3 0.9 1.0 1.3 1.8 10.6 22.0 0.7 0.3 0.8 0.2 17.0 13.1 11.2 7.6 0.6 5.8 11.7 2.3 21.7 1.4 0.4 5.0 0.4 0.8 0.9 0.4 0.9 1.4 7.1 0.9 1.0 6.3 13.6 0.0 0.9 0.4 0.0 2.0 1.5 33.5 0.0 2.7 6.3 0.2 0.5 0.5 0.0 0.2 1.2 0.3 0.5 0.3 0.1 0.0 0.1 0.2 1.6 0.1 0.6 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.3 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.7 2.5 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 12.2 11.6 21.4 10.6 22.0 17.0 13.1 11.2 21.7 7.1 13.6 33.5 1.2 0.0 0.0 2.6 1.1 0.0 0.1 0.0 6.2 2.3 0.3 1.9 0.6 0.0 0.6 0.0 0.0 0.7 2.0 0.1 0.0 0.3 62.5 0.4 9.4 3.1 5.3 0.0 5.6 0.0 0.6 11.2 1.1 0.2 0.0 4.2 6.8 0.0 0.9 5.0 12.7 0.0 0.0 0.3 0.0 15.1 0.3 0.5 0.0 1.0 0.0 3.0 0.0 1.5 1.1 0.1 0.0 2.2 0.2 0.1 0.0 0.0 5.1 7.0 46.0 8.6 7.6 12.7 1.8 2.2 0.0 1.5 3.2 1.8 0.0 0.0 AP3S1 CLAPS3 ENSG00000177879 "Adaptor related protein complex 3 subunit sigma 1" Q92572 5 115841592-115914081 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA Vesicles "HPA049270: AB_2680696" "prognostic unfavorable (1.22e-4)" "unprognostic (2.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.60e-2)" "unprognostic (3.83e-3)" "unprognostic (4.42e-3)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.57e-8)" "unprognostic (2.73e-2)" "unprognostic (3.62e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-1)" 63.7 45.0 65.6 39.1 67.7 134.5 60.7 63.0 85.2 70.7 63.5 54.2 62.5 55.7 114.6 66.4 46.5 49.6 53.0 69.2 68.5 37.8 75.3 38.4 65.2 69.0 65.9 63.9 70.2 63.7 25.1 19.8 60.6 71.0 44.0 60.7 34.3 59.9 86.4 22.1 61.2 82.1 64.7 66.6 39.4 38.0 57.8 66.4 41.4 49.7 34.7 61.6 60.8 25.6 70.9 134.3 44.8 95.2 63.4 257.4 369.1 89.2 142.6 132.4 94.1 152.0 98.9 121.4 107.5 68.4 162.8 115.4 38.1 58.8 230.4 157.6 320.3 114.4 45.1 43.8 146.2 139.8 76.2 84.6 168.6 177.9 100.2 112.1 123.5 109.4 122.1 47.1 80.9 150.3 49.9 87.3 129.0 71.1 65.5 74.4 85.0 141.9 172.0 123.2 58.8 35.1 53.8 222.8 42.7 146.3 86.2 70.3 116.1 115.4 173.1 116.5 127.1 113.4 71.6 47.3 91.8 129.9 144.2 73.5 81.9 70.7 174.8 37.6 79.2 63.7 67.1 47.1 52.3 54.5 47.3 39.9 41.6 110.0 48.3 75.8 94.8 60.3 70.6 65.6 67.7 63.0 85.2 69.2 68.5 69.0 65.9 63.9 71.0 66.6 66.4 70.9 75.6 22.4 21.9 31.3 90.1 203.0 92.8 308.5 95.0 68.0 72.9 59.3 26.4 67.2 115.0 46.0 25.0 74.1 95.0 129.7 70.5 93.6 130.2 37.8 62.1 73.9 76.1 31.7 83.1 86.5 309.4 158.3 43.8 35.1 83.6 39.6 81.8 87.2 152.6 26.9 61.2 131.5 105.8 111.7 185.7 217.4 173.1 88.4 115.6 68.4 103.9 19.6 74.2 46.3 49.9 111.4 105.5 111.3 103.6 118.3 361.1 156.7 59.8 77.7 32.9 48.2 118.0 108.8 104.7 131.5 227.9 128.7 79.0 60.7 74.9 112.5 GRB2 NCKAP2 ENSG00000177885 "Growth factor receptor bound protein 2" P62993 17 75318076-75405709 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 340.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002589, HPA030749, HPA030750" Approved Supported Nucleoplasm,Nucleoli NA NA 400000 Nucleoplasm Nucleoli "CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591" "unprognostic (4.83e-3)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "unprognostic (3.42e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.04e-7)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.89e-2)" "unprognostic (1.08e-2)" "unprognostic (8.13e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.58e-1)" 56.2 58.5 68.4 99.2 67.2 128.2 40.6 58.6 67.5 35.8 53.1 55.2 57.9 46.8 31.8 51.4 39.8 43.6 50.5 73.3 68.0 50.8 54.4 66.1 117.9 66.3 66.8 67.4 39.7 35.3 40.1 42.9 65.1 63.1 42.1 53.1 24.3 41.0 46.2 49.2 36.6 61.1 59.5 68.1 92.9 45.0 18.7 68.9 83.9 38.0 39.5 108.2 68.2 36.4 72.9 98.6 87.7 58.9 71.1 64.1 54.5 129.5 91.2 70.5 89.3 87.3 75.8 66.7 128.9 57.9 97.0 77.5 58.5 84.0 76.1 89.8 63.4 76.5 137.2 55.7 111.8 57.3 162.8 259.0 55.2 78.0 112.9 55.8 62.3 128.3 125.3 95.5 88.8 64.9 127.4 160.3 160.5 40.5 98.9 81.3 113.7 123.8 94.9 82.7 75.0 66.6 101.1 83.7 85.4 114.7 102.8 94.4 264.9 83.4 100.0 71.0 81.8 104.9 161.1 127.3 205.5 79.1 125.8 75.3 134.5 136.1 164.9 52.3 160.9 45.0 94.5 48.0 52.2 101.2 96.5 46.8 47.8 273.8 51.5 185.1 71.9 56.5 102.9 68.4 67.2 58.6 67.5 73.3 68.0 66.3 66.8 67.4 63.1 68.1 68.9 72.9 73.5 60.9 62.2 18.3 210.5 47.0 45.7 31.0 67.7 35.7 45.6 37.5 59.7 41.5 46.9 16.5 31.3 71.9 137.6 74.4 52.8 64.8 3.0 52.9 56.4 60.9 41.9 55.5 41.5 63.4 340.9 47.2 47.9 57.6 124.4 30.0 41.7 42.3 260.3 35.3 41.1 46.4 22.4 182.0 243.8 5.6 25.1 259.9 46.2 81.5 237.0 47.1 73.2 31.7 41.5 77.2 69.6 41.8 236.3 63.3 60.1 69.9 55.1 46.4 6.6 34.6 50.5 27.4 49.9 76.3 44.8 87.2 109.0 59.7 44.9 92.7 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153682-197201293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 3.5 4.8 5.9 3.1 5.5 1.3 7.0 7.5 5.8 5.3 2.9 3.3 3.3 4.2 4.7 3.4 3.8 4.3 3.2 5.3 6.0 5.3 4.5 3.4 3.9 6.8 7.0 4.3 6.8 4.0 4.8 3.9 3.3 6.2 4.3 3.6 7.1 4.0 3.4 3.7 3.5 2.9 3.2 7.0 4.4 4.4 3.9 6.4 5.3 7.5 4.7 3.4 4.0 2.4 7.8 8.1 4.6 5.8 4.7 9.0 13.6 4.6 4.8 7.8 4.9 4.6 2.9 6.7 3.0 6.8 10.9 3.0 6.5 4.1 4.1 7.7 2.7 2.4 2.4 6.0 2.6 8.0 4.8 2.3 5.6 10.6 5.0 8.6 10.0 3.4 3.4 5.7 3.5 12.8 3.9 3.6 2.7 2.3 5.6 1.6 2.5 8.1 5.4 6.0 4.5 8.3 7.4 8.6 14.9 9.3 4.2 11.4 3.6 5.6 9.7 5.6 7.8 6.3 4.0 2.2 3.2 4.6 1.7 13.8 0.3 0.1 0.1 0.2 0.1 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.4 0.1 0.1 0.2 0.1 5.9 5.5 7.5 5.8 5.3 6.0 6.8 7.0 4.3 6.2 7.0 6.4 7.8 11.6 19.2 8.9 21.2 9.4 7.5 6.9 5.8 11.4 13.6 17.5 10.7 14.7 10.0 10.0 16.5 2.1 4.3 10.6 4.2 1.9 6.3 3.2 14.5 18.0 8.2 13.1 1.7 32.1 5.7 4.0 13.3 7.7 11.3 1.3 18.5 6.8 9.2 4.4 25.2 27.9 7.3 2.0 7.3 5.2 4.6 15.5 8.1 12.4 13.1 9.3 28.5 11.3 19.6 41.0 6.8 2.9 12.0 6.3 9.4 4.3 10.4 12.8 9.1 6.6 13.3 12.7 7.0 4.9 10.8 10.1 3.4 7.7 16.0 7.0 6.0 UBE2N "MGC8489, UBC13, UbcH-ben" ENSG00000177889 "Ubiquitin conjugating enzyme E2 N" P61088 12 93405673-93441947 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 15 "Early spermatids: 2532.0;Late spermatids: 8141.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044976 Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 1800000 Nucleoplasm "Nucleoli fibrillar center" "HPA044976: AB_2679163" "unprognostic (1.74e-2)" "unprognostic (5.53e-1)" "unprognostic (1.26e-2)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (8.09e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (8.49e-3)" "unprognostic (2.72e-1)" "unprognostic (4.28e-3)" "unprognostic (1.07e-1)" "unprognostic (9.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.48e-1)" "unprognostic (1.30e-3)" 52.8 49.1 43.4 62.7 51.8 70.5 42.0 41.8 52.0 35.0 29.8 56.5 42.9 44.3 38.6 60.8 37.6 33.7 58.1 49.3 55.8 50.8 45.9 38.6 80.6 46.7 44.2 47.7 31.5 30.8 40.8 32.9 49.9 50.4 46.4 44.5 50.8 36.3 34.9 83.8 40.3 42.6 43.0 43.4 43.3 41.4 188.4 45.9 80.2 29.2 70.9 74.4 77.2 38.9 60.8 190.3 133.2 221.1 142.6 82.9 81.4 154.5 259.4 135.6 201.0 167.3 239.8 80.0 380.2 57.3 151.1 133.8 147.7 245.2 188.7 189.7 323.3 128.4 258.0 66.6 214.2 106.4 311.9 165.1 86.3 75.2 120.8 148.9 143.1 157.3 146.9 292.8 58.0 210.9 155.3 310.4 286.2 288.9 165.9 189.4 237.3 179.9 186.6 170.1 280.9 214.9 195.6 136.1 158.5 130.0 118.7 207.5 188.0 165.8 135.7 114.6 124.1 189.9 99.5 289.4 324.0 53.5 162.5 170.2 133.7 89.5 101.3 99.3 123.3 116.8 174.0 124.8 124.1 119.6 144.7 109.3 104.9 27.7 106.0 141.7 89.6 198.6 202.5 43.4 51.8 41.8 52.0 49.3 55.8 46.7 44.2 47.7 50.4 43.4 45.9 60.8 87.5 38.5 45.8 24.8 151.4 322.2 231.3 219.1 92.2 72.1 84.3 60.5 74.6 60.1 112.2 90.1 27.1 236.0 104.3 76.3 191.7 141.4 2532.0 79.7 79.0 95.3 74.7 75.9 44.6 99.0 226.0 100.9 49.5 96.5 93.8 68.3 55.3 55.3 165.6 87.5 49.0 78.6 187.2 67.8 216.3 8141.3 93.8 97.0 147.7 33.7 152.9 111.9 79.3 38.7 42.1 135.5 83.8 86.1 113.3 218.2 61.2 171.3 88.9 57.6 46.0 101.9 146.2 338.4 227.6 142.2 322.5 284.7 128.2 86.4 94.9 260.3 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152762396 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 155.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 214.0;eosinophil: 161.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 214.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" NA Yes "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 5.0 3.9 3.2 1.8 3.9 8.4 4.8 3.3 2.9 4.3 2.4 3.4 2.4 4.2 1.2 6.0 3.8 1.2 2.6 2.5 3.8 2.5 1.9 4.0 3.4 3.9 3.4 2.3 5.1 2.7 1.1 3.1 4.4 4.1 3.1 1.9 3.2 3.9 1.8 3.5 6.9 3.5 1.6 4.0 4.4 3.1 5.4 3.5 4.0 3.3 2.0 2.5 4.2 5.6 5.4 9.6 6.2 13.7 3.9 4.1 4.6 19.7 11.6 4.9 9.6 12.2 14.2 13.3 17.2 10.6 5.2 4.3 10.7 8.1 5.7 10.4 26.1 15.1 14.2 5.3 13.0 4.5 12.1 12.4 3.3 6.5 10.6 8.9 3.4 7.5 11.9 14.9 10.6 7.8 7.1 12.1 12.6 13.3 3.2 12.7 13.0 13.4 13.9 4.5 7.2 11.6 12.0 10.4 1.1 9.7 4.7 4.7 7.9 10.0 14.4 9.9 10.2 10.3 9.9 10.3 13.1 6.8 10.4 12.3 214.0 9.1 161.8 13.2 10.2 13.2 20.3 13.3 13.5 10.9 18.4 13.6 11.4 24.8 9.7 12.8 24.8 19.7 13.2 3.2 3.9 3.3 2.9 2.5 3.8 3.9 3.4 2.3 4.1 4.0 3.5 5.4 34.3 16.0 10.0 30.7 41.9 106.6 48.5 74.0 50.7 6.3 20.3 14.9 4.3 17.2 29.9 11.0 4.2 155.7 42.4 14.1 17.6 24.9 14.1 17.7 20.0 31.3 13.8 81.0 21.0 18.6 136.2 27.9 30.1 25.0 27.3 19.4 28.5 5.9 39.8 8.4 23.8 22.2 38.7 24.2 57.2 24.2 19.6 33.6 46.2 30.9 46.2 19.8 32.0 38.7 56.8 22.5 18.6 17.0 33.8 40.3 16.3 8.8 29.2 15.8 32.9 22.2 24.9 24.4 30.0 43.4 106.6 108.4 45.2 27.9 24.5 51.3 ZNF354C KID3 ENSG00000177932 "Zinc finger protein 354C" Q86Y25 5 179060373-179083977 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.8" "Low region specificity" "Detected in all" "HPA030904, HPA068570" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA030904: AB_10603842, HPA068570: " "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (6.56e-4)" "unprognostic (4.76e-1)" "unprognostic (2.40e-3)" "unprognostic (2.61e-2)" "unprognostic (2.83e-2)" "unprognostic (1.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (5.57e-2)" "unprognostic (1.62e-1)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "unprognostic (4.00e-2)" "unprognostic (2.83e-1)" 3.2 2.2 2.5 2.4 3.5 0.6 4.1 6.1 2.7 3.7 1.8 2.5 1.2 5.2 1.9 2.0 3.6 2.6 2.8 2.3 2.9 2.2 1.4 2.6 3.4 3.0 3.5 1.6 7.1 2.0 3.1 1.2 3.2 3.4 3.5 1.7 6.4 2.1 3.4 2.2 1.9 2.0 3.8 3.0 3.3 2.0 2.3 3.2 4.4 4.7 4.4 3.5 2.5 2.3 4.4 1.0 1.4 11.1 17.8 5.6 9.0 0.0 5.0 4.3 5.4 6.1 0.0 2.2 0.0 5.9 5.4 9.0 3.4 0.0 1.7 10.2 0.0 0.1 0.0 0.5 0.0 5.3 0.0 2.4 6.8 1.6 5.4 0.0 1.7 2.6 0.0 0.1 0.0 6.5 0.6 10.6 0.0 7.7 0.8 0.0 0.0 0.0 0.0 2.0 0.4 6.7 11.2 7.8 0.1 5.2 4.7 4.6 4.2 3.3 0.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.1 0.1 0.5 0.2 0.5 0.3 0.7 0.5 0.2 0.3 0.7 0.6 0.0 0.3 0.6 0.0 0.5 0.3 2.5 3.5 6.1 2.7 2.3 2.9 3.0 3.5 1.6 3.4 3.0 3.2 4.4 6.4 3.2 3.1 10.4 2.6 0.9 0.6 1.4 2.8 10.5 1.7 3.0 6.1 4.3 2.3 0.0 0.0 2.2 2.2 0.1 0.0 1.3 0.4 1.3 5.5 4.3 0.0 2.1 8.0 0.9 1.4 5.1 0.5 1.3 1.3 7.4 4.6 0.9 1.7 16.8 2.5 0.5 2.0 1.6 2.2 0.4 3.1 1.7 1.8 4.7 0.6 5.4 1.0 17.6 16.2 0.7 0.1 5.7 0.7 0.6 0.2 0.6 1.3 5.0 6.6 7.0 3.9 2.3 1.3 2.2 0.9 0.5 2.2 4.3 0.7 0.3 CAPZA3 "CAPPA3, Gsg3" ENSG00000177938 "Capping actin protein of muscle Z-line subunit alpha 3" Q96KX2 12 18738119-18739188 "Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 84 "testis: 184.0" "Group enriched" "Detected in some" 186 "Early spermatids: 2526.3;Late spermatids: 7326.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038688 Enhanced NA NA "HPA038688: AB_2676151" "unprognostic (5.56e-2)" "unprognostic (1.43e-1)" "unprognostic (4.45e-3)" "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.4 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 2.1 0.0 0.0 0.0 0.0 1.3 184.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2526.3 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7326.9 26.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 25.3 14.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MAMDC4 "AEGP, DKFZp434M1411, EDTB" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 30.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 22.9;Hepatocytes: 26.6;Horizontal cells: 16.8;Intestinal goblet cells: 21.8;Proximal enterocytes: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.9" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 3.2 1.6 1.7 1.6 1.4 2.4 6.4 3.1 3.6 1.0 5.8 3.9 2.5 0.3 2.8 4.5 0.7 4.9 1.2 1.8 7.0 30.9 3.6 0.9 1.7 1.4 0.8 3.1 7.5 0.6 15.1 1.0 3.5 7.8 0.9 0.7 3.3 1.0 2.5 1.6 5.8 0.5 1.0 9.8 3.9 4.3 1.9 0.7 11.4 0.9 0.2 2.6 3.1 3.1 1.5 2.5 1.3 2.6 0.5 0.1 16.9 2.5 0.3 0.3 0.5 1.9 1.4 1.3 0.6 0.6 0.7 2.1 0.3 1.2 0.0 1.9 0.9 0.8 6.1 2.2 1.0 0.1 4.6 0.8 1.5 1.2 0.5 1.3 0.7 2.3 2.6 1.1 0.2 4.0 0.9 3.5 1.3 1.0 0.7 1.5 0.4 2.3 0.8 1.3 1.5 1.9 0.5 1.2 1.1 0.8 4.0 0.8 0.7 6.8 4.2 1.4 0.4 2.8 1.6 0.4 1.5 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.6 6.4 3.1 1.2 1.8 1.7 1.4 0.8 3.5 1.0 1.9 3.1 1.0 0.0 3.4 6.8 2.0 0.8 1.0 3.9 1.2 5.9 2.4 3.6 7.9 11.5 1.8 1.8 0.0 2.5 2.6 22.9 1.9 0.8 2.2 0.6 1.1 1.5 0.0 3.2 1.1 4.8 3.9 2.4 4.1 1.4 0.0 6.7 2.5 26.6 2.6 16.8 2.1 21.8 6.1 1.9 1.2 2.7 1.8 1.6 0.0 0.0 1.7 2.9 1.0 2.5 1.9 0.9 11.3 1.5 3.0 1.4 23.4 2.5 2.9 7.6 0.0 1.0 2.4 1.6 2.1 0.9 0.4 2.3 1.8 1.8 12.4 0.6 ODF3 "CT135, hSHIPPO, SHIPPO1" ENSG00000177947 "Outer dense fiber of sperm tails 3" Q96PU9 11 196761-200261 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 9.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 95.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038919, HPA039241" Enhanced NA NA "HPA038919: AB_2676270, HPA039241: AB_10673417" "unprognostic (4.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.24e-2)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 34.4 38.5 26.9 29.7 27.0 18.1 35.8 25.6 26.9 41.3 32.0 36.6 29.4 37.3 37.6 30.4 39.1 27.8 32.5 24.8 29.4 40.6 53.9 35.7 33.2 30.2 27.7 23.2 54.1 80.6 40.2 56.4 30.0 26.9 43.7 30.0 17.3 53.4 42.0 22.7 34.4 39.8 31.6 26.3 39.7 43.5 33.3 26.8 28.5 37.8 23.6 36.0 37.7 33.5 29.0 46.2 37.6 22.0 27.3 66.5 58.3 31.8 48.1 62.8 50.6 51.5 47.3 43.4 40.5 22.9 87.7 36.4 42.1 25.6 44.0 38.3 31.6 27.7 37.5 21.5 48.2 61.4 43.2 70.2 66.2 58.1 29.8 79.6 58.7 34.7 28.2 55.7 41.3 32.7 25.0 31.7 27.3 33.6 66.8 42.3 32.6 32.6 27.7 41.8 20.3 23.9 29.0 42.9 68.5 47.7 31.5 35.2 33.6 38.6 39.0 18.0 16.0 24.0 72.2 35.9 35.6 52.7 35.6 36.4 58.5 19.0 66.0 28.4 27.5 34.1 31.9 32.5 29.1 19.0 25.0 37.4 29.6 43.5 27.9 25.8 22.1 27.4 32.5 26.9 27.0 25.6 26.9 24.8 29.4 30.2 27.7 23.2 26.9 26.3 26.8 29.0 9.8 12.8 17.0 3.9 23.0 9.3 16.8 12.8 16.5 6.8 21.3 19.0 14.5 15.7 10.7 14.7 8.4 15.8 16.9 24.4 21.5 12.8 58.8 8.6 13.2 10.6 7.8 12.0 3.6 23.4 28.2 19.4 20.9 10.1 38.0 10.2 18.2 39.3 22.7 3.3 4.4 23.1 14.2 16.4 12.7 142.9 22.1 18.4 7.2 2.8 14.8 9.1 10.3 4.0 4.7 18.6 26.1 18.8 68.3 29.2 39.2 28.7 12.6 10.4 6.6 12.8 15.9 47.2 21.8 11.9 11.6 26.3 19.4 8.9 17.1 29.3 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990762-153992155 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "prognostic favorable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 5590.8 3483.4 3570.3 2866.5 3609.9 7260.9 8752.0 3520.1 5876.8 7295.6 3601.9 4832.4 1905.3 4538.6 4077.7 4744.8 5906.8 2293.4 3496.8 3521.5 3604.2 4249.6 3671.7 4111.6 7196.0 3646.1 3575.7 3484.0 12508.9 7568.8 3168.4 3837.4 2234.1 3606.2 5442.0 3615.5 1424.2 4386.8 3477.5 5004.1 7445.0 5484.3 2801.8 3557.6 6934.2 5070.5 1681.1 3616.9 8556.5 4731.7 4161.5 9261.6 5543.8 5778.5 3685.7 3446.4 3986.5 5147.0 2805.0 11901.1 11649.6 3148.9 4096.1 9832.9 5421.0 4866.7 8059.8 3705.0 7817.4 3304.5 6009.8 1792.6 3390.5 4624.1 6847.5 4577.2 3804.0 5945.0 3090.0 5442.0 5323.3 7881.7 6945.8 3888.2 11426.5 13193.2 4334.0 7920.5 8011.4 4546.6 6426.6 3865.0 4112.2 5239.5 8711.2 7513.7 4328.1 6227.9 11540.0 5775.4 4735.7 3753.2 6114.5 5064.7 6938.6 2702.3 5977.7 2340.0 8120.1 7572.9 6970.2 4531.0 13542.1 2672.3 1841.0 3043.3 2963.9 4141.0 8191.3 9166.7 9585.2 3202.5 3805.3 2591.7 12942.7 11463.1 5536.5 28801.5 11225.6 34790.5 56947.7 43040.6 37135.0 13993.9 48738.8 53667.4 42304.0 2458.8 27662.5 10603.9 23115.6 32257.9 76381.9 3570.3 3609.9 3520.1 5876.8 3521.5 3604.2 3646.1 3575.7 3484.0 3606.2 3557.6 3616.9 3685.7 3187.7 2201.9 3978.4 11.4 13562.6 12494.3 5398.2 7693.2 4868.2 411.9 6937.5 6570.1 939.8 5752.0 4175.1 2155.5 193.9 6037.3 9149.7 2192.5 4431.5 4142.9 2927.6 1809.2 4392.1 3779.0 3022.4 4789.2 5.4 10431.2 6808.0 4116.6 2102.4 2597.5 4306.7 4628.6 6451.6 8222.0 4303.1 191.8 6.0 6849.8 1953.1 9173.5 14035.0 10184.0 7097.1 4890.7 5914.2 5.6 9465.8 1961.9 9527.4 3.0 6.8 6134.0 5941.1 3543.1 3703.6 4365.2 6412.1 6526.1 1955.9 646.0 2734.7 5847.6 4188.0 1563.3 1638.3 4859.8 14322.5 6382.1 11013.6 1757.5 6839.1 4530.7 RIC8A "synembryn, synembryn-A" ENSG00000177963 "RIC8 guanine nucleotide exchange factor A" Q9NPQ8 11 207511-215113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041491, CAB046012" Approved Approved "Plasma membrane,Cytosol" NA NA 10000 Cytosol "Plasma membrane" "CAB046012: AB_11129402, HPA041491: AB_2677510" "unprognostic (3.93e-2)" "unprognostic (8.69e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.60e-4)" "unprognostic (1.61e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.13e-3)" "unprognostic (8.70e-2)" "unprognostic (7.68e-2)" "unprognostic (1.56e-1)" "unprognostic (8.35e-2)" "unprognostic (2.63e-3)" "unprognostic (5.35e-2)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.60e-1)" 38.6 40.0 41.2 35.1 41.6 40.9 37.7 40.5 48.9 41.1 43.7 43.5 29.8 44.6 42.2 43.5 41.4 30.8 41.0 44.2 42.9 36.1 38.1 37.9 37.9 41.0 42.8 43.2 40.1 39.6 34.4 38.4 34.4 41.8 39.3 31.1 25.0 34.6 40.7 33.1 39.9 38.4 49.9 41.6 41.9 38.4 44.4 41.9 42.0 34.0 28.6 42.1 46.3 36.9 42.9 176.3 83.9 66.8 66.7 89.7 73.4 46.3 124.1 99.2 166.0 114.2 72.6 121.1 69.6 50.5 189.0 125.7 93.4 76.4 131.4 92.0 84.5 76.7 39.4 59.5 67.8 72.3 66.5 125.8 80.6 114.3 103.2 92.6 85.2 82.8 72.8 68.7 66.0 129.3 71.1 79.6 52.6 61.1 74.0 103.0 74.0 66.0 47.5 96.9 45.6 69.2 62.2 96.3 107.1 67.1 63.9 76.1 52.8 93.4 109.2 96.5 40.4 117.3 72.6 117.6 67.8 107.7 59.5 83.5 72.9 41.1 88.3 79.0 49.7 78.2 64.4 70.1 69.0 43.7 55.1 59.9 60.6 59.9 73.0 61.0 35.8 65.0 86.6 41.2 41.6 40.5 48.9 44.2 42.9 41.0 42.8 43.2 41.8 41.6 41.9 42.9 30.9 16.0 21.1 10.7 28.7 17.7 20.5 38.6 17.1 28.1 22.5 27.2 23.5 28.6 25.5 25.8 10.4 41.4 46.5 26.3 27.4 53.1 20.2 15.9 24.3 27.2 20.3 27.4 9.4 44.2 60.0 30.4 23.0 19.7 17.7 28.8 27.8 17.1 46.8 32.0 8.4 19.2 30.5 27.4 11.5 17.3 30.7 27.5 28.4 11.2 38.9 43.4 30.9 5.0 7.8 71.6 25.5 39.9 35.2 26.5 29.9 23.0 20.8 33.1 19.7 20.7 35.4 93.2 62.5 20.9 19.5 32.4 34.8 30.2 25.0 17.0 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP U3 small nucleolar ribonucleoprotein 3" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA060955: AB_2684397, HPA061177: AB_2684445" "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 45.9 62.3 39.4 26.6 40.2 29.5 44.2 40.6 49.5 34.8 46.3 38.2 36.9 30.4 30.7 80.4 33.0 14.4 46.5 40.5 41.8 49.0 91.2 34.2 35.2 40.4 39.5 39.1 33.5 51.1 23.4 40.4 21.3 40.9 40.0 24.6 17.9 45.2 22.4 72.1 68.0 52.0 14.1 41.5 63.5 51.3 16.9 39.9 35.1 36.4 33.4 38.7 35.4 47.8 43.3 75.1 82.9 39.5 68.8 68.6 39.0 58.5 61.6 48.8 49.3 56.6 64.1 64.3 88.7 65.5 32.2 54.5 121.7 131.1 100.0 43.4 67.2 157.3 93.6 64.9 112.8 50.6 95.9 62.5 36.1 81.0 39.8 48.8 36.6 32.8 71.3 122.8 70.4 45.4 89.9 76.3 232.9 106.4 75.7 86.4 82.1 48.4 98.3 68.1 100.2 67.1 69.4 52.2 89.8 119.4 56.8 78.5 87.9 37.6 64.0 51.9 46.4 84.6 95.4 188.5 100.3 70.7 153.2 43.0 80.6 109.0 85.2 137.4 87.3 148.8 143.2 131.5 133.8 117.4 127.3 150.7 144.3 13.7 126.4 87.4 119.3 140.9 192.2 39.4 40.2 40.6 49.5 40.5 41.8 40.4 39.5 39.1 40.9 41.5 39.9 43.3 85.9 38.5 41.6 6.5 81.4 228.5 93.1 177.0 149.7 22.4 72.1 79.4 12.1 77.2 89.7 40.5 14.6 106.8 79.0 47.5 144.8 105.2 1.6 71.7 54.9 74.0 43.9 56.8 6.8 105.9 106.5 63.0 78.0 70.9 48.7 50.8 76.4 114.1 94.2 21.9 7.1 71.2 93.6 54.3 106.6 6.6 60.9 51.0 97.8 8.4 118.0 58.2 152.4 6.0 10.2 113.7 56.0 44.0 66.5 107.0 113.8 209.5 65.2 23.7 26.3 46.1 50.7 13.9 38.2 144.4 237.4 54.9 83.3 77.2 98.8 86.9 ASB8 "FLJ21255, MGC5540" ENSG00000177981 "Ankyrin repeat and SOCS box containing 8" Q9H765 12 48147789-48181213 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 294.7;tongue: 186.1" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003299 Approved NA NA "HPA003299: AB_1845072" "unprognostic (1.35e-2)" "unprognostic (1.32e-1)" "unprognostic (2.91e-2)" "unprognostic (8.82e-3)" "unprognostic (1.07e-1)" "unprognostic (1.06e-2)" "unprognostic (2.40e-3)" "unprognostic (3.51e-2)" "unprognostic (3.66e-2)" "unprognostic (1.29e-3)" "unprognostic (3.82e-3)" "unprognostic (1.14e-1)" "prognostic favorable (6.57e-6)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.04e-2)" "unprognostic (6.26e-2)" 19.9 22.8 21.3 20.3 23.0 62.2 21.4 35.3 28.4 16.0 18.1 22.2 21.7 19.4 21.7 22.9 18.8 16.0 45.9 22.2 22.0 28.0 28.5 17.5 23.3 21.9 21.1 23.2 22.3 21.9 33.7 16.8 15.6 23.5 20.8 26.8 73.8 21.4 22.0 294.7 21.5 20.7 24.6 19.6 22.9 21.6 17.3 21.3 29.6 18.8 186.1 27.0 17.9 13.3 25.4 19.3 16.1 17.6 26.9 26.9 23.9 12.7 33.1 23.1 23.1 20.6 24.4 23.4 31.5 26.6 30.4 12.7 16.5 28.3 19.8 26.2 37.3 24.9 38.9 22.1 12.8 20.4 36.5 33.9 23.4 18.8 29.5 17.1 39.6 23.3 35.5 29.5 38.6 20.9 18.2 33.8 25.8 6.6 24.1 28.4 21.7 27.1 32.6 18.3 19.6 27.6 17.6 18.9 24.5 21.2 16.3 45.7 24.8 17.9 19.4 14.0 19.9 15.0 33.1 41.4 27.1 24.6 81.6 11.0 91.7 23.2 117.0 30.8 26.3 28.5 28.6 32.8 31.4 22.8 20.9 32.9 34.3 53.5 36.7 35.8 24.4 33.7 23.1 21.3 23.0 35.3 28.4 22.2 22.0 21.9 21.1 23.2 23.5 19.6 21.3 25.4 26.7 22.4 22.6 11.8 26.9 7.0 9.1 15.4 17.6 63.4 18.5 22.4 68.4 27.1 16.1 16.5 62.6 23.2 35.3 29.5 41.1 22.6 24.0 10.4 17.0 23.1 18.6 40.8 19.2 21.8 12.8 22.5 20.9 12.4 20.3 25.5 23.2 31.7 24.6 40.4 21.0 24.3 12.2 24.8 11.8 75.3 24.2 22.9 21.4 7.5 33.5 55.8 46.4 15.6 19.1 19.1 24.3 27.8 25.4 10.8 31.2 42.0 16.0 120.0 52.6 37.4 24.0 35.9 21.1 22.9 11.1 17.1 29.3 37.0 22.1 9.2 LCN15 "PRO6093, UNQ2541" ENSG00000177984 "Lipocalin 15" Q6UWW0 9 136759634-136766255 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.0;seminal vesicle: 3.3" "Cell type enriched" "Detected in some" 4 "Enteroendocrine cells: 391.5" "Cancer enriched" "Detected in some" 19 "colorectal cancer: 23.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 17.7" "Low region specificity" "Detected in all" HPA060584 Enhanced "Secreted in other tissues" NA NA "HPA060584: AB_2684327" "unprognostic (5.24e-1)" "unprognostic (2.61e-1)" "unprognostic (2.14e-1)" "unprognostic (3.67e-1)" "unprognostic (3.45e-2)" "unprognostic (3.28e-2)" "unprognostic (2.39e-1)" "unprognostic (1.83e-1)" 0.0 0.0 1.9 0.0 1.9 0.0 0.1 1.9 2.3 0.0 1.9 3.0 12.0 0.0 1.4 0.0 0.0 0.0 0.9 1.9 1.9 0.0 0.0 0.0 0.0 1.9 1.9 1.9 0.0 0.0 0.0 0.0 0.1 1.9 0.3 1.9 0.0 0.0 3.3 0.6 0.0 3.7 0.0 1.9 0.1 0.0 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.9 2.3 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.2 0.0 0.6 391.5 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 96.9 24.4 0.3 0.4 2.8 0.0 0.1 1.8 0.0 0.0 0.0 0.0 1.0 0.8 0.0 14.7 0.0 0.0 0.2 5.5 0.1 0.0 0.9 0.0 0.3 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.9 0.4 ODF3B FAP123 ENSG00000177989 "Outer dense fiber of sperm tails 3B" A8MYP8 22 50529710-50532580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 89.6" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 455.4;Late spermatids: 807.7;Respiratory ciliated cells: 417.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 92.0;intermediate monocyte: 75.6;myeloid DC: 55.5;neutrophil: 56.2;non-classical monocyte: 53.6" "Group enriched" "Detected in many" 16 "dendritic cells: 55.5;granulocytes: 56.2;monocytes: 92.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.5;Karpas-707: 40.8;U-266/70: 57.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062837 Enhanced NA NA "HPA062837: AB_2684877" "unprognostic (4.30e-3)" "unprognostic (1.45e-2)" "unprognostic (5.98e-2)" "prognostic favorable (2.84e-4)" "unprognostic (2.60e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (5.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (2.72e-1)" "unprognostic (1.51e-2)" "unprognostic (6.10e-2)" "unprognostic (3.61e-2)" 22.1 6.1 13.4 27.1 11.0 13.4 24.5 10.4 4.5 13.6 19.2 8.1 7.0 6.1 0.9 14.5 89.6 9.9 16.5 5.7 15.7 16.1 32.6 36.7 14.2 26.3 20.0 1.0 2.1 9.0 4.0 8.0 6.9 15.7 20.0 1.6 0.0 46.9 5.5 5.4 11.9 12.4 2.1 17.8 24.3 12.4 16.4 14.7 6.0 22.1 1.7 4.2 6.8 11.4 7.6 2.9 1.8 0.3 0.7 0.0 3.6 1.7 0.1 0.6 0.1 1.8 3.2 13.5 1.0 3.4 0.1 0.5 8.1 0.0 0.0 0.0 1.4 0.9 0.6 2.5 2.4 10.0 0.0 6.5 2.1 1.7 0.0 0.0 1.0 0.2 1.0 0.8 40.8 0.0 0.0 0.0 1.5 0.2 0.8 1.9 1.5 0.2 7.2 0.0 0.0 0.2 11.6 1.3 1.6 0.2 0.2 1.2 2.0 1.0 0.3 1.1 0.8 0.2 57.9 5.9 0.9 1.3 0.2 1.0 10.1 92.0 11.3 0.6 75.6 0.9 4.2 1.6 1.1 55.5 2.2 1.0 0.6 56.2 0.1 53.6 5.3 2.3 28.6 13.4 11.0 10.4 4.5 5.7 15.7 26.3 20.0 1.0 15.7 17.8 14.7 7.6 73.3 19.2 52.9 0.0 32.3 24.1 21.9 70.0 61.5 0.2 63.8 61.8 5.3 24.3 66.5 3.7 0.0 3.4 8.9 8.6 0.0 76.7 144.5 455.4 8.9 33.0 20.4 0.4 0.0 74.8 39.6 29.1 27.5 22.0 6.3 0.0 21.0 30.2 36.2 0.0 0.1 23.6 46.8 66.0 33.2 807.7 5.3 82.5 17.8 1.0 113.8 0.0 7.2 0.0 0.0 35.0 29.4 3.4 73.3 30.4 53.0 16.9 417.1 0.1 0.0 36.0 27.6 10.0 3.7 46.4 36.1 5.5 11.4 0.0 9.2 33.7 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 66.2" "Group enriched" "Detected in many" 4 "Early spermatids: 329.9;Excitatory neurons: 124.1;Inhibitory neurons: 137.2;Late spermatids: 363.0;Oligodendrocyte precursor cells: 124.1;Spermatocytes: 143.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 9.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 6.1 5.4 4.6 0.5 4.4 3.0 4.8 7.6 7.3 11.4 5.7 4.0 0.6 7.9 4.1 1.4 6.4 2.8 19.1 4.0 4.5 12.7 0.2 1.3 0.9 2.9 3.5 3.1 11.1 2.7 9.0 10.6 1.2 3.0 9.3 1.3 14.6 1.6 4.8 0.5 1.6 1.7 3.5 1.5 1.7 2.9 66.2 2.6 0.7 13.2 0.7 0.6 6.4 5.2 5.8 1.0 2.6 2.2 5.4 0.6 0.0 0.2 1.8 1.8 2.4 3.1 0.4 0.8 2.8 1.8 0.7 2.9 0.4 2.7 0.3 3.6 1.5 1.7 4.6 1.4 1.7 0.5 3.4 1.4 1.5 0.1 1.1 0.0 6.1 0.8 2.2 1.9 2.9 3.9 1.7 0.2 1.4 2.1 0.4 2.4 0.0 1.8 0.0 4.6 0.5 7.0 0.7 0.6 0.2 1.0 0.9 1.9 0.9 0.5 3.2 4.2 0.5 4.6 7.5 9.3 0.0 3.4 1.6 3.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 4.6 4.4 7.6 7.3 4.0 4.5 2.9 3.5 3.1 3.0 1.5 2.6 5.8 6.7 3.2 0.0 23.2 0.2 0.5 2.9 0.1 2.2 49.6 1.9 1.8 32.3 1.5 3.8 12.9 14.6 2.0 0.3 0.1 5.9 0.4 329.9 5.6 7.1 1.7 0.0 7.2 124.1 0.0 1.3 2.2 0.5 2.1 2.5 1.2 1.4 0.1 0.3 3.3 137.2 0.1 6.1 0.0 0.4 363.0 7.2 0.4 7.2 11.2 0.1 9.2 0.0 124.1 5.0 0.2 0.0 8.6 0.5 2.9 0.0 6.4 11.6 6.7 26.3 3.8 19.9 143.3 4.9 0.2 0.4 1.4 0.8 3.6 0.1 1.1 SPATA31E1 "C9orf79, FAM75E1, FLJ35866" ENSG00000177992 "SPATA31 subfamily E member 1" Q6ZUB1 9 87882877-87888903 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 77 "brain: 7.7;testis: 7.6" "Group enriched" "Detected in some" 95 "Early spermatids: 43.3;Late spermatids: 14.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "hippocampal formation: 7.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.7;SCLC-21H: 1.4" "Low region specificity" "Detected in some" HPA024253 Enhanced NA NA "HPA024253: AB_1845839" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C2orf73 FLJ40298 ENSG00000177994 "Chromosome 2 open reading frame 73" Q8N5S3 2 54330034-54383742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 51.0" "Group enriched" "Detected in some" 8 "Early spermatids: 1101.7;Late spermatids: 600.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055221, HPA059596" Uncertain NA NA "HPA055221: AB_2682744, HPA059596: AB_2684077" "unprognostic (1.56e-2)" "unprognostic (7.00e-3)" "unprognostic (1.51e-2)" "unprognostic (1.39e-2)" "unprognostic (5.46e-2)" "unprognostic (2.74e-2)" "unprognostic (6.69e-3)" "unprognostic (2.36e-2)" "unprognostic (1.62e-3)" "unprognostic (7.69e-2)" "unprognostic (3.00e-2)" "unprognostic (5.01e-3)" "unprognostic (1.17e-2)" "unprognostic (8.99e-2)" "unprognostic (3.80e-2)" 0.1 0.6 3.0 0.0 2.0 0.0 0.1 1.8 2.1 0.4 5.2 0.0 0.0 0.3 1.3 0.0 7.6 0.0 0.1 1.7 2.1 0.5 0.0 1.1 0.0 3.0 2.8 1.4 0.3 0.6 0.9 1.4 0.0 2.3 0.3 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 3.9 0.1 0.0 51.0 2.4 0.0 1.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.0 1.8 2.1 1.7 2.1 3.0 2.8 1.4 2.3 3.9 2.4 2.2 0.7 0.0 0.0 13.7 0.0 0.3 0.4 1.8 0.0 0.3 0.5 0.9 0.1 0.0 9.7 3.7 0.0 0.0 0.0 0.0 5.9 0.2 1101.7 36.0 0.6 0.8 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 2.1 0.0 2.0 0.0 0.4 600.3 7.8 0.3 0.0 1.0 0.0 2.4 0.0 1.5 2.1 0.0 0.0 4.1 0.0 0.2 0.0 3.7 56.4 1.7 0.0 0.2 0.8 97.8 7.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 GPR150 PGR11 ENSG00000178015 "G protein-coupled receptor 150" Q8NGU9 5 95620087-95622142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8;pancreas: 7.0" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Extravillous trophoblasts: 5.3;granulocytes: 5.7;Hofbauer cells: 3.5;NK-cells: 2.1;Spermatocytes: 2.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.4;SiHa: 1.2;TIME: 2.7" "Low region specificity" "Detected in some" HPA026635 Uncertain NA NA "HPA026635: AB_1849266" "unprognostic (3.03e-2)" "unprognostic (6.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-2)" "unprognostic (5.95e-2)" "unprognostic (5.34e-4)" "unprognostic (1.98e-2)" "unprognostic (6.36e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-2)" "unprognostic (1.76e-1)" "unprognostic (3.23e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" 0.6 0.1 1.6 0.0 2.8 0.0 0.7 0.0 2.4 0.3 0.0 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.1 2.3 0.8 0.0 0.1 0.3 0.3 0.6 0.2 2.4 0.0 7.0 1.3 0.6 0.1 0.3 0.4 0.1 0.0 0.2 0.2 0.2 0.5 0.4 0.0 0.0 0.4 1.6 0.2 1.5 0.1 0.1 0.0 0.1 0.3 0.2 1.6 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.8 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.2 0.0 0.3 0.0 0.0 0.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 2.8 0.0 2.4 2.3 0.8 0.6 0.2 2.4 0.3 0.0 1.5 1.6 0.5 0.0 0.6 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 4.0 0.1 0.1 0.2 0.0 0.4 0.0 0.2 5.3 0.9 0.0 0.0 5.7 0.0 0.4 0.5 3.5 0.0 0.0 0.3 0.0 0.3 0.3 1.1 0.0 0.9 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.2 0.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.3 2.5 0.5 0.1 0.3 0.0 1.4 0.0 0.8 0.1 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253178-54256229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "testis: 21.7" "Group enriched" "Detected in some" 6 "Spermatocytes: 33.9;Spermatogonia: 22.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 69 "K-562: 8.3" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.6 0.1 0.1 0.3 0.1 0.0 0.5 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 33.9 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC75B "C22orf36, FAM211B, MGC131773" ENSG00000178026 "Leucine rich repeat containing 75B" Q2VPJ9 22 24585620-24593208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 34.3;Hepatocytes: 25.6;Muller glia cells: 39.9;Proximal enterocytes: 46.7;Proximal tubular cells: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 5.3;MCF7: 5.0;SH-SY5Y: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002540 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002540: AB_1079263" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.47e-1)" "unprognostic (2.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.21e-2)" "unprognostic (4.52e-2)" "unprognostic (2.48e-2)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (2.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-2)" "unprognostic (9.69e-2)" 1.7 0.7 4.6 0.0 4.3 0.3 1.8 4.7 7.5 1.9 2.6 2.6 0.0 1.0 0.5 2.1 1.5 0.0 2.7 4.1 4.8 5.5 3.7 0.8 0.0 4.8 5.0 3.8 3.2 3.5 0.0 1.3 0.1 4.8 2.8 0.1 0.6 2.0 0.4 2.5 1.8 1.6 0.0 4.5 0.5 2.5 7.5 4.7 0.1 1.6 0.0 0.1 3.5 2.0 4.8 0.1 2.8 0.0 1.5 0.3 1.1 0.2 0.4 0.4 0.9 1.0 2.0 0.0 0.0 0.7 0.8 0.8 3.0 0.2 1.5 0.0 0.9 1.8 0.2 0.3 5.3 2.6 0.0 0.0 0.0 1.1 1.0 0.1 0.5 0.7 0.0 0.1 0.0 0.1 5.0 0.0 1.0 1.3 3.4 1.1 0.0 0.1 0.0 1.2 0.3 1.4 4.2 1.4 0.4 0.5 0.3 0.0 0.5 1.5 1.6 0.9 0.6 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.6 4.3 4.7 7.5 4.1 4.8 4.8 5.0 3.8 4.8 4.5 4.7 4.8 1.6 12.8 5.9 9.4 0.3 0.0 2.5 0.0 2.2 2.8 16.2 18.7 4.4 34.3 0.0 7.3 0.0 2.5 0.9 10.7 11.7 9.8 1.6 2.3 3.6 1.8 1.2 1.3 3.8 8.9 0.4 7.1 14.3 6.1 0.0 7.2 2.9 25.6 1.1 1.7 4.1 8.0 0.0 1.6 0.0 7.9 12.8 1.4 0.0 1.0 0.3 39.9 0.0 7.1 2.2 4.0 6.2 9.8 0.6 8.0 46.7 44.5 0.0 1.8 0.0 4.5 4.2 0.5 1.3 2.5 0.0 1.1 0.8 2.0 6.4 1.3 DMAP1 "DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4" ENSG00000178028 "DNA methyltransferase 1 associated protein 1" Q9NPF5 1 44213455-44220681 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028419, CAB033018, HPA069527" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033018: AB_2230431, HPA028419: AB_2672597, HPA069527: " "unprognostic (1.91e-3)" "unprognostic (2.79e-3)" "unprognostic (4.90e-2)" "unprognostic (6.52e-2)" "unprognostic (4.80e-2)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" "unprognostic (1.86e-2)" "unprognostic (2.29e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" 18.7 54.2 30.0 13.3 30.7 14.7 20.7 31.0 37.7 22.5 28.2 20.5 13.7 20.5 9.8 19.0 20.2 11.8 25.3 30.8 30.1 26.0 29.0 18.0 17.1 29.9 30.0 31.1 26.8 34.2 25.7 25.3 14.7 29.8 24.5 11.8 19.7 21.5 13.4 36.4 21.3 22.2 10.8 28.6 27.8 24.4 25.4 30.7 21.1 23.6 25.4 14.5 21.7 19.6 30.6 21.1 22.2 30.6 16.0 15.5 14.6 35.0 18.3 24.4 43.3 37.2 35.7 25.9 31.5 24.1 29.7 16.9 17.0 27.4 23.6 22.8 25.0 44.3 29.0 41.2 36.2 28.0 28.7 21.2 23.0 25.8 35.8 20.5 27.9 28.3 29.5 20.6 28.2 25.7 24.5 40.4 35.9 43.6 10.8 27.0 40.5 30.8 34.5 23.1 26.2 28.0 23.3 34.4 24.3 35.8 29.1 20.1 32.8 27.5 12.2 36.5 28.5 37.6 33.9 21.8 25.4 23.1 28.2 20.6 45.0 23.1 23.1 30.8 20.9 31.9 27.7 31.2 32.2 24.0 28.3 27.8 27.5 9.9 43.8 17.6 19.2 37.5 24.6 30.0 30.7 31.0 37.7 30.8 30.1 29.9 30.0 31.1 29.8 28.6 30.7 30.6 23.4 32.1 23.8 11.1 23.6 19.2 25.9 36.4 19.4 43.0 18.6 22.2 22.8 18.6 24.5 11.0 25.0 72.6 30.9 32.8 29.4 31.9 41.9 15.4 14.1 23.9 54.4 25.7 10.4 41.5 34.4 20.5 28.5 14.8 27.3 38.1 23.6 19.1 32.6 23.5 12.1 32.0 44.7 22.3 12.7 69.2 18.0 15.4 17.8 4.7 26.3 46.3 25.7 9.0 9.6 22.9 38.6 17.7 26.8 9.7 46.9 36.2 26.8 56.1 6.6 23.9 25.1 24.5 47.2 15.7 17.8 52.4 25.5 29.3 29.8 16.3 ADAMTSL1 "ADAMTSR1, C9orf94, FLJ35283" ENSG00000178031 "ADAMTS like 1" Q8N6G6 9 17906563-18910950 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 13.4" "Cell type enriched" "Detected in some" 6 "Excitatory neurons: 245.4" "Cancer enhanced" "Detected in many" "prostate cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 118.3;HSkMC: 61.2;hTEC/SVTERT24-B: 64.3;hTERT-RPE1: 55.8;LHCN-M2: 64.3;TIME: 207.9;U-138 MG: 96.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057437, HPA074973" Uncertain Approved Vesicles "Secreted in other tissues" NA NA 28000000 Vesicles "HPA057437: AB_2683440, HPA074973: " "unprognostic (4.64e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-3)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (7.77e-2)" "unprognostic (2.01e-4)" "unprognostic (3.66e-2)" "unprognostic (1.21e-1)" "unprognostic (6.41e-2)" "unprognostic (7.29e-3)" "unprognostic (2.58e-2)" "unprognostic (1.87e-1)" "unprognostic (6.59e-2)" "unprognostic (1.50e-2)" 3.9 5.6 0.9 1.9 0.8 0.0 2.4 1.6 0.8 3.9 0.0 3.1 1.8 13.4 1.2 5.5 4.1 5.0 1.0 3.5 8.1 2.1 0.9 1.2 0.8 2.1 3.4 0.9 1.6 1.4 0.2 1.8 0.6 0.5 8.2 2.9 0.4 1.3 1.6 0.4 0.9 1.8 11.3 0.8 0.7 5.2 1.0 6.3 0.5 0.9 0.8 0.9 2.6 2.0 1.1 6.4 0.5 1.2 0.0 17.5 118.3 0.0 3.6 16.3 14.8 33.3 0.0 0.1 0.1 0.1 44.1 5.5 0.0 6.6 1.1 41.7 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 61.2 0.0 64.3 0.2 55.8 27.1 0.0 0.1 0.3 64.3 0.0 0.2 0.1 5.6 0.0 0.3 0.0 10.1 0.2 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 207.9 96.9 2.5 2.6 15.8 0.0 0.0 0.0 31.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.6 0.8 3.5 8.1 2.1 3.4 0.9 0.5 0.8 6.3 1.1 1.6 0.0 0.0 5.2 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.4 1.4 0.0 0.6 0.0 0.0 0.0 0.0 3.1 0.0 0.1 7.2 0.3 1.1 8.9 0.0 0.0 245.4 0.0 0.0 15.1 0.5 0.5 0.0 0.1 1.1 0.0 0.1 0.0 39.5 0.4 0.0 0.0 0.8 2.9 5.0 0.1 0.0 1.9 0.0 0.0 0.0 9.0 5.7 0.0 0.4 1.2 0.0 0.6 0.2 0.4 0.0 0.0 0.0 0.1 1.2 2.9 1.6 0.1 0.1 0.1 0.0 0.1 1.7 0.1 CALHM5 "C6orf188, dJ493F7.3, FAM26E, MGC45451" ENSG00000178033 "Calcium homeostasis modulator family member 5" Q8N5C1 6 116511639-116524788 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 10.6;Endothelial cells: 2.6;Fibroblasts: 2.0;Granulosa cells: 2.6;Smooth muscle cells: 3.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.3;fHDF/TERT166: 5.6;HUVEC TERT2: 5.6;LHCN-M2: 5.9;TIME: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034969, HPA034970" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA034969: AB_10670299, HPA034970: AB_2674390" "unprognostic (2.71e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-2)" "unprognostic (1.01e-1)" "unprognostic (1.36e-1)" "unprognostic (3.92e-1)" "unprognostic (1.93e-2)" "unprognostic (5.37e-2)" "unprognostic (4.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.06e-1)" "unprognostic (9.16e-2)" "unprognostic (1.24e-7)" "unprognostic (1.16e-2)" "unprognostic (2.98e-2)" "unprognostic (7.69e-2)" "unprognostic (6.65e-3)" 3.3 0.5 0.6 1.1 0.6 0.0 1.6 0.5 0.8 1.3 0.9 1.3 0.6 1.4 0.6 1.2 0.9 1.5 2.3 0.6 0.5 1.9 0.5 1.7 0.9 0.6 0.6 0.5 0.5 0.1 0.5 0.3 4.4 0.6 0.9 1.0 0.0 0.6 0.7 1.6 0.9 0.9 2.2 0.5 1.7 0.6 0.7 0.7 0.1 0.9 2.5 0.5 1.4 1.2 0.6 0.0 0.0 4.5 0.0 2.7 4.3 0.0 3.6 5.3 1.4 3.8 0.2 0.0 0.0 0.3 5.6 3.8 0.0 0.0 0.0 1.5 0.0 0.2 0.8 0.0 0.0 0.6 0.0 0.0 2.6 0.0 3.4 0.0 1.0 5.6 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.9 2.5 0.8 0.3 0.2 0.0 0.0 0.0 2.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 0.8 0.6 0.5 0.6 0.6 0.5 0.6 0.5 0.7 0.6 10.6 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 IMPDH2 ENSG00000178035 "Inosine monophosphate dehydrogenase 2" P12268 3 49024325-49029447 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001400, CAB020717" Approved Supported "Cytosol,Rods & Rings" NA NA 340000 Cytosol "Rods & Rings" "CAB020717: , HPA001400: AB_1079139" "unprognostic (2.09e-2)" "unprognostic (2.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (7.31e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.30e-1)" "unprognostic (2.65e-1)" "unprognostic (2.17e-1)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.30e-1)" "unprognostic (3.85e-1)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (4.47e-2)" 109.0 90.0 40.5 68.7 40.7 106.2 190.5 42.9 41.9 169.8 38.0 101.4 76.0 114.5 48.7 170.3 201.0 65.5 70.3 38.1 46.4 68.0 64.1 84.0 79.3 45.3 41.5 36.5 333.9 316.5 56.2 65.5 81.6 44.4 98.5 122.4 22.2 88.6 67.1 275.0 180.2 74.7 101.8 45.2 69.2 94.2 36.4 42.4 96.8 75.7 125.5 123.0 120.8 138.7 47.8 271.8 150.6 201.6 211.3 309.2 558.4 200.6 180.8 298.2 425.5 361.0 265.8 235.2 485.7 128.2 220.7 119.5 183.1 433.6 369.8 371.1 119.9 135.3 362.2 205.0 257.8 264.4 388.4 139.0 497.7 403.1 414.6 756.5 331.8 313.5 337.7 221.7 266.2 354.1 213.4 327.0 258.9 269.0 255.4 300.2 143.5 218.4 487.9 251.7 166.2 130.2 128.9 198.1 216.5 341.3 170.2 277.3 166.1 151.4 181.0 347.7 449.5 468.8 253.3 193.3 227.3 214.1 421.9 188.1 21.8 27.8 10.7 43.6 46.8 81.9 79.7 58.4 47.7 51.1 79.6 84.9 71.6 10.9 60.5 41.6 38.0 40.2 45.2 40.5 40.7 42.9 41.9 38.1 46.4 45.3 41.5 36.5 44.4 45.2 42.4 47.8 40.5 64.1 60.9 3.9 92.2 202.7 255.0 253.8 229.9 16.1 202.7 231.8 32.3 74.4 122.4 36.8 14.6 327.3 34.5 51.1 80.3 133.6 2.7 49.0 120.5 60.9 60.7 112.5 2.9 187.1 280.6 104.4 70.3 51.2 66.1 98.0 52.8 24.9 95.3 15.2 4.1 124.4 114.0 55.9 105.4 6.7 123.3 50.0 88.9 1.0 67.3 26.5 24.7 4.0 5.2 108.8 70.8 71.1 64.6 160.1 47.4 92.0 53.7 15.8 39.5 149.4 215.1 22.6 62.5 195.7 195.6 314.0 52.3 166.8 266.5 157.2 ALS2CL "DKFZp686I0110, FLJ36525, RN49018" ENSG00000178038 "ALS2 C-terminal like" Q60I27 3 46668995-46693704 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.8;kidney: 30.1;skin 1: 29.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Gastric mucus-secreting cells: 41.3;Respiratory ciliated cells: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 31.6;HaCaT: 17.1;HBEC3-KT: 33.1;hTCEpi: 20.9;RT4: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB046465, HPA048301" Uncertain NA NA "CAB046465: AB_10638285, HPA048301: AB_2680346" "unprognostic (6.38e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-3)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.86e-2)" "unprognostic (1.04e-2)" "unprognostic (1.92e-1)" "unprognostic (8.60e-2)" "unprognostic (4.28e-2)" "unprognostic (1.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-3)" "unprognostic (4.45e-2)" "unprognostic (5.20e-2)" "unprognostic (6.79e-2)" "unprognostic (4.14e-3)" 4.5 2.2 0.9 1.6 0.8 0.8 5.1 1.6 2.0 7.2 0.7 4.0 3.5 2.2 0.1 37.8 4.4 2.7 7.8 0.4 0.7 30.1 7.2 10.9 1.8 1.3 0.7 0.8 1.8 5.9 0.5 4.3 1.3 1.2 4.6 1.0 0.0 11.1 2.2 5.3 29.5 4.7 0.8 0.4 6.6 3.6 0.8 0.5 1.1 15.8 1.9 1.4 4.8 19.7 1.0 9.8 2.2 0.0 0.0 0.0 0.0 0.1 0.7 1.1 0.0 0.3 0.1 31.6 0.0 8.9 0.8 0.5 17.1 0.0 33.1 0.1 0.1 0.0 0.8 3.7 0.0 0.3 0.0 0.0 0.0 20.9 0.0 3.2 0.2 0.9 2.0 0.0 0.2 0.0 0.9 0.0 0.1 0.3 4.7 1.9 0.1 0.0 12.0 7.7 15.8 0.3 0.2 12.6 9.7 0.0 0.5 2.2 0.2 6.6 0.1 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.8 1.6 2.0 0.4 0.7 1.3 0.7 0.8 1.2 0.4 0.5 1.0 17.5 73.7 15.3 2.3 0.5 15.2 8.4 21.8 12.0 0.3 4.7 5.5 10.2 18.6 29.9 11.0 0.0 1.5 0.1 29.0 0.0 10.1 0.6 5.1 1.8 13.1 0.0 0.0 8.0 13.5 7.3 4.5 41.3 5.5 1.3 0.1 7.1 7.6 2.7 0.0 2.9 6.4 24.4 0.3 4.1 0.2 0.3 1.4 1.8 10.3 0.8 0.1 0.0 0.0 0.3 26.3 12.0 0.0 0.1 17.7 5.9 0.4 46.9 0.1 19.7 5.6 8.5 1.3 2.7 22.3 16.3 2.1 1.3 0.3 11.8 27.7 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 184.0;testis: 396.7" "Group enriched" "Detected in many" 10 "Early spermatids: 4964.0;Late spermatids: 12837.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.7" "Lineage enriched" "Detected in single" 9 "T-cells: 8.7" "Cell line enhanced" "Detected in many" "A-431: 84.0" "Low region specificity" "Detected in all" "HPA069479, HPA079339" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA069479: AB_2686140, HPA079339: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 11.0 6.9 21.7 3.1 19.8 3.2 17.6 20.8 22.2 9.9 31.8 8.2 1.9 16.1 14.9 10.2 68.5 15.2 126.1 19.3 28.8 21.4 3.6 18.1 2.9 25.6 22.3 16.6 12.9 9.7 20.4 18.3 2.7 23.4 6.2 4.8 47.3 5.1 4.6 184.0 6.0 4.0 14.3 24.7 3.5 6.3 396.7 20.2 2.3 16.7 108.1 4.8 14.3 4.3 25.5 84.0 7.7 28.4 0.1 13.8 18.1 7.8 6.8 8.4 31.9 30.5 0.0 44.8 0.0 29.3 13.1 42.8 16.3 0.3 14.2 44.5 0.0 15.3 3.9 6.3 0.9 10.2 0.0 6.4 10.5 22.3 13.8 8.8 28.2 7.3 0.0 6.3 0.1 22.2 12.5 0.0 0.2 7.6 46.4 21.3 0.0 15.4 0.7 25.0 6.4 34.8 21.7 38.1 13.7 43.9 27.7 41.1 8.9 3.8 27.2 27.2 35.4 31.0 15.6 8.2 0.1 20.0 0.1 20.6 0.0 0.0 0.0 2.8 0.0 1.4 0.5 6.9 6.9 0.2 0.3 1.5 3.2 0.3 0.9 0.3 0.1 8.7 2.0 21.7 19.8 20.8 22.2 19.3 28.8 25.6 22.3 16.6 23.4 24.7 20.2 25.5 42.0 25.6 28.2 11.8 6.0 44.7 143.4 35.3 27.3 14.9 52.8 68.7 231.2 17.2 55.2 20.2 33.3 0.7 12.0 12.8 72.4 26.9 4964.0 203.9 29.3 28.4 33.9 3.6 20.2 7.6 5.0 56.3 18.8 24.0 43.8 10.0 18.5 0.2 8.0 10.1 14.1 29.3 28.5 4.1 19.7 12837.2 69.9 11.5 23.2 3.7 1.0 28.5 3.1 9.0 12.7 10.2 14.3 50.4 3.4 37.4 1.3 36.6 329.7 71.1 19.7 131.0 40.5 854.2 192.2 10.4 34.2 1.6 25.3 55.9 14.7 83.1 NDUFAF3 "2P1, C3orf60, DKFZP564J0123, E3-3, MGC10527" ENSG00000178057 "NADH:ubiquinone oxidoreductase complex assembly factor 3" Q9BU61 3 49020459-49023495 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 332.4" "Group enriched" "Detected in all" 4 "Distal tubular cells: 475.4;Early spermatids: 1124.6;Late spermatids: 1303.4;Proximal tubular cells: 658.1;Spermatocytes: 913.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035376, HPA035377" Enhanced NA NA "HPA035376: AB_2674597, HPA035377: AB_10673219" "unprognostic (2.90e-2)" "unprognostic (2.72e-2)" "unprognostic (6.88e-2)" "unprognostic (3.03e-2)" "unprognostic (3.57e-2)" "unprognostic (2.61e-1)" "unprognostic (6.28e-3)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.64e-2)" "unprognostic (8.62e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.86e-5)" "unprognostic (7.97e-2)" "unprognostic (1.73e-1)" "unprognostic (8.02e-2)" "unprognostic (1.60e-1)" 62.6 122.9 104.4 36.7 109.6 52.1 61.2 115.6 124.5 57.2 105.0 43.3 35.2 59.1 48.1 48.9 62.2 32.6 155.7 100.6 111.4 88.7 85.8 52.7 45.7 113.8 108.2 99.4 59.9 49.2 84.8 99.7 30.2 111.4 57.7 27.3 26.4 71.3 52.0 128.1 31.8 41.8 30.9 113.4 54.3 50.2 332.4 110.0 52.5 71.8 100.5 38.0 51.5 46.1 119.6 47.7 68.4 60.6 59.9 78.5 66.6 35.0 59.6 57.5 82.8 64.5 98.9 75.1 55.1 68.5 92.1 113.4 34.9 43.3 95.4 29.6 72.9 76.8 109.5 129.9 124.8 110.4 92.2 50.8 68.5 72.5 116.6 85.8 98.9 73.0 169.4 31.4 136.0 90.8 73.9 134.1 46.5 20.1 78.1 183.0 41.1 24.3 169.3 136.7 97.4 52.9 61.6 55.0 115.1 59.1 27.3 66.5 177.6 64.4 76.4 52.0 108.0 100.1 110.8 79.3 86.6 93.2 48.4 121.8 144.3 164.6 143.9 157.6 175.3 168.4 244.1 172.6 160.6 144.9 234.0 223.3 170.2 51.8 154.9 201.2 297.8 180.5 250.4 104.4 109.6 115.6 124.5 100.6 111.4 113.8 108.2 99.4 111.4 113.4 110.0 119.6 117.4 93.0 95.2 7.2 95.3 53.3 143.7 113.6 66.0 60.4 119.4 125.5 198.0 104.4 109.6 150.8 2.1 135.2 81.9 124.6 475.4 171.7 1124.6 123.4 81.8 104.3 132.0 118.2 7.2 155.7 128.0 121.2 50.0 58.2 117.3 73.1 114.9 150.6 217.8 69.0 8.3 118.1 103.7 114.1 73.8 1303.4 170.2 129.5 136.9 11.2 149.6 171.5 103.0 6.6 19.6 139.5 148.0 120.7 151.1 175.5 176.9 658.1 199.2 52.8 72.3 87.5 106.4 913.0 88.6 108.4 54.8 106.9 91.2 105.6 109.4 154.9 C2orf69 FLJ38973 ENSG00000178074 "Chromosome 2 open reading frame 69" Q8N8R5 2 199911293-199955935 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 132.1;Spermatocytes: 124.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045225 Approved "Secreted to blood" NA Yes "HPA045225: AB_10960841" "unprognostic (6.94e-3)" "unprognostic (1.09e-1)" "unprognostic (7.17e-2)" "unprognostic (3.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (4.39e-3)" "unprognostic (1.92e-2)" "unprognostic (5.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.33e-3)" "unprognostic (1.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.41e-3)" "unprognostic (8.87e-2)" "unprognostic (1.03e-2)" "unprognostic (5.86e-2)" 9.8 14.2 9.6 6.8 10.7 22.3 7.5 9.6 11.9 5.7 8.0 8.1 8.5 6.4 6.6 6.9 3.9 6.3 6.8 11.2 10.9 9.0 10.1 6.1 7.4 9.8 10.3 10.0 4.8 8.3 9.3 4.2 5.4 9.9 6.5 8.1 10.5 6.2 4.7 9.1 6.5 7.5 7.7 9.8 7.0 7.2 14.8 11.0 5.3 6.8 9.9 7.5 6.9 4.1 12.0 16.1 7.2 13.2 18.0 18.2 22.8 22.3 22.6 13.5 15.0 17.7 16.3 11.4 13.2 12.9 16.0 15.9 12.8 14.1 12.0 25.1 19.8 12.8 20.4 12.4 20.8 10.6 20.7 24.2 11.8 10.5 17.2 14.9 8.1 17.0 8.8 14.9 25.5 25.6 13.9 11.6 18.1 19.4 7.1 19.1 11.0 17.2 11.9 14.8 16.4 21.5 9.4 10.9 8.1 17.4 16.9 12.0 17.7 14.9 23.3 19.0 26.2 18.2 16.7 29.0 13.0 18.6 13.1 12.0 5.4 2.7 7.2 3.6 3.5 5.2 3.1 4.0 3.4 2.4 3.0 4.2 4.5 2.3 2.0 2.7 1.3 4.1 2.8 9.6 10.7 9.6 11.9 11.2 10.9 9.8 10.3 10.0 9.9 9.8 11.0 12.0 13.5 3.2 5.1 12.4 22.9 38.0 29.8 8.8 9.1 21.8 10.1 3.7 11.4 12.8 7.6 16.5 29.2 13.3 11.0 16.4 27.4 12.8 132.1 7.9 10.2 16.1 18.6 27.8 19.4 18.3 18.0 17.0 13.7 7.1 8.2 14.8 23.6 19.7 11.8 13.5 13.9 16.9 10.2 18.0 32.1 78.1 13.4 13.4 16.0 12.2 14.0 56.5 12.3 12.5 27.0 14.6 9.3 21.8 8.6 24.6 18.1 20.4 11.8 26.5 19.7 14.0 14.9 124.3 44.1 15.7 44.9 9.9 18.1 11.1 17.5 19.5 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 181.8;Early spermatids: 97.1;Late spermatids: 80.5;Oligodendrocyte precursor cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.7;naive B-cell: 2.9;neutrophil: 2.1" "Group enriched" "Detected in many" 13 "B-cells: 2.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.5;HUVEC TERT2: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.1 1.9 13.0 1.7 12.4 0.1 8.9 12.7 15.4 3.2 8.9 5.1 7.7 2.2 2.1 5.5 10.8 2.7 0.7 11.9 11.6 24.2 28.0 5.0 2.1 14.5 13.9 11.2 0.8 12.8 10.7 8.2 6.2 12.9 2.6 3.9 14.4 12.1 2.1 0.8 12.2 16.8 0.7 11.6 1.3 9.0 17.0 14.0 1.1 3.9 3.2 3.9 2.1 3.7 10.2 1.6 0.0 4.0 3.0 0.7 1.8 5.2 3.5 3.1 0.7 2.1 0.0 13.5 0.4 1.0 2.0 1.4 1.3 0.7 1.5 1.8 1.9 0.6 0.3 0.1 0.0 1.4 0.2 0.0 3.0 1.0 0.6 0.1 7.1 10.2 4.5 0.0 0.1 1.1 0.4 1.6 0.2 0.3 1.4 0.5 0.0 0.8 2.4 4.2 1.9 0.8 1.1 1.0 5.2 3.4 1.6 3.6 0.0 2.2 1.5 2.8 0.0 0.3 2.2 1.3 1.9 2.2 0.1 1.8 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.2 0.0 2.9 0.1 0.1 2.1 0.1 0.0 0.0 0.0 0.0 13.0 12.4 12.7 15.4 11.9 11.6 14.5 13.9 11.2 12.9 11.6 14.0 10.2 4.5 12.8 10.5 181.8 15.6 1.0 6.9 3.0 5.2 0.2 9.9 7.0 0.9 15.7 7.1 14.7 37.5 17.5 0.3 10.1 31.3 4.4 97.1 33.3 8.5 4.7 4.9 2.7 29.7 2.7 3.7 1.5 6.6 51.9 0.0 1.4 5.7 17.0 1.5 11.8 4.3 5.5 4.1 0.3 0.8 80.5 2.8 0.9 1.8 9.4 0.1 13.4 0.0 82.4 1.7 2.3 9.3 1.5 6.3 2.8 34.3 14.0 27.9 19.7 0.0 1.2 1.7 28.2 6.7 6.8 4.7 42.4 1.9 5.0 5.3 7.0 STAP2 "BKS, STAP-2" ENSG00000178078 "Signal transducing adaptor family member 2" Q9UGK3 19 4324043-4342786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 91.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 294.5;Paneth cells: 343.4;Proximal enterocytes: 415.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 7.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.2;NK-cells: 7.9;T-cells: 2.5" "Cell line enhanced" "Detected in many" "A-431: 87.3;HaCaT: 70.3;MCF7: 104.3;RT4: 138.1" "Region enriched" "Detected in many" 13 "cerebellum: 20.5" "Low region specificity" "Detected in some" "HPA002375, HPA027761" Approved NA NA "HPA002375: AB_1078285, HPA027761: AB_1845364" "unprognostic (1.42e-1)" "prognostic favorable (2.76e-4)" "unprognostic (3.52e-1)" "prognostic favorable (3.03e-5)" "unprognostic (4.35e-2)" "unprognostic (9.35e-3)" "unprognostic (4.52e-1)" "unprognostic (7.81e-2)" "unprognostic (3.43e-1)" "unprognostic (2.00e-2)" "unprognostic (1.93e-2)" "unprognostic (9.05e-2)" "unprognostic (1.43e-3)" "unprognostic (1.38e-2)" "unprognostic (1.72e-1)" "unprognostic (3.00e-2)" "prognostic favorable (4.13e-4)" 4.3 18.3 2.8 7.6 2.8 0.4 16.8 3.5 4.3 11.6 3.5 73.5 78.2 5.7 10.7 91.7 15.3 7.2 3.9 3.0 2.6 28.4 55.8 8.3 3.2 2.7 2.5 3.0 11.6 30.9 21.5 4.5 3.4 3.5 38.2 60.2 0.5 45.8 9.9 1.2 72.4 72.6 4.0 2.4 1.5 24.4 2.1 2.6 8.0 15.4 0.7 13.1 16.6 41.4 2.9 87.3 0.4 6.2 5.8 0.4 4.7 35.7 1.6 8.8 2.8 2.2 52.0 34.8 0.1 13.3 2.8 17.9 70.3 1.1 50.3 1.6 14.9 0.7 0.3 0.4 35.1 10.9 0.1 0.7 3.5 41.7 4.8 12.2 7.0 8.9 2.1 3.4 18.6 1.3 104.3 1.3 0.7 4.8 55.3 20.4 3.6 0.8 2.2 29.4 138.1 2.1 3.5 0.1 25.9 14.6 2.2 60.7 0.3 12.5 0.2 1.2 0.7 1.8 0.1 1.4 1.3 0.3 0.4 5.7 0.4 0.1 0.0 0.6 0.0 2.3 0.6 0.8 0.1 0.7 0.1 2.3 1.4 0.1 7.9 0.0 2.2 2.5 0.8 2.8 2.8 3.5 4.3 3.0 2.6 2.7 2.5 3.0 3.5 2.4 2.6 2.9 6.7 9.6 14.4 0.3 2.4 40.5 59.8 171.4 42.7 0.6 33.8 30.1 6.9 38.6 87.2 29.5 0.0 16.9 2.3 294.5 25.4 137.5 1.2 9.0 3.6 10.1 85.8 4.4 1.5 101.0 3.0 4.5 55.5 13.4 8.9 5.2 7.5 29.6 1.8 0.0 1.2 147.5 91.6 4.1 9.4 0.9 4.7 1.8 19.6 0.0 12.5 1.0 1.0 0.5 1.8 139.4 343.4 1.9 1.4 92.6 415.7 125.0 44.9 0.8 0.0 1.7 7.9 0.6 2.6 86.0 61.8 12.4 3.3 5.7 173.2 117.0 HTR3C ENSG00000178084 "5-hydroxytryptamine receptor 3C" Q8WXA8 3 184053047-184060673 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "lung: 2.5" "Cell type enhanced" "Detected in single" "Enteroendocrine cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (1.61e-1)" "unprognostic (2.88e-2)" "unprognostic (1.68e-2)" "unprognostic (8.72e-2)" "unprognostic (1.75e-1)" "unprognostic (3.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 TSSK6 "CT72, FLJ24002, SSTK" ENSG00000178093 "Testis specific serine kinase 6" Q9BXA6 19 19512418-19515548 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 116 "testis: 168.9" "Cell type enriched" "Detected in some" 5 "Late spermatids: 8709.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;CACO-2: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.12e-1)" "unprognostic (7.89e-2)" "unprognostic (7.26e-2)" "unprognostic (6.64e-2)" "unprognostic (3.39e-1)" "unprognostic (7.20e-5)" "unprognostic (3.38e-1)" "unprognostic (5.51e-3)" "unprognostic (5.17e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-4)" "unprognostic (2.28e-2)" "unprognostic (5.34e-3)" "unprognostic (2.74e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-3)" "unprognostic (9.89e-2)" 0.5 0.7 0.4 0.0 0.6 0.1 0.7 0.4 0.5 0.4 0.1 0.6 0.5 0.8 0.0 0.7 0.6 0.0 0.3 0.2 0.3 0.9 1.2 0.4 0.3 0.7 0.5 0.0 0.5 1.0 0.0 0.7 0.0 0.7 1.0 0.0 0.0 0.6 0.0 0.3 1.4 1.0 0.0 0.6 1.2 0.9 168.9 0.5 0.1 0.9 0.0 0.1 0.6 0.6 0.7 0.0 0.6 0.0 0.0 0.0 0.1 3.4 0.1 0.2 0.0 0.1 1.7 0.0 0.7 0.1 0.0 0.0 0.4 0.1 0.6 0.0 0.5 0.0 0.4 0.4 0.0 0.4 0.4 0.7 0.3 0.1 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.3 0.7 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.5 0.2 0.9 0.2 0.8 0.6 0.0 0.7 0.4 0.9 0.0 0.1 0.3 0.1 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.8 0.4 0.1 0.0 0.0 0.2 0.1 0.2 0.4 0.6 0.4 0.5 0.2 0.3 0.7 0.5 0.0 0.7 0.6 0.5 0.7 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.3 0.1 1.7 1.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1462.5 0.5 0.4 2.7 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.8 0.0 0.1 0.7 0.5 0.1 0.0 0.0 0.0 2.0 0.8 0.5 8709.8 47.8 2.2 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 57.2 0.1 0.1 0.5 0.2 0.3 0.0 19.7 1.1 0.3 57.7 25.7 0.0 0.1 0.1 0.2 0.0 0.1 0.1 BOLA1 CGI-143 ENSG00000178096 "BolA family member 1" Q9Y3E2 1 149887890-149900798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Distal tubular cells: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 49.3;MCF7: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007005 Approved "Intracellular and membrane" NA NA "HPA007005: AB_1078294" "unprognostic (5.73e-2)" "unprognostic (9.86e-3)" "unprognostic (8.84e-2)" "unprognostic (8.18e-2)" "unprognostic (9.33e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.67e-2)" "unprognostic (2.19e-1)" "prognostic favorable (6.41e-4)" "unprognostic (3.14e-3)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (8.73e-2)" "unprognostic (1.31e-1)" "unprognostic (9.58e-2)" "unprognostic (1.93e-3)" 14.2 21.4 6.9 5.9 7.6 4.0 16.3 8.2 18.1 15.6 5.6 20.9 15.4 17.3 0.9 15.8 15.7 3.7 19.0 6.5 6.4 20.7 26.6 10.1 7.1 7.5 6.3 6.0 14.6 19.8 5.5 14.5 2.7 7.0 16.9 1.8 1.1 19.5 7.3 23.3 22.0 16.0 2.0 7.5 16.3 20.5 9.9 7.4 5.3 15.9 5.0 1.4 19.2 13.9 9.0 16.4 21.3 2.0 4.2 1.2 4.1 4.0 6.7 1.7 5.0 4.1 15.2 22.0 2.1 16.6 2.8 2.3 17.9 0.0 3.5 0.2 22.8 8.2 1.1 6.1 2.4 7.7 0.0 16.8 3.8 7.3 1.5 0.5 2.0 6.0 49.3 9.1 5.4 2.7 52.9 21.1 5.3 1.3 14.7 6.1 16.4 1.2 4.4 2.3 2.1 13.5 14.8 8.8 14.5 15.9 1.7 26.9 4.5 2.5 6.4 10.5 14.6 0.2 29.5 23.3 0.2 9.0 5.1 6.8 8.6 9.4 12.4 14.8 8.1 15.3 16.2 13.5 11.5 9.9 14.6 18.8 18.1 4.6 9.1 5.2 19.2 18.8 9.3 6.9 7.6 8.2 18.1 6.5 6.4 7.5 6.3 6.0 7.0 7.5 7.4 9.0 11.9 3.2 9.5 5.5 10.0 4.5 16.3 19.0 10.8 7.3 23.9 30.5 21.1 34.3 11.2 23.9 4.2 20.2 6.3 12.8 68.4 24.6 8.8 12.1 13.6 13.7 12.6 27.1 2.4 19.8 25.3 16.4 19.4 10.4 5.1 13.9 20.7 40.9 17.0 10.1 3.3 22.8 18.3 12.5 3.5 3.5 15.8 6.6 5.4 1.0 10.3 23.5 19.6 2.5 7.5 15.7 17.6 20.7 18.0 23.1 41.5 57.4 14.2 12.3 39.5 10.9 15.7 22.6 16.2 18.4 6.7 14.0 10.1 22.8 21.2 10.0 PDE4DIP "CMYA2, KIAA0454, KIAA0477, MMGL" ENSG00000178104 "Phosphodiesterase 4D interacting protein" Q5VU43 1 148808181-149048286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "heart muscle: 736.4;skeletal muscle: 2184.5;tongue: 1392.0" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 702.6;Rod photoreceptor cells: 272.3;Syncytiotrophoblasts: 309.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 289.6;ASC TERT1: 233.8;K-562: 222.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012678 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012678: AB_1855123" "unprognostic (2.14e-1)" "unprognostic (3.27e-1)" "unprognostic (5.31e-2)" "unprognostic (6.73e-2)" "unprognostic (7.82e-2)" "unprognostic (1.16e-2)" "unprognostic (2.17e-1)" "unprognostic (9.72e-2)" "unprognostic (7.65e-2)" "unprognostic (1.67e-1)" "unprognostic (2.23e-2)" "unprognostic (5.08e-2)" "unprognostic (1.70e-3)" "unprognostic (1.82e-1)" "unprognostic (4.14e-2)" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" 32.4 17.1 113.0 21.0 92.0 15.9 22.5 149.0 113.9 28.2 36.1 22.7 24.4 17.5 74.2 38.2 20.0 19.7 736.4 116.5 116.1 42.4 64.0 36.4 21.8 110.4 99.5 95.7 8.7 21.6 85.3 53.5 69.1 111.2 29.5 25.6 174.8 35.2 23.1 2184.5 26.4 29.7 19.0 97.1 17.4 30.0 9.3 124.9 12.2 17.1 1392.0 23.4 24.3 17.3 131.2 39.2 7.5 10.6 11.6 289.6 233.8 60.7 45.2 42.3 42.7 55.7 35.5 24.1 19.8 13.7 64.5 121.3 19.8 25.7 31.5 72.1 14.7 36.8 10.0 16.2 14.2 76.2 8.8 10.2 167.5 61.9 181.7 97.8 96.9 17.1 16.3 222.1 45.0 76.8 66.2 6.9 5.4 37.1 32.3 15.9 14.6 26.5 7.7 25.4 39.9 50.1 4.7 44.1 123.4 36.1 44.7 37.5 11.7 22.9 49.3 11.2 124.7 100.9 19.9 29.6 29.1 200.6 8.0 30.2 10.6 5.7 4.5 5.3 6.1 5.5 12.0 10.6 7.1 7.0 11.0 8.1 4.5 1.3 4.9 2.1 3.0 14.4 4.8 113.0 92.0 149.0 113.9 116.5 116.1 110.4 99.5 95.7 111.2 97.1 124.9 131.2 5.7 51.3 45.1 81.3 24.0 28.8 9.9 19.8 23.3 71.0 16.1 11.3 702.6 24.3 45.4 69.9 114.7 184.6 9.5 24.0 62.6 13.1 38.9 41.1 14.2 15.7 43.2 7.4 85.8 7.1 148.3 54.2 20.4 27.0 13.9 6.1 5.3 80.8 45.0 33.7 81.1 32.0 20.3 46.1 90.4 50.0 10.5 68.7 55.2 6.5 21.5 45.7 14.4 65.9 41.5 4.5 25.1 9.8 37.5 4.1 48.8 20.7 88.0 272.3 32.9 131.2 40.1 8.7 15.9 14.6 16.3 309.2 24.0 4.2 24.2 4.3 DDX10 "Dbp4, HRH-J8" ENSG00000178105 "DEAD-box helicase 10" Q13206 11 108665069-108940927 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 162.3" "Low region specificity" "Detected in all" HPA004691 Approved Approved Nucleoli NA NA Nucleoli "HPA004691: AB_1078629" "unprognostic (9.49e-2)" "unprognostic (9.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (7.97e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.52e-5)" "unprognostic (2.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.00e-1)" "prognostic favorable (2.14e-5)" "unprognostic (5.20e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-1)" "unprognostic (2.43e-3)" 7.4 6.9 3.8 6.9 4.4 6.4 9.3 4.7 5.2 8.0 2.3 6.4 5.1 10.5 7.4 7.4 8.5 5.1 6.2 4.5 4.4 11.8 7.1 5.4 8.6 2.8 3.8 3.7 10.7 7.6 7.7 4.6 7.9 3.0 7.0 7.7 11.2 6.3 6.8 7.1 7.6 4.8 10.0 2.4 7.2 5.8 16.0 4.5 8.5 7.8 4.7 8.9 10.4 6.9 4.3 21.3 20.7 19.3 27.0 18.5 15.0 20.0 22.6 12.2 26.7 26.3 59.3 30.6 71.8 41.3 17.3 28.7 23.5 55.4 27.3 37.8 27.8 25.0 48.5 11.6 22.3 33.0 49.9 22.4 13.5 21.0 30.4 37.6 15.9 24.6 18.4 70.0 7.8 26.7 14.0 42.7 42.5 24.8 40.0 31.0 35.9 31.3 67.9 16.3 18.2 35.2 18.4 31.7 27.4 12.3 25.4 33.4 17.7 26.0 27.8 28.3 26.8 30.9 11.7 22.0 162.3 9.5 59.7 28.7 1.6 4.4 1.2 7.8 6.7 10.8 10.5 7.0 9.6 8.5 12.0 7.4 7.2 0.4 10.1 6.8 8.0 6.3 4.4 3.8 4.4 4.7 5.2 4.5 4.4 2.8 3.8 3.7 3.0 2.4 4.5 4.3 20.2 16.0 28.8 29.0 23.7 28.4 24.5 11.0 28.5 21.1 14.9 11.9 20.5 12.8 17.6 3.7 95.9 24.3 19.8 9.7 19.6 18.7 47.2 16.9 31.4 24.3 15.0 11.6 84.7 21.3 21.3 26.3 15.3 23.3 14.5 28.1 10.4 11.0 14.7 18.5 75.9 9.7 6.1 8.8 12.0 10.9 29.5 15.4 7.2 51.5 20.6 8.9 27.8 67.3 59.5 17.2 5.7 21.4 13.2 24.8 3.7 133.3 13.1 25.1 13.1 32.6 20.3 63.0 45.8 19.3 29.0 25.9 17.7 26.6 15.6 14.8 GOLGA8Q ENSG00000178115 "Golgin A8 family member Q" H3BV12 15 30552078-30562501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "thyroid gland: 10.7" "Group enriched" "Detected in some" 4 "Early spermatids: 44.4;NK-cells: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "THP-1: 4.9;U-937: 6.0" NA NA "unprognostic (2.65e-2)" "unprognostic (6.48e-2)" "unprognostic (2.24e-1)" "unprognostic (5.52e-4)" "unprognostic (9.86e-3)" "unprognostic (1.26e-1)" "unprognostic (7.17e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" 0.9 0.3 0.2 0.1 0.2 1.6 0.6 0.1 0.5 1.0 0.5 0.5 0.0 1.1 2.1 0.3 0.7 0.2 0.6 0.5 0.2 0.3 0.4 0.6 0.0 0.5 0.7 0.1 1.2 1.1 1.7 1.2 0.1 0.2 0.4 0.2 0.4 0.5 0.2 0.5 0.4 0.5 0.6 0.2 0.3 0.5 4.2 0.3 0.1 10.7 0.9 0.0 0.6 0.6 0.7 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 1.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.5 0.5 0.2 0.5 0.7 0.1 0.2 0.2 0.3 0.7 0.2 0.0 0.5 0.0 0.8 0.0 0.3 0.1 0.0 0.7 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 44.4 1.5 0.3 0.3 1.2 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 1.0 0.4 0.5 0.5 5.0 0.0 0.1 0.0 1.0 0.5 2.3 2.1 0.6 1.8 0.0 1.6 0.3 19.6 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.2 0.1 0.1 1.0 6.6 0.8 0.6 6.2 1.9 0.0 0.1 0.0 1.1 0.8 0.2 0.2 PPP1R42 "dtr, LRRC67, TLLR" ENSG00000178125 "Protein phosphatase 1 regulatory subunit 42" Q7Z4L9 8 66964099-67056604 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 5.0;testis: 8.8" "Group enriched" "Detected in many" 5 "Early spermatids: 68.1;Endometrial ciliated cells: 79.3;Respiratory ciliated cells: 127.2;Spermatocytes: 111.8" "Cancer enhanced" "Detected in some" "glioma: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024313, HPA027983, HPA028628" Uncertain NA NA "HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064" "unprognostic (8.03e-3)" "unprognostic (5.45e-2)" "unprognostic (4.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.99e-2)" "unprognostic (1.03e-1)" "unprognostic (3.61e-3)" "unprognostic (6.86e-2)" "unprognostic (8.58e-3)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-1)" 0.0 0.1 0.8 0.0 0.3 0.0 0.0 0.4 0.4 0.0 1.1 0.0 0.0 0.1 0.3 0.0 5.0 0.0 0.0 0.3 0.8 0.2 0.0 0.4 0.0 1.2 0.9 0.1 0.0 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 8.8 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.4 0.4 0.3 0.8 1.2 0.9 0.1 0.8 1.1 0.4 0.6 0.0 0.0 1.1 11.8 0.0 0.0 0.0 6.0 0.0 0.1 0.7 1.0 0.9 0.0 10.8 5.5 0.0 0.0 0.0 0.0 3.9 0.5 68.1 79.3 0.7 0.2 0.0 0.0 3.2 0.0 0.0 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.0 1.7 2.8 0.0 6.1 0.0 0.0 16.5 0.6 0.3 0.0 1.0 0.0 3.6 0.0 3.5 2.9 0.1 0.0 1.9 0.0 0.0 0.0 1.9 127.2 3.5 6.6 0.0 1.4 111.8 3.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 612.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Approved Nucleoplasm,Mitochondria,Cytosol No No 7600 Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 97.7 173.0 102.7 69.8 106.3 151.2 102.7 113.5 140.8 64.4 111.2 123.9 103.2 70.3 91.9 143.8 64.5 69.3 334.4 103.3 112.4 182.4 407.5 89.4 105.8 113.4 111.7 102.2 52.8 112.6 137.9 72.7 74.4 113.1 89.3 121.0 131.0 98.2 73.1 612.6 93.9 101.3 81.3 110.5 87.1 134.9 80.2 108.8 91.0 73.3 543.0 105.9 123.3 77.1 121.3 136.5 139.8 159.1 148.4 116.6 164.0 133.4 165.4 266.5 217.7 205.5 265.1 109.4 209.4 149.5 158.6 200.3 66.9 157.5 175.5 208.8 104.6 136.6 133.0 135.3 364.8 133.6 373.8 159.2 139.2 144.3 134.9 146.2 156.8 239.3 184.3 216.5 644.0 204.6 171.6 263.5 328.9 131.4 750.5 172.3 124.5 118.2 794.2 354.3 218.7 167.0 122.3 164.6 188.0 220.3 113.6 174.2 282.8 145.8 273.4 194.3 198.8 223.0 180.4 292.3 237.1 195.4 166.0 181.0 250.8 161.8 194.2 118.1 196.1 148.3 237.6 176.9 140.5 237.9 201.1 153.5 142.7 76.0 124.2 187.9 315.1 231.9 231.8 102.7 106.3 113.5 140.8 103.3 112.4 113.4 111.7 102.2 113.1 110.5 108.8 121.3 107.3 80.1 145.8 17.6 143.1 148.0 319.0 629.4 159.4 101.2 165.0 167.3 69.9 178.7 339.5 150.8 87.6 344.1 146.6 211.0 876.5 415.2 271.5 160.3 108.2 117.3 106.5 165.4 32.9 531.4 323.3 122.0 144.3 183.9 120.3 109.7 96.4 351.5 313.5 94.2 37.3 201.7 480.1 115.7 267.1 186.2 122.1 170.2 231.3 17.8 293.2 167.1 96.8 32.2 46.5 530.3 201.2 102.0 244.9 554.3 349.9 810.6 293.4 184.2 105.2 124.0 196.3 217.4 175.0 226.5 147.6 289.4 165.7 266.7 227.3 469.0 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 158.9;Late spermatids: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favorable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 11.9 18.6 10.7 6.0 10.3 5.5 14.3 10.7 12.5 13.4 13.1 9.0 7.9 9.9 13.2 18.5 37.2 10.6 9.6 10.0 11.7 21.3 9.1 10.0 9.2 10.8 10.9 9.8 15.3 39.0 14.0 14.6 9.7 10.6 10.3 8.0 6.5 11.7 9.6 11.1 18.9 9.7 7.0 11.3 10.9 14.8 51.4 10.4 9.5 19.4 6.9 12.4 10.8 11.6 10.3 12.0 16.6 10.2 20.0 28.5 37.8 12.4 9.9 27.5 16.5 15.8 11.7 14.9 4.9 13.7 27.3 14.3 7.8 13.4 26.1 11.5 7.0 9.1 5.3 13.9 22.0 18.7 15.0 10.5 25.7 26.6 20.9 46.1 42.0 26.0 11.2 4.3 12.0 16.4 20.8 6.6 10.1 16.8 25.3 15.5 3.5 1.5 35.7 44.4 19.0 6.5 21.1 10.9 30.1 23.7 16.8 21.3 16.2 15.9 6.4 9.7 22.6 9.2 37.8 21.9 3.0 24.2 8.3 12.9 12.0 11.1 5.5 13.9 13.7 25.0 23.9 22.4 17.1 11.7 21.1 18.7 12.5 10.9 22.6 12.8 8.1 29.5 12.8 10.7 10.3 10.7 12.5 10.0 11.7 10.8 10.9 9.8 10.6 11.3 10.4 10.3 26.8 16.0 12.2 8.5 27.3 25.6 21.6 28.5 22.8 30.2 35.5 40.5 1.2 27.1 20.8 27.6 18.8 28.2 30.0 25.0 37.2 40.7 158.9 61.2 21.5 16.3 19.1 11.1 10.7 39.4 40.0 19.8 28.5 24.6 24.7 32.4 15.0 5.9 19.2 40.4 9.5 22.3 20.3 12.9 24.5 306.6 24.2 16.8 21.4 2.8 23.5 25.8 13.4 6.6 5.5 21.5 21.3 18.4 18.2 10.0 50.4 49.9 75.3 58.4 46.0 19.1 19.0 110.7 33.4 26.5 34.1 18.3 27.1 29.7 30.0 17.3 ZNF114 MGC17986 ENSG00000178150 "Zinc finger protein 114" Q8NC26 19 48270081-48287608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "thyroid gland: 5.9" "Cell type enhanced" "Detected in some" "Spermatogonia: 4.4;Syncytiotrophoblasts: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.2;Hep G2: 27.8;NTERA-2: 13.8;REH: 14.6" "HPA025019, HPA029553" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA025019: AB_1859080, HPA029553: AB_10603005" "unprognostic (1.82e-1)" "unprognostic (1.88e-1)" "unprognostic (5.41e-2)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-1)" "unprognostic (3.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (4.56e-3)" "unprognostic (5.21e-2)" "unprognostic (1.13e-7)" "unprognostic (9.74e-2)" "unprognostic (2.78e-1)" "unprognostic (9.15e-2)" "unprognostic (1.63e-1)" 0.8 0.4 1.8 0.7 1.5 0.8 0.6 1.9 2.1 1.1 0.6 0.3 0.3 1.1 0.8 0.5 0.9 0.5 0.7 1.6 2.9 0.5 0.2 0.7 0.6 1.3 1.4 1.1 0.4 0.8 1.6 0.4 1.4 1.2 0.4 0.2 0.6 0.4 0.6 0.5 1.0 0.1 0.2 0.7 0.6 0.1 0.9 1.2 0.2 5.9 0.4 0.6 0.2 0.3 2.2 3.8 5.9 6.9 0.2 0.0 0.0 22.2 0.4 0.0 2.1 2.8 2.2 5.6 0.0 6.4 0.3 2.4 7.4 9.5 0.1 2.5 0.1 0.6 0.3 1.4 27.8 1.5 3.7 0.5 0.4 0.7 1.1 0.0 0.5 0.1 0.4 0.7 0.0 0.2 10.9 0.3 11.6 13.8 10.3 0.9 14.6 0.0 0.0 0.2 2.7 2.7 3.1 3.7 0.1 3.7 4.2 1.4 7.0 0.9 0.5 2.2 1.7 0.6 0.2 0.2 0.0 0.2 1.8 0.5 1.8 0.3 0.3 0.2 0.2 0.1 0.4 0.2 0.1 0.7 1.2 0.1 0.1 2.0 0.7 0.2 1.0 0.1 0.1 1.8 1.5 1.9 2.1 1.6 2.9 1.3 1.4 1.1 1.2 0.7 1.2 2.2 2.3 3.2 1.8 0.7 0.2 0.4 1.3 0.5 0.0 1.2 0.3 0.4 0.5 0.0 2.6 0.0 0.0 2.1 0.2 0.0 1.9 0.5 2.6 3.3 1.6 1.4 0.0 1.3 0.2 0.6 2.5 0.6 0.0 3.9 0.0 0.9 2.2 0.8 1.8 0.0 0.9 0.0 0.0 0.3 2.0 0.8 1.2 0.6 0.0 0.0 0.2 1.3 0.0 2.0 0.2 0.3 0.0 0.7 0.1 0.9 0.0 0.4 0.8 0.7 0.0 0.9 0.6 0.8 4.4 0.0 0.1 15.3 0.5 0.7 0.1 1.1 ZNF518B KIAA1729 ENSG00000178163 "Zinc finger protein 518B" Q9C0D4 4 10439880-10457426 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031215, HPA031216" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031215: AB_10600200, HPA031216: AB_10601449" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-1)" "unprognostic (7.74e-3)" "unprognostic (2.11e-1)" "unprognostic (7.99e-2)" "unprognostic (1.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (1.27e-1)" "unprognostic (5.44e-2)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" 6.4 4.5 4.4 6.5 5.3 4.0 7.1 8.2 4.6 3.8 4.6 3.6 3.7 4.9 3.7 4.3 3.0 4.4 6.5 5.8 5.7 3.3 2.2 4.3 6.7 3.2 3.9 4.1 7.8 1.6 3.7 2.9 7.0 3.7 6.9 3.0 7.1 7.4 7.2 6.0 3.7 5.1 5.6 3.9 6.7 3.5 9.1 6.1 8.7 8.0 8.8 8.8 4.2 3.8 4.0 8.2 5.5 20.8 6.1 2.7 3.9 0.1 9.1 2.3 5.7 6.6 0.0 0.0 0.1 9.2 13.7 16.1 0.2 4.8 10.4 12.6 0.0 8.8 26.2 0.0 0.0 11.9 0.0 11.2 11.7 6.0 9.0 0.0 11.6 19.6 19.3 28.9 0.0 4.7 0.0 18.2 0.6 20.4 4.1 12.5 15.5 8.6 3.0 0.3 11.2 15.5 4.6 4.3 0.0 2.8 16.6 3.4 7.0 14.9 0.0 18.7 0.1 8.8 10.7 8.5 15.1 1.1 1.4 1.1 2.2 2.0 9.6 2.1 1.9 2.6 7.9 3.3 2.4 3.5 3.5 3.4 3.2 4.9 5.0 4.7 1.2 2.6 1.7 4.4 5.3 8.2 4.6 5.8 5.7 3.2 3.9 4.1 3.7 3.9 6.1 4.0 15.7 3.2 6.3 4.2 12.1 15.9 22.8 8.0 8.6 9.6 5.7 5.1 26.3 4.3 9.5 0.0 10.4 8.9 3.7 3.6 3.9 2.5 13.1 5.0 9.2 13.1 1.2 4.6 12.1 4.0 9.3 11.9 4.6 10.2 16.5 22.5 12.8 1.8 9.2 11.8 10.6 3.5 14.2 10.2 8.0 20.8 16.1 7.3 1.8 7.5 6.5 6.1 6.2 4.5 3.5 1.6 3.3 21.4 5.3 20.0 6.2 1.3 6.7 10.3 0.0 6.7 8.6 13.7 11.2 6.8 14.2 9.2 8.1 19.7 4.3 19.5 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755540-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 14.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: AB_2682423" "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.0 0.6 2.1 0.0 4.3 0.1 0.0 14.9 8.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.0 0.0 0.0 0.0 1.4 0.6 6.2 0.0 0.9 0.0 2.9 0.0 4.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 4.3 14.9 8.0 3.0 3.0 1.4 0.6 6.2 4.2 0.0 1.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.1 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPINK6 "BUSI2, MGC21394, UNQ844" ENSG00000178172 "Serine peptidase inhibitor Kazal type 6" Q6UWN8 5 148202794-148215137 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.9;salivary gland: 6.9;vagina: 10.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.5;Hofbauer cells: 2.8;Oligodendrocyte precursor cells: 1.0;Prostatic glandular cells: 5.2" "Group enriched" "Detected in many" 6 "cervical cancer: 21.4;head and neck cancer: 21.0" "Region enhanced" "Detected in some" "cerebellum: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 74 "HeLa: 3708.0;SiHa: 2339.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA011039 Uncertain "Secreted - unknown location" NA NA "HPA011039: AB_2668412" "unprognostic (2.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.65e-1)" "unprognostic (4.87e-2)" "prognostic favorable (7.16e-4)" "unprognostic (2.49e-2)" "unprognostic (4.04e-1)" "unprognostic (1.80e-2)" "unprognostic (2.09e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" 0.6 0.2 0.0 0.0 0.5 0.0 0.2 2.7 0.8 2.7 0.0 1.0 0.0 0.0 1.2 2.4 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.3 6.9 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.1 0.0 0.6 10.2 1.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.5 3708.0 4.0 0.0 0.6 0.0 0.0 28.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 2339.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 40.8 0.2 0.1 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.8 0.2 0.2 0.5 0.6 0.1 0.8 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.8 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.4 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.1 ZNF366 FLJ39796 ENSG00000178175 "Zinc finger protein 366" Q8N895 5 72439903-72507410 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 19.0;Cone photoreceptor cells: 31.3;Endothelial cells: 18.3;Langerhans cells: 9.3;Microglial cells: 54.4;monocytes: 14.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "myeloid DC: 10.4" "Lineage enriched" "Detected in many" 9 "dendritic cells: 10.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.3;TIME: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023128, HPA023526, HPA074074" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023128: AB_1859223, HPA023526: AB_1859224, HPA074074: " "unprognostic (3.49e-1)" "unprognostic (8.44e-2)" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "unprognostic (6.17e-2)" "unprognostic (1.95e-3)" "unprognostic (9.25e-2)" "unprognostic (6.67e-2)" "unprognostic (1.43e-1)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (1.27e-1)" "unprognostic (1.88e-3)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (6.29e-2)" 5.9 0.8 6.9 3.4 4.6 0.1 3.2 4.4 5.7 2.8 2.6 1.4 1.5 3.1 0.7 1.8 2.4 2.3 3.8 4.1 4.4 2.1 1.0 2.6 5.0 5.8 5.3 2.9 0.8 0.7 1.1 0.4 9.0 5.4 0.9 1.5 0.5 0.8 1.5 5.1 2.2 1.9 3.9 3.7 6.5 1.4 0.5 6.1 3.2 2.3 5.6 4.0 1.7 1.1 5.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.5 6.9 4.6 4.4 5.7 4.1 4.4 5.8 5.3 2.9 5.4 3.7 6.1 5.5 19.0 0.0 0.6 0.0 0.1 0.5 0.4 0.0 0.6 0.4 0.1 0.3 1.6 0.0 0.6 0.0 31.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 18.3 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.4 0.5 0.0 0.3 0.0 0.0 4.6 9.3 0.5 0.3 2.4 0.0 54.4 14.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 1.2 0.7 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.0 LCORL "FLJ30696, MLR1" ENSG00000178177 "Ligand dependent nuclear receptor corepressor like" Q8N3X6 4 17841199-18021876 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 133.6;Microglial cells: 135.9;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 164.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028794, HPA028795, HPA060033" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: AB_2684192" "unprognostic (1.06e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.65e-4)" "unprognostic (3.22e-3)" "unprognostic (3.62e-2)" "unprognostic (2.54e-4)" "unprognostic (8.90e-4)" "unprognostic (3.46e-1)" "unprognostic (3.52e-2)" "unprognostic (7.59e-2)" "unprognostic (2.10e-1)" "unprognostic (1.22e-1)" "unprognostic (7.39e-2)" "unprognostic (1.70e-2)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" 2.5 3.7 3.0 3.0 3.5 3.7 2.8 6.6 3.5 2.7 2.4 3.3 5.8 3.0 2.8 2.5 2.0 3.5 1.6 2.5 5.4 4.0 3.4 2.9 3.6 3.3 4.0 2.7 4.1 3.3 4.6 1.7 4.0 3.7 2.7 3.7 6.6 2.3 2.1 2.8 4.9 7.0 2.7 3.3 3.4 4.6 5.8 5.4 3.9 3.7 2.9 2.7 2.7 1.9 5.5 5.3 3.4 11.5 5.1 7.1 10.5 2.8 5.9 6.3 5.0 6.7 2.1 7.0 11.4 2.7 3.5 8.8 2.2 4.9 2.2 5.4 1.6 3.7 9.7 5.6 2.4 4.6 7.5 6.7 6.0 2.9 3.3 8.1 7.9 7.1 6.9 5.6 12.1 6.3 1.7 7.3 13.0 5.3 4.1 5.3 7.8 9.1 6.1 7.1 3.0 8.7 10.2 4.8 2.7 3.3 5.2 5.0 4.3 5.8 7.9 4.6 6.7 11.5 12.0 6.2 9.6 6.5 7.9 7.1 7.6 3.3 3.3 2.2 3.5 1.7 2.8 1.3 1.3 2.8 3.5 1.5 2.2 2.5 2.3 3.0 2.3 2.2 1.3 3.0 3.5 6.6 3.5 2.5 5.4 3.3 4.0 2.7 3.7 3.3 5.4 5.5 16.9 12.8 15.6 65.6 18.2 23.8 4.4 7.9 17.1 18.4 13.0 9.0 9.4 34.3 9.5 7.3 41.7 8.8 20.9 16.1 9.8 12.3 33.2 14.0 13.1 23.4 35.4 10.1 69.2 10.9 9.0 10.2 14.8 11.8 19.6 26.5 12.8 13.6 16.4 20.2 133.6 23.5 8.2 18.9 29.2 20.1 14.6 23.5 3.6 135.9 21.0 10.4 13.4 117.1 164.2 12.4 16.1 7.5 40.7 10.1 34.1 14.6 15.9 22.5 19.7 13.6 12.8 52.2 16.3 13.6 19.0 9.9 11.6 19.8 16.5 6.3 PARD6G "PAR-6G, PAR6gamma" ENSG00000178184 "Par-6 family cell polarity regulator gamma" Q9BYG4 18 80157232-80247514 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 38.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 39.6;Oligodendrocyte precursor cells: 25.6;Squamous epithelial cells: 25.3;Suprabasal keratinocytes: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 36.4;hTCEpi: 34.0;RT4: 27.9;U-2 OS: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047017 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA047017: AB_2679904" "unprognostic (1.11e-1)" "unprognostic (4.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.40e-2)" "unprognostic (2.97e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.80e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.09e-2)" "unprognostic (6.86e-3)" "unprognostic (9.65e-2)" "unprognostic (1.01e-1)" "unprognostic (4.85e-1)" "unprognostic (2.72e-1)" 3.3 1.7 7.9 1.4 5.7 0.6 5.3 4.2 8.1 7.9 5.8 4.7 1.8 6.6 2.7 18.2 6.2 3.3 2.8 9.8 7.3 6.9 3.6 2.9 2.5 8.2 5.9 5.0 6.3 2.1 2.1 3.8 5.5 7.9 5.8 2.0 1.8 4.5 6.0 1.9 38.4 3.0 5.5 5.4 2.1 2.7 2.1 6.7 5.4 18.1 1.0 4.3 5.7 12.1 13.4 3.0 4.3 17.7 13.4 0.6 0.7 12.9 3.3 0.7 2.9 0.4 1.2 1.2 0.0 1.4 1.5 5.1 13.4 6.4 19.2 2.8 0.5 5.7 0.2 3.5 10.4 0.8 4.0 36.4 5.7 34.0 0.3 1.8 2.2 1.4 4.2 1.4 0.8 4.3 5.0 3.6 0.4 5.3 1.4 5.2 0.1 11.7 1.5 0.5 27.9 7.4 7.7 4.1 2.2 20.0 8.6 2.6 3.4 1.1 5.9 28.8 2.2 1.6 0.9 1.2 0.3 1.9 0.9 11.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 5.7 4.2 8.1 9.8 7.3 8.2 5.9 5.0 7.9 5.4 6.7 13.4 3.3 3.2 0.6 7.5 0.7 39.6 13.7 11.0 18.8 1.3 4.1 10.3 2.8 1.5 2.3 3.7 0.0 0.6 9.7 0.4 0.0 0.4 0.5 9.8 10.1 8.2 0.0 0.0 6.5 0.2 9.5 4.1 0.5 3.3 0.0 3.1 10.8 1.5 0.8 0.0 8.5 0.7 8.2 0.9 6.5 0.7 1.8 0.8 12.4 15.9 0.0 2.0 0.0 25.6 4.8 0.8 0.0 1.9 3.6 6.6 0.0 7.6 2.6 2.5 19.7 1.9 13.6 1.5 6.0 25.3 63.9 0.4 8.0 2.0 0.6 13.4 ZNF454 FLJ37444 ENSG00000178187 "Zinc finger protein 454" Q8N9F8 5 178941191-178966433 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.0;Cone photoreceptor cells: 16.7;Rod photoreceptor cells: 13.1;Spermatocytes: 24.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;EFO-21: 1.9;HHSteC: 1.4;HSkMC: 1.7;NTERA-2: 1.4;SuSa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024556 Uncertain NA NA "HPA024556: AB_1859283" "unprognostic (1.27e-1)" "unprognostic (9.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (4.21e-2)" "unprognostic (1.41e-1)" "unprognostic (8.35e-2)" "unprognostic (3.72e-2)" "unprognostic (2.34e-2)" "unprognostic (9.52e-3)" "unprognostic (1.52e-1)" "unprognostic (3.95e-2)" "unprognostic (9.58e-2)" "unprognostic (3.68e-2)" "unprognostic (8.43e-3)" "unprognostic (2.78e-1)" 0.8 0.5 0.7 0.2 0.5 0.0 1.1 3.0 1.0 1.2 0.0 0.7 0.3 1.4 0.6 0.4 1.7 0.8 0.8 0.6 0.8 0.7 0.1 0.6 0.1 0.7 0.7 0.4 1.9 0.9 0.9 2.4 0.7 1.2 1.4 0.5 2.4 0.8 1.2 0.1 0.5 0.4 1.4 0.0 0.4 0.7 2.1 1.2 0.3 1.2 0.3 0.2 1.1 0.9 1.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 1.9 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 3.0 1.0 0.6 0.8 0.7 0.7 0.4 1.2 0.0 1.2 1.1 4.4 3.2 6.4 3.3 0.2 0.1 1.3 0.3 1.2 22.0 1.2 1.4 1.2 1.5 5.0 0.0 16.7 1.2 0.2 0.3 1.9 2.3 8.4 1.1 4.7 4.1 0.0 0.0 5.1 0.5 1.2 2.7 1.1 0.7 1.3 5.1 1.1 0.1 0.3 5.0 5.5 0.1 0.0 0.0 0.4 1.8 4.1 0.5 0.0 1.0 0.0 3.5 0.0 7.1 2.3 0.5 0.0 2.6 0.1 1.5 0.2 0.4 2.9 13.1 0.0 3.3 2.2 24.2 7.2 0.4 0.4 0.8 0.3 4.1 0.3 0.8 SH2B1 "FLJ30542, SH2B" ENSG00000178188 "SH2B adaptor protein 1" Q9NRF2 16 28846600-28874212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060663, HPA076175" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA060663: , HPA076175: AB_2686782" "unprognostic (3.60e-2)" "unprognostic (1.94e-2)" "unprognostic (8.94e-2)" "unprognostic (2.27e-1)" "unprognostic (3.27e-1)" "unprognostic (3.27e-3)" "unprognostic (6.10e-2)" "prognostic favorable (9.40e-4)" "unprognostic (3.94e-2)" "unprognostic (1.18e-1)" "prognostic favorable (4.38e-4)" "unprognostic (1.39e-2)" "prognostic favorable (2.81e-6)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.60e-4)" 36.1 57.9 47.6 33.1 47.4 38.9 39.8 51.6 75.8 57.4 33.1 58.5 46.8 55.3 21.1 39.7 54.8 30.2 49.1 47.7 36.8 62.6 45.0 35.9 39.5 43.6 41.5 43.9 70.0 53.8 55.7 70.6 21.1 48.0 58.2 28.7 29.4 49.6 37.1 58.7 40.9 57.5 25.0 31.2 63.9 52.3 49.2 43.8 36.8 72.2 51.0 25.4 47.5 45.3 51.9 29.9 43.2 32.3 41.7 33.3 28.2 26.9 30.4 17.1 23.4 25.3 29.0 49.2 27.4 41.7 24.5 20.2 46.4 21.3 33.9 13.2 35.9 27.6 24.4 111.3 45.0 25.2 24.8 22.4 39.4 27.2 32.9 13.3 40.0 27.4 27.8 39.8 39.1 31.3 40.3 37.2 36.4 41.9 15.6 17.3 62.3 19.4 46.1 27.2 22.2 36.9 49.7 14.7 42.4 22.3 19.1 33.4 26.5 38.8 26.9 22.5 23.8 23.6 74.0 40.2 30.9 41.8 43.0 27.5 3.3 1.4 0.6 2.0 1.1 1.9 1.6 1.6 1.4 1.1 1.7 1.2 1.1 2.1 0.6 1.1 1.9 1.8 0.9 47.6 47.4 51.6 75.8 47.7 36.8 43.6 41.5 43.9 48.0 31.2 43.8 51.9 14.1 6.4 13.7 37.5 13.9 10.8 15.9 15.4 22.8 26.7 17.4 13.8 18.4 17.2 15.7 22.0 33.3 16.6 12.8 31.1 15.6 9.5 2.2 11.0 11.0 12.7 27.6 7.8 25.6 12.9 8.2 15.0 19.4 11.4 6.3 20.1 13.9 8.9 12.2 28.6 26.8 24.7 14.2 8.7 7.2 5.4 22.1 10.8 3.6 13.1 10.7 18.1 22.6 21.6 19.0 12.8 24.9 23.7 10.5 10.4 26.3 10.2 12.5 28.9 26.3 12.9 15.7 9.9 12.8 17.4 11.1 13.7 15.3 20.4 28.4 12.3 ZC3H12D "C6orf95, dJ281H8.1, MCPIP4" ENSG00000178199 "Zinc finger CCCH-type containing 12D" A2A288 6 149446795-149485014 "Disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 3.6;intestine: 4.7;lymphoid tissue: 12.7" "Cell type enhanced" "Detected in many" "B-cells: 14.6;Distal enterocytes: 7.7;Kupffer cells: 12.4;Macrophages: 7.4;Proximal enterocytes: 7.5;T-cells: 17.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036897 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA036897: AB_10672104" "unprognostic (2.89e-2)" "unprognostic (3.91e-4)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.47e-6)" "unprognostic (2.20e-2)" "unprognostic (2.50e-3)" "unprognostic (1.34e-1)" "unprognostic (3.30e-2)" "unprognostic (2.33e-2)" "unprognostic (1.86e-1)" "unprognostic (1.28e-4)" "unprognostic (1.21e-2)" "unprognostic (9.24e-3)" "unprognostic (6.99e-2)" "unprognostic (5.52e-2)" 0.7 0.4 1.0 7.2 0.7 3.6 0.4 0.4 0.9 0.2 0.5 1.3 2.8 0.2 0.2 0.3 0.3 0.6 0.2 0.8 1.3 0.6 0.3 0.8 9.9 0.7 0.5 0.9 0.3 0.1 0.0 0.2 0.3 0.8 0.3 1.4 0.5 0.7 0.3 0.4 1.1 4.7 0.5 0.5 5.8 0.8 0.3 0.6 1.1 0.5 0.0 12.7 1.0 0.2 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.1 8.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 34.3 0.2 0.3 1.2 2.7 0.0 2.8 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 2.5 0.0 0.0 0.0 7.1 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 4.6 0.0 0.2 0.1 0.1 0.1 0.1 0.2 2.9 0.4 2.5 0.1 0.7 0.8 0.1 0.1 0.5 0.2 1.4 1.5 0.7 0.8 1.3 0.9 0.2 0.5 0.3 1.4 0.4 3.5 0.8 1.0 0.7 0.4 0.9 0.8 1.3 0.7 0.5 0.9 0.8 0.5 0.6 0.9 1.0 3.2 3.9 1.3 14.6 0.4 0.5 0.0 0.0 0.7 0.3 0.3 1.4 1.5 0.6 0.0 4.2 0.0 3.7 7.7 1.9 0.0 0.4 0.4 0.4 1.3 0.0 0.4 1.2 0.4 0.0 0.7 0.5 0.6 0.0 0.2 1.4 0.3 3.7 0.0 0.7 1.1 0.0 12.4 4.4 0.5 0.0 7.4 1.8 1.0 1.6 0.8 0.0 0.0 0.7 0.3 0.8 0.0 4.6 0.4 7.5 1.6 0.0 1.1 0.0 0.9 0.4 0.2 0.4 0.1 1.4 0.0 17.4 0.0 2.6 0.4 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3" "Not detected" "Not detected" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.5 1.0 2.2 0.2 2.4 0.3 0.7 4.5 2.5 0.5 1.5 0.9 0.0 0.5 2.2 0.6 0.8 0.3 1.8 2.3 2.0 1.2 1.0 0.8 0.4 2.3 2.0 2.2 1.2 0.6 1.2 3.4 0.6 2.5 1.3 0.3 8.3 0.9 0.6 2.4 1.8 0.7 0.3 1.3 1.1 0.5 1.3 1.8 0.4 1.8 2.7 0.3 0.9 0.6 2.5 0.2 0.0 0.8 0.9 0.0 0.2 0.4 0.2 0.3 0.2 0.8 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.3 0.0 2.9 0.4 0.0 0.3 0.1 0.2 0.5 0.3 0.3 0.0 0.1 0.4 0.1 0.3 0.1 0.4 0.4 0.1 0.2 0.9 0.2 0.0 0.3 0.2 0.5 0.4 0.2 0.5 1.5 0.6 0.0 0.2 0.0 0.4 0.4 0.3 0.0 0.6 0.1 0.1 0.3 2.5 3.3 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.4 4.5 2.5 2.3 2.0 2.3 2.0 2.2 2.5 1.3 1.8 2.5 0.4 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 4.5 0.2 0.0 0.3 0.0 0.6 0.0 2.1 0.2 1.4 0.0 0.0 0.3 0.0 0.2 0.1 0.6 0.0 0.4 1.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.1 6.7 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.0 2.5 0.3 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 4.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.2 POGLUT3 "KDELC2, MGC33424" ENSG00000178202 "Protein O-glucosyltransferase 3" Q7Z4H8 11 108472112-108498384 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624" "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (6.27e-5)" 24.9 13.3 5.7 17.4 4.9 7.6 16.4 4.9 5.4 33.9 7.3 17.0 9.5 35.3 27.5 21.2 23.2 21.9 14.6 4.1 8.9 15.7 13.3 16.1 10.5 5.2 5.5 3.7 36.8 8.4 25.4 5.4 32.9 5.4 28.6 17.1 5.8 14.0 28.7 5.5 13.8 11.3 37.4 5.4 12.5 11.4 5.8 5.6 16.6 12.2 14.0 9.6 22.7 19.0 6.0 10.9 12.4 46.5 47.8 76.5 88.5 44.8 47.0 43.7 66.0 71.1 58.9 78.1 0.1 28.6 61.6 73.1 7.9 35.6 1.2 69.3 19.4 27.4 18.1 12.1 27.2 30.8 47.7 0.2 51.1 14.6 35.0 1.0 40.1 56.6 0.3 41.5 0.3 101.0 7.9 30.9 27.2 20.3 11.5 34.8 1.5 72.5 0.2 12.3 30.3 9.7 29.5 89.1 6.2 13.3 21.4 42.3 18.0 56.8 127.0 24.9 10.8 49.7 0.4 0.1 0.3 32.6 48.9 103.1 0.1 0.1 0.0 2.0 0.7 1.7 0.2 1.0 1.7 0.5 0.3 1.0 1.5 0.1 1.9 0.4 1.0 0.9 0.5 5.7 4.9 4.9 5.4 4.1 8.9 5.2 5.5 3.7 5.4 5.4 5.6 6.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 27.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.5 14.7 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 21.2 0.5 0.0 0.0 0.0 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915153-143976734 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 259.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 257.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "PC-3: 384.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Supported "Intermediate filaments,Focal adhesion sites,Cytosol" NA NA 7400000 "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 40.6 31.1 42.2 22.8 23.6 43.6 38.2 24.1 40.0 54.8 7.7 56.3 21.3 55.6 8.6 60.2 48.4 23.0 63.4 40.5 43.7 30.0 31.6 49.7 22.3 40.5 24.9 21.0 47.5 27.8 8.1 33.3 18.4 32.0 49.9 13.1 3.9 43.3 20.0 259.0 78.7 54.2 28.0 28.2 46.4 49.5 15.4 35.7 14.5 25.9 75.4 15.9 57.0 56.1 25.9 92.6 247.3 15.1 20.3 31.6 66.9 62.8 125.9 49.3 32.3 18.7 39.2 88.5 8.9 82.9 179.7 54.6 98.9 10.3 162.6 13.3 58.7 10.0 24.9 268.0 34.0 54.0 9.6 26.1 71.8 40.7 84.6 164.2 28.3 43.0 7.6 16.2 25.9 39.7 175.3 5.1 19.8 12.2 29.4 384.8 1.8 46.2 24.6 67.7 147.7 16.6 16.8 217.4 50.0 21.1 21.7 55.7 12.4 125.7 117.8 217.3 110.6 155.1 4.7 3.7 6.3 106.9 15.2 176.2 0.0 2.0 0.1 0.6 1.7 1.3 0.6 1.2 0.9 1.6 0.6 0.8 0.5 0.4 0.3 1.2 1.3 1.4 2.0 42.2 23.6 24.1 40.0 40.5 43.7 40.5 24.9 21.0 32.0 28.2 35.7 25.9 83.8 28.9 15.6 78.0 27.0 108.0 53.1 62.9 50.7 15.8 29.4 27.9 39.3 31.5 42.9 40.5 25.0 34.4 27.1 257.8 0.0 39.3 1.4 39.4 52.6 68.2 32.2 11.8 47.3 20.2 32.1 45.7 170.2 57.3 8.2 14.4 63.1 69.0 35.2 30.3 36.5 79.9 10.2 67.5 100.4 5.0 44.4 61.2 33.8 27.2 54.9 11.2 15.5 14.6 3.4 157.8 194.1 74.9 39.3 144.9 124.9 4.6 50.3 10.8 6.6 42.1 61.5 1.2 7.1 72.2 76.7 69.0 35.0 18.8 61.6 121.0 SH2D4B ENSG00000178217 "SH2 domain containing 4B" Q5SQS7 10 80537902-80646560 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.8;Inhibitory neurons: 1.0;Spermatogonia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 87 "REH: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040022 Uncertain NA NA "HPA040022: AB_10805601" "unprognostic (1.19e-2)" "unprognostic (4.51e-3)" "unprognostic (4.45e-2)" "unprognostic (2.94e-2)" "unprognostic (3.31e-1)" "unprognostic (1.09e-1)" "unprognostic (2.36e-1)" "unprognostic (2.87e-2)" "unprognostic (3.80e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" "unprognostic (2.65e-6)" "unprognostic (9.37e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-3)" "unprognostic (3.81e-1)" 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 RNF212 "FLJ38841, LOC285498" ENSG00000178222 "Ring finger protein 212" Q495C1 4 1056250-1113564 "Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 9.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 62.6;Spermatocytes: 52.3;Spermatogonia: 42.4" "Cancer enhanced" "Detected in many" "cervical cancer: 5.3;ovarian cancer: 5.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "A-431: 11.8;HeLa: 39.4;JURKAT: 18.0;SiHa: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA057527 Uncertain NA NA "HPA057527: AB_2683457" "unprognostic (2.75e-2)" "prognostic favorable (1.39e-4)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (1.10e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "unprognostic (1.33e-1)" "unprognostic (2.09e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (8.36e-2)" "unprognostic (1.60e-1)" "unprognostic (5.52e-2)" "unprognostic (1.05e-1)" 1.5 1.2 1.1 0.7 1.4 2.0 1.6 3.9 1.1 1.5 0.9 1.5 0.5 1.0 1.0 1.2 2.1 0.8 0.6 1.1 0.7 2.7 0.2 1.4 1.0 0.9 0.8 0.7 5.0 9.3 1.3 7.4 0.3 1.5 1.8 0.6 1.3 1.7 0.5 0.5 1.9 1.1 0.8 0.7 1.1 1.0 3.1 0.9 0.8 3.2 0.6 0.7 0.9 1.8 1.0 11.8 0.7 0.1 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 5.3 0.1 0.0 2.9 0.0 3.1 0.0 0.0 0.0 18.0 0.1 0.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 3.8 0.0 22.6 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.2 0.5 0.2 1.2 0.2 0.4 0.6 1.1 0.3 0.0 0.1 0.0 0.1 0.2 0.3 1.1 1.4 3.9 1.1 1.1 0.7 0.9 0.8 0.7 1.5 0.7 0.9 1.0 1.1 3.2 6.9 1.3 1.3 2.8 5.6 1.5 13.6 3.0 3.9 4.8 0.6 1.5 6.8 0.0 2.1 0.0 1.1 0.5 62.6 3.8 3.9 0.5 2.5 0.8 4.9 0.0 4.7 0.9 0.2 11.7 1.1 1.1 4.5 1.9 0.4 0.0 0.6 0.0 1.7 2.8 0.0 0.8 1.8 7.5 8.4 1.8 0.0 2.8 0.9 5.1 2.1 0.0 4.4 0.8 1.6 0.7 0.8 4.6 0.7 8.9 2.2 6.4 0.0 6.8 1.7 52.3 42.4 4.5 3.1 0.3 1.8 2.1 1.2 4.5 PRSS36 FLJ90661 ENSG00000178226 "Serine protease 36" Q5K4E3 16 31138926-31150083 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 11.7;Distal enterocytes: 13.2;Hofbauer cells: 18.7;Paneth cells: 15.4;Proximal enterocytes: 46.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HeLa: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA036079 Uncertain "Secreted to extracellular matrix" NA NA "HPA036079: AB_10602290" "unprognostic (3.74e-2)" "prognostic favorable (2.97e-7)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (4.26e-3)" "unprognostic (1.31e-5)" "unprognostic (4.18e-2)" "unprognostic (5.05e-2)" "unprognostic (2.65e-2)" "unprognostic (8.03e-2)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (9.86e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-1)" 1.2 0.8 0.4 0.4 0.5 0.4 0.5 0.4 0.8 0.2 0.4 0.6 1.0 0.1 0.0 0.3 0.3 0.1 0.3 0.4 0.5 0.2 0.3 0.7 0.1 0.4 0.4 0.3 0.1 0.2 0.1 2.6 0.7 0.5 0.2 0.2 0.0 0.5 0.1 0.2 1.0 0.7 0.3 0.4 0.2 0.3 0.4 0.4 0.9 0.3 0.0 0.2 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.8 2.6 0.4 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.0 0.1 0.0 0.2 0.0 0.0 0.4 0.5 0.4 0.8 0.4 0.5 0.4 0.4 0.3 0.5 0.4 0.4 0.4 0.3 0.0 1.1 0.7 0.2 1.9 2.6 8.9 1.8 0.5 5.9 11.7 1.1 2.8 3.5 0.0 0.0 0.8 1.2 13.2 0.0 1.7 1.7 0.9 0.6 0.6 0.0 0.4 0.6 2.8 1.2 1.3 1.1 0.9 0.0 0.5 3.3 3.3 18.7 0.0 0.8 4.1 2.0 3.2 3.8 0.9 2.8 4.2 0.0 0.0 5.4 0.6 4.1 0.0 0.1 1.8 15.4 2.6 0.0 1.7 46.9 1.9 1.2 0.0 0.0 0.4 0.4 0.6 4.4 1.5 2.6 0.5 0.5 1.1 3.9 1.9 ZNF543 DKFZp434H055 ENSG00000178229 "Zinc finger protein 543" Q08ER8 19 57320472-57330770 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 12.5;Late spermatids: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046330 Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: " "unprognostic (9.20e-2)" "unprognostic (8.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-1)" "unprognostic (2.45e-2)" "unprognostic (9.86e-2)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.44e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.03e-5)" "unprognostic (1.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-1)" "unprognostic (2.84e-2)" 1.5 1.5 1.4 1.4 1.5 1.8 2.7 4.8 1.9 1.7 0.1 1.2 0.7 1.9 1.7 2.0 2.2 1.5 1.4 1.3 1.6 1.6 1.1 1.7 2.4 1.3 1.6 1.7 4.9 1.9 3.1 1.8 2.8 2.4 2.0 1.1 2.8 1.7 2.3 1.8 2.3 1.2 1.9 0.7 2.5 1.6 3.2 1.3 3.3 2.6 1.9 2.4 1.5 1.3 1.8 2.3 3.0 2.8 4.4 2.4 2.1 3.3 1.3 2.4 2.5 4.4 0.9 1.3 3.6 1.8 1.9 1.6 1.3 2.4 2.5 3.3 1.6 6.5 3.5 3.4 2.8 2.6 3.5 2.3 2.3 2.6 1.9 4.1 2.1 1.9 4.2 1.9 0.7 1.8 0.3 4.0 1.1 2.5 0.2 2.3 3.8 4.1 3.9 1.6 5.6 5.1 3.6 3.9 1.5 2.6 2.4 1.8 3.2 1.8 3.6 2.5 0.7 2.5 5.3 3.8 4.1 1.8 1.5 1.9 0.9 1.4 3.1 1.5 1.4 1.8 2.3 1.6 2.2 1.5 2.3 1.9 1.9 1.5 2.1 1.5 1.0 0.9 1.5 1.4 1.5 4.8 1.9 1.3 1.6 1.3 1.6 1.7 2.4 0.7 1.3 1.8 4.1 3.2 0.5 0.7 4.2 2.7 1.3 1.9 3.4 4.5 2.3 1.3 1.9 5.7 2.4 0.0 6.2 3.1 4.8 0.5 5.9 1.6 12.5 3.5 2.4 3.8 0.0 1.3 4.4 0.4 1.5 1.7 0.5 4.4 2.5 4.9 2.9 0.8 1.7 6.7 5.3 1.3 8.2 1.6 1.2 15.2 1.5 1.3 1.8 5.6 0.2 3.8 0.0 4.0 2.5 0.2 0.3 2.2 3.2 1.9 0.6 0.9 0.5 6.3 6.6 2.4 2.9 3.3 2.4 4.4 2.6 2.2 2.6 3.3 1.3 1.5 TMEM151B "bA444E17.5, C6orf137, TMEM193" ENSG00000178233 "Transmembrane protein 151B" Q8IW70 6 44270450-44307506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 57.3" "Group enriched" "Detected in some" 5 "Excitatory neurons: 27.0;Inhibitory neurons: 31.4" "Cancer enhanced" "Detected in single" "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055167 Uncertain NA NA "HPA055167: AB_2682723" "unprognostic (1.28e-3)" "unprognostic (6.25e-2)" "unprognostic (5.06e-2)" "unprognostic (7.02e-3)" "unprognostic (6.61e-2)" "unprognostic (1.22e-3)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-4)" "unprognostic (1.48e-1)" "unprognostic (4.56e-3)" "unprognostic (1.85e-1)" "unprognostic (9.15e-2)" "unprognostic (3.86e-2)" "unprognostic (1.66e-1)" 0.1 3.0 11.7 0.4 22.0 0.2 0.2 46.6 57.3 0.2 0.0 0.9 0.5 0.2 0.0 0.2 0.3 0.0 0.4 36.8 3.0 0.2 0.2 0.1 0.2 10.4 7.2 20.5 0.3 0.4 0.0 4.0 0.0 26.1 0.3 0.3 2.9 0.3 0.0 0.2 0.2 0.7 0.1 1.8 0.3 0.5 0.8 16.8 0.1 0.3 0.0 0.0 0.1 0.4 19.0 0.0 0.1 6.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.7 0.1 0.2 0.0 0.0 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.0 0.1 0.7 4.9 0.1 0.2 0.5 0.0 0.1 0.0 0.1 28.6 5.9 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.4 0.3 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 22.0 46.6 57.3 36.8 3.0 10.4 7.2 20.5 26.1 1.8 16.8 19.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 5.3 0.1 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 27.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 31.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.8 0.0 0.4 0.0 4.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT11 GalNAc-T11 ENSG00000178234 "Polypeptide N-acetylgalactosaminyltransferase 11" Q8NCW6 7 152025674-152122340 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Notch signaling pathway" "Glycosyltransferase, Transferase" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 332.8;kidney: 231.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 131.1;Inhibitory neurons: 130.7;Proximal tubular cells: 196.7" "Cancer enhanced" "Detected in all" "renal cancer: 30.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039330 Uncertain NA NA "HPA039330: AB_10795249" "unprognostic (6.09e-2)" "unprognostic (1.22e-1)" "unprognostic (4.98e-2)" "unprognostic (3.48e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.76e-1)" "unprognostic (9.10e-3)" "unprognostic (1.56e-3)" "unprognostic (1.38e-1)" "unprognostic (3.65e-1)" "unprognostic (3.82e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.24e-6)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (2.97e-1)" "unprognostic (9.51e-2)" 32.7 25.6 26.1 15.4 30.8 12.8 29.3 23.4 29.6 23.9 332.8 19.8 14.7 24.0 24.8 26.5 22.6 26.3 26.7 39.9 24.8 231.6 20.1 27.8 16.2 20.8 23.7 28.0 28.3 84.8 58.4 24.6 46.2 23.4 32.6 17.8 40.9 23.0 25.9 28.7 24.0 15.1 24.5 14.6 20.6 22.2 11.9 27.3 24.0 34.8 26.2 17.9 24.4 24.2 26.8 28.9 25.4 36.8 41.2 83.1 81.3 37.7 22.6 25.6 18.6 17.4 20.7 29.7 0.1 57.8 36.8 51.8 13.3 17.6 31.9 22.8 23.5 26.3 5.8 23.4 18.2 27.3 26.2 29.3 72.1 40.3 15.5 13.0 32.3 34.1 19.9 29.5 0.2 47.0 24.9 22.7 23.6 30.4 45.1 20.2 0.1 16.1 0.9 61.1 43.8 32.6 43.3 37.5 18.0 31.0 39.0 26.8 22.3 31.1 24.8 8.8 31.6 25.1 8.4 11.4 0.5 51.6 25.1 86.6 10.2 12.7 13.5 28.1 15.2 27.8 9.5 15.4 25.8 13.0 5.7 13.1 19.9 6.6 26.2 21.3 4.0 12.7 14.4 26.1 30.8 23.4 29.6 39.9 24.8 20.8 23.7 28.0 23.4 14.6 27.3 26.8 28.7 12.8 25.2 44.4 12.9 10.5 24.6 20.5 13.1 123.9 23.5 20.7 30.7 15.7 16.1 35.0 27.1 84.0 49.1 8.7 60.7 17.8 4.8 31.5 38.8 22.8 22.8 7.8 131.1 18.7 13.5 33.8 11.7 57.1 14.5 26.0 22.1 15.8 25.3 75.7 130.7 10.0 8.2 19.7 12.5 3.5 19.9 21.7 17.8 46.9 18.0 37.8 43.3 54.3 42.0 13.0 8.3 36.1 20.3 26.3 9.6 196.7 21.2 39.4 0.0 36.3 25.0 38.7 27.5 24.7 11.8 36.3 29.1 24.3 9.3 19.1 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882474 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.9;retina: 3.0" "Group enriched" "Detected in some" 6 "Bipolar cells: 15.3;Excitatory neurons: 18.4;Inhibitory neurons: 14.0;Oligodendrocyte precursor cells: 25.1;Oligodendrocytes: 14.3" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 3.0;AF22: 1.2;LHCN-M2: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074835 Enhanced "Secreted in brain" NA NA 330000 "HPA074835: " "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.0 0.1 3.1 0.0 8.9 0.0 0.0 0.0 10.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.0 0.0 0.0 0.0 0.0 2.8 1.3 11.4 0.0 1.1 0.0 1.9 0.0 2.3 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 11.9 3.0 0.0 1.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 8.9 0.0 10.6 7.9 1.0 2.8 1.3 11.4 2.3 0.0 3.1 11.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 15.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 25.1 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favorable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 57.9 150.0 110.9 52.4 102.9 42.1 70.4 100.5 125.5 141.7 111.5 116.4 67.1 123.8 83.8 65.6 130.9 60.2 77.0 102.4 114.1 114.5 98.5 78.5 61.7 102.3 103.2 102.4 207.7 137.8 91.7 209.1 46.5 103.2 160.6 51.4 49.9 100.0 74.8 72.0 64.2 106.3 68.8 99.9 113.8 94.1 61.7 112.5 55.2 179.7 38.1 53.9 119.8 91.3 103.9 61.4 82.4 133.7 113.7 87.8 71.1 90.1 89.4 73.1 98.7 79.4 73.9 86.2 98.3 55.5 143.2 75.8 68.1 107.8 125.0 70.0 78.3 71.8 93.1 223.0 98.8 88.8 97.3 40.3 128.5 87.3 91.1 68.4 136.2 73.0 101.8 54.0 102.4 90.6 121.7 113.5 109.8 119.1 55.7 75.9 65.5 57.3 61.8 117.6 179.3 64.9 121.0 66.8 54.1 40.6 96.9 94.8 76.7 98.4 72.7 116.1 71.3 121.1 177.3 82.7 84.3 98.7 122.2 53.4 6.4 11.5 12.8 19.0 15.5 21.1 13.0 13.9 14.4 13.5 12.8 15.8 12.2 3.9 14.6 8.0 17.0 12.6 16.8 110.9 102.9 100.5 125.5 102.4 114.1 102.3 103.2 102.4 103.2 99.9 112.5 103.9 16.0 22.4 48.5 67.9 28.0 17.8 24.3 32.0 27.9 26.0 48.1 43.1 3.1 42.9 38.5 47.8 47.9 46.5 21.4 18.4 9.8 30.7 4.3 34.6 32.3 20.8 72.3 16.6 9.3 26.0 21.0 24.1 36.7 39.2 29.1 66.7 26.0 44.7 26.8 37.0 17.5 32.3 28.5 19.2 20.2 7.0 38.2 18.7 12.4 22.5 24.7 39.0 12.3 27.2 23.3 28.0 23.5 28.2 29.9 26.2 30.8 31.3 26.2 46.4 26.3 20.0 21.0 43.0 34.9 15.5 11.4 56.5 25.9 44.7 36.4 19.9 PRM3 ENSG00000178257 "Protamine 3" Q9NNZ6 16 11273199-11273629 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 89.6" "Cell type enriched" "Detected in some" 4 "Late spermatids: 3440.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "TIME: 3.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.5 0.0 0.6 2.7 0.0 2.6 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.4 0.2 0.0 0.2 0.6 0.0 0.0 0.1 0.2 0.0 89.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 2.6 1.5 0.9 0.0 0.5 0.2 0.2 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 854.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3440.3 12.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNP2 TP2 ENSG00000178279 "Transition protein 2" Q05952 16 11267748-11269533 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 371 "testis: 49.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 919.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 219.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 919.5 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11465 "epididymis: 4604.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 5.7;RPMI-8226: 1.7" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4604.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GEN1 "FLJ40869, Gen" ENSG00000178295 "GEN1 Holliday junction 5' flap endonuclease" Q17RS7 2 17753858-17788946 "Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA020078, HPA021141" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020078: AB_2670352, HPA021141: AB_2670599" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.64e-2)" "unprognostic (1.67e-3)" "unprognostic (7.90e-4)" "unprognostic (4.53e-2)" "unprognostic (1.70e-3)" "unprognostic (8.60e-3)" "unprognostic (8.04e-2)" "unprognostic (6.99e-2)" "unprognostic (1.89e-12)" "unprognostic (3.97e-3)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (1.49e-3)" 1.6 1.8 1.2 4.8 1.1 15.3 3.2 1.1 1.2 2.3 12.6 5.2 3.3 1.8 9.4 5.6 1.4 4.4 2.1 1.5 1.4 1.7 8.7 2.0 10.9 1.9 1.6 0.7 0.9 2.3 1.1 3.0 4.0 1.6 2.7 7.0 2.5 5.6 2.7 1.7 7.6 4.5 1.4 2.2 5.2 3.1 8.6 1.3 5.5 1.9 1.5 11.9 1.5 3.7 1.7 29.4 15.0 14.0 9.9 3.2 4.1 23.9 21.3 6.7 9.9 9.6 19.6 13.0 27.4 8.2 7.3 10.4 18.4 16.4 12.8 13.7 21.4 9.1 15.7 16.3 9.5 1.9 20.2 17.0 3.1 4.7 16.8 7.7 3.0 8.0 13.7 21.0 19.6 16.4 14.1 15.2 16.4 9.5 9.4 6.8 17.7 36.3 10.9 5.6 19.6 15.3 20.8 11.5 14.3 7.5 9.5 9.8 10.6 10.7 22.4 9.8 12.2 21.8 13.1 26.0 45.1 9.6 18.3 16.0 0.1 0.4 0.3 0.3 0.3 0.2 1.7 0.3 0.6 0.6 0.7 0.4 0.4 0.1 0.4 0.4 0.6 0.5 0.3 1.2 1.1 1.1 1.2 1.5 1.4 1.9 1.6 0.7 1.6 2.2 1.3 1.7 3.6 6.4 3.6 12.1 16.9 2.8 2.7 5.2 5.7 5.7 4.5 3.0 4.4 1.5 8.1 3.7 12.5 4.4 6.9 9.3 0.0 2.1 4.6 4.9 8.5 4.0 1.8 15.3 14.1 2.3 4.8 4.2 17.3 6.6 1.3 14.5 2.2 5.4 3.8 3.3 13.0 7.3 0.0 3.1 1.0 3.7 1.8 4.0 1.8 6.5 2.9 3.8 1.0 12.5 11.0 2.9 4.0 0.7 11.2 3.2 5.3 2.5 5.0 3.6 6.6 15.0 5.3 14.2 11.4 8.1 1.8 3.3 3.7 8.0 7.2 2.9 TMPRSS9 ENSG00000178297 "Transmembrane serine protease 9" Q7Z410 19 2360238-2426239 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 4.2;lymphoid tissue: 2.4;testis: 3.7" "Cell type enhanced" "Detected in some" "Early spermatids: 23.4;Erythroid cells: 48.6;Granulosa cells: 22.1;Late spermatids: 59.9;Theca cells: 41.0" "Cancer enhanced" "Detected in some" "liver cancer: 1.5;melanoma: 1.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2;SK-BR-3: 1.2;U-266/70: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051483 Uncertain NA NA "HPA051483: AB_2681501" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (5.62e-3)" "unprognostic (1.86e-1)" "unprognostic (1.54e-2)" "unprognostic (1.87e-3)" "unprognostic (3.30e-1)" "unprognostic (6.44e-2)" "unprognostic (7.29e-2)" "unprognostic (2.07e-1)" "unprognostic (6.30e-2)" "unprognostic (9.20e-3)" "unprognostic (2.28e-3)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (3.07e-3)" "unprognostic (6.73e-2)" 0.1 0.7 0.8 0.1 0.6 0.8 0.4 0.8 1.4 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 4.2 0.0 0.1 0.8 0.4 0.2 0.2 0.7 0.0 0.1 0.0 1.7 0.1 0.0 0.1 0.2 0.0 0.6 0.5 0.1 0.0 0.2 2.4 0.1 3.7 0.5 0.2 0.0 0.0 0.0 0.1 0.0 1.6 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.2 0.0 0.3 0.0 0.1 0.2 0.0 0.3 0.4 0.0 0.3 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.7 0.1 0.3 0.3 0.3 0.3 2.2 0.5 0.4 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.6 0.8 1.4 0.9 0.2 0.8 0.4 0.2 1.7 0.2 0.5 1.6 0.2 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.0 0.7 0.2 0.9 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 23.4 0.2 0.5 0.1 0.0 48.6 2.4 0.0 0.1 0.5 0.0 0.9 0.0 22.1 0.7 4.8 0.2 0.0 2.1 0.0 0.0 0.0 0.3 59.9 0.9 0.4 0.0 0.0 0.1 0.1 0.0 2.5 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 11.0 3.5 0.0 0.0 0.5 0.1 41.0 0.0 0.0 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610356 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.9;liver: 16.3" "Cell type enhanced" "Detected in many" "Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 0.9 13.3 2.8 0.7 2.9 0.6 1.2 4.5 3.3 0.8 0.8 2.3 28.9 0.8 1.0 0.4 0.8 1.2 0.8 2.5 3.3 6.0 16.3 0.5 0.8 3.2 2.9 2.9 6.0 4.0 0.5 1.5 0.8 3.5 4.1 2.1 5.6 0.7 0.4 0.9 0.9 25.6 0.4 2.5 0.9 2.4 8.2 3.0 0.1 1.5 0.2 0.1 0.8 0.6 3.8 1.0 3.4 1.4 2.2 3.1 0.8 1.3 1.6 0.8 1.6 0.7 8.2 1.6 1.6 0.7 0.8 12.3 0.9 0.6 0.1 0.8 4.7 1.2 1.3 1.3 13.6 1.0 2.8 1.4 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.9 1.0 1.9 1.7 0.9 2.0 1.4 7.8 3.1 1.3 3.3 0.6 0.9 1.2 1.3 0.9 2.1 0.5 0.8 1.1 1.5 0.3 0.9 1.2 3.7 2.4 1.0 1.0 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.2 0.4 0.0 0.5 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.2 2.8 2.9 4.5 3.3 2.5 3.3 3.2 2.9 2.9 3.5 2.5 3.0 3.8 0.6 0.0 0.0 3.9 0.8 0.1 0.9 0.4 1.8 7.5 2.1 1.3 0.7 7.2 0.2 1.8 0.0 7.5 0.6 10.8 0.0 1.1 42.0 1.2 0.8 0.5 4.2 0.0 13.5 4.0 11.4 1.5 3.6 0.8 4.5 17.1 0.4 35.9 1.2 0.0 14.6 2.9 0.0 0.6 0.4 65.0 15.5 0.5 1.8 1.0 0.0 30.7 0.0 9.0 9.9 2.5 5.5 11.3 0.3 1.4 33.2 19.9 0.2 5.0 0.0 0.5 1.2 56.0 6.4 0.4 0.1 15.9 0.7 21.4 6.4 0.4 TMEM11 "C17orf35, PM1, PMI" ENSG00000178307 "Transmembrane protein 11" P17152 17 21197954-21214176 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051795, HPA062854" Uncertain Supported Mitochondria No No Mitochondria "HPA051795: AB_2681612, HPA062854: AB_2684882" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (3.55e-1)" "unprognostic (3.36e-3)" "unprognostic (1.45e-2)" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (1.40e-1)" "unprognostic (1.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.17e-2)" "unprognostic (4.61e-2)" 17.7 11.8 18.7 12.5 19.0 38.0 10.9 20.6 25.3 10.7 17.6 14.0 12.6 11.9 18.8 14.3 9.4 9.0 21.5 18.6 18.9 10.0 10.0 11.9 13.9 19.8 18.7 18.4 12.3 30.7 15.1 1.3 17.2 20.1 12.3 10.1 11.0 23.9 9.2 82.0 16.9 14.3 9.9 18.5 11.6 13.3 7.7 19.1 16.0 12.7 54.6 9.9 15.8 1.9 18.9 25.3 27.5 22.7 22.1 33.9 24.1 31.2 38.9 17.7 35.8 31.3 74.5 13.5 27.4 29.7 36.3 29.0 35.0 30.0 35.8 17.9 23.2 46.5 19.8 27.0 32.1 36.8 25.1 22.0 26.5 27.7 36.4 26.2 17.2 22.8 19.3 23.0 9.5 26.9 39.9 37.8 46.6 30.5 68.8 15.3 27.2 49.8 19.6 25.2 21.3 13.8 24.0 17.6 19.0 36.9 87.2 18.4 24.8 21.4 25.1 29.7 42.5 49.3 9.6 13.2 69.3 24.9 31.9 22.6 31.2 70.6 76.2 33.1 58.9 29.6 49.4 33.1 31.8 47.1 47.4 37.0 31.8 58.4 40.8 67.9 38.8 40.3 68.1 18.7 19.0 20.6 25.3 18.6 18.9 19.8 18.7 18.4 20.1 18.5 19.1 18.9 35.0 48.1 21.8 5.5 26.0 84.9 61.9 77.7 35.3 32.9 40.2 39.9 49.9 22.8 49.1 36.8 18.8 80.7 36.6 49.4 50.9 55.3 20.7 23.9 23.6 36.8 31.9 51.3 4.4 40.5 80.9 33.9 20.9 29.1 27.3 23.1 32.2 28.1 54.3 23.5 5.1 67.4 73.2 25.3 34.5 16.3 35.8 26.3 40.9 8.4 48.6 31.6 33.0 6.0 8.0 47.4 60.6 57.6 19.9 63.6 55.0 55.9 33.0 39.9 32.9 25.7 42.0 40.4 38.4 34.7 92.6 90.8 28.7 31.3 49.6 80.2 ZNF354B "FLJ25008, KID2" ENSG00000178338 "Zinc finger protein 354B" Q96LW1 5 178859953-178888122 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 134.1;choroid plexus: 84.3" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029056 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029056: AB_10603006" "unprognostic (2.15e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (4.19e-2)" "unprognostic (5.24e-1)" "prognostic favorable (9.52e-4)" "unprognostic (2.88e-4)" "unprognostic (6.72e-2)" "unprognostic (1.26e-3)" "unprognostic (1.11e-3)" "unprognostic (6.22e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.32e-2)" "unprognostic (3.15e-3)" 11.0 6.3 44.4 6.1 50.3 4.3 12.1 80.7 134.1 10.3 84.3 8.8 6.3 9.8 5.5 6.4 9.1 5.5 5.6 40.8 26.7 7.9 6.0 7.7 7.8 82.1 31.1 24.1 9.4 10.1 6.9 8.2 14.1 66.4 10.1 5.5 11.2 8.2 7.6 4.8 7.6 8.0 6.5 34.2 9.2 8.1 5.2 51.0 6.8 11.7 5.6 6.9 8.4 8.8 70.4 5.2 4.0 7.4 16.9 7.2 6.9 18.9 6.4 5.8 6.1 7.0 5.1 9.1 0.0 6.7 5.7 8.4 10.6 9.4 10.8 7.4 0.0 7.7 6.0 15.6 3.8 6.2 0.1 4.1 6.4 6.4 5.0 7.6 9.3 5.5 8.9 5.0 0.0 6.6 5.8 9.8 13.5 3.9 2.5 5.4 9.1 4.0 5.8 5.3 6.2 8.3 8.6 7.7 6.8 4.9 7.2 6.0 10.4 6.5 10.7 9.6 3.9 4.8 3.7 5.7 0.2 0.7 0.0 5.7 2.0 1.8 0.7 3.1 1.1 2.8 2.6 2.1 1.7 1.6 3.8 2.6 2.7 0.5 1.3 1.2 2.0 2.0 0.9 44.4 50.3 80.7 134.1 40.8 26.7 82.1 31.1 24.1 66.4 34.2 51.0 70.4 21.5 9.6 4.8 3.3 4.0 4.6 6.9 2.4 4.6 6.8 5.3 6.5 6.9 4.3 6.2 7.3 8.4 20.4 5.3 1.0 0.0 4.6 1.2 2.8 8.7 10.1 0.0 2.1 6.0 2.3 6.7 8.0 6.1 3.7 0.0 7.7 8.9 2.0 4.9 11.8 5.7 2.4 0.0 3.5 4.9 0.1 5.0 4.4 0.0 4.7 3.2 3.5 12.3 4.0 6.5 2.1 0.8 5.3 2.6 5.8 1.7 2.4 5.2 6.5 0.0 9.8 7.0 10.4 11.1 3.3 5.4 34.6 5.6 7.8 1.8 3.9 KCNG2 "KCNF2, Kv6.2" ENSG00000178342 "Potassium voltage-gated channel modifier subfamily G member 2" Q9UJ96 18 79863668-79900184 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "brain: 3.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 19.2;Horizontal cells: 114.4;Inhibitory neurons: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 5 "hippocampal formation: 10.3" HPA048628 Enhanced NA NA "HPA048628: AB_2680466" "unprognostic (1.07e-2)" "unprognostic (1.34e-2)" "unprognostic (8.39e-2)" "unprognostic (4.41e-1)" "unprognostic (1.99e-1)" "unprognostic (9.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (2.40e-1)" "unprognostic (3.78e-1)" "unprognostic (3.61e-3)" "unprognostic (1.09e-1)" "unprognostic (3.18e-5)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "unprognostic (4.08e-2)" "unprognostic (3.63e-2)" 0.1 0.0 0.5 0.0 1.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.1 0.3 0.0 0.2 0.0 0.2 1.5 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 3.0 3.4 1.1 0.2 1.5 0.6 0.2 0.3 0.5 0.6 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.5 0.0 0.0 0.0 0.0 6.9 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 19.2 0.0 8.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 114.4 31.3 0.1 0.0 1.5 0.0 0.0 0.3 0.8 0.0 6.5 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.9 0.0 0.0 0.0 1.2 2.1 0.0 0.0 6.3 0.0 0.1 0.2 0.0 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397488-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 14.4;kidney: 21.5" "Group enriched" "Detected in some" 7 "Distal tubular cells: 43.0;Fibroblasts: 19.4;Hepatic stellate cells: 55.0" "Cancer enhanced" "Detected in many" "lung cancer: 7.6;renal cancer: 7.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AN3-CA: 219.6;PC-3: 130.4" "Region enriched" "Detected in many" 23 "olfactory bulb: 51.7" "Region enriched" "Detected in many" 8 "spinal cord: 21.4" HPA054754 Approved "Lipid droplets,Cytosol" NA Yes Cytosol "Lipid droplets" "HPA054754: AB_2682593" "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.1 1.8 2.0 1.9 1.4 0.0 2.3 1.2 1.7 0.6 1.2 5.1 2.2 0.2 0.3 1.8 0.6 1.1 14.4 1.0 2.2 21.5 0.6 5.8 7.1 3.1 12.1 0.7 0.3 0.2 0.2 0.6 0.0 2.0 0.8 3.0 0.1 0.6 1.0 1.6 0.4 10.5 4.4 1.5 0.4 2.9 0.6 6.5 0.1 5.1 1.4 0.8 3.5 1.3 4.9 0.0 0.0 0.0 219.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 23.7 0.1 0.0 0.0 23.3 0.0 0.0 0.0 2.6 0.0 0.1 0.0 6.6 0.0 0.8 0.4 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 1.2 0.0 10.1 0.0 130.4 0.2 0.0 0.0 9.0 0.0 0.1 0.3 0.0 0.0 0.0 8.1 0.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 1.2 1.7 1.0 2.2 3.1 12.1 0.7 2.0 1.5 6.5 4.9 4.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 3.7 0.0 0.0 0.1 0.1 43.0 0.0 0.0 0.1 2.5 3.7 0.0 5.3 0.0 0.0 0.0 19.4 0.5 0.1 0.0 1.1 55.0 0.2 0.1 0.0 0.1 0.1 0.0 0.6 0.3 0.0 3.4 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 2.4 0.0 0.1 0.0 0.2 1.4 0.5 0.4 0.1 0.0 0.0 0.0 2.4 0.1 0.0 OR2D3 ENSG00000178358 "Olfactory receptor family 2 subfamily D member 3" Q8NGH3 11 6920974-6922043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052551 Uncertain NA NA "HPA052551: AB_2681867" "unprognostic (4.52e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALML3 CLP ENSG00000178363 "Calmodulin like 3" P27482 10 5524961-5526771 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 511.2;skin 1: 152.9;vagina: 202.4" "Cell type enriched" "Detected in some" 8 "Squamous epithelial cells: 1257.1" "Cancer enhanced" "Detected in many" "cervical cancer: 150.9;head and neck cancer: 196.3" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0" "Not detected" "Not detected" "CAB010070, HPA044999" Approved NA NA 1200000 "CAB010070: , HPA044999: AB_2679177" "unprognostic (1.02e-3)" "unprognostic (1.18e-2)" "unprognostic (4.33e-2)" "unprognostic (1.37e-1)" "unprognostic (1.29e-2)" "unprognostic (2.16e-1)" "unprognostic (2.93e-1)" "unprognostic (3.11e-1)" "unprognostic (1.02e-2)" "unprognostic (9.64e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-2)" "unprognostic (1.71e-1)" "unprognostic (2.56e-1)" "unprognostic (1.65e-1)" "unprognostic (4.43e-3)" 0.3 0.1 0.2 0.0 0.1 0.0 5.4 1.5 0.1 51.5 0.0 0.1 0.0 0.1 0.1 511.2 1.2 0.0 0.1 0.0 0.4 17.5 1.6 0.0 0.0 0.5 0.4 0.0 0.1 0.2 0.0 0.3 0.0 0.2 3.0 0.0 0.0 121.9 0.1 1.1 152.9 0.2 0.0 0.0 0.1 0.3 1.7 0.6 80.2 0.1 0.0 40.2 0.2 202.4 0.0 21.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 0.1 0.0 0.4 0.5 0.4 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 28.4 29.8 6.3 157.1 2.2 13.3 22.4 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 4.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 28.5 0.0 1.4 8.3 0.3 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.5 0.0 59.6 0.7 0.3 0.0 0.0 0.9 6.7 0.1 1257.1 55.0 0.0 0.7 0.0 0.2 30.6 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499570 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 2852.4" "Group enriched" "Detected in some" 4 "Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "A-431: 400.3" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" NA NA 48000000 "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favorable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 2.5 0.5 0.0 0.0 0.0 0.1 41.6 0.0 0.0 45.1 0.0 0.7 0.0 0.3 0.7 68.0 0.1 0.0 1.2 0.0 0.0 0.3 1.8 0.8 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 558.9 0.0 11.8 2852.4 0.6 0.0 0.0 0.4 0.8 1.0 0.0 9.3 0.6 0.0 13.5 0.1 309.1 0.0 400.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.8 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 27.3 0.3 2.2 0.0 0.0 172.1 156.1 0.2 0.0 1.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 11.1 0.0 0.0 0.4 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.2 0.3 6.8 390.7 0.0 1.2 0.0 0.0 3.3 ZFAND2A AIRAP ENSG00000178381 "Zinc finger AN1-type containing 2A" Q8N6M9 7 1152071-1160759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 490.1;Paneth cells: 310.4;Prostatic glandular cells: 255.2;Urothelial cells: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 179.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019469 Approved NA NA "HPA019469: AB_1859009" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (3.08e-2)" "unprognostic (1.03e-2)" "unprognostic (7.12e-2)" "unprognostic (1.10e-2)" "unprognostic (2.10e-3)" "unprognostic (7.52e-2)" "unprognostic (8.78e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (5.47e-7)" "unprognostic (5.44e-3)" "unprognostic (7.60e-2)" "unprognostic (6.46e-2)" "unprognostic (2.59e-2)" 26.2 26.2 62.5 10.7 59.7 81.2 24.3 63.9 86.3 18.1 58.4 25.4 17.9 20.9 14.8 21.7 18.9 18.3 18.6 72.0 60.8 30.8 81.8 32.8 15.5 62.9 59.5 57.5 21.1 34.0 16.5 22.6 21.3 63.0 23.4 18.3 15.2 19.7 12.2 13.3 20.4 20.0 14.5 64.1 24.5 32.7 27.1 62.5 13.5 27.3 8.0 11.9 25.4 21.9 69.6 44.7 50.6 12.8 29.3 28.6 20.3 20.3 40.1 32.6 40.1 30.6 35.7 35.4 14.5 15.8 33.5 63.3 59.8 10.2 10.6 40.5 11.9 21.1 9.8 22.7 179.8 54.4 29.2 19.3 19.1 34.2 32.9 58.3 28.2 14.0 32.8 56.0 33.0 29.6 69.6 8.3 32.8 51.8 105.8 69.3 25.3 2.4 23.0 16.5 19.0 18.6 19.0 14.3 39.1 50.5 26.7 40.1 58.5 18.2 29.6 23.2 34.3 54.7 40.0 51.2 27.3 29.1 32.5 64.3 71.6 25.8 34.2 31.3 24.7 28.8 32.3 28.1 33.0 18.7 34.5 26.9 23.4 31.8 33.2 25.3 34.6 39.5 30.0 62.5 59.7 63.9 86.3 72.0 60.8 62.9 59.5 57.5 63.0 64.1 62.5 69.6 65.4 32.1 17.2 4.2 40.6 22.6 490.1 27.6 46.7 15.6 39.8 34.7 17.9 22.8 17.4 7.3 16.7 18.9 49.1 211.8 23.5 21.6 9.7 46.3 33.4 40.7 126.9 17.2 5.6 39.5 46.6 50.8 54.0 83.8 116.4 9.7 20.3 50.3 40.6 11.8 5.8 207.9 18.3 29.2 119.6 12.6 13.4 121.1 32.0 1.0 31.6 23.7 21.6 2.5 7.4 65.7 310.4 18.0 89.7 255.2 29.3 34.1 13.1 25.6 0.0 16.6 40.5 47.1 39.0 64.8 27.7 65.9 156.4 13.3 123.6 322.2 PLEKHM3 "DAPR, PLEKHM1L" ENSG00000178385 "Pleckstrin homology domain containing M3" Q6ZWE6 2 207821288-208025527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 99.1;Inhibitory neurons: 70.5;Microglial cells: 36.5;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 86.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035046 Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA035046: AB_10603128" "unprognostic (3.62e-1)" "unprognostic (1.58e-2)" "unprognostic (8.27e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (4.77e-2)" "unprognostic (6.06e-2)" "unprognostic (8.20e-2)" "unprognostic (4.13e-2)" "unprognostic (2.92e-3)" "unprognostic (2.17e-1)" "unprognostic (1.09e-1)" "unprognostic (4.86e-4)" "unprognostic (2.42e-1)" "unprognostic (3.12e-1)" "unprognostic (5.72e-2)" "unprognostic (1.33e-2)" 2.8 4.1 1.3 1.3 2.5 4.3 2.4 0.4 2.7 2.6 0.0 2.7 0.9 2.5 0.9 1.6 2.0 1.4 2.8 2.2 1.9 1.9 3.2 3.0 1.5 1.9 2.4 2.2 3.1 2.3 4.1 2.5 1.5 2.2 2.5 1.5 8.4 2.2 1.4 2.4 2.6 1.9 1.9 0.3 1.9 2.3 1.8 1.1 2.2 3.6 1.6 1.4 2.0 2.5 2.7 0.7 0.7 1.6 0.9 2.7 2.7 2.5 1.5 1.6 1.2 1.1 0.9 0.7 0.6 1.5 1.8 1.2 0.8 1.7 2.2 1.6 1.2 2.6 1.3 2.2 1.3 1.6 1.4 0.7 2.2 2.6 1.3 1.6 1.9 1.3 2.1 0.8 1.7 1.5 0.4 1.7 0.9 1.6 0.5 0.8 1.3 1.4 1.3 0.6 0.9 3.5 1.8 1.4 0.1 1.5 2.7 0.4 1.1 1.8 1.9 1.1 1.1 1.0 2.0 2.4 0.6 2.2 0.8 1.4 1.3 0.8 0.4 0.9 0.3 0.3 0.9 0.8 0.8 0.7 0.6 1.0 0.8 2.6 0.9 0.7 0.7 0.5 0.2 1.3 2.5 0.4 2.7 2.2 1.9 1.9 2.4 2.2 2.2 0.3 1.1 2.7 6.3 19.2 21.7 29.0 2.7 0.0 0.2 0.1 0.6 3.1 4.1 3.7 1.2 1.5 5.6 1.8 12.5 0.3 4.1 1.2 0.0 3.1 2.5 4.1 6.3 2.3 0.0 4.0 99.1 3.4 0.5 3.0 2.0 4.7 0.0 25.0 0.4 0.6 0.6 6.7 70.5 0.1 0.0 1.0 2.4 5.2 0.3 3.8 0.0 36.5 4.6 2.3 0.0 45.2 86.9 3.5 1.6 0.0 2.0 0.2 1.1 4.9 0.8 9.6 0.0 1.7 3.8 0.4 0.7 1.1 0.1 0.1 2.5 6.9 0.5 0.1 ZNF223 ENSG00000178386 "Zinc finger protein 223" Q9UK11 19 44051367-44067999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.4" "HPA067823, HPA079175" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA067823: AB_2685906, HPA079175: " "unprognostic (6.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.42e-1)" "unprognostic (8.36e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (1.85e-1)" "unprognostic (6.32e-2)" "unprognostic (4.33e-1)" "unprognostic (4.95e-2)" "unprognostic (3.67e-1)" "unprognostic (2.58e-4)" 3.0 3.8 2.9 3.6 3.2 2.1 5.6 4.4 4.0 3.7 2.7 4.5 4.0 3.4 6.0 3.1 4.0 3.8 5.0 2.9 3.6 3.5 2.6 4.0 3.6 3.2 3.4 3.0 4.1 2.9 4.9 4.1 5.5 3.4 6.6 5.8 4.5 3.6 4.8 2.2 5.0 4.4 3.9 2.7 5.0 4.9 3.3 3.6 2.8 6.4 1.6 4.4 4.0 3.1 3.5 2.8 1.5 5.9 1.4 3.8 4.7 0.1 4.2 4.6 3.7 5.3 2.8 4.6 0.0 3.9 3.3 2.2 2.6 0.0 4.7 3.9 0.1 4.5 5.6 5.0 3.9 2.8 0.3 0.1 4.6 3.7 3.1 3.0 5.2 4.2 0.1 0.2 0.0 4.2 2.2 0.0 2.1 4.4 1.9 2.1 0.0 2.4 1.3 4.5 23.4 3.6 8.5 7.3 0.9 2.9 7.5 4.1 5.2 4.2 3.5 3.3 1.9 1.6 2.7 5.0 0.0 1.5 0.1 3.4 15.0 4.9 7.8 2.4 5.9 3.5 3.2 3.8 1.9 5.4 3.3 7.4 3.2 0.4 6.2 2.7 6.6 3.6 2.4 2.9 3.2 4.4 4.0 2.9 3.6 3.2 3.4 3.0 3.4 2.7 3.6 3.5 2.4 0.0 1.1 4.2 1.3 0.0 0.6 0.0 1.2 3.6 1.7 1.4 0.9 2.8 0.0 1.8 2.1 2.1 0.9 2.2 3.9 2.3 3.8 1.4 1.0 1.8 0.0 3.0 6.1 0.5 0.8 1.8 2.0 1.5 0.0 1.8 3.3 0.4 1.7 3.3 5.0 2.8 0.0 2.4 0.0 1.0 1.5 1.3 0.0 1.9 1.7 1.2 3.1 4.5 3.4 1.4 1.5 1.9 0.3 0.6 2.3 1.1 0.7 1.6 0.0 0.7 1.4 1.9 2.1 1.9 0.0 1.0 0.7 1.3 1.7 0.7 HTR1A "5-HT1A, ADRB2RL1, ADRBRL1" ENSG00000178394 "5-hydroxytryptamine receptor 1A" P08908 5 63957874-63962507 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "brain: 10.9;ovary: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NTERA-2: 1.2;SCLC-21H: 1.1" "Low region specificity" "Detected in many" HPA018073 Uncertain NA NA "HPA018073: AB_1856704" "unprognostic (1.81e-1)" 0.0 0.0 1.1 0.0 5.8 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.0 1.6 0.0 0.0 0.0 0.0 3.2 10.9 6.5 3.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.8 0.0 9.5 10.0 1.6 3.2 10.9 6.5 4.2 0.0 3.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC185 "C1orf65, FLJ35728" ENSG00000178395 "Coiled-coil domain containing 185" Q8N715 1 223393415-223395465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "testis: 35.7" "Cell type enriched" "Detected in some" 8 "Early spermatids: 518.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.71e-1)" "unprognostic (1.55e-2)" "unprognostic (2.41e-6)" "unprognostic (9.69e-2)" "unprognostic (1.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.37e-3)" "unprognostic (3.13e-1)" "unprognostic (2.61e-2)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 518.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 FAM220A "ACPIN1, C7orf70, MGC12966, SIPAR" ENSG00000178397 "Family with sequence similarity 220 member A" Q7Z4H9 7 6329411-6348981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 90.6;testis: 56.4" "Group enriched" "Detected in many" 13 "Early spermatids: 280.0;Late spermatids: 363.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055050 Approved Vesicles NA NA Vesicles "HPA055050: AB_2682684" "unprognostic (3.49e-2)" "unprognostic (3.53e-1)" "unprognostic (2.69e-2)" "unprognostic (9.79e-2)" "unprognostic (3.26e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (2.78e-1)" "unprognostic (1.43e-2)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (8.84e-3)" "unprognostic (1.14e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (3.71e-2)" 7.1 8.7 13.9 7.0 15.7 2.6 8.4 18.8 16.8 9.1 10.5 6.2 5.5 10.4 7.5 11.6 7.6 7.6 13.9 15.7 15.4 8.3 6.4 6.3 9.9 12.8 13.8 15.2 10.8 9.9 19.3 0.6 7.9 13.5 8.1 5.3 11.6 8.5 8.4 90.6 10.2 4.9 9.4 13.9 8.0 6.1 56.4 14.4 12.1 11.8 39.4 10.5 9.7 0.5 15.4 26.9 16.6 11.9 28.0 27.0 22.7 13.1 13.4 16.6 15.9 18.5 10.5 14.6 22.2 15.1 15.9 31.8 19.2 18.2 11.3 20.6 15.5 11.7 7.3 10.0 12.6 29.2 13.5 10.8 12.7 37.5 11.9 28.5 15.3 15.0 16.4 14.6 20.7 13.9 20.9 8.4 24.7 27.8 14.0 21.4 21.6 17.9 18.7 14.7 9.6 12.1 21.0 18.8 23.0 28.6 23.9 22.1 34.9 11.4 12.5 28.5 20.6 17.5 19.7 37.2 23.2 14.6 24.1 39.3 6.6 4.2 8.0 4.7 3.5 4.4 9.1 5.4 6.5 7.7 7.7 8.4 6.8 2.0 12.9 3.8 6.8 6.6 3.7 13.9 15.7 18.8 16.8 15.7 15.4 12.8 13.8 15.2 13.5 13.9 14.4 15.4 4.1 3.2 1.1 1.3 8.1 7.8 4.9 6.2 12.0 2.9 6.0 6.9 9.2 0.0 8.2 1.8 6.2 6.3 5.4 3.8 1.9 4.9 280.0 6.0 5.5 4.6 6.1 7.8 4.7 4.8 7.5 6.8 7.7 4.8 1.3 4.4 6.4 3.5 6.2 0.0 4.7 4.2 4.1 6.8 10.5 363.4 8.4 7.4 3.6 2.8 7.1 5.2 6.2 4.0 3.9 4.8 2.1 13.2 3.9 5.5 3.3 2.8 3.4 2.3 0.0 6.3 5.4 23.7 11.4 10.3 10.1 8.2 5.2 3.9 3.4 6.7 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346888-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 24.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 47.1;Distal enterocytes: 36.8;Exocrine glandular cells: 42.9;Hepatocytes: 44.6;Intestinal goblet cells: 26.9;Pancreatic endocrine cells: 27.6;Paneth cells: 26.2;Proximal enterocytes: 59.6;Undifferentiated cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 10.5;CACO-2: 19.1;EFO-21: 17.2;MCF7: 18.8;OE19: 18.6" "Region enhanced" "Detected in single" "midbrain: 1.2" "Low region specificity" "Detected in all" HPA039953 Approved Vesicles NA NA Vesicles "HPA039953: AB_2676770" "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favorable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavorable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 0.5 0.2 0.7 0.4 0.9 0.2 0.3 1.7 0.9 1.1 0.7 2.6 5.7 0.6 0.4 0.0 0.7 3.1 0.1 0.7 1.0 3.7 24.3 0.1 0.1 1.8 1.5 0.6 0.0 5.6 2.0 0.2 0.2 2.0 0.2 2.2 0.3 1.4 0.1 0.0 0.4 5.0 0.2 0.9 0.2 3.1 0.6 0.8 0.0 4.5 0.0 0.0 0.1 0.7 1.3 0.9 5.6 0.0 10.5 0.0 0.0 2.4 0.0 1.9 0.5 1.3 19.1 4.0 0.0 17.2 0.5 0.6 0.2 1.2 0.0 1.5 0.0 3.5 0.2 0.4 6.3 1.1 0.1 1.2 0.2 0.1 0.6 0.1 2.8 0.5 0.1 0.1 0.2 0.6 18.8 0.0 0.1 0.1 18.6 5.8 0.0 3.6 0.1 0.3 0.1 2.6 0.6 0.1 0.3 2.4 0.1 6.7 0.0 0.2 0.6 2.1 0.1 0.6 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.9 1.7 0.9 0.7 1.0 1.8 1.5 0.6 2.0 0.9 0.8 1.3 0.2 0.0 1.1 1.0 0.3 0.6 1.5 3.0 0.0 0.3 5.9 3.7 0.5 47.1 2.0 1.8 0.0 0.1 0.3 36.8 0.0 16.0 4.1 6.2 4.5 0.6 21.0 0.0 0.5 42.9 0.3 3.8 10.2 5.9 1.3 4.7 1.4 44.6 0.1 3.3 0.2 26.9 0.0 0.8 0.4 1.9 0.0 0.4 3.6 0.0 0.6 0.6 0.0 0.0 5.7 27.6 26.2 0.7 0.0 0.7 59.6 18.6 5.7 0.5 0.0 0.5 2.1 1.9 1.9 0.0 0.3 0.4 0.5 1.0 26.2 0.4 NEUROG2 "Atoh4, bHLHa8, Math4A, ngn-2, NGN2" ENSG00000178403 "Neurogenin 2" Q9H2A3 4 112513516-112516180 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.4;testis: 1.6" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Breast myoepithelial cells: 3.4;Early spermatids: 1.9;Late spermatids: 1.1;Muller glia cells: 8.1;Spermatocytes: 1.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 203.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 10 "hippocampal formation: 12.3" CAB012342 Uncertain NA NA "CAB012342: " "unprognostic (1.09e-1)" "unprognostic (2.52e-2)" "unprognostic (7.51e-2)" "unprognostic (4.10e-1)" "unprognostic (1.62e-1)" "unprognostic (7.75e-2)" "unprognostic (1.04e-1)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (3.30e-1)" 0.0 0.0 0.7 0.0 0.9 0.0 0.2 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 2.0 203.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 1.3 2.2 3.4 0.3 0.5 0.2 0.3 0.3 0.1 0.2 0.8 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEP295NL "DDC8, KIAA1731NL" ENSG00000178404 "CEP295 N-terminal like" Q96MC4 17 78870910-78903217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 9.4;testis: 33.9" "Group enriched" "Detected in some" 133 "Early spermatids: 298.6;Late spermatids: 504.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;Karpas-707: 1.1;TIME: 1.2;U-2 OS: 1.9" "Not detected" "Not detected" "HPA023609, HPA024619, HPA025717" Uncertain Approved Vesicles NA NA Vesicles "HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900" "unprognostic (1.68e-3)" "unprognostic (4.56e-2)" "unprognostic (2.62e-1)" "unprognostic (5.04e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (9.03e-2)" "unprognostic (8.16e-2)" "unprognostic (9.80e-2)" "unprognostic (2.08e-1)" "unprognostic (3.89e-3)" "unprognostic (3.65e-3)" "unprognostic (1.03e-1)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.75e-3)" 0.1 0.1 2.3 0.0 1.8 1.3 0.1 0.5 2.6 0.3 1.4 0.1 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.9 1.2 0.0 0.0 0.1 0.0 2.6 1.8 0.1 0.3 0.1 0.0 0.1 0.1 3.7 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.1 0.3 0.1 33.9 2.2 0.0 0.0 0.0 0.0 0.1 0.3 9.4 0.3 0.0 0.0 0.3 0.1 0.2 1.4 0.6 0.0 0.2 0.3 0.1 0.2 0.0 0.4 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.3 0.0 0.4 1.2 0.5 1.9 0.6 0.2 0.4 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 2.3 1.8 0.5 2.6 0.9 1.2 2.6 1.8 0.1 3.7 1.1 2.2 9.4 0.7 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 298.6 0.3 1.7 0.5 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.5 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 504.5 2.8 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 3.0 1.4 0.1 0.0 0.0 0.1 0.7 0.0 0.1 BEND3 KIAA1553 ENSG00000178409 "BEN domain containing 3" Q5T5X7 6 107065182-107115515 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 6.2;Late spermatids: 6.9" "Cancer enriched" "Detected in all" 4 "testis cancer: 12.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA017891, HPA062067" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017891: AB_2064595, HPA062067: AB_2684675" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (9.47e-3)" "unprognostic (4.25e-3)" "unprognostic (1.04e-1)" "unprognostic (2.43e-2)" "unprognostic (8.37e-8)" "unprognostic (1.59e-1)" "unprognostic (9.71e-2)" "unprognostic (3.99e-2)" "unprognostic (2.71e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (8.65e-2)" "unprognostic (3.49e-1)" "unprognostic (1.09e-1)" "unprognostic (4.37e-1)" 0.8 0.7 1.0 0.9 0.7 0.9 0.7 2.1 0.8 0.6 0.4 1.5 1.2 0.8 1.0 0.9 0.9 0.6 1.0 0.7 0.7 0.7 0.7 0.9 0.8 0.6 0.8 0.5 0.7 1.6 0.6 0.8 0.5 0.9 1.1 1.5 0.8 1.5 0.4 1.2 0.6 1.1 0.7 0.7 0.6 2.0 1.9 0.9 1.0 0.8 0.6 0.9 0.7 0.5 0.7 2.9 4.0 11.3 6.4 1.3 0.9 9.3 1.1 1.4 1.4 1.6 4.7 2.1 8.6 2.8 3.0 2.6 2.8 12.2 6.3 2.3 3.4 6.1 2.2 3.1 5.2 1.0 6.1 2.9 2.4 2.6 2.2 3.1 1.0 1.9 4.0 6.7 3.4 1.9 5.8 5.3 4.7 15.9 7.4 2.5 7.3 3.2 5.7 2.4 8.6 11.3 5.5 3.6 6.0 2.2 5.7 3.6 4.9 2.2 4.1 3.7 1.8 5.5 2.3 3.4 8.7 1.3 4.7 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 2.1 0.8 0.7 0.7 0.6 0.8 0.5 0.9 0.7 0.9 0.7 1.3 3.2 2.7 1.3 0.7 2.9 1.1 0.8 1.8 1.0 1.3 0.8 3.0 4.3 1.8 0.0 6.2 1.1 0.8 0.6 0.0 1.0 5.8 1.3 1.8 1.2 1.2 0.8 1.2 1.8 1.2 1.2 2.6 1.5 0.0 1.9 0.0 0.5 0.6 0.0 2.1 2.4 0.0 1.0 1.2 6.9 0.9 1.0 0.0 1.0 0.1 0.5 0.0 3.0 1.6 1.4 0.8 0.0 1.6 1.6 0.5 0.9 1.1 1.5 0.0 2.1 2.5 0.7 2.5 1.8 3.0 0.8 1.1 0.5 3.3 0.9 NT5DC1 "dJ486I3.1, MGC24302, NT5C2L1" ENSG00000178425 "5'-nucleotidase domain containing 1" Q5TFE4 6 116100851-116249497 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 95.8" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 429.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030352, HPA079264" Uncertain Approved Nucleoplasm,Cytosol NA NA 140000 Nucleoplasm Cytosol "HPA030352: AB_2154066, HPA079264: " "unprognostic (1.30e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.61e-4)" "unprognostic (1.14e-1)" "unprognostic (3.13e-2)" "unprognostic (7.80e-2)" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (2.31e-2)" "unprognostic (4.61e-1)" "unprognostic (1.47e-1)" "prognostic favorable (7.49e-7)" "unprognostic (1.41e-1)" "unprognostic (8.53e-2)" "unprognostic (2.79e-1)" "unprognostic (9.63e-2)" 19.6 24.2 10.3 12.8 23.7 10.1 19.4 21.1 17.0 10.5 95.8 20.0 29.7 9.2 22.6 16.7 20.8 15.8 26.1 10.2 15.4 28.4 43.0 16.9 21.5 24.9 20.7 7.9 13.4 22.4 24.0 9.7 8.3 23.1 28.5 20.1 11.3 22.9 16.7 21.7 10.8 27.0 11.4 20.8 13.6 21.8 10.7 20.1 14.6 28.5 23.5 22.6 15.9 9.5 40.2 24.7 20.3 17.7 23.7 19.2 11.6 31.0 17.7 40.3 27.4 32.2 29.4 24.8 50.3 37.4 15.9 29.7 38.7 12.1 28.1 23.8 78.4 26.7 21.0 16.7 31.0 20.9 46.8 1.9 21.7 22.2 17.6 15.0 59.2 24.7 30.0 26.6 27.5 34.8 25.3 9.0 16.3 16.2 54.1 27.0 52.3 48.3 27.2 25.5 29.2 11.8 17.6 37.9 28.7 26.5 19.4 26.6 9.3 21.6 12.3 20.8 23.7 35.6 40.2 59.2 39.8 29.3 31.0 22.4 14.5 18.2 33.2 20.2 10.5 31.4 41.3 29.8 25.4 24.6 30.1 28.2 24.3 12.9 23.1 12.7 12.4 32.4 19.7 10.3 23.7 21.1 17.0 10.2 15.4 24.9 20.7 7.9 23.1 20.8 20.1 40.2 15.4 64.1 45.7 62.3 37.9 26.1 37.9 66.5 29.6 14.0 30.3 23.6 44.2 25.8 44.5 18.4 27.1 41.6 24.9 19.1 64.6 39.6 19.8 32.9 10.7 21.7 26.5 16.2 96.1 40.8 30.4 14.0 26.5 19.0 23.5 16.2 33.5 49.3 31.8 45.4 70.1 30.6 30.5 29.2 14.2 8.3 19.0 18.5 19.6 54.4 49.6 19.8 10.3 29.7 429.4 28.8 19.6 20.7 25.3 28.0 54.6 57.4 76.7 20.2 32.9 29.2 23.9 17.2 28.5 27.4 21.5 25.6 23.8 18.3 35.9 31.5 TIMM23B-AGAP6 LINC00843 ENSG00000178440 "TIMM23B-AGAP6 readthrough (NMD candidate)" 10 49942056-50011654 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.42e-1)" "unprognostic (6.27e-3)" "unprognostic (3.47e-2)" "unprognostic (2.15e-1)" "unprognostic (4.82e-2)" "unprognostic (1.69e-2)" "unprognostic (3.65e-1)" "unprognostic (1.33e-1)" "unprognostic (7.28e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.84e-4)" "unprognostic (6.36e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "unprognostic (4.84e-2)" "unprognostic (1.60e-2)" 0.4 0.2 0.8 0.6 0.8 1.1 0.2 1.3 1.1 0.2 1.2 0.1 0.6 0.3 0.2 0.2 0.1 0.1 0.3 0.9 0.9 0.1 0.3 0.2 0.8 1.0 0.8 0.8 0.3 0.3 0.1 0.0 0.9 0.4 0.3 0.5 0.4 0.3 0.8 0.4 0.1 0.3 0.7 0.5 0.2 0.9 0.9 0.7 0.1 0.8 0.5 0.2 1.1 1.0 0.5 1.4 2.6 0.5 0.3 1.8 0.9 0.6 1.0 1.0 1.9 0.5 1.3 1.5 0.9 0.8 1.9 1.4 0.5 0.9 0.6 1.2 0.6 1.7 1.7 0.7 0.8 2.4 0.8 1.1 2.4 1.1 0.8 1.1 2.9 2.5 1.4 0.0 2.0 4.1 5.6 1.7 1.0 3.8 1.5 0.7 1.9 0.4 0.4 1.6 1.7 0.4 1.4 0.9 1.6 0.9 2.3 0.7 0.9 2.2 0.3 2.0 1.6 2.3 1.9 1.1 2.2 0.8 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.8 0.8 1.3 1.1 0.9 0.9 1.0 0.8 0.8 0.9 0.7 0.9 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532467-6645729 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 174.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 740000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.3 0.3 13.8 1.4 14.8 0.5 0.8 13.9 23.9 0.2 12.0 1.0 0.9 0.4 5.2 3.2 0.7 0.8 0.1 14.0 13.8 37.7 174.9 1.0 1.7 13.2 12.6 14.0 0.3 0.1 0.0 5.0 15.3 13.5 0.5 0.4 1.6 1.1 1.0 1.3 2.7 0.8 0.0 12.4 1.2 1.0 3.5 14.0 0.0 5.1 0.1 1.2 1.1 0.1 14.6 0.6 4.9 2.1 25.6 0.2 0.4 235.7 0.1 0.0 0.0 0.1 58.2 0.5 0.3 5.6 0.1 0.7 0.4 0.0 0.7 0.2 1.2 13.4 0.2 0.3 38.3 0.0 0.1 45.6 0.0 0.1 1.8 0.3 1.0 9.0 4.3 0.0 0.5 1.2 1.5 0.9 0.2 27.5 4.6 3.8 1.3 0.0 0.5 95.4 1.0 22.6 11.7 0.0 21.4 0.3 13.9 5.3 0.1 3.0 0.6 0.6 2.6 1.3 1.1 34.4 0.1 0.8 2.4 5.1 0.4 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.3 13.8 14.8 13.9 23.9 14.0 13.8 13.2 12.6 14.0 13.5 12.4 14.0 14.6 0.2 0.0 0.0 17.6 1.9 0.0 0.0 0.2 1.2 0.4 1.5 0.6 0.7 11.5 0.1 31.3 0.0 79.0 0.2 0.0 5.9 0.0 12.6 5.4 0.5 0.6 0.0 0.0 21.6 0.2 41.6 0.3 0.0 10.7 0.0 1.1 2.2 120.5 7.0 0.0 15.9 0.0 0.0 2.8 0.3 10.8 0.3 0.4 0.0 1.9 0.0 9.6 0.0 52.3 1.8 0.1 0.0 0.0 15.1 0.0 0.0 31.6 0.0 0.4 0.0 1.7 0.8 4.5 5.1 0.4 0.0 46.0 0.8 0.0 0.0 0.1 COX14 "C12orf62, MGC14288" ENSG00000178449 "Cytochrome c oxidase assembly factor COX14" Q96I36 12 50112082-50120457 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 835.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria NA NA Mitochondria "HPA044618: AB_10960419, HPA062014: AB_2684657" "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavorable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 122.5 107.3 106.2 47.6 109.9 66.8 106.5 118.3 130.7 64.1 123.8 87.0 84.2 46.6 131.7 69.1 55.4 63.5 227.5 103.4 113.9 145.1 146.6 62.9 75.1 112.4 109.3 103.3 53.3 62.5 129.0 88.7 55.2 112.1 67.5 78.3 61.2 85.7 81.5 250.0 49.7 84.7 59.2 113.9 67.4 77.2 32.9 112.0 55.4 88.1 279.1 62.5 74.9 47.7 118.0 78.4 168.3 32.8 79.4 169.4 105.7 60.5 61.1 92.7 98.8 89.5 156.7 109.1 69.9 171.9 78.3 82.6 79.0 57.2 87.5 91.7 78.7 236.6 154.3 140.4 139.2 65.1 112.1 133.7 123.8 129.9 67.1 76.7 100.5 96.2 83.1 70.2 153.4 109.1 193.3 93.7 170.3 51.5 116.4 211.3 77.6 52.4 176.8 155.0 149.1 91.0 51.4 92.4 177.5 195.6 72.6 115.1 103.6 75.2 55.0 58.1 92.3 50.1 106.3 199.0 93.5 77.9 105.0 30.9 258.8 197.8 172.7 146.1 194.5 155.6 213.7 186.9 167.0 190.0 188.0 176.7 173.7 67.0 153.1 178.2 247.2 224.8 214.8 106.2 109.9 118.3 130.7 103.4 113.9 112.4 109.3 103.3 112.1 113.9 112.0 118.0 91.5 60.9 120.6 11.1 108.8 124.9 91.2 212.9 87.0 68.2 169.2 192.5 524.4 161.5 138.7 222.5 22.9 191.9 111.1 320.9 565.4 131.4 7.1 117.5 58.7 99.2 156.0 69.2 13.1 170.1 122.6 90.3 81.6 88.1 65.4 64.0 88.9 397.9 219.6 47.1 16.3 214.7 187.2 152.3 110.4 22.9 129.2 117.7 149.4 6.5 181.2 111.0 111.2 7.1 22.3 116.8 262.4 109.4 93.0 129.5 492.6 835.5 157.5 67.4 105.2 51.5 130.8 51.1 56.0 121.6 159.3 127.5 112.2 115.4 227.4 118.6 MCMDC2 "C8orf45, FLJ25692" ENSG00000178460 "Minichromosome maintenance domain containing 2" Q4G0Z9 8 66870749-66922048 "Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.0" "Group enriched" "Detected in many" 4 "Early spermatids: 50.7;Spermatocytes: 65.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 12.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026522 Approved "Actin filaments" NA NA "Actin filaments" "HPA026522: AB_10603453" "unprognostic (6.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.42e-1)" "unprognostic (9.46e-2)" "unprognostic (9.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.79e-3)" "unprognostic (7.87e-2)" "unprognostic (3.06e-2)" "unprognostic (8.49e-2)" "unprognostic (2.31e-5)" 1.1 1.9 0.9 1.4 1.1 4.1 0.7 2.1 1.0 0.4 0.0 0.7 1.4 1.2 0.9 1.6 1.0 1.1 2.5 0.8 0.6 1.0 0.6 0.8 2.8 1.0 0.9 0.4 3.1 1.5 1.1 0.9 0.5 1.3 0.9 0.7 4.4 1.4 0.3 6.0 2.2 1.4 0.1 1.0 1.2 1.0 12.0 1.0 0.2 1.4 1.5 0.2 0.8 0.3 2.1 2.7 5.6 2.8 3.4 0.4 1.3 1.5 2.5 0.4 0.2 0.2 4.8 3.5 4.1 1.0 0.2 1.5 2.3 0.0 0.1 0.8 2.1 6.9 5.1 8.9 5.8 0.6 2.3 2.7 0.9 0.8 0.1 0.0 4.1 0.2 3.9 3.2 3.8 1.1 5.3 5.8 7.2 3.5 4.5 5.1 2.0 1.0 1.8 0.5 4.1 1.9 3.5 0.8 1.0 12.3 1.6 3.5 6.0 1.2 1.9 2.7 3.2 3.1 3.1 1.8 3.9 2.1 4.8 2.0 0.9 0.5 0.2 0.9 0.4 1.2 1.0 1.4 1.1 1.1 1.0 1.6 1.4 0.2 1.3 0.3 1.2 1.1 0.5 0.9 1.1 2.1 1.0 0.8 0.6 1.0 0.9 0.4 1.3 1.0 1.0 2.1 0.4 0.0 0.5 12.4 0.7 0.4 0.5 0.4 1.2 2.0 1.8 1.3 2.7 0.0 0.4 1.8 6.2 1.2 0.2 0.4 0.0 0.2 50.7 4.9 0.9 0.7 0.0 0.0 6.2 0.2 0.6 0.5 2.6 0.6 0.0 0.7 0.4 0.0 0.5 1.7 5.1 0.8 0.0 1.6 0.3 12.4 1.8 0.4 1.8 0.0 0.0 2.0 1.0 6.0 12.0 0.1 0.3 0.7 0.2 0.2 0.2 0.8 3.6 2.4 0.0 1.0 0.6 65.7 11.1 1.3 1.0 0.0 0.7 1.2 1.2 0.6 TUBAL3 FLJ21665 ENSG00000178462 "Tubulin alpha like 3" A6NHL2 10 5393101-5404828 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 28.5" "Group enriched" "Detected in some" 4 "Distal enterocytes: 19.8;Proximal enterocytes: 19.7" "Cancer enriched" "Detected in some" 4 "colorectal cancer: 3.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 13.3;JURKAT: 7.7;K-562: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045900, HPA063394" Uncertain NA NA "HPA045900: AB_10961130, HPA063394: AB_2685003" "unprognostic (2.63e-1)" "unprognostic (1.69e-2)" "unprognostic (5.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.59e-2)" "unprognostic (2.13e-2)" "unprognostic (3.02e-2)" "unprognostic (4.02e-1)" "unprognostic (1.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" "unprognostic (4.52e-2)" "unprognostic (2.75e-1)" "unprognostic (1.35e-4)" "unprognostic (7.93e-4)" 0.1 0.0 0.6 0.5 0.4 0.2 0.4 0.4 0.7 0.1 1.2 12.0 24.5 0.0 0.0 0.3 0.2 0.1 0.5 0.4 0.5 5.9 0.0 0.2 0.1 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.1 10.9 0.0 0.8 0.0 0.1 0.3 28.5 0.3 0.5 0.0 0.2 1.0 0.9 0.3 0.0 1.4 0.0 0.1 0.2 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 13.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.7 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.4 0.7 0.4 0.5 0.8 0.5 0.2 0.7 0.5 0.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 19.7 4.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.4 0.1 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989889-49007153 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 155.3;Respiratory ciliated cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 11.5 37.4 44.8 4.9 49.0 5.9 12.5 40.9 68.4 17.4 74.5 14.3 12.2 17.8 18.9 8.3 40.2 11.3 25.8 49.3 50.6 29.7 12.0 15.8 6.5 48.4 46.7 51.6 20.2 38.8 39.7 76.5 11.1 45.9 18.6 7.4 16.5 19.7 16.9 15.3 9.9 13.1 7.5 40.8 10.8 25.3 23.8 45.8 5.5 26.7 11.4 3.8 13.0 13.2 50.1 8.6 27.9 4.8 0.1 15.5 17.6 0.4 16.8 24.6 13.2 14.8 6.3 55.6 8.1 15.8 21.6 10.5 4.8 12.5 6.6 4.1 30.4 19.5 0.0 42.1 0.0 38.6 8.3 0.2 11.0 6.3 13.4 1.1 51.4 15.0 0.1 0.0 37.9 6.5 48.1 1.2 1.0 6.8 52.6 31.2 0.0 0.0 53.5 24.4 15.9 20.9 0.2 17.7 25.0 0.1 1.1 20.1 13.1 9.9 8.0 6.1 19.9 14.5 50.0 28.6 0.1 54.9 0.7 7.1 8.0 9.0 5.9 6.7 3.5 9.6 8.4 12.3 11.7 9.4 15.9 13.0 8.3 0.8 5.9 4.5 1.6 17.0 6.0 44.8 49.0 40.9 68.4 49.3 50.6 48.4 46.7 51.6 45.9 40.8 45.8 50.1 15.1 22.4 17.3 36.2 16.1 9.2 34.6 41.1 12.5 72.9 28.7 23.0 12.0 41.5 44.0 46.0 87.6 31.4 13.4 27.4 19.6 38.3 138.4 106.4 23.7 12.6 80.9 12.4 55.7 39.1 9.9 28.1 48.9 31.2 22.9 31.6 15.4 8.5 16.8 117.8 48.6 40.4 65.1 6.3 12.8 155.3 30.4 13.0 12.4 20.6 11.3 58.4 14.4 17.1 32.3 23.6 51.8 25.9 28.9 24.4 56.2 30.4 169.4 72.5 19.7 32.9 24.7 32.5 7.0 12.9 10.4 26.1 25.0 23.9 40.9 31.2 UCN3 "SPC, UCNIII" ENSG00000178473 "Urocortin 3" Q969E3 10 5364966-5374692 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.9;pancreas: 5.8;stomach 1: 3.4" "Cell type enriched" "Detected in some" 29 "Enteroendocrine cells: 242.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.4" "Group enriched" "Detected in some" 5 "amygdala: 1.8;medulla oblongata: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 1.2" "Region enhanced" "Detected in some" "hypothalamus: 5.1" HPA038281 Uncertain "Secreted to blood" NA NA "HPA038281: AB_10672408" "unprognostic (2.00e-2)" "unprognostic (2.31e-1)" "unprognostic (1.60e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-3)" "unprognostic (8.42e-2)" "unprognostic (3.55e-2)" "unprognostic (2.91e-2)" 0.0 0.8 1.8 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 2.3 8.9 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.4 0.7 0.0 0.6 0.0 2.0 0.3 0.0 0.0 5.8 0.0 2.7 0.1 0.1 0.3 2.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.1 0.0 0.4 2.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 242.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 0.0 0.0 0.3 0.6 2.9 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 70.7" "Cancer enriched" "Detected in all" 4 "glioma: 54.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 1.0;T-cells: 2.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 84.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 31.0 58.7 115.8 15.9 117.9 7.2 36.7 114.8 139.3 91.4 108.8 88.7 11.6 96.3 51.1 24.4 92.8 24.8 62.5 123.0 111.0 52.1 12.4 37.5 21.4 108.3 110.7 117.7 125.3 42.3 39.7 146.2 28.3 114.7 82.8 16.9 81.5 31.7 48.6 21.2 20.0 46.5 48.9 103.8 46.4 51.4 29.2 110.3 23.9 76.5 16.7 15.6 65.5 61.2 117.1 8.8 22.7 65.9 0.1 0.0 0.1 0.4 13.8 35.4 29.7 30.0 11.8 36.5 12.3 20.5 30.0 0.3 14.2 0.0 1.7 20.9 31.1 4.1 7.1 39.4 12.5 49.4 0.0 0.1 24.5 16.7 22.8 0.3 84.4 33.6 0.1 0.0 40.9 23.1 19.2 38.4 0.3 52.1 7.2 2.0 0.0 55.1 0.7 2.8 22.7 47.7 75.5 10.9 3.1 7.0 15.8 38.4 18.9 0.1 38.6 15.3 17.9 20.2 66.2 53.6 0.2 24.8 0.1 20.6 0.0 0.0 0.0 2.5 0.0 0.6 0.1 0.9 1.2 0.1 0.1 0.8 1.6 0.0 1.0 0.0 0.3 2.2 1.2 115.8 117.9 114.8 139.3 123.0 111.0 108.3 110.7 117.7 114.7 103.8 110.3 117.1 4.9 16.0 15.6 25.8 2.9 6.2 10.0 8.7 21.1 47.8 12.2 19.9 11.0 11.5 10.5 12.9 50.1 0.5 10.6 0.5 13.7 8.2 0.9 17.8 17.4 8.5 15.6 4.4 29.9 1.9 0.3 15.1 6.1 5.5 5.7 17.2 15.0 0.6 0.6 70.7 29.3 0.9 10.2 2.0 2.1 2.8 34.2 1.6 3.6 8.4 0.8 27.4 36.0 25.1 19.0 2.6 0.0 31.6 5.8 7.1 0.0 4.6 30.9 42.0 46.0 11.5 37.5 4.6 5.7 2.8 2.8 1.2 10.4 16.8 0.7 3.5 KLHL11 FLJ10572 ENSG00000178502 "Kelch like family member 11" Q9NVR0 17 41848518-41865423 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 108.3;Late spermatids: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023021, HPA052403, HPA054269" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432" "unprognostic (9.90e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-1)" "unprognostic (2.07e-1)" "unprognostic (1.84e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-2)" "unprognostic (1.50e-1)" "unprognostic (1.83e-2)" "unprognostic (3.25e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-3)" "unprognostic (4.05e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-2)" "unprognostic (5.07e-2)" 2.1 2.5 6.9 2.0 7.9 9.1 3.6 9.6 9.0 2.2 2.2 1.9 1.7 2.8 4.1 1.8 2.5 1.6 1.9 10.1 8.2 2.6 2.5 2.3 2.9 7.5 7.7 7.3 3.9 3.0 4.6 0.8 2.0 8.4 2.9 1.8 7.1 2.3 2.8 4.3 3.2 1.7 1.8 5.8 2.8 2.3 9.8 7.8 2.8 4.5 1.9 2.9 1.6 0.8 10.8 3.3 5.6 3.9 10.3 5.3 2.8 6.8 3.1 2.9 3.3 3.1 5.2 2.5 10.7 3.4 3.8 3.0 9.3 10.1 4.4 6.0 4.1 4.5 3.8 8.2 7.1 4.9 4.7 4.1 3.4 4.0 4.4 8.3 3.4 3.4 5.3 3.4 9.1 4.3 4.2 7.1 4.9 3.4 2.9 1.8 6.1 9.5 7.7 3.7 5.7 9.8 4.8 5.4 24.9 4.2 3.8 10.9 3.8 5.3 5.1 6.9 4.9 6.2 5.6 5.1 7.9 5.4 4.9 4.8 0.2 0.5 0.3 0.5 0.7 0.8 0.6 0.6 0.6 0.5 0.8 0.7 0.6 0.2 0.4 0.4 0.3 0.4 0.4 6.9 7.9 9.6 9.0 10.1 8.2 7.5 7.7 7.3 8.4 5.8 7.8 10.8 1.2 0.0 0.5 6.8 4.5 0.5 1.4 0.2 14.8 3.8 0.9 1.8 0.2 0.0 1.5 0.0 4.2 0.4 3.6 0.3 0.0 0.4 108.3 1.6 3.4 1.5 0.0 3.0 16.6 0.2 0.4 3.0 10.7 1.9 0.0 1.1 0.0 0.0 0.3 8.4 18.0 0.7 0.0 0.0 1.0 41.8 0.3 1.5 1.8 4.7 0.9 1.8 1.0 11.1 13.9 0.5 0.1 0.0 5.8 0.9 0.9 0.2 0.0 3.6 6.6 2.2 3.2 5.5 2.1 5.5 0.3 0.4 4.6 0.9 0.6 0.9 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Human disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Microglial cells: 1.9" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HEK 293: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Uncertain Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924491-7926135 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 226.7;endometrium 1: 86.4" "Cell type enriched" "Detected in many" 4 "Endometrial ciliated cells: 127.7" "Group enriched" "Detected in all" 4 "endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 4.0 12.6 171.8 0.9 226.7 0.1 3.2 0.0 174.4 32.8 0.0 39.6 0.9 86.4 2.9 2.6 43.4 0.2 1.0 201.2 27.3 10.7 0.4 7.0 0.0 91.0 17.7 137.0 6.3 2.2 1.1 57.4 0.3 150.1 16.4 0.4 0.2 6.5 12.5 0.5 4.0 4.8 4.9 0.0 1.4 8.9 28.0 43.6 0.3 2.8 0.1 0.0 21.4 13.3 52.9 33.5 8.1 20.5 96.4 0.0 0.3 4.8 8.5 2.3 4.1 2.4 2.4 5.0 0.2 16.2 2.0 2.2 35.9 4.7 0.9 0.2 3.0 67.5 0.7 5.3 1.5 0.9 1.8 1.9 0.0 2.7 1.4 0.9 9.8 5.4 9.1 21.3 0.3 0.5 40.5 18.5 13.6 72.4 2.4 34.1 57.3 0.0 6.4 15.0 1.4 56.2 94.5 5.2 2.8 9.9 1.7 21.2 0.6 8.3 2.1 33.1 3.9 4.8 0.7 1.0 4.8 8.0 3.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.8 226.7 0.0 174.4 201.2 27.3 91.0 17.7 137.0 150.1 0.0 43.6 52.9 0.6 0.0 0.0 3.3 0.7 1.1 4.1 1.5 2.2 0.3 15.3 6.7 0.4 1.5 1.0 9.2 4.2 0.2 0.2 0.5 3.9 7.8 9.5 127.7 22.4 1.6 9.1 0.0 20.6 0.4 0.4 3.0 0.0 7.9 0.0 13.3 0.7 0.1 0.3 0.0 3.5 0.5 2.0 0.3 0.5 27.1 1.2 0.5 1.8 4.7 0.0 0.6 0.0 1.5 2.9 1.7 1.2 1.9 0.0 19.9 0.0 11.9 21.0 0.4 0.0 0.2 17.7 6.0 16.0 0.3 2.0 0.3 0.6 3.2 0.2 6.4 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856926-48898904 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 96.1;RPMI-8226: 138.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 20.9 30.2 15.4 12.0 16.7 10.8 18.1 17.8 16.5 8.2 14.3 26.7 66.2 10.5 4.7 9.2 13.0 15.9 47.5 14.7 17.1 25.9 149.6 15.8 14.7 16.9 16.5 14.2 5.9 30.7 17.5 11.7 7.4 16.6 11.8 23.8 4.5 20.1 9.0 67.1 10.2 53.2 15.3 17.0 20.8 21.2 9.2 16.5 17.5 11.5 61.6 16.3 11.4 8.5 17.6 4.1 12.8 9.7 13.8 30.1 11.8 1.9 22.3 11.8 15.2 15.8 16.3 19.1 19.0 15.6 35.1 18.7 4.1 24.5 9.8 11.6 47.9 11.8 26.4 19.2 20.4 14.0 27.8 48.1 14.9 11.2 20.6 3.8 6.1 20.2 28.1 24.1 96.1 20.2 10.9 30.4 13.7 5.1 22.9 27.6 10.6 5.9 138.4 16.4 10.1 3.9 13.6 20.7 0.2 11.4 13.6 30.5 12.9 16.6 17.2 3.2 25.5 16.4 35.6 27.0 21.8 24.5 19.5 23.3 60.8 101.1 215.2 97.4 79.7 62.2 36.8 53.1 71.2 97.5 33.0 41.2 69.1 48.6 64.6 83.7 120.5 60.7 112.3 15.4 16.7 17.8 16.5 14.7 17.1 16.9 16.5 14.2 16.6 17.0 16.5 17.6 7.5 6.4 2.7 13.1 7.0 1.8 2.5 4.6 3.4 1.1 4.0 3.6 42.2 4.3 4.4 0.0 6.2 2.3 13.6 28.4 3.9 3.5 1.3 2.3 4.6 5.5 7.3 16.4 2.2 4.3 2.3 6.1 9.2 2.1 1.3 3.8 7.5 64.2 16.9 0.0 3.8 12.7 2.0 13.4 4.5 1.8 10.5 10.0 1.8 1.0 31.3 2.9 32.0 1.0 6.0 3.7 16.4 12.4 12.6 3.9 51.8 16.7 5.9 1.3 0.0 5.4 5.3 8.3 7.1 4.1 1.3 1.2 14.4 27.7 16.6 2.9 CA8 "CALS, CARP" ENSG00000178538 "Carbonic anhydrase 8" P35219 8 60185412-60281400 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.6;parathyroid gland: 40.4" "Cell type enhanced" "Detected in many" "Astrocytes: 92.7;Enteroendocrine cells: 35.2;Gastric mucus-secreting cells: 40.2;Oligodendrocyte precursor cells: 129.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 24 "basophil: 76.2" "Lineage enriched" "Detected in many" 24 "granulocytes: 76.2" "Cell line enhanced" "Detected in some" "HEK 293: 10.1;JURKAT: 11.0;K-562: 20.3;NB-4: 12.3;OE19: 17.4" "Region enriched" "Detected in all" 38 "cerebellum: 1260.5" "Region enriched" "Detected in all" 9 "cerebellum: 86.3" "HPA024748, CAB025545, CAB047309" Enhanced NA NA "CAB025545: , CAB047309: , HPA024748: AB_1846003" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "unprognostic (4.43e-2)" "unprognostic (3.46e-3)" "unprognostic (6.67e-2)" "unprognostic (3.19e-1)" "unprognostic (3.85e-2)" "unprognostic (3.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.79e-5)" "unprognostic (3.23e-2)" "unprognostic (1.68e-2)" "unprognostic (2.12e-1)" "unprognostic (1.71e-2)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" 1.4 0.9 5.1 0.3 4.8 0.5 4.6 18.6 5.6 4.3 2.2 1.3 1.0 1.9 10.2 0.2 1.5 0.3 3.8 4.4 5.7 5.2 0.0 1.0 0.4 4.7 4.7 4.0 0.2 2.0 40.4 8.5 6.2 10.4 1.5 2.0 2.3 3.8 0.2 1.2 0.3 1.0 0.5 3.2 0.8 4.4 4.2 5.1 1.3 0.3 2.3 0.3 0.6 0.3 4.5 0.0 2.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 10.1 4.5 0.0 0.0 3.6 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 11.0 20.3 0.2 0.0 0.0 3.3 12.3 0.2 17.4 0.0 0.0 0.0 0.2 0.4 0.8 5.1 0.0 0.0 1.1 0.0 2.0 4.5 0.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 76.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.1 5.1 4.8 18.6 5.6 4.4 5.7 4.7 4.7 4.0 10.4 3.2 5.1 4.5 22.0 0.0 4.8 92.7 1.6 1.0 0.4 4.1 0.0 8.2 15.6 10.3 4.7 0.0 5.7 3.7 0.0 8.3 10.9 2.0 3.9 8.1 9.9 9.8 2.4 16.7 35.2 13.5 4.7 6.0 0.3 4.0 40.2 26.2 0.0 1.1 0.0 0.0 9.9 0.0 25.6 25.0 6.1 1.9 1.1 4.9 1.5 1.1 7.2 18.7 0.0 2.6 1.0 129.7 0.4 1.6 3.5 1.5 14.0 2.1 0.3 0.0 1.2 1.0 0.0 0.8 2.3 3.8 5.5 0.2 0.4 1.4 0.7 3.1 3.3 1.5 CD28 ENSG00000178562 "CD28 molecule" P10747 2 203706475-203738912 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 31.1;placenta: 14.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 34.1;T-cells: 52.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 101.9" "Lineage enriched" "Detected in many" 7 "T-cells: 101.9" "Group enriched" "Detected in some" 14 "Karpas-707: 360.6;RPMI-8226: 173.2;U-266/70: 294.1;U-266/84: 283.7" "Region enhanced" "Detected in single" "olfactory bulb: 1.0" "Not detected" "Not detected" HPA070003 Enhanced NA NA "HPA070003: AB_2686226" "unprognostic (5.54e-2)" "unprognostic (2.16e-4)" "unprognostic (1.90e-3)" "unprognostic (2.49e-3)" "unprognostic (3.44e-2)" "unprognostic (6.07e-5)" "unprognostic (9.09e-2)" "unprognostic (4.66e-2)" "unprognostic (3.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-1)" "unprognostic (1.68e-1)" "unprognostic (5.78e-5)" "unprognostic (4.77e-2)" "unprognostic (2.93e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-2)" 4.0 0.3 0.0 15.0 0.1 3.3 0.8 0.1 0.3 1.2 0.9 1.7 1.1 0.7 0.4 0.9 0.5 4.2 0.6 0.1 0.1 0.5 1.3 1.9 28.2 0.1 0.1 0.1 0.3 0.5 0.2 0.1 14.9 0.1 1.0 2.0 0.1 0.6 0.8 0.3 0.3 3.0 1.5 0.1 7.3 2.6 0.7 0.1 31.1 0.5 0.1 18.8 4.7 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.7 2.0 0.0 360.6 0.2 0.0 19.9 0.0 0.1 0.0 0.0 0.1 0.3 173.2 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.3 294.1 283.7 2.9 0.3 0.1 0.0 1.7 0.6 1.0 8.3 0.5 50.6 0.3 54.5 26.1 0.1 0.3 48.1 18.6 13.8 0.2 0.5 0.2 101.9 14.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 1.3 0.0 2.4 2.9 0.1 0.0 0.6 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 3.2 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.3 1.0 2.0 0.1 1.3 0.0 0.0 0.1 34.1 0.0 0.0 0.0 0.0 0.8 5.3 0.2 0.0 4.4 0.0 1.0 1.5 0.0 2.1 0.0 0.1 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.2 1.6 0.1 52.6 0.0 0.0 0.0 EPM2AIP1 "FLJ11207, KIAA0766" ENSG00000178567 "EPM2A interacting protein 1" Q7L775 3 36985043-36993131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.24e-2)" "prognostic favorable (2.70e-4)" "unprognostic (6.24e-2)" "unprognostic (5.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-1)" "unprognostic (5.32e-3)" "unprognostic (1.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-2)" "unprognostic (7.73e-2)" "unprognostic (4.30e-3)" "unprognostic (1.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (2.25e-3)" 7.4 11.2 12.2 11.3 11.6 13.7 12.3 19.3 13.4 12.3 9.9 8.5 7.9 14.2 16.4 7.2 12.5 6.8 13.2 11.0 16.4 9.6 10.3 10.1 12.6 13.7 14.2 11.1 18.2 8.1 13.2 14.5 8.2 14.7 15.1 8.9 28.7 9.8 10.6 12.7 8.7 10.2 10.5 10.8 14.6 8.8 8.2 15.4 15.4 21.6 10.6 12.0 8.7 10.1 18.2 5.8 5.5 26.6 0.1 11.7 16.6 6.2 12.7 8.4 9.0 10.7 4.8 10.0 17.1 5.3 9.5 10.2 12.2 7.7 7.9 10.7 8.7 7.4 13.5 30.2 10.3 7.4 15.9 7.9 18.9 7.1 10.5 6.3 14.3 9.0 18.9 13.5 34.4 12.7 5.7 9.8 11.5 3.9 4.6 6.6 7.7 18.8 9.1 8.5 14.2 11.1 14.0 14.9 18.6 4.1 8.8 31.6 9.9 10.8 13.5 11.1 10.2 9.4 18.7 12.0 10.6 9.1 12.1 7.8 5.7 2.9 5.6 3.0 3.9 3.6 4.4 4.7 2.8 3.1 4.9 4.4 3.8 2.8 4.9 8.7 4.6 2.9 1.4 12.2 11.6 19.3 13.4 11.0 16.4 13.7 14.2 11.1 14.7 10.8 15.4 18.2 24.9 41.7 34.3 5.5 50.0 20.3 33.1 15.9 26.7 68.4 26.8 23.0 39.9 31.5 23.7 35.0 41.7 20.3 36.5 16.6 11.7 10.2 7.6 14.2 35.3 25.7 34.3 24.8 7.5 10.0 7.4 36.2 16.8 14.5 26.0 40.4 30.4 28.4 13.0 69.0 10.6 21.7 22.4 29.5 32.8 6.4 41.0 29.9 24.9 5.6 24.7 45.9 44.3 6.6 9.8 9.0 16.6 37.2 42.2 25.0 15.4 12.9 17.0 61.0 13.1 47.2 32.9 25.5 18.5 24.2 26.9 8.9 39.7 43.5 19.0 18.6 ERBB4 "ALS19, HER4" ENSG00000178568 "Erb-b2 receptor tyrosine kinase 4" Q15303 2 211375717-212538841 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Lactation, Transcription, Transcription regulation" "Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;fallopian tube: 11.3" "Cell type enhanced" "Detected in many" "Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9" "Group enriched" "Detected in many" 4 "breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000276, HPA012016, CAB025522" Enhanced NA NA 220000 "CAB000276: , CAB025522: , HPA012016: AB_1846541" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (4.31e-3)" "unprognostic (1.76e-3)" "unprognostic (3.59e-1)" "unprognostic (2.75e-1)" "unprognostic (2.88e-1)" "unprognostic (9.56e-2)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (7.14e-3)" "unprognostic (1.49e-3)" "unprognostic (1.41e-1)" "unprognostic (1.14e-1)" "unprognostic (4.11e-2)" 0.2 0.4 10.3 0.0 13.4 0.0 5.6 10.5 11.3 3.0 0.0 0.0 0.0 0.2 0.0 0.1 11.3 0.0 3.0 9.6 28.6 5.2 0.0 0.9 0.0 6.8 15.4 9.9 0.1 0.6 3.1 2.4 0.1 7.6 0.3 0.0 2.0 4.8 1.2 1.5 0.3 0.0 0.0 2.2 0.0 0.4 3.3 7.1 0.0 1.6 1.7 0.0 0.1 0.1 9.0 0.0 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 5.1 0.7 0.0 0.3 0.2 0.0 0.0 0.1 3.8 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 5.6 0.3 3.1 0.2 0.0 0.1 0.1 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 13.4 10.5 11.3 9.6 28.6 6.8 15.4 9.9 7.6 2.2 7.1 9.0 0.4 0.0 12.6 2020.2 0.0 0.6 0.9 1.1 0.6 15.9 45.6 17.0 27.2 0.0 10.2 12.9 0.0 0.0 0.2 0.0 5.9 0.5 6.7 25.4 1.0 1.0 0.0 0.0 62.0 0.5 0.2 1.8 0.0 25.8 0.0 5.4 0.0 0.0 0.1 0.0 6091.7 0.0 2.0 0.0 0.3 2.2 1.8 0.3 3.6 96.5 0.0 9.1 0.0 2369.0 1049.9 0.0 0.0 0.4 0.0 1.6 0.0 0.2 28.1 1.9 6.6 4.1 3.0 1.8 2.6 0.2 1.3 0.0 0.2 0.0 0.0 1.2 MAF c-MAF ENSG00000178573 "MAF bZIP transcription factor" O75444 16 79585843-79600737 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Mental retardation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 407.6;Hofbauer cells: 273.6;Inhibitory neurons: 378.7;Kupffer cells: 394.7;Proximal enterocytes: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 38.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 38.1" "Group enriched" "Detected in some" 13 "Karpas-707: 207.0;RPMI-8226: 355.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010296, HPA028289" Approved NA NA "CAB010296: AB_638562, HPA028289: AB_10602024" "unprognostic (6.76e-2)" "unprognostic (1.74e-2)" "unprognostic (6.45e-2)" "unprognostic (7.65e-2)" "unprognostic (7.89e-3)" "unprognostic (1.07e-2)" "unprognostic (1.63e-2)" "unprognostic (2.33e-1)" "unprognostic (8.76e-2)" "unprognostic (3.16e-2)" "unprognostic (9.46e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.74e-4)" "unprognostic (4.54e-2)" "unprognostic (7.83e-2)" "unprognostic (1.09e-2)" "unprognostic (4.56e-3)" 24.8 15.6 15.2 20.9 12.8 4.1 17.4 11.2 14.9 33.2 18.3 10.9 71.0 23.7 6.0 22.8 20.3 16.9 6.7 13.9 17.8 48.6 25.9 19.0 31.2 19.4 19.5 8.5 39.5 3.2 51.2 5.3 36.4 18.8 18.6 10.8 4.7 11.9 15.5 50.0 58.3 83.6 18.0 23.1 26.2 13.2 10.1 20.4 18.1 23.2 20.0 24.1 17.8 30.7 25.9 0.0 0.0 22.4 0.0 0.8 0.0 0.5 2.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 1.2 0.0 0.8 0.7 0.4 0.0 7.2 8.3 0.0 0.0 0.2 1.0 0.1 14.3 0.1 6.4 0.0 0.2 0.0 0.0 0.3 2.4 207.0 1.5 0.1 0.2 0.4 13.5 0.0 0.0 0.1 6.2 355.1 0.0 1.9 0.5 0.3 0.9 0.2 0.6 8.7 0.2 0.0 4.5 0.0 6.9 0.5 0.9 0.0 0.0 0.0 0.9 0.0 1.4 38.1 0.3 0.0 1.1 1.1 8.6 0.0 3.2 2.7 0.1 0.0 0.2 0.5 0.0 0.9 0.3 0.0 4.7 0.6 15.2 12.8 11.2 14.9 13.9 17.8 19.4 19.5 8.5 18.8 23.1 20.4 25.9 40.2 9.6 14.6 24.8 10.4 88.3 3.7 30.1 51.2 9.7 8.5 33.1 8.2 57.2 7.7 3.7 0.0 1.7 71.5 18.2 11.7 1.7 1.1 8.1 114.1 42.7 3.0 8.4 5.1 0.8 3.0 73.0 12.8 6.6 22.1 73.0 407.6 63.7 273.6 0.0 378.7 8.9 16.2 394.7 57.9 9.0 149.8 127.2 44.4 122.7 2.7 78.1 40.2 67.3 20.0 4.0 9.9 115.1 48.1 33.9 288.9 146.6 3.0 2.7 13.1 42.7 40.0 1.1 2.0 107.4 141.2 4.2 122.2 28.0 10.1 5.4 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 179.1;skin 1: 397.7" "Cell type enhanced" "Detected in many" "Muller glia cells: 185.7;Suprabasal keratinocytes: 291.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 13.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067089 Enhanced Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA 35000 "Nucleoplasm, Cytosol" "Nucleoli, Vesicles" "HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 34.7 11.2 30.0 11.3 28.4 22.6 35.6 37.7 31.7 35.4 15.1 15.1 18.9 11.9 78.1 179.1 12.7 10.4 37.4 29.9 30.0 17.5 15.8 26.6 8.8 32.7 30.8 27.0 14.7 36.2 11.0 19.8 28.4 36.6 24.7 10.3 27.8 53.5 14.3 39.4 397.7 15.1 11.0 27.1 9.4 23.0 27.3 37.7 19.8 21.1 22.5 25.3 13.4 85.8 27.9 74.8 10.9 65.9 50.4 9.8 16.2 21.1 14.4 25.2 20.9 13.3 5.4 92.6 22.9 41.0 18.7 21.6 37.3 7.7 85.9 9.6 58.0 11.9 14.9 3.4 69.3 20.3 11.3 8.4 18.2 83.5 26.7 27.0 17.7 57.2 42.4 26.8 10.5 13.0 45.6 25.3 41.6 35.0 60.0 18.7 28.4 19.3 14.7 10.7 25.2 72.1 45.4 32.9 29.4 44.4 22.3 36.3 27.2 37.7 13.4 16.4 20.4 32.2 22.9 32.5 27.0 5.0 56.6 54.5 2.6 5.2 13.8 2.6 1.8 1.6 1.7 1.3 2.1 6.4 1.5 1.3 1.2 3.7 8.6 1.2 2.0 1.3 2.6 30.0 28.4 37.7 31.7 29.9 30.0 32.7 30.8 27.0 36.6 27.1 37.7 27.9 150.6 28.9 13.9 30.0 9.6 103.1 42.3 16.1 40.5 9.0 39.9 33.3 14.0 24.3 17.0 18.4 8.4 71.3 23.5 20.5 33.2 20.9 116.3 20.0 17.9 42.7 49.1 20.0 18.0 18.7 43.2 15.7 30.1 38.5 0.0 27.2 20.0 25.6 58.0 16.8 14.1 37.5 12.2 43.0 97.4 34.8 14.9 38.3 48.0 12.2 33.6 185.7 71.1 17.1 24.1 37.6 28.3 23.0 13.3 53.5 28.6 30.5 5.2 12.8 46.0 15.0 24.5 72.1 43.6 154.0 291.5 48.4 17.2 14.3 28.6 60.5 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "retina: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB125 DEFB-25 ENSG00000178591 "Defensin beta 125" Q8N687 20 87250-97094 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "epididymis: 1.5;seminal vesicle: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSAPL1 ENSG00000178597 "Prosaposin like 1" Q6NUJ1 4 7430285-7434930 "Predicted secreted proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skin 1: 93.8;stomach 1: 38.9" "Cell type enriched" "Detected in some" 13 "Gastric mucus-secreting cells: 41.8" "Group enriched" "Detected in some" 5 "head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038013, HPA038482" Approved Enhanced Cytosol "Secreted - unknown location" NA NA 31000 Cytosol "HPA038013: AB_10673652, HPA038482: AB_2676037" "unprognostic (2.64e-2)" "unprognostic (2.40e-1)" "unprognostic (9.33e-2)" "unprognostic (2.40e-1)" "unprognostic (2.61e-1)" "unprognostic (7.90e-3)" "unprognostic (2.52e-1)" "unprognostic (2.08e-2)" "unprognostic (2.75e-1)" "unprognostic (2.63e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 93.8 0.0 0.0 0.0 0.0 38.9 3.5 0.1 0.2 0.0 0.0 3.1 0.0 0.2 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 OTOS OTOSP ENSG00000178602 Otospiralin Q8NHW6 2 240139026-240144562 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "pituitary gland: 103.9;thyroid gland: 44.2" "Cell type enhanced" "Detected in single" "Astrocytes: 1.3" "Cancer enriched" "Detected in some" 4 "thyroid cancer: 28.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.6" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (8.52e-2)" "unprognostic (1.73e-1)" "unprognostic (9.01e-3)" "unprognostic (1.35e-1)" "unprognostic (2.72e-1)" "unprognostic (3.27e-3)" 0.0 0.0 8.4 0.0 8.4 0.0 0.1 10.3 11.6 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 11.5 0.3 0.2 0.0 0.0 8.4 9.2 7.2 0.0 0.0 0.0 103.9 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 9.1 0.0 44.2 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 8.4 10.3 11.6 9.3 11.5 8.4 9.2 7.2 9.7 7.7 9.1 10.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTPBP6 "FLJ20977, PGPL" ENSG00000178605 "GTP binding protein 6 (putative)" O43824 X 304529-318819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA013336, CAB034924, HPA035467, HPA055418" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: " "unprognostic (5.00e-2)" "unprognostic (5.10e-2)" "unprognostic (1.60e-1)" "unprognostic (1.10e-2)" "unprognostic (4.90e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (1.17e-1)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "prognostic favorable (1.71e-4)" "unprognostic (3.38e-2)" "unprognostic (4.45e-2)" "unprognostic (4.99e-3)" "unprognostic (2.23e-1)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" 31.6 24.4 20.3 17.3 20.4 26.4 30.2 18.5 33.5 25.6 14.0 29.6 19.9 28.4 3.2 27.0 29.9 10.0 42.0 17.3 16.5 33.1 39.0 26.2 19.4 23.1 20.1 15.7 30.7 43.0 12.1 17.2 9.7 21.2 26.3 5.9 4.2 30.4 12.4 70.0 30.3 26.5 6.8 18.9 27.0 36.1 13.5 18.7 13.4 27.7 27.3 6.9 29.8 22.8 27.1 40.4 65.4 14.2 29.9 16.1 17.5 52.6 24.5 18.0 30.4 27.7 100.8 32.9 50.1 34.0 13.8 41.3 24.6 15.0 23.9 4.9 42.1 44.1 41.5 32.2 70.0 43.2 28.2 38.9 21.7 31.0 20.3 14.8 11.2 24.7 32.8 31.1 23.0 12.7 79.5 50.4 37.1 34.8 8.1 46.0 22.3 25.0 80.7 17.9 46.3 39.8 33.9 26.8 30.0 46.2 7.6 26.9 24.3 33.0 44.2 30.4 66.0 38.3 30.9 30.1 78.0 23.0 36.8 20.9 5.3 4.1 4.8 4.8 4.3 4.8 4.9 4.2 5.5 4.0 3.4 5.1 4.6 0.5 3.7 4.0 7.3 6.3 2.6 20.3 20.4 18.5 33.5 17.3 16.5 23.1 20.1 15.7 21.2 18.9 18.7 27.1 35.3 19.2 19.2 17.0 33.8 28.2 48.2 7.9 34.7 28.1 38.1 34.0 20.3 32.9 9.2 27.6 27.1 22.0 45.1 32.1 52.8 13.1 1.4 20.1 27.3 26.2 17.9 16.6 10.9 15.0 46.0 32.9 37.8 23.6 11.4 44.9 21.0 38.1 29.3 13.5 9.6 24.7 16.2 25.7 28.0 1.6 19.6 32.6 26.6 6.5 16.7 22.0 33.0 12.1 18.7 10.4 17.4 18.8 32.5 98.1 23.2 89.5 6.7 27.2 6.6 33.2 31.2 4.5 13.5 36.9 26.6 29.4 38.9 54.3 38.1 51.2 ERN1 "IRE1, IRE1P" ENSG00000178607 "Endoplasmic reticulum to nucleus signaling 1" O75460 17 64039080-64130819 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Transcription, Transcription regulation, Unfolded protein response" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 53.4;pancreas: 67.3" "Cell type enhanced" "Detected in many" "Plasma cells: 325.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 17.9" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0" "Cell line enhanced" "Detected in many" "Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009495, HPA027730" Supported NA Yes "CAB009495: AB_2098712, HPA027730: AB_10602494" "unprognostic (2.52e-1)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (2.81e-2)" "unprognostic (9.14e-2)" "unprognostic (2.72e-2)" "unprognostic (4.55e-1)" "unprognostic (6.17e-2)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.65e-1)" "unprognostic (1.89e-1)" "unprognostic (1.36e-2)" "unprognostic (3.11e-2)" 7.4 53.4 1.7 5.4 1.8 13.5 7.6 2.6 3.1 20.1 3.2 6.1 6.3 10.2 6.5 9.6 14.4 6.2 5.7 1.8 2.6 5.6 23.7 16.6 5.8 1.6 1.3 1.6 17.0 67.3 4.3 19.6 5.7 1.5 10.0 4.5 8.8 15.8 7.2 6.9 11.0 10.6 5.6 1.1 15.9 16.3 2.8 1.9 6.9 10.3 2.4 6.7 8.4 11.8 2.0 4.0 4.0 2.2 4.8 4.8 4.4 9.8 4.1 9.7 2.8 1.3 2.5 2.3 6.6 3.2 2.8 3.5 3.6 1.9 4.5 6.1 1.6 1.5 6.0 3.2 2.4 19.6 3.2 2.1 3.8 8.1 6.4 21.5 3.5 5.0 4.7 4.2 74.6 2.8 3.9 4.5 1.0 0.6 3.6 3.2 4.2 4.2 40.2 1.1 5.5 7.1 3.5 4.3 6.1 5.7 3.5 3.8 5.9 5.9 2.5 4.1 6.4 2.7 77.4 23.9 4.8 4.0 2.1 4.2 17.9 0.9 0.4 4.9 0.4 9.0 0.2 3.3 4.1 0.4 0.3 0.9 0.9 4.9 2.5 0.3 7.7 0.8 1.0 1.7 1.8 2.6 3.1 1.8 2.6 1.6 1.3 1.6 1.5 1.1 1.9 2.0 31.9 0.0 36.1 7.2 27.8 22.0 54.3 8.3 15.4 4.0 35.0 29.7 8.6 11.5 8.6 12.9 6.2 8.1 106.4 10.0 1.9 12.6 2.3 26.1 49.1 18.3 79.7 11.2 8.6 27.3 8.8 42.2 52.0 79.4 8.2 11.8 13.9 26.8 8.0 3.3 6.1 8.2 8.2 15.7 71.3 1.7 4.7 60.4 74.7 12.2 10.2 3.5 28.8 6.0 4.6 17.9 7.3 6.0 325.8 44.7 7.9 4.4 6.1 26.5 0.0 19.0 25.7 4.0 4.1 27.7 45.0 54.9 88.2 12.0 9.6 60.1 GPR35 ENSG00000178623 "G protein-coupled receptor 35" Q9HC97 2 240605430-240631259 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 82.8;granulocytes: 38.1;Intestinal goblet cells: 32.2;Langerhans cells: 35.7;Paneth cells: 38.6;Proximal enterocytes: 99.3;Undifferentiated cells: 31.1" "Group enriched" "Detected in many" 4 "colorectal cancer: 20.7;pancreatic cancer: 6.9;stomach cancer: 9.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "classical monocyte: 36.3;eosinophil: 40.1;intermediate monocyte: 51.7;myeloid DC: 32.5;non-classical monocyte: 14.5" "Group enriched" "Detected in many" 16 "dendritic cells: 32.5;granulocytes: 40.1;monocytes: 51.7" "Cell line enhanced" "Detected in some" "CACO-2: 20.7;CAPAN-2: 51.2;HDLM-2: 17.6;Hep G2: 33.6;HMC-1: 31.5;NB-4: 16.4;OE19: 38.7;U-937: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.53e-1)" "unprognostic (5.99e-2)" "unprognostic (3.94e-3)" "unprognostic (2.71e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.98e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (7.03e-3)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-3)" 1.9 0.8 5.4 4.3 4.1 4.5 2.4 3.7 5.8 4.3 2.3 18.8 41.4 3.8 1.2 2.5 7.4 5.9 2.6 4.7 4.1 5.0 1.6 3.4 1.7 4.7 4.2 3.6 5.4 1.8 0.2 6.7 0.5 5.4 4.6 16.7 2.0 1.6 1.0 7.0 2.6 38.5 1.9 3.7 10.4 15.9 5.5 4.8 1.8 3.0 0.3 1.0 3.0 2.7 5.7 0.1 0.5 0.3 1.1 0.9 0.0 0.4 0.1 0.3 0.1 0.3 20.7 51.2 0.3 0.2 0.2 0.7 0.5 0.0 0.0 0.1 17.6 0.7 8.7 0.5 33.6 0.4 0.4 31.5 0.2 0.1 0.6 0.3 0.4 0.1 1.3 0.3 2.9 0.0 0.7 0.4 16.4 0.8 38.7 0.2 1.9 0.1 0.5 0.2 0.2 2.0 0.8 0.0 0.1 0.4 0.5 0.2 5.9 0.7 0.2 0.2 1.4 0.1 3.5 1.6 0.2 0.1 18.2 0.4 0.1 36.3 40.1 1.5 51.7 2.6 0.0 0.8 0.8 32.5 0.1 0.5 1.2 0.4 0.8 14.5 0.6 0.3 13.6 5.4 4.1 3.7 5.8 4.7 4.1 4.7 4.2 3.6 5.4 3.7 4.8 5.7 0.6 0.0 4.4 7.8 1.6 2.0 0.1 0.2 0.0 1.4 0.4 0.4 1.2 2.8 0.3 1.8 0.0 0.1 5.1 82.8 0.0 0.9 0.1 3.1 0.6 0.4 6.7 0.0 1.9 3.3 0.0 0.3 25.0 3.1 38.1 0.8 0.4 0.3 10.7 1.7 2.1 32.2 0.0 8.5 35.7 0.0 0.3 22.3 0.0 1.9 9.7 0.2 1.0 0.5 1.5 14.1 38.6 1.2 1.2 0.0 99.3 3.7 0.9 2.5 0.0 0.2 0.9 1.2 0.6 0.1 1.1 0.3 8.0 0.1 31.1 0.3 C10orf53 Em:AC069546.1 ENSG00000178645 "Chromosome 10 open reading frame 53" Q8N6V4 10 49679651-49710261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.9" "Group enriched" "Detected in some" 10 "Early spermatids: 499.3;Late spermatids: 1522.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037951 Enhanced NA NA "HPA037951: AB_10671382" "unprognostic (9.09e-2)" 0.0 0.0 0.5 0.0 0.3 0.3 0.0 1.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 39.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.3 1.7 0.9 0.3 0.2 0.7 0.3 0.2 0.7 0.1 0.4 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.3 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1522.4 4.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 98.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 358.3;Inhibitory neurons: 315.3;Oligodendrocyte precursor cells: 344.8;Oligodendrocytes: 95.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.8;PC-3: 2.4;SCLC-21H: 7.1;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Approved Uncertain "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 0.6 2.3 5.5 0.4 9.9 0.0 3.2 0.0 14.9 2.3 5.8 0.7 0.7 2.7 0.8 0.7 0.9 0.9 1.4 9.3 9.3 1.5 0.6 0.4 0.2 0.5 1.5 8.2 3.4 3.8 1.2 3.4 0.2 1.9 1.6 0.9 6.5 2.3 2.1 0.1 0.7 0.6 2.5 0.0 0.8 0.7 0.6 5.2 0.5 2.3 0.7 0.2 0.6 1.0 7.8 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.4 0.0 0.3 0.1 0.5 0.0 0.2 0.0 0.7 0.4 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.0 0.6 0.5 0.0 7.1 5.8 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.2 0.0 0.3 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 9.9 0.0 14.9 9.3 9.3 0.5 1.5 8.2 1.9 0.0 5.2 7.8 2.5 3.2 5.1 81.6 0.2 5.2 4.0 2.3 6.8 55.7 16.2 13.5 8.7 5.7 1.6 11.0 70.9 0.3 0.0 0.7 3.9 2.7 2.9 2.3 9.6 3.6 7.7 0.0 358.3 2.3 0.1 8.2 2.0 2.3 0.0 47.9 1.4 3.6 2.6 11.8 315.3 4.7 4.1 0.3 1.6 1.7 7.5 0.4 7.2 7.5 0.0 19.6 0.0 344.8 95.4 0.9 1.9 8.2 0.0 0.6 1.7 7.2 0.5 20.4 6.6 4.4 23.0 0.6 1.6 6.3 4.5 0.3 0.2 13.2 2.6 2.0 ZNF713 FLJ39963 ENSG00000178665 "Zinc finger protein 713" Q8N859 7 55887456-55942530 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 18.6;Excitatory neurons: 16.2;Late spermatids: 16.2;Oligodendrocytes: 25.6" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basophil: 2.1;eosinophil: 2.3;neutrophil: 3.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "SH-SY5Y: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059425, HPA062887" Uncertain Approved Nucleoli NA NA Nucleoli "HPA059425: AB_2684013, HPA062887: AB_2684894" "unprognostic (5.27e-2)" "unprognostic (2.50e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" "unprognostic (1.36e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-3)" "unprognostic (1.46e-1)" "unprognostic (7.07e-2)" "unprognostic (4.63e-2)" "unprognostic (2.77e-3)" "unprognostic (7.78e-2)" "unprognostic (4.80e-2)" "unprognostic (8.00e-2)" "unprognostic (8.16e-3)" "unprognostic (1.34e-1)" "unprognostic (1.63e-3)" 0.6 0.9 1.1 0.6 1.1 1.7 1.2 1.4 1.5 0.9 0.2 0.7 1.1 1.7 1.0 0.6 1.9 0.8 0.8 1.0 0.5 1.0 0.6 0.8 0.6 1.5 1.0 0.6 1.8 1.3 0.6 1.8 0.7 1.9 1.2 0.5 2.4 0.9 0.8 1.7 1.1 0.7 1.0 0.7 0.9 1.5 3.9 1.2 1.5 1.3 0.7 0.6 0.4 0.4 4.2 1.0 0.4 3.5 3.5 0.3 0.7 1.3 0.4 0.3 0.6 0.6 0.3 1.3 1.5 1.4 0.3 1.1 0.3 0.8 0.3 0.4 0.9 1.5 0.4 1.5 1.1 0.7 2.0 1.1 0.8 0.6 0.3 0.5 0.8 0.8 2.1 1.1 0.8 0.5 0.7 2.3 1.4 2.6 1.2 0.7 1.6 1.0 0.2 1.7 1.8 3.8 5.2 1.8 0.6 0.7 1.7 1.6 1.4 0.7 0.6 1.9 0.4 0.6 0.9 1.2 0.7 0.4 1.1 3.2 2.1 0.4 2.3 0.2 0.4 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.3 3.6 0.4 0.4 0.4 0.1 0.1 1.1 1.1 1.4 1.5 1.0 0.5 1.5 1.0 0.6 1.9 0.7 1.2 4.2 1.8 0.0 3.7 11.4 1.2 1.3 3.8 2.6 0.6 3.0 1.6 0.8 1.8 7.2 3.3 0.0 10.4 1.1 0.8 1.3 0.0 1.2 18.6 6.5 2.5 2.2 0.0 3.0 16.2 1.4 1.0 1.6 1.1 2.4 1.3 6.9 1.1 0.3 0.4 8.4 13.3 1.6 4.1 1.3 3.1 16.2 0.6 1.3 0.0 3.7 0.7 6.0 0.0 11.6 25.6 1.6 0.3 2.6 0.1 2.1 0.4 0.5 8.2 2.9 6.6 3.9 2.2 7.0 7.7 0.9 1.8 2.1 1.3 1.2 0.9 2.3 PARP10 "ARTD10, FLJ14464" ENSG00000178685 "Poly(ADP-ribose) polymerase family member 10" Q53GL7 8 143977153-144012772 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028122, HPA052427" Approved Supported "Nucleoli rim,Golgi apparatus,Cytosol" No No "Nucleoli rim" "Golgi apparatus, Cytosol" "HPA028122: AB_10601979, HPA052427: AB_2681828" "unprognostic (9.80e-3)" "unprognostic (5.89e-2)" "unprognostic (2.63e-3)" "unprognostic (9.10e-2)" "unprognostic (1.74e-2)" "unprognostic (1.46e-2)" "unprognostic (7.37e-2)" "unprognostic (3.61e-1)" "unprognostic (9.05e-2)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (4.69e-3)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (8.69e-2)" "unprognostic (5.30e-3)" 24.3 35.2 8.5 36.7 9.3 23.9 24.8 8.2 13.3 31.7 9.2 30.9 28.6 29.3 3.8 21.7 36.0 10.0 12.8 6.8 12.6 38.2 40.0 35.0 36.1 12.1 9.4 5.4 41.0 21.9 6.3 26.2 10.3 9.5 36.0 5.0 6.5 38.6 16.7 18.5 21.7 35.7 7.4 9.0 61.7 25.8 35.7 9.8 34.5 29.7 4.5 10.7 18.0 25.3 15.3 17.8 1.8 1.2 3.3 8.4 7.3 9.3 3.0 3.7 18.7 21.0 0.9 29.6 21.9 39.8 9.2 21.4 6.7 0.4 10.1 0.8 49.5 0.1 24.1 10.8 11.0 7.8 9.5 27.7 4.7 9.9 9.3 3.8 2.1 2.9 30.6 0.4 16.9 3.7 21.4 33.4 16.5 1.0 0.2 13.9 30.8 3.5 29.4 7.7 21.6 1.0 1.1 19.8 2.0 38.8 0.4 22.0 13.9 13.1 9.6 14.2 16.4 10.9 28.4 18.3 5.1 13.9 31.6 5.3 0.0 2.4 3.6 4.4 2.8 2.7 1.1 2.1 3.6 2.3 2.0 1.5 2.4 1.0 1.8 2.8 16.5 1.5 3.5 8.5 9.3 8.2 13.3 6.8 12.6 12.1 9.4 5.4 9.5 9.0 9.8 15.3 22.3 3.2 5.2 10.4 19.1 7.6 8.2 10.7 17.6 5.7 12.3 16.0 3.2 7.2 6.3 9.2 14.6 2.2 42.2 20.5 1.9 9.2 6.2 12.0 12.7 10.7 19.2 5.7 0.4 5.6 4.0 12.7 23.9 13.3 19.1 25.9 9.3 21.1 12.0 0.0 0.6 17.3 6.1 16.6 6.8 7.9 15.8 21.4 7.2 12.2 25.8 13.4 34.0 4.5 1.0 6.5 13.8 11.3 15.2 4.5 22.0 25.1 6.7 20.4 6.6 11.7 13.4 19.6 9.1 10.4 4.7 1.4 27.0 17.7 16.4 4.0 DYNAP "C18orf26, FLJ39106" ENSG00000178690 "Dynactin associated protein" Q8N1N2 18 54587757-54599493 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "esophagus: 29.6" "Cell type enriched" "Detected in single" 4 "Squamous epithelial cells: 1.7" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA011148 Uncertain NA NA "HPA011148: AB_1845609" "unprognostic (9.88e-2)" "unprognostic (2.51e-2)" "unprognostic (1.75e-3)" "unprognostic (1.45e-1)" "unprognostic (8.09e-3)" 0.8 0.4 1.7 0.6 1.4 2.2 0.6 2.3 2.6 0.4 0.0 0.6 0.6 1.0 2.1 29.6 0.5 0.7 1.0 1.6 1.0 0.9 0.8 0.5 1.1 0.9 0.4 0.7 0.8 0.5 0.3 0.0 0.4 1.2 0.3 0.7 2.6 2.0 0.5 0.9 1.1 0.5 0.8 0.1 2.4 0.4 1.0 1.0 0.3 0.5 0.4 1.9 0.3 0.2 2.5 0.5 0.2 1.3 0.6 0.6 1.4 1.3 0.3 0.5 1.0 1.0 0.7 0.5 0.7 0.5 0.6 1.1 0.5 0.9 0.0 0.5 0.2 0.2 0.2 0.9 0.4 0.5 0.7 0.6 0.6 0.1 0.9 0.3 0.3 0.2 0.6 1.0 12.9 0.1 0.2 0.5 0.4 2.0 0.2 0.3 0.5 1.5 0.6 0.3 0.7 0.5 0.7 0.2 0.3 2.4 0.9 0.4 0.8 2.2 0.4 2.4 0.5 0.4 0.5 0.4 1.0 0.6 0.3 0.3 0.3 0.3 0.6 0.2 0.3 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.1 0.8 0.2 0.8 0.2 0.0 0.0 1.7 1.4 2.3 2.6 1.6 1.0 0.9 0.4 0.7 1.2 0.1 1.0 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937007-32001038 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 12.5 11.9 7.0 18.9 7.0 45.8 15.2 12.0 8.6 11.7 7.3 15.0 16.1 15.4 12.1 14.2 11.1 12.1 10.4 6.2 7.2 16.6 18.2 12.7 33.2 6.2 6.9 5.5 11.5 11.6 20.0 6.7 18.9 7.3 13.4 16.6 26.8 10.6 12.3 8.1 13.1 15.4 14.8 6.4 18.6 15.4 27.6 7.0 38.8 18.4 11.1 30.2 15.7 9.1 7.9 46.5 40.4 37.2 42.9 21.1 26.8 38.2 44.2 38.8 53.0 63.7 30.9 25.5 100.7 33.2 27.7 45.4 40.1 56.0 25.5 85.7 35.8 54.0 69.9 32.9 22.3 24.8 111.5 68.7 18.7 28.1 53.1 40.4 32.1 33.1 47.3 68.8 135.6 46.2 16.2 133.3 64.4 21.3 32.4 24.4 78.5 95.3 81.9 31.1 44.6 47.5 37.1 71.3 22.7 43.3 25.8 66.0 91.5 24.7 41.9 38.0 50.8 69.3 73.5 98.4 122.5 30.7 67.4 38.7 0.6 0.7 1.6 1.4 1.1 1.1 2.4 1.6 1.6 0.6 1.8 1.5 2.1 1.6 1.8 0.7 1.9 1.8 0.4 7.0 7.0 12.0 8.6 6.2 7.2 6.2 6.9 5.5 7.3 6.4 7.0 7.9 44.5 41.7 45.8 43.1 50.1 58.5 50.2 21.8 31.9 77.6 54.2 36.8 32.3 27.1 32.6 35.0 108.4 61.5 65.2 24.0 17.6 28.3 16.2 52.8 55.8 45.1 29.4 93.6 71.6 21.9 53.1 35.1 31.1 54.2 15.8 41.4 38.2 42.3 32.9 62.2 69.5 31.8 10.2 42.1 58.2 13.9 26.8 47.3 24.9 45.0 73.1 45.7 38.1 75.4 71.3 27.8 15.4 25.6 66.2 62.8 21.5 26.6 29.6 80.9 13.1 47.2 38.4 121.7 128.9 48.6 71.7 69.5 52.5 52.8 35.6 66.7 NSUN3 FLJ22609 ENSG00000178694 "NOP2/Sun RNA methyltransferase 3" Q9H649 3 94062980-94131832 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036181 Uncertain NA NA "HPA036181: AB_10602715" "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.13e-1)" "unprognostic (7.35e-4)" "unprognostic (1.44e-1)" "unprognostic (9.50e-2)" "unprognostic (1.22e-1)" "unprognostic (8.63e-3)" "unprognostic (6.94e-3)" "unprognostic (6.47e-2)" "unprognostic (2.67e-1)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.33e-2)" 2.5 2.9 2.1 2.7 2.7 3.7 2.9 2.8 2.9 2.7 1.3 3.5 3.2 2.8 3.2 2.3 2.6 2.3 2.3 1.9 1.6 2.4 3.1 2.7 3.2 1.8 1.6 1.8 3.2 3.1 2.3 2.3 2.2 1.8 2.8 4.0 3.4 2.7 2.0 1.2 3.3 3.0 2.5 1.5 3.6 3.2 3.3 1.9 3.3 3.0 1.4 2.8 2.6 2.5 2.9 2.5 2.9 3.5 2.9 2.1 3.0 1.5 3.5 2.7 3.9 4.3 1.7 2.3 3.9 4.1 2.4 2.7 3.3 3.9 2.8 5.4 6.1 2.7 6.1 4.0 2.8 2.4 6.5 5.2 2.8 3.1 3.1 3.1 3.5 3.2 4.0 2.5 5.3 3.5 2.5 5.8 3.4 3.2 2.9 3.6 4.8 6.0 3.8 3.4 2.3 6.5 4.8 3.6 2.6 3.8 2.4 4.3 4.0 3.5 3.1 3.1 1.8 4.2 4.3 5.2 6.6 4.1 5.7 4.6 5.5 1.9 2.0 2.2 1.9 2.3 2.0 2.0 2.1 1.6 1.8 2.1 2.5 3.3 2.9 2.9 2.3 2.3 1.3 2.1 2.7 2.8 2.9 1.9 1.6 1.8 1.6 1.8 1.8 1.5 1.9 2.9 8.5 6.4 3.2 34.3 13.9 3.1 7.3 11.3 9.6 8.3 5.2 3.6 4.5 4.3 12.4 7.3 10.4 6.4 11.6 11.9 5.9 8.1 79.3 9.9 9.8 8.0 2.4 32.2 27.1 7.8 3.8 7.4 13.3 7.1 2.5 10.2 7.1 6.3 6.4 11.8 29.6 9.4 12.2 10.7 4.6 26.2 4.4 9.9 3.6 30.0 10.4 13.2 10.3 38.2 42.9 8.1 9.9 4.1 7.1 5.0 12.6 9.5 12.7 7.2 6.6 5.4 7.2 8.7 8.4 6.1 3.4 4.0 10.8 9.3 6.9 7.9 KCTD12 "C13orf2, KIAA1778, PFET1" ENSG00000178695 "Potassium channel tetramerization domain containing 12" Q96CX2 13 76880175-76886405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 281.2;Endothelial cells: 192.2;Enteroendocrine cells: 386.7;Hofbauer cells: 218.9;Kupffer cells: 395.9;Macrophages: 221.3;monocytes: 206.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 3.9;myeloid DC: 3.7" "Group enriched" "Detected in many" 17 "dendritic cells: 3.7;granulocytes: 1.0;monocytes: 3.9" "Cell line enhanced" "Detected in many" "ASC diff: 111.4;HUVEC TERT2: 229.0;TIME: 186.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056987, HPA077376" Supported Approved Mitochondria NA NA 21000000 Mitochondria "HPA056987: , HPA077376: " "unprognostic (6.42e-2)" "unprognostic (2.67e-1)" "unprognostic (5.13e-1)" "unprognostic (1.04e-3)" "unprognostic (5.82e-2)" "unprognostic (3.98e-2)" "unprognostic (2.02e-1)" "unprognostic (1.32e-3)" "unprognostic (1.35e-2)" "unprognostic (1.90e-1)" "unprognostic (9.83e-3)" "unprognostic (1.23e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" 76.8 28.1 21.0 56.2 21.7 12.1 52.8 28.6 24.9 44.8 23.2 39.9 22.7 51.8 17.9 38.7 75.6 55.5 22.0 27.5 35.2 31.3 14.0 58.5 39.7 31.9 30.9 14.0 47.5 12.6 25.4 6.4 84.6 31.2 14.8 42.9 3.4 20.2 18.6 16.7 23.1 28.4 65.9 37.1 65.3 28.2 27.1 41.8 18.5 16.5 37.5 33.6 39.5 17.5 35.1 1.7 1.5 15.3 0.0 111.4 52.5 4.3 6.9 1.5 4.2 5.5 0.5 0.3 0.0 3.8 18.8 4.9 53.9 6.6 66.4 3.5 1.5 35.1 0.2 38.3 0.0 4.7 18.6 0.1 21.4 21.5 2.7 48.9 8.5 229.0 13.2 0.3 0.2 53.9 1.4 8.5 0.3 7.8 16.6 7.7 0.4 7.4 19.6 17.7 0.2 4.3 7.9 17.3 0.5 2.2 18.5 1.0 12.1 186.0 2.7 4.9 0.4 14.0 2.7 0.5 0.0 42.5 4.0 16.1 0.0 3.9 0.7 0.0 2.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 1.0 0.0 1.5 1.9 0.0 0.9 21.0 21.7 28.6 24.9 27.5 35.2 31.9 30.9 14.0 31.2 37.1 41.8 35.1 281.2 25.6 8.4 2.9 7.5 40.0 2.7 11.9 28.5 4.4 11.2 27.3 21.8 4.3 16.3 97.5 14.6 3.0 30.4 19.7 17.6 6.5 3.6 4.9 44.6 192.2 386.7 6.1 4.8 0.6 90.6 80.0 12.2 3.3 7.0 53.1 61.1 2.5 218.9 0.0 11.5 71.5 12.2 395.9 75.4 11.8 157.2 221.3 51.6 45.9 206.7 4.8 7.2 0.5 0.9 0.5 15.7 44.8 7.6 4.5 0.7 7.5 72.8 1.5 26.3 153.2 32.2 1.9 7.0 16.9 34.4 4.2 5.5 24.0 46.6 1.9 DHFR2 "DHFRL1, DHFRP4, FLJ16119" ENSG00000178700 "Dihydrofolate reductase 2" Q86XF0 3 94047836-94063389 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Ductal cells: 6.3;Respiratory ciliated cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "hTERT-RPE1: 154.6" HPA051465 Uncertain Approved Mitochondria NA NA Mitochondria "HPA051465: AB_2681494" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-2)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (1.38e-1)" "unprognostic (5.92e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (4.62e-2)" "unprognostic (2.95e-1)" "unprognostic (1.52e-1)" "prognostic favorable (2.30e-6)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-2)" 3.3 5.0 4.7 3.9 5.8 1.8 5.3 6.2 5.3 5.3 5.5 4.2 4.2 7.9 6.4 3.5 6.3 5.2 3.8 4.5 4.8 6.0 6.7 4.5 5.7 5.3 5.1 4.6 10.2 5.3 6.5 2.5 3.2 5.5 6.5 4.6 3.3 4.4 4.9 1.4 4.2 4.9 5.5 4.4 5.0 4.7 4.7 4.6 5.7 6.7 2.1 4.7 3.3 2.4 7.0 3.8 6.5 4.2 4.4 5.7 7.2 1.7 5.7 6.0 2.8 3.2 1.4 5.7 2.5 3.8 3.0 3.7 5.0 3.3 3.9 4.4 8.5 1.8 3.1 2.9 3.4 6.0 2.2 3.6 7.6 5.1 3.3 4.2 154.6 2.9 11.9 1.6 5.6 3.7 4.5 10.8 1.2 3.7 10.8 6.7 2.7 5.7 4.1 4.1 1.9 5.4 5.3 8.3 2.2 9.6 3.3 5.6 3.1 4.8 4.4 7.4 1.8 2.2 4.1 4.4 3.5 4.4 5.5 6.2 2.2 1.1 2.0 1.8 1.7 3.3 1.8 2.4 2.9 0.7 2.2 3.2 3.0 1.7 1.4 1.8 2.1 3.2 1.3 4.7 5.8 6.2 5.3 4.5 4.8 5.3 5.1 4.6 5.5 4.4 4.6 7.0 2.8 12.8 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.6 3.4 0.0 0.0 1.8 3.7 0.0 2.4 2.3 0.0 3.9 6.3 0.0 3.5 4.4 2.5 0.0 0.0 0.0 5.5 1.7 2.5 0.0 2.9 2.5 4.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.6 8.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 1.3 3.5 0.0 0.0 RPP25 FLJ20374 ENSG00000178718 "Ribonuclease P and MRP subunit p25" Q9BUL9 15 74954418-74956772 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 95.1;Hofbauer cells: 77.0;Rod photoreceptor cells: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 25.8" "Group enriched" "Detected in many" 5 "dendritic cells: 25.8;monocytes: 10.1" "Cell line enhanced" "Detected in many" "HHSteC: 46.0;SCLC-21H: 42.9;SK-MEL-30: 67.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "olfactory bulb: 23.0" HPA046900 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA046900: AB_10962049" "unprognostic (9.36e-2)" "unprognostic (7.17e-3)" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (7.18e-2)" "unprognostic (5.73e-3)" "unprognostic (5.50e-3)" "unprognostic (7.78e-2)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.71e-3)" "unprognostic (5.50e-3)" "unprognostic (5.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.53e-1)" 5.8 13.4 9.2 2.7 8.7 0.4 4.6 14.9 9.1 6.0 6.9 8.0 7.3 3.7 1.8 7.0 4.4 4.5 4.6 5.8 11.6 4.1 3.1 5.8 4.0 16.4 12.1 6.1 15.5 7.6 23.2 5.2 7.3 17.3 4.2 4.9 12.9 4.7 1.7 1.4 4.9 5.7 2.6 11.6 10.9 7.1 3.0 11.7 2.5 9.0 1.5 3.4 7.7 5.4 19.3 23.6 17.5 4.4 0.1 1.5 0.9 7.4 4.3 5.2 1.3 1.2 24.1 21.0 0.0 19.4 4.4 1.2 6.9 13.7 0.8 0.3 8.9 0.7 0.1 19.9 0.5 46.0 0.0 13.3 5.9 0.6 8.5 0.0 0.9 20.4 5.5 16.1 0.0 4.6 9.1 3.8 6.3 20.8 40.9 7.0 0.1 0.0 15.8 4.2 0.4 42.9 32.1 32.6 28.8 67.4 2.2 5.7 18.7 4.6 0.0 1.4 3.8 0.2 0.4 0.1 0.1 2.3 36.6 25.1 0.0 5.2 0.0 2.3 10.1 1.3 3.4 1.5 1.8 5.1 3.7 3.8 3.0 0.4 0.5 7.7 25.8 0.7 2.5 9.2 8.7 14.9 9.1 5.8 11.6 16.4 12.1 6.1 17.3 11.6 11.7 19.3 5.3 3.2 1.1 0.3 4.9 11.0 7.5 9.1 11.4 95.1 11.8 9.9 1.6 14.3 6.4 9.2 4.2 2.3 17.0 24.4 13.7 13.7 0.3 1.6 4.7 8.9 10.2 0.8 0.7 19.3 4.3 23.9 14.8 3.6 0.0 3.4 31.8 1.6 77.0 21.9 10.0 12.5 14.2 14.8 8.6 2.6 39.4 9.3 14.2 1.0 16.1 13.4 4.1 0.0 6.3 13.8 20.5 30.1 8.2 19.1 27.5 16.6 1.3 72.3 13.1 4.3 10.4 1.4 6.5 18.2 11.5 2.3 2.1 26.6 20.7 10.5 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990056-143993415 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 432.6;monocytes: 355.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 264.9 220.1 132.1 110.0 124.9 217.0 238.4 121.5 228.2 174.3 75.4 129.2 72.8 139.0 80.4 135.3 150.3 75.1 142.9 136.1 124.5 200.4 450.7 236.0 78.3 136.5 133.3 111.4 154.0 98.0 145.5 128.7 86.9 127.9 177.5 33.5 182.3 117.6 183.3 146.6 165.9 139.2 75.8 116.1 313.8 105.5 271.5 142.9 59.0 188.9 57.9 55.6 163.4 140.4 125.2 79.3 155.9 76.4 129.5 392.6 196.9 114.5 112.5 258.9 184.4 168.7 95.5 64.3 57.9 120.2 249.7 128.6 69.8 136.8 162.3 75.5 83.1 95.9 60.2 85.9 114.5 412.0 12.7 90.7 254.2 441.0 132.7 193.3 194.5 90.1 23.9 56.1 76.8 160.7 489.5 34.7 32.6 53.4 75.8 231.2 45.4 39.9 111.4 93.2 229.1 52.3 84.8 163.5 177.9 225.8 104.1 342.2 77.6 91.8 115.4 127.1 158.0 82.1 124.3 78.3 44.6 147.4 79.0 67.6 1.8 32.0 9.7 2.5 36.4 3.5 8.3 2.5 2.9 13.3 7.1 4.5 4.1 18.6 3.3 36.1 22.9 2.3 16.0 132.1 124.9 121.5 228.2 136.1 124.5 136.5 133.3 111.4 127.9 116.1 142.9 125.2 54.5 19.2 52.7 35.3 45.4 37.2 32.5 58.7 121.3 91.1 62.7 79.4 23.2 45.8 27.9 53.3 79.2 137.2 22.6 29.1 23.5 75.0 273.8 36.8 56.1 47.7 42.1 60.0 21.3 69.1 55.8 67.7 16.8 36.1 16.4 76.2 51.4 194.5 178.4 33.7 26.6 24.3 42.7 225.1 86.7 432.6 61.5 184.3 37.4 22.5 355.1 89.9 6.2 12.5 9.3 66.0 54.5 67.7 44.4 46.7 72.9 73.6 29.4 95.8 46.0 32.4 45.6 96.0 16.9 83.2 36.9 264.2 20.8 38.7 31.4 25.5 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049672 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease variant, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 254.3;Endothelial cells: 200.6;Langerhans cells: 138.1;Leydig cells: 130.8;Macrophages: 130.9;Peritubular cells: 259.2;Squamous epithelial cells: 237.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 24.6" "Group enriched" "Detected in many" 7 "dendritic cells: 10.8;granulocytes: 24.6;monocytes: 9.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.3;CAPAN-2: 39.2;EFO-21: 33.5;HaCaT: 33.1;hTCEpi: 42.6;OE19: 29.8;THP-1: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol NA NA 5550000 1300000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 47.6 11.5 2.1 19.8 1.8 15.6 25.7 1.6 3.3 16.9 5.7 14.7 5.6 12.7 3.1 37.1 27.7 26.7 29.3 2.3 15.7 12.3 9.8 57.2 14.7 4.2 2.3 1.5 7.0 13.3 10.0 20.5 28.7 3.3 8.1 5.9 0.2 10.9 4.6 41.0 71.0 20.2 15.7 2.9 43.9 31.1 7.6 6.8 5.2 35.8 17.7 8.1 21.0 21.1 5.5 11.5 9.9 0.3 0.0 24.3 1.4 0.2 0.2 0.0 0.0 0.0 0.0 39.2 0.0 33.5 3.4 1.7 33.1 0.0 1.8 0.0 0.0 0.1 0.1 1.0 0.0 4.7 0.0 0.2 1.1 42.6 0.7 2.8 23.0 11.0 0.0 4.2 0.0 0.9 0.8 0.0 4.2 0.1 29.8 1.6 0.0 0.0 4.9 0.2 16.2 0.7 0.0 9.4 1.2 17.4 2.9 0.0 24.8 21.7 0.1 0.6 3.2 0.0 0.0 0.0 0.0 2.0 5.8 0.8 0.0 4.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 24.6 2.0 8.7 10.8 0.0 2.0 2.1 1.8 1.6 3.3 2.3 15.7 4.2 2.3 1.5 3.3 2.9 6.8 5.5 254.3 22.4 21.4 0.0 2.0 34.3 10.4 9.5 23.3 0.1 3.9 5.3 16.8 1.5 21.3 0.0 0.0 3.2 16.9 0.0 0.0 1.8 0.9 1.9 1.8 200.6 0.0 2.7 0.3 0.2 37.1 46.1 2.6 7.2 7.6 0.2 65.3 0.8 14.9 0.0 0.7 0.4 4.1 32.4 138.1 4.9 130.8 130.9 16.0 1.0 8.1 0.0 0.0 0.0 0.0 9.0 0.0 259.2 2.3 4.5 0.0 0.3 2.5 0.0 6.6 51.4 39.0 0.2 1.0 237.3 98.6 42.4 3.2 2.8 0.1 58.2 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Cell type enhanced" "Detected in single" "Paneth cells: 1.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HEL: 16.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA072646 Approved Cytosol NA NA 270000000 Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.1 0.0 0.2 0.6 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.3 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 COX5A ENSG00000178741 "Cytochrome c oxidase subunit 5A" P20674 15 74919791-74938083 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1385.7;skeletal muscle: 1624.9;tongue: 1751.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027526 Supported NA NA 530000 "HPA027526: AB_10602802" "unprognostic (7.32e-2)" "prognostic favorable (2.15e-4)" "unprognostic (4.06e-2)" "unprognostic (9.85e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (3.79e-2)" "unprognostic (9.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.77e-1)" "unprognostic (8.62e-2)" "prognostic favorable (6.06e-7)" "unprognostic (9.78e-2)" "unprognostic (2.22e-1)" "unprognostic (1.30e-1)" "unprognostic (3.81e-3)" 164.1 178.1 197.1 106.0 200.4 149.8 152.1 238.0 260.2 97.3 198.8 458.4 329.9 99.0 111.7 295.3 90.1 68.4 1385.7 197.7 228.2 347.1 352.5 134.1 126.7 224.2 214.7 188.6 71.6 261.5 388.7 142.2 88.7 218.4 119.4 402.0 195.8 212.9 100.1 1624.9 167.9 271.8 95.8 197.3 152.0 309.3 219.5 229.8 152.1 142.7 1751.2 199.6 142.5 147.5 229.2 300.4 309.1 376.8 331.1 227.2 260.2 443.1 262.7 222.3 317.7 294.8 346.0 352.1 700.0 322.0 219.5 387.8 567.7 898.3 368.4 263.7 401.0 906.2 566.6 299.7 436.0 283.9 642.7 335.0 266.6 389.9 198.3 445.1 217.4 377.7 450.0 522.2 429.9 321.2 222.4 558.8 494.6 408.7 575.8 540.1 499.0 369.7 778.4 469.8 472.4 570.5 250.1 396.6 569.2 871.3 407.6 286.3 507.6 274.3 241.4 238.7 303.9 421.1 508.4 1000.3 759.0 258.2 836.1 224.5 332.4 361.5 210.2 198.1 465.6 238.6 296.4 242.4 235.7 452.9 227.3 171.6 198.0 87.4 354.9 432.7 365.2 372.6 426.4 197.1 200.4 238.0 260.2 197.7 228.2 224.2 214.7 188.6 218.4 197.3 229.8 229.2 120.7 99.3 119.6 20.5 166.6 158.2 235.3 623.6 151.4 113.4 202.6 313.4 1645.3 221.6 324.0 171.0 39.6 502.8 162.7 987.6 1475.2 407.5 1046.3 199.4 124.3 163.8 461.4 227.3 18.9 436.7 528.2 156.3 247.2 192.8 104.0 143.3 117.8 471.8 571.5 92.5 25.1 890.5 496.4 286.0 209.1 819.6 100.3 238.6 250.8 17.8 413.7 159.9 162.7 15.6 20.2 412.1 817.3 85.7 350.7 319.3 1276.3 921.7 242.7 176.8 92.1 139.6 590.9 523.0 253.6 371.3 159.0 511.0 144.2 216.5 1045.6 393.3 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014365-94028597 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.5;intestine: 13.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0" "Not detected" "Not detected" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.1 0.0 0.5 1.7 0.4 0.0 5.4 0.4 0.6 2.8 3.0 13.1 7.7 0.8 16.5 6.1 1.4 1.8 0.1 0.3 1.0 0.2 0.1 4.0 0.0 0.5 0.5 0.2 0.1 6.8 4.6 0.1 0.1 0.2 3.9 13.5 1.2 8.9 0.1 0.1 9.2 8.2 0.3 0.3 0.4 7.4 0.2 0.1 0.2 0.1 0.0 1.3 0.2 2.9 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 4.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.3 1.0 0.5 0.5 0.2 0.2 0.3 0.1 0.4 0.4 16.0 15.9 1.0 0.2 1.7 2.2 6.4 2.8 3.0 5.6 3.7 0.1 0.0 9.9 0.0 12.5 0.2 0.1 39.4 1.9 4.4 1.9 15.9 2.1 0.2 0.0 0.0 3.9 8.2 0.0 0.1 10.2 19.7 0.0 0.1 0.0 0.0 0.2 0.0 2.4 31.7 10.2 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.5 0.0 1.0 1.6 7.1 38.0 0.7 0.0 1.5 19.2 0.1 16.1 14.8 0.0 1.0 0.5 0.2 0.1 2.7 1.8 0.3 0.3 0.0 15.7 1.6 ERFE "C1QTNF15, CTRP15, FAM132B, FLJ37034" ENSG00000178752 Erythroferrone Q4G0M1 2 238158970-238168900 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 15.1;testis: 12.9;thyroid gland: 25.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 6.3;Club cells: 2.5;Collecting duct cells: 1.8;Distal tubular cells: 3.9;Glandular and luminal cells: 1.8;granulocytes: 5.1;Respiratory ciliated cells: 2.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 20.3;RH-30: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 277000 "unprognostic (1.66e-1)" "unprognostic (9.14e-2)" "unprognostic (3.64e-4)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.84e-1)" "unprognostic (9.61e-4)" "unprognostic (4.68e-3)" "unprognostic (3.16e-3)" "unprognostic (9.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.31e-4)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (4.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.33e-2)" 0.6 0.1 3.0 2.2 4.1 4.1 0.4 4.2 6.8 0.7 2.3 0.4 0.6 0.4 0.0 0.4 0.5 0.3 0.9 3.8 2.9 3.6 0.5 0.9 0.1 2.4 2.7 3.2 0.1 0.4 0.0 0.1 1.3 2.9 0.7 0.2 0.0 0.3 0.4 15.1 0.1 0.9 0.5 2.5 0.8 0.5 12.9 2.7 0.1 25.1 0.6 0.1 2.4 0.3 3.0 3.1 0.8 1.4 3.0 0.2 4.9 0.3 2.0 3.2 4.9 8.7 0.2 7.7 0.0 5.4 0.5 10.0 0.3 13.7 0.7 4.5 0.0 15.2 0.0 0.3 0.2 1.8 0.1 1.1 10.5 1.5 20.3 14.3 0.6 0.1 6.5 4.6 0.0 13.6 3.8 0.0 8.9 2.1 0.9 1.5 17.3 25.6 0.8 10.7 0.1 0.4 7.7 3.1 0.5 9.7 2.5 0.4 15.5 1.0 8.2 7.1 3.2 10.7 0.0 0.0 1.1 12.2 4.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.1 4.2 6.8 3.8 2.9 2.4 2.7 3.2 2.9 2.5 2.7 3.0 0.2 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.5 1.8 0.0 0.2 0.7 0.0 3.9 0.1 0.0 1.2 0.2 0.5 0.0 0.0 0.0 0.0 0.2 1.2 0.0 1.8 5.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 FAM219B "C15orf17, FLJ00005" ENSG00000178761 "Family with sequence similarity 219 member B" Q5XKK7 15 74899992-74906883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048929, HPA058064" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA048929: AB_2680561, HPA058064: AB_2683592" "unprognostic (1.12e-1)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.08e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "unprognostic (2.41e-2)" "unprognostic (5.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.92e-1)" "unprognostic (3.17e-2)" "unprognostic (3.11e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (4.91e-3)" 22.1 20.0 31.9 10.0 31.2 6.5 13.8 32.9 35.7 15.5 31.4 16.1 12.1 17.0 22.7 23.8 22.5 10.7 30.6 32.1 36.0 16.2 6.7 17.1 15.3 33.3 32.8 30.2 19.7 13.1 32.6 28.3 13.4 34.4 24.2 14.7 45.1 18.3 17.2 18.9 22.2 14.0 17.9 32.5 24.4 15.4 6.3 33.6 8.6 18.4 25.3 17.6 20.2 16.2 31.9 6.6 9.6 25.9 11.4 42.9 31.6 11.6 18.7 9.8 16.7 10.5 9.1 18.0 12.9 10.4 13.0 16.8 16.8 35.9 10.3 9.1 32.5 20.4 12.3 22.9 7.7 20.3 11.9 16.2 19.2 47.3 7.3 13.7 36.0 18.7 9.6 9.6 15.4 17.1 5.5 7.1 10.4 14.3 19.4 14.4 19.0 9.0 9.7 25.7 21.1 21.7 14.1 20.9 11.6 33.7 27.1 23.3 14.0 21.7 13.5 7.3 11.4 15.2 11.6 12.1 5.5 17.1 24.2 13.8 3.8 1.0 6.9 1.4 0.9 2.4 2.2 2.1 1.2 1.0 2.0 0.9 1.5 1.2 1.8 1.3 0.1 0.2 1.3 31.9 31.2 32.9 35.7 32.1 36.0 33.3 32.8 30.2 34.4 32.5 33.6 31.9 13.3 19.2 20.6 22.5 18.4 6.4 21.2 17.9 13.6 41.6 16.2 13.5 5.1 10.0 18.9 27.6 58.4 17.1 22.3 23.3 13.7 14.4 1.0 22.9 14.8 16.0 20.9 7.6 23.9 10.5 11.4 17.4 9.7 13.9 24.7 15.0 17.2 5.8 17.9 23.5 20.8 16.0 28.5 13.3 8.5 4.7 23.3 13.0 14.2 13.1 19.8 26.7 30.9 11.1 9.4 17.5 16.2 28.6 15.7 19.9 23.3 11.9 30.6 69.2 26.3 15.8 15.2 9.1 17.5 18.2 7.7 8.3 16.0 15.0 14.0 22.6 ZHX2 KIAA0854 ENSG00000178764 "Zinc fingers and homeoboxes 2" Q9Y6X8 8 122781655-122974510 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 252.1;Microglial cells: 81.5;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 176.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 49.3;REH: 53.1;U-698: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006769, HPA006996" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006769: AB_10669919, HPA006996: AB_10670555" "unprognostic (8.28e-2)" "unprognostic (3.80e-3)" "unprognostic (6.48e-2)" "unprognostic (6.90e-2)" "unprognostic (8.19e-3)" "unprognostic (3.61e-2)" "unprognostic (2.03e-2)" "unprognostic (2.68e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (7.29e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-1)" "unprognostic (7.61e-3)" "unprognostic (3.04e-1)" 11.2 11.8 18.9 14.1 24.8 6.9 11.6 19.6 19.3 15.2 10.1 8.1 5.5 14.8 7.1 9.8 15.2 12.4 15.8 17.6 22.9 8.8 15.2 14.0 27.8 24.5 21.1 13.9 27.9 17.8 7.7 12.1 6.5 22.3 15.2 6.6 11.8 13.4 9.8 34.1 9.3 12.1 11.6 18.7 16.0 8.0 2.8 21.6 14.3 13.9 22.1 23.4 13.1 10.8 31.6 5.7 2.7 14.9 3.0 7.1 2.2 0.0 3.2 9.9 3.5 4.6 0.6 18.0 49.3 13.0 10.7 2.7 4.7 10.1 6.3 3.8 22.8 7.0 22.3 3.3 17.5 7.9 5.5 7.0 6.4 7.4 3.3 17.2 16.6 4.2 8.9 0.8 16.7 4.2 16.2 5.2 5.1 8.7 2.9 3.7 53.1 8.1 4.1 17.2 13.5 6.6 3.7 12.9 38.8 6.8 9.9 6.6 12.6 6.9 2.8 7.3 3.4 7.0 4.5 0.1 48.4 2.8 4.3 4.7 13.0 1.0 5.5 6.5 1.3 6.8 11.6 4.7 6.3 1.2 10.0 6.8 5.7 5.2 7.0 2.1 5.4 5.2 3.5 18.9 24.8 19.6 19.3 17.6 22.9 24.5 21.1 13.9 22.3 18.7 21.6 31.6 6.0 6.4 4.6 252.1 24.8 5.5 5.1 3.4 8.6 1.8 12.0 6.2 11.2 12.8 2.7 9.2 0.0 0.5 19.5 3.5 3.9 10.7 7.7 4.2 9.1 7.1 4.2 1.7 4.4 6.2 0.4 15.4 5.6 11.8 8.2 3.0 5.7 11.5 1.9 5.0 23.5 5.0 8.2 5.5 18.0 2.6 10.5 5.5 10.6 81.5 4.1 12.6 8.2 200.6 176.9 6.2 3.9 19.5 16.6 13.0 4.9 5.2 2.8 0.8 0.0 21.4 9.8 0.6 0.1 8.3 8.8 1.4 16.1 4.2 4.0 10.2 CPN2 ACBP ENSG00000178772 "Carboxypeptidase N subunit 2" P22792 3 194339768-194351328 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 220.4" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 171.8" "Cancer enriched" "Detected in some" 32 "liver cancer: 72.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "Hep G2: 61.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA004732 Uncertain "Secreted to blood" NA NA 25000000000 "HPA004732: AB_1078561" "unprognostic (4.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.42e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.27e-1)" "unprognostic (8.65e-2)" "unprognostic (8.56e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.91e-2)" "unprognostic (2.40e-1)" "unprognostic (6.90e-5)" "unprognostic (8.42e-2)" 0.4 3.1 0.5 0.4 0.6 1.5 0.2 0.6 1.0 0.2 0.0 0.2 0.0 0.4 0.4 0.1 0.2 0.4 1.0 0.8 0.4 14.8 220.4 0.2 0.3 0.3 0.2 0.5 0.3 0.1 0.1 0.0 0.4 0.4 0.2 0.2 1.1 0.2 0.1 0.1 0.6 0.2 0.2 0.0 1.2 0.4 0.7 0.4 0.1 0.3 0.0 0.2 0.1 0.0 1.2 0.2 0.1 0.3 0.3 0.1 0.8 0.2 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.3 0.8 0.4 0.5 0.1 0.0 0.2 0.1 0.2 0.3 0.6 61.8 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.3 0.5 0.6 0.0 0.3 0.2 0.3 0.3 0.1 0.1 0.1 0.5 0.0 0.1 0.4 0.3 0.2 0.3 0.2 0.4 0.3 0.2 1.4 1.6 0.2 2.1 0.2 0.1 0.2 0.2 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 1.0 0.8 0.4 0.3 0.2 0.5 0.4 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 171.8 0.2 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CPNE7 ENSG00000178773 "Copine 7" Q9UBL6 16 89575758-89597246 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;epididymis: 19.5;pituitary gland: 14.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.2;Collecting duct cells: 20.2;Excitatory neurons: 9.3;Inhibitory neurons: 9.1;Spermatogonia: 10.2;T-cells: 9.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 5 "T-cells: 4.9" "Cell line enhanced" "Detected in many" "HHSteC: 103.2;TIME: 58.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043359 Uncertain NA NA "HPA043359: AB_10794884" "unprognostic (6.77e-2)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-1)" "unprognostic (6.47e-2)" "unprognostic (5.88e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.87e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-1)" "prognostic favorable (7.22e-4)" 0.4 0.5 13.7 0.9 13.6 0.9 1.5 0.4 17.7 1.3 0.3 0.6 3.6 0.6 19.5 2.1 2.1 3.3 0.4 15.6 9.3 4.2 1.2 1.7 0.5 3.5 16.4 15.9 0.5 0.9 2.4 14.2 0.3 4.9 1.8 0.1 1.6 1.4 6.1 0.0 1.6 3.4 0.2 0.7 0.8 3.2 4.2 32.1 1.6 0.8 0.1 0.4 1.6 1.3 10.1 0.1 24.7 0.2 0.4 40.8 41.8 0.3 10.7 4.5 14.6 11.2 24.8 20.7 0.0 9.5 4.2 0.5 16.8 15.4 0.7 5.0 6.0 12.2 0.2 21.5 0.5 103.2 0.1 4.1 16.3 1.1 7.7 29.0 49.3 0.2 17.4 27.3 0.3 35.1 3.8 8.0 4.8 16.1 15.6 19.1 0.4 0.0 17.6 2.2 0.1 13.7 0.2 3.6 5.2 1.1 0.3 4.6 3.2 58.8 28.4 0.0 17.7 0.0 0.1 0.0 5.0 27.8 17.3 12.0 0.0 0.0 0.1 0.7 0.0 4.9 0.0 1.1 1.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.2 0.2 13.7 13.6 0.4 17.7 15.6 9.3 3.5 16.4 15.9 4.9 0.7 32.1 10.1 0.5 0.0 0.6 1.3 0.1 2.3 1.1 0.1 0.6 11.2 3.9 5.2 0.8 1.5 0.8 20.2 0.0 0.0 1.4 0.1 0.0 0.9 0.0 1.0 0.5 0.7 0.0 0.4 9.3 0.2 0.2 0.3 3.1 2.2 0.0 0.1 0.4 0.0 0.1 0.0 9.1 0.3 0.0 0.0 0.4 0.6 0.3 0.9 1.8 0.0 0.0 0.3 0.0 3.5 0.6 0.6 0.0 0.7 0.1 1.2 0.7 1.7 0.2 0.9 0.0 0.3 0.5 0.3 10.2 1.2 1.1 0.0 9.5 0.0 1.9 2.1 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "salivary gland: 183.4;skin 1: 104.2" "Group enriched" "Detected in some" 12 "Early spermatids: 320.9;Late spermatids: 189.9" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 54.2;PC-3: 90.8;SiHa: 20.2;U-2 OS: 58.2;U-251 MG: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058999, HPA079692" Supported Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" NA NA 54000 "Nuclear speckles" Mitochondria "HPA058999: , HPA079692: " "unprognostic (1.72e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.1 0.7 0.7 0.2 0.0 0.1 0.4 0.4 0.0 0.2 8.9 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 2.2 0.3 0.9 0.0 0.6 183.4 0.1 0.8 104.2 0.0 3.2 0.0 0.0 0.0 19.3 0.0 0.3 0.2 0.1 0.3 0.0 3.7 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 2.4 1.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.6 0.0 0.2 0.2 0.0 4.6 0.2 0.0 0.0 0.0 0.0 1.1 0.0 8.9 54.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.8 0.0 0.5 0.0 0.0 0.1 0.0 0.0 20.2 0.3 0.3 11.1 0.0 0.0 0.0 10.0 58.2 0.8 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.8 0.0 0.0 9.2 3.7 11.0 15.7 0.2 1.8 0.0 0.5 0.2 0.0 0.0 15.9 320.9 0.7 0.4 0.3 0.0 0.0 0.0 3.3 0.6 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 189.9 1.8 0.2 3.6 0.0 0.6 7.7 0.0 0.0 0.0 4.2 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 2.1 1.1 0.8 0.0 20.6 1.4 0.1 0.0 0.0 0.2 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531475 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.8;brain: 14.4;lymphoid tissue: 8.3" "Group enriched" "Detected in some" 4 "dendritic cells: 7.1;Hofbauer cells: 6.2;Kupffer cells: 8.7;Langerhans cells: 6.5;Macrophages: 16.6;monocytes: 13.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 4 "cerebral cortex: 14.4" "Immune cell enhanced" "Detected in many" "eosinophil: 75.9" "Group enriched" "Detected in many" 53 "dendritic cells: 25.0;granulocytes: 75.9;monocytes: 31.7" "Group enriched" "Detected in some" 6 "HL-60: 1.7;NB-4: 2.4;THP-1: 1.9;U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060449 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 1.5 0.4 0.1 8.3 0.2 7.8 0.7 0.1 14.4 0.4 1.1 0.7 0.7 0.3 0.0 0.3 0.3 2.1 0.2 0.1 0.7 0.2 0.8 1.7 0.9 0.4 0.2 0.0 0.1 0.9 0.1 0.2 0.9 3.2 0.4 0.9 0.0 0.3 0.1 0.3 0.1 1.6 1.8 0.2 3.8 0.6 0.3 1.0 0.6 0.2 0.1 0.9 2.6 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 1.1 0.0 1.5 31.7 75.9 0.1 13.6 0.3 0.0 0.0 0.0 25.0 0.0 0.0 0.2 33.3 0.8 1.9 15.6 0.0 11.8 0.1 0.2 0.1 14.4 0.1 0.7 0.4 0.2 0.0 3.2 0.2 1.0 1.1 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.6 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.4 0.2 6.2 0.0 0.0 0.0 0.0 8.7 6.5 0.2 0.0 16.6 0.0 0.0 13.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 GDPD4 GDE6 ENSG00000178795 "Glycerophosphodiester phosphodiesterase domain containing 4" Q6W3E5 11 77216558-77301687 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 1.5;testis: 3.7" "Group enriched" "Detected in some" 9 "Early spermatids: 10.9;Late spermatids: 18.0;Spermatocytes: 17.7;Spermatogonia: 5.3;Theca cells: 5.6" "Cancer enriched" "Detected in single" 10 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 23 "olfactory bulb: 2.3" NA NA "unprognostic (6.73e-6)" "unprognostic (3.30e-1)" "unprognostic (2.01e-2)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (3.55e-4)" "unprognostic (4.13e-2)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "unprognostic (2.63e-2)" "unprognostic (3.10e-2)" "unprognostic (4.75e-2)" "unprognostic (1.05e-4)" "unprognostic (1.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (1.64e-2)" 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.0 18.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 17.7 5.3 0.0 0.0 0.3 0.0 5.6 0.0 0.0 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 25.1;pituitary gland: 35.0;testis: 17.1" "Cell type enhanced" "Detected in many" "Early spermatids: 88.9;Endometrial ciliated cells: 133.2;Enteroendocrine cells: 46.2;Late spermatids: 57.1;Respiratory ciliated cells: 73.9;Spermatocytes: 30.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;SCLC-21H: 1.6;SH-SY5Y: 2.7" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favorable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.0 1.6 2.1 0.0 2.2 0.0 0.0 3.0 2.1 0.8 0.3 0.8 0.0 0.8 0.1 0.1 25.1 0.0 0.4 2.2 2.2 0.7 0.0 2.4 0.0 1.2 1.1 2.5 0.1 0.8 0.1 35.0 0.0 1.2 0.4 0.3 4.9 0.0 0.5 0.1 0.0 0.3 0.3 0.1 0.0 0.9 17.1 1.4 0.0 0.0 0.0 0.0 0.3 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 2.7 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.2 3.0 2.1 2.2 2.2 1.2 1.1 2.5 1.2 0.1 1.4 1.1 0.0 19.2 1.5 0.0 0.0 0.0 0.0 1.0 0.0 8.5 1.1 0.4 15.7 0.0 9.3 5.5 16.7 0.0 0.0 0.1 3.9 3.8 88.9 133.2 0.8 0.4 46.2 0.0 1.8 0.9 0.0 1.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.1 3.2 0.0 0.0 0.0 57.1 0.6 0.2 3.6 0.0 0.0 0.8 0.0 1.0 0.2 0.4 0.1 1.5 0.0 0.1 0.1 3.0 73.9 3.0 0.0 0.5 1.8 30.1 8.9 0.0 0.0 0.0 0.2 0.1 0.8 0.0 MPI ENSG00000178802 "Mannose phosphate isomerase" P34949 15 74890005-74902219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007200 Approved Approved "Plasma membrane,Cytosol" NA NA 350000 Cytosol "Plasma membrane" "HPA007200: AB_1854079" "unprognostic (1.38e-1)" "unprognostic (7.18e-2)" "unprognostic (1.63e-1)" "unprognostic (1.65e-3)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (1.79e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (3.34e-2)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.09e-1)" "unprognostic (6.58e-2)" 18.1 51.0 47.4 16.8 46.7 11.8 20.3 51.7 49.6 23.7 39.8 32.1 46.0 23.8 35.6 28.0 28.0 16.2 41.7 46.5 46.7 31.5 39.5 15.1 21.1 53.7 49.8 45.9 30.9 32.0 31.3 23.1 16.3 56.3 27.7 31.7 33.9 23.9 23.1 52.7 16.6 33.3 22.7 45.5 23.2 21.1 26.4 51.1 23.4 23.4 71.6 24.4 24.4 19.7 51.5 27.2 36.9 29.8 34.0 66.7 32.2 26.0 22.8 37.2 38.4 53.4 36.7 35.0 38.3 48.6 33.6 30.6 65.9 60.0 66.7 36.2 29.4 74.9 68.8 35.3 39.9 47.5 32.0 19.4 43.1 16.9 36.2 64.4 58.1 52.9 45.2 23.4 30.7 50.1 23.2 34.6 14.2 16.4 40.9 31.0 35.0 28.0 94.9 45.5 30.4 55.7 24.4 26.7 47.5 28.7 43.5 65.3 21.9 24.1 22.9 19.4 17.3 22.6 75.0 48.4 25.1 47.9 45.8 17.1 2.3 16.2 5.7 28.2 17.0 37.0 27.4 38.3 32.6 23.0 31.9 56.0 40.8 2.7 43.1 15.5 19.1 53.1 29.0 47.4 46.7 51.7 49.6 46.5 46.7 53.7 49.8 45.9 56.3 45.5 51.1 51.5 5.6 6.4 15.0 7.8 10.8 1.9 7.6 16.4 5.2 23.4 9.2 10.7 54.1 7.2 10.9 14.7 4.2 31.8 9.1 28.3 15.6 19.6 18.9 5.6 9.2 9.6 10.8 4.2 4.9 8.8 11.4 10.9 6.1 8.5 15.2 13.3 6.1 18.8 23.9 35.3 6.1 19.0 8.2 7.2 2.2 31.3 11.1 6.6 3.6 3.7 9.7 20.7 12.3 2.0 6.9 12.2 33.2 8.6 11.8 7.2 70.1 31.4 7.8 16.7 6.6 8.2 10.1 34.5 9.0 9.1 2.7 16.3 11.1 21.0 16.4 6.2 H1-8 H1FOO ENSG00000178804 "H1.8 linker histone" Q8IZA3 3 129543214-129551467 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037992 Enhanced NA NA "HPA037992: AB_10671517" "unprognostic (5.43e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 21.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 41.9;Horizontal cells: 32.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 6.0;Hep G2: 10.5" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 2.6 3.8 1.0 1.3 1.5 2.5 3.5 4.1 2.1 4.2 0.5 2.1 3.6 2.9 0.5 1.4 6.5 1.1 1.8 0.9 1.0 4.1 5.7 1.9 2.3 1.1 0.9 1.0 4.4 6.1 1.3 3.6 0.4 2.1 4.5 0.2 0.9 2.1 1.6 2.6 2.4 3.3 0.2 0.8 3.2 21.8 11.4 1.1 1.1 4.6 0.4 0.4 2.2 3.1 1.6 1.0 3.2 1.3 1.9 0.0 0.6 0.5 0.4 0.1 0.0 0.7 0.0 1.5 1.8 0.3 0.2 0.2 1.1 0.3 0.0 0.1 4.1 6.0 1.1 2.8 10.5 0.6 0.6 4.2 1.7 0.0 0.2 0.3 0.9 0.0 2.5 0.6 4.9 0.0 0.7 1.7 2.1 0.1 0.3 1.0 2.8 0.2 0.9 0.3 0.0 1.6 1.2 2.0 0.7 1.9 0.5 0.5 1.9 1.2 0.9 1.4 1.3 0.8 2.3 1.4 1.8 1.2 2.6 1.1 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.3 0.3 0.0 0.2 0.3 0.2 1.0 1.5 4.1 2.1 0.9 1.0 1.1 0.9 1.0 2.1 0.8 1.1 1.6 3.8 0.0 0.5 0.0 15.5 0.9 3.2 3.1 4.6 21.9 5.1 4.2 2.5 1.5 3.3 5.5 18.8 2.1 8.7 1.6 5.9 1.8 5.9 9.2 13.4 2.8 4.9 3.4 0.1 4.7 0.7 4.7 16.8 5.6 0.0 41.9 2.9 3.0 3.0 32.0 0.1 3.2 4.1 2.4 1.2 11.4 6.5 3.1 1.8 0.0 2.5 5.8 9.2 0.0 0.1 2.9 4.0 3.8 11.2 3.3 10.0 4.7 5.4 14.5 0.0 14.6 4.1 9.1 2.5 3.3 2.0 1.1 6.8 14.2 3.4 2.6 OPLAH "5-Opase, OPLA" ENSG00000178814 "5-oxoprolinase, ATP-hydrolysing" O14841 8 144051266-144063965 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 67.1" "Group enriched" "Detected in many" 4 "Early spermatids: 115.7;Late spermatids: 231.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.1;neutrophil: 1.1" "Group enriched" "Detected in many" 9 "granulocytes: 1.1;monocytes: 1.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;BEWO: 21.0;Hep G2: 18.8;PC-3: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026562, HPA028260, HPA052429" Uncertain Approved "Nucleoli fibrillar center" NA NA 34000 "Nucleoli fibrillar center" "HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830" "unprognostic (7.89e-2)" "unprognostic (3.08e-2)" "unprognostic (1.69e-1)" "unprognostic (9.09e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-3)" "unprognostic (2.04e-2)" "unprognostic (9.37e-2)" "unprognostic (2.90e-1)" "unprognostic (1.26e-1)" "unprognostic (6.82e-2)" "unprognostic (3.62e-1)" "prognostic favorable (1.53e-6)" "unprognostic (4.03e-3)" "unprognostic (4.33e-1)" "unprognostic (3.54e-2)" "unprognostic (8.24e-2)" 8.0 14.9 2.8 1.9 4.2 2.7 8.6 7.5 3.7 5.1 4.2 12.1 14.0 4.8 0.6 15.7 4.2 2.5 35.4 2.0 2.7 15.9 34.6 6.5 0.8 9.8 5.0 0.2 5.7 10.1 6.7 3.2 1.3 9.9 8.9 2.2 0.3 11.3 5.8 34.5 11.8 12.3 1.2 3.1 9.2 19.9 67.1 4.8 0.3 5.9 15.5 0.5 4.9 9.6 5.7 4.2 4.2 0.4 33.9 1.5 3.1 21.0 2.1 1.3 1.2 0.7 8.1 7.8 0.0 6.8 3.8 0.0 5.5 1.0 3.1 0.1 1.1 0.0 1.4 7.0 18.8 10.5 0.1 0.0 4.4 13.8 1.4 0.0 0.0 0.2 5.8 5.1 0.0 0.0 4.8 0.3 3.3 2.8 6.5 26.2 0.4 0.0 5.6 3.6 5.1 1.2 0.1 0.0 1.4 0.1 0.4 8.8 4.6 0.2 0.0 5.5 0.0 1.4 1.1 1.5 1.1 0.5 1.1 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.4 2.8 4.2 7.5 3.7 2.0 2.7 9.8 5.0 0.2 9.9 3.1 4.8 5.7 1.1 3.2 3.2 9.1 0.8 2.0 2.8 4.4 3.4 1.1 6.1 6.1 2.9 7.2 4.7 9.2 0.0 1.7 0.2 37.6 11.7 3.8 115.7 2.6 2.7 1.1 1.2 0.0 0.2 2.7 2.7 2.7 18.3 5.5 0.0 6.0 2.2 25.1 2.4 0.0 0.3 10.0 4.1 6.0 0.5 231.7 2.5 3.4 0.0 1.0 2.1 4.3 0.0 0.5 2.6 3.6 13.1 3.8 0.6 1.9 23.8 13.3 2.2 0.1 0.0 3.6 2.2 3.1 2.3 7.2 1.8 2.5 0.6 10.2 18.2 3.0 TMEM52 ENSG00000178821 "Transmembrane protein 52" Q8NDY8 1 1917590-1919279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "pancreas: 218.0;skeletal muscle: 301.7;tongue: 209.6" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 22.3;Hepatocytes: 25.9;Spermatocytes: 34.6;Spermatogonia: 39.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 20.5;OE19: 18.2;RPMI-8226: 37.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA079372 Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079372: " "unprognostic (4.39e-2)" "unprognostic (2.60e-1)" "unprognostic (3.76e-2)" "unprognostic (7.35e-3)" "unprognostic (1.04e-5)" "unprognostic (1.46e-1)" "unprognostic (6.71e-3)" "unprognostic (3.68e-2)" "unprognostic (9.49e-2)" "unprognostic (1.69e-1)" "unprognostic (3.83e-3)" "unprognostic (5.80e-2)" "unprognostic (8.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" 1.8 53.0 1.9 0.2 1.8 0.5 2.1 1.9 3.7 1.0 2.4 2.3 3.6 0.7 0.4 7.0 3.4 0.4 1.2 1.6 1.5 2.4 13.6 1.9 0.4 1.6 1.7 1.8 2.2 218.0 3.1 1.8 0.2 1.9 1.8 1.3 0.2 19.9 0.4 301.7 3.4 2.4 0.3 1.3 2.8 6.9 29.4 1.5 0.4 0.8 209.6 0.3 0.6 2.1 1.4 3.4 0.3 0.9 1.8 0.3 0.1 7.5 0.5 0.2 2.2 1.3 5.6 2.3 0.8 2.2 3.5 0.8 1.1 5.5 1.5 0.4 0.4 4.0 0.0 0.9 20.5 1.1 0.0 1.3 0.1 3.1 0.7 0.3 0.1 0.1 3.9 5.1 1.9 0.0 6.4 0.5 1.5 2.9 18.2 10.6 1.5 0.0 37.1 1.2 0.2 3.7 2.6 0.0 3.1 0.4 1.3 2.1 0.4 0.0 0.0 1.4 1.0 0.0 2.4 0.8 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 1.8 1.9 3.7 1.6 1.5 1.6 1.7 1.8 1.9 1.3 1.5 1.4 0.4 0.0 0.0 0.0 1.2 4.5 2.9 1.2 2.8 0.4 3.9 5.2 0.8 8.6 2.4 0.0 0.0 1.9 0.8 6.8 1.9 1.8 3.9 3.8 0.3 0.8 0.0 0.4 0.6 22.3 7.0 1.6 5.1 0.8 0.0 5.1 0.7 25.9 0.6 0.0 0.5 11.1 8.2 0.8 2.2 5.8 14.9 0.7 8.8 0.0 0.6 1.8 0.0 0.0 0.1 6.7 2.5 9.8 4.3 14.2 15.4 11.5 8.7 1.0 0.0 15.4 1.6 34.6 39.4 2.5 2.8 3.7 1.2 15.5 7.1 3.1 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.1;kidney: 32.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.1 2.7 3.5 2.2 5.2 0.0 3.2 5.8 3.9 9.0 2.1 5.8 34.1 1.2 1.3 0.4 6.8 7.2 2.4 1.1 3.8 32.5 9.3 5.2 0.3 8.7 6.5 0.3 0.4 8.7 6.8 1.8 5.2 7.7 0.9 4.5 0.8 4.8 3.2 0.1 1.2 19.5 0.4 7.6 0.9 2.5 3.9 5.3 0.0 7.2 0.0 0.1 1.8 0.3 13.6 22.4 1.6 0.3 0.1 0.0 0.0 14.3 0.2 0.0 0.0 0.0 5.2 40.8 0.3 27.9 0.0 1.8 18.5 0.0 9.3 0.0 0.3 0.0 0.0 2.4 3.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.9 0.0 1.3 0.0 0.5 0.0 1.5 1.6 1.0 0.0 0.5 1.6 0.4 0.3 0.0 70.5 5.6 0.4 0.1 1.1 25.0 0.2 0.5 68.5 0.0 0.0 0.3 0.7 0.0 0.1 0.0 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.8 0.0 0.6 0.1 3.5 5.2 5.8 3.9 1.1 3.8 8.7 6.5 0.3 7.7 7.6 5.3 13.6 0.6 16.0 5.9 0.7 0.2 0.1 2.1 2.8 0.0 0.2 8.2 15.5 2.3 27.1 5.4 51.5 0.0 30.5 0.2 28.9 35.2 49.0 14.8 16.2 1.6 0.7 3.6 0.0 0.0 4.7 5.2 0.4 3.1 17.9 0.0 2.2 1.4 16.2 1.9 0.0 0.2 6.7 0.0 0.6 0.3 13.6 0.0 0.7 5.4 0.0 1.1 7.7 0.0 0.0 5.2 30.6 23.3 0.0 0.0 1.2 90.7 89.1 3.8 0.1 0.0 0.0 0.9 0.1 0.2 0.6 0.0 6.4 0.8 0.7 12.9 1.4 RNF186 FLJ20225 ENSG00000178828 "Ring finger protein 186" Q9NXI6 1 19814029-19815283 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 67.8;intestine: 132.3;pancreas: 43.8" "Group enriched" "Detected in some" 5 "Distal enterocytes: 41.6;Enteroendocrine cells: 86.6;Intestinal goblet cells: 46.6;Paneth cells: 123.4;Proximal tubular cells: 142.7;Undifferentiated cells: 110.3" "Group enriched" "Detected in many" 4 "colorectal cancer: 18.5;renal cancer: 12.1;stomach cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034547, HPA035558" Enhanced NA NA "HPA034547: AB_10670975, HPA035558: AB_2674678" "unprognostic (1.66e-2)" "unprognostic (2.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.93e-3)" "unprognostic (1.77e-3)" "unprognostic (3.23e-1)" "unprognostic (3.05e-1)" "unprognostic (3.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (1.40e-1)" "unprognostic (8.60e-3)" 0.3 0.0 0.0 5.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 18.8 132.3 0.1 67.8 0.0 0.0 0.4 0.0 0.0 0.0 26.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 43.8 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.3 0.4 0.0 0.0 45.2 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 5.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 41.6 5.9 9.6 0.0 0.8 0.1 0.1 86.6 0.0 0.0 18.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 123.4 0.0 0.0 0.1 16.1 142.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 110.3 0.2 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 20.6" "Group enriched" "Detected in many" 4 "Early spermatids: 169.8;Late spermatids: 185.7;Spermatocytes: 64.1" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 3.2 2.6 1.7 3.2 1.8 3.9 4.2 3.4 3.7 3.4 2.1 2.7 4.8 6.1 4.1 1.6 3.5 3.0 2.1 0.8 2.9 5.4 3.5 3.1 4.6 2.7 1.8 0.2 3.9 1.8 3.2 2.6 3.6 2.8 2.8 3.4 4.0 2.3 2.0 0.8 2.2 3.4 2.5 1.9 4.4 3.6 20.6 2.2 1.8 14.3 0.4 3.3 2.7 2.4 7.2 0.9 3.7 1.5 0.2 1.8 6.4 2.8 2.1 0.4 0.6 1.0 1.7 5.2 0.3 5.8 0.7 0.0 1.0 0.0 0.4 3.5 0.1 0.5 4.9 3.4 0.5 1.8 3.8 0.5 1.2 1.7 2.4 0.0 4.4 4.1 3.8 1.5 9.0 2.2 0.1 1.7 2.1 0.8 2.6 2.9 4.5 1.1 1.8 8.3 3.0 1.1 0.5 1.1 0.1 2.5 1.1 6.0 4.5 1.5 0.2 1.1 0.3 1.0 9.4 6.9 0.9 5.5 7.3 3.8 2.8 1.0 0.3 0.5 0.6 0.4 2.2 0.4 0.3 0.5 2.6 1.2 0.7 0.0 0.5 0.4 0.3 0.1 0.3 1.7 1.8 3.4 3.7 0.8 2.9 2.7 1.8 0.2 2.8 1.9 2.2 7.2 5.3 9.6 2.2 7.2 7.9 0.8 1.8 0.9 0.6 2.5 2.3 2.4 6.2 1.5 1.3 0.0 0.0 0.3 1.3 0.4 0.0 1.0 169.8 1.9 2.5 6.0 3.0 1.3 8.0 0.9 0.1 4.1 2.6 5.4 6.3 1.3 4.6 0.5 1.9 3.3 10.1 0.4 2.0 2.9 2.0 185.7 1.8 2.6 0.0 32.8 2.7 1.0 0.0 13.0 19.5 1.1 0.3 3.8 1.4 1.1 1.2 1.6 3.3 2.9 0.0 3.2 4.0 64.1 24.5 0.0 0.6 0.0 2.3 1.2 0.7 1.3 MSC "ABF-1, bHLHa22" ENSG00000178860 Musculin O60682 8 71841560-71844412 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 40.9;Fibroblasts: 31.4;Leydig cells: 42.6;Melanocytes: 26.6;monocytes: 50.7;Pancreatic endocrine cells: 27.5;Peritubular cells: 41.3;Sertoli cells: 26.3;Skeletal myocytes: 70.0;Smooth muscle cells: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory CD8 T-cell: 25.8" "Group enriched" "Detected in many" 37 "B-cells: 6.9;dendritic cells: 6.4;T-cells: 25.8" "Cell line enriched" "Detected in many" 15 "HDLM-2: 819.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "cerebral cortex: 16.3;hippocampal formation: 13.2" HPA062878 Supported Nucleoplasm NA NA Nucleoplasm "HPA062878: AB_2684891" "unprognostic (2.58e-2)" "unprognostic (1.62e-1)" "unprognostic (1.86e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (3.70e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (3.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.75e-2)" "unprognostic (3.73e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.07e-13)" "unprognostic (1.65e-2)" "unprognostic (1.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.40e-2)" 11.7 9.0 2.3 11.5 1.0 3.9 7.0 0.2 4.4 6.2 1.0 2.3 2.2 4.8 0.9 3.1 4.2 11.2 16.6 5.1 0.7 6.2 3.6 9.6 12.2 2.5 0.7 1.0 5.2 5.2 0.3 3.3 16.4 1.5 5.6 1.1 0.0 4.4 3.1 3.1 3.5 5.4 2.3 0.4 6.4 5.5 3.0 0.6 1.7 4.5 2.4 3.5 20.7 6.5 2.2 0.1 6.2 0.0 0.0 28.1 4.9 0.0 1.2 23.8 0.5 1.3 0.0 0.0 0.0 0.3 4.8 28.5 1.3 0.0 1.5 0.0 819.3 0.3 0.0 0.0 0.0 49.8 0.0 2.8 11.1 0.0 49.2 30.1 11.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 6.7 0.0 0.0 0.0 55.3 0.0 0.0 0.0 2.4 0.0 0.1 0.0 44.9 0.5 0.0 5.5 0.0 0.2 0.1 7.8 0.3 5.0 0.2 0.1 20.4 0.1 34.5 0.0 0.1 0.0 5.2 0.1 7.2 6.9 9.2 25.8 0.1 6.2 0.2 8.7 0.2 0.0 0.3 6.4 13.0 3.2 2.3 1.0 0.2 4.4 5.1 0.7 2.5 0.7 1.0 1.5 0.4 0.6 2.2 1.2 0.0 0.0 0.0 2.7 5.1 0.2 0.4 0.0 0.0 0.2 0.3 1.9 0.0 0.0 1.8 0.0 0.1 4.3 0.0 0.0 16.1 0.6 0.3 1.0 4.5 0.0 0.0 1.1 40.9 0.1 31.4 1.5 0.1 0.0 0.0 3.9 0.0 1.8 0.0 0.1 0.0 0.0 0.3 8.9 1.5 42.6 5.8 26.6 0.0 50.7 0.0 0.0 0.0 0.2 27.5 0.0 41.3 7.0 0.7 0.0 1.2 0.0 0.0 26.3 70.0 27.8 0.4 0.3 0.3 3.3 0.0 10.0 8.1 0.0 0.3 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 125.6" "Cell type enriched" "Detected in many" 4 "Adipocytes: 781.6" "Cancer enhanced" "Detected in all" "renal cancer: 24.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 36.7;HDLM-2: 19.3;hTERT-RPE1: 15.1" "Group enriched" "Detected in all" 4 "basal ganglia: 5.7;olfactory bulb: 20.1" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 125.6 15.8 42.2 15.5 31.1 0.3 91.4 32.4 38.8 44.2 25.3 11.7 3.9 15.9 2.4 35.6 30.7 34.7 42.5 29.4 33.1 13.1 17.8 17.2 5.7 40.2 37.7 25.3 7.0 24.3 28.2 10.6 87.3 40.8 12.9 12.1 5.8 10.4 5.7 34.6 15.3 10.8 52.9 32.5 6.1 12.2 3.0 39.9 10.7 65.4 29.0 3.3 28.5 18.3 37.5 6.4 0.2 36.7 1.2 1.1 2.1 0.3 6.0 9.9 6.0 8.7 2.4 6.5 2.0 0.5 2.3 2.1 2.0 1.4 0.3 10.1 19.3 1.4 0.5 2.0 0.0 2.2 1.0 0.6 1.4 1.7 2.1 4.7 15.1 4.6 3.5 0.5 2.5 3.1 1.3 1.0 1.1 0.2 1.5 1.1 2.9 0.8 0.9 0.7 0.6 3.1 3.4 5.7 0.5 13.6 0.6 0.2 3.1 5.6 1.3 2.0 8.1 5.5 1.8 0.9 1.4 2.0 4.0 6.9 2.2 0.3 0.2 0.3 0.1 0.4 1.0 0.7 0.5 0.2 0.8 0.5 0.3 1.6 0.3 0.2 0.6 1.1 0.1 42.2 31.1 32.4 38.8 29.4 33.1 40.2 37.7 25.3 40.8 32.5 39.9 37.5 781.6 6.4 5.3 17.3 15.9 18.1 2.5 1.4 6.8 4.4 5.4 5.8 11.9 4.3 5.9 0.0 4.2 2.9 13.3 5.3 0.0 1.1 2.9 0.7 7.2 169.4 3.6 18.9 5.3 0.4 1.4 25.0 1.1 1.3 7.6 5.8 62.4 3.8 6.6 3.3 7.0 6.3 2.0 14.2 27.1 2.1 4.4 6.6 28.4 32.8 5.9 39.6 29.9 5.0 28.5 1.2 0.6 0.4 5.7 2.9 2.3 0.5 5.4 4.8 111.7 17.5 193.5 5.5 1.0 2.3 15.5 1.0 18.3 1.1 9.3 3.7 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "stomach 1: 95.5" "Cell type enriched" "Detected in some" 22 "Pancreatic endocrine cells: 113.9" "Cancer enhanced" "Detected in many" "stomach cancer: 19.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA058911: AB_2683853, HPA078021: AB_2732368" "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 1.8 1.1 4.0 2.3 3.7 0.0 1.8 5.2 5.4 9.4 6.0 15.4 14.1 1.7 0.4 0.6 3.0 0.6 0.4 3.1 5.2 1.4 0.1 1.2 0.2 15.6 6.6 2.2 2.9 0.3 0.3 2.1 0.6 19.1 4.3 10.5 0.3 2.3 0.3 5.5 1.3 15.3 0.5 3.3 0.1 95.5 0.2 4.0 0.2 0.1 3.2 0.1 0.5 1.3 11.9 0.0 0.0 2.7 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.4 1.8 1.3 0.0 0.1 4.9 0.2 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.8 0.0 13.8 0.1 0.8 19.8 2.1 0.0 0.0 34.8 0.0 0.1 0.0 2.9 37.0 0.0 0.0 11.1 0.2 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.7 5.2 5.4 3.1 5.2 15.6 6.6 2.2 19.1 3.3 4.0 11.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 0.0 0.1 0.5 0.1 0.0 0.0 0.0 2.6 0.1 0.6 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078648-144080648 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 95.7" "Group enriched" "Detected in many" 4 "Early spermatids: 320.6;Late spermatids: 856.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 430.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024792, HPA065103" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA024792: AB_1848325, HPA065103: " "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favorable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 16.4 31.5 13.8 11.5 14.1 15.0 17.1 13.9 23.6 13.2 13.0 18.7 15.5 17.1 5.1 27.8 16.2 7.2 22.8 13.5 14.6 22.6 35.3 16.2 12.2 14.7 12.4 12.9 12.4 18.9 10.3 17.8 9.3 13.6 18.9 5.8 3.5 26.8 12.6 21.4 21.8 15.3 6.2 13.4 23.9 24.2 95.7 13.8 10.2 14.1 8.3 6.7 17.6 15.3 14.0 51.8 104.8 18.1 44.2 15.6 11.7 51.8 39.9 15.2 28.9 28.9 73.4 33.4 28.9 54.6 15.5 21.0 40.4 33.8 40.5 8.3 42.5 117.8 42.7 77.9 83.3 25.9 31.4 48.6 16.9 40.9 33.2 26.2 11.4 14.8 32.0 68.8 19.8 23.8 177.8 51.4 62.0 47.6 51.2 430.6 21.7 30.2 74.8 27.7 48.3 57.6 75.4 46.6 59.7 95.4 9.3 68.1 49.0 15.2 29.9 66.3 73.6 68.1 52.4 67.8 37.5 43.1 50.8 47.7 61.5 78.3 34.1 37.4 76.6 38.7 59.7 29.3 37.4 75.0 60.2 37.7 36.2 22.9 45.6 43.0 97.4 36.1 49.5 13.8 14.1 13.9 23.6 13.5 14.6 14.7 12.4 12.9 13.6 13.4 13.8 14.0 16.3 9.6 21.3 2.9 17.8 94.4 45.2 58.6 45.5 10.0 40.7 41.4 22.3 24.3 31.9 27.6 8.4 48.2 17.2 46.6 123.3 50.6 320.6 23.8 28.3 25.5 25.9 24.6 3.2 46.3 44.2 24.7 25.0 18.8 14.0 21.0 19.2 54.9 44.7 6.7 3.3 35.6 48.8 29.8 40.7 856.7 18.6 29.9 35.6 0.0 45.7 23.5 14.4 3.0 3.6 61.7 52.4 21.1 32.5 55.5 41.0 102.5 31.7 8.2 13.1 14.7 43.5 97.0 34.7 48.1 87.9 48.2 12.8 37.8 47.1 48.7 DPY19L3 ENSG00000178904 "Dpy-19 like C-mannosyltransferase 3" Q6ZPD9 19 32405543-32485895 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Horizontal cells: 79.1;Oligodendrocyte precursor cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008325 Approved Approved Microtubules NA NA Microtubules "HPA008325: AB_1847853" "unprognostic (9.58e-3)" "unprognostic (3.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.55e-4)" "unprognostic (2.00e-2)" "unprognostic (3.76e-2)" "unprognostic (1.28e-3)" "unprognostic (3.27e-1)" "prognostic favorable (1.70e-4)" "unprognostic (3.26e-1)" "unprognostic (1.02e-2)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" 6.0 7.4 10.9 5.2 12.2 9.0 6.9 12.0 11.9 8.1 12.2 4.4 2.9 7.3 6.2 4.2 6.1 6.9 3.0 13.5 12.8 5.8 5.2 5.4 4.8 10.6 10.7 9.3 13.2 5.1 8.3 6.4 8.4 11.6 10.9 4.6 9.2 7.9 5.6 1.9 3.0 4.2 5.3 9.0 6.7 6.9 8.9 10.6 5.6 10.5 3.0 4.6 5.4 3.5 10.4 4.6 8.7 32.9 15.0 32.9 16.8 16.4 14.2 10.1 5.8 10.5 10.5 5.4 18.6 8.7 10.5 4.2 2.4 13.8 6.5 11.2 9.1 8.6 24.5 9.1 9.6 21.6 13.0 13.9 17.6 3.4 7.1 6.9 11.0 13.9 8.6 17.7 5.9 15.1 7.8 3.4 6.4 13.7 9.0 3.5 9.1 13.1 5.7 10.9 11.4 7.3 19.4 7.0 6.7 7.8 18.1 5.3 15.1 15.4 11.9 8.3 7.1 15.1 8.6 19.0 12.5 16.5 15.3 19.5 5.3 1.6 5.2 1.1 1.3 0.6 1.3 1.0 1.1 1.4 1.7 0.8 0.9 5.8 0.9 1.9 1.0 1.6 0.6 10.9 12.2 12.0 11.9 13.5 12.8 10.6 10.7 9.3 11.6 9.0 10.6 10.4 8.1 6.4 15.1 71.5 4.8 2.0 3.8 2.7 5.2 15.2 8.3 5.5 3.3 4.3 5.2 14.7 10.4 6.8 4.7 4.3 1.9 2.4 2.1 13.0 16.6 8.4 3.6 6.1 30.1 3.9 5.5 11.9 9.2 17.1 1.3 21.1 20.3 5.8 5.8 79.1 35.6 8.9 6.1 19.5 3.4 2.7 10.8 4.7 1.8 25.3 4.1 22.1 9.2 97.5 24.8 2.6 5.4 11.7 6.4 11.9 5.5 3.0 6.5 13.3 0.0 12.5 6.7 11.5 18.7 4.5 3.0 14.9 2.9 11.5 3.5 3.5 TAF7 "TAF2F, TAFII55" ENSG00000178913 "TATA-box binding protein associated factor 7" Q15545 5 141260225-141320784 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006429 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA006429: AB_1080196" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (4.79e-2)" "unprognostic (4.28e-2)" "unprognostic (8.17e-2)" "unprognostic (1.15e-3)" "unprognostic (1.66e-1)" "unprognostic (5.78e-2)" "unprognostic (6.75e-2)" "unprognostic (9.43e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (2.85e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-2)" 58.5 63.5 58.1 54.3 59.3 80.4 77.5 66.9 69.8 57.9 67.7 53.9 45.1 74.5 82.8 49.4 74.2 43.1 104.1 58.9 64.0 61.8 67.1 56.2 80.1 60.5 60.7 54.5 105.0 53.3 43.8 63.0 61.4 59.9 68.2 56.9 92.8 57.1 57.5 144.1 54.2 60.0 63.5 64.5 70.3 52.3 76.7 59.4 120.7 61.2 131.9 89.5 51.5 44.2 73.8 82.4 67.4 150.3 110.7 131.2 120.9 93.7 104.9 93.0 145.4 141.4 95.3 90.2 220.1 204.6 107.3 157.5 68.7 95.9 97.4 146.0 96.8 106.6 39.8 80.1 79.8 119.4 55.2 80.2 111.1 141.9 56.8 99.9 114.6 106.5 98.7 85.8 167.3 141.7 103.3 124.7 133.1 54.4 103.7 24.4 156.7 200.7 162.4 107.5 109.0 120.0 137.1 85.6 121.7 118.1 114.5 174.1 178.2 98.5 20.5 69.9 67.6 129.2 45.0 195.3 198.9 89.3 126.8 83.6 183.7 35.9 161.5 53.1 44.5 69.1 58.2 62.6 60.2 50.2 54.7 84.9 72.3 104.2 89.1 55.2 55.5 57.7 70.6 58.1 59.3 66.9 69.8 58.9 64.0 60.5 60.7 54.5 59.9 64.5 59.4 73.8 142.3 86.6 68.7 0.0 146.0 120.4 353.0 96.4 67.7 132.7 78.9 72.8 168.4 77.2 92.8 82.8 95.9 94.8 147.4 123.7 82.2 113.7 50.8 92.9 115.7 112.6 84.2 52.6 0.0 76.0 73.3 127.3 70.3 90.8 155.1 70.0 96.0 70.9 51.0 121.1 0.0 110.2 69.2 52.5 92.3 36.8 146.9 86.3 112.1 0.0 94.6 141.4 132.8 0.0 0.0 123.7 150.4 129.1 68.0 243.3 120.0 77.3 107.2 101.4 164.3 175.2 135.8 124.7 141.1 75.7 170.5 141.3 161.5 111.9 106.8 245.9 ZNF852 ENSG00000178917 "Zinc finger protein 852" Q6ZMS4 3 44494847-44510636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 9.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA048312, HPA071850" Uncertain Approved Cytosol NA NA Cytosol "HPA048312: AB_2680352, HPA071850: AB_2686458" "unprognostic (2.64e-1)" "unprognostic (2.62e-1)" "unprognostic (5.93e-3)" "unprognostic (1.73e-1)" "unprognostic (2.29e-2)" "unprognostic (1.30e-3)" "unprognostic (3.47e-2)" "unprognostic (2.55e-2)" "unprognostic (5.11e-2)" "unprognostic (1.43e-1)" "unprognostic (3.80e-2)" "unprognostic (1.03e-1)" "unprognostic (6.62e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (8.05e-2)" "unprognostic (1.11e-2)" 1.3 1.4 1.0 2.5 0.8 1.6 2.2 3.7 1.5 2.0 3.2 1.9 1.8 2.2 1.7 0.9 1.6 1.3 0.4 1.2 1.1 1.7 1.7 1.8 2.5 1.1 0.9 0.6 2.5 2.1 2.9 0.8 2.3 2.3 2.7 3.1 0.9 3.7 2.1 0.5 2.5 2.0 1.9 0.4 2.8 3.0 1.3 1.1 2.9 1.7 0.9 3.2 1.1 0.8 2.5 1.0 1.4 3.9 6.6 0.8 2.3 2.4 1.0 1.3 2.1 3.1 2.1 1.1 3.2 0.7 0.8 0.9 0.8 4.3 1.1 2.8 2.8 1.5 3.1 6.5 1.9 1.2 3.3 5.7 0.8 1.9 2.7 1.1 2.2 1.7 3.3 3.7 1.4 2.5 0.2 3.0 3.8 2.4 1.2 0.8 1.5 4.3 1.9 1.6 3.2 3.0 2.5 2.2 0.9 0.7 6.6 2.2 3.5 2.8 2.6 2.5 1.4 1.0 2.4 1.9 1.9 1.1 2.6 1.7 0.0 0.4 0.7 0.2 0.5 0.3 1.1 0.5 0.3 0.2 0.9 0.5 0.7 0.6 0.4 0.2 1.4 0.2 0.1 1.0 0.8 3.7 1.5 1.2 1.1 1.1 0.9 0.6 2.3 0.4 1.1 2.5 2.0 0.0 5.4 5.9 2.3 3.3 0.8 0.9 1.2 2.1 1.5 1.5 1.8 2.8 1.4 0.0 2.1 0.8 5.1 0.8 3.9 1.9 0.3 2.6 1.6 2.0 0.0 3.2 5.7 1.4 0.9 1.4 1.1 1.5 1.3 1.8 2.2 1.4 0.7 1.7 6.8 0.9 2.0 0.3 1.0 0.4 0.6 1.4 1.8 1.9 1.4 2.8 3.1 9.0 9.2 1.5 0.1 1.2 6.8 1.1 1.0 1.0 4.2 1.6 0.0 2.4 1.6 2.0 1.6 0.5 1.8 0.3 2.3 1.6 0.8 0.9 FOXE1 "FKHL15, FOXE2, HFKH4, TITF2, TTF-2" ENSG00000178919 "Forkhead box E1" O00358 9 97853226-97856717 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "thyroid gland: 196.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 7.9;Basal squamous epithelial cells: 9.1;Cardiomyocytes: 2.7;Club cells: 2.1;Spermatogonia: 2.8;Squamous epithelial cells: 6.1;Urothelial cells: 3.2" "Cancer enriched" "Detected in some" 4 "thyroid cancer: 84.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 13.9;BJ hTERT+: 8.4;HaCaT: 7.9;HeLa: 20.9;RPTEC TERT1: 19.5;SiHa: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.78e-3)" "unprognostic (9.18e-3)" "unprognostic (3.79e-5)" "unprognostic (2.19e-4)" "unprognostic (8.29e-3)" "unprognostic (1.04e-1)" "unprognostic (7.65e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-1)" "unprognostic (3.86e-1)" "unprognostic (6.05e-5)" "unprognostic (8.41e-2)" "unprognostic (1.86e-1)" "unprognostic (6.59e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.3 5.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.1 196.1 0.0 24.3 0.0 3.3 0.0 13.9 4.5 0.0 0.0 0.0 0.0 0.0 1.3 8.4 1.0 1.4 0.0 1.1 0.0 0.6 0.0 0.0 7.9 0.9 0.1 4.0 0.0 0.7 0.0 20.9 0.0 0.0 0.0 1.4 0.0 0.9 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 19.5 1.3 0.0 0.0 14.7 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.8 7.9 9.1 0.0 0.0 0.1 2.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.2 1.3 2.8 6.1 0.3 0.0 0.0 0.0 0.0 3.2 PFAS "FGARAT, GATD8, KIAA0361, PURL" ENSG00000178921 "Phosphoribosylformylglycinamidine synthase" O15067 17 8247618-8270491 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 49.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022140, HPA022886" Enhanced Approved Vesicles NA NA 670000 Vesicles "HPA022140: AB_1855232, HPA022886: AB_1855233" "unprognostic (1.90e-1)" "unprognostic (9.21e-2)" "unprognostic (2.12e-1)" "unprognostic (5.19e-3)" "unprognostic (2.59e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (5.47e-3)" "unprognostic (1.08e-3)" "unprognostic (9.51e-3)" "unprognostic (3.63e-2)" "unprognostic (6.57e-2)" "unprognostic (2.88e-3)" "unprognostic (3.85e-1)" 7.9 10.0 3.9 7.8 5.1 9.9 8.3 6.1 5.8 7.4 2.3 6.4 4.8 9.1 2.7 8.5 8.0 2.9 6.2 5.1 3.4 8.2 10.1 5.9 9.8 3.6 3.9 4.6 9.8 10.4 5.6 5.6 5.2 5.0 7.0 5.7 5.9 6.4 4.7 6.5 6.8 7.7 6.9 2.8 11.1 7.9 7.9 3.8 7.6 7.9 3.2 8.3 7.6 6.2 6.0 15.6 67.0 33.8 50.2 12.1 10.0 38.7 19.4 7.4 35.1 26.4 32.9 13.7 69.8 30.8 11.4 12.4 35.1 78.5 25.6 25.8 30.6 64.0 40.0 63.2 41.9 10.4 32.9 28.3 9.5 6.2 40.5 25.5 9.9 29.5 36.6 54.8 10.1 13.7 23.0 58.1 28.4 55.7 8.5 29.9 86.0 35.2 32.6 16.1 25.5 20.4 31.7 24.1 15.3 22.2 17.9 15.3 14.9 20.9 19.2 25.0 35.7 49.0 11.8 23.5 33.7 21.0 45.4 32.9 20.2 5.1 12.7 6.8 4.5 8.7 14.8 8.8 7.9 4.4 16.7 10.9 8.6 49.1 5.2 3.7 12.9 5.0 2.3 3.9 5.1 6.1 5.8 5.1 3.4 3.6 3.9 4.6 5.0 2.8 3.8 6.0 2.9 0.0 7.9 3.9 6.0 2.4 1.7 1.9 1.8 8.1 4.5 3.7 4.3 1.5 4.1 3.7 6.2 5.2 3.2 2.1 0.0 3.7 2.1 2.4 5.9 3.6 0.0 9.2 5.8 3.0 4.3 4.0 5.6 3.7 1.3 9.7 2.5 4.2 4.6 1.7 5.4 3.5 2.0 2.5 1.4 1.1 5.3 3.4 3.6 4.7 4.5 1.6 4.1 6.6 3.9 1.9 4.9 1.5 5.3 2.9 0.8 2.7 5.1 7.3 0.0 5.1 3.2 5.6 8.8 3.9 2.0 3.1 3.3 7.7 6.2 1.4 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43450989-43453989 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 29.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5" "Low region specificity" "Detected in all" HPA040092 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favorable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favorable (2.72e-5)" 31.9 23.0 25.3 9.4 26.0 12.2 19.5 27.1 36.5 23.2 25.3 21.5 44.5 23.5 15.5 15.2 24.4 18.9 21.0 23.9 29.7 29.5 44.9 23.2 11.4 28.0 25.7 23.3 42.5 54.2 25.4 14.7 10.6 27.3 19.9 12.4 4.1 35.6 47.4 21.0 16.3 34.7 13.3 26.9 12.3 24.1 4.0 27.5 8.9 19.2 10.3 9.3 17.6 15.5 29.7 58.7 7.3 2.2 3.5 9.8 15.1 0.2 48.4 35.7 52.6 34.3 24.2 97.7 0.0 4.1 29.7 25.1 10.9 0.0 45.8 21.6 15.2 20.5 10.2 25.0 0.0 58.8 0.0 0.0 9.4 12.4 64.0 0.0 56.3 106.7 0.5 1.2 0.0 34.5 1.2 9.6 8.8 11.1 5.6 15.5 46.0 0.0 0.3 37.5 2.2 27.2 20.3 56.0 30.4 13.2 8.7 9.2 72.0 59.5 3.7 0.0 12.4 99.2 0.0 0.0 0.0 4.1 13.4 105.5 10.6 1.7 3.7 4.2 1.3 5.5 4.3 7.1 3.3 5.8 5.3 6.6 2.0 0.1 7.5 1.8 29.9 0.7 4.0 25.3 26.0 27.1 36.5 23.9 29.7 28.0 25.7 23.3 27.3 26.9 27.5 29.7 29.8 19.2 64.4 5.9 16.1 28.0 45.2 22.8 51.8 16.9 41.0 65.3 0.4 65.8 23.0 57.0 10.4 18.6 19.2 56.6 45.0 106.7 1.2 9.9 23.6 23.2 69.5 21.5 1.4 86.1 115.9 45.7 25.5 18.7 43.2 33.5 25.0 59.0 29.8 8.4 1.9 89.1 16.2 8.5 31.0 4.5 31.7 23.5 40.9 1.9 15.8 45.0 8.2 4.5 4.8 109.6 97.0 30.5 41.7 33.7 232.5 146.9 12.4 16.7 26.3 31.3 58.2 1.4 3.0 27.3 22.0 12.0 12.3 49.8 47.6 38.4 CYBC1 "C17orf62, Eros, FLJ90469, MGC4368" ENSG00000178927 "Cytochrome b-245 chaperone 1" Q9BQA9 17 82442586-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Chronic granulomatous disease, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 47.4;Ductal cells: 39.7;Granulosa cells: 56.1;Hofbauer cells: 80.2;monocytes: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA045696: AB_2679421" "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 39.5 36.0 34.1 70.8 35.4 37.5 37.7 36.2 42.9 38.2 36.1 34.1 24.9 34.0 23.9 34.4 35.2 46.4 28.6 32.7 37.6 39.5 65.4 41.8 111.4 41.3 37.2 31.4 34.1 45.4 24.7 26.1 31.0 37.8 43.7 27.9 9.9 31.0 23.4 15.1 29.6 49.7 41.0 37.4 118.4 37.2 17.9 37.3 63.9 29.1 13.7 72.7 50.2 28.5 39.8 48.5 67.4 37.1 61.4 57.9 60.6 35.0 42.2 51.6 61.8 73.1 26.2 47.8 122.4 37.8 60.6 75.4 48.3 25.7 32.4 42.6 87.4 21.1 33.4 19.2 30.6 59.3 38.1 94.4 68.5 45.7 53.1 29.3 59.0 81.5 90.3 28.4 88.2 52.9 50.8 160.2 33.0 27.5 65.0 35.3 120.1 22.7 93.1 44.8 60.7 31.7 60.7 77.0 88.1 55.7 66.3 91.4 148.3 27.9 46.7 46.0 79.3 45.9 157.8 58.3 93.1 61.2 61.0 42.5 223.8 136.7 182.9 96.3 181.3 74.7 114.8 88.2 93.6 125.2 115.9 73.0 71.1 300.6 104.5 169.4 130.9 101.1 161.4 34.1 35.4 36.2 42.9 32.7 37.6 41.3 37.2 31.4 37.8 37.4 37.3 39.8 35.6 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 19.0 17.1 0.0 0.0 0.0 22.0 0.0 27.6 47.4 0.0 9.8 39.7 0.0 11.9 21.9 12.9 0.0 0.0 0.0 33.6 36.1 10.9 0.0 12.4 0.0 56.1 0.0 0.0 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 54.8 0.0 0.0 0.0 0.0 34.9 0.0 0.0 11.1 0.0 0.0 19.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 27.6 19.5 23.8 0.0 0.0 TPRX1 FLJ40321 ENSG00000178928 "Tetrapeptide repeat homeobox 1" Q8N7U7 19 47801243-47819051 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 1.1;testis: 1.2" "Cell type enhanced" "Detected in some" "Rod photoreceptor cells: 1.9;Spermatocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044922 Uncertain NA NA "HPA044922: AB_10962509" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LGALS7B GAL7 ENSG00000178934 "Galectin 7B" P47929 19 38789200-38791754 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 6193.8" "Group enriched" "Detected in many" 10 "Basal keratinocytes: 1529.6;Suprabasal keratinocytes: 5136.5" "Cancer enhanced" "Detected in many" "cervical cancer: 142.7;head and neck cancer: 185.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "HaCaT: 3.9;OE19: 3.9" "HPA001549, CAB025100" Supported "Intracellular and membrane" NA NA 4000000 "CAB025100: , HPA001549: AB_1078938" "unprognostic (4.20e-2)" "unprognostic (2.15e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (5.92e-2)" "unprognostic (3.66e-3)" "unprognostic (6.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (1.29e-3)" 4.3 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 235.2 0.0 1.5 0.0 1.0 0.0 1475.1 0.9 0.0 2.6 0.0 0.0 2.1 3.0 2.7 0.0 0.0 0.0 0.0 1.4 2.7 0.0 2.2 0.0 0.0 5.1 0.0 0.0 168.6 0.1 10.3 6193.8 1.7 0.0 0.0 22.1 3.1 5.0 0.0 0.2 2.3 0.0 1.6 1.1 841.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1529.6 6.3 253.5 102.4 0.0 1.2 13.3 0.4 0.0 64.4 1.8 0.0 0.0 0.0 0.3 0.0 0.0 5.4 3.1 0.2 3.2 1.2 0.0 0.0 0.2 0.1 3.4 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 22.4 0.0 41.3 12.3 0.0 0.3 44.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 2.1 0.3 0.3 9.3 0.0 0.0 1.3 4.2 7.5 1.9 329.6 5136.5 0.0 1.6 0.4 0.1 14.0 ZNF552 FLJ21603 ENSG00000178935 "Zinc finger protein 552" Q9H707 19 57803841-57814913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "breast cancer: 23.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 25.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 25.3" "Cell line enhanced" "Detected in all" "BEWO: 30.3;RT4: 42.5;T-47d: 69.6" "Low region specificity" "Detected in all" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "prognostic favorable (4.57e-4)" "unprognostic (2.09e-1)" "prognostic favorable (2.66e-4)" "unprognostic (9.03e-2)" "unprognostic (9.89e-2)" "prognostic favorable (9.96e-4)" "unprognostic (3.03e-2)" "unprognostic (1.29e-3)" "unprognostic (3.36e-3)" "unprognostic (6.72e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-1)" "unprognostic (2.24e-3)" "unprognostic (2.41e-2)" "unprognostic (9.01e-2)" "unprognostic (3.09e-1)" "unprognostic (2.04e-3)" 3.0 2.3 2.7 4.8 2.8 8.2 26.3 12.8 6.6 9.9 7.3 9.5 7.2 5.1 5.4 5.5 5.6 8.8 2.9 3.1 1.9 7.2 4.7 6.1 5.3 2.3 1.6 1.4 4.2 4.3 6.1 2.5 6.5 5.6 12.5 12.2 4.0 17.7 6.9 4.9 9.7 7.4 3.1 0.4 6.1 14.0 3.0 2.7 5.1 4.1 2.7 5.5 14.9 5.9 3.1 5.6 3.2 3.7 5.9 3.0 1.5 30.3 2.0 2.4 4.5 2.5 9.6 8.8 7.6 3.8 3.6 1.0 4.8 7.6 5.0 5.4 3.4 15.1 2.6 8.4 7.1 7.1 8.5 3.4 3.3 10.9 3.1 3.2 2.8 6.0 8.0 5.5 2.5 3.0 5.0 3.7 2.5 5.2 6.9 7.3 7.6 4.7 8.0 13.4 42.5 4.9 3.5 10.2 22.6 5.1 10.4 69.6 3.5 4.5 3.8 4.2 2.5 3.5 11.0 8.1 6.1 3.1 6.4 2.2 2.1 3.3 7.4 2.7 3.3 2.5 3.7 3.4 4.3 1.7 3.7 4.5 3.8 25.3 2.4 1.4 2.3 3.0 2.4 2.7 2.8 12.8 6.6 3.1 1.9 2.3 1.6 1.4 5.6 0.4 2.7 3.1 2.9 12.8 3.1 4.2 7.8 2.5 14.8 9.7 8.0 6.2 19.4 9.8 3.1 18.6 15.0 20.2 2.1 22.1 5.3 9.4 25.4 6.9 5.7 20.2 4.9 3.7 8.4 6.1 7.7 1.8 5.2 3.8 19.4 15.0 8.8 14.2 7.1 4.2 5.2 3.3 8.1 14.5 14.2 2.4 3.1 1.5 2.8 3.6 1.8 1.9 3.1 2.3 2.1 4.5 5.1 3.1 13.4 2.2 4.8 8.3 15.6 4.8 20.5 12.7 6.6 2.9 3.5 3.8 4.6 7.0 2.7 21.3 7.1 5.4 9.3 14.2 SMIM10L2A "LED, LINC00086, LINC0086, MGC39606, NCRNA00086" ENSG00000178947 "Small integral membrane protein 10 like 2A" P0DMW4 X 135421944-135428075 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 30.5;brain: 24.6;epididymis: 14.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.5;Distal tubular cells: 7.9;Granulosa cells: 8.4;Proximal tubular cells: 12.4;Rod photoreceptor cells: 6.6;Theca cells: 16.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.1;CACO-2: 2.6;HAP1: 10.3;hTCEpi: 5.4" NA NA "unprognostic (4.22e-2)" "unprognostic (4.72e-2)" "unprognostic (4.50e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (8.62e-3)" "unprognostic (5.83e-2)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (9.55e-3)" "unprognostic (1.36e-1)" "prognostic favorable (8.28e-8)" "unprognostic (5.29e-2)" "unprognostic (3.26e-1)" "unprognostic (7.37e-3)" "unprognostic (2.28e-2)" 0.8 30.5 16.9 0.4 19.4 0.1 1.9 9.4 24.6 1.9 4.5 0.7 0.2 1.5 14.5 1.4 2.3 0.6 3.2 20.1 21.3 5.7 0.2 2.1 0.5 15.5 17.5 21.3 4.7 3.2 4.6 4.0 0.3 17.7 2.1 0.3 5.2 2.8 1.8 0.3 2.4 0.6 0.8 9.9 3.1 1.4 5.4 17.4 0.4 3.6 0.5 0.5 0.8 1.4 16.1 0.0 0.1 0.2 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.8 0.1 1.9 0.0 10.3 1.3 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.4 0.4 5.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.5 2.4 0.0 0.0 0.0 1.5 0.1 0.3 0.9 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 19.4 9.4 24.6 20.1 21.3 15.5 17.5 21.3 17.7 9.9 17.4 16.1 0.9 0.0 3.3 0.0 0.0 0.0 1.0 0.0 4.6 6.5 1.6 5.7 3.8 2.8 0.0 5.5 0.0 0.0 0.0 0.0 7.9 0.7 0.4 0.8 0.6 1.8 1.2 0.0 0.0 0.4 0.0 0.7 0.0 1.0 1.3 8.4 3.3 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.4 0.1 12.4 0.0 6.6 0.0 1.2 0.6 1.1 0.4 1.3 0.0 0.3 0.3 16.3 0.1 0.7 GAK DNAJC26 ENSG00000178950 "Cyclin G associated kinase" O14976 4 849276-932373 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 134.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027405, HPA027459, HPA027463" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.24e-3)" "unprognostic (1.07e-1)" "unprognostic (3.50e-3)" "unprognostic (1.68e-1)" "unprognostic (7.07e-2)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.70e-6)" "unprognostic (1.09e-3)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "prognostic favorable (7.41e-4)" 32.0 41.0 17.6 26.1 18.6 35.8 34.3 15.5 30.0 41.7 15.7 47.3 51.6 42.3 8.1 50.1 43.3 17.8 24.8 18.0 14.4 55.2 48.1 46.4 25.8 25.0 16.2 16.4 40.9 53.6 22.9 37.4 15.7 20.4 42.1 15.0 9.4 71.6 13.5 31.7 40.8 57.8 9.9 13.7 62.0 54.6 46.1 16.4 21.8 38.8 6.6 13.0 39.0 39.7 17.5 36.0 28.3 16.9 29.0 16.6 14.2 43.6 33.0 19.7 22.3 18.5 35.9 49.8 30.4 20.9 20.1 40.3 29.7 17.7 27.4 10.5 30.7 27.9 35.3 29.5 27.5 31.1 36.2 53.0 20.5 23.2 22.7 11.0 14.2 24.7 35.3 38.4 37.4 15.2 34.7 61.6 92.1 30.4 38.2 46.3 50.2 19.4 27.4 18.2 28.8 29.0 31.3 19.3 24.2 23.3 14.1 39.2 30.7 40.8 30.9 18.0 31.8 45.1 59.5 41.3 33.8 34.9 43.7 29.0 3.0 10.3 12.8 8.8 9.8 7.6 4.9 5.8 6.1 6.5 3.9 3.3 4.8 7.4 4.8 24.6 7.6 5.6 9.4 17.6 18.6 15.5 30.0 18.0 14.4 25.0 16.2 16.4 20.4 13.7 16.4 17.5 24.7 25.6 33.2 34.0 33.9 17.0 15.3 17.9 14.8 27.2 25.3 17.7 12.2 18.6 28.2 25.8 64.6 19.0 46.2 131.3 9.8 18.8 99.1 32.2 21.6 26.7 29.4 26.1 25.7 28.0 17.5 19.5 93.8 52.5 18.3 31.2 18.5 31.6 36.6 11.8 23.5 66.5 26.4 35.9 18.4 134.7 25.1 35.5 16.0 59.0 28.8 16.3 35.0 9.0 24.4 37.6 71.1 18.8 26.1 28.4 65.8 31.0 33.8 26.9 19.7 17.9 18.0 32.9 27.4 19.9 22.3 31.1 34.6 41.6 65.0 44.6 ZBTB7A "DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A" ENSG00000178951 "Zinc finger and BTB domain containing 7A" O95365 19 4043303-4066899 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037214, CAB037285, HPA046387" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648" "unprognostic (8.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.02e-1)" "prognostic favorable (6.50e-6)" "unprognostic (7.54e-2)" "unprognostic (3.65e-3)" "unprognostic (3.71e-2)" "unprognostic (1.12e-1)" "unprognostic (1.56e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.75e-1)" "prognostic favorable (1.34e-6)" "prognostic favorable (1.79e-4)" "unprognostic (2.01e-1)" "unprognostic (4.25e-1)" "unprognostic (1.36e-2)" 14.8 13.3 21.1 8.8 18.0 13.0 13.0 10.2 55.8 15.1 0.5 21.9 16.5 20.1 3.3 39.5 15.6 5.9 13.3 26.0 10.5 9.8 15.1 13.8 6.7 18.6 13.1 19.8 12.1 9.6 8.9 13.5 4.9 22.0 13.6 6.4 8.2 16.4 7.3 34.0 25.1 17.7 4.8 4.9 13.4 19.1 4.5 24.1 5.7 12.8 10.5 5.6 19.1 21.4 25.9 26.5 13.5 2.1 7.5 16.5 17.2 9.3 19.2 11.0 5.0 5.2 4.9 10.7 12.4 12.4 13.7 6.9 23.1 2.7 8.9 4.3 23.4 13.2 7.1 10.2 6.3 11.7 10.1 25.2 9.5 14.5 6.9 7.1 10.6 5.7 5.5 14.4 10.2 5.7 18.3 13.1 7.6 5.5 11.8 16.9 9.8 6.3 12.4 8.0 11.7 9.8 7.4 11.6 24.8 11.5 1.8 13.9 17.9 18.0 19.2 9.3 26.6 24.4 23.6 10.6 6.9 24.7 10.3 12.3 0.7 0.9 0.3 0.7 1.1 0.5 1.1 0.3 0.5 0.2 0.6 0.3 0.6 1.5 1.2 1.0 0.7 0.3 0.2 21.1 18.0 10.2 55.8 26.0 10.5 18.6 13.1 19.8 22.0 4.9 24.1 25.9 76.3 41.7 32.8 27.4 73.1 88.5 69.7 26.5 175.2 104.7 73.5 57.4 26.6 104.4 27.7 42.3 54.2 22.6 93.7 185.8 27.4 20.9 5.5 66.4 63.8 64.5 47.9 118.0 39.0 20.2 10.7 54.1 77.5 67.6 26.6 21.6 72.8 67.9 23.6 159.9 35.5 115.6 8.2 72.9 80.7 7.7 44.1 74.3 37.4 25.3 52.1 32.7 76.2 17.6 34.2 33.1 98.0 49.2 71.6 83.6 68.0 19.9 31.0 72.8 32.9 80.0 60.2 3.8 1.8 181.1 113.9 53.8 74.9 36.5 136.3 113.0 TUFM "EF-TuMT, EFTu" ENSG00000178952 "Tu translation elongation factor, mitochondrial" P49411 16 28842411-28846348 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Elongation factor" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018991, HPA024087, CAB075730, CAB075731, CAB075732" Enhanced Enhanced Mitochondria NA NA 610000 Mitochondria "CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459" "unprognostic (1.40e-1)" "unprognostic (7.56e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (2.55e-2)" "unprognostic (3.39e-1)" "unprognostic (1.23e-3)" "unprognostic (8.05e-2)" "unprognostic (8.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.69e-6)" "unprognostic (5.26e-2)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (7.36e-2)" 67.6 115.5 62.7 67.8 65.3 75.7 66.3 72.3 78.7 59.8 78.7 99.9 105.4 65.4 35.0 106.1 74.2 47.0 152.1 61.6 66.8 107.1 146.3 58.8 69.8 68.0 69.3 57.2 61.9 115.2 118.0 55.8 48.0 66.7 58.2 86.9 36.2 89.7 60.3 226.2 75.2 84.6 54.0 65.7 66.8 107.0 73.8 69.9 60.4 63.2 223.5 80.0 67.7 63.4 67.1 176.2 323.1 102.4 216.2 144.9 131.4 208.7 125.8 144.4 194.9 183.0 351.3 189.4 390.5 228.5 126.4 112.4 337.6 244.2 242.9 116.2 155.4 370.8 151.7 254.8 433.6 171.7 273.8 134.8 169.9 188.1 211.9 208.7 126.8 235.2 213.0 339.0 150.3 144.4 355.0 262.3 266.3 231.8 213.9 196.9 361.8 187.3 569.6 169.3 168.4 178.8 219.6 110.0 388.5 180.2 84.6 231.5 217.6 150.1 115.9 136.4 146.7 196.6 229.8 253.6 172.2 148.6 336.8 157.1 94.6 155.8 72.3 103.1 153.6 115.3 100.6 97.2 108.7 199.3 98.8 91.7 95.3 32.4 97.2 119.2 123.1 140.1 185.6 62.7 65.3 72.3 78.7 61.6 66.8 68.0 69.3 57.2 66.7 65.7 69.9 67.1 108.2 70.5 76.7 29.4 144.6 168.1 262.5 322.0 158.2 102.4 165.1 139.2 134.4 190.1 182.6 176.6 87.6 333.1 113.2 260.0 334.6 230.2 381.8 116.1 92.5 111.3 148.5 148.1 17.5 289.8 299.2 111.2 153.4 79.6 105.9 170.6 108.5 247.1 253.8 74.0 19.9 230.5 217.7 167.5 146.4 669.0 109.3 128.6 138.7 14.0 167.5 140.6 88.6 28.6 30.3 199.7 215.3 111.7 264.9 245.3 330.7 451.9 237.3 116.3 85.5 105.5 129.1 205.7 177.4 230.1 156.0 287.0 120.2 288.2 418.7 277.6 ERICH3 "C1orf173, DKFZp547I048, RP11-653A5.1" ENSG00000178965 "Glutamate rich 3" Q5RHP9 1 74568117-74673792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 17.5;testis: 24.2" "Group enriched" "Detected in some" 4 "Early spermatids: 326.4;Endometrial ciliated cells: 139.8;Late spermatids: 326.9;Respiratory ciliated cells: 234.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028655, HPA072916" Approved NA NA "HPA028655: AB_10961002, HPA072916: " "unprognostic (4.49e-4)" "unprognostic (1.02e-2)" "prognostic favorable (1.56e-5)" "unprognostic (1.71e-2)" "unprognostic (5.94e-2)" "unprognostic (6.83e-2)" "unprognostic (6.53e-2)" "unprognostic (4.76e-2)" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-4)" "unprognostic (9.21e-3)" "unprognostic (2.25e-1)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" 0.0 2.5 2.3 0.0 4.3 0.0 0.8 0.3 5.8 5.5 0.0 0.0 0.0 1.0 0.0 0.0 17.5 0.0 0.0 3.8 3.4 0.0 0.0 2.7 0.2 0.2 0.9 3.5 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.2 2.5 0.6 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.3 0.3 5.8 3.8 3.4 0.2 0.9 3.5 0.2 0.0 2.5 0.5 0.0 3.2 3.1 3.6 0.3 0.0 0.0 0.0 0.0 3.5 2.8 0.3 0.6 0.0 28.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 326.4 139.8 1.0 0.4 3.5 0.0 56.8 0.0 0.0 0.5 0.0 3.2 1.3 0.0 0.0 0.1 0.0 0.0 51.8 0.0 0.0 0.0 0.0 326.9 3.1 0.7 0.0 1.0 0.0 0.1 1.0 24.6 3.2 0.0 0.0 3.8 0.0 0.6 0.0 0.0 234.6 0.5 6.6 0.0 0.1 32.9 1.5 0.0 0.0 0.1 0.3 0.1 0.0 0.3 RMI1 "BLAP75, C9orf76, FLJ12888" ENSG00000178966 "RecQ mediated genome instability 1" Q9H9A7 9 83980798-84004074 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 70.0;Late spermatids: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021661 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "HPA021661: " "unprognostic (9.59e-2)" "unprognostic (7.96e-2)" "unprognostic (6.72e-3)" "unprognostic (3.03e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.65e-1)" "unprognostic (3.39e-3)" "unprognostic (1.32e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.68e-3)" "unprognostic (3.42e-1)" "unprognostic (2.42e-1)" "unprognostic (9.24e-2)" 2.5 8.3 3.4 6.0 3.5 3.9 4.5 5.0 3.5 3.2 5.7 6.6 6.2 3.5 5.7 4.9 5.9 2.8 3.4 2.8 5.8 4.4 5.8 3.3 10.3 3.7 3.9 2.9 4.4 5.8 7.7 3.7 3.7 4.0 4.8 7.5 7.0 6.0 3.2 3.8 5.1 6.8 3.3 3.6 6.5 6.3 9.0 4.0 10.3 6.1 3.9 9.7 3.6 2.4 4.2 25.2 14.9 33.6 12.4 5.5 7.7 33.9 24.1 13.6 20.7 19.4 7.5 17.0 55.4 8.5 12.4 21.7 36.9 22.0 12.3 25.3 29.2 6.1 23.0 12.1 11.8 7.7 42.6 23.1 7.4 7.8 17.6 12.6 6.7 11.1 28.2 16.7 26.3 23.2 18.1 54.4 17.4 31.3 31.6 15.7 47.8 33.9 21.0 10.8 10.4 30.4 19.3 21.3 18.6 9.8 15.4 19.4 20.8 6.6 22.9 14.7 23.2 20.1 11.6 25.6 20.2 14.6 19.7 26.4 14.2 4.5 8.8 1.8 5.5 2.2 2.8 2.1 1.9 7.2 2.6 2.2 2.5 7.8 2.8 6.5 2.2 3.0 2.6 3.4 3.5 5.0 3.5 2.8 5.8 3.7 3.9 2.9 4.0 3.6 4.0 4.2 5.4 9.6 5.1 10.1 5.9 2.7 3.2 4.3 4.0 4.1 4.3 3.3 8.5 2.8 9.0 1.8 4.2 7.9 2.1 6.1 5.9 5.5 70.0 13.9 6.5 3.8 6.7 24.4 7.1 3.0 16.2 3.3 8.2 10.2 4.5 9.0 5.0 13.3 8.1 10.1 11.2 9.8 0.0 10.7 4.3 62.1 2.1 7.4 12.4 8.4 8.5 7.7 5.2 26.2 12.6 2.7 5.6 2.2 7.8 4.2 8.9 4.9 11.1 5.2 0.0 3.3 3.4 34.0 22.6 6.9 4.8 4.2 4.4 7.7 10.1 2.4 CTC1 "AAF132, C17orf68, FLJ22170" ENSG00000178971 "CST telomere replication complex component 1" Q2NKJ3 17 8224815-8248056 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052436 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052436: " "unprognostic (6.47e-2)" "unprognostic (1.06e-2)" "unprognostic (6.16e-3)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-3)" "unprognostic (3.96e-1)" "unprognostic (2.07e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "prognostic favorable (6.49e-5)" "unprognostic (2.89e-3)" "unprognostic (3.24e-1)" "unprognostic (5.76e-2)" "unprognostic (1.47e-1)" "unprognostic (1.77e-2)" "unprognostic (1.66e-2)" 12.9 11.8 14.1 14.8 14.9 18.6 16.1 19.5 18.9 17.2 13.9 16.7 8.1 13.6 10.8 11.1 17.3 7.0 10.8 14.4 14.0 16.7 18.4 18.7 24.3 14.6 14.1 14.1 20.1 18.4 10.5 21.5 6.1 16.8 16.8 10.5 22.4 12.5 9.1 7.0 14.3 25.2 9.4 12.9 37.5 15.9 10.9 14.0 31.5 18.1 5.7 21.6 14.9 13.5 15.7 3.0 6.6 5.9 5.5 18.1 4.3 7.2 3.4 3.8 4.8 3.2 5.0 8.8 10.8 3.4 5.9 3.5 10.0 7.0 5.2 3.0 8.0 6.8 5.3 7.2 6.5 3.0 1.7 16.1 4.4 5.5 6.3 8.6 9.5 8.7 15.4 5.1 3.6 3.4 3.9 18.6 7.3 4.8 9.7 1.6 8.7 2.3 6.9 12.4 7.1 5.2 5.9 6.7 8.6 6.0 10.9 5.3 5.0 11.6 1.5 3.6 3.6 4.0 7.4 4.7 7.1 2.9 6.5 4.5 2.0 0.7 1.2 2.0 0.9 2.0 2.2 2.0 1.9 0.7 2.6 2.8 2.5 2.5 1.3 1.2 2.2 1.8 1.0 14.1 14.9 19.5 18.9 14.4 14.0 14.6 14.1 14.1 16.8 12.9 14.0 15.7 6.3 0.0 11.1 8.5 16.7 1.9 3.0 1.0 3.4 7.7 6.2 4.1 3.4 7.2 3.0 5.5 37.5 6.4 12.0 4.6 1.9 3.6 3.7 3.6 2.6 6.4 6.7 1.7 10.2 3.8 3.9 3.8 5.6 5.5 6.3 4.0 5.7 8.1 3.9 1.7 10.3 5.8 2.0 8.2 1.0 6.2 4.4 3.5 0.0 3.7 5.6 2.5 6.2 9.0 6.6 4.4 9.4 2.2 9.6 4.1 4.5 2.2 3.0 17.3 0.0 3.1 4.1 4.7 4.2 3.9 2.0 11.1 10.3 2.1 3.5 3.4 FBXO34 "Fbx34, FLJ20725" ENSG00000178974 "F-box protein 34" Q9NWN3 14 55271344-55370053 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.2;Late spermatids: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052592 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052592: AB_2681877" "unprognostic (6.19e-2)" "unprognostic (1.73e-1)" "unprognostic (5.47e-2)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (9.87e-3)" "unprognostic (3.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.49e-2)" "unprognostic (3.14e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" 9.1 8.0 8.1 12.0 11.7 17.4 12.7 7.5 15.2 12.1 7.6 27.6 14.5 11.1 16.0 33.8 15.1 13.4 13.3 15.0 9.1 18.4 12.1 15.3 12.9 5.4 6.8 10.6 11.7 10.6 11.7 6.5 10.1 7.0 13.0 27.0 16.2 17.6 11.7 31.5 11.6 15.2 11.8 5.8 14.0 18.3 25.0 7.2 17.1 22.9 45.1 16.0 16.5 16.2 9.1 30.1 17.2 13.5 12.3 17.3 14.1 14.8 14.9 25.4 22.1 25.5 15.7 37.8 24.0 12.1 12.9 14.4 29.0 17.5 15.0 28.3 14.8 10.2 25.2 10.4 9.7 13.4 30.5 23.8 11.5 21.6 15.4 15.4 17.2 17.0 25.8 19.9 18.8 14.3 20.2 24.0 21.6 8.0 26.3 13.3 25.5 33.1 13.4 20.3 34.2 14.9 16.2 18.0 17.9 14.8 16.3 21.5 19.5 13.0 19.3 24.9 10.5 11.8 9.1 8.2 27.1 13.7 16.4 11.3 9.4 11.2 2.5 9.9 7.5 11.8 7.0 10.1 10.8 11.1 7.0 8.8 9.3 6.1 13.2 14.0 5.1 6.9 8.7 8.1 11.7 7.5 15.2 15.0 9.1 5.4 6.8 10.6 7.0 5.8 7.2 9.1 16.2 22.4 31.6 22.9 27.3 21.0 32.9 18.5 15.9 36.7 15.6 12.7 21.5 7.2 32.5 18.4 22.9 13.9 57.8 63.7 17.6 22.8 165.2 27.1 17.4 24.1 26.4 52.8 109.1 30.3 4.7 14.7 31.1 28.9 17.2 21.1 9.3 7.8 9.9 37.0 75.5 30.0 30.5 13.5 24.3 219.1 23.0 27.8 12.4 46.9 12.6 14.1 24.7 35.2 20.7 18.0 35.3 16.6 27.4 31.2 20.0 17.0 34.5 32.4 6.6 24.2 19.3 34.1 16.3 20.7 24.3 27.0 44.1 11.4 29.3 63.2 SELENOW "SELW, SEPW1" ENSG00000178980 "Selenoprotein W" P63302 19 47778585-47784686 "Predicted intracellular proteins" Antioxidant "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1622.2;skeletal muscle: 1740.1;tongue: 1987.2" "Cell type enhanced" "Detected in many" "Adipocytes: 855.4;Breast myoepithelial cells: 490.5;Distal tubular cells: 633.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 541.5;HUVEC TERT2: 624.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (7.21e-2)" "unprognostic (2.98e-2)" "unprognostic (6.28e-2)" "unprognostic (4.17e-2)" "unprognostic (4.46e-3)" "prognostic favorable (5.44e-4)" "unprognostic (1.73e-1)" "unprognostic (2.42e-1)" "unprognostic (1.36e-1)" "unprognostic (6.78e-2)" "unprognostic (1.45e-3)" "unprognostic (4.58e-2)" "unprognostic (1.36e-1)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" 190.2 104.4 1310.6 108.5 1311.4 45.1 206.1 1301.7 1622.2 272.4 1353.8 417.4 128.6 220.3 261.1 269.1 309.6 242.6 998.0 1350.5 1268.0 147.7 110.4 201.4 113.0 1302.4 1306.5 1269.3 172.4 133.7 170.1 139.7 154.8 1279.6 235.2 226.8 129.2 197.6 294.2 1740.1 314.8 179.0 471.1 1305.1 147.3 209.6 55.8 1306.8 114.7 158.1 1987.2 88.6 326.6 174.7 1329.0 74.4 119.6 174.0 141.4 124.7 268.1 43.7 76.7 59.6 71.4 53.8 49.6 57.1 0.0 64.3 163.1 70.1 57.8 293.6 389.6 124.1 216.4 72.9 34.9 61.7 63.2 138.0 9.1 131.8 285.1 541.5 119.4 113.0 158.7 624.7 109.1 46.4 28.6 317.7 179.0 156.6 115.4 68.0 186.0 91.4 26.9 18.3 23.5 208.0 130.8 72.4 51.5 77.6 203.0 77.9 299.2 114.2 43.7 213.9 71.0 151.2 50.7 141.3 46.3 153.1 16.1 75.3 93.2 165.0 309.3 187.8 448.3 303.8 226.2 265.1 182.4 333.6 311.7 147.8 159.2 331.0 288.3 19.9 216.1 293.5 166.8 436.6 414.1 1310.6 1311.4 1301.7 1622.2 1350.5 1268.0 1302.4 1306.5 1269.3 1279.6 1305.1 1306.8 1329.0 855.4 333.3 282.3 0.0 20.4 0.0 0.0 0.0 0.0 0.0 347.1 490.5 0.0 0.0 219.7 154.5 0.0 157.0 127.3 0.0 633.9 278.3 0.0 350.2 221.5 220.8 0.0 0.0 0.0 244.5 327.9 145.5 0.0 188.4 119.8 153.8 0.0 0.0 251.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.3 0.0 0.0 156.6 0.0 0.0 0.0 0.0 243.7 0.0 0.0 21.3 0.0 0.0 380.8 303.9 0.0 0.0 0.0 210.7 0.0 0.0 0.0 0.0 182.4 66.9 341.7 0.0 0.0 EIF3K "ARG134, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001" ENSG00000178982 "Eukaryotic translation initiation factor 3 subunit K" Q9UBQ5 19 38619082-38636955 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045446, HPA054590" Uncertain Supported Cytosol No No Cytosol "HPA045446: AB_10962716, HPA054590: AB_2682534" "unprognostic (7.07e-3)" "prognostic favorable (1.31e-4)" "unprognostic (3.04e-2)" "unprognostic (2.10e-3)" "unprognostic (1.67e-2)" "unprognostic (3.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (7.06e-3)" "unprognostic (2.92e-2)" "unprognostic (4.26e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.82e-1)" "unprognostic (1.00e-1)" "unprognostic (6.49e-2)" "unprognostic (3.69e-2)" 234.6 179.4 99.4 84.3 99.1 174.2 230.2 105.1 115.1 205.7 111.9 281.9 143.3 188.2 111.2 288.4 190.1 73.8 533.6 98.1 100.2 286.0 190.6 170.7 143.1 102.5 101.4 96.1 216.6 264.4 181.1 174.4 72.6 101.3 173.6 167.3 58.4 199.1 101.3 688.4 279.2 220.9 114.7 102.4 224.3 267.9 67.1 103.5 145.0 170.0 466.5 183.6 220.3 218.4 104.5 135.3 421.3 110.1 175.4 196.5 197.7 134.3 104.2 180.7 220.9 192.5 272.0 118.6 300.2 121.2 174.2 128.7 122.4 221.2 280.8 165.1 145.7 184.6 214.0 134.4 197.2 201.0 345.1 170.7 219.6 252.3 151.4 269.6 118.8 242.3 156.6 217.9 250.8 188.8 215.2 185.3 158.6 103.5 474.4 211.4 222.7 197.0 235.7 225.3 311.0 141.5 139.4 114.8 377.1 174.0 117.3 145.9 260.3 133.9 135.0 134.8 81.3 185.9 246.4 276.3 255.6 114.9 321.6 155.0 154.8 267.8 138.2 182.8 297.8 232.1 252.0 222.3 213.2 359.0 218.0 228.9 204.0 72.4 201.2 305.7 209.4 296.4 441.8 99.4 99.1 105.1 115.1 98.1 100.2 102.5 101.4 96.1 101.3 102.4 103.5 104.5 372.1 93.0 166.1 26.4 430.3 395.6 547.4 674.4 345.4 83.6 477.2 755.1 502.5 320.3 331.0 217.0 66.7 422.9 376.3 466.2 1097.6 345.5 160.6 182.0 231.8 309.3 326.1 284.2 23.8 453.2 484.8 267.7 231.9 180.6 248.2 239.0 311.7 278.6 660.9 23.5 25.0 567.7 305.2 640.7 552.1 274.4 265.3 470.7 466.0 10.3 572.6 276.9 415.1 14.6 24.7 330.2 487.2 199.7 386.6 461.9 874.5 974.2 198.3 174.9 203.8 331.4 450.3 109.0 83.4 594.2 457.0 454.1 424.0 319.1 719.5 622.7 MRFAP1L1 MGC9651 ENSG00000178988 "Morf4 family associated protein 1 like 1" Q96HT8 4 6707701-6709865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (5.77e-2)" "unprognostic (2.21e-2)" "unprognostic (1.71e-1)" "unprognostic (7.79e-2)" "unprognostic (4.40e-1)" "unprognostic (3.36e-2)" "unprognostic (3.10e-2)" "unprognostic (4.35e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.80e-5)" "unprognostic (2.87e-1)" "unprognostic (2.59e-1)" "unprognostic (2.57e-2)" "prognostic favorable (5.26e-5)" 32.5 42.1 76.1 32.1 78.2 19.2 52.7 77.4 85.3 46.0 65.7 36.0 25.5 47.4 50.4 40.6 41.7 33.6 52.9 75.4 77.5 42.9 56.0 36.4 53.8 76.2 76.6 72.7 52.1 30.3 46.4 39.5 40.4 76.8 49.7 33.2 52.9 48.5 40.7 50.0 37.4 33.6 37.2 78.0 44.1 40.2 20.5 77.1 48.4 41.4 51.2 46.8 43.0 39.6 78.3 60.3 37.0 82.4 66.1 82.2 69.8 51.9 54.5 88.8 66.3 62.2 40.2 78.6 70.7 53.8 66.5 88.3 42.4 66.0 79.4 72.2 48.7 46.1 96.4 67.8 95.3 51.3 66.6 53.4 72.9 92.3 59.2 59.4 61.7 63.7 48.2 98.3 55.9 65.5 74.8 94.6 133.6 84.5 59.9 87.1 59.5 99.6 59.8 90.6 51.2 94.4 73.4 44.5 44.9 92.0 48.8 83.8 68.2 56.9 55.5 47.2 41.7 76.1 83.9 133.5 53.7 54.3 103.2 53.6 288.6 44.5 170.5 144.0 44.8 142.1 89.5 134.7 149.5 57.0 85.2 134.2 137.9 94.7 127.1 55.0 54.3 143.1 119.5 76.1 78.2 77.4 85.3 75.4 77.5 76.2 76.6 72.7 76.8 78.0 77.1 78.3 17.4 32.1 51.8 9.8 36.7 34.0 24.1 31.9 47.3 28.2 26.5 23.5 53.5 42.9 39.6 18.4 16.7 42.5 37.0 11.2 23.5 23.1 3.4 22.2 34.4 29.8 18.6 40.0 12.5 18.5 31.8 33.5 25.0 24.3 34.7 21.4 28.2 44.0 22.2 53.8 11.3 16.5 36.7 26.0 22.2 3.8 30.7 17.8 26.6 12.2 22.4 45.9 54.6 9.0 14.4 21.8 14.2 28.2 38.1 31.2 12.7 32.1 49.2 21.8 26.3 24.1 24.2 33.3 32.2 40.9 37.4 29.7 49.0 25.7 14.6 24.9 SNX18 "SH3PX2, SH3PXD3B, SNAG1" ENSG00000178996 "Sorting nexin 18" Q96RF0 5 54517759-54546586 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.6" "Cell type enhanced" "Detected in many" "Granulosa cells: 90.0;Kupffer cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037800 Approved Approved Cytosol NA NA 12000 Cytosol "HPA037800: AB_10672465" "unprognostic (2.22e-2)" "unprognostic (3.96e-3)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (4.12e-1)" "unprognostic (2.22e-1)" "unprognostic (9.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (9.13e-2)" "unprognostic (3.81e-3)" "prognostic favorable (1.58e-4)" "unprognostic (6.79e-3)" "unprognostic (7.96e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" 15.1 8.8 15.4 11.3 19.5 68.6 9.2 20.6 12.4 11.6 10.9 8.0 9.4 13.6 6.4 10.2 9.5 11.5 7.2 10.4 12.9 12.9 15.3 11.4 13.4 23.5 19.6 7.2 26.9 9.4 12.1 3.6 21.9 23.8 8.6 5.6 15.0 11.2 11.6 7.3 7.1 9.6 14.2 21.8 18.9 12.1 7.4 18.3 5.6 15.8 8.1 7.1 11.3 7.8 27.7 9.0 7.4 11.4 13.0 26.2 27.8 61.7 14.8 37.1 7.6 12.6 9.1 16.4 0.4 23.1 23.1 13.9 8.2 10.8 14.5 9.6 4.6 7.7 2.7 4.6 5.7 43.5 5.0 2.5 44.1 17.2 10.4 10.8 13.5 16.1 6.5 4.8 60.7 13.3 8.6 4.7 5.7 5.7 3.7 7.6 12.4 6.4 14.5 7.4 26.0 14.1 8.3 12.4 14.2 16.2 17.4 16.7 8.4 5.5 28.4 13.8 21.1 15.6 40.0 41.8 2.5 11.0 11.8 29.9 0.0 0.9 0.1 0.7 1.5 0.1 0.8 0.3 0.4 1.1 0.6 0.1 0.5 3.8 1.0 3.8 2.5 0.2 0.3 15.4 19.5 20.6 12.4 10.4 12.9 23.5 19.6 7.2 23.8 21.8 18.3 27.7 14.4 54.5 26.8 7.5 16.6 9.8 4.4 12.8 10.2 10.0 13.6 10.5 16.5 7.2 22.5 22.0 73.0 26.5 48.2 4.2 15.6 14.2 0.3 7.5 9.8 16.5 6.1 3.4 10.3 15.2 30.3 23.0 27.5 6.2 5.7 90.0 43.9 28.1 41.6 5.0 9.2 7.3 12.2 87.4 26.2 2.5 14.0 52.1 10.6 37.5 42.6 11.2 35.0 6.6 21.6 12.8 7.3 17.7 12.7 5.6 8.6 6.9 24.0 47.5 0.0 13.3 38.5 3.6 13.1 8.9 11.8 8.2 12.5 58.6 10.8 13.1 EXD1 "EXDL1, MGC33637" ENSG00000178997 "Exonuclease 3'-5' domain containing 1" Q8NHP7 15 41182725-41230757 "Predicted intracellular proteins" "Meiosis, RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 15.1" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Early spermatids: 13.4;Late spermatids: 5.7;Spermatocytes: 23.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "pons: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-1)" "unprognostic (6.33e-3)" "unprognostic (2.51e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-2)" "unprognostic (6.50e-2)" "unprognostic (4.57e-2)" "unprognostic (4.54e-2)" "unprognostic (2.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.92e-1)" "unprognostic (2.11e-6)" "unprognostic (2.15e-1)" "unprognostic (2.29e-1)" "unprognostic (2.72e-1)" "unprognostic (2.71e-2)" 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.2 0.3 0.2 0.0 1.5 0.2 0.2 0.3 0.1 0.0 1.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.3 0.5 0.0 0.6 3.7 0.0 0.0 0.1 0.0 0.0 0.0 13.4 0.2 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.6 5.7 0.0 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.1 23.6 2.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.4;lymphoid tissue: 60.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 7.9" "Group enriched" "Detected in many" 6 "B-cells: 2.5;T-cells: 7.9" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 1.3;white matter: 4.0" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.1 1.2 0.1 14.3 0.2 44.4 1.8 0.2 0.2 1.7 0.1 11.2 12.2 1.7 0.4 18.8 0.6 1.5 0.6 0.1 0.3 0.9 2.0 2.5 37.0 0.1 0.2 0.0 0.5 0.6 0.3 0.2 8.3 0.3 0.8 11.1 0.0 2.7 0.3 5.5 9.4 11.7 3.3 0.1 12.1 4.7 1.2 0.3 60.7 0.6 0.0 36.9 3.5 5.9 1.0 196.5 130.9 191.1 93.0 4.2 6.5 73.4 91.7 49.5 186.2 170.6 171.5 57.4 193.3 46.2 37.0 77.0 139.8 140.1 62.6 153.7 84.9 231.3 115.7 78.3 146.1 0.7 62.2 109.2 3.5 2.9 109.4 67.7 18.5 86.5 123.6 73.3 73.4 82.9 92.9 225.1 87.4 119.6 63.9 57.6 149.8 176.1 80.5 41.2 38.2 41.2 59.1 81.7 36.5 61.2 56.5 63.5 41.4 33.9 74.3 75.6 67.6 243.3 53.2 37.7 147.9 35.7 92.9 153.4 0.0 0.4 0.6 0.5 0.3 0.1 1.1 1.3 2.1 0.5 2.5 0.1 0.7 0.9 0.3 0.2 0.2 7.9 0.9 0.1 0.2 0.2 0.2 0.1 0.3 0.1 0.2 0.0 0.3 0.1 0.3 1.0 0.3 0.0 0.5 0.0 7.6 4.5 1.8 6.1 0.6 0.0 1.8 2.2 1.4 0.0 2.6 0.0 0.0 40.5 1.8 13.2 0.0 0.4 0.1 0.5 1.6 3.1 0.0 59.3 0.0 0.0 89.1 5.7 6.1 2.1 4.5 24.7 6.1 0.7 29.4 0.0 0.0 10.8 0.0 5.7 7.3 0.2 0.6 5.1 1.8 0.0 0.9 0.0 3.1 0.0 0.1 0.3 2.8 0.0 15.4 1.2 1.5 0.1 0.2 0.0 0.0 0.1 4.8 1.6 7.2 11.8 2.4 9.0 4.3 1.0 22.0 2.8 TAS1R2 "GPR71, T1R2, TR2" ENSG00000179002 "Taste 1 receptor member 2" Q8TE23 1 18839599-18859682 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.9;salivary gland: 4.7;testis: 10.9" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 92.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 11 "hypothalamus: 2.3;thalamus: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 0.2 1.9 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.7 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.5 4.9 0.0 0.1 1.1 0.0 2.7 4.7 0.1 3.0 0.0 0.1 0.1 0.0 0.0 0.3 10.9 1.7 0.1 0.2 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 6.2 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.7 0.0 0.1 0.0 28.3 0.0 0.0 2.0 0.0 23.9 0.3 3.0 0.0 1.4 0.0 6.2 0.0 0.4 1.7 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 12.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.3 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 1.0 0.0 12.3 0.0 1.0 0.7 0.0 0.0 0.7 0.0 0.8 0.0 0.0 1.2 1.1 0.0 10.0 0.2 92.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 MRFAP1 "PAM14, PGR1" ENSG00000179010 "Morf4 family associated protein 1" Q9Y605 4 6640091-6642745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB042447, HPA056367" Approved Supported Nucleoplasm No No Nucleoplasm "CAB042447: AB_2145271, HPA056367: AB_2683107" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (3.82e-2)" "unprognostic (1.31e-2)" "unprognostic (7.03e-2)" "unprognostic (9.55e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-3)" "unprognostic (1.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-3)" "unprognostic (1.02e-1)" "prognostic favorable (2.90e-7)" "unprognostic (1.24e-1)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" 218.1 294.2 357.3 127.6 359.9 109.1 210.9 368.7 392.7 223.1 336.6 222.0 148.4 256.9 209.7 190.5 223.3 135.5 257.3 351.5 365.5 222.6 247.3 205.2 115.8 421.9 360.9 331.3 245.3 157.4 262.8 264.2 195.9 385.5 194.8 134.0 167.1 166.1 208.9 375.4 179.0 164.8 217.0 380.0 182.7 197.7 156.0 386.2 132.2 179.4 310.9 133.9 222.2 196.2 398.2 344.4 371.8 311.7 360.9 373.9 336.6 245.7 444.2 407.3 401.1 398.9 368.7 362.7 214.4 333.0 411.9 455.0 192.2 425.4 462.3 482.5 85.4 306.6 319.6 430.5 405.8 349.7 241.6 151.2 351.0 416.2 369.2 371.6 380.2 452.2 185.9 427.9 136.4 401.2 432.5 182.2 565.1 387.7 297.6 472.6 233.6 564.5 182.3 490.3 255.6 488.0 381.6 287.7 204.2 429.7 270.4 569.8 291.2 408.6 350.3 235.2 262.6 592.2 196.8 266.4 351.5 362.5 507.6 347.7 202.0 186.2 163.2 126.9 154.0 127.9 89.4 125.3 127.0 177.8 94.8 127.8 126.3 198.6 137.1 153.1 143.8 147.1 196.4 357.3 359.9 368.7 392.7 351.5 365.5 421.9 360.9 331.3 385.5 380.0 386.2 398.2 141.8 160.3 158.9 14.4 84.7 188.5 262.6 155.6 130.9 113.9 148.6 155.2 227.0 163.0 124.4 88.3 16.7 547.5 103.7 83.8 219.2 241.8 43.1 161.8 184.2 196.4 178.1 123.1 18.7 204.2 312.7 197.2 69.8 166.8 150.4 141.4 171.4 179.7 200.4 111.0 20.9 129.7 130.2 144.4 114.1 65.1 314.0 106.8 126.3 12.2 158.5 270.7 113.3 12.5 33.7 189.0 121.3 304.6 61.1 257.3 168.0 252.6 126.0 111.5 216.9 230.7 197.7 349.3 211.8 126.3 173.8 322.2 121.4 337.1 138.3 236.7 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149959-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 341.2;Late spermatids: 312.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 147.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: AB_2674307, HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favorable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 10.3 8.9 7.7 11.2 9.3 42.4 12.6 11.6 10.6 10.7 8.2 11.2 9.8 9.2 11.0 12.2 10.7 9.8 9.9 8.1 8.5 10.5 14.3 10.2 17.8 8.5 9.2 7.6 11.7 7.9 10.8 4.9 12.5 9.0 10.2 11.1 7.8 8.8 9.6 8.0 8.2 10.0 11.0 8.4 13.3 10.5 33.1 8.5 21.1 12.1 10.8 18.6 12.6 5.2 13.2 16.6 17.4 32.5 17.7 22.5 19.8 15.0 26.3 31.5 38.6 51.9 19.5 22.5 22.8 23.1 24.5 18.4 11.8 23.7 19.2 33.1 40.1 11.7 27.1 12.3 16.9 30.8 37.9 22.5 27.7 20.1 26.1 21.8 25.2 23.1 23.7 18.0 25.1 43.4 19.4 38.3 16.9 40.0 31.0 18.8 23.9 11.4 21.5 25.7 22.6 10.1 14.6 24.1 14.2 42.2 26.2 25.5 30.0 20.6 24.2 25.7 147.7 29.8 22.6 36.2 33.0 18.8 29.8 23.0 47.8 22.3 24.1 16.8 32.4 21.4 26.0 15.3 17.2 23.5 22.3 15.1 15.6 9.7 23.4 27.4 16.2 20.5 21.6 7.7 9.3 11.6 10.6 8.1 8.5 8.5 9.2 7.6 9.0 8.4 8.5 13.2 13.3 19.2 7.5 5.9 30.9 11.7 18.8 19.9 14.2 21.6 11.0 9.5 6.9 8.6 16.7 5.5 22.9 21.6 24.4 13.9 19.6 16.7 341.2 14.4 13.3 10.8 16.2 23.5 9.7 13.7 22.7 17.3 11.7 10.2 14.0 14.2 11.4 7.5 26.7 6.7 9.1 13.3 14.2 23.9 25.1 312.0 16.4 24.0 16.0 6.5 28.0 23.2 23.7 10.1 15.0 15.3 19.3 15.1 17.5 18.6 16.1 14.5 21.2 24.8 13.1 14.9 16.6 75.7 12.2 14.9 14.1 25.6 24.6 18.1 11.1 22.5 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480930-18485974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 19.7" "Cell type enhanced" "Detected in some" "Cholangiocytes: 5.7;Collecting duct cells: 9.2;Endometrial ciliated cells: 4.4;Gastric mucus-secreting cells: 5.6;Hepatocytes: 7.6;Proximal tubular cells: 9.9;Respiratory ciliated cells: 5.0" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.4;CAPAN-2: 10.4;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.5;RT4: 9.5;T-47d: 10.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056616: AB_2683193" "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favorable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.88e-4)" 0.5 0.0 0.0 0.0 0.0 0.0 4.6 0.7 0.2 2.3 6.8 0.7 0.4 0.0 0.2 1.3 0.8 1.0 0.0 0.5 0.1 19.7 4.7 1.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.1 0.0 0.1 0.4 0.7 0.0 1.7 1.1 0.0 0.0 0.3 0.0 0.0 0.0 4.9 0.2 0.1 0.0 1.6 0.0 0.0 3.2 0.3 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.1 10.4 0.0 5.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.1 0.0 0.2 0.0 0.0 11.5 9.5 2.8 0.0 0.0 0.8 0.0 1.0 10.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 1.7 0.4 1.2 5.7 2.2 9.2 0.0 0.1 0.0 0.3 1.9 2.0 0.4 4.4 0.3 0.1 0.0 0.0 0.0 2.2 0.1 0.1 5.6 3.0 0.0 0.1 0.0 7.6 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 1.1 0.0 9.9 5.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 TMEM107 "JBTS29, MGC10744, MKS13" ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8172457-8176399 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease variant, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 110.8;Respiratory ciliated cells: 164.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" Yes No "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: AB_2681870, HPA059653: AB_2684096" "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favorable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 9.4 13.5 11.9 6.6 11.8 15.1 9.9 11.8 13.4 10.4 17.3 9.0 3.6 11.4 20.9 10.6 27.2 7.3 8.8 11.3 13.9 14.7 4.5 11.4 7.4 12.3 12.0 11.1 7.8 11.3 17.0 23.6 6.9 11.6 7.4 5.0 29.9 10.8 6.6 1.7 11.7 7.6 6.7 12.4 13.9 8.0 17.2 11.6 9.0 16.3 1.8 7.7 8.5 9.7 12.2 45.0 16.9 21.8 11.3 12.2 17.8 4.8 11.1 8.2 8.2 10.9 2.0 26.6 10.5 14.6 9.7 7.4 30.5 8.3 16.9 13.6 18.1 11.5 7.6 29.0 4.7 4.9 2.6 8.3 7.9 11.2 20.7 9.4 18.4 13.1 17.7 5.9 23.5 18.0 12.2 6.8 7.7 2.2 6.3 7.2 13.1 6.5 19.1 15.8 3.5 7.3 10.7 13.5 2.4 9.1 5.1 8.1 8.8 10.6 4.8 9.6 7.6 6.1 9.5 5.5 4.9 27.3 10.0 8.7 21.0 22.1 51.6 28.2 27.9 24.3 45.4 27.6 30.3 19.7 59.2 30.9 32.2 20.0 26.4 56.8 31.6 24.8 21.0 11.9 11.8 11.8 13.4 11.3 13.9 12.3 12.0 11.1 11.6 12.4 11.6 12.2 30.8 9.6 9.8 2.9 38.1 19.2 19.5 35.2 11.4 17.3 31.1 43.3 7.9 35.8 25.1 33.1 45.9 17.3 30.0 12.9 13.7 21.7 12.2 99.9 22.9 25.1 9.1 15.4 5.1 11.1 21.3 18.2 48.9 26.9 36.7 12.7 27.1 24.0 45.5 11.8 3.6 14.1 16.2 45.6 31.6 10.1 12.8 55.9 33.8 3.7 22.0 37.7 28.8 1.5 1.7 11.0 12.7 15.1 110.8 16.3 26.0 21.7 164.3 63.2 0.0 15.3 16.8 69.4 50.3 13.0 28.6 13.3 34.8 13.2 17.6 11.1 RRS1 KIAA0112 ENSG00000179041 "Ribosome biogenesis regulator 1 homolog" Q15050 8 66429014-66430733 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055549, HPA060937" Approved Supported Nucleoli NA No Nucleoli "HPA055549: AB_2682846, HPA060937: AB_2684390" "unprognostic (7.68e-2)" "unprognostic (1.02e-1)" "unprognostic (3.72e-2)" "unprognostic (5.25e-2)" "unprognostic (2.64e-1)" "unprognostic (3.84e-3)" "unprognostic (4.93e-3)" "unprognostic (2.82e-3)" "unprognostic (3.55e-1)" "unprognostic (1.96e-2)" "unprognostic (2.13e-2)" "unprognostic (1.01e-2)" "unprognostic (3.46e-2)" "unprognostic (8.61e-2)" "unprognostic (2.30e-1)" "unprognostic (5.29e-2)" "unprognostic (8.35e-3)" 16.2 14.7 11.1 12.1 10.3 6.6 14.5 9.9 9.7 14.3 10.4 15.2 8.3 19.4 3.9 18.4 16.7 3.6 15.4 8.9 9.2 9.2 15.0 9.9 10.3 14.7 10.4 8.0 17.3 41.3 6.1 6.2 5.9 10.8 11.0 5.3 4.5 11.5 7.0 50.4 16.0 12.1 7.4 10.4 13.2 19.1 5.1 12.0 6.6 8.5 14.7 9.6 18.8 13.9 10.8 68.2 83.7 16.9 35.7 17.8 14.3 27.2 41.7 18.3 31.6 23.3 37.7 43.8 91.3 14.2 22.1 44.6 62.5 41.7 47.5 34.7 50.6 70.2 72.8 25.4 67.8 26.3 43.6 37.2 18.9 37.7 34.9 46.1 12.9 20.8 27.5 64.7 37.6 23.3 78.6 87.3 79.2 109.5 76.0 97.2 18.4 21.6 38.3 44.8 54.9 23.0 50.6 20.4 33.4 48.9 17.4 57.6 38.5 36.0 58.5 53.4 49.5 97.5 67.1 64.7 69.8 27.2 68.0 40.4 0.0 13.1 1.0 14.1 17.5 24.8 9.3 17.6 16.5 22.7 8.8 16.1 18.8 0.4 17.3 12.1 10.6 14.2 10.2 11.1 10.3 9.9 9.7 8.9 9.2 14.7 10.4 8.0 10.8 10.4 12.0 10.8 8.6 32.1 16.2 3.6 10.0 70.0 42.9 17.9 20.5 9.7 11.8 9.9 29.6 8.6 18.3 12.9 12.5 21.2 13.1 7.1 11.7 28.7 0.2 6.9 16.4 14.6 6.7 13.2 1.5 28.3 23.1 13.6 11.7 8.9 7.6 11.5 12.5 14.8 20.3 6.7 2.8 13.4 8.2 12.2 11.9 1.0 19.0 9.8 23.2 0.0 15.6 8.6 26.8 0.5 2.0 22.1 9.5 17.3 8.7 37.9 3.4 30.0 9.6 13.1 19.7 28.9 21.6 6.2 16.8 19.6 59.8 38.6 20.1 17.9 22.1 30.6 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184379-67190185 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 45.0" "Cell type enhanced" "Detected in many" "Adipocytes: 26.4;Endothelial cells: 19.6;Granulosa cells: 20.8;Hepatic stellate cells: 28.9;Leydig cells: 15.5;Peritubular cells: 18.4;Theca cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HUVEC TERT2: 3.5;SCLC-21H: 6.4;SuSa: 2.1;TIME: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 4.6 0.4 1.9 0.4 0.0 4.2 1.0 0.8 2.3 0.1 1.3 0.9 2.8 0.1 1.4 1.8 1.1 4.0 0.4 0.4 7.2 2.1 10.0 1.4 0.7 0.4 0.3 3.6 1.7 0.8 2.0 5.9 1.1 2.4 0.4 0.2 1.6 0.6 2.1 1.2 1.8 0.9 0.0 45.0 1.5 2.1 0.3 0.1 7.2 0.8 0.2 1.7 1.3 0.7 0.1 0.0 0.7 0.2 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.8 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 3.5 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.4 0.8 0.7 0.1 0.0 0.1 6.4 0.8 0.8 0.1 0.0 2.1 0.6 0.0 2.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.4 0.4 1.0 0.8 0.4 0.4 0.7 0.4 0.3 1.1 0.0 0.3 0.7 26.4 0.0 0.0 0.3 0.3 0.9 2.1 2.8 5.7 1.5 3.0 5.2 1.6 0.0 0.4 3.7 0.0 0.6 0.2 4.6 7.9 1.0 2.0 0.1 0.3 19.6 1.2 2.7 0.1 3.7 4.3 2.6 1.5 0.4 0.0 20.8 28.9 1.4 0.8 3.3 0.3 3.4 2.0 1.9 0.2 5.5 15.5 1.8 0.0 1.0 4.0 0.3 0.0 1.0 0.0 0.6 3.1 18.4 0.0 0.4 8.9 0.2 0.3 0.9 0.0 0.3 1.1 4.0 8.6 1.2 2.0 0.8 0.2 32.5 2.7 1.6 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 4.1;testis: 2.6" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 145.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.7 33.8 0.0 0.0 0.0 0.1 18.3 0.2 1.4 0.0 0.0 0.2 0.5 0.0 0.0 0.0 7.5 0.9 6.4 0.1 0.0 2.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 145.3 0.0 0.0 0.2 0.1 7.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.1 0.0 0.0 1.6 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.5 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.4 6.4 0.0 0.0 8.9 0.1 0.0 0.0 0.3 RCC2 TD-60 ENSG00000179051 "Regulator of chromosome condensation 2" Q9P258 1 17406760-17439677 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072281 Approved NA NA 110000 "HPA072281: AB_2686505" "unprognostic (2.50e-2)" "prognostic favorable (3.31e-4)" "unprognostic (9.91e-2)" "unprognostic (1.72e-1)" "unprognostic (2.74e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (3.42e-8)" "unprognostic (3.05e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (1.73e-1)" "unprognostic (1.31e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (4.03e-8)" "unprognostic (6.81e-3)" "unprognostic (2.09e-1)" "unprognostic (9.44e-2)" "unprognostic (4.41e-2)" 18.1 18.6 14.3 19.0 13.2 33.5 22.4 13.7 13.7 23.9 12.5 20.8 11.5 18.9 9.9 65.7 16.4 11.9 12.6 13.0 13.0 18.0 16.0 24.4 27.9 14.8 14.3 11.4 22.3 21.5 9.5 11.5 16.3 14.7 22.5 17.8 3.1 36.3 7.9 8.5 54.0 27.8 10.3 15.6 39.5 18.4 20.8 15.2 34.5 19.1 4.2 35.5 19.9 31.5 15.3 62.2 34.3 68.4 57.9 25.3 25.4 56.6 24.3 20.9 49.2 40.4 37.0 83.4 133.8 80.4 25.3 14.5 67.4 121.0 70.0 34.1 64.3 61.1 117.6 50.5 36.0 31.8 142.7 79.7 40.5 51.8 55.1 48.7 30.7 53.3 88.7 82.4 188.4 22.0 62.9 117.4 115.9 94.7 76.0 26.0 155.7 68.6 86.5 37.3 29.0 102.9 72.6 61.4 59.5 93.6 56.7 53.2 91.3 41.9 44.8 56.0 18.1 51.1 81.7 72.9 165.8 19.3 158.6 90.9 0.9 1.9 0.7 1.4 2.6 1.2 1.6 1.1 1.4 3.1 1.7 0.8 1.4 0.1 1.7 2.1 2.5 1.0 1.1 14.3 13.2 13.7 13.7 13.0 13.0 14.8 14.3 11.4 14.7 15.6 15.2 15.3 22.6 25.6 15.3 16.6 26.4 46.5 14.7 25.3 27.9 6.6 36.5 34.3 0.9 18.6 26.6 22.0 10.4 25.0 32.2 27.5 3.9 24.4 6.8 28.0 38.3 24.9 24.1 28.8 11.0 22.7 48.9 17.4 14.8 37.5 17.7 55.9 17.5 7.3 32.6 6.7 4.9 25.9 24.4 31.4 70.0 21.0 9.3 43.0 16.0 20.6 27.9 15.3 22.6 20.6 15.3 28.8 20.6 6.0 25.9 32.2 7.5 7.0 17.9 5.4 0.0 20.7 16.7 17.6 21.2 42.9 64.5 16.3 19.7 25.6 36.4 19.4 OR13D1 ENSG00000179055 "Olfactory receptor family 13 subfamily D member 1" Q8NGV5 9 104694379-104695485 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055921 Uncertain NA NA "HPA055921: AB_2682970" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.1 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704312-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;skin 1: 1.0" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Distal tubular cells: 21.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026459, HPA037851" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026459: , HPA037851: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 1.0 0.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.2 1.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.6 0.0 0.5 0.3 2.9 2.4 4.7 1.4 0.6 1.3 7.5 5.3 1.7 0.0 3.1 23.9 0.0 0.0 1.0 1.5 21.5 3.3 1.4 5.3 1.2 0.9 3.6 0.0 3.2 4.3 0.0 0.7 2.0 5.8 2.5 0.7 0.4 0.4 1.5 1.7 1.7 5.8 8.2 0.3 1.0 4.6 1.5 0.6 0.0 0.0 0.7 0.5 2.1 1.5 0.3 9.5 2.6 0.7 0.3 4.0 0.3 2.2 6.1 0.9 0.0 0.5 1.0 0.0 0.4 0.7 1.7 0.0 2.9 3.1 2.8 8.4 C9orf50 FLJ35803 ENSG00000179058 "Chromosome 9 open reading frame 50" Q5SZB4 9 129612225-129620776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 8.6" "Group enriched" "Detected in some" 11 "Early spermatids: 60.9;Late spermatids: 233.9" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA026743 Enhanced NA NA "HPA026743: AB_1845829" "unprognostic (2.23e-1)" "unprognostic (3.80e-2)" "unprognostic (3.27e-1)" "unprognostic (2.05e-1)" "unprognostic (3.79e-3)" "unprognostic (5.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" "unprognostic (9.28e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (4.20e-2)" "unprognostic (4.01e-2)" "unprognostic (6.08e-2)" "unprognostic (1.24e-1)" "unprognostic (4.44e-3)" "unprognostic (5.28e-2)" 0.1 0.1 1.2 0.0 0.9 0.0 0.1 1.3 2.0 0.3 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.1 1.0 1.5 0.6 0.0 0.1 0.0 1.4 1.1 0.8 0.1 0.0 0.0 0.6 0.0 1.1 0.3 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.0 1.1 0.1 0.1 8.6 1.0 0.0 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 1.3 2.0 1.0 1.5 1.4 1.1 0.8 1.1 1.1 1.0 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.2 0.2 0.4 0.3 1.5 0.2 3.7 0.0 0.0 0.0 0.0 5.9 0.2 60.9 5.3 0.5 0.3 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.8 233.9 0.9 0.1 0.0 0.0 0.0 12.5 0.0 2.5 0.2 0.2 0.0 1.9 0.0 0.2 0.0 1.6 0.4 0.4 0.0 0.1 0.5 1.4 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 ZFP42 "REX1, ZNF754" ENSG00000179059 "ZFP42 zinc finger protein" Q96MM3 4 187995771-188005046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.1" "Group enriched" "Detected in some" 4 "Early spermatids: 44.8;Extravillous trophoblasts: 59.3" "Cancer enriched" "Detected in some" 41 "testis cancer: 40.5" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 13 "BEWO: 115.5;SuSa: 77.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB025557 Uncertain NA NA "CAB025557: " "unprognostic (2.30e-1)" "unprognostic (1.07e-4)" "unprognostic (4.88e-3)" "unprognostic (3.75e-1)" "unprognostic (1.77e-1)" "unprognostic (3.86e-1)" "unprognostic (2.27e-1)" "unprognostic (4.66e-3)" 0.0 0.1 0.3 0.2 0.5 0.4 0.1 0.5 0.5 0.0 0.3 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.4 0.6 0.2 0.3 0.1 0.0 0.0 0.0 0.7 0.4 0.1 0.2 0.1 0.1 0.1 0.7 0.5 0.1 0.1 0.1 0.5 0.2 2.1 0.5 0.2 0.1 0.0 0.2 0.1 0.0 0.9 0.3 0.0 0.1 0.2 0.0 0.0 115.5 0.0 0.1 0.2 0.2 0.2 0.0 0.2 0.1 0.1 0.2 7.5 0.2 0.0 0.4 0.2 0.1 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.4 0.1 0.1 0.5 0.3 0.0 0.4 0.2 0.3 0.3 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.1 77.1 0.1 0.2 0.0 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.4 0.2 0.2 1.6 0.2 0.3 0.5 0.2 0.4 0.5 0.4 0.3 0.1 0.5 0.4 0.4 1.3 0.7 0.2 0.3 0.4 0.1 0.3 0.5 0.5 0.5 0.3 0.1 0.6 0.2 0.3 0.4 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 59.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 9.4 0.1 0.0 0.0 0.2 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85683848-85686195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 44.0" "Cell type enriched" "Detected in some" 9 "Early spermatids: 434.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 3.1;SCLC-21H: 3.9;U-2197: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040628 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.6 0.9 1.2 0.3 0.7 0.0 1.3 1.5 0.7 1.0 0.9 0.6 0.3 2.6 1.0 0.3 7.9 1.0 1.0 0.5 1.5 1.1 0.2 1.1 0.3 1.5 1.2 0.5 4.8 0.1 1.3 1.3 0.7 1.5 1.3 0.7 1.6 0.3 1.5 0.4 0.4 0.5 1.5 1.6 0.5 1.1 44.0 0.8 0.4 0.2 0.4 0.1 0.8 0.6 1.2 0.0 0.0 0.0 0.0 2.3 2.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.1 2.5 2.1 2.5 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.1 0.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.1 1.3 3.9 0.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.1 0.0 4.8 1.7 0.0 2.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 1.5 0.7 0.5 1.5 1.5 1.2 0.5 1.5 1.6 0.8 1.2 0.1 0.0 0.6 1.0 0.0 0.3 0.1 1.0 0.0 0.3 0.4 0.4 0.1 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.1 434.9 7.3 2.0 0.4 0.0 0.0 0.5 0.0 0.1 1.7 0.0 0.2 0.0 0.4 0.4 0.0 1.7 6.7 0.6 0.1 2.0 0.8 0.0 43.1 3.1 0.2 0.0 1.9 0.0 1.0 0.0 0.5 0.5 0.0 0.0 4.5 0.4 0.0 0.0 1.5 30.2 0.8 0.0 1.7 1.4 45.9 1.4 0.0 0.3 0.0 0.2 0.8 0.0 0.1 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;choroid plexus: 3.8;testis: 7.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.6;Early spermatids: 18.8;Excitatory neurons: 13.1;Horizontal cells: 20.2;Inhibitory neurons: 24.0;Late spermatids: 28.6;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 15.6;Spermatocytes: 26.4;Spermatogonia: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 14.5;Karpas-707: 46.0;U-2197: 23.9;U-266/70: 35.7;U-266/84: 82.6" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.0 1.2 5.3 0.0 5.6 0.0 0.2 4.6 9.6 0.5 3.8 0.0 0.0 0.3 0.2 0.0 0.3 0.1 0.9 5.0 6.0 0.0 0.0 0.0 0.0 4.9 6.0 4.7 0.4 0.0 0.0 2.2 0.0 5.6 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.2 4.9 0.0 0.0 7.7 5.8 0.0 0.2 0.0 0.0 0.0 0.1 5.4 0.3 2.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.8 46.0 0.0 0.0 0.0 0.0 1.1 0.0 11.6 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.3 0.0 0.0 0.0 0.9 1.1 23.9 1.0 35.7 82.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.6 4.6 9.6 5.0 6.0 4.9 6.0 4.7 5.6 4.9 5.8 5.4 0.1 0.0 0.0 3.6 0.0 0.6 0.0 0.0 0.0 13.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.8 0.0 0.4 0.1 0.0 0.0 13.1 0.0 0.1 0.5 0.0 0.0 0.0 3.0 0.7 0.0 0.0 20.2 24.0 0.0 0.0 0.0 0.3 28.6 1.2 0.1 0.0 1.0 0.0 2.9 0.0 22.6 15.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.2 26.4 39.0 0.0 0.1 0.0 0.1 3.7 0.0 0.0 DPM3 "MGC125904, MGC125905, MGC34275" ENSG00000179085 "Dolichyl-phosphate mannosyltransferase subunit 3, regulatory" Q9P2X0 1 155139891-155140595 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014667 Approved NA NA 290000 "HPA014667: AB_1847848" "unprognostic (6.47e-2)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "prognostic favorable (7.09e-5)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.67e-2)" "unprognostic (6.83e-3)" "unprognostic (4.71e-1)" "prognostic favorable (8.97e-5)" "unprognostic (1.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.75e-1)" "unprognostic (1.50e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "prognostic favorable (8.64e-4)" 71.8 136.1 51.0 24.2 50.3 51.7 81.2 54.7 102.3 85.1 63.2 89.6 63.1 90.2 57.8 58.0 81.9 37.7 84.5 49.2 52.1 106.6 146.7 68.1 38.2 49.4 48.5 45.7 80.1 128.0 59.3 129.7 18.4 49.6 88.2 18.7 10.5 94.0 56.1 77.8 60.6 72.8 19.9 52.1 83.3 91.5 60.3 54.4 25.1 96.7 34.6 13.6 72.9 68.3 51.2 97.5 106.6 32.6 79.0 59.2 54.9 35.3 31.1 39.9 41.5 44.0 34.1 113.8 31.3 93.3 26.4 14.2 68.6 12.7 37.8 5.4 44.7 219.2 34.4 156.2 120.8 57.0 31.2 44.9 54.8 68.4 30.1 13.3 19.5 50.3 77.7 40.7 165.9 31.8 239.1 71.0 71.3 81.3 110.5 80.5 60.6 36.8 189.2 52.6 67.4 57.2 117.6 71.4 86.0 116.1 11.9 58.9 148.6 39.3 25.8 62.4 37.4 46.2 138.4 75.8 101.6 68.6 68.1 20.0 57.2 101.3 101.0 86.8 69.0 95.8 109.3 91.0 85.3 104.2 99.6 86.6 82.0 57.3 95.6 69.6 118.2 81.1 86.6 51.0 50.3 54.7 102.3 49.2 52.1 49.4 48.5 45.7 49.6 52.1 54.4 51.2 99.3 51.3 75.4 4.2 59.4 27.4 63.6 101.6 52.3 31.6 108.0 116.1 120.7 95.8 80.1 176.6 10.4 69.4 46.4 137.8 66.5 60.3 56.7 115.2 116.1 68.3 99.2 56.4 5.5 162.4 70.6 72.5 63.7 111.6 71.0 53.4 84.3 279.1 87.6 13.5 6.1 213.9 77.3 58.6 59.9 18.8 92.6 60.5 97.8 7.5 44.3 115.1 53.5 3.0 9.5 61.0 176.7 97.8 101.2 58.1 178.3 152.2 107.3 31.5 39.5 54.7 75.8 62.2 9.6 56.5 33.8 40.8 53.9 76.7 157.2 63.3 C12orf42 FLJ25323 ENSG00000179088 "Chromosome 12 open reading frame 42" Q96LP6 12 103237591-103495978 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 17.3" "Group enriched" "Detected in some" 13 "Early spermatids: 398.6;Late spermatids: 372.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.1;naive B-cell: 5.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.96e-2)" "unprognostic (1.05e-2)" "unprognostic (2.66e-1)" "unprognostic (9.83e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (8.96e-4)" "unprognostic (4.89e-2)" "unprognostic (2.20e-3)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-2)" "unprognostic (3.30e-1)" 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 17.3 0.0 1.5 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 5.1 1.3 1.6 0.2 5.3 1.4 1.5 0.0 0.0 0.0 1.1 2.2 1.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.5 27.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 398.6 0.0 0.0 0.2 0.0 0.0 8.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.2 372.8 2.8 0.9 0.0 12.2 0.3 0.0 0.0 24.6 0.7 0.0 1.1 1.5 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 10.7 2.3 0.0 0.0 0.0 3.3 0.0 0.0 0.1 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095039-144097525 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 737.0;tongue: 731.4" "Cell type enhanced" "Detected in all" "Distal tubular cells: 817.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 1125.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Approved Mitochondria NA NA 45000 Mitochondria "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favorable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 78.9 174.7 89.1 63.0 90.4 105.3 73.3 109.9 104.6 66.5 91.6 143.4 172.8 76.5 36.0 156.8 68.4 39.9 423.9 89.9 97.8 153.2 181.9 57.2 56.3 97.5 93.1 84.4 64.2 102.1 164.7 58.7 46.2 99.6 68.3 112.0 42.4 105.3 70.6 737.0 107.1 128.5 60.5 88.9 70.7 140.7 39.2 102.5 64.0 65.3 731.4 61.5 92.8 87.2 96.9 172.0 381.4 98.9 208.4 80.5 88.5 189.6 96.7 116.7 240.2 156.9 269.4 208.2 241.0 210.8 129.8 116.2 247.3 217.9 191.2 89.8 148.2 289.2 259.7 306.5 250.4 143.1 154.7 162.5 129.4 234.9 153.2 301.4 80.6 141.3 163.7 240.4 208.2 127.7 616.8 292.0 143.5 115.1 476.8 1125.5 253.7 132.4 422.1 199.7 273.0 263.3 117.2 267.8 365.7 200.0 54.0 302.5 233.2 108.8 152.1 321.6 169.6 299.7 229.1 179.7 183.8 193.2 261.9 198.4 185.7 340.4 95.7 131.6 360.4 139.8 208.7 108.1 141.5 444.1 180.3 104.9 134.6 32.7 187.8 278.8 251.0 158.2 397.1 89.1 90.4 109.9 104.6 89.9 97.8 97.5 93.1 84.4 99.6 88.9 102.5 96.9 77.0 19.2 29.3 23.5 94.0 156.1 191.9 394.8 62.6 113.6 110.7 102.6 402.3 181.6 156.0 79.1 81.3 263.6 61.7 516.1 817.8 239.9 81.2 59.1 68.1 88.0 146.4 130.6 14.4 289.1 257.1 102.8 144.8 60.2 59.7 89.2 62.4 239.4 246.3 87.5 21.6 390.4 272.6 104.8 139.4 88.6 88.9 101.4 179.7 12.2 208.4 115.2 92.7 12.1 17.5 290.6 332.5 90.7 149.9 237.9 570.0 468.6 86.1 100.9 72.3 109.4 250.6 83.1 116.7 212.9 163.7 236.8 63.8 197.5 602.6 258.3 PER1 "PER, RIGUI" ENSG00000179094 "Period circadian regulator 1" O15534 17 8140472-8156506 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 49.8;hTCEpi: 56.6;hTERT-HME1: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047947, HPA067064" Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA047947: AB_2680219, HPA067064: AB_2685774" "unprognostic (7.64e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.54e-2)" "unprognostic (1.20e-1)" "unprognostic (2.59e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.67e-2)" "unprognostic (6.21e-3)" "unprognostic (6.87e-2)" "unprognostic (4.68e-2)" "unprognostic (7.09e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.08e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-2)" 120.0 73.9 14.8 36.9 16.4 53.8 114.2 20.0 27.5 74.1 21.7 82.5 10.5 64.5 6.2 62.4 102.7 36.9 85.4 16.5 61.3 55.4 74.1 96.3 18.5 17.4 15.5 14.5 169.9 104.6 49.9 104.1 20.7 19.6 84.6 11.8 22.2 63.0 28.1 213.5 183.2 58.5 30.8 13.0 55.0 83.2 36.0 17.0 12.9 100.9 67.9 11.6 81.7 91.3 23.3 2.2 8.2 9.4 13.4 29.8 21.7 5.2 3.4 5.9 4.1 4.8 8.3 5.4 15.6 2.5 4.7 4.4 6.7 9.4 49.8 2.9 4.9 11.7 8.4 18.5 2.6 40.7 3.3 11.9 33.8 56.6 7.0 54.9 5.4 9.0 11.9 10.9 21.0 7.5 7.6 9.6 6.8 7.9 2.6 5.4 13.2 5.3 8.3 9.7 1.8 4.0 9.9 6.9 7.9 6.6 3.8 5.8 2.5 15.5 4.7 8.7 1.8 2.8 12.7 5.1 5.3 6.3 4.1 3.3 0.0 1.2 0.6 0.6 0.9 0.7 0.3 0.5 0.4 1.8 0.6 0.5 0.3 1.2 0.2 0.4 0.2 0.4 0.5 14.8 16.4 20.0 27.5 16.5 61.3 17.4 15.5 14.5 19.6 13.0 17.0 23.3 88.8 54.5 78.5 24.8 47.6 53.2 38.9 31.5 118.9 37.7 39.2 37.5 24.4 51.5 37.7 27.6 98.0 5.9 63.9 16.8 5.9 6.5 28.2 48.3 23.6 39.4 50.2 50.9 18.7 4.0 4.0 50.5 60.1 54.4 70.2 11.9 40.7 48.8 19.7 20.2 9.9 22.9 16.2 59.2 70.1 52.4 41.0 91.5 48.0 15.0 12.1 40.0 3.1 8.0 5.6 8.5 21.7 33.8 55.4 34.4 38.9 6.3 48.7 49.2 32.9 89.3 47.1 6.6 10.0 63.0 59.8 13.5 84.4 12.8 16.4 19.9 HTR1F "5-HT1F, HTR1EL" ENSG00000179097 "5-hydroxytryptamine receptor 1F" P30939 3 87792706-87993839 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 1.8;retina: 3.6" "Group enriched" "Detected in some" 7 "Excitatory neurons: 232.6;Inhibitory neurons: 79.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.3;LHCN-M2: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005555 Uncertain NA NA "HPA005555: AB_1856708" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.03e-2)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (4.78e-1)" "unprognostic (1.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (2.67e-6)" "unprognostic (1.25e-4)" "unprognostic (1.55e-2)" "unprognostic (3.33e-2)" "unprognostic (3.31e-2)" 0.5 0.2 0.0 0.0 0.2 0.6 0.4 0.0 1.5 0.4 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.3 0.1 0.0 0.6 0.0 0.1 0.3 0.1 0.3 1.8 0.7 0.1 0.0 3.6 0.0 0.3 0.2 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.3 0.5 0.1 0.2 0.2 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.5 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.6 2.2 0.0 0.0 4.6 0.0 0.4 0.0 0.0 0.0 0.1 0.8 0.3 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 2.2 0.0 3.0 232.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.1 0.0 0.6 0.5 0.2 0.0 0.4 1.8 13.1 0.2 20.4 0.0 2.5 3.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 19.7 0.1 12.7 0.3 1.9 0.0 0.0 0.0 0.2 0.2 0.1 0.1 TMTC2 DKFZp762A217 ENSG00000179104 "Transmembrane O-mannosyltransferase targeting cadherins 2" Q8N394 12 82686880-83134870 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 59.5" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 2152.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 32.0;WM-115: 80.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026954, HPA026955" Uncertain Approved "Plasma membrane,Actin filaments" No No "Plasma membrane" "Actin filaments" "HPA026954: AB_2256025, HPA026955: AB_10602282" "unprognostic (1.56e-1)" "unprognostic (5.62e-2)" "unprognostic (9.61e-2)" "unprognostic (7.38e-2)" "unprognostic (2.60e-2)" "unprognostic (3.66e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (7.16e-2)" "unprognostic (1.73e-3)" "unprognostic (5.06e-2)" "prognostic favorable (2.84e-5)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.06e-2)" "unprognostic (8.06e-2)" 3.7 0.8 10.5 4.8 32.9 2.1 4.6 17.6 16.8 4.8 0.0 9.0 2.8 5.4 4.5 9.9 10.1 7.9 1.9 7.9 18.7 6.6 1.2 6.5 1.9 25.6 27.8 3.7 2.0 4.5 2.9 3.5 3.4 29.8 6.2 5.7 5.6 6.9 11.3 1.2 4.9 4.7 6.9 13.4 1.3 10.3 3.0 21.8 1.5 6.4 1.7 2.2 7.6 7.4 59.5 1.7 6.4 32.0 0.2 4.3 3.9 2.9 2.1 0.7 1.7 0.3 0.3 3.4 0.0 0.5 11.9 1.2 2.8 9.7 4.9 0.5 7.5 5.8 0.0 5.2 0.2 0.4 2.2 1.0 1.1 4.3 0.2 1.6 3.4 2.7 3.5 0.0 4.2 0.4 3.4 1.6 8.8 1.1 6.0 5.3 0.0 1.3 0.6 2.9 14.1 8.3 15.1 2.9 4.6 21.0 5.4 4.9 0.5 1.7 5.3 1.8 7.2 2.7 7.8 5.7 1.2 1.2 3.8 80.2 0.0 0.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 10.5 32.9 17.6 16.8 7.9 18.7 25.6 27.8 3.7 29.8 13.4 21.8 59.5 10.7 9.6 8.9 333.3 2.0 14.4 15.5 12.0 18.2 38.1 8.9 5.5 1.8 11.5 18.4 14.7 8.4 13.6 3.1 3.6 0.0 5.4 12.9 13.5 7.5 10.3 2.4 0.8 117.1 8.2 1.7 9.8 12.8 13.1 0.0 0.2 2.5 1.4 1.9 8.4 377.0 9.8 2.0 6.6 9.6 5.0 5.9 6.2 32.0 86.2 9.3 13.9 1.0 38.7 2152.4 9.4 3.3 1.2 7.3 11.9 2.7 2.1 17.0 1.6 6.6 0.8 2.2 0.6 2.2 16.2 11.5 4.1 2.8 1.0 5.9 14.5 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120592-8124106 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9" "Cell type enhanced" "Detected in some" "Melanocytes: 3.6;Smooth muscle cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.0;Daudi: 6.0;HAP1: 8.3;HDLM-2: 6.5;HeLa: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA072105: AB_2686488" "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.3 0.1 0.3 0.0 0.3 0.0 0.3 1.9 1.6 0.7 0.0 0.3 0.0 0.7 0.0 0.3 0.5 0.1 0.9 0.5 0.1 0.4 0.0 0.9 0.1 0.2 0.2 0.5 0.9 0.1 0.4 0.4 0.6 0.8 0.4 0.0 0.5 0.7 0.0 0.2 0.5 0.2 0.0 0.1 0.4 0.2 1.2 0.7 0.0 0.5 0.0 0.1 0.2 0.8 0.4 6.0 0.4 0.5 1.8 0.1 0.2 0.2 0.3 0.5 0.5 2.2 0.1 0.3 6.0 0.1 0.0 1.0 0.7 8.3 0.7 0.0 6.5 3.9 0.2 13.9 0.1 0.7 0.7 0.8 0.1 1.1 1.8 4.4 1.0 0.1 1.0 0.2 2.9 0.2 0.1 0.1 0.3 0.2 0.5 1.5 0.6 0.3 1.2 0.2 0.0 0.3 2.9 0.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 1.3 1.4 2.1 3.9 0.9 0.4 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.9 1.6 0.5 0.1 0.2 0.2 0.5 0.8 0.1 0.7 0.4 0.9 0.0 0.0 1.0 0.2 2.2 1.0 0.3 1.2 2.3 2.3 1.7 1.3 0.0 0.1 1.8 0.0 0.0 0.8 0.2 0.0 0.1 1.7 0.2 0.1 1.7 0.0 0.0 1.1 0.0 0.0 1.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 2.0 0.3 1.8 0.0 0.0 0.5 3.6 0.0 0.6 0.9 0.0 1.0 0.0 0.0 0.0 0.4 0.1 1.6 0.0 0.1 0.2 0.7 0.0 1.5 5.9 0.1 0.6 1.0 1.6 0.3 0.3 0.0 0.2 0.2 FARSA "CML33, FARSL, FARSLA" ENSG00000179115 "Phenylalanyl-tRNA synthetase subunit alpha" Q9Y285 19 12922479-12934037 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001911 Enhanced Approved Cytosol NA NA 55000 Cytosol "HPA001911: AB_1848427" "unprognostic (1.52e-1)" "prognostic favorable (8.23e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.22e-4)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (5.76e-2)" "unprognostic (2.86e-1)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (1.45e-3)" "prognostic favorable (8.32e-4)" "unprognostic (2.59e-1)" "unprognostic (8.25e-2)" "unprognostic (1.84e-2)" 24.5 32.8 28.2 29.6 30.7 31.9 25.2 26.4 40.3 21.0 17.0 29.4 26.4 24.5 12.2 39.5 24.2 16.5 34.1 30.6 31.3 29.3 40.9 20.9 36.3 30.4 30.4 29.6 23.3 36.6 30.7 32.3 22.6 33.2 25.7 17.3 14.8 30.7 21.9 57.5 33.3 26.7 17.9 22.8 32.3 30.9 22.8 29.2 33.3 25.7 30.9 25.6 30.9 25.8 33.6 135.7 125.6 49.3 106.9 33.4 31.4 88.9 93.6 60.8 133.0 103.9 154.2 56.1 148.7 147.1 54.1 53.9 101.9 121.0 108.4 48.1 87.9 183.7 117.0 106.8 124.2 108.4 227.7 147.8 43.4 78.7 102.8 82.1 43.8 73.1 148.7 179.6 30.6 56.7 181.5 273.4 283.5 154.2 83.4 210.6 139.5 51.2 191.4 70.5 78.7 153.8 141.4 64.2 109.2 69.0 23.0 85.9 137.5 71.3 108.0 47.8 165.6 180.6 199.6 186.5 156.8 97.7 203.4 114.1 66.6 111.0 86.3 87.1 119.0 108.2 88.2 85.1 81.4 120.4 94.5 85.4 82.3 7.0 118.0 92.8 97.0 87.6 130.2 28.2 30.7 26.4 40.3 30.6 31.3 30.4 30.4 29.6 33.2 22.8 29.2 33.6 15.0 9.6 21.4 9.1 24.7 25.4 28.0 63.4 20.5 25.1 18.8 18.5 25.7 14.3 35.4 23.9 10.4 87.5 17.5 26.7 58.7 55.4 5.8 16.0 18.6 20.0 22.8 61.8 12.1 46.4 78.7 18.4 27.5 15.8 23.5 26.3 21.0 25.8 62.9 18.5 12.8 32.6 69.2 23.5 21.2 9.4 19.0 19.7 33.8 1.9 45.5 23.6 25.7 8.5 7.5 47.0 26.3 13.2 40.9 32.6 30.4 55.7 22.3 17.1 6.6 16.5 24.3 20.2 41.9 26.3 29.5 96.7 22.5 28.9 44.7 26.8 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606403-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 7.6 8.7 2.5 8.7 2.7 34.6 10.1 3.9 6.3 10.7 4.3 7.8 7.1 7.7 5.7 8.2 6.7 10.2 5.0 3.0 5.0 9.0 10.4 7.3 8.3 2.5 2.8 2.4 9.7 7.9 8.2 4.0 8.7 2.7 8.7 8.2 4.5 9.5 5.7 7.9 7.5 6.6 7.9 2.8 7.4 7.6 4.2 2.9 8.6 10.1 7.5 9.7 9.4 5.3 3.4 11.8 11.2 9.0 12.7 14.3 15.1 13.5 17.3 18.9 14.2 16.8 10.4 5.2 27.0 9.3 16.3 11.0 12.1 15.3 13.4 20.5 14.1 14.0 10.6 6.4 9.5 14.1 22.6 20.4 12.7 13.6 9.3 17.8 10.1 15.3 15.8 15.3 41.7 15.9 12.2 15.5 9.3 8.5 22.8 12.6 14.2 25.1 11.4 14.9 16.9 8.8 12.3 15.1 17.8 12.3 11.7 11.0 9.6 13.7 13.7 11.7 27.1 10.8 14.3 19.0 21.0 16.4 12.6 11.8 4.7 1.9 2.9 2.7 2.9 4.1 1.2 2.6 2.8 1.7 1.1 2.4 2.6 2.2 3.7 2.8 1.4 3.1 1.8 2.5 2.7 3.9 6.3 3.0 5.0 2.5 2.8 2.4 2.7 2.8 2.9 3.4 42.3 25.6 47.7 5.2 38.0 55.8 19.6 17.1 32.5 13.7 55.0 39.5 21.6 18.6 29.9 27.6 10.4 14.3 75.3 31.7 17.6 25.3 2.4 47.4 53.8 29.1 44.3 15.4 9.9 24.9 26.5 35.3 40.2 74.1 57.7 20.5 22.9 28.5 16.3 11.8 9.6 39.4 24.4 33.4 49.6 3.2 19.0 44.3 16.0 15.0 24.4 12.4 49.4 9.0 8.9 27.7 29.8 13.9 83.6 28.0 21.0 17.4 47.5 11.4 32.9 42.9 28.2 14.2 17.3 41.6 66.3 27.5 69.7 27.1 24.4 29.2 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23202696-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.9;testis: 12.5" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 38.5;Early spermatids: 40.2;Endometrial ciliated cells: 18.2;Late spermatids: 32.8;Proximal tubular cells: 17.9;Respiratory ciliated cells: 35.7;Spermatocytes: 70.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;SiHa: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038131 Approved Approved Vesicles,Microtubules,Mitochondria NA No "Vesicles, Microtubules, Mitochondria" "HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.0 0.2 1.8 0.2 1.5 0.3 0.1 0.8 1.4 0.1 4.0 0.1 0.5 0.2 1.4 0.1 4.9 0.2 0.7 1.5 2.2 3.5 0.4 3.0 0.3 1.7 1.5 1.3 0.5 0.2 0.4 1.2 0.1 1.5 0.0 0.0 0.9 0.1 0.1 0.5 1.3 0.3 0.0 1.2 0.2 0.1 12.5 1.3 0.0 0.6 0.1 0.1 0.0 0.0 1.7 0.7 0.1 0.9 0.1 0.0 0.2 0.3 0.1 0.0 0.9 0.8 0.2 1.3 0.1 0.1 0.8 0.1 3.0 0.1 0.3 0.8 0.3 0.2 0.3 0.7 0.2 0.5 0.1 0.2 0.2 1.0 0.3 0.4 0.1 0.0 0.1 0.3 0.5 0.0 0.3 0.1 0.2 0.5 0.0 0.1 0.1 0.1 0.1 0.7 0.2 0.5 0.2 3.9 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.8 0.2 0.1 0.5 0.1 0.0 1.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.0 0.2 0.1 0.2 1.2 0.0 1.8 1.5 0.8 1.4 1.5 2.2 1.7 1.5 1.3 1.5 1.2 1.3 1.7 0.0 38.5 2.4 0.3 0.0 2.8 0.1 1.9 0.0 0.4 0.0 0.0 1.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.9 0.2 40.2 18.2 0.2 0.1 0.0 0.0 4.7 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 32.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.2 0.0 0.7 0.0 0.0 0.0 17.9 35.7 1.6 6.6 0.0 0.1 70.1 5.2 0.0 1.3 0.0 0.3 0.5 0.1 0.0 SAMD4B "FLJ10211, hSmaug2, MGC99832, SMGB" ENSG00000179134 "Sterile alpha motif domain containing 4B" Q5PRF9 19 39342396-39385710 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016800, HPA059385" Approved Enhanced Cytosol No No Cytosol "HPA016800: AB_1856552, HPA059385: AB_2684000" "unprognostic (2.56e-1)" "unprognostic (6.76e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.17e-6)" "unprognostic (3.41e-2)" "unprognostic (8.66e-2)" "unprognostic (6.24e-3)" "unprognostic (2.31e-2)" "unprognostic (1.15e-1)" "unprognostic (4.98e-2)" "unprognostic (2.30e-1)" "unprognostic (4.92e-2)" "unprognostic (1.34e-2)" "unprognostic (1.32e-1)" "unprognostic (9.91e-3)" "unprognostic (2.12e-1)" "unprognostic (1.89e-2)" 44.9 40.0 34.5 24.7 42.7 20.5 42.5 29.3 37.8 53.2 15.8 43.3 19.0 50.1 16.9 65.5 47.7 26.9 36.8 32.5 31.1 32.9 31.5 46.1 15.2 49.9 43.7 26.4 61.3 34.5 36.6 48.4 26.4 47.4 42.2 15.9 23.6 43.1 33.6 36.3 53.6 35.2 28.1 36.2 33.2 40.6 41.8 37.7 19.4 44.5 19.4 15.2 46.5 53.4 51.9 97.8 131.0 65.6 49.7 62.7 75.1 54.1 55.1 60.0 43.2 35.7 114.6 53.2 32.3 70.2 88.4 56.0 46.2 65.3 50.4 29.5 65.3 106.1 32.4 55.5 48.6 64.7 35.5 32.7 74.1 58.5 70.8 52.3 52.6 41.3 42.9 97.6 34.0 53.3 65.8 38.1 17.3 52.2 63.5 51.6 45.9 42.2 28.3 36.3 77.8 66.6 65.0 72.1 48.8 39.2 49.4 39.5 37.8 54.6 70.0 50.6 153.5 97.8 64.0 62.2 35.8 93.4 26.7 70.2 1.2 1.0 1.5 1.0 0.4 0.7 1.2 0.8 0.9 0.8 0.6 1.3 0.9 2.7 0.9 0.3 0.9 0.3 0.5 34.5 42.7 29.3 37.8 32.5 31.1 49.9 43.7 26.4 47.4 36.2 37.7 51.9 28.8 12.8 30.4 55.8 21.6 33.3 62.7 22.4 12.0 56.9 37.1 32.9 8.4 24.3 18.9 36.8 166.8 25.7 21.7 26.4 5.9 26.2 6.9 44.9 42.5 31.9 51.0 19.8 26.6 27.3 23.1 39.1 19.9 55.3 18.9 39.0 36.8 26.6 20.7 52.2 31.0 28.1 10.2 25.5 38.2 5.4 43.8 28.5 19.6 25.3 18.4 31.4 16.5 34.2 106.0 41.0 19.6 33.1 19.3 65.7 20.2 12.3 30.7 67.9 65.7 43.9 30.9 70.3 42.7 15.6 43.5 54.6 20.4 33.8 24.5 65.9 CYP11B2 "ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo" ENSG00000179142 "Cytochrome P450 family 11 subfamily B member 2" P19099 8 142910559-142917843 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 763 "adrenal gland: 180.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049171, HPA049565, HPA056348, HPA057752" Supported Uncertain Mitochondria NA NA Mitochondria "HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516" 0.0 180.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIMAP7 "IAN7, MGC27027" ENSG00000179144 "GTPase, IMAP family member 7" Q8NHV1 7 150514872-150521073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 171.5" "Cell type enhanced" "Detected in many" "Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 92.9;MOLT-4: 78.6" "Not detected" "Not detected" "HPA020266, HPA020268" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA020266: AB_1849680, HPA020268: AB_1849682" "unprognostic (4.85e-3)" "unprognostic (1.65e-3)" "unprognostic (6.11e-2)" "unprognostic (1.32e-2)" "unprognostic (3.71e-1)" "prognostic favorable (7.43e-4)" "prognostic favorable (8.98e-5)" "unprognostic (6.49e-3)" "unprognostic (5.24e-2)" "unprognostic (6.12e-3)" "unprognostic (2.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.07e-3)" "unprognostic (2.07e-1)" "unprognostic (3.14e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" 50.3 15.1 16.7 74.3 17.4 6.6 37.8 17.3 21.5 19.4 17.6 20.5 21.3 28.1 19.9 12.7 21.7 22.3 35.9 15.6 17.1 21.1 20.6 61.5 171.5 19.3 17.8 14.4 7.5 7.7 10.5 5.6 31.7 18.7 11.0 23.5 1.2 13.9 12.1 28.0 9.4 40.4 33.9 17.4 125.4 22.2 4.6 18.5 53.0 28.4 56.6 100.0 29.8 13.1 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 92.9 9.4 0.0 0.0 0.0 0.0 78.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.7 656.5 9.6 1184.0 595.9 1164.2 6.5 1762.9 1440.6 286.3 6.5 2269.3 1597.2 52.5 1121.0 666.6 16.3 1076.9 2581.7 16.7 17.4 17.3 21.5 15.6 17.1 19.3 17.8 14.4 18.7 17.4 18.5 18.8 265.8 0.0 13.2 0.3 13.1 2.4 0.4 0.0 2.8 0.0 2.8 5.6 14.6 5.7 0.6 1.8 0.0 0.2 125.1 0.2 0.0 0.5 1.3 0.9 0.6 263.3 0.0 17.0 0.0 0.7 0.0 8.0 3.1 0.7 13.9 0.0 267.4 5.3 15.5 0.0 0.0 0.1 0.0 156.8 10.6 2.0 2.5 54.9 1.8 22.5 140.8 0.4 632.4 0.5 0.1 0.4 1.2 0.4 19.3 0.2 0.0 1.7 0.7 0.4 0.0 6.0 9.4 0.2 0.9 1.1 3.3 0.4 255.9 0.9 0.2 0.0 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skin 1: 50.8" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.1;Pancreatic endocrine cells: 6.3;Prostatic glandular cells: 1.8;Spermatocytes: 1.8;Spermatogonia: 1.7;Suprabasal keratinocytes: 1.8" "Group enriched" "Detected in some" 4 "cervical cancer: 1.1;head and neck cancer: 3.9;melanoma: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.4;HBEC3-KT: 10.1;hTCEpi: 7.3;hTERT-HME1: 13.7;T-47d: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: AB_2732385" "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.0 0.0 1.0 0.0 0.3 0.0 1.7 1.5 2.3 0.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.9 0.7 0.4 0.0 0.1 0.4 0.2 0.1 1.3 0.1 0.0 0.1 0.3 0.0 0.1 50.8 0.0 0.0 0.2 0.0 0.0 0.8 1.4 0.0 0.0 0.0 1.2 0.0 1.9 1.6 6.4 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.4 0.1 0.5 0.2 0.2 0.1 2.9 0.4 0.8 10.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.3 0.1 13.7 0.0 0.0 0.9 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 0.0 4.4 0.0 0.1 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 1.5 2.3 1.2 0.3 0.9 0.7 0.4 1.3 0.2 1.4 1.6 0.1 0.0 0.0 0.0 0.0 0.3 2.1 1.2 0.0 0.0 0.6 0.5 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.4 0.1 0.1 0.2 0.0 0.0 1.2 0.9 1.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 1.7 0.3 1.8 1.1 0.0 0.0 0.0 0.6 EDC3 "FLJ21128, hYjeF_N2-15q23, LSM16, YJDC, YJEFN2" ENSG00000179151 "Enhancer of mRNA decapping 3" Q96F86 15 74630558-74696292 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 117.2;Late spermatids: 192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040650, HPA044206, HPA066137" Uncertain Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA040650: AB_2677061, HPA044206: AB_2678857, HPA066137: AB_2685625" "unprognostic (4.22e-1)" "unprognostic (1.85e-1)" "unprognostic (9.13e-2)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (3.06e-1)" "unprognostic (2.58e-2)" "unprognostic (4.45e-2)" "unprognostic (1.33e-1)" "unprognostic (3.92e-1)" "unprognostic (1.19e-1)" "unprognostic (8.85e-2)" "unprognostic (2.80e-1)" "unprognostic (3.81e-1)" "unprognostic (4.81e-2)" 12.9 8.7 14.9 11.9 16.2 8.0 14.0 17.9 16.8 13.1 15.3 12.4 10.5 15.3 11.1 15.6 16.5 10.2 9.8 14.4 14.9 10.5 11.3 10.6 15.2 15.5 15.3 14.3 18.7 10.6 13.5 12.0 12.5 15.4 14.4 14.0 11.9 10.4 10.9 14.9 15.4 12.4 17.2 13.5 13.0 11.6 35.1 15.3 18.7 13.3 11.6 18.3 13.1 10.7 19.0 24.9 20.8 39.0 34.9 24.6 22.5 35.7 26.1 30.5 42.4 40.6 58.9 30.2 39.6 24.1 35.8 39.2 50.6 99.0 40.4 29.5 33.7 54.3 41.0 46.9 30.8 29.4 47.8 24.4 23.0 36.9 36.8 39.0 26.8 38.9 45.7 59.3 30.4 30.5 39.8 32.8 26.7 39.2 34.0 22.9 40.8 42.7 40.0 19.4 42.7 42.5 38.8 38.8 33.5 41.8 51.8 34.6 34.6 24.3 36.7 20.3 22.2 38.4 31.9 65.2 44.3 29.1 46.6 29.5 6.1 5.8 4.6 9.6 5.9 10.3 8.3 6.8 7.9 6.8 6.3 6.9 7.5 1.9 13.7 5.0 6.7 8.5 7.1 14.9 16.2 17.9 16.8 14.4 14.9 15.5 15.3 14.3 15.4 13.5 15.3 19.0 10.8 6.4 7.8 21.9 7.2 4.7 5.0 7.6 9.6 9.7 6.8 6.2 6.3 8.6 6.7 7.3 0.0 9.7 8.4 7.0 3.9 11.4 117.2 10.2 7.5 9.6 15.6 7.8 19.5 8.1 12.1 7.9 9.7 9.4 4.5 10.2 8.2 8.2 7.6 5.0 18.0 6.8 8.2 7.1 2.4 192.2 9.0 4.6 8.8 17.8 11.5 5.2 11.3 18.6 19.0 9.5 11.1 6.4 14.0 7.6 6.6 5.8 11.3 6.3 13.1 4.6 6.8 12.8 16.3 7.7 2.8 9.3 7.4 7.6 6.0 8.1 TCAIM "C3orf23, DKFZp313N0621, TOAG-1" ENSG00000179152 "T cell activation inhibitor, mitochondrial" Q8N3R3 3 44338119-44409451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.3" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.15e-1)" "unprognostic (9.21e-2)" "unprognostic (1.98e-1)" "unprognostic (4.24e-1)" "unprognostic (1.82e-1)" "unprognostic (8.55e-2)" "unprognostic (1.93e-3)" "unprognostic (5.07e-3)" "unprognostic (5.60e-2)" "prognostic favorable (2.19e-7)" "unprognostic (4.03e-1)" "unprognostic (1.49e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.81e-4)" 8.6 8.6 8.5 6.8 9.0 4.8 6.6 12.6 10.6 5.9 8.9 9.7 8.3 6.7 8.5 10.2 6.5 9.8 19.6 7.5 9.3 24.4 43.3 9.4 6.9 10.0 9.6 7.3 8.2 5.7 11.5 3.5 9.3 10.0 10.0 9.9 10.4 4.7 6.0 22.2 7.8 9.2 8.8 9.2 7.3 9.5 5.7 9.4 8.5 7.4 19.1 8.0 9.9 4.2 11.5 15.5 7.5 8.3 10.6 13.5 10.8 17.3 14.8 17.4 15.7 16.5 7.0 35.6 22.0 10.8 10.0 11.4 7.1 8.0 16.5 17.4 9.2 8.8 15.5 10.4 16.5 23.5 25.9 14.4 12.7 33.0 15.9 17.9 14.9 21.3 22.1 19.2 12.5 16.2 10.8 25.2 13.2 7.8 17.4 17.5 5.0 9.1 16.8 36.6 24.2 8.3 20.3 16.5 22.6 24.1 14.4 17.1 15.3 18.1 9.4 11.2 24.7 22.4 8.4 16.5 16.1 21.2 20.9 16.1 14.8 7.9 10.6 3.6 10.0 4.2 2.3 4.7 3.6 10.3 3.7 3.8 5.5 3.6 3.6 10.1 5.5 9.4 4.0 8.5 9.0 12.6 10.6 7.5 9.3 10.0 9.6 7.3 10.0 9.2 9.4 11.5 12.5 9.6 16.1 38.5 7.4 10.3 9.3 12.2 12.0 18.9 11.1 8.3 30.1 24.3 10.5 14.7 12.5 13.6 14.5 12.0 60.7 23.6 3.3 10.3 7.8 11.6 6.0 7.2 55.8 20.9 21.0 7.5 12.2 17.7 21.0 15.1 15.0 47.7 20.0 25.2 90.4 17.1 12.2 18.8 10.1 2.0 8.7 17.6 7.2 20.6 16.0 17.1 9.2 42.7 47.1 25.6 14.7 4.9 7.4 10.8 11.7 46.2 11.4 13.1 13.1 8.1 12.8 6.2 11.0 16.8 9.5 13.4 8.2 14.6 17.3 13.4 FUCA1 ENSG00000179163 "Alpha-L-fucosidase 1" P04066 1 23845077-23868290 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 165.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046542, HPA056371" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 60000000 Vesicles "HPA046542: AB_2679691, HPA056371: AB_2683108" "unprognostic (6.94e-3)" "unprognostic (6.53e-2)" "unprognostic (2.68e-3)" "prognostic favorable (2.45e-4)" "unprognostic (5.64e-3)" "unprognostic (2.59e-3)" "unprognostic (1.56e-2)" "unprognostic (1.79e-3)" "unprognostic (4.99e-1)" "unprognostic (2.18e-2)" "unprognostic (2.05e-1)" "unprognostic (4.23e-2)" "prognostic favorable (5.70e-13)" "unprognostic (3.75e-2)" "unprognostic (4.35e-2)" "unprognostic (1.54e-2)" "unprognostic (2.13e-3)" 34.5 34.8 8.5 50.3 8.7 7.8 26.6 8.5 12.1 55.0 22.3 125.3 91.2 20.9 114.0 17.1 51.6 47.0 20.8 8.3 12.3 78.9 105.7 55.6 169.6 9.5 8.5 8.1 24.0 24.1 57.3 17.8 73.3 8.9 50.7 142.0 5.7 41.1 61.0 15.9 15.0 82.0 26.9 9.1 72.4 64.5 27.9 10.3 27.0 71.3 17.9 94.9 75.6 13.3 12.9 15.9 10.6 2.2 31.9 4.2 0.3 11.0 16.6 34.4 17.1 31.6 14.5 165.1 23.9 40.9 21.3 18.8 9.4 15.3 35.4 22.4 16.9 25.6 19.7 9.2 32.7 14.2 2.0 62.7 15.3 19.7 6.2 8.1 55.2 6.9 13.3 9.3 0.5 20.6 17.5 5.0 17.7 5.4 48.1 16.9 26.9 0.2 26.2 63.5 40.5 10.9 10.6 47.9 18.5 26.2 17.9 13.6 7.8 1.8 5.8 9.0 38.9 5.6 28.5 31.0 8.5 14.5 58.9 9.5 54.8 100.4 51.9 27.2 99.9 23.1 23.8 19.5 22.9 44.0 14.1 18.9 22.0 12.8 44.6 91.1 25.4 21.4 64.8 8.5 8.7 8.5 12.1 8.3 12.3 9.5 8.5 8.1 8.9 9.1 10.3 12.9 12.9 25.6 28.6 4.2 10.5 3.6 27.4 99.3 6.8 4.4 22.2 10.4 5.6 40.0 77.8 84.6 0.0 181.7 13.9 226.6 15.6 64.1 61.0 31.5 2.8 11.6 10.8 20.6 5.8 50.3 24.2 16.7 33.1 13.3 8.2 11.1 25.7 42.7 156.4 0.0 6.3 44.4 44.7 121.0 13.5 24.4 23.3 85.4 8.8 2.8 29.6 13.0 10.3 4.0 4.7 34.9 221.0 19.5 8.7 23.6 210.9 40.2 53.7 5.0 6.6 16.7 13.2 109.0 24.8 8.5 2.8 200.6 11.2 34.6 79.5 40.3 PXT1 STEPP ENSG00000179165 "Peroxisomal testis enriched protein 1" Q8NFP0 6 36390551-36442854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 2.4" "Group enriched" "Detected in some" 4 "Spermatocytes: 10.6;Spermatogonia: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "HDLM-2: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA044042 Approved Vesicles NA NA Vesicles "HPA044042: AB_10963537" "unprognostic (1.85e-2)" "unprognostic (1.12e-3)" "unprognostic (9.92e-2)" "unprognostic (5.49e-2)" "unprognostic (4.43e-1)" "unprognostic (9.38e-2)" "unprognostic (2.28e-2)" "unprognostic (2.92e-3)" "unprognostic (4.64e-2)" "unprognostic (1.92e-1)" "unprognostic (5.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.94e-5)" "unprognostic (2.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.21e-3)" "unprognostic (2.61e-3)" 0.1 0.0 0.2 0.3 0.1 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 2.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.0 0.0 1.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.9 0.2 0.4 0.1 0.0 0.0 0.7 0.2 0.1 0.2 1.1 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.2 0.0 1.8 0.0 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.2 10.6 4.9 0.0 0.0 0.3 0.5 0.1 0.2 0.2 GGN "FLJ35713, MGC33369" ENSG00000179168 Gametogenetin Q86UU5 19 38384267-38388082 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 97.0" "Group enriched" "Detected in some" 4 "Early spermatids: 550.6;Late spermatids: 790.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.6;HEK 293: 1.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (8.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-2)" "unprognostic (6.22e-3)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.88e-2)" "unprognostic (1.64e-1)" "unprognostic (8.10e-2)" "unprognostic (1.06e-2)" "unprognostic (5.89e-4)" "unprognostic (4.86e-4)" "unprognostic (1.30e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (2.40e-1)" 0.3 0.3 1.2 0.2 0.7 0.3 0.5 0.9 1.1 0.4 0.0 0.3 2.9 0.4 0.0 0.4 0.3 0.2 0.3 1.0 0.4 0.6 0.1 0.5 0.0 0.9 0.5 0.3 0.3 0.3 0.3 1.3 0.0 1.3 0.8 0.0 0.0 0.7 0.2 0.7 0.7 2.9 0.1 0.5 0.1 0.3 97.0 0.6 0.0 1.1 0.0 0.0 0.3 0.5 1.9 0.2 0.4 0.1 0.2 0.0 0.2 2.6 1.5 0.3 0.1 0.3 0.6 0.3 0.3 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.9 1.8 0.2 0.4 0.2 0.3 0.7 0.0 0.1 0.0 0.4 0.0 0.7 0.7 0.1 0.8 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.6 0.2 0.2 0.0 0.6 0.3 0.2 1.6 0.2 0.2 0.0 0.1 0.3 0.0 0.9 0.2 1.3 0.9 0.7 0.2 0.6 0.0 0.9 0.3 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.7 0.9 1.1 1.0 0.4 0.9 0.5 0.3 1.3 0.5 0.6 1.9 0.2 0.0 0.0 0.0 0.2 0.5 0.8 0.8 0.0 0.6 0.8 0.6 0.6 0.0 0.3 1.8 0.0 0.1 0.0 0.2 0.0 0.5 550.6 0.1 0.1 0.9 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.3 4.1 0.0 0.4 790.0 6.5 0.6 0.0 0.0 0.0 1.3 0.0 0.5 0.1 0.6 2.5 3.8 0.0 0.5 19.8 0.2 0.0 0.1 0.0 0.9 0.3 148.4 3.7 0.0 0.3 0.4 0.1 0.1 0.5 0.2 HNRNPCL1 HNRPCL1 ENSG00000179172 "Heterogeneous nuclear ribonucleoprotein C like 1" O60812 1 12847377-12848720 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.9;Langerhans cells: 1.7;Smooth muscle cells: 2.7;Suprabasal keratinocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.13e-1)" "unprognostic (3.57e-1)" "unprognostic (2.57e-1)" "unprognostic (4.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (3.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.11e-1)" "unprognostic (1.05e-1)" "unprognostic (6.03e-1)" "unprognostic (1.71e-1)" "unprognostic (8.28e-2)" "unprognostic (8.64e-3)" "unprognostic (8.88e-2)" "unprognostic (3.43e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 2.7 0.1 0.1 0.0 1.7 0.3 0.1 0.0 0.0 0.5 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269983-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 76.4;pancreas: 90.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol Yes NA "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.3 0.7 23.6 3.2 35.1 0.2 11.7 32.0 27.6 16.6 18.1 21.3 35.8 1.6 18.4 11.0 15.6 11.4 0.5 21.9 26.4 14.1 1.1 76.4 0.3 37.8 34.4 19.6 1.4 90.4 22.3 31.2 4.4 35.9 22.2 21.2 0.1 32.1 7.2 0.0 12.5 27.7 0.8 30.0 0.3 27.7 1.5 30.3 0.4 45.3 0.0 2.5 3.0 3.4 48.6 26.8 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 20.6 48.3 0.1 1.2 0.0 0.0 11.7 0.0 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.1 0.1 1.1 31.3 0.0 0.0 0.0 0.7 0.4 8.5 12.4 0.1 0.0 41.2 0.0 3.6 33.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 23.6 35.1 32.0 27.6 21.9 26.4 37.8 34.4 19.6 35.9 30.0 30.3 48.6 0.2 121.8 136.9 0.0 0.9 0.0 2.3 18.0 0.6 0.0 30.4 15.2 0.5 42.9 56.0 16.5 0.0 33.5 0.1 72.7 17.6 39.1 3.7 20.1 1.4 0.6 21.7 0.0 0.2 38.5 2.2 0.6 45.3 13.1 1.3 4.9 0.0 0.0 2.4 0.0 0.2 63.0 34.6 0.0 0.2 7.9 0.3 0.6 0.0 0.0 0.6 1.7 1.0 0.0 55.3 22.7 40.1 1.2 0.6 12.2 164.2 33.9 43.8 0.0 0.0 0.0 2.3 1.4 0.3 2.1 0.4 7.3 1.0 0.1 38.6 9.1 ZNF664 "DKFZp761B128, ZFOC1, ZNF176" ENSG00000179195 "Zinc finger protein 664" Q8N3J9 12 123971845-124015439 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 151.6;Late spermatids: 301.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047846 Approved Nucleoplasm NA NA Nucleoplasm "HPA047846: AB_2680179" "unprognostic (4.16e-2)" "unprognostic (1.32e-1)" "unprognostic (5.75e-3)" "unprognostic (1.90e-2)" "unprognostic (8.12e-2)" "unprognostic (3.79e-1)" "unprognostic (2.49e-3)" "unprognostic (3.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (1.85e-2)" "unprognostic (1.85e-2)" 52.8 30.6 82.9 25.6 89.6 12.9 42.8 90.5 92.6 44.8 72.5 51.5 79.3 38.9 71.6 28.4 56.7 33.9 49.2 73.5 86.7 60.5 45.2 44.3 24.1 88.0 90.2 65.6 30.3 60.8 128.2 38.6 36.7 92.8 43.0 59.4 71.6 55.9 38.8 51.1 17.8 82.7 30.0 93.8 25.0 43.7 20.2 85.2 33.9 92.5 57.4 29.2 31.1 27.8 96.0 87.5 60.0 93.9 98.6 71.9 54.4 79.8 50.1 67.2 50.6 41.3 75.1 46.7 85.4 59.4 68.1 36.6 74.8 135.7 61.5 93.1 72.7 98.6 132.9 79.1 64.2 86.5 81.2 70.2 34.7 134.6 52.8 85.8 119.1 81.8 82.3 82.9 35.0 45.5 67.4 80.5 37.0 88.1 85.6 129.7 69.5 91.4 51.9 110.5 141.9 193.9 140.7 86.0 90.4 85.6 77.9 161.6 42.6 54.0 43.6 70.5 62.5 52.5 48.0 64.2 65.8 75.8 55.9 68.7 0.0 0.2 0.2 1.0 0.1 1.5 0.7 0.8 0.8 0.4 1.0 0.9 0.8 0.1 0.6 0.0 0.3 1.5 0.6 82.9 89.6 90.5 92.6 73.5 86.7 88.0 90.2 65.6 92.8 93.8 85.2 96.0 15.2 25.6 57.8 0.0 16.7 12.6 14.5 18.6 33.0 28.4 39.3 21.2 58.7 28.6 36.1 20.2 20.9 9.9 8.9 72.5 29.4 35.0 151.6 52.7 19.7 20.3 43.8 22.7 0.0 31.6 8.8 22.1 37.2 38.0 13.3 26.7 23.6 43.5 12.3 32.0 0.0 60.3 32.6 15.1 10.5 301.5 23.3 10.3 21.4 0.0 6.8 29.3 9.2 0.0 0.0 43.0 42.8 17.3 38.6 32.0 94.0 30.5 74.1 30.4 19.7 19.2 24.8 32.9 24.5 32.5 8.8 10.0 14.5 22.4 57.5 20.1 SIGLECL1 "C19orf75, FLJ40235, SIGLEC23P, SIGLECP7" ENSG00000179213 "SIGLEC family like 1" Q8N7X8 19 51246348-51269330 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 22.7" "Group enriched" "Detected in some" 8 "Early spermatids: 46.6;Late spermatids: 65.9;Spermatocytes: 73.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079471 Enhanced NA NA "HPA079471: " "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 65.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALR "cC1qR, CRT, FLJ26680, RO, SSA" ENSG00000179218 Calreticulin P27797 19 12938578-12944489 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1717.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001513, HPA002242, CAB019952, CAB079775" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 210000000 "Endoplasmic reticulum" "CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (8.46e-2)" "unprognostic (4.25e-2)" "unprognostic (9.44e-3)" "unprognostic (6.93e-2)" "unprognostic (2.47e-2)" "unprognostic (4.60e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.10e-4)" "unprognostic (2.07e-1)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.37e-1)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (5.27e-2)" 298.1 259.7 209.0 356.1 208.4 559.5 220.8 242.7 214.2 258.4 305.2 307.5 289.9 278.1 653.4 340.9 269.0 165.6 297.6 201.0 290.3 298.1 788.7 311.6 231.9 267.4 227.6 185.1 274.5 322.4 294.6 286.7 406.6 250.3 280.4 340.0 97.1 301.7 249.5 120.8 180.4 279.5 352.9 255.3 279.5 303.2 166.5 274.3 247.6 709.3 105.6 322.0 254.6 238.6 295.5 1681.4 673.6 832.5 1984.9 1110.8 861.5 724.6 2075.3 1160.8 839.6 1280.4 1044.2 1353.5 1087.2 1960.0 2528.4 1064.5 672.1 906.1 1476.5 800.7 730.0 588.1 894.3 689.0 1619.6 2667.5 3638.5 1171.8 946.8 638.7 1222.3 957.7 1472.5 1507.8 743.1 814.5 536.3 911.7 1222.3 1040.0 2511.9 808.7 952.0 970.1 777.0 770.8 1329.9 1138.3 846.9 312.4 668.4 1438.7 769.8 472.6 789.9 1014.4 1558.9 1460.6 1113.2 666.2 1533.6 938.3 644.3 569.7 985.8 1567.6 1616.3 1258.1 67.5 72.8 39.7 172.8 147.8 119.3 90.0 99.7 130.0 76.3 77.5 73.0 134.4 23.8 103.1 122.7 215.6 83.4 75.8 209.0 208.4 242.7 214.2 201.0 290.3 267.4 227.6 185.1 250.3 255.3 274.3 295.5 385.2 147.4 160.7 34.6 385.7 261.7 336.3 217.3 221.4 76.8 214.9 140.8 43.7 163.0 175.4 222.5 127.2 652.9 515.5 524.4 64.6 582.7 27.8 206.3 364.2 305.6 353.6 266.1 14.2 285.5 1717.5 422.5 289.5 348.2 207.4 341.6 312.7 612.4 789.3 35.3 23.8 595.1 93.6 208.8 433.2 30.6 318.7 378.4 213.5 31.9 229.9 316.5 360.5 28.6 31.1 410.2 462.8 311.1 1059.6 426.1 377.8 182.8 147.5 167.7 203.8 224.2 328.9 276.1 306.6 245.5 213.5 964.4 345.8 399.4 471.4 329.6 MAGED1 "DLXIN-1, NRAGE" ENSG00000179222 "MAGE family member D1" Q9Y5V3 X 51803007-51902354 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 335.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 534.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043645 Approved Cytosol NA NA Cytosol "HPA043645: AB_2678597" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (1.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-3)" "unprognostic (2.04e-2)" "unprognostic (3.92e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-3)" "unprognostic (1.42e-1)" "unprognostic (6.10e-3)" "unprognostic (2.14e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.71e-3)" 32.7 126.4 62.6 38.1 73.7 16.8 38.4 35.8 72.4 100.5 83.8 40.4 32.7 57.7 103.3 26.9 65.2 59.4 70.9 68.6 89.2 43.3 72.0 40.8 29.5 55.8 55.7 66.4 63.0 80.9 77.4 158.2 117.2 64.7 72.4 40.0 37.5 86.0 89.8 47.2 28.7 32.6 78.3 46.8 35.7 55.1 57.0 72.0 49.5 74.3 39.5 31.8 45.8 35.8 71.2 21.3 76.2 238.5 205.8 184.3 330.4 128.1 281.2 357.7 152.5 240.0 157.3 71.0 29.9 53.6 534.9 54.4 15.6 215.5 99.6 113.2 31.8 83.1 20.3 0.4 205.7 140.9 75.8 35.8 312.2 35.0 128.6 29.1 267.7 184.8 77.1 31.5 57.6 310.5 194.8 87.7 25.4 187.6 69.4 154.3 88.4 154.2 4.1 156.7 37.4 60.9 340.1 0.0 80.6 41.9 232.0 145.6 18.8 185.6 66.1 166.5 234.7 31.8 37.5 59.5 60.3 257.9 6.9 175.1 1.5 4.4 3.1 21.1 6.0 18.7 17.2 13.7 18.5 13.2 19.4 17.1 20.5 1.3 16.3 6.1 55.8 21.1 14.3 62.6 73.7 35.8 72.4 68.6 89.2 55.8 55.7 66.4 64.7 46.8 72.0 71.2 12.2 76.9 34.5 85.8 17.1 11.5 20.4 48.1 12.5 33.2 41.9 27.9 53.4 32.9 63.8 35.0 8.4 335.2 17.1 18.6 29.4 47.9 2.5 35.6 73.4 24.5 57.1 13.9 97.5 49.9 171.5 69.5 34.7 54.3 17.7 60.7 39.7 62.5 114.6 45.4 138.5 74.4 54.9 9.2 6.8 10.0 43.2 6.3 24.9 42.2 4.9 39.7 13.4 101.6 55.0 33.5 13.5 57.6 72.6 20.2 15.9 33.2 48.3 12.5 13.1 28.2 50.0 5.7 5.9 12.4 8.2 185.7 11.9 169.9 25.2 18.8 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381303-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 14.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.9;Distal tubular cells: 9.8;granulocytes: 3.8;Granulosa cells: 7.0;Proximal tubular cells: 6.7;Theca cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" NA NA "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: AB_2683429" "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 1.0 1.5 1.3 1.4 1.6 1.1 1.9 3.2 2.1 1.7 3.5 1.2 1.4 1.8 1.9 0.4 2.0 0.7 0.9 1.3 0.6 1.4 0.7 0.9 1.9 0.7 0.2 1.7 2.2 6.6 1.0 2.4 0.8 1.3 1.2 1.5 14.3 1.9 0.8 1.1 1.4 1.3 0.9 0.1 1.7 1.4 3.4 0.8 2.4 1.9 0.6 1.6 0.9 1.3 1.8 1.1 1.2 4.4 3.2 1.2 1.6 1.5 0.6 0.5 1.1 1.1 3.0 2.0 3.6 1.2 0.5 1.3 2.6 1.9 0.8 1.9 2.0 1.2 1.9 5.0 1.3 0.7 2.5 1.2 0.7 1.2 1.4 0.8 1.0 0.9 4.9 1.2 2.3 0.4 1.3 2.4 3.8 0.9 0.9 1.4 3.7 2.9 1.9 0.7 0.8 6.5 2.9 1.2 0.7 0.7 1.7 2.1 0.8 0.6 2.1 2.2 3.2 0.7 2.1 1.6 4.6 0.8 1.7 1.1 1.5 0.3 0.4 0.4 0.2 0.3 0.5 0.6 0.5 0.2 0.6 0.6 0.6 1.0 0.8 0.2 0.3 0.8 0.2 1.3 1.6 3.2 2.1 1.3 0.6 0.7 0.2 1.7 1.3 0.1 0.8 1.8 2.1 0.0 3.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 2.3 0.0 0.0 2.5 1.8 0.0 1.1 1.7 0.0 9.8 1.2 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.6 0.6 1.4 0.0 0.6 3.8 7.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.7 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.9 5.5 0.0 0.0 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 92.4;Excitatory neurons: 68.6;Microglial cells: 104.9;Oligodendrocyte precursor cells: 308.6;Oligodendrocytes: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 4.8;non-classical monocyte: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 63.7;RH-30: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavorable (2.14e-5)" 10.9 4.5 11.5 4.7 13.1 1.4 18.8 20.4 10.1 7.3 6.7 3.1 2.0 8.6 3.2 6.8 5.9 4.9 3.4 9.5 12.0 2.9 1.7 3.9 3.6 19.9 16.9 7.5 11.3 3.9 1.3 5.1 2.3 17.3 11.3 2.1 1.1 20.8 4.2 5.6 13.8 3.6 5.4 18.1 2.1 3.7 3.6 15.5 3.6 3.3 3.0 3.6 5.9 6.9 20.6 11.5 10.7 32.3 19.7 25.2 27.5 24.7 6.5 5.8 14.3 12.7 8.0 7.0 0.0 4.8 7.1 21.4 5.7 10.0 14.6 19.9 1.0 21.1 36.5 6.6 2.3 33.2 8.0 4.0 33.1 63.7 6.5 56.0 5.8 24.3 0.0 9.6 1.3 26.7 6.4 0.0 1.8 13.3 1.2 18.4 0.0 60.3 3.5 2.5 1.6 11.0 24.8 11.3 12.2 36.6 12.5 16.9 10.6 24.7 17.0 15.3 1.4 21.8 0.7 0.0 0.0 8.6 9.6 31.3 1.4 4.8 0.5 0.0 4.5 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 6.4 0.2 0.0 1.8 11.5 13.1 20.4 10.1 9.5 12.0 19.9 16.9 7.5 17.3 18.1 15.5 20.6 3.5 0.0 3.2 92.4 0.5 15.4 7.4 3.6 10.8 0.4 31.1 12.1 0.6 0.0 1.7 0.0 0.0 2.6 0.7 0.2 0.0 3.8 13.0 1.2 10.8 15.4 0.0 2.5 68.6 1.1 13.1 9.1 0.5 0.9 0.0 11.4 25.4 0.6 4.0 0.0 8.4 0.0 0.0 15.4 4.9 22.6 9.6 9.5 7.2 104.9 6.2 0.9 0.0 308.6 215.5 1.2 0.1 24.8 0.1 20.3 0.0 1.8 0.8 0.1 13.1 21.3 9.9 0.4 3.0 19.3 26.0 1.4 1.1 9.8 0.5 3.4 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252261-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.6;lymphoid tissue: 3.8;ovary: 6.4;skeletal muscle: 3.8" "Cell type enhanced" "Detected in some" "Astrocytes: 157.0;Excitatory neurons: 54.4;Inhibitory neurons: 70.0;Oligodendrocyte precursor cells: 108.0;Skeletal myocytes: 28.7" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 10.8;hTERT-HME1: 14.1;U-2 OS: 19.4;U-251 MG: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" NA NA 19000 "Plasma membrane" "HPA015613: AB_2732414" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 0.1 1.3 7.6 0.0 4.1 0.1 0.2 0.0 3.4 0.5 0.0 0.2 0.0 0.2 0.0 0.2 0.6 0.1 0.1 3.2 3.4 0.3 0.2 0.3 0.0 1.7 2.0 3.4 6.4 0.5 0.1 0.5 0.0 1.6 0.3 0.0 0.8 0.3 0.8 3.8 0.7 0.2 0.0 0.0 3.8 0.2 0.9 7.4 0.2 0.3 0.0 0.0 0.2 0.2 1.3 0.1 1.2 10.8 0.0 0.2 0.7 0.2 3.1 0.0 5.6 0.6 0.3 0.0 0.0 0.3 3.7 3.6 4.1 0.0 6.2 2.2 0.3 0.0 0.0 0.1 0.1 7.1 0.0 0.1 1.1 1.4 1.1 14.1 3.0 1.2 0.4 0.0 0.1 2.1 0.4 0.1 0.1 1.3 0.0 0.1 0.0 0.0 1.6 3.2 0.0 1.0 2.7 0.0 0.1 0.1 1.6 0.0 0.0 0.0 0.0 19.4 0.1 35.2 6.3 0.1 0.1 6.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.6 4.1 0.0 3.4 3.2 3.4 1.7 2.0 3.4 1.6 0.0 7.4 1.3 0.0 3.2 0.0 157.0 0.0 0.3 0.4 0.0 0.0 1.8 0.4 0.9 1.6 0.0 0.7 0.0 2.1 0.0 0.1 0.1 0.0 1.3 0.9 0.1 0.3 0.2 0.0 0.0 54.4 0.0 0.0 1.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 16.8 70.0 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.0 10.3 0.0 19.9 0.0 108.0 24.9 0.2 0.0 0.4 0.0 0.6 0.0 0.1 0.0 1.6 0.0 28.7 0.4 0.1 2.2 0.0 0.3 0.0 0.1 0.4 0.0 0.3 SMCO3 "C12orf69, LOC440087" ENSG00000179256 "Single-pass membrane protein with coiled-coil domains 3" A2RU48 12 14804650-14814182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 3.5;kidney: 3.0" "Cell type enhanced" "Detected in some" "Cholangiocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 5.9;Erythroid cells: 2.7;Hepatic stellate cells: 4.6;Proximal tubular cells: 7.3" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 7 "spinal cord: 3.6" "HPA040574, HPA047804" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040574: AB_2677026, HPA047804: AB_2680160" "unprognostic (1.16e-1)" "unprognostic (2.09e-4)" "unprognostic (2.40e-4)" "unprognostic (5.10e-2)" "unprognostic (3.88e-2)" "unprognostic (6.45e-2)" "unprognostic (4.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (3.66e-2)" "unprognostic (1.48e-8)" "unprognostic (2.85e-1)" "unprognostic (7.53e-3)" "unprognostic (2.05e-1)" "unprognostic (1.38e-1)" 0.5 0.4 0.1 0.1 0.1 0.3 0.2 0.0 0.1 3.5 0.4 0.2 0.0 0.3 0.1 0.1 0.3 1.9 0.6 0.1 0.1 3.0 1.5 1.1 0.5 0.1 0.2 0.0 0.2 0.2 0.5 0.2 1.1 0.1 0.8 0.1 1.3 0.1 1.6 0.1 0.1 0.1 0.1 0.1 1.8 0.1 0.2 0.1 0.0 0.8 0.0 0.1 0.1 0.6 0.3 0.0 0.0 0.1 1.9 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.5 2.8 0.0 1.8 0.0 0.1 0.0 0.0 5.9 0.2 0.0 0.0 0.2 0.3 0.0 2.7 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 4.6 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 7.3 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 993.4;tongue: 451.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 901.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 78.3 63.9 73.3 49.8 75.0 86.5 71.6 72.9 96.4 57.4 66.9 79.6 48.8 65.5 31.5 70.7 64.6 38.5 133.7 74.7 74.8 54.4 70.9 67.0 56.4 75.4 73.0 71.9 56.7 77.4 66.6 48.1 55.9 77.3 58.0 36.1 24.7 68.6 53.0 993.4 72.9 53.2 55.3 73.3 54.9 67.0 49.1 74.7 53.5 55.3 451.9 44.3 79.2 57.6 79.1 138.0 52.6 55.7 57.4 91.5 104.1 94.7 66.1 130.2 152.6 137.2 59.8 95.3 117.3 150.0 99.4 104.4 102.7 78.0 137.7 55.9 170.0 109.8 47.2 57.3 58.3 181.7 102.1 130.7 107.9 199.6 110.1 208.9 89.7 105.4 188.0 124.1 102.1 138.2 139.8 126.6 124.2 76.5 124.6 135.6 65.4 59.4 189.6 118.9 53.8 104.3 81.8 75.4 129.1 145.8 40.2 100.4 173.7 82.5 214.9 57.4 263.3 203.9 148.2 133.8 86.0 177.9 193.3 183.2 31.3 76.3 64.9 81.1 102.4 87.3 77.5 66.8 69.1 68.3 73.5 63.3 73.4 9.2 79.1 105.3 86.0 82.0 69.1 73.3 75.0 72.9 96.4 74.7 74.8 75.4 73.0 71.9 77.3 73.3 74.7 79.1 120.2 86.6 56.2 11.8 127.6 120.4 176.8 165.2 122.3 51.7 110.3 121.3 59.5 108.7 108.4 55.2 20.9 212.0 99.6 95.7 166.3 179.5 193.1 74.3 76.9 120.4 87.3 901.4 22.0 191.0 240.1 101.4 101.9 74.1 111.5 77.7 86.4 96.2 175.3 52.2 22.9 138.5 136.3 88.3 170.3 44.1 118.4 119.6 142.3 12.2 182.5 73.9 94.7 15.6 25.8 184.1 119.0 114.0 159.0 351.3 139.9 163.3 91.1 56.1 111.7 138.3 129.3 263.6 179.6 153.3 146.5 244.8 113.0 117.8 154.8 211.1 PCARE "C2orf71, FLJ34931, RP54" ENSG00000179270 "Photoreceptor cilium actin regulator" A6NGG8 2 29060976-29074523 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "retina: 28.7" "Cell type enriched" "Detected in single" 20 "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.28e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (3.15e-1)" "unprognostic (1.88e-1)" "unprognostic (5.88e-3)" "unprognostic (6.68e-3)" "unprognostic (1.21e-1)" "unprognostic (6.61e-2)" "unprognostic (3.81e-2)" "unprognostic (2.37e-1)" "unprognostic (2.08e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-4)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.4 0.4 0.0 0.1 0.0 0.2 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.7 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.8 0.1 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957223 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 30.5 46.7 24.0 14.2 24.0 20.8 30.1 23.9 41.7 31.1 22.1 34.9 12.6 34.6 7.7 42.1 30.9 7.6 66.2 23.6 24.9 41.2 52.6 25.4 13.6 26.4 24.6 23.2 28.9 39.3 11.7 34.9 11.1 25.4 37.4 4.8 7.5 29.1 9.6 80.8 31.0 25.6 6.9 23.5 32.8 33.4 22.8 26.8 8.9 31.1 23.3 6.5 36.6 28.6 26.3 68.7 56.9 23.5 33.2 16.1 20.8 32.7 49.4 24.5 48.2 39.5 79.1 27.1 49.1 79.8 29.8 34.7 47.0 28.9 48.2 12.4 32.1 140.5 34.9 78.6 90.2 39.2 58.2 51.3 24.7 38.4 33.6 27.5 25.7 28.3 46.1 53.6 18.8 30.3 100.6 93.2 122.8 65.0 44.0 176.7 68.1 23.7 79.2 38.1 39.9 71.9 65.7 36.8 49.3 60.4 11.6 38.4 54.7 46.4 93.0 32.9 81.7 92.3 73.4 55.1 52.0 64.5 72.7 54.8 13.4 35.6 12.6 33.3 34.6 33.1 102.5 51.3 53.1 43.6 84.1 55.1 40.0 2.1 39.9 29.9 41.4 46.9 29.5 24.0 24.0 23.9 41.7 23.6 24.9 26.4 24.6 23.2 25.4 23.5 26.8 26.3 111.9 41.7 51.6 6.5 132.4 145.4 189.2 198.9 83.6 59.9 127.0 141.1 157.0 114.4 123.4 138.0 22.9 321.9 101.5 232.1 401.1 265.8 41.8 166.8 139.9 151.8 139.1 159.3 6.1 381.7 355.8 138.3 88.2 130.6 73.6 158.1 146.7 288.8 245.5 37.0 8.1 205.7 101.7 132.9 228.9 56.0 191.3 106.0 179.7 8.4 253.1 103.9 95.8 7.1 14.7 311.5 138.3 170.4 142.4 247.0 215.9 616.7 160.6 88.8 190.7 141.0 164.4 85.4 129.4 153.3 160.8 204.3 105.6 235.8 258.9 171.0 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974760 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 8.6" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 17.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 19.8" "Not detected" "Not detected" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.1 0.9 0.4 0.1 0.4 0.7 0.3 0.8 0.6 0.1 1.3 1.4 0.2 0.1 0.2 0.1 0.1 0.3 8.6 0.4 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.3 0.1 0.2 0.8 0.1 0.0 0.7 0.1 0.3 0.7 0.4 0.0 0.1 0.3 0.3 0.3 0.2 0.0 0.3 0.3 0.3 0.1 0.2 0.2 0.0 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.8 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.7 0.4 1.2 0.0 0.4 0.3 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 1.0 19.8 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.4 1.5 0.4 0.1 0.4 0.0 0.1 0.4 0.4 0.8 0.6 0.4 0.2 0.5 0.3 0.3 0.7 0.2 0.3 0.8 0.5 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.7 1.3 17.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.5 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.0 2.1 0.5 0.1 0.2 0.3 0.3 0.0 0.1 0.1 0.5 0.1 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291894-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 111.8" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 70.1" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 1.4 44.7 0.0 60.2 0.0 0.0 67.0 54.5 0.0 3.3 0.3 0.1 0.0 0.0 0.0 0.1 0.8 0.4 45.0 52.2 0.1 0.2 0.1 0.0 82.3 67.9 38.4 0.2 1.1 0.3 9.7 0.0 75.1 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.1 0.0 72.2 0.0 5.4 0.3 57.9 0.0 0.0 0.0 0.0 0.0 0.1 111.8 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.0 1.1 0.0 3.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 15.3 3.5 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 60.2 67.0 54.5 45.0 52.2 82.3 67.9 38.4 75.1 72.2 57.9 111.8 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.7 4.3 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.0 7.7 0.0 11.6 0.4 0.0 1.0 9.2 0.1 0.0 0.0 0.0 0.0 0.1 15.2 11.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 2.5 0.0 2.0 70.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 PTPN11 "BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2" ENSG00000179295 "Protein tyrosine phosphatase non-receptor type 11" Q06124 12 112418351-112509918 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005377 Approved Supported "Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol" NA NA 74000 "Nucleoplasm, Nucleoli rim" "Actin filaments, Cytosol" "CAB005377: AB_632401" "unprognostic (2.18e-3)" "unprognostic (1.73e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "unprognostic (4.25e-2)" "unprognostic (3.55e-2)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (8.85e-2)" "unprognostic (3.75e-3)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.62e-2)" "unprognostic (1.80e-2)" 63.4 36.9 85.1 35.0 104.6 46.7 38.0 87.3 104.6 38.2 50.6 32.1 27.9 38.1 29.0 39.2 24.5 29.6 69.3 78.2 101.2 40.1 53.5 34.7 35.8 99.7 94.8 68.1 26.5 31.9 53.8 16.2 38.3 104.8 35.5 30.9 52.2 26.1 42.8 75.8 32.3 26.3 46.1 95.5 26.9 30.6 18.4 95.9 35.9 47.2 64.6 32.7 40.5 23.7 115.3 116.9 107.6 77.0 73.4 109.7 106.1 92.7 136.4 148.2 105.5 78.5 107.7 43.4 124.5 69.4 127.4 66.7 68.1 100.1 121.6 173.8 93.1 85.0 181.5 102.6 59.8 109.2 145.8 108.0 86.6 119.6 113.6 159.8 101.3 88.7 92.0 140.2 41.3 103.3 83.2 101.0 69.7 94.1 112.3 73.4 102.4 114.6 70.5 97.3 126.7 53.3 66.1 133.7 99.8 85.2 77.6 114.8 97.8 108.1 122.9 110.0 74.2 121.8 79.4 141.6 120.2 102.2 99.7 117.7 32.2 11.7 16.8 14.8 10.2 14.0 18.1 13.3 12.4 13.6 20.8 15.3 11.9 10.7 12.6 13.7 18.3 10.9 7.2 85.1 104.6 87.3 104.6 78.2 101.2 99.7 94.8 68.1 104.8 95.5 95.9 115.3 49.0 60.9 68.2 27.7 25.8 25.6 39.9 25.3 20.5 29.9 40.5 32.4 131.6 24.3 41.8 36.8 16.7 23.5 34.2 25.4 33.2 37.5 63.1 31.3 92.6 46.2 13.1 21.7 67.6 42.8 25.3 35.8 21.9 40.9 28.4 33.1 26.0 101.5 26.8 13.5 54.7 22.0 18.3 33.3 21.6 28.5 51.6 31.8 14.2 40.3 31.1 59.8 29.9 32.6 73.0 59.3 19.6 79.7 37.0 73.4 16.6 39.8 23.5 22.2 32.9 58.2 49.2 7.1 6.6 37.5 27.4 35.2 31.7 30.5 22.2 66.8 NSUN7 FLJ14001 ENSG00000179299 "NOP2/Sun RNA methyltransferase family member 7" Q8NE18 4 40749925-40811184 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.6" "Cell type enhanced" "Detected in many" "Early spermatids: 47.5;Late spermatids: 75.6;Respiratory ciliated cells: 36.4;Spermatocytes: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "A-431: 2.6;CAPAN-2: 5.5;Karpas-707: 4.0;MCF7: 2.6;SuSa: 3.0;T-47d: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020653 Uncertain Approved Vesicles NA NA Vesicles "HPA020653: AB_1848710" "unprognostic (2.32e-1)" "unprognostic (4.22e-1)" "unprognostic (4.77e-2)" "unprognostic (1.50e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (4.01e-3)" "unprognostic (4.37e-2)" "unprognostic (3.06e-1)" "unprognostic (2.24e-1)" "unprognostic (8.42e-2)" "prognostic favorable (2.76e-8)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-2)" 0.4 0.9 1.1 1.0 0.6 0.6 3.8 0.7 0.6 2.0 6.0 2.2 1.7 2.2 2.7 1.9 6.8 1.2 1.7 0.4 1.7 4.3 0.4 3.3 0.3 1.5 1.4 0.2 2.3 7.3 3.3 3.6 1.3 1.3 4.6 2.4 0.8 4.9 1.6 0.0 1.4 2.1 1.2 1.3 2.7 3.3 16.6 1.3 0.3 4.8 0.2 0.4 1.4 1.2 0.8 2.6 0.1 1.2 0.0 0.0 0.0 1.7 0.0 0.2 0.1 0.1 1.0 5.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 2.6 0.1 0.0 1.4 0.0 0.3 0.1 0.0 0.0 2.4 0.7 0.6 1.5 0.3 1.7 0.0 3.0 3.9 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.7 0.6 0.4 1.7 1.5 1.4 0.2 1.3 1.3 1.3 0.8 0.1 9.6 7.8 3.6 4.3 1.1 3.1 1.5 2.2 0.1 8.6 7.1 3.5 0.0 10.5 9.2 0.0 9.2 0.1 2.7 9.8 5.8 47.5 20.7 0.9 0.6 8.3 0.4 0.7 5.4 3.6 1.2 4.6 5.4 0.0 8.5 0.7 0.2 3.8 0.0 0.9 7.1 4.1 0.8 0.4 75.6 1.5 2.2 0.0 8.4 1.0 2.1 0.0 18.1 1.3 4.7 2.7 0.0 0.3 4.5 2.2 5.5 36.4 0.1 0.0 0.4 0.8 38.9 11.4 8.2 1.0 4.5 0.7 3.4 7.7 5.7 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656068-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6" "Region enriched" "Detected in single" 9 "hippocampal formation: 2.8" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.0 1.1 0.0 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM156B TMEM29B ENSG00000179304 "Family with sequence similarity 156 member B" Q8NDB6 X 52891306-52908560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 80.8" "HPA056640, HPA056643" Uncertain NA NA "HPA056640: AB_2683200, HPA056643: AB_2683201" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (3.24e-5)" "unprognostic (2.97e-1)" 26.9 40.0 33.8 12.1 34.3 13.7 25.9 34.4 38.5 22.3 37.6 19.7 18.6 17.6 18.7 17.7 22.7 17.3 24.3 33.6 33.6 31.1 27.5 19.1 20.6 34.9 33.1 34.9 23.7 23.4 10.6 48.5 50.4 33.9 26.0 18.9 14.4 15.8 20.1 8.0 49.4 18.5 18.1 31.4 32.2 19.9 24.4 35.3 10.7 22.6 5.7 13.3 22.7 17.9 34.5 5.0 8.4 11.9 29.1 14.2 29.2 37.2 10.5 16.5 13.0 18.4 10.9 18.9 4.4 3.5 35.1 11.5 9.2 25.3 19.5 16.6 3.7 10.6 3.4 80.8 18.0 26.9 8.0 8.6 37.5 15.3 20.3 13.1 43.0 12.4 16.0 10.8 19.5 32.9 10.2 8.3 33.3 13.8 8.4 14.2 14.4 9.9 13.4 14.3 9.6 10.2 12.6 3.3 22.7 9.4 31.8 9.5 11.2 15.8 47.7 8.5 20.1 12.0 5.5 8.4 13.2 21.6 29.3 8.2 0.0 4.0 1.0 0.9 5.5 1.3 0.8 0.6 0.9 6.1 1.6 1.8 0.6 0.8 2.5 5.4 3.5 2.0 2.7 33.8 34.3 34.4 38.5 33.6 33.6 34.9 33.1 34.9 33.9 31.4 35.3 34.5 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enhanced" "Detected in many" "Early spermatids: 73.4;Late spermatids: 99.6;Oligodendrocyte precursor cells: 110.1" "Cancer enriched" "Detected in many" 4 "glioma: 18.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 40.0;HUVEC TERT2: 24.7;OE19: 26.4;PC-3: 24.8;RH-30: 50.5;SCLC-21H: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 2.2 2.3 23.2 1.0 20.5 0.0 1.8 29.0 17.6 1.1 6.7 6.8 3.5 1.2 0.2 0.6 1.0 1.0 1.7 17.2 19.3 4.3 0.5 1.4 1.3 29.4 23.3 15.3 0.5 1.5 0.9 3.5 4.9 24.5 0.6 3.9 5.7 1.2 0.7 11.5 1.3 4.3 1.3 24.5 13.7 1.3 11.3 24.7 1.1 0.9 3.8 0.9 0.8 0.8 27.2 0.0 5.8 40.0 3.2 0.2 0.0 2.1 4.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 10.0 0.3 0.0 0.0 13.6 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.0 24.7 0.1 0.0 0.9 1.2 0.8 0.0 0.0 13.3 26.4 24.8 0.0 50.5 1.6 8.4 2.1 15.5 0.0 0.2 0.0 0.0 4.1 0.0 0.3 0.1 0.0 1.4 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 20.5 29.0 17.6 17.2 19.3 29.4 23.3 15.3 24.5 24.5 24.7 27.2 7.7 0.0 0.0 11.8 0.1 0.4 0.0 0.0 0.6 24.1 0.2 0.1 3.8 0.0 0.0 1.8 0.0 0.7 0.1 22.4 1.9 0.3 73.4 0.1 0.0 5.9 0.0 0.0 2.7 0.2 0.1 0.2 0.0 0.0 0.0 0.7 10.0 0.4 1.2 1.7 12.5 3.3 0.0 0.8 0.4 99.6 0.6 0.0 1.8 4.7 0.0 9.8 0.0 110.1 20.6 0.2 6.5 0.0 0.0 0.0 21.5 1.4 0.0 3.5 0.0 6.0 0.7 0.4 3.3 0.1 0.6 0.0 0.3 0.1 5.8 0.1 RAB39A RAB39 ENSG00000179331 "RAB39A, member RAS oncogene family" Q14964 11 107928448-107963482 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.5;lymphoid tissue: 3.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Excitatory neurons: 5.2;Inhibitory neurons: 8.8;Microglial cells: 20.6;Spermatocytes: 6.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.6;NTERA-2: 8.6;RPMI-8226: 15.5;SCLC-21H: 27.8;SH-SY5Y: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042505 Uncertain NA NA "HPA042505: AB_2678030" "unprognostic (1.45e-1)" "unprognostic (1.48e-2)" "unprognostic (1.83e-1)" "unprognostic (3.40e-2)" "unprognostic (4.99e-1)" "unprognostic (4.30e-2)" "unprognostic (4.26e-3)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (7.36e-2)" "unprognostic (4.22e-3)" "unprognostic (2.24e-2)" "unprognostic (1.41e-3)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (5.02e-2)" "unprognostic (2.43e-1)" 0.7 0.9 3.0 3.0 1.7 0.6 0.3 3.2 3.7 0.2 0.2 0.5 0.5 0.2 0.0 0.3 0.2 0.8 0.2 5.0 3.5 0.6 0.6 0.9 2.1 3.4 1.9 1.1 0.2 0.3 0.2 0.4 1.2 3.7 0.2 0.8 1.1 0.2 0.1 0.0 0.3 0.7 0.7 3.0 3.0 0.6 0.8 3.9 2.6 0.3 0.1 1.4 0.9 0.0 6.5 0.0 1.8 7.3 0.1 0.0 0.0 0.9 0.1 0.0 0.8 0.6 0.0 0.0 0.4 0.1 0.0 11.6 0.0 7.4 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.5 6.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 4.0 15.5 0.1 0.0 27.8 17.1 0.0 0.0 0.4 1.6 0.4 3.0 0.0 0.1 1.9 0.0 1.3 0.1 4.3 0.0 0.4 1.7 4.1 0.1 1.4 0.0 0.0 2.2 0.0 0.8 0.0 0.0 1.0 0.5 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.4 3.0 1.7 3.2 3.7 5.0 3.5 3.4 1.9 1.1 3.7 3.0 3.9 6.5 0.0 0.0 1.1 0.7 0.8 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.8 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 8.8 0.0 0.0 4.1 3.7 0.8 0.0 4.1 0.0 20.6 1.8 0.0 0.0 4.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 6.4 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CLK3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 35.0 29.0 29.5 26.8 30.1 113.4 34.9 34.1 36.2 36.3 30.7 35.9 29.2 32.5 26.1 38.9 31.5 33.0 28.5 28.0 30.1 30.1 29.6 34.2 38.0 31.2 30.0 25.8 38.7 34.2 35.6 32.6 31.8 30.7 32.2 22.0 33.4 36.4 30.0 51.1 40.7 33.9 26.4 27.1 42.0 35.4 44.8 30.2 56.3 32.6 52.5 30.5 38.1 34.0 33.6 56.7 35.1 45.5 25.6 57.2 43.4 35.8 37.7 59.2 52.7 64.3 47.9 36.4 51.2 27.2 33.9 73.5 39.0 85.4 36.3 34.3 73.2 46.9 63.0 52.0 33.6 90.7 17.2 46.6 54.8 71.0 69.4 57.4 64.0 58.6 51.0 31.3 36.2 31.1 39.9 50.9 57.3 29.1 55.7 24.6 40.7 21.8 33.7 41.1 40.3 25.5 29.9 30.2 33.0 34.3 34.7 31.4 33.8 27.3 31.0 23.7 19.7 50.2 59.0 51.8 42.2 27.2 82.4 40.1 74.2 65.5 90.0 68.9 74.1 68.2 71.0 73.6 71.9 61.3 78.8 74.4 70.9 115.9 90.7 97.7 69.5 87.7 85.9 29.5 30.1 34.1 36.2 28.0 30.1 31.2 30.0 25.8 30.7 27.1 30.2 33.6 29.8 6.4 38.4 14.0 34.1 44.9 44.9 41.6 26.2 35.5 22.8 15.9 18.6 28.6 35.1 12.9 56.3 27.7 41.8 46.7 31.3 34.2 83.6 25.8 19.9 28.6 29.3 31.5 6.6 24.2 46.2 24.5 37.8 41.5 21.5 27.4 21.4 13.4 27.5 28.6 7.9 34.7 42.7 23.3 34.4 19.8 27.7 28.4 28.4 6.5 29.5 18.0 29.9 7.1 9.6 30.8 52.0 20.3 26.6 38.9 35.5 18.6 23.4 42.6 13.1 20.4 35.8 45.4 21.4 21.0 41.9 58.6 40.1 20.4 28.1 63.5 HLA-DQB1 "CELIAC1, HLA-DQB, IDDM1" ENSG00000179344 "Major histocompatibility complex, class II, DQ beta 1" 6 32659467-32668383 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 180.7;lymphoid tissue: 304.4" "Cell type enhanced" "Detected in many" "B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5" "Group enriched" "Detected in all" 6 "B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5" "Cell line enriched" "Detected in some" 6 "HDLM-2: 599.9" HPA013667 Enhanced Supported "Golgi apparatus,Rods & Rings" NA NA "Rods & Rings" "Golgi apparatus" "HPA013667: AB_1853932" "unprognostic (8.60e-3)" "unprognostic (1.91e-2)" "unprognostic (5.91e-2)" "unprognostic (9.85e-3)" "unprognostic (4.48e-1)" "unprognostic (5.30e-2)" "unprognostic (4.75e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-2)" "unprognostic (1.48e-1)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.34e-2)" "unprognostic (3.13e-1)" "unprognostic (4.16e-1)" "unprognostic (2.43e-1)" "unprognostic (1.40e-1)" 48.2 24.1 2.0 78.6 2.6 40.3 45.7 2.4 3.1 19.5 3.1 46.2 0.2 19.1 128.0 21.5 22.4 44.0 21.8 1.9 6.7 34.4 37.4 180.7 304.4 5.2 3.3 1.2 7.4 14.4 10.7 21.5 10.2 11.0 17.2 39.4 1.7 24.4 12.0 9.7 31.9 78.6 11.3 3.9 140.4 129.1 7.1 2.5 109.2 26.5 0.0 123.3 90.7 17.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 93.9 2.2 0.0 0.0 19.2 0.0 19.2 0.0 599.9 13.4 0.0 0.0 0.0 0.0 0.2 7.8 0.0 3.0 0.0 0.0 0.0 0.0 2.9 0.0 1.8 0.0 7.2 0.1 0.9 0.1 0.0 0.0 0.0 0.1 0.2 0.0 1.3 0.0 0.1 1.6 1.1 1.4 0.0 3.3 10.9 0.2 0.0 0.6 0.8 0.4 68.7 2.1 66.0 47.1 0.1 0.0 0.3 153.5 27.9 12.8 142.9 6.6 159.2 6.9 20.0 386.3 169.1 0.4 6.3 11.8 10.4 41.1 116.5 41.1 217.0 2.0 2.6 2.4 3.1 1.9 6.7 5.2 3.3 1.2 11.0 3.9 2.5 5.1 162.9 41.7 181.1 0.0 995.1 89.9 8.7 23.1 31.3 5.1 16.8 32.1 3.2 27.1 40.7 18.4 10.4 1.4 188.2 10.3 7.9 38.8 16.5 4.1 1.0 135.3 22.8 37.2 0.2 20.0 3.0 18.8 41.8 5.2 38.5 7.9 25.0 2.3 422.1 0.0 0.8 24.7 12.2 487.3 4144.8 7.5 6.5 1090.5 97.8 8.4 1038.0 1.1 25.7 0.0 0.1 28.3 27.4 9.8 86.9 8.7 417.9 18.5 53.0 2.7 6.6 4.8 9.6 2.7 2.5 18.5 66.3 3.0 84.5 0.9 36.1 49.1 GATA2 NFE1B ENSG00000179348 "GATA binding protein 2" P23769 3 128479427-128493201 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Phagocytosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 261.6;Glandular and luminal cells: 116.5;granulocytes: 638.7;Syncytiotrophoblasts: 321.4" "Group enriched" "Detected in all" 5 "endometrial cancer: 12.7;prostate cancer: 36.7;urothelial cancer: 13.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 330 "basophil: 513.2" "Lineage enriched" "Detected in single" 4344 "granulocytes: 513.2" "Cell line enhanced" "Detected in many" "BEWO: 281.0;HEL: 360.7;HMC-1: 187.4;SH-SY5Y: 325.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005633, CAB024847" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB024847: , HPA005633: AB_1078954" "unprognostic (1.71e-1)" "unprognostic (8.90e-2)" "unprognostic (1.12e-1)" "unprognostic (8.61e-2)" "unprognostic (8.67e-2)" "unprognostic (4.17e-2)" "unprognostic (5.96e-3)" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.12e-2)" "unprognostic (3.58e-2)" "unprognostic (3.04e-1)" "prognostic favorable (2.04e-4)" "unprognostic (2.50e-1)" "unprognostic (8.07e-2)" "unprognostic (2.08e-1)" "prognostic favorable (5.22e-5)" 15.1 9.9 8.2 2.8 4.2 5.1 12.9 3.5 4.8 31.7 4.0 6.0 4.4 43.0 7.2 4.9 50.1 10.8 15.1 3.6 2.9 18.1 1.3 35.1 2.8 6.9 6.2 1.6 4.3 13.8 7.0 9.8 22.7 8.0 54.8 2.9 0.1 4.9 52.7 6.5 8.1 8.6 10.9 3.5 11.5 6.7 2.8 7.0 0.8 7.4 5.3 1.3 34.1 24.1 5.6 24.4 5.9 1.3 15.9 2.0 0.6 281.0 53.8 45.2 18.0 6.5 10.0 10.7 0.5 14.8 31.9 1.5 25.5 14.7 0.0 7.6 0.0 8.3 360.7 42.9 16.0 4.0 36.8 187.4 0.3 0.3 0.7 0.3 2.9 28.6 0.2 96.7 0.5 0.4 9.0 0.1 74.2 1.0 0.2 1.8 0.1 7.0 0.4 0.5 21.5 21.8 325.9 13.6 70.1 2.4 14.4 13.5 15.0 52.0 1.2 0.7 12.7 7.4 0.1 0.0 0.2 0.6 2.5 3.7 513.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 8.2 4.2 3.5 4.8 3.6 2.9 6.9 6.2 1.6 8.0 3.5 7.0 5.6 69.0 6.4 27.7 0.0 0.9 4.8 25.5 0.0 1.2 0.2 1.5 1.5 5.7 0.0 1.8 75.4 0.0 63.4 2.3 0.5 1.9 0.2 10.1 74.2 43.2 75.4 3.0 62.4 0.0 14.2 261.6 8.8 0.5 116.5 638.7 0.9 57.5 0.2 10.8 0.0 0.0 0.3 0.0 0.3 4.6 6.4 0.6 7.9 8.8 15.9 0.7 0.1 0.0 0.0 0.0 0.9 0.0 0.4 5.4 29.5 0.0 0.2 0.7 0.2 0.0 2.2 11.0 0.6 4.7 0.9 2.4 321.4 14.0 0.2 0.3 10.5 ARID3B "BDP, DRIL2" ENSG00000179361 "AT-rich interaction domain 3B" Q8IVW6 15 74541206-74598131 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0" "Cancer enhanced" "Detected in all" "testis cancer: 10.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 28.8" HPA050320 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050320: AB_2681085" "unprognostic (2.97e-1)" "unprognostic (5.91e-2)" "unprognostic (6.41e-2)" "unprognostic (8.15e-2)" "unprognostic (8.42e-2)" "unprognostic (1.13e-1)" "unprognostic (3.33e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (4.71e-2)" "unprognostic (3.52e-2)" "unprognostic (9.45e-3)" "unprognostic (2.20e-1)" 2.6 2.4 2.8 6.2 2.2 24.8 2.6 4.5 2.9 2.9 5.5 4.1 4.5 2.3 1.9 6.2 2.6 2.4 2.3 3.0 2.8 3.6 4.1 7.3 7.3 2.8 2.5 1.6 1.5 5.7 1.7 6.3 15.8 3.1 4.7 4.0 18.9 3.8 1.7 3.4 3.1 7.0 1.7 2.0 9.6 7.1 22.3 3.2 6.1 3.9 2.2 6.4 3.2 3.9 2.5 7.6 3.1 40.7 8.9 1.5 0.8 43.8 1.8 2.0 2.5 2.7 49.9 3.6 0.7 2.0 1.9 14.3 9.0 49.8 6.8 2.2 47.7 11.6 29.5 6.0 13.7 1.0 4.7 18.5 1.0 3.0 4.2 4.3 2.0 4.3 11.7 26.1 16.8 0.7 1.8 12.9 15.7 87.8 3.2 2.7 5.7 1.6 12.1 2.4 7.9 10.4 18.4 2.2 4.5 8.8 95.4 5.8 8.5 2.7 3.4 4.3 2.7 5.6 53.0 36.1 5.3 1.8 7.3 1.3 2.6 1.9 7.0 5.0 1.5 3.0 3.1 2.9 3.8 1.4 1.4 2.2 2.9 13.0 4.0 2.0 1.9 4.4 3.4 2.8 2.2 4.5 2.9 3.0 2.8 2.8 2.5 1.6 3.1 2.0 3.2 2.5 3.5 3.2 5.6 10.7 11.8 5.2 5.2 3.5 3.4 23.9 4.4 2.3 1.2 4.3 1.9 0.0 43.8 36.0 10.2 10.2 0.0 2.5 45.4 20.5 4.4 4.8 5.4 9.7 7.3 3.5 20.6 2.3 8.6 45.6 2.5 4.2 4.2 2.5 8.3 11.8 7.8 6.0 0.0 8.7 9.1 65.8 2.8 9.5 3.6 5.6 6.4 5.9 18.6 5.5 7.8 7.6 8.4 3.0 19.2 7.8 7.0 1.7 3.8 50.8 0.0 1.5 1.8 17.2 19.4 10.4 3.3 64.0 12.8 5.5 4.0 8.0 TMEM31 MGC39655 ENSG00000179363 "Transmembrane protein 31" Q5JXX7 X 103710909-103714032 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 110.9" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3288.8" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;BEWO: 4.3;MCF7: 6.4;NTERA-2: 1.8;U-937: 2.4" "Low region specificity" "Detected in all" HPA052760 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA052760: " "unprognostic (9.42e-5)" "unprognostic (1.46e-2)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (7.75e-3)" "unprognostic (1.22e-2)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (1.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.39e-2)" "unprognostic (3.77e-1)" "unprognostic (5.91e-5)" "unprognostic (1.75e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (4.68e-2)" 0.3 0.2 2.4 0.1 2.6 0.0 0.6 2.4 3.4 1.4 1.8 0.2 0.0 0.7 0.5 0.1 1.0 0.2 0.3 2.3 2.4 0.5 0.3 0.3 0.2 2.5 2.4 2.1 1.8 0.2 1.3 0.9 0.9 2.6 0.6 0.0 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.3 0.4 0.2 110.9 2.5 0.3 0.3 0.0 0.0 0.4 0.6 2.9 0.0 0.0 1.8 0.1 0.1 0.0 4.3 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.2 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.2 6.4 0.1 1.2 1.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 2.4 2.6 2.4 3.4 2.3 2.4 2.5 2.4 2.1 2.6 2.3 2.5 2.9 0.3 0.0 0.0 0.0 0.0 0.8 0.7 0.2 0.0 0.0 0.4 1.5 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 641.3 10.1 0.4 1.1 0.0 0.0 0.2 0.7 8.6 0.6 0.0 0.2 0.0 1.1 0.7 0.2 0.4 0.0 0.1 0.1 0.0 0.3 0.3 3288.8 13.4 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 7.5 0.0 0.3 0.0 0.2 0.0 0.0 13.1 0.3 0.3 19.6 12.1 0.0 0.3 2.9 0.0 0.2 0.0 0.2 PACS2 "KIAA0602, PACS1L" ENSG00000179364 "Phosphofurin acidic cluster sorting protein 2" Q86VP3 14 105300563-105398147 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 126.7;skeletal muscle: 99.4" "Cell type enhanced" "Detected in all" "Horizontal cells: 97.6;Oligodendrocytes: 169.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077892 Approved Mitochondria NA NA Mitochondria "HPA077892: AB_2686865" "unprognostic (4.31e-2)" "unprognostic (2.61e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.18e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "prognostic favorable (2.95e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.56e-4)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.30e-1)" 22.0 16.3 60.3 10.7 84.4 9.0 18.9 95.6 52.7 17.9 3.3 21.0 11.0 21.2 5.4 11.3 19.1 11.3 21.9 37.6 52.6 12.4 6.9 16.2 8.5 120.2 104.9 27.3 20.2 29.1 11.7 21.7 8.9 118.9 15.1 6.7 12.3 16.4 11.6 99.4 12.6 14.3 10.1 92.3 16.2 17.6 19.9 84.0 9.5 14.2 46.6 5.5 19.4 14.2 126.7 17.5 23.8 21.9 20.7 21.5 20.6 25.9 13.0 15.0 11.0 9.6 10.4 32.5 19.0 21.5 20.0 14.1 19.7 13.5 18.7 7.9 23.7 11.0 8.7 10.0 15.6 28.1 7.1 15.0 24.1 17.5 7.7 17.7 13.9 20.1 18.9 5.4 17.2 9.7 54.9 12.1 9.5 8.5 22.1 19.4 26.5 13.3 12.1 9.3 39.7 49.0 25.8 12.4 11.1 19.4 13.7 28.1 13.2 30.8 16.2 7.2 25.6 13.1 22.3 15.6 7.2 24.6 12.8 16.1 0.0 0.6 0.1 0.3 1.1 0.6 0.0 0.3 0.4 1.1 0.2 0.1 0.4 0.1 1.0 1.9 2.3 0.8 0.4 60.3 84.4 95.6 52.7 37.6 52.6 120.2 104.9 27.3 118.9 92.3 84.0 126.7 28.3 9.6 14.7 41.1 3.3 9.1 7.5 7.1 8.0 30.5 15.1 14.4 21.4 8.6 12.6 5.5 12.5 4.3 15.1 21.5 13.7 13.9 77.1 13.8 15.7 21.1 13.1 4.2 29.7 23.0 3.2 15.5 20.4 18.3 1.3 28.8 19.2 10.8 17.6 97.6 41.0 14.6 8.2 15.7 23.0 78.7 17.4 17.1 26.6 30.9 8.4 17.0 7.2 23.1 169.3 14.2 12.6 16.6 7.1 9.0 19.3 12.3 7.7 23.4 6.6 20.6 14.2 18.3 14.6 8.1 8.4 3.4 8.0 30.6 19.5 8.0 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524168-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA047600: AB_2680098" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favorable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.82e-2)" 10.8 14.0 7.3 8.8 8.2 8.7 14.4 10.4 7.6 10.0 12.0 12.3 13.0 11.0 13.3 8.7 10.8 9.1 11.5 6.6 8.2 14.6 15.8 8.6 8.9 8.9 8.4 5.5 8.6 8.9 15.6 7.5 9.7 8.4 13.1 13.2 18.1 9.2 9.8 4.4 9.4 15.4 10.3 9.5 7.6 10.4 8.0 8.2 12.6 17.0 5.4 10.3 9.5 6.0 11.4 11.3 12.4 24.9 19.1 25.4 29.2 16.0 26.3 24.7 14.3 17.1 12.2 23.7 18.5 11.3 16.5 17.3 10.1 23.8 16.7 17.6 18.1 14.2 15.3 10.2 16.0 23.1 23.6 13.0 20.1 27.2 12.2 12.5 22.6 15.9 22.2 19.9 29.6 24.8 8.2 25.6 8.1 13.2 16.4 10.1 29.7 19.2 12.0 20.7 17.9 11.8 43.6 17.3 17.5 19.3 27.7 17.1 9.7 16.3 32.7 11.6 15.5 27.6 30.8 47.1 23.1 23.9 18.2 25.3 2.3 6.6 8.0 6.6 7.1 7.4 3.2 5.8 7.2 5.6 6.0 5.9 5.9 15.3 7.5 5.7 9.8 7.3 4.4 7.3 8.2 10.4 7.6 6.6 8.2 8.9 8.4 5.5 8.4 9.5 8.2 11.4 14.6 28.9 17.7 22.5 13.1 9.2 11.0 30.3 11.4 20.7 14.7 10.5 14.3 7.2 26.4 18.4 18.8 23.2 19.9 17.6 1.9 22.2 3.9 29.0 24.4 14.5 9.1 7.4 20.2 26.5 8.7 15.5 9.2 15.7 19.7 17.8 11.4 27.1 19.0 15.2 15.6 10.9 22.4 16.4 11.0 1.5 13.1 13.8 17.8 19.7 14.1 16.3 9.2 20.6 35.3 25.6 12.9 10.9 21.7 10.3 27.1 15.9 44.9 24.7 6.6 10.0 18.3 26.9 19.1 12.4 11.6 20.1 13.9 10.9 12.0 8.6 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 50.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 28.9 24.8 8.1 19.2 9.0 10.2 10.4 1.2 50.3 9.6 0.1 3.9 1.5 5.6 0.4 6.0 17.4 30.3 11.4 15.8 2.5 4.7 3.0 5.9 11.5 5.7 0.0 5.3 15.5 4.5 13.9 6.9 1.0 5.0 14.5 3.2 4.5 3.2 0.9 1.9 43.3 3.9 12.6 1.1 3.3 6.5 5.4 0.3 19.6 8.5 3.2 6.0 14.9 3.6 6.8 0.2 0.0 0.2 0.3 1.8 5.5 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.4 0.5 0.2 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.5 0.6 0.2 0.2 0.0 0.8 0.1 0.2 0.3 0.1 0.0 31.9 0.0 0.2 0.1 2.2 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.5 0.0 22.5 0.3 1.4 0.1 0.0 0.3 0.1 0.2 0.4 0.4 0.1 0.0 0.9 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.1 9.0 1.2 50.3 15.8 2.5 5.7 0.0 5.3 5.0 1.1 0.3 6.8 80.2 6.4 11.2 0.3 46.7 23.1 31.9 43.8 39.3 2.3 73.0 68.2 47.1 0.0 12.2 0.0 0.0 1.3 9.3 3.5 0.0 3.3 18.4 47.1 52.7 36.5 284.3 0.0 16.0 4.2 1.3 33.9 35.2 116.6 108.7 21.8 37.5 0.5 4.7 0.0 0.9 19.2 8.2 19.0 20.3 11.6 3.1 27.8 21.4 3.7 0.0 5.1 0.0 1.0 0.7 4.5 2.2 0.4 3.7 16.1 0.2 0.1 5.7 1.3 0.0 41.3 35.9 0.3 0.2 16.5 50.0 9.7 11.5 6.5 7.0 9.8 CATSPERE "C1orf101, MGC33370" ENSG00000179397 "Catsper channel auxiliary subunit epsilon" Q5SY80 1 244454377-244641177 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 21.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Endometrial ciliated cells: 8.6;Respiratory ciliated cells: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.22e-1)" "unprognostic (4.50e-2)" "unprognostic (2.02e-1)" "unprognostic (7.31e-2)" "unprognostic (3.32e-1)" "unprognostic (2.50e-3)" "unprognostic (3.76e-3)" "unprognostic (5.39e-4)" "unprognostic (1.96e-2)" "unprognostic (3.41e-2)" "unprognostic (4.37e-4)" "unprognostic (4.43e-2)" "unprognostic (9.09e-2)" "unprognostic (1.76e-1)" "unprognostic (5.79e-2)" "unprognostic (6.74e-3)" "unprognostic (5.85e-2)" 0.5 0.6 1.0 0.2 1.2 0.6 0.6 0.9 0.9 0.6 0.5 0.2 0.1 0.5 2.7 0.2 1.3 0.4 0.1 0.7 1.2 0.8 0.6 0.5 0.2 1.1 1.1 0.7 0.7 0.4 0.8 1.1 0.5 1.2 0.5 0.2 0.7 0.4 0.5 0.6 0.3 0.3 0.2 1.3 0.5 0.3 21.7 1.1 0.3 0.9 0.5 0.2 0.4 0.4 1.5 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.2 0.9 0.9 0.7 1.2 1.1 1.1 0.7 1.2 1.3 1.1 1.5 0.7 3.2 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 1.3 1.8 0.0 0.2 0.1 0.0 0.0 0.4 0.0 8.6 1.1 0.1 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.8 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 8.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.0 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398621-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.6;kidney: 7.4;testis: 6.1" "Cell type enriched" "Detected in some" 20 "Astrocytes: 3868.1" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 49.9;HeLa: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA040152: AB_2676863, HPA044081: AB_2678801" "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.1 1.7 11.3 0.3 15.1 0.1 0.0 7.7 11.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.5 1.0 9.6 9.4 7.4 1.3 3.3 0.2 16.9 12.6 7.7 0.4 0.1 0.0 1.7 0.4 21.6 0.1 0.5 0.5 0.1 0.5 0.0 0.1 0.1 0.1 5.1 0.0 0.1 6.1 17.9 0.1 1.1 0.0 0.0 0.0 0.1 12.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.9 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 27.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.6 0.0 1.7 0.0 0.8 0.0 0.2 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.0 3.4 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 11.3 15.1 7.7 11.2 9.6 9.4 16.9 12.6 7.7 21.6 5.1 17.9 12.4 0.0 0.0 2.7 3868.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.1 0.0 0.1 64.6 0.0 1.6 0.0 0.0 0.1 0.0 0.0 116.6 0.0 0.0 0.4 0.0 0.1 0.0 7.9 0.0 0.0 0.1 0.0 190.6 0.1 0.0 0.0 0.4 1.0 0.3 0.1 0.0 118.0 0.6 0.0 0.0 127.2 20.9 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.7 0.8 0.3 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.1 VWA1 "FLJ22215, VWA-1, WARP" ENSG00000179403 "Von Willebrand factor A domain containing 1" Q6PCB0 1 1434861-1442882 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 205.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 275.1;Endothelial cells: 142.7;Syncytiotrophoblasts: 290.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 47.2;CACO-2: 46.7;CAPAN-2: 136.6;Hep G2: 84.4;SCLC-21H: 47.6;T-47d: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 250000 "unprognostic (2.78e-1)" "unprognostic (4.85e-2)" "unprognostic (5.91e-3)" "unprognostic (2.75e-1)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (9.52e-3)" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (3.47e-1)" "unprognostic (2.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-2)" "unprognostic (3.08e-2)" "unprognostic (6.71e-2)" 36.1 15.3 45.1 31.8 72.4 0.2 38.7 67.1 60.2 46.6 18.2 87.2 15.4 71.0 11.6 41.6 50.8 22.6 34.7 44.5 71.5 57.6 134.4 29.8 13.8 91.7 72.0 30.8 22.7 55.8 12.6 20.2 38.7 81.6 132.4 5.3 2.4 64.5 205.4 10.2 25.6 38.0 20.6 72.0 11.8 53.0 27.3 65.2 3.0 67.9 3.4 5.2 119.5 51.1 141.4 47.2 15.4 2.2 15.7 0.4 1.4 24.5 3.1 0.1 2.2 0.1 46.7 136.6 0.0 43.0 1.3 5.0 12.1 15.9 8.1 0.3 3.0 11.3 1.5 0.1 84.4 3.5 0.0 5.5 2.7 0.4 1.0 0.0 0.4 0.6 0.0 1.6 0.0 0.1 11.7 0.1 0.9 6.1 16.5 4.3 0.6 0.8 2.2 2.7 7.9 47.6 7.4 0.0 41.7 5.8 3.7 61.1 0.6 1.4 0.1 0.6 0.4 15.2 0.3 0.2 0.2 2.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 72.4 67.1 60.2 44.5 71.5 91.7 72.0 30.8 81.6 72.0 65.2 141.4 103.4 19.2 36.1 5.9 2.8 6.5 19.1 5.2 12.0 7.6 40.4 59.4 3.6 44.3 14.2 53.3 4.2 275.1 1.4 24.2 7.9 82.0 0.6 16.0 46.2 142.7 12.5 2.7 0.5 65.0 99.2 28.3 16.8 17.7 1.3 2.0 8.2 49.4 22.8 15.2 1.5 8.9 6.1 1.0 4.3 4.0 34.2 1.1 24.9 18.7 2.6 52.1 0.0 13.0 48.7 48.0 11.0 59.0 2.6 21.5 0.8 5.4 10.7 4.3 6.6 62.4 17.2 0.8 2.1 11.9 8.5 290.3 1.3 6.3 10.4 14.9 DNAJB8 "CT156, MGC33884" ENSG00000179407 "DnaJ heat shock protein family (Hsp40) member B8" Q8NHS0 3 128462439-128467248 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 515 "testis: 51.5" "Group enriched" "Detected in some" 135 "Early spermatids: 1108.7;Late spermatids: 4086.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1108.7 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4086.0 16.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 19.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GEMIN4 "DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97" ENSG00000179409 "Gem nuclear organelle associated protein 4" P57678 17 744421-753999 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065699, HPA067891" Uncertain Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA065699: AB_2685534, HPA067891: AB_2685918" "unprognostic (1.85e-1)" "unprognostic (3.36e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-2)" "unprognostic (1.60e-1)" "unprognostic (7.41e-3)" "unprognostic (2.00e-2)" "unprognostic (7.95e-2)" "unprognostic (1.98e-2)" "unprognostic (1.63e-1)" "unprognostic (1.89e-2)" "unprognostic (8.67e-3)" "unprognostic (4.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (4.74e-2)" "unprognostic (8.56e-3)" 12.3 7.7 2.9 8.2 3.0 15.7 12.4 10.1 6.4 13.0 5.0 9.3 8.1 12.2 5.7 14.9 12.4 13.2 9.9 2.8 3.0 4.8 8.7 9.9 13.7 2.5 2.7 3.0 15.8 9.8 6.3 5.7 6.7 5.2 14.5 6.4 3.5 11.8 8.2 14.0 39.2 9.8 8.6 2.1 10.1 14.6 49.2 2.6 13.3 15.7 10.2 12.4 11.9 12.5 2.6 44.8 77.8 25.5 38.3 15.8 19.9 31.7 25.0 17.4 44.4 39.1 44.5 23.6 77.9 32.5 21.6 23.6 55.4 48.3 47.0 35.3 29.6 72.3 28.0 40.9 25.1 11.3 30.1 36.8 19.3 23.3 36.5 25.6 15.4 25.3 44.9 39.6 31.7 24.0 31.7 49.8 17.0 24.7 37.4 33.0 53.1 12.1 36.6 18.9 32.5 26.4 21.4 25.7 26.1 11.7 18.2 27.8 21.7 20.2 27.3 24.6 35.6 61.4 5.3 12.4 44.8 23.5 41.9 31.8 1.6 7.0 0.3 7.9 9.6 13.6 11.8 8.6 8.4 9.3 12.3 10.1 10.2 0.9 8.7 11.6 5.2 6.0 10.0 2.9 3.0 10.1 6.4 2.8 3.0 2.5 2.7 3.0 5.2 2.1 2.6 2.6 2.9 16.0 6.7 1.3 8.5 20.4 14.3 6.6 9.1 2.9 4.6 4.7 38.4 4.3 8.5 0.0 0.0 8.4 4.4 3.1 3.9 7.5 148.3 2.6 3.9 5.8 1.2 3.0 1.2 6.4 8.3 6.4 7.7 2.9 1.3 11.1 4.6 5.2 5.4 5.0 1.5 7.0 8.2 3.9 5.7 157.2 11.5 2.6 5.4 1.0 4.8 2.4 2.1 0.0 0.5 8.4 1.8 6.8 4.3 7.4 2.3 2.2 4.4 1.4 0.0 6.2 6.4 57.0 11.2 8.7 16.1 4.0 3.2 7.4 8.7 9.8 HNRNPCL4 ENSG00000179412 "Heterogeneous nuclear ribonucleoprotein C like 4" "P0DMR1, B7ZW38" 1 13163914-13165631 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "HDLM-2: 1.1" NA NA "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four-jointed box kinase 1" Q86VR8 11 35618460-35620865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 29.0;Cytotrophoblasts: 25.6;Endometrial ciliated cells: 30.6;Endometrial stromal cells: 35.4;Granulosa cells: 31.2" "Cancer enhanced" "Detected in all" "glioma: 34.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059220: AB_2683950" "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavorable (6.56e-4)" 5.3 6.0 7.3 1.7 9.5 0.1 3.5 6.7 9.7 5.4 3.5 1.7 0.3 5.3 1.5 3.8 4.9 2.3 2.5 9.4 7.2 3.4 2.3 2.8 1.1 7.8 9.4 8.1 9.2 3.5 0.7 2.3 3.5 6.9 5.2 0.2 0.7 2.5 2.2 1.1 5.9 1.3 1.7 9.0 5.0 1.6 0.8 10.5 1.0 3.0 0.3 1.7 3.8 3.4 9.3 23.3 11.4 12.0 3.8 4.1 12.6 3.7 25.4 17.3 24.1 17.2 14.5 7.1 0.0 5.7 10.2 49.6 24.3 4.2 42.6 20.4 0.3 33.0 2.1 4.4 0.6 9.7 2.7 0.1 4.8 31.8 12.7 38.1 3.9 11.1 1.2 12.5 0.1 23.6 5.4 0.8 0.0 16.4 0.1 33.6 1.4 26.6 5.4 18.6 28.5 11.2 6.4 2.7 2.1 7.5 8.7 48.2 0.5 21.7 19.0 35.5 3.7 60.9 0.0 0.0 0.0 33.9 1.1 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 9.5 6.7 9.7 9.4 7.2 7.8 9.4 8.1 6.9 9.0 10.5 9.3 7.8 0.0 0.0 9.4 0.2 17.5 15.8 14.0 29.0 1.8 5.3 13.3 1.2 0.0 3.9 0.0 12.5 25.6 0.0 0.1 1.9 7.6 0.3 30.6 35.4 11.8 0.0 0.0 6.6 0.2 13.9 7.2 0.0 6.5 0.0 31.2 17.9 0.4 3.6 0.0 3.9 0.0 2.0 0.6 1.7 0.1 0.6 1.1 0.0 1.0 0.0 12.5 0.0 6.6 1.7 1.4 0.0 0.7 0.0 22.9 0.0 8.0 4.3 0.5 0.0 6.0 22.3 0.6 1.0 5.6 9.5 11.9 0.4 3.1 0.0 2.5 KLHL28 "BTBD5, FLJ20081" ENSG00000179454 "Kelch like family member 28" Q9NXS3 14 44924324-45042322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 27.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000988 Approved Cytosol NA NA Cytosol "HPA000988: AB_1845480" "unprognostic (8.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (7.84e-3)" "unprognostic (9.20e-2)" "unprognostic (4.36e-3)" "unprognostic (4.92e-2)" "unprognostic (2.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.68e-2)" "unprognostic (7.55e-2)" "unprognostic (4.34e-1)" "unprognostic (1.75e-2)" "unprognostic (6.53e-2)" 4.7 4.8 3.1 6.5 4.0 27.2 5.8 9.5 5.0 5.2 6.2 5.0 5.1 5.3 5.0 6.6 5.5 5.5 4.2 3.2 4.0 4.6 6.5 5.6 8.7 3.7 3.8 2.2 7.9 3.8 4.2 3.0 5.7 3.9 5.5 6.0 8.2 4.3 4.0 4.7 5.1 5.0 5.9 4.0 5.8 5.0 7.4 3.6 9.2 7.7 8.0 7.5 5.6 3.5 6.8 4.5 6.7 8.6 5.6 7.7 6.8 6.5 5.8 6.4 8.4 7.1 3.0 6.8 6.6 6.2 10.1 2.2 7.6 7.7 6.1 9.2 12.3 4.2 5.7 6.9 3.4 6.9 9.2 12.0 5.3 8.6 5.4 8.6 4.8 6.8 10.2 5.1 16.0 4.9 6.5 7.4 4.7 5.3 5.0 6.3 6.3 9.6 3.7 4.8 8.0 9.8 6.0 7.5 5.0 8.1 5.5 9.4 3.9 8.7 7.5 8.6 5.3 3.3 9.4 11.0 9.2 2.6 4.1 4.6 31.5 7.3 18.3 17.0 10.2 31.5 14.9 17.0 18.0 6.4 13.0 20.0 17.2 16.8 20.3 11.2 8.7 14.2 6.9 3.1 4.0 9.5 5.0 3.2 4.0 3.7 3.8 2.2 3.9 4.0 3.6 6.8 15.7 16.0 9.4 17.0 30.1 24.5 16.4 20.1 27.9 24.8 12.9 10.4 12.1 11.5 17.6 18.4 35.5 7.7 27.5 14.9 7.9 10.0 40.2 20.0 13.6 15.4 13.9 27.8 32.6 5.6 8.3 18.0 17.3 9.7 19.0 10.2 16.8 13.1 9.2 15.2 30.0 12.1 6.1 15.8 23.6 62.8 21.8 19.1 23.2 16.9 15.7 23.2 23.7 36.7 40.4 10.3 12.7 17.7 27.0 12.6 13.1 8.5 32.3 23.4 13.1 14.6 19.8 10.8 5.1 19.4 30.1 14.1 38.6 7.7 9.5 15.8 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565674-23630075 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.8;retina: 9.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "JURKAT: 26.3;K-562: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 0.2 0.1 3.8 0.4 7.0 1.8 0.5 4.3 5.9 0.1 1.8 0.4 0.2 0.4 1.6 3.4 3.2 0.1 0.1 4.4 4.6 0.3 0.1 0.2 0.7 5.7 5.7 3.0 0.2 0.4 0.0 1.1 3.3 6.8 0.3 0.1 9.0 3.1 0.2 0.8 0.4 0.3 0.1 4.7 0.6 0.2 2.4 5.5 2.4 0.2 0.8 0.8 0.2 0.2 13.8 8.5 2.9 6.1 5.6 0.0 0.0 13.0 0.9 0.0 4.3 4.5 14.7 0.0 0.1 0.1 0.0 11.8 12.5 2.4 0.0 2.7 0.1 0.5 15.3 17.0 0.9 0.4 18.6 10.2 0.6 0.0 5.8 0.0 2.8 0.0 26.3 30.6 12.9 3.5 0.0 20.3 7.3 0.0 9.6 12.1 10.7 2.5 7.5 0.0 0.1 1.6 4.4 0.0 7.7 0.1 0.2 4.2 5.2 0.1 13.5 9.9 0.9 9.6 16.8 24.5 8.6 7.9 0.1 0.1 0.6 0.2 0.1 0.6 0.0 0.3 0.2 0.2 0.4 0.0 0.2 0.6 2.3 0.4 0.1 0.1 0.3 0.1 0.3 3.8 7.0 4.3 5.9 4.4 4.6 5.7 5.7 3.0 6.8 4.7 5.5 13.8 0.0 0.0 0.0 0.7 0.1 0.5 1.2 0.0 0.0 13.8 0.3 0.0 0.7 0.0 0.1 0.0 25.0 0.8 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.6 0.5 0.0 0.1 1.8 1.0 0.1 3.4 0.0 6.0 9.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 7.4 0.0 0.7 1.6 2.6 0.9 1.8 0.0 0.5 0.2 0.1 0.0 0.4 ZBTB18 "C2H2-171, RP58, TAZ-1, ZNF238" ENSG00000179456 "Zinc finger and BTB domain containing 18" Q99592 1 244048939-244057476 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 181.3;skeletal muscle: 86.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.8;Muller glia cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 217.5" "HPA024656, HPA074019" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA024656: , HPA074019: " "unprognostic (3.48e-3)" "unprognostic (9.17e-3)" "unprognostic (3.69e-3)" "prognostic favorable (1.34e-4)" "unprognostic (6.83e-2)" "unprognostic (4.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.15e-2)" "unprognostic (1.15e-2)" "unprognostic (8.43e-2)" "unprognostic (1.01e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-3)" "prognostic favorable (6.78e-6)" 8.8 6.3 42.7 15.0 53.0 28.5 9.1 181.3 57.9 7.4 26.2 9.3 13.4 7.3 18.7 5.9 8.7 7.4 12.1 68.5 26.1 12.0 19.2 10.0 18.3 26.6 30.7 46.8 7.3 24.8 6.2 4.9 9.5 69.8 10.1 10.9 42.6 10.7 11.6 86.3 8.2 14.7 6.1 25.2 20.4 11.5 22.5 27.1 42.2 8.4 37.8 15.9 10.1 5.4 43.4 23.7 8.2 31.2 1.2 4.0 4.1 21.7 13.0 9.6 20.5 12.4 6.3 18.7 17.9 1.2 25.2 6.6 2.4 20.1 6.4 25.5 6.4 17.7 3.0 3.1 3.0 6.3 3.8 9.1 3.5 5.3 12.3 7.7 24.7 22.5 19.3 2.3 7.5 24.5 0.3 31.4 15.2 16.1 7.3 3.6 9.1 21.2 5.1 13.1 8.0 45.8 44.6 5.4 0.2 14.8 13.0 0.4 27.2 33.7 10.5 12.9 6.5 28.0 3.2 0.4 7.0 10.6 11.6 21.6 0.1 0.2 1.3 0.1 0.3 0.1 0.6 0.2 0.2 0.3 0.9 0.5 0.3 2.3 0.1 0.6 0.9 0.2 0.1 42.7 53.0 181.3 57.9 68.5 26.1 26.6 30.7 46.8 69.8 25.2 27.1 43.4 18.5 9.6 18.5 37.2 16.2 11.2 3.3 5.0 8.0 6.1 32.6 6.1 22.2 8.6 10.0 18.4 12.5 1.5 8.2 10.5 0.0 4.5 3.8 18.2 3.3 15.3 19.3 0.0 51.8 5.1 2.0 3.8 10.7 11.0 6.3 5.1 12.8 44.3 6.1 6.7 19.8 16.1 18.3 25.4 26.7 5.0 2.1 16.1 3.6 15.0 13.9 52.1 2.1 21.6 20.8 8.5 7.9 4.9 2.2 5.2 6.6 12.0 17.4 27.6 13.1 10.9 6.2 9.8 7.7 8.7 19.7 1.0 7.2 1.7 14.8 4.2 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 51 "brain: 5.0" "Cell type enriched" "Detected in some" 40 "Oligodendrocytes: 76.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 1.1 0.0 1.9 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 3.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 1.2 1.0 0.2 1.2 3.2 2.0 0.0 2.8 2.5 2.0 5.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 76.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C14orf28 "DRIP-1, DRIP1" ENSG00000179476 "Chromosome 14 open reading frame 28" Q4W4Y0 14 44897275-44907257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 184.9;Late spermatids: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059635 Approved Cytosol NA NA Cytosol "HPA059635: AB_2684091" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.23e-1)" "unprognostic (3.06e-6)" "unprognostic (1.18e-1)" "unprognostic (6.64e-3)" "unprognostic (2.37e-2)" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (5.35e-2)" "unprognostic (3.13e-3)" "unprognostic (7.33e-2)" "unprognostic (3.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.30e-1)" "unprognostic (4.68e-2)" "unprognostic (2.01e-1)" 5.4 2.4 2.6 2.5 3.0 1.0 3.5 2.8 3.5 3.9 2.8 4.4 4.1 6.2 3.8 3.1 4.5 2.7 5.0 2.7 2.8 2.8 4.8 2.9 2.7 2.9 2.9 2.6 6.5 3.5 2.6 2.1 2.8 3.0 3.9 3.1 2.3 3.6 4.5 4.7 3.3 4.3 4.5 2.7 3.0 3.8 8.7 2.9 1.4 3.6 4.6 2.9 5.4 2.6 3.4 1.9 1.3 2.5 4.3 4.9 2.6 5.6 3.7 4.1 1.8 2.8 0.1 2.4 2.5 2.2 2.6 4.0 1.0 0.6 1.8 3.1 9.3 0.5 1.2 0.5 2.6 1.4 1.1 2.8 2.0 3.0 0.5 2.9 3.4 1.0 3.0 0.6 3.4 1.4 3.7 1.1 2.2 0.4 3.6 1.4 1.8 3.0 1.0 2.5 2.4 0.5 0.7 1.5 3.0 1.7 2.0 5.4 1.1 1.5 6.8 3.3 1.1 0.7 4.8 4.2 1.6 1.9 0.6 2.2 1.1 1.1 4.6 2.6 1.7 2.9 4.8 2.5 3.3 1.2 3.1 5.4 3.2 2.3 2.5 2.3 2.1 3.1 1.4 2.6 3.0 2.8 3.5 2.7 2.8 2.9 2.9 2.6 3.0 2.7 2.9 3.4 5.9 3.2 2.7 1.6 8.8 3.1 9.4 10.3 10.8 3.2 6.5 7.2 12.1 5.7 4.7 5.5 0.0 5.6 6.0 6.7 9.8 8.4 184.9 1.6 4.8 5.3 3.0 2.1 4.0 8.7 4.9 8.9 5.6 2.8 1.3 2.9 5.3 11.5 4.6 3.3 3.8 7.0 8.2 5.4 3.1 127.9 10.5 3.8 5.4 6.5 4.4 3.4 5.2 9.0 9.5 5.9 4.9 16.1 5.5 14.2 15.8 16.0 1.8 2.9 19.7 3.6 11.2 18.5 10.2 5.4 4.4 6.6 6.5 3.3 5.2 7.6 ALOX12B 12R-LOX ENSG00000179477 "Arachidonate 12-lipoxygenase, 12R type" O75342 17 8072636-8087716 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 81.0" "Cell type enhanced" "Detected in some" "Horizontal cells: 1.7;Rod photoreceptor cells: 1.2;Spermatogonia: 1.2;Suprabasal keratinocytes: 1.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 11.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 4.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "A549: 1.1;HEK 293: 1.3;hTCEpi: 1.6;JURKAT: 2.7;OE19: 1.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA024002 Supported Supported Vesicles,Cytosol NA NA 7000 Cytosol Vesicles "HPA024002: AB_1844757" "unprognostic (1.27e-2)" "unprognostic (1.59e-2)" "unprognostic (4.28e-3)" "unprognostic (1.38e-2)" "unprognostic (3.94e-3)" "unprognostic (1.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-1)" "unprognostic (4.40e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.02e-1)" "unprognostic (8.01e-2)" "unprognostic (3.46e-2)" 0.0 0.0 0.3 0.1 0.4 0.1 2.1 0.3 0.5 2.7 0.0 0.1 0.3 0.0 0.0 5.7 0.2 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.5 0.4 0.3 0.4 0.0 0.2 1.2 0.1 0.0 0.5 0.4 0.1 0.6 0.8 0.0 0.4 81.0 0.2 0.0 0.0 0.2 0.2 0.2 0.6 0.6 0.0 0.0 19.3 0.0 15.1 0.2 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.3 0.0 0.0 0.0 1.3 0.0 0.4 0.1 0.0 0.2 0.0 0.0 1.6 0.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.0 0.9 0.0 0.4 0.4 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.4 0.6 0.1 0.2 0.0 0.1 0.5 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.4 0.3 0.5 0.4 0.3 0.4 0.3 0.4 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.5 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.8 1.2 0.0 1.8 0.0 0.0 0.0 0.1 0.1 SLC17A8 "DFNA25, VGLUT3" ENSG00000179520 "Solute carrier family 17 member 8" Q8NDX2 12 100357074-100422055 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.2;intestine: 5.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 13.3;Proximal enterocytes: 43.1" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Region enhanced" "Detected in many" "basal ganglia: 8.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" CAB079058 Supported NA NA "CAB079058: " "unprognostic (4.52e-3)" "unprognostic (2.18e-1)" "unprognostic (8.56e-2)" "unprognostic (1.32e-3)" "unprognostic (3.65e-1)" "unprognostic (7.67e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-2)" "unprognostic (8.89e-2)" "unprognostic (3.55e-1)" 0.0 0.0 0.5 0.0 8.2 0.0 0.0 0.0 1.5 0.0 0.6 0.4 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.0 4.8 3.0 1.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.3 1.2 0.0 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.1 1.6 1.4 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.2 0.0 1.5 0.4 1.2 4.8 3.0 1.0 2.7 0.1 1.6 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 13.3 0.1 0.1 0.0 0.0 0.4 0.0 3.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 6.6 1.1 0.0 3.2 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 0.0 0.0 0.0 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 SHARPIN "DKFZP434N1923, SIPL1" ENSG00000179526 "SHANK associated RH domain interactor" Q9H0F6 8 144098633-144108124 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 391.4;Late spermatids: 1255.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024825, HPA044453" Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA024825: , HPA044453: AB_10962490" "unprognostic (4.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.35e-2)" "unprognostic (7.88e-2)" "unprognostic (3.32e-2)" "unprognostic (9.54e-2)" "unprognostic (1.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.13e-3)" "unprognostic (5.44e-2)" "unprognostic (7.91e-2)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.24e-1)" "unprognostic (1.00e-1)" 29.0 39.5 34.0 16.6 33.4 32.9 27.5 33.5 52.6 29.6 30.1 34.8 20.9 29.7 11.3 30.1 29.0 19.6 39.6 30.5 32.6 36.7 39.4 27.3 22.0 37.8 33.5 29.1 27.6 35.4 29.0 26.9 17.3 34.0 34.0 12.8 9.0 34.1 22.4 49.9 26.7 26.5 17.5 32.0 33.7 34.5 95.5 34.4 19.8 29.3 40.1 14.0 31.5 26.7 34.6 26.9 43.5 20.4 17.9 34.2 35.1 22.5 23.5 29.5 34.0 32.9 24.9 42.0 12.0 38.5 30.6 17.1 28.4 10.8 42.2 8.2 33.0 23.3 31.4 40.1 29.9 61.6 11.6 23.1 40.4 59.4 28.3 30.8 37.6 36.8 36.6 18.2 27.3 30.2 43.8 35.2 26.6 9.3 53.6 124.2 23.6 16.7 39.4 35.2 28.3 20.3 30.7 45.0 62.1 41.5 14.3 69.4 35.8 34.0 26.5 38.9 32.5 32.4 30.0 25.4 16.3 38.3 25.9 23.5 22.6 33.5 53.5 29.9 41.2 32.4 23.3 28.5 38.3 30.0 21.8 23.5 24.7 17.5 33.9 34.8 42.7 34.1 22.4 34.0 33.4 33.5 52.6 30.5 32.6 37.8 33.5 29.1 34.0 32.0 34.4 34.6 56.3 9.6 18.1 10.4 39.4 24.0 32.9 37.0 26.2 27.1 43.5 44.4 20.9 31.5 26.1 35.0 4.2 56.7 44.4 87.2 119.3 53.8 391.4 28.3 26.8 38.9 35.4 88.0 8.0 49.5 52.6 35.9 52.0 24.4 13.3 35.1 36.4 37.2 59.0 48.8 9.5 45.6 44.7 42.1 32.9 1255.3 49.0 33.0 46.2 15.0 57.7 45.4 59.8 9.0 14.3 95.2 81.3 43.6 31.2 36.1 83.1 86.4 20.6 28.9 52.6 26.8 44.2 181.7 67.9 33.5 32.4 43.1 38.8 37.4 59.0 33.9 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 5.3;liver: 8.8;stomach 1: 3.2" "Cell type enhanced" "Detected in some" "Hepatocytes: 3.7;Proximal tubular cells: 7.5;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 10.5;Hep G2: 22.1;SK-MEL-30: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 1.9;olfactory bulb: 1.0" HPA044257 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA044257: AB_2678880" "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 1.3 0.3 0.3 0.4 0.3 0.4 0.6 0.8 0.3 0.3 0.1 1.1 5.3 0.3 0.2 0.2 0.2 0.4 0.3 0.1 0.2 1.3 8.8 0.5 0.4 0.4 0.2 0.0 0.1 0.7 0.1 0.0 0.5 0.4 0.3 0.1 0.1 0.5 0.3 0.4 0.9 4.8 0.2 0.1 1.1 3.2 0.1 0.2 0.0 0.3 0.0 0.1 0.3 0.2 1.2 4.4 1.6 0.0 0.1 2.0 1.5 7.1 0.3 0.2 0.4 0.4 10.5 6.2 0.2 1.7 0.8 0.6 1.7 0.0 0.3 0.0 9.0 1.8 4.7 0.7 22.1 1.4 0.3 3.0 1.9 1.6 1.6 0.3 0.2 1.8 0.1 3.1 2.2 0.3 2.3 0.1 0.7 0.4 1.7 0.2 0.4 0.4 0.2 0.2 1.4 0.2 1.1 2.6 0.4 10.1 0.1 0.2 0.3 4.1 1.5 6.6 8.1 0.2 2.9 2.3 0.2 1.5 0.8 4.8 0.5 1.5 0.1 0.3 0.8 0.2 0.0 0.1 0.4 0.8 0.0 0.1 0.2 0.6 1.1 2.2 0.2 0.0 0.7 0.3 0.3 0.8 0.3 0.1 0.2 0.4 0.2 0.0 0.4 0.1 0.2 1.2 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.7 0.5 0.7 1.5 0.5 1.8 0.0 0.3 0.5 0.9 0.0 0.6 0.0 0.4 0.5 1.0 2.4 0.4 0.0 0.6 0.5 1.3 1.1 0.2 0.0 0.0 1.4 3.7 1.1 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 2.4 7.5 0.7 0.0 6.6 0.0 0.9 0.4 0.1 0.3 0.1 0.5 0.5 0.2 1.0 0.1 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 2.1 1.7 2.7 1.5 3.4 4.6 2.2 1.9 3.6 2.8 2.8 2.9 1.6 2.5 2.1 1.6 2.7 1.4 1.9 1.8 2.5 1.6 2.9 3.4 2.5 4.5 3.0 2.1 3.3 1.7 0.4 2.2 0.8 4.7 2.4 1.4 4.1 1.8 1.3 2.1 2.3 3.3 1.5 2.5 2.8 2.0 10.4 3.2 2.1 2.4 0.8 2.0 2.4 2.5 6.0 2.1 2.0 2.4 1.9 2.0 2.9 2.6 1.0 1.2 0.7 0.9 1.3 2.3 2.4 0.4 1.0 1.8 3.7 1.1 1.1 0.9 1.5 2.3 1.8 3.7 1.5 1.3 2.1 0.8 2.0 1.8 2.2 3.6 1.2 0.6 3.1 2.0 2.3 1.0 0.6 0.9 3.0 2.6 0.7 2.0 1.4 0.9 1.5 1.3 1.6 1.1 2.2 0.8 2.2 1.9 1.8 1.3 2.5 1.2 1.3 1.4 1.8 1.4 6.6 5.0 3.0 1.3 2.6 1.7 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.0 0.2 0.2 0.1 2.7 3.4 1.9 3.6 1.8 2.5 4.5 3.0 2.1 4.7 2.5 3.2 6.0 2.3 0.0 3.4 69.5 3.8 0.9 1.2 1.9 0.6 9.9 2.7 3.0 3.8 0.0 4.3 0.0 4.2 0.3 4.0 2.2 0.0 0.3 12.7 4.0 1.5 2.8 0.0 35.6 41.4 0.4 0.2 2.2 2.6 3.6 1.3 4.7 3.3 4.8 0.8 10.1 32.8 1.7 0.0 2.5 1.5 13.9 0.9 4.0 0.0 19.7 2.2 3.4 3.1 36.2 67.4 0.4 1.6 1.2 1.7 1.8 2.2 0.6 7.3 9.5 0.0 2.1 1.7 19.5 2.0 1.5 3.8 0.7 2.4 1.8 2.1 1.8 SLITRK4 DKFZp547M2010 ENSG00000179542 "SLIT and NTRK like family member 4" Q8IW52 X 143622790-143636101 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.2;brain: 9.6;skeletal muscle: 8.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 52.3;Granulosa cells: 33.9;Inhibitory neurons: 48.8;Leydig cells: 49.7;Oligodendrocyte precursor cells: 29.7;Sertoli cells: 26.3" "Cancer enriched" "Detected in many" 4 "renal cancer: 3.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 11.6" "Group enriched" "Detected in many" 64 "dendritic cells: 3.2;granulocytes: 11.6;monocytes: 4.1" "Cell line enhanced" "Detected in some" "HeLa: 5.4;HHSteC: 2.7;LHCN-M2: 2.0;T-47d: 8.8;U-2 OS: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000431 Enhanced NA NA 420000 "HPA000431: AB_2665991" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.63e-2)" "unprognostic (1.15e-3)" "unprognostic (4.09e-1)" "unprognostic (1.75e-2)" "unprognostic (3.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.97e-2)" "unprognostic (1.86e-1)" "unprognostic (3.64e-2)" "unprognostic (9.61e-2)" "unprognostic (6.02e-2)" "unprognostic (1.02e-5)" "unprognostic (1.29e-2)" "unprognostic (7.75e-2)" "unprognostic (9.23e-3)" 2.7 11.2 2.6 0.3 6.7 1.3 2.0 9.6 8.1 5.1 0.0 0.2 0.1 1.2 2.9 0.6 0.4 0.3 2.2 5.8 5.4 3.0 0.0 0.4 0.4 0.1 2.0 5.1 3.6 1.0 0.4 0.0 0.4 2.4 1.6 0.3 0.4 1.0 1.4 8.3 1.4 0.2 0.9 0.0 0.1 0.1 1.1 2.2 0.6 0.3 4.8 0.0 0.3 0.3 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 2.7 0.4 0.5 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 4.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.9 2.6 6.7 9.6 8.1 5.8 5.4 0.1 2.0 5.1 2.4 0.0 2.2 2.1 0.6 0.0 0.0 3.3 0.0 12.0 0.6 0.0 0.0 3.3 3.2 2.2 1.3 2.8 0.0 3.7 0.0 0.0 0.0 0.1 1.9 0.0 0.5 0.4 2.1 1.1 0.0 0.0 52.3 1.5 0.0 11.0 0.0 1.6 0.0 33.9 0.0 0.0 4.1 0.0 48.8 0.0 0.0 4.3 18.5 2.1 49.7 4.7 21.4 1.0 6.6 0.0 1.0 29.7 2.6 0.7 0.0 16.1 0.0 1.4 0.0 0.9 0.0 0.4 26.3 4.1 4.5 0.4 1.1 0.0 11.6 0.0 1.1 6.4 0.0 0.6 HTR1D "5-HT1D, HT1DA, HTRL, RDC4" ENSG00000179546 "5-hydroxytryptamine receptor 1D" P28221 1 23191895-23194729 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.7;intestine: 9.5" "Group enriched" "Detected in some" 7 "Cholangiocytes: 5.7;Proximal enterocytes: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.5;hTERT-RPE1: 9.8;OE19: 14.3;TIME: 26.4;U-2 OS: 8.4" NA NA "unprognostic (1.73e-2)" "unprognostic (8.69e-3)" "unprognostic (8.86e-3)" "unprognostic (2.03e-1)" "unprognostic (2.65e-2)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.87e-3)" "unprognostic (8.88e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (5.30e-4)" "unprognostic (3.17e-2)" "unprognostic (3.28e-6)" "unprognostic (9.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.45e-1)" "unprognostic (8.02e-3)" 0.0 0.0 1.6 0.2 5.7 0.2 0.1 0.3 3.1 0.0 0.2 0.2 9.5 0.1 0.0 0.0 0.5 1.6 0.0 1.4 3.7 0.0 0.0 0.1 0.0 1.2 3.1 1.9 0.0 0.2 0.1 0.1 0.2 1.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 8.2 0.1 1.2 0.1 0.1 0.2 4.1 0.0 0.1 0.0 0.1 0.1 0.0 0.7 3.2 10.5 0.1 0.0 0.0 0.2 0.9 0.0 0.8 0.3 0.4 0.7 7.5 0.0 3.0 0.4 5.2 2.2 2.1 0.0 0.5 0.0 0.9 0.0 6.0 0.1 0.4 0.0 0.0 0.1 0.2 1.3 0.4 9.8 6.1 0.1 0.1 0.0 0.2 1.3 0.0 0.0 2.5 14.3 0.1 0.0 0.0 0.0 0.2 0.0 2.5 0.0 7.0 0.4 0.1 0.8 0.1 0.0 26.4 0.0 8.4 0.1 2.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.6 5.7 0.3 3.1 1.4 3.7 1.2 3.1 1.9 1.7 1.2 4.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.7 GCC1 "FLJ22035, GCC1P, GCC88, MGC20706" ENSG00000179562 "GRIP and coiled-coil domain containing 1" Q96CN9 7 127580628-127593611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 102.7;Late spermatids: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019369, HPA021323" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA019369: AB_1849552, HPA021323: AB_1849554" "unprognostic (1.09e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.08e-2)" "unprognostic (4.81e-2)" "unprognostic (4.50e-3)" "unprognostic (1.17e-3)" "unprognostic (4.17e-3)" "unprognostic (1.22e-1)" "unprognostic (8.65e-2)" "unprognostic (9.96e-2)" 6.6 6.7 5.7 7.9 6.2 13.6 9.3 6.3 6.0 7.1 6.3 6.9 6.5 6.2 6.5 7.1 6.0 6.3 4.7 5.2 5.7 6.3 10.7 7.0 8.7 6.2 6.2 4.9 8.1 7.0 9.5 4.5 7.6 6.1 7.4 6.3 3.6 8.3 6.8 6.7 7.9 6.5 5.2 6.3 8.3 7.8 11.1 6.0 8.4 7.7 6.8 10.0 7.2 4.7 7.1 15.7 20.8 9.0 19.5 19.7 13.5 12.4 13.4 15.5 13.2 16.5 17.5 10.5 14.4 8.0 12.6 29.7 17.0 13.1 14.7 14.1 20.3 11.9 10.6 11.4 9.2 29.2 18.5 16.9 12.7 39.7 14.1 27.8 12.4 12.6 14.2 17.6 16.1 15.0 15.6 18.0 16.0 18.8 17.2 16.1 12.7 9.8 16.5 11.4 12.0 14.2 20.6 14.4 67.9 27.5 16.1 11.6 13.2 16.4 19.5 6.3 17.0 15.6 43.6 20.6 9.1 19.3 18.6 20.2 5.3 7.1 13.2 7.1 6.9 9.1 6.6 6.4 7.0 6.6 6.3 5.1 5.2 13.1 8.7 8.2 3.8 6.5 8.1 5.7 6.2 6.3 6.0 5.2 5.7 6.2 6.2 4.9 6.1 6.3 6.0 7.1 4.8 12.8 7.7 0.0 9.6 10.6 5.0 2.7 12.0 4.1 11.5 6.1 3.6 4.3 3.7 3.7 4.2 7.2 7.3 10.0 5.9 5.1 102.7 4.3 5.5 6.7 7.2 8.2 0.0 6.4 4.6 5.0 8.6 6.8 1.3 5.9 5.0 7.4 5.2 11.8 0.0 8.2 2.0 10.1 8.3 131.7 5.3 7.6 12.4 0.0 6.9 4.9 5.2 0.0 0.0 5.9 6.6 3.8 6.3 5.4 6.0 4.5 2.4 5.9 6.6 5.9 6.5 7.8 4.6 6.3 10.4 10.4 8.8 5.8 5.8 5.4 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279087-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 24.1;skeletal muscle: 16.7" "Cell type enriched" "Detected in some" 6 "Late spermatids: 283.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.4 0.4 2.9 0.1 4.5 0.4 0.3 2.9 3.7 1.2 1.7 0.4 0.3 0.7 0.2 0.5 0.7 0.2 24.1 2.9 2.9 0.5 0.2 0.4 0.0 3.5 3.7 2.5 1.2 0.2 0.0 0.1 0.1 3.5 0.4 0.1 0.3 0.2 0.4 16.7 0.2 0.3 0.4 2.8 0.2 0.3 3.9 3.3 0.0 0.2 5.5 0.0 0.4 0.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.5 2.9 3.7 2.9 2.9 3.5 3.7 2.5 3.5 2.8 3.3 6.0 1.0 0.0 0.6 0.7 0.3 1.0 0.2 0.2 0.0 0.2 1.5 0.9 4.4 0.0 0.8 1.8 0.0 0.1 0.3 0.9 0.0 0.1 40.5 3.3 0.6 0.8 0.0 0.0 0.2 0.2 0.1 0.4 0.0 10.1 5.1 0.2 0.0 0.3 0.1 0.0 0.2 0.3 0.0 0.3 0.4 283.1 1.2 0.3 1.8 0.0 0.0 0.5 0.0 0.0 2.8 0.2 0.0 0.7 0.0 0.4 1.5 0.1 0.2 0.2 0.0 1.4 4.7 1.8 1.1 0.4 1.3 0.1 0.2 0.1 0.7 0.1 RNF151 ENSG00000179580 "Ring finger protein 151" Q2KHN1 16 1966823-1968975 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 524 "testis: 191.7" "Group enriched" "Detected in some" 137 "Early spermatids: 2202.5;Late spermatids: 1521.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055054 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Cytosol "Nuclear speckles, Vesicles" "HPA055054: " "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-2)" "unprognostic (4.01e-3)" "unprognostic (1.15e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.20e-1)" "unprognostic (4.39e-3)" "unprognostic (4.63e-1)" "unprognostic (1.98e-4)" "unprognostic (1.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (2.43e-2)" 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 191.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.2 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2202.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1521.4 9.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.2 0.1 13.5 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CIITA "C2TA, MHC2TA, NLRA" ENSG00000179583 "Class II major histocompatibility complex transactivator" P33076 16 10866222-10943021 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Kinase, Transferase" "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.7" "Cell type enhanced" "Detected in many" "B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016084, HPA054757" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016084: AB_627261, HPA054757: " "unprognostic (1.45e-3)" "unprognostic (1.38e-2)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" "unprognostic (5.66e-2)" "unprognostic (2.88e-3)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.72e-1)" "unprognostic (1.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.33e-3)" "unprognostic (2.74e-1)" "unprognostic (1.05e-2)" 8.5 6.6 6.3 39.5 7.4 9.3 7.8 7.7 10.0 10.8 10.5 6.8 20.7 7.4 2.7 5.5 7.5 15.1 5.4 5.5 13.1 7.3 4.7 24.3 57.7 13.3 7.7 3.2 3.6 3.9 2.6 3.0 2.6 10.9 4.9 8.3 1.4 12.3 7.0 5.0 8.7 25.0 7.3 10.6 51.7 13.0 2.1 10.7 16.1 5.3 2.5 57.5 9.1 4.2 14.7 0.4 0.4 0.7 0.6 0.1 0.0 0.5 0.2 0.0 0.3 0.4 0.6 12.0 11.2 1.6 0.0 1.7 1.8 0.0 0.0 0.2 51.1 0.6 6.3 2.6 1.3 0.0 0.9 0.9 2.1 0.0 0.2 0.0 1.8 0.0 0.7 0.8 4.1 0.2 0.7 0.6 1.0 0.3 0.4 0.3 89.5 0.6 7.9 0.1 3.6 1.8 0.3 2.1 0.6 2.1 0.6 1.0 3.8 0.5 4.3 0.7 1.2 0.5 18.0 1.4 25.8 16.0 1.1 14.7 0.7 29.1 17.5 0.8 23.5 0.4 47.3 0.3 1.4 46.2 63.3 0.2 0.4 6.8 1.8 29.0 48.3 1.2 5.4 6.3 7.4 7.7 10.0 5.5 13.1 13.3 7.7 3.2 10.9 10.6 10.7 14.7 14.5 6.4 19.5 0.3 48.8 2.3 0.3 1.3 1.2 0.8 1.7 2.0 5.3 1.5 1.5 3.7 0.0 0.2 17.9 2.0 0.0 5.5 0.8 1.5 0.4 7.3 2.4 6.9 1.4 2.0 0.3 1.2 4.6 1.4 10.8 7.7 1.4 0.7 8.7 0.0 1.8 1.9 0.0 16.1 51.8 0.0 0.6 43.8 7.2 42.2 51.8 0.2 2.1 0.0 0.3 1.1 0.1 0.0 1.1 0.4 12.3 4.8 5.6 1.6 0.0 1.0 1.2 0.0 0.0 1.0 2.8 0.1 3.0 0.4 1.5 0.5 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453280-88537031 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 19.3;K-562: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 1.7 2.5 4.5 1.9 2.1 9.3 1.9 5.1 5.8 2.3 3.1 1.6 12.6 2.2 1.1 1.8 4.0 1.5 3.9 5.5 1.9 2.4 8.7 2.2 2.7 3.1 2.2 2.2 2.3 10.5 1.4 5.6 0.9 3.0 3.2 0.8 0.7 2.8 1.3 1.6 3.4 6.9 0.2 1.2 5.0 13.8 5.8 2.3 1.6 4.0 0.3 1.2 2.3 2.1 1.8 1.4 3.8 2.8 5.9 0.5 0.1 11.9 4.0 0.5 1.3 0.4 12.1 1.5 5.9 3.0 0.6 1.4 9.5 0.1 3.3 0.3 4.6 2.5 19.3 8.1 10.7 2.1 1.1 6.2 1.3 2.1 1.4 0.5 1.4 1.3 1.6 29.2 0.4 1.0 7.3 6.9 7.0 1.9 9.3 3.2 2.0 1.3 2.9 1.3 4.8 7.7 12.8 4.9 0.3 3.9 1.4 3.1 3.1 4.8 4.9 3.1 2.2 0.8 1.4 1.0 0.5 1.4 2.3 4.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 2.1 5.1 5.8 5.5 1.9 3.1 2.2 2.2 3.0 1.2 2.3 1.8 16.7 3.2 2.2 12.4 4.8 0.9 6.1 0.7 0.0 20.7 13.5 25.8 17.2 5.7 0.4 1.8 29.2 0.4 27.5 10.8 1.9 1.3 0.7 24.1 23.7 6.3 6.0 4.8 6.8 5.1 0.2 10.9 14.3 20.1 0.0 16.0 5.0 8.8 0.9 35.3 8.0 6.7 0.0 5.3 1.2 1.1 0.9 7.5 1.8 8.4 1.6 58.0 2.1 5.5 13.4 2.9 6.2 1.5 9.5 1.4 1.3 1.3 0.4 23.9 0.0 16.1 12.4 0.7 1.0 1.9 1.4 0.3 9.6 37.4 5.2 2.1 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase type B" O15296 17 8039034-8049134 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 112.8;prostate: 73.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 75.8;Basal respiratory cells: 22.0;Kupffer cells: 42.2;monocytes: 87.9;Prostatic glandular cells: 25.6;Squamous epithelial cells: 44.4" "Cancer enriched" "Detected in all" 5 "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 3.9;myeloid DC: 4.3" "Group enriched" "Detected in many" 8 "dendritic cells: 4.3;monocytes: 3.9" "Cell line enhanced" "Detected in some" "HHSteC: 7.7;HSkMC: 16.6;hTCEpi: 35.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010562: AB_2668305" "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 2.1 1.7 0.9 1.3 1.2 0.4 112.8 0.8 3.8 6.5 0.7 1.7 0.1 1.1 1.0 39.4 1.6 0.7 0.6 0.8 1.0 0.5 0.4 24.7 3.0 1.7 0.8 0.6 0.7 1.4 0.2 0.5 1.3 2.1 73.7 0.3 0.3 3.7 0.1 0.3 27.1 3.8 0.1 1.0 3.8 4.4 0.5 1.0 0.7 1.9 0.1 7.6 1.8 33.6 2.0 0.1 0.0 0.0 0.1 0.5 0.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 16.6 35.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.9 0.9 1.2 0.8 3.8 0.8 1.0 1.7 0.8 0.6 2.1 1.0 1.0 2.0 1.4 0.0 75.8 0.0 0.3 3.1 0.6 22.0 7.4 0.0 19.8 12.3 0.3 1.5 8.2 0.0 0.0 0.2 0.2 0.2 0.0 0.1 1.3 0.0 0.8 0.4 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.2 1.3 0.0 0.7 0.3 4.2 0.0 0.0 0.0 2.0 42.2 1.1 0.8 0.0 15.4 5.4 0.0 87.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 25.6 0.0 0.0 2.2 0.0 0.0 0.1 1.3 0.6 0.8 44.4 1.1 0.8 0.0 0.0 0.0 2.2 PLD6 ENSG00000179598 "Phospholipase D family member 6" Q8N2A8 17 17200995-17206333 "Metabolic proteins, Predicted membrane proteins" "Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 21.3" "Cell type enhanced" "Detected in many" "Spermatocytes: 32.4;Spermatogonia: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.8;NK-cells: 6.3;T-cells: 11.9" "Cell line enhanced" "Detected in many" "HAP1: 41.2;REH: 31.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA049345 Approved NA NA "HPA049345: AB_2680722" "unprognostic (1.71e-1)" "unprognostic (6.80e-3)" "unprognostic (3.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (7.83e-2)" "unprognostic (9.01e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (3.51e-1)" "unprognostic (2.24e-1)" 4.3 4.2 10.8 1.4 10.3 2.0 3.8 10.2 10.8 7.5 9.2 6.8 1.7 3.5 5.1 1.6 5.8 2.3 4.0 10.3 11.1 2.9 5.9 2.8 3.0 9.9 10.6 10.8 7.9 5.0 5.7 8.2 1.8 12.0 5.6 1.7 3.6 3.2 4.5 5.2 4.5 3.2 2.4 8.1 4.4 4.5 21.3 11.6 1.6 3.3 1.4 2.2 4.3 4.5 10.7 7.1 5.4 0.2 6.0 2.3 0.9 0.3 2.2 3.6 4.0 2.4 6.3 2.0 15.4 3.3 2.2 2.4 1.9 41.2 1.2 3.8 9.7 12.0 14.9 4.2 11.3 10.2 11.2 6.0 2.0 4.4 2.4 9.7 4.5 1.0 7.1 13.5 0.4 4.6 9.0 8.3 15.8 0.1 8.0 7.4 31.5 3.1 11.3 3.7 0.5 23.4 9.7 2.8 3.9 7.2 4.3 3.8 17.8 1.1 0.1 0.3 9.0 4.5 1.9 7.5 0.1 4.8 11.4 8.6 0.4 0.4 0.2 2.9 0.3 9.9 5.8 11.3 6.0 0.1 4.8 11.9 5.5 0.5 6.3 0.2 1.5 9.4 4.1 10.8 10.3 10.2 10.8 10.3 11.1 9.9 10.6 10.8 12.0 8.1 11.6 10.7 0.6 3.2 3.3 4.6 3.3 5.5 4.5 1.7 9.6 4.5 2.2 3.9 7.2 1.5 1.9 1.8 0.0 5.5 0.5 0.5 1.9 1.4 7.1 7.5 1.5 0.8 1.2 3.4 6.0 0.7 1.3 2.8 1.5 3.4 1.3 3.3 1.8 2.1 2.7 6.7 9.8 2.0 6.1 0.6 1.7 2.7 4.4 0.8 3.6 2.8 0.7 6.5 0.0 3.0 7.1 1.0 0.1 4.9 10.1 5.9 0.8 1.4 6.0 1.3 0.0 1.4 1.5 32.4 23.7 1.3 1.6 0.8 3.6 5.6 1.5 1.2 GPHB5 "GPB5, ZLUT1" ENSG00000179600 "Glycoprotein hormone subunit beta 5" Q86YW7 14 63312835-63318935 "Predicted secreted proteins" Hormone "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRM8 "GLUR8, GPRC1H, mGlu8, MGLUR8" ENSG00000179603 "Glutamate metabotropic receptor 8" O00222 7 126438598-127253093 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 9.6;choroid plexus: 36.6" "Cell type enhanced" "Detected in some" "Early spermatids: 59.5;Excitatory neurons: 104.9;Inhibitory neurons: 134.0;Late spermatids: 69.1;Oligodendrocyte precursor cells: 32.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.9;HEK 293: 1.4;NTERA-2: 3.5;RH-30: 2.4;SCLC-21H: 3.3;SH-SY5Y: 1.7;U-2 OS: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051481 Uncertain NA NA "HPA051481: AB_2681499" "unprognostic (4.57e-3)" "unprognostic (5.10e-4)" "unprognostic (1.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.83e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (3.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (1.32e-2)" "unprognostic (1.12e-2)" 0.0 0.6 2.5 0.3 3.8 0.0 0.0 0.7 3.8 0.0 36.6 1.7 0.1 0.0 0.0 0.0 0.1 0.5 2.4 4.1 3.1 0.6 3.7 0.2 0.0 7.4 8.2 1.3 0.8 0.5 0.0 0.3 0.0 9.6 0.1 2.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.7 2.2 0.0 0.9 0.0 0.1 0.5 0.0 6.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.5 0.0 0.0 0.0 2.4 0.0 0.1 0.0 3.3 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.8 0.7 3.8 4.1 3.1 7.4 8.2 1.3 9.6 0.0 2.2 6.3 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.1 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 59.5 0.0 0.0 0.6 1.2 0.0 104.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 1.2 0.0 0.0 134.0 0.7 0.0 0.0 0.0 69.1 0.6 0.0 0.0 13.1 0.0 0.3 0.0 32.6 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 1.2 1.6 0.0 0.0 0.0 0.0 0.1 0.9 0.0 CDC42EP4 "BORG4, CEP4, KAIA1777, MGC17125, MGC3740" ENSG00000179604 "CDC42 effector protein 4" Q9H3Q1 17 73283624-73312005 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Horizontal cells: 753.7;Muller glia cells: 570.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 20.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023335, HPA024797" Approved Supported Supported "Plasma membrane,Actin filaments,Microtubules" NA NA "Actin filaments, Microtubules" "Plasma membrane" "HPA023335: AB_10603783, HPA024797: AB_10600696" "unprognostic (8.76e-2)" "unprognostic (4.38e-3)" "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (6.29e-2)" "unprognostic (9.01e-3)" "unprognostic (2.44e-3)" "unprognostic (1.08e-1)" "unprognostic (8.00e-2)" "unprognostic (2.41e-1)" "unprognostic (4.16e-2)" "unprognostic (6.73e-2)" "unprognostic (3.97e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" 80.7 55.3 77.6 15.4 75.9 15.0 75.2 85.8 77.0 45.9 67.7 47.3 36.0 53.1 60.6 33.5 70.0 19.3 43.7 76.7 187.4 28.8 32.4 38.9 16.3 133.2 93.5 57.4 71.3 78.2 20.7 45.3 23.0 85.5 39.1 17.5 98.9 41.9 43.5 29.0 40.6 36.3 25.7 96.5 24.3 42.7 20.6 93.0 20.4 45.8 19.0 27.8 34.1 39.9 103.9 30.1 70.1 24.7 20.9 48.8 40.5 65.0 26.2 32.6 24.3 17.9 14.8 42.1 0.1 22.9 31.6 27.6 20.6 17.2 18.0 14.6 1.4 17.0 6.7 35.2 34.7 24.3 1.1 7.3 51.4 14.9 21.2 10.5 19.2 27.9 0.6 18.9 1.4 14.9 23.2 1.2 8.6 13.5 87.8 48.4 0.8 11.0 3.1 28.8 34.3 16.4 24.8 19.7 53.1 18.4 19.0 64.3 9.8 28.7 22.7 47.6 18.1 18.9 1.4 1.2 0.2 37.3 4.7 60.7 3.3 3.2 5.9 0.1 8.5 0.2 0.1 0.0 0.0 4.3 0.0 0.2 0.0 5.4 0.3 20.1 0.1 0.0 2.1 77.6 75.9 85.8 77.0 76.7 187.4 133.2 93.5 57.4 85.5 96.5 93.0 103.9 117.1 12.8 15.6 54.9 2.8 48.7 58.5 54.9 97.9 11.5 45.8 37.1 10.8 31.5 29.1 12.9 6.2 32.1 2.5 47.3 11.7 29.4 0.6 29.7 47.6 43.8 31.2 9.1 1.0 43.6 35.0 46.1 31.1 41.2 13.3 19.6 42.8 27.7 6.1 753.7 1.3 41.3 14.2 5.5 30.1 2.7 18.3 9.1 30.2 6.5 11.1 570.4 0.0 2.5 2.5 30.4 33.5 15.4 2.5 42.6 53.1 8.0 18.0 26.2 131.5 98.0 69.9 1.1 2.0 83.2 44.9 84.3 6.0 13.6 30.2 124.1 OR2AP1 OR2AP1P ENSG00000179615 "Olfactory receptor family 2 subfamily AP member 1" Q8NGE2 12 55572468-55575612 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 1.0;U-937: 1.0" NA NA 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.5 0.3 0.3 0.3 0.2 0.3 0.3 0.1 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C4 ENSG00000179626 "Olfactory receptor family 6 subfamily C member 4" Q8NGE1 12 55549602-55555832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.6 0.3 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.3 0.2 0.0 0.1 0.4 0.1 0.0 0.3 0.2 0.4 0.1 0.1 0.1 0.2 0.7 0.2 0.2 0.2 0.3 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.2 0.3 0.6 0.3 0.2 0.2 0.1 0.1 0.2 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB42 ZNF925 ENSG00000179627 "Zinc finger and BTB domain containing 42" B2RXF5 14 104800596-104804712 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 11.7;Exocrine glandular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "eosinophil: 5.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "HDLM-2: 19.3;MCF7: 33.7;T-47d: 26.9" "Not detected" "Not detected" HPA066961 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066961: AB_2685756" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (8.68e-2)" "unprognostic (1.59e-1)" "unprognostic (6.99e-2)" "unprognostic (6.67e-2)" "unprognostic (6.17e-3)" "unprognostic (2.56e-1)" "unprognostic (4.35e-1)" "unprognostic (2.70e-2)" "unprognostic (1.63e-1)" "unprognostic (3.42e-1)" "prognostic favorable (2.30e-9)" "unprognostic (1.34e-1)" "unprognostic (2.75e-1)" "unprognostic (1.58e-3)" "unprognostic (5.45e-2)" 2.3 3.5 1.0 1.7 0.9 0.3 3.3 0.9 0.9 1.7 1.3 2.9 3.2 2.2 1.8 4.9 4.5 1.8 4.0 0.8 1.7 4.1 5.5 4.4 1.5 1.6 1.2 0.6 1.1 11.6 2.3 1.1 1.2 1.1 6.2 1.8 0.4 6.3 3.3 6.6 2.6 3.0 1.4 1.3 2.3 6.6 2.4 1.1 1.4 4.7 2.6 1.3 2.3 2.2 1.1 1.3 4.4 1.3 5.3 1.0 1.1 5.4 1.9 2.0 3.4 3.0 2.8 5.1 0.4 3.7 1.9 2.3 5.8 1.1 1.8 0.5 19.3 1.3 1.8 2.3 3.3 1.6 0.4 10.3 2.0 2.1 1.4 0.7 2.4 1.5 3.8 3.0 2.9 0.6 33.7 3.6 2.8 0.8 8.9 4.0 5.0 0.3 2.7 2.5 8.6 5.9 2.5 1.5 7.9 3.4 1.2 26.9 2.1 2.4 1.3 3.0 0.3 0.6 3.1 1.8 0.3 4.3 1.8 2.8 0.0 0.1 5.4 0.3 0.0 0.5 0.4 0.4 0.1 0.0 0.4 0.3 0.4 0.0 0.1 0.0 0.4 0.3 0.2 1.0 0.9 0.9 0.9 0.8 1.7 1.6 1.2 0.6 1.1 1.3 1.1 1.1 3.1 3.2 11.7 0.3 1.2 0.4 5.0 1.9 1.2 0.3 8.1 3.4 4.4 5.7 8.2 0.0 0.0 1.2 1.1 4.3 3.9 4.2 2.6 2.3 1.2 2.6 5.4 4.4 0.0 13.5 1.9 1.1 3.1 3.9 0.0 2.3 2.5 7.3 1.1 0.0 0.0 6.4 2.0 2.5 0.6 0.9 0.6 0.9 1.8 0.0 0.8 2.8 5.2 0.5 0.0 7.5 3.2 0.4 0.7 6.9 3.4 4.3 3.1 0.4 0.0 1.5 1.6 8.4 3.4 3.4 0.1 0.8 1.8 0.5 4.9 5.1 LACC1 "C13orf31, FAMIN, FLJ38725" ENSG00000179630 "Laccase domain containing 1" Q8IV20 13 43879284-43893932 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.0;eosinophil: 3.1;intermediate monocyte: 5.2;myeloid DC: 2.7;non-classical monocyte: 8.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.7;granulocytes: 3.1;monocytes: 8.0" "Cell line enhanced" "Detected in many" "HMC-1: 37.1;TIME: 118.2" "Low region specificity" "Detected in all" "CAB034228, HPA040150, HPA044211" Uncertain NA NA "CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258" "unprognostic (2.48e-1)" "unprognostic (3.27e-2)" "unprognostic (4.54e-2)" "unprognostic (3.31e-3)" "unprognostic (1.17e-2)" "unprognostic (3.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.43e-2)" "unprognostic (3.03e-3)" "unprognostic (1.78e-2)" "unprognostic (6.06e-3)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (3.30e-1)" "unprognostic (9.36e-3)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" 6.4 6.7 16.3 12.3 23.0 1.9 5.5 12.5 17.8 4.6 9.7 10.4 10.0 3.9 3.2 6.8 3.2 9.9 10.2 13.3 21.6 4.8 7.3 6.5 8.8 16.8 20.0 10.8 3.5 3.6 10.0 2.9 6.2 20.5 5.4 13.4 0.8 4.7 4.9 1.4 4.8 13.9 5.9 14.8 7.3 6.8 9.5 16.7 6.6 3.5 1.2 8.3 11.2 2.9 29.9 4.7 2.5 1.3 0.0 2.7 12.3 9.5 10.3 25.7 2.8 3.9 5.3 10.5 9.9 2.3 13.8 6.0 6.7 0.3 2.9 4.5 6.6 1.7 12.3 2.6 1.9 12.5 2.9 37.1 16.3 8.5 10.3 12.6 3.4 5.9 1.1 0.0 7.1 6.4 2.3 0.3 3.7 0.9 2.6 2.2 2.3 0.0 5.2 7.4 5.5 1.6 2.5 3.4 1.2 4.9 6.8 1.5 6.2 118.2 3.5 1.1 18.8 0.1 0.0 0.0 2.4 10.0 3.7 8.0 1.0 3.0 3.1 0.7 5.2 0.8 0.8 0.6 0.6 2.7 1.0 0.2 0.3 0.1 0.4 8.0 0.5 0.8 1.0 16.3 23.0 12.5 17.8 13.3 21.6 16.8 20.0 10.8 20.5 14.8 16.7 29.9 4.6 12.8 6.8 1.0 5.9 5.7 8.4 8.1 3.4 0.5 5.1 4.6 24.2 4.3 7.8 11.0 0.0 6.5 1.0 7.6 1.9 5.5 1.3 5.1 3.4 7.4 5.4 1.7 2.1 3.8 4.3 4.5 2.0 8.5 8.2 9.7 5.0 5.1 15.3 0.0 6.2 4.4 6.1 17.6 10.3 3.1 2.1 24.2 1.8 1.9 7.8 2.0 1.0 2.0 39.2 8.0 11.2 1.5 0.5 11.4 10.5 8.2 7.2 0.2 6.6 5.3 6.0 17.1 16.7 8.4 10.2 9.2 4.3 4.6 6.7 10.2 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104461-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA024821: AB_2671696, HPA058548: AB_2683751" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 96.7 85.1 83.7 62.2 85.0 165.8 93.2 83.6 99.1 96.9 79.9 149.6 62.6 102.7 64.2 82.4 94.1 63.6 166.1 80.2 79.8 90.3 61.6 78.6 79.2 88.3 84.5 78.2 111.2 85.3 88.1 71.5 65.7 84.0 104.5 58.8 35.7 78.1 95.5 417.0 70.0 93.0 81.2 83.4 97.2 103.0 77.0 85.0 91.7 79.2 297.3 70.0 131.8 84.8 87.4 119.8 187.1 85.4 86.3 229.0 113.3 68.9 91.8 151.0 140.5 142.1 69.2 129.1 131.0 150.4 154.9 78.1 71.4 117.4 129.9 103.0 115.4 139.5 144.5 127.8 109.6 154.1 62.0 94.4 100.7 150.0 112.8 211.4 156.7 153.6 94.1 112.5 86.9 85.0 281.2 230.9 112.3 64.0 216.3 490.2 90.3 119.7 141.8 89.0 88.8 123.8 102.2 122.0 156.7 152.6 79.5 106.7 93.9 93.0 65.0 146.0 116.1 117.5 102.7 86.0 62.2 107.8 113.7 44.0 50.4 98.0 126.5 72.8 76.1 81.0 110.2 105.0 117.5 107.6 129.9 110.9 105.0 52.9 93.1 78.4 81.0 84.1 111.9 83.7 85.0 83.6 99.1 80.2 79.8 88.3 84.5 78.2 84.0 83.4 85.0 87.4 76.8 16.0 15.6 6.8 95.2 92.9 92.4 51.6 53.5 41.4 76.5 77.8 54.2 42.9 24.8 44.1 14.6 106.4 113.9 82.6 105.7 101.1 86.1 30.0 39.3 69.7 93.3 129.0 5.0 107.9 103.6 66.3 28.5 43.6 32.5 77.3 67.5 29.3 97.6 37.0 5.5 89.7 32.6 72.3 85.6 41.0 88.3 84.9 78.2 6.5 138.0 82.0 138.0 7.1 10.7 106.0 97.4 93.3 60.3 170.3 155.0 110.2 12.9 37.6 98.6 65.5 84.8 96.1 43.3 54.0 89.8 144.3 87.6 72.4 88.5 122.4 TPPP2 "C14orf8, CT152, p18, p25beta" ENSG00000179636 "Tubulin polymerization promoting protein family member 2" P59282 14 21024109-21036276 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 256.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 9161.6" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004120 Enhanced NA NA "HPA004120: AB_2303582" "unprognostic (2.91e-2)" "unprognostic (2.49e-3)" "unprognostic (2.54e-1)" "unprognostic (1.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.57e-3)" "unprognostic (4.63e-4)" "unprognostic (3.83e-1)" "unprognostic (3.16e-1)" "unprognostic (1.09e-1)" "unprognostic (4.64e-4)" "unprognostic (2.51e-4)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (3.21e-1)" 0.1 0.4 0.7 0.1 0.7 0.0 0.5 0.7 1.1 0.2 1.0 0.1 0.1 0.2 3.5 0.0 0.2 0.3 0.6 0.7 0.7 0.9 13.4 0.1 0.0 0.8 0.7 0.4 0.8 0.2 0.2 0.1 0.1 0.7 0.4 0.3 0.3 1.4 0.2 3.2 0.1 0.3 0.0 0.8 0.1 0.1 256.8 0.7 0.0 0.1 4.8 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.7 1.1 0.7 0.7 0.8 0.7 0.4 0.7 0.8 0.7 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.1 1897.4 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9161.6 47.5 2.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 52.0 30.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 FCER1A FCE1A ENSG00000179639 "Fc fragment of IgE receptor Ia" P12319 1 159289714-159308224 "FDA approved drug targets, Predicted membrane proteins" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.9" "Cell type enriched" "Detected in many" 7 "Langerhans cells: 1962.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 8 "basophil: 21557.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 21557.7" "Cell line enriched" "Detected in some" 99 "HEL: 447.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB022102, HPA036051, CAB055526" Approved NA NA "CAB022102: , CAB055526: , HPA036051: AB_2674919" "unprognostic (1.78e-2)" "unprognostic (2.26e-2)" "unprognostic (7.32e-2)" "unprognostic (7.51e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-3)" "unprognostic (7.19e-2)" "unprognostic (1.97e-3)" "unprognostic (2.44e-1)" "unprognostic (7.20e-2)" "unprognostic (8.54e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.20e-4)" "unprognostic (1.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.70e-1)" "unprognostic (3.39e-2)" 3.9 1.7 0.4 5.8 0.4 14.4 17.5 0.4 0.8 10.7 0.7 7.1 7.2 7.2 5.5 23.2 3.0 15.1 3.2 0.4 0.5 4.7 4.4 14.6 2.5 0.5 0.6 0.3 0.7 1.3 2.6 0.8 0.2 0.6 6.0 10.8 0.1 4.1 9.1 2.9 33.9 8.9 7.5 0.3 8.1 3.5 2.4 0.5 4.8 1.2 3.9 11.0 12.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 447.9 0.0 0.0 0.0 0.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21557.7 14.4 36.4 0.4 4.1 4.4 2.8 4.4 1.5 2645.6 3.1 2.3 3.4 17.2 14.6 11.0 361.0 2.8 132.1 0.4 0.4 0.4 0.8 0.4 0.5 0.5 0.6 0.3 0.6 0.3 0.5 0.5 1.6 6.4 33.1 0.3 5.5 37.7 0.1 0.0 0.6 0.0 0.6 1.8 0.6 0.0 1.8 0.0 0.0 0.0 76.8 0.0 0.0 0.0 0.3 0.1 0.0 3.4 0.0 37.8 0.0 0.0 0.1 4.2 0.0 0.1 270.7 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 4.0 1962.9 1.1 0.0 169.1 46.2 0.0 46.8 0.0 3.1 0.0 0.0 0.0 0.1 0.0 1.3 0.1 0.0 0.0 1.5 0.0 13.1 0.1 2.6 0.1 0.3 0.2 34.1 0.0 6.8 0.0 0.0 0.0 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979253 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 12.0" "Group enriched" "Detected in some" 6 "Enteroendocrine cells: 31.8;Excitatory neurons: 17.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Daudi: 12.4;HEK 293: 3.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 90.0" HPA062668 Uncertain NA NA "HPA062668: AB_2684827" "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.1 0.0 2.4 0.0 12.0 0.0 0.3 0.1 7.3 0.1 0.0 0.2 0.0 0.0 0.6 0.3 0.2 0.0 0.4 6.6 5.2 0.0 0.0 0.1 0.0 1.8 0.7 6.7 0.0 0.2 0.0 0.4 0.0 2.4 0.1 0.0 0.0 0.2 0.0 1.3 1.6 0.2 0.0 0.0 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.5 0.7 0.2 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 12.0 0.1 7.3 6.6 5.2 1.8 0.7 6.7 2.4 0.0 1.2 4.9 2.2 0.0 0.0 1.6 0.4 0.4 0.0 0.0 0.0 2.5 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.2 31.8 0.0 17.4 3.9 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.3 2.3 0.0 0.0 0.5 0.0 0.3 0.0 1.8 1.0 0.0 0.0 0.0 1.0 1.4 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.1 0.5 1.1 0.0 0.0 0.0 0.3 0.0 ARL14 "ARF7, FLJ22595" ENSG00000179674 "ADP ribosylation factor like GTPase 14" Q8N4G2 3 160677160-160678448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 130.2;intestine: 51.7;stomach 1: 77.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 588.3;Gastric mucus-secreting cells: 377.7;Intestinal goblet cells: 154.6;Paneth cells: 519.2;Proximal enterocytes: 174.5" "Group enriched" "Detected in many" 5 "colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 15 "memory B-cell: 1.8" "Lineage enriched" "Detected in single" 18 "B-cells: 1.8" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 36.2;HaCaT: 9.0;OE19: 25.3;RT4: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.65e-1)" "unprognostic (7.26e-3)" "unprognostic (2.64e-2)" "unprognostic (3.70e-3)" "unprognostic (6.36e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.64e-5)" "unprognostic (2.30e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (4.74e-2)" "unprognostic (4.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.70e-2)" 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 43.3 51.7 0.1 0.0 1.0 0.1 130.2 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.1 36.4 0.0 0.1 0.0 0.0 0.2 34.4 2.8 0.0 0.1 77.9 0.0 0.0 0.3 0.6 0.0 3.3 24.0 0.3 0.0 9.7 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 36.2 0.0 0.8 0.0 4.2 9.0 0.0 0.9 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 25.3 2.0 0.0 0.0 0.3 2.9 17.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.0 1.9 4.5 2.6 0.0 0.0 0.2 0.1 0.0 18.6 1.2 0.0 0.0 0.0 0.0 588.3 0.0 12.6 0.0 5.6 0.4 0.1 89.1 0.0 0.0 41.4 0.1 0.5 377.7 10.7 8.9 0.0 0.0 0.0 0.0 0.0 0.0 154.6 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 519.2 0.0 1.0 1.2 174.5 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.9 0.0 1.4 0.0 112.0 25.9 OR6C2 OR6C67 ENSG00000179695 "Olfactory receptor family 6 subfamily C member 2" Q9NZP2 12 55444069-55453347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.37e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WDR97 KIAA1875 ENSG00000179698 "WD repeat domain 97" A6NE52 8 144107726-144118328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.0;Cone photoreceptor cells: 6.2;Gastric mucus-secreting cells: 5.1;Horizontal cells: 5.0;Rod photoreceptor cells: 8.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059409 Uncertain NA NA "HPA059409: AB_2684005" "unprognostic (3.95e-2)" "unprognostic (1.31e-2)" "unprognostic (3.58e-3)" "unprognostic (1.70e-1)" "unprognostic (2.70e-1)" "unprognostic (3.01e-4)" "unprognostic (3.10e-2)" "unprognostic (2.40e-1)" "unprognostic (6.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.97e-3)" "unprognostic (6.92e-2)" "unprognostic (6.11e-6)" "unprognostic (2.79e-3)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (3.73e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.8 0.0 1.7 0.0 0.9 0.0 0.2 0.0 0.6 7.0 1.3 1.3 0.0 1.5 0.0 0.0 6.2 0.1 3.1 0.3 1.9 0.7 4.4 2.2 0.4 0.4 0.0 0.4 0.0 0.2 0.0 0.4 5.1 0.7 0.0 0.8 0.7 1.7 0.2 5.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.6 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.6 2.6 0.0 0.5 0.6 1.5 0.2 0.7 8.5 0.0 2.1 0.6 3.8 2.2 0.8 0.0 0.0 0.6 0.0 0.7 0.3 NLRP8 "CLR19.2, NALP8, NOD16, PAN4" ENSG00000179709 "NLR family pyrin domain containing 8" Q86W28 19 55947832-55988629 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 15.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056989 Uncertain NA NA "HPA056989: AB_2683301" "unprognostic (2.43e-2)" "unprognostic (3.35e-1)" "unprognostic (3.13e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.4;lymphoid tissue: 36.3" "Cell type enhanced" "Detected in many" "Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 63.3;K-562: 48.9;SK-BR-3: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favorable (5.36e-5)" 6.4 40.4 3.1 18.1 2.7 10.7 6.1 2.6 3.5 6.4 2.2 8.1 2.2 8.7 2.0 3.1 9.4 6.0 2.9 2.3 4.7 6.0 3.9 9.1 36.3 4.0 3.7 2.3 23.6 2.8 1.2 2.3 3.7 3.6 5.8 2.7 0.8 3.3 2.4 1.3 2.4 12.3 4.5 3.6 29.8 3.9 13.8 4.0 7.2 3.4 1.2 24.3 9.7 5.5 4.6 3.4 63.3 1.5 0.0 0.5 0.0 3.0 2.0 3.5 0.7 0.3 3.2 12.3 11.5 3.4 6.5 1.2 9.2 0.0 9.4 0.0 13.5 0.0 0.4 0.6 1.3 1.3 2.7 0.5 0.2 4.1 1.1 7.1 8.8 2.7 0.8 48.9 10.6 4.4 1.5 0.7 2.3 10.6 7.9 0.9 0.2 1.6 8.2 9.7 5.2 0.4 0.0 5.7 31.0 0.0 3.2 5.7 4.0 0.8 0.2 0.9 0.1 2.2 11.4 8.6 20.3 3.0 8.7 0.3 1.7 1.1 2.8 42.5 2.3 48.3 50.1 50.7 54.1 6.4 35.6 88.8 83.5 4.5 30.1 2.6 38.1 59.1 35.4 3.1 2.7 2.6 3.5 2.3 4.7 4.0 3.7 2.3 3.6 3.6 4.0 4.6 3.4 3.2 5.6 30.3 23.6 1.1 0.9 4.2 9.1 2.5 4.4 6.2 0.5 0.0 1.5 1.8 0.0 0.5 21.1 0.2 0.0 3.2 0.9 5.1 1.4 3.4 10.2 0.4 32.4 12.8 9.1 3.1 1.5 10.3 1.3 47.8 9.7 0.3 37.6 0.0 2.2 1.4 0.0 4.3 1.8 2.5 3.7 10.7 1.8 60.0 5.3 0.9 23.7 17.6 0.6 11.7 0.8 0.7 28.1 1.4 0.1 0.4 0.8 0.1 0.0 1.3 4.4 0.7 0.2 2.8 0.6 2.1 36.2 22.4 0.3 4.2 APOBEC3B "FLJ21201, PHRBNL" ENSG00000179750 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3B" Q9UH17 22 38982347-38992804 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.6;intestine: 12.2" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 11.8;Ductal cells: 14.7;Erythroid cells: 14.1;Plasma cells: 26.2;Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 256.0;Karpas-707: 283.6" "HPA056980, HPA066719" Approved Nucleoplasm NA NA Nucleoplasm "HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (2.92e-2)" "prognostic favorable (2.58e-5)" "unprognostic (4.29e-2)" "unprognostic (1.19e-1)" "unprognostic (2.50e-1)" "unprognostic (1.35e-1)" "unprognostic (1.69e-2)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (6.36e-2)" "unprognostic (1.08e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.47e-2)" "unprognostic (2.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.04e-1)" 0.6 1.2 0.1 5.8 0.1 28.6 2.0 0.1 0.2 0.7 0.1 12.2 7.4 1.0 0.4 3.0 0.7 1.1 0.7 0.1 0.1 1.5 1.1 1.9 6.0 0.1 0.1 0.0 0.7 3.4 1.2 0.2 1.6 0.1 0.4 12.1 0.3 2.9 0.2 0.4 2.1 4.4 1.5 0.1 6.5 4.1 0.3 0.2 2.6 1.4 0.2 8.7 7.7 1.5 0.2 256.0 28.0 10.5 68.1 1.5 6.0 18.6 23.0 19.7 43.0 56.5 54.7 46.6 3.0 20.4 22.9 63.0 108.2 1.3 4.5 43.1 92.1 2.5 72.5 5.6 14.0 0.7 61.7 43.0 2.3 0.5 45.1 2.2 8.9 17.0 0.0 41.6 283.6 68.1 6.9 0.2 35.3 0.3 24.6 25.2 1.8 105.0 95.6 9.1 42.2 1.8 0.0 0.0 0.3 16.0 1.8 33.0 18.1 10.2 48.0 81.9 7.5 0.7 62.8 18.0 0.3 34.4 68.2 100.7 0.4 1.0 0.0 0.2 4.9 0.0 7.2 0.5 0.3 0.6 3.1 0.0 0.3 1.4 1.7 1.7 0.0 2.8 3.5 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 1.7 0.0 2.2 5.4 3.2 11.8 0.6 0.0 1.5 0.5 0.3 0.0 8.1 0.0 0.0 1.0 0.4 4.6 0.0 14.7 0.0 5.9 0.6 0.2 0.0 14.1 0.0 1.8 1.8 0.8 3.1 5.3 0.0 0.8 0.4 0.0 2.1 0.0 0.0 0.4 10.2 1.2 6.3 0.0 0.0 2.3 7.2 0.0 1.4 0.0 0.0 0.0 0.0 6.0 9.9 0.0 26.2 1.4 0.4 0.3 9.3 0.0 0.0 0.0 0.9 0.0 0.0 4.2 3.3 0.8 0.5 0.1 1.6 11.4 SYCN "FLJ27441, INSSA1, SYL" ENSG00000179751 Syncollin Q0VAF6 19 39202825-39204263 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1004 "pancreas: 28602.4" "Cell type enriched" "Detected in some" 7 "Exocrine glandular cells: 4000.5" "Cancer enriched" "Detected in single" 842 "pancreatic cancer: 369.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047654 Enhanced "Intracellular and membrane" NA NA 920000 "HPA047654: AB_2680112" "unprognostic (8.02e-2)" 3.8 0.8 0.0 0.4 0.0 0.0 2.5 0.0 0.1 1.4 0.0 0.8 4.0 0.9 0.2 1.6 0.6 0.0 4.5 0.0 0.0 1.0 3.0 0.5 0.6 0.0 0.0 0.0 11.3 28602.4 0.0 0.9 1.6 0.0 1.6 0.0 0.0 4.1 0.0 0.8 1.4 1.8 0.0 0.0 1.2 2.3 28.4 0.0 0.0 0.5 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 4.4 0.0 0.0 0.3 0.0 0.0 0.0 4000.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 1.2 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 506.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PIPOX LPIPOX ENSG00000179761 "Pipecolic acid and sarcosine oxidase" Q9P0Z9 17 28950513-29057216 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "kidney: 147.4;liver: 510.7" "Group enriched" "Detected in many" 6 "Hepatocytes: 225.4;Proximal tubular cells: 163.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 73.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 36.7;Hep G2: 120.2;NTERA-2: 68.4;RH-30: 90.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 380000 "unprognostic (8.02e-2)" "unprognostic (3.50e-4)" "unprognostic (3.03e-1)" "unprognostic (6.25e-3)" "unprognostic (1.52e-1)" "unprognostic (5.01e-2)" "unprognostic (1.95e-3)" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (3.45e-1)" "prognostic favorable (1.49e-4)" "unprognostic (2.39e-1)" "unprognostic (3.13e-3)" "unprognostic (2.58e-3)" "unprognostic (2.01e-1)" "unprognostic (2.79e-2)" "unprognostic (1.22e-1)" 0.4 0.6 13.6 0.6 15.9 0.3 0.3 17.2 15.7 0.7 10.8 2.7 13.7 1.6 24.6 1.8 8.9 3.4 0.4 13.1 14.3 147.4 510.7 1.2 1.0 14.9 14.9 11.9 0.9 0.7 1.7 0.8 4.3 15.3 2.0 1.1 4.4 0.5 3.5 0.3 0.7 4.4 2.1 12.2 1.0 0.9 0.3 16.2 0.4 0.2 0.1 0.5 1.3 0.5 13.6 0.0 0.0 36.7 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.8 0.0 0.1 0.2 0.6 0.0 0.1 0.5 0.5 0.5 0.2 120.2 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 1.1 0.0 0.2 0.0 0.7 68.4 2.4 0.0 0.3 90.7 2.2 0.0 0.1 11.2 3.8 0.3 0.2 0.5 5.9 0.2 4.4 0.0 0.1 0.2 0.1 4.3 0.9 11.4 0.4 0.0 0.6 3.6 1.0 0.2 0.3 0.3 0.2 0.3 0.1 0.1 0.4 1.8 0.2 0.1 0.8 1.4 0.3 0.1 0.1 0.4 0.3 13.6 15.9 17.2 15.7 13.1 14.3 14.9 14.9 11.9 15.3 12.2 16.2 13.6 0.4 0.0 0.6 12.4 1.4 0.3 0.3 0.2 0.0 2.9 0.2 0.3 0.5 5.7 0.1 0.0 4.2 0.2 0.7 0.2 9.8 0.0 1.5 0.2 0.3 0.8 1.2 5.3 0.2 0.2 7.7 0.7 1.5 0.2 5.7 1.3 5.3 225.4 1.2 0.0 0.5 0.0 0.0 6.0 2.1 2.1 0.3 2.2 0.0 1.0 2.2 29.0 0.0 1.0 0.1 0.0 0.0 1.2 0.2 0.3 1.9 163.7 0.0 1.4 0.0 0.7 0.4 0.1 1.0 0.0 0.1 0.4 1.2 0.1 0.1 0.1 FOXS1 "FKHL18, FREAC10" ENSG00000179772 "Forkhead box S1" O43638 20 31844303-31845604 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Peritubular cells: 56.8;Sertoli cells: 131.5;Smooth muscle cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;hTERT-RPE1: 13.1;RH-30: 10.9;U-2 OS: 14.1;U-251 MG: 4.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042475 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042475: AB_10964265" "unprognostic (2.28e-1)" "unprognostic (8.05e-2)" "unprognostic (1.72e-2)" "unprognostic (5.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.86e-1)" "unprognostic (3.10e-2)" "unprognostic (4.23e-1)" "unprognostic (2.65e-1)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (1.10e-8)" "unprognostic (1.09e-3)" "unprognostic (2.04e-2)" "unprognostic (5.02e-2)" "unprognostic (9.00e-2)" 3.7 1.6 2.4 1.4 2.2 0.0 2.8 2.4 3.8 3.6 2.6 1.3 0.3 4.0 2.5 1.0 2.0 2.0 8.9 2.1 2.2 3.4 0.8 5.4 2.5 2.5 2.4 1.7 2.0 1.0 0.6 2.3 4.9 2.5 2.4 0.6 0.0 1.1 3.1 1.7 1.3 1.4 1.2 2.0 3.0 1.2 5.6 2.3 1.0 3.5 1.8 0.9 2.6 2.4 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.9 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 14.1 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 2.4 3.8 2.1 2.2 2.5 2.4 1.7 2.5 2.0 2.3 2.5 4.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.2 0.0 1.1 2.6 0.0 0.0 0.0 0.5 0.0 7.2 0.0 0.1 0.0 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.9 4.9 5.0 0.2 1.8 8.4 0.0 0.0 0.0 0.0 0.0 5.7 0.0 56.8 0.0 0.1 0.0 0.0 0.0 0.1 131.5 0.4 31.5 0.6 0.5 0.1 0.3 0.3 0.1 6.6 0.0 0.1 ATOH7 "bHLHa13, Math5" ENSG00000179774 "Atonal bHLH transcription factor 7" Q8N100 10 68230595-68232113 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;liver: 3.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Excitatory neurons: 1.7;Hepatocytes: 1.1;Spermatogonia: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 7.5" "Region enriched" "Detected in some" 9 "cerebellum: 28.7" "Low region specificity" "Detected in some" HPA027008 Uncertain NA NA "HPA027008: AB_10600783" "unprognostic (7.17e-2)" "unprognostic (2.81e-1)" "unprognostic (7.66e-2)" "unprognostic (1.86e-2)" "unprognostic (2.20e-3)" "unprognostic (7.40e-2)" "unprognostic (7.76e-2)" "unprognostic (6.16e-2)" "unprognostic (2.46e-1)" "unprognostic (9.28e-4)" "unprognostic (4.96e-3)" "unprognostic (1.17e-1)" "unprognostic (5.06e-4)" "unprognostic (1.72e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (7.18e-2)" 0.1 0.2 1.4 0.0 1.6 0.0 0.1 2.6 2.0 0.1 0.8 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 1.9 1.2 1.2 3.1 0.0 0.0 0.8 0.9 1.8 0.1 0.4 0.0 0.2 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 7.5 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 2.6 2.0 1.9 1.2 0.8 0.9 1.8 1.0 0.8 0.9 1.4 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.5 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404784 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 237.9" "Cell type enhanced" "Detected in many" "Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 752.5;TIME: 655.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1300000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 84.6 14.0 18.4 15.0 15.1 0.2 72.0 14.7 16.7 16.0 15.2 16.3 8.0 20.0 8.7 12.5 17.3 29.9 61.1 13.4 14.2 19.2 24.2 95.8 13.3 16.2 16.3 10.2 8.1 7.8 10.4 7.5 237.9 16.3 11.7 10.3 1.3 12.1 9.2 42.2 14.6 17.1 28.0 14.7 20.6 13.5 10.6 19.9 5.2 37.8 59.4 8.0 22.3 14.3 16.7 0.5 0.6 4.6 0.0 0.0 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 119.8 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 752.5 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.0 15.7 0.0 2.4 0.0 0.1 655.1 0.0 0.9 0.1 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.4 15.1 14.7 16.7 13.4 14.2 16.2 16.3 10.2 16.3 14.7 19.9 16.7 311.9 0.0 6.2 1.3 0.7 4.1 0.0 0.0 1.8 0.0 1.0 2.7 17.9 5.7 0.6 1.8 0.0 6.6 0.5 0.0 0.0 0.2 33.5 0.5 0.6 206.1 0.0 10.7 0.1 0.0 48.9 7.1 0.0 1.3 3.8 0.0 185.6 1.7 2.3 0.0 0.1 0.0 0.0 35.7 6.3 84.6 6.2 1.2 12.4 28.1 0.1 0.3 0.0 0.5 0.1 0.0 0.0 2.6 2.5 0.1 0.0 0.0 0.0 0.0 0.0 5.0 5.4 10.9 0.3 0.3 3.0 80.7 1.5 3.0 0.1 0.2 LRRC3B LRP15 ENSG00000179796 "Leucine rich repeat containing 3B" Q96PB8 3 26622806-26717537 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 26.6;choroid plexus: 7.8;skeletal muscle: 9.6" "Cell type enhanced" "Detected in some" "Astrocytes: 256.9;Early spermatids: 115.3;Inhibitory neurons: 50.0;Oligodendrocyte precursor cells: 38.2" "Group enriched" "Detected in some" 9 "endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;SuSa: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015568 Approved NA NA "HPA015568: AB_1853282" "unprognostic (1.22e-2)" "unprognostic (2.94e-1)" "unprognostic (1.87e-1)" "unprognostic (7.42e-2)" "unprognostic (8.82e-4)" "unprognostic (2.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.91e-4)" "unprognostic (3.31e-2)" "unprognostic (2.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.82e-1)" 0.2 0.1 17.7 0.0 20.1 0.0 0.4 26.6 24.7 0.2 7.8 0.4 0.0 0.8 0.0 0.4 0.4 0.0 0.3 22.2 16.0 0.0 0.1 0.0 0.0 16.3 18.0 19.8 1.6 0.0 0.0 1.5 0.0 19.7 0.1 0.5 1.1 0.5 0.1 9.6 0.1 0.3 0.4 15.6 0.1 0.5 7.2 15.6 0.7 0.1 0.2 0.0 4.8 0.2 16.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 20.1 26.6 24.7 22.2 16.0 16.3 18.0 19.8 19.7 15.6 15.6 16.8 0.8 0.0 0.0 256.9 0.0 0.1 0.0 0.0 0.0 1.6 1.2 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.3 0.2 3.2 0.3 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.0 11.6 0.6 0.1 0.0 9.4 0.0 0.8 0.0 38.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.6 0.0 1.6 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.1 FAM216B "C13orf30, FLJ40919" ENSG00000179813 "Family with sequence similarity 216 member B" Q8N7L0 13 42781550-42791549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 78.3" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 162.2;Respiratory ciliated cells: 294.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040118 Uncertain NA NA "HPA040118: AB_10674429" "unprognostic (1.03e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.35e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (2.54e-2)" "unprognostic (5.44e-3)" "unprognostic (1.32e-1)" "unprognostic (2.27e-1)" "unprognostic (8.14e-3)" "unprognostic (1.37e-1)" "unprognostic (1.30e-2)" 0.1 0.0 6.6 0.9 1.6 0.0 0.0 2.3 0.9 1.4 4.7 0.1 0.1 1.5 0.0 0.0 78.3 0.2 10.1 1.1 4.5 0.0 0.0 9.9 1.8 8.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 9.2 0.1 0.2 0.0 2.6 0.0 0.0 0.0 3.6 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.6 2.3 0.9 1.1 4.5 8.6 6.4 0.0 5.9 9.2 2.6 3.9 0.0 0.0 3.9 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 19.8 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 162.2 1.0 0.7 0.0 0.0 0.2 0.0 0.0 2.2 0.0 2.3 1.3 0.0 0.0 0.0 0.3 0.0 0.9 0.0 12.2 0.0 0.0 9.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 294.3 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 MRGPRX4 MRGX4 ENSG00000179817 "MAS related GPR family member X4" Q96LA9 11 18172837-18174280 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "melanoma: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SK-MEL-30: 1.4;WM-115: 1.8" NA NA "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYADM ENSG00000179820 "Myeloid associated differentiation marker" Q96S97 19 53864763-53876435 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 207.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056301 Approved "Nuclear speckles" NA NA 27000 "Nuclear speckles" "HPA056301: " "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (2.94e-1)" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (8.21e-3)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.97e-2)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (7.71e-7)" "unprognostic (2.28e-3)" "unprognostic (1.29e-1)" "unprognostic (2.37e-2)" "unprognostic (6.14e-3)" 181.0 25.9 15.1 67.0 18.1 198.0 83.1 2.1 18.3 91.3 27.0 124.4 49.3 250.7 22.4 77.6 147.8 125.7 89.2 18.8 14.6 19.7 46.7 111.7 37.5 16.6 13.5 18.7 74.0 101.9 31.4 18.0 90.3 13.3 75.7 40.3 3.7 49.2 101.9 37.1 44.6 64.4 182.4 6.3 42.9 80.2 28.6 14.4 37.5 58.4 21.3 15.4 105.7 65.3 21.5 28.8 231.6 29.2 23.3 96.2 66.0 45.3 145.9 105.9 57.0 58.7 94.4 84.1 2.6 53.7 187.4 61.6 56.4 14.6 56.7 48.5 34.9 34.2 38.0 35.8 75.6 219.2 78.4 131.3 72.3 12.7 73.4 10.5 93.4 52.0 14.9 41.5 68.7 36.4 32.0 21.4 60.9 27.9 104.3 65.3 82.1 31.0 13.3 63.8 3.0 0.4 43.8 1.2 44.6 14.1 58.4 44.4 66.8 105.5 125.8 44.5 17.0 66.2 44.7 29.9 0.6 78.4 37.1 2.1 74.3 48.1 165.5 20.9 27.1 19.6 5.4 13.4 15.2 59.5 7.1 12.5 11.0 207.4 17.8 23.5 22.3 5.4 20.0 15.1 18.1 2.1 18.3 18.8 14.6 16.6 13.5 18.7 13.3 6.3 14.4 21.5 125.9 163.5 59.1 2.9 138.9 103.0 173.3 73.1 96.8 4.1 141.0 105.8 67.1 97.2 91.5 20.2 4.2 46.2 143.3 43.8 0.0 106.6 2.7 97.0 164.1 117.2 202.4 35.7 9.1 51.8 243.9 279.7 83.1 195.5 347.6 27.0 182.8 18.5 73.5 10.1 8.3 203.9 24.4 120.4 217.2 2.2 90.1 180.3 60.5 11.2 68.0 4.0 19.6 7.1 13.9 71.4 54.7 116.6 189.9 56.6 2.7 0.5 57.0 1.4 151.2 340.1 199.0 35.9 14.5 19.7 59.8 49.5 221.5 20.5 93.8 75.0 MRGPRX3 MRGX3 ENSG00000179826 "MAS related GPR family member X3" Q96LB0 11 18120955-18138488 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 1.0;salivary gland: 2.7" "Cell type enriched" "Detected in some" 24 "Basal respiratory cells: 53.8" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.3;melanoma: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HBEC3-KT: 13.8" NA NA "unprognostic (1.54e-3)" "unprognostic (5.07e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (2.09e-1)" 0.0 0.0 0.5 0.3 0.5 0.2 0.6 0.5 0.7 0.0 0.3 0.0 0.1 0.1 0.0 1.0 0.0 0.1 0.0 0.5 0.5 0.0 0.0 0.1 0.1 0.5 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.1 2.7 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.3 0.0 13.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.5 0.2 0.2 0.3 0.3 0.1 0.1 1.4 0.9 0.3 0.1 0.5 0.1 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.5 0.5 0.4 0.4 0.5 0.0 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MROH1 "HEATR7A, KIAA1833" ENSG00000179832 "Maestro heat like repeat family member 1" Q8NDA8 8 144148016-144261940 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 59.2" "Cell type enhanced" "Detected in all" "Gastric mucus-secreting cells: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024287, HPA044465" Approved Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024287: , HPA044465: AB_10960985" "unprognostic (1.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (6.74e-4)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.48e-2)" "unprognostic (6.64e-2)" "unprognostic (1.92e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-2)" 8.9 17.1 6.9 6.4 6.4 18.1 11.1 4.3 14.9 10.4 4.7 13.8 13.4 9.1 5.4 17.1 11.1 3.7 13.8 6.6 2.4 17.2 11.8 17.1 7.0 9.9 3.3 8.4 7.8 26.9 5.7 22.5 5.5 10.1 17.4 3.4 0.9 17.4 5.7 5.3 17.2 17.8 2.1 0.8 21.9 19.0 13.1 4.3 4.2 59.2 2.1 3.7 13.0 12.7 7.3 17.0 6.9 0.9 6.5 3.1 3.3 29.3 7.3 5.1 4.0 5.5 11.6 29.7 8.9 10.5 4.2 9.8 15.9 1.0 11.2 1.8 5.1 9.5 10.8 22.1 10.7 7.8 4.8 11.0 6.1 11.4 6.4 9.2 4.7 5.8 7.2 4.5 3.9 4.5 36.3 8.4 10.2 2.5 11.6 32.0 10.8 2.2 9.3 5.9 33.0 7.4 6.4 18.3 17.5 5.4 2.5 12.8 6.7 14.6 8.1 15.2 16.6 6.1 6.8 3.6 9.5 16.0 14.3 4.9 4.8 5.7 1.5 1.8 7.5 1.3 0.9 1.5 1.8 4.3 1.5 1.4 1.0 1.1 0.8 6.8 1.3 4.6 2.2 6.9 6.4 4.3 14.9 6.6 2.4 9.9 3.3 8.4 10.1 0.8 4.3 7.3 5.2 9.6 26.3 33.0 6.5 6.2 8.5 9.2 6.8 36.4 12.6 9.5 12.4 5.7 16.6 5.5 12.5 31.3 7.0 39.8 3.9 12.2 5.1 17.8 6.7 7.8 23.4 1.7 56.7 16.6 19.2 6.4 63.7 25.2 14.5 14.3 3.9 7.0 19.7 37.0 61.2 24.8 18.3 11.9 11.4 12.2 3.1 14.5 1.8 13.1 11.4 5.7 7.2 14.6 7.9 18.6 17.5 2.6 9.7 17.6 30.7 5.8 18.8 3.5 6.6 7.2 6.7 19.1 26.2 9.7 5.8 50.1 9.1 7.8 22.3 14.8 SERTAD2 "KIAA0127, Sei-2, TRIP-Br2" ENSG00000179833 "SERTA domain containing 2" Q14140 2 64631621-64751005 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 86.4" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 177.6;Basal squamous epithelial cells: 153.1;Suprabasal keratinocytes: 148.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019021, HPA020904" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019021: AB_1856740, HPA020904: AB_1856741" "unprognostic (1.40e-2)" "unprognostic (7.41e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.15e-2)" "unprognostic (8.15e-2)" "unprognostic (3.39e-3)" "unprognostic (1.06e-1)" "unprognostic (9.55e-2)" "unprognostic (5.95e-3)" "unprognostic (1.98e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.21e-3)" "unprognostic (6.78e-2)" "unprognostic (4.98e-2)" "unprognostic (3.84e-1)" 14.2 6.8 4.4 13.9 5.8 86.4 9.5 5.3 6.2 10.5 4.4 8.6 6.3 8.7 8.0 23.0 7.0 9.5 10.4 5.1 5.4 7.6 14.7 9.8 19.3 6.2 6.1 3.7 13.7 6.7 10.8 3.6 12.7 5.5 9.4 8.7 15.8 11.8 8.5 8.7 18.2 9.1 8.2 5.7 19.4 9.3 7.2 5.3 35.6 8.2 9.7 27.6 16.0 16.9 7.3 30.9 9.0 16.5 16.6 13.9 35.2 18.9 24.2 23.2 14.1 13.2 23.1 23.0 26.0 13.0 39.8 19.6 12.0 10.9 14.8 29.6 2.5 16.4 17.2 8.8 16.8 3.1 15.3 8.4 24.0 19.1 32.2 20.9 21.1 8.6 12.7 10.9 14.1 33.2 7.4 16.5 16.7 9.0 16.9 23.6 14.3 28.2 10.2 19.1 28.0 19.1 7.5 17.1 11.9 31.5 15.3 7.9 12.1 26.1 75.7 39.1 44.8 19.9 24.0 9.8 29.6 28.0 27.7 30.3 1.3 1.6 2.3 0.9 1.5 0.5 2.5 0.9 1.0 1.5 2.5 2.2 1.6 2.0 1.5 1.8 4.9 0.5 0.9 4.4 5.8 5.3 6.2 5.1 5.4 6.2 6.1 3.7 5.5 5.7 5.3 7.3 25.6 6.4 23.6 22.9 40.8 177.6 40.9 22.5 153.1 24.8 28.7 28.6 26.4 32.9 25.9 9.2 18.8 38.6 33.0 31.6 1.9 12.8 51.2 57.8 18.5 35.4 11.3 26.5 27.3 10.0 42.8 35.1 17.3 97.7 8.8 4.8 25.4 24.1 23.6 10.1 19.8 17.1 18.3 39.3 84.7 35.4 17.1 43.6 39.2 38.4 27.4 20.0 14.4 19.6 35.5 20.7 45.4 10.5 28.1 43.9 11.6 9.5 24.9 24.3 13.1 26.8 31.0 10.8 6.7 135.4 148.3 60.1 25.5 3.7 13.3 71.5 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 13.9;intestine: 3.9" "Cell type enhanced" "Detected in many" "dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "basophil: 3.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "CACO-2: 10.9" "Group enriched" "Detected in all" 5 "amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8" "Group enriched" "Detected in all" 5 "amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB004308: AB_626655, HPA053891: AB_2682294" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.3 0.3 5.7 1.4 13.9 0.6 0.5 0.1 8.0 0.4 0.0 3.8 0.5 1.3 0.1 0.5 0.5 0.9 0.2 6.9 3.1 1.3 0.8 1.8 1.9 0.9 0.3 5.2 0.4 0.2 0.4 1.0 1.1 2.9 0.5 3.9 0.7 0.3 0.5 0.2 0.5 1.4 1.3 0.0 1.3 0.5 0.3 0.5 0.9 0.5 0.0 1.6 0.6 0.3 3.1 1.3 1.0 1.3 0.8 0.4 0.1 4.2 0.9 0.4 1.2 1.5 10.9 3.3 1.0 2.0 0.7 0.1 0.4 2.8 0.2 1.1 2.0 2.4 3.3 2.0 0.9 0.1 0.4 0.4 0.4 0.1 0.8 0.0 2.1 0.4 2.4 0.4 0.7 0.7 0.8 2.7 0.2 1.0 0.1 0.5 3.3 0.5 0.2 1.9 1.2 3.3 1.4 1.1 0.1 0.2 3.8 1.0 0.2 0.6 1.4 4.2 0.1 1.7 2.2 2.6 2.4 0.9 0.4 0.2 3.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.0 5.7 13.9 0.1 8.0 6.9 3.1 0.9 0.3 5.2 2.9 0.0 0.5 3.1 0.4 6.4 2.4 1.6 2.8 0.9 1.3 0.5 1.2 7.4 1.8 1.4 1.6 1.5 0.2 0.0 8.4 0.6 15.6 5.1 0.0 0.6 2.6 0.5 1.4 1.9 0.0 2.7 17.2 0.2 1.9 2.1 0.5 1.0 67.6 0.9 0.4 0.7 0.5 8.4 5.5 28.7 0.0 0.3 2.9 0.9 0.0 1.2 1.8 0.0 0.3 0.9 16.5 3.0 1.6 0.8 2.2 0.0 6.4 1.2 0.8 1.4 0.2 7.7 0.0 2.2 0.8 0.5 4.9 0.1 0.9 0.7 12.4 0.3 6.2 0.9 NKPD1 FLJ33600 ENSG00000179846 "NTPase KAP family P-loop domain containing 1" Q17RQ9 19 45149750-45160815 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 14.8" "Cell type enhanced" "Detected in some" "Horizontal cells: 5.0;Spermatocytes: 2.4;Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 1.4;SiHa: 1.2;U-266/70: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA043339 Uncertain NA NA "HPA043339: AB_10962493" "unprognostic (3.98e-2)" "unprognostic (5.94e-2)" "unprognostic (2.14e-1)" "unprognostic (8.30e-4)" "unprognostic (2.23e-1)" "unprognostic (4.60e-2)" "unprognostic (2.41e-3)" "unprognostic (2.01e-2)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (7.73e-4)" "unprognostic (1.30e-1)" "unprognostic (2.77e-5)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" 0.1 0.1 0.5 0.0 0.2 0.2 0.5 0.3 0.4 0.7 0.0 0.0 0.0 0.1 0.2 1.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.6 0.9 0.0 0.3 0.5 0.5 0.1 14.8 0.1 0.0 0.0 0.2 0.0 1.7 0.3 0.0 0.3 0.0 0.0 0.2 3.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.3 0.2 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 1.2 0.7 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.4 0.2 0.1 0.4 0.1 0.1 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.4 0.0 0.6 0.9 0.2 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.1 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.1 5.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.2 0.5 1.3 0.1 0.0 0.2 0.0 0.1 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585478-3593541 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.8" "Group enriched" "Detected in some" 4 "Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 4.2 2.2 1.4 1.0 0.9 0.3 2.8 0.9 1.1 3.0 0.7 1.7 1.3 2.8 3.0 5.2 2.1 2.1 2.9 1.1 1.0 3.6 1.4 3.8 2.4 1.5 1.0 0.7 0.7 0.7 2.7 1.0 1.1 1.3 3.5 1.4 16.8 0.7 2.4 1.7 1.0 4.5 8.4 1.2 3.9 2.0 0.3 1.8 3.2 3.1 1.9 1.6 1.1 1.9 1.3 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.9 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 1.5 0.0 0.2 6.9 19.0 0.0 0.7 0.0 11.8 0.2 0.0 1.1 0.0 0.0 2.1 0.2 3.2 0.0 0.3 0.0 0.0 1.1 0.7 0.0 1.2 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.5 0.0 4.7 1.1 0.0 23.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.9 1.1 1.1 1.0 1.5 1.0 0.7 1.3 1.2 1.8 1.3 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.4 0.1 0.3 2.4 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 12.8 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.8 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.2 1.1 0.0 0.4 0.1 0.3 0.1 0.3 0.1 0.0 0.1 RNF227 LINC02581 ENSG00000179859 "Ring finger protein 227" A6NIN4 17 7913339-7916289 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "skin 1: 56.5" "Cell type enhanced" "Detected in some" "Adipocytes: 3.9;Breast glandular cells: 3.9;Breast myoepithelial cells: 4.1;Endometrial ciliated cells: 5.0;Endometrial stromal cells: 8.9;Glandular and luminal cells: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 17.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 17.5" "Cell line enhanced" "Detected in many" "SiHa: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.85e-3)" "prognostic favorable (8.89e-5)" "unprognostic (1.50e-2)" "unprognostic (4.88e-2)" "unprognostic (3.72e-3)" "unprognostic (1.44e-2)" "unprognostic (2.02e-5)" "unprognostic (9.48e-2)" "unprognostic (9.22e-3)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (3.31e-2)" "unprognostic (7.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.30e-2)" "unprognostic (1.80e-2)" 4.1 3.2 5.9 1.9 6.0 1.7 4.9 7.3 6.9 3.4 4.5 2.8 3.5 6.2 4.7 4.5 5.1 1.9 1.8 6.0 5.6 2.5 1.1 3.5 2.5 5.5 5.4 5.6 5.1 3.6 4.8 3.9 2.2 5.8 2.9 2.0 12.0 3.1 2.1 1.4 56.5 2.9 2.7 5.3 3.0 2.5 3.3 5.6 2.3 1.7 1.6 2.7 2.3 4.2 5.6 7.0 1.4 2.6 2.6 2.0 1.8 2.2 6.5 2.6 1.8 2.0 4.1 2.0 1.3 3.8 2.6 1.6 5.0 1.5 3.3 3.2 0.8 1.7 1.8 5.1 0.3 3.8 3.8 3.3 2.3 9.4 2.9 3.1 0.9 0.4 6.9 2.1 1.3 4.1 0.8 5.1 4.8 1.8 2.1 1.0 2.4 6.4 1.5 2.6 0.9 1.1 3.6 14.1 0.6 2.8 0.8 1.7 2.8 0.4 0.1 3.6 3.1 1.3 1.8 0.6 1.9 3.8 4.2 4.9 17.5 1.3 0.4 1.7 0.9 2.2 1.9 1.9 2.2 2.0 1.3 3.5 2.4 0.8 2.7 0.8 1.3 1.5 1.5 5.9 6.0 7.3 6.9 6.0 5.6 5.5 5.4 5.6 5.8 5.3 5.6 5.6 3.9 3.2 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 3.9 4.1 0.0 0.0 0.0 0.0 0.0 1.3 2.7 0.0 1.9 1.0 0.0 5.0 8.9 1.1 0.0 0.0 0.0 0.2 0.5 1.9 0.0 5.5 0.0 2.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.8 2.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.7 0.7 2.2 0.0 0.0 CITED4 ENSG00000179862 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4" Q96RK1 1 40861054-40862363 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 172.1;Breast glandular cells: 183.7;Breast myoepithelial cells: 225.0;Cholangiocytes: 258.7;Endometrial ciliated cells: 350.4;Glandular and luminal cells: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 91.3;THP-1: 264.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA056434 Approved Approved Vesicles NA NA Vesicles "HPA056434: AB_2683132" "unprognostic (5.39e-3)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "prognostic favorable (4.38e-5)" "unprognostic (3.43e-3)" "unprognostic (1.90e-2)" "unprognostic (3.44e-3)" "unprognostic (3.42e-2)" "unprognostic (2.67e-1)" "unprognostic (1.98e-3)" "unprognostic (2.25e-2)" "unprognostic (6.00e-2)" "unprognostic (2.29e-3)" "unprognostic (2.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (6.13e-2)" 13.8 15.2 9.1 1.1 8.2 19.2 30.6 9.3 9.6 14.9 4.0 21.1 1.6 17.3 2.4 29.2 14.6 1.9 22.1 5.4 12.4 20.5 39.1 11.5 1.7 13.3 12.5 6.9 10.4 49.5 4.5 5.0 1.7 15.8 16.6 0.4 0.8 34.5 8.6 33.4 48.8 7.7 2.4 10.2 30.1 13.5 25.6 10.2 1.2 7.4 9.3 1.3 9.0 23.9 9.5 29.5 5.7 1.6 34.6 0.7 1.3 34.4 1.9 2.1 0.7 0.8 3.0 38.5 0.1 4.6 0.5 1.0 44.6 2.4 24.0 0.6 0.1 0.4 0.2 3.3 4.9 5.9 1.0 0.4 4.2 10.1 2.3 7.6 2.8 1.8 0.4 0.1 0.1 1.3 0.9 0.5 19.6 11.1 0.9 3.9 0.3 0.0 0.1 91.3 16.9 6.7 1.9 1.4 35.8 2.0 3.7 17.4 264.9 2.3 0.0 0.0 0.4 1.1 0.0 0.8 0.0 0.0 13.8 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 9.1 8.2 9.3 9.6 5.4 12.4 13.3 12.5 6.9 15.8 10.2 10.2 9.5 17.4 9.6 1.1 1.3 4.0 19.1 172.1 2.1 37.0 4.0 183.7 225.0 10.4 258.7 3.5 22.0 0.0 1.0 11.9 3.7 43.0 14.2 47.9 350.4 24.4 48.9 7.7 9.7 2.0 43.6 0.9 14.0 17.9 202.6 0.0 30.5 11.4 43.1 1.3 1.7 1.7 4.8 2.0 10.4 3.2 64.8 5.0 13.7 19.6 1.0 4.6 46.1 2.1 2.0 3.8 33.0 3.4 5.7 2.4 65.6 0.2 88.0 6.5 3.0 19.7 72.2 19.7 0.9 1.5 49.9 24.3 0.1 14.6 37.3 3.6 122.3 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647497 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "bone marrow: 45.0" "Group enriched" "Detected in some" 5 "Basal respiratory cells: 33.8;Club cells: 25.8;Respiratory ciliated cells: 101.5" "Cancer enhanced" "Detected in some" "lung cancer: 2.0" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.8;LHCN-M2: 2.4;U-2 OS: 6.4;U-266/84: 2.9" "Not detected" "Not detected" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.0 0.0 0.1 0.1 0.3 45.0 0.6 0.2 0.2 0.3 0.3 0.2 0.2 0.1 1.1 1.3 1.2 0.3 0.0 0.3 1.7 0.5 0.3 1.3 0.1 0.1 0.4 0.1 0.0 0.7 0.0 1.2 0.0 0.1 0.0 0.3 0.4 0.9 0.2 0.0 0.9 0.1 0.0 0.1 0.5 0.0 1.6 0.1 0.6 3.0 0.0 1.8 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.0 1.3 0.0 1.2 0.3 0.7 1.4 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.2 0.0 0.1 2.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 6.4 0.3 1.0 1.9 2.9 0.0 0.8 0.3 0.2 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.2 0.3 1.7 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.1 33.8 0.0 0.0 1.2 0.3 10.5 0.0 25.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.8 0.5 0.2 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.9 0.2 0.0 0.5 0.2 6.1 0.0 0.0 6.1 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 101.5 0.0 0.0 0.1 1.8 3.6 3.7 1.7 0.0 0.0 0.1 0.1 0.5 0.2 NLRP11 "CLR19.6, NALP11, NOD17, PAN10, PYPAF6" ENSG00000179873 "NLR family pyrin domain containing 11" P59045 19 55785397-55836800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.1;liver: 1.0" "Group enriched" "Detected in some" 5 "Early spermatids: 13.0;Late spermatids: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 115.6;RPMI-8226: 66.1;U-266/70: 110.2;U-266/84: 51.2;U-698: 83.9" "Not detected" "Not detected" "HPA046402, HPA078027" Uncertain Supported Cytosol NA NA Cytosol "HPA046402: AB_10962951, HPA078027: AB_2732369" "unprognostic (2.36e-2)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (4.36e-3)" "unprognostic (3.31e-2)" "unprognostic (7.88e-2)" "unprognostic (9.95e-3)" "unprognostic (8.04e-2)" "unprognostic (1.94e-1)" "unprognostic (2.52e-1)" "unprognostic (3.75e-2)" "unprognostic (3.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.06e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-2)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 115.6 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.0 0.0 0.0 0.4 0.7 0.1 0.0 0.4 0.0 2.0 66.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.1 1.8 1.9 0.1 0.1 110.2 51.2 83.9 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.3 0.3 5.1 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TIGD5 FLJ14926 ENSG00000179886 "Tigger transposable element derived 5" Q53EQ6 8 143597831-143603224 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9;Theca cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.90e-1)" "unprognostic (7.91e-2)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.22e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (2.79e-2)" "unprognostic (1.12e-1)" "unprognostic (6.72e-2)" "unprognostic (2.75e-3)" "unprognostic (3.16e-1)" "prognostic favorable (9.16e-5)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (2.32e-1)" "unprognostic (4.04e-1)" 2.0 2.9 1.7 0.2 1.6 0.1 2.1 3.7 1.7 2.7 0.4 3.2 0.4 3.2 0.1 3.5 3.0 0.2 3.2 1.4 1.2 3.0 2.3 1.8 0.3 2.0 2.0 1.5 4.0 6.0 0.7 3.8 0.2 2.3 3.0 0.1 0.1 2.8 0.3 4.5 3.7 2.7 0.1 1.1 3.6 3.0 1.5 1.7 0.2 3.0 0.4 0.2 3.2 2.5 1.4 0.9 1.5 0.4 1.2 0.6 0.6 0.6 0.5 0.4 0.5 0.4 0.5 0.6 1.7 2.7 0.4 0.5 1.2 0.4 0.4 0.0 5.9 1.8 1.0 1.7 0.2 1.1 0.4 1.4 0.6 1.1 0.3 0.5 0.7 0.4 0.4 1.2 0.2 0.2 1.6 2.9 1.7 0.6 1.0 2.9 1.1 0.3 0.8 0.5 0.6 1.4 1.8 1.1 0.9 1.2 0.1 2.6 1.2 0.7 1.0 0.8 1.0 3.5 0.9 0.4 0.2 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.6 3.7 1.7 1.4 1.2 2.0 2.0 1.5 2.3 1.1 1.7 1.4 5.0 3.2 1.3 0.7 3.8 1.7 5.4 0.9 1.2 16.0 6.3 4.6 5.9 4.3 1.3 5.5 20.9 1.4 4.9 5.1 0.0 2.3 1.0 4.0 8.1 4.4 0.0 4.0 0.8 1.8 1.3 4.2 2.0 5.5 1.3 15.4 4.6 2.6 3.4 16.8 1.1 3.6 0.0 3.2 0.8 0.7 7.8 3.0 0.0 1.0 3.2 10.0 6.2 0.5 0.4 3.6 1.7 4.5 1.0 4.9 3.3 2.2 1.1 15.1 0.0 10.6 4.2 0.8 1.2 2.4 1.0 1.8 3.5 29.3 5.1 3.8 PDXDC1 KIAA0251 ENSG00000179889 "Pyridoxal dependent decarboxylase domain containing 1" Q6P996 16 14974591-15139339 "Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 483.6;Late spermatids: 733.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047369, HPA049121, HPA051484" Approved Enhanced "Golgi apparatus,Vesicles" NA NA 9600 "Golgi apparatus, Vesicles" "HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502" "unprognostic (3.67e-2)" "unprognostic (4.99e-1)" "unprognostic (1.97e-3)" "unprognostic (1.84e-1)" "unprognostic (9.08e-2)" "unprognostic (2.18e-1)" "unprognostic (6.47e-3)" "unprognostic (4.97e-2)" "unprognostic (2.43e-1)" "unprognostic (2.74e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.13e-4)" "unprognostic (4.58e-2)" "unprognostic (8.11e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 32.4 38.3 5.4 21.1 5.0 13.0 33.4 13.3 6.6 35.8 6.9 50.7 53.0 32.2 17.2 43.7 29.5 21.0 37.9 6.5 4.9 47.6 105.4 34.9 13.5 7.6 5.8 5.8 31.3 71.0 27.3 63.7 23.7 8.1 56.3 48.2 13.5 81.1 25.5 52.5 27.8 61.6 18.6 2.8 32.0 57.2 114.1 6.6 11.8 43.2 16.7 15.1 39.5 35.0 8.6 21.4 30.9 31.1 26.1 16.9 20.4 51.4 19.6 17.4 14.3 19.7 38.0 45.3 40.7 42.0 26.5 20.5 34.0 22.1 20.1 20.5 25.0 30.2 24.7 51.8 100.2 44.3 19.7 56.4 21.5 20.4 25.0 20.9 28.0 15.3 21.6 18.5 26.0 34.1 52.2 12.9 10.4 15.3 20.8 11.7 19.9 12.9 48.6 22.7 33.9 31.9 22.8 52.6 30.0 50.9 19.7 121.0 30.3 23.8 11.0 10.0 12.3 25.7 24.2 25.1 39.3 22.7 16.4 35.8 2.9 7.8 11.6 9.4 7.7 10.8 8.3 6.8 7.7 11.7 9.0 8.2 8.1 1.0 7.5 6.2 5.4 6.6 8.2 5.4 5.0 13.3 6.6 6.5 4.9 7.6 5.8 5.8 8.1 2.8 6.6 8.6 29.6 38.5 64.6 32.7 33.0 38.2 42.2 21.6 18.8 32.1 57.9 27.8 45.7 58.6 52.9 29.5 31.3 51.7 30.6 149.8 27.4 38.2 483.6 48.1 41.7 35.1 161.2 33.2 80.7 58.3 56.5 36.0 71.9 75.3 39.3 42.1 27.5 123.6 30.5 40.4 68.3 216.7 24.4 33.1 16.8 733.8 49.0 30.9 26.6 31.9 27.5 19.7 39.1 55.8 45.0 46.5 114.4 45.5 45.4 58.1 115.6 53.4 48.3 47.4 46.0 24.0 28.0 142.3 72.7 24.6 42.6 80.7 33.9 21.2 127.2 76.5 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "fallopian tube: 107.4;testis: 149.0" "Cell type enhanced" "Detected in some" "Early spermatids: 2151.8;Endometrial ciliated cells: 931.5;Late spermatids: 3412.7;Respiratory ciliated cells: 808.8;Spermatocytes: 514.1" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.1" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 1.5;SCLC-21H: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.0 0.1 2.7 0.0 2.0 0.0 0.2 2.1 2.8 1.1 11.8 0.3 0.3 1.1 1.2 0.1 107.4 0.0 0.0 2.4 3.1 0.2 0.0 4.4 0.0 3.3 2.5 1.6 0.1 0.9 0.2 2.5 0.0 2.7 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.2 0.0 0.3 149.0 2.1 0.3 0.4 0.0 0.0 0.3 0.0 2.4 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.7 2.0 2.1 2.8 2.4 3.1 3.3 2.5 1.6 2.7 2.2 2.1 2.4 0.0 0.0 4.1 0.7 0.2 0.0 0.2 53.9 0.0 0.6 0.8 0.9 3.5 0.0 61.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2151.8 931.5 6.1 1.8 0.0 0.0 1.1 0.2 0.0 0.7 0.0 11.2 3.8 0.0 0.0 0.0 0.1 0.0 1.0 0.4 57.0 0.0 0.3 3412.7 21.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 18.8 0.0 2.4 0.0 0.8 808.8 0.0 6.6 0.2 9.0 514.1 20.2 0.0 0.1 0.0 1.1 0.0 0.2 0.4 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 11.8;granulocytes: 10.8;Oligodendrocyte precursor cells: 10.6;Rod photoreceptor cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.2;HSkMC: 2.9;MOLT-4: 4.4;NTERA-2: 2.9;SuSa: 6.1" "Low region specificity" "Detected in all" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 1.1 2.9 2.6 3.2 3.1 1.2 2.1 5.8 2.9 1.4 4.3 2.7 1.1 0.8 1.5 2.1 0.9 2.0 2.7 2.9 2.6 2.1 0.7 1.6 4.9 2.1 2.4 2.5 1.4 1.5 3.7 5.1 3.1 3.2 2.2 1.3 4.6 2.4 3.6 1.7 0.8 2.5 1.4 1.0 4.6 1.2 0.9 2.5 6.2 5.9 1.5 4.4 2.4 0.8 2.3 0.1 0.2 5.2 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.1 0.2 0.3 0.1 1.3 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.8 0.1 1.8 0.3 0.4 2.9 0.0 0.3 0.0 1.8 0.1 0.2 0.2 0.3 1.2 0.1 4.4 0.2 2.9 0.1 0.1 0.2 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.0 6.1 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.2 0.0 0.2 0.0 0.8 0.1 2.0 0.2 0.0 0.6 0.4 0.2 0.4 0.1 1.0 0.3 0.3 0.6 0.5 0.0 0.5 0.0 0.2 2.6 3.1 5.8 2.9 2.9 2.6 2.1 2.4 2.5 3.2 1.0 2.5 2.3 2.0 0.0 1.9 11.8 7.5 0.4 1.5 0.5 0.6 8.1 1.9 2.2 4.2 1.5 1.0 1.8 8.4 0.2 5.5 0.1 0.0 2.5 0.0 0.5 1.4 2.7 0.0 0.4 7.3 0.2 0.2 1.2 2.0 0.8 10.8 2.2 3.6 0.2 1.6 8.4 7.2 0.0 2.0 0.6 1.7 0.2 0.3 1.2 0.0 1.9 0.7 3.4 4.1 10.6 1.4 0.1 0.0 1.5 2.5 1.3 0.0 0.2 1.3 10.3 0.0 1.5 3.6 0.6 1.1 0.5 0.4 0.3 2.6 0.3 0.0 2.0 R3HDM2 KIAA1002 ENSG00000179912 "R3H domain containing 2" Q9Y2K5 12 57253762-57431005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 274.9;Inhibitory neurons: 204.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038327, HPA038328" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038327: AB_10674681, HPA038328: AB_2675962" "unprognostic (9.46e-2)" "unprognostic (1.40e-1)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (7.41e-2)" "unprognostic (2.20e-1)" "unprognostic (8.17e-2)" "unprognostic (1.90e-1)" "unprognostic (2.46e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-2)" "unprognostic (8.89e-2)" "unprognostic (1.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (7.49e-2)" 20.0 18.6 10.6 20.2 15.7 24.5 18.5 13.7 25.2 19.4 1.0 17.8 22.6 24.0 11.1 20.6 23.7 20.4 34.6 16.1 7.8 17.5 22.2 18.1 23.3 7.7 8.1 11.6 32.7 20.4 24.4 19.6 18.0 8.7 28.5 17.0 35.2 15.9 16.1 43.2 23.8 21.0 18.0 2.7 24.7 20.4 19.5 11.1 28.8 20.8 29.6 18.5 16.7 17.8 20.6 20.4 28.0 22.7 28.4 36.5 51.2 15.2 20.9 25.3 14.4 13.2 9.2 23.4 22.5 25.3 29.6 16.1 26.1 13.7 24.8 16.7 31.4 17.7 27.6 11.1 12.0 27.0 18.4 33.9 35.0 38.7 23.8 52.5 62.1 20.5 38.3 19.5 28.6 24.8 25.1 25.9 13.6 5.8 12.4 20.3 15.7 16.8 14.8 12.8 21.9 23.0 25.0 19.8 26.1 21.3 13.0 23.0 33.5 24.3 15.0 11.4 34.4 21.3 17.1 9.0 9.1 31.4 19.0 27.4 4.6 2.2 1.8 1.6 2.1 2.0 4.7 2.9 1.5 1.3 1.9 3.0 1.8 4.9 3.1 5.7 2.0 0.9 0.8 10.6 15.7 13.7 25.2 16.1 7.8 7.7 8.1 11.6 8.7 2.7 11.1 20.6 53.2 32.1 27.7 82.6 60.0 43.5 28.1 13.3 46.1 112.2 50.1 43.2 33.8 32.9 12.7 38.6 79.2 22.9 60.9 28.5 50.9 13.3 18.2 44.9 83.9 28.5 24.7 22.7 274.9 11.1 19.2 39.7 41.3 51.5 25.9 53.2 31.8 79.6 19.3 109.4 204.6 31.3 10.2 63.1 34.7 33.6 59.7 46.7 26.6 65.6 26.5 40.0 57.7 114.1 130.7 11.7 42.2 48.2 27.6 25.1 38.2 68.3 19.4 77.5 32.9 71.5 43.9 42.3 47.1 40.2 51.4 24.4 55.7 56.0 29.8 27.9 B3GNT3 "B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3" ENSG00000179913 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3" Q9Y2A9 19 17794828-17813576 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.4;salivary gland: 31.6;stomach 1: 43.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 65.8;Cytotrophoblasts: 78.9;Distal enterocytes: 108.4;Paneth cells: 67.4;Proximal enterocytes: 50.5;Syncytiotrophoblasts: 68.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 44.2;BEWO: 40.9;CAPAN-2: 112.5;OE19: 102.1;RT4: 41.3;SK-BR-3: 38.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024298 Enhanced "Intracellular and membrane" NA NA 74000 "HPA024298: AB_1845236" "unprognostic (1.10e-1)" "unprognostic (5.19e-2)" "unprognostic (1.84e-1)" "unprognostic (4.84e-3)" "unprognostic (1.10e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (3.26e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (7.38e-2)" "unprognostic (1.26e-1)" "unprognostic (7.10e-2)" "unprognostic (2.57e-2)" 0.3 0.1 0.4 5.7 0.1 0.2 3.4 0.6 0.4 4.5 0.4 44.4 32.9 0.4 0.0 21.9 1.0 24.0 0.0 0.2 0.2 3.8 2.4 0.5 0.5 0.3 0.2 0.2 0.1 3.9 0.5 0.0 12.7 0.4 2.2 40.9 0.1 31.6 3.3 0.0 2.6 29.7 1.7 0.0 0.1 43.6 0.1 0.2 0.2 0.3 0.0 4.8 18.6 8.1 0.5 44.2 12.5 0.0 0.2 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.7 112.5 0.0 28.9 0.0 0.1 4.2 0.0 12.9 0.0 0.0 0.2 0.0 0.2 5.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.2 0.1 0.4 102.1 19.2 0.2 0.0 1.2 23.9 41.3 0.0 0.1 0.0 38.4 0.0 0.0 1.7 0.2 0.1 0.3 3.3 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.6 0.4 0.2 0.2 0.3 0.2 0.2 0.4 0.0 0.2 0.5 0.1 0.0 2.3 0.0 0.2 0.1 3.6 5.1 0.0 0.0 7.1 6.2 0.4 65.8 17.1 16.5 0.0 78.9 0.5 108.4 1.9 17.9 0.0 3.8 0.8 2.3 16.3 0.0 0.1 28.4 7.5 0.7 19.9 7.7 5.7 0.0 0.7 0.2 6.0 0.0 0.2 40.7 6.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 33.2 67.4 0.0 0.0 7.8 50.5 3.5 7.7 0.0 0.0 0.0 0.9 0.2 0.3 0.2 0.0 68.3 0.2 0.5 28.4 39.6 ITLN1 "FLJ20022, hIntL, HL-1, ITLN, LFR" ENSG00000179914 "Intelectin 1" Q8WWA0 1 160876540-160885180 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 343.5;intestine: 1260.1" "Cell type enriched" "Detected in many" 14 "Intestinal goblet cells: 1818.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 61.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "intermediate monocyte: 9.2;non-classical monocyte: 24.1" "Lineage enriched" "Detected in many" 17 "monocytes: 24.1" "Group enriched" "Detected in some" 4 "HEL: 2.6;HL-60: 1.9;OE19: 7.2;U-937: 7.1" "Not detected" "Not detected" "CAB012652, HPA063275, HPA067326" Enhanced "Secreted to blood" NA NA 294000000 6400000 "CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764" "unprognostic (9.69e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-3)" "unprognostic (2.28e-1)" "unprognostic (1.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (5.22e-3)" "unprognostic (1.66e-2)" "unprognostic (4.38e-1)" "unprognostic (9.96e-2)" "unprognostic (3.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-2)" 343.5 0.3 0.0 26.7 0.0 2.6 0.5 0.0 0.0 0.3 0.0 448.3 275.1 0.5 2.2 0.4 6.2 0.8 125.0 0.0 0.0 3.4 3.2 40.7 0.3 0.0 0.0 0.0 9.8 3.3 0.0 0.4 1.3 0.0 0.6 1260.1 0.0 25.1 3.3 0.7 0.2 418.9 7.8 0.0 2.5 16.0 2.1 0.0 0.7 0.6 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 1.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.2 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 7.1 0.0 0.0 0.5 0.0 0.0 9.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.0 24.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 4.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.6 71.4 2.1 3.7 0.0 0.1 0.1 46.4 0.0 37.7 0.8 0.0 0.0 4.3 18.0 4.0 0.0 3.6 1.4 87.8 8.6 0.0 1.3 1.4 60.7 1.9 0.8 0.0 0.0 1818.6 0.0 124.7 0.0 0.7 14.6 1.8 0.0 0.0 0.3 0.0 1.0 0.0 0.0 7.3 17.7 3.0 0.0 0.3 15.4 0.1 0.8 0.0 0.0 0.0 10.8 0.1 0.9 0.0 0.0 0.3 2.1 15.3 59.4 0.1 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918503-51225575 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 151.5" "Group enriched" "Detected in many" 5 "Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" NA NA 1400000 "Plasma membrane" "HPA071400: AB_2732180" "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 1.1 2.1 25.1 1.1 64.2 0.3 0.8 151.5 80.2 2.2 0.0 8.1 0.9 1.1 3.0 2.0 0.8 1.2 3.4 55.8 24.7 0.4 0.5 0.4 0.3 8.2 13.7 59.7 0.9 1.4 0.0 6.0 0.0 61.5 2.8 2.7 7.2 2.4 8.5 0.2 0.9 2.7 1.0 1.5 0.2 2.3 5.6 14.1 1.3 0.6 0.8 0.2 2.3 3.1 38.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 31.3 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 3.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 25.1 64.2 151.5 80.2 55.8 24.7 8.2 13.7 59.7 61.5 1.5 14.1 38.5 0.1 0.0 0.0 4025.1 0.0 0.0 0.3 0.0 3.4 116.0 3.1 3.7 19.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.1 201.6 0.1 2.8 1.0 1.8 0.0 3206.3 0.0 0.0 2.3 0.0 0.1 0.0 0.2 3.3 0.2 0.1 77.4 2116.2 0.0 0.0 0.0 0.6 103.4 2.5 0.6 1.8 174.3 0.0 22.7 0.0 4897.8 678.0 0.2 0.0 0.7 1.4 0.5 0.0 0.2 0.0 9.7 0.0 2.5 1.3 13.3 5.8 0.6 0.1 0.3 0.1 0.1 0.0 0.1 SEPHS2 "SPS2, SPS2b" ENSG00000179918 "Selenophosphate synthetase 2" Q99611 16 30443631-30445874 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 405.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 385.4;Proximal tubular cells: 384.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 477.5" "Low region specificity" "Detected in all" HPA047931 Approved Approved Nucleoplasm No No 29000 Nucleoplasm "HPA047931: AB_2680216" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (1.92e-2)" "unprognostic (9.85e-2)" "unprognostic (2.67e-2)" "unprognostic (6.29e-2)" "unprognostic (5.67e-2)" "unprognostic (7.69e-3)" "unprognostic (2.38e-1)" "unprognostic (9.86e-2)" "unprognostic (9.66e-3)" "unprognostic (1.49e-1)" "prognostic favorable (4.35e-8)" "unprognostic (2.24e-2)" "unprognostic (1.35e-1)" "unprognostic (3.25e-2)" "unprognostic (3.62e-2)" 27.7 30.9 18.1 34.0 18.1 26.2 34.2 19.3 20.1 25.0 21.6 76.2 137.2 20.1 24.1 20.5 20.7 34.3 28.1 19.6 21.2 160.0 405.9 29.1 45.1 19.3 20.1 18.6 15.0 35.5 49.3 20.6 25.3 19.8 29.0 66.6 19.9 33.9 23.4 42.0 21.3 106.7 26.1 20.1 30.1 63.0 11.6 23.0 43.9 38.0 32.5 42.2 28.0 14.4 21.5 77.6 68.9 23.8 83.1 71.7 45.7 62.5 52.3 64.5 50.5 62.2 42.9 57.7 110.8 79.0 56.0 45.7 42.1 44.5 47.9 51.0 71.2 137.5 110.8 35.9 204.0 90.5 62.0 477.5 58.4 100.5 47.6 87.7 31.6 47.0 80.1 91.1 69.7 45.4 114.5 93.9 127.8 59.3 58.0 51.4 90.2 41.8 85.3 62.6 68.9 50.5 43.1 44.8 129.3 179.7 47.8 113.7 204.2 39.6 52.2 37.1 50.9 32.0 59.6 103.4 57.6 45.3 114.3 59.7 8.7 19.4 30.2 14.8 16.1 22.2 17.8 20.9 21.4 21.6 20.2 25.0 17.2 17.6 31.9 20.5 15.4 22.8 14.8 18.1 18.1 19.3 20.1 19.6 21.2 19.3 20.1 18.6 19.8 20.1 23.0 21.5 76.2 44.8 40.3 3.9 34.3 37.5 1.4 47.6 58.6 0.5 66.2 52.7 49.4 1.5 39.4 64.4 0.0 1.3 41.5 108.9 385.4 112.2 0.1 34.2 25.1 32.4 35.5 20.8 6.7 82.7 1.1 30.4 68.8 59.2 31.0 20.5 0.7 9.1 1.4 0.0 8.6 31.0 63.1 2.9 34.9 0.1 0.0 42.5 44.4 5.6 37.1 0.2 1.0 5.5 4.6 57.4 42.4 0.0 30.6 1.6 11.1 384.9 27.2 1.1 0.0 2.0 49.4 0.8 0.8 45.4 42.6 1.2 35.7 52.6 46.0 0.9 OR10A7 ENSG00000179919 "Olfactory receptor family 10 subfamily A member 7" Q8NGE5 12 55221025-55221975 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055111 Uncertain NA NA "HPA055111: AB_2682698" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPBAR1 "BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5" ENSG00000179921 "G protein-coupled bile acid receptor 1" Q8TDU6 2 218259496-218263861 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 26.3;breast: 18.0;gallbladder: 17.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 20.3;Enteroendocrine cells: 46.0;Hofbauer cells: 16.3;Kupffer cells: 50.6;Macrophages: 19.9;monocytes: 45.3" "Cancer enhanced" "Detected in many" "pancreatic cancer: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "classical monocyte: 288.1;intermediate monocyte: 712.0;non-classical monocyte: 695.6" "Lineage enriched" "Detected in many" 5 "monocytes: 712.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.1;HHSteC: 1.7;U-937: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA062890 Enhanced NA NA "HPA062890: AB_2684896" "unprognostic (8.47e-2)" "unprognostic (3.72e-3)" "unprognostic (1.88e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (2.54e-1)" "unprognostic (2.63e-1)" "unprognostic (8.76e-3)" "unprognostic (4.32e-2)" "unprognostic (4.64e-2)" "unprognostic (1.55e-1)" "unprognostic (7.40e-7)" "unprognostic (4.18e-2)" "unprognostic (4.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.29e-1)" 26.3 1.6 0.2 2.7 0.2 2.3 18.0 0.4 0.8 0.5 0.3 3.6 1.0 0.9 0.0 0.6 1.2 17.5 3.8 0.3 0.2 2.3 1.9 2.3 0.8 0.2 0.2 0.1 1.8 1.7 0.0 0.8 4.0 0.2 1.1 0.5 0.0 0.8 0.3 0.6 1.3 4.9 10.2 0.1 7.6 6.5 2.4 0.4 0.4 1.7 0.7 0.2 4.8 0.8 0.2 0.1 0.0 0.1 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 1.7 0.1 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.9 0.8 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 1.9 0.1 0.6 288.1 0.4 0.7 712.0 0.7 0.2 0.5 0.7 140.2 0.7 0.6 0.4 6.5 0.5 695.6 6.0 0.9 156.5 0.2 0.2 0.4 0.8 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.4 0.2 6.2 0.0 3.4 0.0 1.1 0.3 0.2 0.2 0.0 0.0 0.1 0.3 0.5 1.5 0.1 3.7 0.0 0.5 1.8 0.2 11.7 0.2 8.2 1.0 20.3 1.5 46.0 0.0 0.0 0.5 4.5 2.8 6.6 0.8 1.3 6.2 1.8 0.0 16.3 0.0 0.0 2.7 0.0 50.6 1.2 1.9 3.4 19.9 0.0 1.9 45.3 0.0 0.0 0.0 0.0 0.5 1.5 2.6 0.3 0.3 0.4 0.2 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.4 1.6 0.8 0.1 0.2 0.4 ZNF784 MGC75238 ENSG00000179922 "Zinc finger protein 784" Q8NCA9 19 55620741-55624566 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059676: AB_2684102" "unprognostic (4.67e-2)" "unprognostic (8.13e-2)" "unprognostic (4.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-1)" "unprognostic (9.44e-2)" "unprognostic (4.74e-1)" "unprognostic (1.26e-1)" "unprognostic (9.11e-3)" "unprognostic (4.86e-2)" "unprognostic (3.48e-3)" "unprognostic (3.87e-1)" "unprognostic (7.93e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.02e-4)" 4.6 8.5 3.0 3.1 3.0 6.3 5.4 4.4 3.9 8.2 2.4 11.2 8.3 10.8 3.8 7.3 9.3 2.8 12.3 3.0 2.8 7.8 11.6 4.9 3.5 3.8 3.0 2.9 11.9 11.4 4.2 7.8 2.6 3.9 11.3 3.3 4.5 6.8 3.8 43.2 6.3 10.3 3.6 2.6 9.2 8.9 5.4 3.0 2.0 7.5 16.2 2.8 10.7 6.7 3.5 4.6 6.4 5.8 3.1 2.2 2.9 5.5 4.7 2.9 2.6 3.5 3.2 5.0 5.5 4.0 3.3 2.0 2.5 1.7 4.1 1.8 3.0 16.7 5.1 5.1 4.1 4.4 4.2 5.3 4.0 4.4 2.2 2.8 4.2 1.7 7.7 6.1 5.5 4.0 4.4 3.3 4.8 5.7 3.5 13.7 6.2 3.9 6.2 4.8 11.5 6.5 8.7 7.7 3.6 2.2 3.8 3.9 7.4 5.4 3.0 2.9 1.9 3.9 6.3 2.8 3.2 4.6 3.1 2.6 0.0 0.4 0.6 0.1 0.4 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.3 0.3 0.2 0.0 0.1 3.0 3.0 4.4 3.9 3.0 2.8 3.8 3.0 2.9 3.9 2.6 3.0 3.5 1.9 0.0 7.4 1.6 3.4 0.9 4.7 1.5 2.8 4.7 2.2 3.2 12.3 8.6 1.9 0.0 2.1 5.5 1.3 10.9 3.9 4.0 2.1 2.7 2.5 2.3 5.4 4.4 0.5 4.1 2.4 3.2 1.5 3.2 2.5 5.5 3.9 6.8 3.5 8.4 0.6 6.2 6.1 3.5 1.0 0.1 4.1 2.4 0.0 1.0 4.5 4.2 0.0 1.5 1.1 4.5 7.4 2.6 2.3 2.1 11.2 5.2 2.2 11.0 13.1 2.9 2.7 0.6 2.3 1.8 1.3 10.1 2.0 7.7 5.5 3.7 ZNF648 FLJ46813 ENSG00000179930 "Zinc finger protein 648" Q5T619 1 182054570-182061712 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.7;Early spermatids: 1.2;Melanocytes: 1.8;Spermatogonia: 1.3;Theca cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 78 "HMC-1: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA053897 Uncertain NA NA "HPA053897: AB_2682297" "unprognostic (3.52e-4)" "unprognostic (1.44e-1)" "unprognostic (7.96e-2)" "unprognostic (1.69e-3)" "unprognostic (2.30e-1)" "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (2.95e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-2)" "unprognostic (8.16e-6)" "unprognostic (4.96e-2)" "unprognostic (3.25e-1)" "unprognostic (2.42e-1)" "unprognostic (2.83e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.5 0.4 0.0 0.5 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 0.5 0.4 0.0 0.5 0.1 0.8 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23095505-23100456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavorable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favorable (3.30e-5)" "unprognostic (1.63e-1)" 38.7 49.6 26.1 34.6 27.8 15.6 47.4 29.7 32.2 41.4 33.1 42.9 33.9 40.5 42.7 46.0 33.5 27.7 36.0 25.7 30.6 42.9 37.5 38.4 34.5 29.6 29.4 24.8 33.8 31.8 35.6 38.7 34.0 29.9 30.8 51.8 25.7 36.5 38.9 33.2 30.8 41.5 49.2 29.9 47.5 41.3 25.4 29.9 40.8 34.2 31.4 51.2 48.0 34.1 30.6 53.9 52.5 77.4 47.2 166.8 144.3 62.1 88.5 129.9 114.1 134.6 41.9 81.3 40.9 44.8 144.2 138.0 89.9 74.6 117.4 157.6 65.2 36.5 61.6 41.4 180.8 130.7 93.2 91.9 177.0 104.1 96.3 70.5 104.0 126.6 72.7 41.9 44.4 127.2 77.8 44.3 72.1 48.7 124.5 79.2 38.6 57.5 47.0 130.8 85.9 37.1 33.8 73.7 68.6 81.0 85.5 46.4 53.2 103.0 54.0 47.0 81.6 40.6 41.5 52.6 50.5 49.4 58.3 49.2 317.0 160.8 302.7 122.6 106.0 140.9 143.9 138.9 137.3 150.7 121.0 144.0 142.6 94.5 131.0 74.4 102.2 188.7 203.2 26.1 27.8 29.7 32.2 25.7 30.6 29.6 29.4 24.8 29.9 29.9 29.9 30.6 50.9 48.1 47.7 4.2 41.9 26.5 89.0 144.5 23.9 28.6 41.9 50.5 23.7 34.3 75.9 31.3 8.4 89.0 53.5 44.1 129.1 95.9 22.6 39.0 45.2 56.2 28.3 65.4 3.8 84.3 105.5 42.9 30.5 33.2 54.4 39.6 46.4 29.6 107.8 20.2 4.4 57.4 81.4 38.9 32.1 15.1 64.0 53.1 48.0 5.6 93.2 36.1 58.7 2.0 11.5 97.0 42.4 48.5 31.4 59.8 61.5 100.3 48.3 21.5 32.9 18.6 47.1 52.7 25.6 33.5 34.0 143.1 46.5 81.3 51.7 83.2 CCR8 "CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1" ENSG00000179934 "C-C motif chemokine receptor 8" P51685 3 39329709-39333680 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 7.8" "Cell type enhanced" "Detected in single" "T-cells: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "T-reg: 25.7" "Lineage enriched" "Detected in single" 32 "T-cells: 25.7" "Cell line enriched" "Detected in some" 22 "HDLM-2: 99.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA042383 Enhanced NA NA "HPA042383: AB_2732497" "unprognostic (2.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.38e-2)" "unprognostic (7.63e-4)" "unprognostic (3.31e-1)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (3.37e-2)" "unprognostic (7.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.65e-8)" "unprognostic (7.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.56e-1)" "unprognostic (4.14e-1)" 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.6 0.3 0.0 0.0 7.8 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 2.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 25.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 GOLGA8J ENSG00000179938 "Golgin A8 family member J" A6NMD2 15 30083053-30093499 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 4.8" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 4.2;Early spermatids: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BBS10 "C12orf58, FLJ23560" ENSG00000179941 "Bardet-Biedl syndrome 10" Q8TAM1 12 76344474-76348415 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Chaperone "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058743 Approved NA NA "HPA058743: AB_2683806" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.53e-1)" "unprognostic (1.18e-1)" "unprognostic (4.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "unprognostic (4.12e-2)" "unprognostic (6.86e-2)" "unprognostic (5.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.77e-2)" "unprognostic (3.49e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" 11.7 12.1 8.3 6.1 9.0 0.9 11.9 9.8 10.9 7.7 7.7 3.7 4.0 8.3 9.9 6.7 7.7 5.5 10.4 7.9 8.6 9.9 9.2 6.1 9.1 8.5 8.8 7.7 12.7 4.4 7.6 4.4 7.7 9.0 8.3 3.9 11.5 9.9 8.0 5.6 7.3 4.5 6.2 8.9 9.3 5.1 6.3 8.3 9.0 9.4 7.9 7.8 5.4 4.8 11.3 10.9 6.9 14.2 7.4 19.9 21.0 6.0 11.9 8.6 10.0 7.5 5.7 5.1 5.2 11.9 6.4 8.8 11.6 9.7 10.2 14.0 9.0 10.3 7.1 7.7 8.1 25.2 7.6 5.4 13.8 14.5 13.3 16.1 26.8 14.0 15.0 8.9 4.0 19.4 6.9 7.7 8.2 8.8 5.3 9.6 7.9 17.6 8.4 9.9 5.6 8.7 16.4 15.5 3.0 11.1 13.6 16.2 8.1 10.9 12.3 7.2 12.5 7.8 8.4 11.3 4.6 8.9 6.1 9.4 2.6 2.1 5.0 0.5 4.0 1.2 1.6 1.0 0.8 2.5 1.2 2.2 1.4 1.8 0.7 7.2 1.6 0.9 1.2 8.3 9.0 9.8 10.9 7.9 8.6 8.5 8.8 7.7 9.0 8.9 8.3 11.3 4.0 3.2 3.6 5.9 3.7 4.0 3.7 3.5 5.2 4.4 3.4 3.2 8.8 1.5 5.1 3.7 0.0 3.7 3.8 0.4 3.9 3.1 0.1 2.8 7.3 4.0 3.0 4.0 5.4 2.5 1.0 6.2 2.0 1.8 0.0 4.1 4.6 8.7 3.0 1.7 5.2 1.6 2.0 7.3 2.1 0.6 8.7 3.4 0.0 6.5 2.4 8.7 1.0 4.5 9.9 3.2 1.7 11.3 0.3 2.2 1.5 8.4 6.7 4.3 6.6 6.5 3.9 8.7 6.5 4.9 4.1 0.8 2.1 2.1 1.6 1.7 FIZ1 "FLJ14768, ZNF798" ENSG00000179943 "FLT3 interacting zinc finger 1" Q96SL8 19 55591376-55601970 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074026 Approved Nucleoplasm NA NA Nucleoplasm "HPA074026: AB_2686653" "unprognostic (1.97e-2)" "unprognostic (6.59e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-1)" "unprognostic (6.43e-2)" "unprognostic (8.33e-3)" "unprognostic (4.51e-3)" "unprognostic (8.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "prognostic favorable (8.42e-4)" "unprognostic (7.02e-2)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (6.92e-2)" "unprognostic (3.03e-1)" "prognostic favorable (2.02e-4)" 7.4 8.5 24.1 5.9 23.5 4.1 8.2 21.8 25.1 10.3 18.1 11.1 6.4 12.5 7.7 9.2 9.2 3.6 12.1 21.5 21.7 10.4 9.8 6.8 5.3 23.2 23.0 20.0 10.0 13.1 10.4 12.0 5.3 23.5 11.5 5.1 11.8 9.4 6.7 12.8 8.6 9.4 6.3 21.0 9.5 11.8 6.5 23.5 8.4 12.0 7.9 5.9 10.9 8.2 22.5 10.8 22.7 14.9 10.6 8.5 6.0 17.0 8.6 5.8 9.6 7.5 12.2 11.4 18.5 8.0 5.4 5.3 10.2 10.3 10.8 9.3 14.6 26.9 14.0 16.0 10.8 8.5 12.3 12.9 7.3 17.7 8.2 10.0 9.1 4.8 11.3 17.8 8.4 7.1 9.1 22.3 9.0 16.5 12.6 15.2 22.4 14.1 10.0 9.6 18.8 20.1 22.9 13.9 9.7 9.7 8.6 10.0 15.0 7.8 9.2 15.0 3.8 11.3 22.1 36.0 12.2 12.7 11.4 10.0 0.0 0.4 0.0 0.2 0.7 0.2 0.6 0.6 0.3 0.2 0.3 0.2 0.4 0.4 0.5 0.3 0.9 0.2 0.2 24.1 23.5 21.8 25.1 21.5 21.7 23.2 23.0 20.0 23.5 21.0 23.5 22.5 6.4 9.6 1.1 3.3 3.1 3.3 3.4 1.5 4.0 13.5 7.1 7.4 5.3 7.2 3.0 5.5 4.2 3.7 3.9 7.5 0.0 4.1 0.8 5.1 5.3 4.8 10.1 1.7 2.7 4.0 3.7 4.3 5.1 5.2 0.0 9.5 3.3 5.9 4.5 13.5 2.7 5.3 0.0 4.4 1.2 1.5 3.1 3.3 0.0 2.8 2.6 10.0 2.1 2.0 3.0 5.3 3.7 3.4 2.0 3.9 5.0 4.8 5.4 13.6 0.0 4.6 3.8 2.5 2.5 2.6 2.3 3.4 2.3 5.0 5.7 3.2 PUF60 "FIR, RoBPI, SIAHBP1" ENSG00000179950 "Poly(U) binding splicing factor 60" Q9UHX1 8 143816344-143829352 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 332.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045733, HPA052096, HPA059714" Enhanced Enhanced Nucleoplasm NA NA 70000 Nucleoplasm "HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110" "unprognostic (3.49e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (4.05e-2)" "unprognostic (1.81e-2)" "unprognostic (3.47e-2)" "unprognostic (1.51e-2)" "unprognostic (4.34e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-2)" "unprognostic (1.75e-1)" "unprognostic (5.45e-2)" "unprognostic (2.36e-2)" "unprognostic (2.64e-2)" "unprognostic (7.00e-2)" "unprognostic (2.28e-2)" "unprognostic (3.42e-2)" 71.9 74.1 6.3 11.1 7.3 39.9 76.1 6.3 23.1 69.5 3.4 81.9 22.5 85.6 6.0 85.6 77.0 7.4 83.0 5.8 8.6 82.9 125.4 64.5 17.9 9.2 6.7 2.3 57.7 63.4 11.8 71.5 19.4 13.3 67.8 5.8 1.4 63.8 18.0 126.5 108.5 70.1 10.6 4.7 72.9 73.8 71.4 12.5 16.0 60.3 9.1 9.7 75.1 69.1 14.7 95.7 211.5 36.7 31.3 16.6 15.6 62.7 74.4 27.4 70.3 75.1 95.4 103.9 89.4 71.2 58.9 52.8 83.0 86.5 91.4 3.6 91.4 147.7 110.2 117.0 106.3 60.4 38.5 70.0 45.4 61.8 89.8 26.9 21.1 69.0 92.1 88.7 37.4 20.5 332.5 156.1 26.4 77.8 63.3 191.6 84.2 42.9 91.8 19.5 91.8 71.5 80.3 101.6 40.4 77.7 9.1 116.7 21.4 79.0 72.9 176.2 85.7 98.6 66.7 103.9 109.7 70.7 73.3 71.9 90.8 112.6 99.8 129.0 133.7 139.3 116.8 103.1 128.6 127.1 135.9 98.6 113.1 58.8 132.6 137.6 76.8 139.0 193.9 6.3 7.3 6.3 23.1 5.8 8.6 9.2 6.7 2.3 13.3 4.7 12.5 14.7 70.2 38.5 46.4 21.5 64.7 107.7 102.1 197.4 65.4 62.8 51.3 67.9 63.7 51.5 103.0 29.5 29.2 146.6 56.4 98.0 92.0 110.7 20.5 65.6 55.3 67.3 66.9 65.0 8.2 89.8 134.3 68.4 74.9 60.3 55.8 75.0 41.7 76.8 101.1 43.7 8.3 75.9 118.0 44.0 62.3 47.8 64.0 52.3 90.7 6.5 105.2 182.6 81.4 9.5 23.7 98.2 91.4 59.0 52.7 83.0 91.9 118.1 85.4 64.8 65.7 57.1 122.9 104.2 128.5 63.1 107.1 173.3 74.2 99.3 97.7 81.2 SSC5D "FLJ35258, S5D-SRCRB" ENSG00000179954 "Scavenger receptor cysteine rich family member with 5 domains" A1L4H1 19 55488404-55519099 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 40.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042008, HPA053316" Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" Yes NA 88000000 "Nucleoplasm, Cytosol" "HPA042008: AB_10804124, HPA053316: " "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.28e-2)" "unprognostic (4.55e-2)" "unprognostic (6.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.34e-3)" "unprognostic (1.40e-1)" "unprognostic (6.20e-3)" "prognostic unfavorable (4.26e-8)" "unprognostic (7.73e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-2)" "unprognostic (2.21e-3)" 11.9 2.2 2.2 3.6 4.1 0.1 8.9 2.7 2.3 21.2 1.7 24.3 1.9 40.0 3.9 5.7 17.1 13.0 12.7 1.6 3.0 3.2 1.7 9.2 1.3 3.9 2.4 0.9 14.6 1.8 0.3 17.8 1.9 3.7 8.9 2.8 1.1 3.4 12.9 3.7 5.3 8.7 20.3 2.0 11.2 9.9 2.6 2.0 2.0 3.9 2.8 0.5 10.7 16.1 1.8 0.1 1.4 0.5 0.0 3.3 26.9 0.0 22.7 5.5 3.7 4.6 0.4 0.0 1.2 0.3 27.5 1.1 0.0 0.0 0.0 1.9 0.1 0.3 5.6 1.5 0.0 5.2 0.1 9.6 12.3 0.0 5.4 0.0 23.2 0.0 0.7 0.2 0.3 0.6 0.1 0.1 0.5 0.9 0.0 0.2 0.7 1.2 0.3 2.5 0.0 2.9 0.4 0.4 0.0 0.5 0.5 0.4 1.2 7.9 1.0 1.3 1.1 3.8 0.4 0.0 0.1 27.8 0.3 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.1 2.7 2.3 1.6 3.0 3.9 2.4 0.9 3.7 2.0 2.0 1.8 3.5 3.2 0.6 4.2 0.3 1.9 0.3 0.3 0.0 5.3 0.8 1.1 2.8 0.0 0.1 0.0 2.1 0.1 0.4 0.8 1.9 0.1 0.6 1.5 19.3 3.3 0.0 0.0 1.5 0.0 0.1 27.0 2.0 0.9 0.0 0.5 2.2 0.0 1.2 3.3 1.1 0.4 0.0 1.0 3.8 1.3 18.0 2.0 1.8 2.8 0.7 2.1 0.0 0.0 0.3 0.1 0.3 15.8 0.3 0.3 4.6 0.2 0.7 1.9 0.0 32.1 6.8 0.9 1.1 0.4 1.8 0.0 0.5 0.9 1.4 0.2 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423615-30430030 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Supported Nucleoplasm,Cytosol NA Yes 61000 "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavorable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 21.1 21.5 18.3 27.6 19.2 22.4 30.8 19.3 22.7 17.8 18.7 56.9 32.3 18.7 20.2 28.5 28.4 19.7 28.3 18.8 20.2 31.0 22.0 16.4 35.8 19.0 18.7 19.0 14.1 25.1 32.4 10.4 16.2 19.7 22.0 58.9 12.3 25.7 19.5 45.1 24.6 27.9 20.7 19.1 28.1 24.5 9.2 18.9 24.7 20.2 37.2 36.0 27.2 19.3 20.0 124.7 149.8 66.8 85.8 18.4 24.1 61.9 58.4 35.1 87.4 87.9 114.7 103.4 168.1 119.1 36.8 54.9 95.9 141.4 115.1 103.5 89.2 221.0 98.3 61.5 150.3 24.1 177.0 144.2 28.6 64.8 96.4 55.6 25.4 88.7 88.2 125.8 57.4 61.5 217.8 210.0 189.9 88.8 124.2 119.2 293.1 74.8 218.1 98.9 80.2 141.4 80.4 39.0 137.7 55.3 41.5 118.4 73.9 45.9 66.0 59.1 85.8 107.2 36.9 118.4 217.5 43.8 145.7 79.6 70.6 36.7 38.1 54.0 70.0 75.8 146.7 68.4 61.4 86.7 128.7 60.9 59.0 4.6 76.1 79.2 94.6 76.4 81.0 18.3 19.2 19.3 22.7 18.8 20.2 19.0 18.7 19.0 19.7 19.1 18.9 20.0 34.0 19.2 15.2 0.7 38.2 90.2 53.3 92.5 33.6 23.3 45.8 48.9 34.8 51.5 37.9 44.1 8.4 103.2 22.7 130.3 127.2 135.6 13.4 32.6 29.9 47.4 38.5 29.6 2.6 124.8 101.0 28.3 27.5 66.5 31.1 40.2 31.1 23.2 76.9 15.2 2.7 142.3 73.2 21.0 49.1 45.1 19.6 26.9 48.0 1.0 73.2 25.0 23.7 2.5 4.4 89.0 115.8 19.9 24.1 86.9 68.8 76.7 27.8 21.4 19.7 23.7 40.0 3.3 44.8 39.4 80.3 27.8 28.3 53.8 168.5 45.7 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407414-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6;REH: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 4.5 7.3 9.5 1.5 10.1 1.2 4.8 8.5 15.8 7.5 2.1 8.3 1.3 13.4 2.0 4.4 10.0 1.4 6.7 12.6 7.4 7.3 13.3 3.2 0.9 8.6 7.0 12.0 10.9 4.9 3.0 8.2 0.5 11.9 9.5 1.5 1.8 4.0 3.7 12.7 3.8 4.7 2.9 4.8 2.5 6.3 3.8 9.6 1.0 5.3 1.5 1.2 10.3 5.4 9.2 4.5 5.2 6.7 5.6 9.3 4.0 5.2 6.3 3.1 3.9 4.1 2.1 2.2 5.2 10.4 3.1 4.8 3.2 6.9 2.8 4.0 1.9 35.6 4.4 3.6 6.8 4.8 2.3 4.9 6.0 2.2 4.9 3.0 4.2 4.0 5.4 10.9 3.1 3.3 8.1 5.4 7.0 5.3 2.7 3.9 23.7 5.1 3.4 2.3 1.8 10.6 6.7 3.4 3.1 4.8 3.4 3.8 2.6 3.8 6.7 8.0 3.9 4.6 4.6 5.4 2.8 4.5 4.9 4.4 0.8 0.7 0.5 1.8 1.4 2.6 1.4 2.2 2.2 1.7 3.3 3.1 2.0 1.0 1.2 0.3 2.3 2.6 1.6 9.5 10.1 8.5 15.8 12.6 7.4 8.6 7.0 12.0 11.9 4.8 9.6 9.2 5.4 3.2 0.5 6.2 3.7 5.1 11.5 1.8 22.2 12.0 9.1 15.7 7.1 20.0 1.5 5.5 10.4 5.5 7.2 7.8 33.2 6.2 1.6 4.5 12.3 7.6 4.2 4.4 8.6 4.4 3.3 12.4 5.6 9.0 1.3 12.6 13.2 19.1 3.5 11.8 9.4 10.0 0.0 1.6 2.4 2.2 25.1 3.2 5.4 5.6 1.3 15.9 2.1 5.5 5.4 2.5 5.1 29.7 4.4 15.5 8.6 29.4 0.7 8.0 13.1 15.2 12.0 1.2 1.8 8.5 6.7 3.6 5.1 9.5 10.0 4.3 TSHZ1 "NY-CO-33, SDCCAG33, TSH1" ENSG00000179981 "Teashirt zinc finger homeobox 1" Q6ZSZ6 18 75210755-75289950 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 84.9;Peritubular cells: 187.3;Theca cells: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 44.4" "Region enriched" "Detected in all" 5 "olfactory bulb: 115.6" "Low region specificity" "Detected in all" HPA006982 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA006982: AB_1079886" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (4.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (1.24e-1)" "unprognostic (4.12e-2)" "unprognostic (9.05e-2)" "unprognostic (5.64e-2)" "unprognostic (1.69e-1)" "unprognostic (3.43e-3)" "unprognostic (1.26e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.42e-3)" 11.9 7.8 17.7 7.2 14.9 3.3 12.2 24.2 23.6 17.6 9.0 15.3 14.0 11.5 9.4 10.1 16.1 10.5 11.0 18.1 16.9 12.2 8.3 8.1 7.4 19.6 13.9 13.4 35.7 7.3 9.2 9.7 30.0 24.6 9.0 9.4 7.9 12.6 11.2 9.3 10.7 13.8 9.4 18.9 9.5 8.9 6.3 14.9 12.4 8.3 6.4 5.4 11.0 11.0 20.7 5.4 7.0 2.2 12.8 18.8 8.9 2.2 24.2 22.6 4.0 7.4 3.2 12.9 10.8 3.0 21.9 4.5 4.8 2.9 6.9 1.4 44.4 23.2 8.3 14.5 4.3 4.9 20.0 9.4 9.1 7.2 3.3 6.5 6.2 10.1 12.5 4.7 19.1 6.6 5.2 14.3 11.4 0.9 6.3 7.6 12.9 6.6 12.9 7.6 3.9 15.9 12.1 6.8 8.8 6.8 0.8 2.0 10.4 7.6 8.7 5.9 6.0 3.9 6.2 15.9 8.7 8.6 16.6 8.1 0.0 0.5 0.5 2.1 0.2 1.4 0.4 1.0 1.8 0.8 0.6 1.5 2.2 0.3 1.5 0.2 0.8 0.4 0.7 17.7 14.9 24.2 23.6 18.1 16.9 19.6 13.9 13.4 24.6 18.9 14.9 20.7 60.2 12.8 14.0 34.3 7.1 17.0 5.6 4.8 27.9 40.8 12.2 12.6 24.4 25.8 7.9 3.7 2.1 4.6 25.6 25.4 3.9 7.5 1.2 12.5 33.9 34.4 16.9 6.9 24.9 10.0 2.2 28.8 4.6 18.2 7.0 22.5 21.0 20.5 6.4 11.8 27.7 15.0 10.2 10.8 30.9 5.9 64.7 14.3 8.8 30.0 11.2 17.9 24.7 84.9 21.3 2.9 14.7 187.3 10.6 7.3 29.7 18.4 9.1 12.1 26.3 21.3 12.2 1.4 4.8 33.1 13.2 3.6 18.2 83.2 17.9 5.4 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 31.3;Spermatocytes: 37.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" No No "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: AB_2675662, HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 0.9 2.3 1.1 0.6 1.3 6.2 3.0 1.3 2.2 1.9 0.2 1.6 1.9 1.9 3.5 1.6 2.0 0.7 1.7 1.3 1.3 2.0 4.2 1.0 0.9 1.6 1.4 1.3 1.3 2.1 1.1 2.6 1.3 2.4 2.0 1.5 0.5 1.9 1.1 3.5 1.6 1.0 1.9 1.2 1.1 1.3 3.2 1.2 1.8 2.4 1.0 1.2 1.4 1.3 2.7 4.1 3.4 1.7 0.8 1.6 3.2 2.1 2.0 3.5 3.0 3.7 4.6 3.4 4.4 3.9 2.5 2.0 2.3 0.7 3.1 3.4 2.4 8.7 2.7 1.2 4.0 4.3 6.7 3.6 3.3 5.2 2.9 5.2 2.7 2.3 3.9 4.3 6.0 4.3 6.6 2.0 3.9 3.3 1.6 4.3 4.5 3.0 4.4 4.3 2.6 1.6 2.1 3.9 3.8 5.3 1.4 1.8 0.4 3.1 2.8 2.6 1.2 4.5 2.6 1.6 5.8 2.4 4.3 0.9 0.0 5.0 6.0 7.4 3.1 8.8 6.2 5.7 7.0 6.7 5.9 7.5 7.7 0.6 6.8 3.6 6.7 3.8 5.3 1.1 1.3 1.3 2.2 1.3 1.3 1.6 1.4 1.3 2.4 1.2 1.2 2.7 3.0 9.6 7.3 14.4 4.6 4.5 5.0 11.0 5.2 8.3 7.1 11.7 5.9 10.0 7.5 5.5 8.4 7.7 8.0 1.6 9.8 4.6 31.3 5.7 5.2 3.2 4.2 3.4 18.8 6.3 3.1 6.0 1.5 11.6 2.5 8.1 3.6 6.3 4.8 5.0 20.3 2.6 14.2 2.1 4.3 5.4 5.3 3.0 5.4 4.7 6.1 8.8 5.2 12.5 29.4 3.7 3.8 5.7 3.3 3.5 3.0 7.7 8.3 11.4 0.0 5.6 8.6 37.5 20.6 5.5 4.7 9.6 6.9 10.8 4.3 3.5 SOCS4 SOCS7 ENSG00000180008 "Suppressor of cytokine signaling 4" Q8WXH5 14 55027230-55049489 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 17.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013478, HPA057961" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013478: , HPA057961: AB_2683564" "unprognostic (7.18e-3)" "unprognostic (1.49e-1)" "unprognostic (9.74e-3)" "unprognostic (4.57e-2)" "unprognostic (3.36e-3)" "unprognostic (3.82e-3)" "unprognostic (3.69e-3)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (4.56e-2)" "unprognostic (7.61e-2)" "unprognostic (4.35e-3)" "unprognostic (1.13e-1)" 6.7 4.9 6.7 7.9 7.3 6.9 5.8 7.9 7.2 4.7 6.3 5.2 5.3 5.9 4.2 5.1 5.2 6.7 5.7 6.6 9.8 6.4 4.9 6.7 9.0 9.0 7.8 5.0 3.9 4.2 5.6 4.5 5.7 8.7 4.8 5.7 10.9 4.5 4.6 4.9 5.1 5.4 6.1 9.5 7.6 7.1 4.3 8.0 8.1 6.9 5.2 7.6 6.6 4.2 10.2 14.2 11.0 16.2 18.9 11.0 12.2 12.0 16.4 12.1 9.9 16.0 9.6 15.2 20.8 11.3 12.4 9.7 19.1 21.4 13.5 23.1 20.8 8.8 12.8 16.3 6.1 11.1 14.3 20.9 9.9 14.4 17.6 13.0 11.5 18.5 22.0 7.4 19.2 19.3 14.6 21.9 11.6 12.7 11.7 12.0 20.3 24.5 8.5 15.2 15.0 21.1 18.5 16.6 9.8 16.8 14.8 14.0 11.2 19.3 25.5 23.9 13.1 14.0 7.4 8.3 19.6 17.2 11.8 20.2 0.9 1.2 1.2 0.8 1.3 1.3 0.8 1.0 0.8 0.9 1.1 0.6 0.6 0.7 1.8 1.8 1.2 1.0 0.5 6.7 7.3 7.9 7.2 6.6 9.8 9.0 7.8 5.0 8.7 9.5 8.0 10.2 30.7 6.4 12.4 9.8 22.3 24.0 10.8 10.7 14.8 13.6 14.7 12.3 20.2 11.5 15.8 14.7 20.9 5.2 27.5 14.7 13.7 9.4 7.4 36.8 22.5 20.9 20.4 16.8 14.3 8.7 6.2 14.8 29.0 20.6 32.9 11.8 15.0 9.4 7.4 37.0 13.6 8.3 8.2 13.3 21.8 2.6 7.2 15.6 3.6 11.2 17.3 21.0 13.4 4.5 20.4 15.6 9.6 10.1 19.4 8.1 6.7 14.6 19.7 17.4 0.0 15.8 21.5 20.7 10.9 14.7 23.2 4.9 21.7 13.7 8.1 11.5 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195113-75209139 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA021468: AB_1858932, HPA053646: AB_2682216" "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.23e-1)" 17.8 13.0 15.5 11.9 17.2 20.9 22.5 19.8 20.7 18.5 14.5 26.6 19.1 15.7 25.0 20.2 18.0 16.0 34.6 17.1 15.5 24.5 32.8 16.5 19.5 16.8 14.6 17.0 24.1 26.8 24.9 21.6 36.9 19.2 17.2 29.0 30.8 24.1 18.4 45.3 22.2 26.2 15.4 16.2 16.2 21.5 7.1 15.0 23.5 28.1 41.1 20.7 16.8 17.1 16.5 21.7 14.1 14.8 30.4 22.6 29.0 16.3 38.5 44.6 14.8 18.5 8.7 30.0 15.2 6.0 38.3 17.4 28.7 18.5 32.6 10.4 94.6 27.1 34.1 32.7 17.0 16.0 58.0 33.2 32.2 31.9 11.9 27.2 27.5 30.9 35.2 18.6 54.0 28.6 25.5 14.6 28.6 3.8 20.9 31.9 31.0 23.7 50.2 28.9 36.2 27.2 22.4 21.4 21.7 24.5 10.4 21.8 28.4 27.7 28.9 22.0 9.2 12.4 8.8 41.2 10.5 19.1 49.5 23.8 1.7 3.4 8.9 3.2 2.9 2.3 2.1 2.6 2.9 2.3 1.5 1.4 2.2 1.7 1.7 3.8 1.7 3.2 1.8 15.5 17.2 19.8 20.7 17.1 15.5 16.8 14.6 17.0 19.2 16.2 15.0 16.5 41.5 35.3 17.9 12.4 7.5 9.7 18.7 13.9 9.6 59.0 15.3 10.8 56.3 20.0 12.5 27.6 6.2 8.4 15.9 24.8 19.6 12.3 0.5 8.5 39.0 24.1 23.4 9.9 16.6 21.1 8.1 26.4 12.8 11.1 7.0 42.6 23.6 25.0 16.4 25.2 14.1 25.1 14.2 20.2 19.1 2.1 36.7 18.3 12.4 12.2 23.9 21.3 13.4 20.6 14.9 15.5 21.9 63.2 6.2 18.5 35.2 19.0 8.1 40.9 19.7 25.5 12.3 0.4 4.9 23.7 11.1 6.7 11.0 73.0 27.2 20.9 OR1E1 "HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P" ENSG00000180016 "Olfactory receptor family 1 subfamily E member 1" P30953 17 3397104-3398410 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF48 "DKFZp762K013, FLJ31751, MGC43952, ZNF553" ENSG00000180035 "Zinc finger protein 48" Q96MX3 16 30378106-30400108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "REH: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023806 Uncertain Approved Mitochondria No No Mitochondria "HPA023806: AB_1859335" "unprognostic (5.35e-2)" "unprognostic (7.91e-3)" "unprognostic (2.41e-3)" "unprognostic (2.06e-1)" "unprognostic (5.20e-2)" "unprognostic (1.66e-2)" "unprognostic (2.77e-3)" "unprognostic (4.25e-2)" "unprognostic (6.06e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.20e-6)" "unprognostic (5.36e-2)" "prognostic favorable (7.50e-5)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" 2.7 5.1 6.9 3.5 7.3 2.0 3.2 7.9 7.9 4.0 3.8 6.6 3.7 7.2 2.5 2.8 5.7 2.5 4.3 7.5 6.3 3.9 4.2 3.5 4.5 5.9 6.1 7.4 3.3 5.7 6.5 5.2 2.0 6.6 4.6 2.4 3.8 4.2 4.4 5.3 4.0 4.1 4.6 5.5 4.2 4.9 2.4 6.4 8.2 3.6 3.8 3.0 5.6 2.8 7.1 7.7 13.4 32.0 25.2 4.3 3.0 9.8 5.7 9.7 12.1 11.2 6.7 10.0 16.2 10.7 5.3 3.4 6.6 15.7 8.9 6.8 12.0 20.2 7.2 6.9 10.2 5.9 9.6 9.1 2.6 11.0 10.0 6.6 11.4 10.9 14.3 12.6 7.2 5.3 28.1 20.8 11.9 26.4 6.0 5.4 47.7 7.4 20.0 7.4 6.6 25.1 31.6 2.5 16.7 2.5 8.4 11.2 8.9 5.1 7.0 8.1 6.3 6.5 8.6 10.9 14.8 4.0 5.8 1.7 0.0 0.0 0.4 0.9 0.0 0.6 0.3 0.4 0.5 0.1 0.3 0.5 0.6 0.0 0.9 0.0 0.4 0.5 0.1 6.9 7.3 7.9 7.9 7.5 6.3 5.9 6.1 7.4 6.6 5.5 6.4 7.1 4.0 3.2 2.2 4.6 6.1 3.1 2.5 1.7 4.0 11.7 4.8 5.1 5.4 14.3 3.9 3.7 8.4 3.7 6.7 4.8 1.9 10.4 0.2 3.7 2.8 5.4 9.6 5.2 4.9 7.4 2.2 2.8 1.5 3.7 17.2 7.5 4.2 3.1 2.7 16.8 5.5 4.0 2.0 1.6 2.6 0.3 2.8 1.7 1.8 2.8 6.9 6.6 3.1 1.0 4.0 7.2 5.4 6.8 2.0 4.3 3.5 4.1 1.0 7.3 0.0 3.0 5.5 3.5 3.3 1.8 5.3 0.3 5.0 3.7 6.1 1.7 OR1R1P "OR17-1, OR1R2P, OR1R3P, OR20A1P" ENSG00000180042 "Olfactory receptor family 1 subfamily R member 1 pseudogene" 17 3385930-3386874 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Cell line enriched" "Detected in single" 6 "HDLM-2: 1.3" "Not detected" "Not detected" NA NA "unprognostic (5.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM71E2 "C19orf16, DKFZp434G1729" ENSG00000180043 "Family with sequence similarity 71 member E2" Q8N5Q1 19 55354908-55363260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 137 "testis: 28.7" "Group enriched" "Detected in some" 18 "Early spermatids: 4.1;Late spermatids: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.97e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225422-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.0;esophagus: 4.6;intestine: 5.5" "Cell type enhanced" "Detected in some" "Early spermatids: 5.6;Excitatory neurons: 23.6;Hepatic stellate cells: 6.1;Horizontal cells: 6.7;Inhibitory neurons: 6.3;Oligodendrocytes: 5.9;Spermatocytes: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 140.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047439 Uncertain NA NA "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 0.7 0.1 1.9 0.6 4.7 0.6 0.4 2.0 6.0 0.3 0.1 5.5 0.7 0.4 0.1 4.6 0.2 0.5 0.2 4.9 2.2 0.1 0.6 0.8 0.0 0.9 0.8 4.4 0.1 0.2 0.3 0.6 0.0 1.4 0.6 1.3 0.1 0.4 0.2 0.0 0.1 0.5 0.7 0.0 1.2 1.1 0.9 0.3 0.0 0.2 0.1 0.1 1.0 1.4 4.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.8 0.1 0.1 0.3 0.0 0.2 2.9 1.7 12.2 3.3 0.1 0.0 2.4 140.5 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 1.3 0.0 0.0 0.1 0.4 29.8 0.0 0.1 0.5 0.0 3.7 0.3 0.0 0.0 1.0 21.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 4.7 2.0 6.0 4.9 2.2 0.9 0.8 4.4 1.4 0.0 0.3 4.6 1.2 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 1.3 4.2 3.0 23.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 6.1 0.3 0.1 6.7 6.3 0.0 0.0 0.0 0.4 1.8 0.3 0.0 0.0 1.9 0.0 0.0 0.0 1.5 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.3 7.1 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 NKX2-6 "CSX2, NKX4-2" ENSG00000180053 "NK2 homeobox 6" A6NCS4 8 23701740-23706756 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "salivary gland: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 5.6;JURKAT: 2.1;LHCN-M2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA025288 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA025288: " "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM150B "DRAM3, TMEM224, TTN2" ENSG00000180061 "Transmembrane protein 150B" A6NC51 19 55312801-55334048 "Predicted membrane proteins, Transporters" Autophagy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "intestine: 64.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 18.1;Kupffer cells: 11.8;monocytes: 8.0;Proximal enterocytes: 68.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 5.7" "Group enriched" "Detected in many" 7 "granulocytes: 1.9;monocytes: 5.7" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;HMC-1: 3.8;THP-1: 2.9;U-937: 18.1" "Not detected" "Not detected" NA NA "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "unprognostic (5.76e-2)" "unprognostic (4.94e-2)" "unprognostic (5.33e-2)" "unprognostic (6.70e-2)" "unprognostic (5.51e-2)" "unprognostic (1.35e-1)" "unprognostic (5.35e-2)" "unprognostic (4.00e-2)" "unprognostic (4.74e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (6.14e-6)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (2.45e-1)" "unprognostic (1.18e-2)" 3.7 1.8 0.5 5.9 0.7 0.7 1.1 0.4 1.9 0.3 1.7 10.3 64.6 0.4 0.1 0.6 0.8 3.0 0.7 0.6 1.7 3.3 2.2 12.0 3.6 1.1 0.7 0.2 0.3 0.9 0.1 0.2 5.6 0.7 0.3 7.3 0.0 0.6 0.4 0.2 0.2 57.5 4.2 0.7 5.7 1.4 0.5 2.8 0.7 0.3 0.2 1.6 2.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.6 0.0 1.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.1 0.1 0.1 1.8 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 18.1 0.1 1.9 5.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.5 0.7 0.4 1.9 0.6 1.7 1.1 0.7 0.2 0.7 0.7 2.8 1.2 0.0 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.5 1.5 0.0 1.8 0.0 0.0 0.0 18.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.8 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.7 3.5 0.0 11.8 1.3 0.0 0.0 3.2 0.0 0.0 8.0 0.0 0.0 0.0 0.9 0.3 1.4 0.0 0.9 0.6 68.9 0.6 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 3.7 0.3 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 18.4;brain: 22.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 33.3;Excitatory neurons: 24.8;Inhibitory neurons: 26.8;Oligodendrocytes: 118.1;Rod photoreceptor cells: 31.2;Spermatocytes: 53.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 17.9" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.0 0.1 2.4 0.3 10.0 18.4 0.5 3.3 5.4 0.4 0.0 0.6 0.3 0.2 0.2 0.8 0.5 0.4 0.5 2.7 3.8 0.9 0.7 0.3 0.2 12.7 9.3 0.8 0.0 2.2 0.6 1.1 0.1 17.8 0.9 0.7 5.0 0.4 0.1 0.0 1.3 0.7 0.2 7.0 0.1 1.0 7.3 8.6 0.3 2.3 0.0 0.1 0.2 0.4 22.4 4.8 3.7 3.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.9 0.0 0.0 0.9 3.5 3.4 0.0 0.0 5.2 0.0 5.6 2.9 0.0 17.9 0.5 0.0 2.3 0.0 3.1 1.7 0.0 7.2 1.7 0.4 0.3 4.6 0.1 0.9 3.7 6.2 2.1 0.0 6.5 6.8 2.1 2.0 1.5 3.0 2.4 0.5 0.2 7.1 2.6 8.3 4.5 0.0 1.3 0.1 0.0 0.3 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.4 10.0 3.3 5.4 2.7 3.8 12.7 9.3 0.8 17.8 7.0 8.6 22.4 0.1 0.0 1.5 1.0 0.1 0.6 2.0 1.5 3.4 3.8 2.3 2.4 9.4 1.5 3.7 1.8 2.1 0.0 0.1 0.8 1.9 5.4 8.0 33.3 1.7 0.2 4.2 0.0 24.8 2.4 0.9 0.2 7.7 19.2 0.0 14.7 0.0 0.5 0.1 0.0 26.8 3.3 2.0 0.0 0.3 2.2 0.6 0.2 0.0 1.0 0.4 9.2 0.0 18.1 118.1 3.9 2.6 0.4 0.1 1.9 1.6 0.3 11.0 31.2 0.0 0.0 0.3 53.5 4.3 3.8 1.7 0.0 1.4 0.3 2.3 1.4 WFDC11 WAP11 ENSG00000180083 "WAP four-disulfide core domain 11" Q8NEX6 20 45648563-45670270 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "epididymis: 94.6" "Cell type enriched" "Detected in some" 12 "Early spermatids: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Group enriched" "Detected in some" 5 "HeLa: 8.7;RPMI-8226: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA 0.0 0.4 1.0 0.2 0.5 3.0 0.3 2.9 2.4 0.1 0.7 0.2 0.0 0.2 94.6 0.2 0.2 0.5 0.1 0.6 0.4 0.2 0.3 0.2 0.2 0.5 0.5 0.1 0.2 0.2 0.1 0.0 0.2 1.3 0.4 0.0 2.0 0.7 0.1 0.1 1.5 0.2 0.1 0.0 0.2 0.3 5.1 0.6 0.0 0.3 0.0 0.1 0.2 0.0 3.1 0.1 0.7 0.0 0.1 0.4 0.5 0.8 0.7 0.1 0.0 0.0 0.5 0.2 0.4 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.8 8.7 0.5 0.0 0.4 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.4 0.1 0.0 0.1 0.3 0.7 0.7 0.2 0.4 0.1 0.3 5.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.1 0.4 0.2 0.1 0.3 0.3 0.0 0.0 1.4 0.2 2.3 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.2 0.0 0.0 1.0 0.5 2.9 2.4 0.6 0.4 0.5 0.5 0.1 1.3 0.0 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226638-55228784 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 11.1;liver: 17.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 7.6;RPMI-8226: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 0.9 2.1 4.1 2.4 4.5 7.0 0.9 4.0 6.8 1.3 3.2 1.5 9.8 1.6 0.1 1.0 1.8 11.1 0.6 4.2 3.3 1.2 17.0 1.3 1.7 4.1 3.5 3.7 1.2 0.7 0.5 2.9 0.7 4.2 1.8 0.3 0.7 0.9 0.6 1.5 1.6 10.3 0.3 2.9 3.7 4.1 3.0 3.5 1.6 2.3 0.4 1.3 1.2 1.0 4.2 1.7 0.0 0.9 1.1 0.1 0.0 3.0 1.2 0.3 0.9 0.9 5.4 1.4 2.4 0.4 0.4 0.3 0.7 0.1 0.2 0.0 0.3 4.0 1.9 0.4 7.6 0.9 1.6 0.9 0.7 1.5 0.5 0.0 0.4 0.0 3.8 3.8 1.4 0.4 1.0 3.8 5.3 0.2 0.6 1.7 3.8 0.5 8.1 0.8 1.6 0.7 1.7 0.0 0.9 4.4 0.7 1.0 1.9 1.2 1.9 1.1 1.1 0.9 1.4 1.5 4.1 1.0 5.2 0.4 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.5 0.3 0.2 0.0 0.6 0.0 0.2 4.1 4.5 4.0 6.8 4.2 3.3 4.1 3.5 3.7 4.2 2.9 3.5 4.2 1.5 6.4 2.7 4.9 1.3 3.3 0.4 1.0 1.8 6.0 1.9 1.1 0.6 37.1 1.5 0.0 2.1 0.4 1.9 2.0 0.0 1.1 3.0 2.5 1.0 1.9 10.7 66.5 5.2 0.2 0.3 0.9 12.8 1.8 0.0 2.5 1.4 33.3 1.0 10.1 4.5 2.8 4.1 5.9 2.8 4.5 0.9 2.5 3.6 0.0 3.1 1.2 2.1 2.5 3.3 1.1 0.3 0.4 2.9 1.2 14.5 1.0 3.8 3.9 0.0 0.8 1.3 1.8 1.2 0.8 2.3 0.3 3.3 1.9 2.7 2.4 OR3A1 "OLFRA03, OR17-40, OR40" ENSG00000180090 "Olfactory receptor family 3 subfamily A member 1" P47881 17 3291017-3298360 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 6.5;Excitatory neurons: 6.9;Microglial cells: 18.7;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HDLM-2: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.69e-3)" "unprognostic (4.73e-2)" 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.3 0.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.3 0.0 0.4 0.7 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 2.5 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEPTIN1 "DIFF6, PNUTL3, SEPT1" ENSG00000180096 "Septin 1" Q8WYJ6 16 30378133-30395991 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 16.8;lymphoid tissue: 36.2" "Cell type enhanced" "Detected in some" "B-cells: 6.7;Cytotrophoblasts: 11.4;dendritic cells: 25.9;Fibroblasts: 4.9;Hofbauer cells: 9.2;Plasma cells: 10.2;Syncytiotrophoblasts: 4.9;T-cells: 6.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 38.2;JURKAT: 48.5;MOLT-4: 66.3;REH: 39.0;U-266/70: 21.6;U-266/84: 33.4;U-698: 23.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA041566, HPA060339, HPA073635" Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA041566: AB_10794671, HPA060339: , HPA073635: " "unprognostic (3.65e-3)" "prognostic favorable (9.72e-5)" "unprognostic (5.06e-2)" "prognostic favorable (3.04e-5)" "unprognostic (3.32e-4)" "prognostic favorable (6.63e-4)" "unprognostic (2.08e-1)" "prognostic favorable (7.24e-5)" "unprognostic (1.24e-2)" "unprognostic (6.52e-3)" "prognostic favorable (2.22e-4)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.40e-7)" "unprognostic (1.48e-1)" "unprognostic (1.41e-1)" "unprognostic (3.95e-1)" "unprognostic (1.72e-2)" 1.3 0.9 0.7 3.7 0.9 0.7 1.1 0.9 1.9 1.7 0.8 2.4 4.1 1.4 0.7 2.0 2.1 0.3 0.8 0.7 0.8 1.3 1.9 2.6 15.4 0.8 0.8 0.7 1.6 0.8 0.5 0.7 0.3 0.8 1.7 0.0 0.1 3.2 0.8 0.2 1.3 16.8 0.7 0.7 36.2 4.4 0.2 1.1 16.2 1.9 0.6 6.6 2.0 1.6 0.8 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 38.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.3 3.0 0.0 0.0 0.3 0.0 5.1 1.2 0.2 0.1 0.1 0.0 0.7 0.0 48.5 0.3 16.7 0.0 0.0 66.3 1.4 0.0 0.0 0.7 39.0 0.0 2.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 21.6 33.4 23.2 0.6 7.0 0.0 118.4 2.5 102.2 319.3 2.3 245.1 170.1 286.7 292.4 9.6 179.4 264.6 268.7 8.5 230.4 1.6 270.6 329.6 272.6 0.7 0.9 0.9 1.9 0.7 0.8 0.8 0.8 0.7 0.8 0.7 1.1 0.8 1.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 11.4 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 4.9 6.1 0.0 0.0 0.0 TRNAU1AP "FLJ20503, SECP43, TRSPAP1" ENSG00000180098 "TRNA selenocysteine 1 associated protein 1" Q9NX07 1 28553085-28578545 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032068, HPA032069" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA032068: AB_2674135, HPA032069: AB_10603998" "unprognostic (4.06e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.93e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (8.64e-5)" "unprognostic (5.79e-3)" "unprognostic (9.48e-3)" "unprognostic (2.24e-2)" "unprognostic (1.37e-1)" "unprognostic (2.28e-3)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.84e-1)" "unprognostic (2.72e-1)" "prognostic favorable (9.45e-4)" "unprognostic (2.76e-1)" 5.2 4.8 8.5 3.9 8.8 4.2 5.2 10.4 10.6 5.2 8.1 5.3 2.7 4.3 5.5 5.2 5.1 2.5 4.9 8.4 8.9 5.1 3.4 5.2 5.9 8.9 9.2 8.3 5.9 5.6 5.7 4.1 4.1 9.2 4.4 4.4 7.2 4.9 5.1 4.0 6.9 4.8 3.7 8.5 5.3 5.1 2.9 8.6 8.6 3.8 3.4 7.0 5.0 4.7 9.6 5.1 3.0 8.6 6.0 7.7 14.6 4.1 6.7 13.5 12.1 10.9 4.7 7.8 7.7 2.6 7.4 5.7 3.8 9.4 10.7 12.1 6.8 10.6 5.8 10.1 3.2 7.1 4.5 4.8 15.7 9.2 9.5 7.4 8.5 17.4 7.8 6.8 6.1 12.0 3.5 7.7 5.2 6.1 5.5 6.5 5.5 6.0 5.4 13.3 5.1 5.0 6.5 8.0 6.9 7.7 9.1 7.7 5.4 5.0 3.1 3.0 5.0 6.1 7.9 10.6 4.8 7.6 9.7 9.1 5.4 2.7 7.3 4.2 4.5 4.2 3.6 4.5 5.3 3.3 4.1 5.3 3.4 1.6 9.7 2.8 2.2 3.3 2.2 8.5 8.8 10.4 10.6 8.4 8.9 8.9 9.2 8.3 9.2 8.5 8.6 9.6 30.3 35.3 36.6 15.0 29.2 17.6 20.0 33.8 17.6 35.1 22.3 23.0 19.9 21.5 39.9 18.4 35.5 30.6 37.1 13.4 17.6 37.4 11.1 41.0 20.4 23.8 10.3 32.2 29.7 32.8 52.8 23.0 14.8 28.0 35.4 28.1 25.4 10.8 33.1 23.5 28.2 13.9 36.7 30.1 23.2 5.0 28.9 27.6 14.2 6.5 35.1 25.5 39.1 17.6 29.9 40.8 12.2 22.6 37.5 22.2 23.4 19.5 84.7 35.4 32.9 22.0 55.0 21.9 25.3 36.3 20.5 68.4 31.8 23.1 14.8 28.9 EXOC3 "SEC6L1, Sec6p" ENSG00000180104 "Exocyst complex component 3" O60645 5 443175-471937 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 61.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037880 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA037880: AB_2675716" "unprognostic (2.94e-1)" "unprognostic (4.74e-3)" "unprognostic (4.82e-3)" "unprognostic (4.10e-1)" "unprognostic (6.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.91e-3)" "unprognostic (1.91e-1)" "unprognostic (6.62e-2)" "unprognostic (3.26e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.82e-1)" "unprognostic (1.70e-1)" 26.3 22.2 14.7 20.5 16.6 24.5 25.8 18.9 18.9 27.1 16.1 34.4 21.0 29.4 10.7 36.7 25.8 19.5 27.6 16.9 17.2 22.7 21.9 22.5 23.8 16.7 17.0 14.5 26.4 32.0 22.2 26.3 18.7 18.0 24.8 14.6 8.1 26.9 20.5 79.5 34.1 27.2 19.2 15.3 26.7 33.1 35.9 16.3 23.1 25.2 41.5 20.3 31.6 27.9 18.4 33.5 55.3 18.2 40.9 30.6 26.3 45.2 29.1 29.9 28.6 34.5 28.0 48.0 28.4 44.2 36.6 35.3 37.2 14.7 25.2 20.9 105.8 25.7 30.6 114.0 21.3 28.6 46.0 73.9 26.8 18.4 32.1 28.0 30.0 32.5 18.3 23.6 18.1 22.5 39.7 33.2 54.8 15.1 20.5 33.0 27.0 20.9 36.5 24.1 41.4 18.2 23.2 72.5 40.5 28.8 17.7 54.8 52.5 24.5 28.3 34.6 22.0 23.8 30.3 23.6 20.2 29.8 55.1 26.2 10.4 10.5 61.0 11.2 12.4 9.8 6.0 8.8 9.1 6.6 6.4 11.1 10.2 14.8 19.4 9.1 4.8 12.4 7.1 14.7 16.6 18.9 18.9 16.9 17.2 16.7 17.0 14.5 18.0 15.3 16.3 18.4 15.5 22.4 29.1 15.0 14.1 42.8 16.3 18.6 20.5 14.0 18.1 16.5 31.4 14.3 21.1 14.7 35.5 25.3 15.6 28.9 27.4 27.3 31.8 16.4 16.2 17.1 5.4 14.7 12.6 30.2 24.2 16.6 23.4 17.0 22.9 27.7 13.9 16.9 24.0 63.9 11.2 20.3 18.3 26.9 23.8 65.3 20.2 24.6 26.6 10.3 25.2 17.0 13.4 10.6 16.7 26.4 23.1 17.0 18.6 18.0 25.5 23.1 29.3 20.2 19.7 19.1 24.8 33.9 29.7 29.4 53.8 34.1 22.7 21.1 23.5 24.6 TDRD6 "bA446F17.4, CT41.2, NY-CO-45, SPATA36" ENSG00000180113 "Tudor domain containing 6" O60522 6 46687875-46704319 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 224.8;Spermatocytes: 82.7" "Cancer enhanced" "Detected in some" "prostate cancer: 2.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA075923, HPA077353" Enhanced Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Vesicles "HPA075923: , HPA077353: " "unprognostic (2.01e-1)" "unprognostic (7.41e-3)" "unprognostic (7.25e-3)" "unprognostic (3.88e-2)" "unprognostic (3.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (7.97e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-3)" "unprognostic (2.20e-1)" "unprognostic (2.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.00e-1)" "unprognostic (2.16e-2)" "unprognostic (4.38e-3)" 0.7 1.7 3.5 3.0 5.6 0.2 0.8 8.4 5.4 1.0 2.4 0.9 0.7 0.9 3.4 0.6 0.8 2.2 1.4 4.5 4.0 1.8 2.6 0.7 4.0 4.3 4.5 4.3 1.1 1.1 0.4 3.0 1.6 5.0 2.0 0.3 9.0 1.3 0.6 2.3 3.5 0.7 0.4 3.6 2.5 0.8 30.6 4.1 0.0 5.7 0.1 0.1 1.1 0.9 5.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 5.6 8.4 5.4 4.5 4.0 4.3 4.5 4.3 5.0 3.6 4.1 5.0 0.8 9.6 0.5 3.9 0.0 0.5 0.4 0.1 1.2 11.3 0.4 0.8 3.4 0.0 3.8 7.3 6.2 0.0 0.0 0.0 1.9 0.3 224.8 1.0 2.2 1.2 4.2 0.0 13.6 0.2 0.0 1.0 0.0 0.7 0.0 0.4 0.7 3.0 0.1 5.0 14.7 0.3 0.0 0.3 0.0 33.8 4.1 0.5 3.6 6.5 0.0 1.1 0.0 14.6 17.8 0.1 0.0 4.5 0.0 0.6 0.4 0.4 0.2 7.5 13.1 3.0 0.5 82.7 34.7 0.0 1.6 0.0 0.0 1.4 0.5 0.2 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 8.8" "Cell type enhanced" "Detected in some" "Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039032 Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039032: AB_2676316" "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 7.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.6" "Group enriched" "Detected in some" 6 "Early spermatids: 30.0;Late spermatids: 23.0;Spermatocytes: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 39 "granulocytes: 7.6" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 7.6 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 1.8 3.5 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 30.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 23.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.6 2.2 16.1 1.2 0.0 2.7 0.3 0.0 0.0 0.1 1.7 LYNX1 SLURP2 ENSG00000180155 "Ly6/neurotoxin 1" P0DP58 8 142771197-142777810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 132.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 34.8;Cardiomyocytes: 76.0;Club cells: 110.5;Excitatory neurons: 35.3;Hepatocytes: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "intermediate monocyte: 6.6;non-classical monocyte: 17.5" "Lineage enriched" "Detected in many" 17 "monocytes: 17.5" "Cell line enhanced" "Detected in many" "BJ: 7.9;fHDF/TERT166: 8.9;GAMG: 11.4;HHSteC: 8.3;HSkMC: 7.5;OE19: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 310000 "unprognostic (8.67e-2)" "unprognostic (6.96e-2)" "unprognostic (1.31e-2)" "unprognostic (2.79e-3)" "unprognostic (1.04e-3)" "unprognostic (5.13e-3)" "unprognostic (1.33e-1)" "unprognostic (5.55e-3)" "unprognostic (1.12e-1)" "unprognostic (3.61e-3)" "unprognostic (7.21e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.82e-4)" "unprognostic (2.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.64e-2)" "unprognostic (1.85e-1)" 11.3 28.7 17.7 3.5 16.6 0.3 10.5 3.3 132.4 12.6 0.0 13.8 4.0 19.8 5.0 21.0 19.0 9.2 69.7 78.6 11.0 12.9 35.2 9.3 1.9 40.3 15.4 13.3 12.9 10.1 28.6 15.1 2.9 58.1 17.7 2.5 7.0 17.4 13.5 6.3 24.1 6.4 11.3 0.0 13.2 11.5 3.1 38.3 0.8 9.5 11.6 2.1 15.2 13.6 55.0 0.1 5.6 0.3 0.0 2.2 0.3 0.1 7.9 0.6 1.1 1.3 0.3 1.3 0.0 3.9 8.9 11.4 1.5 0.2 0.0 0.3 0.0 0.2 0.0 0.2 1.4 8.3 0.0 3.8 7.5 1.3 2.3 0.0 0.2 0.9 0.0 0.0 0.3 0.8 0.0 0.0 0.1 1.9 7.8 0.1 0.0 0.0 0.0 3.0 0.0 0.6 4.5 0.6 6.1 0.0 3.5 6.5 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 0.2 6.6 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 17.5 0.0 0.0 0.3 17.7 16.6 3.3 132.4 78.6 11.0 40.3 15.4 13.3 58.1 0.0 38.3 55.0 2.5 0.0 0.0 8.8 0.3 5.7 1.1 34.8 0.6 8.7 7.8 3.8 76.0 4.3 110.5 0.0 0.0 0.2 0.1 0.0 3.9 1.0 0.3 0.1 1.5 5.8 0.0 2.7 35.3 0.4 0.3 6.1 1.1 0.1 1.3 1.1 15.4 34.5 3.5 21.9 22.0 0.2 16.2 3.2 3.6 1.2 5.0 1.7 5.4 8.4 0.4 12.3 0.0 7.1 12.9 0.3 0.0 8.2 0.1 1.0 0.0 2.7 26.6 6.3 6.6 6.9 18.9 0.7 1.9 30.7 33.2 0.5 0.3 2.4 0.0 3.1 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171815 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 55 "adrenal gland: 198.4;brain: 177.6" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 9.0;Extravillous trophoblasts: 12.4;Leydig cells: 3.4;Syncytiotrophoblasts: 2.2" "Cancer enriched" "Detected in some" 5 "urothelial cancer: 4.0" "Group enriched" "Detected in many" 6 "midbrain: 167.5;pons: 177.6;white matter: 69.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "PC-3: 60.8;SK-BR-3: 21.0" "Region enhanced" "Detected in many" "olfactory bulb: 178.8" "Region enriched" "Detected in many" 20 "midbrain: 594.4" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374" "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 3.3 198.4 7.7 0.1 2.2 0.0 0.0 0.2 9.5 0.5 0.0 0.1 0.0 0.5 0.1 0.7 0.2 0.4 0.1 1.3 23.5 0.1 0.4 0.0 0.0 15.9 167.5 0.5 0.7 0.2 0.0 1.7 0.1 177.6 0.3 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.7 0.2 0.3 0.5 15.8 0.0 0.0 0.0 0.0 1.4 1.5 69.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 60.8 0.0 0.0 0.0 0.1 0.1 1.1 0.2 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 2.2 0.2 9.5 1.3 23.5 15.9 167.5 0.5 177.6 0.7 15.8 69.0 0.3 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.2 1.8 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.4 9.0 0.4 0.0 0.0 0.1 0.0 12.4 0.4 0.0 0.3 0.0 0.0 1.1 0.2 0.5 0.0 0.3 0.1 0.0 0.0 0.3 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 2.2 0.1 0.3 0.2 0.2 MED14 "CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170" ENSG00000180182 "Mediator complex subunit 14" O60244 X 40648305-40735858 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064182 Approved Nucleoplasm NA NA Nucleoplasm "HPA064182: AB_2685204" "unprognostic (5.21e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.07e-1)" "unprognostic (2.34e-1)" "unprognostic (2.08e-3)" "unprognostic (2.16e-1)" "unprognostic (7.95e-3)" "unprognostic (4.38e-2)" "unprognostic (5.05e-2)" "unprognostic (7.78e-2)" "unprognostic (1.16e-1)" "unprognostic (4.89e-2)" "unprognostic (8.54e-2)" "unprognostic (2.32e-1)" "unprognostic (1.64e-1)" 10.6 10.3 11.5 12.6 13.3 22.6 9.9 13.6 16.0 11.4 14.8 14.4 18.1 11.3 20.6 14.0 9.8 9.7 14.1 12.3 12.4 11.4 15.3 11.1 17.4 13.1 12.5 11.1 13.2 12.1 18.8 10.8 13.4 13.1 11.1 14.9 19.3 9.6 9.4 61.3 16.6 14.0 10.2 11.0 11.2 12.5 5.1 12.8 25.2 14.7 33.7 18.7 14.3 12.7 16.2 44.3 21.4 33.8 30.0 14.7 19.0 6.9 17.1 21.3 24.1 30.6 19.8 21.4 25.4 11.4 21.8 51.7 32.7 57.8 27.1 35.9 23.3 43.5 25.7 25.8 18.1 15.8 27.2 25.4 13.7 16.3 35.3 30.5 28.5 29.5 16.6 17.7 24.1 25.5 22.8 25.1 24.2 37.5 27.9 24.7 12.6 36.1 25.6 23.3 20.2 21.6 19.2 40.6 18.3 19.2 62.7 26.8 16.1 26.9 24.5 25.6 31.1 21.2 22.4 24.6 25.2 23.7 18.4 18.1 1.9 1.5 2.8 1.9 3.2 2.2 1.6 1.8 1.8 2.5 1.5 2.0 1.6 0.8 3.5 1.8 1.3 1.8 1.2 11.5 13.3 13.6 16.0 12.3 12.4 13.1 12.5 11.1 13.1 11.0 12.8 16.2 12.6 16.0 12.0 36.9 17.5 23.7 11.7 8.4 11.4 16.5 13.9 9.8 14.1 11.5 12.1 12.9 18.8 6.3 22.2 24.0 5.9 8.4 0.8 16.9 14.8 12.9 20.4 8.4 30.9 10.0 5.4 11.3 29.6 21.6 10.8 21.5 8.2 20.9 9.3 18.5 35.6 19.0 8.2 15.6 17.4 1.0 8.7 17.3 12.4 27.2 16.0 6.3 12.3 41.7 63.5 13.9 15.0 8.6 23.8 17.6 19.1 9.2 6.8 16.3 26.3 12.7 14.2 20.5 7.7 18.7 30.3 6.6 16.7 12.5 17.2 27.3 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 64.7" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 112.2;Proximal tubular cells: 210.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favorable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 12.4 21.6 9.0 8.6 9.8 10.1 9.5 9.9 11.5 7.8 9.1 22.8 36.5 9.8 8.1 19.4 7.0 12.2 17.9 11.7 10.9 64.7 59.0 7.1 7.5 11.1 9.4 10.0 8.1 15.9 12.2 9.6 7.6 11.7 9.5 14.4 6.7 11.3 10.8 31.0 16.8 27.3 8.8 9.6 8.5 21.2 10.2 11.1 7.9 7.9 24.9 6.4 11.4 11.2 12.9 20.1 44.6 20.9 36.9 27.0 19.5 12.9 32.4 16.0 21.1 22.9 28.6 20.4 12.8 26.6 20.2 32.7 40.5 16.4 25.8 19.0 19.3 39.0 11.5 38.7 67.0 26.2 20.0 21.2 25.8 33.3 19.3 12.9 17.8 27.8 15.3 12.1 12.8 26.8 92.5 10.9 30.1 12.4 18.4 33.0 24.6 28.3 36.4 76.8 24.9 40.4 33.6 42.3 33.5 52.0 13.8 49.4 13.4 41.1 34.4 24.6 20.5 17.8 18.6 42.3 15.1 22.0 14.5 15.1 15.8 40.8 16.5 25.1 51.5 22.5 37.2 24.7 27.3 42.6 32.7 27.0 24.8 3.5 38.1 38.4 33.1 28.4 24.3 9.0 9.8 9.9 11.5 11.7 10.9 11.1 9.4 10.0 11.7 9.6 11.1 12.9 14.6 25.6 16.4 2.9 11.2 14.0 13.3 29.6 13.1 19.8 12.4 15.7 42.9 27.1 17.2 42.3 27.1 22.6 10.9 50.8 50.9 57.2 89.8 16.8 19.8 16.3 29.3 36.4 8.0 39.2 14.2 15.5 17.3 18.2 5.1 13.8 9.7 35.5 30.5 18.5 8.6 25.6 24.4 9.1 14.2 45.0 14.6 13.7 16.0 4.7 18.9 17.4 20.6 3.0 6.4 34.9 36.7 15.4 4.0 11.2 112.2 210.9 14.4 24.2 13.1 12.7 16.5 9.9 9.1 27.2 24.0 15.3 9.8 30.3 52.7 9.6 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489803-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 151.3;Early spermatids: 80.7;Syncytiotrophoblasts: 272.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 56.1;HBEC3-KT: 27.6;hTERT-RPE1: 23.7;SuSa: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol NA NA 52000 "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 7.0 10.4 13.8 2.3 13.3 0.2 8.8 13.4 14.5 12.8 20.9 5.6 2.1 10.1 9.9 3.9 18.7 10.8 4.4 13.0 14.6 16.8 16.0 9.8 4.5 14.2 13.8 12.2 19.6 9.0 16.2 16.8 36.7 13.1 14.8 2.6 17.0 6.6 8.6 1.7 3.4 5.0 5.1 12.8 4.0 6.1 14.1 14.5 4.8 24.9 2.7 5.1 9.9 7.7 12.5 9.9 9.8 16.7 0.0 0.0 0.0 56.1 5.6 3.5 5.3 4.6 0.0 0.0 0.0 2.3 1.8 5.3 2.1 0.0 27.6 6.6 0.0 0.7 0.1 0.0 14.8 6.4 0.0 4.1 6.4 21.4 0.0 10.0 23.7 0.8 0.1 1.2 0.0 5.7 0.0 0.1 0.1 20.0 0.0 2.1 0.0 0.0 0.0 17.0 14.5 5.0 8.1 0.0 17.2 4.5 27.4 5.7 0.0 0.3 0.3 1.7 0.0 0.5 0.0 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 13.3 13.4 14.5 13.0 14.6 14.2 13.8 12.2 13.1 12.8 14.5 12.5 20.4 22.4 15.4 41.8 1.0 23.5 28.6 7.3 39.3 17.8 15.8 10.8 4.4 12.8 10.5 18.4 2.1 151.3 0.4 0.5 43.0 10.2 80.7 19.5 10.7 21.2 7.8 0.0 33.3 4.8 61.2 12.2 0.5 7.3 0.0 9.7 7.9 21.0 12.7 10.1 39.9 1.6 16.2 1.9 5.8 16.1 7.2 7.4 8.8 53.4 0.2 9.2 0.0 16.6 4.5 2.9 1.0 6.4 2.5 34.3 0.0 20.7 28.4 12.4 19.7 9.0 10.5 21.5 11.0 7.1 7.0 272.1 0.9 1.7 0.7 14.7 RCC1 CHC1 ENSG00000180198 "Regulator of chromosome condensation 1" P18754 1 28505943-28539300 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 789.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015413, HPA027573, HPA027574" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA 47000 Nucleoplasm "Nuclear membrane" "CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236" "unprognostic (6.23e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.91e-5)" "unprognostic (3.93e-2)" "unprognostic (2.03e-3)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.43e-11)" "unprognostic (1.04e-2)" "unprognostic (2.78e-1)" "unprognostic (3.02e-1)" "unprognostic (6.23e-2)" 12.7 12.2 6.4 31.3 6.4 59.0 17.4 7.4 7.6 14.8 7.0 24.7 27.4 14.4 10.4 32.4 19.1 13.0 6.4 6.5 7.3 7.8 24.1 12.4 37.7 7.4 6.5 5.7 16.2 16.2 5.8 3.8 17.8 7.6 11.0 28.4 6.1 20.8 9.3 13.4 14.7 23.6 19.4 8.0 16.2 18.7 58.3 7.7 44.7 11.8 8.1 38.3 23.8 15.9 10.0 263.2 109.7 94.8 112.9 68.4 86.5 106.2 100.2 60.2 158.5 122.9 111.9 206.2 331.0 60.0 99.2 65.3 155.0 306.6 158.1 125.1 133.7 185.0 295.0 140.0 147.2 51.6 329.0 171.5 111.6 106.0 150.0 125.6 100.7 110.6 194.5 222.8 101.1 66.0 140.8 260.5 118.0 205.3 117.8 106.4 252.9 163.3 164.0 60.5 119.9 150.6 76.7 105.3 171.5 87.6 52.7 72.6 99.8 84.5 81.6 162.5 102.0 198.2 60.9 91.2 248.8 80.5 469.7 89.5 5.1 7.7 3.3 5.0 7.9 9.4 7.1 7.8 8.2 14.0 7.2 6.8 7.6 1.8 5.9 5.7 7.7 7.6 6.3 6.4 6.4 7.4 7.6 6.5 7.3 7.4 6.5 5.7 7.6 8.0 7.7 10.0 8.9 0.0 10.3 2.0 57.4 36.7 12.4 13.6 92.2 0.8 18.9 15.4 4.6 5.7 16.2 7.3 2.1 25.6 10.7 10.7 3.9 34.0 176.5 12.7 21.1 16.6 5.4 118.1 4.5 23.7 43.5 17.4 68.8 17.4 1.3 14.8 2.9 6.6 20.8 13.5 5.0 16.0 12.2 11.3 20.0 789.4 17.1 21.3 14.2 1.9 16.6 0.5 15.5 2.0 2.9 39.5 7.0 10.5 75.5 21.6 9.6 5.7 14.1 0.3 6.6 15.0 16.6 19.2 18.4 185.3 33.8 24.5 31.7 12.5 25.0 18.4 WFDC9 "dJ688G8.2, WAP9" ENSG00000180205 "WAP four-disulfide core domain 9" Q8NEX5 20 45607939-45631284 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 464 "epididymis: 998.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 998.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYLPF "HUMMLC2B, MRLC2, MYL11" ENSG00000180209 "Myosin light chain, phosphorylatable, fast skeletal muscle" Q96A32 16 30370934-30377991 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 108 "skeletal muscle: 20095.7;tongue: 5974.2" "Cell type enriched" "Detected in many" 29 "Skeletal myocytes: 654.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 73 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 73 "dendritic cells: 19.6" "Group enriched" "Detected in some" 18 "BEWO: 75.4;HSkMC: 166.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039262, HPA055059" Enhanced NA NA 1000000 "HPA039262: AB_2676418, HPA055059: AB_2732591" "unprognostic (8.81e-3)" "unprognostic (7.55e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.37e-3)" "unprognostic (8.26e-4)" "unprognostic (1.28e-1)" "unprognostic (1.16e-2)" "unprognostic (5.52e-2)" "unprognostic (4.14e-4)" "unprognostic (1.84e-1)" "unprognostic (3.88e-1)" "unprognostic (7.07e-3)" "unprognostic (1.44e-2)" 1.5 0.5 0.1 0.2 0.1 0.6 3.4 0.4 0.3 0.3 0.0 0.9 0.0 0.5 0.1 70.5 0.0 0.0 1.5 0.1 0.1 0.4 1.2 1.0 0.3 0.1 0.1 0.0 0.7 1.3 0.0 0.5 1.2 0.3 45.1 0.1 0.1 120.3 0.1 20095.7 2.0 0.7 0.2 0.0 0.5 0.7 4.9 0.0 10.1 2.1 5974.2 0.6 0.1 0.8 0.3 0.0 0.2 0.0 0.4 0.0 0.0 75.4 0.1 0.0 0.1 0.0 3.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.2 166.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.2 0.3 0.7 0.4 0.1 0.2 0.0 3.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.6 1.2 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 19.6 0.0 0.2 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.3 1.6 3.2 2.3 0.3 2.5 0.9 1.7 8.3 0.6 1.1 8.6 7.2 1.9 4.3 5.0 7.3 0.0 15.9 13.2 2.2 0.0 0.8 14.9 3.0 3.8 3.0 3.6 0.4 0.4 0.9 16.5 2.4 1.1 6.2 8.8 0.7 5.3 1.3 4.2 0.0 0.5 2.9 2.0 4.7 11.5 22.4 1.2 5.3 1.8 1.0 3.1 1.6 19.6 1.0 1.2 0.4 5.7 0.4 2.9 1.5 1.1 4.2 3.8 1.9 0.0 654.1 5.9 4.7 1.7 1.2 1.1 6.6 4.8 0.4 2.2 2.7 F2 ENSG00000180210 "Coagulation factor II, thrombin" P00734 11 46719196-46739506 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1655 "liver: 1227.2" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 991.0" "Cancer enriched" "Detected in some" 110 "liver cancer: 508.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "Hep G2: 281.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016780, HPA051476, HPA054698" Enhanced "Secreted to blood" NA NA 108000000000 41000000000 "CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "unprognostic (2.64e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (2.23e-2)" "unprognostic (3.94e-2)" "unprognostic (5.79e-2)" "unprognostic (8.29e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.75e-12)" "unprognostic (5.65e-3)" "unprognostic (5.80e-2)" "unprognostic (1.54e-3)" 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 1227.2 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.9 0.0 0.2 2.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 281.0 0.0 1.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.2 0.0 37.5 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 21.8 991.0 0.0 0.0 0.2 0.2 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.1 FAM71C MGC39520 ENSG00000180219 "Family with sequence similarity 71 member C" Q8NEG0 12 99647753-99650114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 33.9" "Group enriched" "Detected in some" 39 "Early spermatids: 305.8;Late spermatids: 496.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebellum: 5.6;cerebral cortex: 1.7;pons: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.82e-2)" "unprognostic (3.58e-2)" "unprognostic (3.22e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 5.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 5.6 1.7 0.3 0.1 0.0 0.2 0.1 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 305.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 496.5 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRKRA "DYT16, HSD14, PACT, RAX" ENSG00000180228 "Protein activator of interferon induced protein kinase EIF2AK2" O75569 2 178431292-178451512 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing" RNA-binding "Disease variant, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 307.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004648, HPA034996, HPA034997" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (5.38e-2)" "unprognostic (4.02e-3)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (8.33e-5)" "unprognostic (9.66e-2)" "unprognostic (7.10e-3)" "unprognostic (2.32e-3)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-3)" "unprognostic (8.99e-2)" "prognostic favorable (5.45e-4)" "unprognostic (1.38e-1)" "unprognostic (6.78e-2)" 27.3 22.1 26.3 13.9 26.4 18.4 26.6 28.2 30.5 23.5 28.6 31.3 13.8 29.0 25.9 23.0 23.6 17.6 33.8 25.9 28.4 26.8 20.4 21.4 17.0 28.5 28.5 25.5 23.6 25.7 26.4 22.7 11.6 27.6 23.6 20.3 31.2 22.8 24.6 101.6 30.5 19.8 29.6 28.4 16.0 26.2 24.5 26.9 20.6 22.3 73.3 20.6 32.4 22.2 30.8 24.6 18.4 48.2 20.8 49.2 56.7 39.6 35.4 37.7 46.4 50.8 50.9 33.8 51.0 39.8 43.6 30.9 21.0 42.0 28.5 50.9 43.9 25.0 29.2 17.0 46.7 58.6 21.2 16.1 32.2 69.3 44.0 49.7 46.0 46.8 32.8 26.7 34.9 62.9 25.3 46.3 52.2 46.7 42.3 33.5 38.5 89.0 46.6 52.4 25.5 30.2 39.4 21.9 20.2 48.3 36.3 30.6 27.4 20.8 32.0 42.6 33.8 29.9 52.5 33.7 62.6 40.8 35.1 20.7 5.4 24.7 25.9 18.1 25.5 26.2 34.3 28.4 22.7 37.2 26.4 31.4 25.8 5.1 25.2 26.3 49.7 38.3 30.9 26.3 26.4 28.2 30.5 25.9 28.4 28.5 28.5 25.5 27.6 28.4 26.9 30.8 35.1 16.0 33.4 23.2 37.7 63.1 90.0 89.3 30.1 53.6 48.1 40.3 43.5 20.0 39.9 25.8 43.8 37.7 49.3 16.9 125.2 51.4 149.5 43.6 36.2 34.5 47.9 19.1 39.5 41.6 53.2 42.7 19.4 27.0 28.5 40.5 21.8 18.5 30.4 10.1 46.4 35.5 93.6 19.8 69.4 307.9 39.4 26.4 69.4 21.5 38.6 49.2 9.2 30.7 47.1 36.0 25.1 37.2 42.5 94.7 30.8 89.0 30.6 86.2 46.0 45.6 66.7 78.7 57.6 43.7 78.4 43.4 33.6 47.0 39.6 73.0 ZNRF2 RNF202 ENSG00000180233 "Zinc and ring finger 2" Q8NHG8 7 30284597-30367689 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072244 Approved Uncertain "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center" "HPA072244: AB_2732197" "unprognostic (9.44e-2)" "unprognostic (2.38e-2)" "unprognostic (8.64e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (4.46e-2)" "unprognostic (1.24e-1)" "unprognostic (3.06e-1)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (5.93e-2)" "prognostic favorable (2.29e-4)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "prognostic favorable (8.71e-4)" "unprognostic (8.67e-2)" 7.5 6.6 4.9 11.6 5.0 13.1 9.7 6.0 4.9 5.1 13.1 19.1 13.3 8.5 10.7 10.4 4.4 9.5 5.1 4.6 8.5 22.2 21.7 7.4 15.4 7.7 6.8 3.9 3.7 10.4 9.2 5.1 9.4 7.7 5.8 16.3 4.7 9.3 5.3 5.7 10.1 15.3 9.6 7.7 10.9 15.1 24.2 7.0 9.0 11.8 6.3 13.3 11.3 4.2 8.9 13.2 4.7 3.8 3.4 4.4 3.0 19.8 4.9 5.1 5.4 7.2 2.4 21.5 13.8 12.6 4.1 14.0 12.5 12.7 8.5 5.7 13.4 11.5 8.6 9.7 6.4 2.3 6.7 15.6 4.6 14.0 3.7 9.1 5.6 4.6 10.5 10.7 26.6 5.9 5.1 13.6 17.5 8.9 13.2 5.9 11.7 8.2 23.8 16.4 28.0 13.0 12.3 9.9 41.2 8.5 22.2 11.1 26.5 5.1 5.2 8.9 5.0 10.5 44.9 41.5 18.1 5.7 14.3 7.8 0.2 0.3 0.4 0.3 0.3 0.5 0.4 0.4 0.5 0.3 0.2 0.2 0.4 0.5 0.3 0.4 2.2 1.0 0.2 4.9 5.0 6.0 4.9 4.6 8.5 7.7 6.8 3.9 7.7 7.7 7.0 8.9 11.3 9.6 8.4 19.9 13.9 15.9 7.4 4.8 8.6 11.3 26.5 10.4 3.6 14.3 5.0 16.5 41.7 10.1 40.8 60.0 7.9 4.9 5.2 32.7 7.6 6.6 31.3 6.1 54.4 10.3 11.4 5.1 14.3 43.7 3.8 4.7 8.2 41.6 10.7 1.7 32.3 14.0 0.0 23.3 16.2 10.1 2.8 23.1 12.4 119.9 13.1 5.1 4.1 41.7 39.7 7.4 19.5 2.2 11.5 8.5 22.6 32.3 5.8 5.8 6.6 7.7 9.8 18.3 7.0 7.9 18.9 11.5 17.6 7.6 23.4 14.3 RRH peropsin ENSG00000180245 "Retinal pigment epithelium-derived rhodopsin homolog" O14718 4 109827972-109849123 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 120 "retina: 76.2" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 40.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.47e-2)" "unprognostic (4.94e-2)" "unprognostic (1.96e-2)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "unprognostic (7.56e-2)" "unprognostic (8.47e-2)" "unprognostic (2.33e-1)" "unprognostic (1.86e-2)" "unprognostic (2.03e-2)" "unprognostic (1.62e-3)" "unprognostic (4.65e-1)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (3.18e-2)" 0.1 0.2 0.4 0.1 0.4 0.0 0.2 0.3 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.3 0.3 0.1 0.1 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.1 76.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.3 0.4 0.1 0.1 0.0 0.2 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.3 0.6 0.4 0.3 0.3 0.2 0.4 0.4 0.2 0.2 0.5 0.1 0.0 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 2.5 3.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473226-102533972 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "stomach 1: 54.3" "Group enriched" "Detected in some" 12 "Collecting duct cells: 25.8;Gastric mucus-secreting cells: 54.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.3;OE19: 6.8;RT4: 4.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 10.6;olfactory bulb: 6.8" "Low region specificity" "Detected in single" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.0 0.3 0.1 0.5 0.8 0.2 0.6 0.7 0.3 0.0 0.0 2.0 0.1 0.1 1.5 0.1 1.2 0.6 0.4 0.4 8.7 0.0 0.0 0.4 0.2 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.4 1.3 0.5 1.5 0.4 0.0 0.0 0.0 0.2 54.3 0.3 0.1 0.1 0.1 0.0 0.5 0.4 0.1 0.6 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 1.3 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.5 6.8 0.2 0.0 0.2 0.1 0.0 4.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.7 0.4 0.4 0.2 0.1 0.4 0.4 0.0 0.1 0.6 0.0 3.2 3.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.4 0.0 0.9 25.8 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 54.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.0 0.0 0.0 0.2 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.1 0.4 0.0 0.3 0.3 ZNF816 ZNF816A ENSG00000180257 "Zinc finger protein 816" Q0VGE8 19 52949379-52962911 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 52.6" HPA042466 Uncertain Approved "Nucleoli rim" NA NA "Nucleoli rim" "HPA042466: AB_10797497" "unprognostic (1.83e-2)" "unprognostic (1.90e-1)" "unprognostic (1.64e-1)" "unprognostic (4.81e-2)" "unprognostic (3.12e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-4)" "unprognostic (1.69e-1)" "unprognostic (1.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (3.72e-2)" "unprognostic (5.36e-3)" "unprognostic (6.21e-2)" "unprognostic (5.45e-1)" "unprognostic (8.59e-2)" "unprognostic (1.39e-2)" 2.9 3.2 2.6 4.6 2.9 3.4 8.0 6.7 3.5 9.6 3.9 9.2 4.9 5.9 8.5 4.3 11.8 5.4 4.6 2.3 3.1 6.1 2.7 5.5 7.7 3.0 2.6 1.6 8.5 5.7 6.0 2.9 6.7 3.4 12.6 10.2 5.9 4.6 6.9 1.8 5.3 5.0 4.7 2.7 6.8 10.1 4.5 3.0 9.7 7.2 3.0 8.9 8.2 4.6 3.2 6.5 0.2 5.8 14.5 10.2 11.6 17.0 5.4 5.5 6.8 10.1 4.7 4.1 17.8 11.2 4.8 10.5 3.9 8.5 6.3 6.6 8.9 17.1 8.3 7.0 7.7 3.5 0.0 12.3 5.5 7.8 4.3 7.9 8.0 5.8 8.1 13.4 0.6 8.7 5.3 14.4 9.6 6.8 3.8 8.0 7.9 12.2 8.6 10.7 52.6 4.4 8.1 0.2 9.1 3.6 11.3 5.7 9.6 5.0 5.0 4.9 3.4 6.1 6.0 18.4 16.1 0.6 8.8 6.0 15.2 8.6 17.3 14.4 7.5 19.5 11.3 13.5 14.3 10.0 11.6 18.5 14.5 3.9 21.3 9.6 9.3 13.9 8.9 2.6 2.9 6.7 3.5 2.3 3.1 3.0 2.6 1.6 3.4 2.7 3.0 3.2 2.0 3.2 1.5 0.0 2.8 0.9 2.8 4.3 2.2 1.6 1.4 1.3 2.2 2.8 7.0 1.8 6.2 4.9 2.5 1.8 7.9 3.8 3.3 4.8 1.8 2.1 0.0 7.8 0.0 1.6 3.7 1.7 2.0 3.7 7.6 3.8 1.4 0.7 2.4 0.0 0.0 3.2 4.1 1.0 1.7 2.3 1.5 1.8 5.4 0.0 3.7 1.0 8.2 0.0 0.0 2.0 2.5 1.2 1.9 1.4 1.6 0.9 4.8 0.9 0.0 1.3 1.8 1.5 5.0 1.6 1.6 3.6 3.3 2.3 3.3 4.1 FGD6 "FLJ11183, ZFYVE24" ENSG00000180263 "FYVE, RhoGEF and PH domain containing 6" Q6ZV73 12 95076749-95217482 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 109.0;Microglial cells: 90.9;Pancreatic endocrine cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007974 Approved Approved Vesicles NA NA Vesicles "HPA007974: AB_1848520" "unprognostic (1.28e-2)" "unprognostic (2.67e-3)" "unprognostic (6.06e-2)" "unprognostic (5.56e-2)" "unprognostic (1.65e-1)" "unprognostic (4.70e-2)" "unprognostic (4.66e-2)" "unprognostic (1.35e-3)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.62e-5)" "prognostic unfavorable (9.83e-4)" "prognostic unfavorable (5.46e-6)" "unprognostic (1.01e-2)" "unprognostic (1.38e-1)" "unprognostic (3.33e-2)" "unprognostic (1.92e-1)" 1.7 3.3 3.3 5.1 4.7 1.5 2.9 0.4 5.7 3.4 4.9 4.0 1.3 3.4 1.2 3.3 1.9 4.9 3.7 3.2 3.6 3.3 3.1 5.3 5.5 2.2 1.8 1.9 4.6 3.4 1.2 1.1 4.4 1.5 3.3 4.2 2.2 2.2 4.0 1.7 7.9 3.5 3.5 1.5 3.4 1.8 3.0 2.6 2.5 5.2 1.3 9.8 3.4 3.5 1.6 22.5 20.1 18.2 2.0 1.9 1.8 9.5 3.1 4.4 1.1 1.8 7.7 15.0 23.8 5.1 2.0 1.3 8.9 3.3 18.7 2.6 2.5 2.0 1.1 3.2 3.8 2.5 2.5 0.2 7.5 8.4 2.2 22.1 7.3 11.9 3.2 5.1 0.4 0.6 1.2 2.0 0.5 7.5 2.8 6.9 5.5 3.6 1.9 12.8 7.1 3.0 4.9 9.0 4.6 0.4 9.1 2.1 0.2 16.4 0.7 2.0 0.9 2.4 2.2 5.3 6.7 0.9 1.6 1.4 0.2 1.6 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.9 1.4 0.1 0.0 0.1 0.1 2.0 0.0 0.0 0.6 3.3 4.7 0.4 5.7 3.2 3.6 2.2 1.8 1.9 1.5 1.5 2.6 1.6 12.4 16.0 17.0 109.0 3.9 48.6 21.9 18.6 29.0 3.8 11.0 10.5 22.2 10.0 14.0 9.2 4.2 4.5 1.5 26.5 0.0 22.6 1.7 10.9 17.3 22.3 12.5 1.7 23.9 21.9 8.8 7.3 6.6 22.1 1.3 10.6 16.4 5.2 11.7 1.7 22.4 15.5 10.2 16.1 11.8 3.1 12.5 11.0 1.8 90.9 12.6 1.9 1.0 4.0 4.1 78.1 17.0 10.5 3.5 19.3 14.9 5.2 12.0 9.7 0.0 3.5 6.1 4.8 16.0 28.3 24.9 43.8 1.7 4.9 5.5 30.7 ADGRD2 "GPR144, PGR24" ENSG00000180264 "Adhesion G protein-coupled receptor D2" Q7Z7M1 9 124451425-124478589 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4;pituitary gland: 1.6;seminal vesicle: 1.2" "Group enriched" "Detected in some" 14 "Early spermatids: 34.0;Late spermatids: 88.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" NA NA "unprognostic (7.39e-4)" "unprognostic (1.34e-2)" "unprognostic (4.21e-2)" "unprognostic (8.01e-3)" "unprognostic (6.29e-2)" "unprognostic (3.23e-6)" "unprognostic (1.15e-1)" "unprognostic (3.15e-1)" "unprognostic (5.82e-2)" "unprognostic (4.22e-2)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "unprognostic (3.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.41e-1)" 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.3 1.4 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 3.1 0.0 0.0 0.0 0.3 4.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 88.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.7 1.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 GPR139 PGR3 ENSG00000180269 "G protein-coupled receptor 139" Q6DWJ6 16 20028239-20073890 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 4.2" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046596 Uncertain NA NA "HPA046596: AB_2679713" "unprognostic (2.94e-1)" 0.0 0.0 1.4 0.0 2.5 0.5 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.2 3.5 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.3 0.3 0.0 1.6 4.2 3.5 0.1 1.4 0.5 3.3 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524697 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 16.1;choroid plexus: 41.7" "Group enriched" "Detected in some" 6 "Inhibitory neurons: 319.5;Oligodendrocyte precursor cells: 127.6;Oligodendrocytes: 226.8" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enhanced" "Detected in all" "cerebellum: 16.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.0;AF22: 10.3;HDLM-2: 5.3;SH-SY5Y: 2.9;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol No No Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: AB_2681105" "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 0.3 1.7 1.7 0.0 2.8 0.0 0.4 16.1 2.6 0.6 41.7 0.1 0.0 1.1 0.2 0.4 1.1 0.1 0.1 3.4 3.7 0.4 0.0 0.2 1.1 2.8 2.8 2.1 2.1 1.0 0.2 2.5 0.4 5.8 0.8 0.1 0.3 0.7 3.0 0.2 0.1 0.1 0.9 2.2 0.7 0.3 1.5 2.2 0.4 0.2 0.0 0.4 0.1 0.3 2.7 0.0 3.0 10.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.8 16.1 2.6 3.4 3.7 2.8 2.8 2.1 5.8 2.2 2.2 2.7 0.1 0.0 0.0 7.8 0.2 0.1 0.0 0.0 1.2 0.5 0.0 1.7 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 9.1 2.9 0.6 0.3 0.0 0.0 35.5 0.0 0.0 3.1 0.0 8.2 0.0 0.7 0.0 0.0 0.0 3.3 319.5 0.2 0.0 0.0 0.0 21.0 5.0 0.1 0.0 5.6 0.0 0.4 0.0 127.6 226.8 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 1.5 1.2 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.1 OAZ2 ENSG00000180304 "Ornithine decarboxylase antizyme 2" O95190 15 64687573-64703281 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 324.9;Sertoli cells: 374.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 418.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047694 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA047694: AB_2680121" "unprognostic (2.67e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (9.05e-4)" "unprognostic (2.09e-2)" "unprognostic (4.44e-2)" "unprognostic (2.32e-3)" "unprognostic (3.46e-2)" "unprognostic (7.94e-2)" "unprognostic (3.11e-2)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-1)" 61.4 69.1 111.9 50.0 112.7 33.2 55.6 113.7 113.4 60.2 107.8 60.7 28.6 65.2 57.7 44.8 60.3 47.3 76.5 110.7 116.1 62.7 90.1 56.3 51.1 115.5 115.9 107.4 56.9 36.2 97.6 75.6 75.8 114.5 53.7 36.2 124.5 45.7 49.6 209.9 44.3 41.2 73.0 114.9 90.5 48.1 81.4 117.3 42.1 66.4 153.9 45.7 56.8 48.7 118.2 71.2 63.5 130.6 43.5 91.8 79.4 24.6 80.5 120.6 113.4 98.5 43.5 62.2 61.6 72.7 113.4 84.5 37.5 126.7 71.6 99.2 82.4 48.3 40.3 48.3 32.5 52.2 35.7 125.7 104.4 49.6 57.0 40.1 147.4 109.2 42.9 30.1 29.6 123.4 45.3 24.5 43.8 223.1 39.1 50.7 57.5 74.5 54.0 102.0 55.7 68.4 125.1 30.4 45.0 80.3 161.6 75.6 52.7 66.0 76.4 102.2 38.0 87.0 65.1 104.6 58.2 87.4 75.2 69.8 22.1 145.3 268.4 29.3 247.8 24.2 30.2 24.6 24.0 91.1 29.1 27.9 25.3 418.0 39.5 209.6 49.4 30.7 115.5 111.9 112.7 113.7 113.4 110.7 116.1 115.5 115.9 107.4 114.5 114.9 117.3 118.2 67.5 25.6 43.5 15.3 36.1 121.7 99.5 67.7 47.8 93.8 57.9 40.4 61.9 44.3 41.0 42.3 104.3 114.1 33.4 19.2 168.3 109.5 324.9 35.2 30.0 109.3 81.9 33.3 14.6 66.0 70.9 61.3 14.3 20.5 103.3 36.9 134.6 83.6 133.9 74.0 13.6 26.0 91.6 115.4 238.1 80.9 114.3 86.6 103.2 20.6 114.2 268.2 49.4 12.1 26.9 81.8 25.7 68.1 19.1 88.9 29.2 94.2 51.1 180.8 374.7 68.1 160.9 166.2 83.9 28.0 121.2 68.5 31.7 44.3 27.4 72.4 WFDC10A "C20orf146, dJ688G8.3, WAP10" ENSG00000180305 "WAP four-disulfide core domain 10A" Q9H1F0 20 45629739-45631196 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 439 "epididymis: 290.6" "Cell type enhanced" "Detected in some" "Early spermatids: 1.1;granulocytes: 4.5;Late spermatids: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "thalamus: 1.9" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 290.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNPLA1 "dJ50J22.1, FLJ38755" ENSG00000180316 "Patatin like phospholipase domain containing 1" Q8N8W4 6 36243203-36313955 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 24.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.9;granulocytes: 4.5;Oligodendrocyte precursor cells: 1.5;Proximal enterocytes: 1.5;Proximal tubular cells: 3.8;Suprabasal keratinocytes: 3.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 69.8;eosinophil: 18.9" "Lineage enriched" "Detected in many" 17 "granulocytes: 69.8" "Cell line enriched" "Detected in some" 4 "U-937: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.57e-2)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-4)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (7.37e-2)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.95e-1)" "unprognostic (2.76e-2)" "unprognostic (2.70e-2)" "unprognostic (9.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.04e-2)" "unprognostic (1.65e-2)" 0.1 0.2 0.1 0.6 0.2 4.4 0.6 0.3 0.3 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 4.7 0.1 0.2 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.2 24.1 0.9 0.2 0.1 0.7 1.8 1.0 0.1 0.1 0.1 0.0 0.1 0.2 0.6 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 17.6 0.0 69.8 4.0 18.9 0.0 2.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.2 6.2 0.1 1.1 0.0 0.0 1.1 0.1 0.2 0.3 0.3 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.0 0.0 0.0 1.0 0.0 0.9 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.2 4.5 0.7 0.0 0.0 0.2 0.0 1.2 0.4 0.0 0.0 0.3 1.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 1.5 0.7 0.1 0.0 0.0 0.0 0.1 1.5 3.8 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 3.7 0.1 0.0 0.4 0.2 0.2 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280220-85301784 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.0;kidney: 3.0" "Cell type enriched" "Detected in some" 5 "Melanocytes: 32.0" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.8 0.4 0.0 0.0 0.7 4.0 0.0 2.3 0.0 0.0 0.2 0.2 3.0 0.0 0.0 0.0 0.1 0.1 0.1 1.7 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.2 1.9 0.9 0.0 1.6 0.0 0.3 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.8 0.0 0.4 0.3 0.1 0.0 6.0 0.0 0.0 0.7 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.6 0.0 10.4 0.5 0.0 0.0 23.3 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 9.3 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 2.7 5.8 0.0 0.0 29.5 4.1 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 2.2 0.2 1.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 CCDC43 FLJ31795 ENSG00000180329 "Coiled-coil domain containing 43" Q96MW1 17 44673069-44689779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023078, HPA023391" Enhanced Enhanced Cytosol NA NA Cytosol "HPA023078: , HPA023391: AB_1846146" "unprognostic (6.05e-2)" "unprognostic (8.91e-2)" "unprognostic (8.75e-3)" "unprognostic (3.58e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (3.42e-5)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.11e-1)" 9.6 10.3 10.5 11.5 11.4 21.0 12.6 12.6 14.4 9.4 9.2 12.2 11.8 10.1 11.0 12.1 9.3 7.6 20.6 11.4 11.0 14.4 9.5 9.8 13.6 10.5 10.4 10.2 8.2 9.7 15.5 4.8 14.1 11.3 12.1 15.1 18.6 9.0 9.0 74.2 11.4 9.8 10.8 10.9 9.9 11.3 9.6 11.3 13.9 13.6 43.0 14.7 11.9 8.2 11.6 24.9 29.3 27.2 24.1 18.2 26.7 49.8 37.1 21.8 35.7 34.9 39.7 26.0 43.1 28.0 30.4 25.5 19.2 45.3 42.9 51.5 53.1 52.5 38.8 48.8 59.0 32.5 54.8 28.0 24.1 42.7 37.2 50.2 24.4 35.1 34.8 41.6 29.3 36.6 31.0 53.7 38.8 28.2 23.5 37.1 34.5 68.2 37.6 36.7 16.0 27.3 26.9 27.2 21.6 39.5 40.7 55.2 36.6 30.6 43.9 32.5 26.6 50.0 29.5 40.1 49.4 32.1 31.4 32.2 11.6 15.7 11.0 11.9 18.4 11.0 9.1 11.3 13.7 17.5 11.3 11.0 12.0 3.2 16.4 12.5 12.4 15.1 10.2 10.5 11.4 12.6 14.4 11.4 11.0 10.5 10.4 10.2 11.3 10.9 11.3 11.6 24.4 12.8 21.0 6.8 19.1 13.3 10.8 20.0 13.1 24.4 15.2 15.7 41.1 17.2 21.5 9.2 10.4 41.1 13.4 10.7 39.2 21.6 0.9 23.4 27.1 23.9 18.0 15.4 10.5 24.5 46.7 17.1 13.7 24.0 32.4 19.9 20.0 15.5 30.6 21.9 8.2 17.1 8.2 18.8 16.0 3.5 14.0 19.2 21.4 1.0 24.6 19.6 9.2 6.6 6.5 21.0 12.4 12.8 26.9 12.9 15.0 36.8 19.8 25.4 6.6 23.4 17.5 3.6 12.4 24.8 11.2 25.3 16.7 22.6 22.6 8.7 KCTD4 bA321C24.3 ENSG00000180332 "Potassium channel tetramerization domain containing 4" Q8WVF5 13 45192853-45194717 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 24.4;choroid plexus: 9.1" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 2.6;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 9.5" "Group enriched" "Detected in some" 5 "glioma: 1.2;renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 20.7;hTERT-RPE1: 12.5;RPTEC TERT1: 11.8;U-138 MG: 13.9;U-87 MG: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040734 Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA040734: AB_10963227" "unprognostic (1.36e-1)" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.19e-2)" "unprognostic (1.70e-1)" "unprognostic (4.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-3)" "unprognostic (1.63e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" 0.0 0.0 20.7 0.0 24.4 0.1 0.5 8.3 17.2 0.1 9.1 0.9 0.2 0.0 0.0 0.0 0.0 0.7 0.2 16.4 12.1 0.2 0.0 0.0 0.0 11.1 10.5 15.4 0.0 0.2 0.0 1.8 0.2 10.7 0.0 0.2 0.0 0.5 0.1 0.0 3.1 0.5 0.7 10.8 0.0 0.0 0.0 12.3 0.0 0.0 0.2 0.0 0.0 0.1 14.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.0 0.2 0.0 0.0 0.0 0.5 0.6 20.7 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.7 12.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.9 0.0 0.0 3.1 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 24.4 8.3 17.2 16.4 12.1 11.1 10.5 15.4 10.7 10.8 12.3 14.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 10.1 9.5 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 MEIOC "C17orf104, FLJ35848" ENSG00000180336 "Meiosis specific with coiled-coil domain" A2RUB1 17 44656404-44690308 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 48.1" "Cell type enhanced" "Detected in some" "Early spermatids: 274.0;Late spermatids: 545.2;Spermatocytes: 242.4;Spermatogonia: 125.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 16.9;HMC-1: 25.4;NTERA-2: 8.7;SiHa: 9.5;SuSa: 12.0;THP-1: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA027266 Enhanced Uncertain "Cell Junctions" NA NA "Cell Junctions" "HPA027266: AB_1848900" "unprognostic (5.82e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.96e-2)" "unprognostic (9.12e-2)" "unprognostic (2.31e-1)" "unprognostic (2.13e-1)" "unprognostic (3.63e-2)" "unprognostic (8.89e-2)" "unprognostic (7.58e-2)" "unprognostic (6.83e-4)" "unprognostic (1.85e-1)" "unprognostic (6.24e-3)" "unprognostic (1.72e-1)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (8.89e-3)" 0.2 0.2 0.2 0.2 0.3 0.8 0.3 0.9 0.6 0.3 0.0 0.3 0.2 0.2 0.0 0.3 0.2 0.2 0.4 0.5 0.2 0.7 0.7 0.2 0.5 0.1 0.1 0.4 0.3 0.2 0.2 0.3 0.1 0.5 0.3 0.0 1.6 0.3 0.0 2.2 0.9 0.3 0.0 0.1 0.3 0.2 48.1 0.1 0.0 0.3 0.0 0.1 0.3 0.2 0.8 0.2 7.7 1.0 1.3 0.2 0.0 0.5 1.0 0.0 0.6 2.1 0.4 0.3 0.8 1.9 0.5 0.2 0.2 16.9 0.0 0.2 0.7 6.8 0.6 0.9 0.4 0.0 0.6 25.4 0.0 0.0 0.9 0.0 1.7 0.0 1.6 0.5 0.7 0.2 1.5 0.5 1.5 8.7 0.2 0.7 0.3 0.8 0.5 0.0 0.2 1.7 2.1 9.5 0.2 0.1 12.0 1.1 12.9 0.3 0.4 0.3 1.9 0.8 0.6 1.1 0.2 0.6 0.9 1.5 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.2 0.3 0.9 0.6 0.5 0.2 0.1 0.1 0.4 0.5 0.1 0.1 0.8 0.2 0.0 1.1 0.0 0.4 0.0 1.0 0.0 1.2 2.0 0.5 0.6 0.0 0.0 0.0 0.0 2.1 0.2 0.8 0.0 3.9 0.1 274.0 0.9 0.7 0.6 0.0 0.8 0.0 0.2 0.4 0.4 0.5 1.0 0.0 0.6 0.0 1.0 0.4 0.0 0.0 0.1 0.0 1.3 0.0 545.2 4.7 0.8 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.2 0.0 3.8 0.4 0.6 0.1 1.2 0.0 2.6 19.7 1.2 0.3 242.4 125.5 0.2 0.0 0.3 0.6 0.3 0.2 0.8 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557484-44561262 "Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.1;myeloid DC: 1.8" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;monocytes: 1.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 53.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: AB_2683497" "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.4 1.6 1.0 1.4 1.1 0.2 1.3 0.8 1.2 5.9 9.0 1.8 0.9 5.3 1.3 0.9 3.8 1.8 2.3 0.9 1.6 2.8 0.2 2.9 0.8 1.2 1.5 0.6 3.4 1.5 2.1 1.1 3.6 1.4 1.8 0.4 0.7 1.1 1.9 0.4 0.6 1.7 1.5 1.1 2.1 1.2 1.5 1.2 0.3 2.4 0.7 0.7 2.0 2.5 1.6 12.9 37.7 38.3 13.8 8.7 6.4 0.4 39.5 30.4 53.4 38.2 28.4 6.2 0.0 8.9 13.9 13.1 5.5 3.6 2.8 30.2 2.9 7.2 1.7 6.6 0.1 7.7 0.2 7.5 10.7 2.8 9.6 8.8 40.8 1.8 4.9 2.5 0.3 20.9 5.9 6.7 3.6 26.8 0.1 6.7 18.1 8.6 1.9 7.7 0.6 3.8 10.9 5.2 1.1 2.3 32.4 14.6 8.4 0.7 24.1 17.5 4.4 22.6 0.8 0.7 3.0 4.0 2.4 11.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.2 1.0 1.1 0.8 1.2 0.9 1.6 1.2 1.5 0.6 1.4 1.1 1.2 1.6 0.5 19.2 0.0 1.6 0.6 0.6 0.3 0.9 0.0 0.0 0.9 2.9 1.9 0.0 0.2 1.8 0.0 1.6 1.8 0.0 0.0 0.3 0.6 1.1 8.4 0.7 1.2 1.3 0.0 1.8 0.5 5.9 0.0 1.5 0.0 1.4 0.7 0.0 4.8 0.0 0.0 0.3 0.0 9.8 6.0 0.4 23.3 5.6 0.0 6.5 6.2 6.0 0.0 0.0 0.2 0.7 0.0 18.0 0.3 0.1 0.0 0.3 0.2 0.4 0.0 0.4 5.3 0.3 1.2 0.3 0.4 2.3 0.2 2.4 0.0 0.0 TIGD2 ENSG00000180346 "Tigger transposable element derived 2" Q4W5G0 4 89111533-89114901 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 25.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 15.9;Hepatocytes: 21.0;Syncytiotrophoblasts: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 11.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054844, HPA071168" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA054844: AB_2682623, HPA071168: AB_2686353" "unprognostic (7.11e-2)" "unprognostic (8.02e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.42e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (8.47e-2)" "unprognostic (4.96e-2)" "unprognostic (9.83e-3)" "unprognostic (1.16e-1)" "unprognostic (8.94e-3)" "unprognostic (2.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.02e-4)" 2.9 2.0 1.9 3.2 2.0 2.5 10.5 4.8 2.1 3.9 3.5 3.4 6.9 2.4 4.1 2.7 1.7 2.9 1.6 1.8 2.3 5.4 25.7 3.1 4.5 2.1 2.5 1.8 2.1 3.7 7.2 3.5 8.6 2.7 3.8 4.1 13.3 10.8 2.5 1.9 2.3 4.9 2.0 1.7 3.6 4.4 3.7 2.2 5.5 5.6 3.2 4.6 3.1 2.7 2.4 15.2 7.0 7.5 9.0 8.1 6.2 3.3 9.0 11.0 8.5 7.1 14.1 14.4 7.3 4.7 3.6 6.1 4.7 8.2 13.8 11.4 12.7 2.6 8.6 7.7 6.8 24.0 4.0 5.9 15.4 13.4 3.4 12.2 7.9 3.2 9.6 11.1 12.3 10.6 5.8 7.6 4.6 9.0 16.2 2.3 11.5 13.1 10.0 7.4 28.7 35.6 7.2 8.8 27.8 11.5 9.9 9.8 8.1 2.5 10.9 10.1 3.5 6.9 19.7 6.4 5.5 9.6 7.0 9.4 11.7 1.3 0.1 1.9 1.9 0.9 1.2 0.9 1.4 1.5 1.0 0.9 1.4 0.0 2.2 1.0 0.2 1.0 0.9 1.9 2.0 4.8 2.1 1.8 2.3 2.1 2.5 1.8 2.7 1.7 2.2 2.4 1.9 0.0 0.5 1.3 1.8 0.3 5.9 1.7 7.4 4.5 4.9 3.3 3.5 7.2 5.5 3.7 10.4 15.9 1.3 1.2 1.9 2.7 1.4 6.3 3.0 2.6 2.4 1.7 1.3 5.7 10.5 1.7 4.6 6.3 0.0 2.8 2.2 21.0 4.9 0.0 1.9 2.9 0.0 2.4 1.1 0.8 1.5 3.5 0.0 0.0 4.3 2.7 1.0 1.5 2.3 3.8 1.9 1.2 2.4 2.3 8.3 10.2 1.5 7.2 0.0 1.5 2.7 2.3 8.0 3.6 0.4 39.0 2.5 2.1 3.2 1.6 ITPRID1 "CCDC129, FLJ38344" ENSG00000180347 "ITPR interacting domain containing 1" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 15.7;salivary gland: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA024103 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 3.2 0.1 3.3 0.1 1.6 10.4 2.2 1.7 0.0 0.5 1.1 0.6 0.1 0.0 0.0 0.1 0.0 0.7 9.1 0.1 0.0 0.0 0.0 7.8 15.7 0.2 0.0 0.1 0.0 0.1 0.0 7.4 0.1 0.1 0.1 5.4 0.0 0.0 2.0 0.5 0.6 1.2 0.0 0.4 1.3 12.3 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 3.3 10.4 2.2 0.7 9.1 7.8 15.7 0.2 7.4 1.2 12.3 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HCLS1 "CTTNL, HS1" ENSG00000180353 "Hematopoietic cell-specific Lyn substrate 1" P14317 3 121631399-121660927 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 155.0;lymphoid tissue: 302.7" "Cell type enhanced" "Detected in many" "B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019143 Enhanced Supported "Plasma membrane,Cytosol" NA NA 870000 "Plasma membrane, Cytosol" "HPA019143: AB_1850532" "unprognostic (2.27e-2)" "unprognostic (1.79e-3)" "unprognostic (5.38e-3)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" "unprognostic (4.02e-3)" "unprognostic (2.35e-1)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "unprognostic (6.76e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-3)" "unprognostic (2.93e-1)" "unprognostic (3.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" 67.6 33.2 13.9 148.5 16.9 155.0 25.7 15.2 18.8 20.9 17.7 29.5 21.4 13.8 6.4 15.9 21.7 38.1 17.3 13.6 19.0 21.4 39.5 53.2 209.3 20.8 15.5 12.0 9.5 12.0 7.8 14.7 51.8 19.8 15.9 31.7 2.3 16.2 11.2 7.3 10.7 69.2 34.9 17.7 302.7 27.3 4.5 19.2 141.6 15.5 19.0 244.7 53.5 13.8 21.2 0.8 0.0 0.2 0.1 20.9 11.5 5.7 4.1 4.0 0.8 1.6 0.1 0.0 265.6 124.6 0.0 0.2 0.3 6.9 9.9 1.1 120.6 0.0 172.6 0.0 0.0 11.6 192.4 362.3 2.2 0.5 0.0 1.5 0.0 153.4 106.2 35.1 235.9 0.0 0.0 137.9 162.9 0.3 0.2 4.5 137.1 0.2 256.5 0.0 68.0 0.3 0.2 0.2 0.4 0.6 0.6 0.1 262.8 203.5 0.0 2.0 0.3 0.9 361.6 118.1 371.5 1.9 181.5 0.2 357.3 713.1 1180.9 405.3 870.4 333.0 345.7 334.2 376.8 636.2 313.1 279.3 326.2 1619.2 280.0 997.1 197.4 494.2 1427.9 13.9 16.9 15.2 18.8 13.6 19.0 20.8 15.5 12.0 19.8 17.7 19.2 21.2 23.0 9.6 31.8 1.0 175.7 3.2 1.0 7.8 0.6 0.5 2.7 5.1 2.3 4.3 13.1 0.0 0.0 122.4 139.5 0.8 0.0 0.3 1.1 8.8 1.6 23.3 0.0 50.5 1.4 0.2 60.0 7.0 8.6 3.1 73.4 0.7 27.8 7.7 126.9 0.0 0.7 0.4 4.1 666.3 105.8 1.5 3.4 269.0 19.6 26.2 245.7 0.4 216.3 0.5 0.3 0.2 0.2 1.2 148.6 0.4 0.1 0.9 24.7 0.8 13.1 3.7 6.7 0.6 0.6 1.3 4.4 145.4 181.4 2.4 0.5 2.2 MTURN "C7orf41, Ells1, FLJ25903" ENSG00000180354 "Maturin, neural progenitor differentiation regulator homolog" Q8N3F0 7 30134986-30162762 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 14 "brain: 1742.3;choroid plexus: 1008.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 156.5" "Cancer enhanced" "Detected in all" "glioma: 29.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 8.2" "Group enriched" "Detected in many" 5 "granulocytes: 8.2;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 52.9;HEL: 96.2;SCLC-21H: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029507 Enhanced Approved Cytosol NA NA Cytosol "HPA029507: AB_10601149" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (3.70e-1)" "unprognostic (7.14e-2)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-3)" "unprognostic (9.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.11e-3)" "unprognostic (8.11e-3)" "prognostic favorable (7.64e-13)" "unprognostic (9.50e-2)" "unprognostic (7.64e-2)" "unprognostic (4.64e-1)" "unprognostic (3.26e-1)" 89.2 10.9 1544.9 9.8 1547.2 23.5 41.9 1362.3 1637.8 25.9 1008.4 27.3 5.5 19.6 96.1 19.6 21.3 10.5 25.3 1215.5 1272.4 50.8 4.1 21.1 5.4 1621.5 1528.9 1121.9 33.7 13.0 15.8 17.5 7.6 1582.2 19.3 10.1 41.4 35.5 24.0 36.9 22.4 13.9 17.1 1586.6 8.4 26.6 11.0 1457.6 7.6 14.8 60.4 5.4 32.4 20.2 1742.3 12.5 2.1 7.1 7.6 52.9 35.9 6.4 6.0 7.0 2.0 2.8 1.0 5.0 0.7 4.8 13.3 11.0 2.4 16.4 23.6 6.4 5.4 13.2 96.2 16.1 6.7 4.1 4.8 30.8 17.9 10.8 6.2 10.9 8.6 3.2 13.1 6.4 5.0 13.8 4.8 5.6 2.3 4.9 11.6 7.5 0.5 16.3 21.4 24.1 5.1 68.7 18.2 3.8 19.1 19.4 6.6 13.5 7.1 15.5 7.8 8.5 16.6 8.5 8.3 12.7 1.1 10.4 10.3 4.0 8.2 0.3 3.6 0.3 0.2 0.1 0.5 0.2 0.1 0.4 0.3 0.1 0.3 2.2 2.1 0.0 1.0 0.7 1.4 1544.9 1547.2 1362.3 1637.8 1215.5 1272.4 1621.5 1528.9 1121.9 1582.2 1586.6 1457.6 1742.3 38.9 16.0 20.0 18.6 5.6 37.5 17.8 6.6 13.1 0.0 48.3 40.8 27.6 17.2 10.2 44.1 0.0 2.6 32.1 3.2 156.5 8.3 14.1 46.6 16.9 18.9 54.1 35.1 55.9 8.6 7.3 24.6 7.7 52.6 6.3 16.6 26.0 5.0 5.3 0.0 34.7 9.1 0.0 23.4 16.8 32.5 17.1 29.3 55.2 37.5 12.1 0.0 6.2 16.6 77.1 10.4 5.9 12.4 4.9 26.6 0.4 11.2 26.6 0.0 6.6 17.8 30.2 2.0 7.3 11.4 36.8 2.2 7.4 5.9 6.0 23.0 ZNF609 KIAA0295 ENSG00000180357 "Zinc finger protein 609" O15014 15 64460742-64686068 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 123.4;Cone photoreceptor cells: 141.8;Excitatory neurons: 142.1;Microglial cells: 139.6;Oligodendrocytes: 208.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040742, HPA040832" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040742: AB_10963581, HPA040832: AB_10960400" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (2.61e-1)" "unprognostic (3.11e-2)" "unprognostic (5.02e-2)" "unprognostic (7.21e-2)" "unprognostic (9.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" 9.2 8.3 11.6 8.4 10.2 5.6 8.6 11.9 9.7 11.3 7.9 10.4 8.8 12.1 4.5 7.9 12.0 7.3 7.5 11.6 8.3 6.8 7.2 11.0 8.8 11.3 10.6 6.2 20.7 7.2 14.2 8.4 12.0 9.7 10.4 7.9 20.7 9.8 9.6 7.2 9.5 8.7 11.2 7.8 9.8 8.3 22.2 9.9 18.2 9.1 10.0 8.4 11.4 10.9 11.0 11.1 27.6 29.1 11.2 11.0 13.8 9.9 14.2 18.8 17.5 17.5 17.1 17.2 19.0 11.7 16.9 23.9 23.2 43.1 19.6 18.2 22.2 9.2 34.7 16.0 8.4 20.2 20.2 22.3 14.1 17.6 18.3 35.8 25.3 32.8 15.9 55.6 12.0 14.5 10.1 15.7 8.5 22.1 14.8 7.7 14.3 26.5 10.0 12.7 19.7 23.6 18.0 19.5 21.9 13.1 27.7 10.9 14.0 33.0 16.2 25.8 8.4 17.9 13.3 16.1 16.6 10.1 21.6 13.4 1.3 0.4 0.6 0.5 0.1 0.3 0.2 0.3 0.4 0.1 0.2 0.8 0.8 0.5 1.1 0.2 0.5 0.2 0.2 11.6 10.2 11.9 9.7 11.6 8.3 11.3 10.6 6.2 9.7 7.8 9.9 11.0 14.6 12.8 25.4 123.4 8.8 18.0 16.2 10.5 8.0 35.8 12.6 11.8 20.1 24.3 20.3 18.4 141.8 19.1 13.9 12.2 3.9 13.8 22.6 42.2 21.9 18.4 18.6 11.1 142.1 14.6 14.7 13.6 13.7 16.1 10.1 19.4 18.9 14.6 10.0 45.4 116.5 11.9 4.1 30.5 18.3 12.7 18.0 16.4 14.2 139.6 19.1 17.3 19.6 108.6 208.0 13.2 13.5 13.9 10.5 22.9 9.9 3.9 33.8 54.9 19.7 14.4 16.9 48.3 17.0 9.3 17.3 31.2 17.0 20.8 11.2 20.1 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles NA NA 1700000 "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.36e-4)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 32.1 18.3 21.4 34.9 25.3 28.4 19.7 26.1 22.3 21.3 22.1 25.9 23.2 22.1 16.1 26.8 20.7 24.0 24.2 20.0 26.0 22.3 34.1 26.6 41.2 27.8 24.4 16.6 20.0 18.6 32.9 8.5 33.6 27.6 20.2 26.9 17.6 14.6 19.1 28.6 16.7 22.7 27.2 27.7 43.9 21.1 15.2 23.6 45.5 19.9 26.1 39.7 34.4 16.1 35.3 140.7 49.1 67.6 49.8 47.1 61.9 100.0 69.1 57.0 73.7 66.8 117.5 70.1 89.4 192.7 70.8 75.1 70.2 72.5 66.2 113.6 39.9 35.2 132.2 52.1 92.5 95.0 130.2 122.0 49.6 53.1 66.2 139.2 78.1 74.3 97.3 65.0 107.5 72.9 146.7 124.8 67.2 40.5 74.7 73.4 112.4 38.6 80.9 64.8 96.7 39.6 44.7 92.8 64.7 52.7 51.9 227.0 92.6 76.9 60.9 33.6 64.3 103.1 72.5 138.9 216.4 50.4 127.6 59.1 37.3 20.0 48.0 10.9 23.2 14.7 11.2 12.7 12.6 25.4 11.3 9.1 10.9 47.6 12.2 21.2 9.3 20.7 14.9 21.4 25.3 26.1 22.3 20.0 26.0 27.8 24.4 16.6 27.6 27.7 23.6 35.3 164.9 80.1 40.2 37.9 142.8 97.4 89.2 41.8 96.2 42.6 59.7 47.5 59.3 62.9 45.1 82.8 52.1 50.3 135.1 69.6 33.2 71.5 57.1 107.9 112.6 104.0 44.9 72.3 32.2 59.0 101.4 68.9 58.1 96.1 148.8 70.9 66.0 138.6 104.3 55.5 38.9 46.4 57.0 160.5 115.9 75.5 60.9 169.6 33.8 46.9 183.2 63.7 140.1 37.2 61.3 100.4 52.1 45.5 100.0 149.4 58.2 85.2 76.4 45.0 39.5 86.0 75.9 24.5 43.0 103.2 86.2 34.9 139.1 96.3 51.0 124.1 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621837 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" Yes No "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 2.7 3.2 3.4 3.6 3.4 3.0 5.2 3.5 4.4 4.8 3.8 3.6 3.0 4.2 5.4 2.5 5.8 3.4 3.0 3.5 3.5 4.0 2.0 3.6 5.0 3.6 3.5 2.8 6.1 3.3 5.4 4.5 3.3 3.7 4.0 4.1 7.9 3.3 3.6 4.6 2.6 2.8 4.9 3.7 4.3 3.3 3.7 3.4 5.2 5.0 2.6 4.9 3.7 3.1 3.6 5.6 2.0 5.8 3.7 8.9 5.2 4.6 6.8 6.4 9.1 7.8 4.3 4.3 15.6 1.6 3.8 5.8 2.8 3.4 6.5 10.1 5.6 4.0 9.5 9.0 4.6 6.2 12.8 3.3 4.9 8.8 7.7 5.1 8.0 6.0 7.7 9.3 2.4 7.2 4.7 10.0 7.5 9.7 4.8 7.5 3.4 5.2 8.6 5.3 1.9 2.2 4.2 8.7 5.5 5.2 4.9 1.9 5.2 3.1 6.6 5.2 6.3 9.9 4.7 5.3 8.0 4.9 14.3 5.5 10.0 1.5 3.5 4.1 2.0 5.4 2.7 7.0 5.0 1.1 1.6 8.0 5.8 0.3 5.1 2.4 1.0 14.8 2.6 3.4 3.4 3.5 4.4 3.5 3.5 3.6 3.5 2.8 3.7 3.7 3.4 3.6 39.7 22.4 22.6 42.7 41.3 28.2 20.1 30.5 15.9 68.5 18.5 21.0 30.5 30.0 29.0 22.0 108.4 23.0 51.5 7.7 29.4 23.7 202.5 58.1 33.5 28.8 21.0 40.8 93.2 10.5 14.6 29.9 18.8 13.9 34.2 38.3 37.9 8.5 18.4 52.2 95.8 11.4 22.4 35.8 27.9 109.6 54.0 20.7 26.6 51.5 56.1 36.8 105.0 70.9 96.7 14.1 9.8 47.8 28.1 25.5 11.5 20.3 51.5 111.5 32.9 38.6 30.9 55.8 46.8 12.1 29.5 16.4 51.7 33.6 14.5 11.4 DEFB124 DEFB-24 ENSG00000180383 "Defensin beta 124" Q8NES8 20 31465506-31476757 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 6.0;testis: 7.2" "Cell type enhanced" "Detected in some" "Club cells: 1.3;Endometrial stromal cells: 6.4;Respiratory ciliated cells: 4.0;Smooth muscle cells: 2.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.7;HMC-1: 1.5;U-2 OS: 1.1;WM-115: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.24e-2)" "unprognostic (9.76e-3)" "unprognostic (1.27e-1)" "unprognostic (3.23e-3)" "unprognostic (6.92e-3)" "unprognostic (3.69e-2)" "unprognostic (3.37e-2)" "unprognostic (1.78e-1)" "unprognostic (9.07e-2)" "unprognostic (4.43e-1)" "unprognostic (3.32e-7)" "unprognostic (1.56e-2)" "unprognostic (1.29e-1)" "unprognostic (4.42e-2)" "unprognostic (4.28e-1)" 2.6 0.4 0.1 0.2 0.0 0.0 1.7 0.0 1.5 3.3 1.3 1.7 0.0 3.2 2.7 0.6 6.0 0.0 0.8 0.1 0.4 0.3 0.1 0.7 0.5 0.2 0.1 0.1 0.6 0.2 0.8 1.0 0.1 0.1 1.2 0.6 0.0 0.7 3.0 1.1 0.4 0.9 0.5 0.0 0.8 0.8 7.2 0.1 0.2 1.0 0.8 0.5 1.4 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 6.4 0.2 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 2.1 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KRTAP9-7 "KAP9.7, KRTAP9L1" ENSG00000180386 "Keratin associated protein 9-7" A8MTY7 17 41275659-41276697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 53 "skin 1: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 2900000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCFD2 "F5F8D, LMAN1IP, SDNSF" ENSG00000180398 "Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit" Q8NI22 2 46901870-46941855 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 253.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022410, HPA034593" Supported "Intracellular and membrane" NA NA 1200000 "CAB022410: , HPA034593: AB_2674239" "unprognostic (1.16e-2)" "unprognostic (5.71e-3)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (2.87e-2)" "unprognostic (3.98e-2)" "unprognostic (3.10e-2)" "unprognostic (3.93e-2)" "unprognostic (8.32e-2)" "unprognostic (1.56e-3)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.64e-4)" 52.5 157.0 40.2 35.9 44.1 35.0 55.7 38.9 40.6 50.8 61.5 28.6 32.8 55.0 42.4 46.3 42.3 45.3 42.7 41.1 42.4 59.9 112.7 45.4 32.3 35.7 37.5 40.7 79.9 105.0 53.0 39.0 70.7 36.1 54.5 27.2 84.0 150.9 83.7 84.0 26.2 33.7 52.9 26.6 45.0 34.2 31.2 44.1 31.1 122.1 85.3 34.5 41.6 29.4 38.0 147.7 86.9 74.7 59.7 151.5 215.1 115.4 248.4 254.1 129.4 116.8 116.9 109.4 96.4 297.7 294.7 154.3 81.8 67.0 127.0 207.7 64.5 67.2 101.9 87.1 182.5 236.5 94.8 158.6 163.2 77.8 206.7 178.7 247.9 210.8 28.0 199.3 56.0 266.8 48.7 56.9 67.6 63.9 102.3 84.1 68.3 133.2 106.7 80.3 59.3 23.9 62.2 93.1 46.9 116.0 86.3 33.1 80.6 341.1 298.3 130.5 97.0 164.2 42.0 43.8 76.4 320.2 88.0 100.8 27.2 21.4 29.7 9.6 23.3 12.2 12.5 10.9 10.2 18.4 12.8 14.3 9.8 12.0 9.9 18.3 16.9 9.7 14.0 40.2 44.1 38.9 40.6 41.1 42.4 35.7 37.5 40.7 36.1 26.6 44.1 38.0 50.8 105.8 89.1 16.6 29.6 48.2 56.5 65.3 36.5 69.3 64.4 48.5 70.3 38.6 68.8 47.8 39.6 75.5 25.4 26.6 21.5 88.6 144.3 76.4 60.2 64.7 26.8 28.2 19.6 178.5 64.5 70.1 20.4 69.9 50.5 44.1 53.9 155.1 54.5 38.7 23.8 28.5 18.3 40.5 31.3 113.7 62.7 39.2 12.4 7.5 33.8 253.2 12.3 16.1 16.2 152.7 23.1 59.5 43.8 82.4 42.2 41.3 69.6 51.3 65.7 63.9 55.4 48.9 32.6 39.6 44.9 102.1 23.4 74.3 22.8 75.8 HARBI1 "C11orf77, FLJ32675" ENSG00000180423 "Harbinger transposase derived 1" Q96MB7 11 46602861-46617909 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 70.9;Late spermatids: 73.0;Spermatocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038671, HPA045457" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038671: AB_10675947, HPA045457: AB_2679332" "unprognostic (1.29e-1)" "unprognostic (6.82e-2)" "unprognostic (7.76e-2)" "unprognostic (2.65e-1)" "unprognostic (1.61e-1)" "unprognostic (3.95e-1)" "unprognostic (1.23e-5)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (9.58e-2)" "unprognostic (3.15e-1)" "unprognostic (6.34e-2)" "unprognostic (6.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (5.01e-2)" "unprognostic (1.13e-1)" 2.1 2.6 2.6 2.4 4.2 5.7 2.4 3.2 3.8 2.4 2.2 3.0 2.7 1.7 3.4 2.4 2.1 2.0 2.5 2.5 3.1 3.0 3.3 2.2 3.4 3.6 3.4 2.5 1.4 2.4 2.2 2.5 2.8 4.1 2.3 3.4 2.7 2.8 1.9 2.6 3.2 2.8 3.0 2.8 2.4 4.0 12.2 3.6 4.3 2.7 2.0 3.5 2.7 1.5 7.2 3.3 5.3 4.3 4.1 8.4 5.1 5.1 4.7 4.5 6.3 8.0 3.7 3.7 5.8 2.9 3.9 7.1 6.3 4.6 4.1 5.9 6.7 5.5 5.9 3.9 4.2 9.8 5.5 7.6 6.5 10.7 4.2 8.2 2.4 4.0 6.2 9.4 7.0 5.3 7.1 6.8 2.3 11.8 10.8 6.4 4.5 6.1 10.3 4.8 3.9 4.1 3.4 5.6 5.9 6.8 5.7 9.9 4.7 3.8 6.3 4.9 8.4 4.3 6.6 7.7 6.3 4.8 3.2 6.6 21.9 7.6 10.9 9.6 10.3 6.7 4.7 7.6 7.0 6.4 6.6 7.2 8.0 11.2 6.9 9.8 8.3 10.2 4.4 2.6 4.2 3.2 3.8 2.5 3.1 3.6 3.4 2.5 4.1 2.8 3.6 7.2 1.0 0.0 1.3 1.3 2.2 1.0 2.7 4.0 1.8 3.5 2.5 1.8 2.3 1.5 4.4 0.0 2.1 4.9 1.5 2.1 5.9 4.1 70.9 4.7 2.2 1.4 1.2 13.5 1.5 2.2 3.4 1.7 2.0 4.7 0.0 1.6 1.8 2.8 3.3 3.3 1.5 2.2 8.2 3.3 0.8 73.0 3.1 1.7 1.8 0.0 4.2 2.9 1.0 0.5 4.6 3.0 0.8 1.9 3.4 1.6 3.4 3.5 6.1 3.7 0.0 2.1 2.0 25.2 13.5 1.7 2.7 9.3 2.2 2.2 1.7 2.3 DEFB123 DEFB-23 ENSG00000180424 "Defensin beta 123" Q8N688 20 31440632-31450257 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 370 "epididymis: 160.2;testis: 149.5" "Group enriched" "Detected in some" 4 "Early spermatids: 14.0;Late spermatids: 50.4" "Cancer enriched" "Detected in single" 17 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (9.16e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 149.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 50.4 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 5.2 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 140.1" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 5.4 10.7 12.5 5.1 13.8 3.8 7.7 12.7 13.9 5.5 11.2 6.9 7.7 5.1 22.8 4.3 7.2 4.4 8.4 12.1 14.9 14.0 22.3 6.0 6.7 14.4 13.7 12.3 7.2 8.8 9.0 13.5 3.7 13.8 8.6 6.3 16.1 9.9 5.8 15.2 8.9 7.6 2.9 12.2 9.4 7.4 140.1 13.1 9.0 12.5 15.3 4.8 4.6 4.1 16.5 1.2 3.9 4.2 13.6 6.2 3.6 2.9 0.6 1.7 1.7 1.5 3.0 23.6 6.8 7.8 1.0 8.1 6.3 2.8 2.9 2.1 7.5 1.6 5.1 3.2 6.9 5.9 3.0 5.5 5.9 3.2 2.2 6.7 1.9 2.1 10.8 5.1 6.0 3.2 5.5 5.5 4.6 2.2 5.5 2.5 3.9 3.4 17.3 3.8 3.0 11.6 4.6 15.3 1.8 2.4 4.4 11.5 1.6 2.1 0.4 5.9 4.6 1.2 5.8 10.1 5.2 0.9 6.9 1.7 15.9 15.4 10.3 8.8 9.8 5.5 5.9 5.7 6.0 9.3 8.3 9.5 9.9 12.3 12.1 11.9 12.0 7.1 10.1 12.5 13.8 12.7 13.9 12.1 14.9 14.4 13.7 12.3 13.8 12.2 13.1 16.5 12.7 3.2 13.4 5.2 8.0 2.7 15.7 6.3 8.6 10.3 18.3 15.9 19.0 0.0 6.2 5.5 4.2 16.1 6.4 15.0 82.2 15.7 589.6 21.2 8.1 8.7 18.1 7.2 4.7 18.9 3.4 9.5 18.8 12.8 6.3 14.1 0.0 0.0 11.5 13.5 5.6 16.7 10.2 0.0 4.1 2360.8 13.1 13.6 5.4 2.8 11.2 31.5 7.2 4.0 18.5 10.5 15.5 9.1 17.2 9.2 33.0 78.6 18.9 14.1 6.6 7.6 8.0 70.6 9.9 10.4 2.6 14.6 7.4 19.6 12.7 11.4 CYP8B1 CYP12 ENSG00000180432 "Cytochrome P450 family 8 subfamily B member 1" Q9UNU6 3 42856005-42875898 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "liver: 407.9" "Cell type enriched" "Detected in some" 76 "Hepatocytes: 920.2" "Cancer enriched" "Detected in some" 46 "liver cancer: 69.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;SK-BR-3: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.58e-2)" "unprognostic (5.41e-2)" "unprognostic (6.38e-2)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (1.42e-3)" "unprognostic (4.47e-3)" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (4.04e-3)" "unprognostic (5.86e-3)" "unprognostic (2.74e-1)" "unprognostic (3.37e-1)" "unprognostic (1.03e-1)" "unprognostic (3.63e-1)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" 0.3 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.9 0.2 0.1 0.5 0.1 0.3 0.1 14.6 407.9 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.9 920.2 0.1 0.0 0.0 0.0 0.0 10.7 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 OR6K6 ENSG00000180433 "Olfactory receptor family 6 subfamily K member 6" Q8NGW6 1 158754720-158755891 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 38 "basophil: 3.7" "Lineage enriched" "Detected in single" 38 "granulocytes: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36674020-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 24.1;fallopian tube: 35.6" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 9.6;Bipolar cells: 17.9;Endometrial ciliated cells: 5.7;Excitatory neurons: 10.8;Granulosa cells: 14.2;Inhibitory neurons: 17.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 1.2;HEK 293: 1.4;NTERA-2: 3.6;SH-SY5Y: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Enhanced Vesicles NA NA Vesicles "HPA054814: AB_2682611, HPA070485: AB_2686272" "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 2.9 1.3 7.9 0.0 6.9 0.0 0.7 0.2 9.0 12.2 0.2 0.2 0.1 24.1 0.7 0.0 35.6 0.0 0.2 17.1 2.9 0.1 0.0 5.5 0.0 0.2 3.5 5.5 6.5 0.3 1.3 11.6 0.0 2.3 0.9 0.0 3.3 0.0 0.6 0.0 0.1 0.0 17.2 0.0 0.0 0.4 0.3 0.4 0.0 9.3 0.0 0.0 0.3 6.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 6.9 0.2 9.0 17.1 2.9 0.2 3.5 5.5 2.3 0.0 0.4 2.8 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.0 0.0 0.0 10.8 0.0 0.0 1.3 0.0 0.6 0.0 14.2 0.0 0.0 0.0 1.7 17.9 0.0 0.0 0.0 0.4 0.0 0.3 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAS1 ENSG00000180447 "Growth arrest specific 1" P54826 9 86944362-86947506 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 106.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 127.1;Muller glia cells: 90.3;Skeletal myocytes: 213.7" "Cancer enhanced" "Detected in all" "ovarian cancer: 30.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 44.2;ASC diff: 29.3;BJ hTERT+: 59.8;HSkMC: 41.1;RH-30: 91.1" "Low region specificity" "Detected in all" "CAB024164, HPA036085, HPA066902" Approved Approved "Nuclear speckles" NA NA 27000 "Nuclear speckles" "CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.97e-2)" "unprognostic (6.15e-2)" "unprognostic (2.84e-2)" "unprognostic (6.46e-2)" "unprognostic (6.91e-2)" "unprognostic (3.32e-1)" "unprognostic (1.28e-3)" "unprognostic (2.25e-3)" "unprognostic (4.30e-2)" "prognostic unfavorable (1.96e-5)" "prognostic unfavorable (8.26e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.13e-5)" "unprognostic (3.59e-2)" 52.2 6.4 4.0 16.7 4.4 0.2 38.6 3.8 4.4 26.2 13.7 21.0 2.2 106.3 15.3 5.9 61.3 10.5 20.5 3.4 3.3 12.3 2.2 7.9 6.9 4.0 4.0 3.1 45.5 11.2 1.9 8.5 22.3 4.2 22.8 2.3 3.4 13.2 9.7 12.3 21.6 9.4 43.8 3.7 3.7 16.4 1.8 4.0 7.2 16.1 9.3 3.1 22.7 27.4 7.1 0.0 0.0 7.5 44.2 29.3 10.9 0.8 8.8 59.8 2.9 2.6 0.0 0.1 0.0 0.5 15.8 0.3 0.6 0.0 0.3 1.2 5.2 17.8 0.0 25.0 0.0 14.9 0.1 0.7 41.1 6.3 1.0 5.3 0.0 0.0 0.9 0.0 0.0 12.6 0.0 0.0 0.4 9.5 0.3 0.1 9.6 91.1 0.0 0.4 0.0 1.0 4.0 12.9 0.0 14.1 4.8 0.1 0.2 0.1 13.0 3.6 0.9 3.0 0.0 0.0 0.0 0.4 0.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.4 3.8 4.4 3.4 3.3 4.0 4.0 3.1 4.2 3.7 4.0 7.1 15.8 0.0 0.6 2.0 0.4 25.9 7.5 10.9 10.2 8.3 3.9 28.3 5.5 0.0 3.1 14.7 10.4 21.5 7.8 0.1 9.8 0.5 0.1 2.4 36.6 5.6 0.0 0.4 1.2 0.4 3.7 127.1 1.1 2.0 0.0 2.1 22.9 0.3 5.8 5.0 2.6 0.3 0.0 1.0 15.4 0.9 32.3 2.2 17.8 1.9 0.2 90.3 7.2 8.5 4.4 0.2 0.0 12.4 2.1 4.5 0.0 2.6 0.7 3.2 39.5 213.7 15.4 0.3 1.3 1.0 12.5 4.5 2.1 0.8 0.2 0.4 ARHGAP45 "HA-1, HMHA1, KIAA0223" ENSG00000180448 "Rho GTPase activating protein 45" Q92619 19 1065923-1086628 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 68.9;intestine: 53.6;lung: 39.8;lymphoid tissue: 106.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019816, HPA079252" Enhanced Supported "Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" "HPA019816: AB_1853923, HPA079252: " "unprognostic (1.34e-1)" "unprognostic (5.13e-3)" "unprognostic (5.17e-3)" "prognostic favorable (6.02e-4)" "unprognostic (2.26e-1)" "prognostic favorable (7.82e-4)" "unprognostic (1.59e-2)" "unprognostic (2.17e-2)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-2)" "unprognostic (1.00e-1)" "unprognostic (4.59e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (5.33e-2)" 9.8 5.5 2.8 43.5 3.7 68.9 5.6 4.5 6.9 4.0 7.9 8.8 7.3 3.6 0.5 5.6 6.7 5.0 3.8 2.9 7.0 7.7 7.4 39.8 58.9 8.4 4.7 1.0 2.1 2.7 0.8 4.5 6.0 6.3 6.0 2.6 8.8 6.4 1.5 2.1 3.9 53.6 2.2 8.5 106.9 11.0 3.5 6.5 33.2 9.1 0.8 18.8 6.7 5.6 7.4 11.2 2.1 0.1 12.1 0.0 0.0 27.8 0.1 0.0 0.0 0.0 29.2 13.9 73.7 3.0 0.0 0.4 9.6 2.1 0.6 0.0 54.7 1.0 10.1 22.6 3.5 0.4 48.6 56.2 0.0 2.9 0.1 0.0 0.0 0.1 46.8 6.8 100.4 0.0 0.6 54.5 43.4 7.6 1.9 5.4 52.0 0.3 74.7 0.0 0.2 0.6 0.2 16.8 0.0 4.5 0.7 3.5 92.3 4.8 0.2 1.9 0.2 0.3 130.8 60.2 58.8 0.3 72.1 5.4 6.7 24.4 25.3 45.7 21.2 38.8 15.9 52.2 54.1 22.5 18.3 68.9 53.6 37.0 28.0 20.9 13.3 43.5 59.8 2.8 3.7 4.5 6.9 2.9 7.0 8.4 4.7 1.0 6.3 8.5 6.5 7.4 2.0 48.1 8.4 0.0 17.8 0.0 0.0 0.0 0.0 0.0 15.2 11.0 0.0 0.0 1.8 11.0 0.0 40.1 62.7 0.0 0.0 2.6 0.0 4.5 0.7 1.6 0.0 0.0 0.0 3.8 56.6 1.3 0.0 3.5 3.8 0.2 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 15.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 75.5 30.2 0.1 0.0 0.0 OR10Q1 ENSG00000180475 "Olfactory receptor family 10 subfamily Q member 1" Q8NGQ4 11 58227882-58228918 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046968 Uncertain NA NA "HPA046968: AB_2679881" "unprognostic (4.82e-1)" "unprognostic (6.34e-2)" "unprognostic (4.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594792 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 78.2" "Cell type enhanced" "Detected in many" "Early spermatids: 20.9;Oligodendrocytes: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 4.1 7.6 10.1 3.6 9.7 8.5 14.7 9.8 11.2 6.5 7.3 3.1 2.2 6.2 10.0 4.2 6.8 5.1 4.2 8.5 6.8 7.4 3.6 3.9 5.6 9.5 6.8 7.3 8.4 3.2 12.0 8.9 5.5 8.2 8.1 3.5 29.1 3.3 4.7 4.2 8.5 2.9 4.8 4.7 5.5 3.9 10.7 7.8 6.2 78.2 3.9 6.0 4.5 4.0 10.9 2.5 1.4 8.6 12.5 6.3 6.4 2.8 3.8 6.0 8.9 11.0 2.7 2.4 13.6 11.6 3.9 6.3 3.3 2.8 4.1 14.8 3.0 10.9 7.3 4.4 1.6 7.2 2.7 7.9 3.5 7.2 8.6 7.8 6.3 1.8 12.1 3.5 1.1 7.3 2.4 13.8 3.0 21.7 4.0 4.8 6.8 4.1 7.2 12.4 16.3 18.5 12.9 8.9 2.9 4.5 17.1 13.3 1.9 1.1 4.1 5.2 4.5 9.8 10.5 23.4 18.5 0.6 1.2 9.1 1.6 0.7 4.4 5.2 1.2 4.8 7.6 5.0 5.3 2.3 7.7 6.0 6.6 1.2 3.2 1.1 3.5 3.8 2.7 10.1 9.7 9.8 11.2 8.5 6.8 9.5 6.8 7.3 8.2 4.7 7.8 10.9 5.5 0.0 2.0 5.2 6.6 1.8 1.2 1.9 5.2 9.5 3.5 3.2 1.6 1.5 4.6 5.5 10.4 2.4 11.9 0.8 3.9 2.3 20.9 3.1 3.1 6.0 1.2 4.8 8.6 1.6 1.8 3.1 2.0 2.4 15.2 5.1 4.6 0.8 1.7 13.5 9.7 1.9 6.1 1.3 2.1 4.3 4.4 1.7 5.4 5.6 0.6 4.9 5.2 17.1 23.9 1.0 1.0 2.6 3.5 1.9 1.1 2.8 4.0 16.0 13.1 4.9 4.2 10.3 6.2 2.9 2.6 1.2 8.7 4.1 1.7 0.5 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391089-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 47.2" "Group enriched" "Detected in many" 7 "Early spermatids: 254.0;Spermatocytes: 306.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.0 2.7 5.3 0.8 5.4 0.3 2.4 6.6 6.1 1.9 2.7 0.7 0.6 2.3 3.7 1.0 3.1 1.0 2.3 5.5 5.0 2.0 1.5 1.2 0.7 4.6 4.9 5.1 7.1 2.6 4.1 2.6 0.9 5.3 1.5 0.4 3.0 1.0 3.0 2.3 1.9 0.8 1.1 4.0 1.6 0.7 47.2 4.7 1.3 2.4 1.6 0.4 0.9 0.9 6.5 0.2 0.4 0.2 0.4 2.9 1.6 0.5 0.4 0.3 0.1 0.2 0.1 0.3 0.2 1.0 0.3 0.7 0.1 0.0 0.1 0.3 0.6 0.2 0.1 0.6 4.2 2.1 0.4 0.0 0.5 0.9 0.4 1.5 2.5 0.1 0.1 0.2 0.5 0.8 0.1 0.4 0.3 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 0.7 0.3 0.5 5.6 1.7 0.2 1.7 0.1 0.8 0.6 7.6 0.9 0.3 0.7 0.7 0.2 0.2 0.2 0.5 0.7 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.5 0.1 0.3 0.5 0.9 0.6 0.3 0.1 0.7 1.0 0.2 5.3 5.4 6.6 6.1 5.5 5.0 4.6 4.9 5.1 5.3 4.0 4.7 6.5 1.5 0.0 3.1 15.0 0.3 0.9 4.6 1.7 3.4 5.6 2.9 3.0 4.0 1.5 1.8 0.0 0.0 1.7 1.5 0.1 9.8 0.6 254.0 4.9 1.4 1.5 0.0 0.4 7.4 0.0 0.2 3.0 1.1 0.5 1.3 1.4 0.0 0.2 0.6 1.7 13.3 0.1 0.0 0.3 0.3 39.0 7.5 0.7 0.0 10.3 0.0 6.7 0.0 27.2 28.1 0.1 0.0 5.7 0.1 1.2 0.1 1.4 14.1 2.0 6.6 5.6 1.9 306.8 19.4 0.3 0.4 0.4 0.6 2.1 0.3 2.1 DEFB119 "DEFB-19, DEFB-20, DEFB120" ENSG00000180483 "Defensin beta 119" Q8N690 20 31377164-31390590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "epididymis: 1942.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 42.6;Cone photoreceptor cells: 39.6;Early spermatids: 61.9;Late spermatids: 99.8;Rod photoreceptor cells: 150.2" "Cancer enriched" "Detected in single" 67 "testis cancer: 3.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.5" HPA043059 Supported "Secreted in male reproductive system" NA NA "HPA043059: AB_10797025" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1942.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 157.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 334.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.1 0.0 0.0 0.0 0.0 99.8 12.5 0.8 0.0 0.0 0.0 22.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 150.2 13.1 0.0 0.0 17.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 33.2;Alveolar cells type 1: 35.3;Breast glandular cells: 28.1;Glandular and luminal cells: 29.1;Proximal tubular cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria NA NA Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 8.9 8.0 6.3 5.4 10.4 6.9 14.3 8.0 9.9 7.2 0.5 6.3 7.4 8.9 5.2 6.3 6.5 7.7 6.6 7.2 10.3 15.0 8.6 6.2 5.4 10.6 9.7 6.9 9.1 6.2 19.0 3.4 7.7 12.7 9.7 5.8 5.7 9.2 6.7 7.2 4.6 8.2 7.4 9.8 6.0 7.5 5.3 9.0 4.6 16.6 9.5 4.2 6.1 3.6 20.1 11.8 7.5 4.6 5.9 11.1 14.3 12.1 16.7 7.8 9.6 9.8 7.7 8.0 5.1 18.0 11.5 11.6 7.9 6.3 9.9 18.0 7.4 6.4 6.0 8.9 3.9 11.4 5.6 4.5 10.4 10.5 19.7 14.2 13.8 9.8 4.5 3.4 6.7 14.8 1.9 5.5 3.2 3.9 5.8 9.2 2.9 11.3 2.6 11.6 12.5 9.2 7.4 7.7 11.4 21.8 7.6 4.4 3.6 15.8 13.7 6.3 20.9 17.6 4.0 6.0 3.2 12.1 4.8 6.0 3.7 2.2 2.7 2.1 2.7 2.2 1.7 1.6 1.7 1.5 2.1 2.4 2.1 1.2 2.4 1.7 1.1 1.7 1.2 6.3 10.4 8.0 9.9 7.2 10.3 10.6 9.7 6.9 12.7 9.8 9.0 20.1 33.2 35.3 26.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 28.1 20.6 0.0 0.0 10.5 23.9 0.0 17.0 16.5 0.0 5.9 16.4 0.0 15.6 27.0 9.9 0.0 0.0 0.0 14.7 14.0 12.9 0.0 29.1 12.6 18.8 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 18.9 0.0 0.0 5.5 0.0 0.0 31.2 8.7 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 13.3 7.5 16.2 0.0 0.0 KCNE1 "IsK, JLNS2, LQT5, minK" ENSG00000180509 "Potassium voltage-gated channel subfamily E regulatory subunit 1" P15382 21 34446688-34512210 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 10.8;fallopian tube: 10.1;heart muscle: 5.5" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 25.0;Endometrial ciliated cells: 23.8;Kupffer cells: 34.6;Macrophages: 20.3;Respiratory ciliated cells: 54.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "eosinophil: 1.9" "Lineage enhanced" "Detected in single" "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.3;CACO-2: 4.0;HBF TERT88: 1.0" "Not detected" "Not detected" NA NA "unprognostic (8.24e-3)" "unprognostic (9.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-2)" "unprognostic (2.45e-2)" "unprognostic (1.47e-2)" "unprognostic (2.58e-1)" "unprognostic (2.06e-1)" "unprognostic (9.30e-2)" "unprognostic (7.90e-3)" "unprognostic (1.41e-2)" "unprognostic (3.27e-2)" "unprognostic (2.34e-2)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" 0.4 0.1 0.7 0.3 0.3 0.5 0.9 0.3 0.8 0.7 10.8 0.1 0.0 0.3 0.2 0.2 10.1 0.0 5.5 0.5 0.5 1.7 1.1 1.6 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.3 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.2 1.6 1.0 0.2 1.5 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.3 0.4 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.3 0.8 0.5 0.5 0.9 1.1 0.0 0.5 1.6 0.7 0.3 0.8 3.2 1.8 0.0 0.6 0.8 0.8 3.3 0.0 1.9 1.0 2.0 6.4 0.0 2.8 0.0 25.0 0.0 0.3 0.8 0.0 0.7 4.8 23.8 0.6 1.9 0.0 2.7 1.4 0.4 0.4 1.2 0.5 4.6 0.0 0.0 1.4 7.3 3.7 0.0 1.6 0.0 2.0 34.6 1.2 2.2 0.3 20.3 0.0 1.9 4.5 0.1 0.0 1.5 2.2 0.5 0.1 0.0 0.1 0.4 0.9 0.2 54.2 1.9 0.0 2.1 1.4 0.9 0.1 0.2 0.3 0.0 0.6 0.0 0.1 1.0 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 30.7 10.3 6.1 10.2 5.5 26.6 14.3 15.4 8.3 24.9 6.8 18.4 16.9 18.3 13.5 9.5 21.6 10.4 5.5 6.6 22.7 16.1 27.1 9.0 8.7 5.7 6.1 4.2 13.4 14.5 7.5 3.3 14.7 6.7 10.4 18.3 32.0 6.2 8.4 22.5 4.2 18.4 20.2 9.0 13.2 8.9 8.2 6.0 17.2 5.7 24.0 7.2 14.2 8.5 9.0 22.1 43.5 34.6 0.0 17.4 11.3 12.6 26.1 11.7 16.0 12.5 8.7 17.3 0.1 14.5 23.3 7.9 11.0 2.2 15.6 33.9 0.0 10.0 33.4 15.3 27.2 10.5 16.7 6.7 14.1 21.3 17.6 20.5 17.8 12.6 4.8 24.1 17.4 11.4 11.8 7.8 0.1 14.5 8.8 13.9 92.4 28.0 0.8 9.8 35.8 3.2 0.1 21.7 11.3 8.8 27.7 27.2 12.9 22.0 13.7 9.1 21.4 10.8 8.5 0.2 0.1 29.0 0.0 6.8 0.0 0.4 0.2 0.3 0.2 1.8 0.3 0.3 0.4 0.6 1.0 0.5 0.2 0.1 0.5 0.5 0.6 0.2 0.2 6.1 5.5 15.4 8.3 6.6 22.7 5.7 6.1 4.2 6.7 9.0 6.0 9.0 33.2 48.1 37.6 60.7 27.4 18.6 122.6 16.2 22.8 33.9 52.9 26.8 18.3 21.5 40.9 29.5 50.1 16.4 20.7 50.1 9.8 23.0 15.8 60.9 99.1 43.0 37.7 24.2 123.7 27.6 120.8 42.3 26.5 130.9 31.5 94.0 27.1 44.7 45.7 21.9 95.0 41.6 18.3 50.4 21.9 19.3 37.6 57.9 8.8 219.2 40.4 56.2 27.8 102.1 78.2 31.4 42.6 27.1 10.1 49.5 43.0 36.5 15.9 63.1 32.9 112.1 38.6 12.1 6.3 23.1 18.8 14.1 19.9 71.0 47.7 99.8 ZSCAN4 "FLJ35105, ZNF494" ENSG00000180532 "Zinc finger and SCAN domain containing 4" Q8NAM6 19 57668935-57679152 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "stomach 1: 2.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Microglial cells: 1.0;Syncytiotrophoblasts: 1.6" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA006491 Uncertain NA NA "HPA006491: AB_10603385" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (2.75e-1)" "unprognostic (4.04e-2)" "unprognostic (2.59e-2)" "unprognostic (2.85e-3)" "unprognostic (1.06e-2)" "unprognostic (7.26e-2)" "unprognostic (1.45e-2)" "unprognostic (3.33e-1)" "unprognostic (1.45e-1)" "unprognostic (4.69e-5)" "unprognostic (1.73e-1)" 0.2 0.0 0.2 0.0 0.3 0.3 0.1 0.9 0.6 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.4 0.1 0.3 0.3 0.2 0.1 0.0 0.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.8 0.4 0.6 0.1 0.2 0.6 0.6 0.2 0.7 0.1 0.0 0.1 0.2 2.8 0.4 0.2 0.2 0.3 0.2 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.6 0.3 0.2 0.3 0.1 0.3 0.4 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 BHLHA15 "BHLHB8, MIST1" ENSG00000180535 "Basic helix-loop-helix family member a15" Q7RTS1 7 98211439-98215457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "pancreas: 507.1;salivary gland: 147.1" "Cell type enriched" "Detected in single" 25 "Plasma cells: 12.6" "Cancer enriched" "Detected in many" 4 "prostate cancer: 16.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 53.5;RPMI-8226: 72.0;U-266/70: 67.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034083, HPA047834" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "CAB034083: AB_2065216, HPA047834: AB_2680172" "unprognostic (2.80e-2)" "unprognostic (9.45e-3)" "unprognostic (8.10e-2)" "unprognostic (6.66e-2)" "unprognostic (4.33e-3)" "unprognostic (1.10e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (3.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (3.70e-4)" "unprognostic (3.36e-1)" "unprognostic (1.94e-1)" "unprognostic (2.95e-1)" "unprognostic (8.25e-3)" 0.1 0.1 0.7 3.7 0.6 0.3 1.5 0.1 2.1 1.9 0.0 4.1 4.0 0.1 0.8 1.0 0.1 0.8 0.2 1.3 0.8 0.4 5.2 0.9 3.9 0.5 0.4 0.7 0.4 507.1 0.1 1.5 0.1 0.6 8.6 1.6 0.0 147.1 4.0 0.2 0.5 3.4 0.0 0.7 5.1 31.6 0.2 1.1 0.7 1.9 0.0 4.7 2.5 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.3 0.1 0.8 0.9 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.6 6.7 5.9 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.2 0.0 0.0 53.5 0.0 0.9 0.0 0.0 0.8 6.2 0.8 0.4 0.0 72.0 0.3 0.0 4.3 1.2 0.0 11.2 0.0 0.0 0.7 0.1 0.0 0.0 0.7 0.1 0.1 67.6 5.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.1 2.1 1.3 0.8 0.5 0.4 0.7 0.6 0.7 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980310 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;choroid plexus: 11.9" "Cell type enriched" "Detected in some" 4 "Astrocytes: 85.2" "Cancer enhanced" "Detected in many" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 81.3;RPTEC TERT1: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.0 0.1 12.4 0.1 13.8 8.5 0.6 22.7 17.9 0.6 11.9 0.2 0.2 0.6 1.1 0.3 1.2 0.2 0.3 16.8 13.0 1.1 0.0 3.3 0.2 17.0 17.6 8.5 0.3 1.7 5.9 1.8 1.3 16.9 0.4 0.1 8.9 1.3 2.1 0.2 0.4 0.3 0.3 13.8 0.2 0.2 3.7 24.2 1.5 1.3 0.1 0.0 0.3 0.4 14.1 0.2 6.5 12.0 0.0 4.1 5.0 0.7 6.3 8.6 17.0 16.4 0.3 0.1 0.0 0.1 6.8 18.5 0.0 14.3 0.1 30.9 0.0 4.7 0.4 81.3 0.0 0.0 0.1 0.0 2.8 0.0 26.3 0.2 19.5 0.3 3.5 0.5 0.0 11.9 0.2 0.1 2.2 6.9 0.1 23.9 3.8 2.9 1.0 67.3 0.0 14.2 13.7 0.6 0.0 24.8 4.4 0.0 2.4 6.5 20.7 4.4 0.2 14.3 0.0 0.0 0.0 14.1 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 13.8 22.7 17.9 16.8 13.0 17.0 17.6 8.5 16.9 13.8 24.2 14.1 0.2 0.0 0.0 85.2 0.1 0.3 0.1 0.0 0.0 19.3 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 0.4 0.1 0.2 0.0 9.7 8.6 0.0 0.1 0.4 0.0 0.1 0.0 5.4 0.0 0.1 0.1 15.2 1.5 0.1 0.0 0.0 0.3 1.4 0.3 0.0 0.0 5.6 0.0 14.7 0.0 2.5 0.4 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.1 1.3 6.6 0.0 1.3 5.7 3.2 0.0 0.0 0.3 0.3 0.0 0.1 0.1 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273488-97277928 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.1" "Group enriched" "Detected in many" 8 "Early spermatids: 172.9;Late spermatids: 419.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 6.0 8.6 10.6 4.4 12.7 1.2 12.3 7.4 11.9 11.5 1.5 7.4 1.8 15.3 15.7 4.6 12.5 6.6 12.5 10.4 15.7 8.7 1.8 7.2 6.3 10.4 9.3 10.2 25.4 8.8 8.1 11.9 4.3 11.7 15.4 3.3 11.4 9.8 18.4 13.0 3.9 4.1 14.4 6.7 7.3 8.5 45.1 12.7 7.5 8.4 10.6 7.3 9.8 4.7 15.2 0.0 15.9 0.0 0.0 0.4 0.4 0.1 12.4 0.0 12.2 7.9 0.0 0.5 0.0 16.8 14.8 0.0 4.4 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 19.4 0.0 17.2 0.0 0.0 0.2 34.9 30.5 0.0 0.5 23.4 0.0 0.0 0.0 0.0 0.2 23.1 0.0 0.1 10.2 0.1 60.8 47.1 0.0 4.1 0.0 8.2 0.0 1.9 0.0 0.0 26.2 0.1 0.0 14.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.0 10.6 12.7 7.4 11.9 10.4 15.7 10.4 9.3 10.2 11.7 6.7 12.7 15.2 7.5 6.4 4.1 0.0 5.5 2.3 4.5 0.7 6.8 12.5 9.9 8.8 16.3 2.8 2.1 9.2 20.9 0.2 2.6 0.0 5.9 5.8 172.9 6.4 13.7 9.8 2.4 3.4 0.0 3.5 0.1 12.1 10.2 2.6 0.0 19.2 6.4 0.8 6.3 8.4 0.0 0.3 2.0 5.0 5.9 419.0 24.5 4.6 7.2 0.0 2.2 13.1 0.0 0.0 0.0 3.7 0.0 21.1 0.8 7.8 0.0 1.4 4.1 12.2 6.6 12.4 9.3 35.5 31.0 5.6 1.6 0.1 1.3 9.9 0.3 4.1 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137032088 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 4.0;brain: 2.1;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 8 "dendritic cells: 66.9;Langerhans cells: 38.7;monocytes: 20.7;NK-cells: 28.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 210.0" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "NB-4: 23.7;THP-1: 24.0;U-937: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.3 0.1 0.3 1.7 1.2 4.0 0.1 0.9 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.4 0.6 0.1 0.1 0.9 4.6 1.6 1.1 0.1 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.1 0.4 6.2 0.3 0.2 0.8 1.0 0.2 0.4 3.2 0.3 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 23.7 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 2.0 7.5 1.5 10.4 1.6 52.5 20.1 52.1 28.9 21.7 5.5 0.9 4.3 91.6 127.1 0.2 210.0 90.2 15.4 0.3 1.2 0.9 0.8 0.4 0.6 1.6 1.1 0.1 1.6 0.4 0.8 2.1 0.1 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 3.7 38.7 0.0 0.0 2.7 0.0 0.0 20.7 0.0 28.8 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.7 0.0 H2AC6 "H2AFL, HIST1H2AC" ENSG00000180573 "H2A clustered histone 6" Q93077 6 26124145-26139116 "Cancer-related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.0" "Cell type enhanced" "Detected in some" "Adipocytes: 10.9;Cardiomyocytes: 23.3;Cytotrophoblasts: 14.3;Extravillous trophoblasts: 28.5;Hofbauer cells: 16.2;Syncytiotrophoblasts: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1552.9" "Lineage enriched" "Detected in all" 14 "granulocytes: 1552.9" "Cell line enhanced" "Detected in many" "U-266/84: 61.0" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.89e-2)" "unprognostic (1.97e-1)" "unprognostic (7.15e-3)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (1.37e-1)" "unprognostic (8.16e-2)" "unprognostic (2.57e-1)" "unprognostic (1.61e-3)" "unprognostic (1.75e-1)" "unprognostic (1.19e-2)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (5.89e-3)" 9.7 12.8 26.4 5.1 35.5 13.1 10.8 37.3 35.4 17.7 23.9 11.7 11.6 4.8 11.4 28.3 10.9 10.4 10.6 34.2 48.1 15.2 30.5 23.1 5.5 42.8 30.8 23.6 12.8 7.3 0.9 10.6 5.3 38.4 26.2 5.3 4.0 10.8 2.1 20.4 15.2 13.3 2.2 47.6 21.4 13.9 4.8 27.2 18.3 12.9 4.7 2.0 12.1 28.8 74.0 13.2 30.7 0.1 0.0 14.4 8.8 1.5 8.4 2.4 4.0 4.1 10.3 3.7 0.0 36.8 4.2 1.8 4.0 0.0 0.8 2.7 18.4 3.5 1.8 21.5 3.8 10.8 0.7 8.8 26.5 4.5 1.4 4.5 10.9 1.4 0.7 23.1 11.9 3.9 20.0 2.9 3.4 1.3 10.4 13.9 2.3 0.2 25.6 13.2 8.7 3.2 3.2 29.5 4.0 13.4 7.1 33.3 2.4 3.2 6.9 20.5 3.6 1.7 32.7 61.0 4.7 2.0 28.4 1.1 440.2 31.9 324.6 28.0 24.6 25.7 61.7 29.7 19.4 28.3 109.5 34.9 19.6 1552.9 33.7 65.6 79.9 33.8 662.0 26.4 35.5 37.3 35.4 34.2 48.1 42.8 30.8 23.6 38.4 47.6 27.2 74.0 10.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 14.3 7.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 28.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 75.9 1.1 0.0 0.0 0.0 EIF2S3B "eIF-2-gamma2, eIF2gA" ENSG00000180574 "Eukaryotic translation initiation factor 2 subunit gamma B" Q2VIR3 12 10505602-10523135 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Club cells: 1.3;granulocytes: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 5.0;MOLT-4: 4.3;RH-30: 3.0" NA NA "unprognostic (2.23e-1)" "unprognostic (6.09e-2)" "unprognostic (1.03e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (9.02e-2)" "unprognostic (7.67e-2)" "unprognostic (2.56e-1)" "unprognostic (2.58e-4)" "unprognostic (4.95e-2)" "unprognostic (2.29e-1)" "unprognostic (3.24e-2)" "unprognostic (9.45e-3)" "unprognostic (2.73e-1)" "unprognostic (4.39e-1)" 0.9 0.8 0.1 0.3 0.1 0.2 0.8 0.1 0.1 1.0 0.0 1.0 1.0 1.4 0.0 0.9 0.8 0.1 0.7 0.0 0.0 0.7 0.6 0.8 0.1 0.1 0.1 0.0 1.7 1.4 0.0 0.4 0.0 0.2 0.5 0.0 0.3 0.9 0.0 1.2 0.9 0.9 0.0 0.0 0.6 1.0 2.4 0.1 0.0 0.6 0.1 0.0 1.1 1.0 0.2 0.4 0.3 0.3 2.0 0.3 0.7 1.3 0.2 0.0 0.0 0.1 0.2 0.2 0.1 1.6 0.1 0.6 2.7 1.0 0.3 0.0 0.5 1.2 0.2 0.8 2.2 0.0 5.0 1.3 0.0 0.0 0.7 0.1 0.1 0.6 0.3 0.3 0.2 0.1 0.0 4.3 0.0 1.0 0.0 0.4 0.1 3.0 0.4 0.1 0.1 0.9 0.2 0.8 0.2 0.3 0.4 0.4 0.1 0.0 0.2 0.1 0.3 2.6 0.3 2.2 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 1.3 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" Q1XH10 10 21513475-21526368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.1;Early spermatids: 17.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.3 0.6 0.4 0.1 0.5 0.6 0.2 0.4 2.3 0.5 0.0 0.4 0.1 0.3 0.2 0.2 0.5 0.1 1.2 0.5 0.0 1.3 1.4 0.3 0.1 0.3 0.3 0.1 1.3 0.5 1.1 0.5 0.8 0.8 0.3 0.2 1.5 0.5 0.6 0.2 1.0 0.2 0.3 0.0 0.1 0.2 1.7 0.0 0.2 1.2 0.2 0.1 0.3 0.3 0.8 0.5 1.1 26.1 6.7 0.5 0.3 12.1 0.5 0.4 0.0 0.1 2.5 0.2 0.2 1.0 0.4 0.2 1.6 2.4 0.5 0.0 0.0 2.9 0.1 1.3 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.2 0.2 0.1 1.1 0.9 0.1 1.6 0.0 0.0 0.4 0.8 0.0 0.5 0.7 2.9 6.0 0.9 4.5 0.1 2.1 0.4 5.4 0.4 0.2 0.8 0.2 0.6 0.1 0.0 0.3 1.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 2.3 0.5 0.0 0.3 0.3 0.1 0.8 0.0 0.0 0.8 1.0 0.0 1.5 5.2 0.2 1.5 1.0 0.6 6.8 19.1 1.8 2.2 6.9 4.3 1.4 1.8 0.0 5.3 0.0 0.1 7.9 0.1 17.9 0.4 1.3 4.3 0.0 0.0 2.8 0.6 3.4 2.1 0.0 0.3 1.3 3.3 4.6 10.3 3.2 1.7 2.2 0.0 0.0 2.2 0.3 10.2 1.5 0.6 0.0 1.0 0.0 6.1 0.0 3.5 2.1 0.3 0.0 2.2 0.1 0.7 0.0 8.5 0.6 4.7 6.6 1.5 1.2 6.5 5.1 4.2 1.8 3.4 0.1 5.2 0.0 0.2 H2BC4 "H2B.1, H2B/l, H2BFL, HIST1H2BC" ENSG00000180596 "H2B clustered histone 4" P62807 6 26114873-26123926 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 18 "neutrophil: 923.6" "Lineage enriched" "Detected in all" 26 "granulocytes: 923.6" "Cell line enhanced" "Detected in all" "K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (8.30e-3)" "unprognostic (2.60e-2)" "unprognostic (2.37e-2)" "unprognostic (9.26e-2)" "unprognostic (3.20e-2)" "unprognostic (5.08e-2)" "unprognostic (4.72e-1)" "unprognostic (6.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (9.01e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (5.41e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (6.60e-3)" 3.3 3.4 10.4 6.1 18.3 25.2 6.8 11.2 11.2 6.2 9.4 3.1 3.3 1.2 3.6 14.8 7.1 4.7 3.7 8.8 20.5 5.4 13.2 8.1 2.9 17.1 10.0 6.2 2.6 2.6 0.9 5.9 7.3 14.9 22.0 2.3 1.5 7.5 0.9 14.6 5.2 3.0 1.2 22.0 5.2 7.1 6.4 16.6 15.0 3.6 8.1 2.3 3.5 10.3 28.0 7.0 4.0 2.1 2.0 1.9 1.1 2.6 6.8 2.5 4.5 3.7 5.6 4.1 2.7 12.5 2.3 3.3 5.2 2.8 2.8 2.2 6.3 2.3 2.2 6.1 9.6 2.6 3.4 8.4 27.3 1.7 1.9 1.1 2.2 1.8 2.1 39.8 21.1 8.6 8.0 7.5 7.2 2.2 7.4 12.4 3.3 3.0 16.3 7.8 1.7 9.4 3.0 75.8 5.8 2.6 5.5 31.8 3.1 5.6 5.5 51.9 3.4 2.8 42.8 57.1 13.2 2.3 8.6 3.8 52.5 9.3 49.9 9.2 10.5 12.4 19.1 13.3 13.0 6.6 35.1 10.3 7.7 923.6 10.5 10.4 22.0 9.3 19.2 10.4 18.3 11.2 11.2 8.8 20.5 17.1 10.0 6.2 14.9 22.0 16.6 28.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 5.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 42.8 0.4 0.0 0.0 0.0 MB21D2 C3orf59 ENSG00000180611 "Mab-21 domain containing 2" Q8IYB1 3 192796815-192917856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 63.8;Inhibitory neurons: 53.0;Langerhans cells: 85.0;Oligodendrocyte precursor cells: 68.9;Syncytiotrophoblasts: 110.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 4.2;T-reg: 3.9" "Lineage enriched" "Detected in single" 9 "T-cells: 4.2" "Cell line enhanced" "Detected in many" "HDLM-2: 114.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044026 Approved Approved Cytosol NA Yes Cytosol "HPA044026: AB_10962840" "unprognostic (3.52e-2)" "unprognostic (1.02e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (3.74e-5)" "unprognostic (2.42e-2)" "prognostic unfavorable (9.94e-4)" "unprognostic (2.76e-2)" "unprognostic (3.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-3)" "unprognostic (5.94e-3)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (3.28e-2)" 3.8 4.2 2.3 3.3 2.9 1.3 3.4 3.4 3.1 2.8 1.8 2.6 8.9 5.1 1.9 2.1 3.6 4.7 3.5 2.9 3.2 4.2 1.5 3.6 1.2 2.0 2.3 2.4 4.1 1.9 2.4 3.6 13.4 2.1 1.9 3.0 2.0 1.6 1.9 2.8 4.6 9.4 5.6 1.7 2.2 3.5 7.2 2.3 1.4 1.7 1.6 1.8 8.9 2.4 2.5 26.6 3.7 6.3 19.0 3.9 5.8 11.2 18.8 17.5 33.4 19.9 17.0 4.2 0.0 11.0 46.6 13.8 11.5 14.6 4.8 36.2 114.8 8.1 3.3 1.8 2.0 7.4 0.4 1.6 7.6 7.4 9.4 5.8 2.7 6.6 3.3 0.2 1.5 5.8 19.8 0.3 0.0 13.1 14.4 45.9 0.6 10.5 5.6 7.8 15.1 9.8 5.0 4.1 12.8 1.9 12.9 19.9 0.4 2.1 6.3 18.4 11.1 36.3 48.1 41.0 0.0 4.4 4.0 8.6 0.0 0.2 0.0 0.2 0.3 1.9 0.1 4.2 1.0 0.4 0.0 2.6 0.7 0.0 0.0 0.0 0.0 3.9 0.9 2.3 2.9 3.4 3.1 2.9 3.2 2.0 2.3 2.4 2.1 1.7 2.3 2.5 2.9 6.4 0.5 16.6 1.2 9.2 0.9 2.0 1.2 10.9 4.6 3.2 1.8 1.5 3.2 0.0 2.1 63.8 0.3 2.4 0.0 6.5 0.2 12.4 2.0 7.7 10.2 0.0 28.6 0.2 9.5 5.9 1.5 15.9 0.0 5.8 9.7 0.2 5.6 8.4 53.0 2.8 4.1 3.8 85.0 1.4 3.1 10.4 14.2 17.8 13.4 1.1 0.0 68.9 30.6 2.2 6.1 6.0 4.2 0.8 15.4 9.6 2.8 1.3 13.1 3.3 4.5 1.8 16.5 1.8 8.7 110.4 3.3 5.4 3.7 2.6 GSX2 Gsh2 ENSG00000180613 "GS homeobox 2" Q9BZM3 4 54099523-54102498 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Dystonia, Mental retardation" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.2" "Not detected" "Not detected" NA NA "unprognostic (4.48e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (1.89e-1)" 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.5 0.2 0.4 0.3 0.3 0.3 0.6 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSTR2 ENSG00000180616 "Somatostatin receptor 2" P30874 17 73165010-73176633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 59.1;Enteroendocrine cells: 35.7;Sertoli cells: 32.9;Smooth muscle cells: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 12.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007264 Uncertain Supported Cytosol NA NA Cytosol "HPA007264: AB_1080053" "unprognostic (2.13e-3)" "unprognostic (2.61e-3)" "unprognostic (7.43e-2)" "unprognostic (9.37e-3)" "unprognostic (6.25e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-3)" "unprognostic (7.46e-2)" "unprognostic (2.96e-1)" "unprognostic (6.55e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.04e-7)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (3.71e-3)" "unprognostic (2.95e-2)" 2.3 3.6 6.1 0.9 9.5 0.9 1.7 7.8 8.1 0.5 1.0 0.8 1.4 0.8 1.7 0.4 1.1 0.6 0.6 9.3 4.7 3.5 1.4 0.4 1.1 3.1 5.0 8.2 0.3 0.7 0.3 2.9 0.1 5.6 1.4 1.1 2.2 0.7 1.4 0.7 0.6 0.9 0.8 2.4 6.1 3.1 0.3 4.5 0.5 1.1 0.2 1.3 0.9 0.7 8.6 0.2 0.3 0.3 0.7 0.1 0.1 0.4 0.1 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.1 0.9 0.3 0.0 0.1 0.1 0.4 0.6 0.3 0.8 0.3 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.2 0.7 0.0 0.3 0.2 0.8 1.0 0.1 0.4 0.4 0.4 0.3 0.2 0.3 12.5 0.9 0.2 0.2 0.1 0.5 1.5 0.2 0.1 0.2 1.4 0.4 0.2 0.5 0.2 1.0 0.2 0.3 0.2 1.4 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 1.2 0.2 0.2 0.2 0.1 0.1 6.1 9.5 7.8 8.1 9.3 4.7 3.1 5.0 8.2 5.6 2.4 4.5 8.6 4.9 6.4 2.7 1.6 0.5 1.1 3.2 0.0 0.0 59.1 3.7 2.5 3.6 1.5 1.3 1.8 4.2 0.7 0.9 0.1 0.0 0.2 7.0 2.1 1.7 11.3 35.7 0.0 17.1 0.0 0.7 14.3 3.1 4.9 2.5 3.0 3.9 1.0 1.0 6.7 8.4 8.2 0.0 2.4 3.0 5.7 0.9 2.4 5.4 1.9 1.7 2.4 1.0 2.0 0.7 0.4 0.1 0.7 5.8 5.4 0.6 18.0 0.7 4.8 32.9 10.0 56.0 0.9 1.9 0.3 1.1 1.0 1.4 0.6 0.5 3.3 ZNF594 KIAA1871 ENSG00000180626 "Zinc finger protein 594" Q96JF6 17 5179535-5191868 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 17.8;Horizontal cells: 15.2;Inhibitory neurons: 15.7;Oligodendrocytes: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060283, HPA067178, HPA069360, HPA074493, HPA077596" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: " "unprognostic (6.67e-2)" "unprognostic (1.07e-2)" "unprognostic (6.93e-2)" "unprognostic (7.92e-3)" "unprognostic (1.11e-1)" "unprognostic (8.24e-3)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (6.67e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-5)" "unprognostic (4.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.99e-1)" "unprognostic (5.21e-2)" "unprognostic (6.59e-2)" 1.8 3.3 3.2 4.2 4.2 0.7 5.0 5.8 4.0 4.2 3.9 3.4 1.6 5.2 4.3 1.9 4.5 2.3 2.8 3.1 2.5 3.5 2.2 2.2 6.3 3.9 3.0 2.9 10.8 3.3 5.4 6.2 3.2 4.2 5.2 2.7 11.8 3.8 4.3 4.0 2.1 4.0 3.0 2.0 5.1 2.9 4.6 3.0 5.2 5.7 3.0 6.0 3.6 2.9 7.0 5.8 2.5 10.5 8.3 1.6 1.8 8.9 3.8 1.9 6.6 6.2 7.3 2.1 13.1 5.9 3.0 4.9 6.2 6.8 0.2 8.3 7.0 6.9 4.2 10.2 3.7 2.4 0.0 4.0 1.4 1.1 4.0 0.0 1.7 0.7 7.5 1.7 3.2 2.2 5.7 3.6 1.8 4.9 0.9 3.5 7.6 8.9 1.7 1.9 1.5 6.2 8.4 2.8 1.5 5.8 4.6 3.4 3.1 0.1 0.1 3.7 3.4 2.7 2.0 4.5 3.0 0.6 0.0 4.1 0.2 0.4 0.5 1.4 0.5 1.0 1.6 1.5 1.4 0.4 2.5 2.3 1.6 0.2 1.3 0.5 2.2 2.4 0.6 3.2 4.2 5.8 4.0 3.1 2.5 3.9 3.0 2.9 4.2 2.0 3.0 7.0 1.8 6.4 3.9 14.0 3.6 1.1 1.3 0.4 1.2 9.5 2.5 2.2 5.5 4.3 2.8 5.5 6.2 1.4 1.3 0.7 7.9 1.6 0.8 0.8 3.1 2.1 1.2 2.5 17.8 1.1 0.7 2.7 1.5 0.8 3.8 9.9 3.9 0.7 1.1 15.2 15.7 1.5 0.0 1.4 0.6 4.3 3.4 1.2 0.0 8.4 1.5 7.7 3.1 14.6 20.3 0.7 1.5 2.6 0.8 0.9 0.6 1.0 5.0 9.2 0.0 3.3 2.4 2.5 4.1 0.9 0.3 0.3 1.8 5.2 1.3 0.5 PCGF5 "MGC16202, RNF159" ENSG00000180628 "Polycomb group ring finger 5" Q86SE9 10 91163012-91284337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 345.7;Oligodendrocytes: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038349, HPA059071" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA038349: AB_10669523, HPA059071: " "unprognostic (1.34e-2)" "unprognostic (8.22e-2)" "unprognostic (1.25e-2)" "unprognostic (7.41e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (6.53e-2)" "unprognostic (6.43e-2)" "unprognostic (3.89e-1)" "unprognostic (3.24e-2)" "unprognostic (3.75e-2)" "unprognostic (1.49e-1)" "prognostic favorable (4.98e-4)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (2.56e-2)" "prognostic favorable (6.90e-4)" 13.8 22.0 20.1 13.2 20.8 5.9 12.0 20.4 20.2 12.1 13.9 15.4 17.7 12.6 10.8 13.0 12.2 12.8 28.6 16.6 27.0 23.6 26.4 13.2 17.0 24.3 22.3 15.2 15.1 16.3 20.0 7.3 16.0 19.9 13.8 14.3 16.4 17.7 14.1 15.3 11.3 21.1 12.0 21.4 18.0 14.8 11.5 22.0 19.6 24.4 16.8 15.8 12.3 8.6 25.9 32.9 14.2 11.6 5.0 16.5 25.7 8.3 18.2 37.3 16.2 22.5 2.2 18.7 43.2 8.3 22.9 13.3 6.3 12.6 12.5 28.4 50.1 9.5 20.4 9.0 22.2 21.8 16.0 31.0 11.7 22.6 12.1 16.8 33.2 13.7 19.0 11.1 23.5 25.4 6.1 36.2 4.1 1.7 7.5 8.1 17.8 21.5 11.7 29.6 5.1 5.5 7.8 8.9 9.4 15.6 4.1 7.6 7.1 35.9 19.0 13.4 11.8 21.8 40.8 26.9 38.2 26.7 11.4 6.0 6.4 1.6 2.7 2.6 4.0 4.7 4.0 3.9 2.7 2.1 3.9 3.9 3.9 2.1 5.1 7.7 0.5 2.4 2.6 20.1 20.8 20.4 20.2 16.6 27.0 24.3 22.3 15.2 19.9 21.4 22.0 25.9 35.8 6.4 24.0 135.8 60.1 34.4 48.7 34.8 38.7 20.2 26.8 30.6 81.2 28.6 28.3 29.5 16.7 16.5 49.7 82.8 49.0 33.9 127.8 25.2 38.7 33.8 21.6 124.8 99.0 63.9 5.0 32.7 33.1 29.0 23.4 14.0 35.3 58.6 50.5 50.5 159.5 65.4 20.3 73.1 64.9 345.7 19.6 65.9 42.7 56.2 74.0 79.9 40.2 107.1 252.6 54.3 55.1 29.7 72.3 61.2 83.7 59.0 27.9 19.3 13.1 59.1 39.4 78.2 14.4 34.4 31.3 5.6 55.9 10.9 49.0 67.2 SLC47A2 "FLJ31196, MATE2, MATE2-K" ENSG00000180638 "Solute carrier family 47 member 2" Q86VL8 17 19678288-19718979 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.1;choroid plexus: 32.2;kidney: 54.5" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 91.3" "Cancer enhanced" "Detected in some" "glioma: 2.6;renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 2.1" "Not detected" "Not detected" NA NA "unprognostic (4.52e-3)" "unprognostic (8.28e-3)" "unprognostic (1.54e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (5.22e-2)" "unprognostic (2.72e-1)" "unprognostic (1.99e-2)" "unprognostic (3.29e-2)" "unprognostic (1.51e-1)" "unprognostic (1.36e-3)" "unprognostic (7.77e-2)" "unprognostic (1.04e-3)" "unprognostic (4.33e-2)" "unprognostic (1.61e-1)" "unprognostic (6.44e-2)" "unprognostic (5.71e-2)" 0.1 0.2 4.1 0.0 2.7 0.0 0.2 5.8 2.4 0.1 32.2 0.0 0.0 0.1 6.7 0.4 10.1 0.0 0.1 2.5 14.1 54.5 0.0 0.0 0.0 10.4 13.4 0.4 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.6 0.4 0.2 1.1 2.3 0.3 0.1 9.3 0.0 0.0 0.0 5.7 0.0 0.2 0.2 0.0 0.0 0.1 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.7 5.8 2.4 2.5 14.1 10.4 13.4 0.4 10.5 9.3 5.7 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.6 0.0 0.0 0.9 0.7 0.0 0.2 5.5 0.0 0.1 0.0 0.2 5.9 0.0 0.6 20.9 0.4 0.1 0.0 0.0 3.3 0.0 0.0 0.5 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 2.0 0.0 0.0 0.7 0.3 0.9 0.0 1.9 0.0 1.3 0.0 2.0 1.4 0.1 0.0 0.0 0.0 0.8 1.7 91.3 2.5 0.5 0.0 3.5 0.1 0.6 0.8 1.0 0.3 0.0 0.6 0.0 0.2 0.2 PRF1 "HPLH2, P1, PFP" ENSG00000180644 "Perforin 1" P14222 10 70597348-70602759 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Cytolysis "Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 28.8;lung: 16.6;lymphoid tissue: 49.8" "Cell type enhanced" "Detected in some" "dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8" "Group enriched" "Detected in all" 50 "NK-cells: 656.8;T-cells: 900.4" "Cell line enriched" "Detected in some" 11 "HDLM-2: 240.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002436, HPA037940" Approved Approved Cytosol "Intracellular and membrane" NA NA 2100000 Cytosol "CAB002436: AB_563955, HPA037940: AB_2675747" "unprognostic (6.11e-3)" "unprognostic (1.26e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.09e-4)" "unprognostic (1.87e-2)" "prognostic favorable (3.54e-4)" "unprognostic (6.98e-3)" "unprognostic (2.62e-1)" "unprognostic (1.44e-3)" "unprognostic (1.69e-2)" "unprognostic (5.22e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (7.38e-2)" "unprognostic (2.70e-1)" "unprognostic (7.97e-3)" "unprognostic (5.22e-3)" 4.6 2.0 0.9 7.7 1.0 28.8 2.7 0.8 1.0 1.3 1.7 2.3 2.3 3.5 1.1 1.9 1.9 4.3 2.1 0.8 0.9 1.7 6.3 16.6 20.5 1.4 1.3 0.4 1.0 1.0 0.5 0.9 2.7 1.3 1.5 1.5 0.0 2.3 1.2 2.6 0.9 5.3 2.1 1.4 49.8 4.7 0.6 1.5 5.8 2.6 1.5 4.9 3.8 1.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 240.1 0.0 1.4 0.0 7.4 0.0 0.3 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 5.2 1.9 0.9 900.4 1.7 628.8 4.0 125.8 499.1 2.0 3.5 52.1 313.0 15.4 656.8 2.6 2.9 108.8 587.5 0.9 1.0 0.8 1.0 0.8 0.9 1.4 1.3 0.4 1.3 1.4 1.5 1.9 3.1 3.2 13.6 0.0 4.4 0.4 0.1 0.0 0.6 0.0 0.5 0.5 0.8 1.5 2.5 0.0 0.0 0.2 542.1 0.1 0.0 0.3 0.0 0.2 0.3 1.9 0.0 19.0 0.0 0.0 0.1 2.1 7.7 0.4 8.8 0.0 10.8 2.7 0.1 0.0 0.0 0.0 0.0 7.8 2.3 0.0 0.0 5.7 0.0 1.9 7.4 0.0 1231.7 0.0 0.1 0.0 0.0 0.0 88.5 0.1 0.1 1.6 1.5 0.0 0.0 1.1 0.8 0.0 0.0 0.5 0.9 0.7 265.4 0.0 0.1 0.0 OR2A4 OR2A10 ENSG00000180658 "Olfactory receptor family 2 subfamily A member 4" O95047 6 131699644-131701401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Endothelial cells: 1.6" "Cancer enriched" "Detected in single" 17 "renal cancer: 0.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 4 "basophil: 12.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.0" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.22e-5)" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35473789-35476689 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.7;retina: 69.3" "Group enriched" "Detected in some" 14 "Bipolar cells: 57.7;Cone photoreceptor cells: 50.1;Horizontal cells: 87.5;Muller glia cells: 151.1;Rod photoreceptor cells: 125.8" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Region enhanced" "Detected in many" "cerebellum: 21.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 36.6;BJ hTERT+: 29.9;BJ hTERT+ SV40 Large T+: 41.7;HBF TERT88: 44.9;hTERT-RPE1: 86.2;SH-SY5Y: 133.5" "Group enriched" "Detected in many" 10 "cerebellum: 40.9;midbrain: 18.6;pons and medulla: 12.4" "Region enhanced" "Detected in all" "cerebellum: 33.0" "HPA049324, HPA059864" Approved Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.3 4.4 1.2 0.5 1.2 0.0 7.6 21.7 2.1 0.4 0.3 1.7 0.5 0.1 0.1 0.2 0.1 0.2 0.7 1.7 0.8 0.1 0.0 0.1 0.8 2.8 7.7 1.3 0.9 0.1 0.0 0.3 0.0 5.5 1.4 0.5 69.3 2.9 0.3 5.7 1.1 1.1 0.2 1.9 0.4 0.7 0.1 2.0 0.4 1.2 0.6 0.3 0.8 1.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 36.6 29.9 41.7 23.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.6 0.1 44.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.1 86.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 3.6 133.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 1.5 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 21.7 2.1 1.7 0.8 2.8 7.7 1.3 5.5 1.9 2.0 2.9 2.6 0.0 0.0 0.0 0.0 0.8 0.5 0.6 0.0 57.7 0.2 0.9 0.5 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 2.5 1.2 0.7 0.0 0.1 87.5 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.4 1.8 0.0 0.0 151.1 0.0 1.5 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 125.8 0.0 5.6 3.1 0.0 0.0 0.0 0.6 0.0 0.1 0.5 0.0 0.3 YOD1 "DKFZp451J1719, DUBA8, OTUD2" ENSG00000180667 "YOD1 deubiquitinase" Q5VVQ6 1 207043849-207052980 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Unfolded protein response" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 59.1" "Cell type enhanced" "Detected in all" "Erythroid cells: 70.9;Glandular and luminal cells: 118.8;Late spermatids: 103.3;Urothelial cells: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 86.3;K-562: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028400, HPA028439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 110000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA028400: AB_10599854, HPA028439: AB_10600994" "unprognostic (3.69e-2)" "unprognostic (8.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.03e-2)" "unprognostic (3.28e-2)" "unprognostic (9.87e-3)" "unprognostic (9.38e-2)" "unprognostic (2.31e-3)" "unprognostic (8.96e-2)" "unprognostic (1.47e-3)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (1.79e-2)" "unprognostic (3.62e-1)" 2.9 4.5 4.2 4.3 4.4 59.1 5.4 4.3 5.9 3.9 4.7 3.9 4.2 3.8 2.9 24.9 2.6 2.8 4.3 4.5 4.3 4.7 5.5 8.5 4.7 6.1 4.5 3.6 3.0 3.2 1.6 2.7 5.7 4.9 3.0 4.0 7.7 6.7 2.7 4.8 14.9 4.9 2.5 4.4 5.8 8.8 3.8 7.7 9.9 5.3 4.2 7.6 4.6 11.0 10.4 11.8 6.1 9.5 5.7 3.3 4.4 18.5 7.6 5.9 5.7 5.7 11.7 11.9 6.1 3.0 4.7 2.7 12.6 0.1 9.3 6.4 4.9 10.3 86.3 27.6 5.6 3.1 11.5 29.2 3.1 7.1 4.6 17.7 6.7 5.0 12.5 61.1 0.0 5.0 0.1 10.1 6.3 9.1 4.9 13.5 5.1 0.4 4.5 5.7 13.0 5.0 11.0 12.5 14.4 16.7 8.4 5.1 8.1 2.4 4.8 12.6 4.0 10.0 9.5 0.6 9.0 5.7 0.0 3.3 1.0 0.3 0.5 0.2 0.3 0.3 0.0 0.3 0.2 0.3 0.1 0.3 0.4 0.7 0.3 0.2 0.1 0.2 0.2 4.2 4.4 4.3 5.9 4.5 4.3 6.1 4.5 3.6 4.9 4.4 7.7 10.4 6.8 41.7 12.2 20.5 3.3 31.6 29.4 8.1 21.1 8.0 6.2 3.8 7.0 2.8 10.0 1.8 4.2 2.7 8.2 39.4 1.9 4.1 35.4 50.5 19.0 6.7 8.9 70.9 8.5 10.5 3.2 5.5 36.2 118.8 8.2 6.1 2.9 8.6 2.8 11.8 6.4 5.0 12.2 10.0 12.5 103.3 1.5 8.3 14.2 6.5 5.2 4.9 6.2 6.0 16.4 24.4 67.8 2.2 4.8 38.2 7.8 7.0 21.6 17.9 6.6 3.6 6.0 10.9 4.6 33.9 40.2 1.8 6.9 9.0 7.5 86.5 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 146.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 62.0;Hepatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Uncertain NA NA "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 17.2 12.2 5.6 9.3 9.4 3.4 8.5 7.4 7.2 15.5 37.0 8.6 9.6 11.0 146.1 10.6 8.9 10.5 7.2 5.4 15.0 13.7 20.9 9.6 13.0 8.9 7.7 4.5 16.5 15.5 6.9 4.7 10.3 8.6 11.5 5.5 1.1 17.9 17.5 9.0 6.3 9.9 16.4 8.3 8.9 7.2 12.4 8.0 5.1 23.1 7.2 12.2 10.7 7.9 15.2 26.5 20.3 10.0 5.4 45.7 33.0 5.5 19.2 18.2 14.8 16.3 5.7 17.8 17.2 7.5 11.8 6.4 9.0 26.9 13.0 19.5 34.8 9.8 32.1 7.3 12.8 16.1 1.9 5.1 43.4 14.0 6.1 13.8 17.1 15.1 4.1 14.8 36.9 25.1 35.3 0.1 4.6 1.5 13.6 10.6 3.8 22.1 8.7 29.2 50.6 7.1 20.0 12.6 10.9 23.5 13.3 10.9 1.5 15.1 14.9 13.1 10.8 15.8 24.3 0.4 18.8 13.4 3.9 20.0 2.7 0.1 0.1 1.5 0.3 1.9 3.1 1.6 1.7 0.3 2.0 0.7 1.1 0.0 3.2 0.4 0.2 0.8 0.9 5.6 9.4 7.4 7.2 5.4 15.0 8.9 7.7 4.5 8.6 8.3 8.0 15.2 16.7 9.6 12.5 5.2 15.7 24.1 12.7 5.4 62.0 0.7 7.3 11.4 20.4 7.2 3.7 22.0 0.0 25.3 18.6 2.5 1.9 3.9 3.7 3.3 9.6 9.0 7.8 18.7 9.9 10.2 6.2 18.1 6.1 4.6 14.0 13.5 6.1 51.7 4.0 1.7 14.1 4.5 8.2 9.7 11.6 3.2 46.9 11.1 24.9 9.4 1.9 4.0 4.1 8.0 46.8 8.8 2.4 21.4 12.6 19.7 16.7 30.6 3.7 0.0 0.0 10.5 11.9 3.4 2.2 17.4 23.4 15.7 13.3 23.7 7.2 8.6 C3orf22 MGC34728 ENSG00000180697 "Chromosome 3 open reading frame 22" Q8N5N4 3 126526999-126558965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 474 "testis: 48.8" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1630.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059199 Enhanced NA NA "HPA059199: AB_2683946" "unprognostic (2.10e-1)" "unprognostic (5.14e-5)" "unprognostic (2.55e-1)" "unprognostic (9.21e-2)" "unprognostic (2.01e-1)" "unprognostic (2.75e-1)" "unprognostic (1.08e-3)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 283.2 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1630.9 10.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10K2 ENSG00000180708 "Olfactory receptor family 10 subfamily K member 2" Q6IF99 1 158418210-158426237 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.5;intestine: 6.9;lymphoid tissue: 16.0;testis: 5.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "basal ganglia: 14.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 16.8" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.1 0.5 1.7 0.2 14.5 1.7 0.1 0.0 4.0 0.1 0.0 1.2 3.3 0.1 0.0 0.0 0.1 0.0 0.1 1.8 5.3 0.0 0.0 0.3 0.1 6.8 0.4 3.0 0.0 0.2 0.2 1.2 0.0 4.8 0.0 0.1 2.5 0.1 0.0 0.0 1.9 6.9 0.1 0.0 16.0 0.6 5.0 2.3 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.5 0.2 0.0 0.1 0.0 2.1 0.0 0.1 0.1 0.1 1.0 0.1 0.2 0.2 0.0 1.8 0.1 1.3 0.1 0.0 1.6 0.2 0.4 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.1 0.4 0.1 0.1 0.0 3.4 0.0 0.0 0.1 10.0 0.2 0.2 0.0 0.1 0.2 0.1 1.7 0.0 0.3 2.8 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 14.5 0.0 4.0 1.8 5.3 6.8 0.4 3.0 4.8 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26052016 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.5;skeletal muscle: 14.4;thyroid gland: 21.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: AB_2681041" "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.5 0.0 1.0 0.2 2.4 0.1 12.5 1.4 2.0 1.7 1.3 0.1 0.7 0.1 7.9 0.2 0.2 0.6 0.2 1.9 1.6 4.7 0.0 4.4 0.5 1.6 1.6 0.9 0.3 0.3 0.1 1.6 0.0 1.9 0.5 0.1 0.0 2.8 0.3 14.4 0.8 0.7 0.1 2.3 0.2 2.1 1.2 1.6 2.6 21.2 1.2 0.7 0.7 0.1 5.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.4 4.2 1.4 0.0 0.0 1.7 26.7 1.0 20.8 0.0 0.0 18.7 1.2 2.3 0.5 15.5 8.4 8.2 0.0 46.3 0.3 1.7 6.5 0.4 0.0 0.4 0.0 5.4 2.6 0.7 0.2 1.6 0.1 0.7 30.4 7.0 0.0 0.0 0.0 0.0 0.0 4.1 0.8 0.1 0.5 0.1 0.2 0.2 0.1 0.4 0.1 0.0 0.2 1.0 1.6 0.4 0.2 0.3 0.1 0.2 0.1 1.0 2.4 1.4 2.0 1.9 1.6 1.6 1.6 0.9 1.9 2.3 1.6 5.6 4.7 0.0 13.1 0.0 0.4 5.4 14.6 2.3 0.6 0.0 24.1 6.2 0.5 0.0 1.5 3.7 0.0 0.3 0.3 0.1 0.0 6.0 2.6 1.0 0.5 5.1 0.0 0.0 0.0 0.2 0.3 2.8 3.1 2.5 0.0 2.4 1.1 0.0 0.8 0.0 1.0 0.1 8.2 0.3 2.3 1.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.5 10.9 1.2 0.0 0.4 0.2 3.9 0.0 0.3 1.1 0.0 0.0 7.6 1.6 0.7 5.1 0.4 1.7 0.1 1.1 0.7 0.0 19.6 S1PR5 "Edg-8, EDG8" ENSG00000180739 "Sphingosine-1-phosphate receptor 5" Q9H228 19 10512742-10517931 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.6" "Cell type enhanced" "Detected in some" "dendritic cells: 93.9;NK-cells: 164.8;Oligodendrocytes: 26.6;T-cells: 33.1" "Group enriched" "Detected in many" 5 "cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 299.4;MAIT T-cell: 184.9;memory CD8 T-cell: 144.9;naive CD8 T-cell: 109.3" "Lineage enriched" "Detected in many" 7 "T-cells: 299.4" "Cell line enhanced" "Detected in many" "HaCaT: 28.5;HBEC3-KT: 10.9;RT4: 18.7;T-47d: 11.6;U-2 OS: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029683 Enhanced NA NA "HPA029683: AB_10603237" "unprognostic (9.07e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (5.55e-4)" "unprognostic (4.21e-1)" "unprognostic (4.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.55e-1)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (2.46e-2)" "unprognostic (2.90e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-1)" 0.6 0.4 29.7 0.8 41.5 19.9 0.6 39.0 38.2 2.8 17.3 0.3 0.2 0.3 4.4 12.9 0.2 0.2 0.5 26.8 34.0 0.7 1.6 3.0 1.0 45.3 42.3 22.4 0.2 1.5 0.1 0.4 1.7 43.9 2.5 0.1 0.0 2.5 0.5 0.6 18.9 0.3 0.2 36.5 11.2 0.3 0.7 38.1 0.9 0.5 0.2 2.1 2.3 11.0 67.6 1.9 2.8 0.6 0.0 0.0 0.1 0.2 0.6 0.5 0.9 0.5 0.3 0.1 0.0 7.6 0.3 1.2 28.5 1.8 10.9 2.0 0.0 1.8 0.2 2.3 0.0 0.1 0.0 0.1 0.0 5.0 3.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 3.7 1.1 0.0 4.5 0.6 0.5 0.0 2.1 0.0 0.0 18.7 0.0 0.0 4.7 0.0 0.5 1.9 11.6 3.3 0.0 1.5 10.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.5 0.5 1.2 299.4 0.2 184.9 0.6 36.3 144.9 0.6 0.5 10.8 109.3 3.9 44.5 1.1 0.8 0.6 64.2 29.7 41.5 39.0 38.2 26.8 34.0 45.3 42.3 22.4 43.9 36.5 38.1 67.6 1.0 3.2 1.9 0.0 0.6 3.6 2.2 10.9 7.4 0.0 0.1 0.9 0.9 1.5 0.9 0.0 0.0 0.1 93.9 0.0 0.0 0.0 6.2 0.1 0.2 0.6 0.0 0.8 0.1 0.2 0.3 1.7 0.5 0.0 2.5 0.0 1.8 0.3 0.2 0.0 0.1 0.0 0.0 0.8 0.3 2.3 0.0 0.6 0.0 2.8 1.2 0.0 164.8 0.0 26.6 0.2 0.0 0.0 14.7 0.2 0.0 0.1 0.4 0.0 0.0 0.1 1.9 0.0 0.2 4.8 5.1 0.1 33.1 0.0 0.0 0.4 CLRN3 "MGC32871, TMEM12, USH3AL1" ENSG00000180745 "Clarin 3" Q8NCR9 10 127877841-127892941 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 89.8;kidney: 44.3;liver: 80.5" "Group enriched" "Detected in some" 5 "Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.3;renal cancer: 30.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 41 "OE19: 96.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA014482 Approved NA NA "HPA014482: AB_2082885" "unprognostic (7.34e-3)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (1.46e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (6.22e-2)" "unprognostic (4.67e-1)" "unprognostic (8.86e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.74e-1)" "unprognostic (2.89e-3)" "unprognostic (3.00e-2)" 0.3 0.1 0.3 5.7 0.3 0.0 0.3 0.2 0.5 0.0 0.2 71.8 74.1 0.1 0.0 0.0 0.0 15.3 0.0 0.4 0.3 44.3 80.5 0.0 0.1 0.3 0.3 0.3 0.0 0.3 0.0 0.2 0.0 0.3 0.0 70.9 0.0 0.0 0.2 0.0 0.0 89.8 1.7 0.3 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 96.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.2 0.5 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 102.0 15.6 0.4 0.0 0.2 0.0 0.1 41.5 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 43.0 0.0 0.0 0.1 75.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.5 95.9 0.0 0.0 0.0 155.4 68.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 45.6 0.0 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129102 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 60.1" "Cell type enhanced" "Detected in many" "Langerhans cells: 268.1;monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 31.8;SK-BR-3: 62.7;U-266/70: 30.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.4 4.8 0.7 4.4 0.7 1.3 3.4 1.0 1.1 5.9 8.7 3.1 4.0 2.9 1.3 30.4 2.9 2.0 9.7 1.3 3.1 2.3 9.1 6.7 3.1 1.6 0.8 0.5 4.4 4.1 15.2 1.5 8.8 1.1 3.6 2.2 0.9 9.0 2.3 60.1 21.9 2.8 1.8 0.5 4.0 3.8 2.0 1.0 2.5 3.3 24.1 7.6 6.8 13.8 1.0 9.0 5.0 1.5 4.1 1.4 1.3 8.0 2.8 1.8 2.3 3.1 4.1 3.4 1.1 3.4 3.0 2.9 18.9 4.6 1.8 3.4 25.2 7.6 0.1 16.0 6.2 4.9 0.1 2.0 1.2 3.9 3.9 2.4 2.3 1.8 3.7 1.4 31.8 0.9 6.5 3.8 1.9 1.7 4.4 6.3 0.6 1.3 4.3 1.4 6.0 2.3 6.1 10.8 62.7 5.2 3.0 8.9 1.1 13.3 7.8 2.0 20.5 1.3 30.6 5.2 0.1 5.8 12.6 3.3 0.7 0.4 0.1 0.6 0.3 0.5 0.4 0.4 0.6 0.2 0.6 0.4 0.5 1.2 0.2 0.1 0.2 0.2 0.2 0.7 0.7 1.0 1.1 1.3 3.1 1.6 0.8 0.5 1.1 0.5 1.0 1.0 3.1 6.4 8.9 0.0 5.3 13.6 10.2 17.8 12.5 0.7 14.7 8.4 13.4 2.8 12.3 5.5 2.1 34.8 2.9 6.8 0.0 3.5 0.1 13.7 6.9 4.0 0.0 0.0 1.4 3.9 10.0 4.8 5.1 26.5 0.0 3.2 2.5 14.8 4.0 1.7 1.2 4.8 10.2 0.8 268.1 0.2 1.8 13.1 7.2 0.0 107.4 1.0 0.0 0.0 0.2 13.9 4.3 5.3 4.7 6.8 7.5 1.6 7.4 1.4 0.0 5.5 4.2 0.6 2.3 43.6 24.3 48.2 3.5 5.0 5.5 16.1 CHST13 C4ST3 ENSG00000180767 "Carbohydrate sulfotransferase 13" Q8NET6 3 126524155-126543291 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 60.1;testis: 18.5" "Group enriched" "Detected in some" 5 "Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2" "Group enriched" "Detected in many" 4 "liver cancer: 25.0;renal cancer: 6.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 5 "eosinophil: 155.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 155.2" "Group enriched" "Detected in some" 8 "CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA067960 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA067960: " "unprognostic (5.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (6.42e-4)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (8.45e-3)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (5.16e-2)" "unprognostic (6.68e-2)" "unprognostic (2.26e-1)" "unprognostic (1.59e-2)" 0.3 0.4 0.2 0.4 0.2 0.6 0.1 0.1 0.4 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.3 3.2 60.1 0.6 0.1 0.2 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 3.6 0.4 18.5 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.7 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.7 0.3 28.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 33.0 155.2 0.0 20.5 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 30.7 0.0 17.5 0.0 0.0 13.1 0.2 0.2 0.1 0.4 0.2 0.3 0.2 0.4 0.2 0.2 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 104.0 0.6 0.0 0.1 1.2 5.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 40.3 13.1 0.0 0.0 1.0 0.0 7.5 1.3 16.9 1.5 6.2 0.0 1.9 7.2 0.0 0.0 0.0 0.1 0.0 2.8 1.2 0.3 0.0 8.5 9.9 0.1 0.0 0.0 0.0 0.0 126.2 2.8 0.0 0.0 0.3 0.2 0.0 1.8 0.0 AGTR2 "AT2, MRX88" ENSG00000180772 "Angiotensin II receptor type 2" P50052 X 116170744-116174974 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.9;lung: 8.9;smooth muscle: 13.3" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 2: 20.4" "Group enriched" "Detected in some" 12 "endometrial cancer: 3.0;lung cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 8 "cerebellum: 2.0" NA NA "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (3.22e-2)" "unprognostic (4.37e-2)" 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.1 0.0 0.1 0.0 8.9 0.8 0.0 2.7 0.1 1.7 0.0 0.0 0.6 0.0 8.9 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144174-93197991 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 5.6 7.5 4.7 9.4 5.4 19.5 4.7 8.3 5.8 5.1 5.4 5.3 2.0 7.2 2.1 5.4 4.8 5.8 5.3 3.9 8.3 9.5 7.9 6.0 5.4 6.9 7.0 3.9 5.7 5.7 6.5 7.8 6.2 7.8 5.0 6.5 15.4 3.7 5.9 2.4 4.1 3.2 8.1 6.2 4.1 4.3 4.4 6.2 7.4 8.9 2.3 6.7 7.0 3.6 8.1 10.4 18.2 36.5 7.3 12.7 25.6 20.5 17.6 29.2 25.6 31.0 14.6 33.1 12.5 9.9 16.5 13.3 12.5 11.4 6.5 23.4 21.1 13.3 14.5 35.3 9.8 10.0 36.6 20.6 12.4 20.0 14.9 9.2 12.0 14.0 17.6 1.3 0.2 26.5 2.6 16.3 27.4 14.8 4.0 18.4 7.2 21.7 5.1 8.7 15.1 33.6 43.8 25.7 9.9 6.4 26.4 18.0 10.6 15.7 48.0 14.8 28.6 26.0 5.1 10.9 0.0 10.9 15.0 25.4 0.1 4.9 5.3 0.8 2.6 1.0 0.9 0.6 1.0 1.9 1.0 1.5 1.0 1.5 0.5 1.7 0.7 0.5 1.1 4.7 5.4 8.3 5.8 3.9 8.3 6.9 7.0 3.9 7.8 6.2 6.2 8.1 11.9 12.8 11.5 35.9 29.5 30.7 43.2 9.7 25.6 21.2 10.3 8.0 11.5 20.0 7.1 20.2 22.9 10.7 13.6 3.1 35.2 24.4 9.9 15.5 19.2 18.5 27.6 5.5 66.8 43.6 25.8 21.9 18.8 5.7 4.5 29.0 13.2 9.1 13.6 26.9 71.0 19.6 10.2 52.3 47.1 4.2 18.0 50.1 21.4 27.2 42.8 20.7 13.4 45.2 59.4 33.2 6.3 15.4 22.1 70.4 0.4 16.2 20.8 24.2 6.6 18.0 18.1 7.3 3.3 11.8 32.0 16.3 15.7 20.6 4.3 30.6 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type palmitoyltransferase 20" Q5W0Z9 13 21372571-21459370 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 93.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 434.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 11.0 9.2 15.3 17.7 46.7 30.3 11.6 46.9 24.4 16.3 2.5 17.0 19.4 14.0 9.7 30.5 11.0 17.2 7.9 10.7 31.6 6.8 9.9 17.1 18.1 59.8 39.4 5.2 9.8 9.0 8.9 4.4 18.9 59.9 15.2 16.2 5.7 8.5 12.3 4.0 22.3 19.2 15.4 44.0 16.2 39.8 32.0 39.2 22.8 16.6 9.5 19.7 23.1 9.3 93.1 32.9 16.4 27.7 18.1 24.5 26.7 68.3 35.6 36.3 23.3 20.6 33.8 102.5 34.8 19.3 44.7 23.8 52.7 30.5 26.5 44.8 40.0 20.4 61.8 11.7 19.6 14.1 43.3 25.8 24.2 19.4 23.6 16.2 30.0 37.6 45.9 17.3 14.9 35.3 27.2 62.0 17.2 22.9 87.3 18.0 49.8 49.1 12.7 28.9 59.7 25.2 11.4 46.0 28.7 19.3 28.6 27.0 21.8 62.6 25.0 24.0 41.7 27.4 15.6 19.9 37.7 18.2 23.6 73.1 12.6 16.2 3.8 10.1 14.9 9.3 4.6 8.7 8.7 8.4 3.4 8.1 8.4 3.0 11.2 13.8 4.1 10.4 13.5 15.3 46.7 46.9 24.4 10.7 31.6 59.8 39.4 5.2 59.9 44.0 39.2 93.1 27.6 51.3 31.5 29.0 19.9 1.0 7.8 1.4 18.2 7.4 21.9 13.7 7.4 14.3 20.7 11.0 8.4 20.7 34.7 35.5 0.0 8.5 91.3 23.4 25.2 25.7 24.0 8.4 69.1 12.2 20.9 13.6 53.0 34.5 14.0 16.1 20.0 20.8 21.7 18.5 80.0 29.1 2.0 92.5 3.2 81.2 15.5 49.0 1.8 46.9 48.4 3.7 30.9 54.8 434.3 22.8 25.5 10.9 18.1 14.5 30.3 6.3 11.7 9.5 19.7 12.7 11.6 10.4 14.1 28.1 1.6 44.6 28.4 9.7 25.1 25.6 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14854038 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.3" "Group enriched" "Detected in some" 8 "Early spermatids: 13.1;Excitatory neurons: 32.6;Inhibitory neurons: 39.3;Late spermatids: 13.9;Spermatocytes: 23.7" "Cancer enriched" "Detected in single" 5 "breast cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 63.1" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA060455: AB_2684282, HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.1 0.1 0.2 0.0 0.4 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 13.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.7 0.0 1.1 4.4 0.3 63.1 0.0 6.7 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.6 0.4 0.3 0.4 0.1 0.4 0.1 0.1 0.1 0.6 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.0 0.0 2.8 1.0 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 1.9 0.0 13.1 0.7 0.1 0.2 1.8 0.0 32.6 0.0 0.4 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.1 0.0 39.3 1.6 0.0 0.3 0.0 13.9 0.9 0.2 0.0 1.0 0.0 0.0 0.0 2.5 1.1 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 23.7 1.7 0.0 0.3 0.5 0.1 0.0 1.1 0.3 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.8;placenta: 7.5;prostate: 6.6" "Group enriched" "Detected in some" 7 "Adipocytes: 44.1;Enteroendocrine cells: 21.3;Sertoli cells: 26.3;Smooth muscle cells: 31.8" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 107 "SCLC-21H: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved NA NA "CAB019995: AB_10283600, HPA051439: AB_2681487" "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 5.8 0.0 0.2 0.7 0.2 0.0 2.4 0.2 0.4 0.4 0.3 1.6 0.4 0.9 0.3 0.1 0.6 0.5 2.6 0.2 0.2 0.7 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.1 0.1 0.5 7.5 0.2 6.6 0.8 0.0 0.2 0.6 2.1 0.2 1.3 1.0 0.2 0.1 0.7 0.2 0.2 0.0 0.5 4.0 0.2 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 44.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.3 4.1 21.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.3 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.4 0.1 0.0 0.0 0.0 26.3 0.7 31.8 0.0 0.2 0.1 0.3 0.0 0.1 0.8 0.1 0.2 ZFP3 "FLJ30726, ZNF752" ENSG00000180787 "ZFP3 zinc finger protein" Q96NJ6 17 5078467-5096374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 5.8;SH-SY5Y: 6.0;SiHa: 5.5" "Low region specificity" "Detected in all" "HPA053085, HPA057290" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053085: AB_2682039, HPA057290: AB_2683400" "unprognostic (3.71e-2)" "prognostic favorable (5.68e-4)" "unprognostic (1.45e-1)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.38e-4)" "unprognostic (5.42e-2)" "unprognostic (3.33e-1)" "prognostic favorable (1.07e-4)" "unprognostic (4.89e-2)" "prognostic favorable (7.69e-7)" "unprognostic (8.30e-2)" "unprognostic (1.16e-1)" "unprognostic (6.32e-2)" "unprognostic (3.29e-3)" 2.6 2.7 3.1 3.9 3.9 1.0 4.7 6.3 4.5 3.3 5.8 4.8 7.1 3.4 3.3 2.7 5.8 2.5 6.9 3.3 3.1 5.3 1.2 3.9 5.3 4.0 3.6 2.4 5.0 4.7 9.5 2.2 2.7 3.9 3.9 5.8 8.0 6.0 3.7 6.9 3.5 6.1 3.2 3.3 5.1 4.4 3.1 3.4 5.0 5.9 9.7 6.2 2.8 2.3 3.8 0.0 1.0 0.2 0.0 0.9 0.4 0.0 2.2 0.0 1.7 1.9 4.5 2.0 0.0 3.1 2.2 0.8 4.5 0.0 0.0 0.9 0.0 0.1 0.1 1.9 0.0 3.0 0.0 5.8 1.5 0.0 1.2 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 3.2 0.4 0.0 0.6 1.5 2.7 2.7 2.7 6.0 5.5 4.5 2.9 1.0 2.7 4.4 0.0 0.0 0.8 1.5 3.2 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.8 0.6 1.0 0.9 0.6 0.8 0.6 0.9 0.5 2.1 1.5 1.1 0.0 0.7 0.8 0.3 0.6 0.7 3.1 3.9 6.3 4.5 3.3 3.1 4.0 3.6 2.4 3.9 3.3 3.4 3.8 1.8 0.0 4.2 1.6 2.1 0.3 0.4 0.9 1.2 4.1 1.6 1.4 7.8 1.5 2.1 1.8 8.4 1.2 2.4 3.1 0.0 1.7 1.8 3.1 2.7 1.8 0.0 0.8 3.0 1.1 0.4 1.8 4.6 0.8 1.3 2.9 4.2 0.1 1.7 3.3 4.5 2.2 0.0 2.5 0.2 0.5 1.5 1.2 0.0 0.0 0.9 2.8 2.1 4.5 3.1 0.6 1.0 1.2 1.8 0.6 2.6 1.4 11.0 6.0 0.0 3.0 1.5 7.1 3.8 2.3 0.1 0.8 1.6 2.9 2.5 0.5 ARSJ FLJ23548 ENSG00000180801 "Arylsulfatase family member J" Q5FYB0 4 113900284-113979727 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 35.3;Astrocytes: 44.1;Basal prostatic cells: 60.3;Prostatic glandular cells: 49.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 46.4;HUVEC TERT2: 42.2;LHCN-M2: 42.8;TIME: 53.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036481, HPA036482" Uncertain Enhanced "Actin filaments" "Secreted in other tissues" NA NA "Actin filaments" "HPA036481: AB_2675146, HPA036482: AB_10672356" "unprognostic (1.98e-1)" "unprognostic (1.55e-2)" "unprognostic (4.23e-1)" "unprognostic (5.31e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (6.08e-4)" "unprognostic (2.54e-2)" "unprognostic (2.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-1)" "unprognostic (5.31e-2)" "unprognostic (2.20e-1)" "prognostic favorable (2.97e-6)" "unprognostic (2.26e-1)" "unprognostic (8.37e-2)" "unprognostic (1.30e-1)" "unprognostic (2.07e-2)" 1.4 1.3 1.2 1.3 1.1 0.0 1.0 4.2 1.8 4.5 0.4 2.1 0.6 2.0 0.9 3.2 2.8 3.7 1.8 1.2 1.1 2.7 1.7 3.4 0.6 0.8 1.2 0.9 2.0 1.1 3.0 0.7 4.3 1.2 3.9 3.4 0.6 5.9 2.2 0.2 0.7 0.7 2.2 0.8 0.2 3.5 0.1 1.5 1.5 0.7 0.6 0.3 3.9 2.1 1.2 2.7 5.3 0.6 0.0 10.1 20.5 0.0 46.4 35.5 29.0 11.3 1.3 3.4 0.0 5.7 22.6 10.3 5.0 0.2 11.7 36.2 0.0 2.1 0.0 4.2 0.0 30.6 0.0 0.0 12.7 11.5 19.7 40.0 20.5 42.2 0.0 0.0 0.0 42.8 0.4 0.0 0.0 1.5 0.0 8.4 0.0 5.1 0.0 38.0 0.0 0.0 1.7 3.1 0.5 2.2 7.5 0.2 0.0 53.6 33.3 8.7 5.0 22.3 0.0 0.0 0.0 16.2 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 4.2 1.8 1.2 1.1 0.8 1.2 0.9 1.2 0.8 1.5 1.2 0.7 35.3 9.8 44.1 0.2 2.9 60.3 23.7 15.9 0.2 4.7 2.9 1.3 11.5 10.8 25.8 0.0 0.3 0.1 7.0 0.0 9.2 0.0 6.2 21.1 4.3 23.4 0.0 27.1 0.9 0.2 13.6 4.6 8.2 0.0 0.0 4.2 1.2 0.5 1.7 1.5 17.3 16.2 0.3 1.6 0.3 2.5 0.3 3.6 7.5 0.0 6.8 1.0 3.0 0.5 5.2 5.0 1.5 0.0 49.6 0.1 4.1 4.6 0.2 0.0 8.6 10.5 0.1 0.3 16.9 1.1 0.4 0.6 3.3 4.1 25.6 HOXC9 "HOX3, HOX3B" ENSG00000180806 "Homeobox C9" P31274 12 53994895-54003337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.1" "Cell type enhanced" "Detected in some" "Distal tubular cells: 41.1;Fibroblasts: 20.1;Granulosa cells: 26.7;Melanocytes: 39.2;Proximal tubular cells: 22.0;Skeletal myocytes: 28.3;Smooth muscle cells: 19.6;Spermatogonia: 21.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;HDLM-2: 28.4;HEK 293: 33.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "spinal cord: 7.7" "HPA063965, HPA072160" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063965: AB_2685162, HPA072160: AB_2686491" "unprognostic (2.38e-1)" "unprognostic (1.03e-1)" "unprognostic (3.19e-5)" "unprognostic (1.23e-1)" "unprognostic (4.09e-3)" "unprognostic (7.12e-2)" "unprognostic (6.92e-3)" "unprognostic (1.06e-3)" "unprognostic (4.32e-1)" "unprognostic (1.58e-2)" "unprognostic (7.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.01e-1)" "unprognostic (2.74e-2)" "unprognostic (1.53e-1)" 6.6 1.7 0.0 0.3 0.0 0.0 6.2 0.0 0.0 0.3 0.0 0.2 0.0 1.0 1.3 0.4 8.1 0.0 0.0 0.0 0.0 8.4 0.0 0.1 1.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 26.1 7.3 6.2 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.5 0.5 0.0 0.8 3.3 0.0 21.5 8.5 7.0 1.5 2.3 2.0 2.8 1.8 0.9 3.3 0.0 1.7 8.8 0.5 3.9 0.5 2.3 2.4 28.4 33.7 0.7 5.9 0.9 0.9 0.1 5.1 7.9 3.6 4.2 1.9 0.0 2.7 0.1 7.1 0.0 5.8 2.5 0.0 2.0 0.0 1.7 0.3 0.4 4.1 0.0 6.5 2.1 0.0 6.2 7.9 4.1 9.5 0.5 6.5 0.3 0.0 5.1 9.0 1.5 2.7 0.0 0.0 0.0 0.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 9.6 0.0 0.0 1.8 0.0 6.5 7.9 0.5 0.0 0.0 1.8 0.0 0.3 0.2 0.0 41.1 0.0 3.7 0.1 0.2 2.1 0.0 0.0 0.0 0.4 11.5 20.1 0.0 0.0 0.0 26.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.9 4.1 4.7 0.5 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.9 0.0 0.1 0.6 22.0 0.0 0.0 6.6 28.3 19.6 9.3 21.2 0.7 9.5 0.4 0.5 7.2 0.1 0.0 MAP3K15 "ASK3, bA723P2.3, FLJ16518" ENSG00000180815 "Mitogen-activated protein kinase kinase kinase 15" Q6ZN16 X 19360056-19515261 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 10.9;choroid plexus: 10.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 5.5;Cone photoreceptor cells: 4.2;Granulosa cells: 7.5;Theca cells: 29.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;HAP1: 4.9;HEK 293: 4.1;JURKAT: 2.5;REH: 2.6;SuSa: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA004006 Approved Vesicles NA NA Vesicles "HPA004006: AB_1079358" "unprognostic (2.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.21e-2)" "unprognostic (6.56e-8)" "unprognostic (3.47e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-3)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-2)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (2.77e-3)" "unprognostic (4.00e-1)" "unprognostic (2.37e-1)" "unprognostic (3.98e-2)" "unprognostic (8.20e-2)" 0.0 10.9 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.4 1.2 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.5 0.7 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.0 4.9 0.0 0.0 0.8 4.1 1.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.1 0.0 1.1 1.3 0.0 0.5 2.6 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.4 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.2 0.0 3.1 0.3 0.0 0.1 0.5 0.0 0.0 1.0 0.2 0.6 2.9 0.0 0.0 5.5 4.2 0.0 0.1 0.2 3.9 0.0 0.4 0.3 0.3 0.1 0.0 0.4 2.6 0.0 0.3 0.4 0.0 0.3 0.0 7.5 0.4 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 1.0 0.0 0.3 0.0 0.5 1.1 0.1 0.0 1.2 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.3 0.2 0.6 1.4 0.0 0.0 0.1 0.2 29.8 0.1 0.0 PPA1 "IOPPP, PP, PP1, Ppase, SID6-8061" ENSG00000180817 "Inorganic pyrophosphatase 1" Q15181 10 70202835-70233911 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 1239.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019878, HPA020096" Supported Supported Vesicles NA NA 1000000 Vesicles "HPA019878: AB_1855601, HPA020096: AB_1855600" "unprognostic (1.50e-1)" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" "unprognostic (2.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-1)" "unprognostic (2.13e-2)" "unprognostic (3.60e-2)" "unprognostic (1.82e-3)" "unprognostic (5.36e-2)" "unprognostic (2.37e-1)" "unprognostic (3.53e-2)" "unprognostic (2.74e-1)" 158.0 200.1 134.8 117.0 147.1 85.7 188.6 171.0 164.3 97.3 133.4 138.6 100.3 86.6 168.1 158.9 111.2 91.1 86.9 133.4 157.1 124.4 151.5 130.1 133.7 162.5 155.2 130.5 57.0 190.0 69.0 92.8 104.5 169.4 69.4 154.0 334.9 117.1 79.4 134.1 82.2 126.1 97.6 167.2 64.7 98.3 74.1 149.8 104.4 127.4 138.5 138.4 168.7 141.2 179.8 446.9 181.2 158.8 471.2 421.6 368.8 148.2 163.5 305.3 250.1 261.8 556.7 230.6 641.0 144.5 164.0 162.8 351.2 470.7 318.4 253.8 599.1 443.5 176.1 169.1 321.7 265.8 439.0 106.9 244.2 372.9 201.3 530.7 273.8 307.9 319.2 416.9 336.4 239.4 262.3 426.5 408.7 165.9 614.2 494.8 256.9 181.7 378.2 527.0 276.3 474.4 159.6 179.3 694.5 148.0 110.8 174.3 194.2 141.0 69.0 262.2 229.4 315.2 110.1 259.2 469.8 106.7 605.2 62.0 0.4 68.8 1.7 48.9 55.2 131.1 83.6 112.3 85.6 190.0 59.4 122.7 106.8 4.1 65.8 63.1 44.4 120.4 105.3 134.8 147.1 171.0 164.3 133.4 157.1 162.5 155.2 130.5 169.4 167.2 149.8 179.8 207.0 224.4 165.9 17.0 122.7 267.9 366.2 427.3 158.2 184.9 347.8 363.7 93.3 218.8 275.7 108.5 173.0 313.2 63.4 203.3 201.5 540.1 31.7 278.8 196.1 182.1 162.7 88.4 36.8 776.1 298.3 156.9 114.2 512.1 36.8 208.2 38.2 141.8 96.5 85.8 41.2 254.9 160.7 80.1 148.1 31.7 109.6 120.3 181.5 29.0 612.7 1239.0 65.9 21.6 98.4 532.9 213.5 117.4 161.2 512.4 444.5 551.2 92.1 278.4 65.7 97.2 136.8 173.7 170.7 245.8 257.1 245.7 120.9 203.0 347.6 613.9 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 114.6" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2" "Cancer enhanced" "Detected in many" "renal cancer: 20.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 319 "spinal cord: 31.8" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053919: AB_2682308" "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 7.3 1.2 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.7 0.0 0.2 0.0 1.5 0.0 0.1 8.9 0.0 0.0 0.0 0.0 22.2 0.0 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.5 114.6 14.7 2.2 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.1 0.7 3.3 0.0 291.5 82.5 75.6 0.5 10.1 24.4 13.6 12.6 0.6 0.9 0.5 2.7 67.6 1.9 31.4 4.1 0.0 6.5 15.2 5.6 3.0 36.2 0.0 0.4 0.0 3.7 36.0 0.5 1.0 0.0 0.0 0.1 8.5 2.3 0.0 9.4 1.8 0.1 7.5 0.1 36.4 1.1 0.0 0.4 0.0 30.6 0.0 0.0 3.9 6.9 10.0 15.7 0.4 99.4 2.2 0.0 8.0 10.2 0.2 13.3 1.3 0.2 0.1 0.1 1.7 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.0 21.2 0.0 0.0 0.0 0.0 4.8 7.9 0.3 0.0 0.0 16.5 0.0 0.0 0.1 0.0 62.6 0.0 0.2 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.6 0.9 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 100.4 0.0 0.0 0.0 22.4 5.2 3.6 4.4 0.0 19.2 0.1 0.4 0.0 0.0 0.0 PSMG4 "C6orf86, PAC4" ENSG00000180822 "Proteasome assembly chaperone 4" Q5JS54 6 3231403-3303373 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067652, HPA074376, HPA075846" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA067652: AB_2685880, HPA074376: , HPA075846: " "unprognostic (3.13e-3)" "unprognostic (6.00e-2)" "unprognostic (3.60e-1)" "unprognostic (4.11e-2)" "unprognostic (4.11e-1)" "unprognostic (2.20e-1)" "unprognostic (6.52e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-2)" "unprognostic (6.74e-3)" "unprognostic (7.40e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.59e-1)" "unprognostic (8.18e-2)" "unprognostic (2.54e-1)" "unprognostic (3.48e-2)" 19.0 18.5 12.5 8.3 15.8 13.9 20.2 19.3 13.8 17.0 4.4 21.5 14.2 19.0 18.7 20.0 18.6 6.9 13.8 11.9 16.1 20.3 27.2 13.8 10.3 18.2 16.2 11.3 16.8 33.7 12.1 22.4 7.1 17.9 19.4 7.0 10.0 20.4 13.5 37.4 20.8 17.0 9.6 14.1 14.5 21.6 16.3 15.5 9.4 21.2 11.2 7.7 20.0 17.0 23.9 61.8 29.0 17.5 42.8 15.3 23.1 29.5 27.2 20.0 25.9 41.4 25.1 20.6 21.0 73.1 16.4 20.2 28.9 15.0 18.9 16.9 34.7 65.2 16.9 33.4 66.6 19.2 48.7 16.9 19.8 20.1 18.8 27.8 14.8 32.4 39.9 65.0 15.1 14.0 58.2 27.6 88.9 21.4 31.3 57.7 36.5 9.5 116.2 21.1 24.0 74.3 21.3 12.9 16.7 61.4 16.5 22.0 21.0 31.7 21.4 20.4 24.6 26.6 48.7 76.4 39.4 15.2 34.1 29.3 16.2 35.5 24.4 25.3 36.9 29.4 50.2 42.1 30.8 28.4 52.1 40.9 35.7 8.9 32.3 36.3 33.9 39.4 23.9 12.5 15.8 19.3 13.8 11.9 16.1 18.2 16.2 11.3 17.9 14.1 15.5 23.9 45.2 22.4 21.2 18.6 25.3 27.9 29.1 44.2 38.7 32.0 53.1 88.4 21.9 37.1 26.9 44.1 8.4 39.3 15.2 23.6 84.1 43.9 31.4 23.6 25.9 35.2 22.8 18.5 9.6 87.5 37.8 30.4 15.8 17.1 22.2 38.8 28.2 64.5 35.1 25.2 17.8 31.1 28.5 19.2 21.1 13.3 37.0 18.4 30.2 5.6 35.7 22.0 32.0 21.6 15.7 57.8 25.8 23.0 18.9 47.0 47.3 67.2 22.6 29.4 46.0 45.5 54.0 29.6 78.2 39.6 38.2 12.0 23.7 30.0 35.4 27.1 BHLHE22 "Beta3, BHLHB5, CAGL85, TNRC20" ENSG00000180828 "Basic helix-loop-helix family member e22" Q8NFJ8 8 64580365-64583627 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.0" "Cell type enriched" "Detected in some" 14 "Bipolar cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "THP-1: 78.4" "Group enriched" "Detected in all" 5 "amygdala: 30.7;cerebellum: 30.7;cerebral cortex: 22.7;hippocampal formation: 46.3;white matter: 13.1" "HPA064128, HPA064872, HPA067500" Enhanced Approved "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855" "unprognostic (9.17e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-2)" "unprognostic (2.28e-5)" "unprognostic (7.22e-3)" "unprognostic (6.47e-4)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.52e-1)" "unprognostic (3.71e-2)" "unprognostic (2.86e-7)" "unprognostic (3.20e-2)" "unprognostic (2.29e-1)" "unprognostic (6.72e-3)" "unprognostic (1.86e-1)" 1.6 0.5 8.9 1.5 6.8 0.0 1.5 12.7 23.0 1.8 0.7 1.2 0.4 0.3 0.1 1.0 0.8 0.4 0.3 19.9 2.0 0.1 0.5 2.0 0.7 4.4 1.6 4.1 0.2 0.7 0.1 1.4 0.0 4.3 0.4 0.5 4.5 0.5 2.4 0.1 0.7 1.5 0.4 1.6 1.4 0.5 0.2 1.7 0.3 0.7 0.0 0.6 1.2 2.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 78.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 6.8 12.7 23.0 19.9 2.0 4.4 1.6 4.1 4.3 1.6 1.7 2.8 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 64.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.1 0.0 3.4 0.2 0.0 0.0 0.6 1.5 0.0 1.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.2 2.9 0.0 0.4 0.1 1.6 0.0 0.1 0.0 0.0 0.0 MAP6D1 "FLJ12748, SL21" ENSG00000180834 "MAP6 domain containing 1" Q9H9H5 3 183815922-183825594 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 112.7;choroid plexus: 36.3;skeletal muscle: 27.2" "Cell type enriched" "Detected in some" 13 "Oligodendrocytes: 101.3" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "T-47d: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037991 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA037991: AB_10672503" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-1)" "unprognostic (1.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (8.81e-12)" "unprognostic (1.08e-1)" "unprognostic (2.96e-3)" "unprognostic (1.86e-1)" "unprognostic (5.72e-2)" 0.8 1.0 49.8 0.3 72.6 0.2 0.9 68.0 72.0 1.1 36.3 1.1 0.7 1.0 0.9 1.4 1.1 0.4 1.5 51.1 61.1 0.8 1.2 0.7 0.7 77.5 71.5 47.6 1.1 4.8 0.5 2.2 0.3 78.2 3.4 0.3 1.0 1.2 0.7 27.2 3.6 1.0 0.4 67.8 1.3 0.7 1.4 66.7 3.7 1.0 14.4 0.4 1.0 1.2 112.7 3.5 2.1 3.6 0.7 0.9 1.2 2.8 4.2 0.8 7.3 5.3 2.5 0.1 0.3 5.4 6.1 3.6 2.7 6.9 1.6 4.5 2.3 11.8 0.5 0.0 0.0 2.3 4.5 1.5 0.5 0.6 1.7 0.8 0.4 1.7 5.5 0.5 0.0 0.7 14.8 10.0 5.8 2.2 2.0 6.7 5.0 5.7 0.0 0.4 0.0 11.7 2.1 2.9 2.2 4.4 2.5 63.9 4.2 0.8 1.8 2.5 2.7 6.1 2.4 1.6 1.4 0.6 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 49.8 72.6 68.0 72.0 51.1 61.1 77.5 71.5 47.6 78.2 67.8 66.7 112.7 0.0 0.0 0.0 4.9 0.1 1.1 0.7 0.9 0.6 2.5 0.0 0.0 2.4 0.0 0.4 0.0 2.1 0.3 0.0 0.9 0.0 0.0 3.4 0.0 0.0 0.3 2.4 0.4 7.4 0.0 0.5 0.4 1.1 0.0 0.0 0.0 0.7 0.4 0.9 1.7 3.5 0.4 4.1 0.0 0.7 2.2 0.9 0.3 0.0 0.0 0.5 0.8 1.0 7.1 101.3 0.0 0.1 0.0 0.2 2.4 0.2 0.0 0.3 1.9 0.0 1.6 0.4 2.9 2.1 1.0 1.4 0.7 0.3 0.0 0.3 0.7 ZNF443 ZK1 ENSG00000180855 "Zinc finger protein 443" Q9Y2A4 19 12429706-12441021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 13.3" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (5.64e-3)" "unprognostic (1.51e-2)" "unprognostic (7.98e-2)" "unprognostic (1.45e-2)" "unprognostic (1.92e-1)" "unprognostic (7.38e-3)" "unprognostic (3.42e-1)" "unprognostic (1.64e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-2)" "unprognostic (7.10e-2)" "unprognostic (2.92e-2)" "prognostic favorable (2.74e-7)" "unprognostic (3.85e-3)" "unprognostic (2.16e-1)" "unprognostic (2.19e-2)" "prognostic favorable (3.91e-4)" 1.4 1.7 3.0 1.4 3.1 0.6 4.3 3.5 3.9 2.9 2.5 2.8 2.1 2.8 3.1 2.6 2.6 2.1 1.5 2.8 2.9 3.0 3.3 1.6 1.8 3.1 3.2 2.5 2.4 2.6 2.9 2.0 3.2 3.0 3.2 3.4 3.3 2.9 3.2 1.1 3.8 2.2 1.8 3.0 1.6 2.4 1.8 3.2 4.0 2.4 1.7 2.3 2.8 2.8 2.8 3.1 1.4 5.4 4.9 1.6 1.3 7.4 2.2 1.6 3.0 2.8 3.0 0.9 3.7 3.9 1.8 1.2 1.8 3.6 2.3 2.5 0.0 1.8 1.5 1.9 7.0 0.4 3.5 4.1 1.2 1.4 1.5 0.7 2.0 1.7 4.5 2.6 0.0 3.3 3.8 13.3 4.8 4.6 3.1 4.6 1.5 5.7 4.5 3.6 11.6 2.6 4.2 3.7 2.0 0.5 3.0 0.0 4.3 1.2 5.9 2.4 3.2 2.2 2.2 3.6 2.3 0.8 3.5 1.2 2.5 0.6 0.9 1.0 0.3 3.7 2.1 2.2 2.2 1.1 1.7 1.9 1.4 0.4 1.6 0.2 0.6 1.8 1.0 3.0 3.1 3.5 3.9 2.8 2.9 3.1 3.2 2.5 3.0 3.0 3.2 2.8 3.5 0.0 0.5 10.7 2.4 1.0 1.5 1.2 2.2 1.2 2.8 2.3 2.3 2.8 1.4 0.0 4.2 7.7 2.6 1.8 1.9 2.7 6.3 2.9 1.2 2.8 3.0 1.7 8.9 1.2 1.2 1.4 1.1 3.4 0.0 3.7 1.4 1.6 1.3 1.7 8.1 2.1 2.0 0.9 1.5 2.7 0.6 1.0 0.0 3.7 0.1 3.0 5.2 8.5 5.0 1.1 2.8 2.2 0.6 0.6 1.7 2.2 2.3 2.2 0.0 1.0 1.7 5.0 6.6 3.0 2.6 1.6 2.1 1.2 2.6 0.7 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137251 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.4;lymphoid tissue: 40.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 52 "neutrophil: 3273.9" "Lineage enriched" "Detected in many" 111 "granulocytes: 3273.9" "Group enriched" "Detected in some" 11 "BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1" "Low region specificity" "Detected in all" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" Yes NA "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 14.0 1.5 0.3 40.4 0.5 7.4 0.8 0.3 2.3 2.2 2.0 0.9 0.2 0.4 1.3 27.4 2.9 7.8 0.9 0.3 0.2 0.4 2.4 6.6 0.8 0.7 0.5 0.0 0.4 2.9 0.4 0.2 4.6 1.5 0.6 0.7 0.0 3.1 3.8 0.5 4.8 1.2 2.4 0.3 27.6 0.7 0.2 0.4 2.8 0.7 11.7 3.1 7.8 7.3 1.7 0.0 0.0 0.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 1.3 0.2 0.0 0.0 0.4 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 15.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 15.1 0.0 63.5 29.5 50.3 28.8 7.4 0.4 0.2 1.3 7.3 13.5 0.2 1.1 9.9 3273.9 6.8 3.6 25.0 0.5 17.4 0.3 0.5 0.3 2.3 0.3 0.2 0.7 0.5 0.0 1.5 0.3 0.4 1.7 0.0 0.0 10.5 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.7 12.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 6.3 3.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.2 1.6 0.0 0.0 2.8 0.0 1.0 3.7 0.0 40.2 0.0 0.1 0.0 2.2 0.0 1.4 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.4 0.0 0.0 11.6 0.1 0.3 4.1 0.1 0.1 1.9 DEFB112 DEFB-12 ENSG00000180872 "Defensin beta 112" 6 50042099-50049929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "epididymis: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GREM2 "CKTSF1B2, DAND3, FLJ21195, Prdc" ENSG00000180875 "Gremlin 2, DAN family BMP antagonist" Q9H772 1 240489573-240612155 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Heparin-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 31.6;liver: 26.5" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 298.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 32.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB009920 Approved "Secreted to blood" NA NA 12000 "CAB009920: AB_2279266" "unprognostic (2.01e-1)" "unprognostic (2.49e-1)" "unprognostic (7.41e-2)" "unprognostic (7.58e-3)" "unprognostic (2.82e-3)" "unprognostic (1.34e-1)" "unprognostic (8.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.31e-2)" "unprognostic (6.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.97e-2)" "unprognostic (3.07e-8)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.38e-2)" 0.8 1.7 1.7 9.8 2.5 0.1 3.4 0.2 6.3 0.5 0.0 17.2 10.9 9.7 2.2 17.3 1.4 31.6 0.0 1.9 1.4 0.7 26.5 1.2 0.2 2.4 2.0 1.5 6.7 0.2 23.1 2.1 4.0 1.8 2.6 20.3 5.8 4.2 1.8 7.3 3.6 15.1 6.5 1.0 3.2 9.4 0.3 3.0 0.3 0.5 0.7 0.2 3.8 0.6 4.0 0.0 0.0 0.1 0.0 1.9 2.4 0.0 6.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 2.8 1.3 0.0 0.0 3.9 0.5 0.8 0.4 1.0 0.0 0.0 3.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 2.5 0.2 6.3 1.9 1.4 2.4 2.0 1.5 1.8 1.0 3.0 4.0 0.2 0.0 0.0 0.3 0.2 4.7 0.0 0.0 0.6 20.8 14.0 0.1 0.6 0.0 0.0 0.0 12.5 7.4 0.6 0.6 0.0 0.0 0.0 2.3 1.2 0.6 1.2 0.0 28.6 0.0 1.7 17.4 0.0 13.7 0.0 0.1 0.7 20.4 1.5 0.0 30.5 0.1 0.0 0.3 6.2 0.2 0.0 0.2 1.8 3.7 0.0 0.4 1.0 1.5 1.2 0.1 0.1 4.5 0.1 0.6 0.0 0.0 0.7 6.7 0.0 0.2 1.4 2.4 2.7 0.6 3.7 298.0 1.6 2.3 0.6 0.1 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205557-6211135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 25.6" "Cell type enriched" "Detected in some" 5 "Late spermatids: 818.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;HeLa: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane, Vesicles" "HPA063404: AB_2685006" "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.0 0.1 0.3 0.2 0.5 0.1 0.1 1.4 0.7 0.1 0.0 0.2 0.9 0.3 0.0 0.1 0.1 0.2 0.1 0.4 0.3 0.2 0.2 0.0 0.2 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.9 0.1 0.0 1.4 0.2 0.0 0.1 1.5 0.7 0.0 0.0 0.2 0.3 25.6 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.1 0.8 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.2 1.3 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.0 0.2 0.3 0.1 0.4 0.1 0.4 0.2 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.3 0.1 0.1 0.1 0.3 0.1 0.3 0.1 0.6 0.1 0.1 0.3 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.4 0.7 0.4 0.3 0.1 0.0 0.6 0.9 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.5 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 818.5 1.5 0.2 0.0 1.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSR4 TRAPD ENSG00000180879 "Signal sequence receptor subunit 4" P51571 X 153793516-153798499 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 3146.2" "Cell type enhanced" "Detected in all" "Plasma cells: 6002.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045209 Enhanced Supported "Endoplasmic reticulum" NA NA 110000 "Endoplasmic reticulum" "HPA045209: AB_10961407" "unprognostic (3.56e-2)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" "prognostic favorable (1.76e-4)" "unprognostic (8.74e-2)" "unprognostic (5.57e-2)" "unprognostic (7.99e-2)" "unprognostic (4.58e-2)" "unprognostic (2.10e-1)" "unprognostic (5.04e-3)" "unprognostic (5.74e-3)" "unprognostic (8.76e-2)" "prognostic unfavorable (5.51e-6)" "unprognostic (8.18e-2)" "unprognostic (2.24e-1)" "unprognostic (6.01e-2)" "unprognostic (5.33e-2)" 182.9 314.1 140.4 234.3 140.5 503.2 255.2 146.9 188.0 321.7 179.8 370.1 344.7 194.0 893.3 235.4 203.4 186.9 252.5 136.5 193.1 204.3 400.9 238.6 321.7 149.5 144.8 132.9 184.3 3146.2 158.4 681.8 121.5 147.8 266.0 270.3 37.4 930.9 420.3 128.4 192.2 258.7 121.6 154.6 399.8 499.5 162.1 152.7 159.4 222.8 74.8 327.3 246.0 219.1 160.4 344.2 428.9 148.7 834.4 785.2 412.4 299.5 278.6 431.1 299.9 407.3 547.9 298.3 476.9 721.8 450.4 262.4 332.8 259.2 270.6 111.8 192.6 212.0 128.4 380.1 446.0 669.0 370.7 352.6 511.9 376.6 256.9 353.2 265.3 327.4 240.8 145.4 1027.1 239.8 616.8 222.3 578.1 90.8 941.3 685.7 247.3 178.4 922.7 394.2 413.9 285.8 228.8 159.3 301.7 333.1 161.9 188.8 821.6 263.9 174.4 189.9 324.4 377.5 1449.6 774.0 576.4 364.7 630.8 295.7 652.3 594.6 286.7 616.7 476.9 762.6 695.6 629.2 613.7 598.0 644.7 538.8 555.2 93.8 697.3 396.5 1751.9 515.9 1330.5 140.4 140.5 146.9 188.0 136.5 193.1 149.5 144.8 132.9 147.8 154.6 152.7 160.4 228.6 166.7 301.9 7.5 824.1 257.2 372.4 566.8 167.9 53.6 451.1 380.1 334.8 357.4 464.7 318.2 56.3 311.4 521.0 473.2 168.3 544.9 476.1 276.9 513.6 263.0 747.5 175.3 3.6 627.4 700.6 357.3 344.0 454.8 352.2 257.0 241.3 723.3 439.0 35.3 5.3 967.6 547.3 339.1 416.6 1753.1 336.7 344.5 1428.3 4.7 409.3 174.7 432.5 8.0 11.1 487.0 595.8 247.1 6002.3 633.3 581.0 414.8 340.6 83.4 118.3 174.3 300.7 199.4 207.9 306.1 322.2 564.6 473.4 600.1 548.8 490.0 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 11.9" "Cell type enhanced" "Detected in many" "Astrocytes: 85.5;Excitatory neurons: 133.8;Inhibitory neurons: 95.8;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 102.6;Respiratory ciliated cells: 77.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 1.0 1.5 3.9 0.3 1.2 0.5 1.4 1.8 4.0 1.0 7.1 0.8 0.6 2.0 3.7 1.4 10.0 1.3 2.3 1.2 2.7 2.8 1.8 2.5 0.3 5.4 3.8 0.4 1.6 0.9 3.9 2.5 0.1 2.3 2.0 0.6 11.9 2.4 1.3 1.7 1.0 0.6 0.6 3.8 1.0 1.3 3.8 1.9 0.6 4.0 3.2 0.3 0.7 0.7 2.5 0.7 2.1 0.6 0.1 1.0 0.7 0.0 0.4 0.1 1.1 1.2 0.0 1.0 0.2 1.8 0.3 0.4 0.5 0.0 1.0 0.8 0.7 0.3 0.9 0.4 0.0 0.0 0.1 0.0 0.3 0.5 0.9 0.2 6.8 0.1 0.7 0.2 0.3 1.5 0.0 1.0 0.8 0.3 0.0 0.3 0.0 0.0 0.1 1.5 0.0 1.2 0.6 0.1 0.0 0.6 0.1 0.7 0.3 0.5 1.0 0.5 0.2 0.1 0.1 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 3.9 1.2 1.8 4.0 1.2 2.7 5.4 3.8 0.4 2.3 3.8 1.9 2.5 3.3 9.6 2.8 85.5 1.7 1.8 2.6 2.9 7.4 1.5 3.1 3.0 8.2 1.5 11.5 5.5 4.2 1.2 0.9 0.4 5.9 1.1 35.8 24.3 2.1 2.3 0.0 4.6 133.8 1.7 0.6 4.8 4.6 0.9 0.0 6.0 3.3 2.4 0.5 1.7 95.8 1.3 2.0 1.6 1.7 14.9 6.2 1.3 0.0 46.9 0.1 6.7 2.1 117.1 102.6 0.6 0.3 7.2 2.5 1.0 0.5 3.5 77.2 22.4 0.0 3.8 3.8 8.5 1.6 4.1 0.6 0.3 1.6 3.3 0.8 0.6 ZNF792 FLJ38451 ENSG00000180884 "Zinc finger protein 792" Q3KQV3 19 34956354-34964229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 7.0;Endothelial cells: 7.5;Hepatic stellate cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.8;HMC-1: 16.1;HUVEC TERT2: 11.0;OE19: 9.7;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "HPA035157, HPA035158" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA035157: AB_2674497, HPA035158: AB_10603010" "unprognostic (1.31e-1)" "unprognostic (7.31e-2)" "prognostic favorable (2.72e-4)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (7.91e-2)" "unprognostic (2.41e-5)" "unprognostic (2.49e-2)" "unprognostic (4.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.88e-1)" "unprognostic (2.48e-1)" "unprognostic (6.02e-2)" "unprognostic (2.77e-3)" 3.4 1.3 0.9 2.2 1.4 1.3 3.6 3.5 1.0 2.4 1.3 1.9 2.1 2.2 1.9 1.0 2.6 1.7 2.0 0.8 1.1 1.6 1.3 4.1 3.9 1.1 1.5 0.6 2.4 1.8 2.8 1.1 3.4 1.9 1.8 2.4 2.5 2.2 2.2 1.2 1.4 2.4 2.6 0.9 3.7 2.5 0.9 1.2 4.1 1.9 2.2 2.9 2.3 1.4 1.1 1.1 3.8 1.8 2.7 1.8 1.4 0.0 1.1 2.0 1.3 1.6 1.5 1.8 1.6 3.4 1.5 0.6 0.7 2.6 2.0 2.0 4.6 0.6 12.8 1.1 2.9 1.3 1.1 16.1 1.6 0.6 1.1 0.5 2.3 11.0 1.1 3.4 0.0 2.2 0.9 4.5 1.1 1.3 9.7 0.8 2.9 0.0 0.2 1.0 3.5 0.9 10.2 1.0 1.0 1.3 1.6 1.2 3.4 4.5 1.9 2.4 0.8 1.2 0.3 1.0 0.9 2.1 0.2 0.9 5.4 0.5 4.1 1.9 0.4 2.3 1.3 3.0 2.7 0.7 0.9 3.3 2.8 0.1 3.0 0.3 0.1 3.2 1.7 0.9 1.4 3.5 1.0 0.8 1.1 1.1 1.5 0.6 1.9 0.9 1.2 1.1 7.0 0.0 1.1 0.7 2.1 0.5 0.1 0.6 0.6 0.8 1.2 0.9 2.0 0.0 0.2 0.0 2.1 0.1 2.9 0.7 0.0 1.8 0.2 0.7 0.7 7.5 1.8 3.4 0.3 2.6 0.4 1.0 2.0 0.8 1.3 1.4 6.4 0.6 1.5 0.0 0.6 1.7 0.0 3.5 1.4 0.4 1.5 1.6 0.0 1.0 1.6 0.5 2.1 2.5 0.3 2.7 1.0 0.0 1.6 0.2 0.5 0.5 0.2 1.8 0.0 0.9 0.6 0.0 1.5 0.4 0.4 0.1 3.0 0.7 1.4 0.1 CUEDC1 ENSG00000180891 "CUE domain containing 1" Q9NWM3 17 57861243-57955412 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Oligodendrocytes: 117.9;Rod photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "plasmacytoid DC: 21.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 21.7" "Cell line enhanced" "Detected in many" "T-47d: 116.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023050, HPA024836" Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA023050: AB_1847332, HPA024836: AB_1847333" "unprognostic (4.46e-1)" "unprognostic (3.76e-3)" "unprognostic (4.77e-2)" "unprognostic (4.87e-3)" "unprognostic (4.04e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (2.65e-5)" "unprognostic (6.69e-2)" "unprognostic (1.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (2.52e-2)" "unprognostic (2.65e-2)" 18.6 19.3 16.0 14.0 25.1 8.7 17.3 21.3 18.6 31.7 16.8 31.7 7.7 24.9 7.9 32.7 32.7 19.9 39.1 13.8 19.5 22.8 6.1 21.4 7.6 33.3 25.5 11.2 9.6 19.1 11.4 21.7 12.0 35.9 24.7 10.7 30.6 31.2 26.5 87.4 10.6 13.3 25.8 20.6 10.7 23.4 3.3 25.4 5.6 18.3 40.1 5.6 31.6 21.4 32.5 27.1 81.7 83.7 15.1 13.5 24.4 2.8 18.8 37.6 38.5 27.7 15.1 100.9 0.4 74.3 36.2 32.6 21.2 9.3 40.1 13.7 52.8 15.8 0.9 58.4 12.6 32.1 0.3 6.3 25.2 23.7 22.5 18.9 33.8 18.8 0.5 1.1 0.4 35.8 15.2 1.4 0.6 2.9 30.7 22.5 2.8 21.6 4.0 25.8 17.5 34.5 18.9 7.9 8.4 32.0 14.2 116.8 2.9 24.2 101.9 63.4 28.2 42.4 0.0 0.4 0.4 44.3 3.7 83.3 0.7 0.5 2.5 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.2 1.9 21.7 0.0 0.2 16.0 25.1 21.3 18.6 13.8 19.5 33.3 25.5 11.2 35.9 20.6 25.4 32.5 14.1 19.2 5.9 22.5 0.9 4.1 15.6 6.5 13.1 47.1 11.5 11.6 16.1 17.2 10.4 22.0 64.6 0.7 30.9 6.2 7.9 20.3 0.4 24.6 6.3 10.7 3.5 0.0 4.8 26.3 0.4 15.8 10.2 22.9 0.0 10.0 3.9 3.4 17.3 10.1 13.0 4.5 18.3 11.3 7.3 2.9 6.8 12.9 5.4 30.9 4.3 31.8 0.0 31.2 117.9 27.7 2.1 5.3 0.1 21.8 0.7 8.6 17.6 64.8 6.6 26.6 15.3 0.0 1.3 19.0 2.4 0.7 0.7 1.6 4.2 17.3 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribble planar cell polarity protein" Q14160 8 143790920-143815773 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 101.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242" "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 18.8 17.2 11.7 7.3 7.9 5.7 23.8 6.8 9.1 34.6 0.0 29.2 9.2 24.9 0.9 101.3 26.2 3.4 21.3 8.7 4.4 27.9 25.7 21.4 4.1 12.0 8.0 4.6 23.2 39.1 5.3 24.9 5.0 9.0 28.6 3.4 1.0 40.5 5.3 54.8 66.7 26.7 2.0 5.8 23.1 30.3 26.6 7.3 3.0 24.8 1.7 3.9 28.0 53.0 15.6 55.7 33.1 12.7 20.5 5.1 6.9 33.0 30.9 5.3 11.2 9.1 15.3 29.8 24.2 39.7 7.2 4.6 52.4 7.9 32.9 1.7 30.8 58.5 24.6 30.5 26.1 10.8 13.0 14.8 5.1 29.9 9.4 5.5 5.1 11.5 19.8 42.2 6.4 7.5 93.0 38.1 26.9 15.7 25.0 55.1 44.5 10.6 25.0 5.6 45.5 29.6 27.1 31.4 30.5 33.6 4.5 41.5 28.2 25.7 10.1 64.1 25.2 44.7 31.6 31.0 23.8 13.1 9.5 19.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.7 7.9 6.8 9.1 8.7 4.4 12.0 8.0 4.6 9.0 5.8 7.3 15.6 12.3 0.0 9.9 33.0 4.4 8.5 5.0 10.2 13.6 11.3 16.8 17.0 11.1 11.5 8.3 14.7 14.6 11.0 9.7 28.7 3.9 8.6 1.5 14.0 7.7 7.8 13.8 13.7 5.0 9.4 6.3 7.3 29.6 27.3 0.0 17.9 3.6 8.8 6.5 5.0 6.2 17.8 18.3 6.0 4.1 0.7 9.0 6.6 8.8 6.5 5.0 10.0 5.2 12.1 15.2 11.5 22.8 9.8 5.6 9.3 16.9 4.5 9.9 16.0 13.1 12.0 8.7 9.4 10.0 19.9 10.7 5.1 7.3 8.0 23.2 7.1 KCTD2 KIAA0176 ENSG00000180901 "Potassium channel tetramerization domain containing 2" Q14681 17 75032575-75065889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 26.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 37.8;Horizontal cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 8.7;K-562: 8.8;MOLT-4: 8.6;U-266/70: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.62e-1)" "unprognostic (1.83e-1)" "unprognostic (2.66e-1)" "unprognostic (1.00e-3)" "unprognostic (1.73e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (1.83e-4)" "unprognostic (5.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.58e-2)" "prognostic favorable (1.25e-5)" "unprognostic (7.19e-2)" "unprognostic (9.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.10e-2)" "unprognostic (1.16e-2)" "unprognostic (1.60e-1)" 3.0 1.3 5.7 0.0 10.8 0.6 1.1 26.6 13.0 1.3 2.1 1.3 0.1 1.5 0.0 1.1 1.7 0.0 0.9 8.9 6.1 1.7 0.4 0.8 0.1 6.1 7.8 7.4 1.8 0.6 0.0 1.1 0.5 12.0 1.0 0.0 0.3 1.2 0.4 3.7 1.7 0.9 0.0 8.0 0.8 1.0 2.2 11.2 0.0 1.1 0.0 0.0 2.0 1.1 9.9 5.3 0.0 0.1 1.2 0.4 1.2 2.6 7.6 0.7 0.0 0.7 1.0 0.0 7.2 8.0 1.4 0.2 3.4 0.0 0.0 0.0 6.4 8.7 0.8 0.7 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 8.8 0.5 0.0 0.0 8.6 1.4 2.1 0.1 6.8 8.0 0.3 1.8 0.0 0.2 1.1 4.4 1.7 0.1 3.3 0.1 0.9 0.5 1.7 0.1 6.3 0.5 6.0 11.4 4.6 2.4 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.7 10.8 26.6 13.0 8.9 6.1 6.1 7.8 7.4 12.0 8.0 11.2 9.9 8.2 3.2 11.6 8.8 3.2 2.8 2.5 3.8 6.2 37.8 9.6 10.4 15.5 4.3 3.4 7.3 0.0 6.2 5.8 6.7 7.9 4.0 4.6 4.4 8.5 8.0 3.0 0.8 11.8 5.3 4.4 7.6 4.1 5.8 1.3 11.8 15.7 6.6 5.0 35.3 14.0 5.2 6.1 11.6 2.1 9.8 10.8 5.2 3.6 5.6 6.9 17.6 7.2 9.5 21.7 5.3 3.4 23.3 5.3 7.2 4.4 7.4 5.2 9.8 0.0 7.3 6.3 5.2 17.0 4.8 5.1 4.4 4.6 14.5 6.1 4.1 D2HGDH "D2HGD, FLJ42195, MGC25181" ENSG00000180902 "D-2-hydroxyglutarate dehydrogenase" Q8N465 2 241734602-241768816 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.5" "Group enriched" "Detected in many" 4 "B-cells: 2.5;T-cells: 1.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056216, HPA060548" Uncertain Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA056216: AB_2683070, HPA060548: AB_2732650" "unprognostic (2.85e-1)" "unprognostic (3.35e-2)" "unprognostic (6.98e-3)" "unprognostic (7.88e-2)" "unprognostic (2.42e-1)" "prognostic favorable (9.11e-4)" "unprognostic (2.49e-3)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (7.82e-3)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (9.60e-2)" "unprognostic (3.05e-2)" 11.6 17.8 5.6 11.3 6.7 18.7 7.7 6.0 6.8 10.6 12.3 16.7 11.5 11.9 13.1 15.1 16.2 14.2 11.5 5.4 5.3 16.1 19.2 10.7 12.1 7.5 5.7 5.4 14.9 16.7 15.3 10.6 9.0 7.7 14.7 14.7 3.3 18.9 15.0 34.1 39.7 15.0 9.4 5.2 15.3 14.9 5.0 6.1 7.5 18.1 23.9 11.6 9.0 9.6 6.9 10.2 10.5 6.2 9.6 14.7 7.9 21.5 9.7 12.2 9.6 7.7 11.8 21.9 8.3 4.4 9.7 11.0 23.2 5.9 7.8 4.0 8.8 5.7 15.9 11.3 20.5 8.2 19.0 12.1 14.1 13.7 7.6 7.3 18.5 9.5 13.1 20.7 5.3 8.6 16.8 16.0 19.7 3.0 13.8 20.8 19.5 6.9 16.2 17.6 36.7 20.4 7.2 9.4 23.8 6.6 4.1 14.7 6.7 4.1 14.9 5.6 7.9 5.8 9.9 1.9 13.4 10.3 20.8 10.0 0.0 0.2 0.0 0.2 0.2 0.4 2.5 0.1 1.0 0.4 0.1 0.6 0.2 0.0 0.0 0.3 0.1 0.8 0.1 5.6 6.7 6.0 6.8 5.4 5.3 7.5 5.7 5.4 7.7 5.2 6.1 6.9 10.4 9.6 14.3 33.3 10.4 19.8 23.5 13.7 25.6 14.3 22.8 22.7 10.6 25.8 16.3 18.4 14.6 44.0 13.0 40.9 23.5 10.5 3.6 12.5 13.2 9.7 31.8 6.9 7.1 8.7 15.9 15.7 23.0 19.2 5.7 28.0 13.2 46.0 18.2 11.8 9.9 56.4 14.2 10.8 7.5 4.8 16.8 12.6 3.6 15.9 5.3 37.4 8.2 28.6 12.8 6.7 32.0 18.0 15.0 19.3 26.4 31.4 13.9 12.0 6.6 14.0 11.7 2.1 7.0 25.7 14.8 22.6 14.0 27.0 49.9 22.2 OXTR ENSG00000180914 "Oxytocin receptor" P30559 3 8750381-8769628 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 14.8;breast: 54.7" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 122.6;Excitatory neurons: 25.8;Oligodendrocyte precursor cells: 21.1;Respiratory ciliated cells: 57.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 421.2;BJ hTERT+: 127.9;BJ hTERT+ SV40 Large T+: 119.4;fHDF/TERT166: 424.5;HBF TERT88: 92.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.18e-1)" "unprognostic (7.94e-2)" "unprognostic (4.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (2.02e-1)" "unprognostic (1.46e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (3.42e-1)" "unprognostic (2.76e-1)" "unprognostic (3.80e-2)" "unprognostic (4.24e-4)" "unprognostic (8.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-1)" 0.4 0.2 4.3 0.1 7.8 0.6 54.7 3.4 7.3 0.3 1.5 0.2 0.1 3.6 0.3 1.6 3.0 0.3 0.4 3.2 10.6 0.5 0.2 0.9 0.2 14.8 11.3 3.6 3.1 0.1 0.1 0.3 0.5 8.4 0.8 0.1 2.7 0.2 0.8 0.2 0.2 0.2 0.5 5.1 0.3 0.2 0.3 9.8 0.3 0.3 0.1 0.1 0.8 0.2 13.5 1.1 4.6 2.5 0.5 0.5 1.2 0.8 421.2 127.9 119.4 63.4 0.6 11.3 0.3 0.9 424.5 1.7 0.9 2.0 0.9 92.4 3.9 2.1 1.1 1.9 0.7 2.2 1.0 1.0 0.7 0.5 1.7 0.9 36.1 0.2 1.3 0.2 0.8 67.5 0.3 0.9 3.3 2.7 1.4 18.7 0.9 1.6 25.5 4.5 0.4 0.7 0.8 0.7 0.9 0.2 8.1 0.3 0.6 0.6 5.9 1.5 1.2 1.2 0.7 1.2 0.2 0.6 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.3 7.8 3.4 7.3 3.2 10.6 14.8 11.3 3.6 8.4 5.1 9.8 13.5 1.3 9.6 1.1 3.3 0.3 0.4 0.6 1.0 0.0 0.8 2.3 122.6 1.5 1.5 6.5 0.0 0.0 0.2 0.4 0.3 0.0 2.7 1.4 4.7 0.6 0.7 0.0 0.0 25.8 0.0 0.1 2.0 0.0 0.9 0.0 4.3 1.4 0.0 0.2 0.0 14.0 0.0 2.0 0.0 0.0 2.0 0.0 3.1 0.0 5.6 0.1 7.9 0.0 21.1 15.4 1.2 0.1 0.4 0.2 2.2 0.0 0.1 57.1 0.2 0.0 2.0 16.9 1.0 1.8 0.0 0.1 0.0 0.3 3.1 0.1 0.3 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 95.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" NA NA "Cell Junctions" "Nuclear speckles" "HPA041700: AB_2677623, HPA048265: AB_2680334" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favorable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 6.7 8.8 4.1 10.4 4.8 7.2 16.1 4.9 4.2 7.6 7.6 10.2 15.1 8.6 12.4 14.4 9.1 9.5 7.1 3.6 5.7 12.6 14.4 11.5 14.5 5.4 4.8 3.2 11.3 8.2 10.8 7.9 10.6 5.1 10.9 10.5 7.3 13.4 8.1 5.8 10.4 14.3 9.1 5.5 13.7 10.1 14.0 5.0 10.8 14.2 5.8 18.1 9.8 7.7 6.9 17.8 11.6 23.2 19.5 18.9 15.3 10.6 14.9 18.2 17.4 18.4 10.6 26.5 10.0 18.4 13.7 18.9 19.4 11.1 14.2 24.9 10.5 7.9 22.3 13.1 8.3 20.3 16.8 37.7 12.7 24.7 15.4 17.9 12.8 18.5 22.2 11.6 6.6 31.1 15.9 18.8 23.1 11.0 14.2 6.7 28.5 10.2 24.5 16.3 19.5 12.0 12.8 15.1 12.2 15.4 10.3 18.0 10.4 18.7 21.1 15.1 15.5 11.4 13.3 17.6 21.3 14.7 14.6 16.8 22.6 9.6 9.2 10.8 10.3 13.2 13.1 10.6 11.7 13.7 12.0 11.4 11.1 0.7 16.6 6.9 3.9 9.8 11.4 4.1 4.8 4.9 4.2 3.6 5.7 5.4 4.8 3.2 5.1 5.5 5.0 6.9 11.4 3.2 11.8 13.7 28.1 14.1 14.5 10.7 15.9 20.3 23.9 13.7 8.6 20.0 9.4 16.5 31.3 24.2 30.2 25.8 7.9 12.2 95.6 12.6 15.1 14.6 18.6 17.0 9.9 9.7 12.7 11.5 15.8 11.5 8.2 26.1 18.9 32.7 16.1 15.2 10.3 20.5 18.3 18.0 11.4 30.9 16.8 13.6 1.8 21.5 17.8 12.1 51.5 17.6 21.5 12.9 15.2 12.4 17.9 13.5 46.3 17.7 6.5 25.5 6.6 11.1 10.1 26.1 13.8 22.0 24.3 26.4 20.0 21.8 17.9 18.2 OR56B4 ENSG00000180919 "Olfactory receptor family 56 subfamily B member 4" Q8NH76 11 6107684-6108835 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.04e-3)" "unprognostic (8.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (3.83e-1)" "unprognostic (3.01e-1)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-1)" "unprognostic (2.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM83H FLJ46072 ENSG00000180921 "Family with sequence similarity 83 member H" Q6ZRV2 8 143723933-143738234 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 71.1;skin 1: 34.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 58.7;hTCEpi: 59.8;MCF7: 118.2;OE19: 62.4;RT4: 70.1;T-47d: 58.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024505, HPA024604" Enhanced Approved Cytosol NA NA Cytosol "HPA024505: AB_1848417, HPA024604: AB_1848418" "unprognostic (3.80e-2)" "unprognostic (3.75e-3)" "unprognostic (6.87e-2)" "unprognostic (1.63e-2)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.93e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (3.95e-2)" "unprognostic (9.69e-3)" "prognostic favorable (4.42e-4)" "unprognostic (5.54e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" 1.5 4.1 1.9 2.1 1.7 0.5 4.5 1.3 2.2 6.4 2.3 6.5 8.5 0.8 3.3 71.1 4.8 3.3 0.6 2.0 1.1 10.0 13.6 6.4 0.9 1.6 1.5 1.7 0.3 14.0 8.0 5.9 3.5 1.6 7.3 4.3 1.1 17.3 3.9 0.1 34.9 9.2 0.3 1.3 1.7 11.1 2.9 1.3 1.5 14.2 0.0 4.1 8.4 23.4 1.5 47.0 28.3 0.3 0.1 0.1 0.0 16.6 4.0 0.0 2.0 0.7 25.8 53.4 0.0 6.1 1.0 0.0 56.1 3.5 51.9 0.9 0.0 0.2 1.5 58.7 18.3 4.3 0.6 1.7 2.9 59.8 0.2 15.0 0.8 0.0 4.2 22.2 0.1 0.0 118.2 0.8 0.4 4.8 62.4 15.3 0.1 0.1 6.0 16.5 70.1 7.1 0.2 38.3 53.8 7.8 7.5 58.2 8.2 0.3 0.1 7.2 3.9 0.2 0.0 0.0 0.2 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 1.3 2.2 2.0 1.1 1.6 1.5 1.7 1.6 1.3 1.3 1.5 0.1 32.1 16.5 0.7 0.6 22.8 17.7 21.9 6.8 2.0 18.2 14.0 4.6 14.3 18.9 29.5 2.1 12.8 0.5 38.5 3.9 22.0 1.2 11.4 2.9 1.0 14.4 0.0 1.3 25.9 17.8 1.6 25.0 25.9 0.0 5.4 0.7 25.5 4.7 10.1 0.5 24.3 16.2 2.8 0.8 0.7 0.0 1.3 1.8 0.0 2.8 6.6 2.1 0.5 0.1 42.7 27.2 0.4 0.4 26.4 23.6 7.0 17.4 2.0 0.0 0.2 1.9 1.7 1.0 38.9 26.9 14.6 0.9 1.2 27.8 33.9 GPR62 ENSG00000180929 "G protein-coupled receptor 62" Q9BZJ7 3 51955381-51957499 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 35.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.0;Cone photoreceptor cells: 4.2;Horizontal cells: 5.0;Oligodendrocytes: 18.7" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.56e-3)" "unprognostic (3.32e-3)" "unprognostic (2.21e-1)" "unprognostic (6.38e-2)" "unprognostic (7.98e-2)" "unprognostic (1.66e-2)" "unprognostic (9.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.03e-2)" "unprognostic (6.17e-2)" "unprognostic (3.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.82e-5)" "unprognostic (3.64e-2)" "unprognostic (2.45e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-2)" 0.1 0.2 11.4 0.0 20.8 0.0 0.1 17.3 15.2 0.1 4.2 0.1 0.0 0.2 0.2 0.0 0.2 0.1 0.3 11.3 15.2 0.1 0.2 0.0 0.0 21.3 19.1 9.6 0.4 0.0 0.0 0.4 0.0 20.7 0.2 0.0 5.2 0.1 0.1 0.7 0.1 0.0 0.0 16.2 0.0 0.1 0.1 17.1 0.0 0.1 0.0 0.0 0.2 0.1 35.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 20.8 17.3 15.2 11.3 15.2 21.3 19.1 9.6 20.7 16.2 17.1 35.6 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.0 0.1 0.1 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 OR56A1 ENSG00000180934 "Olfactory receptor family 56 subfamily A member 1" 11 6019336-6034338 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ZNF572 FLJ38002 ENSG00000180938 "Zinc finger protein 572" Q7Z3I7 8 124973295-124979389 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 3.9;Inhibitory neurons: 2.5;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.7;Spermatogonia: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 4.1" "Low region specificity" "Detected in all" HPA066838 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA066838: AB_2685734" "unprognostic (8.65e-2)" "unprognostic (3.11e-1)" "unprognostic (5.59e-2)" "unprognostic (2.33e-2)" "unprognostic (1.49e-3)" "unprognostic (8.37e-2)" "unprognostic (4.11e-2)" "unprognostic (1.81e-2)" "unprognostic (3.36e-1)" "unprognostic (8.88e-2)" "unprognostic (8.67e-2)" "unprognostic (2.42e-2)" "unprognostic (1.43e-1)" "unprognostic (8.95e-3)" "unprognostic (2.89e-1)" "unprognostic (2.82e-1)" "unprognostic (6.17e-2)" 0.5 0.3 0.9 1.0 1.3 0.1 1.9 1.0 1.2 1.0 0.6 1.0 0.9 1.5 2.2 0.5 1.5 0.7 1.0 0.8 1.2 1.7 0.9 0.8 1.9 1.2 1.1 0.7 2.3 1.0 0.6 0.4 1.5 1.2 1.4 1.3 1.9 1.3 1.5 0.2 0.8 0.9 0.8 1.1 1.5 1.4 3.7 1.0 1.9 1.8 0.2 1.9 1.1 0.8 1.6 1.0 0.5 1.1 0.0 1.5 1.7 0.0 0.3 0.1 1.3 0.7 1.4 0.7 2.5 1.6 0.4 0.2 1.9 0.6 0.0 1.1 0.0 0.5 0.0 0.7 1.7 1.2 0.0 1.2 1.3 1.6 1.3 0.0 0.3 0.8 0.0 1.5 0.0 1.7 4.1 0.0 0.0 0.0 2.4 0.0 1.6 2.8 0.3 0.7 0.7 2.5 2.4 1.5 2.4 2.6 2.1 1.0 1.6 0.5 1.5 1.7 0.4 0.0 0.0 1.4 1.1 0.3 0.0 0.1 0.0 0.1 0.3 0.2 0.3 0.4 0.6 0.2 0.1 0.1 0.6 0.8 0.5 0.0 0.7 0.2 0.0 0.0 0.1 0.9 1.3 1.0 1.2 0.8 1.2 1.2 1.1 0.7 1.2 1.1 1.0 1.6 0.2 0.0 0.0 3.9 0.8 0.1 0.2 0.0 0.0 1.0 0.3 0.4 0.6 0.0 0.6 0.0 0.0 0.9 0.2 0.2 1.9 0.3 0.5 0.9 0.5 0.4 0.0 0.4 1.3 0.2 0.3 0.4 0.0 0.3 0.0 1.6 0.4 0.3 0.4 0.0 2.5 0.1 0.0 0.3 0.0 0.4 0.0 0.2 0.0 2.8 0.6 2.3 1.0 2.5 2.7 0.0 0.1 1.2 0.0 0.1 0.1 1.0 0.9 0.6 0.0 0.1 0.2 2.4 2.8 0.3 0.0 0.3 0.3 0.5 0.6 0.1 ST20 HCCS-1 ENSG00000180953 "Suppressor of tumorigenicity 20" Q9HBF5 15 79898840-79923702 "Metabolic proteins, Predicted intracellular proteins" "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 51.3;monocytes: 84.8;Proximal tubular cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "eosinophil: 88.6;neutrophil: 313.4" "Lineage enriched" "Detected in all" 11 "granulocytes: 313.4" "Cell line enhanced" "Detected in many" "SK-MEL-30: 54.6" NA NA "unprognostic (2.48e-1)" "unprognostic (1.28e-1)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (2.04e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (1.35e-3)" "unprognostic (4.21e-2)" "unprognostic (3.03e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (7.69e-8)" "unprognostic (6.49e-2)" "unprognostic (2.61e-2)" "unprognostic (9.88e-2)" "unprognostic (4.19e-2)" 6.7 5.5 9.7 7.0 9.5 4.9 7.6 11.7 12.5 7.7 9.4 7.2 2.0 5.2 8.4 6.4 8.0 2.8 8.7 9.3 9.9 11.6 24.0 10.5 7.6 9.1 9.2 9.1 7.1 6.6 4.9 11.3 3.3 10.1 11.1 2.7 9.0 6.1 3.4 4.1 6.9 10.1 2.8 9.0 24.3 5.7 11.1 9.6 6.3 10.6 4.9 5.6 7.9 5.9 10.8 8.6 17.6 7.7 9.3 12.9 10.9 16.2 8.7 5.8 4.5 5.8 3.8 13.7 10.4 5.5 6.5 14.8 14.0 16.2 5.0 3.3 14.8 13.6 12.1 13.5 5.4 11.6 4.6 6.8 12.1 6.4 3.2 9.2 12.4 5.0 19.6 10.1 6.1 7.1 26.4 6.2 31.6 17.8 26.8 11.6 9.1 2.5 5.5 11.4 7.2 11.0 11.9 16.2 10.8 54.6 19.8 9.0 29.4 6.0 11.4 2.9 0.0 7.3 6.6 37.4 16.5 8.8 25.3 5.9 2.2 17.5 88.6 8.0 10.9 6.8 17.1 9.1 8.9 14.1 17.0 8.5 7.8 313.4 18.8 27.8 8.0 8.8 11.0 9.7 9.5 11.7 12.5 9.3 9.9 9.1 9.2 9.1 10.1 9.0 9.6 10.8 2.7 6.4 17.9 0.0 6.1 4.8 6.8 17.5 1.2 8.6 16.5 22.1 13.5 7.2 11.8 14.7 8.4 12.2 5.6 12.1 23.5 17.0 17.1 6.9 6.5 5.2 19.3 4.0 0.0 11.9 9.9 5.9 4.1 10.0 7.0 10.2 6.1 51.3 40.0 1.7 0.0 11.7 16.2 8.8 8.1 6.4 7.2 17.7 5.4 0.0 84.8 14.8 2.1 0.0 0.0 15.9 23.2 4.9 1.6 10.9 23.9 52.3 9.8 5.9 6.6 4.4 6.2 23.4 23.5 3.2 4.3 43.1 6.0 6.5 10.7 6.6 PITPNB VIB1B ENSG00000180957 "Phosphatidylinositol transfer protein beta" P48739 22 27851669-27920134 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol NA NA 300000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (9.29e-2)" "unprognostic (1.64e-1)" "unprognostic (4.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.34e-1)" "unprognostic (7.52e-3)" "unprognostic (4.78e-2)" "unprognostic (8.22e-3)" "unprognostic (1.56e-3)" "unprognostic (2.42e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (6.28e-2)" "unprognostic (2.89e-2)" "unprognostic (1.64e-1)" 40.6 27.4 31.5 33.6 32.9 21.8 33.3 33.4 34.9 29.2 30.8 44.0 22.1 31.8 28.8 53.0 29.5 35.7 36.1 33.4 33.7 25.5 57.4 32.4 34.8 32.3 34.2 29.1 30.2 28.6 24.2 22.6 49.6 31.9 27.7 30.4 18.2 24.9 37.3 21.4 30.5 28.3 44.6 31.7 28.0 35.6 19.6 33.2 33.7 25.0 21.9 41.4 54.8 36.9 32.6 94.1 39.8 71.5 53.8 62.3 74.7 54.5 88.8 77.4 95.5 91.7 63.4 43.1 64.7 46.0 86.0 70.5 96.6 103.0 88.7 133.2 111.1 97.4 66.1 62.0 58.5 66.9 152.5 102.6 67.2 85.0 115.7 119.6 62.9 94.4 44.8 95.3 130.5 88.5 50.0 64.9 74.7 54.4 97.8 52.1 81.6 112.9 95.6 79.1 87.6 83.6 104.7 60.8 72.7 75.7 75.9 39.4 53.7 93.2 94.9 138.9 72.9 94.2 53.0 66.7 125.2 81.6 74.1 82.2 36.0 18.6 18.6 30.9 21.7 34.0 35.2 29.7 32.3 24.9 30.9 28.4 28.0 16.7 27.4 21.2 22.2 40.8 26.0 31.5 32.9 33.4 34.9 33.4 33.7 32.3 34.2 29.1 31.9 31.7 33.2 32.6 97.0 28.9 32.4 57.8 44.3 96.0 128.9 40.8 65.4 24.1 37.4 33.4 57.8 35.8 48.4 31.3 14.6 39.7 45.9 26.1 37.2 49.0 21.4 55.4 72.5 62.4 25.2 15.8 51.8 50.2 52.3 65.9 32.6 79.8 21.5 37.0 30.7 45.8 27.3 32.0 45.7 26.7 24.4 23.6 42.2 6.9 32.0 35.1 26.6 68.4 55.6 17.4 48.4 60.8 67.0 66.7 21.1 48.2 54.2 97.5 17.2 29.6 22.8 16.1 26.3 57.9 76.7 44.0 35.4 60.9 82.1 48.6 42.3 46.9 24.0 112.9 TCEAL8 "MGC45400, WEX3" ENSG00000180964 "Transcription elongation factor A like 8" Q8IYN2 X 103252995-103255192 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059115 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059115: AB_2683909" "unprognostic (1.51e-2)" "unprognostic (4.56e-2)" "unprognostic (9.24e-2)" "unprognostic (7.13e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (8.53e-6)" "unprognostic (3.71e-3)" "unprognostic (1.88e-2)" "unprognostic (5.52e-2)" "unprognostic (4.80e-3)" "unprognostic (4.03e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (3.26e-2)" "unprognostic (7.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.32e-2)" 43.3 63.2 60.2 36.6 61.3 29.6 60.6 62.8 69.2 67.8 61.7 48.4 30.7 58.8 132.3 39.2 45.7 57.6 94.0 60.5 65.2 70.0 43.1 44.2 48.0 61.3 60.7 57.6 70.0 41.3 71.6 57.0 62.7 61.7 59.8 50.0 33.4 62.0 56.6 19.0 39.6 40.7 63.7 63.7 46.2 42.4 43.3 61.2 72.6 72.0 32.3 46.1 57.8 36.8 63.8 49.2 26.4 110.9 51.8 161.9 269.3 53.2 104.9 154.7 90.6 141.0 20.6 94.5 25.8 68.2 120.7 157.7 32.1 19.6 120.0 116.5 0.4 61.5 111.2 34.5 30.8 98.8 114.4 105.6 184.9 68.0 79.5 0.0 190.3 123.9 75.3 135.0 23.8 223.6 0.0 98.2 43.9 123.2 4.4 52.7 37.1 152.8 7.6 124.7 36.4 57.7 75.4 58.3 18.1 130.8 105.7 33.9 38.0 83.1 53.5 71.0 164.4 35.2 26.2 49.8 1.1 86.7 61.0 87.6 73.7 31.9 20.0 66.3 29.3 76.6 62.4 78.1 71.4 58.2 52.6 84.5 73.5 3.0 120.6 23.2 101.3 109.5 54.5 60.2 61.3 62.8 69.2 60.5 65.2 61.3 60.7 57.6 61.7 63.7 61.2 63.8 72.3 51.3 66.7 6.8 32.7 60.8 83.9 169.4 68.9 52.3 70.5 69.2 76.6 104.4 89.4 97.5 10.4 188.8 48.5 27.5 273.9 137.8 6.8 46.2 71.8 85.0 78.5 33.2 10.3 109.4 176.3 93.9 29.6 49.7 69.6 76.2 169.6 102.5 98.7 50.5 10.0 133.7 81.4 90.6 81.1 17.2 125.9 52.4 120.9 10.3 71.4 110.4 104.0 7.1 11.3 68.2 49.2 121.9 27.2 51.3 73.5 276.2 60.1 37.5 85.5 80.6 77.4 5.6 4.0 47.6 59.5 134.9 45.1 68.1 78.7 79.5 OR52E4 ENSG00000180974 "Olfactory receptor family 52 subfamily E member 4" Q8NGH9 11 5880629-5887079 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Cell type enhanced" "Detected in single" "Early spermatids: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.3 0.1 0.4 0.2 0.1 1.0 0.9 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.6 0.1 0.0 0.2 0.5 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.9 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.1 0.1 0.5 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.9 0.4 0.0 0.1 0.1 0.6 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol NA NA 26000 "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favorable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 7.6 7.4 4.8 5.6 4.6 22.2 7.6 4.7 8.0 6.9 4.1 9.4 6.5 7.8 5.6 9.7 8.4 5.3 6.9 6.1 3.5 7.9 6.2 8.7 6.7 3.8 3.5 4.6 8.7 7.4 14.1 6.0 7.9 4.3 6.7 10.8 15.0 8.1 5.9 6.1 9.4 8.1 7.4 3.3 6.8 7.8 5.8 4.4 9.7 7.1 6.9 7.4 6.8 8.7 5.5 14.7 11.0 19.5 13.8 16.5 12.7 9.7 20.5 11.2 14.7 15.4 23.3 11.0 6.8 13.8 16.9 16.5 22.7 13.2 16.7 14.7 12.8 12.2 27.7 23.6 10.7 14.7 17.8 15.0 14.0 22.8 13.2 17.1 10.1 23.7 17.3 21.9 14.5 13.6 6.6 9.8 7.5 4.6 26.6 8.5 15.1 19.6 10.5 9.8 24.4 9.8 11.9 24.8 16.3 11.8 12.7 16.1 19.6 24.3 16.5 11.4 17.5 15.5 11.9 36.4 29.0 8.9 16.4 21.0 36.9 9.7 32.0 7.4 14.6 9.3 5.8 7.2 7.2 10.2 7.1 5.8 7.3 12.2 16.9 19.3 5.9 8.5 6.9 4.8 4.6 4.7 8.0 6.1 3.5 3.8 3.5 4.6 4.3 3.3 4.4 5.5 16.3 9.6 10.8 6.8 10.4 5.7 13.6 6.5 6.8 13.6 9.6 8.1 11.1 15.7 7.3 9.2 60.5 11.6 18.8 16.4 13.7 10.9 18.7 13.5 13.8 17.3 12.5 15.8 17.1 9.8 19.3 12.7 9.2 13.2 14.5 10.2 19.2 7.5 14.1 20.2 8.8 13.1 6.1 14.2 4.8 20.0 9.6 13.1 7.2 7.5 21.9 21.1 20.6 11.6 8.3 15.2 15.9 16.1 8.4 12.4 15.2 8.4 14.8 87.4 6.6 16.9 10.1 7.8 6.4 11.4 5.5 15.9 11.3 18.4 12.2 12.8 OR52N2 ENSG00000180988 "Olfactory receptor family 52 subfamily N member 2" Q8NGI0 11 5820314-5821348 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "Early spermatids: 2.2;Late spermatids: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 40 "basophil: 4.9" "Lineage enriched" "Detected in single" 40 "granulocytes: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.45e-1)" "unprognostic (2.81e-1)" "unprognostic (3.44e-1)" "unprognostic (7.82e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MRPL14 "MRP-L32, RPML32" ENSG00000180992 "Mitochondrial ribosomal protein L14" Q6P1L8 6 44113451-44127452 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 183.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 622.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038769, HPA076790" Uncertain Supported Mitochondria NA NA Mitochondria "HPA038769: AB_10673288, HPA076790: AB_2686815" "unprognostic (4.58e-1)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.21e-2)" "unprognostic (7.20e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.74e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (7.46e-5)" "unprognostic (7.13e-2)" "unprognostic (1.65e-1)" "prognostic favorable (1.08e-4)" "unprognostic (3.27e-2)" 23.7 41.3 27.0 22.7 27.5 20.8 25.2 26.6 28.7 22.7 26.3 37.1 36.4 29.6 25.8 42.3 23.1 16.3 42.7 27.0 27.1 34.8 80.9 58.3 26.2 26.8 26.4 26.6 16.3 25.1 20.8 23.4 26.6 27.0 25.2 35.2 23.8 30.2 19.4 183.5 43.6 29.8 27.9 27.6 26.3 30.4 51.8 27.2 35.6 24.5 110.4 28.9 36.2 27.8 27.9 216.0 90.2 62.5 87.1 53.0 51.4 79.6 78.5 77.8 102.6 101.6 189.1 73.8 93.1 86.7 67.4 98.2 85.9 71.2 127.9 80.8 111.2 193.8 96.1 77.2 235.1 65.3 92.1 64.8 48.2 68.5 96.7 57.1 78.7 85.9 78.8 205.9 58.3 91.7 216.3 111.4 144.6 54.8 622.6 85.8 78.8 70.2 126.7 170.8 104.9 138.8 54.2 50.4 97.5 101.7 53.9 89.5 93.1 69.1 90.4 135.6 65.6 137.9 71.9 68.3 221.8 102.3 90.5 67.4 45.3 115.6 26.3 79.0 113.7 95.1 111.9 100.3 90.5 108.3 105.3 79.2 81.1 6.7 171.4 78.4 122.2 76.1 107.1 27.0 27.5 26.6 28.7 27.0 27.1 26.8 26.4 26.6 27.0 27.6 27.2 27.9 48.2 375.0 250.0 3.6 64.5 231.1 200.5 362.7 65.4 29.8 126.6 146.3 136.9 112.9 217.2 57.0 31.3 179.5 51.1 257.9 203.5 205.3 293.1 94.9 66.0 82.0 93.4 78.4 5.0 220.2 206.2 76.4 82.0 101.5 44.4 83.4 50.3 341.2 279.8 33.7 5.3 158.3 219.7 52.0 164.6 122.9 74.6 66.1 69.4 3.7 152.9 66.0 85.5 4.5 7.3 333.0 278.5 53.4 73.7 376.8 203.7 258.7 157.5 70.0 46.0 63.3 149.4 199.2 122.3 116.6 281.3 160.1 56.3 100.5 199.5 376.3 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52552836-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 16.0;epididymis: 8.1;retina: 17.5" "Group enriched" "Detected in many" 5 "Excitatory neurons: 85.5;Inhibitory neurons: 125.4;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 9 "NK-cells: 1.5;T-cells: 1.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 0.5 0.8 5.9 0.2 4.9 0.9 0.5 16.0 8.3 0.6 0.0 0.4 0.7 0.8 8.1 0.4 0.3 1.2 1.0 5.1 7.1 0.3 0.6 0.8 0.4 7.3 7.9 6.3 0.7 0.2 0.4 1.5 0.4 7.7 0.7 0.4 17.5 0.2 0.4 0.5 0.2 0.3 0.5 3.2 1.0 0.4 2.9 7.3 0.3 0.6 0.6 0.1 0.4 0.3 9.3 0.8 0.3 6.6 6.4 1.7 0.6 2.7 3.3 2.2 3.2 7.8 0.9 1.4 0.2 1.9 2.2 6.5 1.5 2.5 0.5 4.5 0.4 1.7 0.3 1.5 0.4 0.1 0.1 1.1 0.4 0.0 2.8 0.2 0.6 1.5 1.1 0.9 2.3 4.4 3.8 0.1 0.6 1.1 0.4 4.1 1.2 4.3 0.3 1.0 4.8 7.4 9.1 1.3 0.2 0.1 2.7 4.4 0.0 0.0 6.8 7.6 5.5 2.3 0.4 1.6 0.8 1.5 0.1 1.9 0.0 0.0 0.0 1.0 0.0 1.4 0.0 0.5 1.4 0.0 0.0 0.3 0.5 0.1 1.5 0.1 0.0 0.5 0.2 5.9 4.9 16.0 8.3 5.1 7.1 7.3 7.9 6.3 7.7 3.2 7.3 9.3 2.8 0.0 1.3 20.2 0.7 0.6 0.7 0.1 2.2 22.4 1.4 1.4 2.5 1.5 0.1 0.0 2.1 0.3 0.4 0.4 0.0 0.3 2.3 3.4 1.6 3.8 1.2 0.0 85.5 0.2 0.3 1.9 1.1 6.2 0.0 5.6 2.2 0.5 0.5 6.7 125.4 0.7 0.0 2.2 0.8 1.5 0.6 0.9 1.8 21.5 0.2 5.4 1.0 101.6 137.4 0.0 0.0 0.7 1.0 1.8 0.1 0.2 0.1 20.2 0.0 1.1 1.7 6.9 5.1 1.3 0.9 0.1 1.2 1.2 0.1 0.5 C1orf105 ENSG00000180999 "Chromosome 1 open reading frame 105" O95561 1 172420685-172468831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 15.5;testis: 26.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 193.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "BEWO: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.50e-2)" "unprognostic (2.48e-4)" "unprognostic (7.11e-2)" "unprognostic (1.12e-2)" "unprognostic (7.07e-4)" "unprognostic (1.27e-3)" "unprognostic (3.02e-2)" "unprognostic (1.47e-2)" "unprognostic (8.22e-2)" "unprognostic (1.92e-1)" "unprognostic (1.18e-1)" "unprognostic (7.65e-4)" "unprognostic (3.85e-1)" "unprognostic (1.94e-1)" 0.0 0.2 0.5 0.0 0.8 2.1 0.0 1.4 0.6 0.0 0.1 0.0 0.1 0.0 5.5 0.5 0.0 0.1 15.5 0.5 0.6 0.2 0.2 0.0 0.1 0.6 0.4 0.4 0.0 0.5 0.0 0.0 0.6 0.7 1.3 0.0 0.2 1.2 0.1 1.4 0.6 0.6 0.0 0.2 0.1 0.1 26.6 0.6 0.4 0.2 3.3 0.0 0.0 0.0 1.5 0.0 0.3 0.3 0.1 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.8 1.4 0.6 0.5 0.6 0.6 0.4 0.4 0.7 0.2 0.6 1.5 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 193.9 0.0 0.0 0.3 0.0 0.0 0.5 0.6 13.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 24.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.9 0.0 0.0 1.2 0.0 0.0 3.8 1.9 0.0 0.0 0.0 0.5 2.7 45.6 3.2 0.0 0.0 1.8 0.0 0.1 0.1 0.0 OR52N1 ENSG00000181001 "Olfactory receptor family 52 subfamily N member 1" Q8NH53 11 5786471-5791265 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054028 Uncertain NA NA "HPA054028: AB_2682348" 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.4 0.3 0.1 0.2 0.4 0.1 0.2 0.5 0.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BBS12 "C4orf24, FLJ35630, FLJ41559" ENSG00000181004 "Bardet-Biedl syndrome 12" Q6ZW61 4 122732702-122744942 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 17.7" "Cell type enhanced" "Detected in many" "Early spermatids: 57.0;Rod photoreceptor cells: 37.1;Spermatocytes: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061856 Approved NA NA "HPA061856: AB_2684626" "unprognostic (9.59e-2)" "unprognostic (2.27e-1)" "unprognostic (8.55e-2)" "prognostic favorable (5.69e-4)" "unprognostic (7.61e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-3)" "unprognostic (1.15e-1)" "unprognostic (2.84e-1)" "unprognostic (2.52e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "prognostic favorable (9.89e-6)" "unprognostic (1.36e-1)" "unprognostic (8.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" 2.2 2.5 2.9 1.4 3.1 0.3 2.7 2.1 3.2 3.0 4.2 2.2 2.5 2.8 4.7 1.5 5.0 1.9 3.7 2.7 3.4 9.5 0.9 2.3 1.5 2.5 2.8 2.7 2.7 1.8 8.0 3.7 2.0 2.5 1.7 2.0 17.7 1.8 2.9 0.6 1.2 2.5 2.6 2.6 1.8 1.5 7.9 3.0 1.8 9.4 1.0 1.6 1.9 1.5 2.5 1.8 1.8 2.8 3.3 8.3 10.1 1.1 2.5 4.6 3.3 3.4 1.2 2.9 1.1 2.0 3.7 3.6 1.4 2.2 3.2 3.3 4.0 1.9 0.4 2.6 1.2 5.6 1.2 1.8 7.2 8.2 4.3 6.1 11.4 3.6 2.0 4.2 1.3 4.5 1.2 2.3 0.8 1.6 1.2 1.5 1.4 7.7 0.6 7.8 0.5 1.7 3.2 3.7 0.8 2.9 5.8 1.1 1.1 3.4 2.8 1.5 2.6 1.4 2.2 1.2 0.8 4.2 0.9 4.6 0.9 1.2 2.0 1.4 1.6 1.7 2.1 1.8 2.1 1.2 0.9 1.9 1.8 0.0 1.2 2.1 1.2 1.9 1.2 2.9 3.1 2.1 3.2 2.7 3.4 2.5 2.8 2.7 2.5 2.6 3.0 2.5 1.3 6.4 1.1 1.6 0.7 1.0 1.2 1.9 0.6 6.1 1.5 1.4 3.9 1.5 2.5 0.0 2.1 6.8 0.4 3.5 3.9 5.5 57.0 7.5 3.1 2.4 3.0 2.7 5.4 2.7 1.7 2.4 1.5 1.9 1.3 3.4 3.3 0.9 1.9 3.3 4.1 2.0 4.1 1.6 1.4 12.0 4.1 0.9 5.4 1.9 1.4 11.7 1.0 4.5 0.9 4.5 5.9 6.8 0.6 1.0 7.4 17.4 12.7 37.1 6.6 1.2 2.3 33.2 4.4 0.9 1.0 4.4 1.2 5.8 2.0 0.7 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418644 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: AB_2732568, HPA060470: AB_2684290" "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 2.1 2.1 5.3 1.3 5.7 0.7 2.7 7.4 6.9 3.6 4.3 2.2 0.7 3.1 4.3 0.9 3.0 1.9 2.4 5.6 5.3 2.0 0.6 1.5 2.6 5.2 5.3 5.3 4.5 1.2 2.8 3.1 2.4 5.4 2.7 1.1 5.2 1.4 1.8 0.8 0.9 1.8 2.3 5.0 2.7 1.3 2.5 5.1 2.9 4.1 1.2 2.6 3.0 2.3 5.7 0.1 2.8 8.6 7.3 2.0 2.8 2.7 2.9 3.2 5.0 6.3 1.3 1.0 7.0 5.5 3.2 4.8 0.3 0.0 0.8 6.1 4.6 4.0 7.2 1.5 1.6 4.9 0.0 5.7 3.8 1.1 3.4 0.9 0.0 2.2 9.8 0.1 0.1 5.3 0.0 12.2 0.1 4.8 0.0 1.2 8.8 5.2 1.5 2.8 3.9 0.4 8.6 0.0 0.6 4.0 6.4 1.7 4.1 0.5 2.1 2.8 4.3 5.6 5.6 3.7 10.0 0.1 0.1 4.6 0.2 0.5 0.7 2.7 0.5 2.6 4.8 2.6 3.0 1.3 4.3 4.0 3.6 0.4 2.5 0.6 1.6 1.7 1.5 5.3 5.7 7.4 6.9 5.6 5.3 5.2 5.3 5.3 5.4 5.0 5.1 5.7 3.6 0.0 6.4 7.5 9.0 1.0 2.3 2.4 1.8 20.3 3.7 3.6 4.6 1.5 3.4 5.5 22.9 7.8 3.5 0.1 9.8 6.0 11.2 2.2 4.6 5.9 3.0 1.7 16.4 1.4 5.9 5.5 0.5 1.7 6.3 11.4 3.3 0.6 4.4 33.7 19.0 0.3 6.1 2.6 3.4 2.5 5.9 3.5 5.4 6.5 1.4 7.9 3.1 21.1 22.1 1.1 0.2 7.5 3.2 1.9 0.4 4.8 6.1 11.8 19.7 4.7 5.0 17.5 9.1 0.6 0.6 1.4 5.7 7.6 0.9 1.2 OR52N5 OR52N5Q ENSG00000181009 "Olfactory receptor family 52 subfamily N member 5" Q8NH56 11 5776165-5783355 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Adipocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 82.3" "Cell type enhanced" "Detected in many" "Early spermatids: 49.2;Glandular and luminal cells: 27.7;Late spermatids: 67.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HeLa: 8.7" "Group enriched" "Detected in many" 4 "amygdala: 1.4;basal ganglia: 1.0;cerebellum: 4.0;olfactory bulb: 3.3" "Low region specificity" "Detected in many" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 2.1 2.1 1.6 0.2 1.8 0.3 1.6 2.2 2.3 1.6 1.4 2.0 0.5 1.1 1.0 2.0 1.6 0.1 2.9 1.4 1.6 4.0 7.3 4.3 0.1 1.6 1.4 1.5 1.7 5.5 0.0 2.3 0.2 1.7 2.5 0.3 0.8 1.7 0.3 82.3 1.3 2.2 0.1 1.4 4.2 2.7 3.0 1.5 0.1 2.2 17.2 0.0 1.8 2.2 2.0 0.0 0.1 0.1 0.6 0.5 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.2 8.7 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.9 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.7 1.3 0.0 0.2 0.4 0.1 0.0 0.2 0.5 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 2.2 2.3 1.4 1.6 1.6 1.4 1.5 1.7 1.4 1.5 2.0 16.8 0.0 2.8 5.9 5.1 5.5 2.7 1.3 9.6 2.1 12.8 23.4 9.9 2.8 2.2 1.8 2.1 1.3 9.5 17.5 0.0 0.8 49.2 12.7 18.4 5.3 3.0 0.0 8.5 0.9 1.1 7.2 7.7 27.7 0.0 0.5 1.1 1.0 4.0 0.0 7.6 5.7 0.0 1.2 4.8 67.8 0.9 13.6 1.8 3.7 1.8 0.6 0.0 1.5 5.0 0.8 7.1 0.4 4.2 6.1 5.2 0.5 1.4 3.2 0.0 22.3 8.1 0.5 0.5 9.5 4.7 1.9 6.3 2.2 5.4 3.6 OR56B2P OR56B2 ENSG00000181017 "Olfactory receptor family 56 subfamily B member 2 pseudogene" 11 5761153-5767465 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NQO1 "DHQU, DIA4, DTD, NMOR1, QR1" ENSG00000181019 "NAD(P)H quinone dehydrogenase 1" P15559 16 69706996-69726668 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 527.4" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 539.8;Respiratory ciliated cells: 471.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 2434.0;OE19: 4177.0;SiHa: 2756.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007308, CAB012421" Enhanced Supported Cytosol NA NA 490000 Cytosol "CAB012421: , HPA007308: AB_1079501" "unprognostic (1.04e-2)" "unprognostic (1.95e-3)" "unprognostic (3.14e-1)" "unprognostic (3.76e-3)" "unprognostic (9.03e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.05e-3)" "unprognostic (1.97e-1)" "unprognostic (5.07e-2)" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-2)" "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.27e-1)" 101.1 95.9 103.5 20.9 106.6 0.8 267.4 99.2 142.8 24.6 116.3 86.4 107.8 16.2 27.5 163.5 29.5 184.7 23.4 101.3 125.2 92.2 5.6 36.8 4.9 115.6 95.2 93.2 9.0 9.2 19.6 15.4 12.1 101.4 20.9 74.7 21.6 48.1 25.4 34.5 11.2 56.6 35.3 93.0 23.0 527.4 6.5 101.4 4.4 113.6 27.2 16.6 79.6 34.4 171.2 224.2 2434.0 203.4 901.3 473.1 682.7 77.5 363.1 632.7 363.9 547.0 302.0 1395.7 7.1 433.1 1850.6 634.3 232.1 79.1 410.3 185.2 91.3 3.3 10.9 564.4 2169.9 631.7 53.8 170.6 166.2 246.8 642.8 74.4 537.9 903.9 18.5 95.3 16.3 1914.1 725.9 11.6 98.7 107.0 4177.0 237.1 18.9 44.0 101.6 708.3 781.5 73.0 17.2 2756.6 384.8 1690.4 226.6 631.3 173.1 626.5 368.8 155.8 140.0 297.1 12.7 53.1 11.2 470.2 29.1 1864.0 1.1 3.9 0.3 6.3 0.4 3.1 5.7 7.3 8.3 3.8 2.4 2.2 5.3 0.9 18.7 0.4 1.3 15.6 5.1 103.5 106.6 99.2 142.8 101.3 125.2 115.6 95.2 93.2 101.4 93.0 101.4 171.2 88.5 25.6 14.6 8.8 2.9 5.2 26.4 185.5 32.5 10.0 31.1 30.5 4.8 138.7 90.9 42.3 4.2 1.7 3.5 165.7 146.8 25.6 0.4 117.2 11.7 81.0 20.4 1.3 1.9 147.5 4.3 32.9 539.8 65.7 19.7 10.1 28.5 2.6 15.2 3.3 1.6 81.7 107.8 3.5 7.6 1.2 25.1 10.9 17.8 4.7 128.5 10.6 7.2 0.0 5.0 75.1 59.4 12.0 2.3 22.6 62.9 44.3 471.3 15.1 6.6 21.1 72.1 0.3 1.3 128.3 4.5 1.9 5.6 17.3 51.5 40.6 OR56B1 OR56B1P ENSG00000181023 "Olfactory receptor family 56 subfamily B member 1" Q8NGI3 11 5736448-5738523 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045043 Uncertain NA NA "HPA045043: AB_10794296" 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621337-88632281 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 62.7" "Cancer enhanced" "Detected in all" "testis cancer: 38.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 7.0 12.3 6.7 10.8 6.7 17.9 6.0 6.4 6.5 6.8 6.4 8.3 5.1 7.6 9.7 9.7 7.1 12.7 6.4 6.1 10.4 7.0 13.6 10.2 12.9 8.2 7.3 6.2 8.0 21.1 4.5 22.6 7.0 7.4 12.2 8.7 1.0 8.4 8.3 15.2 6.4 9.1 10.2 7.3 15.4 13.3 9.9 8.5 10.8 10.3 3.7 12.0 11.6 6.0 8.0 14.9 64.5 39.6 34.2 17.4 20.7 83.7 51.5 46.8 39.1 47.8 53.8 28.2 63.6 16.1 28.3 35.0 20.9 148.0 42.1 32.6 15.7 58.2 34.0 26.4 89.9 42.0 28.5 32.8 25.6 36.4 48.5 39.7 14.0 33.0 20.6 54.6 35.2 48.3 34.4 35.5 24.0 96.0 30.8 36.9 45.4 28.2 46.9 16.5 31.9 31.1 28.5 20.8 23.7 40.1 90.7 19.7 32.0 29.9 39.5 55.1 16.2 70.5 67.0 48.5 54.7 36.0 31.5 79.1 0.0 2.3 0.8 6.2 3.7 12.0 10.9 10.8 8.4 5.2 10.3 11.6 10.6 0.6 3.9 4.9 3.1 19.6 9.2 6.7 6.7 6.4 6.5 6.1 10.4 8.2 7.3 6.2 7.4 7.3 8.5 8.0 6.9 6.4 8.1 4.2 21.0 18.6 25.8 6.2 12.0 1.2 21.4 15.4 3.9 8.6 12.9 1.8 0.0 4.7 8.4 5.6 3.9 11.4 23.6 22.5 5.3 7.6 9.0 11.8 20.5 7.6 16.3 9.0 11.7 17.7 2.5 12.3 2.5 6.3 4.5 1.7 16.0 9.9 26.4 4.7 26.4 62.7 4.4 7.8 14.2 3.7 14.2 3.1 9.2 9.0 2.5 11.5 6.2 2.6 26.9 27.8 2.3 5.5 5.4 0.9 13.1 12.0 11.6 10.2 18.2 10.9 28.3 6.2 14.9 6.8 9.7 25.4 FKRP "FKTR, LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 10.0 9.2 8.5 8.2 8.1 8.9 10.0 4.0 11.7 11.4 4.0 11.9 4.8 15.4 5.0 8.9 12.7 6.0 14.8 8.6 9.9 11.4 12.0 10.5 7.5 10.3 7.2 8.9 12.8 11.2 7.5 16.9 10.2 9.0 13.6 4.3 5.8 11.2 7.5 19.8 7.1 10.6 5.9 4.6 14.9 11.0 9.4 8.5 5.7 13.7 9.9 4.9 13.1 10.6 9.7 12.7 26.5 17.8 12.5 15.4 16.9 15.8 31.7 21.0 12.6 19.9 17.0 21.4 11.7 17.0 18.2 20.9 13.0 6.6 14.8 11.5 21.9 22.2 11.7 14.4 10.7 13.3 9.3 19.8 19.4 12.5 15.6 15.2 14.6 16.7 6.0 12.2 11.0 12.7 5.8 6.8 22.8 17.2 7.8 6.5 18.3 11.1 4.0 8.0 26.4 12.0 23.1 15.8 7.6 10.6 11.7 8.9 7.3 16.8 18.4 19.8 6.7 25.7 11.6 15.4 11.0 15.0 7.5 25.6 1.3 1.8 0.8 1.5 1.0 0.9 1.7 1.1 1.7 1.1 2.4 1.2 1.6 2.2 2.0 1.1 1.9 0.6 1.2 8.5 8.1 4.0 11.7 8.6 9.9 10.3 7.2 8.9 9.0 4.6 8.5 9.7 4.7 9.6 7.4 6.8 3.9 0.8 4.8 3.0 1.2 9.8 5.3 5.2 15.5 4.3 5.6 5.5 6.2 9.6 9.1 4.5 5.9 4.2 12.0 7.9 7.3 6.0 7.8 7.8 6.8 2.4 5.9 6.6 3.6 5.1 1.3 6.7 11.4 16.6 7.6 3.3 8.2 4.2 2.0 10.0 1.2 13.2 5.6 4.3 5.4 3.7 6.1 7.8 2.1 8.0 6.2 4.1 4.7 4.1 3.6 4.3 4.2 8.2 9.7 11.0 6.6 7.2 7.0 12.2 4.0 2.4 1.6 18.7 4.3 4.5 4.0 4.3 TRAPPC5 "MGC52424, TRS31" ENSG00000181029 "Trafficking protein particle complex 5" Q8IUR0 19 7680833-7687703 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 57.5;Gastric mucus-secreting cells: 86.2;Plasma cells: 76.9;Squamous epithelial cells: 80.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 314.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042221, HPA049064" Uncertain Approved Vesicles NA NA Vesicles "HPA042221: AB_2677907, HPA049064: AB_2680618" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" "unprognostic (1.14e-1)" "unprognostic (3.21e-3)" "unprognostic (1.80e-1)" "unprognostic (2.86e-1)" "unprognostic (6.28e-2)" "unprognostic (2.55e-2)" "unprognostic (2.12e-2)" "unprognostic (6.82e-2)" "unprognostic (4.86e-8)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-1)" 56.4 87.5 48.2 25.8 50.9 63.2 58.9 49.0 113.5 53.8 42.5 53.4 27.9 52.6 8.2 86.3 45.1 13.9 90.4 51.8 49.5 75.8 100.5 36.2 23.6 48.8 48.9 50.3 50.5 67.7 20.1 58.8 19.3 50.2 71.7 8.4 9.1 65.3 17.3 113.3 90.6 48.9 11.6 48.5 61.1 58.0 182.9 50.4 17.0 56.5 27.5 12.3 56.0 56.7 48.9 61.0 129.4 20.7 56.9 16.3 24.1 62.1 47.1 33.8 45.3 46.1 76.9 41.2 62.9 92.0 32.7 25.8 55.2 13.0 47.2 8.9 48.3 199.2 23.7 86.7 163.7 56.8 42.1 45.3 40.0 61.9 34.6 15.8 15.4 57.6 64.3 34.3 89.3 22.3 190.7 72.3 148.8 66.1 27.1 314.1 46.6 28.8 91.1 50.7 142.8 54.1 47.0 40.1 74.6 69.1 7.1 60.1 44.3 58.8 54.2 44.9 103.3 47.7 80.8 44.2 44.3 75.3 51.2 74.2 207.5 373.4 151.4 116.7 394.1 112.3 313.7 145.0 129.3 442.0 289.2 141.7 124.7 518.4 97.4 365.5 188.8 222.5 329.3 48.2 50.9 49.0 113.5 51.8 49.5 48.8 48.9 50.3 50.2 48.5 50.4 48.9 1.8 3.2 3.6 15.3 36.1 1.9 1.2 2.4 57.5 5.1 6.3 4.2 1.0 1.5 5.1 5.5 2.1 3.5 1.2 26.7 0.0 26.9 13.3 3.8 4.8 5.6 11.4 41.0 13.5 19.3 5.3 14.3 86.2 3.7 1.3 2.0 8.2 13.4 9.9 8.4 16.4 15.7 0.0 18.8 3.3 44.4 1.5 52.2 1.8 11.2 17.0 1.5 4.1 11.6 22.8 19.8 26.3 3.4 76.9 1.9 28.0 9.2 2.6 4.8 0.0 1.4 8.4 5.0 1.2 80.1 1.7 3.4 18.0 2.7 14.1 1.5 RPH3AL Noc2 ENSG00000181031 "Rabphilin 3A like (without C2 domains)" Q9UNE2 17 212389-386254 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 53.0;pituitary gland: 44.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 35.2;Hepatocytes: 43.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 22.1;PC-3: 7.2;TIME: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024311 Approved NA NA "HPA024311: AB_1856429" "unprognostic (4.55e-2)" "unprognostic (1.66e-1)" "unprognostic (3.85e-2)" "unprognostic (9.43e-3)" "unprognostic (8.40e-2)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (6.71e-2)" "unprognostic (1.02e-1)" "unprognostic (2.24e-3)" "unprognostic (1.33e-2)" "prognostic favorable (1.03e-8)" "unprognostic (9.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.14e-1)" "unprognostic (3.59e-3)" 9.3 18.6 1.7 1.1 1.3 0.3 9.6 3.3 1.7 4.2 1.7 5.1 5.2 3.1 4.6 8.2 3.9 2.8 5.5 1.1 2.3 13.6 24.4 9.6 1.2 4.2 2.4 1.2 10.9 53.0 1.6 44.8 2.5 4.6 5.6 2.6 2.0 3.5 2.2 8.4 4.6 6.6 1.0 1.3 17.8 9.2 2.8 2.2 1.5 12.1 1.5 1.5 5.4 6.1 4.5 0.3 22.1 0.3 0.1 0.2 0.1 1.8 0.0 0.0 0.0 0.1 3.0 3.8 0.4 3.1 2.2 1.4 0.3 0.8 0.2 0.0 0.9 1.4 0.0 1.8 5.2 0.6 0.2 2.2 0.0 0.1 0.0 0.0 0.7 0.9 2.3 1.5 4.5 1.3 5.4 0.3 0.1 1.2 2.6 7.2 0.4 0.2 4.0 4.0 4.9 0.3 0.7 0.3 0.1 0.3 1.3 2.0 2.1 7.2 0.3 2.9 0.5 0.6 0.7 0.2 0.2 0.3 3.0 0.0 0.3 0.7 1.5 0.8 2.2 0.3 0.6 0.4 0.6 1.1 0.6 0.7 0.4 1.6 0.3 1.8 2.8 0.3 0.3 1.7 1.3 3.3 1.7 1.1 2.3 4.2 2.4 1.2 4.6 1.3 2.2 4.5 21.8 22.4 17.0 1.3 2.0 2.4 13.4 9.7 5.2 1.5 8.8 6.5 2.3 17.2 5.2 22.0 0.0 0.2 7.8 13.2 5.9 10.3 3.6 7.7 7.8 15.9 35.2 2.7 4.6 8.7 0.3 3.4 23.4 4.9 7.0 14.3 28.2 43.3 11.6 11.8 6.2 14.2 12.2 7.0 2.9 4.0 5.3 2.9 3.6 12.2 2.0 26.4 3.1 6.0 1.3 7.7 12.9 1.9 0.9 3.9 9.3 5.9 2.1 1.9 6.6 6.1 3.4 3.4 1.8 6.9 3.1 0.4 1.7 7.6 10.8 9.4 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063994-19113030 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 82.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7" "Group enriched" "Detected in many" 6 "B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7" "Cell line enhanced" "Detected in many" "K-562: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Yes No Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favorable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favorable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 8.1 7.5 16.3 4.3 15.6 8.4 7.9 13.8 18.4 13.2 14.6 7.8 5.2 10.2 3.7 5.2 12.6 3.5 12.6 17.1 15.6 33.2 82.7 6.6 9.0 14.2 14.4 16.4 17.1 11.4 6.1 14.5 2.6 15.5 10.0 2.4 8.5 9.3 5.3 46.9 6.5 9.4 5.0 12.8 12.8 8.4 7.1 15.6 8.2 25.8 32.9 7.6 9.7 9.2 14.2 7.3 1.0 1.8 3.2 6.8 5.6 2.8 3.5 5.2 5.3 6.0 1.4 14.3 5.2 8.0 3.3 5.3 1.3 3.7 2.9 3.0 1.3 7.0 1.8 2.0 11.8 5.4 0.8 3.6 5.6 2.0 4.0 2.4 4.3 2.4 16.8 20.9 9.2 2.8 6.6 9.0 8.4 1.0 2.0 7.4 6.8 3.2 10.2 2.1 1.3 2.0 1.5 3.7 0.1 1.6 2.4 6.5 4.1 2.2 3.9 2.2 8.2 3.4 10.7 6.2 4.1 4.1 11.2 2.0 0.0 0.1 0.1 2.7 0.3 1.4 3.3 1.5 2.4 0.2 3.2 1.0 1.4 0.0 1.8 0.3 0.4 1.7 0.9 16.3 15.6 13.8 18.4 17.1 15.6 14.2 14.4 16.4 15.5 12.8 15.6 14.2 4.6 0.0 13.1 12.4 14.2 3.2 2.8 3.3 2.8 67.7 5.9 6.6 9.7 5.7 4.1 9.2 18.8 7.7 16.5 3.1 13.7 1.5 1.2 2.5 5.4 4.1 8.4 13.7 18.6 3.1 3.8 5.1 4.1 3.6 3.8 8.3 5.3 52.1 1.8 3.3 25.0 3.8 6.1 0.6 1.9 1.6 5.0 1.4 3.6 6.5 1.3 12.5 32.0 16.1 8.6 2.5 4.6 6.4 16.4 2.4 9.2 39.6 3.0 41.4 6.6 9.6 5.8 10.6 7.6 0.9 2.8 4.7 10.9 8.0 3.1 1.7 FCRL6 "FcRH6, FLJ16056, IFGP6" ENSG00000181036 "Fc receptor like 6" Q6DN72 1 159800511-159816257 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.0;lymphoid tissue: 12.9" "Cell type enhanced" "Detected in some" "dendritic cells: 60.6;NK-cells: 150.4;T-cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 142.9;memory CD8 T-cell: 134.3;naive CD8 T-cell: 102.8;NK-cell: 51.3" "Group enriched" "Detected in many" 26 "NK-cells: 51.3;T-cells: 142.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.64e-3)" "unprognostic (1.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.62e-3)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.79e-3)" "unprognostic (6.65e-3)" "unprognostic (2.76e-2)" "unprognostic (3.91e-1)" "unprognostic (1.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.52e-5)" "unprognostic (3.98e-1)" "unprognostic (1.13e-1)" "unprognostic (8.78e-2)" "unprognostic (9.18e-2)" 0.8 1.5 0.4 2.0 0.4 8.0 1.1 0.7 1.1 0.6 1.0 0.7 1.0 1.3 2.3 0.6 1.0 2.2 0.8 0.5 1.8 0.6 3.3 5.8 5.8 0.7 0.5 0.2 1.4 0.3 0.3 0.3 0.5 0.6 0.7 0.5 0.0 2.3 0.4 0.5 0.2 1.5 0.9 0.6 12.9 0.8 0.4 0.6 1.3 0.6 0.1 1.9 1.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.4 0.2 0.1 142.9 0.3 3.0 0.1 25.5 134.3 3.7 0.1 10.9 102.8 1.5 51.3 1.4 0.2 0.1 53.6 0.4 0.4 0.7 1.1 0.5 1.8 0.7 0.5 0.2 0.6 0.6 0.6 1.1 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.0 60.6 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 2.7 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 1.0 1.1 0.0 150.4 0.0 0.1 0.0 0.0 0.0 5.1 0.0 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 METTL23 "C17orf95, LOC124512" ENSG00000181038 "Methyltransferase like 23" Q86XA0 17 76726830-76733936 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 182.5;Spermatocytes: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022889 Approved Vesicles No No Vesicles "HPA022889: " "unprognostic (5.45e-3)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "unprognostic (1.35e-1)" "unprognostic (7.70e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (4.18e-6)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.93e-7)" "unprognostic (1.13e-2)" "unprognostic (1.82e-1)" "unprognostic (3.79e-1)" "unprognostic (3.65e-1)" 30.0 32.9 21.7 24.4 23.7 27.5 31.0 23.6 28.1 28.0 24.9 26.3 22.8 26.1 35.0 24.1 27.9 20.0 27.7 21.4 23.7 37.4 47.7 27.0 43.1 23.1 23.0 20.6 29.6 42.6 35.3 33.5 19.9 23.2 28.3 27.6 23.1 29.3 22.1 35.0 29.3 30.9 23.7 23.0 48.5 30.3 52.0 22.7 37.3 42.5 26.2 40.8 26.3 25.0 27.3 68.3 58.4 32.6 30.0 79.2 66.5 31.3 33.7 68.2 43.5 41.9 29.5 47.1 38.0 32.2 43.0 56.7 37.6 23.8 61.0 48.9 19.2 55.8 49.5 38.0 56.6 77.4 35.1 41.7 64.0 57.3 54.0 74.6 68.5 69.1 46.5 48.1 46.0 53.1 38.5 44.3 30.1 24.2 75.2 65.3 29.9 54.5 106.5 63.0 33.9 30.9 44.5 33.8 51.6 123.3 78.8 72.3 43.7 25.8 49.8 24.9 48.9 59.9 63.2 26.0 38.6 47.5 25.0 46.3 23.0 28.9 34.1 48.0 30.3 53.6 51.3 53.0 53.5 32.1 44.7 50.2 51.1 9.4 51.8 27.9 48.3 57.6 34.5 21.7 23.7 23.6 28.1 21.4 23.7 23.1 23.0 20.6 23.2 23.0 22.7 27.3 39.5 28.9 14.5 8.5 49.6 16.4 47.2 64.8 42.1 13.9 34.9 48.4 17.7 27.1 35.6 20.2 10.4 42.9 50.7 11.7 119.3 42.0 182.5 31.7 23.4 28.0 22.8 22.3 4.2 39.5 41.1 26.6 24.5 25.9 31.1 21.8 25.7 49.9 57.0 6.7 5.4 24.5 40.7 33.3 23.5 54.5 32.6 33.9 24.9 8.4 50.1 38.6 81.4 7.5 13.4 33.2 26.3 25.9 49.2 33.2 27.5 87.8 32.7 23.7 52.6 28.1 43.0 198.9 49.5 32.2 16.2 17.2 55.3 53.3 32.1 34.1 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 11.5 36.8 27.6 9.0 24.0 16.5 11.9 13.5 23.2 16.1 19.6 11.0 7.2 11.7 9.0 7.5 13.6 7.7 6.8 20.3 37.2 19.2 10.3 19.0 14.2 26.8 25.0 22.1 22.7 10.7 11.9 35.4 9.1 24.4 16.9 4.2 11.7 11.4 9.3 6.0 12.5 11.3 6.1 17.1 22.7 10.1 4.8 35.9 3.4 25.0 3.7 5.6 11.7 12.2 22.5 0.7 12.4 14.3 11.1 7.1 5.2 16.1 6.7 8.4 15.6 9.4 13.6 2.5 0.1 13.1 7.4 11.3 4.4 8.0 5.2 6.1 15.7 14.4 0.0 17.5 13.5 18.6 0.0 2.2 9.5 8.4 7.5 3.4 1.4 13.3 2.7 6.4 16.8 9.3 11.6 0.6 0.3 6.5 3.5 11.7 0.5 1.6 5.7 14.2 13.6 5.4 16.9 6.8 17.0 18.3 22.0 20.4 0.3 9.9 11.8 6.9 10.4 0.9 17.8 7.4 1.8 6.2 0.0 10.1 0.0 1.0 0.0 0.7 0.4 1.1 0.2 1.2 1.0 0.6 0.1 1.9 0.8 0.0 0.0 0.1 0.0 1.7 0.9 27.6 24.0 13.5 23.2 20.3 37.2 26.8 25.0 22.1 24.4 17.1 35.9 22.5 8.8 6.4 13.4 22.2 3.9 4.6 8.9 5.0 5.2 27.2 9.6 9.9 2.5 5.7 5.6 12.9 58.4 14.5 5.6 3.2 1.9 7.5 0.6 7.1 7.0 12.4 10.2 2.7 13.4 6.0 8.8 8.1 3.6 11.6 1.3 15.4 8.2 2.2 15.2 3.3 17.2 3.2 8.2 11.4 10.5 0.7 17.1 15.1 3.6 12.2 4.2 22.8 5.2 12.1 13.3 3.4 3.9 12.4 2.2 9.0 7.0 6.0 4.4 40.8 32.9 6.4 7.7 0.2 5.3 2.4 4.7 26.0 8.2 16.4 2.6 5.3 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42782908-42804490 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 638.8;Distal tubular cells: 632.0;Paneth cells: 610.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 509.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favorable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favorable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 122.4 131.2 156.9 75.9 162.4 54.2 82.2 171.0 200.6 71.0 153.3 297.9 163.7 66.5 96.0 164.3 63.1 80.0 326.1 160.7 174.4 200.7 346.4 67.1 51.3 170.1 171.8 149.1 39.7 61.4 112.3 91.2 65.2 174.9 102.4 302.9 154.0 75.7 97.2 175.9 69.3 136.0 97.1 178.4 49.3 147.2 64.2 165.6 53.3 116.5 319.5 80.7 100.4 121.1 194.4 159.9 67.0 182.9 165.2 420.3 244.3 195.2 205.1 151.0 168.4 165.8 132.8 166.7 95.8 120.5 161.8 114.0 92.9 143.0 203.0 225.6 135.5 145.9 301.0 127.6 257.4 191.8 180.4 131.4 274.0 233.7 129.0 181.4 94.7 159.8 135.1 299.7 110.3 247.3 51.1 96.1 61.1 162.7 133.7 176.5 80.9 138.0 72.1 454.1 361.1 82.7 108.2 187.6 142.0 207.0 182.9 145.0 130.0 166.1 127.4 105.2 341.1 219.1 89.7 184.1 207.2 165.2 185.7 100.6 115.7 66.2 130.5 72.9 115.4 65.8 56.6 71.5 73.6 77.2 43.6 60.3 70.5 70.0 65.6 143.2 509.4 99.4 171.5 156.9 162.4 171.0 200.6 160.7 174.4 170.1 171.8 149.1 174.9 178.4 165.6 194.4 50.1 54.5 82.4 32.3 39.7 131.2 153.1 244.8 59.2 35.7 86.4 62.0 351.5 80.1 133.0 138.0 10.4 114.1 99.5 638.8 632.0 113.3 8.4 87.3 41.2 50.8 82.0 126.8 32.8 145.0 202.7 98.1 100.9 63.6 93.3 49.7 59.6 197.9 77.1 28.6 27.3 193.5 343.8 46.9 113.3 13.0 30.7 63.4 176.1 21.5 82.7 232.5 43.3 14.1 32.9 279.4 610.7 52.3 65.5 193.5 122.4 296.4 106.0 41.2 78.9 28.8 119.8 186.1 78.7 94.2 204.6 299.9 50.7 101.5 168.0 254.2 CHRM2 ENSG00000181072 "Cholinergic receptor muscarinic 2" P08172 7 136868652-137020255 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 36.5;intestine: 14.9" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 59.9;Excitatory neurons: 49.4;Inhibitory neurons: 119.2" "Cancer enhanced" "Detected in single" "stomach cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 86.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022338, HPA029795" Approved NA NA "CAB022338: , HPA029795: AB_10601357" "unprognostic (3.51e-2)" "unprognostic (3.73e-4)" "unprognostic (5.77e-2)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.00e-1)" "unprognostic (2.69e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" 0.1 0.2 2.6 1.3 1.7 0.1 0.0 0.1 3.3 0.3 0.0 14.9 0.7 0.4 0.0 0.3 0.3 10.8 36.5 0.5 2.6 0.0 1.1 0.8 0.0 8.1 5.7 1.0 0.2 0.1 0.0 0.0 1.5 9.2 0.2 3.5 0.8 0.0 0.0 0.0 0.1 4.4 9.7 1.5 0.0 5.9 0.6 7.9 0.1 0.0 0.0 0.0 9.0 0.6 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 17.6 0.2 0.0 0.0 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.7 0.1 3.3 0.5 2.6 8.1 5.7 1.0 9.2 1.5 7.9 10.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 59.9 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.2 0.0 0.0 49.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 119.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 OR52N4 ENSG00000181074 "Olfactory receptor family 52 subfamily N member 4" Q8NGI2 11 5754243-5755905 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.8" "Cell type enhanced" "Detected in single" "Excitatory neurons: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-4)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (3.03e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (5.62e-2)" "unprognostic (1.41e-3)" "unprognostic (1.41e-1)" "unprognostic (3.80e-2)" "unprognostic (3.18e-2)" "unprognostic (4.41e-2)" 0.6 0.2 0.2 0.5 0.2 0.5 0.7 0.1 0.3 0.5 0.1 0.4 0.1 0.6 1.3 0.3 0.9 0.3 0.4 0.2 0.3 0.5 0.2 0.8 1.3 0.3 0.2 0.1 1.6 0.1 0.0 0.5 0.0 0.2 0.7 0.3 0.7 0.4 0.7 0.2 0.3 1.8 0.1 0.2 2.8 0.2 0.4 0.1 0.5 0.4 0.1 1.2 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716340-143722458 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 46.1;fallopian tube: 47.1" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 62.5;Respiratory ciliated cells: 107.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.6;HeLa: 20.7;MCF7: 14.3;T-47d: 14.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.8 0.1 7.8 0.2 5.4 0.0 1.9 3.8 8.2 4.2 46.1 0.9 0.3 2.5 2.4 1.1 47.1 0.2 0.4 5.3 6.9 6.9 0.3 12.2 0.4 9.0 10.1 3.4 0.9 4.4 9.5 7.0 0.3 7.3 2.2 0.2 0.0 2.2 1.7 0.1 4.0 0.8 0.4 7.9 0.7 0.8 11.5 4.3 1.1 16.3 0.0 0.2 0.5 2.1 2.9 0.4 0.6 1.9 0.0 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.5 9.6 0.0 1.6 0.0 0.0 5.5 0.1 0.2 0.0 1.0 2.0 0.0 20.7 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.2 3.4 0.0 0.0 14.3 0.0 0.0 2.5 1.2 1.2 0.0 3.7 0.5 1.0 1.6 3.6 5.1 0.0 3.3 0.0 0.2 14.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 5.4 3.8 8.2 5.3 6.9 9.0 10.1 3.4 7.3 7.9 4.3 2.9 0.1 0.0 6.4 0.0 0.1 0.4 0.3 5.7 0.0 0.0 1.0 1.3 0.7 0.0 11.8 0.0 0.0 0.0 0.0 0.1 0.0 1.1 13.8 62.5 0.5 0.3 0.0 0.0 0.2 0.0 0.7 0.8 0.0 1.7 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.6 16.2 0.0 0.0 11.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 1.4 107.9 0.0 0.0 0.4 2.2 2.3 0.9 0.0 0.3 0.1 0.2 0.1 0.3 0.1 EHMT1 "bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D" ENSG00000181090 "Euchromatic histone lysine methyltransferase 1" Q9H9B1 9 137618992-137870016 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 167.0;Plasma cells: 170.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060022, HPA074729" Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA060022: AB_2684190, HPA074729: " "unprognostic (1.18e-1)" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.03e-1)" "prognostic favorable (8.91e-4)" "unprognostic (5.87e-2)" "unprognostic (1.74e-2)" "unprognostic (4.18e-3)" "unprognostic (2.34e-1)" "unprognostic (2.26e-2)" "unprognostic (7.55e-3)" "unprognostic (2.01e-2)" "unprognostic (6.58e-3)" "unprognostic (4.24e-1)" "unprognostic (7.12e-3)" "unprognostic (7.75e-2)" 17.6 18.4 10.1 22.5 11.9 30.8 18.4 13.1 10.6 16.9 11.1 18.8 19.0 21.6 9.8 19.3 18.2 14.1 13.6 7.5 6.0 11.0 14.5 15.9 29.8 9.8 9.1 5.4 20.1 15.0 13.9 13.0 15.1 11.1 16.3 13.2 13.8 18.5 14.1 31.7 19.3 19.8 15.2 4.0 26.1 18.4 40.8 9.4 23.1 19.8 15.1 21.4 18.5 16.3 19.1 26.7 52.3 57.4 53.2 23.9 24.6 48.1 34.5 21.4 24.7 20.2 34.7 32.5 81.6 32.7 26.0 29.9 56.2 34.8 37.8 19.2 45.3 24.7 34.4 54.2 22.4 20.9 52.9 39.5 22.6 25.9 29.9 28.9 18.1 41.3 30.1 52.6 27.5 17.9 61.9 62.5 26.3 56.0 42.1 34.8 79.3 49.5 47.2 20.7 47.7 50.6 41.1 65.4 45.4 15.3 40.6 51.1 42.0 39.0 28.9 29.5 44.8 33.2 17.2 52.0 67.0 21.3 27.6 32.0 19.5 16.2 21.2 18.0 14.3 11.3 16.4 15.6 15.6 12.9 23.0 14.9 13.5 28.8 17.3 15.6 23.3 14.2 9.7 10.1 11.9 13.1 10.6 7.5 6.0 9.8 9.1 5.4 11.1 4.0 9.4 19.1 34.3 19.2 19.2 130.6 64.9 17.5 23.4 26.9 32.5 39.7 30.5 26.7 31.5 25.8 24.7 22.0 52.1 23.8 36.9 24.4 3.9 24.1 86.8 29.3 44.8 29.9 28.1 31.7 74.4 21.0 21.8 27.6 45.3 40.6 18.9 55.8 18.9 41.7 19.7 50.5 76.4 22.2 10.2 25.8 18.1 167.0 35.8 26.9 12.4 71.2 31.2 19.7 51.5 64.3 104.0 25.4 30.3 37.6 170.6 34.9 20.7 14.3 22.6 46.8 13.1 34.7 28.5 80.4 51.9 35.3 20.2 26.5 38.9 81.3 23.8 28.8 ADIPOQ "ACDC, ACRP30, adiponectin, apM1, GBP28" ENSG00000181092 "Adiponectin, C1Q and collagen domain containing" Q15848 3 186842704-186858463 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hormone "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 28 "adipose tissue: 906.8;breast: 251.0" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Group enriched" "Detected in some" 8 "breast cancer: 6.5;pancreatic cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 672 "ASC diff: 312.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB046467, HPA051767" Uncertain "Secreted to blood" NA NA 8360000000 910000000 "CAB046467: AB_1078104, HPA051767: AB_2681598" "unprognostic (1.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.20e-2)" "unprognostic (6.99e-3)" "unprognostic (1.87e-1)" 906.8 9.0 0.1 2.5 0.1 0.2 251.0 0.2 0.2 0.0 0.0 7.8 0.1 0.1 0.0 1.2 0.1 7.6 6.6 0.0 0.1 0.7 0.1 0.1 1.4 0.1 0.0 0.1 0.0 6.3 0.1 0.1 0.0 0.1 0.3 6.2 0.1 18.9 0.0 2.3 6.3 8.6 1.2 0.0 0.0 4.0 0.1 0.0 2.2 2.9 20.4 0.0 2.4 0.9 0.3 0.0 0.0 0.0 0.1 312.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F2R "CF2R, PAR-1, PAR1, TR" ENSG00000181104 "Coagulation factor II thrombin receptor" P25116 5 76716126-76735770 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.1" "Cell type enriched" "Detected in many" 5 "Hepatic stellate cells: 307.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 25.4" "Group enriched" "Detected in many" 14 "NK-cells: 7.0;T-cells: 25.4" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 196.9;HUVEC TERT2: 366.2;WM-115: 345.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008973, CAB012962" Approved NA NA "CAB008973: , CAB012962: AB_2533198" "unprognostic (3.03e-1)" "unprognostic (7.76e-2)" "unprognostic (5.55e-2)" "unprognostic (7.76e-2)" "unprognostic (7.14e-2)" "unprognostic (3.46e-1)" "unprognostic (2.51e-1)" "unprognostic (3.75e-2)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (2.21e-7)" "unprognostic (2.72e-3)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (6.74e-3)" 12.3 13.7 1.7 12.2 1.4 4.1 18.5 1.9 2.7 15.5 2.7 10.1 14.4 23.4 4.3 11.2 3.9 39.9 30.7 1.2 2.1 19.2 24.1 23.0 16.3 2.6 2.5 0.9 2.9 10.0 7.4 4.4 10.6 1.9 7.3 11.8 0.7 30.7 12.1 3.6 46.0 19.0 19.0 1.8 70.1 10.4 8.8 1.7 4.9 15.3 12.0 8.6 15.5 4.5 1.5 5.7 17.5 53.3 8.8 98.4 170.5 2.6 30.3 102.5 19.5 69.8 3.9 47.0 0.1 50.1 13.0 88.1 13.2 23.1 18.1 36.6 4.4 19.3 120.2 3.8 14.7 147.7 0.6 4.9 96.9 60.2 37.2 10.5 196.9 366.2 21.4 22.8 22.1 40.1 2.4 9.6 0.4 17.0 0.3 93.5 17.1 31.9 4.3 91.2 0.8 6.3 28.7 8.9 0.2 45.2 48.0 0.7 1.3 169.0 121.8 26.7 1.3 56.7 59.0 18.5 0.2 32.4 2.3 345.5 1.1 0.2 0.4 25.4 0.5 6.5 0.6 5.7 17.7 0.0 0.2 0.9 12.7 1.1 7.0 0.1 0.3 0.6 11.2 1.7 1.4 1.9 2.7 1.2 2.1 2.6 2.5 0.9 1.9 1.8 1.7 1.5 25.8 0.0 9.2 1.6 4.4 17.2 0.7 9.3 1.2 3.5 3.4 2.4 2.6 7.2 4.5 7.3 0.0 0.2 56.2 0.3 0.0 2.0 10.7 2.8 47.1 51.8 6.6 11.6 1.0 2.2 0.4 39.5 8.2 5.4 6.3 13.0 307.0 4.3 2.1 0.0 3.3 3.9 16.2 16.6 10.7 6.0 0.9 5.4 12.4 5.6 1.1 0.1 54.6 0.5 0.1 10.8 0.2 10.5 35.8 1.4 0.5 3.4 4.2 1.4 0.0 8.1 24.9 12.7 5.4 1.5 40.1 0.3 40.1 9.5 1.3 0.4 ZNF707 ENSG00000181135 "Zinc finger protein 707" Q96C28 8 143684452-143713898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 19.7;NK-cells: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA044991 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044991: AB_10961134" "unprognostic (5.12e-2)" "unprognostic (5.65e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (1.73e-1)" "unprognostic (5.91e-2)" "unprognostic (2.94e-2)" "unprognostic (1.65e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-1)" "unprognostic (6.98e-2)" "unprognostic (5.07e-2)" "unprognostic (2.30e-2)" "unprognostic (1.14e-2)" "unprognostic (5.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.08e-2)" 3.1 3.3 1.0 1.8 1.0 1.8 3.4 0.7 1.1 3.9 1.2 3.4 1.5 3.8 1.8 3.7 3.4 1.3 2.8 0.8 0.8 3.3 3.4 3.9 2.6 1.1 0.9 0.7 2.9 4.2 1.7 3.8 1.1 0.9 4.1 0.8 0.9 3.8 1.1 1.8 5.8 4.3 1.0 0.7 8.1 3.6 7.4 0.8 2.1 4.5 1.4 1.8 3.6 3.6 1.1 1.7 2.2 2.4 2.6 2.4 2.2 2.4 2.5 1.7 2.7 1.3 1.5 2.4 1.6 2.7 1.6 1.2 2.1 2.5 2.9 1.7 3.3 0.9 4.3 5.7 2.3 1.6 1.1 2.0 2.3 3.3 3.6 2.2 2.3 2.4 2.0 2.0 1.6 0.7 3.6 4.5 1.3 0.1 1.8 3.8 3.0 1.5 1.6 1.4 1.5 1.8 2.1 3.3 2.3 3.0 1.6 3.0 2.3 3.8 1.6 5.5 2.0 3.8 3.3 1.4 0.7 2.3 2.4 1.2 0.3 0.2 0.4 0.5 0.1 0.4 0.2 0.3 0.3 0.2 0.1 0.2 0.3 0.3 0.9 0.1 0.3 0.4 0.2 1.0 1.0 0.7 1.1 0.8 0.8 1.1 0.9 0.7 0.9 0.7 0.8 1.1 2.4 0.0 1.5 2.9 3.6 2.8 2.7 2.4 5.2 2.7 2.2 1.8 1.9 0.0 2.0 3.7 0.0 2.1 5.6 2.8 3.9 1.9 19.7 1.4 1.8 1.5 0.0 0.4 1.9 1.3 2.5 1.6 2.0 2.5 1.3 3.6 3.3 1.1 1.9 1.7 1.2 1.8 0.0 3.5 4.3 5.3 1.2 2.4 0.0 1.9 5.2 0.6 12.3 1.0 1.2 1.7 2.1 2.2 4.3 2.2 1.9 0.9 1.6 3.4 6.6 1.0 1.5 4.3 3.1 2.3 3.1 2.6 4.8 2.6 1.6 2.2 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 16.1;fallopian tube: 6.0;salivary gland: 6.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4" "Cancer enriched" "Detected in many" 4 "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 23.3;HeLa: 45.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" NA NA 25000 "CAB055172: AB_2148831, HPA065600: AB_2732736" "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 16.1 0.0 0.0 0.0 2.1 0.0 0.3 6.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 6.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.6 2.8 0.0 0.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.3 0.1 40.3 0.0 0.0 4.1 0.9 3.4 1.5 81.8 0.0 0.0 2.1 0.2 0.0 0.0 0.2 14.3 74.3 14.8 1.2 0.0 0.0 0.4 0.0 0.4 1.0 0.0 157.8 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 99.7 0.3 0.0 16.4 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 197.4 0.0 0.0 0.0 8.6 0.3 0.2 0.0 0.3 3.3 0.6 0.0 0.0 0.7 NPM1 "B23, NPM" ENSG00000181163 "Nucleophosmin 1" P06748 5 171387116-171411810 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011384, CAB012983" Supported Enhanced "Nucleoplasm,Nucleoli rim" NA Yes 2000000 "Nucleoli rim" Nucleoplasm "CAB012983: AB_2533084, HPA011384: AB_1854692" "unprognostic (1.84e-3)" "unprognostic (2.59e-1)" "unprognostic (2.23e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (7.48e-4)" "prognostic unfavorable (4.82e-6)" "unprognostic (1.86e-2)" "unprognostic (5.25e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.24e-2)" 483.8 373.7 192.5 472.6 202.8 796.0 603.1 201.3 235.4 749.8 216.0 449.2 350.2 662.8 425.2 628.0 601.3 358.5 339.8 182.5 225.5 378.8 373.4 367.6 783.3 208.0 200.2 170.0 1397.0 817.4 280.3 316.8 427.3 219.0 389.5 425.4 162.7 388.3 321.5 454.6 366.2 377.3 439.7 232.0 361.0 471.6 287.3 208.5 689.7 514.6 284.9 767.9 529.9 570.1 221.5 2476.2 1522.7 1864.0 2663.1 1073.3 1915.6 2736.9 2111.3 1826.0 2678.1 2387.2 3640.2 1622.2 6243.9 1683.2 1194.5 1927.6 1386.6 2552.2 4639.2 3423.4 2027.9 2027.3 2149.1 1361.9 2740.2 1593.2 4556.3 1790.7 1732.2 1559.7 1845.8 3572.3 2184.3 2019.4 1460.9 2712.8 1406.5 1945.5 2826.5 3071.1 3087.4 2400.7 1280.7 1857.2 2695.2 2051.7 3241.9 2306.9 1583.1 1433.8 1167.4 1210.6 2084.4 4091.0 1288.7 2513.8 2000.7 1289.5 916.7 2114.4 1082.5 3705.3 1161.5 2139.6 3702.2 1403.3 3561.5 1897.0 153.6 287.1 92.3 443.1 311.4 834.2 847.9 832.8 654.3 564.2 634.9 1189.9 973.4 38.0 656.2 264.4 516.8 782.6 1076.1 192.5 202.8 201.3 235.4 182.5 225.5 208.0 200.2 170.0 219.0 232.0 208.5 221.5 462.2 346.1 461.1 12.4 911.0 1400.1 1224.1 1692.5 993.1 177.2 779.0 1045.4 243.5 514.8 764.5 323.7 43.8 1647.8 615.9 175.3 743.4 1073.6 135.8 466.3 707.3 568.2 362.1 865.5 15.6 919.2 2021.0 685.9 489.8 544.6 443.8 688.8 383.8 254.1 1071.0 127.9 20.3 656.0 679.5 629.2 817.6 98.6 974.9 557.2 610.1 19.7 862.8 339.2 476.8 14.6 21.2 922.5 370.1 649.9 671.6 1051.5 404.2 911.0 357.4 144.1 433.9 617.8 1074.1 855.7 578.6 907.2 1019.1 1538.8 865.1 1019.5 866.2 967.3 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165521 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 161.4" "Cell type enhanced" "Detected in many" "Early spermatids: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 22.5 14.6 46.9 8.8 52.6 3.6 19.6 40.0 78.7 19.7 35.7 13.3 6.5 16.5 161.4 12.4 16.1 11.2 14.4 48.6 50.3 15.8 9.5 13.9 10.1 41.8 42.6 49.2 26.0 14.7 39.0 28.3 17.5 42.8 15.4 7.7 17.7 10.7 32.7 8.0 14.1 11.2 16.1 41.3 13.4 14.1 26.6 48.6 10.1 22.9 8.9 12.2 17.6 15.2 46.6 27.3 19.6 62.9 43.7 21.3 22.5 18.7 17.8 22.0 16.7 22.3 17.1 25.8 4.4 26.7 28.1 39.2 24.0 99.0 34.9 21.2 20.2 33.0 8.1 16.0 10.9 25.7 4.9 14.4 23.1 23.6 28.6 17.0 15.8 19.0 13.2 7.8 3.0 16.9 14.1 2.1 8.4 43.4 23.1 32.0 20.0 28.2 6.9 23.4 22.6 46.4 30.7 28.6 4.9 22.2 50.1 7.7 7.0 17.8 13.9 22.6 41.7 8.3 0.0 0.2 9.1 15.3 13.1 19.4 6.6 6.8 2.1 29.6 9.2 34.3 16.4 26.1 27.5 7.3 22.8 26.5 31.3 2.3 30.0 6.5 8.9 17.5 19.4 46.9 52.6 40.0 78.7 48.6 50.3 41.8 42.6 49.2 42.8 41.3 48.6 46.6 4.7 16.0 4.8 2.9 9.7 41.0 19.4 30.8 23.9 16.8 5.0 6.2 7.1 4.3 14.8 3.7 8.4 35.6 5.9 1.0 15.6 24.9 74.7 3.9 10.4 6.6 5.4 10.8 8.1 11.7 15.3 18.2 7.1 5.8 4.5 27.9 6.8 1.7 7.0 5.0 8.3 3.6 6.1 2.9 9.9 32.7 27.1 5.7 5.4 2.8 2.9 30.6 14.4 5.0 3.7 18.0 1.7 19.5 7.7 17.0 0.5 6.5 4.4 6.1 6.6 9.4 16.3 1.4 1.5 11.2 29.5 20.8 11.2 27.0 2.6 22.5 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068954-12123221 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 130.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 227.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Enhanced Supported Mitochondria NA NA Mitochondria "HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617" "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 10.8 8.5 8.3 6.9 10.1 3.8 8.5 12.7 8.2 8.8 10.9 10.2 7.7 6.3 6.9 7.6 6.2 5.4 13.3 7.8 8.2 43.1 130.6 5.5 8.6 9.7 9.0 7.0 10.1 18.2 12.8 5.6 7.8 10.0 13.0 10.9 7.6 13.2 5.7 18.8 5.6 6.9 5.8 8.6 7.8 11.0 4.7 9.2 10.6 11.7 23.3 9.7 6.3 6.2 11.6 27.0 20.4 29.8 23.8 18.2 10.8 35.9 13.3 8.6 23.4 20.6 13.1 15.7 19.3 4.3 8.4 10.8 37.4 31.6 10.4 26.6 10.9 14.2 10.6 7.7 10.1 17.8 4.2 3.8 13.3 7.9 13.7 5.5 9.2 13.0 23.1 16.7 15.1 6.3 52.3 14.4 7.7 16.7 24.9 4.7 24.3 9.7 16.5 15.2 6.4 7.7 34.9 26.3 46.3 15.4 31.7 102.2 15.2 5.8 7.5 5.4 15.8 9.9 13.4 10.3 12.6 9.7 7.4 12.8 23.8 6.8 15.4 4.2 9.2 4.5 13.0 3.2 2.7 11.9 9.9 3.1 4.1 19.4 14.3 17.0 17.3 5.7 4.9 8.3 10.1 12.7 8.2 7.8 8.2 9.7 9.0 7.0 10.0 8.6 9.2 11.6 6.9 12.8 38.8 21.5 21.3 5.2 6.7 5.3 10.2 13.3 13.7 8.3 31.1 28.6 7.8 16.5 10.4 35.4 23.2 14.6 19.6 10.9 3.5 8.8 17.3 8.1 11.3 21.9 12.8 11.1 25.1 8.1 21.9 20.8 8.8 45.2 11.0 227.4 10.3 26.9 17.3 18.0 4.1 15.3 10.1 4.2 12.5 13.5 5.4 17.8 13.4 10.4 8.2 15.6 20.5 12.4 9.6 12.0 22.6 9.6 9.4 62.5 5.2 19.2 13.1 10.6 7.4 6.7 3.8 16.2 6.0 13.5 8.4 21.8 16.6 7.8 PENK ENSG00000181195 Proenkephalin P01210 8 56436674-56446671 "Plasma proteins, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 379.8;brain: 157.7;testis: 130.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 758.4;Leydig cells: 1137.9;Peritubular cells: 225.7;Spermatocytes: 274.1" "Cancer enhanced" "Detected in many" "lung cancer: 4.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;ASC TERT1: 8.6;BJ: 7.7;THP-1: 7.7" "Region enriched" "Detected in all" 7 "basal ganglia: 3626.9" "Region enriched" "Detected in all" 7 "basal ganglia: 923.2" "HPA013138, CAB016390" Enhanced "Secreted in other tissues" NA NA 220000 "CAB016390: AB_2161515, HPA013138: AB_1855191" "unprognostic (6.89e-2)" "unprognostic (1.21e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "unprognostic (1.56e-2)" "unprognostic (3.58e-3)" "unprognostic (1.31e-2)" "unprognostic (3.60e-1)" "unprognostic (6.34e-2)" "unprognostic (5.73e-2)" "unprognostic (3.47e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-3)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.98e-3)" 8.6 379.8 29.6 4.5 157.7 0.0 5.0 38.6 35.0 9.2 0.9 17.0 1.1 8.2 0.0 1.4 7.7 12.6 25.8 2.8 47.7 0.2 0.2 3.8 0.1 73.5 18.3 6.1 30.0 1.2 0.0 17.2 2.9 51.3 22.6 2.0 0.6 2.7 23.7 3.0 0.8 4.2 4.7 42.3 0.1 10.1 130.0 30.6 0.2 1.0 5.4 0.1 0.6 6.3 15.6 0.0 0.0 0.1 0.0 14.3 8.6 0.0 7.7 2.5 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 29.6 157.7 38.6 35.0 2.8 47.7 73.5 18.3 6.1 51.3 42.3 30.6 15.6 0.2 0.0 1.5 0.3 0.5 0.1 0.2 758.4 0.0 0.3 0.1 0.6 0.8 0.0 8.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 85.7 0.1 3.1 0.9 0.0 0.0 0.4 0.0 0.1 16.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 15.4 0.0 2.0 0.0 0.7 60.8 1137.9 1.2 0.0 1.9 0.0 0.0 0.0 0.5 0.4 0.0 0.0 225.7 0.0 0.2 0.0 0.0 3.6 0.0 6.6 1.7 1.2 274.1 19.1 0.1 0.4 0.0 0.2 3.1 0.0 0.0 C4orf50 FLJ46481 ENSG00000181215 "Chromosome 4 open reading frame 50" Q6ZRC1 4 5897373-6200555 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "brain: 4.4" "Group enriched" "Detected in some" 4 "Excitatory neurons: 12.7;Inhibitory neurons: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.02e-3)" "unprognostic (6.55e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (6.64e-3)" "unprognostic (1.11e-1)" "unprognostic (4.35e-2)" "unprognostic (9.94e-5)" "unprognostic (4.31e-2)" "unprognostic (4.86e-3)" "unprognostic (2.61e-1)" "unprognostic (2.88e-6)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.68e-2)" 0.0 0.0 2.7 0.0 4.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 1.4 0.3 2.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.4 0.0 2.5 2.7 0.6 1.4 0.3 2.7 1.5 0.0 0.8 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.7 5.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.1 0.0 1.1 0.4 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 H2AW "HIST3H2A, MGC3165" ENSG00000181218 "H2A.W histone" Q7L7L0 1 228456979-228457873 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 36.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.2;Cytotrophoblasts: 14.1;dendritic cells: 13.8;Extravillous trophoblasts: 10.8;Hofbauer cells: 28.4;Syncytiotrophoblasts: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 29.7;U-266/70: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (3.65e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.73e-4)" "unprognostic (1.84e-3)" "unprognostic (2.49e-2)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-2)" "unprognostic (3.20e-2)" "unprognostic (1.96e-1)" "unprognostic (6.67e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" 4.1 36.2 5.6 0.9 6.3 5.9 6.9 13.8 7.0 18.4 9.1 5.0 3.2 5.4 1.6 19.3 7.2 1.2 14.2 6.2 6.4 4.4 1.1 4.4 1.2 5.1 5.8 6.0 14.2 4.0 3.7 13.0 1.0 6.5 11.2 0.9 4.9 10.4 0.4 1.0 17.6 5.5 0.3 5.4 13.1 6.3 5.8 6.6 1.8 2.2 0.7 0.9 5.4 24.4 7.0 5.9 3.1 4.0 5.6 3.3 3.3 4.8 2.9 2.8 8.2 5.7 3.1 4.8 2.7 3.4 0.6 0.0 14.3 2.9 1.4 1.9 4.2 29.7 4.2 4.0 0.0 7.6 3.0 8.1 7.3 8.4 1.5 3.5 3.3 3.5 5.4 15.0 0.0 0.0 8.4 3.9 0.0 6.2 3.5 7.5 0.0 0.0 22.9 1.4 3.5 24.7 17.4 10.2 8.9 20.7 0.6 15.7 2.2 1.3 0.0 0.1 11.0 2.6 29.4 22.4 0.0 2.9 3.0 2.1 4.4 1.4 0.0 5.8 2.8 4.3 2.7 5.5 4.3 3.0 2.1 4.2 4.1 0.6 6.5 7.0 0.5 10.4 3.4 5.6 6.3 13.8 7.0 6.2 6.4 5.1 5.8 6.0 6.5 5.4 6.6 7.0 0.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 14.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 53.8 2.4 0.0 0.0 0.0 ZNF746 "FLJ31413, PARIS" ENSG00000181220 "Zinc finger protein 746" Q6NUN9 7 149472696-149497817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020272 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA020272: AB_2670398" "unprognostic (2.66e-1)" "unprognostic (4.94e-2)" "unprognostic (4.27e-3)" "unprognostic (1.80e-2)" "unprognostic (2.10e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.32e-5)" "unprognostic (2.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.33e-1)" "prognostic favorable (4.22e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (7.47e-6)" "unprognostic (2.21e-2)" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" 7.8 8.2 7.6 6.4 6.9 21.7 7.5 7.1 9.1 8.6 4.0 7.8 4.1 9.0 3.6 7.0 8.6 4.2 6.2 9.6 6.8 7.1 9.6 8.6 7.2 9.0 7.1 6.8 8.0 7.9 6.0 10.7 5.8 8.7 8.6 3.0 4.8 6.9 4.0 6.4 8.4 7.9 4.3 5.5 15.9 7.5 16.3 6.6 7.4 7.6 4.1 4.6 8.6 7.4 7.9 9.4 14.7 7.6 21.0 8.5 7.3 11.6 9.4 7.6 7.3 6.3 9.4 6.9 13.4 13.3 8.2 10.7 10.1 10.0 10.6 4.4 17.0 14.0 6.5 7.7 13.2 10.3 12.7 16.7 8.1 12.7 6.0 6.6 6.6 7.7 10.8 20.2 10.0 9.4 14.3 29.1 17.2 18.9 5.8 10.1 19.1 7.1 11.8 7.1 11.1 10.8 14.9 12.4 13.5 8.9 4.5 6.3 15.6 10.9 9.2 3.3 16.0 13.9 18.5 9.4 10.7 12.1 10.1 16.6 2.0 0.7 0.8 0.4 0.4 0.4 0.2 0.6 1.0 0.4 0.3 0.7 0.5 6.9 0.4 0.4 0.6 1.1 0.3 7.6 6.9 7.1 9.1 9.6 6.8 9.0 7.1 6.8 8.7 5.5 6.6 7.9 6.4 0.0 7.2 8.8 7.6 3.6 5.2 2.6 4.6 15.4 5.4 4.2 7.1 4.3 4.1 11.0 4.2 7.0 11.0 4.3 0.0 3.5 10.9 4.3 8.8 5.7 6.0 17.2 13.8 2.4 6.9 6.6 9.7 4.4 6.3 6.2 5.0 7.4 8.3 26.9 12.8 4.3 4.1 14.2 4.0 16.0 6.2 7.7 3.6 7.5 9.1 7.6 8.2 6.0 8.2 4.1 3.1 6.8 4.9 6.6 2.3 4.2 4.3 11.1 0.0 8.0 5.5 18.3 9.7 6.0 3.4 8.8 8.4 10.1 3.9 5.3 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" 17 7484366-7514616 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.4;lymphoid tissue: 1.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012226, CAB016388, HPA021563, HPA053012" Enhanced Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 0.1 0.7 0.4 1.6 0.4 0.2 0.1 0.3 1.4 0.0 0.6 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.1 0.7 0.7 0.1 0.0 0.2 0.2 2.4 0.9 0.0 0.1 0.0 0.1 0.2 1.0 0.2 0.2 0.3 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.2 0.0 0.7 1.2 0.2 0.0 0.1 0.0 0.0 1.6 1.0 1.7 0.5 1.5 0.4 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.4 0.0 0.6 1.0 2.1 0.0 0.0 0.3 0.0 0.5 0.0 0.9 0.0 1.6 2.9 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 1.0 0.4 2.1 0.0 0.0 2.5 2.3 1.0 0.0 2.7 3.5 2.8 1.2 0.8 0.0 0.0 0.8 1.6 0.0 1.0 0.5 1.1 2.0 0.4 0.2 1.6 1.1 0.8 1.0 0.0 2.2 0.8 2.0 0.9 2.5 1.1 0.3 0.8 2.2 0.5 1.3 1.0 0.0 2.0 4.2 0.0 3.2 10.1 0.4 0.4 0.3 1.4 0.7 0.7 2.4 0.9 0.0 1.0 0.4 1.2 1.6 124.2 22.4 41.6 13.4 68.0 42.8 40.7 33.8 64.3 90.4 56.5 187.1 26.9 38.6 30.3 23.9 110.5 35.9 153.5 55.0 3.9 27.0 25.0 74.9 64.4 57.7 76.7 43.3 18.1 30.2 28.7 53.3 103.0 67.3 42.5 46.0 40.4 29.9 45.4 55.5 14.9 43.9 26.4 42.1 38.3 7.4 37.0 65.7 37.4 19.7 38.2 27.3 26.8 17.6 17.8 32.0 35.9 41.8 62.0 27.9 42.5 13.2 38.4 90.5 6.6 94.4 53.9 58.5 120.2 73.8 41.2 53.8 89.2 49.8 32.6 30.8 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 31.9" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 217.3;Microglial cells: 160.2;Oligodendrocyte precursor cells: 580.6" "Group enriched" "Detected in some" 4 "glioma: 1.6;ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "gdT-cell: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Group enriched" "Detected in some" 7 "AF22: 3.7;ASC diff: 5.2;Daudi: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 78000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 31.9 2.7 9.0 0.3 7.2 0.1 14.1 6.5 7.4 16.9 13.6 1.3 0.3 5.5 3.8 3.1 11.9 1.1 2.8 6.4 7.0 0.4 0.1 1.5 1.1 9.1 13.6 6.0 8.7 2.7 0.1 0.7 2.5 8.7 2.4 0.4 3.7 1.7 4.1 0.5 1.9 1.8 1.0 6.7 0.3 1.3 1.3 9.4 1.0 0.9 3.4 0.4 4.8 9.3 8.5 0.0 0.0 3.7 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 7.2 6.5 7.4 6.4 7.0 9.1 13.6 6.0 8.7 6.7 9.4 8.5 1.9 0.0 0.0 70.2 0.0 0.4 0.0 0.0 0.0 18.6 0.0 0.0 1.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 1.1 0.2 7.6 26.1 1.0 0.0 0.0 32.2 0.0 0.0 6.3 0.0 9.8 0.0 3.7 0.0 0.0 0.1 0.0 217.3 0.1 0.0 0.0 1.1 0.2 9.0 0.1 1.8 160.2 0.0 0.4 0.0 580.6 42.3 0.1 0.0 15.1 0.0 0.0 0.1 0.1 0.0 2.3 0.0 0.8 2.5 0.1 0.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 SLC25A41 "APC4, FLJ40442, MGC34725" ENSG00000181240 "Solute carrier family 25 member 41" Q8N5S1 19 6426037-6433779 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 6.4;choroid plexus: 3.9;testis: 2.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 92.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.0;U-937: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043591 Uncertain NA NA "HPA043591: AB_10964585" "unprognostic (1.87e-3)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (8.75e-2)" "unprognostic (2.67e-1)" "unprognostic (8.29e-4)" "unprognostic (4.43e-3)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.19e-3)" "unprognostic (3.11e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" "unprognostic (3.63e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" 0.0 0.1 4.3 0.0 4.8 0.0 0.0 4.2 6.4 0.2 3.9 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.3 4.4 4.0 0.1 0.3 0.0 0.0 4.4 4.1 4.0 0.3 0.1 0.0 0.2 0.0 4.4 0.4 0.0 0.3 0.1 0.1 0.3 0.2 0.2 0.1 3.9 0.1 0.2 2.1 4.2 0.0 0.2 0.0 0.0 0.3 0.2 4.3 0.1 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.6 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.8 4.2 6.4 4.4 4.0 4.4 4.1 4.0 4.4 3.9 4.2 4.3 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.3 0.0 1.0 0.2 0.3 0.5 0.0 0.0 0.0 2.1 0.4 0.1 0.4 0.0 0.3 92.2 0.1 0.1 0.0 0.0 0.0 5.0 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 3.3 4.5 0.4 0.0 0.0 0.0 20.6 0.9 0.1 0.0 0.0 0.0 1.1 0.0 1.0 1.6 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 1.2 0.0 0.1 0.1 0.3 0.6 0.0 0.3 0.5 0.0 0.0 0.4 0.1 TLCD5 "MGC17839, TMEM136" ENSG00000181264 "TLC domain containing 5" Q6ZRR5 11 120325296-120333686 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 52.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 28.3;Cytotrophoblasts: 10.0;Extravillous trophoblasts: 4.2;Fibroblasts: 6.1;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA074432: AB_2686689" "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 3.3 13.2 10.9 1.0 14.7 0.2 3.3 13.2 10.7 5.0 8.4 2.3 0.6 5.2 7.7 1.5 5.8 3.3 10.7 10.9 13.7 3.6 0.8 4.8 1.4 13.2 15.3 9.5 7.8 4.0 4.5 7.1 7.2 12.3 5.0 1.2 52.4 2.0 3.3 1.2 1.2 1.9 3.9 12.0 2.6 2.5 3.2 12.8 0.8 5.5 2.0 1.4 3.5 3.6 14.1 2.4 6.0 15.8 10.9 10.9 16.8 3.0 5.0 12.3 8.4 12.7 3.2 10.2 0.0 15.3 3.2 16.2 1.6 10.1 3.8 9.8 0.0 6.3 8.1 6.1 5.4 12.4 0.0 0.0 14.7 2.8 11.4 17.0 19.7 9.2 9.5 2.2 14.8 10.9 2.9 0.0 0.1 5.1 0.6 3.8 6.3 4.9 0.8 10.4 2.2 8.3 7.2 7.3 0.9 1.5 13.4 9.3 0.2 6.9 8.7 9.0 2.0 3.1 0.2 0.0 0.0 2.6 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.0 10.9 14.7 13.2 10.7 10.9 13.7 13.2 15.3 9.5 12.3 12.0 12.8 14.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 OR5AK2 ENSG00000181273 "Olfactory receptor family 5 subfamily AK member 2" Q8NH90 11 56988872-56989867 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 1.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.5 0.1 0.0 0.4 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRAT2 ENSG00000181274 "FRAT regulator of WNT signaling pathway 2" O75474 10 97332497-97334729 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "testis cancer: 70.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 15.0;neutrophil: 58.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 58.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049763: AB_2680868" "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favorable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.3 3.6 7.4 10.5 7.2 31.3 8.1 8.2 7.4 6.0 9.5 17.3 25.3 4.1 6.3 14.5 7.1 4.0 4.9 6.5 7.1 5.5 18.4 9.8 8.8 7.9 7.8 6.1 2.8 14.1 5.2 3.0 7.4 7.1 8.0 15.7 3.3 15.2 4.3 10.2 20.2 16.0 4.1 7.1 29.2 13.3 14.7 7.6 9.0 5.3 9.2 10.9 6.8 8.2 7.0 10.9 4.3 6.9 31.2 4.9 4.0 25.7 2.4 8.9 3.7 3.7 6.8 12.5 13.3 8.4 2.5 2.2 20.3 18.3 9.5 2.9 20.0 28.0 17.9 9.2 15.0 2.8 28.9 20.6 3.2 20.0 3.6 11.4 7.9 9.3 11.7 15.8 4.2 1.8 17.9 12.6 36.5 42.9 36.2 17.5 12.8 2.9 19.1 8.9 9.8 12.5 10.2 3.1 19.1 12.6 28.0 28.8 44.8 4.2 2.2 2.7 1.7 6.4 11.4 12.5 6.6 2.6 49.3 0.8 8.3 7.2 15.0 1.1 4.8 0.6 1.1 1.3 1.8 3.8 3.2 2.2 1.3 58.2 1.6 7.9 1.0 0.7 2.3 7.4 7.2 8.2 7.4 6.5 7.1 7.9 7.8 6.1 7.1 7.1 7.6 7.0 18.2 0.0 3.9 2.9 15.7 31.7 25.3 6.6 46.1 19.7 24.7 19.6 6.4 20.0 5.0 14.7 4.2 6.1 26.1 31.0 11.7 2.2 40.7 39.6 9.7 10.3 13.8 14.5 2.0 5.3 18.5 6.4 37.2 46.3 1.3 16.7 8.6 11.3 8.6 11.8 2.8 30.6 4.1 28.3 9.0 42.3 2.1 25.2 10.6 7.5 24.7 5.0 14.4 2.0 1.1 3.4 21.6 2.6 8.4 30.0 13.5 3.7 4.5 18.1 0.0 14.9 8.7 2.3 4.4 37.7 52.7 7.8 18.8 20.1 31.6 32.3 TMEM102 "CBAP, FLJ36878" ENSG00000181284 "Transmembrane protein 102" Q8N9M5 17 7435435-7437679 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 69.0;Pancreatic endocrine cells: 32.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 10.6;HMC-1: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024433 Uncertain Approved Vesicles NA NA Vesicles "HPA024433: AB_1858071" "unprognostic (2.42e-2)" "unprognostic (2.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-2)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.61e-1)" "unprognostic (2.91e-2)" "unprognostic (2.69e-2)" "unprognostic (2.69e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.10e-3)" "unprognostic (8.40e-2)" "unprognostic (1.67e-1)" "unprognostic (1.42e-3)" 2.4 8.2 0.4 1.5 0.5 1.5 3.5 0.7 0.3 2.3 0.2 3.6 2.8 1.8 1.0 10.3 1.8 1.0 2.0 0.2 0.5 4.7 4.5 3.1 2.5 0.7 0.5 0.1 0.5 5.5 1.6 1.0 0.8 0.7 2.3 1.1 0.2 6.3 0.8 3.6 8.9 6.0 0.3 0.6 6.4 4.5 6.7 0.5 1.5 3.8 0.1 1.8 2.6 4.6 0.7 5.3 3.7 0.4 0.0 1.3 0.6 2.9 1.1 1.4 0.7 1.5 2.0 5.5 5.3 4.8 0.5 0.7 10.6 0.9 5.8 0.1 4.8 6.5 4.9 2.2 1.9 0.6 2.9 11.9 0.4 5.4 0.4 1.0 1.8 2.4 4.5 1.9 0.3 0.0 3.2 3.3 5.2 0.2 5.1 3.0 5.4 0.4 1.9 5.0 3.4 0.2 3.4 0.6 4.7 1.4 0.9 2.5 1.2 3.2 0.2 0.3 0.6 0.1 1.0 1.4 0.7 1.6 2.5 2.4 0.0 0.4 3.8 0.7 0.9 0.4 0.8 0.8 0.9 0.5 0.8 0.6 0.6 0.0 1.0 1.0 0.5 0.7 0.4 0.4 0.5 0.7 0.3 0.2 0.5 0.7 0.5 0.1 0.7 0.6 0.5 0.7 2.4 0.0 0.0 0.0 8.8 3.7 5.6 5.2 8.6 0.0 4.0 3.4 1.1 7.2 4.2 1.8 0.0 9.1 6.5 18.2 7.9 21.6 16.8 7.1 1.1 3.0 1.2 2.5 0.1 21.9 7.9 0.4 9.7 11.0 0.0 4.5 2.2 3.6 7.1 1.7 0.1 8.2 6.1 7.2 10.6 69.0 0.9 4.5 1.8 0.0 11.6 1.6 8.2 0.0 0.5 32.5 15.3 0.7 5.9 2.9 15.2 9.0 2.4 0.6 0.0 0.4 1.4 1.1 2.7 5.7 7.1 5.1 8.1 0.6 7.6 13.1 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5" "Cancer enriched" "Detected in some" 4 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 170000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.3 0.1 4.4 0.0 2.8 0.0 0.1 5.8 5.1 0.3 0.1 0.1 1.3 0.1 0.0 0.1 0.1 0.1 0.2 2.3 4.7 3.6 0.4 0.1 0.1 17.6 5.2 2.4 0.2 0.0 0.0 0.1 0.1 8.9 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.8 0.1 8.8 0.3 0.1 1.9 6.5 0.0 0.3 0.0 0.1 0.1 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 4.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 4.4 2.8 5.8 5.1 2.3 4.7 17.6 5.2 2.4 8.9 8.8 6.5 11.5 0.1 0.0 0.0 2.6 0.1 0.3 0.0 0.0 0.0 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 6.4 0.0 0.0 1.9 0.7 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 0.2 0.5 1.2 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA043161: AB_2678346, HPA046692: AB_2679755" "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favorable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favorable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 7.8 12.1 11.5 7.8 12.4 1.3 12.9 12.8 12.1 15.5 11.5 8.9 9.4 15.7 13.4 8.7 11.5 9.9 7.8 11.0 12.2 12.0 9.4 10.0 9.9 12.5 13.0 10.6 18.0 8.3 17.8 7.1 11.3 12.7 15.0 11.0 14.4 8.8 14.0 6.6 6.0 8.2 10.6 13.1 11.8 9.2 11.2 12.3 10.2 15.4 12.9 9.8 10.9 7.5 15.7 9.3 6.8 26.2 31.0 17.3 22.5 9.7 12.3 16.1 16.6 20.1 13.3 5.5 11.0 28.5 10.6 20.8 11.5 19.7 7.4 20.8 17.3 18.0 19.5 8.7 13.2 19.5 0.0 17.3 14.1 27.0 10.7 12.3 20.8 14.4 13.5 23.3 11.7 18.3 5.2 14.1 16.9 7.8 8.5 8.4 15.4 18.6 16.0 10.1 14.5 21.3 22.7 14.5 13.6 25.9 12.8 12.5 12.8 14.4 27.8 11.0 11.4 12.4 12.2 25.8 10.8 5.8 2.9 28.4 3.3 8.4 10.8 10.5 7.2 7.6 11.2 5.3 6.9 6.9 9.0 6.1 9.1 8.0 17.8 11.9 7.8 4.5 5.1 11.5 12.4 12.8 12.1 11.0 12.2 12.5 13.0 10.6 12.7 13.1 12.3 15.7 24.8 6.4 10.5 3.9 18.0 4.0 17.3 4.8 14.8 32.1 23.9 31.2 5.8 12.8 11.1 9.2 8.4 12.5 16.1 9.9 35.2 17.7 4.1 14.2 32.6 20.1 19.7 7.2 5.3 10.2 11.3 21.9 10.2 15.7 13.3 30.0 18.2 7.6 13.3 47.1 7.0 14.1 8.2 8.9 5.3 3.7 30.1 11.7 8.8 6.5 12.7 26.7 10.3 11.1 10.3 16.1 12.8 26.4 11.8 26.4 10.2 13.3 8.1 13.9 32.9 20.6 22.2 26.0 15.7 12.0 6.5 9.6 9.1 37.7 10.0 24.9 NME9 "NM23-H9, TXL-2, TXNDC6" ENSG00000181322 "NME/NM23 family member 9" Q86XW9 3 138261437-138329886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5;choroid plexus: 12.2;fallopian tube: 17.7" "Group enriched" "Detected in some" 6 "Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020943, HPA040000, HPA043881" Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712" "unprognostic (2.71e-5)" "unprognostic (1.68e-1)" "unprognostic (5.09e-2)" "unprognostic (3.01e-3)" "unprognostic (3.67e-1)" "unprognostic (1.69e-3)" "unprognostic (4.58e-2)" "unprognostic (5.19e-2)" "unprognostic (1.66e-1)" "unprognostic (1.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.72e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (9.14e-2)" "unprognostic (4.89e-2)" "unprognostic (7.17e-3)" 0.6 0.7 8.2 0.4 4.4 2.9 0.7 9.5 5.5 0.8 12.2 0.6 0.2 0.6 0.7 0.4 17.7 0.4 0.5 3.8 4.5 0.9 0.4 2.2 0.3 6.5 6.2 3.9 0.7 1.3 0.9 3.7 0.2 5.3 0.8 0.0 7.5 1.6 0.7 2.7 0.8 0.8 0.2 6.2 0.5 0.6 4.3 5.0 0.5 1.2 0.0 0.2 0.5 0.5 5.0 0.3 0.2 0.4 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.3 0.6 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.8 0.1 0.0 1.0 1.7 0.3 0.0 0.0 0.0 0.7 0.0 0.7 0.2 0.4 0.0 0.1 0.1 1.0 0.2 0.1 0.3 0.3 0.0 0.3 0.5 0.9 0.9 0.2 0.6 0.1 0.1 0.3 0.3 0.0 1.1 0.3 0.2 0.3 0.1 0.3 0.4 0.4 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.0 8.2 4.4 9.5 5.5 3.8 4.5 6.5 6.2 3.9 5.3 6.2 5.0 5.0 0.2 0.0 0.5 27.4 0.0 0.0 0.2 1.1 0.0 1.5 0.1 0.0 1.5 2.8 2.3 1.8 0.0 0.1 0.0 0.0 0.0 0.2 3.1 20.0 0.2 0.3 0.0 0.0 26.6 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.4 0.0 0.0 3.3 17.9 0.0 0.0 0.3 0.0 1.4 0.3 0.0 0.0 1.0 0.0 2.7 0.0 67.8 36.6 0.0 0.0 0.0 0.3 0.2 0.0 0.5 48.4 2.3 0.0 0.5 0.7 5.0 0.7 0.0 0.0 0.3 0.2 0.4 0.0 0.1 SPEM1 "C17orf83, FLJ40081" ENSG00000181323 "Spermatid maturation 1" Q8N4L4 17 7420324-7421632 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 333 "testis: 69.2" "Cell type enriched" "Detected in some" 6 "Late spermatids: 5248.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 808.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5248.6 11.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 13.8 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021354-94114208 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "esophagus: 4.5;lymphoid tissue: 9.6;skin 1: 2.4;vagina: 4.6" "Cell type enriched" "Detected in some" 5 "Basal keratinocytes: 10.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 1.4;HBEC3-KT: 2.6" "Region enriched" "Detected in single" 12 "olfactory bulb: 1.2" "Not detected" "Not detected" HPA031517 Uncertain NA NA 260000000 "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavorable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 9.6 0.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 10.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.8 0.0 0.6 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.4 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 62.1;SK-MEL-30: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 5.5 21.7 6.4 6.5 5.2 16.2 0.5 2.4 8.0 1.3 1.0 20.4 47.8 4.0 0.2 2.1 1.3 3.1 2.4 7.1 6.3 2.1 0.6 4.7 5.7 4.2 6.6 5.5 4.5 7.1 4.7 3.1 3.5 5.5 1.9 9.0 2.3 1.3 1.1 2.9 2.2 44.4 2.4 3.9 21.7 7.5 10.7 5.0 0.5 5.0 0.7 1.6 1.6 0.5 5.7 8.9 6.3 7.6 6.0 0.2 0.2 1.3 2.4 0.4 1.8 1.5 7.9 2.6 0.6 6.6 0.2 3.7 3.7 0.2 0.0 0.0 3.4 6.5 62.1 3.9 0.0 0.3 1.5 7.3 0.0 0.0 0.4 0.0 3.2 2.3 9.4 3.9 1.7 0.1 12.8 15.3 6.7 1.7 20.3 0.7 5.8 5.5 0.8 0.4 1.8 16.6 4.6 0.6 1.8 21.7 3.3 1.4 1.4 0.0 2.2 10.5 6.7 11.9 12.2 2.6 2.0 0.8 5.1 7.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.7 0.3 0.4 1.0 0.0 0.0 0.4 6.4 5.2 2.4 8.0 7.1 6.3 4.2 6.6 5.5 5.5 3.9 5.0 5.7 40.5 41.7 69.7 10.7 21.6 0.0 9.6 0.0 2.2 9.1 24.9 13.3 0.7 14.3 19.8 1.8 6.2 16.1 24.8 52.5 19.6 3.9 7.1 30.0 61.0 14.7 24.7 9.7 5.3 7.1 20.4 30.5 2.0 58.7 29.7 25.0 11.0 10.0 12.0 3.3 3.6 52.2 0.0 13.9 0.0 8.0 16.4 22.9 0.0 1.0 7.7 21.3 2.1 4.0 4.2 6.2 36.0 11.3 12.0 8.7 65.4 19.4 8.7 18.2 13.1 22.9 19.4 8.0 6.5 1.1 0.0 16.7 18.6 66.3 66.0 7.5 OR5M8 ENSG00000181371 "Olfactory receptor family 5 subfamily M member 8" Q8NGP6 11 56490349-56491395 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL13 "CKb10, MCP-4, MGC17134, NCC-1, SCYA13, SCYL1" ENSG00000181374 "C-C motif chemokine ligand 13" Q99616 17 34356480-34358610 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 30.7;urinary bladder: 30.6" "Cell type enhanced" "Detected in some" "Hofbauer cells: 48.7;Langerhans cells: 81.2;Melanocytes: 17.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;BJ hTERT+: 1.7;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;HMC-1: 1.3;HSkMC: 1.7" "Secreted to blood" NA NA 336000 "unprognostic (2.22e-2)" "unprognostic (3.56e-2)" "unprognostic (8.41e-3)" "unprognostic (1.49e-3)" "unprognostic (4.43e-2)" "unprognostic (1.58e-1)" "unprognostic (7.58e-2)" "unprognostic (8.49e-2)" "unprognostic (1.18e-1)" "unprognostic (2.83e-2)" "unprognostic (1.35e-2)" "unprognostic (5.98e-2)" "unprognostic (8.63e-8)" "unprognostic (2.26e-1)" "unprognostic (2.57e-1)" "unprognostic (1.37e-1)" "unprognostic (1.71e-2)" 24.2 4.5 0.0 7.1 0.0 0.3 18.6 0.0 0.5 2.4 0.0 30.7 21.5 0.6 0.3 12.0 4.5 2.7 11.9 0.0 0.0 1.2 0.2 22.7 3.3 0.0 0.0 0.0 0.3 0.7 1.7 0.1 9.8 0.0 1.6 25.3 0.0 2.6 0.8 0.6 4.2 27.3 9.0 0.0 0.1 3.0 2.4 0.0 8.8 1.8 5.8 1.8 30.6 3.3 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.2 1.7 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.0 8.8 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.4 7.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 81.2 0.3 0.0 6.6 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.1 4.7 0.3 1.0 0.0 0.0 0.1 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 11.4;fallopian tube: 25.9;retina: 9.3;testis: 9.5" "Group enriched" "Detected in many" 4 "Early spermatids: 204.5;Late spermatids: 164.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 10.8" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.0 0.1 7.6 0.0 2.5 0.0 0.1 3.1 2.1 0.7 11.4 0.1 0.0 0.5 1.8 0.0 25.9 0.4 0.0 1.9 6.0 0.4 0.0 2.7 0.0 7.0 8.2 0.6 0.0 0.3 0.1 3.5 0.0 6.0 0.1 0.2 9.3 0.1 0.1 0.0 0.0 0.4 0.0 7.4 0.0 0.3 9.5 3.3 0.0 0.9 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 2.5 3.1 2.1 1.9 6.0 7.0 8.2 0.6 6.0 7.4 3.3 3.4 0.1 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.8 7.7 8.8 0.0 4.3 6.8 0.0 12.5 0.0 0.1 1.1 0.0 0.6 204.5 45.1 0.5 0.2 29.1 0.0 0.0 1.5 0.0 0.2 2.0 1.8 0.0 0.2 0.0 0.1 0.1 0.0 0.0 25.2 0.0 0.0 0.0 164.3 0.6 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 1.8 0.7 0.0 1.1 1.9 1.1 29.2 19.5 0.0 0.1 0.0 14.4 5.7 0.0 0.0 0.0 0.2 0.1 5.1 0.1 DDX60L FLJ31033 ENSG00000181381 "DExD/H-box 60 like" Q5H9U9 4 168356735-168537786 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 32.8" "Group enriched" "Detected in all" 4 "granulocytes: 32.8;monocytes: 13.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 44.0" "HPA043211, HPA055501" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043211: AB_10794390, HPA055501: AB_2682838" "unprognostic (8.86e-2)" "unprognostic (2.77e-1)" "unprognostic (1.16e-1)" "unprognostic (2.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.20e-2)" "unprognostic (1.05e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.13e-1)" "unprognostic (8.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.69e-1)" 7.0 2.8 3.8 16.0 4.7 51.7 5.9 2.2 3.9 6.7 4.3 9.2 8.7 6.8 2.1 3.2 5.5 9.3 3.5 1.8 4.5 2.3 8.3 10.2 9.7 7.3 2.7 0.5 5.3 3.2 3.0 0.4 20.9 4.9 3.8 9.1 6.3 9.1 3.2 1.0 3.1 11.1 7.4 3.7 12.9 13.7 2.2 6.6 15.6 3.6 3.6 7.4 5.9 0.7 12.1 12.3 7.1 2.7 1.1 6.9 19.9 13.3 12.0 25.3 44.0 30.4 0.1 28.0 0.2 0.6 12.2 23.9 4.7 1.2 7.3 12.8 7.0 1.0 27.0 8.1 0.7 8.4 11.1 6.5 5.6 2.1 15.9 1.4 9.2 31.5 6.0 0.5 0.3 28.6 0.3 10.0 7.0 0.6 1.1 5.9 5.4 6.1 0.0 4.2 7.1 0.5 3.6 21.4 2.6 12.2 0.5 1.9 15.3 34.1 2.4 15.6 5.6 4.2 11.2 1.9 0.1 7.8 32.2 3.4 2.4 5.9 5.4 3.7 9.1 5.1 1.2 3.7 3.8 3.6 2.0 2.9 3.3 32.8 2.7 13.1 0.0 5.5 2.5 3.8 4.7 2.2 3.9 1.8 4.5 7.3 2.7 0.5 4.9 3.7 6.6 12.1 29.0 9.6 6.7 11.4 14.7 1.0 2.6 3.9 3.4 1.7 11.2 3.3 8.3 2.8 5.1 3.7 22.9 6.1 16.0 24.0 0.0 7.6 15.7 8.5 15.6 18.9 0.0 5.9 1.5 10.1 39.4 13.0 44.4 7.1 8.8 20.3 6.1 6.6 26.1 0.0 5.5 14.1 10.2 23.8 6.0 4.4 3.4 46.2 0.0 33.7 35.6 2.9 24.7 28.6 2.4 26.4 31.5 4.1 6.0 2.1 13.2 3.7 11.5 19.4 6.6 7.1 5.7 0.7 1.4 4.3 2.4 7.1 24.1 12.2 4.5 2.0 SYNE4 "C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4" ENSG00000181392 "Spectrin repeat containing nuclear envelope family member 4" Q8N205 19 36003307-36008813 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 32.0;Breast myoepithelial cells: 35.9;Cytotrophoblasts: 32.6;Syncytiotrophoblasts: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 32.5;Hep G2: 29.1;MCF7: 34.2;SK-BR-3: 40.1;T-47d: 31.0" "Region enriched" "Detected in single" 15 "cerebellum: 6.8" "Not detected" "Not detected" HPA060253 Uncertain NA NA "HPA060253: AB_2684233" "unprognostic (8.54e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.24e-1)" "unprognostic (5.54e-2)" "unprognostic (2.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.03e-2)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (3.36e-3)" "unprognostic (6.02e-2)" "prognostic favorable (8.64e-9)" "unprognostic (1.25e-1)" "unprognostic (2.54e-2)" "unprognostic (4.50e-1)" "unprognostic (1.97e-2)" 0.2 0.2 2.2 0.2 0.9 0.2 5.3 6.7 1.3 2.6 2.0 1.7 3.2 0.7 7.8 1.2 3.9 1.7 0.2 0.7 2.7 6.9 12.1 3.1 0.2 3.2 2.5 0.6 0.3 5.4 12.2 12.8 1.7 3.8 11.0 1.5 0.2 9.3 4.1 0.3 1.1 1.3 0.2 1.4 0.4 3.4 0.2 2.4 1.7 8.7 0.0 0.3 0.8 1.3 3.2 0.3 0.3 0.2 0.4 0.1 0.2 4.3 0.0 0.0 0.0 0.1 32.5 3.8 0.3 0.4 0.0 0.2 0.0 0.3 0.4 0.0 1.1 0.5 0.1 0.8 29.1 0.5 0.0 0.2 0.2 0.2 1.1 0.0 0.0 0.2 1.6 0.4 0.4 0.0 34.2 0.5 0.1 0.2 0.3 0.2 0.9 0.0 0.4 2.2 1.0 5.0 0.0 0.0 40.1 0.2 0.2 31.0 0.3 0.0 0.3 0.6 0.5 0.2 0.5 0.7 0.6 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.9 6.7 1.3 0.7 2.7 3.2 2.5 0.6 3.8 1.4 2.4 3.2 0.3 6.4 17.5 0.3 0.7 0.5 14.9 19.9 5.2 0.9 32.0 35.9 0.4 24.3 20.2 29.5 4.2 32.6 0.8 5.4 25.4 21.2 0.0 9.1 1.0 0.8 29.8 0.0 0.6 8.6 24.7 0.7 8.2 10.7 1.3 0.5 0.7 12.5 2.6 0.0 0.9 10.6 26.4 0.6 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.9 11.7 16.9 0.0 0.0 23.9 4.5 24.2 17.3 0.4 0.0 0.3 1.6 0.1 0.4 2.1 0.4 33.9 1.2 0.1 8.8 9.2 OGFOD3 "C17orf101, FLJ22222" ENSG00000181396 "2-oxoglutarate and iron dependent oxygenase domain containing 3" Q6PK18 17 82389210-82418637 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052099 Uncertain Approved Nucleoplasm NA NA 9700 Nucleoplasm "HPA052099: AB_2681725" "unprognostic (1.12e-2)" "unprognostic (5.85e-2)" "unprognostic (9.66e-2)" "unprognostic (9.69e-2)" "unprognostic (4.11e-3)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.99e-1)" "unprognostic (5.41e-2)" "unprognostic (7.15e-2)" "unprognostic (8.05e-3)" "unprognostic (2.95e-1)" "prognostic favorable (5.72e-4)" "unprognostic (7.43e-2)" "unprognostic (1.40e-1)" "unprognostic (7.08e-2)" "unprognostic (1.02e-1)" 14.5 19.7 4.3 9.1 4.7 10.2 14.1 5.5 7.0 13.8 8.5 13.6 10.0 16.2 6.4 12.6 13.4 8.1 24.2 3.7 4.4 15.4 20.7 13.8 8.4 5.1 4.5 3.9 14.7 25.9 15.4 22.2 9.0 5.2 15.6 5.5 2.7 19.1 10.3 24.5 13.1 11.2 5.8 3.3 11.5 15.9 8.6 3.9 5.5 19.1 9.0 5.5 14.5 11.6 5.1 23.0 28.6 9.4 31.5 17.8 22.4 16.1 22.9 21.4 23.5 24.0 30.8 30.9 15.7 17.8 18.0 23.9 16.9 8.1 19.4 9.7 12.5 24.5 23.6 22.6 39.7 15.9 27.8 27.0 18.1 14.0 10.9 9.3 17.1 24.8 17.2 30.4 12.0 6.9 21.7 19.1 29.1 8.9 24.3 33.5 12.4 18.0 24.4 13.5 21.3 20.2 40.1 39.4 36.1 18.8 7.9 21.4 36.2 19.4 44.0 27.3 17.5 30.0 20.9 2.0 14.6 27.5 15.9 23.2 0.2 13.8 4.5 6.5 12.9 7.4 13.6 9.4 13.0 23.6 11.9 11.1 9.3 1.6 7.0 8.5 12.3 3.9 8.0 4.3 4.7 5.5 7.0 3.7 4.4 5.1 4.5 3.9 5.2 3.3 3.9 5.1 13.9 25.6 16.5 3.3 21.6 11.3 23.8 27.1 13.1 23.1 26.0 29.7 18.6 18.6 19.1 22.0 10.4 37.9 12.7 19.8 9.8 27.3 28.2 23.1 17.0 18.4 28.8 21.8 6.3 31.4 59.2 25.3 19.4 16.8 9.5 20.8 8.9 28.0 37.1 30.3 7.7 24.0 12.2 22.4 16.4 45.7 20.8 19.9 14.2 3.7 27.1 12.4 34.0 8.5 6.9 20.1 32.4 18.8 53.1 35.1 42.3 27.8 18.2 16.1 6.6 30.2 23.1 16.1 10.3 19.9 12.8 31.7 15.9 27.0 28.6 28.1 WASHC1 "FAM39E, FLJ00038, WASH1" ENSG00000181404 "WASH complex subunit 1" A8K0Z3 9 14475-73865 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 50.9;Proximal tubular cells: 47.5;Syncytiotrophoblasts: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002689 Uncertain Supported Vesicles NA NA Vesicles "HPA002689: AB_1078803" "unprognostic (9.43e-2)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (5.00e-1)" "unprognostic (5.40e-3)" "unprognostic (3.37e-3)" "unprognostic (6.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-1)" "unprognostic (3.38e-1)" "unprognostic (2.31e-2)" "unprognostic (1.02e-1)" 15.7 18.3 12.7 7.2 13.5 16.4 17.8 12.7 14.6 24.5 15.4 19.6 10.3 20.5 22.1 19.3 24.3 9.1 16.7 12.8 13.6 26.1 21.1 17.2 13.5 15.4 15.1 12.1 23.2 22.1 5.2 21.3 6.7 13.9 27.2 4.7 16.1 17.7 13.6 23.0 26.3 22.1 15.5 12.6 29.2 18.5 24.3 13.6 8.6 22.2 6.9 6.0 19.9 20.7 14.2 13.5 8.5 5.0 10.3 8.5 5.7 12.4 11.7 11.4 6.9 5.5 8.4 8.3 5.7 6.6 4.8 6.2 16.7 7.4 5.7 2.5 5.9 14.4 5.5 7.0 8.6 4.7 11.3 10.0 4.3 4.2 3.5 4.7 17.3 2.1 5.0 12.6 21.0 2.2 4.0 11.6 9.4 9.2 9.1 10.5 7.9 4.3 7.2 5.1 9.8 5.6 14.9 6.8 14.3 8.6 6.2 8.6 10.5 8.0 9.2 6.7 4.0 10.3 9.4 7.9 4.5 8.6 12.0 8.6 1.2 2.5 2.2 1.9 2.7 1.5 1.3 1.5 1.6 2.3 1.2 1.6 1.3 1.4 2.1 4.0 2.1 1.8 1.5 12.7 13.5 12.7 14.6 12.8 13.6 15.4 15.1 12.1 13.9 12.6 13.6 14.2 34.5 22.4 22.5 0.0 10.5 0.0 0.0 0.0 0.0 0.0 29.0 28.3 0.0 0.0 7.4 60.7 0.0 37.4 21.5 0.0 50.9 13.7 0.0 24.7 28.6 7.5 0.0 0.0 0.0 15.8 26.1 10.8 0.0 22.9 16.4 27.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 13.1 0.0 0.0 6.7 0.0 0.0 47.5 8.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 42.8 11.4 14.3 0.0 0.0 UTS2R GPR14 ENSG00000181408 "Urotensin 2 receptor" Q9UKP6 17 82371400-82375586 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.6;testis: 3.2;thyroid gland: 1.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1" "Region enhanced" "Detected in single" "cerebral cortex: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.2;U-266/70: 15.2;U-266/84: 2.7" NA NA "unprognostic (1.55e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.92e-1)" "unprognostic (1.46e-2)" "unprognostic (8.26e-2)" "unprognostic (2.30e-2)" "unprognostic (3.98e-1)" "unprognostic (6.38e-2)" "unprognostic (4.44e-2)" "unprognostic (8.73e-2)" "unprognostic (1.81e-1)" "unprognostic (1.32e-1)" "unprognostic (7.84e-2)" 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.0 1.6 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.1 3.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 1.8 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 15.2 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 1.6 0.1 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81110487-81166221 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 179.1" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 243.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 2.0" "Group enriched" "Detected in some" 6 "CACO-2: 60.1;SH-SY5Y: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.2 32.2 3.2 64.4 3.7 2.3 31.6 57.7 2.5 0.0 6.3 31.2 0.9 0.5 1.8 2.9 2.7 3.4 22.8 36.1 0.9 0.9 9.6 0.9 89.4 62.1 13.9 0.9 20.8 3.0 17.5 2.0 100.5 5.2 0.5 2.1 5.9 3.3 0.6 4.6 23.9 0.8 39.5 9.7 5.8 0.7 58.6 0.1 2.9 1.1 0.2 2.8 4.2 179.1 0.3 0.5 0.7 4.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 60.1 0.2 0.0 0.3 0.0 0.0 1.2 0.6 0.0 0.0 0.0 2.0 2.2 3.2 2.8 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 0.0 6.6 0.0 0.2 0.7 0.6 0.3 2.1 4.1 0.6 0.0 0.2 4.5 17.1 0.2 0.4 2.3 0.2 1.1 2.2 2.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 0.2 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 32.2 64.4 31.6 57.7 22.8 36.1 89.4 62.1 13.9 100.5 39.5 58.6 179.1 6.3 32.1 20.3 17.0 0.3 0.3 1.0 1.9 0.6 43.0 1.3 5.1 2.2 2.8 0.1 0.0 4.2 0.1 0.5 6.8 0.0 0.6 0.0 0.4 0.2 1.8 1.8 0.0 34.6 1.8 0.1 0.5 7.1 0.6 6.3 2.0 1.1 0.1 2.1 21.9 36.0 4.6 0.0 2.8 0.4 0.0 1.5 8.2 5.4 2.8 1.5 9.6 4.1 21.1 243.2 1.1 4.2 2.6 0.1 0.9 34.1 0.9 0.0 4.4 0.0 4.3 0.8 0.4 0.5 0.0 0.3 2.3 1.4 0.4 7.0 0.2 DDN KIAA0749 ENSG00000181418 Dendrin O94850 12 48995149-48999375 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 159.0;skeletal muscle: 299.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.7;Excitatory neurons: 5.9;Inhibitory neurons: 2.5" "Cancer enhanced" "Detected in some" "glioma: 2.2;head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 12.0;NB-4: 7.0;RPMI-8226: 23.3;SCLC-21H: 11.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "amygdala: 165.3;basal ganglia: 212.8;cerebral cortex: 178.3;hippocampal formation: 171.2;olfactory bulb: 62.7" HPA060952 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060952: AB_2684396" "unprognostic (2.80e-2)" "unprognostic (3.19e-3)" "unprognostic (4.56e-2)" "unprognostic (8.10e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (6.20e-5)" "unprognostic (8.61e-4)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (5.08e-2)" "unprognostic (1.37e-6)" "unprognostic (1.72e-2)" "unprognostic (5.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.53e-2)" 0.1 0.1 153.1 0.2 135.1 1.0 0.1 0.0 159.0 0.0 4.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 127.9 22.0 19.0 0.1 0.1 0.2 36.7 5.5 151.0 0.0 0.1 0.1 1.3 0.0 50.9 1.4 0.0 0.3 1.7 0.0 299.6 0.3 0.1 0.0 0.0 0.3 0.3 0.2 10.0 0.0 0.1 9.3 0.2 0.0 0.1 86.9 0.4 0.4 0.2 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 5.2 0.5 0.0 0.2 0.1 0.0 1.8 12.0 0.0 0.1 0.6 5.4 2.7 0.6 1.2 0.0 6.5 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.0 4.0 0.2 0.2 6.3 7.0 0.1 0.9 1.6 5.7 0.3 23.3 0.0 0.1 11.8 1.1 0.2 0.6 0.3 0.1 0.3 0.9 0.1 0.3 0.5 0.3 0.0 1.4 2.8 5.5 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 153.1 135.1 0.0 159.0 127.9 22.0 36.7 5.5 151.0 50.9 0.0 10.0 86.9 0.4 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.4 0.6 0.0 0.0 3.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.8 5.9 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.2 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.4 0.1 0.1 0.0 0.1 0.0 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 4.9" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 9.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 8.9 23.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.4 0.4 0.1 0.4 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF467 "EZI, Zfp467" ENSG00000181444 "Zinc finger protein 467" Q7Z7K2 7 149764182-149773588 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 60.2;Distal tubular cells: 39.2;Hepatic stellate cells: 40.7;Kupffer cells: 56.8;monocytes: 37.1;Muller glia cells: 75.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 22.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 48.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 48.6" "Cell line enhanced" "Detected in many" "AN3-CA: 28.8;EFO-21: 13.5;HMC-1: 15.9;MCF7: 12.9;SK-BR-3: 12.7;T-47d: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042907 Uncertain Approved Mitochondria NA NA Mitochondria "HPA042907: AB_10966965" "unprognostic (3.01e-1)" "unprognostic (2.41e-1)" "unprognostic (6.40e-4)" "unprognostic (5.99e-2)" "unprognostic (2.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (5.14e-2)" "prognostic favorable (4.56e-4)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.25e-2)" 10.4 9.5 6.2 3.8 10.8 10.8 8.9 5.2 7.2 9.8 5.0 9.1 1.0 10.6 1.5 5.5 13.9 3.1 9.6 6.1 7.9 22.0 14.7 16.5 3.7 8.2 7.9 5.3 8.5 14.9 5.7 14.6 2.0 7.8 7.4 1.4 11.2 9.4 3.8 1.6 9.2 7.9 2.8 6.3 27.8 16.3 1.5 7.1 4.2 16.2 3.1 2.3 7.0 6.9 7.3 0.0 3.4 4.2 28.8 0.1 0.0 0.1 0.1 0.0 0.4 0.1 1.0 8.6 0.2 13.5 0.2 0.1 0.3 2.2 0.1 0.2 0.1 0.4 1.6 0.0 0.0 8.7 0.0 15.9 5.8 1.2 0.0 0.1 10.9 3.0 0.6 2.5 0.7 0.0 12.9 0.5 1.4 0.4 1.3 8.3 2.3 0.1 10.7 2.1 0.0 1.4 1.2 0.0 12.7 0.0 1.4 15.6 1.3 6.3 0.2 4.4 0.0 0.0 0.6 0.0 0.2 0.2 4.9 0.1 0.0 8.9 4.4 0.3 3.7 0.2 0.0 0.4 0.4 5.8 0.0 0.6 0.2 48.6 0.2 1.2 2.9 0.0 2.4 6.2 10.8 5.2 7.2 6.1 7.9 8.2 7.9 5.3 7.8 6.3 7.1 7.3 10.3 0.0 0.5 4.2 1.2 3.6 0.6 1.3 0.6 60.2 13.3 6.9 2.0 2.8 4.1 0.0 2.1 0.4 10.6 0.0 39.2 7.7 0.4 2.6 5.0 23.7 3.0 8.0 0.8 2.9 0.2 3.9 2.6 2.1 0.0 0.3 40.7 7.7 22.3 6.7 2.9 0.0 8.2 56.8 19.4 0.3 1.5 23.0 1.8 2.8 37.1 75.3 6.2 0.5 0.2 1.8 0.0 1.9 1.1 0.8 0.0 8.5 1.7 6.5 0.0 0.6 2.8 1.0 2.9 0.7 7.4 0.4 2.8 0.3 0.0 0.5 SOX2 ENSG00000181449 "SRY-box transcription factor 2" P48431 3 181711925-181714436 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.5;esophagus: 24.7" "Group enriched" "Detected in some" 6 "Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 0.3 0.9 54.8 0.5 53.1 0.0 0.2 50.3 57.1 1.8 7.7 4.2 0.4 0.1 0.2 24.7 3.1 0.3 0.4 46.2 83.5 0.0 0.1 1.8 0.0 51.4 51.0 35.0 0.3 0.1 0.0 13.7 0.0 44.1 2.6 0.4 15.2 18.5 0.3 0.1 0.5 1.4 0.2 51.6 0.0 8.0 1.9 56.2 0.4 0.1 0.1 5.4 1.3 4.8 62.5 0.1 9.0 277.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.1 0.0 0.2 0.7 118.6 3.2 0.0 0.1 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 226.2 12.4 0.5 0.0 0.6 0.0 31.0 0.4 0.5 1.2 0.0 0.0 0.1 45.7 1.7 0.1 0.0 0.0 4.2 0.0 54.0 0.0 0.0 0.0 0.2 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.8 53.1 50.3 57.1 46.2 83.5 51.4 51.0 35.0 44.1 51.6 56.2 62.5 0.2 0.0 6.0 0.0 0.0 0.3 35.5 28.5 362.0 4.9 0.2 0.4 0.5 0.0 48.4 3.7 0.0 0.2 0.0 1.1 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.1 1.6 19.4 0.0 1.3 0.2 0.7 0.1 0.1 0.0 0.0 0.5 38.7 0.0 0.4 0.4 0.6 0.8 3.6 0.0 0.0 383.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 5.8 0.0 0.1 52.8 13.1 0.0 0.2 1.6 3.9 0.4 229.1 0.4 0.3 0.6 0.2 0.0 7.5 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Nucleoli, Mitochondria, Cytosol" "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 2.5 3.1 2.2 3.0 2.9 3.4 3.7 3.5 2.8 3.6 1.4 3.0 2.3 3.8 2.4 2.1 3.2 3.2 1.9 2.3 2.9 2.6 2.2 3.2 4.5 2.9 2.7 1.5 4.0 3.3 2.4 1.5 4.2 3.2 4.1 4.1 5.8 2.7 2.5 1.5 1.4 2.2 2.4 2.2 3.6 3.3 4.0 2.7 4.4 5.4 2.7 4.0 2.1 2.3 5.6 2.5 4.0 13.6 15.5 1.6 3.7 8.3 3.3 3.2 4.8 4.9 3.3 2.9 9.7 8.3 1.5 2.5 4.6 8.3 2.2 7.6 4.2 15.8 4.5 2.9 2.0 3.0 8.0 12.0 3.3 3.8 2.8 6.0 3.5 4.5 10.9 12.4 15.1 5.2 2.0 11.3 2.8 12.1 3.6 6.3 8.4 8.9 3.9 3.4 7.7 5.8 11.2 4.8 5.6 2.3 6.6 7.9 9.2 3.3 5.9 5.5 5.2 6.6 4.8 11.8 10.5 2.3 1.4 6.2 5.4 0.6 0.8 1.3 0.1 1.6 3.7 1.3 0.8 1.2 2.6 1.2 1.7 0.1 1.4 0.4 1.8 1.7 0.8 2.2 2.9 3.5 2.8 2.3 2.9 2.9 2.7 1.5 3.2 2.2 2.7 5.6 10.9 3.2 7.3 21.2 7.8 2.3 4.0 2.9 2.2 12.2 5.5 2.9 4.2 4.3 4.5 3.7 4.2 2.1 8.2 6.8 1.9 4.0 0.9 4.6 6.0 6.5 9.6 10.3 11.7 5.2 2.4 6.5 7.1 4.8 3.8 9.4 5.3 3.0 1.8 1.7 17.2 4.8 4.1 3.1 3.7 0.6 7.5 3.3 0.0 17.8 3.3 4.7 5.2 38.2 44.7 3.3 7.3 2.6 5.8 5.4 1.3 1.4 5.5 7.3 0.0 12.3 4.9 7.6 10.5 3.1 0.6 1.4 5.8 4.2 3.8 3.8 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skin 1: 479.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA062101: AB_2684682" "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 19.6 18.2 1.6 11.8 3.3 2.0 43.2 1.7 2.2 25.4 2.6 9.3 3.7 18.5 3.2 16.7 21.1 19.1 14.7 1.5 2.1 3.7 99.9 13.2 2.6 2.3 1.9 1.5 12.0 23.5 2.7 23.1 41.3 1.9 9.2 6.7 1.7 27.2 6.4 3.3 479.0 6.5 25.7 1.8 5.0 7.0 13.4 2.0 1.6 9.2 2.5 51.2 19.7 80.2 2.1 28.6 2.0 2.7 9.6 406.9 118.3 0.3 66.9 62.0 9.4 84.8 2.5 0.6 0.0 32.6 44.1 24.6 31.9 2.4 13.0 23.4 7.2 8.4 23.9 9.3 8.0 25.7 0.4 1.5 125.4 7.4 17.1 25.4 39.0 3.5 0.0 0.6 3.2 22.6 0.3 0.1 0.7 3.2 0.0 16.8 0.0 23.3 0.4 0.6 1.0 2.9 19.4 16.4 8.5 7.3 18.2 0.8 13.6 9.3 62.9 44.3 0.5 15.2 53.8 32.9 0.1 49.7 1.9 42.6 0.0 0.9 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.6 1.6 3.3 1.7 2.2 1.5 2.1 2.3 1.9 1.5 1.9 1.8 2.0 2.1 1.6 60.9 61.4 0.7 3.0 94.6 5.4 425.3 9.6 3.2 19.1 8.9 2.5 1.5 841.5 0.0 0.0 2.6 0.4 0.2 0.0 7.5 207.3 3.0 79.1 8.9 1.2 1.3 0.8 14.9 46.3 56.3 2.0 2.0 65.0 10.7 15.0 137.1 5.8 8.4 2.4 2.0 63.1 6.5 25.4 25.4 16.1 6.6 23.2 13.1 1.1 3.5 0.0 16.1 11.8 6.5 2.6 27.8 26.8 3.1 0.3 0.2 121.0 0.9 6.6 22.8 56.6 1.5 3.3 5.4 254.9 7.5 6.4 26.7 0.1 4.4 RAP2B ENSG00000181467 "RAP2B, member of RAS oncogene family" P61225 3 153162226-153170627 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 236.8;Squamous epithelial cells: 259.0;Urothelial cells: 269.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 160000 "unprognostic (2.44e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (3.51e-2)" "unprognostic (3.04e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (2.00e-1)" "prognostic favorable (9.21e-4)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (5.97e-2)" "unprognostic (2.96e-1)" "unprognostic (2.32e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" 5.0 2.5 4.9 6.0 7.6 15.7 3.5 1.9 7.5 4.8 4.0 3.8 2.6 3.5 2.9 15.0 2.7 6.4 2.1 11.0 4.8 2.7 4.4 5.1 6.4 3.5 4.9 6.6 3.6 2.5 2.3 1.2 8.7 2.7 2.4 3.6 0.9 4.8 2.3 1.3 4.6 3.6 3.1 3.5 7.5 8.8 1.4 6.4 4.8 2.1 1.7 5.1 8.3 7.1 4.9 29.0 10.4 5.0 7.4 10.7 9.7 13.7 7.3 10.8 4.9 5.4 5.5 16.6 2.0 8.0 6.8 8.1 28.5 3.9 13.3 5.7 11.7 7.5 11.7 5.6 10.2 5.6 10.9 17.8 10.5 11.1 7.3 13.6 8.6 11.9 5.5 6.8 23.9 9.3 11.5 10.3 15.7 10.4 6.0 16.1 8.9 13.7 26.3 7.7 27.8 0.1 2.7 7.6 6.9 23.5 8.9 5.1 5.6 23.9 7.5 11.6 8.1 18.5 15.3 2.7 5.2 10.0 12.0 7.9 28.0 17.9 7.5 19.5 27.8 14.7 6.4 16.6 17.2 13.1 3.8 9.3 14.7 7.2 14.1 27.6 9.5 12.7 13.8 4.9 7.6 1.9 7.5 11.0 4.8 3.5 4.9 6.6 2.7 3.5 6.4 4.9 39.7 12.8 16.5 1.6 26.0 193.0 145.8 61.1 236.8 3.7 41.3 22.4 4.8 30.0 39.4 16.5 2.1 17.3 94.4 135.3 3.9 31.3 0.6 107.8 40.4 21.5 48.6 40.8 8.9 21.7 49.4 30.7 120.8 173.4 26.6 51.3 25.4 14.7 132.1 3.3 3.0 53.5 40.7 170.6 159.9 1.5 19.3 117.0 35.6 4.7 120.1 7.9 110.2 4.5 1.9 60.6 121.3 14.7 27.8 102.1 31.1 12.3 22.1 5.9 0.0 11.1 18.0 3.8 6.1 259.0 195.2 15.2 52.6 12.3 33.6 269.2 ZBTB2 "bA351K16.2, KIAA1483, ZNF437" ENSG00000181472 "Zinc finger and BTB domain containing 2" Q8N680 6 151364115-151391559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023136, HPA023137, HPA023458, HPA023487" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945" "unprognostic (1.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.93e-1)" "unprognostic (2.42e-2)" "unprognostic (8.36e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.36e-2)" "unprognostic (2.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (8.27e-2)" "prognostic unfavorable (9.36e-6)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (7.73e-2)" 8.5 4.8 5.2 8.5 5.5 16.3 8.6 6.4 6.2 6.9 5.4 8.1 7.6 8.5 7.0 6.0 7.8 7.9 6.1 5.6 5.5 7.0 9.5 9.8 14.5 5.8 5.9 5.1 13.4 8.4 7.1 3.1 8.8 6.1 6.2 9.1 3.2 7.2 6.0 9.2 7.0 8.2 9.4 5.7 9.4 7.4 6.7 6.0 20.9 30.0 9.8 12.8 11.1 5.4 7.0 15.3 10.9 16.3 12.4 17.1 17.9 17.4 23.6 33.9 29.2 27.7 21.1 12.2 38.9 12.8 23.9 29.5 17.8 26.5 28.7 36.1 17.7 19.7 17.5 12.6 32.2 25.3 47.9 20.8 19.0 16.9 26.8 32.6 16.6 17.4 18.1 32.5 22.2 20.8 34.2 26.1 22.3 19.8 18.8 16.4 24.6 15.4 15.6 22.2 22.7 18.1 12.6 18.6 24.2 18.8 16.3 16.3 28.4 14.4 24.5 26.8 11.3 31.8 29.4 32.9 43.2 10.1 25.7 17.8 18.7 6.5 16.8 11.3 7.1 14.2 6.3 10.2 13.5 7.1 4.5 8.4 10.4 7.3 8.9 12.9 2.9 9.2 7.1 5.2 5.5 6.4 6.2 5.6 5.5 5.8 5.9 5.1 6.1 5.7 6.0 7.0 13.3 9.6 4.6 4.6 13.2 15.7 11.4 5.8 42.7 3.0 14.4 7.4 8.8 5.7 9.1 0.0 0.0 5.9 18.0 4.6 13.7 4.8 9.4 18.7 14.2 12.7 9.0 8.2 5.6 2.9 19.6 9.9 6.6 29.5 9.5 4.9 5.7 3.3 7.5 1.7 4.4 6.3 18.3 8.8 17.4 10.5 8.7 10.8 10.6 1.0 4.4 3.1 12.3 5.5 11.1 5.0 2.0 4.1 11.1 14.8 5.8 5.3 7.1 2.3 6.6 6.2 10.8 4.1 6.7 23.8 18.3 12.4 16.3 3.7 7.3 9.6 RNF135 MGC13061 ENSG00000181481 "Ring finger protein 135" Q8IUD6 17 30970984-30999911 "Enzymes, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 63.3" "Low region specificity" "Detected in all" "HPA021576, HPA052404" Approved Approved Vesicles NA NA Vesicles "HPA021576: AB_1856331, HPA052404: AB_2681817" "unprognostic (1.13e-1)" "unprognostic (1.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-2)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (1.24e-1)" "unprognostic (4.60e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.51e-5)" "unprognostic (6.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-1)" "unprognostic (4.47e-1)" 19.7 13.0 10.3 13.6 12.6 11.7 18.7 10.2 14.6 15.7 14.4 17.7 13.7 13.4 16.6 22.6 15.8 9.7 8.3 9.1 12.1 21.8 8.7 15.6 14.0 12.6 11.2 7.5 12.7 13.6 16.9 5.6 18.2 15.2 14.1 18.2 2.3 15.3 15.3 7.5 26.4 14.1 13.8 11.3 26.0 12.0 5.1 12.7 8.0 15.9 10.2 12.8 14.9 17.4 12.5 12.7 25.6 1.5 25.4 34.0 28.5 22.7 9.7 14.9 9.4 8.4 0.0 9.4 11.5 14.8 19.0 17.0 17.0 13.2 12.1 7.8 10.0 5.6 4.8 8.1 0.0 24.3 12.8 10.7 27.7 63.3 10.1 33.5 16.1 15.8 0.0 0.0 34.9 15.6 17.0 0.1 13.5 10.5 25.7 14.4 27.9 0.0 39.2 13.6 18.2 9.8 0.5 14.9 5.9 14.9 16.6 39.4 20.2 13.3 0.0 3.5 15.6 11.5 0.4 1.3 7.3 16.5 22.1 13.3 25.3 61.6 31.3 12.8 57.3 7.2 28.4 6.8 6.8 46.4 28.4 3.7 6.2 54.0 13.9 70.2 17.1 10.1 29.2 10.3 12.6 10.2 14.6 9.1 12.1 12.6 11.2 7.5 15.2 11.3 12.7 12.5 14.1 3.2 5.9 7.8 14.1 9.3 13.4 16.8 22.2 0.1 13.1 15.0 4.0 7.2 7.8 11.0 0.0 47.5 10.5 23.4 29.4 9.9 0.4 14.5 12.8 13.2 4.9 11.2 0.8 18.6 37.1 13.2 5.6 12.4 1.3 14.1 25.4 2.7 51.1 0.0 1.0 12.0 8.2 73.9 8.4 1.6 16.8 35.5 16.0 26.2 45.3 3.9 19.6 9.0 0.7 11.9 13.1 15.4 9.0 22.2 27.5 49.3 10.4 0.6 26.3 8.2 14.2 0.7 4.0 24.1 14.6 43.6 7.5 10.6 14.6 11.2 OR6T1 ENSG00000181499 "Olfactory receptor family 6 subfamily T member 1" Q8NGN1 11 123942785-123943873 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060893 Uncertain NA NA "HPA060893: AB_2684380" "unprognostic (9.30e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.7" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA051772: AB_2681603" "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favorable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favorable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.53e-4)" 10.9 17.4 12.8 6.3 12.5 4.2 13.0 12.3 16.8 18.6 11.1 19.0 30.1 14.5 4.1 7.1 22.5 6.7 10.9 11.9 13.0 24.5 93.7 9.7 10.0 12.9 12.7 11.1 19.4 20.1 14.6 15.9 4.3 12.5 21.7 5.8 10.4 14.2 12.3 6.9 9.0 26.1 5.8 12.6 16.3 14.8 4.3 12.9 5.4 21.3 5.2 6.5 15.8 13.7 11.6 7.9 15.4 1.9 4.2 3.5 6.4 5.1 2.9 6.1 4.7 9.2 6.0 10.8 8.4 7.4 4.3 2.8 7.3 2.6 4.8 1.9 12.2 5.9 4.2 11.3 12.0 7.5 1.6 11.1 6.4 4.6 1.7 2.4 16.1 4.6 7.7 2.7 13.1 2.3 5.3 6.0 2.1 0.3 8.3 4.2 4.8 0.5 18.8 11.8 5.1 3.1 1.4 2.1 3.1 8.9 1.0 20.1 3.0 1.7 1.2 3.6 1.8 1.8 20.4 5.9 2.6 6.8 2.1 2.0 4.4 2.3 3.5 2.9 2.6 3.2 3.7 3.4 3.2 2.0 5.0 3.7 4.3 0.5 4.0 1.7 1.3 4.3 3.2 12.8 12.5 12.3 16.8 11.9 13.0 12.9 12.7 11.1 12.5 12.6 12.9 11.6 5.7 3.2 3.0 12.4 7.8 1.9 5.9 3.9 2.8 16.6 7.4 6.9 9.7 14.3 2.6 3.7 22.9 6.3 5.9 9.6 7.9 7.3 1.4 2.0 2.7 5.3 6.0 2.1 7.2 7.1 1.3 7.3 4.6 3.6 8.2 7.4 5.0 21.8 5.3 11.8 8.5 7.8 6.1 1.9 2.6 5.0 6.8 3.1 3.6 2.8 4.5 14.7 5.2 4.5 1.9 5.6 12.5 7.5 5.2 3.1 56.8 25.6 2.6 16.8 6.6 8.7 7.7 2.5 5.2 3.1 1.8 6.3 6.4 4.4 9.1 2.8 OR8D4 ENSG00000181518 "Olfactory receptor family 8 subfamily D member 4" Q8NGM9 11 123902167-123909229 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "Granulosa cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 SGSH "HSS, MPS3A, SFMD" ENSG00000181523 "N-sulfoglucosamine sulfohydrolase" P51688 17 80206716-80220923 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023436, HPA023451" Enhanced "Intracellular and membrane" NA NA "HPA023436: AB_1856806, HPA023451: AB_1856807" "unprognostic (4.33e-2)" "unprognostic (4.03e-2)" "unprognostic (1.06e-2)" "unprognostic (4.01e-2)" "unprognostic (4.26e-3)" "unprognostic (1.39e-3)" "prognostic unfavorable (7.71e-4)" "prognostic favorable (2.72e-4)" "unprognostic (6.08e-2)" "unprognostic (3.65e-1)" "prognostic favorable (3.10e-4)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.42e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (7.50e-2)" "unprognostic (3.68e-2)" 15.0 46.3 1.3 12.3 1.7 3.6 17.3 0.4 5.3 12.6 7.1 14.3 12.9 17.3 4.6 11.1 16.2 10.7 9.0 1.4 4.1 15.5 9.6 18.3 13.5 3.0 2.6 0.8 12.4 20.6 16.1 17.2 12.5 2.5 19.9 6.5 2.8 21.9 11.2 7.1 18.4 16.9 10.7 1.0 28.6 17.9 3.9 4.0 4.3 21.4 4.7 6.9 15.6 11.6 2.1 2.6 7.9 9.8 15.6 22.5 20.2 10.4 16.0 40.4 27.7 24.2 9.0 9.5 0.1 25.7 24.9 13.2 9.9 6.2 11.7 4.7 5.3 9.6 0.0 22.3 25.0 62.2 0.0 5.9 33.9 12.0 9.9 10.5 5.8 50.7 4.7 7.1 26.2 17.9 16.2 0.3 0.2 3.3 10.0 13.2 1.4 3.7 21.1 20.2 18.5 2.0 11.7 18.4 44.1 10.6 4.9 32.8 0.5 32.5 31.9 7.0 11.4 7.4 26.1 3.6 3.9 13.6 0.0 16.3 0.0 20.6 0.0 12.1 8.0 16.0 3.5 10.5 11.3 20.4 3.8 8.2 6.7 2.1 9.3 8.0 1.5 13.5 12.7 1.3 1.7 0.4 5.3 1.4 4.1 3.0 2.6 0.8 2.5 1.0 4.0 2.1 7.5 3.2 10.8 4.2 5.5 5.1 3.7 5.9 5.7 3.7 9.3 9.3 1.7 5.7 7.3 7.3 8.4 18.2 5.2 12.0 0.0 8.9 0.2 5.3 9.2 10.1 3.0 2.7 2.6 15.9 8.7 10.1 17.9 10.0 0.0 13.6 9.7 4.5 17.7 0.0 3.4 9.3 4.1 18.2 7.6 0.5 11.5 13.0 1.8 2.8 8.4 4.1 6.2 4.5 1.7 6.8 6.0 14.3 5.5 5.5 8.1 4.9 3.8 3.9 13.1 4.0 5.3 0.3 0.5 6.4 5.5 27.0 7.2 32.0 8.0 2.9 MAB21L2 ENSG00000181541 "Mab-21 like 2" Q9Y586 4 150582151-150584693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 129.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.0;Cholangiocytes: 28.6;Horizontal cells: 25.2;Muller glia cells: 7.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3;pancreatic cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTERT-RPE1: 101.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA049324, HPA059864" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (1.12e-1)" "unprognostic (3.67e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-1)" "unprognostic (2.32e-1)" "unprognostic (3.85e-2)" "unprognostic (8.99e-2)" "unprognostic (2.76e-2)" "unprognostic (2.75e-1)" "unprognostic (6.60e-2)" "unprognostic (4.78e-3)" "unprognostic (1.18e-1)" "unprognostic (6.81e-2)" "unprognostic (1.68e-1)" 0.9 4.1 5.0 8.8 2.2 0.0 0.1 1.0 2.6 0.0 6.0 129.1 9.0 0.1 1.3 1.4 0.1 1.0 1.1 0.5 1.9 0.0 0.9 0.0 0.0 16.6 5.8 0.3 0.0 0.1 0.0 0.2 0.0 17.4 0.1 10.3 7.4 5.8 0.3 0.2 0.1 39.1 20.5 5.9 0.0 0.5 0.0 6.7 0.7 3.4 0.0 0.0 0.1 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.5 0.0 0.0 0.0 101.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.2 1.0 2.6 0.5 1.9 16.6 5.8 0.3 17.4 5.9 6.7 9.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 0.0 1.4 28.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 25.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 FANCB "FAAP95, FAB, FLJ34064" ENSG00000181544 "FA complementation group B" Q8NB91 X 14835961-14873069 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.5;brain: 3.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 12.4;Oligodendrocytes: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003124 Uncertain NA NA "HPA003124: AB_1078813" "unprognostic (3.49e-2)" "unprognostic (1.92e-3)" "unprognostic (1.16e-2)" "unprognostic (8.42e-3)" "unprognostic (7.99e-2)" "unprognostic (2.42e-2)" "unprognostic (4.05e-5)" "unprognostic (6.93e-3)" "unprognostic (1.77e-3)" "unprognostic (7.70e-3)" "unprognostic (2.76e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-11)" "unprognostic (4.46e-2)" "unprognostic (1.92e-1)" "unprognostic (6.88e-2)" "unprognostic (5.96e-2)" 0.2 0.1 2.2 0.7 2.9 3.5 0.5 1.2 1.4 0.3 0.0 0.3 0.2 0.3 0.1 0.4 0.2 0.1 0.1 0.8 1.0 0.1 0.1 0.2 1.3 1.8 2.2 0.3 0.4 0.1 0.1 0.0 0.9 2.7 0.2 0.5 0.0 0.2 0.1 0.1 0.3 0.3 0.3 1.4 0.4 0.2 0.2 3.4 1.5 0.2 0.1 1.3 0.3 0.3 2.9 7.3 5.0 4.8 3.9 0.3 1.1 1.7 11.2 3.0 8.8 9.9 3.5 5.3 10.6 1.9 4.4 6.6 7.0 11.3 4.1 15.0 5.1 5.9 4.1 7.9 1.7 0.1 5.8 3.3 0.1 0.4 9.0 2.0 0.9 4.4 3.5 7.3 7.2 5.2 3.5 5.7 3.2 6.1 3.0 7.1 5.1 11.4 5.2 0.8 2.6 3.1 3.5 5.7 2.4 3.2 11.2 3.6 2.0 1.8 6.7 3.7 14.5 6.8 1.8 3.9 7.2 3.0 4.1 14.3 0.3 0.2 0.2 0.2 0.1 0.1 0.7 0.1 0.3 0.2 0.5 0.1 0.1 0.4 0.4 0.1 0.2 0.4 0.2 2.2 2.9 1.2 1.4 0.8 1.0 1.8 2.2 0.3 2.7 1.4 3.4 2.9 1.9 3.2 0.5 1.0 5.2 1.7 1.1 1.5 0.6 3.0 1.6 3.3 0.4 0.0 1.8 0.0 0.0 7.0 6.2 0.9 0.0 1.2 0.4 2.1 2.7 1.9 0.0 5.0 6.3 1.5 12.4 2.0 1.5 2.3 3.8 6.6 1.4 0.3 3.6 3.3 4.8 0.8 4.1 0.3 1.8 0.6 1.2 2.7 0.0 2.8 1.0 0.4 3.1 3.0 33.1 0.7 0.1 1.2 6.5 0.7 0.2 0.4 1.2 0.5 0.0 2.4 2.3 5.2 4.2 3.8 1.0 3.8 4.1 0.7 1.8 1.5 EDDM3B "FAM12B, HE3-BETA" ENSG00000181552 "Epididymal protein 3B" P56851 14 20768404-20770948 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 279 "epididymis: 2585.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 2.6" "Not detected" "Not detected" HPA001323 Enhanced "Secreted in male reproductive system" NA NA "HPA001323: AB_1848377" "unprognostic (2.40e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2585.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2, histone lysine methyltransferase" Q9BYW2 3 47016429-47164113 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favorable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 10.0 6.6 7.7 10.8 9.6 24.0 10.4 23.9 7.4 12.7 9.8 9.8 9.2 13.4 6.1 9.9 11.1 8.6 7.3 5.6 6.9 10.9 10.1 9.5 13.6 7.9 8.2 4.0 15.4 13.4 16.3 2.3 11.5 10.1 10.3 11.1 10.7 9.7 9.7 11.2 9.0 10.4 12.0 7.9 11.5 10.8 13.2 7.9 19.4 15.6 14.6 13.4 9.9 4.0 11.4 21.1 13.2 25.4 14.5 15.3 18.9 11.3 17.9 17.0 20.8 19.9 15.4 13.8 43.5 11.6 25.5 20.0 12.4 29.5 17.6 27.6 27.5 12.2 47.3 24.8 12.4 11.7 34.1 26.5 15.2 17.3 20.7 24.6 15.3 20.1 22.8 29.9 16.6 17.8 9.5 26.7 8.5 20.6 9.4 15.4 17.5 25.6 23.2 12.4 26.6 10.9 17.6 29.5 11.8 12.0 17.2 12.9 27.5 26.7 24.6 18.1 21.5 29.9 22.0 25.4 43.7 14.2 19.6 14.6 1.3 1.2 2.9 2.0 1.1 1.1 2.2 1.2 1.6 1.4 2.5 1.7 1.6 3.3 3.6 1.1 1.5 0.6 0.6 7.7 9.6 23.9 7.4 5.6 6.9 7.9 8.2 4.0 10.1 7.9 7.9 11.4 50.5 48.1 58.8 115.9 58.3 33.3 22.6 15.6 54.1 40.5 31.0 29.1 67.2 27.1 53.2 11.0 41.7 20.3 58.2 32.6 11.7 20.9 26.1 62.8 63.0 41.2 22.1 38.9 131.4 22.4 12.7 39.2 56.6 66.2 58.8 68.9 23.6 29.8 16.8 26.9 129.4 28.2 14.2 28.8 26.5 35.1 30.4 42.7 17.8 148.9 37.9 22.7 43.3 113.1 143.2 23.7 22.3 33.1 54.0 31.2 24.6 11.5 49.7 39.9 13.1 56.1 42.6 71.0 29.3 60.2 35.7 18.5 65.3 57.1 29.5 34.7 EDDM3A "FAM12A, HE3-ALPHA" ENSG00000181562 "Epididymal protein 3A" Q14507 14 20745887-20748380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "epididymis: 641.7" "Cell type enriched" "Detected in some" 26 "Collecting duct cells: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049952 Approved "Secreted in male reproductive system" NA NA "HPA049952: AB_2680970" "unprognostic (1.42e-1)" "unprognostic (9.88e-2)" "unprognostic (8.56e-3)" "unprognostic (2.10e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 641.7 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 29.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;choroid plexus: 9.4;pituitary gland: 10.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 15 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 0.7 6.3 16.6 0.5 13.1 0.0 0.4 13.8 18.1 0.7 9.4 0.8 0.4 0.5 0.7 1.5 0.6 0.2 0.6 14.8 16.8 2.3 0.8 1.0 0.8 19.6 14.6 12.4 1.5 0.2 0.1 10.0 0.4 15.6 0.5 0.3 0.7 0.5 1.0 3.7 0.8 0.5 0.4 14.9 0.8 0.3 1.5 16.4 0.5 0.9 1.2 0.8 0.6 0.9 19.3 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 2.7 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.5 10.7 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.7 0.1 1.2 0.0 0.3 0.1 0.1 0.3 2.3 0.3 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.4 0.4 16.6 13.1 13.8 18.1 14.8 16.8 19.6 14.6 12.4 15.6 14.9 16.4 19.3 1.9 0.0 0.0 0.3 0.0 0.8 0.2 0.5 0.0 3.8 0.2 0.6 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.9 0.4 0.5 0.2 0.0 0.7 0.0 0.0 1.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.4 0.1 0.6 0.0 0.8 0.0 0.0 0.0 0.4 1.5 0.6 0.3 0.0 1.9 0.1 1.4 0.0 0.0 0.3 1.2 0.0 0.4 0.0 0.3 0.0 0.0 0.6 0.5 0.0 1.1 1.0 2.6 3.2 0.0 0.9 0.1 0.2 0.1 0.0 0.2 MEX3D "KIAA2031, OK/SW-cl.4, RKHD1, RNF193, Tino" ENSG00000181588 "Mex-3 RNA binding family member D" Q86XN8 19 1554669-1568058 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 78.9" "Cell type enriched" "Detected in many" 4 "Late spermatids: 340.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "REH: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065385 Approved NA NA "HPA065385: AB_2685482" "unprognostic (2.71e-1)" "unprognostic (9.01e-2)" "unprognostic (3.90e-1)" "unprognostic (1.61e-2)" "unprognostic (2.04e-1)" "unprognostic (1.80e-2)" "unprognostic (9.35e-3)" "unprognostic (3.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.85e-1)" "unprognostic (3.74e-1)" "unprognostic (9.37e-3)" "unprognostic (2.75e-3)" "unprognostic (5.13e-2)" "unprognostic (2.67e-2)" "unprognostic (2.57e-1)" "unprognostic (1.36e-2)" 7.7 3.9 10.3 2.6 9.0 0.4 8.1 8.6 9.4 8.9 0.6 7.7 4.7 12.7 5.9 9.6 7.8 2.8 6.1 7.7 6.5 4.9 5.5 7.8 1.2 15.9 9.9 6.5 12.4 6.3 2.3 4.9 6.9 16.4 6.9 2.7 0.8 9.3 2.7 1.7 10.8 5.2 3.6 10.7 2.7 6.9 78.9 10.2 1.6 6.2 1.5 2.1 7.8 9.3 17.8 40.6 3.1 17.5 20.3 6.4 6.1 43.2 24.9 5.4 9.6 10.0 9.9 6.9 12.9 27.5 9.3 2.4 20.5 7.7 6.2 11.7 21.2 9.5 3.1 3.3 12.2 5.1 9.4 8.5 4.6 9.0 5.2 4.1 7.6 15.4 6.7 18.7 12.2 11.4 8.1 22.2 10.0 36.5 8.8 11.6 67.4 18.5 10.0 8.7 6.1 26.2 29.6 20.3 11.1 15.2 14.6 14.2 10.4 28.0 19.6 27.4 30.4 32.3 13.6 5.8 13.5 8.3 13.8 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 9.0 8.6 9.4 7.7 6.5 15.9 9.9 6.5 16.4 10.7 10.2 17.8 18.1 12.8 8.4 2.0 0.6 14.8 3.5 3.8 6.2 2.4 23.4 13.2 7.3 8.6 4.2 9.2 0.0 5.2 3.4 10.8 0.0 11.9 73.8 15.6 15.6 10.5 18.6 4.0 0.9 9.6 12.8 11.0 2.6 19.9 1.3 8.2 12.5 13.6 2.4 1.7 0.6 7.3 6.1 2.5 8.1 340.7 14.9 3.3 7.2 0.0 1.2 6.0 1.0 3.0 3.5 20.9 6.4 9.4 0.8 8.9 6.2 2.7 1.7 1.7 0.0 5.9 13.6 3.7 4.3 10.1 17.6 16.6 2.5 2.6 9.6 5.1 OR52D1 ENSG00000181609 "Olfactory receptor family 52 subfamily D member 1" Q9H346 11 5488685-5489749 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "olfactory bulb: 3.1" HPA046965 Uncertain NA NA "HPA046965: AB_2679878" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 187.7;Proximal tubular cells: 190.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" No No Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavorable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 21.8 37.8 22.3 26.6 23.7 24.6 25.7 22.8 29.8 17.7 21.3 22.4 24.0 25.6 30.0 25.3 25.0 16.9 67.7 23.9 24.3 38.9 24.7 22.1 31.3 23.8 23.9 23.4 20.4 40.0 47.9 20.5 20.8 24.9 36.5 20.5 32.1 21.1 25.0 62.0 19.6 20.9 22.0 24.1 21.9 39.7 23.5 22.8 30.5 37.1 44.9 27.2 28.5 18.2 27.1 137.6 137.0 71.7 75.7 42.6 49.5 82.5 86.9 64.9 118.4 90.8 102.6 80.1 173.1 251.9 67.0 109.3 66.3 113.8 102.3 98.2 137.7 135.9 125.4 51.3 179.9 80.9 165.7 115.9 45.4 89.9 87.9 90.8 54.0 75.8 90.9 190.5 60.4 94.0 117.8 154.8 96.1 86.8 153.7 142.8 111.1 120.4 144.0 91.7 65.1 95.8 149.2 65.5 54.5 177.6 52.0 169.1 121.8 66.9 100.0 127.5 100.8 186.3 131.6 301.3 197.5 95.1 102.3 93.7 67.7 41.2 66.2 39.2 51.5 41.2 44.3 38.9 39.9 57.8 47.9 41.3 41.5 6.6 47.2 37.8 54.6 41.3 45.8 22.3 23.7 22.8 29.8 23.9 24.3 23.8 23.9 23.4 24.9 24.1 22.8 27.1 34.9 48.1 33.6 3.6 30.2 33.4 40.4 109.4 26.7 41.6 30.1 42.4 187.7 27.1 60.5 47.8 12.5 81.6 30.0 18.4 148.7 84.8 5.9 42.5 37.0 40.0 22.1 28.4 6.1 100.0 87.0 37.4 29.6 36.3 23.4 43.9 24.3 39.7 85.5 50.5 6.8 29.2 69.2 35.2 23.5 10.0 32.6 31.5 40.9 4.7 67.1 63.1 48.4 2.5 10.0 87.7 25.5 39.5 29.1 58.9 20.8 190.8 55.6 64.4 26.3 37.5 43.8 38.3 85.9 39.3 32.5 42.5 27.4 65.4 40.9 34.2 OR52H1 ENSG00000181616 "Olfactory receptor family 52 subfamily H member 1" Q8NGJ2 11 5544489-5548533 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (2.87e-1)" 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.1 0.6 0.6 0.3 0.1 0.4 0.3 0.3 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 FDCSP "C4orf7, FDC-SP" ENSG00000181617 "Follicular dendritic cell secreted protein" Q8NFU4 4 70226124-70235252 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 27 "lymphoid tissue: 3284.0;salivary gland: 6662.8" "Group enriched" "Detected in some" 25 "Breast glandular cells: 90.8;Breast myoepithelial cells: 87.9;Ductal cells: 75.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 336.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.6;GAMG: 7.5;HL-60: 1.5;K-562: 1.4;RH-30: 2.1;U-87 MG: 5.4" "Not detected" "Not detected" "HPA014326, CAB014890" Enhanced "Secreted in other tissues" NA NA "CAB014890: , HPA014326: AB_1845719" "unprognostic (1.26e-3)" "unprognostic (2.32e-1)" "unprognostic (8.73e-3)" "unprognostic (9.62e-2)" "prognostic favorable (2.38e-4)" "unprognostic (5.99e-3)" "prognostic favorable (1.32e-4)" "unprognostic (2.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.79e-1)" "unprognostic (1.96e-1)" "unprognostic (3.68e-2)" "unprognostic (2.80e-1)" "unprognostic (7.83e-2)" 4.8 1.8 0.0 316.8 0.0 0.0 185.5 0.0 0.0 0.2 0.2 24.9 1.8 4.8 0.1 13.5 0.9 2.7 1.6 0.0 0.2 0.3 1.9 1.5 1061.2 0.1 0.6 0.0 0.5 2.7 0.0 0.5 0.7 0.0 1.6 18.5 0.0 6662.8 0.1 1.4 0.4 49.9 4.3 0.0 33.5 10.2 0.3 0.3 17.4 3.4 0.0 3284.0 11.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.1 5.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 90.8 87.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 75.6 0.0 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 GPR135 "HUMNPIIY20, PAFR" ENSG00000181619 "G protein-coupled receptor 135" Q8IZ08 14 59429022-59465342 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 150.0;Late spermatids: 215.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045337 Uncertain NA NA "HPA045337: AB_10960528" "unprognostic (1.55e-1)" "unprognostic (3.00e-1)" "unprognostic (6.09e-3)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (8.47e-2)" "unprognostic (3.22e-1)" "unprognostic (3.91e-2)" "unprognostic (4.64e-2)" "unprognostic (1.09e-1)" "unprognostic (2.47e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-5)" "unprognostic (1.33e-2)" "unprognostic (1.90e-1)" "unprognostic (2.71e-2)" "unprognostic (2.68e-3)" 1.1 1.7 2.3 0.6 1.3 0.2 0.9 3.4 1.6 2.2 2.9 1.2 0.2 2.0 1.1 0.6 3.1 0.8 1.5 1.1 1.4 0.8 0.6 1.0 0.3 1.5 1.2 0.9 2.5 0.9 2.6 3.4 0.6 1.4 1.9 0.5 0.8 0.6 2.8 0.8 0.6 0.9 1.2 1.1 0.5 1.0 6.0 0.9 0.2 1.4 0.3 0.3 2.1 1.5 1.3 0.4 0.5 0.8 1.0 0.7 1.0 0.7 0.9 0.5 0.6 0.6 0.2 0.9 0.4 0.6 1.1 0.2 0.5 0.4 0.3 0.8 0.9 0.3 0.3 2.8 0.3 0.6 0.5 0.4 0.6 0.6 0.9 0.4 1.3 0.4 0.4 0.5 0.6 0.8 0.3 0.1 1.2 0.6 0.0 1.8 0.6 0.6 0.4 0.6 0.4 1.1 1.3 2.1 0.3 0.1 0.4 0.4 0.2 1.5 1.5 1.2 0.4 1.0 0.1 0.0 0.3 0.5 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 1.3 3.4 1.6 1.1 1.4 1.5 1.2 0.9 1.4 1.1 0.9 1.3 1.0 0.0 0.5 9.1 1.1 0.3 0.8 0.4 0.0 5.0 0.5 0.4 2.6 1.5 2.7 3.7 2.1 0.4 0.3 0.0 0.0 0.6 150.0 9.7 4.5 0.7 3.0 0.8 21.3 0.7 0.3 2.4 0.5 0.5 0.0 7.0 1.1 0.2 0.1 1.7 20.6 0.2 0.0 0.0 0.5 215.5 3.1 0.6 0.0 3.7 0.4 4.3 1.0 7.5 13.3 0.5 0.0 3.8 0.4 1.1 0.4 1.1 7.6 2.4 0.0 3.6 2.8 22.7 1.8 0.2 0.1 0.1 0.5 5.4 0.7 0.2 SLX1B "GIYD2, MGC5178" ENSG00000181625 "SLX1 homolog B, structure-specific endonuclease subunit" Q9BQ83 16 29454501-29458219 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.8;Erythroid cells: 12.4;Plasma cells: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 59.3" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (2.93e-1)" "unprognostic (1.11e-1)" "unprognostic (2.16e-2)" "unprognostic (5.12e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (7.20e-2)" "unprognostic (2.72e-2)" "unprognostic (2.35e-3)" "unprognostic (3.63e-1)" "unprognostic (1.22e-1)" "unprognostic (3.64e-2)" "unprognostic (2.51e-7)" "unprognostic (4.84e-2)" "unprognostic (1.96e-1)" "unprognostic (4.44e-1)" "unprognostic (5.25e-3)" 15.2 8.3 12.5 12.9 12.8 11.9 15.0 13.1 20.1 14.8 11.4 11.6 22.6 15.4 0.5 9.1 14.7 1.4 7.6 12.3 12.7 8.8 30.7 16.5 7.3 12.0 11.6 12.1 12.2 7.7 4.4 6.6 5.4 14.5 11.1 3.8 4.5 19.1 2.6 32.7 16.9 21.5 3.7 11.4 15.9 16.3 1.3 11.8 15.9 16.4 3.6 6.0 15.5 11.9 13.1 6.7 10.7 17.2 6.4 2.9 2.3 6.7 4.1 8.5 10.4 6.0 3.9 20.4 4.0 5.9 5.1 7.3 7.1 3.0 7.7 3.4 2.8 2.7 5.4 9.1 22.8 6.4 4.5 10.3 5.2 2.1 12.1 6.9 12.2 1.7 29.3 2.3 25.6 4.0 16.1 13.4 7.0 7.5 19.8 2.6 26.7 0.2 19.2 8.2 9.5 5.8 8.4 1.4 59.3 4.5 4.1 8.3 13.5 11.2 15.9 2.0 7.2 2.9 8.5 17.9 11.1 16.9 6.8 9.1 3.6 18.1 9.2 6.7 22.2 2.6 10.0 6.8 7.5 16.5 7.7 3.4 4.0 13.3 8.4 15.5 3.9 18.2 9.7 12.5 12.8 13.1 20.1 12.3 12.7 12.0 11.6 12.1 14.5 11.4 11.8 13.1 0.3 0.0 0.5 0.0 1.7 0.0 0.1 0.0 2.8 0.0 0.3 0.1 14.8 0.0 0.0 0.0 0.0 1.7 0.1 0.5 0.0 0.8 0.1 0.1 0.2 1.7 0.0 12.4 0.0 1.5 0.6 1.6 2.6 0.1 0.0 0.1 0.4 0.5 1.1 0.0 0.0 0.2 0.0 0.9 0.4 0.0 0.0 2.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.4 3.7 0.3 3.6 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 0.1 1.4 1.7 0.0 0.6 0.2 ANKRD62 DKFZp779B1634 ENSG00000181626 "Ankyrin repeat domain 62" A6NC57 18 12093843-12129764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 1.1;pancreas: 1.0;testis: 1.6" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 92.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059835 Enhanced Uncertain "Nucleoplasm,Nuclear bodies,Actin filaments" NA NA "Nucleoplasm, Nuclear bodies" "Actin filaments" "HPA059835: AB_2684136" "unprognostic (2.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-3)" "unprognostic (9.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (6.61e-2)" "unprognostic (7.95e-2)" "unprognostic (3.27e-1)" "unprognostic (2.55e-4)" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (4.52e-3)" "unprognostic (8.70e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.4 0.1 0.6 0.3 0.0 0.8 0.0 0.0 0.6 0.1 0.0 1.3 0.3 0.1 0.4 0.3 0.0 0.0 1.7 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.2 0.1 0.2 0.5 0.0 0.0 16.5 1.7 0.6 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.6 0.8 2.6 0.6 0.2 0.0 1.0 0.0 0.1 1.0 1.0 0.2 0.5 1.1 0.4 0.0 0.8 0.2 0.0 0.0 0.9 0.0 1.3 0.3 92.8 15.8 0.5 1.1 0.0 0.2 0.1 0.2 0.5 P2RY13 "FKSG77, GPR86, GPR94, P2Y13" ENSG00000181631 "Purinergic receptor P2Y13" Q9BPV8 3 151326312-151329549 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.4;lymphoid tissue: 37.2" "Group enriched" "Detected in some" 9 "Kupffer cells: 124.4;Macrophages: 53.2;Microglial cells: 66.5;monocytes: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 581.5" "Group enriched" "Detected in many" 6 "granulocytes: 581.5;monocytes: 185.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049047 Enhanced NA NA "HPA049047: AB_2680611" "unprognostic (1.09e-3)" "unprognostic (7.51e-4)" "unprognostic (1.68e-2)" "unprognostic (2.37e-3)" "unprognostic (3.95e-2)" "unprognostic (8.66e-3)" "unprognostic (7.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.84e-3)" "unprognostic (1.83e-1)" "unprognostic (4.97e-2)" "unprognostic (1.17e-1)" "unprognostic (4.05e-1)" "unprognostic (4.46e-1)" "unprognostic (5.95e-2)" "unprognostic (2.21e-3)" "unprognostic (3.78e-1)" 4.9 3.8 1.7 20.8 2.1 25.4 4.2 1.9 2.4 2.6 2.4 4.5 4.7 1.9 0.9 3.3 3.1 3.9 1.4 2.0 2.0 1.6 8.2 7.6 18.3 2.7 2.5 1.4 1.6 1.2 1.6 0.5 3.3 2.9 1.5 6.2 0.1 3.0 3.2 0.7 2.1 11.1 5.4 4.7 37.2 3.1 0.7 3.5 4.5 1.3 3.8 8.5 4.2 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 152.5 137.2 0.3 155.4 0.3 1.5 0.2 0.2 66.4 0.6 0.2 0.3 581.5 0.1 185.6 1.1 0.2 77.6 1.7 2.1 1.9 2.4 2.0 2.0 2.7 2.5 1.4 2.9 4.7 3.5 3.5 0.9 0.0 6.1 0.0 1.3 0.0 0.1 0.0 0.0 0.8 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 3.6 0.3 0.0 0.2 0.6 0.5 0.0 2.5 0.0 0.7 0.4 7.7 1.7 0.2 0.0 0.0 124.4 4.5 0.0 0.0 53.2 0.0 66.5 63.3 1.1 2.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784652-114806039 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 9.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 25.6;Basal squamous epithelial cells: 14.8;Endometrial ciliated cells: 15.7;Glandular and luminal cells: 28.9;Squamous epithelial cells: 13.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 13.2;hTEC/SVTERT24-B: 8.6;HUVEC TERT2: 16.7;OE19: 16.0;RT4: 16.5;TIME: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 0.8 0.7 0.2 2.5 0.2 0.1 0.9 0.1 0.6 1.5 0.6 1.8 9.6 1.0 0.9 1.2 0.9 2.0 0.0 0.2 0.2 3.3 0.2 4.2 0.8 0.4 0.1 0.1 0.1 0.1 0.8 0.1 4.4 0.2 4.1 2.1 0.0 4.8 1.9 0.1 0.6 3.5 2.0 0.4 0.5 2.9 0.1 0.2 0.6 0.9 0.0 1.1 4.7 0.7 0.3 0.5 4.4 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.2 3.0 1.6 0.0 0.0 0.5 13.2 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 16.7 0.0 0.0 0.9 0.4 0.6 0.0 0.0 0.3 16.0 0.0 0.0 0.1 0.0 0.1 16.5 0.1 0.0 0.0 0.7 0.0 5.6 1.2 0.0 7.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.6 0.2 0.2 0.4 0.1 0.1 0.2 0.4 0.2 0.3 0.2 12.8 12.1 0.0 0.1 0.5 7.7 25.6 14.8 0.3 3.7 3.7 0.6 1.5 4.9 7.3 0.0 0.7 0.4 8.0 0.0 4.9 0.7 15.7 2.9 0.3 0.0 0.0 0.1 2.0 0.2 1.2 8.2 28.9 0.0 0.0 0.0 0.0 2.3 0.0 0.7 2.4 2.0 0.3 5.1 0.1 0.0 5.0 0.0 0.0 5.3 0.1 0.0 0.0 0.1 1.3 0.5 0.4 1.2 4.9 8.9 9.3 1.0 0.3 0.0 0.4 3.0 0.0 0.0 13.7 0.6 0.3 1.0 0.1 7.4 6.5 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" Q8N8Y5 8 143246821-143262705 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 2.9 3.5 5.4 2.3 5.2 1.5 2.8 1.9 5.2 3.6 0.0 3.8 3.4 4.3 1.4 3.0 4.1 1.9 3.1 4.2 3.3 3.6 3.4 2.2 2.6 6.9 4.8 2.3 5.4 3.5 4.0 5.4 1.1 8.0 3.7 1.5 2.5 4.8 2.6 3.2 4.8 3.7 2.0 2.0 3.2 3.6 6.4 5.4 2.4 4.2 1.8 2.1 3.4 3.0 8.5 6.7 10.5 4.5 6.0 5.1 3.9 5.3 4.0 2.1 7.6 5.2 5.2 5.5 3.7 5.8 5.2 7.7 5.4 4.9 5.2 3.7 5.9 6.0 4.7 5.6 4.1 7.1 1.8 2.8 4.1 7.2 4.9 7.2 5.2 3.6 2.6 10.1 3.5 3.6 12.0 5.0 2.0 6.7 8.2 10.3 2.6 3.7 1.3 3.3 6.0 5.7 7.8 11.2 3.0 5.9 3.8 7.7 3.6 3.8 5.7 10.2 4.5 6.4 5.6 4.6 1.7 5.1 4.5 7.7 0.0 0.1 0.0 0.3 0.2 0.5 0.1 0.2 0.2 0.1 0.2 0.4 0.3 0.0 0.1 0.0 0.9 0.2 0.2 5.4 5.2 1.9 5.2 4.2 3.3 6.9 4.8 2.3 8.0 2.0 5.4 8.5 1.6 0.0 2.0 2.9 2.3 1.1 0.7 0.8 0.6 2.5 2.3 1.9 3.2 5.7 1.1 3.7 6.2 0.3 0.8 3.7 1.9 1.9 1.5 1.8 2.3 1.6 3.0 0.8 2.2 0.9 1.1 1.6 2.6 1.2 0.0 2.7 2.5 3.9 1.2 6.7 3.4 2.4 2.0 2.2 0.5 2.6 1.2 1.5 1.8 1.0 0.9 2.5 2.1 1.5 4.4 1.6 4.1 2.2 1.6 0.5 3.4 1.4 3.2 2.0 0.0 1.6 1.9 7.9 3.7 1.8 0.3 0.3 0.9 1.6 3.4 0.4 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.0;placenta: 80.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 4600.4;Extravillous trophoblasts: 2222.5;Syncytiotrophoblasts: 9959.7;Urothelial cells: 2892.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 17 "dendritic cells: 1.9;monocytes: 1.2;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HDLM-2: 395.9;PC-3: 326.0;SK-MEL-30: 289.9;WM-115: 358.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli NA NA Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavorable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 6.8 2.8 1.2 3.6 1.0 1.2 5.4 1.7 2.7 8.5 2.8 9.0 7.4 4.8 0.8 43.0 4.7 3.1 2.9 1.0 1.9 12.0 5.9 7.9 0.3 4.1 1.8 0.8 2.5 4.1 0.4 2.8 80.3 4.4 15.5 1.7 0.0 10.3 0.9 0.9 16.7 6.5 0.8 1.5 2.7 17.9 0.8 1.5 0.1 5.6 0.4 1.3 12.9 18.9 1.9 42.2 31.1 1.9 0.5 0.4 9.8 43.4 72.4 21.4 12.9 11.8 15.4 91.8 0.0 41.9 12.1 32.2 51.8 0.1 42.8 2.4 395.9 14.1 0.0 13.9 10.4 32.7 0.1 23.5 13.9 20.2 11.1 12.1 8.8 10.9 0.0 9.2 0.7 6.5 148.9 0.1 6.1 16.5 26.8 326.0 0.0 0.0 29.6 32.2 13.7 4.1 0.3 31.6 25.0 289.9 2.0 7.4 3.3 51.9 31.2 13.6 45.7 32.1 0.6 0.8 0.3 28.2 5.4 358.2 0.0 1.2 0.0 0.3 1.1 0.4 0.0 1.8 0.3 1.9 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.8 0.5 1.2 1.0 1.7 2.7 1.0 1.9 4.1 1.8 0.8 4.4 1.5 1.5 1.9 27.1 19.2 28.9 1.0 13.0 394.7 1494.1 518.9 116.1 0.0 274.4 221.4 6.0 64.3 328.3 44.1 0.0 4600.4 9.2 506.0 9.8 164.7 2.4 84.9 28.6 37.8 197.3 2.7 2.1 143.7 2222.5 92.0 278.8 175.6 82.6 0.4 15.7 6.2 405.9 0.0 1.0 384.5 258.4 12.9 303.6 0.8 3.7 79.6 103.2 1.9 10.5 0.1 0.0 0.0 0.4 502.3 871.7 3.0 13.2 1318.1 201.9 1.7 133.0 0.4 52.6 10.5 293.5 0.4 3.8 545.6 685.5 9959.7 50.5 0.2 292.8 2892.3 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Metabolic proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;skin 1: 11.5" "Cell type enhanced" "Detected in many" "Early spermatids: 50.7;Endometrial ciliated cells: 28.6;Late spermatids: 30.3;Respiratory ciliated cells: 25.9;Syncytiotrophoblasts: 115.5" "Cancer enhanced" "Detected in many" "testis cancer: 6.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 8.9" "Lineage enriched" "Detected in many" 5 "T-cells: 8.9" "Group enriched" "Detected in some" 5 "BEWO: 13.0;CAPAN-2: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 1.7 0.4 1.6 0.2 0.2 0.7 1.0 0.8 0.3 0.0 0.0 0.4 1.1 8.3 1.0 0.2 0.0 0.6 1.7 0.0 0.0 0.2 0.8 1.2 1.4 0.7 0.1 0.0 0.0 1.6 4.1 1.5 0.2 0.0 0.8 0.5 0.0 0.2 11.5 0.0 0.0 1.2 0.1 0.1 2.0 1.5 0.3 0.1 0.0 0.8 0.1 1.6 1.5 0.6 0.0 0.7 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.1 4.2 0.3 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.6 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.5 0.4 0.6 0.0 1.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.0 1.0 0.9 5.0 1.3 0.0 1.6 8.9 3.4 0.0 0.4 0.1 0.7 5.4 1.4 1.7 1.6 0.7 1.0 0.6 1.7 1.2 1.4 0.7 1.5 1.2 1.5 1.5 0.4 0.0 0.0 0.0 2.8 0.0 0.2 1.9 0.6 4.0 0.7 0.9 1.4 1.5 1.6 0.0 0.0 10.2 1.5 0.3 0.0 0.3 50.7 28.6 3.3 1.1 0.0 0.0 2.7 0.2 2.5 0.5 0.0 15.4 14.7 7.8 2.2 0.0 1.9 0.0 7.7 0.0 4.1 0.3 0.4 30.3 0.6 0.8 0.0 0.0 0.3 0.5 1.0 0.5 0.6 3.8 0.0 0.7 0.4 0.3 0.0 0.1 25.9 0.6 0.0 0.0 0.9 19.8 12.7 0.8 0.3 115.5 4.7 0.1 0.2 1.9 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538139-100542021 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 72.2" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.1;Excitatory neurons: 1.8;Hepatocytes: 2.2" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Region enhanced" "Detected in many" "basal ganglia: 72.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HSkMC: 1.6;SCLC-21H: 2.0" "Region enriched" "Detected in many" 10 "basal ganglia: 718.8" "Region enriched" "Detected in many" 42 "basal ganglia: 273.1" HPA007488 Approved NA NA "HPA007488: AB_2667844" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.4 0.3 3.5 0.3 72.2 0.0 7.2 0.2 12.0 0.1 0.4 0.6 0.3 0.1 0.0 0.1 0.1 0.0 0.2 2.9 13.0 0.1 8.9 0.1 0.1 21.2 1.4 3.9 2.6 0.0 1.0 1.1 0.0 13.4 0.3 0.3 0.3 0.4 0.0 0.2 0.0 0.4 0.1 0.7 10.6 0.2 0.1 12.5 0.2 0.1 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 72.2 0.2 12.0 2.9 13.0 21.2 1.4 3.9 13.4 0.7 12.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF875 HKR1 ENSG00000181666 "Zinc finger protein 875" P10072 19 37312837-37369365 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 142.3" "Cell type enhanced" "Detected in some" "Adipocytes: 5.1;Cardiomyocytes: 19.8;Cytotrophoblasts: 11.0;Extravillous trophoblasts: 5.7;Hofbauer cells: 7.3;Syncytiotrophoblasts: 9.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA036126, HPA044855" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA036126: AB_10670708, HPA044855: AB_2679113" "unprognostic (1.04e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-1)" "unprognostic (3.58e-1)" "unprognostic (2.78e-1)" "unprognostic (4.81e-2)" "unprognostic (2.29e-1)" "unprognostic (1.02e-3)" "unprognostic (4.92e-3)" "unprognostic (9.82e-2)" "prognostic favorable (4.41e-4)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.34e-1)" "unprognostic (5.04e-2)" "unprognostic (2.00e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" 18.8 37.7 29.4 10.9 26.4 14.9 26.1 36.5 31.6 24.2 41.2 20.8 8.4 20.5 24.1 17.5 24.1 14.5 30.1 28.8 27.5 29.0 18.4 18.9 16.8 27.2 25.6 28.4 28.3 20.2 32.1 36.8 18.5 29.1 39.7 14.1 142.3 27.3 19.4 21.5 28.6 19.6 17.6 19.8 28.2 21.3 30.6 27.2 19.4 38.2 18.3 19.1 21.9 22.2 31.0 7.8 19.7 24.9 32.3 18.0 15.1 17.2 13.2 20.0 23.7 25.8 10.0 9.1 27.8 31.4 14.0 11.1 6.6 16.5 17.7 24.9 14.5 28.4 9.8 26.9 10.4 23.3 8.6 23.9 23.4 21.5 16.4 35.4 23.8 14.8 19.9 1.9 1.6 17.6 16.0 20.0 17.7 51.0 13.9 11.3 13.7 10.7 10.9 21.2 31.9 32.1 42.5 13.1 16.7 16.9 36.2 24.1 17.4 13.6 18.8 13.1 14.2 21.0 34.9 40.4 29.8 2.2 10.7 21.3 12.8 4.5 7.4 7.6 5.8 14.9 11.1 10.6 11.5 6.9 12.6 14.3 12.0 4.1 11.4 4.0 8.4 13.9 6.8 29.4 26.4 36.5 31.6 28.8 27.5 27.2 25.6 28.4 29.1 19.8 27.2 31.0 5.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 11.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 5.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.9 0.4 0.0 0.0 0.0 PLAG1 ZNF912 ENSG00000181690 "PLAG1 zinc finger" Q6DJT9 8 56160909-56211324 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 32.0;Microglial cells: 28.1;Rod photoreceptor cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;ASC TERT1: 20.9;hTERT-HME1: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA072290 Supported "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA072290: AB_2686508" "unprognostic (1.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-3)" "unprognostic (1.63e-4)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (5.63e-3)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (7.99e-2)" "unprognostic (3.42e-2)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (2.83e-2)" "unprognostic (3.94e-1)" "unprognostic (1.21e-2)" "unprognostic (6.14e-2)" 0.7 1.4 0.9 1.0 1.3 0.9 0.9 2.6 1.1 3.1 0.8 0.7 1.4 1.4 4.1 0.7 3.1 0.7 3.1 0.8 1.2 1.3 0.4 1.9 1.8 1.6 1.6 0.7 4.9 0.8 1.3 3.8 1.6 1.9 1.3 0.6 7.8 3.1 1.9 0.4 1.4 2.4 0.4 1.4 2.6 1.3 2.4 1.2 2.9 1.3 1.4 2.3 1.3 3.0 2.1 2.0 0.0 11.9 0.1 16.0 20.9 3.7 5.4 6.9 2.5 1.1 0.8 6.2 0.2 5.1 2.9 0.7 0.4 3.4 7.1 2.5 0.2 7.4 8.0 0.8 1.8 3.3 2.5 2.3 14.9 3.9 1.4 15.6 6.9 4.7 5.3 3.4 0.1 5.3 0.1 0.7 4.7 3.4 0.5 1.8 6.1 0.8 4.9 3.2 0.7 0.1 0.0 0.1 0.1 0.4 8.0 0.1 2.4 7.2 3.6 4.6 5.9 1.4 1.8 1.5 2.9 4.1 0.9 1.0 0.6 0.0 0.4 0.1 0.0 0.1 1.3 0.4 0.2 0.0 0.7 1.8 1.8 0.4 0.3 0.2 0.1 0.1 0.4 0.9 1.3 2.6 1.1 0.8 1.2 1.6 1.6 0.7 1.9 1.4 1.2 2.1 2.6 6.4 3.2 2.9 13.0 1.0 2.5 6.2 1.8 23.6 1.6 0.6 12.2 4.3 6.7 5.5 25.0 8.3 2.0 1.0 0.0 0.7 6.2 3.0 2.3 3.7 5.4 5.0 16.8 1.3 4.2 4.0 2.6 4.2 1.3 0.4 15.7 0.7 5.8 32.0 12.3 3.6 6.1 2.9 2.2 6.7 15.2 2.8 16.0 28.1 1.2 16.3 4.1 2.0 19.2 1.4 4.1 10.1 6.3 5.0 5.1 0.8 9.1 27.8 0.0 2.4 1.4 9.0 8.8 1.1 0.9 7.1 4.5 0.9 3.6 12.9 OR8H1 ENSG00000181693 "Olfactory receptor family 8 subfamily H member 1" Q8NGG4 11 56288462-56292254 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.6 0.3 0.1 0.1 0.0 0.3 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T1 OR5T1P ENSG00000181698 "Olfactory receptor family 5 subfamily T member 1" Q8NG75 11 56274154-56276819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050952 Uncertain NA NA "HPA050952: AB_2681287" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YIPF6 "FinGER6, MGC21416" ENSG00000181704 "Yip1 domain family member 6" Q96EC8 X 68498562-68537282 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 278.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003720 Uncertain Approved Vesicles NA NA Vesicles "HPA003720: AB_1080626" "unprognostic (5.07e-3)" "unprognostic (2.13e-1)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (7.17e-2)" "unprognostic (5.90e-3)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-2)" "unprognostic (3.15e-1)" "unprognostic (8.85e-3)" "unprognostic (8.48e-2)" "unprognostic (2.90e-2)" "unprognostic (3.25e-1)" "unprognostic (6.32e-2)" 14.5 14.9 14.7 7.9 16.3 6.6 15.1 16.5 15.5 14.6 15.5 12.6 11.8 13.4 14.6 11.7 13.3 11.2 11.7 13.7 16.6 19.1 21.8 12.5 6.4 16.5 16.9 13.3 10.6 14.6 20.8 15.1 18.4 15.5 20.1 14.2 14.5 16.5 14.7 17.1 10.8 11.5 13.0 16.2 8.3 15.5 6.3 16.1 6.7 22.0 16.5 7.5 12.5 8.5 16.4 23.5 22.4 22.6 7.9 28.7 17.8 24.8 18.0 22.5 13.8 17.4 23.5 23.5 0.1 32.6 15.1 22.8 18.2 29.8 12.2 23.2 6.8 20.2 10.4 22.6 19.6 26.4 11.4 14.3 17.6 22.3 20.5 25.4 24.1 13.8 13.4 16.6 22.3 18.8 24.8 6.6 9.7 24.0 34.0 23.3 6.7 27.5 12.3 22.9 25.9 23.5 24.6 30.6 20.9 21.7 20.4 12.9 11.8 18.8 15.4 14.8 49.2 35.0 12.2 15.0 4.6 22.8 17.2 26.1 5.3 4.0 4.7 2.2 4.7 1.5 3.9 2.2 2.0 3.0 2.1 2.2 1.9 10.5 2.9 4.2 3.6 2.6 2.8 14.7 16.3 16.5 15.5 13.7 16.6 16.5 16.9 13.3 15.5 16.2 16.1 16.4 42.1 70.5 99.6 25.5 25.6 34.9 62.3 110.0 21.6 54.6 47.4 32.3 33.7 32.9 88.6 57.0 47.9 101.6 19.8 43.8 35.2 47.4 25.9 50.9 35.2 41.7 54.4 80.4 18.8 43.9 111.3 53.1 27.5 47.8 53.7 33.6 42.1 60.2 44.1 45.4 21.9 61.8 93.6 25.9 42.0 63.2 42.6 38.5 35.6 23.4 23.4 63.5 29.9 26.7 34.9 47.3 34.7 47.4 42.7 90.4 42.4 62.4 81.6 52.7 26.3 50.8 44.6 31.5 28.1 31.4 43.3 278.8 29.0 29.6 33.5 89.5 OR5T2 ENSG00000181718 "Olfactory receptor family 5 subfamily T member 2" Q8NGG2 11 56231282-56234255 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314500-115147288 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.9" "Cell type enhanced" "Detected in many" "Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA015551: AB_2669217, HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 4.2 4.0 27.2 1.1 43.2 2.5 3.4 59.4 44.2 3.4 4.1 1.7 0.8 3.6 9.7 1.2 2.4 2.3 3.6 60.4 66.9 5.2 5.4 1.8 1.8 45.3 32.2 5.9 6.8 3.5 2.3 1.4 1.0 34.0 5.4 1.4 8.6 3.1 4.9 7.9 2.3 0.8 2.9 26.4 2.5 1.7 15.9 33.4 1.9 5.0 9.0 1.8 1.6 0.7 40.8 1.4 2.7 1.0 2.8 4.2 1.8 0.0 1.3 2.5 0.8 0.6 1.7 0.5 0.4 3.7 3.2 0.8 0.0 4.0 0.6 0.7 0.3 0.1 0.4 1.7 1.3 0.8 0.1 0.0 1.8 0.2 1.4 0.4 2.4 0.8 0.2 0.1 0.6 4.4 0.0 0.1 0.1 0.3 0.0 0.1 0.1 3.4 0.0 2.9 0.0 0.3 0.7 0.5 0.0 0.9 0.1 0.0 0.3 4.8 1.0 3.5 0.2 1.8 0.9 0.0 0.1 1.7 0.2 1.3 9.7 1.5 6.4 6.8 2.3 4.6 20.4 6.4 6.4 1.9 11.3 8.3 6.8 3.5 5.3 4.6 4.9 3.6 3.5 27.2 43.2 59.4 44.2 60.4 66.9 45.3 32.2 5.9 34.0 26.4 33.4 40.8 278.1 160.3 122.6 1998.0 115.4 25.7 38.2 11.3 22.2 123.6 103.7 81.8 48.5 108.7 25.2 294.3 60.5 0.2 56.1 10.3 49.0 231.4 450.3 109.8 628.3 106.4 31.8 20.4 72.3 82.9 0.6 174.5 36.7 170.5 80.6 194.5 56.0 106.0 4.3 80.8 462.3 14.5 40.7 20.4 28.5 111.1 105.6 36.0 32.0 855.4 29.3 127.7 36.0 1908.5 2090.4 107.8 10.5 120.7 58.4 28.0 19.2 198.4 36.4 108.6 85.5 301.2 124.6 6.9 8.7 14.2 18.5 0.5 67.4 140.7 17.2 25.0 OR2Z1 OR2Z2 ENSG00000181733 "Olfactory receptor family 2 subfamily Z member 1" Q8NG97 19 8721634-8732160 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048760 Uncertain NA NA "HPA048760: AB_2680513" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DIPK2A "C3orf58, DIA1, HASF, MGC33365" ENSG00000181744 "Divergent protein kinase domain 2A" Q8NDZ4 3 143971823-144048719 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.5;Cardiomyocytes: 19.6;dendritic cells: 11.3;Fibroblasts: 22.6;Hofbauer cells: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 147.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048992 Approved "Secreted in other tissues" NA NA "HPA048992: AB_2680591" "unprognostic (5.96e-2)" "unprognostic (8.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-1)" "unprognostic (2.43e-1)" "unprognostic (2.85e-2)" "unprognostic (3.74e-2)" "unprognostic (2.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (3.44e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (2.92e-7)" "unprognostic (4.82e-3)" "unprognostic (2.87e-1)" "unprognostic (1.70e-1)" "unprognostic (1.50e-2)" 9.9 7.5 12.5 10.6 15.5 32.7 15.8 27.0 17.5 13.7 7.0 8.2 6.8 14.3 6.0 14.2 12.8 14.3 7.1 11.6 15.7 6.9 19.0 13.0 11.4 13.7 13.5 11.4 20.4 4.5 15.1 3.5 38.4 14.4 11.6 8.9 5.8 9.1 12.7 4.7 24.6 6.0 15.3 12.3 10.8 8.4 8.1 13.1 16.7 12.8 7.3 11.1 11.6 9.8 26.3 24.9 9.9 24.8 147.9 22.6 20.4 13.5 17.7 17.2 16.6 17.6 6.7 9.8 15.5 13.6 6.8 11.9 13.9 37.2 14.3 25.9 7.3 13.5 23.0 9.4 10.1 9.8 21.3 10.3 17.0 7.5 10.2 15.4 16.7 26.1 7.0 4.1 43.9 21.2 6.7 7.7 10.4 15.7 10.3 6.2 11.3 12.8 17.2 10.3 29.1 16.5 0.0 12.7 5.8 5.8 6.7 15.5 11.5 12.5 14.6 7.0 22.9 20.6 17.4 6.5 22.1 23.6 10.0 19.3 24.9 11.9 20.1 3.5 7.8 5.8 8.2 4.2 3.7 14.9 7.1 3.6 3.6 3.3 9.5 10.6 9.3 3.9 6.0 12.5 15.5 27.0 17.5 11.6 15.7 13.7 13.5 11.4 14.4 12.3 13.1 26.3 23.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 1.6 11.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 3.4 2.6 0.0 0.0 0.0 MACIR "C5orf30, FLJ25291" ENSG00000181751 "Macrophage immunometabolism regulator" Q96GV9 5 103258763-103278660 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Inflammatory response, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.5" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 37.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 37.6" "Cell line enhanced" "Detected in many" "BJ: 177.1;fHDF/TERT166: 108.5;U-138 MG: 115.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043434 Uncertain NA NA "HPA043434: AB_2678480" "unprognostic (1.18e-1)" "unprognostic (1.49e-1)" "unprognostic (6.59e-3)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.85e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.15e-1)" "unprognostic (3.85e-2)" "unprognostic (8.76e-2)" "unprognostic (4.36e-2)" "unprognostic (1.88e-1)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (2.29e-1)" "unprognostic (5.23e-2)" "unprognostic (1.83e-2)" 7.8 4.2 26.0 4.4 27.3 31.7 10.0 25.1 33.3 3.5 20.7 22.8 9.6 2.2 3.1 4.8 6.1 8.2 4.0 26.9 24.9 5.8 1.0 3.8 2.7 25.8 27.1 27.1 4.7 8.0 11.3 4.1 7.7 26.5 6.6 21.9 20.9 3.2 5.0 8.5 5.9 11.8 3.4 25.1 4.4 13.3 5.9 27.6 4.1 5.2 3.5 2.6 2.9 2.7 36.5 10.6 22.2 21.8 12.9 12.0 14.2 13.9 177.1 50.1 21.4 19.5 1.4 23.2 0.1 17.1 108.5 12.6 12.2 12.6 15.1 33.5 30.1 20.6 18.0 28.3 7.1 6.1 9.1 11.4 10.9 19.5 8.7 17.1 38.3 12.8 13.2 9.1 24.2 24.8 13.5 5.2 13.2 14.9 5.7 13.6 26.4 14.5 38.7 9.2 10.1 23.0 21.2 6.3 11.7 45.2 15.4 24.3 10.3 33.6 115.6 9.5 24.8 29.9 13.6 22.6 19.6 14.5 5.1 45.7 37.6 3.6 6.2 3.4 3.2 2.9 4.1 2.8 3.6 3.5 2.0 2.5 2.4 3.2 7.3 3.7 2.0 7.3 3.0 26.0 27.3 25.1 33.3 26.9 24.9 25.8 27.1 27.1 26.5 25.1 27.6 36.5 2.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 22.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 103.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 21.5 0.5 0.0 0.0 0.0 OR8K5 ENSG00000181752 "Olfactory receptor family 8 subfamily K member 5" Q8NH50 11 56159394-56160317 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "stomach cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504178-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.6;Excitatory neurons: 9.6;Inhibitory neurons: 15.9;Rod photoreceptor cells: 9.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Cell line enhanced" "Detected in many" "SK-BR-3: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046152: AB_2679559" "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 3.9 10.8 11.5 2.8 14.3 0.4 3.3 12.2 21.1 3.4 7.4 5.4 2.1 4.3 11.8 2.8 3.4 2.8 8.6 13.9 14.2 5.3 2.9 4.7 4.1 11.8 11.3 13.5 8.9 6.9 12.5 7.5 1.9 13.8 6.4 2.4 23.6 7.7 7.8 19.5 2.2 3.8 4.6 6.8 3.4 4.7 2.9 13.8 2.7 6.6 12.0 3.3 4.0 2.8 13.2 2.3 1.1 2.4 8.3 3.0 1.3 2.9 3.6 2.0 4.4 2.1 0.5 0.1 0.1 1.0 2.5 1.0 1.2 6.5 0.2 3.7 0.9 0.5 0.0 1.6 0.7 2.5 1.9 4.6 0.6 2.8 1.5 0.0 0.4 1.1 1.3 1.9 0.0 0.1 4.1 0.4 3.9 1.3 2.0 2.5 0.6 0.0 0.3 5.1 1.1 8.1 2.7 0.9 11.0 3.2 1.0 3.2 2.8 1.0 0.1 4.8 3.0 1.5 0.2 0.0 0.0 1.6 0.0 2.4 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.9 1.1 0.0 0.0 2.3 1.7 0.0 0.9 0.0 0.0 0.7 0.4 11.5 14.3 12.2 21.1 13.9 14.2 11.8 11.3 13.5 13.8 6.8 13.8 13.2 0.6 3.2 2.0 5.9 0.2 0.6 0.4 0.3 0.6 33.6 2.4 1.4 8.9 1.5 0.3 3.7 4.2 1.3 0.6 1.5 0.0 1.2 0.0 0.4 0.4 1.6 4.8 0.0 9.6 0.9 0.2 1.9 0.0 0.7 0.0 1.4 1.1 1.0 0.2 5.0 15.9 1.0 2.0 0.6 0.0 0.1 2.1 0.2 0.0 2.8 0.8 6.7 0.0 3.0 2.1 0.8 1.6 5.7 0.1 1.1 2.3 0.8 0.1 9.4 0.0 4.3 1.5 1.2 1.4 0.2 0.4 0.3 1.8 0.9 1.5 0.3 OR8H3 ENSG00000181761 "Olfactory receptor family 8 subfamily H member 3" Q8N146 11 56122373-56123311 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H2 ENSG00000181767 "Olfactory receptor family 8 subfamily H member 2" Q8N162 11 56103687-56107658 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR3 ACCA ENSG00000181773 "G protein-coupled receptor 3" P46089 1 27392622-27395814 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.7" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Basal squamous epithelial cells: 2.8;Cardiomyocytes: 2.8;Enteroendocrine cells: 4.8;Horizontal cells: 5.0;Inhibitory neurons: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB006254 Uncertain NA NA "CAB006254: AB_425462" "unprognostic (4.42e-2)" "unprognostic (2.22e-1)" "unprognostic (4.05e-2)" "unprognostic (1.55e-2)" "unprognostic (1.38e-2)" "unprognostic (1.27e-1)" "unprognostic (7.30e-3)" "unprognostic (6.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-1)" "unprognostic (5.94e-2)" "unprognostic (1.97e-1)" "unprognostic (1.46e-1)" "unprognostic (8.17e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (1.03e-2)" 1.6 0.6 1.7 0.7 1.7 1.0 1.3 4.0 7.5 0.5 0.3 0.6 0.2 0.5 0.0 0.5 0.8 0.7 3.6 1.9 7.7 1.3 0.4 2.3 0.2 3.7 2.4 1.4 0.4 0.7 0.5 4.4 0.4 4.8 0.9 0.2 1.6 0.5 0.1 0.5 0.6 0.5 0.6 2.0 0.2 0.8 0.2 2.9 0.2 1.8 1.5 0.1 0.9 0.4 4.3 1.9 1.0 5.3 5.9 0.2 0.6 0.7 3.4 4.0 5.2 3.8 1.6 1.1 0.3 0.8 1.6 5.3 1.3 1.4 4.2 4.0 0.1 0.2 1.5 0.3 3.4 0.6 3.4 4.5 0.7 0.0 7.3 1.6 0.5 1.6 2.3 4.3 5.8 6.4 2.7 0.7 4.8 7.8 2.7 8.4 9.2 4.2 2.5 2.2 0.4 1.0 2.5 1.7 0.7 6.6 2.2 0.1 0.7 1.0 3.9 7.1 23.0 4.2 0.7 4.3 0.5 5.9 1.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.7 4.0 7.5 1.9 7.7 3.7 2.4 1.4 4.8 2.0 2.9 4.3 5.5 0.0 0.0 0.7 0.1 0.1 2.3 1.0 2.8 1.6 0.7 0.5 2.8 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.6 0.3 1.4 4.8 0.0 2.6 0.0 0.3 1.4 1.1 0.6 0.0 0.0 0.0 0.0 0.2 5.0 4.6 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 1.7 1.0 0.0 0.1 0.7 0.0 0.1 0.1 0.1 0.5 0.4 TMEM252 "C9orf71, MGC34760" ENSG00000181778 "Transmembrane protein 252" Q8N6L7 9 68536580-68540883 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 22.2;kidney: 36.0" "Group enriched" "Detected in some" 5 "Proximal enterocytes: 21.6;Proximal tubular cells: 20.6" "Cancer enriched" "Detected in many" 17 "renal cancer: 35.7" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Immune cell enriched" "Detected in single" 8 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 40 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "PC-3: 1.2;RPTEC TERT1: 2.2;SK-BR-3: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA079457 Enhanced NA NA "HPA079457: " "unprognostic (2.64e-1)" "unprognostic (3.28e-3)" "unprognostic (3.72e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.64e-2)" "unprognostic (6.42e-2)" "prognostic favorable (1.75e-7)" "unprognostic (7.63e-2)" "unprognostic (6.15e-2)" "unprognostic (7.66e-2)" "unprognostic (2.50e-1)" 1.1 2.9 0.1 1.2 0.0 0.0 0.6 1.2 0.1 1.2 0.0 6.2 1.6 5.5 0.0 6.0 3.3 1.3 4.5 0.0 0.0 36.0 1.6 0.3 0.3 0.1 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.5 2.8 0.2 1.3 0.2 0.0 1.3 0.5 22.2 0.0 0.0 0.5 2.0 0.1 0.2 0.0 0.4 0.3 0.0 6.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 20.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "skeletal muscle: 8.3;testis: 23.6" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1184.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.3 0.3 0.7 0.0 0.7 0.0 0.3 0.4 0.9 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.5 0.5 0.2 0.3 0.2 0.0 0.7 0.6 0.4 0.1 0.1 0.0 0.1 0.2 1.3 0.2 0.0 0.1 0.0 0.0 8.3 0.1 0.2 0.0 0.4 0.7 0.1 23.6 0.7 0.0 0.3 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.4 0.9 0.5 0.5 0.7 0.6 0.4 1.3 0.4 0.7 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.8 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1184.9 8.4 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 7.6 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR5AS1 ENSG00000181785 "Olfactory receptor family 5 subfamily AS member 1" Q8N127 11 56027654-56038191 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 8.7;Club cells: 5.6;Respiratory ciliated cells: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.5 0.4 2.2 0.6 3.4 1.9 0.5 7.0 6.9 0.2 0.3 0.4 0.4 0.4 0.8 0.3 0.2 0.4 0.7 3.0 0.6 0.3 1.1 0.5 0.6 1.7 1.7 1.8 0.7 0.5 0.2 0.0 0.8 3.0 0.6 0.4 3.1 0.6 0.5 0.7 1.5 0.5 0.3 0.4 0.6 0.5 1.0 0.8 0.4 0.4 0.2 0.3 0.2 0.0 6.5 0.7 0.3 0.7 0.7 0.2 0.3 0.7 0.5 0.1 0.1 0.2 0.6 0.6 1.1 0.6 0.3 0.7 0.7 0.2 0.2 0.4 1.1 0.3 0.7 1.8 0.5 0.1 0.8 0.9 0.3 0.4 0.6 0.3 0.4 0.3 0.6 0.9 1.6 0.1 0.5 1.1 0.7 1.1 0.4 0.3 0.6 0.8 0.4 0.3 0.8 0.5 0.6 0.4 0.4 0.3 0.8 0.8 0.4 1.1 1.0 0.8 0.7 0.6 1.2 1.0 0.3 0.6 0.7 1.4 1.5 0.4 0.2 0.4 0.3 0.3 0.2 0.3 0.3 0.2 0.6 0.3 0.3 1.0 0.4 0.4 0.3 0.1 0.0 2.2 3.4 7.0 6.9 3.0 0.6 1.7 1.7 1.8 3.0 0.4 0.8 6.5 0.0 6.4 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 ACTL9 MGC33407 ENSG00000181786 "Actin like 9" Q8TC94 19 8697400-8698795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1127 "testis: 112.6" "Group enriched" "Detected in some" 178 "Early spermatids: 979.9;Late spermatids: 2374.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019231, HPA026693" Uncertain NA NA "HPA019231: AB_1853883, HPA026693: AB_1853884" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 979.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2374.9 6.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741125-150763477 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: AB_2684470" "prognostic favorable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 14.6 79.4 17.2 20.9 16.8 45.1 17.3 17.0 22.5 48.4 16.4 17.9 13.6 33.7 18.8 46.4 27.5 14.4 16.4 19.5 16.0 12.2 61.7 13.3 36.1 18.4 15.2 15.2 24.6 21.0 16.0 11.1 43.5 18.6 19.5 15.6 7.9 16.5 35.0 12.4 30.0 13.0 29.6 16.4 24.6 18.1 8.1 17.0 25.3 8.0 12.9 45.7 23.7 40.0 25.5 54.0 13.4 10.5 20.1 35.4 26.4 41.7 22.9 26.5 27.3 32.4 28.4 24.7 31.3 31.0 24.1 22.8 31.4 28.6 20.7 25.6 24.4 19.5 61.5 16.0 94.7 50.4 34.3 16.0 24.1 47.0 16.3 36.9 21.7 21.5 60.2 15.5 110.8 17.4 66.4 58.7 17.4 33.1 52.3 26.0 44.0 22.7 110.4 17.4 17.9 38.4 19.1 17.4 15.4 39.8 23.8 99.5 50.0 15.0 17.7 15.8 40.1 31.0 130.6 55.9 42.0 17.6 48.6 9.2 8.9 2.2 8.6 1.6 1.2 2.5 2.2 2.8 2.5 2.0 2.2 1.4 1.4 4.7 1.4 1.3 2.6 1.6 0.9 17.2 16.8 17.0 22.5 19.5 16.0 18.4 15.2 15.2 18.6 16.4 17.0 25.5 15.9 6.4 4.8 6.8 99.0 146.7 82.3 11.8 153.1 47.0 32.3 22.2 17.8 25.8 11.7 22.0 37.5 192.0 62.6 30.2 13.7 8.5 3.4 56.0 29.2 22.5 38.3 226.7 14.1 6.6 23.4 28.8 44.4 96.5 10.2 18.7 20.7 54.4 32.6 35.3 11.0 39.9 14.2 115.5 102.7 2.1 44.1 70.4 44.4 14.0 22.7 32.7 32.0 5.0 11.5 10.5 17.9 30.9 128.7 56.7 20.7 17.9 16.5 2.8 13.1 11.8 29.9 0.7 10.8 154.1 142.4 389.4 86.1 28.6 34.5 81.8 COPG1 COPG ENSG00000181789 "COPI coat complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 57000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 81.5 112.0 68.4 59.5 72.1 59.9 80.5 72.8 81.3 101.3 91.5 108.6 87.5 76.1 158.8 87.5 70.6 54.3 95.5 72.7 75.4 83.3 150.7 85.2 55.2 77.1 71.9 71.7 78.5 163.8 97.1 140.1 82.6 81.2 108.7 110.8 33.7 131.7 73.4 76.4 72.8 87.4 72.8 71.2 82.5 114.9 46.9 76.7 54.0 84.0 43.6 67.7 67.8 72.8 85.5 167.8 83.2 119.1 104.0 272.8 219.0 126.9 266.3 251.8 179.5 225.2 153.9 101.2 91.1 150.8 380.7 145.6 98.4 99.5 157.2 193.6 112.0 41.4 151.9 103.2 252.6 247.9 116.4 156.4 230.9 135.6 143.8 235.0 196.1 164.3 68.9 54.2 213.6 219.2 253.4 68.7 117.7 71.3 243.6 100.9 73.3 111.8 178.3 227.3 136.7 74.1 86.1 204.2 150.3 255.9 129.8 167.1 167.6 223.9 96.9 91.7 207.2 104.2 165.7 86.1 158.9 236.4 86.9 190.0 79.1 49.9 37.2 44.1 59.2 53.6 24.9 39.8 43.9 57.0 26.9 30.0 36.2 37.2 57.0 57.3 52.2 43.8 56.2 68.4 72.1 72.8 81.3 72.7 75.4 77.1 71.9 71.7 81.2 71.2 76.7 85.5 16.6 16.0 31.5 7.8 19.2 8.8 16.9 35.4 12.0 9.2 18.9 8.6 23.3 17.2 34.6 27.6 4.2 55.6 19.7 77.0 43.0 44.5 10.4 26.2 27.7 22.8 38.6 22.9 14.1 46.5 63.1 32.5 53.0 36.9 15.2 28.6 28.9 56.5 39.0 5.0 14.8 75.1 22.4 31.2 14.8 4.7 41.0 21.6 23.2 7.5 36.5 12.7 18.6 4.5 11.8 40.8 44.6 31.2 68.4 24.4 64.5 39.5 32.6 7.1 19.7 20.2 33.3 24.3 17.0 16.4 10.2 72.2 19.4 27.7 44.6 20.6 ADGRB1 BAI1 ENSG00000181790 "Adhesion G protein-coupled receptor B1" O14514 8 142449430-142545009 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 38.6" "Cell type enhanced" "Detected in some" "Astrocytes: 58.8;Excitatory neurons: 47.5;Horizontal cells: 126.2;Inhibitory neurons: 38.0;Oligodendrocyte precursor cells: 70.9" "Cancer enriched" "Detected in many" 5 "glioma: 11.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 12.1;MCF7: 4.6;NB-4: 6.1;RPMI-8226: 17.5;U-2 OS: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (9.57e-4)" "unprognostic (1.28e-1)" "unprognostic (3.87e-3)" "unprognostic (8.50e-3)" "unprognostic (9.98e-2)" "unprognostic (5.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.14e-2)" "unprognostic (2.76e-1)" "unprognostic (2.55e-1)" "unprognostic (6.48e-2)" "unprognostic (3.43e-1)" "unprognostic (7.30e-11)" "unprognostic (6.27e-2)" "unprognostic (7.42e-2)" "unprognostic (4.52e-3)" "unprognostic (3.29e-2)" 0.4 1.8 21.7 0.4 17.5 0.1 0.6 0.9 38.6 2.9 0.0 0.8 0.3 1.2 0.7 0.7 0.8 0.1 0.5 18.6 12.1 0.4 0.2 0.8 0.4 12.1 9.1 20.3 1.3 0.4 1.6 6.5 0.9 14.8 1.5 0.0 1.6 0.9 0.5 0.1 3.5 1.1 0.1 0.8 2.5 0.8 1.9 19.0 0.2 0.6 0.1 0.1 0.4 1.3 9.8 0.0 0.1 0.1 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.9 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 6.1 1.9 0.2 0.0 0.1 0.0 17.5 0.0 0.0 3.2 3.2 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 17.5 0.9 38.6 18.6 12.1 12.1 9.1 20.3 14.8 0.8 19.0 9.8 0.1 0.0 0.0 58.8 0.3 0.0 0.6 0.0 1.8 18.5 1.3 0.8 5.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 0.2 0.0 0.1 0.4 0.0 0.0 47.5 0.0 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.0 0.1 126.2 38.0 0.1 0.0 0.3 0.0 1.0 0.3 0.3 0.0 9.4 0.8 3.9 0.0 70.9 2.6 0.1 0.1 13.5 0.0 0.2 0.0 0.2 0.0 0.9 6.6 0.4 0.4 0.0 0.8 0.1 0.0 0.0 0.3 0.3 0.1 0.2 OR6S1 OR6S1Q ENSG00000181803 "Olfactory receptor family 6 subfamily S member 1" Q8NH40 14 20640696-20641691 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC9A9 "FLJ35613, NHE9" ENSG00000181804 "Solute carrier family 9 member A9" Q8IVB4 3 143265222-143848485 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 149.8;Inhibitory neurons: 159.5;Microglial cells: 396.3;Oligodendrocyte precursor cells: 272.9;Oligodendrocytes: 431.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;ASC TERT1: 24.9;HSkMC: 17.6;Karpas-707: 62.8;RPMI-8226: 30.4;U-266/70: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058234 Approved NA NA 280000 "HPA058234: AB_2683648" "unprognostic (8.22e-2)" "unprognostic (6.88e-2)" "unprognostic (7.23e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.18e-4)" "unprognostic (2.66e-1)" "unprognostic (1.35e-3)" "unprognostic (7.73e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (5.57e-7)" "unprognostic (5.01e-2)" "unprognostic (4.69e-2)" "unprognostic (1.56e-1)" "unprognostic (4.28e-2)" 12.9 5.1 9.5 8.8 13.2 2.0 5.3 12.4 11.4 7.0 8.5 6.3 3.0 4.2 3.7 12.9 6.9 9.7 4.2 9.6 15.3 2.3 7.2 5.9 14.8 20.2 13.2 7.4 8.0 1.1 3.0 3.4 16.1 18.3 8.9 5.9 1.3 4.5 8.6 2.1 7.7 7.1 8.0 13.6 13.2 5.0 1.8 12.6 15.6 3.6 5.0 13.6 11.5 7.7 17.9 0.5 0.5 0.8 1.0 19.3 24.9 0.3 1.0 6.6 0.5 3.1 0.0 0.2 3.0 0.2 2.9 1.5 0.7 0.9 1.9 0.8 12.8 0.2 1.6 0.4 0.0 2.2 0.8 1.3 17.6 5.2 0.7 0.9 1.1 0.3 2.3 0.0 62.8 4.2 0.0 1.5 0.0 0.2 0.0 0.5 2.6 0.1 30.4 0.0 0.5 0.4 0.0 1.5 0.0 0.0 0.4 0.2 0.6 0.0 2.4 0.6 2.8 1.4 29.1 0.1 0.1 4.3 0.4 1.2 0.2 6.2 0.7 4.7 10.6 4.0 3.3 4.9 7.5 8.4 3.7 2.7 4.0 0.5 4.2 9.0 0.6 9.3 4.8 9.5 13.2 12.4 11.4 9.6 15.3 20.2 13.2 7.4 18.3 13.6 12.6 17.9 4.5 0.0 1.1 149.8 13.2 3.7 10.4 8.7 22.8 0.2 0.6 1.3 1.5 0.0 3.4 3.7 2.1 0.5 10.4 0.0 0.0 1.0 4.8 0.8 10.1 4.4 0.0 9.9 25.6 0.2 0.5 26.5 7.1 0.8 0.0 0.7 21.8 0.0 55.4 0.0 159.5 0.0 6.1 30.5 9.9 4.4 9.3 31.0 7.2 396.3 24.3 2.8 13.4 272.9 431.8 0.8 0.1 7.2 10.9 11.1 0.0 0.4 1.6 0.1 0.0 18.0 7.0 0.3 0.4 23.9 5.1 1.1 19.7 3.7 0.1 3.9 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397908 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 35.8 33.0 53.1 32.3 52.5 24.1 33.1 54.0 68.1 32.1 54.2 50.5 20.3 36.6 30.7 27.0 31.9 22.9 71.6 53.0 56.5 42.4 52.1 30.9 52.7 54.5 54.1 51.8 31.9 30.8 37.3 42.1 18.1 54.9 41.2 17.9 9.8 29.4 30.8 166.4 29.1 37.0 28.2 54.8 55.8 39.0 29.1 55.7 27.4 31.3 111.3 48.0 43.2 28.5 55.0 54.6 81.2 29.9 80.7 68.9 67.2 31.0 47.9 69.4 75.1 57.1 36.4 50.6 127.4 64.5 65.0 55.6 29.3 51.2 62.1 49.5 87.1 61.2 64.1 47.1 87.1 83.8 49.0 90.3 56.8 54.4 67.6 47.6 40.7 77.8 71.7 60.2 60.5 53.4 96.3 54.8 55.5 77.5 67.0 83.3 40.9 28.8 86.3 73.6 32.6 38.1 28.7 38.7 49.4 120.6 47.9 25.5 41.3 52.2 34.0 47.3 90.0 76.0 79.5 115.7 102.4 68.4 73.9 78.7 240.2 264.1 340.1 125.3 266.4 139.0 386.4 125.1 132.0 189.4 388.0 112.1 120.7 346.4 111.6 256.4 243.9 172.3 301.8 53.1 52.5 54.0 68.1 53.0 56.5 54.5 54.1 51.8 54.9 54.8 55.7 55.0 27.8 12.8 14.4 3.9 82.2 32.2 37.2 53.3 13.1 17.4 40.9 44.4 55.9 21.5 30.4 46.0 6.2 56.1 58.5 23.4 140.8 40.7 9.7 18.6 32.7 31.7 28.2 40.2 8.6 47.1 58.8 36.8 19.4 23.3 41.2 25.7 32.2 66.8 105.7 18.5 9.1 23.4 63.1 77.0 89.3 32.9 38.8 67.6 51.6 7.5 72.0 41.0 66.9 3.5 6.7 47.4 35.3 47.0 67.0 40.3 47.7 106.4 12.4 14.3 13.1 28.4 38.8 7.8 23.4 27.7 40.1 40.0 51.0 43.3 28.5 27.3 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.2" "Cell type enhanced" "Detected in many" "Adipocytes: 30.5;Microglial cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 59.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 13.6 2.4 14.4 4.9 15.0 25.9 7.9 21.0 15.1 5.2 11.2 8.4 6.3 5.5 2.8 6.4 5.1 6.2 6.0 9.0 23.8 3.9 4.9 6.7 4.8 28.0 20.3 6.4 3.5 2.3 1.5 1.5 6.2 25.8 3.0 6.6 3.2 3.6 3.8 15.9 12.5 5.5 6.0 31.6 7.4 12.4 1.6 20.6 3.8 12.6 4.4 4.9 7.9 4.1 44.2 4.8 5.1 12.9 11.1 10.8 6.2 10.8 8.0 6.9 5.5 7.2 16.8 5.7 1.3 5.7 6.9 9.8 4.3 4.1 7.2 9.6 0.2 2.1 1.8 4.7 18.2 8.1 6.0 4.5 10.6 10.2 7.5 8.2 3.4 24.9 3.3 3.1 5.0 6.4 4.4 7.5 8.3 3.2 6.9 1.5 2.5 45.0 2.2 13.2 5.9 2.9 8.5 6.1 6.6 10.6 3.2 18.0 3.2 29.6 13.8 8.7 10.1 9.5 2.5 2.6 7.3 11.7 12.8 11.4 0.8 15.2 27.4 5.1 5.7 6.3 0.7 6.2 4.9 8.5 0.2 5.3 7.0 59.3 7.7 5.5 9.8 5.5 5.1 14.4 15.0 21.0 15.1 9.0 23.8 28.0 20.3 6.4 25.8 31.6 20.6 44.2 30.5 9.6 3.1 16.3 2.9 3.3 2.5 1.7 10.8 0.4 8.1 9.5 2.1 5.7 3.9 0.0 0.0 1.4 9.8 8.4 0.0 3.1 6.5 5.5 9.9 14.4 1.2 3.4 3.3 8.6 3.6 10.7 22.4 2.4 2.5 0.5 6.4 0.9 2.6 3.3 2.4 1.6 0.0 3.2 2.7 8.1 3.7 9.2 1.8 36.5 4.1 4.0 0.0 22.6 12.5 10.3 2.9 6.0 15.5 2.7 6.7 0.2 3.3 1.4 13.1 18.8 16.4 0.8 0.3 5.5 4.7 5.2 10.6 5.1 1.1 3.8 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56245082 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035462, HPA057957" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152, HPA057957: " "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 3.4 6.0 3.3 5.6 3.4 8.6 5.2 11.6 4.0 5.2 1.5 4.0 5.3 5.6 5.3 4.7 5.7 4.1 3.2 3.2 3.4 3.6 4.0 4.8 8.9 3.4 3.9 2.8 6.4 3.3 5.7 2.7 5.4 4.8 4.7 5.1 11.1 3.8 5.4 8.9 10.0 4.6 5.8 2.3 7.5 4.8 8.8 3.7 15.4 5.2 9.9 9.4 5.7 2.9 4.2 7.7 15.6 31.3 22.0 11.0 13.9 7.6 6.6 9.1 8.3 13.1 8.4 6.3 24.0 9.7 9.9 7.7 20.9 18.7 14.7 11.1 13.3 6.6 31.5 19.0 17.6 11.6 24.1 4.6 12.0 21.7 9.0 19.5 12.2 14.7 24.1 14.2 12.7 11.9 9.8 21.3 6.9 13.4 5.9 4.5 23.1 20.0 19.8 9.2 24.0 16.4 18.8 8.2 8.3 9.4 21.5 7.1 15.3 11.9 21.8 11.3 5.1 13.2 10.2 11.4 27.6 7.8 22.2 9.7 2.0 0.2 0.5 0.5 0.3 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.6 0.0 0.5 0.2 0.5 1.1 0.3 3.3 3.4 11.6 4.0 3.2 3.4 3.4 3.9 2.8 4.8 2.3 3.7 4.2 8.6 6.4 13.4 108.4 9.7 13.4 4.4 9.5 20.5 16.2 9.9 7.5 6.5 2.8 6.2 7.3 10.4 4.2 7.3 5.3 3.9 3.4 19.9 7.2 10.3 9.4 4.8 17.1 149.4 4.7 1.4 6.8 4.6 6.4 12.6 14.2 7.9 8.9 5.6 16.8 164.0 5.7 10.2 9.5 8.8 15.9 6.5 8.8 5.4 91.8 8.4 5.1 2.1 187.0 169.7 3.7 6.0 10.5 7.9 6.6 4.3 4.2 8.5 9.1 0.0 13.2 7.0 6.6 6.8 16.8 17.6 1.6 9.0 10.6 6.8 5.6 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813016 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 85.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 25.7 7.3 6.7 10.8 6.2 2.4 20.0 6.5 6.7 9.6 5.6 20.0 24.6 8.9 2.4 41.8 7.4 12.4 8.3 5.8 6.7 7.0 85.2 10.3 6.6 7.7 7.3 5.0 6.4 13.5 5.6 10.4 15.1 7.2 10.0 14.4 1.6 26.3 6.0 6.8 4.9 24.3 10.0 6.0 8.4 18.7 5.2 8.4 4.5 6.7 7.0 10.1 13.9 15.0 7.4 10.3 25.8 6.3 16.3 19.9 19.8 19.5 22.1 20.1 13.3 14.4 10.7 15.2 10.4 9.9 27.3 19.4 26.0 13.4 13.6 6.5 24.8 14.5 5.9 20.4 20.6 42.6 11.4 16.2 23.8 16.3 9.2 11.1 16.2 17.6 10.3 13.3 13.8 14.4 21.8 5.9 9.0 27.5 39.9 34.6 7.2 10.5 21.5 15.1 25.4 6.0 8.6 16.6 16.3 9.5 6.6 13.7 6.0 25.7 25.0 14.7 46.1 15.6 9.8 26.9 4.9 18.5 14.4 14.2 9.7 11.6 12.5 11.0 11.9 12.3 5.0 18.0 14.7 9.6 3.7 9.3 8.0 1.8 5.6 8.7 8.2 13.0 10.1 6.7 6.2 6.5 6.7 5.8 6.7 7.7 7.3 5.0 7.2 6.0 8.4 7.4 5.5 0.0 11.2 2.6 6.2 3.6 8.9 12.7 3.4 1.9 11.1 3.0 50.6 22.8 26.7 5.5 2.1 13.8 6.4 54.6 0.0 18.4 4.9 7.3 6.7 10.6 9.6 3.6 2.0 41.9 14.0 10.5 23.4 11.4 2.5 5.2 6.8 42.2 14.7 3.3 2.1 40.6 4.1 9.3 4.8 6.0 6.5 6.3 1.8 2.8 9.5 2.8 7.2 1.0 2.1 50.6 54.0 5.7 13.6 11.8 58.0 4.7 11.4 1.1 0.0 3.6 9.7 4.0 4.3 12.7 2.4 15.3 6.5 5.7 26.4 20.1 TIGIT "DKFZp667A205, FLJ39873, VSIG9, VSTM3" ENSG00000181847 "T cell immunoreceptor with Ig and ITIM domains" Q495A1 3 114276913-114310288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 39.0" "Group enriched" "Detected in some" 10 "dendritic cells: 64.2;NK-cells: 69.0;T-cells: 78.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 195.5" "Lineage enriched" "Detected in many" 11 "T-cells: 195.5" "Cell line enhanced" "Detected in single" "HDLM-2: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.24e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.22e-3)" "unprognostic (2.22e-6)" "unprognostic (9.84e-2)" "prognostic favorable (3.96e-4)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (5.50e-4)" "unprognostic (3.51e-3)" "unprognostic (1.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.30e-8)" "unprognostic (3.54e-2)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (6.18e-3)" 0.6 0.3 0.4 12.2 0.5 2.1 0.7 0.4 0.4 0.8 0.1 2.1 1.7 0.9 0.7 2.1 0.5 3.7 0.8 0.3 0.3 0.4 2.9 2.9 39.0 0.6 0.3 0.1 0.5 0.2 0.1 0.2 0.3 0.5 1.5 2.5 0.3 1.8 0.2 0.1 1.0 5.2 0.9 0.4 15.1 3.7 0.8 0.3 9.0 0.9 0.0 20.6 5.1 0.5 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.5 0.0 0.2 0.1 0.0 0.4 0.2 0.1 29.8 0.2 3.5 1.4 48.5 90.3 0.2 0.9 5.2 39.8 0.7 17.3 0.2 1.0 195.5 22.0 0.4 0.5 0.4 0.4 0.3 0.3 0.6 0.3 0.1 0.5 0.4 0.3 0.8 0.9 0.0 3.3 0.0 3.7 3.1 0.1 0.0 0.6 0.4 0.4 0.6 0.6 0.0 1.3 0.0 2.1 0.1 64.2 0.0 0.0 0.0 0.0 0.2 1.0 0.6 0.0 0.4 0.0 0.0 0.0 0.9 2.6 0.4 1.3 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 1.8 4.2 0.3 0.0 2.3 3.6 0.0 0.9 0.1 69.0 0.0 0.1 0.0 0.0 0.0 6.9 0.2 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.7 3.0 0.2 3.3 0.0 78.4 0.0 0.2 0.0 RNF41 "NRDP1, SBBI03" ENSG00000181852 "Ring finger protein 41" Q9H4P4 12 56202179-56221933 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016812 Approved Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA "Nucleoplasm, Nuclear bodies" "Midbody ring" "HPA016812: AB_1856370" "unprognostic (1.14e-2)" "unprognostic (6.30e-2)" "unprognostic (4.04e-2)" "unprognostic (6.86e-2)" "unprognostic (9.59e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (6.93e-2)" "unprognostic (4.18e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.64e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" 32.5 24.8 18.7 18.2 23.0 19.8 21.6 15.5 23.3 21.4 12.2 21.1 12.5 22.5 13.3 23.3 24.6 25.7 33.0 22.4 23.8 19.9 15.2 24.0 23.6 16.5 19.1 21.3 23.1 23.2 27.6 23.0 21.5 19.2 34.2 19.2 24.0 15.1 20.9 34.4 14.6 16.2 28.8 14.9 20.8 17.1 16.0 23.0 26.8 28.9 41.2 25.3 28.5 17.2 21.5 21.6 32.6 34.7 55.2 71.0 51.3 25.8 70.8 69.5 62.2 50.2 40.0 27.6 41.6 36.7 60.2 20.6 24.3 47.4 34.1 44.9 43.8 25.7 55.8 22.3 23.2 148.3 61.6 58.3 66.0 78.6 52.0 91.0 81.7 61.3 34.5 40.4 41.3 35.1 34.9 35.6 27.6 41.9 21.6 37.8 38.2 24.9 25.3 33.3 31.3 62.9 38.1 61.9 35.0 55.4 34.3 49.2 71.3 37.3 31.3 32.9 40.6 27.8 29.6 36.6 37.5 37.2 36.4 38.0 59.1 27.2 99.9 27.6 26.7 24.9 50.3 23.0 24.3 30.6 55.1 23.4 24.0 36.2 33.1 28.3 23.7 29.4 31.0 18.7 23.0 15.5 23.3 22.4 23.8 16.5 19.1 21.3 19.2 14.9 23.0 21.5 18.9 44.8 22.6 11.1 42.2 12.0 19.9 8.6 19.9 30.7 22.2 21.1 24.6 24.3 18.8 16.5 22.9 15.2 17.0 10.2 17.6 15.3 92.8 13.9 14.2 20.7 20.4 11.1 15.0 21.3 18.5 22.7 9.7 14.2 25.9 16.8 30.0 16.7 19.3 28.6 15.7 13.9 8.2 34.9 22.7 58.0 23.0 25.0 7.2 9.4 33.5 26.2 15.5 14.6 12.3 20.8 20.3 25.9 14.6 33.5 12.3 19.6 18.0 18.3 26.3 23.2 27.4 10.4 14.2 14.4 16.6 16.8 16.6 17.1 14.3 23.1 SLC2A4 GLUT4 ENSG00000181856 "Solute carrier family 2 member 4" P14672 17 7281718-7288257 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 75.8;skeletal muscle: 225.5" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 135.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "Hep G2: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" CAB016544 Enhanced NA NA "CAB016544: AB_629533" "unprognostic (2.53e-1)" "unprognostic (7.40e-3)" "unprognostic (2.27e-1)" "unprognostic (8.12e-4)" "unprognostic (2.40e-1)" "unprognostic (6.28e-2)" "unprognostic (1.70e-2)" "unprognostic (1.66e-2)" "unprognostic (1.35e-1)" "unprognostic (3.83e-2)" "unprognostic (9.66e-2)" "unprognostic (2.24e-2)" "unprognostic (1.34e-3)" "unprognostic (4.23e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-2)" "unprognostic (2.07e-2)" 14.9 5.2 1.4 0.2 1.4 1.1 11.3 0.9 1.5 8.4 0.9 37.4 0.8 9.4 1.2 5.9 11.4 0.7 75.8 1.2 1.2 2.5 3.8 2.1 0.2 1.2 1.4 1.0 3.2 0.8 3.4 4.4 0.6 1.6 9.9 1.1 0.4 6.3 3.3 225.5 3.7 9.8 4.4 0.9 0.3 11.8 3.3 1.2 0.1 4.6 63.8 0.0 27.2 5.6 1.1 0.0 0.0 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.4 0.9 1.5 1.2 1.2 1.2 1.4 1.0 1.6 0.9 1.2 1.1 1.7 0.0 0.0 1.0 0.0 1.8 0.9 0.3 2.2 0.1 1.5 1.3 135.2 0.0 0.2 0.0 0.0 0.3 0.0 1.0 7.9 0.1 16.6 0.2 0.1 3.7 0.0 10.7 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.3 1.8 2.8 0.1 0.0 0.0 0.8 0.0 0.3 0.3 4.8 0.0 0.1 7.2 1.0 0.0 6.0 0.0 0.0 0.0 0.1 1.2 8.6 0.0 0.8 0.8 0.3 0.4 0.4 32.9 7.0 19.8 1.7 2.2 0.5 1.1 1.0 0.1 0.5 1.0 0.7 FTMT MtF ENSG00000181867 "Ferritin mitochondrial" Q8N4E7 5 121851882-121852833 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Iron storage" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 546 "testis: 54.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 761.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 761.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.2 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 27.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 IBA57 "C1orf69, FLJ12734" ENSG00000181873 "Iron-sulfur cluster assembly factor IBA57" Q5T440 1 228165804-228182257 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Heme biosynthesis" Transferase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030555, HPA030556, HPA030557" Approved Supported Mitochondria NA NA Mitochondria "HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433" "unprognostic (3.00e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-1)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "unprognostic (8.16e-3)" "unprognostic (1.03e-1)" "unprognostic (6.11e-2)" "unprognostic (7.01e-2)" "unprognostic (8.00e-3)" "unprognostic (2.87e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.71e-9)" "unprognostic (4.94e-2)" "unprognostic (5.02e-1)" "unprognostic (5.04e-3)" "unprognostic (7.14e-2)" 2.0 2.8 2.4 1.4 2.4 4.2 1.4 2.8 2.4 1.3 2.1 1.7 1.7 1.8 0.5 1.7 1.3 1.0 3.0 2.1 2.0 2.1 2.8 1.9 1.6 2.7 2.3 1.8 1.9 2.9 2.2 0.9 1.4 2.5 1.2 1.4 0.5 1.7 1.0 6.1 3.0 1.7 1.7 2.1 1.7 2.0 1.1 2.7 1.3 1.3 4.0 1.7 1.3 1.2 3.5 2.5 2.5 2.7 1.2 1.3 1.4 3.3 1.5 0.7 1.1 0.6 5.3 2.1 5.3 3.1 1.6 0.6 4.4 2.0 3.2 1.0 1.1 4.5 3.1 3.5 2.6 1.1 3.7 3.5 2.2 1.8 1.3 1.5 1.0 1.6 3.2 5.4 2.4 1.1 2.0 3.6 2.2 2.0 3.4 2.8 4.4 3.1 2.4 1.6 5.1 4.1 2.8 2.4 7.5 1.9 0.5 6.0 4.9 3.8 3.0 2.8 2.1 3.7 1.8 0.9 2.6 1.4 1.6 2.3 1.6 0.4 0.2 0.6 0.4 1.0 0.4 0.5 0.5 0.3 0.7 0.7 0.7 0.5 0.8 0.4 1.0 0.5 0.2 2.4 2.4 2.8 2.4 2.1 2.0 2.7 2.3 1.8 2.5 2.1 2.7 3.5 5.7 9.6 11.0 4.2 10.2 8.2 8.8 3.9 2.8 5.8 5.6 5.6 15.3 8.6 9.2 0.0 12.5 10.7 5.0 14.5 7.9 5.4 22.2 5.2 6.0 8.8 7.2 49.3 3.8 6.9 8.6 5.2 5.1 10.3 15.2 6.7 5.3 7.9 5.5 3.3 4.1 8.0 4.1 4.4 6.4 30.7 3.7 6.0 7.2 6.5 4.2 4.4 4.1 3.0 5.8 8.8 6.3 7.2 5.8 6.3 9.4 6.7 3.2 19.5 6.6 9.7 4.7 14.9 11.2 4.4 6.0 16.3 7.2 8.3 11.9 8.3 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 344.1;intestine: 250.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1391.1;Pancreatic endocrine cells: 822.1;Paneth cells: 1276.4;Proximal enterocytes: 1390.9;Urothelial cells: 975.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 84.1;CACO-2: 90.2;CAPAN-2: 173.2;HaCaT: 364.9;MCF7: 129.8;OE19: 139.6;SK-BR-3: 150.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favorable (8.96e-11)" "prognostic favorable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favorable (1.85e-4)" "unprognostic (1.62e-1)" 6.7 8.1 0.4 17.8 0.5 0.2 31.5 0.6 0.6 29.6 0.5 192.9 148.0 4.8 44.3 344.1 41.6 27.6 2.6 0.4 0.6 100.9 40.5 62.3 0.9 0.7 0.5 0.3 1.5 109.4 49.4 31.3 14.3 0.6 44.9 129.8 1.1 170.6 30.3 1.5 12.2 250.9 6.3 0.6 5.7 5.2 1.9 0.6 2.4 77.3 0.0 21.4 40.9 97.1 0.7 10.8 1.1 0.2 0.3 0.0 0.6 84.1 0.3 0.3 0.0 0.0 90.2 173.2 0.1 3.2 0.4 0.4 364.9 0.1 11.2 0.0 0.1 1.9 0.1 2.4 0.0 6.5 0.1 0.8 1.5 17.3 0.0 0.6 0.0 8.1 0.1 1.0 0.3 0.1 129.8 0.1 1.2 0.6 139.6 3.4 0.2 0.0 2.5 0.1 0.0 20.4 0.4 1.1 150.2 0.0 6.6 55.0 1.3 16.8 0.2 0.6 0.7 0.2 0.1 0.3 0.1 1.2 0.0 0.3 0.0 0.3 0.0 0.5 0.8 1.3 0.1 0.3 0.8 0.4 0.9 0.9 1.7 0.0 0.7 0.0 0.0 0.3 0.5 0.4 0.5 0.6 0.6 0.4 0.6 0.7 0.5 0.3 0.6 0.6 0.6 0.7 4.4 112.2 55.6 0.0 7.4 2.0 295.4 316.3 66.6 0.7 200.4 102.4 0.6 240.2 550.3 321.8 8.4 281.3 3.1 1391.1 39.2 787.5 0.1 210.1 26.6 9.0 326.8 4.0 0.0 790.0 342.7 5.2 15.3 225.5 5.7 0.1 3.6 41.2 33.7 0.0 0.0 741.7 362.2 4.1 6.4 0.2 1.2 11.0 24.9 1.9 11.0 1.6 0.0 0.0 0.0 822.1 1276.4 0.0 0.5 406.5 1390.9 78.6 498.5 6.7 0.0 0.2 38.6 0.4 3.5 366.1 2.6 588.9 10.2 1.0 691.9 975.8 ZNF329 FLJ12586 ENSG00000181894 "Zinc finger protein 329" Q86UD4 19 58126248-58155110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044373, HPA077958" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044373: AB_10966569, HPA077958: " "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (6.01e-2)" "unprognostic (2.58e-1)" "unprognostic (6.53e-3)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "prognostic favorable (8.58e-9)" "unprognostic (9.23e-2)" "unprognostic (1.37e-2)" "unprognostic (1.78e-2)" "unprognostic (2.52e-1)" 3.9 3.9 4.7 2.7 5.0 6.4 6.1 6.2 6.0 5.2 5.1 3.9 1.6 5.2 5.2 2.9 5.3 2.8 4.2 4.6 4.5 6.1 4.9 3.5 3.9 4.7 4.8 4.9 5.6 3.1 9.0 5.3 4.1 4.6 5.0 3.0 8.5 3.4 4.5 1.4 4.2 3.6 5.0 3.5 4.6 3.6 7.7 4.6 5.8 5.8 3.2 4.0 4.8 3.9 6.0 3.6 1.9 8.6 15.3 6.6 6.9 0.1 4.9 10.2 4.8 3.5 1.0 2.8 2.3 2.5 8.8 3.1 1.2 1.3 6.7 5.9 1.8 11.7 7.7 2.5 2.8 6.5 4.6 6.9 7.4 7.1 5.0 10.3 8.1 6.9 5.5 1.8 10.0 7.4 1.0 7.9 2.8 6.5 2.0 6.3 4.4 8.4 2.4 5.6 7.4 5.6 5.4 7.0 0.9 3.9 10.9 8.7 2.5 3.7 13.3 3.6 1.1 0.0 5.7 18.5 5.8 2.8 0.1 7.8 3.1 0.9 4.1 1.4 1.0 2.5 4.1 2.7 2.4 1.2 4.8 4.4 2.6 2.8 3.5 0.7 3.0 1.3 1.4 4.7 5.0 6.2 6.0 4.6 4.5 4.7 4.8 4.9 4.6 3.5 4.6 6.0 4.2 3.2 0.5 7.2 5.2 1.7 2.1 1.7 2.8 12.5 3.4 3.2 6.9 7.2 2.8 3.7 6.2 2.2 3.4 0.9 1.9 2.9 2.2 4.6 5.1 4.6 2.4 5.2 14.5 1.6 1.2 3.1 1.5 3.5 2.5 6.2 3.9 3.7 1.5 8.4 13.5 1.6 0.0 2.1 2.1 2.0 2.8 1.7 0.0 4.7 0.5 5.7 5.2 11.6 9.5 0.9 1.3 1.5 1.0 1.9 0.9 2.5 2.0 10.0 0.0 3.9 3.6 7.6 6.7 1.3 1.6 1.5 4.4 4.0 1.3 1.7 ZNF101 "DKFZp570I0164, HZF12" ENSG00000181896 "Zinc finger protein 101" Q8IZC7 19 19668796-19683509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.8" "Cell type enhanced" "Detected in many" "NK-cells: 24.7;T-cells: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 82.5" "HPA023449, HPA055486" Uncertain NA NA "HPA023449: AB_2671211, HPA055486: AB_2682831" "unprognostic (5.05e-2)" "prognostic favorable (5.76e-5)" "unprognostic (1.68e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.15e-4)" "unprognostic (2.43e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.62e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.34e-3)" "unprognostic (1.63e-2)" "unprognostic (8.84e-3)" "prognostic favorable (1.11e-4)" "unprognostic (3.15e-2)" "unprognostic (7.02e-2)" "prognostic favorable (4.37e-4)" 3.1 2.1 2.2 13.2 2.3 13.3 6.3 2.9 3.6 3.2 2.3 4.8 3.3 2.3 2.8 6.9 2.4 2.6 2.2 2.3 1.9 3.4 3.1 3.5 27.8 2.3 2.1 2.1 1.8 2.4 2.0 1.9 3.3 2.6 2.3 4.6 4.3 3.1 1.9 1.7 3.8 8.2 2.1 1.7 11.1 4.7 10.7 2.4 25.6 3.1 1.3 24.9 5.7 3.0 3.0 6.0 5.5 6.7 8.7 2.5 4.5 13.3 7.0 3.8 5.3 9.2 6.9 7.8 35.5 7.5 3.7 5.6 5.6 11.8 7.1 10.7 4.7 6.2 11.2 5.1 11.0 2.0 20.9 18.7 3.5 4.0 9.7 7.1 3.2 6.7 25.7 8.1 19.8 6.5 7.2 27.4 6.8 18.8 6.2 8.6 10.3 8.9 16.0 5.5 10.1 3.4 4.1 8.0 5.1 2.5 8.3 7.7 12.0 5.3 7.5 2.9 11.6 7.2 9.5 18.8 82.5 4.4 11.2 7.2 16.4 4.3 7.7 12.8 5.9 23.2 13.8 30.9 20.3 6.4 15.6 43.3 32.3 6.0 11.1 7.4 10.1 61.2 16.0 2.2 2.3 2.9 3.6 2.3 1.9 2.3 2.1 2.1 2.6 1.7 2.4 3.0 6.0 12.8 6.8 2.0 18.2 2.5 2.2 4.1 1.2 7.3 5.0 3.8 2.8 1.5 4.3 9.2 6.2 5.6 9.8 5.1 3.9 4.5 12.7 2.9 2.7 6.5 3.0 4.2 3.1 6.6 5.1 2.5 2.6 3.6 6.3 4.0 5.7 3.1 6.8 1.7 3.0 3.7 0.0 9.7 3.5 9.9 2.8 5.7 3.6 1.0 8.8 3.5 24.7 4.0 3.6 5.5 4.6 1.5 13.9 2.9 4.3 2.9 5.8 11.5 0.0 3.3 2.7 13.0 8.6 1.8 2.3 2.1 23.8 2.5 2.7 3.3 OR4C6 ENSG00000181903 "Olfactory receptor family 4 subfamily C member 6" Q8NH72 11 55662201-55666195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 4.2;Karpas-707: 4.4" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C5orf24 FLJ37562 ENSG00000181904 "Chromosome 5 open reading frame 24" Q7Z6I8 5 134845680-134859735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057749, HPA062502" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA057749: AB_2683515, HPA062502: AB_2684785" "unprognostic (8.10e-2)" "unprognostic (1.59e-1)" "unprognostic (8.33e-3)" "unprognostic (2.03e-1)" "unprognostic (2.72e-2)" "unprognostic (9.45e-2)" "unprognostic (3.27e-2)" "unprognostic (3.31e-2)" "unprognostic (1.72e-2)" "unprognostic (2.04e-1)" "unprognostic (1.54e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (6.55e-2)" "unprognostic (2.37e-1)" "unprognostic (5.04e-2)" "unprognostic (4.75e-2)" 24.3 26.2 23.4 17.9 26.9 25.2 20.4 32.4 30.6 20.4 22.7 19.2 22.3 29.2 16.0 21.2 17.6 21.5 19.7 24.1 23.9 41.4 43.6 23.1 16.4 24.3 25.1 23.3 20.2 13.3 27.0 15.5 28.8 25.5 21.7 18.6 19.4 18.5 18.5 21.7 19.3 17.3 26.9 25.7 16.8 16.3 12.5 25.3 15.1 30.0 26.9 14.7 22.4 16.9 29.3 26.0 21.5 43.8 63.7 53.0 62.3 15.7 54.7 38.5 29.6 35.3 28.7 29.0 24.0 46.4 39.1 37.6 17.3 25.0 37.9 51.3 18.0 35.3 27.1 50.4 33.9 40.1 11.8 30.8 51.6 45.0 42.9 48.9 59.5 55.2 39.5 19.0 29.1 64.7 14.8 26.0 20.4 9.8 16.1 21.8 29.4 41.6 27.4 75.4 23.9 27.0 51.5 56.7 15.0 82.2 19.4 30.8 38.1 61.4 59.4 25.7 43.8 39.5 30.3 23.2 30.3 43.6 33.2 44.9 4.5 9.0 9.6 5.5 6.9 4.4 6.7 3.7 4.5 7.8 6.4 6.9 4.3 1.7 5.5 5.7 10.5 4.9 4.2 23.4 26.9 32.4 30.6 24.1 23.9 24.3 25.1 23.3 25.5 25.7 25.3 29.3 71.8 86.6 34.1 21.2 44.1 43.1 34.7 50.0 56.9 47.2 64.3 56.8 33.2 64.3 34.8 106.7 37.5 33.4 45.9 26.4 58.7 52.0 18.6 33.0 85.6 83.6 53.9 45.0 31.1 43.7 35.4 60.1 27.0 48.2 21.5 48.0 78.1 94.4 32.2 69.0 33.9 32.4 28.5 33.6 47.9 10.8 70.5 33.3 64.0 22.5 40.3 28.2 68.0 22.6 44.3 83.9 34.7 71.5 32.3 44.7 42.4 132.8 29.1 45.9 72.3 61.3 88.0 66.9 44.6 67.8 49.3 22.2 37.6 34.6 35.0 25.0 ADO "C10orf22, FLJ14547" ENSG00000181915 "2-aminoethanethiol dioxygenase" Q96SZ5 10 62804720-62808479 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 186.2;Late spermatids: 317.6;Spermatocytes: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "PC-3: 99.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039194, HPA040437" Approved NA NA "HPA039194: AB_10794994, HPA040437: AB_10795633" "unprognostic (4.41e-2)" "unprognostic (1.44e-1)" "unprognostic (9.25e-2)" "unprognostic (1.73e-2)" "unprognostic (1.54e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.01e-5)" "unprognostic (4.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (4.24e-2)" "unprognostic (8.64e-2)" "unprognostic (8.68e-2)" "unprognostic (4.11e-2)" "unprognostic (7.46e-2)" "unprognostic (2.64e-1)" "unprognostic (4.59e-2)" 8.9 8.5 14.0 7.7 17.9 5.1 9.3 20.7 17.7 8.4 8.8 7.2 7.0 8.8 13.2 6.8 7.1 7.4 14.6 13.2 15.2 11.4 7.4 7.7 10.0 19.4 19.3 13.0 10.6 8.0 12.5 4.0 7.3 18.5 9.8 6.4 10.6 6.4 8.9 11.8 6.1 6.5 9.4 22.0 8.5 7.4 37.9 17.2 9.0 12.1 17.5 10.0 8.7 5.0 30.2 14.3 10.3 20.1 33.2 21.6 16.3 11.9 17.3 20.5 18.2 19.7 16.2 11.2 13.3 8.9 17.8 14.4 21.6 21.0 13.3 19.3 18.3 15.8 9.1 10.8 13.7 22.3 31.3 22.8 14.0 25.3 19.1 30.7 27.8 14.0 17.3 16.8 12.5 24.4 13.6 20.5 30.5 18.7 13.7 99.1 23.9 16.1 8.2 17.6 9.0 20.9 34.3 17.4 23.8 36.4 16.1 15.5 21.5 12.1 18.3 18.9 15.0 29.0 22.8 44.8 21.1 22.2 32.8 12.0 0.8 0.8 0.2 0.4 1.3 0.8 1.3 0.5 0.6 0.9 0.8 0.4 0.8 0.0 0.8 0.9 0.6 0.3 0.4 14.0 17.9 20.7 17.7 13.2 15.2 19.4 19.3 13.0 18.5 22.0 17.2 30.2 7.6 9.6 7.3 3.9 7.2 15.9 11.9 4.3 9.6 23.4 9.9 7.1 32.2 5.7 4.3 14.7 6.2 9.1 8.5 5.3 19.6 6.6 186.2 2.7 13.2 9.0 4.9 4.0 9.5 5.3 7.9 11.5 8.2 4.4 2.5 9.2 10.8 3.7 12.7 32.0 7.8 6.8 0.0 11.9 13.3 317.6 10.5 10.9 12.4 3.7 11.3 12.5 7.2 6.0 22.4 7.5 3.4 26.7 3.2 12.1 4.8 15.8 5.6 17.7 13.1 13.0 11.7 90.5 8.4 9.4 21.7 3.8 8.9 12.5 8.4 10.8 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favorable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 39.8 97.0 43.6 37.2 48.4 25.6 39.4 48.3 52.4 36.6 43.3 45.0 49.4 36.1 32.8 48.4 40.5 40.7 63.7 42.9 50.9 70.9 100.5 31.6 47.7 48.5 47.5 40.6 38.1 46.9 50.1 34.4 38.0 47.7 45.5 42.6 15.9 43.1 36.5 72.8 32.2 50.1 32.7 47.6 37.4 41.9 31.9 47.0 32.6 56.2 56.4 36.3 55.1 37.7 54.2 106.4 201.9 80.2 119.0 70.6 86.6 79.3 107.4 75.5 126.0 107.2 147.4 132.5 91.3 214.7 90.2 99.9 105.7 124.2 146.1 98.3 120.6 115.1 156.3 118.1 141.8 130.5 107.2 115.0 109.4 136.1 207.0 136.6 70.9 120.0 87.0 135.3 87.5 118.3 210.8 83.7 168.1 104.3 422.7 205.9 96.2 174.3 244.0 137.5 101.3 72.5 121.3 99.0 110.7 295.3 78.8 162.3 108.0 83.8 102.8 91.7 212.9 142.8 103.3 125.1 313.1 57.0 132.0 121.4 18.5 49.6 12.7 35.9 52.2 47.0 58.1 42.0 37.8 61.1 48.5 44.6 48.2 3.4 43.1 51.4 80.2 47.7 38.6 43.6 48.4 48.3 52.4 42.9 50.9 48.5 47.5 40.6 47.7 47.6 47.0 54.2 48.9 35.3 36.0 6.8 48.6 53.5 75.7 89.7 47.8 19.5 64.3 86.1 66.7 85.8 55.5 55.2 22.9 168.8 36.7 97.8 129.1 89.2 37.3 77.2 90.9 49.7 72.6 68.3 3.6 94.9 111.3 54.2 69.3 72.0 62.1 83.9 33.2 184.1 97.5 18.5 5.8 98.6 28.5 44.8 34.2 13.3 55.0 44.7 28.4 2.8 55.2 67.5 49.4 8.5 18.8 98.2 85.1 38.4 47.3 139.5 174.2 266.2 47.1 18.5 6.6 81.6 51.0 78.7 34.2 86.3 51.3 122.3 39.9 150.7 121.2 98.7 OR4P4 OR4P3P ENSG00000181927 "Olfactory receptor family 4 subfamily P member 4" Q8NGL7 11 55635113-55640309 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059458 Uncertain NA NA "HPA059458: AB_2684027" 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRKAG1 ENSG00000181929 "Protein kinase AMP-activated non-catalytic subunit gamma 1" P54619 12 49002274-49018807 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 339.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077805: AB_2686855" "unprognostic (3.24e-2)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.45e-1)" "unprognostic (4.68e-2)" "unprognostic (1.93e-2)" "unprognostic (5.35e-2)" "unprognostic (8.49e-2)" "prognostic favorable (1.83e-4)" "unprognostic (3.40e-1)" "unprognostic (2.57e-1)" "unprognostic (1.97e-2)" "unprognostic (5.57e-2)" 42.4 54.9 38.3 30.0 42.3 47.8 51.0 42.5 48.3 37.9 43.9 41.1 32.9 33.2 59.6 44.6 33.7 31.6 78.3 39.9 40.5 50.9 49.8 31.1 39.0 36.8 36.1 38.7 25.9 37.7 59.6 34.2 35.4 38.4 38.0 48.3 42.6 36.4 40.3 123.7 42.3 30.2 45.2 34.6 28.8 33.8 33.8 37.5 42.1 38.1 113.4 51.2 40.4 31.0 42.7 79.8 45.8 50.5 76.3 157.8 141.6 33.2 85.5 117.4 84.4 55.7 50.9 66.1 50.4 72.9 98.9 53.9 65.4 42.5 115.6 80.4 69.6 57.1 70.4 66.5 34.2 120.2 97.7 54.6 110.0 94.6 65.9 141.4 123.6 90.3 67.6 60.1 70.0 108.6 52.8 45.8 31.5 29.1 339.6 96.8 24.1 53.3 59.7 114.0 67.6 42.1 57.7 61.0 99.1 142.5 39.7 134.1 49.5 72.5 44.4 52.3 87.7 63.5 109.1 113.3 36.0 89.3 69.9 34.5 87.3 59.8 59.9 53.0 58.7 50.0 51.9 46.1 47.6 68.7 51.3 41.3 43.0 70.9 71.8 56.0 45.2 66.8 73.0 38.3 42.3 42.5 48.3 39.9 40.5 36.8 36.1 38.7 38.4 34.6 37.5 42.7 20.2 9.6 22.7 16.6 31.2 20.0 30.3 64.5 11.4 29.2 24.3 20.8 49.8 18.6 29.9 36.8 37.5 65.6 30.5 24.5 76.3 48.3 11.3 11.4 21.3 21.9 21.0 30.3 18.1 46.4 57.7 26.7 15.8 12.9 21.5 31.4 30.4 23.2 52.2 15.2 24.1 31.6 63.1 36.2 26.5 15.7 36.7 26.7 37.4 9.4 55.5 41.6 55.6 23.1 21.1 47.8 16.5 27.1 25.0 24.2 38.6 69.3 19.2 30.1 19.7 18.5 27.5 49.3 43.9 19.1 26.0 67.0 26.3 33.6 32.2 23.6 GINS3 "FLJ13912, PSF3" ENSG00000181938 "GINS complex subunit 3" Q9BRX5 16 58295080-58406147 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-698: 146.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041216, HPA048209" Uncertain Enhanced Nucleoplasm No No Nucleoplasm "HPA041216: AB_10794989, HPA048209: AB_2680314" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-3)" "unprognostic (6.34e-2)" "unprognostic (4.70e-2)" "unprognostic (2.82e-1)" "unprognostic (1.75e-4)" "unprognostic (7.76e-2)" "unprognostic (1.76e-3)" "unprognostic (7.19e-2)" "unprognostic (4.50e-2)" "unprognostic (2.67e-3)" "unprognostic (1.14e-7)" "unprognostic (9.76e-3)" "unprognostic (5.34e-2)" "unprognostic (8.23e-2)" "unprognostic (1.07e-2)" 4.2 7.4 2.6 4.3 4.6 8.5 3.7 4.0 2.7 2.7 2.3 4.6 3.3 2.8 3.7 9.1 2.4 1.5 6.3 2.7 2.8 1.7 2.6 2.1 7.8 3.5 3.6 2.0 1.3 1.7 3.7 2.0 3.7 3.2 2.2 4.2 1.8 3.4 4.6 1.8 4.2 2.9 3.8 3.0 5.4 2.6 6.8 3.0 8.9 2.0 5.0 8.1 3.1 6.7 3.0 20.2 22.4 26.5 14.3 2.9 3.7 13.3 22.4 9.8 35.4 26.8 16.9 20.2 35.0 17.5 7.6 26.3 18.7 24.5 18.8 39.6 19.5 30.4 20.4 12.0 20.5 1.6 26.1 33.7 4.2 3.5 18.4 6.3 7.9 24.4 28.9 33.5 14.4 15.0 20.9 48.1 24.2 24.5 17.2 45.3 82.6 29.4 44.4 12.8 12.6 30.3 20.1 37.3 24.3 12.8 10.6 12.9 21.4 10.4 23.5 27.8 14.2 28.4 14.3 20.2 146.3 16.2 26.1 29.3 0.1 1.8 0.1 1.9 1.6 1.5 2.5 1.6 2.9 4.1 4.4 1.5 2.5 0.4 4.1 1.0 8.2 2.4 1.5 2.6 4.6 4.0 2.7 2.7 2.8 3.5 3.6 2.0 3.2 3.0 3.0 3.0 3.9 0.0 2.6 9.1 3.2 1.8 4.9 2.7 4.0 1.5 2.0 1.7 4.1 0.0 1.4 0.0 2.1 9.1 4.5 1.6 0.0 3.7 20.7 1.8 2.1 4.3 0.0 12.4 0.6 2.0 7.6 2.5 1.5 7.9 1.3 6.9 3.6 0.8 2.8 5.0 0.2 0.9 0.0 1.6 1.1 9.2 1.5 1.9 1.8 2.8 2.6 1.8 2.1 5.0 1.2 1.9 0.3 1.2 6.2 1.7 0.2 0.5 1.1 1.8 6.6 1.6 3.0 4.6 8.7 13.0 2.4 3.1 2.4 3.2 2.8 4.9 OR4C15 ENSG00000181939 "Olfactory receptor family 4 subfamily C member 15" Q8NGM1 11 55554307-55555419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061939 Uncertain NA NA "HPA061939: AB_2684643" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A15 ENSG00000181958 "Olfactory receptor family 4 subfamily A member 15" 11 55367974-55368918 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A16 OR4A16Q ENSG00000181961 "Olfactory receptor family 4 subfamily A member 16" Q8NH70 11 55343151-55344231 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K2 ENSG00000181963 "Olfactory receptor family 52 subfamily K member 2" Q8NGK3 11 4449295-4450361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 3.3" "Lineage enhanced" "Detected in single" "granulocytes: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEUROG1 "AKA, bHLHa6, Math4C, NEUROD3, ngn1" ENSG00000181965 "Neurogenin 1" Q92886 5 135534282-135535964 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "brain: 4.2" "Cell type enriched" "Detected in single" 15 "Bipolar cells: 9.1" "Cancer enriched" "Detected in single" 12 "testis cancer: 1.1" "Region enriched" "Detected in single" 10 "midbrain: 4.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072232 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA072232: " "unprognostic (3.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC149 DKFZp761B107 ENSG00000181982 "Coiled-coil domain containing 149" Q6ZUS6 4 24806117-24980204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 1.5" "Lineage enriched" "Detected in single" 5 "monocytes: 1.5" "Cell line enhanced" "Detected in many" "U-87 MG: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044158, HPA047913" Uncertain Approved Nucleoli NA NA Nucleoli "HPA044158: AB_2678840, HPA047913: AB_2680207" "unprognostic (1.68e-1)" "unprognostic (2.43e-1)" "unprognostic (1.09e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.06e-1)" "unprognostic (4.11e-4)" "unprognostic (9.71e-5)" "unprognostic (2.68e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-2)" "unprognostic (8.59e-3)" "unprognostic (2.25e-1)" "unprognostic (2.80e-3)" "unprognostic (8.87e-2)" "unprognostic (2.25e-1)" "unprognostic (5.03e-2)" "unprognostic (4.80e-2)" 9.3 5.4 10.1 6.2 12.1 2.0 12.0 7.5 13.0 9.9 7.5 9.5 3.7 10.5 6.3 4.7 10.2 6.9 8.2 11.2 10.6 6.2 8.7 9.0 2.2 9.1 8.8 11.1 10.7 19.3 8.2 7.3 8.5 10.2 11.5 5.9 8.6 18.9 6.8 7.0 6.4 5.9 10.3 7.5 5.0 13.2 3.8 11.2 2.5 8.9 7.6 2.2 9.0 7.1 11.3 6.0 2.3 4.8 0.8 7.5 13.4 1.3 8.4 13.4 6.9 7.9 0.1 6.9 0.0 3.9 17.0 7.8 1.1 1.4 1.0 4.5 0.0 0.0 0.0 0.4 0.5 6.2 0.0 0.0 9.3 6.5 4.1 0.0 18.8 5.6 0.0 0.0 1.2 4.2 6.3 0.0 0.1 5.3 0.6 5.3 0.0 0.0 0.4 12.5 4.2 5.3 0.1 3.2 5.5 17.8 5.1 9.3 13.8 12.0 10.0 0.9 7.5 7.3 0.1 0.0 0.0 30.6 1.4 6.8 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.5 10.1 12.1 7.5 13.0 11.2 10.6 9.1 8.8 11.1 10.2 7.5 11.2 11.3 14.3 0.0 9.5 23.5 0.4 6.2 7.2 2.7 6.8 11.9 11.7 6.9 5.7 5.7 3.7 7.3 10.4 7.1 0.1 2.3 0.0 6.6 1.1 7.4 6.6 13.6 1.8 2.7 30.2 10.4 1.5 8.1 6.6 7.8 0.0 8.3 10.4 6.4 12.2 5.0 39.8 11.9 0.0 9.7 2.1 1.7 10.8 8.1 8.8 16.9 6.7 9.1 0.0 27.6 20.9 8.7 5.6 11.7 1.1 11.0 0.7 2.3 3.1 11.6 6.6 12.5 9.7 1.6 2.8 1.7 3.1 10.7 0.7 2.0 5.2 6.7 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480776 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043752: AB_2678653, HPA050345: AB_2681100" "unprognostic (2.66e-1)" "prognostic favorable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favorable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 8.9 17.1 11.6 4.0 11.7 2.8 8.7 12.4 18.4 5.2 10.8 9.2 8.0 5.3 3.8 11.0 4.8 4.6 21.6 12.2 11.7 14.1 20.7 5.3 5.6 12.2 12.2 11.3 3.6 10.6 3.8 7.6 2.3 12.6 7.5 3.5 2.5 6.1 3.4 24.9 7.2 7.4 4.3 11.4 8.1 9.7 9.0 12.1 5.1 9.7 15.1 4.5 8.5 5.6 12.1 10.5 41.1 6.1 10.4 13.8 6.6 16.1 8.3 14.6 10.7 11.5 28.9 16.0 9.7 17.0 7.1 11.3 14.8 17.9 11.5 5.5 12.8 43.8 13.2 23.1 32.0 16.5 4.5 8.3 13.4 11.1 9.2 9.2 5.8 14.3 12.3 9.6 4.3 18.1 45.1 9.3 19.0 16.3 13.4 43.8 19.0 11.6 23.0 15.5 28.4 19.3 9.6 8.6 21.6 33.6 5.3 19.8 24.7 6.8 15.2 16.8 9.9 12.5 8.5 16.5 11.7 18.3 11.2 16.3 31.1 25.1 19.3 15.1 27.6 17.6 27.5 17.2 17.8 29.5 18.2 18.1 17.6 9.5 30.1 17.8 31.9 35.1 26.0 11.6 11.7 12.4 18.4 12.2 11.7 12.2 12.2 11.3 12.6 11.4 12.1 12.1 42.1 6.4 20.4 10.4 30.4 22.8 27.5 69.2 31.9 36.9 38.1 47.2 6.3 35.8 39.6 46.0 47.9 91.0 34.6 85.5 135.0 63.9 30.2 27.1 37.8 34.2 24.7 40.6 14.0 66.8 89.7 32.7 25.0 32.5 33.6 40.4 44.6 92.6 90.5 26.9 15.0 60.3 50.8 33.1 24.5 34.2 33.2 31.0 32.0 8.4 65.0 44.4 72.1 16.6 16.8 67.0 70.7 42.5 36.5 32.2 90.8 145.3 29.7 45.1 19.7 29.7 51.8 90.3 42.0 49.1 28.3 89.6 32.3 96.0 64.6 34.5 SNRPE Sm-E ENSG00000182004 "Small nuclear ribonucleoprotein polypeptide E" P62304 1 203861599-203871152 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 34000 "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (4.35e-2)" "unprognostic (8.32e-3)" "unprognostic (4.87e-1)" "unprognostic (3.01e-3)" "unprognostic (2.86e-3)" "unprognostic (3.31e-2)" "unprognostic (1.59e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.34e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (3.54e-1)" "unprognostic (1.31e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-3)" 36.9 50.5 38.9 50.9 40.5 87.9 66.3 44.2 61.7 38.4 44.7 53.0 32.1 42.8 60.0 39.4 38.8 24.3 32.0 39.1 41.4 36.6 46.4 25.8 50.4 39.8 40.5 36.6 65.2 38.3 38.0 25.1 39.6 41.6 29.9 41.9 38.1 33.2 29.5 40.3 29.7 34.2 27.4 42.4 33.6 36.0 22.5 40.1 101.3 28.0 22.5 58.7 51.9 34.2 44.2 262.9 85.4 307.0 157.4 64.6 131.4 179.1 187.1 111.6 159.9 147.5 103.1 200.6 258.4 154.3 111.9 164.0 185.7 258.1 206.8 205.2 105.1 120.4 166.4 169.8 144.5 106.8 375.6 168.1 113.7 55.7 190.1 176.1 151.4 146.4 288.3 310.0 155.7 138.9 150.7 372.6 360.0 413.1 175.6 91.4 242.9 295.0 303.9 201.5 96.1 160.9 210.2 130.5 275.7 347.6 271.2 203.7 261.7 98.4 127.6 216.4 115.9 341.7 130.7 184.3 574.1 125.6 198.3 146.9 14.6 22.6 13.7 19.7 21.1 30.2 24.0 26.7 20.9 34.1 21.5 26.7 26.3 7.4 37.0 25.4 46.0 23.1 19.1 38.9 40.5 44.2 61.7 39.1 41.4 39.8 40.5 36.6 41.6 42.4 40.1 44.2 125.2 128.2 116.4 5.5 153.6 244.1 284.5 442.3 101.3 48.5 190.2 204.1 73.3 204.5 226.4 128.8 14.6 454.6 146.1 92.2 424.6 408.6 23.1 179.9 197.6 173.5 163.4 176.9 8.1 473.8 612.3 159.3 72.4 188.6 112.7 190.0 138.5 278.7 300.7 57.2 7.7 241.2 341.8 172.9 177.6 34.8 237.0 117.6 172.5 5.6 304.5 149.7 212.1 7.5 8.8 421.8 136.7 164.0 97.7 351.2 113.4 434.3 162.7 48.3 98.6 272.0 240.4 217.7 239.5 128.8 256.0 225.1 126.2 178.5 313.8 294.1 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lung: 78.2" "Group enriched" "Detected in many" 10 "Alveolar cells type 1: 1753.2;Early spermatids: 480.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Immune cell enriched" "Detected in some" 8 "T-reg: 16.7" "Lineage enriched" "Detected in single" 72 "T-cells: 16.7" "Cell line enhanced" "Detected in many" "A-431: 45.2;HaCaT: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.2 0.1 0.1 1.7 0.4 0.8 1.1 0.7 1.5 0.8 0.0 1.6 1.3 0.9 0.1 7.2 0.2 0.7 0.1 0.3 0.0 0.4 0.2 78.2 3.5 0.1 0.0 0.2 0.2 0.1 0.4 0.8 1.3 0.3 1.1 2.0 0.9 1.4 0.2 0.0 1.2 1.5 0.4 0.0 1.4 1.2 7.7 0.0 3.9 0.6 0.0 3.4 1.2 3.1 0.5 45.2 2.6 23.2 10.8 0.0 0.1 5.6 6.4 7.4 7.2 11.2 18.7 8.9 0.1 2.8 2.6 7.3 35.3 13.1 1.0 7.4 6.4 8.9 7.5 5.4 7.8 0.1 9.9 5.6 0.3 0.6 8.8 0.9 3.8 1.1 11.8 0.5 0.2 9.7 5.6 19.8 13.1 9.8 6.7 8.7 16.9 24.9 0.1 4.6 19.5 12.6 14.5 4.3 14.8 6.0 6.8 13.4 5.6 0.1 3.3 20.8 0.2 16.5 0.1 0.1 17.2 4.2 0.0 5.2 0.1 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.4 0.1 0.1 0.6 0.3 0.2 0.1 0.0 0.1 16.7 0.2 0.1 0.4 0.7 1.5 0.3 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.5 0.4 1753.2 45.8 0.3 1.5 4.7 10.2 3.0 0.0 0.7 5.0 3.6 0.5 1.5 10.9 0.0 0.0 9.0 2.0 1.9 0.0 1.6 480.3 5.6 1.4 0.7 1.8 1.7 21.5 1.6 7.2 2.9 7.1 10.8 3.8 12.9 1.1 0.0 2.4 0.0 2.5 8.5 6.1 0.6 2.9 102.8 2.1 2.1 1.8 1.0 0.4 0.3 0.0 0.5 1.0 15.4 0.7 1.9 3.3 9.7 0.5 1.9 2.8 0.5 0.0 0.6 3.4 23.5 24.6 26.2 1.8 2.1 17.4 2.9 7.0 97.3 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.1 23.0 40.8 0.9 51.0 0.7 4.8 21.1 59.4 4.5 17.1 2.9 0.7 12.6 16.4 1.2 22.3 5.2 15.1 46.3 49.0 8.8 0.4 1.7 0.3 31.4 33.8 49.0 17.3 6.3 16.0 37.0 2.6 36.6 8.9 0.7 35.9 6.1 9.7 1.6 1.2 1.3 7.2 20.1 0.6 1.8 22.7 39.1 30.4 15.6 1.1 0.6 3.1 1.6 53.5 0.0 13.9 19.7 19.6 5.6 12.7 3.5 1.3 0.2 2.4 1.2 0.2 1.6 0.1 18.1 0.9 6.8 0.2 32.9 5.3 1.6 0.1 12.2 0.0 0.5 0.5 9.4 0.2 0.2 3.3 6.5 8.2 0.0 1.8 2.0 11.9 36.3 0.2 35.9 0.1 0.2 0.2 16.5 0.0 0.0 0.0 21.5 0.0 8.2 0.1 16.0 31.3 0.1 0.3 0.0 18.0 0.2 0.3 1.2 0.0 0.2 0.2 6.8 0.1 0.1 0.2 0.3 0.1 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.0 0.0 40.8 51.0 21.1 59.4 46.3 49.0 31.4 33.8 49.0 36.6 20.1 39.1 53.5 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.0 0.0 1.8 11.0 0.0 1.9 0.0 0.0 3.9 0.9 0.0 8.4 2.3 0.3 0.0 0.0 0.0 0.0 0.5 2.8 0.0 1.3 0.0 13.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 10.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.0 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007668-124093598 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 69.0" "Group enriched" "Detected in many" 11 "granulocytes: 69.0;monocytes: 38.7" "Cell line enhanced" "Detected in many" "Karpas-707: 66.0;REH: 90.4;U-266/70: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol NA NA 690000 Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavorable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 15.4 10.5 9.7 20.0 21.2 7.1 11.5 6.8 15.3 10.4 21.9 16.6 9.9 8.0 8.4 9.5 15.2 12.9 4.9 17.3 9.5 8.6 13.7 17.3 18.0 9.6 8.7 10.2 37.3 14.2 2.9 8.4 6.6 8.2 9.8 8.9 2.8 9.4 13.9 13.9 9.3 15.5 10.7 11.1 37.0 11.6 4.3 10.5 9.4 19.9 5.8 14.3 12.5 9.3 10.2 32.3 21.2 7.8 1.7 7.5 4.0 0.1 6.4 8.6 3.4 4.9 0.6 17.1 0.0 20.1 26.4 2.3 35.9 1.5 20.8 2.9 0.2 5.9 0.1 9.3 16.0 2.4 0.0 39.2 2.5 23.5 9.5 8.0 8.3 6.9 0.1 0.0 66.0 17.0 18.0 0.1 0.1 6.8 4.9 0.1 90.4 10.6 21.6 17.1 3.1 0.8 1.7 17.1 9.6 0.0 19.3 7.0 0.1 8.3 0.9 0.3 24.3 1.0 59.5 15.7 16.9 0.2 0.0 0.1 0.0 21.8 15.3 0.0 33.3 0.0 4.5 0.0 0.0 4.2 4.4 0.3 0.0 69.0 0.0 38.7 4.9 0.3 9.1 9.7 21.2 6.8 15.3 17.3 9.5 9.6 8.7 10.2 8.2 11.1 10.5 10.2 14.3 22.4 9.6 4.2 13.5 16.8 16.1 15.3 2.2 5.6 10.5 5.2 2.2 12.8 12.1 20.2 0.0 1.8 7.2 0.1 0.0 9.7 29.5 7.4 5.9 18.2 1.8 0.0 43.8 0.7 2.3 8.4 0.5 14.0 5.7 0.4 42.1 9.0 10.5 0.0 33.2 0.0 16.2 50.2 3.6 34.8 10.2 34.0 1.8 43.1 30.3 0.1 2.1 35.2 1.0 9.8 0.0 1.9 34.3 14.7 0.0 0.7 11.9 0.5 19.7 13.4 11.5 10.4 10.0 2.4 11.6 1.0 1.4 0.8 0.1 15.8 ADIG "MGC39724, RP5-1100H13.2, SMAF1" ENSG00000182035 Adipogenin Q0VDE8 20 38581195-38588463 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 53.9" "Cell type enriched" "Detected in some" 4 "Late spermatids: 1714.0" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041124 Uncertain NA NA "HPA041124: AB_10795534" "unprognostic (2.97e-2)" "unprognostic (7.69e-3)" "unprognostic (2.27e-1)" "unprognostic (4.52e-3)" "unprognostic (1.34e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.9 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 409.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1714.0 3.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.2 0.0 0.0 6.6 0.0 0.0 5.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USH1G "ANKS4A, FLJ33924, Sans" ENSG00000182040 "USH1 protein network component sans" Q495M9 17 74916083-74923256 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 7.8" "Group enriched" "Detected in some" 5 "Early spermatids: 8.2;Late spermatids: 17.9;Muller glia cells: 11.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.8;hTCEpi: 1.6;K-562: 1.3;MCF7: 2.0;OE19: 1.9" "Region enriched" "Detected in single" 12 "olfactory bulb: 9.9" "Not detected" "Not detected" HPA024360 Uncertain NA NA "HPA024360: AB_1858660" "unprognostic (2.95e-1)" "unprognostic (6.17e-2)" "unprognostic (6.34e-4)" "unprognostic (2.92e-2)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (5.59e-4)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (8.64e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (3.10e-4)" "unprognostic (1.57e-1)" "unprognostic (8.48e-2)" "unprognostic (2.25e-1)" "unprognostic (3.35e-2)" 0.0 0.9 0.2 0.0 0.2 0.1 0.0 1.1 0.2 0.2 0.0 0.0 0.1 0.8 1.9 7.8 0.1 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.5 0.0 0.0 2.2 0.2 0.5 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 0.1 0.7 0.1 0.1 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 1.7 0.6 0.0 0.2 0.0 0.0 0.1 0.2 0.4 1.6 0.3 0.3 0.0 0.1 0.0 0.1 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 3.7;pituitary gland: 3.2;testis: 4.8;thyroid gland: 6.3" "Group enriched" "Detected in some" 8 "Astrocytes: 876.3;Excitatory neurons: 988.4;Inhibitory neurons: 1438.9" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 6.0;SCLC-21H: 2.5;SuSa: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016418 Approved Approved "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Vesicles, Plasma membrane" "Centriolar satellite" "HPA016418: AB_2732416" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 0.2 0.9 1.4 0.0 2.1 0.1 0.0 0.3 1.4 0.1 0.0 0.3 0.0 0.0 3.7 0.0 0.1 0.1 1.6 1.1 1.6 0.0 0.1 0.1 0.0 1.0 2.4 1.3 0.0 0.1 0.0 3.2 0.0 1.3 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.1 0.0 0.8 0.0 0.1 4.8 1.7 0.0 6.3 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.1 0.3 1.4 1.1 1.6 1.0 2.4 1.3 1.3 0.8 1.7 1.3 0.1 6.4 1.1 876.3 0.0 0.1 0.2 1.5 0.0 11.2 0.0 0.0 10.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 123.9 0.1 0.1 4.2 0.0 0.0 988.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1438.9 0.0 4.1 0.0 0.0 98.9 16.1 0.3 0.0 34.7 0.2 0.5 0.0 32.2 17.2 0.4 0.0 4.1 0.0 0.3 0.0 0.1 0.0 1.8 0.0 0.4 0.2 3.8 1.5 0.0 0.1 0.0 0.5 6.2 0.0 0.3 TRIM49B ENSG00000182053 "Tripartite motif containing 49B" A6NDI0 11 49027501-49038451 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2" P48735 15 90083045-90102477 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 1314.6;tongue: 1625.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 425.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria NA NA 5200000 Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favorable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 33.1 10.6 53.3 60.8 60.1 162.4 51.6 55.5 60.2 34.5 65.7 92.5 98.1 29.3 12.6 141.9 33.0 32.0 343.5 45.2 51.3 150.0 277.0 32.3 77.7 86.1 57.6 45.3 13.8 129.8 104.9 15.6 88.0 72.9 76.9 84.9 5.4 164.6 91.2 1314.6 61.7 85.0 80.6 43.5 37.1 177.1 5.4 59.6 150.1 16.1 1625.6 66.5 53.8 49.8 54.9 61.3 33.5 169.9 169.8 23.3 28.3 144.5 74.5 110.8 68.0 72.6 16.1 51.1 72.7 21.0 61.2 65.1 20.8 25.1 22.4 32.0 143.8 16.9 122.9 12.7 119.7 28.1 85.1 118.2 59.7 12.7 16.3 13.0 82.1 141.0 246.4 18.9 59.3 53.0 175.3 425.0 131.2 51.8 81.9 14.3 352.0 122.4 213.7 105.6 71.3 244.5 125.3 92.1 359.8 29.9 94.2 290.9 256.9 34.0 120.4 17.0 16.1 34.9 101.5 20.5 9.0 38.4 175.0 71.2 45.0 112.8 75.6 105.9 199.1 53.2 70.1 77.0 120.1 136.9 47.7 42.9 71.8 22.9 99.9 252.1 79.4 72.4 163.4 53.3 60.1 55.5 60.2 45.2 51.3 86.1 57.6 45.3 72.9 43.5 59.6 54.9 16.9 6.4 21.0 40.1 64.2 39.9 98.8 91.6 12.5 6.2 90.5 48.1 445.9 114.4 95.8 75.4 10.4 732.5 84.0 70.0 1168.0 252.8 5.6 96.4 25.7 41.6 61.7 193.8 11.8 288.8 586.7 44.7 88.2 50.9 31.6 29.2 38.2 283.1 263.7 10.1 8.3 158.3 229.9 77.7 101.1 3.2 14.0 79.0 58.7 5.6 85.3 20.9 119.4 16.6 27.3 116.6 105.0 35.3 185.9 170.3 69.6 205.0 167.9 5.4 13.1 60.8 73.4 0.6 15.6 113.3 67.1 573.0 88.1 14.7 305.1 140.1 OR52A1 HPFH1OR ENSG00000182070 "Olfactory receptor family 52 subfamily A member 1" Q9UKL2 11 5146824-5154757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Club cells: 9.9;Respiratory ciliated cells: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: AB_2682604" "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favorable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 111.2 120.8 49.7 69.3 53.7 83.1 113.4 51.2 75.1 112.4 57.6 117.2 67.4 108.9 22.5 115.6 111.8 48.4 127.4 49.1 51.9 119.8 163.9 129.6 75.8 63.3 56.9 45.3 107.4 128.4 83.9 155.4 50.7 68.7 127.4 34.2 39.5 110.1 46.0 113.6 124.3 136.8 35.5 50.9 193.0 116.5 102.0 53.4 72.6 134.3 48.7 48.2 104.1 114.1 61.6 125.0 78.3 53.6 61.3 64.7 62.2 94.4 101.1 89.5 83.7 89.9 73.2 68.6 84.8 98.5 78.9 39.4 138.9 54.4 102.0 36.9 108.5 88.0 50.4 102.9 81.2 114.6 98.1 122.5 83.7 102.2 67.5 83.6 79.5 73.7 85.6 85.5 168.2 56.8 54.9 106.5 89.9 78.3 63.1 60.2 120.8 40.6 110.1 66.3 115.1 73.7 77.8 64.9 82.2 73.9 43.0 80.9 125.3 87.0 83.0 47.2 118.5 108.2 240.2 95.7 96.2 98.3 79.3 84.6 0.6 1.7 1.0 2.2 1.4 1.6 1.6 1.3 2.2 2.5 1.3 1.3 1.6 1.1 1.2 2.3 2.9 1.4 1.6 49.7 53.7 51.2 75.1 49.1 51.9 63.3 56.9 45.3 68.7 50.9 53.4 61.6 73.6 32.1 49.9 64.6 70.1 62.3 54.5 26.0 51.2 118.5 50.3 44.7 14.1 30.0 27.6 66.2 98.0 59.2 90.0 114.1 11.7 28.4 18.3 46.5 56.4 50.4 40.2 21.0 36.3 34.3 51.4 49.6 122.3 63.5 15.2 89.4 40.7 52.0 51.1 104.3 40.8 78.4 18.3 30.0 58.1 11.4 42.6 55.2 44.4 36.5 28.7 65.9 26.8 35.2 58.4 42.9 75.8 34.3 89.1 63.7 56.2 20.7 26.3 170.2 32.9 48.5 51.2 45.4 38.5 53.8 64.9 82.4 69.3 126.4 62.6 66.3 GET1 "CHD5, WRB" ENSG00000182093 "Guided entry of tail-anchored proteins factor 1" O00258 21 39377698-39428528 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Adipocytes: 12.0;Cardiomyocytes: 38.3;Cytotrophoblasts: 37.6;Extravillous trophoblasts: 35.3;Fibroblasts: 10.4;Hofbauer cells: 31.5;Syncytiotrophoblasts: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018527 Approved NA NA "HPA018527: AB_1858860" "unprognostic (4.34e-3)" "unprognostic (3.28e-1)" "unprognostic (2.88e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (5.08e-2)" "unprognostic (6.86e-2)" "unprognostic (1.57e-3)" "unprognostic (8.74e-2)" "unprognostic (1.15e-2)" "unprognostic (4.02e-3)" "unprognostic (9.48e-2)" "unprognostic (6.50e-3)" "unprognostic (2.21e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-3)" "unprognostic (8.13e-2)" 20.5 44.8 74.6 11.9 75.9 8.9 25.9 74.8 93.4 28.3 88.0 17.9 18.7 29.6 46.2 15.5 71.7 18.9 29.7 73.8 84.2 38.9 33.7 19.1 14.5 75.0 79.4 73.0 42.2 18.0 15.7 29.3 22.3 76.7 24.9 15.0 112.2 16.3 21.3 38.4 10.2 18.8 23.4 77.2 13.8 17.5 56.4 80.6 16.0 28.7 30.4 15.0 16.3 15.2 83.1 36.8 33.2 58.9 34.6 74.8 69.7 18.6 50.6 51.2 23.8 21.7 31.2 50.3 59.6 35.0 54.9 29.0 13.8 47.5 31.8 33.5 26.4 32.2 43.0 28.5 50.8 44.7 33.3 15.8 44.8 30.3 37.9 34.7 67.0 60.2 61.2 65.8 36.8 63.4 82.4 38.4 25.3 52.8 66.7 25.0 42.1 34.6 44.4 69.1 19.1 29.2 44.5 44.7 23.1 53.9 31.1 43.1 37.7 35.6 30.2 10.6 41.2 23.0 46.4 70.4 27.3 72.3 55.3 34.2 37.7 26.7 27.6 19.8 20.4 17.6 30.8 24.1 20.8 30.7 20.6 27.0 25.6 47.1 27.3 21.2 39.4 23.8 39.5 74.6 75.9 74.8 93.4 73.8 84.2 75.0 79.4 73.0 76.7 77.2 80.6 83.1 12.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 37.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 35.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 13.7 0.6 0.0 0.0 0.0 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 28.3 18.4 12.7 29.2 9.6 52.2 30.4 14.5 14.3 38.4 2.2 48.0 25.5 58.1 16.5 26.2 43.9 22.6 21.2 11.9 4.2 22.9 20.0 32.3 16.3 7.2 2.9 2.8 46.4 29.8 35.3 22.4 30.9 6.2 36.4 22.8 12.3 29.0 34.6 24.2 33.1 29.2 36.7 1.9 25.4 34.1 22.8 3.8 17.4 32.9 11.2 14.7 41.2 32.2 8.5 72.8 63.4 51.5 43.4 42.9 50.6 133.8 50.4 47.3 27.4 29.0 26.3 62.4 49.3 48.3 74.7 60.8 79.7 30.2 60.5 23.0 21.6 19.2 31.4 56.6 43.1 37.1 104.3 111.2 51.2 70.0 54.8 63.2 39.5 31.3 43.6 45.4 27.2 35.3 120.0 24.6 127.2 4.5 47.5 48.0 27.0 25.7 37.3 22.3 91.3 22.3 53.4 38.8 102.5 37.0 23.1 106.9 106.1 78.7 78.3 109.6 47.0 36.7 38.6 44.1 46.2 44.1 72.6 94.1 14.2 3.8 3.6 1.7 1.5 1.2 2.2 1.2 1.0 1.4 2.3 0.9 1.7 20.8 3.2 2.1 5.4 1.9 0.2 12.7 9.6 14.5 14.3 11.9 4.2 7.2 2.9 2.8 6.2 1.9 3.8 8.5 25.6 9.6 29.0 59.7 7.4 9.3 3.7 9.8 13.6 51.7 15.8 25.9 7.5 14.3 12.4 14.7 2.1 14.5 20.4 33.6 1.9 5.0 14.4 22.2 29.7 17.3 31.3 9.7 40.9 6.6 3.8 17.8 19.4 36.2 14.0 48.3 29.6 25.4 11.2 50.5 45.6 30.4 8.2 41.8 12.4 18.8 18.3 22.8 5.4 71.2 25.9 31.0 11.3 32.6 20.3 9.0 10.6 19.9 12.1 6.5 7.4 5.4 11.1 4.0 19.7 18.4 21.2 0.4 2.1 12.5 8.8 10.0 12.3 18.6 25.1 3.8 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729940-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.6" "Cell type enhanced" "Detected in some" "Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 0.4 0.6 16.0 0.2 16.4 0.1 0.4 20.7 14.4 1.2 4.3 1.0 0.2 0.7 0.1 0.3 1.0 0.0 0.9 13.5 13.4 0.4 0.0 0.0 0.0 24.6 16.0 8.9 0.8 0.5 0.1 1.3 0.0 16.5 0.6 0.0 0.6 0.8 0.5 0.2 0.3 0.4 0.1 21.9 0.0 0.4 0.2 19.1 0.0 0.8 0.1 0.2 1.2 0.7 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.3 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 16.4 20.7 14.4 13.5 13.4 24.6 16.0 8.9 16.5 21.9 19.1 23.3 0.7 0.0 0.0 56.2 0.0 0.3 0.2 0.1 0.0 0.8 1.0 3.6 2.9 0.0 0.1 5.5 0.0 0.0 0.0 0.0 3.9 0.1 0.0 24.1 1.8 1.3 0.0 0.0 0.4 0.0 0.0 1.2 0.0 2.4 0.0 0.6 0.0 0.0 0.1 0.0 0.6 1.5 0.0 0.0 0.3 0.4 0.6 0.2 1.8 1.9 0.0 18.4 0.0 22.1 19.0 0.0 0.0 0.4 0.0 0.2 0.1 0.4 0.1 1.1 0.0 1.6 7.0 0.1 1.6 0.3 0.0 0.0 0.1 2.2 0.2 0.1 TMEM30B CDC50B ENSG00000182107 "Transmembrane protein 30B" Q3MIR4 14 61277370-61281761 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4" "Not detected" "Not detected" HPA043162 Uncertain NA NA "HPA043162: AB_10796688" "unprognostic (4.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.72e-1)" "unprognostic (3.47e-2)" "unprognostic (2.01e-1)" "unprognostic (6.20e-2)" "unprognostic (2.45e-3)" "unprognostic (3.43e-2)" "unprognostic (9.10e-2)" "unprognostic (2.20e-1)" "unprognostic (5.10e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.89e-5)" "unprognostic (2.21e-1)" "unprognostic (2.89e-1)" "unprognostic (2.60e-1)" "unprognostic (1.85e-1)" 3.0 1.6 0.5 3.7 0.8 0.4 15.0 0.5 1.0 16.5 1.0 29.3 43.7 3.9 28.5 14.2 15.4 24.1 1.4 0.4 0.7 12.5 12.4 14.6 1.2 0.6 0.6 0.3 2.5 36.0 59.6 18.3 5.8 0.6 22.1 26.3 0.3 27.9 13.5 1.2 8.7 34.7 1.8 0.5 0.7 42.6 2.6 0.7 5.3 50.4 1.9 4.5 16.3 9.4 0.5 68.7 0.2 0.0 0.0 6.7 1.6 0.1 0.1 0.0 0.0 0.0 11.6 54.4 0.0 0.1 0.0 0.0 31.7 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 29.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 44.6 0.0 0.1 0.6 28.2 1.6 0.0 1.5 0.2 0.0 94.9 11.2 0.1 0.8 25.6 0.1 1.9 30.4 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.7 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.8 0.5 1.0 0.4 0.7 0.6 0.6 0.3 0.6 0.5 0.7 0.5 0.6 28.9 31.9 0.0 0.6 64.9 124.0 19.5 61.5 0.0 32.2 16.5 1.9 47.1 24.5 40.5 0.0 28.0 1.1 90.8 13.7 24.8 0.9 23.8 3.9 3.9 23.4 0.0 0.0 37.2 11.4 5.5 62.7 45.3 2.5 0.7 4.2 14.1 2.0 0.0 0.0 73.1 20.3 1.0 6.8 1.6 8.7 1.5 5.4 1.0 0.6 2.9 2.1 0.0 0.1 31.9 75.3 79.0 0.4 101.1 73.6 1.0 22.7 0.3 13.1 2.4 5.4 5.9 3.6 43.3 63.6 35.8 3.6 0.9 64.7 131.9 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942468 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 34.0 82.9 54.5 10.9 51.7 5.5 29.6 59.6 60.6 35.2 42.3 38.1 14.7 34.8 23.6 25.2 34.4 11.3 96.1 42.6 52.4 33.3 92.1 27.5 12.6 58.6 55.8 42.2 34.9 30.0 21.1 38.3 13.1 63.8 39.5 8.0 6.2 23.7 20.5 129.7 27.5 25.2 15.6 50.3 30.8 34.3 14.9 65.2 11.7 28.6 59.2 10.6 33.8 29.1 54.6 18.1 25.9 13.6 24.1 54.1 29.5 12.5 27.2 28.0 17.4 16.5 12.2 18.5 21.4 39.9 31.0 19.0 22.9 16.2 29.3 14.9 50.4 36.4 10.7 17.1 52.3 30.9 18.3 19.3 30.2 33.1 17.1 19.7 28.2 25.3 29.7 24.5 20.8 19.6 31.9 22.9 19.9 19.1 22.3 26.5 21.2 18.0 32.8 21.9 13.3 28.0 24.7 26.0 28.2 22.6 11.4 22.5 31.6 28.1 17.5 18.7 41.9 18.0 27.2 22.6 6.2 15.4 38.7 20.2 1.3 0.5 7.2 4.6 0.6 4.2 0.5 4.0 5.4 0.3 4.1 4.7 4.6 0.5 3.0 0.2 2.0 3.3 1.0 54.5 51.7 59.6 60.6 42.6 52.4 58.6 55.8 42.2 63.8 50.3 65.2 54.6 23.3 6.4 12.1 10.1 12.4 33.3 40.5 9.7 21.6 18.8 19.1 26.0 0.0 41.5 5.9 27.6 12.5 28.1 11.5 8.5 76.3 24.8 8.1 10.5 21.4 27.1 14.9 15.6 8.0 36.2 21.4 33.8 10.7 7.4 1.3 30.4 46.1 106.3 41.2 23.5 13.3 14.5 14.2 15.5 15.8 14.9 75.2 14.6 16.0 8.4 10.7 57.0 18.6 3.5 6.7 31.2 10.1 85.7 14.9 70.7 17.8 70.9 8.8 14.8 19.7 29.9 26.1 3.8 3.7 18.4 32.5 11.6 19.2 38.4 17.5 39.0 ZNF716 FLJ46189 ENSG00000182111 "Zinc finger protein 716" A6NP11 7 57450177-57473559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Early spermatids: 3.9;Late spermatids: 4.0;Spermatocytes: 3.3;Spermatogonia: 6.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.2" NA NA "unprognostic (1.57e-1)" "unprognostic (1.95e-2)" "unprognostic (1.21e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.2 3.3 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 NOP10 "MGC70651, NOLA3, NOP10P" ENSG00000182117 "NOP10 ribonucleoprotein" Q9NPE3 15 34341719-34343136 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 878.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059198 Supported Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA059198: AB_2683945" "unprognostic (2.65e-1)" "unprognostic (1.72e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.48e-5)" "unprognostic (3.12e-1)" "unprognostic (2.39e-3)" "unprognostic (8.11e-3)" "unprognostic (9.99e-2)" "unprognostic (2.28e-1)" "unprognostic (8.31e-3)" "unprognostic (1.77e-3)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" "unprognostic (2.61e-1)" "unprognostic (2.59e-1)" "unprognostic (1.05e-1)" "unprognostic (6.77e-3)" 136.5 146.9 127.3 105.7 128.3 210.1 153.3 130.7 150.8 119.6 129.3 165.9 110.3 92.7 288.0 176.4 121.0 91.0 154.9 127.9 141.5 169.3 243.1 149.2 147.4 132.5 128.7 124.0 63.8 91.1 143.8 91.2 127.8 132.1 99.1 204.1 48.8 94.3 103.2 185.9 111.1 111.1 165.1 136.8 168.9 120.0 42.0 135.7 215.2 113.9 229.4 220.4 215.6 122.3 142.6 212.2 471.9 325.1 205.3 520.4 443.7 172.4 281.3 471.8 555.4 703.6 358.5 200.3 146.7 328.6 457.7 627.3 292.8 599.1 502.8 526.0 216.0 341.7 461.6 396.5 523.7 724.2 303.2 228.6 513.8 471.0 508.3 588.1 305.0 795.6 399.9 417.0 206.4 695.3 295.8 234.0 486.1 319.8 628.7 453.3 252.2 223.4 241.8 754.0 475.5 210.4 279.5 202.1 211.7 221.4 442.9 235.4 619.4 331.2 295.3 219.6 418.2 242.7 198.9 427.1 406.8 377.5 495.8 214.5 1080.4 852.4 889.6 368.7 867.8 394.9 723.0 476.7 442.7 636.3 639.5 503.6 441.2 2797.7 534.1 696.7 824.6 700.1 1065.2 127.3 128.3 130.7 150.8 127.9 141.5 132.5 128.7 124.0 132.1 136.8 135.7 142.6 202.7 109.0 153.3 7.2 175.1 239.5 179.8 470.8 130.3 30.9 158.6 195.2 299.7 143.0 273.9 149.0 12.5 210.7 158.0 286.1 446.1 365.6 15.0 230.7 148.1 257.5 195.7 169.5 6.7 351.9 402.1 154.2 122.9 234.0 164.0 81.3 240.9 359.7 878.9 13.5 7.1 283.9 315.3 504.5 321.5 16.8 103.8 309.2 190.3 12.2 322.1 70.0 250.3 5.0 10.0 600.6 362.9 100.1 209.5 251.2 304.2 668.9 298.6 33.7 105.2 91.7 336.0 19.0 101.8 224.8 302.8 214.0 154.2 128.7 241.0 451.3 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040254 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 60.5;placenta: 68.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 186.3;Extravillous trophoblasts: 267.5;Rod photoreceptor cells: 102.5;Syncytiotrophoblasts: 278.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 145.4;SK-MEL-30: 81.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: AB_2683890, HPA059578: AB_2684070" "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 60.5 18.2 15.2 4.8 15.0 6.0 36.8 20.6 15.4 10.8 20.1 4.1 1.7 7.6 1.7 6.6 7.1 5.9 8.0 13.6 22.0 22.1 9.3 19.4 5.9 21.6 20.2 11.9 6.1 10.7 6.1 5.8 68.7 20.8 7.2 2.7 17.4 5.3 4.6 5.9 28.2 4.7 4.2 20.7 17.7 7.7 3.0 23.3 2.9 5.5 6.8 4.8 9.0 9.3 19.5 0.9 13.7 6.3 13.4 15.0 3.0 145.4 7.8 5.8 2.8 5.1 21.1 12.1 0.0 1.8 5.1 16.7 8.4 12.0 1.9 2.3 42.4 28.9 6.7 0.3 0.9 57.6 5.0 35.2 50.1 26.6 0.0 13.2 0.1 7.4 15.0 53.4 8.6 2.7 5.0 3.2 8.8 9.4 12.6 4.3 16.6 20.3 16.0 10.1 14.8 5.8 16.1 2.6 1.2 81.6 13.9 0.8 29.2 1.1 22.5 0.1 0.4 14.7 18.3 23.7 11.6 6.7 9.8 45.7 1.4 0.2 0.0 0.2 0.0 0.3 0.3 0.2 0.5 0.0 0.1 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.2 15.2 15.0 20.6 15.4 13.6 22.0 21.6 20.2 11.9 20.8 20.7 23.3 19.5 82.3 0.0 2.6 3.6 4.2 30.1 22.0 0.3 8.0 48.1 3.8 5.2 3.3 7.2 0.7 0.0 77.2 186.3 4.9 0.3 3.9 2.8 1.3 1.3 39.3 44.5 0.0 14.9 1.1 3.3 267.5 11.6 0.5 2.6 4.5 0.5 10.8 11.1 51.0 8.4 10.8 0.6 0.0 19.6 2.1 3.6 2.8 8.5 21.4 22.5 0.5 26.2 1.0 10.1 2.0 4.4 0.5 1.5 1.4 30.2 0.0 5.1 0.1 102.5 0.0 9.9 8.5 4.2 11.6 1.7 32.8 278.3 5.5 0.4 1.3 15.4 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;choroid plexus: 13.9;epididymis: 21.8" "Cell type enhanced" "Detected in some" "Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "RPTEC TERT1: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles NA NA Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 0.4 4.2 22.6 0.5 25.5 0.0 1.0 18.0 28.5 2.8 13.9 0.5 0.2 1.7 21.8 0.3 1.7 1.9 0.4 20.8 26.7 3.7 0.1 1.0 0.5 23.5 24.6 21.7 0.3 1.4 1.3 1.0 1.2 23.7 1.5 0.5 5.8 0.4 5.7 0.1 0.3 0.3 1.1 23.0 1.5 0.4 2.7 28.0 0.1 0.7 0.2 0.5 0.5 0.6 25.1 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 25.5 18.0 28.5 20.8 26.7 23.5 24.6 21.7 23.7 23.0 28.0 25.1 0.0 0.0 0.0 57.8 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 2.0 1.2 0.0 0.0 18.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 50.5 221.4 0.0 0.0 0.0 0.6 0.7 5.0 0.1 0.0 167.7 0.0 0.2 0.0 196.1 2.8 0.0 0.0 11.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.4;testis: 22.4" "Cell type enhanced" "Detected in many" "Early spermatids: 23.9;Late spermatids: 60.4;Spermatocytes: 43.2;Spermatogonia: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.4 3.2 5.3 4.4 5.6 1.4 4.5 8.4 5.7 2.1 2.7 3.1 2.3 1.6 6.0 1.8 2.0 1.9 3.6 6.0 6.4 2.8 3.6 4.4 5.9 7.6 6.1 5.5 0.9 3.0 30.4 4.6 3.6 8.5 6.1 4.0 9.7 7.0 5.7 4.3 2.2 2.2 2.8 5.3 6.4 2.9 22.4 6.5 10.1 7.4 4.9 5.5 2.7 1.7 6.9 10.8 9.4 8.1 18.8 0.5 0.8 7.7 1.8 1.0 5.6 3.7 6.1 15.1 12.6 16.3 0.7 13.1 6.4 11.9 12.5 8.5 32.5 8.3 12.6 2.6 4.2 3.4 2.4 2.0 1.0 4.8 11.8 5.0 1.6 5.9 24.3 9.8 11.0 1.8 29.3 20.3 3.9 6.2 16.0 16.0 2.5 5.0 26.2 9.6 5.3 11.7 19.2 13.2 10.5 12.4 14.5 22.9 9.4 2.4 2.6 4.6 8.2 10.2 22.2 29.4 14.1 12.0 10.1 3.6 5.2 0.9 2.0 8.2 4.3 12.5 3.9 7.6 8.3 2.0 3.6 5.6 6.9 0.6 7.7 8.0 5.3 9.9 4.1 5.3 5.6 8.4 5.7 6.0 6.4 7.6 6.1 5.5 8.5 5.3 6.5 6.9 1.0 3.2 8.3 2.3 2.5 0.3 2.1 1.5 0.6 3.4 4.4 1.1 4.8 0.0 2.2 7.3 4.2 2.7 2.4 0.7 1.9 3.1 23.9 1.5 0.2 1.7 0.0 2.1 6.6 2.5 2.9 0.5 2.6 1.2 4.5 4.6 1.4 1.6 5.4 6.7 5.9 0.9 2.0 2.6 1.3 60.4 0.3 2.3 1.8 2.8 2.2 1.8 0.0 6.0 8.3 1.9 0.3 2.2 1.9 1.6 0.1 1.4 1.4 3.5 13.1 1.9 1.0 43.2 27.4 0.4 0.1 2.5 2.9 0.6 0.9 1.8 ZNF708 "KOX8, ZNF15, ZNF15L1" ENSG00000182141 "Zinc finger protein 708" P17019 19 21291160-21329425 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 58.8;Oligodendrocytes: 211.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (4.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.96e-2)" "unprognostic (3.98e-2)" "prognostic favorable (7.16e-4)" "unprognostic (2.96e-3)" "unprognostic (1.11e-2)" "unprognostic (1.67e-3)" "unprognostic (2.05e-2)" "prognostic favorable (3.53e-4)" "unprognostic (4.00e-3)" "unprognostic (1.22e-2)" "unprognostic (5.39e-2)" "unprognostic (2.94e-2)" "unprognostic (9.30e-2)" "unprognostic (8.21e-2)" "unprognostic (1.22e-3)" 2.6 3.8 2.8 6.1 15.3 5.3 6.1 9.7 10.4 5.2 0.2 3.3 3.6 4.0 4.0 2.2 3.8 3.3 3.1 4.7 11.0 2.7 1.9 4.0 8.2 15.2 12.3 2.3 10.9 4.9 2.8 3.3 3.2 16.2 5.3 3.2 6.3 4.5 3.2 2.4 2.8 3.6 2.1 8.3 4.8 5.2 3.9 10.6 6.2 6.6 3.7 6.1 3.1 2.9 30.2 1.8 1.3 11.5 6.4 3.3 2.9 10.1 3.4 1.5 2.1 3.8 3.4 2.8 0.1 4.9 2.5 2.0 1.8 4.0 2.2 3.5 1.5 6.3 9.6 4.7 2.6 1.5 8.6 2.5 2.5 2.4 1.4 2.1 3.3 3.0 4.8 6.7 0.7 3.9 2.5 7.3 6.6 15.9 0.5 3.8 8.9 5.7 4.5 1.4 12.1 9.0 5.3 3.1 0.0 2.9 6.4 4.3 5.9 4.7 3.0 1.8 4.1 3.7 5.5 5.3 11.8 0.2 3.4 2.4 13.6 2.1 4.8 4.0 2.0 5.9 4.4 5.3 6.2 2.5 4.9 6.4 5.8 8.6 5.1 2.0 2.3 4.0 2.9 2.8 15.3 9.7 10.4 4.7 11.0 15.2 12.3 2.3 16.2 8.3 10.6 30.2 11.6 32.1 8.4 34.6 19.2 1.3 6.1 4.2 4.0 11.2 5.7 5.8 3.3 2.8 4.2 9.2 10.4 3.7 20.2 3.2 5.9 7.6 0.8 9.6 22.5 8.8 7.2 8.0 38.4 5.3 2.6 16.8 13.7 12.2 12.0 52.7 7.5 1.8 2.6 16.8 43.9 3.1 2.0 2.4 1.6 1.2 8.4 5.8 3.6 30.0 3.8 12.9 20.6 58.8 211.2 6.6 1.0 6.8 8.3 4.6 2.0 2.2 5.9 15.6 6.6 19.5 12.7 8.4 6.1 3.4 0.6 3.4 18.8 36.6 2.6 3.7 IST1 "CHMP8, KIAA0174" ENSG00000182149 "IST1 factor associated with ESCRT-III" P53990 16 71845996-71931199 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041802, HPA054532" Approved Supported Vesicles NA NA 270000 Vesicles "HPA041802: AB_10794491, HPA054532: AB_2682517" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-3)" "unprognostic (2.04e-2)" "unprognostic (3.13e-3)" "unprognostic (2.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "prognostic favorable (4.55e-4)" "unprognostic (1.64e-2)" "unprognostic (7.88e-3)" "unprognostic (8.43e-3)" "prognostic favorable (8.88e-4)" 47.9 44.5 43.5 39.1 49.9 81.7 51.0 47.1 51.0 49.4 45.5 69.0 52.9 56.4 42.8 50.9 61.9 47.2 50.9 43.5 48.0 69.3 38.2 50.4 64.9 47.3 48.6 41.1 60.6 47.3 91.1 57.6 60.6 47.6 46.1 63.5 32.7 52.5 46.2 64.6 52.9 52.4 61.4 48.4 51.0 53.0 47.9 47.4 62.8 59.9 81.5 82.2 53.5 44.7 55.0 57.0 81.9 113.3 73.2 110.7 77.9 95.7 70.0 87.1 95.2 98.9 90.1 77.1 80.5 84.2 81.2 67.7 83.8 112.0 74.2 120.4 53.7 54.1 68.1 46.8 146.9 83.8 66.9 91.9 92.7 100.8 85.5 81.6 94.8 120.6 74.8 94.5 28.7 99.5 94.9 87.4 55.6 129.7 92.7 50.6 135.7 62.0 99.1 78.5 81.8 85.0 63.3 77.2 40.3 63.9 138.2 73.7 82.2 60.7 71.8 70.9 44.5 55.9 75.0 145.5 226.7 60.7 59.2 88.6 234.9 195.1 243.5 158.7 185.4 172.6 179.1 150.6 166.9 180.1 178.5 159.6 150.1 300.0 193.7 185.1 124.9 244.9 293.9 43.5 49.9 47.1 51.0 43.5 48.0 47.3 48.6 41.1 47.6 48.4 47.4 55.0 59.7 48.1 51.8 39.8 57.1 70.1 41.2 49.8 39.9 29.2 69.1 50.0 43.9 60.1 48.1 46.0 25.0 56.7 68.4 130.6 35.2 47.1 18.4 50.0 52.8 55.4 75.4 30.7 35.5 41.7 44.3 48.1 42.3 70.1 61.4 55.1 61.1 40.8 53.4 21.9 41.6 76.3 46.8 81.1 73.8 22.5 41.0 57.2 42.7 38.4 75.9 22.2 51.5 34.2 59.7 58.1 88.4 47.8 45.2 51.5 82.2 52.4 56.2 30.3 59.2 45.3 44.4 52.4 57.3 34.4 70.0 65.7 51.8 31.3 57.6 66.4 ERCC6L2 "C9orf102, FLJ37706, HEBO, RAD26L" ENSG00000182150 "ERCC excision repair 6 like 2" Q5T890 9 95871264-96121154 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 105.8;Excitatory neurons: 90.1;Inhibitory neurons: 88.5;Oligodendrocyte precursor cells: 130.7;Oligodendrocytes: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021259, HPA021260, HPA021271, HPA022422" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021259: AB_1859542, HPA021260: AB_1859544, HPA021271: AB_1859543, HPA022422: " "unprognostic (6.70e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-1)" "unprognostic (1.28e-1)" "unprognostic (8.30e-2)" "unprognostic (3.62e-2)" "unprognostic (4.64e-2)" "unprognostic (3.92e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.32e-1)" "prognostic favorable (8.70e-5)" "unprognostic (3.63e-1)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (7.39e-2)" 3.0 3.9 3.1 2.6 4.6 5.2 4.1 6.0 4.3 4.5 3.4 4.1 2.6 4.7 3.5 3.3 3.3 3.4 2.9 4.1 4.4 3.9 3.6 3.2 4.4 3.5 3.5 3.3 5.1 2.9 5.5 2.1 3.9 4.2 4.3 3.6 5.5 2.8 4.1 3.7 3.0 2.7 4.2 3.6 4.8 4.3 4.6 3.7 6.9 5.6 3.9 3.9 3.4 2.8 7.0 5.4 8.5 8.3 9.0 5.2 4.3 3.7 5.9 7.8 8.1 5.9 8.9 4.4 6.6 2.6 9.5 10.5 8.0 12.0 5.0 8.6 3.9 3.8 8.2 7.5 5.4 4.8 9.4 6.0 5.2 2.9 8.2 6.0 3.4 6.0 7.9 8.2 3.7 4.5 6.4 8.2 4.9 6.0 6.1 5.1 6.3 14.5 2.7 5.3 5.7 7.7 6.0 5.8 4.3 4.1 4.9 5.6 4.0 7.6 8.1 6.7 9.3 6.8 3.0 4.0 3.6 6.5 5.8 7.0 1.2 1.9 2.0 3.7 1.7 4.8 2.6 4.2 3.9 2.0 4.3 5.1 5.1 1.5 2.7 3.0 5.4 3.2 1.1 3.1 4.6 6.0 4.3 4.1 4.4 3.5 3.5 3.3 4.2 3.6 3.7 7.0 20.2 16.0 16.2 105.8 13.8 5.0 12.6 7.2 12.5 0.0 6.6 6.2 18.8 8.6 13.5 0.0 0.0 6.3 18.3 7.5 0.0 8.8 7.8 9.0 32.4 12.9 4.9 12.4 90.1 8.2 3.5 19.3 11.7 11.3 15.2 24.9 8.6 6.6 6.3 0.0 88.5 8.4 6.1 11.1 3.8 3.8 26.8 10.8 3.6 62.8 13.7 0.0 12.3 130.7 117.9 8.3 4.5 27.8 13.5 9.7 7.2 4.0 15.5 0.0 19.7 26.1 19.9 17.0 11.1 12.2 4.4 4.8 15.7 45.9 6.4 9.5 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551879-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 343.2;skeletal muscle: 411.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 909.5;Distal tubular cells: 972.4;Hepatocytes: 856.2;Late spermatids: 839.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 503.2;PC-3: 471.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria NA NA Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 84.5 75.3 183.7 23.1 167.4 26.3 57.9 167.3 343.2 52.4 130.1 63.8 45.8 46.3 8.5 42.7 47.0 15.0 266.1 172.0 151.9 80.1 159.1 42.5 24.8 172.5 152.2 178.2 61.6 45.2 42.5 55.6 12.3 152.4 114.0 17.6 10.0 70.2 26.4 411.4 55.4 57.3 12.3 143.5 54.7 79.8 40.6 181.8 16.3 45.3 130.5 13.2 59.9 45.8 162.3 93.7 165.9 25.5 61.9 40.7 35.5 122.1 112.8 33.1 59.1 47.4 122.6 49.6 71.0 148.4 31.5 78.0 186.5 37.4 60.0 6.4 97.9 208.6 62.0 91.9 193.6 92.8 101.1 211.4 67.3 85.4 51.5 18.2 23.4 55.4 58.7 147.8 26.8 32.6 503.2 33.7 337.6 94.6 118.0 471.6 40.1 44.0 95.9 50.5 67.7 85.7 88.6 78.0 138.6 194.5 15.2 124.0 91.5 95.4 93.1 121.3 162.9 153.4 78.4 146.2 133.7 101.8 104.4 70.9 425.2 305.5 251.8 225.6 272.9 211.5 313.8 235.0 257.0 260.3 249.7 221.0 206.2 38.3 180.8 254.2 422.6 332.2 350.3 183.7 167.4 167.3 343.2 172.0 151.9 172.5 152.2 178.2 152.4 143.5 181.8 162.3 99.0 28.9 33.6 59.7 90.7 140.1 138.3 239.3 121.3 52.4 193.9 221.5 909.5 178.7 121.1 263.0 10.4 115.9 89.7 670.5 972.4 157.8 299.6 165.2 136.0 103.1 268.5 66.0 30.6 192.1 147.7 127.1 192.7 136.7 54.0 85.4 102.1 856.2 244.8 28.6 47.7 332.9 229.9 122.7 115.4 839.0 121.8 106.0 224.1 15.9 162.1 102.7 95.8 8.0 31.1 222.8 446.5 104.6 146.9 223.1 458.4 657.6 134.9 47.5 111.7 66.8 143.8 112.6 79.7 175.6 166.1 82.2 112.8 249.9 348.8 176.8 ENPP7 "alk-SMase, NPP7" ENSG00000182156 "Ectonucleotide pyrophosphatase/phosphodiesterase 7" Q6UWV6 17 79730943-79742219 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 105.5" "Group enriched" "Detected in some" 7 "Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7" "Cancer enriched" "Detected in some" 6 "liver cancer: 6.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA024603 Approved "Intracellular and membrane" NA NA 450000 "HPA024603: AB_1848174" "unprognostic (4.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.49e-2)" "unprognostic (4.83e-2)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (1.24e-1)" "unprognostic (1.01e-1)" "unprognostic (8.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (5.21e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 11.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 9.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002086 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 141.1;Syncytiotrophoblasts: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: AB_2669210" "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 20.4 30.0 7.1 18.7 12.0 24.0 23.1 7.5 9.1 30.6 40.4 20.5 22.5 34.2 27.0 15.1 22.8 15.1 19.5 6.6 13.8 19.7 12.6 19.4 12.9 11.2 9.6 4.3 29.2 30.3 60.0 25.3 39.7 15.2 21.8 17.7 5.0 28.9 23.4 6.2 8.0 23.1 29.5 9.0 13.1 17.6 9.0 12.4 10.1 65.9 9.5 20.6 19.7 20.1 15.7 13.1 19.9 37.6 0.6 62.9 61.7 28.1 65.1 104.0 44.4 44.7 27.5 11.7 2.6 16.8 71.1 24.1 6.9 21.9 47.1 86.9 19.1 10.8 83.4 26.7 67.6 41.4 25.3 115.5 25.4 29.2 56.0 65.3 45.5 59.7 6.5 43.8 37.4 52.9 23.5 8.0 31.6 13.6 17.9 13.7 17.5 19.8 22.1 35.3 13.2 9.4 22.3 21.1 54.0 29.1 21.7 7.9 18.9 63.1 59.5 8.7 72.3 24.2 43.9 16.2 16.9 70.9 71.3 135.0 10.4 5.5 6.0 7.3 3.0 9.8 3.9 5.4 8.2 5.7 3.9 2.0 3.4 2.0 7.2 1.6 11.9 12.5 3.2 7.1 12.0 7.5 9.1 6.6 13.8 11.2 9.6 4.3 15.2 9.0 12.4 15.7 30.6 6.4 25.9 18.6 27.3 12.2 9.7 18.9 8.0 12.0 32.0 25.4 17.5 21.5 34.9 23.9 10.4 62.6 39.5 24.7 13.7 10.2 56.3 18.1 86.6 31.6 15.7 12.0 7.5 17.6 93.0 49.6 16.3 42.4 49.4 27.8 29.6 24.3 56.3 15.2 10.6 21.0 20.3 34.9 25.6 18.7 61.8 30.7 26.6 63.7 21.4 5.4 40.2 55.8 48.0 14.4 18.2 103.0 141.1 35.1 66.2 7.9 22.4 12.3 39.5 62.3 50.2 3.4 7.4 9.5 7.1 144.5 26.6 11.1 17.0 44.0 P2RY8 P2Y8 ENSG00000182162 "P2Y receptor family member 8" Q86VZ1 X 1462581-1537185 "Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 31.4;lymphoid tissue: 40.4" "Group enriched" "Detected in some" 4 "B-cells: 42.0;dendritic cells: 56.2;monocytes: 26.1;NK-cells: 56.7;Plasma cells: 49.3;T-cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 119.2;MOLT-4: 60.6;NB-4: 59.6;RPMI-8226: 74.3;THP-1: 73.7;U-266/70: 96.8;U-698: 192.8;U-937: 60.6" "Low region specificity" "Detected in single" HPA003631 Enhanced NA NA "HPA003631: AB_1079543" "unprognostic (4.32e-2)" "unprognostic (3.22e-5)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.80e-5)" "prognostic favorable (1.73e-4)" "unprognostic (5.27e-3)" "unprognostic (5.76e-3)" "unprognostic (5.52e-3)" "prognostic favorable (6.54e-4)" "unprognostic (4.29e-2)" "unprognostic (8.45e-3)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.80e-1)" 3.2 4.7 0.5 19.4 0.9 31.4 2.4 0.8 1.7 0.7 1.0 3.4 3.5 0.8 0.9 1.3 0.7 3.9 3.6 0.3 0.7 3.3 1.9 3.0 40.4 1.2 0.9 0.1 1.1 2.2 2.1 2.1 1.2 0.9 1.5 3.3 0.7 3.4 1.1 2.6 1.8 7.6 1.4 0.6 20.1 5.2 0.4 0.7 16.6 8.0 1.4 33.7 4.5 0.5 1.7 0.6 0.5 0.5 1.5 0.0 0.0 1.3 0.2 0.1 0.0 0.1 0.4 0.7 119.2 0.6 0.0 0.5 0.5 0.0 0.1 0.0 4.7 0.4 1.0 1.3 6.1 0.1 53.2 12.3 0.1 0.1 0.1 0.0 1.1 0.0 35.1 1.1 48.9 0.1 0.1 60.6 59.6 0.7 0.1 1.3 54.1 0.6 74.3 0.1 0.9 0.2 0.8 0.4 1.1 0.3 1.1 0.6 73.7 0.3 1.0 1.1 0.5 0.3 96.8 19.6 192.8 0.2 60.6 0.2 49.9 18.9 31.1 58.6 12.7 53.6 34.2 44.5 55.8 13.6 38.3 34.7 36.4 11.3 37.5 5.2 3.6 37.6 53.3 0.5 0.9 0.8 1.7 0.3 0.7 1.2 0.9 0.1 0.9 0.6 0.7 1.7 5.9 0.0 1.8 0.3 42.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 1.2 0.0 0.6 1.8 0.0 0.0 56.2 0.1 0.0 0.0 0.0 0.1 0.1 5.2 0.0 9.9 0.7 0.2 0.0 0.4 2.6 0.1 1.3 0.3 3.9 0.3 1.9 0.0 0.7 0.0 0.0 11.2 1.8 0.0 0.0 8.7 1.8 1.9 26.1 0.0 56.7 1.0 0.4 0.0 0.0 0.0 49.3 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.4 0.0 40.7 0.9 0.2 0.0 UNC5C ENSG00000182168 "Unc-5 netrin receptor C" O95185 4 95162504-95549206 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 2078.8" "Cancer enriched" "Detected in many" 4 "thyroid cancer: 6.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 310000 "unprognostic (1.55e-1)" "unprognostic (2.72e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (3.03e-1)" "unprognostic (3.20e-1)" "unprognostic (3.48e-1)" "unprognostic (3.40e-1)" "unprognostic (3.12e-1)" "unprognostic (1.11e-3)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (2.70e-5)" "unprognostic (1.25e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (3.62e-4)" 1.1 9.1 8.0 1.0 15.9 0.0 1.3 5.0 17.9 1.8 0.0 2.9 1.4 2.4 1.8 0.6 1.9 2.0 2.3 6.7 10.1 1.1 1.0 2.6 0.5 17.1 13.5 5.9 2.8 0.3 0.1 1.2 1.8 19.9 3.4 3.4 6.5 6.3 3.9 0.1 0.2 1.9 2.0 7.1 4.3 2.1 2.7 10.2 1.9 12.0 0.4 0.3 2.6 1.6 39.8 0.0 0.5 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 82.9 0.0 0.0 0.2 4.8 0.3 12.3 0.0 0.1 1.2 0.0 7.9 0.0 0.0 0.0 0.1 9.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 15.9 5.0 17.9 6.7 10.1 17.1 13.5 5.9 19.9 7.1 10.2 39.8 0.7 0.0 0.0 105.4 0.0 0.1 0.1 0.1 0.0 1.9 0.7 1.5 1.7 0.0 0.2 1.8 0.0 0.5 0.0 2.6 0.0 0.0 0.7 0.5 3.4 0.7 1.2 0.0 326.1 0.0 0.1 4.6 0.0 1.2 0.0 20.2 0.4 0.0 1.8 0.0 448.3 0.5 0.0 0.8 0.0 0.8 21.1 0.4 1.8 57.1 0.0 1.3 0.0 308.1 2078.8 0.0 26.9 11.7 0.0 0.3 0.0 0.1 0.0 12.5 6.6 0.3 4.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 MRGPRG "GPR169, mrgG" ENSG00000182170 "MAS related GPR family member G" Q86SM5 11 3217944-3218813 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058909 Uncertain NA NA "HPA058909: AB_2683852" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSEN54 "SEN54, SEN54L" ENSG00000182173 "TRNA splicing endonuclease subunit 54" Q7Z6J9 17 75515944-75524735 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease variant, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 78.4;granulocytes: 81.7;NK-cells: 87.6;T-cells: 70.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024543, HPA053097" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024543: , HPA053097: AB_2682043" "unprognostic (3.52e-2)" "unprognostic (2.52e-3)" "unprognostic (9.60e-3)" "unprognostic (2.55e-3)" "unprognostic (1.81e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (2.33e-2)" "unprognostic (8.37e-2)" "unprognostic (9.04e-2)" "prognostic favorable (2.62e-5)" "unprognostic (7.26e-3)" "unprognostic (5.01e-2)" "prognostic favorable (7.78e-5)" "unprognostic (8.69e-2)" "unprognostic (2.03e-2)" "prognostic favorable (8.54e-4)" 10.1 15.0 2.3 1.3 3.4 2.2 12.8 4.5 2.9 14.1 1.8 15.8 3.0 11.9 0.2 23.4 15.7 3.1 8.4 2.0 2.7 22.4 18.3 18.0 2.9 4.4 3.5 1.7 12.5 30.2 4.1 18.5 1.7 3.3 20.2 2.1 0.4 17.6 3.5 9.6 23.5 22.7 2.3 3.6 25.6 20.5 14.3 2.8 5.2 18.2 1.8 2.5 15.2 17.2 4.2 21.8 25.3 2.6 7.2 2.7 2.7 14.7 6.1 6.6 14.4 13.0 35.4 3.9 32.5 9.1 3.6 12.3 11.9 14.3 11.1 7.5 7.7 33.9 26.2 4.7 23.9 11.8 7.5 36.0 2.7 13.7 6.2 5.8 2.0 14.0 20.7 31.5 6.0 2.8 36.6 46.7 19.1 9.0 31.7 30.5 26.4 23.6 25.1 8.4 9.5 19.0 17.0 13.2 30.8 14.3 8.5 11.9 17.3 3.0 6.2 20.7 13.7 12.5 22.6 14.1 19.0 6.1 32.7 6.4 20.0 4.1 14.4 82.1 9.7 56.1 11.5 34.1 62.4 10.8 7.2 26.5 50.0 0.2 47.7 9.8 26.2 21.2 27.1 2.3 3.4 4.5 2.9 2.0 2.7 4.4 3.5 1.7 3.3 3.6 2.8 4.2 9.8 9.6 9.6 15.7 13.3 26.4 10.7 19.0 17.6 15.4 11.3 11.9 2.6 20.0 11.6 9.2 4.2 13.6 78.4 25.4 11.7 17.8 6.1 7.7 6.9 10.8 18.7 14.9 14.7 17.2 18.2 8.1 29.0 7.0 81.7 10.2 8.6 8.6 13.2 32.0 15.0 16.9 24.4 4.7 11.1 4.6 4.7 9.2 16.0 5.6 12.5 15.4 87.6 14.1 23.9 14.5 13.8 7.5 29.2 22.3 23.1 13.1 5.0 7.7 13.1 5.9 7.4 15.0 33.8 21.3 24.3 7.5 70.4 14.6 22.6 8.7 RGMA RGM ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 200.7" "Cell type enhanced" "Detected in many" "Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 2000000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 25.6 3.2 56.0 22.8 56.1 0.4 30.5 69.6 59.5 56.3 0.4 62.2 9.9 51.3 2.9 57.9 40.2 7.8 22.5 51.6 55.1 3.7 0.6 4.7 2.5 116.8 94.1 21.7 38.8 11.5 0.8 6.9 1.3 77.6 12.9 6.3 1.0 24.4 6.4 200.7 16.5 43.3 61.2 76.4 1.3 74.2 33.7 100.7 2.6 10.1 45.4 3.4 10.1 29.5 62.9 2.1 0.3 50.0 0.8 10.3 5.7 14.6 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.2 0.4 0.0 3.4 8.4 0.2 0.0 0.0 9.2 0.1 0.3 0.0 0.0 0.1 0.2 6.1 0.2 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 1.0 15.5 0.2 22.2 0.1 0.0 13.1 11.4 0.1 0.0 0.5 5.1 3.0 0.5 0.2 0.0 2.6 4.0 2.7 0.0 0.1 10.4 0.3 0.1 0.1 0.0 0.2 0.2 0.2 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 56.0 56.1 69.6 59.5 51.6 55.1 116.8 94.1 21.7 77.6 76.4 100.7 62.9 4.2 0.0 1.5 143.3 0.5 5.5 20.4 10.2 40.5 1.9 7.5 4.4 4.4 0.0 3.9 0.0 2.1 4.4 0.5 0.3 0.0 6.5 1.2 0.6 10.9 2.7 0.0 0.4 16.8 0.7 1.2 40.5 1.5 2.3 0.0 0.6 1.8 0.3 2.1 0.0 2.8 0.0 12.2 2.5 2.3 6.4 119.0 1.6 3.6 9.4 0.6 4.5 0.0 11.1 1.6 0.4 0.0 116.9 0.1 61.3 0.0 0.1 1.3 1.2 13.1 69.3 20.3 0.9 43.8 58.3 2.8 2.5 1.4 0.1 0.1 29.2 ASB18 ENSG00000182177 "Ankyrin repeat and SOCS box containing 18" Q6ZVZ8 2 236194872-236264409 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.0;heart muscle: 7.5;skeletal muscle: 11.5" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 6.5;Excitatory neurons: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068447 Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA068447: AB_2685991" "unprognostic (1.12e-1)" "unprognostic (7.33e-3)" "unprognostic (3.07e-1)" "unprognostic (1.78e-6)" "unprognostic (4.75e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.7 0.0 4.0 0.0 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 1.0 1.6 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 1.4 0.0 0.0 0.5 3.0 0.0 0.0 1.6 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.0 1.4 0.8 1.0 1.6 2.3 1.5 0.0 1.8 1.4 3.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805209-49813953 "Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA 370000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: AB_2683631" "prognostic favorable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.48e-4)" 20.8 21.6 9.7 33.0 10.2 40.6 20.9 10.1 12.2 25.2 10.8 27.6 43.8 22.6 15.7 18.9 24.0 28.0 17.5 9.2 11.3 25.7 23.2 35.7 51.6 12.8 10.0 8.0 33.1 17.3 2.9 14.2 19.6 11.3 35.1 26.4 1.3 42.7 22.7 9.2 20.6 49.0 20.8 10.8 66.1 27.8 5.8 11.7 40.2 32.0 10.4 33.8 23.3 23.5 16.4 11.6 0.1 0.9 0.3 30.2 31.7 3.5 6.1 27.0 42.7 56.7 0.0 23.9 0.4 4.8 22.4 18.3 6.2 0.1 10.9 3.7 29.9 0.1 55.7 0.6 3.5 22.3 5.3 103.7 49.0 0.7 16.9 1.0 29.6 21.7 2.0 0.1 3.4 10.0 0.3 11.6 13.7 0.1 0.0 1.2 14.6 1.0 1.9 8.8 22.3 0.0 0.9 7.4 10.7 3.8 0.6 1.1 36.8 9.7 8.3 1.1 3.7 2.4 0.1 0.2 0.3 23.2 19.8 2.0 20.7 22.5 38.5 16.4 32.9 14.3 17.1 15.0 14.5 21.3 18.1 13.4 12.4 6.8 17.1 27.6 7.6 15.9 22.0 9.7 10.2 10.1 12.2 9.2 11.3 12.8 10.0 8.0 11.3 10.8 11.7 16.4 17.3 32.1 20.3 11.4 28.0 3.8 6.3 10.5 6.8 0.2 9.2 9.1 6.9 17.2 16.6 12.9 0.0 5.2 15.5 28.7 0.0 9.5 6.9 5.8 3.0 13.5 9.5 8.0 0.2 7.8 3.5 11.8 52.5 6.5 83.0 13.2 16.1 7.6 21.6 0.0 0.1 21.7 8.2 20.1 6.4 34.1 11.1 32.5 0.0 15.0 16.8 2.4 19.6 1.0 0.1 5.2 21.7 11.3 14.1 4.4 51.8 5.6 12.8 1.2 6.6 5.8 8.1 0.9 0.3 7.3 4.7 2.9 17.7 6.9 20.2 6.6 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 23.4 38.1 10.3 18.5 11.2 20.3 22.8 12.1 13.9 17.9 13.5 26.4 25.0 21.8 14.7 32.3 19.2 12.7 41.1 10.8 12.2 30.3 39.8 17.7 22.5 12.2 11.5 11.1 18.7 27.6 22.0 20.7 13.0 11.0 19.7 22.2 8.4 23.9 15.4 76.8 25.1 22.6 16.8 11.0 23.4 27.6 21.1 11.5 21.6 17.8 46.7 22.6 21.0 20.3 14.7 84.5 120.5 40.7 55.6 29.1 27.2 65.7 36.7 62.7 49.6 50.5 147.1 78.4 97.8 40.3 36.9 45.2 74.5 43.1 73.2 30.6 54.6 50.4 59.6 61.0 108.5 58.4 79.3 51.4 40.5 54.5 51.4 120.4 37.9 54.2 83.3 92.4 52.2 49.7 92.3 83.4 70.1 52.7 53.7 211.1 75.1 56.1 69.4 48.4 51.3 26.9 49.8 43.5 164.2 83.7 22.5 121.1 38.1 44.8 46.9 83.3 50.3 74.6 79.0 91.4 75.0 50.5 89.5 32.1 31.3 33.0 26.3 26.1 37.3 28.2 42.9 28.4 24.8 27.3 47.5 29.9 26.9 15.0 28.1 30.1 41.8 31.4 39.5 10.3 11.2 12.1 13.9 10.8 12.2 12.2 11.5 11.1 11.0 11.0 11.5 14.7 38.0 6.4 32.4 13.7 59.9 35.1 73.9 103.1 42.7 28.0 76.5 87.6 101.1 58.6 71.4 47.8 31.3 118.0 34.0 77.4 248.4 103.7 68.1 54.6 57.8 56.3 54.5 79.8 18.2 119.7 160.7 45.0 52.0 48.4 30.4 52.5 46.8 157.2 154.5 20.2 19.3 102.8 75.3 64.5 36.0 37.8 62.1 57.2 65.8 13.1 78.3 47.9 52.5 9.0 10.7 127.5 55.9 41.8 88.8 126.6 88.6 239.2 51.1 36.2 0.0 38.7 69.0 124.5 70.8 92.8 44.2 106.9 42.6 87.5 114.9 99.0 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633168-52669683 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 1.7;brain: 5.8;intestine: 3.8;lymphoid tissue: 5.7;pituitary gland: 2.0" "Cell type enhanced" "Detected in some" "B-cells: 4.3;dendritic cells: 9.8;Endometrial stromal cells: 2.6;Hofbauer cells: 1.8;Macrophages: 2.2;T-cells: 6.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 5.8" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0" "Cell line enhanced" "Detected in some" "Daudi: 4.1;Karpas-707: 9.4;NB-4: 2.9;RPMI-8226: 13.0" "Region enhanced" "Detected in some" "hypothalamus: 4.0" "Low region specificity" "Detected in some" HPA030744 Uncertain NA NA "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.3 0.2 0.9 2.4 0.7 1.7 0.2 0.8 1.0 0.6 0.4 0.3 0.3 0.4 0.7 0.2 0.6 0.3 0.1 0.5 5.8 0.3 0.2 0.7 5.7 1.0 1.2 0.4 0.0 0.2 0.0 2.0 0.1 1.2 0.4 0.3 0.1 0.3 0.3 0.3 0.0 3.8 0.0 1.2 5.5 0.5 0.8 1.7 1.0 0.7 0.2 5.2 0.3 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 2.9 1.6 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.0 0.0 3.9 10.1 6.2 5.6 0.0 9.8 4.3 2.6 0.0 5.9 0.0 0.0 2.1 1.6 0.9 0.7 0.8 1.0 0.5 5.8 1.0 1.2 0.4 1.2 1.2 1.7 1.4 0.6 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.6 2.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.4 0.5 0.0 0.0 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: AB_2681644" "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 2.9 2.3 3.1 2.9 5.0 7.4 5.6 3.7 3.4 4.4 5.8 3.0 1.1 4.4 9.1 3.7 3.9 4.3 1.4 3.0 4.4 2.7 2.1 2.7 4.9 5.4 4.6 2.4 6.4 2.1 4.9 2.1 4.1 5.6 2.5 2.6 3.0 13.2 2.3 1.3 3.7 2.4 4.4 4.8 2.7 2.6 1.8 4.7 6.0 2.5 1.3 4.4 3.7 4.6 7.3 15.3 5.9 6.5 3.9 5.9 10.0 4.0 7.6 5.8 8.2 10.5 4.2 20.1 18.6 4.8 4.7 9.4 13.4 4.1 12.1 11.1 8.4 4.2 8.9 5.4 3.3 3.2 7.6 8.6 5.1 9.0 9.4 9.9 3.8 7.4 13.5 7.3 8.4 6.7 11.9 14.9 2.7 3.8 14.6 5.9 16.6 7.7 6.8 6.3 4.3 4.4 2.9 6.0 2.2 13.1 7.6 10.1 6.8 2.0 9.9 9.6 7.8 6.3 4.0 4.4 14.9 5.5 13.1 5.7 17.4 5.7 5.7 8.1 4.8 6.6 14.2 7.6 8.6 6.5 11.8 9.4 8.9 0.7 8.5 4.7 6.4 9.4 4.5 3.1 5.0 3.7 3.4 3.0 4.4 5.4 4.6 2.4 5.6 4.8 4.7 7.3 5.1 0.0 1.1 150.8 13.3 6.6 5.1 6.4 5.7 1.8 8.4 5.1 1.6 0.0 4.0 1.8 8.4 5.4 3.5 1.1 3.9 1.9 3.0 5.3 3.7 4.5 4.8 4.6 21.5 1.4 6.7 4.2 3.1 3.6 4.5 6.8 1.8 0.8 6.5 1.7 22.0 3.8 2.0 3.4 3.5 1.9 3.7 4.2 8.8 263.3 6.8 5.8 3.1 157.3 375.2 1.0 0.6 4.5 8.9 2.4 2.7 1.8 8.4 6.0 0.0 3.6 7.0 6.2 3.2 5.6 7.0 4.0 7.0 4.4 1.8 4.6 CRYGB CRYG2 ENSG00000182187 "Crystallin gamma B" P07316 2 208142573-208146158 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "Early spermatids: 1.1" "Group enriched" "Detected in some" 6 "ovarian cancer: 1.1;testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.6 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1 regulator of NFKB signaling" O95751 X 141111605-141177129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 124.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9" "Region enriched" "Detected in many" 5 "cerebellum: 19.2" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 26.8 34.3 3.5 0.9 5.2 0.1 28.2 2.1 8.5 45.6 0.0 15.8 0.9 54.3 1.8 21.5 49.0 1.6 11.6 6.6 4.2 33.3 4.8 19.8 0.8 4.9 3.5 5.8 47.2 19.5 10.6 124.3 0.0 4.8 34.5 0.3 3.4 55.5 6.0 5.5 31.1 12.6 2.0 1.0 14.4 18.5 10.9 5.0 0.9 54.2 0.4 0.8 33.4 30.9 6.3 0.0 24.7 3.0 8.4 5.0 6.2 0.0 5.0 5.8 6.3 8.8 0.0 8.0 0.0 4.2 7.7 6.1 10.4 3.4 7.1 4.5 0.0 6.6 0.0 11.7 0.0 2.0 0.0 1.9 10.9 3.6 5.5 2.9 5.1 5.7 0.0 0.1 0.0 5.7 31.9 0.0 0.0 3.3 0.0 34.3 0.0 2.7 0.0 7.7 4.7 0.0 3.2 0.0 4.0 0.0 1.6 5.1 0.0 11.9 0.0 6.8 0.0 21.9 0.0 0.0 0.0 3.5 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.8 0.9 2.5 0.8 0.2 2.1 2.2 1.4 0.0 6.4 0.0 1.4 2.6 1.0 3.5 5.2 2.1 8.5 6.6 4.2 4.9 3.5 5.8 4.8 1.0 5.0 6.3 8.6 0.0 5.3 4.2 4.9 6.0 16.8 4.6 16.5 29.3 23.8 20.2 2.2 30.0 8.2 23.9 8.4 2.8 5.7 0.1 43.0 13.8 0.7 7.8 13.5 12.8 5.4 0.8 9.4 14.0 1.8 16.1 3.6 6.0 2.5 8.8 12.8 0.1 0.9 20.2 9.9 0.4 8.2 0.3 1.8 1.1 22.1 1.0 3.6 7.5 0.3 21.2 5.2 7.1 15.0 13.7 0.2 38.7 0.9 11.9 0.0 43.8 4.6 13.0 13.1 15.3 26.2 0.9 7.6 16.7 6.8 1.5 5.2 13.5 0.3 15.0 ARL6IP4 "SFRS20, SR-25, SRp25, SRrp37" ENSG00000182196 "ADP ribosylation factor like GTPase 6 interacting protein 4" Q66PJ3 12 122980060-122982913 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052098 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052098: AB_2681724" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-1)" "unprognostic (4.23e-2)" "unprognostic (2.04e-3)" "unprognostic (6.48e-4)" "unprognostic (1.06e-2)" "unprognostic (1.38e-1)" "unprognostic (8.62e-2)" "unprognostic (3.03e-5)" "unprognostic (4.01e-2)" "unprognostic (8.41e-8)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (1.43e-2)" "prognostic favorable (1.08e-4)" 130.8 169.8 152.7 89.3 143.8 164.0 131.8 140.1 179.7 130.7 135.6 154.1 109.8 118.1 64.3 119.3 121.5 75.6 180.1 142.1 141.2 159.4 209.1 107.9 118.9 150.9 147.3 138.3 143.6 194.2 110.2 121.4 67.9 149.5 132.5 59.7 44.5 153.1 93.5 377.0 118.5 117.0 64.6 141.5 136.6 162.4 92.0 153.9 101.5 115.7 175.6 83.2 147.1 118.5 155.3 233.9 248.5 160.3 108.3 110.3 144.7 125.7 131.0 156.0 192.5 145.4 123.9 96.2 220.5 160.3 166.8 90.1 120.3 129.1 212.6 85.2 197.1 134.8 367.3 227.3 246.5 211.4 202.8 155.6 151.0 168.3 148.4 193.7 210.1 214.8 174.6 166.4 104.3 156.2 274.1 237.5 367.4 126.5 140.1 156.0 178.1 175.9 262.6 168.2 195.1 155.1 185.2 123.7 204.3 314.5 69.6 268.4 259.5 194.5 110.7 202.4 106.6 166.1 221.6 115.0 255.4 159.9 233.8 141.6 182.2 250.1 266.6 194.6 327.5 209.3 241.1 231.4 217.0 315.8 233.8 219.7 198.4 68.5 216.9 385.2 215.0 272.3 298.5 152.7 143.8 140.1 179.7 142.1 141.2 150.9 147.3 138.3 149.5 141.5 153.9 155.3 239.4 93.0 127.9 33.6 228.0 204.4 313.8 271.4 156.5 111.1 309.0 379.5 0.0 207.3 146.2 211.5 43.8 282.2 262.0 361.9 516.5 306.3 200.5 141.3 168.6 218.7 223.3 147.5 27.1 635.5 261.0 197.4 171.8 112.1 167.1 273.3 240.2 465.6 386.5 97.6 26.5 332.6 170.9 401.4 412.8 380.8 222.4 270.7 377.1 23.4 477.6 231.0 324.4 18.6 26.4 395.6 332.8 180.9 241.6 337.3 706.6 814.9 135.8 125.5 177.5 215.3 242.7 189.1 164.2 188.8 203.3 240.2 228.5 353.8 331.7 370.1 EXT1 "LGCR, LGS, ttv" ENSG00000182197 "Exostosin glycosyltransferase 1" Q16394 8 117794490-118111826 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant, Hereditary multiple exostoses, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 229.6;Inhibitory neurons: 421.4;Microglial cells: 144.3;Oligodendrocyte precursor cells: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 95.5;fHDF/TERT166: 82.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044394 Uncertain NA Yes 17000000 "HPA044394: AB_10963838" "unprognostic (1.29e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.73e-2)" "unprognostic (2.02e-3)" "unprognostic (2.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.70e-1)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (6.58e-2)" "unprognostic (1.27e-2)" "unprognostic (9.84e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.85e-1)" 5.1 4.2 1.6 5.3 2.6 1.1 4.3 2.4 2.4 7.7 4.5 7.7 14.2 5.0 2.9 5.6 3.9 5.8 7.1 3.2 1.9 3.9 13.4 8.0 3.0 1.2 2.2 2.1 5.1 5.5 3.3 1.8 11.2 1.4 5.1 8.3 2.8 3.2 7.8 1.5 7.8 11.8 6.1 1.4 5.2 5.4 2.4 1.3 3.0 5.3 2.4 3.8 11.9 4.3 2.0 29.3 8.5 13.5 5.5 22.8 23.0 5.9 51.5 95.5 40.9 39.4 10.0 3.1 0.5 24.8 82.1 24.0 19.8 5.0 31.4 55.7 12.5 9.9 1.5 5.9 6.5 10.0 0.0 1.6 10.8 10.8 38.8 38.5 47.7 28.1 2.9 0.9 7.4 18.7 3.2 1.8 0.2 4.6 13.7 10.1 0.0 4.1 1.3 23.1 7.6 4.5 4.0 8.0 3.9 9.2 32.6 5.3 0.5 32.0 35.2 28.7 32.0 15.8 5.5 5.1 2.4 36.5 0.0 9.2 0.1 0.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.4 0.2 0.3 0.1 1.6 2.6 2.4 2.4 3.2 1.9 1.2 2.2 2.1 1.4 1.4 1.3 2.0 21.1 19.2 6.0 127.3 3.0 54.8 23.0 27.7 10.2 23.6 7.8 10.8 6.5 24.3 13.7 7.3 14.6 6.5 5.1 49.2 0.0 37.3 1.8 17.7 37.1 25.9 4.8 1.7 229.6 20.1 3.9 32.6 11.7 18.2 7.0 108.3 16.8 32.9 2.5 10.1 421.4 25.5 4.1 37.9 13.9 2.7 17.4 9.6 19.6 144.3 8.1 5.9 4.1 162.8 101.8 27.4 16.1 36.1 5.3 19.3 44.9 4.9 14.2 22.4 0.0 17.1 36.4 0.6 5.1 12.6 47.3 12.2 4.2 35.0 26.3 26.8 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229573-57234935 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 183.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 2292.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Supported Microtubules,Mitochondria NA NA 390000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavorable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 22.4 25.6 20.6 43.7 19.4 41.8 24.0 21.0 22.1 20.5 19.2 32.7 35.8 19.5 19.0 46.8 23.5 20.4 24.4 21.2 20.7 32.7 183.8 23.8 52.6 21.3 20.8 17.5 26.0 62.8 15.7 15.9 33.9 22.9 13.9 27.5 14.0 31.0 11.8 36.9 36.7 27.2 27.5 21.5 35.1 32.5 5.1 22.6 36.4 35.0 30.8 59.1 26.6 23.8 22.9 246.9 137.6 123.5 368.0 101.8 152.4 238.1 140.8 237.9 197.0 176.5 200.1 120.4 499.8 217.3 186.5 80.6 167.3 229.4 250.6 108.9 265.0 201.9 199.7 79.6 180.1 680.9 333.1 181.0 191.2 351.9 163.4 538.4 176.0 175.3 283.8 223.0 472.3 141.0 210.6 271.0 217.9 123.1 111.8 223.4 181.2 2292.7 433.6 95.9 151.1 265.4 119.9 73.0 170.1 518.3 48.5 222.9 424.2 108.8 84.6 150.5 96.1 185.0 574.1 338.4 421.4 169.6 320.2 154.0 34.9 41.2 23.3 26.6 50.6 31.5 127.5 46.3 29.4 59.6 137.9 21.1 22.0 2.0 40.1 34.1 20.4 202.8 53.8 20.6 19.4 21.0 22.1 21.2 20.7 21.3 20.8 17.5 22.9 21.5 22.6 22.9 9.1 9.6 14.1 4.2 58.2 34.7 23.0 43.5 39.9 7.0 26.5 24.0 12.1 21.5 23.5 3.7 0.0 55.4 11.6 9.6 13.7 45.7 0.4 6.3 22.6 17.1 9.6 53.8 3.7 47.7 52.7 25.5 23.4 10.9 29.2 18.7 22.1 182.8 50.2 8.4 3.2 24.2 34.6 36.0 25.1 0.9 18.0 23.5 39.2 3.7 32.0 45.3 21.6 4.0 2.4 40.1 18.7 16.1 74.4 18.2 15.9 63.6 13.3 6.2 6.6 23.9 40.2 1.9 6.6 52.9 32.5 37.4 21.1 39.5 37.4 23.8 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 29.8 19.8 36.0 19.4 36.3 24.4 28.5 37.9 40.0 26.5 37.0 49.5 18.2 31.0 36.8 52.4 34.7 28.0 43.9 35.9 36.6 18.8 20.2 24.9 27.0 37.2 37.5 34.7 28.3 33.0 35.1 11.3 25.9 37.0 32.8 35.2 14.7 35.5 42.7 51.3 50.4 28.8 49.4 37.0 25.3 28.1 14.3 37.1 34.5 24.5 71.0 27.2 40.3 31.9 37.0 29.3 31.2 18.3 15.7 44.2 30.8 17.1 22.5 30.9 40.4 31.8 20.1 39.0 20.9 16.7 50.6 26.0 34.8 28.1 48.6 24.3 28.8 44.3 16.0 11.7 26.2 30.2 21.2 24.2 25.1 57.9 21.9 25.3 32.7 43.6 27.0 26.3 21.2 20.7 20.6 27.4 37.7 23.0 54.3 29.4 19.9 19.0 22.2 34.4 26.9 34.6 37.3 27.3 34.0 27.9 23.0 15.9 21.3 37.7 25.6 13.1 8.3 14.5 21.6 22.3 21.8 17.9 20.3 19.8 9.7 8.7 11.9 16.2 9.2 13.6 8.1 14.1 13.7 10.6 11.0 11.6 10.2 7.1 12.1 13.4 7.5 15.3 10.6 36.0 36.3 37.9 40.0 35.9 36.6 37.2 37.5 34.7 37.0 37.0 37.1 37.0 84.8 6.4 10.0 6.5 20.2 82.2 30.1 39.4 12.0 18.4 27.8 33.3 14.8 12.8 18.4 7.3 12.5 31.1 64.5 58.6 27.4 33.5 24.3 18.9 17.7 58.2 20.9 36.2 15.2 38.5 31.0 23.3 16.8 29.2 24.8 20.3 33.9 9.0 26.4 43.7 10.9 32.8 32.6 18.2 39.3 12.1 23.9 28.1 56.9 11.2 29.4 21.5 81.4 6.6 14.8 39.6 63.2 51.1 17.0 48.6 54.3 23.9 12.9 21.4 85.5 20.8 68.3 29.8 41.1 13.7 82.0 59.4 36.4 20.2 27.7 37.6 HHIPL1 KIAA1822 ENSG00000182218 "HHIP like 1" Q96JK4 14 99645129-99680569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3" "Cell type enhanced" "Detected in some" "Astrocytes: 33.3;Bipolar cells: 10.5;Excitatory neurons: 8.3;Inhibitory neurons: 12.2;Muller glia cells: 13.1;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.1;fHDF/TERT166: 5.6;SiHa: 3.7;THP-1: 3.9" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA 120000 "unprognostic (6.16e-2)" "unprognostic (3.44e-2)" "unprognostic (3.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (2.75e-2)" "unprognostic (4.70e-3)" "unprognostic (6.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.35e-3)" "unprognostic (8.49e-6)" "unprognostic (2.52e-2)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (7.12e-6)" 1.2 0.3 6.6 1.1 7.7 0.1 0.9 3.8 8.3 1.4 2.6 1.6 0.5 2.5 0.4 0.8 1.3 1.2 1.3 6.9 4.4 0.4 0.6 0.7 1.0 5.4 4.3 7.2 1.0 0.2 0.3 0.9 0.6 5.8 1.7 0.3 2.1 0.8 0.9 0.3 0.5 0.9 1.8 3.2 1.0 0.8 0.4 5.0 0.1 0.5 0.4 0.6 1.3 1.1 4.9 0.0 0.2 0.4 0.1 0.1 0.0 1.7 1.6 0.4 0.3 0.1 0.1 0.5 0.1 3.1 5.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.9 0.1 1.2 0.2 0.1 1.4 0.1 0.0 0.1 0.9 0.2 0.0 0.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.6 3.7 0.0 0.0 0.6 0.0 3.9 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 7.7 3.8 8.3 6.9 4.4 5.4 4.3 7.2 5.8 3.2 5.0 4.9 1.6 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.0 10.5 0.3 0.8 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 2.0 1.7 0.0 0.0 8.3 0.0 0.1 2.6 0.0 0.0 0.0 0.9 0.7 0.3 1.9 0.0 12.2 0.0 0.0 2.1 0.7 0.2 0.3 0.3 3.6 6.5 0.0 13.1 0.0 13.0 6.2 0.0 1.4 1.9 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.9 0.9 0.3 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.1 ATP6AP2 "APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR" ENSG00000182220 "ATPase H+ transporting accessory protein 2" O75787 X 40579372-40606848 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 771.3" "Cell type enhanced" "Detected in all" "Hofbauer cells: 702.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003156 Approved NA NA 140000 "HPA003156: AB_1078245" "unprognostic (1.45e-1)" "unprognostic (3.80e-3)" "unprognostic (1.30e-1)" "unprognostic (7.19e-2)" "unprognostic (8.58e-3)" "unprognostic (1.29e-1)" "unprognostic (1.63e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-1)" "unprognostic (4.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.01e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-1)" "unprognostic (1.62e-2)" "unprognostic (2.86e-2)" 81.9 72.2 93.7 61.1 101.0 125.5 96.1 91.5 112.9 107.0 90.2 83.7 32.4 87.4 92.1 70.7 76.3 80.4 55.6 102.1 116.7 167.1 97.6 88.1 68.0 94.8 97.1 101.1 69.5 53.7 771.3 30.9 107.8 97.0 87.4 89.9 100.2 39.7 98.8 18.5 72.5 48.2 125.8 96.8 69.6 49.6 40.7 96.9 72.6 178.7 40.5 73.1 98.7 41.7 125.6 83.9 117.5 78.7 106.7 472.6 312.4 47.9 182.4 274.1 127.0 152.9 68.0 142.6 48.4 88.1 257.0 141.3 86.6 114.0 136.0 168.2 92.7 97.7 57.5 100.2 66.5 172.0 104.6 111.6 259.6 175.2 154.2 121.4 200.3 168.1 46.1 63.8 130.7 201.7 109.8 45.5 93.7 73.4 140.8 112.7 43.8 132.6 161.6 182.8 96.8 55.2 51.9 185.8 111.7 118.4 284.2 147.8 97.1 172.5 175.0 91.3 207.7 62.8 38.0 70.7 46.2 139.1 93.0 138.5 269.0 511.1 404.8 156.1 364.9 164.3 106.7 157.3 161.9 341.3 110.3 174.8 159.3 255.9 141.2 378.6 124.2 167.2 692.9 93.7 101.0 91.5 112.9 102.1 116.7 94.8 97.1 101.1 97.0 96.8 96.9 125.6 102.3 57.7 65.6 36.2 65.4 97.3 135.4 254.3 46.1 155.8 74.1 61.2 30.4 94.4 175.4 138.0 54.2 173.4 109.6 70.3 62.6 146.6 3.6 97.2 115.5 94.7 57.1 62.3 44.8 59.1 106.3 156.5 34.7 124.5 87.5 63.7 96.0 64.0 702.2 188.4 56.3 54.6 349.9 279.5 263.3 9.5 117.4 222.0 149.4 28.1 185.4 193.0 72.1 40.2 40.6 64.0 58.9 151.2 74.8 97.9 61.0 106.4 127.4 93.3 105.2 116.7 138.7 106.7 43.1 60.0 99.9 174.4 100.3 188.2 63.6 121.1 ZAR1 Z3CXXC6 ENSG00000182223 "Zygote arrest 1" Q86SH2 4 48490252-48494389 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.8;testis: 1.4" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Inhibitory neurons: 1.9;Late spermatids: 8.6;Oligodendrocyte precursor cells: 3.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 2.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "midbrain: 2.1" NA NA "unprognostic (9.71e-2)" "unprognostic (2.58e-1)" "unprognostic (4.59e-3)" "unprognostic (2.47e-2)" "unprognostic (6.83e-2)" "unprognostic (2.41e-1)" "unprognostic (3.54e-1)" "unprognostic (1.08e-1)" "unprognostic (6.35e-2)" "unprognostic (6.32e-5)" "unprognostic (4.51e-1)" 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.8 0.0 0.8 0.1 2.8 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 12.8 13.1 10.6 5.6 9.1 7.9 12.3 9.9 9.9 9.5 14.2 8.8 6.2 10.2 15.4 8.2 26.6 8.8 13.5 9.2 13.2 18.0 12.7 8.3 4.8 10.1 10.4 8.1 13.2 11.5 10.9 16.7 6.7 8.9 11.4 7.2 30.3 10.4 11.7 10.7 9.7 6.4 8.7 9.8 6.0 8.9 8.9 10.0 7.6 21.5 13.7 5.5 7.5 7.9 8.2 24.6 17.9 8.5 22.4 14.8 13.0 5.0 12.5 12.2 13.0 12.4 11.3 4.6 10.5 8.6 10.0 7.6 21.3 18.9 16.1 19.4 7.1 21.9 6.9 24.6 16.3 6.7 12.4 4.7 11.2 19.9 22.8 20.2 8.0 14.0 25.3 5.2 7.0 7.3 10.7 19.5 5.0 10.7 16.0 18.2 13.2 3.9 10.7 20.4 4.7 11.4 7.6 19.9 10.8 11.6 8.5 12.6 5.0 9.9 9.9 8.7 17.8 15.9 3.7 9.7 5.8 20.8 6.7 6.5 0.3 0.9 0.0 1.0 0.7 1.1 1.2 0.8 0.5 1.2 0.5 2.1 1.1 0.9 0.6 0.4 0.5 0.8 0.7 10.6 9.1 9.9 9.9 9.2 13.2 10.1 10.4 8.1 8.9 9.8 10.0 8.2 21.8 12.8 19.5 5.9 4.5 5.1 6.7 4.9 1.8 4.8 22.2 18.4 0.3 7.2 11.0 5.5 20.9 4.2 7.7 5.0 13.7 4.2 71.9 45.5 16.3 14.7 6.0 0.8 6.8 3.1 2.7 13.2 13.3 27.2 10.8 4.6 6.8 8.3 3.9 1.7 5.9 8.5 4.1 1.6 4.3 42.6 4.7 29.1 5.4 2.8 0.3 6.7 0.0 0.5 2.2 7.7 4.5 3.8 5.1 7.8 4.5 11.9 47.3 20.3 6.6 41.9 7.5 4.4 2.7 8.5 6.1 2.6 4.4 2.9 8.3 2.5 FAM153B ENSG00000182230 "Family with sequence similarity 153 member B" P0C7A2 5 176060689-176116015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.8;ovary: 7.3;pituitary gland: 6.8;testis: 22.1" "Cell type enhanced" "Detected in many" "Early spermatids: 285.8;Excitatory neurons: 59.6;Leydig cells: 101.2;Peritubular cells: 51.6;Sertoli cells: 309.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 5 "U-2 OS: 1.5" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain NA NA "HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836" "unprognostic (1.08e-2)" "unprognostic (4.15e-2)" "unprognostic (1.92e-1)" "unprognostic (2.66e-2)" "unprognostic (2.45e-1)" "unprognostic (1.09e-3)" "unprognostic (1.66e-2)" "unprognostic (3.62e-3)" "unprognostic (3.59e-1)" "unprognostic (4.47e-2)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (5.66e-2)" "unprognostic (2.62e-2)" "unprognostic (3.06e-1)" 0.1 0.9 11.1 1.4 4.0 0.9 0.1 16.2 16.8 0.6 0.0 0.1 0.1 0.3 2.2 0.2 3.1 1.3 0.7 9.4 1.1 0.2 0.1 0.5 2.9 0.2 0.1 5.3 7.3 1.7 0.5 6.8 0.0 7.4 2.4 0.2 0.9 0.6 0.7 0.3 0.8 0.3 0.0 0.0 1.1 0.6 22.1 0.3 0.3 1.2 0.0 1.2 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 1.2 1.0 0.2 0.2 0.0 1.0 0.2 0.1 11.1 4.0 16.2 16.8 9.4 1.1 0.2 0.1 5.3 7.4 0.0 0.3 5.6 0.0 0.0 0.5 5.2 0.1 2.0 3.2 0.9 2.2 7.1 0.1 0.1 1.8 2.8 0.3 0.0 2.1 0.0 1.3 0.1 0.0 0.8 285.8 0.2 0.2 1.8 0.0 0.4 59.6 0.2 0.2 3.9 0.0 0.1 0.0 8.0 1.8 0.3 0.0 0.0 32.7 0.0 2.0 0.0 4.1 31.3 101.2 0.9 1.8 0.0 0.2 1.3 0.0 0.5 0.3 0.2 0.0 51.6 0.0 3.1 0.1 0.0 2.8 1.0 309.0 2.1 7.0 3.7 2.3 0.7 2.7 0.0 1.8 1.4 0.0 1.3 BACE2 "AEPLC, ALP56, CEAP1, DRAP" ENSG00000182240 "Beta-secretase 2" Q9Y5Z0 21 41167801-41282530 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.0" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 290.4;Syncytiotrophoblasts: 514.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;eosinophil: 5.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 5.2" "Cell line enhanced" "Detected in many" "OE19: 73.8;SK-BR-3: 53.3;SK-MEL-30: 52.6;WM-115: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035416 Approved "Intracellular and membrane" NA NA "HPA035416: AB_2732467" "unprognostic (1.71e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (5.23e-2)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.52e-2)" "unprognostic (2.58e-2)" "unprognostic (2.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (8.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (5.83e-2)" 8.8 1.6 3.7 4.3 2.8 0.6 7.7 4.7 6.2 6.1 8.9 7.3 3.5 8.8 1.9 9.5 6.3 8.3 4.5 2.9 3.7 9.8 1.7 4.4 3.1 7.1 3.6 1.4 2.7 13.2 2.3 1.5 3.0 4.8 8.4 4.5 0.3 27.0 2.7 2.2 4.5 4.6 4.8 6.4 4.8 23.2 1.0 5.4 1.1 4.6 2.2 3.6 6.7 5.7 9.7 27.4 2.1 12.6 0.0 2.5 2.1 0.1 6.3 0.0 3.9 3.8 0.0 9.6 0.1 12.2 7.1 7.2 8.1 0.0 13.6 1.4 0.0 12.6 6.2 3.3 0.0 1.0 0.0 14.4 5.5 2.8 0.5 2.7 20.9 12.1 6.4 0.0 0.1 6.0 6.1 3.4 0.0 8.5 73.8 12.1 1.0 0.0 9.8 11.5 2.5 0.4 0.1 0.5 53.3 52.6 1.0 12.0 0.1 15.8 7.3 5.3 6.5 10.9 0.1 0.1 0.0 17.8 0.0 46.2 2.9 0.0 5.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 2.8 4.7 6.2 2.9 3.7 7.1 3.6 1.4 4.8 6.4 5.4 9.7 55.0 12.8 15.9 11.8 28.6 18.5 91.6 25.6 42.7 0.8 40.3 33.8 9.7 123.0 72.5 20.2 2.1 127.6 0.5 40.5 93.9 146.3 24.3 65.4 19.8 90.2 18.5 22.1 11.7 105.2 64.2 34.0 186.6 115.8 90.7 6.7 35.3 1.0 28.0 0.0 7.5 86.2 44.7 17.0 8.2 16.0 14.3 3.6 179.7 20.6 2.9 3.1 0.0 9.5 46.0 86.6 23.9 18.8 3.2 290.4 7.3 1.4 76.5 0.8 0.0 15.9 23.6 0.6 1.4 43.5 11.8 514.7 6.2 8.7 56.6 134.2 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591794 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 652.7;Inhibitory neurons: 399.4;Microglial cells: 402.8;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 845.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 41.7;intermediate monocyte: 50.3;memory B-cell: 35.1;myeloid DC: 57.6;naive B-cell: 40.1;non-classical monocyte: 54.4;plasmacytoid DC: 74.0" "Group enriched" "Detected in all" 6 "B-cells: 40.1;dendritic cells: 74.0;monocytes: 54.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm No No Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 22.1 9.0 14.4 10.7 18.9 7.1 18.5 15.9 28.3 21.0 12.0 14.2 4.6 18.3 26.0 17.5 13.8 15.6 20.0 19.8 18.6 16.9 13.5 18.0 16.6 15.3 15.1 17.4 16.4 7.1 13.6 12.1 7.5 16.1 14.8 4.9 16.8 12.0 13.5 16.1 16.3 8.4 19.0 13.1 14.4 11.7 15.3 15.6 18.3 14.0 12.5 12.7 16.3 17.9 28.9 36.7 12.9 33.3 0.6 29.0 32.1 30.3 22.6 38.2 20.8 29.0 3.6 29.2 31.7 15.1 19.9 28.5 3.5 24.5 35.2 26.5 0.2 24.6 0.0 15.3 4.3 20.8 0.0 24.5 25.6 36.2 30.0 50.0 21.1 20.2 24.5 1.9 32.4 19.0 5.9 16.8 7.2 23.7 20.7 18.6 34.9 13.0 36.8 20.4 0.8 8.5 17.7 24.8 14.4 0.4 23.8 30.7 20.9 17.8 20.4 29.1 13.8 25.7 31.2 10.9 49.4 19.2 14.2 5.8 0.1 41.7 0.2 0.7 50.3 0.9 35.1 1.4 0.6 57.6 40.1 9.1 3.5 1.1 2.5 54.4 74.0 0.7 15.7 14.4 18.9 15.9 28.3 19.8 18.6 15.3 15.1 17.4 16.1 13.1 15.6 28.9 13.3 22.4 9.8 159.3 48.4 25.6 12.2 77.2 34.7 24.0 31.3 27.1 38.2 15.7 28.1 31.3 16.7 34.8 24.2 0.9 68.4 12.0 24.2 9.6 30.8 24.6 1.8 8.2 652.7 29.2 43.1 42.1 5.6 18.8 0.0 38.5 14.6 41.4 47.7 32.0 399.4 1.1 67.1 47.3 73.9 16.0 39.4 49.2 78.2 402.8 40.5 14.8 1.0 513.2 845.2 13.9 1.2 53.0 32.8 64.6 0.0 152.7 17.3 3.6 32.9 14.9 67.3 36.3 91.0 44.1 42.3 38.6 4.6 15.1 0.7 8.6 SYNM "DMN, KIAA0353, SYN" ENSG00000182253 Synemin O15061 15 99098217-99135593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 414.2;skeletal muscle: 630.6;urinary bladder: 409.7" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5" "Cancer enhanced" "Detected in all" "prostate cancer: 28.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 36.8;HeLa: 58.0;WM-115: 124.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017192, HPA040066, HPA044200, HPA077856" Enhanced Supported "Intermediate filaments" NA NA "Intermediate filaments" "CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (3.52e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.34e-2)" "unprognostic (6.75e-2)" "unprognostic (3.54e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-2)" "unprognostic (5.92e-3)" "unprognostic (3.26e-3)" 37.6 20.5 61.9 26.8 67.4 0.4 57.3 78.6 58.7 11.3 57.2 414.2 27.3 51.2 12.8 171.2 36.8 19.4 138.6 49.8 102.4 4.4 4.9 23.3 4.3 88.2 70.6 46.8 14.2 6.4 8.3 23.3 14.1 83.3 151.9 52.5 40.7 25.8 294.1 630.6 15.7 106.6 162.5 82.4 2.9 159.7 5.2 78.5 3.8 11.3 279.6 4.1 409.7 41.3 91.5 6.6 36.8 8.1 21.9 15.9 0.9 0.5 3.7 5.3 2.1 1.3 5.4 4.9 0.0 5.3 5.3 17.7 4.2 5.5 0.1 1.6 0.5 9.0 0.1 58.0 5.4 9.0 0.0 1.0 0.9 0.3 3.7 0.8 6.0 4.3 0.0 0.2 7.4 5.5 3.7 0.7 0.8 7.2 0.7 11.4 0.0 7.5 5.5 2.1 3.6 3.6 4.2 21.9 3.4 13.5 12.7 0.2 3.6 4.8 4.1 0.4 2.9 8.9 0.1 1.0 0.0 0.4 0.0 124.5 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 61.9 67.4 78.6 58.7 49.8 102.4 88.2 70.6 46.8 83.3 82.4 78.5 91.5 14.8 0.0 1.7 15.3 0.9 2.3 0.7 0.9 2.8 12.6 32.7 103.5 502.5 0.0 1.2 0.0 16.7 1.5 6.6 2.1 0.0 0.5 9.5 1.3 1.0 24.2 3.0 0.0 15.6 1.3 0.7 20.3 5.1 4.2 0.0 1.1 3.6 1.3 0.3 42.1 9.8 0.9 0.0 0.0 5.1 4.5 1.2 2.0 5.4 12.2 0.6 127.8 1.0 2.5 14.0 0.2 2.3 4.1 5.4 2.0 0.6 0.3 3.1 10.2 32.9 19.6 98.5 7.9 11.5 2.1 3.7 0.4 5.9 0.2 0.7 0.9 KCNA4 "HK1, HPCN2, KCNA4L, Kv1.4" ENSG00000182255 "Potassium voltage-gated channel subfamily A member 4" P22459 11 30009730-30017030 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 6.1;brain: 19.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001977, HPA016422" Approved NA NA "CAB001977: , HPA016422: AB_1855574" "unprognostic (1.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" "unprognostic (6.71e-2)" "unprognostic (1.17e-1)" 0.8 6.1 3.3 0.0 19.4 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 5.2 4.0 0.2 0.0 0.7 0.0 2.9 1.8 6.6 0.0 0.0 0.0 1.3 0.2 4.2 0.0 0.0 1.9 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 6.9 0.0 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 19.4 0.0 5.7 5.2 4.0 2.9 1.8 6.6 4.2 0.0 6.9 6.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 8.2 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 13.5 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.4 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRG3 ENSG00000182256 "Gamma-aminobutyric acid type A receptor subunit gamma3" Q99928 15 26971181-27541984 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 12.3;retina: 27.3;testis: 9.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 444.7;Inhibitory neurons: 615.5;Late spermatids: 351.0;Muller glia cells: 179.9" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 4.5;PC-3: 5.5;SK-MEL-30: 3.5;U-2 OS: 2.5;U-266/70: 3.2;U-87 MG: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054010 Approved NA NA "HPA054010: AB_2682342" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (3.50e-2)" "unprognostic (2.61e-1)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (4.41e-1)" "unprognostic (1.43e-5)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" 0.0 0.4 2.6 0.2 3.2 0.0 0.4 0.0 5.9 0.8 0.0 0.0 0.0 0.1 2.0 0.0 0.4 0.0 0.0 1.3 12.3 0.2 0.1 0.0 0.6 1.1 0.2 1.3 0.0 0.0 0.0 3.0 0.0 1.7 6.6 0.0 27.3 0.8 0.2 0.0 0.2 0.0 0.0 0.0 1.0 0.0 9.3 6.8 1.0 1.5 0.0 0.8 0.0 0.2 3.8 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 5.5 0.0 0.0 1.0 0.0 0.0 0.1 1.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.2 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.2 0.0 5.9 1.3 12.3 1.1 0.2 1.3 1.7 0.0 6.8 3.8 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 4.6 2.5 1.4 0.9 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 86.2 3.2 0.1 0.3 0.0 0.0 444.7 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 615.5 0.0 0.0 0.0 0.0 351.0 0.9 0.2 0.0 7.5 0.0 179.9 0.0 16.1 7.9 0.0 0.0 0.7 0.0 3.1 0.0 0.3 0.0 4.6 0.0 0.1 0.1 1.6 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7957537-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 1.4;skin 1: 5.3" "Cell type enriched" "Detected in single" 5 "Microglial cells: 1.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7" "Region enhanced" "Detected in some" "olfactory bulb: 2.1" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.1 0.0 0.1 0.1 1.4 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 22.3 0.0 0.0 0.1 0.0 0.3 0.1 5.9 2.8 1.3 2.8 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 1.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 161.3;Inhibitory neurons: 82.9;Oligodendrocyte precursor cells: 309.6;Oligodendrocytes: 129.4;Sertoli cells: 72.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 34 "basophil: 3.3" "Lineage enriched" "Detected in single" 34 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "AF22: 18.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 3.0 2.0 3.9 0.4 4.4 0.8 2.0 2.5 3.9 2.2 0.1 2.0 0.4 1.2 1.2 0.6 2.0 1.1 3.2 2.4 5.2 2.0 3.2 1.4 0.6 3.1 4.0 2.5 4.6 2.9 0.4 2.6 1.1 3.4 1.6 0.8 1.4 2.6 2.7 1.0 0.9 1.4 0.9 1.8 3.0 1.8 1.2 4.2 0.2 1.1 1.7 0.2 1.8 2.4 4.9 6.4 2.3 18.6 0.0 0.0 0.0 6.8 2.4 1.6 1.7 3.2 0.0 2.2 0.0 6.6 2.6 3.4 0.9 6.2 2.6 1.3 0.0 4.6 0.0 4.7 4.6 1.5 0.0 0.0 0.8 2.2 3.3 9.0 2.6 4.0 0.0 0.0 0.0 5.1 1.6 0.0 0.0 7.9 0.4 2.9 0.0 6.3 0.0 4.2 2.1 2.9 2.5 0.0 1.8 1.7 10.3 2.0 0.0 0.4 7.6 6.8 0.0 5.1 1.1 0.0 0.0 2.3 0.0 4.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 4.4 2.5 3.9 2.4 5.2 3.1 4.0 2.5 3.4 1.8 4.2 4.9 2.9 6.4 7.3 161.3 0.7 1.9 0.1 2.8 1.8 24.4 5.7 2.7 19.4 20.0 3.0 12.9 0.0 21.2 0.2 0.1 1.9 3.7 3.8 0.7 0.7 2.1 0.0 0.0 53.4 1.5 7.4 11.6 4.1 1.6 0.0 23.6 7.9 13.5 1.4 6.7 82.9 0.0 4.1 0.0 1.6 6.4 51.9 0.6 17.8 28.1 0.0 4.3 0.0 309.6 129.4 1.1 0.0 34.3 0.0 1.8 0.0 8.1 4.0 2.1 72.3 16.6 17.8 1.1 1.2 1.0 0.4 16.8 0.2 7.0 0.0 0.0 IZUMO1 "IZUMO, MGC34799, OBF" ENSG00000182264 "Izumo sperm-egg fusion 1" Q8IYV9 19 48740852-48746909 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 19.1" "Group enriched" "Detected in some" 44 "Early spermatids: 156.4;Late spermatids: 112.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038104 Enhanced NA NA "HPA038104: AB_10670655" "unprognostic (2.03e-1)" "unprognostic (1.86e-3)" "unprognostic (3.73e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (7.92e-2)" "unprognostic (3.49e-2)" "unprognostic (2.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" "unprognostic (4.83e-2)" "unprognostic (1.32e-2)" "unprognostic (3.68e-1)" "unprognostic (2.92e-1)" "unprognostic (4.31e-3)" "unprognostic (6.92e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.3 0.0 0.0 0.0 0.6 0.1 0.4 0.2 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.9 19.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 1.6 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.3 0.7 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 156.4 0.3 0.2 2.3 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.9 0.0 0.0 2.9 0.0 0.4 0.0 0.3 0.5 2.0 0.0 1.3 112.7 1.2 0.9 1.8 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 3.0 1.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 141.7" "Group enriched" "Detected in some" 28 "Distal enterocytes: 291.9;Paneth cells: 125.5;Proximal enterocytes: 476.6" "Cancer enriched" "Detected in single" 5 "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021946 Approved Mitochondria NA NA Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 141.7 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 291.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 125.5 0.0 0.0 0.0 476.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.5 0.0 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369499-382117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.6;ovary: 28.0" "Cell type enhanced" "Detected in many" "Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 0.7 0.6 23.5 0.9 17.3 0.0 3.3 5.8 33.6 15.0 0.0 4.7 0.6 14.2 0.6 2.4 12.0 0.5 1.1 24.2 11.8 0.5 0.3 0.5 0.3 20.1 20.6 21.0 28.0 1.1 2.6 18.0 0.0 19.6 6.3 0.2 5.4 2.0 1.2 0.1 2.1 2.9 1.0 8.2 0.3 2.2 1.5 16.0 0.3 0.5 0.0 0.3 1.8 6.3 16.8 0.0 4.8 35.4 20.4 0.0 0.1 8.4 6.5 1.7 2.9 0.8 3.7 0.0 0.0 4.8 0.7 5.6 1.4 4.8 8.5 0.8 0.0 12.3 0.0 13.4 11.4 0.4 0.0 8.7 0.6 5.0 0.2 3.8 12.7 0.4 1.9 11.5 0.0 0.0 10.8 0.4 0.0 32.0 0.6 14.0 0.0 0.0 4.9 0.4 0.0 39.5 47.6 2.4 1.7 0.5 3.7 14.0 0.0 9.0 2.0 11.1 3.5 0.4 0.1 1.7 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 17.3 5.8 33.6 24.2 11.8 20.1 20.6 21.0 19.6 8.2 16.0 16.8 0.1 0.0 0.0 133.2 0.2 0.8 1.5 1.4 0.6 23.8 6.5 8.9 12.5 0.0 0.1 1.8 4.2 0.1 0.3 0.1 0.0 1.3 0.0 0.6 7.1 0.6 1.8 0.0 31.2 0.0 0.0 2.4 0.0 1.1 0.0 6.9 0.0 0.0 0.2 33.7 32.3 0.1 2.0 0.0 0.0 0.0 3.1 0.1 3.6 2.8 0.2 45.6 0.0 28.1 32.5 0.2 0.0 1.2 0.0 2.6 0.0 0.0 0.1 8.6 0.0 0.0 3.3 0.1 0.2 0.1 0.3 0.3 0.1 0.6 0.5 0.4 AP1S2 "MRX59, MRXS5, PGS, SIGMA1B" ENSG00000182287 "Adaptor related protein complex 1 subunit sigma 2" P56377 X 15825806-15854931 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "epididymis: 669.1" "Cell type enhanced" "Detected in all" "Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2" "Group enriched" "Detected in all" 5 "dendritic cells: 221.1;monocytes: 326.8" "Cell line enhanced" "Detected in all" "Karpas-707: 298.0;SK-MEL-30: 442.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049894, HPA060945" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA049894: AB_2680939, HPA060945: AB_2684393" "prognostic favorable (9.86e-4)" "unprognostic (4.62e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.47e-3)" "unprognostic (3.85e-1)" "unprognostic (2.03e-3)" "unprognostic (5.76e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.53e-6)" "unprognostic (1.85e-2)" "unprognostic (5.61e-2)" "unprognostic (5.08e-2)" "unprognostic (6.35e-2)" "unprognostic (3.13e-1)" "unprognostic (9.34e-2)" "unprognostic (6.47e-2)" 28.6 21.6 31.6 37.0 33.6 38.6 15.2 35.7 37.2 31.8 31.4 34.0 12.0 52.7 669.1 21.6 13.6 20.3 75.5 28.0 51.7 13.3 16.0 26.0 33.5 43.8 40.2 30.1 8.9 7.9 16.8 19.6 42.3 48.5 11.7 22.3 44.1 9.5 30.8 70.7 14.1 20.3 77.0 37.4 43.3 19.6 23.7 35.1 29.0 12.6 94.6 29.0 26.3 12.8 61.3 12.0 14.2 130.1 78.4 29.5 19.1 5.0 47.1 22.7 31.1 41.1 9.6 11.1 22.6 183.0 72.6 50.4 16.1 31.7 10.8 57.0 30.1 64.9 15.3 16.7 14.7 24.2 63.1 16.9 12.2 11.2 36.0 33.1 50.4 78.1 19.1 14.3 298.0 72.4 8.7 12.9 39.5 171.0 6.4 42.5 29.5 116.7 50.6 37.4 2.5 14.8 69.2 18.4 4.8 442.2 84.1 52.7 69.2 43.9 67.8 21.2 92.5 41.9 25.5 58.7 37.3 33.6 28.0 159.7 50.9 326.8 34.6 21.1 325.0 24.8 30.8 25.5 20.6 221.1 28.0 18.5 18.1 52.8 27.9 175.4 82.2 38.1 228.0 31.6 33.6 35.7 37.2 28.0 51.7 43.8 40.2 30.1 48.5 37.4 35.1 61.3 130.8 3.2 13.1 37.2 77.0 55.2 12.7 9.1 8.6 34.7 12.0 11.4 195.6 12.8 3.2 9.2 12.5 5.3 114.2 9.2 33.2 13.7 5.1 50.4 32.6 166.3 26.9 32.6 15.1 6.4 18.9 38.0 7.7 78.0 78.6 15.6 147.4 8.6 259.8 11.8 73.2 8.4 12.2 392.6 609.2 17.5 17.4 362.7 149.4 31.9 630.0 21.1 62.8 19.1 85.0 10.3 14.0 7.2 26.0 19.0 6.5 9.0 1.6 39.3 39.5 26.7 39.1 55.7 28.8 10.6 51.6 5.6 58.3 4.0 8.5 6.7 C8orf33 FLJ20989 ENSG00000182307 "Chromosome 8 open reading frame 33" Q9H7E9 8 145052465-145066685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 180.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024812, HPA026104" Approved Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA024812: AB_10599490, HPA026104: AB_10600875" "prognostic unfavorable (2.77e-4)" "unprognostic (6.51e-3)" "unprognostic (1.85e-1)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (8.95e-4)" "unprognostic (4.75e-2)" "unprognostic (3.51e-1)" "unprognostic (2.45e-2)" "unprognostic (5.17e-2)" "unprognostic (2.71e-1)" "unprognostic (1.05e-1)" "unprognostic (5.29e-2)" "unprognostic (1.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" 16.6 42.5 34.8 13.2 34.1 18.3 25.1 36.0 40.0 17.9 30.8 21.9 13.3 20.6 27.3 19.7 23.0 16.7 22.5 34.6 36.2 18.9 17.2 15.1 18.4 36.0 36.4 32.1 41.0 21.0 34.2 5.6 21.3 35.7 19.0 33.7 24.8 16.5 24.4 17.0 17.6 10.2 19.7 34.4 12.3 11.6 13.2 35.2 19.4 33.5 26.3 18.5 19.0 9.0 35.8 28.3 32.7 45.8 22.7 51.3 35.5 17.2 16.6 41.7 42.0 23.3 9.2 39.2 30.3 55.3 40.5 19.5 22.4 67.5 41.2 45.3 15.0 48.4 38.1 32.1 11.5 53.1 30.6 15.1 41.0 60.4 43.0 96.8 34.5 28.1 44.9 75.4 26.3 46.1 42.4 86.3 12.3 31.8 89.1 55.2 51.2 14.9 46.6 44.1 16.3 44.1 39.1 44.3 39.3 39.0 26.1 41.1 29.1 13.8 27.5 37.3 24.2 37.8 21.7 16.9 72.2 65.9 47.0 55.1 1.0 13.7 8.7 16.3 17.4 18.4 13.4 16.2 17.8 19.6 13.3 21.3 15.6 1.4 28.2 16.0 18.4 12.6 16.3 34.8 34.1 36.0 40.0 34.6 36.2 36.0 36.4 32.1 35.7 34.4 35.2 35.8 67.8 28.9 27.2 4.9 34.8 44.4 32.8 31.9 24.5 48.3 52.8 47.9 18.4 45.8 33.8 25.8 31.3 36.9 45.3 180.5 62.6 79.5 5.6 49.9 55.1 50.2 35.3 17.5 5.7 64.9 40.2 41.7 20.9 53.0 21.5 58.5 37.1 66.8 28.7 50.5 6.0 36.4 14.2 21.5 21.2 5.6 37.9 23.0 16.0 7.5 32.3 61.2 45.3 4.0 6.0 55.3 37.7 38.7 20.4 48.1 22.1 66.1 26.6 54.5 26.3 32.8 37.9 26.2 34.8 25.4 42.9 24.9 23.6 94.9 53.0 28.5 DCAF4L1 WDR21B ENSG00000182308 "DDB1 and CUL4 associated factor 4 like 1" Q3SXM0 4 41981756-41986465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 24.9" "Group enriched" "Detected in some" 9 "Early spermatids: 35.4;Spermatocytes: 89.6;Spermatogonia: 128.4" "Cancer enriched" "Detected in single" 49 "testis cancer: 8.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "REH: 1.1" CAB073535 Enhanced NA NA "CAB073535: " "unprognostic (6.24e-2)" "unprognostic (7.52e-3)" "unprognostic (8.11e-3)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (9.63e-3)" "unprognostic (4.64e-4)" "unprognostic (1.62e-1)" "unprognostic (1.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.83e-2)" "unprognostic (4.03e-1)" "unprognostic (3.76e-3)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-4)" 0.2 0.2 0.5 0.2 0.6 0.1 0.1 0.8 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.5 0.3 0.4 0.4 0.3 0.1 0.5 0.4 0.5 0.1 0.1 0.0 0.8 0.0 0.5 0.2 0.0 0.8 0.2 0.0 1.1 0.3 0.2 0.0 0.4 0.6 0.1 24.9 0.5 0.0 0.2 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.2 0.6 0.7 0.1 0.0 0.7 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.1 0.2 1.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.6 0.2 0.9 0.1 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.8 0.7 0.5 0.3 0.5 0.4 0.5 0.5 0.4 0.5 0.7 0.8 0.0 0.0 0.7 0.5 0.4 0.3 0.2 0.0 1.2 0.9 0.5 1.2 1.5 0.3 0.0 0.0 0.2 0.6 0.3 0.0 0.3 35.4 0.9 0.9 0.9 0.0 0.4 1.4 0.6 0.3 0.5 0.0 1.2 0.0 0.1 0.0 0.6 0.3 0.0 0.8 0.4 2.0 2.2 0.3 8.6 1.2 0.8 3.6 0.0 0.7 0.7 2.1 0.5 0.6 0.9 0.1 0.4 0.9 1.2 0.2 0.1 0.5 1.6 0.0 2.9 0.7 89.6 128.4 0.6 0.9 0.5 0.6 0.2 0.7 0.6 SPACA6 "LET7EH, LINC00085, NCRNA00085, SPACA6P" ENSG00000182310 "Sperm acrosome associated 6" W5XKT8 19 51689128-51712387 "Predicted intracellular proteins, Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 2.5;testis: 7.5" "Cell type enhanced" "Detected in some" "Breast glandular cells: 14.9;Breast myoepithelial cells: 16.6;Collecting duct cells: 18.4;Distal tubular cells: 7.9;Proximal tubular cells: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HeLa: 2.9;U-87 MG: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (6.12e-2)" "unprognostic (5.80e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.13e-2)" "unprognostic (1.45e-1)" "unprognostic (8.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.10e-3)" "unprognostic (1.06e-1)" "unprognostic (2.82e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (1.98e-10)" "unprognostic (6.64e-3)" "unprognostic (1.98e-1)" "unprognostic (6.05e-2)" "unprognostic (1.14e-2)" 0.4 0.4 0.8 0.3 1.0 0.0 0.2 1.7 2.5 0.6 0.0 0.4 0.0 0.7 0.1 0.1 0.8 0.0 0.1 1.0 1.6 0.2 0.0 0.1 0.0 1.9 1.5 0.3 0.4 0.2 0.1 0.4 0.5 1.5 0.4 0.0 0.1 0.2 0.2 0.5 0.0 0.2 0.0 0.9 0.2 0.1 7.5 1.4 0.0 0.1 0.0 0.0 0.5 0.3 2.0 1.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.4 0.0 0.1 0.0 0.2 1.2 0.0 0.2 0.0 0.0 4.3 0.2 2.9 0.0 0.2 0.0 0.3 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.1 0.4 0.0 0.0 0.4 0.3 0.6 0.3 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.7 2.5 1.0 1.6 1.9 1.5 0.3 1.5 0.9 1.4 2.0 4.2 0.0 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 16.6 0.0 0.0 2.5 18.4 0.0 0.0 2.7 0.0 7.9 2.3 0.0 6.3 5.2 1.9 0.0 0.0 0.0 1.7 0.0 2.1 0.0 4.8 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 17.8 2.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 MBD3L3 ENSG00000182315 "Methyl-CpG binding domain protein 3 like 3" A6NE82 19 7056209-7058640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSCAN22 "HKR2, ZNF50" ENSG00000182318 "Zinc finger and SCAN domain containing 22" P10073 19 58326994-58342332 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 14.7" "Low region specificity" "Detected in all" HPA006471 Uncertain Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA006471: AB_2221026" "unprognostic (5.55e-3)" "unprognostic (2.24e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (3.82e-2)" "unprognostic (2.47e-3)" "unprognostic (1.52e-1)" "unprognostic (2.91e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-3)" "unprognostic (5.00e-2)" "unprognostic (7.59e-2)" "unprognostic (2.59e-2)" "unprognostic (1.74e-1)" "unprognostic (5.22e-3)" "unprognostic (1.07e-1)" 1.1 1.6 1.4 1.3 1.6 0.7 1.1 2.9 1.8 1.7 0.9 1.4 1.2 1.5 0.9 1.8 1.3 0.7 1.1 1.4 1.2 1.2 2.4 1.1 1.2 1.4 1.2 1.6 1.5 1.4 1.6 2.6 1.2 1.9 1.4 0.9 0.8 1.2 1.0 1.1 2.2 1.3 1.2 1.1 1.4 1.4 1.2 1.2 1.1 1.3 1.0 1.4 1.5 1.6 2.8 2.4 4.2 2.3 3.5 2.6 1.6 2.4 2.0 1.0 1.2 1.1 2.3 1.7 1.9 1.3 1.6 1.5 1.8 3.3 2.2 1.3 3.0 14.7 4.1 4.2 2.1 2.1 3.3 4.2 1.8 2.2 2.6 2.7 2.2 1.8 1.9 4.1 3.6 2.1 1.9 1.6 1.5 2.0 3.0 4.8 2.2 3.6 3.3 1.2 3.1 3.6 2.6 3.0 4.0 2.0 1.8 1.9 2.3 1.8 6.5 1.9 1.6 3.5 3.6 5.3 1.4 2.6 2.2 2.3 0.0 0.8 1.0 2.0 0.7 1.3 0.8 1.1 1.6 1.1 1.0 0.9 1.0 0.2 1.2 0.9 0.5 0.9 1.0 1.4 1.6 2.9 1.8 1.4 1.2 1.4 1.2 1.6 1.9 1.1 1.2 2.8 1.1 0.0 4.1 1.6 1.5 1.8 0.6 1.0 0.0 0.7 1.3 0.9 0.6 1.5 1.6 1.8 0.0 0.9 0.8 0.4 1.9 0.9 0.3 1.1 1.2 0.9 0.0 1.7 2.1 0.6 0.9 1.1 1.1 1.6 0.0 1.1 0.0 1.3 0.5 1.7 2.1 0.5 0.0 0.8 0.8 0.0 2.1 2.3 1.8 0.0 1.3 0.5 0.0 1.0 2.2 1.1 1.6 0.4 1.1 0.9 0.8 0.6 1.1 0.7 0.0 1.7 0.8 4.3 1.9 1.1 3.7 0.7 1.2 0.9 1.0 0.4 KCNJ14 "IRK4, Kir2.4" ENSG00000182324 "Potassium inwardly rectifying channel subfamily J member 14" Q9UNX9 19 48455574-48466980 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "retina: 59.3" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 326.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA071765 Approved Nucleoli NA NA Nucleoli "HPA071765: AB_2686444" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (1.33e-5)" "unprognostic (5.77e-2)" "unprognostic (9.41e-2)" "unprognostic (5.26e-2)" "unprognostic (7.05e-4)" "unprognostic (7.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.48e-2)" "unprognostic (4.43e-3)" "unprognostic (4.92e-2)" "unprognostic (5.02e-6)" "unprognostic (1.47e-1)" "unprognostic (4.98e-2)" "unprognostic (6.82e-3)" "unprognostic (4.41e-2)" 0.7 0.3 2.1 0.3 2.9 2.1 0.7 2.9 2.3 0.8 1.7 0.5 0.3 0.6 0.6 1.3 0.9 0.4 0.4 2.0 1.9 0.7 0.9 0.7 0.5 2.8 2.9 1.8 1.0 0.6 0.2 0.9 0.3 3.8 1.4 0.3 59.3 0.6 0.2 1.6 2.2 0.6 0.3 1.9 0.7 0.5 1.2 2.9 0.3 1.2 0.3 0.3 0.6 1.0 2.6 0.9 2.3 0.4 1.5 0.9 0.9 1.5 0.3 0.2 0.5 0.7 2.2 1.2 1.1 0.4 0.3 1.1 3.2 0.7 0.4 1.2 0.8 1.2 0.6 1.5 0.6 0.5 0.9 1.8 0.9 1.6 1.1 1.3 0.6 0.3 1.0 1.0 1.1 0.3 1.4 0.4 7.6 0.8 1.2 1.1 1.5 0.9 0.2 0.3 2.7 0.8 1.0 1.0 1.5 0.9 0.8 1.0 0.8 0.5 1.5 2.0 1.6 1.8 1.2 1.9 0.7 0.4 2.4 1.6 1.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.1 0.1 0.0 2.1 2.9 2.9 2.3 2.0 1.9 2.8 2.9 1.8 3.8 1.9 2.9 2.6 3.7 0.0 3.4 5.2 1.2 4.5 3.6 1.0 1.8 17.0 4.9 2.4 0.6 2.8 0.7 1.8 41.7 1.4 0.3 1.3 0.0 1.1 4.7 4.1 2.8 2.3 0.0 0.8 2.3 1.1 2.4 1.3 0.5 5.6 0.0 2.4 0.7 0.5 0.6 15.2 3.1 1.4 0.0 0.0 0.7 0.6 1.2 1.0 0.0 1.9 0.6 24.5 0.0 0.0 0.9 3.1 0.3 0.4 0.7 4.4 0.5 0.1 1.8 326.4 0.0 6.5 1.5 3.9 3.3 2.6 5.4 1.0 0.9 1.2 1.7 2.9 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008867 Approved Nucleoplasm,Vesicles Yes No Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavorable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 4.6 4.8 2.0 1.4 1.9 2.1 5.0 2.1 3.2 3.7 2.1 6.3 4.6 3.6 0.6 7.3 3.1 1.1 3.2 1.8 1.9 4.6 10.9 3.9 1.8 2.1 2.0 1.7 2.2 8.2 1.6 3.8 1.8 2.0 4.2 1.8 0.5 5.2 1.6 4.3 6.4 7.9 0.7 2.0 6.9 5.5 5.2 2.1 1.5 3.3 0.3 1.2 4.7 4.3 1.9 9.0 3.0 2.1 13.3 2.7 0.7 3.8 4.4 5.1 4.5 3.1 3.2 3.9 4.1 5.3 2.2 2.2 5.8 2.4 6.1 1.0 7.6 3.0 8.2 1.6 7.9 4.0 2.1 8.4 1.2 5.5 2.5 6.6 1.2 3.7 6.7 3.8 6.6 1.7 16.7 6.0 1.9 2.6 9.8 8.3 6.7 2.4 14.0 6.0 3.0 3.1 3.0 5.1 8.0 7.7 1.2 13.2 3.7 3.3 2.2 8.1 10.8 5.4 2.5 2.1 3.0 3.4 5.1 2.9 0.0 0.1 0.6 0.4 0.4 0.3 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.3 1.6 0.7 0.0 0.0 2.0 1.9 2.1 3.2 1.8 1.9 2.1 2.0 1.7 2.0 2.0 2.1 1.9 17.9 6.4 2.0 4.6 10.1 5.7 6.0 2.1 7.4 9.9 13.2 12.8 1.1 7.2 4.6 0.0 14.6 8.3 17.3 18.2 5.9 5.2 1.9 5.2 6.8 5.9 2.4 3.0 7.4 6.2 11.6 5.2 13.7 7.8 1.3 7.7 6.8 6.7 6.9 1.7 5.6 19.4 2.0 4.7 7.6 1.6 5.3 9.0 5.4 4.7 2.6 7.9 6.2 2.0 2.7 7.5 10.8 1.9 20.1 8.2 43.7 8.1 2.0 9.0 0.0 5.1 13.6 5.0 7.8 14.8 6.7 3.8 10.7 9.9 17.3 6.3 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 2939.4" "Cell type enhanced" "Detected in many" "Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1" "Cancer enhanced" "Detected in all" "liver cancer: 276.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 18 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2" "Not detected" "Not detected" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 93000000000 14000000000 Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favorable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 420.2 137.4 26.2 209.6 27.5 1.7 254.6 27.1 44.7 311.8 56.6 175.2 85.4 210.7 148.5 154.3 318.2 548.6 124.8 24.6 45.9 60.8 2939.4 226.8 211.0 45.3 30.5 23.7 490.2 62.6 22.0 33.4 53.3 33.3 176.0 217.4 9.8 97.7 140.4 57.5 91.8 155.5 254.1 30.5 170.0 151.4 90.8 31.9 88.9 140.2 156.1 194.1 460.0 191.4 37.0 0.2 18.6 1.2 10.2 769.5 1012.7 4.5 143.3 336.1 74.7 135.7 0.9 2.0 0.5 19.7 179.6 20.2 1.1 0.3 2.1 6.7 0.7 0.7 0.5 5.6 48.2 230.3 1.8 0.9 540.2 2.8 60.2 4.4 94.2 0.1 0.2 0.4 0.1 9.9 0.0 0.4 1.6 10.3 0.0 0.6 0.2 1.1 1.5 3.1 2.5 0.8 0.9 86.6 1.8 2.1 17.4 0.1 0.0 0.5 34.2 2.6 133.8 0.2 0.6 0.5 0.8 73.6 1.2 2.5 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 26.2 27.5 27.1 44.7 24.6 45.9 45.3 30.5 23.7 33.3 30.5 31.9 37.0 37.6 16.0 41.0 9.4 5.7 76.2 18.9 22.2 23.9 0.9 4.5 15.4 21.5 171.6 15.5 3.7 0.0 3.7 0.7 0.1 1.9 285.2 6.6 8.7 272.4 30.6 0.0 112.2 2.9 42.9 2.5 687.0 11.2 7.3 5.1 25.7 93.5 2795.1 8.1 5.0 1.7 0.0 2.0 62.8 103.7 29.9 1193.2 6.4 88.9 19.7 1.0 15.2 0.0 1.5 0.6 31.7 0.1 640.1 1.8 9.7 0.0 7.1 4.6 1.1 138.1 34.9 127.6 6.3 5.3 6.3 53.8 2.6 12.8 30.7 0.2 5.2 GLTPD2 ENSG00000182327 "Glycolipid transfer protein domain containing 2" A6NH11 17 4788964-4790589 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 74.4" "Group enriched" "Detected in some" 5 "Hepatocytes: 83.7;Proximal tubular cells: 135.8" "Cancer enriched" "Detected in many" 5 "liver cancer: 25.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 3.4;CACO-2: 9.2;Hep G2: 13.7;MCF7: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058295, HPA065267" Uncertain Approved Vesicles "Secreted - unknown location" NA NA 150000 Vesicles "HPA058295: AB_2683671, HPA065267: AB_2685451" "unprognostic (4.00e-1)" "unprognostic (1.93e-1)" "unprognostic (1.95e-3)" "unprognostic (1.70e-1)" "unprognostic (3.03e-2)" "unprognostic (1.79e-4)" "unprognostic (1.40e-1)" "unprognostic (1.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.33e-2)" "unprognostic (5.62e-4)" "unprognostic (7.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.25e-1)" "unprognostic (4.79e-1)" "unprognostic (1.71e-4)" "unprognostic (7.59e-3)" 0.5 0.5 1.1 0.5 1.1 1.5 0.3 1.7 2.6 0.4 0.0 0.5 10.1 0.5 0.0 0.8 0.4 0.3 0.2 1.0 1.6 11.7 74.4 0.4 0.1 3.2 1.4 1.3 0.3 0.7 0.2 0.8 0.1 1.6 0.4 0.0 0.3 1.0 0.0 1.3 1.7 6.2 0.0 0.3 1.2 1.1 0.1 1.2 0.0 0.2 0.0 0.0 0.5 0.5 1.2 0.5 1.8 0.1 1.5 0.0 0.0 3.4 0.4 0.0 0.0 0.0 9.2 0.6 0.8 0.9 0.0 0.3 1.7 0.0 0.0 0.0 1.7 1.2 0.1 0.7 13.7 0.1 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.5 0.4 0.0 4.1 0.1 0.1 0.2 0.6 0.7 0.7 0.5 0.2 0.0 0.7 1.1 0.7 1.6 0.3 0.4 0.0 1.0 0.1 1.7 0.5 0.7 0.4 0.3 0.1 0.5 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 1.1 1.7 2.6 1.0 1.6 3.2 1.4 1.3 1.6 0.3 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.3 0.2 1.5 0.5 0.0 0.0 0.0 0.1 0.4 17.6 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.0 0.0 2.2 83.7 0.1 0.0 0.2 0.6 0.0 1.3 0.4 0.2 0.6 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.6 0.3 21.1 135.8 0.3 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.1 0.3 0.3 0.1 0.3 0.4 KIAA2012 ENSG00000182329 KIAA2012 2 202073255-202205188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 6.4;choroid plexus: 2.6;fallopian tube: 9.3" "Group enriched" "Detected in some" 6 "Early spermatids: 38.9;Endometrial ciliated cells: 12.3;Excitatory neurons: 24.8;Late spermatids: 28.6;Respiratory ciliated cells: 43.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077834 Enhanced NA NA "HPA077834: " "unprognostic (1.91e-2)" "unprognostic (3.17e-1)" "unprognostic (2.56e-1)" "unprognostic (5.35e-2)" "unprognostic (2.85e-2)" "unprognostic (3.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "unprognostic (7.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.81e-2)" "unprognostic (6.94e-5)" "unprognostic (1.60e-1)" "unprognostic (9.44e-2)" "unprognostic (3.37e-1)" "unprognostic (9.95e-3)" 0.0 0.0 4.9 0.0 2.3 0.0 0.0 1.4 1.6 0.2 2.6 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 1.8 2.9 0.0 0.9 0.8 0.0 4.8 4.7 0.8 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 2.3 1.4 1.6 1.8 2.9 4.8 4.7 0.8 3.1 6.4 1.8 1.0 0.2 3.2 0.0 1.0 0.1 0.0 0.3 0.0 0.0 2.9 0.4 0.1 1.0 0.0 1.8 0.0 2.1 0.1 0.2 0.0 0.0 0.0 38.9 12.3 0.6 0.4 0.0 0.0 24.8 0.2 0.1 0.6 0.0 0.6 0.0 0.2 1.1 4.8 0.1 3.3 2.8 0.0 0.0 0.0 0.0 28.6 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 43.0 2.4 0.0 0.8 0.2 1.5 3.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 PRAMEF8 ENSG00000182330 "PRAME family member 8" Q5VWM4 1 13281035-13285174 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049887, HPA051704" Uncertain NA NA "HPA049887: AB_2680935, HPA051704: AB_2681581" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIPF "HGL, HLAL" ENSG00000182333 "Lipase F, gastric type" P07098 10 88664441-88678814 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 142 "stomach 1: 37514.0" "Cell type enriched" "Detected in some" 444 "Gastric mucus-secreting cells: 1509.7" "Cancer enriched" "Detected in some" 75 "stomach cancer: 278.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1" "Region enriched" "Detected in single" 77 "olfactory bulb: 7.6" HPA045930 Enhanced "Secreted to digestive system" NA NA "HPA045930: AB_10959518" "unprognostic (1.53e-1)" "unprognostic (1.83e-1)" 3.6 2.9 0.1 0.0 0.0 0.0 4.6 0.1 0.0 3.1 0.0 8.7 264.5 1.9 0.0 118.8 5.5 0.0 2.2 0.0 0.1 11.5 5.0 7.3 0.0 0.2 0.2 0.0 2.2 4.5 0.0 7.3 0.5 0.1 6.8 0.0 0.0 2.6 0.0 1.6 1.7 1.9 0.0 0.1 2.6 37514.0 2.9 0.1 0.0 1.3 0.0 0.1 2.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 3.4 0.0 0.0 2.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 2.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1509.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR5P3 JCG1 ENSG00000182334 "Olfactory receptor family 5 subfamily P member 3" Q8WZ94 11 7824818-7830840 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060787 Uncertain NA NA "HPA060787: AB_2684364" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 DAOA G72 ENSG00000182346 "D-amino acid oxidase activator" P59103 13 105465867-105491034 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Schizophrenia "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053114 Uncertain NA NA "HPA053114: AB_2682048" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF804B FLJ32110 ENSG00000182348 "Zinc finger protein 804B" A4D1E1 7 88759700-89338528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.2;thyroid gland: 4.0" "Group enriched" "Detected in some" 13 "Excitatory neurons: 608.6;Inhibitory neurons: 266.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026702 Uncertain NA NA "HPA026702: AB_1859459" "unprognostic (1.10e-1)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.9 0.0 0.0 0.0 1.0 0.9 0.5 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.5 0.2 0.4 1.0 0.9 0.5 0.5 0.0 0.6 0.5 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 608.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 266.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 1.8 29.0 0.0 0.0 0.0 7.1 6.9 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 1.2 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 KBTBD3 BKLHD3 ENSG00000182359 "Kelch repeat and BTB domain containing 3" Q8NAB2 11 106051098-106077459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047385 Uncertain NA NA "HPA047385: AB_2680023" "unprognostic (9.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (2.17e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-2)" "unprognostic (4.09e-2)" "unprognostic (8.73e-3)" "unprognostic (6.35e-3)" "unprognostic (1.01e-1)" "unprognostic (3.63e-2)" "unprognostic (2.43e-1)" "prognostic favorable (3.42e-7)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.54e-3)" "unprognostic (1.55e-2)" 2.2 2.6 4.3 1.7 5.3 1.2 2.9 9.5 7.0 2.7 2.2 2.4 1.9 2.5 4.4 1.9 2.4 1.1 3.2 4.3 5.2 4.3 2.8 2.3 1.7 5.7 5.2 4.1 3.7 3.8 2.8 3.9 1.0 6.6 2.4 1.7 10.4 3.9 2.9 3.5 2.2 2.3 1.9 5.4 2.0 2.4 3.7 5.5 2.2 4.0 3.1 1.9 2.4 2.4 9.1 1.9 1.3 2.6 3.1 3.3 3.4 0.6 1.6 2.0 1.4 0.9 1.1 3.6 1.0 4.2 0.5 1.9 1.2 1.3 1.3 1.0 2.0 0.5 2.7 0.8 1.0 1.5 1.1 2.4 1.3 3.9 1.2 1.2 2.9 1.9 1.8 1.0 2.6 1.3 0.3 2.6 2.7 1.1 2.2 1.7 1.2 1.6 4.7 4.9 0.4 2.1 2.6 2.4 2.4 2.0 1.9 3.0 1.5 1.6 0.7 1.1 0.6 0.6 0.9 0.6 2.4 1.4 2.4 1.2 30.8 5.6 18.5 12.1 3.2 11.0 13.2 13.7 12.6 7.5 10.9 12.9 11.6 3.6 15.0 3.4 4.5 15.5 7.2 4.3 5.3 9.5 7.0 4.3 5.2 5.7 5.2 4.1 6.6 5.4 5.5 9.1 13.0 9.6 12.8 11.1 10.8 6.2 16.5 38.6 12.5 17.6 13.3 16.0 28.5 18.6 18.9 12.9 20.9 10.8 9.3 8.8 37.2 14.4 103.5 11.5 5.3 12.7 6.0 5.7 23.5 29.5 8.8 14.3 6.1 14.3 16.5 6.9 15.7 19.2 9.7 16.8 22.6 15.0 40.7 6.3 10.4 22.8 11.8 6.4 19.6 10.3 14.5 21.4 18.6 23.1 44.3 13.4 14.1 17.0 5.6 6.2 19.0 34.3 17.8 19.3 13.1 10.9 10.2 21.5 4.6 5.2 9.8 2.6 15.4 10.3 13.5 10.1 YBEY C21orf57 ENSG00000182362 "YbeY metalloendoribonuclease" P58557 21 46286342-46297751 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 79.5" "Cell type enhanced" "Detected in all" "Early spermatids: 376.6;Late spermatids: 276.0;Spermatocytes: 273.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 85.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016593, HPA018162" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016593: AB_1845698, HPA018162: AB_1845699" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (7.24e-3)" "unprognostic (4.81e-1)" "unprognostic (2.78e-2)" "unprognostic (7.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-3)" "unprognostic (2.95e-1)" "unprognostic (1.51e-2)" "unprognostic (7.50e-2)" "unprognostic (7.48e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-3)" 10.9 13.1 14.8 5.4 16.0 5.9 13.6 16.4 18.0 11.9 14.0 14.7 11.6 10.1 14.5 9.8 10.2 8.8 13.5 14.3 16.0 13.5 18.4 7.9 11.5 16.0 15.5 13.3 12.7 17.2 11.9 11.9 6.0 16.8 12.9 12.2 7.5 13.8 8.2 16.6 15.9 16.3 4.3 16.0 11.1 11.1 79.5 15.6 11.0 9.5 12.9 14.4 8.9 9.3 17.7 24.4 21.1 17.7 21.5 13.2 50.0 17.2 16.4 24.3 15.8 19.2 11.2 4.0 30.7 13.9 17.0 8.4 7.9 7.7 7.5 14.3 29.3 29.9 8.9 13.9 4.4 37.7 10.1 1.0 34.8 31.9 12.5 25.9 20.7 10.5 15.2 21.6 36.0 18.6 20.7 19.9 13.2 51.5 9.3 21.7 41.4 8.4 59.6 32.5 11.2 13.0 22.6 22.3 10.0 46.6 5.8 5.1 8.8 12.8 15.1 5.6 12.2 10.8 44.4 85.2 53.8 27.5 11.1 9.3 27.7 9.1 7.3 13.2 10.4 13.2 32.7 16.3 16.9 10.5 24.9 15.8 18.2 3.2 21.3 12.5 24.1 26.6 10.3 14.8 16.0 16.4 18.0 14.3 16.0 16.0 15.5 13.3 16.8 16.0 15.6 17.7 16.9 3.2 7.4 12.1 35.2 46.3 38.4 49.6 45.5 14.4 44.7 46.1 21.6 21.5 23.1 18.4 8.4 17.5 33.3 45.1 64.6 36.4 376.6 31.4 31.2 22.3 32.0 13.7 7.9 77.2 27.9 27.6 28.5 17.9 11.4 20.5 26.4 50.5 25.2 16.8 13.5 55.5 30.5 37.8 45.8 276.0 40.7 24.6 39.2 7.5 27.7 21.3 40.2 11.6 18.4 47.9 58.4 24.5 36.9 28.1 103.4 65.6 20.6 20.8 6.6 21.1 19.5 273.7 31.8 31.2 60.5 9.6 30.2 32.5 55.6 36.8 CLN8 "C8orf61, EPMR, FLJ39417, TLCD6" ENSG00000182372 "CLN8 transmembrane ER and ERGIC protein" Q9UBY8 8 1755778-1801711 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 136.8;Syncytiotrophoblasts: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 76.7" "Lineage enriched" "Detected in all" 5 "dendritic cells: 76.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.86e-2)" "unprognostic (1.95e-2)" "unprognostic (6.40e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (4.05e-3)" "unprognostic (1.21e-1)" "unprognostic (3.45e-1)" "unprognostic (3.03e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-3)" "unprognostic (1.83e-1)" "prognostic favorable (4.36e-8)" "unprognostic (1.36e-1)" "unprognostic (1.70e-1)" "unprognostic (6.24e-2)" "unprognostic (8.38e-2)" 5.5 5.2 12.0 3.7 14.3 9.1 4.4 14.3 12.4 4.0 9.3 4.2 5.0 3.2 11.3 9.8 3.3 7.6 6.1 9.9 11.9 6.3 9.0 9.0 6.5 17.5 15.7 8.1 2.5 10.2 8.0 3.5 6.0 17.5 3.8 4.4 3.8 5.1 3.6 6.0 12.8 6.3 4.1 18.3 8.0 6.9 5.9 14.5 3.3 5.2 3.4 7.3 4.4 5.8 24.0 3.6 8.5 6.2 6.5 8.3 8.4 14.8 8.3 5.1 4.2 5.2 8.6 10.0 4.4 2.3 8.2 5.6 13.7 4.9 15.6 8.6 3.3 3.6 4.4 3.2 4.9 4.7 3.7 19.1 8.4 12.2 5.8 4.1 10.1 9.2 3.2 6.0 2.6 13.1 9.0 6.0 3.2 6.1 14.0 7.3 4.2 4.3 3.4 7.8 15.4 3.2 3.9 3.5 8.1 4.6 12.7 16.2 4.2 17.3 11.3 3.2 0.9 5.2 1.5 5.4 5.0 11.4 7.3 16.9 7.4 10.6 4.7 6.4 13.6 7.1 10.3 6.9 4.5 10.6 14.0 6.7 4.4 3.7 5.1 12.5 76.7 8.0 6.4 12.0 14.3 14.3 12.4 9.9 11.9 17.5 15.7 8.1 17.5 18.3 14.5 24.0 18.3 9.6 17.5 6.2 30.1 54.7 71.6 38.6 26.7 27.6 23.4 13.2 7.7 20.0 37.2 31.3 31.3 38.0 115.3 28.5 15.6 27.2 5.4 20.5 6.9 34.7 19.7 40.8 7.4 19.0 18.0 32.7 13.7 37.2 27.3 17.1 27.8 28.5 44.1 40.4 7.6 17.5 50.8 54.6 136.8 5.9 8.1 69.8 21.4 8.4 22.3 13.9 23.7 10.1 27.1 19.3 20.7 12.0 9.1 76.5 19.5 10.6 27.1 26.1 13.1 22.5 16.8 34.4 23.5 20.1 63.5 131.6 22.0 16.1 15.4 61.2 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 34.7;Distal enterocytes: 34.2;Gastric mucus-secreting cells: 33.1;Paneth cells: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 110.4;HEL: 172.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA007721 Approved Approved Cytosol NA Yes Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 12.2 4.2 5.2 9.5 5.5 33.2 9.8 8.2 21.3 9.0 0.2 8.0 8.7 5.6 1.4 17.6 9.2 8.9 5.0 3.9 0.5 5.2 10.1 7.5 17.5 2.8 16.3 1.0 12.9 7.5 3.2 7.8 7.8 8.7 7.6 5.8 6.1 11.5 3.7 8.5 18.9 12.6 2.7 0.0 17.7 27.1 6.8 3.9 9.0 10.5 2.7 9.1 6.1 9.8 12.1 28.4 110.4 25.7 38.8 5.0 3.9 20.4 24.4 2.9 12.8 12.4 40.6 29.1 34.8 17.9 10.7 19.0 8.5 6.3 15.9 6.7 21.2 46.2 172.6 36.1 59.7 15.6 17.4 63.1 20.1 1.9 47.0 4.9 8.6 9.7 57.2 44.0 18.7 9.2 8.2 52.3 24.2 57.8 7.1 19.2 29.1 13.3 53.9 3.9 12.9 25.9 15.0 24.6 14.4 21.1 17.5 27.6 22.0 7.2 17.1 28.2 18.5 26.9 6.3 17.9 86.4 11.0 44.4 18.2 3.7 2.7 5.4 1.9 6.0 2.7 1.6 1.4 2.4 2.0 5.6 1.8 1.9 3.3 1.2 9.0 2.1 3.2 2.3 5.2 5.5 8.2 21.3 3.9 0.5 2.8 16.3 1.0 8.7 0.0 3.9 12.1 15.8 9.6 34.7 5.5 4.1 6.9 13.6 3.9 2.2 7.4 4.7 3.6 6.5 10.0 2.8 0.0 2.1 10.1 4.9 34.2 0.0 6.3 0.9 1.6 3.4 6.1 3.0 9.9 5.3 1.8 11.3 6.1 33.1 3.2 3.8 32.1 4.6 6.9 5.5 8.4 6.1 11.2 0.0 7.3 9.8 0.9 2.5 11.9 0.0 5.6 3.7 2.3 9.2 0.5 5.7 18.8 40.9 3.8 2.7 5.3 3.0 1.7 1.3 7.1 13.1 6.5 7.9 8.4 15.9 4.2 8.7 27.0 3.8 2.8 9.4 8.0 NXPH4 NPH4 ENSG00000182379 "Neurexophilin 4" O95158 12 57216794-57226449 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.3;skin 1: 18.7" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 14.5;Cytotrophoblasts: 29.0;Muller glia cells: 18.5;Suprabasal keratinocytes: 10.4;Syncytiotrophoblasts: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 76.8;RH-30: 62.3;RPMI-8226: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.08e-2)" "unprognostic (4.84e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (6.21e-4)" "prognostic unfavorable (5.42e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (3.07e-1)" "unprognostic (1.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (7.83e-2)" "unprognostic (2.73e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-3)" 1.6 0.6 4.6 0.3 4.6 0.4 0.7 7.6 4.4 1.1 0.5 0.0 0.0 0.0 0.2 3.0 0.1 0.0 2.8 8.6 13.2 0.4 0.8 0.3 0.5 11.8 7.5 3.3 0.0 1.5 1.7 0.3 2.7 13.3 4.5 0.0 5.1 4.0 0.0 0.2 18.7 0.2 0.1 5.8 0.4 0.1 1.3 5.1 0.1 0.4 0.0 0.3 0.1 2.8 10.8 18.1 1.4 0.4 76.8 8.6 2.2 7.1 4.9 11.5 2.1 2.7 5.0 0.9 19.4 7.6 5.1 3.2 16.2 10.3 2.4 0.6 3.4 20.6 0.1 0.6 0.3 7.4 0.7 2.5 2.0 4.0 2.0 3.2 2.5 0.0 1.2 0.8 20.0 1.5 18.6 0.0 0.0 0.7 0.4 13.5 1.0 62.3 43.1 0.0 3.2 12.3 0.7 11.0 22.5 23.2 0.2 22.4 0.6 0.0 5.4 17.8 2.3 5.8 10.8 2.3 6.9 3.5 9.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.6 7.6 4.4 8.6 13.2 11.8 7.5 3.3 13.3 5.8 5.1 10.8 0.8 0.0 0.0 0.7 8.0 14.5 0.4 1.1 3.4 4.7 0.7 0.9 0.8 0.0 0.7 0.0 8.4 29.0 0.3 0.1 0.0 0.8 0.0 0.1 0.4 0.5 7.2 0.0 0.7 0.0 1.9 1.1 0.5 0.1 0.0 1.1 0.0 0.1 2.0 1.7 1.4 0.0 2.0 0.0 0.8 0.0 0.0 0.4 3.6 0.0 0.0 18.5 0.0 0.0 0.1 0.6 0.0 0.4 0.3 3.3 0.0 0.0 1.0 0.5 0.0 2.4 3.6 0.7 4.5 1.8 10.4 29.3 0.4 0.0 0.0 0.4 CACNB4 EJM4 ENSG00000182389 "Calcium voltage-gated channel auxiliary subunit beta 4" O00305 2 151832771-152099167 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 16.9;skin 1: 7.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Cell line enhanced" "Detected in some" "Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015601 Approved NA NA "HPA015601: AB_1845873" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" "unprognostic (3.70e-1)" "unprognostic (9.42e-4)" "unprognostic (1.23e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.55e-2)" "unprognostic (7.26e-3)" "unprognostic (3.93e-2)" "unprognostic (9.55e-3)" "unprognostic (2.45e-1)" 0.6 0.7 4.1 0.4 10.3 0.7 1.6 16.8 16.9 0.4 1.5 0.3 0.4 0.4 0.6 1.5 0.3 0.9 0.2 6.2 5.9 1.4 0.1 2.0 0.3 1.9 7.4 5.4 0.3 0.4 0.4 1.8 0.9 5.5 2.1 0.5 1.8 1.7 1.9 0.1 7.3 0.3 0.5 0.2 0.4 0.6 2.3 8.7 1.2 1.5 0.2 1.0 2.0 0.5 7.8 0.0 0.0 0.7 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.9 0.0 1.9 0.0 0.1 0.3 3.2 0.0 0.2 4.1 0.0 0.2 20.2 0.2 0.1 0.4 0.0 1.7 0.0 0.8 0.0 0.5 0.1 0.0 0.2 0.3 0.5 0.1 0.6 2.0 0.2 0.6 1.1 0.5 1.3 0.7 0.0 0.0 0.0 0.1 3.3 0.8 0.0 1.8 2.0 0.6 0.4 0.3 0.0 0.0 0.4 5.9 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.1 4.1 10.3 16.8 16.9 6.2 5.9 1.9 7.4 5.4 5.5 0.2 8.7 7.8 1.1 12.8 53.3 80.6 0.8 12.4 16.3 3.5 30.7 9.9 6.8 7.2 1.3 0.0 3.8 3.7 4.2 0.1 0.3 0.3 3.9 0.5 0.9 3.0 3.0 1.3 0.0 0.0 495.6 1.5 0.0 7.9 1.1 5.4 0.0 84.1 0.7 0.0 3.4 20.2 470.7 0.0 0.0 1.2 7.5 2.1 3.4 2.4 1.8 136.8 1.2 2.3 1.0 155.3 31.2 1.0 0.1 4.5 2.0 29.0 0.1 0.9 1.2 3.4 0.0 0.6 1.2 0.7 4.1 3.2 8.2 0.0 1.1 6.6 0.1 16.3 IFNL1 "IL-29, IL29" ENSG00000182393 "Interferon lambda 1" Q8IU54 19 39296407-39298673 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "dendritic cells: 3.0;Langerhans cells: 6.4;NK-cells: 14.4;T-cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "gdT-cell: 2.7;MAIT T-cell: 2.8;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.7;myeloid DC: 2.3;naive CD8 T-cell: 1.4;NK-cell: 4.6" "Group enriched" "Detected in many" 33 "dendritic cells: 2.3;NK-cells: 4.6;T-cells: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 97000 "unprognostic (3.08e-2)" "unprognostic (8.74e-2)" "unprognostic (2.46e-4)" "unprognostic (5.76e-2)" "unprognostic (6.91e-3)" "unprognostic (5.73e-3)" "unprognostic (3.94e-2)" "unprognostic (4.80e-2)" "unprognostic (2.96e-5)" "unprognostic (7.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 2.8 0.0 1.3 2.7 2.3 0.0 0.1 1.4 0.0 4.6 0.0 0.0 0.2 0.6 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.5 0.0 0.0 0.4 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.6 0.0 0.0 0.0 TRAPPC6B ENSG00000182400 "Trafficking protein particle complex 6B" Q86SZ2 14 39147811-39170532 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047928 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA047928: AB_2680214" "unprognostic (3.89e-1)" "unprognostic (4.94e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (7.60e-2)" "unprognostic (1.55e-2)" "unprognostic (3.79e-2)" "unprognostic (1.04e-2)" "unprognostic (3.09e-2)" "unprognostic (2.07e-2)" "unprognostic (4.57e-1)" "unprognostic (2.18e-2)" "prognostic favorable (1.76e-4)" "unprognostic (2.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" 12.8 15.9 16.9 11.3 21.0 4.8 14.8 20.4 23.7 11.6 15.7 12.0 11.0 12.2 12.3 15.1 9.7 9.6 13.9 21.2 19.0 14.0 24.6 10.5 12.3 15.8 15.9 19.9 10.2 11.0 14.0 12.7 13.0 16.7 13.0 10.5 24.8 10.5 13.3 16.7 11.5 10.4 11.9 14.8 13.0 11.1 13.0 16.5 13.7 16.0 18.7 12.3 12.9 12.1 21.1 17.5 7.7 13.0 12.6 18.1 20.4 10.3 22.0 19.4 19.6 19.2 12.7 32.6 10.9 15.2 20.5 9.7 13.4 19.2 14.0 23.8 19.9 9.4 14.9 10.6 37.3 25.8 21.1 19.8 19.4 23.2 16.9 22.4 31.1 17.3 19.8 16.7 22.4 20.5 21.6 15.7 15.2 11.1 13.5 29.7 12.2 24.0 10.7 21.4 34.0 12.7 10.3 26.2 15.9 24.7 13.5 30.2 13.2 24.8 18.0 9.1 15.4 12.1 20.8 30.7 15.9 8.9 12.1 17.4 8.7 3.2 5.6 2.9 6.8 2.6 3.3 4.0 3.3 4.8 2.1 3.4 3.4 3.3 7.7 7.1 4.8 3.6 2.4 16.9 21.0 20.4 23.7 21.2 19.0 15.8 15.9 19.9 16.7 14.8 16.5 21.1 20.0 22.4 19.4 24.2 20.3 22.6 19.7 17.9 25.6 25.3 18.2 12.6 24.0 10.0 15.6 18.4 35.5 14.2 28.7 12.4 54.8 14.3 38.8 12.1 17.6 17.5 16.6 27.6 47.0 17.4 13.1 22.0 18.8 18.4 29.2 15.5 23.6 22.8 15.7 23.5 50.6 9.6 26.4 15.0 21.3 16.0 16.1 23.0 17.8 13.1 18.2 16.0 27.8 31.2 45.0 22.2 12.6 17.7 21.4 19.2 11.3 20.7 10.8 39.4 26.3 15.5 21.1 58.9 31.3 29.7 25.1 22.6 22.3 26.8 10.1 30.1 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102083-34108686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.9" "Low cell line specificity" "Detected in many" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 0.8 0.8 2.2 1.6 2.2 2.8 1.1 2.9 3.2 0.7 1.8 0.9 1.1 0.7 1.3 0.8 1.1 0.7 1.5 2.2 2.3 1.1 1.3 0.7 2.0 3.2 2.3 2.4 0.9 1.0 1.5 0.6 0.6 3.3 0.9 1.1 2.4 0.7 0.8 5.4 1.6 1.2 0.6 1.8 1.5 1.4 1.8 2.3 1.3 1.1 1.3 1.6 0.6 0.6 3.5 1.0 1.9 1.3 2.2 3.9 2.5 0.8 1.7 1.6 1.0 1.3 1.3 1.4 2.2 1.3 1.3 2.1 3.0 0.8 1.9 1.3 2.4 2.0 3.7 4.2 1.0 1.6 1.2 3.2 1.9 2.2 1.4 2.5 1.8 1.1 4.1 2.6 2.6 2.2 0.8 2.1 2.9 0.5 2.2 1.4 3.1 1.8 1.1 1.4 2.3 1.9 1.7 0.8 1.9 0.6 1.6 1.8 1.9 1.3 3.2 1.8 1.7 1.1 3.1 2.1 1.2 2.8 2.9 1.9 3.9 0.5 0.6 0.4 0.4 0.3 0.5 0.6 0.4 0.3 0.9 0.9 0.8 1.1 0.6 0.3 0.6 0.5 0.2 2.2 2.2 2.9 3.2 2.2 2.3 3.2 2.3 2.4 3.3 1.8 2.3 3.5 1.4 0.0 3.2 2.0 4.1 0.8 2.5 1.8 3.4 5.6 1.9 1.3 5.8 2.8 2.9 0.0 6.2 2.0 5.6 3.1 9.8 1.2 11.6 2.0 3.8 2.1 0.0 2.5 2.7 0.7 0.6 1.8 3.6 2.3 1.3 1.8 3.6 2.2 1.3 10.1 3.1 2.5 4.1 2.8 0.4 11.5 1.2 2.2 0.0 1.0 2.1 2.1 3.1 2.0 3.9 2.1 2.5 0.4 1.6 2.0 3.6 1.4 3.9 6.9 13.1 3.9 1.9 7.6 1.6 2.3 0.3 3.3 4.6 2.7 2.9 1.5 CDY2A CDY2 ENSG00000182415 "Chromodomain Y-linked 2A" Q9Y6F7 Y 18025787-18027746 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "epididymis: 1.1;testis: 2.0" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPLOC4 "FLJ20657, KIAA1499, NPL4" ENSG00000182446 "NPL4 homolog, ubiquitin recognition factor" Q8TAT6 17 81556887-81648465 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 165.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 20.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021560, HPA023295" Enhanced Supported Nucleoplasm,Cytosol NA NA 30000 "Nucleoplasm, Cytosol" "HPA021560: AB_1854586, HPA023295: AB_1854587" "unprognostic (3.17e-1)" "unprognostic (2.98e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.06e-2)" "unprognostic (4.42e-1)" "unprognostic (2.97e-1)" "unprognostic (4.15e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.95e-7)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.72e-1)" 36.9 47.0 24.7 32.7 25.4 42.0 32.3 21.2 27.9 28.1 24.9 34.4 24.7 35.6 23.7 52.0 29.0 23.6 50.8 25.2 26.0 42.3 55.2 38.2 33.5 30.2 25.8 25.6 26.1 37.0 29.9 33.5 27.4 30.6 33.6 21.5 20.3 32.7 22.9 165.6 41.8 34.7 29.5 21.8 43.2 37.1 43.2 26.0 33.7 28.7 56.0 29.0 33.4 32.0 31.4 91.9 118.6 46.2 72.1 56.0 46.0 57.2 74.2 82.3 120.4 110.6 90.7 80.2 67.2 57.9 87.7 87.8 72.5 46.0 62.6 104.5 43.0 60.8 77.5 95.5 81.5 53.4 83.4 95.4 45.8 59.1 113.2 40.1 57.7 124.8 62.0 84.1 99.1 73.6 59.5 113.0 45.2 54.3 45.5 74.0 73.6 73.8 54.4 43.6 86.8 61.6 70.6 92.6 127.4 85.7 87.1 100.1 60.9 89.6 156.1 108.1 86.1 121.4 74.8 57.9 84.0 124.6 55.2 102.9 4.1 20.0 4.4 4.6 4.9 2.8 4.7 3.1 3.7 6.3 3.3 2.8 3.7 5.6 2.8 3.1 4.8 3.2 10.0 24.7 25.4 21.2 27.9 25.2 26.0 30.2 25.8 25.6 30.6 21.8 26.0 31.4 19.2 12.8 18.1 24.8 15.3 17.6 16.2 12.7 7.4 24.3 19.5 16.1 44.5 11.5 18.5 20.2 29.2 19.5 22.2 38.9 1.9 19.0 96.2 32.8 19.6 22.2 30.5 20.6 38.0 37.4 21.3 15.9 26.0 38.8 3.8 29.2 27.1 54.3 19.1 20.2 36.4 17.2 8.2 27.3 18.7 79.6 17.7 22.8 12.4 19.7 28.7 19.6 14.4 23.1 38.6 47.2 22.8 12.8 16.5 28.4 22.2 27.9 21.5 33.5 19.7 22.3 18.5 29.7 23.9 15.7 24.2 37.1 16.9 19.3 18.9 28.7 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041030 Uncertain "Secreted in other tissues" NA NA "HPA041030: AB_10795000" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 KCNK4 "K2p4.1, TRAAK" ENSG00000182450 "Potassium two pore domain channel subfamily K member 4" Q9NYG8 11 64291302-64300031 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "brain: 7.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Endometrial stromal cells: 9.8;Excitatory neurons: 9.0;Extravillous trophoblasts: 3.6;Horizontal cells: 3.3;Muller glia cells: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.85e-1)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" 0.0 0.0 5.4 0.0 3.9 0.0 0.0 0.5 7.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 1.4 0.0 0.0 0.0 0.0 0.9 0.6 4.1 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.5 7.0 5.3 1.4 0.9 0.6 4.1 2.0 0.0 1.2 2.9 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.9 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 9.8 0.1 0.0 0.0 9.0 0.0 3.6 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 3.3 2.4 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 1.0 0.0 4.4 0.0 0.5 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 TEX19 FLJ35767 ENSG00000182459 "Testis expressed 19" Q8NA77 17 82359247-82363775 "Predicted intracellular proteins" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 206 "testis: 31.1" "Group enriched" "Detected in some" 10 "Spermatocytes: 244.5;Spermatogonia: 180.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 28.2;HMC-1: 22.7;JURKAT: 10.8;MOLT-4: 20.0;U-266/70: 29.3;U-937: 11.0" "Not detected" "Not detected" HPA054577 Enhanced NA NA "HPA054577: AB_2682528" "unprognostic (3.58e-2)" "unprognostic (5.43e-2)" "unprognostic (8.63e-3)" "unprognostic (3.85e-2)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (4.51e-5)" "unprognostic (4.14e-1)" "unprognostic (2.72e-1)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (1.67e-15)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (3.43e-2)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.0 0.3 3.8 0.1 0.0 0.1 0.1 2.3 0.1 28.2 5.3 0.0 0.1 1.1 1.9 0.1 0.1 0.0 2.8 0.1 0.0 1.4 0.0 0.1 22.7 0.0 0.0 0.0 0.1 0.4 0.0 10.8 1.2 0.4 0.0 1.4 20.0 1.0 0.5 1.1 0.3 1.4 0.3 5.2 0.1 0.1 0.1 0.5 0.2 8.9 1.4 0.9 0.7 0.6 0.0 0.1 0.8 2.0 0.1 29.3 1.5 2.6 0.0 11.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 244.5 180.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSHZ2 "C20orf17, OVC10-2, TSH2, ZABC2, ZNF218" ENSG00000182463 "Teashirt zinc finger homeobox 2" Q9NRE2 20 52972358-53495330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.0;T-reg: 2.4" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7" "Low region specificity" "Detected in all" HPA038123 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038123: AB_10670657" "unprognostic (9.24e-3)" "unprognostic (1.58e-1)" "unprognostic (9.35e-2)" "unprognostic (1.13e-1)" "unprognostic (1.21e-4)" "unprognostic (3.30e-1)" "unprognostic (4.30e-1)" "unprognostic (1.28e-1)" "unprognostic (2.16e-1)" "unprognostic (3.23e-2)" "unprognostic (3.33e-1)" "unprognostic (3.14e-2)" "unprognostic (9.88e-8)" "unprognostic (6.26e-2)" "unprognostic (3.81e-2)" "unprognostic (3.37e-7)" "unprognostic (2.97e-3)" 16.5 14.9 3.1 4.5 3.4 0.2 10.7 3.9 3.7 9.1 0.0 5.7 2.3 6.8 16.6 8.3 8.8 12.6 3.4 5.9 7.9 2.3 12.7 2.9 4.0 6.4 6.1 1.1 18.6 3.5 5.5 2.8 1.3 5.3 5.5 2.1 1.7 13.0 13.7 1.6 5.3 2.8 8.9 7.9 5.2 6.2 4.9 6.6 2.0 5.3 2.6 3.5 7.6 5.7 7.9 0.0 0.0 1.8 26.7 11.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.8 0.0 0.1 0.0 0.1 0.0 5.2 1.4 0.0 23.6 0.0 0.3 0.0 0.6 4.1 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.7 4.4 15.3 0.1 0.0 0.7 0.0 0.0 0.0 0.1 2.6 13.7 0.0 0.1 0.3 0.0 2.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.4 3.0 0.2 0.6 0.1 0.0 0.1 2.4 0.5 3.1 3.4 3.9 3.7 5.9 7.9 6.4 6.1 1.1 5.3 7.9 6.6 7.9 171.4 0.0 0.6 32.7 7.0 45.4 19.9 43.8 37.0 6.7 24.4 161.5 2.8 54.3 41.6 36.8 2.1 1.3 1.3 0.1 0.0 52.2 11.1 32.7 144.4 125.7 6.6 0.0 188.2 9.8 0.5 93.3 3.1 68.9 1.3 395.6 11.7 92.1 1.2 0.0 58.1 1.9 18.3 1.3 16.6 20.3 468.2 2.8 12.4 104.9 1.9 39.0 1.0 23.6 4.9 6.8 2.7 803.8 16.0 27.5 0.8 0.4 19.9 1.9 39.5 10.9 48.2 2.6 1.8 43.9 40.5 0.8 24.2 396.9 2.6 8.2 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "gallbladder: 23.0;liver: 25.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 41.4;Cholangiocytes: 41.5;NK-cells: 39.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 9 "basophil: 59.3;NK-cell: 25.5" "Group enriched" "Detected in many" 9 "granulocytes: 59.3;NK-cells: 25.5" "Cell line enriched" "Detected in some" 14 "HMC-1: 35.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 3.0" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA053322: AB_2682111" "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.5 0.2 0.5 1.3 0.5 0.5 0.6 0.4 0.7 5.3 0.4 1.1 2.6 1.1 0.7 1.0 2.9 23.0 0.7 0.6 0.7 3.5 25.0 2.6 2.2 0.6 0.5 0.5 0.3 1.9 0.5 0.3 0.2 0.8 0.4 1.0 0.0 5.4 1.2 0.4 2.8 1.0 0.8 0.4 1.9 2.0 0.5 1.6 1.3 0.3 0.0 2.8 0.5 0.9 0.8 0.2 1.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.1 2.4 0.1 0.6 0.0 0.0 0.3 1.0 0.0 0.6 0.0 0.1 0.0 0.2 0.7 0.7 0.0 0.0 35.1 0.6 2.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.4 0.7 0.6 0.0 0.1 0.0 0.5 59.3 0.1 3.6 4.4 0.0 4.4 2.6 1.3 2.4 0.1 3.8 0.0 1.1 0.7 25.5 0.0 0.0 1.0 1.2 0.5 0.5 0.4 0.7 0.6 0.7 0.6 0.5 0.5 0.8 0.4 1.6 0.8 2.5 12.8 41.4 0.7 14.8 9.4 9.2 16.5 4.0 1.6 3.3 4.6 0.9 41.5 8.5 5.5 0.0 1.7 17.7 4.3 0.0 11.6 0.8 7.8 2.8 2.6 3.6 1.3 0.5 7.2 9.4 1.1 8.6 21.2 5.1 0.9 2.5 16.1 1.0 0.0 0.2 21.4 10.2 1.3 3.3 0.6 0.6 1.4 3.6 1.0 1.0 1.4 39.1 0.0 0.3 5.4 6.0 0.4 9.8 5.4 9.7 21.7 10.0 0.6 0.0 2.3 3.0 0.3 2.4 3.4 9.5 2.9 19.1 2.2 15.7 4.8 EXOC7 "BLOM4, EXO70, Exo70p, KIAA1067, YJL085W" ENSG00000182473 "Exocyst complex component 7" Q9UPT5 17 76081016-76121576 "Human disease related genes, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022840, HPA022842" Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA022840: AB_1848316, HPA022842: AB_1848317" "unprognostic (5.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (3.49e-2)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (1.30e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (7.39e-3)" "unprognostic (1.53e-2)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.18e-1)" 40.7 31.7 33.0 33.0 34.8 53.6 31.5 29.6 35.6 37.8 30.6 35.8 32.8 40.5 33.4 52.7 52.7 35.7 47.6 34.7 33.5 32.2 30.5 36.2 33.0 33.2 32.6 33.6 50.1 41.4 61.7 41.3 35.6 34.6 48.5 28.2 24.9 51.1 43.5 43.4 37.3 35.0 43.9 30.0 32.6 30.6 25.1 32.9 43.9 43.4 41.8 32.6 44.7 30.3 32.8 65.6 79.4 71.9 58.5 66.6 47.0 74.5 58.9 77.6 103.9 74.7 67.5 43.0 33.7 42.0 103.0 65.6 52.7 43.9 57.1 69.0 29.3 59.1 55.8 64.0 72.3 46.4 62.9 55.7 66.1 44.3 80.5 39.2 73.5 116.9 59.8 38.1 33.7 65.6 59.8 102.1 27.8 37.8 49.5 83.4 54.0 123.3 34.6 59.7 133.6 38.9 91.4 66.5 48.6 44.6 68.8 79.7 51.0 77.5 111.3 66.3 74.1 65.8 46.0 18.2 31.2 66.4 28.0 59.0 55.1 41.1 66.1 35.5 57.4 24.4 26.7 26.9 30.4 28.9 26.9 27.7 23.9 46.2 36.4 79.7 12.3 32.0 44.9 33.0 34.8 29.6 35.6 34.7 33.5 33.2 32.6 33.6 34.6 30.0 32.9 32.8 31.0 19.2 35.0 36.6 37.7 19.8 40.1 40.8 31.3 87.6 30.2 28.8 7.5 28.6 41.4 40.5 143.9 51.5 37.5 47.6 33.2 38.3 22.4 35.1 25.8 27.1 48.9 48.6 26.2 37.1 29.0 31.6 27.0 34.4 41.1 65.0 30.7 27.0 37.7 67.3 31.1 43.8 54.9 29.6 21.3 52.2 37.3 26.9 24.9 15.0 36.8 52.1 56.7 44.2 35.0 44.6 41.4 38.4 15.7 41.5 62.8 35.3 43.7 108.8 46.0 27.8 49.5 32.1 16.6 20.3 19.9 71.1 35.8 56.6 29.8 44.8 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035636-68047364 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 211.0" "Cell type enhanced" "Detected in all" "Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 160000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 26.1 16.1 21.2 45.7 21.8 100.0 15.4 21.1 24.7 17.5 19.0 31.0 26.3 17.7 25.9 41.7 10.9 19.6 20.5 23.5 25.0 16.4 23.3 18.0 72.7 21.8 23.4 21.0 6.5 10.1 10.7 15.7 44.2 23.3 8.2 36.2 22.4 15.6 11.7 14.9 21.2 23.5 34.9 23.0 28.6 19.2 211.0 22.3 95.6 11.0 16.8 105.7 38.9 17.9 25.8 556.0 712.3 667.1 264.4 95.7 93.9 421.1 467.9 372.9 758.1 587.9 499.5 250.4 514.4 146.7 273.4 375.1 297.4 753.8 359.4 870.7 203.8 437.5 446.5 311.7 482.7 101.9 387.6 294.3 58.1 69.3 426.0 267.2 105.8 746.8 211.0 360.8 346.0 686.1 517.3 484.4 249.8 451.4 455.2 365.8 271.5 605.1 280.6 304.0 250.0 262.2 286.3 269.5 839.1 291.9 609.6 495.6 196.9 288.6 416.7 506.2 290.6 647.3 291.5 451.9 504.7 203.0 334.9 458.0 30.1 31.0 12.7 24.1 46.5 19.2 45.8 18.8 27.3 56.2 39.6 13.3 21.5 0.9 43.9 39.6 41.4 37.7 31.3 21.2 21.8 21.1 24.7 23.5 25.0 21.8 23.4 21.0 23.3 23.0 22.3 25.8 41.0 12.8 31.0 6.2 49.4 109.7 32.2 73.7 43.3 20.1 39.8 45.5 13.8 7.2 39.7 18.4 8.4 128.3 96.4 27.7 15.6 31.4 863.9 70.8 55.1 48.6 42.9 70.9 8.5 25.5 279.7 64.9 31.1 68.0 44.4 68.2 21.8 17.2 126.0 32.0 7.3 27.6 97.6 42.9 132.1 266.6 19.3 60.0 53.4 3.7 72.1 31.2 18.6 6.6 5.9 20.7 11.9 14.7 60.3 27.6 9.3 31.2 22.7 20.0 32.9 52.4 74.1 552.9 185.2 61.3 88.5 118.9 79.8 28.0 49.3 24.2 WASH6P "CXYorf1, FAM39A" ENSG00000182484 "WASP family homolog 6, pseudogene" X 156020826-156025710 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "granulocytes: 225.3" "Cancer enhanced" "Detected in all" "urothelial cancer: 10.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA002689 Uncertain Approved Vesicles NA NA Vesicles "HPA002689: AB_1078803" "unprognostic (2.01e-1)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (4.69e-2)" "unprognostic (4.20e-2)" "unprognostic (1.53e-2)" "unprognostic (2.23e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-2)" "unprognostic (1.33e-3)" "unprognostic (3.94e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (2.15e-1)" "unprognostic (1.45e-1)" "unprognostic (5.86e-3)" 1.0 1.3 0.9 1.7 1.2 3.5 1.0 1.0 1.5 0.5 1.0 1.0 2.7 1.6 2.7 0.4 1.2 0.8 1.2 1.1 1.0 2.3 0.7 1.2 1.8 2.2 0.9 0.5 1.7 4.2 0.7 1.2 1.7 1.1 0.7 3.6 0.9 1.2 6.5 3.1 2.2 0.6 0.5 2.9 1.7 2.3 1.2 1.2 1.2 0.6 0.9 0.7 1.8 9.6 1.5 1.6 5.0 0.7 0.0 5.9 2.5 0.4 0.8 1.5 0.4 5.2 3.1 1.7 1.4 4.0 7.3 1.2 2.0 0.7 0.7 1.7 4.7 0.6 1.3 0.0 1.8 3.7 0.2 0.9 1.4 2.0 0.5 1.2 0.9 6.2 4.6 0.0 1.2 7.9 4.1 2.3 4.2 0.9 7.0 3.0 2.0 0.3 0.4 4.2 6.3 3.1 4.7 5.7 1.3 6.6 5.8 3.1 3.5 3.4 3.3 3.9 8.0 9.8 1.8 0.8 3.1 3.9 0.4 0.2 0.0 0.3 0.2 0.3 0.4 0.0 0.3 0.2 0.3 0.1 0.2 0.1 0.8 1.1 0.2 0.4 0.3 0.9 1.2 1.0 1.5 1.1 1.0 2.2 0.9 0.5 1.7 0.5 1.2 1.8 0.0 35.3 23.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.2 5.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 225.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 5.3 0.0 XKRX "XKR2, XPLAC" ENSG00000182489 "XK related X-linked" Q6PP77 X 100913445-100929433 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9;skin 1: 8.7" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Excitatory neurons: 4.3;Inhibitory neurons: 6.0;Microglial cells: 3.7;Oligodendrocytes: 5.5;Syncytiotrophoblasts: 2.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "hypothalamus: 3.9" "Group enriched" "Detected in some" 5 "naive B-cell: 1.9;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2" "Group enriched" "Detected in many" 18 "B-cells: 1.9;T-cells: 1.5" "Cell line enriched" "Detected in some" 5 "CACO-2: 8.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (3.35e-1)" "unprognostic (2.38e-2)" "unprognostic (4.51e-3)" "unprognostic (1.87e-1)" "unprognostic (8.53e-2)" "unprognostic (2.67e-2)" "unprognostic (2.96e-2)" "unprognostic (5.18e-2)" "unprognostic (3.69e-2)" "unprognostic (7.37e-2)" "unprognostic (5.70e-2)" "unprognostic (1.58e-2)" "unprognostic (5.60e-6)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.18e-1)" 0.0 0.6 0.5 0.8 0.2 0.1 0.6 0.1 0.2 0.4 0.0 0.7 0.3 0.2 1.1 2.3 0.7 0.1 0.0 0.2 3.9 0.1 0.0 1.2 1.6 0.3 0.4 0.1 0.2 0.0 0.0 1.0 0.3 0.3 0.3 0.8 0.2 0.5 1.0 0.1 8.7 2.4 0.1 0.2 0.5 0.3 0.2 0.8 1.8 0.5 0.0 3.5 0.3 1.7 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 8.2 1.0 0.6 0.0 0.0 0.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.4 0.1 0.0 0.3 1.6 0.0 0.0 0.0 1.6 0.1 1.3 0.2 0.7 0.1 0.7 0.0 0.1 0.2 0.0 1.4 0.0 0.2 0.0 0.0 1.2 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.9 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 0.2 0.2 3.9 0.3 0.4 0.1 0.3 0.2 0.8 0.2 0.0 0.0 0.0 9.4 0.7 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 6.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.8 3.7 0.1 0.2 0.0 1.0 5.5 0.1 0.1 0.0 0.0 0.1 1.2 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.3 1.0 0.9 2.6 0.2 0.0 0.2 0.4 BGN "DSPG1, SLRR1A" ENSG00000182492 Biglycan P21810 X 153494980-153509546 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Aortic aneurysm, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003157, CAB003678" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA 3300000 "Golgi apparatus" "Endoplasmic reticulum" "CAB003678: AB_425325, HPA003157: AB_1078282" "unprognostic (1.74e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-3)" "unprognostic (3.60e-1)" "unprognostic (5.42e-2)" "unprognostic (3.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.22e-2)" "unprognostic (1.76e-3)" "unprognostic (1.30e-2)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (6.00e-8)" "unprognostic (7.05e-3)" "unprognostic (2.40e-2)" "unprognostic (5.66e-2)" "unprognostic (2.57e-3)" 151.5 214.7 49.8 94.0 57.1 0.3 119.0 45.1 97.6 321.0 109.7 63.5 22.2 236.3 84.4 46.2 145.0 328.9 545.7 48.3 47.3 307.8 350.8 481.4 42.7 53.6 44.3 37.1 95.7 68.4 26.8 145.2 200.7 50.9 185.8 25.0 1.2 108.6 136.8 32.7 119.8 49.2 215.1 40.4 354.9 52.0 70.5 50.1 16.1 252.1 47.1 36.2 127.9 181.5 61.8 0.0 0.0 29.7 0.1 31.5 70.5 1.1 312.6 400.8 56.7 18.6 39.5 0.0 0.0 56.9 568.9 2.0 0.1 0.0 0.0 10.2 0.0 0.0 0.0 0.6 3.9 27.0 0.0 0.2 283.9 2.2 235.2 10.7 29.0 561.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.5 0.3 0.2 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.1 11.8 1.3 0.0 120.0 249.5 2.3 1.0 1.5 0.9 0.1 0.0 0.1 0.3 114.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 57.1 45.1 97.6 48.3 47.3 53.6 44.3 37.1 50.9 40.4 50.1 61.8 30.5 3.2 5.6 5.9 0.6 104.1 1.3 7.3 5.7 0.2 1.2 5.6 16.1 4.3 2.5 9.2 0.0 15.5 0.7 0.0 1.9 2.7 1.8 1.4 28.3 45.2 0.0 5.3 0.1 0.2 50.0 180.0 7.7 1.1 3.8 8.4 223.5 1.6 4.4 3.3 0.1 0.0 0.0 4.0 43.6 13.5 147.9 3.0 35.6 25.3 2.0 0.1 0.0 20.6 0.0 1.2 0.0 782.7 0.0 3.0 0.0 0.8 1.6 0.2 1485.7 3.1 401.3 0.8 1.2 1.8 54.1 56.9 3.0 7.7 0.0 1.6 CEP97 "FLJ23047, LRRIQ2" ENSG00000182504 "Centrosomal protein 97" Q8IW35 3 101724593-101770562 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002980 Uncertain NA NA "HPA002980: AB_1848820" "unprognostic (7.36e-2)" "unprognostic (4.70e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (2.01e-3)" "unprognostic (1.00e-1)" "unprognostic (2.85e-1)" "unprognostic (4.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.79e-1)" "unprognostic (1.05e-1)" 2.1 2.7 4.8 3.7 8.0 4.9 2.7 6.4 7.0 2.3 3.1 2.0 1.7 3.6 2.6 2.1 5.3 2.3 2.0 5.1 6.1 2.2 1.3 2.3 4.6 6.2 6.9 4.4 3.3 1.1 6.1 2.7 2.7 6.6 2.4 2.3 5.6 2.0 2.2 2.6 2.7 1.8 4.2 6.0 3.0 2.3 7.4 6.2 6.0 3.4 3.6 4.5 2.4 2.0 13.0 12.0 7.0 11.7 8.7 6.5 5.2 3.6 12.6 8.8 9.6 11.8 3.0 5.5 10.6 5.6 7.1 7.7 7.9 8.8 6.9 16.1 11.5 4.3 6.0 7.6 2.2 3.2 7.6 8.9 3.0 5.6 8.2 6.9 5.1 5.4 10.4 4.9 17.9 11.8 3.6 12.4 4.0 4.2 4.3 9.1 9.0 16.1 7.2 3.3 4.5 22.4 9.2 6.8 4.5 6.1 6.1 7.4 6.8 5.4 12.9 9.5 3.8 9.4 11.3 11.0 18.3 5.3 6.8 13.0 2.1 0.1 0.6 0.7 0.0 0.5 1.0 0.6 0.4 0.1 0.5 0.4 0.3 0.9 0.3 0.4 0.4 0.8 0.2 4.8 8.0 6.4 7.0 5.1 6.1 6.2 6.9 4.4 6.6 6.0 6.2 13.0 8.7 3.2 6.2 24.5 9.1 4.7 2.4 4.7 9.1 13.6 5.2 4.3 7.0 4.3 9.6 1.8 12.5 3.7 14.6 1.6 3.9 4.4 20.7 32.7 14.3 6.4 4.2 9.1 28.6 2.1 2.9 8.8 5.1 10.4 9.5 14.5 3.9 4.1 2.8 18.5 36.0 3.7 10.2 3.1 2.7 9.1 7.8 3.0 8.8 8.4 3.4 19.6 4.1 50.8 96.5 4.0 1.0 7.5 24.0 1.8 0.9 3.1 42.5 14.6 13.1 13.1 8.6 30.4 11.9 8.0 3.7 1.9 9.2 11.0 3.3 1.5 LHFPL1 ENSG00000182508 "LHFPL tetraspan subfamily member 1" Q86WI0 X 112630648-112680054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.0;salivary gland: 2.9" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Inhibitory neurons: 1.1;Ionocytes: 2.0;Microglial cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.6;SuSa: 3.8" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 4 "olfactory bulb: 3.3" HPA003029 Uncertain NA NA "HPA003029: AB_1079248" "unprognostic (2.23e-2)" "unprognostic (2.78e-3)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "unprognostic (2.65e-1)" "unprognostic (1.54e-1)" "unprognostic (5.31e-3)" "unprognostic (1.29e-1)" "unprognostic (4.41e-3)" "unprognostic (5.19e-5)" "unprognostic (1.33e-1)" "unprognostic (7.63e-3)" "unprognostic (4.83e-2)" "unprognostic (1.21e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-1)" 0.0 0.1 4.3 0.1 5.1 0.0 0.6 0.8 2.6 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.7 2.7 5.2 0.1 0.0 0.0 0.1 3.2 10.0 2.7 0.3 0.0 0.1 1.3 0.1 3.1 0.3 0.1 0.1 2.9 0.8 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 5.7 0.9 0.5 0.7 0.1 0.1 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.6 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 2.6 3.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 4.3 5.1 0.8 2.6 2.7 5.2 3.2 10.0 2.7 3.1 0.1 5.7 1.4 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.4 0.9 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.1 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.1;lymphoid tissue: 111.8" "Cell type enhanced" "Detected in many" "Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 315.8" "Group enriched" "Detected in many" 4 "dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7" "Cell line enhanced" "Detected in many" "HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 27.7 8.1 9.0 20.3 8.0 84.1 21.4 8.9 10.9 17.9 9.5 11.8 5.9 15.8 2.4 6.0 19.2 14.1 17.0 7.7 11.6 11.7 25.4 31.2 13.9 9.9 8.2 6.9 13.6 7.9 2.4 5.6 16.4 9.4 18.1 4.6 1.5 58.8 8.1 6.1 7.6 12.6 10.8 9.4 111.8 9.7 4.5 9.5 4.3 16.1 7.0 5.7 15.3 13.7 10.8 0.4 0.8 0.8 10.3 3.1 8.8 17.9 2.9 0.1 5.1 2.9 2.6 0.1 6.8 0.5 6.0 0.2 1.5 1.7 0.3 1.6 3.3 1.1 63.5 0.0 11.9 6.8 56.9 116.6 8.8 0.1 7.6 0.0 0.0 31.2 9.4 1.8 0.2 0.0 21.3 1.8 76.1 3.2 2.5 0.0 8.6 0.1 0.1 0.0 0.2 0.4 0.1 0.0 2.8 2.3 2.9 0.1 110.8 24.9 0.2 10.4 0.2 0.2 0.1 8.0 2.5 0.3 48.0 2.4 64.4 151.7 315.8 0.5 88.6 0.4 5.2 0.3 0.4 162.6 4.1 0.2 0.3 100.5 51.4 39.8 65.0 0.2 81.5 9.0 8.0 8.9 10.9 7.7 11.6 9.9 8.2 6.9 9.4 9.4 9.5 10.8 46.8 3.2 5.8 3.6 5.0 3.8 5.4 0.5 0.6 0.2 4.1 3.8 3.4 8.6 0.5 1.8 0.0 5.3 25.6 0.6 3.9 7.3 1.7 2.0 4.2 29.1 3.0 8.0 2.8 4.3 4.2 9.0 2.0 4.2 29.2 10.7 20.0 15.0 48.7 0.0 0.2 2.0 2.0 92.3 27.9 8.4 9.0 51.9 7.2 5.6 57.8 2.5 26.8 2.0 0.3 2.1 2.0 10.1 4.0 3.1 0.7 1.5 0.2 1.9 13.1 4.6 12.9 4.4 15.9 1.0 2.8 4.5 6.7 3.3 3.7 5.2 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 196.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 518.5;Erythroid cells: 1134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria NA NA Mitochondria "HPA042465: AB_10794048, HPA063716: AB_2685102" "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favorable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 37.6 52.6 45.4 17.7 46.3 180.2 27.4 45.3 50.6 22.5 48.1 45.2 46.7 19.4 39.4 24.7 23.8 17.6 77.6 48.0 46.2 75.2 106.4 18.4 23.3 44.7 45.9 45.1 33.1 31.8 46.7 19.1 38.1 45.4 27.1 37.7 10.2 29.6 29.9 196.9 17.6 33.5 24.6 44.6 20.9 34.5 36.0 46.2 40.7 27.0 170.4 27.3 24.7 15.2 45.5 77.1 92.7 61.4 68.0 74.2 57.5 202.0 54.9 56.1 69.4 69.1 124.8 87.5 111.7 77.4 42.8 39.2 75.5 116.5 79.6 71.5 68.5 94.4 100.3 63.4 202.2 73.5 160.9 96.5 55.4 74.1 49.9 81.1 28.1 76.1 94.4 115.7 88.3 61.2 205.5 133.6 165.9 81.5 89.7 107.8 220.8 184.3 67.8 93.3 89.3 127.9 75.2 54.8 81.3 87.7 59.9 107.7 72.6 55.6 30.5 65.0 77.6 85.7 41.7 57.9 92.0 67.2 99.8 72.2 0.4 2.9 4.8 3.4 4.3 4.9 4.6 4.6 6.0 4.7 5.4 3.7 3.9 1.3 3.9 2.7 9.0 6.2 1.8 45.4 46.3 45.3 50.6 48.0 46.2 44.7 45.9 45.1 45.4 44.6 46.2 45.5 78.7 28.9 30.0 7.8 41.1 108.5 58.7 7.5 61.5 38.5 112.8 135.9 150.0 64.3 10.4 95.6 33.3 97.8 66.5 76.3 518.5 15.2 312.0 49.7 61.5 58.9 54.0 1134.9 15.0 15.6 164.9 66.2 46.4 48.3 14.7 110.3 47.2 147.2 58.7 50.5 16.4 72.1 4.1 41.7 58.7 90.2 54.3 50.7 87.2 7.5 21.3 128.1 52.5 12.5 15.2 15.2 39.5 73.7 75.2 108.2 51.8 281.4 9.1 43.0 59.2 61.1 92.7 115.4 79.0 102.2 124.9 53.8 48.8 169.0 88.0 76.6 FAM104B "CXorf44, FLJ20434" ENSG00000182518 "Family with sequence similarity 104 member B" Q5XKR9 X 55143102-55161310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 134.0;Late spermatids: 238.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049082 Approved NA NA "HPA049082: AB_2680625" "unprognostic (2.46e-2)" "unprognostic (1.10e-3)" "unprognostic (1.90e-1)" "unprognostic (5.98e-2)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.23e-4)" "prognostic favorable (1.22e-4)" "unprognostic (9.35e-2)" "unprognostic (5.12e-3)" "unprognostic (2.17e-2)" "unprognostic (1.81e-3)" "unprognostic (9.32e-3)" "unprognostic (1.05e-1)" "unprognostic (2.40e-3)" "unprognostic (1.65e-1)" "unprognostic (5.27e-3)" 11.2 16.2 29.1 11.0 30.5 12.7 17.3 29.9 38.1 23.4 26.1 17.8 8.4 20.5 49.4 14.8 46.4 10.4 16.5 28.4 29.5 38.2 19.1 14.2 15.4 29.8 29.4 26.8 18.6 10.6 28.0 15.3 11.4 30.5 13.6 16.4 30.9 10.9 16.9 20.7 17.6 10.6 16.6 29.2 10.8 13.7 15.1 29.0 20.1 34.1 22.6 16.4 16.8 13.4 33.0 26.9 20.9 24.3 22.2 16.4 21.3 7.2 13.8 10.2 14.2 12.2 12.4 23.9 12.8 28.5 12.6 25.4 18.6 36.7 21.4 22.7 12.1 36.7 17.5 23.7 14.9 13.2 23.1 14.4 18.6 18.7 22.7 17.5 16.7 17.3 26.3 22.7 17.7 18.2 23.9 30.9 21.7 36.1 25.1 37.4 17.6 30.8 30.5 41.1 29.0 31.3 25.3 23.0 17.9 28.0 35.4 34.4 15.2 17.2 16.5 21.7 40.8 18.2 13.1 12.6 12.2 21.0 40.3 14.5 12.7 16.1 11.0 14.5 22.6 15.7 17.8 16.6 17.5 22.6 14.9 18.9 18.6 7.9 17.9 19.5 21.9 19.1 12.7 29.1 30.5 29.9 38.1 28.4 29.5 29.8 29.4 26.8 30.5 29.2 29.0 33.0 13.3 41.7 17.2 6.5 12.2 15.2 19.2 60.3 18.8 8.0 22.6 26.7 49.0 22.8 24.4 25.8 0.0 35.9 10.6 21.3 45.0 35.6 134.0 63.6 19.9 16.7 18.8 51.1 7.4 29.4 52.8 23.0 9.2 18.5 50.0 14.2 16.4 26.0 33.3 5.0 7.3 25.3 26.4 16.2 15.4 238.3 19.6 14.3 26.6 8.4 12.7 27.2 20.6 10.6 10.7 18.4 47.6 22.2 11.5 15.3 12.2 115.4 96.9 12.5 19.7 17.1 23.4 31.6 22.2 23.6 25.3 27.2 13.8 27.7 26.6 20.9 TBPL2 "TBP2, TRF3" ENSG00000182521 "TATA-box binding protein like 2" Q6SJ96 14 55413541-55456726 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.7" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Smooth muscle cells: 2.0" "Cancer enriched" "Detected in single" 40 "testis cancer: 2.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;HMC-1: 2.7;U-2 OS: 2.5;U-937: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056241 Uncertain NA NA "HPA056241: AB_2683076" "unprognostic (3.42e-1)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (3.06e-4)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" 0.2 0.5 0.5 0.8 0.5 0.5 0.0 1.5 1.2 0.4 0.3 0.2 0.9 0.7 0.0 0.2 0.2 0.1 0.0 0.5 0.3 0.2 0.2 0.4 0.4 1.4 0.6 0.1 0.1 0.2 0.1 0.0 0.2 0.8 0.3 0.2 0.1 0.6 0.1 1.7 1.3 0.6 0.0 0.2 0.5 0.5 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.4 2.0 0.5 0.0 0.6 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.2 0.3 0.4 1.6 0.0 0.2 0.5 0.1 0.0 0.0 5.7 0.0 0.4 0.6 0.0 0.0 0.0 2.7 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.3 1.9 0.0 1.4 0.3 1.0 0.4 0.0 0.5 0.5 0.0 0.4 0.0 0.8 0.7 0.5 0.0 0.1 0.2 0.0 0.8 0.7 0.0 0.2 2.5 0.2 0.4 1.7 0.9 0.2 0.3 4.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.5 0.5 1.5 1.2 0.5 0.3 1.4 0.6 0.1 0.8 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.3 2.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733802-8841808 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 184.4;tongue: 73.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 94.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 5.7 0.1 0.1 22.5 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 2.5 0.2 184.4 0.2 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 73.4 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 11.0 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 MXRA7 "FLJ46603, PS1TP1, TMAP1" ENSG00000182534 "Matrix remodeling associated 7" P84157 17 76672551-76711016 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 663.8" "HPA044819, HPA075316" Uncertain Enhanced "Endoplasmic reticulum" "Secreted to blood" NA NA 100000 "Endoplasmic reticulum" "HPA044819: AB_10964134, HPA075316: " "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (2.92e-1)" "unprognostic (1.19e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (3.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.51e-3)" "unprognostic (2.07e-2)" "unprognostic (8.33e-2)" "unprognostic (5.39e-3)" "unprognostic (4.67e-3)" "unprognostic (6.21e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.80e-5)" 173.1 246.6 119.5 53.9 168.6 13.6 134.7 123.7 137.7 143.5 242.4 230.0 37.8 270.6 210.6 158.5 182.6 104.5 531.3 131.4 130.0 74.6 30.1 126.0 32.0 138.5 131.3 115.2 187.0 91.1 237.7 49.2 103.7 133.1 155.7 76.8 519.1 62.6 317.8 69.5 65.7 90.2 286.9 131.7 151.0 125.0 116.7 124.6 45.0 274.6 76.5 33.6 252.6 124.2 127.6 19.1 56.1 82.4 155.3 424.0 384.4 41.0 263.8 212.8 188.8 182.8 75.1 2.9 0.5 116.8 368.0 196.8 75.7 92.5 146.5 306.4 1.4 91.7 48.7 39.2 126.8 258.4 22.9 5.9 241.1 171.2 219.3 178.7 421.8 282.0 12.3 35.2 1.2 440.8 5.3 2.9 15.9 26.5 30.0 156.7 43.2 322.2 16.5 153.1 4.8 28.8 207.3 78.5 1.0 152.6 231.6 51.5 29.3 348.5 422.7 90.1 174.3 282.6 24.5 4.9 1.4 663.8 9.9 62.5 1.3 2.8 0.5 4.0 0.8 3.1 2.3 2.1 4.5 2.1 0.4 1.3 2.9 1.1 5.4 0.3 2.4 0.5 3.4 119.5 168.6 123.7 137.7 131.4 130.0 138.5 131.3 115.2 133.1 131.7 124.6 127.6 128.3 16.0 14.6 8.5 2.0 10.3 27.0 15.0 13.6 142.0 9.4 42.5 117.3 2.8 10.3 31.3 95.9 1.4 62.6 1.3 1.9 25.5 3.5 48.7 203.7 56.1 6.7 0.8 19.3 4.1 8.1 97.2 2.0 63.9 2.5 64.7 52.5 4.2 3.5 111.0 27.9 7.5 10.2 5.0 13.3 12.4 101.2 7.4 14.2 10.3 1.3 365.7 6.2 15.1 8.9 6.5 0.3 143.3 11.0 21.2 1.6 8.1 10.2 163.8 13.1 132.1 83.6 2.3 10.7 6.0 8.8 0.8 19.7 218.5 1.5 21.1 LIMK2 ENSG00000182541 "LIM domain kinase 2" P53671 22 31212239-31280080 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 115.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "eosinophil: 40.0;neutrophil: 96.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 96.9" "Cell line enhanced" "Detected in all" "BEWO: 135.5;hTCEpi: 251.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008183, CAB019313, HPA053882" Approved Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB019313: , HPA008183: AB_1079252, HPA053882: AB_2682291" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (4.02e-2)" "unprognostic (5.99e-2)" "unprognostic (1.21e-1)" "unprognostic (2.95e-1)" "unprognostic (3.96e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.57e-6)" "unprognostic (4.48e-2)" "unprognostic (1.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.37e-1)" 17.2 14.6 25.3 40.2 24.9 54.3 31.1 26.0 19.9 22.9 30.0 34.3 21.4 17.1 7.7 72.4 34.5 21.4 13.6 19.3 28.3 27.7 33.3 47.2 23.4 37.2 29.6 17.7 21.8 29.0 27.2 22.1 48.4 31.8 37.0 35.1 25.7 51.1 19.3 18.9 72.0 29.5 16.0 31.7 37.8 30.3 19.4 32.7 21.5 42.3 9.3 17.9 25.9 45.6 33.1 26.6 4.4 17.9 10.0 7.6 8.8 135.5 17.2 8.0 16.9 14.2 22.7 12.2 25.8 29.9 26.0 8.1 52.6 20.9 90.3 10.6 19.1 22.8 18.8 21.1 24.7 11.4 35.1 33.1 14.3 251.5 13.7 41.0 114.5 43.6 20.6 10.7 18.2 23.3 20.9 21.5 12.0 16.7 68.3 6.7 28.1 30.0 14.3 19.6 62.3 22.8 20.4 13.0 82.1 35.1 54.8 68.7 13.9 26.6 15.1 23.5 8.3 16.3 10.0 16.2 22.4 9.6 16.4 6.6 5.8 5.1 40.0 3.1 3.5 5.9 2.0 5.7 4.3 1.9 2.4 5.6 4.4 96.9 6.7 1.4 4.4 15.2 4.4 25.3 24.9 26.0 19.9 19.3 28.3 37.2 29.6 17.7 31.8 31.7 32.7 33.1 19.5 32.1 17.9 16.3 5.2 35.9 37.7 24.8 59.2 9.4 18.0 23.2 25.1 10.0 32.6 5.5 20.9 69.8 15.3 39.3 3.9 13.0 1.4 49.6 19.2 22.4 13.2 10.3 6.4 45.0 52.4 7.6 48.9 41.6 23.5 8.6 14.3 7.1 18.2 3.3 11.3 42.8 18.3 8.9 8.2 1.6 4.4 13.8 3.6 16.9 5.4 16.6 2.1 2.5 15.5 25.9 21.2 4.5 6.2 27.1 12.0 10.5 36.3 22.8 19.7 7.5 17.2 15.6 18.4 46.1 39.1 115.5 9.3 7.1 51.7 29.9 MFSD5 "HsMOT2, MGC11308" ENSG00000182544 "Major facilitator superfamily domain containing 5" Q6N075 12 53251251-53254406 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039773 Uncertain NA NA "HPA039773: AB_10793920" "unprognostic (9.42e-3)" "unprognostic (9.03e-3)" "unprognostic (4.25e-2)" "unprognostic (1.10e-1)" "unprognostic (1.37e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (2.20e-2)" "unprognostic (1.69e-1)" "unprognostic (4.25e-1)" "unprognostic (9.79e-2)" "unprognostic (4.52e-2)" "unprognostic (5.63e-2)" "unprognostic (1.65e-2)" "unprognostic (2.12e-1)" "unprognostic (6.51e-3)" "unprognostic (1.19e-2)" 17.7 29.1 16.8 12.3 17.2 22.3 16.7 18.7 17.8 16.4 18.5 16.5 13.6 16.7 12.9 61.8 13.4 11.5 19.2 16.7 17.8 17.0 15.9 15.7 14.8 18.0 17.5 16.5 10.0 22.3 20.0 11.8 16.3 17.9 15.9 14.8 27.2 26.3 13.4 19.1 60.1 18.7 13.6 18.3 20.6 19.7 10.7 17.9 9.9 13.0 14.1 20.5 18.3 30.8 19.6 23.8 51.1 15.2 27.9 57.7 32.7 17.6 34.7 43.3 36.4 34.1 27.2 43.8 19.4 29.6 50.1 34.4 43.1 24.9 28.7 24.2 25.0 34.7 14.8 18.6 36.2 40.0 28.6 35.8 40.8 39.5 34.5 17.1 39.4 33.7 18.7 27.8 34.4 35.5 89.2 14.0 35.3 26.4 27.3 44.5 17.1 15.3 26.3 26.8 41.1 12.5 18.8 25.0 34.3 28.0 17.8 59.6 26.4 32.2 30.9 20.0 32.0 22.8 20.8 27.3 15.1 41.1 27.4 30.2 58.3 32.3 103.7 26.6 25.9 32.7 50.1 31.4 30.2 38.1 44.6 23.4 22.4 17.5 27.8 17.7 31.9 27.9 23.4 16.8 17.2 18.7 17.8 16.7 17.8 18.0 17.5 16.5 17.9 18.3 17.9 19.6 5.5 9.6 10.6 6.2 12.1 13.0 5.8 15.9 14.2 5.4 9.4 7.4 9.5 10.0 18.1 12.9 31.3 38.4 7.8 20.3 5.9 20.4 0.5 5.2 8.0 10.8 2.4 9.9 2.2 26.5 24.5 12.1 9.2 7.7 5.7 7.6 11.4 10.9 28.6 3.3 2.7 10.9 10.2 18.8 13.4 2.0 6.2 11.7 16.0 0.0 17.2 7.8 14.4 3.5 3.4 21.9 13.3 4.9 10.9 8.7 12.0 10.9 10.3 14.3 6.6 7.7 8.4 4.7 14.2 21.3 17.0 33.2 12.1 6.2 8.5 7.9 RNASE10 "RAH1, RNASE9" ENSG00000182545 "Ribonuclease A family member 10 (inactive)" Q5GAN6 14 20505537-20511169 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Fertilization" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "head and neck cancer: 2.0;testis cancer: 1.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SiHa: 7.2;U-2 OS: 10.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052593 Uncertain "Secreted - unknown location" NA NA "HPA052593: AB_2681878" "unprognostic (2.48e-3)" "unprognostic (2.22e-1)" "unprognostic (2.46e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (5.91e-3)" "unprognostic (5.03e-3)" "unprognostic (5.58e-3)" "unprognostic (4.20e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-3)" "unprognostic (1.11e-1)" "unprognostic (7.88e-4)" "unprognostic (1.58e-1)" "unprognostic (3.62e-1)" "unprognostic (8.76e-2)" "unprognostic (2.58e-1)" 2.1 1.8 3.0 1.6 3.1 1.1 0.4 2.5 4.2 0.5 2.8 0.7 1.6 2.0 1.1 1.1 1.1 0.6 0.4 3.1 2.4 0.9 0.8 1.6 0.8 3.6 2.9 2.4 1.1 0.4 0.4 0.5 0.8 3.2 1.2 0.4 0.5 0.9 0.7 2.0 2.5 1.7 0.5 1.7 1.3 1.1 1.9 3.5 0.5 0.7 0.2 0.4 0.7 0.5 5.1 4.4 2.0 0.9 1.9 0.2 0.4 2.8 0.2 0.4 0.1 0.3 0.9 1.2 0.5 1.3 0.5 0.6 2.3 0.0 0.3 0.1 1.7 0.7 0.0 1.5 0.6 0.5 0.1 2.0 0.7 1.5 0.1 2.3 0.4 1.0 0.7 1.0 2.3 0.0 1.2 0.7 1.1 0.5 0.6 0.2 3.3 0.3 2.6 0.7 1.8 1.1 1.4 7.2 1.7 0.9 0.9 1.6 0.7 0.4 0.7 10.8 0.9 0.8 2.2 0.9 0.2 0.8 0.6 0.9 1.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.3 0.3 0.0 0.0 3.0 3.1 2.5 4.2 3.1 2.4 3.6 2.9 2.4 3.2 1.7 3.5 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ADI1 "APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL" ENSG00000182551 "Acireductone dioxygenase 1" Q9BV57 2 3497366-3519531 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 595.5" "Cell type enhanced" "Detected in all" "Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035403, HPA035404" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 130000 Nucleoplasm "Golgi apparatus" "HPA035403: AB_10603576, HPA035404: AB_2674611" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "unprognostic (3.65e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-3)" "unprognostic (4.23e-3)" "unprognostic (2.36e-3)" "unprognostic (4.00e-3)" "unprognostic (2.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.90e-2)" "unprognostic (1.56e-1)" "unprognostic (9.94e-2)" "unprognostic (6.76e-2)" "unprognostic (8.74e-2)" 54.7 77.5 30.0 28.3 30.9 32.0 50.9 29.8 42.4 54.7 39.1 55.2 106.2 46.0 43.7 48.6 45.6 67.3 147.7 29.8 28.8 202.0 595.5 45.0 30.4 31.4 30.1 28.4 50.4 35.2 50.0 33.7 41.6 31.8 102.0 52.8 17.2 54.1 56.4 122.3 35.0 69.5 38.2 29.8 57.6 83.1 16.9 29.5 27.2 36.8 56.5 34.8 58.4 36.8 32.8 46.5 64.5 55.9 50.2 187.5 85.0 91.9 95.6 124.1 102.7 74.5 86.9 59.2 22.1 143.4 109.5 21.4 45.1 62.9 49.0 59.2 39.5 131.4 67.6 42.2 184.1 165.4 71.2 151.3 91.4 72.3 55.0 63.7 45.3 75.8 36.1 51.8 45.3 87.4 137.8 25.6 147.1 44.4 131.9 86.4 27.1 31.3 128.2 90.2 83.3 57.0 54.0 53.0 75.0 37.2 36.8 55.6 95.5 54.1 75.9 29.0 35.9 56.6 35.4 91.6 88.7 58.6 115.5 41.0 87.6 134.3 336.9 28.5 126.5 31.8 66.8 67.4 26.7 127.7 53.4 79.3 25.6 59.4 54.5 117.4 186.3 67.4 189.0 30.0 30.9 29.8 42.4 29.8 28.8 31.4 30.1 28.4 31.8 29.8 29.5 32.8 44.8 67.3 111.1 25.1 73.1 76.0 154.5 107.8 92.2 9.2 103.0 88.9 275.8 338.8 109.5 152.6 14.6 395.0 80.6 140.1 888.3 157.2 8.8 65.9 116.3 61.6 57.2 123.1 9.4 87.2 247.1 129.1 66.3 116.3 41.8 75.1 207.8 1234.6 263.2 8.4 15.0 146.1 236.0 168.8 67.6 23.8 137.0 90.0 204.5 7.5 108.2 197.2 40.2 5.5 19.0 79.7 272.5 210.3 97.4 143.6 409.8 1546.8 38.0 15.3 164.3 45.5 109.3 5.3 11.3 113.6 76.9 381.4 53.0 120.8 147.2 156.9 RWDD4 "FAM28A, MGC10198, RWDD4A" ENSG00000182552 "RWD domain containing 4" Q6NW29 4 183639635-183659203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036501, HPA036502" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA036501: AB_2675159, HPA036502: AB_10670800" "unprognostic (1.30e-1)" "unprognostic (4.15e-1)" "unprognostic (7.50e-2)" "unprognostic (2.30e-1)" "unprognostic (7.80e-2)" "unprognostic (1.72e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.27e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-2)" "unprognostic (2.98e-1)" "prognostic favorable (1.01e-6)" "unprognostic (6.77e-2)" "unprognostic (1.14e-1)" "unprognostic (3.51e-2)" "unprognostic (4.65e-2)" 12.0 52.5 10.7 9.0 11.1 14.8 19.3 12.4 12.2 12.5 15.2 12.1 11.1 12.2 14.4 14.6 13.9 12.8 16.4 10.6 15.3 23.9 16.0 9.7 10.8 11.8 12.4 10.2 40.7 26.4 11.9 19.2 11.7 11.0 15.3 12.2 6.3 20.8 11.1 45.4 11.3 10.1 10.8 11.1 9.9 13.8 10.1 12.3 16.0 22.4 32.4 12.6 14.1 10.5 11.7 25.6 14.6 22.0 27.2 35.1 36.5 16.7 31.8 25.4 38.9 24.7 9.5 32.8 38.6 7.1 26.6 18.8 11.8 31.1 29.7 40.8 25.5 14.0 27.7 16.4 24.4 24.7 42.5 20.3 24.2 30.0 21.6 24.0 30.2 29.8 29.7 27.0 48.5 42.0 10.8 44.7 36.7 14.7 9.8 19.2 30.7 17.0 24.8 38.5 12.1 21.0 29.6 29.9 34.4 29.0 16.9 17.3 25.8 20.9 16.3 8.0 17.6 24.9 16.2 13.1 13.1 30.6 31.8 23.7 3.2 3.4 6.8 4.4 4.5 4.4 3.8 4.0 4.2 4.4 2.5 3.7 3.9 2.9 6.5 5.5 4.7 5.7 3.5 10.7 11.1 12.4 12.2 10.6 15.3 11.8 12.4 10.2 11.0 11.1 12.3 11.7 29.4 22.4 19.5 7.2 25.6 33.6 35.4 32.0 27.3 17.9 39.2 40.8 11.5 37.1 25.3 18.4 6.2 25.9 32.9 19.7 74.3 38.8 10.6 38.4 28.6 27.3 21.7 30.3 10.3 77.5 42.4 33.4 28.1 28.2 35.5 35.9 26.4 35.6 36.1 10.1 9.5 21.6 38.7 30.1 21.9 9.9 74.0 23.8 56.9 6.5 34.7 30.9 32.0 6.6 7.7 55.8 17.1 70.7 32.5 90.3 19.6 116.1 32.0 22.1 19.7 44.5 27.4 47.7 59.7 46.0 35.5 27.1 26.7 70.2 25.4 59.1 SPNS3 "MGC29671, SLC62A3" ENSG00000182557 "Sphingolipid transporter 3 (putative)" Q6ZMD2 17 4433940-4488208 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "bone marrow: 31.4" "Cell type enhanced" "Detected in many" "dendritic cells: 30.9;Langerhans cells: 16.4;Proximal tubular cells: 51.8;T-cells: 23.7" "Cancer enhanced" "Detected in many" "renal cancer: 2.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "eosinophil: 354.8;plasmacytoid DC: 127.7" "Group enriched" "Detected in many" 37 "dendritic cells: 127.7;granulocytes: 354.8" "Group enriched" "Detected in some" 4 "JURKAT: 29.5;NB-4: 46.8;THP-1: 35.5;U-937: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023928 Uncertain NA NA "HPA023928: AB_1844393" "unprognostic (4.39e-2)" "unprognostic (8.10e-5)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.94e-4)" "unprognostic (2.86e-2)" "unprognostic (1.96e-2)" "unprognostic (1.81e-2)" "unprognostic (6.46e-2)" "unprognostic (1.37e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (6.18e-2)" "unprognostic (6.57e-2)" "unprognostic (4.13e-2)" "unprognostic (9.69e-2)" 0.1 0.1 0.3 1.4 0.3 31.4 0.3 0.5 0.4 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.7 0.7 0.2 0.3 0.7 0.2 0.1 0.2 2.0 0.8 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.7 0.1 0.6 2.1 0.3 0.0 0.4 3.7 0.0 0.0 1.1 0.3 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 2.4 0.0 0.0 8.1 46.8 0.0 0.2 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 6.6 0.0 22.1 0.0 0.3 6.5 354.8 1.1 1.3 0.7 0.2 0.0 1.5 47.6 0.3 0.4 1.7 1.0 0.2 0.1 127.7 0.0 6.2 0.3 0.3 0.5 0.4 0.3 0.7 0.8 0.7 0.1 0.7 0.6 0.4 0.8 0.5 3.2 1.1 0.0 4.3 1.3 0.1 0.4 0.0 0.0 1.0 0.8 0.8 1.5 1.6 0.0 0.0 0.3 30.9 0.5 3.9 2.0 1.1 0.8 0.0 0.6 0.0 4.8 0.9 0.0 6.1 0.3 2.0 0.1 0.0 0.0 0.7 0.3 1.4 0.0 0.8 2.1 6.1 5.5 16.4 2.6 0.0 9.8 1.8 3.7 6.7 0.0 11.3 0.0 0.1 1.1 1.4 0.0 0.6 0.5 10.9 51.8 5.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.4 0.3 23.7 0.0 2.5 2.1 CLEC4G "LSECtin, UNQ431" ENSG00000182566 "C-type lectin domain family 4 member G" Q6UXB4 19 7728958-7733906 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 15.1;liver: 53.7;lymphoid tissue: 15.2" "Cell type enriched" "Detected in some" 15 "Hepatic stellate cells: 730.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 18.8;myeloid DC: 15.1" "Group enriched" "Detected in many" 4 "dendritic cells: 15.1;monocytes: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003789, HPA014044" Enhanced NA NA "CAB003789: , HPA014044: AB_1846916" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.64e-1)" "unprognostic (4.47e-2)" "unprognostic (1.35e-1)" "unprognostic (7.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.23e-1)" "unprognostic (3.29e-2)" "unprognostic (7.45e-2)" "unprognostic (3.04e-1)" "unprognostic (2.13e-8)" "unprognostic (5.21e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (6.65e-2)" 15.1 0.5 2.2 2.4 2.0 1.2 2.6 3.7 3.0 0.1 2.0 1.2 0.4 0.1 0.3 0.4 4.8 1.6 1.0 2.5 2.1 0.4 53.7 1.0 15.2 2.4 2.2 1.9 0.5 0.3 0.0 0.1 1.0 2.4 0.3 0.9 0.0 1.1 0.3 0.4 1.0 2.1 1.0 2.2 3.4 0.9 0.4 3.5 0.2 0.5 0.0 0.3 7.8 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 18.8 0.0 0.0 4.2 0.0 0.3 0.0 0.0 15.1 4.2 0.1 0.0 0.4 0.5 0.5 0.7 0.0 4.5 2.2 2.0 3.7 3.0 2.5 2.1 2.4 2.2 1.9 2.4 2.2 3.5 2.6 0.1 0.0 0.0 0.3 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 0.0 18.7 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 730.3 7.1 0.8 0.0 1.1 0.0 0.0 46.7 2.9 0.0 0.3 2.6 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.7 0.0 0.3 0.3 1.1 0.8 0.0 0.1 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345377-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 377.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "naive CD4 T-cell: 113.7" "Group enriched" "Detected in all" 4 "NK-cells: 63.4;T-cells: 113.7" "Cell line enhanced" "Detected in many" "HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144, HPA070534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favorable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 16.3 10.4 6.9 29.1 18.6 43.2 13.3 0.1 29.5 10.8 0.9 26.2 16.2 13.7 24.2 12.3 18.0 17.7 26.2 18.0 7.0 10.9 15.6 15.8 38.4 0.7 7.9 6.9 13.9 29.0 32.6 22.7 5.0 6.9 22.7 18.7 30.1 44.4 26.2 90.4 21.6 21.1 11.9 0.4 27.6 18.7 6.7 0.2 377.8 24.7 49.4 28.1 24.8 12.4 8.9 2.1 0.0 12.7 0.0 17.2 16.6 1.4 3.4 12.3 2.9 9.8 0.5 22.9 4.7 0.4 4.1 1.0 0.2 46.4 5.4 5.9 455.3 28.0 0.1 1.1 0.0 2.5 26.7 3.8 7.4 4.0 0.1 0.6 35.1 3.3 213.3 0.6 24.3 2.2 0.4 107.7 33.9 18.5 1.5 1.5 126.5 6.2 4.9 4.8 15.7 5.9 34.5 0.0 3.9 0.3 10.0 98.5 192.7 1.7 12.6 7.9 5.9 3.7 1.3 0.4 10.0 10.3 101.3 5.7 21.1 1.9 4.6 44.2 2.0 78.6 1.6 29.9 23.0 3.5 13.0 113.7 69.5 4.1 63.4 1.1 4.0 6.0 26.6 6.9 18.6 0.1 29.5 18.0 7.0 0.7 7.9 6.9 6.9 0.4 0.2 8.9 19.3 25.6 29.6 48.3 44.6 14.3 12.3 10.9 12.0 12.1 33.2 18.0 70.0 22.8 15.0 31.3 87.6 0.5 71.1 11.0 1.9 16.9 8.2 31.6 15.3 17.0 32.4 22.5 180.2 12.5 0.2 16.4 8.6 11.6 23.4 20.6 35.0 20.9 9.3 0.0 283.4 30.8 4.1 41.5 36.4 4.3 8.4 45.5 10.6 41.2 23.0 15.5 56.7 168.9 28.8 10.5 23.6 8.2 20.6 21.7 24.6 9.1 50.9 63.1 6.6 8.3 10.2 3.2 9.3 20.5 22.0 0.3 84.0 16.8 25.7 19.7 NXPH3 NPH3 ENSG00000182575 "Neurexophilin 3" O95157 17 49575871-49583827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 14.0;Bipolar cells: 23.3;Fibroblasts: 7.6;Muller glia cells: 8.5;Peritubular cells: 14.3;Smooth muscle cells: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 11.4;BJ: 3.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 41.1" HPA073819 Approved "Vesicles,Mitotic spindle" "Secreted in brain" Yes NA Vesicles "Mitotic spindle" "HPA073819: " "unprognostic (2.39e-2)" "unprognostic (4.75e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-1)" "unprognostic (1.92e-1)" "unprognostic (3.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.01e-2)" "unprognostic (4.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-2)" "unprognostic (6.33e-2)" "unprognostic (4.62e-4)" "unprognostic (2.59e-2)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (5.05e-3)" 3.6 0.9 0.9 1.0 1.6 0.0 3.0 13.8 3.2 8.8 0.4 8.0 0.4 12.1 0.6 1.6 7.0 1.7 2.8 3.3 4.0 0.4 0.1 2.8 0.6 5.2 4.6 0.5 5.3 0.6 1.3 7.6 1.3 6.1 5.9 0.3 0.7 3.1 4.8 1.2 2.1 1.7 2.5 0.0 1.0 3.4 1.6 3.9 0.3 1.4 2.0 0.3 9.0 7.0 3.0 0.0 0.0 0.1 0.0 0.0 0.2 11.4 3.2 0.4 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 13.8 3.2 3.3 4.0 5.2 4.6 0.5 6.1 0.0 3.9 3.0 0.5 0.0 1.3 14.0 0.0 0.4 0.3 0.2 0.6 23.3 0.9 0.5 1.7 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 2.5 0.2 3.2 7.6 0.0 0.5 0.0 0.0 6.4 0.0 0.2 0.0 1.5 0.0 0.0 0.3 1.4 0.0 4.4 0.3 1.8 0.0 4.2 8.5 0.0 2.5 0.5 0.0 0.0 14.3 0.7 0.3 0.0 0.0 0.0 1.2 0.0 0.8 8.9 0.1 1.3 0.0 1.1 0.1 0.2 0.1 0.0 0.1 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 114.3;placenta: 104.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 444.6;non-classical monocyte: 646.9" "Lineage enriched" "Detected in many" 5 "monocytes: 646.9" "Group enriched" "Detected in some" 4 "BEWO: 123.0;SK-BR-3: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1600000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 51.7 31.3 16.8 75.8 20.9 5.7 19.5 20.5 21.6 21.8 29.1 22.1 24.5 12.2 5.9 21.2 17.4 41.0 16.7 17.6 51.2 7.2 27.7 36.9 54.9 39.7 24.3 9.6 12.8 10.0 11.9 5.8 104.2 36.9 9.2 21.7 1.5 10.2 21.0 3.2 13.5 37.6 42.3 39.1 114.3 21.2 7.1 34.5 14.4 6.1 11.9 21.9 43.0 3.8 58.4 4.5 0.2 0.0 0.0 1.9 0.4 123.0 0.2 0.2 0.0 0.0 3.8 0.0 5.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.2 1.1 3.0 0.0 6.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 6.1 0.1 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.2 0.2 0.0 47.8 0.0 1.9 0.0 20.7 0.0 0.8 0.2 0.1 3.3 0.0 0.3 0.1 6.6 2.6 0.0 3.0 138.4 4.0 0.6 444.6 0.6 0.3 0.2 0.4 139.0 0.2 0.3 0.2 21.6 0.2 646.9 11.1 0.5 132.7 16.8 20.9 20.5 21.6 17.6 51.2 39.7 24.3 9.6 36.9 39.1 34.5 58.4 2.0 0.0 3.8 0.0 4.3 2.8 0.0 0.0 1.2 0.0 0.5 2.3 3.1 4.3 0.0 0.0 0.0 6.2 2.8 0.0 0.0 0.0 4.8 0.0 0.1 10.5 0.0 2.5 0.4 0.0 103.2 2.2 1.5 0.2 2.5 8.3 2.9 1.5 340.4 0.0 0.5 0.3 0.0 291.2 73.4 5.4 1.8 196.3 3.6 134.9 39.4 0.0 1.0 1.5 0.3 0.1 1.7 0.0 1.0 0.0 0.0 0.1 0.7 0.5 13.1 1.2 2.0 2.2 0.2 0.4 1.3 26.4 1.3 2.2 0.2 0.0 EPHB3 "ETK2, Hek2, Tyro6" ENSG00000182580 "EPH receptor B3" P54753 3 184561785-184582408 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Angiogenesis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 49.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 38.1;Breast myoepithelial cells: 50.8;Enteroendocrine cells: 71.5;Intestinal goblet cells: 43.3;Squamous epithelial cells: 44.3;Undifferentiated cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 28.8;HaCaT: 40.2;OE19: 28.3;SK-BR-3: 30.9;T-47d: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007698, HPA008184, CAB034350" Enhanced NA NA 100000 "CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.17e-2)" "unprognostic (7.80e-2)" "unprognostic (1.52e-1)" "unprognostic (9.19e-2)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (5.51e-2)" "unprognostic (1.76e-1)" "unprognostic (7.42e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (7.88e-5)" "unprognostic (8.83e-3)" "unprognostic (3.03e-2)" "unprognostic (9.59e-3)" "unprognostic (2.10e-3)" 1.6 0.7 2.8 3.7 2.6 0.1 10.5 5.6 4.0 19.3 0.8 10.4 6.5 10.1 1.8 30.9 4.0 2.9 1.7 2.8 2.4 1.9 0.9 3.4 0.9 5.0 3.3 2.6 8.4 15.0 1.1 2.1 5.8 6.0 10.1 11.0 0.5 32.0 3.5 0.6 49.1 6.4 3.8 2.0 1.0 23.0 0.9 3.5 0.7 0.9 0.4 2.4 4.0 21.1 4.1 6.6 2.3 14.8 1.6 4.5 0.3 28.8 1.1 1.9 2.2 1.2 2.0 0.2 0.0 2.8 6.3 1.0 40.2 5.4 1.9 0.6 0.2 1.1 0.0 0.3 0.0 0.3 0.0 0.2 1.2 13.0 1.8 0.2 0.7 0.0 0.0 0.0 0.0 1.0 17.6 0.0 6.4 1.4 28.3 2.5 1.5 9.0 0.0 0.0 5.8 1.9 2.2 1.2 30.9 1.3 7.8 20.5 0.1 0.0 3.6 5.1 1.8 2.5 0.0 0.0 0.1 0.3 0.0 14.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.6 5.6 4.0 2.8 2.4 5.0 3.3 2.6 6.0 2.0 3.5 4.1 0.9 3.2 2.7 11.1 0.2 24.1 7.6 5.3 17.1 0.9 38.1 50.8 1.8 2.8 4.6 0.0 0.0 10.1 1.1 21.5 1.9 0.5 0.6 3.7 4.0 1.4 71.5 0.0 4.6 1.6 18.7 6.9 27.0 7.5 4.5 2.1 1.8 0.0 23.5 15.2 5.8 43.3 10.2 0.3 9.8 0.4 2.8 2.4 0.0 1.0 0.8 0.1 0.0 5.0 0.3 3.2 7.2 6.0 0.0 6.0 1.7 0.2 1.4 1.0 0.0 4.5 2.9 0.4 0.6 44.3 35.8 16.3 0.8 1.6 55.0 20.7 VCX "VCX-10r, VCX-B1, VCX1, VCX10R" ENSG00000182583 "Variable charge X-linked" Q9H320 X 7842262-7844143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 33.7" "Group enriched" "Detected in some" 9 "Spermatocytes: 855.2;Spermatogonia: 1008.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.7;RPMI-8226: 1.4;THP-1: 1.5;U-138 MG: 1.4;U-266/70: 2.8" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.65e-1)" "unprognostic (3.39e-1)" "unprognostic (1.17e-3)" "unprognostic (1.71e-1)" "unprognostic (1.50e-1)" "unprognostic (2.73e-1)" "unprognostic (7.89e-2)" "unprognostic (6.44e-2)" "unprognostic (1.20e-1)" "unprognostic (7.18e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.7 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 33.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 1.7 0.8 0.3 0.2 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.6 1.5 0.0 1.4 0.3 1.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.7 0.3 0.3 0.3 0.2 0.3 0.3 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 98.1 7.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 85.5 0.0 0.0 855.2 1008.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ACTL10 C20orf134 ENSG00000182584 "Actin like 10" Q5JWF8 20 33666498-33668525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "testis: 60.8" "Group enriched" "Detected in many" 37 "Early spermatids: 379.0;Late spermatids: 534.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HaCaT: 1.9;Karpas-707: 1.8;OE19: 2.0;RPMI-8226: 3.2;SK-BR-3: 2.6" NA NA "unprognostic (5.69e-3)" "unprognostic (3.62e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-1)" "unprognostic (5.91e-3)" "unprognostic (4.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.31e-2)" "unprognostic (2.35e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-3)" "unprognostic (5.90e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (8.61e-2)" 0.5 0.6 0.7 0.2 0.3 0.0 0.8 0.0 1.0 0.6 0.4 0.9 0.6 0.9 0.0 1.7 0.9 0.2 0.4 0.6 0.0 0.8 0.4 0.6 0.2 1.2 0.2 0.1 1.0 3.2 0.2 0.7 0.0 0.4 2.0 0.2 0.0 1.7 0.3 0.2 1.1 1.3 0.1 0.0 1.2 1.2 60.8 0.1 0.2 1.1 0.0 0.2 1.0 0.9 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.1 1.1 1.8 0.6 1.0 0.3 0.0 1.9 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.9 0.0 0.0 0.0 2.0 0.3 0.0 0.1 3.2 0.4 0.6 0.6 0.1 0.7 2.6 0.0 0.0 1.1 0.0 0.3 0.1 0.0 0.2 0.0 0.7 1.5 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.3 0.2 0.0 0.0 0.6 0.1 0.1 0.4 0.0 0.7 0.3 0.0 1.0 0.6 0.0 1.2 0.2 0.1 0.4 0.0 0.1 0.6 0.6 0.0 0.5 0.0 0.9 0.5 4.6 1.0 3.4 0.4 2.8 2.3 0.5 4.3 1.3 1.8 0.0 0.3 1.6 3.3 1.9 4.8 379.0 1.3 1.3 1.2 1.2 2.7 0.0 7.6 0.8 0.9 5.1 1.9 0.0 0.2 0.4 0.4 0.9 0.0 0.0 5.3 12.2 1.0 0.4 534.2 5.3 3.7 1.8 0.0 1.9 1.4 7.2 0.0 0.3 4.0 2.7 3.0 4.4 2.6 2.9 2.0 0.5 0.2 0.0 1.6 1.2 7.9 1.5 3.0 1.3 0.1 1.9 1.7 3.7 2.8 EPGN "ALGV3072, EPG, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308470-74316789 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 49.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.0;Basal prostatic cells: 7.3;Basal squamous epithelial cells: 25.6;Urothelial cells: 5.1" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTCEpi: 157.9;U-2197: 74.8" "Not detected" "Not detected" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 0.7 0.1 0.2 1.6 0.2 0.3 1.4 0.5 0.7 2.5 0.2 0.1 0.1 0.0 1.1 49.4 1.5 0.1 0.7 0.3 0.2 0.1 0.2 0.5 0.1 0.2 0.2 0.3 0.1 0.1 2.3 0.1 0.5 0.3 0.2 0.0 0.2 3.6 3.2 0.1 3.0 0.1 0.0 0.1 0.3 0.0 1.1 0.2 0.9 0.0 0.0 3.5 1.3 9.7 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.4 0.0 0.8 0.0 0.1 1.8 0.2 3.6 0.0 2.8 0.0 0.0 0.0 0.5 20.2 0.0 0.2 0.0 0.7 0.0 157.9 2.9 11.7 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.0 0.0 0.3 0.0 3.6 0.4 0.0 0.0 0.3 0.3 0.1 0.0 8.3 3.3 0.0 0.0 0.5 0.0 0.2 0.4 0.1 74.8 0.2 0.0 0.0 0.1 0.7 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.3 0.3 0.1 0.7 0.3 0.1 0.2 0.1 0.1 0.2 0.2 0.5 0.7 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.2 0.3 0.0 0.0 1.5 0.0 0.0 6.0 7.3 0.9 25.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 3.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 3.0 1.6 0.1 0.2 0.0 0.0 5.1 KRTAP11-1 KAP11.1 ENSG00000182591 "Keratin associated protein 11-1" Q8IUC1 21 30880644-30881580 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 70 "skin 1: 116.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "endometrial cancer: 1.3;urothelial cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054008 Enhanced NA NA 2700000 "HPA054008: AB_2682341" 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 116.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.9;skin 1: 29.1" "Group enriched" "Detected in some" 22 "Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "basophil: 2.8" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.8" "Cell line enriched" "Detected in some" 13 "Hep G2: 59.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 0.9 0.9 7.3 0.2 11.2 0.5 14.3 21.4 9.1 0.7 0.6 2.3 0.9 0.7 0.5 1.0 1.3 0.0 0.8 11.3 26.1 1.3 7.5 0.9 0.6 34.0 19.0 2.7 0.7 1.7 0.3 1.6 0.2 26.1 1.5 0.3 0.6 4.7 0.1 1.0 29.1 1.7 0.1 36.6 1.1 0.8 8.2 29.5 0.1 0.6 0.0 0.0 0.9 0.8 61.9 0.9 0.0 0.3 1.4 1.0 1.6 2.4 0.3 0.0 0.3 0.7 0.0 0.2 0.0 0.7 0.1 0.5 0.5 0.0 0.0 0.0 0.6 2.1 0.5 0.4 59.6 0.8 0.1 1.7 0.0 1.3 0.4 0.8 0.7 1.6 0.6 0.1 0.2 0.2 0.2 0.2 0.5 0.0 0.0 2.2 0.4 0.6 0.4 0.1 0.9 0.2 0.8 0.4 0.0 2.2 1.0 0.1 2.6 0.9 0.2 0.8 0.8 0.8 3.8 4.7 0.2 0.1 1.4 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 11.2 21.4 9.1 11.3 26.1 34.0 19.0 2.7 26.1 36.6 29.5 61.9 3.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 367.0 324.9 0.0 0.0 0.0 1.8 0.0 0.1 10.1 0.0 5.9 0.5 0.0 3.8 0.4 6.3 0.0 0.0 0.0 0.8 0.1 2.9 0.0 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 2.3 0.9 0.0 0.0 HS3ST4 3OST4 ENSG00000182601 "Heparan sulfate-glucosamine 3-sulfotransferase 4" Q9Y661 16 25691959-26137685 "Enzymes, Metabolic proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 34.6" "Group enriched" "Detected in some" 9 "Excitatory neurons: 431.4;Microglial cells: 536.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.09e-2)" "unprognostic (1.87e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.43e-3)" "unprognostic (1.27e-1)" "unprognostic (3.84e-1)" "unprognostic (8.81e-3)" "unprognostic (6.71e-2)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (3.67e-2)" 0.0 0.0 13.8 0.0 17.8 0.0 2.2 7.5 15.2 0.2 3.8 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 34.6 11.3 0.0 0.0 0.0 0.0 18.2 14.2 15.5 0.0 0.0 3.6 0.3 0.0 20.4 0.8 0.0 2.0 0.1 0.0 0.0 0.5 0.0 0.0 8.0 1.6 1.7 0.5 29.1 0.2 0.0 0.0 0.0 0.3 0.5 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 17.8 7.5 15.2 34.6 11.3 18.2 14.2 15.5 20.4 8.0 29.1 18.5 0.0 0.0 0.0 7.5 0.1 0.0 0.4 0.1 0.0 26.0 2.6 2.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 431.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 536.8 0.0 0.4 0.0 6.6 9.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225890 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 170.5;skeletal muscle: 264.9;tongue: 204.4" "Cell type enhanced" "Detected in all" "Astrocytes: 173.0;Cardiomyocytes: 262.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RT4: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: AB_2668495" "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favorable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 26.2 13.2 23.3 17.3 25.2 18.4 18.2 26.9 28.3 13.8 24.9 27.4 34.8 12.3 10.5 29.5 20.0 27.1 170.5 24.3 18.9 20.2 15.4 24.3 23.0 24.7 29.4 20.4 8.5 13.2 32.5 17.8 15.4 23.2 15.5 25.7 97.6 44.4 13.3 264.9 45.5 42.4 17.0 19.2 22.4 61.6 12.2 25.7 18.1 31.7 204.4 22.7 34.1 18.5 21.9 22.2 19.2 37.9 16.4 25.6 24.9 48.9 29.5 33.5 19.0 20.6 12.8 30.7 43.9 15.1 75.2 20.4 10.7 26.5 68.8 20.6 39.6 18.8 30.4 19.9 35.6 12.8 34.6 22.9 21.4 28.9 41.9 38.0 28.1 38.6 11.6 15.7 34.4 24.4 9.2 3.7 18.1 16.4 60.4 14.8 16.1 14.1 36.8 26.3 165.3 23.8 27.9 11.3 16.3 16.2 31.4 14.6 29.3 39.6 16.6 19.2 99.0 17.4 25.7 23.0 38.9 18.2 30.2 16.4 0.9 1.3 0.5 0.6 2.4 0.5 2.4 0.9 0.7 1.5 3.6 0.3 0.9 0.6 1.0 1.4 2.5 0.4 0.7 23.3 25.2 26.9 28.3 24.3 18.9 24.7 29.4 20.4 23.2 19.2 25.7 21.9 27.4 32.1 32.4 173.0 23.9 38.0 16.3 32.1 30.1 22.7 18.5 17.7 262.0 24.3 38.1 14.7 100.1 23.0 13.9 61.4 1.9 10.8 1.1 53.3 21.8 23.9 22.8 6.5 62.0 12.3 18.3 14.0 81.1 70.0 10.8 11.5 6.8 10.3 15.7 33.7 81.3 39.5 26.4 15.7 33.4 3.0 1.8 23.3 24.9 97.4 17.9 27.8 4.1 105.1 64.8 24.2 37.1 2.6 5.4 18.5 97.9 10.2 80.6 139.9 32.9 15.9 29.9 1.0 3.9 27.5 43.2 15.7 7.5 4.6 35.6 27.0 TSPAN10 OCSP ENSG00000182612 "Tetraspanin 10" 17 81637171-81648749 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Horizontal cells: 13.5" "Cancer enriched" "Detected in many" 15 "melanoma: 32.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 17.8;U-138 MG: 6.0;U-87 MG: 7.6" "Region enriched" "Detected in single" 4 "olfactory bulb: 1.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.81e-2)" "unprognostic (3.67e-1)" "unprognostic (2.17e-3)" "unprognostic (1.08e-3)" "unprognostic (3.74e-1)" "unprognostic (3.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" "unprognostic (5.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.31e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" 0.5 1.2 0.1 0.2 0.0 0.0 0.7 0.2 0.2 0.9 0.5 0.2 0.1 0.7 0.4 0.8 0.7 0.3 0.2 0.0 0.3 0.9 0.9 0.3 0.9 0.1 0.1 0.0 0.8 0.7 0.6 0.3 0.5 0.1 1.2 0.0 0.0 0.9 0.3 0.0 1.3 0.3 0.0 0.1 0.4 0.3 1.3 0.1 0.3 0.6 0.0 0.2 0.3 0.5 0.1 1.8 1.9 0.2 0.2 0.5 0.6 0.2 1.8 5.7 2.7 1.5 0.6 3.0 0.7 0.6 1.7 1.5 0.0 0.1 0.4 0.3 0.6 3.4 0.0 0.4 0.4 0.4 0.0 1.0 0.6 0.7 3.2 0.1 5.8 0.0 0.7 0.0 0.2 2.7 0.2 0.1 0.4 0.2 0.0 2.8 1.3 0.0 0.0 0.2 0.5 0.0 1.2 3.1 0.4 17.8 1.5 3.4 0.4 0.1 6.0 1.9 0.5 1.6 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 3.2 7.3 0.7 2.1 0.0 2.6 0.0 0.6 2.5 5.1 6.3 1.8 4.3 2.5 12.9 4.2 2.1 1.1 1.7 9.8 3.6 0.9 3.4 2.1 2.9 0.0 0.8 0.5 2.4 6.2 3.2 1.5 4.4 7.6 3.3 3.6 1.5 10.0 13.5 0.5 1.2 0.0 1.6 0.0 2.1 1.5 2.3 0.0 2.8 0.0 5.4 0.0 0.5 1.7 0.9 0.1 1.2 0.0 1.7 1.1 4.5 3.6 5.0 0.0 3.6 1.7 5.7 5.8 1.2 0.0 1.4 1.3 8.6 1.1 1.3 OR2V2 "OR2V3, OST713" ENSG00000182613 "Olfactory receptor family 2 subfamily V member 2" Q96R30 5 181147586-181159285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049953 Uncertain NA NA "HPA049953: AB_2680971" 0.1 0.0 0.1 0.1 0.2 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLCB1 "KIAA0581, PLC-I, PLC154" ENSG00000182621 "Phospholipase C beta 1" Q9NQ66 20 8077251-8968360 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 79.9" "Cell type enhanced" "Detected in many" "Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 79.9" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 45.5;Hep G2: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004275, CAB005334, HPA034743, HPA057910" Enhanced Approved "Plasma membrane" NA NA 6600 "Plasma membrane" "CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552" "unprognostic (2.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.63e-2)" "unprognostic (9.77e-2)" "unprognostic (9.87e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-4)" "unprognostic (1.13e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" "unprognostic (7.12e-3)" "unprognostic (6.57e-2)" "unprognostic (2.87e-3)" "unprognostic (3.20e-2)" "unprognostic (4.41e-2)" "unprognostic (1.71e-2)" "unprognostic (2.12e-1)" 7.4 9.0 14.9 5.7 43.1 4.9 7.7 0.0 79.9 8.3 0.0 13.4 7.3 9.4 3.6 5.5 9.7 8.5 11.8 21.7 16.4 12.7 4.4 5.1 1.8 12.4 2.6 7.5 3.8 14.8 44.6 4.4 19.7 22.3 13.5 4.1 7.1 29.2 19.0 14.5 2.6 5.8 8.2 0.0 3.6 8.1 3.1 8.6 6.8 3.9 11.1 0.9 16.0 6.7 29.6 0.2 1.2 4.8 0.3 8.7 16.1 6.3 20.2 13.1 5.2 3.1 45.5 5.0 2.2 8.2 3.9 0.3 0.0 3.7 0.0 3.8 0.0 4.4 1.0 3.5 68.7 2.2 1.1 0.7 1.1 0.8 7.1 0.0 6.5 10.6 13.0 7.1 26.0 0.1 6.2 1.0 3.3 15.0 10.6 6.6 14.7 0.0 12.1 4.0 16.8 16.9 7.2 0.1 4.1 0.9 17.1 19.9 6.6 1.9 16.8 7.5 1.3 12.7 19.4 24.5 33.9 8.6 12.6 29.5 0.3 1.3 1.2 1.4 0.3 2.0 0.1 0.4 0.5 0.1 0.2 0.2 0.4 0.8 1.1 0.1 0.3 0.1 0.2 14.9 43.1 0.0 79.9 21.7 16.4 12.4 2.6 7.5 22.3 0.0 8.6 29.6 74.8 0.0 3.4 563.5 1.1 1.9 20.8 2.3 8.0 7.6 8.1 23.2 26.9 7.2 2.6 16.5 0.0 2.4 16.8 1.3 33.2 1.2 9.9 42.1 5.1 54.6 0.0 6.5 2569.1 13.4 2.8 25.8 3.6 83.6 1.3 0.2 26.4 2.8 0.8 1.7 1774.0 2.1 0.0 8.2 1.2 4.3 3.4 9.1 7.2 211.7 12.2 18.2 15.5 783.1 34.8 1.8 0.5 3.8 6.1 20.2 0.1 9.4 9.9 4.1 0.0 7.4 13.3 4.7 5.6 2.5 1.7 1.8 15.4 1.1 1.2 18.9 SKA2 "FAM33A, FLJ12758" ENSG00000182628 "Spindle and kinetochore associated complex subunit 2" Q8WVK7 17 59109857-59155260 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059235 Uncertain NA NA "HPA059235: AB_2683953" "unprognostic (2.67e-1)" "unprognostic (6.42e-3)" "unprognostic (9.69e-3)" "unprognostic (5.93e-3)" "unprognostic (2.07e-1)" "unprognostic (4.44e-2)" "unprognostic (7.70e-3)" "unprognostic (9.81e-2)" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (3.96e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (2.59e-1)" "unprognostic (1.39e-1)" "unprognostic (4.75e-3)" "unprognostic (1.05e-1)" 20.1 12.7 34.4 20.3 36.3 24.4 11.9 47.4 37.1 18.5 32.2 22.3 18.9 20.5 12.6 24.6 18.3 13.1 34.8 31.7 38.5 22.1 22.6 16.2 33.9 38.7 39.7 28.8 16.8 11.6 26.3 15.0 23.1 38.0 16.5 20.1 44.8 11.0 20.1 12.7 14.1 17.0 24.8 40.4 15.9 18.4 12.7 37.4 54.2 25.7 20.6 28.7 20.5 18.3 42.2 217.6 78.6 249.4 85.6 32.4 24.5 76.8 107.1 102.8 163.1 182.5 120.2 122.6 114.1 118.8 87.0 124.3 90.9 162.9 149.3 231.0 197.8 127.4 179.4 142.2 75.1 36.8 142.3 112.5 35.6 63.1 104.8 84.5 64.4 77.2 127.3 114.3 164.5 117.1 297.7 215.4 71.9 66.6 238.3 145.1 114.0 281.3 81.0 121.4 93.2 112.3 96.2 119.1 53.8 66.9 165.4 179.2 112.0 68.0 160.5 153.4 130.5 244.8 111.7 255.6 135.9 85.4 105.3 117.6 26.7 13.1 17.2 18.7 23.5 14.4 18.4 25.6 24.1 15.4 13.7 19.8 22.4 2.4 22.9 38.3 18.3 48.3 12.8 34.4 36.3 47.4 37.1 31.7 38.5 38.7 39.7 28.8 38.0 40.4 37.4 42.2 24.8 25.6 18.2 23.2 24.6 21.4 21.6 49.2 25.6 36.1 10.8 17.1 46.3 12.8 26.7 9.2 25.0 62.6 25.8 16.1 39.2 38.3 20.8 22.4 30.2 26.9 10.3 96.8 10.9 25.2 61.7 26.9 30.5 21.0 18.3 26.6 25.4 33.0 46.3 50.5 20.1 23.0 14.2 37.0 22.6 9.4 27.1 28.2 23.2 15.0 42.9 49.3 39.1 15.1 26.3 31.9 24.7 25.6 52.0 8.9 12.8 32.1 26.8 39.4 0.0 13.8 41.5 38.8 30.7 34.1 13.5 30.9 35.0 33.8 35.2 18.9 RXFP3 "GPCR135, RLN3R1, RXFPR3, SALPR" ENSG00000182631 "Relaxin family peptide receptor 3" Q9NSD7 5 33936386-33938918 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027833 Uncertain NA NA "HPA027833: AB_1849247" "unprognostic (1.93e-2)" "unprognostic (3.66e-1)" "unprognostic (2.89e-1)" "unprognostic (2.86e-1)" "unprognostic (9.68e-2)" "unprognostic (1.72e-1)" "unprognostic (8.67e-3)" 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.9 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.1 2.8 0.9 2.1 0.0 0.6 0.1 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G7 ENSG00000182634 "Olfactory receptor family 10 subfamily G member 7" Q8NGN6 11 124036013-124041325 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687305 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA074457: AB_2686691" "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 47.3 49.8 44.9 11.2 43.3 1.2 35.4 29.3 40.1 69.8 31.0 30.9 11.2 64.3 24.2 17.0 47.6 24.0 32.9 39.4 73.0 12.7 4.5 19.8 11.0 37.6 43.0 36.9 70.4 11.9 8.7 56.8 32.8 42.6 27.5 10.8 21.0 12.9 39.6 14.8 11.4 20.9 33.8 33.7 19.3 20.5 18.7 59.3 6.9 17.6 22.6 6.7 31.6 40.8 47.0 0.1 0.0 55.0 0.0 52.9 20.1 0.1 35.4 0.0 0.8 9.6 0.0 0.0 0.0 0.1 10.6 8.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 13.3 0.0 31.8 71.3 0.0 10.2 0.0 0.0 0.0 21.7 1.2 0.0 18.0 0.0 27.6 0.1 44.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.1 0.4 0.0 0.4 0.0 57.4 9.4 0.0 0.0 2.6 80.4 0.0 0.1 51.7 51.7 0.0 5.5 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.2 1.5 0.0 0.0 44.9 43.3 29.3 40.1 39.4 73.0 37.6 43.0 36.9 42.6 33.7 59.3 47.0 24.1 25.6 11.0 6.8 0.3 13.0 13.8 0.3 27.9 66.0 2.3 19.8 36.8 15.7 1.4 12.9 20.9 1.9 2.9 18.5 23.5 17.9 2.5 1.4 60.8 18.7 6.7 4.2 7.8 10.7 1.4 103.1 4.1 1.1 0.0 83.9 38.9 0.2 7.3 50.5 21.8 4.3 0.0 7.6 13.3 8.6 236.4 2.8 39.2 9.4 0.7 88.7 0.0 9.5 16.4 4.5 2.6 207.6 0.0 6.9 8.1 1.1 4.1 51.0 98.6 91.4 94.0 28.5 21.8 13.4 8.2 2.5 1.4 121.8 7.1 4.1 CCDC172 "C10orf96, MGC35062" ENSG00000182645 "Coiled-coil domain containing 172" P0C7W6 10 116324448-116380029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 3.1;testis: 12.3" "Cell type enhanced" "Detected in some" "Early spermatids: 32.9;Late spermatids: 9.6;Spermatocytes: 107.9;Spermatogonia: 22.9" "Cancer enriched" "Detected in single" 14 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "NTERA-2: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.85e-2)" 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.6 0.9 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 107.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4Q3 "C14orf13, OR4Q4" ENSG00000182652 "Olfactory receptor family 4 subfamily Q member 3" 14 19743571-19749469 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049924 Uncertain NA NA "HPA049924: AB_2680955" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTM "CEPU-1, HNT, IGLON2, NTRI" ENSG00000182667 Neurotrimin Q9P121 11 131370478-132336822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 324.3;choroid plexus: 101.3;retina: 75.4" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 175 "plasmacytoid DC: 17.4" "Lineage enriched" "Detected in single" 175 "dendritic cells: 17.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB024875 Enhanced "Intracellular and membrane" NA NA 58000000 "CAB024875: " "unprognostic (1.52e-2)" "unprognostic (4.38e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.25e-1)" "unprognostic (1.07e-1)" "unprognostic (9.99e-3)" "unprognostic (9.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-2)" "unprognostic (4.29e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.10e-8)" "unprognostic (4.60e-3)" "unprognostic (1.37e-1)" "unprognostic (2.94e-1)" "unprognostic (9.31e-3)" 18.1 4.8 146.4 2.3 146.9 0.0 3.0 170.6 324.3 1.6 101.3 9.0 2.5 1.3 0.6 9.5 0.9 9.7 19.6 145.2 134.8 1.2 0.3 26.0 0.4 150.4 149.2 136.4 0.3 0.9 22.3 0.9 0.7 153.4 1.9 3.8 75.4 2.7 2.8 0.9 6.1 4.7 4.5 141.3 0.6 2.0 0.6 157.1 0.5 1.1 5.1 0.4 3.5 1.8 167.9 0.1 0.0 7.5 0.1 0.9 22.2 0.0 36.7 19.5 11.7 6.8 0.1 0.0 0.0 0.0 20.3 0.0 0.3 0.0 43.6 12.6 0.1 0.4 0.0 0.0 0.4 0.4 0.0 0.2 2.0 0.0 38.0 45.0 29.0 7.5 0.0 0.0 0.3 122.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 3.9 20.8 0.0 2.4 3.8 0.0 0.0 0.2 1.3 0.0 0.1 8.1 47.7 81.8 2.2 31.6 0.0 0.0 0.2 0.1 0.0 166.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 146.4 146.9 170.6 324.3 145.2 134.8 150.4 149.2 136.4 153.4 141.3 157.1 167.9 1.2 608.9 27.6 2164.2 0.0 1.8 0.0 1.5 2.2 225.3 0.9 4.4 13.7 0.0 29.7 20.2 950.8 0.0 5.4 0.4 0.0 0.6 10.9 0.0 0.5 2.9 0.0 2.7 651.0 0.0 0.0 22.2 0.5 0.0 53.0 0.1 0.7 0.0 0.1 40.4 1056.6 0.1 0.0 0.0 3.8 2.2 0.3 0.7 3.6 139.6 0.0 30.5 0.0 1930.7 1257.6 0.1 0.2 0.4 0.1 0.1 0.0 0.1 1.5 1415.0 0.0 20.6 7.5 0.4 0.9 0.5 4.8 0.0 0.8 0.0 0.8 0.1 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 46.2 29.6 28.7 27.3 25.5 26.6 43.6 37.4 36.3 59.8 38.2 34.9 24.9 39.3 59.2 28.2 35.2 35.7 28.2 39.2 14.7 38.0 31.9 24.6 29.7 11.5 13.8 21.9 61.1 43.3 39.4 35.9 29.2 14.3 51.7 36.7 63.5 50.4 41.8 27.9 30.9 30.6 34.9 7.6 27.5 41.3 27.6 12.6 38.3 65.4 30.9 29.5 30.9 9.5 22.6 72.9 25.4 115.3 22.2 108.9 156.8 40.0 77.5 96.0 34.2 46.1 34.0 35.8 62.3 26.6 130.9 32.1 23.3 35.3 47.9 48.2 66.3 25.0 125.6 38.0 44.1 39.6 70.9 39.1 81.9 28.8 35.0 31.0 68.8 51.6 54.1 77.3 71.1 65.2 56.0 69.4 18.8 33.3 48.0 42.6 91.6 55.3 33.2 39.4 55.3 87.7 67.6 97.2 55.2 49.1 26.5 62.2 27.3 68.3 49.2 19.5 61.2 30.4 71.1 55.1 60.6 80.7 69.9 37.9 4.8 6.2 6.8 11.5 6.4 17.1 13.0 13.3 15.8 10.8 15.1 23.2 14.4 1.0 12.8 8.6 17.3 10.0 4.8 28.7 25.5 37.4 36.3 39.2 14.7 11.5 13.8 21.9 14.3 7.6 12.6 22.6 78.3 125.0 142.7 161.3 144.8 65.9 94.8 102.7 86.0 347.7 175.8 140.1 134.7 68.6 118.2 75.4 227.2 50.1 129.5 67.8 166.3 91.1 192.7 115.0 217.4 78.9 190.2 65.4 424.5 75.3 93.5 171.0 131.5 132.0 64.6 256.8 99.6 94.4 61.4 329.7 396.0 163.1 99.7 95.2 83.7 192.4 210.0 86.8 211.7 111.5 87.4 196.5 93.7 321.7 261.9 73.3 96.5 261.1 167.6 121.4 72.8 96.1 108.6 233.9 52.6 245.8 127.9 400.0 258.4 91.7 62.8 52.7 109.7 204.1 148.1 103.9 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537225-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;lymphoid tissue: 2.3;retina: 4.6" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.1 0.4 1.2 0.0 2.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 2.6 1.9 0.0 0.0 0.0 0.0 1.6 2.6 1.3 0.0 0.5 0.0 1.1 0.0 0.6 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 2.3 0.5 0.3 1.6 0.8 0.0 0.0 0.1 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.2 0.0 1.6 2.6 1.9 1.6 2.6 1.3 0.6 0.5 1.6 1.4 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.2 17.4 0.0 0.0 0.3 0.0 0.0 1.8 264.8 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 17.9 0.0 279.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 241.2 0.6 0.0 0.0 0.0 6.8 1.2 0.0 0.0 3.7 0.0 0.7 0.0 11.6 4.7 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.1 0.1 0.4 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "skeletal muscle: 1215.8" "Group enriched" "Detected in some" 14 "Early spermatids: 56.5;Skeletal myocytes: 108.8" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "HL-60: 206.4;THP-1: 385.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042227, HPA048632" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042227: , HPA048632: AB_2680469" "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 0.2 0.9 0.1 0.0 0.1 1.3 0.4 0.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.4 0.1 0.0 0.2 0.7 0.2 0.0 0.1 0.1 0.1 0.2 0.4 0.0 11.9 0.0 0.2 1.8 0.0 0.0 5.8 0.0 1215.8 1.6 0.2 0.0 0.0 0.2 0.1 0.5 0.1 0.1 0.4 48.1 0.0 0.1 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 206.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.2 0.0 0.0 385.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 1.2 2.9 1.3 2.4 0.6 0.0 0.2 0.0 0.0 3.0 0.3 1.6 0.0 0.0 56.5 0.9 0.7 0.9 1.2 0.0 0.0 0.5 2.7 0.6 0.0 1.5 0.0 0.7 1.1 1.2 0.6 0.0 0.0 1.1 0.0 0.0 0.4 5.7 0.9 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.3 4.7 0.2 0.2 0.2 0.0 108.8 0.5 1.7 0.6 1.2 0.1 1.4 0.2 0.2 1.6 0.5 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 11.8;Cone photoreceptor cells: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 18.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "spinal cord: 3.1" HPA063522 Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA063522: AB_2685029" "prognostic favorable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favorable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favorable (8.06e-5)" 5.0 6.6 8.5 3.4 8.7 3.0 5.9 23.1 18.8 8.4 4.8 9.5 4.8 8.3 1.3 4.3 8.6 1.9 12.7 8.1 8.1 13.9 8.0 10.3 4.3 10.1 8.6 9.4 7.1 5.6 1.4 14.4 2.6 13.2 11.0 0.6 4.6 5.9 2.5 11.2 4.5 10.5 1.2 5.8 16.8 7.5 17.6 8.1 2.2 23.5 1.7 1.3 9.0 6.1 8.8 3.3 6.3 7.5 4.7 1.2 1.1 15.6 3.1 0.4 1.8 2.6 8.3 8.0 1.6 2.0 0.6 1.9 8.6 1.1 1.1 1.1 6.0 3.4 2.1 18.4 2.0 0.7 0.7 4.7 1.6 2.3 2.5 0.6 2.2 0.9 6.9 2.3 4.3 0.4 8.6 5.1 12.8 8.4 0.7 3.7 16.8 5.6 5.9 2.0 2.5 5.8 5.5 2.9 3.6 3.1 3.0 3.4 4.4 2.3 8.0 6.6 6.7 2.7 13.5 6.6 4.7 1.5 5.0 3.8 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 8.5 8.7 23.1 18.8 8.1 8.1 10.1 8.6 9.4 13.2 5.8 8.1 8.8 2.4 3.2 4.4 10.4 1.6 0.4 0.4 1.1 0.0 11.8 1.8 1.5 0.5 0.0 0.7 5.5 25.0 2.0 1.3 2.4 0.0 0.9 2.4 0.9 1.1 2.2 1.2 2.1 5.7 0.6 0.9 1.1 4.1 1.5 4.5 4.8 1.1 1.2 1.2 5.0 5.5 1.0 2.0 1.9 2.0 10.2 1.2 2.8 1.8 2.8 2.5 4.5 4.1 3.5 5.2 1.0 0.8 2.6 1.5 0.9 1.9 0.6 3.4 10.9 0.0 1.2 1.3 4.0 1.9 0.4 1.1 0.8 1.7 1.6 3.1 0.3 GALR2 GALNR2 ENSG00000182687 "Galanin receptor 2" O43603 17 76074781-76077537 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 6.5;smooth muscle: 1.7" "Cell type enhanced" "Detected in some" "B-cells: 1.7;Endometrial ciliated cells: 1.0;Macrophages: 1.5;Respiratory ciliated cells: 1.6;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;NTERA-2: 2.0;PC-3: 1.3;THP-1: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044513 Uncertain NA NA "HPA044513: AB_10962510" "unprognostic (1.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (1.37e-2)" "unprognostic (2.62e-2)" "unprognostic (3.54e-1)" "unprognostic (3.49e-2)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-1)" "unprognostic (9.32e-5)" "unprognostic (2.31e-1)" "unprognostic (2.11e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (4.04e-2)" "unprognostic (8.14e-2)" 0.1 0.1 0.3 0.3 0.0 0.9 0.0 0.1 0.3 0.1 0.0 6.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.8 1.7 0.4 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.9 0.2 0.2 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 1.1 0.0 0.7 1.2 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 0.1 2.0 0.0 1.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.7 0.3 0.2 0.0 0.3 3.0 0.1 0.1 0.3 0.1 0.2 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.2 0.4 0.2 0.0 0.2 0.4 0.3 0.2 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.9 0.0 0.4 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.4 1.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.4 0.2 1.6 0.0 0.0 0.0 0.1 0.7 1.1 0.0 0.1 0.3 0.3 0.0 0.2 0.4 RESP18 ENSG00000182698 "Regulated endocrine specific protein 18" Q5W5W9 2 219327407-219333177 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "brain: 14.3" "Group enriched" "Detected in some" 6 "Early spermatids: 9.4;Late spermatids: 32.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.57e-2)" "unprognostic (2.12e-1)" 0.0 0.0 3.0 0.0 14.3 0.0 0.0 1.5 6.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.1 0.0 0.0 0.0 0.0 7.1 4.8 2.3 0.0 0.0 0.0 0.2 0.0 4.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 14.3 1.5 6.3 5.2 5.1 7.1 4.8 2.3 4.4 1.8 4.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 32.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGIP "C5orf53, LOC492311" ENSG00000182700 "IgA inducing protein" A6NJ69 5 140125937-140129392 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 52.1" "Cell type enhanced" "Detected in many" "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 13.7;ASC TERT1: 13.1" "Low region specificity" "Detected in all" "HPA041877, HPA048615" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA041877: AB_2677721, HPA048615: AB_2680462" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" "unprognostic (2.00e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (1.10e-1)" "unprognostic (2.38e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.94e-1)" "prognostic favorable (6.25e-6)" "unprognostic (2.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.98e-2)" "unprognostic (7.77e-2)" 8.2 9.0 50.9 2.9 46.6 0.1 7.7 45.9 51.2 12.3 36.1 11.8 3.7 9.3 9.0 6.4 9.0 3.7 11.5 44.7 48.5 9.4 10.1 9.5 4.6 48.1 49.5 41.6 10.0 8.4 13.9 18.8 4.3 50.9 12.1 3.8 19.7 8.0 8.1 10.4 9.1 8.4 4.6 52.1 7.9 9.3 4.0 49.9 4.2 12.0 9.3 4.0 10.7 11.7 47.5 2.0 0.6 0.9 2.8 13.7 13.1 1.3 5.1 5.0 1.1 1.5 2.0 1.6 3.8 5.3 6.9 0.6 2.1 1.1 3.1 2.3 3.4 1.9 0.8 3.0 1.5 3.2 1.0 1.3 4.5 7.7 2.2 4.2 8.6 1.4 2.8 0.6 1.5 4.4 1.8 1.2 2.6 0.2 1.6 1.5 1.2 2.4 1.7 6.6 1.8 1.0 1.5 2.8 1.8 3.1 1.0 1.4 3.0 8.8 3.5 0.3 1.2 2.8 3.6 2.5 1.3 3.7 2.6 2.6 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.2 0.0 50.9 46.6 45.9 51.2 44.7 48.5 48.1 49.5 41.6 50.9 52.1 49.9 47.5 6.5 12.8 5.1 14.0 2.3 2.0 2.1 3.2 0.0 21.3 4.5 3.7 14.4 8.6 5.4 3.7 14.6 2.5 1.4 5.5 0.0 3.3 1.9 2.4 3.5 5.4 9.0 0.0 22.2 1.8 1.5 4.4 3.6 2.2 8.2 3.0 7.9 5.9 1.0 28.6 19.8 4.2 0.0 2.2 1.3 1.3 6.5 2.2 7.2 14.0 3.9 5.9 3.1 9.5 17.6 2.8 4.4 17.0 1.3 3.7 7.8 4.2 6.1 8.8 0.0 11.2 5.5 2.4 1.3 1.7 4.0 1.8 1.9 2.8 4.0 2.2 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798153 "Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 239.2" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 506.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 168.0;ASC diff: 282.5;OE19: 188.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted to blood" NA NA 6200000 Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (2.87e-4)" "prognostic favorable (1.66e-4)" "prognostic unfavorable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 90.1 12.2 4.2 8.4 4.5 2.1 81.1 6.5 5.1 135.3 23.5 19.3 37.5 46.8 20.8 63.3 68.3 15.1 28.3 6.7 4.4 41.9 239.2 15.2 2.5 4.4 3.0 4.5 47.4 16.9 6.4 14.9 30.6 5.0 44.4 14.5 4.1 34.2 24.8 9.6 57.2 32.6 41.5 1.7 7.0 28.5 9.2 3.8 4.7 37.9 5.7 5.6 41.9 100.4 5.2 3.7 168.0 19.1 18.4 282.5 36.1 34.6 5.9 32.2 12.6 12.0 22.2 48.0 0.3 32.7 21.1 53.7 68.6 10.9 42.7 3.9 35.7 5.9 8.3 43.5 63.1 53.6 3.0 11.9 37.3 46.0 22.5 18.2 24.0 15.7 6.4 19.9 1.4 11.7 81.9 0.5 6.5 24.5 188.9 7.4 5.9 18.3 28.7 29.7 29.7 16.8 28.5 32.7 25.7 15.4 15.8 34.5 2.7 4.9 35.4 28.2 86.8 14.2 1.1 0.6 1.4 16.6 8.9 6.4 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.0 4.2 4.5 6.5 5.1 6.7 4.4 4.4 3.0 4.5 5.0 1.7 3.8 5.2 6.2 0.0 0.5 1.0 0.5 17.3 12.1 25.8 27.9 3.5 13.6 13.2 3.2 11.5 12.1 1.8 0.0 50.0 0.1 33.2 0.0 6.7 0.2 8.1 35.6 5.8 7.8 13.5 0.5 21.7 71.8 33.0 14.8 10.6 1.3 38.7 9.7 506.3 9.9 0.0 0.1 12.4 26.4 9.1 6.4 2.0 37.3 0.8 5.4 1.9 1.6 9.2 0.0 0.0 0.0 21.3 21.2 45.1 0.1 14.6 28.6 21.9 3.0 0.6 0.0 1.0 11.3 0.4 2.0 22.3 22.6 43.8 1.6 8.6 13.8 20.1 CMC4 "MTCP1, MTCP1NB, p8, P8MTCP1" ENSG00000182712 "C-X9-C motif containing 4" P56277 X 155061622-155071136 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 113.5" "Low region specificity" "Detected in all" HPA045866 Approved Supported Mitochondria NA NA Mitochondria "HPA045866: AB_10964642" "unprognostic (4.54e-3)" "unprognostic (7.31e-2)" 14.6 11.6 14.2 9.4 15.8 8.2 12.3 16.8 17.8 13.2 14.2 13.9 12.6 12.5 16.9 11.3 11.9 10.7 53.1 13.5 15.8 13.6 23.5 8.5 15.1 17.3 15.7 13.0 15.3 33.0 12.8 11.9 8.3 15.8 13.0 7.1 7.4 19.1 12.7 32.1 10.8 10.2 8.0 16.5 9.8 11.8 8.1 15.2 6.8 14.2 24.8 8.5 12.5 11.7 17.6 63.7 16.6 9.5 19.8 24.5 23.6 14.2 12.0 17.5 16.7 28.3 10.2 11.1 40.7 30.8 13.9 48.0 20.5 11.8 16.2 10.8 45.5 30.7 6.2 10.2 13.5 25.2 12.8 9.3 22.8 24.9 16.7 20.2 15.9 13.3 25.3 6.2 15.2 17.1 23.5 17.2 23.8 5.6 25.3 42.5 14.6 20.9 28.5 18.3 4.2 19.0 14.4 16.0 17.9 20.3 10.9 13.3 8.1 17.3 26.1 16.9 16.4 16.8 62.9 67.3 113.5 23.7 29.5 16.9 2.0 12.9 22.2 14.8 7.5 15.3 19.1 11.9 14.3 19.6 18.6 3.5 9.5 1.2 23.1 3.0 3.8 15.1 8.3 14.2 15.8 16.8 17.8 13.5 15.8 17.3 15.7 13.0 15.8 16.5 15.2 17.6 3.9 0.0 4.1 3.3 1.9 0.8 1.1 2.6 2.8 1.0 3.4 5.0 0.0 1.5 6.0 0.0 0.0 1.0 3.9 0.9 3.9 1.5 0.1 2.4 2.7 1.8 1.8 7.8 1.6 0.5 1.0 2.8 2.0 1.4 5.1 2.5 2.2 4.7 1.0 0.0 2.3 0.8 0.0 1.3 2.6 1.4 3.7 1.9 1.8 1.9 1.0 1.4 2.1 2.5 4.6 0.7 1.2 1.9 4.0 0.5 2.0 4.1 4.8 0.3 0.0 1.2 2.0 1.4 0.8 4.2 2.4 1.2 2.9 1.2 1.6 0.7 ANXA2 "ANX2, ANX2L4, CAL1H, LIP2, LPC2D" ENSG00000182718 "Annexin A2" P07355 15 60347134-60402883 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" RNA-binding "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 2202.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 174.7" "CAB004311, HPA046964, HPA061798" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 19000000 "Plasma membrane" Cytosol "CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "prognostic favorable (6.88e-5)" "unprognostic (4.06e-3)" "unprognostic (5.42e-3)" "prognostic unfavorable (2.54e-5)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.94e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (7.74e-2)" "unprognostic (2.55e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.59e-5)" 859.8 373.6 44.3 466.0 46.0 153.1 714.6 46.5 97.7 726.2 93.2 637.3 506.5 298.7 269.6 2202.8 391.8 457.9 357.4 42.0 106.2 348.1 187.1 886.1 202.3 83.0 67.5 36.7 188.6 327.0 346.6 165.2 655.8 74.8 402.7 612.1 30.4 941.0 390.0 307.3 1105.5 491.5 429.1 70.3 304.0 382.4 117.2 91.3 190.5 354.1 207.6 545.6 850.4 1267.2 79.0 4183.3 4421.4 223.6 105.5 2962.4 4744.2 971.0 4703.6 2968.4 2868.4 2534.9 2083.5 1903.6 10.0 3907.2 5983.6 2185.1 4304.9 992.9 8695.5 3113.5 846.8 103.9 78.2 1918.7 882.7 1782.0 4.5 59.9 2324.4 2278.6 2013.2 4335.0 3477.2 5455.0 58.4 320.9 447.9 6271.8 468.4 18.5 239.1 508.2 3444.1 3283.5 48.9 1198.8 226.6 5172.4 2410.7 295.1 171.9 1774.5 424.8 1942.8 2305.1 922.7 173.6 6336.8 2534.1 3406.8 8668.0 4807.4 172.6 616.3 83.8 2449.2 47.9 5206.0 4429.7 2762.3 355.0 603.8 2401.9 668.5 657.9 686.4 701.7 4018.8 412.1 77.0 313.9 73.6 287.1 2686.5 609.4 1681.4 3754.4 44.3 46.0 46.5 97.7 42.0 106.2 83.0 67.5 36.7 74.8 70.3 91.3 79.0 673.9 2141.0 414.8 0.3 101.3 2512.2 3396.9 5755.6 246.4 2.5 395.9 337.4 28.2 773.5 3086.6 560.9 0.0 1874.5 135.9 933.6 13.7 3941.4 93.0 855.9 457.1 772.0 103.4 38.7 0.2 2411.4 2714.4 1076.7 328.7 1376.3 105.7 97.5 474.0 64.2 1537.2 0.0 1.3 689.0 1668.2 429.6 1992.1 126.6 771.1 715.1 1417.6 15.9 1284.0 19.4 138.0 1.5 0.1 5217.8 920.9 638.7 144.5 4575.5 845.8 51.8 2446.8 8.1 184.1 437.7 831.1 13.0 29.3 789.7 2325.1 1150.1 224.1 8.6 749.9 4326.1 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932429-72566530 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell type enhanced" "Detected in many" "Astrocytes: 97.3;Early spermatids: 173.5;Excitatory neurons: 652.7;Inhibitory neurons: 256.1;Late spermatids: 298.0" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 11.5;Karpas-707: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 4.7 0.2 2.1 0.6 2.5 1.5 4.1 0.9 9.4 5.0 0.0 1.0 0.3 1.4 2.6 0.4 2.2 1.2 11.3 4.0 3.1 1.9 0.1 0.9 0.1 17.3 14.7 3.6 1.2 0.2 8.2 1.7 3.1 22.6 0.4 1.0 1.7 0.9 1.4 1.1 0.8 0.8 1.3 4.8 0.9 0.4 10.6 4.4 0.3 5.7 0.8 0.5 0.7 0.9 16.4 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 40.1 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.3 1.2 2.1 2.5 0.9 9.4 4.0 3.1 17.3 14.7 3.6 22.6 4.8 4.4 16.4 5.8 0.0 0.0 97.3 0.2 0.3 0.0 0.0 0.0 2.2 2.1 2.4 22.6 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 173.5 2.8 0.9 2.6 0.0 5.3 652.7 0.2 0.1 3.1 0.0 7.1 0.0 0.4 0.0 0.0 0.2 0.0 256.1 0.0 0.0 0.0 0.0 298.0 1.8 8.3 0.0 44.0 5.1 0.0 0.0 36.2 8.9 0.0 0.0 7.5 0.2 0.0 0.0 0.4 0.0 0.4 13.1 0.4 18.6 2.3 1.3 0.2 0.1 0.8 0.5 0.1 0.0 0.7 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575507-48578350 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 19.7" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 28.5;Collecting duct cells: 64.4;Glandular and luminal cells: 25.1;Hepatic stellate cells: 24.3;NK-cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 63.7;HMC-1: 37.5;K-562: 33.7" "Region enriched" "Detected in single" 36 "pons and medulla: 3.5" "Group enriched" "Detected in some" 13 "medulla oblongata: 3.7;spinal cord: 4.7" HPA057432 Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA057432: AB_2683437" "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 7.0 3.1 0.6 3.7 2.5 0.7 3.6 0.0 0.6 6.8 0.1 7.7 2.6 3.4 19.7 3.4 12.9 3.4 0.9 0.0 0.1 6.2 1.1 4.6 2.3 11.0 0.2 0.0 0.3 1.2 4.4 0.0 2.6 4.4 1.0 2.4 0.0 0.3 7.7 2.6 2.5 5.1 4.3 7.3 4.4 4.3 1.2 2.3 1.9 1.0 3.9 1.4 2.9 2.2 6.3 0.3 0.5 0.0 0.2 12.2 9.2 5.2 0.0 0.0 0.8 0.4 6.2 3.1 9.2 63.7 3.3 0.7 0.3 11.8 0.0 0.2 23.3 21.5 21.9 1.6 0.0 12.5 0.0 37.5 10.0 0.0 14.9 0.0 1.2 18.4 14.6 33.7 0.6 15.1 0.0 5.5 0.2 0.0 5.8 0.0 0.0 12.3 4.5 12.5 5.4 0.0 0.0 1.7 0.0 8.7 4.2 0.5 4.3 6.0 0.4 0.5 2.2 0.4 5.0 11.9 2.1 4.3 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.6 2.5 0.0 0.6 0.0 0.1 11.0 0.2 0.0 4.4 7.3 2.3 6.3 19.9 0.0 0.0 0.0 3.0 3.8 1.3 0.0 28.5 0.0 2.7 1.7 0.9 0.0 0.0 64.4 0.0 23.5 18.4 1.0 11.7 0.2 0.2 18.5 2.7 19.0 0.0 5.0 0.0 0.0 13.1 8.2 0.5 25.1 3.8 0.0 24.3 0.2 4.0 0.0 0.0 2.3 0.0 2.8 4.4 0.2 0.3 2.1 5.4 0.0 1.3 0.0 38.1 0.0 0.0 0.0 1.9 0.0 6.6 0.5 1.0 2.0 0.7 0.0 0.0 5.9 6.4 6.0 23.2 15.5 1.8 6.0 9.9 0.1 1.8 3.1 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922301-136925660 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.4" "Cell type enriched" "Detected in single" 9 "Ionocytes: 8.2" "Group enriched" "Detected in some" 5 "colorectal cancer: 3.3;stomach cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 15.4" "Group enriched" "Detected in many" 5 "basal ganglia: 29.6;olfactory bulb: 8.5" "Region enriched" "Detected in many" 6 "basal ganglia: 20.1" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: AB_2685854" "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.0 0.9 0.3 0.0 2.2 0.2 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.0 1.1 2.0 0.2 0.0 0.4 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 15.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.2 0.0 1.2 0.0 3.2 1.1 2.0 0.2 1.7 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 PAQR7 "MPRA, mSR" ENSG00000182749 "Progestin and adipoQ receptor family member 7" Q86WK9 1 25861484-25875708 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1939.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 75.5;HaCaT: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046936 Approved Approved Cytosol NA NA Cytosol "HPA046936: AB_2679869" "unprognostic (1.12e-1)" "unprognostic (2.08e-2)" "unprognostic (8.03e-2)" "unprognostic (4.54e-3)" "unprognostic (1.32e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.47e-1)" "unprognostic (4.59e-3)" "unprognostic (7.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.05e-5)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.15e-2)" "unprognostic (1.54e-2)" 4.9 24.1 9.6 4.4 8.9 5.2 5.2 8.5 9.4 11.1 10.2 5.6 21.1 11.2 28.4 17.8 20.2 7.9 3.0 8.4 10.8 35.7 7.4 5.6 4.4 9.9 10.1 8.8 35.6 6.7 13.8 6.7 21.6 9.8 8.0 2.9 1.5 5.4 24.6 3.0 31.7 19.1 9.6 9.7 10.3 8.2 46.5 10.0 3.5 5.2 1.9 5.0 13.7 13.6 10.4 30.7 6.0 5.8 18.9 7.1 14.8 20.4 19.9 17.5 19.2 17.0 9.8 75.5 0.3 13.6 19.2 6.3 62.6 3.2 33.0 11.4 12.1 3.4 25.6 8.4 12.1 12.0 0.4 3.1 14.9 43.3 13.7 10.2 16.9 7.5 2.8 2.8 2.1 14.4 7.0 0.2 1.9 9.3 3.1 10.3 2.1 0.6 3.8 39.3 22.9 3.1 11.5 32.1 40.7 14.8 7.9 11.6 4.6 8.1 3.1 9.7 10.2 5.4 0.4 0.4 1.3 14.5 0.7 6.6 5.4 7.3 15.7 1.4 13.9 1.4 4.0 0.8 1.0 7.6 1.7 1.3 1.9 3.7 3.4 17.5 0.8 0.2 1.4 9.6 8.9 8.5 9.4 8.4 10.8 9.9 10.1 8.8 9.8 9.7 10.0 10.4 4.9 0.0 3.1 11.4 2.2 18.1 4.3 4.6 4.6 2.1 9.4 9.5 1.9 17.2 5.1 77.3 0.0 52.8 1.3 0.7 21.5 5.6 350.9 23.4 11.5 5.9 4.8 0.0 11.9 13.9 12.3 7.8 0.5 9.0 7.0 4.6 10.4 5.5 11.0 3.3 11.2 2.2 0.0 10.3 14.9 1939.3 19.9 7.8 21.4 7.5 7.6 1.6 0.0 8.5 4.0 6.4 3.0 15.1 0.7 3.1 27.9 70.2 8.6 0.6 13.1 4.3 4.7 11.6 10.0 4.7 13.1 35.7 1.6 5.8 3.7 3.1 PAPPA "ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1" ENSG00000182752 "Pappalysin 1" Q13219 9 116153791-116402321 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 72.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 92.2;Collecting duct cells: 165.5;Endometrial stromal cells: 101.3;Proximal tubular cells: 51.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 50.0;ASC TERT1: 37.8;HSkMC: 137.4;U-138 MG: 36.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA001667, CAB016724" Enhanced "Secreted in female reproductive system" NA NA 78000000 "CAB016724: , HPA001667: AB_1854960" "unprognostic (3.25e-1)" "unprognostic (6.18e-6)" "unprognostic (2.47e-1)" "unprognostic (6.49e-2)" "unprognostic (2.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (5.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.87e-2)" "unprognostic (6.87e-3)" "unprognostic (8.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.37e-3)" "unprognostic (2.48e-1)" "unprognostic (4.01e-1)" "unprognostic (1.02e-3)" 2.8 1.5 0.5 1.8 0.3 0.1 0.8 0.4 0.7 4.2 2.1 1.7 0.3 3.9 0.6 2.5 3.1 2.0 1.8 0.2 1.3 3.8 0.3 1.9 1.2 1.8 2.2 0.0 2.5 0.8 9.2 0.4 72.9 2.0 1.1 1.5 1.0 0.4 2.2 0.3 0.9 0.9 4.2 0.3 0.3 1.1 0.9 1.4 0.8 1.1 1.4 1.0 4.6 2.4 1.3 0.0 14.9 22.3 0.0 50.0 37.8 0.0 12.2 21.4 3.3 5.6 0.0 0.0 0.0 0.0 8.6 1.1 1.7 0.0 0.0 15.6 0.0 0.0 2.6 12.8 0.1 24.3 0.0 0.0 137.4 0.0 16.4 1.9 26.9 0.1 0.0 0.5 0.0 3.8 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.1 1.2 1.8 0.0 0.0 6.8 0.0 0.0 28.9 36.3 1.8 1.0 1.4 0.0 0.0 0.0 25.8 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.7 0.2 1.3 1.8 2.2 0.0 2.0 0.3 1.4 1.3 0.2 0.0 1.5 3.9 1.0 2.9 0.2 4.0 92.2 17.6 0.8 0.4 3.4 0.0 1.6 165.5 12.5 0.5 0.1 0.1 9.8 5.9 20.1 4.7 101.3 1.4 0.0 0.0 10.0 0.9 19.5 31.8 0.5 2.6 1.3 10.4 4.6 0.1 0.4 0.0 19.6 0.0 0.0 0.0 5.8 17.9 14.3 1.0 1.8 7.5 0.0 2.5 1.0 15.1 2.9 0.3 0.0 8.6 1.2 1.2 0.2 51.5 1.6 2.9 0.0 3.3 10.9 2.2 0.6 19.7 1.1 14.0 1.3 0.2 0.1 0.3 MAFA "hMafA, RIPE3b1" ENSG00000182759 "MAF bZIP transcription factor A" Q8NHW3 8 143419182-143430732 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 25.8" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 42.7;Skeletal myocytes: 12.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;MCF7: 1.9;RH-30: 1.2;SCLC-21H: 2.8;T-47d: 2.6;U-2 OS: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (5.92e-3)" "unprognostic (9.89e-3)" "unprognostic (2.81e-3)" "unprognostic (1.42e-8)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (6.08e-2)" "unprognostic (5.67e-2)" "unprognostic (4.41e-1)" "unprognostic (3.71e-1)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.00e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-2)" 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.2 0.0 0.0 0.0 0.8 0.3 0.1 0.0 2.4 0.5 0.5 0.3 0.4 0.1 0.0 0.1 0.4 0.0 25.8 0.1 0.0 0.0 2.1 0.1 0.1 4.0 0.3 0.0 0.2 1.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.3 0.3 0.0 0.1 0.3 1.2 0.2 0.0 0.0 2.8 0.1 0.7 0.0 0.0 0.4 2.6 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.1 0.2 0.4 0.1 0.8 0.3 0.1 0.4 2.1 0.3 0.5 6.8 0.0 0.0 0.0 3.9 0.5 0.5 0.0 2.8 2.7 2.3 1.9 6.0 0.0 0.0 3.7 2.1 0.3 4.0 6.5 0.0 0.0 0.5 1.8 0.5 0.9 42.7 0.0 0.0 0.0 0.1 0.8 5.1 2.3 0.0 0.4 0.4 0.0 0.1 0.0 0.0 4.0 0.0 0.0 1.0 0.2 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 3.5 0.0 1.0 0.4 1.0 0.0 0.0 3.9 0.0 12.8 3.3 0.8 2.9 2.9 1.1 0.3 1.8 0.0 2.8 0.3 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90275778 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 388.2;skeletal muscle: 380.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Yes No Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 61.5 92.7 330.9 33.2 338.4 31.9 62.0 318.2 388.2 69.3 318.0 47.4 40.1 64.0 99.2 52.2 65.9 47.5 134.3 335.6 343.1 72.4 59.6 50.7 32.0 323.7 327.8 325.4 68.4 46.8 88.3 3.0 46.8 323.1 80.8 51.6 158.4 46.7 89.8 380.4 32.9 35.9 75.2 330.0 37.4 41.9 54.7 330.6 40.0 74.7 294.4 37.7 69.9 2.8 326.0 62.1 127.8 151.7 99.7 138.4 63.9 70.4 100.7 88.4 110.5 94.0 133.2 90.5 38.4 113.8 108.9 110.2 118.2 120.3 64.7 121.5 42.6 104.6 61.0 88.4 110.6 117.7 44.5 36.1 83.4 183.3 60.8 132.9 83.7 79.5 45.7 105.0 64.7 112.8 106.5 35.9 53.5 152.7 198.8 55.0 65.6 72.8 63.1 109.8 168.3 145.8 117.0 107.1 90.1 239.1 149.1 141.9 82.6 64.6 138.3 92.3 85.7 161.7 96.9 268.2 66.4 76.8 90.1 106.4 66.4 62.1 99.0 87.2 65.2 109.9 107.7 106.1 101.9 59.2 105.7 122.6 106.8 23.4 86.7 76.0 62.8 133.5 108.0 330.9 338.4 318.2 388.2 335.6 343.1 323.7 327.8 325.4 323.1 330.0 330.6 326.0 10.8 19.2 27.4 21.5 26.2 7.1 10.6 3.7 75.1 10.4 9.1 5.8 10.1 1.5 21.6 5.5 10.4 5.9 5.0 12.1 5.9 33.6 1.9 16.2 14.6 15.8 26.5 12.0 58.3 23.4 4.5 23.0 30.1 9.4 20.3 5.5 7.5 3.8 4.2 16.8 54.0 14.4 4.1 3.8 3.6 4.0 9.0 8.4 8.8 16.9 11.6 15.1 0.0 12.5 22.2 29.9 20.0 8.6 25.0 9.2 12.6 7.8 59.8 11.2 13.1 10.5 19.6 5.2 4.3 55.2 5.1 6.7 19.9 5.7 15.4 8.7 GRID1 "GluD1, KIAA1220" ENSG00000182771 "Glutamate ionotropic receptor delta type subunit 1" Q9ULK0 10 85599552-86366795 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5" "Group enriched" "Detected in some" 19 "Astrocytes: 149.8;Excitatory neurons: 284.5;Inhibitory neurons: 301.2;Oligodendrocyte precursor cells: 316.2;Oligodendrocytes: 534.1" "Group enriched" "Detected in many" 5 "glioma: 3.6;thyroid cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;HEL: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.60e-2)" "unprognostic (2.75e-2)" "unprognostic (5.92e-2)" "unprognostic (4.31e-2)" "unprognostic (4.24e-1)" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.49e-3)" "unprognostic (8.30e-2)" "unprognostic (8.26e-2)" "unprognostic (4.58e-9)" "unprognostic (3.15e-3)" "unprognostic (5.91e-2)" "unprognostic (2.21e-1)" "unprognostic (8.65e-3)" 0.6 1.0 5.3 0.1 5.6 0.0 0.8 3.9 7.0 1.4 0.2 0.3 0.3 1.0 0.7 0.2 1.2 0.2 0.2 5.5 4.5 0.1 0.1 0.4 0.3 5.4 5.4 5.2 0.4 0.2 0.2 0.2 0.7 5.8 0.4 0.1 0.7 0.1 1.0 0.2 0.4 0.3 0.4 4.1 0.0 0.4 0.9 5.3 0.1 2.0 0.0 0.2 0.1 0.6 7.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 2.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.6 3.9 7.0 5.5 4.5 5.4 5.4 5.2 5.8 4.1 5.3 7.5 1.1 3.2 0.5 149.8 0.0 0.5 0.1 0.1 2.2 10.5 0.0 0.1 1.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.0 0.0 0.3 0.3 0.0 0.0 284.5 0.2 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 301.2 0.0 0.0 0.0 0.4 3.0 2.1 0.2 5.4 15.9 0.0 0.8 0.0 316.2 534.1 0.0 0.0 4.5 0.0 0.2 0.0 0.0 0.0 0.5 13.1 0.2 5.7 0.1 0.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540459 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 5841.9;Extravillous trophoblasts: 6575.5;Prostatic glandular cells: 6309.4;Urothelial cells: 5768.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 340000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: AB_2682686" "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 1691.7 1549.9 1215.1 1533.2 1226.6 3848.8 3096.3 1198.5 1782.7 1793.7 1280.9 1740.3 1330.7 1503.4 1984.5 2285.2 1778.2 889.9 1116.0 1189.0 1256.3 1291.4 1660.2 1142.1 2855.8 1255.3 1205.2 1159.3 3603.6 3417.5 866.3 995.2 1108.3 1253.5 1430.4 1492.0 481.4 2069.7 976.5 1604.0 2490.2 1330.4 1198.6 1262.6 1573.1 1568.4 378.5 1251.7 2030.4 1227.6 1072.9 2584.5 1581.7 1805.5 1274.3 3535.7 4567.8 3027.7 2844.3 3850.6 6013.0 3418.3 3504.2 3142.7 2924.3 2235.3 5420.6 3683.5 5561.4 3680.3 3142.1 2276.7 4963.3 6162.5 4765.3 2251.9 4262.2 8647.1 3224.4 5009.5 4698.1 5817.4 4197.2 2100.2 5478.2 7877.0 1959.5 6027.1 4520.5 3281.1 3993.8 3909.8 4288.1 3200.3 6205.4 3467.9 7403.5 4567.2 4224.9 2885.2 3333.8 3746.8 4676.4 3425.9 6945.5 2678.6 3325.2 2101.9 4289.8 9110.0 3205.5 3707.5 10012.4 2932.1 2388.1 3534.7 2353.9 6119.2 3312.3 7992.5 5635.5 2580.9 8286.2 2335.3 519.6 1072.5 302.9 1155.2 949.1 1830.0 2371.9 1954.3 1477.4 1685.5 2173.6 2280.0 1986.3 148.5 1335.8 859.0 1700.9 1707.8 3337.5 1215.1 1226.6 1198.5 1782.7 1189.0 1256.3 1255.3 1205.2 1159.3 1253.5 1262.6 1251.7 1274.3 118.0 814.1 1488.0 8.1 1824.1 43.2 5841.9 11.0 675.6 83.2 1696.6 859.5 428.3 2093.2 1039.5 176.6 50.1 3419.1 1523.2 487.4 545.9 1846.4 75.5 269.9 496.3 1390.0 963.5 1971.9 5.5 3041.8 6575.5 973.4 375.1 305.1 937.3 67.5 2470.1 3241.0 2716.5 42.1 6.3 2545.9 2.0 3330.0 46.3 229.6 4400.2 1201.6 30.2 7.5 3519.0 296.5 3137.0 6.0 10.1 2490.2 2021.5 1873.5 547.9 6309.4 1840.9 1036.8 504.2 121.4 1183.3 2746.2 689.9 611.9 701.6 1140.4 63.9 3414.9 1379.0 53.7 3448.3 5768.6 HCAR2 "GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG" ENSG00000182782 "Hydroxycarboxylic acid receptor 2" Q8TDS4 12 122701293-122703357 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1" "Group enriched" "Detected in many" 8 "cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2" "Group enriched" "Detected in some" 11 "cerebral cortex: 5.3;pons: 1.3" "Immune cell enriched" "Detected in many" 5 "neutrophil: 176.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 176.7" "Cell line enriched" "Detected in some" 6 "HaCaT: 118.4" HPA028660 Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (2.05e-1)" "unprognostic (6.65e-2)" "unprognostic (1.33e-1)" "unprognostic (3.33e-3)" "unprognostic (7.26e-2)" "unprognostic (2.17e-1)" "unprognostic (1.77e-2)" "unprognostic (7.10e-2)" "unprognostic (7.33e-2)" "unprognostic (4.83e-4)" "unprognostic (5.76e-2)" "unprognostic (5.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" 22.4 0.3 0.1 9.9 0.1 22.3 7.6 0.1 5.3 4.9 0.3 0.6 0.9 0.2 0.3 41.2 0.7 0.8 0.7 0.2 0.2 3.8 2.9 12.0 0.6 0.1 0.1 0.1 0.1 0.2 5.5 0.3 4.6 1.3 3.5 0.3 0.2 14.3 14.8 0.2 27.8 1.0 0.3 0.1 26.2 1.5 2.8 0.2 10.6 0.5 1.9 10.2 7.0 14.2 0.2 4.5 0.4 0.1 0.1 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 118.4 0.0 7.3 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.1 3.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 19.5 0.2 0.0 0.4 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 38.7 2.5 2.6 0.0 5.3 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 176.7 0.0 23.9 0.0 0.0 1.4 0.1 0.1 0.1 5.3 0.2 0.2 0.1 0.1 0.1 1.3 0.1 0.2 0.2 0.4 0.0 4.3 0.0 0.5 94.4 84.7 52.0 120.1 0.5 3.4 1.1 0.1 0.0 40.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 24.9 0.4 0.2 1.2 0.0 0.0 0.0 0.0 26.3 2.4 0.0 0.3 2.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 87.5 4.1 124.0 2.7 0.0 17.8 8.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 8.5 0.1 0.0 0.1 1.4 0.0 0.1 47.2 106.1 2.6 1.5 0.0 0.0 32.5 OR2T29 ENSG00000182783 "Olfactory receptor family 2 subfamily T member 29" Q8NH02 1 248556912-248562772 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC87 FLJ10786 ENSG00000182791 "Coiled-coil domain containing 87" Q9NVE4 11 66590176-66593063 "Predicted intracellular proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 13.9" "Group enriched" "Detected in some" 4 "Early spermatids: 32.1;Spermatocytes: 19.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;SCLC-21H: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.48e-2)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (6.37e-2)" "unprognostic (2.25e-3)" "unprognostic (2.71e-2)" "unprognostic (8.59e-3)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (5.17e-2)" "unprognostic (2.16e-3)" "unprognostic (2.56e-2)" "unprognostic (3.97e-3)" "unprognostic (8.25e-2)" "unprognostic (2.29e-1)" "unprognostic (3.39e-2)" "unprognostic (2.42e-1)" 0.0 0.2 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.3 0.1 0.1 0.2 1.8 0.1 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 1.1 0.5 0.0 0.1 0.2 0.1 1.4 0.1 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.1 13.9 0.1 0.2 0.9 0.1 0.0 0.1 0.0 0.2 0.4 1.3 0.2 0.3 0.3 0.1 0.1 0.1 0.3 0.2 0.1 0.8 0.3 0.0 0.5 0.2 0.5 0.6 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.1 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.5 0.2 0.2 0.4 0.8 0.2 0.4 0.3 0.0 0.5 0.0 2.3 0.3 0.5 0.5 0.1 0.3 0.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.1 1.8 2.1 0.0 0.0 0.0 0.0 0.5 32.1 0.2 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.6 0.0 0.0 0.0 19.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 GSTA5 ENSG00000182793 "Glutathione S-transferase alpha 5" Q7RTV2 6 52831655-52840843 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "Smooth muscle cells: 23.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA004342, HPA048934, HPA053817" Uncertain Approved Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.97e-2)" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 2.2 0.4 0.0 0.0 0.0 23.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018522-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.2;lung: 73.6;stomach 1: 59.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 176.3;Alveolar cells type 2: 99.4;Club cells: 68.5;Urothelial cells: 128.1" "Cancer enhanced" "Detected in many" "prostate cancer: 65.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 57.7;CAPAN-2: 99.5;HaCaT: 123.1;HBEC3-KT: 118.6;hTCEpi: 61.4;RPTEC TERT1: 56.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 180000 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favorable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.1 0.4 0.0 1.7 0.0 0.8 10.5 0.0 0.1 7.6 0.0 8.9 24.8 0.2 0.7 103.2 2.6 9.9 0.3 0.0 0.0 5.8 0.5 73.6 0.0 0.0 0.0 0.0 0.1 13.0 0.0 0.3 0.2 0.0 51.4 8.4 0.0 29.7 1.9 0.5 38.0 20.4 0.3 0.0 0.2 59.2 0.9 0.0 0.3 4.3 0.5 16.2 20.8 31.4 0.0 57.7 7.7 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.1 99.5 0.0 6.5 0.0 0.0 123.1 0.0 118.6 0.0 0.1 0.0 10.6 1.0 1.6 0.0 0.0 0.6 0.0 61.4 0.0 34.2 0.0 0.0 0.2 6.9 0.1 0.0 0.1 0.1 0.2 0.1 37.3 3.3 0.0 0.0 0.2 56.4 15.1 0.1 0.3 1.1 11.1 0.5 0.4 0.2 0.2 0.0 0.0 0.3 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 176.3 99.4 0.0 0.3 20.8 53.0 26.8 10.8 0.0 5.4 7.2 49.9 30.0 68.5 11.0 0.0 0.1 0.1 40.7 15.6 24.3 5.7 6.7 1.4 1.7 10.7 0.0 0.1 24.4 0.0 1.6 50.4 14.9 6.3 0.0 0.0 0.0 0.2 0.0 0.1 19.8 12.2 0.0 1.2 5.5 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 60.7 35.3 0.0 0.3 56.5 31.8 0.3 41.0 0.0 0.0 0.0 2.8 0.1 0.0 24.3 23.3 0.0 0.3 0.1 8.9 128.1 MAGEB17 ENSG00000182798 "MAGE family member B17" A8MXT2 X 16167481-16171464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 2.0;testis: 1.7" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 2.7;U-2 OS: 6.0;U-266/70: 14.8" HPA003756 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003756: AB_2250114" "unprognostic (1.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-1)" "unprognostic (4.04e-4)" "unprognostic (2.75e-1)" "unprognostic (5.11e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (1.88e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-1)" "unprognostic (7.05e-2)" "unprognostic (2.88e-1)" "unprognostic (5.45e-2)" "unprognostic (6.44e-2)" 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 1.5 0.0 0.0 2.7 6.0 0.0 0.1 14.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 1108.5" "Cell type enhanced" "Detected in many" "Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6" "Group enriched" "Detected in all" 30 "B-cells: 109.9;T-cells: 115.6" "Cell line enhanced" "Detected in many" "EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 160000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 178.2 45.1 127.0 31.6 141.4 1.5 163.9 110.0 261.5 93.0 105.5 91.9 27.3 139.2 36.7 128.3 131.1 48.4 1108.5 140.1 148.1 170.7 53.1 187.4 30.3 126.1 120.3 135.0 51.7 46.5 19.4 176.4 50.0 126.4 89.7 8.4 4.1 100.9 73.6 53.0 123.9 83.5 32.3 112.6 104.9 66.7 93.5 141.0 10.5 156.9 43.1 16.6 122.4 101.3 109.3 2.5 201.2 37.9 98.3 4.3 19.9 10.0 17.5 1.9 2.8 1.0 7.1 44.2 0.2 321.9 73.8 4.5 166.8 3.6 50.8 0.1 2.3 1.9 0.2 132.5 73.8 24.3 0.0 25.5 10.5 4.4 5.2 26.2 38.4 192.7 0.2 0.5 1.4 26.8 306.5 0.5 0.6 10.0 45.7 143.4 0.4 7.7 9.9 140.1 0.6 61.6 175.3 30.0 303.7 1.9 4.9 266.4 0.1 259.3 82.7 38.8 2.3 50.5 0.7 0.6 0.9 24.3 0.3 179.3 0.2 1.9 0.0 7.5 0.9 6.8 52.1 80.4 17.2 3.6 109.9 17.8 4.5 1.0 3.7 0.5 0.5 115.6 10.4 127.0 141.4 110.0 261.5 140.1 148.1 126.1 120.3 135.0 126.4 112.6 141.0 109.3 459.4 157.0 33.7 17.9 15.0 153.2 96.7 206.4 29.0 2.7 110.0 140.7 863.3 107.2 127.1 189.4 4.2 2.6 8.2 0.9 154.6 106.8 37.9 125.1 28.8 510.4 25.2 9.7 16.4 87.6 30.5 132.9 32.1 126.6 7.6 0.4 346.3 30.4 3.0 94.2 3.0 0.3 81.4 11.8 92.6 84.0 28.0 9.3 156.5 27.2 2.5 57.2 1.0 4.5 3.1 48.9 0.1 14.7 7.0 37.4 0.2 17.0 155.7 4.0 276.1 108.1 339.5 27.8 46.1 20.1 196.8 32.0 32.5 5.9 0.2 103.2 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68020916-68023232 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 5.5 10.1 3.8 4.9 4.2 16.9 5.6 4.0 4.3 3.7 3.9 5.1 3.9 6.1 5.1 8.3 5.1 2.8 6.7 4.1 4.5 6.5 8.7 4.3 7.8 4.1 4.0 4.0 5.5 5.6 7.1 3.7 4.7 4.3 3.5 4.3 1.6 5.0 3.5 15.5 9.4 7.1 3.7 4.0 9.0 6.4 9.8 4.1 5.6 4.0 7.8 6.5 5.6 4.3 4.4 10.2 14.7 7.1 8.5 9.5 5.3 16.5 6.9 9.8 16.4 11.6 14.4 15.5 37.6 10.2 8.3 9.0 17.9 10.1 16.1 9.6 5.1 16.7 13.6 7.4 14.9 12.8 21.7 14.1 10.3 17.2 13.5 12.4 5.7 9.2 24.9 24.5 5.7 7.4 22.4 22.9 30.0 17.2 10.2 10.7 22.1 6.6 40.3 11.6 11.4 14.8 9.9 27.6 7.8 15.3 8.0 14.9 23.1 7.0 7.3 6.3 10.6 11.2 12.8 16.9 36.7 9.0 16.4 10.1 24.0 22.3 27.4 17.0 22.4 18.7 14.3 15.6 18.5 20.8 19.0 24.2 18.2 7.2 21.5 23.4 10.2 16.0 20.8 3.8 4.2 4.0 4.3 4.1 4.5 4.1 4.0 4.0 4.3 4.0 4.1 4.4 4.4 6.4 6.8 0.7 10.9 9.2 14.2 11.7 8.0 5.6 4.8 4.3 4.1 8.6 8.3 3.7 0.0 27.9 4.0 2.9 13.7 12.0 6.6 5.4 4.4 5.7 4.8 9.5 0.9 9.7 12.5 4.4 5.1 5.4 3.8 8.0 6.8 11.6 17.1 3.3 1.0 3.5 6.1 8.5 3.1 4.0 5.0 6.8 7.2 0.0 13.3 7.5 25.7 0.5 1.4 7.4 4.2 3.4 4.2 5.7 2.0 19.7 5.3 4.3 13.1 4.4 9.4 22.7 14.1 6.7 10.7 99.9 7.6 12.5 6.1 8.8 KRTAP13-2 KAP13-2 ENSG00000182816 "Keratin associated protein 13-2" Q52LG2 21 30371390-30372271 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 1.9;skin 1: 7.6" "Group enriched" "Detected in some" 4 "Distal enterocytes: 31.1;Paneth cells: 27.0;Prostatic glandular cells: 11.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1000000 "unprognostic (2.44e-2)" "unprognostic (5.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.0 7.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.4 ACBD3 "GCP60, GOCAP1, GOLPH1, PAP7" ENSG00000182827 "Acyl-CoA binding domain containing 3" Q9H3P7 1 226144679-226186741 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015594 Approved Supported "Golgi apparatus" NA NA 29000 "Golgi apparatus" "HPA015594: AB_1844491" "unprognostic (1.82e-3)" "unprognostic (1.53e-2)" "unprognostic (7.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.85e-1)" "unprognostic (5.34e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.66e-3)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-3)" "unprognostic (2.54e-3)" 21.8 17.1 13.0 20.6 13.2 26.1 24.6 14.3 13.1 27.8 17.7 23.5 17.7 23.0 20.7 31.1 18.0 23.7 21.6 12.0 14.9 20.3 24.5 22.6 21.5 13.9 13.5 10.8 23.4 22.9 28.2 14.7 31.9 14.1 23.0 25.7 16.2 24.3 16.5 21.7 19.4 17.7 21.9 14.9 17.9 32.0 19.0 14.5 18.2 29.0 20.5 25.9 27.2 20.4 14.8 43.7 29.3 24.3 15.1 73.6 65.4 47.2 53.7 55.7 31.5 40.3 38.0 53.2 46.3 48.0 69.7 28.5 33.5 34.6 35.2 43.9 19.4 40.4 22.5 30.3 34.8 47.2 36.5 26.7 48.7 46.0 39.1 51.1 44.7 36.6 22.2 42.6 32.0 51.3 22.1 27.2 28.5 36.1 72.5 38.0 25.0 53.3 47.1 29.4 39.2 27.6 39.8 47.8 52.7 53.0 34.0 54.2 41.5 46.2 31.4 22.0 76.7 51.5 60.4 67.4 57.3 37.3 24.2 52.8 2.1 1.4 1.4 0.9 1.8 1.6 5.0 1.3 0.9 1.0 4.4 1.4 1.3 1.5 1.0 1.5 1.4 1.7 0.7 13.0 13.2 14.3 13.1 12.0 14.9 13.9 13.5 10.8 14.1 14.9 14.5 14.8 53.5 67.3 41.5 14.0 50.4 52.0 63.4 17.9 38.7 35.1 50.6 37.2 35.7 27.1 37.9 35.0 56.3 45.3 44.2 46.1 15.6 25.0 24.0 56.6 84.0 47.6 43.5 10.7 29.8 34.7 60.7 55.8 50.4 85.8 24.6 29.8 28.2 52.0 37.9 26.9 31.3 71.9 28.5 25.1 51.0 7.3 40.7 39.4 49.8 20.6 18.0 52.1 18.6 27.6 29.2 39.0 28.4 32.7 87.3 61.7 26.7 32.1 26.9 39.4 32.9 46.6 51.4 72.1 55.8 46.7 77.7 62.4 34.0 33.1 35.6 98.3 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091644-9121635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 107.1" "Cell type enhanced" "Detected in all" "Late spermatids: 643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: AB_2685850" "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.2 17.6 16.7 18.4 19.8 107.1 17.4 17.0 22.6 16.0 15.7 15.1 14.9 15.4 17.5 19.7 12.9 19.2 15.7 19.7 20.0 18.8 27.0 17.6 20.2 16.0 18.2 19.4 14.3 18.7 22.5 9.9 17.3 18.3 16.1 15.2 21.0 14.3 14.9 32.7 16.9 13.7 16.9 16.0 21.0 16.0 17.4 17.9 19.6 18.9 28.0 22.2 18.0 15.3 19.7 17.3 18.9 29.6 27.1 34.4 26.7 15.5 33.2 27.6 18.8 19.3 15.9 22.0 30.8 18.6 38.6 14.8 19.8 27.5 29.4 39.2 20.3 15.4 20.7 27.2 33.6 44.4 26.3 23.2 40.7 45.3 31.5 44.7 30.1 33.1 31.7 31.6 45.7 33.6 24.9 23.5 23.3 36.1 17.7 16.5 39.6 36.1 33.1 24.6 31.3 19.1 21.4 39.9 27.8 35.1 27.4 32.1 26.6 38.3 36.6 24.0 47.6 21.7 51.7 48.0 42.5 32.6 23.2 30.3 5.5 2.8 3.2 3.7 3.1 4.2 2.5 3.1 2.6 2.2 3.0 3.5 3.2 10.9 2.3 3.4 2.8 2.7 1.7 16.7 19.8 17.0 22.6 19.7 20.0 16.0 18.2 19.4 18.3 16.0 17.9 19.7 65.3 48.1 37.2 17.6 47.5 76.9 45.4 13.0 78.6 43.6 81.6 53.8 39.3 35.8 19.1 22.0 87.6 29.6 76.0 45.8 19.6 28.1 210.0 75.7 75.1 52.5 48.2 21.7 27.6 29.4 35.7 42.9 35.2 115.7 18.3 51.9 38.6 59.5 32.5 43.7 28.2 35.1 8.2 83.8 65.6 643.5 24.5 83.5 32.0 28.1 49.0 41.8 33.0 24.6 33.3 38.9 37.7 27.1 59.2 52.0 44.5 36.8 15.9 51.2 32.9 78.0 56.3 41.5 22.3 84.5 64.4 57.1 58.8 35.3 34.9 70.1 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306952-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;heart muscle: 33.5;ovary: 22.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 3.9 12.8 5.7 0.5 4.3 0.0 2.4 16.5 4.3 2.8 1.2 0.8 0.5 1.1 0.9 0.6 3.4 2.5 33.5 3.4 9.4 6.0 1.6 1.8 1.6 7.8 9.3 3.2 22.7 3.7 0.3 5.3 0.1 11.9 1.0 0.6 0.7 0.4 1.0 0.6 0.6 1.2 1.2 7.7 0.2 5.0 0.4 11.5 0.5 1.5 0.7 0.3 1.4 4.1 11.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.4 34.3 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.7 4.3 16.5 4.3 3.4 9.4 7.8 9.3 3.2 11.9 7.7 11.5 11.1 8.7 0.0 0.0 7.5 0.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 138.2 5.7 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.3 0.9 1.7 58.7 13.6 42.4 5.3 27.8 0.0 2.0 10.3 0.0 1.1 0.0 33.4 33.2 0.4 0.1 1.7 163.5 2.2 0.0 0.6 0.3 4.4 7.8 0.2 0.0 52.5 0.0 0.4 0.0 7.5 1.3 0.9 0.0 0.4 0.0 0.3 0.1 10.4 0.0 0.2 6.6 0.2 2.9 0.2 0.0 0.2 0.0 0.1 0.3 9.7 0.1 0.1 VMO1 ENSG00000182853 "Vitelline membrane outer layer 1 homolog" Q7Z5L0 17 4785285-4786433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.0;pituitary gland: 27.9" "Group enriched" "Detected in many" 4 "Club cells: 923.5;monocytes: 857.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "non-classical monocyte: 111.9" "Lineage enriched" "Detected in many" 9 "monocytes: 111.9" "Cell line enhanced" "Detected in some" "A549: 3.0;MCF7: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023038 Uncertain "Secreted to blood" NA NA 2900000 "HPA023038: AB_10964632" "unprognostic (1.30e-1)" "unprognostic (5.71e-2)" "unprognostic (1.65e-3)" "unprognostic (9.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (5.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (7.41e-2)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (2.69e-1)" 4.5 2.5 3.6 7.1 3.6 2.5 2.3 4.0 6.5 3.0 5.9 2.0 4.9 1.6 0.1 1.7 1.6 3.4 1.8 3.6 4.8 3.5 10.4 9.0 2.1 5.1 4.1 3.4 1.0 2.4 13.4 27.9 2.3 4.5 3.0 0.8 0.5 5.3 1.6 10.2 2.0 5.7 0.9 4.3 22.0 1.6 0.7 4.3 2.1 1.4 1.5 0.5 4.7 2.5 4.9 0.2 3.0 0.3 1.8 0.3 0.7 0.3 0.6 1.1 0.1 0.3 0.9 1.1 0.1 0.0 0.1 0.2 0.5 0.0 0.4 0.2 2.2 0.4 0.1 0.6 0.8 0.6 0.0 1.3 0.5 0.4 0.1 0.4 0.6 0.0 0.4 0.3 0.4 0.6 3.9 0.0 0.9 0.7 0.7 1.3 0.7 1.5 0.3 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.2 1.2 0.1 0.3 1.2 0.1 0.3 0.2 0.0 0.3 0.0 0.5 0.6 0.9 0.1 0.2 0.0 0.0 9.7 0.0 0.0 0.0 0.0 12.3 0.1 0.0 0.1 0.0 0.4 111.9 0.0 0.0 3.7 3.6 3.6 4.0 6.5 3.6 4.8 5.1 4.1 3.4 4.5 4.3 4.3 4.9 2.8 3.2 7.7 1.0 2.8 8.5 13.4 217.2 0.6 6.7 2.8 3.7 0.9 1.5 923.5 0.0 0.0 0.4 0.8 1.1 1.9 0.9 8.2 0.4 0.8 5.2 1.2 3.2 0.5 1.5 0.3 2.5 0.0 0.4 14.0 0.3 79.6 3.3 16.2 0.0 0.9 1.0 101.7 59.8 210.9 40.3 0.3 70.8 5.4 1.0 857.9 1.0 0.0 0.0 0.6 1.5 0.3 1.2 0.7 11.2 4.3 2.4 158.4 2.9 13.1 1.3 45.5 0.6 1.5 0.8 7.2 0.3 2.0 0.5 1.3 14.2 OR4F15 ENSG00000182854 "Olfactory receptor family 4 subfamily F member 15" Q8NGB8 15 101812202-101820197 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG12 "CDG1G, ECM39" ENSG00000182858 "ALG12 alpha-1,6-mannosyltransferase" Q9BV10 22 49900229-49918438 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003076, HPA051665" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003076: AB_2666777, HPA051665: AB_2681566" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (4.39e-3)" "prognostic favorable (6.09e-4)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (4.27e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-1)" "unprognostic (3.32e-2)" "unprognostic (1.42e-1)" "unprognostic (2.21e-1)" "prognostic favorable (3.60e-5)" "unprognostic (1.62e-2)" "unprognostic (3.00e-2)" "unprognostic (9.89e-3)" "unprognostic (6.32e-2)" 6.3 8.1 3.7 7.4 4.0 5.9 6.5 5.5 4.6 7.5 4.0 8.1 11.2 8.4 6.6 8.1 7.7 6.7 8.1 3.7 3.0 9.4 14.6 7.0 5.7 4.2 4.1 3.0 7.2 11.5 11.9 6.6 5.4 5.1 9.1 4.1 3.1 12.1 5.6 6.1 7.1 9.0 4.5 3.4 7.3 10.4 4.5 4.8 6.6 11.8 4.5 4.9 7.8 6.8 8.3 8.6 8.5 8.8 14.7 16.4 7.6 9.8 8.8 7.9 10.2 8.2 14.0 12.0 4.6 7.8 7.8 11.1 15.2 10.7 10.4 5.0 7.3 15.9 4.2 14.7 14.1 18.6 10.6 8.9 11.6 10.5 9.9 14.3 11.2 9.9 10.3 5.3 11.2 5.4 19.6 10.4 8.6 8.4 11.3 7.7 17.2 11.0 12.1 10.6 9.6 5.9 9.6 14.0 26.3 11.4 11.7 10.8 9.4 7.7 11.2 8.5 7.9 6.8 9.8 4.9 6.1 12.5 8.0 10.9 21.4 8.7 7.7 11.5 8.5 11.7 4.8 8.9 11.4 7.6 6.4 7.3 8.6 7.1 16.9 10.1 7.7 12.8 8.1 3.7 4.0 5.5 4.6 3.7 3.0 4.2 4.1 3.0 5.1 3.4 4.8 8.3 6.8 9.6 3.1 21.5 10.2 4.1 10.2 12.1 9.1 5.2 11.1 10.2 1.2 8.6 10.3 18.4 2.1 20.5 8.5 16.6 3.9 15.9 6.9 6.6 8.0 8.1 6.7 7.4 23.2 13.5 22.4 10.6 11.7 9.2 8.2 7.0 5.3 15.0 18.6 3.3 30.4 12.9 12.2 9.2 5.3 4.3 8.7 8.7 10.6 9.4 9.0 2.9 18.6 17.6 40.4 10.3 9.7 8.2 15.6 11.3 18.8 6.8 5.6 5.2 0.0 8.5 7.7 12.9 9.1 10.4 6.0 26.3 11.9 8.3 16.3 9.1 LCK ENSG00000182866 "LCK proto-oncogene, Src family tyrosine kinase" P06239 1 32251239-32286165 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 346.1" "Group enriched" "Detected in many" 9 "dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in all" 12 "gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7" "Group enriched" "Detected in all" 12 "NK-cells: 641.5;T-cells: 1682.7" "Group enriched" "Detected in some" 6 "JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA003494, CAB003816" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB003816: AB_562158, HPA003494: AB_1852751" "unprognostic (6.38e-3)" "unprognostic (5.45e-3)" "unprognostic (8.39e-2)" "prognostic favorable (2.96e-6)" "unprognostic (2.20e-2)" "prognostic favorable (2.91e-4)" "unprognostic (4.78e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.65e-5)" "unprognostic (3.07e-2)" "unprognostic (3.80e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (8.15e-2)" "unprognostic (4.05e-2)" "unprognostic (7.39e-2)" "unprognostic (1.17e-2)" 2.4 2.2 0.4 51.0 0.6 13.8 2.3 0.4 0.6 2.2 1.0 6.9 7.6 1.8 13.1 3.9 2.1 9.5 1.9 0.5 0.6 2.7 3.8 11.5 111.9 0.9 0.5 0.3 1.7 0.9 0.5 0.8 1.1 0.6 2.8 6.6 0.0 4.9 1.4 1.3 1.9 23.3 2.3 0.6 40.3 12.3 1.1 1.0 346.1 3.7 1.4 80.3 13.3 2.7 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.7 64.1 3.5 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.6 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 365.7 0.2 0.0 0.0 0.0 536.9 0.2 5.9 4.6 0.3 20.6 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.3 0.3 0.4 0.6 0.4 0.0 0.0 1.7 0.1 0.1 0.7 0.3 302.7 0.0 0.1 0.0 12.8 5.2 6.0 1109.8 4.9 1034.8 62.0 1123.8 1201.7 5.2 98.9 1260.7 1168.7 33.6 641.5 6.0 7.7 1682.7 1836.9 0.4 0.6 0.4 0.6 0.5 0.6 0.9 0.5 0.3 0.6 0.6 1.0 0.9 4.9 0.0 9.3 0.0 23.4 4.6 1.2 0.4 0.0 0.0 3.5 5.2 1.8 4.3 1.6 3.7 0.0 0.3 143.9 0.9 0.0 0.6 0.1 1.0 0.5 3.4 2.4 10.1 0.2 0.5 0.2 3.1 7.7 0.7 5.1 0.0 4.6 1.5 0.3 0.0 0.2 0.3 0.0 7.8 7.3 0.0 0.0 8.1 3.6 0.0 8.7 0.0 272.9 0.5 0.1 4.7 0.0 0.4 15.7 1.0 0.0 1.4 1.8 0.0 0.0 1.5 2.4 4.5 2.0 0.5 3.1 0.4 255.5 2.9 1.3 1.1 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329589 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.9;thyroid gland: 13.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.7;Collecting duct cells: 27.6;Excitatory neurons: 37.1;Inhibitory neurons: 13.1;Proximal tubular cells: 8.2" "Group enriched" "Detected in some" 5 "glioma: 0.9;ovarian cancer: 0.5;renal cancer: 1.6;thyroid cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-87 MG: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles NA NA Vesicles "HPA075016: AB_2686729" "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 4.3 1.2 6.6 0.1 11.5 0.0 0.1 18.3 21.9 3.5 0.0 1.2 0.2 0.8 2.3 0.1 1.9 0.0 0.4 10.9 3.7 7.7 0.2 0.5 0.3 6.1 5.6 10.1 1.3 0.1 0.2 8.5 0.0 8.7 1.0 0.0 0.6 0.2 0.3 0.1 0.1 0.5 0.0 0.5 0.9 0.6 0.7 10.0 0.1 13.1 0.0 0.0 0.5 0.8 10.7 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 11.5 18.3 21.9 10.9 3.7 6.1 5.6 10.1 8.7 0.5 10.0 10.7 0.0 0.0 0.6 2.6 0.0 0.0 0.5 0.0 0.0 7.7 0.1 0.0 1.6 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.4 1.3 0.0 0.0 37.1 0.0 0.0 2.7 0.0 0.8 1.3 0.0 0.0 0.0 0.2 3.3 13.1 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 5.6 0.0 1.7 0.0 2.0 2.9 0.1 0.0 1.9 0.0 0.6 0.0 8.2 0.0 3.3 0.0 0.9 0.6 0.0 0.1 0.0 0.1 0.1 0.0 2.0 0.1 0.8 COL18A1 "KNO, KNO1, KS" ENSG00000182871 "Collagen type XVIII alpha 1 chain" P39060 21 45405165-45513720 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 566.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0" "Region enriched" "Detected in all" 6 "cerebellum: 22.1" "Low region specificity" "Detected in all" "HPA030933, HPA036104" Supported Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 290000000 "Golgi apparatus" "HPA030933: , HPA036104: AB_2674943" "unprognostic (4.32e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (3.47e-2)" "unprognostic (3.25e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.23e-3)" "unprognostic (9.93e-2)" "unprognostic (3.48e-1)" "unprognostic (2.77e-1)" "unprognostic (5.50e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-2)" "unprognostic (9.44e-2)" "unprognostic (9.10e-3)" "unprognostic (2.25e-3)" 126.8 88.3 20.1 34.2 18.8 16.0 97.9 24.9 22.0 220.2 39.9 76.9 30.7 136.7 35.7 50.5 119.3 29.1 108.8 14.8 28.0 219.9 566.4 83.9 20.0 42.5 29.5 8.4 259.5 103.2 8.0 107.3 41.1 35.2 91.8 5.5 5.5 36.1 47.3 26.8 78.4 66.3 28.8 31.6 87.5 44.9 30.2 25.1 9.1 101.9 7.4 7.2 110.8 113.1 49.6 10.5 84.0 20.6 18.0 38.6 31.9 3.3 82.0 139.0 39.1 10.5 48.8 28.9 1.5 309.4 82.8 21.6 37.9 4.6 5.0 7.4 0.7 20.0 47.9 1.4 69.6 37.3 0.7 4.4 37.6 3.3 3.8 4.5 8.5 121.3 0.5 49.6 0.3 14.4 16.7 0.8 3.2 170.6 3.2 30.7 0.7 12.6 4.0 131.6 1.3 22.8 16.3 7.6 7.8 26.6 73.0 7.5 9.9 186.0 0.5 11.4 0.4 17.7 0.4 0.8 1.5 0.1 1.7 32.7 0.8 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 0.1 0.0 0.1 20.1 18.8 24.9 22.0 14.8 28.0 42.5 29.5 8.4 35.2 31.6 25.1 49.6 156.9 0.0 4.1 6.5 3.9 67.7 15.5 19.0 67.7 13.5 9.3 32.1 15.7 61.5 5.0 112.2 4.2 1.9 3.4 0.1 9.8 117.5 1.5 58.3 99.5 91.2 0.0 33.0 4.9 5.8 1.1 101.1 3.6 144.2 57.8 6.6 75.0 479.6 2.4 0.0 15.8 0.1 4.1 12.1 32.5 6.7 79.9 6.5 49.8 82.4 3.2 141.9 7.2 4.0 28.0 9.9 0.0 126.0 4.6 14.0 0.0 72.9 0.7 6.3 223.5 138.2 268.6 4.1 6.0 7.9 28.6 2.5 15.3 47.5 0.4 2.6 RBM10 "DXS8237E, GPATC9, GPATCH9, KIAA0122, S1-1, ZRANB5" ENSG00000182872 "RNA binding motif protein 10" P98175 X 47145221-47186813 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034972, HPA057372" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA034972: AB_10602919, HPA057372: AB_2683421" "unprognostic (9.07e-2)" "prognostic favorable (6.71e-4)" "unprognostic (7.83e-2)" "unprognostic (1.61e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-2)" "unprognostic (4.47e-3)" "unprognostic (8.11e-2)" "unprognostic (9.86e-3)" "unprognostic (1.76e-1)" "prognostic favorable (2.86e-6)" "unprognostic (1.18e-1)" "unprognostic (6.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.40e-2)" "unprognostic (1.20e-3)" 22.9 31.3 26.4 20.1 26.4 32.8 24.1 29.8 36.6 33.5 24.3 28.6 18.2 29.8 12.5 34.5 31.7 12.2 29.3 26.7 25.6 26.6 32.5 24.1 25.3 26.7 26.1 26.0 40.9 32.5 16.0 38.3 17.4 27.6 34.1 11.4 14.9 23.8 15.8 26.7 26.8 28.1 12.6 24.1 34.2 26.6 12.9 27.1 23.8 33.4 12.5 16.1 28.5 30.2 29.9 50.1 52.5 48.9 58.8 25.7 21.0 57.3 36.8 21.4 37.2 35.8 46.4 39.8 60.1 22.0 25.6 47.5 47.7 64.9 46.1 20.4 61.6 59.0 45.1 65.1 48.8 37.5 46.0 52.1 27.7 22.0 61.2 49.8 26.5 40.4 56.5 38.3 47.0 23.0 74.9 84.8 78.2 81.9 37.1 58.0 74.0 41.0 62.2 27.7 42.9 58.6 44.5 56.0 41.6 35.6 29.3 50.9 45.7 35.8 43.7 54.9 47.8 39.5 48.4 42.9 49.5 38.8 32.8 62.3 13.5 8.1 11.4 12.7 10.7 12.0 11.2 10.2 10.8 9.2 11.1 10.0 9.7 7.5 9.9 15.8 10.7 12.7 9.3 26.4 26.4 29.8 36.6 26.7 25.6 26.7 26.1 26.0 27.6 24.1 27.1 29.9 17.4 41.7 36.9 22.5 21.6 11.1 22.4 15.0 22.8 26.7 16.5 16.8 36.6 21.5 28.8 9.2 14.6 34.2 21.3 32.2 11.7 20.5 1.3 23.6 20.1 19.6 35.8 14.9 14.8 17.7 28.5 20.2 31.6 31.5 24.1 29.1 16.8 23.3 19.7 21.9 15.4 31.5 10.2 14.2 10.0 2.7 18.0 15.4 16.0 8.4 19.9 14.7 20.6 15.1 18.1 19.8 20.8 25.6 22.5 18.7 23.1 14.3 28.8 27.0 0.0 21.4 21.8 10.7 8.7 23.4 10.5 46.1 23.8 19.7 34.2 18.1 ADGRG3 "GPR97, Pb99, PGR26" ENSG00000182885 "Adhesion G protein-coupled receptor G3" Q86Y34 16 57668277-57689378 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 148.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.4;dendritic cells: 2.9;Endothelial cells: 2.8;Erythroid cells: 5.3;T-cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebral cortex: 9.3" "Immune cell enhanced" "Detected in some" "eosinophil: 142.3;neutrophil: 169.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 169.8" "Group enriched" "Detected in some" 6 "NB-4: 5.0;SK-MEL-30: 2.1;U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA040469 Uncertain NA NA 1200000 "HPA040469: AB_10794032" "unprognostic (4.41e-3)" "unprognostic (3.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" "unprognostic (8.84e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-4)" "unprognostic (5.25e-3)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.67e-3)" "unprognostic (4.75e-2)" "unprognostic (3.77e-1)" "unprognostic (1.00e-1)" "unprognostic (2.90e-1)" 8.6 0.3 0.2 14.7 0.2 148.4 1.7 0.2 9.3 1.0 0.8 1.6 2.2 1.0 0.0 1.0 4.3 2.3 1.1 0.1 0.1 0.8 2.3 12.1 0.3 0.3 0.3 0.1 0.4 0.7 0.0 0.2 1.7 2.1 0.6 1.4 0.0 0.4 0.1 0.3 0.7 3.4 2.6 0.1 29.7 1.3 0.3 0.4 0.6 3.2 2.8 0.4 3.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 75.5 0.0 142.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 36.4 0.1 0.0 0.0 0.9 0.2 0.2 0.2 9.3 0.1 0.1 0.3 0.3 0.1 2.1 0.1 0.4 0.3 1.0 9.6 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 1.8 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.6 0.5 0.2 2.8 0.0 5.3 0.1 0.0 0.1 0.9 0.0 0.4 2.5 0.2 2.2 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.2 1.5 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.1 4.2 0.0 0.0 0.1 GLUD2 GLUDP1 ENSG00000182890 "Glutamate dehydrogenase 2" P49448 X 121047610-121050094 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "liver: 4.0;testis: 15.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.6;Cytotrophoblasts: 4.6;Early spermatids: 2.6;Hepatocytes: 4.6;Proximal tubular cells: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;K-562: 4.3;OE19: 2.1;SK-MEL-30: 5.5;THP-1: 2.7;WM-115: 6.0" "HPA042492, HPA044839, HPA061369" Uncertain Approved Mitochondria NA NA Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.44e-1)" "unprognostic (5.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.42e-1)" "unprognostic (2.61e-1)" "unprognostic (2.35e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (4.77e-3)" "unprognostic (5.96e-2)" 1.5 1.7 0.1 0.1 0.3 0.0 1.3 0.0 0.6 0.4 0.4 0.5 0.0 0.4 1.7 0.5 0.4 0.4 0.8 0.4 0.7 1.6 4.0 0.6 0.1 0.1 0.0 0.4 0.4 1.0 0.5 0.4 0.8 0.1 0.4 0.0 0.1 0.6 0.2 0.5 0.5 0.4 0.1 0.0 0.1 0.6 15.5 0.1 0.0 0.4 0.1 0.1 0.4 0.4 0.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.8 0.0 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.1 1.2 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.4 0.7 0.1 0.0 0.4 0.1 0.0 0.1 0.2 1.8 0.0 0.0 2.3 0.1 0.0 0.5 0.0 0.6 0.0 0.4 0.1 2.6 0.0 0.0 0.0 2.1 4.6 0.1 0.1 1.9 0.2 2.6 0.6 0.8 0.9 0.0 0.0 1.2 0.4 0.5 0.8 0.0 0.5 0.0 0.1 0.0 4.6 0.5 0.0 0.4 0.1 0.0 1.2 0.3 2.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.2 3.3 0.0 0.1 0.0 0.9 0.4 1.2 1.0 0.1 0.1 2.5 0.3 0.7 0.2 0.3 TMEM95 "MGC129793, UNQ9390" ENSG00000182896 "Transmembrane protein 95" Q3KNT9 17 7355123-7357219 "Predicted intracellular proteins, Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 11.2" "Group enriched" "Detected in some" 30 "Early spermatids: 43.3;Late spermatids: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "unprognostic (5.15e-2)" "unprognostic (7.42e-2)" "unprognostic (7.44e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 36.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.5 1.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084141-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "SK-BR-3: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL35A "eL33, GIG33, L35A" ENSG00000182899 "Ribosomal protein L35a" P18077 3 197950190-197956610 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, tRNA-binding" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 11000 "unprognostic (9.48e-3)" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (5.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.89e-3)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.51e-1)" "unprognostic (3.41e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.37e-6)" "unprognostic (1.03e-2)" "unprognostic (4.65e-2)" "unprognostic (3.85e-2)" "unprognostic (7.72e-2)" 1067.4 926.6 551.1 553.3 556.3 1171.3 1219.6 554.0 882.6 1392.5 561.4 916.0 525.4 979.5 604.6 1079.9 1211.1 254.7 911.8 541.0 581.0 757.5 648.7 732.0 782.8 558.4 553.3 533.6 2414.5 1804.9 507.2 702.5 377.7 558.0 958.8 467.7 329.4 907.2 422.6 886.8 1246.7 837.5 382.4 573.3 934.5 1033.9 361.7 562.4 916.3 760.7 622.3 742.4 899.9 1157.8 571.2 2272.2 669.9 1091.7 982.0 737.1 1529.0 1215.9 1067.3 916.3 1121.8 841.4 2189.3 934.5 1922.7 3792.9 680.8 669.3 1163.5 924.8 990.5 1121.2 439.8 1629.0 1117.0 1082.0 1513.0 1173.4 1973.2 899.3 1383.4 1121.0 605.3 1672.3 1389.3 1085.5 810.5 1049.2 2182.5 1071.6 3132.8 1295.6 2533.4 1729.9 1681.6 1618.3 1221.8 942.7 2976.8 1286.5 1394.9 1052.5 969.8 676.7 2283.5 3031.5 1176.3 3953.6 3116.9 1031.2 652.8 872.6 979.3 2042.8 1709.4 2192.8 2579.9 934.9 3009.7 1045.6 461.7 737.7 233.9 705.6 543.2 1155.3 1223.1 1275.3 970.1 796.3 1105.2 1645.4 1249.0 118.2 741.6 513.4 929.9 878.3 2092.3 551.1 556.3 554.0 882.6 541.0 581.0 558.4 553.3 533.6 558.0 573.3 562.4 571.2 1882.9 1060.9 1722.6 24.5 4121.3 5337.3 4473.1 3629.9 3843.2 320.9 5257.9 6722.9 541.7 2116.1 2284.9 941.7 100.1 2684.9 2686.7 1217.3 3470.9 2107.4 1845.9 1520.8 2914.9 2334.0 1638.9 2465.7 23.1 4595.8 4411.0 2262.0 1398.1 1765.7 2045.0 2514.8 3040.2 1877.8 2449.5 156.5 25.7 3361.4 1184.0 3417.8 4894.1 1595.8 4527.5 2304.4 2968.6 28.1 3705.1 1155.2 2747.7 13.6 30.9 3218.5 2744.3 2315.1 2374.0 4080.9 2776.5 3992.3 1300.9 435.6 1610.6 4280.8 2712.8 850.7 723.4 3869.4 6022.9 2692.1 3610.9 2182.6 3544.4 4170.3 RGS7 ENSG00000182901 "Regulator of G protein signaling 7" P49802 1 240775514-241357230 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.0;brain: 24.7;retina: 13.0" "Cell type enhanced" "Detected in some" "Astrocytes: 288.3;Excitatory neurons: 1353.2;Inhibitory neurons: 1095.0;Oligodendrocyte precursor cells: 615.8" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 6.2;HaCaT: 5.3;hTERT-HME1: 7.2;RH-30: 6.4;SH-SY5Y: 5.6;U-2 OS: 5.9;U-251 MG: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017561 Enhanced Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017561: AB_2285043" "unprognostic (6.48e-2)" "unprognostic (4.30e-2)" "unprognostic (4.67e-2)" "unprognostic (6.65e-2)" "unprognostic (7.84e-3)" "unprognostic (4.09e-2)" "unprognostic (1.49e-2)" "unprognostic (3.61e-1)" "unprognostic (1.42e-2)" "unprognostic (2.51e-4)" "unprognostic (3.54e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (2.28e-1)" 0.0 8.0 10.7 0.0 15.3 0.0 0.1 21.5 24.7 0.1 0.4 0.1 0.2 0.2 0.0 0.1 0.0 0.4 0.0 16.3 11.5 2.4 0.4 0.1 0.3 5.3 8.2 13.3 0.5 0.5 0.2 2.9 0.0 10.6 0.1 0.1 13.0 0.0 0.5 0.0 0.1 0.1 0.0 4.4 0.2 2.9 5.3 8.0 0.0 0.0 0.0 0.2 0.0 0.0 16.4 0.9 0.0 0.0 0.0 0.2 0.7 0.0 2.5 4.8 6.2 0.4 0.0 0.0 0.0 0.3 3.3 3.4 5.3 0.0 0.0 3.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.5 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.3 0.3 0.2 0.0 6.4 0.0 0.0 0.0 5.3 5.6 0.3 0.2 0.2 0.2 0.0 0.0 2.6 0.0 5.9 0.3 7.2 0.0 4.1 0.0 0.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.7 15.3 21.5 24.7 16.3 11.5 5.3 8.2 13.3 10.6 4.4 8.0 16.4 0.0 0.0 0.0 288.3 2.8 0.0 0.1 0.0 0.0 29.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.1 2.3 0.0 3.5 0.2 7.2 0.0 1353.2 0.0 0.0 0.5 1.5 0.1 0.0 10.0 0.4 0.4 0.1 62.2 1095.0 0.4 0.0 0.0 0.3 4.1 0.0 0.1 0.0 29.0 0.0 1.0 0.0 615.8 86.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.7 6.3 10.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563450-17590995 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 142.2;choroid plexus: 84.7;liver: 112.4" "Group enriched" "Detected in many" 4 "Astrocytes: 195.2;Hepatocytes: 72.8" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;BEWO: 8.5" "Low region specificity" "Detected in all" HPA068110 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068110: " "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 14.5 1.0 123.3 0.3 120.0 0.1 7.2 111.4 142.2 2.3 84.7 2.4 0.3 2.9 0.2 0.3 3.8 0.9 2.2 116.2 113.3 1.9 112.4 1.2 0.3 121.4 121.9 104.2 1.2 1.1 0.2 1.6 0.1 124.3 7.8 0.1 1.9 0.5 0.4 6.3 0.9 1.9 0.6 98.6 4.9 1.5 4.2 132.2 0.3 0.6 4.0 0.1 0.8 1.4 104.6 0.3 0.6 2.2 0.4 3.8 0.0 8.5 0.3 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.0 2.5 0.7 0.0 0.0 0.0 0.3 1.0 0.3 0.3 0.5 1.5 0.3 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.3 0.0 0.4 0.1 0.5 2.0 0.9 1.4 2.9 0.8 0.0 0.1 0.4 0.8 0.3 0.2 0.4 0.7 1.6 2.5 1.0 0.1 0.1 0.3 0.2 0.3 0.9 1.2 0.0 1.8 0.2 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.3 120.0 111.4 142.2 116.2 113.3 121.4 121.9 104.2 124.3 98.6 132.2 104.6 1.0 28.9 10.3 195.2 0.3 0.0 0.3 0.1 0.6 0.6 0.3 0.0 1.5 5.7 7.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.6 0.4 0.9 1.7 0.0 10.7 2.0 0.0 0.3 4.7 0.0 0.7 6.3 8.5 3.6 72.8 0.3 0.0 3.0 0.3 0.0 4.1 0.3 0.6 0.9 3.9 0.0 10.3 0.1 2.2 1.0 13.0 11.5 0.0 0.0 2.6 0.1 4.3 0.1 0.8 15.8 3.4 0.0 2.7 2.5 4.8 5.9 0.0 0.1 1.8 2.6 2.6 0.0 0.2 ZNF721 KIAA1982 ENSG00000182903 "Zinc finger protein 721" Q8TF20 4 425815-499156 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065313 Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA065313: AB_2685464" "unprognostic (2.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "unprognostic (7.66e-2)" "unprognostic (1.51e-2)" "unprognostic (3.26e-2)" "unprognostic (3.48e-2)" "unprognostic (1.96e-2)" "unprognostic (3.43e-2)" "unprognostic (1.25e-1)" "unprognostic (5.12e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-3)" "prognostic favorable (2.76e-4)" 12.3 11.0 8.7 14.5 9.2 18.1 19.0 19.6 13.0 12.2 4.9 11.0 10.5 13.1 14.3 10.5 14.9 10.1 8.2 10.2 6.4 11.9 12.9 12.7 22.8 7.1 6.0 7.7 15.5 15.2 15.6 11.2 10.0 9.3 11.6 12.1 20.0 11.2 10.1 10.6 18.6 11.4 10.4 4.6 15.0 13.0 14.3 6.9 19.2 16.9 16.2 22.2 10.9 12.0 12.9 17.2 10.4 20.2 25.0 14.5 19.9 12.7 15.2 13.1 16.4 14.5 15.4 17.1 28.8 16.3 14.9 23.6 11.3 20.9 19.0 22.0 10.4 24.4 51.0 10.7 10.4 14.2 21.5 2.4 17.5 16.3 18.0 27.3 25.6 17.1 40.4 29.9 19.7 23.0 16.4 35.3 32.4 32.1 11.3 22.1 28.6 30.1 16.4 17.9 22.8 29.6 18.9 20.2 11.6 19.3 17.3 21.2 22.4 22.0 14.5 5.3 11.5 27.3 22.7 22.2 68.7 11.1 5.2 13.9 8.0 8.3 12.9 12.1 8.7 12.2 16.6 13.3 12.0 8.4 15.9 20.8 16.5 11.4 13.5 8.2 10.3 16.7 7.3 8.7 9.2 19.6 13.0 10.2 6.4 7.1 6.0 7.7 9.3 4.6 6.9 12.9 44.4 25.6 31.9 29.7 44.9 21.0 26.4 18.6 25.6 38.0 25.0 27.3 16.7 25.8 24.8 18.4 31.3 16.9 33.0 10.9 15.6 12.9 34.5 29.6 31.9 30.7 12.7 33.2 37.6 14.9 10.6 26.0 29.0 29.0 26.0 32.0 28.5 17.6 10.9 23.5 30.1 16.4 4.1 18.8 19.1 12.3 19.6 18.8 12.4 11.2 14.8 24.7 46.4 24.6 32.7 13.8 11.3 12.0 23.4 27.8 12.4 14.5 24.9 35.1 19.7 30.5 20.1 35.2 34.3 23.1 23.2 17.4 40.9 29.5 15.8 31.0 TCEAL7 "MGC23947, WEX5" ENSG00000182916 "Transcription elongation factor A like 7" Q9BRU2 X 103330229-103332326 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 117.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 42.9;Fibroblasts: 55.2;Horizontal cells: 48.8;Leydig cells: 43.8;Muller glia cells: 88.3;Oligodendrocytes: 46.5;Peritubular cells: 39.1;Skeletal myocytes: 48.3;Smooth muscle cells: 38.7" "Cancer enriched" "Detected in many" 10 "glioma: 39.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 83.8;BJ hTERT+ SV40 Large T+ RasG12V: 75.1;GAMG: 115.3;hTEC/SVTERT24-B: 83.8;LHCN-M2: 72.0;SCLC-21H: 210.1;U-87 MG: 78.9" "Low region specificity" "Detected in many" "HPA051507, HPA065080" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051507: AB_2681512, HPA065080: AB_2685419" "unprognostic (1.09e-2)" "unprognostic (4.36e-2)" "unprognostic (5.54e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (4.52e-2)" "unprognostic (2.17e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (1.12e-1)" "unprognostic (4.18e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.62e-1)" "unprognostic (2.28e-2)" "unprognostic (1.35e-3)" 6.1 28.2 83.7 4.3 86.8 0.0 9.2 87.0 117.4 26.0 57.4 14.8 4.0 48.7 18.4 5.6 17.1 12.0 12.7 85.5 100.8 5.1 2.5 6.2 2.3 96.7 94.0 83.8 29.3 1.2 1.1 37.6 2.1 98.6 12.4 7.8 23.7 3.6 13.4 3.7 1.7 8.4 30.2 93.0 5.9 6.6 3.1 93.7 5.1 3.9 10.0 1.4 9.8 15.8 112.3 0.0 0.0 83.8 0.0 36.3 55.5 15.0 12.0 61.9 26.4 75.1 0.0 0.0 0.0 0.0 12.9 115.3 0.0 0.0 1.8 45.5 0.0 0.8 0.3 0.0 0.0 18.2 0.0 0.1 46.6 0.0 83.8 0.1 0.0 27.6 0.0 0.5 0.2 72.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 53.1 0.3 0.0 0.0 210.1 56.6 0.0 0.4 0.0 0.4 0.0 0.0 0.0 38.8 1.4 0.6 0.0 0.0 0.0 0.0 78.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.7 86.8 87.0 117.4 85.5 100.8 96.7 94.0 83.8 98.6 93.0 93.7 112.3 4.8 0.0 1.3 5.9 0.0 2.5 5.3 0.3 1.2 36.4 0.9 19.2 13.6 0.0 0.7 3.7 4.2 1.4 0.1 0.0 5.9 0.2 0.2 1.0 42.9 5.2 0.0 0.0 21.2 0.0 0.7 55.2 0.0 0.7 0.0 19.2 1.8 0.0 0.7 48.8 26.5 0.0 0.0 0.0 4.0 1.8 43.8 0.6 8.8 4.7 0.0 88.3 0.0 19.6 46.5 0.3 0.0 39.1 0.1 1.1 0.0 2.1 0.0 12.9 13.1 48.3 38.7 3.0 1.5 0.8 3.1 0.3 0.5 5.1 0.0 0.8 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "kidney: 575.1;liver: 260.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 370.4;Proximal tubular cells: 1136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA 1300000 "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favorable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 20.3 24.8 10.2 19.3 16.3 7.5 31.7 15.2 14.9 20.9 16.5 41.2 53.5 21.9 19.7 17.8 32.6 47.6 21.7 9.6 13.8 575.1 260.9 30.5 21.6 16.7 16.1 9.7 30.3 52.0 21.1 16.8 25.5 15.7 40.0 44.3 20.8 29.2 25.2 42.2 21.4 51.9 21.0 13.1 17.4 38.3 20.0 12.8 28.4 36.3 55.2 23.6 17.1 13.0 25.2 9.4 13.5 30.9 18.3 23.5 26.8 36.1 13.8 23.6 13.8 19.0 5.6 52.9 39.4 85.5 25.6 14.4 22.2 37.5 10.0 19.4 39.9 11.4 21.7 34.9 26.5 27.7 20.7 11.0 24.7 17.0 24.7 16.6 34.8 21.6 26.2 29.6 26.6 12.8 8.0 33.0 23.7 10.5 64.9 22.1 31.4 40.8 62.2 74.6 19.6 15.2 20.2 23.0 28.2 27.7 22.7 65.9 13.4 13.5 13.0 10.0 22.5 6.6 12.0 38.2 37.8 9.8 29.2 23.3 75.0 30.0 74.0 21.7 21.5 22.3 27.1 22.1 24.7 23.0 23.0 27.0 23.7 100.9 24.8 19.0 31.9 31.5 18.8 10.2 16.3 15.2 14.9 9.6 13.8 16.7 16.1 9.7 15.7 13.1 12.8 25.2 25.1 64.1 54.7 28.1 27.4 5.5 10.6 18.4 21.1 18.0 21.6 14.6 34.7 190.1 33.5 47.8 16.7 51.4 21.6 53.6 178.1 17.4 14.4 34.2 20.5 18.3 22.2 23.1 23.7 13.9 14.8 23.9 32.6 43.6 15.2 40.2 29.6 370.4 17.5 15.2 27.8 37.1 28.5 29.2 7.2 6.4 25.7 22.2 8.8 15.9 18.2 17.0 10.3 25.6 37.8 13.1 38.4 23.0 25.7 29.0 75.0 1136.3 36.2 19.7 6.6 28.9 17.0 38.6 17.4 17.6 9.9 62.0 21.1 16.3 35.6 22.9 CEP63 FLJ13386 ENSG00000182923 "Centrosomal protein 63" Q96MT8 3 134485721-134575017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 179.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 179.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058154, HPA058313" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA058154: AB_2683624, HPA058313: " "unprognostic (1.80e-1)" "unprognostic (1.03e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-2)" "unprognostic (2.23e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (3.08e-2)" "unprognostic (5.24e-2)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 24.1 15.3 8.1 14.1 9.3 30.4 16.3 10.5 13.8 13.2 7.3 14.9 10.1 13.1 17.0 12.5 12.3 11.4 25.4 8.3 8.5 15.2 22.1 11.9 18.7 10.0 10.6 6.5 16.3 17.2 19.0 12.8 14.5 11.0 14.6 14.4 22.2 16.1 16.1 41.9 14.8 11.3 16.5 8.4 16.3 14.9 45.6 9.5 27.8 19.1 29.3 17.6 15.8 12.6 12.3 32.9 12.6 26.2 17.5 36.9 30.7 24.6 35.1 29.1 26.7 21.9 11.8 13.7 36.5 21.0 24.4 26.0 18.6 14.5 18.0 32.3 41.7 7.4 47.9 15.0 16.1 25.3 30.5 22.0 26.4 23.3 14.8 47.1 28.8 27.9 48.2 14.7 31.3 32.4 20.1 37.7 34.5 18.4 20.1 16.9 23.5 38.7 52.8 23.7 20.3 14.8 14.6 31.2 12.1 47.3 30.2 24.7 38.1 30.1 30.1 18.4 30.3 26.9 27.1 21.9 46.7 33.4 30.8 39.2 72.7 20.1 34.3 12.7 20.6 16.9 15.9 12.2 16.5 24.6 22.2 17.2 13.1 179.4 20.3 29.5 16.3 16.8 12.7 8.1 9.3 10.5 13.8 8.3 8.5 10.0 10.6 6.5 11.0 8.4 9.5 12.3 19.9 19.2 27.6 39.2 25.5 10.7 14.6 22.6 13.6 31.6 16.8 22.5 84.7 22.8 23.1 7.3 20.9 25.3 16.5 11.8 31.3 25.8 93.2 21.8 23.6 21.0 13.1 26.5 63.5 20.0 26.0 25.8 14.8 17.9 52.6 25.2 14.6 17.3 29.4 32.0 58.3 16.0 16.2 27.7 12.8 54.9 23.9 25.1 17.8 28.1 30.2 26.3 19.6 71.4 67.8 21.0 16.2 25.9 27.3 19.2 12.5 29.6 31.1 43.8 19.7 31.7 25.1 139.1 51.7 17.3 9.8 17.4 20.6 18.8 16.2 16.2 WFDC10B WAP12 ENSG00000182931 "WAP four-disulfide core domain 10B" Q8IUB3 20 45684653-45705019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 27.6;retina: 11.8" "Cell type enhanced" "Detected in some" "Astrocytes: 3.6;Early spermatids: 5.5;Late spermatids: 10.1;Microglial cells: 3.7;Rod photoreceptor cells: 9.6;Spermatocytes: 4.8" "Cancer enhanced" "Detected in some" "lung cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.9" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (2.31e-1)" "unprognostic (1.37e-4)" "unprognostic (1.60e-1)" "unprognostic (2.69e-1)" "unprognostic (4.81e-2)" "unprognostic (4.30e-3)" "unprognostic (5.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.36e-1)" "unprognostic (0.00e+0)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" "unprognostic (2.21e-2)" "unprognostic (3.17e-1)" 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.3 0.6 0.3 0.2 0.5 0.0 0.3 27.6 0.1 0.4 0.2 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.5 0.5 0.2 0.1 0.0 0.0 0.1 0.4 0.3 0.7 0.5 11.8 0.0 0.2 0.0 1.1 0.2 0.4 0.5 0.0 0.3 4.4 0.2 0.2 0.0 0.0 0.0 5.9 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.6 1.9 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.6 0.2 0.2 0.5 0.5 0.2 0.3 0.5 0.2 0.4 0.0 0.0 0.5 3.6 0.0 0.0 0.1 0.4 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.3 0.0 0.1 0.0 0.0 1.3 0.4 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.4 2.0 0.0 0.0 10.1 0.0 0.0 0.0 3.7 0.0 0.9 0.0 1.5 0.9 1.2 0.1 0.0 0.0 0.4 0.3 0.0 0.0 9.6 0.0 0.0 0.1 4.8 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.7 SRPRA "SR-alpha, Sralpha, SRP-alpha, SRPR" ENSG00000182934 "SRP receptor subunit alpha" P08240 11 126262938-126269144 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 19000 "unprognostic (1.23e-3)" "unprognostic (6.87e-2)" "unprognostic (6.11e-2)" "prognostic favorable (8.56e-4)" "unprognostic (1.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-1)" "unprognostic (4.78e-1)" "unprognostic (3.96e-2)" "unprognostic (2.22e-2)" "unprognostic (2.73e-1)" "unprognostic (3.72e-1)" "unprognostic (1.33e-2)" "unprognostic (4.38e-2)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" 64.5 79.5 25.6 72.0 26.1 83.3 58.5 27.1 32.4 86.3 47.5 55.2 53.6 65.3 145.4 56.2 57.9 65.3 63.5 26.7 33.3 54.6 165.3 66.1 68.0 28.2 27.1 24.9 56.3 256.9 72.1 89.6 50.4 28.9 82.5 62.5 36.6 238.8 88.5 91.9 53.7 52.7 69.4 25.8 67.2 97.1 33.0 29.2 62.4 91.0 69.9 87.2 82.8 49.0 33.0 65.5 63.5 59.5 90.9 160.1 124.0 79.5 183.8 168.5 87.4 102.9 117.5 163.4 122.2 186.4 182.3 109.2 126.4 91.1 105.8 87.2 134.9 71.9 223.8 49.1 117.9 223.7 198.7 139.9 106.4 132.5 134.6 245.0 105.5 120.9 47.7 76.2 284.3 124.1 87.6 95.9 78.5 39.7 193.1 135.5 62.8 82.3 128.4 86.8 132.2 85.5 80.3 125.6 150.9 95.7 48.0 198.7 117.5 115.5 153.2 68.2 88.0 132.8 123.3 85.0 73.9 85.3 177.5 202.5 72.1 61.8 95.9 91.3 67.4 79.7 48.7 62.6 74.0 59.4 41.1 56.3 65.2 64.3 62.3 82.8 78.1 53.5 94.7 25.6 26.1 27.1 32.4 26.7 33.3 28.2 27.1 24.9 28.9 25.8 29.2 33.0 52.9 44.8 69.3 0.0 69.1 0.0 53.5 0.0 44.9 30.4 37.6 24.9 0.0 32.9 46.4 22.0 8.4 38.0 81.7 12.1 1.9 64.3 9.8 33.5 53.2 36.5 12.2 24.6 0.0 90.9 42.4 42.9 35.2 67.9 49.2 25.9 32.9 77.9 25.7 60.6 0.0 14.2 0.0 27.0 0.0 8.4 36.4 43.4 0.0 0.0 56.6 28.0 52.5 0.0 0.0 67.6 9.5 46.6 232.5 60.6 25.1 19.2 21.1 28.8 46.0 42.3 30.7 18.5 34.3 36.3 0.0 81.0 64.3 38.4 9.5 66.3 OTOP3 ENSG00000182938 "Otopetrin 3" 17 74935898-74949992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "intestine: 80.3" "Group enriched" "Detected in some" 5 "Paneth cells: 58.8;Proximal enterocytes: 19.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.28e-3)" "prognostic favorable (3.86e-4)" "unprognostic (2.77e-1)" "unprognostic (8.60e-2)" "unprognostic (3.42e-1)" "unprognostic (1.03e-1)" "unprognostic (8.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 80.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 14.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 58.8 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.2 0.1 EWSR1 EWS ENSG00000182944 "EWS RNA binding protein 1" Q01844 22 29268009-29300525 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Calmodulin-binding, Repressor, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004230, HPA051771, HPA062953" Enhanced Enhanced "Nucleoplasm,Nucleoli rim" No No 59000 Nucleoplasm "Nucleoli rim" "CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910" "unprognostic (1.96e-1)" "unprognostic (6.39e-3)" "unprognostic (1.32e-1)" "unprognostic (3.93e-2)" "unprognostic (3.59e-1)" "unprognostic (3.15e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (1.33e-1)" "unprognostic (1.09e-2)" "unprognostic (2.71e-2)" "unprognostic (7.04e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (1.21e-5)" "unprognostic (7.33e-3)" "unprognostic (1.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.50e-3)" 84.1 103.0 61.4 94.1 63.9 173.8 81.0 67.7 69.7 84.8 58.1 89.0 88.8 106.0 62.4 99.7 86.8 56.6 100.0 62.1 73.4 79.8 85.7 77.5 121.1 65.1 62.9 53.6 87.6 79.7 98.8 64.6 70.8 63.3 79.1 85.2 112.1 77.1 78.0 141.1 87.8 93.3 87.6 55.9 101.8 85.0 136.6 61.0 184.7 77.9 80.7 127.8 88.9 86.9 78.4 307.7 239.7 327.6 249.1 166.0 136.0 218.2 188.1 301.3 309.9 264.5 270.3 154.5 428.0 114.1 294.3 234.9 238.9 471.5 392.6 313.7 287.5 341.6 323.9 218.8 262.7 246.5 499.5 219.3 211.1 162.5 259.1 413.0 152.2 244.2 201.1 248.3 186.0 233.8 310.6 505.9 185.8 221.1 261.4 182.8 348.1 317.2 253.3 288.0 328.2 261.4 247.7 236.3 258.5 195.9 216.2 170.9 261.0 246.3 184.4 198.2 115.1 272.3 236.2 205.5 387.4 169.9 220.6 224.4 203.9 201.1 182.6 195.2 283.5 199.5 169.4 181.3 194.4 227.5 191.3 175.8 170.9 148.1 216.9 293.0 122.0 244.0 314.2 61.4 63.9 67.7 69.7 62.1 73.4 65.1 62.9 53.6 63.3 55.9 61.0 78.4 77.5 102.5 106.8 68.6 130.8 69.5 145.2 153.2 108.1 72.4 63.8 46.6 68.0 87.2 127.2 64.4 75.0 141.0 91.3 92.4 66.5 121.7 165.4 96.3 88.1 88.3 80.9 102.0 55.8 107.6 133.5 85.4 117.2 115.2 121.0 88.5 71.7 71.7 99.3 82.4 60.8 110.9 136.3 69.7 94.0 32.7 61.5 91.9 81.8 47.8 110.9 72.8 122.6 49.8 67.6 116.5 106.4 62.1 156.6 97.4 79.4 72.6 128.9 84.9 52.6 93.1 141.4 209.6 107.5 105.5 58.5 152.4 121.4 84.9 110.2 115.1 ODF3L1 MGC48986 ENSG00000182950 "Outer dense fiber of sperm tails 3 like 1" Q8IXM7 15 75724041-75727688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 22.8" "Cell type enriched" "Detected in some" 9 "Early spermatids: 111.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;HeLa: 1.2;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.24e-2)" "unprognostic (1.97e-2)" "unprognostic (4.58e-2)" "unprognostic (8.42e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (7.55e-4)" "unprognostic (9.65e-2)" "unprognostic (9.96e-3)" "unprognostic (6.40e-2)" "unprognostic (4.14e-2)" "unprognostic (8.94e-3)" "unprognostic (1.45e-2)" 1.4 0.1 0.6 0.3 0.3 0.3 1.1 1.4 0.5 0.6 0.4 1.1 0.5 1.2 0.1 1.2 1.0 2.6 0.7 0.5 0.4 0.2 1.2 1.6 0.1 0.2 0.3 0.2 0.2 0.4 0.1 1.1 0.2 0.6 0.4 0.4 0.0 0.1 0.1 0.1 1.5 0.9 0.9 0.0 0.3 1.7 22.8 0.2 0.6 1.4 0.0 0.1 0.9 0.2 0.7 0.0 1.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.7 0.4 0.0 1.2 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.4 0.5 0.5 0.4 0.2 0.3 0.2 0.6 0.0 0.2 0.7 0.1 0.0 1.1 0.0 0.4 6.1 9.7 0.9 0.0 0.0 0.6 0.3 0.0 0.0 2.5 0.0 0.0 1.6 0.1 0.7 0.0 0.3 111.2 2.7 0.5 0.3 0.0 0.0 0.1 0.0 0.9 2.1 1.5 1.8 0.0 0.2 1.1 0.3 0.4 0.0 0.0 1.2 0.0 0.0 2.7 11.9 0.0 1.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.7 0.8 0.9 1.6 0.7 0.3 0.0 6.6 2.7 1.0 8.0 0.4 0.0 6.5 1.9 0.4 0.1 0.5 4.1 HMGN4 "HMG17L3, NHC" ENSG00000182952 "High mobility group nucleosomal binding domain 4" O00479 6 26538366-26546933 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 39.3;Basal squamous epithelial cells: 38.7;Plasma cells: 51.5;Squamous epithelial cells: 34.8;T-cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077364 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA077364: AB_2686835" "unprognostic (1.91e-1)" "unprognostic (2.48e-2)" "unprognostic (5.88e-2)" "unprognostic (8.81e-2)" "unprognostic (4.10e-2)" "unprognostic (6.02e-2)" "unprognostic (4.00e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (3.22e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (9.01e-2)" "unprognostic (6.07e-3)" 39.3 34.8 23.4 49.7 23.3 33.2 54.8 23.4 26.8 45.8 31.0 51.7 41.1 57.2 50.6 35.6 46.4 38.7 38.4 23.1 27.2 49.0 20.1 46.4 69.2 24.4 24.4 22.4 50.5 26.5 58.9 22.5 41.5 23.7 47.4 56.3 18.8 33.5 57.2 38.9 31.0 49.3 67.4 24.5 52.8 33.1 31.6 24.8 71.2 57.5 32.9 72.2 55.8 36.1 26.2 81.3 29.7 60.2 79.3 78.6 118.0 37.4 67.0 116.1 99.2 138.0 30.6 50.5 94.4 104.0 95.1 101.0 37.4 100.2 85.0 109.3 118.9 94.1 96.7 42.3 58.9 86.9 85.2 98.9 87.6 114.0 80.0 132.7 93.0 95.5 121.2 92.8 152.8 91.5 40.7 151.0 114.9 36.2 68.0 51.9 53.8 66.6 168.8 77.9 54.6 95.0 85.4 55.4 45.0 138.6 71.0 50.1 45.6 71.2 68.5 52.1 63.5 61.7 100.4 276.9 79.3 33.1 190.1 91.1 182.8 42.1 81.9 81.8 41.5 80.5 71.7 85.2 85.8 57.2 61.2 71.0 70.2 62.5 75.7 53.9 47.9 93.6 92.5 23.4 23.3 23.4 26.8 23.1 27.2 24.4 24.4 22.4 23.7 24.5 24.8 26.2 4.2 3.2 5.8 6.8 39.3 7.5 4.0 3.1 38.7 0.5 5.6 3.0 2.1 7.2 7.5 1.8 0.0 3.5 13.9 2.9 5.9 2.2 0.4 3.9 10.0 4.8 0.0 16.8 16.1 1.4 10.1 11.8 13.3 5.7 8.8 1.8 3.3 0.7 4.0 0.0 13.9 2.3 2.0 5.1 11.1 0.4 1.5 16.3 8.8 6.5 7.5 2.6 8.2 17.1 13.5 2.6 1.9 2.6 51.5 3.7 4.3 7.8 1.1 0.8 0.0 4.4 8.3 0.6 1.2 34.8 5.1 8.1 32.5 2.5 1.9 2.1 SPATA13 "ARHGEF29, FLJ31208" ENSG00000182957 "Spermatogenesis associated 13" Q96N96 13 23979805-24307074 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 65.8" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 102.6;Oligodendrocytes: 206.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.4;HDLM-2: 46.4" "HPA040185, HPA041208" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040185: AB_10795521, HPA041208: AB_10794193" "unprognostic (8.80e-2)" "unprognostic (9.32e-3)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-3)" "unprognostic (6.23e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (2.00e-2)" "unprognostic (2.76e-3)" "unprognostic (9.15e-3)" "unprognostic (1.78e-1)" "unprognostic (4.21e-1)" "prognostic favorable (1.16e-4)" 7.0 14.5 19.5 18.9 30.7 31.5 14.6 25.6 24.5 10.7 30.2 11.1 12.0 9.5 14.4 3.7 10.0 12.3 8.2 19.1 28.7 17.5 24.6 20.5 23.6 40.8 30.3 13.2 14.5 38.7 6.5 9.7 10.7 33.8 14.7 12.5 4.8 8.3 6.6 2.6 7.3 13.4 7.5 26.7 65.8 18.1 6.5 28.8 18.8 13.0 6.5 16.7 9.7 5.3 39.7 3.1 5.0 25.6 3.2 0.9 2.1 1.0 7.7 33.4 3.9 3.3 6.5 13.2 20.4 4.1 7.0 2.0 5.7 7.4 2.3 9.7 46.4 8.9 4.9 4.6 7.5 1.2 7.9 3.7 2.8 0.3 4.2 2.4 3.4 6.5 10.7 0.0 16.7 4.1 11.2 14.6 2.7 8.4 21.5 6.4 12.5 9.9 11.0 17.3 9.9 9.3 7.1 1.5 16.3 15.0 5.5 2.3 4.5 7.6 5.1 4.0 0.4 5.5 3.8 0.1 0.0 4.4 7.5 24.4 5.0 6.4 0.0 33.6 8.4 26.2 2.6 28.6 35.3 4.7 2.0 30.1 31.3 39.2 20.4 10.6 5.2 29.8 13.3 19.5 30.7 25.6 24.5 19.1 28.7 40.8 30.3 13.2 33.8 26.7 28.8 39.7 9.0 3.2 23.9 61.0 8.6 5.4 3.2 2.5 4.6 3.2 39.5 17.9 5.3 0.0 17.8 14.7 0.0 1.3 18.6 27.4 3.9 25.3 10.8 58.3 12.9 29.0 32.3 6.3 9.2 15.8 14.1 12.5 51.0 102.6 70.2 4.9 0.0 0.0 10.1 0.0 11.1 24.9 4.1 0.0 8.5 6.3 7.5 29.8 5.4 62.8 15.2 14.1 66.9 19.6 206.5 13.5 32.0 7.5 2.8 23.8 25.0 7.2 40.5 0.8 0.0 21.9 8.2 2.2 2.2 4.6 6.1 22.3 37.8 34.5 23.7 17.0 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.3;smooth muscle: 32.9" "Group enriched" "Detected in many" 4 "Sertoli cells: 157.8;Smooth muscle cells: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 9.6 0.7 3.0 3.6 3.3 0.8 5.3 9.2 3.8 9.1 4.8 21.0 1.6 24.9 2.9 2.8 5.3 5.4 11.0 2.4 1.6 1.4 0.7 7.3 2.8 2.2 3.2 1.0 2.3 1.4 3.4 0.6 40.3 3.8 9.0 2.9 1.0 1.2 18.8 4.6 1.8 5.3 32.9 1.1 0.7 7.6 8.9 4.1 1.7 6.8 6.0 2.0 11.5 6.2 2.7 44.5 21.9 62.0 18.9 8.3 10.6 20.5 50.3 36.6 50.0 52.6 12.4 24.7 0.5 2.3 46.4 69.9 10.1 29.2 13.7 70.8 0.5 19.8 0.4 12.1 1.6 3.8 0.3 1.7 8.8 1.6 37.0 11.8 20.4 17.1 9.6 1.8 0.5 31.4 0.4 6.7 4.3 29.5 0.1 16.2 39.5 73.8 0.3 11.4 16.8 10.2 21.5 4.6 0.5 16.2 41.3 10.9 8.0 12.3 43.8 39.3 22.2 38.9 0.4 11.3 32.5 15.9 0.3 40.7 2.0 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.2 0.2 0.2 1.0 0.5 0.1 0.2 0.1 0.1 3.0 3.3 9.2 3.8 2.4 1.6 2.2 3.2 1.0 3.8 1.1 4.1 2.7 11.7 0.0 0.0 0.7 0.2 2.0 1.7 0.5 0.0 3.4 0.6 1.4 25.1 0.0 0.2 1.8 2.1 0.5 0.4 0.1 0.0 1.5 1.5 1.4 14.9 19.5 0.0 0.0 8.1 0.0 2.6 6.3 0.0 3.0 0.0 9.4 4.2 0.3 1.5 13.5 1.4 0.0 0.0 0.3 4.2 0.3 1.5 1.2 3.6 1.0 0.6 0.2 0.0 0.0 0.3 0.6 0.0 2.2 0.0 1.4 0.0 0.3 0.2 0.9 157.8 4.8 101.1 15.6 28.4 0.6 3.0 0.5 0.8 7.8 0.1 1.3 SOX1 ENSG00000182968 "SRY-box transcription factor 1" O00570 13 112067149-112071706 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "brain: 9.4" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 4.0;Melanocytes: 3.6;Spermatogonia: 2.4" "Group enriched" "Detected in some" 6 "colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 29.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (1.71e-3)" "unprognostic (6.03e-2)" "unprognostic (6.41e-2)" "unprognostic (4.85e-1)" "unprognostic (5.93e-2)" 0.0 0.0 2.8 0.0 3.9 0.0 0.0 1.5 2.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 5.2 0.0 0.0 0.0 0.0 1.9 1.9 1.8 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.8 9.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.9 1.5 2.7 1.7 5.2 1.9 1.9 1.8 1.7 1.1 9.4 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 181.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: AB_2677487" "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 8.5 7.8 6.0 11.5 6.6 17.6 12.7 7.9 7.2 11.0 7.1 11.7 9.9 10.8 11.6 9.9 14.2 8.7 7.8 5.9 6.7 10.7 12.6 9.9 14.7 6.3 6.2 5.5 12.4 9.5 13.1 10.4 8.6 6.3 9.1 14.0 6.5 8.6 7.6 9.6 13.4 10.7 10.2 5.9 14.7 9.2 40.2 6.4 19.9 12.4 5.9 16.6 9.9 8.8 7.7 24.4 26.7 27.2 25.9 12.9 14.8 181.2 20.1 20.0 28.0 31.3 20.5 20.5 39.6 13.0 14.4 18.1 20.9 32.5 26.5 27.8 34.5 33.3 51.0 23.2 20.0 37.6 42.3 18.9 10.9 23.3 30.9 40.4 18.7 23.2 36.4 54.1 30.1 16.6 20.1 38.0 20.4 41.2 28.0 25.3 37.9 18.5 39.8 18.0 28.1 15.5 29.9 29.5 41.1 24.4 19.3 40.0 47.4 14.3 17.3 24.6 23.0 33.7 30.8 67.8 39.6 17.7 31.7 21.4 18.5 12.0 17.7 11.4 17.1 12.4 15.3 18.6 13.7 15.1 17.4 18.1 16.0 9.6 10.2 25.2 8.4 16.0 12.3 6.0 6.6 7.9 7.2 5.9 6.7 6.3 6.2 5.5 6.3 5.9 6.4 7.7 11.6 16.0 22.8 28.4 19.6 10.5 7.2 13.0 9.1 16.8 9.4 9.0 13.2 14.3 15.3 14.7 33.3 14.8 21.0 15.3 5.9 12.9 60.3 23.4 12.9 14.1 15.6 21.2 37.7 13.5 17.1 12.0 15.3 14.1 10.8 17.2 12.8 9.8 11.9 15.2 36.5 10.6 10.2 18.8 14.3 34.3 9.6 14.5 12.4 20.6 37.2 7.4 10.3 29.1 35.3 11.7 16.4 10.5 17.5 6.6 15.2 7.0 29.9 20.9 6.6 14.9 12.5 63.0 33.1 10.2 14.5 8.2 20.1 17.8 14.4 7.3 OR4M2B ENSG00000182974 "Olfactory receptor family 4 subfamily M member 2B" 15 21637909-21638992 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTA1 ENSG00000182979 "Metastasis associated 1" Q13330 14 105419820-105470729 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004508, HPA005544" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004508: AB_627969, HPA005544: AB_1079420" "unprognostic (6.79e-3)" "unprognostic (4.22e-2)" "unprognostic (1.06e-1)" "unprognostic (6.36e-2)" "unprognostic (2.91e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.59e-2)" "unprognostic (1.47e-1)" "unprognostic (6.72e-3)" "prognostic favorable (9.48e-5)" "unprognostic (4.57e-3)" "unprognostic (1.39e-2)" "unprognostic (2.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-1)" 23.0 24.0 22.0 10.9 20.7 15.5 24.8 22.0 31.3 30.1 16.5 27.1 13.2 30.1 11.7 22.8 32.1 6.2 36.7 22.0 17.8 21.2 24.3 19.8 12.2 22.5 19.3 20.0 38.9 30.4 9.4 37.2 9.3 19.5 32.1 5.7 8.4 23.8 12.8 25.8 19.8 22.3 9.0 17.3 26.9 22.7 37.9 19.3 16.6 30.6 7.8 9.2 29.4 24.6 20.2 33.6 26.3 47.9 48.2 18.0 30.5 42.3 26.2 19.9 25.4 24.3 34.4 44.1 65.4 26.7 19.3 17.9 45.3 35.1 25.0 17.1 43.2 59.0 34.1 25.2 35.5 39.6 43.2 25.3 34.4 30.9 18.0 41.1 35.5 36.4 48.0 39.3 27.7 13.4 60.4 78.3 85.2 69.1 47.7 55.1 73.1 29.1 21.5 20.6 26.0 76.9 80.1 35.5 40.5 40.8 24.3 36.7 40.7 26.6 20.4 21.6 34.1 27.8 55.9 28.9 41.3 25.6 28.7 36.6 0.1 0.2 0.8 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.3 0.4 0.0 0.4 0.1 0.9 0.2 0.2 22.0 20.7 22.0 31.3 22.0 17.8 22.5 19.3 20.0 19.5 17.3 19.3 20.2 32.1 3.2 16.0 37.9 20.9 15.6 28.8 14.6 13.1 0.0 64.8 38.6 9.2 27.1 15.2 35.0 0.0 11.6 17.7 17.2 17.6 13.2 32.8 25.0 28.4 20.4 18.6 25.4 17.2 19.6 8.0 21.8 28.1 23.9 5.7 47.6 18.2 15.5 11.0 0.0 16.1 21.6 10.2 18.5 13.5 11.3 36.1 15.7 12.4 21.5 13.8 0.0 20.6 32.6 27.0 16.3 11.5 32.0 17.8 45.4 18.5 8.8 27.0 0.0 19.7 30.5 25.4 21.5 13.3 16.8 19.0 9.3 18.7 27.1 24.9 46.2 ZNF662 FLJ45880 ENSG00000182983 "Zinc finger protein 662" Q6ZS27 3 42906142-42919334 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.4;SH-SY5Y: 3.2;THP-1: 3.3;U-2 OS: 4.6" "Low region specificity" "Detected in all" "HPA039116, HPA040377" Uncertain NA NA "HPA039116: AB_2676355, HPA040377: AB_2676949" "unprognostic (2.37e-2)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.14e-1)" "unprognostic (2.55e-4)" "unprognostic (1.80e-3)" "unprognostic (1.09e-2)" "unprognostic (7.99e-2)" "unprognostic (2.96e-2)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (5.39e-3)" "unprognostic (7.18e-4)" "unprognostic (1.19e-1)" "unprognostic (3.60e-1)" "unprognostic (6.62e-2)" 5.5 4.8 3.9 1.4 4.2 0.9 7.3 7.1 6.5 10.8 5.0 6.6 2.0 9.2 4.6 5.8 8.3 2.6 5.2 3.8 3.5 5.1 5.1 4.3 1.6 4.1 3.7 3.5 14.3 10.8 1.3 7.3 2.0 5.1 10.5 3.4 11.2 8.3 4.0 3.5 10.7 4.4 4.2 3.3 4.7 6.3 7.5 3.7 1.1 8.3 2.9 1.5 7.9 8.2 5.6 0.1 0.0 0.2 0.0 0.0 0.0 2.4 1.0 0.0 0.7 0.5 2.4 1.4 0.2 1.7 1.1 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.5 0.5 0.0 0.9 0.1 0.4 2.3 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.3 2.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.7 0.1 1.7 3.2 0.0 1.1 0.0 0.6 0.0 3.3 0.1 0.8 4.6 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.1 0.4 0.3 1.3 1.3 0.4 0.5 0.1 0.4 0.2 0.2 3.9 4.2 7.1 6.5 3.8 3.5 4.1 3.7 3.5 5.1 3.3 3.7 5.6 4.2 12.8 4.6 7.2 0.2 2.4 2.5 0.2 2.2 6.5 4.4 3.9 2.9 4.3 3.9 1.8 6.2 1.9 0.2 1.4 1.9 1.8 2.0 1.3 5.6 3.4 5.4 1.3 4.3 3.2 2.4 4.6 12.2 2.3 0.0 9.7 3.6 3.4 0.1 6.7 6.5 2.4 2.0 0.8 2.6 4.4 11.5 0.8 5.4 6.5 0.0 4.1 0.0 16.1 8.0 2.9 1.2 4.5 0.1 1.9 0.4 1.7 1.3 10.9 13.1 6.0 3.3 18.5 11.0 0.9 1.8 2.9 0.4 2.2 4.0 2.1 CADM1 "BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1" ENSG00000182985 "Cell adhesion molecule 1" Q9BY67 11 115169218-115504957 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 290.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 8.0;myeloid DC: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 8.1;T-cells: 8.0" "Cell line enhanced" "Detected in many" "CACO-2: 294.7;WM-115: 187.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037266 Enhanced Supported "Cell Junctions" NA NA 220000000 "Cell Junctions" "CAB037266: AB_532287" "unprognostic (1.50e-1)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "prognostic favorable (1.32e-4)" "unprognostic (4.11e-3)" "unprognostic (1.50e-1)" "unprognostic (2.75e-3)" "unprognostic (1.13e-2)" "unprognostic (1.77e-1)" "unprognostic (2.67e-1)" "unprognostic (6.61e-3)" "unprognostic (9.22e-2)" "unprognostic (2.92e-3)" "unprognostic (1.77e-2)" "unprognostic (1.54e-1)" "unprognostic (3.67e-2)" "unprognostic (5.40e-2)" 7.1 30.2 49.0 6.1 61.0 0.4 17.1 80.7 53.5 21.5 8.5 9.0 7.9 17.6 104.6 12.7 22.8 12.2 25.9 48.1 65.1 29.3 65.8 72.6 14.2 42.1 41.4 49.4 12.4 16.2 57.0 26.2 38.2 47.9 15.4 8.2 290.3 38.4 28.2 7.3 11.0 8.9 8.6 26.8 8.1 12.6 50.9 48.4 8.7 70.4 8.2 14.7 13.2 4.9 44.0 0.4 23.3 25.6 0.1 0.0 0.0 0.1 24.1 41.1 3.1 0.3 294.7 26.1 0.0 75.9 36.5 25.2 4.8 4.8 27.4 2.0 1.0 38.3 0.0 7.8 114.5 0.3 0.1 56.5 0.0 38.6 0.0 63.8 16.5 1.1 17.3 0.0 2.7 4.3 19.3 20.0 0.6 24.0 0.3 0.0 0.1 0.4 61.6 44.8 0.9 50.2 107.1 0.0 25.4 21.7 102.4 92.4 1.3 0.0 2.3 44.9 23.3 13.0 64.9 98.9 18.7 36.3 0.2 187.5 0.2 0.0 0.0 8.0 0.0 3.4 1.5 2.9 2.1 8.1 0.3 0.1 1.8 0.0 0.5 0.1 0.0 4.7 1.9 49.0 61.0 80.7 53.5 48.1 65.1 42.1 41.4 49.4 47.9 26.8 48.4 44.0 14.0 464.8 195.3 980.7 6.5 20.6 26.7 2.8 19.4 566.6 22.1 22.5 61.7 34.3 27.5 36.8 350.3 71.6 6.8 1.5 11.7 39.2 189.1 88.5 6.0 10.6 7.8 5.3 301.7 2.0 5.0 13.2 3.6 126.9 24.1 36.8 2.9 45.9 36.8 30.3 310.9 2.1 4.1 8.5 20.9 224.0 5.9 14.2 44.4 60.0 13.3 489.9 2.1 676.5 622.8 9.3 0.5 4.1 88.9 38.5 0.3 8.2 8.7 759.5 0.0 13.3 11.7 55.2 23.0 9.2 23.4 32.2 8.1 5.2 4.3 13.5 ZNF320 "DKFZp686G16228, ZFPL" ENSG00000182986 "Zinc finger protein 320" A2RRD8 19 52860851-52897693 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 105.9;U-266/84: 56.1" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "unprognostic (3.33e-2)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-1)" "unprognostic (2.92e-2)" "unprognostic (7.12e-2)" "unprognostic (1.47e-4)" "unprognostic (8.90e-2)" "unprognostic (3.71e-3)" "unprognostic (2.75e-3)" "unprognostic (2.50e-1)" "unprognostic (2.01e-3)" "unprognostic (6.41e-3)" "unprognostic (1.32e-1)" "unprognostic (2.76e-1)" "unprognostic (7.65e-2)" "unprognostic (2.61e-3)" 5.0 6.4 5.1 6.7 6.2 5.0 10.5 8.6 5.8 9.0 5.5 9.1 7.0 10.1 9.9 5.1 10.5 7.4 7.2 4.8 5.3 9.2 1.5 6.0 6.7 5.7 5.0 4.1 13.5 6.8 12.4 6.6 11.2 6.4 10.4 9.7 13.1 6.3 8.1 7.0 9.2 5.3 7.9 3.2 7.5 7.9 5.4 5.2 6.4 10.9 3.7 6.5 9.6 7.1 7.8 11.2 0.5 16.8 28.1 3.8 6.2 19.8 8.0 7.3 10.5 12.7 6.7 3.8 12.5 10.3 6.9 9.3 3.1 0.1 5.7 7.4 0.1 3.6 12.6 16.6 0.1 7.8 0.8 14.2 10.7 4.8 12.2 2.6 4.8 7.8 5.5 12.9 0.8 7.7 0.0 16.1 9.8 20.4 0.2 9.5 12.0 15.3 14.1 10.2 105.9 13.3 26.4 0.3 7.0 2.9 23.3 10.0 1.3 9.0 4.4 11.0 2.7 12.2 14.1 56.1 9.3 0.3 0.2 9.8 3.2 2.1 1.8 3.2 2.6 2.9 2.2 1.8 2.4 2.5 3.2 3.4 3.5 3.5 7.9 2.4 3.7 2.0 2.5 5.1 6.2 8.6 5.8 4.8 5.3 5.7 5.0 4.1 6.4 3.2 5.2 7.8 0.6 3.2 1.7 13.7 2.8 1.9 5.8 3.4 1.2 8.3 0.2 0.1 13.2 14.3 5.9 1.8 10.4 10.5 2.9 9.0 0.0 0.3 6.7 1.9 1.0 4.5 10.7 4.2 10.2 0.0 6.3 5.0 6.1 2.8 1.3 0.6 6.8 0.8 4.3 16.8 10.1 9.0 4.1 3.2 3.9 2.7 4.4 1.6 3.6 3.7 2.4 5.6 9.2 17.6 12.4 0.1 6.3 2.6 0.5 9.4 4.1 0.2 4.4 12.4 0.0 9.2 3.2 5.6 5.8 5.3 4.3 7.7 1.8 0.4 7.3 7.5 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803666-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.8" "Cell type enriched" "Detected in many" 6 "Early spermatids: 452.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 0.8 4.7 1.1 0.5 1.3 0.8 0.8 1.3 1.5 0.6 1.8 0.5 0.1 0.4 1.4 0.4 1.4 0.8 3.1 1.0 1.1 2.6 6.0 1.0 1.8 1.3 1.3 1.0 0.5 1.0 1.1 0.7 0.7 1.4 0.9 0.4 6.5 0.8 0.5 1.3 0.5 0.5 0.2 1.4 3.3 0.9 14.8 1.3 0.8 1.3 0.8 1.0 0.5 0.4 1.7 1.8 1.9 1.9 5.5 2.0 1.4 1.7 1.3 0.7 1.3 1.6 0.8 1.9 1.5 1.5 0.4 2.0 2.0 2.1 4.3 1.8 3.6 2.2 1.2 0.5 1.3 1.7 1.8 0.6 0.7 2.6 1.3 2.9 1.8 2.6 2.5 2.0 0.3 1.9 0.6 0.7 1.1 6.6 2.7 1.1 2.2 3.3 2.3 2.5 0.5 1.4 1.7 2.8 0.7 2.6 5.6 2.2 0.8 2.0 1.2 1.3 0.9 1.5 0.9 0.7 5.1 1.5 1.7 1.7 0.1 0.5 1.7 0.9 0.6 1.5 1.6 0.7 1.3 0.5 1.0 1.8 1.5 0.1 1.6 0.3 0.4 1.6 0.4 1.1 1.3 1.3 1.5 1.0 1.1 1.3 1.3 1.0 1.4 1.4 1.3 1.7 0.9 0.0 0.0 6.8 3.3 0.3 0.5 3.9 0.0 4.0 1.2 1.7 3.6 0.0 3.0 5.5 20.9 1.8 0.9 0.3 7.9 1.8 452.6 3.6 0.6 1.8 0.0 11.6 3.1 1.1 1.6 2.2 0.0 1.1 0.0 1.0 0.0 1.1 1.3 1.7 3.7 0.4 8.2 0.9 0.8 72.6 3.1 1.0 0.0 1.0 2.8 2.8 5.2 10.6 10.8 0.8 0.2 2.6 1.2 0.5 0.3 3.4 8.0 17.0 19.7 2.0 1.6 31.9 8.9 0.2 1.0 0.3 2.8 0.5 0.5 0.3 PYCR1 P5C ENSG00000183010 "Pyrroline-5-carboxylate reductase 1" P32322 17 81932384-81942412 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis, Stress response" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 112.7;salivary gland: 122.1" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 63.8;Extravillous trophoblasts: 63.8;Intestinal goblet cells: 83.4;Prostatic glandular cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 4.2" "Group enriched" "Detected in many" 8 "B-cells: 4.2;dendritic cells: 1.9;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047660 Approved NA NA "HPA047660: AB_2680115" "unprognostic (1.12e-2)" "unprognostic (2.13e-2)" "unprognostic (7.04e-2)" "unprognostic (7.27e-2)" "unprognostic (9.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (2.80e-1)" "unprognostic (9.36e-3)" "unprognostic (6.65e-2)" "unprognostic (3.02e-3)" "unprognostic (7.12e-2)" "prognostic unfavorable (7.33e-12)" "unprognostic (7.98e-2)" "unprognostic (1.56e-1)" "unprognostic (1.12e-2)" "unprognostic (5.92e-2)" 5.1 4.1 14.2 14.0 12.4 12.6 17.5 12.5 15.3 24.4 8.7 24.1 14.5 10.7 2.5 18.9 9.8 9.0 8.8 13.3 13.1 4.0 8.8 13.7 7.0 15.0 12.8 12.2 7.6 112.7 1.9 21.8 11.8 15.1 25.7 14.5 0.9 122.1 7.8 11.6 6.0 12.6 12.3 12.8 8.0 42.8 15.3 14.5 2.6 8.6 2.0 6.8 12.2 10.4 15.1 107.4 111.9 62.7 228.3 36.7 69.0 117.2 176.0 85.4 54.7 73.7 129.3 116.9 163.2 38.0 188.9 33.3 45.8 148.2 67.1 32.7 42.4 18.6 96.5 56.5 350.8 213.8 64.8 70.6 58.5 129.8 68.2 178.7 64.8 95.5 129.4 314.0 147.2 35.1 376.4 68.1 49.5 52.8 291.9 170.1 0.9 105.6 205.5 49.9 38.7 237.7 167.2 36.9 203.6 219.5 46.3 210.0 117.1 70.1 53.7 201.8 91.4 66.3 183.4 141.3 156.2 57.2 0.8 178.1 0.0 0.1 0.0 0.2 0.2 0.4 4.2 0.7 0.2 1.3 1.8 1.6 1.2 0.0 0.3 0.0 1.9 0.3 1.1 14.2 12.4 12.5 15.3 13.3 13.1 15.0 12.8 12.2 15.1 12.8 14.5 15.1 2.3 0.0 3.9 2.3 9.1 7.0 11.4 12.2 4.6 0.3 50.6 29.5 0.6 1.5 7.2 3.7 0.0 2.0 2.3 17.2 0.0 13.3 13.8 3.4 14.6 4.7 10.8 27.8 0.9 63.8 63.8 24.9 35.7 13.8 4.5 13.9 2.5 1.8 5.0 3.3 1.4 83.4 8.2 0.0 5.4 32.4 7.5 0.8 8.8 0.0 0.7 0.5 0.0 3.5 0.7 48.0 19.5 3.8 34.1 59.6 1.2 1.9 1.3 0.2 0.0 3.3 17.8 28.2 16.9 8.0 6.0 3.8 1.9 15.5 43.1 8.6 NAA38 "LSMD1, MGC14151, PFAAP2" ENSG00000183011 "N-alpha-acetyltransferase 38, NatC auxiliary subunit" Q9BRA0 17 7856685-7885238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059189 Supported Nucleoplasm "Intracellular and membrane" No No Nucleoplasm "HPA059189: " "unprognostic (6.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.30e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (3.35e-1)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-1)" "unprognostic (7.28e-3)" "unprognostic (1.48e-3)" "unprognostic (3.31e-1)" "unprognostic (5.83e-3)" "unprognostic (1.58e-1)" "unprognostic (6.02e-2)" "unprognostic (2.66e-1)" "unprognostic (9.75e-2)" 68.4 103.0 118.7 33.6 120.9 76.6 67.8 122.5 189.5 57.1 113.9 73.1 31.1 55.4 31.2 66.3 57.9 29.3 93.5 117.5 118.6 88.1 68.4 51.1 46.1 118.3 116.3 117.3 45.6 60.6 77.3 73.5 22.8 117.0 72.2 27.2 29.7 56.7 32.1 131.6 59.2 49.6 24.7 117.8 73.1 66.5 98.5 121.3 45.6 60.6 94.2 31.6 60.5 56.0 121.5 131.4 234.9 129.4 132.9 70.8 78.3 44.8 59.7 68.4 108.3 89.9 89.0 54.6 89.6 98.5 63.6 69.2 105.4 69.8 110.3 26.8 134.1 318.2 137.3 279.7 131.0 68.4 38.6 101.9 114.3 60.4 71.0 46.3 74.5 105.9 201.9 29.1 95.3 63.6 157.3 140.0 91.6 29.2 98.9 271.5 142.0 59.6 59.4 101.0 72.6 57.6 110.5 46.6 111.1 87.3 18.7 68.8 100.0 57.6 72.2 52.0 59.0 170.8 39.1 43.8 34.8 121.5 159.1 72.2 313.1 275.2 196.9 176.1 244.0 163.4 273.8 186.3 181.9 332.4 234.2 167.1 173.6 201.1 152.9 239.8 304.0 215.3 299.0 118.7 120.9 122.5 189.5 117.5 118.6 118.3 116.3 117.3 117.0 117.8 121.3 121.5 263.1 76.9 140.5 16.3 117.8 94.1 85.8 171.8 144.5 98.5 218.1 305.4 344.3 128.7 107.7 253.8 50.1 160.2 107.4 227.2 518.5 100.6 646.3 189.4 104.9 183.6 226.6 201.2 18.3 158.4 128.0 102.6 80.5 133.1 100.1 131.1 213.5 381.3 210.5 40.4 21.7 211.2 146.5 222.8 96.8 1601.4 116.8 149.9 76.5 14.0 195.2 221.6 182.3 34.7 13.3 134.0 161.6 113.2 161.7 86.8 184.1 468.0 107.1 126.5 111.7 70.2 109.8 120.5 132.4 182.1 99.4 91.9 103.5 175.3 289.5 129.3 SPNS2 SLC62A2 ENSG00000183018 "Sphingolipid transporter 2" Q8IVW8 17 4498881-4539035 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.4" "Cell type enhanced" "Detected in many" "Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068717 Uncertain NA NA "HPA068717: AB_2686021" "unprognostic (3.03e-2)" "unprognostic (4.76e-2)" "unprognostic (8.08e-2)" "unprognostic (3.53e-2)" "unprognostic (2.78e-1)" "unprognostic (6.30e-3)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.99e-2)" "unprognostic (2.98e-2)" "unprognostic (4.48e-2)" "unprognostic (2.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.19e-2)" "unprognostic (6.89e-2)" 15.7 2.6 12.0 5.2 11.6 7.9 14.8 10.8 15.7 10.0 0.1 6.0 12.3 8.7 0.6 51.4 7.8 12.2 9.0 12.2 10.3 28.8 3.8 28.6 5.0 22.7 14.2 8.1 1.9 10.0 1.1 2.1 7.9 27.1 5.4 2.2 0.6 16.7 2.1 4.4 22.0 10.9 4.9 11.6 11.5 21.2 1.3 12.9 1.7 8.5 3.9 13.4 6.7 22.8 22.7 9.7 1.2 0.0 0.2 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.5 8.1 0.5 11.8 0.0 0.1 0.5 0.0 0.7 0.0 0.1 0.2 0.6 0.2 0.0 0.1 3.0 0.0 0.0 0.2 0.0 0.0 0.0 4.2 4.7 0.0 0.0 0.0 3.8 0.2 17.0 0.1 17.6 0.3 0.8 0.0 0.3 161.7 0.5 5.4 0.2 0.0 76.7 0.0 5.1 2.7 7.5 0.2 0.2 0.7 0.3 0.1 0.3 0.3 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.0 11.6 10.8 15.7 12.2 10.3 22.7 14.2 8.1 27.1 11.6 12.9 22.7 32.7 6.4 10.6 1.6 0.2 1.8 0.4 2.1 0.0 1.2 4.3 3.6 1.2 22.8 16.2 22.0 0.0 1.3 0.2 2.8 1.9 16.7 0.2 0.5 1.0 34.5 0.0 3.2 23.4 3.0 30.5 1.7 26.0 2.8 0.0 0.0 12.5 6.7 1.1 6.7 26.2 12.7 2.0 0.3 1.6 0.2 0.6 1.9 1.8 37.5 0.0 0.4 0.0 3.5 97.8 18.6 0.0 0.4 1.2 11.7 1.9 24.3 16.9 1.1 0.0 1.4 3.1 0.6 0.5 0.6 2.4 1.9 1.6 0.1 1.1 39.8 MCEMP1 "C19orf59, MGC132456" ENSG00000183019 "Mast cell expressed membrane protein 1" Q8IX19 19 7676628-7679826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "bone marrow: 66.5;lung: 74.9;lymphoid tissue: 35.4" "Cell type enriched" "Detected in some" 4 "Macrophages: 147.5" "Cancer enhanced" "Detected in many" "lung cancer: 3.7" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Group enriched" "Detected in some" 5 "classical monocyte: 102.1;neutrophil: 45.9" "Group enriched" "Detected in many" 5 "granulocytes: 45.9;monocytes: 102.1" "Group enriched" "Detected in some" 6 "THP-1: 53.7;U-937: 166.6" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" HPA014731 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014731: AB_1845619" "unprognostic (4.84e-2)" "unprognostic (9.81e-4)" "unprognostic (2.41e-1)" "unprognostic (4.36e-2)" "unprognostic (8.85e-3)" "unprognostic (2.62e-3)" "unprognostic (5.57e-3)" "unprognostic (1.42e-1)" "unprognostic (2.19e-1)" "unprognostic (4.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.69e-5)" "unprognostic (1.15e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" 4.1 0.5 0.0 19.9 0.0 66.5 0.5 0.0 2.0 0.1 0.1 0.4 0.2 0.1 0.0 0.5 1.7 0.6 1.1 0.0 0.1 0.7 1.5 74.9 0.1 0.0 0.1 0.0 0.2 0.7 0.0 0.2 1.8 0.9 0.5 0.1 0.0 0.8 0.0 0.3 0.1 0.6 5.1 0.0 35.4 0.9 0.2 0.5 0.9 0.4 1.5 0.1 4.8 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 1.4 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 166.6 0.0 0.0 102.1 2.8 0.2 6.0 0.0 0.0 0.3 0.0 14.9 0.0 0.0 0.3 45.9 0.6 0.4 0.9 0.2 38.3 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.5 0.1 0.4 19.2 34.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 11.2 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 2.2 0.0 3.6 0.0 0.0 1.0 2.9 0.0 0.0 7.6 0.0 0.0 0.3 28.8 0.0 0.0 0.0 0.0 28.3 0.0 0.1 0.0 147.5 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 5.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.8 2.9 0.0 0.0 0.1 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 subunit alpha 2" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles NA NA 10000000 Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: AB_2678283" "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favorable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 19.6 18.2 3.3 1.3 5.0 4.5 16.8 11.0 9.9 19.9 0.9 22.3 5.4 18.1 1.5 12.8 18.3 2.0 18.0 4.6 2.9 34.6 30.2 19.1 3.2 1.1 3.3 4.7 17.6 25.5 3.7 25.8 5.2 3.6 20.5 5.0 5.9 14.7 4.0 14.2 14.4 19.7 5.6 0.0 58.1 20.7 15.6 2.6 3.8 14.0 1.6 2.6 19.2 15.9 8.2 7.5 2.9 3.7 10.7 13.8 14.2 9.1 10.2 3.3 6.0 4.9 1.3 7.3 7.4 8.7 12.3 5.7 8.9 8.9 5.6 3.9 5.5 23.2 2.1 10.4 3.9 5.3 2.8 4.9 16.8 6.1 3.1 6.1 14.8 8.5 5.0 5.9 4.7 6.3 0.4 2.6 3.2 2.0 9.1 17.9 4.2 2.6 8.1 9.2 6.2 12.3 10.0 11.4 9.2 1.7 6.3 5.4 0.8 13.3 1.9 2.3 2.8 5.2 4.3 3.9 5.3 4.0 3.7 3.1 1.5 1.7 1.5 1.1 1.7 0.5 0.5 1.1 0.6 1.4 1.0 1.1 1.2 2.1 1.1 1.4 1.3 2.1 0.6 3.3 5.0 11.0 9.9 4.6 2.9 1.1 3.3 4.7 3.6 0.0 2.6 8.2 38.1 38.5 21.8 29.4 14.3 14.3 12.4 13.3 7.4 50.9 27.2 23.0 12.9 21.5 15.9 62.5 60.5 42.1 17.3 45.3 39.2 37.5 46.7 64.0 44.6 36.6 35.2 27.1 37.2 18.0 45.2 28.7 16.3 86.7 27.3 31.0 80.3 59.8 82.8 101.0 36.4 32.3 18.3 104.7 26.9 28.3 34.5 51.8 8.8 41.2 31.2 30.4 39.1 23.1 21.9 25.8 24.2 27.8 13.6 16.9 43.5 70.4 23.5 69.2 26.3 20.7 22.6 72.7 28.0 11.2 11.4 28.5 19.7 30.5 37.0 11.5 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 118.6" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 44.2" "Group enriched" "Detected in many" 6 "granulocytes: 44.2;monocytes: 11.5" "Cell line enhanced" "Detected in many" "BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 6.1 4.1 13.9 7.2 23.1 2.0 1.6 0.0 25.7 4.7 0.0 7.2 5.0 19.9 5.6 6.0 5.6 6.5 118.6 28.1 19.9 17.7 3.2 5.9 3.3 1.7 18.9 14.0 2.5 1.9 0.7 0.8 11.3 3.9 19.0 4.9 5.9 1.0 27.4 0.3 1.3 5.5 23.6 0.2 7.3 3.5 0.7 11.0 2.0 0.8 0.9 1.6 9.0 2.5 21.7 3.0 2.2 2.1 0.2 3.1 6.4 0.0 28.9 11.1 9.4 6.1 0.0 4.7 0.1 2.2 70.4 10.1 1.1 0.5 4.8 9.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.5 3.7 0.0 10.8 19.8 4.3 0.7 0.0 0.0 0.4 12.1 0.0 0.9 0.1 1.4 0.3 4.0 7.8 14.8 0.0 3.3 0.4 3.2 0.6 0.0 0.0 0.0 9.7 0.1 0.6 9.8 8.8 0.3 0.0 3.1 1.6 0.0 0.0 1.4 1.7 1.4 0.0 8.3 0.0 0.0 9.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 44.2 0.0 11.5 0.3 0.0 1.1 13.9 23.1 0.0 25.7 28.1 19.9 1.7 18.9 14.0 3.9 0.2 11.0 21.7 10.3 3.2 2.8 39.5 3.6 1.3 0.0 0.2 1.2 79.1 0.5 5.8 743.1 2.8 0.6 35.0 4.2 0.5 0.3 0.0 0.0 0.0 1.1 2.3 52.8 15.1 0.0 3.0 1267.5 0.0 1.6 26.6 1.5 3.0 0.0 0.2 12.1 0.3 29.3 0.0 631.3 2.5 0.0 78.0 26.7 1.4 0.0 88.8 1.8 574.3 42.7 32.0 1.0 753.0 20.5 0.1 3.8 8.2 0.7 0.2 24.7 0.5 0.0 7.2 13.1 1.4 46.6 0.2 1.2 0.5 3.1 1.1 1.2 0.7 2.5 0.1 OR1G1 "OR17-209, OR1G2" ENSG00000183024 "Olfactory receptor family 1 subfamily G member 1" P47890 17 3126584-3127581 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A21 "ODC, ODC1" ENSG00000183032 "Solute carrier family 25 member 21" Q9BQT8 14 36677921-37172606 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 6.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 27.8;Excitatory neurons: 14.1;Exocrine glandular cells: 10.0;Inhibitory neurons: 10.4;Oligodendrocyte precursor cells: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "K-562: 26.4;Karpas-707: 54.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000662 Uncertain NA NA "HPA000662: AB_1080000" "unprognostic (6.81e-3)" "unprognostic (6.98e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-1)" "unprognostic (2.78e-2)" "unprognostic (2.20e-1)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.32e-2)" "unprognostic (6.86e-2)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-4)" "unprognostic (9.09e-3)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (1.07e-1)" 0.9 1.2 0.3 0.3 0.3 6.3 0.5 0.3 0.3 0.5 0.1 0.4 0.7 1.3 0.2 1.2 0.7 0.6 1.3 0.2 0.3 1.7 0.4 0.5 0.1 0.4 0.3 0.2 2.0 2.8 0.9 0.3 0.1 0.3 1.6 0.3 1.0 1.6 0.5 0.7 0.3 1.2 0.7 0.3 0.5 0.8 4.0 0.3 0.3 1.5 0.9 0.1 0.6 0.3 0.5 1.3 1.0 0.4 3.2 0.1 1.0 0.0 0.3 0.8 1.7 0.7 0.2 0.9 0.1 1.4 0.4 0.0 1.0 0.0 0.7 0.6 0.8 9.5 0.9 0.8 0.8 1.0 0.0 0.0 0.7 1.1 0.0 0.5 0.9 3.9 0.0 26.4 54.4 0.8 2.7 0.0 0.0 2.1 0.0 4.1 0.0 0.0 0.0 0.8 3.9 2.6 0.0 2.6 0.2 1.3 0.4 2.9 0.0 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.3 0.4 0.3 0.2 0.3 0.3 0.3 0.5 0.3 0.0 0.0 2.3 0.2 1.0 1.8 1.8 6.8 0.1 1.0 0.9 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.9 0.9 1.4 0.1 1.0 0.7 1.8 27.8 14.1 10.0 0.0 0.9 0.0 0.2 0.0 0.4 0.7 0.3 0.2 1.7 10.4 0.5 2.0 0.0 0.4 1.4 1.5 0.1 0.0 4.7 0.0 4.3 0.0 11.6 5.2 3.7 0.0 0.7 0.0 2.7 0.1 4.2 0.4 1.5 0.0 1.1 1.1 3.1 3.6 3.6 0.9 0.0 0.1 1.9 1.0 0.6 OTOP2 ENSG00000183034 "Otopetrin 2" Q7RTS6 17 74922950-74933912 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 20.3" "Cell type enriched" "Detected in some" 20 "Paneth cells: 627.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 41 "HDLM-2: 10.1" "Region enriched" "Detected in some" 12 "olfactory bulb: 12.7" "Low region specificity" "Detected in many" "HPA024524, HPA053090" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024524: AB_2671592, HPA053090: AB_2682041" "unprognostic (1.62e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (3.21e-2)" "unprognostic (3.62e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.81e-1)" "unprognostic (9.04e-2)" "unprognostic (2.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.3 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.0 0.1 1.4 0.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 30.0 0.0 0.0 9.3 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 19.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 627.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 0.0 CYLC1 ENSG00000183035 "Cylicin 1" P35663 X 83861126-83886699 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 315 "testis: 31.4" "Group enriched" "Detected in some" 72 "Early spermatids: 499.8;Late spermatids: 1411.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA070355, HPA078303" Enhanced NA NA "HPA070355: AB_2686261, HPA078303: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.8 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1411.6 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867438-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 609.6;seminal vesicle: 1292.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 600.9;Distal tubular cells: 645.6;Horizontal cells: 1398.2;Proximal tubular cells: 941.2" "Cancer enhanced" "Detected in many" "prostate cancer: 41.7;thyroid cancer: 48.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 215.9;T-47d: 64.7" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favorable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favorable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 5.3 53.4 196.0 2.0 501.1 0.0 8.5 161.8 168.6 173.9 429.8 81.3 5.2 128.0 368.8 230.4 10.3 4.2 4.5 126.1 185.8 52.7 0.5 0.6 0.2 163.0 321.1 66.0 3.6 6.2 19.8 8.9 2.0 145.7 326.3 32.6 388.7 21.5 1292.4 0.6 13.6 6.0 55.1 59.0 2.7 7.1 0.9 609.6 8.0 229.9 0.0 1.0 471.9 129.7 89.2 0.0 0.0 3.1 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 2.3 1.9 0.0 0.0 0.0 0.0 215.9 0.5 0.0 0.3 0.3 0.0 34.8 0.0 0.2 64.7 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 196.0 501.1 161.8 168.6 126.1 185.8 163.0 321.1 66.0 145.7 59.0 609.6 89.2 0.0 0.0 1.5 15.3 2.9 3.1 0.4 0.0 0.0 600.9 0.4 0.4 8.8 2.8 0.0 77.3 62.6 0.3 0.0 0.1 645.6 0.4 1.3 0.0 0.2 5.0 1.2 0.0 71.3 0.2 0.3 1.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1398.2 21.5 0.2 0.0 0.0 7.5 0.4 9.6 7.0 21.4 8.4 0.0 68.4 0.0 7.5 11.9 0.8 0.2 0.4 0.0 4.4 0.0 941.2 0.0 200.0 0.0 0.0 77.4 3.4 9.5 0.0 6.0 2.9 2.2 0.5 0.5 1.0 ABAT "GABA-T, GABAT" ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674596-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 134.6;liver: 348.5;pancreas: 139.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9" "Cancer enhanced" "Detected in all" "glioma: 27.3;liver cancer: 26.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria No No 2100000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favorable (5.36e-5)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favorable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 3.3 28.0 93.4 4.7 99.1 2.2 5.2 86.6 101.8 3.9 60.9 7.7 44.0 3.9 9.7 7.7 6.2 4.5 14.3 82.4 121.6 134.6 348.5 4.5 5.0 87.6 103.0 78.6 10.6 139.5 8.3 56.2 3.4 102.7 21.9 7.9 29.9 6.5 3.6 1.6 2.7 20.2 2.7 75.3 4.1 7.5 13.5 115.9 4.2 29.6 1.5 6.0 10.0 4.2 67.7 0.7 0.2 32.1 18.7 5.0 1.7 2.0 4.2 2.2 1.8 0.7 12.7 0.9 4.0 1.4 2.3 1.2 8.3 2.1 7.7 2.4 2.3 2.1 5.5 0.1 127.5 8.1 1.3 8.3 6.5 3.4 3.2 1.4 0.9 0.6 10.7 1.1 2.6 0.6 81.9 2.1 0.6 2.8 23.2 0.3 9.7 67.4 1.8 1.2 20.9 5.1 15.7 1.9 1.0 0.2 6.2 42.6 3.4 0.6 0.8 5.7 2.7 0.1 3.0 0.3 0.8 0.8 5.7 4.2 0.7 1.9 2.7 1.5 2.2 0.7 0.6 1.0 1.1 1.2 1.2 0.7 1.1 6.1 1.2 4.2 0.2 1.1 1.2 93.4 99.1 86.6 101.8 82.4 121.6 87.6 103.0 78.6 102.7 75.3 115.9 67.7 1.7 0.0 6.9 39.5 6.1 1.5 4.0 3.3 2.2 27.3 9.1 5.0 10.8 20.0 5.8 1.8 4.2 1.4 5.3 8.9 23.5 1.6 13.0 12.9 6.2 2.4 15.6 13.9 41.8 6.2 1.5 3.2 5.6 12.9 1.3 59.5 7.1 268.2 5.2 35.3 95.0 3.9 2.0 15.7 7.4 8.7 3.7 8.2 1.8 19.7 6.5 48.6 9.2 76.9 17.7 6.8 6.1 4.5 1.0 7.4 15.7 94.9 3.6 5.8 0.0 4.3 3.8 3.7 0.9 9.5 0.6 1.4 6.3 2.3 6.9 5.0 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 184.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "Hep G2: 158.9;SK-BR-3: 116.6" HPA023048 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favorable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.31e-4)" 18.0 15.0 4.9 3.1 4.6 9.5 16.9 5.4 6.2 6.2 5.5 15.8 21.6 3.8 2.7 39.1 9.3 5.5 9.4 4.5 4.8 71.2 184.8 4.4 2.5 7.9 5.0 4.2 4.8 36.1 17.4 6.4 1.8 5.6 17.4 6.9 0.6 26.2 6.2 5.8 17.2 20.2 0.9 5.5 4.8 24.2 35.3 5.3 3.9 9.7 2.0 3.0 9.2 11.6 6.4 45.3 81.8 7.6 38.1 2.9 2.3 15.3 19.2 6.1 23.2 17.4 49.5 18.4 20.2 14.3 4.5 11.2 28.3 10.8 19.3 4.2 14.9 66.2 16.7 49.0 158.9 3.3 37.5 19.5 1.6 10.0 16.5 3.2 4.5 13.6 27.9 28.0 24.3 8.2 85.4 54.3 40.0 7.8 18.8 63.9 41.0 16.3 63.6 21.1 39.6 49.8 34.0 18.1 116.6 4.0 2.0 50.3 20.4 6.1 17.9 58.6 26.5 34.4 15.3 8.3 12.0 7.8 39.0 15.9 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.0 1.0 0.0 0.1 0.2 0.2 4.9 4.6 5.4 6.2 4.5 4.8 7.9 5.0 4.2 5.6 5.5 5.3 6.4 1.4 0.0 2.2 1.6 1.3 0.0 4.5 0.0 2.2 4.9 14.6 7.5 3.8 17.2 3.1 14.7 0.0 16.4 2.3 10.2 25.4 16.9 30.5 22.3 3.8 1.5 4.9 8.2 1.2 22.9 6.9 2.3 18.8 16.4 0.0 5.1 3.6 42.3 8.0 0.0 1.7 15.3 0.0 2.4 0.0 76.9 2.1 2.0 0.0 0.0 0.8 1.9 3.1 0.5 1.2 9.9 19.3 1.9 4.3 4.7 50.9 84.6 7.3 4.2 0.0 1.3 1.6 27.9 3.1 15.9 0.0 4.2 1.5 5.3 27.2 7.9 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349547-12835545 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 58.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 75.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 75.1" "Cell line enhanced" "Detected in many" "HDLM-2: 113.8;U-266/70: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favorable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 6.2 4.8 14.7 8.5 16.3 6.9 4.3 5.6 32.5 7.5 0.9 11.5 3.5 3.2 2.8 8.7 3.9 6.0 14.5 28.7 8.2 1.9 8.3 7.5 9.7 3.0 1.7 16.7 2.8 17.1 0.9 2.8 3.0 9.5 4.7 12.5 58.4 4.4 7.1 1.6 18.6 6.3 5.2 0.5 11.0 3.2 6.1 2.0 23.7 13.1 2.4 12.7 7.2 9.3 14.3 0.3 6.1 6.8 0.3 4.0 1.4 0.4 0.9 2.2 1.4 2.0 8.6 4.8 3.4 0.7 0.6 3.4 3.2 8.4 1.2 1.1 113.8 4.1 13.6 19.4 0.4 1.1 0.3 11.8 0.2 5.2 2.7 0.2 14.6 0.8 7.2 0.4 0.4 1.7 7.2 26.9 5.6 4.6 0.0 2.7 20.2 3.7 6.4 0.2 6.5 10.4 4.8 13.2 4.9 0.0 0.9 3.4 3.3 0.3 5.6 8.1 18.1 4.0 50.3 16.8 11.3 8.2 8.8 0.1 19.5 4.9 75.1 3.8 7.1 3.9 12.1 3.3 4.8 9.3 14.7 3.8 2.6 29.8 3.1 8.7 2.8 1.1 3.4 14.7 16.3 5.6 32.5 28.7 8.2 3.0 1.7 16.7 9.5 0.5 2.0 14.3 12.5 3.2 25.2 130.6 68.0 22.9 8.6 26.3 13.1 167.4 3.4 1.7 17.1 12.8 36.6 1.8 392.0 0.2 22.1 36.7 0.0 9.0 20.4 3.6 4.0 13.7 16.1 7.6 416.9 22.0 0.9 30.4 2.0 2.0 23.4 2.0 15.0 13.7 16.0 45.4 233.6 27.4 10.2 50.1 61.2 9.2 23.6 36.2 3.6 168.6 34.8 24.2 30.9 111.6 7.2 10.5 42.8 60.9 23.9 4.9 2.0 1.2 27.5 214.2 26.3 7.2 10.2 4.8 11.0 24.6 41.2 0.3 21.6 8.7 33.2 20.9 RGPD6 RGP6 ENSG00000183054 "RANBP2 like and GRIP domain containing 6" Q99666 2 110513802-110577222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 17.1;Club cells: 8.1;Excitatory neurons: 10.7;Inhibitory neurons: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;SCLC-21H: 10.5" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 12.5 8.5 3.9 0.7 2.4 6.3 13.4 5.3 6.9 13.3 6.0 10.6 1.5 9.8 0.9 7.4 12.3 0.0 11.3 3.2 9.5 9.5 14.1 14.5 2.3 4.6 2.3 3.5 15.4 18.2 2.0 23.0 1.8 3.0 14.9 0.6 1.9 9.8 0.1 14.8 17.1 12.1 1.0 4.9 9.6 11.9 32.2 2.8 0.7 14.4 2.1 0.7 10.9 10.8 7.8 7.0 2.6 1.2 2.0 0.0 0.5 2.9 1.3 0.0 0.8 0.1 5.7 1.5 0.4 4.2 2.5 3.4 5.2 0.2 2.4 0.0 1.6 11.5 6.8 0.9 1.0 0.1 2.2 0.3 0.4 1.5 1.3 3.1 1.0 0.0 2.1 2.7 2.0 0.0 3.7 1.8 0.0 7.6 1.4 6.7 2.6 4.1 0.0 2.6 0.7 10.5 4.8 1.1 0.2 3.1 4.1 0.1 0.4 1.5 1.4 4.0 0.4 6.0 3.8 0.4 0.5 2.6 0.0 2.5 4.7 1.5 2.0 1.6 0.8 2.4 2.0 2.3 1.7 1.0 3.1 2.3 1.4 4.7 1.5 1.8 2.2 0.5 0.3 3.9 2.4 5.3 6.9 3.2 9.5 4.6 2.3 3.5 3.0 4.9 2.8 7.8 0.1 9.6 17.1 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.1 0.1 1.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 1.8 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.3 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA029152: AB_10602033, HPA059824: AB_2684135" "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 6.5 5.5 6.0 1.7 6.4 3.1 6.8 6.1 6.8 8.4 6.2 8.9 4.8 9.5 3.4 11.2 8.2 1.5 18.6 6.2 6.1 9.1 11.9 7.7 2.4 6.0 6.5 6.3 8.9 8.1 5.8 7.1 2.8 6.1 9.6 3.3 5.3 9.6 4.2 10.4 16.4 7.9 3.9 5.7 8.0 7.9 7.7 6.9 3.9 5.0 5.9 3.8 7.9 9.5 7.0 3.5 3.3 6.5 3.8 7.1 6.4 3.9 3.9 2.7 3.3 4.8 8.2 3.0 3.8 2.3 3.6 5.8 10.1 5.1 6.3 3.8 0.8 9.2 2.5 7.2 5.7 4.1 1.8 4.6 3.7 9.2 3.0 3.6 2.0 4.5 10.9 6.2 4.8 2.2 4.1 4.8 5.1 4.3 9.7 3.7 3.4 4.6 1.9 5.9 9.0 3.7 3.3 7.2 2.2 3.9 8.3 1.5 3.5 5.8 2.7 7.3 3.7 1.7 6.3 9.1 3.1 3.5 4.5 2.9 0.0 1.3 5.3 2.1 1.9 1.7 1.0 3.0 2.6 0.6 1.7 3.5 1.6 0.4 0.7 2.7 3.0 3.2 2.4 6.0 6.4 6.1 6.8 6.2 6.1 6.0 6.5 6.3 6.1 5.7 6.9 7.0 7.0 6.4 3.3 4.6 2.5 8.7 8.1 4.6 8.0 8.0 3.5 6.3 12.8 7.2 3.9 3.7 10.4 2.6 4.9 4.4 1.9 4.1 7.3 1.3 3.0 4.8 3.0 6.1 9.8 9.7 2.0 6.8 3.6 1.7 0.0 2.9 3.9 3.4 4.3 10.1 11.4 6.2 6.1 2.2 3.7 8.1 5.3 3.9 1.8 8.4 8.1 11.6 3.1 6.0 7.4 7.2 3.0 6.8 3.9 2.1 3.9 5.3 2.5 10.0 13.1 3.9 5.7 12.7 11.3 8.1 9.1 1.4 2.9 2.2 2.6 3.5 WBP2NL "FLJ26145, GRAMD7, MGC26816, PAWP" ENSG00000183066 "WBP2 N-terminal like" Q6ICG8 22 41998725-42058456 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Group enriched" "Detected in many" 10 "Early spermatids: 254.5;Late spermatids: 807.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048557 Enhanced Approved Cytosol NA NA Cytosol "HPA048557: AB_2680440" "unprognostic (1.90e-2)" "unprognostic (2.25e-4)" "unprognostic (2.77e-3)" "unprognostic (6.12e-2)" "unprognostic (6.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (9.84e-4)" "unprognostic (3.31e-2)" "unprognostic (4.19e-2)" "unprognostic (1.79e-1)" "unprognostic (2.06e-1)" "unprognostic (2.85e-3)" "unprognostic (9.36e-5)" 0.2 0.1 0.7 0.0 0.7 0.0 0.7 0.7 1.0 0.2 0.1 0.2 0.1 0.2 1.2 0.1 0.5 0.2 0.0 0.7 0.7 0.3 0.1 0.3 0.2 1.0 0.9 0.6 0.6 0.7 0.4 0.3 0.1 1.0 0.3 0.1 0.7 0.5 0.3 0.1 0.4 0.2 0.1 0.9 0.2 0.3 18.0 0.6 0.1 0.6 0.1 0.1 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.7 0.7 1.0 0.7 0.7 1.0 0.9 0.6 1.0 0.9 0.6 1.6 0.3 0.0 2.8 50.6 4.3 0.4 2.1 1.0 2.8 16.4 1.8 2.4 0.7 2.8 3.7 0.0 20.9 2.2 0.6 1.7 3.9 0.9 254.5 0.9 1.5 1.3 4.8 0.4 16.0 1.3 1.0 0.9 1.5 1.3 0.0 4.7 2.2 1.5 1.4 10.1 18.6 2.2 4.1 2.8 1.9 807.7 6.5 2.3 1.8 9.4 1.8 2.9 3.1 9.5 16.6 0.9 3.9 5.7 1.5 1.2 3.4 2.0 0.8 23.0 0.0 0.6 0.7 30.6 20.2 1.2 0.9 1.9 1.9 1.6 2.7 1.4 IGSF5 JAM4 ENSG00000183067 "Immunoglobulin superfamily member 5" Q9NSI5 21 39745407-39802096 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 8 "Syncytiotrophoblasts: 114.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 5.8" HPA057282 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA057282: AB_2683395" "unprognostic (1.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.06e-2)" "unprognostic (9.73e-5)" "unprognostic (1.56e-2)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (2.09e-1)" "unprognostic (8.35e-2)" "unprognostic (9.61e-2)" "unprognostic (4.01e-1)" "unprognostic (4.18e-1)" "unprognostic (3.75e-2)" "unprognostic (6.89e-2)" "unprognostic (1.07e-2)" 0.3 1.3 2.2 0.2 2.4 0.4 0.9 0.4 1.5 0.7 1.8 0.4 0.3 0.7 1.9 0.2 0.7 0.4 3.4 1.3 1.8 0.4 0.4 0.3 0.4 1.3 1.2 0.8 1.0 1.5 0.2 0.6 2.6 1.7 1.4 0.7 1.2 0.5 0.4 0.2 0.6 0.3 0.4 0.6 0.4 0.5 1.1 2.4 0.6 0.7 0.1 0.4 0.4 0.1 1.2 0.7 0.4 2.4 0.6 2.3 1.8 0.6 0.4 0.6 0.6 1.0 0.4 0.7 0.8 0.6 0.9 0.9 0.6 0.8 1.6 1.3 1.3 1.1 0.7 1.9 0.3 1.4 1.0 0.3 1.7 2.9 1.5 1.7 1.2 0.3 0.3 1.4 0.5 0.9 0.9 0.2 0.3 1.3 0.6 0.4 0.4 1.1 0.4 1.0 1.0 1.1 0.3 0.6 1.6 1.0 1.0 5.8 0.6 0.2 1.0 1.2 0.5 1.0 0.5 0.4 0.5 0.6 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.2 2.4 0.4 1.5 1.3 1.8 1.3 1.2 0.8 1.7 0.6 2.4 1.2 0.0 0.0 0.0 8.5 0.0 0.0 0.2 0.0 0.0 1.2 1.0 0.8 9.7 0.0 0.1 1.8 0.0 1.6 0.0 0.6 5.9 0.6 12.8 0.0 0.4 0.2 0.0 0.0 2.9 0.2 1.7 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 4.1 0.4 0.0 0.0 0.0 4.8 0.3 0.1 0.0 0.0 0.0 1.0 0.0 5.0 1.0 0.2 0.2 0.4 0.0 1.4 0.0 6.8 0.1 0.2 0.0 0.0 0.2 0.5 0.2 0.0 0.0 114.1 0.1 1.1 0.4 2.0 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235311 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 204.3" "Cell type enriched" "Detected in some" 26 "Cardiomyocytes: 68.4" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 32.9;NTERA-2: 11.4;SK-MEL-30: 15.2;U-2 OS: 25.4;U-251 MG: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065034: AB_2685409" "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 204.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 35.1 0.0 0.1 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 5.0 1.7 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 7.6 32.9 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.1 0.5 6.3 0.0 15.2 4.2 0.0 0.1 0.0 5.9 25.4 7.8 20.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 AFMID "DKFZp686F03259, KF" ENSG00000183077 Arylformamidase Q63HM1 17 78187317-78207701 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Tryptophan catabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 174.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 118.3;Proximal tubular cells: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.4;intermediate monocyte: 16.7;memory B-cell: 5.4;myeloid DC: 7.6;non-classical monocyte: 11.0;plasmacytoid DC: 5.1" "Group enriched" "Detected in all" 5 "B-cells: 5.4;dendritic cells: 7.6;monocytes: 16.7" "Cell line enhanced" "Detected in all" "Hep G2: 186.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023861, HPA026536" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023861: AB_1844636, HPA026536: AB_1844637" "unprognostic (3.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.53e-1)" "unprognostic (2.65e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.78e-1)" "unprognostic (1.83e-1)" "unprognostic (1.49e-3)" "unprognostic (1.53e-2)" "unprognostic (5.78e-2)" "unprognostic (9.59e-3)" "unprognostic (9.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (7.79e-2)" 14.2 7.7 56.4 11.8 73.7 10.9 66.2 69.6 66.8 14.8 38.7 16.0 18.1 15.4 14.0 18.8 23.1 19.2 22.5 53.0 66.0 84.4 174.6 27.3 12.1 69.6 73.9 50.5 32.2 59.8 9.1 9.2 26.9 72.8 28.6 19.0 4.1 39.1 18.6 19.4 33.2 15.6 13.5 61.8 14.7 22.3 13.4 69.4 9.0 15.2 14.6 13.5 13.3 19.2 116.8 21.3 29.4 25.4 23.3 27.9 32.5 13.7 29.8 16.8 20.4 24.5 31.5 17.2 65.8 19.2 22.8 11.9 17.8 43.5 26.0 28.5 41.9 34.6 53.2 35.2 186.5 24.4 44.4 26.2 43.8 26.9 23.9 31.0 33.5 38.8 19.6 54.7 22.4 16.0 20.9 34.0 67.2 20.9 51.1 49.8 38.3 25.9 79.2 27.9 19.3 56.2 41.5 25.5 75.5 24.4 25.1 22.8 42.3 19.3 31.2 20.5 19.9 21.4 33.8 24.2 68.0 25.7 21.5 8.2 1.7 6.4 0.8 0.7 16.7 1.2 5.4 1.1 1.2 7.6 2.1 0.6 0.6 1.8 1.9 11.0 5.1 1.1 1.8 56.4 73.7 69.6 66.8 53.0 66.0 69.6 73.9 50.5 72.8 61.8 69.4 116.8 17.9 16.0 16.0 0.7 9.7 26.4 19.8 11.5 79.6 1.2 44.7 34.3 13.2 58.6 12.1 64.4 4.2 12.9 2.1 15.1 17.6 11.5 0.2 21.3 14.5 16.7 13.1 11.3 7.7 8.5 11.2 18.6 23.9 23.8 2.5 9.5 17.9 118.3 10.1 1.7 4.0 26.8 10.2 20.9 20.7 2.7 22.4 21.9 30.2 6.5 8.8 1.6 2.1 3.0 74.2 7.8 27.6 21.8 25.4 15.7 17.8 105.8 14.7 1.7 0.0 15.2 18.1 1.5 13.3 52.1 41.1 11.5 4.3 21.6 30.6 14.5 GAS6 "AXLLG, AXSF, DKFZp666G247, FLJ34709" ENSG00000183087 "Growth arrest specific 6" Q14393 13 113820549-113864076 "Predicted secreted proteins" "Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 348.3;Sertoli cells: 322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 70.7" "Lineage enriched" "Detected in many" 50 "dendritic cells: 70.7" "Cell line enhanced" "Detected in many" "BJ: 347.0;BJ hTERT+: 494.0;HSkMC: 281.3;RPMI-8226: 493.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008275, HPA056080" Approved Approved "Centriolar satellite,Cytosol" "Secreted to blood" NA NA 8900000 3600000 Cytosol "Centriolar satellite" "HPA008275: AB_1849497, HPA056080: AB_2683032" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.97e-3)" "unprognostic (1.37e-1)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (2.92e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.55e-1)" "unprognostic (4.81e-3)" "unprognostic (1.97e-1)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "prognostic unfavorable (8.93e-6)" 113.5 32.8 24.1 19.0 23.3 3.6 78.0 32.2 32.2 209.0 57.0 63.2 49.1 173.1 13.9 63.8 162.7 59.4 158.6 21.1 30.7 72.9 37.4 98.2 22.7 34.2 32.3 19.6 119.0 50.3 59.0 58.8 52.1 35.0 101.8 25.5 6.3 85.1 64.4 100.0 100.2 48.2 58.4 25.0 29.6 70.6 60.6 30.4 40.0 102.1 68.1 10.7 128.1 173.5 31.5 151.3 6.6 4.4 3.8 169.5 94.0 18.4 347.0 494.0 141.3 168.4 9.6 71.0 1.4 11.4 157.2 24.9 139.1 2.4 77.7 35.6 0.2 20.1 1.1 11.1 1.0 120.8 1.0 2.1 281.3 44.9 39.1 39.0 243.2 5.3 2.3 2.6 79.9 231.9 7.4 0.8 1.5 9.5 24.0 9.9 4.5 0.1 493.5 51.9 1.9 23.5 21.3 38.3 1.3 0.4 23.8 45.9 119.4 81.7 36.9 45.0 4.4 100.5 0.1 8.0 1.5 41.9 3.6 5.8 0.0 1.4 0.0 0.0 1.1 0.0 0.1 0.2 0.0 11.3 0.1 0.0 0.0 0.0 0.1 0.3 70.7 0.0 1.4 24.1 23.3 32.2 32.2 21.1 30.7 34.2 32.3 19.6 35.0 25.0 30.4 31.5 133.2 198.7 25.9 23.2 20.8 84.4 94.7 18.5 70.0 38.0 17.9 114.3 86.8 50.1 23.4 31.3 0.0 1.8 59.1 92.4 27.4 45.7 5.1 35.2 33.1 71.9 10.3 5.3 26.2 6.7 1.9 152.7 19.9 32.3 8.2 154.7 159.9 21.6 101.6 348.3 31.9 69.5 8.2 22.3 100.4 8.9 92.2 48.6 122.7 41.2 9.8 32.7 0.0 3.0 7.5 24.1 58.6 59.5 147.4 30.5 84.1 0.6 15.5 12.5 322.1 22.9 121.1 5.3 17.6 27.6 71.9 2.9 4.7 214.8 151.4 31.1 FREM3 ENSG00000183090 "FRAS1 related extracellular matrix 3" P0C091 4 143577302-143700675 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Cell type enhanced" "Detected in some" "Astrocytes: 1.6;Excitatory neurons: 9.7;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.1;hypothalamus: 2.8;thalamus: 4.4" HPA041641 Uncertain "Secreted to extracellular matrix" NA NA "HPA041641: AB_2677592" "unprognostic (1.19e-2)" "unprognostic (4.09e-9)" "unprognostic (3.09e-3)" "unprognostic (2.74e-1)" "unprognostic (1.66e-1)" "unprognostic (4.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-1)" "unprognostic (2.68e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.11e-3)" "unprognostic (3.24e-1)" 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.4 0.0 0.1 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.7 0.5 0.7 0.1 0.2 1.2 0.3 0.0 0.6 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.2 0.6 0.3 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 1.0 0.0 0.0 0.0 4.5 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 NEB "NEB177D, NEM2" ENSG00000183091 Nebulin P20929 2 151485336-151734487 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 69 "skeletal muscle: 9386.7;tongue: 2517.7" "Cell type enriched" "Detected in many" 8 "Skeletal myocytes: 662.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 8.8;RH-30: 34.3;U-266/70: 12.8" "Group enriched" "Detected in some" 6 "cerebellum: 6.5;olfactory bulb: 4.0" "Region enriched" "Detected in some" 6 "cerebellum: 11.8" HPA016601 Enhanced NA NA 120000 "HPA016601: AB_1854361" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (2.13e-2)" "unprognostic (2.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-3)" "unprognostic (2.54e-2)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-13)" "unprognostic (6.80e-2)" "unprognostic (2.22e-2)" "unprognostic (4.07e-3)" "unprognostic (4.06e-2)" 1.9 6.4 2.3 0.7 4.7 1.3 2.9 4.3 2.7 0.5 1.5 1.0 1.1 0.6 1.7 16.3 0.5 12.8 23.6 2.3 5.0 1.8 4.9 2.3 1.3 2.7 2.8 1.8 0.9 2.0 0.1 2.6 0.8 3.1 22.3 0.1 3.6 86.6 0.2 9386.7 7.0 1.8 0.2 2.2 3.1 1.1 1.7 3.0 1.2 13.1 2517.7 0.8 0.4 1.2 2.9 0.5 0.5 0.8 0.7 0.1 0.1 2.3 0.4 0.0 0.0 0.0 6.1 0.7 1.7 1.2 0.1 0.2 1.2 0.1 0.0 0.0 0.8 0.9 0.6 1.1 2.0 0.0 1.1 1.5 5.0 0.3 0.1 0.0 0.3 0.8 0.5 1.2 8.8 0.5 0.7 0.6 1.1 1.4 3.0 1.0 1.6 34.3 0.2 0.1 1.2 2.0 0.3 0.3 0.4 0.2 1.3 0.9 1.1 0.8 0.9 1.2 0.1 1.2 12.8 2.0 0.4 0.2 0.8 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.3 4.7 4.3 2.7 2.3 5.0 2.7 2.8 1.8 3.1 2.2 3.0 2.9 0.3 0.0 1.1 14.0 2.0 0.8 1.2 0.2 2.8 2.4 0.5 0.4 82.6 18.6 0.7 0.0 0.0 0.5 1.2 0.0 0.0 0.5 7.6 1.4 1.5 2.1 1.8 0.0 13.1 0.0 0.4 10.6 2.0 2.5 1.3 2.2 0.7 2.4 0.7 3.3 9.2 0.0 4.1 1.3 0.7 7.6 0.6 2.7 0.0 7.5 0.2 0.4 0.0 6.0 5.2 0.1 0.0 0.0 2.0 1.1 0.3 0.4 0.1 1.7 0.0 662.8 1.9 1.4 1.6 0.2 1.3 0.8 1.1 1.5 0.0 0.2 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;pancreas: 24.0;pituitary gland: 19.8" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 143.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Group enriched" "Detected in some" 7 "HeLa: 56.6;SH-SY5Y: 129.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.2 3.2 14.4 0.4 14.4 4.0 1.7 13.6 27.4 2.8 0.0 1.1 2.6 2.5 0.8 1.0 6.0 1.2 1.9 20.9 4.7 1.0 0.7 1.4 0.6 6.5 2.6 15.4 4.8 24.0 4.6 19.8 1.6 6.3 4.1 0.2 2.2 1.5 1.3 0.7 1.1 2.7 0.8 0.4 5.8 1.2 2.8 2.4 1.0 1.0 0.1 0.5 1.5 1.3 11.4 0.8 3.3 1.8 11.1 0.0 0.0 0.3 0.3 0.0 0.5 0.1 0.0 1.1 0.3 0.5 0.5 2.5 0.4 0.5 0.0 0.0 0.0 1.1 5.1 56.6 0.0 0.1 0.2 0.3 0.3 0.2 0.9 1.2 0.0 0.1 0.7 0.6 0.1 0.0 4.4 0.4 1.6 1.3 0.3 1.9 0.1 0.3 7.0 0.0 0.2 2.9 129.7 3.0 0.1 3.0 0.0 0.9 13.7 0.0 0.4 3.8 0.1 0.0 0.0 0.0 0.2 9.2 2.5 0.3 0.8 0.1 3.4 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.0 0.1 14.4 14.4 13.6 27.4 20.9 4.7 6.5 2.6 15.4 6.3 0.4 2.4 11.4 0.8 0.0 0.6 18.6 0.3 2.4 1.8 0.3 0.0 3.7 0.5 1.1 2.3 0.0 0.7 0.0 0.0 0.1 0.2 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.0 0.0 18.4 8.0 0.2 1.5 0.0 0.1 9.5 0.1 1.4 0.0 0.3 143.0 10.9 0.0 0.0 0.0 0.8 0.8 1.8 0.3 1.8 4.7 1.1 0.8 0.0 15.6 0.8 2.9 1.1 6.8 0.3 1.6 2.7 0.1 0.1 2.3 0.0 1.7 0.7 0.9 1.5 0.3 2.0 0.1 0.3 0.4 0.4 0.4 GPC6 ENSG00000183098 "Glypican 6" Q9Y625 13 93226807-94408020 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA017671 Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 420000 "Golgi apparatus, Vesicles" "HPA017671: AB_1849833" "unprognostic (5.24e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" "unprognostic (9.76e-2)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "unprognostic (1.28e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.33e-2)" "unprognostic (3.71e-2)" "unprognostic (2.53e-3)" "unprognostic (6.21e-3)" "unprognostic (7.42e-2)" "unprognostic (3.36e-1)" "unprognostic (3.35e-3)" 9.2 2.3 1.3 9.0 1.5 0.1 2.2 1.8 1.2 3.6 1.6 6.3 2.3 2.4 2.4 5.2 4.1 17.2 6.2 1.1 8.1 7.8 17.9 3.6 0.4 1.7 2.2 1.2 7.3 1.6 1.8 2.9 1.3 1.9 6.2 6.6 5.7 3.1 15.3 0.7 1.0 4.4 7.8 2.2 2.3 5.4 2.0 1.7 1.8 1.8 1.9 0.9 11.7 2.4 2.1 0.0 4.7 10.2 4.5 62.5 19.5 0.0 7.2 0.0 4.9 6.4 0.0 0.0 0.2 0.0 16.0 0.0 0.0 5.7 1.2 9.1 0.0 4.1 0.0 0.1 20.2 37.8 0.1 0.1 70.8 0.5 11.7 8.1 64.3 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.1 6.4 0.0 3.4 0.0 1.6 0.1 5.5 0.0 4.1 16.8 0.0 1.9 0.0 39.5 14.0 0.0 0.0 26.9 22.6 25.4 12.3 15.9 0.1 0.0 52.8 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 1.5 1.8 1.2 1.1 8.1 1.7 2.2 1.2 1.9 2.2 1.7 2.1 0.6 0.0 0.5 163.2 0.0 0.6 0.5 0.5 0.6 50.3 0.6 1.9 1.7 4.3 0.7 7.3 10.4 0.2 0.0 0.1 0.0 0.3 6.7 1.6 25.9 1.1 0.0 0.0 333.6 0.0 0.1 31.2 0.0 3.1 0.0 36.0 5.7 41.2 0.5 0.0 496.1 0.1 2.0 1.3 1.0 5.0 4.7 0.5 1.8 31.9 0.0 2.7 0.0 691.6 13.2 0.1 0.0 1.9 0.1 1.6 0.0 14.5 0.0 115.0 0.0 34.4 20.9 4.2 2.7 0.5 0.4 0.1 0.7 11.9 0.1 0.2 ARHGEF37 FLJ41603 ENSG00000183111 "Rho guanine nucleotide exchange factor 37" A1IGU5 5 149551947-149634968 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Muller glia cells: 36.8;Oligodendrocytes: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 9.3;neutrophil: 3.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 9.3" "Cell line enhanced" "Detected in many" "EFO-21: 13.9;HaCaT: 26.1;hTCEpi: 33.8" "Region enhanced" "Detected in many" "cerebellum: 10.4" "Low region specificity" "Detected in all" "HPA043885, HPA053487" Uncertain Approved Cytosol NA NA Cytosol "HPA043885: AB_2678715, HPA053487: AB_2682167" "unprognostic (3.51e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-1)" "unprognostic (3.92e-1)" "unprognostic (1.17e-1)" "unprognostic (6.87e-2)" "unprognostic (1.54e-3)" "unprognostic (1.54e-1)" "unprognostic (2.64e-1)" "unprognostic (6.93e-2)" "unprognostic (2.13e-3)" "unprognostic (1.16e-2)" "prognostic favorable (6.85e-4)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.50e-2)" "unprognostic (2.10e-1)" 3.9 3.8 32.7 2.2 40.2 5.3 24.7 36.2 30.3 5.5 34.9 16.2 6.8 7.5 13.7 14.1 10.7 6.4 11.6 26.4 32.5 9.1 2.6 6.5 1.5 42.7 39.6 23.4 3.9 10.8 28.3 6.7 3.2 41.7 23.5 7.6 14.6 40.3 35.7 20.6 45.4 7.5 10.2 39.5 1.4 23.5 5.6 38.3 1.6 3.0 10.6 4.9 10.7 9.0 55.3 4.4 1.7 1.2 5.1 0.3 0.6 3.0 0.5 0.9 0.8 0.8 0.0 5.6 0.6 13.9 0.6 1.5 26.1 0.4 2.6 1.6 1.1 1.3 0.4 2.9 0.3 1.0 0.0 0.8 0.7 33.8 2.6 3.3 2.7 4.2 1.8 0.6 1.1 0.0 0.6 0.8 0.8 0.3 10.7 3.1 0.5 0.6 0.0 5.7 2.1 2.1 5.0 3.2 0.3 0.5 0.6 7.7 0.1 3.4 0.3 0.9 0.1 0.7 0.7 1.6 0.5 1.0 0.1 3.6 9.3 0.5 0.3 0.2 0.8 0.3 0.1 0.1 0.2 0.2 0.4 0.5 0.4 3.0 0.2 0.3 0.7 0.1 0.0 32.7 40.2 36.2 30.3 26.4 32.5 42.7 39.6 23.4 41.7 39.5 38.3 55.3 9.2 0.0 4.5 5.9 2.8 6.8 9.6 10.4 0.6 4.6 32.7 24.4 15.8 17.2 16.5 9.2 4.2 6.2 4.6 18.2 0.0 3.7 5.3 9.4 2.0 7.4 11.4 14.3 5.1 4.9 1.4 2.7 9.7 9.9 7.0 1.7 6.8 3.2 3.1 5.0 7.5 9.6 8.2 2.5 3.3 1.5 1.8 2.9 3.6 12.2 3.9 36.8 7.2 2.0 62.3 5.1 10.1 10.5 2.0 10.5 15.9 1.4 17.8 7.6 6.6 5.7 4.5 16.0 5.7 4.8 9.7 4.5 3.3 1.5 10.5 5.7 FAM43B FLJ44952 ENSG00000183114 "Family with sequence similarity 43 member B" Q6ZT52 1 20552573-20555020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 21.2;brain: 21.5" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Distal tubular cells: 3.9;Excitatory neurons: 2.6;Fibroblasts: 3.8;Inhibitory neurons: 7.5" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;BJ hTERT+: 2.4;fHDF/TERT166: 4.9;Hep G2: 3.7;SCLC-21H: 4.3;SiHa: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA050813 Approved Approved Cytosol NA NA Cytosol "HPA050813: AB_2681244" "unprognostic (1.51e-1)" "unprognostic (5.85e-2)" "unprognostic (2.80e-3)" "unprognostic (1.48e-1)" "unprognostic (5.97e-3)" "unprognostic (1.74e-1)" "unprognostic (8.33e-2)" "unprognostic (5.87e-4)" "unprognostic (1.86e-2)" "unprognostic (7.46e-2)" "unprognostic (8.85e-3)" "unprognostic (2.73e-1)" "unprognostic (1.78e-4)" "unprognostic (1.06e-2)" "unprognostic (6.05e-3)" "unprognostic (6.48e-2)" "unprognostic (2.12e-2)" 0.9 21.2 11.4 0.2 9.8 0.0 0.3 11.3 12.8 0.4 2.4 0.7 0.1 1.0 3.1 0.3 0.9 0.2 3.5 13.8 13.1 1.5 0.4 0.4 0.0 17.1 21.5 9.1 0.3 0.5 0.0 0.8 0.6 13.7 0.7 0.1 0.4 0.5 0.1 0.9 0.2 0.3 0.8 9.1 0.8 0.3 0.5 16.1 0.1 1.2 1.4 0.0 0.7 0.4 14.3 0.0 1.7 0.2 3.3 0.1 0.1 0.0 0.3 2.4 0.4 0.0 0.1 0.0 0.0 0.2 4.9 0.8 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.5 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 9.8 11.3 12.8 13.8 13.1 17.1 21.5 9.1 13.7 9.1 16.1 14.3 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.1 1.9 1.6 0.0 0.0 2.6 0.0 0.1 3.8 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.0 7.5 0.0 0.0 0.6 0.0 0.1 0.3 0.1 0.0 1.0 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.3 0.1 0.9 0.7 0.0 0.0 0.1 0.1 0.1 0.0 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" Q96PZ7 8 2935353-4994972 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4;testis: 2.6" "Group enriched" "Detected in some" 20 "Excitatory neurons: 4868.4;Inhibitory neurons: 3913.1;Oligodendrocyte precursor cells: 4521.8" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 4.9;U-2 OS: 2.2;U-266/70: 2.2;U-266/84: 2.1;U-698: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles NA NA Vesicles "HPA074707: AB_2686707" "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 0.0 0.0 3.9 0.0 6.1 0.0 0.2 0.0 8.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 6.2 1.5 0.5 0.0 0.1 0.0 0.4 0.2 6.9 0.0 0.0 0.1 0.1 0.6 1.4 0.1 0.0 1.6 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.6 0.0 2.6 0.3 0.0 0.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.0 0.0 2.2 2.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.1 0.0 8.4 6.2 1.5 0.4 0.2 6.9 1.4 0.0 0.3 3.0 0.6 0.0 0.5 108.4 0.0 0.3 0.0 0.0 2.2 15.0 1.0 0.9 2.2 0.0 0.6 1.8 0.0 3.4 0.0 0.1 0.0 0.0 52.5 1.5 0.3 2.2 0.0 0.0 4868.4 0.0 1.3 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 3913.1 0.1 0.0 0.0 0.7 15.0 0.3 0.2 0.0 220.2 0.7 0.5 0.0 4521.8 135.2 0.0 0.1 0.4 0.0 0.0 0.0 1.2 9.7 0.6 0.0 0.2 0.5 10.2 5.3 1.0 0.1 3.6 0.1 2.8 0.0 0.1 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Early spermatids: 2.2;Extravillous trophoblasts: 6.7;Late spermatids: 2.0;Syncytiotrophoblasts: 1.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/84: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 2.6 0.3 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 14.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 PTGDR2 "CD294, CRTH2, DP2, GPR44" ENSG00000183134 "Prostaglandin D2 receptor 2" Q9Y5Y4 11 60850933-60855950 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;skeletal muscle: 7.4;stomach 1: 9.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 178.1;eosinophil: 234.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 234.1" "Cell line enhanced" "Detected in some" "HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014259 Uncertain NA NA "HPA014259: AB_1849304" "unprognostic (9.77e-2)" "unprognostic (1.35e-3)" "unprognostic (5.45e-3)" "unprognostic (1.69e-1)" "unprognostic (1.90e-1)" "unprognostic (1.85e-3)" "unprognostic (1.70e-1)" "unprognostic (2.30e-4)" "unprognostic (2.61e-1)" "unprognostic (7.92e-2)" "unprognostic (8.68e-3)" "unprognostic (1.52e-1)" "unprognostic (1.32e-2)" "unprognostic (1.52e-1)" "unprognostic (3.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.99e-2)" 0.6 0.0 5.7 0.6 5.8 0.0 0.6 4.8 9.3 0.3 3.7 4.8 4.4 0.4 0.2 0.8 0.7 0.6 3.5 4.9 5.0 0.1 0.5 0.6 0.1 5.2 5.7 4.3 0.1 0.5 3.4 0.3 1.0 7.3 0.5 4.1 0.1 0.1 0.1 7.4 0.4 6.9 0.3 4.5 0.5 9.4 0.3 5.3 5.0 0.1 3.9 0.1 0.5 0.2 4.8 0.0 0.0 0.1 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 9.6 0.0 4.8 1.0 0.0 5.9 1.9 0.1 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 3.1 14.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 178.1 0.1 234.1 0.0 10.9 0.0 0.0 1.5 1.1 5.2 0.0 0.0 0.0 0.7 0.1 35.8 1.1 1.6 2.3 5.7 5.8 4.8 9.3 4.9 5.0 5.2 5.7 4.3 7.3 4.5 5.3 4.8 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 2.2 1.2 0.0 0.2 0.0 0.0 4.1 0.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 2.4 0.0 0.3 0.5 0.0 1.9 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.9 6.8 0.1 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 CEP57L1 "bA487F23.2, C6orf182, MGC21731" ENSG00000183137 "Centrosomal protein 57 like 1" Q8IYX8 6 109095110-109174418 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 50.3;Spermatocytes: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040378 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040378: AB_10794028" "unprognostic (5.93e-3)" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-2)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (4.69e-3)" "unprognostic (3.63e-2)" "unprognostic (7.25e-2)" "unprognostic (1.27e-1)" "unprognostic (2.33e-1)" "unprognostic (9.97e-2)" "unprognostic (2.42e-5)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (8.48e-2)" "unprognostic (1.72e-1)" 10.6 7.6 5.5 7.9 6.4 10.3 10.3 11.4 7.9 8.2 5.1 8.6 8.8 9.4 10.5 6.3 6.0 9.5 7.6 6.0 5.1 8.1 10.1 6.7 8.9 5.7 5.0 6.1 6.6 7.6 17.0 5.6 10.2 6.4 6.5 11.0 12.1 5.3 6.4 6.1 6.9 7.9 10.9 4.3 7.8 7.4 26.4 5.2 14.6 8.7 6.7 7.4 6.5 6.6 8.5 17.9 7.9 23.1 22.9 21.2 35.2 18.1 40.3 22.1 35.8 39.8 11.9 15.3 16.0 18.4 20.9 30.8 9.1 16.1 15.4 56.1 20.3 16.1 34.8 18.9 12.3 19.6 28.5 14.5 21.2 11.0 30.3 29.9 19.2 32.4 52.5 63.9 52.5 32.4 11.8 32.0 24.6 7.6 14.7 14.6 25.7 17.4 15.7 17.0 7.4 17.4 14.4 19.8 14.7 12.9 15.0 18.2 43.9 14.7 23.1 13.6 24.4 42.9 15.4 19.1 25.3 21.8 43.1 18.9 15.9 5.2 6.6 4.7 6.1 5.1 3.3 4.8 6.7 5.7 6.3 4.5 6.7 3.6 11.6 9.6 6.0 6.9 4.6 5.5 6.4 11.4 7.9 6.0 5.1 5.7 5.0 6.1 6.4 4.3 5.2 8.5 12.9 6.4 5.3 12.4 6.3 3.3 7.6 7.4 7.4 6.6 6.8 7.2 10.3 2.8 6.8 5.5 20.9 9.8 9.7 4.2 7.9 7.0 50.3 12.8 18.5 10.6 5.4 18.1 31.9 5.4 13.2 15.5 8.2 6.9 5.1 20.5 8.2 6.3 10.2 5.0 31.1 3.1 8.2 4.1 6.8 39.3 17.4 7.7 8.8 27.2 7.7 10.4 8.2 26.2 36.1 6.0 4.5 12.4 13.2 4.4 5.7 13.4 9.8 12.3 13.1 21.8 14.1 75.7 13.0 5.8 4.4 8.5 6.7 13.6 6.1 5.0 RIPPLY3 DSCR6 ENSG00000183145 "Ripply transcriptional repressor 3" P57055 21 37006150-37019662 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 3.0;Extravillous trophoblasts: 2.9;Hepatic stellate cells: 1.8;Squamous epithelial cells: 1.6;Urothelial cells: 1.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.1;PC-3: 1.0;RPTEC TERT1: 1.3;RT4: 1.2;SCLC-21H: 3.9;T-47d: 3.2" "Low region specificity" "Detected in many" HPA055541 Uncertain NA NA "HPA055541: AB_2682840" "unprognostic (1.77e-1)" "unprognostic (2.40e-2)" "unprognostic (3.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-3)" "unprognostic (2.19e-2)" "unprognostic (3.08e-1)" "unprognostic (1.91e-2)" "unprognostic (2.11e-2)" "unprognostic (2.17e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-2)" "unprognostic (3.58e-1)" "unprognostic (2.31e-1)" "unprognostic (1.57e-4)" "unprognostic (2.69e-1)" 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 1.3 1.2 3.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 1.2 0.0 0.4 1.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.2 3.0 0.0 0.2 0.0 2.9 0.4 0.0 0.6 0.0 0.2 1.8 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.4 0.4 1.6 0.4 0.0 0.0 0.2 0.1 1.4 ANKRD20A2P ANKRD20A2 ENSG00000183148 "Ankyrin repeat domain 20 family member A2, pseudogene" Q5SQ80 9 40223285-40266845 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.5;testis: 3.3" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 10.5" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753" Uncertain NA NA "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592" "unprognostic (4.24e-3)" "unprognostic (9.19e-2)" 0.3 0.1 0.7 0.0 2.3 0.0 0.3 0.1 2.5 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.7 1.5 1.1 0.1 0.1 0.8 0.0 2.2 1.2 1.8 0.1 0.9 0.0 0.5 0.0 1.6 0.2 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.0 0.3 0.3 0.1 3.3 1.5 0.1 0.3 0.0 0.0 0.0 0.4 2.5 0.1 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 10.5 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.1 2.5 1.5 1.1 2.2 1.2 1.8 1.6 0.3 1.5 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 GPR19 ENSG00000183150 "G protein-coupled receptor 19" Q15760 12 12660890-12696207 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4;pituitary gland: 7.8" "Cell type enhanced" "Detected in some" "Astrocytes: 7.8;Excitatory neurons: 15.2;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 5.9" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 6.5" "Group enriched" "Detected in many" 15 "granulocytes: 2.9;T-cells: 6.5" "Cell line enhanced" "Detected in many" "HDLM-2: 39.9;NTERA-2: 39.7;SuSa: 28.5;WM-115: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013955 Uncertain NA NA "HPA013955: AB_1849287" "unprognostic (1.92e-1)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (8.62e-5)" "unprognostic (1.60e-1)" "unprognostic (3.21e-1)" "unprognostic (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "unprognostic (6.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.70e-2)" "unprognostic (2.67e-12)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-1)" 0.3 0.8 7.3 2.0 7.3 0.9 0.3 9.2 10.4 0.1 3.8 0.5 0.3 0.1 0.1 0.5 0.2 0.3 0.1 6.9 8.9 0.1 0.2 0.2 1.8 6.7 6.7 7.0 0.0 0.3 0.1 7.8 0.3 6.8 0.1 0.6 2.0 0.1 0.1 0.0 0.8 0.5 0.3 6.4 0.7 0.4 4.3 7.3 2.8 0.1 0.0 2.4 0.3 0.1 6.8 1.6 0.6 16.6 0.4 0.0 0.0 7.0 1.6 1.7 2.9 2.5 6.6 10.1 6.8 2.5 1.2 2.3 1.3 2.7 0.3 4.8 39.9 0.3 1.6 0.7 1.1 0.0 1.7 0.6 0.1 0.0 3.1 1.9 1.2 0.5 0.7 0.3 13.8 0.6 2.4 0.6 1.0 39.7 1.7 3.0 4.4 2.5 0.2 0.2 1.4 5.4 5.0 0.7 1.4 13.4 28.5 0.9 1.7 0.0 0.8 7.2 1.3 3.9 7.6 7.2 13.3 3.1 4.7 20.4 0.0 0.0 0.0 1.2 0.0 0.8 0.2 2.4 1.4 0.0 0.1 0.4 0.9 2.9 0.3 0.0 0.0 6.5 0.3 7.3 7.3 9.2 10.4 6.9 8.9 6.7 6.7 7.0 6.8 6.4 7.3 6.8 0.2 0.0 0.0 7.8 0.4 0.1 0.1 0.0 0.0 1.8 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 4.7 0.1 0.2 0.1 0.0 2.7 15.2 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.1 0.0 15.6 0.1 0.0 0.3 0.3 1.6 0.3 0.2 0.0 2.8 0.0 1.7 0.0 15.6 5.9 0.2 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.8 3.6 0.6 0.0 0.0 0.1 1.2 0.0 0.3 0.1 GJD3 "Cx30.2, CX31.9, GJA11, GJC1" ENSG00000183153 "Gap junction protein delta 3" Q8N144 17 40360652-40364737 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 28.3;MCF7: 10.6;T-47d: 10.2" "Not detected" "Not detected" NA NA "unprognostic (5.54e-4)" "unprognostic (4.53e-2)" "unprognostic (1.69e-2)" "unprognostic (6.07e-3)" "unprognostic (5.84e-2)" "unprognostic (8.01e-3)" "unprognostic (3.75e-3)" "unprognostic (7.89e-2)" "unprognostic (5.35e-2)" "unprognostic (2.23e-1)" "unprognostic (8.43e-3)" "unprognostic (9.91e-3)" "unprognostic (1.01e-3)" "unprognostic (1.90e-1)" "unprognostic (1.73e-4)" 1.9 1.0 0.3 2.4 0.3 0.3 0.4 0.1 0.3 1.4 0.1 2.0 2.4 1.4 1.3 3.4 1.8 2.8 2.4 0.3 0.6 1.4 1.5 3.9 2.3 0.4 0.4 0.3 0.5 1.7 0.4 0.0 0.8 0.4 2.5 0.9 0.1 1.7 3.4 1.7 2.8 2.5 1.6 0.1 8.1 2.3 0.8 0.7 1.7 4.3 1.5 0.6 2.3 0.2 0.2 2.4 6.0 0.6 2.2 0.0 0.0 8.9 2.7 0.1 0.4 1.2 0.4 1.2 0.0 2.1 1.5 0.1 8.0 0.0 0.0 0.0 2.5 4.6 0.5 0.8 6.5 28.3 1.2 3.3 1.7 0.0 0.1 0.0 2.3 0.0 1.8 5.2 0.0 0.0 10.6 0.7 3.5 0.7 0.8 1.4 2.9 0.0 0.4 0.1 8.7 0.6 2.4 4.0 0.3 1.2 0.7 10.2 3.9 3.1 0.1 0.2 2.0 0.0 0.7 0.0 1.1 0.6 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.3 0.6 0.4 0.4 0.3 0.4 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 RABIF "mss4, RASGRF3" ENSG00000183155 "RAB interacting factor" P47224 1 202878282-202889149 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3764.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027715 Approved NA NA "HPA027715: AB_10602151" "unprognostic (4.87e-2)" "unprognostic (3.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.37e-1)" "unprognostic (3.51e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.70e-1)" "unprognostic (5.62e-3)" "prognostic favorable (5.64e-5)" "unprognostic (4.40e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.23e-1)" "unprognostic (5.21e-2)" "unprognostic (8.54e-2)" "unprognostic (2.47e-1)" 3.7 3.9 6.3 5.7 7.0 8.4 4.0 6.1 8.5 4.1 4.9 5.5 5.7 3.4 3.9 9.0 3.0 4.1 4.2 7.1 7.0 5.6 5.3 4.8 6.8 6.5 6.2 6.6 2.0 3.3 3.2 4.0 4.9 6.8 4.2 6.0 6.9 4.8 3.2 4.9 5.5 5.4 4.8 6.3 6.3 3.8 18.1 6.8 5.7 3.1 4.4 8.7 5.1 4.9 7.8 11.7 12.2 8.8 10.6 13.4 9.9 9.5 12.9 7.1 12.8 11.8 8.9 9.9 9.6 6.0 10.0 8.8 10.9 6.9 8.0 9.7 11.8 12.7 7.9 9.8 9.1 10.8 11.1 13.4 8.5 11.2 16.0 4.1 6.3 16.9 12.4 12.7 10.3 12.5 19.5 12.5 12.0 7.2 9.1 15.1 8.7 12.3 13.2 13.2 12.2 12.3 11.0 11.0 19.1 10.4 10.6 12.6 8.1 13.3 8.9 8.2 4.3 11.2 5.4 13.0 10.1 8.8 10.3 8.5 32.4 21.1 31.6 18.4 23.2 13.5 17.8 17.3 17.4 19.0 17.8 15.6 16.5 33.3 17.9 22.0 18.1 21.1 18.3 6.3 7.0 6.1 8.5 7.1 7.0 6.5 6.2 6.6 6.8 6.3 6.8 7.8 11.8 0.0 15.9 4.6 26.2 54.3 37.8 53.3 17.6 5.4 18.9 12.3 11.2 17.2 33.8 12.9 2.1 52.5 39.1 42.4 15.6 37.3 696.1 17.9 8.5 20.6 23.4 21.2 9.0 53.4 50.5 16.6 13.7 14.5 12.7 8.0 20.3 34.9 42.1 1.7 7.0 14.7 40.7 37.4 36.0 3764.0 28.3 29.1 53.4 5.6 48.4 18.2 62.8 5.5 7.3 77.5 40.9 30.1 27.1 28.2 34.3 59.1 32.0 6.0 13.1 9.5 21.7 98.0 62.7 23.4 51.9 78.9 35.0 10.8 14.6 49.2 TMEM119 OBIF ENSG00000183160 "Transmembrane protein 119" Q4V9L6 12 108589851-108598320 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Biomineralization, Differentiation, Osteogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 61.5" "Cell type enhanced" "Detected in some" "Early spermatids: 8.3;Fibroblasts: 30.5;Late spermatids: 9.3;Melanocytes: 8.8;Microglial cells: 15.0;Peritubular cells: 24.0;Smooth muscle cells: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 559.2;ASC TERT1: 152.6;BJ hTERT+: 168.0;fHDF/TERT166: 81.9;HSkMC: 238.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051870, HPA052650" Enhanced NA NA "HPA051870: AB_2681645, HPA052650: AB_2681901" "unprognostic (4.90e-2)" "unprognostic (2.66e-1)" "unprognostic (6.84e-2)" "unprognostic (5.97e-2)" "unprognostic (2.35e-1)" "unprognostic (3.29e-2)" "unprognostic (6.67e-2)" "unprognostic (8.40e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.61e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (1.29e-2)" "unprognostic (8.76e-3)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" 23.9 8.1 6.8 16.3 7.9 3.0 27.4 8.2 8.3 61.5 4.8 12.7 15.3 19.0 14.2 6.9 12.0 36.1 9.5 6.7 11.2 5.9 0.9 37.9 48.2 15.3 10.3 4.3 1.4 7.6 5.6 6.2 6.6 14.0 12.8 15.3 0.9 6.9 26.3 1.6 13.1 23.3 11.3 15.4 11.5 10.6 5.9 13.3 5.1 21.9 1.7 27.4 32.5 18.6 14.9 0.1 0.3 1.3 0.7 559.2 152.6 0.8 11.8 168.0 0.4 3.0 0.2 0.6 0.3 0.4 81.9 0.3 0.2 0.1 0.2 0.1 0.5 0.0 0.3 0.6 1.0 7.2 0.3 1.2 238.4 0.3 7.0 0.1 0.7 0.1 0.2 0.5 0.5 0.5 0.7 0.3 1.6 0.1 0.0 0.9 0.6 0.9 0.8 0.1 0.7 0.2 39.5 0.0 0.3 0.3 4.5 0.2 1.8 1.2 13.1 0.4 11.2 0.5 2.6 3.1 0.6 6.8 0.5 0.1 1.4 0.2 0.3 0.2 0.1 0.2 0.2 0.4 0.2 0.1 0.4 0.3 0.3 1.4 0.2 0.4 0.2 0.1 0.1 6.8 7.9 8.2 8.3 6.7 11.2 15.3 10.3 4.3 14.0 15.4 13.3 14.9 1.3 0.0 0.0 0.0 0.2 3.8 0.1 0.0 0.6 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 8.3 0.2 5.8 1.3 0.0 0.0 0.0 0.0 0.2 30.5 0.0 0.2 0.0 0.0 0.7 0.0 1.4 0.0 0.0 0.0 0.0 1.9 4.4 9.3 4.1 1.1 8.8 15.0 1.6 0.0 0.0 0.0 0.0 0.1 1.1 24.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 9.7 0.1 0.1 0.0 3.7 0.3 0.7 0.5 0.0 0.1 FANCF FAF ENSG00000183161 "FA complementation group F" Q9NPI8 11 22622533-22625823 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Distal tubular cells: 45.0;Early spermatids: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008899 Supported Nucleoplasm NA NA Nucleoplasm "HPA008899: " "unprognostic (1.16e-2)" "unprognostic (4.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.37e-2)" "unprognostic (4.55e-2)" "unprognostic (8.84e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (4.29e-2)" "unprognostic (1.11e-1)" "unprognostic (2.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (3.73e-2)" "unprognostic (1.81e-1)" "unprognostic (9.14e-2)" "unprognostic (7.64e-3)" 2.1 3.8 4.1 5.6 4.0 2.8 5.3 4.6 3.9 4.9 5.8 5.6 7.9 4.0 8.6 2.9 8.9 3.2 3.6 3.6 4.4 5.1 4.3 3.5 8.3 4.3 4.5 3.7 6.2 8.2 4.9 3.7 3.0 4.2 4.7 5.9 5.2 6.1 4.8 1.3 5.2 7.7 2.5 4.5 6.4 7.1 5.0 4.7 9.4 5.7 1.1 7.7 3.5 2.1 4.8 2.3 6.7 8.6 9.5 4.5 5.4 3.5 4.3 5.3 5.0 5.5 4.3 3.5 11.3 1.2 4.5 8.9 9.6 7.2 7.5 2.5 18.5 3.3 4.3 2.7 7.0 5.2 8.0 4.6 5.2 14.1 1.7 7.7 8.5 8.1 15.9 10.9 13.8 3.2 7.0 20.4 7.5 9.8 19.2 8.4 17.0 4.1 12.8 9.7 8.7 32.0 15.1 2.4 7.7 7.8 9.2 15.5 7.1 5.7 5.0 5.1 9.3 6.4 8.0 11.0 3.4 8.1 3.2 11.8 12.3 7.6 16.8 15.3 8.1 18.0 16.1 14.3 14.9 9.2 20.9 19.3 16.2 1.1 15.0 8.7 13.5 10.7 10.6 4.1 4.0 4.6 3.9 3.6 4.4 4.3 4.5 3.7 4.2 4.5 4.7 4.8 4.7 3.2 2.2 2.3 13.9 3.3 6.2 8.8 6.8 15.2 7.1 6.0 5.7 18.6 6.3 3.7 10.4 11.6 15.3 10.2 45.0 18.8 168.1 14.1 6.8 6.3 3.5 8.0 2.6 18.7 7.5 5.4 10.7 6.8 2.5 9.6 6.4 10.7 6.9 16.8 3.3 16.5 10.2 6.9 2.6 25.5 9.6 6.7 5.4 5.6 11.3 13.1 22.6 0.5 6.2 10.7 10.3 9.8 7.1 5.6 13.2 22.5 24.4 18.0 6.6 3.2 5.3 23.1 16.7 10.1 2.3 2.3 11.2 11.1 15.8 2.4 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 11.4;brain: 44.7;lymphoid tissue: 25.0" "Cell type enhanced" "Detected in some" "Astrocytes: 88.8;Excitatory neurons: 130.6;Inhibitory neurons: 212.7;Oligodendrocyte precursor cells: 44.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Karpas-707: 44.5" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.1 11.4 10.7 0.0 19.8 0.6 0.2 44.7 14.4 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 23.6 39.9 0.0 0.2 0.0 0.0 24.6 17.1 12.0 0.1 1.0 0.0 0.5 0.0 30.7 0.2 0.1 1.9 0.0 1.2 0.0 3.4 0.0 0.0 17.1 0.0 0.0 3.2 8.0 25.0 0.1 0.0 0.0 0.0 3.3 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 44.5 0.0 0.0 0.1 0.0 6.0 0.0 0.0 7.1 0.0 0.8 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 7.2 0.1 0.0 7.0 7.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 19.8 44.7 14.4 23.6 39.9 24.6 17.1 12.0 30.7 17.1 8.0 26.3 0.0 0.0 0.0 88.8 0.0 2.3 0.4 0.0 0.0 3.8 0.0 0.6 5.6 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.8 0.1 0.1 0.3 0.0 2.1 130.6 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.4 0.4 0.1 0.0 212.7 1.5 0.0 0.3 0.7 7.0 0.0 0.1 0.0 14.0 0.0 0.2 1.0 44.7 15.7 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.0 0.8 0.0 6.1 0.2 8.8 12.8 0.0 9.8 0.1 0.2 0.2 0.1 0.1 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: AB_2684257" "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favorable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favorable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favorable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 11.8 14.0 21.9 6.2 22.4 17.8 19.7 26.1 28.0 14.4 21.0 14.2 10.4 12.4 19.6 12.7 15.3 7.5 19.5 22.2 22.3 18.3 15.2 9.8 16.2 21.9 21.9 21.9 22.7 21.7 18.1 15.0 7.3 22.7 16.2 11.3 16.2 22.9 13.6 35.9 14.6 13.6 8.5 21.6 12.7 17.8 7.0 21.8 12.5 18.7 38.3 12.3 12.5 12.0 22.7 5.7 3.7 7.4 8.9 13.1 9.5 5.8 2.0 10.0 12.1 10.5 7.1 5.3 7.8 2.4 10.3 3.4 6.1 9.8 10.4 7.7 3.8 15.7 4.7 8.1 10.3 16.5 8.6 5.9 7.4 17.3 4.8 9.9 6.9 12.2 5.1 7.9 12.3 8.4 11.2 12.1 13.0 2.8 14.1 2.7 10.8 6.5 20.8 15.5 6.4 9.2 6.0 5.0 11.1 12.8 3.7 9.3 9.3 4.8 5.1 5.3 4.5 3.9 8.2 9.8 16.9 7.9 8.5 4.1 4.0 5.8 2.9 3.1 3.1 5.9 5.9 8.6 4.5 8.4 7.2 9.3 6.0 0.5 5.5 4.5 6.4 5.4 5.4 21.9 22.4 26.1 28.0 22.2 22.3 21.9 21.9 21.9 22.7 21.6 21.8 22.7 161.1 83.3 109.3 11.8 295.0 166.7 202.2 157.3 191.2 71.6 400.9 477.3 350.9 237.4 160.3 204.1 20.9 308.7 127.8 285.6 573.2 160.0 114.0 156.8 81.1 138.2 345.2 135.7 10.5 199.6 190.6 127.8 150.3 127.2 91.4 55.4 161.3 380.1 256.1 55.5 12.8 356.5 262.4 164.5 200.6 131.9 189.2 187.7 211.7 5.6 125.8 196.4 124.6 7.5 13.8 193.7 314.0 149.0 275.8 238.2 486.7 623.4 223.7 109.5 124.9 133.6 202.7 256.0 55.5 271.5 274.1 308.8 186.3 151.7 308.8 272.2 GABRR3 ENSG00000183185 "Gamma-aminobutyric acid type A receptor subunit rho3" A8MPY1 3 97986673-98035304 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "retina: 14.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 19.8;Rod photoreceptor cells: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.22e-2)" "unprognostic (2.06e-3)" "unprognostic (5.65e-2)" "unprognostic (2.82e-1)" "unprognostic (1.43e-4)" "unprognostic (2.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2CD4C "FAM148C, KIAA1957, NLF3" ENSG00000183186 "C2 calcium dependent domain containing 4C" Q8TF44 19 405445-409147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.5" "Cell type enhanced" "Detected in some" "Adipocytes: 13.2;Excitatory neurons: 3.6;Granulosa cells: 3.7;Hepatic stellate cells: 3.6;Rod photoreceptor cells: 7.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.4;MCF7: 4.4;NTERA-2: 6.2;SCLC-21H: 11.1;U-2 OS: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055915 Uncertain Approved Vesicles NA NA Vesicles "HPA055915: AB_2682968" "unprognostic (1.29e-1)" "unprognostic (9.43e-2)" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (9.39e-3)" "unprognostic (2.14e-1)" "unprognostic (1.67e-1)" "unprognostic (9.81e-2)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.43e-2)" "unprognostic (5.04e-2)" "unprognostic (5.09e-2)" "unprognostic (1.74e-1)" 2.9 1.0 8.8 0.3 10.7 0.0 3.1 2.7 17.5 2.8 1.7 1.3 0.4 2.3 0.0 0.7 2.0 2.8 3.0 9.4 13.1 2.4 0.7 1.8 0.1 6.6 6.6 12.7 0.3 1.0 0.1 2.6 0.4 6.4 1.0 0.0 0.8 0.3 0.0 0.9 0.7 1.4 0.1 5.4 1.1 0.8 2.1 10.4 0.1 3.9 0.5 0.0 0.6 1.0 6.7 0.0 0.5 1.5 1.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 2.0 0.0 0.5 0.0 0.7 2.4 2.4 0.2 0.1 6.4 1.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.0 4.4 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.1 3.2 1.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 6.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 10.7 2.7 17.5 9.4 13.1 6.6 6.6 12.7 6.4 5.4 10.4 6.7 13.2 0.0 0.0 0.3 0.1 0.3 0.3 0.3 0.0 0.5 0.3 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.2 1.9 3.0 0.0 3.6 0.4 0.0 0.1 0.0 0.2 0.0 3.7 3.6 0.1 0.0 0.0 3.1 0.0 2.0 0.0 0.4 0.3 0.0 0.0 0.0 1.9 0.0 2.0 0.0 3.0 0.6 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 7.6 0.0 0.4 0.4 0.7 2.2 0.0 0.3 0.0 0.1 0.0 0.0 0.1 CHST6 MCDC1 ENSG00000183196 "Carbohydrate sulfotransferase 6" Q9GZX3 16 75472052-75495445 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.5;cervix: 9.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 60.0;Oligodendrocytes: 17.0;Respiratory ciliated cells: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 9.3;CAPAN-2: 9.9;NTERA-2: 4.8;SK-MEL-30: 4.1;U-2 OS: 5.0;WM-115: 5.4" HPA068029 Approved "Intracellular and membrane" NA NA "HPA068029: " "unprognostic (2.28e-2)" "unprognostic (2.25e-2)" "unprognostic (1.07e-1)" "unprognostic (3.93e-3)" "unprognostic (3.30e-2)" "unprognostic (4.02e-2)" "unprognostic (7.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (3.16e-2)" "unprognostic (1.07e-1)" "unprognostic (1.10e-7)" "unprognostic (1.23e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (2.80e-4)" 0.1 5.4 8.8 0.2 10.5 0.1 0.0 9.1 6.6 9.5 2.9 0.8 4.5 0.4 0.2 1.3 1.2 0.1 1.2 7.2 13.5 0.2 0.0 0.9 0.1 11.9 12.0 3.9 0.0 0.0 0.2 1.3 0.1 11.3 0.4 1.5 0.3 2.7 0.1 0.1 0.1 3.9 0.3 10.5 0.1 0.1 0.8 12.4 0.1 0.1 0.1 0.0 0.2 0.1 11.8 0.1 0.5 0.6 9.3 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.2 9.9 0.1 1.1 0.0 0.1 0.1 0.9 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 4.1 1.4 0.0 0.3 0.1 0.0 5.0 0.0 0.0 0.1 0.1 2.1 0.2 0.0 5.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 8.8 10.5 9.1 6.6 7.2 13.5 11.9 12.0 3.9 11.3 10.5 12.4 11.8 0.2 0.0 2.4 7.5 0.2 0.0 1.7 0.7 0.0 0.7 0.2 0.1 1.0 0.0 4.8 3.7 0.0 2.1 0.1 3.8 0.0 0.1 1.3 60.0 0.8 0.4 0.0 0.0 0.4 0.0 0.2 1.6 0.0 7.5 1.3 0.2 0.0 0.0 0.2 0.0 1.3 4.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 1.9 0.0 0.6 0.0 6.0 17.0 0.2 8.9 0.0 0.0 1.5 8.9 0.0 16.4 0.4 0.0 1.0 0.7 0.3 0.6 0.0 0.0 0.7 0.4 0.1 2.2 3.9 POTEC "A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18" ENSG00000183206 "POTE ankyrin domain family member C" B2RU33 18 14507339-14543585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 2.5" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.63e-1)" "unprognostic (9.88e-2)" "unprognostic (8.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 40.1 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.1 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993562-49015970 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA 53000 "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 23.6 21.9 44.7 27.0 41.2 51.8 22.8 44.9 55.0 23.7 47.1 30.0 28.2 19.5 15.4 37.0 72.8 15.9 37.4 45.2 41.1 19.6 24.2 19.8 31.0 42.4 42.0 41.1 26.0 34.8 28.4 6.6 24.2 43.9 20.4 17.5 15.1 32.7 25.6 60.9 31.0 25.0 19.2 40.9 20.8 22.8 111.7 43.3 39.2 24.1 39.5 21.5 22.8 7.2 51.7 236.5 346.0 63.3 250.2 45.0 50.9 88.8 105.4 86.3 214.9 162.5 267.4 148.7 219.9 78.5 106.8 93.7 134.6 99.9 210.3 68.5 99.2 323.7 158.8 196.7 241.0 119.1 318.8 96.8 78.0 68.0 145.0 113.5 59.2 114.1 232.8 266.6 121.3 90.5 195.2 234.1 218.5 122.6 162.4 152.4 227.4 156.9 155.8 110.5 182.7 155.7 169.9 132.2 164.2 66.2 30.4 125.9 179.4 104.8 100.8 135.1 63.8 318.1 171.4 177.1 223.6 76.2 174.6 156.4 51.1 54.9 18.9 42.6 52.4 46.8 54.5 45.2 42.3 65.9 52.6 42.9 40.0 3.7 47.4 48.5 48.9 49.2 55.4 44.7 41.2 44.9 55.0 45.2 41.1 42.4 42.0 41.1 43.9 40.9 43.3 51.7 16.5 12.8 20.7 4.2 25.3 27.8 52.0 89.8 37.5 17.5 30.4 33.7 48.5 24.3 55.7 33.1 33.3 104.6 15.0 33.8 46.9 78.3 614.5 131.7 29.6 27.3 17.5 58.1 6.1 71.8 81.8 36.6 28.5 25.4 13.3 32.8 23.2 34.2 51.1 18.5 5.2 38.5 52.9 22.9 25.5 945.1 36.1 18.9 26.6 1.9 35.5 31.2 27.8 4.5 5.6 56.0 30.6 42.9 41.3 43.5 33.1 70.4 253.6 31.4 19.7 28.9 65.4 394.2 43.9 49.2 27.6 115.9 20.8 37.1 61.0 38.8 GDPGP1 C15orf58 ENSG00000183208 "GDP-D-glucose phosphorylase 1" Q6ZNW5 15 90233808-90245811 "Enzymes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA048189, HPA059841" Approved Approved Cytosol NA NA Cytosol "HPA048189: AB_2680307, HPA059841: AB_2684138" "prognostic favorable (6.32e-4)" "unprognostic (1.85e-1)" "unprognostic (2.17e-1)" "unprognostic (2.42e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (3.68e-2)" "unprognostic (4.46e-3)" "unprognostic (1.53e-1)" "unprognostic (3.00e-1)" "unprognostic (1.82e-2)" "unprognostic (2.93e-3)" "unprognostic (8.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.02e-3)" 1.8 3.2 3.3 3.0 3.1 2.0 2.4 4.2 3.6 2.0 2.8 5.8 5.3 2.3 3.1 2.4 4.6 3.1 5.9 3.2 2.7 3.1 5.0 2.9 3.5 3.8 3.0 3.9 2.9 3.5 4.9 3.8 1.0 4.3 3.8 7.7 2.8 3.8 3.1 8.0 2.1 3.9 2.8 1.6 3.2 3.6 4.6 2.8 3.1 3.8 1.5 4.1 3.4 1.5 5.0 3.0 11.8 1.4 4.3 4.3 0.9 3.9 2.7 1.7 3.5 3.3 3.5 11.5 7.5 5.2 2.1 2.6 5.0 4.5 3.2 1.4 6.7 7.8 6.7 7.0 5.1 4.6 3.6 4.2 1.1 2.1 2.4 1.3 3.9 4.2 4.4 2.5 2.6 2.1 6.5 2.7 1.6 1.8 9.2 4.8 4.7 1.0 3.8 4.1 5.9 4.5 2.0 4.3 6.6 4.5 2.6 7.6 3.7 4.2 1.8 1.9 2.7 2.7 5.8 7.3 3.4 4.1 3.0 3.3 3.8 2.2 1.0 3.1 2.6 2.7 2.3 2.9 3.7 2.0 4.2 3.0 2.8 3.1 3.4 2.2 2.1 3.9 1.4 3.3 3.1 4.2 3.6 3.2 2.7 3.8 3.0 3.9 4.3 1.6 2.8 5.0 1.4 0.0 3.2 0.3 2.1 0.0 2.8 0.9 1.8 3.8 3.4 2.2 6.4 8.6 1.5 7.3 6.2 2.4 2.5 6.5 3.9 3.8 3.0 3.8 1.6 1.7 5.4 1.7 2.6 6.0 1.2 1.5 4.1 2.3 3.8 2.3 1.4 4.5 4.1 1.7 2.8 3.6 0.0 2.2 0.0 2.4 2.8 3.5 0.0 1.0 2.3 3.5 2.1 1.0 2.1 4.9 5.5 2.2 2.4 2.2 3.8 5.8 3.4 4.4 0.0 3.8 1.0 2.9 2.8 1.8 0.3 0.4 3.2 1.5 4.2 3.1 CTNNA3 "MGC26194, VR22" ENSG00000183230 "Catenin alpha 3" Q9UI47 10 65912523-67696195 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 172.3" "Cell type enriched" "Detected in some" 14 "Oligodendrocytes: 4054.6" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 1.5;NTERA-2: 1.7;RPMI-8226: 2.4;SCLC-21H: 1.5;U-266/70: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061818 Enhanced NA NA "HPA061818: AB_2684618" "unprognostic (2.19e-1)" "unprognostic (1.57e-1)" "unprognostic (8.64e-4)" "unprognostic (8.13e-3)" "unprognostic (6.43e-3)" "unprognostic (9.90e-2)" "unprognostic (2.60e-4)" "unprognostic (8.27e-2)" "unprognostic (5.10e-2)" "unprognostic (2.55e-1)" "unprognostic (9.09e-3)" "unprognostic (1.15e-1)" "unprognostic (2.67e-3)" "unprognostic (7.93e-5)" "unprognostic (6.43e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" 0.7 0.5 30.4 0.6 81.7 0.1 0.5 43.3 50.6 1.4 0.0 1.5 0.3 1.3 0.1 1.5 0.7 0.6 18.8 24.1 40.2 0.3 8.5 0.1 0.2 74.3 67.7 10.6 1.8 0.1 0.2 0.2 0.4 85.1 0.4 0.6 0.4 0.3 0.2 12.2 0.2 0.8 2.6 65.8 0.3 1.2 2.2 59.0 0.1 0.3 23.6 0.3 0.6 0.6 172.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.6 0.7 0.1 0.0 2.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 6.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.4 81.7 43.3 50.6 24.1 40.2 74.3 67.7 10.6 85.1 65.8 59.0 172.3 0.4 0.0 0.0 24.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 75.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 217.8 0.0 1.5 1.2 0.0 0.0 49.8 0.0 0.0 2.5 0.0 0.1 0.0 2.6 0.4 5.7 0.0 0.0 50.6 0.0 0.0 0.8 0.3 275.5 4.4 0.3 0.0 30.0 0.0 1.4 0.0 50.3 4054.6 0.0 0.1 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 9.3 4.0 1.6 0.0 0.1 0.0 0.1 4.6 0.1 0.0 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545678-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 6.2" "Cell type enhanced" "Detected in some" "Early spermatids: 30.7;Late spermatids: 49.4;Spermatocytes: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.6 0.1 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.2;pituitary gland: 29.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 21.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.1 0.9 4.2 0.1 3.9 0.0 2.5 4.0 21.2 0.6 0.0 0.3 0.2 0.6 0.3 0.3 1.2 0.1 0.1 10.0 0.0 2.5 0.2 1.0 0.0 3.9 0.0 4.6 0.7 2.8 2.0 29.9 0.0 12.2 2.5 0.0 5.1 4.2 0.3 0.0 0.6 0.2 0.0 0.0 0.1 0.8 0.8 0.1 0.1 1.1 0.0 0.0 0.3 0.3 2.4 0.1 0.9 6.6 5.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 2.9 0.0 1.9 0.0 0.6 0.1 5.1 0.0 0.0 0.0 6.4 0.0 0.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.2 0.1 0.1 0.0 3.0 0.3 0.3 2.5 0.4 0.6 28.7 0.0 0.3 3.7 5.4 8.0 17.9 0.0 0.3 0.0 0.5 9.1 0.0 0.0 0.0 3.2 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 3.9 4.0 21.2 10.0 0.0 3.9 0.0 4.6 12.2 0.0 0.1 2.4 0.3 0.0 0.0 1.0 0.5 0.0 0.8 0.0 2.2 13.4 9.2 7.7 1.3 2.8 0.0 5.5 12.5 0.2 0.2 0.2 5.9 3.0 5.4 4.5 0.7 0.2 3.6 0.0 6.9 0.9 0.4 0.3 2.6 6.7 0.0 1.1 0.0 0.5 0.1 10.1 5.8 0.7 0.0 0.0 0.0 0.7 0.6 0.4 0.0 3.7 0.0 5.4 0.0 4.5 0.8 0.9 0.1 0.0 0.6 1.3 0.1 1.5 0.0 4.5 0.0 0.3 1.1 0.3 3.7 3.1 0.0 0.3 0.3 0.5 0.3 1.0 OR51B4 ENSG00000183251 "Olfactory receptor family 51 subfamily B member 4" Q9Y5P0 11 5301014-5301946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 3.8;U-2197: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.16e-2)" "unprognostic (5.01e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTTG1IP "C21orf1, C21orf3, PBF" ENSG00000183255 "PTTG1 interacting protein" P53801 21 44849585-44873903 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034146, HPA061827" Uncertain Supported Nucleoplasm NA Yes 26000 Nucleoplasm "CAB034146: AB_1568894, HPA061827: AB_2684620" "unprognostic (1.78e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (5.24e-3)" "unprognostic (3.18e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (1.22e-2)" "unprognostic (1.98e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (9.30e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.40e-4)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.90e-1)" 123.5 132.9 139.4 99.3 150.0 92.8 115.0 148.2 148.1 132.2 129.7 134.0 124.3 133.5 119.5 89.9 110.3 143.0 165.9 133.3 167.7 142.9 131.6 161.8 75.9 172.7 144.9 121.0 111.6 86.4 84.8 69.3 181.6 160.1 109.5 112.5 29.9 119.3 152.8 71.3 86.4 128.4 146.3 150.2 98.5 171.5 67.5 163.9 58.4 128.5 63.8 62.6 140.9 94.1 156.0 245.3 134.6 155.3 148.2 300.6 174.8 127.0 212.9 309.8 174.1 166.6 290.0 323.9 32.9 789.8 344.4 417.0 109.8 73.0 140.2 161.1 56.3 81.0 254.3 80.0 260.1 293.8 97.6 83.5 269.9 225.1 189.1 130.8 346.3 376.6 88.6 131.7 83.1 539.5 106.0 71.0 99.5 166.8 352.9 169.8 70.4 158.4 162.0 735.6 82.7 117.2 182.0 240.0 262.5 482.0 188.7 203.7 163.7 511.8 216.9 126.5 170.6 340.0 78.5 79.4 42.2 146.7 220.6 199.8 336.2 181.2 109.1 48.4 146.7 79.5 25.5 62.7 51.3 203.3 23.6 59.7 41.0 248.8 67.3 167.0 92.5 87.3 223.7 139.4 150.0 148.2 148.1 133.3 167.7 172.7 144.9 121.0 160.1 150.2 163.9 156.0 140.9 394.2 169.6 39.8 28.0 50.7 84.1 181.3 61.5 14.6 102.0 96.8 173.0 75.8 248.9 145.3 6.2 218.6 56.8 321.4 49.0 323.0 51.5 115.0 115.0 191.6 79.3 37.8 8.5 120.6 72.7 117.1 140.6 187.7 81.5 181.3 124.2 102.2 109.3 11.8 10.7 89.1 130.2 88.0 69.6 98.7 72.1 136.3 87.2 22.5 91.1 78.8 51.5 20.1 31.9 294.3 255.2 98.9 36.4 112.8 268.1 71.2 192.3 15.2 65.7 61.1 127.9 73.7 43.4 92.4 42.9 366.7 45.6 54.6 100.3 169.9 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177516961 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: AB_2680527" "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 26.6 29.3 14.9 28.9 15.4 22.5 25.6 12.6 20.9 26.1 12.8 26.7 25.0 25.4 17.0 34.0 30.9 18.5 18.8 17.9 13.7 26.7 27.4 24.7 24.9 14.6 13.0 12.7 28.9 23.7 31.4 18.1 22.9 15.7 22.5 19.5 14.8 28.9 19.3 43.8 33.8 28.9 20.2 11.4 27.0 26.9 18.1 15.8 24.5 29.2 20.5 25.2 25.0 27.8 17.1 62.1 71.4 42.4 44.9 43.4 45.2 125.1 58.4 35.1 47.1 36.1 107.7 61.3 67.2 83.3 57.6 67.6 47.8 57.2 128.5 33.2 175.4 68.0 90.5 70.8 66.5 52.5 89.3 82.3 48.7 47.0 45.3 59.0 43.5 53.4 68.1 72.3 50.0 55.6 135.5 80.6 45.9 62.0 59.0 61.3 72.7 48.1 86.2 50.5 78.8 45.0 41.9 64.6 83.2 56.5 27.1 54.6 110.2 51.3 74.4 42.8 43.6 87.6 49.6 75.9 120.1 81.3 100.1 47.0 14.3 31.4 22.3 18.3 28.5 23.5 17.0 18.3 16.8 27.2 14.4 14.6 18.8 9.2 25.8 31.4 11.2 18.8 25.6 14.9 15.4 12.6 20.9 17.9 13.7 14.6 13.0 12.7 15.7 11.4 15.8 17.1 17.0 25.6 17.8 7.8 20.6 21.0 22.9 37.9 18.2 16.9 17.5 16.5 9.0 25.8 24.3 9.2 2.1 46.6 22.9 22.9 41.1 42.1 11.2 16.1 16.5 22.3 11.4 25.2 6.0 39.6 63.2 17.6 17.3 19.2 29.8 21.3 16.1 18.0 48.8 8.4 6.4 27.0 18.3 23.5 15.4 22.9 14.9 22.2 12.4 4.7 34.6 23.9 20.6 5.0 3.9 33.5 23.9 21.1 23.2 19.0 29.5 40.1 20.5 10.3 13.1 14.5 29.0 24.5 26.7 26.2 20.3 37.5 19.0 25.6 31.0 22.7 ABHD16B "C20orf135, dJ591C20.1" ENSG00000183260 "Abhydrolase domain containing 16B" Q9H3Z7 20 63861498-63862988 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.0" "Group enriched" "Detected in some" 77 "Early spermatids: 131.8;Late spermatids: 270.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 16.0;PC-3: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059272, HPA075886" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059272: AB_2683963, HPA075886: " 2.1 1.5 2.8 2.6 1.8 1.0 0.1 2.1 3.5 0.1 1.8 0.8 1.8 1.0 0.0 0.4 0.2 0.4 1.0 2.5 2.9 1.1 0.3 1.0 1.7 2.2 2.3 2.0 0.9 2.2 0.0 0.1 0.6 3.0 1.3 0.0 0.3 1.6 0.0 1.6 1.1 1.6 0.0 1.5 3.6 2.3 16.0 4.1 0.0 0.4 0.0 0.0 0.1 0.2 3.8 4.9 3.2 0.6 1.2 0.0 0.0 7.2 5.7 0.0 0.1 0.0 16.0 6.3 4.5 4.6 0.0 1.4 12.6 0.0 0.0 0.0 3.1 3.8 2.9 6.7 11.8 0.0 1.7 7.9 0.0 0.0 0.0 0.0 0.3 0.0 3.4 5.6 5.2 0.0 8.5 2.7 4.8 1.3 0.6 18.8 5.8 0.7 1.7 0.0 3.3 2.2 1.9 5.4 3.1 0.8 0.2 6.3 0.8 1.9 3.3 5.8 1.7 2.4 4.2 2.6 2.9 2.4 1.8 2.4 0.1 0.7 2.7 0.7 0.4 0.4 0.3 0.2 0.5 0.6 0.6 0.5 0.4 0.2 0.2 0.3 0.6 0.8 0.8 2.8 1.8 2.1 3.5 2.5 2.9 2.2 2.3 2.0 3.0 1.5 4.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 131.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 270.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E8 ENSG00000183269 "Olfactory receptor family 52 subfamily E member 8" Q6IFG1 11 5856674-5857734 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC60 MGC39827 ENSG00000183273 "Coiled-coil domain containing 60" Q8IWA6 12 119334712-119541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 19.0;fallopian tube: 18.4;testis: 11.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 28.6;Early spermatids: 155.1;Late spermatids: 74.7;Respiratory ciliated cells: 43.7;Urothelial cells: 32.9" "Cancer enhanced" "Detected in some" "cervical cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-1)" "unprognostic (2.05e-2)" "unprognostic (7.73e-3)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-3)" "unprognostic (1.00e-1)" "unprognostic (2.70e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (3.92e-1)" "unprognostic (4.29e-2)" "unprognostic (4.11e-1)" "unprognostic (2.54e-1)" 0.0 0.0 5.0 0.5 1.1 0.0 0.0 1.0 0.8 5.6 19.0 1.7 0.1 0.4 0.6 1.7 18.4 0.0 0.0 0.8 2.6 0.0 0.0 1.3 0.0 4.3 2.9 0.2 0.0 0.0 0.0 0.0 0.5 3.0 3.1 4.6 2.5 1.1 1.6 0.1 0.0 0.1 0.0 4.9 0.0 0.3 11.7 2.0 0.1 0.0 0.0 2.3 3.2 2.4 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.1 1.0 0.8 0.8 2.6 4.3 2.9 0.2 3.0 4.9 2.0 1.5 0.0 0.0 0.0 1.6 0.2 0.8 28.6 3.1 8.6 0.3 0.0 0.0 0.3 0.0 4.7 0.0 14.6 0.0 0.0 0.3 0.0 0.1 155.1 19.4 0.2 0.1 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.1 10.2 0.0 0.0 74.7 0.9 0.1 0.0 2.8 0.0 0.2 0.0 0.0 1.0 0.1 0.5 0.4 0.0 5.5 0.1 0.0 43.7 1.0 0.0 0.0 1.2 23.1 2.3 5.9 0.0 0.0 0.0 0.1 0.7 32.9 PLGLB1 "PLGL, PRP-B" ENSG00000183281 "Plasminogen like B1" Q02325 2 87002559-87021852 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in all" 6 "liver: 236.8" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 95.9" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (7.25e-2)" "unprognostic (7.25e-2)" "unprognostic (2.35e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-5)" "unprognostic (7.04e-3)" "unprognostic (1.15e-1)" "unprognostic (8.53e-4)" "unprognostic (1.60e-1)" "unprognostic (4.56e-4)" "unprognostic (9.90e-3)" "unprognostic (2.96e-5)" "unprognostic (1.02e-1)" "unprognostic (1.16e-1)" "unprognostic (4.32e-2)" "unprognostic (3.98e-5)" 3.5 5.5 20.4 4.6 21.2 8.6 3.6 32.9 26.7 6.4 21.5 4.5 3.9 6.0 8.2 4.0 4.4 4.8 4.8 20.4 19.7 6.1 236.8 3.3 8.0 18.4 19.3 21.6 6.7 4.1 2.3 9.6 2.3 23.0 6.6 2.7 42.8 4.9 3.2 8.9 14.3 5.4 2.4 15.8 9.5 4.0 4.3 19.6 7.3 5.7 4.4 4.3 4.9 4.9 23.4 2.7 3.7 4.6 2.6 3.6 5.2 4.5 3.2 2.3 1.7 2.6 2.9 6.9 7.3 3.3 1.3 1.3 2.4 1.2 0.5 1.8 8.2 3.1 5.8 6.6 3.1 2.5 3.5 1.5 4.0 4.2 4.7 4.8 7.9 0.8 8.0 3.0 5.9 2.2 3.9 13.3 11.5 5.9 2.4 2.4 3.1 1.7 3.9 4.5 2.9 3.6 4.0 2.9 2.5 2.7 4.6 1.3 7.6 5.0 3.3 2.3 2.3 2.0 6.7 5.1 2.9 1.9 4.7 1.9 1.9 0.3 0.4 0.7 0.1 0.6 1.2 0.7 0.5 0.1 0.8 0.9 0.5 1.0 0.4 0.3 0.6 1.1 0.1 20.4 21.2 32.9 26.7 20.4 19.7 18.4 19.3 21.6 23.0 15.8 19.6 23.4 1.3 0.0 3.4 0.7 1.0 1.1 0.3 0.4 1.2 10.3 1.1 1.0 2.6 1.5 1.5 0.0 6.2 0.2 1.5 0.7 0.0 1.1 0.8 1.0 1.0 1.6 1.2 4.0 0.9 0.2 0.2 1.6 0.5 0.9 0.0 1.0 1.8 95.9 0.2 5.0 1.1 2.5 0.0 1.3 0.4 0.3 1.2 1.1 3.6 0.0 1.6 2.7 1.0 0.0 0.8 0.3 0.3 1.9 0.9 0.5 0.7 1.8 2.3 18.2 0.0 2.5 1.0 0.7 0.5 1.5 1.3 0.0 1.4 0.9 0.9 0.3 DAZAP2 KIAA0058 ENSG00000183283 "DAZ associated protein 2" Q15038 12 51238724-51271362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045940 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA045940: AB_2679506" "unprognostic (1.00e-2)" "unprognostic (3.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "unprognostic (5.47e-2)" "unprognostic (4.75e-3)" "unprognostic (8.43e-2)" "unprognostic (4.75e-2)" "unprognostic (3.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.42e-1)" "prognostic favorable (3.94e-9)" "unprognostic (1.79e-1)" "unprognostic (2.40e-1)" "unprognostic (3.04e-1)" "unprognostic (5.84e-3)" 137.6 116.8 106.2 189.1 119.6 619.0 155.6 130.5 125.5 151.8 105.7 208.1 196.7 132.8 123.6 131.1 182.1 169.5 204.0 100.0 126.7 253.7 200.1 194.9 222.4 125.0 118.4 87.4 115.1 117.5 229.2 30.9 80.1 130.0 154.2 217.6 75.8 141.9 173.4 114.4 122.3 202.2 149.7 122.5 226.3 175.9 53.1 117.4 215.1 211.7 107.7 243.5 192.1 77.0 146.7 159.8 209.0 95.4 92.2 201.1 171.5 57.6 104.6 208.9 187.7 162.8 155.9 239.0 153.2 262.2 209.9 130.0 147.8 134.2 178.4 189.2 167.3 160.2 227.1 129.7 91.0 216.4 265.5 350.2 220.5 252.1 175.3 147.2 207.2 234.8 118.8 141.6 303.1 155.4 252.6 219.8 145.6 19.6 109.2 58.7 123.2 144.7 165.3 244.9 260.2 103.3 101.0 159.3 137.9 121.3 56.7 190.5 382.7 195.7 111.1 102.4 136.9 132.6 231.5 237.5 158.6 161.2 175.0 66.9 2018.1 2144.1 3354.3 1055.9 1770.0 979.3 1090.7 962.8 1037.9 1354.1 1068.7 1063.1 918.3 3499.5 1045.4 1727.1 875.9 1420.3 4885.3 106.2 119.6 130.5 125.5 100.0 126.7 125.0 118.4 87.4 130.0 122.5 117.4 146.7 116.7 144.2 205.1 19.6 271.9 113.8 201.2 144.6 167.9 50.6 127.7 88.5 114.3 165.8 127.9 235.4 58.4 55.8 167.4 337.2 266.1 158.6 28.1 115.1 87.2 138.3 126.3 155.6 16.8 194.7 53.5 108.0 171.8 142.1 182.2 72.2 157.1 177.1 209.4 67.3 16.8 230.6 140.4 444.4 214.2 85.6 117.4 282.0 135.2 19.7 324.4 88.7 221.4 15.6 43.9 198.0 275.8 95.5 169.5 179.9 233.3 292.7 155.9 55.2 46.0 63.2 130.4 39.4 35.4 153.5 133.3 124.9 249.6 72.8 182.4 268.7 CCBE1 "FLJ30681, KIAA1983" ENSG00000183287 "Collagen and calcium binding EGF domains 1" Q6UXH8 18 59430939-59697662 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 33.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 56.1;Rod photoreceptor cells: 38.2;Theca cells: 78.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 6 "basophil: 9.2" "Lineage enriched" "Detected in single" 19 "granulocytes: 9.2" "Cell line enhanced" "Detected in many" "BJ: 101.2;BJ hTERT+: 103.2;BJ hTERT+ SV40 Large T+ RasG12V: 96.4;HBF TERT88: 113.3;hTERT-HME1: 153.2;LHCN-M2: 176.9;TIME: 93.3" "Group enriched" "Detected in many" 5 "cerebral cortex: 2.7;hippocampal formation: 8.7" "Low region specificity" "Detected in many" "HPA041361, HPA041374" Uncertain Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA041361: AB_10796667, HPA041374: AB_10794515" "unprognostic (3.09e-1)" "unprognostic (5.01e-2)" "unprognostic (9.54e-5)" "unprognostic (1.66e-2)" "unprognostic (2.40e-2)" "unprognostic (5.68e-5)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (2.17e-2)" "unprognostic (3.62e-3)" "unprognostic (4.04e-3)" "unprognostic (1.64e-1)" "unprognostic (7.45e-2)" "unprognostic (2.02e-2)" 3.7 10.3 2.5 1.2 3.4 0.6 1.8 2.0 2.7 10.6 0.8 12.3 1.1 7.0 0.5 2.8 8.4 1.3 2.1 5.8 1.2 3.4 5.7 10.0 1.3 0.4 2.1 2.6 33.8 1.2 2.9 0.4 0.5 0.8 2.4 2.8 1.1 0.6 4.1 15.5 3.0 2.5 3.2 0.2 0.5 1.6 0.6 3.0 1.2 0.9 0.9 0.7 0.8 1.3 1.8 20.6 1.9 0.0 0.2 15.1 47.2 30.7 101.2 103.2 73.5 96.4 0.3 0.3 0.4 0.2 40.6 16.7 2.3 0.2 65.5 113.3 0.4 0.3 0.2 0.4 0.3 35.1 0.3 0.2 32.0 2.9 57.0 153.2 31.2 3.6 0.3 0.2 0.5 176.9 0.6 0.1 0.2 0.3 0.0 0.6 0.1 0.2 0.2 3.9 2.0 0.4 0.7 0.3 0.2 0.9 7.2 0.3 0.5 93.3 0.2 10.0 15.3 0.3 0.3 0.3 0.2 5.0 0.3 2.4 9.2 0.2 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.5 0.4 0.1 0.2 0.1 0.1 2.5 3.4 2.0 2.7 5.8 1.2 0.4 2.1 2.6 0.8 0.2 3.0 1.8 1.5 3.2 1.3 3.9 0.2 4.6 2.0 1.0 2.2 6.4 0.8 0.4 1.6 2.8 1.9 0.0 8.4 1.0 0.2 0.2 0.0 0.2 0.8 8.8 5.1 2.2 0.0 0.0 56.1 0.2 1.3 14.5 0.0 0.6 1.3 6.8 9.7 0.2 0.4 15.2 15.1 0.0 0.0 1.0 8.9 1.1 9.6 0.5 7.2 1.0 0.2 2.4 0.0 0.5 0.7 0.3 0.0 0.4 0.1 1.5 0.1 0.1 0.9 38.2 0.0 1.6 5.9 0.4 0.9 0.2 4.3 0.8 1.2 78.0 0.1 0.9 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" O60613 1 86862445-86914424 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" No No 420000 Nucleoli Cytosol "HPA054937: AB_2682642" "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favorable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 119.2 139.2 83.7 119.9 85.5 108.9 148.9 87.2 107.0 157.9 102.6 129.1 114.5 118.5 213.3 84.4 131.2 124.4 85.4 80.8 100.1 161.7 175.4 116.0 141.7 88.8 86.8 79.4 125.7 94.2 116.7 89.1 157.1 89.1 122.1 135.5 91.5 105.0 117.5 46.0 66.8 112.3 108.1 91.7 108.2 117.9 67.3 85.3 136.8 236.1 65.3 128.0 148.0 73.3 98.8 203.1 133.3 118.0 129.1 383.0 396.4 178.3 249.1 317.3 251.4 254.8 176.8 261.8 245.2 309.7 248.9 195.7 131.8 135.2 150.7 296.0 222.1 180.2 252.4 108.5 178.2 245.2 336.8 166.1 272.3 233.0 152.8 253.0 180.2 220.2 207.8 241.4 262.3 253.3 90.2 254.4 227.3 170.7 211.2 197.9 207.7 205.1 251.9 355.5 198.5 149.5 122.6 241.6 235.6 349.2 104.7 104.0 298.5 205.3 180.0 122.9 347.6 277.0 155.1 158.7 251.9 107.7 268.4 216.7 170.9 111.3 113.4 89.7 115.9 116.1 161.4 98.7 97.2 107.1 194.2 98.8 102.3 109.3 82.3 132.4 166.3 115.2 171.3 83.7 85.5 87.2 107.0 80.8 100.1 88.8 86.8 79.4 89.1 91.7 85.3 98.8 131.6 118.6 155.2 0.0 52.4 0.0 0.0 0.0 0.0 0.0 142.1 107.7 0.0 0.0 74.9 108.5 0.0 248.6 89.3 0.0 74.3 235.9 0.0 102.2 119.1 73.2 0.0 0.0 0.0 193.5 338.3 85.2 0.0 98.1 64.3 68.8 0.0 0.0 241.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 64.1 0.0 0.0 0.0 0.0 197.8 0.0 0.0 19.1 0.0 0.0 151.5 70.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 315.2 53.9 122.2 0.0 0.0 OR5P2 JCG3 ENSG00000183303 "Olfactory receptor family 5 subfamily P member 2" Q8WZ92 11 7795905-7796973 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "Rod photoreceptor cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 3.7 4.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM9A TEX39A ENSG00000183304 "Family with sequence similarity 9 member A" Q8IZU1 X 8790795-8801383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 4.3" "Group enriched" "Detected in some" 6 "Spermatocytes: 55.2;Spermatogonia: 36.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-266/84: 9.0" HPA056076 Uncertain NA NA "HPA056076: AB_2683030" "unprognostic (3.43e-2)" 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.2 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 55.2 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA2B "MAGE2, MAGEA2, MGC16973" ENSG00000183305 "MAGE family member A2B" P43356 X 152714586-152718607 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 37.9;GAMG: 164.8;HMC-1: 39.9;K-562: 35.6;SH-SY5Y: 53.3;U-266/84: 47.8" NA NA "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 1.4 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 164.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 10.8 0.0 0.0 0.1 0.0 0.0 16.7 3.5 0.0 0.0 0.0 0.0 0.1 12.3 53.3 0.0 16.1 2.2 0.0 0.1 1.3 0.0 0.0 1.4 0.2 0.6 28.0 47.8 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116297-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.0;prostate: 6.6" "Cell type enhanced" "Detected in some" "granulocytes: 1.3;Hofbauer cells: 2.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.1;neutrophil: 1.6" "Group enriched" "Detected in many" 7 "granulocytes: 1.6;monocytes: 1.1" "Cell line enhanced" "Detected in some" "AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8" "Low region specificity" "Detected in all" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 0.3 0.6 5.4 0.9 6.9 1.0 0.7 3.7 7.8 0.2 1.8 0.2 0.2 0.3 0.9 0.3 0.3 0.2 1.0 9.0 4.4 0.2 0.1 0.3 0.1 4.1 3.6 6.8 0.2 1.1 0.1 1.6 0.7 5.2 6.6 0.2 1.3 0.4 0.2 1.3 0.5 0.2 0.3 4.0 0.7 0.2 1.9 4.4 0.1 0.1 0.4 0.1 0.3 0.2 6.8 0.0 0.0 6.0 0.8 0.0 0.0 0.0 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.1 0.0 0.1 0.2 3.0 0.0 0.3 0.1 14.2 2.1 0.0 0.0 0.3 0.8 0.0 11.9 0.6 0.6 0.2 0.2 0.0 0.2 0.4 0.9 0.0 9.8 0.3 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 5.4 6.9 3.7 7.8 9.0 4.4 4.1 3.6 6.8 5.2 4.0 4.4 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 1.3 0.9 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636019-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "PC-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 5.6 5.0 3.5 1.9 3.1 0.6 5.5 2.6 3.8 7.4 2.2 6.7 2.3 7.0 1.8 6.2 6.7 1.5 5.9 3.5 3.5 4.5 5.7 5.3 2.3 3.8 3.3 3.5 8.5 5.4 2.8 6.0 1.8 4.4 5.9 2.0 1.7 6.1 1.3 7.2 7.8 6.5 2.1 2.3 6.9 5.4 7.2 3.0 2.1 5.3 1.8 1.9 7.6 6.5 3.4 3.0 6.9 2.6 2.5 4.1 8.0 2.5 2.9 3.8 4.7 3.3 2.4 2.5 1.8 3.6 6.5 3.2 1.9 3.0 1.9 3.7 5.1 2.3 7.5 7.3 2.2 3.2 1.7 2.1 3.3 3.8 2.0 8.7 5.1 3.3 4.9 6.1 3.3 3.4 6.6 5.8 2.4 3.4 3.7 18.3 4.0 2.3 2.8 2.6 4.0 6.4 6.2 11.9 2.4 4.0 2.6 5.4 5.2 1.5 4.4 1.5 1.8 2.4 1.9 2.3 2.8 3.2 2.8 3.6 1.1 0.2 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.4 0.2 0.5 0.5 0.4 0.2 3.5 3.1 2.6 3.8 3.5 3.5 3.8 3.3 3.5 4.4 2.3 3.0 3.4 4.6 6.4 3.9 3.9 5.8 1.7 3.1 1.6 7.4 5.9 4.4 4.2 10.3 7.2 1.5 7.3 6.2 5.9 4.7 5.8 3.9 5.9 5.4 3.0 8.1 5.8 5.4 9.9 7.5 3.8 6.0 5.6 4.6 5.0 1.3 9.2 7.1 6.6 5.8 15.2 5.3 5.3 2.0 6.6 2.4 4.5 8.4 4.6 3.6 4.7 8.3 7.2 7.2 5.5 5.4 4.4 2.3 13.9 2.8 4.5 5.4 3.9 1.3 7.0 19.7 8.2 5.1 10.8 13.9 6.2 2.6 4.8 5.8 5.8 5.2 1.7 OR2T34 ENSG00000183310 "Olfactory receptor family 2 subfamily T member 34" Q8NGX1 1 248573801-248574757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52L1 ENSG00000183313 "Olfactory receptor family 52 subfamily L member 1" Q8NGH7 11 5985892-5986985 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHA10 "FLJ16103, FLJ33655" ENSG00000183317 "EPH receptor A10" Q5JZY3 1 37713880-37765133 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.5;intestine: 8.0;testis: 13.5" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 91.8;Early spermatids: 59.1;Late spermatids: 183.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;HDLM-2: 19.4;SCLC-21H: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027497 Uncertain "Intracellular and membrane" NA NA "HPA027497: AB_10601158" "unprognostic (9.27e-2)" "unprognostic (1.21e-1)" "unprognostic (2.94e-2)" "unprognostic (1.24e-6)" "unprognostic (1.06e-1)" "unprognostic (1.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.40e-1)" "unprognostic (7.06e-3)" "unprognostic (1.50e-1)" "unprognostic (8.81e-5)" "unprognostic (2.55e-2)" "unprognostic (2.97e-2)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 0.0 0.4 4.6 1.0 4.7 0.3 0.9 0.0 8.5 0.1 0.0 8.0 3.6 0.1 3.9 0.4 0.9 1.0 0.1 4.1 2.6 0.2 0.0 0.1 0.2 2.5 0.8 6.5 0.0 2.7 1.3 6.8 0.0 1.7 0.6 6.4 3.1 1.4 0.2 0.0 0.2 6.8 0.4 0.0 0.1 3.1 13.5 3.0 0.1 0.4 0.0 0.1 0.2 0.2 2.5 1.5 1.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 1.6 2.7 0.0 0.4 0.0 0.2 0.1 0.1 0.0 0.0 19.4 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.7 0.0 1.0 0.0 0.1 0.7 2.0 0.6 0.0 0.0 0.4 0.3 1.7 8.6 0.4 1.1 0.0 0.0 0.2 2.8 0.1 0.0 0.0 0.9 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 4.7 0.0 8.5 4.1 2.6 2.5 0.8 6.5 1.7 0.0 3.0 2.5 0.0 0.0 0.5 0.3 0.2 0.1 0.0 0.0 0.0 5.6 1.3 0.9 1.5 0.0 0.1 0.0 91.8 0.0 0.0 23.8 0.0 0.4 59.1 0.0 0.0 0.1 18.7 0.0 24.5 2.5 0.0 0.3 1.5 0.1 0.0 0.1 0.0 0.0 0.0 11.8 15.8 10.5 0.0 0.0 0.0 183.7 1.8 0.1 0.0 1.0 0.0 0.4 0.0 2.5 2.2 2.3 21.1 0.4 0.0 0.2 7.8 0.0 0.0 3.1 0.0 0.0 0.1 18.2 2.6 0.0 0.0 0.0 0.1 0.0 11.0 0.2 SPDYE4 ENSG00000183318 "Speedy/RINGO cell cycle regulator family member E4" A6NLX3 17 8753106-8758559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 7.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.6;HeLa: 1.7;NB-4: 1.0" "Not detected" "Not detected" "HPA025704, HPA051750" Enhanced NA NA "HPA025704: AB_1853093, HPA051750: AB_2681590" "unprognostic (3.20e-1)" "unprognostic (7.16e-4)" "unprognostic (3.15e-3)" "unprognostic (2.79e-1)" 0.0 0.1 0.6 0.2 0.1 0.8 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 7.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.3 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.3 0.7 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 15.0;neutrophil: 11.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "T-47d: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 3.4 3.9 2.5 2.9 2.4 11.1 7.1 2.7 2.8 2.8 2.6 4.8 4.9 2.7 2.7 4.6 3.6 3.3 2.0 2.1 2.6 3.4 13.0 3.3 2.9 2.7 2.7 2.0 3.1 5.2 3.2 4.4 3.9 3.1 7.0 5.6 3.3 6.6 2.0 2.0 3.8 5.4 1.3 2.2 3.5 6.0 1.4 2.6 2.4 2.9 1.1 2.4 3.2 2.9 3.8 3.1 5.0 0.9 14.0 1.6 0.9 17.9 1.8 2.6 1.2 0.7 4.4 15.3 5.5 10.4 2.1 1.1 3.9 10.3 5.3 1.1 19.4 8.1 3.5 7.5 8.6 4.2 3.9 1.9 5.5 2.6 5.7 1.7 2.8 2.0 6.6 10.6 2.3 1.1 12.5 4.9 6.1 0.2 3.9 3.2 7.2 0.0 7.4 6.7 3.5 5.8 3.6 3.7 8.2 2.8 0.2 27.0 3.9 2.3 1.1 2.0 3.4 2.9 10.8 17.8 2.0 3.5 20.5 0.5 6.9 1.0 15.0 1.1 1.0 0.9 1.1 0.9 0.8 1.7 0.8 0.8 0.5 11.4 1.1 2.8 1.3 0.7 0.9 2.5 2.4 2.7 2.8 2.1 2.6 2.7 2.7 2.0 3.1 2.2 2.6 3.8 4.7 25.6 20.4 21.9 5.7 1.0 4.0 8.5 7.4 4.7 13.4 10.3 5.9 7.2 16.8 1.8 2.1 34.2 4.4 11.0 5.9 13.7 0.9 31.6 5.6 3.4 1.2 9.2 17.2 12.2 8.5 5.5 28.5 15.1 15.8 9.9 1.8 17.9 6.1 3.3 16.7 14.1 10.2 4.1 2.7 1.9 2.1 8.7 1.8 17.8 7.8 4.5 5.2 16.1 13.4 8.6 17.1 2.2 6.9 5.5 9.6 8.9 60.7 7.4 0.0 5.3 4.7 1.8 3.1 8.5 1.0 12.4 5.2 14.1 7.9 4.8 REC114 "C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677" ENSG00000183324 "REC114 meiotic recombination protein" Q7Z4M0 15 73443164-73560013 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 39.5" "Group enriched" "Detected in some" 5 "Early spermatids: 184.0;Spermatocytes: 143.4" "Cancer enriched" "Detected in single" 11 "testis cancer: 1.3" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.0" "Region enhanced" "Detected in many" "olfactory bulb: 6.1" "Low region specificity" "Detected in many" NA NA "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (4.58e-2)" "unprognostic (2.97e-1)" "unprognostic (8.06e-2)" "unprognostic (2.63e-2)" "unprognostic (2.48e-2)" "unprognostic (1.53e-7)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (1.98e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.0 0.1 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 25.1 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.4 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BOLA2 "BOLA2A, My016" ENSG00000183336 "BolA family member 2" Q9H3K6 16 29443056-29454964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.7;Erythroid cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 24.7;HEK 293: 32.4;Hep G2: 22.1;MCF7: 33.7" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 390000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" 6.2 8.1 0.3 0.9 0.3 2.6 5.8 0.2 0.8 4.4 0.3 7.3 2.4 4.0 0.0 10.3 3.9 0.5 7.0 0.2 0.3 8.2 7.6 6.8 2.0 0.3 0.2 0.2 2.2 5.4 0.3 8.0 0.4 0.3 5.2 0.1 0.0 6.6 0.2 6.5 6.4 9.1 0.1 0.2 12.3 8.0 13.3 0.3 0.2 5.0 0.0 0.3 6.7 6.2 0.3 7.0 24.7 0.7 1.3 0.5 0.8 9.2 1.9 0.8 2.3 2.5 12.5 3.2 4.4 9.2 0.2 2.6 4.5 0.4 1.6 0.1 10.2 32.4 8.2 9.4 22.1 1.2 2.8 5.9 0.4 0.7 2.8 0.1 0.2 1.9 11.2 2.6 1.2 0.4 33.7 3.4 6.7 2.9 0.2 18.6 8.0 2.9 8.6 0.5 5.5 3.7 3.3 2.2 4.3 2.0 0.0 1.9 1.3 3.3 5.8 1.6 4.1 3.4 8.4 8.7 7.6 4.2 6.4 3.5 6.0 7.1 7.2 5.0 9.8 6.1 15.3 6.2 6.7 4.4 12.4 5.3 5.3 1.6 4.6 8.2 10.6 8.3 8.8 0.3 0.3 0.2 0.8 0.2 0.3 0.3 0.2 0.2 0.3 0.2 0.3 0.3 0.4 0.0 2.7 0.3 0.7 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 0.3 1.0 0.7 0.0 0.4 0.5 0.4 0.6 0.2 0.0 2.7 0.9 0.8 0.2 0.4 0.0 0.8 1.3 0.4 0.0 0.4 0.2 0.0 1.0 0.3 0.0 0.6 0.0 0.6 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.5 0.6 0.6 0.4 0.0 0.3 0.4 0.8 0.1 0.7 0.0 0.0 0.5 0.4 0.2 0.4 0.5 0.3 0.3 0.8 0.1 0.3 0.3 BCOR "FLJ20285, KIAA1575" ENSG00000183337 "BCL6 corepressor" Q6W2J9 X 40049815-40177329 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056308, HPA073591" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA056308: AB_2683095, HPA073591: AB_2732227" "unprognostic (2.75e-2)" "unprognostic (2.83e-1)" "unprognostic (2.45e-1)" "unprognostic (9.26e-2)" "unprognostic (1.55e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.30e-5)" "unprognostic (3.82e-3)" "unprognostic (6.86e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.91e-3)" "unprognostic (6.83e-2)" "unprognostic (9.57e-2)" "unprognostic (2.63e-1)" "unprognostic (1.55e-1)" 10.2 14.2 3.1 8.4 3.5 22.4 10.0 3.0 4.0 11.5 3.6 13.0 8.9 11.1 5.4 14.6 11.0 7.5 13.8 2.1 2.2 11.8 14.8 12.5 15.1 3.8 3.4 1.0 20.2 14.0 14.1 12.0 12.4 3.8 12.6 6.9 14.3 12.0 8.5 20.7 14.6 11.3 8.8 2.1 10.8 12.3 9.1 3.2 26.0 15.8 7.2 12.6 11.0 11.5 5.3 35.5 21.9 45.1 50.5 4.7 3.3 7.8 11.4 18.6 14.4 11.7 8.9 13.5 31.3 13.3 21.7 8.9 31.0 70.8 9.3 12.0 56.0 67.4 36.2 31.8 31.7 7.6 28.7 19.3 5.6 12.0 16.7 7.0 20.0 19.8 20.2 94.7 74.3 14.8 17.9 65.8 27.2 43.4 14.2 33.9 32.3 47.5 36.2 17.3 20.8 32.5 57.6 25.5 20.5 15.5 18.9 22.8 51.5 16.8 15.5 18.5 23.1 12.8 39.1 36.1 33.8 13.1 23.5 24.6 4.6 3.1 2.1 3.8 3.6 2.7 1.9 2.5 2.4 4.5 2.5 2.1 2.3 0.5 3.3 3.9 1.4 2.7 8.8 3.1 3.5 3.0 4.0 2.1 2.2 3.8 3.4 1.0 3.8 2.1 3.2 5.3 20.3 22.4 24.5 24.2 16.8 14.7 4.7 8.0 33.6 35.7 10.4 13.1 9.2 10.0 5.9 11.0 12.5 4.5 20.6 6.4 1.9 5.4 2.1 24.1 8.6 15.9 16.3 20.4 21.6 10.5 6.3 11.9 11.7 25.6 24.6 12.8 16.4 10.7 7.5 15.2 20.4 11.4 10.2 8.4 25.6 2.4 10.5 11.5 5.4 27.2 12.0 7.6 7.2 27.6 31.3 6.4 3.9 7.9 16.9 7.6 6.5 4.1 7.1 23.8 0.0 16.4 17.4 2.0 13.2 21.0 13.9 2.1 21.1 6.4 8.8 2.8 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.1;Late spermatids: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: AB_2732646" "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 7.5 6.3 4.6 7.7 4.7 1.7 8.9 4.8 4.8 9.9 4.8 7.2 7.3 8.4 7.5 6.0 10.2 6.7 6.1 4.4 5.1 6.6 4.2 6.3 9.4 5.0 5.1 4.1 13.3 5.1 6.9 4.2 8.4 5.0 8.5 9.1 11.1 8.9 7.0 4.1 7.9 8.4 6.9 4.9 7.6 8.7 11.8 4.9 9.7 9.7 4.4 9.3 6.9 6.1 5.6 9.4 5.8 11.8 8.9 23.1 25.7 8.6 15.6 10.5 10.9 14.2 9.8 22.2 12.8 22.3 14.4 13.9 14.5 5.9 10.6 12.6 13.9 5.5 11.9 17.0 7.5 18.7 6.8 7.4 12.2 16.3 15.8 19.6 20.3 10.0 14.5 6.4 5.5 17.9 1.9 8.8 19.8 1.8 16.7 7.9 8.9 11.5 10.5 13.5 9.7 4.7 8.6 9.1 6.2 7.1 11.0 7.6 9.1 12.4 21.1 9.4 18.6 6.4 4.7 10.9 7.5 9.8 10.9 9.2 3.3 2.6 2.6 1.6 2.1 2.3 2.2 2.6 2.0 2.6 1.6 3.2 2.9 0.9 1.8 2.5 4.1 1.3 1.6 4.6 4.7 4.8 4.8 4.4 5.1 5.0 5.1 4.1 5.0 4.9 4.9 5.6 6.2 9.6 5.8 4.2 5.0 4.7 10.3 6.6 2.8 7.4 7.6 8.9 6.8 15.7 12.0 0.0 4.2 6.0 11.7 9.0 1.9 11.5 171.1 9.9 13.6 5.8 6.0 4.8 3.4 5.1 5.0 9.9 7.1 6.8 3.8 5.0 6.4 2.2 5.0 8.4 3.0 10.5 4.1 7.2 5.2 49.3 8.4 6.0 1.8 1.0 6.9 5.2 6.2 3.5 8.2 8.2 4.5 9.4 2.4 8.4 7.6 6.1 25.3 12.3 0.0 6.0 9.6 9.9 4.9 5.3 6.0 4.0 4.8 7.5 9.7 8.4 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662929-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.9;testis: 15.6" "Group enriched" "Detected in some" 10 "Endometrial ciliated cells: 60.4;Respiratory ciliated cells: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "MOLT-4: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 0.9 0.5 6.2 0.2 4.7 0.0 1.2 5.1 4.4 4.3 5.7 1.1 0.3 3.5 0.5 0.3 26.9 0.8 0.1 4.6 10.0 1.8 0.3 4.1 0.0 6.4 7.0 4.1 0.2 0.5 2.9 4.3 0.8 7.1 4.2 0.6 0.9 1.0 2.6 0.1 0.2 0.5 0.7 9.6 1.0 0.5 15.6 4.8 0.1 0.7 0.0 0.1 0.4 0.6 7.7 0.0 0.2 0.1 0.0 0.0 2.5 0.0 0.4 1.7 0.3 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.9 0.5 0.1 0.0 0.1 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 4.7 5.1 4.4 4.6 10.0 6.4 7.0 4.1 7.1 9.6 4.8 7.7 1.9 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.0 0.8 0.0 60.4 4.1 0.4 0.0 0.0 0.0 0.2 0.2 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 88.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.0 0.0 GBP6 DKFZp686G0786 ENSG00000183347 "Guanylate binding protein family member 6" Q6ZN66 1 89364059-89388160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 329.9" "Cell type enriched" "Detected in some" 25 "Squamous epithelial cells: 325.0" "Group enriched" "Detected in many" 7 "cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "A-431: 5.4;HaCaT: 11.3" "Low region specificity" "Detected in all" HPA027744 Enhanced NA NA "HPA027744: AB_10602809" "unprognostic (7.60e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (7.05e-3)" "unprognostic (5.85e-2)" "unprognostic (5.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "unprognostic (7.99e-4)" "unprognostic (1.63e-1)" "unprognostic (2.04e-6)" "unprognostic (1.43e-1)" "unprognostic (1.03e-1)" "unprognostic (3.41e-1)" "unprognostic (3.91e-3)" 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.3 12.4 0.1 0.0 0.0 0.1 0.1 329.9 0.3 0.2 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.4 0.2 0.2 0.4 0.1 0.0 0.8 0.0 0.5 0.1 0.0 0.1 63.3 0.1 0.2 0.9 0.0 0.0 0.3 0.2 0.3 0.0 0.4 1.1 0.2 0.2 55.5 0.1 32.3 0.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.3 0.3 0.7 0.2 0.1 0.1 0.6 0.1 0.2 0.2 0.3 0.3 0.3 0.3 0.4 0.2 0.2 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.2 12.5 0.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.5 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.4 0.0 0.0 12.8 0.0 0.0 0.0 1.2 0.0 0.1 325.0 0.0 0.0 0.2 1.2 0.0 1.2 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6008482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favorable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 6.3 5.2 14.0 5.6 17.0 6.5 6.3 25.0 12.0 7.9 22.2 5.9 4.8 8.0 5.8 6.1 6.4 5.8 5.7 10.5 11.1 6.1 4.9 6.0 6.8 14.1 14.0 9.1 10.3 5.2 8.7 6.3 7.0 15.7 6.3 5.0 10.5 6.2 5.4 9.5 8.2 5.7 6.4 11.7 8.2 6.6 11.6 13.2 8.4 8.5 9.5 5.9 6.3 7.2 15.9 7.1 3.5 7.2 4.6 5.4 8.5 3.2 4.6 6.8 4.4 4.0 2.3 4.0 8.8 1.7 5.8 5.5 3.5 4.2 3.9 6.5 19.2 3.0 26.5 8.4 3.7 4.2 9.4 11.6 5.3 5.0 3.9 6.4 8.3 6.9 5.7 2.8 16.2 5.5 2.2 5.1 17.2 4.0 4.1 2.8 5.3 4.6 4.5 4.8 4.9 9.3 5.3 4.3 4.0 3.7 4.9 4.1 12.6 7.8 8.4 4.7 4.2 5.3 11.1 9.5 8.8 4.3 4.3 2.3 5.0 2.3 7.0 4.2 1.9 4.8 5.9 4.1 3.8 0.9 3.8 4.5 4.8 6.0 4.8 4.5 2.9 2.6 0.8 14.0 17.0 25.0 12.0 10.5 11.1 14.1 14.0 9.1 15.7 11.7 13.2 15.9 47.8 44.8 34.0 99.9 40.3 44.6 29.9 21.4 37.5 89.0 33.5 25.5 53.7 42.9 22.1 38.6 79.2 17.1 51.9 31.0 7.9 18.2 33.0 28.3 40.9 39.7 38.5 18.7 97.8 13.4 10.6 33.2 31.1 46.7 20.2 43.5 29.3 18.7 16.9 45.4 119.1 34.7 16.2 25.5 28.8 17.2 70.5 31.9 23.2 113.4 55.1 47.7 95.8 116.1 170.1 18.4 29.1 76.3 35.4 34.4 30.1 11.9 18.2 81.5 46.0 45.8 40.1 127.7 121.2 38.3 52.4 30.0 45.1 38.7 28.5 42.0 OVCH2 OVTN ENSG00000183378 "Ovochymase 2" 11 7689437-7706421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "epididymis: 190.6;retina: 93.1" "Group enriched" "Detected in some" 7 "Collecting duct cells: 7.3;Rod photoreceptor cells: 16.6" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "REH: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.59e-2)" "unprognostic (3.74e-1)" "unprognostic (8.03e-2)" "unprognostic (9.77e-2)" "unprognostic (1.85e-1)" "unprognostic (1.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.84e-2)" "unprognostic (3.06e-1)" "unprognostic (9.27e-2)" "unprognostic (7.65e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.1 0.0 0.6 0.4 3.4 0.7 0.3 0.1 0.0 0.0 0.0 0.2 190.6 0.1 0.3 0.0 0.0 0.0 0.1 5.4 0.0 2.4 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.1 0.0 93.1 0.8 5.8 0.4 9.1 0.1 0.0 0.0 0.0 0.5 0.5 0.7 0.0 0.0 0.0 0.1 0.9 0.2 0.7 3.4 0.0 0.3 0.0 0.0 0.0 0.5 0.8 0.6 0.1 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 25.2 0.0 0.2 0.2 2.7 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.7 0.3 0.0 0.1 0.6 0.4 0.0 1.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.1 1.3 0.1 0.0 0.0 7.3 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.1 0.0 0.7 0.0 16.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 SYNDIG1L "capucin, DSPC1, IFITMD4, TMEM90A" ENSG00000183379 "Synapse differentiation inducing 1 like" A6NDD5 14 74405894-74426210 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 34 "brain: 378.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.7;Bipolar cells: 10.9;Inhibitory neurons: 4.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Region enhanced" "Detected in all" "basal ganglia: 378.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 280.7" "Region enriched" "Detected in many" 7 "basal ganglia: 125.1" "HPA042594, HPA048487" Uncertain NA NA "HPA042594: AB_2678069, HPA048487: AB_2680416" "unprognostic (5.75e-2)" "unprognostic (9.96e-3)" "unprognostic (2.25e-2)" "unprognostic (5.51e-2)" "unprognostic (3.08e-3)" "unprognostic (5.72e-2)" "unprognostic (5.83e-2)" "unprognostic (4.51e-2)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (8.85e-2)" "unprognostic (1.63e-1)" "unprognostic (3.85e-2)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" 0.4 0.1 40.1 0.0 378.6 0.0 0.3 1.3 48.3 0.3 0.6 0.4 0.0 0.3 11.1 0.1 0.2 0.2 0.2 3.7 33.7 0.3 0.1 1.4 0.1 96.9 48.3 12.5 0.2 0.2 0.0 0.7 0.0 126.8 0.3 0.2 4.7 0.2 0.2 0.2 0.4 0.5 0.3 12.4 0.2 0.2 0.2 99.6 0.0 0.3 0.0 0.0 0.2 0.3 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 378.6 1.3 48.3 3.7 33.7 96.9 48.3 12.5 126.8 12.4 99.6 8.0 0.1 0.0 2.7 1.0 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 FHL3 SLIM2 ENSG00000183386 "Four and a half LIM domains 3" Q13643 1 37996770-38005606 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 26 "skeletal muscle: 1618.3;tongue: 812.7" "Cell type enhanced" "Detected in many" "granulocytes: 73.1;NK-cells: 52.5;Skeletal myocytes: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "eosinophil: 336.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 336.1" "Cell line enhanced" "Detected in many" "HEL: 72.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045723 Approved Nucleoplasm NA NA Nucleoplasm "HPA045723: AB_10966278" "prognostic favorable (5.62e-4)" "unprognostic (1.12e-1)" "unprognostic (3.02e-3)" "unprognostic (6.97e-2)" "unprognostic (2.26e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.02e-3)" "unprognostic (1.80e-1)" "unprognostic (1.36e-1)" "unprognostic (9.05e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (4.20e-11)" "unprognostic (8.88e-3)" "unprognostic (2.38e-1)" "unprognostic (4.94e-2)" "unprognostic (2.77e-2)" 13.6 11.5 8.0 16.8 6.5 21.6 12.9 7.1 7.5 26.6 5.8 32.5 3.5 47.2 7.9 37.1 30.0 14.8 14.9 6.0 7.9 8.9 6.0 19.3 5.7 8.6 6.9 5.2 20.9 10.2 6.6 5.6 9.7 8.1 16.8 6.1 0.5 23.9 16.6 1618.3 14.4 11.5 29.8 8.7 13.1 15.7 7.2 9.0 3.8 8.2 812.7 5.4 41.1 16.1 9.2 15.4 5.6 14.3 14.4 13.3 52.9 9.3 12.0 23.1 22.1 16.3 12.2 11.8 0.1 19.7 26.8 10.3 5.8 9.5 14.2 10.8 5.8 17.2 72.0 12.5 14.2 51.7 5.6 49.8 47.4 15.8 24.9 14.2 46.3 30.9 7.2 61.7 0.3 41.6 8.1 1.9 23.5 18.5 1.1 3.7 9.5 12.2 1.0 14.1 2.8 1.8 7.4 10.9 1.0 17.1 27.0 4.3 4.9 21.6 9.2 21.6 2.7 11.1 3.9 14.5 1.7 4.4 33.0 9.9 6.0 28.7 336.1 14.1 18.2 15.1 0.3 3.5 7.2 18.0 0.6 2.6 3.4 34.5 14.3 12.0 0.8 8.1 13.8 8.0 6.5 7.1 7.5 6.0 7.9 8.6 6.9 5.2 8.1 8.7 9.0 9.2 11.6 0.0 3.0 3.3 2.0 20.9 20.9 4.5 23.3 1.5 12.1 29.3 5.1 5.7 3.5 7.3 0.0 9.2 18.0 0.2 1.9 19.8 0.8 2.4 27.4 20.8 0.0 9.4 1.3 28.1 29.1 25.6 0.5 3.2 73.1 2.7 12.1 1.0 26.1 0.0 0.4 0.2 12.2 21.7 33.1 1.4 22.4 23.5 5.4 9.4 20.3 2.9 52.5 0.5 0.1 34.5 0.0 32.0 1.3 8.9 0.0 3.6 0.2 0.5 26.3 54.4 38.1 1.1 16.6 8.6 16.2 9.7 12.6 14.9 0.2 11.6 OR56A4 ENSG00000183389 "Olfactory receptor family 56 subfamily A member 4" Q8NGH8 11 5999445-6006946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.4 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PMCH MCH ENSG00000183395 "Pro-melanin concentrating hormone" P20382 12 102196459-102197833 "Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein, Hormone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 91 "brain: 97.3" "Group enriched" "Detected in some" 4 "B-cells: 2.7;Exocrine glandular cells: 2.0;monocytes: 1.0;T-cells: 1.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "thalamus: 97.3" "Immune cell enriched" "Detected in some" 10 "T-reg: 9.5" "Lineage enriched" "Detected in single" 85 "T-cells: 9.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 44.9" "Group enriched" "Detected in many" 129 "hypothalamus: 624.3;thalamus: 339.8" "Region enriched" "Detected in some" 34 "hypothalamus: 83.0" "HPA046055, HPA061884" Enhanced Supported "Secreted to blood" NA NA 274000 "HPA046055: AB_2679517, HPA061884: AB_2684632" "unprognostic (3.23e-3)" "unprognostic (8.04e-2)" "unprognostic (3.96e-4)" "unprognostic (2.09e-2)" "unprognostic (1.75e-1)" "unprognostic (7.73e-2)" "unprognostic (4.31e-3)" "unprognostic (1.43e-2)" "unprognostic (3.18e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-1)" "unprognostic (2.16e-6)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "unprognostic (5.10e-2)" "unprognostic (3.53e-2)" 0.0 0.0 36.1 0.5 1.8 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 64.7 0.0 0.0 0.1 1.0 0.3 22.5 0.1 0.0 0.0 0.0 0.1 0.0 6.4 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.4 0.5 0.0 97.3 1.0 0.0 0.1 0.4 0.1 0.0 0.2 0.4 0.2 0.5 0.4 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.2 0.2 0.0 0.0 0.0 44.9 0.0 0.7 0.8 0.4 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.2 5.3 0.5 0.9 0.0 0.0 0.0 0.8 1.5 0.6 0.7 1.3 0.4 0.6 1.8 0.0 0.3 0.5 0.5 0.6 0.8 0.1 0.3 0.3 0.1 0.6 0.6 0.5 0.2 0.7 0.1 0.8 0.6 0.5 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.5 0.0 36.1 1.8 0.1 0.3 0.0 64.7 0.3 22.5 0.1 6.4 0.0 97.3 0.2 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621769 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.9" "Group enriched" "Detected in some" 16 "Early spermatids: 329.4;Late spermatids: 228.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053577 Uncertain NA NA "HPA053577: AB_2682196" "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.2 0.0 0.1 1.7 0.1 0.1 0.4 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.0 0.1 0.5 24.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.3 0.0 0.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.9 0.4 0.1 0.2 0.1 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 329.4 0.0 0.0 0.1 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 228.6 2.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 17.3 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 C19orf71 LOC100128569 ENSG00000183397 "Chromosome 19 open reading frame 71" A6NCJ1 19 3539154-3544030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 54.1" "Group enriched" "Detected in some" 69 "Early spermatids: 566.4;Late spermatids: 357.0" "Cancer enriched" "Detected in all" 5 "melanoma: 23.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HeLa: 92.7;SK-MEL-30: 48.2;WM-115: 170.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA048654 Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Endoplasmic reticulum" "HPA048654: AB_2680480" "unprognostic (1.06e-1)" "unprognostic (1.21e-1)" "unprognostic (7.04e-3)" "unprognostic (7.37e-2)" "unprognostic (4.74e-2)" "prognostic favorable (2.35e-4)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (7.23e-2)" "unprognostic (3.13e-2)" "prognostic favorable (2.03e-5)" "unprognostic (6.19e-2)" "prognostic favorable (2.02e-5)" "unprognostic (5.52e-3)" "unprognostic (1.02e-1)" "unprognostic (3.84e-2)" "unprognostic (1.97e-3)" 2.6 4.6 3.7 8.2 3.6 10.6 2.3 12.0 5.0 3.4 0.0 2.5 8.6 5.0 0.8 3.6 4.5 3.8 2.5 4.4 2.5 6.3 3.5 4.4 9.6 3.9 3.2 0.8 4.7 7.7 0.7 7.6 3.2 6.1 4.2 0.6 3.4 12.5 2.4 2.5 13.1 7.4 0.9 0.8 9.9 6.1 54.1 2.7 1.9 11.0 0.6 1.2 2.7 2.6 10.7 15.9 12.8 4.1 5.5 0.1 0.1 8.3 9.8 0.0 0.0 0.0 8.1 4.7 2.8 7.2 0.1 20.8 13.8 0.1 0.7 0.0 16.0 7.5 2.1 92.7 2.4 0.0 2.1 9.7 0.1 0.2 0.3 0.1 4.5 0.1 7.3 11.1 13.9 0.0 11.1 3.5 5.2 3.5 0.5 3.9 5.3 6.1 14.9 0.0 6.2 9.7 8.9 17.0 8.5 48.2 1.9 9.6 5.2 13.2 7.6 9.9 23.2 9.3 11.0 3.1 4.1 22.7 9.4 170.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.6 12.0 5.0 4.4 2.5 3.9 3.2 0.8 6.1 0.8 2.7 10.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 566.4 0.3 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 357.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.1 0.0 6.6 0.0 0.0 2.7 1.6 0.0 0.0 0.1 0.1 0.2 0.0 0.1 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 275.7;Late spermatids: 277.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 14.4 43.8 27.7 17.5 30.3 32.9 18.3 27.1 41.3 30.0 26.5 23.6 23.1 22.7 25.1 18.4 24.2 20.8 21.6 30.7 26.3 25.7 36.3 23.0 21.0 31.2 30.8 23.1 31.6 23.4 39.8 33.8 9.4 35.2 45.5 11.9 12.5 21.8 18.7 6.2 19.1 24.2 13.9 26.4 42.1 26.4 43.6 29.3 12.5 30.6 6.7 14.6 24.4 21.9 35.9 3.7 3.2 2.6 8.0 10.3 14.8 2.7 5.8 6.0 6.7 8.9 1.0 3.8 3.0 14.7 11.0 2.0 3.0 1.5 9.2 4.1 15.0 2.2 7.2 2.5 3.9 17.9 2.8 10.4 17.8 24.0 4.9 6.5 7.1 19.2 5.3 6.5 33.6 3.4 4.5 4.5 6.0 1.4 5.0 11.5 4.8 0.0 19.6 6.1 5.3 1.1 4.3 5.9 6.6 11.0 4.6 9.8 11.9 12.8 5.3 1.6 9.3 5.5 30.8 8.0 6.2 7.2 14.7 7.9 51.5 52.8 38.5 21.5 46.3 21.1 16.0 14.6 20.2 31.6 20.4 13.2 10.4 25.3 30.2 33.8 8.4 31.5 23.5 27.7 30.3 27.1 41.3 30.7 26.3 31.2 30.8 23.1 35.2 26.4 29.3 35.9 10.7 16.0 13.6 7.5 14.5 7.5 15.4 14.9 10.8 11.3 12.5 8.9 9.8 12.8 16.7 18.4 41.7 5.1 12.4 13.0 25.4 8.2 275.7 9.0 8.8 10.3 10.8 4.6 4.5 9.5 5.5 8.1 30.5 10.0 34.2 11.5 12.8 10.9 23.3 6.7 3.0 12.5 10.2 26.7 14.8 277.4 11.5 20.3 12.4 2.8 28.9 16.6 39.1 2.0 10.2 8.7 24.0 13.5 15.0 16.6 29.2 38.6 16.9 27.9 0.0 5.2 8.4 4.7 3.9 11.0 8.1 6.0 17.9 20.1 9.5 19.7 RIPK4 "ANKK2, ANKRD3, DIK, PKK, RIP4" ENSG00000183421 "Receptor interacting serine/threonine kinase 4" P57078 21 41739369-41767089 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 52.3;Endometrial ciliated cells: 76.5;Gastric mucus-secreting cells: 61.2;Glandular and luminal cells: 174.2;Squamous epithelial cells: 71.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 32.2;GAMG: 41.2;HaCaT: 47.5;hTCEpi: 31.4;RPTEC TERT1: 28.3;RT4: 30.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA030942 Enhanced NA NA "HPA030942: AB_2732462" "unprognostic (8.93e-2)" "unprognostic (2.67e-1)" "unprognostic (6.32e-3)" "unprognostic (7.87e-2)" "unprognostic (1.24e-1)" "unprognostic (5.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.22e-5)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.98e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.69e-1)" "unprognostic (2.95e-3)" "unprognostic (2.28e-1)" "unprognostic (2.78e-2)" 0.8 0.0 0.1 0.4 0.0 0.6 4.4 0.1 0.1 6.4 3.0 3.1 9.8 1.1 2.5 72.8 5.9 5.2 0.8 0.1 0.1 11.5 19.2 4.2 0.1 0.2 0.3 0.0 0.1 14.4 7.4 10.9 2.3 0.1 10.8 2.1 0.6 14.9 9.9 0.0 21.3 13.7 0.1 0.2 0.0 15.6 2.0 0.2 7.9 8.0 0.0 5.2 6.4 22.5 0.1 14.3 9.0 0.0 0.0 0.0 0.0 13.7 0.1 0.1 0.2 0.2 23.5 32.2 0.0 13.3 2.9 41.2 47.5 0.7 19.2 0.0 0.0 9.4 0.0 6.9 8.8 0.0 0.0 0.0 0.0 31.4 0.2 4.2 0.0 0.0 14.3 0.0 0.0 0.0 10.3 2.0 0.0 0.8 9.3 26.1 0.0 0.0 2.3 28.3 30.8 4.5 0.3 15.5 15.7 15.1 1.3 9.6 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 4.2 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.1 28.9 9.1 0.0 0.1 15.8 27.4 24.0 52.3 0.0 13.0 12.4 1.1 17.2 28.0 3.7 0.0 8.3 0.3 22.8 9.8 12.4 1.5 76.5 16.9 0.9 22.7 0.0 0.0 10.4 5.1 0.6 61.2 174.2 2.5 0.0 0.0 17.0 1.0 0.0 0.0 14.2 16.2 0.6 1.4 1.6 0.0 0.9 7.2 0.0 0.0 0.4 0.0 0.0 0.0 19.0 11.8 0.0 0.0 24.0 26.5 13.5 22.2 0.9 0.0 0.0 1.3 1.4 2.5 71.2 15.2 2.5 1.5 0.0 11.2 24.1 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848107-109872315 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "retina: 17.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 33.3;Muller glia cells: 10.2;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.2 0.2 0.4 0.1 0.5 0.1 0.3 0.3 0.6 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.3 0.0 0.1 0.4 0.3 0.8 0.4 0.2 0.1 0.4 0.3 0.4 0.2 0.3 0.0 0.2 0.0 0.4 0.3 0.0 17.7 0.2 0.1 0.3 0.6 0.2 0.0 0.3 0.3 0.2 0.5 0.2 0.1 0.3 0.0 0.1 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.6 0.4 0.3 0.4 0.3 0.4 0.4 0.3 0.2 0.5 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 33.3 0.0 0.0 0.0 1.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 10.2 0.0 0.5 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 704.0" "Cell type enhanced" "Detected in many" "Early spermatids: 64.4;Excitatory neurons: 37.7;Respiratory ciliated cells: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 76.6" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 55.0 49.8 279.4 10.8 276.2 12.8 55.0 297.5 704.0 67.9 265.4 72.9 5.7 57.6 0.0 47.5 75.3 7.8 57.9 279.7 276.1 43.1 44.9 52.0 14.7 285.8 275.2 276.3 103.1 49.7 14.0 158.2 8.4 285.3 71.1 9.2 38.7 41.4 26.9 70.2 59.9 49.6 30.3 270.0 56.3 50.4 97.5 272.6 17.2 57.8 23.8 12.0 68.2 57.3 278.7 0.4 12.5 56.7 22.0 0.1 0.9 9.9 22.0 15.3 19.9 17.5 8.6 13.6 3.6 30.4 30.5 23.5 9.9 26.4 3.0 20.1 11.3 10.0 0.0 20.9 47.0 76.6 28.3 6.4 42.8 42.6 16.6 29.6 11.6 9.7 19.0 3.2 15.2 22.7 26.9 0.0 14.5 0.6 0.0 0.6 10.8 0.3 5.2 32.1 26.7 2.4 21.0 11.6 1.4 29.1 6.7 4.4 24.2 2.0 26.4 1.2 0.4 7.2 8.3 6.7 7.5 0.9 1.8 14.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 279.4 276.2 297.5 704.0 279.7 276.1 285.8 275.2 276.3 285.3 270.0 272.6 278.7 6.8 6.4 20.0 22.2 4.4 9.3 1.0 3.7 12.5 9.0 8.1 7.4 2.0 7.2 17.6 9.2 6.2 2.6 6.5 5.1 0.0 5.3 64.4 5.2 7.3 6.2 4.9 9.1 37.7 2.0 1.8 9.9 3.6 4.0 22.1 5.3 6.8 3.3 2.3 6.7 27.2 5.3 4.1 4.7 4.1 22.3 21.5 3.9 0.0 5.6 6.1 3.2 4.1 24.1 17.5 4.4 4.3 19.2 14.7 1.5 4.1 1.0 37.4 6.3 19.7 6.8 5.5 14.9 10.8 9.6 4.0 1.2 5.1 2.3 6.1 1.0 SF3A3 "PRP9, PRPF9, SAP61, SF3a60" ENSG00000183431 "Splicing factor 3a subunit 3" Q12874 1 37956975-37990075 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032054, HPA032055" Supported Supported "Nucleoplasm,Nuclear speckles" NA NA 57000 "Nuclear speckles" Nucleoplasm "HPA032054: AB_10602184, HPA032055: AB_2674130" "unprognostic (1.56e-1)" "unprognostic (1.21e-1)" "unprognostic (7.08e-3)" "unprognostic (6.19e-3)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.74e-3)" "unprognostic (9.18e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (2.52e-3)" "unprognostic (8.39e-2)" "unprognostic (2.24e-1)" "unprognostic (3.68e-2)" 24.8 23.6 22.5 29.5 23.1 58.4 32.0 24.3 29.3 25.8 23.5 25.3 20.6 30.7 34.0 23.6 27.8 19.3 18.7 22.2 23.0 26.2 27.6 23.1 39.3 22.6 22.9 21.5 32.4 20.5 30.9 16.3 25.6 23.3 25.1 30.3 30.2 23.7 29.0 50.1 29.4 21.6 32.0 23.8 27.7 20.2 27.7 23.3 43.8 27.2 27.6 45.0 28.4 19.0 24.2 84.4 57.0 108.1 90.8 63.3 57.7 129.6 82.2 69.1 131.9 106.4 97.2 84.4 165.8 68.1 73.6 51.6 71.5 136.7 108.6 162.3 74.9 125.7 206.3 92.3 86.7 57.9 261.1 93.5 54.9 75.4 135.5 88.4 58.6 89.9 112.6 176.1 60.0 95.2 53.2 131.4 123.0 268.0 80.4 89.9 156.8 197.0 110.7 59.4 83.5 95.8 69.4 104.2 47.1 83.9 95.1 54.0 90.3 82.0 70.3 79.6 64.9 157.2 57.6 89.5 166.4 65.6 215.6 92.1 37.2 41.3 28.4 56.1 53.3 55.0 54.9 65.3 56.7 53.1 68.9 69.4 58.9 4.6 56.2 61.8 32.5 75.5 61.7 22.5 23.1 24.3 29.3 22.2 23.0 22.6 22.9 21.5 23.3 23.8 23.3 24.2 37.3 51.3 35.0 11.4 42.2 47.3 38.6 46.6 55.2 37.0 21.3 27.7 22.7 20.0 42.3 22.0 22.9 59.1 40.7 12.1 39.2 44.4 37.9 23.7 42.4 35.8 15.6 53.6 15.7 38.1 69.2 41.6 15.3 25.3 42.4 43.0 25.0 23.6 51.5 26.9 14.9 23.9 34.6 28.0 39.8 14.0 39.7 34.2 39.2 6.5 82.9 45.6 44.3 11.1 11.5 35.4 13.1 54.2 41.5 28.5 19.0 29.2 27.8 38.6 39.5 47.2 68.3 120.8 55.2 36.5 41.8 33.0 42.9 53.5 31.4 24.0 TFDP3 "CT30, E2F-like, HCA661" ENSG00000183434 "Transcription factor Dp family member 3" Q5H9I0 X 133216662-133218354 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 4.3" "Group enriched" "Detected in some" 17 "Spermatocytes: 23.5;Spermatogonia: 31.1" "Cancer enhanced" "Detected in some" "liver cancer: 0.7;testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077304 Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA077304: " "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.5 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM61 RNF35 ENSG00000183439 "Tripartite motif containing 61" Q5EBN2 4 164954446-164977668 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 34.5;Late spermatids: 14.0;Spermatocytes: 50.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 15.1;SuSa: 10.2;U-266/70: 17.2" "Not detected" "Not detected" HPA049109 Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA049109: AB_2680636" "unprognostic (2.05e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (1.02e-2)" "unprognostic (8.24e-2)" "unprognostic (1.51e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (7.81e-2)" "unprognostic (1.51e-1)" "unprognostic (3.67e-1)" "unprognostic (2.92e-1)" "unprognostic (9.77e-5)" "unprognostic (4.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.36e-1)" "unprognostic (4.32e-2)" 2.1 3.6 1.9 2.2 2.4 3.7 1.3 2.2 2.5 2.9 0.6 1.4 1.9 1.5 2.2 1.0 3.6 2.9 3.0 1.9 2.7 1.0 1.1 2.3 3.2 2.5 2.1 1.9 5.0 1.4 1.2 1.0 1.7 2.3 1.8 1.4 2.8 0.9 2.0 0.9 1.1 1.4 2.2 1.5 2.1 1.3 8.9 2.5 2.6 5.7 1.4 2.9 2.3 0.2 2.8 0.9 0.8 2.0 2.1 1.1 1.1 1.2 4.2 1.3 0.9 0.8 0.7 1.4 0.9 1.1 5.3 1.0 1.0 1.4 1.5 0.9 1.6 0.8 1.6 1.5 0.9 15.1 1.6 1.4 9.0 1.3 3.7 1.4 8.5 0.8 1.3 1.8 3.6 0.8 1.0 1.4 1.0 6.5 1.0 0.7 1.4 1.1 1.2 0.6 2.6 1.7 1.1 1.0 1.5 1.2 10.2 0.5 1.6 0.9 2.7 1.8 0.9 1.7 17.2 8.2 2.3 1.0 0.9 1.9 5.4 1.4 0.1 2.9 1.2 3.3 3.5 1.8 3.3 1.5 5.8 4.4 3.6 0.3 8.0 1.1 4.1 0.8 1.4 1.9 2.4 2.2 2.5 1.9 2.7 2.5 2.1 1.9 2.3 1.5 2.5 2.8 0.2 0.0 3.3 1.0 3.8 0.3 1.2 0.4 0.0 1.1 0.1 0.1 2.3 0.0 0.2 3.7 4.2 0.3 2.3 0.0 0.0 0.3 34.5 0.4 2.1 0.9 0.0 1.3 1.9 0.7 0.0 1.6 0.5 0.1 0.0 4.8 0.0 0.4 1.1 1.7 1.4 0.0 0.0 0.6 0.7 14.0 1.2 0.9 0.0 0.0 1.7 2.7 1.0 3.5 4.3 0.1 0.1 1.5 6.4 0.6 0.0 3.7 0.1 0.4 0.0 1.5 1.3 50.1 3.7 0.2 0.0 0.3 2.2 2.8 0.0 0.6 GRIN2A "GluN2A, NMDAR2A" ENSG00000183454 "Glutamate ionotropic receptor NMDA type subunit 2A" Q12879 16 9753404-10182928 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 29.2" "Group enriched" "Detected in some" 13 "Excitatory neurons: 839.8;Inhibitory neurons: 904.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022725 Enhanced NA NA "CAB022725: " "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (5.97e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-2)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (2.08e-1)" "unprognostic (5.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (3.75e-3)" "unprognostic (4.79e-3)" "unprognostic (2.05e-1)" "unprognostic (3.92e-3)" "unprognostic (3.33e-2)" 0.3 0.3 4.0 0.0 8.6 0.0 0.1 0.0 29.2 0.2 0.0 0.2 0.3 0.3 2.6 1.1 2.1 0.1 3.0 18.4 11.5 0.4 0.0 0.4 0.0 0.0 0.7 8.7 0.1 0.2 0.0 0.1 0.0 6.5 0.1 0.2 2.2 0.2 0.3 0.0 0.5 0.2 0.4 0.0 0.0 0.4 2.2 1.1 0.6 0.2 0.2 0.2 0.1 0.4 8.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.3 1.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.6 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 8.6 0.0 29.2 18.4 11.5 0.0 0.7 8.7 6.5 0.0 1.1 8.2 0.2 0.0 0.0 16.0 0.0 1.9 2.2 0.5 3.4 10.3 0.3 0.0 18.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 2.1 17.2 0.3 0.1 0.5 0.0 0.0 839.8 0.2 0.0 2.7 0.0 0.7 0.0 3.3 0.0 0.3 0.1 1.7 904.7 0.0 0.0 0.3 0.4 15.1 0.9 0.1 0.0 15.9 0.0 15.6 0.0 27.6 65.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 13.9 0.0 0.0 5.4 8.2 10.0 0.2 0.4 0.0 0.0 0.0 0.1 0.3 URAD PRHOXNB ENSG00000183463 "Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase" A6NGE7 13 27977717-27988693 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Purine metabolism" "Decarboxylase, Lyase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 17.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 44.4;Intestinal goblet cells: 110.6;Paneth cells: 43.3;Proximal enterocytes: 196.3;Undifferentiated cells: 54.7" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 2.6;CACO-2: 2.4" HPA038972 Uncertain NA NA "HPA038972: AB_10671869" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (5.21e-2)" 0.2 0.0 0.0 1.7 0.0 0.0 0.2 0.7 0.1 0.0 0.0 13.9 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 44.4 3.9 0.1 0.3 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 110.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 43.3 0.0 0.0 0.0 196.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 54.7 0.0 GTF2H2C ENSG00000183474 "GTF2H2 family member C" Q6P1K8 5 69560191-69595221 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 10.1" "Cell line enhanced" "Detected in many" "U-266/84: 37.5" HPA047001 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047001: AB_2679899" "unprognostic (3.70e-1)" "unprognostic (3.46e-2)" "unprognostic (2.11e-2)" "unprognostic (1.95e-1)" "unprognostic (5.97e-2)" "unprognostic (4.33e-2)" "unprognostic (8.59e-3)" "unprognostic (5.34e-2)" "unprognostic (7.12e-2)" "unprognostic (6.03e-2)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-1)" "unprognostic (7.52e-2)" "unprognostic (2.68e-1)" "unprognostic (2.40e-3)" "unprognostic (2.55e-1)" 7.2 6.9 3.2 4.0 3.5 2.9 7.3 4.5 4.2 8.8 2.5 7.7 1.4 8.3 3.0 5.5 8.3 1.7 6.0 3.4 3.0 9.3 11.4 8.3 4.0 3.6 4.2 2.9 8.7 10.7 2.8 6.4 1.5 4.4 6.1 2.0 4.5 6.9 2.3 6.0 4.8 7.2 3.8 2.6 8.0 7.3 9.9 3.2 3.9 10.0 1.3 1.1 7.2 6.8 7.0 8.0 5.8 4.6 5.7 2.7 3.9 6.5 13.2 5.1 8.7 10.0 8.6 4.8 19.7 15.3 4.0 3.1 3.2 6.9 7.5 13.5 20.2 11.0 21.8 4.7 9.0 4.3 13.6 6.7 1.5 2.0 4.7 3.9 3.5 2.7 8.5 16.1 10.5 0.8 8.2 17.8 6.5 7.2 0.7 4.3 6.5 19.5 19.0 10.5 7.5 6.4 13.0 17.9 4.8 9.3 3.8 6.4 8.7 12.7 7.3 4.5 5.2 18.0 7.4 37.5 14.7 7.4 16.6 13.3 10.1 1.6 2.1 0.9 1.4 1.7 1.5 1.0 1.6 1.3 1.7 1.2 2.4 5.0 1.5 1.2 1.4 1.8 1.2 3.2 3.5 4.5 4.2 3.4 3.0 3.6 4.2 2.9 4.4 2.6 3.2 7.0 4.9 9.6 10.9 6.8 14.3 3.6 4.9 8.6 6.8 10.6 7.5 3.9 8.2 14.3 10.4 14.7 12.5 4.9 4.9 5.9 9.8 7.1 16.2 15.7 10.3 6.3 2.4 12.4 9.6 5.7 2.9 8.1 8.6 15.4 0.0 7.7 7.9 6.9 4.3 18.5 10.5 4.1 14.2 6.3 3.3 17.8 9.0 7.6 3.6 5.6 3.5 6.5 13.4 5.5 9.8 5.9 4.0 11.7 8.7 6.1 5.8 14.2 10.8 14.6 0.0 3.2 7.1 32.5 23.5 7.2 4.1 1.4 7.1 6.7 5.4 7.4 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602589-100651701 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 4.6 3.6 4.4 4.6 4.8 13.0 5.1 5.1 4.8 5.3 5.4 6.8 4.6 5.4 6.6 4.7 5.7 3.8 3.9 4.4 4.5 6.8 6.8 4.9 6.3 4.6 4.5 4.6 5.7 3.5 6.8 3.2 4.3 4.6 4.7 6.4 5.0 4.6 4.3 3.1 4.5 4.5 6.1 4.4 5.9 4.3 6.8 4.7 7.1 6.2 4.8 6.4 5.2 3.6 5.2 6.7 14.5 6.6 7.9 8.6 9.2 7.5 7.2 13.0 11.8 12.3 8.8 13.2 10.9 6.4 9.2 11.6 14.5 9.2 9.4 12.2 7.6 9.8 14.4 9.0 8.8 13.0 8.6 12.3 8.9 10.3 9.6 15.8 11.4 11.0 11.7 8.6 8.9 6.8 7.2 6.7 8.7 6.3 14.9 6.9 9.0 14.1 9.2 11.8 14.8 6.5 9.2 11.1 10.8 15.0 12.5 7.6 10.7 8.4 10.3 9.5 7.3 10.2 10.6 23.5 10.4 8.0 7.8 8.3 1.2 5.8 10.2 5.2 4.7 4.2 4.3 4.5 6.4 5.1 4.2 6.2 4.4 5.2 4.3 3.1 3.3 5.7 4.8 4.4 4.8 5.1 4.8 4.4 4.5 4.6 4.5 4.6 4.6 4.4 4.7 5.2 4.6 0.0 5.4 14.7 6.6 6.5 2.3 3.5 13.1 4.9 6.2 4.1 3.4 12.8 6.4 3.7 6.2 3.8 9.9 12.9 1.9 5.7 4.0 8.1 8.3 6.7 8.4 3.0 20.6 4.9 3.0 4.0 7.1 8.1 10.8 7.3 4.2 8.0 6.0 13.5 15.0 6.2 4.1 7.8 4.3 2.1 5.0 5.2 3.6 20.6 7.8 3.1 6.2 16.6 17.4 6.5 9.7 5.3 4.9 5.5 5.4 7.1 10.3 5.0 0.0 4.3 4.3 9.9 8.2 10.8 4.5 5.9 8.2 6.7 5.8 5.6 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 2.1;testis: 3.1" "Group enriched" "Detected in some" 4 "Early spermatids: 21.1;Late spermatids: 35.1" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 1.6 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.2 0.3 0.1 0.0 0.0 0.1 1.7 0.1 0.2 0.0 0.1 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.7 1.3 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 21.1 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 3.0 0.0 0.0 0.4 0.0 TREX2 ENSG00000183479 "Three prime repair exonuclease 2" Q9BQ50 X 153444720-153470587 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 24.7" "Cell type enhanced" "Detected in single" "Suprabasal keratinocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 11 "basophil: 1.7;eosinophil: 2.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "HEK 293: 5.4;U-698: 7.3;U-937: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA054060 Uncertain NA NA "HPA054060: AB_2682362" "unprognostic (2.32e-2)" "unprognostic (2.05e-3)" "unprognostic (1.13e-3)" "unprognostic (7.18e-4)" "unprognostic (6.05e-2)" "unprognostic (1.81e-2)" "unprognostic (8.40e-2)" "unprognostic (2.19e-1)" "unprognostic (2.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (1.52e-1)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-2)" 0.8 0.5 0.4 0.6 0.5 0.7 0.8 0.5 1.1 2.8 4.0 0.6 0.2 1.2 0.6 2.9 1.2 0.7 0.9 0.7 0.2 1.4 0.6 1.1 1.4 0.4 0.3 0.2 0.9 0.8 0.2 0.7 0.9 0.4 1.4 0.2 0.0 1.9 2.4 0.3 24.7 1.1 0.5 0.2 2.5 0.7 1.0 0.4 0.6 1.3 0.1 1.1 0.6 3.2 0.3 2.1 2.6 0.2 0.9 0.3 0.5 0.2 0.6 0.5 0.5 1.4 0.7 0.5 0.2 1.3 0.5 0.1 2.2 0.9 1.4 0.0 2.3 5.4 0.2 0.5 0.3 0.2 0.6 1.4 0.6 1.3 0.6 0.5 0.3 0.2 0.4 0.3 2.5 0.1 2.5 1.5 1.6 0.8 0.4 1.7 3.5 0.7 1.7 0.2 0.7 0.6 0.3 0.2 0.2 0.8 0.0 0.4 0.7 0.0 0.9 1.6 2.0 0.8 2.8 2.1 7.3 0.2 7.0 1.1 1.7 0.0 2.7 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.5 1.1 0.7 0.2 0.4 0.3 0.2 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.7 0.1 0.1 0.0 0.1 GPR132 G2A ENSG00000183484 "G protein-coupled receptor 132" Q9UNW8 14 105049395-105065445 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.1;lymphoid tissue: 7.8" "Cell type enhanced" "Detected in some" "B-cells: 23.6;Langerhans cells: 45.5;Macrophages: 30.2;monocytes: 19.1;NK-cells: 15.5;T-cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HDLM-2: 26.9;Karpas-707: 26.6;THP-1: 8.2" "HPA029694, HPA029695" Supported NA NA "HPA029694: AB_10600213, HPA029695: AB_10601984" "unprognostic (2.71e-3)" "prognostic favorable (3.21e-4)" "unprognostic (1.68e-2)" "unprognostic (1.07e-3)" "unprognostic (1.16e-1)" "prognostic favorable (6.44e-4)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (3.35e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (4.18e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (6.71e-2)" "unprognostic (4.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.72e-1)" 1.7 0.7 0.8 7.0 0.8 8.1 0.9 0.7 1.0 0.8 1.2 1.1 1.0 0.6 0.4 0.8 1.6 1.4 0.6 0.8 2.1 2.3 0.5 2.7 7.8 1.4 1.0 0.6 0.3 0.7 0.3 0.5 1.5 1.1 0.8 0.9 0.3 0.9 0.3 0.5 2.6 4.3 0.8 1.0 7.8 1.7 0.3 1.0 1.9 4.7 0.6 4.5 2.4 1.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.5 3.5 0.6 0.0 0.0 0.7 0.0 0.0 0.0 26.9 0.3 0.6 0.1 0.0 0.1 2.1 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 26.6 0.0 0.8 0.0 2.7 0.1 0.0 0.0 2.1 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 8.2 0.4 0.1 0.1 0.0 0.3 0.7 2.6 0.3 0.0 2.4 0.0 9.6 6.0 5.5 6.1 7.7 5.9 4.2 4.8 5.5 5.7 4.5 4.8 5.3 4.7 5.8 9.1 3.1 3.6 5.0 0.8 0.8 0.7 1.0 0.8 2.1 1.4 1.0 0.6 1.1 1.0 1.0 1.2 0.6 0.0 1.9 0.7 23.6 1.7 0.1 1.0 0.0 0.0 0.3 0.3 0.8 0.0 0.7 1.8 0.0 0.1 12.2 0.0 1.9 0.4 0.0 2.2 0.8 0.9 0.0 4.0 0.7 0.6 0.3 0.4 1.1 5.2 12.7 0.0 0.0 0.0 3.9 0.0 0.6 0.0 0.0 7.1 45.5 0.2 0.0 30.2 5.4 7.5 19.1 0.0 15.5 0.0 0.1 1.2 0.0 0.0 11.7 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 1.6 0.0 20.7 0.0 0.0 0.9 MX2 MXB ENSG00000183486 "MX dynamin like GTPase 2" P20592 21 41361999-41409393 "Plasma proteins, Predicted intracellular proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.7" "Cell type enhanced" "Detected in many" "Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in all" 4 "neutrophil: 150.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 150.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6" "Low region specificity" "Detected in all" HPA030235 Uncertain NA NA "HPA030235: AB_10601970" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "unprognostic (7.90e-3)" "prognostic unfavorable (3.71e-5)" "unprognostic (2.50e-1)" "unprognostic (2.30e-1)" "unprognostic (7.77e-2)" "unprognostic (3.36e-1)" "unprognostic (2.63e-1)" "unprognostic (6.64e-2)" "unprognostic (2.01e-2)" "unprognostic (9.48e-2)" "unprognostic (3.38e-14)" "unprognostic (6.31e-2)" "unprognostic (1.59e-3)" "unprognostic (5.61e-2)" "unprognostic (1.16e-2)" 11.7 1.4 1.1 16.5 1.3 13.4 9.8 0.7 1.2 7.7 0.9 4.9 6.9 2.6 0.9 6.0 5.0 13.5 6.5 0.8 1.1 3.4 2.3 6.8 14.3 2.6 0.8 0.4 3.3 2.4 1.5 1.4 5.0 1.6 2.8 2.9 0.0 6.0 1.6 2.4 4.4 9.6 5.8 1.0 25.0 13.2 2.4 1.1 30.7 4.5 4.3 14.1 14.9 6.8 5.9 0.3 0.0 0.0 0.0 3.4 6.5 0.0 0.0 19.9 143.6 136.9 0.0 31.1 0.0 0.0 1.9 27.6 0.0 0.0 0.0 4.9 1.1 0.0 30.4 0.0 20.3 0.8 1.1 0.0 11.9 0.0 2.7 0.0 0.0 0.0 0.9 1.4 18.3 0.0 0.0 56.8 23.0 36.1 7.1 0.0 8.6 0.0 4.5 0.0 3.8 0.0 0.0 2.4 0.0 2.5 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 84.2 1.2 3.9 90.6 15.3 6.0 31.4 24.4 11.7 37.5 14.7 13.8 19.0 14.1 22.6 11.5 19.1 13.2 150.8 7.4 35.9 10.8 16.3 21.8 1.1 1.3 0.7 1.2 0.8 1.1 2.6 0.8 0.4 1.6 1.0 1.1 5.9 32.1 6.4 7.1 0.0 28.4 4.1 2.2 1.2 2.2 0.1 1.8 2.3 3.7 0.0 9.8 1.8 0.0 0.4 27.2 1.4 1.9 0.8 0.5 0.9 9.5 15.6 3.0 1.3 1.0 2.9 1.3 19.7 40.8 0.9 12.6 1.0 3.3 0.2 15.1 0.0 0.4 3.2 0.0 28.6 27.4 1.7 6.8 57.6 10.6 5.6 42.4 0.2 24.7 1.0 0.3 5.2 1.1 4.1 10.3 2.7 4.6 0.1 9.1 0.3 26.3 2.6 11.1 1.4 7.3 3.5 1.4 0.3 30.3 2.2 2.1 5.8 EP400 "CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12" ENSG00000183495 "E1A binding protein p400" Q96L91 12 131949942-132080460 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;dendritic cells: 4.7;T-cells: 1.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016704, HPA049013" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA016704: AB_1854888, HPA049013: AB_2680598" "unprognostic (2.28e-1)" "unprognostic (4.04e-1)" "unprognostic (4.33e-1)" "unprognostic (8.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.10e-1)" "unprognostic (1.37e-2)" "unprognostic (4.90e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-1)" "unprognostic (2.46e-2)" "unprognostic (2.24e-1)" 11.4 14.1 19.1 7.6 16.3 12.3 12.0 14.6 18.2 16.3 9.7 14.1 6.0 14.6 13.3 11.5 15.2 6.0 10.7 18.8 11.9 12.0 11.8 11.4 11.5 15.4 13.0 14.0 19.7 12.6 9.5 17.5 6.5 16.9 14.4 6.7 18.2 10.4 8.9 19.5 15.5 13.3 7.4 8.8 18.7 11.8 14.7 14.0 11.8 14.4 9.0 8.6 13.2 12.7 16.7 23.5 30.6 28.3 14.2 16.6 16.3 22.3 13.0 9.9 9.8 8.4 18.3 7.1 19.9 11.8 16.2 11.1 17.6 13.7 13.0 13.2 8.3 20.6 28.5 10.8 20.8 13.7 30.9 21.3 14.0 12.1 18.1 16.3 16.7 16.9 12.7 28.3 5.5 14.3 29.6 23.5 42.1 22.6 12.7 26.3 24.6 19.0 8.1 13.3 28.3 22.8 19.2 15.1 10.4 15.0 20.4 17.4 24.1 25.4 15.6 24.3 17.6 18.9 14.1 11.6 19.8 16.2 17.0 16.0 0.7 0.7 0.6 1.1 0.6 1.1 4.0 1.0 0.9 0.6 4.0 1.2 1.7 0.6 0.6 0.6 4.7 0.7 0.6 19.1 16.3 14.6 18.2 18.8 11.9 15.4 13.0 14.0 16.9 8.8 14.0 16.7 19.1 3.2 17.9 44.4 27.8 9.9 10.5 11.0 17.1 34.2 14.0 10.5 13.9 7.2 14.3 16.5 39.6 12.6 22.4 13.2 1.9 11.3 12.5 21.3 25.5 18.6 14.4 14.9 59.6 10.4 11.4 17.3 14.8 21.8 6.3 34.1 15.7 12.1 15.0 25.2 56.4 13.8 12.2 14.1 7.6 6.8 16.4 17.9 7.2 24.4 16.7 15.7 29.9 55.8 48.9 15.3 14.0 17.0 24.3 17.8 8.8 4.2 35.9 37.2 19.7 31.2 20.2 62.8 54.3 20.0 13.1 17.8 26.5 26.9 13.5 13.4 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046119 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix: 12.2;testis: 47.2" "Group enriched" "Detected in many" 8 "Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 1.9 0.4 1.4 1.5 2.0 2.1 1.5 3.1 3.3 12.2 0.1 2.6 0.6 6.3 0.5 1.0 1.3 2.5 2.2 2.2 1.1 0.7 0.9 1.5 2.8 1.1 1.4 2.0 5.7 0.6 0.2 0.8 2.3 1.2 2.5 0.7 0.8 2.7 3.2 1.6 1.0 1.2 1.4 0.7 1.1 1.0 47.2 2.5 6.5 0.8 2.1 1.0 1.5 4.2 1.4 0.2 2.5 17.2 65.9 1.4 2.0 4.9 2.1 1.0 3.6 3.2 0.5 0.4 3.2 1.2 3.9 1.1 0.5 8.2 0.3 2.5 0.7 5.3 49.2 2.8 2.2 2.8 0.6 15.1 1.0 1.3 2.0 4.0 8.4 7.6 6.1 2.4 0.0 6.2 1.6 8.3 4.2 22.4 0.1 0.6 11.4 10.4 1.7 0.1 0.0 13.7 26.2 3.5 0.6 2.4 4.8 0.2 0.8 6.9 9.0 10.3 5.0 3.1 6.1 3.4 3.7 2.9 5.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.0 3.1 3.3 2.2 1.1 1.1 1.4 2.0 1.2 0.7 2.5 1.4 3.6 0.0 0.6 0.0 1.3 2.8 0.4 1.4 5.2 3.1 6.0 8.0 4.5 1.5 0.4 0.0 2.1 11.3 1.6 0.7 0.0 0.8 204.7 1.8 13.5 5.3 1.2 7.2 2.1 0.2 8.7 8.3 0.5 1.3 1.3 99.5 2.5 0.2 1.5 0.0 3.4 1.0 0.0 1.0 9.8 201.1 6.5 5.0 7.2 1.0 0.5 5.2 0.0 4.0 1.3 0.5 0.2 4.5 0.8 0.8 0.0 0.0 0.3 2.9 6.6 1.9 16.8 2.7 18.8 5.8 2.0 2.5 2.0 1.0 1.4 0.2 TENT5C "FAM46C, FLJ20202" ENSG00000183508 "Terminal nucleotidyltransferase 5C" Q5VWP2 1 117606048-117628389 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Nucleotidyltransferase, RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 89.8" "Cell type enhanced" "Detected in some" "B-cells: 41.8;Breast glandular cells: 34.0;Breast myoepithelial cells: 43.2;dendritic cells: 104.5;Plasma cells: 47.7;T-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 29.3" "Group enriched" "Detected in many" 17 "B-cells: 13.3;granulocytes: 29.3;T-cells: 13.7" "Cell line enhanced" "Detected in many" "Karpas-707: 296.2;RPMI-8226: 185.5;U-266/70: 81.7;U-266/84: 72.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054049 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA054049: AB_2682356" "unprognostic (3.76e-2)" "unprognostic (3.85e-3)" "unprognostic (3.24e-3)" "prognostic favorable (3.75e-5)" "unprognostic (1.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.29e-1)" "unprognostic (2.88e-2)" "unprognostic (5.75e-2)" "unprognostic (1.36e-3)" "unprognostic (9.41e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.77e-5)" "unprognostic (6.26e-2)" "unprognostic (3.16e-2)" "unprognostic (3.08e-2)" "unprognostic (1.10e-2)" 2.4 2.4 0.7 17.2 0.9 89.8 11.7 1.0 2.3 11.0 23.2 24.0 16.1 3.2 19.3 3.6 4.8 7.9 6.9 1.4 1.2 7.6 10.4 10.6 18.9 1.6 1.9 0.4 9.1 47.2 11.3 2.6 3.9 1.1 6.7 25.1 0.1 26.1 4.2 29.7 1.1 13.1 2.9 1.8 21.9 30.5 43.8 1.0 6.3 14.4 11.0 37.6 14.2 1.9 1.3 0.2 0.1 0.1 1.3 0.1 0.0 1.3 0.6 26.9 0.5 0.2 1.7 0.2 4.9 0.3 0.8 0.3 0.3 0.1 0.5 0.2 17.6 1.6 37.9 0.2 0.0 0.1 22.4 46.8 0.0 0.1 0.4 0.0 0.1 0.1 10.0 5.2 296.2 0.0 3.8 0.1 22.8 3.8 4.5 2.4 0.1 0.1 185.5 0.3 3.7 2.2 0.2 1.7 2.4 1.8 0.6 1.9 0.2 0.5 0.3 2.1 0.1 0.4 81.7 72.8 1.9 1.7 8.1 2.4 29.3 0.0 15.9 3.4 0.0 3.1 13.3 3.3 4.4 0.1 10.4 0.4 1.9 1.6 1.1 0.0 0.3 13.7 2.9 0.7 0.9 1.0 2.3 1.4 1.2 1.6 1.9 0.4 1.1 1.8 1.0 1.3 17.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 34.0 43.2 0.0 0.0 0.0 1.8 0.0 1.9 104.5 0.0 11.7 0.8 0.0 8.3 5.4 2.9 0.0 0.0 0.0 5.2 2.2 3.2 0.0 13.7 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 47.7 0.0 0.0 9.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 2.2 48.4 1.0 0.0 0.0 COA5 "C2orf64, FLJ27524, MGC52110, Pet191" ENSG00000183513 "Cytochrome c oxidase assembly factor 5" Q86WW8 2 98599314-98608515 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 180.0;Proximal tubular cells: 175.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057768 Uncertain Supported Mitochondria No No Mitochondria "HPA057768: AB_2683521" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (1.67e-3)" "unprognostic (2.61e-2)" "unprognostic (7.11e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.32e-3)" "unprognostic (3.71e-3)" "unprognostic (8.00e-3)" "unprognostic (3.08e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.93e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.00e-5)" 14.3 21.1 41.7 10.5 42.8 9.8 18.7 48.1 46.4 17.6 37.8 19.5 14.8 18.7 30.1 11.8 19.4 11.0 19.5 41.9 42.3 26.5 22.9 13.0 16.5 42.5 43.2 42.6 21.3 15.7 22.2 23.7 13.5 42.7 19.9 14.6 38.7 15.3 17.8 28.8 16.9 17.9 12.5 42.6 19.6 18.0 13.0 43.9 17.5 22.8 22.2 15.7 18.2 14.2 46.1 18.5 7.9 24.4 17.5 28.1 22.6 20.4 10.6 8.5 11.4 11.8 16.3 15.1 9.6 18.4 8.7 21.7 13.1 21.2 11.5 13.8 24.5 18.5 13.3 15.2 26.0 20.4 13.1 11.6 22.7 23.6 8.1 10.5 19.7 12.0 26.6 18.6 10.8 12.4 14.6 17.2 22.9 16.9 19.8 16.7 10.4 17.2 21.1 24.8 9.9 18.4 23.1 9.1 11.3 27.6 27.4 13.9 26.4 11.1 17.2 15.3 10.4 9.0 17.6 25.0 12.0 21.0 28.0 14.5 20.2 24.9 29.4 23.9 23.5 20.3 23.6 21.0 22.5 24.0 25.3 25.5 25.5 28.0 20.1 25.8 31.2 31.1 22.9 41.7 42.8 48.1 46.4 41.9 42.3 42.5 43.2 42.6 42.7 42.6 43.9 46.1 39.5 16.0 28.7 10.4 27.3 10.5 26.3 46.5 28.5 25.5 45.5 62.6 66.6 37.1 32.6 47.8 6.2 36.9 34.8 26.3 180.0 43.4 28.0 52.8 30.4 30.6 27.0 29.4 12.0 24.5 38.8 29.8 21.9 35.6 26.6 33.3 31.8 63.6 52.8 21.9 12.4 37.2 59.0 38.1 12.5 14.9 32.6 30.5 28.4 4.7 41.3 51.4 54.6 8.5 19.1 30.8 29.6 35.0 24.0 34.4 46.1 175.0 49.2 32.0 13.1 23.5 29.7 118.4 33.8 32.5 11.6 32.7 23.5 46.1 33.2 33.6 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11 small subunit processome component" Q9Y3A2 1 38009258-38024820 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 112.3;tongue: 86.3" "Cell type enhanced" "Detected in many" "Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 15.5 18.9 11.7 15.5 12.7 16.8 13.7 12.6 16.0 11.5 11.7 15.6 11.4 16.0 13.6 18.6 12.4 13.0 18.5 12.6 13.0 12.4 17.1 11.5 15.0 13.3 12.8 11.7 11.1 15.8 12.1 7.3 14.9 13.2 13.8 13.4 7.1 14.2 13.0 112.3 14.7 10.0 19.9 12.8 10.8 14.1 15.3 12.7 13.6 11.1 86.3 17.7 19.9 11.1 15.4 37.6 22.9 38.5 36.8 27.8 37.8 34.6 41.5 39.4 55.4 50.4 32.8 44.9 62.6 37.9 34.2 27.2 31.6 44.2 37.2 68.8 47.3 39.9 72.6 27.9 28.8 37.9 72.7 45.3 35.3 23.7 61.4 53.3 34.1 44.6 47.6 84.1 32.5 63.5 26.6 56.9 75.4 92.1 41.9 29.1 49.7 80.8 57.3 36.5 36.2 49.8 41.5 36.1 30.7 67.8 40.1 28.1 44.5 33.2 36.8 45.0 40.8 80.0 31.0 65.8 52.6 49.3 79.3 46.5 18.1 27.6 15.2 23.1 30.6 24.3 15.0 18.3 19.3 27.6 17.5 16.3 20.3 8.3 32.2 36.5 26.3 23.4 20.5 11.7 12.7 12.6 16.0 12.6 13.0 13.3 12.8 11.7 13.2 12.8 12.7 15.4 37.9 35.3 43.6 0.0 5.7 0.0 0.0 0.0 0.0 0.0 29.8 27.6 0.0 0.0 21.1 25.8 0.0 54.2 23.6 0.0 39.2 60.2 0.0 23.6 43.5 31.4 0.0 0.0 0.0 67.4 51.7 23.4 0.0 24.8 25.2 19.0 0.0 0.0 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 19.1 0.0 0.0 0.0 0.0 72.6 0.0 0.0 3.5 0.0 0.0 49.4 25.5 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 77.8 10.5 39.1 0.0 0.0 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183488 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.6" "Group enriched" "Detected in all" 4 "Early spermatids: 673.8;Spermatocytes: 544.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.3 9.9 3.5 9.2 4.4 17.5 6.9 2.9 6.0 7.3 2.3 10.6 9.0 7.9 4.8 11.9 6.5 5.4 8.3 4.9 4.0 9.8 16.0 5.7 9.0 2.4 2.6 3.3 7.2 10.9 5.2 8.1 7.8 3.1 5.6 10.0 4.9 7.4 3.3 13.9 7.0 8.3 5.1 1.9 6.3 7.1 40.6 3.2 6.3 10.9 5.7 6.3 7.9 7.4 4.3 104.0 34.7 23.5 32.9 12.3 15.1 65.0 55.3 25.9 44.8 28.2 66.6 26.9 113.7 28.9 17.1 38.1 28.5 40.3 30.3 30.2 48.9 61.6 209.6 52.4 83.6 21.9 101.0 40.4 18.9 24.6 46.2 46.5 9.8 24.9 47.0 160.4 61.9 27.2 58.2 63.0 54.7 82.2 38.9 53.5 99.6 29.8 115.8 19.1 30.4 77.6 22.7 70.4 39.1 57.4 4.0 36.6 51.4 26.7 50.1 16.8 66.7 79.9 46.4 79.3 96.8 42.0 170.4 38.6 10.6 6.8 3.9 10.5 9.0 12.3 12.0 14.7 12.4 12.2 10.6 11.5 10.3 0.6 7.5 9.1 11.3 13.7 7.9 3.5 4.4 2.9 6.0 4.9 4.0 2.4 2.6 3.3 3.1 1.9 3.2 4.3 23.7 6.4 17.6 5.2 17.8 136.0 44.1 68.6 43.9 14.2 31.3 39.0 24.8 22.8 39.9 20.2 4.2 108.9 12.6 14.7 66.5 50.8 673.8 20.8 36.5 26.3 29.9 63.3 7.5 49.7 118.6 31.8 18.8 21.6 36.1 26.2 18.9 32.7 59.5 8.4 8.0 45.7 69.2 17.7 35.5 88.4 31.7 25.0 46.2 3.7 24.4 18.0 12.3 3.5 5.9 32.4 20.0 33.1 31.7 41.5 30.6 89.4 20.8 19.7 26.3 29.5 31.3 544.1 98.7 51.7 97.7 54.5 20.1 54.7 56.9 27.9 PRR14L "C22orf30, MGC50372" ENSG00000183530 "Proline rich 14 like" Q5THK1 22 31676256-31750140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062645 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062645: AB_2684817" "unprognostic (2.87e-1)" "unprognostic (1.34e-1)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" "unprognostic (2.13e-1)" "unprognostic (1.37e-2)" "unprognostic (4.10e-2)" "unprognostic (8.86e-3)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (4.90e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.48e-2)" "unprognostic (4.14e-3)" 3.8 3.7 3.6 5.4 3.8 8.7 5.7 6.4 4.2 4.6 8.2 6.3 4.4 4.3 4.2 5.7 5.1 3.4 3.2 3.5 3.3 4.3 4.3 4.5 7.0 2.7 2.6 3.4 7.0 4.2 6.6 4.7 5.3 3.2 4.0 7.1 5.0 4.2 3.8 2.8 7.0 4.7 5.1 1.4 5.7 6.0 5.6 4.2 7.7 5.3 4.6 7.3 4.8 4.1 7.1 11.4 10.8 11.6 11.5 10.4 9.7 12.0 6.1 7.2 9.4 8.7 9.9 4.1 12.9 5.8 12.0 7.0 11.0 22.9 9.1 9.7 17.3 9.7 7.8 9.7 8.0 8.8 24.3 16.2 8.7 9.0 13.0 11.2 8.1 13.3 10.1 12.0 8.3 9.9 10.8 8.6 7.7 13.4 16.3 4.1 12.8 18.5 7.4 7.8 12.8 16.0 9.4 14.2 8.5 7.8 13.6 7.5 9.6 12.7 5.7 11.4 7.7 8.4 12.8 16.4 9.5 8.9 11.7 8.9 9.1 4.3 5.4 2.9 5.1 2.6 3.5 1.8 2.4 3.3 3.1 2.6 2.8 8.1 2.9 11.8 3.7 2.7 1.8 3.6 3.8 6.4 4.2 3.5 3.3 2.7 2.6 3.4 3.2 1.4 4.2 7.1 18.1 22.4 20.3 31.0 18.1 7.5 13.4 18.5 16.5 11.9 16.0 12.3 22.2 10.0 28.7 11.0 20.9 19.0 21.1 29.5 9.8 19.3 7.4 25.9 27.3 16.2 10.2 14.3 48.0 17.1 14.2 15.6 25.0 24.4 26.6 56.6 11.7 18.4 14.6 15.2 38.8 19.4 10.2 21.3 9.2 5.9 14.9 21.2 1.8 35.6 24.7 12.1 20.6 21.6 46.7 24.6 13.9 8.2 12.4 19.3 20.3 11.9 23.2 11.7 13.1 21.9 15.6 14.0 18.4 19.9 9.7 22.2 14.4 27.9 18.5 20.3 KLRC4 NKG2-F ENSG00000183542 "Killer cell lectin like receptor C4" O43908 12 10407382-10409757 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.5" "Cell type enhanced" "Detected in some" "dendritic cells: 22.2;NK-cells: 8.2;Plasma cells: 4.7;T-cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 20 "gdT-cell: 8.2;memory CD8 T-cell: 5.9;naive CD8 T-cell: 6.7;NK-cell: 4.7" "Group enriched" "Detected in many" 59 "NK-cells: 4.7;T-cells: 8.2" "Cell line enhanced" "Detected in some" "HeLa: 5.5;SuSa: 1.8;U-698: 1.7" NA NA "unprognostic (3.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.60e-1)" "unprognostic (7.00e-2)" "unprognostic (1.55e-4)" "unprognostic (1.89e-2)" "unprognostic (1.52e-1)" "unprognostic (3.32e-1)" "unprognostic (2.92e-1)" "unprognostic (4.36e-1)" "unprognostic (3.44e-7)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (5.51e-3)" 0.6 0.8 2.0 2.3 2.1 1.7 1.5 1.0 2.0 0.6 0.2 1.2 1.4 0.8 0.6 0.8 0.5 2.3 0.3 1.6 1.6 0.2 1.2 1.8 4.7 2.5 1.6 1.3 0.4 0.1 0.0 0.1 0.5 2.2 0.5 1.4 0.1 1.1 0.1 0.0 0.1 2.7 0.5 1.3 9.5 2.3 0.6 1.8 0.6 0.7 0.0 3.3 0.6 0.5 2.3 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.3 0.0 0.0 5.9 0.0 0.0 0.0 6.7 0.1 4.7 0.0 0.0 0.0 1.8 2.0 2.1 1.0 2.0 1.6 1.6 2.5 1.6 1.3 2.2 1.3 1.8 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.4 0.0 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 11.1 0.2 0.0 0.1 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 278.8" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 237.8" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles NA NA Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 25.8 2.5 6.4 0.7 4.7 0.6 10.7 4.6 4.7 2.1 2.8 2.9 0.8 1.2 7.1 1.0 1.7 2.3 2.5 5.2 6.6 25.6 278.8 2.2 1.9 7.1 5.9 3.2 0.8 0.6 1.0 0.5 1.4 6.5 0.6 1.3 0.5 0.9 0.9 14.0 2.1 2.0 1.0 6.2 4.6 3.4 0.9 7.5 0.7 4.3 1.7 0.7 1.1 2.2 8.4 0.0 0.0 0.1 0.1 5.3 11.5 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 13.8 0.0 0.8 0.1 0.2 0.0 0.0 0.1 0.5 1.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 8.5 0.1 0.0 0.1 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 6.4 4.7 4.6 4.7 5.2 6.6 7.1 5.9 3.2 6.5 6.2 7.5 8.4 0.4 0.0 0.0 1.0 0.5 0.0 0.1 0.0 0.0 0.0 0.8 0.4 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.5 0.5 0.0 0.3 1.2 0.0 13.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 6.1 237.8 3.7 0.0 0.2 0.0 0.0 11.7 1.5 0.8 9.3 3.5 0.0 7.5 1.3 0.9 0.0 1.5 0.1 0.0 0.0 6.0 0.0 0.2 0.0 52.1 0.0 0.1 0.0 11.3 0.3 0.2 0.3 0.1 0.6 0.0 0.7 0.9 0.1 0.2 C10orf120 bA318C4.1 ENSG00000183559 "Chromosome 10 open reading frame 120" Q5SQS8 10 122697709-122699846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "testis: 31.2" "Cell type enriched" "Detected in some" 4 "Early spermatids: 592.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 592.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.6 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IZUMO1R "Folbp3, FOLR4, JUNO" ENSG00000183560 "IZUMO1 receptor, JUNO" A6ND01 11 94305592-94307721 "Predicted intracellular proteins, Transporters" Fertilization Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.56e-3)" "unprognostic (1.37e-1)" "unprognostic (7.22e-3)" "unprognostic (8.39e-2)" "unprognostic (2.92e-3)" "unprognostic (2.47e-1)" "unprognostic (5.08e-2)" "unprognostic (8.61e-2)" 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERHL2 ENSG00000183569 "Serine hydrolase like 2" Q9H4I8 22 42553617-42574382 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "breast: 424.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 18.1;Hepatic stellate cells: 21.8;Sertoli cells: 19.7" "Group enriched" "Detected in all" 5 "breast cancer: 8.0;prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 3.5;naive B-cell: 8.4;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 12 "B-cells: 8.4;dendritic cells: 3.9" "Cell line enriched" "Detected in many" 10 "SK-BR-3: 276.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.14e-1)" "unprognostic (1.56e-2)" "unprognostic (8.61e-2)" "unprognostic (2.52e-2)" "unprognostic (3.27e-1)" "unprognostic (7.24e-2)" "unprognostic (1.25e-3)" "unprognostic (1.47e-2)" "unprognostic (1.55e-3)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.92e-1)" "unprognostic (7.04e-2)" "unprognostic (4.08e-2)" "unprognostic (2.06e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" 1.9 2.6 4.2 1.0 4.9 2.1 424.7 5.2 7.4 3.4 3.0 1.9 0.7 3.1 36.7 2.4 3.4 1.6 3.9 4.4 4.2 2.0 1.7 1.6 4.0 3.8 3.8 4.3 13.8 0.6 5.4 1.1 0.8 4.6 10.3 1.2 1.1 6.4 5.5 1.4 13.5 2.1 2.0 3.5 1.9 3.0 2.9 4.3 0.7 2.9 1.3 1.4 2.6 2.9 4.5 0.7 0.0 1.6 3.0 3.7 8.7 0.5 2.2 2.0 2.0 2.6 0.1 0.5 1.3 1.2 5.4 1.2 1.4 1.5 0.9 1.1 0.5 0.9 1.2 0.1 2.9 1.9 1.8 2.5 8.7 1.5 1.3 0.2 1.7 0.6 0.2 11.7 0.2 2.1 5.8 29.0 1.8 0.3 0.7 0.7 15.6 0.0 0.5 0.9 0.7 0.5 0.8 0.5 276.7 0.3 2.9 1.2 1.9 2.0 1.0 0.3 1.5 0.0 1.2 0.1 13.5 1.8 0.2 1.2 0.0 0.0 0.4 0.1 0.0 0.2 3.5 0.1 0.3 0.1 8.4 0.0 0.1 0.0 0.2 0.1 3.9 0.0 0.3 4.2 4.9 5.2 7.4 4.4 4.2 3.8 3.8 4.3 4.6 3.5 4.3 4.5 2.6 3.2 0.0 3.6 3.2 1.3 6.1 1.5 1.8 1.4 18.1 6.3 0.5 1.5 2.4 12.9 0.0 5.4 3.2 0.5 3.9 1.3 3.5 2.4 2.2 8.5 0.0 2.7 5.0 0.2 3.7 4.0 0.5 5.0 0.0 0.7 21.8 1.2 1.2 1.7 4.4 1.7 0.0 1.6 1.9 3.1 5.3 2.4 5.4 4.7 0.0 4.1 1.0 3.0 9.9 0.5 0.6 6.8 0.1 13.2 0.4 1.0 2.5 1.5 19.7 3.1 3.3 5.3 8.3 2.6 1.6 8.1 1.3 3.3 1.2 4.5 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 82.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 159.4;Cone photoreceptor cells: 50.1;Horizontal cells: 116.1;Late spermatids: 79.8;Muller glia cells: 49.3;Rod photoreceptor cells: 83.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.0;HDLM-2: 56.9;HSkMC: 40.8;SH-SY5Y: 46.9;U-87 MG: 25.0;U-937: 31.3" "Region enriched" "Detected in all" 5 "olfactory bulb: 229.1" "HPA030247, HPA073145" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244, HPA073145: " "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 7.1 7.2 8.8 7.5 6.8 9.0 4.6 32.5 11.5 6.6 2.5 11.1 1.7 8.8 7.5 1.4 5.4 2.6 2.9 13.2 8.4 2.6 1.3 2.9 3.4 26.7 12.9 6.3 3.9 2.7 0.1 22.7 1.3 28.1 2.3 1.6 82.2 1.8 0.8 0.4 2.1 8.8 7.9 7.0 10.1 4.8 14.9 16.4 19.1 1.0 1.7 2.9 4.2 2.8 17.0 0.0 0.0 0.5 0.0 13.7 29.0 0.2 1.8 0.4 3.1 1.4 0.0 0.0 0.0 0.7 8.2 3.9 0.1 1.7 0.0 0.5 56.9 0.2 0.0 0.0 0.0 13.7 0.0 0.0 40.8 0.2 0.5 0.8 0.0 0.0 2.0 0.0 0.2 1.8 0.7 16.5 3.3 0.8 0.1 2.8 0.0 0.1 2.4 0.0 0.0 4.9 46.9 1.2 0.0 0.0 1.3 0.0 8.7 0.0 0.0 0.1 12.3 0.0 0.7 3.1 0.0 25.0 31.3 1.1 2.1 0.2 3.0 0.7 0.1 0.1 1.3 0.4 0.0 0.0 1.4 0.7 0.1 0.7 0.3 0.1 0.0 0.4 0.2 8.8 6.8 32.5 11.5 13.2 8.4 26.7 12.9 6.3 28.1 7.0 16.4 17.0 0.6 0.0 0.0 2.3 6.2 0.3 0.1 0.3 0.0 159.4 0.1 0.5 3.6 0.0 0.7 1.8 50.1 0.1 0.3 0.0 0.0 0.1 36.5 0.2 8.9 2.2 3.0 0.0 3.8 0.2 0.1 2.3 0.5 0.3 0.0 0.2 2.2 0.0 0.4 116.1 4.6 0.1 0.0 0.0 0.7 79.8 8.4 0.9 3.6 1.0 0.0 49.3 0.0 0.5 5.5 0.9 0.1 12.8 4.1 1.3 0.0 0.4 0.0 83.1 0.0 1.1 3.9 34.1 21.2 0.0 0.0 0.0 2.5 0.2 0.2 0.5 PGPEP1L ENSG00000183571 "Pyroglutamyl-peptidase I like" A6NFU8 15 98968229-99007792 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 31.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.1;Distal tubular cells: 1.9;Early spermatids: 3.8;Excitatory neurons: 3.8;Inhibitory neurons: 3.3;Late spermatids: 1.7;Skeletal myocytes: 2.1;Spermatocytes: 2.7;Spermatogonia: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA041781 Uncertain NA NA "HPA041781: AB_10795642" "unprognostic (2.48e-1)" "unprognostic (2.82e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-3)" "unprognostic (7.18e-2)" "unprognostic (3.99e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (9.78e-2)" "unprognostic (1.58e-1)" "unprognostic (4.53e-3)" "unprognostic (1.86e-1)" "unprognostic (2.62e-1)" "unprognostic (2.00e-2)" "unprognostic (1.65e-1)" 0.2 0.1 0.5 0.2 0.8 0.1 0.4 0.0 1.1 0.2 0.0 0.3 0.2 0.2 0.0 0.8 0.1 0.5 3.9 0.5 0.5 0.4 0.0 0.2 0.3 0.3 0.2 0.7 0.1 0.6 0.0 0.1 0.2 0.4 0.5 0.0 0.1 0.6 0.5 31.2 0.0 0.1 0.1 0.0 0.0 0.2 2.1 0.2 0.1 0.1 7.5 0.0 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 1.1 0.5 0.5 0.3 0.2 0.7 0.4 0.0 0.2 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 3.8 0.1 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.9 2.7 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 SETD3 "C14orf154, FLJ23027" ENSG00000183576 "SET domain containing 3, actin histidine methyltransferase" Q86TU7 14 99397748-99480889 "Enzymes, Predicted intracellular proteins" "Actin-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 206.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003591, HPA003639" Approved Approved Mitochondria NA NA Mitochondria "HPA003591: AB_1079930, HPA003639: AB_1079931" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-2)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (1.04e-2)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" "unprognostic (2.73e-2)" "unprognostic (2.01e-1)" "unprognostic (4.42e-1)" "prognostic favorable (1.89e-15)" "unprognostic (6.81e-2)" "unprognostic (3.21e-1)" "unprognostic (2.20e-1)" "unprognostic (2.62e-3)" 39.1 26.9 55.2 25.5 54.7 23.8 30.4 52.4 57.1 29.4 48.6 42.2 36.7 26.5 84.2 36.9 47.0 29.6 79.8 53.3 50.5 97.0 47.6 37.7 24.3 52.0 50.6 45.9 22.2 38.0 40.4 21.8 43.0 51.3 36.2 38.3 65.0 58.3 42.0 175.6 31.8 37.7 39.8 51.3 28.6 29.3 85.8 53.1 24.7 53.8 119.2 25.0 36.6 24.6 55.8 39.9 44.6 33.1 31.7 37.6 42.0 117.1 49.4 37.4 50.3 51.1 43.5 65.7 38.8 39.5 55.6 39.5 50.4 40.8 55.2 79.6 38.5 22.0 35.3 27.8 40.2 46.9 53.6 51.2 29.6 71.3 44.7 64.8 37.9 63.4 57.2 28.3 56.9 56.3 74.7 56.6 57.9 19.9 98.5 50.7 34.1 67.8 32.0 72.6 48.4 58.9 27.4 44.3 45.4 38.4 59.7 61.6 46.2 56.6 22.6 31.5 153.8 38.2 40.6 49.3 42.1 42.6 52.5 35.3 7.6 18.1 24.9 17.7 21.5 20.6 11.4 15.0 16.6 22.4 8.9 12.3 15.4 10.8 20.6 19.2 14.1 12.2 14.8 55.2 54.7 52.4 57.1 53.3 50.5 52.0 50.6 45.9 51.3 51.3 53.1 55.8 31.1 25.6 44.5 43.1 16.9 24.3 18.6 14.4 21.6 26.0 22.8 17.1 83.0 18.6 24.8 25.8 27.1 61.9 37.3 37.2 33.2 24.7 206.6 29.9 24.9 29.1 21.7 11.3 47.7 28.0 45.4 22.2 17.3 30.7 32.9 7.5 22.9 27.5 35.8 18.5 43.6 28.2 14.2 29.7 23.2 121.0 19.0 35.9 10.6 52.5 27.9 47.6 60.8 38.2 36.8 25.7 20.3 21.1 23.6 26.1 30.1 101.5 28.1 39.5 6.6 25.3 23.0 130.4 73.0 25.0 32.4 30.0 27.9 9.2 30.5 20.8 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 87.7;smooth muscle: 85.5" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077484: AB_2732347" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (3.51e-4)" 9.4 3.8 9.0 7.2 7.2 0.8 5.7 3.5 7.2 13.4 4.6 8.6 1.6 87.7 6.0 20.5 46.0 6.3 5.9 13.8 6.2 2.7 2.5 15.6 3.9 5.3 8.3 7.8 16.0 2.4 0.9 3.0 2.0 4.7 6.8 8.7 0.3 3.9 5.5 4.7 23.1 8.0 85.5 5.2 20.0 5.9 4.5 5.9 0.9 5.4 3.5 3.2 18.7 15.3 6.3 0.1 0.4 0.1 0.2 35.0 87.8 0.4 0.3 0.1 1.0 1.6 0.1 1.0 0.1 1.5 5.0 11.2 0.1 1.2 0.8 0.4 0.1 0.7 0.0 2.4 5.9 9.1 0.3 1.9 32.5 7.1 6.7 26.8 5.8 78.7 0.1 0.1 0.1 74.5 0.9 0.0 0.6 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.8 0.1 0.1 0.1 0.1 0.9 0.5 0.6 105.5 8.0 0.5 26.5 2.3 0.4 0.0 0.1 16.7 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.6 0.3 0.2 0.2 0.0 0.0 9.0 7.2 3.5 7.2 13.8 6.2 5.3 8.3 7.8 4.7 5.2 5.9 6.3 1.2 0.0 0.5 4.6 0.0 3.3 1.1 0.4 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.3 2.3 1.7 3.9 10.3 0.0 4.5 0.4 0.0 5.8 0.0 0.1 0.0 7.1 1.8 0.3 2.9 0.0 14.4 3.3 2.0 2.9 10.8 0.7 9.0 3.5 1.8 1.0 0.6 0.1 0.0 1.0 2.6 0.1 1.5 5.3 0.1 0.4 0.0 0.1 1.3 0.2 6.6 1.6 9.3 23.7 0.8 0.3 8.4 0.0 0.1 0.1 1.5 0.5 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883572-29057488 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Astrocytes: 504.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 2.8 7.2 11.2 1.4 11.2 0.3 2.6 7.6 13.9 4.5 1.1 3.3 3.0 5.1 13.5 3.4 4.8 2.1 2.6 12.2 10.3 8.3 6.6 4.4 0.5 12.3 8.8 7.0 5.9 3.4 8.8 2.7 5.1 10.6 7.3 3.4 1.1 7.6 7.8 3.8 5.3 2.8 4.7 4.4 1.2 4.4 5.0 13.5 1.3 4.1 1.9 0.6 3.3 3.3 7.2 5.8 13.7 12.5 3.5 2.3 2.6 23.7 3.5 1.7 2.7 2.6 20.8 3.2 0.1 5.4 1.8 4.9 9.8 8.7 5.5 3.3 7.8 8.9 2.3 2.5 46.1 2.0 6.9 2.3 2.7 5.0 4.3 4.3 2.3 2.4 4.1 5.0 3.2 3.9 5.6 0.2 3.5 4.6 7.3 5.4 6.9 8.2 5.3 11.6 8.5 20.6 7.6 6.2 6.1 3.5 3.8 4.1 3.1 2.3 10.3 8.8 8.2 5.8 4.3 6.3 8.1 4.4 3.9 5.5 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 11.2 11.2 7.6 13.9 12.2 10.3 12.3 8.8 7.0 10.6 4.4 13.5 7.2 4.2 12.8 23.6 504.1 0.3 12.6 5.2 4.9 15.9 3.7 5.7 9.5 7.5 8.6 5.3 12.9 0.0 28.1 0.5 2.1 1.9 5.0 12.7 8.0 8.0 5.8 8.4 4.0 62.9 2.5 2.5 5.8 5.6 15.5 0.0 5.4 2.2 17.6 3.5 1.7 37.4 9.4 0.0 1.0 3.1 15.0 10.8 0.8 0.0 82.4 0.0 6.0 0.0 54.8 34.4 3.7 2.1 12.8 0.6 9.6 2.4 11.6 4.9 3.9 0.0 16.0 6.6 4.6 3.2 7.8 7.5 7.7 0.7 14.5 12.9 2.8 FBXL7 "FBL6, FBL7, KIAA0840" ENSG00000183580 "F-box and leucine rich repeat protein 7" Q9UJT9 5 15500180-15939795 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 976.2;Inhibitory neurons: 295.1;Oligodendrocyte precursor cells: 335.8;Oligodendrocytes: 766.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055464 Uncertain NA NA "HPA055464: AB_2682822" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" "unprognostic (3.34e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (4.54e-2)" "unprognostic (1.46e-1)" "unprognostic (1.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.41e-2)" "unprognostic (4.29e-3)" "unprognostic (3.42e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.94e-3)" 16.5 22.9 17.5 3.7 18.4 0.0 14.0 16.1 16.0 18.1 14.7 13.8 2.0 26.6 10.4 9.8 15.9 8.5 16.2 14.6 12.9 4.2 2.1 9.7 2.6 21.6 16.0 12.0 27.1 1.9 1.0 4.8 6.7 16.9 13.4 5.2 4.3 5.7 19.7 4.0 4.8 6.8 24.8 14.8 5.1 10.3 4.4 15.6 2.4 8.2 5.8 2.2 16.8 13.2 22.2 0.1 1.4 16.1 23.5 13.1 10.0 0.0 14.1 17.0 9.9 10.3 0.0 0.0 0.0 0.0 21.7 10.2 0.0 8.1 5.2 9.8 0.0 1.1 0.0 0.0 0.0 5.1 0.0 0.0 11.8 0.0 8.0 0.7 12.1 23.2 0.0 0.0 6.1 7.5 0.0 0.0 0.0 5.4 0.0 2.6 0.0 11.4 0.1 0.0 0.0 4.7 15.9 0.0 4.9 15.3 14.5 0.0 0.0 22.9 20.6 4.1 11.7 6.3 0.0 0.0 0.0 11.4 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 18.4 16.1 16.0 14.6 12.9 21.6 16.0 12.0 16.9 14.8 15.6 22.2 21.4 3.2 1.9 976.2 0.3 2.4 2.7 2.4 2.2 3.2 0.9 1.1 11.8 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 2.0 11.8 16.7 0.0 0.0 3.7 0.0 0.1 15.9 0.0 2.0 1.3 13.1 15.4 0.2 0.8 30.3 295.1 0.0 0.0 0.6 2.7 0.7 30.1 0.5 5.4 146.1 0.0 2.4 0.0 335.8 766.0 0.0 0.0 41.3 1.2 3.1 0.0 1.2 3.8 2.5 6.6 16.1 8.1 1.4 2.1 1.5 1.7 0.0 0.3 20.7 0.0 2.4 TANGO2 "C22orf25, DKFZp761P1121" ENSG00000183597 "Transport and golgi organization 2 homolog" Q6ICL3 22 20017014-20067164 "Disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 79.6" "Cell type enhanced" "Detected in all" "Erythroid cells: 111.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003080 Approved NA NA 200000 "HPA003080: AB_1078350" "unprognostic (4.05e-1)" "unprognostic (1.90e-3)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (3.48e-1)" "unprognostic (1.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (6.13e-2)" "unprognostic (6.76e-2)" "prognostic favorable (3.01e-4)" "unprognostic (2.21e-1)" "unprognostic (1.83e-3)" "unprognostic (3.95e-2)" "unprognostic (5.49e-2)" "unprognostic (2.60e-1)" "unprognostic (2.62e-2)" 16.1 26.9 23.8 13.9 20.3 51.0 13.6 19.9 24.4 10.7 16.6 14.6 9.9 13.1 9.3 11.6 11.0 11.0 79.6 22.5 21.2 21.4 20.2 19.3 17.8 25.1 26.9 20.2 8.0 15.5 27.9 19.8 11.7 27.1 17.3 11.4 6.4 12.3 12.3 27.9 12.3 16.3 12.1 21.5 34.3 21.4 7.6 26.6 12.5 24.5 29.3 11.8 15.2 9.8 25.2 15.6 14.2 4.8 9.6 33.6 10.9 8.7 15.7 20.8 14.5 12.8 10.0 12.1 6.2 11.1 42.4 20.2 18.9 11.2 17.5 9.2 36.8 11.4 16.9 11.9 12.0 24.6 15.7 29.1 15.6 12.9 21.0 11.6 14.5 21.6 10.4 44.0 13.1 20.8 17.7 10.3 10.7 2.3 37.7 9.5 9.5 12.9 4.0 11.7 19.9 8.4 4.7 16.1 27.7 35.3 10.3 7.0 14.3 14.7 19.0 14.4 25.2 11.0 6.7 4.1 6.4 25.9 12.9 13.6 76.3 44.1 77.8 14.9 53.4 16.2 20.5 15.9 19.2 41.6 15.7 10.0 13.1 55.8 31.3 70.1 14.3 28.7 39.6 23.8 20.3 19.9 24.4 22.5 21.2 25.1 26.9 20.2 27.1 21.5 26.6 25.2 5.8 16.0 5.8 10.7 11.9 3.8 3.9 4.2 2.2 4.9 3.9 3.4 17.1 10.0 4.6 7.3 4.2 10.6 10.2 11.5 19.6 11.5 5.5 2.7 3.4 5.7 6.6 111.4 20.6 9.7 17.4 5.9 9.2 4.9 15.2 4.5 6.4 6.4 39.4 10.1 13.3 7.0 8.2 21.6 7.1 15.9 5.0 24.0 19.6 15.9 24.8 7.6 19.6 3.0 30.9 11.6 9.2 4.9 7.2 4.8 13.8 7.7 6.1 2.9 19.7 3.0 6.6 4.8 3.1 5.3 4.5 11.5 9.7 13.0 6.3 3.5 H3C13 HIST2H3D ENSG00000183598 "H3 clustered histone 13" Q71DI3 1 149813225-149813693 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 7.7;U-266/70: 19.2" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (3.35e-2)" "unprognostic (1.84e-1)" "unprognostic (4.73e-2)" "unprognostic (2.88e-2)" "unprognostic (9.27e-3)" "unprognostic (3.39e-1)" "unprognostic (1.83e-2)" "unprognostic (9.61e-2)" "unprognostic (1.48e-2)" "unprognostic (7.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.59e-1)" "unprognostic (8.93e-4)" "unprognostic (6.95e-2)" "unprognostic (1.57e-1)" "unprognostic (2.04e-2)" "unprognostic (2.48e-3)" 0.5 0.8 4.1 0.8 1.7 3.3 0.5 13.1 2.1 0.7 3.2 0.7 0.2 0.4 0.0 1.1 0.7 0.8 0.8 1.8 5.1 0.5 0.7 1.1 0.7 2.8 3.4 1.3 1.5 0.7 0.0 0.4 0.2 4.2 1.0 0.0 0.1 0.2 0.0 0.1 0.5 1.2 0.0 4.2 1.3 1.1 0.8 8.1 0.5 0.6 0.0 0.1 0.4 0.8 4.5 0.6 0.0 0.1 2.3 0.3 0.0 0.2 1.3 0.0 0.0 0.0 0.3 0.4 0.5 0.3 0.0 0.2 0.8 0.0 0.0 0.0 1.2 0.4 0.2 3.5 0.0 0.2 0.0 1.7 0.6 0.0 0.4 0.2 0.3 0.0 0.6 1.7 1.5 0.0 1.2 2.0 7.7 1.7 0.4 3.1 1.0 0.0 1.3 0.0 0.8 0.4 0.3 1.1 0.0 0.1 0.1 0.4 0.4 0.4 1.1 0.0 0.7 0.0 19.2 2.1 1.3 0.3 0.4 0.6 0.0 1.2 0.5 0.9 1.5 1.8 0.9 1.2 1.4 1.0 4.7 0.4 0.3 9.8 0.4 0.5 2.2 0.1 0.3 4.1 1.7 13.1 2.1 1.8 5.1 2.8 3.4 1.3 4.2 4.2 8.1 4.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SFXN4 SLC56A4 ENSG00000183605 "Sideroflexin 4" Q6P4A7 10 119140767-119165714 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018028, HPA020872" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA018028: AB_1856792, HPA020872: AB_1856793" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (3.61e-1)" "unprognostic (1.12e-1)" "unprognostic (1.27e-2)" "unprognostic (9.49e-2)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (6.84e-2)" "unprognostic (4.56e-2)" "unprognostic (8.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.70e-3)" "unprognostic (4.22e-3)" "unprognostic (1.43e-1)" "unprognostic (6.21e-3)" "unprognostic (3.07e-3)" 12.8 36.2 10.4 10.2 12.0 16.6 14.2 12.1 13.7 14.1 14.6 21.1 20.6 11.2 13.6 19.3 14.5 8.6 33.4 9.9 12.1 24.7 36.7 8.5 14.6 11.2 10.6 9.2 16.2 33.9 23.3 21.7 8.9 11.3 19.0 23.0 5.8 28.1 13.3 51.9 11.4 17.4 12.3 10.1 21.1 17.4 12.0 11.1 11.1 24.9 59.9 18.0 16.5 13.9 12.4 26.2 27.6 8.7 41.8 10.4 19.7 33.0 16.3 19.8 21.0 21.8 45.9 43.2 62.6 15.6 14.9 22.4 48.2 57.5 36.3 24.3 33.1 65.7 28.7 18.4 47.3 37.1 49.7 28.8 21.1 34.4 22.0 63.8 19.5 25.0 46.5 45.2 17.5 13.6 29.6 53.8 60.4 11.8 50.2 32.5 51.7 27.1 49.0 24.3 17.3 25.2 13.9 10.8 42.2 61.9 11.1 26.0 28.4 11.5 10.6 21.9 19.8 37.6 42.6 53.0 56.3 16.2 72.6 7.2 2.5 18.1 1.9 6.5 19.5 10.8 12.5 7.9 7.1 21.2 7.0 12.1 9.8 2.2 7.3 15.9 10.6 6.0 11.1 10.4 12.0 12.1 13.7 9.9 12.1 11.2 10.6 9.2 11.3 10.1 11.1 12.4 8.0 6.4 5.6 29.0 16.9 12.0 25.8 39.9 23.3 7.9 17.8 18.2 36.2 12.8 19.1 14.7 2.1 37.6 6.2 13.2 58.7 28.4 27.4 7.6 8.9 8.4 18.0 33.6 22.3 23.8 25.8 12.4 14.3 7.9 5.7 28.5 7.1 31.5 29.2 6.7 29.1 24.7 30.5 17.6 5.0 69.3 8.7 13.1 12.4 8.4 11.3 7.7 10.3 22.1 19.5 17.6 12.1 13.5 31.9 28.0 29.8 65.6 13.5 11.3 6.6 22.3 10.6 27.7 15.2 26.9 9.1 21.9 9.2 44.5 45.8 20.5 GKN2 "blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465" ENSG00000183607 "Gastrokine 2" Q86XP6 2 68945232-68952893 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 57 "stomach 1: 4654.7" "Cell type enriched" "Detected in some" 22 "Gastric mucus-secreting cells: 2770.2" "Cancer enriched" "Detected in some" 8 "stomach cancer: 43.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.1;HaCaT: 1.1;HMC-1: 2.0;MOLT-4: 1.6;NTERA-2: 2.3;PC-3: 4.5;U-2 OS: 1.6;U-266/70: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA057765 Enhanced "Secreted to digestive system" NA NA "HPA057765: AB_2683520" "unprognostic (1.81e-1)" "unprognostic (1.44e-4)" "unprognostic (2.22e-1)" 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.1 81.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.5 4654.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.3 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.2 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.4 109.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.9 2770.2 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 121.2 0.0 0.0 10.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 FAM167B "C1orf90, DIORA-2, MGC10820" ENSG00000183615 "Family with sequence similarity 167 member B" Q9BTA0 1 32247222-32248856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.2" "Group enriched" "Detected in many" 14 "Adipocytes: 68.5;Endothelial cells: 102.5;Hepatic stellate cells: 200.3" "Cancer enhanced" "Detected in all" "melanoma: 46.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.6;EFO-21: 12.0;SK-MEL-30: 30.9;U-2197: 29.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA029398, HPA062074" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA029398: AB_10602807, HPA062074: AB_2684677" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.03e-2)" "unprognostic (1.74e-2)" "unprognostic (3.36e-3)" "unprognostic (7.44e-3)" "unprognostic (3.64e-1)" "unprognostic (3.00e-3)" "unprognostic (1.02e-2)" "unprognostic (1.30e-2)" "unprognostic (8.89e-2)" "unprognostic (4.80e-2)" "unprognostic (2.69e-2)" "unprognostic (1.60e-1)" "unprognostic (8.04e-2)" "unprognostic (5.08e-2)" 13.0 19.8 6.0 4.2 3.5 0.2 10.1 3.5 5.8 12.1 3.9 7.1 2.9 13.0 0.5 4.0 10.4 4.3 8.3 4.2 3.9 38.2 10.8 20.7 2.8 4.4 4.3 3.1 4.1 8.4 4.3 14.5 4.2 5.0 16.7 2.1 1.4 4.7 6.0 3.0 2.2 8.2 5.9 4.0 1.9 7.6 0.9 5.3 0.8 20.1 1.1 1.6 13.3 7.7 8.5 0.9 1.8 0.6 0.0 1.2 1.1 0.0 4.3 9.6 1.9 2.7 0.1 0.9 0.2 12.0 7.3 2.2 1.4 0.3 0.0 0.6 0.1 0.0 0.0 4.6 0.5 0.4 0.0 0.1 1.0 0.7 1.4 0.4 2.6 3.5 0.6 0.0 0.1 0.2 0.6 0.2 0.0 0.3 0.2 4.1 0.9 0.0 1.2 1.2 0.4 1.8 0.4 2.8 0.2 30.9 0.8 0.5 0.1 3.2 0.8 0.9 29.9 0.1 0.1 0.3 0.7 0.3 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.1 0.5 0.0 0.1 0.0 0.0 1.7 0.2 6.0 3.5 3.5 5.8 4.2 3.9 4.4 4.3 3.1 5.0 4.0 5.3 8.5 68.5 0.0 1.1 0.3 3.2 0.3 0.5 0.2 0.0 0.4 2.8 2.8 0.4 0.0 0.1 5.5 0.0 0.1 2.7 1.3 0.0 0.5 0.0 1.3 3.5 102.5 0.0 8.0 0.0 0.8 0.2 3.7 1.5 1.0 0.0 0.2 200.3 1.7 0.6 0.0 0.1 1.3 0.0 8.5 2.2 0.0 2.8 1.4 1.8 2.8 0.0 0.0 2.1 0.5 0.4 0.2 1.2 1.2 0.6 0.6 0.0 0.1 1.3 0.5 0.0 0.6 1.6 0.0 0.3 0.3 1.0 0.3 2.1 0.9 0.7 0.3 MRPL54 ENSG00000183617 "Mitochondrial ribosomal protein L54" Q6P161 19 3762682-3768575 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 427.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042117, HPA046767" Uncertain Approved Mitochondria No No Mitochondria "HPA042117: AB_2677856, HPA046767: AB_2679795" "unprognostic (2.09e-1)" "unprognostic (1.00e-3)" "unprognostic (3.81e-2)" "unprognostic (1.85e-3)" "unprognostic (1.00e-1)" "unprognostic (4.43e-2)" "unprognostic (1.23e-2)" "unprognostic (1.32e-3)" "unprognostic (7.19e-2)" "unprognostic (1.70e-2)" "unprognostic (2.22e-2)" "unprognostic (2.88e-2)" "unprognostic (1.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.26e-1)" "unprognostic (2.64e-2)" "unprognostic (6.54e-3)" 53.3 86.2 65.6 41.3 65.1 110.0 55.3 67.2 80.6 45.3 66.0 54.2 54.3 50.2 36.7 58.9 58.3 34.9 78.2 63.6 69.9 79.0 123.9 43.4 64.0 66.4 65.3 62.1 47.3 88.6 71.9 64.5 31.7 66.0 58.4 44.4 38.4 72.5 37.4 58.3 53.6 49.2 37.9 66.9 54.8 71.3 54.9 67.1 64.0 58.3 58.3 50.9 50.8 44.2 69.0 115.1 64.4 58.4 57.6 34.2 54.6 49.6 53.8 69.0 126.8 108.5 55.7 39.8 82.1 54.4 66.8 47.6 71.3 77.6 70.9 53.8 53.0 118.4 41.8 33.6 72.0 89.1 89.7 95.0 64.2 121.3 53.2 92.7 49.0 105.8 56.4 80.2 157.1 67.3 77.9 81.1 94.5 77.8 79.8 46.9 69.4 33.2 122.8 97.8 57.9 81.6 67.6 43.8 103.4 83.4 27.8 69.7 126.6 75.5 79.5 45.8 136.5 117.2 95.4 140.5 82.4 78.6 142.3 60.6 96.9 121.2 81.9 103.4 132.8 96.0 139.1 112.5 122.3 134.7 125.8 107.6 99.1 35.3 133.0 133.7 122.7 168.4 144.1 65.6 65.1 67.2 80.6 63.6 69.9 66.4 65.3 62.1 66.0 66.9 67.1 69.0 61.1 76.9 79.3 5.5 101.2 49.1 91.9 111.1 63.2 55.6 89.2 98.8 55.2 91.5 91.7 79.1 18.8 134.4 69.7 183.5 358.1 112.7 94.2 90.1 54.7 60.5 105.4 63.1 3.6 193.6 125.7 62.8 90.7 78.8 106.5 47.6 62.4 249.8 157.7 38.7 4.7 234.8 79.3 115.3 65.4 63.0 56.2 90.9 71.2 2.8 120.7 105.1 106.1 2.0 10.1 128.7 185.4 44.8 123.2 116.2 234.4 427.8 76.0 90.9 26.3 65.7 64.4 113.4 47.1 106.7 57.3 176.9 94.6 109.3 171.5 118.2 ZNF438 bA330O11.1 ENSG00000183621 "Zinc finger protein 438" Q7Z4V0 10 30820207-31031937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.0;U-937: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039843 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039843: AB_10795159" "unprognostic (1.69e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" "unprognostic (9.21e-2)" "unprognostic (4.75e-2)" "unprognostic (1.22e-2)" "unprognostic (3.98e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (4.85e-2)" "unprognostic (1.08e-2)" "unprognostic (9.96e-2)" "unprognostic (1.52e-1)" "unprognostic (8.52e-3)" "unprognostic (9.50e-2)" 10.2 3.6 5.7 6.5 5.6 5.6 7.5 5.0 7.4 8.4 6.0 9.1 3.8 9.2 6.7 4.6 8.3 5.7 10.7 5.5 5.7 4.4 5.4 8.4 4.0 5.5 5.0 4.8 6.0 3.2 3.7 4.9 4.0 5.3 5.5 4.1 4.6 6.2 5.6 24.8 6.6 5.4 8.8 5.1 10.3 6.0 8.4 5.8 7.9 9.8 17.5 3.1 9.4 6.8 6.5 3.7 3.7 3.1 2.7 18.0 12.5 1.7 2.9 4.2 4.5 5.6 0.2 4.4 5.0 3.3 5.2 4.2 1.0 1.6 2.2 6.3 11.6 1.2 2.2 2.0 0.2 10.1 1.7 2.3 6.0 3.7 6.4 3.6 4.1 19.0 5.8 4.3 3.5 6.2 2.7 5.9 9.7 0.3 2.7 1.5 2.6 4.5 2.9 6.4 0.9 2.3 2.5 1.4 0.6 2.1 2.0 1.4 16.2 7.9 2.0 3.5 6.1 3.6 0.8 1.5 0.1 4.0 25.3 1.5 1.3 7.2 3.3 2.0 6.9 1.5 1.0 1.5 2.7 2.2 3.7 3.1 1.7 13.1 3.9 4.3 2.8 3.6 3.5 5.7 5.6 5.0 7.4 5.5 5.7 5.5 5.0 4.8 5.3 5.1 5.8 6.5 7.8 3.2 4.8 111.3 3.2 1.0 2.0 1.7 5.2 5.5 2.1 2.2 13.0 5.7 4.2 3.7 6.2 3.5 2.0 1.8 7.9 3.6 25.2 2.7 5.6 6.1 0.0 2.5 55.3 4.2 4.6 9.1 7.1 2.4 12.6 4.1 6.4 1.8 6.9 3.3 74.7 2.6 0.0 12.9 3.5 9.6 4.1 36.3 0.0 76.8 7.3 2.4 7.2 137.2 86.9 3.7 0.8 8.2 3.6 1.3 2.5 3.9 3.9 5.3 6.6 17.0 6.7 12.8 8.0 6.0 2.4 1.6 4.2 2.4 2.3 1.8 HMCES "C3orf37, DC12, SRAPD1" ENSG00000183624 "5-hydroxymethylcytosine binding, ES cell specific" Q96FZ2 3 129278828-129306186 "Predicted intracellular proteins" "DNA damage" "DNA-binding, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 124.9;Spermatocytes: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044968 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044968: AB_2679160" "unprognostic (9.18e-3)" "unprognostic (1.11e-3)" "unprognostic (4.16e-2)" "unprognostic (2.80e-2)" "unprognostic (2.93e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (3.00e-1)" "unprognostic (4.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-2)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.25e-2)" "unprognostic (9.08e-3)" 35.6 22.2 27.2 37.7 30.6 38.1 33.2 27.0 32.7 24.7 22.9 36.5 29.7 24.2 23.2 42.0 27.2 21.3 39.5 29.1 31.2 27.7 54.2 27.3 100.5 27.5 27.5 28.2 28.5 15.4 69.4 22.3 21.1 28.8 24.8 31.1 27.9 27.0 26.4 58.3 35.7 29.1 23.4 26.0 30.0 26.6 40.2 31.6 57.6 22.6 48.9 132.1 28.7 29.1 28.2 149.4 66.2 74.4 85.9 90.6 37.8 66.8 51.2 41.5 73.1 56.6 105.0 67.9 286.0 53.9 46.9 57.2 106.3 94.8 110.8 83.7 58.0 51.2 59.7 52.7 76.0 38.8 52.1 41.9 36.7 56.6 61.1 60.2 35.6 45.5 63.5 61.2 244.2 40.9 197.3 74.8 45.1 48.4 108.5 42.8 66.6 63.8 50.5 77.0 88.8 74.0 45.6 114.4 70.8 70.6 45.6 121.0 52.1 36.8 36.3 63.7 87.3 66.5 135.8 87.2 289.3 43.4 41.9 41.1 35.5 25.5 65.0 30.4 27.4 31.6 37.5 36.7 36.3 26.3 62.1 36.1 40.0 52.5 27.2 40.9 28.1 48.0 31.2 27.2 30.6 27.0 32.7 29.1 31.2 27.5 27.5 28.2 28.8 26.0 31.6 28.2 26.1 32.1 25.6 11.4 23.5 58.2 71.2 72.4 54.7 21.5 18.8 16.1 35.6 30.0 30.4 22.0 10.4 49.2 32.0 30.8 37.2 39.6 8.6 16.0 10.2 27.8 21.0 28.2 13.6 47.0 37.6 23.3 17.9 15.7 22.2 11.0 20.7 26.1 19.7 26.9 14.7 17.3 32.6 8.1 39.4 8.6 24.5 15.7 58.7 10.3 16.4 38.6 25.7 7.1 10.6 33.8 16.9 31.2 124.9 37.3 19.9 21.1 25.2 12.5 13.1 21.0 27.1 127.8 83.6 30.7 43.9 35.0 47.3 23.9 30.7 61.0 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.2;granulocytes: 1.3;Melanocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 25 "basophil: 3389.4;eosinophil: 2509.9" "Lineage enriched" "Detected in many" 109 "granulocytes: 3389.4" "Cell line enriched" "Detected in some" 10 "RPMI-8226: 29.6" "Not detected" "Not detected" "CAB003795, HPA069514" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003795: AB_562259, HPA069514: " "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.1 0.0 0.1 1.6 0.2 0.4 0.0 0.0 0.4 0.1 1.3 0.8 1.3 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.1 0.1 0.1 0.6 0.5 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.7 0.0 0.0 0.1 1.7 0.7 2.6 0.9 0.0 1.5 1.2 0.2 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 2.6 0.1 0.8 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.3 0.0 29.6 0.0 2.4 0.1 0.0 0.1 0.8 0.0 0.8 0.0 0.7 0.0 0.1 0.2 0.0 0.1 3.0 2.6 0.0 0.0 0.5 0.0 3389.4 1.0 2509.9 0.5 1.5 0.8 1.2 2.6 1.4 1.1 0.7 0.3 0.9 115.8 0.5 1.4 3.5 31.1 7.6 0.1 0.2 0.0 0.4 0.1 0.1 0.4 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 DGCR6 ENSG00000183628 "DiGeorge syndrome critical region gene 6" Q14129 22 18906028-18914238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 46.5;skeletal muscle: 185.0" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1045.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 8 "OE19: 46.5" NA NA "unprognostic (9.80e-3)" "unprognostic (2.12e-3)" "unprognostic (1.51e-1)" "unprognostic (3.93e-3)" "unprognostic (2.41e-1)" "unprognostic (3.14e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (5.77e-2)" "unprognostic (2.23e-2)" "unprognostic (3.38e-2)" "unprognostic (8.08e-2)" "unprognostic (3.11e-1)" "unprognostic (1.28e-1)" 13.4 10.1 6.8 0.7 6.5 2.0 15.1 8.3 7.4 5.6 7.3 3.8 1.4 2.1 2.3 7.3 4.0 1.1 46.5 6.7 6.4 9.7 27.3 9.7 1.7 7.3 6.1 7.0 2.2 13.2 1.8 20.1 1.3 8.0 6.9 0.9 4.6 12.7 1.5 185.0 25.0 5.0 0.8 5.2 4.2 5.5 26.4 7.2 1.4 22.0 7.0 1.4 4.8 8.0 7.3 0.7 2.5 3.8 2.9 1.7 1.5 0.8 0.9 0.8 1.4 0.9 0.6 1.5 0.3 1.2 1.4 0.8 1.7 2.9 1.5 1.0 1.2 5.6 0.6 3.1 0.6 1.2 1.5 0.5 1.0 2.1 1.1 0.4 1.2 0.6 1.9 3.9 1.8 1.3 1.7 1.3 2.2 1.5 46.5 1.7 2.2 3.3 0.2 0.7 0.2 3.5 1.7 1.2 0.5 0.5 2.8 1.9 0.3 0.3 2.5 2.1 0.7 0.7 1.8 0.3 0.4 1.6 2.5 1.8 10.3 1.1 1.9 0.4 1.8 1.1 0.3 1.2 1.0 3.0 0.1 1.8 1.5 0.4 0.4 1.1 0.2 1.2 2.4 6.8 6.5 8.3 7.4 6.7 6.4 7.3 6.1 7.0 8.0 5.2 7.2 7.3 3.8 9.6 5.1 17.3 1.4 16.4 10.2 19.6 0.0 6.0 6.9 17.8 60.4 7.2 15.2 7.3 4.2 2.3 2.0 1.5 23.5 1.3 245.4 3.8 1.8 3.9 1.8 0.0 6.3 2.6 2.7 8.9 0.5 1.1 8.9 0.6 1.8 16.3 2.6 30.3 5.4 3.9 14.2 4.6 16.3 1045.2 4.4 2.3 80.0 3.7 2.5 11.3 0.0 10.6 5.4 1.9 0.1 8.2 1.1 2.9 10.5 4.9 46.4 2.7 6.6 11.0 11.6 5.1 3.2 0.0 31.7 2.3 2.9 0.9 1.6 8.5 GOLGA8G DKFZp434K052 ENSG00000183629 "Golgin A8 family member G" 15 28519611-28533014 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 92 "testis: 9.2" "Group enriched" "Detected in some" 14 "Early spermatids: 11.8;Spermatocytes: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR32 CXorf64 ENSG00000183631 "Proline rich 32" B1ATL7 X 126819729-126821786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "tongue: 22.6" "Cell type enriched" "Detected in single" 13 "Cardiomyocytes: 1.3" "Cancer enriched" "Detected in single" 5 "glioma: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 10.7;pons and medulla: 13.5;thalamus: 8.2" "Not detected" "Not detected" HPA048386 Uncertain Approved "Nuclear speckles,Plasma membrane,Centrosome" NA NA "Plasma membrane" "Nuclear speckles, Centrosome" "HPA048386: AB_2680380" "unprognostic (7.10e-3)" "unprognostic (7.97e-2)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 2.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 22.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3 "P53TG3, TP53TG3A" ENSG00000183632 "TP53 target 3" Q9ULZ0 16 32673528-32676732 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Early spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RP1L1 DCDC4B ENSG00000183638 "RP1 like 1" Q8IWN7 8 10606349-10712187 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 117 "retina: 44.5" "Group enriched" "Detected in some" 20 "Cone photoreceptor cells: 93.8;Rod photoreceptor cells: 68.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024686, HPA024744" Enhanced NA NA "HPA024686: AB_2671650, HPA024744: AB_2671668" "unprognostic (3.27e-1)" "unprognostic (9.97e-2)" "unprognostic (1.24e-1)" "unprognostic (6.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-5)" "unprognostic (3.57e-1)" "unprognostic (5.22e-2)" "unprognostic (2.08e-4)" "unprognostic (8.52e-2)" "unprognostic (5.77e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 44.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.6 0.8 0.1 0.0 4.0 0.2 0.3 0.8 0.0 0.0 0.0 93.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 3.3 0.0 0.5 0.6 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 68.0 0.0 1.6 0.5 0.0 0.5 0.0 0.9 0.0 0.1 0.1 0.0 1.0 KRTAP8-1 KAP8.1 ENSG00000183640 "Keratin associated protein 8-1" Q8IUC2 21 30812697-30813274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "skin 1: 39.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 21 "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOATZ "C11orf88, FLJ46266" ENSG00000183644 "HOATZ cilia and flagella associated protein" Q6PI97 11 111514785-111537031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 27.2;fallopian tube: 89.7;testis: 29.4" "Cell type enriched" "Detected in single" 28 "Cardiomyocytes: 5.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;Karpas-707: 1.7;SuSa: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" NA NA "unprognostic (2.25e-1)" "unprognostic (3.07e-5)" "unprognostic (3.85e-4)" "unprognostic (4.16e-2)" "unprognostic (4.44e-5)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "unprognostic (5.49e-3)" "unprognostic (2.86e-1)" "unprognostic (9.96e-3)" "unprognostic (2.70e-1)" "unprognostic (4.40e-2)" "unprognostic (6.80e-3)" "unprognostic (7.57e-2)" "unprognostic (6.22e-2)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" 0.0 0.0 8.1 0.1 2.3 0.1 0.0 3.2 2.1 4.2 27.2 0.0 0.2 3.1 0.4 0.0 89.7 0.2 0.0 1.2 5.5 0.0 0.0 11.8 0.1 8.8 7.1 0.1 0.1 0.0 0.0 0.4 0.3 7.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 8.4 0.2 0.1 29.4 3.5 0.1 0.8 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.2 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 8.1 2.3 3.2 2.1 1.2 5.5 8.8 7.1 0.1 7.0 8.4 3.5 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF530 KIAA1508 ENSG00000183647 "Zinc finger protein 530" Q6P9A1 19 57599885-57612722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 8.6;Muller glia cells: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HEK 293: 75.0;U-266/84: 58.8" HPA045868 Uncertain Approved Vesicles NA NA Vesicles "HPA045868: AB_2679478" "unprognostic (1.57e-1)" "unprognostic (3.02e-3)" "unprognostic (5.65e-2)" "unprognostic (2.90e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (9.69e-3)" "unprognostic (4.98e-3)" "unprognostic (3.19e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.06e-1)" 1.2 1.5 4.2 1.2 3.9 3.3 1.7 6.1 5.5 0.6 4.9 1.0 1.0 1.0 1.9 0.9 0.7 0.8 3.7 4.3 3.9 1.1 0.8 0.9 2.0 4.1 3.6 3.6 0.9 1.6 0.8 0.7 1.2 4.1 1.4 0.8 2.6 1.2 1.4 6.4 2.0 1.1 0.7 3.6 2.2 1.8 1.2 3.7 2.3 1.0 2.7 2.3 1.0 0.8 4.5 6.7 5.8 4.3 3.7 0.3 1.9 6.8 4.1 1.7 6.8 3.8 4.1 1.0 0.8 3.3 1.5 4.1 2.2 3.6 3.0 7.2 0.2 75.0 13.4 11.6 2.6 0.5 4.9 6.1 1.3 1.7 6.4 1.8 1.9 1.5 4.7 1.7 3.0 2.3 2.6 7.0 3.8 6.4 0.5 14.2 0.9 13.6 6.3 1.3 11.3 4.9 4.5 4.8 1.2 1.4 3.8 3.1 7.6 2.0 8.5 5.3 1.9 8.5 14.6 58.8 9.3 5.2 5.2 6.0 1.0 1.5 1.0 3.0 0.9 2.2 3.5 2.0 3.1 1.8 2.5 2.7 2.2 1.7 3.1 1.1 1.7 2.9 1.6 4.2 3.9 6.1 5.5 4.3 3.9 4.1 3.6 3.6 4.1 3.6 3.7 4.5 2.7 6.4 1.5 1.6 2.3 1.8 0.7 1.7 1.8 3.3 1.8 1.0 8.6 1.5 0.9 0.0 0.0 2.0 3.1 0.6 1.9 1.9 0.3 0.9 0.8 2.7 0.0 4.0 1.4 2.9 1.5 1.4 1.1 0.8 2.5 2.2 2.9 0.7 2.0 0.0 1.0 0.2 2.0 0.8 2.0 0.3 0.9 0.6 5.4 0.0 1.5 9.1 2.1 0.5 0.9 1.4 1.7 1.5 2.5 1.3 0.9 0.8 0.7 4.2 6.6 1.5 1.7 2.1 2.9 1.6 1.7 1.4 2.3 1.1 1.0 0.9 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2435.4;Hepatocytes: 1690.0;Proximal tubular cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 240.0 399.7 403.6 110.0 415.3 168.8 233.8 419.8 593.4 178.7 433.8 306.3 167.2 166.3 179.9 283.8 178.6 61.7 1107.6 409.5 437.3 458.8 507.3 183.9 119.4 411.7 409.8 403.8 164.0 208.0 376.9 317.2 61.6 416.6 223.4 123.6 263.2 235.5 60.0 870.8 143.7 227.8 70.0 411.3 215.8 294.8 113.1 407.9 232.7 252.4 1063.1 107.0 193.8 204.1 421.6 198.3 388.3 332.5 208.4 219.1 160.7 143.0 243.2 143.7 147.5 135.4 236.9 341.0 187.0 215.7 151.3 205.8 249.6 198.4 212.3 133.9 280.8 425.1 361.3 665.8 308.5 178.2 290.4 196.4 202.5 132.0 159.5 140.7 334.8 136.7 353.7 199.0 370.1 211.8 759.0 286.6 250.0 166.4 779.6 492.1 253.3 309.7 274.2 397.7 491.3 210.8 152.8 486.6 289.7 338.3 277.7 432.0 435.0 291.8 89.3 173.0 181.3 161.7 288.4 477.2 422.0 278.4 208.5 187.9 456.1 566.8 447.5 247.4 409.6 288.5 373.7 361.5 286.0 508.6 306.8 355.4 343.9 721.3 296.6 386.6 604.6 438.9 653.6 403.6 415.3 419.8 593.4 409.5 437.3 411.7 409.8 403.8 416.6 411.3 407.9 421.6 158.5 166.7 227.4 11.4 187.4 128.7 102.1 334.5 96.8 84.6 328.2 353.6 2435.4 467.5 237.0 389.9 39.6 260.3 170.4 627.2 1166.1 245.4 175.8 326.0 208.6 188.2 317.4 256.1 18.4 427.7 118.8 203.6 189.6 225.8 215.8 96.2 397.3 1690.0 422.3 55.5 21.7 515.9 268.5 619.8 179.3 57.3 262.5 281.7 332.6 10.3 478.1 223.3 241.0 11.1 15.0 294.4 628.7 241.1 201.6 97.9 845.2 1614.3 337.6 183.3 223.5 172.4 188.2 138.8 151.5 204.5 176.2 205.8 163.7 97.4 540.6 116.3 MARCHF11 "MARCH-XI, MARCH11, RNF226" ENSG00000183654 "Membrane associated ring-CH-type finger 11" A6NNE9 5 16067139-16180762 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 83.0" "Cell type enriched" "Detected in single" 30 "Cardiomyocytes: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 83.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (9.91e-3)" "unprognostic (1.08e-1)" "unprognostic (2.98e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" 0.1 0.7 4.3 0.0 4.7 0.0 0.3 5.0 6.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.7 6.9 0.2 0.1 0.0 0.0 5.3 4.6 4.7 0.3 1.3 0.0 10.0 0.0 5.1 0.3 0.0 3.6 1.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 83.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 83.8 0.0 0.0 0.0 7.5 0.0 0.0 0.0 1.5 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.7 5.0 6.8 5.7 6.9 5.3 4.6 4.7 5.1 3.6 4.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759326-85794925 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;NK-cells: 2.5;T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebral cortex: 29.1;hippocampal formation: 16.3" HPA023450 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 6.3 2.5 6.2 2.6 6.9 0.5 5.4 5.5 9.8 4.3 4.8 3.8 4.7 6.6 3.1 5.7 4.0 2.3 3.9 8.0 6.9 3.7 15.3 4.4 1.9 5.9 7.6 4.5 3.3 1.6 2.2 3.7 1.1 5.6 4.6 1.1 0.8 3.6 3.2 6.6 8.4 3.4 2.8 4.3 1.6 5.0 10.6 6.7 2.0 2.5 3.0 1.3 3.7 5.0 6.7 2.7 8.1 11.6 5.7 2.3 1.2 6.0 3.4 1.6 4.6 3.5 10.9 4.4 1.7 1.7 2.8 2.9 6.6 12.5 6.4 1.0 1.7 5.8 0.5 3.5 8.4 2.7 0.5 2.0 2.4 2.1 4.5 1.5 2.0 2.5 5.8 0.7 1.5 2.0 5.0 4.3 2.6 10.5 4.6 4.2 8.7 6.9 2.8 1.7 5.6 16.1 11.1 4.9 5.6 2.2 4.7 10.2 0.6 2.1 4.9 8.9 3.2 6.2 1.6 3.7 1.7 2.2 3.0 2.8 0.0 0.1 0.2 1.0 1.2 0.5 0.0 1.0 0.7 0.2 0.2 1.7 1.1 0.0 2.5 3.8 0.6 0.9 0.5 6.2 6.9 5.5 9.8 8.0 6.9 5.9 7.6 4.5 5.6 4.3 6.7 6.7 0.8 0.0 1.9 3.6 1.2 2.7 4.0 2.1 0.0 3.3 4.0 2.8 4.3 1.5 1.5 0.0 0.0 1.0 3.6 6.3 1.9 2.3 13.0 3.0 3.6 1.8 10.7 0.0 7.7 2.7 1.5 2.4 8.6 3.2 0.0 2.0 2.2 12.4 0.8 13.5 4.1 7.6 4.1 1.3 2.7 4.6 0.9 1.4 7.2 1.0 0.6 2.7 2.1 6.0 0.9 5.3 3.1 1.5 1.3 2.7 2.7 2.1 2.1 1.1 6.6 2.9 2.9 3.3 4.1 4.4 4.7 1.8 4.0 1.4 5.2 4.3 TAFA1 "FAM19A1, TAFA-1" ENSG00000183662 "TAFA chemokine like family member 1" Q7Z5A9 3 68004247-68545621 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 18.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 6 "T-cells: 20.7" "Cell line enriched" "Detected in single" 10 "REH: 1.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 12.5;cerebral cortex: 35.6;hippocampal formation: 33.0" HPA013407 Approved "Secreted in brain" NA NA "HPA013407: AB_1848386" "unprognostic (5.19e-2)" "unprognostic (4.64e-3)" "unprognostic (1.97e-2)" "unprognostic (1.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.40e-2)" "unprognostic (3.42e-3)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-1)" "unprognostic (1.41e-2)" "unprognostic (7.87e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.99e-1)" "unprognostic (3.50e-4)" "unprognostic (5.77e-2)" 0.2 1.1 5.4 0.3 9.4 0.0 0.0 0.0 15.3 0.0 1.8 0.2 1.3 0.2 1.1 0.1 0.0 0.7 0.1 14.4 8.4 0.3 0.3 0.1 0.6 13.1 5.8 12.8 0.0 0.0 0.0 0.4 0.0 18.4 1.4 0.1 0.3 0.1 3.8 0.1 0.0 0.2 0.3 0.1 0.4 0.1 0.2 6.3 0.0 0.1 0.2 0.2 0.1 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 20.7 0.0 15.9 0.0 16.6 11.1 0.0 0.0 11.9 15.9 0.4 3.7 0.0 0.1 8.4 3.3 5.4 9.4 0.0 15.3 14.4 8.4 13.1 5.8 12.8 18.4 0.1 6.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 73.1" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavorable (2.99e-5)" "prognostic unfavorable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.25e-4)" "unprognostic (1.04e-2)" 6.0 5.9 5.5 5.5 5.5 3.1 8.8 4.7 7.2 6.6 5.2 5.7 4.6 6.5 6.1 5.7 7.7 4.4 5.8 6.4 5.0 7.6 6.0 6.0 6.5 4.5 4.2 5.4 5.0 5.2 8.6 4.8 5.5 4.6 7.0 6.6 8.2 7.8 6.2 9.8 5.3 5.0 8.2 3.8 5.6 5.7 6.5 5.3 8.4 8.9 10.0 6.8 6.7 4.4 5.2 14.8 12.6 10.3 8.1 19.0 9.7 2.5 9.1 10.6 13.1 11.2 7.7 10.0 14.9 12.3 9.4 8.5 10.1 14.7 14.9 15.4 14.8 11.2 14.4 12.8 2.6 14.8 0.0 11.2 12.1 19.6 12.9 16.2 3.8 11.1 15.4 20.4 10.1 8.2 73.1 17.2 6.1 0.0 33.9 11.5 5.4 6.9 9.9 12.1 15.7 17.3 13.8 13.4 49.5 19.5 8.7 14.1 6.1 8.9 9.1 23.8 6.8 10.4 10.4 15.6 5.8 8.2 5.0 7.5 0.4 3.5 3.8 2.3 2.9 3.0 2.1 3.2 2.5 2.8 2.8 3.9 3.9 1.3 3.1 3.3 0.8 2.1 2.4 5.5 5.5 4.7 7.2 6.4 5.0 4.5 4.2 5.4 4.6 3.8 5.3 5.2 4.9 9.6 7.5 2.0 11.2 5.2 6.1 3.5 7.4 5.6 5.5 4.7 3.9 7.2 2.2 3.7 16.7 7.3 8.4 4.2 5.9 5.6 18.6 6.3 4.9 5.7 3.0 1.7 1.5 6.2 5.4 4.5 6.6 3.6 9.5 7.7 4.2 5.4 5.1 8.4 1.8 4.4 4.1 4.1 2.5 21.0 4.1 5.2 5.4 1.0 8.1 4.0 9.2 1.0 1.2 4.3 3.9 6.0 8.4 4.8 3.9 8.2 7.6 8.2 0.0 8.2 6.5 14.2 5.8 4.7 4.3 4.9 6.3 7.9 4.9 4.6 PSG9 "PSG11, PSGII" ENSG00000183668 "Pregnancy specific beta-1-glycoprotein 9" Q00887 19 43211791-43269530 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 135 "placenta: 107.3" "Cell type enriched" "Detected in some" 60 "Syncytiotrophoblasts: 277.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.2;GAMG: 16.3;HBF TERT88: 9.3;SuSa: 10.7;U-2197: 9.7" HPA046327 Supported "Secreted in female reproductive system" NA NA 43000000 "HPA046327: AB_2679624" "unprognostic (9.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.15e-1)" 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 107.3 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 5.2 2.9 4.5 2.3 0.1 0.1 0.0 0.2 1.4 16.3 0.3 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.6 10.7 4.3 0.0 0.2 0.1 2.1 9.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.3 1.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 4.6 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 277.3 0.0 0.0 0.0 0.0 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.9" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 12.3;Granulosa cells: 42.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 1.2 2.8 0.1 0.2 0.9 0.0 0.7 0.5 0.3 1.4 9.9 0.3 0.1 0.5 0.2 4.5 0.5 1.2 1.4 0.7 0.4 0.4 0.0 0.2 0.8 0.1 0.2 0.1 1.3 0.0 0.4 0.2 3.9 0.2 0.2 0.3 0.7 0.9 0.1 0.7 4.2 0.3 1.0 0.0 0.0 0.1 0.9 0.2 0.0 0.3 2.4 0.3 1.0 5.6 0.0 2.2 0.2 1.8 0.0 0.4 7.5 0.6 14.4 24.7 8.8 7.4 0.0 0.0 0.0 0.8 7.3 0.6 0.2 0.7 0.0 2.9 0.0 0.3 0.0 4.2 0.0 133.9 0.0 0.0 5.5 61.8 12.5 20.0 10.2 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 6.9 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.3 6.1 2.9 0.0 0.0 1.6 0.1 0.0 0.3 10.5 4.8 12.5 1.1 0.0 0.0 0.0 3.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.5 0.3 0.7 0.4 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 12.3 4.5 0.0 0.0 0.0 42.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.9 1.2 0.0 0.0 0.8 1.0 0.7 0.5 0.0 0.0 0.4 BMP8A OP-2 ENSG00000183682 "Bone morphogenetic protein 8a" Q7Z5Y6 1 39491636-39529869 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "thyroid gland: 92.4" "Group enriched" "Detected in some" 7 "Early spermatids: 42.2;Late spermatids: 164.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 7.0;HL-60: 5.8;U-2197: 22.2;U-266/70: 8.6;U-266/84: 7.9" HPA047254 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA047254: " "unprognostic (9.62e-3)" "unprognostic (2.11e-2)" "unprognostic (7.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.91e-3)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (2.95e-9)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" 0.6 0.8 2.4 1.4 4.2 1.3 0.2 2.9 4.4 2.3 0.4 1.0 1.4 3.3 3.8 0.5 3.5 1.2 1.1 2.9 2.1 0.5 0.3 0.4 1.8 6.3 3.9 2.5 3.0 2.6 0.8 0.5 0.4 4.8 1.2 0.6 1.9 1.2 3.5 2.6 1.8 2.1 5.1 5.1 1.6 0.9 3.3 3.5 5.9 92.4 0.1 0.5 0.9 0.5 10.1 0.4 1.1 0.8 0.5 0.1 0.1 0.6 0.2 0.0 0.0 0.0 1.2 0.2 0.3 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.8 1.0 0.1 2.0 0.1 7.0 5.8 0.2 0.2 0.0 0.0 0.0 0.1 0.0 2.2 0.3 3.7 0.0 1.6 0.2 1.2 2.0 0.2 0.1 0.8 0.1 3.2 0.0 0.3 1.2 0.2 0.3 0.3 0.5 1.0 1.0 1.1 0.2 0.1 0.8 22.2 0.1 8.6 7.9 0.5 0.2 0.7 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 2.4 4.2 2.9 4.4 2.9 2.1 6.3 3.9 2.5 4.8 5.1 3.5 10.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.2 0.1 0.0 0.0 5.7 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 164.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ALYREF "ALY, ALY/REF, BEF, REF, THOC4" ENSG00000183684 "Aly/REF export factor" 17 81887835-81891586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 150.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016281, HPA019799, HPA061282" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (4.89e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.13e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.77e-2)" "unprognostic (2.26e-1)" "unprognostic (2.55e-3)" "unprognostic (6.58e-2)" "unprognostic (8.07e-2)" "unprognostic (1.74e-3)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" 35.7 30.3 18.0 50.6 18.0 150.2 35.2 19.1 23.1 30.5 16.8 34.3 33.2 35.4 17.3 58.1 31.6 19.7 37.1 18.9 19.8 29.6 29.9 36.3 63.0 19.7 18.8 17.2 32.6 27.1 21.5 29.1 32.3 19.1 30.3 24.5 9.5 30.5 16.1 62.1 43.5 34.7 21.2 20.6 45.1 31.8 73.3 19.5 66.3 30.8 21.4 49.2 36.0 36.7 20.7 263.7 237.8 165.5 164.6 34.4 44.8 213.8 130.0 68.0 257.0 161.0 269.4 173.7 291.4 100.8 104.9 155.6 150.5 241.9 137.5 111.7 111.8 425.9 210.8 151.2 295.1 68.6 341.4 183.0 46.1 61.8 155.3 62.0 37.8 155.5 204.6 275.9 175.2 97.2 279.8 721.2 587.2 231.3 152.0 254.2 472.3 206.1 155.1 54.1 152.1 229.8 299.0 123.9 304.8 110.4 89.9 222.1 343.3 103.9 275.1 270.9 130.0 443.2 201.8 107.3 377.6 143.7 217.0 238.2 0.3 1.1 0.1 1.5 1.2 1.0 1.0 1.1 1.0 1.2 1.2 0.3 0.8 0.2 0.9 1.1 2.2 0.6 0.6 18.0 18.0 19.1 23.1 18.9 19.8 19.7 18.8 17.2 19.1 20.6 19.5 20.7 68.4 0.0 16.0 1.3 22.9 34.9 22.9 7.5 9.1 11.0 24.7 32.5 13.0 11.5 8.4 20.2 0.0 9.8 59.0 16.1 1.9 5.2 2.3 52.9 49.0 23.4 12.6 43.3 1.7 8.4 23.1 24.9 17.3 53.7 15.2 39.1 8.9 14.8 17.9 5.0 1.7 24.3 6.1 13.9 33.8 3.2 3.4 31.3 14.2 3.7 12.7 21.5 8.2 2.5 5.0 10.5 10.1 4.1 46.4 33.1 7.4 4.3 8.4 7.6 0.0 27.9 30.6 16.5 8.8 22.6 43.0 16.6 27.6 38.2 21.9 31.6 RFLNB "Cfm1, FAM101B, MGC45871, RefilinB" ENSG00000183688 "Refilin B" Q8N5W9 17 439978-445939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 78.6" "Cell type enhanced" "Detected in many" "Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 201.5" "Lineage enriched" "Detected in many" 21 "granulocytes: 201.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030879, HPA060388" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Actin filaments" "Plasma membrane, Cytosol" "HPA030879: AB_2673643, HPA060388: AB_2732649" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (3.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.87e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-3)" 17.6 5.9 2.6 7.4 2.6 78.6 15.8 2.5 3.0 7.7 8.7 12.2 3.2 10.1 3.6 3.1 7.2 4.7 11.0 3.4 4.9 8.7 3.5 13.4 5.4 2.8 2.6 2.1 5.7 3.5 3.9 4.3 10.5 2.3 9.6 1.9 1.5 4.1 2.8 8.0 5.9 9.7 6.2 2.7 10.6 8.6 3.8 2.6 16.8 8.3 4.0 4.8 11.9 5.4 2.4 30.5 8.0 4.0 18.9 13.0 9.4 20.8 48.8 21.4 15.8 7.7 0.5 1.1 0.0 1.2 95.5 7.0 3.0 11.2 1.1 14.5 0.2 6.5 1.3 1.5 2.2 19.0 11.4 222.1 5.2 0.3 5.0 1.9 6.1 16.0 4.8 4.7 0.3 18.1 0.4 0.6 74.8 8.6 0.8 0.3 3.2 8.6 0.0 2.9 0.1 0.3 43.6 19.8 0.0 17.6 14.9 0.4 34.7 3.2 12.4 11.0 7.5 0.1 7.1 7.7 0.0 0.2 64.1 19.5 201.5 6.9 80.7 6.1 5.4 6.2 0.1 6.1 5.2 2.1 0.1 9.7 8.7 35.5 2.2 7.3 9.1 4.3 3.8 2.6 2.6 2.5 3.0 3.4 4.9 2.8 2.6 2.1 2.3 2.7 2.6 2.4 101.3 0.0 4.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.1 7.4 0.0 0.0 1.8 1.8 0.0 0.8 16.5 0.0 0.0 1.1 0.0 2.3 1.9 51.1 0.0 0.0 0.0 0.9 1.2 9.2 0.0 6.0 1.3 12.5 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 5.9 0.0 0.0 0.5 1.5 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.5 10.7 4.2 0.0 0.0 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147872-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 14.4;fallopian tube: 14.8" "Cell type enhanced" "Detected in many" "Astrocytes: 32.0;Early spermatids: 78.6;Endometrial ciliated cells: 55.3;Respiratory ciliated cells: 79.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 16.4;NK-cell: 5.8" "Group enriched" "Detected in many" 7 "granulocytes: 16.4;NK-cells: 5.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.7;HEL: 3.7;HMC-1: 12.0;NB-4: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034492 Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227" "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.3 0.3 2.8 0.3 1.9 1.4 0.7 1.8 1.4 2.7 14.4 0.9 0.3 3.7 3.4 1.9 14.8 1.4 3.0 1.4 5.0 1.3 0.0 2.1 0.2 5.1 3.4 0.8 1.7 0.1 0.2 3.2 0.8 2.6 1.9 0.3 2.0 8.2 3.7 0.0 3.6 0.5 1.7 3.3 0.3 0.9 6.8 2.2 0.5 2.3 0.1 0.4 0.5 0.9 2.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.1 3.7 0.0 0.0 0.0 0.0 12.0 0.2 0.2 0.1 0.0 0.1 0.0 0.6 1.1 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 1.5 0.0 0.6 0.1 0.6 0.1 0.3 0.1 0.5 0.7 1.5 5.8 0.0 0.0 0.0 0.9 2.8 1.9 1.8 1.4 1.4 5.0 5.1 3.4 0.8 2.6 3.3 2.2 2.7 0.1 0.0 3.9 32.0 0.0 3.1 6.0 9.6 1.2 0.2 0.4 0.5 10.8 4.3 5.1 0.0 2.1 0.0 1.6 1.2 1.9 0.9 78.6 55.3 6.0 0.3 0.0 1.7 7.2 5.9 0.1 0.8 0.0 17.1 16.4 3.8 0.4 0.0 0.3 0.0 1.7 1.5 4.1 0.0 0.4 19.0 6.8 4.9 0.0 0.0 0.4 5.3 3.1 1.5 0.2 1.0 0.0 7.2 0.2 1.0 3.8 0.7 79.6 0.1 6.6 0.1 3.7 11.3 10.5 7.3 2.8 0.3 1.6 0.4 5.2 6.0 NOG "SYM1, SYNS1" ENSG00000183691 Noggin Q13253 17 56593699-56595611 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;placenta: 10.7" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 72.8;naive CD8 T-cell: 34.9" "Lineage enriched" "Detected in single" 78 "T-cells: 72.8" "Cell line enhanced" "Detected in many" "EFO-21: 123.3;LHCN-M2: 38.1;NB-4: 28.8;PC-3: 37.9;U-2 OS: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061318 Approved "Secreted to blood" NA NA "HPA061318: AB_2684478" "unprognostic (1.49e-1)" "unprognostic (1.17e-2)" "unprognostic (1.49e-5)" "prognostic favorable (6.66e-4)" "unprognostic (4.69e-2)" "unprognostic (5.23e-3)" "unprognostic (1.26e-2)" "unprognostic (3.06e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (6.86e-5)" "unprognostic (2.88e-1)" "unprognostic (1.14e-6)" "unprognostic (8.39e-2)" "unprognostic (1.40e-1)" "unprognostic (5.00e-1)" "unprognostic (1.65e-1)" 0.5 0.1 5.6 0.6 4.4 0.2 0.3 1.9 4.2 4.1 0.4 0.2 0.1 0.3 0.1 0.2 0.5 0.0 0.3 4.0 3.6 0.4 0.1 0.7 1.8 2.5 4.5 2.3 0.0 0.1 0.0 0.7 10.7 2.1 0.8 0.0 0.0 0.3 1.4 3.5 0.3 0.5 0.1 2.0 0.8 0.9 0.7 9.5 0.6 0.4 0.8 0.4 0.8 2.7 2.0 6.3 0.2 0.2 0.0 0.2 0.0 0.0 3.2 3.5 1.2 1.3 0.4 1.2 0.0 123.3 1.5 4.8 0.5 2.2 0.3 3.4 0.1 2.2 0.0 5.2 0.0 0.0 0.9 0.0 0.5 0.7 0.0 0.5 0.4 0.1 0.1 0.0 0.0 38.1 0.2 1.1 28.8 2.6 0.0 37.9 17.0 11.6 0.0 2.9 0.0 0.2 0.0 6.5 0.1 0.0 9.9 0.1 0.5 0.7 2.3 38.5 0.2 2.7 0.0 0.1 0.4 0.0 3.2 0.0 0.9 0.1 0.2 0.6 0.2 0.2 0.1 4.3 0.5 0.1 0.1 72.8 34.9 0.8 0.4 0.3 0.3 3.4 3.1 5.6 4.4 1.9 4.2 4.0 3.6 2.5 4.5 2.3 2.1 2.0 9.5 2.0 0.4 0.0 0.0 2.0 0.3 0.0 0.4 0.0 0.6 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.1 0.6 1.5 0.3 0.0 2.5 0.2 0.0 12.2 1.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.0 1.5 0.1 0.6 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 2.3 0.4 0.0 1.7 0.4 0.1 0.8 2.0 0.0 0.0 0.1 MRGPRX2 MRGX2 ENSG00000183695 "MAS related GPR family member X2" Q96LB1 11 19054455-19060717 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skin 1: 1.0" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055220 Approved NA NA "HPA055220: AB_2682743" "unprognostic (1.56e-2)" "unprognostic (1.79e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPP1 "UDRPASE, UP, UPASE, UPP" ENSG00000183696 "Uridine phosphorylase 1" Q16831 7 48088628-48108736 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 67.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 250.1;Extravillous trophoblasts: 260.3;Macrophages: 199.5;Paneth cells: 260.8" "Cancer enhanced" "Detected in all" "testis cancer: 62.8" "Region enhanced" "Detected in all" "hypothalamus: 20.2" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "hTERT-HME1: 362.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054040, HPA055394" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "HPA054040: AB_2682352, HPA055394: AB_2682805" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (3.21e-3)" "unprognostic (6.36e-2)" "unprognostic (1.78e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.81e-2)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-3)" "unprognostic (2.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.39e-1)" 14.5 9.5 2.5 7.6 3.5 12.6 10.1 2.6 5.5 10.7 1.9 7.2 4.3 4.0 0.8 67.4 5.7 5.9 8.6 2.7 20.2 22.4 12.0 19.0 3.7 3.7 2.5 3.2 1.9 4.6 5.0 7.5 3.9 3.8 4.9 5.3 0.6 14.3 1.2 3.7 2.9 6.5 3.5 1.0 20.5 4.1 2.2 4.6 1.2 8.0 0.9 6.6 9.2 31.4 4.2 19.5 26.0 2.4 5.2 8.9 4.0 29.7 7.9 15.5 14.5 17.5 10.8 9.9 0.0 2.5 9.7 89.9 13.9 5.2 46.1 9.4 4.1 4.5 0.8 4.8 4.6 7.4 0.9 1.3 5.0 21.8 6.4 362.8 5.9 9.1 0.4 1.5 13.5 7.6 2.3 0.0 2.9 9.4 4.2 20.7 0.0 4.8 6.0 33.7 11.5 2.3 1.6 10.2 3.0 63.4 29.3 2.4 0.9 12.4 29.6 22.9 7.3 22.6 21.4 34.7 3.7 29.6 3.0 77.8 11.5 16.0 12.2 11.8 12.1 8.9 0.2 7.8 8.7 6.5 0.6 8.1 8.1 6.2 5.4 14.8 0.5 8.4 10.9 2.5 3.5 2.6 5.5 2.7 20.2 3.7 2.5 3.2 3.8 1.0 4.6 4.2 107.4 19.2 58.5 5.2 19.1 46.8 26.3 104.4 19.4 27.6 9.0 16.1 11.6 24.3 51.0 11.0 33.3 15.1 122.9 250.1 70.5 50.5 1.0 42.1 22.4 108.1 13.1 4.4 16.5 40.5 260.3 34.1 5.1 91.1 25.9 3.8 72.5 17.5 110.0 16.8 29.4 35.0 85.5 130.5 118.1 2.4 5.3 199.5 87.2 1.0 61.4 13.3 71.1 4.0 3.6 117.9 260.8 2.2 30.3 30.4 42.8 23.3 11.9 29.2 6.6 21.1 32.2 0.3 9.5 42.9 29.8 78.7 71.0 1.5 29.1 34.9 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 81 "testis: 8.1" "Group enriched" "Detected in some" 113 "Early spermatids: 29.9;Late spermatids: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNL2 "IL-28A, IL28A" ENSG00000183709 "Interferon lambda 2" Q8IZJ0 19 39268396-39270188 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Breast myoepithelial cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "HDLM-2: 10.9" CAB025489 Uncertain "Secreted to blood" NA NA "CAB025489: " "unprognostic (1.37e-1)" "unprognostic (2.84e-1)" "unprognostic (1.05e-1)" "unprognostic (2.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPCML "IGLON1, OBCAM, OPCM" ENSG00000183715 "Opioid binding protein/cell adhesion molecule like" Q14982 11 132414977-133532519 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 40.0;parathyroid gland: 10.4;retina: 11.7" "Group enriched" "Detected in some" 34 "Excitatory neurons: 2120.9;Inhibitory neurons: 1900.4;Oligodendrocyte precursor cells: 3173.2" "Cancer enriched" "Detected in some" 4 "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BJ: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 7100000 "unprognostic (1.59e-1)" "unprognostic (2.26e-2)" "unprognostic (3.70e-2)" "unprognostic (3.31e-4)" "unprognostic (8.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (8.46e-3)" "unprognostic (2.59e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.19e-1)" 0.2 0.4 8.4 0.1 17.1 0.0 0.1 25.1 40.0 0.4 0.0 0.1 0.1 0.6 0.1 0.4 0.5 0.2 0.3 16.2 13.1 1.4 0.0 0.0 0.0 0.8 7.4 19.2 0.3 0.0 10.4 1.3 0.0 8.8 0.1 0.1 11.7 0.2 0.6 0.1 0.1 0.1 0.5 0.0 0.7 0.2 0.4 12.5 0.0 0.1 0.3 0.0 0.1 0.1 17.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 9.4 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 17.1 25.1 40.0 16.2 13.1 0.8 7.4 19.2 8.8 0.0 12.5 17.2 0.0 0.0 0.0 25.5 0.0 0.1 0.0 0.0 0.0 40.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 0.0 0.4 0.0 0.0 2120.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.7 1900.4 0.0 0.0 0.3 0.4 14.9 0.0 0.1 0.0 69.3 0.0 1.3 0.0 3173.2 30.3 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 4.2 6.6 0.0 1.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" NA NA Nucleoli "Intermediate filaments" "HPA054565: AB_2682525, HPA056819: AB_2683245" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favorable (4.07e-4)" 9.0 10.0 11.4 8.6 11.7 8.8 9.1 14.5 13.3 13.9 11.4 11.7 8.2 10.2 9.2 7.1 12.4 5.5 10.6 11.7 11.4 12.4 11.7 12.2 14.4 12.4 11.6 11.1 16.1 15.7 9.2 19.0 5.9 13.0 15.3 6.7 21.7 11.6 7.1 6.8 10.0 13.2 5.3 10.4 18.9 11.0 11.6 11.9 10.9 17.4 3.9 9.8 12.1 10.9 12.5 4.3 4.9 7.8 10.0 13.8 8.7 6.9 4.6 4.1 4.4 3.8 7.1 7.7 9.3 4.9 5.0 12.0 7.8 4.2 6.2 5.1 16.0 8.9 3.6 21.4 6.0 3.3 11.0 7.9 8.7 5.1 4.7 2.7 7.2 5.3 13.5 3.8 21.3 4.6 8.1 6.1 10.0 2.7 4.8 6.3 7.1 4.2 6.4 3.7 5.6 8.8 7.1 6.6 4.7 4.4 6.8 8.8 7.4 6.5 8.8 4.6 4.2 4.4 15.5 8.1 6.3 10.0 9.5 3.5 5.8 2.2 5.2 7.1 1.9 7.9 4.9 7.5 7.8 1.8 3.5 9.2 7.5 2.3 5.1 1.9 2.4 5.5 3.3 11.4 11.7 14.5 13.3 11.7 11.4 12.4 11.6 11.1 13.0 10.4 11.9 12.5 11.9 19.2 23.6 6.5 20.5 8.8 6.5 3.1 8.0 27.8 6.7 6.7 9.4 8.6 15.0 7.3 39.6 3.7 28.1 7.2 3.9 3.5 27.2 10.3 14.4 14.0 9.0 8.6 9.5 2.5 1.1 12.6 6.6 11.8 17.7 21.2 7.9 3.5 4.2 28.6 10.5 8.3 2.0 6.0 9.7 5.4 12.8 10.3 5.4 9.4 12.5 17.3 35.0 6.6 8.1 2.3 8.1 9.4 24.9 4.5 8.1 3.4 11.6 42.9 0.0 20.3 13.3 25.2 11.0 5.5 6.1 4.2 25.9 19.0 7.8 4.1 LHFPL6 "LHFP, MGC22429" ENSG00000183722 "LHFPL tetraspan subfamily member 6" Q9Y693 13 39209116-39603528 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "myeloid DC: 6.2;plasmacytoid DC: 2.1" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 255.1;HSkMC: 186.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058975 Approved Approved Nucleoli NA NA Nucleoli "HPA058975: AB_2683866" "unprognostic (6.98e-2)" "unprognostic (2.71e-1)" "unprognostic (2.00e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (4.10e-2)" "unprognostic (5.84e-2)" "unprognostic (1.08e-1)" "unprognostic (2.76e-1)" "unprognostic (5.45e-2)" "unprognostic (8.68e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (4.41e-3)" "unprognostic (5.25e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (2.30e-4)" 142.3 55.6 44.6 18.7 45.9 1.1 129.9 56.4 45.6 51.1 56.7 43.4 10.9 79.5 47.9 37.3 89.7 75.2 98.6 43.7 53.0 32.1 14.3 83.3 39.4 52.8 54.7 37.6 50.0 17.3 18.3 27.1 135.7 50.9 31.1 16.9 12.1 35.0 37.2 32.4 35.6 29.3 69.5 45.5 30.7 28.1 20.6 59.9 17.2 64.7 90.0 17.8 49.5 48.7 48.6 11.5 4.0 118.3 5.1 255.1 115.1 51.6 61.8 88.3 30.8 23.1 0.5 11.6 17.5 1.3 86.6 40.0 17.3 15.0 36.2 25.3 16.9 17.2 47.3 3.7 0.0 26.7 0.8 0.9 186.4 4.7 27.7 45.7 27.6 29.1 1.1 0.0 0.1 59.9 9.9 0.0 14.5 8.8 0.2 15.8 7.7 51.3 0.1 20.9 15.0 0.7 3.8 5.6 7.2 16.8 67.4 6.7 0.1 54.3 77.9 11.7 24.4 33.9 0.9 0.0 48.9 32.4 0.2 57.2 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.3 44.6 45.9 56.4 45.6 43.7 53.0 52.8 54.7 37.6 50.9 45.5 59.9 48.6 195.2 3.2 12.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 4.4 28.6 0.0 0.0 9.9 0.0 0.0 5.0 1.4 0.0 1.9 0.6 0.0 2.7 78.1 32.0 0.0 0.0 0.0 0.6 156.9 113.0 0.0 2.8 2.5 22.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 3.6 2.2 0.0 0.0 0.0 131.6 0.0 0.0 0.0 0.0 6.2 1.2 45.8 0.0 0.0 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696743 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 68.0;Granulosa cells: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 3.9 5.0 36.6 2.8 34.7 2.5 5.7 35.4 35.5 3.9 26.7 15.8 12.1 4.4 20.3 6.1 10.7 3.0 4.0 44.1 36.9 24.9 4.1 8.4 0.6 44.0 42.0 31.7 3.4 19.4 33.0 14.5 2.1 36.5 7.8 12.7 7.9 11.2 3.8 3.3 6.9 13.0 3.4 42.7 2.0 31.7 7.0 40.5 0.5 38.9 2.1 1.1 3.2 4.2 45.0 16.0 12.9 7.8 19.1 2.6 4.2 31.7 6.6 5.9 3.5 5.6 24.2 17.7 0.7 10.8 3.9 4.8 20.0 19.7 7.8 5.2 1.3 17.2 1.7 5.3 15.2 5.6 1.4 3.0 6.7 13.4 4.2 8.1 11.9 2.0 2.3 8.0 4.1 5.1 18.5 0.1 3.2 8.7 28.6 8.6 3.5 10.6 4.9 15.2 14.2 17.9 7.1 27.4 14.6 9.3 5.6 15.3 3.4 4.3 6.5 7.0 1.8 6.6 1.4 3.3 0.7 8.1 3.2 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 36.6 34.7 35.4 35.5 44.1 36.9 44.0 42.0 31.7 36.5 42.7 40.5 45.0 2.6 22.4 11.1 32.7 0.8 5.2 8.8 21.9 4.6 9.5 23.5 10.8 7.1 15.7 19.3 23.9 8.4 5.0 1.6 51.7 13.7 15.9 1.9 20.7 2.7 4.3 39.0 0.8 68.0 24.0 29.6 3.5 27.5 12.3 4.5 67.6 1.8 6.1 2.4 30.3 37.7 24.1 20.3 2.8 0.9 3.0 2.5 1.9 3.6 7.5 4.4 24.2 0.0 37.7 51.3 30.8 19.5 3.0 0.6 29.0 30.7 19.9 40.0 11.1 6.6 3.1 8.8 6.4 7.7 7.5 5.5 2.9 0.9 2.5 43.4 19.4 TMEM50A SMP1 ENSG00000183726 "Transmembrane protein 50A" O95807 1 25338317-25362361 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065192 Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA065192: AB_2685429" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-3)" "prognostic favorable (8.64e-5)" "unprognostic (1.45e-1)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (7.39e-2)" "unprognostic (7.92e-3)" "unprognostic (2.53e-1)" "unprognostic (1.02e-2)" "unprognostic (2.44e-2)" "unprognostic (2.39e-3)" "unprognostic (6.66e-2)" "unprognostic (2.91e-1)" "unprognostic (3.91e-3)" "unprognostic (3.44e-2)" 47.6 63.6 47.6 44.9 51.2 42.2 56.1 48.1 56.3 47.4 47.0 59.1 50.0 36.0 53.4 36.8 38.7 46.1 44.6 48.4 51.0 55.5 33.6 58.6 52.6 49.9 48.0 46.8 26.5 32.9 49.9 14.7 58.2 49.4 54.8 66.3 45.8 82.2 53.2 17.0 41.4 55.9 46.4 48.7 47.3 50.0 16.2 48.2 47.6 47.5 26.8 47.7 55.7 30.0 53.6 43.3 44.6 74.3 42.3 132.9 119.8 28.1 89.0 123.6 143.4 159.5 36.5 110.9 50.2 47.9 274.6 55.7 62.6 56.3 61.9 161.2 126.1 81.4 104.7 47.5 55.2 96.5 82.4 80.3 128.0 91.4 106.1 60.5 69.7 107.0 50.8 73.1 79.5 140.9 30.6 53.2 90.2 90.6 73.7 37.1 45.7 85.3 88.9 148.8 30.9 64.5 42.3 89.0 64.2 72.2 69.3 32.7 52.0 171.0 86.5 36.6 144.9 36.8 52.3 61.5 45.0 117.1 117.2 50.3 275.5 76.9 109.8 87.9 94.7 91.9 49.6 77.2 91.1 55.9 40.9 55.1 76.6 159.2 80.5 117.3 51.9 95.4 106.3 47.6 51.2 48.1 56.3 48.4 51.0 49.9 48.0 46.8 49.4 48.7 48.2 53.6 244.8 144.2 84.2 21.2 107.9 253.4 184.5 392.3 146.8 43.9 162.0 164.8 105.6 102.9 212.7 169.2 27.1 108.9 191.0 175.6 50.9 300.3 25.4 136.4 119.3 203.3 83.0 93.6 31.6 215.6 312.5 198.1 91.3 180.8 126.6 58.2 152.0 68.3 227.1 25.2 27.3 170.7 309.3 162.4 245.1 12.7 151.9 223.8 199.3 16.9 253.8 102.0 154.5 28.1 48.8 315.3 164.8 98.9 168.2 340.6 120.0 113.1 205.1 41.7 210.4 71.6 200.6 94.7 47.0 166.8 317.7 181.6 180.9 116.9 106.9 274.3 FIGLA bHLHc8 ENSG00000183733 "Folliculogenesis specific bHLH transcription factor" Q6QHK4 2 70777310-70790643 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "retina: 1.1" "Group enriched" "Detected in some" 17 "Early spermatids: 1.9;Late spermatids: 6.4;Spermatogonia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071241 Supported NA NA "HPA071241: " "unprognostic (1.82e-1)" "unprognostic (4.04e-1)" "unprognostic (1.73e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASCL2 "ASH2, bHLHa45, HASH2" ENSG00000183734 "Achaete-scute family bHLH transcription factor 2" Q99929 11 2268498-2270588 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 7.0;salivary gland: 8.1;skin 1: 6.7" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 1042.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 76.1;stomach cancer: 23.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 7.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 25.1;NB-4: 8.1;OE19: 14.2;SCLC-21H: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.71e-3)" "prognostic favorable (5.11e-4)" "unprognostic (2.03e-1)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (2.69e-2)" "unprognostic (2.93e-2)" "unprognostic (7.88e-2)" "unprognostic (3.79e-2)" "unprognostic (1.22e-2)" "prognostic favorable (4.73e-4)" "unprognostic (5.85e-2)" "unprognostic (1.45e-6)" "unprognostic (8.86e-3)" "unprognostic (5.48e-2)" "unprognostic (6.12e-4)" "unprognostic (1.07e-3)" 0.3 0.2 1.0 1.3 0.9 0.9 0.7 0.6 0.9 1.7 0.5 3.9 7.0 2.2 0.5 1.7 0.4 0.1 0.1 0.9 0.5 1.3 0.8 0.6 0.7 1.2 2.1 0.7 0.1 0.7 0.1 0.1 5.5 1.0 2.4 2.5 0.0 8.1 1.6 0.2 6.7 5.6 0.1 1.3 2.4 2.1 0.8 1.8 0.5 0.5 0.0 0.6 1.5 1.9 2.0 0.0 0.0 0.4 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.7 0.0 8.1 0.6 14.2 0.0 0.0 0.0 0.0 0.0 0.6 20.5 0.1 0.0 0.5 0.0 0.0 2.5 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.9 1.2 7.9 2.2 1.7 0.1 0.0 0.5 1.3 0.8 0.0 0.1 1.3 0.9 0.0 1.4 0.0 0.0 0.4 1.0 0.9 0.6 0.9 0.9 0.5 1.2 2.1 0.7 1.0 1.3 1.8 2.0 1.2 0.0 0.0 0.0 1.4 13.6 14.1 3.3 23.3 0.0 7.2 3.3 0.9 1.5 0.7 20.2 0.0 18.7 29.2 14.4 7.9 0.2 0.1 1.4 4.7 2.6 78.2 4.4 0.0 0.0 1042.9 1.5 10.2 3.5 0.0 0.0 23.2 0.5 31.1 0.0 0.0 31.4 2.0 22.0 7.0 0.2 1.8 14.3 1.8 3.7 22.6 0.0 110.2 0.0 0.0 0.0 3.6 1.5 1.3 6.5 9.1 0.4 1.0 0.1 0.0 0.1 0.3 0.3 13.7 9.1 4.7 23.3 8.9 0.1 112.1 9.4 TBK1 NAK ENSG00000183735 "TANK binding kinase 1" Q9UHD2 12 64452090-64502114 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045797, HPA060211" Uncertain Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045797: AB_2679457, HPA060211: AB_2684222" "unprognostic (4.73e-2)" "unprognostic (8.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.90e-1)" "unprognostic (1.94e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (1.69e-1)" "unprognostic (2.54e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (4.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-2)" "unprognostic (9.56e-3)" 11.3 15.5 6.1 10.2 6.1 17.1 11.5 5.7 6.9 9.9 5.7 10.2 15.2 11.0 6.7 11.4 9.6 10.2 9.5 5.9 5.6 11.9 17.5 13.0 14.7 6.5 7.1 5.9 9.6 7.6 11.7 9.8 13.8 6.2 10.7 8.5 6.3 10.3 9.1 18.6 8.6 11.5 10.9 5.6 13.5 10.3 23.7 6.8 6.9 8.6 15.0 13.0 16.1 10.3 7.2 23.3 24.2 11.1 10.6 24.7 26.1 29.0 22.9 37.6 22.5 21.1 14.9 12.4 31.5 21.4 26.8 34.4 19.0 19.4 20.0 26.4 29.5 17.1 33.0 15.3 19.1 30.2 35.2 36.4 18.5 19.1 23.1 23.6 42.3 32.4 11.0 27.9 38.7 31.6 27.0 0.9 17.0 29.9 22.9 13.8 14.9 15.3 31.8 25.1 36.9 9.8 14.7 33.3 36.0 23.5 23.5 33.1 24.9 25.9 20.2 18.1 14.9 24.0 25.4 54.3 30.3 28.1 18.6 26.1 41.8 10.1 24.3 13.9 17.7 16.3 12.8 10.1 15.2 12.2 10.1 2.8 8.7 17.8 26.6 15.5 2.1 13.6 10.0 6.1 6.1 5.7 6.9 5.9 5.6 6.5 7.1 5.9 6.2 5.6 6.8 7.2 23.7 19.2 20.5 28.4 21.6 11.0 25.7 20.1 15.4 17.0 14.9 9.1 10.9 8.6 23.4 22.0 10.4 28.8 30.0 14.1 11.7 19.3 34.5 19.2 17.9 28.6 17.3 18.3 50.5 23.6 32.6 21.3 15.3 30.2 43.1 17.5 16.8 17.1 20.2 18.5 42.2 10.5 12.2 23.0 30.2 29.2 19.3 31.1 14.2 46.9 31.4 12.7 33.0 39.2 52.3 16.9 10.9 20.7 25.6 43.7 13.6 12.3 20.8 16.3 26.3 22.4 18.7 68.9 12.7 14.0 14.9 92.6 27.1 11.5 10.1 41.6 CBX6 ENSG00000183741 "Chromobox 6" O95503 22 38861422-38872249 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048653 Uncertain Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA048653: AB_2680479" "unprognostic (1.65e-2)" "unprognostic (8.66e-2)" "unprognostic (6.20e-3)" "unprognostic (3.14e-3)" "unprognostic (1.56e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.90e-2)" "unprognostic (3.72e-3)" "unprognostic (5.97e-2)" "prognostic favorable (2.46e-6)" "unprognostic (2.75e-1)" "unprognostic (1.27e-3)" "unprognostic (7.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (2.26e-2)" 16.4 22.6 65.4 16.7 54.3 28.5 12.4 10.4 82.9 18.1 0.0 29.7 6.5 34.3 14.6 13.4 27.2 11.4 17.5 87.7 20.5 18.0 6.3 17.4 14.3 18.1 14.6 59.1 24.6 17.3 49.9 27.7 4.4 26.1 22.2 7.2 8.6 13.8 26.2 8.9 8.1 17.2 26.4 4.6 16.0 20.7 4.3 23.4 12.6 19.2 6.8 15.4 31.3 12.0 35.6 40.3 41.7 9.1 31.3 68.5 38.2 2.8 42.8 24.5 21.8 20.3 21.1 36.5 65.3 31.2 29.5 15.3 46.8 17.0 18.3 11.9 63.1 53.0 6.7 18.5 7.4 37.2 32.6 31.1 57.0 9.1 49.7 23.5 30.1 24.9 18.4 14.9 32.2 15.1 45.5 20.2 9.5 8.1 23.1 31.9 29.9 30.5 25.9 31.3 37.4 44.3 9.8 27.5 36.4 23.7 3.2 25.0 19.3 32.7 18.9 57.9 33.2 29.6 32.9 34.1 23.5 37.0 33.6 40.1 2.2 9.1 4.7 18.6 12.4 15.3 6.7 12.6 13.1 9.1 7.7 10.3 12.6 4.0 9.1 12.5 46.1 8.0 20.0 65.4 54.3 10.4 82.9 87.7 20.5 18.1 14.6 59.1 26.1 4.6 23.4 35.6 30.5 16.0 14.7 9.8 25.1 33.9 47.4 18.4 16.5 100.4 42.6 31.6 27.5 52.9 22.1 73.5 39.6 12.4 83.0 9.6 35.2 102.6 1.1 6.9 46.0 36.4 122.7 17.7 28.9 50.1 2.0 48.5 3.1 17.5 6.3 18.7 46.8 32.4 19.8 124.5 27.3 3.2 30.5 40.8 121.1 2.9 74.3 33.2 81.8 14.0 91.1 91.2 57.7 15.1 23.3 46.9 9.1 80.9 24.5 58.9 0.1 51.7 18.0 59.4 72.3 54.4 85.1 4.2 6.8 10.4 34.0 4.7 35.8 40.9 0.9 82.6 MACC1 "7A5, SH3BP4L" ENSG00000183742 "MET transcriptional regulator MACC1" Q6ZN28 7 20134655-20217404 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 11.8" "Cell type enhanced" "Detected in many" "Club cells: 102.4;Glandular and luminal cells: 100.5;Pancreatic endocrine cells: 136.4;Respiratory ciliated cells: 93.4;Urothelial cells: 238.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 98.0;CAPAN-2: 22.2;HaCaT: 66.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020081, HPA020103, HPA029476, CAB068194" Supported Approved Mitochondria NA NA Mitochondria "CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136" "unprognostic (1.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.26e-1)" "unprognostic (1.42e-2)" "unprognostic (7.01e-2)" "unprognostic (2.52e-2)" "unprognostic (2.05e-1)" "unprognostic (2.43e-2)" "unprognostic (2.43e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.71e-9)" "unprognostic (4.49e-2)" "unprognostic (2.91e-1)" "unprognostic (1.78e-1)" "unprognostic (6.93e-3)" 0.6 2.3 1.5 1.3 0.6 1.0 4.4 0.9 1.5 3.0 0.0 2.7 9.9 0.8 0.7 8.9 1.0 2.9 0.2 1.1 0.3 6.7 0.4 5.4 0.9 0.9 0.8 0.5 0.1 3.3 0.4 0.3 0.2 1.1 1.0 3.2 0.6 5.7 2.6 0.1 2.9 11.8 0.3 0.5 0.8 5.0 0.5 0.5 0.6 1.1 0.0 3.6 3.9 3.0 1.5 98.0 0.4 0.4 0.0 0.1 0.2 0.9 0.1 0.0 0.0 0.0 21.6 22.2 13.8 1.0 0.0 0.1 66.9 0.2 0.9 0.0 0.1 0.4 13.0 0.3 0.0 0.0 5.5 0.4 0.0 0.7 0.0 0.1 0.2 0.1 0.3 14.2 6.5 0.1 8.1 0.0 1.4 1.0 19.1 0.1 0.0 0.6 10.5 16.5 6.7 0.3 0.5 0.0 7.5 0.1 0.4 3.9 0.2 0.4 0.2 0.2 0.1 0.2 20.1 1.0 5.0 0.1 0.7 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.1 1.5 0.6 0.9 1.5 1.1 0.3 0.9 0.8 0.5 1.1 0.5 0.5 1.5 4.1 70.5 57.4 0.7 6.5 2.8 75.8 11.3 2.8 3.3 22.2 7.5 0.6 24.3 102.4 40.5 2.1 0.8 2.2 16.9 7.9 51.4 2.9 59.6 16.3 4.1 38.7 4.2 1.0 63.8 0.2 5.7 18.3 100.5 12.6 0.4 2.2 0.8 4.4 1.7 2.9 19.5 34.6 0.9 3.8 1.2 2.1 11.0 1.8 0.0 8.4 0.3 1.0 0.0 0.9 136.4 20.4 2.6 6.3 72.8 40.2 17.5 93.4 1.3 0.0 0.8 3.6 0.4 0.6 13.2 4.0 0.3 2.9 0.3 17.5 238.8 ACSM2A "A-923A4.1, ACSM2, MGC150530" ENSG00000183747 "Acyl-CoA synthetase medium chain family member 2A" Q08AH3 16 20451461-20487669 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 1182 "kidney: 279.8;liver: 366.3" "Group enriched" "Detected in some" 17 "Hepatocytes: 708.7;Proximal tubular cells: 372.5" "Group enriched" "Detected in some" 479 "liver cancer: 22.7;renal cancer: 25.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "Hep G2: 1.9" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.17e-4)" "prognostic favorable (1.41e-5)" "unprognostic (5.25e-1)" "unprognostic (2.42e-1)" "unprognostic (9.28e-3)" "unprognostic (1.52e-1)" "unprognostic (5.10e-1)" "unprognostic (2.09e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 279.8 366.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 1.0 4.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 21.5 0.0 7.3 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 2.7 0.0 13.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.2 708.7 0.0 0.0 0.2 0.0 0.0 18.3 0.0 0.2 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 372.5 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.0 0.1 0.3 1.7 0.0 0.0 0.1 TBL3 "SAZD, UTP13" ENSG00000183751 "Transducin beta like 3" Q12788 16 1972053-1982929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 113.8;Late spermatids: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042562, HPA055695" Enhanced Supported Enhanced Nucleoli NA NA Nucleoli "HPA042562: AB_10964911, HPA055695: AB_2682888" "unprognostic (1.96e-1)" "unprognostic (5.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.56e-1)" "unprognostic (4.67e-1)" "unprognostic (2.65e-1)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (3.78e-2)" "unprognostic (8.03e-2)" "unprognostic (2.14e-2)" "unprognostic (8.32e-2)" "prognostic favorable (7.33e-4)" "unprognostic (3.65e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.77e-1)" 3.4 3.5 1.7 3.2 2.1 2.1 3.9 3.9 2.7 3.0 0.8 3.2 2.4 3.8 0.6 5.0 3.0 1.4 4.3 2.3 1.9 3.3 3.1 2.9 2.3 3.1 1.7 2.2 3.7 5.9 2.8 2.4 1.3 3.2 2.8 1.0 1.5 4.9 1.1 10.7 5.3 3.5 1.4 1.5 3.0 3.7 6.8 2.0 2.0 3.2 3.1 1.6 3.3 3.5 2.5 7.1 13.4 3.6 7.2 3.5 2.8 11.8 6.4 4.2 5.4 4.4 17.3 13.3 9.4 14.6 4.9 4.9 18.8 5.9 7.5 2.8 6.9 8.5 5.9 7.1 6.6 4.0 10.3 5.4 2.8 5.5 6.7 3.9 4.3 6.8 5.6 12.1 6.7 3.2 11.3 13.2 5.8 8.6 6.2 5.4 23.1 6.7 15.7 2.6 2.7 8.4 6.5 5.8 14.6 6.0 3.5 11.1 6.9 10.8 7.4 8.8 6.6 12.6 12.1 5.6 15.0 4.5 6.5 8.7 4.5 9.4 5.5 10.6 11.0 9.3 6.4 7.6 10.4 10.4 6.9 9.7 7.4 2.2 14.5 11.8 5.3 9.2 8.5 1.7 2.1 3.9 2.7 2.3 1.9 3.1 1.7 2.2 3.2 1.5 2.0 2.5 9.1 3.2 12.2 2.3 11.9 13.0 15.8 21.9 12.0 13.0 12.6 10.4 16.4 7.2 16.4 18.4 8.4 26.4 10.7 23.4 7.9 25.4 113.8 7.4 8.5 11.2 13.8 18.5 2.0 22.5 26.0 10.5 20.4 9.7 14.7 14.5 7.1 12.7 19.6 10.1 2.1 16.1 18.3 8.9 6.6 72.1 14.9 8.5 7.2 0.0 24.1 13.6 9.2 2.0 2.0 24.0 22.0 10.9 13.5 15.6 31.9 16.9 8.8 9.8 26.3 11.1 24.7 21.8 20.8 13.7 18.3 22.4 11.1 11.6 24.2 14.4 BPY2 "BPY2A, VCY2, VCY2A" ENSG00000183753 "Basic charge Y-linked 2" O14599 Y 22973819-23005465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACP7 "FLJ16165, PAPL, PAPL1" ENSG00000183760 "Acid phosphatase 7, tartrate resistant (putative)" Q6ZNF0 19 39083913-39111493 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.3;lymphoid tissue: 2.6;skin 1: 6.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 33.3;U-87 MG: 45.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA042613 Uncertain "Secreted - unknown location" NA NA "HPA042613: AB_10963214" "unprognostic (6.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-3)" "unprognostic (1.92e-3)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (4.94e-3)" "unprognostic (2.66e-1)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" "unprognostic (1.51e-5)" "unprognostic (4.36e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-2)" "unprognostic (2.42e-1)" 0.0 0.0 2.5 0.0 3.3 0.0 0.2 6.3 3.0 0.5 0.9 0.0 0.0 0.0 0.4 0.8 0.0 0.2 0.0 2.0 2.4 0.0 0.0 0.0 0.0 4.0 3.8 1.8 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.0 0.0 0.5 0.0 0.0 6.0 0.0 0.0 2.2 0.0 0.1 0.0 3.1 0.0 0.0 0.0 2.6 0.1 0.6 4.7 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.6 0.8 0.4 5.2 0.0 0.0 0.0 33.3 0.3 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 9.5 0.3 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.1 1.1 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.3 6.3 3.0 2.0 2.4 4.0 3.8 1.8 5.1 2.2 3.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073035-29168333 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 59.1;Skeletal myocytes: 82.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 4.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "RH-30: 34.7;U-2197: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No 1100000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: AB_2683739" 7.1 13.6 9.9 9.6 21.1 4.1 7.6 7.1 10.7 9.2 5.5 13.2 6.7 6.8 8.8 37.5 11.0 4.0 22.9 12.2 10.2 9.0 2.4 12.0 3.0 10.6 8.8 8.4 22.4 4.6 48.7 6.6 6.2 10.3 9.2 11.4 4.1 28.6 9.9 28.9 36.6 11.2 6.2 4.7 9.1 9.4 12.6 8.8 22.6 9.6 43.0 16.5 9.3 13.8 9.3 5.2 3.6 11.8 6.2 3.9 11.9 9.9 1.4 12.0 3.8 5.7 16.5 2.4 0.1 4.5 5.6 9.6 24.7 24.6 9.9 4.1 6.2 15.5 1.4 1.7 15.6 4.1 0.1 1.3 11.4 19.7 4.3 2.4 1.6 0.6 10.1 5.4 0.3 4.8 4.4 0.1 1.7 0.5 34.0 2.5 0.8 34.7 0.3 4.1 9.7 23.6 13.1 14.2 5.0 18.3 3.9 18.5 0.9 0.4 15.7 4.8 59.3 1.7 1.2 0.4 0.2 10.0 2.2 18.5 1.3 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 4.6 0.3 0.2 0.6 0.1 0.1 9.9 21.1 7.1 10.7 12.2 10.2 10.6 8.8 8.4 10.3 4.7 8.8 9.3 2.0 16.0 18.4 59.1 0.3 15.3 14.0 14.1 7.4 4.4 5.7 6.1 23.9 14.3 18.3 7.3 0.0 15.5 0.3 3.9 1.9 5.4 3.2 6.2 19.7 3.9 0.0 17.2 10.3 4.2 1.8 24.4 8.6 8.0 19.0 5.9 5.3 2.6 2.6 0.0 2.7 19.4 4.1 24.1 6.8 10.8 17.7 2.5 0.0 15.9 2.7 22.2 2.1 10.6 6.3 3.0 9.5 10.5 0.1 10.9 2.2 4.7 18.4 3.4 13.1 82.2 7.9 8.1 6.0 26.3 19.5 5.3 2.3 33.5 10.2 10.5 TRAIP "RNF206, TRIP" ENSG00000183763 "TRAF interacting protein" Q9BWF2 3 49828601-49856574 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 10.8" "HPA036261, HPA036262" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036261: AB_10673348, HPA036262: AB_2675029" "unprognostic (5.30e-3)" "unprognostic (9.41e-2)" "unprognostic (1.48e-1)" "unprognostic (6.50e-3)" "unprognostic (1.88e-1)" "unprognostic (7.68e-3)" "prognostic unfavorable (8.77e-5)" "unprognostic (4.61e-2)" "unprognostic (1.52e-2)" "unprognostic (8.61e-2)" "unprognostic (1.24e-2)" "unprognostic (7.97e-2)" "unprognostic (9.01e-5)" "unprognostic (5.84e-2)" "unprognostic (4.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" 1.2 1.0 1.5 1.9 2.5 6.8 1.9 0.8 1.7 1.9 0.5 2.4 1.5 1.7 1.4 2.9 1.8 1.0 0.9 1.6 1.3 0.8 0.8 0.9 4.6 1.6 0.8 1.5 2.1 1.0 0.8 1.2 1.6 1.1 1.4 2.9 2.3 1.2 0.9 2.0 4.2 2.0 2.1 0.7 2.0 1.2 8.0 1.2 5.4 1.4 1.2 4.4 1.3 1.9 1.0 10.4 12.4 17.4 17.6 1.6 2.4 14.4 12.4 5.8 25.3 24.0 15.2 11.6 25.5 8.5 7.1 17.7 13.4 18.5 14.0 18.8 14.7 12.2 19.2 16.3 13.6 0.7 15.8 15.4 1.6 2.0 20.4 10.7 3.0 6.7 22.3 14.0 17.8 11.4 15.1 26.5 20.1 14.0 12.3 20.3 14.4 11.7 14.8 4.6 14.2 8.4 14.4 13.6 11.3 8.8 12.4 10.2 22.4 5.2 16.1 19.0 22.5 24.4 13.0 33.7 27.3 8.1 21.2 14.6 0.0 0.6 0.3 0.9 0.3 0.9 2.9 0.5 2.1 0.6 1.5 0.7 1.1 0.1 1.2 1.3 0.7 0.3 0.6 1.5 2.5 0.8 1.7 1.6 1.3 1.6 0.8 1.5 1.1 0.7 1.2 1.0 0.6 3.2 0.6 1.0 1.8 1.1 0.6 1.5 2.2 2.8 1.2 1.4 2.6 0.0 0.3 3.7 0.0 4.2 1.2 1.8 0.0 2.0 4.3 0.6 0.9 0.8 0.0 3.8 1.4 1.0 8.2 2.0 1.5 0.9 0.0 5.7 1.1 0.7 3.5 0.0 0.9 2.0 0.0 0.8 0.4 4.8 2.5 0.7 1.8 1.0 1.8 1.7 0.0 0.5 0.6 1.1 0.3 1.2 4.3 0.8 0.9 0.3 0.5 3.3 0.0 1.4 1.7 15.6 9.1 2.3 0.3 1.0 1.2 1.2 4.6 0.2 CHEK2 "bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53" ENSG00000183765 "Checkpoint kinase 2" O96017 22 28687743-28742422 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatogonia: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001878, CAB002030" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB002030: AB_563660, HPA001878: AB_1078514" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (5.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.42e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-3)" "unprognostic (5.08e-3)" "unprognostic (3.33e-3)" "unprognostic (9.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (7.80e-9)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (7.27e-2)" "unprognostic (6.79e-3)" 3.4 6.2 2.6 8.9 2.7 15.5 5.8 2.6 3.7 4.7 3.0 8.9 6.4 4.2 7.3 7.3 3.8 4.7 3.3 2.5 3.1 3.0 6.4 4.4 12.2 2.8 2.7 2.4 8.3 2.3 1.3 2.7 7.9 2.9 4.2 11.0 0.5 3.3 3.9 1.3 6.7 7.0 4.9 3.0 6.8 4.1 8.5 2.9 9.5 3.3 1.1 12.1 6.9 5.0 3.0 30.7 9.7 31.1 32.4 10.1 42.7 18.7 15.2 19.9 18.7 27.8 29.1 21.8 36.3 13.0 11.5 21.6 32.1 42.7 29.0 25.0 24.6 31.2 45.3 25.5 46.2 9.4 33.4 38.0 18.6 13.5 25.0 23.0 14.1 25.4 29.4 30.5 33.9 19.8 39.2 24.6 61.5 40.6 41.3 21.6 52.6 18.2 42.7 17.1 11.2 17.8 9.7 16.7 31.4 17.4 22.8 22.6 32.2 7.8 17.1 19.4 14.3 9.1 21.8 28.3 65.4 17.1 34.9 21.0 9.9 4.0 1.2 1.1 8.1 2.4 11.9 2.1 2.1 8.2 7.8 4.0 2.6 0.6 3.4 4.1 6.1 2.8 3.6 2.6 2.7 2.6 3.7 2.5 3.1 2.8 2.7 2.4 2.9 3.0 2.9 3.0 2.3 9.6 4.8 2.9 5.5 6.4 5.3 8.3 8.6 1.1 3.2 3.9 1.8 0.0 5.0 1.8 0.0 15.4 1.1 3.8 0.0 1.8 7.0 2.9 10.1 3.0 1.2 11.2 2.9 1.4 13.6 12.4 5.1 7.0 3.8 7.4 2.5 1.3 9.7 0.0 1.2 5.3 8.2 2.4 8.5 1.2 6.2 5.1 1.8 2.8 3.9 0.8 6.2 0.0 1.0 1.0 4.7 4.5 11.4 2.7 3.0 3.9 2.9 1.1 0.0 10.2 3.0 6.7 31.2 8.3 2.3 3.4 3.3 5.7 10.0 4.5 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947137 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 45.2;parathyroid gland: 12.6" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 208.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA069613 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA069613: AB_2686160" "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 2.6 1.2 0.0 0.6 0.0 0.0 0.6 0.8 11.4 0.3 0.0 0.0 7.4 0.4 0.0 12.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.8 0.7 0.2 45.2 0.1 12.6 10.0 0.1 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.8 1.5 0.0 0.0 0.1 0.0 0.0 2.1 0.8 4.9 1.8 0.2 3.4 0.0 0.0 1.4 0.1 0.0 0.4 0.0 0.0 0.3 0.0 2.2 5.6 0.2 1.1 0.0 0.0 0.1 0.0 0.0 8.1 0.9 0.0 0.0 0.1 0.0 0.0 7.1 0.0 0.0 1.1 0.0 0.0 8.4 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 5.6 0.0 0.0 0.3 0.0 5.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.6 0.8 0.6 0.6 0.8 0.7 0.2 0.7 0.7 1.5 0.8 0.2 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 41.8 1.6 0.0 0.0 0.0 0.2 0.3 20.9 0.0 1.0 0.0 208.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 6.2 1.8 1.4 0.0 1.0 0.0 0.3 48.4 0.0 0.0 AIFM3 "AIFL, FLJ30473" ENSG00000183773 "Apoptosis inducing factor mitochondria associated 3" Q96NN9 22 20965108-20981360 "Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 57.6;choroid plexus: 109.0" "Cell type enhanced" "Detected in many" "Astrocytes: 92.1;Distal enterocytes: 76.5;Intestinal goblet cells: 31.3;Muller glia cells: 25.3;Paneth cells: 27.5;Undifferentiated cells: 37.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 1.1;intermediate monocyte: 3.0;myeloid DC: 1.9;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 24 "dendritic cells: 1.9;monocytes: 3.0" "Cell line enhanced" "Detected in some" "Hep G2: 7.6;HMC-1: 10.8;T-47d: 5.3;THP-1: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001271 Supported Mitochondria NA NA Mitochondria "HPA001271: AB_1078114" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (7.49e-2)" "unprognostic (9.99e-2)" "unprognostic (6.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.73e-3)" "unprognostic (3.28e-1)" "unprognostic (1.56e-1)" "unprognostic (4.13e-3)" "unprognostic (5.13e-2)" "unprognostic (7.99e-2)" "unprognostic (6.78e-2)" "unprognostic (1.47e-1)" "unprognostic (3.37e-1)" "prognostic favorable (7.13e-5)" 0.4 0.4 36.9 3.1 29.0 3.7 0.4 37.3 51.1 0.3 109.0 19.4 2.5 0.4 0.0 0.4 0.6 0.6 0.2 26.3 26.3 0.8 0.3 1.1 0.6 44.1 38.5 21.2 0.3 0.4 0.5 4.5 0.4 39.6 1.0 8.5 1.8 1.0 0.7 0.1 0.1 1.9 0.8 31.4 2.2 0.6 0.6 57.6 0.1 0.3 0.0 0.0 1.2 0.4 27.0 1.0 1.7 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.2 0.0 1.9 0.0 7.6 0.2 0.0 10.8 0.5 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 1.3 0.0 1.3 1.4 0.9 0.8 0.1 0.0 0.1 5.3 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.5 36.9 29.0 37.3 51.1 26.3 26.3 44.1 38.5 21.2 39.6 31.4 57.6 27.0 1.0 0.0 1.5 92.1 1.0 0.6 1.9 1.7 0.6 14.5 3.1 2.4 2.9 0.0 1.4 1.8 6.2 1.0 0.0 76.5 11.7 0.7 0.0 1.7 0.4 0.5 10.3 0.0 12.5 0.6 0.7 0.6 1.5 1.4 1.3 0.5 1.4 2.4 3.6 0.0 8.1 31.3 2.0 3.2 1.9 0.1 0.0 2.5 0.0 4.7 3.2 25.3 0.0 2.5 1.6 0.5 27.5 0.0 0.3 2.2 4.8 8.1 1.9 3.7 0.0 0.2 1.2 0.4 1.9 0.7 0.9 0.8 0.2 0.3 37.9 2.8 KCTD16 KIAA1317 ENSG00000183775 "Potassium channel tetramerization domain containing 16" Q68DU8 5 144170873-144485686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 8.4" "Group enriched" "Detected in some" 15 "Excitatory neurons: 801.9;Inhibitory neurons: 788.9;Oligodendrocyte precursor cells: 362.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.9;TIME: 6.2;U-87 MG: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044590, HPA050154" Approved NA NA "HPA044590: AB_2679008, HPA050154: AB_2681034" "unprognostic (7.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.54e-2)" "unprognostic (6.81e-5)" "unprognostic (9.88e-2)" "unprognostic (1.21e-1)" "unprognostic (7.74e-3)" "unprognostic (3.23e-2)" "unprognostic (1.94e-2)" "unprognostic (9.57e-2)" "unprognostic (9.38e-3)" "unprognostic (6.20e-3)" "unprognostic (2.52e-8)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (5.80e-3)" "unprognostic (1.22e-2)" 0.0 0.5 1.1 0.0 8.4 0.0 0.0 0.0 7.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 5.0 3.6 0.6 0.0 0.6 0.0 2.5 0.1 5.8 0.0 1.5 0.0 0.5 0.0 1.5 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.4 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 6.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 8.4 0.0 7.1 5.0 3.6 2.5 0.1 5.8 1.5 0.0 0.0 2.6 0.5 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 14.3 0.0 0.1 0.7 1.5 0.0 0.0 2.1 0.1 0.0 0.1 0.0 4.3 9.7 0.3 0.1 0.6 0.0 0.0 801.9 5.5 0.0 0.9 0.0 0.0 0.0 0.1 0.4 0.0 0.1 20.2 788.9 0.4 0.0 0.0 0.5 5.3 0.0 0.0 0.0 16.9 0.1 0.8 0.0 362.4 34.9 1.8 0.0 0.0 0.0 0.0 0.1 0.8 0.9 2.9 0.0 0.1 0.4 4.8 2.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 37.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 23.5;RPTEC TERT1: 27.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 8.6" "HPA054092, HPA054684" Approved "Intracellular and membrane" NA NA "HPA054092: AB_2682375, HPA054684: AB_2682573" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favorable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.0 0.3 3.5 1.0 7.3 0.0 2.6 1.1 3.1 2.2 1.6 22.6 27.6 0.7 1.3 1.6 1.3 5.6 0.0 2.4 3.9 0.2 0.1 0.1 0.0 3.3 1.9 1.0 0.3 3.4 0.0 1.8 0.0 2.5 0.4 37.7 0.8 4.6 0.1 0.0 0.8 34.0 0.8 1.3 0.0 5.0 0.4 4.8 1.0 1.2 0.3 2.0 1.3 2.3 0.8 0.0 0.9 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 23.5 0.0 0.2 0.2 2.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.3 0.2 0.6 0.0 2.7 0.1 27.1 1.7 4.6 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.7 0.2 1.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 7.3 1.1 3.1 2.4 3.9 3.3 1.9 1.0 2.5 1.3 4.8 0.8 0.1 0.0 0.0 6.5 0.3 0.0 0.5 0.1 0.0 7.4 8.0 8.1 2.2 10.0 5.3 5.5 0.0 0.0 0.2 196.4 0.0 7.5 0.4 0.2 5.9 0.4 28.9 0.0 3.6 4.7 0.0 0.2 13.3 0.2 4.5 0.8 0.0 0.0 0.0 0.0 4.8 47.4 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 1.4 0.0 11.1 1.0 9.2 72.5 0.0 0.0 0.6 94.1 0.1 1.5 0.2 0.0 0.1 0.4 0.1 1.7 0.5 0.0 0.0 0.5 0.0 57.7 9.7 ZNF703 "FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1" ENSG00000183779 "Zinc finger protein 703" Q9H7S9 8 37695782-37700019 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.3" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "intermediate monocyte: 3.3;non-classical monocyte: 4.3" "Lineage enriched" "Detected in single" 12 "monocytes: 4.3" "Cell line enhanced" "Detected in many" "HEK 293: 156.8;OE19: 61.2;SK-MEL-30: 60.0;T-47d: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023930, CAB068249" Supported NA NA "CAB068249: AB_2665667, HPA023930: AB_1859425" "unprognostic (4.64e-2)" "unprognostic (3.15e-2)" "unprognostic (7.01e-3)" "unprognostic (1.71e-3)" "unprognostic (2.54e-1)" "unprognostic (1.42e-1)" "unprognostic (6.93e-2)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (2.70e-7)" "unprognostic (5.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-1)" "unprognostic (2.23e-1)" 21.3 14.5 16.1 7.7 13.3 1.9 27.6 9.7 17.0 36.1 7.8 42.5 15.2 28.0 12.8 18.3 33.5 6.3 16.2 12.7 9.3 5.5 4.2 10.8 4.1 20.9 15.8 10.3 19.8 8.8 1.9 6.0 12.2 14.5 21.9 12.8 0.5 18.4 8.8 109.3 51.8 26.1 11.7 13.4 19.1 23.0 2.9 12.5 2.8 10.7 33.6 2.9 37.1 28.9 11.1 3.2 6.6 0.8 5.2 15.1 7.9 5.2 29.1 13.6 8.8 7.4 27.2 36.0 0.0 7.2 18.4 4.0 17.2 3.0 4.4 6.8 0.8 156.8 0.0 9.5 17.5 14.9 0.0 3.0 26.6 8.2 9.1 3.7 19.0 7.8 0.3 0.4 0.0 14.1 27.4 0.1 0.8 2.6 61.2 11.6 2.7 4.7 3.7 2.7 14.2 2.9 0.2 5.4 4.6 60.0 6.2 52.6 3.1 23.1 10.3 23.7 16.1 12.3 1.9 0.1 0.2 9.1 3.2 6.7 0.0 0.4 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 16.1 13.3 9.7 17.0 12.7 9.3 20.9 15.8 10.3 14.5 13.4 12.5 11.1 11.9 6.4 0.0 14.7 15.3 48.2 13.2 28.9 103.0 3.7 39.3 27.8 9.1 2.8 14.5 5.5 0.0 41.4 7.7 52.0 3.9 7.1 0.4 30.8 37.0 9.5 79.6 0.0 1.5 2.5 37.2 36.0 14.8 20.3 0.0 5.8 2.5 2.2 36.2 0.0 2.8 95.4 10.2 23.6 31.9 0.7 31.4 31.2 33.8 11.2 7.9 9.3 0.0 0.0 0.6 3.7 56.9 15.8 1.9 9.7 35.4 2.8 7.7 0.9 52.6 54.9 66.4 0.0 0.6 99.7 74.6 434.1 6.0 6.1 92.6 10.7 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904676-234324511 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 15.6" "Group enriched" "Detected in some" 6 "Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 35 "plasmacytoid DC: 3.5" "Lineage enriched" "Detected in single" 35 "dendritic cells: 3.5" "Cell line enriched" "Detected in some" 7 "HDLM-2: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.0 1.1 4.1 0.3 13.8 0.1 2.5 10.1 15.6 0.3 0.0 0.3 0.1 0.3 0.7 0.5 0.4 0.1 0.0 5.8 3.2 0.6 0.0 0.2 0.8 3.0 1.4 7.0 0.1 3.6 1.4 2.7 0.0 5.8 0.5 0.1 0.3 2.5 0.2 0.2 0.6 0.2 0.2 0.7 0.2 0.7 0.2 3.2 2.4 0.5 0.1 0.5 0.0 0.5 9.8 3.0 7.9 1.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 14.9 0.0 0.0 0.1 0.2 0.6 0.1 7.7 0.0 111.9 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.1 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 9.0 0.0 0.0 0.0 7.7 0.0 4.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 4.1 13.8 10.1 15.6 5.8 3.2 3.0 1.4 7.0 5.8 0.7 3.2 9.8 0.1 0.0 0.0 8.5 0.9 0.4 2.4 0.3 10.8 2.1 3.0 8.9 0.7 0.0 0.1 0.0 0.0 0.0 9.5 0.0 3.9 1.4 0.7 5.9 1.6 0.1 1.8 0.0 485.2 3.4 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 216.1 0.1 26.4 0.0 0.0 0.9 0.0 0.6 0.0 9.4 0.9 0.0 0.0 190.5 45.4 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.5 0.0 0.8 0.1 0.6 1.5 0.8 0.1 0.0 0.4 0.0 0.0 0.2 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173903-44448809 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.6;retina: 6.9" "Group enriched" "Detected in some" 4 "Astrocytes: 169.4;Excitatory neurons: 223.7;Inhibitory neurons: 445.3;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 610.8" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.2;NTERA-2: 1.5;SCLC-21H: 5.7;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031562 Enhanced Approved Vesicles NA NA Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 0.7 0.2 5.9 0.0 11.6 0.0 0.0 26.6 8.2 1.0 3.2 0.7 0.0 1.4 0.2 0.1 0.2 0.3 0.2 6.9 11.9 0.8 0.0 0.1 0.0 10.4 13.9 4.2 1.5 0.6 1.0 0.0 0.0 10.5 0.4 0.1 6.9 0.4 0.9 1.5 0.1 0.1 0.6 11.2 0.0 1.6 1.3 9.9 0.0 3.1 1.1 0.0 0.1 0.3 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 11.6 26.6 8.2 6.9 11.9 10.4 13.9 4.2 10.5 11.2 9.9 16.0 0.1 0.0 0.0 169.4 0.0 0.0 0.6 0.0 1.8 2.6 1.3 0.3 0.3 4.3 0.0 3.7 4.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 3.5 1.0 0.0 0.0 223.7 0.0 0.0 1.0 0.0 0.1 0.0 2.0 0.4 0.0 0.1 0.0 445.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 71.2 0.0 4.4 0.0 322.7 610.8 0.2 0.0 0.0 0.0 1.2 0.0 1.9 0.0 17.1 0.0 1.7 0.2 0.1 1.6 1.0 0.0 0.1 0.0 10.0 0.0 0.1 TUBA8 TUBAL2 ENSG00000183785 "Tubulin alpha 8" Q9NY65 22 18110100-18146683 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 130.1;skeletal muscle: 335.4;tongue: 156.1" "Cell type enhanced" "Detected in some" "Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4" "Group enriched" "Detected in many" 7 "granulocytes: 5.0;NK-cells: 10.4" "Group enriched" "Detected in many" 5 "NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3" "Group enriched" "Detected in all" 4 "cerebellum: 54.7;olfactory bulb: 53.9" "Low region specificity" "Detected in all" "HPA043684, CAB046031, HPA063394" Approved Supported Microtubules NA NA 80000000 Microtubules "CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.07e-1)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (1.52e-2)" "unprognostic (2.74e-1)" "unprognostic (8.92e-2)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-2)" "unprognostic (3.36e-1)" "unprognostic (2.90e-5)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.61e-4)" 6.3 2.0 6.8 1.0 13.3 4.8 7.2 24.5 17.6 2.5 1.3 1.9 0.8 2.8 6.4 4.3 4.8 1.0 130.1 16.4 5.9 2.3 4.4 2.4 3.5 3.8 11.3 9.3 2.3 4.5 2.8 14.6 0.6 9.8 2.5 0.5 2.8 4.5 0.7 335.4 4.2 2.6 0.7 1.0 4.2 4.8 52.7 12.2 0.8 6.5 156.1 1.0 2.0 2.2 13.4 0.6 1.1 1.2 1.4 1.8 0.5 0.4 0.6 0.3 1.4 0.8 0.9 1.1 0.9 2.2 0.7 0.4 0.6 2.2 0.4 0.3 0.8 1.6 2.2 1.7 0.9 1.0 1.0 1.0 0.7 0.8 0.8 0.6 0.5 2.0 0.9 0.6 0.9 0.6 3.4 1.0 30.2 1.0 0.5 0.5 0.9 0.5 0.2 0.7 1.1 10.9 1.1 0.6 1.9 1.0 0.5 0.6 4.8 36.3 0.9 1.0 1.0 0.4 2.2 1.3 0.7 0.9 1.4 0.6 2.8 0.7 2.7 0.5 0.6 0.7 0.4 0.4 0.3 0.4 0.6 0.7 0.4 5.0 10.4 0.4 1.0 0.8 17.1 6.8 13.3 24.5 17.6 16.4 5.9 3.8 11.3 9.3 9.8 1.0 12.2 13.4 0.2 0.0 1.7 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 4.7 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.3 16.4 0.2 0.1 0.4 0.0 0.0 8.1 1.1 0.0 0.3 0.0 0.2 2.5 0.1 0.7 0.0 0.1 3.3 5.6 0.0 0.0 0.3 0.0 22.9 0.3 0.1 0.0 0.0 0.2 0.1 1.0 3.5 1.7 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.0 0.2 6.6 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363628-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 20.4;granulocytes: 11.4;Respiratory ciliated cells: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "THP-1: 17.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 24.3 24.6 19.4 1.3 19.6 4.1 23.1 24.4 26.5 23.6 14.2 35.5 2.8 33.1 8.4 21.4 18.2 5.2 22.8 20.2 17.4 21.3 22.2 22.1 3.1 19.9 20.3 17.7 43.3 28.3 4.9 78.9 1.4 22.6 32.7 2.7 10.9 18.8 2.9 34.2 24.6 24.8 2.8 15.5 29.1 26.3 43.1 19.7 5.4 29.1 4.2 1.5 26.0 23.9 21.0 1.1 1.5 5.4 0.8 9.9 10.3 0.8 2.1 5.0 6.9 7.0 2.3 1.0 2.3 0.6 5.5 2.1 2.3 1.8 5.5 3.5 4.5 2.1 3.0 7.8 11.3 1.5 0.8 4.1 2.1 9.1 2.7 3.6 3.1 3.7 8.5 3.2 1.7 6.7 1.2 2.4 3.6 7.7 4.5 0.9 0.8 0.8 0.7 5.9 2.1 0.0 0.8 6.0 2.7 6.7 0.7 2.6 17.7 8.9 0.0 2.8 8.5 0.4 4.8 7.1 8.2 1.0 4.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.4 19.6 24.4 26.5 20.2 17.4 19.9 20.3 17.7 22.6 15.5 19.7 21.0 2.0 0.0 3.7 8.8 1.6 4.8 0.4 2.3 8.6 2.0 1.5 2.9 4.1 4.3 2.5 1.8 0.0 0.6 0.7 0.6 0.0 0.1 20.4 2.4 2.1 1.8 0.0 6.9 10.2 0.2 0.3 4.8 1.5 0.9 11.4 2.9 2.2 1.8 0.3 1.7 8.1 0.5 2.0 1.0 2.3 4.1 1.5 1.2 0.0 1.9 0.1 0.8 0.0 7.1 6.9 0.0 0.0 0.7 0.8 0.4 0.4 0.2 11.1 2.5 0.0 2.2 2.9 5.8 1.0 6.2 4.5 0.3 1.8 0.1 0.6 0.2 BPY2B VCY2B ENSG00000183795 "Basic charge Y-linked 2B" O14599 Y 24607560-24639207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359962-41366818 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 54.1" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2" "Group enriched" "Detected in many" 5 "glioma: 10.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0" "Region enriched" "Detected in single" 30 "cerebellum: 3.3" "Region enriched" "Detected in single" 4 "spinal cord: 4.1" "HPA044034, HPA059912, HPA078559" Enhanced Approved "Golgi apparatus,Microtubules,Cytokinetic bridge" "Secreted to extracellular matrix" Yes NA 1200000 "Golgi apparatus" "Microtubules, Cytokinetic bridge" "HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.5 1.5 2.5 0.1 2.4 0.0 3.6 2.4 3.6 7.6 1.8 3.6 0.6 2.3 54.1 0.8 4.2 0.3 7.4 2.2 2.2 1.0 0.6 0.3 0.1 3.7 2.7 1.6 9.0 0.2 0.1 1.8 0.0 3.3 6.7 0.3 0.0 1.0 10.0 0.9 3.2 1.7 1.0 2.7 0.1 2.1 1.7 2.6 0.5 0.3 2.6 0.2 2.4 4.7 3.3 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 11.1 0.0 0.2 0.0 1.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.0 1.3 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.4 2.4 3.6 2.2 2.2 3.7 2.7 1.6 3.3 2.7 2.6 3.3 0.6 0.0 0.0 0.7 0.0 0.9 0.2 0.0 0.0 0.3 1.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 17.7 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.7 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 1.8 0.1 0.0 4.7 0.0 0.1 0.0 3.5 0.1 0.0 1.2 4.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 OLFML1 UNQ564 ENSG00000183801 "Olfactomedin like 1" Q6UWY5 11 7485388-7511377 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.1" "Cell type enhanced" "Detected in some" "Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 31.2;U-2197: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058824 Approved "Secreted - unknown location" NA NA 260000 "HPA058824: " "unprognostic (3.05e-1)" "unprognostic (5.35e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-2)" "unprognostic (5.32e-1)" "unprognostic (1.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.16e-1)" "unprognostic (7.33e-2)" "unprognostic (1.37e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (3.13e-3)" "unprognostic (2.00e-2)" "unprognostic (3.34e-2)" "unprognostic (8.72e-3)" 18.1 6.3 1.5 5.3 1.9 0.4 12.6 2.2 1.9 27.4 7.1 8.5 5.1 19.2 21.5 8.2 17.7 24.0 14.4 1.9 1.8 6.5 10.8 19.0 9.4 2.1 1.5 1.1 49.1 2.9 2.3 3.1 7.4 2.1 14.2 10.3 0.2 5.7 18.5 5.2 8.3 7.2 18.2 1.3 14.8 5.5 4.1 1.7 3.3 8.3 12.2 5.6 15.0 17.9 2.1 0.0 0.0 0.4 0.0 1.9 1.9 31.2 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.2 0.1 0.1 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 6.4 0.0 0.0 0.1 0.2 0.1 20.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.8 0.1 0.0 0.0 1.5 1.9 2.2 1.9 1.9 1.8 2.1 1.5 1.1 2.1 1.3 1.7 2.1 6.1 0.0 0.0 1.0 0.4 5.2 0.0 0.0 1.2 0.1 0.2 0.3 1.0 0.0 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 13.3 2.9 0.0 0.0 0.1 0.0 2.0 52.3 0.0 0.4 0.0 0.0 5.0 0.9 0.6 0.0 0.1 0.0 0.0 0.0 6.1 0.7 39.7 0.4 7.2 2.8 0.0 0.0 0.0 0.5 1.4 0.1 0.0 39.5 0.2 0.1 0.0 0.3 0.0 0.0 26.3 9.4 16.3 0.3 0.1 0.2 3.7 0.3 0.7 5.0 0.0 0.1 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765719 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 65.7" "Group enriched" "Detected in some" 4 "Adipocytes: 34.6;Sertoli cells: 65.7;Smooth muscle cells: 105.1" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 8.7;BJ hTERT+: 23.5;BJ hTERT+ SV40 Large T+ RasG12V: 22.1;HHSteC: 6.3;HSkMC: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036112, HPA060342" Enhanced NA NA "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 14.4 15.0 3.6 0.8 4.9 0.0 11.0 2.3 7.1 13.0 2.9 2.9 0.9 5.9 7.5 4.4 10.2 5.2 6.4 4.7 3.2 4.4 0.9 18.1 1.6 3.4 3.2 3.4 5.8 1.7 3.7 6.6 65.7 3.8 6.2 2.2 0.2 8.3 13.5 5.4 2.7 2.3 3.7 3.0 0.1 3.6 2.6 3.4 1.9 9.8 10.7 1.2 8.0 10.0 5.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 8.7 23.5 3.7 22.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.9 2.3 7.1 4.7 3.2 3.4 3.2 3.4 3.8 3.0 3.4 5.0 34.6 0.0 0.0 1.3 0.0 1.3 0.1 0.0 1.2 0.0 0.9 0.8 0.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 16.9 0.7 15.7 13.7 0.0 0.0 14.8 0.0 0.2 14.1 0.0 0.4 0.0 0.1 3.6 0.0 0.5 0.0 6.9 0.0 0.0 0.0 2.1 2.2 2.1 0.7 1.8 3.7 0.0 0.0 0.0 6.6 0.5 0.2 0.0 5.3 0.0 0.2 0.0 0.1 0.0 0.1 65.7 2.2 105.1 10.3 5.9 0.6 0.9 0.5 2.3 0.1 0.0 0.0 RBM12B ENSG00000183808 "RNA binding motif protein 12B" Q8IXT5 8 93729356-93741017 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 15.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024398, HPA053050" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA024398: AB_1856109, HPA053050: AB_2682026" "unprognostic (4.57e-2)" "unprognostic (7.72e-2)" "unprognostic (3.39e-1)" "unprognostic (3.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.66e-2)" "unprognostic (2.40e-3)" "unprognostic (3.05e-1)" "unprognostic (3.92e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.54e-2)" "unprognostic (1.84e-3)" "unprognostic (9.15e-2)" "unprognostic (4.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.62e-2)" 6.6 7.3 3.2 15.0 4.9 9.3 11.9 14.6 5.3 11.5 3.6 9.0 9.2 14.4 9.0 8.6 11.8 8.5 9.4 3.7 3.7 9.0 6.4 8.6 20.0 4.0 5.3 3.2 22.0 7.9 9.5 5.6 13.5 5.1 13.1 9.4 24.9 10.3 8.4 5.6 8.5 9.1 8.3 1.8 13.7 10.7 17.7 3.1 16.5 16.0 6.3 17.0 8.5 7.2 11.3 26.0 19.3 48.3 34.4 11.7 22.3 23.4 21.4 15.8 23.9 24.9 14.6 34.6 45.5 33.2 12.0 25.4 26.0 42.3 11.3 26.7 32.3 21.8 59.0 48.2 12.6 13.7 22.2 28.7 14.6 14.2 15.7 15.5 15.8 16.4 26.6 49.4 37.0 21.3 15.0 41.3 17.3 0.2 19.6 20.4 30.2 34.2 15.0 12.3 21.9 31.6 25.0 23.0 7.2 17.8 33.0 27.5 16.7 32.0 22.2 33.3 16.3 22.3 43.0 34.2 38.3 15.8 31.0 38.0 15.0 2.3 4.4 2.3 2.0 3.5 1.5 3.0 2.4 2.2 2.1 4.1 3.5 3.3 3.0 2.4 2.9 3.8 2.1 3.2 4.9 14.6 5.3 3.7 3.7 4.0 5.3 3.2 5.1 1.8 3.1 11.3 16.8 6.4 8.1 23.2 17.9 4.0 7.1 7.2 11.4 31.8 9.9 9.1 11.8 10.0 6.6 12.9 43.8 7.9 13.7 5.5 3.9 6.9 1.4 11.3 21.4 12.8 15.7 17.7 23.7 4.8 4.8 13.5 7.7 12.8 0.0 30.3 11.4 8.4 4.7 45.4 26.6 9.2 8.2 11.1 5.8 2.4 12.5 8.9 5.4 21.5 15.9 21.9 17.5 32.6 40.2 6.8 7.1 10.1 8.7 8.8 5.9 5.0 12.5 32.1 19.7 23.2 13.1 19.1 10.9 7.3 4.3 4.0 11.8 13.5 8.0 4.9 CCR4 "CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5" ENSG00000183813 "C-C motif chemokine receptor 4" P51679 3 32951644-32956349 "CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.1;urinary bladder: 5.5" "Cell type enhanced" "Detected in some" "granulocytes: 2.5;Horizontal cells: 5.0;Plasma cells: 2.1;Spermatogonia: 1.8;T-cells: 7.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "T-reg: 60.9" "Lineage enriched" "Detected in many" 41 "T-cells: 60.9" "Cell line enriched" "Detected in some" 17 "HDLM-2: 206.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA031613 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031613: AB_10601096" "unprognostic (4.63e-3)" "unprognostic (8.70e-3)" "unprognostic (2.82e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (4.59e-7)" "unprognostic (3.02e-1)" "unprognostic (5.05e-3)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (5.53e-4)" "unprognostic (1.54e-1)" "unprognostic (1.40e-1)" 0.5 0.2 0.3 8.7 0.3 1.7 0.6 0.7 0.8 0.6 0.2 0.9 0.6 0.4 0.4 1.2 0.2 3.4 0.2 0.4 0.2 0.3 0.6 1.7 7.1 0.3 0.1 0.6 0.2 0.3 0.2 0.0 0.1 0.6 0.8 1.2 0.1 0.5 0.1 2.1 2.2 1.5 0.6 0.1 3.2 1.4 0.8 0.1 13.1 0.3 0.1 8.1 5.5 0.2 0.5 0.3 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 206.5 0.0 12.2 0.7 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.2 0.0 5.8 3.2 0.8 0.0 0.0 1.8 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.5 0.0 0.1 0.7 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.2 0.1 0.2 0.2 0.2 0.0 1.4 0.3 0.3 0.4 0.3 0.4 0.3 11.5 3.4 0.1 0.4 0.3 0.3 1.1 0.3 0.3 0.4 60.9 1.7 0.3 0.3 0.7 0.8 0.4 0.2 0.3 0.1 0.6 0.6 0.1 0.1 0.5 0.1 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.5 0.0 0.4 0.1 0.1 5.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.7 0.8 0.0 0.5 0.2 0.0 1.8 0.0 0.1 0.0 7.8 0.0 0.0 0.6 LIN9 TGS ENSG00000183814 "Lin-9 DREAM MuvB core complex component" Q5TKA1 1 226231149-226309869 "Predicted intracellular proteins" "Cell cycle, DNA synthesis" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 20.2;Spermatocytes: 36.3;Spermatogonia: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030241 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA030241: AB_10601542" "unprognostic (9.90e-2)" "unprognostic (8.00e-2)" "unprognostic (1.23e-1)" "unprognostic (8.82e-3)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (3.51e-5)" "unprognostic (2.80e-2)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.59e-3)" "unprognostic (1.17e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-2)" "unprognostic (1.79e-1)" "unprognostic (3.22e-1)" "unprognostic (8.26e-2)" 1.8 1.6 1.0 2.8 1.3 6.6 3.6 3.8 1.6 1.8 0.9 3.2 4.2 3.3 1.6 3.2 2.4 1.5 12.9 1.1 1.1 2.1 1.4 2.6 5.0 0.9 1.3 1.1 5.0 2.0 2.2 0.6 4.1 1.6 2.1 4.0 1.8 2.1 2.0 3.6 3.4 3.9 2.8 1.0 2.6 3.0 9.8 1.0 8.2 2.2 3.5 4.8 1.9 1.7 1.4 15.9 10.0 16.2 11.6 1.5 3.8 31.2 11.4 7.3 20.2 18.1 10.8 20.0 15.0 14.1 5.3 8.9 14.4 15.9 6.1 18.0 14.4 28.1 9.4 12.2 7.7 1.4 18.6 9.7 1.5 4.3 10.5 10.6 4.9 10.0 13.7 33.5 17.8 12.3 5.8 19.5 12.0 26.0 20.1 18.2 18.7 27.5 19.4 6.6 8.2 14.2 19.9 20.3 23.6 14.7 10.0 13.4 23.8 4.8 11.4 16.3 15.7 29.4 8.2 20.2 31.0 6.6 16.7 27.2 4.1 1.0 1.1 1.2 1.3 1.9 2.2 1.9 2.7 0.5 1.6 3.4 2.6 0.2 1.7 2.8 0.6 2.8 1.0 1.0 1.3 3.8 1.6 1.1 1.1 0.9 1.3 1.1 1.6 1.0 1.0 1.4 3.1 9.6 5.1 3.3 3.3 3.3 1.4 2.8 3.4 1.2 2.1 2.2 15.7 1.5 2.2 0.0 0.0 13.0 2.8 1.6 1.9 2.3 20.2 2.0 3.4 3.1 2.4 16.4 11.1 3.3 6.9 3.3 2.0 1.6 1.3 4.3 2.2 1.4 2.8 3.3 8.7 2.5 0.0 3.5 1.1 4.0 4.4 1.9 0.0 6.5 0.4 1.9 2.1 10.1 4.7 2.8 3.8 4.5 6.4 1.2 2.0 1.7 3.7 1.0 0.0 3.0 4.5 36.3 18.7 5.1 1.8 15.5 2.8 1.9 4.9 1.5 BTBD9 "dJ322I12.1, KIAA1880" ENSG00000183826 "BTB domain containing 9" Q96Q07 6 38168451-38640148 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Astrocytes: 191.3;Excitatory neurons: 390.4;Inhibitory neurons: 257.0;Microglial cells: 142.4;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 218.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041930 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041930: AB_10795270" "unprognostic (4.40e-1)" "unprognostic (1.74e-1)" "unprognostic (1.75e-3)" "unprognostic (1.64e-2)" "unprognostic (6.59e-2)" "unprognostic (3.94e-2)" "unprognostic (1.48e-1)" "unprognostic (1.76e-3)" "unprognostic (5.44e-2)" "unprognostic (6.13e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-1)" "prognostic favorable (4.20e-13)" "unprognostic (1.35e-1)" "unprognostic (6.56e-2)" "unprognostic (8.67e-2)" "unprognostic (1.15e-2)" 4.2 4.8 13.1 4.3 13.7 8.4 3.8 1.5 20.6 3.8 8.7 5.1 5.3 5.3 4.4 5.7 8.7 5.8 8.3 18.9 7.4 6.3 3.2 9.3 4.7 3.5 5.8 13.5 8.1 3.6 13.8 4.3 4.3 4.9 5.3 5.7 7.1 4.5 4.2 7.9 4.9 7.3 5.1 0.6 4.8 4.7 8.1 5.6 3.8 6.8 6.8 4.5 4.7 3.5 10.9 5.4 4.7 6.8 8.5 4.6 6.7 5.4 5.3 7.4 5.4 6.3 6.2 3.1 3.1 3.7 8.2 7.3 3.5 3.2 6.7 5.9 7.4 7.0 6.9 5.1 2.5 4.0 6.5 13.4 5.2 6.0 7.4 7.9 4.9 9.3 4.8 3.2 5.2 5.6 3.4 4.6 2.7 2.0 4.9 3.6 3.0 4.7 6.1 5.1 12.3 10.2 5.8 4.5 5.7 5.2 4.6 5.8 5.3 7.0 5.6 3.7 6.6 5.5 3.3 2.5 3.7 4.9 4.4 6.6 12.3 1.8 3.2 2.4 2.6 3.3 2.6 2.4 2.2 1.7 3.7 3.0 2.7 4.5 3.3 4.0 2.6 4.1 1.9 13.1 13.7 1.5 20.6 18.9 7.4 3.5 5.8 13.5 4.9 0.6 5.6 10.9 3.9 3.2 17.9 191.3 14.2 4.6 2.2 2.9 4.6 11.5 3.6 2.9 11.8 8.6 6.7 9.2 8.4 2.7 7.3 15.5 5.9 4.6 17.5 12.8 5.3 4.1 4.9 1.3 390.4 5.8 1.5 4.6 10.2 8.1 0.0 5.5 7.5 3.0 2.6 5.0 257.0 3.9 6.1 3.5 3.0 24.6 3.1 5.6 1.8 142.4 1.5 5.9 2.1 193.5 218.3 5.5 5.0 3.4 10.4 2.1 13.1 6.8 8.7 5.6 0.0 5.4 6.1 3.1 2.9 4.4 5.8 4.7 11.1 3.7 6.0 3.2 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 176.1;Proximal enterocytes: 206.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: AB_2683809" "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 16.5 24.1 15.9 3.5 18.8 2.2 19.4 19.1 28.7 7.7 23.7 10.6 12.7 6.5 3.5 17.6 8.9 6.5 27.2 17.9 20.2 29.0 19.6 20.2 5.9 17.4 19.0 19.2 6.5 40.8 16.1 61.5 3.3 18.0 18.7 2.9 4.7 17.3 2.9 31.9 12.9 16.4 1.8 17.7 12.6 17.7 14.1 16.9 3.6 22.3 12.9 2.1 8.5 11.4 24.8 18.1 24.2 2.1 9.4 2.8 3.3 38.1 5.0 6.5 8.0 11.5 17.5 18.7 1.3 24.4 2.6 17.8 22.7 1.1 13.6 0.7 9.5 17.7 4.0 10.4 12.2 19.9 4.8 46.7 4.7 16.7 1.9 1.4 3.4 15.9 8.8 6.4 2.9 2.8 52.5 0.6 0.0 12.6 42.7 33.5 9.4 21.9 10.8 8.8 51.2 32.8 4.8 9.0 0.2 21.7 3.9 18.8 23.1 38.3 13.2 5.8 9.5 5.1 1.4 1.0 2.2 19.4 5.5 4.9 6.2 40.5 1.2 12.6 40.8 7.5 12.8 9.6 8.0 33.5 10.2 9.4 10.8 1.3 15.2 68.6 17.0 6.0 19.2 15.9 18.8 19.1 28.7 17.9 20.2 17.4 19.0 19.2 18.0 17.7 16.9 24.8 66.1 12.8 28.5 5.2 12.4 38.9 101.7 123.4 52.9 12.1 46.8 78.5 54.5 40.0 41.2 35.0 18.8 44.7 16.1 88.2 176.1 94.1 3.1 59.3 8.0 61.6 37.3 10.1 5.9 30.8 18.2 14.7 30.5 31.0 38.8 11.9 27.1 28.0 137.0 35.3 3.0 62.6 73.2 27.4 27.1 9.8 11.5 33.9 46.2 12.2 35.6 38.3 22.6 0.5 5.8 51.2 132.4 3.8 7.7 51.9 206.9 169.1 65.7 19.1 0.0 39.0 11.4 12.4 48.5 30.4 19.0 38.2 26.8 5.2 75.4 82.2 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173608336-173669851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 8.8;choroid plexus: 12.0;fallopian tube: 12.8;parathyroid gland: 9.4;testis: 11.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Early spermatids: 48.8;Endometrial ciliated cells: 23.7;Late spermatids: 16.8;Respiratory ciliated cells: 31.8;Spermatocytes: 54.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.5;BJ hTERT+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;GAMG: 1.9;HBF TERT88: 1.9;SH-SY5Y: 5.7" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.1 0.6 4.9 0.0 4.3 0.2 0.1 3.0 2.9 1.3 12.0 0.2 0.0 1.6 0.7 0.0 12.8 0.3 0.2 4.0 8.8 1.3 0.0 1.2 0.0 4.9 6.0 2.0 0.7 0.3 9.4 1.8 0.0 3.5 0.8 0.1 2.6 0.0 0.3 0.2 0.0 0.0 1.1 3.8 0.4 0.1 11.1 3.5 0.2 0.5 0.0 0.0 0.1 0.1 4.1 0.0 0.0 5.5 0.0 0.0 0.3 0.1 0.0 2.0 1.7 2.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 5.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.9 4.3 3.0 2.9 4.0 8.8 4.9 6.0 2.0 3.5 3.8 3.5 4.1 0.2 0.0 1.7 12.4 0.0 0.3 0.3 1.1 0.0 0.7 0.1 0.4 0.9 0.0 1.5 5.5 37.5 0.2 0.0 0.3 1.9 0.6 48.8 23.7 1.3 1.3 0.0 0.0 4.6 0.5 0.3 0.4 0.0 0.6 0.0 1.1 3.3 0.0 0.1 0.0 4.1 0.0 6.1 0.0 0.0 16.8 1.8 0.2 0.0 2.8 0.0 3.3 0.0 0.5 3.2 0.1 0.0 0.4 0.0 0.2 0.0 0.4 31.8 1.7 0.0 0.1 0.8 54.9 7.9 0.0 0.0 0.1 0.0 5.5 0.4 0.1 CFAP91 "AAT-1, AAT1, AAT1alpha, C3orf15, CaM-IP2, MAATS1, SPATA26" ENSG00000183833 "Cilia and flagella associated protein 91" Q7Z4T9 3 119703022-119767102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;hTERT-RPE1: 1.4;RPTEC TERT1: 2.4;SCLC-21H: 3.5;SH-SY5Y: 2.5;T-47d: 1.8;U-87 MG: 1.9" HPA074084 Supported NA NA "HPA074084: " "unprognostic (6.70e-2)" "unprognostic (3.54e-2)" "unprognostic (3.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.40e-2)" "unprognostic (1.89e-2)" "unprognostic (1.36e-1)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (4.07e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (4.46e-2)" 0.6 2.1 0.9 0.0 0.9 0.0 1.8 0.9 1.1 2.6 4.6 1.1 0.0 4.0 5.1 0.3 14.2 1.2 0.3 0.9 2.6 2.5 0.4 2.1 0.1 2.1 1.7 0.4 3.5 4.9 4.0 7.2 0.2 1.5 2.3 0.5 4.1 1.5 4.6 0.1 0.3 0.6 0.8 1.6 2.4 1.7 8.8 1.0 0.4 4.7 0.0 0.3 1.1 1.1 0.9 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.2 1.2 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 2.4 0.0 3.5 2.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.9 1.1 0.9 2.6 2.1 1.7 0.4 1.5 1.6 1.0 0.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PNMA3 "MA3, MA5, MGC132756, MGC132758" ENSG00000183837 "PNMA family member 3" Q9UL41 X 153056409-153060467 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 37.6" "Group enriched" "Detected in some" 4 "Excitatory neurons: 42.1;Inhibitory neurons: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.2;SCLC-21H: 1.0" "Low region specificity" "Detected in all" HPA047920 Approved NA NA "HPA047920: AB_2680210" "unprognostic (1.66e-2)" "unprognostic (8.97e-3)" "unprognostic (8.70e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (9.43e-2)" "unprognostic (3.10e-3)" "unprognostic (1.16e-1)" "unprognostic (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (6.20e-2)" "unprognostic (7.62e-4)" "unprognostic (1.93e-1)" "unprognostic (5.92e-3)" "unprognostic (2.93e-3)" "unprognostic (7.25e-2)" "unprognostic (7.84e-2)" "unprognostic (2.07e-2)" 0.2 1.3 3.7 0.8 5.0 0.3 0.2 1.5 9.3 0.3 0.4 0.3 0.2 0.3 37.6 0.3 1.6 0.2 1.5 4.8 5.9 1.5 0.4 0.4 1.5 5.5 3.8 4.7 0.5 0.4 0.6 9.4 0.1 5.9 0.5 0.1 2.1 0.3 0.4 0.1 0.4 2.2 0.1 1.7 2.5 0.4 9.0 5.2 0.5 1.2 0.2 1.3 0.2 0.3 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.0 1.5 9.3 4.8 5.9 5.5 3.8 4.7 5.9 1.7 5.2 6.5 0.1 0.0 0.0 9.4 0.3 0.3 0.0 0.0 0.0 7.5 0.2 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.3 0.2 0.0 0.0 42.1 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.4 0.0 0.1 6.7 38.6 0.0 0.0 0.9 0.3 1.4 1.2 0.4 0.0 3.7 0.1 3.4 1.0 9.5 2.7 0.0 0.0 0.4 0.2 0.2 0.0 3.8 0.0 2.9 0.0 0.0 0.3 0.1 2.1 0.0 0.0 0.0 1.0 0.7 0.0 0.1 GPR39 ENSG00000183840 "G protein-coupled receptor 39" O43194 2 132416805-132646582 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 6.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Astrocytes: 12.1;Early spermatids: 20.6;Late spermatids: 19.4;Oligodendrocyte precursor cells: 18.6;Spermatocytes: 32.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "A-431: 32.0;CAPAN-2: 26.9;hTEC/SVTERT24-B: 30.8;RT4: 27.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA022111 Approved NA NA "HPA022111: AB_1849298" "unprognostic (4.06e-2)" "unprognostic (2.49e-1)" "unprognostic (2.23e-1)" "unprognostic (1.50e-2)" "unprognostic (5.19e-2)" "unprognostic (1.85e-1)" "unprognostic (8.54e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.28e-1)" "unprognostic (1.64e-1)" "unprognostic (3.72e-1)" "unprognostic (4.69e-2)" "unprognostic (1.25e-1)" "unprognostic (6.58e-3)" 0.1 0.0 1.6 0.9 0.6 0.0 2.1 0.7 0.6 4.4 1.0 6.8 4.7 0.4 0.8 0.9 3.6 2.2 0.0 0.4 0.8 2.7 3.3 4.0 0.0 1.2 1.4 0.3 0.0 3.9 5.1 0.1 0.1 1.9 0.5 5.7 0.0 0.5 1.0 0.0 1.0 3.7 0.3 1.4 0.0 6.1 0.2 0.4 0.0 1.3 0.0 0.2 2.6 0.6 0.4 32.0 18.1 0.3 0.0 0.5 3.6 0.0 2.8 11.1 5.8 3.3 17.7 26.9 0.0 9.7 1.9 13.1 18.6 0.0 12.9 5.7 0.1 0.0 0.0 1.9 0.7 0.6 0.0 0.0 1.1 9.7 30.8 3.1 7.0 0.1 0.0 0.0 0.0 4.2 3.0 0.0 0.0 0.3 7.3 10.5 0.0 0.5 0.0 21.2 27.9 0.0 0.1 2.0 10.3 0.1 1.1 5.8 0.0 5.6 12.4 12.2 4.2 16.8 0.0 0.0 0.1 18.9 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.6 0.7 0.6 0.4 0.8 1.2 1.4 0.3 1.9 1.4 0.4 0.4 0.0 16.0 8.7 12.1 0.0 0.1 0.7 2.4 0.0 0.2 1.5 0.9 0.2 2.8 6.7 0.0 0.0 0.0 2.7 10.3 0.0 5.6 20.6 2.6 0.2 0.1 2.4 0.0 3.9 3.1 0.0 0.2 4.1 1.8 0.0 0.0 0.0 3.6 0.0 0.0 4.9 1.6 0.0 0.6 0.3 19.4 0.3 0.3 0.0 1.0 0.6 1.4 0.0 18.6 1.8 5.9 3.0 0.4 0.1 0.3 1.9 0.7 6.1 0.0 0.0 0.1 0.3 32.4 1.2 0.5 0.0 0.0 0.0 0.0 4.9 1.2 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "FAM3 metabolism regulating signaling molecule B" P58499 21 41304212-41357727 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 143.9;pancreas: 214.0;salivary gland: 120.5;stomach 1: 115.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 304.6;Exocrine glandular cells: 399.9;Proximal enterocytes: 831.6" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 1.4;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "CACO-2: 19.5;CAPAN-2: 11.7;Hep G2: 32.1;OE19: 27.3;RPMI-8226: 80.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777, CAB034131" Enhanced Approved Vesicles "Secreted to blood" NA NA 2080000 250000 Vesicles "CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194" "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 1.1 0.1 0.1 2.5 0.1 0.8 17.9 0.1 0.3 3.8 1.1 6.0 143.9 0.3 22.3 56.7 17.4 16.4 0.4 0.1 0.3 18.0 2.6 9.4 1.5 0.1 0.1 0.1 0.2 214.0 0.5 5.5 15.3 0.2 38.2 0.1 0.0 120.5 8.8 0.1 2.0 136.1 0.5 0.1 0.6 115.9 7.0 0.1 3.1 8.0 0.0 17.0 34.7 16.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.5 11.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.9 27.3 0.0 0.2 0.0 80.6 0.0 5.8 0.4 0.4 0.0 0.7 0.4 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.3 1.4 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.3 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.3 1.0 22.4 25.7 0.0 0.8 1.3 17.0 2.9 1.2 0.0 101.3 123.1 0.2 102.9 36.5 66.2 0.0 304.6 1.4 2.7 25.4 172.1 25.2 0.2 0.1 2.5 0.0 0.0 0.1 399.9 11.1 3.4 147.3 0.7 1.3 0.6 0.4 0.3 27.0 0.0 0.1 120.9 42.7 5.0 15.8 11.5 0.6 3.9 5.4 1.9 2.1 0.0 0.0 0.0 0.1 144.6 169.0 0.4 0.2 64.9 831.6 0.7 22.4 0.0 0.0 0.4 1.8 28.0 8.1 29.1 1.3 161.3 0.9 0.0 125.2 130.5 ZNF730 ENSG00000183850 "Zinc finger protein 730" Q6ZMV8 19 23075210-23147221 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 4.5;testis: 5.1" "Cell type enhanced" "Detected in some" "Astrocytes: 9.1;Early spermatids: 29.8;Granulosa cells: 7.3;Late spermatids: 20.1;Oligodendrocyte precursor cells: 12.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 23.3;REH: 21.3;U-698: 19.4" NA NA "unprognostic (6.75e-3)" "unprognostic (2.49e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-3)" "unprognostic (3.33e-2)" "unprognostic (1.78e-2)" "unprognostic (4.24e-4)" "unprognostic (9.34e-2)" "unprognostic (1.01e-1)" "unprognostic (4.92e-2)" "unprognostic (3.10e-2)" "unprognostic (5.98e-2)" "unprognostic (1.37e-3)" "unprognostic (5.53e-2)" "unprognostic (1.90e-1)" "unprognostic (6.67e-2)" "unprognostic (1.43e-2)" 0.2 0.2 2.4 0.3 1.2 1.6 1.1 1.5 1.4 0.6 0.0 0.4 0.1 1.2 1.4 0.6 1.0 0.8 0.4 0.7 3.2 0.2 0.2 0.6 1.8 3.4 3.8 0.3 2.6 0.4 0.7 0.1 1.8 4.5 1.7 0.8 0.9 0.2 0.4 0.3 0.4 0.0 1.0 1.6 0.4 0.2 5.1 3.9 2.6 1.1 0.2 2.0 0.4 0.2 3.0 0.0 0.0 17.1 12.3 0.7 1.3 3.7 5.2 0.1 10.3 17.4 0.0 0.0 0.0 6.3 3.2 5.0 0.0 1.8 0.6 15.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 2.3 2.0 0.0 4.7 1.5 1.1 0.0 13.7 6.3 0.0 9.4 2.4 16.2 5.0 23.3 0.0 2.9 21.3 10.3 1.1 1.4 11.6 0.0 9.8 0.1 0.0 0.0 11.8 8.1 5.6 0.2 0.1 0.9 3.5 5.2 0.0 4.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 1.2 1.5 1.4 0.7 3.2 3.4 3.8 0.3 4.5 1.6 3.9 3.0 0.3 0.0 1.8 9.1 0.4 0.0 0.4 0.0 0.0 3.6 0.3 0.3 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.3 29.8 0.7 1.3 0.9 0.0 3.8 0.6 0.2 1.8 1.3 0.0 0.4 0.0 7.3 0.0 0.0 0.2 0.0 2.9 0.3 0.0 0.0 0.0 20.1 0.0 0.2 0.0 2.8 0.7 0.2 0.0 12.1 2.5 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 1.3 3.2 3.2 0.3 0.0 1.4 0.3 5.2 0.2 0.2 KIRREL1 "KIRREL, NEPH1" ENSG00000183853 "Kirre like nephrin family adhesion molecule 1" Q96J84 1 157993273-158100262 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 6.2;Alveolar cells type 1: 19.2;Breast myoepithelial cells: 6.9;Endometrial stromal cells: 19.4;Fibroblasts: 7.2;Smooth muscle cells: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 169.8;WM-115: 262.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030458 Approved NA NA 890000 "HPA030458: AB_10601438" "unprognostic (8.92e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.76e-1)" "unprognostic (1.07e-3)" "unprognostic (7.96e-3)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.12e-8)" "unprognostic (2.11e-3)" "unprognostic (5.24e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.85e-4)" 22.9 13.5 3.3 12.0 2.6 0.1 18.1 3.9 3.2 16.1 9.2 13.7 3.8 22.4 5.0 7.9 17.5 21.4 9.6 1.7 6.3 15.1 2.8 17.0 4.4 3.1 3.9 2.1 22.9 4.3 3.2 4.8 27.8 2.6 10.0 8.2 6.0 8.3 16.9 3.8 7.2 8.7 25.3 2.8 8.7 7.7 3.0 3.4 4.6 10.7 5.9 3.7 14.3 10.7 2.7 24.7 31.4 67.2 56.2 100.6 82.4 0.0 65.1 87.7 50.9 42.2 59.3 49.0 0.0 101.0 75.8 36.2 45.5 38.9 56.8 47.9 0.2 7.6 0.1 34.8 0.0 70.6 0.0 0.6 104.2 25.0 84.4 74.9 71.9 33.5 15.4 0.5 0.3 54.1 0.1 9.1 0.1 49.2 0.0 26.4 9.2 30.5 0.4 169.8 0.9 9.6 0.7 55.3 0.2 114.6 75.3 4.4 1.3 59.9 64.5 40.5 64.5 86.5 0.1 0.3 0.3 56.1 0.2 262.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.6 3.9 3.2 1.7 6.3 3.1 3.9 2.1 2.6 2.8 3.4 2.7 6.2 19.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 6.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.9 4.7 0.0 1.7 19.4 2.4 0.0 0.0 0.0 0.4 0.2 7.2 0.0 3.6 0.0 4.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.4 0.1 5.0 0.0 0.0 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavorable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 0.7 0.7 0.2 2.2 0.4 15.7 0.6 0.0 0.6 0.7 0.1 4.2 6.7 0.5 1.1 5.3 0.2 0.7 0.4 0.5 0.3 0.6 0.6 1.6 1.6 0.8 0.3 0.1 0.1 0.2 0.1 0.1 2.9 0.8 0.4 5.0 0.0 1.0 0.1 0.3 3.7 5.8 2.9 0.1 0.8 4.6 3.8 0.4 3.4 0.2 0.0 2.2 0.9 2.1 1.5 59.2 28.4 25.6 18.1 1.6 4.0 12.4 43.1 28.3 41.0 36.6 32.4 52.5 5.2 15.6 25.2 21.6 54.6 17.5 22.1 36.3 0.1 15.7 7.8 62.6 16.1 0.2 9.7 0.1 1.2 2.5 34.3 50.0 10.0 24.1 12.5 16.1 8.1 30.2 31.2 5.7 13.7 18.6 57.7 28.0 18.9 28.8 6.1 10.4 20.3 16.3 25.2 38.7 44.9 14.9 29.8 35.8 25.6 16.8 36.8 43.7 30.4 51.4 4.0 2.1 2.4 12.4 15.1 42.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.4 0.0 0.6 0.5 0.3 0.8 0.3 0.1 0.8 0.1 0.4 1.5 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.4 0.6 0.0 1.4 1.3 1.0 2.8 0.1 0.0 0.0 2.2 0.1 3.9 0.0 0.3 6.5 0.5 0.7 0.6 1.2 6.5 0.7 0.0 3.6 0.9 11.2 1.4 0.0 4.4 2.5 0.4 3.9 0.0 0.2 3.7 0.0 1.3 6.1 26.6 0.3 1.9 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.5 0.4 0.8 0.4 0.0 0.0 0.0 0.0 1.4 6.4 2.6 3.6 1.0 0.8 0.2 0.3 7.4 0.4 CNGA2 "CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA" ENSG00000183862 "Cyclic nucleotide gated channel subunit alpha 2" Q16280 X 151738451-151745304 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Calmodulin-binding, Ion channel, Ligand-gated ion channel" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA015065 Uncertain NA NA "HPA015065: AB_1847034" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TOB2 "APRO5, bK223H9, TOB4, TOBL, TROB2" ENSG00000183864 "Transducer of ERBB2, 2" Q14106 22 41433494-41446801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016603, HPA054112" Approved Approved Cytosol NA Yes Cytosol "HPA016603: AB_2669400, HPA054112: AB_2682385" "unprognostic (1.21e-3)" "unprognostic (3.10e-2)" "unprognostic (3.41e-1)" "prognostic favorable (3.08e-5)" "unprognostic (3.89e-2)" "unprognostic (1.38e-1)" "unprognostic (1.36e-1)" "unprognostic (5.36e-2)" "unprognostic (4.94e-2)" "unprognostic (5.74e-2)" "unprognostic (3.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.18e-6)" "unprognostic (1.50e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-1)" "unprognostic (7.13e-2)" 46.5 31.6 36.3 15.7 51.3 9.8 25.7 71.3 37.0 26.3 17.5 28.8 22.6 25.2 12.0 26.9 38.7 29.0 35.7 37.8 49.2 24.8 27.3 20.9 18.7 62.8 40.3 25.0 38.3 29.3 35.9 22.9 22.2 49.2 26.9 15.7 55.5 17.4 19.6 87.2 26.5 24.1 20.3 38.0 20.8 30.8 13.7 42.1 19.7 36.4 68.7 19.9 23.6 21.2 71.3 36.8 16.6 28.5 19.4 65.4 45.5 27.5 23.9 36.7 29.8 26.2 21.9 17.0 22.4 23.5 34.8 11.6 31.4 26.7 13.4 27.1 23.0 34.2 12.3 23.9 33.4 44.8 33.5 15.9 42.1 22.5 35.6 15.4 30.1 30.2 7.6 18.9 24.5 24.6 40.8 13.9 19.2 24.4 48.1 17.6 29.7 19.2 19.4 21.3 25.3 13.1 8.8 60.0 32.2 44.6 17.7 17.9 16.5 37.9 29.3 27.1 23.0 22.7 22.9 10.7 12.2 17.8 14.2 19.7 3.9 5.9 4.1 7.5 8.0 7.1 10.0 6.2 6.3 5.3 7.5 3.2 4.7 3.8 3.8 8.4 8.0 5.5 6.1 36.3 51.3 71.3 37.0 37.8 49.2 62.8 40.3 25.0 49.2 38.0 42.1 71.3 48.5 48.1 59.6 48.6 61.4 126.8 66.6 24.3 105.3 56.0 83.1 56.9 59.8 58.6 31.7 47.8 64.6 34.7 56.9 76.9 23.5 29.7 41.1 88.6 59.3 45.3 54.3 16.8 12.2 19.1 37.3 54.1 42.3 116.9 34.1 13.7 52.5 29.7 19.6 25.2 15.1 67.7 10.2 22.0 117.9 61.6 66.8 51.4 53.4 14.0 34.6 58.3 18.6 10.1 43.6 32.3 60.0 82.0 26.2 73.6 103.6 29.2 45.9 105.2 52.6 97.4 60.9 23.8 28.9 88.7 136.7 63.3 57.4 19.6 61.9 92.2 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649687 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "heart muscle: 42.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 77.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 27.6;RH-30: 22.8" "Group enriched" "Detected in many" 5 "amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0" "Region enhanced" "Detected in many" "basal ganglia: 5.4" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.2 0.1 1.9 0.1 1.2 0.2 0.2 0.0 0.6 1.7 0.0 0.2 0.2 0.7 0.0 0.1 0.3 0.1 42.3 0.2 1.2 0.0 0.0 0.1 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.4 0.2 0.2 0.3 0.1 2.0 0.2 0.5 1.7 0.1 0.2 0.3 0.1 0.1 0.1 0.3 1.8 0.0 0.2 1.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.4 0.1 0.0 0.2 3.6 0.0 0.0 0.0 1.0 0.5 2.7 0.0 0.4 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 0.0 2.1 2.8 0.4 0.0 0.0 27.6 1.4 0.0 0.0 2.6 0.0 0.0 0.0 22.8 0.0 0.0 3.2 0.4 3.1 0.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.6 0.2 1.2 0.4 0.2 0.2 0.2 0.1 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 2.7 0.0 0.3 77.1 0.0 0.1 0.0 14.6 0.2 0.0 0.0 0.0 0.1 1.2 0.1 3.2 2.8 0.0 0.0 0.5 0.0 0.3 3.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 6.3 0.3 0.6 0.2 0.0 3.7 0.0 0.6 0.0 1.5 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.9 0.0 7.3 3.1 0.2 1.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 ARSI "FLJ16069, SPG66" ENSG00000183876 "Arylsulfatase family member I" Q5FYB1 5 150296343-150339307 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA038386, HPA038398" Uncertain Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA038386: AB_10669781, HPA038398: AB_2675995" "unprognostic (6.08e-2)" "unprognostic (1.70e-2)" "unprognostic (9.41e-3)" "unprognostic (4.77e-3)" "unprognostic (1.54e-3)" "unprognostic (2.83e-3)" "unprognostic (2.76e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.06e-1)" "unprognostic (5.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.26e-1)" "unprognostic (3.39e-7)" "unprognostic (7.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.19e-4)" 1.0 0.3 1.5 2.3 2.2 0.6 0.4 2.1 2.0 2.3 0.6 1.3 0.6 3.2 0.6 1.9 2.1 1.1 1.0 1.2 1.7 0.7 0.4 4.5 0.3 4.0 2.2 0.9 0.4 0.4 0.6 1.0 2.8 3.7 1.7 0.4 0.4 0.5 0.8 0.8 4.9 0.7 2.8 2.9 0.8 0.9 0.4 2.2 0.3 0.2 0.5 0.4 3.8 2.7 5.3 1.0 3.8 1.1 0.0 0.0 0.8 0.0 8.1 12.1 15.7 11.5 1.1 1.8 0.0 3.1 11.5 1.3 31.4 0.2 5.3 5.6 0.0 0.1 0.0 0.4 19.9 1.5 0.0 0.0 0.8 3.4 30.9 0.9 10.7 0.2 0.0 0.0 0.2 2.5 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.2 0.0 6.7 0.9 1.3 11.2 0.0 0.0 0.0 0.3 10.2 0.3 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 2.1 2.0 1.2 1.7 4.0 2.2 0.9 3.7 2.9 2.2 5.3 0.1 0.0 0.0 0.3 0.0 12.1 0.0 2.4 0.0 0.1 0.1 0.4 1.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 1.1 10.8 0.0 0.0 4.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.1 0.0 0.8 0.2 0.6 0.0 21.4 0.0 0.0 3.9 0.0 0.0 2.5 0.4 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.3 0.0 1.8 6.6 0.1 0.9 0.9 4.7 1.4 1.1 0.0 0.0 0.0 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "white matter: 34.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2" "Low region specificity" "Detected in all" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 3.6 3.5 4.3 2.4 4.3 6.9 3.5 0.0 10.3 0.0 0.0 2.9 2.6 0.0 9.5 4.1 0.0 3.6 2.7 5.6 0.0 3.1 4.2 4.2 2.1 5.7 0.0 0.0 0.0 3.5 2.9 4.0 3.5 6.0 8.1 6.2 4.6 4.3 6.3 5.8 5.0 6.3 0.0 0.0 3.5 2.9 3.8 11.3 0.0 3.8 5.2 6.0 3.7 0.0 34.4 0.0 2.5 0.0 0.0 0.0 0.0 8.7 4.5 7.7 5.0 7.5 0.0 0.0 12.4 0.0 5.1 0.0 0.0 0.0 0.0 6.9 6.9 0.0 20.6 0.0 0.0 6.4 0.0 0.0 7.8 7.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 5.5 0.0 7.1 0.1 0.0 0.0 0.0 0.0 3.1 5.6 5.4 8.3 4.9 0.0 0.0 0.0 14.9 8.5 0.0 4.4 5.9 8.7 0.0 0.0 3.1 13.5 16.4 20.2 0.8 0.0 0.0 1.8 1.7 3.8 2.6 1.9 3.7 2.9 2.6 2.1 1.8 3.2 3.6 2.7 3.9 5.8 2.2 2.9 3.2 1.1 4.3 4.3 0.0 10.3 5.6 0.0 5.7 0.0 0.0 6.0 0.0 11.3 34.4 0.0 16.0 25.3 58.4 35.4 11.3 18.4 8.2 44.3 35.2 0.0 0.0 6.1 5.7 10.7 18.4 64.6 10.0 8.0 3.0 0.0 4.8 0.4 0.0 0.0 9.0 1.8 19.6 66.7 0.0 3.7 9.3 37.8 0.0 16.4 0.0 12.5 2.1 3.0 37.0 65.2 3.3 2.0 14.2 14.5 2.0 10.8 12.7 8.8 54.4 18.1 12.8 25.7 57.8 65.8 1.5 2.2 11.7 23.2 14.0 2.9 2.6 10.7 37.4 0.0 4.7 5.0 4.0 6.8 33.2 15.3 13.3 25.1 0.0 2.9 21.3 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.4;breast: 5.2;choroid plexus: 5.5" "Group enriched" "Detected in some" 4 "Breast glandular cells: 25.0;Distal tubular cells: 90.1" "Group enriched" "Detected in some" 4 "breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 13 "Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.1 0.2 10.3 0.2 8.2 0.7 5.2 7.9 11.4 2.3 5.5 0.1 0.2 1.2 0.1 0.2 0.1 0.2 0.5 7.8 8.2 1.5 0.1 0.1 0.3 8.8 8.5 6.5 0.2 0.2 0.0 0.0 0.1 8.9 0.7 0.0 0.8 3.1 0.0 0.2 0.6 0.1 0.0 7.5 0.2 0.3 0.2 9.5 0.0 1.2 0.0 0.0 0.1 0.0 9.5 0.3 0.1 0.3 0.4 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.6 7.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.6 0.5 0.0 0.4 0.3 0.3 0.1 0.1 0.2 0.2 0.3 0.2 0.0 0.1 0.4 0.6 0.3 13.6 0.2 0.4 4.3 0.4 0.2 0.4 0.3 0.3 0.1 0.2 0.5 0.2 0.2 0.2 0.6 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.2 1.8 0.3 0.1 0.1 0.0 0.0 10.3 8.2 7.9 11.4 7.8 8.2 8.8 8.5 6.5 8.9 7.5 9.5 9.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.1 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC138969.1 ENSG00000183889 "Novel member of the nuclear pore complex interacting protein NPIP gene family" 16 16317444-16350590 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.6;Club cells: 4.3;granulocytes: 8.8;Respiratory ciliated cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HMC-1: 234.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.91e-1)" "unprognostic (3.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (8.96e-2)" "unprognostic (2.31e-2)" "unprognostic (3.69e-3)" "unprognostic (1.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.45e-7)" "unprognostic (1.22e-2)" "unprognostic (5.04e-6)" "unprognostic (6.04e-2)" "unprognostic (9.80e-2)" "unprognostic (1.79e-1)" "unprognostic (2.22e-3)" 96.1 92.5 198.3 21.1 200.1 43.8 94.0 243.6 295.0 112.4 173.3 129.1 18.9 109.2 87.9 89.6 131.5 52.9 97.3 201.3 182.1 76.6 100.7 90.2 35.5 204.7 193.7 192.0 172.9 118.4 42.2 233.8 21.7 212.5 123.2 56.4 64.3 69.6 44.4 122.5 110.3 88.0 63.6 172.9 97.5 93.3 117.8 191.2 37.5 106.3 50.1 42.2 117.6 104.1 201.7 30.3 20.9 57.7 54.3 80.8 75.8 40.6 61.1 30.1 31.8 41.7 14.6 18.0 24.5 55.3 67.3 25.5 53.1 36.9 25.4 47.7 9.9 34.8 58.3 167.0 99.7 83.0 37.1 234.1 70.8 158.4 49.6 82.6 61.3 20.7 45.3 21.6 81.4 47.0 50.8 59.2 135.2 26.7 27.9 14.5 69.9 23.8 25.0 50.5 100.5 36.0 36.7 29.8 44.2 107.5 41.6 47.2 108.9 14.1 49.0 29.3 30.3 23.2 36.7 73.4 49.3 28.2 39.2 25.8 0.0 0.2 0.1 0.7 0.0 0.2 1.3 0.6 0.7 0.0 0.3 0.4 0.1 0.0 0.0 0.2 0.2 0.4 0.2 198.3 200.1 243.6 295.0 201.3 182.1 204.7 193.7 192.0 212.5 172.9 191.2 201.7 0.4 3.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 4.3 0.0 0.0 0.8 0.4 0.0 0.0 1.0 0.0 0.9 1.3 1.6 0.0 0.0 0.0 1.3 0.6 1.3 0.0 0.7 8.8 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 TTC32 ENSG00000183891 "Tetratricopeptide repeat domain 32" Q5I0X7 2 19896631-19901983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036024 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036024: AB_10673493" "unprognostic (2.77e-3)" "unprognostic (5.44e-2)" "unprognostic (8.85e-2)" "unprognostic (8.80e-3)" "unprognostic (1.08e-1)" "unprognostic (2.62e-1)" "unprognostic (5.25e-2)" "prognostic favorable (9.44e-4)" "unprognostic (4.46e-2)" "unprognostic (1.48e-2)" "unprognostic (4.92e-3)" "unprognostic (6.22e-2)" "prognostic unfavorable (5.45e-6)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-2)" "unprognostic (2.27e-2)" 9.7 8.9 11.1 12.4 12.8 35.0 16.8 16.0 15.4 12.2 11.0 10.5 12.4 14.0 26.2 7.5 12.0 6.8 7.2 11.2 12.2 8.7 12.4 10.0 15.6 12.5 12.5 11.2 16.6 8.7 8.3 11.3 8.6 13.7 16.2 10.3 33.2 11.2 9.4 22.7 13.8 13.2 8.0 12.0 15.7 11.5 12.6 12.1 19.9 12.5 7.8 10.2 11.4 11.3 16.6 22.5 14.4 12.8 9.6 5.6 12.3 2.7 4.8 8.0 7.7 5.0 7.3 25.6 14.5 2.7 5.1 9.6 14.6 5.6 15.4 4.9 21.3 23.3 14.8 20.4 12.8 12.1 14.2 25.5 11.7 9.6 8.6 20.4 6.5 7.5 23.3 27.1 28.5 6.4 6.8 10.7 21.7 9.6 8.4 24.1 12.6 8.5 24.1 21.6 8.6 20.6 19.1 16.1 8.5 18.2 14.1 11.9 5.5 5.6 11.6 12.4 11.5 6.6 29.8 27.3 24.0 17.9 13.9 6.7 9.2 7.6 23.1 7.3 5.7 8.7 12.2 11.6 7.8 7.2 11.9 15.8 12.2 28.0 6.7 6.9 5.0 15.6 4.9 11.1 12.8 16.0 15.4 11.2 12.2 12.5 12.5 11.2 13.7 12.0 12.1 16.6 23.2 9.6 14.4 8.5 24.7 18.9 33.4 36.0 34.7 66.9 27.4 39.0 15.8 15.7 26.4 12.9 14.6 14.6 13.7 10.0 45.0 12.2 27.2 25.8 6.1 16.2 28.3 34.0 7.1 24.8 8.7 19.6 14.8 13.2 8.8 7.2 7.5 24.1 9.1 42.1 8.6 19.9 32.6 8.8 8.9 7.2 19.9 17.4 7.2 5.6 14.6 67.8 11.3 9.5 22.0 14.6 12.9 9.8 12.3 15.8 13.7 28.5 48.7 39.2 13.1 21.1 21.3 113.2 38.7 22.4 26.1 9.6 21.6 9.0 11.7 26.7 LRRC55 FLJ45686 ENSG00000183908 "Leucine rich repeat containing 55" Q6ZSA7 11 57181747-57191717 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 16.2" "Cell type enhanced" "Detected in some" "Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2" "Group enriched" "Detected in some" 9 "glioma: 9.0;ovarian cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 19.4" "Region enhanced" "Detected in all" "olfactory bulb: 105.4" "Low region specificity" "Detected in all" HPA014053 Uncertain NA NA "HPA014053: AB_2137630" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (3.68e-2)" "unprognostic (3.03e-2)" "unprognostic (2.78e-3)" "unprognostic (2.29e-3)" "unprognostic (2.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (9.43e-2)" "unprognostic (2.11e-2)" "unprognostic (3.32e-2)" "unprognostic (7.17e-4)" "unprognostic (6.66e-2)" "unprognostic (3.59e-1)" "unprognostic (3.79e-2)" 0.4 0.5 4.5 1.0 2.8 0.0 0.1 1.4 3.3 0.1 0.0 0.5 0.3 1.8 0.0 0.0 0.3 0.2 0.3 4.3 5.3 0.3 1.2 0.2 2.1 16.2 11.7 2.3 0.0 0.2 0.0 0.0 0.9 4.3 0.0 0.5 0.1 0.6 0.0 0.3 0.1 0.5 1.0 5.7 1.3 0.1 0.2 4.7 0.9 0.1 0.3 0.5 0.0 0.0 7.4 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 2.8 1.4 3.3 4.3 5.3 16.2 11.7 2.3 4.3 5.7 4.7 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAH2 "DNHD3, FLJ46675, KIAA1503" ENSG00000183914 "Dynein axonemal heavy chain 2" Q9P225 17 7717354-7833744 "Predicted intracellular proteins, Predicted membrane proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 13.2;parathyroid gland: 10.6;retina: 21.3" "Group enriched" "Detected in many" 4 "Respiratory ciliated cells: 43.0;Rod photoreceptor cells: 123.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.6;CACO-2: 4.0;CAPAN-2: 2.4;OE19: 1.8;SCLC-21H: 2.3;SiHa: 2.3" "Low region specificity" "Detected in some" HPA067103 Enhanced Approved Microtubules NA NA Microtubules "HPA067103: AB_2685778" "unprognostic (2.03e-2)" "unprognostic (1.79e-2)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-1)" "unprognostic (7.50e-3)" "unprognostic (1.29e-2)" "unprognostic (8.28e-2)" "unprognostic (2.51e-3)" "unprognostic (1.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (8.74e-3)" "unprognostic (4.60e-2)" 0.3 0.1 5.7 0.1 2.2 0.5 0.5 1.5 1.7 0.7 5.9 0.2 0.2 0.5 1.6 0.1 13.2 0.4 0.1 1.8 2.5 0.1 0.4 1.9 0.1 4.7 5.4 1.2 2.5 0.5 10.6 0.4 1.7 2.9 0.3 0.2 21.3 0.1 0.0 0.1 0.2 0.1 0.2 4.6 0.2 0.2 6.6 2.1 0.3 0.3 0.0 0.1 0.2 0.1 1.7 2.6 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 4.0 2.4 0.1 1.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.3 0.1 0.6 0.1 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.5 0.1 0.2 0.2 1.8 0.8 0.1 0.2 0.0 0.0 0.7 2.3 0.1 2.3 0.0 1.2 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.0 5.7 2.2 1.5 1.7 1.8 2.5 4.7 5.4 1.2 2.9 4.6 2.1 1.7 1.1 0.0 1.1 1.3 0.7 0.3 1.0 1.7 0.0 2.7 0.6 1.0 1.9 0.0 3.6 0.0 2.1 0.0 0.0 0.0 0.0 0.4 6.2 20.2 0.6 1.2 6.7 0.0 6.1 0.0 0.0 0.8 0.0 0.8 0.0 2.3 0.4 0.1 0.1 1.7 4.9 0.5 8.2 0.3 0.7 2.3 0.3 0.2 0.0 1.0 0.0 4.6 0.0 3.0 2.1 0.1 1.1 0.0 0.0 0.7 0.0 0.4 43.0 123.9 0.0 1.0 1.0 9.6 2.6 0.0 0.1 0.0 0.2 0.5 0.2 0.9 SH2D1A "DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD" ENSG00000183918 "SH2 domain containing 1A" O60880 X 124227868-124373197 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "lymphoid tissue: 264.9" "Group enriched" "Detected in some" 7 "dendritic cells: 77.6;NK-cells: 138.0;T-cells: 108.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 54 "gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3" "Group enriched" "Detected in many" 70 "NK-cells: 162.2;T-cells: 175.8" "Group enriched" "Detected in some" 6 "HDLM-2: 101.1;JURKAT: 193.0;Karpas-707: 201.3;MOLT-4: 257.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA072265 Approved Cytosol NA NA Cytosol "HPA072265: " "prognostic favorable (2.03e-4)" "unprognostic (1.18e-3)" "unprognostic (4.35e-3)" "unprognostic (9.66e-5)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (9.25e-3)" "unprognostic (3.34e-2)" "unprognostic (1.88e-2)" "unprognostic (2.80e-3)" "unprognostic (9.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.94e-6)" "unprognostic (1.27e-1)" "unprognostic (9.00e-2)" "unprognostic (2.36e-1)" "unprognostic (3.14e-3)" 1.0 1.1 0.1 10.9 0.2 5.4 1.2 0.2 0.2 0.9 0.2 1.6 1.5 0.7 0.6 1.1 0.5 4.1 0.3 0.1 0.2 0.4 2.8 3.2 38.7 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.3 0.2 1.1 1.5 0.0 1.3 0.3 0.3 0.4 2.5 0.6 0.2 14.8 2.7 0.2 0.2 264.9 0.7 1.2 16.7 5.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 101.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 193.0 0.0 201.3 0.0 0.0 257.2 4.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 32.7 33.3 0.0 0.2 0.0 0.0 1.4 0.6 0.1 120.2 0.5 162.9 1.1 90.4 175.8 0.5 0.2 91.2 108.3 2.4 162.2 1.2 0.8 125.3 91.3 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 1.1 3.2 4.7 0.0 3.0 1.5 0.1 0.0 0.0 0.0 0.7 0.8 0.2 1.5 0.0 0.0 0.0 0.1 77.6 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 7.4 0.1 0.0 0.0 2.0 1.1 0.2 3.8 0.0 3.6 0.9 0.1 0.0 0.0 0.0 0.0 5.6 4.4 0.0 0.0 4.3 5.4 0.0 2.3 0.0 138.0 0.5 0.2 0.0 0.0 0.0 14.1 0.2 0.0 0.5 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.2 1.0 0.1 108.9 0.0 0.0 0.0 SDR42E2 ENSG00000183921 "Short chain dehydrogenase/reductase family 42E, member 2" A6NKP2 16 22165583-22191754 "Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.8;choroid plexus: 1.4;fallopian tube: 2.2;pituitary gland: 1.2;testis: 2.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 38.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 4.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.9" "Cell line enriched" "Detected in single" 6 "RPMI-8226: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.03e-3)" "unprognostic (2.80e-1)" "unprognostic (2.06e-1)" "unprognostic (1.72e-4)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (8.77e-2)" "unprognostic (3.72e-1)" "unprognostic (4.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.32e-3)" "unprognostic (2.01e-1)" "unprognostic (7.09e-2)" "unprognostic (4.76e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (6.61e-2)" 0.0 0.0 3.8 0.0 0.9 0.0 0.0 0.9 1.2 0.2 1.4 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.5 1.0 0.0 0.0 0.4 0.0 0.9 2.0 0.3 0.1 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.2 0.3 0.5 0.3 0.3 0.1 0.8 0.5 0.3 4.9 0.4 0.1 0.3 0.3 0.2 3.8 0.9 0.9 1.2 0.5 1.0 0.9 2.0 0.3 1.1 2.2 0.9 0.8 8.9 0.0 2.4 2.6 8.7 0.8 0.7 0.9 0.6 7.7 5.2 11.6 1.9 10.0 0.4 0.0 0.0 0.9 7.4 15.6 0.0 0.9 1.8 3.9 8.4 2.6 2.4 5.7 2.0 0.5 0.3 2.6 12.8 3.2 2.5 1.7 5.0 3.4 2.3 5.0 0.7 15.1 4.1 13.1 3.8 1.4 5.9 5.1 1.8 0.0 6.4 14.7 10.3 0.5 0.4 0.3 3.2 1.5 5.9 1.1 38.2 0.6 3.5 3.7 0.0 0.9 3.0 0.6 0.6 1.4 1.7 1.4 11.1 2.6 8.8 0.3 PRKX PKX1 ENSG00000183943 "Protein kinase X-linked" P51817 X 3604340-3713649 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 34.1" "Cell type enhanced" "Detected in many" "dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 11.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015324 Supported Supported Nucleoplasm No No Nucleoplasm "HPA015324: AB_1855715" "unprognostic (1.07e-1)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.63e-1)" "unprognostic (2.45e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (4.14e-1)" "unprognostic (1.68e-1)" "unprognostic (2.68e-1)" "unprognostic (2.92e-1)" "unprognostic (1.07e-3)" "unprognostic (2.15e-2)" "unprognostic (9.91e-2)" "unprognostic (2.52e-1)" "unprognostic (1.70e-2)" 5.6 1.6 9.6 9.9 12.0 7.7 8.0 13.3 8.7 7.9 12.3 6.6 5.1 4.6 9.7 14.0 19.6 4.4 3.0 8.0 12.9 10.5 1.9 9.1 12.9 16.2 14.0 6.8 4.0 4.4 3.1 2.0 5.3 15.0 3.8 6.2 1.7 6.1 6.0 2.3 12.1 6.3 3.7 14.2 12.5 4.0 6.9 13.8 15.5 34.1 3.2 10.0 4.6 12.5 17.5 9.1 8.3 22.4 16.7 4.2 5.6 20.5 5.3 2.1 2.6 3.5 12.4 6.1 0.7 5.3 4.3 5.4 6.2 21.1 16.1 4.5 10.2 14.7 10.0 6.7 0.2 4.4 13.0 74.7 3.8 16.8 2.8 10.3 7.1 25.7 12.3 11.8 12.7 8.6 8.0 15.0 11.7 15.0 7.0 9.4 27.7 21.5 17.2 20.6 7.6 14.9 9.6 5.6 3.6 5.5 35.1 2.8 10.3 14.2 2.2 3.8 3.7 3.6 0.3 0.7 11.6 1.3 11.6 5.8 11.0 2.0 1.2 2.3 2.4 2.4 1.6 2.4 2.2 1.6 1.5 1.9 2.1 0.5 2.4 3.2 1.9 1.8 1.2 9.6 12.0 13.3 8.7 8.0 12.9 16.2 14.0 6.8 15.0 14.2 13.8 17.5 32.0 3.2 9.4 7.8 35.5 21.4 22.3 9.7 21.6 1.8 14.4 9.1 1.6 30.0 10.1 5.5 0.0 30.8 108.3 8.8 13.7 10.8 11.9 164.0 23.8 19.7 4.8 7.2 1.3 3.1 5.8 10.4 6.1 179.5 85.1 11.8 13.2 2.3 16.9 1.7 20.2 13.5 24.4 19.4 24.1 49.2 19.9 29.0 5.4 39.4 53.4 2.2 139.0 11.1 7.0 5.6 13.1 21.8 38.2 29.0 10.7 6.1 18.0 0.6 32.9 46.4 12.4 1.3 21.6 34.1 26.9 7.8 63.5 10.6 23.6 20.4 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409353 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064495: AB_2685273" "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 13.6 10.2 21.5 15.4 20.6 39.5 13.2 19.8 23.1 20.2 17.8 16.7 12.9 21.5 13.0 41.0 21.9 13.7 14.8 21.2 19.5 11.8 14.1 15.6 15.5 21.3 21.6 19.4 12.1 19.8 11.5 10.7 16.7 22.5 30.4 14.5 11.8 24.2 19.8 24.7 28.2 15.7 16.8 20.0 16.9 17.0 8.0 20.9 18.1 26.0 15.5 16.7 16.7 25.9 23.4 37.3 24.3 27.8 43.5 18.1 30.9 40.1 57.4 26.3 32.0 26.9 28.8 21.9 84.9 33.1 37.5 11.7 35.8 41.6 21.7 33.3 39.3 45.0 68.8 26.4 15.2 26.5 54.8 18.8 15.1 27.1 34.7 32.8 30.2 26.2 36.4 136.8 38.1 27.5 29.9 58.1 84.9 13.8 34.6 29.0 70.4 22.1 24.1 22.8 43.4 37.9 30.9 51.3 28.3 28.6 23.6 39.6 75.3 32.4 35.2 26.0 42.3 42.3 23.0 25.9 75.9 24.6 29.6 29.9 2.3 1.2 4.3 1.3 2.1 2.7 1.7 1.6 2.1 1.0 1.1 0.9 1.1 1.8 2.3 2.1 2.0 1.5 0.3 21.5 20.6 19.8 23.1 21.2 19.5 21.3 21.6 19.4 22.5 20.0 20.9 23.4 34.5 12.8 14.5 0.0 12.7 0.0 17.6 0.0 20.5 20.8 32.0 27.3 0.0 7.2 6.8 27.6 6.2 15.1 22.4 10.4 7.9 9.2 10.1 46.8 43.8 20.7 4.9 62.1 0.0 9.4 16.6 14.7 15.8 41.1 2.5 21.3 30.4 19.5 17.7 3.3 0.0 22.2 0.0 16.8 0.0 3.2 16.1 19.6 0.0 0.0 3.4 28.7 7.2 0.0 0.0 13.6 9.6 42.9 15.9 24.1 14.3 13.1 11.7 17.9 6.6 23.2 19.7 9.7 10.2 38.8 0.0 14.2 14.5 18.4 12.7 22.5 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148510-19535642 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 10.8" "Group enriched" "Detected in some" 63 "Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 4 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.0 1.8 9.4 0.3 13.8 0.2 0.5 8.8 14.3 0.3 5.5 0.6 0.4 0.1 0.1 0.1 0.2 0.4 0.1 8.9 10.0 0.1 0.1 0.0 0.8 12.1 11.3 7.8 0.1 1.5 0.1 10.8 0.0 14.9 0.7 0.5 3.5 1.1 0.2 0.0 0.4 1.1 0.1 8.0 1.1 1.4 1.7 12.6 0.4 0.2 0.0 0.7 0.1 0.3 17.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.4 13.8 8.8 14.3 8.9 10.0 12.1 11.3 7.8 14.9 8.0 12.6 17.7 0.0 0.0 0.0 2.0 9.7 0.5 1.6 0.0 0.0 4.2 1.1 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 3.2 0.1 0.1 0.1 3.6 0.0 9.3 0.6 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 10.4 1.5 0.0 0.0 0.0 1.9 0.0 0.1 3.6 1.0 0.0 3.4 0.0 331.7 989.4 0.5 0.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 0.2 0.5 1.2 3.4 0.0 0.0 0.1 0.3 0.1 0.6 0.4 SMTN ENSG00000183963 Smoothelin P53814 22 31064105-31104757 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 606.3;urinary bladder: 454.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 200.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001721, HPA051778, HPA058590" Enhanced Supported "Nucleoplasm,Actin filaments" No Yes 140000 Nucleoplasm "Actin filaments" "CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765" "unprognostic (1.36e-2)" "unprognostic (4.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (1.08e-3)" "unprognostic (2.05e-2)" "unprognostic (4.56e-1)" "unprognostic (2.15e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (2.75e-2)" "unprognostic (1.84e-1)" "unprognostic (8.41e-3)" "unprognostic (6.34e-2)" 53.0 19.4 11.2 25.6 11.1 4.8 42.5 9.8 13.2 96.3 7.9 606.3 30.3 253.1 7.1 65.7 133.6 21.0 124.8 8.3 9.4 35.4 15.5 38.5 5.6 12.1 12.1 6.2 34.3 25.5 3.4 9.9 17.5 10.5 152.2 29.5 15.4 16.5 179.6 96.6 34.6 152.8 128.4 9.4 55.0 233.1 12.6 11.5 2.9 26.6 26.4 2.5 454.3 92.3 11.9 73.0 21.2 7.2 27.0 11.0 17.2 58.0 106.8 49.1 85.7 58.4 29.9 22.4 32.1 9.3 59.3 17.3 10.6 7.2 62.8 40.4 10.6 58.2 33.9 18.3 36.1 9.7 51.5 57.4 14.2 5.8 114.0 18.7 29.2 74.7 12.3 37.3 25.9 59.6 64.5 5.9 11.4 8.2 36.1 90.0 20.3 20.5 34.6 34.5 23.2 11.5 12.7 33.4 15.9 15.7 7.4 18.8 8.2 118.7 62.1 58.4 59.4 79.8 24.6 32.5 18.8 91.0 19.7 200.5 0.0 1.0 0.0 0.1 0.2 0.0 1.3 0.1 0.3 0.4 0.0 1.0 0.5 0.1 0.1 0.2 0.2 0.0 0.6 11.2 11.1 9.8 13.2 8.3 9.4 12.1 12.1 6.2 10.5 9.4 11.5 11.9 94.5 6.4 3.3 23.8 2.0 65.1 33.5 16.1 19.4 46.6 18.6 26.7 39.5 5.7 6.1 9.2 283.5 13.4 2.7 12.8 9.8 14.8 1.2 4.0 52.1 62.8 29.2 0.0 0.2 20.1 68.8 35.9 18.3 7.3 0.0 11.0 121.3 2.6 6.0 5.0 1.9 29.9 14.2 6.8 14.6 1.9 22.4 4.7 14.2 7.5 1.0 31.2 1.0 4.5 2.0 73.2 11.4 48.5 2.1 21.7 5.6 18.4 2.2 54.0 184.1 18.4 116.4 5.7 7.9 9.7 69.3 21.9 3.7 16.3 27.0 14.9 NPW PPL8 ENSG00000183971 "Neuropeptide W" Q8N729 16 2009926-2020755 "Predicted intracellular proteins, Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 10.6" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 188.1;Enteroendocrine cells: 158.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 6 "NB-4: 43.5;PC-3: 35.6;RPMI-8226: 74.7;SCLC-21H: 118.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.2" HPA064874 Approved "Secreted to blood" NA NA "HPA064874: AB_2685378" "unprognostic (7.54e-2)" "unprognostic (4.45e-3)" "unprognostic (3.20e-1)" "unprognostic (4.31e-3)" "unprognostic (8.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.20e-2)" "unprognostic (6.26e-3)" "unprognostic (2.37e-1)" "unprognostic (1.81e-5)" "unprognostic (6.53e-3)" "unprognostic (1.26e-1)" "unprognostic (4.41e-1)" "unprognostic (3.43e-2)" 0.3 0.1 1.3 0.4 0.5 1.3 0.1 0.5 2.7 0.8 0.8 0.5 0.6 1.1 1.3 0.4 0.6 0.0 0.1 0.8 1.4 0.4 10.6 0.1 0.2 0.9 0.8 0.4 0.4 0.4 0.0 2.7 0.1 1.4 0.3 0.1 0.0 0.2 0.2 0.0 1.6 0.2 0.2 0.7 0.7 2.4 1.2 1.7 0.0 0.2 0.0 0.4 0.2 0.6 3.4 0.4 1.7 0.2 2.5 0.4 0.0 0.7 0.9 0.2 0.5 1.0 3.8 1.5 0.4 0.1 0.8 0.6 0.8 1.1 0.3 0.5 1.8 2.9 0.1 3.0 1.7 2.3 0.4 0.1 1.0 1.3 0.9 1.9 0.1 0.0 2.5 10.8 1.7 0.1 0.9 0.4 43.5 1.9 1.5 35.6 10.5 0.0 74.7 0.4 0.0 118.8 9.9 1.3 2.2 0.3 0.6 5.6 4.4 1.7 0.3 0.6 0.5 0.1 3.6 1.1 1.1 0.6 0.9 0.4 1.2 0.7 0.7 0.2 0.4 0.6 0.4 0.1 0.0 0.7 0.4 0.2 0.1 1.5 0.6 0.2 0.4 0.4 0.2 1.3 0.5 0.5 2.7 0.8 1.4 0.9 0.8 0.4 1.4 0.7 1.7 3.4 2.5 0.0 0.0 0.0 2.9 2.0 3.2 1.9 4.0 1.5 2.7 7.1 0.3 0.0 2.0 0.0 0.0 1.2 0.1 6.0 0.0 0.5 0.9 9.9 188.1 4.4 158.5 12.2 0.4 0.2 0.9 14.0 15.8 8.5 8.9 0.5 0.7 35.9 2.3 0.0 0.7 35.8 0.0 0.3 0.3 2.1 2.1 1.6 3.6 0.0 0.1 0.0 0.0 0.0 0.1 2.1 12.4 2.2 1.5 11.9 3.2 0.8 0.3 0.3 0.0 0.5 2.7 8.8 35.4 4.1 2.3 1.6 2.3 1.6 3.9 4.6 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "bone marrow: 2.0;testis: 7.5" "Group enriched" "Detected in some" 106 "Early spermatids: 420.0;Late spermatids: 301.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.1 0.1 0.0 0.1 0.0 2.0 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.1 7.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.4 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 420.0 0.2 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 301.8 2.5 0.2 0.0 0.0 0.0 0.1 0.0 2.0 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.1 3.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 COA3 "CCDC56, COX25, HSPC009, MITRAC12" ENSG00000183978 "Cytochrome c oxidase assembly factor 3" Q9Y2R0 17 42795147-42798704 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 710.2;Proximal tubular cells: 729.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031966, HPA071122" Approved Enhanced Mitochondria NA NA 13000 Mitochondria "HPA031966: AB_10602115, HPA071122: " "unprognostic (1.20e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.65e-2)" "prognostic favorable (8.93e-4)" "unprognostic (7.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.78e-2)" "unprognostic (1.16e-2)" "unprognostic (1.48e-1)" "unprognostic (2.25e-2)" "unprognostic (8.44e-3)" "unprognostic (1.52e-1)" "prognostic favorable (6.62e-4)" "unprognostic (1.64e-1)" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" "unprognostic (3.01e-2)" 60.4 73.6 124.4 31.1 123.1 15.4 64.2 128.1 161.8 65.1 124.3 101.0 106.9 56.1 173.8 129.5 74.4 43.3 94.7 125.6 124.9 225.2 160.2 46.1 41.3 126.5 125.5 122.0 56.3 174.1 107.7 60.2 39.2 127.6 85.7 90.6 35.2 66.6 67.3 120.5 57.0 81.8 41.9 124.0 50.9 129.5 25.4 124.4 43.1 58.3 95.2 50.2 61.1 79.3 126.2 66.8 219.9 99.4 54.7 89.5 75.8 61.0 51.1 77.2 119.2 107.3 87.5 81.8 3.9 141.0 62.5 112.4 63.5 77.3 124.8 111.9 65.1 202.8 44.7 96.3 280.8 63.4 61.0 52.0 77.4 92.0 112.7 64.2 61.0 96.1 31.6 72.9 55.5 106.9 108.9 20.2 132.9 45.7 135.9 78.5 79.4 145.1 113.6 122.6 90.2 73.8 61.9 52.2 54.9 91.5 85.3 170.3 78.5 59.3 129.6 67.5 55.4 69.0 65.1 76.3 36.2 97.3 60.1 89.8 206.7 209.6 141.5 136.2 208.1 143.5 218.9 140.0 138.3 178.8 187.5 128.4 126.2 22.7 187.5 177.7 120.3 191.1 245.9 124.4 123.1 128.1 161.8 125.6 124.9 126.5 125.5 122.0 127.6 124.0 124.4 126.2 55.4 28.9 68.7 7.5 44.5 36.8 52.2 192.7 50.7 36.5 99.9 110.9 263.9 173.0 113.8 266.7 20.9 153.9 30.3 233.8 710.2 136.5 13.2 203.0 70.0 65.4 79.9 54.3 8.1 239.8 177.5 72.5 103.5 154.6 35.5 77.5 69.3 390.1 121.6 45.4 9.2 205.9 195.3 75.3 33.4 18.8 55.9 54.8 88.9 6.5 86.0 94.7 63.8 6.6 11.8 134.7 201.6 45.1 73.2 79.0 221.7 729.1 145.2 37.0 39.5 46.2 88.0 48.4 52.1 242.0 55.5 102.2 43.4 97.6 258.9 67.7 NPB "PPL7, PPNPB" ENSG00000183979 "Neuropeptide B" Q8NG41 17 81900745-81902905 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 7.0" "Group enriched" "Detected in many" 6 "Spermatogonia: 41.5;Syncytiotrophoblasts: 97.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;PC-3: 3.4;RH-30: 1.8;SH-SY5Y: 2.7;U-2 OS: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (2.44e-2)" "unprognostic (6.21e-2)" "unprognostic (2.90e-1)" "unprognostic (3.47e-3)" "unprognostic (9.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.31e-1)" "unprognostic (1.92e-1)" "unprognostic (3.55e-2)" "unprognostic (5.40e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-2)" "unprognostic (3.71e-1)" "unprognostic (4.32e-1)" 0.3 0.1 2.2 0.0 2.2 0.0 0.2 2.2 2.5 0.3 0.0 0.2 0.0 0.3 0.0 0.3 0.3 0.0 0.3 1.3 5.3 0.3 0.8 0.1 0.1 4.9 3.8 1.6 0.5 0.1 0.2 0.4 0.2 3.7 0.2 0.0 0.2 0.2 0.1 0.2 0.3 0.5 0.1 4.8 0.4 0.6 1.5 5.7 0.2 0.1 0.0 0.1 0.2 0.3 7.0 0.2 0.8 0.6 0.1 0.1 0.1 0.5 0.3 0.1 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.4 0.0 0.3 0.1 0.2 2.2 0.0 0.4 0.1 0.0 0.1 0.0 0.2 0.0 0.7 0.2 0.1 0.4 0.0 0.4 0.6 0.0 0.1 0.1 0.0 0.4 0.2 0.1 3.4 0.1 1.8 0.0 0.0 0.2 0.4 2.7 0.2 0.0 0.3 1.0 0.0 0.0 0.2 0.2 2.3 0.0 0.2 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.2 2.2 2.5 1.3 5.3 4.9 3.8 1.6 3.7 4.8 5.7 7.0 1.1 0.0 0.0 1.3 0.4 2.5 0.6 1.8 1.2 1.0 3.3 6.6 0.0 1.5 0.6 0.0 0.0 2.1 0.1 1.2 1.9 0.9 1.5 0.8 3.0 0.9 0.0 0.0 0.4 0.2 3.6 3.3 4.6 0.3 0.0 2.6 1.1 0.2 1.2 0.0 1.2 0.4 0.0 2.6 1.6 3.8 5.0 0.2 5.4 0.0 0.1 0.4 0.0 1.0 4.5 1.8 3.7 2.6 0.2 0.9 0.9 2.1 0.7 1.2 0.0 1.0 3.4 10.7 41.5 1.3 1.1 97.0 0.4 0.5 0.6 0.4 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074746-76634603 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.5" "Group enriched" "Detected in many" 4 "Microglial cells: 912.5;Oligodendrocytes: 698.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 35.8;HUVEC TERT2: 45.9;SK-MEL-30: 62.3;TIME: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054566: AB_2682526, HPA055399: AB_2682806" "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 7.4 1.4 5.9 1.9 11.8 3.1 6.4 14.0 7.8 1.9 10.1 2.1 0.7 5.9 0.5 1.9 2.7 2.5 4.4 6.5 10.9 8.8 2.1 5.3 2.1 14.5 10.1 2.6 2.3 0.9 4.5 2.1 3.2 15.2 1.1 2.4 3.9 1.1 1.6 1.6 0.7 1.4 4.5 16.8 1.4 1.5 0.3 11.6 0.9 13.5 6.6 0.7 2.6 1.7 20.5 0.2 0.0 35.8 0.0 0.6 0.0 0.0 0.0 4.2 0.6 0.4 11.9 0.1 0.6 2.4 0.3 2.3 0.1 0.0 0.4 0.3 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.6 0.0 0.0 1.1 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 2.9 0.0 1.8 1.7 0.0 0.0 0.0 2.7 8.8 0.0 0.0 62.3 8.3 0.0 0.2 20.6 0.3 2.8 0.1 3.3 0.0 0.0 0.0 0.0 8.4 5.5 0.0 6.3 2.8 0.0 2.2 0.0 2.6 0.3 0.5 2.3 3.8 1.3 1.4 3.9 0.3 4.3 0.0 0.0 1.9 5.9 11.8 14.0 7.8 6.5 10.9 14.5 10.1 2.6 15.2 16.8 11.6 20.5 59.8 3.2 1.5 174.3 5.6 0.3 0.2 0.0 0.6 3.2 0.6 1.0 1.2 0.0 0.0 3.7 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.1 4.5 23.2 0.0 0.4 107.0 0.0 0.1 2.5 3.6 0.1 0.0 0.8 66.0 0.8 1.1 0.0 101.4 0.5 0.0 9.8 0.7 0.8 0.0 3.7 5.4 912.5 3.0 12.3 1.0 23.1 698.3 0.2 3.4 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 1.1 1.3 0.2 0.7 0.1 0.4 0.1 2.0 6.9 0.3 0.1 PTP4A2 "HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2" ENSG00000184007 "Protein tyrosine phosphatase 4A2" Q12974 1 31906421-31944856 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 917.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003281, CAB011204" Uncertain NA NA 490000 "CAB011204: AB_532271, HPA003281: AB_1855903" "unprognostic (2.67e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-3)" "unprognostic (3.73e-2)" "unprognostic (2.70e-2)" "unprognostic (6.20e-2)" "prognostic unfavorable (2.62e-5)" "unprognostic (6.90e-2)" "unprognostic (4.63e-2)" "unprognostic (5.12e-2)" "unprognostic (1.99e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.10e-11)" "unprognostic (1.16e-2)" "unprognostic (3.81e-1)" "unprognostic (2.89e-1)" "prognostic favorable (2.72e-5)" 146.5 71.6 343.6 148.5 360.8 298.5 127.7 277.9 349.0 86.2 207.9 126.7 115.3 73.8 71.1 67.5 82.2 101.7 153.0 263.8 319.4 92.4 118.1 106.9 167.4 317.1 344.3 232.9 86.1 100.6 72.8 66.8 91.8 352.8 89.1 128.4 52.8 105.0 89.7 308.9 50.2 104.0 100.6 321.2 117.2 115.0 99.8 322.6 493.8 165.1 188.0 173.8 188.4 73.5 414.7 297.7 166.6 163.1 305.9 321.5 321.2 109.1 290.3 387.9 218.5 224.3 144.1 409.3 532.0 214.0 393.2 245.2 118.3 172.2 161.9 398.1 479.8 94.6 371.6 282.7 155.6 340.4 304.7 353.1 319.6 127.6 305.6 297.9 224.8 220.7 425.1 482.4 195.4 283.3 138.5 930.8 149.2 221.7 220.3 238.7 165.8 275.2 222.3 153.8 519.7 160.1 115.3 296.9 199.1 328.8 265.9 560.5 167.4 243.5 257.0 224.7 403.8 319.8 215.3 336.0 259.2 263.5 246.7 261.6 204.3 50.9 87.4 74.8 105.3 58.4 44.2 63.4 85.1 46.0 39.6 40.8 69.4 53.5 60.7 148.0 33.6 57.4 60.7 343.6 360.8 277.9 349.0 263.8 319.4 317.1 344.3 232.9 352.8 321.2 322.6 414.7 206.8 121.8 126.5 25.5 199.0 194.1 502.4 87.8 136.1 60.5 287.0 125.5 187.0 153.0 117.0 202.3 60.5 50.0 360.2 247.3 191.7 154.9 48.1 132.4 135.8 131.2 128.3 209.3 41.6 185.4 128.7 158.2 141.2 218.2 87.5 118.0 94.6 169.3 125.0 99.3 33.9 204.0 65.1 219.8 405.2 51.2 176.7 336.0 115.6 38.4 488.3 145.8 568.5 30.7 176.4 185.6 191.3 175.3 270.0 623.3 126.9 170.3 74.7 56.3 131.5 134.1 135.2 130.6 107.5 148.7 196.5 160.1 281.1 67.0 199.7 917.5 ACTG1 "ACTG, DFNA20, DFNA26" ENSG00000184009 "Actin gamma 1" P63261 17 81509413-81523847 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 9107.1;Exocrine glandular cells: 8305.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041264, HPA041271" Approved NA NA 4900000000 "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (3.95e-2)" "unprognostic (3.38e-1)" "prognostic favorable (2.41e-4)" "unprognostic (2.73e-2)" "unprognostic (1.16e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-3)" "unprognostic (2.45e-3)" "unprognostic (3.47e-2)" "unprognostic (3.06e-2)" "unprognostic (4.54e-2)" "unprognostic (9.03e-2)" "unprognostic (1.51e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-3)" 1425.0 958.2 534.8 1337.4 560.4 1140.1 1168.2 596.1 633.6 1426.6 585.9 1080.7 1003.5 1643.5 563.0 2441.6 1327.4 1190.0 573.0 575.7 704.3 910.4 769.1 1529.3 1710.7 662.2 585.2 526.3 2063.7 1707.5 613.3 830.9 930.0 610.8 730.0 668.5 296.5 1301.8 648.8 361.4 1436.9 1034.9 745.8 633.3 1043.2 1396.9 441.9 599.2 1360.1 1263.2 273.3 1303.3 1554.8 1584.4 718.7 3652.9 4010.4 4601.5 2275.7 813.0 2758.2 1601.3 4193.6 3154.7 3546.5 2675.5 3699.5 1690.3 2114.0 2566.1 4263.6 2867.3 2049.5 1722.7 3395.6 1727.7 3745.8 2549.8 1724.3 1784.6 3515.1 2165.8 1909.2 2003.4 3599.7 1366.0 3586.4 938.0 4516.4 5237.2 1343.4 331.2 2723.2 3288.0 2677.4 6305.5 2235.8 1970.8 2272.7 2122.3 3520.6 1537.3 1716.3 3385.4 2838.3 1234.4 1284.1 4804.4 969.0 5127.0 1530.7 2192.3 1908.9 5402.3 4755.5 1993.3 2802.6 7012.2 908.3 791.7 1505.4 3808.4 1910.5 2940.1 4240.1 1897.3 3013.3 2108.9 2333.9 2026.4 1297.8 1892.2 2024.3 3012.5 939.2 1391.8 1827.7 1532.7 1355.2 2939.2 1616.5 2980.5 5301.8 534.8 560.4 596.1 633.6 575.7 704.3 662.2 585.2 526.3 610.8 633.3 599.2 718.7 1602.0 974.4 558.2 107.1 1285.4 5276.1 9107.1 3827.4 2541.1 493.3 1477.5 1943.4 233.6 825.0 1924.3 1140.3 244.0 2002.6 1886.0 2460.0 1058.5 4368.6 293.0 1028.0 1501.0 1664.2 1914.5 567.0 59.0 8305.0 4361.7 1595.3 2440.4 1433.3 588.7 3067.7 1031.6 517.1 3219.5 267.5 65.7 2206.9 1957.2 1426.0 1807.7 258.5 1718.6 1840.3 1398.1 70.3 4004.3 3402.9 1971.2 78.4 111.9 7194.7 2426.5 1363.9 1369.6 3987.9 1673.2 566.6 950.0 571.1 1360.8 873.0 2277.1 756.5 995.7 3085.9 5371.9 2827.2 1823.7 2394.4 2187.5 6279.2 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464300-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 282.9;stomach 1: 147.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA034493, HPA035787" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA "Plasma membrane" "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favorable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.6 0.2 0.4 14.0 0.4 0.1 20.2 0.2 0.5 5.1 2.5 103.9 79.2 1.0 2.8 36.4 10.8 24.3 0.2 0.3 0.4 47.7 33.8 40.2 0.2 0.5 0.3 0.5 0.2 112.3 4.0 1.5 0.2 0.3 282.9 78.7 0.2 76.9 7.8 0.1 6.8 90.3 3.3 0.1 0.2 147.6 1.5 0.2 0.8 19.4 0.1 10.3 36.0 7.7 0.5 0.1 0.0 0.1 0.0 0.1 0.1 2.3 0.0 0.0 0.1 0.1 22.8 3.3 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 3.7 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 10.5 0.3 1.0 2.3 35.9 0.2 0.1 0.0 2.6 1.3 57.8 0.2 0.7 0.3 11.7 0.3 0.4 8.8 0.0 0.0 0.1 0.6 0.6 0.1 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.5 0.3 0.4 0.5 0.3 0.5 0.3 0.1 0.2 0.5 0.1 51.3 109.8 0.0 1.7 0.3 30.9 6.8 0.0 0.0 34.0 25.8 0.6 32.9 42.1 47.8 0.0 0.7 1.1 404.8 23.5 39.2 21.3 7.4 0.5 1.3 18.0 2.7 0.2 60.4 0.1 1.0 155.4 5.8 7.0 0.0 0.4 32.0 0.1 0.0 0.1 84.1 44.7 0.3 0.3 4.8 0.0 2.0 10.6 0.0 0.6 0.0 0.0 0.0 0.0 65.1 368.3 0.0 0.0 203.4 159.6 3.8 36.6 0.0 0.0 1.6 2.0 0.4 1.4 2.1 0.1 0.3 1.1 0.0 105.7 166.6 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265959 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA052923: AB_2681989, HPA055009: AB_2682669" "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 45.2 23.7 81.0 23.4 89.4 21.9 36.6 88.9 81.4 35.6 51.2 34.8 5.8 38.8 14.2 17.5 37.8 23.5 55.4 67.3 86.4 22.5 15.8 46.5 16.9 85.4 89.8 61.0 30.4 23.4 18.7 20.7 29.0 86.8 24.7 13.0 35.0 19.6 40.4 26.9 16.2 20.4 47.9 78.9 31.6 23.9 15.9 87.7 28.2 22.2 34.0 16.1 40.8 25.3 85.4 18.8 23.3 63.7 56.1 113.0 92.0 61.7 69.2 99.8 85.7 104.5 16.4 13.6 0.0 30.5 129.0 82.4 12.7 64.3 22.5 111.4 73.0 30.9 6.2 32.2 34.5 61.0 34.4 13.9 76.8 11.5 51.1 74.6 59.7 83.8 21.9 33.6 0.3 101.9 11.0 19.4 15.1 19.7 3.2 28.6 34.2 46.1 0.3 41.6 13.4 15.9 32.1 65.8 29.7 27.2 70.4 15.7 24.6 59.2 63.0 41.0 78.7 47.3 1.4 0.4 18.7 63.4 14.1 51.9 4.4 5.0 5.7 0.1 6.3 0.6 1.8 1.3 1.3 4.6 0.2 3.8 1.9 10.8 1.0 9.2 1.1 0.0 1.9 81.0 89.4 88.9 81.4 67.3 86.4 85.4 89.8 61.0 86.8 78.9 87.7 85.4 34.1 19.2 14.5 43.8 7.4 21.7 19.3 10.3 10.2 9.7 15.3 13.8 33.2 14.3 8.0 14.7 60.5 15.9 6.4 0.3 0.0 7.3 1.1 26.3 31.8 31.3 6.6 7.8 47.7 6.7 20.1 27.1 3.1 57.8 2.5 11.6 21.4 10.9 21.8 13.5 74.2 2.2 4.1 36.3 63.4 2.0 21.5 48.9 19.6 68.4 41.1 11.6 3.1 136.2 287.1 8.4 1.4 20.7 0.9 32.5 0.1 10.3 4.8 10.5 26.3 34.4 31.6 7.9 12.3 6.3 8.2 11.2 6.3 16.0 0.8 15.0 OR2T10 ENSG00000184022 "Olfactory receptor family 2 subfamily T member 10" Q8NGZ9 1 248590487-248597700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "kidney: 5.1" "Cell type enriched" "Detected in single" 8 "Proximal tubular cells: 4.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052019 Uncertain NA NA "HPA052019: AB_2681696" "unprognostic (8.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-2 KAP20.2 ENSG00000184032 "Keratin associated protein 20-2" Q3LI61 21 30635206-30635619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "skin 1: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAG1B "CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1" ENSG00000184033 "Cancer/testis antigen 1B" P78358 X 154617609-154619282 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "U-266/70: 671.4" CAB015453 Enhanced NA NA "CAB015453: AB_784921" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 7.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 671.4 41.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122227456 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria NA Yes Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 24.0 34.6 29.4 17.4 30.3 32.8 25.5 33.1 37.0 20.0 29.8 27.9 21.9 27.2 36.5 31.0 23.5 18.2 28.3 28.6 32.3 34.4 40.0 21.4 21.2 32.1 31.5 28.6 28.0 27.9 32.5 41.7 26.0 31.9 22.1 24.8 27.8 29.1 19.7 37.7 25.2 27.1 20.6 31.9 24.5 26.8 53.7 30.6 27.2 26.0 34.8 25.1 32.3 24.8 33.2 49.0 94.7 65.4 44.7 45.9 44.6 50.2 49.5 48.3 56.9 50.8 82.4 24.9 59.2 45.4 45.2 42.4 47.4 72.2 59.3 67.0 51.1 56.4 65.2 36.6 76.7 65.3 71.0 25.9 62.2 41.3 67.3 100.1 64.4 66.8 57.9 75.9 24.5 56.1 72.4 58.6 103.8 52.9 69.5 88.0 52.3 65.2 65.4 64.4 74.7 61.7 62.6 66.1 26.2 54.8 73.3 87.9 49.2 46.0 43.7 53.6 50.0 45.4 52.8 95.5 84.3 55.8 53.6 58.8 43.3 39.8 39.8 39.9 41.4 37.8 46.3 36.4 37.2 48.3 36.4 35.6 36.1 17.9 45.5 40.1 37.5 46.3 42.0 29.4 30.3 33.1 37.0 28.6 32.3 32.1 31.5 28.6 31.9 31.9 30.6 33.2 0.2 0.0 0.6 7.2 19.7 5.0 5.9 7.6 31.3 7.3 0.0 0.0 1.3 10.0 3.3 0.0 4.2 11.3 3.0 8.2 0.0 0.2 6.3 0.0 0.0 3.8 7.3 20.4 14.5 0.0 10.8 7.7 25.5 0.0 4.5 0.0 5.3 2.9 6.5 3.3 14.1 8.8 8.2 3.3 3.6 4.6 5.6 7.1 3.6 3.7 2.7 7.6 9.2 9.0 15.1 0.2 11.9 3.4 29.2 3.9 16.8 0.1 1.7 11.1 6.6 2.6 4.9 19.2 16.3 30.4 4.8 13.4 13.2 0.0 9.9 3.9 VPS33B FLJ14848 ENSG00000184056 "VPS33B late endosome and lysosome associated" Q9H267 15 90998673-91022603 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040415 Approved NA NA "HPA040415: AB_10795419" "unprognostic (7.49e-2)" "unprognostic (1.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.55e-2)" "unprognostic (3.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (1.30e-1)" "unprognostic (2.84e-3)" "unprognostic (2.78e-2)" "unprognostic (7.94e-2)" "unprognostic (3.70e-1)" "unprognostic (6.75e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-2)" "unprognostic (1.00e-2)" 5.2 5.5 5.3 5.1 6.5 2.9 6.2 5.7 7.7 5.8 5.8 6.8 5.9 6.4 7.1 6.9 8.1 4.7 3.6 5.8 6.2 5.9 4.3 5.6 7.0 5.9 5.5 5.4 6.8 6.9 8.1 5.3 6.9 5.7 6.6 6.5 5.9 6.8 6.8 4.2 10.5 6.9 6.2 5.4 7.0 8.0 6.2 6.3 5.4 5.6 4.3 6.6 6.2 6.5 7.0 5.6 16.4 3.4 6.0 8.9 15.1 17.7 6.8 12.7 10.7 10.9 7.0 11.0 7.1 9.4 11.9 9.6 10.0 4.7 10.3 5.6 3.8 4.9 7.7 6.6 10.3 10.9 9.6 10.3 17.0 10.7 8.0 9.5 9.3 15.2 8.6 12.6 1.7 7.9 11.9 6.5 6.8 8.3 14.8 5.8 4.9 8.9 8.7 12.2 12.3 5.2 9.6 10.0 7.9 17.5 8.1 8.1 12.6 10.4 7.0 7.8 5.0 5.2 3.6 12.9 2.7 14.7 9.3 6.4 12.5 7.1 12.1 7.7 11.8 8.9 5.6 6.8 6.9 9.5 7.8 7.8 11.0 3.2 7.9 13.4 4.7 5.9 6.4 5.3 6.5 5.7 7.7 5.8 6.2 5.9 5.5 5.4 5.7 5.4 6.3 7.0 2.2 0.0 7.3 5.5 5.3 2.2 3.0 3.5 1.8 9.2 2.6 1.8 4.8 2.8 4.4 3.7 2.1 16.8 5.0 6.9 5.9 9.0 3.1 3.0 2.7 4.7 2.4 5.7 11.4 9.4 10.8 2.9 7.7 2.9 8.2 6.7 5.7 4.9 8.0 8.4 11.3 5.1 4.1 6.0 4.1 4.0 3.7 4.5 8.8 3.7 7.7 6.3 3.1 7.5 9.7 9.3 5.0 5.3 4.9 4.1 7.9 4.3 7.9 7.0 6.6 2.7 3.5 11.0 8.2 2.3 2.6 12.3 5.0 3.6 4.3 3.0 TBX1 "CATCH22, VCF" ENSG00000184058 "T-box transcription factor 1" O43435 22 19756703-19783593 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.0;tongue: 36.8" "Cell type enriched" "Detected in many" 4 "Late spermatids: 181.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 24.6;K-562: 121.6;NB-4: 28.6;TIME: 40.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029330 Approved "Nuclear bodies,Cytoplasmic bodies" NA NA "Nuclear bodies, Cytoplasmic bodies" "HPA029330: AB_2673002" "unprognostic (2.54e-1)" "unprognostic (4.28e-3)" "unprognostic (7.53e-3)" "unprognostic (1.59e-1)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (2.53e-1)" "unprognostic (5.48e-2)" "unprognostic (1.18e-1)" "unprognostic (4.42e-2)" "unprognostic (2.25e-2)" "unprognostic (8.30e-3)" "unprognostic (9.14e-2)" "unprognostic (4.44e-1)" "unprognostic (8.31e-2)" "prognostic favorable (8.90e-4)" 3.8 0.6 0.5 1.0 0.6 0.1 8.0 0.5 2.2 5.8 1.8 1.8 0.7 2.7 0.2 3.0 7.8 0.4 0.6 0.5 0.3 0.4 0.4 4.3 2.9 0.5 0.3 0.2 2.3 0.3 7.7 0.7 0.1 0.7 5.3 0.3 0.0 8.2 0.5 62.0 8.9 3.0 0.6 0.2 0.6 1.2 16.9 0.7 0.0 11.3 36.8 1.2 2.7 7.1 1.0 15.3 1.4 0.2 10.7 0.0 0.0 2.1 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.3 0.3 1.5 0.8 12.0 10.4 0.0 0.6 24.6 0.2 2.9 0.0 0.0 0.1 0.1 0.1 0.1 2.4 0.0 0.0 0.0 0.5 121.6 0.0 7.7 2.8 0.3 28.6 1.7 0.0 16.8 0.3 10.6 0.1 0.0 0.0 1.5 0.4 0.0 0.2 0.0 3.1 5.1 7.7 40.0 0.1 0.4 0.2 0.2 0.3 0.5 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 2.2 0.5 0.3 0.5 0.3 0.2 0.7 0.2 0.7 1.0 11.4 0.0 2.8 0.0 0.3 2.4 1.6 3.3 0.0 0.6 1.1 0.9 2.4 0.0 1.6 0.0 0.0 0.2 0.6 0.1 0.0 0.0 43.3 0.2 0.1 7.5 0.0 0.0 0.3 0.2 1.7 1.5 0.0 0.2 2.5 0.1 2.5 0.0 2.0 0.0 0.9 1.0 6.1 1.3 3.6 181.9 2.5 1.0 0.0 0.0 0.1 0.3 2.1 0.0 0.0 0.1 0.0 2.2 0.0 1.0 0.1 0.0 2.3 0.1 0.0 1.1 0.8 1.9 12.8 0.3 2.4 0.1 0.7 0.0 0.2 2.0 ADAP2 CENTA2 ENSG00000184060 "ArfGAP with dual PH domains 2" Q9NPF8 17 30906344-30959322 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 86.2;Hofbauer cells: 195.8;Kupffer cells: 186.8;Macrophages: 97.2;monocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 22.4;intermediate monocyte: 34.3;myeloid DC: 12.6;non-classical monocyte: 43.5" "Group enriched" "Detected in many" 9 "dendritic cells: 12.6;monocytes: 43.5" "Cell line enhanced" "Detected in some" "EFO-21: 7.0;HAP1: 17.6;HEK 293: 11.0;RPMI-8226: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.00e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (2.25e-1)" "unprognostic (9.26e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (3.12e-4)" "unprognostic (2.38e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (9.49e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.17e-2)" "unprognostic (1.14e-2)" 11.4 9.0 5.6 15.4 9.4 3.9 4.6 6.2 12.9 2.9 10.1 6.6 5.7 3.2 2.9 3.1 3.3 9.3 4.4 5.6 13.6 5.1 11.1 9.9 9.9 9.8 6.9 4.1 1.9 3.1 9.1 2.0 19.9 11.4 2.5 8.0 1.3 3.1 3.2 1.8 6.6 5.6 9.9 8.4 22.7 4.4 2.0 11.1 4.6 3.2 6.5 6.8 9.1 2.2 13.0 0.1 1.7 0.2 0.4 0.4 0.5 4.5 0.1 0.0 0.3 0.1 0.7 0.7 1.0 7.0 0.1 0.2 0.1 17.6 0.2 0.3 0.4 11.0 0.0 1.0 2.0 2.9 0.4 1.9 1.1 4.4 0.9 0.6 0.2 0.0 0.0 0.2 1.8 0.6 3.6 0.1 0.3 0.1 0.4 0.1 0.3 0.0 22.9 2.4 2.3 0.3 0.1 0.3 0.2 0.1 1.5 3.8 2.9 0.0 0.4 1.1 0.8 0.1 0.8 0.5 1.0 0.4 0.4 0.0 0.2 22.4 0.0 0.0 34.3 0.0 3.0 0.1 0.1 12.6 2.1 0.1 0.1 1.7 0.0 43.5 0.4 0.4 6.6 5.6 9.4 6.2 12.9 5.6 13.6 9.8 6.9 4.1 11.4 8.4 11.1 13.0 5.4 3.2 5.2 2.6 8.6 2.0 0.5 0.5 2.2 0.8 0.7 2.4 1.5 1.5 0.9 0.0 2.1 23.5 0.2 3.1 0.0 0.3 0.6 1.7 0.6 7.8 0.0 0.4 1.1 1.4 86.2 1.9 0.0 1.2 3.8 0.4 4.6 1.6 195.8 0.0 1.4 0.6 0.0 186.8 13.1 0.5 0.9 97.2 0.0 40.3 88.2 0.6 2.1 2.0 1.3 0.9 0.9 0.4 2.6 0.9 0.3 8.3 2.2 2.8 39.5 1.2 26.5 0.9 0.9 1.0 6.5 26.4 1.6 0.2 0.3 0.6 UQCR10 "HSPC051, QCR9, UCCR7.2, UCRC" ENSG00000184076 "Ubiquinol-cytochrome c reductase, complex III subunit X" Q9UDW1 22 29767369-29770413 "Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 513.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 4406.3;Distal tubular cells: 2296.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (2.96e-3)" "unprognostic (1.56e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (2.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.75e-3)" "unprognostic (3.05e-2)" "unprognostic (9.24e-3)" "unprognostic (2.94e-1)" "unprognostic (1.12e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.80e-3)" 77.0 169.0 165.9 59.5 169.1 72.8 71.4 175.3 223.0 56.3 166.7 112.8 112.7 54.5 72.7 111.9 71.0 52.9 354.7 170.4 173.1 171.2 171.4 76.1 69.0 168.1 164.8 161.6 62.4 74.0 144.1 99.5 54.1 166.4 95.4 88.5 91.2 86.1 64.6 513.9 71.6 99.0 53.4 167.9 90.5 122.7 102.5 171.8 81.7 87.1 467.6 66.4 80.2 71.6 169.1 173.3 177.3 167.7 131.3 154.0 100.8 93.1 93.8 116.2 164.1 170.8 230.4 96.8 129.6 99.6 149.7 120.5 168.2 200.6 219.9 101.8 162.6 423.2 162.2 200.9 512.2 110.1 210.7 170.0 169.8 132.0 171.6 115.1 137.4 124.1 137.3 112.6 169.8 163.8 434.9 159.4 246.5 96.6 413.1 232.4 171.3 134.6 235.1 289.7 324.3 184.6 92.9 109.3 231.7 156.2 105.7 164.5 198.9 98.2 168.4 204.8 104.8 141.3 127.2 140.2 176.0 152.2 161.4 108.7 982.0 782.2 1009.7 455.0 820.3 503.6 1000.7 620.1 587.4 842.3 830.2 670.6 571.5 552.9 554.9 762.4 864.6 890.3 1160.1 165.9 169.1 175.3 223.0 170.4 173.1 168.1 164.8 161.6 166.4 167.9 171.8 169.1 138.4 246.8 290.2 42.7 231.0 181.8 205.4 1090.3 149.1 167.6 354.1 421.9 4406.3 443.2 563.5 627.1 77.2 680.2 215.8 819.5 2296.9 438.5 356.7 361.2 190.9 200.9 380.1 380.7 26.0 553.2 549.2 291.0 423.5 345.2 150.1 279.1 180.2 1306.4 737.2 114.4 33.8 791.0 783.3 390.7 254.0 652.3 234.6 337.1 311.3 15.9 424.2 455.0 310.0 16.1 32.4 499.6 771.6 206.5 293.4 335.2 1114.8 1872.1 522.9 307.1 210.4 150.2 327.7 577.2 165.7 490.0 281.7 582.0 226.2 346.5 782.7 389.6 FAM120C "CXorf17, FLJ20506, ORF34" ENSG00000184083 "Family with sequence similarity 120C" Q9NX05 X 54068324-54183281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047677 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047677: AB_2680118" "unprognostic (4.70e-2)" "unprognostic (2.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.20e-2)" "unprognostic (3.21e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.86e-2)" "unprognostic (3.53e-3)" "unprognostic (2.74e-2)" "unprognostic (4.90e-2)" "unprognostic (2.71e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (1.76e-3)" "unprognostic (5.21e-2)" "unprognostic (5.28e-2)" "unprognostic (3.28e-2)" 3.1 3.7 8.6 1.8 9.9 3.5 2.9 8.3 8.7 3.9 2.7 2.5 1.3 3.8 5.2 3.5 3.5 1.7 2.6 7.9 8.7 3.0 3.1 2.4 2.9 11.7 9.0 7.5 4.6 2.6 4.1 4.3 2.2 9.4 3.3 1.7 5.9 2.7 3.1 5.9 3.2 2.5 2.8 8.5 3.4 2.1 2.7 9.0 4.1 3.4 2.9 3.1 3.4 3.4 11.5 4.0 7.2 3.6 8.3 8.2 5.9 6.7 3.8 6.3 5.7 6.1 3.4 4.2 5.6 2.5 3.3 8.4 10.7 10.6 2.8 5.0 4.4 11.6 3.0 11.3 5.6 3.7 2.7 3.0 4.1 3.5 5.0 5.8 6.6 3.6 5.7 3.2 4.5 4.6 10.9 4.5 10.8 6.8 2.3 15.9 5.3 5.8 5.9 4.7 2.2 5.0 5.0 9.8 7.4 2.7 8.8 8.8 2.4 6.5 5.0 6.5 6.6 3.1 5.4 5.6 4.2 5.7 8.2 6.1 0.0 1.4 0.1 1.3 0.8 1.1 2.6 1.2 1.0 2.5 2.1 1.3 1.5 0.0 0.9 0.3 3.1 0.4 0.9 8.6 9.9 8.3 8.7 7.9 8.7 11.7 9.0 7.5 9.4 8.5 9.0 11.5 4.5 3.2 2.6 21.9 7.8 5.9 5.4 5.0 15.4 10.5 5.5 3.7 5.7 8.6 2.5 0.0 4.2 8.9 4.6 0.8 9.8 3.0 0.1 7.0 7.2 5.5 4.8 7.4 18.1 2.7 5.5 5.5 3.1 7.7 2.5 9.2 5.3 6.1 4.1 6.7 19.0 1.1 2.0 3.2 4.7 0.7 6.5 5.3 1.8 10.3 3.5 5.1 8.2 33.2 32.9 1.5 1.6 4.9 3.0 3.3 0.8 5.6 3.9 8.6 0.0 9.0 5.4 2.0 6.9 12.0 4.7 2.5 5.6 8.7 2.5 3.4 TRIML1 "FLJ36180, RNF209" ENSG00000184108 "Tripartite motif family like 1" Q8N9V2 4 188139441-188147743 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 122 "testis: 12.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 138.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "BEWO: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.99e-2)" "unprognostic (5.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 138.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 29.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 EIF3C "eIF3-p110, EIF3S8" ENSG00000184110 "Eukaryotic translation initiation factor 3 subunit C" Q99613 16 28688558-28735727 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 67.3;Alveolar cells type 2: 101.4;Cardiomyocytes: 157.0;Club cells: 91.1;Respiratory ciliated cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034045, HPA047097, HPA049495, HPA050112" Supported Supported Cytosol NA NA Cytosol "CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (2.42e-1)" "unprognostic (2.69e-2)" "unprognostic (2.07e-1)" "unprognostic (2.18e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (1.85e-2)" "unprognostic (5.75e-2)" "unprognostic (7.23e-2)" "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (6.54e-3)" "unprognostic (3.53e-3)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "unprognostic (1.10e-3)" 175.6 100.7 91.3 114.5 90.5 151.1 187.6 73.6 92.4 138.1 79.5 191.5 150.0 139.3 52.1 161.1 187.5 87.5 136.6 93.3 86.1 174.4 144.3 105.5 125.9 83.6 86.9 84.1 238.5 221.5 229.6 87.5 123.9 92.0 116.2 167.7 95.7 189.2 113.9 363.4 189.8 146.2 150.3 79.2 117.2 125.5 142.1 86.6 91.9 177.3 294.5 190.6 146.2 105.1 99.3 182.1 321.5 419.3 481.5 368.0 453.1 627.7 444.1 380.9 587.7 425.4 620.6 333.9 461.7 556.7 322.2 366.5 214.5 361.4 618.1 650.0 188.4 376.0 518.9 466.8 860.4 471.9 791.3 344.6 521.4 367.4 370.4 582.8 253.6 679.5 439.3 595.7 394.5 314.5 783.0 622.0 299.2 652.8 304.0 491.2 638.8 612.7 447.0 317.8 406.4 379.1 573.2 396.8 531.0 478.0 263.3 551.6 356.6 570.3 372.3 370.1 180.4 299.9 325.8 279.0 860.7 378.7 320.4 398.7 54.5 198.1 90.2 122.0 204.0 140.6 114.3 131.8 129.1 213.2 113.9 127.4 120.5 14.3 163.8 220.5 98.3 147.2 267.3 91.3 90.5 73.6 92.4 93.3 86.1 83.6 86.9 84.1 92.0 79.2 86.6 99.3 5.0 67.3 101.4 1.0 9.6 11.9 10.0 3.9 15.4 7.0 5.3 3.0 157.0 5.7 91.1 5.5 41.7 3.7 6.2 4.6 1.9 3.3 2.8 8.7 7.7 16.0 6.0 17.5 1.4 3.5 3.1 33.2 10.2 12.9 39.1 7.3 7.9 4.8 3.1 0.0 1.5 5.9 2.0 5.0 8.4 3.5 6.5 12.6 5.4 5.6 3.9 1.9 2.1 4.5 1.0 4.1 5.2 5.3 21.4 5.7 7.1 5.2 168.1 16.2 0.0 6.9 18.5 3.9 4.6 16.9 13.8 5.6 11.2 6.1 6.3 8.8 CLDN5 "AWAL, BEC1, CPETRL1, TMVCF" ENSG00000184113 "Claudin 5" O00501 22 19523024-19527545 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 375.8;breast: 424.6;lung: 402.2" "Group enriched" "Detected in many" 10 "Adipocytes: 2644.3;Endothelial cells: 775.2;Hepatic stellate cells: 701.4" "Cancer enriched" "Detected in all" 4 "glioma: 32.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 18.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 18.8" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 85.4;SCLC-21H: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002607 Approved NA NA "CAB002607: " "unprognostic (1.26e-1)" "unprognostic (2.05e-3)" "unprognostic (1.77e-2)" "unprognostic (2.07e-1)" "unprognostic (3.05e-3)" "unprognostic (6.00e-2)" "unprognostic (4.98e-2)" "unprognostic (3.24e-3)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (2.29e-3)" "unprognostic (1.15e-1)" "unprognostic (7.31e-2)" "unprognostic (2.01e-2)" "unprognostic (2.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.96e-2)" 375.8 16.3 123.1 6.2 88.3 0.3 424.6 102.4 128.4 70.4 195.3 70.6 9.3 86.8 3.0 54.9 83.9 6.6 88.0 83.8 92.7 40.9 17.0 402.2 9.7 114.4 104.5 66.8 36.7 20.9 1.5 17.0 12.6 110.8 50.6 3.6 2.0 36.3 3.5 102.4 91.7 71.6 6.4 96.4 45.2 41.8 10.6 146.3 1.8 123.5 15.0 2.3 104.6 76.6 117.9 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.1 0.1 0.2 1.1 0.0 0.0 0.0 0.0 85.4 0.1 0.7 0.2 0.1 0.0 0.1 0.5 0.2 0.0 0.2 0.9 0.7 0.1 0.0 0.0 53.0 0.3 0.0 0.0 0.0 0.0 0.4 0.2 7.1 0.1 1.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 18.8 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.2 4.6 0.2 5.8 0.0 0.1 0.1 0.0 26.9 123.1 88.3 102.4 128.4 83.8 92.7 114.4 104.5 66.8 110.8 96.4 146.3 117.9 2644.3 3.2 7.7 0.7 2.4 32.4 1.1 0.1 3.4 1.8 5.9 7.6 14.8 2.8 0.6 7.3 0.0 0.3 4.2 0.0 0.0 0.7 5.0 8.1 0.7 775.2 2.4 8.0 0.0 0.8 0.1 12.5 0.0 1.0 1.3 0.3 701.4 2.7 0.8 0.0 0.1 0.2 4.1 17.0 33.3 5.5 5.3 46.2 14.2 129.3 0.7 2.4 1.0 0.5 0.3 0.0 0.0 0.7 2.8 4.0 0.0 0.0 0.3 7.3 0.0 61.7 12.1 1.1 1.9 1.2 30.5 0.0 4.6 25.0 0.0 6.7 NIPSNAP1 ENSG00000184117 "Nipsnap homolog 1" Q9BPW8 22 29554808-29581327 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 294.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 116.7;Proximal tubular cells: 134.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059227 Uncertain NA NA "HPA059227: AB_2683951" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (2.15e-2)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "unprognostic (1.43e-2)" "unprognostic (1.23e-2)" "unprognostic (1.78e-1)" "prognostic favorable (8.82e-6)" "unprognostic (2.81e-2)" "unprognostic (8.69e-2)" "unprognostic (9.03e-2)" "unprognostic (1.72e-1)" 9.6 44.3 33.6 17.6 38.2 15.6 31.8 32.3 39.0 21.7 31.4 37.8 67.6 19.6 25.1 26.0 27.0 19.9 22.0 37.9 40.9 118.9 294.2 18.0 23.5 36.3 36.9 37.3 32.5 24.6 68.6 36.7 17.4 41.7 24.1 38.9 46.6 26.3 27.5 4.4 19.6 49.6 17.9 29.0 19.3 29.6 12.0 36.2 37.0 33.2 5.4 28.5 20.3 18.5 39.9 69.1 81.1 165.3 206.9 29.2 59.4 30.7 39.5 70.7 53.2 68.7 55.5 90.6 48.8 76.8 56.9 56.0 68.2 87.7 100.7 65.1 98.8 90.5 16.8 37.0 173.5 44.1 36.5 23.0 59.5 50.8 44.1 55.0 129.0 73.4 105.3 31.8 78.9 49.2 156.4 59.3 50.1 140.0 106.2 67.5 115.9 51.7 142.6 128.3 59.1 203.9 179.5 46.1 83.2 92.1 79.5 137.1 57.7 34.7 23.2 79.6 28.6 31.9 106.4 56.5 45.6 62.1 57.3 39.4 10.8 9.4 15.9 34.2 17.4 41.2 29.0 34.4 36.2 21.6 27.3 32.6 39.5 13.8 39.5 10.7 11.0 44.9 22.1 33.6 38.2 32.3 39.0 37.9 40.9 36.3 36.9 37.3 41.7 29.0 36.2 39.9 7.4 25.6 15.7 6.8 16.3 4.8 12.6 15.8 18.8 22.6 25.5 18.5 22.9 28.6 18.6 42.3 10.4 44.4 9.2 14.4 68.4 45.8 2.1 6.2 13.7 10.1 41.9 24.6 16.9 18.5 14.6 14.2 25.5 12.0 26.0 33.5 11.7 116.7 14.4 10.1 19.9 31.5 26.4 8.7 4.3 6.1 11.1 8.1 5.4 3.7 21.3 38.7 28.8 6.6 10.3 17.8 20.2 14.3 7.3 6.8 35.2 134.7 9.8 24.4 13.1 7.2 12.3 1.4 8.3 20.5 8.1 14.8 20.5 48.1 47.4 8.8 OR4F6 OR4F12 ENSG00000184140 "Olfactory receptor family 4 subfamily F member 6" Q8NGB9 15 101803509-101806887 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNTN2 "AXT, TAG-1, TAX, TAX1" ENSG00000184144 "Contactin 2" Q02246 1 205042937-205078289 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cell adhesion" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 251.1" "Cell type enriched" "Detected in some" 11 "Oligodendrocytes: 335.5" "Cancer enriched" "Detected in some" 9 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 3.9;SCLC-21H: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001397, HPA012497" Approved "Secreted in brain" NA NA 58000 "HPA001397: AB_1847146, HPA012497: AB_1847147" "unprognostic (1.90e-1)" "unprognostic (1.86e-1)" "unprognostic (2.87e-2)" "unprognostic (4.52e-3)" "unprognostic (2.98e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (1.43e-2)" "unprognostic (8.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (5.62e-2)" "unprognostic (1.73e-7)" "unprognostic (9.82e-3)" "unprognostic (1.19e-1)" "unprognostic (3.35e-2)" "unprognostic (3.07e-2)" 0.3 0.5 90.3 0.4 135.7 0.0 0.1 120.8 113.0 0.5 36.8 1.7 0.1 0.0 0.0 0.2 0.1 0.1 0.4 83.6 103.0 0.0 0.0 0.0 0.0 143.1 132.4 63.5 0.0 0.1 0.0 8.0 0.0 145.4 0.3 0.5 1.2 0.4 0.6 0.0 0.5 0.9 0.2 128.4 0.1 0.5 6.2 122.8 0.1 0.1 0.0 0.3 0.2 0.7 251.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.3 135.7 120.8 113.0 83.6 103.0 143.1 132.4 63.5 145.4 128.4 122.8 251.1 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 2.4 0.9 1.3 3.7 0.0 0.6 1.8 0.0 0.0 1.2 0.0 0.0 0.6 13.7 0.6 0.5 0.5 0.0 0.0 18.4 0.6 0.0 0.4 0.0 1.2 0.0 2.6 0.0 0.0 0.0 3.3 16.0 0.0 0.0 0.0 0.0 29.0 0.6 0.5 0.0 4.7 0.0 0.2 0.0 9.5 335.5 0.6 0.0 0.0 0.4 0.0 0.0 0.3 1.5 0.8 0.0 0.0 0.3 3.2 0.6 0.0 0.0 0.0 0.5 0.2 0.0 0.2 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970648-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 104.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 54.2" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 104.7 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.9 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" Q96E66 11 72080337-72096895 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 67.7;testis: 49.7" "Group enriched" "Detected in many" 12 "Early spermatids: 574.9;Late spermatids: 2222.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 4.6 4.6 21.2 2.5 20.6 2.1 8.7 20.6 24.3 8.8 23.0 5.2 3.8 7.3 17.3 3.8 67.7 3.4 3.8 18.7 21.1 11.8 8.0 7.8 3.2 22.7 22.5 17.2 8.2 9.0 10.4 8.9 5.5 20.7 9.4 7.8 19.9 4.5 5.4 7.6 5.9 3.4 5.8 23.3 4.0 5.6 49.7 21.1 4.6 11.1 4.6 3.7 4.1 3.9 21.5 3.9 13.7 8.9 6.9 7.3 6.7 2.1 4.4 3.6 4.0 3.5 6.6 20.4 5.1 6.6 7.8 9.6 7.3 6.3 10.8 4.5 9.4 6.2 3.5 6.3 4.8 1.3 3.0 3.9 2.9 5.4 6.0 4.6 6.4 1.5 10.2 4.0 7.8 6.0 13.6 9.0 6.0 4.4 22.8 3.6 10.8 8.6 7.7 15.9 4.7 8.2 6.2 8.7 19.4 10.4 6.1 39.6 3.3 6.5 4.0 5.7 11.3 3.1 8.0 9.4 5.8 4.0 2.5 4.5 1.8 1.7 3.5 2.0 1.9 1.9 3.2 2.1 1.6 1.0 3.5 1.8 1.8 6.1 6.6 1.3 2.8 4.6 1.4 21.2 20.6 20.6 24.3 18.7 21.1 22.7 22.5 17.2 20.7 23.3 21.1 21.5 4.6 0.0 1.5 3.3 2.5 2.3 7.5 10.0 1.8 3.5 8.4 7.5 2.2 5.7 10.7 3.7 12.5 12.7 1.4 4.4 11.7 7.5 574.9 84.3 3.0 6.5 1.2 3.6 2.0 2.5 7.7 5.3 4.1 7.2 0.0 2.2 3.6 6.0 3.1 6.7 1.9 10.8 10.2 1.6 2.8 2222.2 14.9 3.3 1.8 1.9 1.4 21.3 4.1 2.0 3.6 2.0 2.5 10.1 5.1 6.8 4.0 19.9 113.1 16.6 6.6 6.1 7.9 90.3 28.1 2.2 2.4 13.1 1.7 2.9 3.4 6.5 OR10J5 ENSG00000184155 "Olfactory receptor family 10 subfamily J member 5" Q8NHC4 1 159535078-159536007 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNQ3 "EBN2, Kv7.3" ENSG00000184156 "Potassium voltage-gated channel subfamily Q member 3" O43525 8 132120859-132481095 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 22.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 501.5;Inhibitory neurons: 485.6;Microglial cells: 502.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 6.6;JURKAT: 3.8;RPMI-8226: 2.8;U-2 OS: 4.3;U-87 MG: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.90e-1)" "unprognostic (1.26e-3)" "unprognostic (1.45e-2)" "unprognostic (3.65e-5)" "unprognostic (2.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.57e-6)" "unprognostic (5.82e-2)" "unprognostic (7.32e-2)" "unprognostic (6.09e-2)" "unprognostic (7.09e-2)" "unprognostic (3.22e-1)" "unprognostic (2.71e-4)" "unprognostic (1.14e-3)" "unprognostic (3.52e-1)" "unprognostic (7.92e-2)" "unprognostic (2.50e-2)" 1.2 1.4 6.4 0.5 15.9 0.0 0.9 0.0 22.3 0.3 0.0 0.3 0.2 0.2 0.1 0.1 0.3 0.3 0.7 9.4 4.4 0.6 0.0 1.9 0.1 6.1 8.2 12.2 0.1 0.9 0.2 2.0 0.2 7.1 0.4 0.2 2.6 0.4 0.6 0.0 0.4 0.6 0.6 0.0 0.5 0.1 0.2 19.1 0.5 0.5 0.0 0.2 0.4 0.4 12.2 0.2 0.1 0.0 0.0 0.3 1.0 0.0 0.3 1.1 0.0 0.0 0.0 1.0 0.0 1.2 1.5 2.5 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 6.6 0.1 0.0 3.8 0.0 0.1 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 2.8 1.6 0.0 1.3 1.2 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 15.9 0.0 22.3 9.4 4.4 6.1 8.2 12.2 7.1 0.0 19.1 12.2 0.4 0.0 14.0 84.5 0.2 0.3 0.0 0.0 0.0 6.7 1.3 0.6 4.6 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 4.3 1.6 0.3 4.2 2.7 0.0 0.0 501.5 6.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 485.6 0.7 0.0 0.3 1.6 2.9 0.0 2.1 0.0 502.2 0.6 0.4 0.0 117.1 31.2 1.8 0.0 0.0 0.0 0.1 4.6 1.6 0.8 0.6 0.0 0.0 2.7 0.0 0.5 0.1 0.1 0.0 0.4 0.1 1.2 0.1 ADRA2C "ADRA2L2, ADRA2RL2, ADRARL2" ENSG00000184160 "Adrenoceptor alpha 2C" P18825 4 3766348-3768526 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 67.9;endometrium 1: 58.1" "Cell type enriched" "Detected in some" 5 "Endometrial stromal cells: 135.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 22.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "basal ganglia: 34.3" HPA057688 Uncertain NA NA "HPA057688: AB_2683503" "unprognostic (1.44e-2)" "unprognostic (2.21e-3)" "unprognostic (1.23e-1)" "unprognostic (2.02e-2)" "unprognostic (4.70e-2)" "unprognostic (1.11e-1)" "unprognostic (7.12e-2)" "unprognostic (6.69e-2)" "unprognostic (1.88e-1)" "unprognostic (3.71e-1)" "unprognostic (3.24e-2)" "unprognostic (9.08e-3)" "unprognostic (1.01e-2)" "unprognostic (6.00e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (6.48e-2)" 14.8 3.7 7.0 0.5 17.6 0.0 8.3 3.3 7.8 67.9 3.3 2.8 0.4 58.1 2.2 2.0 22.9 0.4 5.5 6.3 7.9 22.9 0.6 4.1 0.8 12.2 5.2 7.6 8.3 3.9 0.2 4.8 3.7 10.8 22.6 0.2 0.8 1.2 18.8 3.5 6.2 3.2 2.2 3.5 22.1 2.4 3.8 6.9 0.4 1.4 1.8 0.1 4.3 14.2 5.9 0.0 4.6 0.1 0.1 0.5 0.0 0.2 0.5 0.0 0.1 0.0 2.4 1.4 0.0 2.3 0.4 0.8 0.0 0.2 0.0 0.0 0.0 6.6 0.0 0.0 13.3 0.6 0.0 0.9 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.2 21.9 0.0 0.0 7.4 8.6 0.0 0.0 6.8 0.0 0.0 0.4 8.0 9.7 3.0 0.0 0.1 1.9 7.0 0.1 0.0 0.0 5.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 17.6 3.3 7.8 6.3 7.9 12.2 5.2 7.6 10.8 3.5 6.9 5.9 26.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.2 1.7 0.8 0.9 1.0 2.8 0.0 12.9 0.0 0.9 0.1 0.1 3.9 0.4 0.0 4.7 135.9 5.4 0.0 0.0 1.2 0.0 0.2 1.4 0.0 2.4 0.0 10.7 1.1 0.0 0.3 3.3 0.6 0.2 0.0 0.0 0.7 0.4 1.5 0.6 0.0 1.0 0.0 5.8 0.0 0.0 0.2 0.1 0.0 3.8 0.0 0.3 0.0 2.4 0.0 0.1 0.0 0.9 5.8 0.1 1.6 0.0 0.0 1.6 0.6 0.0 0.1 0.2 NR2C2AP TRA16 ENSG00000184162 "Nuclear receptor 2C2 associated protein" Q86WQ0 19 19201409-19203414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042054, HPA055653" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA042054: AB_10965022, HPA055653: AB_2682877" "unprognostic (9.54e-2)" "unprognostic (2.93e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.36e-2)" "unprognostic (6.81e-2)" "unprognostic (6.26e-3)" "prognostic unfavorable (5.63e-5)" "unprognostic (1.60e-2)" "unprognostic (1.53e-1)" "unprognostic (8.77e-2)" "unprognostic (3.65e-3)" "unprognostic (5.89e-2)" "unprognostic (7.62e-3)" "unprognostic (1.17e-2)" "unprognostic (5.99e-2)" "prognostic favorable (1.65e-4)" "unprognostic (2.10e-2)" 13.6 10.0 13.7 12.6 14.0 7.7 15.7 14.0 14.3 14.4 12.7 14.2 8.3 14.9 13.8 17.1 15.1 6.8 10.3 14.0 13.9 11.7 10.7 9.6 13.7 14.2 13.9 13.6 16.6 15.4 7.8 8.3 7.6 14.2 14.9 11.1 3.5 13.4 10.7 12.7 20.9 12.5 11.5 14.2 13.5 13.5 5.6 13.7 10.3 11.2 7.8 13.7 18.0 14.7 15.4 50.7 29.2 13.6 28.9 11.1 11.1 52.7 28.3 16.0 37.9 35.8 19.7 60.4 27.3 77.2 15.0 26.5 44.2 36.0 37.3 23.1 24.3 39.0 15.6 18.0 21.9 12.9 30.5 23.2 11.3 45.1 26.3 35.4 10.7 15.2 31.0 28.4 35.0 22.8 130.0 51.2 27.6 24.4 72.9 58.8 36.3 22.0 53.3 23.5 26.4 45.2 20.7 24.3 47.1 37.0 16.5 25.6 18.9 12.2 24.5 23.3 61.7 54.7 20.7 32.4 36.3 28.5 51.3 33.2 2.6 14.9 1.5 31.4 21.5 41.2 43.6 40.7 30.4 12.6 42.8 42.3 39.7 2.7 27.4 17.4 24.7 37.7 26.3 13.7 14.0 14.0 14.3 14.0 13.9 14.2 13.9 13.6 14.2 14.2 13.7 15.4 14.7 0.0 9.4 2.3 19.2 31.7 41.3 19.8 38.1 3.8 26.8 31.8 2.5 5.7 12.3 7.3 0.0 24.8 17.2 10.3 7.9 20.8 0.7 8.9 7.8 13.5 4.8 8.8 2.9 16.2 34.3 12.1 6.6 11.4 14.0 14.0 5.3 4.5 18.5 8.4 1.7 12.8 10.2 5.0 11.0 1.2 16.4 9.3 10.6 1.0 15.2 5.5 11.3 2.0 2.4 19.0 5.4 13.5 8.0 67.8 7.6 10.9 9.2 3.9 0.0 11.7 10.9 4.6 16.7 26.3 25.1 12.6 16.3 8.7 17.9 36.0 C1QTNF12 "ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127" ENSG00000184163 "C1q and TNF related 12" Q5T7M4 1 1242446-1246722 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 6.9;kidney: 3.4;skin 1: 4.8" "Cell type enhanced" "Detected in some" "Adipocytes: 19.5;Extravillous trophoblasts: 11.2;Proximal tubular cells: 45.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 4.1;U-2 OS: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024107 Uncertain Approved Vesicles "Secreted to blood" NA NA 38200000 Vesicles "HPA024107: AB_2101207" "unprognostic (1.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.45e-1)" "unprognostic (1.24e-2)" "unprognostic (6.60e-3)" "unprognostic (2.43e-1)" "unprognostic (2.67e-3)" "unprognostic (1.01e-2)" "unprognostic (2.58e-1)" "unprognostic (1.05e-2)" "unprognostic (8.02e-3)" "unprognostic (1.10e-2)" "unprognostic (9.68e-3)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.09e-1)" "unprognostic (1.20e-1)" 0.8 0.1 0.5 0.2 0.4 0.0 0.8 0.3 0.4 0.4 0.0 2.2 6.9 0.3 0.0 1.3 0.5 0.1 0.5 0.3 0.5 3.4 0.5 0.4 0.0 0.8 0.3 0.3 0.2 0.2 0.0 0.3 0.2 0.5 0.3 0.7 0.0 0.3 0.0 0.4 4.8 6.8 0.0 0.4 0.2 0.4 2.4 0.7 0.0 0.4 0.0 0.1 0.3 0.6 0.7 0.1 0.0 0.0 0.3 0.2 0.0 0.8 0.6 0.0 0.0 0.0 0.3 0.2 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 4.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.4 0.3 0.5 0.8 0.3 0.3 0.5 0.4 0.7 0.7 19.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 3.9 0.5 0.0 0.6 1.2 0.7 0.0 0.0 0.0 0.8 11.2 0.5 0.0 0.7 2.5 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 45.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.0 CRELD2 MGC11256 ENSG00000184164 "Cysteine rich with EGF like domains 2" Q6UXH1 22 49918167-49927540 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 349.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000603, CAB025604" Approved "Intracellular and membrane" NA NA 480000 "CAB025604: , HPA000603: AB_1078565" "unprognostic (1.12e-1)" "unprognostic (7.35e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.42e-7)" "unprognostic (5.04e-2)" "unprognostic (5.43e-2)" "unprognostic (3.21e-3)" "unprognostic (2.71e-1)" "unprognostic (3.60e-1)" "unprognostic (1.24e-1)" "unprognostic (2.57e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (1.34e-9)" "unprognostic (6.13e-2)" "unprognostic (3.01e-1)" "unprognostic (7.30e-2)" "unprognostic (4.02e-1)" 25.6 28.7 17.2 26.1 18.2 18.2 24.3 18.2 20.2 24.7 18.2 25.8 26.7 31.7 42.2 26.8 28.5 13.7 32.2 16.8 28.5 26.6 98.7 31.8 19.3 20.8 17.6 15.5 23.7 124.3 13.1 66.0 14.5 18.4 27.5 16.6 7.8 39.8 17.3 15.9 16.9 27.0 16.0 17.5 40.6 46.4 43.6 22.5 15.6 67.9 7.7 15.3 27.3 21.5 21.7 37.5 25.5 29.3 96.6 30.6 34.6 39.1 76.4 46.0 41.9 35.5 44.7 44.0 20.4 59.6 66.2 42.3 36.4 37.1 38.3 18.0 11.0 60.1 11.2 37.3 55.8 126.1 44.1 41.4 31.8 33.6 36.4 30.6 29.5 42.9 21.8 16.5 79.5 31.8 119.3 17.2 46.2 21.1 73.9 54.7 41.1 51.9 46.4 20.3 33.6 19.0 53.5 64.9 75.2 32.0 19.3 30.8 51.8 32.7 35.5 59.2 33.1 23.9 65.4 16.9 17.9 52.6 32.5 57.3 33.5 12.4 17.2 17.2 14.9 17.7 29.2 14.9 23.2 13.7 28.1 12.4 10.2 6.4 35.4 8.9 52.2 11.3 12.9 17.2 18.2 18.2 20.2 16.8 28.5 20.8 17.6 15.5 18.4 17.5 22.5 21.7 42.4 6.4 16.1 12.7 82.6 32.8 34.4 49.0 10.2 34.7 35.3 34.2 17.7 31.5 39.6 9.2 25.0 32.4 65.6 45.6 7.9 41.2 112.5 28.4 41.5 32.2 39.9 12.4 9.7 63.2 120.5 56.8 50.4 37.0 36.2 27.0 47.2 63.9 74.6 25.2 10.9 136.3 26.4 25.7 47.0 25.8 44.1 33.8 96.0 6.5 27.8 41.7 80.3 9.5 16.2 51.2 35.1 41.3 349.6 82.4 28.2 16.6 37.4 32.0 13.1 25.7 39.7 143.5 104.8 21.6 30.7 55.1 53.0 41.0 55.7 43.8 OR1D2 "OLFR1, OR17-4" ENSG00000184166 "Olfactory receptor family 1 subfamily D member 2" P34982 17 3088484-3104422 "G-protein coupled receptors, Predicted membrane proteins" "Chemotaxis, Fertilization, Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9" "Cell type enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.5 0.4 2.7 0.5 2.8 1.5 0.5 3.3 3.9 0.2 1.1 0.2 0.4 0.4 1.0 0.2 0.5 0.5 0.4 2.7 1.6 0.7 0.7 0.4 0.8 2.6 1.9 2.3 0.7 0.3 0.2 0.0 0.4 2.7 0.5 0.4 2.5 0.6 0.3 0.6 1.1 0.4 0.2 1.1 0.8 0.4 0.6 2.3 0.4 1.3 0.3 0.5 0.3 0.0 3.7 0.4 0.3 0.5 0.7 0.2 0.2 1.1 0.3 0.1 0.2 0.3 1.4 0.6 0.6 0.7 0.3 0.8 0.7 0.2 0.1 0.3 0.7 0.6 1.8 1.0 0.2 0.2 0.6 1.2 0.1 0.4 0.2 0.1 0.5 0.2 0.6 0.7 1.9 0.1 0.5 0.4 1.1 0.7 0.2 0.1 0.4 0.3 0.5 0.4 0.8 1.0 0.5 0.4 0.2 0.4 1.3 0.6 0.6 0.5 0.5 1.3 0.4 0.3 0.9 0.5 0.5 0.4 0.5 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.0 2.7 2.8 3.3 3.9 2.7 1.6 2.6 1.9 2.3 2.7 1.1 2.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SCFD2 "FLJ39514, STXBP1L1" ENSG00000184178 "Sec1 family domain containing 2" Q8WU76 4 52872982-53366066 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 63.0;Excitatory neurons: 126.2;Inhibitory neurons: 131.6;Microglial cells: 82.4;Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036526, HPA036527" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA036526: AB_10673499, HPA036527: AB_2675175" "unprognostic (1.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.99e-2)" "unprognostic (3.31e-1)" "unprognostic (4.22e-2)" "unprognostic (6.16e-2)" "unprognostic (1.27e-2)" "unprognostic (7.08e-2)" "unprognostic (4.02e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "prognostic favorable (3.81e-6)" "unprognostic (9.39e-3)" "unprognostic (1.10e-1)" "unprognostic (4.86e-3)" "unprognostic (2.51e-2)" 7.3 9.1 4.8 7.4 5.9 7.7 7.4 5.1 6.3 6.3 4.6 6.4 5.7 7.0 3.4 8.6 4.7 4.5 6.4 5.5 6.2 7.2 5.6 5.2 7.4 6.8 6.0 5.5 6.6 6.2 5.7 5.8 6.1 6.8 4.4 6.2 4.0 5.6 5.2 7.6 7.2 4.3 7.6 5.5 5.8 5.9 2.8 6.0 6.5 5.3 6.3 8.0 6.1 6.7 8.2 13.5 12.2 6.8 16.0 22.2 22.3 8.3 30.0 22.6 10.3 8.7 8.7 16.6 25.7 22.8 57.7 11.1 8.1 22.2 26.2 19.6 7.7 13.0 14.1 12.1 10.6 10.3 18.3 24.8 15.5 15.6 19.9 7.8 9.9 18.2 6.5 24.4 14.3 17.7 15.2 25.0 10.8 4.3 37.6 15.0 15.4 6.6 26.8 11.4 8.7 19.5 11.3 6.8 25.0 13.7 7.9 9.8 8.2 16.3 22.1 14.2 25.7 22.3 16.5 9.8 29.7 15.1 20.7 65.0 0.1 7.2 1.8 9.2 12.2 9.5 8.0 7.4 10.6 19.6 6.4 10.9 10.1 1.4 17.9 13.5 12.7 7.1 11.1 4.8 5.9 5.1 6.3 5.5 6.2 6.8 6.0 5.5 6.8 5.5 6.0 8.2 5.4 0.0 3.1 63.0 10.3 3.7 5.4 5.8 8.0 4.1 3.9 3.4 2.9 11.5 3.5 3.7 6.2 8.4 5.4 3.5 1.9 3.8 2.9 2.6 8.4 4.2 1.2 5.5 126.2 5.1 6.7 7.3 5.6 3.6 12.7 5.9 4.2 6.0 5.3 5.0 131.6 3.5 2.0 2.5 3.1 1.5 6.5 10.0 5.4 82.4 2.7 2.7 3.1 182.0 153.7 2.5 2.8 5.7 14.3 2.8 2.4 8.5 4.3 3.3 0.0 5.3 3.8 5.4 3.5 10.5 5.4 4.2 6.8 16.4 4.9 3.5 UBE2F NCE2 ENSG00000184182 "Ubiquitin conjugating enzyme E2 F (putative)" Q969M7 2 237966827-238042782 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 282.2;monocytes: 215.5;NK-cells: 193.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA037444 Approved Approved Cytosol NA NA Cytosol "HPA037444: AB_10672491" "unprognostic (1.73e-1)" "unprognostic (1.65e-1)" "unprognostic (3.80e-2)" "unprognostic (6.92e-3)" "unprognostic (3.39e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.43e-3)" "unprognostic (6.64e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.59e-7)" "unprognostic (2.04e-2)" "unprognostic (6.39e-2)" "unprognostic (3.60e-2)" "unprognostic (2.51e-1)" 26.2 29.9 35.3 25.8 33.7 42.2 23.0 35.7 40.9 27.9 33.7 28.8 24.9 23.3 53.4 43.5 18.9 29.0 51.2 33.8 36.4 26.1 44.6 22.8 32.4 37.9 36.7 31.7 12.7 71.1 42.2 21.2 40.2 38.8 25.6 34.0 16.1 25.4 30.6 61.2 18.0 27.1 35.9 38.1 23.9 26.8 26.2 37.8 34.8 35.7 69.7 33.3 41.1 23.7 41.1 42.9 23.9 53.6 55.1 69.2 83.0 74.8 38.9 55.5 43.3 44.4 26.0 26.4 22.0 13.7 88.7 93.7 35.1 62.3 84.9 67.9 33.7 22.7 31.6 28.5 86.6 86.2 13.1 70.1 48.1 137.7 57.9 87.1 40.1 78.1 100.8 94.2 13.7 80.1 64.0 35.1 55.9 59.8 60.9 33.8 41.8 35.0 39.1 66.3 17.8 36.0 53.0 45.2 36.2 77.0 89.4 31.0 52.8 49.7 47.6 41.7 54.9 43.1 17.1 14.3 43.6 57.1 38.4 35.8 112.4 50.0 63.8 66.3 68.2 26.2 26.2 44.8 40.4 45.0 25.4 40.7 41.4 37.3 102.3 78.5 56.4 51.6 63.6 35.3 33.7 35.7 40.9 33.8 36.4 37.9 36.7 31.7 38.8 38.1 37.8 41.1 17.6 6.4 18.4 0.0 26.4 32.5 24.1 33.0 11.4 24.2 37.7 24.9 48.1 30.0 21.6 27.6 8.4 84.9 87.3 38.6 56.7 49.7 23.6 15.0 23.9 27.1 41.8 102.5 0.0 79.4 282.2 24.9 15.8 13.8 21.5 13.1 22.1 41.7 152.7 26.9 0.0 58.1 32.6 72.2 105.7 61.3 25.7 67.6 35.6 0.0 215.5 28.3 193.6 0.0 0.0 71.8 31.9 30.9 25.7 46.0 49.7 62.2 23.4 21.7 39.5 14.8 31.4 123.5 79.4 19.0 40.3 65.7 36.2 16.0 35.5 34.6 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium inwardly rectifying channel subfamily J member 12" Q14500 17 21376357-21419870 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 24.7;skeletal muscle: 69.8;tongue: 26.0" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 89.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 24.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.0 1.1 3.6 0.6 2.1 0.4 0.8 24.7 3.1 1.1 0.0 0.9 0.1 0.5 0.6 1.4 2.1 0.4 6.1 1.5 2.7 1.2 0.1 1.9 0.1 3.3 7.4 1.9 0.4 0.2 5.6 0.8 0.4 9.1 0.6 0.3 1.3 0.7 0.6 69.8 3.0 0.4 0.6 0.9 1.2 1.1 0.8 12.1 0.1 1.1 26.0 1.0 0.8 0.5 2.8 0.0 0.7 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.0 0.0 4.3 0.0 0.6 1.1 0.0 0.0 4.8 0.2 2.5 0.0 1.1 5.2 0.0 0.0 2.0 0.0 0.3 4.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.1 24.7 3.1 1.5 2.7 3.3 7.4 1.9 9.1 0.9 12.1 2.8 1.4 0.0 0.0 0.7 0.0 1.5 0.0 2.3 0.0 2.9 0.0 0.3 14.3 0.0 1.2 1.8 0.0 0.0 0.1 1.1 1.9 0.0 0.5 0.4 0.5 3.4 1.2 0.0 2.8 0.0 0.0 3.4 0.5 1.8 0.0 0.0 6.8 0.1 0.2 89.2 5.7 1.4 4.1 0.0 1.2 0.5 7.5 0.1 0.0 2.8 0.0 10.2 0.0 0.0 0.2 0.0 0.5 4.1 0.0 0.2 0.0 0.8 0.1 1.5 0.0 3.0 0.7 0.6 2.5 0.0 2.3 0.1 0.5 0.0 1.8 0.2 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53048789-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 18.5" "Cell type enhanced" "Detected in some" "Astrocytes: 43.4;Excitatory neurons: 19.7;Inhibitory neurons: 14.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 42.3" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.2 2.8 12.0 1.4 11.1 1.0 2.0 13.4 11.8 5.8 3.9 3.4 0.6 5.5 2.1 1.0 6.4 1.4 3.1 11.6 11.5 2.9 0.4 2.6 1.0 10.5 11.5 11.3 12.1 0.8 1.1 18.5 2.1 11.2 4.0 1.1 7.0 1.4 2.3 2.4 1.7 2.1 1.9 9.0 3.4 2.0 1.5 12.7 1.5 1.8 1.0 0.4 3.2 3.7 11.4 0.0 0.0 7.8 0.8 4.1 2.4 0.3 1.4 2.7 2.0 2.3 0.8 0.1 0.2 1.9 2.6 5.9 0.8 9.5 0.0 1.7 0.9 1.3 0.6 9.3 0.3 6.0 0.5 0.2 5.8 0.0 3.0 4.1 6.6 3.2 0.2 0.0 5.4 2.9 4.6 0.2 0.1 6.2 0.4 3.5 0.2 2.6 0.7 0.4 0.4 5.8 7.9 0.0 0.8 0.0 4.7 1.2 0.2 5.7 3.4 5.0 2.6 1.1 0.2 0.7 0.8 2.5 0.0 1.8 3.3 0.1 0.2 0.4 0.1 0.2 0.2 0.2 0.1 0.0 0.4 0.2 0.2 0.6 0.8 0.2 0.3 0.1 0.0 12.0 11.1 13.4 11.8 11.6 11.5 10.5 11.5 11.3 11.2 9.0 12.7 11.4 0.5 0.0 0.0 43.4 0.2 0.3 0.4 0.6 0.0 6.6 0.1 0.3 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 5.2 1.1 3.5 0.0 19.7 0.0 0.0 1.5 0.0 0.3 0.0 7.1 1.8 0.1 0.2 6.7 14.1 0.4 0.0 0.3 0.7 0.0 3.1 0.2 1.8 11.2 0.0 3.2 0.0 49.3 42.3 0.1 0.0 4.5 0.0 0.3 0.0 0.1 0.1 3.1 0.0 2.0 2.5 0.1 0.2 0.0 0.0 0.1 0.1 2.8 0.1 0.2 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514428-195543386 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 431.9;Spermatocytes: 354.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 142.1;U-266/70: 224.2" "Low region specificity" "Detected in all" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 18.5 15.2 15.6 21.5 17.5 68.8 22.9 14.5 17.1 16.8 17.9 21.5 26.0 21.4 25.4 22.6 18.5 19.9 24.9 18.5 21.0 21.2 15.1 17.6 29.4 16.4 18.7 16.8 14.1 13.6 16.9 15.8 17.6 17.1 21.1 20.0 16.2 17.0 19.3 86.6 16.4 22.5 21.8 14.8 21.7 17.9 29.4 16.9 28.4 23.4 56.7 25.5 21.3 18.4 20.5 43.8 9.8 14.7 17.0 24.1 25.8 29.1 25.8 36.6 26.4 22.6 142.1 18.0 17.3 99.2 31.1 27.8 18.1 15.1 25.6 32.1 33.0 30.3 18.6 14.0 47.5 37.2 20.5 18.8 31.4 19.4 19.7 39.6 20.8 23.0 17.1 14.7 33.4 23.4 32.3 34.4 22.9 15.6 49.2 42.1 16.6 25.6 50.4 31.8 32.1 34.9 20.0 31.6 33.1 46.5 27.0 52.5 19.9 27.9 16.9 19.3 28.8 36.7 224.2 105.7 79.5 23.9 37.0 33.3 120.6 64.7 257.5 71.8 68.2 98.2 100.3 149.3 99.1 68.8 95.8 178.6 122.8 152.3 94.2 69.0 103.5 168.4 129.2 15.6 17.5 14.5 17.1 18.5 21.0 16.4 18.7 16.8 17.1 14.8 16.9 20.5 106.9 22.4 47.8 13.1 165.7 94.2 138.6 70.1 89.4 51.5 80.6 61.5 53.5 38.6 56.3 22.0 58.4 67.7 148.2 48.6 125.2 69.5 431.9 119.5 65.0 99.6 57.4 33.6 30.8 66.3 43.0 62.5 45.3 67.9 111.0 26.7 51.0 27.1 61.0 52.2 41.7 48.5 69.2 73.3 170.6 243.8 51.6 103.4 97.8 25.3 120.9 50.5 74.2 23.1 19.1 74.5 65.1 63.6 188.4 123.0 77.3 106.0 80.3 91.1 26.3 48.7 71.1 354.3 92.4 88.2 77.6 103.2 230.1 58.0 54.7 186.2 TSPYL2 "CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX" ENSG00000184205 "TSPY like 2" Q9H2G4 X 53082367-53088540 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 370.5" "Cell type enhanced" "Detected in all" "dendritic cells: 190.0;T-cells: 224.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 114.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044133 Approved NA NA "HPA044133: AB_10965838" "unprognostic (3.29e-2)" "unprognostic (2.68e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (3.87e-3)" "unprognostic (1.06e-1)" "unprognostic (9.58e-2)" "unprognostic (1.36e-1)" "unprognostic (5.99e-3)" "unprognostic (3.18e-2)" "unprognostic (1.59e-1)" "prognostic favorable (6.74e-8)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.16e-7)" "unprognostic (6.50e-2)" "unprognostic (9.93e-2)" "unprognostic (2.31e-1)" "unprognostic (3.10e-2)" 67.2 149.9 96.2 24.0 106.9 67.9 66.4 99.7 111.5 128.8 53.8 89.1 9.3 122.1 59.7 31.5 126.5 31.4 82.7 97.4 110.6 43.3 40.0 76.0 34.0 75.3 85.9 90.7 370.5 70.6 22.8 314.2 10.8 85.2 132.9 11.5 35.7 43.1 56.1 100.1 48.7 78.5 30.3 61.6 86.2 87.4 164.4 107.5 20.4 87.9 27.1 22.5 121.4 82.5 91.5 4.3 13.8 14.0 57.7 10.5 12.7 19.9 29.9 31.6 19.3 18.7 20.4 9.5 32.2 5.5 15.9 14.7 12.5 11.6 11.8 17.5 8.1 25.1 8.1 60.9 26.7 30.9 13.3 9.9 24.8 21.3 26.2 44.2 11.6 14.0 11.1 6.4 29.1 10.7 19.4 18.9 15.8 21.1 6.4 25.5 14.8 17.5 23.8 3.4 23.7 17.0 10.3 23.6 8.6 16.3 63.9 13.0 4.0 20.4 8.8 14.7 114.4 5.7 31.2 20.9 29.6 14.8 21.6 18.5 4.8 0.1 2.2 7.4 0.7 9.3 6.0 10.6 6.0 0.2 7.7 14.1 10.4 1.2 7.4 1.3 15.2 8.4 5.8 96.2 106.9 99.7 111.5 97.4 110.6 75.3 85.9 90.7 85.2 61.6 107.5 91.5 45.4 9.6 43.5 17.3 98.0 40.8 80.8 20.3 63.7 100.1 48.8 60.7 33.3 10.0 30.3 18.4 45.9 5.0 190.0 9.2 1.9 8.8 11.1 28.1 47.0 38.9 72.7 5.2 43.4 6.0 15.8 64.3 40.2 61.2 64.6 36.7 27.8 5.8 6.2 30.3 65.0 18.7 14.2 11.4 79.0 11.9 39.1 51.7 44.4 9.4 5.1 53.0 11.3 13.6 9.4 5.1 12.0 51.9 141.4 44.9 4.2 1.4 19.1 34.3 59.2 76.4 75.4 59.7 94.2 17.7 36.4 16.4 224.7 29.6 12.0 31.0 GOLGA6L4 ENSG00000184206 "Golgin A6 family like 4" A6NEF3 15 84235773-84245368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Early spermatids: 118.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 1.1;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 1.1;NK-cells: 2.3" "Cell line enhanced" "Detected in many" "HEK 293: 4.3;U-266/70: 5.7" NA NA "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (3.66e-1)" "unprognostic (3.74e-1)" "unprognostic (3.53e-1)" "unprognostic (6.83e-2)" "unprognostic (4.49e-2)" "unprognostic (1.41e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-1)" "unprognostic (7.23e-2)" "unprognostic (6.23e-2)" "unprognostic (1.72e-3)" "unprognostic (4.70e-2)" "unprognostic (1.48e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" 5.9 7.1 1.7 1.3 1.8 2.2 6.3 1.3 2.8 8.7 2.1 5.0 0.8 5.9 3.6 4.2 5.5 1.7 4.3 1.9 1.8 4.8 4.9 4.7 1.3 1.8 1.6 1.8 15.2 6.3 0.9 4.9 1.3 1.7 5.9 1.9 3.1 4.5 1.3 2.9 4.4 4.0 1.8 1.5 3.3 4.3 10.3 1.7 0.7 6.4 1.1 0.7 5.6 7.7 2.0 0.2 0.1 1.4 1.6 1.7 1.6 0.1 1.3 0.5 0.0 0.4 0.0 0.3 1.1 1.3 1.1 0.5 0.3 1.1 0.4 0.3 0.7 4.3 0.7 1.4 1.1 0.4 1.5 2.1 0.6 0.7 0.2 0.4 2.1 2.1 1.7 2.6 1.8 0.8 1.0 0.1 1.3 0.6 0.0 0.5 0.3 0.3 1.0 1.3 1.4 0.6 1.1 0.8 0.6 0.9 2.9 0.6 1.0 1.6 0.4 1.0 1.2 1.3 5.7 1.8 0.5 0.6 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 2.3 0.0 0.2 0.0 0.0 1.7 1.8 1.3 2.8 1.9 1.8 1.8 1.6 1.8 1.7 1.5 1.7 2.0 5.0 0.0 2.0 0.0 0.9 3.6 1.6 2.1 1.2 7.8 2.1 2.8 1.2 1.5 3.8 1.8 12.5 1.1 1.7 0.6 0.0 4.3 118.3 2.8 6.6 5.0 1.2 0.8 0.2 4.4 0.1 5.9 5.6 4.9 5.1 8.3 4.6 3.9 1.8 0.0 0.1 0.4 0.0 1.6 7.7 17.1 6.8 2.2 7.2 0.0 0.7 3.0 2.1 0.0 0.0 11.2 2.7 5.7 1.7 1.5 0.4 0.6 2.3 8.7 13.1 6.0 5.9 22.8 4.7 2.7 4.5 0.8 3.4 10.9 1.2 0.7 PGP ENSG00000184207 "Phosphoglycolate phosphatase" A6NDG6 16 2211593-2214840 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.6" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 404.5;Early spermatids: 480.5;Late spermatids: 1591.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043096, HPA046739" Approved Approved "Nuclear bodies" NA NA 250000 "Nuclear bodies" "HPA043096: AB_2678311, HPA046739: AB_2679779" "unprognostic (8.33e-2)" "unprognostic (4.77e-3)" "unprognostic (2.36e-2)" "unprognostic (7.23e-2)" "unprognostic (2.12e-3)" "unprognostic (1.76e-1)" "unprognostic (5.75e-3)" "unprognostic (5.87e-2)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (6.50e-2)" "unprognostic (9.04e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "prognostic favorable (6.42e-4)" 7.4 11.9 15.5 6.1 17.8 8.4 7.7 19.4 26.9 6.0 10.4 10.3 6.1 8.8 4.8 6.9 7.3 3.2 25.8 16.5 14.6 12.8 11.5 10.1 6.4 25.5 16.3 19.3 4.8 7.9 5.6 12.0 5.3 27.7 8.4 3.9 7.8 7.3 4.8 41.5 7.8 11.6 3.5 12.5 13.8 10.4 52.6 17.6 5.6 16.2 18.1 3.9 8.6 5.4 23.8 16.2 26.0 18.9 17.5 7.3 6.1 35.4 18.5 8.6 16.5 17.0 40.3 20.0 12.3 17.7 8.5 13.5 26.7 12.7 15.7 7.4 17.0 35.3 12.4 44.3 18.4 4.9 21.8 19.6 6.8 7.0 15.6 5.7 6.3 10.9 20.0 22.4 12.7 9.3 44.1 25.1 35.7 24.1 9.8 23.9 40.9 16.3 27.5 13.9 10.1 24.1 14.8 16.8 29.8 13.1 13.4 22.9 25.3 10.9 17.6 22.5 15.9 18.7 30.1 13.9 17.8 5.8 19.2 13.7 0.0 0.8 2.5 0.7 1.2 0.1 0.2 0.4 0.5 0.5 0.8 0.2 0.4 0.6 0.1 1.2 0.7 0.5 0.2 15.5 17.8 19.4 26.9 16.5 14.6 25.5 16.3 19.3 27.7 12.5 17.6 23.8 35.0 6.4 7.8 17.6 20.9 23.3 7.8 2.6 4.0 196.1 31.1 33.8 40.7 17.2 5.7 40.5 404.5 121.1 44.8 63.6 58.7 10.4 480.5 28.5 22.5 24.7 29.8 38.3 38.0 14.0 107.1 20.3 28.5 27.7 10.2 54.1 20.3 39.2 58.0 144.7 30.9 37.3 2.0 33.1 64.8 1591.0 25.7 37.9 35.6 7.5 20.2 63.4 42.2 11.6 21.9 14.4 32.5 28.2 36.9 21.9 34.8 39.4 3.4 220.6 39.5 19.3 94.3 162.9 64.8 12.7 31.8 54.5 30.0 70.8 50.5 15.2 SNRNP35 U1SNRNPBP ENSG00000184209 "Small nuclear ribonucleoprotein U11/U12 subunit 35" Q16560 12 123458088-123473154 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059145, HPA067031" Supported Supported Nucleoli NA NA Nucleoli "HPA059145: AB_2683926, HPA067031: AB_2685766" "unprognostic (3.80e-2)" "unprognostic (1.17e-2)" "unprognostic (6.16e-2)" "unprognostic (1.35e-3)" "unprognostic (6.78e-2)" "unprognostic (1.96e-1)" "unprognostic (7.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.75e-1)" "unprognostic (6.24e-2)" "unprognostic (2.56e-3)" "unprognostic (7.24e-2)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (7.10e-2)" "unprognostic (2.30e-2)" "unprognostic (1.31e-3)" 18.5 20.2 37.8 16.1 39.2 17.7 18.8 40.5 46.7 23.9 37.5 20.7 15.5 22.3 15.3 26.4 19.2 10.4 34.2 37.3 37.8 24.1 26.6 19.3 20.2 39.2 38.8 36.4 17.3 19.3 20.6 24.7 16.9 40.6 25.1 18.0 18.5 23.9 12.8 80.3 26.7 23.5 16.4 36.8 31.0 23.1 16.5 39.5 18.9 23.5 43.7 19.4 18.6 21.6 41.9 22.8 23.7 28.1 14.4 20.0 18.6 24.6 19.5 28.4 20.1 14.6 14.9 15.3 45.0 14.0 28.4 14.5 23.0 24.3 34.9 17.2 33.0 19.7 21.1 22.0 34.6 14.0 21.8 32.5 22.7 24.0 18.0 17.1 36.3 27.8 14.0 27.5 8.9 28.4 48.0 23.6 49.1 19.6 30.5 22.4 18.0 12.3 24.0 46.8 45.2 23.9 35.3 17.3 36.1 28.2 27.8 43.6 29.1 32.4 13.3 24.3 16.9 17.7 22.0 23.8 26.6 21.7 21.1 18.6 81.0 45.6 74.3 43.3 48.5 43.0 71.5 54.3 49.2 47.0 66.2 41.9 45.2 70.2 47.9 47.0 47.8 79.3 36.8 37.8 39.2 40.5 46.7 37.3 37.8 39.2 38.8 36.4 40.6 36.8 39.5 41.9 21.4 51.3 20.1 14.0 25.0 14.0 19.1 57.3 13.1 30.9 16.3 19.3 29.5 18.6 36.7 33.1 12.5 51.6 31.3 26.9 50.9 35.2 38.3 26.1 21.2 22.5 14.9 29.2 8.4 33.6 34.8 19.3 27.0 22.9 13.3 19.9 23.9 27.1 33.1 15.2 12.1 22.4 44.7 17.0 10.2 10.9 24.2 19.3 16.0 11.2 35.9 37.1 39.1 12.1 27.1 35.0 33.4 25.9 15.9 20.6 37.4 48.9 32.5 28.6 32.9 19.0 24.1 25.3 24.2 18.9 14.5 42.0 24.4 18.3 18.1 25.4 DGAT2L6 "DC3, FLJ25989" ENSG00000184210 "Diacylglycerol O-acyltransferase 2 like 6" Q6ZPD8 X 70177483-70205704 "Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "breast: 2.1;skin 1: 3.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.90e-2)" "unprognostic (3.08e-1)" "unprognostic (1.43e-3)" "unprognostic (3.47e-3)" "unprognostic (8.60e-2)" "unprognostic (5.82e-2)" "unprognostic (1.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010506-154019902 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: AB_2682501" "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 47.7 61.7 25.4 38.0 24.3 83.1 41.1 22.6 31.5 27.6 18.6 38.1 43.7 32.1 7.8 69.7 29.0 20.4 34.1 20.9 26.9 44.5 65.3 49.3 34.0 36.5 27.0 18.5 29.1 85.6 12.5 37.7 17.9 28.9 46.5 15.2 4.6 41.9 21.2 93.3 42.6 51.5 16.5 28.2 70.5 42.2 20.9 30.8 19.6 24.7 16.9 24.2 48.1 36.8 35.3 467.2 178.9 24.5 201.2 48.4 38.5 108.3 68.8 64.5 104.0 96.0 142.3 199.4 200.8 371.4 73.6 157.6 124.3 57.6 112.4 39.8 156.7 173.4 73.3 158.6 85.7 110.8 174.2 118.7 53.2 96.1 99.0 107.8 53.2 62.8 39.6 130.9 220.3 73.3 171.4 70.8 152.1 60.9 148.4 353.5 181.6 126.4 334.7 68.5 86.3 137.4 98.7 82.2 88.6 135.2 9.5 34.3 179.2 86.4 123.8 194.6 284.6 424.2 274.8 190.6 358.2 179.6 205.1 130.8 1.3 7.2 6.2 5.3 9.2 4.7 6.5 4.3 4.4 4.8 7.9 2.5 4.7 5.2 5.4 7.5 10.9 2.3 3.3 25.4 24.3 22.6 31.5 20.9 26.9 36.5 27.0 18.5 28.9 28.2 30.8 35.3 20.2 0.0 13.3 5.9 29.7 13.4 14.5 10.9 5.2 9.1 23.9 19.0 9.3 18.6 16.0 11.0 6.2 11.4 33.0 41.4 7.9 40.5 0.9 9.8 13.5 18.1 20.4 18.1 9.7 113.6 20.9 15.2 18.3 17.3 12.7 25.5 13.2 35.9 57.2 16.8 8.9 27.2 0.0 51.4 24.7 3.8 18.0 43.0 14.2 11.2 24.2 21.8 13.4 4.5 6.6 75.0 28.6 21.4 33.5 30.0 39.4 19.6 10.0 5.3 0.0 14.5 14.9 1.6 8.1 15.1 13.1 12.3 19.6 18.4 39.4 25.3 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog" Q9BQ75 3 99817837-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 215.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavorable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 23.8 33.4 23.7 16.0 22.5 21.0 23.6 27.1 30.4 21.4 17.9 17.8 8.7 21.9 9.8 15.9 21.1 10.6 24.9 22.1 20.5 16.6 15.1 15.9 17.3 24.4 20.2 22.5 23.8 26.9 22.0 24.7 11.7 21.7 16.1 11.7 24.8 14.1 13.5 70.0 17.5 12.7 13.3 18.7 13.9 16.5 30.6 20.7 16.8 14.9 30.2 15.2 24.7 18.2 24.8 116.2 51.0 50.0 72.6 34.7 40.1 51.0 53.5 28.8 93.3 77.0 64.1 37.5 126.3 90.6 28.2 82.4 68.4 70.3 60.2 120.3 66.8 66.5 99.9 32.9 53.2 62.6 137.0 51.3 28.2 56.7 71.4 116.6 30.3 65.2 100.9 63.5 78.1 67.0 78.8 110.3 126.4 73.0 109.4 126.1 49.1 81.3 134.1 57.2 27.5 139.9 58.9 52.8 42.5 125.0 47.8 51.4 84.0 18.5 73.6 207.4 43.3 109.8 56.3 121.1 244.9 49.1 149.4 124.8 1.0 11.0 2.3 22.2 27.3 32.0 57.3 32.8 30.3 23.8 55.7 41.3 42.0 4.1 28.6 25.1 62.1 33.9 18.2 23.7 22.5 27.1 30.4 22.1 20.5 24.4 20.2 22.5 21.7 18.7 20.7 24.8 26.7 6.4 19.4 48.6 41.3 62.2 37.4 45.5 26.2 32.8 43.8 40.4 41.7 42.9 23.2 62.5 18.8 41.7 25.1 8.5 97.8 42.1 165.0 21.7 56.8 38.7 15.0 30.9 154.3 47.7 56.6 44.3 9.7 19.8 62.1 47.7 24.7 61.4 27.2 127.9 132.8 14.4 16.2 7.9 45.5 215.8 50.7 18.7 37.4 58.1 12.8 28.0 19.6 114.1 116.2 35.8 4.6 58.6 36.2 82.8 1.1 87.9 22.4 27.0 26.3 67.3 50.1 163.4 146.1 21.3 66.1 21.9 30.1 54.1 22.6 27.0 OLIG1 "BHLHB6, bHLHe21" ENSG00000184221 "Oligodendrocyte transcription factor 1" Q8TAK6 21 33070141-33072413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 188.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 64.6;Oligodendrocyte precursor cells: 371.5;Oligodendrocytes: 134.7" "Cancer enriched" "Detected in some" 18 "glioma: 116.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 12.1;eosinophil: 37.6" "Lineage enriched" "Detected in many" 15 "granulocytes: 37.6" "Group enriched" "Detected in some" 6 "NB-4: 39.2;RPMI-8226: 20.8;THP-1: 25.5;U-937: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.13e-2)" "unprognostic (6.46e-2)" "unprognostic (4.06e-1)" "unprognostic (3.58e-1)" "unprognostic (9.01e-3)" "unprognostic (2.40e-1)" "unprognostic (7.93e-2)" "unprognostic (1.50e-1)" "unprognostic (3.82e-3)" "unprognostic (5.19e-2)" "unprognostic (8.17e-2)" "unprognostic (2.51e-1)" "unprognostic (4.05e-2)" "unprognostic (5.96e-3)" "unprognostic (3.20e-2)" "unprognostic (1.17e-1)" 0.0 0.0 124.7 0.1 149.8 0.8 0.0 130.7 118.5 0.0 39.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 99.5 117.8 2.8 0.1 0.7 0.0 156.6 153.1 83.3 0.0 0.1 0.0 0.5 0.0 188.8 0.0 0.0 0.0 0.2 0.0 1.3 0.6 0.2 0.0 127.2 0.6 0.2 2.0 132.5 0.0 0.1 0.6 0.0 0.1 0.0 171.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 2.6 0.7 0.0 0.0 0.0 0.0 1.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 39.2 0.2 0.0 0.0 0.0 0.1 20.8 0.0 0.0 1.3 0.0 0.0 0.0 4.7 0.0 0.2 25.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 29.1 1.6 12.1 2.4 37.6 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 2.5 0.1 0.0 0.6 124.7 149.8 130.7 118.5 99.5 117.8 156.6 153.1 83.3 188.8 127.2 132.5 171.7 0.0 0.0 0.0 13.7 0.3 0.0 0.1 0.0 0.0 0.0 0.9 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 1.8 0.0 0.0 3.2 0.0 0.5 0.0 2.4 5.4 1.0 24.1 0.0 1.0 371.5 134.7 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 2.7 3.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 162.0" "Cell type enhanced" "Detected in many" "Astrocytes: 4339.5;Excitatory neurons: 5259.8;Inhibitory neurons: 2489.4;Oligodendrocyte precursor cells: 6313.8;Oligodendrocytes: 14117.8" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 4.5;memory B-cell: 5.3;naive B-cell: 17.3" "Group enriched" "Detected in many" 9 "B-cells: 17.3;granulocytes: 4.5" "Cell line enhanced" "Detected in many" "AF22: 25.1;LHCN-M2: 41.6;TIME: 48.9;U-698: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome NA NA 2900000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 3.8 2.2 38.2 0.4 80.1 3.4 1.0 38.5 72.3 0.9 0.0 0.9 0.2 0.2 1.2 0.3 0.4 1.5 4.9 38.8 46.5 2.5 1.5 1.5 0.7 55.2 55.7 28.6 0.6 1.3 0.0 2.0 0.0 69.0 1.6 0.5 9.5 0.3 4.2 1.3 0.1 0.5 0.5 34.0 0.9 1.9 0.9 55.0 2.3 1.0 1.1 0.7 0.7 1.0 162.0 0.0 19.3 25.1 0.0 6.6 5.1 0.0 3.8 0.2 2.7 1.0 0.1 0.1 5.7 0.1 2.9 0.9 0.0 2.1 0.6 1.2 0.0 10.1 0.3 0.2 0.0 6.3 0.7 0.3 12.1 0.7 3.1 5.0 0.6 2.1 2.2 0.6 0.3 41.6 1.6 12.2 0.0 0.2 0.5 2.5 18.2 0.8 0.0 0.5 0.0 3.2 1.3 0.0 0.1 0.3 0.6 0.0 0.1 48.9 1.4 1.2 5.9 2.0 7.3 0.0 64.2 10.6 0.0 5.0 4.5 0.0 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 17.3 0.1 0.1 0.1 0.9 0.0 1.2 0.0 0.2 38.2 80.1 38.5 72.3 38.8 46.5 55.2 55.7 28.6 69.0 34.0 55.0 162.0 5.6 19.2 68.0 4339.5 29.1 1.9 2.5 0.0 1.8 318.8 9.2 14.7 152.5 0.0 4.4 5.5 20.9 0.2 4.3 0.9 9.8 1.9 3.6 0.3 6.4 4.7 62.4 2.5 5259.8 0.0 0.2 76.3 11.7 0.3 1.3 1.0 19.2 8.6 0.3 198.5 2489.4 1.4 0.0 1.9 1.4 3.0 29.5 3.7 10.6 237.0 0.3 87.8 2.1 6313.8 14117.8 0.3 1.2 14.7 1.4 2.0 0.0 0.8 0.0 27.1 6.6 27.9 25.4 6.8 5.4 1.2 0.3 0.0 2.7 3.7 0.8 0.8 ACOT1 "ACH2, CTE-1, LACH2" ENSG00000184227 "Acyl-CoA thioesterase 1" Q86TX2 14 73537143-73543796 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.8" "Cell type enhanced" "Detected in some" "Astrocytes: 10.7;Cardiomyocytes: 51.5;Excitatory neurons: 13.8;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 30.5;T-47d: 49.8" HPA043705 Approved Approved Mitochondria NA NA Mitochondria "HPA043705: AB_2678626" "unprognostic (4.74e-3)" "unprognostic (3.81e-3)" "unprognostic (7.65e-2)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (1.29e-1)" "unprognostic (4.54e-2)" "unprognostic (1.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.84e-1)" "unprognostic (4.16e-1)" "prognostic favorable (5.09e-8)" "unprognostic (1.35e-3)" "unprognostic (4.60e-2)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" 14.9 13.0 10.7 3.7 10.4 2.5 13.1 9.7 11.4 5.1 8.5 10.6 10.9 13.3 11.7 3.5 7.3 3.5 16.5 10.4 9.8 26.2 44.8 7.4 2.4 11.6 10.2 9.8 3.6 3.0 2.2 2.1 2.9 10.5 5.7 5.5 3.0 5.1 9.4 19.8 6.7 11.9 21.0 9.7 2.6 6.4 4.2 10.6 2.6 3.6 29.5 2.2 9.6 4.0 9.7 10.7 9.0 3.3 0.7 15.2 9.1 0.1 2.9 8.5 7.0 12.6 3.9 6.9 0.0 0.4 5.8 0.9 6.0 0.0 1.4 3.4 4.5 2.8 4.6 2.8 30.5 14.4 0.1 5.1 12.0 0.6 5.6 0.0 0.7 3.2 0.0 0.0 0.0 5.5 4.7 0.6 1.0 3.4 1.4 4.9 9.5 6.8 0.2 6.9 8.7 4.9 6.4 9.0 20.2 12.2 0.9 49.8 9.9 4.2 5.2 7.5 4.2 0.7 0.1 0.0 2.6 6.2 0.0 6.8 0.7 0.9 0.7 4.1 1.1 3.5 2.6 3.9 3.4 3.8 1.9 3.5 3.9 0.1 3.5 1.1 2.2 5.1 2.6 10.7 10.4 9.7 11.4 10.4 9.8 11.6 10.2 9.8 10.5 9.7 10.6 9.7 0.2 0.0 3.2 10.7 0.0 0.0 0.1 0.6 1.8 0.0 0.4 0.4 51.5 0.0 0.4 0.0 0.0 0.7 1.3 0.2 0.0 0.4 0.6 0.3 0.3 0.7 0.0 2.7 13.8 8.0 0.3 2.6 0.0 0.3 0.0 0.1 0.0 1.1 0.9 0.0 12.0 0.0 2.0 0.3 0.0 0.0 0.0 0.5 1.8 3.7 0.0 0.0 0.0 8.5 15.1 2.6 0.0 0.4 0.3 0.0 0.0 3.7 0.3 0.0 0.0 0.0 3.6 0.1 0.2 0.6 0.0 0.8 0.2 0.0 0.2 0.0 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120211032-120230334 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 399.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4" "Group enriched" "Detected in many" 14 "dendritic cells: 2.4;monocytes: 3.3" "Cell line enhanced" "Detected in many" "EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 69000000 Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 55.0 92.3 37.0 18.2 49.4 10.8 43.0 29.5 57.6 66.8 34.6 49.1 48.1 54.7 16.1 23.0 55.1 34.8 50.7 42.0 41.6 51.3 399.9 19.3 5.9 39.3 31.4 36.9 61.5 74.7 6.7 27.6 8.1 34.5 33.8 36.8 30.9 54.4 13.8 13.3 12.0 57.8 29.4 29.0 54.9 33.8 3.8 32.5 4.7 26.2 12.3 3.7 43.0 40.7 37.9 24.9 7.5 30.9 14.4 47.8 53.4 1.7 47.7 53.8 20.5 30.0 7.5 37.3 0.0 115.5 35.6 33.7 25.7 8.9 13.2 8.2 18.7 21.1 21.1 4.7 190.1 42.4 46.7 7.9 66.8 7.9 19.8 54.8 39.9 59.7 12.7 14.0 22.7 5.0 9.4 0.3 139.9 11.6 7.3 40.8 11.8 0.9 23.7 31.8 13.4 1.5 10.0 14.0 15.2 40.2 8.6 4.8 74.7 32.7 39.3 14.7 40.8 4.6 0.8 0.7 0.4 30.3 76.2 14.1 0.0 3.3 0.0 0.1 1.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.1 0.0 0.3 0.5 0.1 0.8 37.0 49.4 29.5 57.6 42.0 41.6 39.3 31.4 36.9 34.5 29.0 32.5 37.9 19.4 0.0 0.6 102.2 3.7 9.4 33.6 7.3 12.5 3.2 6.0 7.0 5.5 34.3 3.5 71.7 2.1 2.1 1.1 135.9 27.4 14.8 0.2 4.7 70.9 40.0 22.8 12.8 0.6 28.7 5.5 135.9 11.7 12.2 1.3 2.6 12.5 218.8 6.0 0.0 2.3 56.5 4.1 11.5 20.9 1.1 16.8 11.0 16.0 23.4 10.2 279.4 0.0 5.5 11.0 28.2 56.5 4.5 14.5 31.3 111.1 79.3 0.4 10.6 52.6 8.6 40.8 0.7 6.9 11.3 10.2 6.2 3.1 149.0 45.8 192.5 ALDH1A3 "ALDH6, RALDH3" ENSG00000184254 "Aldehyde dehydrogenase 1 family member A3" P47895 15 100877714-100916626 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 135.7;urinary bladder: 126.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7" "Cancer enriched" "Detected in many" 5 "prostate cancer: 80.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "olfactory bulb: 4.5;spinal cord: 15.8" "HPA046271, HPA064749" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046271: AB_10965992, HPA064749: AB_2685344" "unprognostic (6.87e-2)" "unprognostic (2.23e-1)" "unprognostic (6.20e-3)" "unprognostic (1.21e-3)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (6.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.62e-2)" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (2.56e-1)" "unprognostic (1.25e-2)" "unprognostic (2.61e-2)" "unprognostic (2.12e-1)" "unprognostic (7.34e-2)" "unprognostic (6.07e-3)" 63.2 11.5 3.1 41.8 2.8 0.6 30.8 4.5 5.0 37.4 13.3 14.1 15.1 8.3 30.6 29.0 25.1 17.2 8.9 3.1 3.5 8.3 5.4 9.9 3.0 4.4 3.6 2.8 6.2 15.2 9.1 7.5 8.4 3.1 135.7 9.0 0.3 94.5 49.8 5.9 3.9 25.4 41.2 3.0 3.1 12.9 16.8 3.0 1.6 2.5 7.0 15.9 126.3 22.5 4.0 363.3 43.5 0.6 0.7 75.0 32.8 1.4 3.2 3.2 1.9 0.8 1.0 285.8 2.6 4.7 97.1 55.7 441.7 8.8 1096.9 6.7 0.1 2.0 1.7 20.1 0.3 25.5 1.4 1.9 23.5 29.8 24.4 4.5 347.7 4.0 0.0 0.7 2.4 1.8 3.8 0.2 1.2 9.0 9.6 316.3 0.7 4.2 2.3 0.2 283.6 0.3 25.4 113.9 94.9 33.3 3.6 9.3 3.2 58.3 0.3 1.0 619.0 14.2 0.7 3.4 1.5 484.7 0.2 516.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 2.8 4.5 5.0 3.1 3.5 4.4 3.6 2.8 3.1 3.0 3.0 4.0 10.0 16.0 6.3 0.3 0.5 0.6 175.4 70.5 4.6 0.0 64.6 18.9 2.0 1.5 141.6 103.0 0.0 9.6 0.9 1.0 3.9 70.5 1.2 20.6 247.9 11.6 3.5 0.0 2.9 1.4 0.5 48.9 1.1 11.7 5.7 0.0 1.8 0.1 1.2 0.0 2.3 2.1 30.5 0.0 1.3 8.5 194.5 3.3 0.0 1.0 0.6 0.0 0.0 36.7 4.6 29.4 0.0 135.4 0.0 580.3 0.1 0.7 78.7 0.0 13.1 20.4 11.5 0.5 0.9 2.9 1.6 4.9 2.0 1.5 0.8 468.7 H2AC20 "H2A, H2A/q, H2AFQ, HIST2H2AC" ENSG00000184260 "H2A clustered histone 20" Q16777 1 149886918-149887411 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 25.6;brain: 80.5;choroid plexus: 22.4" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.7;dendritic cells: 8.1;Extravillous trophoblasts: 18.2;Hofbauer cells: 9.7;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 60.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.50e-3)" "unprognostic (4.97e-2)" "unprognostic (9.34e-2)" "unprognostic (6.95e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-3)" "unprognostic (1.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (3.24e-2)" "unprognostic (4.25e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (1.20e-10)" "unprognostic (1.42e-1)" "unprognostic (1.73e-1)" "unprognostic (4.89e-2)" "prognostic favorable (7.86e-5)" 3.2 3.6 21.0 0.8 22.7 25.6 3.6 27.6 22.4 4.4 22.4 2.6 0.2 2.0 0.0 2.3 2.7 0.4 2.3 14.4 80.5 2.3 2.6 4.8 0.5 34.5 14.8 8.8 4.4 2.4 0.1 3.0 0.5 24.2 3.2 0.1 0.5 1.5 0.1 0.7 3.6 3.3 0.4 25.4 5.2 2.5 1.2 29.0 1.6 1.8 0.0 0.1 2.5 4.1 30.4 3.9 4.2 5.0 15.7 0.0 0.7 7.8 1.2 0.9 2.4 3.3 2.5 1.1 8.0 0.2 0.2 0.5 2.0 0.3 1.6 0.0 0.7 5.7 1.9 1.6 12.2 0.0 4.7 4.6 0.9 0.2 0.2 0.5 0.1 1.6 2.0 1.7 10.0 0.5 60.6 5.7 5.4 6.7 4.5 10.0 1.8 2.2 1.4 1.0 2.4 1.8 7.5 3.2 1.2 3.8 0.4 0.6 4.4 1.5 1.1 10.9 1.9 2.9 5.5 4.0 4.2 2.9 6.3 2.3 47.2 33.8 19.0 22.9 22.6 20.2 13.1 20.1 18.5 17.7 33.1 14.0 14.8 98.4 19.1 25.6 24.9 16.3 22.6 21.0 22.7 27.6 22.4 14.4 80.5 34.5 14.8 8.8 24.2 25.4 29.0 30.4 2.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.7 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 18.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.8 1.5 0.0 0.0 0.0 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47509290-47570985 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 6.8;pituitary gland: 3.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 10.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 19.0;Extravillous trophoblasts: 33.7;Inhibitory neurons: 30.4;NK-cells: 11.3" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 10.5;SCLC-21H: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 0.0 0.1 1.6 0.1 1.3 0.1 0.0 6.8 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.1 3.1 1.3 1.7 0.0 0.0 0.0 3.6 0.1 4.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.6 0.0 0.3 10.5 0.0 0.8 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 1.3 6.8 5.6 1.5 0.6 3.1 1.3 1.7 4.2 1.3 1.5 2.6 0.2 0.0 0.0 0.3 3.2 0.1 0.1 0.0 0.0 10.2 0.2 0.3 1.3 0.0 0.0 0.0 14.6 0.2 2.6 0.0 0.0 0.0 8.3 0.2 0.4 0.1 0.0 0.4 19.0 0.0 33.7 0.3 0.5 0.1 0.0 1.0 0.0 0.0 0.4 1.7 30.4 0.0 0.0 0.3 0.4 5.2 0.3 0.0 0.0 0.0 0.1 0.6 11.3 1.0 8.2 0.0 0.0 0.4 4.7 0.6 0.0 0.1 0.0 5.3 0.0 0.2 0.4 3.9 2.5 0.0 0.0 0.8 3.0 1.3 0.0 0.1 H2AC21 HIST2H2AB ENSG00000184270 "H2A clustered histone 21" Q8IUE6 1 149887469-149887965 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011483: AB_732909, HPA041189: AB_2677357" "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 0.2 0.1 3.7 0.0 5.7 3.5 0.3 16.7 3.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 9.5 0.1 0.1 0.2 0.0 2.8 2.1 2.9 0.3 0.1 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.5 0.0 2.7 0.3 0.1 0.1 1.9 0.3 0.1 0.0 0.0 0.1 0.2 4.8 0.5 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.3 0.4 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.7 0.2 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.3 0.2 0.0 3.3 1.9 0.4 0.3 0.5 0.7 0.2 0.7 0.0 0.1 0.6 0.4 0.8 0.0 0.1 0.0 0.2 1.4 0.0 0.3 1.2 0.0 0.3 1.6 1.9 0.5 0.6 0.1 0.2 1.5 1.9 0.8 2.2 1.7 2.0 3.7 3.7 3.3 2.1 6.6 2.3 2.5 9.8 3.6 2.0 4.0 2.0 0.5 3.7 5.7 16.7 3.3 2.4 9.5 2.8 2.1 2.9 4.1 2.7 1.9 4.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 POU6F1 "BRN5, MPOU, TCFB1" ENSG00000184271 "POU class 6 homeobox 1" 12 51186936-51217708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Excitatory neurons: 22.2;Inhibitory neurons: 29.4;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 23.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 5.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047021, HPA050411" Enhanced Supported "Nuclear bodies,Actin filaments" NA NA "Nuclear bodies" "Actin filaments" "HPA047021: AB_2679905, HPA050411: AB_2681119" "unprognostic (4.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.48e-3)" "unprognostic (1.45e-2)" "unprognostic (2.72e-1)" "unprognostic (6.58e-2)" "unprognostic (9.70e-2)" "unprognostic (7.11e-3)" "unprognostic (4.45e-1)" "unprognostic (2.05e-1)" "prognostic favorable (6.61e-4)" "unprognostic (2.48e-2)" "unprognostic (9.36e-2)" "unprognostic (2.09e-3)" "unprognostic (1.74e-1)" "unprognostic (2.02e-1)" "unprognostic (2.33e-1)" 2.0 1.5 0.2 1.2 1.0 0.4 1.7 2.1 5.1 3.1 0.0 1.9 0.6 2.5 0.1 0.7 2.2 1.2 1.1 1.2 0.0 1.2 0.5 1.8 0.8 0.5 0.0 0.0 3.2 1.3 0.8 2.6 0.6 1.2 2.1 0.2 1.3 2.1 1.4 4.0 1.4 1.5 1.5 0.0 1.5 1.3 0.3 0.2 0.2 2.3 1.3 0.5 1.8 1.7 2.0 0.3 0.8 1.0 1.4 0.3 1.2 0.5 0.5 0.6 0.6 0.7 0.1 0.5 1.8 0.2 0.4 0.3 0.0 1.2 0.0 0.0 2.8 1.8 0.5 1.1 0.0 1.0 0.4 2.4 0.6 0.5 1.0 0.1 1.4 2.0 0.7 0.7 4.9 0.3 0.0 0.2 0.7 1.8 0.0 0.0 0.5 0.6 0.0 0.3 0.0 1.3 2.2 1.2 0.0 2.3 0.5 0.5 1.7 1.5 1.1 0.9 0.3 1.3 3.2 2.8 0.2 1.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 2.1 5.1 1.2 0.0 0.5 0.0 0.0 1.2 0.0 0.2 2.0 4.5 6.4 2.8 20.9 2.1 3.1 1.3 0.4 0.0 10.0 2.3 1.3 3.1 1.5 1.7 7.3 4.2 0.6 1.1 0.1 1.9 0.8 5.3 0.9 1.7 4.8 0.0 2.7 22.2 2.0 0.2 3.2 0.5 1.6 5.1 2.4 3.6 1.2 0.3 1.7 29.4 0.3 4.1 2.2 3.9 3.7 5.9 1.1 1.8 8.4 1.7 3.7 0.0 21.1 23.6 1.6 0.2 6.8 0.7 1.8 0.0 0.7 2.7 7.9 0.0 3.8 4.1 0.1 0.7 0.5 2.8 0.4 1.8 0.2 0.6 0.7 DEFB108B ENSG00000184276 "Defensin beta 108B" Q8NET1 11 71833200-71837710 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 82 "epididymis: 13.0" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 31.2 38.7 65.3 23.7 70.7 28.4 34.3 64.7 71.2 37.0 59.6 29.6 24.8 41.2 43.9 24.1 34.5 29.9 45.9 68.4 73.6 32.5 58.5 28.3 30.8 62.6 67.7 67.1 56.2 30.5 41.0 36.0 31.9 64.8 33.0 24.4 32.6 34.7 35.6 44.9 27.2 26.4 32.4 63.0 29.4 29.3 28.2 68.1 29.8 45.6 56.2 32.0 33.1 28.8 68.9 20.1 48.9 25.6 46.6 71.9 53.1 31.3 25.9 42.6 30.0 33.4 26.4 55.5 32.5 34.9 35.5 50.7 45.9 40.3 33.3 23.7 31.2 88.4 48.7 39.9 45.4 47.2 38.4 55.8 44.2 66.3 18.1 37.4 42.1 42.1 41.5 40.6 47.8 47.9 40.8 28.3 40.2 39.5 90.4 16.2 33.9 32.3 51.0 61.5 52.0 34.3 31.3 35.8 37.4 54.3 43.7 35.5 49.8 33.7 31.6 32.5 21.2 28.9 45.0 71.2 35.3 26.9 47.5 26.7 36.4 40.6 81.9 41.2 41.9 46.4 30.6 33.6 31.6 29.1 44.8 44.1 41.4 69.6 52.4 32.4 24.6 38.4 41.3 65.3 70.7 64.7 71.2 68.4 73.6 62.6 67.7 67.1 64.8 63.0 68.1 68.9 52.4 25.6 28.7 22.2 55.8 66.3 58.5 142.3 32.5 47.1 42.6 45.8 35.7 35.8 67.9 42.3 33.3 73.7 51.9 23.0 19.6 61.0 8.0 28.1 38.2 48.8 27.0 30.3 41.5 42.3 64.7 53.7 23.0 44.8 25.3 37.6 60.3 56.6 32.3 69.0 55.3 23.2 91.6 42.1 36.4 10.8 73.7 39.2 26.6 37.5 44.4 60.6 56.7 29.1 45.8 27.8 20.7 62.8 41.3 66.6 32.6 39.5 47.2 46.8 72.3 40.1 67.0 89.3 84.2 25.0 55.4 91.0 55.1 21.5 27.8 40.0 TSSC4 ENSG00000184281 "Tumor suppressing subtransferable candidate 4" Q9Y5U2 11 2400488-2403878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041801, HPA058763" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041801: AB_10793934, HPA058763: AB_2683811" "unprognostic (1.98e-1)" "unprognostic (9.22e-2)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" "unprognostic (8.13e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "unprognostic (1.13e-1)" "unprognostic (3.29e-2)" "unprognostic (2.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (6.50e-2)" "unprognostic (1.32e-2)" "unprognostic (7.38e-2)" 32.6 26.2 23.5 16.7 23.4 42.9 31.1 23.5 32.8 33.7 19.5 38.2 17.8 43.4 6.5 33.8 37.1 16.1 34.9 21.5 22.0 30.2 47.2 32.1 21.3 23.6 23.3 20.9 31.3 28.6 9.7 31.6 12.0 23.9 40.0 6.1 6.0 25.3 19.5 62.8 39.0 29.5 13.2 23.2 39.4 31.7 73.2 23.9 17.3 29.9 16.8 10.5 40.0 29.6 24.5 48.1 62.4 18.9 29.8 15.4 11.1 35.8 31.9 21.8 38.0 26.1 46.8 60.2 34.9 27.6 24.8 42.6 46.6 21.5 37.5 7.1 40.7 66.7 20.3 34.7 47.3 43.0 35.9 40.5 27.3 51.9 24.2 22.7 16.2 27.2 33.7 47.0 37.5 18.0 64.7 41.9 61.9 54.4 35.7 74.3 46.6 17.2 30.6 19.0 42.0 48.7 49.2 28.3 59.8 38.5 9.7 31.4 40.8 36.1 49.4 26.0 47.3 37.2 73.8 70.3 29.1 42.9 35.4 53.1 105.4 64.9 69.6 64.2 58.7 68.9 64.1 63.6 66.6 67.3 87.2 56.6 53.3 64.0 70.5 65.5 65.0 74.9 57.6 23.5 23.4 23.5 32.8 21.5 22.0 23.6 23.3 20.9 23.9 23.2 23.9 24.5 56.4 19.2 17.8 8.1 33.8 67.3 56.3 59.0 18.2 35.3 36.0 36.2 20.5 31.5 34.0 12.9 12.5 50.9 44.3 72.7 50.9 55.0 88.1 31.6 31.9 42.4 57.3 52.8 4.0 50.5 45.9 32.4 29.6 31.6 17.2 33.4 37.5 32.0 39.0 28.6 4.1 44.9 63.1 29.8 34.9 178.8 44.4 32.3 32.0 6.5 53.4 43.7 57.7 5.5 6.8 62.3 53.9 33.8 27.9 71.9 58.2 46.7 20.9 40.6 39.5 43.3 45.6 129.3 73.1 27.9 82.3 82.1 38.2 38.9 46.9 55.8 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575433-58577252 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 997.5;salivary gland: 472.3;skin 1: 424.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 6559.0;Basal respiratory cells: 3141.0;Club cells: 2499.0;Prostatic glandular cells: 3724.1;Squamous epithelial cells: 2716.6;Urothelial cells: 8102.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 15.0" "Group enriched" "Detected in many" 79 "dendritic cells: 4.3;granulocytes: 15.0;monocytes: 4.2" "Cell line enhanced" "Detected in many" "A-431: 766.6;CAPAN-2: 1005.9;HaCaT: 1010.0;RT4: 355.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favorable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 3.7 1.2 0.3 1.3 0.3 13.6 137.1 0.3 0.4 111.6 1.7 1.0 0.7 19.3 25.6 997.5 27.9 13.1 0.7 0.3 0.4 80.4 4.1 71.8 1.0 0.3 0.3 0.2 1.5 81.7 3.5 2.4 17.8 0.3 127.9 0.9 0.0 472.3 98.0 1.9 424.2 1.2 2.0 0.2 1.0 66.3 0.5 0.3 9.3 5.0 0.3 181.5 236.8 378.1 0.7 766.6 0.1 0.0 1.5 0.0 0.0 280.1 0.2 0.0 0.0 0.1 0.7 1005.9 0.1 94.7 64.2 0.1 1010.0 0.0 186.5 0.0 0.7 0.0 0.2 19.7 0.3 0.3 0.1 0.8 0.2 274.5 0.4 11.3 0.0 42.5 0.0 0.2 1.3 0.0 166.3 0.6 1.1 0.5 167.0 1.4 0.2 0.1 0.6 137.0 355.3 0.2 0.3 32.4 264.9 1.0 3.2 173.6 1.5 45.4 1.0 1.7 0.8 1.7 0.4 0.9 0.7 1.0 0.3 0.7 0.0 4.2 15.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.8 0.3 0.3 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.7 9.0 346.1 109.2 0.0 3.1 1490.5 6559.0 3141.0 1226.5 0.0 789.8 445.6 0.4 338.8 2499.0 1278.2 0.0 107.1 9.1 2.8 43.0 2165.2 0.0 482.3 48.6 60.4 0.0 0.0 0.1 1263.4 8.1 36.3 143.2 608.7 8.8 0.2 1.4 0.5 8.8 0.0 0.0 8.5 1143.4 0.8 203.4 0.0 0.0 34.8 113.8 0.0 31.3 0.0 0.0 0.0 0.6 1778.0 3.6 0.0 1.4 3724.1 0.2 3.4 1080.4 0.0 0.0 1.3 142.4 0.4 1.1 2716.6 1531.8 78.4 32.8 0.0 1.5 8102.8 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 10.0;lymphoid tissue: 31.4" "Group enriched" "Detected in some" 4 "B-cells: 87.0;dendritic cells: 24.0;Hofbauer cells: 22.2;Kupffer cells: 82.3;Langerhans cells: 64.6;Macrophages: 23.9;monocytes: 55.9;Plasma cells: 42.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory B-cell: 120.9" "Lineage enriched" "Detected in many" 5 "B-cells: 120.9" "Group enriched" "Detected in some" 5 "HEL: 49.7;Karpas-707: 66.2;U-698: 173.0;U-937: 95.6" "Low region specificity" "Detected in many" HPA063928 Supported "Plasma membrane,Centriolar satellite" NA NA "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 1.1 1.6 0.9 10.0 1.1 1.9 2.1 1.6 2.1 0.9 1.7 3.0 2.7 0.9 0.0 0.7 0.8 2.5 0.4 1.1 1.2 0.4 2.1 2.1 25.0 1.5 1.3 0.5 0.5 0.2 0.3 0.3 0.7 1.6 0.7 4.3 0.1 1.3 0.5 0.1 0.4 10.0 1.8 1.9 16.4 4.5 0.9 1.3 5.3 0.6 0.2 31.4 3.0 0.3 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.2 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.1 0.2 1.2 173.0 0.0 95.6 0.0 2.4 7.9 0.4 4.5 14.4 0.1 120.9 3.9 9.7 18.7 54.3 0.2 1.4 0.3 0.3 15.5 25.4 0.2 5.2 0.9 1.1 1.6 2.1 1.1 1.2 1.5 1.3 0.5 1.6 1.9 1.3 2.8 0.3 0.0 0.0 0.0 87.0 2.0 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.0 1.8 0.0 0.0 0.1 24.0 0.1 0.0 0.0 1.0 0.1 0.1 0.3 0.0 4.4 0.0 0.2 0.1 0.6 0.0 0.1 5.1 0.0 0.4 0.4 22.2 0.0 0.0 0.2 0.0 82.3 64.6 1.4 0.3 23.9 12.4 1.0 55.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 0.4 0.0 0.0 6.6 0.1 0.1 0.0 0.2 0.1 1.8 0.3 11.2 0.0 0.0 0.1 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60509146-60512850 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.4;pituitary gland: 28.6;retina: 6.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 29.2;Horizontal cells: 48.8;Muller glia cells: 160.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Group enriched" "Detected in some" 25 "hypothalamus: 7.4;thalamus: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 13.4;MOLT-4: 44.0" "Region enriched" "Detected in single" 14 "hypothalamus: 3.6" "Region enriched" "Detected in single" 12 "hypothalamus: 1.6" HPA001403 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 44.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 1.3 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PRKD1 "PKC-mu, PKCM, PKD, PRKCM" ENSG00000184304 "Protein kinase D1" Q15139 14 29576479-30191898 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 362.1;Excitatory neurons: 147.4;Inhibitory neurons: 171.1;Microglial cells: 89.0;Oligodendrocyte precursor cells: 390.6" "Cancer enhanced" "Detected in all" "prostate cancer: 10.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 21.6;fHDF/TERT166: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018367, HPA029834" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB018367: AB_2253119, HPA029834: AB_10602821" "unprognostic (5.35e-2)" "unprognostic (3.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.70e-2)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-3)" "unprognostic (8.88e-2)" "unprognostic (2.37e-2)" "unprognostic (5.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.56e-1)" "prognostic favorable (2.44e-5)" "unprognostic (9.45e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.89e-1)" 7.6 9.7 8.3 2.2 8.1 0.0 7.7 7.2 6.0 5.8 3.8 7.2 1.0 7.9 3.6 2.1 6.5 4.4 4.8 7.5 9.6 11.7 1.6 7.5 0.3 9.3 7.9 4.7 11.3 5.5 10.7 5.7 1.9 8.1 14.8 1.3 4.7 2.9 9.3 1.7 2.7 3.6 6.4 8.3 2.3 4.6 11.7 7.0 2.5 6.0 2.6 0.6 13.2 4.7 10.3 0.0 4.4 4.8 3.1 21.6 16.5 0.1 14.1 10.4 16.7 7.3 0.0 0.3 0.0 1.9 19.4 4.0 0.1 7.9 2.1 6.8 0.0 6.2 0.0 0.0 0.5 8.8 0.0 0.1 18.4 0.3 1.4 1.5 6.1 2.6 0.0 1.4 0.4 17.4 1.8 0.0 0.0 2.6 0.0 9.6 0.0 6.3 5.2 9.7 6.6 4.3 13.0 2.6 0.0 4.5 4.6 0.0 0.1 5.6 13.6 6.7 1.0 3.7 0.0 0.0 0.0 3.5 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 8.1 7.2 6.0 7.5 9.6 9.3 7.9 4.7 8.1 8.3 7.0 10.3 4.6 0.0 7.4 362.1 0.2 0.5 4.8 0.4 0.6 1.4 1.4 1.5 1.2 10.0 0.0 12.9 6.2 0.0 0.0 0.1 29.4 2.4 39.5 2.8 9.2 6.1 3.0 2.7 147.4 4.2 0.1 6.4 0.5 8.4 0.0 18.7 10.8 2.5 0.2 1.7 171.1 0.2 0.0 1.6 0.9 16.9 7.5 0.7 7.2 89.0 0.0 16.7 0.0 390.6 76.6 2.0 0.1 12.8 0.4 12.4 0.2 4.5 0.1 2.9 0.0 13.3 4.5 3.2 7.8 0.0 0.9 0.3 0.6 29.6 0.1 1.3 CCSER1 "FAM190A, KIAA1680" ENSG00000184305 "Coiled-coil serine rich protein 1" Q9C0I3 4 90127535-91601913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.9;retina: 3.6" "Group enriched" "Detected in many" 4 "Excitatory neurons: 1954.8;Inhibitory neurons: 1639.5;Oligodendrocyte precursor cells: 577.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;OE19: 2.4;RT4: 1.2;SCLC-21H: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041880, HPA054709" Uncertain NA NA "HPA041880: AB_10796461, HPA054709: AB_2682581" "unprognostic (4.03e-4)" "unprognostic (4.21e-3)" "unprognostic (6.45e-2)" "unprognostic (2.44e-2)" "unprognostic (3.32e-1)" "unprognostic (3.45e-2)" "unprognostic (5.61e-2)" "unprognostic (8.13e-2)" "unprognostic (1.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.87e-1)" "unprognostic (2.04e-1)" "unprognostic (2.42e-6)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (1.64e-4)" "unprognostic (6.94e-2)" 0.2 1.3 1.0 0.2 1.8 0.7 0.9 2.5 2.9 0.1 0.1 0.3 0.3 0.3 0.3 0.2 0.8 0.3 1.0 2.4 0.7 1.1 0.1 0.2 0.4 0.6 0.3 0.9 0.1 0.6 0.3 0.4 0.1 0.7 0.5 0.2 3.6 1.1 0.3 0.0 0.5 0.4 0.2 0.0 0.4 0.4 2.6 0.8 0.3 0.9 0.1 0.2 0.6 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.1 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 2.4 0.2 0.0 0.0 0.1 0.1 1.2 1.3 0.4 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 2.5 2.9 2.4 0.7 0.6 0.3 0.9 0.7 0.0 0.8 2.2 12.4 6.4 3.2 72.5 21.4 4.5 11.9 0.1 15.9 23.7 5.5 4.4 11.1 1.5 2.2 3.7 177.2 3.6 0.2 9.0 9.8 1.2 261.8 2.4 0.4 3.1 3.5 2.5 1954.8 3.5 5.6 0.9 23.4 4.8 5.1 0.8 3.3 0.2 1.0 5.0 1639.5 10.9 2.0 0.6 8.6 339.4 3.1 5.7 1.8 89.0 2.4 2.6 0.0 577.5 33.7 4.9 7.7 1.2 5.7 8.8 13.0 2.6 0.2 78.8 6.6 0.4 0.5 5.6 4.7 1.6 2.3 1.8 0.5 0.3 5.1 14.9 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type palmitoyltransferase 23" Q8IYP9 3 113947901-113965401 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 26.7;Excitatory neurons: 72.2;Late spermatids: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favorable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 1.0 3.3 3.0 8.3 1.2 2.6 0.0 5.8 1.3 10.8 9.5 7.4 1.2 1.5 1.5 2.4 1.6 1.0 7.0 2.6 5.6 4.0 3.3 2.8 0.1 0.0 8.2 0.9 4.8 7.4 3.2 0.9 1.3 2.5 11.6 3.6 6.6 1.8 1.2 3.8 6.9 1.3 0.0 2.4 6.3 12.3 0.6 1.2 6.2 0.9 3.8 1.9 1.5 4.7 17.8 4.4 0.5 10.1 1.5 0.3 14.8 6.9 2.1 1.3 2.0 7.1 11.6 8.1 5.9 4.0 11.0 11.4 13.0 1.9 2.2 4.9 6.0 7.5 7.0 4.4 0.5 8.5 6.7 0.3 2.2 0.3 0.8 1.6 1.1 8.5 0.0 4.6 0.2 10.2 7.0 0.5 3.1 18.2 4.9 1.2 5.8 6.8 7.0 8.6 17.6 4.4 5.3 17.5 3.3 3.9 10.5 2.7 0.3 4.8 9.6 1.0 3.1 5.2 7.3 13.2 4.1 5.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 3.3 8.3 0.0 5.8 7.0 2.6 0.1 0.0 8.2 1.3 0.0 0.6 4.7 3.3 0.0 1.5 12.1 10.5 3.1 2.0 2.3 0.6 2.1 4.8 4.2 1.4 7.2 2.2 16.5 8.4 0.9 2.7 21.8 0.0 2.1 26.7 13.6 1.6 2.8 13.8 0.4 72.2 1.9 1.6 1.0 9.2 8.5 0.0 3.2 4.2 6.4 0.4 0.0 4.0 12.7 0.0 0.3 2.2 41.0 1.2 1.3 3.6 2.8 1.0 4.2 0.0 2.5 5.4 0.7 8.3 0.0 2.3 3.9 10.9 4.4 8.7 0.9 0.0 1.7 0.7 18.2 2.9 2.1 2.7 0.3 1.3 0.9 12.6 1.7 MROH7 "C1orf175, FLJ46354, HEATR8" ENSG00000184313 "Maestro heat like repeat family member 7" Q68CQ1 1 54641754-54710266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 55.9" "Group enriched" "Detected in some" 57 "Early spermatids: 179.0;Late spermatids: 546.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071840 Enhanced NA NA "HPA071840: AB_2732187" "unprognostic (1.52e-3)" "unprognostic (1.51e-3)" "unprognostic (1.65e-2)" "unprognostic (2.77e-4)" "unprognostic (1.81e-1)" "unprognostic (9.88e-4)" "unprognostic (1.09e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (4.16e-2)" "unprognostic (1.79e-2)" "unprognostic (7.93e-2)" "unprognostic (7.40e-3)" "unprognostic (2.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.15e-2)" 0.2 0.6 2.7 0.0 2.2 0.7 0.2 2.9 2.9 0.7 6.0 2.5 0.1 1.1 1.0 0.6 1.3 0.2 2.5 2.1 3.4 2.3 1.1 0.4 0.1 2.9 2.6 1.6 2.9 0.3 0.5 4.3 0.0 2.8 2.3 0.3 0.5 1.8 0.7 0.7 1.0 1.4 0.1 2.3 0.2 1.7 55.9 2.7 0.0 5.3 0.2 0.0 1.8 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.2 2.9 2.9 2.1 3.4 2.9 2.6 1.6 2.8 2.3 2.7 2.2 0.0 0.0 1.3 0.0 0.2 0.9 0.9 0.1 0.0 1.7 0.3 0.5 4.0 0.0 1.4 0.0 0.0 0.0 0.0 4.0 0.0 0.1 179.0 1.1 0.2 0.3 2.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 5.1 0.3 0.4 0.3 0.4 0.0 0.0 3.0 0.0 1.0 0.7 546.1 4.4 0.5 0.0 0.0 0.7 2.5 0.0 0.0 0.0 0.1 6.1 4.5 0.0 0.3 5.0 0.2 1.0 0.4 0.0 1.9 0.2 6.3 2.8 0.0 0.4 0.1 0.2 0.5 2.2 1.1 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416520-153423222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 5.7;lymphoid tissue: 5.9;skin 1: 1.6;vagina: 2.7" "Group enriched" "Detected in some" 8 "Early spermatids: 2.8;Late spermatids: 3.0;Suprabasal keratinocytes: 1.8" "Group enriched" "Detected in many" 4 "head and neck cancer: 25.6;melanoma: 12.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA006997 Supported Uncertain Cytosol NA NA Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 SRPK3 "MSSK1, STK23" ENSG00000184343 "SRSF protein kinase 3" Q9UPE1 X 153776412-153785732 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 213.4;tongue: 77.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 25.0;Cone photoreceptor cells: 8.4;Oligodendrocytes: 7.4;Skeletal myocytes: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 47.0;U-266/70: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.79e-3)" "unprognostic (6.21e-2)" "unprognostic (1.79e-2)" "unprognostic (7.24e-2)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-1)" "unprognostic (4.47e-4)" "unprognostic (2.83e-1)" "unprognostic (1.71e-1)" "unprognostic (4.10e-4)" "unprognostic (8.70e-2)" "unprognostic (5.38e-7)" "unprognostic (1.97e-2)" "unprognostic (1.97e-1)" "unprognostic (3.83e-2)" "unprognostic (1.07e-4)" 1.3 4.3 11.4 2.2 15.1 2.2 1.4 18.4 19.3 3.1 7.8 12.4 3.3 8.5 1.6 6.6 2.9 1.5 45.4 10.9 11.9 0.8 0.7 1.1 2.2 13.6 13.6 10.0 2.3 1.6 1.4 18.9 0.5 16.5 7.9 1.7 1.8 7.6 1.1 213.4 5.8 4.0 3.1 11.0 1.9 5.1 1.1 15.0 0.4 0.6 77.5 0.1 6.8 2.7 21.8 5.1 6.7 1.2 3.3 0.0 0.2 1.5 0.6 0.0 0.3 0.1 5.7 0.9 5.1 0.6 0.6 0.5 1.4 0.0 0.1 0.0 4.4 4.6 2.7 5.1 0.9 0.1 1.3 7.6 4.1 0.0 0.0 0.0 0.3 0.0 7.1 3.5 5.8 1.3 10.8 1.0 7.5 1.2 0.3 1.8 2.3 47.0 1.5 0.1 2.3 8.0 3.8 0.0 3.5 1.6 0.5 4.4 5.8 0.1 1.8 4.2 3.5 0.7 19.4 3.5 3.3 1.0 9.5 2.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.4 15.1 18.4 19.3 10.9 11.9 13.6 13.6 10.0 16.5 11.0 15.0 21.8 0.1 0.0 0.0 3.3 0.0 0.6 1.0 0.1 0.0 4.3 2.5 1.0 25.0 0.0 0.1 0.0 8.4 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.2 0.5 1.2 0.0 0.7 0.0 0.1 1.1 1.5 0.2 0.0 0.2 0.0 0.0 0.0 1.7 1.8 4.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.1 0.5 0.0 0.5 7.4 0.0 0.0 3.0 0.2 0.7 0.0 0.0 0.1 0.5 0.0 18.9 2.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.6 0.4 GDF3 ENSG00000184344 "Growth differentiation factor 3" Q9NR23 12 7689784-7695775 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "kidney: 1.0" "Cell type enriched" "Detected in some" 25 "Granulosa cells: 30.2" "Cancer enriched" "Detected in some" 422 "testis cancer: 383.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "NTERA-2: 452.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA018468 Uncertain "Secreted to blood" NA NA "HPA018468: AB_1849586" "unprognostic (9.48e-2)" "unprognostic (3.90e-2)" "unprognostic (3.30e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-1)" "unprognostic (5.40e-2)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (2.89e-1)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (1.25e-3)" "unprognostic (8.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.45e-1)" "unprognostic (2.03e-1)" 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 452.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 77.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF2 ENSG00000184345 "IQ motif containing F2" Q8IXL9 3 51861615-51863424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 64 "testis: 14.1" "Group enriched" "Detected in some" 187 "Early spermatids: 1040.3;Late spermatids: 2718.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1040.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2718.3 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLIT3 "MEGF5, SLIL2, Slit-3, SLIT1, slit2" ENSG00000184347 "Slit guidance ligand 3" O75094 5 168661733-169301139 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 12.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051630 Approved Supported "Cell Junctions" "Secreted in other tissues" NA NA "Cell Junctions" "HPA051630: AB_2681557" "unprognostic (2.86e-2)" "unprognostic (2.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-2)" "unprognostic (3.53e-2)" "unprognostic (9.21e-3)" "unprognostic (3.06e-2)" "unprognostic (1.71e-1)" "unprognostic (9.50e-3)" "unprognostic (1.57e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.45e-5)" "unprognostic (5.90e-3)" "unprognostic (8.56e-2)" "unprognostic (4.27e-1)" "unprognostic (3.53e-1)" 62.5 20.9 6.5 12.0 11.2 0.1 33.0 12.3 7.7 36.7 3.2 17.2 5.5 24.1 8.9 21.6 22.4 43.9 40.1 12.9 4.9 13.2 1.5 38.4 6.2 11.6 1.7 6.2 17.1 7.9 45.2 4.4 21.9 12.1 10.4 9.8 3.1 17.0 15.5 4.4 21.9 10.5 27.4 0.3 14.4 10.1 2.7 6.0 20.2 23.4 6.5 4.2 56.1 24.6 6.3 0.0 11.0 0.1 0.0 310.3 5.7 0.0 18.1 3.1 4.0 8.4 0.1 0.0 0.0 4.2 116.0 13.1 0.0 2.9 1.2 0.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.8 4.2 0.5 3.9 44.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 101.1 1.1 73.3 0.0 0.0 0.0 12.5 0.0 0.0 0.0 3.0 1.9 25.5 0.1 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 6.5 11.2 12.3 7.7 12.9 4.9 11.6 1.7 6.2 12.1 0.3 6.0 6.3 11.7 0.0 2.3 4.2 0.5 26.6 1.8 5.5 3.4 8.6 1.1 3.8 25.9 0.0 0.4 0.0 0.0 2.3 0.5 0.0 0.0 0.2 11.9 1.3 35.7 5.4 0.0 0.0 202.3 0.0 0.5 112.7 4.6 3.6 1.3 0.5 1.8 0.0 1.2 0.0 20.2 0.0 0.0 0.0 32.5 8.2 0.9 1.1 35.6 14.0 0.0 13.7 0.0 8.0 2.9 0.0 0.0 0.4 0.8 1.1 0.1 1.9 0.2 0.9 85.5 1.8 99.3 1.2 2.2 1.1 17.6 1.1 1.8 0.3 0.0 0.8 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376894-107670937 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Astrocytes: 291.2;Excitatory neurons: 798.5;Inhibitory neurons: 373.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 35.2;RPTEC TERT1: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol NA Yes 10000 "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: AB_2682355" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.92e-7)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 4.1 1.1 2.6 2.0 6.4 0.1 4.0 1.3 13.9 10.2 0.1 2.3 0.8 1.1 2.0 7.2 2.9 2.7 6.8 2.7 7.7 3.5 0.3 2.5 0.8 1.5 0.7 3.1 4.1 0.5 2.5 2.7 2.4 3.1 4.3 2.4 2.5 5.7 4.8 0.5 9.8 0.8 2.2 0.0 5.4 2.5 1.4 1.6 1.4 1.0 1.4 2.5 3.5 4.9 5.6 12.7 22.2 35.2 0.0 16.7 14.2 3.6 0.3 6.3 4.5 11.6 0.2 13.9 0.0 20.5 2.4 7.1 13.1 19.4 18.0 3.6 0.0 12.9 0.1 11.9 0.0 3.1 0.6 0.0 16.0 15.4 0.0 14.4 3.9 13.8 0.0 0.0 0.0 8.3 12.0 0.0 0.0 4.6 0.1 1.9 0.0 16.9 0.4 50.9 15.5 5.8 14.7 6.0 8.9 3.8 11.2 3.9 2.2 0.2 28.3 5.0 17.4 7.1 1.2 0.0 8.3 12.4 0.8 31.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.1 2.6 6.4 1.3 13.9 2.7 7.7 1.5 0.7 3.1 3.1 0.0 1.6 5.6 1.1 9.6 24.4 291.2 0.0 15.9 22.5 18.5 6.2 4.3 11.8 8.5 30.6 11.5 26.0 14.7 0.0 20.3 3.3 4.3 23.5 1.7 1.8 3.2 14.8 8.2 12.0 0.0 798.5 1.3 3.3 16.9 5.6 6.3 0.0 0.1 9.7 0.0 1.7 6.7 373.1 8.5 18.3 0.3 7.0 3.7 18.3 0.4 8.8 37.5 3.6 4.7 2.1 26.2 8.7 13.9 4.9 21.8 1.7 14.1 0.0 0.1 19.6 1.4 0.0 1.3 3.7 0.1 4.0 14.9 24.2 3.8 2.2 2.3 5.9 23.1 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3225030-3232417 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 34 "brain: 26.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 1.0;RPMI-8226: 2.7;SCLC-21H: 3.9" "Low region specificity" "Detected in all" HPA046556 Uncertain NA NA "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.0 0.3 1.9 0.0 2.3 0.6 0.1 4.0 5.5 0.7 0.0 0.2 0.0 0.5 0.3 0.1 0.6 0.1 0.4 0.3 6.3 0.0 0.0 0.0 0.0 22.5 5.9 0.2 0.0 0.1 0.0 0.1 0.1 26.4 0.2 0.0 0.6 0.2 0.3 0.0 0.1 0.1 0.2 2.5 0.4 0.0 0.0 3.9 0.0 0.2 0.1 0.0 0.1 0.4 16.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.3 4.0 5.5 0.3 6.3 22.5 5.9 0.2 26.4 2.5 3.9 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-1 KAP19.1 ENSG00000184351 "Keratin associated protein 19-1" Q8IUB9 21 30479706-30480367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 83 "skin 1: 10.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 19 "melanoma: 17.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HEK 293: 20.8" NA NA "unprognostic (2.36e-2)" "unprognostic (8.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 H1-5 "H1b, H1F5, H1s-3, HIST1H1B" ENSG00000184357 "H1.5 linker histone, cluster member" P16401 6 27866792-27867588 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 7.8;brain: 7.3;choroid plexus: 3.9;lymphoid tissue: 2.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3" "Cell line enhanced" "Detected in some" "MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9" "Not detected" "Not detected" "CAB012241, HPA055907, HPA060331" Supported Supported Nucleoplasm NA NA 2300000 Nucleoplasm "CAB012241: , HPA055907: AB_2682966, HPA060331: " "unprognostic (2.34e-1)" "unprognostic (3.75e-4)" "unprognostic (2.12e-2)" "unprognostic (3.63e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.20e-1)" "unprognostic (8.47e-2)" "unprognostic (6.23e-3)" "unprognostic (5.85e-2)" "unprognostic (5.68e-4)" "unprognostic (2.10e-1)" "unprognostic (9.79e-2)" "unprognostic (1.35e-1)" 0.0 0.0 2.7 0.2 0.7 7.8 0.1 4.0 0.8 0.0 3.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 3.9 0.0 0.0 0.1 1.6 1.9 1.6 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 2.2 0.4 0.1 0.1 3.7 2.1 0.0 0.0 0.3 0.3 0.0 7.3 1.4 0.0 0.5 0.0 0.0 0.0 1.0 0.4 0.3 0.7 0.3 0.4 0.9 1.7 0.2 0.5 0.4 0.5 0.0 0.0 0.0 0.6 0.8 2.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.5 1.1 1.7 1.2 0.0 0.2 9.2 4.9 1.4 1.3 0.0 2.7 0.0 0.0 0.2 0.0 1.2 0.6 1.5 0.3 0.0 0.4 0.6 1.6 0.5 0.8 0.1 0.8 0.6 1.8 0.0 3.9 1.2 0.6 0.8 0.0 0.9 0.0 3.1 0.8 1.5 4.6 2.9 3.2 5.1 10.3 1.7 1.9 0.8 1.7 1.1 12.1 3.3 2.1 2.7 0.7 4.0 0.8 0.5 3.9 1.9 1.6 0.0 2.3 2.2 3.7 7.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 SPATA32 "AEP2, C17orf46, FLJ25414, TEX34, VAD1.2" ENSG00000184361 "Spermatogenesis associated 32" Q96LK8 17 45254393-45262094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 76 "testis: 44.0" "Group enriched" "Detected in some" 98 "Early spermatids: 194.2;Late spermatids: 615.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA024549 Approved NA NA "HPA024549: AB_1845589" "unprognostic (5.27e-2)" "unprognostic (1.15e-1)" "unprognostic (5.88e-2)" "unprognostic (1.79e-4)" "unprognostic (7.84e-2)" "unprognostic (1.36e-2)" "unprognostic (3.58e-1)" "unprognostic (6.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-1)" "unprognostic (2.87e-3)" "unprognostic (8.93e-4)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.75e-4)" 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.0 0.3 0.6 0.3 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 194.2 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 615.3 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 2.7 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 296.8;skin 1: 218.8;vagina: 105.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0" "Region enriched" "Detected in single" 37 "cerebellum: 8.9" "Low region specificity" "Detected in all" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: AB_2684908" "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavorable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 0.8 0.1 0.2 3.7 0.2 0.0 9.2 0.1 0.4 25.7 0.0 23.7 31.3 1.4 4.8 296.8 7.5 4.9 0.6 0.2 0.2 1.6 0.8 9.8 0.1 0.5 0.2 0.3 0.3 27.7 9.2 16.0 11.0 0.5 20.0 10.3 0.0 53.2 5.1 1.0 218.8 28.8 0.5 0.2 0.2 29.4 0.7 0.2 2.5 12.9 0.1 8.8 9.3 105.2 0.3 151.3 28.8 0.0 0.6 0.1 0.2 60.3 1.2 1.0 3.1 1.6 59.2 102.6 0.1 6.0 1.1 6.4 199.1 0.0 75.1 0.5 0.1 36.9 0.1 18.0 41.7 0.6 0.0 0.3 0.5 126.9 0.5 30.8 0.5 0.5 0.0 45.3 0.9 0.4 94.9 0.5 0.2 0.3 75.6 49.1 0.8 0.3 0.6 1.6 29.9 41.1 0.7 42.7 148.0 0.2 1.8 53.8 0.4 5.4 1.0 5.2 2.7 0.8 0.2 0.4 0.1 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.2 0.5 0.2 0.3 0.5 0.2 0.2 0.3 0.2 16.0 13.0 0.0 1.1 72.1 52.0 56.1 54.7 0.2 27.7 26.5 1.1 11.5 36.8 12.9 0.0 133.8 0.4 345.0 0.0 83.8 0.0 16.1 1.8 1.8 21.7 0.0 0.2 62.9 176.8 2.3 91.3 27.4 13.4 0.4 0.0 0.3 13.2 0.0 0.0 95.1 36.7 0.3 6.5 0.4 0.9 0.9 1.8 0.0 2.0 0.6 0.0 0.0 0.0 140.2 248.9 0.0 0.2 63.5 195.6 0.9 17.9 0.2 0.0 0.0 2.8 0.2 1.7 114.1 88.7 109.7 1.6 0.0 142.9 60.4 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.1;epididymis: 36.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "basophil: 3.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051508: AB_2681513, HPA059537: AB_2684054" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.1 2.9 10.5 0.3 17.4 0.7 0.4 14.1 68.1 0.3 0.0 0.7 0.7 0.6 36.7 0.2 2.4 0.5 0.3 13.9 14.6 3.5 0.1 0.2 0.2 34.0 11.2 15.6 0.3 1.1 0.0 3.9 7.7 32.4 0.8 0.8 14.7 0.2 2.0 0.5 0.9 1.2 0.4 3.7 0.1 8.8 9.6 25.8 2.3 0.1 0.1 0.3 0.1 0.3 59.3 0.0 13.3 1.1 0.1 0.1 0.3 0.0 1.4 0.0 0.2 0.1 19.3 0.5 2.3 2.0 0.0 0.2 0.0 0.0 0.0 0.1 1.0 25.0 0.0 21.4 11.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 5.0 1.0 0.0 0.3 0.0 0.0 1.5 0.0 29.1 5.0 12.8 4.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.5 1.4 0.1 1.4 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 10.5 17.4 14.1 68.1 13.9 14.6 34.0 11.2 15.6 32.4 3.7 25.8 59.3 0.2 3.2 0.0 4.6 0.6 1.8 0.3 7.2 0.6 29.1 0.9 1.1 1.2 0.0 2.5 0.0 2.1 93.0 0.8 2.2 3.9 1.3 16.4 0.6 0.2 0.7 9.6 0.0 45.5 0.9 9.2 1.1 28.1 0.7 0.0 12.3 0.0 0.2 6.1 18.5 55.2 0.6 2.0 0.0 0.7 17.8 0.6 0.7 0.0 6.5 0.0 2.8 0.0 11.1 3.6 0.8 4.8 1.9 0.9 1.0 3.5 18.8 6.9 8.1 0.0 0.6 0.8 57.8 134.9 0.9 1.6 30.6 0.4 0.9 1.3 0.5 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 58.9;granulocytes: 113.5;Hepatic stellate cells: 53.2;Sertoli cells: 59.2;Skeletal myocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 13.2;eosinophil: 22.3" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.3" "Cell line enhanced" "Detected in many" "ASC diff: 220.0;BJ hTERT+: 149.5;GAMG: 142.1;HHSteC: 338.7;HSkMC: 216.4;hTERT-RPE1: 153.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" NA NA 270000 22000000 "Plasma membrane" "Nuclear bodies" "HPA076624: AB_2686810" "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 65.5 37.8 28.8 24.7 27.9 18.6 46.8 34.1 25.1 23.5 29.1 26.4 13.4 21.2 5.2 15.8 28.8 32.2 28.3 20.8 28.8 17.4 16.5 48.0 28.4 39.7 30.1 14.7 22.3 17.6 10.6 8.8 41.6 32.8 21.6 16.4 1.5 19.1 16.8 11.5 17.6 26.9 17.7 34.1 48.4 22.2 3.7 32.5 13.6 22.4 11.4 12.3 42.3 29.9 44.2 9.3 29.3 14.7 5.7 220.0 138.3 5.7 36.0 149.5 25.9 23.9 1.3 4.5 0.2 47.0 80.1 142.1 6.8 5.7 11.0 9.4 99.5 5.3 10.9 17.3 10.3 338.7 0.0 13.7 216.4 3.2 57.5 33.0 153.1 5.4 2.8 2.9 5.5 31.2 0.5 0.3 1.8 5.3 2.4 3.1 1.0 8.4 0.9 10.9 7.9 0.5 1.6 9.7 2.6 12.6 16.7 2.3 1.0 19.2 27.8 10.5 123.7 22.1 2.8 1.1 0.3 70.7 0.1 106.6 13.2 0.0 22.3 0.3 0.0 0.6 0.0 0.9 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.2 28.8 27.9 34.1 25.1 20.8 28.8 39.7 30.1 14.7 32.8 34.1 32.5 44.2 30.6 9.6 35.5 11.8 2.3 7.4 5.1 7.9 13.1 0.3 10.0 9.3 3.2 14.3 5.3 3.7 0.0 0.8 2.0 0.6 0.0 40.4 0.4 20.6 9.3 21.6 7.8 11.1 0.3 2.3 0.5 58.9 4.6 24.8 113.5 0.3 53.2 3.0 9.2 0.0 1.0 0.8 0.0 3.5 13.1 0.3 25.1 8.2 10.6 28.1 1.6 1.8 0.0 3.0 17.5 9.3 1.6 8.6 1.9 8.0 1.2 0.9 1.1 0.2 59.2 94.4 37.1 0.6 0.7 5.6 5.5 0.8 20.9 0.7 1.0 2.6 COLEC10 CL-L1 ENSG00000184374 "Collectin subfamily member 10" Q9Y6Z7 8 118995452-119108455 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 66.2" "Cell type enhanced" "Detected in some" "Excitatory neurons: 6.9;Hepatic stellate cells: 10.4;Inhibitory neurons: 5.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.8" "Cancer enhanced" "Detected in some" "liver cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 3.4;SK-BR-3: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 30000000 "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (3.79e-4)" "unprognostic (6.25e-3)" "unprognostic (1.80e-3)" "unprognostic (7.73e-2)" "prognostic favorable (5.79e-4)" "unprognostic (1.05e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.25e-2)" "unprognostic (9.02e-5)" "unprognostic (2.47e-1)" "unprognostic (1.82e-1)" "unprognostic (5.85e-5)" "unprognostic (7.12e-2)" 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.4 0.1 0.4 0.4 66.2 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.0 0.2 1.0 0.0 0.0 0.0 0.0 10.4 0.4 0.3 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.8 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 47.8" "Cell type enriched" "Detected in many" 6 "Early spermatids: 1021.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 18.1;HSkMC: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.6 1.0 3.6 0.7 1.8 0.4 1.1 2.4 9.7 1.5 2.2 0.9 1.1 1.1 0.8 1.0 2.1 0.9 1.0 5.5 1.7 2.5 2.7 1.2 0.8 3.0 1.8 1.5 1.6 0.6 1.2 1.4 1.0 2.8 1.2 0.8 0.8 0.6 1.9 0.7 0.4 0.8 1.6 3.1 0.4 1.3 47.8 3.2 0.8 1.5 0.7 0.9 1.7 0.7 6.4 4.0 2.5 0.2 1.1 18.1 5.5 0.0 4.7 3.0 3.1 2.6 0.0 5.2 0.0 6.5 5.9 2.0 2.5 1.5 2.5 3.3 2.9 1.7 9.3 1.9 0.5 3.0 1.1 0.9 11.8 0.6 3.8 0.7 2.0 5.8 0.9 0.0 0.0 5.7 2.0 0.2 0.1 4.5 3.5 5.3 0.6 0.0 0.1 3.3 1.0 3.1 2.1 5.9 1.4 0.1 0.6 2.5 4.1 2.4 0.0 0.0 2.5 0.0 0.4 0.2 0.2 1.1 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.9 0.3 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.6 1.8 2.4 9.7 5.5 1.7 3.0 1.8 1.5 2.8 3.1 3.2 6.4 0.9 0.0 1.5 0.3 0.1 0.4 1.3 1.6 1.2 1.6 0.4 0.4 0.7 0.0 2.0 0.0 2.1 1.7 0.1 0.2 1.9 2.3 1021.8 1.1 0.6 1.8 0.0 0.4 0.2 2.1 1.3 1.7 0.5 0.9 1.3 1.3 2.2 2.1 1.5 3.3 0.2 1.3 0.0 0.8 0.7 161.0 9.6 2.2 1.8 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.1 5.7 0.2 0.7 0.5 2.8 2.1 1.3 13.1 1.1 1.4 24.6 4.6 1.2 0.0 0.8 1.3 3.8 1.2 0.4 PLA2G6 "iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9" ENSG00000184381 "Phospholipase A2 group VI" O60733 22 38111495-38214778 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Lipid metabolism, Phospholipid metabolism" "Calmodulin-binding, Hydrolase" "Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 28.5;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001171 Approved Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA001171: AB_1079145" "unprognostic (5.26e-2)" "prognostic favorable (7.29e-4)" "unprognostic (8.74e-2)" "unprognostic (6.27e-2)" "unprognostic (3.83e-1)" "unprognostic (3.70e-3)" "unprognostic (8.67e-3)" "unprognostic (9.55e-2)" "unprognostic (3.48e-1)" "unprognostic (1.91e-1)" "unprognostic (2.37e-3)" "unprognostic (4.95e-2)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (3.00e-1)" "unprognostic (1.48e-1)" "prognostic favorable (1.55e-4)" 18.5 22.4 13.7 4.7 14.9 12.3 19.6 14.0 20.4 23.2 11.1 10.8 9.3 17.9 10.7 10.3 26.4 13.3 9.4 12.8 12.3 24.0 13.4 10.5 8.6 15.8 13.7 11.5 24.5 16.2 6.7 17.9 4.2 18.0 25.1 2.9 8.4 16.1 9.3 10.8 16.4 12.6 3.5 13.9 17.3 13.3 42.5 13.8 11.8 52.2 4.5 4.7 13.4 14.5 24.2 0.8 1.3 2.6 6.3 8.0 5.5 9.8 0.9 1.0 0.5 1.2 3.2 2.4 5.9 6.7 1.3 0.9 3.5 2.2 2.5 0.3 9.2 11.1 39.1 3.4 3.5 3.1 2.6 25.6 13.3 3.7 2.3 4.6 6.6 0.8 11.7 8.0 13.3 0.7 3.1 8.5 3.0 3.4 2.7 1.3 6.5 1.2 6.1 2.8 5.9 7.1 1.9 1.9 3.1 6.7 3.9 4.1 2.4 0.6 2.1 4.5 0.9 0.6 20.6 2.7 4.0 4.0 3.2 2.0 1.4 0.1 0.0 1.0 0.0 0.7 0.5 1.0 1.5 0.4 0.3 0.4 1.2 0.6 3.7 0.2 1.3 1.6 0.7 13.7 14.9 14.0 20.4 12.8 12.3 15.8 13.7 11.5 18.0 13.9 13.8 24.2 5.6 3.2 2.7 19.9 4.6 3.1 3.5 4.0 4.6 9.9 7.4 6.5 2.0 4.3 5.0 12.9 4.2 3.3 11.1 11.3 0.0 2.1 28.5 9.5 4.4 3.1 11.4 7.4 6.4 1.0 2.7 3.3 11.2 8.7 0.0 10.6 3.6 3.5 1.7 15.2 5.9 8.6 2.0 1.0 0.8 18.3 5.9 2.1 1.8 4.7 2.3 4.9 8.2 4.5 25.2 1.1 12.6 3.8 4.7 2.9 21.9 1.9 7.6 7.5 6.6 2.6 3.4 44.5 7.7 4.1 3.4 4.9 6.6 6.8 8.4 2.1 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343195 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favorable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 9.8 2.8 6.0 6.3 5.1 3.1 14.4 15.3 4.1 10.7 7.0 6.1 3.0 5.4 1.8 5.6 8.1 7.8 4.2 6.9 13.7 9.9 2.4 9.8 8.7 10.1 7.9 1.8 8.0 5.9 6.0 4.0 12.3 8.7 7.5 6.3 6.9 11.1 5.7 2.0 7.5 4.9 6.6 7.6 10.4 4.8 2.3 6.6 13.8 6.6 4.8 7.1 8.8 6.5 8.5 10.7 2.0 17.8 4.7 18.1 20.7 3.8 12.1 17.9 7.8 8.1 1.3 22.1 2.3 27.7 28.1 4.1 9.6 3.6 11.7 10.7 52.8 1.3 1.4 3.7 4.1 10.5 0.1 0.0 30.4 1.1 13.9 8.2 14.3 4.5 0.3 6.1 3.2 14.0 0.9 0.2 2.9 1.9 5.5 3.3 3.7 3.4 12.3 11.6 14.8 0.1 1.6 4.5 1.9 5.0 5.7 1.7 0.5 19.7 13.6 3.2 4.7 7.7 2.2 0.4 3.3 6.5 2.0 25.6 0.1 0.6 0.0 0.8 0.3 1.3 0.9 1.6 2.1 0.6 1.2 3.2 2.2 2.6 2.4 0.4 0.5 0.6 1.2 6.0 5.1 15.3 4.1 6.9 13.7 10.1 7.9 1.8 8.7 7.6 6.6 8.5 43.5 16.0 8.6 690.5 35.4 19.5 21.5 12.6 19.9 44.1 28.6 43.1 5.3 18.6 16.6 12.9 91.8 15.4 21.8 31.0 11.7 19.3 1.4 61.6 49.4 24.0 6.7 2.7 81.6 0.4 26.0 41.6 20.9 52.3 1.3 44.0 9.3 0.4 18.6 0.0 36.8 7.6 4.1 19.2 21.2 3.0 8.7 29.3 12.4 579.9 26.0 21.9 16.5 1300.8 311.4 15.0 16.8 8.6 18.1 19.1 9.4 17.1 24.2 25.9 32.9 3.6 51.5 0.6 0.8 19.4 13.5 13.0 38.1 9.0 14.3 19.2 PABPC1L2B RBM32B ENSG00000184388 "Poly(A) binding protein cytoplasmic 1 like 2B" Q5JQF8 X 73002939-73006106 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.8;pituitary gland: 2.1;prostate: 2.7;salivary gland: 2.1;testis: 1.7" "Cell type enhanced" "Detected in some" "Early spermatids: 1.7;Excitatory neurons: 2.2;Inhibitory neurons: 2.7;Oligodendrocytes: 1.7" "Cancer enriched" "Detected in single" 23 "prostate cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" HPA041573 Approved NA NA "HPA041573: AB_2677556" "unprognostic (1.73e-1)" "unprognostic (2.26e-1)" "unprognostic (3.31e-1)" 0.0 0.6 2.1 0.0 2.3 0.0 0.0 0.5 5.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 2.0 1.4 2.2 0.0 0.0 0.0 2.1 0.0 2.0 2.7 0.0 0.4 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 0.5 5.8 1.7 2.8 2.0 1.4 2.2 2.0 0.1 1.7 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 A3GALT2 "A3GALT2P, IGB3S, IGBS3S" ENSG00000184389 "Alpha 1,3-galactosyltransferase 2" U3KPV4 1 33306766-33321098 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.86e-2)" "unprognostic (2.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (2.61e-3)" "unprognostic (4.96e-2)" "unprognostic (6.83e-2)" "unprognostic (5.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" "unprognostic (4.90e-8)" "unprognostic (1.17e-1)" "unprognostic (1.12e-2)" "unprognostic (7.87e-2)" 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N5 ENSG00000184394 "Olfactory receptor family 4 subfamily N member 5" Q8IXE1 14 20138820-20145471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 60 "HEL: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SS18L1 "CREST, KIAA0693" ENSG00000184402 "SS18L1 subunit of BAF chromatin remodeling complex" O75177 20 62143769-62182514 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011827, HPA059046" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011827: AB_778216, HPA059046: AB_2683888" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "unprognostic (1.54e-1)" "unprognostic (3.03e-2)" "unprognostic (6.57e-2)" "prognostic favorable (8.00e-5)" "unprognostic (1.39e-1)" "prognostic favorable (3.74e-4)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" "unprognostic (2.47e-3)" "unprognostic (6.43e-2)" "unprognostic (2.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (9.94e-3)" 7.5 8.9 10.5 6.7 10.8 6.7 7.9 23.7 14.3 10.3 7.9 8.2 7.8 8.1 8.4 11.0 9.3 5.0 7.9 10.5 10.7 10.4 38.1 9.8 6.5 12.5 11.3 10.7 10.7 12.2 6.5 11.9 7.2 15.5 9.1 6.1 10.8 8.5 5.4 13.4 19.9 8.4 5.7 7.6 10.2 9.3 9.0 12.4 6.6 9.2 9.5 5.9 8.6 10.1 19.4 11.1 12.5 17.7 16.3 7.6 8.8 12.9 10.3 3.9 16.6 8.0 44.1 10.2 6.6 13.3 5.8 8.6 27.9 10.5 9.8 15.2 4.5 6.9 29.6 30.9 23.5 5.7 11.2 25.6 5.5 20.5 8.4 7.0 9.7 7.5 11.3 20.3 12.8 9.6 13.2 16.7 17.2 7.3 11.0 13.7 18.5 23.1 7.8 12.5 13.9 33.4 18.6 17.7 22.4 15.6 11.3 20.8 17.6 9.3 31.8 19.0 12.0 14.6 13.8 13.2 5.6 15.9 10.6 10.9 0.0 0.4 0.1 0.3 0.3 0.2 0.1 0.2 0.3 0.3 1.2 0.6 0.2 0.6 0.4 0.7 0.2 0.2 0.1 10.5 10.8 23.7 14.3 10.5 10.7 12.5 11.3 10.7 15.5 7.6 12.4 19.4 9.7 9.6 7.0 19.6 5.2 16.4 4.8 8.9 17.1 17.9 10.8 8.8 10.3 2.8 11.4 7.3 22.9 5.6 6.7 7.1 3.9 5.0 10.8 11.9 8.1 9.7 14.3 4.8 29.5 2.7 3.3 8.9 7.7 12.8 1.3 10.8 8.6 40.4 4.8 15.2 32.8 6.6 14.2 10.4 12.7 20.8 7.5 7.4 12.4 20.6 10.0 4.4 4.1 8.5 25.5 8.2 7.3 3.4 7.4 9.5 8.3 9.1 9.0 16.5 6.6 11.1 7.7 4.6 10.2 10.6 17.5 7.7 6.0 10.6 7.1 6.9 KCND2 "KIAA1044, Kv4.2, RK5" ENSG00000184408 "Potassium voltage-gated channel subfamily D member 2" Q9NZV8 7 120273175-120750337 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 47.2" "Group enriched" "Detected in some" 11 "Excitatory neurons: 690.0;Inhibitory neurons: 1068.2;Oligodendrocyte precursor cells: 1952.8" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.8;HSkMC: 2.9;NTERA-2: 2.4;RT4: 2.7;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029068 Enhanced NA NA "HPA029068: AB_10601436" "unprognostic (4.22e-1)" "unprognostic (2.79e-4)" "unprognostic (3.79e-2)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-3)" "unprognostic (9.07e-3)" "unprognostic (1.03e-1)" "unprognostic (1.14e-1)" "unprognostic (9.77e-3)" "unprognostic (1.51e-1)" "unprognostic (4.51e-4)" "unprognostic (4.07e-5)" "unprognostic (2.71e-2)" "unprognostic (2.92e-2)" "unprognostic (1.83e-3)" 1.7 0.5 8.8 0.5 8.8 0.0 1.0 47.2 9.0 1.1 0.0 0.3 0.3 3.3 0.1 0.1 1.2 4.3 0.2 6.6 10.8 0.0 0.1 0.2 0.1 26.2 16.8 5.5 3.4 0.2 0.7 1.9 0.4 27.6 0.2 0.2 1.0 0.3 0.9 0.2 0.1 0.1 2.0 4.7 0.0 0.2 1.7 22.0 0.3 0.4 2.8 0.0 1.1 0.6 27.1 0.0 0.0 0.2 0.0 1.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 2.7 13.2 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 8.8 47.2 9.0 6.6 10.8 26.2 16.8 5.5 27.6 4.7 22.0 27.1 0.6 0.0 0.0 108.7 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 1.2 4.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 2.7 1.0 1.9 0.3 0.0 2.7 690.0 0.2 0.0 6.0 0.0 0.8 0.0 6.6 0.7 0.0 0.0 0.0 1068.2 0.0 2.0 0.0 0.0 1.7 3.7 0.1 0.0 40.3 0.0 0.0 0.0 1952.8 9.7 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.5 0.0 10.9 3.0 5.0 3.4 0.0 0.1 0.0 0.0 4.3 0.0 0.1 TOP1MT ENSG00000184428 "DNA topoisomerase I mitochondrial" Q969P6 8 143304384-143359979 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MOLT-4: 197.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001915, HPA021542" Approved Supported Mitochondria NA NA Mitochondria "HPA001915: AB_1080331, HPA021542: AB_1858186" "unprognostic (5.02e-3)" "unprognostic (3.79e-2)" "unprognostic (6.57e-2)" "unprognostic (6.92e-3)" "unprognostic (2.32e-2)" "unprognostic (1.04e-2)" "unprognostic (3.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (1.52e-7)" "unprognostic (3.66e-2)" "unprognostic (3.62e-2)" "unprognostic (8.55e-3)" "unprognostic (5.66e-3)" 13.8 17.5 6.8 9.5 5.8 48.7 13.9 2.7 8.0 22.2 3.5 12.7 7.6 11.8 4.9 18.5 13.5 9.3 6.4 8.8 4.7 13.2 30.5 10.6 12.1 6.7 4.8 6.6 32.4 19.1 10.2 9.3 7.5 7.2 13.3 9.8 2.0 14.3 8.2 7.3 21.2 11.7 7.8 2.8 12.7 13.0 23.6 5.2 21.6 22.1 3.4 11.5 18.0 19.3 6.3 25.5 38.3 15.8 59.4 22.0 24.5 28.1 11.6 14.8 20.5 21.1 48.4 35.8 74.2 42.6 16.2 14.7 26.8 33.8 21.3 17.6 29.5 52.4 65.6 21.5 49.5 24.8 44.4 68.4 25.1 22.3 17.4 24.8 17.7 25.0 21.1 80.5 28.2 18.3 106.3 197.8 87.9 27.6 54.9 65.4 24.7 20.7 112.2 15.3 40.4 28.1 34.1 33.2 29.3 61.7 19.3 19.3 72.5 16.5 14.3 57.7 16.4 30.2 15.2 17.0 38.0 24.1 64.9 17.4 31.4 10.5 0.5 6.2 6.3 6.3 28.9 11.3 8.6 35.3 14.4 24.2 18.8 0.7 0.4 1.2 30.9 3.2 9.2 6.8 5.8 2.7 8.0 8.8 4.7 6.7 4.8 6.6 7.2 2.8 5.2 6.3 11.4 6.4 8.6 3.3 11.9 23.7 32.3 13.1 14.2 1.2 15.3 11.6 3.3 10.0 10.5 9.2 0.0 11.7 7.3 6.7 7.9 11.4 29.3 3.9 10.9 7.7 4.9 41.3 2.5 9.3 23.6 8.9 5.6 5.8 7.0 24.7 6.4 12.1 11.1 3.3 3.5 11.3 2.0 8.8 24.9 11.1 8.7 9.4 21.4 0.0 9.3 1.4 2.1 1.5 2.9 7.1 11.2 4.5 6.1 29.7 2.8 15.8 3.1 0.2 6.6 13.5 10.0 31.3 36.4 17.8 23.9 10.1 8.6 21.4 20.8 22.8 COPB2 "beta'-COP, betaprime-COP" ENSG00000184432 "COPI coat complex subunit beta 2" P35606 3 139353946-139389736 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036867, HPA058180" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA 63000 "Endoplasmic reticulum" "Golgi apparatus" "HPA036867: AB_10672271, HPA058180: AB_2683630" "unprognostic (3.37e-2)" "unprognostic (2.04e-1)" "unprognostic (9.38e-2)" "unprognostic (6.93e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.41e-7)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (8.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (6.05e-2)" "unprognostic (4.95e-2)" 47.1 58.6 18.5 51.0 20.1 22.5 61.0 21.0 21.2 77.1 33.8 63.1 57.9 48.9 63.0 55.5 47.9 48.9 48.4 17.8 29.7 53.4 71.7 44.7 45.2 21.0 20.0 16.4 39.2 90.4 68.7 60.4 69.5 20.9 72.8 72.4 37.3 71.7 57.6 33.8 36.5 53.9 64.1 22.0 43.1 61.2 35.3 20.2 54.9 64.9 31.5 62.0 56.7 42.6 25.5 192.1 84.0 111.2 99.0 247.2 214.9 96.8 223.9 235.9 158.2 204.7 143.4 83.5 90.2 203.0 287.1 145.1 110.9 136.2 141.0 210.6 139.0 85.2 138.2 114.9 152.3 152.7 121.9 139.7 160.1 114.7 132.2 138.5 178.6 161.6 76.5 86.7 105.7 199.4 138.6 59.4 59.7 102.2 215.0 99.5 75.8 93.6 149.5 141.2 133.4 85.2 61.7 254.6 212.0 147.2 168.6 193.2 123.2 185.1 90.3 66.4 122.8 83.7 148.0 80.8 129.7 115.2 61.0 138.0 74.4 49.8 52.0 36.0 56.3 35.8 35.3 31.0 37.6 57.7 23.8 24.2 31.1 45.0 44.1 57.2 30.2 38.1 44.2 18.5 20.1 21.0 21.2 17.8 29.7 21.0 20.0 16.4 20.9 22.0 20.2 25.5 36.6 57.7 46.6 18.3 45.8 19.6 39.5 61.2 29.6 38.0 41.3 29.3 58.5 32.9 74.5 20.2 31.3 83.3 34.9 52.4 41.1 83.4 40.8 64.9 62.9 45.2 63.9 51.1 25.1 82.1 76.1 66.6 75.4 54.8 45.0 50.4 36.4 48.5 52.7 42.1 25.5 86.7 46.8 34.6 21.3 8.6 54.7 42.8 21.4 13.1 60.1 62.0 29.9 20.1 30.8 79.7 34.8 50.0 118.6 46.6 46.9 42.4 108.6 51.1 19.7 47.3 69.6 83.1 45.6 36.5 14.9 133.1 37.5 74.4 44.7 52.9 LRRC19 FLJ21302 ENSG00000184434 "Leucine rich repeat containing 19" Q9H756 9 26993136-27005672 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 36.5;kidney: 43.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 152.3;Paneth cells: 36.0;Proximal enterocytes: 82.1;Proximal tubular cells: 57.0;Undifferentiated cells: 36.0" "Group enriched" "Detected in some" 5 "colorectal cancer: 6.0;renal cancer: 5.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 190000 "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (6.30e-2)" "unprognostic (5.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (4.16e-2)" "unprognostic (9.21e-5)" "unprognostic (1.87e-2)" "unprognostic (4.48e-2)" "prognostic favorable (7.08e-8)" "unprognostic (2.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" 0.0 0.1 0.3 2.7 0.1 0.3 0.0 0.4 0.1 0.0 0.8 36.5 23.7 0.1 0.0 0.0 0.0 6.0 0.0 0.1 0.1 43.2 1.4 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 32.9 0.2 0.0 0.1 0.2 0.2 31.6 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 18.6 0.0 23.9 0.0 0.0 0.1 152.3 9.8 0.1 0.1 0.4 0.4 0.2 6.0 0.0 0.7 0.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 3.7 0.0 0.0 0.7 20.3 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 36.0 0.4 0.0 0.0 82.1 57.0 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.2 36.0 0.0 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 162.9;Spermatogonia: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 106.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA Nucleoplasm "Nuclear membrane, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 16.1 27.1 11.7 5.7 10.8 4.9 18.2 11.7 19.8 21.2 13.0 20.7 8.0 20.5 4.9 15.6 21.1 5.8 19.0 10.5 12.9 20.2 38.1 13.6 8.8 11.8 12.8 10.1 22.0 27.1 9.9 39.8 4.2 12.1 29.4 2.5 2.7 19.1 9.3 40.0 18.7 19.2 3.6 11.0 24.4 23.4 35.8 12.4 7.7 21.1 14.5 3.8 21.7 16.8 11.4 23.5 25.0 6.9 11.8 6.0 7.5 14.2 12.1 11.6 15.9 14.7 11.5 13.5 17.2 11.9 7.6 8.4 16.4 6.1 12.1 2.4 17.1 36.4 21.6 18.7 14.9 18.5 22.2 13.4 7.2 15.0 14.0 12.9 7.0 8.4 13.1 106.2 19.8 8.8 29.3 24.4 13.7 9.6 16.0 24.7 19.0 13.6 10.4 8.4 11.8 13.5 11.7 15.1 19.5 21.5 3.2 22.4 14.6 5.5 25.4 19.5 15.4 12.8 27.6 17.4 14.1 27.6 14.3 22.4 1.9 22.1 8.8 27.2 23.9 36.1 50.0 32.8 27.4 21.3 36.9 45.2 36.3 1.9 24.0 25.3 31.6 30.7 24.9 11.7 10.8 11.7 19.8 10.5 12.9 11.8 12.8 10.1 12.1 11.0 12.4 11.4 18.7 16.0 25.7 6.2 33.3 19.1 20.3 24.5 14.8 31.5 25.0 30.4 14.8 37.1 18.3 25.8 14.6 31.2 23.8 22.4 64.6 28.2 30.0 16.6 15.7 20.3 22.2 16.2 5.8 38.2 30.1 25.8 20.4 10.6 21.5 21.0 18.5 35.3 27.8 13.5 5.8 22.8 30.5 15.8 11.5 44.0 41.7 14.2 40.9 1.0 27.5 52.0 45.3 3.5 7.2 23.9 19.7 32.4 28.6 31.4 38.4 57.4 22.6 27.1 39.5 22.8 43.5 162.9 119.4 16.7 16.3 29.6 28.8 31.1 21.7 13.2 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.7" "Cell type enhanced" "Detected in many" "Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 7.1 7.6 3.7 11.8 3.7 42.7 7.6 4.8 5.3 8.0 3.8 8.5 9.0 5.3 5.3 12.3 6.9 3.4 4.0 3.6 3.7 6.7 6.4 8.1 16.6 3.6 3.6 3.8 8.3 6.6 2.9 5.7 5.8 4.0 7.4 12.0 5.6 7.8 3.0 2.5 15.3 14.7 4.7 3.4 18.3 7.2 28.4 3.9 17.9 5.4 1.4 17.5 6.2 9.0 5.1 33.8 27.6 77.8 17.9 5.9 10.8 35.0 30.6 19.8 29.7 27.9 26.2 27.6 40.2 15.6 14.9 19.5 45.4 34.1 19.1 39.1 28.8 23.7 49.7 57.1 27.1 2.0 49.3 32.8 5.8 4.3 30.7 20.2 15.5 20.5 50.5 50.4 29.4 22.6 25.0 40.9 113.0 39.4 16.3 34.5 55.4 37.8 44.8 17.8 35.6 24.1 31.0 55.7 11.7 16.7 46.2 44.4 28.1 15.1 33.7 32.3 33.3 36.3 39.3 42.3 61.0 20.1 31.3 39.6 2.5 0.5 1.8 0.7 0.7 0.6 1.6 1.1 1.3 0.5 0.9 0.8 1.0 1.6 0.9 1.0 0.8 0.5 0.3 3.7 3.7 4.8 5.3 3.6 3.7 3.6 3.6 3.8 4.0 3.4 3.9 5.1 4.3 0.0 2.6 3.3 8.1 4.2 1.9 1.9 2.2 2.2 3.1 3.4 1.8 0.0 1.9 5.5 4.2 7.0 3.8 3.0 0.0 1.5 30.4 3.3 3.9 2.9 0.0 29.5 6.2 0.4 5.9 2.9 10.2 5.2 1.3 14.7 2.2 1.3 4.8 0.0 4.5 2.3 0.0 2.2 4.7 17.7 4.7 4.0 1.8 4.7 1.6 1.1 2.1 2.5 4.4 0.8 1.0 3.0 28.7 1.0 1.5 0.5 5.0 5.0 6.6 3.1 2.9 40.7 39.9 4.9 2.3 2.9 5.3 2.1 5.8 1.6 CCR10 GPR2 ENSG00000184451 "C-C motif chemokine receptor 10" P46092 17 42678889-42683917 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.4" "Cell type enhanced" "Detected in many" "B-cells: 14.1;Bipolar cells: 12.8;Plasma cells: 62.7;Sertoli cells: 19.7;Smooth muscle cells: 16.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "plasmacytoid DC: 24.7;T-reg: 72.4" "Group enriched" "Detected in many" 8 "dendritic cells: 24.7;T-cells: 72.4" "Cell line enhanced" "Detected in some" "Karpas-707: 8.4;RPMI-8226: 6.5;U-266/70: 17.1;U-266/84: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB011684, HPA048007, HPA069188" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100" "unprognostic (3.25e-2)" "unprognostic (2.71e-2)" "unprognostic (5.70e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (2.23e-3)" "unprognostic (5.18e-4)" "unprognostic (1.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.21e-3)" "unprognostic (1.01e-2)" "unprognostic (2.32e-11)" "unprognostic (2.84e-2)" "unprognostic (1.53e-1)" "unprognostic (1.88e-2)" "unprognostic (1.87e-1)" 4.1 2.1 1.9 0.7 1.5 0.2 5.2 2.9 2.7 6.2 0.0 4.3 1.9 8.5 0.3 0.8 8.6 0.2 4.4 0.6 5.0 2.8 0.8 4.2 0.3 3.7 2.4 0.2 6.2 2.3 0.0 20.4 0.7 4.3 3.9 0.2 0.7 2.2 0.6 4.8 1.4 3.1 0.5 1.0 3.2 2.6 4.0 2.8 0.2 2.8 0.4 0.0 2.5 3.3 2.1 0.5 0.8 0.8 4.7 0.3 0.7 1.1 1.7 0.5 0.2 0.4 0.7 0.3 0.1 0.3 0.3 1.6 0.8 0.0 0.1 0.1 2.0 1.2 0.0 3.2 0.4 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.5 0.1 0.3 2.6 8.4 0.0 0.3 0.1 2.4 0.6 0.0 1.2 0.6 0.1 6.5 1.1 0.0 0.7 1.0 0.4 0.0 0.2 0.3 0.8 0.9 1.9 2.1 0.5 0.7 0.2 17.1 8.4 2.5 1.3 0.6 0.9 0.0 0.6 0.2 0.4 0.1 0.3 5.3 10.9 5.4 0.4 5.9 1.3 1.8 0.2 0.2 0.4 24.7 72.4 1.5 1.9 1.5 2.9 2.7 0.6 5.0 3.7 2.4 0.2 4.3 1.0 2.8 2.1 7.3 0.0 0.0 0.7 14.1 0.8 0.3 0.4 0.6 12.8 1.0 1.3 2.1 0.0 0.1 0.0 0.0 0.2 0.6 0.0 3.9 0.3 0.5 1.6 2.9 2.9 1.8 0.0 5.1 0.5 0.3 5.4 1.5 0.9 0.0 0.6 2.2 0.2 1.9 1.7 4.6 0.6 2.0 2.5 3.7 2.5 5.6 1.2 5.4 0.0 3.8 2.5 2.1 1.0 1.3 0.3 0.1 2.6 62.7 0.3 0.2 0.7 1.0 3.2 19.7 2.3 16.7 1.6 2.1 0.3 0.3 0.0 2.9 1.9 0.7 0.1 NCMAP "C1orf130, FLJ42528, MP11" ENSG00000184454 "Non-compact myelin associated protein" Q5T1S8 1 24556087-24609328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 7.4;pancreas: 8.6;salivary gland: 7.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 17.7;Ductal cells: 19.3;Exocrine glandular cells: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;RPTEC TERT1: 1.6;T-47d: 4.0;U-266/70: 3.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "spinal cord: 147.1" HPA013656 Uncertain NA NA "HPA013656: AB_2275006" "unprognostic (3.38e-2)" "unprognostic (3.52e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.83e-6)" "unprognostic (3.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.73e-1)" "unprognostic (2.41e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-3)" "unprognostic (9.88e-2)" "unprognostic (9.53e-2)" "unprognostic (1.63e-2)" "unprognostic (7.27e-3)" 0.2 0.2 0.4 0.2 0.5 0.5 1.5 1.1 0.7 1.1 0.3 0.7 5.0 0.4 0.2 0.2 1.0 7.4 0.1 0.4 0.6 1.2 4.7 3.9 0.3 0.5 0.4 0.4 0.1 8.6 0.0 3.4 0.8 0.7 1.4 0.3 1.3 7.9 0.1 0.3 0.4 2.2 0.0 0.2 0.1 4.9 0.1 0.5 0.0 4.2 0.4 0.4 0.6 0.1 1.8 0.1 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.5 1.6 0.5 0.1 0.1 0.0 0.1 0.0 0.5 4.0 0.1 0.3 0.1 0.1 0.1 0.1 3.0 0.4 0.0 0.0 0.1 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.5 1.1 0.7 0.4 0.6 0.5 0.4 0.4 0.7 0.2 0.5 1.8 0.0 3.2 17.7 0.3 0.1 0.0 1.6 0.7 0.0 0.4 3.6 1.9 1.1 8.6 3.2 3.7 4.2 1.4 0.2 0.8 0.0 19.3 0.0 1.8 1.0 0.3 1.8 0.0 0.6 48.3 0.2 0.4 0.5 5.7 1.3 0.0 0.0 2.0 0.1 0.0 0.6 0.7 4.1 0.0 0.4 0.0 0.0 0.2 3.6 7.5 1.1 3.6 0.0 0.5 1.2 10.4 1.7 0.0 2.8 2.3 4.2 1.1 1.0 0.5 0.0 1.4 0.3 0.1 0.1 0.0 0.1 9.3 0.6 0.0 0.9 2.2 BPIFC "BPIL2, dJ149A16.7" ENSG00000184459 "BPI fold containing family C" Q8NFQ6 22 32413847-32464484 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "skin 1: 64.1" "Cell type enhanced" "Detected in some" "Early spermatids: 22.8;Late spermatids: 9.8;Suprabasal keratinocytes: 4.7" "Group enriched" "Detected in some" 11 "head and neck cancer: 1.6;melanoma: 1.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 22 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.74e-1)" "unprognostic (3.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (2.58e-1)" "unprognostic (3.48e-2)" "unprognostic (2.74e-1)" "unprognostic (2.58e-1)" "unprognostic (2.76e-3)" "unprognostic (1.41e-2)" "unprognostic (2.80e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 3.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 64.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 9.8 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 WDR27 MGC43690 ENSG00000184465 "WD repeat domain 27" A2RRH5 6 169457212-169702067 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 44.1;Excitatory neurons: 57.2;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037497, HPA037498" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037497: AB_10671503, HPA037498: AB_2675509" "unprognostic (2.10e-1)" "unprognostic (8.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (8.59e-2)" "unprognostic (1.98e-3)" "unprognostic (3.81e-3)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (8.63e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (3.15e-2)" "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" 4.9 4.6 3.0 3.1 2.2 2.6 6.7 2.9 3.1 9.3 5.0 6.6 3.5 8.1 4.9 6.4 10.0 3.3 3.1 2.2 2.1 5.0 4.4 4.7 4.1 2.3 2.3 2.2 11.0 6.2 3.1 5.1 3.0 2.4 6.8 3.6 2.5 6.2 2.0 4.1 4.7 6.2 2.3 1.9 4.8 5.8 10.6 2.0 3.5 10.0 0.8 3.0 6.4 8.1 3.8 3.8 6.5 17.6 6.4 4.2 8.3 4.4 5.8 1.6 3.5 4.1 6.1 4.8 3.1 3.5 1.8 5.0 8.5 3.1 4.4 5.1 4.0 6.0 6.7 13.4 6.1 2.5 3.3 1.0 4.3 4.1 4.4 3.3 6.5 6.5 7.3 15.6 6.1 4.6 4.9 2.1 12.3 4.6 2.8 3.3 5.0 3.6 5.6 3.3 3.5 7.3 7.5 3.8 3.6 2.1 4.7 4.3 6.1 5.6 4.6 3.7 4.3 5.1 5.8 2.2 7.5 4.2 7.7 4.7 0.0 0.1 0.3 0.3 0.1 0.8 0.3 0.4 0.4 0.1 0.8 1.6 0.2 0.0 0.1 0.1 0.4 0.4 0.3 3.0 2.2 2.9 3.1 2.2 2.1 2.3 2.3 2.2 2.4 1.9 2.0 3.8 7.0 9.6 3.9 44.1 6.6 2.2 5.6 6.7 8.0 13.5 8.5 9.0 4.3 7.2 5.4 12.9 6.2 5.2 3.2 3.2 0.0 2.3 28.3 26.9 15.5 7.2 4.2 7.8 57.2 1.5 2.8 7.3 11.2 6.2 3.8 13.7 9.3 4.1 2.2 21.9 52.6 4.7 2.0 2.4 2.5 10.3 8.1 3.4 3.6 38.4 1.4 5.9 4.1 51.3 47.4 2.1 5.7 9.8 4.8 4.3 4.2 2.1 25.7 12.7 0.0 5.2 6.3 21.7 10.7 8.1 1.1 1.9 5.4 6.3 7.0 5.4 TXNRD2 "SELZ, TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941820 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2 OS: 139.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Approved Mitochondria,Cytosol NA NA 2800000 "Mitochondria, Cytosol" "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 10.6 44.7 9.8 8.9 10.0 14.6 12.4 15.2 19.4 11.6 17.1 14.2 10.4 10.7 6.2 10.2 10.7 6.3 24.9 10.6 10.0 24.8 65.9 13.7 9.2 9.7 10.4 10.3 16.6 16.1 13.6 14.6 9.9 11.9 27.0 4.6 4.4 15.5 8.3 23.2 10.6 12.1 5.2 9.2 17.1 26.6 14.7 10.4 4.9 15.3 16.2 6.1 11.9 10.5 9.7 19.4 39.2 3.5 14.9 6.9 9.6 8.8 18.8 21.1 31.8 23.4 36.7 19.4 10.9 43.2 19.0 32.7 33.2 17.8 25.2 12.1 21.6 46.5 18.8 34.4 22.4 12.9 21.1 8.4 9.2 18.5 16.2 13.8 12.9 91.3 2.2 106.4 17.4 24.8 47.1 7.2 30.1 17.7 46.9 27.6 10.5 85.2 10.0 19.3 21.0 19.1 16.4 32.0 39.9 21.8 5.8 33.7 27.6 52.2 23.0 139.5 19.8 38.4 17.6 14.0 6.9 22.4 15.5 30.3 2.7 10.5 5.8 3.5 8.2 2.6 3.9 3.0 3.2 7.8 2.6 3.9 3.2 0.9 3.8 7.9 2.9 2.1 4.6 9.8 10.0 15.2 19.4 10.6 10.0 9.7 10.4 10.3 11.9 9.2 10.4 9.7 5.6 16.0 23.6 11.1 10.3 4.2 23.1 15.1 3.4 22.1 11.4 9.1 16.7 15.7 15.7 20.2 10.4 60.7 8.8 14.7 58.7 22.0 26.4 9.8 8.4 14.4 1.2 33.1 9.2 32.0 24.3 12.4 23.4 10.0 1.3 27.6 8.9 49.5 25.9 10.1 8.5 16.9 20.3 22.0 7.8 18.2 15.5 14.6 5.4 10.3 27.2 18.7 10.3 8.5 7.2 22.3 13.9 9.1 12.2 17.8 15.6 52.0 16.6 11.0 6.6 11.3 13.3 10.9 14.0 6.4 5.3 42.0 11.4 36.4 16.4 15.7 C1QTNF8 "CTRP8, UNQ5829" ENSG00000184471 "C1q and TNF related 8" P60827 16 1088226-1096244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 1.9;pituitary gland: 2.0" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Endometrial ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056438 Uncertain "Secreted - unknown location" NA NA "HPA056438: AB_2683134" "unprognostic (8.65e-2)" "unprognostic (2.56e-2)" "unprognostic (5.46e-2)" 0.0 0.3 1.1 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 1.5 0.0 0.0 0.1 0.0 1.5 1.3 0.1 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.9 0.4 0.3 1.5 1.5 1.3 0.1 1.2 2.5 0.9 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A3 "OR56A3P, OR56A6" ENSG00000184478 "Olfactory receptor family 56 subfamily A member 3" Q8NH54 11 5938751-5951347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXO4 "AFX1, MLLT7" ENSG00000184481 "Forkhead box O4" P98177 X 71095851-71103532 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 117.5" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 260.7;Syncytiotrophoblasts: 307.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 6 "BEWO: 159.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039560, HPA040232" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039560: AB_2676572, HPA040232: AB_2676894" "unprognostic (4.64e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (4.79e-2)" "prognostic favorable (4.61e-4)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-2)" "unprognostic (2.13e-2)" "unprognostic (8.16e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (1.20e-1)" "unprognostic (1.75e-3)" 15.9 33.9 83.6 6.6 83.4 22.2 14.0 66.5 69.5 12.9 50.3 18.9 11.1 17.3 16.6 12.1 17.7 9.5 15.8 65.8 64.8 9.4 7.3 10.1 7.2 78.7 76.8 59.0 23.4 12.8 16.1 7.0 117.5 82.5 14.5 8.1 7.6 16.8 19.4 67.9 14.7 14.4 8.2 69.8 14.0 13.6 17.5 76.9 14.6 11.0 49.8 6.4 17.3 13.3 80.7 4.6 1.2 3.4 4.9 7.9 5.7 159.1 3.4 3.9 1.8 4.5 3.3 6.5 5.9 4.7 4.5 1.9 2.1 8.8 4.2 2.2 6.0 13.7 8.5 27.3 5.0 4.8 4.9 6.9 5.1 9.7 1.7 1.1 7.9 4.7 8.4 17.5 12.5 0.8 0.9 8.6 8.0 16.9 11.5 5.6 5.7 8.5 10.1 3.0 2.6 2.8 7.3 7.1 1.1 8.3 24.7 1.9 3.1 4.3 1.1 2.3 8.3 0.8 7.7 4.3 1.0 4.3 13.6 1.3 0.0 0.1 1.0 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.1 0.4 0.9 0.2 0.1 0.0 0.3 0.3 83.6 83.4 66.5 69.5 65.8 64.8 78.7 76.8 59.0 82.5 69.8 76.9 80.7 10.1 0.0 2.7 0.3 3.8 5.4 3.9 0.6 9.1 1.3 8.2 7.7 6.6 5.7 1.5 9.2 4.2 260.7 6.5 20.6 1.9 2.7 0.3 3.2 2.8 6.1 6.1 17.7 0.8 3.0 24.3 4.0 5.1 3.1 2.5 3.1 5.0 2.9 22.3 1.7 0.8 12.2 0.0 7.1 5.2 1.4 6.8 4.4 3.6 1.0 2.6 4.4 4.1 1.0 2.2 3.1 8.6 15.4 7.3 2.5 17.1 4.4 1.5 0.8 6.6 4.0 3.8 0.6 0.4 6.0 3.4 307.8 7.0 48.3 7.4 3.8 POU3F2 "BRN2, OCT7, OTF7, POUF3" ENSG00000184486 "POU class 3 homeobox 2" P20265 6 98834574-98839458 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 16.5" "Cell type enhanced" "Detected in some" "Astrocytes: 77.4;Excitatory neurons: 8.8;Muller glia cells: 11.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 13.4" "Cancer enriched" "Detected in some" 11 "glioma: 16.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 125.4;SK-MEL-30: 18.3;U-251 MG: 39.9;WM-115: 33.8" "Low region specificity" "Detected in all" "HPA047081, HPA056261" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA047081: , HPA056261: AB_2683081" "unprognostic (5.94e-4)" "unprognostic (7.80e-2)" "unprognostic (3.07e-3)" "unprognostic (1.83e-1)" "unprognostic (3.57e-1)" "unprognostic (1.38e-1)" "unprognostic (1.17e-3)" "unprognostic (1.84e-1)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (4.77e-1)" "unprognostic (9.38e-11)" "unprognostic (4.77e-2)" "unprognostic (2.84e-2)" "unprognostic (8.47e-3)" "unprognostic (4.04e-1)" 0.0 0.0 9.9 0.0 9.9 0.0 0.0 12.7 14.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 11.9 0.0 0.0 0.0 0.0 12.2 16.5 6.2 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 125.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.6 0.0 0.0 0.2 7.6 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.0 0.0 0.1 0.0 1.0 0.0 0.6 0.0 5.5 4.3 1.0 0.0 0.0 0.0 6.9 3.6 0.0 0.0 18.3 0.1 1.0 0.1 0.0 0.7 0.0 0.2 39.9 0.1 0.0 0.0 0.2 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.9 12.7 14.8 8.6 11.9 12.2 16.5 6.2 9.5 11.6 10.1 13.2 0.1 0.0 0.0 77.4 0.0 0.1 0.4 0.0 0.0 0.2 0.1 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 8.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.8 0.0 11.1 0.0 27.2 13.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.4 0.3 1.4 0.0 0.1 0.0 0.4 0.0 0.1 0.3 PTP4A3 "PRL-3, PRL-R, PRL3" ENSG00000184489 "Protein tyrosine phosphatase 4A3" O75365 8 141391995-141432454 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 503.4;pituitary gland: 209.1;skeletal muscle: 744.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 102.9;Cardiomyocytes: 272.8;Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 226.5;Smooth muscle cells: 140.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 55.0;non-classical monocyte: 54.1" "Group enriched" "Detected in all" 6 "granulocytes: 55.0;monocytes: 54.1" "Cell line enhanced" "Detected in many" "HDLM-2: 128.7;Karpas-707: 45.9;RPMI-8226: 38.1;U-266/84: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003281 Uncertain NA NA "HPA003281: AB_1855903" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.55e-2)" "unprognostic (1.10e-3)" "unprognostic (2.08e-1)" "unprognostic (6.18e-2)" "unprognostic (3.61e-2)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (2.50e-1)" "unprognostic (5.73e-3)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.81e-5)" "unprognostic (2.25e-1)" "unprognostic (1.12e-2)" "unprognostic (2.28e-2)" "unprognostic (1.77e-1)" 43.1 16.8 9.2 2.0 7.7 0.7 43.6 6.9 14.2 68.3 7.6 56.3 2.1 70.5 3.0 15.2 67.8 1.4 503.4 8.0 8.2 49.3 9.9 58.9 1.1 8.5 7.7 7.7 47.2 117.2 2.6 209.1 2.3 8.8 74.2 0.7 36.3 30.2 2.1 744.2 22.9 37.8 4.5 7.1 57.3 100.5 22.1 11.9 1.1 35.5 62.6 1.3 40.8 36.0 8.4 0.3 0.9 0.6 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.1 2.3 0.0 9.8 0.1 0.1 0.0 0.1 0.1 0.0 128.7 1.9 5.2 0.2 1.8 0.5 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.4 1.0 3.1 45.9 0.1 11.3 0.7 0.2 2.1 1.0 0.7 19.3 0.1 38.1 0.0 0.1 11.4 3.9 0.6 0.1 2.6 1.2 1.8 0.0 0.5 0.1 2.2 0.1 0.0 11.6 42.0 0.3 0.1 2.8 0.1 1.5 3.3 12.5 3.1 28.2 1.8 5.1 5.8 3.0 2.0 1.2 6.5 3.4 55.0 1.5 54.1 8.6 5.3 5.1 9.2 7.7 6.9 14.2 8.0 8.2 8.5 7.7 7.7 8.8 7.1 11.9 8.4 52.7 3.2 44.5 5.5 21.1 9.9 5.2 23.7 7.4 102.9 9.8 7.4 272.8 4.3 8.3 7.3 123.0 0.3 5.6 0.8 9.8 8.2 10.9 2.0 3.1 57.7 10.2 0.8 5.3 62.9 0.3 21.7 5.6 2.0 1.3 6.6 15.0 0.3 4.1 15.2 10.3 2.9 26.4 2.8 20.1 7.1 3.7 4.0 21.4 8.4 12.8 36.7 2.1 2.5 0.7 10.8 0.2 1.9 79.8 11.9 0.2 5.0 1.1 226.5 32.9 17.1 140.8 4.4 24.8 1.8 10.2 0.3 13.7 3.4 3.0 3.6 FOXD4L1 FOXD5 ENSG00000184492 "Forkhead box D4 like 1" Q9NU39 2 113498665-113501155 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Cell type enriched" "Detected in some" 11 "monocytes: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.5" "HPA012836, HPA069839" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012836: AB_2105429, HPA069839: " "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "unprognostic (3.02e-2)" "unprognostic (6.61e-2)" "unprognostic (3.22e-1)" "unprognostic (6.41e-4)" "unprognostic (2.54e-1)" "unprognostic (5.77e-3)" "unprognostic (5.93e-2)" "unprognostic (4.21e-2)" "unprognostic (9.54e-4)" "unprognostic (3.98e-2)" "unprognostic (1.18e-8)" "unprognostic (1.57e-2)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (5.91e-4)" 0.0 0.1 0.2 0.1 0.1 0.5 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.3 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 1.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.5 0.1 0.3 0.4 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.5 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759226-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 31.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 13.5 6.2 1.4 3.7 1.7 0.7 10.7 1.2 2.2 10.1 2.1 3.9 1.7 8.5 0.3 4.0 8.2 3.6 6.4 1.7 3.3 10.1 3.4 13.3 2.4 2.1 1.5 1.1 4.3 3.1 1.6 3.6 1.1 2.0 7.1 1.4 0.4 4.2 2.2 3.0 4.1 4.8 5.1 1.3 8.3 4.3 3.4 1.7 0.8 11.3 3.9 1.8 7.5 7.2 1.9 10.3 0.0 0.6 0.0 2.8 0.0 0.1 4.8 10.7 5.5 3.5 0.4 0.2 0.2 0.1 7.7 12.5 1.5 1.1 0.7 2.3 0.1 0.9 0.3 0.4 0.0 1.4 2.9 28.6 1.8 2.3 11.7 4.6 15.7 38.8 0.6 0.1 0.2 12.0 0.2 1.5 0.9 1.0 1.6 39.3 1.8 0.8 25.1 5.4 0.5 2.2 5.1 0.2 1.5 0.1 1.0 0.6 8.2 35.9 1.6 10.3 0.6 1.7 0.0 0.0 1.9 40.6 2.7 0.3 31.2 5.4 0.7 0.0 5.5 0.0 0.9 0.0 0.0 1.5 2.8 0.0 0.0 2.7 0.0 4.0 0.0 0.0 1.4 1.4 1.7 1.2 2.2 1.7 3.3 2.1 1.5 1.1 2.0 1.3 1.7 1.9 65.0 6.4 4.8 2.3 1.9 5.9 1.2 0.9 1.2 0.9 1.1 1.7 9.1 0.0 0.2 1.8 0.0 0.1 0.3 0.0 1.9 8.2 0.8 0.3 0.8 81.5 1.2 3.2 2.7 1.7 0.1 4.7 0.0 0.2 39.3 2.3 105.0 0.7 12.9 0.0 0.1 0.2 0.0 17.4 14.6 1.1 7.8 16.3 8.8 7.5 3.4 0.5 0.0 0.0 0.6 1.3 0.1 3.0 1.4 1.7 0.0 0.1 0.5 0.8 6.6 0.9 3.6 5.1 19.1 0.2 4.7 0.0 1.8 2.1 0.3 1.0 PROS1 PROS ENSG00000184500 "Protein S" P07225 3 93873051-93980003 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 91.5;heart muscle: 117.8;liver: 285.5" "Cell type enhanced" "Detected in many" "Fibroblasts: 83.1;Hepatocytes: 307.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 64.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 112.3;ASC TERT1: 100.1;HSkMC: 78.2;SK-MEL-30: 157.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007724, HPA023974, CAB032610" Approved "Secreted to blood" NA NA 22500000000 5000000000 "CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738" "unprognostic (2.00e-2)" "unprognostic (2.81e-2)" "unprognostic (9.21e-2)" "unprognostic (8.03e-3)" "unprognostic (3.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (5.18e-2)" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.90e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.42e-5)" 33.9 8.8 1.9 8.2 1.3 0.3 24.9 1.5 3.0 14.8 91.5 17.4 13.7 16.5 2.0 16.8 19.5 34.0 117.8 3.2 5.0 38.0 285.5 39.5 4.7 2.1 2.5 0.8 32.9 5.7 13.6 8.6 32.3 2.2 8.5 21.8 4.6 12.4 10.4 4.9 18.3 20.7 19.4 1.8 11.3 10.6 5.1 2.3 1.5 17.2 17.1 3.7 18.7 15.2 1.5 0.4 2.7 3.0 27.1 112.3 100.1 1.6 4.6 9.4 1.0 6.6 12.7 1.4 0.0 30.0 3.0 18.8 0.0 1.4 0.9 1.8 0.1 7.3 51.4 1.4 29.8 8.7 1.5 1.2 78.2 0.4 4.0 0.6 63.0 7.2 3.7 32.8 0.1 49.2 0.0 0.1 0.0 3.1 2.7 6.5 0.3 1.2 0.0 27.7 0.0 7.6 19.8 5.0 0.0 157.0 0.6 0.0 19.9 9.4 14.8 2.8 8.2 1.7 0.0 0.0 0.0 60.4 30.4 27.8 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 3.2 1.9 1.3 1.5 3.0 3.2 5.0 2.1 2.5 0.8 2.2 1.8 2.3 1.5 55.9 64.1 33.8 17.9 1.9 14.8 3.6 2.1 4.0 0.5 1.7 14.0 44.6 14.3 7.5 1.8 10.4 0.6 0.5 7.5 3.9 9.8 3.2 2.1 30.7 47.1 15.7 16.4 28.4 4.4 0.7 83.1 2.0 1.1 30.9 5.0 65.7 307.1 12.8 1.7 19.7 11.6 0.0 31.5 20.6 6.3 28.6 14.6 19.6 27.2 1.3 22.8 0.0 10.6 4.6 5.6 19.3 36.9 0.3 4.5 1.9 42.2 56.6 8.1 13.1 32.4 28.4 0.4 0.7 11.8 33.2 1.6 2.1 10.8 12.6 2.3 GAST GAS ENSG00000184502 Gastrin P01350 17 41712331-41715969 "Cancer-related genes, FDA approved drug targets, Predicted secreted proteins" Hormone "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 167 "stomach 1: 9634.4" "Cell type enriched" "Detected in some" 5 "Glandular and luminal cells: 103.7" "Group enriched" "Detected in many" 6 "pancreatic cancer: 38.8;stomach cancer: 23.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 34.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB000038 Enhanced "Secreted to digestive system" NA NA 87000 "CAB000038: " "unprognostic (1.27e-1)" "unprognostic (4.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.75e-2)" "unprognostic (5.68e-2)" "unprognostic (2.11e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-1)" "unprognostic (9.07e-2)" 0.0 0.0 1.0 0.0 0.5 0.0 0.7 0.3 0.9 0.2 0.3 0.0 57.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.1 0.0 3.7 0.0 0.7 0.7 0.4 0.0 0.0 0.0 0.1 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 9.4 9634.4 0.3 1.9 4.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 5.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 34.8 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.9 0.4 1.8 0.7 0.7 0.4 0.7 0.7 1.9 0.9 0.8 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.3 0.9 0.4 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 2.2 13.5 18.7 0.7 0.0 0.0 0.0 0.0 0.1 1.0 0.5 103.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.8 0.2 0.2 0.0 0.0 8.8 1.0 0.0 0.0 0.4 NUTM1 "C15orf55, DKFZp434O192, FAM22H, NUT" ENSG00000184507 "NUT midline carcinoma family member 1" Q86Y26 15 34343315-34357737 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 19.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 89.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA040421 Enhanced NA NA "HPA040421: AB_10793965" "unprognostic (4.14e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-1)" "unprognostic (7.38e-2)" "unprognostic (1.99e-1)" "unprognostic (8.37e-2)" "unprognostic (8.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-2)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (4.27e-2)" "unprognostic (4.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 89.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HDDC3 "MESH1, MGC45386" ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929968-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 13.1 13.2 14.0 8.0 13.5 10.5 9.3 13.5 20.2 6.5 12.3 11.3 10.4 4.3 8.2 6.0 10.5 4.7 13.4 13.4 13.4 12.2 11.5 6.5 8.3 13.5 13.3 13.1 6.5 20.1 15.8 8.1 7.0 13.8 7.0 9.2 7.2 20.8 5.9 13.4 7.6 12.0 4.0 13.4 9.4 9.8 4.5 14.3 7.4 9.9 14.7 9.3 5.5 5.5 13.8 12.7 15.7 5.3 6.4 11.8 11.8 9.0 8.5 11.4 7.7 11.5 7.7 25.5 24.2 8.5 7.0 6.1 19.3 11.1 19.3 6.3 30.4 24.4 30.5 6.0 17.7 23.9 11.6 14.1 10.5 30.1 13.9 24.8 12.2 17.0 19.5 24.6 20.7 6.9 19.1 16.1 10.0 4.3 47.2 15.6 13.2 2.1 38.2 15.8 13.2 13.3 8.5 7.1 19.2 21.4 11.0 29.2 30.5 9.8 4.7 10.5 8.1 10.9 33.5 41.4 16.7 17.5 22.4 14.3 10.1 20.1 8.5 23.3 27.4 30.1 35.1 30.0 26.3 27.4 31.4 34.6 25.5 4.7 31.5 26.7 44.0 31.9 25.6 14.0 13.5 13.5 20.2 13.4 13.4 13.5 13.3 13.1 13.8 13.4 14.3 13.8 42.8 28.9 7.4 5.9 23.5 5.6 14.1 22.5 6.8 13.8 27.8 30.1 1.1 44.3 21.6 16.5 4.2 48.2 19.1 18.1 76.3 42.3 4.6 18.8 12.4 19.0 19.9 34.3 4.8 56.5 33.0 12.7 13.7 18.6 7.0 14.3 15.7 41.4 45.9 15.2 5.2 32.9 12.2 15.1 10.9 4.3 14.3 19.6 14.2 1.9 36.3 39.9 34.0 1.0 3.9 28.4 30.2 11.7 31.7 14.7 59.7 71.5 20.6 38.8 6.6 13.2 11.5 29.6 38.4 17.2 8.4 24.2 21.4 21.7 33.0 13.5 BEX5 NGFRAP1L1 ENSG00000184515 "Brain expressed X-linked 5" Q5H9J7 X 102153708-102155977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 127.6;pituitary gland: 78.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 171.6;Distal tubular cells: 137.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 45.7;thyroid cancer: 14.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 6.2;MAIT T-cell: 15.5;memory CD4 T-cell: 11.6;memory CD8 T-cell: 8.1;naive CD4 T-cell: 16.4;naive CD8 T-cell: 10.1;NK-cell: 10.1;T-reg: 11.9" "Group enriched" "Detected in many" 6 "NK-cells: 10.1;T-cells: 16.4" "Group enriched" "Detected in some" 4 "HAP1: 16.4;Karpas-707: 61.9" "Low region specificity" "Detected in all" HPA059058 Enhanced NA NA "HPA059058: AB_2683894" "unprognostic (1.88e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (2.63e-3)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.25e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.23e-1)" "unprognostic (2.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.63e-2)" "prognostic favorable (1.97e-4)" "unprognostic (3.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.48e-2)" 3.2 15.7 72.1 3.7 77.3 2.1 7.8 58.9 127.6 4.1 51.0 5.2 4.0 6.3 33.6 1.9 5.0 13.1 3.8 80.8 101.0 20.1 3.5 13.8 4.9 77.6 80.6 76.9 13.8 26.5 33.9 78.1 0.0 77.6 6.6 6.1 31.0 7.6 3.7 0.5 3.4 3.4 3.4 62.9 4.4 8.3 13.2 81.9 1.1 26.0 0.5 7.8 2.1 3.4 113.5 0.0 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 0.3 1.4 16.4 0.3 0.0 0.0 0.8 5.5 0.0 0.0 0.1 0.0 2.5 0.0 0.2 0.0 2.4 0.4 0.1 6.0 2.5 61.9 0.3 7.1 0.4 0.1 7.3 0.0 2.6 0.0 0.0 0.2 5.8 0.0 8.9 0.9 0.1 0.1 0.0 1.2 1.6 0.0 6.0 0.4 4.2 0.5 0.0 7.1 4.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 6.2 0.0 15.5 2.1 11.6 8.1 0.1 0.9 16.4 10.1 0.0 10.1 0.0 0.8 11.9 2.9 72.1 77.3 58.9 127.6 80.8 101.0 77.6 80.6 76.9 77.6 62.9 81.9 113.5 9.0 3.2 5.6 4.2 12.2 14.9 24.2 0.1 10.2 53.2 25.9 32.1 19.4 171.6 7.4 38.6 0.0 0.0 13.4 2.1 137.0 16.5 1.3 6.7 0.7 16.3 35.9 1.7 18.1 22.8 0.1 5.8 2.6 8.4 22.8 25.1 26.7 18.2 0.3 57.2 14.0 31.9 0.0 0.8 6.2 7.0 2.5 1.3 30.2 6.5 6.0 55.5 7.2 6.6 3.5 8.5 2.5 0.4 24.5 16.4 0.5 23.2 6.8 25.4 0.0 8.8 2.3 2.1 1.2 4.3 11.2 0.0 13.4 21.5 6.2 11.0 ZFP1 "FLJ34243, ZNF475" ENSG00000184517 "ZFP1 zinc finger protein" Q6P2D0 16 75148494-75172236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-698: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044916, HPA062910" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044916: AB_2679144, HPA062910: AB_2684902" "unprognostic (1.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.24e-5)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.99e-1)" "unprognostic (1.50e-1)" "unprognostic (4.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.13e-2)" "unprognostic (1.24e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (5.55e-1)" "unprognostic (6.64e-2)" "unprognostic (2.08e-1)" 4.2 3.3 4.1 1.7 4.7 1.9 3.9 4.8 5.1 4.6 2.2 4.5 1.7 5.8 2.3 2.7 4.8 2.8 3.5 4.9 4.1 3.3 11.2 3.5 3.1 3.7 4.2 4.3 5.2 2.1 4.6 3.8 3.0 4.1 2.9 2.0 5.9 2.3 3.1 5.9 2.7 3.0 4.1 3.4 2.5 3.0 4.2 4.1 8.3 4.9 4.3 3.2 4.8 3.6 5.4 3.1 6.6 9.1 8.2 5.1 6.7 3.6 3.7 4.4 8.2 9.8 5.3 2.4 13.1 4.2 3.0 3.2 3.8 8.1 5.6 9.5 7.2 4.9 4.8 2.4 4.0 4.4 4.7 14.8 4.5 5.5 6.1 7.9 8.6 5.4 12.3 5.6 2.7 6.4 11.9 16.4 4.6 2.8 2.6 2.5 15.1 4.0 4.2 3.6 2.8 9.0 7.2 9.0 2.7 3.5 2.3 6.0 3.9 3.7 7.4 7.9 3.4 4.3 11.2 11.5 28.6 3.6 6.7 5.8 1.1 0.7 0.2 1.5 1.2 1.6 1.2 1.1 1.7 0.7 1.6 1.4 1.5 0.0 1.9 0.5 0.3 1.7 0.9 4.1 4.7 4.8 5.1 4.9 4.1 3.7 4.2 4.3 4.1 3.4 4.1 5.4 5.4 6.4 4.8 6.8 5.1 5.4 2.5 2.3 5.7 6.9 3.8 3.4 4.2 1.5 2.0 1.8 0.0 2.9 7.6 1.0 1.9 3.6 4.6 2.9 7.5 5.3 7.2 4.6 9.5 2.3 2.7 5.9 0.0 3.9 1.3 5.1 3.9 11.7 2.0 13.5 8.5 0.9 0.0 4.1 2.7 5.2 3.4 1.8 1.8 7.5 3.6 6.8 4.1 7.1 11.7 1.6 1.0 4.1 2.7 2.3 0.8 3.6 2.6 3.8 0.0 5.6 8.2 15.9 8.8 5.0 5.8 4.1 5.5 4.7 1.8 2.4 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787115-790113 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 216.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Supported Approved Mitochondria NA NA Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 0.1 5.5 44.0 1.0 57.4 0.0 0.1 35.6 216.3 0.2 4.1 3.0 0.6 0.9 0.2 0.4 0.1 0.0 0.8 59.4 51.0 0.7 0.3 0.2 0.3 76.6 41.8 39.6 0.2 0.2 0.3 26.2 0.0 93.5 3.2 0.1 7.6 0.2 1.5 0.2 0.2 1.4 0.5 6.4 0.3 0.9 0.3 89.7 0.0 0.2 0.0 0.1 0.8 1.1 97.5 0.0 0.7 0.7 1.4 0.2 0.3 0.2 1.3 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.5 13.6 0.5 0.0 0.0 0.0 8.5 0.3 0.0 0.1 0.0 0.1 0.0 5.3 0.6 0.0 0.8 0.0 0.0 0.2 0.0 0.0 31.0 0.5 0.1 0.3 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 54.1 20.4 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 1.2 0.9 21.1 6.2 1.3 28.6 0.2 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 44.0 57.4 35.6 216.3 59.4 51.0 76.6 41.8 39.6 93.5 6.4 89.7 97.5 0.1 0.0 0.0 17.6 0.5 0.1 0.1 0.0 0.0 94.2 0.0 0.0 0.5 0.0 0.0 0.0 10.4 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.4 0.6 0.0 0.0 42.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 75.7 45.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 6.5 0.0 6.7 0.0 15.1 10.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.0 25.5 0.0 0.1 1.7 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.1 0.0 C6orf58 LEG1 ENSG00000184530 "Chromosome 6 open reading frame 58" Q6P5S2 6 127519455-127591820 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 618.3;salivary gland: 2275.9" "Group enriched" "Detected in some" 12 "Early spermatids: 14.3;Gastric mucus-secreting cells: 41.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 17.1;stomach cancer: 14.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;RPMI-8226: 2.8;WM-115: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036263, HPA041449" Enhanced "Secreted to digestive system" NA NA 30000 "HPA036263: AB_10673349, HPA041449: AB_2677486" "unprognostic (1.49e-1)" "unprognostic (8.55e-2)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (3.26e-2)" "unprognostic (7.72e-3)" "unprognostic (1.69e-1)" "unprognostic (6.62e-4)" "unprognostic (2.10e-2)" "unprognostic (2.31e-1)" "unprognostic (1.53e-2)" "unprognostic (8.99e-3)" 0.1 0.6 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.1 0.0 0.1 618.3 0.0 0.0 16.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 2275.9 0.0 0.2 0.0 0.2 0.1 0.0 0.3 270.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.2 2.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 2.8 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 14.3 0.1 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.2 41.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.8 0.7 0.0 0.1 0.3 0.0 0.2 0.0 0.3 DHRS7C SDR32C2 ENSG00000184544 "Dehydrogenase/reductase 7C" A6NNS2 17 9771434-9791592 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 311.0;tongue: 370.7" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 87.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (6.83e-2)" 0.1 0.1 0.5 0.0 0.6 0.0 0.1 0.4 1.1 0.0 0.4 0.4 0.2 0.0 0.0 4.0 0.0 0.0 85.4 0.7 0.5 0.0 0.1 0.1 0.0 0.5 0.5 0.5 0.0 0.1 0.0 0.2 0.0 0.5 0.5 1.1 0.0 3.0 0.0 311.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.5 0.0 0.0 370.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.4 1.1 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554051-1572271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 5.5 2.2 4.3 0.2 2.7 1.1 6.0 0.4 8.7 4.6 0.0 11.1 0.0 8.5 0.6 1.4 8.7 0.5 16.0 5.3 1.3 5.4 3.6 9.6 0.4 3.6 1.9 3.3 2.4 15.8 0.2 25.7 0.1 5.8 5.1 0.3 1.6 6.1 0.2 13.4 4.2 6.9 1.2 0.2 3.2 8.3 3.2 0.8 0.2 3.7 0.0 0.1 3.7 4.2 2.7 0.6 0.3 0.4 0.0 0.0 0.0 1.1 0.1 0.4 0.1 0.6 0.6 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.1 0.3 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 1.4 1.7 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.8 0.3 0.8 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.7 0.4 8.7 5.3 1.3 3.6 1.9 3.3 5.8 0.2 0.8 2.7 14.9 3.2 1.1 0.0 6.3 9.8 8.1 2.7 2.8 113.6 32.1 24.3 6.0 14.3 3.2 12.9 47.9 0.3 11.1 57.8 1.9 7.7 0.3 31.5 24.7 6.5 42.3 0.0 11.1 11.3 0.5 4.3 8.6 65.6 0.0 0.4 1.4 0.6 0.5 90.9 11.3 32.6 6.1 0.0 3.4 0.2 0.6 4.7 5.4 2.8 1.0 22.3 1.0 3.0 5.2 11.0 22.4 0.4 4.7 17.4 19.1 1.6 2.8 35.5 6.6 8.0 15.1 0.8 0.6 2.2 4.8 5.9 10.5 0.7 25.0 14.2 SOCS3 "CIS3, Cish3, SOCS-3, SSI-3" ENSG00000184557 "Suppressor of cytokine signaling 3" O14543 17 78356778-78360077 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 989.2;Endothelial cells: 635.9;Fibroblasts: 394.4;Langerhans cells: 381.5;Skeletal myocytes: 485.9;Smooth muscle cells: 381.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "hypothalamus: 160.6" "Immune cell enhanced" "Detected in many" "neutrophil: 9.5" "Group enriched" "Detected in many" 6 "granulocytes: 9.5;T-cells: 3.1" "Cell line enhanced" "Detected in many" "HDLM-2: 154.2;HSkMC: 73.3;U-266/70: 76.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 9.8" "CAB012220, HPA068569" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB012220: AB_443287, HPA068569: AB_2686008" "prognostic favorable (4.80e-4)" "unprognostic (2.67e-1)" "unprognostic (5.05e-2)" "unprognostic (1.64e-3)" "unprognostic (4.41e-3)" "unprognostic (2.48e-3)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (9.61e-3)" "unprognostic (1.84e-1)" "unprognostic (2.00e-2)" "prognostic unfavorable (9.34e-9)" "unprognostic (1.08e-2)" "unprognostic (8.80e-2)" "unprognostic (7.59e-3)" "unprognostic (8.40e-2)" 288.0 50.8 21.9 99.9 19.4 127.5 115.1 17.3 27.7 35.4 22.8 102.1 19.6 53.8 1.9 73.4 309.3 192.1 68.2 15.3 160.6 69.5 84.8 236.9 47.2 43.3 19.7 14.5 56.0 46.6 23.7 56.1 78.1 26.9 62.3 27.5 4.3 36.6 17.3 26.3 44.3 64.8 126.2 22.3 52.4 125.0 6.0 27.7 117.0 54.5 37.4 11.9 189.7 31.9 42.0 6.4 10.2 7.3 3.8 2.8 44.3 19.1 31.4 28.3 32.1 13.6 6.6 4.4 0.2 6.7 7.5 20.4 2.0 1.5 3.1 12.7 154.2 0.9 5.8 24.1 1.4 14.5 0.1 2.7 73.3 2.6 24.9 9.3 19.4 14.0 0.5 17.4 58.2 15.1 3.3 3.3 1.0 5.2 1.2 12.8 0.2 36.9 1.1 51.4 6.3 0.3 4.6 9.5 2.5 1.3 26.8 2.9 1.4 8.4 62.7 17.6 22.2 18.4 76.0 46.9 0.1 51.6 0.8 4.1 0.0 1.0 0.2 0.8 0.1 1.9 0.0 2.1 0.9 1.1 0.0 3.1 0.6 9.5 0.3 0.0 1.0 1.3 0.5 21.9 19.4 17.3 27.7 15.3 160.6 43.3 19.7 14.5 26.9 22.3 27.7 42.0 989.2 48.1 125.6 0.7 64.7 164.3 120.7 75.0 125.2 1.0 176.3 136.4 23.1 18.6 51.7 38.6 2.1 14.9 42.1 20.5 5.9 44.4 0.8 106.7 207.6 635.9 33.0 11.6 0.0 38.6 46.0 394.4 125.4 166.8 36.0 5.8 307.3 20.2 94.6 0.0 0.1 25.0 30.5 78.4 381.5 1.7 78.3 231.0 85.4 1.0 33.6 7.7 1.0 0.0 1.0 43.0 28.1 2.2 115.5 72.0 24.3 11.5 38.1 2.7 13.1 485.9 381.7 0.4 1.0 36.3 133.0 62.1 88.7 5.3 41.0 90.5 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425616-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 571 "testis: 129.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 129.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792790-85806683 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 28.0;urinary bladder: 14.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 22.8;Bipolar cells: 41.7;Club cells: 27.4;Ionocytes: 16.2;Respiratory ciliated cells: 41.6" "Cancer enhanced" "Detected in many" "breast cancer: 21.1;urothelial cancer: 18.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.8;OE19: 24.2;RT4: 101.4;WM-115: 23.7" "Region enhanced" "Detected in many" "thalamus: 22.6" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" NA NA 28000 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: AB_2669026" "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.1 0.2 1.0 0.9 3.0 0.0 3.2 1.9 1.4 1.2 0.1 5.6 3.5 1.0 2.5 1.9 0.5 1.4 1.5 0.1 1.8 0.1 0.9 3.4 0.0 0.9 2.3 0.3 0.0 0.2 0.0 0.1 0.9 1.4 7.7 6.9 4.8 28.0 2.2 0.0 5.6 5.8 0.4 0.3 0.1 1.5 0.3 4.4 0.2 0.3 0.1 0.1 14.8 1.4 0.9 0.0 2.9 0.1 0.5 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.9 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 28.8 0.0 3.3 2.7 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 24.2 1.9 0.2 0.0 0.0 0.0 101.4 1.0 1.2 0.5 0.1 0.1 1.7 0.5 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.0 1.9 1.4 0.1 1.8 0.9 2.3 0.3 1.4 0.3 4.4 0.9 0.1 0.0 1.8 0.0 0.0 3.8 5.0 22.8 0.0 41.7 5.3 1.5 0.4 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 4.3 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.0 2.7 0.0 2.2 2.2 0.0 0.2 0.0 0.4 1.7 16.2 0.0 0.6 0.0 9.6 0.1 0.0 1.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.4 0.0 1.5 0.0 0.1 41.6 2.0 0.0 0.0 0.8 0.0 0.1 3.8 2.4 0.0 0.2 0.1 0.5 4.5 PIWIL3 HIWI3 ENSG00000184571 "Piwi like RNA-mediated gene silencing 3" Q7Z3Z3 22 24719034-24774720 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "Early spermatids: 23.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061955 Uncertain NA NA "HPA061955: AB_2684647" "unprognostic (9.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.12e-4)" "unprognostic (2.73e-1)" "unprognostic (7.33e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6635960 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.1" "Cell type enhanced" "Detected in many" "B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 18.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 83.8;T-cells: 66.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA013170 Approved NA NA "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favorable (6.56e-5)" "unprognostic (7.43e-2)" 1.4 2.6 5.1 5.3 5.5 1.0 1.3 5.9 6.0 3.2 3.7 9.0 9.8 0.5 2.7 21.1 1.6 1.7 2.6 4.9 9.7 0.7 1.3 1.9 9.0 9.3 6.7 3.3 0.7 0.5 0.8 1.0 5.5 8.6 1.0 8.4 0.2 5.5 1.3 0.2 6.6 8.9 1.0 9.6 9.4 7.3 1.6 9.0 2.6 1.6 0.1 12.5 2.1 9.7 13.5 5.8 0.7 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 10.5 4.3 1.3 0.0 0.1 7.0 0.0 3.2 0.0 0.0 0.0 19.6 0.6 0.4 0.0 0.0 26.0 0.0 3.5 0.1 1.5 0.0 0.0 4.0 14.8 0.0 0.0 0.5 0.6 6.1 0.1 9.4 1.0 4.8 0.0 0.0 0.0 3.3 0.1 0.1 3.0 0.0 0.0 1.1 0.0 2.2 0.1 0.0 3.9 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 10.4 0.3 0.1 66.8 3.4 51.2 83.8 11.2 40.2 17.3 82.7 10.8 24.6 0.8 4.6 6.1 1.1 18.0 20.1 5.1 5.5 5.9 6.0 4.9 9.7 9.3 6.7 3.3 8.6 9.6 9.0 13.5 0.2 0.0 0.0 0.0 26.5 1.5 0.4 3.9 1.8 0.0 0.6 0.5 2.8 1.5 4.4 1.8 0.0 0.3 2.8 16.9 0.0 0.3 4.9 0.4 0.1 1.5 1.2 0.8 0.2 0.9 0.2 0.6 3.6 0.7 16.5 0.0 1.1 0.2 38.0 0.0 0.3 11.1 2.0 15.6 7.0 14.5 0.0 13.9 0.0 33.7 4.6 0.1 17.5 0.5 0.1 9.4 16.8 0.0 2.7 0.7 18.4 0.1 0.6 0.1 0.0 0.1 0.2 0.6 1.4 10.3 1.3 0.5 6.9 0.0 13.0 2.2 XPOT XPO3 ENSG00000184575 "Exportin for tRNA" O43592 12 64404392-64451125 "Predicted intracellular proteins, Transporters" Transport "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048067, HPA057602" Enhanced Nucleoplasm,Cytosol NA NA 9800 Nucleoplasm Cytosol "HPA048067: AB_2680246, HPA057602: AB_2683481" "unprognostic (4.53e-3)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (3.78e-3)" "unprognostic (1.01e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (1.81e-7)" "unprognostic (1.50e-2)" "unprognostic (2.22e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (2.41e-12)" "unprognostic (2.72e-1)" "unprognostic (3.68e-1)" "unprognostic (5.20e-2)" "prognostic unfavorable (5.79e-4)" 19.7 16.0 20.6 21.2 21.3 32.5 15.7 20.8 21.7 15.9 23.7 12.8 10.8 14.7 19.5 19.0 12.3 12.7 10.9 18.8 23.4 13.8 21.1 16.0 21.4 22.9 21.3 16.8 11.7 31.7 26.6 13.9 19.5 22.6 15.0 14.6 33.3 20.4 13.1 14.8 18.1 11.0 17.0 22.7 15.9 15.6 19.1 22.8 21.9 50.8 13.2 23.0 17.6 16.5 24.2 76.3 51.9 51.5 64.9 76.2 80.9 94.1 99.4 83.3 65.5 59.2 52.0 25.4 153.9 69.3 126.9 69.8 56.0 99.1 77.2 94.7 96.6 52.3 85.8 46.6 46.0 134.5 159.2 74.1 57.8 194.5 73.2 223.7 84.6 59.3 112.7 145.0 299.0 70.3 93.8 88.6 63.5 98.5 53.8 91.8 69.5 61.9 116.5 36.2 44.2 57.2 66.9 58.3 66.3 146.4 49.9 117.4 157.3 62.4 51.1 51.4 74.4 78.9 186.4 154.2 118.3 114.0 122.3 84.5 6.7 7.4 10.2 9.9 7.3 13.3 7.1 11.2 10.4 9.9 5.0 10.0 8.7 2.2 11.2 6.9 3.4 10.2 6.8 20.6 21.3 20.8 21.7 18.8 23.4 22.9 21.3 16.8 22.6 22.7 22.8 24.2 17.9 12.8 9.1 39.2 13.4 19.6 19.0 16.3 14.2 16.8 16.8 10.2 11.3 12.8 14.3 14.7 12.5 24.4 17.3 7.6 17.6 9.4 7.3 16.0 32.1 18.1 11.4 15.8 25.9 13.0 20.5 19.0 9.2 13.1 24.7 13.0 19.6 33.6 14.4 13.5 34.8 11.1 8.2 21.9 21.7 5.3 20.2 15.7 21.4 23.4 11.4 80.3 10.3 18.1 29.6 15.2 6.6 20.3 22.6 26.1 5.4 13.4 15.8 25.4 13.1 14.5 16.2 12.4 17.1 21.6 22.4 17.0 18.4 10.8 12.9 18.7 STING1 "ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173" ENSG00000184584 "Stimulator of interferon response cGAMP interactor 1" Q86WV6 5 139475533-139482935 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038116, HPA038534" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA038116: AB_2675841, HPA038534: AB_2676067" "unprognostic (1.45e-1)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (2.70e-2)" "unprognostic (1.71e-2)" "unprognostic (7.66e-2)" "unprognostic (2.77e-2)" "unprognostic (6.30e-2)" "unprognostic (1.01e-1)" "unprognostic (5.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.59e-8)" "unprognostic (9.18e-3)" "unprognostic (4.14e-2)" "unprognostic (4.45e-2)" "unprognostic (1.34e-1)" 35.4 9.4 4.5 18.6 5.0 17.0 26.4 4.4 5.4 31.4 12.5 14.8 6.7 25.2 6.9 21.7 36.5 12.0 31.7 4.1 5.3 17.4 5.6 48.5 15.2 5.1 4.6 3.8 22.1 5.4 3.3 11.9 13.0 5.1 20.9 11.7 0.3 24.7 15.7 7.6 14.1 19.1 18.9 4.9 38.1 11.7 3.2 6.3 12.6 20.4 8.5 27.3 21.9 28.7 5.0 2.9 0.7 0.2 0.0 4.0 12.0 0.2 15.3 64.4 7.6 24.4 0.0 18.8 0.0 83.8 49.0 1.9 10.8 0.4 22.9 4.8 200.5 3.3 13.5 6.6 0.8 7.5 4.1 0.8 16.2 1.2 4.6 5.7 12.8 27.8 1.4 3.9 58.3 33.6 0.0 2.2 24.1 0.1 0.8 4.7 0.7 6.1 18.0 9.4 7.0 5.8 0.0 6.5 5.3 16.0 0.6 0.7 73.3 17.2 1.9 1.3 6.8 5.6 0.0 20.0 0.1 0.3 56.2 11.3 16.6 60.9 0.1 56.9 40.0 29.3 0.6 57.4 47.8 55.6 0.3 40.3 35.0 5.0 90.6 17.5 19.2 65.3 60.6 4.5 5.0 4.4 5.4 4.1 5.3 5.1 4.6 3.8 5.1 4.9 6.3 5.0 25.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.8 17.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.6 8.4 0.0 0.0 0.0 0.0 0.0 0.0 67.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 1.8 5.8 0.0 0.0 0.0 PDE4B DPDE4 ENSG00000184588 "Phosphodiesterase 4B" Q07343 1 65792514-66374579 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 76.2;brain: 108.0" "Group enriched" "Detected in many" 5 "Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 88.9" "Group enriched" "Detected in all" 5 "B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003005 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA003005: AB_1079587" "unprognostic (7.86e-2)" "unprognostic (3.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.90e-1)" "unprognostic (3.21e-1)" "unprognostic (3.33e-3)" "unprognostic (1.35e-1)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (6.10e-2)" "unprognostic (8.78e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (2.89e-2)" "unprognostic (3.54e-1)" "unprognostic (9.04e-3)" "unprognostic (8.33e-3)" 18.5 3.1 41.5 39.9 74.1 76.2 20.3 57.4 50.4 7.2 3.5 8.4 4.7 8.3 1.2 4.6 4.2 10.2 15.0 39.9 75.2 4.8 11.0 14.8 23.4 84.4 71.8 30.5 2.1 1.6 1.4 3.9 17.4 76.1 23.2 10.6 14.2 21.3 12.2 44.7 7.8 12.3 12.5 63.5 22.8 5.2 3.8 61.3 14.2 7.3 15.1 20.1 32.4 4.6 108.0 0.2 18.5 34.7 61.8 1.6 1.7 0.1 11.5 13.3 10.1 13.4 0.0 0.0 5.3 0.2 20.7 0.4 0.1 0.3 0.0 9.7 15.5 0.1 0.3 5.2 0.0 1.2 13.1 0.0 3.4 0.5 4.5 0.2 1.6 93.2 0.0 0.0 3.3 4.7 0.3 0.0 7.5 56.1 0.0 0.7 2.6 6.2 3.6 8.7 0.0 0.2 26.6 0.0 3.0 58.6 2.9 0.2 4.5 52.6 7.2 1.9 4.6 1.9 1.5 51.6 19.3 8.6 13.4 3.7 10.8 6.8 22.0 10.1 5.8 19.5 36.8 19.4 14.8 6.2 37.4 21.3 15.0 88.9 11.3 5.7 6.4 34.7 9.6 41.5 74.1 57.4 50.4 39.9 75.2 84.4 71.8 30.5 76.1 63.5 61.3 108.0 24.7 9.6 12.2 531.8 233.3 20.3 28.4 0.5 27.9 40.9 51.6 34.3 25.4 0.0 6.9 5.5 0.0 7.3 79.8 0.4 0.0 0.8 14.4 1.7 14.9 36.8 4.2 0.0 315.6 0.9 2.0 20.2 9.7 4.2 15.2 0.2 11.7 2.4 13.0 114.4 559.7 1.9 8.2 40.6 187.4 9.4 0.3 176.9 51.6 173.3 67.0 19.3 1.0 1722.6 4039.6 0.1 0.4 2.6 351.9 93.6 0.0 2.1 1.5 4.0 0.0 54.0 10.3 0.7 0.8 4.8 8.1 5.6 143.1 0.4 1.3 9.4 TAFA3 "FAM19A3, TAFA-3" ENSG00000184599 "TAFA chemokine like family member 3" Q7Z5A8 1 112720419-112727235 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "adrenal gland: 15.6;retina: 51.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.3;BJ hTERT+: 4.7;HEL: 1.8;U-87 MG: 1.7" "Region enriched" "Detected in single" 21 "olfactory bulb: 3.5" "Low region specificity" "Detected in all" HPA055927 Approved "Secreted in other tissues" NA NA "HPA055927: AB_2682972" "unprognostic (9.96e-2)" "unprognostic (4.30e-1)" "unprognostic (3.36e-2)" "unprognostic (5.63e-4)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.66e-1)" "unprognostic (3.40e-2)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (1.32e-1)" "unprognostic (9.82e-2)" "unprognostic (2.51e-1)" "unprognostic (5.14e-6)" "unprognostic (2.10e-4)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" 0.1 15.6 1.7 0.1 0.7 0.0 0.2 1.1 0.7 0.1 0.4 0.0 0.0 0.2 0.7 0.2 0.3 0.1 0.1 0.5 1.4 0.0 0.0 0.0 0.4 1.7 2.7 0.4 0.6 0.0 0.0 0.3 0.1 1.0 0.3 0.0 51.7 0.1 0.2 0.0 0.2 0.0 0.1 0.9 0.0 0.0 8.1 4.3 0.1 0.3 0.0 0.1 0.1 0.3 1.0 1.3 0.2 0.1 0.0 0.0 0.3 0.3 0.1 4.7 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.8 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 1.7 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 1.1 0.7 0.5 1.4 1.7 2.7 0.4 1.0 0.9 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 C14orf180 "C14orf77, NRAC" ENSG00000184601 "Chromosome 14 open reading frame 180" Q8N912 14 104579764-104590515 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 38.4;breast: 26.9;heart muscle: 100.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.7;Cardiomyocytes: 7.6;Fibroblasts: 2.0;Hepatic stellate cells: 3.3;Horizontal cells: 3.3;Smooth muscle cells: 1.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Region enhanced" "Detected in single" "hippocampal formation: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "ASC diff: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (3.19e-3)" "unprognostic (1.89e-1)" "unprognostic (3.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.32e-1)" "unprognostic (9.80e-2)" 38.4 3.2 0.0 0.1 0.1 0.0 26.9 0.2 0.2 0.8 11.0 0.6 0.3 1.1 0.0 0.0 1.8 0.2 100.4 1.6 0.1 1.8 4.2 0.4 0.0 0.5 0.5 0.0 0.8 0.8 0.1 1.8 0.8 0.4 0.6 0.0 0.1 0.9 0.4 5.8 0.5 1.4 0.0 0.1 0.5 2.2 0.1 0.4 0.0 0.9 0.7 0.0 1.1 0.6 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 1.6 0.1 0.5 0.5 0.0 0.4 0.1 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 2.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 SNN ENSG00000184602 Stannin O75324 16 11668455-11679152 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 121.8;skeletal muscle: 115.8" "Cell type enhanced" "Detected in many" "Langerhans cells: 108.2;Macrophages: 64.7;Muller glia cells: 146.9" "Cancer enhanced" "Detected in all" "glioma: 62.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "AF22: 74.9;REH: 73.1" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 57.9 29.7 112.8 20.0 121.8 24.7 24.5 92.1 100.4 16.6 52.2 13.8 9.2 14.2 20.4 19.3 12.9 22.2 25.5 113.5 84.7 12.9 9.4 21.8 31.1 97.3 103.4 96.2 17.2 8.8 10.0 15.6 8.3 96.7 14.4 5.8 40.9 18.5 22.1 115.8 14.3 14.5 10.6 89.3 34.9 14.2 4.0 99.5 28.9 17.4 37.2 27.7 18.6 14.8 91.5 7.6 7.2 74.9 20.5 48.7 13.8 7.2 3.2 6.8 9.0 9.1 11.7 5.2 7.8 30.6 10.6 15.9 14.6 22.7 9.1 6.9 2.1 5.1 25.8 8.1 15.3 12.9 1.8 14.9 12.1 40.7 4.8 10.0 12.7 16.8 22.4 4.1 12.0 8.4 12.7 21.0 5.8 39.0 9.5 5.2 73.1 10.0 53.8 8.5 21.9 44.4 18.0 17.4 22.6 11.5 29.1 9.1 15.2 15.1 10.4 21.3 61.2 3.3 4.8 3.3 18.1 6.2 22.0 13.4 0.1 21.0 16.0 0.6 36.2 0.6 15.2 3.3 1.5 19.9 15.5 6.1 4.5 53.0 0.7 48.6 8.0 2.2 17.1 112.8 121.8 92.1 100.4 113.5 84.7 97.3 103.4 96.2 96.7 89.3 99.5 91.5 27.5 0.0 6.1 11.8 46.8 18.4 19.9 9.5 18.8 7.5 7.3 10.0 16.6 14.3 6.9 5.5 0.0 1.3 16.8 0.4 25.4 16.7 0.7 6.8 7.8 17.9 5.3 0.0 28.6 18.3 23.1 9.4 3.1 8.4 13.4 5.7 27.1 3.0 20.7 6.7 11.6 0.5 14.2 39.5 108.2 0.5 5.0 64.7 21.4 11.2 58.2 146.9 4.1 8.5 5.0 14.6 0.3 15.4 2.9 14.6 0.9 5.2 6.7 6.5 6.6 17.7 16.9 0.4 3.8 15.3 19.0 1.4 12.1 1.1 0.4 13.2 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838767 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 6.3;retina: 1.6" "Group enriched" "Detected in some" 7 "Excitatory neurons: 685.6;Inhibitory neurons: 352.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 6.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SCLC-21H: 6.0;SK-BR-3: 5.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebral cortex: 53.0" HPA018039 Uncertain NA NA "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.0 0.1 0.3 0.1 1.1 0.1 0.0 1.5 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 1.1 0.0 0.7 0.0 0.0 0.7 0.0 1.2 0.0 0.1 0.0 0.2 0.0 1.6 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.5 6.3 1.5 1.1 0.7 0.0 1.2 1.6 0.0 0.2 0.3 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.1 0.0 0.0 685.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.1 21.9 352.4 0.0 0.0 0.6 0.0 68.3 0.0 0.1 0.0 4.7 0.0 0.2 0.0 20.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 115.4;fallopian tube: 60.6;retina: 85.9" "Cell type enriched" "Detected in many" 6 "Excitatory neurons: 652.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1" "Lineage enriched" "Detected in many" 10 "T-cells: 111.1" "Cell line enhanced" "Detected in some" "AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" NA NA 6400000 Vesicles "HPA035714: AB_2674746, HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favorable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.5 17.1 30.7 11.0 63.7 7.4 1.9 3.1 115.4 23.3 53.3 2.0 26.5 2.2 0.4 1.2 60.6 1.9 0.4 95.8 47.1 1.2 1.0 5.1 20.9 2.3 2.6 60.5 0.8 0.9 0.2 34.8 0.3 10.5 27.5 2.2 85.9 1.4 2.0 0.3 9.4 15.4 2.8 0.0 6.2 2.9 3.0 3.7 8.8 6.6 0.6 15.9 4.1 4.2 46.8 0.3 0.1 104.6 3.5 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 8.3 12.4 0.0 0.0 0.2 25.3 0.2 0.0 0.0 27.5 0.4 8.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 1.6 0.2 0.4 0.0 0.4 0.2 0.4 41.2 0.0 14.0 0.2 12.7 0.2 0.0 0.0 75.6 1.8 0.0 0.4 0.0 1.3 0.1 0.7 0.0 0.4 3.8 0.1 2.1 27.5 29.5 40.3 0.2 0.2 0.4 0.2 0.2 0.0 5.0 0.1 24.9 0.2 30.3 52.9 0.1 0.1 70.4 111.1 0.5 11.0 0.1 0.1 0.4 26.7 30.7 63.7 3.1 115.4 95.8 47.1 2.3 2.6 60.5 10.5 0.0 3.7 46.8 0.3 0.0 1.3 48.0 1.0 1.1 0.0 0.0 5.7 35.4 0.4 0.6 0.5 2.8 6.2 0.0 33.3 0.1 2.5 5.8 0.0 0.0 0.4 0.7 0.8 0.7 0.0 0.0 652.4 0.2 0.3 3.7 0.0 0.3 0.0 49.4 0.0 0.0 0.1 1.7 108.4 0.9 0.0 0.0 1.5 1.0 0.0 0.4 0.0 18.7 1.3 7.9 1.0 74.4 16.5 0.4 0.4 0.4 0.5 0.3 18.5 0.2 21.9 58.3 0.0 4.1 4.6 1.9 4.2 0.2 1.1 0.1 23.4 0.1 2.9 0.1 KRBA2 ENSG00000184619 "KRAB-A domain containing 2" Q6ZNG9 17 8356902-8376704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 34.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 16.7;Rod photoreceptor cells: 30.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA022849 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022849: AB_1852996" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.92e-1)" "unprognostic (3.10e-2)" "unprognostic (2.98e-2)" "unprognostic (8.35e-3)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (2.80e-2)" "unprognostic (2.13e-1)" "unprognostic (7.61e-4)" "unprognostic (6.14e-2)" "unprognostic (5.02e-7)" "unprognostic (1.82e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (1.08e-1)" 1.7 1.9 3.6 1.8 5.0 1.1 2.5 5.3 4.0 2.4 2.2 1.5 1.6 2.5 2.5 1.5 1.7 1.3 7.0 3.3 3.3 3.6 0.8 1.6 1.6 4.1 4.0 2.6 2.6 1.8 4.0 1.9 1.8 3.9 2.6 1.6 34.8 2.4 1.7 6.2 3.0 1.7 1.9 2.5 1.7 1.6 2.0 3.7 2.5 2.9 6.8 1.3 1.7 1.5 6.7 0.4 3.6 4.6 4.4 2.0 2.8 2.3 0.6 1.3 1.6 2.3 0.0 1.5 0.3 2.6 0.5 1.1 0.9 1.6 0.5 2.2 1.9 1.0 0.6 2.5 1.3 0.7 0.2 1.0 2.5 0.2 1.8 0.6 1.0 2.9 2.3 0.1 0.6 1.4 0.7 1.9 0.5 0.7 0.2 1.2 3.4 2.5 0.4 1.2 2.4 1.6 3.0 3.4 1.2 1.0 3.1 1.5 0.2 1.5 1.3 2.2 0.5 0.7 1.6 0.9 0.3 1.6 0.1 3.1 10.1 1.3 2.3 2.0 1.2 1.9 1.7 2.0 1.6 0.8 2.9 3.5 1.9 1.6 1.5 2.7 1.6 2.2 0.4 3.6 5.0 5.3 4.0 3.3 3.3 4.1 4.0 2.6 3.9 2.5 3.7 6.7 9.9 0.0 1.1 6.2 2.2 0.3 1.3 1.3 4.6 3.6 2.9 3.0 0.7 1.5 0.4 1.8 16.7 2.5 1.7 1.5 3.9 3.4 0.4 0.9 3.0 4.5 4.2 7.4 2.6 1.1 0.6 2.8 2.6 0.9 5.1 3.5 2.2 0.4 0.9 3.3 4.1 1.5 2.0 1.0 1.0 0.6 1.5 1.2 1.8 1.9 1.2 2.9 4.1 5.5 4.1 2.1 0.1 3.0 3.8 0.6 1.3 1.4 2.3 30.2 0.0 2.4 2.9 2.3 2.4 3.1 0.9 1.2 2.4 2.5 1.6 0.3 MED12 "ARC240, CAGH45, FGS1, HOPA, KIAA0192, Kto, OKS, OPA1, TNRC11, TRAP230" ENSG00000184634 "Mediator complex subunit 12" Q93074 X 71118556-71142454 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003184, HPA003185" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA003184: AB_1079349, HPA003185: AB_1079350" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (5.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.89e-3)" "unprognostic (7.14e-2)" "unprognostic (1.68e-2)" "unprognostic (1.15e-2)" "unprognostic (2.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (2.50e-1)" "unprognostic (1.22e-3)" "unprognostic (1.28e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.16e-2)" 18.8 32.6 9.2 13.5 10.6 15.3 19.5 9.4 12.3 20.4 8.5 14.8 8.2 18.3 10.8 13.5 18.0 8.5 13.5 8.6 10.5 13.1 10.3 15.3 13.7 11.7 9.7 7.5 29.1 15.0 14.2 16.5 16.9 10.1 17.6 9.3 8.3 14.4 12.7 15.5 14.8 16.1 12.8 9.5 28.6 15.6 13.5 9.9 19.3 18.2 10.7 12.3 15.3 17.2 10.7 14.2 16.4 25.5 15.3 18.3 16.1 37.1 9.9 14.0 15.2 10.8 19.8 13.1 18.5 12.7 17.2 10.5 13.8 29.7 12.3 12.1 19.6 23.0 30.7 37.9 27.5 14.3 28.8 26.2 18.9 13.2 20.0 23.3 19.6 23.8 23.1 29.0 31.6 15.2 24.3 30.5 16.3 14.7 18.2 21.3 28.0 28.5 14.0 11.8 27.5 14.0 16.9 22.7 11.8 12.2 26.2 13.9 14.2 21.1 16.5 19.7 15.4 7.0 15.4 9.5 13.7 9.8 15.8 11.2 6.9 2.1 4.3 3.0 1.9 2.5 2.0 2.1 2.8 2.1 1.9 2.3 2.0 4.1 2.7 1.3 2.8 4.4 2.4 9.2 10.6 9.4 12.3 8.6 10.5 11.7 9.7 7.5 10.1 9.5 9.9 10.7 15.4 9.6 4.2 7.2 8.4 6.0 6.3 6.5 4.6 7.2 8.6 11.0 9.3 11.5 7.6 9.2 6.2 20.7 10.9 10.8 1.9 6.9 0.4 7.9 8.9 12.8 7.8 13.7 3.8 6.3 8.0 8.2 8.6 7.1 9.5 21.1 14.6 4.4 9.1 13.5 4.2 5.8 2.0 6.5 9.8 2.3 14.0 8.9 5.4 6.5 7.4 6.3 13.4 4.0 4.2 9.4 10.0 13.5 7.3 7.5 7.5 2.7 7.5 4.9 0.0 10.0 7.6 6.6 7.3 6.1 5.7 27.2 8.8 27.9 6.8 8.6 ZNF93 "FLJ12488, HPF34, TF34, ZNF505" ENSG00000184635 "Zinc finger protein 93" P35789 19 19900913-19963464 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 35.2" NA NA "unprognostic (1.49e-1)" "unprognostic (2.28e-2)" "unprognostic (9.05e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-2)" "unprognostic (8.25e-2)" "unprognostic (4.88e-3)" "unprognostic (1.66e-1)" "unprognostic (6.80e-5)" "prognostic favorable (9.31e-6)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (3.18e-6)" "unprognostic (7.35e-2)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (6.06e-2)" 1.7 1.1 1.4 3.6 2.4 3.2 3.5 3.9 2.3 3.3 0.6 2.1 1.1 4.6 3.0 1.5 2.1 3.2 1.3 1.3 1.3 2.2 1.1 1.9 5.2 1.5 1.3 1.1 4.6 3.1 1.9 1.1 3.1 2.2 3.0 2.9 3.4 2.0 2.2 1.8 4.1 1.6 4.0 1.0 3.2 2.5 4.1 1.4 6.2 7.1 1.5 5.1 3.3 1.4 2.7 0.1 0.0 19.1 21.8 1.9 1.7 18.3 7.6 4.2 15.9 19.3 4.6 4.0 5.6 6.4 4.4 13.3 0.7 0.0 0.4 19.8 0.2 1.0 0.1 0.7 0.4 1.4 0.1 0.3 2.8 1.5 14.6 1.4 2.9 0.5 0.2 3.7 0.7 15.5 2.1 24.1 11.7 35.2 0.0 4.4 21.5 19.0 8.0 4.5 12.7 10.8 7.9 0.4 1.9 3.5 21.5 6.4 13.5 0.4 15.6 0.7 15.8 11.0 2.7 11.6 13.9 0.3 3.0 5.4 3.9 2.5 7.2 1.1 3.0 1.5 4.0 2.1 1.8 2.5 6.0 2.9 1.6 5.3 4.0 3.1 2.2 4.0 1.4 1.4 2.4 3.9 2.3 1.3 1.3 1.5 1.3 1.1 2.2 1.0 1.4 2.7 3.0 3.2 2.0 2.6 5.1 1.0 5.2 1.0 0.0 1.5 3.5 4.6 3.3 2.8 2.7 1.8 2.1 5.0 1.8 1.1 7.9 5.7 3.4 6.5 3.8 3.1 0.0 2.1 2.2 6.2 14.7 3.6 2.6 9.2 7.0 15.2 1.4 0.1 8.4 3.3 3.7 2.0 4.1 3.7 2.2 1.5 1.2 5.2 1.8 1.9 5.4 2.4 2.1 7.1 4.1 5.2 0.8 3.0 5.8 2.6 0.5 1.7 3.5 2.9 0.0 1.1 5.7 9.6 10.5 2.5 2.7 5.1 2.8 3.1 2.0 3.9 SEPTIN9 "AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1" ENSG00000184640 "Septin 9" Q9UHD8 17 77280569-77500596 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042564, HPA050627" Approved Enhanced "Actin filaments" No No 770000 "Actin filaments" "HPA042564: AB_2678054, HPA050627: AB_2681193" "unprognostic (7.65e-2)" "unprognostic (5.44e-2)" "unprognostic (5.46e-3)" "unprognostic (2.34e-1)" "unprognostic (2.65e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.23e-3)" "unprognostic (1.56e-1)" "unprognostic (8.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (1.33e-1)" "unprognostic (2.80e-1)" 67.5 88.6 54.9 150.1 55.5 89.9 73.4 69.6 86.0 99.6 52.7 119.2 95.8 128.6 27.2 82.6 89.8 89.1 57.9 61.7 65.0 72.7 100.3 78.5 225.6 108.9 57.8 46.7 77.0 39.0 67.7 63.8 81.4 66.6 96.8 52.4 15.8 77.4 76.3 73.8 78.9 146.3 85.2 63.3 154.2 104.0 60.5 61.8 262.6 53.3 43.5 152.8 124.0 83.1 69.7 246.1 342.0 221.3 186.4 257.0 417.1 121.7 188.9 214.1 122.4 89.0 278.4 243.4 338.7 153.4 388.5 161.2 149.1 96.6 354.8 90.4 6.2 65.0 128.8 147.3 483.2 212.0 84.6 218.3 215.6 128.8 159.6 136.0 180.3 167.5 196.4 144.6 44.1 110.7 258.1 628.1 72.0 207.5 281.4 281.1 290.7 192.6 117.1 197.5 337.9 171.0 324.3 214.2 349.6 207.2 248.6 260.2 60.7 243.6 165.8 147.6 197.4 130.2 10.5 19.5 562.6 245.6 73.7 348.7 4.2 18.4 31.1 22.3 46.3 19.0 16.3 28.7 26.4 17.0 17.4 29.6 25.8 6.1 16.9 55.3 38.7 31.8 24.9 54.9 55.5 69.6 86.0 61.7 65.0 108.9 57.8 46.7 66.6 63.3 61.8 69.7 29.9 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 78.2 34.8 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 152.8 9.4 0.0 0.0 0.0 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 70.6 6.8 0.0 0.0 0.0 PRSS55 "CT153, T-SP1, UNQ9391" ENSG00000184647 "Serine protease 55" Q6UWB4 8 10525532-10554166 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 28.0" "Group enriched" "Detected in some" 46 "Early spermatids: 260.4;Late spermatids: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.64e-1)" "unprognostic (8.44e-3)" "unprognostic (6.10e-2)" "unprognostic (7.40e-2)" "unprognostic (6.23e-5)" "unprognostic (6.62e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 260.4 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 85.4 1.5 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODF4 "CT136, OPPO1" ENSG00000184650 "Outer dense fiber of sperm tails 4" Q2M2E3 17 8339840-8346048 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 132 "testis: 13.1" "Group enriched" "Detected in some" 48 "Early spermatids: 32.1;Late spermatids: 36.0;Spermatocytes: 47.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072129 Enhanced NA NA "HPA072129: " "unprognostic (5.16e-2)" "unprognostic (5.13e-1)" "unprognostic (3.54e-4)" "unprognostic (3.64e-1)" "unprognostic (5.40e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 36.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "brain: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.2 0.0 0.1 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 1.2 1.2 0.2 0.5 0.3 0.1 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25459199-25507911 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 6.5;lymphoid tissue: 11.5;testis: 19.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.2 0.0 0.0 2.6 0.0 6.5 0.6 0.1 0.0 0.2 0.1 1.9 1.6 0.3 0.0 1.4 0.1 0.3 0.3 0.0 0.1 0.0 0.1 0.2 5.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.1 2.2 0.1 0.2 0.0 0.0 1.2 1.8 0.9 0.1 0.8 0.9 19.6 0.2 11.5 0.1 0.1 6.8 0.6 0.3 0.6 36.5 30.2 29.4 24.2 2.3 4.5 20.2 37.7 22.6 32.9 32.4 25.7 15.8 42.6 16.0 16.2 34.6 31.6 42.9 20.0 48.5 16.2 12.0 43.2 22.4 15.2 0.6 18.4 19.4 2.5 1.0 23.5 15.8 3.3 24.5 24.5 33.6 45.8 30.6 13.9 54.5 8.7 31.0 24.1 14.5 26.3 33.4 15.2 9.2 18.7 12.0 13.3 33.3 16.1 14.3 14.7 17.4 9.4 16.6 23.9 39.3 44.7 35.6 7.1 16.5 44.4 17.7 24.3 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.6 0.2 0.0 1.1 0.0 2.7 1.1 0.5 1.7 0.0 0.7 0.9 0.8 23.3 0.0 0.2 0.0 0.0 7.2 0.5 1.8 0.0 0.2 49.9 0.8 1.2 1.1 0.0 19.0 0.2 0.0 13.4 2.5 4.1 1.4 0.0 8.8 1.1 0.1 4.1 0.0 0.1 1.3 0.0 2.9 0.6 24.2 1.2 2.1 0.0 0.0 0.6 0.1 2.1 0.5 0.6 0.2 0.1 0.0 15.8 0.5 0.5 1.2 0.9 0.5 13.1 0.1 2.1 66.6 27.8 10.7 0.9 1.6 2.9 1.3 3.6 0.5 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 20.0;brain: 73.6;kidney: 19.3" "Cell type enriched" "Detected in some" 5 "Excitatory neurons: 2828.9" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "OE19: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055868: AB_2682950, HPA059112: AB_2683908" "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 0.1 20.0 26.1 0.2 37.6 0.2 0.1 73.6 45.4 0.0 1.6 0.5 0.4 0.1 0.7 0.0 0.6 5.1 2.4 27.5 33.0 19.3 0.3 0.1 0.1 15.2 22.4 33.9 0.0 2.4 0.0 6.2 1.2 33.0 0.2 0.4 9.1 0.6 2.0 0.2 0.2 0.7 0.1 10.9 2.5 0.5 0.4 25.0 0.0 0.1 0.3 0.1 0.1 0.1 33.2 0.1 0.0 4.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 31.5 0.2 0.0 0.4 0.0 0.0 0.0 0.7 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 37.6 73.6 45.4 27.5 33.0 15.2 22.4 33.9 33.0 10.9 25.0 33.2 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 38.5 1.0 0.6 5.0 21.5 0.0 7.3 2.1 0.0 0.0 0.0 178.1 1.0 2.2 0.0 0.0 0.9 1.8 0.0 2828.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 33.7 531.4 0.6 0.0 0.0 0.0 1.5 0.3 0.0 0.0 68.4 0.0 32.8 0.0 495.6 36.3 0.1 0.0 0.0 0.0 0.0 11.7 19.4 0.0 5.2 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 4.0 0.1 0.1 AMER1 "FAM123B, FLJ39827, RP11-403E24.2, WTX" ENSG00000184675 "APC membrane recruitment protein 1" Q5JTC6 X 64185117-64205708 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 15.4" "Cell type enhanced" "Detected in many" "Sertoli cells: 6.6;Theca cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065214, HPA065265" Approved Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Nuclear bodies" "Vesicles, Plasma membrane" "HPA065214: AB_2685435, HPA065265: AB_2685450" "unprognostic (1.56e-2)" "unprognostic (8.85e-2)" "unprognostic (6.86e-2)" "unprognostic (2.74e-1)" "unprognostic (2.12e-2)" "unprognostic (1.86e-1)" "unprognostic (3.57e-2)" "unprognostic (1.48e-1)" "unprognostic (8.02e-2)" "unprognostic (1.75e-1)" "unprognostic (6.31e-2)" "unprognostic (3.43e-1)" "unprognostic (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (1.13e-1)" "unprognostic (6.19e-2)" "unprognostic (2.89e-1)" 1.1 1.4 1.3 1.3 1.3 1.2 1.3 1.7 1.5 1.9 0.0 1.4 1.5 1.9 4.0 2.8 2.2 1.0 1.3 0.9 1.4 1.8 2.2 1.2 1.2 1.3 1.2 0.9 6.3 2.0 1.6 0.7 0.9 1.5 1.7 1.4 1.3 2.2 2.2 4.1 2.2 1.4 2.8 0.7 1.3 1.7 0.5 1.5 1.6 1.4 15.4 1.6 1.3 1.3 1.3 3.1 2.2 5.8 4.6 2.2 2.1 4.7 1.4 1.2 2.1 1.3 7.3 1.1 5.9 1.8 3.0 1.6 4.3 12.5 4.1 2.0 2.5 2.5 3.7 4.9 4.9 1.6 7.7 0.9 3.0 5.3 1.6 3.2 1.7 1.2 4.6 5.6 5.9 1.1 3.7 5.2 4.0 15.6 4.0 4.4 11.7 9.4 4.3 0.9 1.0 2.6 3.9 3.7 5.0 1.9 4.8 1.6 2.1 0.8 2.5 5.8 6.7 1.9 3.0 2.2 4.4 1.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.3 1.7 1.5 0.9 1.4 1.3 1.2 0.9 1.5 0.7 1.5 1.3 0.9 0.0 0.0 1.0 1.5 2.2 0.6 0.9 2.8 5.0 1.7 1.5 2.6 4.3 0.3 0.0 2.1 1.1 3.4 1.1 0.0 1.2 0.1 3.3 2.6 1.5 1.2 0.8 0.8 1.6 0.8 1.8 3.6 2.0 0.0 3.9 1.4 2.6 0.4 0.0 1.3 1.0 0.0 1.0 0.3 0.2 2.5 0.5 1.8 1.0 1.2 0.2 0.0 1.0 0.6 0.7 0.5 4.1 2.4 1.2 0.8 0.8 0.0 1.0 6.6 2.3 4.4 0.0 0.2 3.6 2.6 0.7 0.9 6.4 1.6 0.7 ZBTB40 "KIAA0478, ZNF923" ENSG00000184677 "Zinc finger and BTB domain containing 40" Q9NUA8 1 22428838-22531157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042386 Approved Nucleoplasm NA NA Nucleoplasm "HPA042386: AB_10794649" "unprognostic (2.78e-1)" "unprognostic (3.39e-1)" "unprognostic (2.29e-1)" "unprognostic (5.17e-2)" "unprognostic (6.91e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.78e-8)" "unprognostic (8.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.12e-5)" "unprognostic (1.52e-1)" "unprognostic (6.74e-2)" "unprognostic (1.98e-2)" "unprognostic (9.51e-2)" "unprognostic (6.66e-2)" "unprognostic (3.34e-2)" 7.9 15.3 8.3 11.0 8.1 9.0 8.2 7.8 8.3 8.8 10.0 9.6 7.8 9.8 7.2 6.5 10.1 8.6 6.9 7.0 7.1 7.4 6.3 8.6 14.3 8.6 8.1 6.4 10.8 12.5 8.9 10.6 5.9 10.2 10.2 8.4 12.7 8.3 7.1 10.5 8.4 14.6 7.1 9.1 17.6 10.0 7.3 8.4 10.0 9.5 7.9 15.1 9.6 6.8 10.2 8.6 10.0 15.7 16.6 11.1 9.7 15.2 7.1 8.2 11.4 12.6 8.9 10.8 10.3 8.9 8.6 8.9 10.6 15.6 7.7 13.5 13.3 13.1 22.1 20.0 10.3 9.6 12.4 20.5 7.9 11.1 14.5 10.9 8.5 9.6 13.7 23.5 0.1 9.0 6.4 8.4 16.1 9.7 7.0 8.0 14.7 11.9 11.5 5.4 9.2 12.7 10.8 14.4 10.4 6.1 10.1 19.1 10.2 12.0 13.3 11.2 14.6 7.3 6.5 9.7 9.8 8.0 15.1 9.6 1.0 0.5 0.3 1.0 1.2 1.3 0.8 0.8 0.8 0.8 1.1 0.8 1.0 0.1 2.9 0.5 0.5 1.4 0.4 8.3 8.1 7.8 8.3 7.0 7.1 8.6 8.1 6.4 10.2 9.1 8.4 10.2 7.6 12.8 16.7 12.1 12.2 5.7 3.1 4.2 8.0 15.0 7.0 5.0 11.8 8.6 11.7 1.8 31.3 4.6 11.0 3.6 1.9 5.2 4.6 8.9 10.8 8.0 16.2 3.4 15.0 7.4 4.5 7.0 6.6 6.0 16.4 21.1 4.2 3.4 4.8 11.8 20.1 5.1 8.2 5.7 5.7 6.7 5.9 8.1 14.2 25.3 4.1 5.6 13.4 18.6 24.1 6.4 8.2 6.8 12.4 4.8 4.7 2.6 8.8 22.7 13.1 11.9 9.6 7.2 8.2 6.9 4.1 2.9 13.3 13.5 5.8 3.5 H2BC21 "H2B, H2B.1, H2B/q, H2BE, H2BFQ, HIST2H2BE" ENSG00000184678 "H2B clustered histone 21" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 86.5;Syncytiotrophoblasts: 160.2" "Cancer enhanced" "Detected in all" "prostate cancer: 87.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 58.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.6" "Cell line enhanced" "Detected in many" "Karpas-707: 56.8;U-266/70: 93.7;U-266/84: 53.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 11.4 15.4 36.9 7.2 39.5 21.4 17.8 39.0 37.7 48.5 37.5 21.1 5.2 7.4 23.0 42.1 27.7 5.6 63.2 33.6 53.5 24.9 18.1 37.5 6.2 44.7 37.1 28.5 62.2 13.5 9.6 32.7 14.9 40.1 96.0 6.2 69.7 23.7 6.7 63.4 70.9 15.0 6.2 38.7 27.5 32.3 13.8 42.4 20.2 15.3 29.4 3.4 25.3 80.1 57.4 2.8 2.8 4.5 0.9 23.5 6.3 2.2 9.7 6.5 4.0 1.3 1.1 4.4 0.5 2.6 8.6 5.7 10.9 3.6 1.7 2.2 3.4 2.8 0.8 11.5 2.1 7.4 0.8 12.6 21.4 7.9 1.7 6.6 4.8 1.3 4.0 12.0 56.8 5.0 16.8 3.1 5.1 2.8 22.6 5.8 3.6 1.7 13.7 3.8 2.3 30.3 4.9 33.4 4.5 2.7 10.7 23.4 2.4 1.7 3.0 33.6 2.2 0.9 93.7 53.8 2.6 4.0 3.6 1.9 21.3 4.8 8.2 1.3 6.2 2.3 1.5 1.8 2.1 3.3 3.8 2.2 2.2 58.6 1.3 12.3 8.9 2.2 10.1 36.9 39.5 39.0 37.7 33.6 53.5 44.7 37.1 28.5 40.1 38.7 42.4 57.4 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.5 0.0 0.0 0.0 0.0 25.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 20.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 160.2 0.3 0.0 0.0 0.0 CLDN6 ENSG00000184697 "Claudin 6" P56747 16 3014712-3020071 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;pancreas: 1.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 35.8;Ductal cells: 23.7;Extravillous trophoblasts: 144.2;Syncytiotrophoblasts: 44.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 73.6;testis cancer: 112.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 477.8;CACO-2: 134.6;NTERA-2: 443.1;SuSa: 328.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.42e-6)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (6.08e-2)" "unprognostic (1.92e-1)" "unprognostic (5.50e-4)" "unprognostic (1.02e-2)" "unprognostic (5.88e-1)" "unprognostic (1.98e-2)" "unprognostic (7.66e-4)" "unprognostic (1.79e-3)" "unprognostic (1.02e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.78e-4)" 0.0 0.2 0.8 0.0 1.0 0.1 0.0 1.2 0.7 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.5 0.1 0.0 0.2 0.0 0.5 0.4 0.8 0.0 1.0 0.0 0.3 0.7 0.8 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.9 0.3 0.7 0.0 477.8 0.1 0.0 0.0 0.0 134.6 0.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.2 0.1 60.2 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.1 1.0 0.0 0.3 443.1 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.6 0.6 0.0 328.9 0.2 0.1 0.5 0.2 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.2 0.7 0.7 0.5 0.5 0.4 0.8 0.8 0.2 0.5 1.3 0.2 3.2 0.0 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.8 1.3 0.3 0.0 0.1 0.0 0.0 35.8 0.0 0.0 0.0 23.7 0.2 1.4 0.1 0.2 0.0 0.0 0.1 0.0 144.2 0.6 0.0 1.6 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 1.8 0.4 0.6 5.4 0.0 0.4 44.1 0.2 0.0 0.1 0.2 OR51M1 ENSG00000184698 "Olfactory receptor family 51 subfamily M member 1" Q9H341 11 5383812-5393263 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056773 Uncertain NA NA "HPA056773: AB_2683233" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 3.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEPTIN5 "H5, HCDCREL-1, PNUTL1, SEPT5" ENSG00000184702 "Septin 5" Q99719 22 19714503-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 324.4" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 3.4;Smooth muscle cells: 2.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 32 "eosinophil: 15.4;neutrophil: 5.8" "Lineage enriched" "Detected in single" 47 "granulocytes: 15.4" "Cell line enhanced" "Detected in many" "K-562: 281.6;THP-1: 75.9" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 860000 "Nucleoplasm, Actin filaments, Cytosol" "CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141" "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 16.7 17.8 146.9 5.8 208.2 41.4 16.6 44.4 324.4 46.3 57.5 16.7 5.3 28.3 46.6 62.6 39.1 14.9 155.6 209.7 112.5 12.8 5.2 17.6 8.5 52.7 42.1 196.1 29.6 17.2 128.2 83.3 12.1 87.0 20.3 6.3 30.6 16.1 10.0 10.9 127.5 8.9 17.4 10.7 14.4 16.4 29.3 69.9 16.1 33.7 16.3 8.2 13.6 43.2 164.6 0.4 10.6 42.0 64.0 3.9 13.1 0.3 15.8 20.1 17.9 10.5 0.7 5.6 1.5 6.1 35.8 26.0 6.0 30.2 6.0 8.8 9.6 3.4 0.7 2.4 0.2 16.2 0.8 47.2 17.4 7.4 6.0 2.5 5.1 7.5 23.1 281.6 0.6 28.2 4.2 4.6 31.2 5.4 1.0 10.4 41.4 1.3 7.2 1.3 1.4 62.3 49.2 2.4 3.5 2.8 10.2 17.3 75.9 3.0 46.4 55.6 2.0 3.2 4.5 0.0 0.4 5.8 2.2 15.2 0.0 0.1 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.8 0.0 0.0 0.3 0.0 6.0 146.9 208.2 44.4 324.4 209.7 112.5 52.7 42.1 196.1 87.0 10.7 69.9 164.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EIF4ENIF1 "2610509L04Rik, 4E-T, Clast4, FLJ21601" ENSG00000184708 "Eukaryotic translation initiation factor 4E nuclear import factor 1" Q9NRA8 22 31436977-31496108 "Plasma proteins, Predicted intracellular proteins" "Protein transport, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 54.6;Late spermatids: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001619, HPA002078" Enhanced Enhanced Vesicles NA NA Vesicles "HPA001619: AB_1078727, HPA002078: AB_1078728" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" "unprognostic (3.01e-2)" "unprognostic (1.53e-1)" "unprognostic (6.72e-2)" "unprognostic (2.28e-3)" "unprognostic (1.30e-2)" "unprognostic (4.95e-2)" "unprognostic (9.92e-2)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.30e-1)" "unprognostic (1.92e-1)" "unprognostic (7.32e-2)" "unprognostic (2.45e-2)" 11.5 12.0 14.4 10.5 15.3 14.5 12.0 19.9 17.3 15.7 11.7 16.7 11.5 15.1 13.2 14.1 13.9 7.8 13.0 15.2 16.1 12.4 8.5 12.2 12.8 14.2 15.1 15.0 15.1 10.6 16.8 10.9 13.7 15.4 13.7 11.6 18.2 12.2 13.3 20.4 15.2 11.9 12.2 11.7 12.4 12.4 35.0 15.2 13.0 13.6 14.7 15.0 15.7 14.5 18.0 19.8 11.6 29.4 16.0 16.1 14.2 11.7 13.7 16.8 21.4 19.8 13.4 7.0 25.3 7.9 20.7 14.3 19.1 26.9 12.5 19.7 20.2 27.0 10.3 20.0 15.4 16.7 41.0 17.9 16.6 16.9 15.8 17.8 19.5 18.4 14.8 25.4 27.0 20.3 22.4 27.8 20.3 13.5 18.3 9.5 31.1 24.5 26.0 21.7 14.7 22.6 20.9 18.9 15.4 14.5 19.4 16.4 16.1 20.5 14.3 18.6 14.4 15.5 19.3 20.4 25.1 13.7 14.8 17.1 1.3 2.4 1.2 3.4 3.0 3.5 4.8 1.8 3.3 2.2 2.0 1.8 3.2 2.0 1.0 8.1 4.4 1.4 1.9 14.4 15.3 19.9 17.3 15.2 16.1 14.2 15.1 15.0 15.4 11.7 15.2 18.0 8.4 12.8 15.2 23.2 10.6 7.4 7.3 6.2 15.4 18.0 9.6 8.9 22.7 10.0 8.5 12.9 12.5 9.8 13.8 8.6 9.8 8.9 54.6 8.0 12.8 10.2 12.0 12.4 21.0 6.4 5.5 8.1 12.2 13.0 6.3 23.1 11.0 8.9 8.0 18.5 20.5 10.8 8.2 9.5 6.2 98.9 14.6 7.5 7.2 13.1 14.5 8.1 14.4 20.1 20.2 10.2 3.6 15.4 10.3 10.7 5.7 9.4 6.3 13.7 6.6 11.8 11.0 38.7 13.3 10.7 10.5 6.7 8.2 9.0 8.1 8.0 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "salivary gland: 292.4" "Cell type enriched" "Detected in many" 5 "Intestinal goblet cells: 598.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Region enhanced" "Detected in single" "cerebellum: 2.5" "Immune cell enriched" "Detected in single" 1177 "plasmacytoid DC: 117.6" "Lineage enriched" "Detected in single" 1177 "dendritic cells: 117.6" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 130.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: AB_2683098" "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favorable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favorable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.0 0.0 0.1 0.3 0.3 0.0 7.4 2.5 0.5 0.4 0.0 10.3 1.7 1.1 0.0 2.8 1.1 0.0 0.0 0.5 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.8 53.6 0.5 0.0 292.4 0.5 0.0 4.8 7.2 0.0 0.1 0.1 5.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 5.4 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.9 0.1 0.3 0.7 20.8 0.1 130.9 0.0 0.0 1.0 0.2 0.5 6.0 0.0 0.0 2.7 0.5 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.6 0.0 0.5 0.1 0.3 2.5 0.5 0.5 0.4 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.6 0.0 0.0 0.3 1.2 1.0 1.7 0.5 0.0 0.0 101.2 64.4 0.4 4.3 1.0 0.0 0.0 0.1 81.8 15.2 1.9 0.1 0.5 13.0 1.6 1.0 9.0 0.0 0.1 0.4 0.0 0.4 9.2 21.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 598.0 4.1 0.0 0.9 1.1 0.0 1.4 56.9 0.0 0.6 0.0 0.0 0.0 0.1 0.2 11.8 0.0 0.6 28.4 28.8 0.1 0.4 0.0 0.0 0.0 0.4 0.2 2.8 3.5 0.3 0.0 0.6 0.0 24.3 3.7 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "retina: 15.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 43.8;Early spermatids: 32.8;Late spermatids: 39.6;Rod photoreceptor cells: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.4 0.0 0.0 1.3 0.0 0.1 0.3 0.3 0.0 6.4 0.5 0.5 0.0 0.0 0.1 0.0 43.8 0.2 0.5 0.4 0.0 0.1 32.8 0.2 0.2 0.5 0.0 0.0 0.4 0.4 0.2 0.2 1.1 0.4 0.0 0.0 0.7 0.0 0.2 5.0 0.4 0.4 0.0 0.3 0.3 39.6 0.3 0.3 0.0 0.0 0.7 5.2 0.0 0.0 1.1 0.1 0.0 0.0 1.6 0.3 0.2 0.1 0.1 54.9 0.0 0.3 0.2 8.3 4.3 0.5 0.0 0.4 0.2 0.0 0.1 0.4 RNLS "C10orf59, FLJ11218, renalase" ENSG00000184719 "Renalase, FAD dependent amine oxidase" Q5VYX0 10 88273864-88584530 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 103.0;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 61.8;Proximal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 18.3;fHDF/TERT166: 17.1;HSkMC: 19.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 10500000000 "unprognostic (3.27e-2)" "unprognostic (9.16e-2)" "unprognostic (1.27e-1)" "unprognostic (2.58e-1)" "unprognostic (1.46e-3)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.29e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.98e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (7.74e-3)" "unprognostic (1.37e-2)" "unprognostic (9.80e-2)" "unprognostic (1.71e-1)" 7.2 13.5 4.2 2.8 2.3 2.2 6.8 6.2 3.3 7.4 6.3 7.7 5.5 5.0 5.3 5.0 6.2 5.5 11.9 1.9 4.1 16.7 8.7 3.0 3.8 4.4 4.4 1.7 5.9 8.2 9.1 5.3 2.1 4.8 7.0 8.3 4.9 6.0 3.9 11.9 4.4 5.7 3.5 3.6 2.8 6.7 5.4 3.1 2.5 9.2 9.9 4.0 4.7 4.4 3.7 18.3 8.2 0.3 0.1 2.4 2.8 0.0 5.1 0.5 2.7 2.3 1.0 5.2 0.0 8.0 17.1 0.0 2.4 0.0 0.9 2.2 3.8 0.1 2.9 5.1 0.2 11.2 0.0 0.5 19.5 1.4 10.2 0.1 0.3 5.7 0.1 1.4 9.2 0.1 6.3 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 4.3 0.1 0.1 4.0 12.4 4.9 2.2 8.9 1.3 2.5 4.1 6.3 3.9 5.3 8.4 0.2 0.0 9.8 0.0 0.0 2.1 1.2 2.3 3.6 1.7 2.4 1.7 1.6 3.1 2.2 1.8 1.4 0.1 2.7 2.3 2.7 0.9 1.8 4.2 2.3 6.2 3.3 1.9 4.1 4.4 4.4 1.7 4.8 3.6 3.1 3.7 1.2 3.2 1.5 32.0 5.5 3.2 6.8 5.7 4.0 6.5 5.5 3.9 16.7 4.3 5.8 1.8 2.1 2.0 3.2 6.2 23.5 6.4 8.9 3.8 3.1 1.3 5.4 4.6 103.0 9.6 0.5 6.2 7.1 3.2 1.3 2.2 2.5 10.1 6.5 5.0 101.1 5.5 2.0 4.7 3.8 4.3 1.5 3.8 3.6 40.3 3.7 6.8 3.1 51.8 61.8 4.2 8.9 6.4 3.9 4.4 8.5 43.1 1.6 5.7 0.0 4.6 4.6 4.7 8.2 10.4 5.5 1.6 3.0 2.9 7.2 6.9 KRTAP6-1 "C21orf103, KAP6.1" ENSG00000184724 "Keratin associated protein 6-1" Q3LI64 21 30613431-30613930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "skin 1: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOBR "APOB100R, APOB48R" ENSG00000184730 "Apolipoprotein B receptor" Q0VD83 16 28494643-28498970 "Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 35.2;intestine: 23.2;lung: 11.7;lymphoid tissue: 36.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 149.9;granulocytes: 39.3;Intestinal goblet cells: 47.5;NK-cells: 65.9;Paneth cells: 84.8;Undifferentiated cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 41.6;HMC-1: 124.8;NB-4: 35.7;THP-1: 25.8;U-937: 30.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041667, HPA042093" Enhanced NA NA 700000 "HPA041667: AB_10793972, HPA042093: AB_10795393" "unprognostic (3.16e-1)" "unprognostic (8.01e-3)" "unprognostic (6.19e-3)" "prognostic favorable (3.26e-4)" "unprognostic (5.48e-2)" "unprognostic (4.79e-3)" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (1.65e-2)" "unprognostic (7.60e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.16e-2)" "unprognostic (1.07e-1)" "unprognostic (1.25e-2)" 3.4 2.0 1.2 20.1 1.3 35.2 1.6 1.2 2.0 1.3 1.2 23.2 6.1 1.1 1.4 1.6 2.4 2.8 1.2 0.9 1.5 1.1 2.8 11.7 6.7 1.9 1.3 0.7 0.4 1.3 0.6 0.7 2.7 2.2 1.8 16.3 0.1 2.1 3.5 1.1 3.1 9.4 2.8 1.8 36.9 4.2 1.3 2.3 3.7 1.3 1.1 3.8 4.8 1.1 1.9 0.1 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.1 0.2 2.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 41.6 0.3 0.5 0.0 15.4 124.8 0.0 0.1 0.0 0.0 0.1 0.0 0.4 1.3 0.7 0.0 1.2 1.5 35.7 0.0 0.0 0.0 0.9 0.1 0.0 0.0 1.9 0.0 0.0 0.1 1.1 0.1 0.1 1.4 25.8 0.1 0.0 0.0 0.1 0.0 0.7 0.3 1.5 0.1 30.8 0.1 10.5 5.8 16.5 2.4 2.9 2.3 0.0 1.3 2.4 5.0 0.1 0.3 1.2 17.1 7.3 2.6 0.9 0.4 2.3 1.2 1.3 1.2 2.0 0.9 1.5 1.9 1.3 0.7 2.2 1.8 2.3 1.9 0.3 3.2 7.7 0.0 2.2 0.8 0.2 0.1 0.0 0.0 2.2 0.6 0.6 0.0 2.7 3.7 0.0 2.1 21.9 149.9 0.0 0.0 0.1 0.2 0.2 0.7 9.1 6.5 0.0 0.2 14.6 1.0 1.1 0.2 39.3 0.1 0.7 0.6 32.3 0.0 0.0 47.5 0.0 30.1 32.5 0.4 0.3 33.9 1.8 1.9 34.8 0.0 65.9 0.0 0.1 0.0 84.8 0.0 5.7 0.1 6.5 0.1 0.8 0.0 6.6 0.0 0.4 0.4 0.3 0.0 0.3 5.9 16.0 0.0 49.3 0.4 FAM110C ENSG00000184731 "Family with sequence similarity 110 member C" Q1W6H9 2 38814-46870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 248.8;Basal squamous epithelial cells: 90.0;Endometrial ciliated cells: 85.6;Glandular and luminal cells: 158.2;Urothelial cells: 236.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 13.3;HBEC3-KT: 10.3;hTCEpi: 10.1;RPTEC TERT1: 17.3;RT4: 24.5;SK-BR-3: 10.9" "Region enriched" "Detected in single" 6 "olfactory bulb: 1.9" "Low region specificity" "Detected in some" "HPA036144, HPA036145" Uncertain NA NA "HPA036144: AB_10670710, HPA036145: AB_2674968" "unprognostic (4.29e-2)" "unprognostic (1.96e-1)" "unprognostic (8.47e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.64e-4)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (1.94e-1)" "unprognostic (3.94e-1)" "unprognostic (1.73e-1)" "unprognostic (8.36e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-2)" "unprognostic (3.64e-2)" "unprognostic (1.41e-2)" "unprognostic (4.82e-3)" "unprognostic (2.68e-1)" 5.1 3.4 2.0 1.8 3.6 0.1 5.3 0.2 2.2 5.9 2.9 8.5 11.0 4.0 20.8 33.0 8.8 8.5 2.8 2.6 1.4 14.1 17.7 3.3 0.2 1.3 0.7 2.7 6.6 14.4 5.4 4.1 0.2 1.0 4.2 10.2 1.1 5.9 20.0 0.1 9.8 9.7 1.8 1.0 0.3 7.6 3.6 1.0 1.9 5.8 0.3 2.2 11.2 15.5 1.9 5.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 8.3 0.0 6.3 0.0 0.3 13.3 0.0 10.3 0.0 0.8 0.4 0.0 1.8 1.1 0.0 0.0 0.0 0.0 10.1 0.0 1.7 0.0 0.0 9.1 0.0 0.0 0.0 9.0 6.0 0.1 1.2 6.1 3.2 0.0 0.0 0.0 17.3 24.5 0.6 0.0 0.0 10.9 0.0 1.0 3.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 2.0 3.6 0.2 2.2 2.6 1.4 1.3 0.7 2.7 1.0 1.0 1.0 1.9 0.1 0.0 5.8 2.3 0.2 22.9 248.8 12.1 90.0 0.1 9.5 4.7 5.8 27.1 17.4 35.0 0.0 0.0 0.7 40.1 19.6 13.5 0.2 85.6 14.2 1.6 29.8 0.0 2.7 5.3 0.0 4.4 10.2 158.2 0.0 57.3 0.7 13.4 0.1 3.3 0.7 35.8 6.1 0.3 0.7 0.9 2.1 1.6 0.0 0.0 0.0 2.2 1.0 0.0 0.3 9.0 38.6 1.9 1.4 23.1 14.6 13.3 4.3 0.1 0.0 0.1 3.4 0.5 0.2 71.8 30.1 0.0 2.6 0.1 11.1 236.0 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999960-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "brain: 2.2;testis: 5.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 62.6" "Cancer enriched" "Detected in single" 4 "testis cancer: 0.7" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.3 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.2 0.3 0.1 0.3 0.1 0.3 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 10.9 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATL3 DKFZP564J0863 ENSG00000184743 "Atlastin GTPase 3" Q6DD88 11 63624087-63671921 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 264.4;Late spermatids: 728.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065702, HPA076616" Enhanced "Endoplasmic reticulum" NA NA 58000 "Endoplasmic reticulum" "HPA065702: AB_2685536, HPA076616: AB_2732318" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.32e-2)" "unprognostic (1.62e-1)" "unprognostic (6.89e-2)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (6.09e-3)" "unprognostic (3.38e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (4.52e-2)" "unprognostic (1.11e-3)" "unprognostic (7.41e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-3)" 28.6 18.3 12.5 18.1 16.3 13.3 22.3 15.4 13.5 23.2 22.2 22.2 10.0 24.5 16.6 24.8 20.3 16.1 10.3 10.4 17.0 12.8 17.9 19.0 12.7 20.5 17.1 9.3 17.1 15.5 13.4 6.7 15.1 18.2 16.9 16.7 4.1 15.5 20.6 6.4 25.4 13.8 33.5 19.0 17.1 17.6 37.2 15.1 10.9 21.0 9.7 15.5 27.3 19.5 21.8 44.2 39.4 11.7 28.4 59.2 82.5 0.2 53.2 60.0 51.9 35.0 32.9 69.7 26.3 53.8 93.6 40.0 28.3 21.8 34.8 69.8 40.4 5.8 27.9 41.8 0.2 40.7 53.2 39.2 54.0 55.6 69.1 42.8 34.7 56.3 28.5 30.6 70.2 59.6 46.6 19.2 30.7 14.9 14.1 33.7 40.7 29.3 37.8 41.2 29.7 6.3 17.0 174.3 37.6 50.5 14.5 65.7 19.1 79.1 109.0 51.9 105.3 38.3 19.0 29.6 51.4 57.7 33.6 67.1 7.1 8.3 3.7 8.9 11.4 9.8 5.3 7.4 7.3 8.6 4.2 5.9 8.2 3.5 6.9 13.4 4.3 9.3 7.8 12.5 16.3 15.4 13.5 10.4 17.0 20.5 17.1 9.3 18.2 19.0 15.1 21.8 56.7 44.8 27.2 16.6 18.8 43.7 45.7 36.4 30.1 4.8 31.9 18.4 8.5 30.0 29.9 33.1 0.0 6.7 28.5 45.2 1.9 41.2 264.4 23.8 46.4 48.2 10.7 29.5 13.5 50.2 20.1 46.2 19.4 63.8 17.1 20.3 49.6 51.3 37.6 5.0 12.1 21.0 28.5 55.3 43.0 728.4 54.3 35.7 42.7 16.9 49.5 12.6 24.7 16.6 35.6 72.7 24.7 67.4 21.0 55.3 27.7 24.7 21.5 8.5 72.3 35.9 55.2 36.0 29.0 32.9 40.6 4.0 28.2 25.6 19.8 50.9 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003748 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 564.0;tongue: 568.1" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 101.1 95.0 165.0 74.6 169.1 94.1 77.9 174.3 230.0 68.4 166.4 150.0 110.2 67.5 87.9 90.5 78.5 53.4 364.8 166.3 177.0 135.1 144.8 70.9 93.2 171.5 166.6 161.3 65.3 60.1 160.9 74.1 80.2 171.6 75.4 145.3 107.8 76.0 78.6 564.0 74.8 102.3 99.2 168.0 98.5 88.6 59.4 171.2 109.9 90.4 568.1 123.0 81.8 73.6 177.1 255.3 281.1 223.6 160.8 183.3 171.8 165.8 118.8 178.5 258.5 234.6 347.6 125.8 293.7 68.8 187.6 141.1 188.2 236.1 278.4 296.7 254.8 282.9 241.2 218.6 358.8 186.3 344.0 285.3 183.0 352.4 215.7 266.9 270.4 222.2 246.0 235.2 130.4 260.8 381.1 238.6 533.6 167.0 313.7 484.0 179.9 189.4 335.2 262.5 393.9 213.2 128.5 201.3 287.3 164.6 193.9 287.2 226.9 243.5 134.1 134.0 195.0 204.2 207.5 349.9 443.7 80.6 293.6 211.2 643.9 420.5 228.2 354.8 512.5 336.4 482.8 479.5 429.9 576.2 415.5 631.9 455.9 62.0 464.6 506.6 355.5 570.8 814.8 165.0 169.1 174.3 230.0 166.3 177.0 171.5 166.6 161.3 171.6 168.0 171.2 177.1 213.5 73.7 68.4 26.8 81.3 108.6 163.9 364.5 71.2 67.4 87.9 171.7 2159.0 135.8 168.3 108.5 64.6 254.0 127.9 172.0 620.3 162.0 240.0 110.3 98.9 206.0 85.3 86.5 19.6 163.9 254.5 172.6 67.2 100.7 58.3 103.5 109.2 149.1 192.3 37.0 29.0 171.8 244.1 103.6 161.9 122.1 97.6 111.1 160.1 13.1 203.5 141.6 199.8 20.6 22.3 234.6 228.8 133.5 98.8 123.8 229.9 338.3 134.7 130.5 105.2 120.8 291.2 156.3 109.8 127.9 127.7 209.6 120.2 181.9 219.2 182.0 SMIM10 CXorf69 ENSG00000184785 "Small integral membrane protein 10" Q96HG1 X 134990991-134992473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 25.5;Endothelial cells: 24.6;Erythroid cells: 39.1;Smooth muscle cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.0;NK-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 39.0" NA NA "unprognostic (2.66e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.79e-3)" "unprognostic (3.23e-2)" "unprognostic (2.22e-4)" "unprognostic (3.63e-2)" "unprognostic (5.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.09e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.69e-6)" "unprognostic (1.59e-2)" "unprognostic (2.25e-1)" "unprognostic (2.13e-1)" "unprognostic (9.28e-2)" 14.7 14.0 10.6 3.8 10.4 12.3 11.3 11.6 13.4 14.6 9.9 12.4 2.5 14.4 4.6 5.8 15.7 6.6 12.0 9.5 13.2 6.7 2.2 8.3 2.9 13.5 11.5 8.5 11.3 3.6 25.0 6.1 3.5 13.3 12.6 4.2 3.3 5.2 11.2 3.7 3.7 7.1 9.3 14.4 10.9 7.3 27.9 12.5 1.6 8.2 6.3 1.8 15.8 11.2 15.0 0.0 0.0 0.1 0.0 17.3 20.8 6.3 9.0 29.5 5.3 7.9 7.6 0.1 0.0 23.4 9.2 26.5 0.0 16.6 0.1 7.7 25.4 15.9 26.8 35.2 0.0 15.2 24.3 5.4 27.8 0.0 15.8 0.0 7.1 4.2 0.0 13.5 0.0 18.8 0.0 0.0 39.0 0.0 0.0 0.0 0.0 2.2 0.0 1.4 4.8 4.6 0.0 11.1 0.0 17.3 0.4 0.0 17.7 0.8 13.2 8.7 28.2 12.9 0.0 0.0 0.0 10.3 26.7 4.9 1.5 0.3 2.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 3.4 0.2 0.0 0.0 0.1 10.6 10.4 11.6 13.4 9.5 13.2 13.5 11.5 8.5 13.3 14.4 12.5 15.0 25.5 3.2 3.6 2.0 0.6 1.8 6.4 0.6 0.0 3.3 3.0 3.9 14.3 1.5 3.8 1.8 0.0 0.9 0.6 0.0 3.9 5.7 4.2 9.3 12.1 24.6 0.0 39.1 0.2 1.2 1.2 13.9 0.5 1.2 9.5 9.5 20.0 0.1 5.5 1.7 0.3 0.2 2.0 2.5 2.4 9.4 18.6 1.3 19.6 2.8 0.5 19.3 1.0 0.5 0.4 0.9 0.2 18.0 0.2 1.0 0.0 1.4 2.2 1.3 6.6 17.6 31.9 3.1 2.9 1.2 1.0 0.5 1.7 8.7 0.5 2.7 DYNLT2 "TCTE3, TCTEX1D3, TCTEX2, Tctex4" ENSG00000184786 "Dynein light chain Tctex-type 2" Q8IZS6 6 169740109-169751587 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 18.3" "Cell type enhanced" "Detected in some" "Adipocytes: 1.8;B-cells: 1.3;Cytotrophoblasts: 1.5;dendritic cells: 3.4;Endothelial cells: 1.1;Extravillous trophoblasts: 1.3;Plasma cells: 2.2;Smooth muscle cells: 1.7;Syncytiotrophoblasts: 1.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (2.22e-2)" "unprognostic (1.05e-2)" "unprognostic (6.15e-2)" "unprognostic (1.70e-2)" "unprognostic (2.63e-2)" "unprognostic (5.11e-2)" "unprognostic (1.87e-1)" "unprognostic (6.11e-5)" "unprognostic (1.58e-1)" "unprognostic (2.04e-10)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (3.56e-5)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.2 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 UBE2G2 UBC7 ENSG00000184787 "Ubiquitin conjugating enzyme E2 G2" P60604 21 44768580-44801826 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 211.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003332 Approved NA NA "HPA003332: AB_1858525" "unprognostic (7.58e-2)" "unprognostic (5.41e-2)" "unprognostic (1.58e-2)" "unprognostic (4.45e-2)" "unprognostic (6.30e-2)" "unprognostic (4.67e-2)" "unprognostic (5.99e-2)" "unprognostic (3.79e-3)" "unprognostic (6.93e-3)" "unprognostic (7.02e-2)" "unprognostic (1.40e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (7.02e-5)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (3.55e-2)" 26.9 21.0 20.9 13.6 21.5 26.2 17.7 21.2 24.9 13.6 19.7 20.9 13.4 20.4 8.5 16.2 16.5 12.2 31.7 21.3 21.4 24.5 27.9 17.0 16.4 21.8 21.7 19.8 13.8 26.9 20.7 8.2 14.3 21.8 15.0 14.3 20.9 12.7 21.5 61.8 15.0 16.7 20.6 20.9 19.9 21.8 12.3 21.9 23.1 17.1 52.3 15.1 21.4 12.6 23.4 51.9 11.5 34.9 44.3 46.2 20.6 31.3 37.0 27.5 29.5 31.7 40.5 6.7 66.4 33.4 35.8 38.6 20.5 49.4 43.5 27.2 61.9 51.1 107.3 7.0 33.6 35.5 79.2 19.4 33.3 50.0 39.5 39.5 14.7 47.0 71.3 99.8 47.9 43.0 24.6 89.2 13.3 86.7 35.4 44.2 73.2 31.1 61.2 41.4 28.3 39.3 72.5 49.6 18.2 52.3 30.5 17.6 68.5 37.3 31.1 21.2 28.5 58.5 73.8 144.7 64.1 29.3 96.1 36.3 3.2 16.1 8.5 20.8 16.8 22.8 16.0 19.0 21.5 17.3 16.2 20.1 21.3 4.9 20.8 20.1 24.6 21.1 17.4 20.9 21.5 21.2 24.9 21.3 21.4 21.8 21.7 19.8 21.8 20.9 21.9 23.4 54.6 57.7 115.4 70.8 48.3 47.7 38.4 32.0 39.3 58.8 37.3 34.0 70.6 28.6 48.4 53.3 66.7 40.7 53.3 29.8 25.4 32.9 63.4 36.8 68.5 54.1 30.0 37.4 56.3 40.7 26.3 41.3 26.0 49.7 43.6 66.6 37.1 69.7 35.3 32.0 57.5 31.2 26.4 42.2 37.4 211.1 41.3 42.9 28.4 32.8 43.2 39.5 49.4 73.9 56.7 43.2 21.5 50.4 53.6 55.6 27.4 36.7 43.0 102.2 26.3 59.3 42.8 42.9 49.4 44.9 56.0 35.8 49.4 75.6 46.0 40.9 SATL1 ENSG00000184788 "Spermidine/spermine N1-acetyl transferase like 1" Q86VE3 X 85092284-85243911 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 12.8;Alveolar cells type 2: 12.9;Club cells: 6.8;Distal tubular cells: 3.9;Early spermatids: 5.4;granulocytes: 6.3;Late spermatids: 14.0;Respiratory ciliated cells: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060369 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060369: AB_2684265" "unprognostic (1.77e-1)" "unprognostic (2.06e-1)" "unprognostic (4.69e-3)" "unprognostic (7.88e-2)" 0.0 0.3 0.2 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 0.4 0.2 0.1 0.1 0.3 0.2 0.0 0.1 0.4 0.0 12.8 12.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 6.8 0.0 0.0 0.0 0.2 0.0 3.9 0.0 5.4 0.3 0.3 1.2 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.2 6.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 14.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.8 0.0 0.4 0.7 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.7 0.3 0.0 0.0 OSBP2 "KIAA1664, ORP-4, ORP4, OSBPL1" ENSG00000184792 "Oxysterol binding protein 2" Q969R2 22 30693782-30907824 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.1;retina: 162.2" "Cell type enhanced" "Detected in many" "Early spermatids: 135.4;Excitatory neurons: 132.8;Inhibitory neurons: 156.3;Late spermatids: 304.4;Oligodendrocytes: 182.8;Rod photoreceptor cells: 619.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 41.9;HeLa: 146.4;hTERT-HME1: 38.2;SiHa: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021514 Uncertain Approved Cytosol NA NA Cytosol "HPA021514: AB_1854813" "unprognostic (2.89e-1)" "unprognostic (2.04e-1)" "unprognostic (2.83e-1)" "unprognostic (6.94e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (1.38e-5)" "unprognostic (3.01e-1)" "unprognostic (2.57e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (2.31e-1)" "prognostic favorable (3.79e-6)" "unprognostic (9.00e-2)" "unprognostic (2.68e-1)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" 1.2 11.9 6.9 2.8 13.3 53.1 1.5 15.3 16.6 1.5 1.7 1.7 7.5 2.0 14.7 3.7 2.0 3.0 12.3 8.6 4.6 2.6 1.0 1.6 2.4 9.5 10.7 6.3 1.6 5.1 9.4 21.1 4.6 12.4 2.3 1.8 162.2 2.9 2.5 2.8 5.4 5.6 1.2 2.4 4.9 3.5 28.9 17.2 0.6 3.3 3.3 1.3 4.5 2.1 15.2 7.1 15.4 1.5 6.7 1.0 5.8 1.6 1.3 3.1 4.8 4.8 14.0 3.9 12.5 5.7 1.9 1.5 4.1 6.2 0.6 3.5 6.7 1.8 41.9 146.4 2.7 0.9 0.2 2.5 0.3 16.8 11.8 38.2 1.6 12.1 4.8 26.7 0.5 11.0 7.8 1.3 4.5 3.8 3.3 13.8 3.5 0.5 0.7 0.6 2.7 16.7 6.8 39.2 4.1 0.4 2.9 4.9 2.2 8.8 3.4 18.1 3.2 6.8 3.2 4.8 2.3 13.3 0.0 2.7 0.0 0.7 0.4 0.5 1.1 1.0 0.5 1.0 0.4 0.6 0.6 1.0 1.1 0.7 1.0 0.9 0.2 0.7 2.0 6.9 13.3 15.3 16.6 8.6 4.6 9.5 10.7 6.3 12.4 2.4 17.2 15.2 1.2 0.0 3.1 37.9 0.2 5.2 0.9 0.4 0.6 93.2 1.3 0.8 11.2 2.8 1.0 1.8 81.3 0.2 0.3 1.3 1.9 1.8 135.4 1.6 0.5 2.8 7.2 91.3 132.8 1.5 0.2 1.6 2.0 1.6 0.0 3.2 0.4 0.1 0.2 18.5 156.3 2.8 0.0 0.3 1.8 304.4 2.5 1.7 1.8 8.4 0.4 31.4 0.0 35.7 182.8 0.8 5.2 1.9 1.4 1.2 0.7 0.8 1.3 619.5 0.0 1.1 2.3 48.6 4.4 1.4 9.5 0.3 0.5 1.2 1.2 1.3 TRARG1 "BEC-1, DSPB1, IFITMD3, LOST1, TUSC5" ENSG00000184811 "Trafficking regulator of GLUT4 (SLC2A4) 1" Q8IXB3 17 1279662-1300978 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "adipose tissue: 102.3;breast: 69.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 294 "ASC diff: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050825 Approved NA NA "HPA050825: AB_2681252" "unprognostic (5.84e-2)" "unprognostic (7.21e-2)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (2.91e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (1.90e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (5.10e-1)" 102.3 1.1 0.0 1.2 0.0 0.0 69.2 0.0 0.4 0.3 0.0 1.0 0.0 0.2 0.0 0.1 0.1 0.6 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.4 0.0 1.2 1.7 2.3 0.0 0.0 0.0 0.6 0.6 0.0 0.1 1.0 0.6 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 1.3" "Group enriched" "Detected in some" 8 "Spermatocytes: 6.4;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 ZBTB7C "ZBTB36, ZNF857C" ENSG00000184828 "Zinc finger and BTB domain containing 7C" A1YPR0 18 48026672-48410752 "Predicted intracellular proteins, Transcription factors" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.1" "Cell type enhanced" "Detected in many" "Astrocytes: 47.0;Basal squamous epithelial cells: 45.5;Distal enterocytes: 52.5;Excitatory neurons: 48.8;Gastric mucus-secreting cells: 49.5;Oligodendrocyte precursor cells: 51.3;Squamous epithelial cells: 96.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RT4: 42.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.83e-3)" "unprognostic (6.60e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.58e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (2.71e-1)" "unprognostic (5.52e-3)" "unprognostic (3.85e-3)" "unprognostic (2.89e-2)" 4.7 11.3 9.4 2.0 4.3 0.4 6.2 4.9 6.2 5.8 0.0 14.7 1.8 1.7 17.4 41.1 14.1 3.4 1.6 4.9 7.2 1.9 0.9 4.6 0.6 8.4 7.0 3.5 6.5 1.0 5.3 1.8 3.7 3.9 3.3 13.5 6.3 14.8 3.9 1.8 21.4 2.9 2.1 6.1 9.3 13.9 9.3 15.2 0.3 16.9 1.6 3.8 11.1 19.7 5.3 0.0 0.0 1.5 1.2 0.2 0.4 0.8 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.5 0.0 1.7 2.7 0.1 0.4 0.2 0.3 1.3 0.2 3.2 0.1 0.0 0.0 0.4 0.1 0.7 0.2 0.4 0.0 0.0 1.2 0.0 0.1 0.6 0.7 1.7 0.5 0.5 8.6 0.0 0.1 0.0 9.7 1.3 42.7 5.4 6.9 0.6 0.3 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.5 0.0 0.1 0.2 0.0 2.7 0.1 0.2 1.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.0 9.4 4.3 4.9 6.2 4.9 7.2 8.4 7.0 3.5 3.9 6.1 15.2 5.3 0.5 6.4 1.5 47.0 0.1 6.1 5.3 11.6 45.5 1.2 6.0 8.4 3.1 12.8 9.5 1.8 0.0 13.7 0.1 52.5 0.0 1.0 9.6 4.8 1.8 2.9 4.8 0.0 48.8 4.0 0.8 3.4 49.5 6.7 0.0 1.0 0.0 0.6 1.5 1.7 7.0 30.8 6.1 2.1 0.8 4.4 3.7 0.4 3.6 22.5 0.1 1.0 0.0 51.3 2.1 1.2 14.6 12.0 0.0 7.5 3.5 0.0 7.6 2.5 13.1 8.8 11.9 0.9 0.9 96.9 8.8 12.6 0.2 6.6 18.3 13.7 APOO "FAM121B, MGC4825, Mic23, MIC26, MICOS26, My025" ENSG00000184831 "Apolipoprotein O" Q9BUR5 X 23833353-23907938 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 180.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003187 Supported Approved Mitochondria,Cytosol "Secreted to blood" NA NA Mitochondria Cytosol "HPA003187: AB_1079375" "unprognostic (2.53e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.86e-2)" "unprognostic (6.38e-3)" "unprognostic (3.45e-1)" "unprognostic (2.42e-1)" "unprognostic (6.18e-2)" "unprognostic (2.95e-1)" "unprognostic (6.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "prognostic favorable (2.56e-6)" "unprognostic (2.53e-2)" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (5.88e-3)" 9.1 23.9 56.6 9.1 58.8 7.9 13.5 59.2 76.8 13.2 65.3 17.4 14.6 10.7 19.7 12.7 21.0 9.4 63.2 58.8 58.3 46.9 18.4 8.7 11.8 58.8 57.5 57.4 9.5 14.3 62.6 29.5 11.0 58.3 13.8 19.0 53.3 19.9 15.1 46.3 7.7 12.1 12.1 57.3 8.5 17.9 17.0 56.7 14.1 20.5 73.8 11.7 11.3 8.2 59.9 36.5 32.7 53.9 37.8 8.8 19.9 8.3 17.9 21.9 37.4 38.8 19.3 17.0 31.5 21.9 16.5 48.5 29.3 68.5 35.7 41.2 33.4 48.7 15.9 28.6 31.1 20.8 40.9 17.1 22.2 20.7 41.2 30.4 20.1 26.6 38.8 22.9 33.2 35.1 34.6 41.2 43.0 49.2 47.5 52.7 31.5 26.6 75.6 74.1 18.4 36.4 26.5 39.0 36.7 39.7 52.4 63.6 17.9 6.5 23.9 14.6 86.6 27.9 26.3 50.5 28.7 38.5 19.8 35.8 14.8 4.8 1.4 12.6 15.9 16.6 10.8 13.7 12.5 14.0 10.2 10.9 10.7 3.0 10.3 16.0 16.6 14.0 7.7 56.6 58.8 59.2 76.8 58.8 58.3 58.8 57.5 57.4 58.3 57.3 56.7 59.9 7.4 16.0 11.5 61.7 11.8 14.0 17.0 74.3 11.4 20.4 14.3 17.0 61.8 21.5 28.3 23.9 14.6 17.2 11.3 12.8 180.0 28.4 25.9 56.0 13.0 10.1 7.2 20.8 61.4 16.0 8.9 11.7 13.3 24.4 3.8 14.2 7.9 13.9 22.7 20.2 76.5 17.0 44.7 14.6 12.0 15.7 11.5 9.9 28.4 74.0 34.2 50.0 8.2 43.7 76.5 10.2 20.0 15.8 14.8 14.1 24.0 80.6 106.9 32.4 6.6 10.8 22.3 26.1 53.2 18.9 7.0 12.4 9.5 17.0 22.3 16.8 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464300-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 30.7" "Group enriched" "Detected in many" 9 "Excitatory neurons: 171.6;Inhibitory neurons: 188.9" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Yes No Nucleoplasm "Midbody, Cytosol" "HPA049254: AB_2680693" "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 7.7 2.9 1.8 5.2 2.2 0.2 8.0 6.2 3.6 15.0 0.0 4.8 1.8 11.9 1.5 1.8 7.1 5.8 12.9 2.0 2.6 3.0 0.9 9.9 1.1 3.3 2.3 2.1 5.7 2.0 1.1 1.8 9.8 3.5 9.4 4.6 7.0 2.7 2.4 26.7 3.7 5.0 8.3 0.4 2.5 4.0 2.4 1.6 0.7 4.4 30.7 0.9 9.6 10.1 2.6 3.7 0.0 8.0 0.0 22.2 77.3 0.0 37.0 83.9 51.5 39.1 0.0 0.2 0.0 0.0 102.1 9.3 0.0 8.1 0.9 53.8 0.0 1.9 0.0 1.2 0.0 21.5 0.2 0.1 62.5 8.9 15.4 48.0 103.0 1.7 0.0 0.1 0.1 97.9 0.0 0.0 0.0 0.9 0.0 1.4 0.0 6.2 0.0 4.3 0.0 0.3 16.1 0.1 0.0 1.1 6.1 0.1 0.1 0.5 117.9 13.3 3.8 19.4 0.3 0.0 0.0 6.7 0.2 4.1 0.1 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.3 1.8 2.2 6.2 3.6 2.0 2.6 3.3 2.3 2.1 3.5 0.4 1.6 2.6 1.4 0.0 0.0 14.0 0.4 1.3 6.2 0.0 0.0 7.5 1.5 1.9 3.2 0.0 0.0 0.0 14.6 0.1 0.1 0.0 0.0 0.1 16.8 0.9 18.9 0.8 0.0 0.0 171.6 0.0 0.0 13.5 0.0 0.8 0.0 0.2 0.4 0.0 0.5 15.2 188.9 0.0 0.0 1.8 2.7 11.6 2.8 1.0 1.8 9.4 0.1 2.6 0.0 7.5 3.9 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.7 0.0 1.4 9.6 0.9 1.4 0.5 0.6 0.5 0.4 3.1 0.0 0.7 TMED9 "HSGP25L2G, p24a2, p24alpha2" ENSG00000184840 "Transmembrane p24 trafficking protein 9" Q9BVK6 5 177592203-177597242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 915.2;Syncytiotrophoblasts: 773.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved NA NA 36000 "HPA014650: AB_1858066" "unprognostic (5.75e-3)" "unprognostic (4.35e-2)" "unprognostic (1.37e-1)" "unprognostic (3.82e-2)" "unprognostic (9.37e-3)" "unprognostic (5.14e-3)" "unprognostic (2.55e-2)" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (7.00e-2)" "unprognostic (4.01e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.88e-5)" "unprognostic (2.88e-1)" "unprognostic (4.71e-2)" "unprognostic (9.07e-2)" "unprognostic (3.65e-2)" 79.3 107.6 30.1 38.6 30.1 38.1 75.1 30.4 34.3 72.4 40.1 74.8 32.1 77.2 66.2 136.8 61.3 26.0 93.9 30.2 32.6 98.0 231.4 101.4 30.0 33.1 31.3 29.3 63.0 255.8 41.2 82.7 59.6 31.0 87.7 46.0 15.9 140.3 34.7 56.1 84.3 76.3 39.8 31.2 102.9 114.9 54.4 32.1 24.7 88.5 17.0 36.7 85.5 83.2 31.2 100.4 115.9 51.0 163.3 131.5 93.0 224.1 181.5 139.1 91.0 125.3 178.5 142.5 57.5 214.3 171.2 179.5 79.9 49.6 244.8 91.1 275.7 73.6 47.8 93.2 151.2 132.7 130.9 170.4 88.1 125.6 95.8 106.7 122.9 137.4 51.7 55.9 100.0 99.3 243.9 31.3 96.4 57.0 89.9 112.7 53.3 66.9 147.8 109.3 86.0 26.6 38.4 89.7 104.1 99.9 80.4 104.7 131.0 121.0 112.2 83.2 93.0 140.5 171.4 109.9 56.7 149.1 165.9 146.5 78.9 98.3 77.2 85.5 94.5 85.3 65.9 68.3 67.0 91.9 63.5 58.0 53.8 39.1 76.8 89.0 201.4 74.8 131.9 30.1 30.1 30.4 34.3 30.2 32.6 33.1 31.3 29.3 31.0 31.2 32.1 31.2 115.6 67.3 69.5 10.1 127.3 145.0 193.4 601.4 48.9 67.4 118.6 94.0 48.0 147.3 235.8 128.8 31.3 525.6 167.8 172.8 29.4 428.6 7.1 51.0 108.4 145.1 112.3 78.9 9.3 354.1 915.2 175.9 79.0 89.8 113.4 141.8 115.6 118.4 384.5 60.6 9.6 323.1 238.0 79.5 139.2 13.5 135.2 121.2 256.1 15.9 189.2 105.4 147.2 17.6 10.3 320.0 155.7 98.2 370.3 229.6 84.2 71.7 94.5 73.7 65.7 83.4 160.3 89.1 175.7 59.9 138.5 773.2 104.7 157.7 182.7 203.6 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440036-175444182 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "brain: 19.7;retina: 8.5" "Group enriched" "Detected in some" 12 "Bipolar cells: 40.1;Horizontal cells: 33.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 26.4" "Region enriched" "Detected in many" 9 "basal ganglia: 164.4" "Region enriched" "Detected in many" 13 "basal ganglia: 86.7" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.3 0.6 3.4 0.0 19.7 0.0 0.2 0.2 7.9 0.3 0.3 0.2 0.1 0.1 0.2 0.3 0.2 0.4 0.0 2.9 8.7 0.2 1.1 0.7 0.0 7.5 1.1 5.7 0.1 0.0 0.0 0.1 1.1 5.3 1.1 0.3 8.5 0.0 0.4 0.0 0.0 0.3 0.1 1.0 0.1 0.2 0.0 2.9 0.3 0.1 0.6 0.1 0.7 0.4 2.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 26.4 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 19.7 0.2 7.9 2.9 8.7 7.5 1.1 5.7 5.3 1.0 2.9 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 40.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 33.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TMEM186 "C16orf51, DKFZP564K2062" ENSG00000184857 "Transmembrane protein 186" Q96B77 16 8780384-8797642 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.8;Late spermatids: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018226, HPA063559" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA018226: AB_1845579, HPA063559: AB_2685041" "unprognostic (3.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.11e-2)" "unprognostic (2.98e-2)" "unprognostic (4.81e-2)" "unprognostic (1.18e-1)" "unprognostic (2.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.06e-2)" "unprognostic (9.35e-2)" "unprognostic (2.45e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.93e-8)" "unprognostic (1.06e-1)" "unprognostic (3.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.89e-2)" 6.9 11.3 8.9 6.3 9.1 2.2 10.1 9.0 10.6 6.5 9.3 10.2 9.6 7.5 12.6 9.7 9.4 4.7 11.2 8.7 9.1 10.2 16.5 5.9 8.7 8.9 8.9 8.9 8.6 9.0 12.5 9.6 7.2 9.1 7.5 11.3 5.1 8.4 7.3 18.6 8.4 9.8 7.6 8.9 10.0 9.6 7.8 9.1 7.9 7.7 21.5 10.8 7.6 6.6 9.5 10.4 16.1 11.8 15.1 19.8 10.5 11.2 11.8 12.1 15.2 12.5 15.9 17.1 31.9 9.8 8.7 10.4 19.8 21.2 16.8 17.3 18.7 20.4 13.4 22.3 34.1 22.0 15.1 10.3 12.7 27.8 16.7 24.4 12.5 14.0 25.9 23.3 17.1 9.0 28.3 11.7 14.7 15.0 22.0 13.9 24.4 15.5 35.3 16.3 8.8 18.1 17.3 16.2 22.7 14.3 12.0 27.1 12.0 8.9 10.8 15.1 27.0 9.9 15.6 17.6 15.5 16.8 27.1 8.8 9.9 8.7 6.8 7.5 8.6 10.0 13.1 8.1 8.8 9.1 11.5 13.7 10.9 4.1 9.1 13.3 7.0 11.7 7.4 8.9 9.1 9.0 10.6 8.7 9.1 8.9 8.9 8.9 9.1 8.9 9.1 9.5 3.4 6.4 6.7 2.6 6.7 8.2 7.1 16.1 5.7 6.9 7.3 6.6 2.7 10.0 13.1 11.0 0.0 23.4 4.4 7.8 21.5 15.1 44.8 4.8 6.0 5.6 13.8 8.2 1.9 11.2 13.3 5.7 6.1 5.0 7.0 9.6 6.1 12.8 13.2 13.5 1.5 9.4 12.2 4.9 4.7 106.9 9.3 2.5 7.2 1.0 9.9 10.8 11.3 1.5 1.9 9.9 6.7 6.4 5.1 9.8 14.8 21.9 9.3 5.6 13.1 6.6 5.3 21.3 11.9 9.5 9.5 15.1 5.0 11.0 16.0 5.8 SDR42E1 HSPC105 ENSG00000184860 "Short chain dehydrogenase/reductase family 42E, member 1" Q8WUS8 16 81988855-82011481 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.3" "Cell type enhanced" "Detected in many" "Ductal cells: 10.0;Ionocytes: 10.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;NK-cells: 2.0;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.5;hTCEpi: 12.1;MCF7: 8.3;RT4: 20.6;SCLC-21H: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014388 Uncertain NA NA "HPA014388: AB_1851226" "unprognostic (2.09e-1)" "unprognostic (4.90e-1)" "unprognostic (9.52e-3)" "unprognostic (3.81e-1)" "unprognostic (3.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.51e-2)" "unprognostic (3.96e-2)" "unprognostic (4.93e-4)" "unprognostic (4.90e-7)" "unprognostic (2.18e-1)" "unprognostic (1.82e-1)" "unprognostic (3.21e-2)" "unprognostic (8.27e-2)" 0.4 0.1 0.0 0.9 0.1 0.4 4.4 0.0 0.0 0.9 0.1 2.5 5.7 1.3 1.9 3.6 1.7 1.1 0.4 0.0 0.1 1.9 1.9 1.7 1.4 0.1 0.1 0.0 0.3 3.2 2.1 1.3 0.3 0.0 1.7 1.8 0.0 3.1 0.9 0.0 9.3 4.8 1.2 0.0 0.8 2.6 1.1 0.1 1.6 2.0 0.0 2.4 2.3 2.4 0.1 3.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.9 0.0 1.8 0.0 0.4 9.5 0.0 6.5 0.0 0.0 0.6 0.0 1.7 0.0 0.3 0.0 0.0 0.3 12.1 1.5 5.9 0.0 0.0 0.0 1.6 0.0 0.8 8.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 2.5 20.6 8.2 0.0 0.2 4.3 0.0 0.2 0.1 0.0 0.2 0.0 4.3 0.0 0.0 4.0 5.9 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 1.1 2.3 0.7 1.2 0.1 1.0 2.2 1.6 0.0 2.0 0.0 0.1 1.5 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.0 0.0 1.1 0.0 2.7 5.9 3.5 6.1 6.2 0.0 5.8 3.9 2.6 7.2 3.3 1.8 0.0 0.6 1.1 2.7 3.9 10.0 1.3 2.8 0.7 0.5 2.4 0.4 0.0 7.5 0.2 0.4 1.1 3.2 0.0 0.4 0.0 3.7 0.0 0.0 0.0 6.0 10.2 0.0 0.3 2.0 0.0 0.2 1.8 0.0 0.0 0.0 1.0 0.0 0.1 6.3 4.5 0.0 1.1 3.8 9.7 2.9 3.6 0.0 0.0 0.0 0.5 8.4 6.2 5.6 9.1 0.3 1.2 0.1 4.1 4.4 RBM33 "DKFZp434D1319, DKFZp686F102, MGC20460, PRR8" ENSG00000184863 "RNA binding motif protein 33" Q96EV2 7 155644451-155781485 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019232, HPA021497, HPA021768" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123" "unprognostic (1.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (3.04e-2)" "unprognostic (2.06e-1)" "prognostic favorable (9.63e-5)" "unprognostic (3.48e-2)" "unprognostic (2.07e-2)" "unprognostic (6.85e-2)" "unprognostic (3.89e-2)" "unprognostic (8.90e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.29e-4)" 23.2 19.5 15.0 15.4 15.4 62.7 23.5 37.0 18.7 25.5 8.6 24.3 14.1 22.5 17.3 24.5 20.7 8.9 20.1 13.0 12.4 22.7 32.4 30.4 18.9 20.0 14.6 6.4 26.3 30.3 8.1 28.5 10.7 22.9 23.2 12.8 34.0 23.2 9.5 31.2 30.4 31.4 9.6 5.4 30.5 27.1 17.1 15.5 31.8 24.7 10.2 15.8 19.6 28.5 22.8 31.9 37.0 22.7 21.1 12.0 15.6 22.9 19.8 14.0 12.0 17.3 34.2 30.0 35.1 25.9 14.7 32.5 22.5 20.8 16.7 15.9 33.3 29.0 33.5 41.7 22.7 13.2 47.7 32.5 15.3 19.3 19.2 27.3 17.4 21.4 38.8 43.6 28.3 17.2 31.1 49.4 40.8 24.4 21.4 23.3 39.2 25.4 29.4 17.4 34.1 23.0 23.5 33.2 21.7 18.0 17.0 16.6 24.8 24.8 20.2 11.9 36.6 26.6 48.8 40.7 52.4 32.7 30.5 26.4 33.5 10.4 23.1 6.6 10.5 5.4 9.5 6.6 8.2 9.1 7.7 6.1 7.8 37.2 9.1 8.3 9.0 9.3 4.2 15.0 15.4 37.0 18.7 13.0 12.4 20.0 14.6 6.4 22.9 5.4 15.5 22.8 36.3 32.1 36.4 68.2 52.3 19.6 20.4 19.7 33.6 57.6 22.2 19.8 30.2 14.3 17.0 3.7 83.4 18.1 60.3 32.4 7.9 20.1 25.6 25.9 43.7 27.6 26.3 37.2 86.8 18.0 17.4 26.0 45.3 43.0 39.2 38.9 17.5 30.0 15.9 132.9 85.5 28.1 16.2 28.3 24.4 42.0 26.1 39.3 12.4 87.1 42.9 23.0 42.2 97.0 115.0 23.5 28.5 17.7 93.1 33.3 37.1 18.2 19.2 91.5 13.1 37.5 31.5 29.5 24.4 26.3 23.4 26.1 53.0 33.9 24.0 36.5 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing X-linked 2" Q7L311 X 101655281-101659850 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 156.1" "Cell type enhanced" "Detected in many" "Sertoli cells: 59.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 164.1;NTERA-2: 117.2;SuSa: 90.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 14.5 46.6 28.5 11.6 30.2 0.5 17.7 23.6 29.2 33.0 27.3 20.4 5.4 30.9 156.1 9.3 29.1 20.8 33.5 29.2 31.4 23.0 3.2 17.0 8.6 26.3 26.4 29.8 48.3 19.1 71.8 78.9 26.5 28.0 28.5 8.0 15.4 44.9 68.6 6.3 6.4 13.1 32.5 24.0 21.5 16.5 5.8 28.2 7.8 60.3 7.6 6.5 27.2 20.3 28.8 0.0 0.0 50.8 0.4 43.6 39.4 0.4 56.0 70.4 1.4 1.4 0.0 21.8 0.0 0.0 74.6 0.0 1.5 0.0 1.3 0.6 0.0 2.0 0.2 60.9 0.0 46.4 0.4 0.1 63.7 17.6 43.5 0.4 68.3 59.7 0.0 0.2 0.3 164.1 0.0 0.0 0.6 117.2 3.4 0.3 14.5 88.9 0.3 2.8 0.0 20.4 36.6 0.0 0.2 1.7 90.3 25.9 0.1 13.0 61.9 65.1 38.8 0.4 0.0 0.0 0.2 55.7 0.1 1.2 0.0 0.4 0.0 1.0 0.9 0.4 2.8 0.9 0.9 0.7 4.0 2.4 2.5 0.0 2.8 0.6 0.9 0.7 1.1 28.5 30.2 23.6 29.2 29.2 31.4 26.3 26.4 29.8 28.0 24.0 28.2 28.8 10.4 16.0 6.4 8.5 8.2 4.2 16.4 5.8 21.1 12.5 18.0 20.8 28.7 5.7 11.4 33.1 8.4 1.2 2.4 0.1 3.9 9.6 0.2 11.2 23.4 13.3 9.1 3.2 15.4 2.0 0.7 28.4 4.6 15.2 2.5 18.1 19.2 0.7 3.8 1.7 14.3 3.0 2.0 2.4 6.5 1.3 24.2 7.4 5.4 11.2 7.1 9.3 0.0 16.1 14.0 2.2 0.1 24.5 2.8 16.5 0.3 4.3 4.9 11.3 59.2 31.8 23.9 1.4 1.9 3.8 3.0 5.1 2.5 4.6 1.6 7.2 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 65.7 26.5 52.0 20.6 52.8 28.4 57.0 48.5 60.8 32.4 48.5 43.7 29.1 31.7 28.4 51.3 31.1 20.7 44.2 54.2 51.4 34.5 44.6 35.0 22.2 50.0 51.2 55.5 37.0 13.3 12.7 40.3 15.8 50.6 44.0 23.4 14.7 43.1 23.7 171.0 48.6 39.8 19.0 47.9 31.7 47.3 79.9 51.5 18.6 30.7 145.9 19.1 39.2 38.0 51.3 50.8 39.8 21.4 56.8 66.8 46.2 0.1 45.6 41.1 69.2 46.9 31.3 45.2 15.9 27.4 67.0 14.5 66.2 41.3 43.9 34.0 41.2 33.5 11.7 58.6 0.0 45.6 35.8 21.7 48.3 59.6 31.9 25.7 26.9 55.9 52.2 0.0 0.3 37.3 71.8 37.8 14.5 9.1 47.6 67.6 40.3 0.1 14.9 26.5 55.0 34.8 14.8 42.9 34.3 35.0 14.7 69.9 45.3 37.9 55.5 1.5 82.1 57.8 10.2 14.7 7.8 57.2 16.4 44.1 0.5 0.6 2.9 2.3 1.0 2.2 1.3 2.4 2.3 0.7 0.7 1.8 1.2 0.3 0.4 0.8 1.5 5.3 0.6 52.0 52.8 48.5 60.8 54.2 51.4 50.0 51.2 55.5 50.6 47.9 51.5 51.3 31.5 25.6 24.3 3.9 5.4 11.7 25.7 6.5 6.2 23.1 24.0 23.4 22.0 14.3 15.3 11.0 6.2 2.8 25.3 31.0 21.5 5.7 15.0 25.6 19.5 17.8 20.4 5.2 12.4 0.0 3.8 17.3 10.2 34.9 24.7 22.2 17.9 15.4 7.8 20.2 12.5 31.2 10.2 9.8 10.0 35.2 9.3 10.3 12.4 8.4 3.6 19.1 5.2 5.0 3.7 1.0 11.6 7.5 7.6 16.3 20.5 11.6 15.5 18.8 13.1 15.7 13.0 7.8 8.3 9.6 12.6 2.2 16.4 15.2 21.9 19.5 SRY TDF ENSG00000184895 "Sex determining region Y" Q05066 Y 2786855-2787682 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 1.8;testis: 2.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.8;Muller glia cells: 2.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.34e-1)" "unprognostic (5.53e-4)" "unprognostic (1.61e-1)" 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 H1-10 "H1FX, H1X, MGC15959, MGC8350" ENSG00000184897 "H1.10 linker histone" Q92522 3 129314771-129316286 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 1012.8" "Cell type enhanced" "Detected in some" "Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 937.8" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 113.0 55.2 28.8 43.0 36.8 1012.8 146.2 54.3 69.1 151.0 15.7 120.7 45.0 144.3 9.3 108.7 143.5 14.1 78.6 35.2 34.4 71.9 101.0 116.8 44.6 22.4 18.3 34.4 170.4 100.9 30.4 113.5 25.6 25.5 125.5 12.1 14.0 99.5 21.0 111.6 227.8 107.6 13.3 14.2 128.8 116.7 41.2 26.5 132.7 95.2 12.4 18.5 132.0 141.9 38.6 141.8 73.4 135.8 59.3 13.6 16.1 129.1 60.5 43.5 70.4 74.3 44.5 75.5 17.8 65.5 21.6 47.2 139.1 57.3 39.0 10.8 129.4 111.7 53.8 55.5 61.1 57.3 62.6 14.1 32.4 51.9 28.7 64.7 32.0 40.7 241.7 83.7 308.5 10.0 147.9 290.9 124.1 127.2 25.8 81.6 207.4 58.1 170.9 22.1 29.1 216.0 250.1 64.1 31.7 196.3 26.1 124.1 125.1 40.9 54.4 283.5 53.5 51.2 937.8 385.2 156.9 44.5 58.6 61.1 0.5 5.5 17.8 4.4 4.2 4.0 5.7 6.7 5.2 7.9 5.3 8.4 4.3 1.2 5.2 3.9 11.4 6.1 2.4 28.8 36.8 54.3 69.1 35.2 34.4 22.4 18.3 34.4 25.5 14.2 26.5 38.6 188.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 66.8 73.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 114.2 46.9 0.0 0.0 0.0 0.0 0.0 0.0 93.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 68.4 17.6 0.0 0.0 0.0 RBM43 "C2orf38, FLJ45645" ENSG00000184898 "RNA binding motif protein 43" Q6ZSC3 2 151247940-151261863 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.4;HSkMC: 18.5" "Low region specificity" "Detected in all" HPA038204 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA038204: AB_10669520" "unprognostic (3.50e-2)" "unprognostic (5.45e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (1.12e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (9.72e-3)" "unprognostic (2.57e-2)" "unprognostic (3.43e-3)" "unprognostic (1.22e-2)" "unprognostic (3.07e-2)" "unprognostic (1.12e-2)" "unprognostic (9.94e-2)" 5.3 8.8 2.5 4.3 2.4 6.8 7.0 1.9 2.3 7.6 3.6 3.9 3.0 7.7 9.5 3.2 12.4 6.8 3.2 2.1 2.9 7.1 6.8 6.2 6.9 2.7 2.7 1.6 15.6 4.0 5.2 2.9 5.8 2.2 6.6 4.4 1.8 5.2 7.8 3.5 4.8 3.9 5.7 2.9 7.9 4.6 3.6 2.5 7.1 12.4 2.5 4.7 3.9 3.1 3.2 3.5 2.2 3.5 4.7 9.4 20.4 2.3 4.0 9.2 5.0 7.2 0.1 5.7 2.7 1.5 7.3 2.7 1.7 1.1 4.6 2.5 4.2 2.5 6.6 1.0 0.2 9.1 8.2 2.2 18.5 5.0 4.0 3.0 7.4 10.7 2.9 2.7 3.0 6.8 3.5 4.7 3.9 1.3 0.1 4.2 3.2 4.1 1.6 8.4 3.0 1.3 4.2 3.8 2.8 7.8 0.6 4.1 5.2 6.1 3.7 3.3 3.2 1.7 1.1 0.8 0.0 9.7 3.3 2.3 1.0 0.7 3.0 1.2 0.9 2.0 1.2 1.6 1.5 0.5 1.3 2.0 1.5 0.8 2.7 2.4 0.2 0.8 0.6 2.5 2.4 1.9 2.3 2.1 2.9 2.7 2.7 1.6 2.2 2.9 2.5 3.2 26.5 3.2 8.9 2.9 9.6 3.3 3.2 5.8 5.7 6.7 8.6 14.9 2.6 11.5 5.7 18.4 0.0 6.8 8.4 1.7 27.4 6.8 3.0 30.9 17.2 16.9 6.1 8.8 1.0 5.9 4.7 21.8 5.6 9.4 3.8 13.4 20.7 9.1 5.1 6.7 1.3 6.9 4.1 10.4 4.3 2.4 28.0 8.2 3.6 2.8 12.3 22.1 13.4 4.0 0.9 4.6 5.6 29.0 5.5 2.8 5.5 18.2 26.3 1.3 0.0 18.4 13.0 0.5 3.6 7.3 3.1 1.4 13.5 30.4 3.7 2.2 SUMO3 "SMT3A, SMT3H1" ENSG00000184900 "Small ubiquitin like modifier 3" P55854 21 44805617-44818779 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012180, HPA042123, HPA048064" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (2.77e-2)" "unprognostic (2.52e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (7.88e-5)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (6.81e-2)" "unprognostic (7.13e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (7.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.00e-2)" "unprognostic (1.62e-1)" "unprognostic (7.50e-2)" "unprognostic (1.80e-2)" 66.5 58.6 57.7 57.2 65.7 119.8 64.1 52.0 76.1 53.8 55.0 54.3 55.6 53.4 50.7 57.6 52.5 45.0 75.0 62.7 67.2 64.2 59.8 62.2 69.3 53.7 60.2 58.6 58.1 49.8 45.1 38.6 49.5 56.9 46.6 46.2 72.6 67.0 47.8 107.5 51.1 58.5 40.2 55.1 62.1 56.8 29.0 64.3 64.3 55.2 74.6 58.0 50.5 54.1 61.5 226.4 88.8 131.7 80.2 105.1 147.9 86.5 152.0 177.2 211.5 173.6 133.6 137.2 78.4 234.6 165.4 122.4 53.0 96.8 123.0 166.3 110.0 106.3 322.7 78.8 123.1 113.3 184.5 172.1 126.0 139.5 123.9 89.9 87.8 109.8 164.6 188.7 215.2 173.8 293.1 220.0 127.7 254.4 223.1 174.9 239.0 8.0 217.1 120.2 111.9 98.8 153.4 136.5 196.2 126.3 48.1 190.6 218.6 172.4 99.1 151.4 151.6 172.8 155.4 234.8 198.7 77.9 265.2 138.6 2.8 123.1 52.0 78.9 130.0 79.7 84.6 74.9 76.5 133.3 77.7 88.7 81.0 14.0 70.6 122.3 162.8 91.2 157.8 57.7 65.7 52.0 76.1 62.7 67.2 53.7 60.2 58.6 56.9 55.1 64.3 61.5 83.4 64.1 50.4 5.5 76.5 96.0 121.7 127.9 74.6 72.2 99.4 88.5 59.5 67.2 66.5 95.6 20.9 122.9 98.1 95.6 166.3 121.7 63.1 36.4 51.7 101.4 59.2 113.8 14.3 112.4 107.8 76.7 52.0 37.9 29.8 63.8 92.8 116.6 200.5 62.2 13.3 91.5 81.4 143.4 172.3 114.2 72.1 137.9 97.8 10.3 280.0 132.4 111.2 3.5 6.5 148.7 112.6 72.6 58.2 150.7 129.2 130.2 33.0 60.5 59.2 43.8 68.7 90.7 77.5 82.7 77.9 136.3 78.2 43.2 99.9 145.1 IMMP2L "IMMP2L-IT1, IMP2" ENSG00000184903 "Inner mitochondrial membrane peptidase subunit 2" Q96T52 7 110662644-111562517 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 247.8;Distal tubular cells: 160.4;Excitatory neurons: 365.4;Inhibitory neurons: 373.9;Microglial cells: 455.3;Oligodendrocyte precursor cells: 273.9;Oligodendrocytes: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026711 Approved Approved Mitochondria NA NA Mitochondria "HPA026711: AB_1851760" "unprognostic (2.55e-2)" "unprognostic (1.40e-2)" "unprognostic (4.29e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (5.64e-3)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (5.68e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.89e-3)" "unprognostic (1.32e-1)" "unprognostic (6.65e-2)" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" 19.3 14.3 11.2 5.2 12.8 5.3 15.9 9.7 11.4 12.2 14.4 12.0 7.7 15.5 12.0 8.1 16.2 8.6 13.2 11.7 19.5 34.3 26.0 8.2 7.6 11.5 10.9 11.6 19.7 12.2 20.3 8.1 9.1 10.6 19.1 8.3 9.3 11.2 21.3 27.6 10.3 13.0 14.3 10.7 8.5 11.9 9.9 11.3 9.0 23.7 25.3 7.6 12.6 10.6 13.3 17.5 10.3 6.1 25.1 15.8 16.0 10.7 11.8 11.9 7.7 8.1 5.1 19.8 28.4 31.4 10.2 14.3 9.6 6.6 23.6 12.7 17.9 6.7 9.7 44.2 14.0 24.2 18.2 1.1 27.9 30.7 3.3 21.4 35.0 10.2 26.2 32.0 21.4 5.9 12.3 24.4 20.3 6.0 33.2 15.8 5.1 50.0 15.0 28.0 7.3 7.0 22.1 5.1 23.8 67.3 17.2 9.6 10.4 6.5 11.8 12.3 11.9 14.4 12.2 3.5 17.4 12.9 8.4 63.1 15.9 9.1 2.9 10.5 11.9 19.4 28.5 18.3 12.3 17.0 38.7 25.0 17.6 0.5 47.0 17.3 21.3 12.4 8.1 11.2 12.8 9.7 11.4 11.7 19.5 11.5 10.9 11.6 10.6 10.7 11.3 13.3 22.3 19.2 13.2 247.8 20.4 32.9 34.4 41.4 39.9 11.3 35.3 39.4 19.5 15.7 23.9 47.8 8.4 22.4 11.9 3.1 160.4 30.1 8.4 10.4 12.6 15.3 19.3 21.9 365.4 8.1 27.1 19.5 12.8 12.0 3.8 11.3 11.7 23.8 11.7 8.4 373.9 7.0 28.5 4.9 14.1 5.6 49.4 6.1 21.4 455.3 10.1 16.3 1.0 273.9 233.7 10.8 6.8 35.0 9.2 36.2 25.5 66.8 13.3 15.6 13.1 19.5 46.7 24.2 12.8 28.0 26.6 16.3 12.6 18.7 11.7 22.1 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125679-102140426 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 163.2;pituitary gland: 191.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 73.5;Bipolar cells: 141.8;Distal tubular cells: 70.5;Granulosa cells: 62.4;Horizontal cells: 97.6;Muller glia cells: 215.8" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 5.7;SCLC-21H: 6.2;U-2 OS: 11.0" HPA076317 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA076317: AB_2686794" "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 4.6 26.1 113.1 2.4 115.7 0.0 5.9 115.2 163.2 23.9 86.3 35.4 3.0 35.0 10.4 6.0 30.2 7.7 14.7 116.5 113.4 19.3 0.6 10.2 0.7 116.4 107.8 111.2 87.6 5.4 25.2 191.3 0.0 122.7 33.9 3.8 62.9 23.9 27.8 0.7 3.0 11.6 18.0 101.1 4.7 25.0 42.5 107.2 1.4 46.3 2.1 1.5 12.6 16.6 123.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 113.1 115.7 115.2 163.2 116.5 113.4 116.4 107.8 111.2 122.7 101.1 107.2 123.2 0.6 6.4 16.3 12.7 0.1 1.9 73.5 0.0 6.8 141.8 0.7 9.7 8.7 4.3 12.4 31.3 6.2 0.1 0.0 0.0 70.5 0.2 3.8 0.2 0.4 5.7 0.0 0.0 30.1 0.4 0.1 11.1 0.0 0.1 2.5 62.4 7.1 0.3 0.0 97.6 30.9 0.0 0.0 0.0 1.1 9.6 6.5 0.9 7.2 4.7 0.6 215.8 0.0 16.6 8.7 1.0 0.0 5.7 0.1 47.3 0.0 0.7 0.0 45.4 6.6 46.3 9.6 4.6 3.6 0.2 1.3 0.0 0.7 0.4 0.0 7.6 CLCNKB hClC-Kb ENSG00000184908 "Chloride voltage-gated channel Kb" P51801 1 16043736-16057308 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 209.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 23.9;Distal tubular cells: 58.7;Early spermatids: 24.6;Ionocytes: 116.0;Late spermatids: 104.2" "Cancer enriched" "Detected in some" 9 "renal cancer: 24.9" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;HeLa: 1.1" HPA057717 Uncertain NA NA "HPA057717: AB_2683509" "unprognostic (9.05e-4)" "unprognostic (1.72e-1)" "unprognostic (2.41e-2)" "unprognostic (2.68e-3)" "unprognostic (1.44e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-4)" "unprognostic (1.87e-1)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (4.57e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.27e-7)" "unprognostic (2.04e-2)" "unprognostic (4.62e-1)" "unprognostic (1.78e-2)" "unprognostic (5.14e-2)" 0.3 1.7 0.2 0.0 0.2 0.0 0.3 6.8 0.3 0.6 0.5 0.4 0.0 0.9 0.7 0.2 0.4 0.2 3.1 0.1 0.5 209.5 0.0 0.5 0.0 0.4 1.1 0.1 1.3 1.2 5.0 2.5 0.3 2.2 0.7 0.3 1.2 48.5 1.5 0.1 0.1 0.1 0.3 0.2 0.1 0.7 2.8 0.4 0.2 16.3 0.1 0.0 0.1 0.4 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.7 0.0 1.6 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 6.8 0.3 0.1 0.5 0.4 1.1 0.1 2.2 0.2 0.4 0.7 0.0 3.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.1 0.3 4.2 0.0 1.4 23.9 0.0 0.3 0.0 0.6 58.7 1.0 24.6 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.3 116.0 0.0 0.0 104.2 0.9 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 1.6 0.9 0.0 0.0 0.5 0.1 0.0 0.9 0.1 DMRTC1B ENSG00000184911 "DMRT like family C1B" Q5HYR2 X 72777009-72848802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 22.7;pituitary gland: 25.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.3;Microglial cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (2.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-1)" "unprognostic (6.52e-2)" 0.2 3.2 18.4 0.8 18.9 0.0 0.6 12.4 22.7 1.1 11.5 0.8 0.4 1.6 6.8 0.2 2.3 0.4 0.1 18.7 17.2 1.4 0.0 0.8 1.0 15.0 13.6 18.1 8.3 3.9 1.5 25.5 0.0 14.9 2.7 0.5 9.8 0.8 1.3 0.0 0.3 1.0 0.4 12.1 1.0 1.0 9.0 18.9 1.2 3.3 0.0 1.6 0.3 0.8 17.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 18.4 18.9 12.4 22.7 18.7 17.2 15.0 13.6 18.1 14.9 12.1 18.9 17.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 JAG2 ENSG00000184916 "Jagged canonical Notch ligand 2" Q9Y219 14 105140982-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 56.1;Basal respiratory cells: 30.9;Basal squamous epithelial cells: 27.3;Breast myoepithelial cells: 26.4;Endothelial cells: 34.2;Horizontal cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 62.6;HBEC3-KT: 21.0;SCLC-21H: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol NA NA 370000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178" "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 7.2 1.1 3.6 1.3 3.5 0.1 9.7 0.8 5.1 4.4 1.8 2.9 1.1 5.3 0.4 8.9 5.3 1.8 9.6 3.3 5.7 3.3 0.9 5.2 0.7 4.7 3.8 3.6 1.5 6.9 1.5 17.5 3.0 5.2 8.1 0.2 0.8 7.9 2.8 9.7 19.6 4.1 1.1 2.2 2.0 3.1 3.2 5.3 1.6 4.7 2.8 0.6 5.3 6.8 4.1 16.8 6.7 0.4 1.7 0.0 0.0 20.0 0.2 0.1 0.0 0.0 5.6 20.1 0.0 13.8 0.0 0.1 62.6 4.0 21.0 0.0 2.3 9.7 0.0 20.0 0.0 0.2 0.1 3.9 0.2 9.9 0.0 2.3 0.2 5.1 0.9 4.1 0.0 0.0 7.6 0.0 0.0 2.0 2.1 2.3 5.3 3.9 7.2 0.1 4.4 31.4 1.0 5.6 1.3 0.2 0.3 15.8 2.5 17.2 0.1 1.7 0.0 0.2 0.9 0.1 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.5 0.8 5.1 3.3 5.7 4.7 3.8 3.6 5.2 2.2 5.3 4.1 56.1 6.4 3.2 1.0 0.2 23.3 7.6 30.9 27.3 2.7 3.8 26.4 6.7 2.8 7.6 0.0 25.0 2.2 2.2 2.7 0.0 3.9 0.1 16.5 0.9 34.2 0.0 0.0 12.1 2.7 1.0 1.8 2.0 7.4 0.0 1.1 7.9 0.6 0.7 26.9 9.9 3.6 4.1 0.8 2.9 1.0 1.5 1.1 7.2 15.0 1.3 0.6 1.0 0.5 1.1 3.3 2.1 0.7 0.9 4.4 8.2 0.3 11.5 4.8 0.0 3.7 3.7 0.8 13.5 6.0 6.8 1.4 3.4 0.3 2.7 1.5 FMNL1 "C17orf1, C17orf1B, FMNL" ENSG00000184922 "Formin like 1" O95466 17 45221444-45247319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 280.1;lymphoid tissue: 105.8" "Cell type enhanced" "Detected in many" "B-cells: 108.1;dendritic cells: 160.0;Kupffer cells: 77.4;Langerhans cells: 141.6;Macrophages: 115.5;monocytes: 132.8;NK-cells: 152.4;Plasma cells: 109.8;T-cells: 134.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 190.8;MOLT-4: 138.4;U-266/70: 158.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008129, HPA028288" Enhanced Approved Cytosol NA NA Cytosol "HPA008129: AB_1848963, HPA028288: AB_10612110" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (8.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.24e-2)" "unprognostic (2.01e-1)" "unprognostic (1.58e-1)" "unprognostic (5.44e-2)" "unprognostic (6.06e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "prognostic unfavorable (4.23e-8)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (3.46e-2)" "unprognostic (2.16e-1)" 21.6 7.5 15.0 69.2 12.2 280.1 13.5 11.0 20.5 9.9 11.7 10.4 11.6 5.6 2.3 8.9 14.2 18.7 12.7 21.6 10.4 8.3 8.6 55.1 70.0 15.4 12.1 11.7 3.5 6.5 6.8 16.4 12.3 16.5 10.5 7.4 1.3 16.4 3.3 4.7 9.5 37.0 8.3 13.7 105.8 13.8 4.2 15.3 50.2 9.1 6.2 39.0 21.6 10.6 16.6 16.9 32.2 0.3 1.7 0.3 7.0 1.7 2.0 4.3 11.8 8.8 1.5 7.2 51.4 16.2 0.6 12.4 2.7 0.0 0.4 3.9 91.1 4.4 29.8 51.0 2.7 32.6 78.6 100.6 5.4 1.4 15.6 6.7 16.4 0.3 55.8 2.7 190.8 8.8 10.9 138.4 80.7 1.6 2.1 1.0 86.2 11.3 92.7 3.3 2.1 10.0 4.8 9.9 1.7 4.0 2.6 9.2 62.7 4.0 0.7 11.1 1.9 73.3 158.9 75.7 52.2 1.4 62.8 2.5 11.1 6.5 11.3 8.6 7.4 5.7 4.5 6.6 9.4 5.6 5.1 4.4 5.8 28.4 7.2 5.9 3.3 8.1 5.3 15.0 12.2 11.0 20.5 21.6 10.4 15.4 12.1 11.7 16.5 13.7 15.3 16.6 7.2 3.2 3.0 0.0 108.1 6.1 2.9 0.9 2.2 4.9 3.3 4.7 2.5 1.5 1.1 1.8 0.0 0.6 160.0 0.7 0.0 1.5 2.5 0.7 4.3 5.7 1.2 34.9 12.8 0.9 1.2 12.9 4.6 1.2 22.9 0.2 6.1 1.5 45.3 3.3 10.3 0.4 0.0 77.4 141.6 0.7 5.3 115.5 44.4 9.4 132.8 0.9 152.4 0.5 1.0 0.5 0.1 0.0 109.8 1.9 0.2 0.8 1.0 1.6 6.6 9.3 2.4 0.8 3.5 0.6 6.1 2.5 134.6 0.2 0.5 1.4 NUTM2A FAM22A ENSG00000184923 "NUT family member 2A" Q8IVF1 10 87225448-87236908 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 10.2" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (1.75e-2)" "unprognostic (1.33e-2)" "unprognostic (1.03e-1)" "unprognostic (8.29e-2)" "unprognostic (5.67e-2)" "unprognostic (8.08e-2)" "unprognostic (1.75e-2)" "unprognostic (6.84e-2)" "unprognostic (2.46e-3)" "unprognostic (1.75e-2)" "unprognostic (7.24e-2)" "unprognostic (1.40e-1)" "unprognostic (4.24e-3)" "unprognostic (1.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-2)" "unprognostic (2.65e-1)" 1.4 1.2 1.8 0.5 2.5 0.9 1.1 0.8 2.0 0.9 0.0 1.3 0.7 1.4 0.9 0.9 1.0 0.5 2.0 1.2 2.2 1.3 1.3 1.2 0.6 3.2 2.1 0.5 1.3 1.7 1.4 1.6 0.7 5.9 1.6 0.5 0.6 2.4 0.4 1.3 1.9 1.2 0.4 1.2 1.3 1.5 2.0 2.4 1.0 1.5 1.6 0.3 1.1 1.2 4.4 1.4 0.1 0.8 0.0 1.3 0.6 0.7 0.6 1.3 0.6 0.4 0.3 0.6 1.2 0.1 0.0 0.2 1.1 0.0 0.9 0.1 0.4 1.0 2.0 0.3 0.3 0.6 0.8 10.2 0.4 3.2 1.0 1.0 1.2 0.0 1.9 1.9 0.3 0.1 1.0 1.0 2.0 2.3 0.0 0.3 1.5 0.1 0.0 0.4 0.1 1.2 2.0 0.6 0.5 0.5 0.1 0.6 0.8 1.4 0.0 0.3 0.6 0.2 0.0 0.2 0.6 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.5 0.8 2.0 1.2 2.2 3.2 2.1 0.5 5.9 1.2 2.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 PTRHD1 "C2orf79, LOC391356" ENSG00000184924 "Peptidyl-tRNA hydrolase domain containing 1" Q6GMV3 2 24789728-24793391 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019951 Approved Approved Nucleoplasm NA NA 100000 Nucleoplasm "HPA019951: AB_1853109" "unprognostic (1.28e-2)" "unprognostic (5.79e-2)" "unprognostic (6.34e-2)" "unprognostic (1.34e-2)" "unprognostic (2.61e-2)" "unprognostic (3.99e-1)" "unprognostic (8.84e-3)" "unprognostic (1.26e-1)" "unprognostic (3.69e-1)" "unprognostic (8.31e-3)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" 10.2 26.2 10.1 4.3 10.1 16.2 11.1 10.7 17.7 7.8 11.5 9.9 10.7 7.3 3.5 17.8 6.4 4.3 16.0 10.5 10.8 15.0 15.0 10.3 8.5 10.8 10.2 9.4 10.3 13.8 3.6 10.9 6.5 10.5 10.7 5.9 3.0 15.2 4.1 24.1 14.9 12.0 3.3 11.3 11.3 12.4 9.1 11.1 7.2 14.6 8.6 6.3 9.5 10.4 11.6 18.2 40.2 12.7 5.5 6.9 15.2 22.1 12.2 11.3 15.4 9.9 39.7 15.9 14.2 5.2 12.7 10.3 11.7 10.4 11.1 5.1 20.1 70.0 25.7 18.2 43.2 14.2 21.8 23.5 14.6 8.9 7.1 7.9 12.3 14.4 12.8 26.4 11.2 11.4 36.6 17.7 39.0 26.8 10.6 23.7 14.9 38.9 23.9 18.1 31.2 19.9 30.9 13.6 18.1 16.4 5.9 17.7 15.9 24.2 13.6 21.4 6.7 11.2 8.7 28.1 15.4 12.4 13.3 9.3 34.8 90.6 20.7 52.6 66.9 26.8 96.4 51.4 46.2 144.5 81.2 46.6 54.8 10.4 52.8 50.1 149.0 84.4 97.0 10.1 10.1 10.7 17.7 10.5 10.8 10.8 10.2 9.4 10.5 11.3 11.1 11.6 27.8 51.3 61.5 1.0 65.0 119.8 79.4 123.3 72.3 10.5 171.4 239.4 81.0 60.1 83.8 66.2 6.2 200.0 87.9 127.0 115.4 91.0 130.9 53.5 37.5 46.9 88.1 68.1 1.9 142.0 153.7 57.4 50.4 48.8 41.2 121.1 62.4 101.5 134.5 1.7 2.2 158.2 79.3 112.5 154.3 157.1 47.2 79.9 67.6 3.7 154.6 78.7 65.9 1.0 2.3 124.2 128.8 39.9 46.6 74.3 120.9 199.2 107.1 12.2 72.3 34.5 56.0 135.6 78.6 133.6 141.8 167.7 52.5 110.4 162.2 125.3 LCN12 MGC48935 ENSG00000184925 "Lipocalin 12" Q6JVE5 9 136949551-136955497 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "epididymis: 80.2" "Cell type enhanced" "Detected in many" "Astrocytes: 19.6;Collecting duct cells: 49.7;Distal tubular cells: 19.6;Endometrial ciliated cells: 29.8;Glandular and luminal cells: 57.2;Muller glia cells: 27.1" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 44.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "unprognostic (7.27e-3)" "unprognostic (5.72e-3)" "unprognostic (2.45e-2)" "unprognostic (7.14e-2)" "unprognostic (4.53e-4)" "unprognostic (9.33e-3)" "unprognostic (1.97e-3)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (7.33e-3)" "unprognostic (2.18e-1)" "unprognostic (5.73e-2)" "unprognostic (5.21e-3)" "unprognostic (3.06e-1)" "unprognostic (5.00e-2)" "unprognostic (7.91e-4)" 0.0 0.1 0.3 0.0 0.4 0.0 0.1 0.3 0.8 2.9 0.5 0.1 0.3 0.2 80.2 0.0 3.4 0.0 0.1 0.4 0.8 0.6 1.2 0.0 0.0 0.9 0.5 0.3 0.0 0.5 0.7 0.6 0.0 0.4 0.0 0.1 0.1 0.1 2.0 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.3 0.2 6.1 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.3 0.8 0.4 0.8 0.9 0.5 0.3 0.4 0.5 0.3 0.4 0.1 0.0 2.2 19.6 0.3 0.0 0.4 0.9 0.0 0.3 2.8 1.3 8.0 2.8 2.3 49.7 2.1 0.1 1.7 2.9 19.6 1.2 1.5 29.8 4.3 0.4 16.4 0.0 1.0 1.2 0.0 0.8 0.0 57.2 0.0 6.7 0.0 13.8 0.2 0.0 0.7 4.0 4.1 0.6 0.0 1.0 14.9 0.5 0.0 3.7 0.0 27.1 2.1 1.0 0.2 0.5 1.2 10.9 0.5 0.7 4.4 6.1 1.3 0.9 0.0 0.0 0.2 1.1 0.5 0.0 0.0 0.3 0.5 7.8 5.7 0.3 OR6A2 "OR11-55, OR6A1, OR6A2P" ENSG00000184933 "Olfactory receptor family 6 subfamily A member 2" O95222 11 6791736-6799689 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 WT1 "AWT1, GUD, NPHS4, WAGR, WIT-2" ENSG00000184937 "WT1 transcription factor" P19544 11 32387775-32435564 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 68.1;fallopian tube: 52.7;ovary: 46.1" "Cell type enhanced" "Detected in some" "Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3" "Cancer enriched" "Detected in many" 14 "ovarian cancer: 55.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000327, HPA035717, HPA053848" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279" "unprognostic (3.09e-3)" "unprognostic (9.97e-4)" "unprognostic (3.32e-1)" "unprognostic (8.24e-3)" "unprognostic (5.20e-2)" "unprognostic (1.98e-3)" "unprognostic (2.94e-2)" "unprognostic (1.59e-2)" "unprognostic (1.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-10)" "unprognostic (2.65e-3)" "unprognostic (1.87e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-2)" 12.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.1 16.4 0.0 0.5 0.0 68.1 5.3 0.0 52.7 1.3 4.5 0.1 0.3 15.9 0.1 0.8 0.0 0.2 0.1 0.0 46.1 0.1 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 33.3 0.0 19.2 0.2 24.3 0.0 0.0 0.0 0.0 0.0 0.2 8.5 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 8.4 20.7 0.0 1.2 4.7 10.8 29.9 0.0 0.0 3.4 0.0 0.0 0.0 0.7 19.6 0.0 2.0 0.0 11.2 37.2 0.8 0.0 6.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 2.1 19.6 0.2 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 20.2 0.0 1.0 0.0 0.0 0.0 0.0 3.6 2.2 70.1 16.3 0.0 0.0 0.1 0.0 0.5 7.3 0.0 1.4 0.0 9.3 1.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 9.3 8.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 2.3 0.0 0.0 6.6 0.0 2.0 4.5 1.0 0.0 0.0 0.8 0.5 0.4 0.0 0.1 ZFP90 "KIAA1954, NK10, ZNF756" ENSG00000184939 "ZFP90 zinc finger protein" Q8TF47 16 68530090-68576072 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029017 Uncertain Supported "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "HPA029017: AB_10669653" "unprognostic (3.27e-1)" "unprognostic (1.71e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (7.33e-2)" "unprognostic (1.35e-3)" "unprognostic (3.43e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.47e-2)" "unprognostic (2.37e-1)" "unprognostic (1.33e-1)" "unprognostic (9.60e-2)" 7.0 6.4 20.3 7.3 19.2 6.2 11.2 25.9 31.4 10.5 9.1 7.2 3.0 10.9 12.3 6.0 9.6 6.6 8.1 19.4 16.3 8.6 5.5 6.8 9.6 16.5 14.6 18.5 12.8 7.4 15.8 13.6 5.9 19.4 9.2 6.2 12.8 6.3 8.9 8.3 9.4 7.3 9.4 9.1 10.6 8.1 9.8 17.3 13.5 8.2 9.1 11.4 7.6 8.1 21.0 10.6 11.4 20.9 19.9 18.1 19.2 9.7 9.7 11.0 13.2 15.2 8.0 7.0 11.5 12.7 12.6 11.1 9.7 12.9 12.5 15.0 10.1 4.7 3.0 2.2 13.4 14.0 0.0 10.3 17.2 20.2 12.1 16.8 23.5 10.7 21.2 5.8 4.1 16.3 18.8 11.6 10.7 7.8 6.3 8.5 21.0 6.5 7.6 9.0 7.2 23.5 17.9 28.1 2.1 10.5 15.4 16.8 14.9 8.4 12.2 7.2 10.4 5.8 8.1 15.9 14.0 4.1 4.0 9.9 7.9 1.5 2.5 5.2 1.6 6.7 4.5 4.9 6.0 2.0 3.3 6.7 5.9 0.3 4.3 1.0 2.3 5.8 2.7 20.3 19.2 25.9 31.4 19.4 16.3 16.5 14.6 18.5 19.4 9.1 17.3 21.0 13.1 19.2 8.9 18.6 15.1 3.4 6.4 10.5 14.8 21.1 8.5 9.4 10.5 10.0 9.0 20.2 14.6 3.4 11.8 1.5 7.9 10.2 20.6 9.8 14.4 10.9 16.1 13.2 34.0 6.1 1.7 14.7 5.1 6.5 12.0 30.3 11.0 5.2 6.9 18.5 41.4 4.7 4.1 7.9 5.7 13.2 16.4 8.3 3.6 11.2 6.4 13.0 19.6 31.2 35.5 6.5 3.2 17.7 7.2 5.9 1.3 8.1 24.2 17.3 0.0 12.4 11.0 12.1 19.1 8.6 4.5 1.4 18.7 13.7 4.5 4.0 AQP12A AQP12 ENSG00000184945 "Aquaporin 12A" Q8IXF9 2 240691851-240698483 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 167 "pancreas: 130.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 1.5;Paneth cells: 1.2;Proximal enterocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042216 Supported NA NA "HPA042216: AB_2677905" "unprognostic (9.82e-2)" "unprognostic (1.63e-2)" "unprognostic (9.48e-2)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 130.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM227A ENSG00000184949 "Family with sequence similarity 227 member A" F5H4B4 22 38578120-38656629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 6.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6;Early spermatids: 87.3;Endometrial ciliated cells: 72.4;Late spermatids: 57.0;Respiratory ciliated cells: 115.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 10.4;Karpas-707: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003077 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003077: AB_1079264" "unprognostic (7.52e-2)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "unprognostic (8.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.91e-3)" "unprognostic (4.79e-5)" "unprognostic (5.91e-2)" "unprognostic (3.04e-2)" "unprognostic (4.04e-2)" "unprognostic (1.85e-2)" "unprognostic (4.62e-2)" "unprognostic (6.46e-6)" "unprognostic (3.74e-1)" "unprognostic (3.47e-2)" "unprognostic (2.65e-3)" "unprognostic (1.35e-2)" 0.1 0.6 3.0 0.2 1.4 0.5 0.8 1.1 1.5 0.9 6.2 0.3 0.2 0.7 1.9 0.1 3.8 0.3 0.3 1.7 1.9 1.0 0.1 1.1 0.2 2.2 2.4 1.2 0.7 0.4 0.6 4.3 0.1 1.7 0.7 0.2 3.5 0.4 0.4 0.1 0.8 0.1 0.3 2.2 0.2 0.3 4.1 1.4 0.2 1.3 0.0 0.1 0.3 0.3 1.5 0.4 0.9 1.4 1.7 0.4 1.0 0.3 0.2 0.2 0.3 0.2 0.1 0.9 0.1 0.4 0.2 0.4 0.9 0.5 0.2 0.4 10.4 0.9 0.1 2.9 0.2 0.2 0.4 0.4 0.5 0.6 1.0 0.4 1.5 0.2 1.6 0.4 17.3 0.1 0.5 0.4 0.5 0.7 0.2 0.5 1.0 0.1 0.6 0.9 0.3 2.0 0.5 1.4 0.1 0.2 0.5 1.1 0.1 0.3 0.4 0.4 0.4 0.1 1.8 0.8 0.1 0.6 0.2 0.2 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 3.0 1.4 1.1 1.5 1.7 1.9 2.2 2.4 1.2 1.7 2.2 1.4 1.5 0.3 3.2 2.6 20.9 0.0 2.4 3.2 3.7 0.0 6.8 4.1 3.8 2.1 2.8 9.0 5.5 39.6 0.3 0.2 0.3 0.0 3.8 87.3 72.4 5.9 1.6 4.8 0.8 15.5 2.5 0.3 2.6 0.0 4.1 0.0 8.5 0.4 0.3 0.2 5.0 11.1 0.7 4.1 0.6 1.2 57.0 2.1 0.6 0.0 2.8 0.3 9.5 1.0 1.5 2.3 2.3 0.2 1.2 0.1 2.1 0.0 1.4 115.2 30.4 0.0 4.6 2.8 16.4 12.9 0.0 3.4 0.1 1.4 9.5 1.2 1.7 OR6C70 ENSG00000184954 "Olfactory receptor family 6 subfamily C member 70" A6NIJ9 12 55469200-55470138 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.3;Inhibitory neurons: 1.1;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "Karpas-707: 2.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC6 ENSG00000184956 "Mucin 6, oligomeric mucus/gel-forming" Q6W4X9 11 1012823-1036718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "pancreas: 172.7;stomach 1: 413.2" "Cell type enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 278.8" "Group enriched" "Detected in many" 4 "pancreatic cancer: 42.9;stomach cancer: 58.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 1.7" "Not detected" "Not detected" CAB002165 Enhanced "Secreted to digestive system" NA NA 75000 "CAB002165: AB_442114" "unprognostic (1.90e-2)" "unprognostic (1.00e-1)" "unprognostic (5.21e-3)" "unprognostic (1.56e-3)" "unprognostic (1.04e-1)" "unprognostic (5.17e-3)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (1.65e-2)" "unprognostic (2.63e-1)" "unprognostic (9.46e-2)" "unprognostic (8.62e-2)" "unprognostic (3.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (4.72e-2)" "unprognostic (5.23e-2)" 0.2 0.2 1.5 0.0 0.6 0.0 0.9 0.4 0.7 14.1 0.0 1.6 15.8 2.1 0.9 5.3 2.5 0.3 0.1 1.0 0.0 2.5 5.4 0.2 0.0 0.2 0.0 0.8 0.2 172.7 0.0 0.2 0.0 0.9 4.4 0.0 0.0 0.1 28.2 0.1 0.1 0.1 0.0 0.0 0.3 413.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.4 0.7 1.0 0.0 0.2 0.0 0.8 0.9 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 11.3 2.8 1.7 54.3 0.0 9.2 0.0 0.0 0.2 0.1 0.0 12.2 0.1 0.5 0.1 0.1 0.0 0.0 1.2 19.1 0.0 0.1 278.8 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 59.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144457-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 72.6;Late spermatids: 80.3;Spermatogonia: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli No No Nucleoli Nucleoplasm "HPA053424: AB_2682147" "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 12.2 11.6 1.7 3.3 1.6 6.2 12.9 1.5 3.1 12.4 0.9 10.6 4.3 12.7 1.6 13.9 12.0 1.9 10.4 2.2 1.7 11.4 13.5 10.6 3.6 2.1 1.5 1.8 14.5 13.7 2.4 11.4 2.7 1.9 11.2 1.8 0.9 11.6 2.2 24.5 15.3 11.4 1.8 1.0 13.6 12.4 33.5 1.5 3.5 11.8 3.2 2.3 11.5 11.3 2.3 14.4 26.0 5.7 9.0 2.8 3.0 29.0 9.7 5.0 12.0 6.5 21.4 6.7 21.8 10.4 5.0 7.1 12.7 10.2 10.7 2.5 8.7 28.3 14.7 8.8 14.4 7.6 17.3 16.5 4.3 7.2 9.2 7.3 4.5 8.3 16.8 25.4 4.9 4.8 17.1 16.6 40.6 16.7 8.6 20.7 21.2 6.3 19.5 6.3 10.6 13.9 11.0 8.2 11.1 7.5 3.3 15.6 10.7 11.1 7.0 17.7 11.3 16.5 12.4 8.2 19.1 10.6 14.8 15.0 1.6 8.4 4.3 7.5 11.7 7.2 9.1 6.9 7.5 11.1 10.7 5.9 5.7 1.2 5.8 9.1 13.1 6.2 5.9 1.7 1.6 1.5 3.1 2.2 1.7 2.1 1.5 1.8 1.9 1.0 1.5 2.3 10.9 9.6 9.1 2.3 15.5 22.3 15.6 20.6 12.0 8.2 11.5 12.1 8.0 20.0 12.4 3.7 0.0 32.3 15.5 15.6 7.9 35.5 72.6 12.1 8.4 13.6 7.3 7.8 2.2 32.9 33.9 14.6 15.3 11.1 15.9 15.8 10.4 11.6 24.9 8.4 2.0 14.5 24.4 11.0 15.8 80.3 14.6 13.2 14.2 1.9 14.5 8.3 6.2 1.5 3.1 28.0 11.2 7.9 12.0 15.4 19.2 21.7 6.2 6.2 19.7 14.2 15.0 37.1 77.1 11.2 21.6 30.5 13.6 24.4 22.7 15.0 USP18 ENSG00000184979 "Ubiquitin specific peptidase 18" Q9UMW8 22 18150170-18177397 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 46.9;Extravillous trophoblasts: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 181.8;BJ hTERT+ SV40 Large T+ RasG12V: 196.2" HPA044768 Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA044768: AB_10963697" "unprognostic (2.06e-1)" "unprognostic (3.55e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-3)" "unprognostic (1.40e-2)" "unprognostic (5.42e-2)" "unprognostic (3.29e-2)" "unprognostic (5.11e-3)" "unprognostic (1.81e-1)" "unprognostic (1.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (4.29e-3)" "unprognostic (2.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.28e-2)" "unprognostic (8.38e-2)" 10.9 5.0 3.9 5.1 4.6 8.2 8.4 3.5 4.5 3.4 4.2 5.0 6.1 3.2 7.8 4.1 7.3 6.6 4.4 3.8 5.1 6.0 23.8 7.9 9.3 5.1 3.9 3.1 2.9 4.2 3.7 5.7 5.8 4.3 5.3 4.4 0.7 14.1 2.5 3.9 3.3 6.8 4.0 3.7 11.1 7.3 9.8 4.0 15.2 7.3 5.6 6.6 4.0 3.6 7.7 14.4 14.6 4.2 18.2 18.2 13.5 18.4 7.3 17.5 181.8 196.2 2.2 20.1 0.2 10.8 4.0 57.5 4.9 21.6 6.4 6.2 64.4 29.4 28.3 1.9 27.0 2.1 6.9 25.7 6.0 2.5 12.8 0.0 1.0 40.8 20.6 1.4 1.7 1.8 24.9 33.4 16.7 12.7 15.6 11.0 13.1 28.4 0.0 3.6 12.4 15.2 11.9 8.8 15.0 71.9 16.3 9.9 6.6 66.7 1.3 3.5 4.1 7.5 3.4 45.4 0.2 16.3 17.1 10.5 3.2 3.9 8.3 8.5 11.0 10.7 5.3 7.2 11.1 1.8 3.4 8.2 9.6 0.7 13.3 8.6 3.3 13.1 5.3 3.9 4.6 3.5 4.5 3.8 5.1 5.1 3.9 3.1 4.3 3.7 4.0 7.7 9.7 9.6 4.8 0.7 2.5 1.7 4.5 5.7 2.2 0.2 8.4 8.3 1.4 8.6 6.9 0.0 0.0 4.6 3.0 6.2 46.9 5.9 1.6 20.1 2.5 8.4 3.0 1.3 0.5 11.1 31.9 7.1 4.1 6.3 0.0 8.5 11.0 5.5 8.7 0.0 0.6 3.5 6.1 6.3 0.8 1.7 3.7 3.8 3.6 0.0 1.6 5.1 8.2 2.0 0.3 13.4 3.2 7.2 2.3 2.5 5.4 8.0 12.2 0.3 6.6 8.0 2.5 10.9 1.0 4.0 1.0 1.5 5.0 5.5 2.8 2.9 NDUFA6 "B14, CI-B14, LYRM6, NADHB14" ENSG00000184983 "NADH:ubiquinone oxidoreductase subunit A6" P56556 22 42085526-42090884 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1536.8;Distal tubular cells: 954.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 181.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.48e-2)" "prognostic favorable (3.87e-4)" "unprognostic (7.00e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (4.02e-2)" "unprognostic (2.71e-2)" "unprognostic (1.47e-2)" "unprognostic (8.28e-2)" "unprognostic (3.61e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (9.49e-2)" "unprognostic (4.84e-2)" 8.7 31.2 13.9 19.4 13.0 26.1 28.3 13.9 19.0 9.7 17.6 38.0 12.6 15.9 21.5 38.8 8.9 11.0 125.3 13.7 18.5 33.3 51.8 15.5 20.7 15.1 13.6 12.7 9.4 31.4 110.1 17.9 25.4 16.0 17.9 58.2 20.0 28.5 18.9 116.2 11.5 38.5 14.4 13.0 18.2 31.0 22.4 14.9 3.7 20.5 102.4 12.0 24.2 9.3 14.5 48.1 1.9 4.5 44.2 94.6 78.9 6.3 0.3 0.3 0.8 1.0 54.1 99.2 0.7 1.4 67.4 2.3 47.9 1.2 1.2 4.5 0.4 0.7 1.0 10.2 181.7 0.9 55.3 73.1 28.1 27.7 57.0 102.2 1.6 33.9 2.0 73.9 94.1 1.6 90.8 35.6 3.7 34.5 134.6 138.7 60.2 48.6 0.3 1.3 6.0 1.0 31.8 96.4 56.5 143.4 6.0 113.2 0.6 0.0 2.3 110.2 41.9 72.6 41.5 64.0 4.5 35.8 95.8 98.9 127.4 109.8 123.4 78.2 114.0 84.8 111.8 106.0 72.9 156.5 85.3 88.4 88.2 37.7 98.6 99.4 99.3 109.0 213.5 13.9 13.0 13.9 19.0 13.7 18.5 15.1 13.6 12.7 16.0 13.0 14.9 14.5 103.3 60.9 94.1 15.7 103.8 185.7 228.5 445.8 76.8 58.7 105.7 132.8 1536.8 164.5 189.2 180.3 45.9 422.1 105.6 349.0 954.8 267.3 181.3 104.0 99.6 123.3 170.8 140.8 9.7 253.9 443.7 152.2 114.7 106.6 105.2 70.1 94.2 598.6 357.9 35.3 13.4 293.3 386.6 114.6 255.4 52.0 100.9 145.8 288.1 5.6 198.0 129.4 117.4 5.0 9.3 260.5 361.8 110.6 166.7 202.6 517.5 597.8 131.4 99.7 105.2 98.9 329.1 142.5 163.8 159.9 186.0 764.1 123.8 117.7 301.9 230.4 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968497-34067458 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 14.3" "Cell type enriched" "Detected in some" 9 "Oligodendrocytes: 178.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.6;HMC-1: 10.4;NB-4: 1.9" "Region enhanced" "Detected in many" "hypothalamus: 13.2" "Low region specificity" "Detected in many" HPA013172 Uncertain NA NA "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.1 0.1 2.9 0.3 6.0 0.4 0.3 3.6 5.8 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.0 1.7 6.5 0.1 0.6 0.1 0.3 10.7 7.9 1.1 0.1 0.3 0.0 0.2 1.5 8.5 0.1 0.0 1.3 0.1 0.0 0.2 0.4 0.5 0.0 3.9 0.2 0.1 1.5 13.9 0.0 0.6 0.0 0.1 0.0 0.1 14.3 0.1 0.1 0.5 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.6 0.2 0.2 0.0 0.4 10.4 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.5 1.0 0.0 0.1 0.2 1.9 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.1 0.1 1.0 0.1 0.1 0.2 0.2 0.1 0.7 0.2 0.3 0.0 0.2 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 2.9 6.0 3.6 5.8 1.7 6.5 10.7 7.9 1.1 8.5 3.9 13.9 14.3 0.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 0.0 5.9 0.2 0.1 0.0 0.0 0.0 8.7 0.0 18.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 12.6 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 2.8 0.1 0.2 1.0 2.5 178.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.8 0.0 0.2 0.0 0.0 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell type enhanced" "Detected in many" "Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071818 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA071818: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 2.5 1.1 11.8 3.4 16.2 1.7 1.6 10.3 16.0 8.0 0.0 3.6 1.4 4.8 3.8 2.2 3.3 3.6 1.8 10.3 9.4 4.7 4.6 4.4 0.9 20.2 17.3 8.3 5.9 0.7 0.0 2.7 0.2 21.2 5.3 1.1 13.0 1.0 2.4 1.1 1.7 2.6 6.3 9.5 0.4 1.6 1.6 13.2 3.1 3.1 1.2 1.2 3.1 3.7 22.3 0.8 1.1 1.3 0.2 0.1 0.0 0.0 0.2 0.1 1.6 0.4 0.2 0.6 0.0 7.6 5.0 1.3 19.6 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.3 0.2 0.0 14.5 0.2 4.3 6.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.4 0.0 0.9 0.0 1.6 9.1 0.2 0.0 0.8 0.7 14.1 0.0 0.0 0.8 0.0 8.4 0.0 4.9 1.4 0.0 0.1 0.0 0.0 0.0 1.6 8.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 16.2 10.3 16.0 10.3 9.4 20.2 17.3 8.3 21.2 9.5 13.2 22.3 0.1 3.2 11.3 107.1 0.0 0.1 0.3 4.6 0.0 70.3 0.1 2.4 2.0 0.0 6.9 5.5 0.0 0.0 0.3 0.0 0.0 0.2 2.2 0.4 0.4 0.3 0.0 0.0 41.4 0.0 0.0 5.0 0.0 0.9 0.0 5.4 0.4 1.6 0.2 1.7 24.3 0.0 2.0 0.3 0.0 11.6 12.8 0.4 1.8 8.4 0.1 33.0 1.0 8.0 76.2 1.1 0.0 7.9 0.1 0.4 0.4 1.4 2.0 2.7 0.0 0.9 1.0 0.1 0.3 0.0 0.4 0.0 0.3 1.5 0.0 0.6 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526583-105530202 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 31.2;Muller glia cells: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 8.1;MCF7: 8.1;PC-3: 10.2;REH: 6.7;SCLC-21H: 5.3;WM-115: 5.4" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 1.7 1.0 4.0 0.5 4.2 0.2 2.4 2.4 6.5 3.9 0.0 2.0 0.2 4.3 0.1 1.0 4.6 0.1 2.1 4.9 2.7 1.9 2.6 1.8 0.3 5.3 3.7 4.7 2.5 2.4 0.6 5.2 0.2 3.7 3.8 0.0 0.0 1.4 0.4 0.3 1.5 1.8 0.2 1.7 3.4 1.8 1.2 2.3 0.1 2.6 0.0 0.0 2.1 2.1 3.8 0.0 4.0 0.4 3.6 0.0 0.2 0.7 2.4 0.5 0.4 0.0 0.0 1.3 1.2 8.1 0.0 0.7 0.4 0.4 0.1 0.0 0.5 1.9 0.0 0.4 1.4 0.6 0.0 1.4 0.2 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.1 0.2 0.0 1.2 0.1 10.2 6.7 0.0 0.1 0.1 0.0 5.3 2.0 0.4 0.0 2.0 0.0 2.4 0.3 1.4 1.1 2.1 0.2 0.4 0.6 0.0 0.0 0.1 0.5 5.4 0.0 0.0 0.0 0.6 0.0 1.0 2.1 1.2 0.6 0.2 0.6 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.2 4.0 4.2 2.4 6.5 4.9 2.7 5.3 3.7 4.7 3.7 1.7 2.3 3.8 10.6 0.0 0.5 2.3 2.8 4.6 2.6 0.1 2.2 5.1 8.9 10.8 1.5 1.5 0.7 5.5 0.0 0.2 0.7 0.0 0.0 1.0 1.7 5.4 5.5 9.5 0.0 3.4 5.7 0.2 2.2 4.6 1.1 1.4 0.0 31.2 10.8 2.3 0.4 10.1 4.8 0.0 0.0 0.6 4.8 2.2 4.4 0.4 7.2 2.8 0.0 14.4 1.0 12.1 11.5 0.0 0.0 6.4 0.5 1.8 0.0 0.1 1.6 1.6 0.0 4.0 3.2 0.7 3.1 0.4 2.6 0.3 3.2 1.8 0.2 0.6 TMEM106A MGC20235 ENSG00000184988 "Transmembrane protein 106A" Q96A25 17 43211835-43220041 "Predicted membrane proteins, Transporters" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.1" "Cell type enhanced" "Detected in many" "Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "basophil: 26.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 26.7" "Cell line enhanced" "Detected in many" "HMC-1: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (9.71e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (9.61e-5)" "unprognostic (4.95e-3)" "unprognostic (8.62e-2)" "unprognostic (1.79e-1)" "unprognostic (9.11e-2)" "unprognostic (1.76e-1)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (2.99e-2)" "unprognostic (6.08e-2)" "unprognostic (7.89e-3)" "unprognostic (1.39e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (8.30e-2)" 4.9 2.4 1.3 10.3 2.3 3.3 4.1 1.1 2.6 3.9 2.3 3.6 4.0 3.6 1.7 1.6 3.3 3.6 1.9 1.3 3.9 22.1 3.5 5.2 7.0 4.2 2.1 0.4 7.9 3.1 2.4 1.6 10.2 3.2 2.5 5.4 0.8 2.8 3.2 1.1 1.4 3.4 8.9 2.2 9.7 4.9 3.3 4.0 4.0 5.3 1.6 6.2 4.9 2.4 3.9 3.1 0.9 0.4 0.2 3.8 4.1 2.3 7.8 5.0 6.7 10.5 2.3 6.4 4.5 1.5 12.1 2.6 1.3 0.8 1.0 7.8 7.1 0.0 3.2 2.7 10.7 2.2 0.1 16.8 2.6 0.2 12.5 0.3 2.4 6.0 5.3 0.1 3.2 8.5 1.3 5.5 2.1 0.3 0.0 0.0 4.0 1.3 2.7 2.9 0.2 0.6 0.0 1.5 3.7 1.8 1.6 5.5 4.5 6.8 3.3 0.4 3.3 1.6 5.0 0.5 1.4 2.8 5.4 6.7 26.7 5.1 5.7 1.5 5.6 0.7 1.9 1.0 1.5 4.2 3.2 0.7 1.3 1.4 2.1 2.0 6.0 2.9 2.2 1.3 2.3 1.1 2.6 1.3 3.9 4.2 2.1 0.4 3.2 2.2 4.0 3.9 4.5 3.2 4.5 1.3 13.6 2.4 11.0 2.4 0.6 4.3 6.5 4.2 1.2 0.0 3.9 7.3 2.1 5.0 22.7 3.9 3.9 2.0 5.9 2.6 7.1 6.5 3.0 2.5 1.0 4.0 8.3 6.6 10.7 3.9 8.2 45.6 5.0 1.7 45.3 0.0 1.0 4.5 0.0 44.8 35.6 2.7 14.0 25.2 0.0 17.8 16.5 1.2 14.4 3.5 4.0 5.5 3.4 7.2 5.4 10.9 2.1 17.8 6.0 3.7 13.1 4.0 4.6 7.4 3.6 0.5 1.7 5.2 7.3 3.2 2.9 13.1 SIVA1 "CD27BP, SIVA, Siva-1, Siva-2" ENSG00000184990 "SIVA1 apoptosis inducing factor" O15304 14 104753147-104768494 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 506.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065398, HPA066693" Supported Nucleoplasm NA NA Nucleoplasm "HPA065398: AB_2685484, HPA066693: AB_2685703" "unprognostic (1.86e-1)" "prognostic favorable (5.95e-4)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (6.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.77e-3)" "unprognostic (2.89e-1)" "unprognostic (2.17e-2)" "unprognostic (7.19e-3)" "unprognostic (5.85e-3)" "unprognostic (3.21e-2)" "unprognostic (4.94e-2)" "unprognostic (3.06e-2)" "unprognostic (4.08e-1)" "unprognostic (3.51e-1)" "unprognostic (7.43e-2)" 79.2 64.8 28.1 28.6 28.5 103.1 81.5 28.6 60.9 95.6 34.0 95.5 40.2 79.2 9.0 76.8 86.9 24.5 99.4 26.2 31.7 79.9 157.0 65.6 40.0 31.1 27.8 25.8 95.1 104.8 16.1 94.9 27.8 28.3 88.6 7.1 3.2 63.7 37.3 170.2 65.7 74.4 10.6 30.7 84.0 91.8 103.5 30.5 70.4 83.6 35.8 12.8 86.1 78.6 31.0 143.3 233.6 58.9 94.8 19.4 24.7 157.8 76.5 41.5 92.2 80.3 179.8 124.1 135.9 109.6 27.5 60.3 138.4 23.2 77.2 7.9 106.6 230.9 56.5 129.5 214.6 48.4 98.8 95.3 29.9 34.5 42.1 13.5 13.6 53.8 382.9 57.7 76.1 22.2 506.6 319.6 225.9 85.9 94.1 317.9 186.6 117.8 107.8 20.7 133.3 151.6 76.2 107.3 63.1 106.4 9.4 123.5 103.0 58.6 74.4 92.8 176.4 124.8 61.0 71.0 161.9 85.6 112.3 84.7 210.7 139.5 255.0 140.4 171.6 159.5 205.1 167.3 154.6 107.5 195.3 182.3 156.1 134.0 102.7 188.2 502.3 195.3 193.9 28.1 28.5 28.6 60.9 26.2 31.7 31.1 27.8 25.8 28.3 30.7 30.5 31.0 127.0 60.9 126.7 8.1 109.3 116.5 213.0 188.9 92.8 38.7 178.1 261.1 54.6 107.2 130.2 103.0 12.5 297.4 147.9 145.0 138.9 91.2 241.3 103.3 88.9 109.6 91.1 148.5 6.3 170.9 345.1 139.8 63.7 74.3 145.1 127.9 163.1 221.0 180.6 38.7 6.3 194.0 103.7 89.7 106.5 54.1 140.8 98.0 108.5 5.6 119.6 143.9 84.5 4.5 9.9 113.2 131.8 124.1 131.3 162.4 201.4 180.2 176.5 45.3 111.7 126.2 143.1 368.9 325.2 112.8 116.9 278.4 115.2 136.3 198.7 218.8 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993645-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 21.0" "Cell type enhanced" "Detected in many" "Late spermatids: 174.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 114.9;U-698: 161.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.3 2.0 8.8 9.0 11.6 5.6 5.6 8.6 11.8 3.0 6.8 15.7 21.0 2.2 2.2 6.9 4.1 4.9 2.6 9.7 9.3 6.9 4.9 2.9 13.9 9.9 10.9 10.6 1.5 5.1 9.1 2.1 2.1 11.7 3.0 15.4 10.1 2.5 2.2 1.7 5.2 19.0 2.6 9.3 6.0 8.3 1.9 10.6 7.0 4.4 2.1 16.4 2.5 2.6 11.5 34.1 43.8 13.8 12.5 10.9 5.6 24.1 22.2 4.6 13.7 7.1 36.1 22.3 114.9 27.8 5.0 8.9 38.7 30.7 17.3 10.9 26.9 25.5 58.4 16.9 24.8 2.2 86.8 72.2 2.5 9.9 15.0 7.1 5.3 5.1 41.0 23.5 8.0 12.0 31.3 45.1 33.3 9.9 29.9 17.3 30.2 23.0 30.7 17.3 46.8 19.0 13.2 27.6 26.9 9.2 4.6 48.8 60.8 5.9 13.0 16.2 12.5 23.4 26.9 49.7 161.8 11.9 28.7 29.1 4.2 2.2 13.1 0.8 1.6 0.8 1.4 0.6 0.7 1.7 1.5 0.5 0.7 2.2 0.9 1.2 4.2 0.7 0.6 8.8 11.6 8.6 11.8 9.7 9.3 9.9 10.9 10.6 11.7 9.3 10.6 11.5 3.4 9.6 10.4 13.4 23.6 12.2 9.1 8.2 5.2 37.1 14.9 6.3 7.2 31.5 9.2 9.2 14.6 15.4 24.3 65.5 3.9 9.1 25.6 16.1 7.2 5.1 7.8 21.5 32.6 10.4 24.0 7.1 32.1 18.0 18.4 7.2 4.2 27.4 19.8 25.2 43.8 42.8 8.2 31.5 26.1 174.4 1.2 23.6 10.6 11.2 28.8 12.1 9.2 11.1 23.4 17.1 43.3 4.1 39.5 9.6 60.2 12.7 15.0 27.9 0.0 9.2 6.9 1.1 11.5 20.7 18.3 5.2 11.5 6.8 72.6 9.7 IFNE IFNE1 ENSG00000184995 "Interferon epsilon" Q86WN2 9 21480839-21482313 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.5" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 4.4;Basal respiratory cells: 3.7;Club cells: 1.2;Glandular and luminal cells: 1.5;Prostatic glandular cells: 2.9;Urothelial cells: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.2;HeLa: 9.6;hTERT-RPE1: 9.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (1.52e-3)" "unprognostic (8.36e-2)" "unprognostic (5.44e-2)" "unprognostic (1.56e-5)" "unprognostic (2.70e-1)" "unprognostic (2.25e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-1)" "unprognostic (2.68e-2)" "unprognostic (1.14e-2)" "unprognostic (1.43e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" "unprognostic (6.58e-3)" "unprognostic (3.34e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.3 0.8 0.5 0.0 0.0 0.3 0.1 0.9 1.5 0.4 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.6 0.0 0.7 0.1 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.6 0.0 0.3 0.0 0.2 1.1 0.9 0.3 1.1 1.9 0.0 0.0 0.9 0.9 0.1 3.2 0.2 0.1 0.2 0.0 2.1 0.0 0.6 0.6 0.3 1.1 0.0 2.0 0.3 0.0 0.0 0.0 9.6 0.0 0.5 0.0 0.0 0.8 0.4 1.2 1.8 9.9 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.8 0.1 0.1 0.3 0.3 0.0 0.8 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.7 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.9 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.7 SLC22A10 "hOAT5, OAT5" ENSG00000184999 "Solute carrier family 22 member 10" Q63ZE4 11 63137867-63369718 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 139 "liver: 101.7" "Group enriched" "Detected in some" 10 "Excitatory neurons: 6.4;Hepatocytes: 21.0" "Cancer enriched" "Detected in single" 14 "liver cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.17e-2)" "unprognostic (9.77e-2)" "unprognostic (7.07e-3)" "unprognostic (7.46e-4)" "unprognostic (7.62e-3)" "unprognostic (2.87e-1)" "unprognostic (1.56e-1)" "unprognostic (6.52e-2)" "unprognostic (4.25e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 101.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 21.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 41.0" "Group enriched" "Detected in many" 4 "Distal enterocytes: 213.5;Proximal enterocytes: 700.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 18.4;PC-3: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Nucleoli rim,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoli, Nucleoli rim" "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 14.0 24.9 4.0 1.8 4.1 5.1 11.9 5.0 5.6 6.1 3.6 12.8 37.3 5.6 1.0 8.7 5.1 2.0 10.3 4.2 3.7 7.7 16.6 6.9 1.9 4.0 4.1 3.9 4.3 6.5 4.0 6.6 1.5 4.3 6.6 4.2 1.6 7.5 2.4 11.8 6.9 41.0 1.6 3.5 9.4 8.7 14.8 4.2 2.3 7.5 3.5 1.4 6.8 6.4 4.0 5.2 4.9 2.2 4.1 3.5 1.5 2.9 3.4 3.1 2.9 2.0 11.2 3.1 2.1 12.4 1.9 1.6 4.0 1.8 4.3 0.6 3.7 5.1 3.3 4.2 18.4 2.5 1.0 3.4 2.1 3.2 2.0 2.1 2.1 2.3 7.3 2.9 5.2 1.9 3.7 6.8 4.1 1.1 10.9 21.2 7.7 0.9 3.4 2.8 2.5 2.6 4.2 4.7 5.2 2.3 0.8 2.9 3.3 2.0 1.6 5.6 3.6 2.8 2.3 0.6 0.8 1.8 6.3 3.2 0.0 0.4 0.7 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.1 0.1 0.0 0.5 0.0 0.4 0.2 0.1 0.2 4.0 4.1 5.0 5.6 4.2 3.7 4.0 4.1 3.9 4.3 3.5 4.2 4.0 34.0 16.0 19.0 15.7 8.5 8.0 12.5 6.3 4.0 24.6 21.6 16.0 20.8 12.8 8.7 18.4 29.2 11.3 17.6 213.5 1.9 9.4 19.2 12.3 13.7 26.5 23.4 17.7 11.2 11.9 10.3 9.3 48.4 21.3 7.0 23.9 12.5 57.4 18.8 18.5 12.8 93.6 4.1 25.5 11.8 25.8 6.8 22.8 5.4 8.4 9.2 21.3 4.1 17.6 7.0 13.3 113.4 6.8 18.8 8.1 700.1 7.4 5.6 23.6 0.0 11.9 12.3 27.7 17.4 12.3 9.2 16.4 12.3 41.1 108.0 20.7 RFX6 "dJ955L16.1, MGC33442, RFXDC1" ENSG00000185002 "Regulatory factor X6" Q8HWS3 6 116877212-116932161 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 4.6;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5" "Cell type enriched" "Detected in some" 14 "Enteroendocrine cells: 68.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA037696 Approved NA NA "HPA037696: AB_2675616" "unprognostic (2.92e-1)" "unprognostic (4.66e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.59e-4)" "unprognostic (2.59e-2)" "unprognostic (1.63e-1)" "unprognostic (1.25e-1)" 0.0 4.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.7 0.0 0.1 1.3 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.4 0.0 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;retina: 15.5" "Group enriched" "Detected in many" 24 "Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 29.8;HEL: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013371, HPA013975" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA 1900000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391, HPA013975: " "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 0.7 2.5 5.8 0.5 13.5 0.0 0.7 0.0 14.2 2.4 0.0 0.8 0.5 2.2 0.4 4.8 0.1 2.3 0.6 9.1 8.8 1.8 1.2 10.1 1.5 14.0 15.1 8.4 7.1 1.6 2.9 1.6 5.2 16.0 1.2 0.4 15.5 1.6 5.8 0.1 2.3 0.7 1.4 7.4 3.0 0.7 3.7 4.7 9.3 0.1 0.4 2.2 1.2 1.7 33.2 0.0 0.0 2.2 0.0 7.5 8.1 0.1 0.3 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 9.8 83.9 1.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.1 9.1 0.0 0.0 1.1 5.1 12.2 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 13.5 0.0 14.2 9.1 8.8 14.0 15.1 8.4 16.0 7.4 4.7 33.2 0.7 0.0 0.5 164.6 0.0 1.8 2.0 0.4 19.4 30.8 0.2 1.0 2.4 1.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.2 1.0 1.7 1.1 0.0 0.0 3438.7 0.0 0.1 10.6 0.0 3.2 0.0 2.3 3.3 0.7 0.1 52.2 4706.0 3.0 0.0 0.0 2.8 3.4 3.1 0.1 0.0 54.4 0.0 2.0 0.0 63.3 52.4 0.2 0.0 6.0 0.0 0.8 0.3 0.1 0.1 5.6 0.0 0.1 0.9 2.9 1.1 15.7 1.1 0.1 0.2 40.5 0.5 0.2 AP3M1 ENSG00000185009 "Adaptor related protein complex 3 subunit mu 1" Q9Y2T2 10 74120255-74150842 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 266.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045591, HPA048380" Uncertain NA NA "HPA045591: AB_2679377, HPA048380: AB_2680379" "unprognostic (1.83e-3)" "unprognostic (1.26e-1)" "unprognostic (6.69e-2)" "unprognostic (7.52e-2)" "unprognostic (3.40e-2)" "unprognostic (1.61e-1)" "unprognostic (4.92e-3)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (6.99e-2)" "unprognostic (9.64e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-1)" "unprognostic (3.84e-1)" "unprognostic (3.43e-2)" 24.8 23.5 10.0 22.9 10.8 16.5 22.7 12.7 13.8 21.5 11.5 22.0 20.9 23.4 16.6 25.8 20.2 18.1 21.7 9.8 13.4 19.9 27.4 19.4 25.8 12.8 12.1 9.0 20.2 24.3 36.3 9.1 32.7 13.4 26.3 27.7 17.8 19.2 22.9 14.5 17.4 19.3 29.3 12.1 22.0 20.6 17.8 11.8 30.8 24.7 20.8 33.1 25.9 14.7 14.4 51.8 52.3 64.8 74.3 41.9 56.3 44.1 50.9 65.1 61.1 67.8 60.1 45.9 52.2 34.0 49.2 35.2 55.0 76.7 48.3 74.6 51.8 55.4 43.6 39.4 35.8 34.9 72.9 43.5 40.0 27.5 52.7 43.6 66.9 81.8 43.5 84.9 63.2 55.2 28.2 70.0 34.0 28.2 56.6 266.0 61.9 52.4 41.7 46.1 40.4 30.5 47.5 40.2 102.5 57.3 52.5 97.6 41.3 60.5 31.0 44.5 40.1 60.4 33.3 62.2 75.0 51.1 80.7 31.3 38.1 22.5 16.9 20.5 24.4 23.6 19.9 18.1 21.5 24.5 18.6 18.9 20.1 13.8 23.5 29.3 15.6 19.3 23.2 10.0 10.8 12.7 13.8 9.8 13.4 12.8 12.1 9.0 13.4 12.1 11.8 14.4 11.5 28.9 12.1 8.8 19.7 11.0 13.3 10.6 18.8 8.2 17.8 12.2 8.6 11.5 17.3 11.0 33.3 38.3 27.8 15.4 7.9 14.1 2.0 16.8 15.1 15.9 12.0 12.4 16.7 15.7 16.8 15.3 18.3 23.6 12.7 20.9 14.3 19.5 21.1 21.9 15.2 17.6 8.2 19.8 8.2 2.0 17.4 17.4 10.6 8.4 23.1 17.3 17.5 18.6 13.7 15.8 10.2 13.9 18.6 13.6 12.3 10.6 5.8 14.5 19.7 12.7 19.4 19.9 14.7 23.6 13.5 34.2 19.2 20.1 15.4 12.9 F8 "DXS1253E, F8C, FVIII, HEMA" ENSG00000185010 "Coagulation factor VIII" P00451 X 154835788-155026940 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Hemophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 46.1" "Group enriched" "Detected in many" 10 "Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2" "Cancer enhanced" "Detected in all" "renal cancer: 7.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB018777 Enhanced "Secreted to blood" NA NA 25000000 "CAB018777: AB_640320" "unprognostic (2.09e-1)" "unprognostic (5.66e-4)" "unprognostic (4.94e-2)" "unprognostic (8.32e-5)" "unprognostic (1.26e-1)" "unprognostic (5.05e-2)" "unprognostic (6.05e-2)" "unprognostic (8.27e-2)" "unprognostic (6.58e-2)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (5.58e-2)" "unprognostic (1.24e-2)" "unprognostic (2.16e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (4.44e-2)" 25.4 15.3 8.3 2.5 8.6 2.1 19.4 7.7 11.3 6.3 9.7 7.6 2.9 11.0 9.2 4.0 8.0 5.0 46.1 8.2 8.4 13.8 20.3 16.9 4.7 8.8 8.7 7.5 14.6 11.7 5.6 6.5 3.3 8.9 9.0 3.8 6.2 4.8 7.6 20.8 3.2 5.0 6.3 7.7 18.0 5.8 6.1 8.9 3.2 11.0 28.4 3.8 8.1 3.7 8.0 6.1 4.5 0.9 2.1 6.5 10.1 0.7 2.9 1.8 2.0 3.4 0.3 6.8 12.0 9.5 3.0 4.7 0.8 1.0 1.0 1.8 5.1 1.9 2.4 2.8 0.2 3.0 2.1 5.6 7.2 0.6 1.8 2.4 3.5 1.2 5.7 1.1 9.0 10.0 2.7 1.7 1.9 1.6 1.8 4.5 1.4 1.5 1.8 1.8 1.3 3.7 2.8 7.0 0.8 3.9 1.0 2.1 4.9 1.5 10.3 5.5 16.6 3.7 5.3 5.1 6.0 9.4 12.3 5.5 4.6 2.8 0.9 5.2 2.4 10.3 2.1 3.1 5.5 2.7 1.9 1.6 4.1 4.4 3.3 2.4 0.4 4.6 2.7 8.3 8.6 7.7 11.3 8.2 8.4 8.8 8.7 7.5 8.9 7.7 8.9 8.0 118.6 0.0 6.3 13.1 2.3 1.8 2.5 1.6 4.0 8.1 3.7 4.2 17.7 7.2 1.9 3.7 2.1 0.9 2.0 0.6 7.9 3.1 1.4 1.5 1.5 120.4 0.0 8.4 7.2 0.7 0.7 6.8 0.0 1.5 1.3 8.2 371.2 11.8 3.2 6.7 5.0 0.6 0.0 19.9 1.1 3.3 11.5 3.0 0.0 8.4 2.4 6.8 2.1 7.5 6.0 4.5 0.1 5.3 2.0 1.4 0.9 11.4 2.4 3.5 6.6 11.1 13.0 2.3 3.4 1.5 1.1 0.1 4.0 4.3 0.4 2.1 NT5C1B "AIRP, CN-IB" ENSG00000185013 "5'-nucleotidase, cytosolic IB" Q96P26 2 18562872-18589572 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 35.8" "Group enriched" "Detected in some" 29 "Early spermatids: 159.5;Late spermatids: 300.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" HPA056683 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA056683: AB_2683207" "unprognostic (4.18e-2)" "unprognostic (1.20e-2)" "unprognostic (7.67e-2)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "unprognostic (4.97e-2)" "unprognostic (4.96e-2)" "unprognostic (4.84e-1)" "unprognostic (8.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.91e-2)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (6.96e-2)" "unprognostic (2.50e-1)" "unprognostic (1.15e-1)" "unprognostic (3.77e-1)" 0.1 0.5 0.3 0.2 0.3 0.4 0.1 0.3 0.2 0.0 2.2 0.1 0.7 0.1 0.0 1.0 0.1 0.7 0.6 0.2 0.7 0.3 0.2 0.2 0.3 0.3 0.3 0.1 0.0 0.4 0.0 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.0 1.1 0.2 0.0 0.2 0.2 0.8 35.8 0.3 0.0 0.7 0.0 0.0 0.4 0.1 0.6 1.2 0.2 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 1.2 0.5 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.4 0.1 0.0 1.0 0.0 0.1 0.2 0.2 0.6 0.1 0.2 0.3 0.0 1.1 0.8 0.4 0.9 0.1 0.5 0.1 0.2 0.2 0.6 0.5 0.3 1.0 0.1 0.3 0.2 0.7 0.9 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.4 0.4 0.1 0.3 0.8 0.7 0.0 0.2 0.0 1.2 0.1 0.1 0.3 0.3 0.3 0.2 0.2 0.7 0.3 0.3 0.1 0.2 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 159.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 300.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 14.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Proximal enterocytes: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 15.6;OE19: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA 27000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favorable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 1.2 2.1 1.5 1.2 1.3 0.3 2.3 1.5 1.5 2.1 0.8 2.4 12.1 0.9 0.6 5.0 1.2 5.4 2.5 1.1 5.7 3.0 3.8 2.4 0.6 1.2 1.3 1.1 1.1 1.1 9.0 2.9 0.3 1.3 1.2 3.0 2.3 4.9 0.7 0.4 5.6 14.8 0.8 0.8 0.7 5.9 0.7 1.1 0.7 5.0 0.3 2.9 2.1 2.5 1.5 0.2 0.4 0.8 0.1 0.5 0.6 0.4 1.0 1.1 0.1 2.9 7.2 5.4 0.4 0.5 1.2 6.0 2.3 2.2 2.9 0.2 1.6 0.9 15.6 2.0 6.7 1.4 0.2 0.6 2.2 0.5 0.2 1.2 1.8 1.6 0.6 4.0 2.9 2.6 0.0 0.3 0.2 0.4 30.6 0.4 0.2 2.2 0.1 8.1 0.3 0.2 0.0 0.5 0.0 1.6 1.0 0.5 0.8 1.5 2.8 3.9 0.1 1.6 1.1 0.6 1.9 5.7 2.2 2.6 0.7 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.2 1.5 1.3 1.5 1.5 1.1 5.7 1.2 1.3 1.1 1.3 0.8 1.1 1.5 1.7 3.2 12.4 7.2 2.9 1.8 2.7 2.7 3.4 1.8 7.0 4.7 6.4 4.3 10.5 12.9 33.3 0.3 2.1 12.3 9.8 4.0 11.3 4.7 2.5 2.7 4.8 3.2 12.2 1.6 0.3 2.9 9.7 7.7 0.0 0.3 8.6 5.8 1.1 0.0 13.7 4.3 2.0 2.5 3.3 13.1 0.0 3.0 5.4 1.9 1.0 1.9 8.2 16.1 4.4 4.4 4.3 0.0 6.9 1.9 52.6 21.0 9.5 5.1 0.0 8.1 1.9 1.3 2.1 9.1 3.1 0.3 2.2 1.0 5.4 2.4 UBOX5 "KIAA0860, RNF37, Ubce7ip5, UIP5" ENSG00000185019 "U-box domain containing 5" O94941 20 3107573-3160196 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028871 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028871: AB_10603140" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "prognostic favorable (4.52e-5)" "unprognostic (2.58e-2)" "unprognostic (1.02e-1)" "unprognostic (3.11e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.80e-5)" "unprognostic (4.02e-2)" "unprognostic (9.71e-3)" "unprognostic (3.33e-1)" "unprognostic (5.58e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-2)" 4.0 4.4 4.0 2.8 4.5 7.0 4.5 5.0 4.7 4.7 2.1 5.5 2.9 5.9 2.7 4.5 4.8 2.6 3.9 4.2 3.6 3.9 3.5 3.8 3.7 3.8 3.5 4.4 5.0 6.2 5.4 4.4 3.4 4.0 5.2 2.9 3.8 4.8 4.4 11.3 7.1 4.2 4.2 2.7 4.3 4.7 4.8 3.4 3.9 3.9 6.9 3.1 5.6 4.2 5.8 6.1 6.1 4.8 3.1 6.3 3.5 2.6 4.9 4.7 6.1 6.0 5.8 5.2 4.8 2.0 4.2 7.0 8.5 3.2 7.8 3.6 1.4 2.7 7.9 2.1 5.4 5.0 3.9 2.9 4.5 5.6 4.9 6.2 5.0 3.9 3.7 6.7 4.4 3.5 4.5 7.0 5.0 3.7 6.3 3.7 4.7 5.8 3.3 3.8 6.7 5.9 5.7 3.4 18.8 4.0 3.7 8.1 2.5 4.3 4.0 2.7 4.6 4.4 5.9 9.4 4.2 2.1 3.5 3.0 7.9 5.1 9.4 4.4 5.1 5.0 6.3 5.2 3.6 5.5 4.8 5.3 5.1 8.1 5.2 5.3 3.7 5.6 4.6 4.0 4.5 5.0 4.7 4.2 3.6 3.8 3.5 4.4 4.0 2.7 3.4 5.8 2.4 12.8 6.0 6.8 3.6 1.9 4.1 3.4 0.6 6.6 2.8 2.0 1.1 1.5 3.1 0.0 6.2 6.9 1.9 5.6 0.0 4.0 1.4 2.5 2.5 3.6 10.2 0.4 9.6 4.2 4.4 3.5 5.1 2.7 2.5 4.5 4.6 4.3 4.9 6.7 8.5 4.9 6.1 5.0 3.2 1.9 6.8 3.5 3.6 3.7 6.6 4.5 4.1 4.5 10.4 3.9 3.4 3.8 2.3 5.8 4.7 5.2 2.7 5.2 6.6 5.2 2.8 10.2 5.2 1.6 2.4 10.1 3.1 3.8 5.3 5.9 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216507 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 682.0;Syncytiotrophoblasts: 479.1;Urothelial cells: 409.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 23.9;neutrophil: 8.7;NK-cell: 21.1" "Group enriched" "Detected in many" 6 "granulocytes: 23.9;NK-cells: 21.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 79.2;SK-MEL-30: 104.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 5.6" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 84.1 23.0 13.3 13.1 9.5 36.6 70.5 10.0 12.9 32.3 10.9 25.2 8.2 29.1 2.1 53.8 64.8 41.7 42.4 8.4 26.4 32.0 31.0 59.7 4.7 15.0 9.9 7.1 54.4 19.9 5.3 19.6 34.8 12.1 39.9 10.4 19.8 28.8 5.5 73.9 45.3 19.7 23.4 13.2 9.4 45.7 3.0 15.8 7.5 25.2 7.0 11.4 54.3 41.8 17.1 20.8 3.3 4.4 6.6 6.9 21.3 20.6 41.4 54.2 19.8 21.0 6.1 16.0 0.7 3.9 16.9 29.5 13.5 1.1 15.7 33.2 3.9 0.6 2.1 2.1 5.2 18.0 1.3 7.1 9.3 25.7 79.2 43.6 17.6 42.1 1.9 4.2 18.6 15.6 4.9 0.8 5.2 3.3 22.0 16.8 1.4 3.8 4.3 19.9 30.6 2.2 3.7 6.1 15.4 104.9 10.7 3.3 1.5 57.9 24.7 19.2 18.8 13.7 7.2 8.0 0.7 37.4 1.4 15.9 23.9 0.4 0.3 2.9 0.7 2.8 0.8 1.7 2.1 1.4 0.5 2.1 1.6 8.7 21.1 3.5 0.2 0.7 1.8 13.3 9.5 10.0 12.9 8.4 26.4 15.0 9.9 7.1 12.1 13.2 15.8 17.1 215.4 54.5 43.4 1.0 19.3 125.9 344.1 56.8 169.0 2.9 302.9 214.1 18.6 67.2 49.5 11.0 0.0 37.8 112.5 134.2 7.9 49.9 0.5 284.7 149.3 97.3 104.8 5.7 0.8 24.2 77.5 134.7 132.5 682.0 22.2 11.5 22.1 8.2 26.0 0.0 1.6 112.5 34.6 14.0 131.1 0.4 9.9 113.5 58.7 1.0 10.2 36.0 17.5 1.5 1.3 76.0 181.0 3.8 25.8 258.4 67.6 3.7 37.9 3.6 19.7 265.2 153.1 2.4 1.0 139.5 103.1 479.1 59.0 8.4 75.5 409.2 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1 RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 10.5 11.5 20.1 5.6 20.1 6.6 10.6 20.6 21.2 12.0 10.9 10.8 7.6 12.2 4.2 10.5 12.9 6.1 10.8 15.8 17.5 11.6 13.2 8.5 8.2 29.2 23.1 15.6 13.1 15.2 10.4 20.6 6.1 25.4 12.1 4.2 7.5 10.2 6.4 17.8 11.2 10.4 4.6 17.5 12.7 11.3 14.7 21.0 7.4 10.6 9.7 5.8 11.6 10.0 35.6 12.6 28.0 11.8 25.3 10.3 11.4 11.9 17.4 11.2 15.4 12.2 20.2 18.8 9.4 16.9 12.0 7.5 24.2 14.4 11.7 8.4 25.2 14.2 11.5 15.1 9.9 11.5 13.7 24.3 11.3 10.1 9.3 11.5 7.8 11.3 19.7 13.1 7.5 7.6 40.9 16.2 17.1 8.6 20.7 27.7 28.2 8.1 9.6 7.6 29.9 37.5 27.8 18.4 14.0 16.0 5.4 33.4 18.9 16.8 12.1 9.6 22.7 14.2 13.8 11.5 8.9 14.5 11.3 16.9 0.4 1.2 2.0 1.6 1.0 1.1 1.5 1.1 1.6 1.2 1.4 1.4 1.3 0.5 2.5 4.0 3.1 1.6 1.6 20.1 20.1 20.6 21.2 15.8 17.5 29.2 23.1 15.6 25.4 17.5 21.0 35.6 11.5 3.2 5.9 17.6 11.4 7.5 7.1 4.5 8.6 18.8 10.7 9.0 8.5 2.8 6.3 3.7 16.7 11.4 15.5 16.2 3.9 5.8 2.3 26.5 10.9 9.5 9.6 6.3 18.3 7.1 8.9 7.7 14.8 16.5 2.5 16.0 8.9 11.3 7.2 30.3 20.8 11.7 4.1 6.7 10.3 1.4 6.5 7.8 8.8 10.3 5.3 7.1 4.1 15.1 34.2 4.8 6.5 4.5 13.4 7.7 8.9 6.1 12.4 20.0 0.0 9.6 8.2 9.2 12.7 7.7 8.8 9.3 11.6 13.2 12.5 5.1 LRRC14B ENSG00000185028 "Leucine rich repeat containing 14B" A6NHZ5 5 191495-196334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 114.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 14 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.6" "Cell line enriched" "Detected in some" 4 "U-266/84: 43.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038046, HPA038047" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038046: AB_10672504, HPA038047: AB_2675806" "unprognostic (7.63e-4)" "unprognostic (4.25e-3)" "unprognostic (8.50e-3)" "unprognostic (7.63e-4)" "unprognostic (4.95e-2)" "unprognostic (3.79e-2)" "unprognostic (6.07e-3)" "unprognostic (9.68e-2)" "unprognostic (6.43e-2)" "unprognostic (6.43e-3)" "unprognostic (2.78e-2)" "unprognostic (6.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.19e-1)" 0.0 0.0 0.2 0.0 0.5 0.3 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.6 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.9 0.4 0.0 114.9 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.8 0.4 0.0 18.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 4.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 10.1 43.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.5 0.9 0.2 0.0 0.8 0.5 0.5 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" Q9NPR2 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 125.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA 61000000 "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 11.9 37.9 18.4 18.2 18.5 9.9 22.7 17.4 21.8 27.8 10.2 47.1 30.4 17.2 8.3 125.4 22.8 17.3 23.5 15.1 26.9 40.0 43.6 20.6 12.1 21.3 21.6 14.4 21.8 38.8 18.2 18.7 18.4 19.0 31.7 12.2 27.3 41.6 17.8 7.9 50.9 34.9 13.5 18.9 30.6 32.5 10.8 20.3 13.3 34.5 8.0 13.1 42.6 60.3 25.0 21.2 56.3 4.2 13.2 3.8 2.6 30.4 6.4 13.9 7.8 8.3 7.0 182.4 14.9 69.2 4.7 45.0 97.8 3.7 91.2 6.4 85.4 11.7 19.7 13.5 9.4 15.1 2.6 8.7 10.8 39.1 8.5 17.5 32.5 8.8 4.4 9.6 23.0 4.3 15.6 5.4 8.4 18.7 46.8 51.1 6.4 3.1 33.1 111.1 124.0 13.3 13.5 22.3 35.4 8.5 9.3 24.7 6.0 20.0 6.3 11.4 13.1 14.5 33.0 43.2 7.5 58.8 16.1 6.3 0.0 2.4 0.3 0.9 1.4 0.6 16.9 0.5 0.5 1.2 14.9 0.5 0.6 5.1 0.4 2.8 0.2 0.2 1.5 18.4 18.5 17.4 21.8 15.1 26.9 21.3 21.6 14.4 19.0 18.9 20.3 25.0 1.8 16.0 22.5 67.3 29.2 65.0 40.0 51.4 23.9 5.7 29.1 18.9 7.8 8.6 44.6 16.5 25.0 13.9 2.4 47.8 3.9 27.3 0.9 15.6 19.6 4.4 4.2 4.0 23.5 35.5 74.5 6.4 34.1 28.3 0.0 8.6 4.6 16.8 13.3 16.8 28.2 17.5 18.3 6.9 7.5 1.2 13.1 5.5 5.4 2.8 5.3 25.1 1.0 8.0 8.3 44.7 26.1 12.0 8.0 46.9 19.6 4.5 22.6 48.3 19.7 5.7 15.3 0.7 3.2 65.3 57.1 12.4 4.3 5.2 20.2 52.0 MROH2A HEATR7B1 ENSG00000185038 "Maestro heat like repeat family member 2A" A6NES4 2 233775679-233833423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 1.8;thyroid gland: 1.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 3.4;Early spermatids: 1.3;Hepatocytes: 1.0;Late spermatids: 1.7;Spermatocytes: 1.5" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "RT4: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052107 Uncertain Uncertain Cytosol NA NA Cytosol "HPA052107: AB_2681729" "unprognostic (7.00e-2)" "unprognostic (3.37e-3)" "unprognostic (4.77e-1)" "unprognostic (1.65e-2)" "unprognostic (4.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.41e-2)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (4.32e-2)" "unprognostic (5.05e-2)" "unprognostic (4.06e-9)" "unprognostic (5.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 3.4 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.3 SPDYE16 ENSG00000185040 "Speedy/RINGO cell cycle regulator family member E16" A6NNV3 7 76531319-76541459 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 12.5;Early spermatids: 19.8;Late spermatids: 36.8;Rod photoreceptor cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 3.4;Karpas-707: 1.6" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (3.22e-1)" "unprognostic (2.79e-1)" "unprognostic (6.99e-3)" "unprognostic (1.70e-1)" "unprognostic (4.54e-2)" 0.4 0.3 0.1 0.2 0.2 0.3 0.5 0.5 0.3 0.4 0.0 0.4 0.3 0.5 0.0 0.5 0.4 0.0 0.4 0.2 0.2 0.4 0.5 0.4 0.3 0.1 0.1 0.1 0.6 0.6 0.0 0.5 0.1 0.3 0.5 0.0 0.4 0.5 0.0 0.6 0.6 0.5 0.0 0.0 0.6 0.4 1.7 0.4 0.0 0.8 0.0 0.0 0.4 0.5 0.3 0.5 0.6 0.1 0.4 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.3 0.4 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.2 3.4 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 1.6 0.0 0.3 0.3 0.3 0.3 0.1 0.1 0.4 0.1 0.7 0.0 0.3 0.2 0.1 0.6 0.2 0.2 0.5 0.1 0.4 0.8 0.6 0.4 0.3 0.2 0.3 0.3 0.6 0.3 0.7 0.3 0.8 0.1 0.8 0.2 0.5 0.2 0.8 0.3 0.5 0.1 0.2 0.4 0.5 2.0 0.2 0.2 1.2 0.3 0.2 0.1 0.2 0.5 0.3 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.4 0.3 0.4 0.0 3.3 0.0 1.3 0.0 0.1 0.0 0.6 3.5 0.4 0.4 0.6 0.0 0.6 1.8 12.5 0.1 0.5 0.3 0.0 0.1 19.8 1.8 1.1 0.5 0.0 0.4 0.9 0.0 0.4 0.5 0.5 2.1 0.0 0.4 0.0 1.3 0.4 3.3 0.6 0.1 0.0 0.6 0.0 36.8 0.0 0.3 0.0 0.0 1.0 0.7 0.0 1.0 0.6 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.7 6.2 0.0 0.6 0.4 2.4 0.3 0.9 0.0 0.7 0.4 0.5 0.2 0.2 CIB1 "CIB, KIP, SIP2-28" ENSG00000185043 "Calcium and integrin binding 1" Q99828 15 90229975-90234047 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012991, HPA042413, HPA048825" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533" "unprognostic (1.20e-1)" "unprognostic (1.59e-1)" "unprognostic (1.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (7.56e-2)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (8.29e-3)" "unprognostic (1.77e-1)" "unprognostic (4.09e-2)" "unprognostic (5.25e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (1.85e-1)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" 62.2 164.9 61.4 80.4 63.6 207.2 68.0 65.2 77.1 94.6 87.0 149.3 131.2 45.0 88.9 128.3 147.9 78.0 94.5 58.5 91.4 190.0 197.3 87.4 97.8 65.7 63.5 56.7 44.3 215.9 99.1 93.7 38.4 63.7 128.7 139.4 29.4 117.6 73.4 59.3 40.4 129.6 45.7 65.8 117.9 100.2 114.7 65.5 65.0 89.8 42.6 121.9 94.6 68.8 65.2 119.5 261.4 23.8 83.7 98.7 102.7 38.9 123.8 107.2 99.6 87.2 104.7 207.4 34.7 129.7 144.0 125.7 124.2 48.0 141.8 54.0 81.9 114.2 77.5 182.3 175.9 96.2 155.2 71.4 72.2 84.9 91.9 64.6 113.7 129.1 83.7 105.8 53.5 76.4 233.3 118.4 179.4 36.7 223.9 134.0 66.1 62.8 139.7 256.1 199.4 18.7 22.8 168.7 136.5 135.7 41.5 105.3 93.3 81.7 109.6 77.0 132.0 153.2 73.0 122.0 40.3 176.1 174.9 47.8 168.9 201.8 271.3 226.9 248.9 188.0 476.4 269.9 249.4 224.4 418.0 221.5 218.0 118.2 205.7 230.0 149.7 245.8 399.6 61.4 63.6 65.2 77.1 58.5 91.4 65.7 63.5 56.7 63.7 65.8 65.5 65.2 77.4 89.8 104.2 14.7 203.7 85.7 253.6 520.1 84.8 12.0 152.0 118.5 86.9 128.7 469.1 183.9 10.4 106.7 198.7 670.9 453.9 372.1 380.8 480.8 101.3 83.9 97.1 62.3 7.7 662.9 117.6 96.5 149.9 222.8 138.8 66.9 79.6 230.1 209.0 3.3 6.6 379.5 463.9 102.5 148.0 1385.8 105.3 180.5 128.1 4.7 187.5 138.4 184.4 5.0 12.2 620.2 794.2 92.6 88.8 699.6 661.4 668.6 1103.6 25.5 39.5 62.3 140.4 160.3 69.0 218.1 67.3 66.1 227.5 91.8 315.5 577.8 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 83.2;skeletal muscle: 34.5" "Group enriched" "Detected in many" 6 "Excitatory neurons: 2224.0;Inhibitory neurons: 1545.5;Oligodendrocyte precursor cells: 1318.0;Oligodendrocytes: 1000.1" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.3;ASC TERT1: 5.8;SCLC-21H: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078230 Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 1.4 3.6 29.6 0.7 56.3 0.1 2.8 50.5 83.2 2.6 0.0 2.9 0.5 2.3 1.4 3.0 3.6 1.2 1.3 56.1 22.8 4.6 1.1 1.0 0.6 9.4 18.9 43.7 9.0 1.1 0.8 10.2 1.8 19.1 3.1 1.0 6.3 3.1 2.7 34.5 1.0 1.1 2.4 0.0 1.1 1.4 7.7 19.4 1.0 5.6 1.8 0.3 2.1 1.7 77.9 0.2 2.2 10.3 2.4 4.0 5.8 0.5 0.0 1.1 0.7 0.8 0.2 0.7 0.8 0.4 1.5 3.1 0.4 0.1 0.0 0.2 1.2 0.7 0.1 0.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.7 0.1 0.6 0.4 0.5 2.9 0.0 1.9 0.7 0.0 0.2 0.1 0.0 11.1 1.1 0.9 3.2 1.2 0.8 3.7 0.1 0.1 0.9 0.9 0.6 0.6 0.0 0.7 0.5 0.9 0.2 0.9 3.7 0.6 1.1 0.7 1.0 1.1 0.9 1.3 0.7 0.6 0.9 1.0 1.0 1.9 1.5 1.6 1.2 4.3 0.6 29.6 56.3 50.5 83.2 56.1 22.8 9.4 18.9 43.7 19.1 0.0 19.4 77.9 0.5 3.2 3.9 228.8 0.8 1.1 1.1 0.2 4.6 32.9 6.3 2.4 2.4 0.0 1.3 9.2 18.8 0.4 0.5 0.0 0.0 0.5 142.2 2.6 0.8 0.8 0.0 0.0 2224.0 0.0 0.3 5.7 1.1 0.9 1.3 0.3 0.4 0.5 0.6 30.3 1545.5 0.0 0.0 0.0 1.9 92.0 1.2 0.4 5.4 84.3 0.2 1.7 1.0 1318.0 1000.1 0.0 1.1 6.0 0.3 0.5 0.0 5.0 3.1 3.4 6.6 12.1 1.8 31.8 3.9 2.6 1.4 0.8 2.1 0.5 0.1 0.6 NELFA "NELF-A, WHSC2" ENSG00000185049 "Negative elongation factor complex member A" Q9H3P2 4 1982717-2041903 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009960, HPA039858, HPA043931" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737" "unprognostic (1.66e-1)" "unprognostic (2.23e-1)" "unprognostic (3.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.32e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (2.40e-1)" "unprognostic (1.12e-1)" "unprognostic (9.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.88e-3)" "unprognostic (1.58e-1)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (2.43e-1)" "unprognostic (3.05e-2)" 9.4 7.9 8.5 10.9 7.7 14.3 6.1 7.4 11.6 7.2 4.9 9.5 13.6 11.4 6.3 9.6 12.5 5.8 6.4 7.4 7.1 6.9 5.9 6.6 10.9 8.1 7.2 6.6 15.7 16.8 10.2 3.0 10.4 6.7 9.0 4.7 7.0 18.4 8.5 12.1 12.9 13.5 5.7 8.0 12.2 12.8 16.6 7.8 9.5 7.5 4.6 7.4 6.8 1.9 9.1 27.2 24.6 21.0 38.8 8.5 8.9 41.6 14.3 10.1 16.9 13.4 41.1 45.7 47.8 20.1 9.3 21.0 25.2 21.3 17.9 8.2 24.5 33.2 31.5 18.0 39.4 12.4 33.1 30.9 7.6 15.6 11.3 12.0 12.5 13.0 26.6 60.5 22.3 7.4 31.7 63.8 94.4 60.8 23.2 36.5 57.6 18.3 30.2 12.1 22.5 57.1 35.7 16.4 19.3 24.4 13.0 37.1 24.5 14.7 17.0 19.2 19.8 31.9 47.2 52.7 53.6 19.4 34.5 21.4 7.0 14.4 14.9 15.4 16.9 18.5 16.3 17.9 13.9 13.9 24.0 15.0 12.0 5.3 15.4 14.0 17.3 22.1 13.1 8.5 7.7 7.4 11.6 7.4 7.1 8.1 7.2 6.6 6.7 8.0 7.8 9.1 11.1 12.8 17.9 30.7 18.5 32.6 18.6 20.3 17.6 19.2 17.6 19.3 4.6 14.3 19.1 12.9 39.6 27.9 16.2 14.6 9.8 18.7 24.0 25.2 17.7 13.2 16.2 17.2 55.9 13.6 28.1 14.7 13.3 28.5 9.5 23.3 11.4 8.3 16.4 37.0 40.9 17.8 14.2 10.1 12.1 7.4 15.5 11.3 14.2 13.1 19.6 18.1 19.6 31.7 30.2 16.2 18.7 13.2 14.0 23.6 17.5 8.9 17.3 21.9 0.0 15.4 15.2 32.9 39.4 29.8 38.2 28.5 18.8 15.8 20.1 27.0 SLC24A3 ENSG00000185052 "Solute carrier family 24 member 3" Q9HC58 20 19212642-19722926 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.8" "Group enriched" "Detected in many" 9 "Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 39 "basophil: 5.8;eosinophil: 1.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Cell line enriched" "Detected in some" 4 "HMC-1: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043400, HPA045497" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA043400: AB_2678462, HPA045497: AB_2679349" "unprognostic (8.74e-2)" "unprognostic (1.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.41e-1)" "unprognostic (7.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.04e-2)" "unprognostic (3.25e-2)" "unprognostic (1.05e-1)" "unprognostic (5.40e-2)" "unprognostic (1.21e-3)" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (6.08e-4)" "unprognostic (7.36e-3)" 10.5 3.1 16.3 4.1 11.5 1.4 4.9 13.4 58.2 18.0 3.3 8.7 3.8 28.6 24.5 20.8 20.1 13.1 1.1 69.8 17.4 1.1 0.7 5.5 1.0 11.8 18.9 8.3 14.7 0.8 7.6 1.2 3.1 7.2 11.0 5.4 7.4 4.7 17.7 41.2 7.1 5.1 29.4 7.5 2.4 3.8 1.6 38.1 1.9 3.0 17.0 2.7 8.7 9.0 6.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.8 13.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 18.2 0.0 0.0 0.7 0.0 75.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 8.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 9.0 0.0 0.6 17.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.3 11.5 13.4 58.2 69.8 17.4 11.8 18.9 8.3 7.2 7.5 38.1 6.9 0.2 3.2 1.1 134.5 0.1 1.1 1.1 0.4 0.0 19.1 5.0 2.3 0.4 0.0 1.3 1.8 0.0 8.5 0.1 0.3 0.0 0.1 17.0 1.2 29.8 0.4 7.7 3.4 11.8 0.0 0.3 1.9 0.0 1.6 26.6 0.1 0.4 0.0 0.6 1.7 327.0 4.1 0.0 0.0 0.7 18.3 3.7 1.1 0.0 12.2 0.0 3.1 0.0 375.5 2.4 0.2 2.8 4.1 0.4 0.8 0.4 0.0 0.0 2.2 0.0 2.7 3.0 0.5 0.8 2.9 4.1 3.4 0.4 0.1 0.7 3.8 SGCZ ZSG1 ENSG00000185053 "Sarcoglycan zeta" Q96LD1 8 14084845-15238431 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.3;ovary: 1.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 477.1;Inhibitory neurons: 2304.3;Oligodendrocyte precursor cells: 1235.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017585 Uncertain NA NA "HPA017585: AB_1856799" "unprognostic (3.83e-1)" "unprognostic (1.41e-1)" "unprognostic (5.87e-4)" "unprognostic (1.21e-1)" 0.1 0.0 0.9 0.0 0.7 0.0 0.4 1.7 1.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.7 0.1 0.0 0.0 0.0 0.6 2.3 0.4 1.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 1.7 1.2 0.5 1.7 0.6 2.3 0.4 0.7 0.3 1.6 0.4 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 477.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2304.3 0.0 0.0 0.0 0.0 0.7 0.9 0.1 0.0 73.1 0.0 0.1 0.0 1235.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 EFCAB10 ENSG00000185055 "EF-hand calcium binding domain 10" A6NFE3 7 105565120-105600875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.0;testis: 23.7" "Group enriched" "Detected in some" 11 "Early spermatids: 205.9;Endometrial ciliated cells: 138.5;Late spermatids: 78.7;Respiratory ciliated cells: 243.9;Spermatocytes: 96.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019751 Uncertain NA NA "HPA019751: AB_1848011" "unprognostic (1.20e-1)" "unprognostic (2.24e-3)" "unprognostic (8.96e-2)" "unprognostic (4.76e-3)" "unprognostic (4.11e-2)" "unprognostic (3.58e-2)" "unprognostic (3.58e-2)" "unprognostic (6.07e-3)" "unprognostic (1.47e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-3)" "unprognostic (6.87e-2)" "unprognostic (3.07e-9)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" "unprognostic (5.67e-2)" 0.5 0.6 5.3 0.6 2.3 2.4 0.5 1.9 1.3 1.2 9.1 0.6 0.5 1.0 0.2 0.8 30.0 0.2 0.5 1.8 6.6 0.7 1.0 3.2 0.8 5.2 5.0 0.9 0.9 1.5 0.0 2.2 0.2 3.3 0.9 0.3 1.3 0.8 0.0 1.2 1.1 0.7 0.0 4.6 1.2 0.6 23.7 2.0 0.2 0.7 0.0 0.1 0.5 0.6 2.7 1.4 3.8 2.0 1.3 0.3 0.1 0.8 1.8 0.0 0.0 0.1 0.7 0.9 1.9 1.6 0.0 0.3 0.5 0.0 0.0 0.0 0.7 3.4 0.9 3.0 2.1 0.2 1.2 1.2 0.1 0.0 0.0 0.0 1.2 0.0 0.9 2.8 1.5 0.0 2.9 1.3 2.5 3.4 0.9 1.4 0.9 2.1 4.1 0.2 0.8 1.8 2.5 1.1 3.9 0.6 2.5 0.7 1.4 1.0 1.9 1.3 4.0 1.2 2.1 2.7 1.7 1.1 1.9 0.9 1.0 0.3 0.2 0.4 0.2 0.4 0.3 0.4 0.3 0.1 0.6 0.6 0.5 0.3 0.3 0.2 0.4 0.3 0.1 5.3 2.3 1.9 1.3 1.8 6.6 5.2 5.0 0.9 3.3 4.6 2.0 2.7 0.1 0.0 4.4 0.3 0.2 0.0 0.1 11.8 0.0 0.7 0.2 0.3 0.3 0.0 13.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 205.9 138.5 1.2 0.3 0.0 0.0 3.4 0.0 0.1 0.3 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 2.1 0.0 6.1 0.0 0.0 78.7 2.5 0.4 0.0 0.0 0.0 0.1 0.0 1.5 0.7 0.0 0.0 1.5 0.8 0.2 0.0 0.5 243.9 0.2 0.0 0.6 3.5 96.3 2.5 0.0 0.0 0.1 0.5 0.1 0.0 0.1 C5orf47 LOC133491 ENSG00000185056 "Chromosome 5 open reading frame 47" Q569G3 5 173973779-174006140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 21.8" "Cell type enhanced" "Detected in some" "Early spermatids: 110.6;Spermatocytes: 517.0;Spermatogonia: 144.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (7.54e-2)" "unprognostic (4.81e-3)" "unprognostic (3.81e-1)" "unprognostic (1.64e-2)" "unprognostic (1.31e-2)" "unprognostic (3.94e-1)" "unprognostic (8.72e-3)" "unprognostic (2.00e-2)" "unprognostic (2.82e-1)" "unprognostic (4.09e-2)" "unprognostic (3.03e-3)" "unprognostic (2.59e-1)" "unprognostic (2.63e-1)" "unprognostic (2.99e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.6 0.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 25.3 6.8 0.4 0.0 0.0 0.7 0.9 1.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 517.0 144.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 KRT76 "HUMCYT2A, KRT2B, KRT2P" ENSG00000185069 "Keratin 76" Q01546 12 52768155-52777345 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 2.6;salivary gland: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "head and neck cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019656, HPA019696" Approved NA NA 310000000 "HPA019656: AB_1852241, HPA019696: AB_1852243" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLRT2 ENSG00000185070 "Fibronectin leucine rich transmembrane protein 2" O43155 14 85530144-85654428 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 29.8;pancreas: 21.9" "Cell type enhanced" "Detected in many" "Astrocytes: 279.5;Excitatory neurons: 549.6;Inhibitory neurons: 321.3;Leydig cells: 219.0;Microglial cells: 432.8;Oligodendrocyte precursor cells: 212.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 60.1;HUVEC TERT2: 38.7;TIME: 55.3;U-138 MG: 58.8;U-2197: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 17000 "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (8.13e-3)" "unprognostic (4.59e-3)" "unprognostic (3.57e-2)" "unprognostic (1.46e-2)" "unprognostic (4.75e-2)" "unprognostic (9.46e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (5.34e-2)" "unprognostic (8.02e-6)" "unprognostic (1.98e-3)" "unprognostic (8.03e-2)" "unprognostic (1.50e-2)" "unprognostic (1.50e-5)" 6.5 4.6 1.3 4.6 2.0 0.1 2.9 0.0 8.2 11.1 2.2 2.7 0.9 6.2 3.0 3.5 6.5 9.2 3.7 4.1 0.3 1.4 1.2 2.3 3.5 2.9 0.2 3.6 29.8 21.9 1.3 1.9 1.2 9.9 5.2 3.1 3.1 1.9 3.3 7.4 6.2 1.7 5.3 0.0 3.1 2.2 4.6 0.2 1.3 4.9 3.2 2.7 5.3 4.3 1.2 0.0 0.2 8.9 0.0 7.9 14.5 0.0 9.7 6.3 9.0 8.4 0.0 0.0 0.0 0.0 28.5 0.9 2.0 13.6 18.6 21.8 0.0 7.8 0.0 5.3 0.0 25.2 2.1 0.0 8.0 10.6 7.5 60.1 2.7 38.7 0.0 0.0 0.0 21.8 0.0 0.0 0.0 4.2 0.0 0.2 0.0 10.8 0.0 0.0 0.0 2.1 0.0 2.3 0.0 3.2 11.8 0.0 0.1 55.3 58.8 9.9 43.0 17.8 0.0 0.0 0.0 18.5 0.0 5.8 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 2.0 0.0 8.2 4.1 0.3 2.9 0.2 3.6 9.9 0.0 0.2 1.2 5.9 0.0 1.3 279.5 0.1 21.4 1.7 5.2 6.2 7.0 3.9 4.4 4.0 10.0 0.4 1.8 0.0 0.4 0.1 0.1 0.0 66.2 3.1 2.2 65.1 15.9 0.0 0.0 549.6 42.8 0.2 34.3 0.5 1.6 0.0 39.9 66.0 0.2 2.4 10.1 321.3 0.0 0.0 1.3 6.6 7.7 219.0 1.2 1.8 432.8 0.6 13.2 0.0 212.1 9.0 20.4 0.0 124.8 0.0 1.1 0.0 0.2 1.7 1.4 13.1 3.2 8.5 1.1 0.6 1.0 24.0 0.8 0.8 32.3 0.0 0.2 INTS5 "INT5, KIAA1698" ENSG00000185085 "Integrator complex subunit 5" Q6P9B9 11 62646848-62653302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046181, HPA056915" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA046181: , HPA056915: AB_2683276" "unprognostic (2.87e-1)" "unprognostic (9.51e-2)" "unprognostic (9.11e-2)" "unprognostic (9.70e-2)" "unprognostic (2.71e-1)" "unprognostic (6.41e-2)" "unprognostic (1.97e-2)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.33e-1)" "unprognostic (5.09e-2)" "prognostic favorable (8.44e-5)" "unprognostic (7.08e-3)" "unprognostic (2.97e-2)" "unprognostic (3.36e-1)" "unprognostic (1.35e-2)" 8.2 9.4 5.1 8.0 5.2 5.5 8.6 5.2 6.0 9.8 4.6 9.0 7.8 11.5 5.3 12.2 13.0 5.9 7.3 5.1 4.8 7.7 12.7 7.8 10.7 5.5 5.2 5.2 10.3 10.4 8.8 6.7 6.0 5.3 9.3 5.9 2.9 11.8 7.0 14.0 12.3 8.8 8.4 5.2 10.6 9.6 6.2 5.4 8.4 7.8 8.4 9.3 9.1 8.8 4.9 17.5 21.1 12.2 11.4 23.5 17.1 11.4 14.2 14.4 18.7 13.4 15.1 19.0 33.1 25.0 18.0 15.5 26.7 24.6 32.9 9.0 20.8 17.1 17.2 15.8 10.2 21.2 19.0 15.7 19.9 25.3 20.1 17.1 14.2 18.8 14.5 26.6 18.9 16.3 35.8 22.0 22.1 18.7 20.7 26.4 22.2 16.5 39.9 14.3 11.3 16.4 13.8 15.9 22.0 22.2 8.6 31.3 12.9 15.7 17.8 13.6 27.6 12.9 26.5 21.9 23.8 20.5 14.3 17.2 4.3 5.3 3.9 6.4 3.5 10.1 4.1 5.9 5.7 5.5 5.0 6.9 6.4 1.9 7.7 4.1 5.5 4.6 6.3 5.1 5.2 5.2 6.0 5.1 4.8 5.5 5.2 5.2 5.3 5.2 5.4 4.9 5.0 3.2 7.8 2.3 8.8 2.2 7.1 8.2 4.6 7.5 6.6 6.3 3.1 7.2 9.3 3.7 0.0 14.0 10.7 4.8 11.7 12.0 6.4 5.7 5.0 6.9 6.7 2.5 2.0 10.6 9.3 5.2 4.1 4.4 8.9 6.7 9.7 11.5 8.7 10.1 2.1 7.9 8.2 7.0 3.1 8.9 6.5 4.3 0.0 1.9 12.6 10.4 8.2 2.0 1.0 9.7 2.2 7.9 7.3 8.5 8.7 10.2 13.2 3.8 13.1 5.1 8.6 10.8 11.3 5.4 4.1 19.8 6.8 9.1 7.6 5.9 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 2535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 134.1 244.4 81.0 72.0 85.3 73.8 128.2 84.6 114.0 123.5 105.9 192.6 158.9 109.3 159.3 71.4 118.9 95.7 171.7 80.6 89.2 195.6 268.2 110.3 84.2 85.9 86.8 79.7 96.7 249.4 94.8 89.3 69.9 86.7 157.5 179.7 32.0 166.2 107.7 191.7 74.2 162.8 81.4 89.0 104.0 176.1 38.4 85.8 87.1 107.3 98.5 68.8 150.5 94.9 92.7 140.4 383.0 340.4 92.9 486.4 571.3 341.3 432.1 306.0 93.8 225.3 71.1 190.0 130.8 150.9 415.9 166.0 52.9 116.5 212.9 155.7 97.8 157.5 108.3 329.1 512.7 558.7 86.8 287.0 452.1 279.0 211.2 158.4 701.2 535.2 81.2 101.6 127.7 785.1 194.1 112.4 134.9 101.0 178.0 112.6 86.9 163.1 149.5 266.7 278.8 49.2 74.7 157.6 65.8 326.2 677.8 145.4 199.1 571.1 490.6 463.8 106.7 195.3 142.3 132.3 117.5 518.5 235.6 453.8 263.8 132.5 164.6 99.4 145.2 125.2 132.0 149.9 118.1 122.0 105.2 116.9 119.4 44.3 110.9 198.2 121.3 305.2 166.0 81.0 85.3 84.6 114.0 80.6 89.2 85.9 86.8 79.7 86.7 89.0 85.8 92.7 210.9 96.1 198.6 9.4 255.9 255.4 262.6 424.8 230.5 33.4 361.3 429.1 349.0 511.9 424.6 410.1 47.9 300.1 144.9 694.7 903.9 802.7 60.9 202.3 185.3 245.8 285.4 184.5 12.6 782.4 1269.2 269.2 327.8 155.5 302.6 250.8 302.0 994.8 542.1 13.5 15.6 742.3 520.8 372.1 358.1 34.4 314.7 270.3 466.0 17.8 1049.6 184.8 221.4 16.1 18.5 1019.3 745.5 297.5 495.5 324.6 1513.1 2535.3 330.9 75.2 263.0 180.5 742.6 144.7 82.1 183.6 247.6 235.2 224.7 214.3 732.5 215.2 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793847-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 16.5;Enteroendocrine cells: 30.5;Horizontal cells: 26.9;Inhibitory neurons: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 47000 "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.1 7.1 15.1 2.1 17.3 0.2 5.1 12.9 18.3 2.9 5.3 6.1 3.5 1.9 6.6 4.8 2.8 1.3 1.1 16.4 19.2 2.7 9.2 3.0 1.2 16.4 15.0 16.9 1.2 10.2 6.0 19.4 0.9 17.6 4.2 6.4 13.4 3.6 2.7 4.0 4.1 3.5 2.3 10.9 2.0 4.7 2.7 18.5 1.3 5.7 2.7 1.9 2.4 2.5 17.2 24.0 30.1 5.4 57.1 7.3 2.7 51.7 4.4 26.0 22.1 9.6 50.3 55.0 40.0 18.8 3.1 26.1 5.4 11.1 5.9 7.9 47.5 23.7 29.4 25.5 41.0 0.5 42.3 23.4 0.9 30.6 1.2 1.1 30.7 0.6 7.1 17.5 30.4 3.5 47.8 11.9 0.1 18.1 57.0 31.8 18.2 39.0 46.2 13.1 62.8 139.8 42.4 63.0 2.0 23.6 1.0 27.3 4.4 3.5 31.0 19.0 30.2 41.0 43.6 45.0 13.1 5.1 13.7 23.2 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 15.1 17.3 12.9 18.3 16.4 19.2 16.4 15.0 16.9 17.6 10.9 18.5 17.2 1.1 3.2 2.7 0.3 1.0 0.5 1.1 0.3 2.2 16.5 4.3 4.3 1.1 1.5 0.6 3.7 4.2 0.2 1.1 2.3 0.0 1.6 0.2 1.1 0.7 0.8 30.5 0.0 9.0 6.0 2.0 1.0 1.1 2.5 0.0 1.8 0.0 5.0 0.9 26.9 12.1 3.7 0.0 0.8 0.4 0.0 0.3 0.5 3.6 3.7 0.0 5.0 0.0 9.5 2.7 2.4 2.3 0.0 2.4 1.7 1.1 0.4 0.2 9.5 0.0 0.7 0.4 0.0 1.5 1.5 0.0 0.1 0.7 0.5 4.1 1.3 ADSS1 "ADSSL1, FLJ38602" ENSG00000185100 "Adenylosuccinate synthase 1" Q8N142 14 104724229-104747325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 1285.2;tongue: 615.2" "Cell type enriched" "Detected in some" 20 "Cardiomyocytes: 137.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052621 Enhanced NA NA 290000 "HPA052621: " "unprognostic (2.23e-2)" "unprognostic (3.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.14e-2)" "unprognostic (2.81e-3)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (2.26e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (2.33e-1)" "unprognostic (2.35e-1)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" 8.2 5.1 4.4 1.0 6.8 0.9 4.4 7.1 5.5 3.6 7.5 2.8 2.7 3.3 4.5 18.6 6.5 5.7 101.2 4.1 6.9 15.0 29.1 3.1 1.1 8.6 6.5 3.4 2.7 8.0 7.4 10.1 7.4 8.0 7.7 1.4 10.2 10.8 4.1 1285.2 5.5 2.8 2.3 5.8 2.0 6.5 18.6 6.9 1.0 7.5 615.2 0.8 6.6 5.4 8.3 0.1 3.2 2.4 7.1 1.7 1.1 0.8 0.9 1.3 0.2 0.7 0.2 2.5 0.0 15.2 0.8 0.5 1.3 0.2 0.5 0.6 1.0 0.5 0.1 7.9 1.1 1.8 0.0 6.0 3.2 2.3 0.0 2.6 2.7 0.4 0.3 2.9 0.1 1.2 14.2 0.0 0.7 2.1 23.2 1.3 0.2 0.3 0.9 0.5 1.7 2.0 4.2 23.1 1.0 3.3 1.8 7.1 2.1 0.8 0.1 0.6 1.6 0.1 4.4 3.5 0.0 2.2 1.0 1.5 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.4 6.8 7.1 5.5 4.1 6.9 8.6 6.5 3.4 8.0 5.8 6.9 8.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.5;skin 1: 28.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 48 "B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2" "Cell line enhanced" "Detected in some" "BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.4 0.1 0.0 7.1 0.0 2.2 1.7 0.0 0.0 0.9 0.2 13.6 34.5 0.5 7.1 6.4 1.2 2.0 0.1 0.0 0.0 3.7 0.3 2.9 12.1 0.0 0.0 0.0 0.1 6.6 0.7 1.3 0.1 0.0 3.0 9.2 0.0 3.0 0.8 0.0 28.0 30.3 0.8 0.0 4.8 7.1 0.2 0.0 9.1 2.5 0.1 8.7 2.4 3.4 0.0 2.7 0.6 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 3.1 29.5 1.9 1.4 0.0 0.1 16.8 0.0 7.0 0.0 2.1 0.0 0.0 0.6 5.1 0.0 0.4 0.0 0.0 5.6 0.0 1.2 0.1 0.0 4.5 0.1 1.9 0.0 3.8 0.5 0.1 0.0 6.0 0.0 0.1 0.0 20.6 5.1 4.4 1.6 0.0 0.3 7.3 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.5 2.1 6.5 3.3 0.0 0.8 3.7 2.8 0.0 4.1 0.0 0.0 8.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.7 0.3 9.1 5.2 4.6 15.3 6.2 0.0 5.5 3.9 2.4 8.6 9.1 3.7 0.0 0.3 3.0 81.0 0.0 10.5 0.8 4.9 1.0 0.8 15.5 0.0 0.3 6.5 3.7 0.6 29.0 11.0 0.0 0.0 0.7 0.3 0.4 0.0 0.2 50.5 14.2 0.3 1.9 0.1 0.0 1.2 3.6 0.0 1.3 0.0 0.0 0.0 0.0 9.0 50.5 0.0 5.0 2.7 87.7 3.7 9.2 0.0 0.0 0.1 1.0 0.2 0.2 7.0 6.3 0.1 12.8 0.0 45.2 5.7 FAF1 "CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A" ENSG00000185104 "Fas associated factor 1" Q9UNN5 1 50437028-50960267 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018253, CAB072814" Approved Supported Nucleoplasm NA NA 12000 Nucleoplasm "CAB072814: , HPA018253: AB_1848351" "unprognostic (1.52e-1)" "unprognostic (1.25e-2)" "unprognostic (6.49e-3)" "unprognostic (4.69e-2)" "unprognostic (6.35e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (9.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.01e-3)" "unprognostic (6.42e-3)" 17.4 17.0 21.2 9.3 22.0 21.2 18.7 21.8 27.7 18.1 19.2 21.3 12.5 18.4 11.8 23.3 15.8 8.7 32.0 22.1 22.1 19.7 23.8 15.0 13.2 21.5 21.8 21.6 20.1 26.4 23.4 20.7 10.7 22.3 18.6 12.8 19.8 18.2 16.4 68.4 28.4 16.5 13.5 21.7 14.1 18.4 48.2 21.5 22.4 18.5 37.9 14.2 21.5 18.9 25.9 37.4 27.1 23.1 39.3 22.4 21.1 33.9 35.5 32.1 53.9 48.8 30.4 26.0 59.9 25.7 30.5 47.5 27.2 37.3 33.1 45.9 40.1 33.5 49.9 33.5 31.6 36.4 54.3 28.5 19.8 29.4 57.0 69.4 27.8 29.5 44.5 58.9 0.2 28.1 15.0 56.6 43.0 30.6 49.3 19.2 52.1 50.7 0.0 54.9 33.1 0.3 28.6 32.3 64.9 56.4 32.0 20.4 64.1 18.2 30.4 37.3 37.8 0.2 45.1 50.6 69.3 0.0 77.6 35.7 1.1 2.1 4.9 4.0 2.7 5.5 2.5 3.6 4.0 3.6 4.2 4.3 2.8 0.7 4.3 3.5 2.9 6.1 1.6 21.2 22.0 21.8 27.7 22.1 22.1 21.5 21.8 21.6 22.3 21.7 21.5 25.9 17.9 6.4 18.2 202.4 26.9 21.4 38.5 27.8 33.6 19.9 16.9 16.9 43.9 11.5 27.2 16.5 27.1 14.2 18.0 13.1 29.4 8.8 75.1 15.1 15.6 14.2 11.4 44.6 296.7 11.6 28.2 16.0 29.0 16.9 5.7 19.2 10.4 18.2 11.4 16.8 278.9 17.8 6.1 13.6 18.0 117.2 11.1 15.4 16.0 177.1 8.9 20.0 15.5 269.9 424.4 8.5 9.7 10.9 35.4 18.3 20.0 28.3 32.7 33.0 6.6 26.2 20.3 36.9 15.6 37.9 28.1 15.3 27.9 19.6 21.6 34.1 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 84.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.0;Cardiomyocytes: 4.2;Early spermatids: 1.5;Excitatory neurons: 1.5;Horizontal cells: 1.7;Inhibitory neurons: 2.4;Skeletal myocytes: 1.0;Undifferentiated cells: 1.0" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041856, HPA048476" Uncertain NA NA "HPA041856: AB_2677709, HPA048476: AB_2680410" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 1.3 0.0 1.2 0.0 0.0 1.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 2.5 0.8 1.5 0.0 0.0 0.0 0.0 1.8 1.3 1.3 0.0 0.2 0.0 0.2 0.0 2.3 0.6 0.0 0.4 1.0 0.0 84.8 0.0 0.3 0.0 0.2 0.0 0.1 0.8 2.0 0.0 0.0 16.9 0.0 0.0 0.0 2.8 0.0 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.4 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 1.0 2.5 0.8 1.5 1.8 1.3 1.3 2.3 0.2 2.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 FAM43A FLJ90022 ENSG00000185112 "Family with sequence similarity 43 member A" Q8N2R8 3 194685883-194689037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.4" "Cell type enhanced" "Detected in many" "Adipocytes: 89.2;Endothelial cells: 102.4;Extravillous trophoblasts: 83.3;Hepatic stellate cells: 97.1;NK-cells: 75.2;Syncytiotrophoblasts: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 123.7;NB-4: 72.8;PC-3: 56.9;TIME: 66.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048345 Uncertain Approved Vesicles NA NA Vesicles "HPA048345: AB_2680367" "unprognostic (1.61e-1)" "unprognostic (1.11e-1)" "unprognostic (9.18e-2)" "unprognostic (1.90e-2)" "unprognostic (5.71e-3)" "unprognostic (5.13e-3)" "unprognostic (9.80e-2)" "unprognostic (8.28e-2)" "unprognostic (4.96e-2)" "unprognostic (1.38e-1)" "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.14e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.91e-3)" "prognostic unfavorable (9.96e-4)" 20.2 4.9 10.3 5.2 6.3 3.7 15.8 6.2 12.8 13.5 4.3 12.6 1.5 13.1 1.2 15.5 15.2 4.0 20.4 10.5 7.1 12.5 5.9 9.8 10.1 26.8 13.1 3.5 4.5 3.0 1.5 8.8 11.3 34.2 22.3 2.3 0.8 8.0 2.7 6.0 25.0 11.7 3.8 6.0 55.4 8.3 4.4 8.2 1.3 8.1 4.0 6.4 17.4 25.3 20.4 0.3 1.8 1.4 1.1 23.3 11.4 10.4 3.8 8.6 0.1 0.0 0.8 0.3 1.3 37.4 11.6 8.5 3.8 2.3 1.0 0.1 0.9 6.4 4.7 10.8 1.3 1.8 1.2 13.5 3.0 4.8 0.5 0.1 0.6 123.7 0.2 2.8 2.5 0.3 1.9 0.0 72.8 6.0 12.8 56.9 6.0 0.4 0.6 0.1 0.2 35.6 3.0 2.4 2.3 7.5 2.4 1.5 15.7 66.3 1.2 1.9 1.6 0.8 0.2 1.5 3.5 0.7 34.3 24.0 2.2 0.6 1.3 0.5 0.5 0.7 1.2 0.3 0.5 0.8 2.5 0.0 0.2 0.9 1.6 0.5 4.5 0.2 0.3 10.3 6.3 6.2 12.8 10.5 7.1 26.8 13.1 3.5 34.2 6.0 8.2 20.4 89.2 0.0 2.5 0.0 26.7 4.0 21.4 6.7 4.6 16.0 10.6 7.0 35.1 0.0 4.0 1.8 8.4 21.1 38.3 39.6 7.9 7.8 0.3 3.2 19.5 102.4 6.6 0.4 3.5 1.8 83.3 30.1 8.6 4.0 15.2 3.8 97.1 1.4 6.0 0.0 7.3 8.0 24.4 13.1 3.9 1.3 16.4 9.3 12.4 28.1 7.7 2.2 75.2 0.0 2.6 7.0 19.1 9.8 8.5 20.3 1.0 0.4 1.4 2.8 26.3 5.2 20.8 0.6 14.2 6.5 4.0 162.4 16.0 3.0 11.0 12.6 NSMCE3 "HCA4, MAGEG1, MAGEL3, NDNL2, NSE3" ENSG00000185115 "NSE3 homolog, SMC5-SMC6 complex component" Q96MG7 15 29264989-29269822 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Ubl conjugation pathway" "Tumor antigen" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 83.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "OE19: 2.6" "Low region specificity" "Detected in single" NA NA "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (6.38e-2)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (1.97e-1)" "unprognostic (2.52e-2)" "unprognostic (2.47e-2)" "unprognostic (2.50e-2)" "unprognostic (4.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.56e-1)" "unprognostic (6.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.41e-2)" 3.8 5.2 0.4 0.1 0.5 0.0 3.6 0.5 0.7 2.9 0.0 3.7 0.1 5.0 0.1 2.5 4.1 0.1 4.0 0.6 0.2 2.7 4.1 3.4 0.2 0.2 0.1 0.3 4.7 2.9 0.2 6.0 0.1 0.4 2.8 0.2 0.4 3.1 0.2 4.0 2.4 4.3 0.1 0.0 5.4 3.4 6.3 0.3 0.2 4.1 0.0 0.1 3.8 2.6 0.4 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.5 0.7 0.6 0.2 0.2 0.1 0.3 0.4 0.0 0.3 0.4 29.6 16.0 9.5 0.0 68.0 0.0 28.1 0.0 29.0 39.7 15.0 21.7 0.0 10.0 0.6 9.2 10.4 22.9 80.2 2.3 15.6 22.5 23.9 15.6 26.1 19.6 13.3 9.0 0.0 16.3 14.0 20.9 11.2 14.0 5.1 22.3 21.0 15.4 20.8 43.7 0.0 4.4 0.0 17.1 0.0 72.8 23.3 34.8 0.0 0.0 20.3 41.5 39.1 0.0 0.0 12.1 4.5 31.6 77.7 19.1 4.6 26.9 2.9 41.2 26.3 30.9 28.0 83.8 31.7 12.9 0.0 11.8 80.6 36.6 4.8 18.5 HSF1 HSTF1 ENSG00000185122 "Heat shock transcription factor 1" Q00613 8 144291591-144314720 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 248.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004239, HPA008888" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004239: AB_627753, HPA008888: AB_1079088" "unprognostic (7.08e-2)" "unprognostic (1.89e-2)" "unprognostic (6.07e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (1.55e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.69e-3)" "unprognostic (1.05e-1)" "unprognostic (4.35e-2)" "unprognostic (1.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" 48.8 56.1 18.2 14.8 16.5 18.2 48.3 16.0 24.2 48.9 14.7 60.0 14.3 52.1 7.4 48.5 52.5 12.5 118.5 16.4 16.8 50.5 46.4 50.0 14.7 20.2 18.3 15.5 57.8 69.3 18.9 48.4 17.1 17.8 53.6 10.9 7.7 40.1 17.2 126.1 48.3 40.0 15.5 16.3 43.1 58.3 108.7 19.4 14.8 46.1 32.5 12.7 59.2 46.6 20.2 40.8 53.8 22.9 19.6 37.6 35.0 37.9 29.7 26.6 28.8 25.0 36.3 34.6 46.7 42.5 41.5 28.2 28.9 35.2 42.7 18.3 29.9 40.7 58.4 51.8 50.1 59.1 17.1 43.4 34.2 39.3 40.6 74.2 30.6 39.4 41.9 39.6 27.1 29.4 82.0 58.0 26.2 29.4 52.6 154.2 37.2 19.9 59.2 20.6 40.5 34.3 27.9 45.4 35.9 52.8 23.8 40.5 34.5 40.2 29.5 66.3 46.8 49.5 18.8 15.4 39.9 41.8 31.4 28.8 14.2 23.2 26.3 16.7 24.9 17.2 19.2 17.8 21.1 24.6 17.3 17.1 15.9 9.7 16.3 32.2 12.6 22.9 19.2 18.2 16.5 16.0 24.2 16.4 16.8 20.2 18.3 15.5 17.8 16.3 19.4 20.2 46.5 6.4 11.2 8.5 40.4 51.4 73.8 53.8 39.9 67.8 37.0 30.5 46.4 22.8 34.7 29.5 62.6 69.9 38.2 43.3 150.6 39.2 248.7 35.1 20.5 44.4 40.9 120.8 12.1 41.1 80.6 34.7 44.9 34.6 37.5 51.1 40.7 63.8 49.5 69.0 14.7 36.8 42.7 25.7 45.6 106.7 37.3 32.7 33.8 12.2 59.7 24.9 34.0 6.0 12.9 45.3 49.3 42.9 40.4 76.6 63.8 34.9 25.9 33.1 59.2 41.3 39.2 84.4 47.7 36.3 45.5 111.0 39.0 105.9 45.8 76.4 C6orf120 bA160E12.4 ENSG00000185127 "Chromosome 6 open reading frame 120" Q7Z4R8 6 169702190-169704856 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 116.9;Late spermatids: 272.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039626 Uncertain "Secreted to blood" NA NA 620000 "HPA039626: AB_10673361" "unprognostic (2.98e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (3.43e-2)" "unprognostic (1.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.30e-3)" "prognostic unfavorable (9.52e-5)" "unprognostic (1.78e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (1.63e-1)" "unprognostic (6.21e-3)" "unprognostic (2.88e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-3)" 21.8 16.8 10.8 14.7 10.4 7.8 15.4 10.7 11.6 13.2 9.5 15.6 16.4 11.3 9.4 13.5 10.4 13.2 9.7 10.9 10.2 19.4 28.3 10.7 16.5 10.1 11.1 10.0 15.8 14.3 12.1 6.1 20.1 9.5 12.1 14.6 26.6 13.8 12.1 13.9 9.0 16.0 13.6 10.3 13.8 15.0 8.8 11.6 12.5 10.5 13.3 15.7 15.4 6.8 11.4 13.9 10.9 26.2 40.1 71.4 59.3 29.6 28.5 40.9 23.3 27.2 14.9 12.7 11.8 22.4 35.0 38.7 20.8 17.2 26.1 38.9 20.0 41.6 16.8 10.5 31.4 50.6 28.2 25.7 73.2 21.0 27.8 32.0 40.8 28.6 26.7 45.0 32.8 40.6 25.1 15.3 19.3 22.4 24.3 12.7 11.1 14.4 32.0 28.9 15.3 10.6 24.0 23.7 14.9 19.6 29.7 24.9 36.7 31.8 9.8 19.2 52.3 19.6 42.2 69.3 16.7 32.5 25.7 26.3 6.2 7.9 7.1 3.2 7.6 4.3 3.2 4.7 5.6 6.3 4.9 6.2 5.2 4.2 3.1 6.0 2.1 3.4 3.9 10.8 10.4 10.7 11.6 10.9 10.2 10.1 11.1 10.0 9.5 10.3 11.6 11.4 11.3 16.0 5.3 7.2 14.1 9.8 12.6 9.9 12.0 15.3 12.5 9.4 8.8 5.7 10.3 14.7 25.0 27.5 13.2 20.2 9.8 10.6 116.9 9.7 18.5 9.7 14.3 18.3 9.5 15.8 31.6 19.5 16.3 10.8 9.5 11.3 8.9 18.9 16.6 8.4 12.9 12.7 14.2 16.9 6.5 272.5 17.7 13.6 19.6 1.9 15.2 28.6 10.3 11.1 10.3 10.9 10.3 11.7 18.8 13.1 22.4 12.7 12.4 24.6 0.0 10.3 10.8 15.4 12.3 12.6 10.2 29.0 10.9 9.2 12.9 14.7 PURA "PUR-ALPHA, PUR1, PURALPHA" ENSG00000185129 "Purine rich element binding protein A" Q00577 5 140107777-140125619 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Cell type enhanced" "Detected in all" "Horizontal cells: 220.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 260000 "unprognostic (2.69e-1)" "unprognostic (1.23e-1)" "unprognostic (2.36e-1)" "unprognostic (3.72e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (2.41e-1)" "unprognostic (2.33e-1)" "unprognostic (3.04e-1)" "unprognostic (9.28e-2)" "prognostic favorable (4.77e-5)" "unprognostic (2.75e-1)" "unprognostic (4.24e-1)" "unprognostic (8.98e-2)" "unprognostic (2.09e-1)" 7.7 9.1 34.4 8.2 18.0 2.5 5.2 12.9 20.7 8.6 0.0 6.4 10.1 6.9 5.6 5.7 5.6 5.7 8.5 15.9 14.7 12.3 8.7 6.8 6.0 26.5 22.9 6.9 10.2 7.3 13.6 4.8 8.2 30.8 9.6 4.4 12.7 9.8 8.1 9.7 7.4 9.0 5.6 25.9 9.9 9.5 5.3 26.6 5.9 11.8 8.3 5.7 6.0 4.8 23.3 15.1 9.2 3.7 21.5 9.3 13.4 20.1 32.5 13.4 15.0 11.7 19.2 15.5 15.8 25.2 12.7 10.0 13.4 8.9 18.6 12.7 25.7 28.0 11.8 13.1 6.7 5.8 9.6 19.0 6.2 8.9 14.1 8.5 9.7 4.3 11.3 11.1 16.4 7.7 18.6 15.3 12.1 4.7 5.0 23.3 15.4 14.6 11.3 9.4 11.9 11.7 12.1 16.5 19.1 18.7 3.6 17.2 9.2 15.2 26.8 19.5 9.5 23.4 26.0 13.5 16.8 12.7 10.5 22.7 6.4 1.8 3.4 2.8 1.2 2.1 3.0 3.1 3.2 1.6 3.7 2.7 3.4 0.9 5.2 1.5 2.5 2.9 1.0 34.4 18.0 12.9 20.7 15.9 14.7 26.5 22.9 6.9 30.8 25.9 26.6 23.3 82.2 51.3 43.3 28.4 43.5 34.3 48.5 15.0 54.1 162.0 58.5 62.2 76.2 62.9 21.7 77.3 125.1 47.2 53.6 48.8 13.7 22.2 25.4 46.2 66.4 71.2 62.9 27.8 45.3 25.4 44.4 57.5 49.5 40.8 25.4 35.9 77.4 62.1 26.4 220.4 46.0 47.9 12.2 32.3 26.2 10.0 76.4 29.2 37.4 34.7 27.0 95.1 49.4 27.2 43.4 26.4 33.9 102.0 43.5 61.7 57.6 48.9 22.5 106.7 72.3 99.8 76.7 38.6 38.7 39.7 45.5 43.4 49.9 52.7 44.0 48.8 H2BC13 "dJ97D16.4, H2B/c, H2BFC, HIST1H2BL" ENSG00000185130 "H2B clustered histone 13" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.2;brain: 2.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 2.1" "Immune cell enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 12.3;U-266/84: 12.5" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 0.0 0.2 0.4 0.0 0.2 6.2 0.1 2.1 1.1 0.2 0.1 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.2 0.3 0.1 0.1 0.2 0.5 0.0 0.1 0.4 0.3 0.3 0.3 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.4 0.2 0.2 0.4 1.3 0.3 0.0 0.4 0.1 0.2 0.3 2.2 2.0 0.6 2.1 0.0 0.0 0.1 1.3 0.3 1.1 2.8 0.9 1.5 0.8 0.5 0.2 0.6 1.4 0.0 0.2 0.4 1.0 2.9 1.6 2.7 3.5 0.0 2.6 2.1 0.9 0.0 0.0 0.0 0.2 0.6 1.8 2.1 5.2 0.0 5.6 12.3 4.5 1.9 1.5 3.0 2.8 0.0 1.3 0.0 2.0 2.7 1.0 3.5 1.4 0.2 0.2 1.2 0.9 0.5 0.1 1.4 1.1 0.9 2.9 12.5 3.9 0.3 4.7 0.5 0.5 0.3 2.3 0.5 0.1 0.7 1.0 0.3 0.6 0.7 0.6 0.2 0.3 4.1 0.2 0.3 0.4 1.1 0.5 0.4 0.2 2.1 1.1 0.2 0.3 0.0 0.1 0.4 0.5 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134697 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 124.2;thyroid gland: 205.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 35.0;Distal enterocytes: 24.0;Inhibitory neurons: 19.5;Muller glia cells: 25.2;Proximal enterocytes: 62.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 19.6;SK-BR-3: 41.1;T-47d: 25.7;U-698: 18.1" "Region enhanced" "Detected in all" "olfactory bulb: 131.0" "Low region specificity" "Detected in all" HPA034539 Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favorable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favorable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 2.1 2.9 0.8 4.5 0.1 9.0 15.7 12.8 3.1 1.6 7.7 16.4 3.1 0.6 2.4 2.4 1.2 22.5 11.2 13.0 32.2 0.4 2.3 0.5 5.1 5.0 3.3 1.2 15.8 124.2 10.1 0.1 7.4 9.3 3.7 5.4 33.4 12.2 2.9 4.1 26.4 1.5 1.0 0.3 13.7 4.4 9.4 0.2 205.8 2.6 0.4 2.7 2.4 5.5 2.1 2.0 1.2 2.3 0.3 0.2 1.1 0.8 0.8 4.1 4.0 1.2 1.3 0.1 1.0 0.4 0.4 2.4 2.5 1.2 1.7 0.0 6.5 0.0 9.7 0.4 0.8 19.6 0.2 0.2 1.3 3.4 0.4 2.7 0.3 0.1 1.8 2.8 0.1 6.4 0.1 0.1 2.3 2.8 0.4 0.0 0.4 4.5 1.7 2.5 9.9 7.5 1.6 41.1 0.5 1.1 25.7 1.6 0.0 0.2 7.3 0.8 0.5 0.1 3.5 18.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 4.5 15.7 12.8 11.2 13.0 5.1 5.0 3.3 7.4 1.0 9.4 5.5 0.7 0.0 4.1 3.3 0.0 0.9 2.3 0.3 1.2 9.5 15.8 7.5 6.1 0.0 1.1 35.0 0.0 0.0 0.2 24.0 11.7 1.4 0.4 1.9 0.4 0.5 0.0 0.0 5.5 2.2 0.2 0.6 4.6 2.7 0.0 0.8 0.0 0.0 0.1 5.0 19.5 6.4 0.0 0.0 1.9 0.6 0.0 0.3 0.0 1.0 0.6 25.2 0.0 2.0 1.0 0.8 12.3 0.0 0.1 2.5 62.3 0.5 0.5 3.1 0.0 0.5 1.3 2.4 1.2 1.1 1.3 0.1 0.4 0.4 8.8 1.6 NPY2R ENSG00000185149 "Neuropeptide Y receptor Y2" P49146 4 155208636-155217078 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 4.7;breast: 1.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.8;Excitatory neurons: 6.7;Leydig cells: 21.1;Oligodendrocytes: 13.7" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;ASC diff: 2.1;HSkMC: 1.0;SH-SY5Y: 7.5" "Group enriched" "Detected in many" 5 "amygdala: 12.9;basal ganglia: 12.3;hippocampal formation: 46.7;hypothalamus: 23.7" "Region enriched" "Detected in many" 6 "hippocampal formation: 14.2" NA NA "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (7.08e-2)" "unprognostic (5.50e-2)" "unprognostic (9.35e-2)" 0.1 0.2 2.0 0.2 1.3 0.0 1.6 0.3 2.5 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 2.5 0.0 0.0 0.0 0.0 1.6 0.6 1.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.5 0.2 0.7 0.0 0.0 0.1 0.3 0.0 0.6 0.1 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.1 0.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.3 0.3 2.5 4.7 2.5 1.6 0.6 1.1 1.0 0.6 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MIXL1 "MILD1, MIXL" ENSG00000185155 "Mix paired-like homeobox" Q9H2W2 1 226223618-226227060 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.4" "Cell type enriched" "Detected in some" 5 "Plasma cells: 18.5" "Cancer enriched" "Detected in some" 9 "testis cancer: 6.3" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA005662 Approved Nucleoplasm NA NA Nucleoplasm "HPA005662: AB_2667382" "unprognostic (4.09e-2)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.03e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (5.05e-2)" "unprognostic (7.40e-3)" "unprognostic (2.78e-2)" "unprognostic (2.70e-1)" "unprognostic (2.71e-13)" "unprognostic (1.54e-1)" "unprognostic (1.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.47e-2)" 0.0 0.1 0.2 1.0 0.2 0.2 0.2 1.1 0.3 0.1 0.2 0.7 1.3 0.2 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.2 2.4 0.2 0.2 0.2 0.2 0.1 0.6 0.0 0.2 0.5 0.1 0.6 0.1 0.2 0.2 0.1 0.2 0.7 0.1 0.1 1.0 0.8 0.4 0.2 0.2 0.1 0.0 3.4 0.6 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.7 0.0 0.1 0.0 0.1 0.1 0.2 9.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 49.7 6.5 13.0 6.4 10.0 12.6 11.3 7.3 7.3 7.2 10.4 9.6 9.7 18.2 19.6 19.5 11.0 10.3 6.2 0.2 0.2 1.1 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.1 0.2 0.6 0.6 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.3 0.2 0.1 1.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.5 0.1 0.1 0.1 0.0 0.5 0.0 0.3 0.1 0.1 1.5 0.0 0.0 0.3 0.1 0.1 0.0 0.1 MFSD6L FLJ35773 ENSG00000185156 "Major facilitator superfamily domain containing 6 like" Q8IWD5 17 8797110-8799365 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 9.4;testis: 25.7" "Cell type enhanced" "Detected in some" "Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 8.3" "Not detected" "Not detected" HPA023164 Uncertain NA NA "HPA023164: AB_2142777" "prognostic favorable (1.84e-4)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (3.64e-2)" "unprognostic (1.07e-4)" "unprognostic (3.31e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (7.26e-2)" "unprognostic (3.98e-3)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (7.68e-3)" "unprognostic (1.25e-1)" 0.0 0.0 0.1 0.4 0.2 0.0 0.5 0.0 0.1 1.8 0.1 2.7 2.4 0.1 1.3 0.6 2.0 0.8 0.1 0.1 0.2 1.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 9.4 4.2 4.9 0.4 0.1 0.4 3.1 0.0 6.8 2.1 0.0 0.3 1.5 0.0 0.2 0.2 4.0 25.7 0.2 0.2 3.4 0.0 0.2 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.7 0.8 0.2 4.3 1.1 1.8 0.0 2.9 0.0 1.7 0.0 7.2 125.7 1.2 0.1 0.1 1.2 0.0 0.0 7.6 0.3 0.0 3.6 2.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.9 28.5 0.6 0.0 46.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.7 1.2 0.1 0.8 0.2 0.0 0.8 0.0 0.0 0.0 0.2 45.0 0.3 0.6 0.0 1.5 0.0 0.0 4.5 1.0 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 25.4" "Cell type enhanced" "Detected in many" "Early spermatids: 101.9;Excitatory neurons: 45.4;Spermatocytes: 66.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 3.8" "Group enriched" "Detected in many" 4 "granulocytes: 1.5;NK-cells: 3.8;T-cells: 2.6" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.4 3.7 8.7 3.7 7.9 25.4 5.2 14.5 10.3 6.7 2.0 4.5 3.4 6.3 4.7 4.2 6.8 3.6 2.5 9.3 4.7 3.6 2.1 5.7 4.7 7.6 5.4 7.1 9.1 3.3 5.7 8.3 3.5 8.4 4.8 4.7 7.0 4.8 2.9 3.6 10.6 5.1 5.3 3.6 6.2 5.0 18.0 5.7 11.0 4.1 1.4 4.5 4.7 5.9 8.3 2.7 5.0 15.6 8.9 3.9 4.7 4.8 2.4 9.0 6.9 8.7 6.8 2.6 7.1 5.0 5.5 8.5 3.6 9.3 1.9 5.4 2.2 7.6 3.4 8.1 2.6 5.8 13.3 5.8 5.1 5.9 6.3 15.9 6.6 5.9 12.1 8.2 6.8 2.6 2.5 23.4 20.5 4.8 2.5 3.3 16.2 3.7 5.9 3.9 6.6 2.9 5.0 6.1 3.8 8.8 5.2 10.4 20.9 5.0 4.8 3.2 10.8 6.1 6.8 10.4 7.5 3.4 13.2 3.4 0.0 0.2 1.5 0.5 0.2 1.0 0.1 1.0 1.4 0.4 0.4 1.4 0.4 0.5 3.8 0.1 0.6 2.6 0.3 8.7 7.9 14.5 10.3 9.3 4.7 7.6 5.4 7.1 8.4 3.6 5.7 8.3 7.4 6.4 9.1 39.2 5.1 4.1 6.9 3.8 2.8 10.0 7.3 5.6 4.7 7.2 7.1 1.8 0.0 2.3 10.0 2.9 9.8 8.9 101.9 7.9 6.3 6.0 1.8 7.4 45.4 10.5 2.3 6.0 1.5 4.7 3.8 7.0 8.2 2.9 9.7 3.3 33.4 5.7 4.1 8.7 6.9 22.9 6.8 7.9 8.8 14.0 9.3 14.5 20.6 39.7 28.3 9.2 1.8 7.2 3.8 9.1 6.8 8.3 7.8 9.7 0.0 8.9 7.8 66.7 13.0 1.6 5.1 2.2 9.0 4.6 4.8 7.7 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144319 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 7.9 7.1 4.5 1.9 4.8 4.3 8.6 4.6 6.0 9.7 3.4 8.0 1.6 8.6 2.4 7.3 10.6 1.0 6.5 4.9 4.3 7.6 7.0 6.8 2.5 4.7 4.6 4.8 13.1 11.3 1.9 8.7 1.3 4.9 8.8 1.4 2.7 7.0 2.4 9.7 12.1 8.1 1.8 4.0 9.7 8.2 6.7 4.3 2.3 8.5 1.5 1.9 9.3 8.0 5.3 4.1 6.5 2.7 3.4 2.5 2.4 5.0 3.1 1.8 4.5 1.9 4.0 2.0 7.2 2.6 1.9 1.0 4.2 6.7 5.0 2.2 1.7 6.5 8.5 3.8 1.3 3.0 6.0 4.7 2.1 3.6 2.5 2.3 5.0 2.4 7.8 6.4 2.3 1.3 4.1 7.4 12.2 4.7 3.4 11.0 8.6 3.6 7.9 3.1 3.2 6.5 3.4 3.4 4.8 3.5 2.2 4.2 5.5 4.2 1.7 5.1 4.1 7.2 6.4 4.0 8.2 3.5 4.5 4.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.1 4.5 4.8 4.6 6.0 4.9 4.3 4.7 4.6 4.8 4.9 4.0 4.3 5.3 9.5 3.2 17.3 5.2 8.4 12.5 10.1 2.9 7.4 28.5 9.9 10.4 4.5 10.0 9.0 3.7 25.0 6.7 12.9 7.6 1.9 4.1 1.0 6.4 9.2 8.6 8.4 5.0 22.1 5.3 6.4 9.5 9.7 8.8 6.3 18.2 6.8 7.3 5.6 33.7 17.1 11.1 0.0 6.3 8.0 1.1 8.4 6.4 10.6 11.2 4.6 11.7 11.3 8.0 9.0 6.0 8.0 8.2 8.4 11.3 3.3 3.4 4.4 28.0 0.0 17.7 9.1 7.0 11.1 6.3 14.1 4.1 11.1 17.2 12.8 6.8 NOMO2 "NOMO, PM5" ENSG00000185164 "NODAL modulator 2" Q5JPE7 16 18417325-18562211 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 302.9" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046697, HPA061174" Approved NA NA "HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (2.58e-3)" "unprognostic (4.11e-3)" "unprognostic (2.58e-2)" "unprognostic (9.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.85e-2)" "unprognostic (4.80e-2)" "unprognostic (9.37e-2)" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (1.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.78e-3)" "unprognostic (2.22e-1)" "unprognostic (3.42e-2)" "unprognostic (8.39e-2)" "unprognostic (1.54e-2)" 55.2 66.7 111.1 27.9 130.6 31.3 55.1 108.4 142.5 53.4 106.8 65.7 35.1 60.3 54.0 57.7 48.6 22.6 176.3 129.9 123.8 77.0 97.4 74.4 24.1 112.3 110.2 117.1 48.8 302.9 77.4 105.1 49.5 122.1 60.0 36.0 42.7 63.8 32.0 127.2 60.3 57.2 41.9 102.3 62.3 89.2 50.8 113.8 23.3 56.4 52.7 29.8 61.8 50.9 129.5 71.1 101.3 37.5 104.5 141.0 85.9 110.3 122.1 144.6 101.5 125.4 87.7 108.6 83.0 433.3 213.4 71.0 80.5 81.2 84.8 88.1 67.7 64.5 37.0 98.2 313.5 195.5 88.7 252.1 91.2 112.6 117.2 106.8 107.9 113.1 70.3 52.3 185.4 120.6 213.9 33.2 197.2 72.9 107.0 42.3 71.1 50.8 230.1 150.9 63.6 52.6 44.2 94.4 128.5 82.4 75.2 99.6 185.8 106.1 60.7 47.0 127.4 86.8 95.6 112.0 44.6 135.3 92.9 85.1 21.8 12.6 11.8 14.3 11.9 11.6 10.8 14.0 14.5 14.1 9.8 9.3 11.8 13.8 8.3 15.4 22.8 22.4 17.5 111.1 130.6 108.4 142.5 129.9 123.8 112.3 110.2 117.1 122.1 102.3 113.8 129.5 0.5 6.4 2.8 2.0 3.8 0.4 0.4 0.6 2.8 0.9 0.5 0.3 124.4 0.0 1.4 0.0 4.2 0.4 1.3 0.4 1.9 0.2 0.2 0.3 0.8 3.2 0.0 2.5 6.4 0.7 0.3 9.1 4.1 0.6 0.0 0.7 0.7 0.8 0.1 0.0 5.1 0.2 0.0 0.8 0.2 0.4 0.0 1.2 0.0 5.6 0.2 0.3 2.1 8.5 7.6 0.4 0.1 0.4 22.7 0.4 0.6 0.1 1.9 0.6 6.6 0.6 4.8 1.2 1.3 3.3 0.6 0.4 3.2 1.1 0.4 0.1 AQP12B INSSA3 ENSG00000185176 "Aquaporin 12B" A6NM10 2 240676418-240682906 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 336 "pancreas: 210.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042216 Supported NA NA "HPA042216: AB_2677905" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 210.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ZNF479 KR19 ENSG00000185177 "Zinc finger protein 479" Q96JC4 7 57119614-57139864 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "testis: 2.2" "Group enriched" "Detected in some" 9 "Early spermatids: 85.7;Late spermatids: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 33.4 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.7 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 401.9;Proximal tubular cells: 627.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 136.0;MCF7: 74.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favorable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favorable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favorable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favorable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favorable (1.54e-5)" 19.3 6.9 40.6 32.7 38.5 33.5 22.5 38.3 59.2 21.2 36.0 32.8 29.2 20.7 19.3 19.3 30.1 20.1 30.1 37.1 38.6 68.3 88.4 34.2 46.2 43.5 38.6 35.4 13.0 48.0 16.4 15.9 9.6 43.0 33.1 13.9 5.7 33.7 17.5 6.7 9.6 46.8 10.4 39.7 68.8 42.4 7.9 41.1 18.6 31.3 10.1 18.1 23.3 18.1 44.9 22.2 59.6 3.7 20.7 3.2 16.9 42.7 3.3 5.1 10.0 8.8 27.7 136.0 6.2 16.2 19.1 1.1 31.4 9.7 11.2 1.6 19.0 35.9 12.7 11.8 0.7 10.6 11.0 20.4 9.2 2.3 1.6 1.3 5.6 29.0 24.0 12.7 0.4 2.8 74.4 31.4 35.6 21.3 44.9 32.6 38.3 0.0 21.6 7.1 14.8 35.9 17.6 0.4 20.1 26.4 9.0 25.4 8.6 34.4 3.0 3.9 5.0 0.0 7.4 13.5 16.2 13.3 24.0 11.6 77.8 42.3 39.0 123.6 48.4 98.7 37.6 101.8 108.3 43.0 28.7 91.7 90.1 22.0 102.4 61.8 16.3 106.1 82.6 40.6 38.5 38.3 59.2 37.1 38.6 43.5 38.6 35.4 43.0 39.7 41.1 44.9 83.1 28.9 34.4 16.6 46.5 16.3 34.1 33.2 43.9 8.6 44.3 40.0 21.3 72.9 35.0 55.2 12.5 17.7 105.6 163.9 62.6 54.1 1.0 47.9 15.0 62.7 78.9 14.7 2.6 73.3 11.4 37.0 80.0 40.7 40.6 15.4 79.6 401.9 51.2 26.9 2.5 106.1 63.1 52.7 31.9 5.1 31.4 61.7 85.4 4.7 46.9 109.2 218.3 1.5 10.4 79.6 153.7 29.7 37.9 24.6 105.3 627.4 75.8 19.2 26.3 21.2 34.7 6.0 69.8 21.1 12.8 10.1 117.3 10.2 93.6 43.6 NRBP2 DKFZp434P086 ENSG00000185189 "Nuclear receptor binding protein 2" Q9NSY0 8 143833583-143840973 "Enzymes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 134.2;Oligodendrocytes: 120.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020944, HPA029051, HPA029052" Approved Approved Cytosol NA NA Cytosol "CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714" "unprognostic (1.84e-1)" "unprognostic (4.66e-2)" "unprognostic (2.54e-2)" "unprognostic (1.53e-3)" "unprognostic (1.01e-1)" "unprognostic (2.00e-2)" "unprognostic (4.03e-1)" "unprognostic (2.86e-1)" "unprognostic (3.97e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (2.01e-5)" "unprognostic (3.86e-2)" "unprognostic (3.98e-1)" "unprognostic (4.56e-2)" "unprognostic (2.04e-1)" 18.9 9.7 21.1 6.5 32.3 1.6 18.5 35.4 29.0 14.2 11.1 22.2 7.7 17.4 7.5 9.6 17.7 10.4 15.2 23.3 33.5 17.8 32.5 16.7 4.6 50.4 35.0 17.3 13.5 10.7 9.0 14.6 5.8 43.1 19.7 5.7 7.5 19.9 12.7 7.0 17.8 11.1 11.8 34.8 7.2 14.1 7.0 30.3 3.9 16.0 7.2 3.4 14.4 14.1 50.6 10.2 12.9 11.4 14.0 16.5 25.6 2.6 18.7 9.0 7.2 10.3 3.1 8.8 1.1 5.3 24.1 5.2 15.5 7.0 6.6 3.2 12.4 4.7 2.0 36.0 5.3 18.1 0.0 4.1 30.3 15.5 3.1 3.5 22.4 10.5 3.4 6.7 12.7 15.2 3.5 0.8 0.4 3.7 10.1 5.5 3.4 10.0 4.5 8.9 3.1 3.9 7.2 25.3 13.3 10.1 5.9 18.7 0.8 22.5 4.6 12.5 20.4 6.8 6.3 0.5 0.3 22.8 4.1 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 32.3 35.4 29.0 23.3 33.5 50.4 35.0 17.3 43.1 34.8 30.3 50.6 15.1 44.8 13.7 134.2 2.0 9.2 6.2 5.2 5.7 15.4 16.3 23.2 9.9 41.5 10.4 11.0 14.6 0.9 3.2 9.2 0.0 4.3 0.5 8.1 15.2 10.4 9.0 0.0 41.8 4.0 1.0 11.2 15.3 14.1 0.0 8.5 7.5 41.7 2.8 16.8 32.7 8.4 16.2 5.7 4.6 1.2 28.9 4.5 10.6 22.5 3.9 17.7 3.1 30.2 120.7 5.4 3.6 21.4 2.3 7.1 3.9 4.4 7.0 11.4 13.1 14.2 18.3 1.2 3.3 4.7 9.1 0.8 4.4 7.2 6.2 5.0 PRSS57 "PRSSL1, UNQ782" ENSG00000185198 "Serine protease 57" Q6UWY2 19 685546-695498 "Enzymes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "bone marrow: 166.6" "Cell type enriched" "Detected in some" 9 "Erythroid cells: 77.8" "Cancer enriched" "Detected in single" 10 "pancreatic cancer: 2.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "NB-4: 377.2;THP-1: 184.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.89e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (3.99e-4)" "unprognostic (3.07e-1)" "unprognostic (1.33e-2)" "unprognostic (3.50e-2)" "unprognostic (4.04e-2)" "unprognostic (7.70e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (8.16e-2)" "unprognostic (2.56e-2)" 0.1 0.0 0.0 0.0 0.0 166.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 7.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 377.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.4 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 3.2 0.0 5.9 1.1 0.0 0.4 0.2 0.0 0.0 0.0 3.1 1.5 0.0 0.0 0.5 0.7 2.5 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 77.8 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 2.5 1.0 8.2 0.0 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 IFITM2 "1-8D, DSPA2c" ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 303655-309397 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 920.0;NK-cells: 1350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 23410.9" "Lineage enriched" "Detected in all" 11 "granulocytes: 23410.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2" "HPA004337, HPA044731" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA 450000 "Cell Junctions" Nucleoplasm "HPA004337: AB_1851427, HPA044731: " "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 865.7 309.5 79.5 260.3 80.3 178.6 686.8 78.3 117.5 686.4 96.4 323.6 41.2 708.7 52.5 239.2 911.6 98.3 622.7 79.7 84.4 659.9 1299.1 1079.2 100.7 82.6 77.6 72.9 655.6 212.9 112.8 202.2 146.5 85.3 409.6 42.2 27.2 230.8 103.5 197.5 229.3 308.2 202.2 80.4 1413.4 306.9 123.9 84.6 30.1 441.3 134.0 106.7 497.3 500.8 93.2 32.2 65.4 313.1 2.9 137.2 358.3 0.9 106.8 65.1 27.0 63.3 1.7 206.9 2.7 126.6 424.6 0.4 68.5 1.1 9.3 9.0 1.8 41.1 75.1 102.6 117.6 547.7 124.1 494.9 710.9 2.3 5.2 3.3 64.4 51.2 22.5 5.2 210.5 11.6 129.9 2.5 603.3 36.4 5.3 229.4 101.0 29.9 1.1 181.6 0.4 0.8 7.0 65.4 74.9 34.5 5.3 86.7 69.8 338.3 5.7 26.8 36.1 1.4 4.5 5.0 3.3 14.5 485.2 18.1 2706.4 537.4 3789.5 666.6 1421.9 480.8 846.9 590.1 639.5 612.5 799.2 511.7 510.3 23410.9 1225.0 2199.0 279.0 411.7 1376.6 79.5 80.3 78.3 117.5 79.7 84.4 82.6 77.6 72.9 85.3 80.4 84.6 93.2 920.0 307.7 540.0 5.9 301.1 104.4 251.1 161.4 215.1 0.3 59.7 66.5 51.8 154.4 209.2 248.3 0.0 8.3 814.7 22.5 487.2 433.0 7.8 67.1 468.6 828.4 9.6 100.7 0.0 256.7 16.9 515.8 30.5 78.5 530.5 68.8 752.1 684.1 223.4 0.0 0.0 39.4 24.4 372.8 255.9 31.5 507.6 645.9 209.9 12.2 177.3 80.5 1350.1 0.0 0.1 161.9 149.2 223.8 123.0 126.3 4.7 45.3 104.8 1.5 315.5 442.5 568.4 8.4 10.4 22.8 83.0 23.4 667.2 61.8 44.3 102.4 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103121476-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 280.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 48.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 785.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 119.5 77.5 8.1 104.6 13.4 107.8 79.1 5.8 13.4 51.6 13.4 39.7 38.3 51.4 6.7 89.0 57.6 103.2 46.3 7.0 18.0 67.8 62.1 143.6 88.1 16.7 8.8 5.9 17.0 33.9 67.3 16.8 48.8 27.1 74.2 27.1 1.7 84.8 15.1 35.3 47.4 53.0 25.0 10.7 149.2 37.7 37.4 17.8 39.8 37.1 32.8 80.9 280.1 75.3 14.3 34.7 156.3 1.1 0.6 10.1 45.9 54.5 9.7 43.2 26.4 8.9 1.6 148.7 0.3 120.3 48.5 142.5 104.2 11.6 0.0 11.9 6.1 0.6 15.4 120.0 0.7 19.2 7.7 20.0 17.8 1.6 8.4 0.1 10.5 14.2 7.7 15.5 35.3 3.6 3.4 0.4 11.6 9.7 19.6 13.4 6.8 18.9 24.9 80.8 785.1 1.3 2.3 150.2 52.4 1.9 5.6 83.8 50.4 28.4 5.1 13.5 30.3 31.5 31.4 2.4 0.9 38.1 34.0 16.1 5.9 16.8 9.0 0.1 18.6 0.1 0.1 0.1 0.0 9.4 0.2 0.1 0.1 48.4 0.2 15.0 0.5 0.0 4.5 8.1 13.4 5.8 13.4 7.0 18.0 16.7 8.8 5.9 27.1 10.7 17.8 14.3 45.8 0.0 25.1 2.3 8.2 28.3 41.8 295.5 6.8 1.1 24.2 11.4 14.1 51.5 126.1 27.6 0.0 1.2 1.3 1.0 0.0 160.9 36.8 92.4 122.2 47.1 17.3 1.7 2.5 44.7 61.2 123.3 5.6 172.8 33.7 4.5 18.9 8.0 54.1 0.0 5.7 0.3 85.5 151.2 198.7 48.8 8.4 163.3 30.2 25.3 351.9 5.9 5.2 1.0 0.9 122.1 18.3 2.2 11.7 186.0 0.7 14.4 121.5 0.7 19.7 104.9 39.7 2.1 4.6 20.7 33.4 4.8 8.3 1.1 1.9 138.6 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431705-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 3.9 3.0 2.3 1.9 2.4 1.3 4.0 4.1 2.4 5.9 1.1 4.2 1.4 5.2 2.0 2.7 5.1 1.6 3.6 2.4 2.1 3.0 4.9 4.1 2.0 2.2 2.2 2.1 7.1 4.4 2.8 5.0 2.0 2.7 4.5 1.8 4.3 3.6 2.1 4.5 3.5 3.5 2.2 1.7 3.9 3.9 3.1 2.2 3.3 3.9 2.7 2.1 4.1 4.5 2.9 1.9 2.1 6.4 5.1 3.5 3.6 2.9 2.5 2.1 3.7 3.7 3.2 1.6 3.3 1.5 2.6 2.3 1.5 4.4 1.7 4.5 3.6 1.6 6.1 4.7 3.2 2.2 7.8 4.9 2.5 2.1 4.2 2.6 3.1 2.6 4.6 4.8 2.4 3.0 1.2 7.5 5.2 4.4 1.2 1.9 3.3 4.0 1.6 2.0 3.8 3.2 3.9 3.9 2.0 1.0 4.7 3.7 3.4 3.2 5.2 4.6 3.2 3.2 1.9 1.5 2.7 1.9 3.8 3.2 1.0 0.3 0.6 0.3 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.3 0.2 1.0 0.5 0.8 0.3 0.1 0.1 2.3 2.4 4.1 2.4 2.4 2.1 2.2 2.2 2.1 2.7 1.7 2.2 2.9 11.7 12.8 17.4 19.2 8.4 4.1 4.4 2.9 9.6 36.0 4.8 4.4 11.1 5.7 7.6 11.0 37.5 4.1 15.7 3.8 1.9 5.8 2.5 6.3 14.1 9.7 7.2 10.3 21.7 8.4 1.7 9.0 7.1 6.8 11.4 26.6 13.2 10.1 5.7 28.6 24.3 6.3 2.0 16.4 4.7 2.2 9.3 10.5 0.0 9.4 11.6 10.1 22.6 11.6 19.5 4.9 6.0 9.8 9.5 5.6 4.3 2.8 9.6 28.4 13.1 14.5 10.6 6.7 6.9 5.6 2.6 1.4 9.8 9.3 7.2 3.8 PGBD2 ENSG00000185220 "PiggyBac transposable element derived 2" Q6P3X8 1 248906196-248919946 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA029888, HPA029889, HPA029890" Uncertain Approved Vesicles NA NA Vesicles "HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002" "unprognostic (1.06e-2)" "unprognostic (8.05e-2)" "unprognostic (2.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.08e-4)" "unprognostic (1.94e-2)" "unprognostic (2.11e-2)" "unprognostic (2.71e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.41e-1)" "unprognostic (7.91e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.05e-4)" 2.9 3.6 3.5 5.4 3.6 4.4 5.8 5.3 4.2 4.8 2.4 4.2 5.9 4.8 5.2 6.1 3.9 4.8 2.4 2.9 2.6 3.7 7.3 3.6 7.5 3.4 3.1 2.8 5.6 6.8 3.3 2.7 5.9 3.8 5.1 6.2 4.4 5.5 3.4 1.4 8.2 7.2 3.7 2.2 9.4 5.2 6.1 3.8 5.7 6.6 2.4 7.2 4.4 4.7 6.3 4.4 5.7 8.5 5.2 7.7 5.0 10.7 4.1 3.4 6.9 6.3 4.2 5.6 11.2 5.0 3.9 3.8 6.9 4.7 5.2 7.6 6.7 2.1 10.7 10.0 6.4 4.4 5.9 10.3 4.5 5.5 8.2 4.5 5.5 3.9 3.8 17.5 9.5 5.0 7.3 2.0 6.5 8.4 14.6 6.6 13.1 2.8 3.5 4.0 5.5 3.0 5.6 6.0 8.5 7.0 5.9 3.6 11.2 5.0 4.7 4.5 4.3 4.6 8.8 9.2 4.1 5.0 12.7 4.4 11.0 6.0 9.4 6.1 4.4 6.1 8.3 5.5 5.9 5.5 8.4 5.5 6.8 4.6 5.9 6.8 2.7 4.1 4.1 3.5 3.6 5.3 4.2 2.9 2.6 3.4 3.1 2.8 3.8 2.2 3.8 6.3 5.3 0.0 8.9 2.6 11.2 5.2 2.9 7.6 14.8 3.6 7.3 5.6 2.2 2.8 9.1 5.5 2.1 11.5 7.9 6.9 1.9 5.1 3.5 6.0 4.9 5.9 1.2 17.9 2.3 3.0 4.4 3.5 6.1 6.9 2.5 7.8 3.3 3.4 2.9 1.7 2.7 4.3 6.1 3.3 4.4 2.7 3.1 3.7 7.2 2.8 4.6 3.2 6.2 6.0 4.3 2.2 6.0 1.9 5.7 2.8 9.0 3.0 4.6 2.7 0.0 4.0 5.6 14.5 10.2 7.9 6.5 27.8 7.8 4.8 5.1 2.1 TCEAL9 "DKFZp313K1940, WBP5, WEX6" ENSG00000185222 "Transcription elongation factor A like 9" Q9UHQ7 X 103356489-103358462 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1165.9;Distal tubular cells: 360.0;Extravillous trophoblasts: 456.2;Syncytiotrophoblasts: 780.1;Theca cells: 323.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 23.6" "Lineage enriched" "Detected in all" 6 "dendritic cells: 23.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011790 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA011790: AB_2214932" "unprognostic (1.26e-1)" "unprognostic (9.24e-2)" "unprognostic (3.35e-2)" "unprognostic (1.67e-3)" "unprognostic (5.52e-2)" "unprognostic (1.00e-3)" "unprognostic (1.31e-3)" "unprognostic (5.85e-2)" "unprognostic (7.64e-2)" "unprognostic (7.50e-3)" "unprognostic (1.59e-2)" "unprognostic (4.32e-2)" "unprognostic (1.10e-3)" "unprognostic (4.33e-3)" "unprognostic (1.26e-1)" "unprognostic (3.28e-2)" "unprognostic (2.58e-2)" 74.8 180.1 70.8 50.3 68.4 13.9 72.3 73.7 96.6 83.6 88.9 68.2 25.1 102.5 186.6 51.6 72.2 82.7 68.4 72.4 75.6 97.0 34.9 82.0 23.6 72.2 69.9 64.6 274.8 46.9 107.9 83.5 221.2 72.2 86.7 56.5 45.8 45.9 106.4 14.5 35.2 38.6 98.4 71.9 55.9 76.9 73.0 70.9 36.3 121.1 31.8 25.8 116.9 61.3 87.7 130.5 64.1 195.0 100.8 412.6 397.8 146.6 267.7 355.5 185.7 300.7 122.0 135.2 0.5 387.2 219.4 342.5 77.2 33.8 169.8 247.8 0.6 73.6 133.2 156.0 79.6 282.8 0.2 0.3 275.6 162.1 248.5 245.0 323.5 312.7 55.2 119.9 9.7 445.4 0.2 66.2 0.8 121.8 0.1 120.4 0.3 389.7 0.7 227.4 239.7 88.3 106.2 168.8 5.4 188.5 209.0 27.0 7.3 258.1 165.0 71.9 502.2 75.9 0.1 7.8 1.1 400.9 0.2 134.4 1.2 1.6 0.0 0.3 1.0 0.0 2.4 1.9 0.7 1.3 1.6 4.0 3.5 0.0 1.6 0.1 23.6 1.2 1.4 70.8 68.4 73.7 96.6 72.4 75.6 72.2 69.9 64.6 72.2 71.9 70.9 87.7 121.4 173.1 70.4 0.0 3.8 0.0 0.0 0.0 0.0 0.0 81.5 125.3 0.0 0.0 47.0 233.6 0.0 1165.9 2.1 0.0 360.0 250.1 0.0 100.6 149.7 85.3 0.0 0.0 0.0 139.8 456.2 130.2 0.0 115.6 11.4 268.5 0.0 0.0 141.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 3.6 0.0 0.0 0.0 0.0 120.8 0.0 0.0 0.9 0.0 0.0 298.6 10.2 0.0 0.0 0.0 74.1 0.0 0.0 0.0 0.0 780.1 4.9 323.7 0.0 0.0 MC2R ACTHR ENSG00000185231 "Melanocortin 2 receptor" Q01718 18 13882044-13915707 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "adrenal gland: 58.4" "Cell type enhanced" "Detected in single" "Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079148 Enhanced NA NA "HPA079148: " "unprognostic (2.09e-1)" "unprognostic (3.63e-2)" "unprognostic (1.85e-2)" 0.0 58.4 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RAB11B H-YPT3 ENSG00000185236 "RAB11B, member RAS oncogene family" Q15907 19 8389981-8404434 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 334.5" "Low region specificity" "Detected in all" HPA054396 Approved "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA054396: AB_2682474" "unprognostic (5.81e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.13e-2)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (4.78e-2)" "prognostic favorable (7.58e-5)" "unprognostic (1.23e-1)" "prognostic favorable (2.06e-4)" "unprognostic (3.66e-1)" "unprognostic (3.87e-1)" "unprognostic (8.85e-2)" "unprognostic (3.29e-3)" 102.8 97.5 81.3 59.8 92.7 69.3 114.7 100.8 132.5 104.9 49.5 99.4 77.2 102.1 23.2 96.0 98.1 51.7 165.1 75.2 82.4 130.3 134.9 99.1 59.3 113.8 105.2 65.9 108.5 130.8 49.4 116.6 54.4 117.2 112.6 23.6 38.5 105.2 49.7 120.6 102.0 98.0 28.1 95.1 119.6 119.0 65.0 101.7 44.5 211.7 37.0 28.4 100.3 95.0 110.7 93.1 115.3 83.1 75.9 43.7 39.9 64.8 54.6 36.8 39.5 42.0 79.4 74.3 54.1 147.7 47.3 53.1 70.8 29.4 78.7 13.1 109.3 142.4 57.5 97.8 98.0 42.4 67.6 102.6 59.5 49.1 44.6 29.6 51.2 50.1 71.7 62.4 137.2 42.2 92.8 116.7 334.5 117.9 44.6 111.3 75.2 56.2 91.0 43.6 130.1 91.4 118.7 67.7 53.8 71.5 33.8 67.9 75.0 98.0 146.2 85.4 114.0 86.2 145.3 101.7 64.1 109.4 75.3 100.6 47.6 44.4 100.7 44.7 45.5 30.6 39.6 40.3 46.8 45.4 41.3 38.1 36.6 65.7 53.7 55.2 59.1 43.0 39.6 81.3 92.7 100.8 132.5 75.2 82.4 113.8 105.2 65.9 117.2 95.1 101.7 110.7 74.0 19.2 25.7 21.2 68.3 62.1 86.2 115.1 75.7 60.1 85.0 79.8 18.1 71.4 59.5 95.6 14.6 152.2 52.4 148.4 127.2 93.8 44.3 58.2 43.2 70.7 114.7 63.1 15.1 94.9 166.7 71.3 99.4 51.0 29.9 56.5 76.1 62.2 109.6 67.3 18.7 112.4 118.0 62.8 52.7 38.0 86.3 62.6 71.2 15.9 76.9 104.1 59.8 8.5 41.3 82.3 154.7 76.3 78.0 81.1 135.5 113.9 59.3 36.0 92.1 50.1 121.0 64.5 38.7 69.8 69.3 209.9 63.3 46.4 92.8 104.6 PRMT3 HRMT1L3 ENSG00000185238 "Protein arginine methyltransferase 3" O60678 11 20387558-20509338 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 54.2;Excitatory neurons: 55.5;Inhibitory neurons: 66.9;Oligodendrocytes: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007832, CAB022083" Uncertain NA NA "CAB022083: , HPA007832: AB_1855721" "unprognostic (2.08e-2)" "unprognostic (4.43e-2)" "unprognostic (1.08e-2)" "unprognostic (5.98e-2)" "unprognostic (2.57e-2)" "unprognostic (8.97e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.01e-1)" "unprognostic (9.92e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (9.15e-2)" "unprognostic (7.22e-2)" "unprognostic (8.86e-2)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (4.11e-2)" 5.1 7.5 6.0 8.2 7.3 8.6 9.7 6.6 8.4 5.2 5.2 6.6 7.7 7.8 3.9 8.3 8.6 5.4 9.8 6.5 6.7 7.0 5.5 4.7 7.9 7.0 6.6 5.3 8.1 6.8 11.2 2.6 7.0 6.9 6.1 7.7 7.8 6.6 5.8 10.3 6.3 6.0 7.4 6.7 5.6 6.7 4.4 6.4 10.0 20.0 7.7 8.8 8.1 4.6 9.5 26.5 31.4 18.9 17.4 11.8 19.5 36.1 17.9 15.5 24.5 18.5 25.9 7.2 55.8 12.8 14.1 22.4 34.0 27.2 25.6 37.7 26.1 26.4 26.9 25.5 23.3 24.0 48.8 11.4 16.3 26.3 16.1 54.6 10.3 19.7 19.8 61.1 15.3 15.6 26.7 38.6 16.6 26.7 45.1 27.8 27.9 42.3 46.3 23.8 20.2 18.9 24.8 31.0 28.5 23.2 20.3 30.1 14.1 13.3 19.8 17.3 32.7 34.2 9.1 9.7 58.3 15.7 34.1 39.0 3.8 5.1 4.4 4.4 6.1 7.7 5.3 5.5 4.9 9.8 4.9 6.0 5.2 1.3 10.7 5.2 2.0 3.6 3.9 6.0 7.3 6.6 8.4 6.5 6.7 7.0 6.6 5.3 6.9 6.7 6.4 9.5 5.5 9.6 5.1 54.2 11.8 6.0 7.7 6.7 15.9 3.8 6.5 4.2 11.8 4.3 5.7 0.0 2.1 11.4 5.0 3.2 9.8 6.9 3.1 6.0 8.2 5.5 7.8 29.2 55.5 5.1 11.0 8.9 11.2 5.5 5.7 8.0 2.9 4.3 6.5 6.7 66.9 7.3 14.2 5.3 3.6 1.0 6.5 10.9 3.6 35.6 6.7 5.6 2.1 41.7 63.2 5.1 2.2 6.4 8.9 9.5 3.5 5.9 5.8 6.6 0.0 7.8 6.7 13.7 9.6 18.7 5.8 7.3 7.0 12.5 7.6 5.7 GP1BA "CD42b, GP1B, GPIbalpha" ENSG00000185245 "Glycoprotein Ib platelet subunit alpha" P07359 17 4932277-4935023 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease variant, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.0;lymphoid tissue: 14.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Macrophages: 14.2" "Cancer enhanced" "Detected in many" "testis cancer: 2.8" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Immune cell enriched" "Detected in single" 13 "basophil: 7.0" "Lineage enriched" "Detected in single" 43 "granulocytes: 7.0" "Cell line enriched" "Detected in some" 24 "HEL: 71.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002496, HPA013316" Supported NA NA 1600000000 "CAB002496: AB_563748, HPA013316: AB_1855459" "unprognostic (4.87e-4)" "unprognostic (8.21e-2)" "unprognostic (2.81e-2)" "unprognostic (6.11e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-3)" "unprognostic (7.30e-3)" "unprognostic (5.58e-2)" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "unprognostic (6.54e-4)" "unprognostic (1.27e-1)" "unprognostic (4.85e-3)" "unprognostic (4.58e-3)" "unprognostic (2.56e-1)" "unprognostic (3.53e-4)" "unprognostic (8.35e-2)" 0.5 0.1 0.2 3.8 0.4 5.0 0.4 2.2 0.2 0.4 0.1 0.6 1.3 0.3 0.0 0.5 0.4 0.3 0.5 0.1 0.0 0.5 0.9 1.6 14.8 0.3 0.1 0.0 0.4 0.3 0.0 0.2 0.3 0.8 0.4 0.5 2.4 0.9 0.0 2.7 2.4 1.8 0.0 0.0 3.7 0.8 0.4 0.2 0.6 0.4 0.0 7.7 0.4 0.5 0.0 0.1 2.3 0.5 0.3 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.2 0.3 2.3 0.7 0.0 0.0 2.3 0.0 0.0 0.0 0.8 1.8 71.6 1.2 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.7 0.0 1.3 0.7 0.7 0.0 0.8 0.6 0.3 0.3 0.2 0.4 1.2 0.5 0.3 0.0 1.4 0.1 0.3 0.9 0.0 0.3 0.6 2.9 1.3 0.3 0.4 0.4 1.5 0.2 1.2 0.5 1.7 1.0 1.1 0.7 7.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.2 0.2 0.4 2.2 0.2 0.1 0.0 0.3 0.1 0.0 0.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 1.5 0.6 0.4 0.0 1.8 0.2 0.5 1.1 0.0 0.2 0.0 2.1 0.3 0.4 0.1 3.9 0.2 0.3 0.8 1.8 0.5 0.0 1.7 0.2 0.0 0.2 0.7 0.0 2.4 0.0 0.1 2.5 0.9 0.1 0.0 0.2 0.0 0.0 0.9 3.3 0.6 0.3 14.2 0.0 0.0 2.6 0.3 1.0 0.0 0.1 0.0 0.0 1.9 0.3 0.4 0.3 0.9 0.0 2.7 0.0 1.4 0.5 1.0 0.6 0.0 1.8 0.3 1.0 0.1 0.1 0.3 PRPF39 "FLJ11128, FLJ20666" ENSG00000185246 "Pre-mRNA processing factor 39" Q86UA1 14 45084107-45116282 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001176, HPA078403" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001176: AB_2171026, HPA078403: " "unprognostic (1.79e-1)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (1.91e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.84e-5)" "unprognostic (9.51e-3)" "prognostic unfavorable (6.51e-4)" "prognostic favorable (8.48e-4)" "unprognostic (4.34e-3)" "prognostic unfavorable (4.04e-4)" "unprognostic (5.02e-3)" "unprognostic (1.83e-1)" "unprognostic (9.04e-2)" "unprognostic (8.93e-2)" "prognostic favorable (2.99e-4)" 4.7 4.1 1.4 0.7 2.1 2.8 4.8 1.3 2.1 5.2 0.1 4.8 1.6 5.2 1.7 3.9 6.4 1.3 3.5 1.2 0.8 2.9 3.4 3.3 1.6 1.3 0.8 0.7 5.5 4.5 1.7 4.1 1.7 1.5 3.5 1.0 2.1 4.4 1.5 7.7 4.8 4.4 1.5 0.1 3.9 5.2 3.0 0.7 1.8 3.6 1.7 1.2 5.4 4.3 2.4 7.8 8.5 7.0 3.4 2.7 2.4 7.0 6.2 3.4 4.9 4.3 5.1 5.2 4.9 6.2 4.5 3.6 5.1 9.0 4.1 7.3 8.9 6.2 6.8 11.5 4.8 3.2 6.5 1.9 1.5 2.5 2.7 3.2 2.6 3.5 6.2 9.8 5.2 5.4 7.0 7.2 3.1 6.5 5.2 8.9 9.5 6.0 6.3 2.8 10.4 6.8 1.8 2.9 3.9 4.9 3.5 3.7 5.2 7.8 4.3 4.0 3.1 8.3 5.1 12.9 11.2 1.8 6.6 2.4 5.2 2.7 4.7 4.5 4.9 6.4 5.6 4.0 4.7 4.9 5.0 5.2 6.1 2.1 4.3 5.2 2.0 5.4 3.2 1.4 2.1 1.3 2.1 1.2 0.8 1.3 0.8 0.7 1.5 0.1 0.7 2.4 14.3 25.6 22.5 21.2 18.2 27.3 15.6 6.5 18.8 19.5 10.6 7.4 14.9 7.2 13.5 7.3 14.6 12.1 21.5 7.0 9.8 8.5 1.3 9.2 19.5 12.8 9.6 15.8 36.6 9.3 10.6 15.5 12.2 11.2 16.4 16.7 10.8 7.5 7.5 16.8 37.1 9.1 6.1 5.1 14.6 4.9 14.9 9.5 14.2 25.3 8.4 10.8 5.2 31.2 55.5 8.0 6.6 14.7 19.1 14.2 14.2 5.4 6.1 24.2 6.6 13.5 16.7 11.6 11.8 18.3 25.3 12.0 19.7 13.4 9.2 10.0 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717268 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 21.2" "Group enriched" "Detected in some" 5 "Spermatocytes: 29.4;Spermatogonia: 30.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.8" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 23.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 30.9 0.0 0.0 5.9 0.0 0.0 0.0 0.0 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 35.9;testis: 19.1" "Cell type enhanced" "Detected in many" "Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.1 0.9 8.4 0.6 5.2 0.2 3.0 5.8 5.3 3.8 10.5 1.1 1.4 3.0 9.0 1.4 35.9 1.1 2.2 4.7 7.3 4.3 0.6 4.7 0.6 7.2 7.1 4.1 5.4 2.4 5.2 2.7 1.1 5.4 1.2 1.0 7.5 2.3 2.7 4.4 1.2 0.7 2.1 8.5 0.8 1.7 19.1 5.3 0.8 11.2 1.7 0.6 1.5 1.3 7.8 1.4 1.2 1.1 6.0 9.2 11.5 0.6 0.0 2.2 0.5 0.1 0.1 1.6 0.0 0.4 0.6 0.8 0.9 1.0 0.0 0.3 0.4 0.4 0.5 0.1 0.0 4.6 0.5 0.2 2.4 5.6 0.2 3.5 8.6 0.7 1.3 0.6 0.4 0.4 0.6 0.1 0.7 0.2 4.0 0.8 0.6 0.0 0.5 4.7 0.1 1.3 2.1 0.1 0.3 3.9 0.3 0.4 0.9 0.3 0.1 0.2 1.0 0.2 0.2 0.1 0.1 1.9 0.1 0.4 0.8 0.1 0.2 0.1 0.1 0.1 1.5 0.2 0.1 0.3 0.5 0.1 0.1 0.4 0.4 0.1 0.4 0.1 0.2 8.4 5.2 5.8 5.3 4.7 7.3 7.2 7.1 4.1 5.4 8.5 5.3 7.8 2.6 6.4 6.9 11.8 1.8 2.2 3.7 18.2 2.8 2.4 5.7 7.0 3.7 2.8 22.1 3.7 2.1 0.8 0.4 0.9 25.4 1.9 374.4 226.5 7.3 1.8 3.0 0.4 15.0 1.2 0.8 3.9 2.6 5.8 0.0 4.1 1.1 0.2 0.4 1.7 6.1 2.0 22.4 0.0 0.3 75.1 5.3 1.1 3.6 3.7 0.6 7.8 0.0 8.5 6.2 0.7 0.8 5.3 0.8 3.8 1.5 13.0 228.6 13.4 0.0 5.2 5.6 101.4 21.5 1.9 3.0 0.7 1.2 3.0 2.0 1.5 ZNF74 "Cos52, Zfp520, ZNF520" ENSG00000185252 "Zinc finger protein 74" Q16587 22 20394115-20408461 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 47.9" HPA003354 Approved Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA003354: AB_1080747" "unprognostic (1.40e-1)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (1.02e-1)" "unprognostic (8.13e-3)" "unprognostic (1.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-1)" "unprognostic (1.20e-3)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (5.58e-2)" "unprognostic (3.04e-1)" "unprognostic (7.91e-2)" "unprognostic (1.44e-3)" 1.7 2.4 5.0 1.2 5.0 0.6 2.1 4.4 5.2 4.3 3.9 3.6 1.3 4.8 2.0 3.2 3.1 0.9 2.3 5.2 5.0 2.4 2.4 1.9 1.5 4.9 5.0 5.2 4.5 4.2 2.7 5.4 1.5 4.9 3.6 1.4 1.7 2.9 3.1 4.8 2.9 2.2 2.4 4.4 2.7 3.2 1.3 4.8 2.6 2.5 2.4 1.1 4.0 3.0 5.2 4.3 4.1 10.4 15.8 2.9 2.8 8.2 4.0 2.9 4.8 4.5 5.7 2.0 0.1 5.6 3.2 1.6 5.2 7.8 5.1 2.7 2.8 17.8 4.9 2.0 8.1 4.8 10.7 5.1 3.1 8.6 3.7 4.2 3.6 4.8 9.3 47.9 0.1 3.4 7.1 10.2 6.6 11.6 8.9 7.2 14.0 6.1 1.6 3.1 4.6 22.8 14.1 4.4 7.9 9.3 5.2 3.6 5.1 3.4 4.6 9.5 5.8 3.0 5.2 6.2 0.1 1.1 6.1 4.0 0.0 1.2 0.9 2.0 1.0 1.6 1.1 1.5 2.4 1.9 1.0 1.8 1.7 0.0 3.8 0.7 1.3 1.4 1.9 5.0 5.0 4.4 5.2 5.2 5.0 4.9 5.0 5.2 4.9 4.4 4.8 5.2 1.4 3.2 2.0 3.6 2.1 1.5 1.9 1.6 2.8 5.1 3.6 3.0 3.1 2.8 2.5 0.0 2.1 3.1 3.8 0.9 3.9 3.8 0.5 2.3 3.7 1.7 4.2 2.1 8.5 2.4 4.6 3.5 3.1 2.0 0.0 5.6 2.5 1.7 2.2 3.3 8.8 2.3 2.0 0.6 0.3 0.3 7.2 1.0 0.0 2.8 1.6 2.6 3.1 6.0 6.6 2.5 1.0 4.9 0.9 4.0 1.5 1.7 0.6 2.1 6.6 2.7 3.2 4.3 3.0 1.8 1.0 1.1 2.7 4.4 2.8 1.1 KIAA0825 "C5orf36, DKFZp686F0372, MGC34713" ENSG00000185261 KIAA0825 Q8IV33 5 94152966-94618597 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 53.2;Cone photoreceptor cells: 50.1;Excitatory neurons: 171.0;Inhibitory neurons: 168.5;Microglial cells: 56.2;Oligodendrocyte precursor cells: 63.3;Oligodendrocytes: 62.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "neutrophil: 12.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 12.4" "Cell line enhanced" "Detected in many" "HeLa: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038030, HPA038031" Uncertain NA NA "HPA038030: AB_10672735, HPA038031: AB_2675794" "unprognostic (1.26e-1)" "unprognostic (7.73e-2)" "unprognostic (1.93e-4)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (7.63e-3)" "unprognostic (4.44e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-1)" "unprognostic (4.95e-3)" "unprognostic (2.14e-1)" "unprognostic (1.07e-1)" "unprognostic (9.02e-5)" "unprognostic (3.00e-2)" "unprognostic (8.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.09e-2)" 0.9 1.1 3.3 0.6 2.2 1.0 1.2 2.2 2.1 1.0 1.0 0.6 0.4 1.4 1.3 1.1 2.6 1.2 0.9 1.7 1.6 1.5 0.9 1.0 0.7 2.6 2.2 1.9 1.6 0.9 1.4 1.0 0.9 1.7 1.0 0.7 3.4 0.6 0.8 0.4 0.6 0.6 1.0 2.2 0.8 0.6 3.0 1.7 0.7 1.9 0.6 0.5 1.0 0.5 1.8 0.5 0.2 0.6 1.6 2.1 2.7 0.2 1.6 1.4 1.0 1.5 0.0 1.1 0.2 1.7 0.6 1.1 0.8 0.3 1.1 1.3 0.0 0.3 0.2 9.9 0.2 1.5 0.3 0.1 1.6 1.1 1.3 0.3 1.3 1.0 0.9 0.2 0.0 1.9 1.1 0.7 0.7 0.9 0.3 0.2 0.8 0.1 0.1 2.0 0.5 1.0 1.3 1.6 0.1 0.3 1.0 0.8 1.2 1.0 0.9 0.2 1.3 0.6 0.4 0.4 0.0 2.0 0.5 0.8 0.0 0.6 0.0 0.4 0.2 0.2 0.8 0.4 0.6 0.6 0.4 0.2 0.3 12.4 0.6 0.4 0.6 0.2 0.2 3.3 2.2 2.2 2.1 1.7 1.6 2.6 2.2 1.9 1.7 2.2 1.7 1.8 3.0 6.4 4.1 53.2 1.5 1.3 1.4 1.4 1.2 9.8 2.8 1.7 2.3 2.8 2.1 1.8 50.1 1.0 2.7 0.8 0.0 1.1 10.4 20.3 6.5 1.6 0.0 1.3 171.0 0.6 0.6 4.6 1.5 2.3 1.3 3.7 1.4 1.8 1.0 15.2 168.5 0.6 2.0 1.0 1.6 6.0 1.2 1.7 0.0 56.2 0.7 4.6 0.0 63.3 62.7 0.8 0.2 1.5 1.7 0.6 1.0 3.3 13.1 20.5 0.0 4.4 3.0 8.7 3.9 1.2 1.1 0.3 4.3 5.8 0.6 0.7 UBALD2 "FAM100B, MGC29814" ENSG00000185262 "UBA like domain containing 2" Q8IYN6 17 76265348-76271298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 231.1" "Cell type enhanced" "Detected in all" "Urothelial cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.8;neutrophil: 29.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 29.2" "Cell line enhanced" "Detected in all" "HDLM-2: 324.7;Karpas-707: 401.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023046 Uncertain NA Yes "HPA023046: AB_1848359" "unprognostic (1.33e-1)" "unprognostic (2.04e-3)" "unprognostic (3.14e-1)" "unprognostic (3.06e-1)" "unprognostic (9.21e-2)" "unprognostic (1.74e-1)" "unprognostic (3.22e-3)" "unprognostic (5.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (4.80e-2)" "unprognostic (3.78e-2)" "unprognostic (9.24e-2)" "unprognostic (3.45e-3)" "unprognostic (1.45e-3)" 43.8 19.5 38.9 54.9 35.7 231.1 44.0 34.1 49.2 25.6 29.6 48.5 80.7 24.7 8.1 98.7 29.7 15.0 39.9 29.8 39.8 38.0 35.5 72.6 45.4 71.2 39.0 25.9 17.8 44.0 26.8 22.2 22.1 45.9 33.5 18.1 7.0 60.0 11.0 173.8 61.8 82.2 9.0 33.7 75.7 51.9 23.2 44.2 39.2 34.5 26.1 25.7 33.4 50.0 68.8 118.6 26.2 23.7 18.9 29.2 27.5 56.0 42.7 32.8 17.9 20.3 30.8 127.9 31.2 44.0 12.5 19.7 43.3 12.1 24.1 14.1 324.7 30.5 34.5 31.4 29.0 20.1 40.9 162.8 24.9 31.8 19.1 50.3 21.0 57.4 99.6 55.5 401.9 23.3 61.3 193.2 99.4 21.8 71.4 48.1 93.9 49.6 87.3 33.8 66.6 60.3 57.4 30.1 41.2 217.0 25.8 29.8 106.3 42.3 35.8 52.1 60.3 68.9 177.7 149.2 67.8 41.6 34.0 99.8 7.8 1.8 3.3 2.3 1.5 1.9 2.7 3.9 2.4 0.7 2.1 4.6 3.7 29.2 1.4 1.1 3.9 2.8 0.6 38.9 35.7 34.1 49.2 29.8 39.8 71.2 39.0 25.9 45.9 33.7 44.2 68.8 81.6 22.4 17.6 5.2 99.8 71.9 84.5 15.5 18.8 12.8 95.5 78.2 18.0 67.2 16.6 23.9 14.6 9.0 115.3 117.2 15.6 31.4 25.5 126.6 43.1 53.1 36.3 59.8 5.1 30.8 18.6 23.5 42.8 181.6 22.2 21.6 29.6 34.3 29.2 11.8 5.8 84.5 10.2 60.5 55.6 8.2 19.9 87.9 49.8 8.4 27.5 31.3 50.4 6.0 8.7 44.7 80.6 20.3 106.6 93.2 119.3 22.4 30.2 18.7 19.7 25.5 28.8 5.1 4.5 38.7 106.3 27.9 100.9 30.6 72.4 205.6 TEX33 "C22orf33, EAN57, MGC35206" ENSG00000185264 "Testis expressed 33" O43247 22 36991120-37007851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 442 "testis: 92.1" "Group enriched" "Detected in some" 43 "Early spermatids: 873.2;Late spermatids: 258.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA005998 Enhanced NA NA "HPA005998: AB_1078352" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 873.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 258.2 4.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 12.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDNF ARMETL1 ENSG00000185267 "Cerebral dopamine neurotrophic factor" Q49AH0 10 14819245-14838575 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.1;tongue: 20.5" "Group enriched" "Detected in many" 9 "Early spermatids: 99.9;Late spermatids: 274.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RPMI-8226: 8.4;U-266/70: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044587 Uncertain "Secreted in other tissues" NA NA "HPA044587: AB_10795881" "unprognostic (2.80e-3)" "unprognostic (2.51e-2)" "unprognostic (6.20e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (4.14e-2)" "unprognostic (1.25e-1)" "unprognostic (4.81e-2)" "unprognostic (1.08e-1)" "unprognostic (8.66e-2)" "unprognostic (6.93e-2)" "unprognostic (2.31e-2)" "unprognostic (3.62e-1)" 2.5 2.4 1.0 0.5 1.1 0.4 3.6 1.3 1.0 1.6 1.2 1.3 1.8 2.1 3.8 1.5 3.9 1.6 2.2 0.8 1.3 3.5 8.7 1.1 1.5 1.4 1.2 0.6 2.8 5.5 2.9 2.1 0.5 1.4 2.9 1.2 1.7 3.8 1.8 26.1 5.0 1.1 0.7 1.4 1.0 2.5 10.2 1.0 1.2 4.1 20.5 1.5 1.2 1.3 1.8 0.4 0.4 1.0 0.4 2.2 1.9 0.1 0.8 1.7 0.7 0.5 0.6 0.9 3.3 0.7 0.5 0.0 0.3 0.1 0.0 0.7 0.3 1.0 0.5 0.5 0.2 1.4 0.2 0.0 1.7 1.2 0.3 1.3 1.1 0.7 1.5 1.0 2.1 1.0 0.9 0.4 0.3 0.6 0.6 0.2 0.6 0.4 8.4 0.4 0.1 0.8 1.3 0.2 0.5 1.4 0.5 1.2 0.3 0.5 0.1 0.3 1.4 0.1 4.5 1.2 0.5 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.3 0.5 0.3 0.3 1.2 0.8 0.0 0.9 0.1 0.4 1.6 0.2 1.0 1.1 1.3 1.0 0.8 1.3 1.4 1.2 0.6 1.4 1.4 1.0 1.8 0.5 0.0 2.2 2.0 2.3 2.0 1.4 0.7 4.0 1.0 2.3 2.2 2.0 2.8 2.3 0.0 2.1 0.9 0.6 0.1 3.9 1.0 99.9 4.2 0.8 0.9 0.0 0.4 1.0 3.6 1.6 2.1 5.1 0.6 0.0 0.7 0.4 5.8 0.4 0.0 1.4 0.5 2.0 1.2 0.6 274.2 1.2 0.4 0.0 1.0 0.2 3.1 3.1 1.5 3.3 0.6 0.5 1.2 4.8 0.9 1.4 5.2 5.8 1.0 0.0 3.2 1.8 18.9 7.5 1.6 0.1 1.4 1.2 0.5 0.7 1.2 NOTUM ENSG00000185269 "Notum, palmitoleoyl-protein carboxylesterase" Q6P988 17 81952507-81961840 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "placenta: 136.8" "Cell type enriched" "Detected in some" 45 "Extravillous trophoblasts: 1002.5" "Cancer enhanced" "Detected in many" "stomach cancer: 48.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 428.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022851 Approved "Endoplasmic reticulum" "Secreted in female reproductive system" NA NA 1900000 "Endoplasmic reticulum" "HPA022851: " "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-2)" "unprognostic (4.80e-3)" "unprognostic (1.97e-1)" "unprognostic (9.02e-3)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (6.49e-2)" "unprognostic (8.72e-2)" "unprognostic (1.40e-1)" "unprognostic (2.01e-2)" "unprognostic (4.48e-6)" "unprognostic (1.76e-1)" "unprognostic (9.88e-2)" "unprognostic (1.22e-3)" "unprognostic (1.00e-1)" 0.0 0.1 1.3 0.0 1.5 0.0 0.2 0.5 1.7 0.2 0.0 0.0 1.1 2.1 0.3 0.3 0.4 0.2 0.2 0.9 0.8 0.6 10.1 2.2 0.0 2.0 2.6 0.9 0.1 0.4 0.9 0.2 136.8 1.3 0.3 0.0 0.0 0.6 0.2 8.3 1.9 0.3 0.1 0.6 0.2 2.1 2.8 1.3 0.0 0.0 0.5 0.0 1.4 0.2 1.4 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.1 10.0 0.4 0.0 1.8 0.3 0.2 0.4 2.4 0.0 0.0 0.1 1.1 2.2 2.8 428.6 0.2 0.4 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.2 11.2 0.0 0.0 0.6 0.0 0.2 0.1 67.9 0.4 0.0 0.2 0.1 0.0 0.2 15.7 1.6 4.2 1.7 6.2 2.3 0.1 4.9 0.0 0.5 6.3 0.0 0.2 0.1 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.5 1.7 0.9 0.8 2.0 2.6 0.9 1.3 0.6 1.3 1.4 0.0 0.0 3.7 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.6 1.3 1.2 0.0 0.0 0.0 0.0 10.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.6 0.0 1002.5 1.2 1.5 0.3 0.0 0.1 0.0 3.6 18.4 0.0 1.1 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.5 12.7 0.0 0.0 22.0 0.1 0.0 0.3 0.0 KLHL33 ENSG00000185271 "Kelch like family member 33" A6NCF5 14 20425852-20436166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 30 "skeletal muscle: 74.0;tongue: 20.4" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 21 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 21 "dendritic cells: 5.8" "Cell line enriched" "Detected in single" 9 "REH: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049985, HPA056560" Enhanced NA NA "HPA049985: , HPA056560: AB_2683174" "unprognostic (6.92e-2)" "unprognostic (6.39e-2)" "unprognostic (2.07e-1)" "unprognostic (4.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.26e-1)" "unprognostic (2.38e-3)" "unprognostic (1.60e-1)" "unprognostic (9.77e-2)" "unprognostic (1.25e-1)" "unprognostic (7.39e-2)" "unprognostic (4.15e-2)" "unprognostic (4.60e-2)" "unprognostic (7.43e-3)" "unprognostic (4.88e-3)" "unprognostic (3.32e-5)" "unprognostic (2.32e-1)" 0.9 0.3 0.4 0.2 0.5 0.2 0.6 1.5 0.7 1.1 0.3 0.7 0.3 1.4 1.0 0.9 0.8 0.8 0.9 0.5 0.5 0.5 0.1 0.4 0.6 0.4 0.6 0.5 1.2 0.2 0.5 0.2 0.2 0.8 1.0 0.3 0.3 0.5 1.0 74.0 0.1 0.5 0.5 0.1 0.6 0.3 0.4 0.5 1.0 0.4 20.4 0.6 0.5 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 5.8 0.0 0.1 0.4 0.5 1.5 0.7 0.5 0.5 0.4 0.6 0.5 0.8 0.1 0.5 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 RBM11 ENSG00000185272 "RNA binding motif protein 11" P57052 21 14216130-14228372 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "epididymis: 45.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6;Excitatory neurons: 13.0;Inhibitory neurons: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 10 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HEL: 1.4;REH: 1.0;SuSa: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045885 Supported Nucleoplasm NA NA Nucleoplasm "HPA045885: AB_10963937" "unprognostic (1.95e-2)" "unprognostic (1.35e-1)" "unprognostic (3.57e-1)" "unprognostic (5.44e-4)" "unprognostic (2.18e-1)" "unprognostic (7.97e-2)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (3.23e-2)" "unprognostic (9.92e-4)" "unprognostic (5.74e-2)" "unprognostic (1.16e-4)" "unprognostic (3.45e-2)" "unprognostic (4.81e-2)" "unprognostic (2.69e-1)" "unprognostic (9.24e-3)" 0.2 0.7 2.4 0.3 2.6 0.5 0.4 2.2 2.9 0.3 2.0 0.3 0.2 0.7 45.6 0.6 0.9 0.2 0.3 2.7 2.8 0.6 0.0 0.3 0.3 2.8 2.7 2.4 2.0 0.3 1.2 1.6 0.1 2.9 0.5 0.1 2.5 0.4 1.1 0.0 0.1 0.3 0.4 2.6 0.4 0.3 1.5 2.7 0.6 1.2 0.0 0.2 0.4 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.9 0.0 1.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.6 2.2 2.9 2.7 2.8 2.8 2.7 2.4 2.9 2.6 2.7 2.9 0.3 3.2 2.7 2.0 2.9 1.8 6.5 0.7 1.8 7.0 2.8 3.7 0.1 0.0 0.8 1.8 0.0 2.3 1.5 0.2 15.6 2.5 9.3 0.7 0.7 0.8 7.7 0.8 13.0 1.2 0.8 1.5 2.6 0.6 2.5 1.3 0.0 0.0 0.8 5.0 14.7 0.9 2.0 0.0 0.4 5.2 0.6 0.3 0.0 0.0 0.8 9.4 2.1 4.0 6.3 0.8 0.4 0.7 0.3 5.1 0.0 0.8 0.8 4.4 0.0 2.1 2.4 7.2 9.8 2.8 1.1 1.2 1.6 1.8 0.4 5.6 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132144-71713600 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3" "Cancer enhanced" "Detected in many" "prostate cancer: 8.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 2.7 8.8 24.7 2.0 38.1 0.0 2.0 37.2 53.0 3.3 37.5 12.0 0.3 16.8 3.1 9.4 8.8 2.5 24.3 52.9 15.9 5.5 0.4 9.4 0.0 4.4 8.3 37.3 31.9 10.1 1.2 13.4 0.2 14.8 14.9 1.0 3.3 3.3 8.3 4.8 1.9 3.9 8.3 0.0 3.5 2.4 5.0 16.3 2.6 10.2 3.0 1.5 21.3 3.3 27.6 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.7 0.0 0.0 45.7 0.0 14.1 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 38.1 37.2 53.0 52.9 15.9 4.4 8.3 37.3 14.8 0.0 16.3 27.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 60.2;Late spermatids: 67.0;Rod photoreceptor cells: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 2.6 1.6 4.2 2.7 7.0 5.7 2.6 6.3 4.3 2.7 2.3 1.8 1.8 2.1 2.4 1.4 2.1 1.6 2.0 3.8 4.9 2.2 2.2 2.7 3.8 7.5 6.1 2.3 3.3 2.0 1.8 2.6 2.1 8.2 2.3 1.6 10.9 2.0 1.4 1.8 3.2 2.3 1.8 5.4 3.9 2.3 9.4 6.5 3.2 2.7 2.2 3.0 2.0 2.3 12.8 1.7 2.5 3.8 1.6 2.3 1.8 4.2 1.5 1.1 2.7 1.9 3.2 2.1 4.6 3.1 2.4 1.4 2.1 3.2 1.7 2.2 2.6 2.0 6.4 3.0 1.6 1.3 3.8 3.9 1.7 1.1 4.0 2.6 1.6 1.4 3.2 5.7 3.0 2.8 1.2 2.6 0.9 3.6 1.3 0.6 1.7 3.3 1.5 1.5 4.2 2.8 3.5 2.1 2.9 2.8 4.0 4.2 3.9 2.5 3.5 3.7 1.7 2.4 5.3 4.2 7.3 2.3 2.1 2.1 0.1 0.4 1.4 1.1 0.4 0.4 0.2 0.5 0.7 0.2 0.6 0.2 0.6 2.3 0.9 0.4 0.9 0.4 0.3 4.2 7.0 6.3 4.3 3.8 4.9 7.5 6.1 2.3 8.2 5.4 6.5 12.8 8.5 6.4 6.3 2.0 9.7 2.9 3.7 3.6 4.0 27.2 5.7 2.8 9.2 12.8 4.2 11.0 33.3 8.3 11.9 4.6 7.9 3.6 60.2 9.1 8.8 6.8 3.5 5.7 1.6 3.8 3.9 7.4 5.1 7.6 2.5 16.9 11.0 4.7 5.0 18.5 2.1 3.9 0.0 15.4 5.5 67.0 8.7 10.0 10.6 2.8 10.6 10.3 18.6 3.5 5.3 2.8 2.7 13.2 5.7 4.3 4.7 5.4 10.6 60.1 6.6 9.5 10.8 23.2 13.2 3.2 5.8 9.2 9.3 11.6 3.6 3.4 NUPR2 NUPR1L ENSG00000185290 "Nuclear protein 2, transcriptional regulator" A6NF83 7 56114681-56116417 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "testis: 357.6" "Cell type enriched" "Detected in many" 4 "Late spermatids: 15101.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 13.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.1" "Group enriched" "Detected in many" 4 "granulocytes: 2.0;T-cells: 5.1" "Cell line enhanced" "Detected in many" "RPMI-8226: 11.9" "Not detected" "Not detected" NA NA "unprognostic (5.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (9.52e-2)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.53e-5)" "unprognostic (1.66e-1)" "unprognostic (8.44e-2)" "unprognostic (2.74e-1)" "unprognostic (5.44e-2)" 2.2 3.3 7.1 0.3 7.5 1.0 2.7 8.4 9.3 1.8 5.4 0.9 1.2 0.7 3.0 0.7 1.6 0.4 1.3 7.4 7.9 17.6 2.3 1.0 0.7 7.1 7.0 7.7 1.3 4.0 3.3 12.8 0.7 7.1 6.5 0.7 2.6 7.8 5.7 1.5 1.3 0.7 0.6 6.3 0.7 6.0 357.6 7.9 1.4 15.6 1.0 0.6 0.6 0.8 7.5 1.0 3.1 1.4 4.0 3.6 1.5 0.5 0.2 1.4 0.7 0.4 0.4 2.2 0.4 4.7 0.1 1.5 0.3 1.9 0.5 0.9 0.7 6.0 2.4 1.4 2.7 1.9 0.8 0.3 2.8 2.0 1.0 4.4 1.7 1.3 3.1 3.0 2.5 1.4 3.3 1.3 3.1 1.3 1.2 3.3 1.1 1.6 11.9 2.3 0.5 3.9 3.6 1.9 0.5 5.4 4.6 1.2 0.7 1.0 0.6 1.7 0.9 0.7 3.8 4.8 4.6 2.4 3.0 1.1 2.0 0.3 0.6 0.3 0.0 0.5 0.4 1.8 0.5 0.4 0.5 5.1 1.4 0.1 0.4 0.5 0.8 0.5 0.8 7.1 7.5 8.4 9.3 7.4 7.9 7.1 7.0 7.7 7.1 6.3 7.9 7.5 0.2 0.0 1.5 0.0 0.2 0.0 21.3 0.0 2.2 1.4 39.6 41.3 0.0 0.0 1.8 90.1 0.0 9.6 0.5 1.4 422.6 3.6 3765.4 3.9 0.1 6.7 14.6 0.0 0.0 1.8 1.7 0.9 9.7 2.4 1.3 0.1 0.0 0.0 0.6 16.8 0.0 3.0 0.0 0.0 0.0 15101.8 94.1 5.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.5 68.4 0.0 24.8 0.1 3.2 2.9 0.8 85.5 0.0 1.5 112.8 53.3 2.7 0.0 2.9 0.6 0.0 2.0 20.4 IL3RA CD123 ENSG00000185291 "Interleukin 3 receptor subunit alpha" P26951 X 1336616-1382689 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 2665.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 2665.0" "Cell line enhanced" "Detected in many" "HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1" "HPA003539, CAB018374" Uncertain NA NA "CAB018374: AB_2233620, HPA003539: AB_1078438" "prognostic favorable (9.78e-4)" "prognostic favorable (4.27e-4)" "unprognostic (8.13e-2)" "unprognostic (9.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" "unprognostic (5.77e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-3)" "unprognostic (9.41e-2)" "unprognostic (2.85e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" 24.7 2.9 9.4 16.0 12.8 25.2 20.8 16.0 9.1 6.4 3.0 8.1 5.5 8.8 1.6 5.5 8.0 11.4 10.4 5.7 6.3 6.3 1.8 25.2 25.3 11.5 10.2 2.9 8.9 5.4 3.4 2.8 6.2 12.5 7.1 6.7 22.2 9.6 3.2 12.2 12.8 9.3 12.4 7.6 11.2 7.0 3.6 10.5 4.4 10.4 8.7 13.1 12.5 6.3 20.9 0.2 9.4 3.6 1.3 0.1 0.0 1.1 1.2 0.3 0.0 0.1 0.9 1.5 1.2 7.2 0.2 0.6 9.6 0.0 0.0 0.0 128.8 3.9 0.6 2.1 0.4 0.0 0.8 15.6 0.0 0.0 0.0 0.0 4.1 8.2 0.9 0.3 6.1 0.0 1.4 0.7 24.9 3.1 0.8 0.5 1.4 4.2 54.1 0.0 1.4 0.6 0.4 0.6 0.3 2.8 1.8 1.2 17.8 0.4 0.5 1.5 0.5 0.3 12.5 3.9 1.1 9.8 2.8 0.1 2665.0 5.6 83.9 0.6 31.7 1.0 2.5 0.9 0.5 14.9 8.9 0.7 0.7 4.6 14.2 42.5 628.5 0.5 12.0 9.4 12.8 16.0 9.1 5.7 6.3 11.5 10.2 2.9 12.5 7.6 10.5 20.9 79.0 3.2 1.8 11.8 6.8 5.9 0.7 0.9 1.2 2.3 0.5 0.9 2.2 1.5 1.0 0.0 10.4 0.1 137.5 4.7 0.0 0.4 0.2 2.7 1.4 83.2 0.0 3.0 7.3 0.2 0.1 4.3 0.5 1.5 11.4 0.4 24.3 0.7 4.6 0.0 14.3 7.3 0.0 2.8 47.6 0.1 0.3 32.9 8.8 13.1 72.6 0.6 1.0 6.0 18.2 0.1 3.4 0.7 4.0 0.7 0.2 0.0 0.4 3.2 0.0 3.6 3.2 0.1 0.7 0.7 5.5 0.3 1.6 1.3 0.6 2.1 SPPL2C IMP5 ENSG00000185294 "Signal peptide peptidase like 2C" Q8IUH8 17 45844881-45847067 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 37.1" "Group enriched" "Detected in some" 146 "Early spermatids: 202.7;Late spermatids: 615.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077339 Supported NA NA "HPA077339: " "unprognostic (6.70e-4)" "unprognostic (1.34e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 615.6 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666737-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes No "Nucleoli, Mitotic chromosome" "HPA052637: AB_2681894, HPA053914: AB_2682306" "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 8.3 9.5 13.8 12.4 13.3 17.9 7.7 13.1 17.7 9.1 13.5 8.7 11.5 7.5 5.6 23.2 7.8 6.1 6.3 13.6 13.4 9.4 10.9 7.7 16.4 13.9 13.9 13.0 6.8 8.3 7.0 6.3 7.8 14.4 11.8 5.8 2.8 10.0 6.5 7.7 23.0 10.8 6.0 12.9 15.7 8.9 10.5 14.1 11.9 7.9 4.6 11.6 9.9 14.0 15.7 38.0 62.8 21.5 35.3 13.9 13.1 35.2 41.6 19.7 53.0 30.6 55.1 22.8 33.8 22.4 21.2 36.6 47.9 34.5 43.8 30.6 19.4 51.7 51.6 30.1 48.0 20.7 46.6 37.5 19.8 26.3 47.6 26.3 14.6 37.4 41.1 53.3 19.1 28.3 34.5 45.7 56.6 46.9 32.9 59.8 55.4 34.6 24.1 19.8 29.6 45.1 57.7 41.1 87.8 37.1 28.9 58.8 48.3 27.8 82.0 53.5 34.9 65.9 53.1 28.7 36.8 30.8 42.9 48.8 2.2 7.7 11.7 11.5 9.6 6.3 10.4 8.7 8.8 7.5 13.2 9.2 8.8 3.3 13.1 11.9 12.9 9.8 5.9 13.8 13.3 13.1 17.7 13.6 13.4 13.9 13.9 13.0 14.4 12.9 14.1 15.7 17.9 22.4 17.0 5.9 29.8 31.7 22.8 19.7 74.6 6.8 17.4 13.7 6.7 15.7 20.9 12.9 2.1 25.7 31.5 19.7 19.6 25.2 1.7 26.5 32.9 20.3 7.2 37.5 4.5 21.4 41.0 16.5 29.0 29.4 19.6 28.1 15.4 11.8 24.3 18.5 4.6 17.0 14.2 12.9 11.5 1.7 13.7 16.8 16.0 4.7 24.2 13.8 37.0 4.0 5.0 35.2 16.0 13.5 25.7 40.0 12.4 15.9 21.6 9.1 6.6 13.7 22.3 30.8 44.9 57.0 34.4 20.8 29.7 22.8 22.4 24.2 SFTPA2 "COLEC5, SP-A2" ENSG00000185303 "Surfactant protein A2" Q8IWL1 10 79555852-79560407 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Gaseous exchange" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 404 "lung: 10893.6" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 16905.3" "Cancer enriched" "Detected in many" 21 "lung cancer: 863.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "BEWO: 7.3;NB-4: 8.3;RPMI-8226: 26.1;U-2197: 14.7" "CAB002439, HPA042638, HPA045752, HPA049368" Enhanced "Secreted in other tissues" NA NA "CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" "unprognostic (4.99e-2)" "unprognostic (4.38e-2)" "unprognostic (4.29e-2)" "unprognostic (1.05e-1)" "unprognostic (5.78e-2)" "unprognostic (5.08e-1)" "unprognostic (4.94e-2)" "unprognostic (1.68e-3)" "unprognostic (3.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.69e-3)" 0.5 12.2 0.3 4.6 0.5 0.0 1.0 2.4 0.8 1.4 0.0 1.5 0.0 0.2 0.1 0.4 0.2 0.0 1.1 0.5 0.2 0.4 1.1 10893.6 0.0 1.1 0.3 0.3 6.6 1.3 0.0 0.4 2.3 1.2 26.9 2.6 0.2 0.4 8.4 1.0 0.9 0.6 0.1 0.0 6.8 10.6 0.5 0.2 2.8 0.8 0.0 0.1 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.3 0.4 0.0 0.0 0.2 0.0 26.1 0.0 0.3 0.3 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 14.7 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.5 2.4 0.8 0.5 0.2 1.1 0.3 0.3 1.2 0.0 0.2 0.5 0.0 1593.0 16905.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 329.9 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 22.3 1.8 0.0 0.3 3.1 0.0 22.0 0.0 0.2 431.4 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.2 2.0 0.0 0.0 1.0 0.0 0.1 135.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.7 0.0 2.4 0.1 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2 like and GRIP domain containing 2" P0DJD1 2 87755960-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.0;dendritic cells: 5.1;Early spermatids: 5.5;Excitatory neurons: 4.3;Late spermatids: 6.7;Plasma cells: 7.5;T-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "T-reg: 9.6" "Lineage enriched" "Detected in single" 11 "T-cells: 9.6" "Cell line enhanced" "Detected in some" "BEWO: 11.0;JURKAT: 5.4;MOLT-4: 13.3;NTERA-2: 5.4;SuSa: 15.2;THP-1: 5.2" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 1.5 2.8 0.8 1.3 0.8 9.0 1.4 2.1 1.9 6.4 1.4 1.7 2.0 1.4 0.4 0.9 3.2 0.4 1.1 0.7 4.5 1.2 9.7 2.7 2.2 1.3 0.9 0.9 2.6 7.9 0.3 5.9 9.6 2.0 1.7 0.7 3.4 1.4 0.7 1.0 1.2 3.7 0.5 0.6 3.2 2.7 16.7 0.8 5.6 1.9 0.3 2.5 0.8 1.7 2.3 0.0 0.0 0.6 0.0 0.0 0.0 11.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 2.6 0.2 0.0 0.1 0.0 5.4 4.0 0.3 0.0 0.4 13.3 0.0 5.4 2.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 2.7 4.5 0.1 0.0 15.2 0.0 5.2 0.1 0.8 0.1 0.0 0.0 2.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.6 2.1 0.4 0.0 0.8 1.0 0.2 0.3 0.1 0.0 0.0 9.6 0.3 0.8 0.8 2.1 1.9 0.7 4.5 1.3 0.9 0.9 2.0 0.6 0.8 2.3 0.9 0.0 1.1 1.0 4.0 0.1 0.0 0.0 0.0 0.5 0.1 0.3 7.0 0.0 0.0 0.0 0.0 0.4 5.1 0.2 0.0 0.1 5.5 1.7 2.3 0.7 0.0 0.0 4.3 0.2 0.6 0.9 0.5 0.7 0.0 0.2 0.4 0.3 0.1 0.0 3.4 0.0 0.0 0.0 0.4 6.7 0.0 1.7 0.0 1.9 0.0 0.0 0.0 1.5 2.2 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.8 1.7 0.0 1.0 0.8 2.5 0.6 0.0 0.0 1.0 4.5 0.1 0.0 0.0 ARL15 "ARFRP2, FLJ20051" ENSG00000185305 "ADP ribosylation factor like GTPase 15" Q9NXU5 5 53883942-54310582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 441.6;Inhibitory neurons: 285.2;Microglial cells: 408.5;Oligodendrocyte precursor cells: 184.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044604, HPA063820" Uncertain Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus" "Plasma membrane, Cell Junctions" "HPA044604: AB_10960542, HPA063820: AB_2685131" "unprognostic (2.18e-1)" "unprognostic (4.32e-2)" "unprognostic (1.82e-2)" "unprognostic (2.41e-2)" "unprognostic (1.08e-1)" "unprognostic (3.70e-1)" "unprognostic (8.52e-3)" "unprognostic (1.16e-2)" "unprognostic (3.05e-2)" "unprognostic (6.56e-2)" "unprognostic (4.26e-3)" "unprognostic (3.86e-1)" "unprognostic (2.48e-3)" "unprognostic (1.35e-1)" "unprognostic (9.15e-2)" "unprognostic (5.60e-2)" "unprognostic (1.08e-1)" 12.6 12.6 7.3 5.7 8.5 1.9 13.1 6.6 10.1 17.8 10.7 10.7 12.0 16.1 7.7 9.8 8.2 14.6 14.2 9.4 7.7 18.0 9.9 7.7 6.4 6.6 7.1 8.2 5.7 5.0 3.2 8.6 22.5 6.9 10.1 11.0 7.6 10.6 6.8 3.3 11.3 10.0 16.7 6.8 8.3 8.4 9.4 8.1 10.7 8.5 11.8 8.1 13.7 8.8 8.2 3.2 5.5 8.5 15.6 7.0 7.8 11.8 10.2 15.1 9.4 20.7 21.1 8.0 32.0 14.9 9.1 11.0 7.7 13.2 14.1 12.4 3.2 13.9 36.9 7.1 2.8 2.5 4.5 43.8 10.0 10.1 15.8 9.5 14.2 20.8 7.0 32.4 5.3 6.5 7.7 7.5 4.3 3.0 1.6 3.9 6.2 10.4 0.8 12.8 30.3 11.3 7.1 13.1 6.7 7.9 15.6 8.6 4.7 11.4 5.7 9.6 5.4 6.7 1.8 1.7 34.8 9.9 10.6 9.5 1.1 1.8 2.2 1.3 1.4 0.7 1.0 0.9 0.9 2.4 0.7 0.9 0.7 3.5 0.7 1.2 0.3 2.3 1.2 7.3 8.5 6.6 10.1 9.4 7.7 6.6 7.1 8.2 6.9 6.8 8.1 8.2 44.5 3.2 7.7 33.6 6.5 9.7 7.9 5.8 8.0 5.1 4.8 5.8 7.5 5.7 4.5 12.9 14.6 52.5 5.2 7.5 21.5 3.2 3.4 4.1 6.9 35.1 20.9 8.6 441.6 4.9 4.9 8.5 6.6 5.1 2.5 3.2 26.0 4.9 8.4 1.7 285.2 7.6 18.3 8.7 8.7 1.5 4.4 12.5 1.8 408.5 5.0 3.2 6.2 184.5 104.7 6.9 7.6 3.8 4.7 5.4 5.7 10.0 3.9 3.0 6.6 3.6 5.3 1.0 3.5 5.9 10.1 42.7 8.9 24.4 7.1 8.4 C12orf56 ENSG00000185306 "Chromosome 12 open reading frame 56" Q8IXR9 12 64264762-64390758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.3;testis: 7.5" "Cell type enhanced" "Detected in many" "Early spermatids: 59.8;Late spermatids: 33.9;Oligodendrocytes: 13.5;Spermatocytes: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "hTEC/SVTERT24-B: 5.2;SCLC-21H: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056986 Enhanced NA NA "HPA056986: AB_2683300" "unprognostic (5.85e-3)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.36e-1)" "unprognostic (9.24e-2)" "unprognostic (9.35e-4)" "unprognostic (1.79e-4)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (9.51e-2)" "unprognostic (6.22e-3)" "unprognostic (4.00e-2)" "unprognostic (2.38e-4)" "unprognostic (8.86e-2)" "unprognostic (3.91e-2)" "unprognostic (3.40e-2)" "unprognostic (1.69e-2)" 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.5 0.4 5.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.1 0.0 1.4 0.2 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 7.5 0.4 1.9 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.5 0.2 0.3 0.4 0.5 0.0 0.7 0.2 0.4 1.7 0.1 0.0 0.0 3.9 0.5 0.4 1.5 0.4 1.8 0.2 0.0 0.0 1.2 0.0 0.4 0.0 0.0 5.6 0.0 0.7 5.9 0.0 59.8 1.2 0.0 0.2 0.0 0.0 2.0 0.0 4.3 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 2.2 1.7 0.0 0.0 2.2 33.9 0.0 0.2 0.0 0.0 0.0 10.4 0.0 1.5 13.5 0.4 1.0 0.4 0.0 1.0 0.0 9.7 0.5 0.7 0.0 0.0 0.0 19.0 2.3 3.1 0.3 1.8 0.0 0.0 1.4 2.4 SCN10A "hPN3, Nav1.8, PN3, SNS" ENSG00000185313 "Sodium voltage-gated channel alpha subunit 10" Q9Y5Y9 3 38696802-38816286 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.57e-2)" "unprognostic (7.85e-2)" "unprognostic (2.09e-4)" "unprognostic (1.42e-1)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696354 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 24.8 38.9 18.1 10.5 18.3 19.7 26.9 17.8 33.1 44.2 18.8 36.5 22.9 26.1 8.8 35.6 36.6 8.7 26.0 18.9 16.9 52.7 77.7 31.3 14.8 16.3 16.3 18.2 43.6 49.6 13.6 55.9 12.6 17.6 39.4 11.4 7.6 25.1 7.5 34.1 27.1 36.4 8.2 15.1 37.8 38.9 17.2 16.2 10.9 55.0 4.1 7.1 32.6 36.8 16.9 27.5 17.8 13.9 5.8 5.7 11.0 14.2 22.3 12.6 15.2 4.9 13.1 21.2 23.9 9.8 19.3 9.1 15.5 5.8 30.8 9.3 5.3 14.1 9.7 21.0 1.7 23.4 15.8 17.1 13.3 10.7 9.3 15.3 10.3 27.0 16.1 25.5 3.2 17.7 36.6 19.5 45.0 28.5 29.7 13.1 26.5 19.0 34.1 27.9 21.2 10.1 29.6 28.0 13.0 6.8 15.2 30.3 25.0 24.1 9.1 26.6 10.1 15.4 11.7 6.4 7.5 16.4 25.0 15.5 5.1 14.0 4.2 14.8 19.7 12.8 7.8 13.2 10.7 18.1 9.0 15.1 12.6 1.5 20.4 15.4 12.4 11.6 11.4 18.1 18.3 17.8 33.1 18.9 16.9 16.3 16.3 18.2 17.6 15.1 16.2 16.9 28.2 12.8 26.6 35.3 21.2 15.4 24.2 26.9 23.3 17.2 24.5 25.1 6.5 38.6 20.0 27.6 25.0 28.6 26.7 44.8 43.0 28.6 6.1 20.7 21.9 23.0 67.7 15.4 44.5 12.5 19.8 19.6 85.1 16.9 9.5 40.3 21.8 41.1 18.8 18.5 33.3 49.4 26.4 17.4 16.0 8.8 23.9 17.0 19.6 17.8 15.5 8.5 26.8 24.6 20.0 13.6 41.5 12.4 20.8 30.7 58.3 53.7 28.1 32.3 6.6 11.4 16.3 27.3 28.7 22.4 15.5 27.9 22.0 54.8 58.2 22.9 SOCS1 "Cish1, JAB, SOCS-1, SSI-1, TIP3" ENSG00000185338 "Suppressor of cytokine signaling 1" O15524 16 11254408-11256204 "Cancer-related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 102.5;dendritic cells: 191.9;T-cells: 161.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "HDLM-2: 107.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010355, HPA074108" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "CAB010355: AB_2193144, HPA074108: AB_2686661" "unprognostic (4.50e-3)" "unprognostic (3.30e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-2)" "unprognostic (1.25e-2)" "prognostic favorable (1.10e-4)" "unprognostic (1.71e-2)" "unprognostic (4.09e-3)" "unprognostic (5.31e-3)" "unprognostic (4.82e-2)" "unprognostic (1.17e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (6.08e-2)" "unprognostic (1.67e-1)" 9.2 4.3 1.0 14.4 1.1 10.0 7.0 5.2 1.3 14.7 1.0 3.9 2.1 5.9 1.1 5.5 4.7 2.3 4.2 0.7 3.1 16.4 27.1 9.8 13.6 2.4 1.2 0.4 9.4 3.1 0.7 15.0 3.8 2.6 6.3 0.9 0.1 4.9 1.7 2.1 6.6 12.5 1.0 0.9 18.7 8.1 7.7 2.7 9.9 4.4 0.5 10.3 6.6 7.0 1.7 2.8 0.5 1.1 0.2 3.3 0.5 4.0 2.2 15.7 1.0 1.3 0.7 0.5 6.3 4.7 1.0 2.9 1.1 0.4 0.2 0.2 107.8 0.8 1.7 0.0 8.6 1.4 0.0 18.5 1.4 0.3 2.2 0.2 0.4 0.3 0.6 14.4 1.8 0.1 2.5 7.2 4.0 11.4 0.2 1.7 0.7 0.7 0.7 1.2 0.5 1.5 0.2 0.5 3.7 1.2 3.1 0.0 0.9 0.1 1.3 6.4 0.9 1.5 0.4 0.6 10.0 2.6 0.8 1.3 13.6 0.1 10.2 2.1 0.0 1.9 1.5 2.4 2.6 0.0 5.3 2.6 2.3 0.3 6.1 0.1 1.3 2.8 0.4 1.0 1.1 5.2 1.3 0.7 3.1 2.4 1.2 0.4 2.6 0.9 2.7 1.7 102.5 0.0 4.4 1.6 67.7 12.2 17.4 1.9 8.6 1.9 33.8 55.5 10.3 2.8 0.7 51.5 6.2 24.1 191.9 30.6 23.5 18.4 64.8 18.1 19.9 14.3 26.0 8.4 0.0 8.5 4.8 61.5 26.0 36.9 52.8 4.9 8.2 3.4 4.5 0.0 0.2 17.7 8.2 5.8 25.7 24.7 7.2 33.8 30.2 1.0 14.2 6.7 24.7 0.5 0.0 5.0 20.2 41.8 89.0 7.4 19.0 9.2 2.5 4.8 0.0 30.2 34.2 0.8 8.3 10.1 6.8 57.7 161.5 23.0 11.8 11.6 TCN2 "D22S676, D22S750, TC2" ENSG00000185339 "Transcobalamin 2" P20062 22 30607003-30627271 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 116.9" "Cell type enhanced" "Detected in many" "Adipocytes: 105.0;Hepatic stellate cells: 137.4;Kupffer cells: 144.1;Proximal enterocytes: 563.6;Proximal tubular cells: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 43.8;intermediate monocyte: 66.5;non-classical monocyte: 24.4" "Lineage enriched" "Detected in many" 8 "monocytes: 66.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 117.6;HUVEC TERT2: 142.6;Karpas-707: 184.0;RPTEC TERT1: 70.7;TIME: 85.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000837 Approved Cytosol "Secreted to blood" NA NA 19000000 Cytosol "HPA000837: AB_1080235" "unprognostic (6.43e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.53e-3)" "unprognostic (3.17e-1)" "unprognostic (1.49e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.64e-4)" "unprognostic (1.52e-2)" "unprognostic (2.90e-1)" "unprognostic (1.07e-1)" "unprognostic (4.03e-2)" "unprognostic (1.59e-1)" "unprognostic (6.95e-3)" "unprognostic (4.94e-3)" "unprognostic (2.09e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" 47.2 30.8 24.5 16.1 22.6 5.6 38.2 24.3 30.9 26.1 29.4 23.6 23.8 28.9 20.5 8.7 21.7 50.6 24.6 21.4 25.7 116.9 17.4 38.1 35.6 25.8 24.9 19.2 15.0 12.3 8.7 15.3 18.8 25.5 16.1 28.1 11.2 13.3 45.8 6.0 8.7 60.0 37.2 24.3 47.1 17.5 22.0 27.4 6.4 26.7 13.9 10.1 22.2 14.9 24.7 0.2 9.5 41.8 0.2 24.6 117.6 1.4 3.1 30.9 8.0 13.1 4.6 21.2 0.6 45.7 6.2 0.7 1.5 3.7 2.2 2.5 0.0 2.3 0.2 1.2 2.0 58.5 0.6 33.7 19.8 2.5 6.1 5.1 8.8 142.6 0.0 0.8 184.0 12.7 0.1 0.1 3.3 16.4 11.7 1.0 4.9 6.0 64.2 70.7 1.1 14.4 1.9 0.3 0.6 12.0 2.8 0.4 2.0 85.3 26.4 3.5 3.3 1.3 5.1 1.4 0.2 9.5 1.7 0.6 0.0 43.8 0.0 0.1 66.5 0.7 0.0 0.8 0.4 7.9 0.0 0.3 0.6 1.4 0.0 24.4 1.5 0.2 18.8 24.5 22.6 24.3 30.9 21.4 25.7 25.8 24.9 19.2 25.5 24.3 27.4 24.7 105.0 3.2 3.9 3.9 3.7 5.2 2.2 4.7 0.6 8.0 7.1 5.1 6.5 27.1 13.7 12.9 20.9 0.4 0.5 70.9 7.9 7.8 1.1 3.5 5.4 64.6 6.7 0.8 0.2 6.0 0.8 19.5 5.1 6.2 4.5 23.4 137.4 5.6 45.9 1.7 1.9 28.6 4.1 144.1 9.4 1.4 10.5 53.8 23.2 8.4 8.8 7.4 0.0 5.5 1.7 5.1 50.2 9.8 13.5 2.0 563.6 125.8 2.8 29.1 13.1 0.9 5.5 1.0 12.6 0.5 5.3 0.4 2.2 5.6 21.0 2.7 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 84.6;Late spermatids: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 77.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favorable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 22.1 36.6 40.7 5.5 34.3 6.5 22.6 34.2 59.0 15.2 22.8 23.5 18.3 18.5 5.4 34.6 16.7 4.2 27.6 39.0 29.8 21.0 18.8 19.5 2.4 45.1 37.2 31.7 9.0 14.6 6.7 22.3 4.2 39.2 22.4 2.0 4.0 24.9 17.1 6.5 49.2 18.0 4.4 33.9 29.3 27.6 51.7 40.1 1.1 15.8 3.9 1.8 17.8 19.8 32.2 20.4 23.1 3.5 14.5 5.5 5.2 22.6 29.7 8.9 12.3 6.4 10.6 14.2 0.1 13.1 15.9 12.9 60.5 6.0 16.8 2.2 27.6 2.9 26.5 19.9 7.5 7.0 0.2 17.8 5.6 11.5 11.9 4.7 8.9 16.5 26.2 12.8 4.1 9.0 17.2 0.5 14.8 5.3 13.5 51.6 0.6 10.3 1.7 7.5 12.8 1.2 19.0 23.0 30.3 17.0 4.4 30.2 4.1 35.5 77.0 53.0 34.6 30.3 0.3 0.4 0.3 34.1 1.0 19.3 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 40.7 34.3 34.2 59.0 39.0 29.8 45.1 37.2 31.7 39.2 33.9 40.1 32.2 34.5 6.4 1.7 28.1 0.4 28.2 7.0 12.3 21.6 3.6 24.0 18.4 5.6 14.3 8.3 1.8 6.2 24.8 0.8 13.4 7.9 12.2 33.8 19.2 9.2 26.2 1.8 19.6 14.8 6.7 14.3 12.0 9.2 10.0 1.3 28.9 84.6 12.0 14.1 13.5 11.4 5.1 20.3 14.5 23.0 89.7 9.6 37.6 12.4 7.5 7.6 5.4 0.0 4.0 4.0 10.2 7.2 11.7 0.2 6.1 41.7 10.1 4.3 20.9 39.5 35.3 23.5 5.4 12.4 27.9 32.4 6.7 2.2 17.8 11.8 4.6 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712353-123761755 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Supported "Vesicles,Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Vesicles, Focal adhesion sites" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 6.0 4.5 5.9 7.1 6.5 10.5 5.7 7.3 6.4 4.6 6.8 5.5 8.7 6.0 3.9 4.4 4.9 3.8 4.6 6.1 5.9 3.7 4.3 6.4 8.3 6.6 5.9 5.3 4.1 5.8 3.7 4.9 3.8 6.5 4.7 5.9 6.7 7.7 4.0 6.6 9.5 7.0 5.2 5.8 6.6 8.8 5.0 6.4 7.6 4.9 3.5 8.2 5.3 4.6 7.9 4.8 10.3 12.0 17.8 9.2 7.0 6.7 6.2 6.2 5.4 5.8 6.9 2.7 18.0 4.2 7.6 5.5 9.0 16.1 6.2 4.5 11.4 10.2 27.9 9.2 5.4 10.2 16.8 51.0 6.7 4.4 5.9 7.4 9.0 5.0 15.0 14.5 3.4 8.1 8.4 15.4 24.8 11.5 6.6 6.5 15.7 9.9 6.4 8.3 10.4 7.2 13.6 9.3 6.9 9.4 6.6 5.9 14.4 8.3 8.0 3.1 10.8 9.1 10.8 12.8 14.9 9.4 12.1 6.5 6.3 0.7 13.7 1.7 0.9 1.0 0.9 1.7 1.5 0.8 3.7 1.6 1.8 2.0 1.7 1.5 2.8 1.0 0.8 5.9 6.5 7.3 6.4 6.1 5.9 6.6 5.9 5.3 6.5 5.8 6.4 7.9 13.0 6.4 11.0 3.9 20.4 10.1 10.8 4.6 11.4 20.5 7.9 5.3 8.8 12.8 8.3 9.2 12.5 5.2 27.9 17.9 0.0 8.1 10.2 11.0 11.9 10.6 13.2 50.3 21.2 10.9 5.7 11.3 18.3 12.3 75.3 8.7 18.2 11.4 8.4 11.8 19.3 9.8 2.0 9.4 17.2 4.5 8.7 11.3 1.8 7.5 13.2 9.0 25.7 10.6 17.1 9.2 9.0 9.4 19.7 15.7 11.1 4.0 13.5 28.8 6.6 12.4 10.9 23.6 12.6 9.6 14.2 6.8 21.8 5.7 11.4 11.4 PRKN "AR-JP, PARK2, parkin, PDJ" ENSG00000185345 "Parkin RBR E3 ubiquitin protein ligase" O60260 6 161347417-162727775 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 28.6;tongue: 16.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Distal tubular cells: 19.6;Proximal tubular cells: 6.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.3" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;HEL: 4.1;HSkMC: 1.7;Karpas-707: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016257, HPA036012" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB016257: AB_628104, HPA036012: AB_2732471" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.69e-3)" "unprognostic (9.85e-2)" "unprognostic (5.85e-2)" "unprognostic (7.07e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-3)" "unprognostic (8.16e-2)" "prognostic favorable (6.75e-12)" "unprognostic (9.93e-2)" "unprognostic (1.51e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-1)" 3.4 3.3 2.9 0.1 3.1 0.3 1.9 0.6 3.7 1.3 0.4 2.1 1.2 1.6 1.2 3.3 1.2 1.5 9.2 4.3 1.9 5.2 1.2 1.0 0.5 2.1 1.7 5.3 2.8 1.2 2.3 1.8 0.4 1.8 1.2 0.6 1.5 1.3 1.4 28.6 2.0 1.1 1.2 0.7 1.0 1.9 5.4 2.0 0.5 1.3 16.1 0.3 2.5 1.0 3.4 0.0 0.0 0.3 2.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.5 4.1 0.1 0.6 0.3 0.0 0.0 1.7 0.0 0.0 0.2 0.3 0.0 0.2 0.2 2.2 0.0 0.2 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.7 0.0 0.0 0.5 1.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.7 1.7 0.3 2.2 0.8 0.1 1.3 0.6 0.8 0.9 0.7 1.6 1.8 1.8 0.5 0.6 0.4 0.0 0.1 0.8 2.9 3.1 0.6 3.7 4.3 1.9 2.1 1.7 5.3 1.8 0.7 2.0 3.4 2.3 9.6 4.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.0 0.0 1.8 1.8 0.0 0.5 0.4 0.0 19.6 1.1 0.0 3.4 1.8 0.7 0.0 0.0 0.0 2.2 0.1 1.8 0.0 3.2 2.5 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.8 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.4 3.7 0.0 0.0 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 66.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 4.7 1.6 4.9 4.9 4.5 6.8 4.7 3.8 7.9 4.0 0.5 4.3 5.1 3.8 1.0 6.8 4.6 1.8 4.1 5.5 3.2 3.3 5.4 4.9 5.4 6.7 3.5 4.7 2.6 3.0 1.0 5.4 1.6 4.2 4.2 1.6 0.5 4.3 2.3 2.3 8.1 5.4 1.1 2.9 6.8 5.9 4.9 4.0 4.6 5.7 0.5 3.2 3.9 4.6 4.6 17.2 38.9 9.2 13.5 0.8 1.5 24.5 13.4 5.0 15.9 14.7 14.0 31.2 25.6 27.2 2.2 6.2 43.5 3.2 14.0 3.0 29.0 16.0 6.5 22.8 13.3 0.6 12.9 17.9 0.3 4.6 10.6 3.5 2.0 6.4 23.2 10.5 31.2 2.5 66.7 26.9 29.6 11.9 14.6 41.8 21.9 13.8 17.9 4.5 14.3 25.7 15.5 13.7 15.8 9.8 2.0 26.0 12.6 7.8 10.9 18.4 33.4 22.4 17.8 8.2 15.7 13.9 14.8 18.0 0.0 0.5 0.6 0.5 0.9 0.4 0.1 0.8 1.4 0.7 0.3 0.6 0.1 0.1 0.0 0.8 2.4 0.6 0.2 4.9 4.5 3.8 7.9 5.5 3.2 6.7 3.5 4.7 4.2 2.9 4.0 4.6 4.8 3.2 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 0.0 0.0 0.6 1.8 0.0 8.0 10.1 0.0 3.9 11.6 0.0 12.0 3.0 4.0 0.0 0.0 0.0 12.7 26.6 3.4 0.0 7.2 0.0 8.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 14.7 0.0 0.0 4.7 0.0 0.0 2.0 3.6 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.0 4.2 2.5 0.0 0.0 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090107-96839562 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Group enriched" "Detected in some" 27 "Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6" "Cancer enhanced" "Detected in many" "breast cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 24000 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.8 4.3 2.5 0.2 4.0 0.0 0.3 0.0 9.7 1.8 0.0 0.2 0.4 2.1 2.1 0.4 0.5 0.2 0.7 11.6 6.7 0.8 0.0 0.0 0.0 0.7 2.7 6.8 0.1 2.2 2.1 2.0 0.0 1.1 0.2 0.1 2.2 0.0 0.3 1.1 0.3 0.4 1.6 0.0 0.0 0.9 0.3 6.0 0.0 2.4 0.0 0.0 2.7 0.2 3.7 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 17.3 0.9 0.7 0.1 0.1 0.0 0.2 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.0 0.0 9.7 11.6 6.7 0.7 2.7 6.8 1.1 0.0 6.0 3.7 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.3 0.6 0.1 0.0 0.0 1308.8 0.6 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 3.3 893.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 38.4 0.0 0.9 0.0 968.6 16.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 0.1 1.8 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 HGS "Hrs, Vps27, ZFYVE8" ENSG00000185359 "Hepatocyte growth factor-regulated tyrosine kinase substrate" O14964 17 81683326-81703138 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 137.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004872, HPA007728" Uncertain Enhanced Endosomes,Lysosomes,Cytosol NA NA 45000 "Endosomes, Lysosomes" Cytosol "HPA004872: AB_1079053, HPA007728: AB_1850681" "unprognostic (6.52e-2)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.29e-1)" "unprognostic (1.31e-2)" "unprognostic (4.91e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.61e-5)" "unprognostic (5.54e-3)" "unprognostic (1.09e-1)" "unprognostic (9.27e-2)" "unprognostic (5.30e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.31e-7)" "unprognostic (3.69e-1)" "unprognostic (2.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" 73.1 96.4 99.0 25.0 99.1 55.0 70.3 96.0 128.1 80.7 94.4 72.1 29.6 67.3 32.9 119.8 70.9 27.3 75.9 100.7 97.0 93.9 86.4 80.8 30.8 103.5 101.4 100.3 75.0 85.8 28.3 82.3 25.0 102.0 87.0 25.6 15.8 73.0 29.9 94.5 93.0 81.9 28.8 95.9 101.4 85.3 106.7 99.8 35.6 69.1 18.7 25.0 81.8 84.6 101.5 104.2 93.1 47.8 66.6 56.0 59.8 57.3 65.5 86.6 99.6 76.8 72.6 65.0 23.4 47.2 106.4 88.6 63.2 43.7 100.6 45.8 19.7 76.0 58.8 98.8 117.5 92.8 47.1 55.4 78.1 100.9 93.9 121.9 82.7 120.9 44.5 54.8 30.4 92.1 77.9 58.1 71.4 43.8 75.9 88.9 51.3 48.6 41.0 94.5 87.7 54.9 86.1 54.6 114.9 78.3 48.3 82.3 98.6 87.3 119.5 82.4 69.6 123.3 41.6 17.6 21.8 96.9 53.3 89.4 48.8 28.7 38.9 24.5 32.3 16.6 16.4 18.5 19.4 23.5 15.8 14.1 16.0 44.7 27.1 33.6 19.3 22.3 35.9 99.0 99.1 96.0 128.1 100.7 97.0 103.5 101.4 100.3 102.0 95.9 99.8 101.5 20.8 25.6 28.7 17.6 22.0 27.9 23.8 27.7 29.6 30.6 27.0 25.9 3.1 17.2 27.6 22.0 35.5 34.0 27.4 60.9 1.9 43.3 72.3 45.6 28.7 26.3 11.4 23.4 14.2 42.6 36.5 21.8 68.8 66.1 23.4 26.3 16.1 20.7 29.5 23.5 12.6 32.4 22.4 22.9 26.6 137.8 28.9 30.3 23.2 15.9 28.1 20.6 25.7 6.6 16.1 68.2 42.7 23.0 27.6 53.9 41.1 14.6 32.3 35.5 13.1 17.8 24.0 36.9 32.5 37.0 30.3 50.2 23.5 22.1 36.2 50.8 TNFAIP8L1 MGC17791 ENSG00000185361 "TNF alpha induced protein 8 like 1" Q8WVP5 19 4639516-4655568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 34.4" "Group enriched" "Detected in many" 5 "Early spermatids: 327.0;Late spermatids: 862.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 33.9;HUVEC TERT2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes "unprognostic (1.39e-1)" "unprognostic (1.14e-2)" "unprognostic (3.70e-1)" "unprognostic (9.03e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (8.39e-2)" "unprognostic (3.88e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (7.65e-2)" "unprognostic (8.99e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" 6.9 3.1 8.5 5.1 9.7 2.4 5.3 7.7 10.0 4.8 5.1 24.0 8.9 4.4 3.3 5.7 23.3 3.7 6.0 10.2 6.7 8.7 34.4 8.2 6.9 6.8 6.4 9.4 3.9 2.6 1.3 4.4 5.2 7.9 3.6 4.5 0.5 2.3 1.5 4.8 6.8 12.6 5.5 6.1 17.7 10.8 14.0 7.5 4.8 5.5 5.7 5.4 7.0 4.5 8.4 17.2 5.4 7.3 11.6 2.2 3.5 3.8 3.1 5.7 6.3 5.7 9.6 6.3 8.2 1.5 4.8 6.8 8.5 4.6 5.5 5.9 13.6 2.1 18.8 3.3 17.6 3.2 2.8 33.9 4.5 1.6 5.7 3.7 7.9 33.1 10.0 10.0 11.8 7.3 5.5 3.4 13.8 3.7 12.0 7.3 9.4 4.7 3.8 6.3 1.5 2.9 6.5 1.5 4.4 6.4 5.4 3.1 7.4 24.1 3.2 12.9 4.9 12.3 6.4 8.4 7.3 6.2 8.6 9.3 3.2 2.3 7.0 1.4 3.3 2.5 3.6 2.5 1.5 1.9 2.6 3.1 2.7 1.0 3.1 5.1 1.6 3.3 2.0 8.5 9.7 7.7 10.0 10.2 6.7 6.8 6.4 9.4 7.9 6.1 7.5 8.4 25.8 0.0 10.3 0.7 12.0 11.6 3.2 7.1 2.8 3.5 3.7 3.4 2.6 8.6 10.0 3.7 0.0 3.8 10.0 4.5 1.9 2.9 327.0 96.9 6.3 46.2 7.7 11.0 5.3 1.2 7.4 5.6 1.1 5.7 49.5 7.1 63.5 41.0 7.7 3.3 2.8 4.3 10.2 11.3 19.3 862.9 8.4 12.5 5.4 6.5 13.5 0.9 11.3 1.0 1.0 2.7 1.4 7.2 6.5 3.4 6.9 20.5 109.9 4.6 19.7 8.3 8.1 10.4 7.6 5.0 11.2 9.3 10.4 5.8 11.4 2.6 OR2V1 "OR2V1P, OST265" ENSG00000185372 "Olfactory receptor family 2 subfamily V member 1" Q8NHB1 5 181123122-181131169 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 1.6;retina: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049953 Uncertain NA NA "HPA049953: AB_2680971" 0.1 0.0 0.5 0.1 0.5 0.3 0.4 0.8 0.9 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.0 0.0 0.8 0.3 0.1 1.6 0.1 0.2 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.7 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.8 0.2 0.1 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.8 0.9 0.8 0.3 0.4 0.2 0.4 0.4 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAD51D "HsTRAD, R51H3, RAD51L3, Trad" ENSG00000185379 "RAD51 paralog D" O75771 17 35092221-35121522 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 116.5;Late spermatids: 217.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.41e-2)" "unprognostic (3.32e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.37e-5)" "unprognostic (7.29e-2)" "unprognostic (9.59e-2)" "unprognostic (1.24e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.73e-2)" "prognostic favorable (3.35e-6)" "unprognostic (2.34e-2)" "prognostic unfavorable (7.20e-9)" "unprognostic (7.34e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-2)" 5.4 3.9 6.9 4.2 7.3 5.1 5.4 6.8 9.0 6.4 6.4 4.9 4.5 6.3 2.8 3.9 4.8 3.9 4.3 7.5 7.2 4.9 4.3 4.6 6.0 7.2 7.3 7.5 6.6 4.9 3.8 4.2 4.9 7.1 5.0 3.7 1.8 3.5 4.7 2.8 3.3 4.7 6.1 6.8 6.6 3.9 5.7 7.6 8.0 5.8 4.7 5.9 6.1 5.3 8.1 10.0 17.4 4.4 9.0 4.1 6.7 6.1 19.1 9.8 14.2 13.4 10.4 10.9 22.4 12.5 10.8 9.3 13.5 9.8 5.8 8.3 12.4 10.8 11.2 11.6 6.6 8.5 22.3 19.7 8.6 5.8 13.5 8.9 6.8 10.5 17.8 14.7 30.7 12.1 10.8 28.0 11.2 6.3 8.8 8.2 20.9 11.1 14.3 5.4 10.2 6.7 6.7 10.3 5.2 12.1 11.1 10.7 14.7 8.6 7.0 8.5 10.5 16.0 6.0 10.7 13.2 10.2 15.5 12.4 3.5 3.6 4.0 7.9 3.5 6.0 7.2 5.0 7.1 4.0 6.7 4.7 6.0 0.7 9.2 5.1 6.5 5.1 3.9 6.9 7.3 6.8 9.0 7.5 7.2 7.2 7.3 7.5 7.1 6.8 7.6 8.1 9.1 0.0 4.8 0.0 8.5 2.3 4.7 1.6 1.8 10.4 5.6 5.6 3.3 4.3 1.5 3.7 10.4 10.8 10.9 3.2 1.9 6.4 116.5 3.3 6.6 8.7 1.2 11.1 0.0 6.8 11.0 7.0 4.6 4.0 6.3 17.7 11.4 4.7 11.0 8.4 0.0 5.0 2.0 5.7 3.1 217.6 9.6 5.8 1.8 0.0 11.0 8.0 28.8 0.0 0.0 7.0 5.7 6.8 8.7 3.7 5.3 8.5 0.8 4.2 0.0 10.7 7.8 7.9 12.6 5.4 1.4 2.9 11.1 14.0 6.3 3.0 OR7A17 HTPCRX19 ENSG00000185385 "Olfactory receptor family 7 subfamily A member 17" O14581 19 14878203-14886132 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 3.4;Club cells: 3.7;granulocytes: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.6 0.2 0.5 0.3 0.0 0.7 0.8 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.1 0.2 0.5 0.4 0.7 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.6 0.2 0.1 0.2 0.1 0.0 0.6 0.5 0.7 0.8 0.5 0.3 0.5 0.4 0.7 0.9 0.2 0.5 0.7 0.2 9.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 MAPK11 "p38-2, p38Beta, PRKM11, SAPK2" ENSG00000185386 "Mitogen-activated protein kinase 11" Q15759 22 50263713-50270767 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.4" "Cell type enhanced" "Detected in many" "Adipocytes: 29.5;Astrocytes: 16.6;Endothelial cells: 21.1;Excitatory neurons: 15.8;Hepatic stellate cells: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012961, HPA045069" Approved Approved Mitochondria NA NA Mitochondria "CAB012961: AB_2533144, HPA045069: AB_2679207" "unprognostic (1.11e-1)" "unprognostic (1.28e-1)" "unprognostic (1.49e-2)" "unprognostic (1.92e-1)" "unprognostic (1.18e-2)" "unprognostic (1.64e-3)" "unprognostic (1.02e-1)" "unprognostic (5.84e-2)" "unprognostic (5.89e-2)" "unprognostic (2.46e-1)" "unprognostic (4.96e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (6.02e-6)" "unprognostic (9.84e-2)" "unprognostic (4.25e-2)" "unprognostic (9.16e-2)" "unprognostic (2.10e-2)" 25.1 6.8 48.1 7.9 51.2 1.1 24.2 43.3 71.4 14.9 37.8 6.9 1.9 15.7 5.8 9.5 16.9 8.8 15.3 51.1 45.9 15.6 4.9 16.9 9.4 45.2 43.7 50.8 12.6 5.8 5.5 28.6 8.4 46.1 18.4 2.6 8.7 7.3 7.3 6.4 7.2 8.4 9.5 42.8 16.4 11.0 6.2 46.3 3.5 11.1 5.8 6.2 11.7 12.4 48.2 2.8 6.8 7.4 27.8 9.5 14.3 0.2 10.2 7.4 6.8 2.7 2.8 5.2 0.0 8.7 9.9 11.3 6.9 4.9 4.2 0.5 13.9 3.4 10.1 10.4 0.6 10.9 2.5 15.0 19.9 12.3 1.9 0.8 7.7 15.2 10.6 8.1 26.8 6.9 12.4 0.5 9.4 0.6 8.4 7.7 26.7 0.1 9.9 10.3 0.0 6.8 18.4 9.0 3.7 7.7 0.9 12.2 7.9 24.0 20.4 16.5 1.5 3.7 1.2 3.2 11.8 10.4 2.9 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.1 51.2 43.3 71.4 51.1 45.9 45.2 43.7 50.8 46.1 42.8 46.3 48.2 29.5 0.0 1.1 16.6 2.2 1.9 1.8 3.2 8.0 3.3 1.1 1.5 6.6 1.5 1.7 0.0 6.2 0.0 1.8 0.1 1.9 1.0 4.7 0.6 1.8 21.1 0.0 0.4 15.8 0.2 0.4 2.7 0.5 1.7 0.0 0.1 20.0 2.1 0.3 0.0 3.6 0.2 2.0 1.3 2.1 9.7 3.1 0.5 5.4 13.1 0.1 5.9 0.0 1.0 0.9 0.7 0.0 2.2 1.6 2.9 0.0 1.9 1.3 11.4 0.0 0.6 1.8 1.3 3.2 1.8 1.3 0.0 3.3 0.7 0.1 1.1 SP140L ENSG00000185404 "SP140 nuclear body protein like" Q9H930 2 230327184-230403732 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA055864 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055864: AB_2682949" "unprognostic (1.44e-2)" "unprognostic (8.91e-2)" "unprognostic (4.44e-2)" "unprognostic (9.70e-3)" "unprognostic (2.07e-1)" "unprognostic (1.42e-2)" "unprognostic (1.22e-3)" "unprognostic (1.77e-1)" "unprognostic (3.87e-1)" "unprognostic (2.31e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-1)" "prognostic unfavorable (5.09e-10)" "unprognostic (9.15e-2)" "unprognostic (7.81e-2)" "unprognostic (9.49e-2)" "unprognostic (2.00e-3)" 9.1 9.8 3.4 19.0 3.6 13.7 8.6 3.1 4.0 7.4 4.7 8.6 11.1 7.1 6.5 7.8 7.8 8.7 5.3 3.1 4.9 7.0 15.2 11.4 25.0 4.3 3.6 2.7 11.9 4.4 1.6 3.5 10.7 4.4 7.0 9.5 2.0 12.6 6.1 5.1 2.8 16.4 6.5 3.9 25.8 9.0 1.8 4.3 12.9 5.5 4.4 20.4 10.8 8.3 6.2 13.6 2.4 3.1 9.6 15.8 17.2 17.2 19.7 22.6 16.0 25.5 1.3 15.3 10.3 20.2 15.4 28.4 2.3 0.0 14.1 26.0 27.1 0.1 18.5 11.1 10.0 29.7 15.1 19.9 14.4 7.6 23.6 15.4 13.7 23.7 15.5 4.5 9.4 29.0 7.5 22.7 21.2 10.7 9.1 7.0 7.8 28.9 8.3 14.5 16.9 0.6 2.9 4.7 9.5 11.2 19.0 14.2 15.9 26.1 14.2 10.5 8.2 15.2 13.7 9.2 14.8 18.9 15.4 25.2 21.4 7.7 4.1 15.4 10.7 18.7 29.5 14.1 12.5 8.3 32.6 19.5 17.4 7.4 23.0 12.5 3.3 9.7 9.6 3.4 3.6 3.1 4.0 3.1 4.9 4.3 3.6 2.7 4.4 3.9 4.3 6.2 30.5 32.1 35.6 1.6 58.8 1.9 13.8 14.6 1.8 2.7 9.3 9.1 4.2 11.5 21.7 16.5 18.8 9.9 40.4 16.8 0.0 22.5 16.3 7.2 16.9 23.3 3.6 9.9 2.4 18.3 17.6 14.6 23.0 14.3 42.3 18.7 13.9 9.4 20.4 0.0 2.0 10.4 16.2 17.1 11.4 5.9 4.4 23.9 5.4 29.0 13.9 1.8 49.4 2.5 1.4 20.0 20.3 8.2 33.7 10.3 14.5 3.3 28.3 1.7 6.6 18.8 14.0 0.8 1.9 7.7 2.6 11.9 47.1 31.7 8.5 23.2 MRPL30 "MRP-L28, RPML28" ENSG00000185414 "Mitochondrial ribosomal protein L30" Q8TCC3 2 99181152-99199561 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047255 Approved NA NA "HPA047255: AB_2680002" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "unprognostic (9.77e-2)" "unprognostic (7.87e-2)" "unprognostic (1.65e-1)" "unprognostic (4.34e-2)" "unprognostic (2.60e-3)" "unprognostic (2.53e-1)" "unprognostic (9.37e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.25e-2)" "unprognostic (1.50e-3)" "unprognostic (2.84e-1)" "unprognostic (3.49e-2)" "unprognostic (3.16e-2)" "unprognostic (2.72e-1)" 9.9 12.6 3.6 5.0 4.1 3.4 9.4 4.9 4.5 9.5 2.8 9.9 7.1 9.8 4.2 14.7 8.1 4.0 14.3 4.2 4.1 12.5 13.7 6.1 5.3 3.3 3.5 3.7 9.7 11.4 7.5 7.3 5.2 3.7 8.6 6.8 6.1 10.0 5.7 29.8 10.6 8.1 5.4 3.1 7.2 10.2 4.0 4.0 7.5 7.0 21.3 7.1 9.4 10.2 4.3 30.7 8.5 14.4 10.6 9.6 15.7 14.3 12.7 11.1 15.3 12.3 23.3 7.4 22.8 7.7 11.3 9.2 15.1 25.9 30.8 24.9 14.8 21.3 23.4 10.9 25.3 13.0 19.8 8.2 13.6 10.6 12.3 23.1 11.8 26.3 12.3 36.3 14.2 14.8 10.8 29.0 16.6 15.6 10.2 24.5 28.1 28.4 19.9 17.7 17.5 20.2 20.3 9.8 21.4 29.3 14.5 17.1 16.4 13.0 20.7 11.2 10.8 15.6 17.2 22.7 33.7 14.2 17.3 22.1 3.1 4.7 3.2 3.5 4.9 3.6 4.6 2.7 5.1 4.0 4.2 3.6 3.4 1.5 3.8 3.1 3.8 4.3 3.3 3.6 4.1 4.9 4.5 4.2 4.1 3.3 3.5 3.7 3.7 3.1 4.0 4.3 15.9 9.6 7.5 11.8 16.2 0.6 12.7 1.0 20.5 9.4 14.0 15.7 27.3 15.7 6.7 11.0 6.2 22.5 15.1 15.4 35.2 23.3 3.0 16.9 28.1 11.5 13.8 16.6 18.9 24.7 25.3 13.6 13.7 20.2 6.3 15.1 14.3 25.8 19.9 16.8 17.3 19.5 2.0 19.7 0.5 2.4 22.4 14.9 1.8 11.2 24.2 9.8 21.6 9.0 17.2 29.7 11.9 22.6 19.1 9.0 20.6 34.6 5.3 9.3 0.0 10.8 12.3 7.5 13.8 22.9 0.9 13.4 14.4 17.9 19.8 10.3 TARS3 "FLJ25005, TARSL2, ThrRS-L" ENSG00000185418 "Threonyl-tRNA synthetase 3" A2RTX5 15 101653596-101724473 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.7;skeletal muscle: 38.9;tongue: 37.0" "Cell type enhanced" "Detected in some" "Adipocytes: 7.7;B-cells: 9.5;Cardiomyocytes: 41.0;dendritic cells: 27.6;Plasma cells: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066697 Enhanced Approved Cytosol NA NA Cytosol "HPA066697: AB_2685705" "unprognostic (9.33e-3)" "unprognostic (2.13e-2)" "unprognostic (1.88e-1)" "unprognostic (2.54e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (8.45e-2)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-2)" "unprognostic (2.26e-3)" "unprognostic (9.76e-3)" "unprognostic (4.00e-2)" "unprognostic (2.23e-1)" "unprognostic (7.52e-2)" "unprognostic (6.48e-3)" "unprognostic (2.79e-2)" 4.9 4.3 18.8 4.1 25.9 3.2 4.7 20.9 21.0 6.0 10.7 6.6 3.8 4.4 3.5 3.8 5.2 3.5 15.3 16.3 20.1 5.2 3.7 3.8 4.7 22.0 21.6 14.7 7.0 6.5 7.5 6.4 1.9 24.2 5.8 3.7 6.2 5.0 5.9 38.9 3.3 6.3 4.2 20.5 4.4 5.8 3.5 20.6 4.2 6.2 37.0 4.7 7.0 4.6 35.7 2.5 4.6 7.9 4.3 8.4 6.4 3.9 8.6 5.8 6.5 4.0 6.8 2.2 3.3 3.3 10.3 5.3 7.6 13.8 4.9 6.0 3.8 22.0 8.1 2.9 5.5 3.9 3.8 1.7 4.5 4.6 3.2 3.7 7.7 4.7 7.0 8.0 6.9 6.6 4.3 2.0 7.4 9.5 12.5 3.3 4.1 12.0 8.6 5.7 2.7 12.5 8.2 11.5 4.5 5.1 14.5 2.9 8.0 6.4 3.2 7.4 6.4 2.8 9.6 11.5 4.1 8.2 6.6 5.9 0.8 1.0 1.5 2.7 1.5 2.7 4.9 5.0 4.3 0.7 7.5 4.9 2.6 0.2 7.9 0.7 1.7 0.9 1.1 18.8 25.9 20.9 21.0 16.3 20.1 22.0 21.6 14.7 24.2 20.5 20.6 35.7 7.7 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 3.3 27.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 5.4 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.2 7.3 0.0 0.0 0.0 SMYD3 "KMT3E, ZMYND1, ZNFN3A1" ENSG00000185420 "SET and MYND domain containing 3" Q9H7B4 1 245749342-246507312 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 406.1;Excitatory neurons: 725.6;Inhibitory neurons: 788.3;Microglial cells: 277.3;Oligodendrocyte precursor cells: 372.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 402.2;K-562: 162.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012229, HPA045821, HPA054352" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB012229: , HPA045821: AB_2679461, HPA054352: AB_2682458" "unprognostic (7.00e-3)" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (6.18e-3)" "unprognostic (3.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.25e-3)" "unprognostic (1.72e-3)" "unprognostic (4.53e-2)" "unprognostic (1.57e-1)" "unprognostic (1.71e-1)" "unprognostic (2.10e-1)" "unprognostic (3.78e-5)" "unprognostic (9.03e-3)" "unprognostic (2.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.58e-1)" 7.3 12.3 8.8 5.0 10.4 9.8 11.2 16.9 9.8 9.2 6.3 7.3 5.0 7.2 22.3 6.5 10.4 8.2 6.4 10.7 10.9 9.4 6.1 9.9 7.8 7.7 8.3 9.2 8.2 7.9 9.5 9.3 5.3 10.4 6.9 8.9 7.1 6.7 5.4 11.7 7.9 6.0 6.8 4.5 5.8 7.4 8.7 11.6 10.9 16.1 9.9 7.8 10.1 6.0 8.5 20.8 12.6 17.8 15.4 19.9 27.1 17.3 28.7 21.4 33.4 74.4 16.2 23.7 33.5 22.6 27.0 20.8 13.2 16.3 32.1 111.3 17.7 16.4 20.0 17.9 19.5 37.3 20.1 402.2 73.5 7.6 44.3 28.5 25.3 23.1 23.5 162.0 11.5 33.0 7.0 38.8 38.8 15.9 29.1 19.5 35.5 21.3 48.9 24.5 29.3 41.9 19.8 13.5 2.0 26.4 19.3 16.5 33.8 17.6 15.9 11.0 11.4 34.8 57.0 16.7 17.3 30.5 27.3 18.8 13.1 4.6 11.5 12.9 4.1 13.7 14.2 13.7 16.4 8.0 15.8 15.1 16.1 3.2 27.5 4.6 5.0 16.2 12.1 8.8 10.4 16.9 9.8 10.7 10.9 7.7 8.3 9.2 10.4 4.5 11.6 8.5 14.2 6.4 30.7 406.1 16.2 12.2 14.7 26.5 13.1 7.7 8.7 9.3 9.1 4.3 18.9 12.9 22.9 8.1 15.8 5.1 15.6 22.3 54.8 24.9 14.3 12.7 25.1 6.3 725.6 31.1 42.6 15.9 9.2 13.6 110.9 25.7 12.5 4.9 12.3 10.1 788.3 7.9 26.4 4.1 10.2 110.9 11.1 6.0 12.4 277.3 3.7 7.6 16.5 372.4 136.5 24.0 3.7 17.3 19.9 4.8 4.0 19.3 36.9 13.2 0.0 12.1 20.7 19.6 27.5 12.0 11.5 7.3 18.3 46.3 8.8 10.0 METTL7A DKFZP586A0522 ENSG00000185432 "Methyltransferase like 7A" Q9H8H3 12 50923472-50932510 "Metabolic proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 444.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 986.4;Kupffer cells: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 95.7;classical monocyte: 35.7;eosinophil: 70.7;intermediate monocyte: 38.0;memory B-cell: 32.4;myeloid DC: 31.0;naive B-cell: 34.4;non-classical monocyte: 59.5;plasmacytoid DC: 25.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 420.7;Karpas-707: 401.7;RPMI-8226: 238.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017434 Supported "Lipid droplets" NA NA 18000 "Lipid droplets" "HPA017434: AB_1853835" "unprognostic (2.31e-2)" "unprognostic (2.82e-2)" "unprognostic (9.85e-3)" "unprognostic (9.43e-2)" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.09e-3)" "unprognostic (2.68e-3)" "unprognostic (5.48e-2)" "unprognostic (9.94e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "prognostic favorable (0.00e+0)" "unprognostic (8.64e-2)" "unprognostic (5.94e-2)" "unprognostic (1.39e-1)" "unprognostic (1.22e-2)" 144.9 87.5 58.2 35.5 65.6 15.4 55.1 69.3 54.0 44.3 63.1 68.3 63.3 43.3 30.0 39.4 89.9 80.3 28.4 50.7 106.7 146.3 444.2 60.6 49.8 81.1 72.5 37.7 91.5 116.5 48.5 17.5 25.6 67.9 28.7 63.9 15.6 61.2 42.0 65.2 25.8 61.0 62.5 61.7 54.0 88.2 19.5 70.7 30.0 245.4 53.6 50.6 51.2 35.7 69.2 1.5 0.2 8.4 61.3 420.7 115.0 130.0 1.1 8.9 1.0 1.5 4.7 5.2 69.7 5.2 4.6 1.0 8.2 6.1 6.9 0.3 7.1 15.4 17.0 11.1 43.2 88.0 4.5 33.7 118.0 0.9 0.9 0.5 2.1 26.9 2.5 10.1 401.7 3.9 0.0 3.3 19.8 44.6 1.6 0.0 3.7 0.5 238.2 20.3 79.1 21.9 37.3 1.5 41.0 1.0 11.5 114.4 4.1 17.1 1.0 1.2 4.8 0.5 18.7 3.7 30.3 7.8 8.4 0.5 95.7 35.7 70.7 2.4 38.0 1.5 32.4 1.0 2.2 31.0 34.4 0.3 1.6 2.1 10.3 59.5 25.3 9.4 17.7 58.2 65.6 69.3 54.0 50.7 106.7 81.1 72.5 37.7 67.9 61.7 70.7 69.2 73.5 201.9 125.6 96.0 47.2 8.7 53.4 41.8 30.1 2.9 37.4 26.7 14.1 240.2 72.5 71.7 0.0 76.7 19.9 159.0 43.0 11.9 2.2 64.2 48.1 43.5 67.9 131.8 4.1 37.3 29.6 83.0 75.4 28.4 32.9 16.5 140.7 986.4 37.3 8.4 5.1 64.4 30.5 308.8 23.1 10.6 216.6 73.2 12.4 45.0 59.8 114.2 29.9 43.2 10.6 3.5 59.3 149.0 65.7 30.2 134.6 145.6 263.1 5.3 52.6 57.3 42.2 1.6 1.4 28.3 9.2 38.3 12.9 52.7 74.8 46.2 IFNLR1 "CRF2/12, IFNLR, IL-28R1, IL28RA" ENSG00000185436 "Interferon lambda receptor 1" Q8IU57 1 24154168-24187959 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 17.4;Proximal enterocytes: 18.2;Urothelial cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 4.9;naive B-cell: 5.9;plasmacytoid DC: 11.3" "Group enriched" "Detected in many" 5 "B-cells: 5.9;dendritic cells: 11.3" "Cell line enhanced" "Detected in many" "U-266/70: 51.4;U-266/84: 19.4;U-698: 40.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017319 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA017319: AB_1851708" "prognostic favorable (5.12e-4)" "unprognostic (7.16e-2)" "unprognostic (8.61e-3)" "unprognostic (8.48e-2)" "unprognostic (8.09e-2)" "unprognostic (1.22e-2)" "unprognostic (7.28e-3)" "unprognostic (2.33e-1)" "unprognostic (5.10e-2)" "unprognostic (1.93e-1)" "unprognostic (5.51e-2)" "unprognostic (4.50e-1)" "unprognostic (3.66e-3)" "unprognostic (5.15e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (1.10e-1)" 0.3 2.2 1.0 2.8 1.4 0.6 2.6 6.0 1.0 1.0 1.6 3.8 5.9 0.9 2.0 3.6 1.9 2.1 2.6 0.6 2.3 2.3 8.5 2.9 7.9 1.9 1.9 0.1 1.3 5.0 5.2 6.0 0.3 3.4 3.4 4.1 1.8 4.5 2.2 3.6 7.4 9.3 0.4 2.3 2.8 2.9 1.0 2.2 1.4 4.4 1.4 9.8 2.2 2.3 1.5 6.7 1.3 0.0 0.0 0.0 0.0 1.6 0.0 0.6 1.2 1.0 11.3 1.9 14.3 15.1 0.0 5.4 5.0 6.6 11.6 0.9 3.0 3.5 0.0 2.3 3.4 0.0 0.0 0.0 0.0 3.8 0.3 3.5 2.5 0.0 2.9 0.3 0.0 0.0 1.6 0.2 0.4 14.0 0.5 4.1 0.1 0.0 1.2 2.6 2.8 2.0 1.3 3.5 2.0 1.4 2.4 2.7 0.1 0.0 0.0 2.7 0.0 0.1 51.4 19.4 40.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 4.9 0.3 1.4 0.0 5.9 0.5 1.4 0.0 0.0 0.0 11.3 0.3 0.5 1.0 1.4 6.0 1.0 0.6 2.3 1.9 1.9 0.1 3.4 2.3 2.2 1.5 0.5 0.0 4.8 2.3 5.9 11.1 10.0 4.1 12.5 3.4 1.4 3.2 3.5 2.8 2.3 1.8 0.0 0.6 5.3 17.4 3.9 2.9 2.2 3.4 0.2 0.5 0.0 0.0 2.2 2.3 1.0 0.8 3.1 2.7 0.0 1.5 0.0 8.4 2.3 0.0 2.8 4.1 0.0 0.8 1.9 4.3 0.3 3.0 0.0 2.8 5.5 2.9 0.0 0.5 0.1 2.4 6.1 0.0 12.5 4.3 18.2 2.3 5.1 2.3 0.0 0.0 0.6 0.0 0.7 8.3 12.6 0.3 2.2 0.1 3.3 17.2 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 1280.3;tongue: 583.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 180.2;Distal tubular cells: 46.9;Early spermatids: 151.2" "Cancer enhanced" "Detected in all" "glioma: 21.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 101.0" "Low region specificity" "Detected in all" CAB003685 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003685: AB_425682" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 9.0 24.2 47.9 3.6 45.6 2.0 11.3 44.1 60.2 10.9 38.9 28.2 6.7 12.4 28.7 20.5 8.2 9.5 155.6 50.5 44.9 13.3 11.9 5.5 2.0 50.5 43.0 39.6 6.0 11.1 10.8 25.8 2.1 45.6 25.4 7.1 14.9 14.3 21.4 1280.3 4.7 8.6 11.1 46.3 3.3 17.0 20.3 45.8 3.2 16.4 583.2 2.2 21.0 8.2 60.8 2.0 2.9 3.7 4.2 5.5 9.2 1.0 2.7 0.6 1.9 1.5 1.6 3.9 6.6 8.9 10.9 14.5 0.3 1.2 3.1 2.9 3.9 7.6 7.6 0.9 3.1 15.1 2.8 1.3 7.6 13.5 7.0 12.1 3.4 1.8 13.9 5.0 7.7 7.8 9.4 3.7 4.2 3.2 6.2 6.2 6.5 13.1 4.5 8.3 1.8 10.0 4.0 5.8 4.9 5.4 2.3 19.8 0.5 1.6 5.0 0.6 3.1 7.9 26.3 5.7 6.7 101.0 5.0 6.9 0.0 0.2 0.0 0.2 0.9 0.9 1.4 0.4 0.9 0.9 0.6 1.6 1.2 0.2 1.2 0.9 3.7 0.1 0.4 47.9 45.6 44.1 60.2 50.5 44.9 50.5 43.0 39.6 45.6 46.3 45.8 60.8 2.4 3.2 3.9 15.3 1.4 2.7 12.8 5.9 1.8 2.1 11.4 25.0 180.2 5.7 4.4 5.5 4.2 3.7 3.2 2.3 46.9 5.1 151.2 11.3 5.0 3.1 1.2 0.8 6.4 21.3 1.7 5.6 3.6 10.6 4.5 5.3 2.2 9.2 2.4 5.0 6.5 1.7 4.1 1.6 2.0 35.4 2.1 1.5 12.4 5.6 1.2 21.2 0.0 3.0 14.6 4.8 3.2 5.7 1.0 3.3 2.3 14.4 6.7 6.2 6.6 22.7 16.9 32.4 23.6 1.1 1.7 1.9 1.4 4.7 2.7 4.6 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617448-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Intestinal goblet cells: 60.9;Late spermatids: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;granulocytes: 2.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "CACO-2: 74.3;MCF7: 91.8;OE19: 76.3;RPMI-8226: 109.6;RT4: 221.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 5.5 5.7 12.6 5.9 12.6 1.1 27.5 9.5 14.7 17.0 8.5 10.8 6.4 8.2 7.3 8.5 24.2 6.1 8.2 14.0 14.0 5.3 6.9 21.2 8.6 14.1 12.4 13.0 16.3 77.3 3.0 26.7 6.7 14.2 32.5 15.3 6.5 52.9 16.4 16.4 8.0 8.6 4.9 8.3 4.1 35.3 18.1 14.5 8.1 37.5 16.0 7.5 26.5 6.6 19.7 0.3 12.2 8.0 2.4 0.0 0.2 1.0 4.6 21.8 0.2 0.0 74.3 8.6 1.2 20.6 0.6 5.8 0.4 13.9 0.5 0.0 0.5 6.5 0.7 1.4 1.0 1.3 1.1 3.2 1.0 0.3 0.2 0.2 0.5 10.5 6.8 1.2 54.7 12.2 91.8 2.7 0.1 39.2 76.3 0.0 8.9 22.5 109.6 5.4 221.3 4.9 3.9 6.4 42.7 14.3 22.7 33.8 7.9 0.0 0.0 1.6 0.3 10.3 1.7 17.2 2.6 0.2 0.8 5.3 0.9 0.6 0.8 0.1 0.7 0.2 0.3 1.8 0.0 0.5 0.3 2.0 2.6 2.9 0.7 0.0 3.5 8.9 0.6 12.6 12.6 9.5 14.7 14.0 14.0 14.1 12.4 13.0 14.2 8.3 14.5 19.7 8.5 105.8 22.2 13.7 1.7 2.3 14.7 1.7 5.7 7.0 26.3 11.3 5.2 5.7 12.6 7.3 8.4 1.4 2.3 3.7 7.9 5.5 22.6 17.8 4.2 10.3 42.1 0.8 24.0 14.6 21.2 4.9 19.4 23.4 18.4 1.3 22.1 7.0 5.4 11.8 24.4 60.9 24.4 3.8 4.8 57.8 5.9 4.9 12.4 22.5 0.4 3.9 0.0 17.1 44.8 19.1 1.6 1.9 6.6 24.2 3.0 1.5 14.5 3.7 0.0 7.7 3.7 1.0 5.0 3.9 3.0 0.7 3.4 1.8 5.5 24.3 FAM47A MGC27003 ENSG00000185448 "Family with sequence similarity 47 member A" Q5JRC9 X 34129756-34132314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 3.0" "Group enriched" "Detected in some" 5 "Early spermatids: 13.1;Late spermatids: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA000610 Uncertain NA NA "HPA000610: AB_1078805" "unprognostic (1.68e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSWIM9 "C19orf68, LOC374920" ENSG00000185453 "Zinc finger SWIM-type containing 9" Q86XI8 19 48170680-48197620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in many" "Adipocytes: 6.1;Granulosa cells: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061028 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061028: AB_2684419" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (5.79e-3)" "unprognostic (1.65e-1)" "unprognostic (8.49e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.35e-5)" "unprognostic (1.26e-1)" "unprognostic (2.93e-1)" "unprognostic (6.96e-2)" "unprognostic (3.19e-3)" "unprognostic (2.20e-2)" "prognostic favorable (2.44e-4)" "unprognostic (3.59e-1)" "unprognostic (2.64e-1)" "unprognostic (7.07e-2)" "unprognostic (1.03e-1)" 3.6 2.4 18.0 2.2 16.0 2.4 3.3 10.9 14.3 5.3 8.0 5.9 2.2 6.2 0.9 4.1 4.9 1.3 4.5 14.1 13.2 2.7 2.7 3.0 2.6 18.9 14.6 13.3 5.6 4.7 2.6 3.6 1.8 16.1 4.2 1.3 1.7 3.5 2.5 9.2 5.2 4.1 2.3 13.1 3.6 3.9 4.0 14.6 2.0 4.4 2.8 1.4 6.2 4.7 13.7 9.5 10.4 6.1 4.5 3.9 2.2 5.5 7.2 3.8 3.3 3.8 1.7 3.0 7.6 3.4 3.3 4.1 7.8 2.0 4.4 3.6 11.5 7.6 4.8 7.0 4.4 4.2 4.4 3.9 2.3 3.5 4.8 5.7 5.9 3.4 6.0 1.2 4.0 2.1 5.1 4.8 18.5 3.8 8.9 6.6 8.9 5.5 2.1 2.3 7.7 4.2 5.2 10.0 3.1 5.0 3.7 4.3 6.6 8.6 3.9 7.1 3.3 7.9 6.5 7.0 4.5 2.3 6.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 16.0 10.9 14.3 14.1 13.2 18.9 14.6 13.3 16.1 13.1 14.6 13.7 6.1 3.2 3.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 5.5 0.0 0.0 0.6 3.7 0.0 5.6 2.2 0.0 3.9 4.1 0.0 3.2 5.6 2.4 0.0 0.0 0.0 5.8 2.8 2.4 0.0 5.5 2.5 11.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.7 0.0 0.0 2.4 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.7 1.7 5.8 0.0 0.0 KPNA7 IPOA8 ENSG00000185467 "Karyopherin subunit alpha 7" A9QM74 7 99173572-99250075 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "stomach 1: 3.6" "Cell type enhanced" "Detected in some" "Ductal cells: 5.7;Gastric mucus-secreting cells: 5.1;Pancreatic endocrine cells: 11.7;Respiratory ciliated cells: 4.4;Urothelial cells: 11.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 3.8;CAPAN-2: 2.8;OE19: 2.8;SK-BR-3: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA031395 Uncertain NA NA "HPA031395: AB_10601584" "unprognostic (7.38e-2)" "unprognostic (7.99e-2)" "unprognostic (2.23e-1)" "unprognostic (8.44e-2)" "unprognostic (8.37e-2)" "unprognostic (9.35e-2)" "unprognostic (9.77e-2)" "unprognostic (2.25e-2)" "unprognostic (2.30e-1)" "unprognostic (3.23e-1)" "unprognostic (7.94e-3)" "unprognostic (5.89e-2)" "unprognostic (2.28e-13)" "unprognostic (2.21e-2)" "unprognostic (1.23e-1)" "unprognostic (3.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.7 0.0 0.5 1.8 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 5.7 0.0 1.3 0.1 0.0 0.0 0.0 0.8 3.1 0.1 0.4 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 11.7 2.2 0.0 0.1 1.9 0.1 0.0 4.4 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 11.4 TMEM179B ENSG00000185475 "Transmembrane protein 179B" Q7Z7N9 11 62787402-62790400 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016585, HPA062068" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA016585: AB_1844357, HPA062068: AB_2684676" "unprognostic (1.18e-2)" "unprognostic (2.83e-1)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.68e-1)" "unprognostic (6.11e-3)" "unprognostic (1.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.44e-1)" "unprognostic (1.25e-2)" "unprognostic (4.61e-3)" "unprognostic (2.76e-2)" "unprognostic (4.56e-1)" "unprognostic (1.64e-1)" "unprognostic (2.16e-1)" "unprognostic (5.74e-3)" "unprognostic (3.60e-2)" 51.8 60.8 30.9 22.2 33.0 21.7 55.5 32.8 36.7 49.8 39.0 42.2 35.0 44.7 71.9 48.3 47.1 28.7 33.7 29.5 34.6 54.5 64.9 51.4 27.1 34.6 32.1 28.5 39.9 59.2 34.4 31.2 30.2 33.8 46.2 40.5 10.5 59.6 26.7 27.4 58.6 50.3 26.5 32.9 48.4 54.4 41.9 33.0 33.3 55.9 21.8 30.1 43.6 46.4 35.9 35.6 68.8 17.7 35.7 136.3 34.3 22.6 38.2 47.5 29.8 34.2 39.3 82.9 16.5 53.1 78.0 44.2 64.8 33.4 35.4 23.2 48.6 44.9 24.1 29.2 36.3 90.8 30.9 32.2 65.8 55.8 57.1 70.0 60.0 30.3 46.9 33.2 46.3 34.5 81.1 40.2 59.5 26.5 76.8 74.6 26.5 28.8 86.1 57.7 42.6 24.4 26.7 49.3 65.3 70.4 35.8 76.2 37.8 42.2 39.6 29.4 73.3 32.2 51.2 32.5 22.6 57.0 19.0 47.3 302.9 300.4 332.7 149.4 305.0 147.9 169.2 135.5 144.9 198.2 140.6 118.2 117.3 224.3 140.2 305.9 366.1 146.6 282.5 30.9 33.0 32.8 36.7 29.5 34.6 34.6 32.1 28.5 33.8 32.9 33.0 35.9 119.6 60.9 59.2 15.3 52.7 68.7 73.9 175.6 86.0 12.4 108.0 122.2 1.3 65.8 121.1 60.7 0.0 174.5 71.7 91.2 37.2 138.1 5.8 75.2 54.5 83.7 65.2 40.4 9.9 149.0 160.5 76.8 54.6 66.5 54.6 43.8 69.9 81.9 133.2 8.4 9.0 103.5 128.1 63.7 83.0 11.0 75.8 76.5 106.7 12.2 98.3 74.4 91.6 16.1 28.1 124.0 137.1 45.9 93.9 97.1 179.4 87.5 122.9 14.7 65.7 50.5 57.8 120.8 100.5 93.2 76.0 185.1 60.0 90.4 94.8 97.5 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236383-89307800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 2.5 1.2 3.0 9.1 7.4 7.8 1.4 18.0 2.9 2.2 0.9 5.4 6.2 1.4 0.7 0.9 0.9 3.5 4.1 2.0 7.1 3.9 2.0 7.0 10.3 4.1 5.8 2.2 3.2 5.1 0.6 2.9 1.0 5.8 0.8 7.1 3.6 1.5 0.6 1.0 0.6 5.4 1.4 5.5 7.2 3.6 0.4 4.7 2.8 1.3 3.2 7.9 2.8 1.0 4.6 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.8 0.1 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 102.6 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.7 0.0 27.7 0.3 0.1 27.2 0.6 0.0 0.1 1.1 1.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 15.9 13.2 0.1 0.5 0.0 0.0 0.0 0.3 0.0 2.8 1.0 3.8 0.2 2.7 2.2 0.9 0.0 1.1 1.1 0.0 1.9 1.5 0.0 3.4 1.0 3.0 7.4 18.0 2.9 2.0 7.1 4.1 5.8 2.2 5.8 5.5 4.7 4.6 11.1 0.0 22.6 10.1 6.7 1.1 0.9 0.1 0.0 12.2 1.6 1.7 20.3 8.6 5.0 3.7 0.0 0.2 51.2 17.4 1.9 2.0 0.2 5.8 3.4 11.7 78.7 6.5 21.7 9.4 0.1 3.0 15.8 15.0 7.6 12.2 1.8 0.4 18.7 26.9 32.7 38.0 0.0 28.2 29.0 0.0 0.3 53.9 1.8 41.2 7.4 1.0 23.7 26.2 0.5 1.3 11.0 1.2 48.6 0.3 16.3 1.9 0.7 10.8 78.9 3.3 32.7 0.1 0.8 0.3 1.0 0.3 76.9 0.7 26.2 0.5 KRT6B KRTL1 ENSG00000185479 "Keratin 6B" P04259 12 52446651-52452146 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "esophagus: 942.0" "Cell type enriched" "Detected in some" 4 "Squamous epithelial cells: 217.5" "Group enriched" "Detected in many" 5 "head and neck cancer: 1424.3;melanoma: 472.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 148.7" "CAB000130, HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440" "prognostic favorable (9.44e-4)" "unprognostic (3.27e-2)" "unprognostic (1.93e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-2)" "unprognostic (2.07e-3)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (5.77e-2)" "unprognostic (9.63e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (9.52e-4)" 0.5 0.2 0.0 2.0 0.0 0.1 16.4 0.0 0.0 109.0 0.0 0.3 0.0 0.1 0.0 942.0 0.2 0.2 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 169.9 0.0 0.3 208.9 0.2 0.0 0.0 0.1 0.7 0.2 0.0 2.1 0.1 0.0 74.9 0.2 231.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 27.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.7 1.1 0.0 0.1 13.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 20.6 1.8 40.4 0.0 0.0 28.7 16.8 0.1 0.0 16.3 0.0 0.0 0.0 0.9 0.3 0.0 46.2 1.8 0.0 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.0 1.7 1.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 5.6 0.0 0.0 2.8 0.0 0.0 0.0 1.4 0.0 0.2 217.5 32.7 0.0 0.3 0.0 0.6 5.9 PARPBP "C12orf48, FLJ20641, PARI" ENSG00000185480 "PARP1 binding protein" Q9NWS1 12 102120183-102197520 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.3;lymphoid tissue: 7.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 20.0;Spermatogonia: 17.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039677 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039677: AB_10673426" "unprognostic (7.84e-3)" "unprognostic (1.34e-2)" "unprognostic (4.54e-3)" "unprognostic (3.03e-2)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" "unprognostic (1.30e-5)" "unprognostic (2.52e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.38e-1)" "unprognostic (3.95e-3)" "unprognostic (2.83e-1)" "unprognostic (5.61e-8)" "unprognostic (3.50e-3)" "unprognostic (2.34e-1)" "unprognostic (9.16e-3)" "unprognostic (6.14e-2)" 0.8 0.6 0.2 3.1 0.2 9.3 1.9 0.3 0.4 1.2 0.2 3.1 2.3 1.3 0.6 3.6 0.6 1.1 0.3 0.2 0.5 0.9 0.6 0.6 4.2 0.3 0.3 0.2 0.7 0.2 0.3 0.2 2.3 0.5 1.0 3.8 0.2 0.9 0.9 0.4 2.0 2.7 1.7 0.3 1.2 1.8 3.9 0.3 7.6 0.5 0.4 5.1 1.9 1.2 0.4 13.5 27.2 23.6 13.7 3.8 3.4 16.7 19.9 11.0 32.0 27.9 14.8 10.4 25.4 11.4 7.8 16.2 14.5 38.5 11.7 34.2 25.7 22.6 31.9 15.7 13.9 1.1 33.5 9.1 3.3 2.8 22.3 14.4 8.3 21.6 18.9 31.0 15.3 21.1 10.7 30.5 31.1 31.7 17.8 26.6 20.4 38.9 16.7 10.3 21.1 15.9 14.7 13.8 16.6 11.8 24.0 27.1 12.1 8.5 16.5 15.7 20.2 25.3 11.3 24.8 22.8 11.4 33.7 22.4 2.6 0.4 1.0 0.5 0.6 0.1 1.1 0.9 0.8 0.7 0.7 0.5 0.6 0.0 0.5 0.4 0.7 1.8 0.7 0.2 0.2 0.3 0.4 0.2 0.5 0.3 0.3 0.2 0.5 0.3 0.3 0.4 1.1 0.0 0.0 2.9 4.3 3.7 1.5 3.6 0.6 1.9 2.4 2.4 0.7 1.5 2.5 1.8 0.0 11.3 2.3 1.5 5.9 1.6 2.5 3.0 11.6 2.5 1.8 20.0 4.1 1.3 13.9 4.8 6.1 3.0 5.7 15.0 2.2 0.1 6.5 3.3 5.3 3.1 10.2 5.7 4.3 2.6 1.2 3.1 0.0 3.7 1.7 0.2 2.1 3.5 4.1 1.2 0.8 0.4 14.2 0.7 1.3 1.8 1.4 0.9 0.0 1.1 2.8 16.0 17.7 9.8 1.6 3.6 4.1 9.3 7.8 1.6 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251188 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 40 "skeletal muscle: 2337.2;tongue: 1179.3" "Cell type enriched" "Detected in many" 7 "Skeletal myocytes: 287.7" "Cancer enhanced" "Detected in all" "head and neck cancer: 11.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 5.8" "Group enriched" "Detected in many" 6 "dendritic cells: 3.6;monocytes: 5.8" "Cell line enriched" "Detected in many" 23 "RH-30: 2282.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039285: AB_2676427, HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 2.8 2.0 3.2 7.4 3.2 18.0 2.2 5.2 5.3 1.5 2.9 2.6 2.0 0.8 2.8 31.5 1.7 2.4 1.4 3.2 3.0 1.8 4.4 6.6 8.9 3.1 3.1 3.0 1.0 1.4 2.6 2.1 2.9 3.8 23.2 3.0 3.2 44.3 1.1 2337.2 2.6 2.6 2.5 2.7 9.2 1.7 12.0 3.1 4.2 2.2 1179.3 7.5 2.5 1.3 4.0 0.6 0.8 2.1 4.0 1.3 2.2 0.8 0.5 0.5 0.5 0.7 0.5 1.9 55.0 1.1 1.2 0.0 1.0 0.9 1.1 0.2 1.4 1.0 27.9 0.3 0.6 0.5 17.2 97.1 10.0 1.6 0.4 0.6 1.3 0.9 6.1 2.9 2.2 7.5 5.4 1.6 36.3 0.1 0.8 1.0 13.0 2282.0 2.6 1.3 1.2 1.4 1.1 1.6 1.5 0.3 0.3 0.9 48.4 1.0 0.5 0.4 1.6 0.4 2.2 1.2 9.6 1.1 32.9 0.7 0.0 4.4 0.3 0.0 5.8 0.0 0.7 0.0 0.2 3.6 0.3 0.0 0.1 0.2 0.0 2.9 1.0 0.2 1.4 3.2 3.2 5.2 5.3 3.2 3.0 3.1 3.1 3.0 3.8 2.7 3.1 4.0 0.4 0.0 0.6 1.3 1.9 1.5 0.4 1.1 0.6 7.5 1.2 1.4 0.3 1.5 0.4 0.0 2.1 1.0 2.8 0.9 0.0 0.8 13.5 1.1 0.6 0.7 2.4 0.4 3.0 1.0 0.7 0.8 1.1 0.9 5.7 1.5 1.8 1.3 39.9 1.7 2.4 1.2 4.1 37.3 16.3 8.9 1.2 24.1 0.0 0.0 26.3 1.5 0.0 1.5 1.2 0.9 1.0 0.7 0.5 1.0 1.6 0.7 2.3 2.5 0.0 287.7 1.0 3.4 1.4 0.6 0.3 1.4 1.6 0.8 1.2 0.4 ROR1 NTRKR1 ENSG00000185483 "Receptor tyrosine kinase like orphan receptor 1" Q01973 1 63774017-64181498 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 27.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Astrocytes: 81.0;Inhibitory neurons: 69.7;Microglial cells: 36.5;Oligodendrocytes: 109.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 40.5;ASC TERT1: 50.3;CACO-2: 36.8;HHSteC: 38.3;HSkMC: 41.6;NTERA-2: 43.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 7700000 "unprognostic (5.15e-2)" "unprognostic (1.19e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-2)" "unprognostic (6.24e-2)" "unprognostic (1.61e-1)" "unprognostic (7.11e-3)" "unprognostic (1.41e-1)" "unprognostic (4.06e-1)" "unprognostic (3.84e-1)" "unprognostic (3.20e-2)" "unprognostic (2.02e-2)" "unprognostic (3.64e-3)" "unprognostic (1.48e-2)" "unprognostic (1.52e-1)" "unprognostic (5.87e-2)" "unprognostic (5.15e-2)" 4.5 1.1 1.7 2.2 1.3 0.4 3.8 3.0 1.0 7.5 4.1 3.5 2.2 7.2 1.4 5.2 2.6 5.2 7.6 0.7 1.2 2.4 0.5 7.0 1.2 0.8 0.9 0.3 8.4 5.6 27.1 0.5 3.1 2.1 5.5 4.1 1.5 1.2 6.5 2.3 2.3 1.7 7.8 0.4 3.2 6.5 1.5 0.9 2.5 1.4 1.6 1.1 4.2 2.3 0.9 15.5 12.2 5.9 0.8 40.5 50.3 4.0 2.9 8.3 1.6 4.3 36.8 4.9 0.3 6.6 7.2 2.9 3.2 0.1 2.9 1.1 0.0 3.7 0.0 1.6 0.5 38.3 0.0 0.0 41.6 10.9 21.7 25.2 8.4 0.7 0.5 0.0 0.3 11.0 0.2 0.2 0.1 43.0 11.3 6.1 0.2 0.2 9.8 8.7 0.3 3.4 13.6 0.8 0.2 6.4 19.9 0.1 0.0 8.4 3.3 5.7 23.0 6.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.7 1.3 3.0 1.0 0.7 1.2 0.8 0.9 0.3 2.1 0.4 0.9 0.9 1.1 51.3 10.5 81.0 1.8 3.8 2.2 0.5 29.0 4.7 3.0 2.0 11.4 1.5 1.3 1.8 0.0 0.2 0.1 1.3 0.0 5.6 9.6 1.2 9.2 1.8 21.5 0.0 11.6 15.2 1.0 14.5 16.8 1.9 0.0 1.1 0.7 0.0 7.6 0.0 69.7 2.2 2.0 0.6 4.9 8.1 27.7 0.5 3.6 36.5 0.0 5.3 0.0 3.5 109.9 15.3 0.8 14.7 0.1 1.4 0.0 3.4 0.8 0.3 6.6 6.8 8.5 1.4 1.8 11.5 4.5 0.3 0.2 0.3 3.3 0.8 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 448.3;stomach 1: 1073.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 1370.0;Collecting duct cells: 491.1;Exocrine glandular cells: 1164.9;Gastric mucus-secreting cells: 640.6;Pancreatic endocrine cells: 1074.8;Respiratory ciliated cells: 555.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Group enriched" "Detected in many" 6 "CAPAN-2: 1146.1;OE19: 548.3;RPTEC TERT1: 870.2;T-47d: 383.6" "Not detected" "Not detected" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4000000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 12.0 6.3 6.8 22.1 7.1 9.5 79.0 6.2 8.7 195.8 5.9 113.1 21.5 40.5 62.2 211.6 121.0 127.0 5.4 6.3 8.4 448.3 3.9 324.2 1.8 9.5 7.1 5.8 9.8 361.5 1.0 14.2 3.3 7.3 44.3 104.6 1.3 136.2 34.7 1.9 17.3 35.5 20.2 7.3 5.4 1073.3 48.2 7.2 1.2 55.2 0.7 18.9 103.0 50.4 7.4 15.3 8.2 5.1 4.8 3.9 4.2 1.7 5.6 12.2 6.2 15.2 0.2 1146.1 0.0 81.9 9.5 2.7 23.2 1.0 0.3 1.8 10.4 0.8 1.8 101.5 0.0 2.4 0.4 36.1 9.5 2.1 2.8 2.2 12.7 2.1 1.9 9.2 15.4 4.3 120.0 1.6 1.2 3.5 548.3 2.1 2.3 0.6 29.3 870.2 0.9 5.1 2.1 28.0 48.3 1.5 4.1 383.6 5.6 2.2 3.9 6.7 10.5 1.2 17.7 9.8 0.2 5.9 1.1 1.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.2 0.1 6.8 7.1 6.2 8.7 6.3 8.4 9.5 7.1 5.8 7.3 7.3 7.2 7.4 2.3 432.7 1370.0 5.9 6.4 0.6 18.5 126.4 0.0 1.3 219.2 48.5 0.4 327.5 374.9 491.1 4.2 0.5 1.5 271.8 35.2 177.3 32.7 245.2 28.8 8.0 30.6 1.3 0.3 1164.9 1.1 7.0 640.6 282.8 48.0 0.3 1.8 0.9 0.2 1.7 0.3 351.5 164.8 2.2 1.0 81.0 2.5 7.2 5.4 1.0 24.3 1.7 0.0 0.5 0.1 1074.8 60.5 1.5 1.3 16.3 6.8 1.3 555.3 0.2 0.0 2.0 22.0 5.8 0.8 3.5 1.1 0.3 10.3 0.1 220.8 154.5 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "FA core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 13.7 17.0 5.8 13.9 6.0 10.2 16.0 12.7 9.5 18.5 5.8 15.9 12.1 17.5 3.1 16.3 19.0 9.6 14.6 5.8 5.8 19.1 22.9 16.1 16.1 7.1 6.2 6.0 19.7 26.8 7.8 22.6 7.3 8.7 20.9 5.0 3.7 14.8 7.9 13.3 15.5 19.0 7.0 4.3 38.4 15.6 13.5 6.7 8.9 24.3 6.1 7.4 18.0 15.6 8.0 11.7 21.3 9.4 26.8 11.0 11.5 14.6 11.2 5.9 14.3 8.9 14.5 14.0 21.0 8.6 15.5 13.8 15.0 4.9 14.5 3.3 6.1 13.9 13.5 23.3 20.0 11.6 15.4 16.0 14.0 10.7 10.4 11.7 17.6 27.0 22.0 20.7 16.5 7.0 23.0 24.4 25.8 11.3 13.6 7.7 22.1 9.4 19.3 10.4 21.1 20.5 17.1 8.5 24.4 10.4 9.7 26.2 20.7 22.8 30.6 18.8 8.3 18.9 18.3 1.5 10.7 8.0 9.9 14.3 0.0 3.0 1.2 2.4 2.8 1.9 3.0 1.6 1.6 2.9 2.0 1.5 1.2 0.4 2.4 1.4 3.2 1.6 2.2 5.8 6.0 12.7 9.5 5.8 5.8 7.1 6.2 6.0 8.7 4.3 6.7 8.0 11.4 3.2 7.5 0.0 7.5 0.0 3.5 0.0 4.6 10.3 9.8 10.9 8.9 10.0 2.5 14.7 4.2 6.1 8.5 7.1 3.9 8.2 1.9 4.5 7.3 7.5 7.3 11.8 0.0 6.9 4.8 8.3 15.8 6.8 0.0 14.9 6.8 11.7 8.4 6.7 0.0 6.2 0.0 14.1 0.0 3.0 5.0 7.0 0.0 0.0 8.9 6.2 4.1 0.0 0.0 8.9 4.4 5.3 6.6 5.3 12.7 6.8 1.5 4.9 0.0 7.4 6.4 7.3 7.5 9.5 0.0 3.1 6.2 10.7 7.3 3.6 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615983 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 38.5;lymphoid tissue: 33.5" "Cell type enriched" "Detected in many" 7 "dendritic cells: 576.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in all" 12 "plasmacytoid DC: 596.9" "Lineage enriched" "Detected in all" 12 "dendritic cells: 596.9" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017694, HPA052757" Approved Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: AB_2681937" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 8.4 2.7 1.2 1.6 1.2 1.6 7.6 1.0 2.1 8.5 1.5 6.9 0.0 3.5 0.0 12.8 4.7 2.2 7.1 1.0 1.3 12.2 38.5 14.5 0.9 2.2 1.5 0.8 4.7 5.9 0.2 6.3 0.7 1.5 9.3 0.3 0.3 8.9 0.8 11.4 7.6 15.4 0.9 0.8 33.5 8.6 1.9 1.6 1.4 10.8 1.3 2.2 5.1 7.4 4.2 0.0 0.0 0.7 0.1 0.0 0.6 0.0 0.4 3.9 15.5 9.6 2.2 0.1 0.0 3.7 0.6 3.7 0.5 0.2 0.1 1.0 0.2 0.0 0.1 0.0 0.2 0.8 0.0 0.0 1.6 0.6 0.0 0.6 0.7 0.1 1.9 0.0 6.5 0.1 0.0 0.7 0.0 0.0 3.1 1.3 0.1 0.2 0.0 0.2 0.1 3.1 0.0 0.6 1.8 0.4 0.3 0.0 1.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.7 20.4 30.6 8.1 46.1 7.8 16.5 6.7 7.0 24.3 20.8 7.5 8.5 12.9 18.7 49.5 596.9 13.5 19.7 1.2 1.2 1.0 2.1 1.0 1.3 2.2 1.5 0.8 1.5 0.8 1.6 4.2 65.0 16.0 19.0 2.9 59.2 34.4 32.3 19.6 18.8 0.4 27.7 20.2 4.3 18.6 18.2 20.2 0.0 6.1 576.1 70.1 9.8 29.9 5.9 20.1 6.3 33.0 26.3 4.8 0.0 16.9 39.0 19.3 40.8 21.2 31.7 20.1 17.9 31.7 37.3 0.0 0.1 42.5 22.4 23.2 65.4 28.9 12.2 67.4 37.4 3.7 65.2 2.7 40.2 1.0 1.3 29.9 73.8 4.9 65.1 24.8 37.6 6.3 25.5 4.6 13.1 8.8 19.8 0.4 5.9 8.0 28.4 24.1 42.7 4.6 18.9 34.6 L3MBTL1 "dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3" ENSG00000185513 "L3MBTL histone methyl-lysine binding protein 1" Q9Y468 20 43489442-43550954 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 5.1" HPA059648 Supported "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA059648: " "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (5.66e-2)" "unprognostic (7.19e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-2)" "unprognostic (7.65e-4)" "unprognostic (6.02e-2)" "unprognostic (6.00e-2)" "unprognostic (2.23e-2)" "unprognostic (1.15e-3)" "unprognostic (1.20e-2)" "unprognostic (1.44e-3)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (2.89e-1)" "unprognostic (1.56e-4)" 2.6 4.8 9.1 0.8 9.0 0.8 4.0 7.1 9.3 6.4 6.6 5.2 1.1 5.1 2.0 4.2 6.9 0.6 3.7 8.8 9.5 5.9 2.0 3.0 0.8 8.7 8.3 9.6 7.5 3.3 1.1 16.9 0.6 8.6 6.4 0.7 3.4 4.6 1.7 5.1 3.8 4.9 0.8 6.7 5.5 3.9 10.2 10.1 0.8 7.0 1.1 0.5 4.9 6.4 8.5 0.1 0.1 1.6 0.9 0.1 0.0 2.6 0.2 0.3 0.5 0.4 0.2 1.7 0.9 0.4 0.9 0.5 1.1 0.0 0.4 0.3 0.0 1.1 0.3 1.4 2.1 0.3 0.0 0.3 0.3 0.6 0.1 0.0 2.9 0.3 0.9 0.6 0.2 0.1 0.3 0.4 1.2 1.0 0.7 1.4 0.6 0.2 0.5 1.2 0.4 0.4 1.3 0.5 0.5 0.1 5.1 0.6 1.7 0.6 0.2 1.1 0.0 0.4 1.0 0.4 0.3 1.5 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.2 9.1 9.0 7.1 9.3 8.8 9.5 8.7 8.3 9.6 8.6 6.7 10.1 8.5 1.2 3.2 3.2 16.0 3.3 0.9 2.0 1.9 8.0 17.2 2.7 2.8 1.9 1.5 4.2 5.5 14.6 2.1 5.2 0.9 1.9 1.3 2.0 2.4 2.6 2.2 1.2 1.7 12.4 0.2 3.3 1.9 2.0 1.8 5.1 8.3 1.8 0.6 1.4 6.7 24.4 2.1 4.1 1.6 1.8 2.8 5.0 2.0 3.6 4.7 1.0 4.7 4.1 31.2 25.4 0.8 1.9 6.0 1.7 2.5 3.1 0.7 6.6 10.8 0.0 4.2 2.8 13.9 12.3 1.5 1.1 1.9 2.3 4.6 1.8 1.4 BRCC3 "BRCC36, C6.1A, CXorf53" ENSG00000185515 "BRCA1/BRCA2-containing complex subunit 3" P46736 X 155071420-155123077 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Metalloprotease, Protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048737 Supported Nucleoplasm NA NA Nucleoplasm "HPA048737: AB_2680504" "unprognostic (1.16e-2)" "unprognostic (2.40e-2)" "unprognostic (5.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (2.88e-2)" "unprognostic (4.48e-2)" "unprognostic (6.47e-3)" "unprognostic (1.33e-1)" "unprognostic (9.68e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (3.71e-3)" "unprognostic (7.14e-3)" "unprognostic (1.57e-1)" "unprognostic (1.17e-1)" "unprognostic (1.90e-1)" 10.0 13.0 6.4 12.2 6.9 15.8 16.0 9.5 7.9 12.9 6.8 22.6 19.5 9.3 18.7 18.6 11.7 8.5 11.4 6.7 7.4 18.0 14.0 9.8 15.6 6.3 6.4 6.6 8.2 11.5 14.8 5.2 14.1 6.9 14.7 23.6 13.1 18.7 11.0 18.0 11.2 17.1 10.7 5.5 11.1 15.8 2.3 7.4 13.6 15.3 17.8 15.6 12.7 6.4 7.7 95.6 45.1 24.4 19.6 20.9 17.7 37.9 35.9 25.8 24.1 52.3 44.0 40.1 84.1 62.8 22.1 36.1 36.3 54.4 33.6 38.0 45.4 42.1 17.7 76.1 41.4 15.8 62.8 25.5 17.3 16.9 35.1 28.5 23.1 30.1 32.2 27.4 24.9 24.6 33.6 25.8 28.8 22.3 101.9 41.9 36.2 43.3 42.0 36.8 36.5 38.0 17.3 25.6 43.6 27.3 31.5 25.2 33.7 31.5 20.4 32.1 27.6 53.8 30.0 56.1 114.5 28.2 61.5 25.3 36.8 18.8 34.0 20.0 22.9 23.4 17.6 19.3 18.2 21.2 16.7 14.8 16.6 10.5 28.4 24.1 13.3 25.4 16.9 6.4 6.9 9.5 7.9 6.7 7.4 6.3 6.4 6.6 6.9 5.5 7.4 7.7 12.0 32.1 23.3 16.6 14.0 5.5 7.0 13.8 6.8 13.0 15.0 14.0 27.2 10.0 28.5 7.3 14.6 26.7 17.6 25.5 19.6 22.9 0.6 13.8 13.7 10.6 9.6 17.1 31.9 19.8 26.6 11.3 12.8 15.9 26.6 13.7 8.6 8.6 17.4 8.4 35.2 22.6 16.2 9.5 7.0 1.3 5.9 14.5 5.4 15.9 22.3 12.9 20.6 26.7 29.2 14.7 16.8 12.0 21.1 10.3 16.3 18.0 25.1 14.5 19.7 12.6 22.9 1.2 1.3 26.2 6.5 13.5 14.9 18.3 27.3 8.3 SV2B "HsT19680, KIAA0735" ENSG00000185518 "Synaptic vesicle glycoprotein 2B" Q7L1I2 15 91099950-91302565 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 33.2;retina: 56.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 137.1;Cone photoreceptor cells: 150.1;Excitatory neurons: 455.0;Rod photoreceptor cells: 139.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 2.1;SCLC-21H: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046247 Approved NA NA "HPA046247: AB_10963538" "unprognostic (2.92e-1)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (4.01e-5)" "unprognostic (2.66e-3)" "unprognostic (7.77e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.57e-2)" "unprognostic (9.89e-2)" "unprognostic (1.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-2)" "unprognostic (3.10e-4)" 1.8 1.1 10.1 0.3 18.3 0.1 0.8 8.9 33.2 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.6 20.4 9.4 0.2 0.2 0.2 0.5 10.6 1.9 17.5 0.0 1.5 0.1 1.0 0.2 13.2 0.8 0.3 56.8 1.0 0.1 0.6 0.2 0.4 0.2 0.0 0.2 0.3 0.8 1.5 0.6 0.2 1.0 1.2 0.1 0.1 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.1 18.3 8.9 33.2 20.4 9.4 10.6 1.9 17.5 13.2 0.0 1.5 21.6 10.9 0.0 0.0 7.2 0.1 0.4 0.1 0.1 0.0 137.1 0.2 0.5 3.0 1.5 0.0 0.0 150.1 0.0 0.0 0.0 0.0 4.2 6.4 0.0 0.0 3.3 0.0 0.0 455.0 5.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.3 11.4 0.0 0.0 0.0 0.4 2.0 0.0 0.2 0.0 27.2 0.0 43.4 0.0 5.5 39.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 139.0 0.0 0.5 0.2 8.0 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.2 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 39.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 9.2;Distal tubular cells: 19.6;Horizontal cells: 38.7;Muller glia cells: 31.8" "Cancer enhanced" "Detected in many" "renal cancer: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.8;HEK 293: 5.3;PC-3: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: AB_2673711" "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favorable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.2 6.9 10.0 0.0 12.5 0.0 0.2 39.7 12.4 0.8 3.0 0.3 0.0 0.5 0.2 1.5 0.5 0.3 5.6 8.3 14.0 8.4 0.5 0.0 0.0 20.8 14.1 7.8 0.4 3.5 3.3 9.4 0.0 24.4 0.2 0.0 3.1 1.9 0.3 0.1 2.5 0.9 0.1 11.7 0.1 1.0 0.7 14.1 0.1 1.2 0.2 0.3 0.2 0.9 20.6 3.3 7.8 0.2 0.4 0.0 0.0 0.0 0.7 0.6 0.8 1.9 0.2 1.7 0.0 0.3 0.4 1.9 0.9 1.0 0.2 0.2 0.0 5.3 0.0 1.6 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.6 2.6 0.5 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.3 1.6 6.0 0.0 0.0 3.5 0.6 0.0 1.1 2.3 0.2 0.9 0.2 0.0 0.2 0.0 1.2 0.1 2.7 0.0 0.0 1.3 0.1 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.5 39.7 12.4 8.3 14.0 20.8 14.1 7.8 24.4 11.7 14.1 20.6 0.1 0.0 0.0 4.9 0.0 0.3 0.4 0.3 0.0 6.5 0.6 1.0 2.1 1.5 0.3 9.2 4.2 0.1 0.0 0.0 19.6 2.6 1.3 0.3 0.1 0.3 3.5 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.7 0.4 0.0 38.7 8.9 0.0 6.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.6 31.8 0.0 0.0 7.1 0.3 0.0 0.0 0.4 0.5 0.0 0.8 0.2 2.4 0.0 2.3 0.4 0.7 3.5 0.2 1.1 0.0 0.1 0.0 0.1 0.5 LMNTD2 "C11orf35, MGC35138" ENSG00000185522 "Lamin tail domain containing 2" Q8IXW0 11 554850-560738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 24.2;testis: 28.4" "Group enriched" "Detected in many" 7 "Early spermatids: 59.7;Late spermatids: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 5.6;hTERT-RPE1: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058474, HPA073912" Uncertain Approved "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA058474: AB_2683727, HPA073912: AB_2686642" "unprognostic (2.20e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (3.75e-4)" "unprognostic (1.33e-3)" "unprognostic (7.05e-4)" "unprognostic (6.06e-2)" "unprognostic (2.30e-1)" "unprognostic (8.85e-2)" "unprognostic (3.51e-1)" "unprognostic (2.42e-2)" "unprognostic (3.01e-3)" "unprognostic (2.04e-3)" "unprognostic (1.10e-2)" "unprognostic (5.02e-3)" "unprognostic (5.02e-2)" "unprognostic (3.72e-3)" "unprognostic (1.48e-3)" 1.7 2.9 0.8 0.6 1.5 1.6 3.2 2.8 1.3 1.5 0.3 2.9 5.2 1.3 0.0 5.3 4.7 0.2 0.5 0.4 0.4 8.3 24.2 3.2 0.4 1.2 0.6 0.2 1.2 8.6 0.0 5.9 0.3 1.2 5.8 0.2 0.4 3.9 0.8 0.4 6.8 5.7 0.2 0.6 5.5 6.5 28.4 0.5 1.3 8.7 0.0 1.1 2.3 2.8 2.4 0.0 2.6 0.6 4.5 0.0 0.0 0.0 0.6 0.3 0.2 0.4 3.8 0.0 2.5 0.0 0.1 1.2 3.4 0.7 1.0 0.1 0.0 0.3 0.6 5.6 2.3 0.4 0.1 1.8 0.4 0.0 0.1 0.1 21.4 0.3 0.6 0.0 2.9 0.0 0.0 0.6 0.0 0.5 2.4 1.2 0.0 0.0 1.5 1.5 0.0 0.3 0.8 0.0 2.5 0.0 4.2 4.9 1.2 0.1 0.4 0.3 0.4 0.4 4.2 1.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 2.8 1.3 0.4 0.4 1.2 0.6 0.2 1.2 0.6 0.5 2.4 1.3 0.0 0.0 0.0 4.3 0.0 2.5 0.0 1.8 0.8 4.3 3.4 0.9 10.0 0.0 3.7 0.0 1.8 1.2 2.9 7.9 3.4 59.7 5.0 0.4 0.7 0.0 3.2 0.1 2.2 1.4 0.2 9.2 4.2 0.0 6.1 0.7 5.4 1.2 0.0 0.1 2.5 0.0 1.2 0.0 96.4 2.1 1.1 0.0 2.8 0.9 3.6 2.1 0.0 0.0 3.6 2.7 0.0 0.7 2.0 4.3 2.8 0.0 1.0 0.0 0.1 0.5 1.7 6.3 2.8 0.0 1.0 1.4 4.2 2.8 3.2 SPATA45 "C1orf227, LOC149643" ENSG00000185523 "Spermatogenesis associated 45" Q537H7 1 212830141-212847649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "pancreas: 3.0;testis: 11.9" "Group enriched" "Detected in some" 24 "Early spermatids: 151.6;Late spermatids: 139.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-698: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049921 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA049921: AB_2680953" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (4.71e-1)" "unprognostic (2.06e-1)" "unprognostic (4.05e-2)" "unprognostic (6.14e-2)" "unprognostic (4.39e-4)" "unprognostic (1.07e-2)" "unprognostic (1.70e-1)" "unprognostic (3.12e-3)" "unprognostic (1.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.06e-2)" "unprognostic (6.14e-3)" "unprognostic (1.32e-2)" "unprognostic (9.50e-2)" "unprognostic (2.67e-3)" 0.2 0.1 0.6 0.1 0.8 0.3 0.3 0.6 0.8 0.1 0.2 0.3 0.1 0.3 0.7 0.2 0.7 0.4 0.1 0.5 0.6 0.3 0.4 0.4 0.8 0.9 0.6 0.4 0.1 3.0 0.1 0.3 0.3 0.8 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.2 0.5 0.6 0.5 0.2 11.9 0.7 0.1 0.4 0.5 0.5 0.2 0.0 1.0 0.1 1.5 0.3 0.9 0.2 0.7 0.9 0.1 0.0 0.3 0.4 0.3 0.2 0.3 0.0 0.0 0.6 0.1 0.6 0.0 0.3 1.4 0.0 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.6 0.8 0.9 0.1 0.3 0.2 0.3 0.5 0.8 0.1 0.0 0.7 0.1 0.3 1.0 0.6 0.0 0.0 0.3 0.2 0.5 0.0 0.3 0.0 0.7 0.4 0.4 0.7 1.7 0.1 0.6 0.4 0.0 0.1 1.6 0.2 0.3 0.3 0.1 0.0 0.0 0.2 1.1 0.2 0.3 0.8 0.1 0.2 0.0 0.1 0.1 0.6 0.8 0.6 0.8 0.5 0.6 0.9 0.6 0.4 0.8 0.6 0.7 1.0 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 5.9 0.0 151.6 0.1 0.0 0.2 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.0 1.3 0.0 0.0 0.0 0.0 139.9 1.5 0.2 0.0 1.0 0.6 0.0 0.0 1.0 2.1 0.1 0.0 0.4 0.0 0.0 0.8 0.3 1.5 0.0 0.0 0.0 0.1 1.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 99 "retina: 2068.0" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 4448.6" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Region enhanced" "Detected in single" "midbrain: 2.1" "Group enriched" "Detected in many" 6 "basophil: 127.0;NK-cell: 220.2" "Group enriched" "Detected in all" 6 "granulocytes: 127.0;NK-cells: 220.2" "Cell line enhanced" "Detected in some" "Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2" "Region enhanced" "Detected in some" "hippocampal formation: 4.7" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 1.5 0.3 0.1 4.7 0.1 7.9 1.0 0.2 0.5 1.0 0.2 1.6 0.6 0.2 0.1 0.8 0.7 2.5 0.5 0.1 0.5 1.7 4.3 3.0 20.8 0.2 2.1 0.0 0.0 0.0 0.1 0.1 12.1 0.2 0.2 1.0 2068.0 0.5 0.4 1.2 0.3 1.6 1.0 0.2 20.0 1.7 0.9 0.3 8.4 0.4 0.3 7.2 3.0 0.1 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 5.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.8 0.2 0.1 0.2 0.4 0.3 0.0 5.8 8.9 0.0 0.0 11.9 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.1 0.1 6.2 0.1 0.8 1.2 0.2 0.0 0.0 0.1 0.1 0.6 0.9 0.4 3.1 0.1 127.0 18.1 30.5 4.1 26.2 1.3 2.7 0.8 2.3 28.9 5.1 2.1 7.4 2.4 220.2 15.5 2.9 0.1 13.5 0.1 0.1 0.2 0.5 0.1 0.5 0.2 2.1 0.0 0.2 0.2 0.3 0.7 0.3 0.0 0.6 0.3 1.1 0.9 0.0 0.0 0.6 422.5 0.3 0.4 0.2 0.0 0.0 5.5 517.1 0.2 4.3 0.1 1.9 0.4 0.8 1.5 0.3 27.2 0.0 1.7 0.2 0.2 0.4 0.2 0.0 0.5 23.6 0.1 2.9 0.2 22.6 262.5 0.1 0.2 0.0 4.8 8.0 2.3 0.0 4.4 3.6 0.0 13.3 709.0 11.3 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.1 1.0 0.0 4448.6 0.0 0.1 0.1 1.1 0.2 0.3 1.4 0.3 1.7 2.1 0.0 0.1 PRKG1 "PGK, PKG, PKG1, PRKG1B, PRKGR1B" ENSG00000185532 "Protein kinase cGMP-dependent 1" Q13976 10 50990888-52298423 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 36.4" "Cell type enhanced" "Detected in many" "Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 7.3" "Lineage enriched" "Detected in single" 49 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007699, CAB009629" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB009629: AB_2170663, HPA007699: AB_1079677" "unprognostic (3.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.44e-2)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (5.54e-1)" "unprognostic (2.23e-1)" "unprognostic (4.94e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (3.40e-1)" "unprognostic (9.26e-2)" "unprognostic (5.50e-3)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (3.78e-4)" 7.1 8.4 8.1 2.7 8.0 0.6 3.2 1.6 7.4 10.4 11.9 5.3 2.4 10.4 3.6 5.3 5.2 7.1 14.3 7.3 8.1 3.9 1.7 6.9 1.2 5.5 4.3 6.5 4.2 1.7 9.6 1.3 10.2 3.7 6.4 5.4 3.7 4.1 8.1 26.1 0.8 3.5 14.7 3.7 2.5 3.4 1.9 7.9 1.5 7.0 36.4 0.9 5.5 4.2 5.2 0.1 0.2 1.7 14.3 6.5 6.0 0.1 5.4 19.2 2.1 2.6 0.1 0.9 0.3 0.0 16.1 2.0 0.1 0.0 0.1 1.7 0.0 5.0 1.0 0.3 0.0 5.5 0.0 0.1 8.1 0.1 4.8 0.1 0.6 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.0 4.1 0.0 2.5 0.0 3.9 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 2.0 0.1 0.0 0.0 11.2 1.9 5.9 3.7 1.5 0.8 0.0 10.0 0.0 2.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 8.1 8.0 1.6 7.4 7.3 8.1 5.5 4.3 6.5 3.7 3.7 7.9 5.2 10.5 16.0 10.8 778.3 0.3 0.9 1.7 0.0 7.4 5.9 2.8 9.4 31.4 0.0 0.0 3.7 0.0 1.0 0.3 2.9 0.0 2.4 56.0 0.4 14.7 7.1 0.0 3.4 244.9 3.6 1.2 24.2 0.5 0.5 4.5 0.1 5.0 0.0 0.4 0.0 473.0 4.2 0.0 0.0 2.2 53.0 32.6 5.3 3.6 188.3 0.0 23.6 0.0 24.6 8.0 4.8 14.1 39.5 0.1 0.5 3.2 0.2 0.9 1.3 39.5 3.9 69.9 0.9 0.9 1.6 0.6 2.2 0.2 7.9 3.6 1.0 NR2F2 "ARP1, COUP-TFII, COUPTF2, COUPTFB, NF-E3, SVP40, TFCOUP2" ENSG00000185551 "Nuclear receptor subfamily 2 group F member 2" P24468 15 96325938-96340263 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 295.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 542.2;Hepatic stellate cells: 395.5;Leydig cells: 510.4;Peritubular cells: 610.5;Sertoli cells: 486.4;Smooth muscle cells: 385.7;Theca cells: 572.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058974 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058974: AB_2732629" "unprognostic (9.28e-2)" "unprognostic (2.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.42e-2)" "unprognostic (8.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.89e-1)" "unprognostic (9.19e-2)" "unprognostic (5.14e-2)" "unprognostic (5.96e-2)" "unprognostic (1.72e-2)" "unprognostic (7.47e-2)" "unprognostic (1.28e-2)" 81.8 43.5 33.9 18.9 16.3 0.1 60.3 15.6 19.3 128.9 26.7 46.3 21.7 121.9 62.4 22.3 102.4 66.3 37.4 21.2 23.2 80.5 32.4 57.3 42.8 16.5 21.3 12.2 295.0 20.2 30.9 20.4 75.4 16.7 61.1 27.0 2.5 23.1 127.6 33.5 21.1 32.4 82.5 10.7 107.1 83.0 26.9 34.7 7.9 46.6 31.8 15.2 46.7 75.1 14.7 154.7 39.1 125.6 78.5 249.1 85.5 41.9 109.1 83.2 111.1 94.3 134.8 153.4 0.1 86.8 55.2 44.1 90.4 22.3 78.3 138.8 0.5 86.5 49.9 48.7 24.6 69.5 38.7 18.0 61.3 26.5 92.5 19.8 130.5 207.3 0.1 135.3 0.4 71.2 105.5 0.1 27.6 1.2 59.6 52.7 0.1 30.9 0.2 244.7 165.7 15.8 0.2 12.3 3.7 17.5 55.0 61.1 2.8 215.3 119.9 39.7 28.3 38.8 0.1 0.4 0.4 67.0 18.9 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 16.3 15.6 19.3 21.2 23.2 16.5 21.3 12.2 16.7 10.7 34.7 14.7 133.4 28.9 18.1 0.7 1.1 14.4 24.9 71.7 39.3 7.5 51.9 50.8 46.4 203.0 34.6 62.5 25.0 126.2 2.0 35.7 46.9 22.0 3.2 70.9 542.2 166.1 26.4 5.3 0.1 10.9 50.3 125.8 80.0 68.9 0.0 41.5 395.5 51.6 10.3 3.3 24.8 35.5 32.6 12.2 20.1 22.9 510.4 5.0 26.6 36.5 0.6 30.2 0.0 0.0 0.5 15.6 23.9 610.5 2.8 22.3 14.3 65.5 37.3 13.8 486.4 27.8 385.7 6.4 7.9 20.5 10.4 35.3 5.8 572.5 27.1 21.3 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 1341.7;pituitary gland: 778.9;placenta: 1644.9" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1" "Cancer enhanced" "Detected in many" "liver cancer: 28.1;testis cancer: 25.4" "Region enhanced" "Detected in many" "hypothalamus: 119.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8" "Region enhanced" "Detected in many" "hypothalamus: 111.7" "Group enriched" "Detected in many" 5 "hypothalamus: 41.2;midbrain: 156.8" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 2600000 "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 3.2 1341.7 7.4 6.1 2.0 0.1 7.1 0.1 12.4 6.2 0.2 0.2 1.8 0.7 0.2 2.6 3.1 2.3 23.5 0.5 119.2 0.6 1.8 0.9 0.5 16.0 38.8 0.2 279.6 21.4 0.0 778.9 1644.9 52.4 1.4 0.0 0.0 27.1 0.0 17.7 1.0 1.3 0.2 2.2 1.1 1.0 41.2 15.4 1.7 0.2 83.8 0.0 1.1 1.5 36.9 0.0 0.0 120.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 12.6 0.3 419.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 1.4 0.1 0.0 0.5 33.7 473.8 0.0 0.1 0.0 2.9 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 2.0 0.1 12.4 0.5 119.2 16.0 38.8 0.2 52.4 2.2 15.4 36.9 0.4 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.3 1.0 2.6 0.0 0.0 0.0 0.0 55.2 0.2 0.0 0.0 4.8 7.1 0.0 0.0 6.7 0.0 0.0 0.0 576.5 45.3 699.3 0.0 0.0 0.0 0.8 0.0 0.0 84.3 0.0 0.0 0.0 0.0 0.0 0.3 35.0 1357.0 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.0 0.0 172.6 0.0 1.3 0.0 0.2 0.0 0.0 59.2 2360.1 3.0 13.5 69.9 0.0 0.4 105.8 0.8 63.2 0.0 0.2 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702816-1710377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 129.3;Distal enterocytes: 112.4;Proximal enterocytes: 68.9;Skeletal myocytes: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 3.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.0;HaCaT: 8.4;SiHa: 11.2;T-47d: 9.4" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 14.2" HPA046063 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA046063: AB_2679520" "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 10.4 9.5 0.8 1.9 0.8 2.1 4.7 1.4 1.0 2.7 2.1 6.7 6.0 1.8 1.2 4.7 2.7 1.8 2.1 0.6 1.0 1.4 7.1 4.0 0.7 1.0 0.8 0.7 2.5 1.2 1.0 1.1 1.6 1.2 1.9 5.4 10.6 2.9 0.9 1.7 2.4 7.0 1.2 0.6 1.3 4.7 0.6 0.9 0.1 1.6 0.8 0.8 3.1 3.5 1.4 1.0 1.1 1.1 3.5 8.1 9.0 0.3 1.9 1.8 1.0 0.7 6.9 3.1 0.1 1.9 3.1 1.0 8.4 1.5 0.9 0.7 0.2 0.7 0.9 2.4 0.3 2.3 0.1 2.4 7.6 3.2 1.2 2.2 2.9 0.7 0.1 0.8 0.4 0.9 1.9 0.1 0.4 0.1 3.4 0.6 0.1 5.3 0.2 0.7 2.7 0.2 0.4 11.2 1.0 1.6 1.5 9.4 0.8 2.6 0.5 2.3 2.1 0.5 0.1 0.1 0.1 0.6 0.3 1.0 3.4 0.2 0.4 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.4 0.2 0.2 1.6 0.3 0.1 0.2 0.1 0.1 0.8 0.8 1.4 1.0 0.6 1.0 1.0 0.8 0.7 1.2 0.6 0.9 1.4 19.0 51.3 55.5 0.3 1.6 0.0 8.2 0.0 4.0 7.9 5.8 9.5 2.7 17.2 18.0 11.0 129.3 4.9 2.0 112.4 0.0 7.3 1.1 12.9 10.4 14.1 9.0 11.2 0.5 9.6 2.6 14.9 20.9 13.3 15.8 3.9 18.9 24.2 5.5 0.0 0.4 24.6 0.0 6.5 0.0 1.8 13.4 10.7 0.0 3.7 1.4 11.7 0.0 0.0 0.1 13.5 40.1 5.7 3.3 6.3 68.9 1.1 19.9 57.8 6.6 124.2 17.8 0.6 0.8 9.1 0.3 4.0 5.1 5.4 35.7 13.0 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.0;retina: 41.7" "Group enriched" "Detected in many" 9 "Astrocytes: 3381.0;Excitatory neurons: 1001.8;Inhibitory neurons: 2137.4;Oligodendrocyte precursor cells: 2480.6;Oligodendrocytes: 933.9" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.0;SH-SY5Y: 22.5;WM-115: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol NA NA 150000000 Cytosol "HPA054051: AB_2682358, HPA076122: AB_2686779" "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 15.8 48.1 5.7 45.1 1.0 1.7 22.2 74.0 22.0 0.0 7.6 2.0 5.0 3.1 4.0 3.1 13.6 2.3 59.7 36.7 2.4 0.8 10.6 5.0 35.0 35.9 32.6 5.5 14.5 9.0 3.8 1.0 37.9 26.3 3.9 41.7 1.3 7.4 0.2 5.1 2.6 3.8 17.7 1.9 3.9 4.6 36.9 1.2 5.0 0.2 6.8 6.5 4.9 42.1 0.2 3.2 11.0 0.3 1.1 3.4 1.1 1.0 0.5 0.4 1.1 0.2 0.7 0.8 0.2 6.0 0.3 0.2 0.2 0.1 0.5 0.5 0.1 0.3 1.0 0.3 0.2 0.8 0.5 2.8 0.0 1.3 0.1 0.2 0.1 1.3 0.4 1.2 0.0 0.3 1.3 0.8 4.1 0.1 0.9 0.2 0.2 0.2 2.8 1.1 2.4 22.5 0.0 0.2 3.5 4.5 0.3 0.8 0.0 2.0 1.5 2.7 0.6 1.3 1.2 0.3 0.4 0.3 55.9 0.9 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.4 0.0 0.1 0.1 0.1 0.0 48.1 45.1 22.2 74.0 59.7 36.7 35.0 35.9 32.6 37.9 17.7 36.9 42.1 0.5 0.0 1.1 3381.0 0.6 7.6 0.3 0.0 0.0 54.2 1.2 0.4 25.5 4.3 0.6 0.0 2.1 0.2 0.0 0.0 0.0 0.0 22.5 0.9 26.5 5.8 0.0 0.0 1001.8 3.6 0.0 25.0 2.6 1.1 0.0 20.1 4.2 0.0 0.3 220.4 2137.4 0.0 0.0 0.0 3.2 22.2 126.2 1.9 56.9 111.5 0.0 126.9 0.0 2480.6 933.9 0.4 0.0 91.7 1.0 18.3 0.0 0.2 0.0 11.3 0.0 0.1 4.0 0.9 0.5 0.6 5.1 0.0 0.4 4.9 0.0 0.6 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978374 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 296.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 114.3;Basal respiratory cells: 83.8;Horizontal cells: 60.6;Ionocytes: 61.1;Pancreatic endocrine cells: 68.2;Respiratory ciliated cells: 66.8;Squamous epithelial cells: 63.7;Suprabasal keratinocytes: 164.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 24.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 135.1;HBEC3-KT: 124.9;hTCEpi: 308.7;hTERT-HME1: 130.3;TIME: 138.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "medulla oblongata: 11.3;midbrain: 10.6;pons: 13.2;spinal cord: 38.9;thalamus: 15.0" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" No No 40000 Cytosol "Plasma membrane" "HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371" "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.23e-5)" 22.8 2.3 11.2 2.4 10.5 0.0 16.5 10.2 16.2 65.8 6.5 73.4 1.4 64.8 2.9 115.0 29.4 5.2 4.2 9.7 11.2 3.4 6.2 5.2 0.1 29.3 14.0 9.5 3.5 1.6 0.7 3.5 1.8 39.3 18.7 8.7 19.2 24.2 28.9 3.6 296.1 20.4 31.9 13.7 0.9 25.4 7.7 21.2 0.4 2.8 4.6 4.7 49.9 87.4 21.0 2.9 107.6 0.1 6.0 120.0 135.1 0.2 10.5 22.3 3.8 1.9 0.3 38.9 0.1 14.5 82.9 85.3 62.9 0.3 124.9 1.7 0.0 0.4 0.0 67.5 0.5 11.0 0.0 3.8 17.6 308.7 12.1 130.3 52.3 54.7 0.0 0.0 0.2 62.8 8.0 0.0 0.0 0.3 9.5 42.9 0.3 5.7 0.1 84.4 0.0 0.6 0.6 46.2 0.1 2.3 2.8 6.0 0.0 138.4 29.3 17.9 33.8 9.9 0.0 0.0 0.0 88.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.2 10.5 10.2 16.2 9.7 11.2 29.3 14.0 9.5 39.3 13.7 21.2 21.0 3.8 12.8 1.1 0.3 0.0 114.3 4.9 83.8 13.1 8.9 2.2 1.3 1.5 0.0 38.2 1.8 2.1 0.2 0.3 0.4 0.0 11.9 24.2 16.0 10.5 13.0 0.0 0.0 8.2 8.7 0.5 31.9 0.0 18.9 17.1 0.1 3.6 2.1 1.0 60.6 5.1 0.0 61.1 0.3 12.7 3.1 0.6 0.7 32.0 3.7 0.0 3.2 0.0 1.5 3.3 68.2 0.0 0.4 0.0 4.5 0.0 0.3 66.8 13.9 0.0 13.1 8.6 0.4 4.3 63.7 164.7 0.1 0.9 0.1 0.2 6.2 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777133-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 240000 "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 11.7 2.9 3.0 2.7 2.5 0.3 11.2 2.3 4.1 24.9 5.2 22.7 3.3 25.5 2.8 8.2 6.4 4.8 16.5 2.2 2.6 4.3 0.7 10.6 2.4 3.1 2.2 1.4 12.1 4.8 4.6 2.8 7.1 2.6 7.4 6.2 2.2 7.0 12.3 10.9 16.2 7.0 16.1 2.0 33.1 5.5 1.1 2.8 3.1 19.3 10.1 3.7 17.8 14.7 2.4 0.8 14.6 1.2 0.4 16.8 160.0 0.1 1.8 8.2 3.5 3.5 0.2 2.2 0.0 3.4 0.1 34.0 25.5 0.4 0.8 4.0 0.0 0.1 0.0 39.8 0.1 0.9 0.0 0.1 11.3 2.7 10.2 1.4 38.0 0.0 0.0 0.0 0.2 1.8 0.4 0.0 0.3 3.4 0.0 0.9 0.0 9.5 0.0 0.0 1.2 0.0 0.1 2.9 0.2 4.3 28.6 3.9 0.5 0.1 5.2 4.6 5.5 0.7 1.9 0.0 0.1 15.2 0.8 64.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 3.0 2.5 2.3 4.1 2.2 2.6 3.1 2.2 1.4 2.6 2.0 2.8 2.4 40.1 0.0 1.3 0.7 0.4 12.0 5.9 17.5 6.2 0.6 2.9 8.3 13.8 1.5 5.5 0.0 2.1 0.3 0.5 0.0 0.0 0.1 0.7 0.2 1.5 21.2 0.0 0.0 0.4 0.6 0.3 29.0 0.5 0.2 0.0 0.9 3.6 0.1 0.1 0.0 0.6 0.0 4.1 1.5 7.9 1.4 2.8 0.9 10.6 8.4 0.1 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.1 4.0 0.0 0.1 11.5 4.0 13.1 63.0 36.4 0.4 0.7 4.5 8.4 0.0 0.6 4.2 0.0 3.5 SP1 ENSG00000185591 "Sp1 transcription factor" P08047 12 53380176-53416446 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000330, HPA001853, HPA012292" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394" "unprognostic (1.12e-1)" "unprognostic (8.52e-3)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (2.03e-1)" "unprognostic (4.64e-3)" "unprognostic (1.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.38e-2)" "unprognostic (5.14e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (4.77e-2)" "unprognostic (2.12e-2)" 22.3 18.7 10.1 23.3 14.2 30.2 26.5 19.6 12.6 23.9 12.4 25.0 31.1 30.1 21.2 38.9 25.7 25.9 13.2 10.0 15.7 20.7 17.1 23.0 24.4 16.0 14.0 8.1 30.0 18.7 22.3 10.8 23.9 15.1 21.0 30.1 20.6 27.7 22.2 25.5 40.4 31.5 26.7 14.0 28.2 28.8 19.6 13.3 37.0 19.8 26.0 30.4 24.5 25.5 17.6 34.2 31.3 40.5 31.2 34.7 39.4 32.1 23.1 29.0 27.2 26.9 27.9 70.3 43.9 29.3 27.1 18.3 49.2 43.6 32.9 33.0 31.3 23.8 38.5 48.2 18.3 24.3 39.4 33.1 40.3 36.4 27.0 53.9 55.1 31.0 35.5 37.6 63.8 23.1 50.2 53.9 31.9 22.4 28.0 25.0 37.8 38.5 28.5 25.7 57.8 21.0 30.5 47.7 42.9 26.8 33.5 52.3 42.6 29.5 35.3 30.3 26.4 25.3 21.3 25.4 42.5 26.3 29.9 28.2 3.1 2.6 1.6 1.3 1.7 1.6 1.4 1.3 1.3 1.5 1.5 1.4 1.5 6.9 1.0 1.9 1.8 1.1 1.0 10.1 14.2 19.6 12.6 10.0 15.7 16.0 14.0 8.1 15.1 14.0 13.3 17.6 29.7 22.4 15.0 13.1 18.5 23.8 19.9 22.4 33.6 10.6 28.3 19.4 8.2 24.3 26.8 31.3 8.4 16.2 16.6 55.8 5.9 16.1 64.1 21.8 23.4 24.7 12.6 25.2 7.7 13.8 16.3 21.5 23.9 34.7 6.3 17.2 28.2 28.4 18.2 16.8 7.2 29.8 6.1 38.6 16.1 50.3 27.4 24.5 8.8 16.9 42.2 22.7 18.6 12.5 20.4 18.8 21.0 25.9 12.0 35.4 34.8 20.8 23.9 10.8 13.1 31.4 21.0 29.4 22.1 44.2 31.3 21.3 14.8 11.7 26.2 47.7 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19432545-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favorable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 39.7 54.9 60.4 26.4 61.6 28.5 48.1 64.7 80.4 50.4 59.9 33.9 26.4 31.6 78.1 36.0 55.3 31.8 101.7 59.2 67.4 69.8 119.7 29.1 35.8 62.8 60.8 58.8 44.9 57.5 85.7 11.3 31.0 62.3 46.8 36.2 35.3 72.7 43.4 137.1 29.4 24.9 32.8 62.8 27.4 34.2 31.7 61.8 29.9 79.8 143.3 41.3 36.7 7.1 66.3 84.8 83.8 26.9 64.0 111.5 98.8 45.4 62.1 95.6 116.9 133.6 105.5 49.0 73.2 71.0 93.7 67.8 82.9 118.8 141.2 122.6 69.8 129.7 72.8 76.0 184.4 158.1 117.7 46.1 102.3 123.6 101.1 179.8 77.3 95.6 35.0 265.8 91.2 127.5 106.9 44.9 77.6 22.7 190.2 100.3 49.7 110.6 44.2 135.9 67.9 45.6 48.3 100.7 94.0 159.7 60.2 80.2 52.9 60.6 118.6 127.3 41.6 64.0 78.1 115.7 147.6 79.2 71.6 99.5 45.1 88.3 76.6 71.7 108.9 82.7 162.7 72.4 74.6 100.1 155.6 85.9 75.6 10.4 90.5 90.2 106.5 91.9 103.5 60.4 61.6 64.7 80.4 59.2 67.4 62.8 60.8 58.8 62.3 62.8 61.8 66.3 43.3 44.8 35.3 8.8 53.8 40.4 73.3 181.9 52.3 31.0 59.4 85.9 86.1 71.4 106.6 47.8 12.5 129.6 42.9 35.2 260.3 83.8 114.9 104.4 61.9 40.3 34.9 27.1 3.6 97.9 128.9 55.9 32.1 46.1 33.7 44.2 40.0 146.3 135.6 21.9 5.8 47.8 91.6 43.6 40.0 152.4 72.4 42.9 85.4 4.7 73.9 120.4 37.0 3.5 12.0 73.9 48.6 72.2 92.6 53.6 89.8 254.9 163.5 50.3 46.0 53.9 74.3 82.9 72.1 64.8 38.5 62.9 35.1 103.8 49.3 52.2 DBX2 FLJ16139 ENSG00000185610 "Developing brain homeobox 2" Q6ZNG2 12 45014672-45051099 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "brain: 8.3" "Group enriched" "Detected in some" 9 "Astrocytes: 11.4;Oligodendrocyte precursor cells: 14.1;Spermatogonia: 5.1" "Cancer enriched" "Detected in single" 32 "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065045, HPA066053" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nucleoplasm, Nuclear membrane" Vesicles "HPA065045: , HPA066053: AB_2685605" "unprognostic (1.13e-4)" "unprognostic (9.99e-2)" "unprognostic (7.82e-3)" "unprognostic (5.24e-2)" "unprognostic (5.62e-2)" "unprognostic (1.51e-1)" "unprognostic (9.22e-2)" "unprognostic (4.76e-2)" "unprognostic (1.64e-1)" "unprognostic (5.19e-1)" 0.4 0.0 3.6 0.0 3.5 0.0 0.2 3.6 3.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 3.5 0.1 0.0 0.0 0.0 7.3 4.2 2.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 8.3 0.0 0.0 0.6 5.3 0.0 0.2 0.2 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.5 3.6 3.7 3.3 3.5 7.3 4.2 2.3 5.4 8.3 5.3 7.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 INKA1 "C3orf54, FAM212A" ENSG00000185614 "Inka box actin regulator 1" 3 49803261-49805030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 19.8;skin 1: 23.9" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4" "Group enriched" "Detected in many" 7 "B-cells: 65.9;granulocytes: 59.6" "Cell line enhanced" "Detected in many" "HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9" "Low region specificity" "Detected in all" HPA041879 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 4.3 2.3 4.7 2.0 5.1 3.5 4.2 5.2 7.7 5.4 3.0 2.8 0.8 4.7 1.4 19.8 2.8 1.5 5.1 5.3 5.1 3.7 1.1 5.4 4.1 5.8 5.2 4.8 2.3 1.3 0.5 2.1 3.2 6.2 6.5 0.5 0.2 4.9 2.1 11.9 23.9 4.3 1.8 6.8 6.7 2.4 2.9 5.6 1.6 2.1 2.3 4.0 5.5 10.4 6.0 1.3 1.1 1.5 1.1 1.8 4.1 0.0 3.0 1.9 1.4 1.7 0.1 0.0 14.9 0.4 2.2 1.5 8.7 0.5 10.4 0.1 2.6 0.0 68.5 0.7 0.2 2.6 10.4 45.1 5.4 14.5 2.9 2.6 0.9 6.1 1.0 4.7 1.2 1.2 0.6 0.9 38.5 1.1 0.0 5.8 13.9 0.8 3.3 0.1 16.9 0.8 5.3 2.7 0.5 1.5 0.4 0.3 42.1 3.8 7.3 0.9 3.4 1.3 1.7 1.7 1.2 3.2 34.9 1.8 59.6 2.4 11.6 1.3 5.9 0.3 65.9 1.5 1.8 0.7 64.4 2.2 3.6 1.3 0.0 8.5 9.3 1.6 6.4 4.7 5.1 5.2 7.7 5.3 5.1 5.8 5.2 4.8 6.2 6.8 5.6 6.0 19.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.7 0.0 0.5 1.6 8.4 0.0 0.0 0.0 1.2 0.7 3.0 0.0 0.1 0.0 0.1 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.4 0.5 0.0 0.0 PDIA2 "PDA2, PDI, PDIP, PDIR" ENSG00000185615 "Protein disulfide isomerase family A member 2" Q13087 16 283164-287215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "pancreas: 2531.2" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 294.9" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.9;HEK 293: 7.9;Hep G2: 6.7;Karpas-707: 2.9;MCF7: 4.6;SH-SY5Y: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051692, HPA053492" Enhanced "Intracellular and membrane" NA NA "HPA051692: AB_2681575, HPA053492: AB_2682169" "unprognostic (3.46e-2)" "unprognostic (7.98e-3)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" "unprognostic (2.17e-2)" "unprognostic (6.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.98e-1)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (2.90e-2)" "unprognostic (1.58e-14)" "unprognostic (3.06e-2)" "unprognostic (1.66e-1)" "unprognostic (8.75e-2)" "unprognostic (2.87e-2)" 1.8 0.6 67.0 0.4 71.9 0.6 0.8 83.0 96.8 0.6 64.2 2.5 24.1 0.3 0.9 0.9 0.7 0.1 3.9 67.0 71.4 0.6 0.6 0.7 0.2 78.9 76.3 67.9 1.5 2531.2 0.0 7.6 2.5 78.7 1.0 0.3 2.4 1.0 0.1 0.6 0.3 7.2 0.0 72.1 0.3 193.2 1.0 71.5 0.0 0.4 0.0 0.5 0.5 0.6 87.5 0.0 1.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 3.9 0.1 0.5 0.0 7.9 0.0 0.3 6.7 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.3 2.9 0.1 4.6 0.1 0.4 0.2 1.6 0.0 0.1 0.0 0.9 0.0 0.0 1.6 3.7 0.0 0.1 0.0 0.5 1.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.0 71.9 83.0 96.8 67.0 71.4 78.9 76.3 67.9 78.7 72.1 71.5 87.5 0.0 0.0 0.5 1.6 1.9 0.5 0.0 0.0 0.0 4.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.1 0.3 0.1 0.0 0.0 12.4 294.9 1.3 5.5 65.7 0.1 0.0 0.1 0.0 0.0 0.4 0.0 14.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 1.6 0.6 0.0 2.0 22.2 25.5 1.4 0.4 0.2 0.0 3.9 1.1 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.4 0.0 PCGF3 "DONG1, FLJ36550, MGC40413, RNF3, RNF3A" ENSG00000185619 "Polycomb group ring finger 3" Q3KNV8 4 705748-770640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061879 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061879: AB_2684631" "unprognostic (1.24e-1)" "unprognostic (2.77e-1)" "unprognostic (2.62e-1)" "unprognostic (1.06e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.73e-4)" "unprognostic (2.76e-2)" "unprognostic (4.21e-2)" "unprognostic (9.52e-2)" "unprognostic (1.47e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.36e-2)" "unprognostic (6.84e-3)" "unprognostic (2.53e-1)" "unprognostic (2.20e-1)" "unprognostic (1.96e-1)" "prognostic favorable (5.25e-4)" 31.3 45.5 19.3 15.7 19.4 30.4 35.0 29.9 20.2 41.3 17.7 31.1 22.8 35.6 8.8 35.8 33.9 14.1 26.3 19.9 17.2 27.5 30.0 35.0 18.5 18.6 18.9 18.6 50.8 28.0 7.9 31.7 20.0 23.5 38.6 10.4 13.4 37.7 9.8 18.5 53.7 36.5 10.8 17.7 51.4 32.4 23.5 18.4 18.8 34.9 11.5 11.9 27.4 39.7 25.4 22.1 19.6 35.3 40.4 15.8 16.2 43.3 29.2 15.9 23.5 23.7 21.5 23.8 15.7 19.1 28.3 23.8 14.9 16.5 23.7 17.8 20.8 17.9 22.6 24.2 38.4 19.3 15.5 28.9 20.5 31.0 20.5 9.3 15.4 30.5 28.2 31.5 12.6 23.3 24.6 41.8 54.6 23.4 14.9 35.0 41.0 22.4 10.1 14.1 35.6 50.2 37.9 15.2 16.1 16.1 22.7 31.5 21.8 36.9 22.8 18.4 19.2 38.1 30.1 27.6 24.6 18.0 24.5 43.0 3.4 7.1 3.1 3.3 5.1 2.8 4.2 2.0 2.1 3.2 5.0 2.5 1.7 4.5 4.7 2.2 4.6 3.3 2.3 19.3 19.4 29.9 20.2 19.9 17.2 18.6 18.9 18.6 23.5 17.7 18.4 25.4 29.5 12.8 28.8 19.6 12.5 25.4 17.3 17.2 25.0 12.3 28.3 21.3 21.7 17.2 21.8 9.2 12.5 13.4 13.5 21.4 3.9 20.6 52.0 17.7 28.7 27.8 19.2 9.1 18.1 19.8 30.0 17.8 35.2 21.2 16.5 22.4 25.4 15.3 12.2 6.7 18.6 21.7 20.3 15.1 21.0 54.4 16.4 20.1 23.2 23.4 14.3 9.1 16.5 27.2 22.8 32.7 19.3 15.4 22.9 24.0 19.1 9.4 14.0 8.5 6.6 18.8 18.8 19.0 25.6 22.5 28.7 23.7 13.3 20.8 20.2 38.2 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.7;Endometrial ciliated cells: 35.2;Respiratory ciliated cells: 37.5;Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 2.0 2.6 3.1 1.2 3.5 1.2 2.2 3.9 4.7 3.1 4.0 2.0 1.0 2.2 10.8 2.2 4.9 2.6 3.2 2.8 3.8 3.4 2.3 2.6 1.3 4.0 3.3 2.8 3.4 3.8 3.8 6.6 2.0 4.7 2.3 2.0 9.8 2.4 3.4 2.5 3.5 1.5 2.0 3.1 1.5 2.0 10.2 4.1 1.1 4.1 2.0 1.2 1.9 2.4 4.0 7.7 2.8 3.3 4.0 6.4 9.0 2.9 3.9 3.6 6.9 5.6 2.8 2.7 2.4 17.7 2.8 14.9 2.8 3.1 3.1 10.0 0.3 2.3 1.4 2.3 2.1 4.0 4.4 2.0 4.3 6.8 8.6 5.5 4.0 3.0 6.0 7.5 4.5 6.7 5.7 2.6 3.8 3.8 5.5 6.7 3.0 0.8 2.6 7.1 2.0 5.4 1.5 5.4 4.8 3.9 3.7 12.5 3.2 6.6 8.4 1.3 10.3 6.7 8.0 16.7 0.7 12.0 7.4 7.8 0.0 0.1 0.1 0.2 0.4 0.3 0.4 0.1 0.3 0.4 0.2 0.4 0.5 0.1 0.3 0.2 0.1 0.0 0.2 3.1 3.5 3.9 4.7 2.8 3.8 4.0 3.3 2.8 4.7 3.1 4.1 4.0 4.4 16.0 14.8 24.5 1.7 2.0 1.5 2.6 4.0 8.1 6.4 4.8 11.6 2.8 9.2 9.2 16.7 3.6 1.2 2.2 0.0 3.5 39.7 35.2 11.5 3.2 4.8 0.8 25.3 2.7 2.2 5.5 1.5 11.5 2.5 6.3 4.2 3.1 5.0 8.4 23.1 3.6 0.0 1.9 2.3 21.9 4.7 2.3 3.6 9.4 1.1 5.9 1.0 6.6 13.7 2.1 1.0 5.7 2.1 1.8 0.7 3.5 37.5 17.7 0.0 6.6 3.8 33.2 23.6 3.7 1.7 2.9 2.1 10.6 2.8 1.1 P4HB "DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB" ENSG00000185624 "Prolyl 4-hydroxylase subunit beta" P07237 17 81843159-81860856 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Chaperone, Isomerase" "Craniosynostosis, Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1872.0;pancreas: 2467.4" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012463, HPA018884" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" No No 110000000 "Endoplasmic reticulum" "CAB012463: , HPA018884: AB_1854896" "unprognostic (9.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.99e-2)" "unprognostic (7.14e-3)" "unprognostic (7.75e-3)" "unprognostic (1.05e-2)" "unprognostic (1.30e-1)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (4.73e-3)" "unprognostic (1.43e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (2.30e-11)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (4.99e-3)" "unprognostic (3.19e-3)" 243.7 512.0 33.4 211.7 34.6 521.6 227.4 37.9 36.0 247.3 58.0 234.9 646.0 208.2 134.1 623.7 185.0 203.8 310.4 30.2 59.5 269.4 1872.0 303.9 104.9 46.5 35.9 27.4 189.3 2467.4 145.4 332.5 337.1 38.2 338.6 175.3 23.5 956.2 185.9 331.2 370.7 559.3 181.5 38.8 432.0 543.6 69.3 50.3 90.1 246.8 152.1 139.1 235.7 325.6 39.7 690.3 580.7 236.8 687.5 813.4 726.7 593.6 1038.5 1081.1 741.9 934.5 550.4 576.9 264.4 501.8 1120.2 407.5 464.1 248.8 647.4 254.1 145.8 320.5 355.2 362.9 953.6 1010.8 1146.4 613.4 618.8 494.8 478.2 596.7 843.0 1250.1 182.1 273.6 978.2 559.5 566.4 260.5 723.2 157.7 791.0 463.8 261.8 342.5 614.0 453.2 492.8 248.7 301.1 586.1 1693.1 808.1 289.6 855.3 1601.2 644.1 980.5 503.1 574.3 586.6 743.5 407.9 204.8 1372.0 591.3 825.4 198.3 268.1 163.0 202.6 154.4 209.8 83.9 138.9 165.7 174.7 68.1 74.9 114.6 72.9 157.0 115.3 311.5 105.6 372.4 33.4 34.6 37.9 36.0 30.2 59.5 46.5 35.9 27.4 38.2 38.8 50.3 39.7 122.3 102.5 162.1 23.2 151.4 120.1 163.6 371.0 140.6 59.2 283.0 170.8 24.1 247.4 211.7 112.2 33.3 790.2 208.9 420.7 41.1 671.9 43.5 78.4 196.8 153.9 199.9 140.9 15.3 1077.9 1349.1 272.5 388.9 209.1 99.1 210.4 190.2 840.7 435.9 62.2 16.2 610.9 189.2 186.9 125.5 64.9 141.4 180.3 136.9 20.6 263.3 122.7 230.7 13.6 19.6 575.2 465.6 112.1 664.3 310.6 914.2 105.0 91.3 54.3 157.8 103.4 226.7 83.4 94.1 302.3 144.6 1001.2 138.8 378.4 475.4 220.8 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236966-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" NA NA 81000 "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favorable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 57.2 41.7 49.6 65.8 49.7 70.0 75.7 50.6 51.9 58.2 50.8 64.7 57.5 51.1 63.2 64.2 52.3 43.3 76.8 50.5 51.3 54.1 72.4 56.7 80.1 51.2 50.8 48.8 40.3 49.3 46.0 18.2 65.4 53.3 67.7 67.4 31.0 46.7 52.5 123.6 62.9 56.1 68.7 51.7 54.8 46.3 44.6 50.7 92.4 48.8 125.4 87.6 66.1 20.2 53.5 240.7 163.7 155.2 163.7 135.3 114.0 102.3 151.8 186.1 277.7 210.6 156.1 352.4 193.0 178.2 172.7 145.5 179.4 154.6 200.2 251.0 202.7 148.7 109.9 52.4 131.7 160.9 203.8 207.7 116.3 149.7 138.4 121.2 114.0 241.7 186.3 249.1 158.1 189.9 126.3 197.4 185.0 243.1 195.0 184.0 168.6 145.3 156.3 190.2 59.2 141.7 111.5 106.5 166.7 111.0 103.6 97.7 123.7 192.6 115.2 96.8 60.3 160.6 161.2 192.4 271.8 185.2 193.0 176.3 198.6 171.3 133.6 145.8 173.0 143.0 125.0 133.1 141.1 176.1 128.6 121.3 130.3 127.8 168.7 194.7 122.1 169.2 286.0 49.6 49.7 50.6 51.9 50.5 51.3 51.2 50.8 48.8 53.3 51.7 50.7 53.5 80.8 48.1 41.4 17.0 64.7 35.8 54.1 124.8 26.2 43.2 43.8 41.7 45.7 52.9 68.8 31.3 31.3 162.3 79.9 76.5 82.2 114.8 39.2 41.6 47.1 75.1 48.0 35.7 16.8 130.8 138.6 55.9 34.1 45.2 67.2 59.9 54.7 59.0 100.5 37.0 15.5 75.2 71.2 47.5 43.5 57.8 68.6 64.4 46.2 11.2 91.9 65.0 71.1 8.5 17.2 123.4 65.5 59.8 73.9 58.7 80.8 76.2 61.3 44.2 85.5 40.8 66.9 94.0 86.4 34.4 38.8 205.8 71.6 73.8 74.2 51.4 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 24.6 32.4 16.8 11.9 23.5 3.2 36.4 11.6 18.1 84.2 3.0 39.6 22.6 138.1 21.7 30.3 75.2 38.0 24.2 15.7 20.2 29.6 7.7 20.9 4.6 9.7 30.6 15.9 52.6 48.5 29.7 14.5 19.7 6.8 38.3 20.0 17.2 44.1 54.3 36.6 10.2 20.0 126.3 13.5 10.3 22.1 6.9 11.4 11.0 35.5 26.8 8.1 40.5 41.8 12.2 2.9 74.4 82.4 19.1 50.8 23.3 3.4 25.2 20.9 8.4 6.1 14.2 11.8 0.0 5.5 47.8 4.3 22.8 31.7 8.1 3.6 3.1 31.3 93.0 56.5 0.3 34.7 0.0 22.2 24.4 0.0 5.4 2.1 19.2 0.3 0.0 0.2 0.0 2.2 47.1 0.2 0.6 111.5 3.8 4.5 0.0 21.6 27.0 6.3 44.1 2.5 39.6 27.8 186.1 0.1 71.4 73.2 0.0 0.5 3.7 8.6 24.2 8.1 8.5 61.2 0.1 0.4 0.2 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 16.8 23.5 11.6 18.1 15.7 20.2 9.7 30.6 15.9 6.8 13.5 11.4 12.2 28.6 22.4 18.6 382.3 2.8 22.8 115.0 39.8 70.6 39.9 129.9 87.8 50.0 98.7 25.3 33.1 110.5 101.3 1.5 29.2 33.2 47.9 91.3 47.7 144.3 47.0 90.9 30.3 475.9 68.7 7.3 126.7 32.1 38.5 71.7 57.6 68.9 18.7 9.7 5.0 405.0 38.2 50.8 1.9 17.5 124.4 63.6 12.1 16.0 125.5 1.6 33.5 1.0 327.2 227.4 31.7 72.5 103.8 2.8 41.5 40.4 57.9 37.3 30.6 39.5 142.0 70.9 2.3 17.5 83.6 28.1 104.7 7.6 168.0 43.7 75.9 NDUFA4L2 "COXFA4L2, FLJ26118, NUOMS" ENSG00000185633 "NDUFA4 mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 307.4" "Group enriched" "Detected in many" 4 "Muller glia cells: 627.0;Sertoli cells: 1130.7;Smooth muscle cells: 525.6" "Cancer enriched" "Detected in all" 5 "renal cancer: 356.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 7 "AN3-CA: 133.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Uncertain Approved Mitochondria NA NA Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 85.3 14.1 36.4 6.8 34.9 0.2 55.5 34.2 62.0 64.0 36.3 16.0 5.9 20.9 2.4 307.4 15.6 17.2 154.9 33.2 34.4 25.8 21.1 63.1 5.9 37.3 36.2 29.1 14.1 14.6 12.2 31.2 72.3 42.8 27.5 2.0 29.7 56.2 9.9 44.2 202.0 14.3 7.5 32.0 74.7 18.2 8.7 34.8 3.3 55.0 29.4 4.8 27.9 185.0 38.7 0.9 1.3 0.3 133.9 5.4 3.1 0.4 2.1 1.5 0.6 1.3 0.0 1.5 5.5 5.6 2.1 0.1 1.2 0.7 1.0 0.0 3.0 0.2 0.6 0.3 0.1 18.6 4.1 2.0 12.0 2.5 0.2 4.7 0.9 0.0 7.6 0.5 7.2 0.4 2.7 1.1 0.2 0.3 0.6 2.4 2.1 1.0 11.0 0.1 0.1 7.1 2.5 0.2 0.3 4.7 0.1 1.5 14.5 0.6 1.2 0.1 1.1 0.7 10.0 3.5 2.5 4.9 9.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 36.4 34.9 34.2 62.0 33.2 34.4 37.3 36.2 29.1 42.8 32.0 34.8 38.7 156.0 0.0 0.5 2.6 2.6 151.2 0.9 89.2 6.8 30.6 2.6 5.8 1.2 0.0 24.8 0.0 18.8 1.0 0.9 0.1 0.0 1.6 1.7 0.4 3.0 91.8 0.0 0.0 2.2 0.0 1.5 21.5 4.6 0.3 8.9 0.1 2.9 1.3 1.9 11.8 3.0 0.2 54.9 0.0 28.9 3.0 3.1 2.0 30.2 18.7 1.0 627.0 0.0 0.5 0.4 4.7 0.0 2.2 1.4 2.0 0.1 0.3 6.2 25.7 1130.7 13.0 525.6 12.3 5.5 20.3 161.4 1.1 1.9 2.5 0.2 1.4 SHC4 "RaLP, SHCD" ENSG00000185634 "SHC adaptor protein 4" Q6S5L8 15 48823741-48963919 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;testis: 10.6" "Cell type enhanced" "Detected in some" "Astrocytes: 16.6;Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 81.8" "Cancer enhanced" "Detected in some" "melanoma: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AN3-CA: 10.0;SK-MEL-30: 19.1;WM-115: 16.5" "Low region specificity" "Detected in all" HPA074146 Approved Cytosol NA NA Cytosol "HPA074146: AB_2686667" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.05e-3)" "unprognostic (1.23e-2)" "unprognostic (3.47e-2)" "unprognostic (2.59e-1)" "unprognostic (2.21e-2)" "unprognostic (3.80e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-5)" "unprognostic (9.84e-3)" "unprognostic (3.26e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-2)" 0.5 0.9 12.2 1.0 19.4 0.1 1.6 14.5 19.0 0.9 6.6 2.0 0.3 0.4 0.9 0.5 1.0 1.4 3.3 12.9 15.5 0.3 0.1 0.3 0.3 16.7 16.7 10.6 0.5 0.2 0.1 1.0 0.4 19.3 0.7 0.5 0.9 2.1 1.3 0.9 0.6 0.8 0.7 13.9 0.2 0.7 10.6 16.5 0.3 0.3 1.2 0.1 0.5 0.9 36.4 0.0 0.4 1.0 10.0 0.4 1.3 0.0 1.5 2.9 0.6 1.2 0.0 0.3 0.1 2.6 0.6 0.1 0.0 0.2 0.4 0.8 2.2 0.1 0.6 0.0 0.0 1.1 0.0 0.2 1.9 0.0 1.3 0.1 1.3 0.1 1.0 0.0 0.2 1.4 1.9 0.4 0.2 0.1 0.0 3.7 0.2 2.7 0.3 2.1 0.4 0.5 0.8 0.2 0.1 19.1 0.9 0.0 0.1 0.0 0.9 0.5 0.6 1.0 0.9 0.1 0.1 0.8 0.5 16.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 19.4 14.5 19.0 12.9 15.5 16.7 16.7 10.6 19.3 13.9 16.5 36.4 0.2 0.0 0.0 16.6 0.0 0.3 0.0 2.3 0.0 0.6 1.6 6.7 2.5 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.0 6.4 2.5 0.4 0.4 0.2 0.0 0.0 9.3 0.0 0.2 1.8 0.0 0.3 0.0 0.0 0.7 0.0 0.1 1.7 6.1 0.0 0.0 0.0 0.4 4.5 1.2 0.1 7.2 1.0 0.0 2.7 0.0 30.7 81.8 0.2 0.0 3.4 0.0 0.0 0.0 0.1 2.6 1.0 0.0 0.5 0.3 6.0 6.3 0.1 0.3 0.8 0.3 0.5 0.0 0.0 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821408-52834311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 43.8" "Cell type enhanced" "Detected in some" "granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "HMC-1: 425.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA 1900000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: AB_2683986" "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 425.5 0.0 0.0 5.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ZFP36L1 "Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B" ENSG00000185650 "ZFP36 ring finger protein like 1" Q07352 14 68787660-68796253 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA transport, Transport" "Developmental protein, DNA-binding, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1973.2;Squamous epithelial cells: 2019.8;Suprabasal keratinocytes: 3223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 2901.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 2901.2" "Cell line enhanced" "Detected in all" "hTERT-HME1: 462.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001301 Uncertain NA NA "HPA001301: AB_1080644" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (7.00e-2)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (3.81e-3)" "unprognostic (1.13e-3)" "unprognostic (1.30e-1)" "unprognostic (1.11e-2)" "unprognostic (6.45e-3)" "unprognostic (5.77e-2)" "unprognostic (2.97e-1)" "unprognostic (5.68e-2)" 320.6 108.9 106.4 220.1 97.8 84.8 308.2 127.9 88.6 448.9 99.7 277.9 128.6 426.6 108.6 295.4 305.9 176.5 135.1 94.5 337.2 158.7 262.2 244.8 201.1 197.8 148.9 60.0 457.2 227.3 162.9 67.9 318.4 141.1 224.3 105.2 58.1 321.9 203.6 93.9 491.5 152.8 318.8 161.4 180.1 198.6 49.8 171.8 131.3 192.2 90.4 151.6 338.7 470.9 170.6 235.6 211.8 94.7 139.0 234.4 187.2 203.9 96.4 169.6 59.1 72.9 93.9 159.5 58.4 59.5 177.4 85.5 108.4 8.8 313.8 70.0 27.9 13.2 21.5 115.0 68.2 133.8 3.3 24.3 157.6 396.4 69.1 462.1 195.2 119.2 17.1 61.5 113.7 314.4 54.1 9.3 11.1 78.7 105.1 31.7 150.5 127.1 17.8 213.4 155.3 1.0 2.5 113.7 163.4 87.8 131.9 148.3 3.0 254.4 167.3 122.8 139.0 101.0 62.9 32.9 39.9 213.5 1.4 66.9 230.8 240.9 3.9 211.1 244.7 197.2 266.0 168.8 150.3 123.8 461.4 179.3 162.2 2901.2 154.3 176.1 16.2 174.5 257.5 106.4 97.8 127.9 88.6 94.5 337.2 197.8 148.9 60.0 141.1 161.4 171.8 170.6 830.2 477.5 415.6 172.7 513.8 1333.5 761.2 830.2 1973.2 4.6 750.7 504.4 84.2 420.4 523.9 364.1 0.0 442.1 276.5 164.4 84.1 575.8 97.0 434.6 479.6 571.0 20.4 87.7 1.5 573.1 476.6 894.3 218.6 656.2 200.8 21.1 292.7 595.6 548.3 0.0 0.7 225.3 215.7 613.9 1272.8 72.2 502.0 670.0 528.3 142.4 499.0 211.9 131.8 63.8 0.9 544.8 138.3 397.2 191.7 657.7 138.4 143.7 314.5 9.2 269.5 562.0 714.4 12.2 13.3 2019.8 3223.6 898.7 405.2 157.1 191.1 817.8 UBE2L3 UBCH7 ENSG00000185651 "Ubiquitin conjugating enzyme E2 L3" P68036 22 21549447-21624034 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 544.4" "HPA045609, HPA062415" Approved Approved Nucleoplasm,Cytosol NA NA 5800000 "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (4.90e-2)" "unprognostic (3.05e-1)" "unprognostic (1.92e-2)" "unprognostic (1.07e-2)" "unprognostic (2.74e-2)" "unprognostic (9.99e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.28e-2)" "unprognostic (3.65e-2)" "prognostic favorable (3.82e-6)" "unprognostic (3.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.18e-2)" "unprognostic (4.66e-2)" "unprognostic (5.09e-2)" "unprognostic (2.77e-1)" "unprognostic (3.15e-3)" 41.9 46.4 64.4 37.4 65.2 54.9 34.2 65.0 72.6 35.8 55.3 43.2 40.0 35.3 41.3 49.5 38.9 34.3 50.7 65.2 65.1 40.5 41.2 34.2 49.2 68.0 65.4 62.8 34.2 30.5 43.6 31.4 43.1 67.4 39.4 46.1 28.3 34.1 37.2 64.0 36.5 41.1 49.0 63.5 37.9 37.8 28.7 67.0 52.4 36.7 53.6 53.0 47.2 32.6 67.1 121.9 68.9 98.3 77.4 105.1 93.1 56.6 100.0 113.6 125.8 118.7 79.0 57.0 114.2 49.0 133.5 94.7 101.4 132.1 108.6 124.3 114.4 142.9 132.1 63.3 94.8 70.0 190.9 91.0 82.7 93.1 91.2 65.7 90.6 143.4 69.4 544.4 59.3 137.9 89.6 100.0 137.6 72.8 134.8 71.6 80.5 147.6 31.2 118.8 96.2 88.0 65.4 79.9 99.1 95.6 89.4 61.7 104.0 103.8 88.6 113.5 75.5 103.6 57.3 99.7 103.7 120.0 87.5 86.0 84.4 87.8 105.7 84.9 102.2 79.7 77.3 79.9 91.6 109.2 73.6 69.0 82.9 73.2 81.2 89.0 106.3 106.1 141.1 64.4 65.2 65.0 72.6 65.2 65.1 68.0 65.4 62.8 67.4 63.5 67.0 67.1 102.6 109.0 83.9 26.1 110.7 125.5 171.6 318.5 51.2 54.5 76.9 72.8 64.9 101.5 180.3 71.7 16.7 312.1 159.0 215.1 197.6 288.2 79.9 133.1 104.6 125.9 126.0 173.0 25.6 385.0 406.5 102.6 60.1 124.9 129.3 79.3 109.6 159.8 298.5 69.0 24.3 153.1 193.3 126.9 159.7 61.1 87.3 140.9 126.3 19.7 257.9 98.4 200.8 22.6 30.4 432.1 222.1 103.8 98.4 186.7 213.5 257.2 173.9 45.5 105.2 81.0 205.4 202.8 121.2 87.6 129.7 372.1 130.1 133.7 154.0 208.4 NTF3 NGF2 ENSG00000185652 "Neurotrophin 3" P20783 12 5432108-5521536 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 18.5;Basal prostatic cells: 36.6;Basal squamous epithelial cells: 89.4;Prostatic glandular cells: 20.5;Sertoli cells: 32.9;Smooth muscle cells: 24.0" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Region enhanced" "Detected in some" "cerebellum: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.4;BJ hTERT+ SV40 Large T+: 14.8;BJ hTERT+ SV40 Large T+ RasG12V: 19.7;HBF TERT88: 18.0;RT4: 8.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebellum: 4.7;cerebral cortex: 2.0;hippocampal formation: 2.2" HPA032001 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA032001: AB_2674106" "unprognostic (3.04e-2)" "unprognostic (7.46e-2)" "unprognostic (7.33e-3)" "unprognostic (4.66e-3)" "unprognostic (8.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.36e-3)" "unprognostic (7.68e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.86e-1)" "unprognostic (2.20e-1)" "unprognostic (7.77e-4)" "unprognostic (4.02e-3)" "unprognostic (1.92e-1)" "unprognostic (8.06e-3)" "unprognostic (4.51e-3)" 3.5 1.8 0.1 0.8 0.3 0.0 2.7 3.4 1.3 5.8 0.3 1.6 1.9 1.9 2.0 3.4 3.0 1.8 2.7 1.2 0.2 2.6 7.7 1.6 0.3 0.3 0.8 0.1 11.2 0.2 0.1 1.1 1.9 0.6 3.6 1.0 0.1 3.2 2.4 1.8 2.7 2.5 0.9 0.2 4.6 2.5 0.8 0.1 0.4 0.9 1.0 0.4 4.7 7.1 0.2 1.9 0.0 6.7 0.0 0.0 0.0 0.0 4.5 11.4 14.8 19.7 0.1 0.2 0.0 6.7 7.3 0.0 2.4 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 4.5 4.7 8.5 0.3 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.2 0.1 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 3.4 1.3 1.2 0.2 0.3 0.8 0.1 0.6 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.0 18.5 36.6 0.7 89.4 0.0 0.2 10.3 0.9 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.2 0.2 1.4 0.0 0.0 0.1 0.0 0.1 6.1 0.0 0.1 0.0 0.0 5.0 2.1 0.0 0.0 1.2 0.1 0.0 0.0 2.1 0.1 8.4 0.3 7.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.9 0.0 20.5 0.2 0.0 0.8 0.0 32.9 6.8 24.0 0.5 0.8 5.0 3.3 0.1 0.5 0.5 0.2 6.9 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 13.7 19.0 32.2 10.3 39.3 18.8 17.7 43.0 37.6 13.0 28.0 12.1 9.8 14.6 22.8 12.0 13.2 11.1 15.6 37.0 36.3 15.9 26.0 13.3 15.9 27.3 30.0 33.5 17.9 20.1 13.2 13.4 17.5 28.2 14.4 12.4 38.9 11.8 11.6 22.1 14.2 11.5 11.2 27.7 11.0 12.2 21.1 38.8 15.1 19.8 24.2 15.1 12.6 12.6 37.1 19.3 7.8 18.6 9.5 10.4 17.2 17.9 11.0 12.7 8.5 9.7 7.1 12.5 59.8 11.0 15.0 9.9 9.1 17.5 12.3 12.9 14.8 14.2 40.9 13.6 12.3 13.7 23.4 11.1 11.2 19.0 11.2 29.0 18.1 11.9 38.7 32.4 30.7 11.5 13.4 15.8 26.8 19.5 23.1 10.7 28.5 14.4 19.4 9.5 12.2 13.9 18.0 23.8 25.0 15.7 6.2 20.7 31.8 14.3 10.6 5.2 6.2 8.1 32.7 24.5 30.1 12.5 24.3 8.7 3.5 4.2 9.7 8.0 5.0 6.1 7.3 6.8 8.3 5.8 4.8 8.2 6.8 4.3 8.4 3.1 5.4 8.5 3.4 32.2 39.3 43.0 37.6 37.0 36.3 27.3 30.0 33.5 28.2 27.7 38.8 37.1 42.5 48.1 49.9 147.6 46.1 63.2 43.8 26.6 52.9 65.5 43.2 24.9 59.0 34.3 39.2 18.4 116.7 64.6 45.0 40.1 45.0 28.9 53.5 46.0 48.2 41.6 35.4 37.6 213.9 34.5 45.2 43.3 57.6 54.8 32.9 42.7 32.2 41.1 24.8 74.0 190.0 34.7 48.8 36.8 52.2 20.7 43.2 35.0 30.2 127.4 37.5 43.1 51.5 170.9 201.9 37.8 34.1 44.8 63.2 63.0 39.2 33.1 48.3 109.1 26.3 47.8 41.4 86.1 81.9 52.8 70.3 99.9 51.1 51.1 36.6 67.1 SMIM23 "C5orf50, LOC644994" ENSG00000185662 "Small integral membrane protein 23" A6NLE4 5 171782432-171796126 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 195 "testis: 25.2" "Cell type enriched" "Detected in some" 4 "Early spermatids: 287.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.47e-3)" "unprognostic (1.71e-1)" "unprognostic (7.80e-2)" "unprognostic (1.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.72e-1)" "unprognostic (5.36e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 287.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 39.8;endometrium 1: 32.5;skin 1: 116.1" "Cell type enriched" "Detected in many" 32 "Melanocytes: 1472.7" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 68 "SK-MEL-30: 8590.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA 11000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: AB_2673976" "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favorable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 2.8 0.8 0.2 0.8 0.2 1.8 8.4 0.7 0.6 39.8 0.5 1.3 1.6 32.5 1.5 0.7 1.3 1.6 0.5 0.2 0.1 2.1 5.1 0.9 5.7 0.3 1.0 0.2 4.3 2.4 1.7 0.7 2.8 0.1 0.9 1.2 0.5 3.6 0.8 0.3 116.1 2.1 3.6 0.0 0.5 1.1 4.9 0.0 0.7 1.1 0.2 2.2 1.3 4.0 0.3 14.8 1.1 5.6 0.2 83.6 0.6 126.2 0.9 0.8 1.9 2.0 12.8 6.0 2.6 6.1 0.8 0.3 2.5 0.6 1.0 1.6 3.0 2.1 2.4 2.5 0.7 0.3 1.0 1.4 0.5 1.0 1.2 0.6 1.3 1.0 1.1 0.5 1.8 0.5 2.7 0.4 1.0 17.1 2.8 0.3 1.6 3.5 1.5 1.4 2.7 0.5 2.6 0.3 2.5 8590.9 4.6 4.4 8.8 1.4 0.9 6.5 0.7 7.9 2.1 10.4 3.2 1.0 2.7 0.3 0.0 0.3 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.7 0.6 0.2 0.1 0.3 1.0 0.2 0.1 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.1 45.9 0.8 1.1 2.8 0.0 1.0 0.9 0.4 1.5 2.2 0.0 0.0 12.1 0.0 1.5 0.0 2.1 8.0 0.7 0.2 1.2 0.0 0.8 0.1 2.3 12.4 1.6 1.1 0.5 0.0 11.1 0.0 2.9 1.7 0.0 0.1 1.6 0.0 0.3 14.6 5.3 12.2 0.6 1472.7 1.0 0.6 0.2 0.0 0.0 0.1 1.0 0.6 0.7 1.2 0.5 2.4 2.8 1.0 0.0 0.0 0.2 1.7 3.9 2.6 1.0 10.2 24.9 0.4 1.3 1.6 0.4 SYN3 ENSG00000185666 "Synapsin III" O14994 22 32507820-33058381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 21.6" "Cell type enhanced" "Detected in some" "Early spermatids: 54.5;Excitatory neurons: 347.7;Inhibitory neurons: 198.6;Late spermatids: 250.7;Oligodendrocyte precursor cells: 75.9" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.2" "Group enriched" "Detected in many" 11 "B-cells: 3.2;granulocytes: 1.6" "Cell line enhanced" "Detected in many" "A-431: 15.0;EFO-21: 12.5;NTERA-2: 7.0;PC-3: 9.0;SCLC-21H: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034566 Uncertain NA NA "HPA034566: AB_10603120" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (5.13e-3)" "unprognostic (2.34e-1)" "unprognostic (9.39e-2)" "unprognostic (3.24e-1)" "unprognostic (7.77e-2)" "unprognostic (8.91e-2)" "unprognostic (8.59e-2)" "unprognostic (7.44e-3)" "unprognostic (4.35e-3)" "unprognostic (1.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (3.52e-1)" 0.7 0.8 13.4 0.6 0.0 2.5 0.6 0.0 21.6 0.3 0.0 0.7 0.6 0.6 0.6 1.5 0.7 1.0 0.6 7.3 1.9 0.6 0.5 0.8 1.2 5.0 0.0 1.5 0.4 1.2 0.4 1.7 2.6 9.4 0.6 0.6 4.1 0.5 0.4 0.5 1.8 1.0 0.6 0.0 1.4 0.9 4.0 0.0 0.7 0.9 0.4 0.6 0.3 0.2 13.4 15.0 0.7 0.4 1.9 0.0 0.4 0.6 0.5 0.1 0.0 0.2 1.4 1.1 0.7 12.5 0.1 6.2 3.6 5.4 0.1 0.0 0.3 1.1 0.7 5.1 3.0 0.0 0.9 0.6 0.2 1.0 0.1 0.0 0.3 0.1 0.3 0.9 0.6 0.0 0.1 0.6 0.5 7.0 0.2 9.0 0.4 0.6 0.6 0.0 1.0 7.4 0.6 1.2 0.1 1.2 3.3 0.2 0.4 0.4 0.7 4.8 1.0 1.0 0.5 0.7 0.6 0.4 0.4 2.8 0.9 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.1 13.4 0.0 0.0 21.6 7.3 1.9 5.0 0.0 1.5 9.4 0.0 0.0 13.4 1.6 0.0 0.0 8.5 1.5 0.4 0.1 0.0 0.0 3.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 54.5 0.1 0.4 0.9 0.0 0.0 347.7 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.3 5.0 198.6 0.0 0.0 0.0 0.5 250.7 1.5 0.1 0.0 12.2 0.0 0.0 0.0 75.9 8.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.6 6.6 0.0 0.9 3.7 9.0 0.0 0.1 1.1 0.0 0.7 0.0 0.0 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38043829-38046793 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 10.3;skin 1: 32.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8" "Group enriched" "Detected in many" 4 "cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.1 1.5 1.5 0.2 5.7 0.0 0.3 1.0 10.3 0.1 0.2 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 9.4 2.2 0.0 0.0 0.0 1.0 2.0 2.4 2.7 0.1 0.1 0.2 0.0 0.0 3.4 0.2 0.0 0.3 0.3 0.1 0.9 32.9 0.0 0.0 0.5 0.1 0.1 0.8 1.9 0.3 0.0 0.5 1.0 0.8 0.3 2.5 0.0 0.0 24.1 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 23.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 5.7 0.0 0.1 0.0 28.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.7 1.0 10.3 9.4 2.2 2.0 2.4 2.7 3.4 0.5 1.9 2.5 12.2 0.0 0.0 2.3 8.3 27.3 2.9 1.4 20.5 7.8 9.9 39.1 5.2 0.0 0.2 0.0 22.9 0.2 13.4 13.8 0.0 0.0 0.2 0.5 2.3 1.9 1.8 2.7 6.4 0.0 0.1 5.2 7.1 1.4 0.0 0.5 0.0 0.0 0.3 1.7 1.1 11.0 0.0 0.0 1.3 0.0 0.3 4.3 7.2 1.0 0.0 14.0 0.0 0.5 0.2 0.0 0.1 0.0 2.7 0.7 0.3 0.1 0.0 21.1 0.0 8.5 7.2 0.2 4.1 20.2 55.8 0.1 5.2 8.3 5.7 3.2 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677688-88686507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 31.5" "Cell type enhanced" "Detected in some" "dendritic cells: 19.7;granulocytes: 9.5;Kupffer cells: 14.6;Langerhans cells: 9.3;Macrophages: 9.4;NK-cells: 17.5;Plasma cells: 14.0;T-cells: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NB-4: 18.2;RPMI-8226: 28.6" "Region enhanced" "Detected in single" "basal ganglia: 1.5" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.6 0.5 1.7 2.4 2.3 1.8 0.4 0.0 3.4 0.5 0.0 0.9 1.5 0.6 0.3 0.6 0.8 1.0 1.8 2.5 0.2 0.7 0.8 2.2 3.9 2.5 0.0 2.8 0.5 1.7 1.5 0.7 0.2 6.0 0.8 0.3 0.3 1.2 0.2 31.5 0.6 3.7 0.2 0.0 7.0 3.3 0.9 0.2 0.8 0.9 7.3 2.6 1.4 0.5 1.3 0.3 0.9 0.3 1.3 0.0 0.0 0.6 0.3 0.0 0.0 0.1 3.5 0.3 2.3 0.5 0.0 0.8 0.8 0.3 0.2 0.0 0.4 1.2 1.1 0.1 1.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.5 2.1 4.3 0.0 3.2 0.2 18.2 0.4 0.3 0.4 3.9 0.3 28.6 0.0 0.4 1.7 0.2 0.7 0.0 0.2 0.4 1.2 2.2 0.3 0.1 1.0 0.2 0.0 0.7 4.2 4.0 0.3 4.9 0.5 5.2 14.1 48.5 10.2 5.3 18.8 7.8 16.7 9.8 16.7 6.1 10.0 6.4 30.9 1.1 1.5 11.9 21.4 10.9 1.7 2.3 0.0 3.4 2.5 0.2 2.5 0.0 2.8 6.0 0.0 0.2 1.3 0.3 3.2 0.0 2.0 8.5 0.5 0.1 0.4 0.0 0.2 0.4 0.5 2.0 0.0 0.7 0.0 0.0 0.0 19.7 0.0 1.9 0.1 0.0 0.6 0.0 0.4 0.0 0.4 6.4 0.4 0.5 0.2 0.5 0.1 9.5 0.0 0.4 0.1 6.9 0.0 3.7 0.1 2.0 14.6 9.3 0.3 0.0 9.4 5.4 0.0 5.3 0.1 17.5 1.0 1.9 0.1 1.1 0.4 14.0 0.1 0.0 0.2 1.0 0.9 0.0 0.7 0.4 0.0 1.5 0.2 0.3 0.1 14.0 0.0 0.3 0.1 ZBTB3 FLJ23392 ENSG00000185670 "Zinc finger and BTB domain containing 3" Q9H5J0 11 62748319-62754184 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035321, HPA035322" Approved Approved Mitochondria NA NA Mitochondria "HPA035321: AB_2674569, HPA035322: AB_10610567" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (3.48e-2)" "unprognostic (1.83e-3)" "unprognostic (2.93e-1)" "unprognostic (5.52e-3)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-2)" "unprognostic (5.02e-2)" "unprognostic (1.23e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.65e-5)" "prognostic favorable (9.98e-4)" "unprognostic (3.37e-3)" "unprognostic (4.15e-2)" "unprognostic (2.43e-2)" 1.4 1.4 2.6 2.2 4.4 2.4 2.0 3.1 3.2 1.8 1.0 2.4 2.3 1.6 1.9 1.9 4.4 1.0 3.1 2.6 2.5 1.8 1.8 2.9 2.4 3.9 3.5 2.3 2.6 2.5 2.2 1.0 2.0 4.0 1.8 2.1 3.1 3.5 2.2 2.8 5.8 2.3 1.8 2.7 2.1 5.0 2.8 3.2 2.8 2.7 3.2 2.6 1.4 1.2 7.8 2.1 3.2 2.6 3.5 4.9 2.4 2.2 2.3 2.4 2.6 2.3 2.1 2.7 3.4 3.3 2.4 1.9 4.6 2.3 2.5 1.2 3.9 3.9 1.8 6.7 2.6 2.4 2.7 3.7 2.7 2.9 2.0 3.0 3.3 2.2 2.7 3.3 3.5 2.6 4.3 3.4 3.1 7.8 1.6 1.6 2.5 2.0 3.3 2.1 2.7 2.4 2.3 2.3 2.9 1.6 3.7 4.3 2.0 2.0 3.9 1.7 2.8 1.3 3.6 2.8 2.9 3.7 1.6 1.5 1.9 7.2 9.4 4.0 5.6 4.8 4.0 4.1 4.9 5.2 3.3 4.6 3.6 2.3 5.0 4.8 1.5 5.9 6.2 2.6 4.4 3.1 3.2 2.6 2.5 3.9 3.5 2.3 4.0 2.7 3.2 7.8 1.4 3.2 2.7 0.7 2.1 0.8 1.6 1.3 2.8 2.7 1.6 1.8 3.3 1.5 1.3 0.0 6.2 4.4 0.9 3.2 7.9 3.2 12.8 1.5 2.4 1.7 0.0 0.4 0.5 1.9 2.4 1.9 2.6 1.6 0.0 2.5 1.1 3.0 2.4 0.0 0.5 3.1 4.1 2.2 0.8 7.5 1.5 1.4 0.0 0.0 2.0 1.7 4.1 0.0 2.2 2.1 3.9 3.0 1.0 1.1 2.8 2.7 1.4 4.5 0.0 0.9 1.8 2.9 3.9 1.0 1.1 2.5 1.5 2.1 1.9 1.1 LYG2 LYGH ENSG00000185674 "Lysozyme g2" Q86SG7 2 99242246-99255282 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.9;retina: 3.5;skin 1: 5.7;testis: 1.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 13.7;Cone photoreceptor cells: 14.6;Excitatory neurons: 19.6;Horizontal cells: 15.2;Inhibitory neurons: 17.5;Rod photoreceptor cells: 29.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.9" "Region enhanced" "Detected in some" "cerebellum: 4.9" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "THP-1: 1.7;U-937: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA039179 Uncertain "Secreted in other tissues" NA NA "HPA039179: AB_10794633" "unprognostic (5.12e-2)" "unprognostic (8.70e-3)" "unprognostic (6.29e-2)" "unprognostic (3.91e-2)" "unprognostic (1.47e-1)" "unprognostic (7.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.78e-2)" "unprognostic (1.90e-1)" "unprognostic (1.30e-2)" "unprognostic (1.30e-5)" "unprognostic (1.40e-3)" "unprognostic (1.08e-13)" "unprognostic (9.98e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-2)" "unprognostic (9.24e-3)" 0.1 0.1 0.2 0.1 0.4 0.5 0.0 4.9 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.3 0.1 0.0 0.0 0.0 0.3 0.0 1.8 0.1 0.0 3.5 0.3 0.0 0.3 5.7 0.1 0.0 0.0 0.2 0.2 1.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.4 0.4 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.3 0.9 0.2 0.0 1.0 0.2 0.0 0.0 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 1.0 0.2 0.6 0.3 0.0 1.2 0.2 0.6 0.4 1.1 0.3 0.5 0.1 0.0 0.0 0.0 0.4 0.3 1.7 0.6 0.6 0.4 0.1 0.4 0.2 0.8 0.1 0.3 2.5 0.4 0.0 0.2 0.1 0.3 0.0 0.2 0.6 0.8 0.4 0.0 1.1 0.3 0.3 0.1 0.2 0.0 0.9 0.1 0.0 0.2 0.4 4.9 0.9 0.6 0.2 0.3 0.3 0.1 1.8 0.0 0.2 0.8 0.9 0.0 0.0 5.5 1.2 0.6 0.5 0.3 0.0 13.7 0.8 0.9 0.3 5.7 0.1 0.0 14.6 0.9 1.6 0.1 0.0 0.1 6.1 0.6 0.9 0.7 0.0 0.0 19.6 0.0 0.2 0.8 0.0 0.3 0.0 0.5 1.1 0.0 0.2 15.2 17.5 0.0 0.0 0.9 0.3 2.2 0.0 0.2 1.8 0.0 0.2 6.9 4.1 7.5 8.9 0.1 0.0 0.7 0.0 0.7 0.3 0.3 0.0 29.9 0.0 2.0 0.9 1.8 1.6 0.0 0.4 0.3 0.9 0.2 0.4 0.1 MORN5 "C9orf113, C9orf18, FLJ46909" ENSG00000185681 "MORN repeat containing 5" Q5VZ52 9 122159908-122200088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 112.0;testis: 82.3" "Cell type enhanced" "Detected in many" "Early spermatids: 490.3;Endometrial ciliated cells: 240.0;Late spermatids: 692.9;Respiratory ciliated cells: 454.7;Spermatocytes: 142.1" "Group enriched" "Detected in many" 4 "endometrial cancer: 9.2;glioma: 4.0;ovarian cancer: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.6;U-87 MG: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.24e-3)" "unprognostic (7.30e-3)" "unprognostic (1.12e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (7.80e-3)" "unprognostic (1.91e-3)" "unprognostic (3.25e-3)" "unprognostic (2.64e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.95e-1)" 0.0 0.1 10.5 0.6 8.3 0.0 0.2 8.6 8.8 2.7 14.6 17.1 0.9 6.2 2.3 2.2 112.0 0.6 0.0 7.7 11.5 1.3 0.0 5.8 0.0 12.5 11.2 6.8 0.5 0.3 2.8 3.9 0.0 11.5 0.8 5.5 10.0 1.0 3.7 0.0 0.0 2.3 17.2 10.9 0.0 3.9 82.3 8.7 0.1 0.0 0.0 0.0 2.3 0.5 9.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 8.3 8.6 8.8 7.7 11.5 12.5 11.2 6.8 11.5 10.9 8.7 9.6 0.1 0.0 3.6 0.3 0.0 0.0 0.2 30.3 0.0 1.1 0.1 0.5 0.1 0.0 36.9 3.7 2.1 0.0 0.0 0.0 0.0 0.1 490.3 240.0 1.6 0.7 0.0 0.0 1.8 0.0 0.0 0.7 0.0 3.0 0.0 0.2 0.0 0.0 0.1 1.7 1.5 0.0 63.1 0.0 0.0 692.9 6.5 0.7 0.0 0.0 0.0 5.6 0.0 1.0 0.3 0.0 0.0 4.1 0.0 1.2 0.0 4.9 454.7 8.1 0.0 0.0 8.4 142.1 6.4 0.0 0.0 0.0 0.3 0.1 0.0 0.1 PRAME "CT130, MAPE" ENSG00000185686 "PRAME nuclear receptor transcriptional regulator" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 105.9" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 249.0" "Cancer enhanced" "Detected in many" "melanoma: 139.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "K-562: 834.1" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 3.8 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 3.4 10.1 0.0 0.5 0.0 0.2 0.0 0.1 1.8 0.1 0.2 0.1 0.1 0.0 0.0 4.8 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.3 0.2 0.1 0.1 0.1 105.9 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.9 53.3 0.0 126.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.4 0.7 3.5 88.8 0.0 0.5 0.1 4.3 0.0 0.0 61.5 14.8 36.0 21.7 0.6 0.0 2.9 172.6 0.0 0.0 0.0 0.0 0.0 0.0 14.9 834.1 15.6 0.0 8.1 0.3 0.2 0.0 27.2 3.5 5.0 0.0 0.2 0.0 0.2 1.1 185.0 0.0 0.6 0.2 0.0 27.8 24.3 5.0 0.1 159.6 0.0 0.2 3.0 14.6 1.3 0.2 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 37.8 22.3 1.1 0.3 0.0 0.0 0.0 0.0 0.9 2.0 0.0 13.0 0.0 60.9 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 41.4 5.6 0.4 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 1.8 0.0 0.4 6.6 0.0 2.7 41.8 249.0 0.0 0.0 0.0 0.1 14.2 0.1 0.0 MYBL1 "A-myb, AMYB" ENSG00000185697 "MYB proto-oncogene like 1" P10243 8 66562175-66614247 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2;testis: 11.9" "Group enriched" "Detected in many" 6 "dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.9;MAIT T-cell: 1.3" "Lineage enhanced" "Detected in single" "T-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008791 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008791: AB_1078540" "unprognostic (1.11e-1)" "unprognostic (2.47e-2)" "unprognostic (2.57e-1)" "unprognostic (7.23e-4)" "unprognostic (2.26e-1)" "unprognostic (1.89e-2)" "unprognostic (6.67e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.78e-2)" "unprognostic (1.13e-2)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.03e-8)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (5.87e-2)" 1.0 0.7 1.3 6.2 2.3 2.5 1.8 2.1 1.7 0.7 0.7 1.0 1.3 1.1 0.6 0.7 0.8 2.3 3.4 1.2 1.6 0.4 2.0 2.4 20.2 3.1 2.6 0.8 0.6 0.2 0.5 0.4 0.9 3.3 1.2 1.4 6.0 0.5 1.6 0.9 1.2 1.9 2.3 2.4 7.6 1.3 11.9 1.7 2.5 0.6 0.8 16.3 1.1 0.8 4.0 35.4 11.9 3.7 10.1 1.0 2.1 2.6 47.7 21.8 82.5 69.4 1.6 34.9 87.7 4.2 40.4 31.0 10.0 3.5 4.0 113.0 10.6 5.5 1.8 13.4 1.6 0.2 0.8 3.4 0.7 0.4 22.7 19.0 14.8 2.7 6.4 0.4 28.3 51.0 3.1 5.8 1.3 2.8 3.3 15.8 1.9 14.1 2.2 19.4 1.2 8.2 3.3 8.4 3.0 8.6 5.6 50.6 2.3 14.5 49.4 11.3 11.1 44.2 8.2 12.1 25.7 13.0 5.3 20.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.3 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 1.3 2.3 2.1 1.7 1.2 1.6 3.1 2.6 0.8 3.3 2.4 1.7 4.0 3.0 0.0 2.3 3.3 4.0 1.8 0.4 0.3 1.8 10.4 4.7 6.6 9.1 2.8 0.1 0.0 2.1 2.0 127.3 0.5 0.0 0.5 3.9 0.8 2.4 1.7 0.0 6.6 3.9 0.0 0.7 2.7 3.1 1.4 0.0 5.6 4.2 0.9 0.7 5.0 2.7 0.4 0.0 1.6 3.2 4.2 0.9 5.1 1.8 8.4 1.6 10.3 107.1 5.5 12.4 0.2 1.1 0.0 40.2 0.3 0.0 0.5 1.5 9.1 0.0 2.5 4.5 35.8 6.8 3.2 0.4 1.5 89.1 1.4 0.8 0.3 MOSMO "ATTHOG, BC030336, C16orf52" ENSG00000185716 "Modulator of smoothened" Q8NHV5 16 22007638-22087534 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 50.9;Breast glandular cells: 18.2;Breast myoepithelial cells: 20.2;Endometrial stromal cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "WM-115: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (2.78e-2)" "unprognostic (8.84e-2)" "unprognostic (5.50e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-2)" "unprognostic (2.22e-3)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (2.75e-1)" 10.4 21.9 8.0 9.2 10.8 2.1 9.3 13.8 15.7 11.4 6.6 7.5 7.9 12.9 7.5 9.7 9.8 10.4 9.8 10.0 8.8 8.6 13.5 10.7 10.3 7.6 9.0 8.6 11.9 7.5 18.4 9.5 12.8 9.1 10.5 8.1 13.2 8.1 7.9 10.3 9.7 7.1 9.8 6.6 9.4 10.1 10.1 9.7 8.7 9.6 11.5 9.5 10.5 11.6 11.9 17.7 6.2 11.9 9.4 20.9 42.4 8.5 18.2 21.7 9.5 14.3 5.9 11.4 9.0 7.2 19.1 14.6 9.8 7.6 19.1 17.5 21.3 8.4 7.6 13.4 20.7 19.2 6.4 11.5 24.5 12.8 14.1 34.5 16.1 22.9 7.4 5.3 23.0 41.5 11.0 6.1 5.5 8.9 8.4 15.9 13.5 12.2 9.4 8.6 8.7 8.1 14.0 9.4 4.7 33.2 11.9 10.0 6.8 13.1 17.9 13.5 13.0 8.0 11.4 11.2 6.0 13.0 7.8 87.1 0.3 0.2 0.4 0.3 0.3 0.2 0.3 0.1 0.1 0.0 1.0 0.3 0.3 0.1 0.3 0.2 0.2 0.6 0.0 8.0 10.8 13.8 15.7 10.0 8.8 7.6 9.0 8.6 9.1 6.6 9.7 11.9 50.9 0.0 8.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 18.2 20.2 0.0 0.0 5.0 5.5 0.0 5.7 12.6 0.0 1.9 4.2 0.0 13.2 35.3 9.1 0.0 0.0 0.0 5.7 4.3 11.3 0.0 12.9 2.5 16.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 3.3 0.0 0.0 8.1 0.7 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 5.1 5.0 13.1 0.0 0.0 DRG1 NEDD3 ENSG00000185721 "Developmentally regulated GTP binding protein 1" Q9Y295 22 31399604-31530634 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 161.7" "Group enriched" "Detected in all" 5 "Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001218 Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 22000 "Nucleoplasm, Nuclear bodies" Cytosol "HPA001218: AB_1078704" "unprognostic (4.94e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (5.26e-2)" "unprognostic (4.66e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (7.71e-4)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" "unprognostic (2.32e-3)" "unprognostic (8.69e-3)" "unprognostic (1.55e-3)" "unprognostic (4.80e-2)" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (2.25e-1)" 31.7 32.8 24.3 21.6 25.6 32.6 35.5 28.7 31.9 27.6 24.6 25.0 22.8 28.1 39.0 27.6 33.0 19.7 45.0 25.0 26.5 36.2 38.2 21.0 29.4 26.0 25.4 24.0 35.3 34.4 38.7 18.8 36.0 26.5 25.2 30.3 30.4 30.8 29.1 101.3 23.7 21.5 34.4 25.9 20.3 24.4 161.7 24.9 40.8 34.9 85.8 38.6 31.0 20.8 28.0 80.3 61.3 73.9 63.3 64.4 75.2 61.5 70.2 81.7 125.7 104.4 100.3 38.3 111.2 38.6 86.9 60.3 64.5 128.5 82.8 134.4 52.0 152.0 71.9 64.9 99.6 91.4 174.2 65.1 65.6 60.9 103.7 152.9 64.6 87.5 61.6 93.9 48.1 97.2 88.0 75.7 88.4 62.1 114.0 65.9 98.7 118.9 97.3 82.1 68.6 80.8 50.4 78.5 79.8 107.2 70.8 59.7 77.2 50.6 57.7 79.3 59.1 81.3 67.2 78.5 108.6 57.0 77.7 77.4 25.0 43.3 46.0 34.3 49.7 39.6 53.6 36.6 43.0 45.2 39.4 40.5 39.8 9.8 46.7 37.5 39.6 50.9 47.0 24.3 25.6 28.7 31.9 25.0 26.5 26.0 25.4 24.0 26.5 25.9 24.9 28.0 22.0 19.2 15.4 3.9 29.4 38.6 40.8 77.2 29.6 18.7 27.2 27.2 52.4 35.8 37.6 27.6 25.0 126.4 20.6 22.5 64.6 56.4 798.4 23.7 24.4 34.4 11.4 37.8 10.3 45.4 104.5 33.2 21.4 21.1 33.7 27.1 35.7 36.9 60.4 15.2 11.2 31.0 48.8 31.1 24.0 651.5 35.8 22.9 17.8 7.5 39.2 27.6 33.0 9.5 11.1 42.7 27.0 37.2 27.1 48.7 42.9 60.3 28.7 18.4 59.2 35.4 36.1 469.3 92.1 33.1 32.1 117.1 25.5 26.2 41.0 45.3 ANKFY1 "ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14" ENSG00000185722 "Ankyrin repeat and FYVE domain containing 1" Q9P2R3 17 4163821-4263995 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024513, HPA024522, HPA065849" Approved Enhanced Endosomes NA NA Endosomes "HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: AB_2685567" "unprognostic (4.57e-3)" "unprognostic (1.25e-1)" "unprognostic (1.26e-1)" "unprognostic (9.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.42e-3)" "unprognostic (1.13e-1)" "unprognostic (7.77e-2)" "unprognostic (1.08e-1)" "unprognostic (4.14e-2)" "unprognostic (7.83e-2)" "unprognostic (2.55e-2)" "unprognostic (4.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.50e-1)" "unprognostic (1.80e-1)" "unprognostic (2.05e-1)" 13.9 16.2 19.6 13.6 24.0 16.5 12.7 24.1 17.8 14.6 14.2 21.7 11.6 18.1 10.7 13.8 15.3 12.0 10.7 17.8 26.1 11.4 14.1 15.5 14.1 27.1 22.6 15.5 20.0 9.7 19.2 12.4 14.3 25.1 12.3 14.1 13.2 13.8 12.3 14.2 20.0 13.8 14.9 23.9 15.2 13.1 6.0 21.7 20.5 14.5 11.5 12.9 14.7 14.0 29.1 20.6 47.2 31.5 21.3 41.7 31.6 20.5 22.5 23.4 35.5 35.2 21.0 13.7 17.8 18.0 34.1 19.0 32.0 29.3 24.0 31.2 9.7 29.7 17.6 34.0 19.6 23.2 10.6 20.4 33.3 24.8 25.5 18.7 19.0 21.3 17.2 17.3 16.7 24.5 16.0 15.9 11.3 13.3 16.0 16.4 23.9 21.0 9.9 18.5 27.7 10.5 16.4 31.9 15.1 20.2 24.3 17.5 13.7 27.3 22.5 11.7 31.0 30.3 5.5 4.6 5.9 27.5 21.1 27.5 1.0 3.9 1.7 2.7 6.4 2.5 0.9 1.8 1.9 2.7 0.9 1.8 1.7 1.6 1.0 7.3 1.1 1.7 2.2 19.6 24.0 24.1 17.8 17.8 26.1 27.1 22.6 15.5 25.1 23.9 21.7 29.1 14.5 28.9 24.6 43.1 8.7 12.4 8.9 12.7 13.1 24.1 12.2 13.2 4.6 8.6 13.6 18.4 29.2 11.2 15.1 13.8 1.9 9.8 4.3 13.9 20.0 15.1 12.1 6.3 59.9 9.7 9.8 15.2 18.8 12.5 3.8 21.1 24.7 19.7 20.2 26.9 60.5 10.9 6.1 24.4 7.6 3.8 14.6 19.1 17.8 39.4 18.8 9.8 19.6 36.7 46.4 13.2 6.4 19.2 7.4 15.4 11.4 7.6 22.4 30.2 6.6 25.5 11.9 12.9 12.8 17.2 11.6 6.2 15.5 16.6 12.5 14.5 YTHDF3 FLJ31657 ENSG00000185728 "YTH N6-methyladenosine RNA binding protein 3" Q7Z739 8 63168553-63212786 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.06e-2)" "unprognostic (9.89e-3)" "unprognostic (6.65e-3)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (7.87e-2)" "unprognostic (9.57e-2)" "unprognostic (2.07e-1)" "unprognostic (6.14e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (1.35e-3)" "unprognostic (1.11e-1)" 25.0 23.1 9.9 20.7 11.5 92.3 22.3 14.0 13.4 24.2 14.6 24.5 21.9 24.8 21.4 21.6 18.9 22.6 29.0 11.7 16.9 24.9 41.4 20.7 21.3 10.0 10.9 9.9 23.7 22.8 24.4 8.8 30.0 11.0 23.1 24.3 15.3 22.3 20.0 34.6 16.1 21.7 29.3 10.2 22.2 19.0 22.7 11.8 25.2 23.4 36.4 21.3 23.6 13.3 11.8 37.6 50.4 47.9 36.3 62.5 53.9 32.2 67.2 56.7 42.5 49.1 42.9 37.5 40.5 14.0 66.5 47.6 35.0 64.1 45.3 61.7 32.7 29.9 74.7 36.5 30.4 57.1 21.9 35.0 71.0 35.0 45.1 63.5 44.4 35.9 24.6 43.9 35.6 66.7 26.9 40.1 22.6 65.8 50.4 36.8 30.5 36.1 19.9 42.7 66.4 19.4 34.8 48.0 42.5 51.0 40.7 57.0 27.2 65.2 38.4 36.4 34.2 36.4 42.6 40.6 56.2 38.9 29.4 47.5 40.3 29.1 30.7 14.2 32.9 15.8 11.7 14.1 17.0 29.0 13.8 17.0 16.3 36.5 18.4 47.2 8.6 16.5 18.1 9.9 11.5 14.0 13.4 11.7 16.9 10.0 10.9 9.9 11.0 10.2 11.8 11.8 33.0 32.1 51.1 41.8 28.2 38.7 22.2 19.1 26.2 15.4 34.1 24.5 49.9 28.6 26.5 20.2 6.2 20.2 34.1 51.0 7.9 15.7 8.0 39.2 72.4 28.2 40.7 14.5 49.8 16.7 27.1 33.5 30.1 77.4 22.8 24.9 28.9 69.3 31.1 20.2 47.2 31.8 10.2 62.1 61.5 12.0 23.9 54.4 17.8 54.4 32.4 15.4 15.5 60.3 61.9 21.3 30.6 26.4 22.9 32.8 27.9 29.7 31.2 13.4 13.1 26.4 31.5 15.1 19.3 37.9 31.4 26.4 28.8 25.5 28.5 35.8 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143299952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA057855: AB_2683545, HPA072473: AB_2686524" "unprognostic (3.23e-2)" "prognostic unfavorable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavorable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favorable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 4.0 3.4 3.7 3.3 3.8 3.6 3.2 5.7 6.6 3.3 0.0 3.2 6.1 4.5 2.6 2.6 3.5 2.1 2.6 4.6 2.4 3.2 4.7 2.9 3.8 5.9 3.5 4.6 4.7 5.1 4.3 3.2 2.7 6.8 3.2 2.0 3.6 5.8 2.3 3.9 6.7 3.7 2.3 1.2 4.0 3.3 3.5 3.3 2.2 3.7 2.5 3.1 3.7 2.8 5.3 8.2 7.4 7.8 8.8 3.2 2.5 14.9 6.3 2.4 4.4 2.7 4.3 6.3 0.7 8.2 2.5 2.5 5.8 8.5 3.8 4.5 9.1 17.9 10.8 8.8 6.7 3.4 4.5 13.5 2.4 6.1 3.0 6.8 3.3 2.2 6.4 22.2 5.3 3.1 17.3 4.6 8.8 10.2 9.7 17.1 9.8 4.4 8.1 3.0 6.3 11.6 16.1 9.3 6.7 8.2 5.3 10.3 8.1 4.5 6.2 13.4 5.5 10.9 9.7 7.3 10.0 4.2 9.2 7.5 1.2 2.0 1.7 2.9 1.1 3.0 2.4 2.1 3.1 2.1 3.2 3.9 3.5 1.2 3.5 2.0 3.8 0.7 1.9 3.7 3.8 5.7 6.6 4.6 2.4 5.9 3.5 4.6 6.8 1.2 3.3 5.3 2.2 0.0 0.0 3.6 3.0 2.9 2.3 0.6 0.0 5.3 1.5 1.3 2.8 2.8 0.3 3.7 6.2 1.7 1.8 2.1 3.9 2.4 1.2 0.8 2.3 2.5 0.0 1.3 3.4 2.0 1.8 1.9 2.0 1.0 0.0 2.9 2.2 2.2 1.2 3.3 3.9 1.0 2.0 0.9 0.7 2.4 4.1 0.7 1.8 1.0 0.9 1.8 6.2 4.5 3.1 1.5 0.3 1.2 2.3 1.7 2.7 1.9 0.3 4.5 6.6 1.7 2.2 3.0 5.7 1.1 2.0 0.4 2.5 2.7 2.0 0.6 ADARB2 "ADAR3, hRED2, RED2" ENSG00000185736 "Adenosine deaminase RNA specific B2 (inactive)" Q9NS39 10 1177313-1737525 "Predicted intracellular proteins" "mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 47.3" "Group enriched" "Detected in many" 4 "Inhibitory neurons: 1726.7;Oligodendrocyte precursor cells: 693.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 4.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.64e-2)" "unprognostic (7.44e-3)" "unprognostic (2.12e-1)" "unprognostic (2.62e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (9.58e-2)" "unprognostic (9.28e-3)" "unprognostic (3.41e-1)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-1)" "unprognostic (3.81e-3)" 0.1 0.2 17.1 0.0 23.8 0.2 0.8 14.3 16.8 0.6 0.1 1.7 0.1 0.2 0.0 0.3 1.1 0.0 0.2 10.9 17.4 0.3 0.1 0.6 0.2 28.7 25.6 8.1 0.1 3.5 0.0 0.5 0.1 22.4 0.5 0.0 3.0 4.3 0.8 0.0 0.3 0.8 0.0 16.4 0.1 0.7 2.9 29.5 1.0 0.1 0.1 0.4 0.6 0.5 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 4.7 1.1 0.0 0.0 0.4 0.1 17.1 23.8 14.3 16.8 10.9 17.4 28.7 25.6 8.1 22.4 16.4 29.5 47.3 0.3 0.0 0.0 57.8 0.7 0.0 0.1 0.0 4.6 11.1 1.7 0.6 1.9 2.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 40.9 1.6 0.1 0.5 0.0 0.0 9.2 0.0 0.0 0.3 0.5 0.3 0.0 4.8 4.6 0.0 0.2 1.7 1726.7 0.0 0.0 0.0 0.0 133.9 0.3 0.0 3.6 6.5 0.0 30.5 2.1 693.7 254.6 0.0 0.0 0.4 0.0 0.1 0.1 2.9 0.0 1.4 6.6 0.0 0.4 1.2 1.0 3.3 0.0 0.0 0.6 0.2 0.3 0.1 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875194-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.7" "Group enriched" "Detected in some" 18 "Astrocytes: 2921.6;Excitatory neurons: 3761.0;Inhibitory neurons: 3088.3;Oligodendrocyte precursor cells: 1175.2" "Cancer enhanced" "Detected in many" "melanoma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;SK-MEL-30: 2.7;U-2 OS: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.1 0.4 17.8 0.3 12.3 0.0 1.3 0.7 19.7 0.0 0.0 0.3 0.1 0.0 0.0 0.1 4.7 2.9 0.2 16.5 2.3 0.7 0.5 0.7 0.1 3.0 7.8 10.8 0.0 0.1 0.1 2.0 0.3 5.4 0.1 0.1 5.3 2.7 0.2 0.0 0.6 0.1 0.1 2.0 0.1 0.3 1.8 10.7 0.0 0.2 0.1 0.0 0.1 0.0 7.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 12.3 0.7 19.7 16.5 2.3 3.0 7.8 10.8 5.4 2.0 10.7 7.1 0.1 0.0 0.0 2921.6 0.1 0.0 0.0 0.0 0.0 15.9 0.7 0.6 0.8 2.8 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.9 31.4 0.0 0.0 0.7 0.0 0.0 3761.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 3088.3 0.0 0.0 0.0 0.0 12.8 0.6 0.1 0.0 148.0 0.0 6.7 0.0 1175.2 50.2 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 SRL SAR ENSG00000185739 Sarcalumenin Q86TD4 16 4189374-4242080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 39 "heart muscle: 243.4;skeletal muscle: 515.1;tongue: 385.7" "Cell type enriched" "Detected in some" 16 "Cardiomyocytes: 247.3" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.5;thyroid cancer: 5.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HSkMC: 4.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "HPA041535, HPA045520" Enhanced "Intracellular and membrane" NA NA 230000 "HPA041535: AB_2677538, HPA045520: AB_2679358" "unprognostic (1.24e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (8.11e-2)" "unprognostic (2.04e-7)" "unprognostic (1.41e-1)" "unprognostic (8.28e-2)" "unprognostic (7.40e-4)" "unprognostic (4.91e-2)" "unprognostic (8.70e-2)" "unprognostic (7.78e-4)" "unprognostic (3.33e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-3)" "unprognostic (1.68e-4)" 3.0 0.4 1.1 1.2 1.0 0.2 1.7 1.0 1.4 2.6 1.0 1.2 0.4 3.0 2.3 9.7 3.1 1.8 243.4 0.8 1.2 1.4 0.4 1.2 0.7 1.2 1.4 0.8 1.3 0.6 0.2 0.5 1.3 1.1 5.6 1.1 8.6 6.5 2.6 515.1 0.8 1.7 3.4 1.1 2.2 1.1 1.1 1.2 1.7 2.3 385.7 1.1 1.4 1.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.1 1.0 1.0 1.4 0.8 1.2 1.2 1.4 0.8 1.1 1.1 1.2 1.1 0.5 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.0 247.3 0.0 0.0 1.8 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.4 0.0 0.0 8.5 0.0 0.1 0.0 0.2 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.3 0.0 1.8 0.1 0.0 1.0 0.0 1.2 0.0 1.0 0.3 0.1 0.0 3.8 0.0 0.3 0.0 0.2 0.0 12.1 6.6 5.5 15.4 0.1 0.2 0.0 0.4 0.0 0.1 0.4 0.0 0.1 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422190-109429167 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 16.4" "Group enriched" "Detected in some" 6 "Excitatory neurons: 52.4;Horizontal cells: 20.2;Inhibitory neurons: 33.3" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.9;fHDF/TERT166: 11.7;SCLC-21H: 2.9" "Low region specificity" "Detected in all" HPA034656 Approved NA NA "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.0 0.1 3.7 0.0 4.3 0.0 0.0 0.0 16.4 0.9 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.0 8.0 7.2 0.0 0.0 0.0 0.0 0.0 2.6 8.6 0.0 0.0 0.0 0.2 0.0 2.2 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.1 0.1 2.9 1.4 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.3 0.0 16.4 8.0 7.2 0.0 2.6 8.6 2.2 0.0 11.2 6.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 52.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.2 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 4.5 5.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFIT1 "G10P1, GARG-16, IFI56, IFNAI1" ENSG00000185745 "Interferon induced protein with tetratricopeptide repeats 1" P09914 10 89392546-89406487 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 63.3;Distal tubular cells: 64.6;Muller glia cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 66.7" "Group enriched" "Detected in all" 8 "granulocytes: 66.7;monocytes: 21.7" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 325.3;BJ hTERT+ SV40 Large T+ RasG12V: 318.1" "CAB045980, HPA053890, HPA055380" Approved Enhanced Cytosol NA NA Cytosol "CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.80e-1)" "unprognostic (7.96e-3)" "unprognostic (1.35e-3)" "unprognostic (2.02e-2)" "unprognostic (6.45e-2)" "unprognostic (3.66e-1)" "unprognostic (3.34e-1)" "unprognostic (8.65e-3)" "unprognostic (1.82e-2)" "unprognostic (7.68e-2)" "unprognostic (2.21e-2)" "unprognostic (2.03e-2)" "unprognostic (5.95e-2)" "unprognostic (9.75e-3)" "unprognostic (6.40e-3)" 16.8 38.3 13.1 4.5 14.8 10.0 14.5 16.4 18.5 13.3 13.8 11.8 3.9 7.0 6.6 5.1 9.6 13.9 18.2 13.3 13.9 23.6 25.1 14.2 3.5 17.6 13.9 12.7 9.2 6.2 12.0 20.4 10.0 14.9 6.7 5.1 8.0 42.4 6.2 17.6 4.7 7.6 8.0 13.2 18.9 6.9 5.4 14.5 13.4 9.2 20.8 2.4 7.6 9.4 25.9 10.0 1.2 2.6 17.2 8.1 16.5 0.2 11.7 68.9 325.3 318.1 1.0 10.4 0.7 3.8 14.6 63.4 8.2 1.0 1.0 15.6 0.6 1.1 1.7 8.4 0.9 9.2 1.4 1.7 13.5 0.3 6.2 0.1 6.4 0.4 1.7 0.2 7.7 3.5 0.3 2.3 6.8 0.3 0.1 6.3 3.1 0.8 2.0 7.9 1.2 0.1 0.6 3.1 2.4 69.6 2.4 1.3 1.5 0.5 1.7 1.9 2.5 1.4 1.0 1.3 0.6 2.2 2.3 0.9 9.9 12.6 15.4 1.6 15.6 2.9 3.0 4.1 2.9 3.7 3.2 5.7 3.5 66.7 1.9 21.7 0.2 4.9 6.6 13.1 14.8 16.4 18.5 13.3 13.9 17.6 13.9 12.7 14.9 13.2 14.5 25.9 63.3 35.3 5.8 7.2 2.5 2.9 3.3 12.9 3.4 26.4 2.4 5.2 19.1 4.3 7.6 9.2 18.8 4.8 4.7 6.3 64.6 12.6 0.4 21.1 3.2 41.4 0.0 4.0 13.8 5.1 20.8 22.8 0.5 7.2 2.5 11.0 9.3 12.1 36.9 32.0 13.3 1.4 4.1 14.5 3.3 3.0 19.3 13.3 1.8 16.9 13.5 77.9 1.0 12.1 14.4 3.6 4.7 43.6 0.7 1.1 9.8 26.7 17.8 13.4 39.5 18.1 11.4 0.5 3.0 1.0 1.7 1.4 3.1 15.4 0.2 1.2 CXorf38 MGC39350 ENSG00000185753 "Chromosome X open reading frame 38" Q8TB03 X 40626921-40647561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050120 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA050120: AB_2681024" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "unprognostic (2.91e-1)" "unprognostic (6.98e-2)" "unprognostic (1.37e-1)" "unprognostic (3.15e-1)" "unprognostic (1.48e-3)" "unprognostic (7.59e-2)" "unprognostic (1.46e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (1.23e-1)" "unprognostic (1.71e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.73e-2)" "prognostic favorable (1.44e-8)" 8.3 8.2 5.3 11.6 5.9 10.6 8.3 6.0 5.7 7.9 4.9 7.6 8.3 7.3 4.7 6.1 10.1 6.4 4.9 5.0 5.8 8.1 8.1 10.3 16.3 6.2 5.8 4.9 9.6 6.1 9.6 4.9 6.9 6.1 6.3 7.7 5.7 6.6 6.1 5.0 8.0 9.7 5.9 5.8 14.5 6.7 2.1 5.8 13.4 11.2 4.1 13.5 7.2 7.1 7.1 11.3 5.9 6.2 4.9 6.5 10.8 3.3 7.5 10.5 9.1 9.1 7.7 15.8 18.5 6.4 11.2 15.2 7.4 7.6 12.5 8.3 25.7 11.4 12.5 7.1 4.6 10.8 22.0 18.6 9.6 9.0 12.7 12.5 8.7 10.4 15.8 5.3 13.7 17.0 10.5 15.4 16.7 5.6 8.2 12.8 12.7 13.2 14.4 10.7 17.0 7.0 9.6 15.1 7.5 8.9 11.6 11.4 10.1 13.0 11.9 6.8 8.7 6.5 14.7 5.5 7.9 15.4 11.4 8.0 9.3 16.0 22.1 9.2 15.8 9.7 6.9 8.7 7.4 14.2 9.6 7.6 7.8 19.7 7.3 25.1 5.9 10.9 10.3 5.3 5.9 6.0 5.7 5.0 5.8 6.2 5.8 4.9 6.1 5.8 5.8 7.1 19.8 9.6 9.1 10.1 26.9 3.6 11.3 6.3 10.8 12.6 10.5 8.0 6.4 18.6 7.6 16.5 18.8 9.2 48.3 15.1 7.9 27.7 1.0 25.2 15.0 14.0 7.3 6.3 11.9 30.1 9.7 8.9 9.7 21.6 17.1 16.5 10.4 10.8 36.6 15.2 13.1 12.7 8.2 30.7 9.8 1.3 9.6 29.5 3.6 8.4 61.9 10.2 41.2 12.1 17.8 40.5 17.2 5.3 16.4 14.7 15.8 14.4 7.8 7.6 6.6 13.5 9.2 6.5 7.4 9.7 5.4 8.2 31.2 20.6 13.3 28.3 CLDN24 CLDN21 ENSG00000185758 "Claudin 24" A6NM45 4 183321764-183322426 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.49e-1)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.93e-3)" 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198853 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 35.2;skeletal muscle: 21.3;tongue: 12.3" "Group enriched" "Detected in some" 30 "Excitatory neurons: 2136.7;Inhibitory neurons: 862.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 34.9;HEL: 23.2;HL-60: 31.5;U-251 MG: 23.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016655 Approved Approved Vesicles NA NA Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.1 1.6 2.0 1.4 10.2 5.1 0.4 0.0 28.8 0.2 0.0 0.3 0.2 0.1 0.0 0.9 0.3 0.3 0.1 7.9 2.2 0.1 0.2 0.3 2.3 19.3 4.6 3.3 0.1 0.1 0.0 0.2 0.4 25.3 1.3 0.3 0.2 1.2 0.9 21.3 0.1 0.7 0.3 0.0 1.1 0.3 1.2 3.0 1.7 4.7 12.3 2.0 0.9 0.6 35.2 4.4 1.1 0.0 0.2 0.0 1.5 0.0 34.9 5.2 5.1 4.3 0.0 0.0 21.2 0.0 11.9 0.4 0.7 0.1 2.1 6.1 0.3 7.2 23.2 0.1 0.0 0.9 31.5 0.0 0.3 0.8 14.5 14.9 3.3 0.0 0.0 1.4 14.2 10.2 0.1 0.0 13.5 1.3 0.0 7.1 0.0 1.1 14.4 1.9 0.0 5.8 2.7 0.0 0.1 13.7 0.2 4.3 2.3 0.0 21.0 9.2 0.1 23.4 14.8 0.4 9.3 0.2 14.9 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.4 0.1 0.3 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.0 10.2 0.0 28.8 7.9 2.2 19.3 4.6 3.3 25.3 0.0 3.0 35.2 0.0 0.0 0.0 38.8 7.6 0.3 3.6 0.7 5.2 0.3 0.4 0.5 3.6 0.0 0.1 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 5.5 2136.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 862.4 0.0 0.0 0.0 1.5 1.6 0.0 0.2 1.8 49.6 0.0 0.1 1.0 30.2 26.7 0.0 0.0 0.0 7.6 5.7 0.0 0.0 0.0 0.2 0.0 6.0 0.8 0.5 0.5 0.8 0.3 0.3 2.8 0.0 0.0 0.7 ADAMTSL5 THSD6 ENSG00000185761 "ADAMTS like 5" 19 1505022-1513604 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 28.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 9.8;Cardiomyocytes: 9.6;Leydig cells: 19.3;Peritubular cells: 18.0;Proximal enterocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044050 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA044050: AB_10962625" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (5.85e-2)" "unprognostic (2.45e-1)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (1.77e-2)" "unprognostic (1.89e-1)" "unprognostic (2.79e-2)" "unprognostic (2.89e-3)" "unprognostic (1.52e-1)" "unprognostic (5.03e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-3)" 1.5 1.5 1.7 0.7 2.0 0.3 2.2 2.3 2.0 28.3 6.8 3.1 9.9 20.0 5.0 15.2 9.6 0.5 17.6 1.9 1.0 1.5 4.2 1.4 0.6 1.2 1.0 1.3 1.4 1.0 1.4 2.6 4.3 1.2 4.6 1.1 0.9 3.9 3.4 15.3 1.9 8.5 12.6 0.2 0.8 1.4 3.7 1.5 0.2 1.5 5.9 1.6 3.9 22.7 1.5 8.1 3.5 0.1 0.1 4.1 3.0 3.8 14.7 9.8 5.6 8.1 20.7 4.0 0.0 3.6 12.3 1.6 6.7 3.5 4.2 4.2 7.9 0.4 1.7 11.0 3.8 4.6 0.2 10.2 1.8 4.6 1.3 3.5 7.4 0.0 2.5 5.0 9.8 0.6 7.5 0.4 0.4 0.1 2.3 1.8 0.2 0.8 2.1 4.5 0.0 0.1 0.3 3.5 0.4 4.4 1.9 9.2 3.0 0.9 0.0 5.4 10.9 0.6 6.2 4.2 1.0 0.1 0.8 2.4 0.2 0.0 0.4 1.4 0.5 0.9 0.0 1.6 1.1 0.0 0.0 2.0 1.3 0.1 0.0 0.9 0.0 0.5 0.5 1.7 2.0 2.3 2.0 1.9 1.0 1.2 1.0 1.3 1.2 0.2 1.5 1.5 0.2 0.0 1.1 3.6 0.3 0.4 2.4 9.8 6.2 0.3 1.9 0.8 9.6 0.0 3.4 0.0 0.0 0.8 0.7 0.6 0.0 0.6 0.6 0.3 4.5 0.4 0.0 0.0 0.1 1.7 2.1 5.8 1.1 0.4 0.0 0.5 0.0 1.8 0.3 0.0 0.1 1.8 4.1 0.0 0.4 2.6 19.3 0.4 1.8 1.0 0.0 3.7 0.0 0.0 0.1 7.0 1.5 18.0 1.8 2.7 12.5 0.5 1.3 2.1 0.0 0.9 3.3 0.6 1.9 8.4 0.4 0.7 1.2 0.3 1.6 3.5 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728606-21948772 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;retina: 18.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles NA NA Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 0.5 2.2 10.8 1.4 19.6 0.0 0.6 17.4 26.3 11.1 0.4 4.9 1.2 6.2 0.6 4.0 2.6 1.1 0.4 18.7 19.3 7.0 0.2 0.5 0.0 10.4 13.1 23.7 1.3 0.5 0.0 4.2 1.0 13.9 0.5 4.2 18.3 0.5 0.3 0.3 0.5 3.9 6.1 3.3 0.3 0.8 0.4 12.8 0.0 6.5 0.0 0.0 1.0 1.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.4 0.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 19.6 17.4 26.3 18.7 19.3 10.4 13.1 23.7 13.9 3.3 12.8 19.2 0.0 0.0 0.0 148.2 0.1 0.0 0.0 0.0 0.0 33.0 0.1 0.0 0.5 0.0 0.0 14.7 0.0 0.1 0.0 0.3 62.6 0.1 9.8 0.2 2.1 1.6 0.0 0.0 9816.7 0.0 0.0 3.1 0.0 0.2 0.0 12.3 1.1 0.2 0.2 0.0 1982.4 0.6 0.0 0.0 0.0 4.2 0.0 0.5 3.6 119.9 0.6 45.9 0.0 5175.8 91.4 0.0 7.8 0.0 0.0 0.0 0.4 15.2 0.0 12.6 0.0 0.2 0.4 0.1 0.7 0.1 0.1 0.1 0.1 14.5 0.7 0.1 SPATA31A6 FAM75A6 ENSG00000185775 "SPATA31 subfamily A member 6" Q5VVP1 9 42183659-42189887 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 2.0" "Cell type enriched" "Detected in single" 4 "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.23e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MORF4L1 "Eaf3, HsT17725, MEAF3, MORFRG15, MRG15" ENSG00000185787 "Mortality factor 4 like 1" Q9UBU8 15 78810487-78898139 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042360, HPA062010" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA042360: AB_10794275, HPA062010: AB_2684655" "unprognostic (5.36e-2)" "unprognostic (4.30e-1)" "unprognostic (3.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-3)" "unprognostic (3.61e-3)" "unprognostic (8.61e-3)" "unprognostic (3.15e-1)" "unprognostic (3.58e-2)" "unprognostic (6.96e-2)" "unprognostic (3.69e-1)" "unprognostic (5.77e-2)" "unprognostic (1.17e-1)" "unprognostic (2.12e-1)" "unprognostic (3.92e-2)" "unprognostic (2.60e-3)" 275.2 309.2 194.3 239.8 202.8 431.4 244.0 206.6 287.9 286.2 199.5 236.8 170.9 308.0 214.9 202.9 260.2 258.8 400.2 196.7 236.5 335.3 261.0 245.6 253.8 242.1 217.4 178.8 321.0 166.9 265.8 176.5 303.4 243.5 230.7 227.9 267.9 197.6 285.3 564.6 138.4 188.9 334.4 218.5 219.3 188.6 594.0 217.6 300.4 272.7 429.0 281.9 268.7 185.8 261.0 362.0 480.3 863.5 355.4 603.2 620.4 453.2 644.3 636.0 570.7 554.0 436.9 532.7 446.7 517.2 649.1 376.0 442.1 1054.3 432.8 534.3 446.0 420.3 493.5 483.5 406.5 617.9 410.4 424.3 436.7 482.5 323.1 447.6 550.1 689.1 309.7 526.3 398.2 659.2 335.3 392.9 301.6 930.7 472.9 208.5 431.8 673.0 431.0 459.2 488.1 443.6 457.7 578.1 367.2 825.7 871.1 441.7 533.9 543.1 667.2 471.6 359.0 549.6 256.4 770.6 499.2 412.3 647.4 501.4 118.5 195.0 197.5 123.0 188.4 149.4 172.7 176.9 141.6 225.5 163.7 241.9 174.2 154.9 145.1 155.8 214.4 214.2 318.6 194.3 202.8 206.6 287.9 196.7 236.5 242.1 217.4 178.8 243.5 218.5 217.6 261.0 374.2 301.3 249.0 38.2 300.0 418.1 624.1 724.2 256.6 104.5 236.1 198.9 372.2 286.0 512.3 290.6 62.6 611.9 309.4 173.4 686.7 545.5 740.6 377.8 352.6 391.1 275.2 298.0 69.6 312.8 815.0 468.2 153.4 282.5 465.8 179.5 372.3 328.6 379.1 200.2 68.5 263.6 451.6 310.9 601.3 504.6 389.5 325.7 501.6 52.5 450.8 322.0 306.9 40.2 80.0 407.4 185.5 464.9 232.0 489.8 178.6 805.1 582.5 97.5 315.5 368.3 500.6 1322.3 467.9 185.3 370.4 663.0 338.2 279.9 199.0 597.1 NLRP9 "CLR19.1, NALP9, NOD6, PAN12" ENSG00000185792 "NLR family pyrin domain containing 9" Q7RTR0 19 55708438-55738402 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 40 "Extravillous trophoblasts: 61.2" "Cancer enriched" "Detected in single" 59 "testis cancer: 14.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042623 Uncertain NA NA "HPA042623: AB_10965692" "unprognostic (2.50e-1)" "unprognostic (3.03e-1)" "unprognostic (1.74e-1)" "unprognostic (2.85e-1)" "unprognostic (8.82e-2)" "unprognostic (6.53e-2)" "unprognostic (9.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.55e-2)" "unprognostic (3.68e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.56e-3)" "unprognostic (2.73e-1)" "unprognostic (3.46e-1)" "unprognostic (9.56e-2)" "unprognostic (8.09e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 61.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 74.7" "Group enriched" "Detected in many" 9 "Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 7.8 7.4 9.9 7.0 10.7 14.8 9.1 10.9 11.8 7.2 10.5 7.6 4.4 8.2 11.1 9.1 7.1 6.4 7.5 10.1 11.1 7.3 10.0 7.0 10.7 10.3 10.2 9.6 7.1 6.0 10.1 6.8 6.4 11.7 7.3 7.2 8.9 7.1 6.2 13.2 11.8 8.0 7.4 9.9 10.9 7.3 74.7 10.3 12.2 7.2 12.7 12.0 7.3 7.7 11.9 39.4 8.5 14.6 13.6 15.0 13.2 23.8 20.1 16.2 23.0 21.7 22.8 20.2 18.9 66.4 13.0 21.2 22.3 18.9 18.4 28.8 30.0 16.3 19.4 21.2 14.6 18.5 26.9 14.3 10.7 25.9 20.6 22.2 11.4 18.7 23.6 18.8 34.5 17.7 36.4 22.5 27.5 19.5 25.7 24.4 26.5 25.3 40.5 12.8 13.4 15.0 15.2 15.0 20.8 32.2 19.8 53.0 24.2 17.2 18.9 18.0 21.5 40.6 29.5 63.8 56.6 12.7 34.2 19.4 13.1 5.5 15.7 8.8 4.7 14.1 7.8 12.2 8.5 4.7 7.5 10.2 6.1 4.7 7.4 7.8 6.2 16.5 5.0 9.9 10.7 10.9 11.8 10.1 11.1 10.3 10.2 9.6 11.7 9.9 10.3 11.9 3.9 0.0 2.8 6.8 3.8 4.2 3.2 8.1 2.8 3.7 3.4 3.4 5.6 2.8 5.8 3.7 0.0 5.7 3.5 1.7 5.9 5.0 313.9 3.3 3.5 4.7 0.0 7.4 5.5 4.2 6.1 3.9 0.5 2.7 9.5 3.2 3.9 2.5 4.3 3.3 4.8 1.6 10.2 3.8 3.0 118.8 5.0 3.9 5.4 10.3 7.3 4.0 4.1 6.0 7.1 3.7 1.9 3.4 3.7 2.9 1.5 5.0 3.1 2.8 19.7 4.0 5.5 135.6 13.9 3.5 4.7 4.7 6.3 4.1 2.7 2.6 DMWD "D19S593E, DMR-N9, gene59" ENSG00000185800 "DM1 locus, WD repeat containing" Q09019 19 45782947-45792845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068172, HPA069843" Approved Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA068172: AB_2685964, HPA069843: AB_2686212" "unprognostic (6.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.03e-2)" "unprognostic (1.65e-3)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.47e-4)" "unprognostic (5.11e-3)" "unprognostic (7.61e-2)" "unprognostic (7.26e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (1.18e-2)" "unprognostic (4.59e-2)" 24.3 19.3 26.3 12.4 21.1 7.4 23.2 7.2 31.9 29.3 7.7 32.3 9.8 40.0 6.8 18.3 29.7 11.9 42.8 29.0 15.3 18.7 10.3 22.8 11.3 16.3 17.8 25.2 29.4 18.2 10.4 29.8 15.1 16.1 25.4 7.5 12.0 17.3 12.4 44.4 15.6 18.5 14.9 5.4 17.1 25.2 36.8 15.5 10.4 23.3 20.2 7.1 30.9 23.4 13.3 31.6 34.3 30.4 21.2 18.1 22.9 23.3 26.9 18.8 23.5 21.2 20.6 17.1 13.2 15.4 30.4 28.8 23.4 16.1 13.4 12.3 38.6 30.0 11.4 37.3 18.2 22.4 1.4 17.6 21.5 16.2 22.0 31.2 26.7 20.3 8.3 28.2 28.9 18.6 25.8 16.0 9.0 13.8 20.6 22.2 16.3 11.0 14.5 14.6 29.7 30.4 33.6 28.9 22.2 19.5 13.4 19.4 7.7 43.3 27.0 26.6 18.1 40.7 41.1 27.4 15.0 28.1 2.1 31.8 0.6 0.2 0.2 1.4 0.6 1.1 0.6 1.2 1.1 0.2 1.4 0.4 0.8 0.6 1.8 0.8 0.2 0.7 0.3 26.3 21.1 7.2 31.9 29.0 15.3 16.3 17.8 25.2 16.1 5.4 15.5 13.3 18.8 6.4 4.7 8.1 6.9 8.4 13.9 4.5 2.2 34.5 11.8 9.8 28.5 10.0 4.4 9.2 60.5 7.3 10.6 10.4 5.9 7.3 17.2 12.4 18.9 16.2 26.3 9.3 8.1 10.6 9.6 15.3 6.1 11.2 11.4 23.3 20.0 4.6 2.0 52.2 7.5 7.9 10.2 4.8 11.4 57.7 17.1 2.6 5.4 5.6 0.9 23.3 14.4 10.1 5.8 13.8 7.2 17.0 6.8 11.5 5.6 7.1 8.9 41.2 13.1 24.5 19.0 10.8 15.7 4.6 7.0 5.5 9.0 20.6 8.1 11.5 SLC52A2 "D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2" ENSG00000185803 "Solute carrier family 52 member 2" Q9HAB3 8 144333957-144361286 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Host cell receptor for virus entry, Receptor" "Deafness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 149.0;PC-3: 167.6" "Low region specificity" "Detected in all" HPA063036 Approved NA NA "HPA063036: AB_2684928" "unprognostic (7.80e-3)" "prognostic unfavorable (7.55e-4)" "unprognostic (2.15e-1)" "unprognostic (2.94e-1)" "unprognostic (3.09e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (7.74e-3)" "unprognostic (9.20e-2)" "unprognostic (2.24e-2)" "unprognostic (4.85e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.12e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" 27.7 31.8 12.1 5.5 11.6 5.6 28.0 13.4 18.7 21.1 12.2 28.3 9.5 23.2 8.1 33.5 17.5 3.2 22.8 11.5 12.6 29.3 17.0 24.8 5.6 13.0 12.3 11.1 15.7 42.0 5.3 24.7 7.7 13.0 22.4 5.8 1.3 30.1 6.3 13.6 29.8 29.8 4.3 12.5 35.1 31.7 31.8 12.9 4.1 21.9 2.8 4.1 25.1 21.4 12.5 38.7 65.0 7.5 17.9 19.3 12.3 37.3 28.1 18.9 26.5 24.6 57.9 42.3 16.3 42.3 27.5 20.7 42.6 18.4 25.3 9.8 18.3 34.5 26.3 31.3 50.1 51.7 9.4 29.4 14.8 34.7 27.4 24.4 19.2 15.8 16.2 40.9 23.7 18.7 149.0 15.6 38.0 17.9 51.5 167.6 29.8 8.9 44.9 30.6 34.4 25.9 29.4 31.1 44.1 35.7 9.9 27.8 18.7 20.2 20.9 46.9 48.2 37.9 9.4 13.8 12.4 37.8 26.6 25.7 0.5 4.2 9.2 5.6 5.9 3.8 3.3 3.9 5.6 4.5 9.8 3.6 2.6 1.1 5.2 7.5 7.6 5.7 1.5 12.1 11.6 13.4 18.7 11.5 12.6 13.0 12.3 11.1 13.0 12.5 12.9 12.5 31.9 6.4 8.7 5.5 24.3 31.2 27.0 41.5 12.0 11.1 30.6 17.0 3.1 12.8 34.4 12.9 2.1 85.0 36.3 81.8 0.0 62.3 3.3 11.6 16.6 24.3 17.4 7.8 3.2 66.9 92.1 22.2 42.3 21.5 10.2 16.6 18.9 5.5 52.4 11.8 3.7 56.3 36.7 13.5 27.8 5.8 12.8 21.4 30.2 2.8 40.7 14.3 19.6 7.1 2.4 85.1 46.7 19.9 43.3 54.7 52.4 14.5 11.7 10.8 19.7 12.1 31.1 34.0 40.2 20.2 36.1 52.5 24.8 23.4 65.6 36.7 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37062846-37073170 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 350.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Yes No Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 34.2 41.7 20.2 12.6 22.2 9.2 35.8 23.8 25.0 23.1 25.2 24.5 19.1 18.5 108.1 17.0 25.9 22.7 40.5 19.7 26.0 36.2 55.2 21.8 16.7 24.5 22.6 18.9 28.2 41.7 52.3 38.3 21.0 24.2 34.0 27.7 28.9 32.5 27.0 44.4 12.5 15.7 17.2 23.5 15.1 23.0 36.8 21.6 22.2 36.7 43.2 19.8 26.5 13.3 27.1 25.9 11.5 23.7 14.8 41.5 28.6 16.9 21.9 38.7 18.6 21.1 15.4 53.7 37.1 45.7 32.0 81.4 19.4 22.7 25.5 18.5 37.4 36.1 86.2 13.8 21.3 26.3 26.9 16.6 26.5 47.2 33.4 43.0 42.2 35.1 80.5 50.7 61.8 38.5 16.5 32.9 25.5 19.6 76.8 27.9 31.0 12.1 37.0 48.2 13.3 49.2 29.8 61.4 43.0 81.8 33.6 35.2 53.2 18.3 12.9 6.6 14.8 19.3 81.1 96.5 42.0 38.1 30.5 43.4 0.4 13.5 3.7 19.6 20.3 24.8 34.2 25.1 21.6 20.9 28.1 33.3 29.0 1.9 16.8 22.6 30.9 20.6 15.6 20.2 22.2 23.8 25.0 19.7 26.0 24.5 22.6 18.9 24.2 23.5 21.6 27.1 37.4 28.9 41.8 9.8 37.0 33.0 58.9 88.9 35.3 21.2 74.1 86.4 82.4 42.9 65.1 44.1 10.4 60.7 29.4 21.6 90.1 61.8 79.3 67.0 35.9 31.3 44.9 25.7 6.9 71.3 52.4 48.9 30.1 49.3 15.9 32.2 35.3 79.8 66.7 16.8 8.7 63.9 65.1 57.6 39.9 75.6 69.0 44.1 37.4 2.8 50.2 37.0 23.7 7.5 18.2 57.7 50.3 35.0 54.3 45.6 52.3 97.1 86.9 33.6 65.7 32.7 44.6 350.8 177.5 44.2 26.3 52.3 31.7 62.6 53.1 63.7 IKZF1 "hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1" ENSG00000185811 "IKAROS family zinc finger 1" Q13422 7 50304068-50405101 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 174.6;lymphoid tissue: 113.5" "Cell type enhanced" "Detected in many" "B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009247, HPA035221, HPA035222" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525" "prognostic favorable (4.28e-4)" "prognostic favorable (2.02e-4)" "unprognostic (2.49e-3)" "unprognostic (2.41e-3)" "unprognostic (5.59e-1)" "prognostic favorable (8.63e-4)" "unprognostic (1.45e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-2)" "unprognostic (2.43e-1)" "unprognostic (6.63e-2)" "unprognostic (2.95e-1)" "unprognostic (1.69e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-2)" "unprognostic (6.77e-2)" "unprognostic (4.67e-2)" 5.0 3.2 3.0 53.5 3.6 174.6 4.4 4.1 4.7 3.6 4.9 7.6 7.0 2.5 2.4 4.8 2.2 7.7 1.5 2.7 6.0 1.4 4.9 11.7 87.8 6.8 4.3 1.2 1.6 0.8 0.8 0.7 3.6 7.2 2.3 6.9 0.2 4.6 1.9 1.0 2.1 15.7 4.1 7.8 49.1 12.1 1.7 7.1 113.5 2.1 1.2 74.4 9.6 1.8 7.9 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 258.6 0.2 52.1 0.0 0.0 0.0 84.5 220.4 0.0 0.0 0.0 0.0 0.0 0.0 128.9 72.4 15.4 0.0 0.0 184.3 80.9 2.4 0.0 0.0 192.3 0.3 39.6 0.0 0.0 1.6 2.0 0.8 1.0 0.8 0.4 0.2 112.1 0.2 0.0 1.9 0.2 0.4 80.8 49.4 342.7 0.5 89.5 0.5 21.2 14.2 25.0 35.4 43.9 29.1 46.7 36.3 35.0 15.1 40.7 48.2 35.7 20.2 24.3 43.3 23.4 32.6 26.4 3.0 3.6 4.1 4.7 2.7 6.0 6.8 4.3 1.2 7.2 7.8 7.1 7.9 2.8 3.2 12.2 0.7 120.5 2.8 0.1 0.0 0.0 0.0 2.8 1.9 1.5 2.8 1.8 1.8 0.0 0.4 221.4 0.3 0.0 0.4 3.8 0.5 0.4 2.6 0.0 89.8 0.2 0.0 0.4 2.5 4.6 0.6 23.4 0.2 3.9 2.0 30.6 0.0 0.3 0.0 0.0 64.3 61.0 5.3 0.0 72.1 19.6 91.8 106.6 0.0 150.4 1.0 0.3 0.1 0.4 0.0 128.9 0.1 0.0 1.0 1.5 0.1 0.0 1.5 1.6 0.1 2.1 0.5 2.7 0.7 182.8 0.1 0.1 0.1 PCYT2 ET ENSG00000185813 "Phosphate cytidylyltransferase 2, ethanolamine" Q99447 17 81900958-81911432 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 167.1;testis: 263.7" "Group enriched" "Detected in many" 7 "Early spermatids: 763.2;Late spermatids: 2829.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 218.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023033, HPA023034" Enhanced Approved Nucleoplasm,Cytosol NA NA 84000 Cytosol Nucleoplasm "HPA023033: AB_1855094, HPA023034: AB_1855095" "unprognostic (4.05e-3)" "unprognostic (4.39e-3)" "unprognostic (3.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (9.86e-2)" "unprognostic (1.24e-2)" "unprognostic (1.06e-1)" "unprognostic (4.24e-1)" "unprognostic (8.97e-3)" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.29e-6)" "unprognostic (1.19e-1)" "unprognostic (8.59e-2)" "unprognostic (1.63e-1)" "unprognostic (4.47e-2)" 30.0 17.0 39.2 9.5 38.8 12.2 25.4 42.6 46.1 14.0 28.9 20.2 64.5 18.2 13.6 26.5 24.1 10.0 38.4 40.1 38.1 44.4 167.1 21.5 12.1 45.8 40.0 38.3 21.1 25.5 20.4 14.5 12.1 45.4 24.4 16.8 8.7 22.5 12.2 33.7 15.7 43.4 9.7 40.2 12.9 35.7 263.7 39.3 13.6 16.3 29.5 12.0 21.4 15.2 44.1 42.6 23.9 18.8 53.1 91.8 48.0 27.9 29.9 63.2 40.7 48.0 94.0 43.0 14.8 16.0 31.1 75.3 34.5 28.6 55.1 23.5 4.5 24.3 32.1 33.3 218.2 97.8 32.5 26.0 39.8 31.4 36.8 28.4 14.5 38.6 44.0 60.6 29.6 30.8 35.7 39.3 40.1 15.1 147.2 25.9 25.4 20.2 52.4 49.2 78.8 23.9 21.9 22.4 121.7 29.0 36.5 33.9 75.3 26.1 30.0 19.7 22.9 25.0 19.3 9.1 15.3 31.2 42.8 29.9 1.5 2.4 0.9 4.6 2.6 3.0 4.2 5.5 4.7 4.5 5.6 4.5 4.6 0.7 3.3 2.1 4.4 3.6 3.1 39.2 38.8 42.6 46.1 40.1 38.1 45.8 40.0 38.3 45.4 40.2 39.3 44.1 11.5 0.0 17.3 15.0 11.1 5.4 8.1 11.7 6.8 12.5 25.1 11.0 17.0 62.9 9.6 25.8 0.0 73.1 21.0 41.6 119.3 19.5 763.2 29.0 7.5 8.7 13.9 47.8 5.3 18.3 39.7 7.7 36.2 15.8 9.5 39.6 21.8 166.0 24.1 16.8 4.6 29.1 20.3 11.8 3.3 2829.0 27.7 8.1 33.8 0.0 14.7 26.7 22.6 3.5 12.2 17.8 18.8 25.9 13.4 11.4 144.4 130.3 29.4 10.6 26.3 6.2 11.5 253.1 18.1 16.5 5.7 50.8 13.6 34.4 48.7 7.7 NAT8L "FLJ37478, Hcml3, Shati" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059327-2069089 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 43.9;brain: 100.2" "Cell type enhanced" "Detected in some" "Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria NA NA Mitochondria "HPA040677: AB_2732486" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 43.9 0.7 55.2 0.1 44.1 0.0 1.7 46.1 100.2 0.0 0.4 0.2 0.1 0.3 1.3 0.1 1.0 0.1 0.8 45.9 29.0 5.3 0.0 0.0 0.2 55.6 45.5 32.7 0.2 2.4 0.9 1.8 0.1 62.2 1.0 0.1 3.8 2.3 1.6 5.8 1.0 0.2 0.2 27.4 0.3 0.4 9.0 86.7 0.2 0.3 2.6 0.0 0.0 0.0 39.5 0.1 9.2 4.9 10.0 0.9 0.0 5.7 0.2 0.0 0.2 0.0 4.1 0.3 0.0 1.9 0.0 1.5 0.1 11.1 0.0 0.1 0.0 13.2 0.1 2.1 6.6 1.5 14.5 6.9 0.0 0.2 0.0 0.0 1.8 0.0 3.4 11.5 0.0 0.4 6.2 0.2 20.8 14.1 0.0 4.1 0.7 2.3 0.4 0.2 0.5 25.8 8.6 6.6 0.0 21.4 0.8 0.7 8.3 0.0 0.0 3.3 0.1 5.6 0.0 0.0 0.2 0.0 6.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 55.2 44.1 46.1 100.2 45.9 29.0 55.6 45.5 32.7 62.2 27.4 86.7 39.5 0.5 0.0 0.0 126.7 0.0 0.3 0.0 0.0 0.0 14.5 1.4 2.2 2.6 0.0 0.0 1.8 6.2 0.0 5.4 0.0 0.0 4.6 1.1 1.7 0.1 0.4 1.8 0.0 46.0 0.6 0.1 0.2 0.0 1.0 0.0 21.9 0.0 0.0 0.8 80.8 37.6 0.0 0.0 0.0 0.3 3.8 0.0 0.7 10.6 17.8 0.0 25.0 0.0 23.1 15.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.8 0.5 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 OR6C76 ENSG00000185821 "Olfactory receptor family 6 subfamily C member 76" A6NM76 12 55426254-55427192 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPAP1 C15orf2 ENSG00000185823 "Nuclear pore associated protein 1" Q9NZP6 15 24675775-24683393 "Predicted intracellular proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;testis: 2.9" "Cell type enriched" "Detected in some" 5 "Granulosa cells: 125.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018828, HPA019562" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA018828: AB_2669941, HPA019562: AB_2670190" "unprognostic (4.40e-2)" "unprognostic (1.85e-2)" "unprognostic (6.98e-3)" "unprognostic (7.45e-2)" "unprognostic (9.90e-2)" "unprognostic (1.08e-2)" "unprognostic (5.11e-3)" 0.0 0.0 0.7 0.0 1.5 0.4 0.1 0.1 1.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.5 1.1 0.3 0.0 0.0 0.1 0.8 0.4 0.6 0.5 0.4 0.0 0.5 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 2.9 1.1 0.0 0.5 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 1.5 0.1 1.0 0.5 1.1 0.8 0.4 0.6 1.2 0.2 1.1 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.2 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 125.9 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.3 24.1 12.7 0.0 0.0 0.0 0.0 0.5 0.0 0.2 BCAP31 "6C6-Ag, BAP31, CDM, DXS1357E" ENSG00000185825 "B cell receptor associated protein 31" P51572 X 153700492-153724565 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Deafness, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003906, CAB015350, CAB015424" Supported Approved Enhanced "Endoplasmic reticulum" NA NA 170000 "Endoplasmic reticulum" "CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270" "unprognostic (1.02e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (3.25e-3)" "unprognostic (4.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.28e-2)" "unprognostic (8.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" 296.7 215.6 168.4 101.8 172.5 152.6 212.7 167.5 215.6 136.7 191.1 159.2 134.5 128.5 230.9 215.7 152.3 119.0 121.2 176.8 174.5 162.2 187.0 145.8 112.7 183.5 180.4 167.4 132.1 268.7 195.3 124.4 144.5 188.7 156.0 168.1 64.4 181.2 179.4 82.6 184.8 145.0 156.4 179.4 139.6 130.4 118.2 186.6 100.6 162.8 76.2 135.7 179.6 147.0 195.2 505.5 482.4 128.0 650.6 593.8 179.1 295.3 269.9 287.5 291.6 371.6 386.8 361.9 315.9 1068.1 412.2 373.9 506.8 337.3 518.6 221.0 152.8 436.9 198.4 350.4 323.3 276.4 335.1 373.2 233.8 454.2 282.3 330.1 298.4 372.6 172.0 268.0 528.3 332.7 535.3 187.3 402.5 145.8 704.6 431.7 207.5 152.8 693.2 459.3 546.8 173.3 241.8 111.8 520.6 350.0 200.3 196.2 320.2 380.0 248.9 234.7 338.9 495.1 518.0 1120.1 397.3 460.9 402.6 223.7 630.5 484.2 489.1 507.5 535.7 454.7 436.1 504.5 507.4 420.7 463.6 439.1 474.7 624.5 449.8 632.3 666.9 457.1 1110.8 168.4 172.5 167.5 215.6 176.8 174.5 183.5 180.4 167.4 188.7 179.4 186.6 195.2 184.9 112.2 114.1 14.7 97.5 141.9 232.2 374.0 172.4 53.0 127.3 165.7 60.3 134.4 222.8 128.8 45.9 467.5 113.5 194.1 37.2 252.4 7.8 99.7 70.1 165.5 103.2 59.3 16.9 210.0 444.8 103.6 78.5 103.9 95.6 68.5 199.6 216.0 356.2 32.0 12.8 155.1 244.1 148.4 125.6 20.6 105.3 166.2 160.1 17.8 137.5 138.2 111.2 11.6 12.9 247.1 187.4 98.9 120.8 191.8 242.8 170.9 172.6 51.8 157.8 42.9 106.5 310.3 231.3 174.0 130.4 538.1 114.6 120.4 187.0 260.4 ARL17A "ARF1P2, ARL17P1" ENSG00000185829 "ADP ribosylation factor like GTPase 17A" Q8IVW1 17 46516702-46579691 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 54.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046814 Uncertain NA NA "HPA046814: AB_2679821" "unprognostic (8.57e-4)" "unprognostic (7.48e-2)" "unprognostic (1.98e-1)" "unprognostic (2.72e-1)" "unprognostic (1.16e-1)" "unprognostic (6.57e-5)" "unprognostic (2.07e-1)" "unprognostic (2.61e-2)" "unprognostic (1.70e-1)" "unprognostic (4.01e-1)" "unprognostic (2.58e-2)" "unprognostic (4.12e-2)" "unprognostic (2.48e-4)" "unprognostic (1.04e-1)" "unprognostic (2.57e-1)" "unprognostic (1.43e-1)" "unprognostic (4.61e-2)" 7.0 7.1 4.9 8.1 5.5 8.2 8.9 14.5 7.1 13.1 5.1 9.3 3.6 9.7 10.3 8.9 11.6 3.2 7.0 6.2 4.5 7.2 5.9 9.2 9.6 6.1 5.2 5.0 12.9 9.6 6.6 13.5 4.0 8.8 11.6 6.7 14.8 11.4 4.9 10.6 10.9 9.5 6.2 4.2 9.8 9.2 7.2 7.6 5.7 11.8 3.5 7.3 9.6 12.1 8.8 4.6 5.4 9.5 8.2 3.8 4.6 4.2 5.8 2.1 2.8 3.6 12.5 6.9 16.3 4.1 2.7 9.1 7.0 5.1 3.7 5.9 13.8 17.5 5.5 23.0 10.3 2.4 8.5 6.1 4.1 7.1 3.7 4.9 6.0 5.4 10.3 7.2 8.9 5.0 1.9 10.5 10.1 4.2 2.0 3.4 14.7 14.1 4.3 3.2 6.8 7.1 4.6 4.1 2.0 1.8 5.4 12.2 7.4 9.3 16.2 8.6 5.2 4.2 10.9 14.8 5.4 4.1 9.9 5.5 4.1 1.6 1.2 3.1 1.2 1.8 2.4 2.2 2.6 1.4 3.4 2.2 2.8 1.4 3.0 1.6 3.2 2.1 0.7 4.9 5.5 14.5 7.1 6.2 4.5 6.1 5.2 5.0 8.8 4.2 7.6 8.8 5.8 22.4 11.8 17.6 10.7 6.0 8.7 9.7 8.0 19.1 7.3 5.5 8.3 4.3 8.1 16.5 54.2 6.4 11.1 5.3 9.8 6.7 8.6 4.2 7.6 5.8 6.7 2.1 24.5 2.6 4.2 6.5 2.6 5.3 6.3 15.2 9.7 4.3 6.4 15.2 26.5 7.9 10.2 9.0 6.9 5.4 13.1 6.0 3.6 14.0 14.2 5.9 2.1 29.7 36.4 3.2 4.6 9.1 3.5 4.9 5.6 6.3 10.6 30.3 13.1 11.1 7.0 12.2 6.1 2.9 8.4 3.6 9.6 9.4 9.1 7.5 GNB1L "GY2, WDR14" ENSG00000185838 "G protein subunit beta 1 like" Q9BYB4 22 19783223-19854939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034627, HPA034628" Approved Approved Cytosol NA NA Cytosol "HPA034627: AB_10600662, HPA034628: AB_10600440" "unprognostic (2.14e-1)" "unprognostic (5.56e-3)" "unprognostic (4.54e-3)" "unprognostic (2.58e-1)" "unprognostic (3.03e-1)" "unprognostic (3.34e-2)" "unprognostic (8.68e-4)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (2.46e-1)" "unprognostic (2.99e-2)" "unprognostic (3.64e-5)" "unprognostic (9.80e-3)" "unprognostic (8.04e-2)" "unprognostic (2.88e-1)" "unprognostic (9.86e-2)" 3.3 2.3 1.4 2.8 1.4 1.7 3.5 0.9 3.7 3.8 0.5 3.6 4.2 4.2 0.4 4.9 3.9 1.0 2.6 1.9 0.8 2.6 2.8 3.1 2.3 1.3 0.6 2.1 3.5 4.0 0.4 2.3 1.4 1.9 3.5 0.3 0.3 3.4 1.3 3.7 5.9 3.7 0.6 1.3 5.4 2.7 2.4 0.9 4.0 3.0 0.6 1.3 4.3 4.2 1.4 13.5 10.2 2.9 8.9 0.9 1.7 8.0 9.1 2.5 4.4 4.1 18.3 5.2 18.1 5.8 2.1 2.1 25.5 2.0 4.3 0.6 11.7 34.0 10.9 13.6 9.1 2.7 12.6 2.9 1.4 2.0 3.9 1.5 1.0 1.7 8.1 66.6 6.8 0.8 19.3 28.1 18.1 5.0 3.9 17.1 14.6 8.1 4.1 0.4 5.4 5.9 6.4 3.5 8.8 15.5 0.5 2.3 3.2 4.2 9.8 11.8 16.1 9.3 8.8 7.8 9.6 10.6 11.1 3.4 7.3 6.0 15.9 13.2 7.9 12.7 9.4 12.6 10.0 9.8 11.9 12.1 11.0 6.1 12.0 5.9 13.3 17.0 7.5 1.4 1.4 0.9 3.7 1.9 0.8 1.3 0.6 2.1 1.9 1.3 0.9 1.4 2.4 3.2 4.4 3.6 6.9 22.0 6.3 11.8 5.2 8.5 4.7 5.5 1.6 2.8 5.7 0.0 12.5 15.2 5.2 4.6 3.9 5.6 28.3 2.9 3.3 4.6 0.0 4.0 6.7 3.3 13.8 4.3 2.0 4.1 12.7 7.8 2.2 2.8 10.3 0.0 4.1 4.6 8.2 7.3 15.5 6.5 3.4 4.6 14.2 1.9 4.9 3.0 6.2 4.5 4.3 5.9 2.6 4.9 5.4 8.8 6.3 4.9 1.9 4.7 6.6 2.8 4.4 13.8 10.2 5.1 16.2 4.7 7.9 2.7 5.2 5.3 DNAH14 "C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277" ENSG00000185842 "Dynein axonemal heavy chain 14" Q0VDD8 1 224896262-225399292 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.3" "Cell type enhanced" "Detected in many" "Early spermatids: 135.0;Excitatory neurons: 65.4;Spermatocytes: 74.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 48.8" "Low region specificity" "Detected in many" "HPA027718, HPA028545, HPA031379" Uncertain Supported Centrosome NA NA Centrosome "HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851" "unprognostic (1.16e-1)" "unprognostic (1.77e-2)" "unprognostic (2.95e-1)" "unprognostic (1.86e-2)" "unprognostic (5.92e-2)" "unprognostic (1.09e-3)" "unprognostic (9.94e-4)" "unprognostic (4.23e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.51e-1)" "unprognostic (2.33e-9)" "unprognostic (6.76e-2)" "unprognostic (7.39e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" 1.1 3.2 3.1 0.7 3.4 1.9 3.3 0.7 3.5 1.8 3.8 1.9 1.0 2.0 3.7 1.2 1.6 1.7 1.0 3.0 7.2 3.4 5.7 2.4 0.4 3.6 3.9 2.6 3.8 5.7 2.1 6.6 1.5 3.4 3.2 2.3 2.8 1.5 1.4 0.1 0.4 0.6 1.1 1.9 0.4 2.6 22.3 6.4 1.4 4.5 0.2 0.2 1.9 1.1 3.4 19.7 9.9 8.9 9.8 3.5 7.1 21.3 4.0 3.7 7.2 6.3 15.6 21.1 0.0 9.7 4.1 0.0 0.2 13.8 3.8 12.2 0.0 23.0 9.4 7.2 3.4 4.3 19.6 3.1 6.9 8.3 10.0 6.9 7.7 2.4 13.5 48.8 0.0 12.4 5.2 3.6 20.3 25.1 22.1 12.0 0.0 33.8 18.0 6.7 9.0 14.9 16.9 15.4 11.5 32.1 14.8 21.2 16.9 0.4 0.1 14.4 0.3 0.1 20.9 14.1 0.2 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.2 0.0 3.1 3.4 0.7 3.5 3.0 7.2 3.6 3.9 2.6 3.4 1.9 6.4 3.4 2.5 12.8 11.5 2.3 0.6 2.0 14.0 6.0 3.4 28.1 10.1 6.2 6.5 10.0 5.7 20.2 33.3 10.6 1.3 2.1 7.9 11.2 135.0 13.1 13.2 3.4 8.3 6.7 65.4 10.0 12.4 4.5 6.6 12.2 14.0 23.3 1.4 7.7 3.4 28.6 44.0 5.2 4.1 0.0 1.2 45.9 2.8 1.2 3.6 6.5 1.0 8.0 1.0 23.6 8.4 9.4 1.1 3.4 1.2 11.2 0.5 8.4 6.7 3.9 6.6 0.5 2.7 74.5 24.9 2.8 0.9 11.5 1.4 10.1 5.0 7.1 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.6;esophagus: 3.3" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 3.9;hTERT-RPE1: 4.8;HUVEC TERT2: 4.8;LHCN-M2: 7.3;TIME: 16.7;U-2197: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.1 0.1 1.5 0.0 1.1 0.0 0.0 1.0 1.1 0.1 0.9 0.0 0.0 0.1 0.3 3.3 0.5 0.4 0.5 1.4 5.6 0.0 0.0 1.8 0.0 1.6 2.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.7 0.0 0.1 0.3 2.5 0.0 0.1 0.1 0.4 0.1 0.0 2.4 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.9 2.4 4.8 4.8 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.4 0.0 8.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 1.0 1.1 1.4 5.6 1.6 2.0 0.4 1.1 0.7 2.5 2.4 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 26.2 0.0 0.0 0.4 0.5 0.1 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.5 EVI2B "CD361, D17S376, EVDB" ENSG00000185862 "Ecotropic viral integration site 2B" P34910 17 31303770-31314105 "CD markers, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 190.7;lymphoid tissue: 171.2" "Cell type enhanced" "Detected in many" "B-cells: 233.2;Kupffer cells: 522.3;Langerhans cells: 169.8;Macrophages: 271.9;monocytes: 426.4;T-cells: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1366.0" "Group enriched" "Detected in all" 5 "granulocytes: 1366.0;monocytes: 381.9" "Cell line enhanced" "Detected in many" "Daudi: 87.9;HL-60: 99.9;HMC-1: 133.3;Karpas-707: 96.4;NB-4: 79.4;RPMI-8226: 147.7;THP-1: 124.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007346, HPA053383" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA007346: , HPA053383: " "unprognostic (1.07e-2)" "unprognostic (1.20e-2)" "unprognostic (5.97e-2)" "unprognostic (4.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-1)" "unprognostic (3.36e-2)" "unprognostic (1.93e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.56e-2)" "unprognostic (3.32e-2)" "unprognostic (8.64e-2)" "unprognostic (2.73e-2)" 24.8 11.1 5.6 101.8 7.2 190.7 13.9 7.0 11.7 13.2 11.3 28.1 24.0 7.5 4.4 11.9 7.9 30.8 6.8 5.8 8.6 5.1 25.1 61.6 160.8 9.9 8.4 4.3 5.5 3.1 3.8 1.8 15.6 10.7 7.4 30.8 1.2 11.9 6.2 2.0 5.2 39.5 17.1 9.6 160.2 34.0 3.7 7.4 77.2 5.3 12.3 171.2 38.9 4.1 15.2 0.6 0.7 0.0 0.0 6.5 8.3 0.1 0.8 5.8 6.7 12.4 0.0 3.4 87.9 0.1 5.5 26.4 0.6 0.0 1.2 7.5 0.1 0.0 2.1 0.0 0.0 66.0 99.9 133.3 15.3 0.0 3.9 5.3 2.2 6.9 7.3 1.4 96.4 19.8 0.0 29.4 79.4 0.1 0.0 0.0 51.0 0.4 147.7 0.3 0.2 0.0 0.1 0.4 0.2 0.5 0.0 0.0 124.8 7.2 1.9 0.2 0.7 7.0 18.4 0.9 18.9 8.6 34.0 2.2 1005.3 328.9 798.7 79.2 240.1 76.8 183.6 120.8 102.8 149.9 146.2 91.9 87.5 1366.0 44.2 381.9 86.3 173.6 251.4 5.6 7.2 7.0 11.7 5.8 8.6 9.9 8.4 4.3 10.7 9.6 7.4 15.2 2.1 0.0 14.8 0.7 233.2 5.4 0.7 0.7 1.8 0.2 1.5 1.7 1.0 2.8 6.7 1.8 0.0 0.6 129.0 1.3 0.0 0.3 8.3 0.1 0.3 5.6 0.0 6.5 2.7 0.0 0.8 4.0 1.5 0.4 82.2 0.0 7.5 2.3 89.1 0.0 3.1 0.1 2.0 522.3 169.8 9.0 0.0 271.9 37.4 11.2 426.4 0.0 117.4 4.0 31.7 1.0 0.0 0.4 110.4 0.4 0.1 1.1 2.4 0.8 19.7 1.2 1.9 0.4 0.4 0.4 3.7 0.3 170.9 0.0 1.3 1.1 TMEM210 ENSG00000185863 "Transmembrane protein 210" A6NLX4 9 137170858-137172056 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 15.0" "Group enriched" "Detected in some" 68 "Early spermatids: 900.5;Late spermatids: 1815.1" "Cancer enhanced" "Detected in single" "prostate cancer: 1.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 33 "dendritic cells: 3.2" "Cell line enriched" "Detected in some" 8 "RPMI-8226: 13.5" "Not detected" "Not detected" HPA066907 Enhanced NA NA "HPA066907: AB_2685747" "unprognostic (5.17e-2)" "unprognostic (5.04e-2)" "unprognostic (2.87e-5)" "unprognostic (4.18e-2)" "unprognostic (3.63e-2)" "unprognostic (3.14e-2)" "unprognostic (8.00e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 900.5 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.7 1815.1 12.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 1.1 0.0 0.0 0.0 0.0 19.7 0.0 0.1 9.1 4.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Astrocytes: 149.5;Early spermatids: 150.6;Excitatory neurons: 255.3;Inhibitory neurons: 182.5;Microglial cells: 391.6;Oligodendrocyte precursor cells: 207.6;Oligodendrocytes: 217.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 25.5 18.8 29.6 26.6 12.0 89.7 25.1 36.2 24.6 28.0 0.0 27.1 17.4 20.7 71.6 19.5 28.1 17.8 20.9 13.2 6.9 25.2 30.7 27.9 39.1 11.2 5.1 0.0 24.6 22.6 6.6 23.8 14.9 10.9 29.1 28.0 31.5 23.5 11.9 28.8 105.3 37.0 13.1 0.0 41.4 26.7 21.0 12.2 17.5 32.2 7.6 27.3 20.7 25.0 7.5 14.0 18.6 17.3 13.7 12.2 17.3 29.3 16.7 5.1 5.5 8.9 38.6 19.2 27.2 12.4 14.5 5.1 15.5 9.4 14.0 10.9 10.9 8.7 10.5 56.2 53.0 8.0 44.2 26.9 13.0 16.8 14.6 24.3 11.3 12.1 21.2 23.3 22.8 8.4 40.0 16.9 27.7 20.8 4.5 9.9 25.4 10.3 15.3 6.2 13.6 17.2 10.5 11.1 12.8 8.2 16.3 16.9 12.9 26.9 29.1 14.7 14.0 14.7 11.6 11.9 27.8 9.2 20.4 14.0 3.1 0.9 0.3 0.7 0.5 0.6 1.0 1.0 0.5 0.2 2.7 0.8 0.9 1.4 2.2 0.6 2.0 0.2 0.2 29.6 12.0 36.2 24.6 13.2 6.9 11.2 5.1 0.0 10.9 0.0 12.2 7.5 7.1 3.2 16.8 149.5 4.3 7.6 1.2 0.9 3.4 5.1 1.3 0.9 2.1 0.0 6.1 0.0 4.2 0.5 7.6 1.7 0.0 1.0 150.6 5.1 5.4 3.6 1.2 4.4 255.3 0.6 0.3 3.6 6.1 8.8 10.8 3.0 1.4 0.8 0.7 1.7 182.5 2.1 2.0 1.2 5.2 25.3 0.3 4.3 0.0 391.6 2.8 1.2 3.1 207.6 217.1 1.4 3.0 0.4 5.9 0.7 1.0 0.1 3.9 6.4 0.0 3.1 3.1 1.5 0.5 2.3 8.4 0.8 7.0 1.8 2.2 0.7 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 10.5" "Cell type enriched" "Detected in many" 4 "Early spermatids: 278.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 13.0" "Low region specificity" "Detected in all" HPA073073 Approved "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA073073: AB_2686567" "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 1.1 0.9 0.6 1.2 0.7 1.1 2.1 1.9 1.0 1.1 0.1 0.8 0.9 1.6 1.0 0.9 1.3 0.9 1.2 0.7 0.5 1.2 0.8 1.0 1.5 0.6 0.6 0.6 2.4 0.9 1.9 0.5 1.5 0.8 1.4 0.7 2.0 1.1 1.2 0.5 1.9 0.7 1.4 0.3 1.6 0.9 10.5 0.7 1.6 1.7 0.8 1.5 1.0 0.9 1.1 0.0 0.8 2.9 0.1 1.5 2.2 1.2 3.3 1.9 3.9 5.5 0.0 0.5 0.1 3.9 2.1 3.7 0.6 0.0 2.3 4.6 0.0 4.1 1.6 0.1 0.1 1.6 0.0 4.2 2.3 2.1 4.3 0.0 1.3 0.4 1.2 0.0 0.1 3.9 0.7 0.7 0.8 5.1 0.0 0.0 0.0 3.7 1.5 1.1 4.5 3.2 4.7 0.1 0.0 2.8 3.8 3.0 0.2 1.1 2.4 3.4 3.3 3.4 7.9 13.0 5.0 0.0 0.0 6.1 1.4 0.2 0.9 0.9 0.1 1.4 0.8 1.0 1.4 0.3 1.2 1.4 1.5 0.4 0.7 0.2 0.5 1.0 0.3 0.6 0.7 1.9 1.0 0.7 0.5 0.6 0.6 0.6 0.8 0.3 0.7 1.1 3.0 0.0 3.4 2.0 4.7 1.5 1.9 1.2 1.2 6.8 2.5 2.0 5.6 2.8 3.7 3.7 4.2 4.0 5.5 0.6 0.0 2.7 278.1 3.1 4.4 3.7 0.0 1.3 4.2 1.0 2.5 3.9 0.5 3.1 1.3 5.5 2.9 0.6 1.5 11.8 3.8 1.0 0.0 1.0 4.6 58.9 5.9 1.4 3.6 1.0 1.7 2.6 5.2 6.0 4.1 0.8 0.1 7.2 1.3 1.9 0.3 1.3 1.6 11.1 0.0 5.9 4.6 10.6 11.2 1.1 2.7 4.2 3.8 3.1 0.5 1.1 TMPRSS11B HATL5 ENSG00000185873 "Transmembrane serine protease 11B" Q86T26 4 68226653-68245694 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 393.8;lymphoid tissue: 82.9;vagina: 119.2" "Group enriched" "Detected in some" 22 "Early spermatids: 10.4;Late spermatids: 14.5;Squamous epithelial cells: 8.2" "Group enriched" "Detected in some" 12 "cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.24e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.92e-1)" "unprognostic (3.96e-1)" 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.2 27.1 0.1 0.0 0.0 0.0 0.0 393.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 59.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.3 0.4 0.2 0.0 0.0 0.0 82.9 0.0 119.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 8.2 0.0 0.0 0.1 0.0 0.0 0.2 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016612-25026664 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 21.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6;Early spermatids: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Cytosol" Mitochondria "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 1.7 6.1 4.1 1.8 4.4 0.6 3.7 3.5 4.5 4.1 3.0 2.7 2.6 3.6 4.9 2.0 5.6 2.0 3.7 4.1 4.4 9.8 21.6 1.5 2.9 4.0 3.7 3.7 7.4 3.1 5.4 3.7 1.7 4.5 2.9 3.1 4.2 3.4 2.7 4.6 2.2 2.4 2.2 3.7 2.2 2.7 5.9 4.1 3.3 8.4 6.0 2.7 1.8 1.5 4.6 7.1 8.1 5.0 10.0 5.0 6.2 1.3 3.4 1.3 3.7 2.4 5.3 8.8 32.7 10.6 1.6 4.0 3.8 7.2 6.4 3.8 4.5 3.9 12.0 2.2 3.4 5.6 0.0 2.0 3.9 11.6 2.7 5.7 6.4 2.5 13.3 10.4 3.8 8.0 11.1 6.6 2.3 9.2 12.3 3.9 3.5 1.3 14.2 10.6 1.6 8.3 4.7 6.8 6.0 12.3 2.6 6.0 0.6 2.5 4.4 3.9 5.9 3.2 2.7 3.8 0.0 7.3 6.6 3.5 0.1 0.4 0.0 2.9 0.5 5.1 5.0 4.1 3.8 2.2 3.8 9.5 6.3 0.6 10.8 0.7 3.7 2.0 3.1 4.1 4.4 3.5 4.5 4.1 4.4 4.0 3.7 3.7 4.5 3.7 4.1 4.6 1.3 3.2 3.2 2.6 3.4 0.6 3.1 5.6 2.8 4.2 2.1 2.9 8.5 1.5 6.1 3.7 0.0 6.1 0.8 0.6 15.6 3.3 29.9 5.1 3.9 1.8 1.2 2.5 4.0 1.3 3.9 2.7 1.5 2.5 0.0 7.8 2.2 9.8 2.1 3.3 5.1 1.8 2.0 0.9 0.8 5.5 2.1 0.6 0.0 4.7 1.5 6.8 0.0 2.0 5.4 1.1 1.0 1.5 0.9 1.8 2.3 11.0 8.7 4.5 0.0 4.3 1.9 8.2 13.6 2.6 1.0 1.0 2.8 11.8 3.5 1.1 TRIM69 "RNF36, Trif, TRIMLESS" ENSG00000185880 "Tripartite motif containing 69" Q86WT6 15 44728988-44767829 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.3" "Cell type enhanced" "Detected in all" "Early spermatids: 213.2;Late spermatids: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "T-reg: 4.2" "Lineage enriched" "Detected in single" 7 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4;U-266/70: 8.2;U-266/84: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA028894 Enhanced NA NA "HPA028894: AB_10603136" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" "unprognostic (4.10e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-2)" "unprognostic (4.20e-1)" "unprognostic (9.27e-2)" "unprognostic (4.95e-2)" "unprognostic (6.49e-2)" "unprognostic (3.53e-3)" "unprognostic (1.38e-1)" "unprognostic (3.72e-2)" "prognostic favorable (2.26e-5)" "unprognostic (4.79e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-2)" "unprognostic (1.49e-2)" 0.8 0.8 4.9 0.4 5.0 0.2 0.8 4.5 7.2 0.9 4.3 1.2 0.4 0.6 0.4 0.7 0.8 0.5 2.4 4.9 4.8 1.3 1.6 1.3 0.9 5.0 4.8 5.0 0.8 0.4 0.3 1.5 0.2 5.0 0.9 0.6 0.7 0.8 0.2 6.0 0.9 1.3 0.6 4.7 2.4 0.7 35.3 4.8 0.5 0.6 6.1 1.2 0.7 0.8 5.5 0.1 0.1 0.2 0.6 0.2 0.7 0.0 0.1 0.3 0.8 1.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 1.7 0.0 0.2 0.1 0.0 0.7 0.0 0.1 0.9 0.6 0.1 0.1 1.1 0.2 0.7 0.0 2.4 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.2 8.2 2.3 1.4 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.6 0.8 0.9 0.0 0.0 0.2 0.6 0.1 0.0 0.2 0.0 4.2 0.1 4.9 5.0 4.5 7.2 4.9 4.8 5.0 4.8 5.0 5.0 4.7 4.8 5.5 41.8 6.4 5.1 9.4 22.1 21.3 21.3 8.0 12.0 10.8 9.3 9.1 60.2 8.6 11.0 9.2 4.2 6.1 20.4 16.5 41.1 42.1 213.2 9.0 12.2 22.2 4.2 5.7 16.0 16.0 4.2 17.8 13.7 10.6 14.0 10.5 11.4 5.1 36.3 23.5 9.8 7.5 8.2 25.4 39.7 93.9 9.3 22.6 12.4 1.0 52.7 21.2 20.6 9.5 1.7 14.8 13.4 11.7 21.9 11.4 18.6 27.0 8.8 4.2 6.6 27.0 19.7 78.8 1.7 25.0 41.2 1.5 25.6 5.1 7.0 52.5 ATP6V0C "ATP6C, ATP6L, ATPL, VATL, Vma3" ENSG00000185883 "ATPase H+ transporting V0 subunit c" P27449 16 2513952-2520218 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 115.3;Basal squamous epithelial cells: 363.7;Gastric mucus-secreting cells: 128.0;Macrophages: 152.4;Plasma cells: 235.0;Squamous epithelial cells: 385.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065100 Approved Cytosol NA NA Cytosol "HPA065100: AB_2685421" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.96e-2)" "unprognostic (7.67e-2)" "unprognostic (2.31e-1)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "prognostic favorable (1.07e-6)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.85e-1)" "unprognostic (5.04e-2)" 183.5 249.3 98.7 96.2 158.5 184.2 166.6 59.8 254.8 162.9 38.0 161.8 95.8 156.1 33.2 339.7 149.1 23.4 207.6 164.1 140.9 411.7 208.8 232.5 51.3 108.6 99.1 159.0 155.6 141.6 104.8 329.8 62.6 136.3 145.5 30.0 111.5 215.9 48.7 303.4 279.8 165.8 30.2 60.6 223.7 177.1 145.0 146.6 45.3 168.1 54.4 31.3 135.5 209.1 231.7 154.4 174.5 84.6 125.9 105.3 54.3 203.5 234.4 72.1 98.2 90.4 163.9 206.4 81.8 209.3 106.0 154.2 193.4 90.7 137.6 45.1 207.1 295.5 95.2 128.1 201.7 152.6 139.9 274.3 98.2 104.4 118.6 59.6 90.8 68.5 88.2 214.5 143.0 80.0 323.5 141.3 363.3 176.3 99.4 211.4 240.8 73.5 251.1 163.8 97.4 277.6 224.4 201.3 215.5 204.4 74.8 222.5 175.9 171.4 154.3 184.6 229.6 160.1 280.9 351.5 146.5 137.1 105.3 161.4 89.4 123.2 203.4 51.4 139.4 53.3 58.5 46.8 56.5 76.6 55.0 52.1 47.0 165.8 52.7 171.7 105.1 50.8 78.8 98.7 158.5 59.8 254.8 164.1 140.9 108.6 99.1 159.0 136.3 60.6 146.6 231.7 1.8 25.6 49.2 38.2 115.3 1.0 0.2 0.4 363.7 0.5 1.1 0.6 0.1 0.0 18.3 1.8 0.0 0.5 3.4 3.4 0.0 0.8 0.0 4.3 2.6 12.7 0.0 73.4 72.7 0.2 1.0 48.8 128.0 3.6 17.7 0.6 1.4 0.7 1.0 0.0 107.3 0.7 0.0 1.3 0.8 0.2 0.6 152.4 0.0 39.4 0.3 0.4 0.0 36.7 53.0 0.6 0.2 0.0 235.0 0.2 2.4 1.1 25.1 0.8 0.0 0.7 17.0 0.8 1.1 385.2 1.0 1.2 72.7 0.4 2.3 0.2 IFITM1 "9-27, CD225, DSPA2a, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 310041-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8" "Group enriched" "Detected in all" 7 "granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 473.6 103.3 280.4 284.5 280.9 370.7 405.2 265.2 405.5 535.7 335.3 251.4 129.5 317.3 1162.5 148.6 542.0 250.0 336.9 261.9 273.4 317.0 192.9 248.6 420.6 301.6 262.4 245.0 612.6 79.5 155.2 146.2 280.8 300.6 192.2 173.7 15.1 201.4 327.4 135.3 158.2 254.5 370.6 276.7 685.2 142.8 56.8 301.3 299.3 265.6 261.6 298.3 310.3 367.8 310.7 125.7 5.5 1011.4 74.5 79.1 279.8 7.4 250.1 1038.8 2266.3 4016.8 3.7 782.2 3.0 157.9 257.1 23.5 269.0 36.5 26.2 52.0 255.3 51.8 125.9 77.5 11.8 668.2 182.8 1138.9 496.3 0.2 26.6 2.6 27.0 4.2 41.1 450.0 880.7 1.7 23.9 85.1 318.2 264.5 0.5 33.5 27.1 3.1 24.5 654.9 0.0 1.0 2.2 122.7 11.9 196.9 138.5 42.1 17.0 8.8 3.8 4.7 1.5 1.1 61.6 44.8 6.8 3.4 253.8 3.1 544.4 62.1 1494.7 2906.3 312.7 2003.4 364.9 3120.6 3000.3 114.2 323.6 2939.3 2996.4 2741.6 4679.9 539.0 33.7 1944.8 4673.8 280.4 280.9 265.2 405.5 261.9 273.4 301.6 262.4 245.0 300.6 276.7 301.3 310.7 240.7 35.3 119.4 2.6 88.2 27.9 17.1 70.2 673.8 0.0 13.0 12.6 8.4 2.8 115.3 33.1 0.0 3.3 258.6 13.7 5.9 1.7 1.4 14.6 96.5 364.4 1.2 27.8 0.0 1.4 30.7 236.0 33.6 20.8 18.9 5.6 164.6 24.6 11.8 0.0 0.0 17.3 10.2 10.1 26.8 3.8 300.8 45.4 78.2 42.2 2.1 0.0 126.7 0.0 0.2 0.7 15.0 124.5 141.2 2.3 15.0 1.0 26.0 0.0 276.1 16.4 213.4 0.6 1.5 50.4 14.3 4.0 595.8 2.1 29.2 5.7 PRSS38 MPN2 ENSG00000185888 "Serine protease 38" A1L453 1 227815693-227846470 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 4.2" "Group enriched" "Detected in some" 17 "Spermatocytes: 28.8;Spermatogonia: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (9.54e-3)" "unprognostic (3.61e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPY2C VCY2C ENSG00000185894 "Basic charge Y-linked 2C" O14599 Y 25030901-25062548 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAMP1 CD107a ENSG00000185896 "Lysosomal associated membrane protein 1" P11279 13 113297239-113323672 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 709.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004260, HPA014750" Supported NA NA 370000000 "CAB004260: AB_626851, HPA014750: AB_1846219" "unprognostic (3.98e-1)" "unprognostic (1.18e-1)" "unprognostic (7.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.04e-3)" "unprognostic (9.26e-2)" "unprognostic (1.07e-1)" "unprognostic (5.80e-2)" "unprognostic (1.44e-2)" "unprognostic (2.91e-3)" "unprognostic (2.04e-1)" "prognostic favorable (4.15e-5)" "unprognostic (2.06e-2)" "unprognostic (2.22e-1)" "unprognostic (2.59e-1)" "unprognostic (1.54e-1)" 140.4 96.1 84.4 84.8 112.7 72.7 125.7 116.9 88.8 113.9 63.5 108.7 110.8 137.2 104.3 126.1 99.6 92.1 100.2 82.8 117.3 148.7 185.3 150.0 77.8 122.6 109.1 71.7 102.5 175.8 110.8 95.7 108.8 117.6 98.9 66.5 36.0 146.1 95.7 71.9 181.2 113.7 93.3 115.0 103.2 109.4 85.4 103.4 64.0 127.8 47.0 56.0 119.6 111.9 141.6 271.7 92.3 93.9 258.1 514.7 192.5 176.7 311.9 325.1 189.8 252.1 181.8 491.1 63.7 139.1 318.6 324.9 338.7 92.9 198.1 128.7 133.8 153.1 105.5 167.6 172.5 265.9 324.5 236.2 236.4 264.6 176.3 114.4 308.4 232.2 61.0 89.3 90.9 236.8 108.9 66.0 158.2 71.5 258.4 99.9 96.1 81.4 96.5 172.3 200.9 85.7 90.1 183.3 268.5 187.6 89.8 259.6 228.0 355.1 193.5 208.2 258.8 141.4 169.4 178.8 66.6 323.4 318.8 229.7 3.8 4.9 9.5 4.0 4.0 3.4 2.2 3.1 4.4 2.5 2.1 3.4 2.8 6.8 3.9 4.4 5.4 3.6 2.1 84.4 112.7 116.9 88.8 82.8 117.3 122.6 109.1 71.7 117.6 115.0 103.4 141.6 152.4 86.6 67.2 31.3 64.5 140.8 144.5 68.3 70.0 42.4 131.1 92.5 56.9 123.0 51.4 183.9 77.2 195.6 103.6 248.7 41.1 99.0 272.1 72.7 73.4 113.9 119.2 50.9 22.3 62.3 198.5 173.6 60.6 101.3 71.0 71.3 162.1 303.3 282.9 30.3 22.4 111.1 32.6 208.9 56.8 709.0 163.8 167.6 99.6 34.7 77.6 50.1 104.0 29.7 83.2 82.7 199.2 170.4 51.8 101.4 288.1 178.1 45.1 84.5 118.3 85.0 107.1 163.1 124.7 96.1 197.5 312.4 94.8 72.4 128.6 124.0 FFAR3 "FFA3R, GPR41" ENSG00000185897 "Free fatty acid receptor 3" O14843 19 35358460-35360489 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.0;breast: 2.3;lymphoid tissue: 2.5" "Group enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 16.8;Macrophages: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "eosinophil: 2.5;neutrophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Not detected" "Not detected" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.15e-1)" "unprognostic (5.16e-3)" "unprognostic (1.45e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-3)" "unprognostic (2.21e-2)" "unprognostic (4.46e-2)" "unprognostic (1.34e-1)" "unprognostic (1.92e-4)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-3)" "unprognostic (2.18e-2)" "unprognostic (3.41e-1)" "unprognostic (3.22e-2)" 3.0 0.1 0.5 2.5 0.5 0.8 2.3 0.3 0.6 0.0 0.4 0.9 0.3 0.0 0.0 0.1 0.3 0.5 0.2 0.5 0.7 0.0 0.2 0.4 0.2 1.3 0.4 0.3 0.2 0.4 0.1 0.4 0.4 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.5 1.2 0.5 0.1 0.5 0.2 0.6 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.1 0.5 0.5 0.3 0.6 0.5 0.7 1.3 0.4 0.3 0.4 0.5 0.5 1.1 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 16.8 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 2.6 1.8 0.3 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 TAS2R60 T2R60 ENSG00000185899 "Taste 2 receptor member 60" P59551 7 143443453-143444409 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030416 Uncertain NA NA "HPA030416: AB_10603344" "unprognostic (1.78e-2)" "unprognostic (7.98e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein O-mannose kinase" Q9H5K3 8 43093498-43131180 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 6.9;Inhibitory neurons: 6.8;Microglial cells: 7.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain NA NA "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 2.3 2.9 9.2 2.5 13.6 6.8 3.9 7.0 13.6 4.2 0.7 3.3 1.6 2.3 7.3 1.9 2.4 1.9 1.4 12.7 10.1 2.0 3.3 2.7 4.0 10.0 9.3 13.8 2.6 3.4 2.6 0.9 3.2 8.6 5.0 3.7 5.9 2.4 2.5 2.8 5.9 1.8 2.6 7.3 3.9 3.3 3.6 10.5 4.9 3.1 2.7 4.2 2.7 0.8 9.5 7.8 9.1 9.2 24.4 8.8 6.6 9.1 4.3 4.7 6.1 6.1 8.4 13.8 9.2 7.7 7.1 2.5 8.2 13.5 11.7 7.9 2.0 4.3 19.2 6.2 15.6 8.3 6.1 9.9 8.7 15.2 11.1 10.8 4.6 9.1 10.1 4.6 15.9 9.7 5.3 14.5 18.6 19.8 11.2 1.7 8.7 10.2 4.1 19.1 11.3 6.5 8.2 12.4 7.5 10.0 10.7 14.9 9.6 9.8 11.6 12.8 11.8 8.1 5.8 11.6 11.7 5.7 6.3 16.0 2.2 0.9 0.8 0.8 0.8 0.9 0.5 0.8 0.8 1.4 1.2 1.0 1.1 2.8 0.9 1.5 2.4 1.2 0.6 9.2 13.6 7.0 13.6 12.7 10.1 10.0 9.3 13.8 8.6 7.3 10.5 9.5 0.6 0.0 0.5 2.9 0.7 0.4 0.1 0.3 1.8 1.6 0.3 0.3 0.3 0.0 1.3 0.0 0.0 0.4 1.0 0.5 0.0 0.2 0.0 0.7 1.9 0.3 0.0 0.4 6.9 0.0 0.8 0.6 1.5 1.0 0.0 1.2 0.0 0.3 0.2 0.0 6.8 0.3 0.0 0.3 0.0 0.0 0.6 0.8 1.8 7.5 1.3 0.3 2.1 5.5 6.5 0.2 0.0 0.0 1.5 0.2 0.5 0.1 0.0 1.0 0.0 0.2 0.6 0.3 1.1 2.3 0.1 0.5 0.9 0.6 0.5 0.2 C16orf54 FLJ35681 ENSG00000185905 "Chromosome 16 open reading frame 54" Q6UWD8 16 29742463-29745990 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 41.8;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" "B-cells: 36.6;dendritic cells: 60.4;granulocytes: 33.6;monocytes: 22.0;NK-cells: 55.6;Plasma cells: 37.1;T-cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 18.6;HL-60: 18.9;HMC-1: 11.7;MOLT-4: 15.7;NB-4: 12.8;REH: 8.8;THP-1: 22.1;U-937: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060546 Uncertain NA NA "HPA060546: AB_2684317" "unprognostic (2.09e-3)" "unprognostic (1.58e-3)" "unprognostic (1.30e-2)" "unprognostic (1.92e-4)" "unprognostic (2.08e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-3)" "unprognostic (2.90e-2)" "unprognostic (2.44e-3)" "unprognostic (1.06e-2)" "unprognostic (1.34e-1)" "unprognostic (2.32e-1)" "unprognostic (9.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-1)" 3.8 0.7 0.6 15.4 0.8 41.8 2.3 0.9 0.9 4.1 1.1 3.5 3.0 0.8 0.7 2.1 0.9 2.9 0.6 0.7 1.3 0.7 1.3 5.6 21.2 1.1 0.8 0.4 0.6 1.2 0.2 0.1 0.7 1.1 1.5 3.7 0.3 2.2 0.5 2.3 0.9 6.3 1.7 1.0 15.0 5.7 0.5 1.0 13.3 0.5 1.0 20.6 4.4 0.3 1.6 5.4 0.0 0.3 0.2 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.2 2.9 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 18.6 0.4 0.1 0.0 18.9 11.7 0.4 0.0 0.0 0.0 0.1 0.0 6.5 0.1 5.1 0.0 0.2 15.7 12.8 1.1 0.0 0.0 8.8 0.1 0.1 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.2 22.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.8 0.2 10.3 0.1 294.4 101.8 380.2 224.8 100.4 212.8 142.8 219.8 196.0 77.4 116.6 178.2 187.4 557.0 224.5 128.3 87.5 129.3 188.0 0.6 0.8 0.9 0.9 0.7 1.3 1.1 0.8 0.4 1.1 1.0 1.0 1.6 0.3 3.2 4.7 0.0 36.6 0.5 0.1 0.2 0.0 0.0 0.4 0.1 0.3 0.0 0.1 0.0 0.0 0.2 60.4 0.2 0.0 0.0 0.0 0.1 0.0 0.5 10.8 5.0 0.0 0.0 0.1 0.7 1.5 0.1 33.6 0.1 1.8 0.6 6.2 0.0 0.0 0.8 0.0 18.7 8.7 0.0 0.0 12.5 5.4 2.8 22.0 0.0 55.6 0.5 0.0 0.0 0.0 0.0 37.1 0.0 0.1 0.5 5.5 0.0 0.0 0.5 0.3 0.1 0.2 0.0 0.9 1.4 52.3 0.0 0.6 0.1 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171598-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 129.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 28.8" "Group enriched" "Detected in many" 10 "granulocytes: 28.8;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 26.1 129.8 13.0 5.6 13.4 6.2 25.1 9.0 15.0 19.1 21.9 39.1 7.2 26.4 10.7 31.3 26.7 16.9 52.6 11.5 17.9 15.5 12.7 17.5 9.9 11.8 13.7 12.0 70.7 9.4 10.5 10.2 12.4 12.8 17.0 3.7 2.3 14.2 13.7 29.8 26.9 14.1 14.3 10.3 13.4 16.8 15.6 15.4 4.3 26.8 13.5 6.9 29.7 22.7 10.0 2.5 5.5 22.4 11.4 13.5 8.0 6.9 8.4 4.7 8.2 6.6 3.6 7.4 0.0 4.6 14.0 2.3 0.1 5.6 5.1 2.1 4.6 1.5 15.1 15.2 9.6 25.6 0.0 8.5 13.3 23.9 10.6 0.8 18.4 21.2 5.3 23.7 0.2 6.3 0.7 1.6 16.7 7.4 1.3 13.1 2.3 2.1 0.7 6.1 1.3 0.9 25.2 6.7 0.2 17.0 4.7 6.8 7.3 9.3 6.2 17.1 11.2 2.6 2.1 0.7 0.3 4.5 0.0 3.1 0.0 5.4 28.8 1.0 8.0 0.4 0.0 0.5 0.7 0.5 0.1 1.8 1.0 9.7 0.0 8.3 0.8 0.2 2.4 13.0 13.4 9.0 15.0 11.5 17.9 11.8 13.7 12.0 12.8 10.3 15.4 10.0 14.1 9.6 10.9 5.9 0.9 7.6 11.5 16.4 10.8 2.2 10.8 9.0 60.7 11.5 14.3 7.3 2.1 10.9 2.4 1.0 17.6 14.3 7.2 6.8 6.9 20.5 6.7 6.5 3.8 5.9 8.5 22.3 2.6 3.3 1.3 7.7 37.1 7.5 41.7 0.0 4.6 3.0 18.3 12.0 2.2 7.7 15.2 10.5 12.4 6.5 2.5 29.4 0.0 3.5 0.7 8.6 1.7 14.3 0.6 8.3 0.7 13.4 4.0 2.7 98.6 28.3 31.1 9.2 8.6 15.5 9.8 49.8 1.5 55.5 1.7 7.9 KLHL34 "FLJ34960, RP11-450P7.3" ENSG00000185915 "Kelch like family member 34" Q8N239 X 21654690-21658330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 25.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.7;Cardiomyocytes: 7.9;Cone photoreceptor cells: 14.6;Horizontal cells: 16.8;Rod photoreceptor cells: 66.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA060287 Uncertain NA NA "HPA060287: AB_2684243" "unprognostic (2.00e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (3.02e-1)" "unprognostic (3.14e-2)" "unprognostic (8.68e-2)" "unprognostic (9.17e-2)" "unprognostic (3.24e-1)" "unprognostic (3.40e-2)" "unprognostic (3.74e-1)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (8.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (3.29e-1)" 0.0 0.0 2.1 0.1 0.6 0.0 0.0 1.7 2.7 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 1.8 2.3 0.2 0.0 0.0 0.0 0.2 0.5 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 3.2 0.1 0.0 25.8 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 2.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.6 1.7 2.7 2.3 0.2 0.5 0.0 1.0 0.7 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.0 7.7 0.1 0.0 7.9 0.0 0.0 0.0 14.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.8 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.1 4.1 0.1 0.0 66.6 0.0 0.8 0.1 0.2 0.9 0.0 0.0 0.0 0.2 0.0 1.1 0.0 SETD4 "C21orf18, C21orf27" ENSG00000185917 "SET domain containing 4" Q9NVD3 21 36034541-36079389 "Predicted intracellular proteins" "Inflammatory response" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 54.3;Spermatocytes: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024073, HPA035405" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024073: AB_1856755, HPA035405: AB_2674612" "unprognostic (4.23e-1)" "unprognostic (5.67e-2)" "unprognostic (6.98e-2)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (8.05e-3)" "unprognostic (7.86e-2)" "unprognostic (2.13e-3)" "unprognostic (2.17e-2)" "unprognostic (5.81e-2)" "unprognostic (1.33e-1)" "unprognostic (4.60e-3)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "unprognostic (8.09e-3)" "unprognostic (3.30e-2)" "unprognostic (1.28e-2)" 8.3 9.4 9.4 6.9 9.4 8.5 9.2 9.1 10.1 10.2 13.7 9.3 11.5 9.7 11.2 11.0 10.8 7.9 10.2 9.1 8.5 9.7 7.3 8.5 8.8 9.0 8.5 8.9 9.8 7.8 10.0 9.0 9.1 9.5 10.3 9.5 9.7 10.1 7.9 9.9 13.7 9.4 11.0 8.0 8.5 10.0 23.3 9.2 11.2 10.2 8.9 11.0 10.0 10.7 11.8 13.3 9.2 13.6 17.3 6.5 7.9 21.9 17.1 15.0 17.3 11.5 19.2 11.5 7.1 11.9 7.8 13.3 9.7 10.3 10.2 15.0 12.7 12.4 19.2 16.2 12.6 15.9 18.3 10.7 8.3 17.2 11.7 15.0 9.8 13.1 9.6 25.5 12.7 10.7 14.3 12.3 26.3 28.2 11.3 11.6 18.2 10.0 17.3 18.9 9.3 11.2 17.9 17.4 18.5 17.6 11.7 16.3 15.2 11.0 15.0 5.6 9.4 15.9 20.3 31.7 11.2 15.6 24.9 13.2 5.9 12.5 11.3 8.1 10.0 9.0 16.2 10.3 8.8 14.6 13.2 7.3 8.6 9.5 11.0 10.2 15.6 13.0 7.7 9.4 9.4 9.1 10.1 9.1 8.5 9.0 8.5 8.9 9.5 8.0 9.2 11.8 9.7 9.6 7.0 11.1 10.8 12.1 11.3 18.6 15.4 13.3 9.0 8.9 9.2 7.2 13.7 9.2 31.3 16.3 13.4 7.9 5.9 12.7 54.3 16.8 10.9 9.3 3.6 7.2 17.4 8.2 9.6 10.4 8.6 8.7 11.4 17.0 7.5 5.5 10.6 3.3 19.2 13.4 26.4 6.9 5.1 10.4 9.6 5.0 10.6 4.7 8.0 7.6 14.4 19.6 19.8 10.0 9.4 10.1 6.2 11.2 20.7 10.3 23.8 21.0 6.6 8.9 9.0 63.1 20.8 13.2 9.1 9.4 8.1 14.8 11.3 11.3 PTCH1 "BCNS, NBCCS, PTCH" ENSG00000185920 "Patched 1" Q13635 9 95442980-95517057 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 27.0" "Cell type enhanced" "Detected in many" "Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 6.1" "Lineage enriched" "Detected in single" 9 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "NTERA-2: 29.6;WM-115: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013717, HPA075072" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB013717: , HPA075072: AB_2686733" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (3.16e-1)" "unprognostic (1.79e-2)" "unprognostic (3.22e-2)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" "unprognostic (3.54e-3)" "unprognostic (2.63e-1)" "unprognostic (8.66e-3)" "unprognostic (1.52e-2)" "unprognostic (2.82e-1)" "unprognostic (1.13e-6)" "unprognostic (8.63e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-1)" "unprognostic (2.82e-1)" 2.5 3.5 10.2 4.1 10.6 0.7 2.8 25.5 6.5 27.0 2.4 11.5 8.2 15.8 2.8 2.9 7.2 8.2 2.9 5.2 16.6 4.6 2.2 5.6 2.2 16.7 11.8 5.0 5.0 6.5 2.5 2.2 3.8 25.3 6.8 12.4 8.4 7.5 4.0 3.0 3.1 11.7 2.4 6.1 3.3 12.6 14.6 17.2 2.1 4.8 4.8 3.0 7.3 2.9 6.1 10.1 4.7 20.3 12.9 3.0 5.0 11.4 1.9 1.7 2.2 1.4 4.9 4.8 8.0 3.3 3.8 4.4 22.3 11.7 1.6 1.4 7.9 7.8 0.0 4.8 2.3 2.7 0.2 4.2 4.7 2.4 2.2 1.4 4.3 4.2 3.5 7.3 9.1 1.0 1.9 0.1 3.2 29.6 7.2 1.8 0.0 15.5 4.2 1.6 1.5 13.8 7.0 7.1 6.8 2.9 18.8 1.8 2.1 1.1 2.6 12.9 13.6 1.5 18.0 16.8 5.3 3.8 3.9 71.0 0.0 0.0 0.0 6.1 0.0 3.3 0.7 1.1 2.5 0.0 0.2 1.9 2.2 0.0 0.3 0.0 0.0 1.2 1.7 10.2 10.6 25.5 6.5 5.2 16.6 16.7 11.8 5.0 25.3 6.1 17.2 6.1 6.0 0.0 6.4 49.0 3.0 4.0 2.7 3.0 4.6 20.3 3.5 4.6 5.9 25.8 2.7 0.0 41.7 3.0 11.8 2.0 5.9 3.5 88.4 12.2 89.8 5.4 21.7 0.4 15.2 4.2 1.9 27.2 1.1 11.0 1.3 2.6 6.4 2.9 0.8 20.2 10.7 11.0 4.1 0.9 1.2 237.5 191.0 1.4 12.4 4.7 0.8 55.6 54.6 39.7 20.5 2.4 3.1 444.5 3.1 4.9 3.1 1.6 5.5 13.4 39.5 4.8 9.4 4.4 35.5 3.0 4.4 1.4 6.5 71.7 4.7 1.4 RTN4RL1 "DKFZp547J144, NgR3, NGRH2" ENSG00000185924 "Reticulon 4 receptor like 1" Q86UN2 17 1934677-2025334 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044428 Uncertain Approved "Nucleoplasm,Plasma membrane,Actin filaments,Midbody" "Intracellular and membrane" Yes NA 35000 "Actin filaments" "Nucleoplasm, Plasma membrane, Midbody" "HPA044428: AB_10963229" "unprognostic (5.23e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-2)" "unprognostic (7.25e-2)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (8.97e-3)" "unprognostic (6.21e-2)" "unprognostic (2.55e-3)" "unprognostic (6.32e-3)" "prognostic unfavorable (7.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (3.15e-2)" 3.9 3.1 5.1 0.3 4.6 0.0 6.5 0.0 9.9 1.9 0.0 0.3 0.1 0.8 0.2 1.3 1.5 0.6 2.1 11.2 1.6 1.2 2.6 1.6 0.1 0.0 1.2 5.2 0.9 1.8 1.3 6.0 0.3 0.9 3.4 0.1 8.6 4.5 2.1 1.8 8.9 0.5 0.3 0.0 1.1 0.8 0.8 2.0 0.2 1.4 0.4 0.1 1.5 2.2 1.5 1.4 1.6 1.8 2.5 2.0 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.0 0.1 10.9 0.2 10.8 4.6 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.1 0.0 3.6 0.0 0.0 2.5 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.3 0.8 0.3 1.2 0.0 0.0 2.2 0.0 0.3 0.8 1.7 0.2 13.3 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 4.6 0.0 9.9 11.2 1.6 0.0 1.2 5.2 0.9 0.0 2.0 1.5 1.0 0.0 2.2 1.6 0.1 2.7 0.2 0.0 1.8 20.6 5.4 4.3 3.0 1.5 1.3 3.7 37.5 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.7 0.0 0.0 43.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.1 3.3 1.8 33.7 18.6 0.0 0.0 0.3 0.4 1.1 0.0 0.1 3.6 7.5 0.0 1.8 0.0 8.5 1.7 0.1 0.0 0.0 0.1 0.9 0.0 0.1 1.5 10.0 0.0 0.0 0.6 0.0 0.2 0.5 2.8 0.0 0.2 0.0 0.0 0.3 OR4C46 ENSG00000185926 "Olfactory receptor family 4 subfamily C member 46" A6NHA9 11 54603069-54603998 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453240-103458900 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sensory transduction, Taste, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 1.6;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPMI-8226: 1.3;U-266/70: 1.1;U-266/84: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061816 Enhanced NA NA "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 0.7 0.1 0.8 0.1 0.0 1.2 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.8 0.0 0.0 0.0 1.8 1.1 0.8 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.8 1.2 1.1 0.9 1.5 1.8 1.1 0.8 2.3 0.2 0.7 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-5 "KRTAP5-11, KRTAP5.5" ENSG00000185940 "Keratin associated protein 5-5" Q701N2 11 1629775-1630707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "skin 1: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.45e-2)" "unprognostic (1.00e-2)" "unprognostic (7.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKAIN3 "FAM77D, FLJ39630, NKAIN3-IT1" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-63014000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "brain: 19.6" "Group enriched" "Detected in some" 6 "Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8" "Cancer enriched" "Detected in single" 5 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;SCLC-21H: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced NA NA "HPA018833: AB_2669943" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.2 1.7 19.6 0.3 11.8 0.9 0.3 1.4 14.0 0.7 0.0 0.4 0.3 0.4 0.7 0.2 0.2 0.3 0.3 16.0 8.1 0.4 2.0 0.2 0.3 5.9 9.5 9.5 0.4 0.3 0.7 0.0 0.2 12.6 0.3 0.4 1.7 1.2 0.4 0.6 0.7 0.4 0.2 1.1 0.4 0.3 0.4 9.7 0.1 0.2 0.1 0.1 0.2 0.0 7.8 0.4 0.6 2.2 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.6 0.5 0.3 0.2 0.2 0.2 0.5 0.1 0.1 0.4 0.1 0.9 1.2 0.3 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.5 1.3 0.1 0.2 0.3 0.5 0.8 0.4 1.1 1.9 0.3 0.2 0.0 0.6 3.7 0.3 0.3 0.4 0.2 0.6 0.3 0.4 0.4 0.5 0.5 0.4 0.3 0.6 0.5 0.2 0.6 0.4 1.2 0.9 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.5 0.2 0.2 0.2 0.1 0.0 19.6 11.8 1.4 14.0 16.0 8.1 5.9 9.5 9.5 12.6 1.1 9.7 7.8 0.0 0.0 0.0 1258.6 0.0 0.4 0.1 0.0 0.0 10.4 1.3 1.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.2 6.3 0.0 0.0 0.0 35.7 0.7 0.1 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 168.5 0.0 0.0 0.0 0.0 4.2 0.3 0.0 1.8 21.5 0.0 0.0 0.0 811.8 3.8 0.6 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.2 0.0 7.6 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.2 0.0 0.2 RNPC3 "FLJ20008, KIAA1839, RBM40, SNRNP65" ENSG00000185946 "RNA binding region (RNP1, RRM) containing 3" Q96LT9 1 103525691-103555239 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 143.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052434 Supported Nucleoplasm NA NA Nucleoplasm "HPA052434: AB_2681832" "unprognostic (1.87e-2)" "unprognostic (9.61e-2)" "unprognostic (1.04e-1)" "unprognostic (4.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.34e-5)" "unprognostic (9.00e-2)" "prognostic favorable (1.53e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "prognostic favorable (7.82e-4)" "prognostic unfavorable (7.70e-4)" "unprognostic (3.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-1)" "unprognostic (3.19e-1)" "prognostic favorable (5.25e-4)" 27.0 25.1 8.7 22.9 7.6 24.6 31.0 17.1 22.0 34.3 0.1 27.8 23.6 34.2 54.5 16.3 35.9 21.4 28.8 7.9 1.5 29.8 17.1 26.3 34.1 5.4 4.1 2.5 38.2 45.3 24.8 33.6 12.6 6.2 25.4 22.5 64.2 37.6 21.6 44.4 38.0 29.4 16.1 0.4 30.3 22.4 16.1 2.5 20.2 55.5 17.1 26.3 27.0 27.7 20.8 10.7 8.7 17.8 8.8 10.4 18.8 11.6 14.4 9.7 11.3 17.1 9.3 17.9 20.0 22.8 7.4 6.7 20.9 11.5 11.1 13.7 13.0 20.3 21.1 52.0 9.5 7.7 28.2 17.4 17.8 16.8 9.9 6.8 16.2 10.4 17.3 13.4 22.4 12.8 5.8 16.8 13.7 11.5 9.8 12.5 22.1 16.7 15.9 14.7 11.7 18.8 9.0 9.9 13.7 14.6 9.7 9.4 12.5 13.9 12.3 12.2 6.5 9.5 17.2 6.4 18.1 21.4 21.5 6.3 249.7 91.0 70.0 53.7 46.1 39.5 109.3 65.0 50.2 28.9 127.7 75.9 69.6 252.6 40.0 53.4 111.9 48.2 15.6 8.7 7.6 17.1 22.0 7.9 1.5 5.4 4.1 2.5 6.2 0.4 2.5 20.8 28.8 28.9 43.5 108.0 31.3 7.5 17.4 13.3 30.1 104.6 21.0 26.5 20.2 12.8 30.8 27.6 133.5 7.9 31.1 23.9 15.6 10.6 44.4 20.7 22.1 18.8 16.9 13.9 89.1 10.5 4.1 19.0 34.1 18.5 20.8 22.3 16.1 9.9 7.6 62.2 76.2 19.5 14.2 23.0 10.8 6.5 24.8 22.3 16.0 44.0 37.3 40.5 25.7 64.8 71.2 10.8 19.0 21.4 26.0 10.5 19.9 7.3 41.8 143.1 26.3 35.2 23.4 22.8 11.9 18.9 8.9 10.9 26.3 16.5 14.3 14.0 ZNF267 HZF2 ENSG00000185947 "Zinc finger protein 267" Q14586 16 31873807-31917357 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 131.1;Macrophages: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003866 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003866: AB_1080698" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.84e-2)" "unprognostic (6.24e-2)" "unprognostic (5.60e-3)" "unprognostic (8.64e-2)" "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" "unprognostic (3.60e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (1.58e-6)" "unprognostic (2.34e-1)" "unprognostic (3.34e-2)" "unprognostic (3.95e-1)" "unprognostic (8.21e-2)" 6.3 3.7 3.5 18.7 4.0 27.7 7.4 3.7 10.7 5.5 7.2 6.2 7.2 6.8 3.1 7.2 6.1 10.1 4.5 3.2 5.9 5.1 6.7 9.4 18.1 4.9 4.3 2.8 6.2 4.9 4.6 2.3 10.1 5.1 5.2 7.2 2.5 5.4 3.9 6.1 4.0 6.0 6.0 5.1 13.3 6.8 9.9 5.9 11.6 5.9 6.7 18.5 13.8 4.5 5.7 8.8 10.0 8.8 7.0 6.2 7.2 26.9 7.0 11.7 9.6 14.7 17.9 13.7 15.6 12.6 5.7 9.6 11.3 14.4 11.4 18.5 23.6 12.1 15.8 5.6 16.1 5.6 17.0 35.3 10.3 7.7 13.6 9.7 7.0 14.0 11.8 25.9 35.9 13.2 12.2 11.4 11.3 8.2 6.8 5.8 11.4 24.8 13.7 10.9 38.8 2.8 4.3 10.8 9.6 10.3 15.3 5.7 23.6 16.8 9.3 8.5 8.2 12.0 20.1 12.3 15.7 12.3 13.6 5.7 36.6 24.0 33.4 12.4 23.4 18.6 21.2 16.2 12.5 18.8 15.9 12.6 15.2 75.3 16.5 27.5 11.3 20.3 12.3 3.5 4.0 3.7 10.7 3.2 5.9 4.9 4.3 2.8 5.1 5.1 5.9 5.7 23.7 9.6 8.0 3.6 37.0 31.9 39.6 15.2 13.1 4.5 12.3 12.2 5.6 8.6 14.0 3.7 0.0 14.1 27.2 5.4 7.9 19.1 23.3 34.8 10.3 33.5 7.7 10.9 7.1 20.0 10.4 17.2 13.7 31.4 60.3 5.4 7.5 2.8 21.5 11.8 3.7 7.0 14.2 25.3 131.1 8.8 5.9 82.2 14.2 15.0 68.5 5.0 22.6 9.5 7.7 49.7 8.0 3.4 19.9 30.1 4.2 12.4 26.2 3.9 0.0 10.8 12.2 20.7 29.6 33.1 25.6 8.3 47.6 5.9 5.6 48.9 IRS2 ENSG00000185950 "Insulin receptor substrate 2" Q9Y4H2 13 109752695-109786583 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016944, HPA054664" Approved Supported Aggresome,Cytosol NA NA Cytosol Aggresome "CAB016944: , HPA054664: AB_2682563" "unprognostic (2.87e-3)" "unprognostic (5.73e-3)" "unprognostic (4.39e-2)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (5.49e-3)" "unprognostic (2.10e-1)" "unprognostic (9.28e-2)" "unprognostic (9.70e-2)" "unprognostic (2.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.09e-2)" "unprognostic (6.21e-3)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (3.17e-2)" "unprognostic (1.24e-1)" 26.4 16.6 23.8 6.0 23.4 51.8 19.1 14.8 30.3 10.7 4.8 9.5 4.4 13.1 6.3 4.3 7.7 4.0 11.3 32.9 33.0 3.6 22.3 11.2 2.3 31.0 26.0 23.1 18.7 4.3 3.6 19.3 6.8 32.6 13.4 3.5 6.1 11.7 6.2 21.6 15.3 6.1 4.8 18.1 5.4 7.9 3.0 23.5 2.3 5.6 7.8 2.2 7.2 8.6 22.7 5.8 6.6 4.2 0.0 34.5 6.9 2.3 6.3 7.4 3.8 3.1 0.6 7.0 0.0 3.9 4.5 5.4 2.6 2.2 5.6 4.7 2.3 29.5 2.8 9.3 0.0 34.8 10.7 3.3 14.5 29.6 1.1 38.1 24.5 1.4 0.5 1.9 0.0 36.9 3.0 0.1 31.1 4.5 3.2 1.4 13.1 3.8 2.8 10.6 1.5 6.1 40.2 3.3 0.1 27.2 3.5 0.8 62.8 0.1 7.8 0.0 0.5 8.5 0.0 3.1 2.1 5.8 10.2 13.7 1.5 0.6 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 3.3 0.0 0.2 0.0 0.2 0.1 23.8 23.4 14.8 30.3 32.9 33.0 31.0 26.0 23.1 32.6 18.1 23.5 22.7 13.7 32.1 33.8 53.8 31.1 113.9 48.0 100.2 81.4 25.8 68.9 98.4 72.3 60.1 79.5 31.3 114.7 20.3 40.0 71.2 5.9 36.4 47.6 81.6 110.6 13.4 122.6 34.5 51.3 3.1 11.1 52.0 28.1 188.5 25.3 25.8 20.0 142.9 24.1 25.2 42.2 42.0 52.9 143.5 24.4 12.3 37.3 131.2 129.9 29.0 59.3 32.4 17.5 46.3 34.8 30.8 44.4 20.3 7.9 76.8 77.3 3.9 40.3 30.6 26.3 57.1 44.0 21.2 10.2 74.6 126.2 30.6 37.5 63.1 42.7 53.6 C7orf61 IMAGE:4839025 ENSG00000185955 "Chromosome 7 open reading frame 61" Q8IZ16 7 100456620-100464260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 69.0" "Group enriched" "Detected in many" 20 "Early spermatids: 588.7;Late spermatids: 349.4" "Cancer enriched" "Detected in some" 5 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 25.2;NB-4: 9.6;TIME: 14.9" HPA060395 Enhanced Approved Vesicles NA NA Vesicles "HPA060395: AB_2684274" "unprognostic (1.88e-1)" "unprognostic (5.02e-1)" "unprognostic (1.26e-2)" "unprognostic (7.70e-5)" "unprognostic (1.65e-1)" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.26e-1)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (2.53e-1)" "unprognostic (6.39e-13)" "unprognostic (9.54e-2)" "unprognostic (2.93e-1)" "unprognostic (1.33e-2)" "unprognostic (1.24e-2)" 1.2 0.6 11.3 0.5 13.5 1.4 0.9 12.0 13.5 1.7 7.4 1.2 0.0 0.9 0.3 0.9 1.4 0.5 1.2 10.4 11.7 1.0 0.9 1.6 0.8 13.0 12.6 9.4 3.0 0.3 0.2 2.9 0.6 12.6 1.5 0.1 1.9 0.5 0.6 0.5 0.8 0.9 0.3 12.2 2.6 0.7 69.0 12.1 0.8 1.1 0.6 0.3 1.1 1.3 15.9 1.0 0.2 0.8 0.9 0.9 2.2 0.3 0.4 1.5 0.2 0.8 1.1 0.5 0.7 1.7 0.9 1.4 0.7 0.3 0.0 0.6 1.0 1.7 1.4 2.2 0.0 1.2 0.5 0.4 0.3 0.4 0.9 1.4 2.4 25.2 2.4 0.7 1.3 1.5 2.4 0.5 9.6 0.6 0.3 1.1 2.5 0.0 0.5 0.4 0.4 0.0 0.0 0.6 0.8 1.5 0.5 0.4 2.6 14.9 1.3 2.2 2.8 0.4 0.3 0.2 1.0 0.3 2.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.6 0.0 11.3 13.5 12.0 13.5 10.4 11.7 13.0 12.6 9.4 12.6 12.2 12.1 15.9 1.7 0.0 0.0 16.0 1.0 8.3 0.5 0.7 4.6 1.7 2.9 5.5 1.4 1.5 0.4 0.0 0.0 0.2 1.7 0.4 0.0 0.5 588.7 0.8 1.2 2.2 0.0 0.0 1.2 0.0 0.4 2.0 0.0 1.1 0.0 1.5 0.7 0.0 0.9 3.3 1.5 0.4 0.0 0.3 16.8 349.4 7.8 1.4 5.4 0.0 0.7 7.4 0.0 4.5 14.1 0.2 0.1 3.8 0.0 0.7 0.5 0.1 0.4 0.1 6.6 1.7 1.8 22.9 2.6 1.6 6.1 0.1 2.2 0.4 0.4 0.4 FAM186A LOC121006 ENSG00000185958 "Family with sequence similarity 186 member A" A6NE01 12 50326230-50396622 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 14.3" "Cell type enriched" "Detected in some" 8 "Early spermatids: 521.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047128, HPA064735" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA047128: AB_10967726, HPA064735: " "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.69e-2)" "unprognostic (3.48e-3)" "unprognostic (1.43e-2)" "unprognostic (1.30e-2)" "unprognostic (6.96e-2)" "unprognostic (4.65e-5)" "unprognostic (1.93e-1)" "unprognostic (2.42e-5)" "unprognostic (1.65e-1)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (3.22e-3)" 0.1 0.3 0.1 0.2 0.4 0.5 0.1 0.5 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.2 0.1 0.3 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.3 0.0 0.9 0.0 0.2 0.3 0.1 0.7 0.2 0.0 1.1 0.3 0.2 0.0 0.0 0.4 0.1 14.3 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.6 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.1 0.4 0.5 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 521.1 0.1 0.2 0.1 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 64.7 0.6 0.1 0.0 2.8 0.0 0.6 0.0 1.5 3.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.4" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 6.4" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "BJ: 18.5;BJ hTERT+: 8.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "midbrain: 2.7;thalamus: 3.8" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035141: AB_2674489, HPA060931: AB_2684388" "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 0.7 0.4 0.6 0.3 0.3 0.9 0.2 1.0 0.5 0.0 0.1 0.2 0.6 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.3 1.1 6.4 0.1 0.1 0.3 0.2 0.0 0.1 5.0 0.4 0.2 0.4 0.6 0.0 1.2 0.5 0.4 0.1 0.0 0.7 0.2 0.1 1.5 0.0 0.3 0.0 0.2 0.0 0.0 3.1 0.1 0.1 0.1 0.1 0.2 0.1 3.0 18.5 8.4 2.7 2.9 0.3 0.2 0.2 0.1 0.4 0.7 0.2 0.2 0.0 0.9 0.1 0.1 0.1 1.4 0.1 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.5 0.0 0.0 0.2 0.1 0.1 0.1 0.8 0.0 0.2 0.1 0.1 0.0 2.9 0.6 0.6 0.4 0.3 0.4 0.5 0.3 0.3 0.1 0.7 0.4 0.5 1.7 0.7 0.6 0.6 0.3 0.3 0.6 0.3 1.0 0.5 0.1 0.1 1.1 6.4 0.1 5.0 0.0 1.5 3.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 LCE3A LEP13 ENSG00000185962 "Late cornified envelope 3A" Q5TA76 1 152622834-152623103 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 108.6" "Cell type enhanced" "Detected in some" "Early spermatids: 3.2;Late spermatids: 1.5;Skeletal myocytes: 12.4;Spermatocytes: 1.6;Spermatogonia: 2.1" "Group enriched" "Detected in some" 9 "head and neck cancer: 26.6;melanoma: 9.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.4;LHCN-M2: 1.5;U-138 MG: 1.7" NA NA "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 108.6 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 1.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BICD2 KIAA0699 ENSG00000185963 "BICD cargo adaptor 2" Q8TD16 9 92711363-92764833 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 83.6;Squamous epithelial cells: 103.2;Suprabasal keratinocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023013, HPA024452" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA023013: AB_1845352, HPA024452: AB_1845353" "unprognostic (9.99e-3)" "unprognostic (1.98e-1)" "unprognostic (7.84e-3)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "unprognostic (2.86e-1)" "unprognostic (2.37e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (6.54e-3)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.25e-1)" "unprognostic (2.26e-1)" "unprognostic (3.95e-1)" "unprognostic (1.39e-2)" 15.5 10.7 11.8 13.6 10.5 12.1 11.0 11.3 10.8 16.4 8.5 14.9 4.7 15.6 6.1 47.4 12.9 9.5 18.8 11.4 9.2 9.2 8.5 16.1 14.8 11.4 10.3 10.2 12.6 9.0 17.8 6.1 10.5 10.7 11.4 5.1 6.6 14.7 13.2 22.5 63.0 10.5 13.8 11.1 17.5 9.6 9.4 10.0 13.9 10.0 15.5 16.9 15.3 31.2 12.6 32.6 26.5 19.2 19.8 36.6 25.1 27.1 30.8 22.2 17.2 13.6 15.6 14.4 36.3 19.5 34.4 22.0 99.4 21.8 49.1 19.4 17.4 23.5 19.2 25.6 21.7 21.8 26.9 30.0 25.8 67.1 28.8 22.0 20.4 26.0 15.4 19.3 27.5 38.1 21.4 25.6 16.7 13.3 23.8 32.0 27.8 41.8 19.3 27.8 27.0 13.4 20.7 21.7 19.9 14.3 19.2 8.2 12.3 34.9 31.8 21.1 53.9 33.9 22.5 17.5 31.9 26.9 16.3 28.4 1.6 3.4 4.4 1.2 3.6 1.2 1.8 1.4 1.6 3.8 2.0 1.3 1.2 7.5 1.1 5.9 3.2 0.9 1.7 11.8 10.5 11.3 10.8 11.4 9.2 11.4 10.3 10.2 10.7 11.1 10.0 12.6 21.7 28.9 12.7 14.7 27.6 73.7 17.1 19.2 83.6 12.8 11.4 10.2 54.5 8.6 16.2 7.3 6.2 8.5 26.1 3.4 3.9 10.1 6.5 21.3 26.7 26.4 10.8 16.0 16.2 5.1 6.5 26.0 5.6 21.1 24.1 13.0 19.2 7.5 14.2 15.2 14.0 1.9 12.2 32.4 30.2 7.6 21.1 40.7 16.0 19.7 38.9 22.0 7.2 9.5 18.5 8.5 3.6 33.4 22.1 18.7 0.8 6.7 14.0 6.4 19.7 23.0 33.1 9.7 8.4 103.2 130.8 7.3 17.2 13.8 3.6 20.3 LCE3E LEP17 ENSG00000185966 "Late cornified envelope 3E" Q5T5B0 1 152565654-152566780 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 46.2;lymphoid tissue: 19.5;vagina: 49.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "head and neck cancer: 40.7;melanoma: 18.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTCEpi: 1.1" NA NA "unprognostic (1.33e-1)" "unprognostic (7.76e-2)" "unprognostic (2.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 19.5 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CCIN "BTBD20, KBTBD14" ENSG00000185972 Calicin Q13939 9 36169388-36171334 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 75.2" "Group enriched" "Detected in some" 87 "Early spermatids: 913.7;Late spermatids: 247.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;BJ: 3.9;fHDF/TERT166: 4.7;hTEC/SVTERT24-B: 5.8;TIME: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.10e-2)" "unprognostic (9.26e-3)" "unprognostic (6.27e-2)" "unprognostic (8.26e-6)" "unprognostic (1.78e-2)" "unprognostic (5.38e-2)" "unprognostic (1.57e-2)" "unprognostic (7.74e-3)" "unprognostic (5.43e-3)" "unprognostic (4.49e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-1)" "unprognostic (5.98e-5)" "unprognostic (3.27e-3)" "unprognostic (7.86e-2)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 0.4 0.4 0.5 0.3 0.5 1.4 0.2 0.3 0.6 0.7 0.2 0.2 0.0 1.2 0.1 0.1 0.2 0.5 0.1 0.6 0.1 0.0 0.0 0.4 0.0 0.3 0.1 0.7 0.0 0.2 0.0 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 1.9 0.2 0.0 0.1 75.2 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.1 1.0 2.5 3.9 0.4 0.1 0.1 0.0 0.0 0.0 1.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 7.9 0.0 1.2 0.2 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.6 0.6 0.1 0.3 0.1 0.7 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 913.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.8 247.8 3.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.7 0.4 4.5 3.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 TMLHE "BBOX2, FLJ10727, TMLH, XAP130" ENSG00000185973 "Trimethyllysine hydroxylase, epsilon" Q9NVH6 X 155489011-155719098 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034589, HPA040331" Approved Supported Mitochondria NA NA Mitochondria "HPA034589: AB_10670571, HPA040331: AB_2676929" "unprognostic (1.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.04e-1)" "unprognostic (5.41e-2)" "unprognostic (6.66e-3)" "unprognostic (1.10e-3)" "unprognostic (6.50e-2)" "unprognostic (1.00e-1)" "unprognostic (3.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.20e-3)" "unprognostic (6.97e-2)" "prognostic favorable (3.68e-6)" "unprognostic (1.69e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-1)" "unprognostic (7.75e-2)" 11.8 10.3 6.7 6.7 7.1 8.4 11.5 8.5 8.0 11.4 7.7 11.7 11.9 9.4 10.5 10.4 10.0 8.1 25.6 6.4 8.3 16.9 18.9 5.7 7.0 8.2 7.5 5.7 12.1 9.6 19.1 5.4 8.5 8.0 6.7 12.6 11.0 12.8 9.8 32.3 5.9 11.3 12.4 8.2 8.8 9.1 2.9 7.5 9.0 10.6 33.7 7.6 8.2 6.7 9.4 25.0 11.9 9.8 28.6 11.8 18.1 0.0 9.9 14.6 12.3 32.4 8.7 13.9 0.0 38.9 17.6 28.2 13.4 21.2 9.7 13.9 10.3 14.3 11.3 19.5 10.2 16.4 10.5 7.6 19.5 20.0 13.6 20.8 18.2 19.5 15.5 15.8 9.0 20.5 9.3 12.8 11.8 3.0 21.6 0.1 12.7 15.5 9.4 15.0 8.5 9.2 13.7 9.3 0.5 11.2 10.5 10.6 11.9 16.5 10.3 9.7 20.4 12.4 11.0 12.6 9.6 12.4 16.4 9.6 3.4 12.6 14.7 4.6 14.9 3.5 8.1 5.0 3.9 13.1 10.6 6.5 5.7 18.2 6.2 21.5 6.1 5.5 5.8 6.7 7.1 8.5 8.0 6.4 8.3 8.2 7.5 5.7 8.0 8.2 7.5 9.4 6.7 0.0 2.3 27.1 10.1 5.2 12.1 14.4 9.6 4.0 5.2 7.5 7.2 7.2 9.7 9.2 0.0 8.8 6.5 7.9 23.5 10.7 0.0 6.8 7.4 6.2 6.1 14.3 22.2 7.6 6.8 10.2 9.2 7.3 10.1 8.1 4.2 12.0 12.4 0.0 29.5 7.3 4.1 16.1 10.4 0.5 8.4 12.1 12.4 51.5 13.1 7.6 10.3 47.7 25.5 8.5 7.3 5.7 5.6 4.3 17.4 17.0 9.5 5.4 0.0 5.9 9.5 0.3 2.5 7.6 4.1 6.7 8.0 10.5 6.5 11.0 GRK1 "GPRK1, RHOK, RK" ENSG00000185974 "G protein-coupled receptor kinase 1" Q15835 13 113667219-113737736 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "retina: 42.9" "Group enriched" "Detected in some" 16 "Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 84.9" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035200, HPA059376" Enhanced NA NA "HPA035200: AB_2674515, HPA059376: AB_2683996" "unprognostic (7.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.24e-5)" "unprognostic (1.76e-3)" "unprognostic (1.53e-1)" "unprognostic (3.59e-2)" "unprognostic (2.21e-2)" "unprognostic (1.84e-3)" "unprognostic (2.00e-2)" "unprognostic (4.02e-2)" "unprognostic (6.91e-2)" "unprognostic (6.18e-2)" "unprognostic (6.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 56.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB128 DEFB-28 ENSG00000185982 "Defensin beta 128" Q7Z7B8 20 187853-189711 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12044 "epididymis: 1204.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1204.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK2 "CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257" ENSG00000185985 "SLIT and NTRK like family member 2" Q9H156 X 145817829-145829856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.6;retina: 33.1" "Cell type enhanced" "Detected in some" "Astrocytes: 33.3;Melanocytes: 26.6;Muller glia cells: 188.6;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 25.7" "Cancer enhanced" "Detected in some" "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HAP1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 150000 "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-3)" "unprognostic (6.79e-6)" "unprognostic (3.39e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-4)" "unprognostic (6.23e-2)" "unprognostic (3.60e-1)" "unprognostic (1.29e-1)" "unprognostic (1.50e-2)" "unprognostic (3.53e-2)" "unprognostic (4.13e-8)" "unprognostic (3.12e-3)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" 1.3 0.2 9.7 0.1 11.9 0.0 0.3 8.2 12.6 0.7 0.2 0.6 0.1 0.2 0.0 0.1 1.8 0.1 0.7 9.7 8.8 0.9 0.1 0.9 0.4 11.8 10.9 9.2 0.3 0.7 0.0 0.8 0.0 10.5 0.6 0.2 33.1 0.5 3.3 0.1 2.0 0.4 0.3 8.9 6.1 0.3 0.1 9.5 0.2 0.6 0.1 0.0 0.9 0.7 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 11.9 8.2 12.6 9.7 8.8 11.8 10.9 9.2 10.5 8.9 9.5 12.0 0.2 0.0 0.0 33.3 0.0 1.1 0.0 0.0 0.0 4.8 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.7 1.8 0.0 9.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 1.4 0.0 0.0 6.7 17.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 26.6 5.6 0.0 188.6 0.0 48.7 25.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 10.8 0.0 1.3 0.4 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 PLK5 "PLK5P, SgK384ps" ENSG00000185988 "Polo like kinase 5 (inactive)" Q496M5 19 1508023-1536046 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.5;cervix: 8.7;testis: 7.2" "Cell type enhanced" "Detected in some" "Astrocytes: 14.7;Leydig cells: 36.4;Muller glia cells: 9.4;Peritubular cells: 67.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enhanced" "Detected in many" "cerebellum: 14.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Region enhanced" "Detected in all" "cerebellum: 42.0" "Group enriched" "Detected in many" 5 "cerebellum: 36.9;cerebral cortex: 10.6;hippocampal formation: 13.9" HPA035024 Enhanced NA NA "HPA035024: AB_2674418" "unprognostic (4.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (7.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (2.69e-1)" "unprognostic (8.38e-2)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" "unprognostic (3.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.18e-3)" "unprognostic (3.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.54e-2)" "unprognostic (4.01e-4)" 0.1 0.2 4.4 0.0 1.7 0.4 0.5 14.5 4.1 8.7 1.6 0.3 0.1 3.0 2.1 0.6 2.5 0.0 0.1 6.5 0.5 0.1 0.1 0.0 0.1 1.5 1.9 1.8 0.5 0.1 0.1 0.8 0.0 7.3 0.9 0.0 0.6 0.2 1.0 0.2 0.3 0.2 1.0 0.2 0.0 0.1 7.2 1.1 0.0 0.1 0.0 0.0 0.1 3.7 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.2 0.1 0.2 0.1 0.0 4.4 1.7 14.5 4.1 6.5 0.5 1.5 1.9 1.8 7.3 0.2 1.1 0.8 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.6 2.7 0.9 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.1 0.0 0.0 2.4 0.0 0.0 1.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.0 36.4 0.4 1.8 0.0 0.0 9.4 0.0 1.0 0.3 0.0 0.0 67.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.4 0.1 1.9 0.4 0.1 0.1 0.0 0.1 0.0 0.1 RASA3 "GAP1IP4BP, GAPIII" ENSG00000185989 "RAS p21 protein activator 3" Q14644 13 113977783-114132623 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 55.0;Horizontal cells: 60.6;NK-cells: 48.4;Plasma cells: 40.0;T-cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046759 Uncertain NA NA 1400000 "HPA046759: AB_10959887" "unprognostic (3.41e-1)" "unprognostic (1.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.75e-1)" "unprognostic (6.15e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-3)" "unprognostic (4.01e-2)" "unprognostic (3.92e-1)" "unprognostic (2.02e-1)" "unprognostic (1.15e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.99e-6)" "unprognostic (8.98e-2)" "unprognostic (8.16e-3)" "unprognostic (5.08e-2)" "unprognostic (4.11e-2)" 30.6 3.6 7.3 11.0 8.1 12.8 23.4 6.5 9.8 24.5 4.1 14.9 2.9 13.8 1.1 5.0 19.4 4.7 11.6 8.1 7.7 8.3 5.0 19.5 15.7 9.3 8.3 7.0 7.6 10.9 0.7 15.3 5.3 10.8 11.4 2.7 2.7 6.9 3.6 14.3 13.0 15.9 4.8 7.7 22.8 9.5 5.9 9.3 9.1 14.5 4.2 7.8 18.7 15.1 13.7 3.8 4.6 20.2 5.8 19.2 21.3 0.0 14.8 22.1 13.1 10.9 0.4 11.6 0.4 8.2 24.1 10.9 0.0 3.0 7.0 10.1 0.9 1.3 29.4 14.1 0.1 9.7 12.3 2.5 19.2 1.4 12.7 9.1 16.2 22.3 0.6 2.2 3.3 19.9 5.1 27.1 20.5 4.3 3.2 6.8 13.6 7.4 60.6 11.9 0.1 2.9 2.1 3.5 15.2 7.5 8.3 3.8 44.7 30.5 19.7 5.4 7.2 16.2 0.1 0.0 0.8 25.7 11.9 32.1 16.7 4.5 6.4 16.9 7.6 12.8 5.2 15.6 17.0 3.0 3.9 16.3 16.4 2.5 12.7 15.3 1.0 19.2 16.9 7.3 8.1 6.5 9.8 8.1 7.7 9.3 8.3 7.0 10.8 7.7 9.3 13.7 5.3 0.0 4.2 27.1 20.6 3.7 1.2 0.7 2.2 7.9 2.0 4.6 7.5 1.5 3.5 1.8 0.0 0.1 55.0 0.3 0.0 1.1 1.5 7.8 13.3 9.3 3.0 5.5 25.6 2.0 0.2 15.2 3.6 5.1 26.0 1.8 3.9 2.4 9.3 60.6 12.2 2.6 2.0 15.1 12.1 0.7 8.7 19.6 10.6 36.5 11.4 1.3 48.4 17.6 27.5 12.5 0.2 3.8 40.0 1.6 0.1 0.4 13.2 3.5 0.0 18.9 11.5 8.6 5.4 0.4 4.8 0.5 45.2 2.5 0.7 1.6 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 38.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 38.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Intracellular and membrane" NA NA Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 12.4 10.3 7.9 12.1 12.0 8.1 11.5 18.6 9.0 16.3 7.9 14.4 7.1 15.7 7.7 10.8 13.9 10.3 14.6 7.5 10.9 8.3 10.4 12.0 17.1 10.1 9.2 6.5 19.0 9.6 12.3 12.3 10.2 11.1 14.1 10.3 19.4 12.1 12.2 19.5 10.7 12.9 15.0 6.4 14.0 11.3 13.2 9.4 15.6 9.8 11.6 18.8 15.0 13.9 15.7 30.5 10.0 28.8 17.5 28.9 35.2 11.0 21.5 25.6 25.3 31.5 26.0 15.5 16.1 33.5 24.9 40.7 19.1 25.7 21.2 34.5 13.3 14.4 29.8 16.2 19.2 18.9 21.4 19.3 25.0 10.9 24.7 31.9 23.0 30.7 14.7 18.1 27.5 23.4 25.1 15.9 7.8 19.3 15.8 22.3 16.0 17.6 10.6 11.3 19.4 14.2 14.4 28.5 18.5 20.1 26.4 39.0 17.1 30.1 19.4 12.0 24.4 22.2 24.5 26.9 15.2 19.8 28.0 20.3 38.9 4.7 10.1 7.4 6.9 6.0 9.3 5.8 6.3 4.1 6.6 5.3 7.5 2.3 7.1 6.9 3.5 6.1 5.4 7.9 12.0 18.6 9.0 7.5 10.9 10.1 9.2 6.5 11.1 6.4 9.4 15.7 19.2 32.1 27.0 64.6 29.7 10.6 18.1 11.4 8.0 56.0 11.6 8.5 15.4 14.3 17.0 9.2 56.3 8.5 25.8 10.4 1.9 10.1 12.8 12.2 22.9 20.8 6.0 11.1 69.8 9.9 6.6 23.8 10.7 16.4 11.4 23.0 34.6 14.2 9.0 38.7 86.1 11.0 8.2 17.6 17.9 9.6 25.1 14.6 17.8 66.5 30.8 19.8 27.8 102.1 139.2 14.1 9.5 28.6 15.1 15.9 7.1 5.2 15.1 43.1 19.7 31.7 22.8 18.0 17.2 9.4 10.5 6.0 19.9 17.0 11.0 14.7 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205455954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "epididymis: 14.9;testis: 55.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4203.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 39.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "cerebellum: 3.9" HPA045425 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.0 0.3 0.3 0.0 0.2 0.0 0.3 2.6 0.6 0.2 0.0 0.0 0.7 0.3 14.9 0.8 1.6 0.1 0.0 0.1 0.4 1.0 0.0 0.4 0.0 1.9 1.3 0.1 0.6 0.0 0.0 0.5 0.1 2.7 0.2 0.0 1.4 1.9 0.4 0.0 0.3 0.2 0.1 0.2 0.0 0.9 55.5 2.7 0.0 0.6 0.0 0.8 0.1 0.6 1.4 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 39.6 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 2.6 0.6 0.1 0.4 1.9 1.3 0.1 2.7 0.2 2.7 1.4 0.0 0.0 2.6 1.0 0.0 0.0 1.2 8.4 4.6 12.1 1.6 0.9 0.0 0.0 6.4 0.0 4.2 0.1 0.0 0.0 0.0 1.9 968.7 0.8 0.1 0.7 0.0 0.0 1.4 0.7 0.1 0.2 0.0 1.1 0.0 0.6 1.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 4203.7 12.8 1.1 0.0 0.0 0.0 1.3 0.0 1.0 0.5 6.8 0.1 13.9 0.0 8.5 0.3 4.3 1.6 0.7 6.6 0.0 0.4 15.6 9.7 0.7 0.0 0.4 0.1 0.1 0.3 4.4 ATP4B ATP6B ENSG00000186009 "ATPase H+/K+ transporting subunit beta" P51164 13 113648804-113658198 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 328 "stomach 1: 1105.7" "Cell type enriched" "Detected in some" 76 "Gastric mucus-secreting cells: 145.8" "Cancer enriched" "Detected in some" 12 "stomach cancer: 8.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045400, HPA052649" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA045400: AB_2679314, HPA052649: AB_2681900" "unprognostic (9.92e-2)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (4.86e-1)" "unprognostic (6.43e-3)" "unprognostic (7.81e-3)" "unprognostic (1.95e-1)" "unprognostic (3.22e-1)" "unprognostic (6.50e-2)" "unprognostic (6.65e-4)" "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (3.78e-2)" 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 2.9 0.2 0.0 0.0 0.0 0.4 3.3 0.0 0.1 0.2 0.0 0.4 0.1 0.4 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1105.7 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.4 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 145.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2947.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 270.5 250.4 547.9 185.8 555.0 321.6 228.9 569.1 732.0 189.8 572.9 327.0 270.9 131.0 417.6 291.0 255.2 166.5 996.3 536.0 565.8 277.0 303.7 156.1 236.8 560.5 544.4 525.9 169.9 276.6 546.1 155.9 188.2 544.9 218.0 214.4 101.6 275.2 222.5 1103.6 184.6 247.1 195.3 556.4 162.0 253.5 210.1 569.1 256.9 223.2 1112.7 179.9 253.2 104.4 568.0 371.4 405.5 443.7 531.6 460.2 416.2 606.4 345.8 488.3 500.0 492.2 639.4 584.9 442.6 952.2 495.2 261.4 307.2 313.0 477.6 177.3 276.5 1052.6 308.9 590.9 834.1 448.0 601.1 517.0 546.5 483.7 322.7 335.5 296.3 382.8 533.1 428.6 728.2 400.3 1115.4 811.2 880.9 528.4 846.6 1004.4 536.0 263.0 830.2 711.1 782.6 508.9 633.2 350.0 551.7 481.1 225.2 367.7 1035.9 307.3 538.4 177.5 583.8 541.0 543.6 430.6 510.3 428.4 624.2 390.8 1210.3 1162.6 963.4 758.6 1263.4 678.0 1284.6 874.1 838.9 1165.9 1097.3 831.6 775.7 411.9 779.9 1054.3 979.4 1246.2 2090.8 547.9 555.0 569.1 732.0 536.0 565.8 560.5 544.4 525.9 544.9 556.4 569.1 568.0 155.1 131.4 184.8 33.0 194.5 129.0 75.9 346.9 117.8 64.8 211.3 181.2 514.5 224.4 251.2 250.1 25.0 426.6 136.6 951.6 610.5 566.0 411.8 154.5 111.5 131.4 556.3 185.3 22.7 578.5 357.2 173.1 225.3 130.5 259.3 51.3 182.4 422.6 333.6 42.1 27.2 719.7 268.5 307.4 197.9 2947.1 153.4 198.3 263.3 19.7 456.7 186.3 183.4 17.6 41.2 490.5 931.9 129.1 272.0 75.0 1114.7 772.0 236.5 84.2 92.1 91.6 196.2 80.6 111.5 210.0 127.0 498.4 177.5 48.0 683.0 87.4 ZNF566 "FLJ14779, MGC12515" ENSG00000186017 "Zinc finger protein 566" Q969W8 19 36445119-36489902 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023456 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023456: AB_2221143" "unprognostic (1.68e-1)" "unprognostic (6.34e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.89e-3)" "unprognostic (5.71e-4)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (1.92e-2)" "unprognostic (7.56e-2)" "unprognostic (8.19e-4)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (9.48e-2)" "unprognostic (3.00e-1)" "unprognostic (5.47e-3)" 4.0 5.1 5.4 3.6 5.7 3.2 4.2 8.6 6.4 4.6 5.0 4.1 3.2 4.7 4.4 2.9 5.1 3.0 4.3 5.3 5.5 4.0 5.7 3.7 4.3 5.5 5.5 4.9 6.3 3.9 4.7 5.1 2.6 5.7 4.0 2.7 5.5 3.0 3.2 4.7 3.8 4.1 4.2 5.0 4.5 3.7 2.4 5.4 3.5 4.8 6.1 4.3 4.2 3.6 6.6 3.7 9.1 10.3 11.5 7.6 7.6 7.1 7.3 6.2 9.0 9.5 3.8 1.5 7.3 7.7 4.6 4.0 2.6 9.5 2.5 10.1 11.7 7.1 7.3 6.2 3.2 5.4 7.9 8.5 6.6 3.8 4.8 7.3 4.2 3.5 7.5 10.8 0.1 6.3 6.0 10.3 3.8 12.5 6.7 4.0 6.7 8.2 4.9 2.7 7.3 9.7 14.4 8.9 4.9 7.0 4.9 4.4 10.7 3.7 7.8 10.8 3.2 7.0 2.8 8.4 10.0 0.3 5.0 10.5 6.5 1.1 1.6 3.9 1.2 6.5 6.5 5.0 4.9 2.3 5.3 6.0 6.1 1.0 4.0 1.3 1.6 5.6 2.5 5.4 5.7 8.6 6.4 5.3 5.5 5.5 5.5 4.9 5.7 5.0 5.4 6.6 7.6 9.6 7.7 14.0 9.3 3.3 4.2 4.4 7.4 22.3 4.5 3.0 10.2 4.3 7.4 5.5 35.5 6.7 8.4 1.6 11.7 4.5 4.1 4.2 8.1 8.1 3.0 8.0 24.0 2.5 3.2 10.5 3.1 4.0 2.5 10.6 10.0 4.3 4.4 32.0 26.9 4.5 6.1 3.2 3.9 0.6 8.4 3.5 10.6 11.2 2.5 8.6 8.2 14.1 20.7 2.3 4.7 14.7 5.2 5.1 2.8 6.8 4.0 22.2 19.7 12.2 9.6 11.4 5.7 5.7 3.3 1.9 9.3 9.6 4.9 2.8 ZNF529 KIAA1615 ENSG00000186020 "Zinc finger protein 529" Q6P280 19 36534774-36605276 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.6;Horizontal cells: 75.7;Inhibitory neurons: 45.7;Oligodendrocytes: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031311 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031311: AB_10604158" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (8.51e-2)" "unprognostic (7.94e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-3)" "unprognostic (8.67e-2)" "unprognostic (1.30e-2)" "unprognostic (3.84e-3)" "unprognostic (7.10e-2)" "unprognostic (1.05e-3)" "unprognostic (6.61e-3)" "unprognostic (3.37e-2)" "unprognostic (1.45e-2)" "unprognostic (1.00e-1)" "unprognostic (9.64e-2)" "prognostic favorable (1.39e-5)" 5.7 5.9 9.1 5.1 12.0 10.2 6.1 10.6 10.5 6.1 7.0 4.6 3.1 7.0 5.5 3.3 8.1 3.9 7.0 7.8 9.6 3.5 4.5 5.9 7.5 9.7 10.5 8.1 9.0 3.6 6.1 5.8 4.9 11.5 5.1 3.1 20.3 4.2 3.4 5.5 6.7 5.2 4.6 10.8 6.0 4.0 9.3 10.3 6.4 5.7 5.6 6.5 4.8 5.2 15.8 4.0 8.1 11.5 12.3 5.4 6.6 4.5 6.1 3.3 3.4 8.6 4.1 3.1 10.7 7.7 4.9 4.4 1.5 8.7 3.9 6.2 14.4 9.7 13.1 7.6 3.0 6.4 9.9 7.9 8.0 5.0 4.6 6.7 5.8 2.9 8.1 5.5 0.7 7.1 1.1 10.0 3.4 7.5 0.2 3.3 2.9 6.9 4.9 3.0 10.6 5.1 10.4 8.5 2.7 2.6 4.4 3.5 6.0 7.0 7.4 5.3 6.1 7.6 13.2 8.5 9.0 0.2 3.3 5.7 4.7 1.1 1.5 2.3 0.6 3.1 2.9 2.5 2.4 1.2 2.2 2.8 2.2 0.5 2.1 0.7 1.4 3.1 1.2 9.1 12.0 10.6 10.5 7.8 9.6 9.7 10.5 8.1 11.5 10.8 10.3 15.8 10.0 3.2 3.3 23.8 14.1 9.8 5.3 2.9 10.2 19.0 12.3 8.1 14.7 5.7 5.7 7.3 25.0 3.6 11.0 1.4 5.9 3.5 4.5 10.1 8.0 10.0 3.0 14.1 46.6 1.6 2.8 7.9 5.1 9.9 2.5 15.2 7.9 6.9 4.0 75.7 45.7 3.5 4.1 5.1 8.4 2.3 6.5 4.3 5.4 19.7 3.1 7.8 6.2 36.2 61.5 2.2 2.5 6.8 7.2 7.0 1.4 4.5 8.8 22.4 0.0 9.1 7.5 18.0 10.3 8.2 9.1 3.3 11.2 9.9 2.8 6.5 ZNF284 DKFZp781F1775 ENSG00000186026 "Zinc finger protein 284" Q2VY69 19 44072159-44089613 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.88e-2)" "unprognostic (2.51e-1)" "unprognostic (3.50e-1)" "unprognostic (5.59e-2)" "unprognostic (3.36e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-3)" "unprognostic (8.56e-2)" "unprognostic (4.32e-2)" "unprognostic (4.15e-2)" "unprognostic (6.62e-3)" "unprognostic (3.10e-2)" "unprognostic (2.21e-1)" "unprognostic (2.46e-1)" "unprognostic (9.71e-2)" "unprognostic (7.63e-2)" "unprognostic (3.95e-3)" 1.2 1.6 1.6 1.1 1.8 0.7 1.2 2.7 2.0 1.3 1.8 1.2 1.3 1.2 1.4 0.9 1.2 0.8 1.3 1.5 1.6 1.2 1.0 1.2 1.6 1.8 1.6 1.5 1.3 1.2 1.1 1.5 1.0 1.9 1.4 0.7 2.3 1.3 0.7 1.7 3.0 1.5 0.7 1.3 2.1 1.2 0.5 1.6 1.7 1.5 0.5 1.2 1.1 1.3 2.3 0.8 0.7 2.2 4.6 2.2 1.9 1.2 1.3 1.0 0.8 2.4 1.3 0.9 0.1 0.9 1.1 0.5 1.7 1.5 1.1 1.6 0.0 1.4 2.8 4.3 1.2 1.2 0.1 2.0 1.9 1.8 1.4 2.1 3.1 1.0 0.5 0.1 0.3 1.5 0.3 2.3 1.8 2.6 0.7 1.1 0.0 3.8 0.6 1.2 2.0 1.3 3.4 0.1 0.3 0.9 1.5 0.9 1.7 2.4 2.5 4.0 1.0 1.0 3.1 1.9 0.1 1.2 0.1 1.0 1.4 1.0 1.8 2.0 1.4 1.7 1.5 2.0 1.6 1.0 1.6 2.4 2.5 1.0 3.7 0.9 0.8 2.2 0.8 1.6 1.8 2.7 2.0 1.5 1.6 1.8 1.6 1.5 1.9 1.3 1.6 2.3 1.9 3.2 1.1 0.7 1.7 1.9 0.4 0.6 0.0 1.0 1.3 0.9 1.6 1.5 0.3 0.0 2.1 0.8 1.1 1.0 3.9 1.1 0.0 0.4 1.5 2.5 2.4 0.8 1.3 0.4 0.5 1.5 0.5 0.5 1.3 2.2 2.2 0.6 0.8 0.0 1.6 1.4 2.0 2.2 1.0 0.8 1.8 1.3 3.6 0.0 0.9 1.1 1.0 1.0 1.6 1.4 4.2 3.0 1.6 0.7 1.6 2.0 1.0 1.3 6.6 1.0 1.5 0.9 1.5 0.5 1.8 1.0 2.2 1.8 1.1 0.7 HTR3E ENSG00000186038 "5-hydroxytryptamine receptor 3E" A5X5Y0 3 184097064-184106995 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "intestine: 1.0" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 3.5;Inhibitory neurons: 1.1;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.5;Paneth cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "RH-30: 1.3" HPA049764 Enhanced NA NA "HPA049764: AB_2680869" "unprognostic (4.12e-2)" "unprognostic (5.86e-2)" "unprognostic (2.15e-1)" "unprognostic (4.57e-4)" "unprognostic (3.61e-3)" "unprognostic (1.15e-1)" "unprognostic (3.16e-1)" "unprognostic (4.47e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-1)" "unprognostic (4.16e-2)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.5 0.9 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 DLEU7 FLJ44882 ENSG00000186047 "Deleted in lymphocytic leukemia 7" Q6UYE1 13 50519364-50843939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 4.9;choroid plexus: 2.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 25.9;Excitatory neurons: 26.8;Inhibitory neurons: 44.9;Kupffer cells: 35.6;Microglial cells: 35.6;Oligodendrocyte precursor cells: 21.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "NTERA-2: 10.4;U-698: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA053750 Uncertain NA NA "HPA053750: AB_2682249" "unprognostic (3.97e-2)" "unprognostic (2.53e-1)" "unprognostic (7.03e-2)" "unprognostic (9.31e-2)" "unprognostic (3.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-1)" "unprognostic (1.24e-1)" "unprognostic (8.75e-3)" "unprognostic (1.23e-1)" "unprognostic (1.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.59e-1)" "unprognostic (4.52e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" 0.0 0.1 4.0 0.0 4.2 0.0 0.0 3.5 4.8 0.0 2.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 3.9 0.1 0.0 0.0 0.0 4.1 4.2 4.3 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.2 0.1 0.0 0.4 4.2 0.6 0.3 0.1 0.0 0.0 0.1 4.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 10.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 4.0 4.2 3.5 4.8 4.4 3.9 4.1 4.2 4.3 4.9 4.2 4.2 4.2 0.1 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 25.9 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.0 26.8 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 6.8 0.0 44.9 0.0 0.0 35.6 1.4 0.0 0.0 7.1 0.0 35.6 7.6 0.2 0.0 21.1 1.9 0.0 0.0 1.5 0.3 0.0 0.0 0.9 0.0 1.8 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 KRT73 "K6IRS3, KRT6IRS3" ENSG00000186049 "Keratin 73" Q86Y46 12 52607570-52618559 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 16.4" "Cell type enriched" "Detected in some" 5 "NK-cells: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 8.8;naive CD8 T-cell: 3.1" "Lineage enriched" "Detected in single" 13 "T-cells: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA044031 Enhanced NA NA "HPA044031: AB_10963434" "unprognostic (2.23e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (2.12e-3)" "unprognostic (2.11e-3)" "unprognostic (4.94e-1)" 0.2 0.0 0.0 0.7 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 16.4 0.9 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.0 8.8 3.1 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TAL2 bHLHa19 ENSG00000186051 "TAL bHLH transcription factor 2" Q16559 9 105662457-105663124 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 13.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Distal tubular cells: 7.9;Enteroendocrine cells: 3.5;Muller glia cells: 2.7;Proximal tubular cells: 2.3" "Group enriched" "Detected in some" 4 "renal cancer: 1.6;testis cancer: 0.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 6.9;naive B-cell: 7.3" "Lineage enriched" "Detected in many" 4 "B-cells: 7.3" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HAP1: 2.9;K-562: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA030886 Uncertain Approved Cytosol NA NA Cytosol "HPA030886: AB_10601596" "unprognostic (3.89e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "unprognostic (5.54e-2)" "unprognostic (2.24e-1)" "unprognostic (9.06e-2)" "unprognostic (4.98e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-3)" "unprognostic (2.63e-1)" "unprognostic (7.00e-4)" "unprognostic (2.84e-2)" "prognostic favorable (2.69e-4)" "unprognostic (2.70e-2)" "unprognostic (1.24e-1)" "unprognostic (1.29e-1)" "unprognostic (7.39e-2)" 0.1 0.2 0.7 0.1 0.6 0.0 0.1 0.5 0.9 0.2 1.2 0.1 0.0 0.2 0.6 0.1 0.2 0.0 0.2 0.6 0.6 3.1 0.2 0.1 0.2 0.6 0.7 0.4 0.3 0.1 0.0 0.4 0.1 0.7 0.1 0.1 0.5 0.1 0.1 13.8 0.1 0.1 0.0 0.6 0.2 0.1 0.3 0.5 0.1 0.1 2.4 0.3 0.1 0.1 0.8 0.0 0.4 1.5 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.2 2.1 0.1 0.0 0.1 0.0 0.4 0.0 2.9 0.0 0.1 0.4 0.3 0.7 0.0 0.0 0.1 0.3 1.1 0.1 0.3 0.1 0.1 0.1 0.0 0.5 8.2 0.2 0.2 0.2 0.5 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.7 0.1 0.1 0.1 0.0 0.2 1.3 0.3 0.2 0.4 0.4 0.6 0.6 1.2 0.0 0.1 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.1 0.7 0.6 0.5 0.9 0.6 0.6 0.6 0.7 0.4 0.7 0.6 0.5 0.8 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.4 0.1 0.2 0.0 0.0 0.0 4.2 0.0 0.1 0.0 7.9 0.1 0.1 0.0 0.2 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 2.3 0.0 1.0 0.0 0.8 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AIDA "C1orf80, FLJ12806" ENSG00000186063 "Axin interactor, dorsalization associated" Q96BJ3 1 222668013-222713210 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027935 Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Yes No Cytosol "Microtubules, Cytokinetic bridge" "HPA027935: AB_10602226" "unprognostic (2.33e-1)" "prognostic unfavorable (7.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (2.63e-2)" "unprognostic (7.28e-2)" "unprognostic (2.58e-2)" "unprognostic (2.26e-2)" "unprognostic (2.73e-1)" "unprognostic (4.43e-2)" "unprognostic (2.09e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.28e-1)" "unprognostic (2.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" 72.9 36.5 58.1 39.4 67.9 22.1 40.6 61.7 64.6 48.2 55.7 41.0 25.6 36.5 56.5 45.6 31.6 41.2 46.2 56.8 65.6 39.7 49.4 46.6 51.6 68.0 61.9 55.1 41.0 32.8 32.7 21.6 48.2 67.3 35.4 36.5 19.6 28.2 42.5 28.6 26.8 29.2 54.7 64.8 37.7 28.4 44.7 63.7 34.1 37.9 50.2 53.4 47.6 31.5 74.7 74.3 56.2 65.5 70.4 181.2 169.9 71.4 135.7 145.0 95.1 87.0 64.3 62.0 39.5 67.2 161.7 73.4 44.8 81.4 89.9 115.4 59.6 30.0 50.4 64.2 61.9 95.2 62.5 28.4 104.0 78.9 113.4 108.9 102.4 117.8 49.6 77.1 54.3 180.8 27.6 40.9 38.4 163.6 83.9 118.8 43.8 183.9 57.9 110.9 49.7 43.1 72.1 91.0 53.4 83.8 100.3 43.5 38.5 94.1 127.4 62.9 124.9 162.7 40.3 80.4 35.2 118.1 38.7 128.0 5.7 2.8 2.9 5.7 4.4 4.8 14.2 7.2 6.2 2.5 13.8 7.4 5.8 1.6 3.5 5.0 7.2 10.2 4.1 58.1 67.9 61.7 64.6 56.8 65.6 68.0 61.9 55.1 67.3 64.8 63.7 74.7 80.2 22.4 49.9 6.5 57.9 32.5 36.2 19.8 20.5 18.8 20.8 18.0 8.6 27.1 18.7 33.1 33.3 20.6 46.5 19.0 29.4 38.6 20.4 27.1 48.9 52.4 36.1 46.7 8.9 37.9 55.0 52.6 12.8 46.6 3.8 32.4 43.9 36.9 31.5 23.5 11.1 22.4 22.4 37.8 40.2 23.8 60.3 42.5 37.4 30.9 58.9 32.1 38.1 10.6 10.0 51.1 19.8 50.8 32.1 61.2 24.4 54.4 32.8 13.8 32.9 66.1 43.9 35.3 17.9 26.6 30.3 9.0 28.0 32.0 17.8 33.7 CDIN1 "C15orf41, FLJ22851, HH114, MGC11326" ENSG00000186073 "CDAN1 interacting nuclease 1" Q9Y2V0 15 36579626-36810248 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 79.3;tongue: 34.8" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 97.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061023: AB_2684417" "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.7 5.1 2.8 2.4 6.8 0.7 2.9 4.3 3.6 5.1 1.4 4.4 6.7 6.9 1.8 9.5 4.1 4.1 79.3 2.4 3.5 2.8 3.7 2.5 2.4 3.9 3.1 2.4 4.4 2.2 2.4 2.4 2.1 4.3 6.0 3.2 9.7 5.0 6.6 12.1 5.6 3.4 9.6 2.6 2.3 3.3 7.1 3.7 4.2 2.5 34.8 3.6 9.6 8.3 4.9 19.0 10.0 12.4 4.7 13.5 15.6 5.1 8.9 4.5 11.1 9.1 13.9 7.4 3.0 8.8 22.1 8.1 33.8 13.0 7.7 12.7 1.5 9.1 9.9 9.0 10.3 11.8 8.4 7.1 12.0 8.3 9.5 5.2 8.5 10.7 9.6 12.9 3.1 15.4 8.6 2.6 4.9 6.8 8.6 5.1 7.9 3.5 2.0 7.4 25.8 7.1 4.4 5.7 5.5 4.8 9.0 5.5 13.1 7.6 10.8 5.9 7.3 2.5 7.2 11.2 13.7 13.7 15.0 10.2 0.0 0.5 0.3 2.5 1.3 2.2 2.1 1.9 2.4 1.4 2.2 2.3 1.9 0.0 3.3 0.4 1.1 5.1 1.1 2.8 6.8 4.3 3.6 2.4 3.5 3.9 3.1 2.4 4.3 2.6 3.7 4.9 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.6 0.0 0.0 0.0 0.0 8.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 6.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 10.8 0.2 0.0 0.0 0.0 CD300LF "CD300f, CLM1, IGSF13, IREM1, NKIR" ENSG00000186074 "CD300 molecule like family member f" Q8TDQ1 17 74694311-74712978 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.2;lung: 17.8;lymphoid tissue: 29.2" "Group enriched" "Detected in some" 5 "granulocytes: 22.8;Hofbauer cells: 20.6;Kupffer cells: 33.2;Macrophages: 47.0;monocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 234.2" "Group enriched" "Detected in many" 43 "dendritic cells: 63.8;granulocytes: 234.2;monocytes: 193.0" "Group enriched" "Detected in some" 6 "THP-1: 25.6;U-937: 48.6" "Low region specificity" "Detected in some" HPA013712 Supported NA NA "HPA013712: AB_2668874" "unprognostic (6.51e-2)" "unprognostic (1.49e-3)" "unprognostic (3.81e-2)" "unprognostic (4.00e-2)" "unprognostic (8.51e-2)" "unprognostic (6.74e-2)" "unprognostic (1.79e-1)" "unprognostic (3.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (9.60e-2)" "unprognostic (4.14e-2)" "unprognostic (7.75e-2)" "unprognostic (4.79e-2)" 2.0 0.6 1.2 13.7 1.9 27.2 0.8 6.3 4.2 1.3 1.7 3.4 3.8 0.6 0.2 0.5 0.7 2.8 0.5 1.4 2.8 0.6 2.2 17.8 8.9 2.5 2.1 1.0 0.2 0.5 0.4 0.4 1.7 3.1 0.7 3.6 0.2 0.8 0.5 0.3 0.1 3.6 3.4 2.4 29.2 1.6 0.4 2.8 2.0 0.4 0.8 5.4 3.0 0.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 2.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 48.6 0.0 48.4 96.3 234.2 0.3 165.3 0.5 0.2 0.1 0.2 63.8 0.2 0.2 0.1 74.7 3.7 193.0 6.7 0.4 44.8 1.2 1.9 6.3 4.2 1.4 2.8 2.5 2.1 1.0 3.1 2.4 2.8 3.3 0.1 0.0 6.4 0.0 1.3 0.1 0.0 0.1 0.0 0.4 0.1 0.4 0.2 1.5 3.3 0.0 2.1 0.1 2.7 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.0 1.7 2.7 0.0 0.2 0.3 0.0 0.0 22.8 0.0 1.1 0.3 20.6 0.0 2.1 0.1 0.0 33.2 0.7 0.2 0.0 47.0 0.0 3.7 39.9 0.0 1.0 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 ZPBP2 "MGC41930, ZPBPL" ENSG00000186075 "Zona pellucida binding protein 2" Q6X784 17 39868202-39877896 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 100 "testis: 96.2" "Group enriched" "Detected in some" 5 "Early spermatids: 273.9;Spermatocytes: 598.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.3;U-698: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027997, HPA053070" Enhanced "Secreted in male reproductive system" NA NA "HPA027997: AB_1859488, HPA053070: AB_2682033" "unprognostic (2.14e-2)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (2.87e-1)" "unprognostic (5.39e-1)" "unprognostic (2.54e-3)" 0.1 0.1 0.4 0.3 0.3 0.3 0.2 0.8 0.7 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.3 0.0 0.2 0.1 0.7 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.6 0.1 0.1 0.4 0.3 0.1 0.0 0.1 0.3 0.2 96.2 0.3 0.1 0.1 0.1 0.9 0.1 0.0 0.7 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.0 1.3 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.3 0.6 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.3 0.4 0.3 0.3 0.2 0.4 1.0 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.4 0.1 4.9 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.8 0.7 0.4 0.3 0.2 0.1 0.2 0.4 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 273.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.2 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 598.2 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520530 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 5912.0;skin 1: 5932.7;vagina: 2168.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2" "Group enriched" "Detected in many" 4 "cervical cancer: 1863.2;head and neck cancer: 3340.4" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 326 "plasmacytoid DC: 32.6" "Lineage enriched" "Detected in single" 326 "dendritic cells: 32.6" "Group enriched" "Detected in some" 7 "HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8" "Region enriched" "Detected in many" 8 "spinal cord: 36.4" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" NA NA 3600000000 "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034" "prognostic favorable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 10.1 1.7 0.3 1.8 0.9 4.7 255.2 0.7 0.7 408.5 47.2 1.7 0.0 2.1 98.1 5912.0 12.6 2.0 3.5 1.8 0.3 1.3 3.5 6.4 3.1 0.2 0.2 0.2 2.2 4.7 0.1 8.3 2.0 0.3 126.9 0.1 0.0 887.4 101.0 10.0 5932.7 1.8 0.6 0.1 1.8 5.1 2.1 0.7 531.9 3.0 0.3 654.1 94.1 2168.5 0.4 50.6 0.0 0.0 0.0 2.3 0.2 0.8 0.0 0.0 0.0 0.0 1.0 0.3 2.4 0.5 0.2 0.0 3368.0 0.2 5990.5 0.2 0.0 0.0 0.2 0.1 0.0 0.6 1.4 2.8 0.3 13326.8 0.6 1049.7 0.0 0.8 0.0 1.8 4.0 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.2 1.0 1.2 0.8 0.9 0.0 0.1 1.2 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.5 0.2 10.1 1.0 0.9 4.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.1 0.3 0.9 0.7 0.7 1.8 0.3 0.2 0.2 0.2 0.3 0.1 0.7 0.4 1.7 0.0 1.1 0.0 0.4 5870.1 1037.6 627.1 1571.3 0.0 43.6 226.2 0.5 0.0 180.7 0.0 0.0 0.0 39.8 0.0 0.0 0.5 0.8 31.3 1.2 26.4 0.0 0.0 0.5 0.0 0.0 29.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 273.6 0.1 0.6 7.3 286.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 22.2 789.7 0.0 0.1 34.8 0.0 0.0 0.2 33.4 0.0 0.0 4370.9 2020.2 0.0 17.8 0.0 0.1 459.8 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.2;Microglial cells: 1.0" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HeLa: 1.9;K-562: 11.6;SK-BR-3: 2.4;SK-MEL-30: 1.9" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 1.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.9 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSAP "LOC54103, PION" ENSG00000186088 "Gamma-secretase activating protein" A4D1B5 7 77310751-77416349 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;NK-cells: 110.2;Oligodendrocyte precursor cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 12.5;U-937: 17.0" "Region enhanced" "Detected in all" "cerebellum: 15.5" "Low region specificity" "Detected in all" HPA023994 Approved Vesicles NA NA Vesicles "HPA023994: AB_1855386" "prognostic favorable (3.36e-4)" "unprognostic (3.70e-1)" "unprognostic (8.55e-3)" "unprognostic (4.53e-3)" "unprognostic (6.80e-3)" "unprognostic (3.52e-3)" "unprognostic (4.36e-2)" "unprognostic (7.18e-3)" "unprognostic (1.09e-1)" "unprognostic (9.98e-3)" "unprognostic (2.07e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (3.61e-1)" "unprognostic (1.82e-2)" "unprognostic (9.49e-2)" "prognostic favorable (4.15e-5)" 5.4 5.3 2.4 11.0 2.1 9.4 6.0 1.8 3.5 3.7 3.1 4.3 2.6 4.0 3.8 3.1 6.5 8.0 5.0 2.3 3.8 6.4 16.5 18.6 13.2 3.2 2.6 1.5 3.7 5.5 11.9 7.4 3.8 3.2 5.5 4.7 11.0 4.8 5.1 2.0 4.5 7.6 3.8 3.2 18.9 7.9 2.0 3.3 6.1 8.4 3.9 13.1 6.0 2.3 4.1 3.8 2.0 0.0 0.0 0.5 2.4 0.4 2.3 7.7 1.2 3.2 0.6 5.4 0.8 0.2 0.1 4.3 1.8 0.1 1.9 3.4 2.5 1.6 4.1 0.2 10.7 3.3 0.3 0.0 0.9 7.0 6.2 12.5 9.2 0.5 0.0 0.1 0.3 10.5 2.1 0.0 8.2 0.6 6.0 2.7 0.0 0.2 0.2 6.9 3.2 0.2 5.7 2.5 1.2 6.3 0.5 2.3 3.4 0.0 2.0 1.4 0.2 7.1 1.5 0.1 1.4 8.8 17.0 1.6 0.0 13.3 1.4 8.5 12.7 5.2 18.6 2.8 6.0 16.3 16.4 3.6 6.1 1.7 16.7 9.4 0.4 0.1 8.2 2.4 2.1 1.8 3.5 2.3 3.8 3.2 2.6 1.5 3.2 3.2 3.3 4.1 15.2 76.9 60.8 29.0 53.3 5.2 11.6 19.3 13.6 17.0 12.5 9.8 8.5 11.5 22.8 3.7 16.7 3.2 60.5 0.7 25.4 8.5 0.1 10.2 1.6 9.2 5.4 4.4 28.2 6.2 0.7 4.9 9.7 15.8 13.3 9.8 3.3 17.2 9.7 20.2 51.9 6.1 10.2 38.2 23.3 0.2 5.3 46.5 8.8 42.2 30.8 41.6 110.2 72.4 12.7 6.8 4.6 3.8 15.4 20.0 1.4 12.0 9.8 20.9 6.6 9.8 3.2 2.5 1.5 8.6 4.5 1.6 22.8 2.0 4.6 17.2 HTR3D ENSG00000186090 "5-hydroxytryptamine receptor 3D" Q70Z44 3 184031544-184039369 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F5 ENSG00000186092 "Olfactory receptor family 4 subfamily F member 5" Q8NH21 1 65419-71585 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGBL4 "CCP6, FLJ14442" ENSG00000186094 "ATP/GTP binding protein like 4" Q5VU57 1 48532854-50023954 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.9;retina: 6.0" "Group enriched" "Detected in some" 5 "Excitatory neurons: 1232.8;Inhibitory neurons: 630.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;SCLC-21H: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037994 Approved NA NA "HPA037994: AB_10673036" "unprognostic (3.06e-2)" "unprognostic (2.76e-1)" "unprognostic (2.58e-2)" "unprognostic (3.31e-4)" "unprognostic (3.42e-4)" "unprognostic (1.72e-1)" "unprognostic (3.86e-3)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (5.85e-3)" "unprognostic (3.91e-2)" "unprognostic (1.51e-4)" "unprognostic (5.95e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.85e-1)" 0.4 1.6 2.7 0.1 2.8 0.2 0.4 0.3 5.9 0.2 2.2 0.1 0.0 0.2 0.8 0.1 2.9 0.1 1.4 2.3 1.4 3.9 1.6 0.4 0.1 0.0 0.6 2.9 0.3 0.8 2.4 2.4 0.9 0.8 0.1 0.1 6.0 0.1 0.4 0.1 0.3 0.1 0.0 0.0 0.3 0.2 2.4 0.4 0.4 1.1 0.1 0.1 0.0 0.1 3.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.7 2.8 0.3 5.9 2.3 1.4 0.0 0.6 2.9 0.8 0.0 0.4 3.1 0.2 0.0 0.0 166.2 0.0 0.3 1.0 0.3 0.0 4.0 0.4 1.1 2.2 0.0 0.9 3.7 85.5 0.2 0.0 0.4 1.9 0.1 12.6 10.7 0.1 0.4 6.0 0.0 1232.8 0.2 0.1 0.5 0.0 0.2 0.0 0.2 0.4 0.1 0.1 5.0 630.3 0.5 2.0 0.0 0.0 9.1 0.3 0.0 0.0 40.3 0.0 2.4 0.0 142.2 19.2 0.0 0.1 0.7 0.0 0.3 0.0 4.4 10.5 22.6 0.0 0.7 0.3 19.9 10.4 0.0 0.0 0.1 0.0 0.4 0.1 0.2 ARGFX ENSG00000186103 "Arginine-fifty homeobox" A6NJG6 3 121567949-121590622 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5" "Cancer enriched" "Detected in single" 119 "testis cancer: 6.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.7" HPA043049 Uncertain NA NA "HPA043049: AB_2678288" "unprognostic (6.00e-2)" 0.1 0.2 0.7 0.3 0.7 1.2 0.3 2.0 1.1 0.0 0.6 0.1 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.8 0.3 0.1 0.1 0.1 0.4 0.7 0.3 1.1 0.2 0.4 0.1 0.0 0.2 1.2 0.2 0.2 0.6 0.4 0.1 0.5 0.8 0.3 0.1 0.2 0.3 0.4 0.3 0.6 0.1 0.3 0.1 0.3 0.1 0.0 1.9 0.1 0.2 0.3 0.3 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.3 0.4 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.2 0.3 0.3 0.6 0.3 0.1 0.5 0.9 0.1 0.5 0.1 0.1 0.2 0.0 0.4 0.3 0.8 0.0 0.3 0.2 0.5 0.4 0.1 0.1 0.3 0.2 0.2 0.2 0.5 0.3 0.3 0.2 1.7 0.1 0.3 0.2 0.2 0.4 0.4 0.3 0.4 0.1 0.5 0.2 0.4 0.3 0.3 0.2 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.8 0.6 0.3 0.4 0.2 0.1 0.7 0.7 2.0 1.1 0.8 0.3 0.7 0.3 1.1 1.2 0.2 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP2R1 ENSG00000186104 "Cytochrome P450 family 2 subfamily R member 1" Q6VVX0 11 14877440-14892231 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 176.3;Late spermatids: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042949 Approved "Intracellular and membrane" NA NA "HPA042949: AB_2678237" "unprognostic (1.62e-2)" "unprognostic (1.82e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-3)" "unprognostic (2.67e-1)" "unprognostic (2.19e-1)" "unprognostic (3.23e-2)" "unprognostic (7.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.90e-2)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.01e-1)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" 2.3 1.8 1.5 3.1 1.9 3.1 4.2 5.0 2.4 2.4 0.8 3.5 4.7 2.2 3.2 4.6 1.8 1.6 2.2 1.7 1.8 1.8 2.3 2.5 3.0 1.7 1.9 1.8 2.0 5.2 1.5 2.6 1.0 2.5 2.8 3.3 3.3 4.6 1.4 2.8 7.0 4.4 1.5 1.7 3.1 5.0 4.4 1.7 2.5 1.9 1.6 2.9 3.0 3.3 2.3 6.1 3.7 3.6 1.5 1.5 2.5 0.0 2.1 1.1 1.2 1.3 4.3 6.8 7.6 1.6 0.4 4.7 0.0 1.2 2.8 0.5 6.3 5.8 3.4 4.7 0.3 5.4 5.9 3.4 2.4 10.6 0.0 4.4 1.1 1.4 9.3 5.1 26.0 0.8 1.6 6.5 11.9 3.4 4.4 3.5 4.6 2.6 11.6 1.4 0.7 3.0 4.7 4.5 5.4 5.2 2.3 4.0 2.2 3.8 3.6 4.4 2.2 2.7 12.8 16.1 9.0 5.0 7.6 3.3 2.4 2.0 1.6 3.0 1.9 4.7 1.6 2.5 1.9 1.7 2.8 3.5 3.0 0.3 2.1 2.3 2.0 3.6 1.2 1.5 1.9 5.0 2.4 1.7 1.8 1.7 1.9 1.8 2.5 1.7 1.7 2.3 4.4 12.8 4.8 8.5 15.4 5.9 13.9 9.3 12.5 1.9 7.0 5.8 4.3 8.6 7.4 5.5 6.2 0.3 9.8 10.1 5.9 8.1 176.3 1.9 3.3 6.7 6.7 4.6 13.1 16.9 0.2 4.4 14.8 3.9 3.8 7.8 5.0 6.0 5.9 1.7 18.4 5.5 0.0 7.6 12.6 106.7 2.1 7.7 14.2 13.1 6.1 5.0 13.4 14.6 13.3 11.3 2.9 4.1 11.9 6.4 12.6 6.2 2.8 5.0 13.1 3.2 4.9 23.8 20.2 20.4 6.7 0.0 16.4 6.7 8.8 6.1 LRRC70 "LOC100130733, SLRN" ENSG00000186105 "Leucine rich repeat containing 70" Q7Z2Q7 5 62578819-62581446 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Adipocytes: 3.6;Endothelial cells: 4.9;Erythroid cells: 1.7;Fibroblasts: 1.8;granulocytes: 3.8;Hepatic stellate cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HUVEC TERT2: 17.6;TIME: 9.6" "Low region specificity" "Detected in all" HPA013409 Uncertain NA NA 17000 "HPA013409: AB_10601911" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (4.04e-1)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.17e-4)" "unprognostic (3.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.60e-1)" "unprognostic (2.19e-1)" "unprognostic (4.15e-1)" "unprognostic (7.40e-4)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 4.7 0.9 0.5 1.4 0.5 3.7 4.7 0.6 1.2 3.5 0.6 1.3 0.8 1.9 1.0 1.7 3.4 3.6 1.4 0.5 0.9 1.9 1.4 1.9 1.9 0.8 0.6 0.4 2.9 0.9 1.2 1.5 4.6 0.6 2.0 1.4 1.0 1.2 0.5 0.7 2.6 1.4 3.4 0.7 4.1 1.1 1.7 0.6 1.0 4.1 0.6 0.7 1.7 2.9 0.9 0.2 0.0 0.2 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 17.6 0.3 0.2 0.7 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 9.6 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.5 0.5 0.6 1.2 0.5 0.9 0.8 0.6 0.4 0.6 0.7 0.6 0.9 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.1 0.1 4.9 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.1 3.8 0.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.4 0.3 0.0 0.3 0.0 0.0 0.0 ANKRD46 ENSG00000186106 "Ankyrin repeat domain 46" Q86W74 8 100509752-100559784 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013758 Approved Approved Cytosol NA NA Cytosol "HPA013758: AB_10962626" "unprognostic (3.71e-3)" "unprognostic (9.01e-2)" "unprognostic (2.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (2.63e-1)" "unprognostic (8.84e-2)" "unprognostic (4.79e-2)" "unprognostic (3.56e-1)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "unprognostic (8.08e-3)" "unprognostic (5.29e-2)" "unprognostic (1.82e-1)" "unprognostic (1.81e-2)" "unprognostic (6.29e-3)" 19.3 39.1 30.8 8.5 34.9 2.2 14.7 29.5 37.2 15.2 19.5 9.3 10.3 12.8 16.5 12.8 11.5 7.7 20.2 32.7 33.1 33.0 41.9 10.8 10.0 28.2 28.0 33.8 22.8 18.7 16.2 10.4 21.0 27.9 13.6 9.2 35.5 17.3 13.3 62.8 11.3 11.1 12.5 27.3 11.2 11.7 8.3 27.2 15.5 20.2 36.5 11.0 9.6 9.9 36.8 10.0 12.2 17.9 10.1 13.6 8.0 20.0 12.8 5.8 9.6 8.1 17.8 5.9 31.2 23.3 4.4 3.1 7.5 18.5 9.5 10.1 11.2 16.3 39.0 6.4 14.1 7.7 9.3 4.7 5.8 17.1 6.1 10.2 10.3 11.9 21.4 20.8 9.9 9.3 11.4 43.3 16.8 13.1 25.6 9.0 33.1 6.0 21.0 14.1 10.6 19.8 20.1 5.5 9.9 8.5 21.5 14.8 15.7 9.0 4.4 4.9 6.5 5.1 23.0 23.8 25.7 4.8 29.6 7.2 16.4 7.3 7.6 14.4 3.7 17.1 12.7 13.5 12.4 9.6 11.1 17.5 15.2 1.8 16.9 6.8 8.8 13.8 10.9 30.8 34.9 29.5 37.2 32.7 33.1 28.2 28.0 33.8 27.9 27.3 27.2 36.8 11.5 6.4 3.9 17.9 14.2 10.8 11.3 9.0 19.4 30.1 10.7 7.4 13.1 12.8 4.8 22.0 18.8 32.1 12.2 5.7 29.4 8.3 1.2 4.6 6.7 12.5 7.3 12.2 41.5 6.0 14.1 11.9 9.7 4.7 4.5 13.8 21.8 34.6 11.4 67.3 36.9 7.6 2.0 6.7 9.3 2.2 21.1 4.0 10.6 24.4 8.1 46.4 10.3 24.1 23.4 3.3 9.1 26.4 13.8 10.5 20.3 61.8 6.5 31.5 26.3 15.1 12.8 14.4 17.2 13.9 14.2 23.4 9.3 11.9 8.5 9.6 PIP5K1C "KIAA0589, LCCS3, PIP5Kgamma" ENSG00000186111 "Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma" O60331 19 3630183-3700468 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Bipolar cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "U-2197: 75.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017168 Approved Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA017168: AB_1855395" "unprognostic (1.20e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.36e-3)" "prognostic favorable (7.28e-5)" "unprognostic (7.03e-2)" "unprognostic (4.02e-3)" "unprognostic (5.80e-3)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (2.57e-3)" "prognostic favorable (2.32e-4)" "unprognostic (1.51e-1)" "prognostic favorable (3.00e-4)" "unprognostic (2.25e-1)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" 21.6 15.8 30.8 11.6 29.6 3.4 19.4 17.7 65.4 23.9 0.0 48.1 8.6 45.3 7.6 20.4 30.1 8.2 30.8 40.6 5.9 15.9 8.8 22.8 6.6 14.5 9.2 25.4 22.4 18.1 10.8 20.8 11.3 37.9 34.2 4.6 13.3 18.3 25.4 17.9 15.7 24.3 16.1 1.4 22.6 30.0 61.9 20.9 5.3 21.3 4.9 4.3 39.8 24.9 33.2 18.9 18.0 13.4 18.0 25.5 21.0 20.3 36.1 22.4 15.2 12.3 16.1 5.2 7.8 13.6 39.0 16.5 16.4 6.5 11.7 6.2 28.7 11.9 9.0 15.0 13.1 22.0 9.4 26.7 23.7 9.9 12.4 4.1 9.9 25.6 11.5 14.1 13.5 14.4 15.7 11.2 6.6 14.4 6.8 24.6 21.4 7.2 11.2 11.5 15.9 13.7 12.0 18.7 10.1 11.1 16.6 7.9 14.1 57.3 21.3 11.8 75.1 17.0 16.0 14.3 3.5 27.6 19.2 15.0 1.0 0.7 0.0 0.7 0.5 0.2 0.6 0.5 0.4 0.8 0.3 0.2 0.4 0.5 0.5 0.8 0.5 0.4 0.6 30.8 29.6 17.7 65.4 40.6 5.9 14.5 9.2 25.4 37.9 1.4 20.9 33.2 20.3 6.4 5.0 8.8 6.2 5.4 3.0 6.1 7.4 56.8 9.6 6.6 7.5 7.2 3.0 16.5 37.5 7.8 10.6 12.2 1.9 7.9 11.6 6.4 29.0 22.1 8.4 2.1 30.6 7.1 7.4 10.7 7.1 11.6 1.3 10.7 16.1 4.0 15.7 30.3 17.9 9.7 6.1 19.6 13.2 24.0 14.9 15.5 5.4 22.5 15.0 14.3 11.3 9.0 6.8 12.1 13.2 24.0 5.7 4.4 7.2 6.4 4.1 26.8 13.1 8.4 10.4 18.6 11.8 7.8 6.8 16.4 8.0 11.9 7.2 5.3 OR5D14 ENSG00000186113 "Olfactory receptor family 5 subfamily D member 14" Q8NGL3 11 55795556-55796500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4F2 ENSG00000186115 "Cytochrome P450 family 4 subfamily F member 2" P78329 19 15878023-15898077 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 80.9;kidney: 41.3;liver: 168.1" "Group enriched" "Detected in some" 4 "Hepatocytes: 139.7;Proximal enterocytes: 204.6" "Cancer enriched" "Detected in some" 9 "liver cancer: 29.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 19 "basophil: 8.1" "Lineage enriched" "Detected in single" 82 "granulocytes: 8.1" "Cell line enriched" "Detected in single" 4 "Hep G2: 3.8" "Low region specificity" "Detected in all" "HPA014048, HPA017265, HPA058960" Supported "Intracellular and membrane" NA NA "HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862" "unprognostic (7.46e-3)" "unprognostic (3.58e-1)" "unprognostic (3.01e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" "unprognostic (2.87e-2)" "unprognostic (4.55e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (4.64e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (8.69e-4)" "unprognostic (3.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.79e-3)" 0.0 0.0 0.3 0.1 0.0 1.1 0.2 0.1 0.2 0.0 0.4 2.2 80.6 0.0 26.0 0.2 0.0 3.3 0.0 0.2 0.2 41.3 168.1 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 6.7 0.9 0.0 0.0 0.1 0.0 0.8 80.9 0.0 0.4 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 12.3 1.9 0.1 5.8 0.0 0.0 0.1 1.8 5.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.4 139.7 0.0 0.0 0.0 8.9 0.0 3.8 0.0 18.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.5 204.6 37.7 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.0 0.1 0.0 0.2 0.1 5.6 0.2 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 416 "testis: 391.6" "Group enriched" "Detected in some" 52 "Early spermatids: 2382.9;Late spermatids: 5035.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073711 Approved Vesicles NA NA Vesicles "HPA073711: " "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.1 0.2 0.2 0.0 0.3 0.2 0.4 0.3 0.4 0.1 0.0 0.1 0.0 0.2 0.9 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.2 0.6 0.8 0.2 0.3 0.5 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.2 391.6 0.2 0.1 0.4 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.3 0.2 0.4 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.3 0.4 0.2 0.2 0.2 0.1 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2382.9 0.2 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5035.0 28.3 1.5 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 18.4 0.1 0.0 0.0 0.0 0.0 0.3 6.6 0.1 0.0 71.0 14.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR5D18 ENSG00000186119 "Olfactory receptor family 5 subfamily D member 18" Q8NGL1 11 55819607-55820597 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB6 "ZID, ZNF482" ENSG00000186130 "Zinc finger and BTB domain containing 6" Q15916 9 122908056-122913323 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054111, HPA076894" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA054111: AB_2682384, HPA076894: AB_2686818" "unprognostic (9.74e-3)" "unprognostic (8.40e-2)" "unprognostic (1.45e-2)" "unprognostic (7.84e-2)" "prognostic favorable (2.06e-5)" "unprognostic (1.81e-1)" "unprognostic (2.39e-3)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (6.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "prognostic favorable (5.08e-4)" "unprognostic (4.31e-2)" "unprognostic (1.53e-1)" "unprognostic (2.67e-1)" "unprognostic (1.92e-2)" 4.3 4.5 4.2 7.1 4.7 3.3 6.9 6.0 5.9 5.5 3.6 5.3 5.9 6.3 4.1 5.0 5.0 4.0 5.5 4.1 4.4 4.8 4.2 4.6 9.8 4.2 4.5 3.8 7.3 4.6 6.7 2.4 4.6 4.5 4.9 4.9 7.3 4.5 4.8 6.8 5.0 5.8 4.7 4.5 6.8 5.6 5.5 4.3 7.4 7.6 7.0 9.3 5.4 2.6 6.1 5.1 5.9 9.3 8.5 9.6 9.2 9.4 8.4 10.3 8.3 7.3 6.1 6.3 8.1 5.1 7.6 7.4 22.8 9.8 10.3 10.3 11.5 7.8 8.6 11.9 5.7 9.5 11.4 14.9 7.6 15.5 7.6 12.5 10.2 7.7 10.1 9.2 9.7 12.1 9.6 11.6 7.7 11.7 15.0 9.9 6.1 25.6 11.4 8.7 8.3 11.7 15.2 13.0 12.6 8.2 9.8 15.8 7.4 7.9 9.0 7.0 9.2 9.8 17.0 21.7 2.2 10.5 7.7 9.3 10.6 1.5 2.3 1.2 1.7 1.7 1.4 1.7 1.2 1.6 1.0 2.4 2.2 2.0 2.5 2.9 0.9 2.0 1.7 4.2 4.7 6.0 5.9 4.1 4.4 4.2 4.5 3.8 4.5 4.5 4.3 6.1 5.3 6.4 3.6 3.6 6.8 2.2 3.1 2.9 3.4 8.0 4.1 2.9 3.5 7.2 6.9 1.8 10.4 2.3 7.2 3.5 0.0 2.7 9.1 4.4 7.6 4.4 3.0 2.1 4.6 2.5 1.3 5.4 4.1 3.7 7.6 5.0 6.1 3.1 2.4 6.7 5.1 3.9 4.1 7.6 4.0 4.4 3.1 4.1 1.8 3.7 4.3 8.8 2.1 6.6 6.8 2.9 2.5 7.9 3.7 4.1 2.9 4.2 5.3 10.6 6.6 5.1 5.2 6.0 5.1 4.9 2.7 1.9 5.8 5.0 3.4 3.2 C2orf76 "AIM29, LOC130355, MGC104437" ENSG00000186132 "Chromosome 2 open reading frame 76" Q3KRA6 2 119302225-119366834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044977, HPA055362" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044977: AB_10961918, HPA055362: AB_2682794" "unprognostic (4.29e-1)" "unprognostic (2.07e-1)" "unprognostic (5.40e-3)" "unprognostic (1.04e-1)" "unprognostic (1.16e-2)" "unprognostic (2.20e-2)" "unprognostic (1.47e-3)" "unprognostic (5.51e-2)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (4.77e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (3.42e-2)" "unprognostic (2.91e-2)" "unprognostic (7.55e-2)" "unprognostic (9.19e-2)" 20.4 19.9 24.7 10.3 25.2 10.1 22.6 25.7 29.8 13.1 23.4 11.8 7.0 17.2 43.8 16.3 20.7 12.7 16.3 23.9 26.4 20.1 14.2 10.0 15.4 26.0 24.9 23.7 18.0 15.9 20.8 10.8 11.4 26.0 16.1 11.9 9.5 16.1 15.5 10.4 20.7 7.7 16.8 26.2 11.0 11.4 19.5 24.9 13.7 20.7 14.6 14.1 14.1 11.0 28.4 17.0 15.7 22.4 14.3 31.7 38.3 12.8 23.4 16.7 15.0 16.3 10.1 11.3 20.7 40.6 24.7 17.4 7.8 10.1 14.9 15.0 17.7 33.5 39.1 11.7 13.5 21.8 15.0 24.6 20.4 25.3 21.3 13.8 19.3 21.7 15.7 12.6 19.6 22.5 25.7 15.7 28.5 12.4 13.3 12.4 9.6 4.7 29.1 33.9 18.0 14.8 16.7 17.0 24.1 33.7 21.0 13.2 52.5 20.3 17.4 13.5 14.6 12.7 12.8 22.5 22.1 17.5 11.1 20.0 29.1 20.9 21.9 19.9 20.2 18.0 20.0 15.2 18.3 21.3 14.7 13.8 19.3 37.2 32.5 12.7 20.1 16.8 11.9 24.7 25.2 25.7 29.8 23.9 26.4 26.0 24.9 23.7 26.0 26.2 24.9 28.4 30.3 6.4 11.4 22.5 11.1 25.0 17.2 47.7 17.1 3.3 18.5 19.7 18.5 12.8 24.4 14.7 0.0 26.4 15.2 7.1 78.2 14.7 11.7 27.6 15.4 20.4 10.9 16.4 12.4 17.8 32.4 20.7 9.7 19.7 22.2 8.4 15.0 11.6 26.7 1.7 8.6 11.2 22.4 15.0 23.4 7.7 19.3 13.8 44.4 12.2 20.6 19.8 26.8 14.6 25.2 14.0 9.2 17.0 8.9 11.8 12.2 47.0 42.8 4.6 6.6 13.8 18.8 38.8 22.4 18.8 35.7 20.7 15.3 11.4 10.0 13.0 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POLR3C "C82, RPC3, RPC62" ENSG00000186141 "RNA polymerase III subunit C" Q9BUI4 1 145824088-145844402 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 16 "Early spermatids: 288.2;Late spermatids: 574.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027508, HPA027516" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA027508: AB_10600091, HPA027516: AB_10600894" "unprognostic (1.43e-2)" "unprognostic (1.70e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.87e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.13e-1)" "unprognostic (1.41e-2)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.34e-1)" "unprognostic (4.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.38e-1)" 15.5 8.6 5.4 10.6 5.7 14.8 15.3 9.2 6.6 14.0 5.2 11.6 8.1 13.5 9.4 11.1 12.4 11.0 9.7 5.9 5.4 9.9 10.8 9.8 14.2 5.1 5.3 5.5 16.2 14.7 12.0 6.3 10.5 5.7 9.7 11.3 8.0 12.5 8.4 14.8 15.0 11.9 13.2 5.3 12.7 11.4 25.0 5.6 15.4 11.5 10.4 15.7 13.1 12.3 6.6 29.9 23.7 19.0 17.6 23.0 29.3 19.8 30.6 31.5 36.2 34.9 32.6 16.4 51.6 28.9 37.2 19.5 31.6 30.6 30.5 34.9 22.7 24.9 27.9 26.5 17.6 42.1 58.4 35.2 29.3 18.9 42.4 61.7 20.8 21.8 22.0 36.3 30.9 35.6 37.2 27.7 22.1 29.0 29.3 29.7 30.1 23.6 34.1 19.7 20.6 18.2 26.4 26.0 37.5 36.7 28.5 29.5 49.6 26.7 34.0 27.4 19.6 41.9 42.9 48.1 58.8 12.4 28.4 28.3 63.0 31.7 31.9 22.5 36.9 29.5 30.4 24.2 23.3 33.9 33.8 25.1 22.7 2.7 34.0 27.0 35.6 23.3 26.1 5.4 5.7 9.2 6.6 5.9 5.4 5.1 5.3 5.5 5.7 5.3 5.6 6.6 12.6 6.4 10.8 12.1 15.6 5.0 8.3 8.8 13.1 3.6 5.5 5.2 23.8 2.8 10.1 3.7 4.2 11.7 18.5 3.5 11.7 14.8 288.2 7.8 7.3 11.2 4.2 19.1 13.0 21.3 12.5 11.0 9.2 7.5 8.2 6.9 9.3 5.2 14.3 1.7 12.4 7.5 8.2 12.6 6.2 574.5 10.2 9.4 1.8 10.3 13.3 5.1 10.3 14.1 12.9 16.5 6.8 14.7 12.2 8.4 8.9 12.8 8.1 3.8 19.7 11.0 9.9 26.1 22.5 10.9 4.3 9.6 13.4 11.1 8.5 9.5 PRR30 "C2orf53, MGC44505" ENSG00000186143 "Proline rich 30" Q53SZ7 2 27136848-27139410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1001 "testis: 148.8" "Group enriched" "Detected in some" 48 "Early spermatids: 646.9;Late spermatids: 773.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 646.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 773.6 5.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131A "DEFB-31, DEFB131" ENSG00000186146 "Defensin beta 131A" P59861 4 9444534-9450514 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "epididymis: 168.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 18 "thyroid cancer: 1.3" "Region enhanced" "Detected in some" "pons: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "TIME: 2.1" "Secreted in other tissues" NA NA "unprognostic (2.11e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 15.1 0.0 168.8 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 14.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 1.1 0.2 0.1 1.9 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBL4B FLJ25690 ENSG00000186150 "Ubiquitin like 4B" Q8N7F7 1 110112443-110113947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 105.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 6512.1" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA031364 Enhanced NA NA "HPA031364: AB_10604000" "unprognostic (2.92e-1)" "unprognostic (3.48e-2)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-2)" "unprognostic (3.43e-2)" "unprognostic (6.87e-3)" "unprognostic (4.46e-1)" "unprognostic (2.20e-9)" "unprognostic (3.29e-2)" "unprognostic (7.39e-2)" "unprognostic (1.59e-4)" "unprognostic (3.90e-2)" 0.3 0.0 1.0 0.0 0.6 0.0 0.6 0.4 1.3 0.1 2.9 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.1 0.5 1.6 0.5 0.1 0.0 0.0 1.1 0.0 0.6 0.2 0.0 0.1 0.4 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 105.8 2.2 0.0 0.0 0.7 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.4 1.3 0.6 1.1 0.5 1.6 0.5 0.6 0.3 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1490.4 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6512.1 29.2 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.5 0.0 51.6 18.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 WWOX "FOR, SDR41C1, WOX1" ENSG00000186153 "WW domain containing oxidoreductase" Q9NZC7 16 78099430-79212667 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" Oxidoreductase "Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050992 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA050992: AB_2681299" "prognostic unfavorable (9.07e-5)" "unprognostic (1.14e-2)" "unprognostic (1.92e-1)" "unprognostic (9.27e-2)" "unprognostic (2.32e-1)" "unprognostic (1.81e-1)" "unprognostic (6.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (4.33e-2)" "unprognostic (3.50e-2)" "prognostic favorable (4.49e-5)" "unprognostic (3.75e-1)" "unprognostic (1.78e-1)" "unprognostic (2.36e-2)" "unprognostic (1.77e-1)" 8.7 6.4 21.6 4.0 22.0 4.2 7.5 23.2 20.2 8.1 19.0 4.8 5.4 8.3 10.2 7.7 9.1 7.5 5.2 17.3 29.2 12.8 12.1 5.3 4.7 22.7 20.9 15.5 7.7 8.3 12.2 9.9 5.3 23.3 7.7 3.2 6.9 8.6 6.5 3.3 7.0 4.5 5.1 22.1 4.7 6.1 9.4 20.1 9.1 22.0 2.1 6.1 6.8 7.1 29.4 11.1 9.5 9.2 7.7 11.0 5.3 11.1 1.6 3.2 3.7 3.2 7.0 9.6 19.5 8.6 1.5 5.2 10.0 5.1 1.3 2.6 11.0 26.8 6.0 1.9 15.7 7.5 16.7 3.4 5.9 3.8 2.3 2.4 0.9 4.4 25.9 9.2 4.2 2.6 85.7 27.7 21.9 8.6 5.9 5.7 32.2 3.9 19.1 5.3 3.9 17.6 10.0 7.1 11.9 4.0 9.3 12.8 12.0 1.6 2.7 10.4 2.2 6.4 0.0 18.3 41.2 10.4 8.4 4.6 7.0 9.1 2.1 11.4 7.9 13.4 9.3 8.2 9.1 7.7 6.6 8.4 8.3 0.7 9.1 5.8 14.5 13.5 6.0 21.6 22.0 23.2 20.2 17.3 29.2 22.7 20.9 15.5 23.3 22.1 20.1 29.4 12.0 6.4 6.9 927.8 9.0 9.2 21.2 8.0 19.4 7.4 12.1 16.1 8.8 17.2 13.3 14.7 4.2 25.7 10.9 4.5 33.2 12.4 43.1 18.2 13.9 9.5 9.6 13.3 270.5 10.3 11.9 12.0 9.2 7.6 12.7 18.7 13.2 18.9 9.2 5.0 540.9 5.1 0.0 5.6 5.7 38.2 14.0 7.7 5.4 471.2 5.9 46.3 9.2 914.9 793.5 4.5 5.9 17.7 18.4 11.5 8.7 28.3 18.7 12.2 6.6 10.3 11.8 19.7 17.9 13.3 6.8 17.4 9.9 12.1 6.8 13.0 CYP4Z1 CYP4A20 ENSG00000186160 "Cytochrome P450 family 4 subfamily Z member 1" Q86W10 1 47067231-47118318 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 6.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Breast glandular cells: 8.3;Early spermatids: 2.5;Excitatory neurons: 8.3;Inhibitory neurons: 5.8" "Cancer enriched" "Detected in some" 50 "breast cancer: 42.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "HDLM-2: 8.1;SK-BR-3: 3.2" NA NA "unprognostic (4.11e-2)" "unprognostic (2.57e-2)" "unprognostic (2.46e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (4.33e-4)" "unprognostic (1.10e-1)" "unprognostic (3.53e-3)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (6.82e-3)" "unprognostic (5.09e-3)" "unprognostic (3.88e-2)" "unprognostic (6.46e-2)" "unprognostic (3.49e-3)" 1.9 0.2 0.8 0.0 0.8 0.0 6.3 0.2 1.1 0.3 0.0 0.2 0.0 0.3 0.3 0.7 0.6 0.0 0.7 0.7 0.9 0.2 0.7 1.6 0.0 0.3 0.4 0.9 0.0 0.1 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.8 0.3 0.7 0.9 0.2 0.0 0.1 0.0 0.4 0.4 0.7 0.2 0.5 0.2 0.2 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 1.1 0.7 0.9 0.3 0.4 0.9 0.4 0.1 0.7 1.1 0.3 9.6 1.1 1.0 0.0 0.1 0.5 0.4 0.0 0.0 8.3 0.4 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.2 0.1 0.9 0.0 0.0 8.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 CENATAC "CCDC84, DLNB14" ENSG00000186166 "Centrosomal AT-AC splicing factor" Q86UT8 11 118998138-119015793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.1;Cardiomyocytes: 8.5;Cytotrophoblasts: 15.3;dendritic cells: 12.1;Hofbauer cells: 9.2;Plasma cells: 8.1;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039906, HPA071715" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA039906: AB_2676740, HPA071715: AB_2686436" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (1.54e-1)" "unprognostic (4.06e-2)" "unprognostic (1.15e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-3)" "unprognostic (3.45e-2)" "unprognostic (4.64e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.93e-5)" "unprognostic (8.14e-2)" "unprognostic (8.24e-2)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 10.9 14.1 8.5 2.0 8.6 3.5 11.2 8.9 11.0 14.3 10.0 12.2 1.9 9.6 3.0 11.3 11.8 1.3 11.9 8.6 8.8 15.6 19.1 15.5 3.0 8.6 8.6 8.5 11.1 11.3 2.2 15.2 1.7 8.8 16.3 1.7 3.6 10.5 2.7 11.0 12.6 14.0 1.8 8.5 21.9 10.8 7.1 8.6 2.9 15.4 2.1 2.8 13.2 11.9 8.9 3.8 3.2 2.7 3.7 2.7 0.9 3.0 3.4 3.5 2.9 1.8 19.1 2.4 1.4 10.7 3.8 4.5 9.8 1.3 1.8 2.9 5.3 2.2 6.4 6.2 5.5 2.6 2.7 3.5 1.1 1.9 2.9 3.3 3.0 1.7 4.3 1.4 4.8 2.9 6.1 7.0 5.1 3.7 5.6 8.6 9.5 5.5 6.4 4.4 5.6 3.8 2.6 8.6 2.4 0.8 4.3 7.7 2.7 1.9 2.8 13.7 4.0 2.3 3.9 4.0 5.8 2.3 5.3 5.3 0.4 1.3 2.6 2.7 0.9 3.4 4.1 3.6 3.0 2.2 4.2 3.4 2.6 2.1 3.7 0.9 2.6 5.8 1.9 8.5 8.6 8.9 11.0 8.6 8.8 8.6 8.6 8.5 8.8 8.5 8.6 8.9 9.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 15.3 12.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.3 1.7 0.0 0.0 0.0 BCL9L "B9L, Bcl9-2, DLNB11" ENSG00000186174 "BCL9 like" Q86UU0 11 118893875-118925608 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049370, HPA053421" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049370: AB_2680732, HPA053421: AB_2682145" "unprognostic (1.67e-2)" "unprognostic (1.48e-2)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (1.17e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-2)" "unprognostic (4.66e-3)" "unprognostic (1.39e-1)" "unprognostic (2.83e-3)" "unprognostic (4.85e-3)" "unprognostic (2.24e-2)" "unprognostic (2.14e-1)" "unprognostic (2.90e-3)" 24.5 25.0 4.7 24.3 3.5 20.7 21.3 17.0 6.8 28.1 4.1 20.5 17.6 32.6 4.8 26.6 29.9 18.3 20.9 3.8 2.7 12.0 10.9 24.6 19.7 2.9 3.1 1.0 29.6 21.5 8.6 7.9 24.6 5.8 18.3 5.5 3.0 26.2 16.7 29.2 30.1 19.9 17.9 0.7 19.7 18.6 6.5 2.3 13.8 16.9 12.4 12.9 24.9 25.1 1.8 40.5 71.6 10.2 18.5 32.2 30.8 64.3 54.6 41.4 16.9 9.9 77.0 78.2 11.0 70.8 57.4 68.7 76.0 5.0 99.9 4.4 13.4 2.6 10.9 41.2 26.8 36.1 3.7 10.0 39.2 60.8 20.3 40.5 32.5 15.1 6.4 14.3 12.4 11.9 67.2 8.2 3.1 12.1 24.1 40.8 17.2 4.3 7.4 17.5 27.6 5.5 8.1 76.7 114.2 10.3 18.0 90.3 4.5 51.1 53.7 40.7 16.4 46.9 2.6 0.1 3.3 29.0 12.5 31.3 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.2 4.7 3.5 17.0 6.8 3.8 2.7 2.9 3.1 1.0 5.8 0.7 2.3 1.8 16.3 16.0 11.5 9.1 18.3 38.7 9.3 18.5 13.1 20.0 23.8 16.5 2.4 15.7 14.1 7.3 4.2 12.7 42.2 10.9 0.0 14.0 0.1 36.6 31.5 12.3 5.4 1.3 3.9 15.1 8.4 14.1 13.3 61.9 2.5 12.2 11.4 9.7 4.4 13.5 4.8 5.4 4.1 6.1 11.6 0.5 14.6 8.0 7.2 12.2 16.5 5.5 32.0 5.0 1.1 29.3 7.4 14.3 14.8 23.5 10.8 3.3 14.0 3.1 26.3 12.4 26.4 0.6 1.4 34.7 45.3 35.4 33.0 8.6 6.8 11.1 POLR1D "AC19, MGC9850, RPA16, RPA9, RPAC2, RPO1-3" ENSG00000186184 "RNA polymerase I and III subunit D" "P0DPB5, P0DPB6" 13 27620742-27744237 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 819.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039337 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039337: AB_10672961" "unprognostic (1.33e-3)" "unprognostic (5.96e-2)" "unprognostic (4.35e-2)" "unprognostic (8.50e-3)" "unprognostic (1.98e-2)" "unprognostic (3.71e-3)" "unprognostic (5.33e-3)" "unprognostic (2.04e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-2)" "unprognostic (2.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (2.56e-2)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" 71.5 125.8 58.3 57.9 61.4 152.1 91.6 80.8 76.1 92.8 69.4 92.1 87.0 68.0 78.8 143.5 76.4 56.3 77.9 61.2 59.9 85.1 81.9 77.2 91.5 56.8 57.8 59.2 119.7 269.6 54.7 69.9 62.8 62.2 89.3 88.2 59.0 113.4 66.3 120.8 133.6 87.3 67.0 55.5 76.2 133.9 76.6 58.5 118.5 62.7 85.7 88.0 92.4 112.7 60.4 103.2 94.8 106.8 110.5 121.6 213.4 143.4 99.2 171.2 129.2 127.7 155.0 203.9 331.3 73.2 113.9 215.7 155.4 200.4 319.8 152.3 102.5 119.0 236.0 97.4 262.9 181.4 215.7 178.0 195.5 330.2 106.0 194.6 143.9 180.9 187.9 132.3 56.6 126.8 106.7 213.2 257.7 259.1 320.2 100.4 144.0 182.6 151.1 204.7 157.2 182.2 142.3 67.3 132.0 381.4 133.9 81.3 198.6 124.9 56.5 90.1 97.9 110.3 92.2 113.1 188.4 49.5 152.3 112.9 80.0 115.9 56.3 71.0 124.4 94.5 83.9 114.9 91.8 130.9 83.8 121.8 98.4 42.0 88.8 113.5 95.9 179.0 83.8 58.3 61.4 80.8 76.1 61.2 59.9 56.8 57.8 59.2 62.2 55.5 58.5 60.4 122.5 89.8 108.8 13.7 147.4 336.6 303.0 247.7 385.3 56.6 171.4 241.4 73.5 118.7 123.8 29.5 16.7 155.0 133.9 104.5 74.3 137.2 464.1 100.9 98.4 111.8 124.4 182.4 30.0 309.2 273.2 100.5 126.4 106.3 95.7 125.8 112.5 81.2 165.7 45.4 22.2 203.5 65.1 205.2 148.2 819.5 116.5 142.5 80.0 19.7 260.9 56.5 151.4 13.6 22.3 232.1 124.6 79.0 105.9 256.2 210.1 152.1 58.5 44.0 78.9 105.2 164.4 268.0 81.9 307.8 317.0 145.8 148.5 179.8 197.2 345.7 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947773 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.8;lymphoid tissue: 14.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.4" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.4 0.4 0.5 3.8 0.4 12.8 0.2 0.7 0.4 0.5 0.2 1.8 2.8 0.4 0.0 5.1 0.2 0.4 0.3 0.3 0.4 0.2 0.4 0.8 5.7 0.5 1.1 0.2 0.1 0.1 0.0 0.1 1.9 0.5 0.2 1.7 0.1 0.7 0.0 0.4 3.0 2.5 1.1 0.4 2.9 1.5 2.9 0.6 14.6 0.2 0.0 4.8 0.6 1.6 1.2 31.5 41.7 35.3 32.8 0.8 3.0 28.1 25.8 10.3 34.6 26.9 34.0 27.4 28.3 10.9 10.8 21.5 34.0 25.1 11.3 17.9 56.6 36.4 35.4 51.7 22.1 0.0 30.0 30.2 0.7 0.6 29.7 12.2 4.7 17.9 29.2 28.1 48.0 18.2 25.9 60.0 31.1 25.4 30.4 28.9 43.5 51.8 19.2 5.8 16.7 26.2 24.7 18.0 16.1 9.8 17.0 30.2 21.6 11.2 49.9 48.0 28.8 56.8 15.1 15.7 34.4 16.3 22.9 33.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.5 0.4 0.7 0.4 0.3 0.4 0.5 1.1 0.2 0.5 0.4 0.6 1.2 0.1 0.0 0.0 0.0 0.9 0.4 0.1 0.2 0.0 0.5 0.5 0.4 2.6 0.0 0.0 0.0 0.0 2.4 0.4 1.9 0.0 0.0 0.0 0.3 0.8 0.6 0.0 9.0 0.3 0.0 3.8 1.4 1.5 0.5 0.0 5.9 0.4 0.3 2.3 0.0 0.3 1.6 0.0 2.2 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 7.1 0.1 0.1 0.0 0.0 2.1 0.2 0.3 0.0 0.0 0.3 0.0 0.2 0.8 1.1 2.9 2.5 0.4 0.8 1.3 0.3 3.2 0.3 ZNRF1 "DKFZp434E229, FLJ14846, nin283" ENSG00000186187 "Zinc and ring finger 1" Q8ND25 16 74999024-75110994 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.4;T-reg: 2.4" "Group enriched" "Detected in many" 4 "granulocytes: 2.4;T-cells: 2.4" "Cell line enhanced" "Detected in all" "HMC-1: 176.9;MOLT-4: 134.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027470 Approved NA NA "HPA027470: AB_10603108" "unprognostic (2.78e-2)" "prognostic favorable (9.90e-4)" "unprognostic (4.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.34e-2)" "unprognostic (1.18e-2)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (1.12e-2)" "unprognostic (5.38e-2)" "unprognostic (3.69e-1)" "unprognostic (2.28e-1)" "unprognostic (1.46e-1)" "unprognostic (4.89e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-2)" "unprognostic (1.44e-2)" 18.4 16.6 20.7 9.7 23.4 6.8 18.0 9.5 21.7 23.6 17.2 26.3 9.7 22.7 9.6 66.4 18.1 7.6 17.6 24.2 22.2 12.6 17.8 24.4 7.7 20.3 16.9 22.5 17.5 11.6 11.9 13.5 11.3 21.2 13.8 12.3 7.4 17.0 7.1 82.0 25.0 15.4 11.5 13.4 4.5 21.2 37.7 25.2 53.7 29.6 30.9 13.4 22.7 26.6 21.8 10.9 15.7 26.7 27.5 27.7 21.4 91.2 13.0 18.3 17.5 17.1 25.4 33.2 2.9 9.9 28.3 16.8 25.5 13.0 17.8 13.9 26.7 7.5 56.7 4.8 47.0 22.0 27.5 176.9 19.5 14.7 18.4 14.9 30.8 29.0 68.3 27.8 8.8 13.7 104.5 134.6 100.6 37.1 31.4 16.7 59.0 10.0 17.4 25.1 30.5 35.4 37.7 20.7 27.0 8.3 21.7 71.6 25.8 19.9 12.0 21.0 21.5 7.9 50.5 55.1 31.6 15.8 30.2 12.6 2.4 0.5 0.4 0.0 0.5 0.5 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.5 0.0 2.4 0.1 20.7 23.4 9.5 21.7 24.2 22.2 20.3 16.9 22.5 21.2 13.4 25.2 21.8 34.8 9.6 14.4 16.6 1.8 15.9 16.0 11.2 4.6 12.6 24.3 22.4 16.4 18.6 14.0 3.7 52.1 6.4 2.3 25.5 0.0 8.9 25.9 30.7 15.1 30.2 19.8 30.5 45.2 12.7 10.1 15.1 18.3 28.0 36.8 23.7 12.8 14.4 10.4 3.3 42.4 14.0 14.2 7.3 10.9 16.3 6.8 7.3 14.2 33.7 7.6 15.0 0.0 33.7 29.5 20.0 12.1 4.1 1.8 17.2 9.6 6.2 15.1 6.5 0.0 12.4 14.7 13.6 18.7 21.0 19.6 4.5 13.3 16.7 12.7 29.6 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 11.5;pituitary gland: 11.1" "Cell type enriched" "Detected in some" 4 "Intestinal goblet cells: 125.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042563 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 4.1 0.4 1.0 0.7 1.3 0.1 1.3 0.6 1.1 0.1 0.4 8.4 0.5 0.0 0.0 0.2 1.0 0.5 0.3 1.0 1.4 0.1 0.4 3.6 0.2 0.6 0.7 1.1 0.0 0.6 0.1 11.1 0.1 0.7 0.1 11.5 0.2 0.1 0.0 0.3 0.9 0.6 0.2 0.6 0.1 0.5 1.5 1.9 0.3 0.1 0.1 0.1 0.1 0.0 0.9 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.2 1.0 1.3 0.6 1.1 1.0 1.4 0.6 0.7 1.1 0.7 0.6 1.9 0.9 0.2 0.0 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.2 0.8 0.4 7.2 0.6 0.0 0.0 0.2 0.0 28.1 0.0 0.8 27.8 0.1 0.0 0.3 20.9 0.0 3.2 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 2.0 125.7 0.0 7.2 4.4 16.7 0.6 7.6 1.8 3.7 0.5 0.0 0.0 0.0 0.3 0.9 23.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.3 BPIFB3 "C20orf185, dJ726C3.4, LPLUNC3, RYA3" ENSG00000186190 "BPI fold containing family B member 3" P59826 20 33055424-33073628 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 1.9;Late spermatids: 1.8" "Cancer enriched" "Detected in single" 7 "ovarian cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "HEL: 3.7;HMC-1: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045741 Uncertain "Secreted in other tissues" NA NA "HPA045741: AB_2679439" "unprognostic (4.33e-2)" "unprognostic (1.06e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFB4 "C20orf186, dJ726C3.5, LPLUNC4" ENSG00000186191 "BPI fold containing family B member 4" P59827 20 33079644-33111751 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "pituitary gland: 8.5" "Cell type enhanced" "Detected in single" "Basal respiratory cells: 2.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HSkMC: 2.3;U-2 OS: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047388 Approved "Actin filaments,Cytosol" "Secreted - unknown location" NA NA "Actin filaments, Cytosol" "HPA047388: " "unprognostic (1.32e-1)" "unprognostic (1.16e-1)" "unprognostic (1.61e-1)" "unprognostic (2.75e-2)" "unprognostic (1.31e-3)" "unprognostic (4.70e-2)" "unprognostic (3.42e-2)" "unprognostic (2.03e-1)" "unprognostic (3.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (8.97e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 8.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062127-137070557 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.9;esophagus: 8.5" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 122.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 0.5 0.3 6.6 2.5 5.0 2.0 1.3 4.9 5.5 1.2 1.5 3.5 4.3 0.4 0.0 8.5 0.3 0.2 0.2 5.6 4.6 1.2 0.2 0.5 2.8 8.9 6.8 4.4 0.1 0.4 0.0 0.5 0.9 8.6 3.1 1.8 0.1 4.2 0.1 0.1 6.0 4.3 0.4 5.2 2.2 2.4 0.5 5.9 2.3 0.3 0.0 2.5 0.4 2.3 7.0 52.1 27.5 10.7 32.0 0.3 0.7 57.1 8.4 5.7 8.8 4.1 52.5 23.2 53.8 26.5 4.1 8.2 72.3 33.6 9.7 2.0 37.4 38.9 23.6 32.7 59.6 0.2 27.0 39.2 0.1 1.5 3.0 5.8 2.3 14.4 27.1 33.1 23.7 2.6 122.1 7.8 72.7 19.9 119.2 61.9 82.9 40.7 60.1 10.9 14.8 55.2 32.7 32.2 89.1 12.2 2.4 71.9 51.1 9.4 7.9 26.6 24.0 41.9 8.2 25.5 26.3 18.4 31.8 25.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.6 5.0 4.9 5.5 5.6 4.6 8.9 6.8 4.4 8.6 5.2 5.9 7.0 0.5 0.0 0.0 0.7 1.9 4.2 0.7 0.5 0.6 0.2 5.0 5.2 1.3 0.0 1.1 0.0 0.0 2.8 1.6 5.4 1.9 0.3 0.0 1.6 0.8 0.9 0.0 3.6 0.2 0.0 3.5 1.1 6.1 6.0 0.0 3.3 1.4 0.0 3.1 0.0 0.2 10.8 0.0 2.8 1.5 0.1 0.0 2.2 0.0 0.0 1.5 0.5 0.0 29.7 5.6 0.6 4.0 0.0 1.8 2.1 0.5 0.0 0.1 0.6 0.0 0.2 1.0 0.0 1.4 5.8 2.7 0.5 1.3 0.6 12.1 1.1 EDARADD ENSG00000186197 "EDAR associated death domain" Q8WWZ3 1 236348257-236502915 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 8.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 26.7;granulocytes: 22.7;Syncytiotrophoblasts: 22.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 8 "basophil: 49.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 49.5" "Cell line enhanced" "Detected in some" "BEWO: 15.9;HDLM-2: 13.2;HMC-1: 52.7;RT4: 45.3;T-47d: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA018836 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018836: AB_1847984" "unprognostic (3.74e-1)" "unprognostic (3.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.12e-2)" "unprognostic (2.06e-3)" "unprognostic (3.12e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (2.57e-2)" "unprognostic (5.72e-2)" "unprognostic (3.00e-1)" "unprognostic (2.47e-1)" "unprognostic (1.90e-2)" "unprognostic (9.62e-3)" 0.3 0.1 0.2 0.4 0.1 0.5 4.8 0.1 0.1 0.7 0.0 0.3 0.4 0.4 5.2 3.3 1.2 0.8 0.9 0.1 0.1 1.1 0.3 0.7 1.2 0.1 0.1 0.1 0.4 3.9 0.1 0.1 4.9 0.1 3.6 0.3 0.0 1.4 6.1 0.0 5.8 0.3 0.1 0.1 1.2 6.3 3.4 0.1 2.3 6.5 0.0 2.6 8.8 1.0 0.1 0.0 3.8 0.3 0.0 0.0 0.0 15.9 0.0 0.0 1.3 0.8 1.0 0.0 0.0 0.0 0.2 4.3 8.8 6.5 9.6 1.2 13.2 7.6 0.1 0.1 1.4 0.0 0.4 52.7 0.0 2.7 0.9 0.8 0.0 0.0 1.8 0.4 0.0 0.0 0.4 0.3 0.0 3.9 0.0 0.0 3.4 0.1 0.0 0.0 45.3 0.4 0.3 0.0 1.2 0.2 0.3 12.6 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 49.5 0.3 0.1 3.1 0.4 4.1 0.1 4.7 6.1 0.5 0.2 0.4 3.2 0.3 5.3 0.2 0.1 5.1 2.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 1.3 0.0 0.4 6.9 7.3 16.3 13.1 0.0 7.1 7.4 4.1 5.7 8.4 0.0 0.0 26.7 3.0 0.1 3.9 1.7 10.6 0.2 1.2 1.2 0.0 2.5 0.5 0.9 14.2 1.1 5.1 0.4 22.7 2.8 5.0 0.5 3.4 0.0 0.6 0.1 8.2 1.5 8.9 9.3 0.3 0.6 12.4 1.0 3.7 0.6 0.0 1.0 0.4 0.6 0.0 0.4 1.8 4.2 0.1 0.4 3.2 0.1 0.0 1.4 6.1 13.4 3.7 6.5 5.3 22.6 6.2 0.3 0.0 5.3 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 subunit beta" Q86UW2 15 65045387-65053397 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 42.2;intestine: 108.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.7 1.2 5.7 3.6 5.0 0.8 0.3 4.3 2.8 42.2 0.0 42.3 87.7 3.1 0.3 2.4 3.7 2.8 2.4 3.9 5.8 19.7 2.2 6.2 0.6 11.8 9.5 1.2 1.2 0.3 0.0 0.4 0.6 8.0 2.7 29.7 0.7 1.0 0.6 1.0 0.8 108.0 1.7 6.2 0.8 0.8 9.7 8.8 0.0 0.7 0.0 0.0 1.5 0.9 4.2 0.0 1.5 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 18.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.1 0.4 0.4 0.1 0.4 0.0 0.0 0.9 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 5.0 4.3 2.8 3.9 5.8 11.8 9.5 1.2 8.0 6.2 8.8 4.2 0.0 0.0 1.1 0.3 1.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.1 0.0 354.6 13.7 0.0 60.8 10.4 0.2 1.2 1.8 2.7 0.0 0.0 0.0 0.5 0.0 1.9 4.5 0.0 0.4 1.8 0.1 0.0 0.0 23.0 0.0 0.3 0.0 14.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.1 0.0 0.0 0.0 721.4 73.3 15.6 0.0 6.6 1.0 0.4 27.9 0.5 0.0 0.0 0.1 0.6 0.1 45.8 0.0 CYP4F12 ENSG00000186204 "Cytochrome P450 family 4 subfamily F member 12" Q9HCS2 19 15673018-15697174 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.9;liver: 40.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 58.8;Gastric mucus-secreting cells: 57.6;Paneth cells: 51.9;Proximal enterocytes: 125.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 6.2" "Group enriched" "Detected in some" 54 "basophil: 6.1;eosinophil: 14.8" "Lineage enriched" "Detected in single" 88 "granulocytes: 14.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 17.6;HaCaT: 32.0;Hep G2: 9.8;Karpas-707: 20.9;OE19: 46.3" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (4.30e-4)" "prognostic favorable (1.21e-4)" "unprognostic (1.86e-1)" "unprognostic (1.48e-2)" "unprognostic (1.37e-2)" "unprognostic (5.32e-3)" "unprognostic (1.84e-3)" "unprognostic (9.13e-2)" "unprognostic (9.11e-2)" "unprognostic (2.50e-1)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-3)" "unprognostic (6.20e-2)" "unprognostic (5.45e-2)" "unprognostic (3.17e-1)" "prognostic favorable (2.33e-4)" 3.1 1.1 0.8 1.2 0.9 0.9 2.8 0.9 1.5 3.6 0.5 13.9 39.5 1.5 0.5 18.2 3.2 2.4 1.3 1.0 6.2 1.8 40.5 1.3 0.5 1.0 0.8 0.4 1.7 0.3 0.0 0.5 0.5 1.4 5.0 7.9 0.1 4.4 1.0 0.6 21.2 41.9 1.9 0.8 1.0 12.1 0.2 0.7 0.8 0.9 0.9 2.6 10.6 11.3 2.1 0.0 4.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.6 0.5 0.0 0.0 0.3 32.0 0.0 0.0 0.0 2.0 0.0 0.0 1.7 9.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.1 0.0 46.3 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.1 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.1 0.0 14.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.9 1.5 1.0 6.2 1.0 0.8 0.4 1.4 0.8 0.7 2.1 6.3 0.0 1.8 2.6 0.5 14.0 10.0 8.3 13.1 0.0 0.5 0.3 1.0 5.7 7.1 0.0 0.0 0.1 0.0 58.8 0.0 0.6 1.6 0.2 0.1 3.0 7.8 8.0 0.2 0.0 0.1 3.8 57.6 0.3 0.0 0.0 1.4 30.3 0.4 0.0 0.2 24.8 2.0 0.9 1.6 3.2 4.1 0.3 1.8 0.0 0.0 2.7 0.0 0.0 0.4 1.9 51.9 1.2 0.2 3.5 125.3 2.2 4.9 0.1 0.0 0.3 2.5 0.4 0.1 20.5 21.2 0.3 0.5 0.1 29.6 24.8 MTARC1 "FLJ22390, MARC1, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786913-220819659 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 194.0;breast: 87.0;liver: 85.2" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 109.8;Extravillous trophoblasts: 47.9;Syncytiotrophoblasts: 75.1" "Cancer enhanced" "Detected in many" "prostate cancer: 14.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "basophil: 30.2;classical monocyte: 33.6;eosinophil: 12.3;neutrophil: 42.8" "Group enriched" "Detected in many" 31 "granulocytes: 42.8;monocytes: 33.6" "Cell line enhanced" "Detected in many" "BEWO: 126.5;HeLa: 56.2;Hep G2: 67.6;NTERA-2: 57.8;OE19: 49.4" HPA028702 Approved Supported Mitochondria NA NA Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 194.0 7.5 8.8 6.9 9.9 18.0 87.0 9.3 13.3 7.9 7.1 19.0 7.6 2.8 14.1 7.6 6.3 4.2 7.0 9.4 29.3 8.3 85.2 9.4 2.8 9.5 10.3 8.9 5.5 9.7 5.4 7.0 16.2 8.7 36.5 17.5 5.7 27.4 13.6 11.1 3.6 9.8 4.0 8.2 10.3 9.4 1.4 11.6 1.6 54.0 9.3 2.1 8.9 5.0 9.0 15.0 7.8 5.9 0.2 1.3 0.3 126.5 1.4 1.2 0.8 1.5 45.4 1.0 0.1 5.3 1.6 0.1 0.1 28.3 2.9 2.1 0.2 25.7 0.1 56.2 67.6 2.7 0.3 0.5 4.5 1.3 0.2 0.0 0.2 1.1 0.1 4.3 0.3 1.1 14.7 0.1 31.9 57.8 49.4 23.8 0.1 0.0 0.3 7.1 17.4 16.4 36.1 8.1 11.4 0.2 16.4 38.5 34.7 0.4 0.1 12.6 0.1 0.1 0.2 0.1 0.1 0.2 0.0 1.1 30.2 33.6 12.3 0.1 2.5 0.0 0.4 0.0 0.0 1.2 0.2 0.1 0.0 42.8 0.0 1.3 0.3 0.0 9.2 8.8 9.9 9.3 13.3 9.4 29.3 9.5 10.3 8.9 8.7 8.2 11.6 9.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 47.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 75.1 0.0 0.0 0.0 0.0 LCE5A "LEP18, SPRL5A" ENSG00000186207 "Late cornified envelope 5A" Q5TCM9 1 152510803-152512177 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 77.9" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 7.4" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.51e-1)" "unprognostic (7.27e-3)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 11.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 77.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 SOWAHB ANKRD56 ENSG00000186212 "Sosondowah ankyrin repeat domain family member B" A6NEL2 4 76894152-76898144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 1.9;Gastric mucus-secreting cells: 4.6;Squamous epithelial cells: 2.7;Urothelial cells: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.9;BEWO: 8.3;CACO-2: 3.9;OE19: 7.4;RT4: 19.4;T-47d: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036809, HPA036810" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA036809: AB_10672479, HPA036810: AB_2675327" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-2)" "unprognostic (1.02e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (3.06e-1)" "unprognostic (2.85e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.22e-15)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "unprognostic (2.03e-2)" "unprognostic (3.73e-3)" 0.0 0.3 0.8 0.7 1.5 0.0 1.3 0.1 2.9 1.0 0.6 7.8 5.6 0.3 0.8 6.3 1.1 1.3 0.0 1.7 1.1 7.7 19.3 1.6 0.0 0.6 0.3 1.6 0.0 5.8 7.0 0.4 0.7 1.2 0.8 6.4 0.2 2.4 2.8 0.0 1.4 8.1 0.2 0.1 0.0 4.7 0.0 0.2 0.2 2.4 0.0 2.3 6.0 2.2 1.4 3.9 0.1 0.3 0.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 3.9 2.6 0.0 0.1 0.0 0.0 0.2 0.3 0.7 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 7.4 0.0 0.0 0.0 0.0 0.5 19.4 0.1 0.0 0.0 1.7 0.0 0.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.1 2.9 1.7 1.1 0.6 0.3 1.6 1.2 0.1 0.2 1.4 0.0 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 1.5 1.9 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 4.6 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 1.1 1.1 0.9 1.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.5 6.1 BLOC1S4 "BCAS4L, CNO, FLJ11230" ENSG00000186222 "Biogenesis of lysosomal organelles complex 1 subunit 4" Q9NUP1 4 6716174-6717664 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043840 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA043840: AB_10965701" "unprognostic (3.09e-1)" "unprognostic (8.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-1)" "unprognostic (9.24e-3)" "unprognostic (5.62e-3)" 8.6 11.8 8.3 8.0 8.4 9.9 9.0 8.6 8.7 9.3 9.0 8.2 9.3 10.0 7.1 11.2 9.3 6.5 7.7 8.6 9.0 9.1 11.4 6.4 12.2 8.4 8.5 8.5 12.1 8.0 5.6 7.3 7.8 8.6 9.5 5.8 4.3 8.3 6.5 10.9 8.6 11.5 5.1 8.7 13.2 8.9 6.4 8.7 9.0 7.7 5.8 8.7 9.7 8.7 8.9 15.3 10.3 15.2 15.6 11.7 15.0 30.5 12.0 13.2 11.0 9.7 9.2 16.0 14.4 12.6 10.9 15.5 10.1 8.6 14.0 8.4 11.7 14.1 22.0 10.3 23.2 14.3 10.8 19.7 14.2 13.6 8.7 7.5 10.8 10.3 12.3 29.3 12.6 11.6 15.1 17.6 37.5 19.7 11.2 20.0 17.9 16.8 13.0 15.3 13.3 13.1 17.5 9.9 7.1 22.7 11.6 22.4 20.8 11.6 10.0 8.9 11.8 15.4 18.8 19.8 19.4 11.2 19.6 16.3 2.5 2.7 14.0 4.4 4.6 4.5 6.3 5.4 4.8 3.6 5.2 8.4 4.5 1.4 2.5 3.1 3.4 5.1 1.7 8.3 8.4 8.6 8.7 8.6 9.0 8.4 8.5 8.5 8.6 8.7 8.7 8.9 18.7 6.4 5.9 3.9 40.8 23.6 35.2 4.9 26.7 29.1 25.2 27.8 5.3 21.5 5.7 23.9 6.2 65.1 49.5 21.7 25.4 9.7 2.5 28.6 28.0 20.2 11.4 26.5 6.8 7.0 93.1 27.8 21.9 25.3 3.8 18.7 32.5 23.6 35.8 30.3 6.6 22.8 4.1 24.0 22.2 1.6 32.3 16.6 30.2 5.6 18.1 38.4 60.8 4.5 8.3 9.9 33.9 22.6 19.7 40.3 33.9 51.3 4.6 24.7 6.6 26.6 20.0 16.0 14.3 23.1 24.9 63.3 47.7 39.1 24.2 34.8 LCE1E LEP5 ENSG00000186226 "Late cornified envelope 1E" Q5T753 1 152786214-152788426 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "skin 1: 61.9" "Cell type enriched" "Detected in some" 10 "Suprabasal keratinocytes: 18.3" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HaCaT: 10.0" NA NA "unprognostic (9.92e-2)" "unprognostic (9.50e-2)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.3 0.0 0.1 0.0 0.0 0.0 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435325-57447101 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 27.9;Excitatory neurons: 24.2;Inhibitory neurons: 21.1;Melanocytes: 23.2;Oligodendrocyte precursor cells: 18.1;Squamous epithelial cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 24.0" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: AB_2683005" "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 1.2 1.2 1.4 1.9 1.4 1.4 1.7 3.4 1.6 1.1 0.8 1.0 1.5 1.3 0.9 1.5 1.6 0.9 1.0 1.7 1.0 1.0 1.6 1.0 1.8 1.0 0.9 1.3 1.7 1.1 1.5 1.1 1.4 1.7 1.3 0.9 4.1 1.5 0.9 1.3 2.2 1.2 1.1 0.4 1.7 1.2 1.3 1.1 1.9 1.3 0.4 1.6 1.3 1.3 2.2 2.8 6.2 5.5 5.9 1.3 1.3 2.3 1.6 1.1 2.6 4.6 2.5 2.0 5.4 1.5 1.6 1.9 2.1 4.9 4.2 3.8 2.3 24.0 4.6 6.5 3.0 1.9 5.6 3.0 1.9 4.6 3.1 7.7 2.5 1.3 5.6 4.7 6.4 2.0 1.3 6.6 2.4 5.6 1.8 8.8 6.9 7.8 4.2 1.4 6.5 5.7 4.7 3.2 2.0 1.5 4.2 2.9 1.8 1.5 5.0 3.7 1.7 4.8 5.0 6.8 5.8 2.8 2.4 3.2 0.2 0.4 0.1 0.6 0.9 0.9 0.9 1.1 0.8 1.1 0.8 1.2 0.8 0.2 0.6 0.4 0.5 0.8 0.8 1.4 1.4 3.4 1.6 1.7 1.0 1.0 0.9 1.3 1.7 0.4 1.1 2.2 1.1 3.2 1.1 7.2 6.7 2.4 1.3 2.9 27.9 1.2 4.0 2.9 0.5 7.2 3.2 0.0 0.0 0.9 2.3 0.4 3.9 1.1 1.0 7.1 1.4 2.3 3.0 8.8 24.2 0.4 0.6 2.5 10.7 3.5 0.0 1.2 1.1 4.0 0.8 3.3 21.1 1.7 2.0 0.8 1.6 0.1 0.6 1.9 23.2 5.6 0.7 0.2 0.0 18.1 10.6 0.8 0.3 0.0 11.6 0.9 3.8 8.1 3.4 0.8 6.6 1.8 2.0 1.2 1.8 35.9 3.1 0.8 4.3 0.3 1.1 1.1 KLHL32 "BKLHD5, KIAA1900" ENSG00000186231 "Kelch like family member 32" Q96NJ5 6 96924620-97140754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 66.8" "Cell type enhanced" "Detected in many" "Astrocytes: 143.7;Excitatory neurons: 168.8;Inhibitory neurons: 143.9;Oligodendrocyte precursor cells: 197.5;Oligodendrocytes: 724.3" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.0;T-cells: 2.6" "Cell line enhanced" "Detected in some" "Daudi: 3.3;HDLM-2: 4.5;RPMI-8226: 2.1;SCLC-21H: 1.8;U-266/70: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039150 Enhanced NA NA "HPA039150: AB_2676367" "unprognostic (1.75e-1)" "unprognostic (7.99e-2)" "unprognostic (6.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (5.00e-1)" "unprognostic (3.12e-3)" "unprognostic (5.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.51e-5)" "unprognostic (5.82e-2)" "unprognostic (6.04e-2)" "unprognostic (7.01e-2)" "unprognostic (1.86e-2)" "unprognostic (7.48e-2)" "unprognostic (4.49e-4)" 0.1 0.9 21.6 0.4 37.6 0.1 0.3 25.5 29.4 0.3 3.1 0.6 0.8 0.2 0.4 0.0 6.5 0.3 0.7 21.8 30.6 1.9 0.6 0.7 0.4 32.0 29.2 19.3 0.9 1.3 0.8 1.2 0.0 36.1 0.2 0.9 2.5 0.5 0.2 1.3 0.1 1.1 0.1 26.3 0.3 0.5 1.6 30.4 0.7 0.7 0.3 0.4 0.1 0.1 66.8 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 3.3 0.1 0.0 0.0 0.1 0.3 0.1 0.0 4.5 0.7 0.2 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 1.6 0.0 0.0 0.8 0.2 0.2 0.1 0.1 0.1 0.0 2.1 0.0 0.0 1.8 0.6 0.0 0.0 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.3 0.4 1.3 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 1.0 1.7 0.6 0.0 0.7 1.9 2.6 0.0 0.4 0.0 0.0 1.2 0.8 21.6 37.6 25.5 29.4 21.8 30.6 32.0 29.2 19.3 36.1 26.3 30.4 66.8 0.2 3.2 0.0 143.7 1.1 0.0 0.3 0.1 0.0 2.5 0.4 0.5 2.6 0.0 0.1 5.5 0.0 0.1 0.2 0.3 3.9 0.2 6.9 7.5 0.1 0.0 11.3 0.0 168.8 0.2 0.0 0.3 1.5 0.2 0.0 3.2 0.4 1.3 0.1 18.5 143.9 4.1 0.0 0.0 0.0 3.3 0.0 0.1 0.0 13.1 0.0 1.1 0.0 197.5 724.3 0.0 0.1 0.0 0.5 0.2 0.5 2.4 15.3 1.1 0.0 0.2 0.1 0.8 1.8 0.0 0.0 0.0 0.7 1.1 0.5 0.0 MRTFB "FLJ31823, MKL2, MRTF-B" ENSG00000186260 "Myocardin related transcription factor B" Q9ULH7 16 14071319-14266773 "Disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 43.9;Cardiomyocytes: 26.9;Cytotrophoblasts: 9.9;Endothelial cells: 9.6;Extravillous trophoblasts: 10.0;Smooth muscle cells: 14.9;Syncytiotrophoblasts: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011286 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA011286: AB_1853973" "unprognostic (2.00e-1)" "unprognostic (5.28e-1)" "unprognostic (1.30e-2)" "unprognostic (3.62e-1)" "unprognostic (7.16e-2)" "unprognostic (7.14e-3)" "unprognostic (1.21e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-1)" "unprognostic (3.19e-1)" "unprognostic (2.32e-1)" "prognostic favorable (6.20e-4)" "unprognostic (5.22e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (5.96e-2)" 18.6 7.3 11.9 8.6 21.1 3.9 18.5 0.0 19.0 19.2 0.0 10.0 9.8 15.1 9.2 14.6 14.1 13.4 11.9 21.8 15.4 8.5 5.9 13.3 7.7 0.0 0.0 21.7 7.2 12.2 22.4 4.9 21.9 1.2 15.6 10.9 8.7 11.7 15.3 12.0 16.7 8.0 15.8 0.0 5.1 10.2 17.7 1.0 10.3 17.0 14.6 8.2 11.4 12.3 1.3 17.6 17.8 17.8 13.2 5.9 11.0 8.0 4.9 13.3 7.4 10.6 7.7 16.4 9.4 12.4 8.4 9.3 13.8 12.9 14.4 13.5 23.1 7.0 6.0 13.6 13.3 8.2 4.2 5.4 8.4 14.6 12.8 8.3 7.8 14.7 12.2 7.9 9.7 5.6 15.1 13.4 2.8 6.0 4.7 4.8 20.5 13.7 8.1 7.3 17.3 6.2 10.8 23.9 10.2 4.9 8.2 18.0 3.5 9.4 15.3 14.9 4.4 6.4 6.6 8.8 8.4 16.6 7.1 11.7 0.2 0.5 0.0 1.1 0.7 1.7 3.7 1.9 0.9 0.7 1.5 2.4 1.3 0.3 1.1 0.8 1.7 0.9 0.6 11.9 21.1 0.0 19.0 21.8 15.4 0.0 0.0 21.7 1.2 0.0 1.0 1.3 43.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 9.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 10.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 10.4 0.4 0.0 0.0 0.0 BTLA "BTLA1, CD272" ENSG00000186265 "B and T lymphocyte associated" Q7Z6A9 3 112463966-112499472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 28.9" "Cell type enriched" "Detected in some" 4 "B-cells: 66.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 65.0;naive B-cell: 96.5;plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 4 "B-cells: 96.5;dendritic cells: 24.9" "Cell line enhanced" "Detected in single" "U-698: 2.0" "Not detected" "Not detected" "HPA047211, HPA062029" Enhanced NA NA "HPA047211: AB_2679983, HPA062029: AB_2684665" "unprognostic (1.13e-3)" "unprognostic (2.13e-3)" "unprognostic (5.79e-4)" "unprognostic (1.01e-4)" "unprognostic (7.08e-2)" "unprognostic (7.74e-6)" "unprognostic (6.20e-3)" "unprognostic (7.59e-3)" "unprognostic (5.98e-2)" "unprognostic (1.53e-5)" "unprognostic (2.33e-2)" "unprognostic (1.23e-1)" "unprognostic (1.57e-5)" "unprognostic (2.57e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-1)" "unprognostic (1.42e-2)" 0.4 0.3 0.0 11.3 0.0 2.1 2.0 0.1 0.4 0.5 0.1 1.7 1.6 0.3 0.1 0.6 0.3 1.1 0.3 0.1 0.0 0.3 0.6 0.9 26.6 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.4 1.7 0.2 1.4 0.1 0.1 0.1 3.1 0.4 0.0 10.9 3.0 0.1 0.1 7.8 0.3 0.1 28.9 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.1 0.0 11.2 0.0 8.3 65.0 13.6 6.5 4.6 96.5 12.7 12.6 0.5 0.3 0.1 24.9 3.4 6.5 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 66.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 2.3 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.5 1.3 0.0 0.4 0.2 0.1 0.0 0.4 0.0 0.0 1.3 4.7 3.6 0.0 1.6 7.2 0.0 1.9 0.0 0.0 1.0 0.3 0.0 0.0 0.0 15.9 0.0 0.0 0.2 0.7 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.3 0.1 8.6 0.0 0.0 0.1 ZNF17 "FLJ40864, FLJ46058, FLJ46615, HPF3, KIAA1947, KOX10" ENSG00000186272 "Zinc finger protein 17" P17021 19 57411161-57421934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Spermatogonia: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (8.49e-3)" "unprognostic (3.54e-1)" "unprognostic (6.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.48e-1)" "unprognostic (8.74e-3)" "unprognostic (3.98e-2)" "unprognostic (2.41e-2)" "unprognostic (4.31e-2)" "unprognostic (8.64e-2)" "prognostic favorable (6.03e-4)" "unprognostic (6.01e-2)" "unprognostic (1.22e-3)" "unprognostic (5.82e-2)" "unprognostic (2.08e-1)" "unprognostic (4.32e-3)" "unprognostic (8.85e-2)" 3.3 2.6 4.5 2.4 5.0 1.9 5.4 7.9 5.9 3.7 3.0 3.1 2.4 4.0 3.2 3.9 3.8 2.5 3.5 4.6 3.6 3.4 2.8 3.3 4.4 3.7 3.7 4.6 6.5 2.2 5.1 4.0 3.5 4.4 3.7 3.0 8.8 2.9 4.0 3.8 3.9 2.6 4.0 2.2 4.5 3.0 3.7 3.2 6.1 5.2 6.3 4.8 3.2 3.3 6.3 3.3 3.5 5.1 4.2 5.4 5.2 3.8 4.0 6.4 5.5 11.2 2.0 1.7 5.3 1.8 5.0 2.8 1.9 4.6 4.6 7.4 3.1 13.1 5.4 7.7 3.1 3.9 7.4 4.0 4.2 5.1 4.3 6.1 5.0 3.1 6.5 3.3 7.0 4.5 2.0 7.0 2.7 3.0 3.2 7.6 6.6 7.2 4.8 2.5 6.5 6.0 3.4 6.2 3.8 2.9 4.5 2.8 4.9 2.6 6.4 3.2 1.7 4.8 6.1 5.7 6.4 3.5 4.9 3.3 1.5 2.2 3.0 4.0 3.0 5.1 4.0 4.5 5.1 2.0 4.7 5.8 4.4 1.4 6.4 3.0 1.1 3.7 3.2 4.5 5.0 7.9 5.9 4.6 3.6 3.7 3.7 4.6 4.4 2.2 3.2 6.3 2.4 0.0 2.0 6.5 5.5 4.8 1.7 2.4 5.2 5.0 2.6 1.4 3.2 1.5 1.8 1.8 14.6 3.4 4.4 1.2 1.9 2.6 1.0 2.0 2.3 3.1 0.0 8.2 6.8 2.2 1.9 2.9 1.1 1.5 1.3 4.8 3.6 1.6 3.2 3.3 7.0 1.6 0.0 1.6 2.2 1.2 2.5 2.9 3.6 1.9 1.4 3.8 3.1 4.5 4.8 1.3 0.8 2.6 2.1 1.6 1.6 1.9 1.9 5.8 0.0 3.0 3.2 9.9 12.8 2.2 5.3 3.3 4.3 3.5 1.6 1.5 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973709-94999519 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 33.6" "Group enriched" "Detected in many" 7 "Early spermatids: 115.7;Late spermatids: 43.7;Spermatocytes: 102.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA055854, HPA064037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055854: AB_2682944, HPA064037: AB_2685180" "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.4 0.6 0.5 0.3 0.5 0.0 0.8 0.5 0.6 0.5 0.4 0.2 0.1 0.5 0.8 0.3 1.0 0.4 1.0 0.5 0.5 0.5 0.3 0.4 0.7 0.6 0.5 0.5 0.9 0.3 0.9 0.5 0.4 0.5 0.6 0.3 2.1 0.6 0.6 0.6 0.7 0.3 0.5 0.5 0.6 0.3 33.6 0.5 0.6 0.7 0.7 0.6 0.4 0.3 0.6 0.5 0.8 3.3 2.4 0.7 0.8 1.5 1.1 1.2 3.0 2.6 0.9 1.0 1.2 3.5 0.9 2.9 1.0 2.1 2.3 2.3 1.4 2.2 1.1 0.4 1.3 0.6 0.5 0.3 1.5 1.2 3.0 2.7 0.4 1.1 4.4 1.2 0.5 1.2 1.0 1.9 1.2 1.4 0.8 4.0 2.6 1.4 0.9 0.7 0.3 1.9 2.3 1.3 1.1 0.9 1.7 1.2 0.4 0.9 2.0 1.2 3.2 1.7 0.7 2.5 0.2 0.7 0.6 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.4 0.6 0.1 0.5 0.5 0.5 0.6 0.5 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.6 0.8 0.0 0.0 2.6 0.2 0.0 0.2 0.8 0.6 7.0 0.8 0.9 1.1 1.5 0.4 0.0 2.1 0.9 1.6 0.0 3.9 0.8 115.7 1.3 1.4 1.1 0.0 0.4 1.8 0.6 0.9 0.9 0.5 0.4 0.0 2.6 2.2 1.3 0.7 3.3 2.6 0.1 0.0 0.6 0.3 43.7 2.1 0.8 0.0 4.7 0.7 3.9 1.0 3.5 4.3 0.2 0.1 1.2 0.5 0.2 0.0 1.3 1.0 3.3 0.0 0.8 0.7 102.5 11.4 0.7 0.0 0.3 0.3 2.5 0.3 0.2 GPAT2 CT123 ENSG00000186281 "Glycerol-3-phosphate acyltransferase 2, mitochondrial" Q6NUI2 2 96021946-96039451 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Breast glandular cells: 84.5;Sertoli cells: 98.6;Smooth muscle cells: 30.3;Spermatocytes: 64.4;Spermatogonia: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 8.2;BJ hTERT+ SV40 Large T+: 19.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.6;OE19: 13.9;U-2 OS: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036841 Uncertain Approved Mitochondria NA NA Mitochondria "HPA036841: AB_10601479" "unprognostic (1.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.69e-2)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.38e-3)" "unprognostic (4.99e-2)" "unprognostic (3.28e-2)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (5.96e-2)" "unprognostic (4.67e-2)" "unprognostic (7.43e-6)" "unprognostic (2.11e-1)" "unprognostic (7.68e-2)" "unprognostic (3.49e-1)" "unprognostic (3.65e-1)" 4.7 0.8 1.4 1.4 1.5 1.2 4.5 1.2 1.7 1.9 2.7 1.8 0.2 1.5 3.1 0.8 1.6 1.6 5.0 1.0 1.4 0.9 1.0 1.3 2.4 1.6 1.5 1.0 1.2 1.7 0.1 0.6 1.4 1.9 1.1 1.1 0.2 2.3 2.8 2.2 1.1 2.2 1.6 1.2 4.6 2.2 7.7 2.3 0.8 1.8 3.0 1.9 2.0 1.4 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 19.6 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.0 0.7 1.0 1.6 0.5 0.7 0.4 2.4 0.3 1.1 0.0 0.1 1.0 0.0 0.5 0.6 1.4 1.5 1.2 1.7 1.0 1.4 1.6 1.5 1.0 1.9 1.2 2.3 2.7 12.9 0.0 1.1 0.3 3.5 1.0 1.1 0.7 0.6 0.7 84.5 3.4 1.3 1.5 0.5 1.8 0.0 0.1 1.7 3.1 1.9 2.2 1.9 0.1 0.5 6.5 0.0 0.8 1.0 2.0 0.6 3.3 1.5 0.5 1.3 0.2 10.8 0.0 2.4 8.4 0.4 0.6 0.0 0.8 2.1 5.3 0.6 1.5 1.8 1.9 0.7 1.0 1.0 0.0 1.4 0.8 1.3 0.0 3.6 0.4 0.0 0.2 0.2 0.4 98.6 3.2 30.3 64.4 45.3 0.4 0.1 0.1 2.2 0.3 2.1 1.8 TOR3A "ADIR, ADIR2, FLJ22345" ENSG00000186283 "Torsin family 3 member A" Q9H497 1 179082070-179098023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 112.6;Plasma cells: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 281.7;U-266/84: 322.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028766 Approved "Intracellular and membrane" NA Yes 24000 "HPA028766: AB_10602251" "unprognostic (5.55e-2)" "unprognostic (6.52e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (3.90e-1)" "unprognostic (8.82e-3)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (4.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "prognostic unfavorable (4.78e-8)" "unprognostic (4.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" 17.1 15.6 17.0 31.1 17.9 40.0 19.7 16.5 18.8 16.9 18.6 26.4 23.5 16.2 12.9 15.9 17.9 18.3 12.2 17.1 18.5 17.1 28.1 20.5 46.8 18.3 17.1 16.8 14.9 23.6 22.7 17.0 15.4 17.1 18.0 26.2 9.6 24.1 17.2 24.6 17.9 23.3 18.9 18.2 37.7 26.8 4.3 18.6 26.9 18.8 14.0 45.2 23.5 13.6 18.0 56.8 65.5 18.6 52.6 38.2 29.9 57.1 41.4 50.0 48.0 34.8 29.8 86.4 90.0 70.2 41.1 28.9 68.5 53.7 34.6 25.3 70.8 49.4 98.3 38.5 45.9 62.9 109.6 80.6 33.1 31.0 35.3 31.9 19.2 35.5 34.8 123.9 164.3 33.8 121.4 66.3 60.5 38.6 68.0 36.4 49.4 33.9 88.4 30.5 76.8 37.8 49.3 61.9 96.9 25.5 32.5 71.5 80.1 22.0 36.2 25.6 59.9 54.3 281.7 322.8 77.4 25.1 77.3 26.5 5.2 71.3 19.3 33.6 56.5 41.4 97.8 29.9 37.7 85.7 73.1 22.7 27.6 14.1 31.5 59.4 93.1 43.3 53.3 17.0 17.9 16.5 18.8 17.1 18.5 18.3 17.1 16.8 17.1 18.2 18.6 18.0 24.8 3.2 11.7 4.9 65.2 17.0 14.0 19.2 10.8 3.7 14.8 11.3 11.5 25.8 11.1 11.0 10.4 30.1 32.5 18.6 3.9 34.0 1.1 10.6 16.8 19.3 14.4 18.3 4.4 44.5 57.5 19.8 20.9 11.1 10.8 14.3 13.9 10.7 57.4 0.0 4.6 18.9 32.6 22.0 112.6 1.1 17.1 36.4 16.0 5.6 50.6 17.1 16.5 3.0 4.0 18.9 17.9 18.8 153.7 19.5 15.1 10.3 13.4 9.6 6.6 18.9 17.3 0.8 5.3 12.7 15.8 10.9 24.8 21.2 27.0 12.3 PABPC1L2A RBM32A ENSG00000186288 "Poly(A) binding protein cytoplasmic 1 like 2A" Q5JQF8 X 73077276-73079512 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.7;prostate: 2.6" "Group enriched" "Detected in some" 10 "Early spermatids: 14.3;Late spermatids: 48.5" "Cancer enriched" "Detected in single" 15 "prostate cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.5" HPA041573 Approved NA NA "HPA041573: AB_2677556" "unprognostic (4.30e-2)" "unprognostic (2.19e-1)" "unprognostic (3.22e-1)" 0.0 1.0 3.6 0.0 4.3 0.0 0.0 2.6 6.5 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 3.5 5.5 0.0 0.0 0.0 0.0 3.0 2.1 3.8 0.0 0.0 0.1 2.0 0.0 3.7 2.6 0.0 1.1 1.8 0.2 0.0 0.0 0.1 0.0 0.8 0.2 0.0 1.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.3 2.6 6.5 3.5 5.5 3.0 2.1 3.8 3.7 0.8 4.0 6.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 48.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor subunit alpha5" P31644 15 26866911-26949208 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 109.8" "Group enriched" "Detected in some" 4 "Excitatory neurons: 27.6;Inhibitory neurons: 14.1" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 35.3;HAP1: 12.0;NTERA-2: 16.2;U-2 OS: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.0 0.0 43.1 0.1 79.7 0.0 0.0 0.0 107.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 0.3 109.8 27.6 0.1 0.1 0.0 0.0 14.8 5.3 90.9 0.0 0.1 0.7 0.5 0.0 10.6 0.2 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.7 10.3 9.1 0.1 0.1 0.3 0.0 0.0 42.5 0.0 35.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 12.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.1 0.2 1.8 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 79.7 0.0 107.6 109.8 27.6 14.8 5.3 90.9 10.6 0.0 10.3 42.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.8 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PPP1CC "PP1C, PP1gamma" ENSG00000186298 "Protein phosphatase 1 catalytic subunit gamma" P36873 12 110719680-110742939 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 639.3;Late spermatids: 923.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022645 Uncertain NA NA 2800000 "CAB022645: " "unprognostic (1.51e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.29e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (2.75e-6)" "unprognostic (6.55e-2)" "unprognostic (4.11e-2)" "unprognostic (6.91e-2)" "unprognostic (4.96e-3)" "unprognostic (5.72e-2)" "unprognostic (2.92e-3)" "unprognostic (1.66e-2)" "unprognostic (1.71e-1)" "unprognostic (8.96e-2)" "unprognostic (1.18e-1)" 63.9 65.5 62.9 77.5 66.0 104.5 73.3 72.3 70.3 59.9 59.7 111.6 195.0 67.3 58.0 92.8 59.8 57.7 84.2 61.7 70.4 60.9 64.9 54.0 140.1 65.2 68.1 56.1 91.1 74.6 68.9 41.8 53.6 69.3 59.1 109.4 126.1 72.2 55.7 159.0 61.2 149.0 77.5 65.6 74.0 74.2 143.5 67.7 108.7 55.4 177.4 132.5 87.1 54.1 70.9 221.0 130.2 217.5 160.0 128.9 176.6 166.0 124.1 183.1 201.0 159.6 223.8 109.0 341.7 91.2 133.8 125.8 122.5 295.3 162.7 278.9 200.2 198.9 221.7 93.0 230.4 105.1 285.5 184.4 112.4 130.5 152.8 135.2 213.2 236.4 190.3 225.1 90.0 186.6 91.7 232.8 318.3 343.6 144.0 190.8 224.9 150.2 216.9 129.6 164.2 174.7 140.3 137.2 162.4 246.7 190.5 254.6 219.9 106.1 102.2 168.8 139.1 158.0 140.4 157.4 291.2 96.2 203.8 159.2 38.3 33.3 54.7 13.2 26.3 12.8 31.7 23.8 18.8 32.8 27.4 19.8 16.4 27.8 14.9 35.0 12.8 25.4 24.3 62.9 66.0 72.3 70.3 61.7 70.4 65.2 68.1 56.1 69.3 65.6 67.7 70.9 71.3 35.3 32.2 27.7 163.4 209.2 124.0 89.6 150.8 203.2 77.6 63.6 138.5 78.6 52.4 36.8 68.8 136.5 61.3 103.9 93.9 75.7 639.3 43.9 72.1 88.8 85.0 131.3 17.9 125.9 204.6 129.6 74.5 47.9 58.4 87.8 62.2 43.4 132.7 102.6 29.9 109.8 93.6 161.3 111.8 923.3 89.8 88.9 128.1 30.0 96.0 91.8 57.7 34.7 34.3 88.3 144.0 138.8 234.3 159.7 305.2 94.6 28.9 110.5 111.7 75.9 133.8 314.6 51.7 161.1 210.0 132.2 106.5 121.8 164.8 156.3 ZNF555 MGC26707 ENSG00000186300 "Zinc finger protein 555" Q8NEP9 19 2841437-2860471 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 81.6;Late spermatids: 62.6;Spermatocytes: 27.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053956, HPA055430" Uncertain NA NA "HPA053956: AB_2682321, HPA055430: AB_2682814" "unprognostic (9.64e-3)" "unprognostic (4.39e-3)" "unprognostic (7.98e-2)" "unprognostic (2.08e-3)" "unprognostic (4.30e-2)" "unprognostic (3.22e-2)" "unprognostic (1.30e-1)" "unprognostic (6.11e-4)" "unprognostic (1.29e-1)" "unprognostic (3.85e-1)" "unprognostic (1.99e-3)" "unprognostic (5.73e-2)" "unprognostic (1.06e-7)" "unprognostic (2.44e-2)" "unprognostic (5.06e-2)" "unprognostic (1.86e-1)" "unprognostic (9.66e-2)" 2.3 1.9 1.0 1.5 1.7 2.8 4.0 2.8 2.4 3.0 0.6 2.2 1.4 3.8 3.0 3.3 3.2 1.4 3.0 1.4 1.2 3.0 2.3 2.2 2.4 2.0 1.6 0.9 6.0 2.7 3.3 1.9 3.9 1.8 2.9 1.8 5.6 2.3 3.5 2.7 2.0 1.7 2.2 1.4 2.8 2.2 5.8 1.6 2.5 4.1 4.7 3.0 2.7 2.4 2.6 2.5 1.2 5.7 4.9 4.6 7.6 2.9 2.2 6.0 5.6 5.6 3.1 2.0 3.1 1.8 3.9 4.3 2.0 4.9 3.1 5.2 0.0 2.3 2.3 1.5 4.0 5.5 0.0 4.0 5.0 4.7 3.0 7.4 6.2 5.6 4.0 5.0 1.7 6.4 0.9 1.9 2.4 3.4 1.5 2.9 4.1 6.0 1.3 6.7 2.5 1.3 4.5 3.2 3.4 5.6 6.6 2.5 4.2 3.8 3.2 1.8 4.7 3.0 1.0 4.7 0.0 3.3 6.4 3.1 5.2 4.7 8.0 3.2 5.6 4.7 3.0 3.6 4.4 6.9 2.1 3.2 2.6 0.5 2.6 9.6 9.6 4.0 3.3 1.0 1.7 2.8 2.4 1.4 1.2 2.0 1.6 0.9 1.8 1.4 1.6 2.6 2.4 0.0 1.1 13.1 2.0 0.6 1.7 1.4 1.8 13.2 2.8 2.5 5.7 1.5 1.0 1.8 18.8 1.9 2.6 0.4 3.9 2.8 81.6 2.4 4.1 2.2 1.2 3.4 8.9 2.0 1.2 3.2 1.5 3.3 0.0 6.2 3.9 0.9 2.1 11.8 11.7 1.3 0.0 1.9 3.8 62.6 5.9 2.7 0.0 1.9 2.9 6.8 1.0 8.5 11.5 1.8 1.5 3.8 5.8 1.7 0.5 2.3 2.3 13.0 0.0 4.7 2.5 27.2 11.3 1.6 1.7 1.6 1.8 4.3 1.0 1.1 OR10T2 ENSG00000186306 "Olfactory receptor family 10 subfamily T member 2" Q8NGX3 1 158398522-158399466 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAP1L3 "MB20, MGC26312, NPL3" ENSG00000186310 "Nucleosome assembly protein 1 like 3" Q99457 X 93670930-93673578 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.8;retina: 41.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 41.8;Excitatory neurons: 27.9;Horizontal cells: 62.2;Inhibitory neurons: 57.1" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Group enriched" "Detected in many" 25 "NK-cells: 3.1;T-cells: 4.1" "Cell line enhanced" "Detected in some" "AF22: 13.6;HAP1: 13.2;NTERA-2: 24.0;SuSa: 20.7;U-2197: 16.1" "Low region specificity" "Detected in all" HPA026075 Approved Vesicles NA NA Vesicles "HPA026075: AB_1854301" "unprognostic (7.18e-2)" "unprognostic (1.81e-2)" "unprognostic (9.26e-2)" "unprognostic (4.83e-4)" "unprognostic (3.06e-1)" "unprognostic (1.28e-2)" "unprognostic (5.10e-2)" "unprognostic (1.76e-1)" "unprognostic (3.31e-2)" "unprognostic (9.29e-2)" "unprognostic (2.75e-3)" "unprognostic (5.01e-2)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.75e-1)" "unprognostic (5.23e-4)" 2.5 13.5 69.2 2.9 68.7 1.2 2.6 62.2 89.8 19.4 27.8 2.7 1.5 12.2 5.6 1.4 10.1 5.5 11.4 62.3 84.0 3.3 1.3 1.8 2.5 61.4 83.4 65.4 16.9 1.3 1.0 18.2 1.5 64.6 4.5 2.4 41.2 1.4 5.4 0.4 1.7 2.0 8.3 49.5 4.6 1.5 16.8 62.6 1.1 5.6 1.2 1.4 3.5 2.8 89.3 0.0 0.2 13.6 9.9 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 7.6 0.3 0.1 13.2 0.0 0.0 0.0 0.3 6.4 0.0 0.2 0.7 0.0 0.4 6.1 0.0 0.6 6.2 0.0 0.0 6.8 0.0 0.0 0.7 0.0 0.0 0.0 24.0 0.0 5.7 0.0 10.5 0.0 0.4 0.1 0.1 1.4 0.0 0.0 0.2 20.7 0.0 0.7 0.0 7.5 10.9 16.1 0.7 10.2 4.5 0.0 4.2 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.7 0.0 2.6 0.9 0.0 0.0 4.1 2.9 0.1 3.1 0.0 0.0 0.8 0.9 69.2 68.7 62.2 89.8 62.3 84.0 61.4 83.4 65.4 64.6 49.5 62.6 89.3 0.8 0.0 0.0 11.8 0.3 0.6 0.3 0.0 0.0 41.8 0.2 1.9 8.3 0.0 0.6 0.0 6.2 0.2 0.8 0.0 17.6 0.1 1.2 0.3 9.9 1.4 0.0 1.3 27.9 0.0 0.2 7.6 0.0 0.3 5.7 7.4 1.1 0.0 0.4 62.2 57.1 0.0 0.0 0.0 0.9 2.2 11.8 0.3 5.4 9.4 0.2 16.6 0.0 16.6 21.2 0.2 0.0 19.5 0.1 0.0 0.0 0.5 1.5 12.9 0.0 6.6 4.0 5.7 7.4 0.0 0.4 0.3 1.6 16.4 0.0 0.0 PRELID2 "FLJ38376, MGC21644" ENSG00000186314 "PRELI domain containing 2" Q8N945 5 145471799-145835369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.8;retina: 15.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 400.3;Inhibitory neurons: 422.9;Proximal enterocytes: 113.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "basophil: 24.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042486 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042486: AB_10797498" "unprognostic (9.45e-3)" "unprognostic (1.95e-1)" "unprognostic (7.58e-3)" "unprognostic (2.71e-5)" "unprognostic (1.96e-3)" "unprognostic (6.53e-4)" "unprognostic (6.62e-5)" "unprognostic (2.27e-1)" "unprognostic (4.21e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (9.65e-6)" "unprognostic (2.65e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-4)" "unprognostic (6.42e-3)" 3.3 1.4 0.5 3.4 1.3 5.0 3.8 0.2 2.2 2.6 0.5 18.3 11.8 2.0 2.5 1.8 2.8 5.6 3.2 1.1 0.3 1.6 2.4 2.1 1.6 0.8 0.8 1.0 4.3 6.2 1.2 1.2 0.7 1.6 1.8 17.5 15.5 2.1 1.9 0.8 2.4 25.8 3.7 1.6 2.0 8.9 1.8 1.9 1.6 4.5 1.4 1.9 2.9 2.6 2.9 16.7 5.4 4.9 8.0 1.1 2.8 0.0 5.5 9.5 10.0 13.9 17.8 26.6 0.0 9.1 6.6 23.0 4.9 3.9 12.3 14.7 4.8 6.3 19.3 5.9 9.3 3.0 2.3 19.3 1.6 5.1 11.5 10.2 13.9 11.4 0.1 10.6 7.3 4.9 2.8 0.0 2.9 2.6 19.4 3.7 0.1 0.0 2.8 4.8 2.5 2.2 4.4 6.9 0.9 10.9 2.3 8.0 3.8 10.7 8.3 4.6 15.4 12.4 0.4 0.1 0.0 15.4 0.0 3.5 24.5 1.3 0.4 0.8 2.2 0.3 1.7 1.5 1.2 5.6 1.6 0.2 1.1 0.3 2.1 1.5 0.6 2.3 1.0 0.5 1.3 0.2 2.2 1.1 0.3 0.8 0.8 1.0 1.6 1.6 1.9 2.9 12.3 0.0 2.7 47.7 2.7 4.1 12.3 15.1 11.4 43.7 8.5 8.0 10.3 14.3 8.1 0.0 400.3 0.4 1.5 87.1 0.0 13.6 8.8 1.5 2.4 7.3 9.6 19.1 65.3 12.9 2.8 8.2 29.0 2.5 17.7 10.8 8.2 1.9 2.7 5.0 422.9 27.0 2.0 2.5 7.4 2.1 3.4 4.3 0.0 67.5 2.9 7.9 0.0 36.7 90.7 17.4 50.9 4.5 4.1 4.3 113.1 2.8 3.5 48.9 0.0 6.5 6.0 2.4 2.9 4.4 3.3 0.3 3.6 9.9 39.3 8.7 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 121.5;pancreas: 273.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 88.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.76e-4)" 15.4 16.2 42.3 8.1 64.4 3.3 11.8 68.0 51.4 18.4 15.5 11.5 6.2 19.9 8.9 13.7 16.1 19.2 11.5 37.4 48.2 14.9 25.8 14.5 5.2 80.6 70.4 31.7 20.6 273.8 18.7 10.8 13.9 72.7 13.6 7.7 45.1 11.1 18.5 12.6 11.1 7.7 21.5 83.6 12.5 9.9 11.3 60.4 3.8 12.3 9.2 5.1 12.5 14.4 121.5 11.5 10.7 22.9 37.3 80.9 82.3 1.0 62.9 44.4 24.4 19.0 4.5 16.4 1.4 14.6 88.3 18.4 17.9 24.3 12.1 20.5 3.1 12.1 6.0 17.3 5.1 36.5 2.5 1.7 68.1 20.2 29.7 31.8 68.0 21.4 3.8 2.7 1.1 46.5 33.4 2.5 2.1 15.5 10.6 25.9 6.4 11.6 1.6 12.2 5.9 31.7 36.7 22.5 2.6 5.9 23.5 26.2 7.6 31.4 45.2 5.0 48.2 19.4 0.7 1.0 1.1 23.8 2.0 34.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.3 64.4 68.0 51.4 37.4 48.2 80.6 70.4 31.7 72.7 83.6 60.4 121.5 12.1 19.2 10.1 16.3 0.3 4.7 4.1 3.4 9.1 53.7 8.7 9.0 8.7 18.6 13.3 5.5 118.9 1.0 0.1 2.0 5.9 7.4 99.9 5.1 32.1 8.3 21.7 1.7 24.9 20.0 1.3 19.5 3.1 8.9 2.5 15.8 6.8 38.6 9.4 57.2 32.0 5.1 2.0 17.2 7.7 343.0 19.3 7.9 3.6 14.0 4.0 17.9 0.0 22.1 99.8 4.3 6.3 22.2 0.1 2.4 1.7 6.3 3.4 55.2 6.6 18.1 14.2 3.4 1.7 10.6 3.4 0.8 1.2 68.0 4.5 3.4 RGS9BP "FLJ45744, PERRS, R9AP" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675848-32678300 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 23.3;retina: 17.5;skeletal muscle: 9.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 29.0;Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 75.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.3;HMC-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.0 0.1 0.7 0.0 0.7 0.0 0.0 1.0 1.0 0.0 23.3 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.9 3.3 0.8 0.3 0.0 0.3 0.0 1.1 1.6 0.3 0.0 0.0 0.2 0.2 0.0 0.9 0.2 0.0 17.5 0.1 0.1 9.1 0.1 0.0 0.0 0.6 0.0 0.1 0.4 1.4 0.1 0.0 3.2 0.0 0.4 0.0 0.7 0.1 0.1 0.0 0.5 0.3 0.1 0.3 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.3 0.0 1.0 0.0 0.0 0.2 0.1 6.3 0.1 0.0 0.1 0.1 1.6 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.8 0.1 0.2 0.0 1.0 0.0 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.3 0.0 0.2 0.3 0.1 0.1 0.3 0.4 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 1.0 1.0 3.3 0.8 1.1 1.6 0.3 0.9 0.6 1.4 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 29.0 0.4 0.4 4.6 0.0 0.0 1.8 56.3 0.3 0.6 0.5 0.0 0.0 5.1 0.2 0.1 0.7 0.0 0.8 0.0 0.0 0.2 0.2 0.0 0.4 0.0 1.8 0.7 0.0 0.2 1.7 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.1 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.9 0.0 75.4 0.0 0.4 0.2 0.5 0.4 0.0 0.0 0.0 0.1 1.1 0.4 0.0 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.3;fallopian tube: 30.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 30.9;Club cells: 25.8;granulocytes: 15.2;Respiratory ciliated cells: 102.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 1.0 1.0 3.2 1.5 6.5 3.8 1.0 17.3 14.2 0.9 0.9 1.9 1.1 1.7 1.6 0.6 30.4 1.1 1.0 5.7 2.0 0.8 6.5 4.3 1.6 1.8 2.0 2.7 1.4 0.9 0.8 0.0 1.2 5.0 1.1 2.0 7.9 1.4 0.6 2.6 2.7 1.5 0.5 0.0 1.5 1.2 2.9 2.0 0.6 1.3 0.3 1.0 0.6 0.0 11.1 2.1 1.5 1.5 1.5 0.4 0.1 3.0 1.2 0.5 0.6 0.6 1.3 1.7 3.0 1.5 0.9 1.4 1.4 1.0 0.8 1.4 4.3 1.4 2.7 4.5 1.5 0.2 2.4 2.2 0.7 0.6 0.8 0.6 0.7 0.8 1.8 2.2 4.5 0.5 1.7 1.7 2.2 2.4 0.9 1.3 1.4 2.1 2.2 0.6 2.2 1.9 1.6 2.1 1.6 1.1 1.4 1.6 1.6 3.6 2.0 2.4 3.4 1.5 2.7 2.3 1.8 1.1 1.4 1.1 3.2 0.7 0.6 0.8 0.6 0.6 0.5 0.5 0.5 0.3 1.1 0.6 0.7 1.5 1.2 0.7 1.1 0.4 0.2 3.2 6.5 17.3 14.2 5.7 2.0 1.8 2.0 2.7 5.0 0.0 2.0 11.1 0.0 35.3 30.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 25.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 9.2 0.2 3.6 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.1 15.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.5 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 0.0 0.3 0.3 0.7 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.1 SLC36A3 "PAT3, TRAMD2, tramdorin2" ENSG00000186334 "Solute carrier family 36 member 3" Q495N2 5 151276358-151303766 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 30 "testis: 7.6" "Group enriched" "Detected in some" 132 "Early spermatids: 48.4;Late spermatids: 110.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.41e-1)" "unprognostic (5.38e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-1)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (2.57e-2)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 110.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC36A2 "PAT2, TRAMD1, tramdorin" ENSG00000186335 "Solute carrier family 36 member 2" Q495M3 5 151314972-151347590 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 60 "kidney: 68.2;skeletal muscle: 81.0;tongue: 30.1" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 53.0" "Cancer enriched" "Detected in single" 9 "renal cancer: 0.5" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA044002, HPA062229" Enhanced NA NA "HPA044002: AB_10964214, HPA062229: AB_2684717" "unprognostic (3.47e-1)" "unprognostic (3.40e-1)" "unprognostic (2.26e-2)" "unprognostic (6.23e-2)" "unprognostic (8.38e-3)" "unprognostic (4.66e-3)" "unprognostic (3.03e-1)" "unprognostic (7.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (3.89e-2)" 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.8 0.6 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.1 0.2 0.1 68.2 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.2 0.9 0.0 81.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 30.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.4 0.2 0.2 1.1 0.4 0.1 0.4 0.1 0.1 0.2 0.1 0.8 0.6 0.2 0.1 0.2 0.0 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.9 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 THBS2 TSP2 ENSG00000186340 "Thrombospondin 2" P35442 6 169215780-169254050 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 86.8;Endometrial stromal cells: 71.1;Fibroblasts: 127.7;Langerhans cells: 69.8;Melanocytes: 56.9;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 55.8;Smooth muscle cells: 33.7;Suprabasal keratinocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 250.2;ASC TERT1: 200.3;BJ hTERT+: 88.6;BJ hTERT+ SV40 Large T+: 96.3;BJ hTERT+ SV40 Large T+ RasG12V: 117.8;HSkMC: 113.2;hTEC/SVTERT24-B: 127.2;U-2197: 107.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017716, HPA044304" Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 21000000 "Plasma membrane" "Nuclear speckles, Cytosol" "CAB017716: , HPA044304: AB_2678891" "unprognostic (2.85e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (8.90e-2)" "unprognostic (3.64e-2)" "unprognostic (8.73e-2)" "unprognostic (2.93e-1)" "unprognostic (5.10e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-2)" "unprognostic (4.00e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (3.77e-6)" "unprognostic (2.19e-3)" "unprognostic (4.38e-2)" "unprognostic (4.16e-2)" "unprognostic (2.48e-3)" 48.1 8.0 6.2 15.0 13.3 0.0 36.5 9.4 8.1 53.9 4.8 16.9 2.5 50.4 0.7 12.1 35.0 50.8 33.4 4.4 11.6 8.2 8.3 20.0 3.3 17.0 13.4 1.5 33.5 5.6 1.7 9.5 2.2 22.9 9.8 2.4 0.1 8.3 2.5 3.4 39.8 9.3 21.4 9.4 3.3 5.5 2.3 13.4 0.6 17.2 1.8 1.2 29.4 31.0 19.1 0.2 0.0 2.5 1.1 250.2 200.3 0.0 76.8 88.6 96.3 117.8 0.4 0.0 0.1 0.1 76.1 0.2 0.1 2.4 3.2 22.5 0.0 0.0 0.0 0.0 0.0 73.1 0.3 0.0 113.2 0.0 127.2 0.0 0.2 0.0 0.0 0.0 0.1 3.7 0.0 0.1 1.7 16.3 0.0 0.6 0.0 0.1 1.1 0.0 0.4 0.3 0.2 0.2 0.1 0.0 0.2 0.0 0.7 0.0 46.1 0.4 107.6 9.3 0.1 0.7 0.0 30.6 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 13.3 9.4 8.1 4.4 11.6 17.0 13.4 1.5 22.9 9.4 13.4 19.1 3.5 6.4 0.0 6.8 0.0 86.8 1.6 0.1 1.8 0.4 2.2 1.8 5.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.2 3.1 71.1 4.6 0.0 0.0 1.2 0.0 0.0 127.7 1.1 1.4 0.0 0.0 15.4 0.0 0.3 0.0 1.7 0.0 0.0 0.0 69.8 0.3 8.1 1.2 56.9 6.5 0.0 0.2 0.0 40.7 55.8 0.5 0.0 16.1 0.0 1.9 0.0 4.4 0.0 0.2 0.0 1.0 33.7 0.0 0.4 1.2 42.3 0.1 2.1 5.5 0.0 0.9 RXRA NR2B1 ENSG00000186350 "Retinoid X receptor alpha" P19793 9 134317098-134440585 "Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 218.9;Kupffer cells: 134.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 19.5" "Group enriched" "Detected in many" 5 "granulocytes: 19.5;monocytes: 12.9" "Cell line enhanced" "Detected in many" "HaCaT: 105.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004565, CAB005352" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "CAB004565: AB_2184877, CAB005352: AB_2184874" "unprognostic (2.68e-1)" "unprognostic (7.94e-2)" "unprognostic (3.67e-2)" "unprognostic (7.22e-2)" "unprognostic (2.07e-2)" "unprognostic (6.69e-2)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.65e-3)" "prognostic favorable (7.02e-4)" "unprognostic (7.72e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" 40.9 22.9 31.9 14.6 30.3 19.0 11.3 24.8 29.6 12.3 16.0 16.7 26.1 13.7 8.8 28.8 16.6 13.7 19.6 25.5 27.3 16.1 33.1 19.0 8.3 32.2 28.5 20.5 21.9 25.7 45.5 3.5 14.6 30.1 15.7 10.1 5.5 21.8 17.2 107.5 88.8 28.3 11.2 26.6 25.3 14.8 8.0 37.0 6.0 17.7 52.3 7.7 16.4 8.3 22.3 19.6 36.4 14.7 21.9 42.8 19.1 66.7 14.1 16.1 9.6 6.5 20.7 28.0 0.0 25.8 22.5 15.1 105.5 7.7 32.8 2.9 26.3 7.2 0.1 47.5 30.0 20.4 18.8 4.8 29.0 52.1 11.5 10.6 12.9 12.8 1.6 26.0 1.1 8.7 61.8 1.1 59.5 17.5 63.4 16.9 7.4 30.3 36.7 12.2 64.3 17.2 10.5 37.3 46.9 10.6 7.1 44.9 78.8 16.5 16.2 23.4 17.4 9.7 1.7 0.2 0.4 11.6 33.9 12.7 1.3 8.1 6.6 1.4 12.9 0.2 0.3 0.9 1.0 3.2 0.1 0.2 1.2 19.5 2.2 11.2 0.7 1.2 3.2 31.9 30.3 24.8 29.6 25.5 27.3 32.2 28.5 20.5 30.1 26.6 37.0 22.3 32.1 32.1 22.9 36.2 4.6 34.5 16.5 21.1 12.5 6.0 16.7 14.4 38.8 72.9 26.2 9.2 25.0 30.1 11.0 72.3 1.9 13.9 4.3 19.8 16.6 28.9 9.6 30.9 9.1 14.1 29.5 23.7 17.9 17.4 1.3 21.3 71.0 218.9 31.9 33.7 17.6 21.2 10.2 134.2 30.0 18.8 32.3 50.4 12.4 10.3 80.4 36.5 14.4 29.1 6.0 15.9 32.4 21.1 7.4 17.7 55.6 19.9 34.4 19.9 19.7 34.6 30.6 0.9 9.4 34.4 46.9 23.9 12.6 15.5 27.5 32.8 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 94.6" "Cell type enhanced" "Detected in all" "Club cells: 257.6;Endometrial ciliated cells: 271.9;Respiratory ciliated cells: 263.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: AB_2683614" "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 15.1 10.4 37.7 4.4 31.4 3.3 13.5 33.1 47.3 21.2 41.7 9.3 7.9 6.1 3.7 70.2 11.8 6.8 24.2 32.1 43.1 14.3 26.4 9.9 4.1 36.3 32.3 29.3 29.3 17.7 1.4 22.0 15.2 35.6 35.5 9.6 94.6 31.5 5.7 30.5 14.9 6.5 4.4 34.1 7.1 9.0 11.3 36.4 5.1 24.2 13.4 7.5 10.9 29.8 40.1 12.6 1.6 1.1 5.4 7.4 4.5 4.9 4.8 3.7 3.7 6.8 2.9 3.4 4.3 2.4 8.4 6.4 4.3 6.5 6.2 4.2 12.4 0.7 2.8 5.8 8.3 3.3 2.4 7.6 1.2 6.4 3.0 3.6 23.8 3.9 2.9 5.0 8.2 9.4 2.6 2.6 12.1 1.7 1.1 8.3 0.5 1.5 13.4 4.5 1.1 7.2 12.9 3.7 4.1 14.4 4.6 4.1 2.3 5.1 6.6 5.0 4.2 5.1 13.3 5.2 2.2 20.9 2.8 6.9 0.5 3.3 8.3 4.1 3.2 3.9 6.8 3.6 6.7 2.0 6.9 2.4 3.4 1.2 3.9 3.3 3.4 4.5 2.5 37.7 31.4 33.1 47.3 32.1 43.1 36.3 32.3 29.3 35.6 34.1 36.4 40.1 39.3 22.4 28.7 9.1 104.2 59.4 41.8 197.9 42.7 29.9 66.9 92.3 1.8 11.5 257.6 9.2 29.2 25.0 69.8 93.8 25.4 25.2 6.2 271.9 18.9 44.7 119.9 8.4 8.0 23.3 43.0 28.6 142.2 96.5 61.7 7.7 12.1 25.8 15.4 10.1 7.9 186.6 89.5 8.1 170.2 3.2 9.3 53.3 142.3 12.2 17.7 99.8 1.0 4.0 4.6 32.3 53.3 11.7 223.5 38.5 60.9 31.5 263.3 115.2 6.6 27.3 38.7 32.1 28.4 54.0 48.2 84.4 65.8 7.4 50.8 20.2 NUDT17 FLJ34433 ENSG00000186364 "Nudix hydrolase 17" P0C025 1 145845630-145848954 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 15.1;Muller glia cells: 9.1;Spermatogonia: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 8.3;eosinophil: 17.5;plasmacytoid DC: 26.6" "Group enriched" "Detected in many" 9 "dendritic cells: 26.6;granulocytes: 17.5" "Cell line enhanced" "Detected in many" "T-47d: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030145 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA030145: AB_10603883" "unprognostic (8.93e-3)" "unprognostic (2.28e-1)" "unprognostic (2.63e-3)" "unprognostic (8.72e-3)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.07e-3)" "unprognostic (6.55e-2)" "unprognostic (6.03e-2)" "unprognostic (1.24e-2)" "unprognostic (5.40e-2)" "prognostic unfavorable (1.81e-7)" "unprognostic (5.59e-2)" "unprognostic (1.63e-1)" "unprognostic (6.16e-2)" "unprognostic (1.96e-1)" 1.6 2.3 5.4 1.7 5.6 3.3 2.0 5.8 7.1 2.7 4.7 2.2 0.5 2.0 1.2 2.2 2.8 1.8 3.3 5.3 5.7 2.6 2.0 1.8 4.3 5.6 5.2 5.1 2.7 2.8 2.3 3.1 0.8 5.2 2.7 1.1 2.6 1.9 2.2 3.1 2.1 2.4 1.2 5.2 4.1 2.1 4.1 5.8 2.0 2.5 2.2 3.3 2.8 2.3 5.2 3.7 2.6 2.4 1.3 1.2 2.0 2.4 1.7 2.8 1.8 2.4 1.6 2.6 5.3 1.8 2.9 0.4 0.7 1.8 1.0 1.2 0.6 3.0 2.1 2.5 2.5 3.8 1.6 6.7 2.0 1.6 1.2 2.0 2.2 3.6 8.6 4.6 4.8 3.3 5.8 1.8 3.1 2.0 2.2 0.3 4.8 0.9 1.7 3.0 0.9 1.1 2.7 1.1 2.2 3.0 2.5 12.2 7.5 2.1 2.1 1.3 1.0 0.7 4.2 2.1 1.4 1.9 2.3 1.6 8.3 0.9 17.5 0.8 2.5 0.5 1.4 0.7 0.5 0.9 0.8 1.5 1.1 0.1 0.3 1.7 26.6 0.8 1.1 5.4 5.6 5.8 7.1 5.3 5.7 5.6 5.2 5.1 5.2 5.2 5.8 5.2 3.1 3.2 5.5 0.7 1.8 1.8 0.8 1.4 2.2 1.9 2.6 4.6 0.8 2.8 3.4 0.0 0.0 0.6 15.1 0.8 1.9 1.0 3.3 3.5 1.7 1.8 1.2 0.4 0.6 0.7 0.7 2.3 2.6 4.1 2.5 1.7 1.8 0.5 3.0 0.0 0.7 0.5 2.0 0.6 1.6 2.1 1.5 2.3 1.8 1.9 0.5 9.1 3.1 2.0 0.9 1.4 1.4 0.4 3.8 1.0 0.7 0.6 1.7 3.8 0.0 3.7 1.2 6.8 14.8 1.6 1.3 0.5 2.2 1.8 1.2 0.8 MINAR2 KIAA1024L ENSG00000186367 "Membrane integral NOTCH2 associated receptor 2" P59773 5 129748094-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "skeletal muscle: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA013760 Uncertain NA NA "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.2 0.1 1.1 0.0 1.0 0.1 0.2 1.0 1.4 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.0 1.2 0.0 0.1 0.2 0.1 1.1 1.0 1.0 0.0 0.1 0.0 0.0 0.4 0.9 0.1 0.0 0.2 0.0 0.1 36.2 0.1 0.0 0.1 0.8 0.4 0.1 0.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.3 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.4 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.4 0.5 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.9 0.2 0.0 0.3 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.7 1.3 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.6 0.1 0.2 0.8 0.1 0.0 1.1 1.0 1.0 1.4 1.0 1.2 1.1 1.0 1.0 0.9 0.8 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ZNF75D "D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28" ENSG00000186376 "Zinc finger protein 75D" P51815 X 135248920-135344109 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 202.9;Late spermatids: 378.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004705 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA004705: AB_1080749" "unprognostic (1.56e-3)" "unprognostic (7.96e-3)" "unprognostic (3.07e-1)" "unprognostic (5.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "prognostic favorable (7.42e-5)" 6.1 14.6 4.8 5.7 5.0 7.0 6.3 4.7 5.4 6.8 5.5 6.4 4.8 6.3 7.5 5.3 7.1 4.8 5.5 4.6 5.2 8.4 11.1 6.7 8.5 5.1 5.0 4.6 6.9 9.9 7.1 7.0 5.0 5.4 10.3 5.6 6.7 6.5 6.0 5.2 6.9 8.2 4.9 5.0 14.0 7.5 2.3 5.2 8.6 9.4 3.9 7.2 6.0 5.8 5.4 3.3 4.3 4.6 7.4 7.7 9.3 7.0 5.5 7.5 4.4 9.4 2.6 4.1 3.5 7.9 4.7 8.5 4.5 15.2 2.5 4.2 3.3 4.0 2.4 8.6 3.5 3.3 4.1 6.6 4.6 5.9 2.7 3.4 5.5 4.6 4.4 2.1 5.4 3.9 8.0 5.0 7.5 2.2 6.7 5.8 4.7 4.6 3.1 5.0 4.5 1.5 5.2 3.1 5.2 0.9 4.9 1.8 5.9 4.8 4.2 1.0 7.1 5.3 2.7 4.1 2.5 2.6 4.5 2.7 2.7 1.0 2.0 2.3 0.8 2.1 1.4 2.5 2.7 0.9 1.6 3.1 2.8 1.1 2.8 0.8 0.8 3.4 1.5 4.8 5.0 4.7 5.4 4.6 5.2 5.1 5.0 4.6 5.4 5.0 5.2 5.4 6.4 6.4 12.9 23.5 7.5 1.8 1.3 1.4 2.8 4.9 3.9 2.0 4.7 1.5 5.0 0.0 6.2 2.4 8.4 3.7 1.9 2.0 202.9 9.2 4.8 7.1 1.8 0.8 18.5 4.0 1.5 4.2 6.1 4.9 6.3 4.9 5.7 5.3 2.4 5.0 21.8 5.0 6.1 2.9 1.6 378.3 6.5 3.8 0.0 28.1 3.9 4.1 6.2 18.6 21.4 3.1 2.8 3.4 5.0 2.3 3.3 3.7 5.1 5.1 0.0 3.4 3.5 7.6 3.1 3.4 1.4 1.8 7.1 10.2 3.6 2.3 CYP4X1 MGC40051 ENSG00000186377 "Cytochrome P450 family 4 subfamily X member 1" Q8N118 1 47023669-47050751 "Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 37.4;salivary gland: 31.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 37.5;Club cells: 59.0;Excitatory neurons: 37.4;Respiratory ciliated cells: 104.6" "Cancer enhanced" "Detected in many" "breast cancer: 24.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.6;CACO-2: 4.6;NTERA-2: 2.1;SCLC-21H: 2.7;T-47d: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017661 Approved NA NA "HPA017661: AB_2669633" "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (1.78e-2)" "unprognostic (9.88e-2)" "unprognostic (1.56e-3)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (2.76e-2)" "unprognostic (3.03e-2)" "unprognostic (1.79e-3)" "unprognostic (3.65e-2)" "unprognostic (8.56e-2)" "unprognostic (5.03e-2)" 9.8 3.2 7.4 0.7 9.4 0.1 15.0 5.9 11.2 37.4 4.6 1.6 1.7 2.1 2.8 14.9 9.4 1.6 6.3 8.8 11.0 5.9 10.6 8.9 1.9 5.5 5.8 8.8 1.2 1.7 1.7 3.8 1.1 6.3 8.1 1.9 2.3 31.3 2.9 4.7 6.4 1.4 1.9 3.8 0.7 22.5 4.0 8.5 1.1 5.0 4.1 9.2 3.4 7.2 7.6 0.0 0.0 0.0 0.0 2.6 0.2 0.1 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.3 0.0 0.4 0.2 2.7 0.0 0.0 0.2 0.0 0.1 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 9.4 5.9 11.2 8.8 11.0 5.5 5.8 8.8 6.3 3.8 8.5 7.6 4.4 22.4 17.0 2.3 0.0 2.5 26.9 37.5 25.0 2.4 31.0 0.9 0.8 1.5 59.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 8.4 7.6 0.8 4.0 0.0 0.0 37.4 0.7 0.0 7.1 4.1 1.4 0.0 0.0 1.1 2.8 3.9 0.0 29.3 0.2 18.3 0.6 0.7 8.6 10.5 0.5 5.4 4.7 0.0 0.1 0.0 1.0 2.0 0.1 0.0 20.7 0.0 8.4 0.5 1.7 104.6 0.8 0.0 2.0 19.1 0.5 3.6 21.4 1.4 0.1 0.5 0.1 1.9 31.8 KRT26 KRT25B ENSG00000186393 "Keratin 26" Q7Z3Y9 17 40766238-40772162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "skin 1: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "basophil: 2.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026890 Enhanced NA NA "HPA026890: AB_2672042" 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.8 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.6 0.2 0.2 0.2 0.3 0.1 0.5 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 KRT10 "CK10, K10, KPP" ENSG00000186395 "Keratin 10" P13645 17 40818117-40822614 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "skin 1: 15560.6" "Cell type enriched" "Detected in all" 5 "Suprabasal keratinocytes: 12515.3" "Group enriched" "Detected in all" 4 "head and neck cancer: 310.0;melanoma: 562.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "hTCEpi: 718.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000132, HPA012014" Enhanced "Secreted in other tissues" NA NA 18000000000 "CAB000132: , HPA012014: AB_1852195" "unprognostic (3.07e-1)" "unprognostic (5.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.37e-2)" "unprognostic (2.00e-2)" "unprognostic (2.60e-1)" "unprognostic (3.02e-2)" "unprognostic (1.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (1.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.32e-5)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-2)" "unprognostic (8.10e-2)" 64.6 48.3 9.7 7.6 10.0 13.5 436.9 10.1 15.0 289.7 10.8 44.6 8.0 55.4 5.5 79.2 45.9 2.3 93.8 10.1 10.2 57.3 65.0 40.0 6.3 10.1 10.0 9.6 52.8 69.7 8.3 77.8 3.8 10.1 60.5 3.4 7.0 165.2 5.5 124.2 15560.6 48.6 4.0 10.2 57.3 58.5 65.4 10.3 44.4 53.9 5.9 13.9 48.9 1115.1 10.7 30.3 31.2 11.0 12.2 14.4 11.5 10.4 29.9 16.5 11.4 10.6 11.2 11.7 8.7 42.0 13.1 16.2 158.5 5.4 11.3 13.4 20.1 27.0 9.2 44.7 19.4 16.4 17.1 24.9 10.1 718.0 9.0 17.3 15.0 7.4 12.3 102.1 16.0 12.2 17.3 25.5 16.2 14.6 23.1 19.1 17.8 16.7 17.7 12.3 26.3 8.9 11.1 19.9 46.0 39.0 17.3 35.5 24.3 9.3 17.6 29.5 22.5 34.4 0.4 19.8 22.4 24.5 10.4 23.4 12.8 2.6 11.1 4.8 2.3 5.4 11.2 5.4 6.8 4.1 5.6 5.8 5.9 0.8 6.9 3.2 8.1 5.5 1.9 9.7 10.0 10.1 15.0 10.1 10.2 10.1 10.0 9.6 10.1 10.2 10.3 10.7 197.8 35.3 40.0 19.2 187.5 2239.7 320.6 370.2 255.6 47.0 304.4 328.2 194.2 174.5 197.2 112.2 20.9 117.4 163.2 138.9 305.2 232.5 150.4 174.3 172.2 170.0 181.1 87.7 19.1 376.9 295.7 204.5 126.9 164.5 74.3 87.0 159.5 237.6 105.0 21.9 16.3 237.6 195.3 90.3 350.7 65.6 216.6 116.8 393.1 20.6 100.1 221.4 162.7 17.6 35.0 236.0 149.8 174.9 311.6 342.0 155.3 233.2 116.8 68.6 105.2 141.0 167.7 345.1 121.2 295.0 12515.3 160.1 164.3 131.4 173.1 515.6 GOLGA8R ENSG00000186399 "Golgin A8 family member R" I6L899 15 30403740-30414162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 69.3;NK-cells: 23.7;Sertoli cells: 13.1;Spermatocytes: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 23.9;THP-1: 7.6;U-937: 8.0" NA NA "unprognostic (1.13e-1)" "unprognostic (8.96e-3)" "unprognostic (1.27e-2)" "unprognostic (9.06e-2)" "unprognostic (1.87e-2)" "unprognostic (4.70e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (9.09e-2)" "unprognostic (9.79e-4)" "unprognostic (2.29e-1)" "unprognostic (2.12e-1)" "unprognostic (4.41e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (9.68e-2)" 2.7 1.8 0.4 1.1 0.6 3.8 2.7 0.3 0.7 3.0 1.1 2.4 0.7 3.1 1.6 1.7 3.1 1.0 2.9 0.2 0.4 1.6 2.4 2.2 0.6 1.7 0.7 0.0 5.6 3.9 1.3 5.3 0.4 2.2 2.0 0.4 1.2 2.8 0.6 2.3 2.1 2.4 0.9 0.3 1.7 2.2 6.2 1.2 0.3 8.9 0.8 0.5 2.9 2.9 1.4 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.3 0.0 0.2 0.0 0.1 0.3 0.2 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 23.9 0.0 0.0 0.3 0.0 0.0 0.4 0.4 0.1 0.0 1.4 0.1 0.2 0.1 0.1 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.1 7.6 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 8.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.6 0.3 0.7 0.2 0.4 1.7 0.7 0.0 2.2 0.3 1.2 1.4 0.6 0.0 1.5 0.3 1.2 0.0 0.2 0.0 0.0 3.2 0.2 0.3 0.8 1.5 1.3 0.0 0.0 0.2 4.1 0.1 0.0 0.1 69.3 4.0 1.2 0.8 0.0 0.4 0.2 0.0 0.0 1.1 0.0 0.8 1.3 1.8 0.4 0.4 0.3 8.4 0.2 0.1 0.0 0.8 0.0 4.9 1.2 0.9 0.0 1.0 1.6 1.1 23.7 0.5 1.4 0.1 0.1 0.4 1.2 0.2 0.5 0.1 0.7 3.6 13.1 1.7 1.0 20.4 1.9 0.0 0.0 0.0 2.8 1.5 0.3 0.3 CD300E "CD300LE, CLM2, IREM2" ENSG00000186407 "CD300e molecule" Q496F6 17 74609885-74623738 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.6;lymphoid tissue: 37.8" "Group enriched" "Detected in some" 5 "Kupffer cells: 71.8;Macrophages: 112.4;monocytes: 100.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 88.0;intermediate monocyte: 135.1;non-classical monocyte: 148.5" "Lineage enriched" "Detected in many" 7 "monocytes: 148.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA015570 Uncertain NA NA "HPA015570: AB_1846294" "unprognostic (1.70e-1)" "unprognostic (6.82e-2)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" "unprognostic (1.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.68e-2)" "unprognostic (7.80e-3)" "unprognostic (4.51e-1)" "unprognostic (1.53e-1)" "unprognostic (2.69e-2)" "unprognostic (5.15e-2)" "unprognostic (4.19e-7)" "unprognostic (1.90e-2)" "unprognostic (2.00e-4)" "unprognostic (7.38e-3)" "unprognostic (1.19e-1)" 14.2 0.8 0.6 37.8 0.3 48.6 0.8 1.3 1.6 0.5 2.1 1.0 0.5 0.6 0.2 0.5 3.2 3.8 1.5 0.4 2.8 0.9 2.5 16.9 1.1 0.5 0.4 0.1 0.4 0.9 0.2 0.3 3.1 1.1 0.6 0.9 0.5 0.6 0.2 1.3 0.7 0.6 10.3 0.1 11.1 1.0 0.5 3.0 0.7 0.5 0.3 0.7 18.3 0.6 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 88.0 0.6 0.2 135.1 0.1 0.1 0.1 0.1 21.8 0.1 0.1 0.0 1.9 0.1 148.5 0.6 0.1 53.9 0.6 0.3 1.3 1.6 0.4 2.8 0.5 0.4 0.1 1.1 0.1 3.0 2.6 0.3 6.4 15.9 0.0 2.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 8.6 1.8 0.0 0.1 2.9 0.0 1.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 4.0 0.5 0.0 3.8 0.0 0.4 0.4 4.1 0.0 0.2 0.0 0.0 71.8 13.0 0.1 0.0 112.4 1.8 0.0 100.1 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.5 1.5 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.6 0.4 2.3 0.0 0.0 0.0 CCDC30 "FLJ20972, LOC728621, PFD6L" ENSG00000186409 "Coiled-coil domain containing 30" Q5VVM6 1 42463221-42657190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 10.7" "Cell type enhanced" "Detected in many" "Early spermatids: 81.9;Endometrial ciliated cells: 62.9;Excitatory neurons: 109.2;Inhibitory neurons: 70.3;Respiratory ciliated cells: 109.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036344, HPA036345" Approved NA NA "HPA036344: AB_10795572, HPA036345: AB_10796213" "unprognostic (3.21e-2)" "unprognostic (8.48e-2)" "unprognostic (3.33e-1)" "unprognostic (4.46e-2)" "unprognostic (2.35e-1)" "unprognostic (5.72e-3)" "unprognostic (6.77e-3)" "unprognostic (7.68e-3)" "unprognostic (4.61e-3)" "unprognostic (1.41e-2)" "unprognostic (3.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.70e-3)" "unprognostic (6.95e-3)" 0.8 1.5 8.5 0.7 3.7 1.6 2.3 4.8 4.3 2.4 10.7 0.7 0.7 1.8 5.1 0.7 6.2 1.3 0.7 3.8 4.6 4.8 0.7 1.8 1.0 5.3 4.5 2.8 2.3 1.5 3.4 1.6 0.9 3.1 1.5 1.0 3.2 1.4 2.0 1.6 1.7 1.1 1.1 4.5 1.2 0.8 3.9 3.9 1.0 4.9 0.5 0.8 0.8 0.2 3.7 1.4 0.9 2.1 2.2 1.0 1.2 0.7 0.7 0.3 1.1 1.0 0.8 2.5 1.6 1.0 0.2 1.2 0.9 1.0 1.2 1.5 1.3 1.4 1.0 2.0 0.7 1.0 1.3 8.8 0.6 2.3 1.9 0.8 2.0 0.8 1.0 0.9 0.9 0.5 0.8 0.8 1.6 1.3 0.7 0.6 0.7 0.8 0.9 2.7 0.7 2.6 2.1 0.8 1.7 1.5 1.9 1.2 3.2 0.3 1.0 1.0 1.3 1.1 1.1 1.0 0.7 1.9 2.4 1.0 5.8 1.0 2.4 1.0 0.6 1.1 1.0 0.6 0.9 0.7 1.4 1.0 0.8 4.6 1.3 1.7 1.8 1.0 0.4 8.5 3.7 4.8 4.3 3.8 4.6 5.3 4.5 2.8 3.1 4.5 3.9 3.7 2.8 6.4 12.9 43.1 2.0 1.3 2.8 2.5 2.2 5.8 5.5 4.2 2.7 5.7 21.1 7.3 8.4 1.6 6.3 3.1 1.9 5.9 81.9 62.9 5.5 3.8 3.0 4.0 109.2 2.4 1.0 5.2 2.0 4.2 8.9 11.8 2.5 0.9 1.2 6.7 70.3 2.0 2.0 2.5 1.7 37.7 5.9 3.0 1.8 33.7 4.5 5.3 5.2 40.2 41.6 1.3 2.9 7.2 1.3 2.3 3.0 9.1 109.1 9.3 6.6 9.0 5.3 42.4 6.6 1.0 1.0 1.8 3.9 7.1 1.3 1.9 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119606443 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 4.1 6.5 11.0 5.7 12.7 6.9 5.4 10.3 14.9 4.1 9.4 3.7 4.2 3.9 4.0 5.6 4.4 3.5 3.9 12.9 13.3 6.0 6.0 4.2 8.7 11.6 10.7 11.5 6.2 3.8 5.3 5.5 6.5 12.1 4.1 3.6 5.4 4.0 3.5 5.5 5.9 4.3 4.1 10.2 5.9 4.1 1.9 12.2 9.6 4.7 4.6 8.5 6.3 4.4 15.8 17.9 18.3 10.4 11.3 8.7 8.5 15.5 10.7 8.5 14.1 15.0 19.8 15.3 31.8 18.4 9.2 12.1 20.4 43.8 16.4 17.2 16.4 28.9 16.8 20.3 12.9 8.3 33.5 11.8 9.5 13.2 16.3 19.2 9.6 14.1 15.3 18.5 12.6 12.5 27.6 20.8 25.2 23.1 26.2 19.9 16.5 15.2 32.7 18.8 12.7 16.7 14.2 15.2 23.1 16.5 10.6 9.7 20.0 12.2 8.7 9.5 19.3 27.1 10.5 14.1 32.9 9.3 36.3 10.1 1.1 0.5 0.7 1.0 0.8 1.1 1.3 1.2 1.3 0.6 1.2 1.9 1.6 0.1 0.5 0.3 0.9 1.8 0.8 11.0 12.7 10.3 14.9 12.9 13.3 11.6 10.7 11.5 12.1 10.2 12.2 15.8 5.4 6.4 8.9 5.9 11.1 19.4 10.4 4.1 6.8 13.3 6.1 6.9 4.5 8.6 3.1 5.5 27.1 14.4 8.5 3.0 1.9 4.2 0.1 6.1 7.4 7.0 10.7 2.5 20.6 3.6 14.3 6.1 3.1 8.1 14.7 6.6 3.3 3.9 6.4 8.4 20.6 4.4 10.2 7.5 33.1 0.6 7.8 11.6 5.4 7.5 5.6 4.4 1.0 9.0 9.2 4.1 1.9 6.8 5.2 10.7 3.6 4.4 3.9 7.9 0.0 10.1 7.2 1.7 1.9 6.9 25.7 14.9 15.7 6.9 7.4 9.5 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-122" ENSG00000186417 Gliomedin Q6ZMI3 15 51341655-51408005 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 83.0" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 510.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050873, HPA059441" Uncertain Supported "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA 410000 "Vesicles, Plasma membrane" "HPA050873: , HPA059441: AB_2684018" "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 15.3 2.3 25.8 1.7 44.9 0.7 9.8 33.1 30.6 1.4 0.0 3.6 0.2 0.5 0.6 0.5 1.2 3.4 5.1 13.6 28.6 0.4 0.1 8.8 0.2 45.0 45.9 3.7 0.6 0.5 0.4 0.6 4.0 57.3 2.5 6.5 1.4 1.4 0.7 1.0 4.8 0.6 0.6 32.2 3.0 2.1 0.3 36.6 0.1 0.9 0.9 0.2 1.5 1.5 83.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.3 2.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 25.8 44.9 33.1 30.6 13.6 28.6 45.0 45.9 3.7 57.3 32.2 36.6 83.0 40.1 0.0 2.6 2.0 0.0 6.2 0.0 0.3 0.0 9.2 0.2 0.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 47.0 0.0 0.0 0.0 0.0 0.1 3.7 1.2 0.0 7.4 0.0 0.6 7.9 4.6 0.2 0.0 4.5 0.0 0.2 4.9 0.0 17.2 1.7 0.0 14.9 9.5 0.0 0.3 16.1 3.6 42.2 0.0 0.3 0.0 2.0 510.8 0.1 28.6 0.0 0.0 0.1 0.0 0.1 0.9 0.8 0.0 4.7 9.8 0.1 0.1 0.0 4.0 100.4 0.6 0.4 5.1 1.6 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874235-54891420 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 26.3;lung: 10.6;lymphoid tissue: 13.6" "Group enriched" "Detected in some" 6 "Kupffer cells: 12.8;Macrophages: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 1.2;neutrophil: 4.0" "Group enriched" "Detected in many" 27 "granulocytes: 4.0;monocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 2.8 0.3 0.0 1.0 0.0 26.3 0.7 0.0 0.2 0.2 0.1 0.5 0.0 0.2 0.0 0.3 3.4 0.0 1.2 0.0 0.0 0.5 1.7 10.6 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.4 0.1 0.4 0.1 0.0 13.6 0.8 0.1 0.0 0.0 0.5 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.1 0.3 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 12.8 0.3 0.0 0.0 18.0 0.0 1.0 2.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.7 0.5 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 KPNA4 "IPOA3, MGC12217, MGC26703, QIP1, SRP3" ENSG00000186432 "Karyopherin subunit alpha 4" O00629 3 160495007-160565571 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 125.8;tongue: 60.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034336, HPA043154, HPA045500" Enhanced Enhanced Nucleoplasm NA NA 110000 Nucleoplasm "CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351" "unprognostic (1.58e-1)" "unprognostic (7.65e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (8.59e-4)" "unprognostic (7.56e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.24e-7)" "unprognostic (7.71e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.20e-1)" "unprognostic (1.21e-1)" "unprognostic (3.98e-2)" "unprognostic (2.21e-1)" "unprognostic (2.17e-3)" "unprognostic (1.48e-1)" 20.4 8.2 5.9 12.1 6.9 15.3 11.2 8.7 10.9 10.4 4.8 14.6 8.9 12.8 8.6 16.7 9.1 9.8 23.0 7.0 13.6 11.2 12.3 11.1 10.5 8.3 6.9 5.5 9.0 13.3 11.1 6.4 12.0 8.0 11.7 8.6 13.3 10.6 12.5 125.8 11.3 9.9 13.6 8.1 11.3 12.2 12.3 7.2 11.3 10.4 60.4 12.1 14.4 11.9 8.6 103.4 29.9 20.0 32.7 30.3 27.8 39.7 70.7 39.6 41.0 33.0 38.5 32.1 52.6 73.8 59.9 52.5 45.8 27.4 38.2 50.2 77.0 20.5 52.8 15.2 9.0 37.7 49.3 33.8 22.0 18.5 38.5 76.6 27.5 53.9 26.5 44.2 33.5 45.5 13.8 38.0 17.7 53.9 33.7 31.4 33.9 41.6 50.4 21.9 22.9 23.3 24.8 60.8 29.7 55.7 22.8 33.7 14.4 72.9 39.4 36.0 37.3 87.9 80.4 50.4 96.3 30.9 45.4 31.6 7.7 2.3 2.9 1.8 3.5 2.5 2.3 1.6 2.6 1.7 1.5 1.3 2.0 4.2 4.0 5.7 1.5 2.7 1.8 5.9 6.9 8.7 10.9 7.0 13.6 8.3 6.9 5.5 8.0 8.1 7.2 8.6 70.5 38.5 25.1 40.1 62.8 123.6 87.3 24.3 60.3 58.6 59.4 48.1 158.8 30.0 38.4 11.0 79.2 26.1 54.5 65.0 35.2 36.5 24.3 71.2 63.2 60.7 28.7 38.1 48.5 37.7 25.3 55.1 45.9 92.1 31.6 57.6 37.5 34.7 39.2 53.8 52.9 38.1 28.5 47.9 97.2 18.4 33.8 80.0 44.4 49.6 43.2 57.5 28.8 45.8 69.2 77.4 44.3 34.6 65.2 86.5 32.0 40.2 40.6 69.6 32.9 102.4 67.4 38.2 25.3 85.3 126.0 40.6 60.6 36.1 43.7 104.4 TRDN TRISK ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 425.5;skeletal muscle: 1962.1;tongue: 1027.2" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6" "Group enriched" "Detected in some" 5 "head and neck cancer: 2.2;prostate cancer: 0.6" "Region enriched" "Detected in all" 6 "hypothalamus: 64.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.9" "Region enriched" "Detected in some" 10 "olfactory bulb: 11.0" "Region enriched" "Detected in some" 23 "olfactory bulb: 28.9" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 16.5 2.6 5.1 0.0 3.6 0.0 2.0 5.7 5.8 0.7 3.2 0.4 0.0 1.7 10.5 18.7 12.6 0.2 425.5 2.9 64.2 0.4 0.1 0.4 0.2 7.0 7.5 2.4 1.3 0.1 0.0 15.4 0.2 7.4 17.2 0.4 84.2 13.2 0.9 1962.1 0.4 0.2 1.0 11.3 0.1 0.1 5.1 6.7 0.3 0.3 1027.2 0.1 0.0 0.6 6.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 3.6 5.7 5.8 2.9 64.2 7.0 7.5 2.4 7.4 11.3 6.7 6.6 0.3 0.0 0.0 4.2 0.0 0.0 0.5 0.0 0.0 7.9 0.0 0.3 1145.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 68.0 0.0 0.0 6.0 0.0 0.0 1.1 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.4 35.5 13.1 0.5 1.8 0.0 0.0 765.7 0.0 3.0 3.2 0.0 0.0 11.3 0.0 0.0 0.0 0.2 0.0 21.8 0.0 398.6 7.1 1.3 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 OR6P1 ENSG00000186440 "Olfactory receptor family 6 subfamily P member 1" Q8NGX9 1 158560606-158570580 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047466 Uncertain NA NA "HPA047466: AB_10963091" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT3 "CK3, K3" ENSG00000186442 "Keratin 3" P12035 12 52789685-52796117 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 3.1;salivary gland: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cervical cancer: 0.7;head and neck cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 9.4;HMC-1: 5.6" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" NA NA 280000000 "unprognostic (1.03e-1)" "unprognostic (2.68e-2)" "unprognostic (2.42e-2)" "unprognostic (2.75e-1)" "unprognostic (9.68e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (3.89e-2)" "unprognostic (2.54e-1)" "unprognostic (3.08e-2)" "unprognostic (1.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.0 0.0 ZNF501 "MGC21738, ZNF52" ENSG00000186446 "Zinc finger protein 501" Q96CX3 3 44729596-44737083 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 10.1;Spermatogonia: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 3.5" HPA044161 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044161: AB_2678841" "unprognostic (8.89e-2)" "unprognostic (5.04e-2)" "unprognostic (9.24e-2)" "unprognostic (3.03e-2)" "unprognostic (1.19e-2)" "unprognostic (3.46e-3)" "unprognostic (2.37e-1)" "unprognostic (2.25e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" "unprognostic (2.81e-1)" "unprognostic (3.81e-4)" "unprognostic (1.18e-1)" "unprognostic (4.48e-1)" "unprognostic (1.09e-2)" "unprognostic (3.02e-2)" 1.5 0.5 1.1 0.7 1.2 0.1 1.8 1.5 1.1 1.4 0.5 1.6 0.4 2.0 0.5 0.9 1.6 0.6 1.2 1.0 1.0 0.9 0.4 0.9 0.8 1.2 1.1 0.8 2.1 1.5 0.5 0.8 1.2 1.1 1.7 0.8 2.0 1.1 1.5 1.2 1.1 1.0 1.3 1.1 1.1 1.1 1.9 1.1 0.9 1.4 1.2 0.9 1.6 1.2 1.1 0.0 0.0 1.1 0.0 2.0 3.5 0.4 1.3 1.2 1.4 1.6 0.5 0.5 1.0 0.0 0.6 1.0 0.4 0.0 0.5 1.3 0.0 0.7 0.0 0.1 1.0 2.8 0.0 0.0 2.0 1.3 1.6 0.1 0.4 0.9 0.0 0.0 0.0 0.4 0.0 0.4 0.0 2.6 0.6 0.0 0.7 0.0 0.5 1.1 0.7 1.4 0.9 0.8 0.8 0.5 2.1 0.0 0.1 0.5 0.0 1.2 1.3 1.0 2.2 1.6 0.0 0.0 0.0 1.7 0.5 0.2 0.9 0.7 0.2 0.9 0.8 0.6 0.7 0.3 1.0 0.9 0.6 0.3 0.8 0.3 0.3 0.7 0.3 1.1 1.2 1.5 1.1 1.0 1.0 1.2 1.1 0.8 1.1 1.1 1.1 1.1 3.5 0.0 0.5 3.6 2.4 0.9 1.5 1.5 2.8 3.5 2.0 1.8 3.5 1.5 1.8 3.7 2.1 1.9 0.9 0.5 0.0 2.9 1.1 1.3 2.5 2.3 1.2 3.4 1.3 1.9 2.0 3.2 3.1 1.1 0.0 3.1 2.2 1.0 1.6 10.1 3.3 1.0 2.0 1.3 0.8 1.9 1.5 0.9 0.0 1.0 1.5 9.0 5.2 3.5 3.9 1.9 0.4 1.5 3.1 0.9 0.7 1.1 0.9 4.0 6.6 3.1 3.8 7.0 11.3 1.8 1.6 0.3 1.8 2.5 1.3 0.8 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 5.9 5.8 3.1 2.0 3.2 1.1 5.7 4.8 3.1 6.2 2.2 6.4 2.1 6.4 2.7 4.6 6.2 2.2 5.4 2.9 3.0 4.7 6.4 4.7 2.4 3.1 3.2 2.5 7.5 6.0 3.4 7.5 2.7 3.3 6.1 2.4 5.8 5.2 2.9 11.7 4.8 5.0 2.7 3.0 4.8 5.3 5.8 3.3 3.3 7.6 4.2 2.3 7.0 5.6 3.7 2.6 1.2 10.4 3.4 5.5 6.4 0.4 5.0 6.5 4.3 4.6 2.1 2.3 2.1 3.1 4.0 2.6 1.7 4.8 4.0 4.4 0.4 1.2 9.0 4.0 1.7 5.7 6.8 2.4 6.7 5.2 4.9 7.3 5.6 3.2 2.8 6.1 3.7 6.3 0.6 3.9 4.9 7.2 2.8 3.4 1.5 7.3 2.9 3.9 2.6 4.2 7.3 4.5 2.3 6.0 5.5 6.2 6.8 3.1 4.5 3.6 7.0 4.2 4.9 5.6 1.4 3.5 2.3 4.5 0.4 0.7 0.5 0.7 0.3 0.6 0.5 0.6 0.6 1.0 1.7 0.7 0.4 0.3 1.3 4.7 1.7 0.8 0.3 3.1 3.2 4.8 3.1 2.9 3.0 3.1 3.2 2.5 3.3 3.0 3.3 3.7 7.3 16.0 8.7 13.1 3.8 2.5 4.6 4.1 5.7 12.4 4.5 3.9 12.3 1.5 9.7 0.0 8.4 1.1 5.7 7.2 1.9 7.4 16.7 4.6 8.0 5.4 6.1 3.0 13.5 8.9 0.7 6.2 3.6 4.5 3.8 10.9 6.8 7.6 4.6 16.8 17.1 6.5 2.0 5.1 3.4 4.5 5.6 5.1 5.4 12.2 8.5 13.2 7.2 14.6 20.1 6.8 5.2 5.3 5.4 5.0 6.4 4.5 4.6 8.5 6.6 6.6 6.4 11.2 5.7 3.3 3.4 0.4 4.6 13.5 5.1 3.6 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060664-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 20.7" "Group enriched" "Detected in some" 145 "Early spermatids: 464.2;Late spermatids: 1195.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;RH-30: 1.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.0 0.3 0.6 0.0 0.3 0.0 0.0 0.2 0.3 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 1.6 0.0 0.0 0.3 0.2 2.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 20.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.0 1.1 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.7 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.3 0.2 1.6 2.0 0.7 0.1 0.7 0.6 0.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 464.2 1.0 0.1 0.6 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 1.3 0.0 1195.5 5.0 0.5 0.0 1.0 0.0 0.0 0.0 1.0 0.7 1.4 0.1 5.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 2.8 0.3 0.0 0.0 0.3 0.0 0.2 0.5 TMPRSS12 "CT151, MGC57341" ENSG00000186452 "Transmembrane serine protease 12" Q86WS5 12 50842920-50887884 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 21.8" "Group enriched" "Detected in some" 8 "Early spermatids: 44.7;Spermatocytes: 121.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (3.03e-2)" "unprognostic (7.25e-3)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-1)" "unprognostic (2.98e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (5.65e-3)" "unprognostic (1.03e-2)" 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 0.0 0.8 0.5 0.1 0.0 0.1 1.8 0.0 0.9 0.1 0.0 0.0 0.0 44.7 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 9.7 4.1 0.1 1.8 0.0 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 121.7 2.4 0.0 0.3 0.7 0.0 0.0 0.0 0.1 FAM228A "C2orf84, FLJ30851" ENSG00000186453 "Family with sequence similarity 228 member A" Q86W67 2 24175053-24200849 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 35.4" "Group enriched" "Detected in some" 5 "Early spermatids: 119.7;Spermatocytes: 176.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.5;hTERT-RPE1: 1.1;TIME: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075817 Approved Nucleoplasm NA NA Nucleoplasm "HPA075817: " "unprognostic (2.57e-1)" "unprognostic (7.14e-2)" "unprognostic (2.92e-2)" "unprognostic (1.98e-3)" "unprognostic (7.13e-4)" "unprognostic (2.19e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (9.57e-2)" "unprognostic (2.14e-1)" "unprognostic (4.44e-5)" "unprognostic (1.73e-2)" "unprognostic (1.04e-4)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-2)" 1.9 0.9 1.4 0.6 1.7 0.0 1.6 1.4 2.9 0.8 0.0 0.7 0.3 0.7 0.9 0.9 0.6 1.1 1.2 1.3 0.9 0.5 0.3 0.8 0.6 1.4 0.9 1.9 0.7 0.4 0.1 0.5 1.0 1.2 0.8 0.3 0.9 0.2 0.9 0.4 0.4 0.4 0.5 0.2 0.4 0.7 35.4 0.9 0.3 0.7 0.4 0.2 0.9 0.5 2.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.2 0.2 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.1 1.4 1.7 1.4 2.9 1.3 0.9 1.4 0.9 1.9 1.2 0.2 0.9 2.0 0.4 3.2 0.5 3.3 0.0 0.5 0.1 0.0 0.0 0.4 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.7 119.7 0.0 0.4 0.5 0.0 0.0 5.5 0.5 0.2 1.6 0.0 0.0 0.0 0.6 1.1 0.1 0.5 1.7 5.8 0.0 0.0 0.8 0.4 24.8 2.8 0.3 0.0 2.8 0.1 0.3 1.0 3.0 3.1 0.7 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.2 6.6 1.0 0.8 176.0 10.4 0.0 0.1 0.1 0.1 0.5 0.0 0.2 DEFB132 "DEFB32, RP5-1103G7.6" ENSG00000186458 "Defensin beta 132" Q7Z7B7 20 257724-261096 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "epididymis: 273.5" "Cell type enriched" "Detected in some" 7 "Collecting duct cells: 11.0" "Group enriched" "Detected in some" 4 "liver cancer: 0.8;prostate cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046399 Approved "Secreted in male reproductive system" NA NA "HPA046399: AB_10960992" "unprognostic (9.27e-3)" "unprognostic (1.61e-2)" "unprognostic (2.54e-2)" 26.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 273.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.5 0.0 11.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 24.4;Excitatory neurons: 34.3;Horizontal cells: 18.5;Inhibitory neurons: 33.7" "Cancer enhanced" "Detected in many" "prostate cancer: 7.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 16.6;Karpas-707: 14.1;NTERA-2: 18.1;U-2197: 14.6;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054050: AB_2682357, HPA057065: AB_2797258" "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.1 6.1 26.3 2.2 34.1 0.5 3.1 38.7 58.8 4.3 14.2 2.9 0.9 5.2 8.3 2.6 4.1 2.3 8.0 35.7 34.6 8.4 1.0 2.3 3.2 27.9 27.3 32.5 9.0 2.5 12.2 14.7 0.0 33.2 11.1 2.9 19.2 3.2 5.9 1.3 5.2 2.2 4.8 20.2 4.3 2.2 2.1 30.5 1.7 8.6 2.9 1.6 3.0 2.7 49.5 0.0 4.8 0.1 9.4 0.6 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.3 0.0 16.6 0.0 8.9 1.0 3.4 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.8 0.4 1.3 0.2 2.4 0.1 0.3 6.6 0.4 14.1 0.0 1.7 5.9 0.0 18.1 0.0 8.4 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 1.1 0.0 3.5 1.8 0.0 0.1 0.0 10.3 14.6 1.2 6.6 31.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.3 1.2 0.8 0.0 0.0 0.6 1.3 0.0 0.5 0.0 0.0 1.0 0.5 26.3 34.1 38.7 58.8 35.7 34.6 27.9 27.3 32.5 33.2 20.2 30.5 49.5 1.0 0.0 3.0 8.5 0.9 6.4 6.2 1.0 8.0 24.4 0.7 2.9 11.1 2.8 0.8 12.9 0.0 0.0 2.9 1.8 13.7 1.1 0.0 0.0 0.2 3.1 7.2 0.0 34.3 0.2 0.0 4.1 1.1 0.1 4.5 0.2 3.6 0.7 0.1 18.5 33.7 0.4 0.0 0.3 0.0 0.4 0.3 0.1 0.0 9.4 0.0 13.7 0.0 9.5 9.1 0.8 0.5 0.4 1.9 3.3 0.0 3.3 0.0 9.9 0.0 5.5 4.0 0.2 0.1 2.6 3.0 0.0 3.5 0.2 0.5 1.0 RPS23 "S23, uS12" ENSG00000186468 "Ribosomal protein S23" P62266 5 82273320-82278396 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Deafness, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA054853 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 180000 "Endoplasmic reticulum, Cytosol" "HPA054853: AB_2682625" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (6.61e-2)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (8.29e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (3.87e-2)" "unprognostic (6.47e-2)" "unprognostic (2.22e-1)" "unprognostic (1.67e-1)" 1761.5 1010.0 1157.0 928.3 1176.9 2315.5 2675.4 1142.8 1506.5 1932.1 1186.1 1491.9 874.2 1505.9 1206.5 1552.2 1686.8 763.3 1201.9 1118.0 1162.6 1222.5 1084.8 1144.5 1880.2 1168.0 1143.5 1103.0 3567.6 1916.0 992.5 844.9 1041.5 1178.2 1260.0 1217.4 474.1 1338.2 995.4 2828.5 2202.4 1442.1 1141.0 1230.6 1564.9 1327.6 369.6 1180.6 2719.2 1047.3 2464.1 2538.9 1483.0 1732.0 1208.5 2194.6 847.0 2383.6 1836.5 3911.6 5242.6 2418.7 2052.4 3094.7 3039.4 2997.3 1198.9 1451.9 5113.6 1398.9 2675.8 1875.0 1105.9 3616.3 5911.6 3136.4 1871.9 2042.4 2101.5 1239.3 1178.4 5159.4 3068.6 1461.8 5082.4 6870.2 2325.0 6036.4 4522.6 3980.7 3201.0 2227.1 1562.5 2659.7 1412.7 3396.2 3089.5 1523.5 1162.4 1956.0 2244.6 3408.7 4676.7 2983.4 911.2 1526.7 1982.2 1057.1 1810.3 4447.1 2355.6 1377.1 4649.1 2839.5 428.0 1674.5 1057.9 3279.8 2227.0 3570.0 3590.9 1014.3 3878.9 965.3 193.0 852.3 128.5 784.5 761.0 1202.8 1945.0 1339.2 1065.9 1358.1 1736.1 1731.5 1494.5 80.8 943.5 645.5 1540.2 1054.5 2806.0 1157.0 1176.9 1142.8 1506.5 1118.0 1162.6 1168.0 1143.5 1103.0 1178.2 1230.6 1180.6 1208.5 2726.7 1064.1 1527.2 28.7 6648.3 5904.9 6058.5 4170.7 4319.6 392.6 6217.4 10450.4 305.7 2573.6 2153.2 1138.5 173.0 4912.5 4340.2 1276.9 3813.2 2523.5 1016.2 1431.7 3705.0 3112.3 1903.4 3545.2 24.5 4768.9 7030.8 2927.9 1667.2 2001.0 1700.8 3926.3 3285.8 3044.2 4261.2 233.9 28.5 4024.3 1175.9 4330.3 6276.8 1790.6 6175.3 3562.9 2865.5 41.2 5041.5 1465.2 3478.9 19.1 34.1 3569.5 3167.2 3089.2 3083.4 6281.6 3384.4 5720.4 861.0 665.2 1702.6 4593.8 3792.9 734.0 995.2 6141.4 7107.0 5202.6 4322.9 3981.9 4731.8 6359.5 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 114.3" "Cell type enhanced" "Detected in many" "dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" NA NA 170000 "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favorable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 51.8 22.2 40.8 41.4 42.6 64.6 21.2 1.1 45.4 12.0 12.6 19.9 15.4 12.3 5.1 14.2 5.8 17.5 13.7 50.3 51.5 7.6 12.8 19.2 48.1 18.0 19.1 51.8 14.5 7.4 3.5 15.0 19.7 18.8 10.7 19.8 15.1 8.1 9.1 5.6 7.8 21.4 20.0 10.7 62.3 16.1 114.3 34.0 62.5 5.7 13.2 45.8 22.4 5.4 28.8 0.0 3.1 77.2 48.6 11.6 15.0 1.2 12.9 15.9 6.1 4.9 6.4 0.2 0.2 1.8 140.2 8.9 0.3 10.4 0.0 4.2 36.4 1.2 0.0 0.7 0.0 6.0 7.4 0.3 25.1 0.0 6.2 0.5 32.2 0.0 67.9 0.0 6.5 39.7 0.0 112.5 12.0 41.1 0.0 9.5 39.4 6.1 2.0 6.4 0.0 11.5 89.2 0.3 0.1 34.5 2.7 0.0 0.3 0.0 18.7 3.1 0.3 9.9 0.2 0.0 5.5 15.5 39.2 249.0 379.4 64.0 177.1 162.8 111.9 110.5 38.1 88.9 134.2 65.8 36.2 55.5 98.5 185.2 25.2 177.3 28.0 143.2 158.6 40.8 42.6 1.1 45.4 50.3 51.5 18.0 19.1 51.8 18.8 10.7 34.0 28.8 11.6 6.4 7.2 3.3 101.3 11.5 0.4 0.0 2.2 18.7 1.5 1.9 1.0 1.5 0.0 3.7 2.1 0.6 251.8 0.8 1.9 0.2 714.4 0.5 2.7 11.7 175.8 20.4 66.2 0.0 0.6 23.9 11.7 0.8 32.3 0.2 11.0 0.9 51.1 0.0 59.6 2.4 0.0 94.1 60.0 1146.4 9.9 84.0 55.2 24.4 33.3 0.7 246.1 96.0 3.2 0.5 0.1 6.0 62.7 0.2 0.1 0.9 0.0 2.2 39.5 10.2 12.2 11.2 4.6 1.3 6.7 0.7 191.5 2.2 0.5 0.2 BTN3A2 BTN3.2 ENSG00000186470 "Butyrophilin subfamily 3 member A2" P78410 6 26365159-26378320 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.1" "Cell type enhanced" "Detected in many" "dendritic cells: 117.2;NK-cells: 239.9;T-cells: 108.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 87.5" CAB019392 Uncertain NA NA "CAB019392: " "unprognostic (3.77e-2)" "unprognostic (1.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.86e-2)" "unprognostic (3.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (3.89e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-3)" "unprognostic (1.12e-1)" "unprognostic (8.45e-2)" "prognostic unfavorable (4.24e-4)" "unprognostic (5.13e-2)" "unprognostic (4.45e-2)" "unprognostic (4.42e-2)" "unprognostic (1.48e-3)" 16.9 27.5 8.4 42.3 9.8 9.6 18.5 7.7 8.9 16.7 8.7 29.3 29.6 21.9 21.2 13.6 22.2 25.3 12.6 8.1 9.6 15.7 23.8 41.4 45.8 11.8 9.0 6.7 29.8 10.5 10.5 12.8 18.5 10.1 15.0 32.0 2.4 19.5 15.1 8.5 21.9 33.2 20.9 9.6 89.1 32.8 7.2 10.5 38.6 14.5 10.8 45.0 23.1 17.1 13.1 10.6 4.8 6.4 6.7 37.4 42.9 2.2 10.2 48.2 18.8 52.6 2.7 34.4 30.6 35.5 16.2 27.5 9.2 9.4 18.6 17.1 18.5 13.2 33.1 19.1 20.1 20.7 18.9 26.5 27.0 7.5 17.9 8.5 43.9 36.0 54.0 8.5 41.1 13.1 1.4 16.2 30.4 0.4 8.6 3.6 24.3 11.5 87.5 17.1 6.5 4.2 12.8 8.2 7.5 25.7 1.9 7.5 14.0 22.4 17.7 4.0 7.6 11.3 86.1 79.7 17.7 32.2 33.2 17.5 67.7 26.7 57.6 128.3 35.9 96.1 64.5 81.3 113.8 19.2 53.4 81.8 100.1 40.0 98.8 47.5 13.5 111.2 71.3 8.4 9.8 7.7 8.9 8.1 9.6 11.8 9.0 6.7 10.1 9.6 10.5 13.1 62.5 32.1 22.2 2.3 61.3 10.3 12.2 8.6 13.1 0.7 16.0 9.9 7.5 17.2 7.4 12.9 0.0 14.3 117.2 21.8 1.9 25.6 0.2 23.6 21.3 46.0 10.1 25.2 1.0 13.7 17.3 20.2 15.8 14.7 47.4 23.4 40.0 9.8 17.8 0.0 2.5 37.9 10.2 54.0 10.0 1.9 11.1 37.1 3.6 20.6 52.7 7.0 239.9 7.1 1.7 10.6 16.9 10.5 76.6 13.2 50.5 3.8 11.8 1.4 13.1 15.7 10.2 1.5 0.2 8.3 13.4 3.3 108.0 51.0 25.5 16.8 AKAP14 AKAP28 ENSG00000186471 "A-kinase anchoring protein 14" Q86UN6 X 119895837-119920716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 44.4;testis: 84.5" "Group enriched" "Detected in some" 4 "Early spermatids: 485.6;Late spermatids: 1648.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;SCLC-21H: 2.4;SuSa: 1.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA060999 Enhanced NA NA "HPA060999: AB_2684407" "unprognostic (1.36e-2)" "unprognostic (2.36e-2)" "unprognostic (2.82e-2)" "unprognostic (1.25e-3)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (4.16e-1)" "unprognostic (4.68e-2)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.73e-2)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 0.0 0.0 2.2 0.0 1.0 0.2 0.1 1.2 0.8 1.2 13.2 0.1 0.3 0.7 0.1 0.0 44.4 0.0 0.0 1.4 2.7 0.0 0.1 3.3 0.0 3.2 2.3 0.7 0.1 0.0 0.0 0.7 0.0 2.2 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.4 0.0 1.6 0.0 0.0 84.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.0 1.2 0.8 1.4 2.7 3.2 2.3 0.7 2.2 1.6 2.3 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 18.7 0.0 0.5 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 485.6 133.5 1.1 0.3 0.0 0.0 0.6 0.0 0.3 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 22.4 0.0 0.0 1648.3 2.5 0.8 0.0 1.0 0.0 0.2 0.0 1.5 0.2 0.0 0.1 7.2 0.0 0.0 0.1 0.1 224.1 0.1 13.1 0.0 4.9 14.0 2.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754012-83162930 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 25.5;pituitary gland: 11.2;retina: 21.9" "Group enriched" "Detected in many" 5 "Excitatory neurons: 655.4;Inhibitory neurons: 746.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 28 "REH: 263.3;U-2 OS: 284.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" NA NA 6000000 "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 1.8 4.2 2.7 0.2 6.2 0.0 2.4 25.5 23.9 1.5 0.0 2.1 1.5 0.3 3.8 2.4 1.0 0.9 1.2 8.7 2.8 4.5 0.1 0.8 0.1 0.1 1.3 2.1 0.8 3.9 4.4 11.2 0.3 3.4 2.5 1.8 21.9 2.5 2.5 0.1 1.8 1.7 0.1 0.0 0.5 1.5 3.7 0.7 1.2 4.6 0.1 0.2 0.6 2.6 5.5 1.2 1.6 1.9 0.0 0.8 0.1 0.0 0.7 0.7 0.5 1.0 0.3 0.7 0.0 0.0 0.8 7.7 0.6 5.7 2.4 2.4 0.3 0.8 0.0 1.2 0.1 0.0 0.8 0.2 0.4 1.8 0.0 9.6 0.5 0.0 0.1 0.0 0.0 0.8 0.8 0.2 0.0 2.0 1.0 4.7 263.3 4.2 0.0 1.9 0.9 4.9 3.4 0.2 2.7 0.6 1.2 3.4 0.6 0.0 0.0 284.5 1.2 0.6 0.2 0.0 0.5 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.2 25.5 23.9 8.7 2.8 0.1 1.3 2.1 3.4 0.0 0.7 5.5 0.6 9.6 17.9 40.5 0.0 2.5 9.0 3.2 13.6 121.9 11.0 9.7 31.2 22.8 12.6 1.8 131.3 1.9 0.0 22.9 7.9 6.4 13.0 7.4 6.7 2.5 60.1 0.0 655.4 4.9 0.4 2.4 20.4 13.5 0.0 24.2 0.0 0.2 1.7 85.8 746.4 15.0 2.0 0.0 0.0 7.9 2.8 0.4 0.0 50.6 0.0 16.2 0.0 73.9 73.7 2.5 21.9 6.4 0.0 3.9 13.5 23.0 7.7 86.9 0.0 0.3 3.2 5.0 19.5 19.3 3.4 0.7 0.3 37.5 9.3 6.0 KLK12 KLK-L5 ENSG00000186474 "Kallikrein related peptidase 12" Q9UKR0 19 51029092-51035230 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 51.8;esophagus: 210.3;salivary gland: 65.2;vagina: 100.3" "Cell type enhanced" "Detected in some" "Early spermatids: 30.7;Enteroendocrine cells: 40.3;Intestinal goblet cells: 24.9;Ionocytes: 14.2;Late spermatids: 34.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025473 Uncertain "Secreted in other tissues" NA NA "CAB025473: " "unprognostic (2.84e-1)" "unprognostic (1.41e-1)" "unprognostic (1.08e-3)" "unprognostic (1.15e-1)" "unprognostic (5.80e-3)" "unprognostic (4.99e-3)" "unprognostic (3.18e-1)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.51e-1)" "unprognostic (1.56e-1)" "prognostic favorable (8.01e-4)" "unprognostic (8.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 51.8 1.8 2.1 4.0 0.0 0.0 210.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.5 0.8 0.0 65.2 0.0 0.0 0.4 5.8 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.1 0.0 9.0 0.0 100.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.5 0.2 0.0 2.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 30.7 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 14.2 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.2 8.4 0.0 0.0 0.0 0.0 1.3 1.7 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506015-64612319 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4" "Group enriched" "Detected in some" 5 "Excitatory neurons: 122.5;Inhibitory neurons: 170.6;Oligodendrocyte precursor cells: 67.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HUVEC TERT2: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: AB_2676591" "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.0 3.2 3.6 0.5 8.1 0.0 0.5 1.6 24.4 4.0 0.0 0.7 0.9 2.3 3.7 1.7 7.9 1.7 2.6 7.0 9.8 2.0 1.0 1.4 0.3 0.7 4.7 6.1 2.4 0.2 0.1 0.8 0.0 3.7 5.3 0.7 4.9 1.8 7.5 0.1 0.4 1.0 1.4 0.0 0.7 0.8 0.8 11.4 0.0 0.3 1.0 0.1 0.9 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 1.6 24.4 7.0 9.8 0.7 4.7 6.1 3.7 0.0 11.4 4.4 0.4 0.0 0.0 5.5 0.1 0.0 0.1 0.1 0.6 6.5 0.7 1.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.1 5.1 4.6 0.0 2.7 122.5 0.0 0.0 0.8 0.0 4.7 0.0 0.1 23.2 0.1 0.0 0.0 170.6 0.0 0.0 0.3 0.0 1.9 7.2 0.1 0.0 12.2 0.0 3.6 0.0 67.8 6.4 0.0 0.0 13.9 0.0 0.1 0.0 0.2 2.2 2.1 6.6 0.1 13.2 0.3 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.2 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 568.2" "Cell type enriched" "Detected in all" 4 "Langerhans cells: 4121.3" "Cancer enriched" "Detected in all" 5 "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 272.8;non-classical monocyte: 500.8" "Lineage enriched" "Detected in all" 6 "monocytes: 500.8" "Cell line enhanced" "Detected in many" "Karpas-707: 1228.9;RPMI-8226: 605.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Uncertain Vesicles NA NA Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.62e-4)" "unprognostic (4.97e-2)" 80.0 37.6 31.1 35.7 38.6 45.9 37.7 46.3 43.3 18.9 54.1 30.1 53.5 19.7 32.0 40.4 17.7 31.9 19.9 31.5 38.8 32.2 568.2 43.6 31.1 60.9 55.1 26.5 24.2 112.6 17.5 19.0 34.4 64.1 63.1 26.6 40.9 71.6 11.4 9.1 35.5 35.5 20.5 40.8 19.1 61.6 34.7 41.8 40.7 12.6 12.1 25.5 37.0 23.4 88.6 158.9 29.0 76.8 48.1 200.6 265.5 41.9 12.5 179.1 36.9 242.6 18.1 225.2 104.0 35.7 98.2 282.2 83.9 53.1 92.6 43.3 32.3 155.5 28.6 51.7 0.0 99.0 49.3 448.7 165.6 50.4 281.8 25.8 27.3 49.8 202.8 53.2 1228.9 47.9 82.2 238.7 128.6 80.0 30.4 20.4 43.5 0.2 605.1 291.6 77.8 57.2 45.5 41.6 29.9 67.8 28.7 29.0 162.0 56.3 40.5 11.8 77.2 33.3 296.8 57.4 93.3 177.6 187.2 38.2 21.3 29.7 13.4 49.3 272.8 25.5 46.5 32.8 41.9 78.5 60.2 32.6 36.7 62.6 27.5 500.8 44.7 77.0 85.2 31.1 38.6 46.3 43.3 31.5 38.8 60.9 55.1 26.5 64.1 40.8 41.8 88.6 91.4 41.7 121.5 39.8 100.5 140.2 59.4 148.2 74.6 16.5 58.0 31.6 43.6 35.8 114.4 40.5 10.4 47.7 79.0 129.1 17.6 52.0 21.2 30.8 11.6 135.6 126.8 38.3 11.1 140.4 189.0 120.4 57.6 67.4 60.4 18.1 33.2 828.9 46.9 38.7 16.9 91.5 185.1 63.6 4121.3 9.7 15.8 381.0 247.3 7.5 29.6 88.7 34.0 17.1 61.8 53.6 86.6 18.4 100.1 180.4 29.1 9.4 68.3 18.1 19.7 36.3 62.0 33.6 45.0 135.8 155.3 130.4 108.2 20.6 48.0 158.5 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331664 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 52.7;pituitary gland: 14.9" "Group enriched" "Detected in many" 4 "Excitatory neurons: 582.4;Inhibitory neurons: 635.5;Oligodendrocyte precursor cells: 265.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 18.6;SH-SY5Y: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles NA NA Vesicles "HPA060245: AB_2732643" "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 0.0 1.4 5.8 0.2 17.1 0.1 0.0 7.3 52.7 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 19.9 7.9 0.0 0.2 0.1 0.0 9.2 0.0 14.3 0.0 0.5 0.0 14.9 0.1 17.6 0.1 0.2 5.5 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 5.8 1.3 0.0 0.1 0.0 0.0 0.1 0.0 21.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 18.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 5.8 17.1 7.3 52.7 19.9 7.9 9.2 0.0 14.3 17.6 0.0 1.3 21.7 0.1 6.4 6.1 16.6 0.0 1.8 0.5 0.0 0.0 46.7 0.5 0.4 4.5 0.0 3.1 1.8 2.1 0.1 0.2 0.1 0.0 0.0 5.0 0.4 0.1 1.3 0.0 0.0 582.4 0.0 0.2 1.3 0.0 0.2 6.3 0.1 0.7 0.4 0.1 117.8 635.5 0.0 0.0 0.6 0.8 4.7 0.0 0.8 0.0 18.7 0.0 1.5 0.0 265.4 11.1 0.1 0.0 1.5 0.1 0.4 0.0 0.2 1.5 7.4 6.6 1.5 0.4 50.0 31.4 0.0 1.0 0.3 0.9 0.1 0.0 0.6 ZNF396 "FLJ31213, ZSCAN14" ENSG00000186496 "Zinc finger protein 396" Q96N95 18 35366694-35377337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 14.4;Late spermatids: 12.0;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 8.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006686 Uncertain NA NA "HPA006686: AB_1080710" "unprognostic (3.28e-2)" "unprognostic (2.07e-2)" "unprognostic (1.24e-2)" "unprognostic (9.58e-3)" "unprognostic (2.27e-1)" "unprognostic (2.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (5.74e-2)" "unprognostic (1.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.72e-2)" "unprognostic (5.75e-7)" "unprognostic (1.10e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (3.91e-2)" 1.4 2.6 2.6 1.5 3.0 2.5 3.4 3.5 3.3 3.0 4.5 1.6 1.1 1.6 2.7 1.0 4.9 2.4 0.8 1.9 2.6 3.6 1.5 2.0 1.3 2.7 2.7 2.0 1.7 3.0 4.4 3.4 0.7 2.9 2.3 1.8 4.0 3.3 2.1 1.4 1.6 2.3 1.2 2.6 1.5 2.7 5.6 2.4 1.5 5.5 1.0 1.6 1.6 1.0 3.2 0.3 2.2 1.9 2.0 1.3 0.8 1.7 0.4 1.1 0.9 1.8 0.7 1.3 0.1 1.0 1.0 1.2 0.2 1.0 1.0 1.3 0.8 1.3 0.8 1.8 1.7 2.2 0.4 1.4 1.1 1.1 0.5 0.5 3.0 1.5 2.7 0.6 2.4 0.7 2.3 0.6 1.0 0.5 0.6 0.4 0.4 0.0 0.7 2.2 1.8 1.0 3.4 1.4 1.1 2.3 1.6 3.3 1.9 0.1 0.3 0.4 0.8 0.6 4.6 1.8 0.1 1.7 0.1 1.5 8.9 1.4 2.6 1.5 0.8 0.9 0.6 1.1 0.9 1.2 1.3 1.6 1.1 5.8 1.5 1.1 1.6 0.5 0.6 2.6 3.0 3.5 3.3 1.9 2.6 2.7 2.7 2.0 2.9 2.6 2.4 3.2 0.6 6.4 5.3 1.6 0.2 0.4 1.0 1.1 0.6 2.7 1.9 1.8 0.8 2.8 2.9 0.0 0.0 0.4 0.5 1.2 0.0 1.8 14.4 7.1 1.9 1.0 0.0 0.4 1.2 2.0 0.3 2.3 1.5 1.4 2.5 0.8 1.1 0.7 0.7 3.3 1.5 1.1 6.1 0.8 1.0 12.0 0.9 1.0 0.0 2.8 1.6 4.5 0.0 3.0 2.6 1.4 1.9 1.2 0.1 0.7 1.1 3.0 19.0 5.9 6.6 2.9 2.2 8.4 1.6 0.8 0.1 0.1 0.8 1.8 0.9 0.8 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA016579: AB_2669392, HPA059374: AB_2683995" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 25.5 38.5 58.5 13.1 56.9 24.0 27.3 55.8 77.4 25.0 53.0 24.9 15.1 28.3 24.6 36.4 29.8 19.3 31.6 58.6 60.3 32.9 49.8 22.6 16.2 61.7 62.3 57.2 26.9 28.9 30.9 38.7 13.1 58.7 39.3 14.6 10.7 27.0 24.1 37.1 27.7 24.0 19.0 56.5 25.2 30.3 29.0 59.8 21.3 29.6 20.8 14.2 27.8 24.4 57.5 26.2 31.2 25.7 42.3 39.2 28.2 20.7 39.6 45.1 52.9 44.8 13.0 53.5 16.5 30.2 42.4 24.6 35.3 28.3 38.5 21.9 22.0 54.4 27.6 24.7 30.1 58.0 27.8 26.5 49.4 21.5 50.8 28.7 24.3 35.7 32.4 21.2 37.1 33.6 23.4 40.1 29.2 48.3 27.0 38.6 32.8 17.7 33.5 51.6 15.2 54.8 48.4 30.6 42.6 39.7 9.2 42.3 44.2 33.1 31.1 26.1 50.6 38.1 39.8 38.5 17.6 47.1 53.3 45.8 38.2 20.6 27.7 32.5 32.5 24.8 37.4 29.7 24.6 18.5 30.0 29.1 30.2 56.3 31.9 35.3 30.4 37.4 25.6 58.5 56.9 55.8 77.4 58.6 60.3 61.7 62.3 57.2 58.7 56.5 59.8 57.5 22.9 9.6 13.5 8.5 25.4 11.7 13.3 26.2 15.9 42.1 24.0 29.2 8.9 18.6 13.3 12.9 14.6 30.9 20.9 24.5 39.2 39.1 25.5 13.2 17.2 20.6 29.9 43.8 12.4 40.5 33.9 22.6 18.8 12.4 17.1 22.0 11.0 15.1 28.3 43.7 15.0 21.0 40.7 8.5 12.9 76.9 20.2 12.2 26.6 6.5 20.6 51.9 22.6 17.1 14.4 48.6 22.7 19.9 18.6 19.9 28.8 19.2 7.9 18.7 13.1 19.6 20.3 27.2 18.0 19.3 13.5 30.8 20.5 22.4 23.1 12.4 OR9Q1 ENSG00000186509 "Olfactory receptor family 9 subfamily Q member 1" Q8NGQ5 11 58023881-58181616 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Excitatory neurons: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.65e-3)" "unprognostic (2.27e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLCNKA hClC-Ka ENSG00000186510 "Chloride voltage-gated channel Ka" P51800 1 16018875-16034050 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.7;parathyroid gland: 49.3" "Cell type enriched" "Detected in some" 4 "Late spermatids: 271.5" "Group enriched" "Detected in some" 7 "renal cancer: 4.4;thyroid cancer: 1.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 7.4" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (4.02e-1)" "unprognostic (2.76e-3)" "unprognostic (8.20e-2)" "unprognostic (6.16e-2)" "unprognostic (1.18e-2)" "unprognostic (6.92e-3)" "unprognostic (3.49e-2)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (8.13e-3)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (4.37e-3)" "unprognostic (1.28e-1)" 0.6 2.9 0.3 0.0 0.3 0.0 0.9 2.1 0.4 0.5 3.9 0.4 0.0 0.6 0.5 0.0 0.5 0.1 0.5 0.7 0.6 96.7 0.2 0.3 0.0 0.4 0.6 0.3 0.9 3.5 49.3 18.4 0.0 0.9 0.8 0.0 2.3 7.0 0.2 0.5 0.7 0.1 0.2 0.3 0.1 3.9 4.5 0.4 0.0 21.8 0.3 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.1 0.4 0.7 0.6 0.4 0.6 0.3 0.9 0.3 0.4 0.3 0.0 3.2 0.5 0.3 0.0 0.1 0.1 0.0 0.0 3.9 0.4 0.1 3.8 0.0 0.7 25.8 0.0 0.4 0.0 0.1 25.4 0.3 40.2 0.1 0.0 0.1 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 13.5 0.2 0.1 67.1 0.0 0.0 271.5 0.3 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.1 1.9 1.2 0.0 0.0 0.7 0.1 0.0 0.3 0.2 OR9Q2 OR9Q2P ENSG00000186513 "Olfactory receptor family 9 subfamily Q member 2" Q8NGE9 11 58189070-58194053 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP30 FLJ00267 ENSG00000186517 "Rho GTPase activating protein 30" Q7Z6I6 1 161046946-161069970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 58.1;lymphoid tissue: 77.7" "Cell type enhanced" "Detected in many" "B-cells: 71.6;dendritic cells: 103.4;Kupffer cells: 77.8;Macrophages: 79.1;monocytes: 133.0;NK-cells: 268.8;T-cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 118.2;HL-60: 92.5;HMC-1: 123.4;Karpas-707: 93.1;MOLT-4: 75.8;THP-1: 90.9;U-266/70: 138.6;U-266/84: 97.7;U-698: 97.9;U-937: 72.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036300 Enhanced Supported Vesicles NA NA Vesicles "HPA036300: AB_10601117" "unprognostic (7.31e-2)" "unprognostic (8.83e-3)" "unprognostic (7.46e-3)" "unprognostic (1.77e-3)" "unprognostic (7.41e-2)" "unprognostic (1.68e-3)" "unprognostic (3.05e-1)" "unprognostic (6.78e-3)" "unprognostic (1.94e-2)" "unprognostic (3.89e-2)" "unprognostic (7.91e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.65e-2)" 12.2 4.9 3.2 56.4 3.8 58.1 5.3 3.9 4.6 3.4 4.4 8.2 9.6 2.9 2.8 14.2 4.6 10.3 2.9 3.1 6.1 3.3 6.7 25.4 77.7 5.6 4.0 2.4 2.1 2.4 1.4 1.8 7.0 5.3 3.4 8.4 0.6 6.5 2.3 2.6 18.8 24.1 8.0 5.4 76.1 11.7 2.3 5.6 64.3 2.9 2.7 61.7 13.9 6.6 6.0 0.8 0.1 0.2 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.3 1.2 118.2 0.6 0.0 0.1 2.3 0.0 0.0 0.2 55.3 0.2 39.7 0.2 0.0 0.0 92.5 123.4 0.0 1.2 0.1 0.0 0.1 0.0 56.8 0.3 93.1 0.0 1.0 75.8 21.3 0.1 0.7 0.1 46.8 0.6 1.6 0.0 1.0 0.7 0.3 0.2 0.7 0.2 0.7 0.8 90.9 0.9 0.1 0.7 0.2 0.5 138.6 97.7 97.9 0.4 72.3 0.1 7.1 29.6 33.1 32.9 32.2 25.1 11.9 21.9 27.1 21.8 12.6 17.9 25.0 48.5 19.3 46.4 15.0 23.8 33.5 3.2 3.8 3.9 4.6 3.1 6.1 5.6 4.0 2.4 5.3 5.4 5.6 6.0 1.5 3.2 20.5 0.3 71.6 5.6 3.3 6.8 0.0 0.5 5.2 2.9 1.3 2.8 13.8 0.0 4.2 0.6 103.4 0.5 0.0 3.4 2.2 6.6 1.2 2.3 0.0 14.5 0.3 6.0 1.9 1.9 3.1 13.7 68.3 0.0 6.1 1.7 55.5 0.0 0.3 0.4 8.2 77.8 44.6 0.7 0.3 79.1 5.4 14.0 133.0 0.1 268.8 0.5 1.2 12.5 0.2 0.0 49.8 5.4 0.0 0.5 15.3 3.0 0.0 1.0 1.9 0.1 0.1 9.9 24.6 4.5 105.1 0.2 0.5 16.7 SEPTIN10 "FLJ11619, SEPT10" ENSG00000186522 "Septin 10" Q9P0V9 2 109542799-109614143 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 56.4;Cardiomyocytes: 21.8;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 59.4;Fibroblasts: 15.5;Hofbauer cells: 19.6;Smooth muscle cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047860, HPA056304, HPA060310" Enhanced Supported "Actin filaments" NA NA "Actin filaments" "HPA047860: AB_2680187, HPA056304: AB_2683094, HPA060310: AB_2684249" "unprognostic (1.84e-1)" "unprognostic (4.29e-3)" "unprognostic (1.94e-2)" "unprognostic (3.18e-2)" "unprognostic (6.34e-2)" "unprognostic (3.41e-2)" "unprognostic (2.02e-3)" "unprognostic (1.80e-2)" "unprognostic (9.67e-2)" "unprognostic (8.61e-2)" "unprognostic (1.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-2)" "unprognostic (3.05e-3)" "unprognostic (2.72e-1)" "unprognostic (2.55e-1)" "unprognostic (9.12e-2)" 57.5 24.4 19.1 22.8 28.4 0.7 53.4 31.3 19.8 41.8 53.0 44.0 22.5 45.0 21.9 89.3 33.7 42.1 42.0 15.5 29.4 43.8 67.0 60.9 18.6 44.2 30.0 11.1 47.1 20.5 27.1 9.5 50.8 40.2 41.0 40.2 13.7 35.0 42.6 28.8 74.0 24.5 58.5 37.6 36.6 30.8 77.6 26.9 20.1 43.7 39.3 23.0 55.6 43.6 45.5 104.7 27.7 99.6 64.1 78.1 145.8 61.1 166.5 290.6 114.8 133.3 52.2 59.0 0.0 82.2 130.4 72.2 47.7 42.8 105.2 151.6 199.4 31.2 0.2 38.5 75.3 58.7 0.2 13.4 91.5 46.9 103.5 135.1 123.9 154.3 0.0 2.7 0.4 141.5 9.9 0.1 10.3 74.4 61.3 53.7 0.1 80.9 17.4 95.7 136.8 29.6 61.8 97.8 2.1 77.0 115.2 26.5 1.2 158.5 120.1 85.1 46.9 69.6 61.4 36.0 0.9 106.7 2.3 148.1 0.0 2.4 0.0 0.1 1.6 0.1 0.8 1.5 0.4 0.6 0.3 0.7 0.2 0.1 0.0 1.0 0.0 3.5 0.8 19.1 28.4 31.3 19.8 15.5 29.4 44.2 30.0 11.1 40.2 37.6 26.9 45.5 56.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 59.4 15.5 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.2;pituitary gland: 6.5" "Cell type enhanced" "Detected in many" "Granulosa cells: 17.5;Proximal tubular cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.5 0.7 1.1 0.4 2.4 0.5 1.0 0.3 6.2 2.2 0.0 1.1 0.8 2.3 0.4 0.6 2.4 0.6 0.8 2.9 1.0 1.1 0.3 0.8 0.3 2.4 0.0 1.7 3.8 0.9 0.4 6.5 0.1 1.7 2.4 0.0 1.7 0.8 0.3 0.8 1.0 0.6 0.1 0.0 0.6 0.7 0.5 0.6 0.1 1.3 0.0 0.0 1.3 1.5 1.8 0.2 1.2 0.0 2.5 0.0 0.4 1.0 2.0 0.2 0.6 0.3 0.7 0.5 0.5 0.1 0.1 0.7 2.2 0.4 0.7 0.2 0.2 0.3 0.1 0.3 0.3 1.1 0.9 0.9 0.1 0.2 0.2 1.7 0.4 0.1 0.9 0.8 0.7 0.0 1.1 0.0 0.6 0.8 0.7 0.2 0.7 0.5 0.1 0.1 0.6 2.1 0.4 0.2 0.2 0.3 0.2 1.0 0.0 0.0 0.4 0.4 1.8 0.5 0.2 0.6 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.3 6.2 2.9 1.0 2.4 0.0 1.7 1.7 0.0 0.6 1.8 1.2 3.2 1.8 0.7 0.9 1.1 3.1 1.0 3.4 2.1 4.7 5.0 0.5 8.6 3.0 1.8 2.1 1.5 0.4 0.8 5.9 5.1 5.8 4.7 2.3 1.6 4.2 1.3 0.3 1.8 1.6 2.6 1.5 1.5 1.3 17.5 2.5 1.3 1.9 1.7 0.3 1.5 0.0 1.3 0.6 6.2 1.8 0.7 3.6 0.0 0.1 2.7 4.1 0.0 0.1 3.5 0.3 2.6 0.1 7.0 0.8 10.3 8.5 1.7 0.0 3.3 2.1 0.9 0.8 3.8 1.3 1.1 0.8 2.3 2.4 1.8 CYP4F8 ENSG00000186526 "Cytochrome P450 family 4 subfamily F member 8" P98187 19 15615218-15630639 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "seminal vesicle: 217.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 1.2;Breast glandular cells: 1.7;granulocytes: 1.3;NK-cells: 1.0;Prostatic glandular cells: 1.3;Skeletal myocytes: 1.7;Urothelial cells: 2.5" "Cancer enhanced" "Detected in some" "urothelial cancer: 10.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" "Low region specificity" "Detected in all" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.70e-2)" "unprognostic (5.46e-3)" "unprognostic (3.21e-2)" "unprognostic (3.97e-6)" "unprognostic (3.51e-3)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-2)" "unprognostic (1.15e-2)" "unprognostic (1.02e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.2 217.7 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.4 1.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 1.7 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 2.5 CYP4F3 "CYP4F, LTB4H" ENSG00000186529 "Cytochrome P450 family 4 subfamily F member 3" Q08477 19 15640897-15662825 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 81.0;liver: 237.7" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 562.4" "Cancer enhanced" "Detected in many" "liver cancer: 30.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 63 "neutrophil: 84.1" "Lineage enriched" "Detected in single" 177 "granulocytes: 84.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 33.0;HaCaT: 14.9;Hep G2: 18.3;OE19: 49.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.73e-2)" "unprognostic (9.70e-3)" "unprognostic (1.21e-1)" "unprognostic (1.16e-3)" "unprognostic (5.40e-1)" "unprognostic (1.57e-1)" "unprognostic (7.15e-3)" "unprognostic (5.19e-2)" "unprognostic (2.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-1)" "unprognostic (1.59e-3)" "unprognostic (2.36e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.07e-1)" 1.6 0.1 0.9 1.2 3.0 81.0 0.2 2.7 1.5 3.4 0.5 2.1 9.5 0.1 0.8 26.9 1.1 15.6 0.2 1.9 2.0 27.6 237.7 2.3 0.1 2.4 2.1 0.7 0.1 0.6 0.0 0.5 0.4 2.6 0.6 1.8 0.1 3.5 0.6 0.1 3.9 15.1 0.3 2.0 7.8 5.2 0.3 1.7 0.7 0.1 0.6 0.7 2.9 9.0 4.3 0.3 7.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 33.0 0.1 0.2 0.0 0.1 14.9 0.0 0.2 0.0 0.6 0.0 0.1 3.5 18.3 0.0 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 49.3 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 84.1 0.0 0.1 0.0 0.0 0.1 0.9 3.0 2.7 1.5 1.9 2.0 2.4 2.1 0.7 2.6 2.0 1.7 4.3 0.0 9.6 3.7 0.7 2.0 1.0 2.1 2.5 1.2 0.0 0.1 0.1 0.9 62.9 5.0 0.0 0.0 0.0 1.4 10.0 0.0 2.3 0.1 0.9 0.2 0.7 53.1 17.3 0.0 0.2 0.2 0.8 7.7 3.1 1.3 0.0 8.2 562.4 0.0 0.0 0.0 14.4 8.2 11.4 0.3 0.7 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.0 7.4 0.0 0.0 3.2 69.9 32.1 1.9 0.0 0.0 0.7 1.3 0.0 0.3 25.7 6.5 0.0 1.1 0.0 10.9 13.1 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 7.4 6.7 4.0 6.1 3.8 3.4 7.3 7.6 5.1 7.5 3.3 6.7 7.1 6.5 5.0 3.9 7.3 3.6 6.3 3.3 3.4 3.7 4.9 5.6 6.9 3.6 3.1 3.4 9.6 6.8 3.6 6.7 4.7 4.7 6.5 4.9 7.7 7.3 5.7 13.8 6.6 7.5 5.9 2.3 6.4 5.0 5.9 3.4 6.3 5.7 10.3 6.6 7.2 6.3 4.4 7.4 13.7 13.5 9.6 9.0 6.1 15.7 11.9 6.7 12.3 12.5 22.0 6.2 19.7 7.8 4.8 8.3 14.2 12.9 7.7 15.3 5.7 13.1 7.2 15.9 6.0 4.5 7.4 6.8 4.4 6.8 12.7 11.1 6.3 6.2 16.6 7.6 7.5 9.7 4.6 13.6 5.3 6.2 8.7 6.6 16.7 6.9 5.0 4.9 8.8 5.5 7.6 11.0 4.5 11.1 10.9 6.7 4.5 5.9 12.0 6.1 10.0 10.4 5.2 7.5 7.1 6.8 6.4 11.9 12.0 2.4 2.3 5.1 3.0 4.3 4.0 3.0 3.3 1.5 2.7 3.4 5.0 1.3 3.1 2.4 4.5 3.5 2.1 4.0 3.8 7.6 5.1 3.3 3.4 3.6 3.1 3.4 4.7 2.3 3.4 4.4 22.9 6.4 27.8 6.5 12.9 5.0 9.3 11.9 14.8 19.3 6.9 8.4 6.3 14.3 14.0 7.3 33.3 9.7 16.5 6.9 1.9 5.7 20.2 3.7 8.9 10.9 3.6 9.7 11.7 3.3 10.9 14.2 4.1 3.5 7.6 14.7 17.2 6.7 12.9 26.9 12.1 5.2 12.2 23.3 9.2 5.9 27.1 17.4 5.4 13.1 16.4 7.9 43.3 4.5 7.1 4.2 2.0 24.8 10.1 7.2 23.3 2.9 17.8 19.9 46.0 43.6 23.9 12.6 14.8 5.1 6.7 8.1 12.1 6.1 6.4 3.5 DEFB105A "DEFB-5, DEFB105" ENSG00000186562 "Defensin beta 105A" Q8NG35 8 7821966-7823889 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD2 "FKHL17, FREAC9" ENSG00000186564 "Forkhead box D2" O60548 1 47438044-47440691 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.9" "Group enriched" "Detected in some" 4 "Distal enterocytes: 22.2;Enteroendocrine cells: 9.1;Intestinal goblet cells: 12.6;Paneth cells: 11.1;Sertoli cells: 6.6;Undifferentiated cells: 18.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 3.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 14.4;WM-115: 23.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "spinal cord: 4.0" NA NA "unprognostic (5.10e-2)" "unprognostic (4.55e-2)" "unprognostic (4.17e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (9.85e-3)" "unprognostic (2.81e-3)" "unprognostic (1.92e-1)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (4.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.79e-12)" "unprognostic (1.00e-3)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (5.91e-2)" 0.4 0.8 0.3 0.6 0.2 0.0 0.3 0.3 0.9 1.0 2.4 5.9 0.4 0.3 0.2 0.1 0.3 0.0 0.1 0.2 0.6 1.9 0.6 0.3 0.1 0.1 1.4 0.3 0.1 0.1 0.1 1.1 0.2 0.2 1.3 4.7 0.2 0.3 0.2 0.2 0.2 0.4 0.1 0.1 0.6 0.7 0.4 0.2 0.1 0.2 1.0 0.0 0.2 0.4 0.2 0.8 0.4 0.0 14.4 0.1 0.1 0.4 0.4 0.1 0.0 0.1 1.0 0.2 0.2 0.6 0.0 1.2 0.2 0.6 0.0 0.0 1.8 2.3 0.5 0.3 0.1 0.0 0.2 1.3 0.0 0.8 0.0 0.0 0.3 0.0 0.8 0.4 0.1 0.1 0.4 0.2 0.6 0.0 0.4 0.5 1.9 1.1 0.7 0.0 0.9 2.0 0.0 0.6 0.8 2.0 0.4 4.0 1.1 0.3 0.5 1.5 0.1 0.7 0.4 0.2 0.3 0.6 0.9 23.2 0.2 0.1 0.4 0.5 0.1 0.4 0.2 0.2 0.4 0.0 0.2 0.1 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.3 0.2 0.3 0.9 0.2 0.6 0.1 1.4 0.3 0.2 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.3 0.1 1.3 0.0 0.2 0.0 0.0 0.0 1.4 22.2 0.0 0.2 0.4 0.1 1.1 0.3 9.1 0.0 0.0 0.7 0.0 0.8 1.1 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 12.6 0.0 1.4 0.8 1.1 0.0 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 11.1 0.7 0.0 0.0 1.3 0.2 0.4 0.2 6.6 0.2 2.0 0.7 1.5 0.0 0.1 0.0 1.0 0.0 18.1 0.0 GPATCH8 "GPATC8, KIAA0553" ENSG00000186566 "G-patch domain containing 8" Q9UKJ3 17 44395281-44503430 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 312.1;Inhibitory neurons: 287.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044380 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA044380: AB_10965696" "unprognostic (3.37e-1)" "unprognostic (5.90e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.07e-3)" "unprognostic (2.13e-2)" "unprognostic (5.86e-3)" "unprognostic (2.25e-1)" "unprognostic (1.38e-1)" "unprognostic (6.84e-3)" "unprognostic (8.47e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-2)" "unprognostic (1.50e-1)" "unprognostic (9.91e-2)" "unprognostic (7.58e-2)" "unprognostic (2.49e-1)" 10.6 9.3 12.1 11.4 13.2 18.5 11.1 14.8 14.1 10.7 9.6 9.0 11.2 14.6 11.9 9.5 11.2 8.9 9.0 11.9 12.5 9.0 7.1 10.8 15.9 13.6 13.1 11.2 17.5 8.0 14.6 0.4 13.2 12.7 9.6 10.5 30.4 9.3 10.3 33.7 15.6 11.1 12.6 12.3 13.2 8.9 10.9 13.2 21.0 11.1 14.0 15.5 9.9 0.8 13.7 22.0 12.8 22.8 18.9 17.5 20.2 23.1 16.7 21.1 18.3 19.2 19.0 13.9 31.1 10.9 23.7 15.8 16.7 23.3 19.3 27.2 25.7 20.8 26.5 15.5 22.5 20.9 25.7 20.3 22.9 20.5 20.9 27.2 18.4 20.2 19.4 20.1 18.7 16.8 10.0 33.7 9.9 16.0 12.5 16.2 27.1 25.8 21.7 16.0 10.6 15.9 19.3 16.6 10.6 20.9 27.0 13.9 17.3 22.5 18.0 12.6 19.3 23.4 20.1 17.9 29.2 16.8 14.1 19.3 8.2 6.1 4.9 9.4 6.0 8.7 8.6 8.2 7.8 6.5 7.1 7.5 7.3 4.6 10.3 13.6 8.0 4.1 5.2 12.1 13.2 14.8 14.1 11.9 12.5 13.6 13.1 11.2 12.7 12.3 13.2 13.7 38.8 22.4 32.5 148.5 64.6 48.7 53.1 52.0 47.8 72.7 28.8 22.7 40.5 30.0 46.0 25.8 123.0 42.4 76.6 25.2 9.8 32.8 19.6 38.7 63.3 38.8 38.8 50.1 312.1 24.5 39.3 48.4 23.9 56.5 42.4 44.6 44.3 19.4 23.0 146.4 287.3 20.3 36.7 36.2 42.3 7.6 63.0 38.6 23.2 108.7 42.5 43.5 161.7 172.9 204.1 34.7 24.7 43.2 58.1 45.3 30.2 14.6 29.8 125.3 52.6 68.6 51.2 93.1 74.2 33.7 46.9 53.4 69.8 43.1 25.4 56.8 CEACAM19 CEAL1 ENSG00000186567 "CEA cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 7.9;Skeletal myocytes: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.2;RPTEC TERT1: 15.8;TIME: 20.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.1" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 3.6 5.6 3.4 1.3 3.6 1.5 3.9 4.3 4.8 6.2 3.2 4.7 3.0 5.3 1.7 5.1 6.8 2.4 8.4 3.9 4.0 7.0 8.3 8.2 1.1 2.8 2.6 3.2 6.6 9.0 1.5 7.1 2.2 3.7 7.8 3.5 2.4 5.7 3.1 14.0 12.1 3.8 3.1 2.0 3.6 4.6 5.7 3.2 1.0 6.6 3.4 2.2 4.2 8.8 4.4 5.1 10.3 1.5 1.0 3.5 4.0 3.8 2.8 4.2 0.9 1.8 0.4 1.1 0.1 1.0 3.8 1.0 6.2 2.6 1.1 0.8 1.5 5.8 0.1 6.7 1.7 3.6 0.2 1.0 1.3 10.0 2.6 6.1 12.2 2.4 0.7 0.3 0.3 1.4 1.2 0.0 0.6 0.9 1.4 1.1 0.0 1.8 0.2 15.8 1.2 1.9 0.5 1.1 1.1 0.9 1.4 1.4 0.3 20.9 0.4 6.8 1.5 0.9 0.1 0.3 0.0 0.5 2.0 1.7 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 3.4 3.6 4.3 4.8 3.9 4.0 2.8 2.6 3.2 3.7 2.0 3.2 4.4 3.6 3.2 2.2 2.0 0.0 2.0 0.9 2.1 1.2 2.9 1.9 1.5 4.5 1.5 2.4 0.0 0.0 0.2 0.1 2.1 0.0 1.6 3.8 0.9 0.9 4.1 1.8 0.0 7.9 3.3 0.2 1.0 3.6 2.4 0.0 0.8 4.6 2.6 0.3 0.0 6.1 2.3 4.1 0.6 0.8 1.9 3.1 0.5 0.0 1.9 0.4 0.3 1.0 2.0 2.4 4.5 2.6 2.6 0.0 1.8 1.2 0.4 1.8 0.6 0.0 8.8 1.7 3.1 0.9 1.2 6.0 0.0 0.2 1.6 2.5 0.9 DEFB107A "DEFB-7, DEFB107" ENSG00000186572 "Defensin beta 107A" Q8IZN7 8 7811720-7815716 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 1404 "epididymis: 140.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.1;Late spermatids: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favorable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 8.9 13.7 18.9 8.5 16.2 8.0 7.6 13.5 28.4 8.5 9.6 10.1 6.3 11.2 6.2 13.6 8.7 5.3 18.4 26.7 13.7 15.4 10.6 9.4 6.5 14.9 18.5 16.0 8.6 12.8 27.7 9.6 4.6 17.0 10.0 5.5 7.4 8.5 6.7 23.0 10.2 8.9 8.1 12.9 9.9 10.1 21.1 17.0 9.4 11.2 19.3 7.1 9.4 7.7 16.4 75.8 36.7 12.2 74.3 21.5 22.0 7.7 57.3 37.9 74.1 53.7 32.7 18.4 21.1 50.4 69.9 48.9 27.1 25.1 37.8 52.0 31.9 12.5 26.8 24.4 26.4 22.4 35.1 28.6 20.1 16.4 53.3 51.0 21.8 47.7 13.7 12.0 18.7 64.5 35.1 21.4 16.6 8.3 16.9 20.4 24.2 56.8 18.8 68.5 37.3 17.0 11.6 36.0 24.5 14.0 9.4 14.9 15.4 92.7 101.1 109.6 44.8 112.5 30.0 26.7 25.5 27.0 14.5 68.5 10.0 10.0 4.2 15.5 14.7 13.1 8.3 11.5 10.4 15.1 8.6 9.7 9.2 2.3 13.2 21.0 10.2 10.7 12.2 18.9 16.2 13.5 28.4 26.7 13.7 14.9 18.5 16.0 17.0 12.9 17.0 16.4 8.1 6.4 20.1 14.7 9.4 14.1 11.6 9.8 8.6 16.3 14.5 9.0 23.1 18.6 10.0 14.7 10.4 11.7 12.7 9.0 21.5 40.0 77.1 14.5 17.7 13.2 13.1 13.9 27.5 24.9 6.7 12.5 7.7 15.2 22.9 12.2 11.7 14.4 13.5 30.3 27.1 7.9 6.1 14.7 7.5 121.4 7.2 10.2 8.8 18.7 8.6 19.1 14.4 17.6 16.7 40.1 14.5 12.4 14.7 13.6 10.5 30.1 8.6 9.6 6.6 13.7 15.6 29.5 8.1 15.5 14.3 3.8 12.9 17.4 11.2 9.5 SMIM29 "C6orf1, LBH, MGC57858" ENSG00000186577 "Small integral membrane protein 29" Q86T20 6 34246381-34249108 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 177.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 72.4;Ductal cells: 50.9;Hofbauer cells: 104.0;monocytes: 44.5;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 412.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037659, HPA037660" Uncertain NA NA "HPA037659: AB_2675591, HPA037660: AB_10671881" "unprognostic (2.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.10e-1)" "unprognostic (3.23e-1)" "unprognostic (1.93e-3)" "unprognostic (1.36e-2)" "unprognostic (2.62e-1)" "unprognostic (4.12e-2)" "prognostic favorable (7.98e-4)" "unprognostic (9.32e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (3.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.66e-1)" 18.6 30.0 124.0 14.5 118.4 14.9 19.7 120.6 177.2 23.8 88.8 20.2 8.4 20.0 34.8 27.2 17.2 17.2 30.0 120.7 124.1 22.7 18.8 28.1 21.5 128.5 123.5 118.3 16.5 15.6 18.7 33.6 13.3 127.6 23.0 6.2 16.2 16.3 16.4 24.7 49.1 18.1 12.3 121.0 31.1 17.1 11.8 124.6 14.7 25.9 23.7 15.6 24.2 26.3 127.6 25.1 31.1 6.2 33.3 79.2 62.2 6.7 24.6 58.4 27.4 34.4 7.6 12.3 14.1 19.8 28.6 56.6 15.6 12.7 31.3 8.9 36.0 17.3 10.5 6.1 19.9 45.4 12.0 62.0 33.7 28.4 38.5 37.6 38.4 40.9 11.6 13.5 81.8 64.0 17.9 13.5 24.2 1.9 42.8 21.5 5.5 3.8 25.1 33.1 32.4 26.0 12.1 2.6 23.8 70.9 5.3 14.1 19.1 26.4 62.1 14.4 65.1 21.6 42.9 66.1 4.7 35.4 25.7 82.9 99.1 83.8 412.8 78.7 62.7 52.6 133.3 62.4 69.1 59.7 126.4 41.8 61.8 231.6 57.1 48.3 50.1 90.3 64.0 124.0 118.4 120.6 177.2 120.7 124.1 128.5 123.5 118.3 127.6 121.0 124.6 127.6 18.1 9.6 13.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 28.5 20.8 0.0 0.0 6.8 31.3 0.0 37.8 13.6 0.0 72.4 50.9 0.0 9.9 8.6 15.5 0.0 0.0 0.0 24.0 11.8 8.0 0.0 15.0 12.6 10.8 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 44.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 1.9 0.0 0.0 43.8 10.2 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 35.4 9.4 17.8 0.0 0.0 DEFB106A "DEFB-6, DEFB106" ENSG00000186579 "Defensin beta 106A" Q8N104 8 7825139-7829053 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16923 "epididymis: 3029.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "NB-4: 2.2" HPA045592 Supported "Secreted in male reproductive system" NA NA "HPA045592: AB_2679378" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3029.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATC1 "MGC61633, SPATA15, SPERIOLIN" ENSG00000186583 "Spermatogenesis and centriole associated 1" Q76KD6 8 144012280-144047114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 37.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 358.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-937: 7.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 13.9" NA NA "unprognostic (2.96e-1)" "unprognostic (1.41e-3)" "unprognostic (3.34e-1)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (4.59e-3)" "unprognostic (6.96e-2)" "unprognostic (4.30e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (4.12e-2)" "unprognostic (4.39e-2)" "unprognostic (1.34e-3)" "unprognostic (2.74e-1)" "unprognostic (5.81e-3)" "unprognostic (2.19e-1)" "unprognostic (2.74e-1)" 0.2 0.1 0.2 1.8 0.2 8.5 0.1 1.2 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.8 0.6 1.6 0.3 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.1 0.0 2.0 0.2 37.8 0.3 0.1 0.0 0.0 0.5 0.1 0.0 0.9 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.2 0.4 0.1 0.2 1.6 0.3 0.0 1.7 0.0 0.3 0.9 0.0 0.0 0.5 5.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 358.1 2.5 0.5 0.0 0.0 4.3 0.0 0.0 1.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2H "GID3, UBC8, UBCH" ENSG00000186591 "Ubiquitin conjugating enzyme E2 H" P62256 7 129830732-129952960 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 365.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003302 Approved Approved Mitochondria NA NA 21000 Mitochondria "HPA003302: AB_1858526" "unprognostic (1.15e-1)" "unprognostic (5.85e-2)" "unprognostic (5.67e-3)" "unprognostic (2.76e-1)" "unprognostic (2.25e-1)" "unprognostic (3.08e-2)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (6.19e-2)" "prognostic unfavorable (2.33e-5)" "unprognostic (1.13e-1)" "unprognostic (3.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.12e-1)" "unprognostic (3.58e-1)" "unprognostic (1.23e-1)" 47.2 65.3 43.9 29.4 44.8 42.7 34.7 47.3 49.5 45.1 59.0 35.9 23.6 44.7 37.9 50.3 45.0 45.0 99.1 42.9 45.9 42.5 44.5 39.2 32.1 51.5 44.6 37.5 42.1 85.0 49.6 29.6 52.9 47.2 36.4 26.3 42.4 39.7 41.9 70.0 31.0 24.6 49.7 42.6 28.8 34.9 36.8 45.5 37.7 45.4 61.2 40.2 40.5 34.0 50.0 82.6 43.8 58.5 56.1 126.1 107.5 86.5 72.0 97.8 45.8 51.1 22.9 92.5 34.0 87.4 76.6 123.8 62.5 46.2 81.6 59.5 40.9 22.6 11.5 63.5 28.6 98.3 23.6 36.8 146.7 106.9 61.3 99.7 106.3 89.7 36.3 27.5 104.1 71.5 29.9 31.1 26.1 80.0 60.5 49.8 24.4 27.8 77.2 95.9 106.5 20.3 59.6 68.3 164.7 43.8 166.0 17.1 27.2 89.1 51.7 24.2 72.2 76.5 83.5 65.6 58.5 102.1 28.9 49.7 2.2 1.4 3.4 2.8 1.2 3.8 2.3 2.8 2.6 1.3 4.5 3.6 3.8 4.8 0.9 1.5 2.3 4.4 1.3 43.9 44.8 47.3 49.5 42.9 45.9 51.5 44.6 37.5 47.2 42.6 45.5 50.0 69.9 41.7 51.8 87.1 43.1 145.8 187.5 65.7 59.7 65.1 83.7 49.4 102.9 44.3 69.3 71.7 60.5 116.3 56.7 38.6 41.1 66.0 93.5 225.7 91.2 81.4 59.1 100.0 97.1 70.9 67.1 65.2 43.8 365.8 14.7 53.9 45.3 73.1 41.8 43.7 116.9 35.3 54.9 40.3 69.8 44.0 44.1 52.0 48.0 89.0 26.2 87.4 51.5 113.1 108.5 118.3 33.6 78.6 60.5 227.6 27.6 49.7 95.3 35.6 13.1 65.9 69.0 46.5 22.5 78.6 153.7 200.4 49.2 79.7 26.6 274.3 DEFB105B ENSG00000186599 "Defensin beta 105B" Q8NG35 8 7487679-7489593 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12955 "epididymis: 2404.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 4.2" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2404.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326895-45328679 "Human disease related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.1;Gastric mucus-secreting cells: 8.2;Undifferentiated cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 111.7;HL-60: 34.2;NB-4: 42.8;SK-BR-3: 72.5" "Low region specificity" "Detected in many" "HPA031997, HPA057346" Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA031997: AB_10602909, HPA057346: AB_2683415" "prognostic favorable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.4 0.3 1.0 1.4 1.3 1.8 0.4 3.3 1.1 1.0 0.0 3.7 2.4 0.7 0.0 2.3 0.6 0.0 0.3 1.0 1.0 0.3 0.1 0.3 1.1 1.4 1.3 0.7 0.6 0.3 0.0 0.3 2.1 1.8 0.6 2.8 0.4 1.0 0.2 1.6 0.8 2.5 0.3 0.8 1.8 3.4 0.3 1.4 1.3 0.6 0.6 0.9 0.5 1.1 1.3 0.1 1.1 0.5 0.1 0.1 0.4 111.7 1.5 0.0 2.0 0.4 28.7 7.7 5.8 0.3 1.5 0.0 7.0 0.0 0.4 0.7 0.2 0.3 0.6 13.4 0.0 0.7 34.2 0.9 1.1 0.2 1.2 0.0 0.1 2.2 0.2 0.0 5.2 0.2 14.6 22.1 42.8 0.5 23.0 0.0 6.6 0.1 19.4 0.4 0.4 22.2 1.5 14.6 72.5 11.4 1.6 0.2 6.3 1.0 0.0 0.3 1.3 0.0 0.9 0.6 21.3 0.1 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.2 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.1 1.0 1.3 3.3 1.1 1.0 1.0 1.4 1.3 0.7 1.8 0.8 1.4 1.3 0.1 0.0 0.0 2.9 1.0 0.1 2.3 0.5 1.2 0.2 0.7 1.0 0.4 0.0 0.1 0.0 0.0 29.1 0.3 3.0 3.9 0.4 0.2 0.1 1.5 0.7 1.2 4.2 0.0 0.0 5.8 0.8 8.2 0.2 0.0 0.9 0.4 0.1 2.5 0.0 0.2 3.3 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.8 1.9 0.0 5.2 2.2 0.4 0.3 0.0 0.4 0.0 0.6 0.8 0.0 1.9 2.1 1.1 5.1 0.4 1.2 7.6 1.5 KATNA1 ENSG00000186625 "Katanin catalytic subunit A1" O75449 6 149594873-149648972 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036207 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036207: AB_10672238" "unprognostic (1.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.95e-2)" "unprognostic (3.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (9.78e-2)" "unprognostic (8.89e-2)" "unprognostic (7.40e-2)" "unprognostic (2.70e-2)" "unprognostic (4.50e-2)" "unprognostic (3.92e-2)" "unprognostic (2.10e-1)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (8.85e-2)" 12.2 8.3 7.8 10.4 8.6 19.4 12.7 10.0 9.2 13.4 11.7 11.9 8.6 13.4 9.9 12.6 11.9 9.8 11.7 7.4 9.0 13.3 9.1 11.3 14.2 8.4 8.1 6.7 19.6 9.6 7.3 7.5 12.8 8.5 10.0 10.0 16.9 9.8 11.0 23.2 12.2 10.1 12.5 8.4 11.9 10.2 45.5 8.2 17.1 11.3 14.4 15.9 12.1 12.8 10.0 22.5 8.3 18.6 42.1 22.9 32.7 28.9 28.7 24.3 29.4 37.2 17.9 11.4 33.7 16.9 28.4 20.4 17.1 34.5 18.5 37.8 30.4 33.8 42.7 17.6 27.9 31.0 60.0 16.4 22.8 22.5 33.3 27.3 27.3 27.8 44.4 46.1 20.7 26.2 32.0 41.2 40.4 19.1 26.2 15.1 30.5 33.3 15.2 21.6 11.6 13.7 20.7 48.9 15.0 22.2 24.3 14.4 61.6 23.7 14.6 23.4 39.2 33.9 20.4 20.3 43.9 19.8 42.7 26.4 39.8 20.4 29.1 25.9 28.5 22.2 27.7 25.2 25.8 26.1 18.3 21.4 20.9 8.7 18.2 25.6 22.3 34.0 20.5 7.8 8.6 10.0 9.2 7.4 9.0 8.4 8.1 6.7 8.5 8.4 8.2 10.0 27.6 16.0 11.3 11.8 20.2 29.3 35.7 23.0 12.5 9.1 17.3 26.9 15.5 10.0 15.0 14.7 29.2 23.6 31.4 12.1 17.6 19.5 416.6 23.2 21.6 19.3 6.0 27.4 8.6 12.4 19.4 25.9 11.7 19.3 20.3 23.9 10.0 7.7 17.4 13.5 9.4 9.7 24.4 12.5 19.4 194.2 21.1 17.3 10.6 7.5 22.1 12.2 27.8 13.6 16.3 15.9 12.5 16.6 9.0 19.4 9.7 20.9 23.8 36.1 6.6 40.0 28.5 109.3 58.8 17.7 28.7 25.6 25.6 17.7 12.1 15.4 FSD2 "RP11-127F21, SPRYD1" ENSG00000186628 "Fibronectin type III and SPRY domain containing 2" A1L4K1 15 82755362-82806070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "heart muscle: 52.8;skeletal muscle: 155.8;tongue: 44.7" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 81.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 3.6;U-266/70: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046263 Approved Cytosol NA NA Cytosol "HPA046263: AB_2679604" "unprognostic (2.80e-1)" "unprognostic (3.54e-1)" "unprognostic (6.63e-2)" "unprognostic (6.30e-2)" "unprognostic (7.71e-2)" "unprognostic (1.83e-1)" "unprognostic (5.97e-2)" "unprognostic (7.66e-2)" "unprognostic (1.07e-1)" "unprognostic (9.37e-2)" "unprognostic (3.05e-2)" "unprognostic (2.21e-1)" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-2)" "unprognostic (1.59e-2)" 0.2 0.7 0.2 0.9 0.2 0.8 0.1 0.8 0.5 0.0 0.0 0.1 0.9 0.4 0.6 2.0 0.3 0.3 52.8 0.3 0.2 0.3 0.1 0.2 1.1 0.1 0.1 0.2 0.6 0.6 0.7 0.1 0.3 0.4 1.2 0.0 2.4 0.8 0.0 155.8 1.5 0.8 0.1 0.0 0.6 0.6 0.7 0.2 0.0 0.9 44.7 0.1 0.1 0.0 0.7 0.7 0.7 1.1 1.3 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.6 1.2 2.3 0.5 0.0 0.6 2.8 0.0 0.0 0.2 0.4 3.1 1.3 3.6 1.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 0.7 0.0 1.0 1.2 2.0 0.0 0.7 0.4 1.4 1.0 0.5 0.6 0.8 0.8 0.6 0.1 1.3 1.1 0.9 0.5 0.5 0.9 0.5 0.9 1.0 0.5 1.6 0.8 0.6 1.0 4.7 2.1 0.8 1.0 2.8 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.8 0.5 0.3 0.2 0.1 0.1 0.2 0.4 0.0 0.2 0.7 0.4 0.0 2.2 1.3 0.2 0.4 1.0 0.2 0.0 2.1 0.5 0.3 81.6 1.5 0.8 0.0 6.2 0.1 0.3 0.1 0.0 0.0 4.8 1.7 0.3 1.2 1.2 0.0 3.9 0.4 0.1 3.0 0.0 1.6 1.3 0.6 0.0 0.0 0.3 11.8 3.6 0.0 2.0 0.3 2.1 6.1 0.3 0.2 0.0 1.0 0.1 0.7 0.0 4.0 3.3 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.5 4.5 0.0 4.5 0.6 0.6 0.3 0.0 0.6 0.3 0.4 0.2 0.1 0.3 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 36000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: AB_2686262" "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favorable (6.41e-4)" "unprognostic (7.56e-3)" 39.4 64.1 40.6 59.1 42.7 98.4 33.7 36.3 50.8 41.3 60.0 35.8 29.8 39.2 14.1 38.0 48.8 44.6 42.7 40.0 41.0 47.9 40.5 72.5 53.8 47.6 40.8 32.7 49.8 37.4 20.5 49.3 35.8 53.3 45.2 18.4 8.7 33.6 25.9 20.3 47.5 43.6 29.0 38.7 118.5 31.5 16.5 44.5 32.5 46.9 20.3 25.4 40.0 37.8 54.2 19.7 41.9 15.2 18.5 63.4 42.9 23.1 26.2 46.5 29.8 29.3 56.0 50.8 42.9 51.3 44.4 40.7 64.5 23.2 64.4 12.5 50.9 28.4 36.6 40.3 81.9 43.7 25.1 98.7 47.5 65.4 48.7 23.4 36.2 33.2 31.3 31.5 17.4 13.9 40.3 38.9 89.3 9.5 35.1 25.9 36.8 23.2 21.3 27.5 61.1 15.7 32.0 19.1 27.9 84.8 19.5 25.1 56.8 37.5 41.0 28.5 42.8 16.4 27.4 14.3 23.0 21.8 37.4 22.3 19.3 24.8 30.7 8.9 39.4 5.2 6.6 5.9 6.8 15.9 4.7 4.5 5.4 50.8 13.4 51.3 5.3 6.7 17.6 40.6 42.7 36.3 50.8 40.0 41.0 47.6 40.8 32.7 53.3 38.7 44.5 54.2 8.9 28.9 32.3 33.6 16.1 7.4 7.5 14.3 15.4 4.3 8.7 7.9 2.6 7.2 9.0 16.5 33.3 9.2 18.3 16.5 9.8 13.5 50.1 14.1 11.7 7.8 23.3 9.9 7.7 7.5 8.9 22.4 16.3 9.1 10.8 36.9 9.7 10.8 43.0 0.0 7.0 12.8 12.2 45.6 25.1 6.4 20.8 57.3 8.8 30.0 29.0 7.4 21.6 17.6 31.5 12.1 10.9 15.1 12.3 4.8 20.9 5.3 20.2 2.8 0.0 8.6 8.8 0.4 2.8 10.8 5.4 4.9 12.4 10.5 15.1 7.4 KIF24 "bA571F15.4, C9orf48, FLJ10933, FLJ43884" ENSG00000186638 "Kinesin family member 24" Q5T7B8 9 34252381-34311371 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 11.2" "Cell type enhanced" "Detected in some" "Astrocytes: 32.3;Early spermatids: 28.9;Late spermatids: 41.6;Spermatocytes: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 19 "basophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020643 Uncertain NA NA "HPA020643: AB_2131749" "unprognostic (2.68e-1)" "prognostic favorable (1.33e-4)" "unprognostic (9.44e-2)" "unprognostic (3.82e-3)" "unprognostic (3.11e-1)" "unprognostic (2.11e-3)" "unprognostic (1.40e-2)" "unprognostic (8.38e-3)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (1.40e-2)" "unprognostic (8.68e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (2.28e-1)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" 0.2 0.6 1.6 0.9 0.9 2.1 0.7 0.9 0.9 0.6 3.7 0.9 0.6 0.6 1.4 0.9 3.2 0.4 0.4 0.8 1.7 0.7 0.3 0.6 1.3 1.7 1.7 0.4 0.4 0.5 1.5 1.0 0.6 1.1 0.4 1.0 0.4 0.3 0.5 0.7 0.9 0.6 0.7 1.7 0.3 0.6 11.2 0.7 3.9 1.2 0.6 1.7 0.3 0.4 0.8 9.8 6.4 7.5 6.2 0.6 1.0 2.8 5.3 3.4 7.0 8.4 3.1 3.0 7.6 1.6 2.5 4.5 4.5 7.6 4.6 7.2 4.9 3.3 3.5 10.7 1.9 0.2 7.2 5.3 0.4 0.9 9.1 3.8 1.3 3.2 5.3 3.6 6.0 3.9 4.0 8.7 6.7 3.0 4.5 3.8 8.0 4.6 2.1 2.9 2.5 3.5 3.4 6.5 3.3 0.9 2.9 3.6 3.5 2.6 6.5 7.1 5.1 6.5 1.7 2.9 4.1 4.4 3.5 8.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.9 0.9 0.9 0.8 1.7 1.7 1.7 0.4 1.1 1.7 0.7 0.8 0.3 0.0 1.1 32.3 0.7 0.4 0.2 0.7 0.6 0.3 0.7 1.1 0.9 1.5 1.6 1.8 0.0 0.6 0.3 0.7 0.0 0.4 28.9 8.2 0.8 0.4 0.0 3.0 7.2 0.2 1.0 0.7 2.0 0.8 0.0 1.5 0.0 0.0 0.7 0.0 3.5 0.8 2.0 0.3 0.3 41.6 0.9 0.4 0.0 3.7 0.1 0.2 0.0 10.1 9.2 0.2 0.0 1.9 2.1 0.1 0.3 0.4 11.0 0.4 0.0 0.5 0.4 14.5 6.9 1.0 0.9 0.3 0.3 0.8 0.7 0.1 PDE2A ENSG00000186642 "Phosphodiesterase 2A" O00408 11 72576141-72674591 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.6" "Group enriched" "Detected in many" 6 "Adipocytes: 114.9;Endothelial cells: 58.5;Enteroendocrine cells: 34.4;Excitatory neurons: 70.1;Hepatic stellate cells: 118.2;Inhibitory neurons: 35.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.8;T-cells: 7.3" "Cell line enriched" "Detected in some" 8 "HeLa: 513.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 5 "amygdala: 83.5;basal ganglia: 146.9;cerebral cortex: 90.5;hippocampal formation: 94.0" "CAB009752, HPA031192" Enhanced Supported Cytosol NA NA Cytosol "CAB009752: AB_2268159, HPA031192: AB_2673781" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (4.58e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-1)" "unprognostic (2.50e-1)" "prognostic favorable (1.76e-6)" "unprognostic (3.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-3)" "unprognostic (3.13e-3)" "unprognostic (1.50e-2)" "unprognostic (1.77e-2)" "unprognostic (2.85e-3)" "unprognostic (6.31e-2)" "unprognostic (7.72e-2)" "unprognostic (7.96e-4)" 88.5 44.5 82.9 5.2 84.9 4.8 84.4 0.0 90.6 35.4 1.1 28.5 6.1 27.4 8.3 18.7 39.7 22.9 37.1 84.5 23.6 32.3 19.6 12.7 6.8 23.4 7.7 103.9 11.7 6.9 5.6 11.9 12.1 33.5 20.9 9.0 3.1 9.3 10.8 16.9 17.1 18.9 18.7 0.0 198.6 17.2 7.4 19.2 3.8 24.3 29.1 3.6 29.1 27.4 55.8 0.3 0.2 0.7 0.2 0.2 0.1 0.3 0.1 0.2 0.2 0.4 0.4 2.5 0.8 12.2 0.2 1.9 0.2 0.9 0.1 0.1 0.1 0.1 0.0 513.6 0.8 0.9 0.0 7.8 0.1 1.1 2.7 20.5 1.1 11.3 0.5 0.8 0.9 0.1 0.0 0.2 0.2 7.4 0.2 14.0 0.0 0.2 1.4 0.1 0.3 44.5 2.4 0.4 0.2 2.2 0.7 0.3 0.1 65.2 0.1 9.4 3.5 0.4 0.4 0.2 0.1 3.9 0.1 0.6 0.0 0.6 0.0 7.3 0.8 4.2 2.8 4.3 4.3 1.0 1.8 2.7 2.3 0.1 0.0 0.4 0.0 1.8 1.5 82.9 84.9 0.0 90.6 84.5 23.6 23.4 7.7 103.9 33.5 0.0 19.2 55.8 114.9 0.0 0.5 2.0 0.7 2.5 0.1 0.0 0.0 4.9 0.6 1.0 7.8 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.6 0.0 0.1 58.5 34.4 5.3 70.1 0.0 0.3 2.1 0.0 0.1 1.3 0.1 118.2 2.1 0.5 1.7 35.6 1.2 0.0 9.4 8.2 2.5 0.3 4.9 1.8 11.2 0.0 0.0 0.0 9.0 5.7 0.1 0.0 0.4 1.5 0.1 0.0 0.1 0.0 0.4 0.0 1.8 6.6 4.8 2.5 0.5 2.8 0.0 0.6 0.2 0.1 0.3 SPDYE17 ENSG00000186645 "Speedy/RINGO cell cycle regulator family member E17" 7 77022319-77032361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.1;testis: 1.3" "Group enriched" "Detected in some" 46 "Astrocytes: 2.9;Excitatory neurons: 5.6;Inhibitory neurons: 5.3;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (6.76e-2)" "unprognostic (6.08e-2)" 0.1 0.0 0.3 0.2 0.1 0.1 0.0 1.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.3 0.1 0.0 0.2 0.8 0.1 0.0 0.0 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 1.1 0.4 0.2 0.1 0.3 0.1 0.0 0.6 0.0 0.2 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052009-24069729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.4;pituitary gland: 8.2;skin 1: 3.7;testis: 2.3" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.5;HMC-1: 3.7;Karpas-707: 3.3;SCLC-21H: 5.4;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain NA NA "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.1 0.3 1.5 0.3 1.5 0.2 0.3 3.4 2.0 0.2 0.0 0.4 0.5 0.2 0.0 0.6 0.1 0.3 0.1 1.8 1.1 0.7 0.2 0.3 0.3 1.6 1.5 1.4 0.1 0.7 0.0 8.2 0.0 1.9 0.3 0.1 1.0 0.6 0.0 0.0 3.7 0.7 0.0 0.2 0.5 0.3 2.3 1.8 0.1 0.5 0.0 0.4 0.1 0.5 2.4 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.2 0.8 0.0 0.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 5.4 2.6 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 3.4 2.0 1.8 1.1 1.6 1.5 1.4 1.9 0.2 1.8 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 PRG2 "BMPG, MBP, proMBP" ENSG00000186652 "Proteoglycan 2, pro eosinophil major basic protein" P13727 11 57386780-57390650 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Immunity "Antibiotic, Antimicrobial, Heparin-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "placenta: 2637.6" "Group enriched" "Detected in some" 10 "Erythroid cells: 44.3;Extravillous trophoblasts: 107.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 36 "basophil: 7.2" "Lineage enriched" "Detected in single" 73 "granulocytes: 7.2" "Group enriched" "Detected in some" 62 "HL-60: 3328.5;HMC-1: 5009.7;NB-4: 10560.9" "Not detected" "Not detected" HPA038515 Supported "Secreted in female reproductive system" NA NA 100000000 "HPA038515: AB_10675800" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (3.39e-2)" "unprognostic (3.49e-1)" "unprognostic (8.62e-4)" "unprognostic (4.77e-3)" "unprognostic (3.20e-2)" "unprognostic (4.17e-2)" "unprognostic (2.26e-2)" "unprognostic (5.19e-3)" "unprognostic (2.17e-1)" "unprognostic (1.40e-11)" "unprognostic (4.26e-2)" "unprognostic (4.52e-3)" "unprognostic (6.47e-2)" "unprognostic (2.32e-1)" 0.6 0.0 0.0 0.1 0.0 217.6 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.1 2.6 1.1 1.4 0.0 0.0 0.0 0.3 3.8 0.0 0.2 2637.6 0.1 0.0 0.4 0.0 0.9 0.0 0.2 2.1 0.4 0.5 0.0 3.0 0.3 0.0 0.0 8.8 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 101.3 0.0 0.0 0.2 3328.5 5009.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 9.0 0.6 0.0 0.0 0.8 10560.9 0.0 0.0 0.0 0.3 0.8 1.0 0.0 0.0 1.6 4.2 0.4 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.4 0.2 0.4 0.3 7.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 44.3 0.0 0.0 107.2 0.5 0.0 0.0 6.3 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.0 PRR5 "FLJ20185k, PP610, Protor-1" ENSG00000186654 "Proline rich 5" P85299 22 44668547-44737681 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 91.3;NK-cells: 77.2;Proximal tubular cells: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 19.1;T-cells: 28.6" "Cell line enhanced" "Detected in many" "U-266/70: 99.2;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054072 Approved NA NA "HPA054072: AB_2682369" "unprognostic (2.63e-2)" "unprognostic (6.63e-3)" "unprognostic (2.61e-2)" "prognostic favorable (2.47e-5)" "unprognostic (1.83e-2)" "unprognostic (3.99e-2)" "unprognostic (7.52e-2)" "unprognostic (1.37e-1)" "unprognostic (8.98e-2)" "unprognostic (5.13e-2)" "unprognostic (1.34e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" 16.3 2.4 5.7 3.2 6.4 7.3 12.3 4.8 11.4 7.8 9.8 4.9 8.7 3.8 2.1 7.7 4.4 2.9 2.6 6.6 7.9 11.4 18.7 3.5 3.9 6.8 6.9 5.0 4.1 6.2 2.3 16.3 4.5 6.6 7.9 2.4 0.4 5.7 3.8 0.8 7.0 9.5 1.1 4.4 20.6 5.3 5.1 7.6 2.4 4.6 1.2 2.5 7.0 7.2 5.7 8.1 9.6 2.0 6.8 0.2 0.3 25.0 7.0 6.2 4.2 3.4 24.4 3.4 0.0 5.2 8.2 4.9 7.2 2.1 7.1 0.7 0.2 19.9 15.9 1.3 28.5 5.8 2.9 5.8 2.9 7.9 0.4 2.2 1.0 0.2 3.7 10.1 0.5 0.9 21.4 1.1 4.6 1.3 11.4 1.4 0.7 4.5 14.5 1.4 3.8 7.0 1.0 1.9 11.4 9.5 5.5 5.3 2.8 0.0 0.1 11.0 1.0 0.1 99.2 31.3 0.2 0.0 6.4 0.8 0.5 0.3 0.1 24.8 3.4 28.6 1.6 8.3 18.8 0.7 0.9 3.5 13.0 0.6 5.6 19.1 0.4 14.8 6.8 5.7 6.4 4.8 11.4 6.6 7.9 6.8 6.9 5.0 6.6 4.4 7.6 5.7 6.0 0.0 3.9 11.4 9.2 8.3 12.0 2.1 4.0 0.7 13.6 13.2 2.0 10.0 2.3 5.5 0.0 32.1 50.3 20.5 5.9 5.2 0.5 4.4 5.4 12.5 9.6 91.3 2.0 7.9 3.3 23.2 8.2 4.7 7.6 5.4 21.4 19.9 32.1 0.0 1.8 22.8 2.0 13.5 8.2 0.5 5.3 7.7 8.8 3.7 3.0 6.0 77.2 1.0 0.2 8.4 7.6 3.8 29.0 24.2 50.9 55.2 1.4 1.5 0.0 11.4 5.3 0.3 20.4 8.0 8.5 44.1 37.1 51.8 25.5 13.5 ZFP91 "PZF, ZNF757" ENSG00000186660 "ZFP91 zinc finger protein, atypical E3 ubiquitin ligase" Q96JP5 11 58579063-58621550 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 243.7;Late spermatids: 179.3;Spermatocytes: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024037, CAB025417, HPA065325" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468" "unprognostic (6.10e-2)" "unprognostic (5.01e-2)" "unprognostic (3.33e-3)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (2.33e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (3.16e-1)" "unprognostic (1.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.61e-1)" "unprognostic (2.23e-1)" "unprognostic (2.00e-3)" 23.6 22.2 31.2 23.2 33.7 59.7 22.1 31.4 31.0 22.2 19.5 29.2 26.2 22.7 17.8 24.6 20.1 21.7 30.0 26.0 29.8 25.3 30.9 21.5 25.0 29.5 31.9 22.6 20.4 22.9 30.0 15.4 20.5 33.8 19.4 33.8 30.1 20.3 22.9 53.7 25.8 29.3 24.6 32.3 24.5 21.3 87.1 30.8 37.0 26.2 45.7 26.4 27.8 20.5 33.5 65.4 36.3 42.0 43.3 39.6 47.5 23.1 52.3 98.3 59.6 50.7 19.9 67.1 77.5 50.6 66.9 59.4 56.7 43.2 56.0 77.9 41.3 24.3 51.2 36.5 21.9 44.9 65.3 80.9 41.8 53.8 83.9 97.3 49.4 60.0 51.5 51.4 71.4 77.7 21.7 56.8 36.1 22.2 37.6 35.4 43.4 71.0 51.8 43.8 60.9 45.1 35.9 67.2 61.0 86.8 22.7 68.2 48.5 67.8 74.8 51.4 114.0 59.3 41.0 32.3 62.9 66.2 36.1 78.1 1.3 1.4 1.0 1.5 1.2 0.8 1.3 0.9 0.9 1.4 1.1 0.9 1.2 1.5 1.0 1.3 2.0 0.8 0.8 31.2 33.7 31.4 31.0 26.0 29.8 29.5 31.9 22.6 33.8 32.3 30.8 33.5 24.6 25.6 33.6 0.0 29.1 60.2 26.1 20.6 44.3 31.9 25.4 17.9 45.7 38.6 20.6 18.4 16.7 12.1 31.7 46.2 13.7 23.7 243.7 30.1 33.7 28.8 25.2 46.7 0.0 31.2 11.4 31.3 23.9 40.9 50.6 32.5 27.5 51.3 16.6 35.3 0.0 27.6 12.2 45.3 55.9 179.3 30.7 36.5 23.2 0.0 36.4 21.1 25.7 0.0 0.0 29.5 18.6 27.1 26.2 35.0 34.6 26.7 24.2 22.4 19.7 34.7 27.6 140.9 41.1 53.7 66.5 13.8 24.2 17.9 39.1 43.4 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991099-67996469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 35.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 55.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 37.3" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 12.1 5.4 6.8 2.8 6.9 4.0 17.0 6.9 10.1 27.0 6.4 8.4 4.0 15.2 7.0 5.1 7.9 4.8 5.8 7.1 6.9 6.2 9.5 3.4 3.2 6.9 7.0 6.8 4.8 4.8 3.3 2.0 35.9 6.7 5.9 7.4 9.0 4.3 3.6 3.5 3.5 4.7 11.0 6.8 2.3 6.9 3.0 6.8 2.2 6.8 7.4 7.1 8.8 7.7 7.0 9.8 9.5 9.3 11.6 6.6 16.6 7.3 4.0 11.4 6.9 11.2 5.6 12.4 13.0 8.9 3.3 12.1 4.9 21.3 8.6 16.6 23.5 21.5 8.4 3.2 17.8 10.4 7.2 14.9 9.2 10.2 6.7 15.4 7.7 32.7 11.2 18.2 19.6 6.7 13.1 1.3 9.5 10.7 23.6 10.0 3.1 10.2 17.4 8.7 6.5 6.9 12.5 6.0 55.5 20.8 11.4 15.8 8.2 6.1 5.8 5.9 4.2 8.5 38.9 30.9 11.6 14.8 12.6 10.5 8.6 2.8 5.0 2.2 2.9 0.7 3.0 0.8 1.7 3.9 0.5 0.3 0.8 1.1 2.7 5.0 0.1 0.4 1.8 6.8 6.9 6.9 10.1 7.1 6.9 6.9 7.0 6.8 6.7 6.8 6.8 7.0 21.6 0.0 1.7 6.2 3.5 4.8 5.5 5.6 7.4 8.9 31.0 21.8 4.7 12.8 6.1 11.0 10.4 28.6 4.1 10.5 23.5 10.1 0.9 21.0 40.5 16.3 3.6 8.4 5.0 9.3 21.7 51.6 19.9 19.4 12.7 3.8 14.3 18.5 16.9 5.0 4.6 15.0 10.2 9.7 21.5 2.8 3.7 7.3 8.8 2.8 18.4 31.9 12.3 3.0 4.6 10.7 10.0 5.3 7.0 11.6 10.9 19.7 16.5 15.6 6.6 36.2 14.1 7.3 6.0 20.7 8.4 15.3 4.1 8.3 10.1 7.6 BCDIN3D ENSG00000186666 "BCDIN3 domain containing RNA methyltransferase" Q7Z5W3 12 49836043-49843106 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 22.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039911 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA039911: AB_10673021" "unprognostic (2.21e-2)" "unprognostic (6.64e-2)" "unprognostic (2.70e-3)" "unprognostic (1.73e-2)" "unprognostic (1.68e-1)" "unprognostic (2.84e-2)" "unprognostic (9.96e-3)" "prognostic favorable (3.24e-4)" "unprognostic (2.30e-3)" "unprognostic (1.62e-3)" "unprognostic (2.12e-3)" "unprognostic (1.84e-1)" "prognostic favorable (1.03e-5)" "unprognostic (2.31e-2)" "unprognostic (3.15e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.06e-4)" 2.1 2.9 5.0 2.8 5.1 1.1 4.0 5.5 6.9 3.0 4.9 2.4 2.4 2.5 3.8 2.7 3.9 2.4 2.6 5.0 4.9 3.3 3.7 2.2 4.9 5.1 4.9 5.0 3.8 3.5 4.3 2.2 2.3 5.3 3.8 2.9 2.6 4.3 2.7 22.3 3.9 2.8 2.6 4.8 3.3 3.2 2.6 4.8 4.2 4.0 3.0 4.2 2.4 2.0 6.0 2.8 4.0 3.8 5.8 8.0 4.7 3.8 3.9 5.1 4.1 4.2 2.1 7.0 2.5 4.2 1.8 3.0 3.4 3.9 2.3 2.2 8.7 5.1 3.3 3.1 1.3 6.3 4.0 3.3 2.5 9.2 2.9 4.1 5.1 1.9 5.3 6.4 6.7 2.6 7.2 4.5 6.4 3.8 6.3 7.1 4.7 3.6 5.0 4.0 2.6 5.2 7.2 4.6 7.4 5.7 3.0 8.9 4.4 2.1 3.2 2.4 5.0 2.1 6.3 5.7 4.8 3.5 2.9 2.2 4.0 3.0 1.6 4.5 4.0 6.0 6.7 5.7 4.4 3.2 5.7 6.4 5.9 2.4 4.4 4.2 1.7 5.3 3.0 5.0 5.1 5.5 6.9 5.0 4.9 5.1 4.9 5.0 5.3 4.8 4.8 6.0 4.0 32.1 25.0 2.9 9.4 2.2 7.3 7.6 5.2 6.8 7.4 6.7 2.4 5.7 10.2 1.8 0.0 12.6 4.8 3.6 13.7 10.1 1.7 5.9 6.0 4.6 1.8 9.5 3.3 9.8 7.4 6.8 5.1 5.0 10.8 4.6 3.9 7.7 5.8 5.0 5.2 5.6 6.1 4.1 1.2 0.9 8.4 4.3 0.0 2.8 3.1 7.2 13.4 4.0 11.0 6.4 4.8 6.4 4.9 5.7 6.9 8.7 14.2 6.2 0.0 4.7 4.5 11.8 8.7 5.1 3.1 7.7 9.1 6.8 5.1 2.8 MAGEE2 HCA3 ENSG00000186675 "MAGE family member E2" Q8TD90 X 75782987-75785254 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.7" "Cell type enhanced" "Detected in single" "Bipolar cells: 1.6" "Cancer enriched" "Detected in single" 9 "glioma: 1.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030625 Uncertain NA NA "HPA030625: AB_10601863" "unprognostic (5.92e-2)" "unprognostic (9.33e-2)" "unprognostic (2.24e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (3.01e-3)" "unprognostic (5.79e-3)" "unprognostic (3.47e-2)" "unprognostic (6.43e-2)" 0.0 0.7 2.2 0.0 2.7 0.0 0.0 2.2 3.7 0.2 0.7 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.9 2.9 0.1 0.0 0.1 0.0 2.1 1.8 2.2 0.4 0.0 0.0 0.8 0.0 2.2 0.1 0.2 1.1 0.1 0.1 0.0 0.1 0.1 0.2 1.3 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.1 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.7 2.2 3.7 1.9 2.9 2.1 1.8 2.2 2.2 1.3 2.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CYP27C1 FLJ16008 ENSG00000186684 "Cytochrome P450 family 27 subfamily C member 1" Q4G0S4 2 127183832-127220313 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 3.3;skin 1: 5.1" "Cell type enhanced" "Detected in some" "Club cells: 5.4;Collecting duct cells: 3.7;Endometrial stromal cells: 5.8;Leydig cells: 7.5;Pancreatic endocrine cells: 7.6;Suprabasal keratinocytes: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 7.6;HDLM-2: 11.8;hTERT-RPE1: 12.5;TIME: 11.6;U-138 MG: 10.9;U-251 MG: 7.9" "HPA062460, HPA068731" Enhanced Vesicles NA NA Vesicles "HPA062460: AB_2732683, HPA068731: AB_2686023" "unprognostic (1.90e-1)" "unprognostic (4.07e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-2)" "unprognostic (3.03e-1)" "unprognostic (7.75e-3)" "unprognostic (3.48e-1)" "unprognostic (2.31e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.81e-3)" "unprognostic (1.11e-1)" "unprognostic (6.29e-4)" "unprognostic (3.49e-4)" "unprognostic (1.83e-1)" "unprognostic (4.27e-2)" "unprognostic (8.64e-2)" 0.6 0.5 0.7 0.4 0.3 0.3 0.4 0.6 0.7 3.3 0.5 0.9 0.3 0.6 0.4 1.7 0.6 0.7 0.5 0.5 0.9 0.2 0.2 0.2 0.3 0.6 2.1 0.4 0.2 0.2 0.0 0.1 0.1 0.6 0.9 0.3 0.1 0.3 0.7 0.4 5.1 0.6 0.2 0.3 0.2 0.3 0.3 1.9 0.0 0.1 0.1 0.8 1.8 2.5 0.8 1.3 3.4 1.9 0.1 0.1 0.0 0.1 0.4 3.2 1.8 0.8 0.1 2.8 0.1 0.1 2.0 1.3 7.6 2.7 1.4 0.6 11.8 1.4 0.0 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 1.1 12.5 0.4 0.3 0.0 0.2 2.1 0.2 0.3 0.1 4.0 0.0 1.0 0.1 0.2 0.0 5.9 1.0 0.1 0.7 4.9 0.0 0.0 1.5 0.1 0.2 11.6 10.9 2.0 5.3 7.9 0.1 0.1 0.0 0.1 0.1 0.9 0.5 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.0 0.7 0.3 0.6 0.7 0.5 0.9 0.6 2.1 0.4 0.6 0.3 1.9 0.8 0.2 0.0 0.6 0.0 0.2 1.8 1.2 2.1 0.0 0.0 1.5 0.3 0.5 0.0 5.4 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 5.8 0.5 0.0 0.0 0.6 0.2 0.0 2.4 0.0 0.5 0.0 0.2 0.4 0.1 0.0 0.0 0.7 0.0 2.0 0.0 1.9 0.1 7.5 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.2 7.6 0.0 0.4 0.0 1.6 0.0 0.0 0.2 0.0 0.0 1.5 1.0 0.1 0.7 0.0 7.2 0.0 0.2 0.0 0.0 2.9 LYRM7 "C5orf31, FLJ20796, MZM1L" ENSG00000186687 "LYR motif containing 7" Q5U5X0 5 131170944-131205428 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 34.0" "Cell type enhanced" "Detected in many" "Early spermatids: 161.3;Late spermatids: 209.3;Spermatocytes: 135.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050053 Approved NA NA "HPA050053: AB_2680999" "unprognostic (1.88e-2)" "unprognostic (2.89e-1)" "unprognostic (3.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.90e-2)" "unprognostic (1.02e-1)" "unprognostic (9.03e-2)" "unprognostic (2.50e-3)" "unprognostic (1.23e-1)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "prognostic favorable (9.84e-6)" "unprognostic (6.61e-2)" "unprognostic (2.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.20e-1)" 8.4 5.2 6.3 6.9 7.1 6.2 5.4 6.8 8.2 4.1 4.4 9.5 7.7 5.6 2.9 6.5 3.9 3.6 12.3 6.6 7.3 8.5 8.6 3.8 8.6 6.8 6.8 6.6 7.1 2.6 8.0 3.1 3.8 7.3 6.0 6.4 9.0 4.0 4.0 27.4 6.9 6.3 5.3 6.1 6.7 5.3 23.2 8.0 7.8 8.4 34.0 6.6 4.0 3.6 9.6 15.1 5.3 7.7 21.0 17.3 16.1 28.1 20.0 4.2 9.7 9.7 13.5 22.5 37.9 23.4 5.5 27.2 20.4 13.5 17.1 17.4 34.3 13.6 20.4 13.7 7.3 7.8 20.7 10.8 10.1 21.7 9.4 20.8 4.3 7.0 19.3 28.1 17.0 12.3 7.9 23.4 17.0 10.2 18.4 9.6 23.0 28.9 28.9 6.8 13.3 17.2 13.5 13.6 11.5 17.7 12.9 19.8 17.0 7.0 20.1 21.8 15.2 26.0 15.9 51.4 50.9 12.5 37.1 16.0 2.5 8.0 6.4 11.9 10.7 16.0 21.0 16.9 14.8 12.4 22.3 22.5 21.8 4.8 13.5 10.8 17.3 13.3 11.6 6.3 7.1 6.8 8.2 6.6 7.3 6.8 6.8 6.6 7.3 6.1 8.0 9.6 15.9 3.2 11.2 15.0 28.6 13.8 10.3 19.8 17.1 40.0 13.4 11.4 82.6 12.8 19.6 16.5 20.9 15.1 19.9 21.9 43.0 9.9 161.3 15.0 18.3 16.7 13.1 30.3 20.6 8.9 30.5 17.6 6.1 9.7 17.7 20.0 22.9 28.2 18.1 30.3 27.7 16.3 14.2 18.1 19.2 209.3 27.1 15.3 8.8 8.4 17.5 32.3 27.8 14.6 27.5 8.0 12.3 27.1 15.5 7.7 31.4 28.8 34.4 34.2 0.0 21.0 16.1 135.6 22.2 22.8 18.6 5.5 21.6 21.4 25.4 7.1 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;choroid plexus: 23.3;fallopian tube: 42.6" "Cell type enriched" "Detected in some" 4 "Endometrial ciliated cells: 110.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.3;REH: 2.2;T-47d: 2.5;U-698: 9.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: AB_2680434" "unprognostic (2.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.4 15.7 0.4 5.5 2.1 0.3 5.4 2.4 2.1 23.3 0.2 0.3 0.5 0.3 0.5 42.6 0.2 0.1 4.0 14.3 1.0 0.5 7.2 0.7 13.8 14.6 0.8 0.4 0.4 0.1 1.2 0.0 11.7 0.6 0.0 0.2 2.3 0.7 0.3 4.8 0.5 0.0 19.0 0.6 4.0 0.5 6.2 0.0 0.8 0.0 1.2 0.2 0.2 3.7 0.2 0.0 0.2 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.3 2.0 4.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.2 1.7 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.7 0.2 0.7 0.3 0.8 0.1 2.2 0.0 0.3 0.5 0.5 0.4 0.1 0.0 0.6 0.0 0.2 2.5 0.0 0.1 0.1 0.7 0.2 0.1 0.4 0.1 9.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 5.5 5.4 2.4 4.0 14.3 13.8 14.6 0.8 11.7 19.0 6.2 3.7 0.0 0.0 1.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 6.2 3.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 110.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.6 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 23.3 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 CCDC73 NY-SAR-79 ENSG00000186714 "Coiled-coil domain containing 73" Q6ZRK6 11 32602246-32794658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.7" "Group enriched" "Detected in some" 16 "Spermatocytes: 160.3;Spermatogonia: 84.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038668, HPA038669" Uncertain NA NA "HPA038668: AB_10673292, HPA038669: AB_2676142" "unprognostic (9.41e-3)" "unprognostic (2.46e-2)" "unprognostic (2.36e-1)" "unprognostic (8.65e-2)" "unprognostic (5.79e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.73e-4)" "unprognostic (1.74e-1)" "unprognostic (2.02e-2)" "unprognostic (2.10e-2)" "unprognostic (3.27e-2)" "unprognostic (1.62e-5)" "unprognostic (3.87e-1)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "unprognostic (1.20e-3)" 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 3.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.8 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 3.2 0.6 2.3 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.9 0.0 4.8 1.8 0.5 0.6 0.0 0.0 4.5 0.2 0.1 0.2 0.0 0.6 0.0 0.2 0.0 1.1 0.2 0.0 3.9 0.1 0.0 0.0 0.0 4.3 0.6 0.1 0.0 7.5 0.1 0.0 0.0 3.5 1.7 0.3 1.2 0.7 0.3 0.3 0.0 0.9 1.0 0.6 6.6 0.0 0.2 160.3 84.2 0.0 0.0 0.1 0.2 4.3 0.0 0.5 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR activator of RhoGEF and GTPase" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 112.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favorable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 19.4 11.2 35.3 11.1 60.3 34.9 17.6 17.7 31.6 14.4 12.0 11.4 10.1 12.4 16.2 24.7 12.2 9.3 12.1 45.7 25.6 21.2 13.9 18.7 13.8 32.9 26.5 27.4 9.5 14.7 20.8 25.2 10.4 34.2 11.9 7.7 7.5 18.5 10.2 5.8 22.5 10.3 8.9 17.8 11.5 16.3 11.1 31.4 14.9 19.9 5.8 10.9 15.4 14.4 16.9 47.6 20.1 30.3 31.2 17.7 12.1 45.6 16.8 15.7 15.2 12.2 35.6 18.7 32.9 30.5 14.4 14.7 47.6 3.6 46.8 4.3 63.3 32.3 28.8 27.7 28.6 22.9 26.9 14.6 10.2 31.1 22.8 19.8 27.0 53.6 23.3 112.5 15.1 7.0 31.3 25.4 21.4 25.8 37.4 19.5 32.9 12.4 21.7 23.7 29.6 27.7 26.3 30.7 26.1 12.6 19.3 16.6 21.7 61.4 9.1 1.0 14.9 14.0 3.4 14.8 11.7 23.4 20.1 14.3 0.0 0.5 0.0 3.1 0.2 1.1 0.6 1.5 1.6 0.4 0.6 1.3 1.7 0.5 1.5 0.5 0.4 0.8 1.4 35.3 60.3 17.7 31.6 45.7 25.6 32.9 26.5 27.4 34.2 17.8 31.4 16.9 19.3 9.6 11.5 51.2 4.5 15.4 11.9 18.2 6.2 22.9 17.1 9.9 7.5 17.2 20.9 18.4 22.9 14.0 23.9 17.7 9.8 14.4 5.6 22.1 8.0 27.8 19.9 5.5 24.6 16.6 6.8 7.1 11.7 31.4 10.8 9.9 70.6 22.1 7.2 23.5 20.7 13.9 12.2 9.3 11.1 13.5 8.7 9.2 5.4 18.7 6.6 13.2 15.5 32.2 7.0 27.7 8.1 5.7 10.7 11.8 10.7 18.2 12.5 9.4 0.0 4.0 6.8 2.7 7.3 9.3 15.8 10.8 10.3 10.0 13.7 13.3 OR10H1 ENSG00000186723 "Olfactory receptor family 10 subfamily H member 1" Q9Y4A9 19 15804549-15815664 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.2" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 57.7;Alveolar cells type 2: 53.1;Club cells: 29.7;granulocytes: 39.1;Respiratory ciliated cells: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 1.4;neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "RT4: 3.1" NA NA "unprognostic (3.29e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-1)" "unprognostic (1.63e-2)" "unprognostic (2.38e-1)" "unprognostic (9.30e-2)" 0.3 0.2 1.7 0.2 2.3 0.8 0.2 4.2 3.9 0.0 1.1 0.2 0.4 0.2 0.4 0.1 0.1 0.2 0.1 1.7 0.8 0.2 0.2 0.1 0.2 2.3 2.1 1.4 0.2 0.1 0.1 0.0 0.1 2.8 0.2 0.2 1.5 0.2 0.1 0.7 0.7 0.3 0.2 0.4 0.2 0.2 0.5 2.3 0.2 0.1 0.1 0.1 0.6 0.0 3.5 0.4 0.2 0.3 0.3 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.1 0.7 0.4 0.4 0.1 0.4 0.3 0.1 0.2 0.1 0.3 0.1 0.5 0.6 0.2 0.0 0.4 0.7 0.1 0.0 0.1 0.1 0.6 0.0 0.3 0.2 0.8 0.1 0.1 0.2 0.4 0.3 0.3 0.1 0.2 0.3 0.2 0.1 3.1 0.2 0.2 1.0 0.3 0.3 0.4 0.1 0.2 0.5 0.8 0.6 0.3 0.6 0.4 0.3 0.3 0.3 0.2 0.2 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.2 0.1 0.2 0.1 0.0 1.7 2.3 4.2 3.9 1.7 0.8 2.3 2.1 1.4 2.8 0.4 2.3 3.5 0.1 57.7 53.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 29.7 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 1.9 0.2 3.4 0.0 0.0 0.0 0.0 0.0 5.5 0.0 2.8 39.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 MPPED1 "239AB, C22orf1, FAM1A" ENSG00000186732 "Metallophosphoesterase domain containing 1" O15442 22 43411196-43507848 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 60.9;liver: 24.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 69.4;Inhibitory neurons: 68.6" "Cancer enhanced" "Detected in some" "liver cancer: 1.6" "Region enhanced" "Detected in many" "cerebral cortex: 60.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 5.3;SCLC-21H: 2.3" "Group enriched" "Detected in all" 5 "amygdala: 105.7;basal ganglia: 66.2;cerebral cortex: 163.5;hippocampal formation: 174.4;white matter: 106.3" "Group enriched" "Detected in all" 6 "cerebral cortex: 95.0;hippocampal formation: 83.0" NA NA "unprognostic (1.15e-1)" "unprognostic (4.29e-1)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (9.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.47e-2)" "unprognostic (2.04e-1)" "unprognostic (3.19e-1)" "unprognostic (4.46e-4)" "unprognostic (1.09e-1)" "unprognostic (4.32e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-1)" "unprognostic (6.92e-3)" 0.0 0.1 11.2 0.0 30.0 0.0 0.1 0.0 60.9 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.1 24.6 4.2 0.0 24.7 0.0 0.0 0.9 1.9 21.2 1.6 0.0 0.0 1.7 0.0 12.4 0.9 0.0 0.5 1.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 2.0 0.0 0.4 0.0 0.0 0.0 0.3 0.3 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.2 30.0 0.0 60.9 24.6 4.2 0.9 1.9 21.2 12.4 0.0 0.0 23.9 0.1 0.0 0.0 3.6 0.0 0.5 0.1 0.0 0.0 2.7 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 68.6 0.2 0.0 0.6 0.0 2.7 0.6 0.0 0.0 4.7 0.0 0.5 0.0 2.0 13.3 0.0 0.0 7.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSCN2 "RFSN, RP30" ENSG00000186765 "Fascin actin-bundling protein 2, retinal" O14926 17 81528377-81537130 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 4.6;retina: 8.8;thyroid gland: 4.2" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 25.0;Exocrine glandular cells: 12.0;Rod photoreceptor cells: 25.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;T-47d: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079270 Enhanced NA NA "HPA079270: " "unprognostic (3.50e-3)" "unprognostic (6.55e-2)" "unprognostic (2.73e-4)" "unprognostic (1.08e-3)" "unprognostic (1.11e-2)" "unprognostic (2.11e-2)" "unprognostic (6.49e-3)" "unprognostic (3.49e-1)" "unprognostic (1.64e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-1)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (1.74e-1)" "unprognostic (2.11e-1)" 0.2 0.2 0.4 0.2 0.8 0.1 0.5 1.3 0.6 0.9 0.1 0.4 0.2 1.3 0.5 0.6 0.8 0.1 0.2 0.4 0.2 0.6 0.1 0.5 0.2 1.0 0.3 0.3 0.9 4.6 2.0 1.0 0.1 0.7 0.8 0.1 8.8 1.8 0.4 0.1 0.5 0.5 0.1 0.6 0.6 0.8 0.5 0.3 0.1 4.2 0.1 0.2 0.3 0.5 0.7 0.7 0.4 0.3 0.5 0.1 0.0 0.5 0.3 0.5 0.0 0.0 0.4 0.5 0.5 1.9 0.5 0.3 0.5 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.9 0.0 0.2 0.1 0.4 0.1 0.3 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.6 0.3 2.0 0.0 0.6 0.6 0.1 0.1 0.2 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.3 0.6 0.4 0.2 1.0 0.3 0.3 0.7 0.6 0.3 0.7 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.2 0.0 3.8 0.6 0.4 0.9 0.0 0.0 0.0 25.0 0.1 0.0 0.1 1.9 0.4 0.5 0.1 0.1 0.2 0.0 0.0 0.7 12.0 0.5 0.1 1.1 0.1 0.0 0.5 0.0 0.0 0.1 3.3 0.9 0.0 0.0 0.0 0.0 3.2 0.3 0.3 0.0 0.0 1.0 4.9 0.0 3.5 0.3 3.0 0.1 0.0 0.2 0.1 0.3 0.1 0.0 25.7 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.8 0.1 0.1 0.2 0.0 FOXI2 FLJ46831 ENSG00000186766 "Forkhead box I2" Q6ZQN5 10 127737185-127741183 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 1.7;esophagus: 1.9;kidney: 2.9" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 2.2;Distal tubular cells: 3.9;Squamous epithelial cells: 1.4;Urothelial cells: 1.7" "Cancer enriched" "Detected in some" 6 "renal cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.12e-3)" "unprognostic (4.71e-4)" "unprognostic (6.78e-3)" "prognostic favorable (4.23e-7)" "unprognostic (6.31e-3)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "unprognostic (1.65e-2)" 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.3 1.9 0.2 0.1 0.2 0.0 0.2 2.9 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.1 0.5 0.1 0.2 0.1 0.5 0.2 0.0 0.2 0.3 0.0 0.2 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.7 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA044559 Uncertain Approved Nucleoli,Cytosol NA Yes Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavorable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 1.7 1.7 1.6 2.7 1.4 10.3 3.3 1.0 1.7 2.3 1.7 3.7 2.2 3.4 2.3 6.0 2.7 2.1 1.0 1.4 2.9 1.5 1.3 3.2 3.6 1.7 1.8 1.3 2.9 1.7 1.7 2.3 4.4 1.5 3.3 4.1 2.1 7.3 1.7 0.5 2.0 2.3 3.5 1.3 2.8 2.2 0.7 2.4 3.1 2.5 0.5 5.6 2.1 2.8 2.0 31.7 8.0 18.2 14.9 3.9 5.5 13.1 15.6 6.5 8.9 10.6 5.4 30.7 0.0 6.7 7.3 10.2 10.3 23.7 11.2 16.2 13.7 7.5 40.5 10.3 4.9 1.7 35.5 30.3 2.6 3.9 14.9 8.0 4.3 9.9 7.0 12.5 38.2 20.4 10.7 11.9 19.0 18.8 5.2 11.5 16.4 39.2 8.7 6.5 8.3 0.1 10.0 27.9 8.1 3.0 37.4 17.4 16.9 4.3 17.9 19.9 29.8 9.8 8.4 10.4 20.5 9.5 28.8 10.7 0.7 0.8 1.6 0.5 0.9 0.2 0.4 0.3 0.3 0.6 0.4 0.1 0.4 0.0 2.6 0.8 0.0 0.2 0.4 1.6 1.4 1.0 1.7 1.4 2.9 1.7 1.8 1.3 1.5 1.3 2.4 2.0 3.0 0.0 2.0 2.3 2.9 3.3 1.4 3.5 6.2 5.7 6.0 4.3 1.5 1.5 5.8 3.7 2.1 6.1 3.9 3.6 1.9 0.6 0.0 3.4 3.2 5.1 6.7 11.1 2.4 1.4 6.8 3.4 2.0 2.1 9.5 3.5 8.6 1.3 2.6 1.7 3.3 6.7 4.1 1.0 2.1 0.4 3.1 2.2 5.4 1.9 1.1 1.3 5.2 3.0 4.5 1.3 6.3 3.4 0.7 2.3 0.6 1.3 5.7 2.8 0.0 2.5 2.6 0.1 0.5 9.8 6.3 3.3 3.1 4.3 5.7 5.7 ZNF732 FLJ59067 ENSG00000186777 "Zinc finger protein 732" B4DXR9 4 270675-305474 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Cell type enhanced" "Detected in some" "Granulosa cells: 2.7;Inhibitory neurons: 1.9;Spermatocytes: 5.0;Spermatogonia: 8.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NTERA-2: 7.7" NA NA "unprognostic (7.83e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.54e-2)" "unprognostic (8.99e-4)" "unprognostic (7.60e-3)" "unprognostic (8.13e-2)" "unprognostic (3.83e-2)" "unprognostic (4.89e-3)" "unprognostic (1.44e-3)" "unprognostic (3.60e-3)" "unprognostic (5.45e-3)" "unprognostic (8.40e-4)" "unprognostic (3.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-1)" 0.1 0.1 0.2 0.2 0.6 0.0 0.4 0.4 0.5 0.6 0.0 0.3 0.0 0.4 0.0 0.3 0.5 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.7 0.3 0.1 0.8 0.2 0.3 0.5 0.0 0.9 0.2 0.0 0.0 0.6 0.2 0.1 0.0 0.4 0.2 1.5 0.1 0.0 0.4 0.0 0.7 0.4 0.4 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.7 0.0 1.8 0.0 0.0 0.0 0.6 0.9 0.0 1.8 0.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.4 0.5 0.2 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.8 0.0 0.4 0.2 0.0 0.0 1.6 0.0 0.6 0.3 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 8.4 0.6 0.3 0.0 0.0 0.3 0.0 0.1 SPIN2B "SPIN-2, TDRD26" ENSG00000186787 "Spindlin family member 2B" Q9BPZ2 X 57118551-57121548 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000162: AB_1080079, HPA069835: AB_2686211" "unprognostic (3.21e-2)" "unprognostic (7.92e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (8.28e-2)" "unprognostic (2.30e-2)" "unprognostic (8.42e-4)" "unprognostic (1.73e-3)" "unprognostic (2.24e-2)" "prognostic favorable (3.43e-4)" "prognostic favorable (3.39e-4)" "unprognostic (9.04e-3)" "prognostic favorable (1.78e-5)" "unprognostic (3.41e-2)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-3)" 9.8 10.4 14.9 5.6 14.7 5.0 9.8 13.7 15.7 14.3 14.7 14.9 4.5 11.6 11.3 8.2 11.3 7.5 10.9 14.5 15.5 12.3 8.6 9.0 10.3 14.9 14.0 14.3 11.8 9.2 7.5 14.9 6.6 14.6 13.7 11.8 7.8 8.2 10.5 9.6 8.8 10.3 10.9 13.4 12.9 11.3 5.2 14.9 7.1 12.8 6.6 9.0 13.9 12.5 15.0 15.6 12.1 14.1 10.8 14.7 14.9 9.3 9.9 6.8 13.1 8.8 15.7 12.8 3.3 16.8 10.3 11.9 2.4 16.7 5.3 14.1 6.4 20.1 9.3 38.5 21.1 11.9 8.1 7.1 13.7 10.7 8.8 9.3 13.7 10.9 8.9 11.6 10.9 14.8 24.0 11.9 15.6 13.4 4.6 13.8 11.2 17.5 15.2 15.0 7.6 9.3 10.0 18.0 4.7 9.9 21.8 10.3 6.0 10.5 11.2 10.6 19.6 6.3 10.8 7.6 9.5 8.6 15.2 6.5 1.6 6.5 0.8 10.4 7.8 15.4 13.3 13.3 14.6 8.1 12.2 14.7 12.2 0.4 15.6 7.2 11.4 16.9 10.0 14.9 14.7 13.7 15.7 14.5 15.5 14.9 14.0 14.3 14.6 13.4 14.9 15.0 9.1 19.2 7.3 3.3 9.5 5.4 7.6 11.3 8.0 10.1 7.9 11.3 9.7 4.3 5.5 11.0 0.0 8.8 7.2 8.7 15.6 6.7 0.1 7.7 7.1 9.5 11.5 7.8 5.8 5.1 6.0 8.4 5.1 6.6 11.4 5.6 6.4 3.0 5.1 11.8 6.6 9.1 18.3 2.6 4.2 0.9 12.2 8.6 8.8 3.7 3.8 5.3 10.3 5.0 5.2 3.7 8.1 18.8 5.9 4.7 5.5 12.0 3.4 5.6 26.3 6.3 10.1 0.1 0.6 7.7 8.9 3.0 8.2 7.4 10.6 5.3 SPATA31D3 "FAM75D3, FLJ44082" ENSG00000186788 "SPATA31 subfamily D member 3" P0C874 9 81943586-81950038 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 82 "testis: 8.1" "Cell type enriched" "Detected in some" 17 "Early spermatids: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXE3 "FKHL12, FREAC8" ENSG00000186790 "Forkhead box E3" Q13461 1 47416285-47418052 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cataract, Disease variant, Peters anomaly" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "Cardiomyocytes: 6.0;Spermatogonia: 2.3" "Group enriched" "Detected in some" 4 "cervical cancer: 0.5;testis cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SuSa: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-1)" "unprognostic (1.31e-2)" "unprognostic (1.23e-3)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.24e-2)" "unprognostic (1.24e-2)" "unprognostic (8.21e-2)" "unprognostic (1.49e-1)" "unprognostic (2.34e-1)" "unprognostic (5.15e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-7)" "unprognostic (2.41e-1)" "unprognostic (5.46e-2)" "unprognostic (3.60e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 HYAL3 "LUCA-3, LUCA14, Minna14" ENSG00000186792 "Hyaluronidase 3" O43820 3 50292831-50299405 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.7" "Group enriched" "Detected in many" 17 "Early spermatids: 79.7;Late spermatids: 268.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 33.2;eosinophil: 54.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 54.6" "Cell line enhanced" "Detected in all" "HEL: 58.8;HMC-1: 101.1;THP-1: 107.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA049402 Uncertain "Secreted to blood" NA NA "HPA049402: AB_2680746" "unprognostic (1.21e-3)" "unprognostic (2.55e-2)" "unprognostic (5.45e-2)" "unprognostic (8.19e-2)" "unprognostic (3.07e-1)" "unprognostic (1.65e-2)" "unprognostic (7.98e-3)" "unprognostic (7.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" "unprognostic (5.40e-2)" "unprognostic (5.71e-2)" "unprognostic (2.61e-1)" "unprognostic (8.09e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.12e-5)" 1.9 2.8 5.0 1.3 5.7 36.7 1.8 7.0 8.4 2.0 3.1 1.9 1.7 1.6 1.1 3.9 1.7 1.8 1.8 5.8 5.1 2.0 5.1 2.1 1.3 7.2 4.7 5.5 1.5 1.9 0.9 1.9 1.5 7.6 3.2 1.1 1.1 3.5 2.5 1.0 2.0 1.9 2.2 4.2 1.7 4.5 14.0 5.9 1.6 1.7 0.9 1.6 1.9 2.7 7.9 6.0 6.9 3.8 4.3 7.6 3.9 2.3 6.5 5.8 8.0 6.1 9.3 6.2 5.2 3.1 7.5 12.4 6.5 7.0 15.2 3.0 12.3 3.6 58.8 18.8 7.6 5.5 6.4 101.1 8.1 11.5 8.1 5.2 5.8 8.4 5.8 4.6 6.3 3.8 3.6 2.4 37.4 2.9 7.0 17.2 2.6 5.1 9.5 9.5 2.6 4.7 5.4 9.6 7.5 5.1 4.4 4.9 107.2 11.1 6.8 4.9 22.2 3.8 3.0 7.0 4.4 6.0 22.5 5.8 33.2 4.1 54.6 1.3 2.3 2.2 1.6 4.1 1.9 8.2 2.9 1.1 1.5 1.4 2.1 1.4 2.0 2.6 2.4 5.0 5.7 7.0 8.4 5.8 5.1 7.2 4.7 5.5 7.6 4.2 5.9 7.9 2.5 3.2 1.1 0.3 0.8 3.1 2.8 8.1 2.8 1.5 2.2 2.8 0.4 1.5 5.0 3.7 4.2 2.8 0.2 0.8 9.8 5.6 79.7 2.0 1.6 3.5 4.2 9.2 2.4 0.7 5.3 1.2 4.1 2.1 7.0 1.1 7.1 2.1 2.1 5.0 1.6 1.9 6.1 1.9 4.4 268.2 1.8 2.0 3.6 1.0 5.9 1.5 0.0 0.5 0.3 3.6 0.4 2.6 1.9 2.2 0.5 2.7 1.8 0.8 6.6 1.2 1.8 4.3 4.6 3.7 3.7 3.0 2.2 1.6 1.8 3.5 KCNK18 "K2p18.1, TRESK, TRESK-2, TRESK2, TRIK" ENSG00000186795 "Potassium two pore domain channel subfamily K member 18" Q7Z418 10 117197489-117210299 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "choroid plexus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044739 Uncertain NA NA "HPA044739: AB_10795008" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA10 IFN-alphaC ENSG00000186803 "Interferon alpha 10" P01566 9 21206181-21207143 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 62.8;salivary gland: 23.7;vagina: 22.5" "Cell type enhanced" "Detected in many" "Horizontal cells: 10.1;Melanocytes: 5.4;Sertoli cells: 6.6;Squamous epithelial cells: 6.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 4.7;OE19: 11.0;T-47d: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060453: AB_2684280, HPA066745: AB_2685712" "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.2 0.1 0.3 0.0 0.2 0.1 0.8 0.8 0.4 9.7 0.0 0.1 0.0 0.0 0.0 62.8 0.1 0.4 0.1 0.2 0.7 0.1 0.7 0.1 0.1 0.4 0.5 0.1 0.2 0.0 0.0 0.1 0.0 0.8 1.2 0.0 0.0 23.7 0.1 0.1 9.8 0.2 0.0 0.1 0.1 0.1 0.3 0.4 0.1 0.1 0.0 6.4 0.2 22.5 0.7 0.0 0.9 0.0 0.3 0.4 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.7 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.5 0.1 0.2 4.7 0.0 0.0 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.4 1.3 0.0 0.4 0.0 0.1 0.6 11.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 8.4 0.0 0.0 0.0 0.1 0.7 0.0 1.1 0.7 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.4 0.2 0.7 0.4 0.5 0.1 0.8 0.1 0.4 0.7 1.2 0.0 0.5 1.3 0.8 0.6 1.1 0.6 1.8 1.6 2.2 1.8 0.9 0.0 0.1 0.0 0.0 0.4 0.2 0.9 0.0 1.1 0.2 0.0 0.3 0.5 1.2 0.0 0.6 0.0 0.9 1.6 1.1 0.2 1.3 1.0 1.4 1.2 4.5 10.1 1.0 0.5 0.0 3.2 0.9 0.7 2.1 2.4 5.4 1.0 1.1 1.4 0.0 0.0 0.9 0.4 1.3 4.1 0.1 1.0 1.6 0.9 0.0 0.6 6.6 1.5 1.2 0.5 2.6 6.1 0.4 0.5 0.4 2.2 0.7 0.7 CXCR3 "CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR" ENSG00000186810 "C-X-C motif chemokine receptor 3" P49682 X 71615916-71618511 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.3;intestine: 6.4;lymphoid tissue: 16.5" "Cell type enhanced" "Detected in some" "dendritic cells: 87.6;NK-cells: 15.5;Plasma cells: 36.5;Proximal enterocytes: 17.6;T-cells: 48.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 306.7" "Group enriched" "Detected in many" 5 "dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7" "Cell line enriched" "Detected in some" 15 "RPMI-8226: 47.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA045942 Enhanced NA NA "HPA045942: AB_2679507" "unprognostic (4.84e-3)" "unprognostic (3.05e-3)" "unprognostic (1.61e-1)" "prognostic favorable (3.44e-6)" "unprognostic (3.93e-2)" "prognostic favorable (3.35e-4)" "unprognostic (1.01e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.90e-4)" "unprognostic (6.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.67e-6)" "unprognostic (4.67e-2)" "unprognostic (2.18e-1)" "unprognostic (2.91e-2)" "unprognostic (5.76e-2)" 0.7 0.8 0.1 5.9 0.1 7.3 0.5 0.2 0.4 0.5 0.0 1.6 5.5 0.4 0.0 0.7 0.5 1.4 0.4 0.3 0.0 0.3 0.5 3.4 16.5 0.2 0.0 0.0 0.4 0.5 0.0 0.1 0.1 0.1 0.4 1.0 0.0 1.9 0.3 0.1 0.6 6.4 0.4 0.1 7.6 2.9 0.3 0.2 3.0 0.9 0.1 5.3 1.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.1 0.0 0.4 0.3 0.2 80.4 0.2 40.9 45.3 90.3 124.7 8.4 9.9 5.5 51.6 1.9 198.9 0.2 306.7 89.4 35.3 0.1 0.1 0.2 0.4 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.6 0.0 0.0 0.0 13.9 0.3 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 87.6 3.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 3.2 0.0 0.2 0.0 0.3 3.1 0.3 1.3 0.0 0.7 0.3 0.3 0.0 0.0 1.8 0.0 0.8 6.1 0.0 0.0 4.0 1.8 0.0 2.1 0.0 15.5 0.0 0.0 0.2 5.3 0.0 36.5 0.0 17.6 0.5 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.6 0.1 48.3 1.5 3.1 0.1 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favorable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 13.0 13.5 18.3 14.5 23.2 5.0 16.3 19.5 19.9 13.6 14.4 12.1 10.7 15.8 12.5 9.9 11.8 10.2 10.4 16.0 17.5 11.4 10.7 10.5 16.3 19.6 21.1 12.8 18.0 12.5 14.9 12.1 12.0 21.8 14.0 14.0 25.2 12.5 12.2 11.8 13.8 12.7 11.6 16.8 16.2 13.4 10.0 20.2 13.2 15.9 11.1 15.9 12.0 11.9 35.1 4.2 7.9 18.7 17.1 20.3 17.0 8.9 8.4 8.3 4.1 5.4 3.0 5.7 21.2 7.4 6.7 5.6 11.1 12.2 9.2 5.7 13.5 7.5 0.9 11.7 8.6 6.7 10.3 7.4 7.7 12.1 4.9 14.1 14.6 2.6 16.1 12.7 14.4 10.7 9.1 17.4 7.8 16.1 3.2 3.2 18.2 5.4 15.1 8.4 11.0 20.2 17.4 13.7 7.2 8.2 16.2 12.5 7.6 4.2 13.6 7.6 4.6 3.8 23.2 9.3 11.9 12.0 7.1 13.1 10.1 4.6 8.3 5.7 7.5 4.1 10.6 5.3 4.7 3.3 11.3 7.8 5.4 11.0 4.7 9.4 7.5 3.0 2.2 18.3 23.2 19.5 19.9 16.0 17.5 19.6 21.1 12.8 21.8 16.8 20.2 35.1 15.5 35.3 21.0 24.5 35.3 4.1 19.4 8.0 10.2 51.0 11.8 10.4 16.4 15.7 17.3 14.7 35.5 22.6 15.8 14.1 13.7 18.7 66.0 10.8 20.4 17.6 31.0 20.4 17.4 10.9 13.4 18.4 12.8 8.9 11.4 31.7 31.1 12.6 10.8 33.7 19.5 11.5 12.2 20.5 5.4 49.6 18.6 11.8 8.8 23.4 20.3 24.6 15.5 30.2 94.1 10.7 18.3 22.6 6.1 15.8 24.3 11.4 16.4 46.1 32.9 25.3 16.6 29.7 23.4 7.8 4.5 14.6 13.9 22.1 16.1 11.1 ZSCAN30 "ZNF397OS, ZNF917" ENSG00000186814 "Zinc finger and SCAN domain containing 30" Q86W11 18 35251058-35290245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007289 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007289: AB_1079726" "unprognostic (6.02e-3)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (8.94e-2)" "unprognostic (3.56e-3)" "unprognostic (7.02e-3)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (3.05e-3)" "unprognostic (2.78e-3)" "unprognostic (8.27e-3)" "unprognostic (1.15e-1)" "unprognostic (8.44e-3)" "unprognostic (8.75e-2)" "unprognostic (1.36e-1)" 9.2 14.2 13.1 8.0 15.3 7.5 10.2 26.6 17.3 11.8 8.5 10.4 8.7 10.7 11.0 7.2 11.8 7.3 16.7 11.6 12.2 11.0 8.4 9.3 11.1 12.1 13.3 11.6 11.2 10.8 13.2 16.8 8.2 14.9 11.4 6.9 28.2 9.4 7.0 17.1 9.9 11.3 7.7 8.5 13.0 9.4 10.1 12.6 11.2 14.8 8.8 8.0 9.8 9.2 27.6 6.2 1.7 13.4 18.2 9.1 17.8 9.3 11.9 15.9 6.7 13.1 5.1 7.6 11.3 7.7 12.5 11.5 4.1 6.5 12.4 18.0 11.5 3.7 7.1 8.9 3.6 9.3 5.9 6.8 11.6 9.6 17.9 15.5 17.5 13.2 15.7 12.1 12.8 18.0 2.8 9.1 10.5 8.9 1.8 5.7 13.6 4.6 8.4 10.4 4.2 19.4 9.9 11.7 3.7 4.8 14.1 5.8 8.3 15.5 24.6 5.2 3.8 4.6 23.4 10.7 10.0 18.4 6.8 13.9 1.4 0.6 2.3 2.1 0.8 1.3 2.5 2.0 1.2 1.1 3.3 2.3 2.6 2.3 2.0 1.0 2.6 2.0 1.2 13.1 15.3 26.6 17.3 11.6 12.2 12.1 13.3 11.6 14.9 8.5 12.6 27.6 8.4 9.6 8.7 22.2 7.5 1.8 2.0 3.2 13.6 30.5 4.8 5.5 15.5 10.0 9.1 1.8 20.9 3.3 6.4 3.4 5.9 5.2 9.3 7.0 11.9 10.7 7.2 7.8 21.8 3.4 1.5 6.0 7.7 6.5 8.8 18.8 10.0 5.2 2.6 20.2 18.4 4.0 2.0 4.7 1.7 9.0 5.9 3.3 0.0 23.4 2.3 12.2 7.2 26.2 52.1 3.1 4.0 7.9 3.3 2.0 5.9 4.5 6.2 19.3 0.0 10.3 6.3 13.5 5.3 4.2 1.0 1.8 5.3 15.4 3.1 1.6 TPCN1 "FLJ20612, KIAA1169, TPC1" ENSG00000186815 "Two pore segment channel 1" Q9ULQ1 12 113221050-113298585 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 174.3;Microglial cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 148.6;hTERT-RPE1: 121.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039757 Approved NA NA "HPA039757: AB_10795156" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" "unprognostic (7.34e-2)" "unprognostic (3.07e-2)" "unprognostic (1.32e-3)" "unprognostic (4.53e-1)" "unprognostic (5.34e-2)" "unprognostic (1.48e-2)" "unprognostic (1.74e-3)" "unprognostic (1.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.23e-1)" "unprognostic (9.08e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-3)" 26.1 49.2 35.0 18.4 48.1 12.6 29.4 63.2 37.5 34.4 41.0 27.5 19.6 30.8 19.5 38.7 35.8 21.9 58.2 32.5 28.9 50.4 28.0 29.8 17.1 51.7 45.3 21.2 41.9 52.4 31.1 38.2 18.9 49.0 28.9 19.7 11.6 36.4 27.5 37.1 21.3 31.7 18.7 31.4 28.8 19.3 14.6 41.5 8.6 55.9 25.0 18.4 25.5 26.6 42.6 15.3 45.0 5.1 6.5 38.5 43.3 14.9 21.2 148.6 10.9 13.1 33.5 50.7 34.5 30.9 21.6 35.7 18.8 11.9 37.6 14.7 4.1 9.2 12.9 23.5 18.7 49.9 4.5 28.1 41.5 18.6 21.3 37.2 121.7 16.9 9.8 15.0 11.9 13.5 18.3 1.3 68.3 8.4 18.6 22.3 2.5 6.2 67.3 34.9 54.4 6.5 9.8 17.0 43.2 17.1 10.3 13.9 41.4 7.1 16.0 7.8 22.3 13.3 20.0 13.1 29.6 47.2 10.9 12.3 6.9 14.6 1.3 1.8 2.4 2.0 3.4 2.4 2.3 9.9 5.2 3.3 2.1 0.5 8.5 0.3 5.0 1.2 4.7 35.0 48.1 63.2 37.5 32.5 28.9 51.7 45.3 21.2 49.0 31.4 41.5 42.6 8.3 9.6 19.6 174.3 9.0 4.6 6.0 15.4 2.8 19.6 17.0 11.2 34.4 12.8 24.4 27.6 16.7 7.2 3.1 35.9 1.9 13.2 13.2 15.0 21.8 8.1 28.8 9.0 24.5 18.7 3.2 20.2 23.0 19.1 31.1 7.7 15.7 18.3 21.5 50.5 26.6 26.8 14.2 17.9 4.7 11.3 21.5 23.7 7.2 79.6 13.7 17.2 3.1 25.1 61.7 11.5 20.3 21.4 4.6 15.9 29.0 19.7 27.9 13.7 0.0 49.8 18.5 3.6 3.3 10.6 4.0 6.6 5.9 13.2 20.3 22.2 LILRB4 "CD85k, HM18, ILT3, LIR-5, LIR5" ENSG00000186818 "Leukocyte immunoglobulin like receptor B4" Q8NHJ6 19 54643889-54670359 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.8;lymphoid tissue: 19.0" "Cell type enhanced" "Detected in some" "dendritic cells: 76.9;Hofbauer cells: 127.6;Kupffer cells: 118.9;Macrophages: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 37.3" "Group enriched" "Detected in many" 44 "dendritic cells: 37.3;monocytes: 10.8" "Cell line enriched" "Detected in some" 32 "Karpas-707: 407.8" HPA052807 Approved NA NA 11000 "HPA052807: AB_2681958" "unprognostic (4.09e-2)" "unprognostic (5.75e-3)" "unprognostic (6.06e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.55e-1)" "unprognostic (5.03e-2)" "unprognostic (3.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.52e-1)" "unprognostic (5.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.91e-2)" "unprognostic (1.08e-1)" "unprognostic (4.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" 7.1 4.6 3.4 11.0 2.7 2.1 3.6 2.7 4.2 0.7 2.1 3.3 1.6 1.0 0.3 1.1 4.1 1.7 2.1 2.3 3.0 2.2 3.0 13.8 11.5 3.7 2.9 1.9 0.7 1.6 0.1 2.2 1.4 5.6 2.0 2.3 0.1 3.7 0.3 0.5 0.5 6.4 0.7 3.0 19.0 1.7 0.3 2.9 0.6 2.4 0.0 2.1 6.1 0.8 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 407.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 1.4 12.8 0.0 0.2 0.0 0.4 0.0 7.8 0.0 0.0 10.8 0.0 0.2 0.0 0.0 11.7 0.5 0.0 0.0 0.1 0.1 8.9 37.3 0.0 3.8 3.4 2.7 2.7 4.2 2.3 3.0 3.7 2.9 1.9 5.6 3.0 2.9 10.6 0.6 0.0 4.1 0.0 13.4 0.4 0.0 0.0 0.0 0.2 0.3 1.7 1.0 1.5 1.3 0.0 0.0 0.3 76.9 0.1 0.0 0.0 0.2 0.0 0.0 4.2 0.0 7.8 0.1 0.0 0.9 0.5 0.0 0.0 1.3 0.0 2.2 0.8 127.6 0.0 0.2 0.0 0.0 118.9 12.6 0.6 0.0 104.0 1.8 14.0 29.3 0.2 1.0 0.0 0.0 0.1 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.2 6.6 0.2 0.1 0.0 0.4 0.1 0.1 0.8 2.2 0.0 0.2 0.1 TNFRSF4 "ACT35, CD134, OX40, TXGP1L" ENSG00000186827 "TNF receptor superfamily member 4" P43489 1 1211340-1214153 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.4" "Cell type enhanced" "Detected in many" "Adipocytes: 112.3;Endothelial cells: 58.0;granulocytes: 67.4;Ionocytes: 40.7;Langerhans cells: 128.1;T-cells: 43.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 9.7;memory CD4 T-cell: 26.6;NK-cell: 14.7;T-reg: 35.3" "Group enriched" "Detected in many" 17 "granulocytes: 9.7;NK-cells: 14.7;T-cells: 35.3" "Group enriched" "Detected in some" 10 "MOLT-4: 6.2;NB-4: 12.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" CAB016128 Enhanced NA NA "CAB016128: AB_626897" "unprognostic (2.24e-1)" "unprognostic (8.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-1)" "prognostic favorable (3.50e-6)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.30e-1)" "unprognostic (1.48e-2)" "unprognostic (7.04e-3)" "unprognostic (1.04e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (1.61e-1)" "unprognostic (5.46e-2)" "unprognostic (2.42e-1)" "unprognostic (5.91e-2)" 8.6 0.5 0.4 6.3 0.1 0.7 6.7 0.6 0.9 1.6 0.1 2.4 1.7 1.1 0.0 1.0 1.2 0.5 7.0 0.5 0.1 2.4 0.7 6.4 6.6 0.3 0.1 0.1 0.8 1.3 0.2 1.6 1.8 0.2 3.7 0.2 0.0 1.8 0.7 2.1 1.1 5.2 0.2 0.3 13.4 2.6 0.3 0.6 1.8 4.7 0.4 1.5 1.7 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 12.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.3 0.4 0.0 3.0 0.0 26.6 2.8 0.0 0.0 2.3 0.1 0.3 14.7 0.0 1.1 35.3 2.8 0.4 0.1 0.6 0.9 0.5 0.1 0.3 0.1 0.1 0.2 0.3 0.6 0.3 112.3 0.0 0.0 0.3 11.1 9.1 0.3 0.9 0.0 0.3 1.0 2.4 1.7 0.0 0.1 0.0 0.0 0.0 25.6 0.0 0.0 0.9 0.0 0.6 3.8 58.0 0.0 2.7 0.7 0.2 0.4 7.7 0.0 0.6 67.4 0.0 13.9 0.4 1.9 0.0 0.1 0.3 40.7 1.9 128.1 0.0 0.3 9.6 10.6 1.0 18.4 0.0 8.2 1.5 0.1 0.0 0.0 0.4 26.2 0.4 0.0 0.2 0.1 0.2 0.0 17.8 2.0 0.0 0.2 0.1 8.4 0.1 43.6 2.5 0.1 0.2 KRT16 NEPPK ENSG00000186832 "Keratin 16" P08779 17 41609778-41615899 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 1034.1;skin 1: 301.4;vagina: 493.4" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 906.1;Basal prostatic cells: 596.6;Suprabasal keratinocytes: 1348.4;Urothelial cells: 506.9" "Group enriched" "Detected in many" 7 "cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9" "Group enriched" "Detected in some" 5 "cerebellum: 3.9;cerebral cortex: 2.0;hippocampal formation: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTCEpi: 816.8" "Not detected" "Not detected" "CAB000136, HPA000539" Approved Approved "Intermediate filaments" NA NA 1700000000 "Intermediate filaments" "CAB000136: , HPA000539: " "unprognostic (3.95e-3)" "unprognostic (6.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-2)" "unprognostic (1.00e-2)" "unprognostic (7.14e-3)" "unprognostic (1.03e-3)" "unprognostic (2.05e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (8.23e-2)" "unprognostic (6.53e-8)" "unprognostic (3.81e-1)" "unprognostic (1.83e-1)" "unprognostic (7.40e-2)" "unprognostic (3.61e-2)" 6.7 1.4 0.1 0.1 0.3 0.3 17.5 3.9 2.0 147.3 2.0 0.2 0.0 1.0 0.0 1034.1 0.7 2.4 0.4 1.0 0.0 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.7 0.0 1.4 0.1 0.1 6.4 0.0 0.0 182.0 38.1 0.5 301.4 0.2 0.1 0.0 0.2 0.6 2.6 0.0 17.0 0.3 0.0 113.0 5.6 493.4 0.4 20.0 1.7 0.0 0.0 0.2 0.0 0.2 1.5 0.4 0.5 0.2 0.3 4.9 0.1 2.9 0.1 0.2 24.8 0.0 5.6 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 816.8 0.3 17.6 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.3 0.0 127.1 0.7 0.0 0.2 98.1 0.8 6.2 0.0 0.0 57.1 1.5 0.0 0.9 0.0 0.0 0.2 0.0 1.6 4.5 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 3.9 2.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 906.1 596.6 70.1 16.5 0.0 37.8 27.1 0.1 0.0 94.6 1.8 0.0 0.1 0.6 0.0 0.0 1.0 0.0 2.6 0.6 9.2 0.0 0.0 0.0 5.8 3.2 11.5 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 94.1 0.0 0.3 1.1 64.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 0.0 0.0 127.3 0.0 0.0 17.1 0.0 0.0 0.0 9.3 0.0 0.3 88.1 1348.4 0.1 3.4 0.0 0.0 506.9 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "HEXIM P-TEFb complex subunit 1" O94992 17 45148475-45152099 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 16.9 32.8 16.6 13.3 15.8 36.6 17.1 16.7 17.0 16.9 15.9 22.2 17.9 19.7 16.1 24.4 21.4 14.5 15.0 14.7 18.1 21.2 27.0 17.5 12.9 17.3 19.0 13.2 14.5 19.8 14.3 19.3 25.4 17.3 24.4 10.3 9.1 19.3 20.0 33.5 22.7 25.1 13.1 17.7 25.8 23.3 21.7 19.8 15.6 20.3 21.8 12.5 19.8 17.8 15.9 35.7 111.1 22.8 33.0 36.7 19.6 55.3 30.9 27.8 25.0 27.8 52.6 49.3 15.5 93.1 32.7 12.1 28.2 13.8 30.4 20.0 32.2 32.9 48.2 65.8 65.0 32.0 30.3 61.4 23.0 25.5 18.6 8.1 62.6 12.7 26.8 21.5 36.6 19.0 47.8 31.9 34.9 20.9 32.9 33.4 13.1 19.9 19.2 66.5 62.1 12.2 9.2 46.6 52.0 52.2 23.0 54.2 23.5 24.3 25.1 34.6 14.6 58.5 33.1 11.4 10.0 23.0 28.1 29.1 16.2 4.0 6.8 4.2 6.1 2.4 3.0 4.2 3.7 3.3 3.2 3.7 3.9 10.0 3.7 7.3 3.4 3.8 2.2 16.6 15.8 16.7 17.0 14.7 18.1 17.3 19.0 13.2 17.3 17.7 19.8 15.9 210.3 73.7 111.8 7.2 76.1 84.5 75.0 57.7 157.1 25.1 127.0 215.9 59.7 87.2 60.5 25.8 22.9 134.8 114.3 250.4 7.9 35.0 2.2 88.8 66.1 91.3 52.8 82.1 10.7 23.6 70.1 99.2 94.3 137.9 125.9 16.5 42.5 40.5 42.1 15.2 12.9 122.0 54.9 33.9 83.2 3.0 35.1 83.0 53.4 9.4 38.4 27.7 28.8 7.1 8.2 25.3 127.1 43.6 44.1 52.1 184.9 53.8 45.7 24.8 26.3 249.2 128.2 2.6 7.9 126.7 71.5 467.5 111.1 16.9 92.2 34.4 SELENOV SELV ENSG00000186838 "Selenoprotein V" P59797 19 39515113-39520686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 10.0" "Cell type enhanced" "Detected in single" "Breast myoepithelial cells: 2.2" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059274 Uncertain NA NA "HPA059274: AB_2683964" "unprognostic (1.38e-3)" "unprognostic (2.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.43e-4)" 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.1 0.1 2.3 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.4 0.2 0.2 0.5 0.3 0.2 0.5 0.2 0.3 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE1A LEP1 ENSG00000186844 "Late cornified envelope 1A" Q5T7P2 1 152827473-152828097 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 257.7" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 40.3" "Cancer enriched" "Detected in some" 6 "melanoma: 14.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.82e-2)" "unprognostic (1.70e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 23.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 257.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 40.3 0.0 0.1 0.0 0.0 0.0 KRT14 "EBS3, EBS4" ENSG00000186847 "Keratin 14" P02533 17 41582279-41586895 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 6996.1" "Group enriched" "Detected in many" 9 "Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 5910.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "spinal cord: 36.3" "CAB000134, HPA000452, HPA000539, HPA023040" Enhanced Enhanced "Intermediate filaments" NA NA 1600000000 "Intermediate filaments" "CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201" "prognostic favorable (2.66e-4)" "unprognostic (1.64e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.00e-2)" "unprognostic (5.74e-3)" "unprognostic (1.49e-8)" "unprognostic (8.91e-2)" "unprognostic (2.00e-1)" "unprognostic (8.80e-3)" "unprognostic (1.22e-2)" 9.9 1.2 0.0 0.0 0.0 2.7 336.3 0.0 0.2 197.3 0.2 1.5 0.0 0.9 0.0 1314.7 1.8 0.0 3.2 0.0 0.0 0.8 2.5 1.7 0.0 0.0 0.0 0.0 1.3 2.9 0.0 4.4 2.3 0.0 29.4 0.0 0.0 707.9 3.8 16.0 6996.1 2.1 0.1 0.0 0.9 1.7 1.5 0.0 188.4 2.3 0.0 264.5 0.7 853.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.7 0.0 4065.2 0.0 2003.9 0.2 0.0 0.0 0.1 1.6 0.0 0.1 0.2 2.5 0.1 2448.6 3.0 794.2 0.0 0.1 0.0 0.5 3.6 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.6 0.2 0.6 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.4 0.0 0.3 9.1 1.7 696.0 0.0 0.9 0.0 0.0 3.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.5 35588.3 1072.7 181.5 2407.4 0.0 103.5 740.9 0.3 0.0 6.0 0.0 0.0 17.9 3.2 7.3 0.0 0.1 0.0 0.1 0.0 129.0 0.0 0.0 0.0 0.0 127.0 116.5 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.4 0.0 0.0 1833.4 0.0 0.0 9.3 1990.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.5 0.0 9.9 702.0 96.8 0.0 2.3 0.0 0.0 0.0 96.3 0.0 0.1 83.2 11677.1 2.5 62.1 0.1 2.3 100.0 TRABD2A "C2orf89, TIKI1" ENSG00000186854 "TraB domain containing 2A" Q86V40 2 84821650-84907008 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 43.2;lymphoid tissue: 11.4;ovary: 26.9" "Cell type enhanced" "Detected in many" "Early spermatids: 575.5;Granulosa cells: 108.7;Late spermatids: 326.8;Undifferentiated cells: 141.9" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 14.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 71.9" "Lineage enriched" "Detected in many" 18 "T-cells: 71.9" "Cell line enhanced" "Detected in many" "BEWO: 41.7;HDLM-2: 35.1;HSkMC: 22.3;hTEC/SVTERT24-B: 17.8;SiHa: 17.8" HPA045817 Approved "Intracellular and membrane" NA NA 18000 "HPA045817: AB_2679460" "unprognostic (7.49e-3)" "unprognostic (3.35e-1)" "unprognostic (3.08e-1)" "unprognostic (3.29e-2)" "unprognostic (3.82e-5)" "unprognostic (2.46e-2)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.68e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.47e-4)" "unprognostic (4.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.41e-3)" "unprognostic (1.37e-1)" 2.5 0.4 1.6 9.0 1.9 3.8 2.2 0.2 3.1 0.3 0.5 40.3 4.2 0.2 0.7 0.3 0.8 0.5 0.3 1.5 1.5 0.6 1.0 2.9 11.4 0.2 2.5 1.4 26.9 0.1 2.1 0.3 0.9 0.6 0.2 43.2 0.0 0.5 0.1 0.1 0.8 10.7 2.8 0.3 3.8 1.1 0.4 3.0 8.2 0.4 0.6 7.9 0.8 0.4 2.2 1.3 1.1 0.4 0.2 12.4 13.4 41.7 2.0 3.3 5.8 10.8 0.5 4.7 0.0 0.5 6.5 10.8 0.0 2.8 0.6 8.6 35.1 0.7 0.0 8.4 0.0 1.5 0.1 0.0 22.3 0.0 17.8 8.1 1.3 0.0 0.3 0.0 0.1 0.8 0.0 0.1 0.1 1.1 2.3 0.9 0.3 0.7 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.2 0.3 0.0 0.2 0.3 5.8 0.8 0.0 2.1 4.0 0.0 0.1 5.3 3.5 0.0 0.0 0.3 0.0 8.5 0.3 10.5 0.7 33.6 12.4 1.8 3.9 71.9 46.1 1.3 3.9 0.2 1.6 23.5 13.2 1.6 1.9 0.2 3.1 1.5 1.5 0.2 2.5 1.4 0.6 0.3 3.0 2.2 9.0 3.2 11.0 0.0 7.8 1.0 0.6 0.6 0.0 1.1 1.4 0.4 85.4 0.0 0.9 0.0 0.0 9.4 4.6 51.1 0.0 0.1 575.5 4.3 0.6 7.5 12.7 0.8 10.6 0.9 41.5 6.1 2.6 1.9 2.5 108.7 2.2 0.1 2.6 0.0 0.7 67.9 0.0 1.3 6.6 326.8 5.0 4.6 3.6 3.7 12.6 0.0 3.1 1.0 0.7 0.6 73.8 2.6 5.4 0.5 17.4 1.2 1.7 0.1 6.6 0.9 7.3 3.5 5.6 0.4 0.6 4.4 29.7 0.2 141.9 0.5 KRTAP17-1 KAP17.1 ENSG00000186860 "Keratin associated protein 17-1" Q9BYP8 17 41314912-41315710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "skin 1: 15.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Enteroendocrine cells: 8.4;Extravillous trophoblasts: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 73 "HDLM-2: 17.5;SCLC-21H: 10.5" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 8.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PDZD7 "bA108L7.8, DFNB57, FLJ23209, PDZK7" ENSG00000186862 "PDZ domain containing 7" Q9H5P4 10 101007679-101032295 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.5;intestine: 20.2;pituitary gland: 6.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 15.9;Cone photoreceptor cells: 22.9;Excitatory neurons: 32.3;Inhibitory neurons: 16.5;Proximal enterocytes: 56.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 7.5;SCLC-21H: 11.7;THP-1: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074542 Supported Nucleoplasm NA NA Nucleoplasm "HPA074542: " "unprognostic (1.46e-1)" "unprognostic (2.85e-3)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "unprognostic (2.15e-2)" "unprognostic (2.83e-2)" "unprognostic (1.38e-2)" "unprognostic (5.31e-2)" "unprognostic (2.52e-2)" "unprognostic (2.95e-2)" "unprognostic (2.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-3)" "unprognostic (3.89e-1)" "unprognostic (1.79e-1)" "unprognostic (3.51e-2)" "unprognostic (2.80e-1)" 1.5 1.3 7.1 1.0 8.2 1.3 0.5 9.7 16.1 0.7 0.7 0.3 12.9 1.4 0.9 0.3 0.5 1.9 0.6 6.9 5.7 1.5 0.1 1.0 0.9 18.9 11.5 7.2 0.6 0.9 1.1 6.0 1.0 21.5 0.7 0.2 2.3 1.1 0.5 0.9 2.4 20.2 1.1 3.5 1.6 1.0 1.2 10.4 0.7 1.2 0.2 0.1 0.4 0.8 15.0 7.5 0.9 0.5 0.7 0.9 0.1 2.3 1.2 0.6 0.0 0.3 1.5 1.7 3.7 3.5 0.3 1.0 2.2 0.2 0.7 0.0 1.0 2.5 0.2 3.8 2.3 0.6 0.5 3.1 0.3 0.1 0.2 0.1 4.2 0.2 3.3 0.6 0.7 0.1 1.8 0.5 1.2 0.6 1.5 2.4 1.6 1.0 0.4 1.8 0.6 11.7 5.4 0.8 0.3 1.2 1.0 2.4 18.2 0.5 1.1 2.4 1.4 1.0 1.5 0.1 0.2 6.4 1.2 0.6 0.6 0.4 0.5 0.3 0.4 0.3 0.3 0.2 0.4 0.1 0.3 0.4 0.2 1.6 0.8 0.3 0.1 0.1 0.3 7.1 8.2 9.7 16.1 6.9 5.7 18.9 11.5 7.2 21.5 3.5 10.4 15.0 0.8 0.0 0.0 1.3 0.1 0.5 0.5 0.2 0.0 15.9 0.5 0.9 1.4 2.8 0.2 1.8 22.9 0.2 0.1 0.2 1.9 0.7 1.7 2.1 0.3 0.7 0.0 0.0 32.3 0.4 5.2 0.8 1.1 0.3 0.0 1.6 0.7 0.0 2.1 1.7 16.5 1.5 0.0 1.3 2.7 2.6 0.3 1.0 0.0 5.6 0.3 0.9 1.0 0.5 6.9 1.3 1.2 1.2 0.3 0.4 56.7 1.6 1.3 8.3 0.0 1.4 1.7 2.9 3.7 0.2 0.4 1.9 0.8 0.1 1.0 0.2 POFUT2 "C21orf80, FUT13, KIAA0958" ENSG00000186866 "Protein O-fucosyltransferase 2" Q9Y2G5 21 45263928-45287898 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 95.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044297 Uncertain "Intracellular and membrane" NA NA "HPA044297: AB_10965176" "unprognostic (1.32e-2)" "unprognostic (1.65e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (1.49e-2)" "unprognostic (4.09e-3)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.62e-1)" "unprognostic (2.15e-1)" "unprognostic (4.16e-2)" "unprognostic (4.20e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.66e-12)" "unprognostic (1.56e-2)" "unprognostic (2.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.25e-2)" 14.4 20.9 10.0 8.6 8.9 14.1 14.2 9.2 11.0 19.6 18.2 16.5 9.8 16.3 9.0 8.6 20.5 10.3 16.1 9.1 12.9 19.6 20.6 16.2 7.8 11.7 10.3 8.1 28.0 19.2 8.2 31.7 16.9 10.4 19.2 6.3 8.7 14.6 10.4 7.9 8.6 15.1 12.1 9.4 17.1 15.5 17.7 12.2 5.3 22.4 5.1 6.6 16.1 14.0 10.9 10.4 11.2 22.1 24.5 39.3 36.1 10.3 57.1 45.4 25.9 38.7 24.0 17.2 7.2 41.9 95.1 58.5 10.4 13.1 22.9 27.9 12.1 15.2 14.4 17.4 18.8 45.4 10.7 18.4 25.6 14.7 32.4 17.7 84.5 25.6 9.5 13.5 11.6 27.4 10.7 5.3 17.7 27.6 17.3 15.7 10.8 6.6 9.1 14.4 9.4 9.6 14.0 33.6 20.3 21.1 24.6 14.8 15.4 28.5 19.5 19.0 30.2 25.8 27.7 15.4 5.5 39.9 13.2 30.8 0.3 0.3 0.8 0.3 0.3 0.5 0.2 0.3 0.2 0.1 0.2 0.4 0.4 0.5 0.3 0.3 0.4 0.3 0.3 10.0 8.9 9.2 11.0 9.1 12.9 11.7 10.3 8.1 10.4 9.4 12.2 10.9 12.4 6.4 9.6 19.6 10.7 6.6 7.0 6.8 6.2 6.9 11.8 9.5 8.7 11.5 7.0 12.9 10.4 9.0 14.7 7.4 3.9 7.6 34.9 29.4 17.5 8.7 10.1 7.4 6.8 6.2 13.5 19.8 13.3 15.9 7.0 20.4 10.0 8.6 6.9 5.0 9.9 14.7 4.1 4.8 8.8 51.2 14.6 8.1 8.8 7.5 8.0 10.2 3.1 11.1 7.6 8.0 7.5 13.9 12.4 7.3 6.6 3.9 30.6 14.5 0.0 14.5 17.5 20.1 5.2 4.5 4.0 13.5 12.3 12.2 7.8 7.9 QRFPR GPR103 ENSG00000186867 "Pyroglutamylated RFamide peptide receptor" Q96P65 4 121328642-121381059 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.2;heart muscle: 1.2;kidney: 1.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.2;Early spermatids: 2.1;Endothelial cells: 3.1;Excitatory neurons: 5.9;Inhibitory neurons: 10.9;Microglial cells: 2.8" "Cancer enriched" "Detected in some" 6 "renal cancer: 5.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 3.6;hTERT-HME1: 4.7;RPTEC TERT1: 2.6;SCLC-21H: 1.7;U-2 OS: 3.7;WM-115: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA050236 Approved NA NA "HPA050236: " "unprognostic (1.24e-2)" "unprognostic (2.30e-1)" "unprognostic (1.93e-2)" "unprognostic (3.21e-1)" "unprognostic (2.77e-1)" "unprognostic (3.21e-4)" "unprognostic (2.71e-1)" "unprognostic (5.77e-3)" "unprognostic (5.37e-2)" "unprognostic (6.33e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.09e-4)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 0.1 0.2 0.7 0.1 0.7 0.2 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.6 4.2 1.2 0.0 0.0 0.0 2.4 1.1 0.4 0.1 0.0 0.1 0.3 0.0 3.5 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.2 2.3 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 4.7 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.5 1.5 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 1.1 0.4 0.1 0.2 0.1 0.1 0.7 0.7 0.2 1.1 0.6 4.2 2.4 1.1 0.4 3.5 0.3 2.3 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 3.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894527-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.5;skeletal muscle: 79.7" "Cell type enhanced" "Detected in many" "Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8" "Cancer enhanced" "Detected in many" "breast cancer: 9.5;glioma: 13.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" "Secreted to blood" NA NA 7100 "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155" "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 4.5 4.4 16.5 0.3 28.0 0.0 9.2 7.8 68.5 1.8 0.0 6.0 0.5 1.0 0.2 8.4 1.0 0.8 6.7 26.5 31.1 14.6 0.6 0.8 0.3 13.7 7.4 31.9 0.6 1.5 2.9 29.7 3.4 24.3 5.4 0.3 17.8 8.5 3.4 79.7 5.9 1.9 0.3 1.7 0.4 1.8 20.4 18.9 0.4 0.9 27.6 0.2 10.3 2.4 62.0 2.9 0.5 0.3 6.4 0.3 0.9 1.8 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.6 0.4 0.5 0.1 2.3 0.3 0.0 69.0 3.4 0.0 0.3 4.2 0.0 0.1 0.1 0.0 0.5 0.1 0.3 0.1 0.0 4.4 0.7 3.6 0.0 7.7 1.0 0.2 0.2 0.7 2.0 0.0 4.0 8.5 0.0 9.1 21.1 9.1 2.5 0.0 1.8 1.0 34.7 0.1 0.1 0.3 0.8 1.7 0.3 0.9 0.3 0.0 0.6 2.0 0.5 0.1 0.0 0.0 0.2 0.7 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.3 0.2 0.1 1.7 0.0 0.7 0.0 16.5 28.0 7.8 68.5 26.5 31.1 13.7 7.4 31.9 24.3 1.7 18.9 62.0 1.9 0.0 9.8 142.4 1.0 1.0 1.4 0.2 1.2 314.4 26.7 21.2 35.2 0.0 0.1 1.8 64.6 0.2 0.4 0.1 7.9 0.5 199.9 0.4 1.7 1.8 0.0 0.0 189.2 0.4 9.1 3.7 0.5 1.3 4.5 1.6 1.1 0.5 0.3 361.7 153.7 0.0 2.0 0.6 1.7 416.6 2.8 0.8 5.4 8.4 0.7 145.7 0.0 129.7 163.8 0.6 0.0 2.6 0.1 2.5 0.1 76.1 0.0 28.3 0.0 28.2 6.0 18.4 8.1 22.7 3.3 0.3 1.5 0.8 0.3 0.6 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239027 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;lymphoid tissue: 3.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No Yes Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.2 0.1 0.1 1.3 0.2 3.3 0.4 0.7 0.2 0.4 0.0 0.9 0.7 0.2 0.2 1.2 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.5 0.3 0.1 1.2 0.5 0.3 0.0 0.1 0.6 0.6 0.3 0.0 0.5 0.8 0.8 0.2 3.6 0.1 0.0 2.7 0.2 0.4 0.5 19.0 16.3 14.6 9.3 1.0 1.7 8.0 19.8 9.1 17.0 17.7 13.3 11.6 30.5 7.3 7.2 23.0 15.2 27.8 14.8 30.1 17.5 20.2 10.5 5.5 7.9 0.0 20.7 14.2 0.2 0.9 23.7 4.4 2.8 9.6 15.1 14.1 7.3 17.6 14.8 19.8 12.1 26.6 18.3 24.8 16.4 26.2 5.4 4.4 11.5 12.0 8.6 14.7 9.8 3.6 11.8 7.5 4.6 6.0 11.4 18.3 21.8 13.1 5.7 9.4 25.9 8.1 14.1 11.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 1.7 0.1 0.1 0.4 0.1 0.1 0.2 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.9 0.3 0.2 0.5 0.0 0.0 0.3 0.6 0.5 1.5 0.2 0.0 0.0 1.1 0.9 0.6 0.0 0.0 0.3 0.9 0.8 0.3 0.0 3.4 0.9 0.0 1.7 0.5 0.0 0.5 0.0 2.5 0.0 0.0 1.0 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.4 2.1 2.4 2.4 0.1 0.4 0.3 0.2 0.9 0.1 OR13F1 ENSG00000186881 "Olfactory receptor family 13 subfamily F member 1" Q8NGS4 9 104504263-104505222 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D3P "OR11-8b, OR11-8c, OR5D3, OR5D4" ENSG00000186886 "Olfactory receptor family 5 subfamily D member 3 pseudogene" 11 55723776-55729621 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM17 FLJ34583 ENSG00000186889 "Transmembrane protein 17" Q86X19 2 62500218-62511894 "Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 25.4;Spermatocytes: 39.2;Spermatogonia: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018100 Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA018100: AB_2240686" "unprognostic (8.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.14e-1)" "unprognostic (5.02e-3)" "unprognostic (3.78e-1)" "unprognostic (1.87e-4)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "unprognostic (3.44e-2)" "unprognostic (2.26e-1)" "unprognostic (2.36e-1)" "unprognostic (7.68e-3)" "unprognostic (1.11e-2)" "unprognostic (3.06e-2)" "unprognostic (3.62e-1)" "unprognostic (1.49e-6)" 2.4 5.1 4.3 0.5 4.2 0.8 2.4 2.7 3.7 1.8 4.2 1.2 1.0 2.3 1.6 2.7 4.4 2.9 2.2 4.1 7.9 4.3 2.3 1.8 1.0 4.3 4.2 4.1 3.2 3.2 6.2 4.3 1.7 4.5 2.5 0.9 4.1 2.2 2.0 1.9 2.4 0.9 1.6 3.2 0.8 1.3 4.9 6.9 1.4 4.6 1.9 0.9 1.5 1.3 3.7 3.3 4.6 4.7 1.8 2.4 3.1 3.0 2.5 2.3 2.0 2.1 0.3 6.1 0.0 3.2 3.3 6.7 3.2 2.1 1.4 1.5 3.2 1.4 1.5 1.8 0.3 3.5 2.3 1.8 2.8 3.9 1.7 3.9 3.4 2.5 0.3 1.4 0.2 5.3 0.9 0.4 0.5 2.3 3.0 2.3 0.2 0.6 0.2 4.3 1.0 1.2 4.0 2.6 0.9 9.1 1.6 1.5 3.0 1.7 4.0 2.2 4.8 2.6 0.4 0.0 0.0 5.8 0.4 8.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.3 0.1 1.9 0.0 0.4 4.3 4.2 2.7 3.7 4.1 7.9 4.3 4.2 4.1 4.5 3.2 6.9 3.7 2.9 3.2 4.1 2.6 0.4 5.0 2.3 10.7 9.1 7.1 3.0 2.8 2.6 4.3 7.5 5.5 8.4 2.3 1.5 0.1 0.0 5.3 4.8 11.4 2.1 2.7 1.2 1.7 2.8 8.5 2.2 4.2 1.1 1.7 1.3 2.8 3.9 2.5 2.6 10.1 3.9 0.9 6.1 0.6 1.5 2.8 4.7 1.4 3.6 1.0 0.9 9.9 0.0 0.0 2.9 7.9 0.3 3.8 1.4 1.0 0.4 2.5 25.4 4.8 6.6 2.4 1.8 39.2 21.7 5.5 2.8 0.4 0.3 5.4 1.1 1.5 TNFRSF18 "AITR, CD357, GITR" ENSG00000186891 "TNF receptor superfamily member 18" Q9Y5U5 1 1203508-1206592 "CD markers, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 38.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 189.0;dendritic cells: 72.2;Langerhans cells: 86.4;Melanocytes: 49.8;Plasma cells: 55.3;Suprabasal keratinocytes: 150.6;T-cells: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cell: 184.5;T-reg: 71.8" "Group enriched" "Detected in many" 11 "NK-cells: 184.5;T-cells: 71.8" "Group enriched" "Detected in some" 12 "RPMI-8226: 225.6;SCLC-21H: 152.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008025 Approved "Secreted to blood" NA NA "HPA008025: AB_1849696" "unprognostic (1.20e-3)" "unprognostic (4.61e-2)" "unprognostic (4.59e-2)" "prognostic favorable (7.72e-6)" "unprognostic (2.73e-4)" "prognostic favorable (4.12e-4)" "unprognostic (3.43e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.01e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.40e-11)" "unprognostic (1.02e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-1)" "unprognostic (2.08e-1)" 1.7 0.6 0.9 7.4 1.1 3.0 2.4 2.2 3.1 10.5 0.7 3.7 7.2 1.4 0.0 6.3 1.4 0.9 0.5 1.1 0.6 1.2 0.9 4.6 5.5 1.1 0.5 1.0 0.3 0.3 9.5 4.9 0.3 1.2 2.8 1.5 0.0 5.6 0.6 0.8 38.9 7.2 0.3 0.7 9.1 5.3 0.9 0.8 1.9 1.4 0.0 3.8 2.0 3.3 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 1.7 0.1 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.2 0.1 0.5 16.1 0.1 0.1 225.6 0.3 0.0 152.8 0.2 0.0 0.6 0.0 0.0 8.2 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.3 0.2 0.6 0.1 0.0 0.2 0.2 0.0 6.8 0.1 12.6 4.6 28.9 4.4 0.1 11.5 0.9 1.5 0.8 184.5 0.1 0.3 71.8 6.7 0.9 1.1 2.2 3.1 1.1 0.6 1.1 0.5 1.0 1.2 0.7 0.8 1.2 11.2 0.0 1.3 0.3 23.5 189.0 12.5 15.5 16.5 0.0 5.0 3.0 2.9 0.0 3.2 0.0 0.0 0.0 72.2 0.3 0.0 0.8 0.0 1.2 1.2 4.1 3.5 0.0 2.0 0.6 1.3 4.7 1.1 2.9 45.7 0.0 0.7 0.0 0.8 0.0 0.3 0.2 20.3 0.3 86.4 0.0 0.0 5.4 49.8 0.0 12.7 0.0 21.6 0.5 0.3 0.4 0.0 0.0 55.3 10.1 0.1 0.1 0.8 0.0 0.0 6.2 2.2 0.0 0.0 0.3 150.6 0.0 75.7 0.0 0.8 7.0 FGF3 "HBGF-3, INT2" ENSG00000186895 "Fibroblast growth factor 3" P11487 11 69809968-69819416 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "brain: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.4" "Region enriched" "Detected in single" 4 "cerebellum: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 3.1" "Not detected" "Not detected" HPA012692 Enhanced "Secreted in brain" NA NA "HPA012692: AB_1848526" "unprognostic (6.42e-3)" "unprognostic (7.82e-2)" "unprognostic (1.89e-1)" "unprognostic (3.61e-1)" "unprognostic (7.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.1 0.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QL4 "C1QTNF11, CTRP11" ENSG00000186897 "Complement C1q like 4" Q86Z23 12 49332409-49337188 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.0;testis: 4.3" "Group enriched" "Detected in some" 8 "Early spermatids: 37.2;Horizontal cells: 25.2;Late spermatids: 84.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 6.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 35.3;HAP1: 5.5;PC-3: 5.9;U-2 OS: 9.0" "Region enhanced" "Detected in some" "midbrain: 6.2" "Region enhanced" "Detected in some" "pons: 7.6" "Secreted in brain" NA NA "unprognostic (1.97e-2)" "unprognostic (2.77e-2)" "unprognostic (4.87e-2)" "unprognostic (7.37e-2)" "unprognostic (4.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.49e-3)" "unprognostic (8.64e-3)" "unprognostic (2.89e-1)" "unprognostic (5.11e-3)" "unprognostic (7.62e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (9.73e-2)" "unprognostic (2.85e-2)" "unprognostic (9.40e-2)" "unprognostic (3.72e-2)" 0.1 0.0 0.7 0.0 1.3 0.0 0.2 0.4 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.0 1.2 6.0 0.5 0.0 0.0 0.1 0.2 0.0 4.1 0.1 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 4.3 1.0 0.0 0.9 0.0 0.0 0.0 1.1 0.8 0.4 1.4 0.4 35.3 0.0 0.0 0.1 0.0 0.1 0.5 1.9 0.9 0.1 0.4 2.0 0.0 2.0 0.1 5.5 0.0 0.6 0.1 2.5 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.1 0.4 0.0 1.2 0.2 0.0 0.0 0.9 0.0 0.0 0.7 0.1 5.9 0.2 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.3 1.6 0.1 0.7 0.2 0.0 0.5 9.0 0.1 0.5 0.3 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.4 0.6 0.2 1.3 1.2 6.0 0.5 4.1 0.1 1.0 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.4 1.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 25.2 0.0 0.0 0.0 0.0 0.3 84.5 0.9 0.0 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 5.6 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RTN4RL2 "NgR2, NGRH1" ENSG00000186907 "Reticulon 4 receptor like 2" Q86UN3 11 57460528-57477534 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 31.2;liver: 41.1;thyroid gland: 30.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.9;Cholangiocytes: 12.8;Excitatory neurons: 16.7;Hepatocytes: 14.0;Oligodendrocyte precursor cells: 9.5;Spermatocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 44.1;Karpas-707: 67.5;REH: 42.3;RPMI-8226: 134.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "amygdala: 13.5;cerebral cortex: 23.8;hippocampal formation: 21.0" "Intracellular and membrane" NA NA 27000000 "unprognostic (6.27e-3)" "unprognostic (2.02e-2)" "unprognostic (4.57e-2)" "unprognostic (8.40e-2)" "unprognostic (8.51e-2)" "unprognostic (7.64e-2)" "unprognostic (6.83e-2)" "unprognostic (3.72e-2)" "unprognostic (7.27e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (3.05e-7)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" "unprognostic (5.16e-3)" "unprognostic (2.18e-2)" 3.5 0.7 20.5 0.3 30.4 0.8 3.5 0.0 31.2 1.9 0.0 1.0 1.1 2.0 0.2 1.6 1.7 3.0 3.0 26.0 1.9 2.8 41.1 2.6 0.4 12.1 0.0 22.7 1.1 2.4 3.8 3.7 1.9 4.9 1.6 0.1 1.0 3.4 0.3 1.7 4.4 1.1 0.7 0.0 1.0 1.5 1.8 0.3 1.9 30.7 0.4 0.3 1.2 1.6 8.8 7.4 10.1 7.6 13.1 3.1 4.4 1.0 0.1 2.9 0.3 2.7 1.3 1.4 0.2 0.2 0.4 4.3 0.2 11.9 0.2 0.1 1.7 4.7 2.3 1.1 7.2 4.4 1.7 44.1 11.9 1.3 1.1 1.1 1.3 0.1 12.9 1.6 67.5 0.1 1.4 0.2 5.3 13.3 0.5 7.6 42.3 5.4 134.0 0.1 0.2 14.0 1.2 1.1 0.6 7.7 0.6 8.5 2.0 0.1 0.5 22.7 3.1 2.4 4.1 9.2 1.4 16.7 7.3 5.8 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.4 0.0 31.2 26.0 1.9 12.1 0.0 22.7 4.9 0.0 0.3 8.8 1.7 0.0 0.0 2.0 0.4 5.7 0.4 0.3 2.8 19.9 2.1 1.5 0.4 12.8 0.1 0.0 0.0 0.0 0.9 0.2 3.9 1.3 2.6 0.6 0.9 2.1 1.8 0.8 16.7 0.6 5.5 1.6 0.5 2.1 0.0 0.0 1.1 14.0 0.4 0.0 1.1 0.6 0.0 0.0 2.1 1.3 0.3 0.6 1.8 3.7 0.5 0.8 2.1 9.5 1.2 0.8 0.1 1.2 0.0 1.0 0.0 1.1 0.0 1.4 6.6 1.0 5.4 10.2 1.7 1.1 2.8 0.0 0.9 0.1 0.2 0.2 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type palmitoyltransferase 17" Q8IUH5 12 76764103-76853696 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 17.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: AB_2732626" "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 15.8 14.3 22.2 12.2 23.2 24.0 16.3 26.1 26.2 15.6 14.7 11.5 7.6 21.9 12.4 8.0 12.9 10.6 12.6 21.9 21.7 11.1 9.9 10.7 15.0 21.3 22.9 21.4 20.3 10.3 12.8 11.1 16.5 21.8 14.2 10.2 31.2 8.2 12.9 11.9 10.2 10.4 14.8 21.8 14.5 8.6 12.9 22.4 15.0 11.9 14.4 11.5 11.8 11.8 30.7 8.2 9.5 30.1 15.4 17.6 18.5 14.6 16.2 13.4 10.5 9.2 7.8 5.8 11.2 9.5 15.9 10.5 7.5 12.1 10.1 16.2 9.5 12.6 16.4 13.1 12.0 11.9 16.5 13.9 17.6 10.3 10.0 14.7 35.2 12.2 15.2 18.0 5.2 13.8 7.6 12.0 21.9 22.1 3.6 11.3 16.1 10.7 12.3 12.0 12.3 11.7 20.1 17.8 6.4 10.7 25.7 14.4 16.3 16.9 14.3 11.0 8.8 9.3 8.1 8.5 11.9 5.4 7.6 15.0 6.2 2.3 5.7 3.6 2.4 2.9 2.5 2.9 2.6 2.8 3.9 3.0 2.5 5.9 2.0 2.5 17.1 1.3 1.5 22.2 23.2 26.1 26.2 21.9 21.7 21.3 22.9 21.4 21.8 21.8 22.4 30.7 33.4 32.1 18.3 75.7 20.1 7.1 10.4 9.8 12.5 54.6 9.9 10.7 21.3 12.8 15.5 12.9 39.6 20.3 74.1 5.0 0.0 8.0 11.3 11.8 23.8 24.8 19.2 12.0 102.2 4.7 10.2 21.2 7.1 10.1 41.2 20.7 20.3 10.6 8.8 28.6 95.1 7.5 8.2 12.3 19.4 13.7 20.2 14.9 5.4 54.4 14.9 26.1 18.6 88.4 115.8 6.8 4.5 21.1 13.5 10.2 8.4 5.5 18.0 38.1 0.0 32.3 22.0 17.7 22.6 9.5 5.5 5.6 18.1 19.6 6.2 5.5 SERPINA11 ENSG00000186910 "Serpin family A member 11" Q86U17 14 94442464-94452800 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "liver: 494.6" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 278.7" "Cancer enriched" "Detected in some" 9 "liver cancer: 94.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 230000000 "unprognostic (2.50e-2)" "unprognostic (3.26e-1)" "unprognostic (9.00e-2)" "prognostic favorable (6.30e-4)" "unprognostic (7.44e-2)" "unprognostic (2.02e-2)" "unprognostic (1.70e-1)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.1 5.3 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 494.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.9 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.3 0.0 0.0 4.3 1.8 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 278.7 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.2 P2RY4 "NRU, P2P, P2Y4, UNR" ENSG00000186912 "Pyrimidinergic receptor P2Y4" P51582 X 70258170-70259764 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "intestine: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" CAB022644 Uncertain NA NA "CAB022644: " "unprognostic (4.59e-2)" "unprognostic (4.23e-1)" "unprognostic (7.10e-2)" "unprognostic (1.69e-1)" "unprognostic (9.53e-4)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (6.77e-2)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.90e-2)" "unprognostic (3.72e-2)" "unprognostic (3.61e-2)" "unprognostic (1.50e-2)" "unprognostic (3.89e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.1 0.2 0.0 0.0 0.7 2.7 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF395 "DKFZp434K1210, HDBP2, PBF, PRF-1" ENSG00000186918 "Zinc finger protein 395" Q9H8N7 8 28345590-28402701 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 140.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049382, HPA076275" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049382: , HPA076275: " "unprognostic (1.28e-1)" "unprognostic (3.02e-1)" "unprognostic (1.95e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (9.35e-3)" "unprognostic (8.90e-2)" "unprognostic (2.15e-2)" "unprognostic (7.08e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (2.46e-2)" "unprognostic (7.42e-2)" 32.2 18.6 22.0 14.5 20.8 37.8 30.7 15.1 20.7 21.7 25.4 24.5 21.1 17.5 14.0 48.0 27.5 14.6 22.3 18.5 18.8 23.3 37.3 19.9 21.5 25.2 18.2 17.7 54.1 47.9 17.9 16.5 34.2 17.9 23.9 14.1 27.4 39.1 17.7 16.4 43.2 24.9 9.6 18.9 22.0 26.4 11.0 29.7 19.1 18.7 14.1 25.4 26.5 29.5 20.8 140.0 19.4 17.9 48.7 13.9 19.6 52.6 16.2 28.4 13.2 30.6 31.0 24.0 66.1 56.2 25.7 30.5 29.3 16.1 40.6 25.6 11.0 12.7 16.4 3.8 6.5 14.2 7.3 6.6 34.9 55.3 2.3 34.3 37.5 6.5 21.2 16.9 14.2 18.3 23.7 31.6 21.7 28.1 33.9 22.7 29.3 19.7 22.1 30.6 26.4 48.1 50.9 3.8 10.3 26.5 15.8 18.9 16.3 1.5 26.6 32.9 15.1 6.6 17.4 9.6 42.9 72.8 13.6 21.5 10.0 4.3 11.5 4.6 0.8 4.4 11.4 5.5 5.6 1.6 13.7 7.1 4.8 1.9 3.7 0.7 6.2 2.4 2.2 22.0 20.8 15.1 20.7 18.5 18.8 25.2 18.2 17.7 17.9 18.9 29.7 20.8 14.8 32.1 22.7 45.7 24.7 16.8 17.2 33.0 45.5 10.3 19.1 16.0 12.4 12.8 20.5 9.2 14.6 17.1 9.3 18.4 3.9 22.5 0.6 18.0 9.9 15.1 27.2 8.6 15.9 24.1 21.6 15.8 11.2 21.8 11.4 11.9 26.0 32.4 5.8 6.7 10.8 21.7 6.1 16.8 6.0 1.5 24.8 5.6 10.6 17.8 7.1 17.4 7.2 15.6 18.3 23.7 8.5 18.0 9.0 14.8 21.9 7.6 19.1 10.2 26.3 25.8 11.6 1.1 3.2 29.2 11.5 6.3 7.9 4.9 27.2 9.7 ZACN "L2, LGICZ, LGICZ1, ZAC, ZAC1" ENSG00000186919 "Zinc activated ion channel" Q401N2 17 76071961-76083666 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 1.1;Respiratory ciliated cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.27e-2)" "unprognostic (2.89e-2)" "unprognostic (8.92e-2)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (1.13e-2)" "unprognostic (5.10e-3)" "unprognostic (5.17e-2)" "unprognostic (4.49e-2)" "unprognostic (7.42e-2)" "unprognostic (3.16e-5)" "unprognostic (2.70e-2)" "unprognostic (5.19e-7)" "unprognostic (6.27e-2)" "unprognostic (3.59e-1)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.7 0.4 0.3 0.1 0.1 0.6 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.4 0.1 0.3 1.1 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.0 0.8 0.4 0.0 0.1 1.0 0.1 0.0 0.4 0.2 0.0 0.1 0.3 0.1 0.3 0.6 0.0 0.1 0.2 KRTAP22-1 KAP22.1 ENSG00000186924 "Keratin associated protein 22-1" Q3MIV0 21 30601087-30601382 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-6 KAP19.6 ENSG00000186925 "Keratin associated protein 19-6" Q3LI70 21 30541535-30541864 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP6-2 KAP6.2 ENSG00000186930 "Keratin associated protein 6-2" Q3LI66 21 30598590-30598902 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C8 ENSG00000186943 "Olfactory receptor family 13 subfamily C member 8" Q8NGS7 9 104569168-104570130 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPARA "hPPAR, NR1C1, PPAR" ENSG00000186951 "Peroxisome proliferator activated receptor alpha" Q07869 22 46150521-46243756 "FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 45.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 99.4;Hepatocytes: 144.5;Proximal enterocytes: 93.2;Rod photoreceptor cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 10.3;plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;granulocytes: 10.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058901, HPA067049, CAB075701" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770" "unprognostic (1.96e-1)" "unprognostic (2.19e-1)" "unprognostic (1.02e-1)" "unprognostic (4.76e-2)" "unprognostic (3.94e-3)" "unprognostic (4.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (2.95e-1)" "unprognostic (5.52e-3)" "unprognostic (4.50e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.39e-9)" "unprognostic (4.84e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "unprognostic (3.18e-2)" 7.9 6.3 8.9 4.5 11.2 6.7 3.8 10.1 7.0 4.2 20.1 11.9 18.6 3.8 3.7 7.8 4.1 4.5 26.5 7.4 9.9 22.7 33.5 4.0 3.4 11.3 10.3 5.3 11.3 8.3 7.4 2.6 4.3 9.4 6.2 9.2 18.4 7.9 5.7 26.5 7.8 18.5 4.4 8.5 4.4 6.1 1.3 10.6 3.7 7.0 45.0 3.9 5.2 4.0 10.4 7.8 1.9 2.4 8.4 13.0 8.3 5.3 6.7 13.2 7.0 7.2 3.8 3.7 2.8 3.3 15.6 6.5 3.5 7.1 8.7 6.3 8.1 8.9 8.7 4.8 8.0 8.1 6.0 14.3 6.6 6.9 5.2 11.8 6.0 1.5 6.3 3.2 6.4 6.6 2.0 6.8 2.2 0.3 6.5 1.9 8.0 8.6 3.6 4.7 4.6 2.4 7.0 2.6 2.4 8.0 3.2 2.7 4.6 2.6 7.3 7.7 6.7 2.9 6.3 4.0 1.2 11.4 6.6 2.3 1.4 0.8 10.3 1.0 1.0 0.8 0.8 0.5 0.5 0.6 1.0 0.6 0.4 0.7 0.7 0.7 3.1 1.4 0.2 8.9 11.2 10.1 7.0 7.4 9.9 11.3 10.3 5.3 9.4 8.5 10.6 10.4 15.0 3.2 13.6 49.6 8.0 23.3 15.0 7.8 9.1 15.0 14.3 11.4 99.4 22.8 8.9 7.3 62.6 8.0 18.4 58.8 9.8 10.3 0.6 9.4 26.4 15.5 19.9 32.0 1.4 16.6 6.7 16.0 14.8 18.4 5.1 19.1 22.5 144.5 8.8 5.0 13.8 31.4 0.0 24.8 10.2 1.1 19.6 10.4 3.6 10.3 12.2 16.0 8.2 19.6 27.2 13.0 24.5 30.1 10.6 19.1 93.2 40.8 5.0 148.0 6.6 31.0 15.8 0.7 1.7 19.3 34.2 3.0 9.6 14.6 37.9 19.9 TMEM232 FLJ43080 ENSG00000186952 "Transmembrane protein 232" C9JQI7 5 110289233-110738956 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.5;testis: 17.1" "Cell type enhanced" "Detected in many" "Astrocytes: 154.8;Early spermatids: 130.7;Endometrial ciliated cells: 80.5;Excitatory neurons: 258.9;Inhibitory neurons: 175.0;Respiratory ciliated cells: 114.0;Spermatocytes: 83.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049386 Uncertain NA NA "HPA049386: AB_2680739" "unprognostic (1.12e-2)" "unprognostic (1.43e-1)" "unprognostic (7.27e-2)" "unprognostic (1.47e-2)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.49e-2)" "unprognostic (9.88e-2)" "unprognostic (1.91e-1)" "unprognostic (1.22e-1)" "unprognostic (6.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.32e-5)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (3.14e-4)" "unprognostic (8.96e-2)" 0.6 1.3 6.7 0.2 2.7 0.1 1.1 2.6 2.5 1.2 7.1 0.4 0.5 0.8 1.7 0.6 14.5 1.8 0.7 1.9 5.9 3.7 0.7 1.7 0.4 6.5 5.8 1.2 0.7 0.4 2.1 1.3 0.4 5.5 0.9 0.4 3.7 0.6 0.7 0.1 0.4 0.3 0.4 7.8 0.2 0.9 17.1 3.6 0.4 3.8 0.3 0.3 0.3 0.1 5.7 0.4 0.1 1.0 0.3 0.8 1.5 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.5 0.3 0.0 1.6 0.3 0.2 0.8 0.2 1.0 0.1 0.1 0.0 0.0 0.7 0.3 0.1 0.4 0.1 0.2 0.4 1.4 0.0 1.2 0.3 0.3 0.5 0.1 0.5 0.3 0.1 0.1 0.0 0.2 0.1 0.2 1.0 0.0 0.8 1.0 0.1 0.0 0.9 1.6 0.4 0.1 0.0 1.1 0.1 0.0 0.0 2.5 0.9 0.4 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.7 2.6 2.5 1.9 5.9 6.5 5.8 1.2 5.5 7.8 3.6 5.7 0.6 0.0 5.4 154.8 0.4 0.4 0.9 4.8 1.2 5.0 1.2 0.8 2.4 1.5 11.7 7.3 27.1 0.3 0.0 0.4 9.8 1.3 130.7 80.5 1.4 0.7 1.2 0.8 258.9 0.5 0.1 0.8 0.0 2.3 0.0 0.7 1.1 0.6 0.1 3.3 175.0 0.6 8.2 1.3 0.0 68.0 1.2 0.7 0.0 32.8 0.0 4.5 0.0 54.8 66.1 0.2 0.1 0.7 0.5 0.7 0.4 5.5 114.0 16.9 0.0 1.6 1.8 83.9 4.3 0.1 0.4 0.3 0.2 1.6 0.3 0.6 KRTAP19-2 KAP19.2 ENSG00000186965 "Keratin associated protein 19-2" Q3LHN2 21 30487043-30487436 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-4 KAP19.4 ENSG00000186967 "Keratin associated protein 19-4" Q3LI73 21 30496824-30497165 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP15-1 KAP15.1 ENSG00000186970 "Keratin associated protein 15-1" Q3LI76 21 30440275-30440945 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP13-4 KAP13.4 ENSG00000186971 "Keratin associated protein 13-4" Q3LI77 21 30430230-30431026 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 60000 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM183A "hCG23177, LOC440585" ENSG00000186973 "Family with sequence similarity 183 member A" A6NL82 1 43145153-43156396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "fallopian tube: 117.9" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 516.6;Late spermatids: 244.5;Respiratory ciliated cells: 1012.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 19.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;hTCEpi: 2.4;NTERA-2: 3.1;SCLC-21H: 2.7;SuSa: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043382, HPA049120" Approved NA NA "HPA043382: AB_2678456, HPA049120: AB_2680640" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (9.56e-2)" "unprognostic (1.42e-3)" "unprognostic (6.79e-2)" "unprognostic (3.79e-2)" "unprognostic (1.44e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-2)" "unprognostic (1.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (4.30e-2)" "unprognostic (1.27e-2)" "unprognostic (7.88e-2)" "unprognostic (1.18e-3)" "unprognostic (1.73e-2)" 0.0 0.0 3.6 0.0 1.3 0.0 1.0 2.0 0.7 2.4 7.7 0.2 0.1 2.1 0.5 1.0 117.9 0.0 0.0 0.8 6.1 0.9 0.1 7.0 0.0 7.5 3.8 0.0 0.2 0.2 0.9 5.6 0.6 3.8 2.0 0.3 0.2 1.4 0.2 0.0 9.8 0.0 0.2 5.3 0.0 0.1 6.9 1.9 0.3 0.0 0.0 0.3 0.5 1.1 2.4 0.3 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.3 0.6 3.5 0.0 0.4 0.2 0.3 0.4 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 1.4 0.6 2.7 0.0 0.0 0.1 0.0 5.2 0.7 0.0 0.5 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 2.0 0.7 0.8 6.1 7.5 3.8 0.0 3.8 5.3 1.9 2.4 0.0 0.0 7.4 0.0 0.0 1.9 14.0 66.1 3.4 0.0 1.4 2.3 0.2 0.0 109.2 3.7 0.0 2.1 0.1 0.4 3.9 0.0 107.7 516.6 3.5 1.3 4.2 0.0 0.0 0.0 0.2 1.2 0.0 5.7 3.8 0.1 0.0 0.0 0.1 0.0 0.0 0.4 54.9 0.0 0.0 244.5 1.8 0.7 3.6 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.7 0.0 3.9 0.0 2.0 1012.8 0.1 0.0 0.0 13.3 7.6 3.5 2.3 2.6 2.1 0.6 0.2 0.5 9.7 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Group enriched" "Detected in many" 8 "Early spermatids: 286.6;Late spermatids: 473.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;RPTEC TERT1: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA003098 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 0.5 0.8 3.2 0.1 1.0 0.0 1.1 0.7 0.8 1.1 5.7 0.4 0.3 1.2 2.1 0.4 7.8 0.6 0.4 1.0 2.5 1.4 0.4 1.2 0.2 2.0 2.5 0.6 1.4 1.2 2.4 2.0 0.2 1.4 0.9 0.2 3.1 0.8 1.2 0.2 0.4 0.2 0.5 2.1 0.1 0.9 24.5 0.9 0.3 3.1 0.2 0.1 0.5 0.4 0.5 0.1 0.3 0.4 0.7 0.6 2.1 0.0 0.5 0.4 0.1 0.2 0.0 0.1 0.0 0.3 0.2 0.8 0.6 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.8 0.5 0.1 0.5 0.1 0.2 0.0 0.0 0.3 1.4 0.0 0.1 0.6 0.4 0.2 0.0 0.0 0.0 1.5 0.3 0.9 0.3 1.4 0.0 0.7 0.3 0.2 0.0 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.0 0.7 0.8 1.0 2.5 2.0 2.5 0.6 1.4 2.1 0.9 0.5 0.2 3.2 1.8 18.9 0.5 0.3 0.9 1.0 2.2 3.0 1.2 1.0 1.7 0.0 2.3 0.0 6.2 0.0 0.0 0.4 0.0 0.9 286.6 21.8 1.5 0.4 0.0 0.0 46.0 0.7 0.1 1.3 1.1 1.9 1.3 1.5 0.4 0.4 0.3 6.7 36.8 0.4 2.0 0.3 0.3 473.7 3.1 0.3 0.0 15.9 0.6 1.7 0.0 15.1 10.2 1.0 0.1 1.5 0.2 0.5 0.1 1.1 20.4 12.5 6.6 1.3 0.8 24.1 4.7 0.8 0.1 0.1 0.1 1.4 0.4 0.3 KRTAP19-5 KAP19.5 ENSG00000186977 "Keratin associated protein 19-5" Q3LI72 21 30501657-30502141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "skin 1: 19.8" "Cell type enriched" "Detected in single" 22 "Syncytiotrophoblasts: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEK 293: 4.3" NA NA 1600000 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 KRTAP23-1 KAP23.1 ENSG00000186980 "Keratin associated protein 23-1" A1A580 21 30348399-30348606 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KANK3 "ANKRD47, FLJ46061" ENSG00000186994 "KN motif and ankyrin repeat domains 3" Q6NY19 19 8322584-8343262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3" "Cancer enhanced" "Detected in all" "testis cancer: 7.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 4 "NK-cells: 1.2;T-cells: 1.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "olfactory bulb: 16.2" HPA051153 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051153: AB_2681365" "unprognostic (1.56e-1)" "unprognostic (1.63e-4)" "unprognostic (1.54e-2)" "unprognostic (8.95e-3)" "unprognostic (1.07e-1)" "unprognostic (2.84e-3)" "unprognostic (1.82e-3)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-2)" "unprognostic (1.34e-2)" "unprognostic (4.77e-1)" "prognostic favorable (1.69e-5)" "unprognostic (5.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.86e-1)" "unprognostic (3.24e-1)" 25.7 7.6 11.6 2.3 8.9 0.6 26.3 8.5 12.3 8.0 5.0 6.2 2.9 10.3 0.7 5.1 11.3 2.5 22.3 7.6 7.9 17.9 4.2 33.6 2.9 11.6 10.5 6.3 3.7 3.9 1.5 7.0 14.7 10.9 7.7 0.5 0.3 4.2 1.8 13.8 6.2 7.3 2.4 8.3 35.7 6.3 2.4 11.4 0.7 15.7 6.1 0.8 8.0 6.9 9.8 0.1 0.6 0.2 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.7 0.2 0.0 2.3 0.0 0.0 0.1 0.5 2.6 0.0 0.7 1.4 0.3 0.3 0.4 0.1 0.2 1.3 0.0 0.8 0.0 0.0 0.0 8.1 0.6 0.0 0.3 0.0 0.4 0.0 0.4 0.5 0.5 0.2 1.4 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.5 0.0 14.8 0.0 1.3 0.3 0.1 5.9 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 1.0 0.0 0.5 0.1 0.5 0.1 0.0 0.1 0.2 0.4 0.2 1.2 0.0 0.0 0.4 0.2 11.6 8.9 8.5 12.3 7.6 7.9 11.6 10.5 6.3 10.9 8.3 11.4 9.8 196.2 6.4 3.2 2.0 0.3 2.5 0.4 0.6 0.6 0.3 1.5 2.5 2.2 0.0 0.8 0.0 4.2 0.4 3.8 0.1 5.9 0.1 6.6 0.5 0.7 83.8 0.0 2.7 0.6 1.8 0.3 6.4 1.5 0.8 0.0 0.2 55.3 1.0 0.5 0.0 0.9 0.0 0.0 1.3 2.1 8.1 0.6 0.9 5.4 18.7 0.0 0.4 12.3 0.5 1.6 0.6 0.1 0.4 0.4 1.0 0.0 0.4 0.7 0.7 19.7 8.3 12.9 6.5 3.6 1.1 1.3 0.3 2.8 4.0 0.1 0.8 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205896-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;lymphoid tissue: 55.2" "Cell type enhanced" "Detected in many" "Astrocytes: 92.1;Granulosa cells: 32.7;Oligodendrocyte precursor cells: 51.8;Theca cells: 151.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 23.1;glioma: 7.8;ovarian cancer: 10.9;thyroid cancer: 7.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HEL: 28.8;NB-4: 102.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 29.3 31.2 4.3 31.6 14.9 2.5 24.6 49.9 5.9 21.5 5.8 5.1 10.1 1.7 1.3 10.5 4.8 1.7 33.5 26.2 14.8 3.4 13.1 7.6 27.3 27.9 31.5 7.1 14.1 12.5 2.1 4.9 26.0 6.1 3.5 0.3 3.7 3.9 0.9 5.4 8.4 2.3 23.4 55.2 7.8 2.3 24.6 4.8 13.3 0.3 2.4 5.0 2.2 29.8 0.0 0.2 4.9 10.5 0.0 0.0 0.7 0.0 0.0 0.4 0.3 5.7 0.7 0.0 4.7 0.1 0.0 0.0 2.5 0.1 0.0 11.5 8.6 28.8 0.1 1.1 0.7 4.1 2.2 0.3 0.2 0.2 0.0 0.0 0.0 6.4 2.5 0.0 0.0 8.0 0.2 102.0 1.1 0.1 0.4 0.0 0.2 11.3 0.0 0.1 13.2 6.3 0.4 0.1 0.2 0.8 4.2 5.4 0.0 0.0 8.0 0.0 0.1 0.5 0.0 0.0 0.0 14.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.2 31.6 24.6 49.9 33.5 26.2 27.3 27.9 31.5 26.0 23.4 24.6 29.8 0.4 0.0 2.5 92.1 0.1 2.8 1.0 0.1 0.0 1.7 5.3 3.9 0.7 4.3 0.6 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.2 10.8 22.6 6.2 0.0 18.5 5.6 1.3 0.1 11.8 0.5 20.0 11.4 32.7 11.4 2.1 0.3 0.0 6.2 0.4 0.0 0.3 5.2 0.5 3.1 0.6 0.0 10.3 0.6 1.1 0.0 51.8 1.0 0.4 0.0 1.9 1.0 1.9 0.1 1.9 0.0 0.4 0.0 17.5 4.0 0.1 1.5 0.0 2.0 0.3 1.1 151.0 0.3 0.4 ACTL7A ENSG00000187003 "Actin like 7A" Q9Y615 9 108862266-108863756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1042 "testis: 232.0" "Group enriched" "Detected in some" 128 "Early spermatids: 1406.2;Late spermatids: 4717.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA021624 Enhanced NA NA "HPA021624: AB_1844549" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1406.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4717.1 20.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 23.8 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP21-1 KAP21.1 ENSG00000187005 "Keratin associated protein 21-1" Q3LI58 21 30755015-30755428 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "bone marrow: 15.9" "Cell type enriched" "Detected in some" 21 "Erythroid cells: 153.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 6.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.3" "Group enriched" "Detected in some" 7 "HEL: 43.0;K-562: 13.0" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.1 0.4 0.8 0.6 1.5 15.9 0.1 1.6 1.2 0.2 0.2 0.1 0.3 0.4 0.1 0.3 0.2 0.4 0.3 0.9 0.3 0.1 0.1 0.2 0.7 1.0 0.6 0.7 0.5 0.4 0.0 0.2 0.3 1.5 0.3 0.1 1.9 2.5 0.0 3.9 2.1 0.3 0.0 0.1 0.6 0.2 0.5 0.6 0.1 0.3 0.0 0.1 0.1 0.1 1.5 0.2 0.0 0.3 0.3 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.3 0.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.2 43.0 1.0 0.2 0.0 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.2 13.0 0.9 0.1 0.2 0.2 0.3 4.0 0.0 0.2 0.3 0.2 0.1 0.0 0.1 0.6 0.4 0.1 0.2 0.1 0.1 0.2 0.6 0.4 0.7 0.2 0.5 0.2 0.4 0.2 0.2 0.6 0.2 0.2 4.3 0.9 2.0 0.6 0.4 0.7 1.0 0.8 0.5 0.1 1.3 0.9 0.8 6.3 1.0 0.6 0.4 0.7 0.6 0.8 1.5 1.6 1.2 0.9 0.3 1.0 0.6 0.7 1.5 0.1 0.6 1.5 0.2 0.0 0.5 1.0 0.6 0.1 0.2 0.0 0.0 0.3 0.1 0.1 1.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.3 1.0 0.0 153.0 5.2 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.1 0.0 4.3 0.0 0.0 0.3 0.3 0.0 0.0 3.0 0.0 3.7 0.0 0.4 0.0 7.1 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 1.2 0.4 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.0 0.1 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 130.2;retina: 118.8;testis: 146.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 13.6;pons: 3.6;thalamus: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 2.6" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 5.8 0.4 2.6 0.9 28.3 9.3 13.6 0.7 30.5 0.3 24.9 91.2 2.4 40.2 34.6 18.8 0.3 0.7 0.5 1.5 62.2 130.2 3.2 0.3 0.7 1.7 0.3 0.4 0.9 27.0 42.5 0.9 3.6 10.0 6.9 118.8 9.5 6.3 0.8 92.5 90.2 0.8 0.3 1.0 2.7 146.5 4.6 1.6 0.4 0.0 1.7 1.3 22.5 0.5 14.1 0.7 0.6 0.1 0.0 0.0 48.9 0.0 0.0 0.2 0.0 29.9 1.5 0.5 6.5 0.0 0.1 32.6 2.3 0.1 0.0 2.0 0.7 0.4 0.7 81.5 0.0 0.6 2.7 0.1 0.6 0.0 0.0 0.0 0.0 1.0 17.6 0.0 0.0 28.2 0.2 1.0 0.6 3.8 12.2 0.0 0.4 10.9 0.2 0.1 21.0 0.7 3.7 160.1 5.0 0.3 53.6 7.4 15.6 0.1 0.8 0.6 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.9 13.6 0.7 0.5 1.5 0.7 1.7 0.3 3.6 0.3 4.6 0.5 0.2 0.0 0.6 0.0 0.8 7.8 2.4 4.5 12.5 5.6 10.7 3.9 1.4 11.5 3.8 9.2 68.8 3.0 0.2 175.5 13.7 0.2 137.5 19.1 0.9 0.8 6.0 8.2 0.2 3.1 0.5 0.3 5.6 12.4 0.0 0.0 3.9 109.4 0.2 0.0 0.2 36.3 8.2 3.2 0.9 461.6 3.7 1.5 0.0 0.0 0.0 272.5 0.0 0.0 0.1 0.1 186.3 2.2 0.0 1.6 512.1 102.2 9.0 72.5 0.0 0.0 0.2 12.3 3.9 17.6 22.7 6.6 1.5 0.0 35.3 2.9 PNLIPRP1 PLRP1 ENSG00000187021 "Pancreatic lipase related protein 1" P54315 10 116590385-116609175 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2341 "pancreas: 10916.9" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 688.3" "Cancer enriched" "Detected in single" 476 "pancreatic cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 340000 "unprognostic (1.21e-1)" "unprognostic (4.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" 1.5 0.2 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.2 2.1 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.0 0.2 0.8 0.2 0.4 0.0 0.0 0.0 4.6 10916.9 0.0 0.5 0.8 0.0 0.4 0.1 0.0 2.7 0.0 0.2 0.4 1.1 0.0 0.0 0.4 1.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 688.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 66.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 PTRH1 "C9orf115, PTH1" ENSG00000187024 "Peptidyl-tRNA hydrolase 1 homolog" Q86Y79 9 127690348-127724873 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 125.4;Theca cells: 460.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021223 Uncertain NA NA "HPA021223: AB_1845798" "unprognostic (6.58e-2)" "unprognostic (7.01e-3)" "unprognostic (3.46e-3)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (3.90e-2)" "unprognostic (1.74e-1)" "unprognostic (6.58e-3)" "unprognostic (8.67e-2)" "unprognostic (4.08e-2)" "unprognostic (5.98e-3)" "unprognostic (5.74e-4)" "unprognostic (1.38e-2)" "unprognostic (1.91e-1)" "unprognostic (1.72e-2)" 14.9 25.7 7.7 5.1 7.0 4.3 15.8 6.1 13.8 11.4 5.0 11.0 4.3 12.8 9.5 10.5 15.2 3.8 16.8 7.8 6.4 25.3 18.2 12.8 3.3 5.9 6.1 7.9 8.4 21.1 7.7 17.9 2.8 6.0 13.7 2.3 2.8 11.6 5.3 20.1 24.8 7.7 3.5 4.5 12.7 14.6 17.5 9.4 4.1 20.2 3.3 2.6 13.0 9.7 7.0 28.4 11.7 2.2 7.5 3.9 5.1 20.3 18.6 5.0 7.0 3.9 5.2 10.1 9.4 24.3 8.0 9.2 31.0 2.4 13.3 2.5 15.4 3.5 4.0 15.4 11.8 11.2 6.3 12.0 4.2 13.1 8.6 8.9 3.5 13.4 14.2 11.8 8.2 7.8 24.4 12.7 7.9 3.5 23.5 52.9 10.0 5.5 22.9 13.2 5.6 11.9 10.7 18.7 23.0 14.4 2.0 20.3 3.0 15.8 9.2 13.9 36.0 11.1 23.5 14.1 7.1 13.2 4.2 11.8 8.5 31.1 14.0 67.5 37.2 69.3 21.7 34.3 68.5 28.0 17.1 24.8 57.0 4.0 28.1 20.1 25.3 37.2 31.6 7.7 7.0 6.1 13.8 7.8 6.4 5.9 6.1 7.9 6.0 4.5 9.4 7.0 17.4 3.2 9.1 2.0 8.6 17.0 41.2 27.4 9.1 28.3 26.5 23.1 0.3 21.5 13.8 47.8 45.9 13.1 13.4 11.2 66.5 60.5 86.6 54.9 25.2 19.7 30.1 10.8 1.3 33.6 23.7 20.1 10.7 25.5 17.2 15.8 18.5 28.1 46.6 16.8 1.0 25.8 32.6 11.3 13.9 18.7 22.1 11.6 16.0 1.0 15.4 22.2 22.6 2.0 1.0 48.1 13.4 94.0 8.8 85.3 14.6 125.4 43.8 59.0 0.0 15.2 17.0 24.6 9.2 14.4 21.2 18.7 16.0 460.9 17.5 34.8 KRTAP21-2 KAP21.2 ENSG00000187026 "Keratin associated protein 21-2" Q3LI59 21 30746794-30747259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Cell type enriched" "Detected in some" 5 "Early spermatids: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HEK 293: 1.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAMD7 DKFZp686E1583 ENSG00000187033 "Sterile alpha motif domain containing 7" Q7Z3H4 3 169911572-169939175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 646 "retina: 135.3" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 47.9;Rod photoreceptor cells: 124.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.27e-3)" "unprognostic (5.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 1.0 0.1 0.0 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.3 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 124.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.2 GPR141 PGR13 ENSG00000187037 "G protein-coupled receptor 141" Q7Z602 7 37683796-37833788 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 28.1" "Cell type enhanced" "Detected in some" "dendritic cells: 8.9;granulocytes: 23.4;Langerhans cells: 8.2;monocytes: 7.5;NK-cells: 13.4;Oligodendrocytes: 14.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 13.0;eosinophil: 9.7;gdT-cell: 5.2;memory CD8 T-cell: 5.1;myeloid DC: 6.6;naive CD8 T-cell: 3.4;neutrophil: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 13.2;HMC-1: 49.7;NB-4: 8.0;NTERA-2: 27.1;THP-1: 8.2;U-937: 21.9" "Not detected" "Not detected" NA NA "unprognostic (4.91e-2)" "unprognostic (3.44e-1)" "unprognostic (3.26e-4)" "unprognostic (4.70e-3)" "unprognostic (8.67e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.51e-2)" "unprognostic (7.93e-3)" "unprognostic (1.44e-1)" "unprognostic (1.51e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-3)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" 1.4 0.4 0.5 4.2 1.5 28.1 0.6 1.3 0.6 1.3 1.6 1.2 0.8 0.7 0.4 1.5 0.5 2.2 0.3 0.3 1.3 0.3 0.7 1.8 1.9 2.4 1.1 0.1 0.1 0.2 0.3 0.1 2.5 2.0 0.4 1.7 0.0 0.3 0.3 0.2 0.9 1.2 1.5 1.6 3.1 0.8 0.8 1.7 1.4 0.3 0.6 1.9 3.8 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 13.2 1.0 0.0 0.0 0.3 49.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 8.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 21.9 0.0 0.0 13.0 9.7 5.2 0.9 0.0 0.0 1.2 5.1 6.6 0.0 0.5 3.4 12.3 0.8 0.1 0.2 0.0 4.3 0.5 1.5 1.3 0.6 0.3 1.3 2.4 1.1 0.1 2.0 1.6 1.7 3.0 0.0 3.2 3.0 0.3 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.1 0.0 0.1 23.4 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 5.4 8.2 1.3 0.0 5.7 0.0 1.9 7.5 0.0 13.4 1.0 14.4 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.6 0.0 0.1 0.3 2.3 0.0 0.0 0.0 TMPRSS6 "FLJ30744, MT2" ENSG00000187045 "Transmembrane serine protease 6" Q8IU80 22 37065436-37109713 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 129.4" "Group enriched" "Detected in some" 11 "Early spermatids: 61.0;Hepatocytes: 99.9;Late spermatids: 143.9" "Group enriched" "Detected in many" 14 "liver cancer: 51.3;thyroid cancer: 14.1" "Region enhanced" "Detected in some" "basal ganglia: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.0;SCLC-21H: 8.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 3.3" NA NA "unprognostic (3.93e-1)" "unprognostic (3.28e-1)" "unprognostic (8.62e-2)" "unprognostic (6.29e-5)" "unprognostic (7.95e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.16e-6)" "unprognostic (2.44e-1)" "unprognostic (3.07e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.58e-2)" "unprognostic (1.15e-7)" "unprognostic (2.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.39e-2)" "unprognostic (3.86e-5)" 0.1 0.1 0.2 0.2 3.6 0.2 0.4 0.1 0.6 0.1 0.0 0.6 2.2 0.1 0.8 0.3 0.5 0.9 0.0 0.2 0.3 0.1 129.4 0.7 0.3 1.9 0.3 0.0 0.1 1.3 0.0 13.1 0.7 0.7 0.2 0.5 0.1 0.0 0.0 0.0 2.3 1.1 0.0 0.1 0.3 3.6 7.8 0.9 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.2 0.1 5.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.9 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.0 8.1 0.3 0.1 0.6 0.0 0.1 0.1 0.0 0.4 0.3 1.0 0.1 0.0 1.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 0.1 0.6 0.2 0.3 1.9 0.3 0.0 0.7 0.1 0.9 0.1 0.0 0.0 0.0 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.6 0.3 0.5 2.8 0.0 0.0 0.0 0.0 0.1 8.8 0.0 0.2 61.0 0.0 0.0 0.3 5.3 8.0 0.1 0.0 2.6 0.0 2.6 0.0 0.0 0.0 2.5 99.9 0.1 0.0 0.1 1.5 0.0 3.2 0.0 143.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.1 0.3 0.3 0.1 0.6 0.0 CYP4A11 "CYP4A2, CYP4AII" ENSG00000187048 "Cytochrome P450 family 4 subfamily A member 11" Q02928 1 46929177-46941484 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 333 "kidney: 220.8;liver: 864.1" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 563.8" "Cancer enriched" "Detected in some" 5 "liver cancer: 73.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.05e-2)" "unprognostic (4.98e-2)" "unprognostic (4.43e-2)" "unprognostic (4.11e-1)" "unprognostic (7.81e-5)" "unprognostic (5.10e-3)" "unprognostic (1.16e-2)" "unprognostic (1.83e-2)" "unprognostic (1.92e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (4.59e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-3)" "unprognostic (1.68e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.6 0.0 1.4 0.0 0.1 1.1 0.1 0.0 0.4 220.8 864.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 32.9 0.0 7.3 0.0 0.0 0.0 0.0 17.6 0.0 0.5 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 563.8 0.0 0.0 0.1 0.0 0.0 7.3 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.1 108.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 TMEM216 "CORS2, HSPC244, JBTS2, MGC13379, MKS2" ENSG00000187049 "Transmembrane protein 216" Q9P0N5 11 61392360-61398863 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 192.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.75e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (9.02e-3)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-2)" "unprognostic (9.66e-2)" "unprognostic (2.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.47e-2)" "unprognostic (8.03e-3)" 11.4 12.6 21.1 8.1 20.9 16.6 19.0 21.0 24.0 16.3 20.9 10.3 8.5 11.7 18.2 10.8 20.6 10.1 8.4 20.5 24.2 12.1 6.5 8.4 13.8 21.1 21.3 20.3 28.5 15.8 11.5 21.0 13.4 20.6 13.3 11.8 11.9 16.0 13.0 4.4 9.7 11.4 10.8 21.1 14.8 11.4 14.9 21.1 12.8 12.8 7.0 16.7 14.1 12.3 20.5 13.9 15.1 23.2 18.6 37.6 18.2 5.6 7.8 11.9 16.9 12.1 24.3 24.4 5.1 25.6 13.0 0.1 18.1 26.1 14.7 19.6 41.2 16.8 9.7 9.3 32.2 21.7 51.8 14.6 16.0 22.7 10.2 20.2 6.1 16.4 1.7 21.7 11.1 10.9 57.9 3.7 84.1 24.8 44.9 34.2 0.6 18.8 16.2 14.5 32.8 10.6 16.9 19.6 11.3 14.4 17.3 12.8 26.4 7.5 0.1 0.6 8.5 0.1 9.1 6.9 7.9 0.2 20.6 8.0 87.2 28.1 192.7 32.5 31.0 30.7 50.5 34.1 32.3 33.9 49.9 36.0 30.5 44.3 68.6 26.1 12.3 42.0 23.6 21.1 20.9 21.0 24.0 20.5 24.2 21.1 21.3 20.3 20.6 21.1 21.1 20.5 11.7 6.4 9.7 11.1 17.8 4.7 17.5 30.8 23.3 4.2 18.8 29.8 2.9 11.5 14.5 1.8 2.1 19.6 11.9 5.1 19.6 14.0 5.7 8.5 15.7 11.3 9.6 12.6 4.0 16.9 20.6 18.5 5.1 5.6 8.8 14.1 12.5 2.0 14.1 5.0 4.1 11.6 14.2 6.2 5.2 2.4 21.1 8.6 7.2 4.7 7.9 25.4 24.7 4.5 2.2 12.5 8.6 13.5 13.9 23.6 8.1 9.2 19.1 5.4 13.1 11.7 9.3 36.5 20.8 19.3 3.4 8.6 16.7 14.5 11.5 14.1 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 97.4 124.0 112.2 43.5 110.2 62.2 95.5 113.7 160.3 73.5 102.7 103.5 43.9 66.0 31.7 95.0 66.2 19.5 110.3 109.1 107.5 123.7 159.8 81.1 48.4 115.4 111.8 100.7 69.5 110.5 47.5 67.0 30.5 113.5 109.0 19.4 24.1 95.2 43.2 105.5 79.7 79.0 19.9 114.3 101.4 102.3 66.3 115.9 40.9 97.5 45.8 34.9 100.8 74.3 113.7 94.8 117.6 54.5 80.4 60.7 39.7 110.8 102.0 87.3 92.5 74.0 131.1 62.1 118.9 107.4 64.5 74.8 73.8 87.8 111.3 32.2 163.8 261.5 110.0 105.5 118.0 88.2 166.8 142.3 60.1 83.1 80.3 96.8 49.4 64.9 87.6 128.0 83.8 61.0 108.0 80.6 164.1 95.1 210.9 209.5 127.3 70.0 182.0 99.7 95.8 121.2 66.9 85.8 137.3 203.1 33.6 98.8 134.8 74.0 77.5 168.8 85.7 141.7 140.3 145.4 188.4 103.3 116.8 183.1 126.8 147.4 187.3 133.0 141.6 123.5 159.7 135.1 140.6 122.4 173.9 129.9 132.8 168.7 128.9 119.4 193.1 165.1 138.3 112.2 110.2 113.7 160.3 109.1 107.5 115.4 111.8 100.7 113.5 114.3 115.9 113.7 113.6 44.8 51.4 13.1 109.5 137.1 94.3 124.3 84.2 98.0 178.6 205.7 73.8 105.8 83.0 97.5 52.1 152.9 114.7 205.5 217.2 174.9 23.6 68.6 69.8 121.0 142.6 83.5 8.7 192.2 231.9 92.0 76.0 81.6 69.8 62.0 116.0 184.8 204.3 35.3 10.9 207.5 130.2 116.4 233.3 40.3 137.0 110.8 108.5 8.4 147.8 139.1 162.7 5.5 18.7 233.5 202.2 126.0 193.3 206.8 274.9 362.2 54.0 103.7 78.9 74.4 100.9 61.6 138.0 87.6 147.9 131.6 115.2 103.1 165.9 132.4 TMPRSS11A "ECRG1, HATL1, HESP" ENSG00000187054 "Transmembrane serine protease 11A" Q6ZMR5 4 67909395-67964140 "Enzymes, Predicted membrane proteins, Transporters" "Cell cycle" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 86.9;lymphoid tissue: 28.7;vagina: 42.0" "Cell type enriched" "Detected in some" 7 "Squamous epithelial cells: 50.7" "Group enriched" "Detected in some" 9 "cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA078316 Enhanced NA NA "HPA078316: " "unprognostic (1.63e-1)" "unprognostic (4.60e-2)" "unprognostic (1.76e-2)" "unprognostic (6.98e-2)" "unprognostic (1.98e-1)" "unprognostic (2.66e-1)" "unprognostic (4.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.36e-2)" "unprognostic (1.05e-1)" "unprognostic (3.50e-1)" "unprognostic (2.33e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.2 9.5 0.0 0.0 0.0 0.0 0.0 86.9 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.4 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.1 0.0 0.0 28.7 0.3 42.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.2 0.2 0.5 0.8 0.7 0.0 1.0 0.1 0.7 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.5 1.2 0.6 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.9 0.0 0.3 0.1 0.1 0.2 50.7 0.0 0.0 0.0 0.0 0.0 7.2 TMEM262 ENSG00000187066 "Transmembrane protein 262" E9PQX1 11 65084979-65089375 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 21.3" "Cell type enriched" "Detected in some" 11 "Early spermatids: 179.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.36e-2)" "unprognostic (2.77e-1)" "unprognostic (1.78e-3)" "unprognostic (1.62e-1)" "unprognostic (1.61e-1)" "unprognostic (1.71e-4)" "unprognostic (1.85e-5)" "unprognostic (3.28e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.19e-3)" "unprognostic (7.18e-3)" "unprognostic (7.13e-9)" "unprognostic (9.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 21.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.3 0.2 0.0 1.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 179.5 0.3 0.2 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 16.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.4 0.2 1.1 1.2 0.5 0.3 0.4 0.5 0.1 0.1 0.1 C3orf70 ENSG00000187068 "Chromosome 3 open reading frame 70" A6NLC5 3 185076838-185153060 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.2;smooth muscle: 14.9" "Cell type enhanced" "Detected in many" "Astrocytes: 45.7;Bipolar cells: 76.8;Melanocytes: 39.2;Oligodendrocyte precursor cells: 143.2;Peritubular cells: 49.7" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 3.9;SCLC-21H: 16.4;SK-BR-3: 7.2;WM-115: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041861 Uncertain Approved Cytosol NA NA Cytosol "HPA041861: AB_10804119" "unprognostic (1.45e-1)" "unprognostic (2.17e-3)" "unprognostic (3.92e-3)" "unprognostic (2.77e-1)" "unprognostic (2.31e-1)" "unprognostic (6.62e-4)" "unprognostic (5.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-1)" "unprognostic (5.98e-3)" "unprognostic (9.91e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.06e-1)" "unprognostic (8.48e-2)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" 2.3 0.9 11.0 2.4 9.1 0.1 1.3 7.8 9.3 2.8 0.7 8.7 2.6 9.9 2.6 5.2 5.3 2.2 1.6 10.3 8.9 0.5 0.3 1.0 0.4 16.1 11.5 7.3 2.3 0.3 2.1 0.8 1.3 11.3 5.2 4.2 3.9 3.1 8.5 0.5 1.3 3.6 14.9 12.0 2.1 2.8 4.0 12.4 0.3 1.1 0.6 0.6 4.9 2.0 16.2 0.0 0.1 1.9 0.0 0.0 0.0 0.1 2.6 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.1 0.0 0.6 2.2 0.1 0.5 0.0 0.3 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.8 2.0 0.1 0.0 3.9 0.0 0.0 0.4 16.4 0.1 0.8 7.2 0.4 0.0 0.4 1.8 0.6 0.0 1.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 11.0 9.1 7.8 9.3 10.3 8.9 16.1 11.5 7.3 11.3 12.0 12.4 16.2 5.1 0.0 0.0 45.7 1.0 4.1 0.3 0.0 0.6 76.8 1.0 0.5 1.6 0.0 0.0 0.0 0.0 10.8 0.0 9.1 0.0 0.1 1.2 0.1 2.3 4.4 1.2 0.0 13.8 0.2 0.6 3.8 0.0 0.1 0.0 3.9 6.8 0.0 4.0 3.3 19.4 8.8 0.0 0.6 0.7 1.5 3.4 0.3 39.2 6.5 0.6 2.5 0.0 143.2 10.1 0.5 2.2 49.7 0.1 0.3 4.6 0.1 0.0 7.3 6.6 1.3 15.4 6.8 12.5 0.2 1.8 0.8 0.2 1.8 6.3 0.3 TEAD1 "AA, TCF13, TEF-1" ENSG00000187079 "TEA domain transcription factor 1" P28347 11 12674421-12944737 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 230.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057339, HPA062471" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA057339: AB_2683413, HPA062471: AB_2684773" "unprognostic (1.00e-1)" "unprognostic (2.53e-2)" "unprognostic (8.84e-2)" "unprognostic (9.93e-3)" "unprognostic (2.05e-2)" "unprognostic (4.50e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" "unprognostic (4.40e-3)" "unprognostic (8.39e-2)" "unprognostic (4.76e-2)" "unprognostic (1.41e-2)" "unprognostic (7.08e-3)" "unprognostic (2.52e-1)" "unprognostic (3.14e-1)" "unprognostic (2.18e-2)" 29.8 12.2 11.8 8.3 11.9 0.0 17.9 10.3 9.4 23.6 28.0 27.6 7.7 26.6 7.2 30.0 19.3 18.7 31.6 14.5 25.3 17.3 13.7 16.0 4.3 16.0 11.2 6.7 22.1 15.3 27.3 14.5 33.6 10.7 19.0 13.1 10.6 10.3 20.3 68.1 12.7 12.0 27.4 14.1 7.4 16.5 8.7 13.5 4.3 17.9 73.2 5.6 34.1 14.8 13.9 62.8 52.1 43.9 58.7 59.9 62.1 65.4 89.2 76.2 71.6 69.7 53.8 54.5 0.4 23.0 120.9 32.3 37.0 53.7 35.9 115.5 0.2 17.6 0.0 107.3 18.1 55.8 0.0 4.7 51.8 18.3 50.4 68.2 58.6 15.2 3.9 26.0 0.2 111.2 13.1 0.1 0.6 17.2 14.5 23.5 0.3 64.8 33.2 48.2 37.2 26.9 31.2 90.9 43.1 59.0 63.8 20.0 4.4 32.0 107.8 76.2 84.9 59.5 8.6 17.3 12.0 41.6 0.2 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 11.9 10.3 9.4 14.5 25.3 16.0 11.2 6.7 10.7 14.1 13.5 13.9 37.9 89.8 21.7 230.8 0.4 99.3 32.2 19.3 39.9 12.9 16.4 20.2 75.0 31.5 33.1 49.7 12.5 24.1 0.2 11.0 1.9 16.6 6.5 80.8 97.4 33.3 46.7 0.0 101.8 12.8 52.4 46.5 18.8 142.9 0.0 57.7 25.7 39.8 3.7 1.7 108.4 13.5 10.2 1.9 16.0 7.2 23.6 1.9 24.9 91.8 0.0 31.2 0.0 121.2 69.7 34.8 8.1 24.0 1.4 69.4 6.7 29.8 53.8 17.5 6.6 73.5 46.7 3.0 22.3 29.9 54.8 12.3 2.0 45.5 10.4 54.6 OR2AK2 OR2AK1P ENSG00000187080 "Olfactory receptor family 2 subfamily AK member 2" 1 247965233-247966386 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.2 0.4 0.3 0.0 0.7 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB106B ENSG00000187082 "Defensin beta 106B" Q8N104 8 7482504-7486400 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 691 "epididymis: 69.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045592 Supported "Secreted in male reproductive system" NA NA "HPA045592: AB_2679378" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLCD1 ENSG00000187091 "Phospholipase C delta 1" P51178 3 38007496-38029642 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 89.5;Theca cells: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009913, HPA020107, HPA021677" Approved Approved Microtubules NA NA Microtubules "CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319" "unprognostic (1.75e-3)" "unprognostic (1.01e-2)" "unprognostic (4.29e-2)" "unprognostic (1.45e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-3)" "unprognostic (1.55e-1)" "unprognostic (7.25e-3)" "unprognostic (3.95e-1)" "unprognostic (1.45e-1)" "unprognostic (2.80e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.25e-11)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (2.93e-1)" "unprognostic (7.88e-2)" 12.5 13.0 12.9 4.6 13.8 4.3 10.7 15.0 15.7 12.8 9.1 15.7 5.0 11.5 4.2 26.4 9.9 5.7 6.6 11.6 20.8 10.0 5.5 11.4 6.7 18.4 15.2 9.0 12.8 6.0 3.9 9.4 3.8 17.1 9.2 10.2 2.9 13.1 8.9 2.9 17.9 8.4 5.7 17.7 7.2 8.4 32.9 16.2 9.2 8.4 4.2 6.7 15.8 19.2 21.2 1.0 2.7 9.4 2.6 25.3 22.2 2.8 2.8 11.1 4.2 6.4 1.0 2.3 0.6 1.4 26.3 2.9 15.0 4.8 3.0 1.3 3.9 1.2 0.5 1.7 4.7 14.7 0.0 1.6 18.0 31.6 12.9 1.7 9.4 8.2 2.2 16.3 1.3 9.6 1.2 2.2 1.1 2.4 5.5 2.7 0.9 1.3 3.6 5.1 5.0 0.1 2.6 0.8 12.4 3.2 3.1 2.7 1.2 4.4 2.5 6.3 6.7 0.1 5.2 2.2 0.6 6.4 0.1 1.3 14.6 2.7 0.2 13.0 3.7 15.2 1.3 16.9 12.8 3.8 0.6 10.1 7.9 9.9 5.9 2.2 2.0 16.6 7.4 12.9 13.8 15.0 15.7 11.6 20.8 18.4 15.2 9.0 17.1 17.7 16.2 21.2 5.2 3.2 7.5 22.9 3.6 2.8 12.4 9.6 8.0 0.9 5.4 6.1 4.7 8.6 7.3 9.2 2.1 1.8 4.2 89.5 3.9 11.4 1.7 3.3 11.3 8.1 4.9 3.6 1.9 3.0 5.1 10.2 6.6 3.8 4.5 3.6 20.0 4.1 4.0 3.3 2.3 28.3 10.2 3.8 14.5 3.6 12.8 4.3 1.8 3.7 3.4 13.3 1.0 7.1 2.2 4.1 34.7 14.3 5.9 13.2 10.0 5.8 6.2 1.7 6.6 5.4 7.2 3.1 3.7 12.6 5.8 0.8 7.4 53.4 11.3 14.7 CCK ENSG00000187094 Cholecystokinin P06307 3 42257825-42266185 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 274.4;choroid plexus: 110.8;intestine: 116.7" "Cell type enhanced" "Detected in many" "Astrocytes: 40.1;Excitatory neurons: 154.8;Fibroblasts: 42.5;Inhibitory neurons: 157.7;Melanocytes: 40.9;Oligodendrocytes: 40.9;Prostatic glandular cells: 63.8" "Group enriched" "Detected in many" 5 "glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "OE19: 236.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 74.4" "HPA045039, HPA069515" Enhanced Supported "Secreted to blood" NA NA 43700000 "HPA045039: , HPA069515: AB_2732135" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (1.40e-3)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.39e-3)" "unprognostic (1.97e-2)" "unprognostic (3.91e-1)" "unprognostic (8.77e-2)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (1.37e-1)" "unprognostic (5.10e-2)" 0.1 0.9 153.7 0.5 200.3 0.0 0.2 104.1 274.4 0.0 110.8 3.5 116.7 0.0 0.0 0.3 0.5 0.0 0.1 174.6 133.7 0.2 0.4 3.4 0.0 135.3 117.3 198.7 0.1 0.4 0.0 18.5 1.2 136.9 19.7 0.1 4.5 0.2 0.2 0.2 0.3 17.1 0.2 110.5 0.0 2.2 2.4 126.0 0.2 0.1 0.0 0.0 0.1 0.1 167.4 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 9.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 236.5 0.1 0.0 0.0 1.1 25.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 153.7 200.3 104.1 274.4 174.6 133.7 135.3 117.3 198.7 136.9 110.5 126.0 167.4 0.4 0.0 0.0 40.1 0.2 5.7 1.3 0.3 0.6 6.8 1.3 1.9 0.3 0.0 0.2 5.5 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 2.5 0.0 0.0 154.8 0.4 0.1 42.5 5.1 0.4 0.0 0.0 1.4 0.0 0.1 0.0 157.7 11.4 2.0 0.3 3.0 0.3 0.0 0.6 40.9 34.7 0.0 36.7 0.0 34.7 40.9 0.7 0.0 0.0 0.0 63.8 0.6 0.1 0.0 3.5 0.0 0.8 6.4 0.1 1.7 0.0 1.3 10.5 0.0 0.0 0.5 8.7 ENTPD5 "CD39L4, NTPDase-5, PCPH" ENSG00000187097 "Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)" O75356 14 73958010-74019399 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 108.2;kidney: 96.1;liver: 265.9" "Cell type enhanced" "Detected in all" "Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0" "Group enriched" "Detected in all" 5 "liver cancer: 18.2;prostate cancer: 39.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 18.3;eosinophil: 9.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 18.3" "Cell line enhanced" "Detected in all" "RT4: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002927 Enhanced "Secreted to blood" NA NA 5900000 "HPA002927: AB_1078744" "unprognostic (4.19e-1)" "unprognostic (9.63e-3)" "unprognostic (3.11e-2)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" "unprognostic (6.01e-2)" "unprognostic (6.20e-2)" "unprognostic (2.55e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.25e-1)" "unprognostic (5.06e-2)" "unprognostic (1.76e-1)" "unprognostic (6.92e-3)" 8.3 7.8 5.3 11.5 7.5 8.1 12.5 7.2 6.4 6.8 6.8 95.5 72.8 6.4 7.8 11.4 5.7 12.2 7.7 5.3 6.4 96.1 265.9 6.6 5.6 7.6 7.7 4.7 6.8 5.0 7.8 5.0 5.6 7.7 38.0 108.2 9.5 10.7 4.4 15.1 8.2 68.9 9.8 7.3 6.0 42.7 8.7 7.1 4.6 6.2 9.2 5.7 17.1 7.2 9.4 9.5 7.8 8.2 15.1 16.5 15.5 9.4 9.6 7.9 6.4 7.1 5.6 10.9 10.6 4.7 12.8 6.0 10.8 8.5 14.1 7.2 8.8 4.0 7.9 5.7 30.9 15.5 4.7 8.8 12.9 14.0 8.7 18.2 8.8 13.1 17.1 8.8 15.4 9.7 13.6 5.4 5.6 2.5 8.5 15.7 6.0 8.0 5.2 11.4 57.1 5.8 6.0 16.6 12.9 9.2 6.4 18.7 4.1 10.8 12.6 12.7 7.5 7.2 10.1 16.9 8.3 8.0 8.8 11.5 18.3 1.2 9.4 2.5 2.3 1.3 1.4 1.3 1.8 1.7 1.5 2.1 2.1 0.1 0.5 1.4 0.9 1.6 1.3 5.3 7.5 7.2 6.4 5.3 6.4 7.6 7.7 4.7 7.7 7.3 7.1 9.4 8.0 16.0 6.7 8.1 4.9 3.7 6.2 8.9 5.2 6.6 15.0 7.9 5.2 10.0 11.3 7.3 4.2 8.2 4.3 209.3 25.4 6.9 19.5 10.0 13.6 7.0 16.2 36.6 5.9 12.9 6.7 7.9 23.0 25.8 1.3 9.6 9.7 134.8 6.2 10.1 8.2 77.1 14.2 9.7 1.9 12.7 2.8 5.2 5.4 11.2 5.4 4.9 8.2 2.0 11.3 9.1 58.4 5.7 3.6 28.5 87.0 63.1 6.4 12.2 13.1 6.0 5.9 27.2 19.1 8.5 3.4 3.3 4.9 10.3 60.9 39.0 MITF "bHLHe32, MI, WS2, WS2A" ENSG00000187098 "Melanocyte inducing transcription factor" O75030 3 69739464-69968336 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Albinism, Cancer-related genes, Deafness, Disease variant, Microphthalmia, Osteopetrosis, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 133.5;Melanocytes: 585.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 240.3" "Cancer enriched" "Detected in all" 4 "melanoma: 39.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 5.2;classical monocyte: 9.4;intermediate monocyte: 3.3;myeloid DC: 6.1;non-classical monocyte: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 6.1;granulocytes: 5.2;monocytes: 9.4" "Cell line enhanced" "Detected in many" "HMC-1: 89.1;SK-MEL-30: 254.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002578, HPA003259" Enhanced NA NA "CAB002578: AB_564111, HPA003259: AB_1079381" "unprognostic (3.29e-1)" "unprognostic (4.26e-2)" "unprognostic (2.98e-2)" "unprognostic (6.04e-2)" "unprognostic (1.03e-1)" "unprognostic (3.25e-1)" "unprognostic (1.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-1)" "unprognostic (5.31e-3)" "unprognostic (3.87e-3)" "unprognostic (1.94e-1)" "prognostic favorable (8.35e-10)" "unprognostic (6.37e-2)" "unprognostic (1.08e-1)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" 10.8 4.4 5.9 3.8 8.4 1.7 10.1 9.1 8.3 51.8 17.7 14.1 2.9 46.6 4.5 9.0 10.4 16.9 31.4 4.9 8.3 20.2 2.2 9.8 3.4 9.1 9.2 2.5 18.9 4.2 16.9 3.8 3.3 9.7 8.5 4.6 1.2 5.1 14.3 51.0 11.0 5.8 46.4 8.6 2.0 9.5 2.3 8.4 2.2 7.7 43.7 1.5 10.7 16.8 12.8 17.2 12.2 1.3 5.1 18.8 0.3 2.0 16.9 9.9 7.8 4.8 6.1 0.8 0.0 4.0 0.3 21.6 8.6 3.7 9.4 8.6 0.0 2.5 37.1 24.5 0.3 4.5 0.8 89.1 15.3 3.9 2.2 8.6 29.1 2.4 0.0 12.3 5.2 5.4 1.2 0.7 1.0 0.7 0.7 8.3 0.1 1.9 7.7 45.2 9.0 0.4 1.9 8.8 3.1 254.1 2.0 0.7 2.3 0.1 3.8 13.3 5.1 3.5 0.6 1.0 0.1 7.7 2.6 9.2 5.2 9.4 0.0 0.0 3.3 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 0.7 1.1 5.9 0.5 0.0 3.1 5.9 8.4 9.1 8.3 4.9 8.3 9.1 9.2 2.5 9.7 8.6 8.4 12.8 4.6 28.9 6.8 34.3 0.2 42.8 3.6 16.7 7.4 1.6 1.8 1.8 109.5 11.5 18.2 14.7 0.0 1.3 0.6 0.4 50.9 14.7 1.6 24.5 94.3 7.4 1.2 8.6 14.7 8.8 1.0 38.3 9.7 71.2 106.8 10.9 4.6 2.1 45.8 6.7 133.5 0.3 12.2 30.8 30.9 3.4 44.4 24.3 585.2 50.6 10.6 1.4 0.0 166.9 240.3 7.7 0.0 50.4 0.4 5.2 0.2 24.3 12.5 0.2 13.1 17.8 22.6 4.0 6.3 7.2 18.9 1.1 3.8 5.5 0.6 7.1 HEATR4 MGC48595 ENSG00000187105 "HEAT repeat containing 4" Q86WZ0 14 73478484-73558947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.6;testis: 11.6" "Cell type enhanced" "Detected in some" "Astrocytes: 27.4;Early spermatids: 85.5;Excitatory neurons: 19.8;Inhibitory neurons: 16.9;Late spermatids: 29.3;Oligodendrocyte precursor cells: 13.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 6.6;pons: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.2;SCLC-21H: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003642, HPA079348" Enhanced Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA003642: AB_1079376, HPA079348: " "unprognostic (5.25e-2)" "unprognostic (2.45e-3)" "unprognostic (2.85e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-2)" "unprognostic (2.60e-2)" "unprognostic (3.50e-1)" "unprognostic (8.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (5.50e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" 0.5 0.5 0.8 0.8 0.2 0.9 0.4 6.6 0.8 0.6 0.0 0.3 1.9 1.0 0.3 0.6 0.6 0.8 0.6 0.9 0.2 0.4 0.9 0.5 1.6 0.2 0.3 0.0 1.0 0.9 0.2 0.5 0.3 2.2 0.4 0.1 3.0 0.8 0.1 1.9 3.6 0.8 0.1 0.0 1.0 0.7 11.6 0.1 0.0 1.0 0.0 0.0 0.3 0.5 0.8 0.7 0.8 0.3 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.2 0.0 2.2 0.2 0.9 0.3 0.2 0.7 0.4 0.4 0.3 0.0 1.1 2.4 0.3 0.8 1.1 1.2 0.5 1.3 0.1 0.4 0.1 0.9 0.7 0.1 0.6 0.2 0.1 0.5 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.2 0.5 0.5 0.3 0.0 0.6 0.5 0.5 0.3 0.3 0.0 0.2 0.2 0.1 0.8 0.2 6.6 0.8 0.9 0.2 0.2 0.3 0.0 2.2 0.0 0.1 0.8 0.2 0.0 1.5 27.4 0.2 0.3 0.5 0.1 0.0 0.8 0.3 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 85.5 0.3 0.3 0.4 0.0 0.0 19.8 0.0 0.2 0.5 0.0 0.9 0.0 0.4 0.0 0.6 0.1 0.0 16.9 0.2 0.0 0.0 1.0 29.3 0.6 0.3 0.0 3.7 0.0 0.6 0.0 13.0 6.8 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.9 0.7 11.1 1.6 0.0 0.9 0.1 0.4 0.1 0.0 0.1 NAP1L1 "MGC23410, MGC8688, NAP1, NAP1L, NRP" ENSG00000187109 "Nucleosome assembly protein 1 like 1" P55209 12 76036585-76084735 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028861 Approved Uncertain Microtubules NA NA 10000000 Microtubules "HPA028861: AB_10603880" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (9.57e-2)" "unprognostic (1.77e-1)" "unprognostic (3.69e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.29e-9)" "unprognostic (1.67e-1)" "unprognostic (1.76e-1)" "unprognostic (1.66e-1)" "unprognostic (5.24e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.14e-13)" "unprognostic (5.59e-2)" "unprognostic (3.07e-2)" "unprognostic (4.81e-2)" "unprognostic (1.15e-1)" 268.9 296.5 265.7 217.5 275.1 340.3 250.5 246.2 273.2 341.8 210.0 210.5 77.4 276.4 173.8 158.2 263.2 219.1 252.6 228.8 271.2 145.8 114.1 323.5 460.1 264.5 258.5 203.3 608.3 138.6 126.5 176.9 203.6 271.2 230.4 124.7 201.5 194.8 213.0 381.3 143.7 176.6 191.9 306.5 280.7 159.8 128.9 278.1 344.6 179.7 146.1 389.9 255.8 246.2 293.7 765.7 575.6 1061.5 673.3 667.4 1066.2 596.5 479.3 655.2 724.9 532.1 633.5 278.5 1791.9 521.0 601.8 305.7 496.1 636.3 763.4 892.0 570.1 627.7 667.6 407.6 646.4 950.1 1075.1 624.2 748.0 810.0 502.4 842.5 1778.1 891.6 640.5 995.1 379.3 1162.6 366.2 1380.9 868.2 1214.7 278.7 529.9 1071.8 1053.2 748.8 640.6 421.8 455.7 654.4 400.9 580.4 1180.9 818.0 860.4 765.8 704.5 561.5 635.1 403.2 687.9 472.7 601.0 1115.1 343.2 552.1 371.0 6.9 114.4 183.5 95.1 350.0 192.7 248.1 218.5 154.4 226.1 205.7 250.8 207.1 28.1 153.6 732.5 165.3 242.4 225.4 265.7 275.1 246.2 273.2 228.8 271.2 264.5 258.5 203.3 271.2 306.5 278.1 293.7 184.6 166.7 227.5 77.4 506.6 459.2 637.5 478.4 352.3 158.1 308.0 327.8 453.8 197.3 271.3 136.1 79.2 523.7 313.5 39.7 238.7 360.5 225.9 333.6 833.9 340.2 247.1 254.9 181.9 281.7 460.0 386.6 66.8 198.3 435.9 345.2 260.9 125.6 428.1 252.4 149.0 160.6 195.3 546.8 738.3 249.5 709.3 644.0 403.8 93.7 839.2 372.8 241.0 92.5 109.3 397.4 61.3 832.8 183.4 601.2 9.7 266.6 341.6 127.0 374.7 457.2 448.4 350.7 159.2 268.7 337.6 417.0 408.4 353.4 182.9 430.0 LILRA5 "CD85, CD85f, ILT11, LILRB7, LIR9" ENSG00000187116 "Leukocyte immunoglobulin like receptor A5" A6NI73 19 54307070-54313166 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.9;lymphoid tissue: 76.9" "Group enriched" "Detected in some" 5 "Kupffer cells: 64.1;Macrophages: 136.1;monocytes: 53.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 128.6;intermediate monocyte: 252.7;neutrophil: 137.2;non-classical monocyte: 311.7" "Group enriched" "Detected in many" 6 "granulocytes: 137.2;monocytes: 311.7" "Cell line enriched" "Detected in single" 31 "RPMI-8226: 4.1" "Secreted to blood" NA NA 670000 "unprognostic (8.52e-2)" "unprognostic (3.61e-1)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "unprognostic (1.57e-2)" "unprognostic (6.56e-2)" "unprognostic (2.90e-1)" "unprognostic (1.86e-1)" "unprognostic (3.11e-1)" "unprognostic (6.61e-3)" "unprognostic (2.01e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (3.61e-2)" "unprognostic (6.51e-3)" "unprognostic (4.68e-2)" "unprognostic (6.21e-2)" 7.1 1.4 0.1 37.3 0.2 43.9 1.9 0.2 0.8 0.6 0.9 1.7 0.0 1.0 0.0 0.9 4.1 1.7 2.5 0.3 0.3 1.7 3.8 22.4 0.5 0.6 0.3 0.0 0.6 1.0 0.0 0.9 1.6 0.6 1.4 1.2 0.0 1.2 0.0 0.7 0.3 2.8 7.0 0.2 76.9 2.1 0.3 0.3 0.4 1.0 0.0 0.4 15.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 128.6 0.5 0.0 252.7 0.3 0.0 0.0 0.0 39.2 0.1 0.0 0.0 137.2 0.3 311.7 20.3 0.1 65.0 0.1 0.2 0.2 0.8 0.3 0.3 0.6 0.3 0.0 0.6 0.2 0.3 0.8 0.1 0.0 8.5 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 3.1 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.1 1.0 0.0 0.0 11.4 0.0 0.4 0.7 6.5 0.0 0.1 0.0 0.0 64.1 14.3 0.0 0.0 136.1 0.0 0.0 53.4 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.4 2.2 0.0 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.1 CMC1 "C3orf68, MGC61571" ENSG00000187118 "C-X9-C motif containing 1" Q7Z7K0 3 28241584-28325142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 418.8;NK-cells: 694.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "NK-cell: 162.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043333 Approved NA NA "HPA043333: AB_10797139" "unprognostic (1.16e-1)" "unprognostic (8.01e-3)" "unprognostic (6.90e-3)" "unprognostic (8.88e-2)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (3.64e-1)" "unprognostic (1.26e-1)" "unprognostic (3.80e-3)" "unprognostic (3.09e-1)" "unprognostic (2.30e-2)" "prognostic favorable (6.81e-4)" "unprognostic (3.54e-1)" "unprognostic (8.12e-2)" "unprognostic (4.55e-1)" "prognostic favorable (5.52e-4)" 13.6 18.9 9.1 4.8 8.6 4.9 11.9 8.7 14.4 10.6 8.9 14.4 7.7 10.2 5.4 12.0 11.5 4.0 32.8 8.5 8.8 23.8 25.0 11.6 4.4 8.9 8.5 8.0 10.5 11.9 5.0 17.0 6.6 9.0 11.5 4.1 3.3 9.3 4.6 25.0 8.3 10.0 3.5 8.3 12.4 14.8 4.2 9.5 4.2 9.7 13.8 3.0 12.3 11.5 9.2 15.2 24.7 6.8 7.1 18.5 18.5 17.4 20.0 6.1 8.5 8.5 7.3 21.0 13.5 24.8 3.3 14.2 7.1 8.7 18.7 5.1 30.4 21.9 14.5 22.1 16.2 19.1 9.3 10.9 9.9 13.8 8.6 10.8 19.2 10.7 34.0 14.2 19.3 6.9 13.7 13.6 25.1 7.9 15.2 27.0 12.7 7.9 11.0 10.9 6.7 6.7 12.5 14.7 9.1 44.9 9.4 18.8 27.4 12.9 9.1 11.2 13.8 13.1 8.9 22.0 19.7 24.1 20.5 19.2 24.2 21.9 17.1 40.2 28.9 57.7 18.4 25.4 69.6 29.9 17.1 18.8 41.9 6.7 162.2 32.9 30.4 27.2 29.4 9.1 8.6 8.7 14.4 8.5 8.8 8.9 8.5 8.0 9.0 8.3 9.5 9.2 51.5 38.5 33.0 26.4 28.3 21.2 38.0 68.6 23.9 16.2 40.0 53.5 202.8 30.0 42.3 31.3 10.4 68.4 418.8 68.2 221.1 61.3 226.4 67.2 38.5 42.1 28.2 128.6 51.5 58.6 42.4 39.4 24.5 42.5 36.7 25.9 50.3 88.7 64.5 3.3 61.2 71.7 67.1 61.7 26.2 31.1 49.4 36.4 30.2 41.2 53.8 37.4 694.1 53.8 63.3 66.1 71.3 39.1 32.7 42.9 56.2 134.4 56.0 25.4 39.5 31.2 71.6 26.3 49.3 28.6 32.8 31.5 222.5 58.2 67.9 42.2 SLIT1 "MEGF4, SLIL1, Slit-1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185959 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 32.2;pituitary gland: 13.6" "Group enriched" "Detected in some" 6 "Early spermatids: 27.0;Excitatory neurons: 96.2;Inhibitory neurons: 34.6;Late spermatids: 25.5;Oligodendrocyte precursor cells: 25.1" "Group enriched" "Detected in many" 4 "glioma: 9.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 23.2;MOLT-4: 81.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" NA NA "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 0.4 0.1 18.3 0.2 30.7 0.2 0.1 0.0 20.4 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.1 32.2 6.6 0.1 0.1 0.2 0.1 6.7 2.5 31.6 0.1 0.6 0.1 13.6 0.0 8.9 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.3 0.3 1.8 9.5 2.4 2.5 0.0 0.1 0.1 0.1 15.0 0.0 0.1 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.3 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 23.2 0.0 0.6 0.0 0.2 81.0 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 4.9 2.1 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 1.7 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.3 30.7 0.0 20.4 32.2 6.6 6.7 2.5 31.6 8.9 0.2 9.5 15.0 0.2 0.0 0.0 6.5 0.5 0.0 0.1 0.0 0.0 3.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 27.0 0.5 0.1 0.1 1.8 0.0 96.2 0.0 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.5 0.0 34.6 0.0 0.0 0.3 0.0 25.5 0.0 0.3 0.0 2.8 0.2 0.1 0.0 25.1 3.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.1 0.2 3.4 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 LYPD6 MGC52057 ENSG00000187123 "LY6/PLAUR domain containing 6" Q86Y78 2 149329985-149474138 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;placenta: 15.9" "Cell type enhanced" "Detected in many" "Astrocytes: 40.8;Early spermatids: 59.7;Inhibitory neurons: 65.9;Late spermatids: 230.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 37.6;fHDF/TERT166: 48.2;HBF TERT88: 25.0;LHCN-M2: 46.2;RT4: 39.9" "Low region specificity" "Detected in all" HPA042805 Enhanced Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA042805: AB_10794159" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (7.23e-3)" "unprognostic (1.64e-2)" "unprognostic (3.25e-1)" "unprognostic (6.49e-3)" "unprognostic (6.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.73e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.14e-3)" "unprognostic (6.75e-2)" "unprognostic (7.33e-4)" "unprognostic (1.39e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.72e-4)" 0.8 0.3 7.4 0.6 4.3 0.0 9.3 4.2 5.2 0.9 1.2 1.5 1.7 2.1 0.1 0.5 1.6 11.2 0.4 4.5 7.1 2.0 0.3 0.2 0.2 6.5 18.2 3.8 0.6 1.9 1.4 0.3 15.9 5.5 1.4 2.5 7.0 0.2 1.4 0.2 0.5 1.5 2.9 5.0 0.6 4.0 6.9 13.3 0.3 0.2 0.1 1.3 2.6 0.4 3.9 0.2 0.0 6.8 37.6 0.0 0.1 0.5 15.0 6.6 18.9 11.7 0.2 3.0 0.0 0.8 48.2 9.1 3.8 5.3 0.1 25.0 0.0 1.7 0.1 9.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 11.0 0.4 0.3 0.0 0.0 0.0 46.2 6.7 0.0 3.6 5.4 3.2 4.3 0.0 20.1 0.0 2.3 39.9 1.5 6.7 10.1 11.2 1.2 12.2 1.5 0.8 0.0 0.4 5.7 0.5 8.2 0.0 0.0 0.0 3.5 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 4.3 4.2 5.2 4.5 7.1 6.5 18.2 3.8 5.5 5.0 13.3 3.9 0.1 0.0 0.0 40.8 0.0 0.1 0.6 1.0 1.2 2.7 11.7 6.6 0.4 10.0 2.0 0.0 0.0 0.0 0.0 0.4 3.9 2.6 59.7 1.7 0.4 0.9 0.0 0.0 0.3 0.9 0.2 1.4 10.7 2.5 0.0 0.7 0.4 0.0 0.3 0.0 65.9 2.8 0.0 0.0 0.0 230.4 3.1 0.0 0.0 1.0 0.0 4.1 0.0 13.6 1.0 4.5 0.4 0.4 0.1 2.1 1.7 0.0 0.8 3.4 0.0 0.1 0.2 1.0 5.2 0.7 0.0 0.3 0.1 0.0 2.0 1.7 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 628.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0" "Cancer enhanced" "Detected in many" "liver cancer: 64.2;lung cancer: 53.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 8 "ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 151.9 14.5 12.8 13.6 13.9 5.8 117.2 14.6 11.6 9.7 7.2 22.0 25.6 6.7 6.6 104.7 11.6 66.3 84.5 9.8 26.9 45.2 628.3 29.1 4.8 21.3 18.5 7.8 15.7 23.5 0.8 9.8 1.7 24.4 17.4 12.3 11.6 74.3 12.6 121.4 33.4 23.6 8.8 18.6 4.1 144.0 13.1 17.5 4.6 47.1 27.6 7.9 71.7 31.5 19.8 0.0 429.6 2.4 426.7 2988.3 358.2 0.2 13.7 95.9 5.4 4.1 8.4 0.5 0.0 6.1 97.7 72.5 3.6 1.6 22.4 2.5 0.1 0.2 12.6 65.6 5415.7 30.0 1.8 0.0 183.9 27.3 44.2 26.7 0.4 10.2 2.9 95.8 0.4 74.7 2.4 0.1 0.4 1.2 2297.1 1.5 0.1 0.8 4.2 24.3 81.4 0.4 1.7 23.8 0.7 0.8 1.3 0.5 7.8 85.3 36.0 2.3 97.6 4.5 1.6 0.5 0.3 129.3 12.1 0.9 1.5 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.0 0.2 0.1 0.2 12.8 13.9 14.6 11.6 9.8 26.9 21.3 18.5 7.8 24.4 18.6 17.5 19.8 21.6 67.3 34.4 2.0 2.4 21.2 27.8 253.8 262.4 3.1 7.6 1.0 3.2 284.5 144.5 62.5 0.0 0.1 0.2 5.9 13.7 67.0 24.0 3.3 1.7 17.1 1.8 52.6 3.4 328.0 0.1 176.3 139.1 4.6 4.5 0.8 21.0 597.7 0.4 0.0 3.1 6.8 20.3 16.1 15.6 9.9 151.6 3.3 106.7 13.1 4.6 51.5 0.0 4.5 0.5 120.2 3.6 147.4 0.4 41.3 20.2 61.9 72.2 4.5 0.0 16.4 24.3 1.9 1.1 229.3 20.5 0.1 2.1 6.4 20.3 306.0 VSTM2B ENSG00000187135 "V-set and transmembrane domain containing 2B" A6NLU5 19 29526499-29564479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 50.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 31.6;Excitatory neurons: 55.9;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 97.5;Oligodendrocytes: 228.2" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (1.87e-3)" "unprognostic (6.64e-2)" "unprognostic (1.08e-2)" "unprognostic (5.35e-2)" 0.0 0.1 36.0 0.0 36.8 0.0 0.0 20.4 50.1 1.9 4.3 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 39.1 25.9 0.0 0.0 0.0 0.0 32.4 33.5 36.6 0.0 0.0 0.0 0.2 0.0 36.6 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.2 21.6 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 1.7 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 36.0 36.8 20.4 50.1 39.1 25.9 32.4 33.5 36.6 36.6 21.6 25.2 45.1 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 55.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.1 0.0 97.5 228.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD3 "Genesis, HFH2" ENSG00000187140 "Forkhead box D3" Q9UJU5 1 63322567-63325128 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.7" "Cell type enriched" "Detected in some" 5 "Melanocytes: 5.4" "Group enriched" "Detected in some" 6 "melanoma: 9.9;testis cancer: 3.5" "Region enriched" "Detected in single" 5 "medulla oblongata: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 13.1;SK-MEL-30: 11.2;WM-115: 15.7" "Region enriched" "Detected in single" 13 "olfactory bulb: 3.4" "Group enriched" "Detected in some" 13 "olfactory bulb: 8.6;spinal cord: 2.2" CAB022455 Uncertain NA NA "CAB022455: " "unprognostic (1.39e-1)" "unprognostic (3.23e-3)" "unprognostic (2.33e-3)" "unprognostic (4.63e-2)" "unprognostic (7.79e-2)" "unprognostic (8.22e-2)" "unprognostic (3.83e-2)" "unprognostic (1.29e-1)" "unprognostic (9.92e-2)" "unprognostic (3.28e-1)" "unprognostic (3.00e-2)" "unprognostic (8.56e-2)" "unprognostic (5.83e-2)" 0.3 0.3 0.3 0.2 0.1 0.0 0.3 0.0 0.0 1.4 0.0 3.7 0.2 0.2 0.0 0.4 0.4 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 1.4 0.2 0.0 0.4 0.5 1.4 0.5 1.3 0.1 0.2 0.0 1.1 1.5 0.2 0.0 0.2 0.2 0.0 1.5 1.5 0.3 0.1 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.3 0.0 0.0 13.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.7 0.0 11.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 1.0 0.3 0.2 0.3 0.0 0.0 0.0 0.2 0.0 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 7.7" "Group enriched" "Detected in some" 8 "Early spermatids: 40.4;Late spermatids: 44.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.7" "Cell line enriched" "Detected in single" 7 "Hep G2: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA032080 Approved Vesicles,Cytosol No NA "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.1 0.3 0.0 0.3 0.6 0.0 1.6 0.6 0.0 0.6 0.0 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.9 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.1 7.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 5.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.0 1.7 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.1 0.6 0.2 0.1 0.1 0.2 0.1 0.3 0.3 1.6 0.6 0.4 0.1 0.2 0.1 0.3 0.7 0.0 0.1 0.3 0.1 0.0 1.1 1.0 0.4 0.3 0.3 0.0 0.6 1.5 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.0 40.4 0.3 0.9 0.3 0.0 0.0 1.6 0.2 0.3 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.1 5.0 1.4 0.0 0.0 0.6 0.4 44.6 0.3 0.3 0.0 0.0 0.1 0.7 0.0 1.0 1.3 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 1.2 0.0 0.9 0.3 1.2 0.4 0.4 0.4 0.3 0.3 0.1 0.3 0.2 RNF220 "C1orf164, FLJ10597" ENSG00000187147 "Ring finger protein 220" Q5VTB9 1 44405194-44651724 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 118.6" "Cell type enriched" "Detected in all" 7 "Oligodendrocytes: 2136.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-937: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027577, HPA027578" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA027577: AB_2672339, HPA027578: AB_10601482" "unprognostic (3.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-2)" "unprognostic (2.56e-1)" "unprognostic (2.94e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.13e-1)" "unprognostic (2.14e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.51e-2)" "unprognostic (1.98e-1)" "unprognostic (1.37e-3)" "unprognostic (6.46e-2)" 7.5 6.0 35.7 7.4 59.3 10.9 6.9 44.1 50.2 7.4 1.3 8.4 7.9 9.0 5.9 6.7 8.2 2.9 8.3 31.6 41.8 6.6 5.3 5.7 6.0 58.4 51.4 18.5 7.6 7.1 5.8 7.1 6.2 69.8 6.0 3.9 7.5 7.4 4.6 24.5 8.4 7.7 5.5 45.9 6.9 6.7 8.2 67.1 7.1 6.3 10.2 5.9 7.1 7.0 118.6 11.6 5.4 22.9 7.8 8.7 7.9 17.1 13.4 12.3 10.1 14.9 9.3 11.2 22.3 11.6 10.8 14.4 7.5 25.8 11.0 13.7 28.0 22.9 30.9 17.9 16.3 14.1 22.0 15.2 8.7 24.7 11.3 17.9 8.4 5.9 11.6 23.1 10.7 6.3 8.1 21.8 16.7 24.9 12.6 12.2 18.3 13.5 15.9 6.5 7.1 10.3 12.7 11.4 7.8 17.4 7.9 5.8 38.1 9.1 10.7 11.4 10.2 25.1 24.4 25.2 16.0 8.7 69.5 6.5 0.9 0.8 1.2 1.2 0.7 0.9 0.8 0.3 1.6 1.3 1.2 0.7 0.6 0.6 0.8 0.5 2.5 1.3 0.6 35.7 59.3 44.1 50.2 31.6 41.8 58.4 51.4 18.5 69.8 45.9 67.1 118.6 16.2 9.6 13.4 66.3 26.9 15.2 13.4 13.2 30.1 25.1 24.7 20.8 22.0 25.8 10.4 23.9 25.0 17.3 33.7 29.0 17.6 17.9 13.1 23.4 20.7 17.2 18.0 41.9 21.9 28.7 24.5 16.7 19.4 20.5 10.8 18.8 17.9 31.4 25.7 23.5 12.9 24.3 22.4 29.3 9.8 16.2 19.3 21.3 12.4 298.9 23.9 19.2 15.5 7.1 2136.9 25.3 20.9 13.9 26.1 22.5 26.5 35.6 8.2 18.3 6.6 23.5 14.8 30.6 31.3 25.1 17.5 10.1 26.1 17.6 26.7 20.5 ANGPTL5 ENSG00000187151 "Angiopoietin like 5" Q86XS5 11 101890674-101916522 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 5.6;ovary: 22.6" "Cell type enhanced" "Detected in some" "Fibroblasts: 19.4;Langerhans cells: 11.3;Leydig cells: 27.7;Melanocytes: 7.2;Peritubular cells: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "ASC diff: 2.7" "Region enhanced" "Detected in some" "spinal cord: 3.3" HPA038516 Uncertain "Secreted in other tissues" NA NA "HPA038516: AB_10672749" "unprognostic (8.28e-3)" "unprognostic (3.08e-2)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (3.23e-2)" "unprognostic (2.18e-1)" "unprognostic (4.88e-2)" "unprognostic (6.74e-4)" "unprognostic (1.96e-1)" "unprognostic (1.53e-8)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-3)" 2.7 0.2 0.2 0.0 0.2 0.0 5.6 0.3 0.4 0.2 0.5 0.3 0.1 0.0 4.4 0.2 0.3 0.2 2.1 0.2 0.2 0.0 0.0 0.9 0.1 0.2 0.2 0.2 22.6 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.1 0.4 0.2 0.4 2.3 0.2 0.0 0.3 0.0 0.1 1.6 0.1 0.0 0.7 1.9 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 2.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.5 0.0 0.0 0.3 0.0 6.2 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.9 0.6 0.8 0.0 0.0 2.7 0.0 0.1 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 11.3 0.8 27.7 0.1 7.2 4.7 0.0 0.2 0.0 1.0 0.2 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.2 1.0 0.2 0.2 0.0 5.5 0.1 0.5 5.7 0.0 0.0 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881477-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 116.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9" "Group enriched" "Detected in many" 42 "dendritic cells: 19.3;monocytes: 19.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 1.9 4.0 73.2 4.5 88.1 0.7 5.0 42.6 58.1 2.9 11.7 4.3 4.2 2.4 4.7 3.1 2.9 3.9 1.3 45.9 53.7 4.8 7.7 6.3 2.9 79.6 70.6 27.3 3.9 12.3 8.1 6.2 3.2 110.0 4.2 5.3 10.6 6.7 1.4 0.3 5.6 4.9 2.1 51.9 4.5 5.7 6.5 78.3 2.7 7.6 0.8 2.3 2.2 2.1 116.8 24.2 13.4 1.3 2.8 0.0 0.0 12.8 2.0 5.3 4.0 7.6 15.1 15.5 0.0 4.0 7.4 11.8 12.2 10.6 8.9 4.1 0.0 11.0 0.0 14.5 8.9 1.7 4.3 3.7 0.5 7.5 4.0 7.5 10.3 9.7 6.4 6.7 0.1 2.8 9.6 0.0 0.1 5.0 4.8 8.9 0.0 17.5 5.4 10.3 3.3 14.5 5.7 16.0 23.3 13.8 15.7 18.4 3.8 17.0 1.4 9.4 0.1 11.7 2.4 0.1 0.0 7.1 0.0 7.2 0.0 19.7 0.2 0.0 12.9 0.0 0.0 0.1 0.0 19.3 0.0 0.1 0.0 0.4 0.0 6.6 12.9 0.4 5.6 73.2 88.1 42.6 58.1 45.9 53.7 79.6 70.6 27.3 110.0 51.9 78.3 116.8 1.4 76.9 35.7 0.0 2.0 0.0 18.9 0.0 15.4 92.3 31.8 15.9 4.9 35.8 23.5 23.9 62.6 42.1 24.7 10.6 21.5 46.4 7.5 43.4 10.6 5.1 17.0 1.7 0.0 53.2 30.9 11.2 36.7 81.1 2.5 23.6 1.8 50.5 37.3 48.8 0.0 15.5 0.0 83.6 0.0 11.7 11.1 77.2 0.0 0.0 90.3 13.8 1.0 0.0 0.0 46.2 42.5 5.3 0.8 25.2 21.2 58.4 18.2 59.4 13.1 18.2 5.0 22.0 39.6 20.5 0.0 20.0 3.1 28.4 15.7 15.4 H1-7 "H1FNT, H1T2, HANP1" ENSG00000187166 "H1.7 linker histone" Q75WM6 12 48328980-48330279 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 218.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA046204 Approved NA NA "HPA046204: AB_2679586" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "unprognostic (1.95e-1)" "unprognostic (1.50e-3)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-5)" "unprognostic (1.91e-1)" "unprognostic (7.68e-4)" "unprognostic (3.41e-1)" "unprognostic (2.87e-2)" "unprognostic (5.79e-3)" "unprognostic (9.84e-2)" 0.1 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.3 0.3 0.0 0.4 0.1 0.0 0.5 0.1 0.3 0.0 0.0 0.3 0.1 218.8 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE4A "LEP8, SPRL4A" ENSG00000187170 "Late cornified envelope 4A" Q5TA78 1 152708160-152709491 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "skin 1: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE2A LEP9 ENSG00000187173 "Late cornified envelope 2A" Q5TA79 1 152698345-152699442 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 119.1" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.8" "Cancer enriched" "Detected in some" 5 "melanoma: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.6;SK-MEL-30: 2.0;U-2197: 1.4" NA NA "unprognostic (3.45e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 119.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.9 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 KRTAP12-1 "KAP12.1, KRTAP12.1" ENSG00000187175 "Keratin associated protein 12-1" P59990 21 44681576-44682163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "skin 1: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.04e-1)" 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE2C LEP11 ENSG00000187180 "Late cornified envelope 2C" Q5TA81 1 152675295-152676574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 255.1" "Cell type enriched" "Detected in single" 35 "Suprabasal keratinocytes: 14.2" "Cancer enriched" "Detected in some" 5 "melanoma: 9.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.47e-2)" "unprognostic (7.00e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 255.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 AL162231.1 ENSG00000187186 "Uncharacterized LOC730098" 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 294.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 24.5;Breast myoepithelial cells: 36.4;Collecting duct cells: 36.8;Distal tubular cells: 25.4;Proximal tubular cells: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 18.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 51.4" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: AB_2686161" "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 5.9 9.9 41.3 2.9 44.6 2.6 7.9 41.7 76.7 8.5 35.3 7.7 3.9 10.5 19.5 2.4 8.4 2.8 27.7 43.4 42.7 11.2 6.8 5.1 1.9 41.8 40.4 40.8 14.1 8.9 6.5 61.1 3.1 42.5 11.8 1.4 6.5 7.4 2.6 37.0 4.6 4.4 2.4 40.1 2.7 6.3 294.7 43.0 2.2 13.7 22.4 0.7 8.1 5.9 42.9 0.6 10.1 9.1 11.9 7.4 3.6 8.2 8.0 2.4 4.9 5.7 1.7 4.0 0.0 1.0 5.4 9.8 2.5 5.9 2.8 0.9 22.1 1.1 0.0 51.4 3.0 1.8 4.5 7.4 3.9 3.1 3.0 3.0 6.8 1.4 12.3 5.5 12.3 3.7 0.0 1.0 4.5 7.7 9.1 2.6 0.0 8.7 1.6 9.3 0.0 9.4 15.2 5.5 1.8 14.0 5.1 4.6 12.5 1.8 17.3 24.0 5.5 1.9 13.1 4.7 1.9 21.4 2.5 24.3 18.2 2.4 2.6 1.8 1.4 1.6 4.4 2.1 0.9 0.8 1.3 2.6 1.3 3.4 4.1 0.8 11.7 2.1 1.3 41.3 44.6 41.7 76.7 43.4 42.7 41.8 40.4 40.8 42.5 40.1 43.0 42.9 1.6 9.6 7.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 24.5 36.4 0.0 0.0 2.5 36.8 0.0 13.7 0.4 0.0 25.4 16.2 0.0 7.3 10.4 0.7 0.0 0.0 0.0 10.7 12.1 6.6 0.0 6.0 2.5 5.4 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 37.1 3.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 7.1 1.0 4.0 0.0 0.0 ZNF546 "MGC43537, ZNF49" ENSG00000187187 "Zinc finger protein 546" Q86UE3 19 39984134-40021038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Oligodendrocytes: 20.1;Spermatocytes: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030838 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030838: AB_10603332" "unprognostic (4.38e-6)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-2)" "unprognostic (6.10e-2)" "unprognostic (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (1.73e-2)" "unprognostic (8.20e-3)" "unprognostic (4.99e-2)" "unprognostic (2.03e-3)" "unprognostic (2.70e-1)" "unprognostic (5.69e-3)" "unprognostic (2.23e-1)" "unprognostic (6.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.58e-5)" 1.8 2.8 1.3 0.7 1.7 0.5 1.9 1.7 1.5 2.2 1.4 1.8 0.4 1.7 0.9 1.0 2.2 0.5 2.3 1.2 0.8 1.9 3.7 1.3 0.9 1.3 1.1 1.0 3.0 1.9 1.2 2.8 0.8 1.4 2.1 0.6 2.4 1.4 1.1 2.5 1.0 1.8 1.4 0.9 3.2 1.5 13.7 1.2 1.0 2.4 1.4 1.1 2.1 1.7 2.7 0.1 2.2 0.8 1.2 1.9 1.1 0.1 0.8 1.2 0.8 1.3 0.1 0.3 1.1 0.9 0.6 0.3 0.0 0.4 0.1 1.3 1.0 1.5 1.4 1.7 0.7 1.0 1.5 0.9 1.1 0.4 0.5 1.3 1.1 1.2 2.0 1.7 2.9 1.0 0.3 0.5 0.3 0.2 0.1 0.2 0.7 0.8 0.5 0.5 0.2 0.5 0.7 0.5 0.0 0.5 0.8 0.3 0.7 0.5 0.3 0.6 0.1 0.5 1.9 2.2 0.2 0.6 0.5 0.4 0.7 0.4 0.8 1.0 0.7 0.7 0.8 0.7 0.6 0.8 0.6 1.3 1.2 0.3 0.8 0.3 0.2 0.9 0.3 1.3 1.7 1.7 1.5 1.2 0.8 1.3 1.1 1.0 1.4 0.9 1.2 2.7 3.1 0.0 4.6 7.8 3.9 0.5 1.0 0.8 2.8 8.4 2.4 1.9 6.8 2.8 1.1 3.7 12.5 1.4 4.1 0.6 1.9 1.4 36.0 2.5 4.5 4.0 0.0 1.7 9.9 0.4 0.2 4.9 0.5 1.5 0.0 6.3 4.6 3.0 1.8 1.7 11.7 0.5 2.0 1.9 0.5 7.4 4.4 2.0 0.0 8.4 1.5 4.8 3.1 8.5 20.1 0.3 0.4 4.1 1.9 0.8 2.4 3.5 4.1 7.9 0.0 6.2 2.6 57.8 5.4 1.0 0.0 0.3 2.3 4.8 0.6 0.7 TSPYL4 "dJ486I3.2, KIAA0721" ENSG00000187189 "TSPY like 4" Q9UJ04 6 116249964-116254075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 95.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044863 Approved NA Yes "HPA044863: AB_10962578" "unprognostic (5.10e-2)" "unprognostic (2.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.65e-3)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-1)" "unprognostic (7.41e-3)" "prognostic favorable (8.46e-5)" "unprognostic (1.30e-1)" "prognostic favorable (5.13e-7)" "unprognostic (3.34e-3)" "unprognostic (2.57e-1)" "unprognostic (3.61e-1)" "unprognostic (5.38e-2)" 8.1 35.7 56.6 7.6 67.1 10.5 14.1 61.7 95.6 15.9 21.6 10.6 5.8 21.7 18.2 11.7 21.2 10.7 20.5 61.2 80.2 15.0 9.1 10.3 10.4 49.4 52.9 58.4 25.6 12.3 28.9 28.6 10.8 53.7 22.6 8.1 30.4 9.7 18.7 5.1 10.5 9.4 15.5 45.6 11.0 15.4 14.9 66.7 17.9 14.5 7.9 9.3 11.9 12.0 78.4 6.2 3.4 47.6 39.7 19.2 16.4 8.9 24.3 16.4 30.6 18.2 9.6 5.9 5.0 9.0 37.5 16.1 13.6 20.7 21.6 45.8 20.7 7.0 10.1 18.8 22.7 15.1 19.1 6.4 16.0 10.0 23.7 12.0 23.9 21.0 28.0 15.7 16.4 25.7 19.2 36.9 11.7 11.5 2.1 8.1 20.9 2.6 4.9 9.2 9.0 55.9 37.6 21.6 9.0 4.3 16.9 16.3 10.5 24.4 25.4 21.3 14.6 14.1 6.6 8.2 0.8 11.7 12.5 16.2 0.5 2.1 2.5 3.2 1.8 3.8 2.4 3.9 3.3 1.9 3.0 4.1 3.1 2.8 3.8 2.8 3.1 3.6 4.0 56.6 67.1 61.7 95.6 61.2 80.2 49.4 52.9 58.4 53.7 45.6 66.7 78.4 7.0 3.2 7.7 11.8 9.2 4.8 11.9 4.9 30.1 21.4 11.8 13.2 44.2 11.5 7.2 11.0 20.9 3.3 13.0 3.2 19.6 5.4 20.3 30.8 31.9 11.5 31.7 6.1 16.2 7.4 2.0 13.3 8.6 25.8 11.4 27.5 11.7 3.7 3.6 40.4 16.8 5.8 6.1 6.8 3.5 6.7 10.2 8.8 5.4 7.5 5.9 20.7 6.2 4.5 8.5 7.1 2.5 10.9 7.3 7.0 0.7 6.4 27.5 28.7 0.0 14.8 16.8 20.1 3.6 14.1 5.3 3.4 11.9 18.9 4.5 8.0 DAZ3 ENSG00000187191 "Deleted in azoospermia 3" Q9NR90 Y 24763069-24813492 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047113 Approved NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MT1X "MT-1l, MT1" ENSG00000187193 "Metallothionein 1X" P80297 16 56682470-56684196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 4064.1;skeletal muscle: 6149.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 12792.4;Proximal tubular cells: 14889.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 1069.7;HBEC3-KT: 1964.6;NTERA-2: 670.6;U-87 MG: 720.2" NA NA "unprognostic (8.15e-2)" "unprognostic (9.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.18e-3)" "unprognostic (7.05e-3)" "unprognostic (7.26e-3)" "unprognostic (9.49e-3)" "unprognostic (9.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.40e-2)" "unprognostic (4.85e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-10)" "unprognostic (1.56e-1)" "unprognostic (4.25e-2)" "unprognostic (4.11e-1)" "unprognostic (1.37e-3)" 1271.9 169.9 467.8 106.0 554.0 28.5 1092.0 555.5 591.9 379.9 365.1 308.4 108.8 127.7 99.5 1053.6 383.1 97.3 363.7 434.5 571.1 806.3 4064.1 561.8 45.2 532.6 529.8 423.2 187.9 1612.1 32.2 252.9 16.2 567.4 509.4 211.1 76.4 589.6 52.1 6149.4 1761.6 216.6 128.0 487.1 43.4 677.3 59.1 562.3 83.1 1034.5 2164.8 117.2 215.5 919.4 509.9 45.0 47.9 1.9 95.2 1069.7 237.5 37.1 142.3 91.7 39.2 43.8 9.0 41.0 35.4 36.6 35.1 47.6 397.4 131.4 1964.6 46.4 135.0 80.7 46.3 26.7 16.4 152.4 298.1 105.2 238.8 375.9 94.7 98.4 35.8 9.1 34.4 8.0 13.1 135.1 124.5 60.9 317.6 670.6 2.8 314.3 62.9 5.5 90.8 394.0 5.7 95.6 33.3 429.1 107.6 30.7 35.1 12.4 75.0 21.0 81.3 97.5 82.4 99.3 14.3 12.3 14.8 720.2 488.8 48.0 73.1 58.0 19.1 75.3 26.9 86.1 15.6 83.5 94.4 58.5 11.7 78.9 98.4 3.1 24.8 11.7 20.1 90.1 52.3 467.8 554.0 555.5 591.9 434.5 571.1 532.6 529.8 423.2 567.4 487.1 562.3 509.9 1563.0 67.3 22.1 47.7 116.0 1747.7 967.7 2932.2 1361.9 0.0 367.7 963.0 158.0 290.2 957.0 581.2 0.0 8.7 162.5 1163.7 2111.0 120.5 2.8 784.0 199.0 256.6 143.9 320.4 2.2 100.3 642.6 621.1 481.2 1883.3 38.7 133.1 307.3 12792.4 67.1 0.0 0.8 1150.7 321.4 327.1 150.8 12.6 495.5 382.8 241.9 4.7 66.7 0.0 41.2 7.5 1.4 174.4 2750.0 118.1 162.8 956.5 3283.6 14889.1 180.0 0.0 72.3 2927.3 670.4 1.6 2.7 1963.3 2398.1 68.4 196.6 77.2 1288.2 265.7 GCNT1 "C2GNT, NACGT2, NAGCT2" ENSG00000187210 "Glucosaminyl (N-acetyl) transferase 1" Q02742 9 76419850-76651203 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 50.4;parathyroid gland: 84.7;stomach 1: 39.3;thyroid gland: 21.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 93.8;Kupffer cells: 42.2;Proximal enterocytes: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 21.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 46.2;HSkMC: 39.4;U-2197: 33.9" "Group enriched" "Detected in all" 6 "cerebellum: 7.6;olfactory bulb: 24.9" "Low region specificity" "Detected in all" "HPA003522, HPA003523, HPA031151" Uncertain Supported "Nuclear speckles" NA NA 84000 "Nuclear speckles" "HPA003522: , HPA003523: , HPA031151: AB_10602904" "unprognostic (3.14e-1)" "unprognostic (2.01e-1)" "unprognostic (2.19e-1)" "prognostic favorable (8.44e-4)" "unprognostic (5.53e-2)" "unprognostic (2.41e-1)" "unprognostic (1.65e-2)" "unprognostic (3.37e-2)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.90e-1)" "unprognostic (3.06e-1)" "unprognostic (3.02e-3)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.96e-4)" 2.8 0.8 1.5 5.1 2.3 5.1 4.7 4.9 1.9 10.7 2.0 8.8 50.4 5.9 0.7 1.8 1.5 2.9 1.1 1.9 1.5 0.9 1.9 4.2 6.7 1.1 1.1 1.3 0.7 2.1 84.7 0.9 2.9 1.7 6.3 9.4 0.1 3.8 1.3 0.3 1.1 32.5 4.8 0.9 7.4 39.3 1.6 1.4 3.0 21.7 0.7 4.8 2.2 0.8 1.5 4.7 0.4 0.3 0.1 5.5 26.5 6.7 18.8 8.4 15.0 10.5 4.7 1.1 3.3 1.8 14.1 2.9 4.0 9.5 7.8 16.6 2.3 1.6 8.2 0.4 0.8 46.2 6.0 2.7 39.4 2.0 14.5 15.5 12.2 13.9 4.1 0.0 3.2 15.1 7.1 3.2 9.7 8.8 11.9 1.1 5.3 9.3 1.6 17.5 8.3 2.0 0.0 2.3 2.5 0.1 6.6 0.0 4.1 5.6 9.3 5.9 33.9 8.4 4.7 0.9 0.0 18.7 10.1 2.3 6.1 3.2 21.6 1.5 7.8 0.5 1.9 1.7 1.5 5.8 10.2 0.3 1.1 1.1 5.8 7.3 2.8 2.5 2.1 1.5 2.3 4.9 1.9 1.9 1.5 1.1 1.1 1.3 1.7 0.9 1.4 1.5 2.9 0.0 1.7 2.0 8.3 0.9 5.0 34.4 0.6 0.0 8.8 4.2 1.0 0.0 15.6 3.7 0.0 2.1 10.7 16.6 0.0 1.0 20.1 15.1 4.2 5.1 27.6 17.9 11.8 24.3 27.1 3.4 93.8 24.6 10.8 0.6 6.4 0.3 8.1 0.0 1.7 21.3 16.2 42.2 8.5 12.9 0.0 18.6 1.8 15.0 6.7 0.1 8.2 0.5 0.8 12.9 14.5 1.2 2.2 6.8 40.7 1.4 17.0 0.4 0.0 0.9 1.8 1.8 3.3 1.0 0.3 19.0 10.6 0.2 38.4 1.5 LCE2D "LEP12, SPRL1A" ENSG00000187223 "Late cornified envelope 2D" Q5TA82 1 152663380-152664659 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "skin 1: 121.9" "Group enriched" "Detected in some" 8 "Melanocytes: 1.8;Suprabasal keratinocytes: 4.7" "Group enriched" "Detected in some" 42 "head and neck cancer: 1.2;melanoma: 4.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.94e-2)" "unprognostic (5.63e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 121.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 SESTD1 "DKFZp434O0515, Solo" ENSG00000187231 "SEC14 and spectrin domain containing 1" Q86VW0 2 179101678-179264832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 175.5;Horizontal cells: 301.2;Oligodendrocytes: 311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058236, HPA077408" Approved Enhanced "Intermediate filaments" NA Yes "Intermediate filaments" "HPA058236: AB_2732619, HPA077408: AB_2732344" "unprognostic (2.76e-1)" "unprognostic (3.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (9.47e-2)" "unprognostic (1.64e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "unprognostic (9.21e-2)" "prognostic favorable (2.78e-11)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.57e-2)" 13.9 2.4 12.4 3.3 17.1 4.7 11.3 12.7 13.8 6.3 4.6 6.1 2.1 5.8 3.9 4.5 4.5 6.4 5.2 9.1 10.9 6.8 3.5 9.3 3.4 15.3 14.8 7.2 4.5 3.4 3.9 3.6 6.9 15.4 4.2 3.9 7.6 11.1 4.6 3.7 4.1 5.4 8.2 17.7 3.5 5.5 9.0 19.3 2.9 3.7 5.8 5.0 10.1 4.8 24.5 0.0 2.1 25.5 4.6 45.2 19.5 13.5 9.0 3.7 3.7 6.3 4.6 6.0 4.5 11.7 8.7 4.5 4.2 11.0 5.1 6.8 3.3 2.9 5.5 11.2 12.3 3.5 3.1 2.3 14.6 2.1 5.7 14.3 8.9 15.2 4.6 0.8 2.3 6.4 3.1 7.2 0.3 6.6 4.7 2.6 10.3 16.8 2.9 10.0 23.2 5.6 9.5 8.0 3.4 2.5 18.7 0.5 3.4 26.7 12.3 6.2 6.3 4.7 1.3 0.0 11.0 6.2 1.2 3.7 0.0 0.9 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.3 1.6 0.0 0.0 0.2 12.4 17.1 12.7 13.8 9.1 10.9 15.3 14.8 7.2 15.4 17.7 19.3 24.5 46.2 109.0 29.9 53.2 30.6 9.8 24.7 19.1 7.4 31.3 30.4 15.6 15.3 28.6 32.9 12.9 18.8 10.7 5.7 11.9 17.6 31.3 9.8 61.3 33.1 32.1 25.0 7.2 110.8 27.7 73.4 65.1 13.7 175.5 0.0 23.1 21.4 9.6 12.3 301.2 147.9 7.3 14.2 28.7 43.4 7.3 12.2 37.2 14.2 89.0 21.9 33.4 5.2 86.5 311.1 33.3 13.3 30.5 4.7 67.7 22.5 39.1 42.8 10.4 19.7 43.7 29.2 34.9 66.0 10.2 10.1 18.1 5.7 9.8 9.7 119.9 LCE3B LEP14 ENSG00000187238 "Late cornified envelope 3B" Q5TA77 1 152613811-152614098 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "lymphoid tissue: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FNBP1 "FBP17, KIAA0554" ENSG00000187239 "Formin binding protein 1" Q96RU3 9 129887187-130043194 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019635, HPA019691, HPA022119, HPA067742" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: " "unprognostic (2.86e-1)" "unprognostic (2.59e-3)" "unprognostic (1.22e-2)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (1.43e-2)" "unprognostic (6.30e-3)" "unprognostic (9.10e-2)" "unprognostic (2.90e-1)" "unprognostic (6.17e-2)" "unprognostic (9.26e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (8.45e-5)" "unprognostic (6.84e-2)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.21e-1)" 20.6 12.0 54.9 58.3 70.2 40.9 16.5 77.3 55.1 31.4 26.6 80.2 15.1 50.4 17.2 39.8 35.1 28.1 15.2 46.2 56.0 16.5 18.6 25.7 78.8 69.1 71.2 38.5 22.3 8.2 10.7 17.9 16.5 74.8 41.8 29.8 12.7 16.4 44.5 24.3 25.8 37.9 47.2 60.3 61.4 29.9 17.5 63.4 112.0 33.6 13.4 74.9 68.9 27.0 88.6 42.5 19.3 34.9 40.8 21.0 25.8 29.5 23.7 20.2 17.6 14.7 20.3 16.2 82.9 20.4 44.5 20.8 20.7 33.0 21.6 17.6 137.7 9.8 22.8 22.8 13.8 35.8 62.3 75.1 18.7 9.3 32.6 19.5 25.6 26.1 143.2 5.4 1.1 16.4 34.0 140.1 60.8 27.5 5.7 32.6 31.9 28.3 24.1 22.1 23.0 5.5 17.6 43.3 42.9 16.5 33.3 30.0 28.3 31.9 16.6 20.7 30.5 15.0 16.4 64.4 3.8 20.0 42.2 25.2 13.2 5.1 9.6 10.8 5.6 9.3 12.7 9.7 10.3 5.8 7.7 8.9 8.6 9.3 6.0 6.5 6.9 10.9 4.5 54.9 70.2 77.3 55.1 46.2 56.0 69.1 71.2 38.5 74.8 60.3 63.4 88.6 27.2 35.3 25.2 317.7 180.4 33.1 21.3 12.8 21.6 20.2 42.5 24.6 14.8 15.7 29.8 22.0 52.1 18.6 217.2 28.3 19.6 22.6 1.7 46.2 38.8 38.3 18.1 31.3 65.6 17.3 24.5 38.8 26.5 78.7 80.4 9.2 71.0 18.4 43.6 28.6 107.8 8.7 20.3 221.2 402.9 5.5 46.6 131.1 76.5 95.5 433.2 42.8 223.5 69.4 522.1 21.8 19.8 51.6 147.9 67.8 0.2 15.0 42.3 29.5 59.2 19.9 41.0 26.5 45.4 26.7 41.1 63.9 233.7 7.1 16.2 42.3 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109410-103479863 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 3.7 3.0 8.6 1.2 5.7 0.3 3.6 6.1 10.3 4.7 13.0 2.6 1.6 4.6 3.8 1.6 6.5 3.3 1.6 4.6 7.6 3.6 0.8 2.8 0.9 8.8 8.4 4.4 5.6 2.9 6.7 6.8 1.4 6.4 2.6 0.7 10.6 2.6 2.5 0.8 2.7 2.1 2.3 7.0 2.0 2.3 8.0 5.4 1.8 4.6 1.5 0.7 3.3 3.0 6.4 1.3 2.7 7.0 3.3 9.5 21.2 0.4 4.0 6.4 6.5 7.0 1.6 1.5 0.0 5.5 8.0 3.1 5.5 5.5 7.7 5.3 0.0 4.6 1.2 4.8 0.2 9.3 2.2 1.3 13.6 2.8 14.9 16.9 10.3 2.7 1.4 0.2 0.0 8.6 5.4 0.7 0.7 1.9 0.0 7.7 0.0 5.9 0.1 7.5 0.9 4.6 3.6 6.5 1.7 3.1 1.7 6.8 1.5 6.4 7.9 3.3 7.7 3.0 0.0 0.0 0.1 2.3 6.7 2.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 8.6 5.7 6.1 10.3 4.6 7.6 8.8 8.4 4.4 6.4 7.0 5.4 6.4 12.7 0.0 13.1 173.7 2.3 6.6 13.4 17.3 9.6 25.9 8.2 9.7 10.1 4.3 18.0 27.6 112.6 0.3 2.1 0.2 1.9 7.0 26.1 124.0 43.7 11.1 17.3 1.3 164.7 3.4 0.5 32.0 5.6 7.5 3.8 15.4 9.3 0.8 2.5 32.0 101.8 1.0 4.1 0.8 5.8 11.1 20.8 3.1 8.8 45.0 0.9 16.5 1.0 86.0 72.6 10.5 2.9 18.4 3.3 4.9 0.9 16.9 171.0 85.1 19.7 40.8 18.5 90.6 11.6 5.0 5.5 0.5 5.0 23.5 1.7 5.9 KRT12 K12 ENSG00000187242 "Keratin 12" Q99456 17 40861303-40867223 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Corneal dystrophy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Distal enterocytes: 3.9;Paneth cells: 12.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055217, HPA055835" Enhanced NA NA "HPA055217: AB_2682742, HPA055835: AB_2682935" "unprognostic (1.89e-1)" "unprognostic (2.40e-2)" "unprognostic (1.01e-1)" "unprognostic (4.82e-1)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.74e-2)" "unprognostic (5.52e-2)" "unprognostic (9.41e-3)" "unprognostic (3.49e-1)" "unprognostic (1.73e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-4)" "unprognostic (6.31e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.8 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MAGED4B ENSG00000187243 "MAGE family member D4B" Q96JG8 X 52061827-52069248 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.8;pituitary gland: 22.4" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 5.1" "Group enriched" "Detected in many" 22 "B-cells: 5.1;dendritic cells: 3.8;T-cells: 3.7" "Cell line enhanced" "Detected in many" "AF22: 49.7;NTERA-2: 40.6;SuSa: 43.0" HPA003554 Approved NA NA "HPA003554: AB_1853497" "unprognostic (7.75e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.01e-6)" "unprognostic (6.45e-2)" 1.6 3.4 23.2 2.3 23.1 0.3 2.8 4.5 16.1 7.6 2.5 5.5 1.9 10.3 1.0 1.3 6.8 3.7 1.0 17.7 45.8 1.3 0.3 1.2 1.1 17.1 13.9 19.2 10.2 3.2 1.4 22.4 3.1 12.9 4.4 1.1 1.8 3.9 2.0 0.2 1.1 3.9 4.7 13.2 1.4 3.1 1.1 31.0 2.4 4.3 0.2 1.0 2.4 4.9 14.6 0.0 2.1 49.7 16.4 13.7 10.3 16.4 28.3 19.8 7.3 14.2 0.0 3.5 0.0 5.6 31.7 17.3 0.0 20.5 0.0 4.2 0.0 3.4 0.0 0.1 24.1 10.9 0.0 6.7 23.7 0.0 15.7 0.5 19.4 14.0 13.4 0.0 0.2 13.0 2.1 5.7 0.0 40.6 0.0 1.4 0.0 29.2 0.0 5.5 0.0 2.1 30.7 0.0 0.0 4.2 43.0 0.0 0.0 1.8 13.6 19.9 0.0 0.0 0.1 0.0 1.1 18.0 0.0 25.0 0.0 0.0 0.0 0.1 0.0 0.3 1.8 1.6 0.8 0.0 5.1 0.0 0.3 0.0 0.1 0.0 3.8 3.7 0.6 23.2 23.1 4.5 16.1 17.7 45.8 17.1 13.9 19.2 12.9 13.2 31.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BCAM "CD239, LU" ENSG00000187244 "Basal cell adhesion molecule (Lutheran blood group)" P50895 19 44809071-44821421 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 318.8" "Cell type enhanced" "Detected in many" "Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 493.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005654 Enhanced Approved "Nucleoli fibrillar center" NA NA 18000000 "Nucleoli fibrillar center" "HPA005654: AB_2667378" "unprognostic (5.63e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.01e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (2.61e-3)" "unprognostic (1.41e-1)" "prognostic favorable (5.94e-6)" "unprognostic (1.83e-2)" "unprognostic (5.74e-2)" "unprognostic (2.14e-2)" "unprognostic (9.97e-3)" 102.1 23.5 22.8 10.0 17.4 3.8 126.7 18.7 39.9 80.0 34.4 32.0 13.6 78.8 21.5 29.4 116.1 15.9 100.7 17.4 24.2 318.8 38.7 89.8 9.8 22.5 18.9 15.8 50.6 52.0 20.2 38.6 44.4 21.0 131.2 5.4 3.1 66.1 49.7 45.1 50.9 31.5 19.8 18.2 36.7 39.6 20.8 22.3 13.9 217.5 31.1 7.1 53.2 72.6 21.9 34.7 44.3 1.2 120.8 0.6 0.8 142.7 13.3 6.3 10.7 7.1 66.8 83.5 0.0 65.7 1.6 0.6 298.4 10.4 74.5 3.2 0.1 7.3 0.2 8.8 93.9 23.6 0.0 15.9 11.6 28.6 3.7 4.4 34.2 6.6 0.0 7.3 0.5 1.6 17.7 0.4 1.2 13.5 10.0 15.1 0.5 14.2 3.6 90.4 21.9 0.4 0.5 54.0 276.8 3.4 13.1 157.2 5.1 17.4 2.7 130.2 3.4 6.5 0.6 1.4 0.1 1.1 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 17.4 18.7 39.9 17.4 24.2 22.5 18.9 15.8 21.0 18.2 22.3 21.9 374.9 6.4 12.3 5.5 4.4 40.7 118.0 454.1 80.2 2.5 109.5 185.4 12.8 52.9 48.5 548.1 0.0 705.4 3.2 8.6 82.2 34.0 1.3 62.9 8.2 214.0 52.0 4.8 0.5 4.0 36.9 21.7 15.8 45.3 0.0 14.3 73.2 31.0 44.7 0.0 1.2 5.6 40.7 8.0 21.3 2.1 29.5 3.5 16.0 9.4 0.1 23.6 0.0 1.0 0.3 14.3 21.4 15.1 2.5 80.4 4.9 149.6 20.7 1.1 157.8 14.1 240.6 3.2 18.3 8.9 24.6 433.3 3.5 6.4 13.0 40.7 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696459-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 349.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 60.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 7.3 6.5 8.2 11.6 9.0 8.3 12.2 18.9 12.2 10.4 10.1 11.4 9.0 12.6 10.4 10.9 9.6 7.4 5.6 8.3 8.6 9.2 11.4 10.6 16.2 8.2 8.9 7.5 14.6 11.3 10.4 7.0 10.0 10.0 10.4 11.8 30.4 9.7 11.5 8.3 7.8 10.5 11.1 8.2 15.1 11.1 26.5 8.3 18.5 16.7 7.7 15.1 9.7 8.3 11.4 15.8 11.9 19.6 34.5 13.4 17.0 9.5 11.5 12.4 16.0 18.2 14.9 27.6 32.4 4.4 12.0 20.2 13.4 26.8 15.0 22.8 17.7 14.4 25.8 18.4 14.7 11.3 32.1 23.3 12.2 10.7 14.7 16.0 12.1 13.5 21.2 35.7 33.0 16.8 18.2 27.7 32.1 14.0 20.3 10.6 28.3 19.6 34.2 10.0 20.5 22.9 24.0 17.5 31.4 12.6 19.9 19.2 16.9 12.9 23.9 21.9 14.5 17.7 14.7 16.7 51.6 11.4 29.2 16.0 21.6 7.4 13.5 9.5 5.8 7.3 11.0 8.4 7.1 4.4 13.5 7.8 8.6 60.6 6.4 6.7 13.9 9.3 2.6 8.2 9.0 18.9 12.2 8.3 8.6 8.2 8.9 7.5 10.0 8.2 8.3 11.4 53.6 57.7 60.3 27.1 85.0 78.8 102.1 76.1 88.8 246.8 52.1 57.3 22.1 61.5 84.4 55.2 235.6 52.7 101.5 77.1 39.2 38.1 271.3 55.5 63.3 60.8 77.5 47.7 44.3 50.4 34.1 55.6 51.5 45.6 70.3 51.3 49.2 56.5 43.7 158.2 47.5 104.6 57.0 48.1 69.0 85.2 101.5 46.4 64.0 34.7 59.0 83.2 132.8 53.8 50.1 35.1 62.7 119.6 74.6 56.7 49.6 28.4 72.0 349.9 72.3 44.2 73.0 108.0 156.7 56.2 75.3 38.7 90.2 61.7 79.1 84.0 NPSR1 "GPR154, GPRA, PGR14" ENSG00000187258 "Neuropeptide S receptor 1" Q6W5P4 7 34658218-34878332 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.1;Early spermatids: 4.4;Excitatory neurons: 3.8;Inhibitory neurons: 2.2;Late spermatids: 2.1;Oligodendrocyte precursor cells: 1.0" "Group enriched" "Detected in some" 5 "colorectal cancer: 2.3;pancreatic cancer: 2.0;stomach cancer: 2.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 6.2" NA NA "unprognostic (3.56e-1)" "unprognostic (9.34e-2)" "unprognostic (7.55e-2)" "unprognostic (1.80e-1)" "unprognostic (2.00e-2)" "unprognostic (9.35e-2)" "unprognostic (6.34e-3)" "unprognostic (2.85e-1)" "unprognostic (1.36e-2)" "unprognostic (2.08e-2)" 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.3 0.4 1.5 0.7 1.3 0.1 0.3 0.1 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 WDR86 ENSG00000187260 "WD repeat domain 86" Q86TI4 7 151375909-151410727 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 29.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 17.9;Endometrial ciliated cells: 13.9;Endometrial stromal cells: 22.5;Fibroblasts: 10.0;Microglial cells: 7.5;Muller glia cells: 11.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 14.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 13.7;NTERA-2: 2.6;SCLC-21H: 5.8;SH-SY5Y: 4.1;SuSa: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (8.93e-3)" "unprognostic (1.83e-2)" "unprognostic (3.13e-4)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.34e-2)" "unprognostic (6.02e-2)" "unprognostic (1.14e-2)" "unprognostic (6.32e-3)" "unprognostic (2.20e-1)" "unprognostic (1.84e-6)" "unprognostic (7.22e-2)" "unprognostic (1.96e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-1)" 6.5 1.3 7.4 0.3 4.6 0.1 8.2 0.6 3.4 18.3 7.2 7.8 0.8 9.2 0.2 1.4 19.3 0.9 0.6 4.7 5.4 3.0 0.8 1.4 1.2 3.7 2.3 5.4 6.3 0.9 7.7 8.0 2.9 1.1 4.1 0.1 0.4 1.3 4.8 0.5 0.7 3.2 0.4 2.6 18.7 5.9 0.8 1.0 0.2 29.3 0.0 0.1 2.3 6.7 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 4.1 0.0 0.0 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.4 4.6 0.6 3.4 4.7 5.4 3.7 2.3 5.4 1.1 2.6 1.0 1.1 3.4 0.0 0.5 2.6 1.3 0.0 0.2 1.9 1.2 0.3 3.4 17.9 1.4 0.0 1.5 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 13.9 22.5 1.5 0.0 0.0 1.8 0.0 1.4 10.0 0.5 3.1 0.0 0.7 0.4 0.2 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 7.5 1.2 11.5 1.0 1.5 0.2 0.0 0.0 3.0 0.4 0.0 0.0 0.0 5.4 0.8 0.0 0.2 4.6 0.1 0.5 0.0 0.3 0.8 3.1 0.1 0.0 0.3 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377207-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 114.7;Hepatic stellate cells: 66.8;Hofbauer cells: 42.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 20.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" NA Yes "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favorable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.6 17.6 6.3 1.4 6.5 22.6 5.0 6.8 8.3 6.1 7.7 2.5 1.4 3.3 13.7 1.4 6.7 2.3 9.3 6.5 6.4 21.2 10.8 6.5 2.2 6.3 6.3 6.1 3.2 11.9 23.4 8.3 8.1 6.5 4.6 1.8 3.4 3.3 7.4 2.4 1.6 2.3 1.8 6.3 12.0 7.9 1.8 6.4 1.8 30.5 1.5 1.6 3.2 3.7 6.6 3.7 1.2 3.6 4.2 5.3 3.4 2.1 2.2 7.0 3.6 4.5 1.3 1.4 2.5 4.0 4.1 5.0 0.9 2.8 1.4 4.1 2.1 1.6 14.3 1.3 2.1 3.8 2.9 5.5 2.4 0.5 4.8 3.3 8.5 8.5 5.3 12.5 12.0 4.1 3.3 2.7 3.5 1.9 2.0 9.6 7.2 6.3 5.6 3.4 1.9 1.4 11.0 1.5 2.0 6.4 3.7 3.6 4.9 3.5 1.9 2.6 6.6 2.1 6.0 4.7 2.8 10.5 2.9 2.1 9.3 3.7 3.0 1.7 4.6 3.6 2.0 3.4 2.5 2.1 1.2 3.7 2.2 10.2 0.8 7.3 0.1 3.3 2.4 6.3 6.5 6.8 8.3 6.5 6.4 6.3 6.3 6.1 6.5 6.3 6.4 6.6 6.1 19.2 18.8 24.8 11.5 2.3 4.0 2.0 2.8 3.8 3.6 6.1 6.5 5.7 3.1 20.2 0.0 2.2 5.2 1.3 3.9 2.2 0.8 9.9 6.8 13.5 8.4 114.7 2.2 3.3 12.2 9.8 15.3 13.9 26.6 1.2 66.8 3.5 42.4 1.7 3.0 3.5 2.0 17.0 4.0 0.6 2.8 15.4 8.8 7.5 4.6 7.9 11.3 1.0 1.6 3.1 0.4 4.1 3.8 1.8 0.2 1.0 2.9 2.5 19.7 3.8 18.5 5.1 7.7 1.6 1.0 3.0 9.6 2.6 1.8 1.2 FAM9C TEX39C ENSG00000187268 "Family with sequence similarity 9 member C" Q8IZT9 X 13035617-13044682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 38.5" "Group enriched" "Detected in some" 14 "Spermatocytes: 89.4;Spermatogonia: 47.9" "Cancer enriched" "Detected in single" 22 "testis cancer: 4.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 60 "AN3-CA: 182.5" NA NA "unprognostic (2.28e-1)" "unprognostic (7.35e-2)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.35e-2)" "unprognostic (2.06e-4)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" 0.1 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.8 0.3 0.0 0.0 0.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 38.5 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 182.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.3 0.3 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.0 1.5 0.0 0.1 0.5 0.3 0.0 0.0 1.2 0.1 0.0 0.8 1.5 0.6 0.0 2.1 0.1 0.1 0.0 0.0 0.1 1.7 0.1 0.1 4.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 1.3 0.0 0.4 0.1 0.5 0.0 0.1 0.0 0.0 0.3 0.8 3.4 0.9 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.7 1.7 0.0 0.4 0.3 89.4 47.9 0.0 0.6 0.1 0.2 0.1 0.1 0.1 KRTAP9-8 KAP9.8 ENSG00000187272 "Keratin associated protein 9-8" Q9BYQ0 17 41237999-41239004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 239 "skin 1: 23.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 31 "HDLM-2: 3.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CIDEC "CIDE-3, FLJ20871, Fsp27" ENSG00000187288 "Cell death inducing DFFA like effector c" Q96AQ7 3 9866711-9880255 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 738.8;breast: 497.0" "Cell type enriched" "Detected in some" 7 "Proximal enterocytes: 219.4" "Group enriched" "Detected in many" 5 "breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC diff: 1683.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018837, HPA020553" Uncertain NA NA "HPA018837: AB_1846767, HPA020553: AB_1846769" "unprognostic (1.83e-2)" "unprognostic (3.08e-2)" "unprognostic (2.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.19e-1)" "unprognostic (7.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-5)" "unprognostic (9.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.48e-3)" "unprognostic (8.14e-2)" "unprognostic (5.37e-5)" "unprognostic (9.47e-3)" "unprognostic (2.02e-1)" "unprognostic (7.46e-3)" "unprognostic (2.94e-2)" 738.8 5.6 0.2 1.1 0.3 0.0 497.0 0.1 0.4 0.9 0.0 11.6 69.6 4.7 0.3 0.7 2.2 5.0 7.0 0.1 0.2 2.1 10.1 0.2 1.2 0.2 0.1 0.0 0.4 7.4 0.1 0.2 0.0 0.1 2.3 3.9 0.0 16.3 3.8 6.2 15.5 90.6 1.6 0.1 0.2 7.5 0.9 0.1 1.5 3.9 11.7 0.0 13.4 4.9 0.3 0.0 0.2 0.0 0.0 1683.2 376.0 1.2 0.1 0.0 0.0 0.0 7.5 9.1 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 19.1 2.8 0.0 0.0 228.9 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.3 0.0 0.6 1.6 0.0 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.3 2.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 2.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 30.0 1.9 0.0 0.5 0.2 0.1 0.1 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.1 8.4 0.0 0.0 0.4 1.0 2.5 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 14.5 0.4 0.0 0.4 219.4 1.1 0.0 0.0 0.0 0.5 0.6 0.6 0.4 0.0 0.0 0.0 0.2 0.1 3.8 0.3 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340197-53535903 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.3;testis: 7.7" "Cell type enhanced" "Detected in some" "Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Approved "Golgi apparatus" NA NA 64000 "Golgi apparatus" "HPA055376: AB_2682798, HPA069552: AB_2686151" "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.0 0.6 0.8 0.2 5.2 0.0 0.0 0.0 4.0 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 6.3 2.6 0.2 0.0 1.4 0.0 1.6 4.0 0.5 0.1 0.3 0.0 0.6 0.0 2.0 0.3 0.1 0.3 0.1 1.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 7.7 1.6 1.0 0.0 0.0 0.3 0.1 0.1 1.2 0.1 0.1 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 112.5 57.1 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.2 0.0 4.0 6.3 2.6 1.6 4.0 0.5 2.0 0.0 1.6 1.2 1.4 0.0 6.0 10.1 0.3 0.0 0.1 0.0 0.0 2.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 205.7 0.0 0.0 0.1 0.0 0.0 439.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 455.8 0.0 0.0 0.0 0.0 174.9 1.2 0.2 0.0 54.4 0.0 0.2 0.0 1305.9 58.6 0.0 0.0 1.2 5.7 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.1 2.6 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TAF9B "DN-7, DN7, TAF9L, TAFII31L, TFIID-31" ENSG00000187325 "TATA-box binding protein associated factor 9b" Q9HBM6 X 78129748-78139650 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045275, HPA058961" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045275: AB_10962831, HPA058961: AB_2683863" "unprognostic (3.62e-3)" "prognostic favorable (5.40e-5)" "unprognostic (1.91e-1)" "unprognostic (1.78e-1)" "unprognostic (4.20e-2)" "unprognostic (6.43e-2)" "unprognostic (1.02e-1)" "unprognostic (5.67e-2)" "unprognostic (3.46e-2)" "unprognostic (2.37e-3)" "unprognostic (5.68e-2)" "unprognostic (9.56e-2)" "unprognostic (8.42e-3)" "unprognostic (8.71e-2)" "unprognostic (9.34e-3)" "unprognostic (9.47e-2)" "unprognostic (2.62e-1)" 15.8 11.5 14.3 10.4 15.4 12.1 15.8 14.9 17.7 15.7 14.7 12.0 6.6 23.3 14.3 18.4 16.2 13.6 23.3 14.7 18.5 18.3 14.1 11.1 11.6 14.9 15.5 12.6 14.5 9.7 23.1 12.0 13.2 14.6 19.9 10.1 33.9 10.2 17.4 15.5 12.4 8.1 31.0 15.0 10.8 11.1 10.5 14.6 17.1 19.1 14.1 10.8 16.6 10.4 19.3 25.6 21.8 52.7 23.3 20.2 20.5 7.9 22.5 20.7 35.6 19.8 30.7 43.3 29.2 31.2 24.5 29.0 19.8 79.5 18.5 36.9 45.7 27.6 16.0 28.7 28.2 20.1 25.4 17.0 26.3 9.8 39.1 26.7 22.5 21.8 28.7 33.4 61.1 32.0 39.1 40.3 19.8 61.9 33.4 40.4 34.3 68.6 26.9 24.6 51.2 33.3 33.1 62.3 26.7 24.7 27.2 43.3 18.2 23.3 27.4 41.6 30.2 27.4 26.2 56.8 21.3 47.6 50.5 39.3 0.8 4.1 1.2 6.6 4.4 12.5 5.6 15.1 11.5 5.2 5.2 15.1 11.3 1.9 14.2 3.3 6.5 17.7 8.7 14.3 15.4 14.9 17.7 14.7 18.5 14.9 15.5 12.6 14.6 15.0 14.6 19.3 14.9 9.6 7.8 2.9 6.6 15.6 26.7 6.1 56.3 16.1 12.2 8.8 26.6 10.0 6.2 20.2 8.4 18.1 4.5 1.4 7.9 6.8 1.0 4.7 8.2 16.4 12.6 14.1 4.0 8.6 16.4 12.9 4.1 5.0 2.5 3.0 13.2 5.6 6.9 8.4 4.0 5.4 12.2 3.5 7.9 1.7 10.5 4.9 23.2 3.7 7.6 22.9 2.1 4.5 8.9 3.9 5.0 13.9 14.1 11.7 1.0 17.6 4.1 13.6 19.7 9.3 20.4 5.9 33.5 23.0 8.8 8.5 9.9 3.0 4.4 13.2 PCDHB13 PCDH-BETA13 ENSG00000187372 "Protocadherin beta 13" Q9Y5F0 5 141213919-141218979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Exocrine glandular cells: 3.1;Horizontal cells: 3.3;Ionocytes: 4.1;Melanocytes: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 7.3;T-47d: 14.4;U-2197: 11.6" "Low region specificity" "Detected in all" NA NA "unprognostic (9.91e-3)" "unprognostic (3.34e-2)" "unprognostic (8.89e-2)" "unprognostic (2.06e-3)" "unprognostic (2.06e-1)" "unprognostic (1.29e-1)" "unprognostic (9.59e-2)" "unprognostic (3.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.61e-3)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (4.49e-2)" "unprognostic (2.80e-2)" "unprognostic (3.99e-2)" "unprognostic (8.19e-2)" "unprognostic (6.93e-3)" 1.2 1.3 0.2 0.5 0.6 0.2 1.1 0.5 1.3 1.4 0.0 0.9 0.2 1.6 1.3 0.8 1.1 1.6 1.4 0.8 0.0 0.8 0.6 0.9 0.3 0.1 0.1 0.6 1.4 1.9 0.7 1.5 1.3 0.4 1.2 0.6 1.3 1.5 1.1 0.5 1.9 0.4 1.3 0.1 0.8 0.8 1.0 0.0 0.1 0.9 0.7 0.2 0.8 0.9 0.6 0.0 0.1 1.8 1.4 4.6 4.9 0.4 0.3 2.4 0.7 1.4 0.0 2.0 0.0 7.3 1.8 2.5 0.5 1.7 0.0 0.4 0.0 0.1 0.0 0.9 0.3 0.1 0.0 0.9 0.4 1.2 0.1 0.1 2.1 0.7 0.2 0.3 1.8 2.3 0.3 0.2 0.1 0.4 0.0 0.2 5.6 0.8 0.0 0.1 0.1 1.7 0.6 2.4 0.2 0.7 0.5 14.4 0.1 2.2 0.5 1.3 11.6 0.0 0.0 0.1 0.0 3.2 0.1 3.6 0.9 0.2 0.8 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.2 0.2 2.9 0.1 0.1 0.2 0.1 0.0 0.2 0.6 0.5 1.3 0.8 0.0 0.1 0.1 0.6 0.4 0.1 0.0 0.6 2.1 0.0 0.0 0.0 0.0 0.8 0.2 1.5 1.8 3.7 0.4 0.4 1.5 2.8 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 1.0 0.5 2.1 1.6 0.0 0.0 0.0 3.1 0.0 1.2 0.0 0.6 0.0 0.5 1.1 0.7 0.1 3.3 0.0 0.2 4.1 0.0 0.0 0.0 0.9 0.1 3.6 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.2 1.2 0.1 0.2 0.0 0.8 0.1 0.3 0.0 2.1 0.8 0.4 0.2 0.9 0.9 0.0 0.0 0.1 0.1 0.6 MAGI2 "ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2" ENSG00000187391 "Membrane associated guanylate kinase, WW and PDZ domain containing 2" Q86UL8 7 78017055-79453667 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Group enriched" "Detected in many" 7 "Astrocytes: 1765.2;Excitatory neurons: 2453.9;Inhibitory neurons: 2438.2;Oligodendrocyte precursor cells: 1208.9;Oligodendrocytes: 4001.5" "Cancer enriched" "Detected in many" 5 "glioma: 7.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "Karpas-707: 81.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013650 Approved NA NA "HPA013650: AB_1853501" "unprognostic (4.32e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-4)" "unprognostic (5.04e-2)" "unprognostic (3.33e-1)" "unprognostic (6.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.17e-1)" "unprognostic (8.80e-3)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "prognostic favorable (1.08e-4)" "unprognostic (4.34e-4)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" 4.0 5.9 12.6 1.1 17.8 0.8 3.1 0.0 24.1 4.1 0.0 3.1 1.8 4.1 3.6 2.2 4.0 3.0 2.6 13.1 0.5 5.3 1.4 2.9 0.7 8.9 4.8 7.1 8.3 3.4 12.6 7.0 1.2 11.6 8.6 1.7 11.7 1.6 8.2 1.9 1.2 2.0 2.6 0.0 2.0 2.3 3.6 8.8 0.6 6.6 2.3 0.5 4.4 3.0 19.8 0.1 0.6 19.5 0.3 4.0 6.2 0.3 3.5 6.4 0.7 1.0 0.1 0.3 0.1 0.1 2.2 2.6 0.3 1.1 0.1 0.9 1.0 0.8 0.3 0.5 1.1 5.8 0.5 1.0 4.7 0.3 0.4 0.2 3.6 0.9 0.7 0.6 81.9 1.7 0.8 0.2 0.4 4.3 0.7 0.2 0.3 0.2 1.4 0.2 0.3 2.9 4.9 0.8 0.3 1.9 2.9 0.4 0.6 1.1 2.8 1.0 7.6 0.5 0.4 0.0 0.2 1.8 0.1 1.2 0.8 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.9 0.2 0.2 0.3 0.1 0.0 12.6 17.8 0.0 24.1 13.1 0.5 8.9 4.8 7.1 11.6 0.0 8.8 19.8 7.9 9.6 12.5 1765.2 0.3 1.0 1.3 0.6 6.2 29.3 3.2 6.7 7.5 4.3 3.3 1.8 20.9 0.4 0.7 1.6 5.9 0.4 25.1 9.1 18.3 5.8 2.4 0.0 2453.9 1.0 0.1 11.0 0.5 4.5 0.0 11.6 2.2 2.0 0.2 47.1 2438.2 1.6 0.0 0.0 0.3 32.5 6.5 1.0 1.8 327.9 0.0 24.5 0.0 1208.9 4001.5 0.4 1.5 19.9 0.5 3.5 1.1 1.7 2.1 23.3 13.1 11.0 12.8 4.8 0.9 1.3 1.0 0.4 0.7 8.9 1.4 0.7 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082638 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 29.2" "Cell type enriched" "Detected in some" 5 "Oligodendrocyte precursor cells: 1890.0" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 0.3 6.5 8.2 0.1 8.7 0.1 0.5 13.2 7.2 0.1 1.0 0.8 0.1 0.2 0.0 0.1 0.0 0.1 0.1 6.2 13.7 0.2 0.9 0.2 0.0 12.1 29.2 6.1 0.0 0.0 0.0 0.6 0.0 14.1 2.4 0.6 1.1 0.1 0.1 0.0 0.1 0.2 0.3 17.4 0.1 0.1 0.5 16.0 0.0 0.0 0.6 0.0 0.3 0.1 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 4.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.2 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.2 8.7 13.2 7.2 6.2 13.7 12.1 29.2 6.1 14.1 17.4 16.0 17.4 0.3 0.0 0.0 11.4 0.0 0.6 0.1 0.0 1.8 6.9 0.3 1.7 0.6 0.0 0.0 3.7 0.0 0.0 0.1 1.2 0.0 0.0 33.7 0.6 0.7 0.1 0.0 0.0 149.4 0.0 0.1 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 371.4 1.7 0.0 0.0 0.0 6.4 0.9 0.1 0.0 4.7 0.0 0.3 0.0 1890.0 9.1 0.2 23.9 0.0 0.0 4.5 0.0 0.7 0.0 0.8 0.0 0.4 0.3 0.3 0.6 0.9 0.3 0.1 0.0 2.4 1.5 1.6 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328700-104907232 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.1;retina: 23.8" "Cell type enriched" "Detected in some" 19 "Oligodendrocyte precursor cells: 4790.3" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.6;SH-SY5Y: 2.1;SK-BR-3: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles No NA Vesicles "HPA069691: AB_2686171" "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.0 0.1 18.2 0.1 10.8 0.0 0.0 13.2 7.1 3.4 0.0 0.4 1.4 0.6 0.0 0.0 0.3 0.0 0.0 5.9 12.9 1.1 0.0 1.6 0.0 7.6 13.6 7.4 0.1 0.9 0.0 0.0 0.0 7.0 0.2 0.1 23.8 0.0 0.0 0.0 0.2 1.2 0.0 7.6 0.4 0.3 0.1 34.1 0.0 0.0 0.0 0.1 0.0 0.2 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 10.8 13.2 7.1 5.9 12.9 7.6 13.6 7.4 7.0 7.6 34.1 10.5 0.0 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 7.7 0.1 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 245.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 1.3 0.0 4790.3 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CHP1 "CHP, p22, p24, Sid470p, SLC9A1BP" ENSG00000187446 "Calcineurin like EF-hand protein 1" Q99653 15 41230839-41281887 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Protein kinase inhibitor" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006616 Approved Approved Vesicles NA NA Vesicles "HPA006616: AB_1857461" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (2.84e-1)" "prognostic favorable (9.63e-4)" "unprognostic (7.29e-2)" "unprognostic (3.74e-1)" "prognostic favorable (4.07e-6)" "unprognostic (2.20e-1)" "unprognostic (7.46e-2)" "unprognostic (3.26e-2)" "unprognostic (1.26e-3)" "unprognostic (2.79e-1)" "prognostic favorable (2.79e-6)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-3)" "unprognostic (2.04e-1)" 67.5 55.7 25.7 28.3 26.4 58.9 33.0 27.9 28.2 31.9 26.9 114.9 86.2 22.0 34.4 75.2 21.0 48.5 53.7 31.1 30.9 76.9 186.6 53.1 18.7 32.5 31.4 26.1 19.3 42.5 54.5 21.8 26.5 35.4 34.6 82.7 20.7 50.3 27.8 81.6 45.8 70.6 27.8 29.5 20.4 113.7 10.8 34.4 20.3 50.3 87.2 41.4 45.2 41.7 38.4 72.4 72.7 28.3 109.0 120.4 113.8 41.0 56.2 69.1 44.8 48.0 66.6 140.4 12.6 59.8 77.7 47.7 89.0 56.0 83.9 51.5 44.8 20.0 50.8 58.1 103.6 93.5 66.5 73.7 116.7 98.8 51.9 53.3 68.0 82.1 37.9 81.2 79.5 52.5 43.5 27.7 72.5 29.0 118.4 35.9 35.9 46.2 34.0 92.5 144.1 17.4 44.3 96.4 178.2 48.7 49.9 101.0 66.3 108.3 47.5 50.3 76.9 36.7 45.0 131.6 59.4 84.9 42.2 44.1 255.5 227.6 274.8 49.5 204.4 51.5 40.2 46.2 50.0 152.1 33.0 29.1 41.4 173.3 56.5 207.4 95.1 60.7 116.5 25.7 26.4 27.9 28.2 31.1 30.9 32.5 31.4 26.1 35.4 29.5 34.4 38.4 28.3 44.8 117.3 20.9 26.8 72.3 62.4 48.1 20.5 11.0 101.6 39.2 80.5 243.1 50.7 103.0 10.4 33.3 38.3 434.4 389.4 96.7 52.5 68.0 48.8 39.5 55.6 58.5 24.8 150.6 62.4 38.2 112.7 114.4 37.4 18.9 78.1 353.6 68.5 11.8 21.0 136.2 34.6 170.1 134.8 122.6 29.5 77.1 129.9 19.7 113.4 32.7 36.0 9.5 23.6 173.9 206.4 29.3 24.0 80.1 425.0 231.1 33.7 10.3 26.3 46.6 41.4 13.7 19.3 50.6 108.5 66.9 32.9 65.7 161.4 130.8 FPR3 "FMLPY, FPRH1, FPRL2, RMLP-R-I" ENSG00000187474 "Formyl peptide receptor 3" P25089 19 51795157-51826190 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 28.5" "Group enriched" "Detected in some" 15 "Hofbauer cells: 56.5;Kupffer cells: 97.4;Langerhans cells: 223.6;Macrophages: 66.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4" "Group enriched" "Detected in many" 44 "dendritic cells: 2.4;monocytes: 6.7" "Group enriched" "Detected in some" 5 "HEL: 10.0;hTERT-RPE1: 2.7" "Not detected" "Not detected" NA NA "unprognostic (3.77e-2)" "unprognostic (1.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-1)" "unprognostic (1.84e-1)" "unprognostic (8.41e-2)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (7.14e-2)" "unprognostic (3.17e-1)" "unprognostic (9.37e-2)" "unprognostic (1.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (1.96e-1)" "unprognostic (4.28e-2)" 10.7 12.2 0.3 24.1 0.8 0.4 5.3 0.3 2.8 5.6 1.9 12.7 11.3 3.8 1.5 5.8 2.0 19.0 3.8 0.4 3.4 3.2 21.4 28.5 14.0 1.7 0.7 0.1 1.7 2.4 2.2 0.9 5.6 2.0 2.5 18.4 0.3 2.5 2.9 0.9 2.8 14.5 9.0 1.0 16.4 7.2 2.7 4.3 8.2 2.2 2.0 11.1 17.6 1.2 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.3 0.8 0.3 2.8 0.4 3.4 1.7 0.7 0.1 2.0 1.0 4.3 2.6 0.5 0.0 1.7 0.3 2.7 5.6 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.0 2.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.1 1.5 56.5 0.0 0.2 0.0 0.0 97.4 223.6 0.2 0.3 66.6 7.2 1.0 3.7 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.4 0.1 0.0 0.0 1.5 0.1 0.0 0.3 0.5 0.0 0.1 0.4 4.5 0.8 0.6 0.0 0.0 0.1 H1-6 "H1FT, H1t, HIST1H1T" ENSG00000187475 "H1.6 linker histone, cluster member" P22492 6 26107412-26108135 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 2.2;choroid plexus: 1.2;testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065718, HPA068266" Enhanced NA NA "HPA065718: AB_2685543, HPA068266: AB_2685967" "unprognostic (1.06e-2)" "unprognostic (1.80e-2)" "unprognostic (9.52e-2)" "unprognostic (9.94e-2)" "unprognostic (5.12e-1)" "unprognostic (1.57e-1)" "unprognostic (7.48e-3)" "unprognostic (6.51e-2)" "unprognostic (6.86e-3)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (6.28e-3)" 0.0 0.0 0.4 0.1 0.9 0.0 0.1 0.2 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.1 0.0 0.0 0.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.4 0.9 0.2 0.6 0.3 0.8 0.8 0.5 0.1 0.7 0.3 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" Q7Z7L8 11 43925342-43943878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 756.8;ovary: 727.4" "Cell type enhanced" "Detected in many" "Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "SH-SY5Y: 197.7" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 394.0 200.6 33.3 39.6 27.7 4.9 205.3 23.9 40.2 303.5 20.8 139.4 19.9 285.7 8.8 45.2 756.8 61.7 210.0 22.1 63.1 177.7 180.7 381.3 6.8 94.5 34.1 18.3 727.4 61.2 3.2 127.5 15.5 37.0 158.6 8.5 1.4 22.4 14.5 111.8 78.9 131.4 28.7 34.4 54.8 242.2 68.3 44.6 5.0 120.4 10.4 0.7 177.8 149.4 55.2 0.0 0.0 0.0 0.0 4.0 2.0 1.1 0.3 1.3 0.0 0.1 0.1 0.0 0.0 0.5 0.5 2.1 0.1 0.4 0.0 0.0 0.0 2.9 6.2 0.1 0.0 0.8 0.5 0.6 0.3 0.1 1.4 0.0 0.0 1.2 2.1 2.3 0.0 0.0 0.0 2.4 2.7 1.7 0.0 0.9 10.3 0.7 4.7 0.0 0.0 2.2 197.7 0.0 0.0 19.4 5.5 0.0 2.3 2.7 9.2 3.8 2.3 0.2 22.5 0.2 3.2 7.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 27.7 23.9 40.2 22.1 63.1 94.5 34.1 18.3 37.0 34.4 44.6 55.2 796.5 6.4 139.9 0.0 1.9 92.9 15.2 1.6 5.2 15.4 8.2 13.7 6.0 0.0 1.9 0.0 2.1 1.5 13.7 0.3 0.0 4.5 4.3 34.1 906.3 260.3 0.0 2.7 0.0 0.6 4.4 801.3 4.1 183.3 13.9 982.4 172.7 6.4 3.8 1.7 0.0 0.2 0.0 8.4 171.8 13.9 215.6 27.1 174.3 0.0 0.1 2.7 0.0 0.0 0.0 1.9 0.0 474.3 9.4 73.6 0.0 0.0 0.9 9.3 302.4 173.2 1942.9 2.1 1.5 6.5 88.5 3.1 14.2 243.9 0.1 50.5 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium inwardly rectifying channel subfamily J member 11" Q14654 11 17385248-17389331 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 135.8;tongue: 41.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048891 Approved NA NA "HPA048891: AB_2680547" "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favorable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.7 0.6 4.3 0.4 6.0 0.2 3.0 12.4 11.9 0.5 0.1 0.9 1.0 0.9 1.6 1.5 0.7 0.5 12.1 5.8 4.4 2.4 1.5 2.5 0.8 7.6 4.5 4.9 0.3 11.4 5.1 7.5 0.1 8.4 2.3 0.4 1.3 2.2 2.4 135.8 1.4 1.3 0.2 2.1 1.6 13.2 0.6 6.9 0.3 5.2 41.0 0.5 0.9 0.5 7.2 1.5 2.1 0.2 4.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 2.0 0.2 6.6 0.2 0.0 0.3 0.3 4.1 0.1 0.2 1.6 12.3 3.4 0.9 0.5 0.1 0.5 0.3 0.1 0.2 0.0 0.1 0.1 0.0 5.6 3.5 3.6 0.0 10.0 0.7 0.1 1.1 4.0 0.3 1.3 1.6 2.0 0.3 0.9 8.5 0.7 0.0 3.4 0.0 0.0 4.2 0.2 0.0 0.0 1.1 0.0 0.0 0.2 6.5 0.8 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 6.0 12.4 11.9 5.8 4.4 7.6 4.5 4.9 8.4 2.1 6.9 7.2 1.5 0.0 2.7 3.3 0.1 0.0 0.1 0.0 0.0 2.1 2.6 0.9 14.1 0.0 0.6 5.5 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.3 0.3 4.2 0.0 5.5 0.4 0.0 0.9 0.0 0.6 0.0 0.2 0.4 1.3 0.1 0.0 5.9 0.9 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 4.0 0.8 0.1 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.7 0.0 1.3 0.2 0.2 0.3 1.0 0.0 0.0 0.0 0.1 0.4 0.2 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 59.9" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 74.2;Respiratory ciliated cells: 160.4" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;HeLa: 1.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.2" HPA076277 Enhanced "Intracellular and membrane" NA NA "HPA076277: AB_2732306" "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.4 0.1 3.6 0.1 1.0 0.2 0.2 1.2 0.4 3.3 0.8 0.4 0.1 1.8 0.4 0.1 59.9 0.1 0.1 0.5 1.7 0.2 0.1 7.4 0.0 2.2 4.5 0.2 0.2 0.0 0.0 0.1 0.1 3.5 0.3 0.1 0.0 0.2 0.2 0.2 1.3 0.1 0.2 1.4 0.0 0.1 7.6 1.2 0.0 0.2 0.0 0.0 0.2 0.4 1.0 0.1 0.5 0.1 0.0 0.1 1.3 0.1 0.1 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.2 1.5 0.3 0.0 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.7 0.0 0.6 0.4 0.0 1.9 2.0 0.2 0.1 0.7 0.1 0.2 0.1 0.1 0.7 0.4 0.1 0.1 1.0 0.5 0.1 0.2 0.1 3.9 3.6 1.0 1.2 0.4 0.5 1.7 2.2 4.5 0.2 3.5 1.4 1.2 1.0 0.2 0.0 3.4 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.1 0.1 0.4 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 74.2 0.9 0.5 0.0 0.0 0.1 0.2 0.1 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 20.3 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 160.4 0.0 0.0 0.2 1.7 4.8 0.8 0.0 0.0 0.0 0.2 0.1 0.2 0.1 COL4A1 ENSG00000187498 "Collagen type IV alpha 1 chain" P02462 13 110148963-110307157 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 907.8" "Cell type enhanced" "Detected in many" "Adipocytes: 401.4;Endometrial stromal cells: 312.2;Endothelial cells: 385.9;Extravillous trophoblasts: 672.4;Sertoli cells: 506.2;Smooth muscle cells: 415.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 501.6;EFO-21: 915.3;TIME: 331.3" "Low region specificity" "Detected in all" CAB001695 Approved "Secreted to extracellular matrix" NA NA 75000 "CAB001695: " "unprognostic (3.82e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (2.27e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-1)" "unprognostic (6.51e-3)" "unprognostic (1.06e-2)" "unprognostic (9.79e-2)" "unprognostic (1.73e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.47e-3)" "unprognostic (1.72e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-2)" 351.6 33.9 11.1 137.1 4.4 0.4 131.5 3.8 13.1 66.3 20.0 85.7 25.1 106.1 14.9 41.2 64.6 117.8 80.0 11.4 23.1 45.2 22.3 138.2 27.9 10.1 6.6 4.9 27.2 36.3 36.6 12.9 907.8 7.7 54.1 30.7 1.8 19.2 86.4 40.4 22.3 43.8 315.7 6.6 76.9 50.6 10.8 11.2 10.8 55.2 47.5 11.2 122.0 38.5 15.1 40.0 15.2 195.9 0.3 501.6 148.9 274.9 246.2 59.5 134.0 65.3 4.2 0.8 0.1 915.3 46.2 59.7 26.8 0.0 55.8 30.3 1.3 29.5 0.2 28.2 0.0 142.8 0.0 0.4 49.7 8.9 132.8 59.4 212.8 207.7 0.1 0.3 0.2 31.1 0.1 0.1 0.8 28.1 0.2 3.6 0.4 58.6 0.1 278.8 0.0 1.4 29.8 0.1 0.4 61.0 192.4 0.1 13.9 331.3 39.9 121.4 1.0 97.4 0.3 1.8 3.9 0.4 0.7 297.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 11.1 4.4 3.8 13.1 11.4 23.1 10.1 6.6 4.9 7.7 6.6 11.2 15.1 401.4 41.7 8.9 5.2 1.9 14.0 9.7 8.5 2.8 1.0 3.5 16.5 41.1 10.0 0.9 23.9 0.0 49.7 0.5 0.1 1.9 22.6 0.7 19.8 312.2 385.9 0.0 0.0 10.5 0.2 672.4 211.8 1.5 48.7 1.3 215.8 134.6 1.3 27.7 0.0 18.9 0.5 0.0 4.4 19.2 2.8 38.5 4.2 30.2 36.5 0.6 2.5 0.0 1.0 0.9 0.6 0.1 109.4 0.5 6.2 0.5 26.7 2.8 0.4 506.2 142.8 415.1 1.2 5.0 0.8 15.2 45.0 4.2 45.9 0.6 2.2 PLEKHG7 "C12orf74, FLJ46688" ENSG00000187510 "Pleckstrin homology and RhoGEF domain containing G7" Q32Q52 12 92702843-92772455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 1.8;epididymis: 1.9;fallopian tube: 2.8" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 72.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 1.9;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SK-BR-3: 1.5" HPA060632 Uncertain NA NA "HPA060632: AB_2684333" "unprognostic (4.47e-3)" "unprognostic (3.95e-2)" "unprognostic (1.16e-1)" "unprognostic (1.05e-3)" "unprognostic (1.80e-2)" "unprognostic (9.91e-5)" "unprognostic (1.38e-1)" "unprognostic (9.44e-2)" "unprognostic (1.61e-1)" "unprognostic (6.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.13e-1)" "unprognostic (2.75e-1)" "unprognostic (3.27e-5)" 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.5 0.3 0.3 1.9 0.0 2.8 0.4 0.0 0.0 0.0 0.3 0.2 0.8 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.4 1.7 0.0 0.0 0.2 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.8 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.9 0.1 0.3 6.1 0.0 0.4 0.0 0.0 0.7 0.0 16.3 1.8 0.0 0.0 0.0 0.2 0.0 0.6 1.0 13.7 0.3 0.1 1.2 0.0 0.1 0.2 0.0 0.0 1.1 1.6 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 4.1 0.0 0.0 0.9 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.3 0.2 0.1 72.0 0.6 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 1.3 GJA4 CX37 ENSG00000187513 "Gap junction protein alpha 4" P35212 1 34792999-34795747 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047981 Approved NA NA "HPA047981: AB_2680228" "unprognostic (2.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.12e-2)" "unprognostic (2.67e-2)" "unprognostic (4.48e-1)" "unprognostic (5.24e-3)" "prognostic favorable (3.28e-4)" "unprognostic (2.01e-2)" "unprognostic (2.23e-1)" "unprognostic (8.17e-2)" "unprognostic (6.83e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.47e-2)" "unprognostic (3.74e-2)" "unprognostic (3.82e-3)" "unprognostic (7.96e-3)" 79.9 20.6 10.9 9.3 11.8 0.3 62.0 10.0 15.2 24.9 10.5 13.6 2.8 34.1 5.5 7.6 40.3 17.4 64.6 10.7 10.4 25.0 17.5 41.1 11.3 10.6 10.5 10.0 18.2 7.0 10.7 6.4 62.2 10.9 19.0 3.8 0.8 10.2 10.8 35.0 12.2 14.0 15.4 10.4 10.0 13.1 5.4 10.6 2.7 40.1 35.6 5.4 28.4 22.6 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.9 11.8 10.0 15.2 10.7 10.4 10.6 10.5 10.0 10.9 10.4 10.6 12.2 90.4 0.0 0.0 0.3 0.6 9.7 1.9 0.2 1.2 0.2 1.1 1.5 9.0 1.5 0.6 3.7 0.0 0.2 0.7 0.0 0.0 11.0 0.1 3.1 0.5 81.4 15.6 2.7 0.0 0.0 0.1 7.7 2.6 4.9 0.0 0.5 234.2 1.8 0.3 0.0 0.0 0.0 0.0 6.3 10.7 1.1 0.9 2.2 19.6 1.0 0.6 0.1 0.0 0.0 0.0 1.0 0.0 12.8 0.2 3.0 0.0 0.1 1.2 0.7 664.0 4.4 306.3 0.2 1.2 0.7 8.7 0.0 1.3 1.6 0.1 5.2 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713551 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047183 Approved Enhanced Nucleoplasm,Cytosol No No 1200000 Nucleoplasm Cytosol "HPA047183: AB_2679972" "unprognostic (1.49e-3)" "prognostic favorable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 1150.1 527.1 938.4 1037.8 1045.9 2342.4 1035.5 931.1 977.9 1189.0 746.9 1035.8 709.4 1120.2 704.5 1195.6 1031.8 570.8 504.0 835.9 907.8 925.9 657.5 941.4 1407.6 996.3 1001.0 736.8 1087.6 1099.5 485.3 401.7 693.8 1026.2 728.7 994.5 441.0 771.8 610.4 308.4 1301.5 943.0 705.5 951.2 903.4 881.1 239.0 1005.6 2078.3 1011.1 248.6 1535.5 904.1 1007.5 1139.5 2436.8 1416.4 1990.8 1788.7 592.5 783.4 2037.5 1614.2 1346.2 1379.8 1436.6 1380.8 2759.6 3811.5 1795.4 1271.0 948.1 1252.2 2830.6 1992.5 1738.6 3027.0 2228.9 4906.7 1096.2 2266.8 732.6 5621.1 2018.0 1143.7 733.1 1226.2 1002.6 1307.0 2286.8 3049.7 2910.9 1573.5 1222.0 3433.7 7998.5 7671.0 3004.9 2381.4 1180.4 5426.1 1408.4 2601.9 1719.2 2116.3 4041.8 2483.3 1851.0 1833.5 1507.1 1552.9 1383.9 4430.2 1704.1 1154.2 2052.5 1429.4 1769.7 1887.9 999.3 7614.4 790.8 3401.9 1897.3 2067.1 1713.8 1146.7 1346.2 1695.8 1945.2 2776.6 1928.5 1640.8 1828.0 2438.2 2109.4 1808.0 321.7 1782.3 1957.1 1944.4 2506.6 4661.6 938.4 1045.9 931.1 977.9 835.9 907.8 996.3 1001.0 736.8 1026.2 951.2 1005.6 1139.5 3907.5 971.2 1529.2 49.6 4518.0 7745.0 3851.3 5347.3 5459.5 703.1 3534.0 3673.7 259.7 1974.5 2483.8 2273.2 294.0 2599.4 4054.7 1741.3 3785.9 3474.2 103.3 2713.9 3364.3 4186.4 1695.3 3942.3 37.4 4190.1 5153.9 2404.0 2340.5 3092.6 2928.1 2349.3 1940.1 1347.6 3134.5 812.6 40.9 3178.6 3733.2 3492.4 8474.1 201.4 1306.3 3470.5 3689.1 78.7 3334.5 2195.9 2988.7 40.7 282.0 3669.3 2492.8 1404.5 3523.3 4524.2 1624.2 3136.2 1925.7 934.2 1926.2 2766.5 4571.8 1157.6 2467.8 5778.6 7944.4 2734.1 4276.7 1312.4 3381.3 4052.2 H2AP "CXorf27, HIP17, HYPM" ENSG00000187516 "H2A.P histone" O75409 X 37990779-37991314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 44.5" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "SuSa: 1.2" "Not detected" "Not detected" HPA003356 Enhanced NA NA "HPA003356: AB_1078593" "unprognostic (2.99e-2)" 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 44.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.4 0.7 0.5 0.4 0.1 0.4 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 HSPA14 "HSP70-4, HSP70L1" ENSG00000187522 "Heat shock protein family A (Hsp70) member 14" Q0VDF9 10 14838306-14871741 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 223.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046180 Approved NA NA "HPA046180: AB_2679571" "unprognostic (5.84e-3)" "unprognostic (5.85e-3)" "unprognostic (5.73e-2)" "unprognostic (6.40e-3)" "unprognostic (7.98e-3)" "prognostic favorable (5.73e-4)" "prognostic unfavorable (3.70e-8)" "unprognostic (2.20e-1)" "unprognostic (9.60e-2)" "prognostic favorable (9.16e-4)" "unprognostic (1.34e-1)" "unprognostic (1.17e-3)" "prognostic unfavorable (1.09e-5)" "unprognostic (7.27e-2)" "unprognostic (2.27e-1)" "unprognostic (5.42e-2)" "unprognostic (2.90e-1)" 9.0 9.3 9.9 14.8 10.4 43.2 13.4 14.5 12.5 8.6 9.0 14.8 13.2 9.3 11.2 11.1 7.2 8.9 11.5 11.0 10.1 10.3 11.9 8.9 19.6 9.3 9.6 10.0 8.0 11.6 8.2 8.9 10.2 10.6 8.9 17.9 10.4 10.2 9.0 21.6 13.4 12.6 9.8 9.3 12.1 9.5 31.1 9.5 18.8 10.4 16.7 19.2 13.1 8.1 11.1 54.0 38.9 33.7 30.7 15.7 21.7 43.6 27.8 14.6 47.5 37.9 52.1 38.9 66.8 21.6 25.7 23.5 43.1 55.3 32.8 49.7 28.2 56.0 62.1 33.0 30.4 13.4 43.6 39.9 15.9 15.0 38.9 11.4 11.8 24.3 53.8 54.3 53.6 35.4 37.3 65.7 30.4 34.9 55.2 20.7 50.3 43.8 53.9 24.7 27.2 19.1 23.5 31.3 43.1 35.8 32.0 49.0 57.6 13.6 19.8 27.7 77.8 45.1 36.6 85.4 67.8 39.6 56.3 11.4 15.8 12.3 13.3 13.7 18.0 14.9 15.1 14.0 17.2 13.4 14.5 11.7 14.6 6.1 17.8 15.8 14.7 20.3 10.7 9.9 10.4 14.5 12.5 11.0 10.1 9.3 9.6 10.0 10.6 9.3 9.5 11.1 8.2 6.4 3.3 7.2 18.7 26.3 20.5 37.9 30.7 16.6 7.8 5.8 19.3 14.3 21.2 3.7 6.2 36.2 17.5 16.2 1.9 4.2 53.9 6.7 8.7 12.1 6.0 20.4 21.8 3.9 65.6 16.2 18.3 8.9 10.2 7.4 11.7 12.6 22.8 6.7 19.5 17.0 26.4 11.6 20.3 14.6 14.0 12.1 14.2 10.3 9.0 17.6 23.7 14.6 15.9 4.7 19.9 12.4 33.3 24.4 15.2 2.0 12.5 13.7 13.1 23.3 33.1 223.8 71.4 25.7 26.1 48.7 21.5 8.0 21.2 22.2 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274789-193378820 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "breast: 17.5;choroid plexus: 32.1;salivary gland: 11.8" "Group enriched" "Detected in some" 5 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031772, HPA031774" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.0 0.1 2.3 0.0 1.9 0.2 17.5 1.5 2.7 0.0 32.1 0.0 0.0 0.1 0.8 0.7 0.1 0.0 0.2 3.3 1.6 0.1 0.0 0.5 0.1 1.8 2.0 1.6 0.2 0.1 0.2 0.3 0.0 2.0 0.0 0.1 0.9 11.8 0.0 1.3 3.5 0.0 0.0 0.8 0.0 1.6 0.4 2.0 0.0 1.3 0.1 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 2.3 1.9 1.5 2.7 3.3 1.6 1.8 2.0 1.6 2.0 0.8 2.0 1.8 0.1 0.0 0.5 37.9 0.0 0.0 0.0 0.3 0.0 0.0 5.8 5.8 0.7 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.4 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.9 0.0 0.0 0.0 26.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SIRT7 ENSG00000187531 "Sirtuin 7" Q9NRC8 17 81911939-81921323 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 22.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027284, HPA028246, CAB037261, HPA053669" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224" "unprognostic (8.15e-3)" "unprognostic (3.24e-2)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.46e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.97e-5)" "unprognostic (3.03e-1)" "unprognostic (2.10e-1)" "unprognostic (2.46e-2)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (4.34e-3)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (2.16e-2)" 8.3 8.1 5.4 7.4 5.8 23.4 8.7 6.0 8.7 9.8 6.1 13.4 13.0 7.0 1.9 42.5 8.1 5.5 5.6 5.4 6.0 11.5 14.3 9.7 11.9 5.7 5.5 5.0 6.0 12.9 5.5 6.9 4.2 5.8 9.9 5.9 0.6 14.2 3.7 6.2 21.5 17.2 3.7 5.6 18.8 18.1 13.4 6.1 9.5 7.9 3.8 7.3 10.9 18.1 6.0 26.5 21.7 2.8 9.5 6.9 6.4 17.0 13.1 10.8 15.1 14.1 18.7 20.7 11.8 9.9 7.3 9.6 18.8 10.5 8.1 4.9 10.2 22.9 10.4 10.7 29.7 20.4 13.6 20.5 6.5 25.0 14.5 11.9 6.4 11.3 6.5 11.3 5.8 7.2 20.9 14.6 19.5 6.8 40.6 22.3 9.7 5.5 11.1 14.7 17.4 11.1 14.6 15.0 35.9 17.7 5.0 15.1 32.1 9.0 6.8 14.9 12.9 24.2 9.5 3.2 9.0 16.6 18.4 11.3 4.5 2.6 22.2 2.8 3.8 0.9 4.5 2.1 2.3 1.4 7.0 2.0 0.7 4.4 1.8 3.3 2.1 1.2 1.5 5.4 5.8 6.0 8.7 5.4 6.0 5.7 5.5 5.0 5.8 5.6 6.1 6.0 15.2 12.8 12.2 12.4 41.4 38.0 25.8 21.1 28.5 23.4 27.4 19.0 4.4 18.6 18.7 18.4 56.3 31.1 62.8 99.0 9.8 22.4 21.8 28.8 14.0 15.4 20.4 16.0 14.3 13.6 33.2 12.4 152.9 37.0 11.4 20.1 15.0 16.0 26.1 30.3 10.6 34.6 28.5 26.4 33.5 14.1 14.3 29.4 24.9 5.6 47.3 14.7 71.1 6.6 13.8 52.7 74.5 10.1 33.2 29.1 74.7 16.0 29.6 39.1 0.0 12.5 15.5 41.3 37.4 52.4 55.5 49.3 50.8 17.9 44.6 53.9 PRR27 C4orf40 ENSG00000187533 "Proline rich 27" Q6MZM9 4 70133616-70176799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 959 "salivary gland: 1116.1" "Group enriched" "Detected in some" 25 "Early spermatids: 25.5;Late spermatids: 9.8" "Cancer enriched" "Detected in single" 10 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036150, HPA036151" Enhanced "Secreted to digestive system" NA NA "HPA036150: AB_10673001, HPA036151: AB_2674971" "unprognostic (9.52e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1116.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 IFT140 "gs114, KIAA0590, WDTC2" ENSG00000187535 "Intraflagellar transport 140" Q96RY7 16 1510427-1612072 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.8;Late spermatids: 25.6;Respiratory ciliated cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042197 Approved NA NA "HPA042197: AB_2677895" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (1.30e-1)" "unprognostic (5.21e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-2)" "unprognostic (5.27e-3)" "unprognostic (3.28e-2)" "unprognostic (2.63e-1)" "unprognostic (4.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (2.77e-2)" "unprognostic (7.55e-2)" "unprognostic (8.95e-2)" "unprognostic (2.91e-3)" "unprognostic (6.22e-3)" 5.2 8.9 12.0 2.2 9.4 1.8 7.1 9.7 13.3 10.5 17.2 6.6 3.4 9.7 5.0 4.1 15.5 5.4 4.6 8.8 12.3 10.5 3.8 8.8 2.4 8.9 11.3 8.6 12.7 7.8 8.5 15.8 3.1 8.8 9.6 1.3 6.4 6.1 5.4 2.8 5.7 4.8 2.5 9.7 4.1 6.8 15.4 9.2 3.2 23.0 1.0 1.1 12.1 7.3 7.7 2.0 12.4 9.5 9.6 8.0 5.9 5.4 2.6 9.5 2.7 3.3 3.4 9.9 3.8 7.3 3.9 3.6 7.5 1.7 1.5 1.9 3.3 7.6 2.3 9.3 8.3 6.9 1.3 4.7 8.4 5.9 3.2 4.2 10.5 2.0 7.6 2.6 2.2 2.1 12.0 6.9 3.9 10.4 2.5 2.9 6.3 3.4 5.7 8.3 6.2 18.0 10.0 2.9 5.0 3.9 5.1 17.4 5.1 3.9 2.2 7.0 4.0 1.1 6.8 2.6 2.4 3.7 0.8 2.9 0.0 0.4 0.2 0.4 0.2 3.7 0.6 0.6 1.4 0.6 0.2 1.9 3.0 0.0 1.1 0.3 0.5 0.1 0.8 12.0 9.4 9.7 13.3 8.8 12.3 8.9 11.3 8.6 8.8 9.7 9.2 7.7 2.9 12.8 11.5 19.9 1.2 1.7 2.9 4.0 4.6 3.7 6.8 6.0 4.0 5.7 6.1 11.0 25.0 7.8 2.2 2.1 1.9 3.2 21.7 27.8 5.9 2.1 5.4 2.5 12.7 1.0 1.3 4.5 7.1 6.2 1.3 11.5 2.2 0.9 2.3 8.4 12.4 6.1 8.2 0.6 0.7 25.6 4.7 1.4 0.0 13.1 0.4 5.6 0.0 6.6 4.9 2.1 1.5 4.1 0.7 1.4 1.0 3.5 31.2 17.2 0.0 3.1 3.0 20.9 7.5 2.0 1.1 2.2 1.6 6.2 3.5 1.5 POTEG "A26C2, CT104.4, POTE-14, POTE14, POTE14alpha" ENSG00000187537 "POTE ankyrin domain family member G" Q6S5H5 14 19402486-19434341 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "prostate: 1.1" "Cell type enhanced" "Detected in single" "Spermatocytes: 1.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (4.01e-1)" "unprognostic (1.51e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (2.69e-2)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (2.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 7.6 15.0 4.7 11.1 3.5 2.9 4.1 4.5 10.6 2.7 3.1 5.0 7.6 3.7 11.3 2.9 7.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 PRAMEF10 ENSG00000187545 "PRAME family member 10" O60809 1 12892896-12898270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 24 "liver: 2.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "liver cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200317-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 123.5" "Cell type enhanced" "Detected in some" "Hepatocytes: 83.0;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 38.5;Proximal enterocytes: 30.5;Proximal tubular cells: 16.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "HSkMC: 3.5;Karpas-707: 7.7;NTERA-2: 3.5;SCLC-21H: 3.2;TIME: 4.0;WM-115: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057900 Uncertain Vesicles NA NA Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 2.8 0.1 0.8 0.6 2.3 0.1 1.8 0.7 1.5 0.1 0.2 1.2 9.8 0.1 14.6 0.2 0.1 3.7 0.4 0.7 1.2 9.0 123.5 0.2 0.5 1.8 1.8 0.9 0.1 0.1 0.0 0.4 0.8 2.0 0.0 0.6 0.1 0.2 0.1 0.3 0.2 15.0 0.1 0.8 0.0 0.3 3.0 1.6 0.2 0.4 0.4 0.1 1.2 0.1 4.2 0.0 2.2 0.0 1.9 0.2 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 1.2 0.0 0.7 3.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.0 1.3 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 15.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.8 2.3 0.7 1.5 0.7 1.2 1.8 1.8 0.9 2.0 0.8 1.6 4.2 10.0 0.0 0.0 6.8 0.3 0.1 0.1 0.7 0.0 0.0 0.2 0.3 0.1 11.5 0.4 3.7 0.0 0.1 0.1 0.5 0.0 0.0 1.3 0.3 0.1 1.2 1.8 2.7 1.3 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.1 83.0 0.1 0.0 1.7 0.4 0.0 1.6 0.5 1.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 33.7 38.5 0.9 0.1 0.0 0.0 0.0 30.5 16.9 0.3 0.0 6.6 0.4 2.4 1.7 6.4 0.1 0.0 0.1 0.2 0.1 0.6 0.0 SBK2 SGK069 ENSG00000187550 "SH3 domain binding kinase family member 2" P0C263 19 55528611-55537133 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 23 "heart muscle: 67.0;tongue: 29.1" "Group enriched" "Detected in some" 6 "Early spermatids: 1.5;Late spermatids: 2.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;MCF7: 2.5;NTERA-2: 7.7;RH-30: 7.0;SuSa: 3.5;U-2 OS: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030631 Enhanced NA NA "HPA030631: AB_10602088" "unprognostic (1.33e-1)" "unprognostic (1.85e-3)" "unprognostic (4.57e-1)" "unprognostic (3.49e-1)" "unprognostic (5.43e-3)" "unprognostic (4.18e-3)" "unprognostic (2.08e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-1)" 0.3 0.0 0.1 0.0 0.1 0.5 0.0 0.8 0.1 0.0 0.6 0.0 0.2 0.3 0.0 0.2 0.0 0.1 67.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.4 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.2 0.0 2.5 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.6 1.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.5 2.5 0.0 0.1 7.7 0.0 0.0 0.2 7.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 3.5 0.0 0.2 0.1 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP26C1 ENSG00000187553 "Cytochrome P450 family 26 subfamily C member 1" Q6V0L0 10 93060798-93069540 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Ectodermal dysplasia" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.2;Microglial cells: 2.8;Rod photoreceptor cells: 1.0;Theca cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.39e-2)" "unprognostic (3.41e-2)" "unprognostic (3.88e-1)" "unprognostic (5.05e-2)" "unprognostic (3.25e-2)" "unprognostic (3.43e-2)" "unprognostic (4.97e-2)" "unprognostic (1.70e-1)" "unprognostic (8.85e-2)" "unprognostic (5.29e-2)" "unprognostic (2.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-2)" "unprognostic (1.74e-4)" "unprognostic (8.59e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 6.9 0.0 0.0 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109404-223143248 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 20.4" "Cell type enhanced" "Detected in many" "Club cells: 23.3;Glandular and luminal cells: 25.6;Kupffer cells: 29.5;Microglial cells: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "classical monocyte: 30.8;intermediate monocyte: 28.1;myeloid DC: 23.4;neutrophil: 25.3;non-classical monocyte: 12.4" "Group enriched" "Detected in many" 11 "dendritic cells: 23.4;granulocytes: 25.3;monocytes: 30.8" "Cell line enhanced" "Detected in some" "A-431: 2.1;HaCaT: 3.2;OE19: 1.8;SK-BR-3: 2.0;T-47d: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.5 1.9 2.3 4.7 2.4 0.5 8.7 2.6 2.8 6.1 3.0 2.0 1.7 2.2 2.6 5.0 5.1 4.5 1.7 2.2 3.7 4.1 1.7 6.3 4.4 3.5 2.6 1.7 20.4 4.0 4.4 0.7 3.5 3.4 3.3 2.2 0.7 10.4 2.5 1.4 2.0 2.1 2.6 3.1 3.0 4.1 1.8 3.4 2.6 1.9 1.6 5.1 4.1 2.4 5.5 2.1 0.2 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.0 3.2 0.0 0.2 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.2 0.1 0.8 0.4 0.0 0.0 0.3 0.5 0.1 1.1 1.8 0.0 0.0 0.0 0.1 0.9 0.4 0.8 0.3 0.6 2.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.2 0.0 30.8 0.4 0.2 28.1 0.4 0.2 1.5 0.4 23.4 0.1 2.3 0.7 25.3 0.4 12.4 0.3 1.2 10.9 2.3 2.4 2.6 2.8 2.2 3.7 3.5 2.6 1.7 3.4 3.1 3.4 5.5 1.0 3.2 17.0 0.0 0.2 0.5 5.8 18.9 4.6 0.1 10.6 5.3 1.7 14.3 23.3 22.0 2.1 1.5 0.3 0.4 3.9 5.9 4.6 13.6 2.0 2.1 1.2 0.0 0.5 3.8 0.3 7.7 3.1 25.6 2.5 4.6 0.7 0.7 18.1 0.0 1.0 0.6 6.1 29.5 3.1 5.7 9.3 22.4 3.6 23.4 14.4 1.4 0.0 1.5 0.1 2.4 0.1 8.6 0.1 3.0 0.5 0.1 11.0 0.2 0.0 4.2 4.1 5.4 5.5 15.9 1.6 0.8 1.7 4.1 1.5 6.3 USP7 HAUSP ENSG00000187555 "Ubiquitin specific peptidase 7" Q93009 16 8892097-8975328 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Developmental protein, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 282.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008108, HPA015641, CAB079904" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA 16000 Nucleoplasm "Nuclear bodies" "CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700" "unprognostic (6.73e-2)" "unprognostic (1.59e-1)" "unprognostic (3.36e-3)" "unprognostic (1.94e-2)" "unprognostic (9.64e-2)" "unprognostic (8.09e-2)" "unprognostic (4.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.81e-1)" "unprognostic (2.49e-1)" "unprognostic (2.35e-1)" "unprognostic (9.93e-2)" "prognostic favorable (8.56e-5)" "unprognostic (1.35e-1)" "unprognostic (1.07e-1)" "unprognostic (7.31e-2)" "unprognostic (2.69e-1)" 22.5 16.2 18.4 27.3 20.4 55.1 20.7 21.2 21.7 20.2 16.6 33.4 22.0 21.7 10.2 29.8 19.1 20.1 21.6 21.4 20.5 19.7 25.3 19.4 40.2 17.6 20.8 20.3 19.9 26.9 35.0 14.0 23.9 18.5 20.9 32.8 21.9 18.8 18.9 45.6 25.3 26.1 25.9 19.8 24.4 25.8 59.3 19.3 51.6 23.0 41.4 45.3 26.5 17.8 21.6 39.9 73.5 62.2 46.9 34.9 42.9 42.9 53.6 44.7 48.1 40.4 66.6 46.7 94.6 33.8 61.0 27.7 48.8 95.2 61.9 79.6 63.1 38.1 78.4 49.5 132.9 49.0 87.6 48.8 37.3 37.7 52.6 61.0 37.0 69.7 139.8 77.7 101.5 49.6 75.4 130.8 16.9 43.9 49.8 41.4 114.5 69.7 86.2 33.4 77.9 58.8 35.5 59.4 55.3 28.7 62.3 55.0 39.4 60.4 52.1 54.1 80.3 40.4 49.1 134.3 145.1 48.5 49.6 43.5 5.2 2.1 2.8 4.5 2.2 5.7 4.0 4.1 5.3 2.2 4.9 4.9 4.3 3.4 2.8 6.1 6.5 5.1 1.1 18.4 20.4 21.2 21.7 21.4 20.5 17.6 20.8 20.3 18.5 19.8 19.3 21.6 40.4 35.3 54.5 22.2 38.0 46.5 23.1 17.9 22.8 51.1 29.7 28.8 74.3 21.5 36.4 29.5 25.0 21.9 51.4 39.8 5.9 22.5 282.4 38.5 50.9 35.8 42.2 46.5 31.4 33.4 14.5 34.4 31.1 57.6 26.6 47.8 25.0 37.5 19.8 43.7 34.9 49.3 10.2 29.2 31.0 112.2 25.4 43.8 19.6 21.5 36.3 29.2 24.7 24.1 30.2 35.6 39.0 34.6 46.8 34.1 31.3 13.7 37.8 44.2 6.6 58.4 39.4 33.8 39.4 41.3 50.0 21.1 40.4 47.6 54.8 35.0 NANOS3 "NANOS1L, NOS3, ZC2HC12C" ENSG00000187556 "Nanos C2HC-type zinc finger 3" P60323 19 13862063-13880757 "Predicted intracellular proteins" "Differentiation, Oogenesis, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.6;testis: 4.2" "Cell type enhanced" "Detected in many" "Spermatogonia: 20.2" "Cancer enriched" "Detected in many" 34 "testis cancer: 132.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA062989 Enhanced NA NA "HPA062989: AB_2684916" "unprognostic (9.42e-3)" "unprognostic (3.17e-2)" "unprognostic (1.58e-1)" "unprognostic (8.58e-2)" "unprognostic (2.69e-1)" "unprognostic (6.89e-3)" "unprognostic (3.23e-3)" "unprognostic (4.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-3)" "unprognostic (5.17e-2)" "unprognostic (4.60e-2)" "unprognostic (3.12e-1)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.8 1.6 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.4 0.0 0.0 0.2 0.0 0.6 0.5 0.6 0.2 0.1 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.1 4.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.8 1.6 0.7 0.4 0.6 0.5 0.6 1.0 0.4 0.3 0.7 0.8 0.0 2.4 0.7 0.4 1.8 1.0 1.9 0.0 1.0 5.6 5.5 0.5 0.0 1.1 1.8 0.0 0.0 0.1 0.2 0.0 2.0 1.1 1.7 0.2 1.1 1.2 0.4 5.1 1.2 0.2 0.8 0.0 2.0 1.3 0.7 0.4 0.2 0.4 0.0 4.5 0.7 0.0 0.8 5.5 3.0 0.0 0.6 3.6 1.9 2.7 4.9 0.0 2.5 0.5 3.2 0.2 0.7 0.2 1.8 0.4 0.0 0.9 0.8 0.0 2.8 1.4 0.2 20.2 0.0 1.3 0.1 0.7 0.0 0.4 1.2 FOXD4L3 FOXD6 ENSG00000187559 "Forkhead box D4 like 3" Q6VB84 9 68302867-68305084 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Cell type enriched" "Detected in single" 5 "monocytes: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (7.93e-4)" "unprognostic (8.71e-2)" "unprognostic (7.04e-2)" "unprognostic (4.75e-2)" 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.2 1.6 0.1 0.2 0.0 0.2 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NHLRC1 "bA204B7.2, EPM2B" ENSG00000187566 "NHL repeat containing E3 ubiquitin protein ligase 1" Q6VVB1 6 18120440-18122677 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" Transferase "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 5.0;Exocrine glandular cells: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 6.8;K-562: 6.1;SCLC-21H: 6.1" "Low region specificity" "Detected in all" HPA066030 Uncertain Vesicles NA NA Vesicles "HPA066030: " "unprognostic (1.61e-1)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (6.95e-3)" "unprognostic (2.45e-1)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.39e-1)" "unprognostic (7.17e-2)" "unprognostic (5.07e-3)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (3.19e-1)" "unprognostic (2.33e-1)" "unprognostic (2.77e-2)" "prognostic favorable (5.30e-4)" 1.2 1.5 1.8 0.9 2.5 1.1 2.0 1.6 2.7 0.8 1.0 1.5 1.4 0.8 2.6 1.1 1.5 0.6 1.8 2.4 2.2 0.8 4.1 1.2 0.7 2.7 2.0 2.5 1.4 1.8 1.3 1.3 0.5 2.9 1.2 1.3 2.1 2.3 1.0 2.6 3.8 1.9 0.8 1.9 1.1 1.4 0.7 1.9 1.0 1.6 1.5 0.8 0.9 0.9 3.8 2.6 1.5 0.6 0.0 1.3 1.2 0.0 2.6 0.8 0.9 0.5 0.1 2.1 0.0 6.8 1.9 0.2 3.0 0.0 1.7 0.7 0.1 0.9 0.4 1.0 0.1 2.0 0.0 1.7 2.1 2.5 1.0 0.9 0.6 2.1 0.0 6.1 0.1 2.1 2.8 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.1 1.4 2.8 6.1 0.1 5.3 4.3 1.6 0.6 3.1 1.7 0.4 0.2 1.3 1.8 0.1 0.1 0.0 0.1 0.1 0.0 2.6 0.5 4.4 0.4 0.6 4.9 0.8 2.3 1.1 0.5 4.7 1.3 1.5 1.0 0.3 1.6 2.3 0.6 1.3 1.8 1.8 2.5 1.6 2.7 2.4 2.2 2.7 2.0 2.5 2.9 1.9 1.9 3.8 0.8 0.0 2.2 0.3 0.2 1.9 1.4 1.4 1.8 0.4 1.5 2.0 0.9 1.5 2.3 0.0 0.0 0.4 0.0 0.2 0.0 2.9 0.0 0.6 1.3 0.3 3.5 5.0 1.0 3.7 0.0 0.8 1.5 0.5 1.3 0.8 0.4 1.1 1.2 0.0 0.7 0.3 0.0 0.8 0.6 0.0 0.6 1.5 1.8 1.0 0.5 1.1 0.0 1.5 1.2 2.0 0.3 0.0 0.0 0.2 0.6 1.2 0.8 1.0 0.0 0.3 0.8 0.2 0.2 1.3 1.8 0.4 0.1 1.1 0.5 0.5 DPPA3 "Pgc7, Stella" ENSG00000187569 "Developmental pluripotency associated 3" Q6W0C5 12 7711433-7717559 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "Cytotrophoblasts: 1.1;Extravillous trophoblasts: 1.0;Spermatocytes: 1.4;Spermatogonia: 2.5;Syncytiotrophoblasts: 1.4" "Cancer enriched" "Detected in single" 779 "testis cancer: 339.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 338.4;NTERA-2: 143.2" "Not detected" "Not detected" NA NA "unprognostic (2.52e-1)" "unprognostic (9.49e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 338.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 143.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347182-93348356 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "testis: 76.8" "Cell type enhanced" "Detected in some" "Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "U-937: 27.4" "Low region specificity" "Detected in many" HPA003127 Approved NA NA "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.4 0.1 0.1 0.0 0.0 0.6 0.4 0.3 0.1 0.1 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 76.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.6 0.7 0.2 0.4 0.6 0.4 0.3 0.7 0.1 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.6 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 865.6 1.2 0.0 0.8 0.0 0.0 0.0 0.0 14.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1864.6 11.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.3 1.2 0.0 19.7 0.0 0.1 424.3 124.5 0.0 0.1 3.4 0.0 0.1 0.0 0.1 PLEKHN1 DKFZP434H2010 ENSG00000187583 "Pleckstrin homology domain containing N1" Q494U1 1 966482-975865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 55.4;skin 1: 44.2;vagina: 24.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 29.6;Pancreatic endocrine cells: 38.5;Prostatic glandular cells: 37.9;Squamous epithelial cells: 19.2;Urothelial cells: 52.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 15.1;HaCaT: 26.0;SK-BR-3: 16.6" "Not detected" "Not detected" HPA031742 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA031742: AB_10670704" "unprognostic (2.72e-3)" "unprognostic (8.05e-3)" "unprognostic (9.03e-2)" "unprognostic (4.47e-2)" "unprognostic (7.50e-4)" "unprognostic (2.93e-2)" "unprognostic (1.38e-2)" "unprognostic (1.78e-1)" "unprognostic (3.24e-1)" "unprognostic (1.01e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (9.98e-2)" "unprognostic (1.96e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" 0.3 1.6 0.0 0.7 0.0 0.4 1.8 0.0 0.1 6.0 0.0 0.4 0.9 0.4 0.3 55.4 0.9 0.7 0.2 0.0 0.0 1.9 0.9 1.1 0.3 0.1 0.0 0.0 0.1 1.1 0.5 0.3 0.4 0.0 3.6 0.1 0.0 10.2 1.2 2.1 44.2 0.8 0.1 0.0 1.2 2.1 0.4 0.0 0.1 0.7 0.0 1.6 7.6 24.4 0.0 15.1 1.4 0.0 1.0 0.1 0.7 2.5 6.8 1.7 4.1 1.1 2.0 11.3 0.0 3.2 3.0 5.7 26.0 0.2 4.5 0.7 5.0 1.0 0.0 5.6 3.3 0.6 0.3 0.2 0.2 3.8 2.9 1.6 3.7 0.5 0.0 0.3 4.0 0.2 8.3 0.0 0.3 0.5 2.4 11.0 0.1 0.0 5.6 4.3 4.2 0.1 0.1 7.5 16.6 1.0 0.4 3.2 0.0 3.2 5.3 2.3 0.5 4.6 3.2 0.1 0.1 6.8 2.5 3.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 1.1 0.0 1.9 4.6 29.6 5.0 1.8 0.5 3.8 1.8 0.9 0.0 6.4 0.0 0.0 7.1 1.0 1.9 0.0 13.8 0.0 3.0 1.1 0.7 0.0 0.0 0.0 14.0 2.0 0.9 3.1 8.2 0.0 0.0 0.7 0.3 1.1 3.3 0.0 0.0 8.2 0.3 1.4 0.0 0.0 0.9 1.8 0.0 1.9 0.2 0.0 0.0 0.0 38.5 3.3 0.0 2.5 37.9 0.0 0.1 5.2 0.2 0.0 0.2 1.0 0.0 0.7 19.2 17.3 9.9 2.8 0.0 0.1 52.9 ZNF385C ENSG00000187595 "Zinc finger protein 385C" Q66K41 17 42025576-42098479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.6;testis: 8.6" "Cell type enriched" "Detected in many" 4 "Early spermatids: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "HDLM-2: 4.3;Hep G2: 16.6;MOLT-4: 4.9;SCLC-21H: 8.6" "Region enriched" "Detected in many" 12 "cerebellum: 28.2" "Region enhanced" "Detected in all" "cerebellum: 19.7" NA NA "unprognostic (1.58e-3)" "unprognostic (3.38e-2)" "unprognostic (2.02e-3)" "unprognostic (3.95e-2)" "unprognostic (3.95e-2)" "unprognostic (2.61e-1)" "unprognostic (3.07e-1)" "unprognostic (2.64e-1)" "unprognostic (2.48e-1)" "unprognostic (8.67e-3)" "unprognostic (1.10e-1)" "unprognostic (8.90e-2)" "unprognostic (2.59e-1)" "unprognostic (8.71e-2)" "unprognostic (1.50e-1)" "unprognostic (6.22e-2)" "unprognostic (6.05e-2)" 0.4 0.1 2.3 0.3 2.2 0.9 1.6 12.6 3.1 0.8 1.4 0.4 0.1 0.9 1.3 0.6 1.9 0.3 0.3 2.2 2.8 0.7 0.3 0.5 0.5 2.3 2.7 2.1 2.6 2.1 0.9 2.5 0.4 5.7 1.2 0.3 4.9 1.5 0.6 2.2 0.7 0.4 0.2 1.9 0.3 0.4 8.6 2.4 1.8 0.5 5.4 0.3 0.4 0.7 2.7 0.3 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.4 1.8 0.0 0.6 0.0 0.0 0.5 0.3 0.1 0.0 4.3 3.2 0.2 0.1 16.6 0.3 0.0 0.4 0.0 2.5 0.0 0.6 0.1 0.0 2.5 0.2 0.0 0.0 0.4 4.9 0.2 0.6 0.8 0.0 0.3 0.0 1.0 0.1 0.2 8.6 0.3 0.1 0.4 0.4 0.9 1.6 1.2 0.0 0.0 0.2 0.1 0.0 1.2 0.4 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 2.3 2.2 12.6 3.1 2.2 2.8 2.3 2.7 2.1 5.7 1.9 2.4 2.7 0.6 0.0 0.5 1.6 0.5 0.4 1.9 2.2 0.0 5.0 1.2 2.2 0.5 1.5 1.5 1.8 0.0 0.2 2.7 0.4 1.9 0.5 27.3 0.3 0.3 0.3 0.0 0.0 2.1 0.5 0.1 0.5 0.5 0.7 0.0 0.8 0.0 0.0 0.8 1.7 3.0 0.5 2.0 0.6 0.9 5.1 1.5 0.3 0.0 5.6 0.0 3.0 1.0 3.5 4.2 0.2 0.3 0.0 0.0 4.1 0.6 0.1 0.5 2.2 0.0 1.4 0.5 1.0 1.9 0.0 0.6 0.0 0.2 0.0 0.6 1.3 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452127-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "epididymis: 520.5" "Cell type enhanced" "Detected in many" "Peritubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 19.0 30.2 49.1 17.8 51.6 5.1 18.6 43.4 56.8 29.3 57.8 18.4 10.3 31.2 520.5 10.1 45.7 18.3 24.3 49.0 57.2 25.8 19.7 23.7 22.9 45.2 48.1 48.0 36.7 28.3 25.7 54.5 21.1 47.6 49.3 11.6 22.2 18.7 44.7 13.0 11.3 17.2 27.5 46.3 20.6 25.5 34.1 51.5 32.3 28.9 17.0 17.1 18.1 16.8 60.8 0.1 5.7 32.6 0.0 51.5 31.0 0.4 36.0 32.9 9.7 26.0 0.1 7.4 0.0 48.2 36.4 18.4 4.9 12.5 13.5 15.2 42.5 2.0 11.4 0.0 4.6 17.0 0.6 14.1 25.8 1.2 5.6 4.1 9.1 15.0 12.0 6.5 43.8 10.8 22.0 30.8 9.8 9.3 0.0 6.8 19.1 4.1 24.0 17.9 0.0 0.2 24.5 0.0 9.5 15.5 24.4 4.7 8.5 17.7 13.3 15.4 8.2 1.9 25.9 35.1 4.9 24.8 15.8 17.2 14.0 9.0 20.5 21.5 14.3 19.4 18.9 35.4 24.6 13.7 17.9 48.2 30.5 1.2 18.9 18.5 28.5 52.1 19.0 49.1 51.6 43.4 56.8 49.0 57.2 45.2 48.1 48.0 47.6 46.3 51.5 60.8 24.9 6.4 14.4 4.9 18.3 8.0 7.8 20.0 5.2 36.7 8.0 14.1 10.4 18.6 12.5 12.9 10.4 2.8 15.7 1.9 13.7 32.2 1.6 2.8 33.5 29.0 15.8 3.0 14.2 10.7 2.0 42.9 3.1 1.9 12.7 11.1 32.9 14.0 15.0 37.0 17.5 8.4 4.1 3.8 11.2 4.0 47.2 6.2 21.4 6.5 9.3 56.8 23.7 18.6 28.4 4.7 8.8 63.9 39.8 13.7 0.8 20.1 6.7 19.6 26.3 44.5 35.0 1.4 2.7 3.3 6.3 1.6 19.9 19.7 4.6 4.8 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73984910-74108176 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 88.5;Oligodendrocytes: 86.7;Suprabasal keratinocytes: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA050845: AB_2681256" "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.2 1.6 4.1 5.2 2.5 19.9 3.0 5.7 14.6 2.0 0.0 4.2 5.5 2.0 1.4 7.7 1.9 2.6 1.1 9.7 2.1 1.6 3.9 4.1 3.7 2.8 2.4 2.3 1.6 2.6 2.0 1.5 4.6 4.5 2.5 4.3 3.6 4.2 1.1 1.2 15.7 6.0 2.1 0.9 3.8 4.3 1.6 2.3 5.8 2.3 1.3 4.2 3.4 4.1 6.3 9.0 8.0 14.5 8.9 1.2 1.3 26.4 1.8 2.4 3.4 2.7 16.6 8.1 14.9 3.5 2.4 1.6 9.4 13.0 5.2 3.6 6.7 5.2 19.2 7.0 5.6 5.1 20.2 11.3 2.0 13.3 4.2 9.9 4.3 5.3 10.3 13.4 4.8 2.0 14.6 10.0 13.0 8.1 7.7 2.7 15.4 9.1 5.2 3.8 16.5 18.1 15.5 4.0 10.3 4.9 5.7 6.6 16.1 6.7 3.7 15.4 1.8 6.8 4.2 2.0 12.7 2.4 13.9 4.9 0.1 0.4 0.2 0.0 0.4 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.2 4.1 2.5 5.7 14.6 9.7 2.1 2.8 2.4 2.3 4.5 0.9 2.3 6.3 4.2 6.4 9.0 31.3 6.4 49.5 3.5 4.2 14.8 16.3 8.0 5.8 2.9 2.8 8.0 1.8 20.9 7.0 7.3 10.5 0.0 3.5 4.7 18.8 11.9 6.6 6.0 24.8 88.5 4.4 30.1 3.4 13.7 29.6 2.5 6.2 3.6 6.1 10.1 10.1 45.7 8.0 8.2 26.9 23.2 0.8 0.6 26.9 10.6 54.4 27.1 1.5 2.1 41.7 86.7 6.2 7.7 3.0 4.8 6.2 10.3 1.5 11.9 8.6 0.0 3.8 7.7 0.5 2.6 24.4 68.2 2.5 5.5 2.3 6.9 7.0 ZNF286A "KIAA1874, ZNF286" ENSG00000187607 "Zinc finger protein 286A" Q9HBT8 17 15699577-15720787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Oligodendrocytes: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 120.0" HPA021594 Approved Nucleoli No No Nucleoli "HPA021594: AB_2670768" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (2.05e-1)" "unprognostic (1.91e-2)" "unprognostic (1.24e-1)" "unprognostic (8.83e-2)" "unprognostic (2.47e-4)" "unprognostic (4.66e-2)" "unprognostic (9.68e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-4)" "unprognostic (5.60e-2)" "unprognostic (1.66e-3)" "unprognostic (4.95e-2)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (4.94e-2)" 5.4 7.8 9.9 6.7 12.2 3.9 8.2 13.1 11.1 9.4 7.5 5.6 3.8 12.8 11.8 10.2 8.7 9.1 16.0 10.5 10.5 7.9 4.1 5.1 8.7 11.4 11.3 9.2 17.6 3.9 14.5 5.7 5.8 12.0 8.5 4.8 11.4 5.1 8.7 4.0 5.6 3.8 10.9 10.3 5.6 5.5 11.1 10.9 13.0 10.4 10.1 8.8 9.0 6.0 16.0 37.4 40.5 56.3 26.4 16.6 23.9 18.7 17.9 14.1 28.1 20.7 24.6 12.8 33.9 13.9 12.5 23.5 31.4 42.4 19.7 34.6 25.1 32.3 23.8 42.2 20.6 16.1 11.0 10.0 21.2 12.1 25.5 26.1 30.8 37.3 54.0 19.7 5.9 39.5 10.2 49.5 9.9 54.5 21.6 9.4 37.0 85.3 16.6 19.5 13.9 18.9 41.1 35.4 15.4 12.1 120.0 15.0 6.3 16.1 16.3 18.0 14.6 24.9 14.0 24.2 0.2 20.4 0.3 19.8 1.2 1.5 1.0 6.1 1.7 6.4 3.7 7.0 6.3 2.5 6.8 8.1 8.6 1.0 6.0 3.9 2.2 9.4 2.5 9.9 12.2 13.1 11.1 10.5 10.5 11.4 11.3 9.2 12.0 10.3 10.9 16.0 2.4 19.2 0.0 5.9 5.5 7.0 5.1 2.5 15.4 1.6 3.5 2.7 4.3 1.5 5.5 1.8 2.1 1.3 3.0 0.4 1.9 4.1 16.1 1.3 5.0 4.4 5.4 4.6 9.5 1.6 1.8 5.2 4.1 1.5 3.8 3.4 2.5 0.8 1.3 3.3 9.9 2.2 0.0 0.8 1.5 13.0 5.0 1.5 1.8 2.8 1.1 1.6 3.1 17.6 17.9 3.7 1.5 5.3 7.8 4.8 0.7 2.7 3.4 2.0 0.0 2.3 4.1 11.9 5.3 9.0 5.5 1.2 5.9 3.5 1.7 4.9 ISG15 "G1P2, IFI15, UCRP" ENSG00000187608 "ISG15 ubiquitin like modifier" P05161 1 1001138-1014540 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 322.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 497.1;Paneth cells: 403.1;Proximal enterocytes: 461.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 1460.2;BJ hTERT+ SV40 Large T+ RasG12V: 1466.7;HeLa: 501.4;SK-MEL-30: 487.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004627 Approved "Secreted to blood" NA NA 5000000 "HPA004627: AB_1079152" "unprognostic (3.65e-1)" "unprognostic (1.06e-1)" "unprognostic (1.12e-2)" "unprognostic (4.62e-2)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-2)" "unprognostic (3.78e-3)" "unprognostic (2.07e-3)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.11e-10)" "unprognostic (4.55e-2)" "unprognostic (4.13e-2)" "unprognostic (1.12e-2)" "unprognostic (7.46e-2)" 43.3 24.5 44.2 37.2 43.6 137.4 39.3 35.1 79.0 50.6 28.7 40.3 42.9 29.8 4.0 24.2 20.1 31.5 49.5 29.9 51.4 72.7 114.5 60.4 29.9 55.6 36.1 27.3 17.7 19.0 8.9 40.6 45.2 57.8 28.4 7.0 1.1 322.8 14.2 16.0 13.4 35.1 18.4 32.0 75.9 31.5 10.6 44.9 48.9 35.0 8.2 11.7 29.4 25.9 133.5 58.1 8.5 4.4 38.2 6.0 11.8 33.2 39.5 95.7 1460.2 1466.7 95.6 91.7 51.4 282.0 33.4 248.2 36.1 4.5 17.3 22.7 58.2 23.7 24.3 501.4 65.2 53.8 15.4 94.5 24.6 5.6 92.7 1.8 4.8 46.1 67.7 14.1 27.4 12.0 282.3 50.0 253.5 4.7 36.3 315.3 85.7 11.0 26.1 19.2 18.0 2.0 1.8 77.1 12.6 487.0 1.9 2.9 29.8 25.8 28.5 27.4 13.2 8.7 35.5 19.6 39.6 27.9 60.2 2.7 508.7 278.6 871.3 228.3 425.4 295.5 259.1 258.6 251.7 174.8 215.7 165.2 191.1 663.3 276.7 381.1 59.4 509.7 217.6 44.2 43.6 35.1 79.0 29.9 51.4 55.6 36.1 27.3 57.8 32.0 44.9 133.5 240.1 38.5 17.5 1.6 71.8 44.6 47.9 83.7 9.1 2.0 29.3 21.5 24.3 25.8 61.8 46.0 0.0 24.2 213.7 289.1 5.9 134.1 3.5 65.5 66.1 200.5 35.2 8.0 0.6 280.4 497.1 84.5 25.0 95.4 60.9 113.8 70.6 58.2 273.6 0.0 2.2 104.9 63.1 62.0 273.8 14.0 32.9 170.4 88.9 13.1 132.5 21.2 134.9 2.5 0.3 192.0 403.1 41.3 48.7 39.3 461.3 32.1 50.7 3.2 98.6 15.4 179.1 6.2 7.3 7.9 36.9 32.3 169.4 63.0 39.5 55.4 EXD3 "FLJ20433, LOC54932, mut-7, Nbr" ENSG00000187609 "Exonuclease 3'-5' domain containing 3" Q8N9H8 9 137306896-137423211 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 73.2;Paneth cells: 178.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.4" "Low region specificity" "Detected in all" HPA047395 Approved Approved "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "HPA047395: AB_10962864" "unprognostic (2.91e-1)" "unprognostic (5.67e-2)" "unprognostic (1.75e-3)" "prognostic favorable (4.30e-4)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (1.37e-1)" "unprognostic (2.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "unprognostic (7.99e-3)" "unprognostic (2.05e-1)" "unprognostic (8.67e-2)" "unprognostic (5.05e-2)" 9.4 10.2 5.8 3.6 6.5 3.5 10.8 5.1 11.1 11.3 5.6 14.5 9.5 9.9 1.5 11.7 12.4 4.3 10.6 6.2 5.0 12.2 8.2 10.3 3.8 6.7 5.3 6.1 10.8 9.9 3.7 13.6 3.4 6.1 14.6 3.6 0.8 10.2 3.7 9.5 9.9 11.4 1.4 4.9 15.0 12.4 4.9 5.4 1.1 11.5 2.6 2.3 11.0 11.3 5.7 8.3 7.0 3.3 9.5 2.8 4.0 7.8 4.0 4.5 3.5 5.3 4.8 17.5 3.5 9.1 3.1 8.7 14.5 1.0 4.4 1.1 8.2 8.1 2.6 13.0 7.9 8.5 1.9 29.4 4.8 6.0 3.1 2.8 10.2 11.9 0.0 7.0 6.4 3.0 22.3 0.1 6.9 3.8 18.1 4.7 6.3 2.6 25.3 7.1 4.7 4.5 7.7 4.0 8.4 3.8 3.8 13.6 9.3 15.0 4.8 4.4 7.5 6.2 8.1 4.1 3.0 8.7 6.4 7.4 10.7 3.4 7.8 2.2 4.5 2.7 2.6 4.0 2.1 3.9 2.4 3.1 2.5 0.8 4.1 4.4 2.5 6.1 2.3 5.8 6.5 5.1 11.1 6.2 5.0 6.7 5.3 6.1 6.1 4.9 5.4 5.7 17.6 0.0 6.3 24.2 5.3 5.9 10.0 8.9 13.6 14.6 13.5 17.0 5.2 10.0 11.2 7.3 14.6 9.9 8.1 46.4 9.8 6.8 17.9 11.5 6.5 14.1 7.3 5.0 21.6 11.3 3.3 7.3 19.4 13.1 61.7 10.5 17.2 7.2 9.2 21.9 24.1 27.6 16.2 5.4 7.3 73.2 5.9 6.9 3.6 13.1 6.2 10.0 12.3 26.2 14.6 6.4 178.2 7.9 6.6 10.0 31.3 11.9 9.3 10.4 13.1 5.5 9.9 2.3 8.9 9.9 8.9 4.0 6.4 19.5 39.0 9.2 OR5W2 "OR5W2P, OR5W3P" ENSG00000187612 "Olfactory receptor family 5 subfamily W member 2" Q8NH69 11 55913650-55914582 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYMK "TMEM226, TMEM8C" ENSG00000187616 "Myomaker, myoblast fusion factor" A6NI61 9 133514586-133528612 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Myogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "HSkMC: 15.2;RH-30: 7.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA051846, HPA055785" Uncertain NA NA "HPA051846: AB_2681636, HPA055785: AB_2682920" "unprognostic (9.17e-3)" "unprognostic (8.63e-2)" "unprognostic (3.76e-1)" "unprognostic (1.13e-1)" "unprognostic (1.03e-1)" "unprognostic (5.37e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-1)" 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.1 0.2 0.4 0.4 0.0 1.7 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410325-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 59.3" "Group enriched" "Detected in many" 5 "Early spermatids: 546.2;Late spermatids: 1313.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 7.0;U-2197: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023583 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.0 5.2 2.0 1.0 1.6 0.7 2.8 1.1 2.5 3.2 2.4 3.8 0.8 3.9 1.8 3.2 9.0 1.8 3.8 1.4 1.4 7.5 2.7 2.8 1.3 1.5 1.7 0.8 3.8 2.9 2.0 7.1 0.3 1.3 3.1 1.1 2.8 3.1 2.4 4.7 3.8 2.5 0.6 1.6 1.5 3.0 59.3 1.0 1.9 7.0 0.7 0.6 2.7 2.5 1.3 2.1 3.0 1.4 1.7 0.7 0.6 0.7 1.5 1.0 1.1 0.7 0.0 3.1 0.5 1.1 3.4 0.9 7.0 3.8 0.8 1.1 0.3 0.4 1.5 2.6 0.2 2.5 0.3 0.6 0.7 1.9 2.6 0.3 1.6 1.2 3.4 0.2 0.0 0.7 1.8 5.2 2.7 2.1 6.2 0.9 0.5 0.3 1.9 4.8 1.7 0.4 1.6 1.9 2.6 0.4 2.3 1.6 2.3 1.1 1.4 0.7 9.1 0.6 0.2 0.2 0.0 1.7 0.7 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.0 1.6 1.1 2.5 1.4 1.4 1.5 1.7 0.8 1.3 1.6 1.0 1.3 1.4 3.2 5.9 2.6 0.8 3.3 3.5 6.5 0.0 4.3 7.7 6.0 6.1 7.2 9.5 20.2 20.9 1.6 0.9 18.4 62.6 13.3 546.2 87.1 6.3 3.3 16.1 5.7 3.3 3.5 0.3 3.5 4.6 8.4 2.5 8.6 2.5 5.3 1.9 1.7 3.1 8.5 14.2 0.0 1.5 1313.1 8.4 2.0 3.6 1.9 3.1 13.5 0.0 0.5 0.9 4.7 6.4 6.4 0.1 4.5 3.8 28.0 55.8 26.4 6.6 3.4 4.6 156.2 12.4 1.8 1.0 0.8 0.8 15.4 10.4 1.6 ZKSCAN4 "FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36" ENSG00000187626 "Zinc finger with KRAB and SCAN domains 4" Q969J2 6 28241697-28252269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009637 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA009637: AB_2668244" "unprognostic (4.29e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (5.01e-2)" "unprognostic (4.23e-3)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.90e-6)" "prognostic favorable (5.04e-4)" "unprognostic (8.73e-3)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (5.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" 2.5 2.8 1.6 2.0 1.7 1.0 2.6 2.8 2.0 3.3 1.6 2.8 2.0 3.5 2.0 2.5 2.7 1.4 2.0 1.6 1.5 2.4 3.0 2.0 3.4 1.8 1.7 1.7 3.2 2.3 2.3 2.2 2.1 2.0 2.7 2.0 2.3 2.9 1.9 1.6 2.8 3.6 1.5 1.5 8.7 2.5 9.0 1.7 4.1 2.4 1.6 3.3 3.0 2.9 1.8 1.4 1.0 2.8 4.7 3.2 3.1 2.6 1.8 2.9 2.6 2.9 1.6 1.2 3.9 3.3 2.1 1.6 1.6 2.9 2.3 2.7 1.8 3.1 3.3 2.5 2.2 2.2 6.6 2.9 3.4 2.8 2.3 2.3 3.3 2.7 3.4 3.1 0.8 2.2 1.4 4.4 6.9 2.2 0.6 1.9 3.4 3.9 2.5 1.6 1.1 4.3 3.1 1.5 2.0 3.3 2.5 1.7 3.0 2.2 2.9 1.7 1.7 1.8 2.5 2.6 1.8 1.0 6.5 1.7 2.8 1.9 2.2 1.9 1.6 2.2 1.8 1.8 1.8 3.2 1.7 2.7 2.6 2.5 2.4 1.9 4.2 1.8 1.4 1.6 1.7 2.8 2.0 1.6 1.5 1.8 1.7 1.7 2.0 1.5 1.7 1.8 1.7 0.0 0.5 2.6 2.2 0.4 0.5 1.0 1.2 1.1 1.5 1.4 1.3 2.8 2.7 1.8 2.1 3.9 3.9 2.2 0.0 2.7 9.8 1.3 3.2 2.2 3.5 3.8 7.9 2.0 2.8 2.5 3.1 1.4 2.5 4.2 2.5 1.0 4.5 1.7 6.5 1.5 0.0 10.7 1.8 6.9 2.8 2.9 1.8 7.5 2.6 2.2 3.1 2.5 3.9 1.7 4.9 3.8 1.3 0.4 2.3 1.7 0.4 1.7 0.0 1.6 1.6 27.4 2.4 1.6 0.3 1.1 2.1 3.5 2.3 0.3 RGPD1 RGP1 ENSG00000187627 "RANBP2 like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 8.6;placenta: 6.9;testis: 15.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Early spermatids: 2.5;Excitatory neurons: 4.3;granulocytes: 3.8;Inhibitory neurons: 4.0;Microglial cells: 2.8;Oligodendrocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.6;MOLT-4: 10.7;NTERA-2: 3.1;RPMI-8226: 2.4;SuSa: 5.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.1 0.1 0.2 0.1 0.4 0.0 0.1 2.2 0.6 8.6 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.2 0.6 0.1 0.1 0.1 0.2 1.5 0.6 0.1 0.1 1.6 0.3 1.5 6.9 1.3 0.1 0.0 2.1 0.2 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.3 15.5 0.6 0.9 0.2 0.0 0.5 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 10.7 0.2 3.1 0.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.7 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.2 0.6 0.2 0.6 1.5 0.6 0.1 1.3 0.1 0.6 0.9 0.1 0.0 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.4 4.3 0.0 0.0 0.8 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 2.8 0.0 0.2 0.0 1.5 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.2 0.8 0.0 0.0 0.3 1.0 0.0 0.0 0.0 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 26.4 39.8 29.1 14.7 29.6 11.6 30.8 28.6 38.7 24.5 30.5 33.8 34.7 19.9 13.0 38.7 18.7 10.7 38.4 28.7 28.6 123.7 137.3 22.6 14.8 30.4 28.8 27.6 25.4 34.2 24.7 16.8 10.1 28.8 32.8 26.8 6.8 24.9 20.9 51.1 36.5 42.4 18.6 29.0 29.5 28.1 41.8 30.1 17.1 21.7 28.8 16.6 26.2 26.4 30.6 18.7 29.0 4.9 24.4 46.2 47.9 0.6 17.3 34.3 24.8 18.4 8.4 22.5 12.6 11.5 35.3 16.0 20.6 22.3 29.1 20.6 43.3 13.3 3.1 24.8 52.4 34.0 15.3 47.9 50.0 36.4 16.3 23.7 17.0 29.5 40.0 10.1 44.9 26.7 61.5 40.4 16.5 9.7 45.9 31.8 64.9 19.9 38.2 35.6 23.7 26.0 15.7 24.5 21.5 15.0 10.3 25.2 24.5 20.8 12.9 13.4 15.4 8.8 25.5 21.1 3.8 11.1 23.7 18.8 4.8 56.3 6.9 19.4 47.2 20.1 21.9 20.9 22.2 45.4 17.4 21.0 19.1 2.6 17.2 29.3 37.4 21.8 33.6 29.1 29.6 28.6 38.7 28.7 28.6 30.4 28.8 27.6 28.8 29.0 30.1 30.6 39.3 16.0 29.6 10.4 17.8 27.8 46.1 56.8 27.9 9.9 45.5 54.4 17.2 47.1 34.3 25.8 2.1 21.2 22.9 37.9 127.2 40.0 20.7 20.6 20.1 32.0 37.3 24.2 7.3 55.7 7.3 36.4 13.3 16.5 17.7 31.8 50.0 204.2 146.1 11.8 6.7 61.7 42.7 55.9 42.8 35.4 43.8 41.9 51.6 10.3 65.0 79.5 35.0 10.1 8.5 30.4 54.9 37.2 10.8 32.5 326.4 581.7 28.6 8.3 32.9 24.2 32.7 17.2 1.7 42.1 40.2 13.0 21.3 37.5 78.1 42.4 SAMD11 MGC45873 ENSG00000187634 "Sterile alpha motif domain containing 11" Q96NU1 1 923923-944575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 266.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.3" "Cell line enhanced" "Detected in many" "HEK 293: 87.6;HeLa: 142.1;SCLC-21H: 71.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030110 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA030110: " "unprognostic (9.96e-2)" "unprognostic (1.75e-1)" "unprognostic (4.11e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-2)" "unprognostic (2.42e-1)" "unprognostic (9.28e-2)" "unprognostic (6.90e-2)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.62e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.35e-5)" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.26e-2)" "unprognostic (1.18e-1)" 2.1 9.1 4.0 3.3 4.0 1.0 1.8 5.9 6.5 6.7 8.3 4.9 5.1 9.7 9.5 2.0 17.8 3.3 7.4 5.1 10.5 14.2 4.3 3.9 2.1 22.5 8.7 2.1 3.3 1.5 1.6 27.8 0.3 9.6 17.1 1.2 24.7 2.0 19.7 0.8 0.7 5.5 4.2 9.0 17.2 4.9 4.8 6.5 0.1 4.8 0.3 0.4 14.2 7.9 9.4 0.3 8.0 0.1 7.4 0.4 0.1 2.0 9.2 0.5 0.6 0.3 0.4 2.4 0.0 19.0 26.0 5.1 15.3 8.8 0.0 0.0 0.8 87.6 0.0 142.1 0.4 1.9 0.0 0.9 5.3 0.0 0.1 0.0 12.1 0.0 0.2 3.5 0.0 0.2 8.4 0.0 0.1 3.8 0.5 0.8 0.7 1.4 5.6 1.2 0.0 71.1 20.9 23.8 12.3 0.2 6.1 12.8 0.5 1.4 3.8 14.4 0.2 2.6 1.3 0.0 0.3 5.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 4.0 4.0 5.9 6.5 5.1 10.5 22.5 8.7 2.1 9.6 9.0 6.5 9.4 0.1 0.0 1.8 12.1 0.3 0.4 0.1 0.3 0.6 25.5 0.7 0.4 0.9 2.8 1.9 3.7 29.2 0.2 0.1 0.2 0.0 1.0 3.9 20.1 43.9 6.1 26.5 0.0 0.1 0.4 0.9 17.0 2.0 6.4 0.0 3.8 4.6 0.2 0.3 35.3 0.2 1.0 0.0 0.6 0.0 12.1 0.9 0.7 0.0 1.0 0.0 25.8 0.0 0.0 0.1 1.6 2.6 4.1 0.4 2.1 0.0 0.3 0.1 266.9 0.0 0.2 4.1 1.5 26.0 0.1 0.6 0.1 0.6 0.0 0.2 0.3 PERM1 "C1orf170, MGC13275, RP11-54O7.8" ENSG00000187642 "PPARGC1 and ESRR induced regulator, muscle 1" Q5SV97 1 975204-982093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 52 "heart muscle: 49.9;skeletal muscle: 196.4;tongue: 137.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.8;Breast myoepithelial cells: 3.9;Cardiomyocytes: 21.5;Early spermatids: 6.0;Late spermatids: 5.8;Spermatocytes: 4.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA031711, HPA031712" Enhanced NA NA "HPA031711: AB_10669636, HPA031712: AB_2674005" "unprognostic (3.67e-2)" "unprognostic (5.72e-2)" "unprognostic (6.05e-2)" "unprognostic (1.89e-1)" "unprognostic (2.86e-2)" "unprognostic (4.25e-2)" "unprognostic (7.58e-4)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (2.64e-1)" "unprognostic (1.69e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.70e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.96e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 2.0 0.2 0.0 49.9 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 2.4 0.0 196.4 1.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 137.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 1.8 0.0 1.2 0.7 3.8 3.9 21.5 0.0 0.0 1.8 0.0 0.1 0.0 0.1 1.9 0.2 6.0 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 1.6 0.5 4.3 0.4 1.1 0.0 0.3 0.0 0.0 0.1 2.3 VMAC ENSG00000187650 "Vimentin type intermediate filament associated coiled-coil protein" Q2NL98 19 5904872-5910853 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 28.1;Late spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" NA NA "unprognostic (6.81e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.67e-6)" "unprognostic (3.59e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.40e-1)" "unprognostic (1.73e-3)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (9.52e-2)" "unprognostic (5.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (7.24e-4)" 4.2 5.2 3.0 5.1 4.4 6.1 5.0 3.9 3.4 4.8 3.4 5.1 3.1 5.3 2.5 5.1 5.2 2.7 3.3 2.4 2.4 3.8 4.5 3.7 5.3 5.7 3.9 1.8 5.1 7.9 2.0 7.0 2.6 5.3 7.4 3.1 2.2 7.0 3.6 2.9 5.2 6.8 2.8 3.3 6.3 7.7 2.6 3.9 3.3 7.3 0.9 4.3 6.0 4.4 9.1 1.4 0.7 1.4 2.4 2.4 1.6 1.4 0.9 1.4 0.4 0.6 1.0 1.5 1.4 3.6 1.4 0.8 2.2 0.3 1.8 0.2 2.9 2.1 1.3 1.6 0.8 1.8 1.7 3.0 3.9 2.1 0.5 1.8 3.5 1.4 4.4 1.0 4.7 0.6 1.6 2.5 1.7 0.7 5.1 2.8 1.9 0.4 3.8 0.9 2.4 0.9 3.9 1.3 4.4 2.0 3.4 3.4 2.5 3.0 1.0 0.4 3.6 1.2 15.9 3.7 1.1 1.7 1.4 1.6 6.6 4.2 3.2 4.6 4.6 3.4 4.0 4.0 5.0 2.6 4.2 5.5 5.2 3.6 3.9 6.3 5.9 6.0 3.9 3.0 4.4 3.9 3.4 2.4 2.4 5.7 3.9 1.8 5.3 3.3 3.9 9.1 3.6 0.0 1.1 2.3 5.2 1.8 5.1 3.9 1.8 1.5 5.0 8.0 1.0 2.8 2.8 11.0 0.0 16.3 11.2 3.7 13.7 6.1 28.1 19.9 3.8 3.0 4.9 5.2 0.9 8.7 5.9 4.3 6.6 5.6 2.5 5.9 5.0 3.4 8.6 0.0 1.1 6.7 6.1 9.1 3.7 31.8 1.2 5.0 3.6 1.9 5.5 4.5 12.3 0.5 2.9 5.1 2.9 2.6 2.6 3.7 4.9 5.4 2.0 3.6 0.0 2.1 3.2 1.3 1.4 3.8 3.0 8.8 6.1 6.0 4.2 4.3 C5orf52 ENSG00000187658 "Chromosome 5 open reading frame 52" A6NGY3 5 157671533-157680158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 36.2" "Cell type enriched" "Detected in some" 4 "Late spermatids: 1980.5" "Cancer enriched" "Detected in single" 4 "colorectal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.64e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 36.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 401.1 1.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1980.5 7.8 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 5.8 6.4 0.1 0.0 0.1 0.0 0.0 0.0 6.6 0.0 0.0 26.4 4.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 HAPLN4 "BRAL2, KIAA1926" ENSG00000187664 "Hyaluronan and proteoglycan link protein 4" Q86UW8 19 19254756-19262804 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 105.2" "Group enriched" "Detected in some" 7 "Excitatory neurons: 16.0;Hepatocytes: 6.7;Inhibitory neurons: 19.9;Proximal enterocytes: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.5;NTERA-2: 8.3;SCLC-21H: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055856 Enhanced "Secreted in brain" NA NA "HPA055856: AB_2682946" "unprognostic (3.36e-4)" 0.1 1.0 16.2 0.1 4.4 0.2 0.2 19.0 105.2 1.9 0.0 0.2 12.5 0.8 0.1 0.0 0.2 0.2 0.1 18.3 17.0 0.4 14.2 0.1 0.1 40.6 16.3 3.5 0.6 0.9 0.0 0.7 0.2 44.3 0.6 0.1 2.3 0.1 0.3 0.0 0.2 15.5 0.2 8.7 0.1 0.3 0.1 36.3 0.0 0.0 0.0 0.0 0.1 0.5 61.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 3.5 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.0 0.1 0.0 0.4 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 4.4 19.0 105.2 18.3 17.0 40.6 16.3 3.5 44.3 8.7 36.3 61.0 0.1 0.0 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.0 0.0 16.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.4 6.7 0.1 0.0 19.9 0.6 0.0 0.0 0.0 0.2 0.3 0.1 0.0 1.0 0.0 0.2 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 15.0 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 ERC2 "CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110" ENSG00000187672 "ELKS/RAB6-interacting/CAST family member 2" O15083 3 55508311-56468467 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 11.3" "Group enriched" "Detected in some" 5 "Excitatory neurons: 818.5;Inhibitory neurons: 674.8;Oligodendrocyte precursor cells: 304.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.4;HUVEC TERT2: 2.1;Karpas-707: 7.9;SH-SY5Y: 2.0;U-266/70: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073739 Enhanced NA NA "HPA073739: AB_2732240" "unprognostic (2.13e-2)" "unprognostic (1.39e-1)" "unprognostic (9.10e-2)" "unprognostic (1.93e-2)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (4.50e-2)" "unprognostic (2.95e-2)" "unprognostic (1.22e-1)" "unprognostic (3.06e-2)" "unprognostic (2.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.24e-2)" "unprognostic (4.49e-2)" "unprognostic (9.09e-2)" 0.0 0.3 9.2 0.0 10.3 0.0 0.1 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 7.6 2.5 0.2 0.0 0.1 0.0 2.9 0.2 9.4 0.8 0.2 0.0 1.7 0.1 1.4 0.3 0.0 2.6 0.2 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 5.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.0 0.0 7.9 0.0 0.8 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 1.6 0.0 0.9 2.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.7 0.0 0.2 6.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 10.3 0.0 11.3 7.6 2.5 2.9 0.2 9.4 1.4 0.0 0.0 5.2 0.1 3.2 0.5 22.9 0.0 0.1 0.2 0.0 1.2 11.3 0.4 0.5 3.4 0.0 1.3 0.0 25.0 0.0 0.0 0.0 0.0 0.4 6.2 0.4 0.3 0.5 0.0 0.0 818.5 0.6 0.1 0.6 0.0 1.2 0.0 0.9 0.0 0.0 0.7 5.0 674.8 0.0 0.0 0.0 0.0 2.5 1.5 0.2 0.0 30.9 0.0 1.3 0.0 304.6 102.4 1.6 0.0 0.7 0.0 0.8 0.0 0.6 1.5 10.8 0.0 0.1 0.1 1.5 2.9 0.4 0.1 0.0 0.0 1.2 0.0 0.3 B3GLCT "B3GALTL, B3Glc-T, B3GTL" ENSG00000187676 "Beta 3-glucosyltransferase" Q6Y288 13 31199975-31332276 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.31e-2)" "unprognostic (2.53e-1)" "unprognostic (4.71e-2)" "unprognostic (6.17e-3)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-1)" "unprognostic (2.91e-1)" "unprognostic (3.28e-3)" "unprognostic (6.74e-2)" "unprognostic (5.51e-3)" "unprognostic (2.26e-1)" "unprognostic (5.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.51e-1)" 3.4 2.1 8.6 3.1 11.5 3.9 4.7 7.9 8.1 3.5 11.9 2.9 2.8 13.0 3.9 3.0 6.1 3.5 18.3 8.5 7.4 6.7 3.4 3.7 3.8 8.3 10.5 7.5 4.8 3.1 8.2 3.1 7.0 7.3 3.5 3.4 8.1 3.8 6.2 4.8 3.4 3.0 12.8 8.6 3.5 3.5 3.8 11.6 4.9 4.9 2.8 5.6 2.6 3.6 8.4 4.8 6.7 27.1 4.9 5.1 5.1 4.4 11.6 13.0 13.9 9.8 3.5 13.2 19.4 8.3 13.6 26.2 7.9 6.1 7.5 12.9 59.8 11.7 1.3 5.9 5.1 3.2 7.8 10.1 5.9 8.4 8.0 6.8 14.2 12.5 9.5 3.5 3.0 11.0 6.1 11.7 2.4 7.9 7.0 4.1 10.4 8.8 0.6 6.2 6.7 2.5 11.0 10.0 4.7 13.2 6.3 2.3 8.9 17.6 14.0 9.4 6.5 11.7 2.4 5.6 7.3 4.5 5.8 18.9 1.7 0.4 1.3 2.4 0.4 3.5 1.3 1.5 2.7 0.4 0.6 1.2 1.6 0.2 1.4 0.4 0.4 0.9 1.4 8.6 11.5 7.9 8.1 8.5 7.4 8.3 10.5 7.5 7.3 8.6 11.6 8.4 4.5 0.0 3.1 0.0 6.6 0.0 3.6 0.0 14.2 10.6 5.1 3.4 23.7 2.8 0.6 9.2 16.7 0.3 7.9 2.5 1.9 4.3 12.1 9.2 5.3 6.5 1.2 1.7 0.0 4.6 2.1 9.0 5.6 4.2 0.0 3.3 8.9 5.5 3.6 0.0 0.0 1.5 0.0 3.2 0.0 2.5 1.5 3.3 0.0 0.0 0.9 5.8 6.2 0.0 0.0 5.6 2.3 3.4 6.4 2.3 2.6 2.6 1.5 4.3 13.1 4.1 5.2 2.1 13.5 7.7 0.0 0.3 6.5 2.3 1.7 1.6 SPRY4 ENSG00000187678 "Sprouty RTK signaling antagonist 4" Q9C004 5 142310427-142326455 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 100.2;WM-115: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008086, HPA055471, HPA072661" Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207" "unprognostic (9.54e-3)" "prognostic unfavorable (7.12e-4)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (8.70e-2)" "unprognostic (3.23e-2)" "unprognostic (3.98e-3)" "unprognostic (1.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.48e-1)" "unprognostic (9.89e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (6.29e-3)" "unprognostic (3.63e-2)" "unprognostic (4.59e-2)" "unprognostic (8.21e-2)" 23.5 19.1 8.7 4.8 8.2 0.0 14.4 6.3 10.0 4.5 11.8 8.8 6.4 6.7 1.5 3.2 7.5 8.1 19.9 8.5 14.9 13.1 12.5 27.0 2.8 9.2 7.9 7.2 2.6 4.7 7.1 20.3 13.9 9.4 9.2 5.3 4.3 4.4 4.7 5.1 3.6 7.9 6.2 5.8 8.8 8.8 1.8 7.6 2.0 19.6 6.6 1.4 8.2 4.1 7.8 3.0 5.0 48.4 100.2 29.0 20.7 12.7 35.9 12.0 5.7 6.0 5.2 5.1 0.0 25.0 9.2 6.1 2.4 0.0 10.6 7.2 0.1 0.0 0.2 0.0 22.9 9.5 0.0 0.2 16.7 0.2 15.8 8.6 9.3 5.5 0.1 11.7 0.1 21.9 4.3 0.0 14.0 21.5 16.8 31.3 1.1 6.8 1.3 17.7 32.2 0.6 14.1 0.7 4.7 42.5 14.1 0.4 2.1 8.3 12.6 0.2 2.5 32.4 0.1 1.7 0.2 19.4 0.1 139.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 8.2 6.3 10.0 8.5 14.9 9.2 7.9 7.2 9.4 5.8 7.6 7.8 39.5 6.4 49.0 6.8 0.2 1.7 3.8 1.7 17.1 9.1 7.6 10.2 3.2 1.5 1.1 3.7 0.0 1.0 0.9 7.3 0.0 2.0 0.8 10.1 4.6 32.8 13.8 0.0 11.2 0.4 2.1 12.4 6.1 17.1 3.8 0.5 37.1 3.2 0.3 0.0 17.1 7.3 0.0 2.6 1.2 1.7 0.3 0.5 7.2 22.5 0.0 1.6 0.0 96.5 0.8 5.1 2.5 0.4 0.1 4.3 5.6 1.2 0.6 0.6 19.7 17.1 24.3 0.1 1.0 3.5 0.3 3.4 1.4 1.3 7.6 1.8 ERAS "HRAS2, HRASP" ENSG00000187682 "ES cell expressed Ras" Q7Z444 X 48826513-48830138 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9" "Cell type enhanced" "Detected in some" "Spermatocytes: 1.7;Spermatogonia: 1.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.1;ovarian cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.47e-2)" "unprognostic (1.28e-2)" "unprognostic (4.50e-2)" "unprognostic (3.93e-2)" "unprognostic (3.61e-1)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (1.87e-2)" "unprognostic (2.72e-4)" "unprognostic (9.40e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (1.98e-1)" "unprognostic (1.08e-1)" "unprognostic (2.25e-2)" 0.1 0.0 1.2 0.0 0.9 0.1 0.1 1.1 1.5 0.4 0.7 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.8 1.9 0.5 0.6 0.1 0.0 1.0 1.1 0.9 0.4 0.0 0.0 1.0 0.0 1.0 0.2 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.8 0.0 0.1 1.0 1.9 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 1.1 1.5 0.8 1.9 1.0 1.1 0.9 1.0 0.8 1.9 1.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.1 1.7 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415571-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 50.0;Hofbauer cells: 50.6;monocytes: 39.4;NK-cells: 49.4" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 78.8;fHDF/TERT166: 108.4;HMC-1: 89.0;SK-MEL-30: 94.7;TIME: 84.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA044993 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavorable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 15.1 20.7 5.9 18.5 8.2 23.0 10.4 4.8 7.7 7.9 3.4 6.7 6.7 7.6 1.8 5.4 7.3 8.6 10.2 5.0 7.2 4.6 4.1 30.5 24.8 9.3 9.6 5.2 7.8 6.3 9.0 1.7 20.3 12.4 6.0 6.3 1.0 4.5 2.6 4.0 6.6 10.8 11.9 5.8 23.9 5.9 2.0 8.2 15.9 6.3 5.6 16.4 10.8 7.2 10.0 0.3 1.6 0.0 0.0 25.6 78.8 4.9 8.3 9.4 9.1 8.9 0.3 0.3 9.6 2.2 108.4 7.8 0.2 0.2 0.0 5.1 43.0 0.7 10.7 0.0 26.1 30.0 14.8 89.0 35.2 0.0 54.0 0.7 4.1 3.8 12.9 37.2 26.0 43.4 0.5 19.1 20.5 0.1 0.1 0.2 11.3 0.3 4.3 40.6 1.1 1.2 0.1 0.0 0.0 94.7 41.0 0.0 12.7 84.9 0.2 0.3 0.3 1.1 0.1 0.3 5.1 8.2 21.6 12.6 60.8 26.6 35.8 63.4 52.8 55.5 19.2 46.0 59.3 58.7 20.3 25.7 44.8 6.8 63.2 49.4 51.3 49.9 43.1 5.9 8.2 4.8 7.7 5.0 7.2 9.3 9.6 5.2 12.4 5.8 8.2 10.0 15.8 0.0 5.3 1.0 11.1 2.8 0.1 0.0 0.0 0.6 0.5 0.4 1.1 1.5 0.6 0.0 0.0 2.2 29.3 0.0 0.0 0.2 0.3 0.4 0.1 12.3 0.0 6.7 3.3 3.6 2.3 11.0 1.1 0.1 50.0 16.7 8.9 0.4 50.6 0.0 2.6 0.0 0.0 19.5 18.2 0.0 1.8 28.7 28.4 4.7 39.4 0.3 49.4 0.5 0.5 4.7 0.1 4.5 15.1 0.0 0.0 0.1 0.8 0.6 26.3 7.9 23.6 1.3 5.9 0.4 1.7 16.1 26.8 2.8 0.0 0.1 AMTN "RSTI689, UNQ689" ENSG00000187689 Amelotin Q6UX39 4 70518569-70532743 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Biomineralization, Cell adhesion" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 28.5;salivary gland: 6.8;stomach 1: 7.3" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 14.0;Ionocytes: 4.1" "Group enriched" "Detected in many" 11 "cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 16.7;hTERT-RPE1: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036136, HPA036137" Uncertain "Secreted in other tissues" NA NA "HPA036136: AB_2674963, HPA036137: AB_10673614" "unprognostic (1.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.86e-2)" "unprognostic (7.35e-2)" "unprognostic (2.55e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 7.3 0.0 0.1 0.3 0.0 0.0 28.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.7 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 23.7 0.1 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 14.0 0.0 0.0 0.1 0.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.3 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 EZHIP "CATACOMB, CXorf67" ENSG00000187690 "EZH inhibitory protein" Q86X51 X 51406948-51408843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 6.0" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 2.3;Extravillous trophoblasts: 2.5;Syncytiotrophoblasts: 1.9" "Cancer enriched" "Detected in some" 6 "testis cancer: 11.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 45 "U-2 OS: 32.8" "HPA004003, HPA006128" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004003: AB_2667113, HPA006128: AB_2667517" "unprognostic (4.21e-2)" "unprognostic (6.36e-2)" "unprognostic (3.37e-2)" "unprognostic (8.58e-3)" "unprognostic (3.57e-4)" "unprognostic (1.47e-6)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (4.26e-1)" 0.0 0.2 0.7 0.0 0.7 0.0 0.0 0.6 0.6 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.9 0.2 0.0 0.1 0.0 0.5 0.3 0.4 0.4 0.1 0.0 1.0 0.9 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 6.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.6 0.6 0.3 0.9 0.5 0.3 0.4 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 C2orf88 "MGC13057, smAKAP" ENSG00000187699 "Chromosome 2 open reading frame 88" Q9BSF0 2 189879609-190203484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 496.6;Early spermatids: 1138.7;Late spermatids: 1344.3;Proximal enterocytes: 462.3" "Group enriched" "Detected in many" 4 "endometrial cancer: 16.2;glioma: 4.8;ovarian cancer: 14.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.7;naive B-cell: 2.8;neutrophil: 7.1;plasmacytoid DC: 3.0" "Group enriched" "Detected in many" 8 "B-cells: 2.8;dendritic cells: 3.0;granulocytes: 7.1" "Group enriched" "Detected in many" 6 "HEL: 108.4;K-562: 92.2;RT4: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049549 Approved NA NA 160000 "HPA049549: AB_2680812" "unprognostic (1.20e-4)" "unprognostic (9.17e-2)" "unprognostic (4.50e-2)" "prognostic favorable (4.97e-4)" "unprognostic (6.09e-3)" "unprognostic (4.55e-2)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "prognostic unfavorable (9.39e-4)" "unprognostic (5.29e-3)" "unprognostic (2.66e-1)" "unprognostic (1.18e-1)" "prognostic favorable (7.79e-4)" "unprognostic (2.64e-2)" "unprognostic (2.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-3)" 4.2 6.6 11.3 4.5 12.6 9.9 9.3 11.6 13.7 48.7 3.6 36.4 35.0 16.0 2.2 2.7 21.1 2.8 11.7 11.2 11.8 6.5 4.7 3.6 3.3 10.9 11.4 7.8 1.9 12.9 35.4 2.7 1.7 12.2 7.2 39.0 4.5 14.2 9.5 13.6 5.7 44.8 3.9 13.2 4.9 5.1 73.7 10.7 0.5 3.6 29.1 5.4 4.8 11.9 20.5 0.1 0.3 0.9 0.3 3.6 11.7 0.8 0.4 0.5 0.2 1.1 3.5 0.2 0.7 14.2 1.1 5.9 0.3 3.0 0.0 1.4 0.6 1.9 108.4 0.4 6.9 0.3 0.7 0.0 5.4 0.3 5.8 0.3 0.2 0.3 0.4 92.2 7.1 1.6 0.4 0.3 0.8 0.4 0.3 0.1 0.4 4.2 0.5 2.2 58.8 0.9 2.2 0.2 0.2 11.6 2.0 0.0 1.1 0.8 0.7 0.7 0.3 0.3 0.5 2.0 2.1 1.0 0.5 0.1 0.0 0.5 0.9 0.0 0.0 0.0 2.7 0.0 0.1 0.1 2.8 0.0 0.0 7.1 0.1 0.0 3.0 0.0 16.5 11.3 12.6 11.6 13.7 11.2 11.8 10.9 11.4 7.8 12.2 13.2 10.7 20.5 4.1 3.2 0.5 15.3 6.4 1.5 12.9 0.6 2.2 9.1 25.0 36.4 41.5 1.5 0.0 3.7 25.0 0.1 1.1 496.6 19.6 0.5 1138.7 164.4 23.8 21.0 4.2 51.8 28.1 15.3 0.5 7.8 2.6 228.4 0.0 21.7 83.9 3.8 0.2 8.4 26.9 67.9 0.0 5.9 1.8 1344.3 9.9 57.9 26.6 12.2 4.2 2.7 7.2 22.1 44.9 3.9 227.4 6.0 27.8 3.2 462.3 33.2 0.0 12.4 0.0 9.2 3.9 37.9 6.0 2.5 2.3 0.4 3.8 6.1 35.0 3.3 OR2T27 ENSG00000187701 "Olfactory receptor family 2 subfamily T member 27" Q8NH04 1 248649838-248655528 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM203 "HBEBP1, MGC14327" ENSG00000187713 "Transmembrane protein 203" Q969S6 9 137204082-137205648 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.31e-1)" "unprognostic (2.65e-2)" "unprognostic (4.53e-2)" "unprognostic (8.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.54e-2)" "unprognostic (2.72e-2)" "unprognostic (1.78e-1)" "unprognostic (1.43e-1)" "unprognostic (7.16e-2)" "prognostic favorable (4.78e-6)" "unprognostic (2.94e-1)" "prognostic favorable (1.50e-5)" "unprognostic (3.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.04e-2)" "unprognostic (1.19e-1)" 25.0 32.9 32.7 17.3 32.7 11.0 25.7 33.3 37.1 27.0 31.5 29.6 22.4 30.2 26.6 31.7 24.4 16.5 39.6 32.4 32.9 31.8 49.6 20.7 27.2 33.4 33.7 32.7 27.9 26.4 31.0 25.8 16.1 32.9 27.4 18.4 16.5 27.1 22.0 50.1 43.7 28.8 17.0 32.2 30.7 30.4 19.3 34.2 20.5 25.3 46.4 22.9 28.1 27.9 32.6 38.0 39.3 36.5 60.7 53.1 41.1 43.6 48.4 46.6 55.1 41.1 32.6 33.3 39.0 45.7 42.2 53.0 72.6 45.3 48.1 32.1 71.0 43.5 27.0 45.5 37.4 44.3 63.1 26.8 39.6 75.4 36.0 47.4 36.8 35.8 50.5 64.2 44.4 43.2 65.2 50.5 54.6 60.8 72.4 63.2 54.2 51.1 78.2 46.5 27.2 48.3 47.3 38.6 48.8 39.2 25.0 68.8 50.6 32.0 56.3 30.1 63.6 55.1 23.8 80.0 49.5 43.5 46.3 47.3 4.7 3.8 4.1 5.2 4.3 6.4 8.3 5.8 6.5 4.6 4.5 8.7 6.0 1.9 7.5 3.9 4.8 4.0 2.6 32.7 32.7 33.3 37.1 32.4 32.9 33.4 33.7 32.7 32.9 32.2 34.2 32.6 23.2 9.6 6.8 4.6 21.4 17.6 22.7 7.0 23.9 33.6 29.6 33.8 13.5 40.0 7.9 31.3 4.2 30.5 23.7 15.9 52.8 49.4 3.5 15.3 24.2 20.7 16.3 29.8 5.7 42.0 26.3 22.3 14.8 13.3 5.7 31.7 21.4 41.1 29.3 32.0 6.2 13.4 10.2 27.1 13.2 9.4 22.1 20.8 24.9 5.6 54.2 58.8 24.7 2.5 6.1 41.7 10.8 20.7 13.3 37.2 18.5 59.2 4.9 25.7 13.1 19.5 32.5 18.6 15.9 28.5 27.3 19.4 24.4 36.2 18.6 17.9 SLC18A3 VACHT ENSG00000187714 "Solute carrier family 18 member A3" Q16572 10 49610310-49612720 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 23.7" "Cell type enriched" "Detected in some" 4 "Fibroblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 7.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 78.1" CAB079011 Supported NA NA "CAB079011: " "unprognostic (2.14e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (9.39e-2)" "unprognostic (4.55e-2)" "unprognostic (3.00e-1)" "unprognostic (5.85e-3)" "unprognostic (7.56e-2)" "unprognostic (1.16e-1)" 0.0 0.0 0.6 0.3 1.5 0.0 0.0 0.0 13.5 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 16.1 5.6 0.9 0.0 0.0 0.0 1.2 0.4 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 13.5 0.1 5.8 16.1 5.6 0.9 23.7 3.2 1.5 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 KBTBD12 "FLJ46299, KLHDC6" ENSG00000187715 "Kelch repeat and BTB domain containing 12" Q3ZCT8 3 127915232-127987671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 14.0;skeletal muscle: 59.3;tongue: 26.0" "Cell type enhanced" "Detected in many" "Astrocytes: 43.4;Early spermatids: 32.0;Excitatory neurons: 29.9;Microglial cells: 74.0" "Cancer enhanced" "Detected in some" "cervical cancer: 1.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 5.1" NA NA "unprognostic (3.60e-2)" "unprognostic (2.19e-2)" "unprognostic (3.37e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (3.01e-1)" "unprognostic (3.35e-2)" "unprognostic (4.69e-3)" "unprognostic (3.62e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-2)" "unprognostic (1.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (5.70e-2)" "unprognostic (9.49e-2)" 0.3 0.2 1.5 0.3 1.5 0.2 0.2 1.7 1.7 0.1 2.4 1.5 0.8 0.3 0.1 0.7 0.9 0.8 14.0 1.7 0.7 1.2 0.0 0.2 0.1 0.9 0.9 1.2 0.1 4.0 0.0 0.5 0.1 1.1 0.5 1.2 0.7 1.9 0.2 59.3 0.3 0.7 0.7 0.8 0.0 2.0 1.0 0.8 0.0 0.0 26.0 0.0 0.8 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 1.5 1.7 1.7 1.7 0.7 0.9 0.9 1.2 1.1 0.8 0.8 1.8 0.0 3.2 3.7 43.4 0.0 0.1 0.1 0.0 0.0 1.0 0.4 0.1 12.1 0.0 1.4 1.8 6.2 0.0 0.1 2.3 1.9 0.1 32.0 1.3 0.0 0.2 2.4 1.7 29.9 9.3 0.0 0.7 7.1 0.8 0.0 0.1 0.0 0.0 0.1 1.7 15.7 5.8 0.0 0.0 1.0 3.2 0.0 0.3 0.0 74.0 0.0 1.6 0.0 3.0 2.2 5.9 5.8 0.0 0.1 0.0 1.4 0.0 1.2 0.9 0.0 1.6 1.0 6.2 5.7 0.0 0.3 0.0 0.0 0.1 1.9 0.1 THSD4 "ADAMTSL6, FLJ13710, FVSY9334, PRO34005" ENSG00000187720 "Thrombospondin type 1 domain containing 4" Q6ZMP0 15 71096952-71783383 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 104.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "spinal cord: 39.0" "Secreted - unknown location" NA NA "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (3.14e-2)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.80e-2)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (3.01e-3)" 2.7 8.5 9.8 1.6 6.7 0.0 14.9 5.9 8.3 104.6 9.8 7.0 7.9 22.4 7.9 60.8 37.3 11.0 33.5 8.4 7.0 8.9 7.1 10.4 0.9 8.3 8.9 4.2 3.1 6.4 0.8 9.8 3.6 7.9 34.3 7.0 1.2 11.5 15.2 3.0 8.0 8.8 10.4 6.8 1.9 12.1 3.1 14.2 1.6 8.8 2.6 2.5 13.4 38.9 7.0 6.0 45.3 0.8 13.0 6.7 40.2 0.2 22.0 53.0 11.2 5.8 0.3 8.7 0.0 17.7 7.8 38.5 17.0 1.8 9.1 6.8 2.0 2.0 0.0 4.4 0.0 4.3 0.0 0.0 3.0 6.7 6.7 26.6 30.5 20.7 0.0 0.0 0.5 9.2 9.1 0.0 0.1 3.9 0.1 7.8 0.0 0.7 0.8 29.5 6.0 0.7 5.5 8.8 10.9 0.0 5.0 43.3 0.1 66.6 0.2 1.0 44.4 11.8 0.0 0.3 0.0 10.4 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 6.7 5.9 8.3 8.4 7.0 8.3 8.9 4.2 7.9 6.8 14.2 7.0 1.1 19.2 9.0 6.5 0.0 13.9 106.4 11.3 449.0 3.0 48.7 43.9 60.1 58.6 7.5 5.5 6.2 0.4 0.8 16.2 1.9 18.3 7.5 19.3 13.2 9.8 3.0 0.0 17.1 1.8 0.4 12.5 2.6 31.8 0.0 0.3 6.1 12.3 0.2 0.0 19.1 6.1 0.0 0.0 2.1 16.9 17.4 1.6 8.8 247.3 0.0 0.3 0.0 8.5 6.7 13.6 11.0 74.4 1.2 94.6 29.3 0.5 11.0 0.9 0.0 16.8 6.6 0.9 1.7 141.5 10.9 0.8 3.1 42.2 13.2 29.7 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73951026-73970366 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 53.7;testis: 19.0" "Group enriched" "Detected in some" 4 "Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA052465: AB_2681842, HPA061330: AB_2732659" "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.1 0.1 3.3 1.2 1.7 4.5 0.2 1.9 1.5 4.7 10.0 0.1 0.6 2.0 5.3 0.1 53.7 2.2 0.1 1.4 3.7 1.0 0.1 3.1 2.1 3.7 3.9 0.7 0.3 0.8 0.1 1.1 0.5 3.2 0.9 0.0 0.5 0.6 2.9 0.3 0.1 2.9 0.1 4.5 1.3 0.2 19.0 1.9 0.0 0.2 0.0 0.0 0.2 0.1 1.7 0.0 0.4 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.7 0.2 0.9 2.1 0.2 0.3 0.5 0.1 0.0 0.0 2.7 0.3 1.0 0.9 0.3 0.0 0.2 0.6 0.0 0.4 0.1 0.0 0.0 0.0 1.4 0.2 2.6 0.4 0.3 0.6 0.9 0.2 0.2 1.5 0.4 1.2 1.1 4.5 0.5 0.3 1.0 0.5 2.2 0.2 0.4 0.3 0.7 0.0 0.0 0.6 0.6 0.0 2.2 2.0 1.9 0.0 0.3 0.1 0.7 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.7 0.2 0.1 3.3 1.7 1.9 1.5 1.4 3.7 3.7 3.9 0.7 3.2 4.5 1.9 1.7 0.2 3.2 0.0 2.0 0.0 0.0 1.9 11.1 0.0 0.2 0.1 0.3 0.2 0.0 7.6 1.8 0.0 0.1 0.0 0.1 0.0 1.7 90.6 114.8 2.4 0.2 0.0 0.0 0.4 0.0 0.1 0.5 0.0 13.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 10.2 0.0 0.0 62.9 1.2 0.3 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 1.2 0.0 1.3 1.4 1.0 104.2 0.9 0.0 1.1 3.3 19.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 1.2 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor subunit delta" O14764 1 2019329-2030758 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 49.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 0.3 1.5 17.1 0.0 17.2 0.0 0.5 49.3 38.1 0.1 1.5 0.2 0.0 0.3 0.1 0.3 0.2 0.4 0.7 13.1 11.0 0.4 0.2 0.9 0.2 14.1 25.1 15.7 0.2 0.1 0.7 2.7 0.1 22.4 0.2 0.0 1.4 0.3 0.0 0.3 0.4 0.2 0.3 1.3 0.3 0.1 3.6 37.6 0.1 0.9 0.4 0.0 0.2 0.2 14.3 0.0 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 2.7 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.1 17.2 49.3 38.1 13.1 11.0 14.1 25.1 15.7 22.4 1.3 37.6 14.3 1.0 3.2 3.6 4.9 0.1 0.5 0.0 0.0 0.0 14.7 0.3 0.0 0.9 0.0 6.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 3.4 0.0 0.0 30.0 0.0 0.3 0.5 0.0 0.2 2.5 0.3 0.0 0.0 0.1 13.5 37.4 0.0 0.0 0.0 0.3 0.2 0.0 0.9 0.0 8.4 0.0 1.4 0.0 3.0 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.4 1.6 0.0 0.0 4.8 0.1 11.3 0.1 0.0 0.3 0.4 0.2 0.1 0.1 AMY1C AMY1 ENSG00000187733 "Amylase alpha 1C" P04745 1 103750406-103758690 "Metabolic proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "pancreas: 127.0;salivary gland: 201.1" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 36.2;Respiratory ciliated cells: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 70000000 "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.3 127.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 201.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.9 0.0 4.6 10.9 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TCEA1 "GTF2S, SII, TCEA, TF2S, TFIIS" ENSG00000187735 "Transcription elongation factor A1" P23193 8 53966552-54022456 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043786 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA043786: AB_10959468" "unprognostic (5.35e-2)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (2.11e-3)" "unprognostic (3.34e-2)" "unprognostic (1.17e-1)" "unprognostic (3.72e-2)" "unprognostic (1.77e-1)" "unprognostic (4.14e-2)" "unprognostic (1.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.80e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" 53.1 46.4 47.7 57.0 51.4 81.9 62.8 49.6 58.8 55.7 48.0 50.2 47.5 56.1 46.2 54.4 52.8 42.9 36.2 46.2 58.9 60.3 91.1 47.1 99.1 51.9 50.4 41.8 62.5 69.0 80.7 28.5 49.7 50.5 59.6 51.2 49.5 57.0 54.8 42.4 50.2 47.3 52.8 52.2 49.9 52.7 37.1 48.4 73.0 125.3 42.0 113.5 55.1 41.7 59.8 161.3 157.9 138.1 145.7 99.3 121.8 100.9 122.1 147.3 143.5 160.2 91.4 131.0 392.5 136.9 147.0 152.5 120.9 182.3 116.6 212.9 225.0 88.5 293.6 71.5 139.5 309.7 116.8 122.7 88.5 308.1 137.4 606.2 121.3 128.2 132.9 191.1 334.0 135.5 75.6 245.8 83.3 229.1 265.0 47.1 185.1 48.2 72.5 204.0 107.0 129.9 95.5 101.9 91.0 356.3 132.2 129.6 132.6 110.6 106.1 96.3 120.6 114.5 201.1 134.4 260.9 184.9 133.2 152.1 82.3 64.1 78.7 103.9 63.1 98.3 213.8 107.0 96.7 81.8 174.1 93.9 99.3 23.1 97.5 60.6 116.7 153.0 73.5 47.7 51.4 49.6 58.8 46.2 58.9 51.9 50.4 41.8 50.5 52.2 48.4 59.8 94.7 89.8 106.2 24.2 253.2 135.5 128.3 98.9 257.2 77.0 129.2 124.3 23.9 82.9 109.4 99.3 89.6 115.5 143.8 61.0 168.3 121.0 86.4 126.9 145.4 92.5 87.2 330.7 17.7 109.9 125.1 118.8 111.6 124.4 98.7 75.7 66.4 160.7 87.7 57.2 20.1 96.6 118.0 89.5 134.2 191.0 134.8 124.2 117.4 17.8 132.5 166.0 170.0 22.1 29.7 121.1 71.6 132.8 341.1 146.0 72.2 207.6 110.6 104.5 78.9 102.6 130.4 94.9 103.1 237.2 150.6 112.1 154.8 108.5 88.1 148.6 NHEJ1 "Cernunnos, FLJ12610, XLF" ENSG00000187736 "Non-homologous end joining factor 1" Q9H9Q4 2 219069357-219160865 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 7.8;Microglial cells: 11.2;Oligodendrocytes: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012334, HPA043869" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB012334: , HPA043869: AB_2678707" "unprognostic (5.66e-2)" "unprognostic (3.01e-2)" "unprognostic (3.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (5.92e-2)" "unprognostic (5.16e-2)" "unprognostic (6.04e-2)" "unprognostic (3.51e-2)" "unprognostic (6.87e-2)" "unprognostic (1.58e-3)" "unprognostic (4.52e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (8.90e-2)" "unprognostic (8.29e-2)" 9.5 8.5 2.5 4.4 2.6 4.6 8.6 3.9 3.9 8.9 2.7 12.3 6.9 8.8 4.3 7.3 7.4 4.8 5.8 2.5 3.0 12.8 8.2 6.9 6.2 3.2 2.8 2.3 9.2 8.5 3.5 2.8 4.7 3.3 6.7 8.4 3.4 5.7 4.3 17.2 8.3 12.3 8.2 3.1 7.0 9.1 18.9 2.9 6.2 4.7 7.6 5.9 10.5 8.8 3.6 5.5 8.2 13.9 12.6 15.6 17.9 8.0 10.9 9.6 13.2 15.4 25.4 5.9 12.2 8.4 11.4 13.4 7.2 20.5 10.9 11.8 13.8 9.0 18.1 10.0 17.5 12.5 8.5 13.9 15.5 21.2 10.5 12.5 8.9 11.1 7.8 22.3 11.8 10.7 4.6 11.5 10.3 15.9 5.1 8.0 14.6 10.2 9.8 10.5 8.2 10.2 11.4 5.0 7.1 15.8 15.6 6.4 8.0 9.9 10.0 9.3 4.4 9.1 6.3 8.0 13.2 6.1 16.2 10.3 6.3 11.9 6.6 7.0 17.7 12.2 12.0 11.4 9.3 8.7 9.0 14.1 10.4 3.3 11.6 15.6 4.8 12.8 9.1 2.5 2.6 3.9 3.9 2.5 3.0 3.2 2.8 2.3 3.3 3.1 2.9 3.6 0.3 0.0 0.0 5.9 3.5 0.4 0.0 0.2 5.7 0.0 0.2 0.1 0.1 0.0 0.7 0.0 0.0 0.2 1.7 7.8 0.0 1.6 0.7 0.1 0.3 1.0 2.4 3.8 4.7 1.9 0.3 0.6 5.6 0.2 0.0 0.0 0.0 0.3 0.3 0.0 5.1 3.4 0.0 0.0 0.0 0.2 0.3 2.1 0.0 11.2 3.1 0.0 0.0 5.0 8.1 1.0 2.9 0.0 6.1 0.2 3.4 0.4 0.0 0.0 0.0 0.1 1.3 0.2 0.5 5.9 0.0 0.3 2.6 0.2 3.1 0.0 FANCA "FA-H, FAA, FACA, FAH, FANCH" ENSG00000187741 "FA complementation group A" O15360 16 89737549-89816657 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.4;testis: 21.7" "Cell type enhanced" "Detected in many" "Spermatocytes: 44.1;Spermatogonia: 38.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063236 Supported Nucleoplasm NA Yes Nucleoplasm "HPA063236: AB_2684966" "unprognostic (5.99e-2)" "unprognostic (5.68e-2)" "unprognostic (2.36e-1)" "unprognostic (5.12e-2)" "unprognostic (1.87e-1)" "unprognostic (7.11e-2)" "unprognostic (1.45e-4)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (2.05e-1)" "unprognostic (4.82e-3)" "unprognostic (8.48e-4)" "unprognostic (7.82e-10)" "unprognostic (3.67e-2)" "unprognostic (2.05e-1)" "unprognostic (2.94e-1)" "unprognostic (1.62e-1)" 1.4 1.9 1.9 6.8 2.1 20.4 1.9 2.6 3.4 1.5 1.7 5.5 5.3 1.2 0.8 6.7 2.0 1.2 1.5 1.9 1.4 1.8 6.1 3.4 12.6 1.5 1.6 1.9 1.4 1.9 1.4 1.9 4.2 1.9 1.7 6.3 1.0 2.1 0.6 0.7 5.3 5.7 2.2 1.2 6.8 3.7 21.7 1.6 8.2 1.7 0.6 13.6 2.3 2.8 2.0 23.2 34.8 40.8 35.7 2.6 5.2 31.2 28.2 15.3 46.5 19.5 30.6 37.3 56.2 12.9 9.8 15.5 34.7 27.7 21.1 48.8 13.4 46.5 16.6 49.1 63.4 1.7 17.1 17.5 1.7 2.2 37.8 12.0 6.6 14.9 28.0 40.9 16.9 24.6 53.6 34.6 73.7 26.5 31.5 21.3 61.4 32.8 10.3 11.8 21.5 36.3 19.7 41.9 12.3 5.4 23.3 22.4 30.4 11.1 37.0 38.9 20.9 30.0 15.1 19.0 56.3 17.5 37.8 36.1 2.5 7.4 9.9 4.2 8.5 3.0 7.0 2.4 3.7 6.2 4.6 0.6 2.6 9.4 8.2 9.2 0.4 9.2 4.2 1.9 2.1 2.6 3.4 1.9 1.4 1.5 1.6 1.9 1.9 1.2 1.6 2.0 1.5 0.0 1.1 0.7 9.6 3.4 1.6 2.6 0.0 8.1 3.0 2.0 2.9 0.0 3.5 16.5 10.4 16.0 12.3 5.1 1.9 2.0 5.9 2.8 3.5 2.1 1.8 20.8 10.0 1.6 9.9 3.3 9.2 3.4 2.5 19.0 5.3 4.7 8.8 3.3 5.7 8.1 2.0 4.1 3.1 4.1 1.5 6.8 0.0 1.0 3.0 1.1 21.6 3.0 1.7 1.9 1.7 0.0 21.1 1.3 6.6 10.4 6.4 7.7 0.0 2.7 3.5 44.1 38.5 3.8 1.8 25.3 9.3 6.8 11.4 2.6 SECISBP2 SBP2 ENSG00000187742 "SECIS binding protein 2" Q96T21 9 89318500-89359663 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 332.4;Late spermatids: 440.3;Spermatocytes: 338.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044314, HPA054905" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA044314: AB_10964885, HPA054905: " "unprognostic (1.07e-1)" "unprognostic (4.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (4.00e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-2)" "unprognostic (7.18e-2)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "prognostic favorable (8.98e-9)" "unprognostic (5.44e-2)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (4.55e-3)" 22.3 27.4 19.4 22.8 21.5 35.4 28.5 22.2 20.2 28.4 23.6 26.2 23.7 27.6 28.2 19.9 28.4 18.8 17.1 18.7 19.4 30.4 29.4 26.1 32.2 19.6 18.9 16.5 41.1 41.1 25.5 28.3 27.3 20.1 25.4 27.8 49.4 27.3 16.5 42.0 29.9 29.6 15.4 18.9 35.1 27.2 69.5 19.7 34.1 35.6 21.4 27.7 24.9 23.8 28.2 29.9 19.9 53.5 31.1 24.7 26.5 38.8 16.9 20.9 19.8 19.4 11.2 24.4 44.4 14.6 15.9 31.5 37.1 36.4 17.0 18.3 29.4 21.6 21.8 16.5 28.7 21.3 44.2 31.5 16.7 31.5 16.8 19.9 21.8 25.0 58.5 28.4 51.1 19.1 27.7 60.9 22.6 55.7 74.5 19.5 29.1 26.2 29.3 22.2 22.7 39.0 38.3 15.3 33.7 45.9 35.4 29.9 37.8 23.2 19.2 22.3 26.0 26.4 61.7 42.3 18.2 33.3 28.3 28.1 17.0 8.2 14.7 10.8 8.9 10.5 14.2 10.9 10.7 7.4 14.8 16.2 13.9 23.0 10.2 11.5 13.0 14.3 6.5 19.4 21.5 22.2 20.2 18.7 19.4 19.6 18.9 16.5 20.1 18.9 19.7 28.2 72.5 44.8 58.0 43.8 81.2 19.5 72.0 29.9 38.1 113.8 49.0 59.8 18.3 31.5 40.2 40.5 91.8 70.6 67.7 41.0 43.0 39.4 332.4 44.8 34.6 46.2 37.3 60.4 55.2 31.4 47.2 36.1 42.8 47.7 36.1 51.8 36.0 36.9 26.9 57.2 55.4 56.7 30.5 32.6 19.4 440.3 40.0 69.6 21.4 51.5 47.2 44.8 69.0 46.8 77.5 35.9 49.6 25.6 81.5 64.1 49.2 54.5 41.8 112.9 32.9 63.2 36.3 338.9 223.2 44.2 25.4 91.8 54.3 43.9 50.0 65.4 OR52B6 ENSG00000187747 "Olfactory receptor family 52 subfamily B member 6" Q8NGF0 11 5580877-5581884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.57e-1)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.7 0.3 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C9orf153 bA507D14.1 ENSG00000187753 "Chromosome 9 open reading frame 153" Q5TBE3 9 86220265-86259657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 21.0" "Group enriched" "Detected in some" 26 "Early spermatids: 268.6;Late spermatids: 244.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.3" "Not detected" "Not detected" HPA079466 Approved "Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane" NA NA "Nuclear bodies, Plasma membrane" "Nucleoplasm, Vesicles" "HPA079466: " "unprognostic (2.03e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.30e-3)" "unprognostic (7.49e-2)" "unprognostic (2.75e-2)" "unprognostic (3.37e-1)" "unprognostic (6.85e-2)" "unprognostic (9.70e-2)" "unprognostic (1.49e-1)" "unprognostic (2.01e-6)" "unprognostic (9.43e-2)" "unprognostic (1.92e-1)" "unprognostic (9.64e-2)" "unprognostic (2.10e-1)" 0.1 0.4 0.7 0.4 0.4 2.6 0.2 1.4 1.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.4 0.0 1.0 0.4 0.1 0.1 0.2 0.5 0.6 0.5 0.0 0.2 0.1 0.1 0.0 0.9 1.5 0.1 0.1 0.6 0.2 0.2 0.0 0.3 0.2 0.1 0.3 0.2 0.3 21.0 0.7 0.1 0.2 0.1 0.0 0.0 0.0 1.6 0.2 0.8 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.2 0.0 0.6 0.8 0.2 0.2 0.5 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.3 0.2 0.1 0.2 0.2 0.1 0.6 0.1 0.0 0.0 0.3 0.9 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.7 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.6 0.1 0.2 0.4 0.1 0.3 0.0 0.1 0.4 0.8 1.6 0.2 0.3 0.6 0.1 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.5 0.3 0.2 0.2 0.1 1.5 0.7 0.4 1.4 1.0 1.0 0.4 0.6 0.5 0.0 1.5 0.3 0.7 1.6 0.3 0.0 0.0 9.8 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 268.6 0.4 0.5 0.7 0.0 0.0 4.8 0.0 0.1 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 244.8 2.8 0.1 1.8 1.0 0.1 0.4 2.1 6.6 9.7 0.1 0.0 0.7 0.4 0.3 0.0 0.1 0.0 0.1 0.0 1.3 0.7 1.8 1.9 0.0 0.1 0.1 0.2 0.3 0.1 0.2 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644061-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.3;RT4: 1.7" "HPA045683, HPA071685" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (1.29e-1)" 0.0 0.0 0.4 0.1 0.4 0.2 0.0 1.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.7 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.7 0.4 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.0 0.7 0.2 0.2 0.7 0.6 0.2 0.8 0.4 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276369-99291003 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 305 "liver: 2761.4" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 200.9" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "ASC diff: 8.2" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" NA NA 38000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 7.2 1.6 0.2 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 9.0 0.3 0.5 0.1 0.5 6.7 0.2 0.0 0.0 0.7 2761.4 0.8 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.3 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.1 1.8 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.1 1.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 15.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.1 0.3 0.0 10.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 8.6 200.9 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 272.6" "Cell type enhanced" "Detected in many" "dendritic cells: 76.5;NK-cells: 92.7;Oligodendrocytes: 310.5;T-cells: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 133.2;HMC-1: 97.2;JURKAT: 89.1;MOLT-4: 120.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved NA NA 7500000 "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favorable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favorable (4.06e-5)" 6.4 12.9 96.9 35.5 150.9 29.0 6.2 137.5 121.1 8.1 49.8 10.5 10.7 6.5 12.3 27.5 11.1 12.4 11.8 81.8 110.6 22.6 4.1 14.3 62.9 163.2 158.7 73.7 6.6 8.1 6.0 13.9 5.6 192.9 12.0 9.8 5.1 12.1 6.6 88.9 16.6 29.1 5.5 151.0 51.7 16.9 10.7 139.5 43.8 11.8 27.8 50.2 11.5 16.4 272.6 12.7 9.2 8.4 12.4 0.4 0.8 19.0 1.1 0.5 2.6 1.7 6.1 13.8 47.3 5.1 0.2 9.7 6.4 7.5 3.6 1.1 133.2 7.5 20.1 3.3 0.7 1.5 26.4 97.2 0.3 2.8 0.6 0.3 0.3 4.9 89.1 4.8 31.5 0.0 20.9 120.9 33.9 20.6 25.0 0.5 38.2 2.8 13.4 16.5 13.0 19.7 13.1 3.4 8.9 0.3 11.7 10.1 14.4 3.2 0.1 7.6 1.0 6.1 34.9 16.3 6.6 6.0 32.1 7.6 17.2 7.5 38.2 22.0 7.0 13.3 4.3 17.5 18.6 2.6 2.5 19.9 23.2 37.0 9.4 8.1 8.0 17.7 14.5 96.9 150.9 137.5 121.1 81.8 110.6 163.2 158.7 73.7 192.9 151.0 139.5 272.6 3.4 6.4 15.7 33.6 35.4 4.6 3.3 2.1 3.4 12.4 9.5 5.5 18.7 5.7 6.9 11.0 2.1 9.0 76.5 1.5 3.9 5.4 2.2 10.9 6.4 5.2 1.8 23.1 44.5 3.3 2.1 6.7 7.7 15.4 42.5 8.0 5.3 1.6 21.6 33.7 17.2 6.3 4.1 28.2 6.1 3.8 7.5 37.4 1.8 49.6 43.7 8.9 92.7 12.1 310.5 3.7 0.7 15.1 53.7 6.5 0.5 14.2 5.7 5.1 0.0 11.4 2.6 0.9 26.1 7.1 5.4 3.7 89.7 2.3 3.3 7.7 KRTAP10-8 "KAP10.8, KRTAP18-8, KRTAP18.8" ENSG00000187766 "Keratin associated protein 10-8" P60410 21 44612079-44612954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "skin 1: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "placenta: 66.0" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 0.5 0.0 0.7 0.5 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.4 0.4 0.5 0.0 0.0 0.0 0.3 66.0 0.5 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 4.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 3.2 49.1 10.0 0.0 0.0 252.1 0.1 0.0 0.0 0.0 16.6 0.1 0.1 0.0 0.1 3.0 0.1 31.2 0.0 0.0 0.0 24.1 36.6 0.0 44.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 86.9 1.2 0.0 0.0 5.6 6.2 44.8 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.1 11.6 0.1 0.3 4.0 44.5 0.0 10.6 1.0 0.1 5.3 0.2 0.1 14.8 22.6 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.1 1.4 0.6 0.6 0.4 0.4 0.5 0.5 0.0 0.5 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 6.2 75.4 0.0 0.0 0.0 0.0 27.5 0.0 0.0 8.3 0.0 0.0 40.2 0.0 83.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 9.7 1.7 5.7 0.0 0.0 0.0 0.0 25.2 0.3 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 6.6 0.0 0.0 6.3 9.9 0.0 0.0 55.8 0.0 0.0 0.0 0.0 DIPK1C "C18orf51, FAM69C" ENSG00000187773 "Divergent protein kinase domain 1C" Q0P6D2 18 74434775-74457944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.5;choroid plexus: 13.9;retina: 16.7" "Cell type enriched" "Detected in single" 27 "Cardiomyocytes: 22.1" "Group enriched" "Detected in some" 18 "glioma: 11.1;melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SK-MEL-30: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048928 Enhanced NA NA "HPA048928: AB_2680560" "unprognostic (6.35e-2)" "unprognostic (1.13e-2)" "unprognostic (8.09e-2)" "unprognostic (3.32e-2)" "unprognostic (4.08e-2)" "unprognostic (3.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (8.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.10e-2)" "unprognostic (1.91e-4)" "unprognostic (2.16e-1)" "unprognostic (6.73e-2)" "unprognostic (3.23e-2)" "unprognostic (4.40e-3)" 0.3 0.1 21.3 0.0 27.5 0.0 0.3 24.3 24.1 1.7 13.9 1.0 0.0 0.2 0.1 0.1 0.2 0.4 7.0 20.5 22.7 0.1 0.3 0.0 0.0 25.4 26.7 18.8 0.0 0.1 0.0 0.3 0.1 29.9 0.4 0.1 16.7 0.3 0.6 1.1 4.2 0.3 0.1 18.5 0.1 1.5 6.9 27.7 0.7 0.0 2.0 0.0 0.1 0.4 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 27.5 24.3 24.1 20.5 22.7 25.4 26.7 18.8 29.9 18.5 27.7 31.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577396 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 2.2;retina: 2.5;testis: 5.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5" "Group enriched" "Detected in some" 4 "head and neck cancer: 2.9;lung cancer: 1.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 5.7;MOLT-4: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: AB_2732305" "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 5.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.4 0.0 0.4 1.4 0.8 0.0 1.1 1.0 0.5 2.2 0.4 6.4 0.5 0.7 0.6 0.6 0.3 0.1 0.0 56.4 0.1 0.0 2.5 0.0 0.0 0.0 87.6 0.0 0.1 0.0 0.0 0.0 43.7 1.4 0.5 1.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 1.7 0.0 0.1 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.8 1.7 36.6 0.6 2.9 0.0 1.0 0.1 1.5 0.0 1.0 52.5 0.1 0.0 0.4 0.4 0.3 0.0 0.1 0.0 7.8 0.0 0.6 0.5 17.4 0.6 0.0 0.1 0.0 0.3 0.4 0.0 0.1 MCRS1 "ICP22BP, INO80Q, MCRS2, MSP58, P78" ENSG00000187778 "Microspherule protein 1" Q96EZ8 12 49556544-49568145 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039057 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA039057: AB_10794085" "unprognostic (2.60e-3)" "unprognostic (5.23e-2)" "unprognostic (1.46e-1)" "unprognostic (1.89e-2)" "unprognostic (1.68e-1)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (2.26e-2)" "unprognostic (2.83e-3)" "unprognostic (6.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.23e-1)" "prognostic favorable (2.70e-4)" "unprognostic (2.28e-1)" "unprognostic (1.69e-1)" "unprognostic (4.35e-2)" "unprognostic (3.26e-2)" 22.4 29.9 28.4 27.5 29.2 32.4 23.6 28.1 31.8 26.5 26.8 30.3 27.5 31.6 23.9 35.2 30.4 23.1 66.7 29.2 26.3 34.6 24.8 24.5 33.5 29.7 27.8 29.3 23.8 33.0 36.0 24.1 24.7 29.5 31.5 26.1 17.4 27.2 27.1 53.7 27.1 29.5 26.4 28.5 33.1 32.1 35.5 29.5 39.7 35.8 62.0 31.4 29.6 26.5 30.8 43.8 81.5 62.9 54.5 33.2 40.9 69.3 37.5 40.4 95.7 53.2 127.3 69.7 72.6 76.4 66.0 43.7 48.5 97.8 89.0 38.3 57.6 120.3 72.4 53.4 46.9 59.6 85.0 76.0 47.7 68.3 63.8 51.3 56.0 71.0 66.0 90.9 48.0 55.4 77.8 59.1 51.1 87.4 40.7 60.1 69.1 50.7 84.0 59.4 40.3 60.6 63.5 40.8 51.7 36.5 42.8 84.4 101.7 51.6 45.8 58.4 44.7 56.7 47.3 50.9 69.2 60.1 49.8 27.8 96.2 63.7 76.4 63.2 82.7 49.1 44.5 53.6 68.1 79.1 46.1 46.8 51.0 31.8 90.7 64.7 53.5 60.4 76.3 28.4 29.2 28.1 31.8 29.2 26.3 29.7 27.8 29.3 29.5 28.5 29.5 30.8 17.0 35.3 13.8 6.2 23.3 10.7 25.1 38.5 10.8 15.6 19.8 19.7 24.2 28.6 22.4 23.9 8.4 52.1 22.1 34.3 52.8 37.7 32.1 16.3 15.3 17.4 27.5 35.1 12.8 36.1 51.8 20.2 39.8 15.7 27.3 24.3 15.0 10.5 40.6 23.5 12.6 27.2 28.5 22.0 12.5 37.8 27.4 20.9 28.4 9.4 38.0 28.1 40.2 7.1 12.3 39.7 37.1 27.1 24.3 26.7 34.1 45.4 22.8 20.5 6.6 14.7 26.9 41.6 64.0 27.4 12.6 59.2 25.6 23.7 33.8 27.0 TMEM72 "bA285G1.3, C10orf127, KSP37" ENSG00000187783 "Transmembrane protein 72" A0PK05 10 44911316-44937010 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 41.1;kidney: 52.6" "Cell type enhanced" "Detected in some" "Collecting duct cells: 27.6;Distal enterocytes: 21.1;Distal tubular cells: 33.2;Late spermatids: 15.9;Paneth cells: 8.9" "Cancer enriched" "Detected in some" 8 "renal cancer: 8.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 123 "RPMI-8226: 44.0;U-937: 26.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039894, HPA062907" Enhanced NA NA "HPA039894: AB_10795261, HPA062907: AB_2684900" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (8.58e-2)" "unprognostic (5.45e-2)" "prognostic favorable (1.01e-4)" "unprognostic (4.99e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" 0.0 0.0 0.6 0.0 0.3 0.4 0.0 0.7 1.0 0.0 41.1 6.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.6 1.1 52.6 0.1 0.0 0.0 1.3 1.4 0.0 0.0 9.2 0.5 0.2 0.0 1.2 0.0 7.8 0.2 2.4 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.2 2.8 2.0 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.7 1.0 3.6 1.1 1.3 1.4 0.0 1.2 0.1 2.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 27.6 0.0 0.0 0.0 21.1 33.2 0.1 5.5 0.7 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 FANCM "FAAP250, KIAA1596" ENSG00000187790 "FA complementation group M" Q8IYD8 14 45135930-45200890 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 65.5;Late spermatids: 206.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055144 Supported Nucleoplasm NA NA Nucleoplasm "HPA055144: AB_2682715" "unprognostic (8.40e-2)" "unprognostic (6.70e-2)" "unprognostic (3.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.15e-1)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.57e-2)" "unprognostic (8.52e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-2)" "unprognostic (7.55e-2)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (8.94e-2)" "unprognostic (1.13e-2)" 1.9 1.6 0.9 2.2 1.7 5.7 2.8 2.0 2.2 2.1 0.4 1.6 1.3 2.5 2.2 1.9 1.6 1.9 1.3 1.1 1.2 1.8 1.5 1.7 3.3 1.6 1.2 0.7 2.9 1.1 1.6 0.8 1.9 1.3 1.7 1.8 2.8 1.4 1.9 1.6 2.7 1.2 1.9 0.7 2.3 1.4 7.6 1.0 4.1 1.5 2.3 2.7 1.5 1.5 1.2 8.2 7.0 8.1 7.5 6.4 3.5 6.5 10.3 4.1 8.1 10.1 11.3 6.2 10.6 5.8 2.6 4.5 10.6 9.5 4.4 11.0 7.6 5.4 5.1 7.8 6.4 1.1 13.0 6.1 2.2 1.6 8.1 5.1 1.8 7.1 6.6 9.1 8.9 6.9 8.1 9.5 9.2 3.2 6.3 11.6 9.0 12.7 4.5 3.4 5.8 7.3 1.9 9.4 7.6 4.0 5.1 8.0 6.0 5.6 11.8 11.0 10.6 8.1 4.4 8.7 10.3 2.3 7.9 7.0 6.6 0.7 2.5 2.0 2.0 1.1 4.3 1.3 0.7 0.6 2.0 2.0 1.7 1.0 1.1 0.9 1.7 1.0 0.6 0.9 1.7 2.0 2.2 1.1 1.2 1.6 1.2 0.7 1.3 0.7 1.0 1.2 6.5 0.0 3.1 9.8 8.3 2.7 1.1 1.9 4.6 6.3 3.9 2.4 8.3 1.5 3.1 1.8 2.1 7.6 5.6 1.7 0.0 2.2 65.5 3.5 5.8 5.1 0.0 12.8 21.0 2.7 3.5 4.6 5.1 3.0 1.3 9.4 5.7 1.7 3.5 3.3 15.6 1.6 4.1 3.8 2.9 206.1 9.0 4.0 3.6 18.7 5.9 4.8 3.1 20.1 22.7 2.4 0.8 5.3 8.4 0.8 1.5 1.9 1.1 6.9 6.6 4.7 6.0 26.5 14.0 4.4 1.8 2.3 5.6 9.5 3.2 0.7 FAM205C FAM205CP ENSG00000187791 "Family with sequence similarity 205 member C" A6NFA0 9 34889066-34895764 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 29.1" "Group enriched" "Detected in some" 91 "Early spermatids: 275.6;Late spermatids: 489.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 103 "THP-1: 14.8" "Not detected" "Not detected" NA NA "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "unprognostic (3.64e-2)" "unprognostic (8.64e-2)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-4)" "unprognostic (1.48e-3)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.1 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.1 29.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.9 0.0 275.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 489.3 1.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 2.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF70 "Cos17, MGC48959" ENSG00000187792 "Zinc finger protein 70" Q9UC06 22 23738682-23751112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018821 Uncertain Approved Cytosol NA NA Cytosol "HPA018821: AB_1859423" "unprognostic (3.17e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" "unprognostic (8.49e-3)" "unprognostic (1.08e-1)" "unprognostic (2.80e-2)" "unprognostic (6.07e-3)" "unprognostic (2.18e-3)" "unprognostic (9.93e-2)" "unprognostic (6.20e-2)" "unprognostic (1.73e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-2)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (4.36e-2)" "unprognostic (5.69e-2)" 1.3 1.2 1.0 1.3 1.3 1.7 1.3 2.3 1.0 1.9 1.6 1.3 0.8 1.9 2.4 0.9 1.9 1.1 1.4 0.8 1.0 0.9 0.7 1.2 1.4 1.8 1.1 0.5 3.9 1.8 2.1 1.6 1.2 1.4 1.5 1.3 3.0 2.1 1.5 2.6 1.1 1.3 1.6 0.6 1.4 1.3 1.2 1.0 1.2 1.8 2.2 1.6 1.4 1.3 2.3 1.2 1.5 2.9 3.0 4.2 2.0 0.9 1.1 2.2 2.5 3.5 1.5 0.8 1.7 0.7 2.4 1.6 1.3 2.0 1.5 3.1 1.1 1.8 3.3 3.0 1.3 2.5 3.0 2.7 2.0 0.9 3.3 2.7 3.2 2.0 1.3 1.2 2.4 1.8 1.6 1.7 1.4 0.7 1.1 0.6 7.2 2.8 0.4 0.9 1.6 1.6 2.0 1.6 2.0 1.2 2.0 1.0 1.4 2.6 2.7 3.4 1.8 1.2 2.4 0.4 1.5 2.4 1.3 2.4 1.5 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.3 0.2 0.3 0.8 0.5 0.2 0.4 0.1 0.1 1.0 1.3 2.3 1.0 0.8 1.0 1.8 1.1 0.5 1.4 0.6 1.0 2.3 1.2 0.0 2.8 0.7 1.0 0.4 1.1 0.0 1.2 3.8 1.1 1.4 2.6 2.8 1.8 3.7 10.4 0.4 2.1 0.3 0.0 1.1 1.4 1.6 3.9 1.7 1.2 0.8 0.8 1.1 0.6 3.2 0.5 1.0 1.3 3.8 4.2 0.5 0.8 6.7 1.2 0.6 0.0 1.6 0.6 3.3 6.2 1.0 0.0 0.0 0.8 2.1 0.0 0.0 1.6 0.4 0.0 4.1 1.5 0.7 0.8 0.9 3.6 4.0 6.6 5.4 2.7 2.7 2.5 1.0 0.0 0.3 1.2 2.8 0.7 0.9 CARD9 ENSG00000187796 "Caspase recruitment domain family member 9" Q9H257 9 136361903-136373681 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.1;lymphoid tissue: 10.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 14.1;Hofbauer cells: 21.2;Horizontal cells: 15.2;Kupffer cells: 18.8;Langerhans cells: 12.9;Macrophages: 22.3;monocytes: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 57.6;non-classical monocyte: 50.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 22.5;HMC-1: 69.7;NB-4: 50.0;THP-1: 63.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059502 Enhanced NA NA "HPA059502: AB_2684042" "unprognostic (7.03e-2)" "unprognostic (5.61e-2)" "unprognostic (8.62e-3)" "unprognostic (2.06e-2)" "unprognostic (2.75e-1)" "unprognostic (2.11e-2)" "unprognostic (3.89e-3)" "unprognostic (6.36e-2)" "unprognostic (2.64e-1)" "unprognostic (1.55e-2)" "unprognostic (7.68e-3)" "unprognostic (6.97e-2)" "unprognostic (2.02e-6)" "unprognostic (2.52e-1)" "unprognostic (4.87e-3)" "unprognostic (3.06e-1)" "unprognostic (1.06e-1)" 1.1 1.3 0.4 4.8 0.6 13.1 1.2 2.5 0.8 1.4 0.3 1.0 1.3 0.8 0.4 1.0 1.8 1.0 0.4 0.4 0.9 1.0 0.9 3.4 1.2 1.4 0.9 0.1 0.3 0.5 0.1 0.8 0.9 1.1 1.8 0.4 0.2 1.2 1.0 0.2 2.7 1.8 1.1 1.1 10.0 0.6 0.4 1.0 0.4 0.4 0.0 1.6 1.2 1.1 1.6 0.1 0.0 0.3 0.0 0.0 0.0 4.6 9.5 0.3 0.2 0.0 0.7 0.0 0.0 0.1 3.5 0.0 0.0 0.3 0.0 0.1 0.0 0.2 22.5 0.1 6.8 4.9 12.2 69.7 0.0 0.1 0.2 0.2 0.0 0.1 0.0 5.3 0.0 0.0 0.2 0.0 50.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 12.3 0.0 16.0 0.1 0.0 4.1 63.7 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 16.0 0.0 6.9 34.5 11.5 0.0 57.6 0.9 0.0 0.0 0.0 26.0 0.0 0.0 0.0 2.3 0.7 50.5 0.1 0.5 14.1 0.4 0.6 2.5 0.8 0.4 0.9 1.4 0.9 0.1 1.1 1.1 1.0 1.6 0.8 0.0 4.6 4.6 1.1 1.8 0.6 0.3 3.4 0.2 4.2 4.3 2.6 0.0 4.9 3.7 0.0 0.4 2.2 0.4 1.9 0.1 1.0 1.2 14.1 1.1 0.0 2.5 2.1 0.0 0.4 2.1 1.5 1.4 10.8 0.4 0.7 0.1 21.2 15.2 1.1 0.0 0.0 18.8 12.9 6.9 0.3 22.3 1.8 6.5 16.3 4.6 3.1 0.0 0.2 0.0 0.1 0.0 1.4 0.1 0.0 0.3 0.6 0.9 0.0 0.3 1.5 1.0 1.5 0.9 1.7 0.4 1.4 0.2 0.2 0.6 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA 62000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 16.6 5.0 2.5 2.3 1.7 2.4 13.1 1.0 4.1 11.6 2.7 4.2 1.6 10.1 1.1 2.6 9.2 7.5 8.3 0.9 1.3 4.7 2.2 11.9 3.8 1.6 1.9 0.1 9.2 2.3 1.7 3.4 11.8 1.6 4.8 0.9 0.4 2.9 3.7 5.8 3.7 4.1 4.6 0.7 7.0 3.7 3.0 2.0 1.5 9.7 7.6 1.1 6.0 7.4 2.8 0.5 2.9 0.8 0.0 0.0 3.7 0.1 11.7 19.5 4.8 2.8 0.3 0.5 0.0 0.6 8.7 0.4 0.2 0.0 29.9 1.3 0.2 0.0 14.8 0.7 0.8 21.6 0.1 0.0 11.3 0.1 6.5 1.5 1.0 52.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 11.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 6.9 0.0 0.0 85.2 0.1 6.4 2.6 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 1.7 1.0 4.1 0.9 1.3 1.6 1.9 0.1 1.6 0.7 2.0 2.8 44.6 0.0 3.2 0.0 0.4 0.9 0.1 0.7 1.2 2.4 0.6 1.3 7.5 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.2 0.2 2.5 30.6 1.8 5.7 0.0 0.4 0.1 10.1 1.5 0.4 1.3 0.1 40.0 0.4 0.5 0.0 0.0 2.3 0.0 1.6 1.5 3.5 44.4 3.0 5.4 12.2 0.4 0.2 0.0 0.0 0.0 1.2 0.0 35.7 0.0 0.2 0.0 0.1 0.2 0.2 26.3 1.7 34.2 1.5 1.5 0.2 1.1 0.3 0.3 1.1 0.3 0.2 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Excitatory neurons: 10.2;Inhibitory neurons: 7.9;Oligodendrocyte precursor cells: 11.1;Spermatogonia: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 0.4 0.5 1.9 1.7 1.3 0.4 0.9 0.1 2.9 1.0 0.0 0.9 0.9 1.4 0.7 0.8 0.5 1.1 0.6 1.6 0.9 0.5 0.8 0.5 1.4 0.6 0.4 1.5 0.6 1.0 0.7 0.5 0.4 0.8 0.6 1.0 1.5 0.4 0.6 0.5 0.5 0.6 1.0 0.4 0.8 0.9 1.4 0.8 1.9 0.9 0.3 1.9 1.3 0.3 1.3 3.6 1.5 6.1 14.8 2.2 5.8 1.7 3.5 3.2 1.5 2.9 1.6 2.3 6.9 3.3 3.0 3.0 1.3 3.1 3.0 3.4 6.0 1.3 2.8 3.5 5.2 1.5 0.4 4.4 1.3 4.9 5.4 7.1 1.5 2.1 9.0 7.5 6.9 4.6 2.5 9.4 0.6 8.1 1.3 1.5 5.3 5.9 3.3 3.0 3.5 8.0 8.4 5.6 4.6 2.4 3.4 2.4 8.0 4.6 4.9 10.4 4.6 5.0 10.4 10.6 14.8 6.5 0.9 5.2 0.0 0.1 0.3 0.9 0.7 1.2 0.6 0.6 0.5 0.4 0.6 1.2 1.0 0.0 0.6 0.2 0.1 1.4 0.3 1.9 1.3 0.1 2.9 1.6 0.9 0.6 0.4 1.5 0.8 0.4 0.8 1.3 1.1 0.0 0.0 1.3 2.4 0.3 0.6 0.3 0.0 3.4 0.8 0.6 0.7 0.0 0.2 1.8 0.0 0.6 1.0 0.1 0.0 1.2 0.0 0.8 1.6 1.3 0.0 0.4 10.2 0.2 1.4 0.7 1.1 0.5 0.0 3.2 1.1 0.1 1.1 0.0 7.9 0.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 1.0 1.1 0.9 3.1 11.1 1.8 1.1 0.3 0.4 2.4 0.3 0.2 0.2 0.1 2.2 0.0 0.9 1.3 1.8 5.7 0.3 0.1 0.0 1.5 0.9 0.4 0.2 TMEM202 FLJ27523 ENSG00000187806 "Transmembrane protein 202" A6NGA9 15 72398302-72408367 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 124 "testis: 12.4" "Group enriched" "Detected in some" 34 "Early spermatids: 67.6;Late spermatids: 58.5;Spermatocytes: 61.2" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 61.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOWAHD ANKRD58 ENSG00000187808 "Sosondowah ankyrin repeat domain family member D" A6NJG2 X 119758588-119760202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.1;lymphoid tissue: 7.2;testis: 5.0" "Cell type enhanced" "Detected in some" "B-cells: 12.2;Extravillous trophoblasts: 38.3;Hofbauer cells: 17.5;Proximal enterocytes: 9.1;Rod photoreceptor cells: 8.2;Syncytiotrophoblasts: 9.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "naive B-cell: 11.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.3;NB-4: 2.9;SK-BR-3: 3.2;THP-1: 8.3;U-937: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA065955 Uncertain NA NA "HPA065955: AB_2685586" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.10e-2)" "unprognostic (8.88e-2)" "unprognostic (1.67e-1)" "unprognostic (4.38e-2)" "unprognostic (2.03e-1)" "unprognostic (7.20e-2)" "unprognostic (3.45e-2)" "unprognostic (6.07e-2)" "unprognostic (5.80e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-5)" "unprognostic (5.82e-2)" "unprognostic (3.14e-2)" "unprognostic (9.22e-2)" "unprognostic (3.74e-3)" 0.3 0.4 0.6 1.8 0.6 2.2 0.2 0.6 0.9 0.2 0.4 0.8 2.1 0.1 0.0 0.2 0.3 0.2 0.2 0.6 0.9 0.6 0.3 1.6 2.5 0.9 0.6 0.3 0.3 0.3 0.7 0.1 1.1 1.0 0.2 0.5 0.7 1.7 0.1 0.0 0.3 4.1 0.1 1.3 7.2 1.2 5.0 0.7 0.6 0.1 0.2 1.5 0.3 0.2 1.1 0.4 0.0 0.1 0.1 0.0 0.0 4.3 0.0 0.0 0.4 0.6 0.8 0.1 0.2 0.6 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.2 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.4 0.0 2.9 0.9 0.8 0.3 2.5 0.1 0.1 0.0 0.1 0.2 0.1 0.9 3.2 0.1 0.3 0.5 8.3 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.0 7.4 0.0 0.0 3.1 1.9 0.0 3.3 0.0 9.1 0.4 0.3 2.0 11.7 1.7 0.9 3.3 0.3 2.9 1.0 0.0 0.7 0.6 0.6 0.6 0.9 0.6 0.9 0.9 0.6 0.3 1.0 1.3 0.7 1.1 0.2 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.8 0.3 0.5 0.5 1.5 0.0 3.7 0.0 6.1 2.7 3.7 0.0 0.4 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.4 38.3 0.1 0.5 0.2 0.0 0.2 0.0 0.0 17.5 1.7 0.0 0.9 0.0 5.4 0.6 1.2 0.0 6.5 0.0 0.0 3.4 0.6 1.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 9.1 0.2 0.0 8.2 0.0 0.0 0.2 0.1 0.9 0.1 0.1 9.4 0.5 0.1 2.3 0.0 ZFP69 "FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A" ENSG00000187815 "ZFP69 zinc finger protein" Q49AA0 1 40477290-40496343 "Predicted intracellular proteins, Transcription factors" "Lipid metabolism, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 5 "THP-1: 58.2" "Not detected" "Not detected" "HPA027808, HPA054942" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027808: AB_10601031, HPA054942: AB_2682644" "unprognostic (1.07e-2)" "unprognostic (6.00e-2)" "unprognostic (7.58e-3)" "unprognostic (4.15e-2)" "unprognostic (1.52e-1)" "prognostic favorable (9.31e-4)" "unprognostic (7.21e-3)" "unprognostic (1.72e-1)" "unprognostic (8.40e-3)" "unprognostic (6.34e-3)" "unprognostic (2.31e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (1.05e-1)" "unprognostic (3.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.81e-1)" 2.0 1.4 3.0 2.3 3.3 1.9 2.1 2.8 2.8 2.4 2.2 2.5 1.9 2.4 2.2 2.0 2.4 1.8 1.7 2.6 2.8 1.7 2.0 2.4 2.9 3.2 2.9 2.7 2.7 2.5 2.5 1.3 2.2 3.0 2.5 2.0 2.1 1.7 2.3 0.5 2.8 2.4 2.6 2.7 3.2 2.1 3.7 2.9 3.0 2.1 0.8 2.9 2.7 2.1 3.4 5.4 0.0 3.1 4.1 3.8 3.9 5.3 2.9 3.4 4.4 5.0 2.8 4.2 9.6 3.7 4.6 5.7 4.3 6.0 2.5 5.0 8.7 4.1 7.2 5.3 4.8 3.0 0.1 7.4 4.0 6.2 2.9 4.5 1.4 2.6 0.2 4.2 0.1 2.5 2.8 7.5 9.1 5.9 0.5 0.1 4.1 11.0 4.5 2.4 4.0 4.1 6.5 4.9 4.5 8.3 4.8 0.1 58.2 1.1 2.0 4.0 5.6 0.3 0.2 7.6 5.9 3.7 1.5 5.6 0.0 0.1 0.0 0.5 0.1 0.6 0.3 0.4 0.6 0.2 0.2 0.2 0.6 0.0 1.9 0.1 0.0 0.2 0.2 3.0 3.3 2.8 2.8 2.6 2.8 3.2 2.9 2.7 3.0 2.7 2.9 3.4 1.5 6.4 0.0 2.3 2.4 1.0 0.4 0.2 4.0 1.4 0.6 0.6 1.5 0.0 0.1 0.0 0.0 1.2 1.8 0.7 1.9 1.5 15.1 0.8 1.4 2.2 0.0 2.1 2.7 1.3 1.8 1.5 1.1 0.6 0.0 2.6 0.7 1.1 1.3 0.0 2.7 0.9 2.0 1.0 1.9 3.5 1.2 1.4 1.8 2.8 2.4 1.5 2.1 6.6 5.4 1.1 0.3 1.9 3.6 0.4 0.3 0.5 0.8 0.9 0.0 1.4 1.4 4.1 4.6 1.5 0.4 0.3 1.9 1.5 1.3 0.3 HELT "bHLHb44, HCM1228, HESL, MEGANE, Mgn" ENSG00000187821 "Helt bHLH transcription factor" A6NFD8 4 185018841-185020804 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Distal tubular cells: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036188, HPA036189" Uncertain NA NA "HPA036188: AB_10672237, HPA036189: AB_2674997" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "liver: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 1.1 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 104.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 173.3;Proximal enterocytes: 576.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 8.0 11.0 3.2 4.9 3.1 5.8 7.3 2.8 3.3 6.2 4.8 8.3 15.9 6.9 4.6 4.3 6.1 5.2 5.1 2.9 5.0 10.3 104.6 5.5 6.2 4.0 3.4 2.4 7.0 9.6 3.6 3.2 3.2 3.8 21.9 5.0 19.2 5.5 7.9 8.2 6.7 27.0 3.9 3.9 6.5 13.2 9.2 3.1 1.2 13.1 0.8 1.9 6.0 5.0 4.1 0.5 3.1 1.1 7.2 4.4 4.4 0.7 6.0 6.6 4.2 5.7 0.0 0.3 0.7 0.4 4.0 0.2 0.4 2.8 0.2 3.0 0.3 1.2 0.4 0.1 2.7 6.7 0.8 0.7 3.0 0.3 1.3 0.3 0.8 1.9 2.7 0.3 0.2 2.6 0.4 1.1 1.3 4.4 0.4 0.0 4.4 0.2 0.5 9.8 0.2 0.4 5.5 0.3 0.1 0.7 1.5 0.3 1.6 4.4 0.2 0.9 2.2 0.4 0.7 0.3 0.2 4.3 1.1 0.4 1.6 2.1 2.1 0.7 1.6 0.9 4.0 1.8 1.1 2.6 9.0 7.4 5.2 1.6 4.2 0.7 1.9 0.4 1.7 3.2 3.1 2.8 3.3 2.9 5.0 4.0 3.4 2.4 3.8 3.9 3.1 4.1 10.1 3.2 11.0 18.3 7.5 9.6 17.7 9.2 23.3 2.5 20.9 26.4 11.6 57.2 9.9 18.4 8.4 12.0 3.1 41.3 21.5 18.0 99.0 6.1 16.3 8.1 3.0 21.7 1.4 23.6 20.6 16.3 33.6 7.6 40.0 13.4 16.1 173.3 24.0 0.0 2.8 32.6 4.1 13.5 6.4 22.2 18.0 13.1 24.9 12.2 4.6 55.0 5.2 17.6 1.6 12.6 32.5 9.8 6.6 36.5 576.7 31.7 6.9 23.6 19.7 17.2 12.7 90.6 8.7 20.7 8.0 4.5 3.0 30.0 21.1 22.3 C2orf78 "COG5373, FLJ43987, hCG1989538" ENSG00000187833 "Chromosome 2 open reading frame 78" A6NCI8 2 73784189-73817147 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 12.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.25e-2)" "unprognostic (6.56e-3)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H1-2 "H1.2, H1c, H1F2, H1s-1, HIST1H1C" ENSG00000187837 "H1.2 linker histone, cluster member" P16403 6 26055740-26056470 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 458.7" "Cell line enhanced" "Detected in many" "K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8" "Low region specificity" "Detected in all" "CAB011507, HPA055907" Supported Supported "Nucleoplasm,Nucleoli rim" NA NA 5500000 "Nucleoplasm, Nucleoli rim" "CAB011507: AB_2117984, HPA055907: AB_2682966" "unprognostic (4.43e-2)" "unprognostic (1.57e-3)" "unprognostic (1.31e-2)" "unprognostic (2.96e-2)" "unprognostic (5.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.96e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.85e-1)" "unprognostic (8.93e-2)" "unprognostic (3.08e-1)" "prognostic favorable (8.06e-5)" 55.5 48.0 66.6 27.4 52.9 231.5 72.4 147.5 64.7 94.7 78.5 49.0 33.9 14.7 42.4 70.9 41.7 19.1 114.7 50.9 104.0 77.6 131.1 61.0 31.8 62.5 62.4 43.6 90.1 61.0 8.8 15.3 44.2 70.6 134.0 44.6 22.2 40.2 16.6 229.3 48.9 43.1 8.0 54.1 57.0 74.0 27.0 81.1 62.6 60.2 100.0 28.1 29.7 91.3 89.5 39.9 27.5 20.5 21.9 49.9 10.0 0.7 19.5 30.8 87.9 92.6 14.9 28.1 3.1 109.6 25.6 32.8 17.3 6.4 15.0 24.3 38.7 23.4 16.5 27.8 17.5 14.7 7.8 38.4 70.4 19.9 11.5 19.2 27.3 13.8 17.6 334.2 243.3 43.7 17.3 20.8 18.3 11.5 96.3 41.4 10.8 9.5 129.1 52.8 28.1 52.6 17.9 311.1 53.0 22.0 19.1 65.8 12.5 6.8 41.1 601.6 12.5 9.0 673.7 661.8 31.3 29.9 253.6 14.4 258.6 14.3 458.7 19.3 14.2 24.4 57.7 31.9 21.4 30.5 76.8 29.4 23.1 229.3 20.2 18.9 31.6 48.3 22.1 66.6 52.9 147.5 64.7 50.9 104.0 62.5 62.4 43.6 70.6 54.1 81.1 89.5 14.9 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.3 0.0 0.0 0.0 0.0 42.7 29.2 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 68.1 9.4 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 298.4 4.5 0.0 0.0 0.0 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394842 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.0;Ductal cells: 5.8;Exocrine glandular cells: 3.6;monocytes: 2.0;Pancreatic endocrine cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria NA NA Mitochondria "HPA048387: AB_2680381, HPA068609: AB_2686011" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 38.7 21.3 6.5 11.1 6.4 3.3 35.3 6.1 8.6 43.3 6.3 23.6 3.1 44.9 6.0 37.7 29.7 6.6 31.1 5.8 7.6 23.6 14.5 33.1 10.6 7.7 6.4 5.5 30.8 16.9 5.6 16.5 7.1 6.8 24.9 3.4 1.2 23.1 8.1 21.3 35.2 22.0 12.4 6.5 41.0 22.1 6.1 6.8 6.4 23.0 11.2 10.6 35.1 38.4 7.2 26.7 6.6 5.7 17.2 19.4 32.8 6.8 24.1 22.1 21.3 19.3 9.8 6.6 7.3 19.4 35.1 9.0 37.6 7.0 41.4 10.9 19.0 4.0 6.7 9.2 6.0 23.6 2.5 8.2 22.6 25.4 20.7 30.1 32.0 32.3 14.5 4.1 5.6 27.1 14.3 7.7 2.0 5.1 7.1 18.3 15.1 4.3 8.3 20.1 17.7 4.7 15.6 13.9 8.8 5.9 5.0 16.0 1.3 53.2 13.9 14.5 15.7 10.3 6.2 7.4 3.0 22.4 8.4 15.9 7.0 24.5 2.8 39.5 34.1 40.8 32.2 72.8 40.7 24.1 32.5 59.2 36.1 2.6 18.0 30.2 2.8 83.5 33.3 6.5 6.4 6.1 8.6 5.8 7.6 7.7 6.4 5.5 6.8 6.5 6.8 7.2 1.0 3.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 5.8 0.0 0.1 1.0 1.0 0.0 0.0 0.0 3.6 0.3 1.0 0.0 0.1 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030534-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 190.5;salivary gland: 165.6" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol NA NA 44000 "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 53.9 12.7 7.6 17.1 7.4 35.3 54.1 7.5 11.0 21.5 11.0 24.8 18.6 19.9 2.2 86.7 21.9 9.0 31.8 7.3 8.8 18.9 64.0 25.2 10.4 9.4 6.8 6.2 22.4 190.5 7.9 9.3 28.8 8.8 19.4 15.5 1.5 165.6 17.1 98.9 19.8 23.3 14.5 10.2 24.1 44.1 5.5 11.2 9.7 9.7 27.5 10.5 33.9 26.7 9.2 146.9 113.2 32.4 193.2 41.3 32.3 77.0 130.5 111.9 128.4 203.5 74.8 56.3 46.3 101.5 121.3 77.1 85.1 109.1 197.5 74.8 36.0 190.9 269.6 52.0 104.9 423.6 98.8 60.4 100.0 314.9 142.0 264.1 40.1 208.2 57.7 152.7 221.8 54.8 141.7 95.9 297.8 186.0 112.9 243.7 80.3 80.4 197.4 49.3 22.3 281.6 200.8 26.1 78.8 534.8 20.3 105.8 192.2 105.2 76.1 167.1 179.9 137.8 185.1 121.6 72.1 173.4 213.4 169.1 51.1 416.3 258.3 27.9 336.6 27.3 130.7 32.8 30.9 335.0 103.3 26.2 26.0 39.4 35.0 268.3 242.6 66.0 258.3 7.6 7.4 7.5 11.0 7.3 8.8 9.4 6.8 6.2 8.8 10.2 11.2 9.2 23.6 9.6 8.3 1.6 25.2 74.4 42.4 114.8 51.8 3.6 84.8 72.8 41.7 57.2 97.3 20.2 2.1 41.3 27.3 70.1 29.4 226.1 17.0 11.6 39.0 54.6 40.2 79.9 0.8 730.0 224.2 68.6 35.7 12.5 18.4 76.0 65.3 103.4 223.4 0.0 1.3 138.2 79.3 108.6 82.2 106.2 43.5 83.9 72.9 1.9 101.9 19.2 21.6 4.0 0.4 277.9 64.5 19.2 38.7 100.2 19.5 103.1 33.5 2.2 13.1 17.6 85.2 1.9 25.5 209.3 85.4 38.6 19.8 69.3 83.8 58.9 P2RX2 "DFNA41, P2X2" ENSG00000187848 "Purinergic receptor P2X 2" Q9UBL9 12 132618776-132622388 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Hearing, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;epididymis: 22.0;prostate: 14.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.6;Endometrial ciliated cells: 2.6;Fibroblasts: 8.3;Gastric mucus-secreting cells: 1.1;Peritubular cells: 3.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Group enriched" "Detected in many" 5 "amygdala: 9.5;cerebral cortex: 11.8;hippocampal formation: 10.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 5.1;T-47d: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.12e-1)" "unprognostic (1.49e-2)" "unprognostic (5.92e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (3.12e-1)" "unprognostic (5.79e-3)" "unprognostic (6.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.11e-2)" "unprognostic (3.66e-2)" "unprognostic (1.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" 0.5 0.1 9.5 0.7 0.5 0.1 0.2 0.4 11.8 0.6 0.0 2.0 1.1 0.2 22.0 7.3 9.4 0.1 0.0 10.3 1.2 0.9 0.4 5.0 1.9 0.2 0.2 1.8 0.3 0.5 0.7 1.3 0.4 0.4 14.3 0.3 0.0 0.1 9.1 0.0 0.2 4.3 0.1 0.1 3.2 1.7 1.6 2.2 0.4 0.2 0.0 0.8 1.0 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 5.1 0.1 0.3 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 1.9 0.0 0.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.5 0.5 0.4 11.8 10.3 1.2 0.2 0.2 1.8 0.4 0.1 2.2 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.1 0.1 0.0 0.0 0.1 0.0 0.1 8.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 ASCL4 "bHLHa44, HASH4" ENSG00000187855 "Achaete-scute family bHLH transcription factor 4" Q6XD76 12 107774385-107776644 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Langerhans cells: 3.1" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036116 Uncertain NA NA "HPA036116: AB_10671833" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.86e-2)" "unprognostic (8.88e-4)" "unprognostic (2.09e-5)" "unprognostic (1.40e-1)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-3)" "unprognostic (9.25e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C75 ENSG00000187857 "Olfactory receptor family 6 subfamily C member 75" A6NL08 12 55362975-55369279 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 8.8;Club cells: 6.2;granulocytes: 8.8;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 8.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 CCDC157 ENSG00000187860 "Coiled-coil domain containing 157" Q569K6 22 30356635-30378658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" "Early spermatids: 118.0;Late spermatids: 142.4;Respiratory ciliated cells: 44.9;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042943 Uncertain NA NA "HPA042943: AB_10794767" "unprognostic (3.69e-3)" "unprognostic (1.72e-4)" "unprognostic (4.35e-2)" "unprognostic (1.24e-2)" "unprognostic (3.61e-1)" "unprognostic (7.74e-3)" "unprognostic (8.72e-4)" "unprognostic (1.35e-2)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.89e-4)" "unprognostic (2.33e-2)" "unprognostic (2.60e-2)" "unprognostic (4.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.42e-1)" "unprognostic (3.45e-2)" 0.6 1.4 5.6 0.9 3.3 1.9 1.2 2.8 3.8 1.3 6.1 0.9 0.9 1.0 1.8 1.2 7.5 1.2 0.6 3.5 4.0 3.1 0.9 2.2 1.1 3.8 4.5 3.5 1.2 1.9 2.2 5.0 0.5 3.4 1.8 0.4 1.9 1.5 0.9 0.6 1.0 1.2 0.4 3.9 1.6 1.1 27.8 3.7 0.8 3.6 0.5 0.7 0.9 1.0 3.1 1.8 2.0 1.8 3.4 1.0 0.6 2.2 0.9 1.1 1.7 1.7 2.6 1.3 1.6 1.1 0.9 2.6 1.9 1.0 1.2 0.9 1.1 4.3 0.9 2.0 1.4 1.1 1.7 1.4 0.6 0.8 3.1 0.5 1.1 1.0 2.3 1.5 1.4 1.4 1.6 2.2 1.8 2.4 1.2 1.0 1.9 1.0 1.4 4.2 1.8 6.1 4.0 2.8 1.1 1.2 1.3 3.3 0.8 1.8 1.8 2.2 1.1 0.8 1.2 0.7 1.2 2.7 1.0 1.4 0.8 0.6 0.8 0.7 0.4 0.8 0.4 0.7 0.8 0.3 0.5 0.4 0.6 2.5 0.7 0.6 0.9 0.7 0.5 5.6 3.3 2.8 3.8 3.5 4.0 3.8 4.5 3.5 3.4 3.9 3.7 3.1 2.6 3.2 3.3 2.0 2.6 1.3 2.4 4.2 0.6 6.2 6.6 5.2 0.9 4.3 7.3 9.2 12.5 2.5 7.0 3.0 0.0 5.5 118.0 31.3 3.3 2.8 1.2 0.4 4.2 2.3 2.3 2.6 2.0 5.0 2.5 3.8 5.7 0.9 2.0 6.7 3.1 1.5 8.2 3.8 3.9 142.4 3.7 3.4 0.0 1.0 2.2 4.4 4.1 1.0 0.6 3.0 3.2 2.6 6.6 1.4 1.7 6.9 44.9 28.3 0.0 6.7 3.8 59.3 16.5 1.5 1.7 3.4 4.8 4.5 1.8 1.9 TTC24 ENSG00000187862 "Tetratricopeptide repeat domain 24" A2A3L6 1 156579723-156587719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 21.4" "Group enriched" "Detected in some" 5 "B-cells: 4.6;dendritic cells: 3.6;Erythroid cells: 1.3;NK-cells: 2.1;Skeletal myocytes: 1.7;T-cells: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NK-cell: 3.7;plasmacytoid DC: 12.4" "Group enriched" "Detected in many" 4 "dendritic cells: 12.4;NK-cells: 3.7" "Cell line enhanced" "Detected in some" "JURKAT: 10.3;MOLT-4: 3.8;REH: 11.9;U-698: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029799 Approved Nucleoplasm NA NA Nucleoplasm "HPA029799: AB_10601684" "unprognostic (2.43e-3)" "unprognostic (5.61e-5)" "unprognostic (5.86e-2)" "unprognostic (1.39e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-6)" "unprognostic (6.26e-2)" "unprognostic (1.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (4.42e-1)" "unprognostic (7.96e-2)" "unprognostic (4.87e-9)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-2)" "unprognostic (9.76e-4)" 0.1 0.0 0.0 1.9 0.1 1.8 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 6.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.2 0.0 0.0 3.0 0.4 0.1 0.0 21.4 0.1 0.1 5.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.1 0.0 3.8 0.7 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 1.1 0.1 1.7 0.2 1.8 0.2 3.7 0.0 12.4 0.0 0.4 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 FAM122A "C9orf42, MGC17347" ENSG00000187866 "Family with sequence similarity 122A" Q96E09 9 68780065-68785566 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056646 Approved Approved "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA056646: AB_2683202" "unprognostic (1.88e-2)" "unprognostic (7.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.16e-1)" "unprognostic (9.79e-2)" "unprognostic (1.45e-2)" "unprognostic (4.18e-1)" "unprognostic (8.49e-3)" "unprognostic (1.45e-2)" "unprognostic (4.58e-3)" "prognostic favorable (1.34e-5)" "unprognostic (9.35e-2)" "unprognostic (3.02e-2)" "unprognostic (2.72e-1)" "unprognostic (6.89e-2)" 9.3 9.4 5.0 5.8 5.0 5.4 9.8 8.4 6.3 9.8 13.2 7.5 4.5 9.4 6.8 8.4 8.6 5.6 8.8 5.6 5.2 9.8 9.9 6.9 7.4 5.3 5.2 4.6 10.6 9.0 11.1 6.8 10.2 5.8 7.8 6.6 6.9 8.3 8.5 9.0 7.5 7.4 7.9 4.7 8.4 7.4 5.0 5.0 6.6 8.6 8.7 7.3 7.2 8.1 5.5 5.2 3.4 4.8 4.1 15.9 10.3 6.4 7.3 6.9 6.3 5.0 1.2 2.5 11.0 3.5 7.7 4.5 9.6 5.3 4.9 7.8 11.9 5.6 6.1 6.0 4.4 9.7 11.2 4.1 8.4 11.0 5.8 4.5 7.1 6.3 7.8 6.5 12.1 6.8 2.9 6.3 2.9 6.0 12.4 6.2 7.6 6.6 3.4 5.7 4.3 7.6 3.4 5.4 4.5 3.8 6.6 2.7 4.8 8.0 5.8 4.2 11.0 5.5 14.2 6.1 4.4 6.3 6.9 6.7 1.9 2.0 1.5 1.7 1.9 1.4 1.5 1.7 1.8 2.2 2.5 3.5 2.0 1.1 1.8 1.9 2.6 2.0 1.0 5.0 5.0 8.4 6.3 5.6 5.2 5.3 5.2 4.6 5.8 4.7 5.0 5.5 10.0 3.2 9.8 0.0 19.6 23.6 18.7 13.3 20.5 18.8 18.2 17.0 15.9 10.0 13.1 5.5 16.7 28.2 11.8 11.3 66.5 18.3 32.0 10.4 20.2 17.2 18.0 27.0 0.0 13.8 17.0 13.9 14.3 8.1 17.7 12.7 17.2 18.6 21.6 8.4 0.0 17.0 10.2 22.3 17.0 15.4 15.2 15.0 14.2 0.0 16.8 38.3 24.7 0.0 0.0 12.9 15.8 17.0 18.3 11.9 11.1 27.2 23.0 19.8 46.0 18.8 43.9 52.4 21.3 19.5 23.7 30.6 16.8 23.1 15.3 17.8 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053363-14062076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 25.9;liver: 56.2;pancreas: 24.7;stomach 1: 30.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 40.9;Cholangiocytes: 22.8;Collecting duct cells: 38.6;Exocrine glandular cells: 27.9;Hepatocytes: 40.5;Spermatogonia: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AN3-CA: 17.6;CACO-2: 20.2;GAMG: 5.5;HAP1: 15.8;NTERA-2: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: AB_2681952, HPA056119: AB_2683042" "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.1 0.2 1.6 0.1 1.5 0.0 0.6 1.3 1.5 1.5 0.9 0.6 1.6 1.0 6.7 0.3 1.8 1.0 0.3 1.3 1.7 25.9 56.2 4.3 0.0 2.6 1.6 1.3 0.2 24.7 6.6 0.4 0.4 2.6 4.0 0.2 0.5 3.7 4.5 0.1 0.4 1.1 0.0 1.6 0.1 30.7 15.3 1.6 0.0 12.8 0.0 0.0 4.7 1.6 2.1 1.4 1.3 2.9 17.6 0.3 0.0 3.3 0.3 0.0 0.7 0.5 20.2 0.3 0.0 0.2 0.4 5.5 0.0 15.8 0.0 0.3 0.0 0.9 0.1 0.5 2.3 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.5 0.0 0.0 3.4 0.0 0.0 3.2 0.2 0.0 10.3 1.6 0.8 0.0 0.0 0.0 0.0 1.7 1.9 2.3 0.1 0.0 0.0 3.2 1.3 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 1.3 1.5 1.3 1.7 2.6 1.6 1.3 2.6 1.6 1.6 2.1 0.1 57.7 40.9 0.3 0.5 0.0 0.6 0.1 0.0 0.7 1.0 1.4 0.3 22.8 10.1 38.6 0.0 0.3 0.0 0.7 1.9 9.4 0.0 3.2 1.0 0.2 1.2 0.0 0.3 27.9 3.1 1.7 7.1 6.3 1.3 0.1 1.8 40.5 0.1 0.0 0.5 3.0 0.0 1.3 0.3 0.5 0.9 0.2 1.8 0.0 1.0 0.8 0.0 0.0 0.1 5.5 1.3 2.6 0.0 1.0 3.2 9.5 2.1 0.6 0.0 0.1 0.2 0.0 18.8 0.0 0.0 2.2 0.3 0.0 1.0 1.0 GFRAL "bA360D14.1, C6orf144, GRAL, UNQ9356" ENSG00000187871 "GDNF family receptor alpha like" Q6UXV0 6 55327469-55402493 "Predicted membrane proteins" Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047372 Uncertain Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Actin filaments, Focal adhesion sites" "HPA047372: AB_2680017" "unprognostic (2.31e-1)" 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FYB2 "ARAP, C1orf168, FLJ43208, RP4-758N20.2" ENSG00000187889 "FYN binding protein 2" Q5VWT5 1 56718789-56819696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 11.7;fallopian tube: 13.8;liver: 17.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 22.4;Collecting duct cells: 31.3;Endometrial ciliated cells: 11.1;Glandular and luminal cells: 10.8;Respiratory ciliated cells: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "T-47d: 5.1" "Region enhanced" "Detected in single" "hippocampal formation: 2.1" "Low region specificity" "Detected in some" NA NA "unprognostic (6.12e-5)" "unprognostic (1.78e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (9.19e-3)" "unprognostic (4.77e-3)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (3.71e-1)" "unprognostic (2.86e-4)" "unprognostic (3.84e-2)" "unprognostic (2.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.3 3.6 11.7 0.2 0.3 0.9 0.3 0.2 13.8 0.0 1.2 1.0 0.3 3.6 17.3 2.0 0.0 0.0 0.1 0.0 0.1 1.0 6.4 0.8 0.0 0.2 1.5 0.4 0.0 2.1 1.7 1.5 0.0 0.6 0.0 0.0 0.0 0.4 1.3 0.1 2.5 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 1.0 0.3 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 22.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 6.3 0.0 0.0 6.8 31.3 0.0 0.5 0.0 0.0 3.9 0.5 0.0 11.1 0.7 0.0 0.0 0.0 0.0 1.5 0.0 7.3 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 48.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55443277 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.3" "Group enriched" "Detected in some" 6 "Erythroid cells: 13.5;Excitatory neurons: 19.4;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.1" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 2.9;HMC-1: 2.8;THP-1: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol NA NA Cytosol "HPA058935: AB_2683857" "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.0 0.4 20.2 0.0 19.6 1.1 0.0 0.6 20.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 7.8 0.0 0.0 0.0 0.0 7.6 4.3 20.6 0.0 0.0 0.0 4.9 0.0 8.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 7.3 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 19.6 0.6 20.3 26.3 7.8 7.6 4.3 20.6 8.9 1.8 7.3 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 13.5 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 16.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 23.1 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC74B ENSG00000187905 "Leucine rich repeat containing 74B" Q6ZQY2 22 21045960-21064168 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.9;choroid plexus: 3.3;fallopian tube: 3.8;lung: 1.0;testis: 1.3" "Cell type enhanced" "Detected in some" "Club cells: 12.4;Endometrial ciliated cells: 25.8;Respiratory ciliated cells: 72.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049947 Uncertain NA NA "HPA049947: AB_2680966" "unprognostic (3.43e-2)" "unprognostic (1.76e-1)" "unprognostic (3.28e-4)" "unprognostic (1.06e-1)" "unprognostic (6.44e-3)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (7.57e-9)" "unprognostic (4.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-2)" "unprognostic (4.92e-2)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.1 0.3 3.3 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.1 0.0 0.8 0.7 1.9 0.0 0.6 1.5 0.6 0.3 0.1 0.0 1.8 2.9 0.1 0.0 0.7 0.0 0.0 1.1 0.3 0.5 0.6 0.0 12.4 0.0 4.2 0.2 0.5 0.0 0.0 0.0 3.7 25.8 0.5 0.5 0.0 0.0 2.0 0.0 0.1 0.7 0.0 0.9 0.0 0.1 0.4 0.4 0.1 1.7 0.6 0.0 0.0 0.0 0.0 1.0 0.3 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 72.1 1.5 0.0 2.5 0.4 4.6 3.1 0.0 0.0 0.3 0.4 0.5 0.1 0.1 DMBT1 "Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin" ENSG00000187908 "Deleted in malignant brain tumors 1" Q9UGM3 10 122560665-122643736 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 19 "intestine: 1666.4;salivary gland: 523.1" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 192.9;Intestinal goblet cells: 113.4;Paneth cells: 388.2;Proximal enterocytes: 167.8;Undifferentiated cells: 314.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 47.6;stomach cancer: 76.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 9.9;LHCN-M2: 16.4;RH-30: 40.3" "Not detected" "Not detected" HPA040778 Enhanced Approved "Centriolar satellite" "Secreted in other tissues" NA NA 5200000 "Centriolar satellite" "HPA040778: AB_2677132" "unprognostic (3.32e-2)" "unprognostic (2.17e-2)" "unprognostic (3.47e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.77e-2)" "unprognostic (2.56e-2)" "unprognostic (3.70e-1)" "unprognostic (7.97e-2)" "unprognostic (1.31e-1)" "unprognostic (4.51e-1)" "unprognostic (2.22e-1)" "unprognostic (2.20e-1)" "unprognostic (1.08e-9)" "unprognostic (2.26e-1)" "unprognostic (2.92e-4)" "unprognostic (2.00e-3)" "unprognostic (2.22e-1)" 0.5 0.2 1.2 45.7 2.5 0.1 0.3 4.1 2.4 12.9 0.1 46.4 1666.4 1.8 0.0 1.6 3.9 46.2 0.1 0.7 1.8 0.1 0.1 58.9 1.0 6.0 5.2 0.2 0.1 1.8 0.0 0.2 0.0 6.8 1.7 17.2 0.0 523.1 0.0 0.3 0.1 523.0 15.4 3.5 0.0 3.9 1.5 3.7 0.1 0.0 0.2 0.2 15.5 0.0 7.7 0.2 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.5 0.2 1.1 0.0 0.4 0.0 0.2 0.0 0.0 3.2 0.5 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 1.3 0.5 9.9 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 2.6 0.2 0.0 0.0 0.0 40.3 6.0 0.0 0.0 0.1 3.0 0.3 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.8 0.5 2.3 5.7 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 4.1 2.4 0.7 1.8 6.0 5.2 0.2 6.8 3.5 3.7 7.7 0.0 6.4 192.9 0.7 1.1 0.0 7.0 0.4 0.0 0.0 1.5 0.9 0.7 0.0 3.8 0.0 0.0 0.0 0.0 52.4 0.0 2.1 2.9 1.1 0.2 7.3 0.0 0.0 0.0 15.1 0.0 0.4 0.0 3.5 10.1 0.0 0.0 0.0 0.0 0.0 0.1 113.4 0.0 0.0 0.0 2.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.7 388.2 0.0 0.0 1.7 167.8 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.8 0.0 0.0 0.0 1.8 0.0 314.4 20.3 CLEC17A FLJ45910 ENSG00000187912 "C-type lectin domain containing 17A" Q6ZS10 19 14583084-14612035 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 6.7;lymphoid tissue: 18.4" "Group enriched" "Detected in some" 4 "B-cells: 20.7;Early spermatids: 5.3;Late spermatids: 12.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 11 "memory B-cell: 21.5;naive B-cell: 43.1" "Lineage enriched" "Detected in many" 14 "B-cells: 43.1" "Group enriched" "Detected in some" 5 "Daudi: 5.7;U-698: 9.9" "Not detected" "Not detected" NA NA "unprognostic (4.71e-5)" "unprognostic (1.34e-2)" "unprognostic (9.64e-4)" "unprognostic (5.02e-3)" "unprognostic (3.90e-1)" "unprognostic (9.00e-4)" "unprognostic (3.18e-3)" "unprognostic (1.60e-3)" "unprognostic (1.32e-2)" "unprognostic (7.11e-2)" "unprognostic (3.78e-2)" "unprognostic (4.43e-2)" "unprognostic (9.13e-3)" "unprognostic (1.65e-1)" "unprognostic (5.91e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" 0.3 0.2 0.8 8.2 1.0 2.2 0.1 1.5 1.0 0.0 0.9 0.5 0.5 0.3 0.3 0.2 0.2 0.6 0.2 0.7 0.7 0.1 0.2 0.2 16.2 1.0 0.7 0.7 0.2 0.0 0.1 0.1 0.2 1.2 0.3 0.6 0.4 0.6 0.1 0.3 0.5 6.7 0.1 1.4 11.5 0.8 0.9 0.8 1.4 0.2 0.1 18.4 1.0 0.0 1.5 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.1 5.7 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.2 1.1 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.4 0.0 0.2 0.1 1.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.3 0.1 9.9 0.3 0.1 0.1 0.7 0.7 0.3 0.2 0.4 0.2 21.5 0.1 0.1 3.0 43.1 0.2 0.2 2.7 0.4 0.3 0.5 0.1 2.2 0.8 1.0 1.5 1.0 0.7 0.7 1.0 0.7 0.7 1.2 1.4 0.8 1.5 0.0 0.0 0.0 1.3 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.7 0.0 0.8 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I2 ENSG00000187918 "Olfactory receptor family 51 subfamily I member 2" Q9H344 11 5449323-5456518 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCN10 ENSG00000187922 "Lipocalin 10" Q6JVE6 9 136738167-136743356 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 32.6" "Cell type enriched" "Detected in single" 32 "B-cells: 6.4" "Cancer enriched" "Detected in single" 8 "thyroid cancer: 1.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "memory B-cell: 6.5;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 18 "B-cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055919 Approved "Secreted in male reproductive system" NA NA "HPA055919: AB_2682969" "unprognostic (2.02e-1)" "unprognostic (1.35e-2)" "unprognostic (2.62e-1)" "unprognostic (1.89e-1)" "unprognostic (5.85e-2)" "unprognostic (6.54e-3)" "unprognostic (2.22e-4)" "unprognostic (4.54e-2)" "unprognostic (3.97e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (2.96e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (2.52e-1)" "unprognostic (8.32e-2)" "unprognostic (3.86e-1)" 3.0 0.1 1.4 1.1 1.3 0.8 2.8 1.2 1.9 5.6 1.3 1.5 0.1 7.8 32.6 1.2 7.9 0.4 5.5 1.3 1.3 0.1 0.1 0.9 1.4 1.3 1.3 1.1 2.1 1.0 0.3 0.1 0.0 1.3 2.7 0.7 0.0 1.6 1.0 0.8 0.7 2.7 3.1 1.3 1.6 2.2 1.2 1.5 0.3 2.1 2.0 1.1 3.2 2.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 1.4 1.3 1.2 1.9 1.3 1.3 1.3 1.3 1.1 1.3 1.3 1.5 1.6 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LDLRAD2 ENSG00000187942 "Low density lipoprotein receptor class A domain containing 2" Q5SZI1 1 21812265-21825225 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.2;Granulosa cells: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 1.2;THP-1: 1.0;TIME: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "basal ganglia: 4.0;midbrain: 5.9" HPA030478 Approved "Secreted - unknown location" NA NA "HPA030478: AB_10601541" "unprognostic (4.16e-2)" "unprognostic (1.22e-1)" "unprognostic (4.13e-2)" "unprognostic (4.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.22e-3)" "unprognostic (1.35e-2)" "unprognostic (4.85e-2)" "unprognostic (7.52e-2)" "unprognostic (3.80e-2)" "unprognostic (5.34e-2)" "unprognostic (5.38e-2)" "unprognostic (1.04e-3)" "unprognostic (7.39e-3)" "unprognostic (3.14e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" 3.5 2.9 1.0 0.8 0.7 1.0 3.0 0.9 0.5 2.5 0.5 3.5 1.6 3.6 0.0 1.7 2.7 0.5 5.7 0.5 1.2 2.2 0.8 1.7 0.7 2.0 2.2 0.0 1.1 2.1 0.0 1.5 0.1 1.8 3.7 0.1 0.0 7.2 0.0 1.2 1.3 2.4 0.1 1.8 2.7 3.7 1.5 0.9 0.0 2.2 0.0 0.3 4.0 2.4 0.3 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.0 2.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.0 0.7 0.9 0.5 0.5 1.2 2.0 2.2 0.0 1.8 1.8 0.9 0.3 2.2 0.0 0.6 0.0 0.6 0.5 0.1 0.4 0.6 0.0 0.1 0.1 0.7 0.0 0.2 1.8 0.0 0.2 0.3 0.0 0.0 0.2 1.7 0.3 1.2 1.6 0.0 1.3 0.2 0.0 0.6 1.3 0.0 0.9 0.0 4.9 0.7 0.2 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.0 1.0 0.5 0.0 0.0 0.0 0.2 0.3 0.1 0.0 1.3 0.5 0.0 0.0 0.8 0.0 0.0 1.2 0.7 0.6 1.2 0.1 0.4 0.3 0.4 0.4 0.0 0.0 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" 2 196804417-196809355 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.0;brain: 5.9;pituitary gland: 3.8" "Cell type enriched" "Detected in some" 7 "Early spermatids: 36.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 9.0;RT4: 2.2;TIME: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 2.8 4.0 2.1 0.2 1.8 0.1 0.5 1.4 2.2 0.0 1.5 0.2 0.0 0.1 0.4 0.2 0.6 0.3 0.4 2.0 5.9 0.2 0.1 0.3 0.0 2.2 2.4 1.8 0.3 0.5 0.1 3.8 0.0 2.4 0.3 0.1 1.9 0.1 0.1 0.0 1.2 0.3 0.0 1.7 0.1 0.2 1.5 2.7 0.1 0.1 0.0 0.1 0.3 0.2 2.3 0.0 0.1 0.2 0.8 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.4 9.0 0.3 0.1 0.0 0.1 0.8 0.2 1.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.4 2.2 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.1 2.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 1.4 2.2 2.0 5.9 2.2 2.4 1.8 2.4 1.7 2.7 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 OVCH1 OVCH ENSG00000187950 "Ovochymase 1" Q7RTY7 12 29412474-29497686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 4.6;testis: 2.4" "Group enriched" "Detected in some" 5 "Excitatory neurons: 14.3;Inhibitory neurons: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Daudi: 5.5" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (3.32e-1)" "unprognostic (2.20e-1)" "unprognostic (2.03e-1)" "unprognostic (1.56e-5)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.36e-1)" "unprognostic (5.48e-2)" "unprognostic (5.59e-3)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" 0.2 0.2 0.5 0.3 1.3 0.1 0.2 0.0 1.3 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.9 0.4 0.1 0.2 4.6 0.1 0.3 0.8 0.9 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.6 0.1 2.4 0.5 0.0 1.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 1.3 0.9 0.4 0.3 0.8 0.9 0.3 0.0 0.5 0.6 0.7 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.1 0.7 0.0 0.0 14.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CYHR1 "CHRP, KIAA0496, MGC13010" ENSG00000187954 "Cysteine and histidine rich 1" Q6ZMK1 8 144449582-144465667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053653, HPA059543" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053653: AB_2682219, HPA059543: AB_2684056" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.58e-2)" "unprognostic (8.28e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (4.02e-2)" "unprognostic (2.63e-1)" "unprognostic (2.13e-1)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (1.54e-2)" 33.8 58.4 55.4 9.3 54.6 11.2 37.4 52.9 76.7 50.3 50.3 41.3 15.9 41.3 23.0 35.0 43.5 16.2 53.5 56.0 53.6 43.1 49.2 26.9 15.4 57.9 55.0 55.1 45.1 61.4 29.2 68.0 10.3 54.4 71.1 8.9 11.3 40.8 27.8 46.2 39.7 30.2 12.1 55.0 35.3 42.4 70.4 54.5 13.8 44.5 22.8 8.5 49.3 40.6 55.5 23.0 27.6 18.3 22.6 30.8 20.7 22.9 15.5 15.9 14.6 18.4 12.8 30.6 10.4 32.5 23.3 18.1 34.0 14.4 22.6 5.6 25.3 23.9 23.6 33.7 22.1 42.9 6.0 12.4 35.6 29.9 18.2 22.7 32.2 16.9 29.0 34.8 27.7 14.0 51.5 28.9 16.6 12.0 34.5 57.5 27.3 7.7 29.6 22.5 19.5 26.7 16.4 33.5 27.9 36.6 13.9 37.5 23.8 20.1 18.4 21.5 20.5 15.6 14.0 9.9 8.4 26.5 20.2 15.2 2.9 11.7 7.0 9.5 8.4 15.5 12.9 11.9 7.8 12.7 14.0 22.2 12.5 5.8 5.3 9.5 27.0 5.0 9.6 55.4 54.6 52.9 76.7 56.0 53.6 57.9 55.0 55.1 54.4 55.0 54.5 55.5 32.6 35.3 26.5 52.5 18.5 30.5 46.2 31.8 43.9 75.6 68.7 69.6 19.0 45.8 28.7 58.8 25.0 29.2 33.3 43.2 43.0 28.1 12.5 37.2 37.3 28.9 33.7 23.4 45.9 28.7 20.1 36.4 32.6 32.7 5.1 42.9 37.9 45.6 25.6 90.9 39.4 44.0 36.7 26.7 23.2 44.1 50.7 23.0 26.6 18.7 31.0 120.5 22.6 31.7 37.2 23.2 42.9 39.9 26.2 48.5 47.6 35.0 41.7 59.0 39.5 37.4 35.5 45.8 32.3 36.8 38.8 16.7 24.3 82.2 47.3 35.6 COL14A1 UND ENSG00000187955 "Collagen type XIV alpha 1 chain" Q05707 8 120059780-120373573 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 207.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023781 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 3200000 Vesicles "HPA023781: AB_1847098" "unprognostic (1.10e-1)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-3)" "unprognostic (5.96e-2)" "unprognostic (4.29e-2)" "unprognostic (7.61e-2)" "unprognostic (3.77e-2)" "unprognostic (4.36e-1)" "unprognostic (5.07e-2)" "prognostic unfavorable (5.79e-5)" "unprognostic (1.07e-2)" "unprognostic (8.21e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.01e-4)" 69.7 16.3 1.9 42.6 1.9 0.4 59.4 1.5 4.2 207.6 5.3 40.2 7.8 78.9 35.5 50.6 46.6 143.5 37.8 1.5 8.4 25.1 19.7 27.9 12.9 3.4 2.1 1.5 83.9 15.8 6.1 4.0 153.9 2.6 44.2 54.4 0.6 13.6 25.2 7.1 13.3 35.6 148.8 3.2 28.6 25.8 5.6 2.3 5.3 43.6 36.4 16.7 109.5 93.8 3.1 0.0 0.0 0.9 0.0 5.4 54.4 0.1 0.1 6.7 0.2 0.1 0.0 0.0 0.6 1.8 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 1.8 0.0 13.2 0.2 0.2 14.4 0.3 2.6 0.0 29.7 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.4 4.2 0.0 0.0 0.0 123.4 0.2 4.8 0.0 0.5 0.2 0.1 0.1 0.1 3.2 0.0 0.1 0.0 1.3 0.3 0.2 2.9 0.4 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.5 4.2 1.5 8.4 3.4 2.1 1.5 2.6 3.2 2.3 3.1 8.0 0.0 1.1 0.0 0.1 11.3 0.4 2.1 75.1 0.1 1.8 25.3 13.2 0.0 4.3 1.8 0.0 34.4 0.3 0.0 0.0 0.0 1.0 6.9 97.0 7.8 0.0 0.0 5.6 0.0 4.0 235.9 6.1 11.3 3.8 0.2 18.5 0.0 6.2 0.0 5.2 0.0 0.0 0.0 18.5 1.4 14.6 1.7 5.4 5.6 0.0 0.1 0.0 1.0 3.3 0.0 0.0 15.4 0.5 0.6 0.0 0.0 0.1 0.5 0.0 4.2 118.2 4.4 2.8 3.9 9.7 25.3 2.7 4.5 0.0 0.3 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714555 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 73.6;brain: 153.5;choroid plexus: 124.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 123.3;Inhibitory neurons: 333.0;Oligodendrocyte precursor cells: 435.8;Oligodendrocytes: 247.7" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "GAMG: 368.0;hTERT-HME1: 149.7;hTERT-RPE1: 409.5;U-138 MG: 252.2;U-87 MG: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced NA NA 7900000 "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 1.5 73.6 90.5 1.3 121.8 0.0 2.4 144.3 84.2 1.7 124.8 3.9 0.4 2.8 5.7 0.3 4.1 0.2 8.2 71.9 130.4 11.3 0.1 1.0 0.3 125.9 127.1 69.7 0.6 0.9 8.9 30.5 0.4 121.6 1.9 1.1 61.1 43.7 0.4 0.9 9.3 1.6 1.2 122.4 0.1 10.8 1.0 153.5 0.5 0.1 0.5 1.2 0.8 1.1 144.3 0.4 1.9 3.9 0.3 0.6 0.5 0.0 0.2 1.4 8.6 2.6 0.0 1.1 0.0 0.4 0.1 368.0 0.1 0.3 1.2 4.3 0.0 0.1 0.0 12.4 0.0 1.4 0.0 0.1 2.6 9.3 6.5 149.7 409.5 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.0 2.5 0.2 14.0 0.1 1.6 0.0 14.6 0.0 30.3 2.5 0.8 0.1 0.8 0.4 0.1 0.0 0.0 252.2 0.0 8.5 39.7 0.0 0.0 0.0 149.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 90.5 121.8 144.3 84.2 71.9 130.4 125.9 127.1 69.7 121.6 122.4 153.5 144.3 0.1 0.0 0.0 68.9 0.0 0.4 5.9 1.9 1.8 123.3 1.6 0.6 12.2 0.0 1.4 3.7 14.6 0.0 0.0 0.0 1.9 0.2 7.3 4.1 1.5 0.6 28.7 0.0 24.1 1.3 0.2 4.3 0.0 6.7 0.0 1.6 0.0 0.0 0.1 11.8 333.0 0.0 6.1 0.0 0.8 1.9 5.9 0.9 19.6 8.4 0.1 52.0 0.0 435.8 247.7 0.3 0.0 6.0 0.0 4.5 0.0 1.2 34.1 55.0 0.0 0.1 0.8 1.2 1.1 0.5 0.0 0.1 0.2 0.6 0.1 0.5 CPSF4L ENSG00000187959 "Cleavage and polyadenylation specific factor 4 like" A6NMK7 17 73248449-73262352 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Skeletal myocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 3.0" "Region enriched" "Detected in single" 36 "cerebellum: 10.2" "Low region specificity" "Detected in many" HPA044047 Uncertain NA NA "HPA044047: AB_10961638" "unprognostic (7.30e-2)" "unprognostic (1.54e-2)" "unprognostic (2.47e-1)" "unprognostic (3.02e-1)" "unprognostic (1.99e-1)" "unprognostic (7.73e-2)" "unprognostic (2.32e-2)" "unprognostic (5.59e-2)" "unprognostic (6.57e-3)" "unprognostic (9.76e-2)" "unprognostic (1.83e-1)" "unprognostic (3.66e-2)" "unprognostic (9.03e-8)" "unprognostic (6.71e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-2)" "unprognostic (7.44e-3)" 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.9 0.5 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.8 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.9 0.5 0.2 0.8 0.3 0.1 0.0 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960584-965719 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 5.2 5.9 4.5 3.9 4.3 3.9 6.0 5.0 8.4 9.3 4.0 6.8 3.5 7.3 0.6 12.4 6.7 2.3 4.9 4.5 3.8 8.8 7.9 7.2 3.7 4.6 4.2 4.3 1.9 7.2 2.3 10.4 2.2 5.1 8.3 0.7 1.7 7.6 1.9 2.8 9.2 7.7 1.2 3.5 12.1 7.5 12.5 4.6 3.0 6.5 0.8 1.6 8.3 8.6 4.9 6.8 7.5 9.2 22.1 3.2 3.3 10.1 13.1 3.5 7.2 7.0 9.9 10.1 2.4 9.0 5.8 6.9 14.4 8.5 5.4 1.1 13.9 20.7 4.4 32.2 14.3 2.1 5.1 13.4 2.8 2.6 7.1 2.0 9.0 4.5 14.0 14.9 4.3 3.2 8.0 8.4 17.8 10.0 2.7 11.0 13.5 3.7 4.8 4.0 2.7 22.3 21.0 3.8 11.8 12.4 2.8 6.4 8.9 7.8 13.7 18.5 12.1 11.1 8.5 3.2 5.9 7.9 11.4 6.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 4.3 5.0 8.4 4.5 3.8 4.6 4.2 4.3 5.1 3.5 4.6 4.9 2.2 0.0 3.1 6.2 1.7 2.5 1.0 1.2 3.4 5.7 2.6 2.8 3.7 0.0 0.7 3.7 2.1 1.2 4.0 1.1 0.0 1.0 1.3 1.8 4.1 1.2 3.0 0.0 5.9 0.8 1.9 1.8 7.7 2.0 0.0 1.4 3.3 0.7 1.2 6.7 4.6 1.6 0.0 1.0 1.8 2.0 0.3 2.1 3.6 2.8 1.4 1.2 1.0 1.5 2.1 2.0 0.3 1.5 2.2 0.9 1.2 1.2 1.1 6.2 0.0 0.8 2.0 4.7 5.3 1.9 3.0 0.8 2.2 0.2 1.4 1.4 ZCCHC13 "4930513O09RIK, Cnbp2, ZNF9L" ENSG00000187969 "Zinc finger CCHC-type containing 13" Q8WW36 X 74304180-74305034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 231 "testis: 23.1" "Group enriched" "Detected in some" 80 "Early spermatids: 247.9;Late spermatids: 541.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003382 Enhanced NA NA "HPA003382: AB_10967182" "unprognostic (1.61e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 247.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 541.7 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLA2G2C UBXN10-AS1 ENSG00000187980 "Phospholipase A2 group IIC" Q5R387 1 20161253-20186518 "Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Early spermatids: 2.9;Late spermatids: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;U-698: 2.0;U-937: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (3.02e-3)" "unprognostic (2.75e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-4)" "unprognostic (9.44e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (3.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (4.84e-2)" "unprognostic (1.67e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (8.16e-2)" 0.1 0.0 0.3 0.1 0.2 0.4 0.0 0.6 0.5 0.1 0.3 0.8 0.2 0.4 0.2 0.7 0.1 0.1 0.1 0.5 0.3 0.0 0.0 0.1 0.2 0.2 0.2 0.4 0.2 0.0 0.1 0.0 0.1 0.4 0.4 0.3 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.3 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.0 0.1 1.7 0.0 0.5 0.3 0.0 0.4 0.1 0.8 0.1 0.3 0.4 0.5 0.1 0.2 0.1 0.6 0.3 0.0 0.2 0.0 0.1 0.3 0.2 0.6 0.5 0.5 0.3 0.2 0.2 0.4 0.4 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.3 0.1 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.6 0.0 9.8 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ZSCAN23 "dJ29K1.3.1, ZNF390, ZNF453" ENSG00000187987 "Zinc finger and SCAN domain containing 23" Q3MJ62 6 28431930-28443502 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Astrocytes: 13.7;Excitatory neurons: 20.2;Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;SCLC-21H: 1.8" "Low region specificity" "Detected in all" "HPA035959, HPA035960" Uncertain NA NA "HPA035959: AB_10696647, HPA035960: AB_2674889" "unprognostic (6.87e-2)" "unprognostic (4.80e-3)" "unprognostic (4.24e-1)" "unprognostic (1.09e-3)" "unprognostic (6.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.36e-1)" "unprognostic (3.05e-1)" "unprognostic (1.32e-2)" "unprognostic (1.69e-1)" "unprognostic (3.43e-1)" "unprognostic (9.58e-2)" "unprognostic (1.97e-3)" "unprognostic (2.32e-3)" "unprognostic (3.35e-1)" "unprognostic (2.19e-2)" "unprognostic (8.32e-3)" 0.1 0.3 0.2 0.1 0.4 0.0 0.7 0.8 0.3 0.4 0.2 0.2 0.1 0.8 1.2 0.1 0.4 0.3 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 1.2 0.3 0.7 0.3 0.3 0.3 0.8 0.3 1.3 0.6 0.6 0.0 0.1 0.2 0.4 0.0 0.3 0.1 0.5 0.1 0.2 0.8 0.1 0.2 0.2 0.2 0.5 0.1 0.0 1.5 0.0 0.7 1.4 0.2 0.4 0.1 0.4 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.6 0.4 0.5 0.0 1.0 0.0 0.0 0.1 0.2 0.4 0.0 0.5 0.3 0.3 0.5 0.8 0.1 0.2 0.6 0.0 0.3 0.0 0.0 0.4 0.7 0.0 0.3 0.3 0.4 0.0 0.2 0.5 1.8 1.1 0.0 0.4 0.0 1.1 0.0 0.1 0.0 1.0 0.8 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.1 0.5 0.5 0.0 0.0 13.7 0.2 0.0 0.2 0.2 1.2 2.1 0.2 0.1 0.4 0.0 0.0 0.0 4.2 0.3 0.0 0.1 0.0 0.2 4.8 0.3 0.8 0.3 1.8 0.0 20.2 0.6 0.1 0.3 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 24.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 5.6 0.0 0.6 0.0 17.6 10.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.0 2.3 0.0 0.5 0.7 1.9 0.6 0.1 0.0 0.1 0.1 1.1 0.1 0.0 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867830-38878275 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 32.5;NK-cells: 45.3;Skeletal myocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 14.2;Karpas-707: 24.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favorable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 4.6 2.5 2.1 5.3 2.6 2.8 4.2 2.5 2.8 2.5 2.6 3.6 1.6 2.0 0.9 6.4 3.3 1.7 3.4 2.2 2.2 6.2 7.9 4.3 9.7 2.4 2.0 2.2 1.5 13.3 2.8 7.3 1.6 2.9 2.5 1.4 2.6 5.3 1.1 2.3 3.1 8.4 1.0 2.1 15.9 4.3 1.1 2.1 3.9 5.2 0.9 7.7 4.6 3.8 2.5 0.0 1.8 0.4 0.2 0.7 0.3 2.8 0.4 0.3 0.4 0.4 1.9 9.2 9.1 3.1 0.4 0.1 0.2 1.7 2.4 0.5 1.7 0.6 10.1 2.6 4.8 1.9 6.4 14.2 2.0 0.4 1.2 0.5 0.3 3.5 5.1 1.8 24.6 0.0 1.6 1.6 4.3 0.8 5.2 0.3 1.2 0.1 6.5 1.7 0.2 3.2 1.3 4.2 6.7 3.6 0.4 0.8 7.7 2.6 0.1 1.9 0.5 0.1 9.1 9.3 6.3 0.7 2.8 0.5 5.3 1.1 1.6 10.3 2.5 6.5 17.4 6.9 7.7 2.0 21.9 5.3 6.4 3.0 5.2 2.5 16.0 8.1 3.6 2.1 2.6 2.5 2.8 2.2 2.2 2.4 2.0 2.2 2.9 2.1 2.1 2.5 6.7 3.2 7.7 0.0 22.4 3.2 5.3 2.9 4.6 4.0 5.8 4.7 3.5 8.6 2.3 3.7 8.4 13.9 32.5 0.6 7.9 7.3 0.5 2.8 1.6 6.9 7.2 9.0 2.2 7.3 7.1 4.3 5.1 6.3 15.2 1.3 8.2 7.5 9.3 0.0 1.6 0.7 14.2 6.8 2.7 1.3 3.1 4.3 10.6 1.0 10.5 6.2 45.3 3.5 0.6 5.1 1.7 2.6 14.8 2.3 0.6 12.7 1.3 10.6 0.0 30.3 2.3 2.7 4.4 6.4 3.8 4.1 24.6 5.0 1.3 3.6 C17orf99 "GLPG464, UNQ464" ENSG00000187997 "Chromosome 17 open reading frame 99" Q6UX52 17 78146353-78166177 "Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 9.1" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "HaCaT: 3.5;HMC-1: 7.1;K-562: 4.2" "Not detected" "Not detected" HPA029655 Uncertain "Secreted to blood" NA NA "HPA029655: AB_10601691" "unprognostic (3.55e-5)" "unprognostic (1.87e-2)" "unprognostic (2.06e-1)" "unprognostic (1.22e-1)" "unprognostic (1.88e-1)" "unprognostic (1.45e-3)" "unprognostic (1.47e-3)" "unprognostic (2.39e-1)" "unprognostic (3.86e-1)" "unprognostic (9.77e-2)" "unprognostic (2.05e-2)" "unprognostic (5.13e-2)" "unprognostic (1.38e-4)" "unprognostic (6.58e-2)" "unprognostic (4.72e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" 0.0 0.0 0.0 0.1 0.0 9.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 1.8 0.4 0.6 1.1 0.1 0.3 0.5 0.0 0.7 1.8 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 52.6 0.3 0.4 0.4 0.4 0.0 0.3 0.0 0.1 0.4 0.2 0.5 0.0 0.3 0.7 0.0 0.0 0.7 0.1 0.6 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.7 0.2 0.1 0.2 0.1 0.0 1.1 0.6 0.1 0.1 0.6 0.9 0.3 0.2 0.9 0.4 0.8 OR7D2 "FLJ38149, HTPCRH03, OR19-4" ENSG00000188000 "Olfactory receptor family 7 subfamily D member 2" Q96RA2 19 9178979-9188818 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Early spermatids: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.7" "Low region specificity" "Detected in all" NA NA "unprognostic (5.00e-4)" "unprognostic (2.03e-1)" "unprognostic (3.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-1)" "unprognostic (2.86e-2)" "unprognostic (2.56e-2)" "unprognostic (3.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "unprognostic (5.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.63e-1)" "unprognostic (4.08e-2)" "unprognostic (4.92e-4)" 0.2 0.2 0.6 0.3 0.5 0.7 0.1 1.1 1.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.6 0.4 0.1 0.1 0.1 0.6 0.4 0.2 0.6 0.1 0.2 0.0 0.2 0.1 0.5 0.2 0.1 0.6 0.2 0.4 0.3 0.5 0.2 0.2 0.1 0.5 0.4 1.1 0.5 0.1 0.2 0.1 0.3 0.2 0.1 1.1 0.1 0.1 0.2 0.7 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.2 0.3 0.0 0.1 0.0 0.2 0.1 1.7 0.3 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.7 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.5 0.2 0.1 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.2 0.0 0.0 0.6 0.5 1.1 1.1 0.6 0.4 0.4 0.2 0.6 0.5 0.1 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.2 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.2 0.3 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.0;vagina: 32.5" "Cell type enriched" "Detected in many" 5 "Early spermatids: 199.7" "Cancer enriched" "Detected in many" 4 "breast cancer: 7.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 10.3 2.0 0.3 1.8 1.1 0.0 23.5 0.5 2.2 13.7 3.0 0.5 0.3 3.1 2.8 51.0 8.5 2.9 1.4 0.4 1.5 0.4 9.0 4.4 0.9 1.3 0.5 0.3 2.2 0.6 0.1 0.2 1.2 1.4 1.3 0.3 0.4 6.2 1.4 9.2 24.1 0.7 3.0 0.8 0.7 0.5 4.8 2.7 1.5 1.4 0.4 9.1 1.0 32.5 1.4 0.9 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.1 0.1 1.1 2.2 1.3 3.4 0.1 0.6 0.2 0.0 0.0 0.0 9.6 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.7 0.2 0.4 0.0 0.0 0.6 23.4 0.3 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.2 0.5 0.0 0.7 4.1 0.6 0.0 0.1 0.3 0.0 0.3 4.3 3.7 0.4 0.1 0.0 0.1 0.0 1.5 0.0 3.8 1.2 0.5 0.1 3.0 4.0 0.4 0.0 0.6 1.5 0.7 0.0 1.1 0.0 3.8 0.9 0.3 1.1 0.5 2.2 0.4 1.5 1.3 0.5 0.3 1.4 0.8 2.7 1.4 0.9 38.5 1.7 3.6 0.9 5.6 19.9 10.5 13.6 1.3 9.8 31.1 0.8 0.0 6.4 0.0 0.0 0.4 5.3 0.2 0.0 0.3 199.7 1.2 1.1 1.0 0.0 2.7 2.8 0.6 0.2 5.5 0.5 0.2 1.3 0.3 0.0 8.4 4.8 0.0 7.9 0.3 2.0 3.5 2.7 24.4 7.2 2.5 0.0 3.7 0.6 0.2 2.1 9.5 2.1 4.5 0.1 3.0 5.6 1.7 0.2 0.2 1.0 0.2 0.0 30.7 5.3 5.1 1.1 4.3 5.8 0.3 14.4 1.2 0.2 5.7 MORN2 MOPT ENSG00000188010 "MORN repeat containing 2" Q502X0 2 38875962-38929072 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 175.6" "Cell type enhanced" "Detected in many" "Early spermatids: 1976.5;Endometrial ciliated cells: 783.4;Late spermatids: 3753.7;Respiratory ciliated cells: 848.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057815 Approved Nucleoplasm NA NA Nucleoplasm "HPA057815: AB_2683537" "unprognostic (7.28e-3)" "unprognostic (3.84e-2)" "unprognostic (8.65e-2)" "unprognostic (1.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (6.01e-2)" "unprognostic (2.60e-2)" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-2)" "unprognostic (3.55e-1)" "unprognostic (8.80e-2)" 12.8 30.8 43.2 6.2 43.7 9.8 20.8 44.0 56.3 30.8 59.3 13.8 6.7 16.8 74.0 13.8 97.1 16.2 25.5 42.4 52.7 70.0 17.7 18.2 5.5 45.0 44.0 40.5 19.6 20.4 80.2 57.2 8.1 44.8 18.2 13.7 37.9 21.4 19.0 20.1 10.0 8.2 11.4 44.6 6.7 15.3 175.6 43.0 8.2 46.4 17.5 5.7 14.6 13.3 44.2 60.9 30.5 37.2 46.0 40.4 60.5 21.0 27.7 42.9 42.5 40.2 18.3 33.5 3.8 21.8 40.9 42.4 15.9 16.5 34.9 63.4 25.3 32.8 12.9 32.6 46.1 34.8 21.2 9.2 35.6 42.8 51.5 18.9 54.0 39.9 11.7 22.7 8.9 35.8 58.6 9.3 40.5 27.6 40.0 31.7 5.2 38.8 13.3 83.0 33.4 37.1 49.4 41.3 27.0 59.6 21.7 36.5 28.5 26.5 30.2 29.8 48.0 44.1 16.6 26.4 2.3 68.8 6.0 54.4 1.5 8.3 1.2 1.6 6.7 3.1 2.5 1.9 2.4 5.9 2.7 3.2 3.3 0.7 2.7 5.5 3.0 4.0 3.8 43.2 43.7 44.0 56.3 42.4 52.7 45.0 44.0 40.5 44.8 44.6 43.0 44.2 14.1 16.0 25.3 2.6 7.9 9.7 25.5 103.9 10.2 16.7 29.5 45.7 40.5 35.8 90.9 60.7 10.4 15.9 4.2 19.5 270.1 61.4 1976.5 783.4 34.1 16.0 22.9 7.4 2.5 44.4 22.9 28.8 18.8 43.6 9.5 35.2 12.8 24.5 23.6 16.8 2.3 18.1 73.2 9.0 6.7 3753.7 53.4 15.1 23.2 0.0 10.2 106.7 3.1 1.5 1.8 41.0 34.3 51.6 5.5 22.4 7.4 396.6 848.6 35.1 26.3 21.3 40.5 530.7 92.0 15.7 10.5 7.7 6.1 51.8 22.0 30.0 RTP5 "C2orf85, CXXC11, FLJ33590, Z3CXXC5" ENSG00000188011 "Receptor transporter protein 5 (putative)" Q14D33 2 241869600-241873823 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 31.3" "Cell type enhanced" "Detected in some" "Early spermatids: 8.8;Inhibitory neurons: 4.1;Late spermatids: 2.8;Oligodendrocyte precursor cells: 17.6" "Cancer enriched" "Detected in single" 10 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "MOLT-4: 1.3;SCLC-21H: 2.6" "Low region specificity" "Detected in all" HPA050902 Enhanced NA NA "HPA050902: AB_2681268" "unprognostic (3.26e-2)" "unprognostic (5.38e-4)" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.01e-1)" "unprognostic (9.40e-4)" "unprognostic (8.68e-3)" "unprognostic (2.04e-1)" "unprognostic (6.34e-4)" "unprognostic (3.30e-1)" "unprognostic (9.01e-3)" "unprognostic (3.91e-1)" "unprognostic (9.08e-8)" "unprognostic (1.81e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.72e-2)" 0.2 0.0 26.9 0.1 10.2 0.3 0.1 0.4 20.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 31.3 23.3 0.1 0.1 0.5 0.5 5.1 15.7 10.4 0.0 0.0 0.0 0.1 0.0 10.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 3.1 1.4 0.3 0.4 18.7 0.3 0.1 0.0 0.1 0.1 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 10.2 0.4 20.2 31.3 23.3 5.1 15.7 10.4 10.4 3.1 18.7 5.8 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 1.0 0.0 0.0 0.0 17.6 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 63.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4" "Group enriched" "Detected in many" 11 "dendritic cells: 7.4;monocytes: 6.2" "Cell line enhanced" "Detected in many" "A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 15.8" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA 240000 Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: AB_2683050" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavorable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 5.6 1.1 0.8 3.6 1.0 1.8 4.2 0.8 1.3 6.1 0.7 2.5 0.5 3.9 0.2 17.4 3.3 1.7 2.1 0.7 1.3 5.8 0.2 16.7 1.8 1.3 1.4 0.6 1.1 0.8 0.1 0.7 2.2 1.2 3.1 1.2 0.0 4.3 1.7 1.0 63.8 1.9 2.1 1.2 0.8 1.4 0.5 2.4 0.4 1.5 1.9 5.2 6.9 9.6 1.1 7.3 87.0 0.1 0.1 8.1 5.2 0.0 6.1 31.4 7.9 12.8 2.6 2.8 0.1 19.0 16.1 10.7 22.2 0.1 45.7 3.7 0.3 0.0 0.3 51.4 15.3 2.2 0.0 0.3 4.1 24.9 17.9 19.9 4.5 1.7 0.0 0.0 0.0 39.8 0.5 0.0 0.0 0.6 0.2 11.5 0.0 5.9 4.7 26.0 18.3 1.2 0.0 5.4 6.1 2.0 24.7 0.2 0.6 8.6 2.9 4.8 47.4 6.3 1.4 1.6 0.2 38.2 0.7 19.1 0.0 0.1 0.0 0.0 3.1 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 7.4 0.1 0.4 0.8 1.0 0.8 1.3 0.7 1.3 1.3 1.4 0.6 1.2 1.2 2.4 1.1 2.0 3.2 0.5 0.7 0.0 10.3 2.3 15.4 4.0 0.0 0.3 0.4 0.3 1.5 5.9 0.0 0.0 0.3 0.0 0.0 1.9 21.7 0.0 2.3 18.4 7.4 0.0 1.3 0.0 24.0 4.4 8.4 0.0 1.3 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.1 0.1 4.1 0.4 1.8 0.0 3.6 0.0 0.0 0.0 0.0 24.2 0.0 0.4 0.0 1.5 0.0 0.3 1.1 0.0 0.0 24.7 9.6 0.1 0.0 5.6 6.5 1.5 0.5 1.1 0.0 2.0 UBQLN2 "Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157" ENSG00000188021 "Ubiquilin 2" Q9UHD9 X 56563627-56567868 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Autophagy "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006431, CAB013481" Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB013481: AB_2533341, HPA006431: AB_1078707" "unprognostic (1.23e-2)" "unprognostic (2.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.66e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-3)" 13.9 20.4 24.2 15.0 29.6 11.2 12.2 22.8 30.0 16.1 15.0 14.2 11.3 16.8 16.1 18.8 17.6 14.6 21.8 28.9 27.2 13.7 19.5 13.9 18.5 23.3 23.9 30.2 25.9 10.6 23.8 16.4 16.0 23.6 20.4 12.2 22.4 14.5 20.2 28.3 13.7 12.5 18.6 21.8 15.1 13.2 4.5 25.0 19.1 20.9 23.0 18.7 18.8 11.2 31.1 36.3 26.5 25.9 30.6 58.3 37.0 16.3 28.6 33.9 21.0 23.2 14.9 16.6 27.6 30.5 34.0 32.9 20.7 50.0 31.9 25.3 43.0 30.1 11.2 34.2 15.9 30.6 22.1 23.7 34.7 39.6 28.3 24.6 30.3 18.7 17.6 13.3 29.5 33.6 16.9 28.5 19.2 21.7 11.6 31.1 25.3 33.7 26.3 42.8 27.9 31.9 29.9 41.3 18.1 17.4 45.2 30.4 16.1 21.2 22.2 22.5 32.4 17.5 11.1 14.8 18.9 24.9 23.1 19.3 50.0 23.6 24.1 15.1 31.1 17.1 7.8 22.9 17.7 17.8 8.6 30.3 18.9 20.4 20.9 34.2 6.5 23.5 20.3 24.2 29.6 22.8 30.0 28.9 27.2 23.3 23.9 30.2 23.6 21.8 25.0 31.1 13.9 22.4 17.2 0.0 30.5 31.2 41.6 27.4 20.5 42.3 14.5 11.3 37.6 15.7 25.0 18.4 18.8 28.8 15.4 12.1 17.6 20.0 0.1 11.8 22.7 18.9 34.2 18.3 0.0 16.6 26.7 27.9 13.7 15.7 12.7 14.2 18.2 20.3 24.7 42.1 0.0 20.3 18.3 30.7 25.3 1.6 24.8 21.1 17.8 0.0 35.9 22.3 42.2 0.0 0.0 18.9 12.7 36.5 23.5 32.0 20.7 16.4 27.5 35.8 13.1 25.4 29.8 0.3 1.5 32.7 30.4 40.0 28.7 12.2 19.3 35.6 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533719 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 61.4;skeletal muscle: 89.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Oligodendrocytes: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 7.6 9.1 17.9 3.1 20.3 2.6 7.5 18.7 18.5 10.5 16.5 8.1 1.3 12.1 4.2 5.1 9.6 3.4 61.4 15.4 15.5 6.5 4.2 6.9 1.8 19.5 19.6 14.4 8.5 3.7 6.7 6.4 7.4 21.9 9.2 1.4 3.0 6.9 7.5 89.7 6.8 4.3 6.4 17.7 4.4 5.5 4.1 18.8 1.6 13.4 41.5 1.0 9.6 7.5 27.5 8.3 11.4 10.1 7.9 11.1 10.4 10.6 14.6 8.1 7.8 6.9 7.1 1.9 0.3 7.1 14.3 5.6 8.9 7.5 7.0 3.1 8.4 13.8 1.1 8.1 10.6 19.4 0.4 3.0 11.9 13.6 8.7 12.5 19.5 8.0 1.5 6.6 0.4 8.0 13.8 0.9 2.7 7.4 2.4 11.9 1.3 5.5 0.4 5.6 8.5 1.6 9.3 7.8 6.7 17.9 5.5 9.0 0.2 16.0 10.2 5.1 14.8 9.4 1.7 0.9 0.2 10.4 0.0 6.5 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.5 0.4 1.1 0.3 0.3 0.3 0.2 0.2 17.9 20.3 18.7 18.5 15.4 15.5 19.5 19.6 14.4 21.9 17.7 18.8 27.5 13.0 38.5 11.7 32.3 0.7 4.6 5.1 3.4 6.2 14.1 4.6 14.7 9.8 4.3 7.2 11.0 6.2 9.1 0.7 0.2 1.9 2.2 1.8 6.3 18.0 8.5 0.0 0.0 28.8 2.2 6.2 9.4 1.1 7.4 1.3 18.9 9.7 1.6 5.7 23.5 16.4 1.3 0.0 1.3 2.4 1.6 15.5 3.3 5.4 18.7 0.9 21.4 0.0 13.6 64.9 2.2 0.5 8.2 0.3 5.1 0.1 2.6 4.1 6.4 6.6 14.4 9.9 0.9 2.9 2.3 3.8 9.3 2.0 21.5 0.7 3.3 C19orf67 ENSG00000188032 "Chromosome 19 open reading frame 67" A6NJJ6 19 14081624-14085875 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "testis: 6.6" "Group enriched" "Detected in some" 28 "Early spermatids: 30.0;Late spermatids: 28.2;Spermatocytes: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046351 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA046351: " "unprognostic (1.21e-1)" "unprognostic (6.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.45e-4)" "unprognostic (1.25e-1)" "unprognostic (6.81e-2)" "unprognostic (1.41e-1)" "unprognostic (4.76e-3)" "unprognostic (9.22e-2)" "unprognostic (1.65e-3)" "unprognostic (4.20e-3)" "unprognostic (3.74e-1)" "unprognostic (1.63e-2)" "unprognostic (3.25e-1)" "unprognostic (1.36e-1)" "unprognostic (1.51e-2)" "unprognostic (1.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.0 0.5 30.0 0.4 0.2 0.1 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 28.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.1 9.9 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.2 ZNF490 KIAA1198 ENSG00000188033 "Zinc finger protein 490" Q9ULM2 19 12576100-12640098 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 10.2;Gastric mucus-secreting cells: 13.7;Inhibitory neurons: 9.3;Oligodendrocytes: 10.0;Plasma cells: 14.8" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA005576 Uncertain NA NA "HPA005576: AB_10602689" "unprognostic (1.81e-2)" "unprognostic (1.32e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (5.77e-2)" "unprognostic (9.53e-2)" "unprognostic (1.90e-2)" "unprognostic (1.38e-3)" "unprognostic (2.80e-1)" "unprognostic (7.59e-2)" "unprognostic (5.79e-2)" 0.7 1.0 1.7 1.3 2.1 1.7 1.4 2.4 2.7 1.3 0.4 1.2 1.2 1.0 2.1 0.8 1.5 1.1 0.9 1.9 1.9 1.3 1.8 1.4 2.0 1.4 1.0 2.3 1.9 1.5 1.9 0.5 1.1 1.8 1.4 1.3 2.1 1.1 1.3 0.9 1.8 0.9 0.9 0.7 2.4 1.2 1.4 1.5 2.2 2.3 1.0 2.5 1.0 0.5 3.3 0.7 0.6 1.2 3.3 3.5 2.3 1.0 0.9 1.6 1.2 1.5 1.1 1.0 1.2 2.0 1.2 0.8 0.9 1.7 1.4 1.6 1.6 1.0 1.5 1.4 1.4 1.9 2.9 3.6 1.8 1.6 1.0 2.2 1.7 1.1 1.4 1.1 1.4 1.6 1.5 2.0 2.2 1.8 0.6 1.8 1.5 1.8 2.1 1.4 1.8 2.2 1.5 1.9 1.2 1.5 1.8 1.7 1.7 1.6 3.0 0.8 2.2 1.0 4.3 3.3 1.5 1.6 1.9 2.0 5.0 1.5 2.3 2.7 2.1 2.5 2.2 1.7 2.6 1.3 2.8 1.5 2.6 1.4 3.8 2.6 3.8 2.3 1.0 1.7 2.1 2.4 2.7 1.9 1.9 1.4 1.0 2.3 1.8 0.7 1.5 3.3 1.7 0.0 1.1 7.2 7.4 0.5 0.3 1.2 2.8 1.4 1.8 1.8 1.2 1.5 1.7 0.0 0.0 0.3 2.7 0.9 1.9 0.2 3.9 1.6 3.0 1.5 0.0 3.8 10.2 0.2 0.2 2.4 13.7 2.3 5.7 1.5 0.0 1.0 0.4 0.0 9.3 0.1 0.0 1.6 1.8 1.6 0.6 2.4 3.6 6.5 0.3 0.5 1.0 4.0 10.0 0.2 0.1 0.0 14.8 0.3 0.9 0.3 0.8 0.8 6.6 0.8 2.2 0.9 1.0 4.9 0.3 0.8 6.0 1.1 0.5 0.2 CLCN1 "ClC-1, CLC1" ENSG00000188037 "Chloride voltage-gated channel 1" P35523 7 143316111-143352083 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 66.5" "Cell type enriched" "Detected in some" 4 "Late spermatids: 149.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HSkMC: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.16e-2)" "unprognostic (4.99e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" "unprognostic (9.53e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.56e-4)" "unprognostic (8.71e-3)" "unprognostic (2.35e-1)" "unprognostic (2.90e-3)" "unprognostic (3.12e-1)" "unprognostic (2.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.47e-1)" "unprognostic (3.55e-3)" "unprognostic (3.57e-2)" 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 66.5 0.0 1.0 0.0 0.0 0.1 0.2 1.0 0.0 0.2 0.0 16.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.1 0.8 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 32.9 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.8 149.6 0.0 0.7 0.0 1.0 0.6 0.0 0.0 0.0 0.7 5.7 15.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 1.4 0.3 0.1 2.2 0.7 0.1 0.0 0.1 0.1 0.2 2.1 NRN1L "MRCC2446, UNQ2446" ENSG00000188038 "Neuritin 1 like" Q496H8 16 67884885-67888855 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 12.0;Astrocytes: 2.9;Bipolar cells: 2.0;Oligodendrocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "BEWO: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041761 Uncertain "Secreted - unknown location" NA NA "HPA041761: AB_10961155" "unprognostic (2.79e-2)" "unprognostic (3.32e-1)" "unprognostic (1.19e-1)" "unprognostic (3.99e-2)" "unprognostic (4.85e-1)" 1.6 1.4 4.4 0.9 5.8 3.8 1.7 6.2 8.3 2.4 8.1 1.3 1.0 1.3 0.4 1.1 2.9 0.7 1.9 4.2 5.6 1.8 2.4 1.9 2.1 5.1 4.8 4.2 4.7 1.3 0.7 6.3 0.6 5.3 2.7 0.6 5.5 1.7 0.8 2.1 3.2 1.7 0.5 3.8 2.5 1.2 1.8 4.6 1.1 2.5 0.7 0.6 2.0 2.1 6.1 0.1 0.5 0.7 0.9 0.3 1.1 38.1 0.4 0.1 0.4 0.3 0.0 0.6 0.5 0.7 0.1 0.0 0.4 0.1 0.3 0.3 0.3 0.9 0.4 1.5 2.0 0.6 0.2 1.4 0.5 1.2 0.1 0.0 0.4 0.1 1.4 0.9 0.7 0.1 1.6 0.5 4.3 7.1 0.0 0.5 1.5 0.0 0.7 0.3 0.4 1.1 0.4 0.5 0.5 0.5 6.8 1.0 1.4 0.6 0.3 0.3 0.0 0.1 0.1 0.4 0.9 0.1 0.4 0.2 0.0 0.5 0.0 1.0 0.3 0.6 0.5 0.6 0.3 0.1 0.2 0.5 0.3 0.6 0.3 0.4 0.1 0.4 0.3 4.4 5.8 6.2 8.3 4.2 5.6 5.1 4.8 4.2 5.3 3.8 4.6 6.1 0.1 3.2 12.0 2.9 0.1 0.3 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719847-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "choroid plexus: 166.2" "Group enriched" "Detected in some" 4 "Astrocytes: 41.4;Endometrial ciliated cells: 83.9;Respiratory ciliated cells: 92.0" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-937: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.0 0.0 5.1 0.0 5.5 0.1 0.2 9.5 7.6 1.3 166.2 0.5 0.0 0.2 0.4 0.2 12.7 0.2 0.0 13.3 10.2 0.2 0.0 1.3 0.0 6.1 9.2 3.0 0.0 1.5 0.0 0.7 0.0 7.6 6.8 0.1 1.1 1.3 1.9 0.0 0.2 0.0 0.0 2.8 0.0 0.8 0.2 8.9 0.2 0.7 0.0 0.0 0.1 0.0 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 5.5 9.5 7.6 13.3 10.2 6.1 9.2 3.0 7.6 2.8 8.9 3.5 0.0 0.0 1.5 41.4 0.3 0.3 1.7 3.5 0.0 0.2 0.5 0.3 0.9 0.0 4.5 0.0 0.0 0.1 0.0 0.4 0.0 0.1 17.9 83.9 0.8 0.3 1.2 0.0 2.4 0.0 0.2 0.3 0.0 3.7 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.6 2.0 0.0 0.4 3.3 0.6 0.3 0.0 0.0 0.0 8.9 0.0 1.5 1.2 0.2 0.4 0.0 0.0 4.0 0.0 0.1 92.0 0.6 0.0 1.1 1.4 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.4 1.4 ARL4C "ARL7, LAK" ENSG00000188042 "ADP ribosylation factor like GTPase 4C" P56559 2 234493041-234497081 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 65.6;lymphoid tissue: 74.6" "Cell type enhanced" "Detected in many" "dendritic cells: 610.9;Langerhans cells: 474.5;NK-cells: 437.7;T-cells: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 149.4;RPTEC TERT1: 284.8;U-2197: 168.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028927 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA028927: AB_10602387" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-3)" "prognostic unfavorable (2.90e-7)" "unprognostic (8.01e-3)" "unprognostic (3.35e-2)" "unprognostic (9.26e-2)" "unprognostic (2.68e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-2)" "unprognostic (3.17e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.69e-8)" "unprognostic (8.57e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.99e-5)" 15.2 10.7 16.9 32.0 15.3 65.6 17.4 18.3 22.9 7.8 38.0 9.2 6.7 5.9 9.6 23.4 12.0 32.1 4.0 13.7 22.6 12.1 12.9 16.2 55.7 20.3 19.0 13.3 2.1 5.5 10.9 7.4 16.6 22.1 10.4 11.3 9.8 21.8 5.4 1.5 24.3 13.3 5.9 14.2 51.5 13.8 1.2 18.9 74.6 3.7 1.7 32.4 25.7 18.2 25.4 32.3 97.4 12.0 1.6 10.4 3.0 31.6 3.2 13.8 3.8 6.6 45.4 60.4 0.1 8.0 7.7 109.0 23.5 12.0 66.4 4.1 30.4 4.2 0.0 0.6 0.6 10.7 0.1 2.8 6.4 42.2 36.6 21.2 149.4 6.4 78.4 0.4 102.4 16.4 4.4 93.7 0.3 12.6 22.5 21.9 0.3 54.1 18.0 284.8 35.2 44.1 8.1 1.1 7.1 4.7 18.2 0.9 1.9 14.8 60.0 23.2 168.2 61.6 51.1 19.7 1.6 101.9 0.1 32.0 79.8 1.2 27.4 86.7 1.6 85.6 18.1 60.0 69.5 10.3 18.3 53.5 59.1 2.2 61.2 0.9 55.2 83.8 30.0 16.9 15.3 18.3 22.9 13.7 22.6 20.3 19.0 13.3 22.1 14.2 18.9 25.4 12.3 73.7 15.9 8.8 63.6 124.8 120.7 18.4 145.1 156.6 40.4 64.6 10.9 67.2 27.0 14.7 8.4 30.0 610.9 2.3 0.0 19.6 7.8 73.9 19.2 23.4 1.8 6.1 15.5 5.7 5.4 23.7 19.9 186.3 27.8 1.1 11.0 3.4 31.4 107.7 103.0 2.5 0.0 208.4 474.5 6.5 0.3 182.1 42.7 6.5 41.8 32.2 437.7 6.0 2.5 16.5 0.1 0.0 132.6 60.4 0.1 0.9 4.7 13.1 0.0 7.0 19.3 0.7 1.9 65.4 42.9 14.6 349.8 0.4 1.2 46.6 RNF133 ENSG00000188050 "Ring finger protein 133" Q8WVZ7 7 122697735-122699117 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 42.5" "Group enriched" "Detected in some" 146 "Early spermatids: 479.8;Late spermatids: 837.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebellum: 6.9;pons: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.82e-1)" "unprognostic (2.52e-2)" "unprognostic (1.77e-1)" "unprognostic (3.04e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.87e-3)" "unprognostic (3.56e-2)" "unprognostic (3.72e-1)" "unprognostic (3.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.02e-2)" "unprognostic (7.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.39e-1)" "unprognostic (2.37e-2)" "unprognostic (7.61e-2)" 0.2 0.1 0.0 0.0 0.1 0.0 0.2 6.9 1.1 0.2 0.3 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 2.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 42.5 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.9 1.1 0.1 0.1 0.0 0.4 0.0 2.5 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 479.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 837.4 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TMEM221 ENSG00000188051 "Transmembrane protein 221" A6NGB7 19 17435509-17448668 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 8.0;retina: 9.5" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 14.6;Muller glia cells: 49.2;Rod photoreceptor cells: 24.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;PC-3: 6.8;REH: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041580, HPA062945" Supported Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700, HPA062945: " "unprognostic (3.60e-2)" "unprognostic (7.86e-2)" "unprognostic (4.51e-4)" "unprognostic (2.09e-2)" "unprognostic (2.61e-2)" "unprognostic (9.14e-3)" "unprognostic (3.19e-1)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (9.47e-4)" "unprognostic (2.37e-2)" "unprognostic (6.67e-2)" "unprognostic (2.76e-1)" "unprognostic (2.42e-2)" "unprognostic (1.23e-1)" 0.5 4.2 3.3 0.2 3.3 0.1 1.2 3.0 4.5 0.8 2.5 0.6 0.1 0.6 0.7 0.5 2.7 0.2 0.5 3.4 3.4 0.5 0.4 0.3 0.2 3.5 2.9 3.3 8.0 2.2 5.4 1.7 0.1 2.9 1.3 0.0 9.5 0.8 1.0 0.2 0.4 0.4 0.1 3.1 0.4 0.4 0.5 3.2 0.5 0.7 0.1 0.1 0.4 1.0 3.2 0.5 1.5 0.6 4.6 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.0 0.4 0.2 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.2 1.0 0.3 6.8 3.9 0.1 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 3.3 3.0 4.5 3.4 3.4 3.5 2.9 3.3 2.9 3.1 3.2 3.2 0.5 0.0 0.5 1.0 0.1 0.0 0.1 0.0 0.0 1.3 0.3 0.3 0.3 1.5 0.0 0.0 14.6 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.0 2.0 0.0 0.0 2.2 0.0 0.2 0.0 0.2 3.3 0.0 3.7 1.7 3.9 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 49.2 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.5 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.1 TREML4 TLT4 ENSG00000188056 "Triggering receptor expressed on myeloid cells like 4" Q6UXN2 6 41228339-41238882 "Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "choroid plexus: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 4.5;neutrophil: 8.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.1" "Cell line enriched" "Detected in single" 6 "HEL: 1.1" "Not detected" "Not detected" HPA065044 Uncertain Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA065044: AB_2685411" "unprognostic (1.49e-1)" "unprognostic (1.51e-1)" "unprognostic (5.58e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (9.50e-3)" "unprognostic (1.18e-4)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (5.26e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 4.5 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.9 0.0 0.0 8.1 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB42 MGC45806 ENSG00000188060 "RAB42, member RAS oncogene family" Q8N4Z0 1 28592200-28595449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 24.7" "Cell type enriched" "Detected in many" 7 "Hofbauer cells: 91.3" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.0;Hep G2: 14.3;HSkMC: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050290 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA050290: AB_2681075" "unprognostic (1.10e-1)" "unprognostic (2.56e-1)" "unprognostic (1.72e-1)" "unprognostic (1.00e-1)" "unprognostic (8.25e-2)" "unprognostic (7.59e-2)" "unprognostic (2.00e-4)" "unprognostic (8.81e-2)" "unprognostic (2.39e-1)" "unprognostic (4.09e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (1.52e-2)" "unprognostic (8.77e-2)" "unprognostic (3.02e-2)" "unprognostic (8.83e-2)" "unprognostic (2.07e-3)" 2.6 0.7 1.1 1.7 1.6 0.8 2.2 1.3 3.1 2.2 1.4 1.8 1.5 1.7 0.6 0.7 1.0 1.7 0.8 0.9 1.5 0.9 1.2 2.9 6.7 1.7 0.9 0.6 0.4 0.5 2.7 0.3 4.6 2.3 0.7 2.4 1.0 2.6 0.6 0.3 0.6 1.6 1.5 1.4 3.5 1.3 1.4 2.5 24.7 0.6 0.6 3.6 1.9 1.1 3.6 0.1 0.7 0.9 0.0 4.1 10.0 0.0 0.4 3.8 4.1 5.3 2.0 1.5 0.2 2.0 4.3 0.4 0.2 4.1 0.0 2.7 0.1 0.0 0.3 6.8 14.3 1.7 1.1 0.0 8.8 0.1 2.2 0.0 0.4 1.2 0.1 0.1 0.1 0.9 0.0 0.1 2.2 4.8 0.0 0.0 6.5 0.0 1.7 1.8 0.0 0.3 1.5 3.7 0.1 0.0 0.6 0.2 1.8 0.4 0.0 1.2 3.9 0.0 0.3 2.1 0.2 0.1 3.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 1.1 1.6 1.3 3.1 0.9 1.5 1.7 0.9 0.6 2.3 1.4 2.5 3.6 0.5 0.0 0.0 0.0 0.7 0.1 0.2 0.7 0.0 0.5 1.2 1.0 0.4 1.5 1.0 0.0 0.0 0.6 0.1 0.2 0.0 8.5 5.3 3.4 3.9 0.3 0.0 0.4 0.1 0.0 0.8 3.4 0.0 3.2 0.0 0.5 2.5 0.0 91.3 0.0 0.1 0.1 0.0 3.5 1.7 12.2 1.5 11.7 0.0 1.0 1.1 1.0 0.0 0.0 0.1 2.9 1.2 0.0 1.2 0.2 0.3 0.5 0.4 0.9 0.0 4.5 0.9 2.5 1.8 0.4 0.4 0.4 0.3 0.2 0.1 0.1 WNT7B ENSG00000188064 "Wnt family member 7B" P56706 22 45920366-45977162 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.5;skin 1: 18.1;urinary bladder: 9.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 33.6;Basal prostatic cells: 26.4;Basal squamous epithelial cells: 42.1;Club cells: 23.9;Pancreatic endocrine cells: 43.3;Prostatic glandular cells: 26.2;Urothelial cells: 46.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 119.4;HeLa: 103.7;RPTEC TERT1: 41.4;SK-BR-3: 51.0;U-87 MG: 93.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-3)" "unprognostic (7.83e-3)" "unprognostic (8.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-1)" "unprognostic (4.05e-2)" "unprognostic (3.85e-3)" "unprognostic (1.69e-2)" "unprognostic (8.58e-4)" "unprognostic (1.90e-1)" "unprognostic (6.73e-2)" "unprognostic (1.36e-1)" "unprognostic (1.22e-2)" 0.0 0.0 4.4 0.0 3.3 0.0 1.2 1.6 5.2 1.8 0.4 0.0 0.0 0.1 0.1 12.5 1.2 2.9 0.0 4.7 3.4 1.4 0.1 3.1 0.0 2.6 2.0 3.5 0.0 0.5 0.1 0.5 0.4 3.8 4.4 0.0 0.0 2.2 1.9 0.0 18.1 0.0 0.0 1.3 0.0 0.0 0.3 3.8 0.7 0.3 0.0 1.0 9.2 8.4 3.0 23.2 119.4 0.3 0.0 0.0 0.0 15.2 0.4 1.3 0.0 0.0 0.5 15.5 0.1 3.7 0.2 1.3 25.8 0.9 15.1 0.0 0.1 1.0 0.0 103.7 0.6 0.0 0.0 0.1 0.0 10.2 0.1 3.0 0.4 0.0 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.1 9.7 22.4 0.0 0.0 1.3 41.4 33.9 4.3 0.0 10.3 51.0 0.0 0.2 8.5 13.6 0.0 2.1 1.8 0.0 1.0 0.0 0.0 0.0 93.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 3.3 1.6 5.2 4.7 3.4 2.6 2.0 3.5 3.8 1.3 3.8 3.0 0.3 6.4 15.6 3.9 0.5 33.6 26.4 16.3 42.1 0.5 4.0 0.6 1.6 8.6 23.9 12.9 4.2 3.5 0.1 0.1 0.0 5.9 0.3 1.7 0.4 0.7 0.0 0.0 0.3 0.5 0.3 1.7 0.0 4.3 2.5 0.2 0.4 0.1 0.1 0.0 1.2 0.0 0.0 0.0 3.7 0.2 0.3 0.3 0.0 1.0 1.0 0.2 0.0 7.5 0.1 43.3 0.0 0.4 1.5 26.2 0.0 0.1 13.8 1.1 0.0 0.8 1.9 0.2 1.8 21.0 20.5 0.7 0.5 0.0 0.0 46.6 C11orf95 MGC3032 ENSG00000188070 "Chromosome 11 open reading frame 95" C9JLR9 11 63759892-63768775 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045002 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA045002: AB_2679179" "unprognostic (4.23e-3)" "unprognostic (7.24e-3)" "unprognostic (6.47e-2)" "unprognostic (9.01e-3)" "unprognostic (7.54e-2)" "unprognostic (3.89e-1)" "unprognostic (8.94e-2)" "unprognostic (3.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" "unprognostic (8.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.52e-3)" "unprognostic (1.85e-2)" "unprognostic (6.60e-2)" "unprognostic (5.68e-2)" "unprognostic (1.31e-3)" 12.0 7.2 13.9 5.1 13.9 2.0 9.7 8.0 18.0 15.6 4.7 11.0 3.8 20.5 6.9 4.9 13.8 7.0 9.5 16.5 12.7 11.0 9.7 5.8 6.1 9.4 9.2 13.2 23.0 8.8 5.4 11.5 11.0 9.5 8.9 3.5 4.3 6.9 10.2 7.8 4.4 7.6 11.4 6.5 6.7 7.3 4.9 11.9 8.3 11.5 5.5 5.5 12.2 11.4 9.8 3.5 4.6 34.7 11.6 17.7 20.3 5.5 13.0 9.3 6.0 4.2 11.4 2.2 11.2 18.6 12.6 4.5 7.9 15.2 5.2 6.8 11.0 10.3 7.5 8.9 5.2 6.2 3.6 6.0 15.2 1.8 9.9 3.2 19.8 13.5 10.0 9.7 5.0 9.7 4.6 13.6 18.5 16.2 2.1 13.4 31.9 6.6 3.5 8.7 4.4 14.6 30.8 6.2 6.6 18.3 14.1 9.3 8.8 21.3 12.2 11.4 15.7 7.6 4.5 6.3 13.5 3.3 9.1 6.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 13.9 13.9 8.0 18.0 16.5 12.7 9.4 9.2 13.2 9.5 6.5 11.9 9.8 8.0 0.0 5.3 6.8 2.2 5.1 1.3 2.8 3.4 4.6 6.3 9.5 7.2 11.5 2.3 0.0 0.0 6.4 2.6 1.0 3.9 2.6 0.3 2.8 11.8 9.0 4.9 0.8 3.9 2.2 0.5 11.3 0.5 4.9 1.3 8.6 13.9 7.0 1.7 6.7 3.0 2.7 4.1 1.6 6.3 1.3 18.3 2.0 3.6 3.7 3.8 11.8 0.0 2.5 0.5 2.1 1.2 7.9 0.7 1.5 0.7 3.6 1.5 3.1 13.1 6.8 11.2 0.4 4.2 1.4 3.4 1.5 1.1 2.3 2.5 1.0 SCGB1C1 RYD5 ENSG00000188076 "Secretoglobin family 1C member 1" Q8TD33 11 193078-194575 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;pancreas: 1.4;retina: 3.4;salivary gland: 1.1" "Cell type enriched" "Detected in single" 5 "Macrophages: 2.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Region enhanced" "Detected in single" "pons: 1.3" "Group enriched" "Detected in some" 32 "basophil: 5.0;neutrophil: 1.3" "Lineage enriched" "Detected in single" 50 "granulocytes: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (5.09e-3)" 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 3.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.5 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS45P "PRSS45, TESPL, TESSP5" ENSG00000188086 "Serine protease 45, pseudogene" Q7RTY3 3 46742092-46750891 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.5;skeletal muscle: 10.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA060284 Uncertain NA NA "HPA060284: AB_2684242" "unprognostic (4.55e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-2)" "unprognostic (2.50e-1)" "unprognostic (6.07e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (6.20e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-4)" "unprognostic (2.33e-2)" "unprognostic (6.60e-3)" "unprognostic (1.27e-2)" "unprognostic (1.57e-2)" "unprognostic (2.15e-1)" "unprognostic (5.97e-3)" 0.2 0.2 0.4 0.0 0.3 0.0 1.1 0.5 0.4 1.3 0.8 0.4 0.1 0.3 6.5 0.2 0.9 0.0 2.0 0.2 0.7 1.7 1.3 0.6 0.1 0.6 0.6 0.2 0.4 2.1 2.8 1.9 0.1 0.6 1.4 0.0 0.2 0.9 1.0 10.5 0.2 0.3 0.1 0.5 0.3 0.3 2.2 0.5 0.2 4.9 0.9 0.0 0.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.5 0.4 0.2 0.7 0.6 0.6 0.2 0.6 0.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLA2G4E FLJ45651 ENSG00000188089 "Phospholipase A2 group IVE" Q3MJ16 15 41981582-42051190 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 17.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 11.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041105, HPA072562" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA041105: AB_2677300, HPA072562: " "unprognostic (2.98e-1)" "unprognostic (5.52e-1)" "unprognostic (2.60e-1)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.77e-1)" "unprognostic (4.22e-2)" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-7)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (4.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 18.1 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 5.1 0.5 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 5.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 44.9 0.0 0.1 0.0 0.2 0.7 GPR89B "GPR89, GPR89C, SH120" ENSG00000188092 "G protein-coupled receptor 89B" P0CG08 1 147928393-147993592 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA076096 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA076096: AB_2686777" "unprognostic (7.78e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.19e-3)" "unprognostic (1.05e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-4)" "unprognostic (1.23e-2)" "unprognostic (2.38e-2)" "unprognostic (1.61e-1)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.69e-1)" "unprognostic (7.15e-4)" 5.8 7.1 5.0 0.2 4.7 3.1 6.4 8.0 8.1 7.3 5.5 5.2 1.7 6.8 2.5 5.7 6.3 1.8 5.1 6.0 6.9 12.6 7.3 5.5 1.4 7.9 6.7 4.8 6.7 4.5 3.2 4.9 2.1 8.4 6.2 2.2 2.0 7.4 2.5 8.9 8.3 7.1 1.2 5.3 5.1 6.4 10.5 6.8 2.6 4.8 6.0 1.3 6.3 6.2 9.6 5.8 0.3 3.5 3.8 5.9 4.1 6.5 4.4 1.8 6.3 9.1 7.7 4.3 4.8 5.1 5.7 4.8 5.4 7.7 0.8 5.3 5.9 6.8 6.6 2.1 4.1 6.3 0.4 3.0 2.0 9.0 5.6 10.4 2.2 3.4 8.2 2.7 8.5 3.5 12.3 9.8 4.4 5.9 6.4 4.4 3.9 9.8 6.8 6.4 5.8 3.0 2.8 9.0 2.2 5.0 5.2 7.2 4.0 1.8 2.5 1.4 2.6 6.5 17.6 11.2 8.0 5.6 4.1 2.8 3.5 2.5 2.4 2.3 1.9 3.3 2.2 3.2 2.4 1.8 3.0 3.1 2.7 1.3 4.4 1.5 2.0 2.6 2.1 5.0 4.7 8.0 8.1 6.0 6.9 7.9 6.7 4.8 8.4 5.3 6.8 9.6 4.4 6.4 5.3 11.1 16.3 0.1 8.2 0.1 24.5 3.0 6.2 4.7 6.6 5.7 3.8 5.5 2.1 13.4 8.8 6.0 0.0 7.2 8.1 2.8 3.0 4.1 4.8 6.7 32.2 7.1 14.1 6.3 16.3 3.2 7.0 4.4 3.3 6.7 4.2 0.0 32.4 7.2 0.0 2.2 0.3 3.7 5.6 3.7 0.0 11.2 4.1 2.4 6.2 19.1 27.8 6.8 7.8 3.4 30.0 4.3 20.4 21.9 3.6 4.0 0.0 3.5 4.0 31.1 10.6 16.1 0.0 15.7 16.1 4.7 5.9 3.6 MESP2 "bHLHc6, SCDO2" ENSG00000188095 "Mesoderm posterior bHLH transcription factor 2" Q0VG99 15 89760591-89778754 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.7;Exocrine glandular cells: 3.8;Rod photoreceptor cells: 7.0;Spermatogonia: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;U-2197: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (3.75e-2)" "unprognostic (8.64e-2)" "unprognostic (2.39e-1)" "unprognostic (1.50e-3)" "unprognostic (6.59e-4)" "unprognostic (5.58e-2)" "unprognostic (4.00e-1)" "unprognostic (5.90e-2)" "unprognostic (3.14e-5)" "unprognostic (2.69e-1)" "unprognostic (1.01e-2)" "unprognostic (2.50e-1)" "unprognostic (3.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.11e-1)" 0.5 0.2 0.8 0.0 0.9 0.0 0.5 0.6 1.2 0.8 0.4 0.5 0.1 0.0 0.7 0.4 0.1 0.3 0.1 0.8 0.9 0.1 0.0 0.0 0.1 0.9 0.8 0.9 0.0 0.1 0.1 0.0 0.0 1.0 0.3 0.4 0.9 0.5 0.2 0.0 0.4 0.2 0.0 0.7 0.0 0.1 0.7 0.7 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 1.1 0.0 0.4 0.6 0.1 0.2 0.2 0.1 0.5 0.1 0.3 0.5 0.0 0.1 0.1 0.0 1.1 0.3 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.6 0.2 0.4 0.2 0.0 0.3 0.5 0.3 0.0 0.1 0.2 0.0 0.1 0.2 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.5 0.1 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.9 0.6 1.2 0.8 0.9 0.9 0.8 0.9 1.0 0.7 0.7 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.7 1.5 0.4 0.0 1.3 0.0 0.0 0.6 0.1 1.2 1.9 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.3 3.8 0.0 0.8 0.0 0.0 0.0 0.4 0.4 0.2 0.5 0.0 0.3 0.8 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.5 0.2 0.4 0.0 0.6 0.0 0.7 0.7 7.0 0.0 0.3 0.3 1.2 2.1 0.2 0.0 0.1 0.0 0.9 0.7 0.9 FAM25A bA96C23.5 ENSG00000188100 "Family with sequence similarity 25 member A" B3EWG3 10 87020294-87024730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 523.7;salivary gland: 141.1;skin 1: 154.2;vagina: 194.7" "Group enriched" "Detected in some" 4 "Suprabasal keratinocytes: 49.6;Syncytiotrophoblasts: 16.1" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 53.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 30.3;SK-BR-3: 70.0" "Low region specificity" "Detected in single" HPA044808 Uncertain NA NA "HPA044808: AB_2679096" "unprognostic (9.94e-2)" "unprognostic (2.57e-1)" "unprognostic (7.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (1.05e-5)" "unprognostic (1.21e-1)" 0.2 2.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 68.4 0.0 0.1 0.0 0.1 0.0 523.7 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 1.5 0.0 0.1 0.0 0.0 141.1 0.0 1.2 154.2 0.0 0.0 0.0 0.1 0.5 0.1 0.0 1.4 0.0 0.0 64.1 0.2 194.7 0.1 30.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.3 0.0 0.0 0.2 0.0 0.0 9.0 0.1 0.0 0.0 0.2 2.0 0.0 0.3 0.0 1.6 1.2 0.0 0.0 0.0 70.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.8 2.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 49.6 16.1 0.0 0.0 0.0 1.9 EYS "bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM" ENSG00000188107 "Eyes shut homolog" Q5T1H1 6 63719980-65707226 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "retina: 25.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 316.9;Early spermatids: 87.3;Inhibitory neurons: 83.8;Late spermatids: 45.7;Rod photoreceptor cells: 140.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "Karpas-707: 1.5;SCLC-21H: 1.1" "Secreted in other tissues" NA NA "unprognostic (2.92e-2)" "unprognostic (1.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-2)" "unprognostic (2.16e-3)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (6.38e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (2.04e-1)" "unprognostic (2.18e-1)" "unprognostic (2.61e-4)" "unprognostic (1.89e-1)" "unprognostic (8.41e-2)" "unprognostic (6.38e-3)" "unprognostic (1.11e-1)" 0.6 0.0 0.3 0.0 0.4 0.3 0.2 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.1 0.1 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.6 25.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.1 0.0 0.0 0.3 0.3 0.4 0.6 0.6 0.4 0.1 0.4 0.1 0.4 0.4 0.0 0.1 0.5 0.1 0.0 1.8 3.9 0.5 0.3 0.7 0.1 0.6 8.3 0.1 0.0 2.1 0.0 0.7 1.8 316.9 0.8 0.2 0.0 0.0 0.4 87.3 1.0 1.0 0.7 20.3 0.0 22.0 0.4 0.4 0.7 0.0 2.1 2.5 0.0 0.0 0.3 0.1 10.1 83.8 0.4 0.0 0.0 0.6 45.7 0.9 0.2 0.0 3.7 0.1 4.0 0.0 5.5 12.9 0.3 0.0 0.7 0.1 0.2 0.1 0.3 0.1 140.2 0.0 1.5 0.3 2.6 1.3 0.4 0.1 1.1 0.6 0.3 0.2 0.2 C6orf132 bA7K24.2 ENSG00000188112 "Chromosome 6 open reading frame 132" Q5T0Z8 6 42101119-42142620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 158.3;skin 1: 71.3" "Cell type enhanced" "Detected in many" "Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA044588 Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA044588: AB_10794293" "unprognostic (7.09e-2)" "unprognostic (8.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.24e-3)" "unprognostic (1.60e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (6.78e-2)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.31e-1)" "unprognostic (4.26e-3)" "unprognostic (1.04e-2)" "unprognostic (5.53e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" 3.3 1.1 0.3 2.2 0.3 1.0 8.8 0.5 0.6 16.3 0.2 14.2 33.7 1.0 0.1 158.3 5.8 6.7 1.5 0.3 0.8 6.5 0.5 5.8 0.3 0.3 0.1 0.3 0.2 18.1 2.5 1.7 1.5 0.3 12.2 11.8 0.9 47.5 2.3 0.9 71.3 20.8 0.5 0.0 0.1 36.5 0.7 0.2 0.7 10.8 0.3 14.0 10.0 55.4 0.5 57.8 0.5 0.0 0.1 0.3 6.1 29.0 2.9 4.4 7.6 7.6 52.0 44.0 0.0 5.4 5.4 0.1 37.5 0.1 17.3 5.2 5.1 7.2 2.8 5.0 12.1 2.0 0.0 0.2 4.0 30.4 5.9 8.8 3.1 0.0 0.3 1.7 0.5 1.7 20.4 0.4 0.3 3.6 181.7 1.5 0.1 0.0 0.3 6.2 25.5 3.0 0.1 4.7 35.2 0.1 4.1 25.2 0.3 0.8 0.4 3.5 13.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.5 0.1 0.0 0.3 0.0 0.1 0.3 0.3 0.5 0.6 0.3 0.8 0.3 0.1 0.3 0.3 0.0 0.2 0.5 0.8 44.8 16.6 0.3 0.2 52.5 88.6 31.8 19.4 0.8 41.7 19.8 5.1 45.8 63.1 51.5 20.9 12.4 1.2 89.9 0.0 57.9 22.2 91.9 9.4 2.8 7.3 0.0 0.5 134.7 1.0 9.2 57.1 135.8 1.3 18.3 1.4 0.0 0.8 5.0 0.5 41.3 38.7 1.2 6.8 163.8 0.6 1.5 12.4 0.0 3.8 0.5 4.1 0.5 0.2 219.9 66.8 1.5 0.3 144.6 102.7 7.7 92.1 7.9 0.0 7.9 4.9 4.9 9.1 81.4 82.0 4.1 1.5 45.4 43.7 226.0 DAZ1 "DAZ, SPGY" ENSG00000188120 "Deleted in azoospermia 1" Q9NQZ3 Y 23129355-23199094 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 2.0" "Cell type enriched" "Detected in single" 38 "Gastric mucus-secreting cells: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "U-266/70: 15.3;U-266/84: 24.5" HPA047113 Supported NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AG2 OR2AG2P ENSG00000188124 "Olfactory receptor family 2 subfamily AG member 2" A6NM03 11 6765626-6771976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Excitatory neurons: 119.0;Inhibitory neurons: 63.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.24e-3)" "unprognostic (7.69e-2)" "unprognostic (1.21e-2)" "unprognostic (1.56e-1)" "unprognostic (7.30e-2)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 119.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 13.6 2.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261716 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "skeletal muscle: 282.0;tongue: 122.0" "Cell type enhanced" "Detected in many" "Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 31.6" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB025483: , HPA054562: AB_2682524" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 8.7 2.3 13.9 3.8 14.9 1.3 7.9 13.3 21.4 10.5 8.4 4.2 3.5 19.2 9.9 6.3 11.3 4.4 12.6 13.6 14.8 10.6 1.4 6.9 4.2 15.8 13.4 14.9 10.7 1.8 4.4 25.3 4.1 13.8 10.1 1.1 1.4 4.3 6.9 282.0 1.4 4.4 8.7 12.8 4.3 5.1 4.6 13.4 0.9 3.2 122.0 1.4 6.1 6.0 13.2 23.2 13.9 5.3 16.3 12.4 13.5 7.5 17.5 15.1 28.2 18.3 19.6 7.2 45.1 23.4 19.6 16.8 15.4 24.3 3.4 5.5 12.8 34.0 29.2 46.7 24.9 37.7 28.4 54.5 29.8 6.0 7.2 0.0 16.8 33.2 4.0 26.3 38.5 13.4 12.8 0.0 35.4 15.9 7.6 22.5 41.4 14.2 43.9 17.5 3.0 18.0 6.5 13.3 0.5 22.1 4.2 7.1 29.6 18.7 28.5 26.1 6.6 11.2 9.3 7.3 24.5 7.2 24.7 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.9 14.9 13.3 21.4 13.6 14.8 15.8 13.4 14.9 13.8 12.8 13.4 13.2 23.1 0.0 3.2 22.9 1.6 0.8 0.7 3.3 1.2 5.5 1.2 1.3 8.8 4.3 0.8 0.0 0.0 0.3 0.9 0.3 1.9 0.5 0.3 0.6 10.0 15.8 1.8 1.7 9.8 0.0 2.8 5.3 2.6 0.7 10.8 0.6 20.7 0.9 6.3 1.7 6.5 0.2 8.2 2.2 0.8 1.9 6.5 2.2 0.0 6.5 0.6 8.1 0.0 5.0 0.9 0.5 0.0 3.8 2.8 3.6 0.4 8.0 0.9 2.2 6.6 3.3 3.0 0.7 12.1 0.8 0.6 0.4 2.2 3.2 0.3 0.2 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783540-32789201 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.7;retina: 18.4;testis: 4.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 572.0;Early spermatids: 129.9;Late spermatids: 302.1" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Region enhanced" "Detected in some" "thalamus: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: AB_2681957, HPA063207: AB_2732697" "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.0 0.0 1.3 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.5 1.7 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 18.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 4.0 4.7 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.5 0.6 1.0 0.5 1.7 0.5 0.3 0.2 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 572.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 129.9 0.0 1.2 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 3.7 0.0 0.0 0.1 1.7 0.3 0.0 0.0 0.0 0.0 302.1 2.8 0.1 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.1 3.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUTM2G FAM22G ENSG00000188152 "NUT family member 2G" Q5VZR2 9 96928310-96940253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;HeLa: 1.7;SiHa: 1.7" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.78e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.50e-2)" "unprognostic (1.92e-2)" "unprognostic (3.50e-3)" "unprognostic (2.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.13e-1)" "unprognostic (4.52e-2)" 0.1 0.2 0.7 0.1 0.7 0.6 0.1 1.3 0.6 0.3 0.2 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 0.8 0.3 0.2 0.1 0.3 0.3 0.8 0.4 0.2 0.4 0.3 0.0 0.2 0.1 0.7 0.3 0.0 0.2 0.4 0.0 0.7 0.8 0.2 0.0 0.1 0.3 0.2 2.9 0.7 0.0 0.3 0.0 0.0 0.2 0.4 1.3 0.6 0.5 0.4 0.8 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.8 0.2 0.6 0.1 0.0 0.5 0.8 0.0 0.0 0.0 0.4 0.7 0.6 1.7 0.8 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.4 0.0 1.0 0.3 0.7 0.9 0.6 0.4 0.4 0.6 0.0 0.0 0.6 0.7 0.2 1.7 0.2 0.1 0.2 0.1 0.0 0.4 0.9 0.3 0.3 0.3 0.2 0.0 0.3 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 1.3 0.6 0.8 0.3 0.8 0.4 0.2 0.7 0.1 0.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439838-108697545 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 108.6" "Cell type enriched" "Detected in many" 9 "Oligodendrocytes: 713.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 87.7;HHSteC: 95.0;HUVEC TERT2: 92.8;TIME: 88.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077177 Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA077177: " "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 6.9 5.6 27.3 2.3 55.5 0.0 8.1 40.2 41.2 36.7 22.7 5.4 3.8 59.7 25.6 9.7 37.8 18.3 8.9 28.4 40.3 12.2 2.5 8.6 1.2 61.1 48.7 22.4 23.1 3.9 17.0 19.8 14.6 58.6 37.3 5.6 6.2 7.4 33.2 7.7 26.6 6.4 47.6 40.1 5.6 34.7 6.0 42.7 2.7 10.6 4.4 1.0 48.0 22.9 108.6 4.5 26.7 47.2 14.9 18.0 10.6 0.3 2.8 11.7 14.2 23.2 24.0 1.9 4.2 0.0 2.0 8.6 21.7 13.2 45.2 17.8 6.7 11.7 3.4 87.7 2.9 95.0 0.0 13.5 49.2 53.6 17.4 37.2 45.2 92.8 0.0 0.2 0.1 13.9 2.0 0.1 0.5 14.0 0.0 16.0 0.1 0.0 0.2 35.9 26.7 0.0 0.0 70.2 2.2 6.0 65.6 12.9 0.0 88.8 9.5 2.8 6.4 4.0 1.9 0.0 0.0 8.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 55.5 40.2 41.2 28.4 40.3 61.1 48.7 22.4 58.6 40.1 42.7 108.6 1.0 6.4 7.3 72.5 0.0 26.9 29.7 29.4 17.1 0.5 14.8 14.7 10.0 2.8 14.2 20.2 0.0 0.7 0.0 0.0 0.0 0.4 0.1 7.4 45.4 4.6 0.0 0.0 1.1 0.9 0.4 12.3 3.1 5.7 1.3 2.0 4.2 0.5 0.4 0.0 1.5 0.2 6.1 0.3 2.1 1.7 20.2 0.6 1.8 20.6 0.0 11.1 0.0 3.5 713.9 0.4 0.0 36.9 0.0 18.1 0.0 0.1 8.2 0.6 6.6 2.4 18.3 0.4 0.9 4.2 15.9 0.7 1.1 21.5 0.1 24.7 KRTAP10-6 "KAP10.6, KAP18.6, KRTAP18-6, KRTAP18.6" ENSG00000188155 "Keratin associated protein 10-6" P60371 21 44591268-44592505 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "skin 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020120-1056118 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 20000000 Cytosol "Plasma membrane" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.7 7.6 4.4 3.8 2.0 14.8 0.0 14.0 13.6 9.1 10.7 7.9 13.8 1.8 15.8 14.8 7.3 9.2 4.9 0.6 44.0 13.4 20.0 1.6 16.0 3.7 2.6 5.6 28.3 3.9 8.4 5.1 17.7 14.5 1.5 0.8 25.0 8.2 4.3 15.6 9.7 2.9 1.8 6.4 13.5 9.8 4.1 2.6 34.9 2.0 1.6 16.4 11.7 6.7 124.3 75.1 11.1 42.7 2.4 3.0 122.1 61.4 19.6 39.7 24.5 60.6 205.3 2.3 236.9 9.6 19.3 210.1 4.1 75.6 4.7 4.4 28.6 0.2 102.1 54.2 17.1 1.8 23.1 10.5 32.2 12.6 27.7 55.9 7.2 1.7 25.7 0.7 3.5 93.0 0.8 17.6 28.4 39.7 54.5 20.1 27.0 18.5 70.0 51.4 2.4 25.9 124.8 129.1 121.9 12.7 114.8 7.4 107.8 47.7 169.0 6.4 50.6 1.2 0.6 3.5 30.4 10.8 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 3.8 0.0 14.0 4.9 0.6 16.0 3.7 2.6 17.7 1.8 4.1 6.7 27.4 25.6 8.8 15.0 2.2 15.0 9.2 94.5 19.9 1.4 32.7 39.2 3.1 61.5 42.0 156.3 8.4 1.6 0.9 29.9 1.9 91.2 0.4 37.2 14.0 29.0 6.7 1.7 23.1 16.9 4.8 8.7 17.9 62.7 2.5 7.2 21.8 13.1 4.1 5.0 7.8 11.6 36.7 2.9 10.1 1.0 5.6 4.3 24.9 12.2 15.6 10.5 0.0 15.1 29.6 87.3 17.7 2.6 0.6 22.3 18.1 16.0 33.0 5.3 6.6 3.3 23.3 0.8 11.4 11.7 6.0 1.2 2.9 2.3 18.3 21.2 NHS ENSG00000188158 "NHS actin remodeling regulator" Q6T4R5 X 17375200-17735994 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Inhibitory neurons: 264.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031497, HPA076257" Uncertain Supported "Cell Junctions" NA NA "Cell Junctions" "HPA031497: AB_10610144, HPA076257: AB_2686789" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.58e-1)" "unprognostic (1.69e-1)" "unprognostic (9.92e-3)" "unprognostic (3.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.78e-1)" "unprognostic (1.61e-3)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.07e-2)" "unprognostic (1.21e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-3)" 2.6 4.2 3.0 1.3 2.7 0.4 2.8 0.0 4.6 6.1 5.9 3.2 0.8 4.8 2.9 1.8 2.7 1.6 0.8 2.2 4.7 5.1 0.2 1.1 0.5 3.6 2.7 1.6 3.6 0.5 0.3 2.8 2.7 2.3 3.4 1.6 7.8 2.0 2.7 0.4 2.3 1.5 2.5 0.9 1.0 2.2 2.5 3.2 2.2 2.6 0.7 0.5 4.1 3.7 1.7 7.9 3.1 5.5 0.0 0.1 0.2 8.7 3.5 2.4 1.5 0.8 0.3 1.5 0.5 12.7 2.4 7.5 6.8 3.5 4.4 2.2 0.1 1.1 0.0 5.4 0.0 0.0 0.0 0.0 0.7 3.1 0.1 6.8 6.7 0.0 0.0 0.0 0.0 0.8 3.8 0.0 0.0 6.7 3.6 2.0 0.0 0.0 0.3 19.2 12.0 1.4 2.8 9.6 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 8.0 0.1 8.4 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 3.0 2.7 0.0 4.6 2.2 4.7 3.6 2.7 1.6 2.3 0.9 3.2 1.7 0.6 3.2 0.0 22.5 0.0 8.3 10.6 4.6 8.6 11.4 2.0 2.4 1.7 0.0 14.7 1.8 22.9 6.0 0.1 1.3 5.9 0.8 0.9 12.4 20.1 3.5 4.2 0.0 40.1 2.2 5.4 6.1 3.6 25.0 0.0 0.2 0.7 0.0 1.4 3.3 264.4 1.9 2.0 4.6 2.6 2.3 16.8 2.4 3.6 40.3 5.0 11.9 0.0 14.1 8.1 6.8 2.4 31.2 0.0 7.0 0.9 7.8 8.2 18.9 6.6 2.0 11.9 0.3 0.6 5.1 3.8 2.6 0.9 4.5 4.3 12.8 OTOG "FLJ46346, mlemp, OTGN" ENSG00000188162 Otogelin Q6ZRI0 11 17547259-17647150 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "pituitary gland: 1.4" "Group enriched" "Detected in some" 5 "Early spermatids: 11.9;Late spermatids: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "CACO-2: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.95e-3)" "unprognostic (1.85e-6)" "unprognostic (1.89e-1)" "unprognostic (3.60e-1)" "unprognostic (5.14e-5)" "unprognostic (1.78e-1)" "unprognostic (8.97e-2)" "unprognostic (1.57e-2)" "unprognostic (4.72e-5)" "unprognostic (5.55e-2)" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 FAM166A ENSG00000188163 "Family with sequence similarity 166 member A" Q6J272 9 137243584-137247770 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 61.3" "Group enriched" "Detected in some" 121 "Early spermatids: 626.7;Late spermatids: 1323.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023307 Enhanced NA NA "HPA023307: AB_1848930" "unprognostic (2.22e-1)" "unprognostic (8.39e-2)" "unprognostic (1.01e-3)" "unprognostic (1.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (9.83e-2)" "unprognostic (2.18e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (2.67e-4)" "unprognostic (7.81e-2)" "unprognostic (1.77e-3)" "unprognostic (1.83e-1)" "unprognostic (2.02e-2)" "unprognostic (2.09e-1)" "unprognostic (4.18e-3)" 0.5 0.4 0.1 0.2 0.1 0.1 0.5 0.3 0.2 0.2 0.0 0.2 0.2 0.3 0.7 0.4 0.3 0.0 0.4 0.2 0.1 1.1 1.9 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.9 0.0 0.2 0.5 0.0 0.4 0.4 0.1 0.2 0.3 0.4 0.0 0.1 0.2 0.3 61.3 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 1.1 0.0 0.0 0.4 0.4 0.1 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 626.7 0.3 0.1 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 3.8 0.1 0.7 0.8 0.1 0.0 0.2 0.0 0.0 0.3 0.0 1323.3 5.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.2 0.1 0.2 1.6 0.6 0.0 0.3 0.3 8.0 4.8 0.0 0.3 0.3 0.3 0.2 0.0 0.2 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33097146 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.5" "Cell type enhanced" "Detected in some" "Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 0.6 0.5 1.1 1.4 0.7 5.5 0.6 0.6 1.5 0.6 3.4 1.0 1.3 0.5 0.6 0.6 0.9 0.6 0.4 1.3 0.5 1.0 0.6 1.1 1.1 1.3 1.3 0.6 0.6 0.7 1.9 0.3 1.2 2.0 0.5 1.3 2.8 0.7 0.6 0.2 1.2 1.1 0.8 0.3 1.5 1.3 0.3 1.8 0.5 1.0 0.3 1.3 0.8 0.4 1.6 1.4 1.9 1.0 1.7 1.2 1.0 27.2 0.6 1.0 1.6 0.9 2.7 3.8 0.8 1.2 1.7 0.9 1.4 1.7 1.5 2.6 4.2 0.6 3.4 1.9 2.1 0.9 3.0 4.7 1.1 1.2 2.0 1.4 0.8 1.9 1.7 2.6 2.9 1.2 1.3 1.2 1.3 1.0 0.4 1.1 1.5 0.6 1.9 1.5 1.9 0.2 0.6 0.9 2.6 0.6 1.3 1.4 4.2 2.7 2.4 3.0 1.3 2.6 2.3 1.6 0.4 3.0 2.2 1.7 0.0 1.1 0.3 0.1 2.4 0.6 0.3 0.2 0.0 1.0 0.1 0.0 0.0 1.9 0.0 1.1 0.2 0.2 0.4 1.1 0.7 0.6 1.5 1.3 0.5 1.3 1.3 0.6 2.0 0.3 1.8 1.6 0.3 0.0 1.3 0.0 0.8 0.8 0.1 0.0 0.0 1.2 0.4 0.4 0.4 0.0 0.2 0.0 0.0 1.1 1.9 1.4 0.0 0.4 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.8 1.7 0.3 0.0 1.1 0.0 0.4 0.4 0.6 0.9 1.7 0.0 0.2 2.0 1.3 1.2 0.0 0.0 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.5 1.4 0.4 1.0 0.2 1.4 0.3 0.4 2.2 0.0 0.2 0.7 0.0 0.0 1.5 0.9 0.4 0.6 0.5 0.6 0.2 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20619939-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 19.8" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: AB_2679397" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 7.4 9.0 3.0 5.5 4.4 3.8 16.2 4.7 4.6 8.4 4.4 2.9 1.6 11.3 7.9 6.4 12.4 9.4 10.1 3.1 3.4 11.1 5.8 5.2 12.3 2.8 3.4 2.5 26.1 7.3 21.6 3.7 7.3 3.1 11.1 3.3 7.6 7.0 9.8 4.7 9.4 2.4 9.5 2.6 7.0 8.1 5.1 3.2 8.7 23.9 6.0 9.8 14.9 4.2 5.7 0.1 0.0 5.9 0.4 6.8 8.7 0.3 6.5 0.6 9.1 7.9 0.1 0.1 0.5 3.0 8.3 10.7 1.1 0.0 0.2 11.6 0.1 0.2 0.0 0.2 2.3 12.1 0.1 0.0 16.6 2.6 5.5 2.8 0.1 4.3 0.1 4.1 0.6 9.6 0.1 0.4 1.1 12.0 0.0 2.9 5.7 4.1 2.1 8.4 6.4 1.6 10.6 0.1 0.7 6.0 10.6 13.7 0.1 0.1 4.2 0.2 16.4 0.5 9.0 19.8 8.6 0.1 0.1 0.5 0.9 1.1 6.3 7.2 1.1 6.8 8.4 7.6 8.2 3.2 10.5 7.0 6.3 11.2 9.8 4.8 4.2 3.8 3.8 3.0 4.4 4.7 4.6 3.1 3.4 2.8 3.4 2.5 3.1 2.6 3.2 5.7 14.0 3.2 8.2 26.4 18.5 9.4 13.7 4.2 10.2 11.1 18.2 18.8 9.8 12.8 6.7 27.6 10.4 17.5 11.1 1.4 31.3 8.7 1.3 19.3 15.0 11.6 2.4 1.7 29.3 9.5 24.9 13.9 6.1 20.8 7.0 19.7 17.2 7.4 11.0 13.5 27.6 1.3 6.1 4.7 9.8 1.7 18.6 5.1 5.4 15.9 2.9 16.2 19.6 37.7 43.0 9.1 0.4 15.4 3.9 17.2 0.1 30.8 12.3 9.5 13.1 11.4 11.9 10.1 16.2 6.1 12.6 43.4 12.3 39.8 0.8 15.5 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188534-93226469 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 97.1" "Group enriched" "Detected in some" 11 "Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1" "Group enriched" "Detected in many" 5 "colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SCLC-21H: 172.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 210000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.1 0.1 2.3 0.0 2.6 9.0 0.0 0.1 0.0 0.0 64.9 30.3 0.0 0.5 0.1 0.0 0.2 0.1 0.0 0.0 15.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 4.4 0.4 7.3 0.2 0.1 0.8 97.1 0.0 2.6 1.4 0.0 0.0 48.4 1.5 0.1 0.1 10.2 3.2 0.1 0.1 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 172.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.4 0.3 1.1 0.7 0.0 0.0 15.1 6.6 0.2 0.0 0.9 5.5 0.0 0.0 0.0 17.2 9.8 0.1 2.5 0.0 0.0 0.1 218.2 18.7 0.5 0.0 0.0 0.1 27.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.6 387.5 349.9 0.0 0.0 2.4 0.0 0.0 7.2 1.0 0.0 0.0 0.0 0.0 2.2 0.0 318.1 0.0 0.1 0.9 11.5 0.0 0.3 0.0 0.0 0.0 0.1 5.6 1.2 0.0 0.1 0.1 0.1 0.0 19.7 0.3 SMTNL2 FLJ42461 ENSG00000188176 "Smoothelin like 2" Q2TAL5 17 4583999-4608319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 504.9;tongue: 137.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.7;Collecting duct cells: 9.2;Distal tubular cells: 33.2;Proximal tubular cells: 35.4;Sertoli cells: 26.3;Skeletal myocytes: 8.2" "Cancer enhanced" "Detected in many" "renal cancer: 10.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 49.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA025706 Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA025706: AB_1848935" "unprognostic (8.62e-2)" "unprognostic (5.40e-2)" "unprognostic (7.13e-2)" "unprognostic (2.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-2)" "unprognostic (4.89e-3)" "unprognostic (2.73e-1)" "unprognostic (3.73e-3)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (5.89e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.43e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-3)" "unprognostic (2.22e-1)" 4.9 0.1 0.9 1.6 0.9 0.0 2.6 0.8 1.6 3.2 0.9 1.0 0.2 3.9 2.4 8.0 7.3 2.1 13.2 2.2 0.7 31.8 0.2 4.8 0.2 0.9 1.1 0.7 6.8 0.6 1.1 2.4 4.9 0.9 5.1 0.5 0.2 6.2 0.9 504.9 1.2 1.2 2.5 0.7 0.8 1.1 1.3 0.9 0.2 1.4 137.4 0.1 4.5 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.4 0.0 0.8 0.0 2.7 0.0 0.6 0.0 2.9 0.0 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.3 3.2 0.0 0.0 0.0 0.1 5.4 0.0 11.4 0.0 0.0 0.0 0.0 10.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.8 1.6 2.2 0.7 0.9 1.1 0.7 0.9 0.7 0.9 0.8 0.3 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 8.7 0.0 0.6 9.2 0.0 0.8 0.0 0.0 33.2 0.1 0.1 1.8 1.3 1.3 0.0 0.0 0.1 0.0 1.5 6.1 0.0 2.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.6 0.3 1.8 1.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 26.3 8.2 7.6 0.0 0.5 0.1 0.0 0.5 0.3 0.1 0.2 0.3 ZC3H6 "FLJ41410, FLJ45877, KIAA2035, ZC3HDC6" ENSG00000188177 "Zinc finger CCCH-type containing 6" P61129 2 112275597-112340063 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036019, HPA036020, HPA076065" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300" "unprognostic (1.05e-2)" "unprognostic (3.01e-1)" "unprognostic (2.77e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-3)" "unprognostic (1.83e-1)" "unprognostic (3.99e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.68e-1)" "unprognostic (4.41e-2)" "unprognostic (6.42e-3)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" 3.1 2.5 3.2 1.8 4.6 1.7 3.3 5.7 4.1 3.2 0.2 2.6 1.4 2.9 3.4 1.8 3.6 1.8 2.9 2.7 2.7 2.1 1.8 2.4 2.9 3.8 3.4 2.3 6.2 2.3 3.1 3.4 1.7 3.7 2.4 1.7 9.5 2.9 2.2 5.8 4.4 2.6 1.8 3.0 3.2 2.2 2.9 3.4 3.9 3.8 5.8 2.6 3.0 3.0 5.6 1.1 0.4 2.3 2.2 2.1 4.1 0.7 1.2 1.9 0.7 1.5 0.2 1.4 1.7 0.9 0.7 2.0 0.6 0.7 0.3 1.0 2.0 0.2 0.3 0.5 0.0 1.9 0.4 0.4 1.6 3.3 0.8 5.5 3.4 1.2 2.2 0.4 3.0 1.7 1.0 1.0 0.6 1.5 0.7 0.5 0.6 0.1 1.6 1.0 0.2 1.7 2.3 1.1 0.6 1.2 1.2 0.7 0.6 1.8 1.1 0.1 1.3 0.5 3.1 0.9 1.5 2.2 1.1 3.0 0.5 0.6 0.8 0.9 0.4 1.0 1.3 1.3 1.0 0.6 1.7 1.4 1.2 1.2 0.6 1.3 1.0 1.2 0.4 3.2 4.6 5.7 4.1 2.7 2.7 3.8 3.4 2.3 3.7 3.0 3.4 5.6 33.3 38.5 32.0 33.3 24.4 17.3 30.0 12.1 33.0 69.3 31.9 33.4 68.7 20.0 20.6 22.0 54.2 21.1 17.5 7.8 29.4 13.1 16.8 39.3 16.0 27.7 16.2 14.5 46.7 14.8 7.3 31.7 7.7 16.2 26.6 41.2 25.7 16.7 12.4 114.4 62.2 13.5 6.1 19.5 14.2 12.4 46.3 16.2 5.4 29.0 21.1 47.6 30.9 43.7 114.4 16.0 10.4 36.1 12.2 30.7 12.1 22.3 30.6 89.5 32.9 50.8 31.0 75.2 46.4 13.7 18.5 7.9 28.6 26.9 12.9 20.6 LAMTOR4 C7orf59 ENSG00000188186 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4" Q0VGL1 7 100148907-100155944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 3294.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020998 Enhanced Supported Vesicles NA NA Vesicles "HPA020998: AB_1845762" "prognostic favorable (2.48e-4)" "prognostic favorable (6.08e-4)" "unprognostic (1.29e-2)" "unprognostic (1.14e-1)" "unprognostic (8.21e-3)" "unprognostic (6.11e-2)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (6.17e-2)" "unprognostic (1.57e-1)" "unprognostic (2.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.45e-1)" "unprognostic (1.68e-2)" 144.4 145.9 184.1 93.7 190.1 196.3 144.6 198.2 262.4 142.9 182.5 166.5 90.2 117.7 66.4 118.5 124.1 98.6 164.5 183.0 188.8 189.6 140.3 129.1 160.3 199.2 188.9 177.9 143.9 125.2 127.8 164.0 68.6 189.6 162.1 106.8 40.3 117.8 76.9 138.6 441.0 152.3 69.6 196.3 254.0 163.5 87.2 199.1 105.8 134.9 106.9 86.2 147.0 127.8 203.8 105.9 250.9 130.2 165.4 135.2 154.9 105.7 62.1 151.0 113.1 138.9 116.9 165.7 169.1 204.7 94.2 205.7 108.9 124.0 160.0 48.1 172.4 353.2 135.2 245.0 205.4 127.4 106.4 187.1 187.3 155.4 118.5 145.6 125.7 174.9 155.3 129.9 264.4 156.1 501.0 104.0 424.7 138.7 291.1 199.9 107.4 107.1 302.8 129.1 126.9 91.6 169.0 114.3 265.8 211.3 99.0 107.1 207.0 118.3 107.1 158.6 223.7 101.7 159.1 231.2 324.2 171.0 293.5 155.9 1033.3 843.2 3121.0 299.6 795.1 251.1 541.8 377.5 312.8 570.0 475.4 381.8 307.2 3294.2 310.1 756.2 482.6 453.0 893.6 184.1 190.1 198.2 262.4 183.0 188.8 199.2 188.9 177.9 189.6 196.3 199.1 203.8 181.8 93.0 150.7 18.9 195.8 274.9 194.0 282.0 167.9 65.3 240.8 277.2 176.6 143.0 172.9 218.8 12.5 258.4 199.9 819.7 534.1 167.3 40.0 152.9 125.8 186.7 299.3 99.3 12.0 326.2 196.5 175.6 146.3 131.4 183.2 120.9 239.1 246.3 531.1 58.9 13.6 423.9 252.3 497.4 351.7 46.6 146.3 365.2 434.0 13.1 411.0 229.9 298.6 11.6 26.2 204.2 867.4 120.4 133.0 169.5 511.6 557.5 194.8 67.0 144.7 142.1 196.9 88.1 101.2 151.3 662.9 201.4 195.9 150.8 511.8 219.0 PRKAR1B ENSG00000188191 "Protein kinase cAMP-dependent type I regulatory subunit beta" P31321 7 549197-727650 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 176.7" "Cell type enhanced" "Detected in many" "Early spermatids: 62.3;Excitatory neurons: 78.7;Inhibitory neurons: 61.1;Late spermatids: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 128.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026719 Approved NA NA "HPA026719: AB_1855419" "unprognostic (4.90e-2)" "unprognostic (4.92e-2)" "unprognostic (2.69e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-3)" "unprognostic (1.02e-3)" "unprognostic (3.28e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-1)" "unprognostic (1.41e-2)" "unprognostic (2.01e-3)" "unprognostic (1.95e-1)" "unprognostic (3.38e-3)" "unprognostic (5.18e-2)" "unprognostic (2.64e-1)" "unprognostic (9.23e-2)" "unprognostic (2.00e-1)" 11.3 11.1 49.9 7.6 98.2 8.9 12.5 0.0 176.7 17.0 0.0 17.8 12.4 23.7 3.7 12.1 16.0 7.7 16.5 89.7 85.5 15.5 13.0 12.5 9.7 72.1 41.0 97.0 28.4 6.5 9.0 36.0 5.5 85.6 12.7 6.5 19.5 7.4 8.3 7.4 7.9 13.6 8.8 0.0 23.0 11.4 15.5 49.5 10.3 8.3 3.9 5.4 10.3 13.6 126.2 83.0 54.2 8.0 19.7 5.1 4.6 22.8 15.9 7.3 10.0 5.7 97.9 17.5 63.2 11.3 7.2 33.1 60.3 27.0 30.6 4.2 12.8 20.1 4.3 33.3 65.4 9.7 39.7 9.5 12.8 9.2 6.8 18.7 11.1 10.8 15.7 61.6 11.8 9.2 77.8 47.5 26.5 128.0 22.1 23.0 30.9 1.6 27.4 25.0 20.8 106.0 81.5 41.2 39.2 32.0 3.2 20.1 14.6 13.0 4.4 9.9 6.0 32.3 7.7 23.4 41.0 8.2 29.8 59.5 1.8 2.4 0.0 5.0 3.0 7.7 7.4 8.9 7.7 2.8 10.0 13.8 13.3 0.9 4.6 1.2 6.6 6.6 10.5 49.9 98.2 0.0 176.7 89.7 85.5 72.1 41.0 97.0 85.6 0.0 49.5 126.2 18.3 3.2 4.4 12.4 7.3 3.8 7.4 6.0 6.2 11.1 9.0 12.8 13.1 4.3 5.0 5.5 4.2 4.0 7.0 10.1 25.4 4.1 62.3 4.5 6.5 15.2 4.2 13.5 78.7 3.4 5.8 8.2 10.7 4.4 7.0 55.0 16.4 8.5 8.9 53.8 61.1 10.9 2.0 6.2 8.6 130.0 11.8 8.7 7.2 15.0 1.6 7.3 5.2 24.1 7.5 7.7 14.1 15.4 8.2 5.6 20.7 24.5 1.4 6.3 0.0 12.8 9.0 15.6 11.1 10.7 4.7 3.4 9.1 12.0 15.5 5.0 NUTM2B "bA119F19.1, FAM22B" ENSG00000188199 "NUT family member 2B" A6NNL0 10 79703227-79714681 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (9.51e-2)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.10e-1)" "unprognostic (3.63e-1)" "unprognostic (6.60e-2)" "unprognostic (2.47e-2)" "unprognostic (7.66e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (7.79e-3)" "unprognostic (1.15e-1)" "unprognostic (9.70e-2)" "unprognostic (9.97e-2)" "unprognostic (5.72e-2)" "unprognostic (5.37e-2)" "unprognostic (2.32e-2)" 0.6 0.7 1.6 0.7 1.3 1.4 0.7 3.0 1.6 0.6 0.0 0.8 0.3 0.8 0.5 0.6 0.9 0.2 1.4 1.8 0.5 1.1 1.1 0.8 0.7 1.5 1.1 0.5 0.9 1.4 0.7 1.8 0.3 3.1 1.2 0.2 0.8 1.0 0.3 1.0 1.1 1.0 0.1 0.3 1.3 0.9 3.4 1.1 0.7 0.9 0.1 0.7 0.6 0.8 2.2 0.7 0.8 1.7 1.0 0.4 0.4 0.7 0.3 0.5 0.4 0.4 0.1 1.5 1.7 0.2 0.4 0.6 0.7 0.1 0.8 0.3 1.1 0.6 1.3 0.2 0.5 0.7 1.2 2.9 1.1 0.4 0.2 0.3 1.5 0.0 2.4 1.9 0.8 0.3 1.4 0.3 2.3 1.6 0.0 0.8 0.4 0.2 0.2 0.5 0.2 0.7 1.8 1.0 1.3 1.7 0.8 0.4 1.4 1.0 0.2 0.3 0.2 0.6 0.3 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 3.0 1.6 1.8 0.5 1.5 1.1 0.5 3.1 0.3 1.1 2.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NCR3LG1 "B7-H6, DKFZp686O24166" ENSG00000188211 "Natural killer cell cytotoxicity receptor 3 ligand 1" Q68D85 11 17351800-17377341 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 7.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 32.2;Inhibitory neurons: 29.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 4.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 53.8;K-562: 30.8" HPA024137 Uncertain NA NA 21000 "HPA024137: AB_1859534" "unprognostic (1.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.52e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.05e-1)" "unprognostic (7.03e-5)" "unprognostic (6.24e-2)" "unprognostic (1.09e-1)" "unprognostic (3.59e-1)" "unprognostic (2.62e-1)" "unprognostic (2.36e-1)" "prognostic favorable (4.21e-12)" "unprognostic (7.88e-3)" "unprognostic (1.72e-1)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" 0.8 0.6 0.2 1.1 0.5 1.9 0.5 4.8 4.6 0.6 3.1 3.5 4.5 1.1 0.5 0.7 1.4 0.9 1.1 0.9 0.6 2.6 0.4 1.1 0.5 0.1 0.5 0.6 1.2 0.8 7.5 1.7 0.4 1.2 0.6 5.1 1.9 0.8 0.6 0.4 0.8 3.4 1.0 0.0 0.6 1.3 2.4 0.1 1.3 2.6 0.1 0.7 1.1 0.5 0.9 3.9 1.3 8.8 1.2 3.0 8.1 0.6 2.8 5.2 3.8 9.0 7.3 1.5 22.4 0.4 3.1 1.2 4.0 14.4 3.6 3.1 3.9 23.8 20.6 10.0 7.2 12.5 53.8 0.9 6.7 1.8 5.3 12.8 1.6 4.2 8.1 30.8 0.1 1.2 0.4 5.2 4.7 0.5 14.4 2.1 1.7 4.6 0.3 3.1 1.4 9.3 3.5 3.1 0.7 2.5 0.1 2.1 11.9 6.1 0.7 1.2 2.3 1.6 2.4 4.5 25.1 3.9 17.6 1.8 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 4.8 4.6 0.9 0.6 0.1 0.5 0.6 1.2 0.0 0.1 0.9 0.8 0.0 2.0 8.1 1.4 2.5 2.1 2.1 5.2 7.2 1.9 0.4 0.8 2.8 1.7 1.8 2.1 0.1 3.1 6.8 0.0 2.3 13.6 2.3 3.2 1.6 1.8 1.3 32.2 0.9 0.0 4.0 5.6 3.2 0.0 1.5 3.6 0.5 0.9 5.0 29.3 6.6 0.0 1.6 13.6 2.5 0.6 4.4 3.6 4.7 0.4 1.4 2.1 8.5 1.7 1.2 5.4 0.4 0.8 1.8 4.1 1.1 5.3 1.1 0.0 3.1 1.9 0.7 1.1 4.1 3.7 1.5 1.6 5.6 7.5 0.9 DCUN1D3 "DKFZp686O0290, FLJ41725, MGC48972, SCCRO3" ENSG00000188215 "Defective in cullin neddylation 1 domain containing 3" Q8IWE4 16 20854925-20900358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 58.6;Late spermatids: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "ASC diff: 52.2;ASC TERT1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041983, HPA043511" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041983: , HPA043511: AB_2678521" "unprognostic (9.34e-2)" "unprognostic (4.56e-2)" "unprognostic (3.47e-2)" "unprognostic (1.33e-2)" "unprognostic (4.24e-2)" "unprognostic (8.71e-2)" "unprognostic (5.90e-2)" "unprognostic (1.73e-1)" "unprognostic (1.81e-1)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.31e-2)" "prognostic unfavorable (5.41e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (5.31e-2)" "unprognostic (2.42e-1)" 20.8 9.5 3.9 6.3 4.6 2.8 9.4 5.1 4.9 6.7 4.5 5.6 3.4 6.2 2.6 8.3 7.0 9.8 6.5 3.5 7.1 5.2 12.0 9.9 2.6 3.9 4.1 3.8 5.0 6.9 4.4 4.7 8.0 3.9 5.5 3.9 12.7 3.7 4.2 28.8 7.1 4.0 8.7 3.7 4.4 6.0 8.4 5.9 3.2 4.4 4.0 2.6 8.4 9.5 7.3 4.8 8.6 4.2 8.7 52.2 38.9 5.4 16.1 13.6 7.9 10.5 10.7 8.5 3.0 12.6 15.8 4.7 6.1 4.8 6.7 10.6 4.0 2.9 2.5 7.1 15.8 13.6 3.7 23.9 25.9 9.0 15.2 8.5 8.4 22.2 2.9 2.9 7.4 16.4 6.6 3.4 5.5 9.9 4.1 2.7 6.1 4.5 2.6 7.0 5.0 3.6 4.8 6.2 6.2 3.6 4.7 4.2 1.8 10.9 16.5 5.4 6.9 4.4 6.9 4.3 2.0 17.1 4.1 8.3 1.3 0.3 0.2 0.4 0.6 0.3 0.2 0.2 0.6 0.4 0.3 0.3 0.6 0.3 0.6 0.5 0.2 0.2 0.2 3.9 4.6 5.1 4.9 3.5 7.1 3.9 4.1 3.8 3.9 3.7 5.9 7.3 25.6 12.8 19.3 4.6 2.9 31.4 11.7 7.5 19.4 12.4 19.0 10.8 5.2 2.8 7.2 9.2 35.5 3.6 8.2 6.3 0.0 3.8 58.6 14.5 16.2 18.4 20.3 1.3 10.6 5.2 2.0 16.5 5.6 34.3 0.0 4.2 9.7 16.3 2.3 13.5 9.7 4.3 6.1 5.0 20.6 48.5 10.8 15.8 12.4 1.9 1.8 5.2 1.0 10.6 10.8 4.9 1.2 9.8 3.3 6.1 3.0 5.2 4.3 24.8 6.6 20.1 19.6 6.4 3.7 10.7 22.6 5.1 5.9 4.1 4.7 18.3 POTEE "A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma" ENSG00000188219 "POTE ankyrin domain family member E" Q6S8J3 2 131218067-131265278 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 2.3;testis: 1.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 6.0;Breast glandular cells: 2.5;Prostatic glandular cells: 2.8;Smooth muscle cells: 2.4;Spermatocytes: 4.9;Spermatogonia: 2.0;Urothelial cells: 2.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.2;K-562: 1.4;U-2 OS: 2.3" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (3.13e-2)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.84e-2)" "unprognostic (1.05e-1)" "unprognostic (6.61e-3)" "unprognostic (5.77e-2)" "unprognostic (7.60e-2)" "unprognostic (7.46e-3)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.1 0.1 0.0 0.2 0.9 0.7 0.0 0.4 2.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.0 0.2 0.0 0.0 2.5 1.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.1 2.4 4.9 2.0 0.0 0.1 0.4 0.1 0.2 0.0 2.2 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 31.3;Early spermatids: 39.6;Horizontal cells: 48.8;Rod photoreceptor cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 11.6;RT4: 10.0;U-266/70: 18.4;U-266/84: 12.7" "Low region specificity" "Detected in all" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 1.8 4.5 6.5 2.5 6.2 1.2 3.6 9.8 6.3 4.8 4.2 3.2 1.9 5.4 3.8 3.3 4.6 2.5 4.1 5.9 5.4 4.2 0.8 2.1 3.7 5.4 5.3 6.3 8.2 2.6 6.1 9.3 2.7 6.6 4.7 3.3 14.8 2.9 3.2 2.4 6.5 2.5 3.3 3.1 3.6 3.0 9.1 5.1 2.8 6.6 2.3 2.8 3.7 4.5 6.4 0.1 0.2 4.5 11.6 0.9 0.9 0.3 3.7 0.2 0.7 0.4 0.2 1.5 3.4 5.6 1.9 1.0 0.5 0.3 2.9 0.3 0.8 4.2 0.4 0.4 0.3 2.4 0.2 2.9 3.5 2.2 0.7 0.1 0.3 0.1 0.4 0.1 0.5 0.5 3.2 0.4 0.4 7.3 0.0 0.2 0.1 0.1 0.8 3.3 10.0 3.4 6.8 0.1 0.1 0.0 8.2 6.7 0.3 0.4 0.1 1.8 0.2 3.5 18.4 12.7 0.2 0.0 0.2 0.6 4.0 0.6 0.5 0.6 0.2 0.9 0.9 1.1 1.0 0.4 1.4 0.7 0.9 1.6 1.6 0.2 0.9 1.0 0.7 6.5 6.2 9.8 6.3 5.9 5.4 5.4 5.3 6.3 6.6 3.1 5.1 6.4 6.5 3.2 5.8 24.2 4.0 3.3 3.8 2.6 6.2 29.1 5.0 5.8 9.7 7.2 5.0 12.9 31.3 5.5 2.9 1.7 3.9 3.6 39.6 5.0 8.7 7.0 9.0 2.1 14.9 1.5 4.1 4.6 1.1 3.9 2.5 21.5 6.4 0.5 0.9 48.8 16.3 2.9 0.0 0.3 3.4 11.2 5.0 0.9 0.0 2.8 1.5 13.6 8.2 19.6 16.7 2.0 1.0 10.1 1.1 2.8 1.0 2.7 5.7 33.6 0.0 8.7 5.3 6.0 6.9 4.0 3.3 1.9 4.0 12.7 3.7 1.9 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241287-137243707 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 121.8 113.5 163.3 98.1 157.8 427.5 95.2 166.9 184.1 88.9 406.0 191.0 143.3 108.6 210.9 346.1 511.6 106.9 362.2 168.0 176.0 123.0 141.3 131.7 96.3 173.9 167.6 143.2 73.5 124.9 88.5 118.9 87.0 187.0 121.2 112.9 264.0 179.5 122.6 204.1 241.9 167.8 120.9 153.1 86.3 162.8 771.6 163.2 164.4 116.6 97.5 120.7 190.2 140.6 192.1 706.2 1032.5 431.7 314.2 213.2 223.6 600.5 643.7 536.0 872.4 598.6 1101.0 840.2 429.0 480.2 631.2 848.2 1305.1 539.5 1039.2 330.2 307.9 458.5 311.2 789.6 877.8 134.5 370.0 331.5 145.0 291.5 667.5 183.1 215.7 631.7 300.6 443.0 239.7 731.2 1936.4 337.4 504.2 457.8 1234.8 1778.1 423.5 822.2 394.2 666.8 647.8 301.5 323.6 853.9 485.8 173.2 244.2 699.0 397.6 495.6 618.1 685.0 710.0 863.6 92.4 274.9 475.1 503.6 286.9 549.8 95.7 30.0 43.2 40.5 30.1 38.2 32.6 31.3 34.4 34.9 30.8 19.7 26.7 56.4 24.4 30.5 36.3 44.7 32.6 163.3 157.8 166.9 184.1 168.0 176.0 173.9 167.6 143.2 187.0 153.1 163.2 192.1 478.5 221.2 146.3 21.5 315.8 326.2 945.7 458.7 327.2 508.1 286.9 389.5 91.9 143.0 284.1 143.5 300.3 346.6 640.9 744.1 221.1 348.6 2190.0 1191.6 224.8 203.9 391.5 419.9 30.1 446.8 545.5 247.8 274.7 415.0 189.2 200.9 142.5 139.2 265.9 244.0 24.3 503.6 323.5 59.9 214.9 2907.1 254.2 299.3 138.7 22.5 224.0 299.3 49.4 15.6 19.7 477.4 697.2 153.1 264.0 475.1 540.7 345.5 1558.7 763.3 111.7 261.8 416.0 1717.5 740.9 419.1 297.6 321.1 362.9 89.8 487.3 592.7 AGAP4 "AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2" ENSG00000188234 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 4" Q96P64 10 45825613-45853875 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 141.3;Late spermatids: 52.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 21.6" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-1)" "unprognostic (7.50e-2)" "unprognostic (2.50e-2)" "unprognostic (4.10e-4)" "unprognostic (4.13e-3)" "unprognostic (5.72e-2)" "unprognostic (3.68e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.76e-5)" "unprognostic (7.49e-2)" "unprognostic (3.19e-1)" "unprognostic (8.58e-2)" "unprognostic (5.28e-4)" 4.9 6.9 11.2 5.2 11.5 5.9 5.3 13.8 13.8 7.5 10.5 5.9 7.5 5.0 5.8 4.9 6.2 3.1 5.7 11.4 10.8 8.8 9.4 5.2 7.2 11.1 11.4 11.6 7.4 7.4 2.5 9.1 3.6 11.5 9.2 3.8 9.9 4.6 4.3 7.3 9.6 6.8 2.7 9.6 10.3 5.9 7.1 10.9 5.4 6.4 2.8 3.5 5.8 5.9 12.3 2.8 3.2 9.3 5.6 3.8 4.5 7.0 3.2 3.0 3.4 3.5 7.3 7.3 4.1 4.7 2.6 1.9 7.8 1.8 4.5 2.4 5.2 5.8 0.3 8.1 9.2 3.7 4.8 3.1 3.0 3.9 3.9 4.1 2.6 1.8 8.5 6.1 4.8 1.9 4.5 4.0 21.6 4.3 2.7 1.2 5.7 3.1 4.5 3.3 3.5 6.5 5.3 1.5 5.7 5.5 4.8 5.1 5.8 5.3 1.5 4.4 3.3 6.8 8.5 5.0 3.6 3.1 6.9 1.7 2.0 0.2 0.7 0.4 0.2 0.3 0.1 0.1 0.4 0.3 0.5 0.2 0.2 1.0 0.4 0.1 0.3 0.1 0.1 11.2 11.5 13.8 13.8 11.4 10.8 11.1 11.4 11.6 11.5 9.6 10.9 12.3 5.4 19.2 8.2 6.2 2.4 0.4 1.6 0.1 0.0 4.2 4.3 4.7 5.2 5.7 5.1 1.8 10.4 4.6 4.3 4.7 0.0 2.0 141.3 4.2 2.7 4.4 1.2 2.1 15.1 1.8 1.4 2.9 10.2 3.0 12.7 6.5 5.7 2.5 2.3 0.0 14.3 4.9 2.0 4.1 0.6 52.9 2.1 2.6 0.0 2.8 4.4 1.8 3.1 8.0 9.9 1.5 1.0 5.3 2.9 2.8 5.5 1.0 6.4 5.5 6.6 3.3 4.8 6.6 5.3 2.1 0.1 1.9 3.4 3.9 5.6 2.1 COMMD6 Acrg ENSG00000188243 "COMM domain containing 6" Q7Z4G1 13 75525219-75549439 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.76e-2)" "unprognostic (2.55e-2)" "unprognostic (2.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.70e-1)" "unprognostic (8.49e-3)" "unprognostic (5.90e-2)" "unprognostic (9.43e-2)" "unprognostic (9.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (8.96e-2)" "unprognostic (3.91e-2)" "unprognostic (2.33e-1)" "unprognostic (3.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-2)" 94.8 167.9 56.8 77.2 58.8 135.2 117.7 60.5 75.8 110.9 62.9 116.5 70.6 120.4 166.5 97.8 116.1 106.0 110.1 55.8 60.2 106.4 101.9 61.5 172.4 59.3 59.2 55.4 236.3 85.5 49.1 61.7 49.3 59.8 83.7 89.7 32.2 85.7 72.8 52.7 80.2 79.6 108.2 64.0 88.8 94.5 44.3 59.7 70.8 146.3 39.3 135.5 110.3 88.4 62.6 201.4 62.2 86.5 73.3 188.8 221.2 60.4 137.5 101.2 46.8 82.0 93.0 109.5 79.2 149.1 115.7 92.4 104.4 56.1 107.3 67.1 164.0 104.3 114.3 52.3 66.8 153.4 132.0 97.2 169.0 176.0 63.8 91.2 264.1 101.3 122.7 32.2 73.1 108.0 49.3 79.3 199.1 51.8 259.7 121.1 75.0 73.7 87.2 96.0 63.7 68.9 112.1 68.5 66.2 184.2 148.4 85.6 196.3 157.6 60.4 59.2 77.2 103.9 92.2 88.7 71.3 195.3 131.2 61.2 564.9 306.4 274.0 308.3 311.8 382.3 684.4 542.9 412.2 382.5 597.2 638.6 548.9 135.4 434.8 294.8 996.5 655.4 582.7 56.8 58.8 60.5 75.8 55.8 60.2 59.3 59.2 55.4 59.8 64.0 59.7 62.6 372.1 179.5 233.1 10.1 597.3 521.4 589.4 948.8 592.4 45.9 722.0 1331.3 250.4 348.9 388.2 343.9 20.9 339.9 663.2 299.8 1054.6 353.2 170.8 282.7 338.0 331.7 401.9 153.7 19.5 327.6 434.0 330.5 224.3 222.6 412.1 354.1 418.4 554.0 493.7 42.1 23.1 541.7 360.1 510.1 737.5 77.1 491.5 451.8 338.0 14.0 613.0 287.0 677.7 19.6 19.2 327.9 390.7 348.3 172.0 401.7 324.1 903.6 287.7 54.6 164.3 455.4 363.8 181.0 218.8 457.8 599.1 271.3 614.7 190.7 554.5 500.5 PLA2G2A "PLA2B, PLA2L" ENSG00000188257 "Phospholipase A2 group IIA" P14555 1 19975431-19980416 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" "Antimicrobial, Bacteriolytic enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 1314.5;intestine: 1990.3;placenta: 763.1;urinary bladder: 821.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 536.5;Exocrine glandular cells: 1031.5;Fibroblasts: 656.0;Intestinal goblet cells: 393.6;Paneth cells: 574.1;Prostatic glandular cells: 921.1;Undifferentiated cells: 861.9" "Cancer enhanced" "Detected in all" "prostate cancer: 875.7" "Region enhanced" "Detected in some" "hypothalamus: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 645.0;OE19: 2384.4" "Not detected" "Not detected" HPA015236 Enhanced "Secreted to blood" NA NA 1000000 680000 "HPA015236: AB_10601047" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (2.79e-2)" "unprognostic (7.85e-3)" "unprognostic (8.71e-2)" "unprognostic (9.27e-2)" "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "prognostic favorable (1.49e-4)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.77e-15)" "unprognostic (2.72e-2)" "unprognostic (9.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" 1314.5 7.1 0.1 282.7 0.1 0.0 27.7 0.1 0.7 3.7 2.3 1487.3 794.0 4.3 3.3 29.6 14.9 58.2 90.5 0.0 4.7 6.6 240.6 16.9 5.4 0.6 0.5 1.4 44.5 7.9 0.9 2.5 763.1 0.2 205.7 1685.8 0.1 24.8 6.1 6.0 16.1 1990.3 166.0 0.1 0.4 11.7 37.1 1.0 1.7 11.2 115.3 15.2 821.3 12.2 0.2 0.0 0.0 1.6 0.0 248.3 0.0 8.5 0.0 0.1 0.1 0.0 11.2 0.0 0.0 1.1 0.0 0.8 18.7 0.0 0.0 0.0 0.1 0.3 0.0 0.3 645.0 0.0 0.1 1.1 2.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.4 2384.4 0.0 0.0 0.0 7.6 0.0 198.2 1.0 4.7 0.0 20.1 0.0 31.1 0.1 0.0 0.0 0.0 0.0 44.7 0.2 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.0 4.7 0.6 0.5 1.4 0.2 0.1 1.0 0.2 20.6 6.4 6.7 0.0 9.1 13.9 10.8 0.2 0.6 0.9 1.0 0.8 14.9 12.8 9.3 0.0 0.0 3.6 0.4 536.5 1.9 0.7 4.0 0.7 43.1 6.9 62.3 13.5 0.0 1031.5 4.6 656.0 6.1 0.6 4.5 0.0 30.0 310.9 9.5 0.0 0.0 393.6 2.0 18.8 31.1 11.6 171.2 3.5 14.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 574.1 1.2 2.6 921.1 328.2 0.2 1.9 0.0 0.0 2.4 37.8 0.9 1.5 4.9 16.8 6.8 6.2 0.1 861.9 32.2 IL17REL FLJ41993 ENSG00000188263 "Interleukin 17 receptor E like" Q6ZVW7 22 49994513-50012659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.3;stomach 1: 2.3" "Cell type enriched" "Detected in single" 21 "Gastric mucus-secreting cells: 12.8" "Cancer enhanced" "Detected in some" "stomach cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045546 Supported NA NA "HPA045546: AB_10963836" "unprognostic (3.33e-1)" "unprognostic (1.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-1)" "unprognostic (6.33e-2)" "unprognostic (4.65e-4)" "unprognostic (2.72e-2)" "unprognostic (1.01e-3)" "unprognostic (4.45e-2)" "unprognostic (1.52e-1)" "unprognostic (3.94e-1)" "unprognostic (3.02e-2)" "unprognostic (4.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (6.31e-3)" "unprognostic (8.31e-2)" 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.2 1.0 2.3 0.1 0.8 3.9 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.4 0.2 0.2 0.0 0.2 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HYKK "AGPHD1, LOC123688" ENSG00000188266 "Hydroxylysine kinase" A2RU49 15 78507564-78537372 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Late spermatids: 33.7;Proximal enterocytes: 37.0;Proximal tubular cells: 39.4;Skeletal myocytes: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Lineage enriched" "Detected in single" 6 "T-cells: 3.0" "Cell line enhanced" "Detected in many" "HEK 293: 22.2;U-266/84: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040706 Approved Approved Vesicles,Aggresome NA NA Vesicles Aggresome "HPA040706: AB_10795528" "unprognostic (9.26e-2)" "unprognostic (1.98e-4)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (2.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (2.73e-1)" "unprognostic (5.16e-2)" "unprognostic (6.24e-3)" "unprognostic (6.37e-2)" "unprognostic (3.44e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-3)" "unprognostic (3.90e-2)" 3.8 4.8 3.1 1.0 3.2 1.3 4.6 2.5 3.3 5.3 1.8 4.2 7.3 3.9 5.9 2.9 4.4 2.4 5.3 2.9 2.3 12.4 5.8 2.1 2.0 2.3 2.2 3.1 6.1 6.9 4.9 3.5 0.7 2.5 4.1 3.5 2.6 3.5 4.1 6.3 2.8 7.3 3.6 1.7 1.3 5.1 5.3 2.3 2.0 4.6 5.4 1.7 3.9 3.8 3.4 4.3 6.3 1.0 11.3 2.3 5.3 2.7 1.5 2.7 3.7 4.2 2.2 4.9 3.1 1.4 2.5 6.3 5.2 10.0 3.3 3.5 1.5 22.2 1.7 3.8 5.6 6.0 0.5 1.9 4.8 6.4 1.4 2.7 1.8 2.7 13.8 4.0 8.4 2.2 5.0 4.2 1.0 0.7 9.8 8.3 2.4 12.4 2.7 7.1 5.1 1.3 1.6 2.9 8.6 10.9 1.9 9.5 0.4 1.9 2.4 1.8 4.3 4.4 12.9 24.2 0.2 3.2 0.2 3.4 0.4 0.1 0.2 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 3.0 0.6 0.3 0.1 0.0 0.3 0.5 0.4 3.1 3.2 2.5 3.3 2.9 2.3 2.3 2.2 3.1 2.5 1.7 2.3 3.4 4.1 12.8 4.1 4.6 1.4 3.6 7.7 4.5 6.2 2.0 4.5 9.8 6.7 0.0 2.9 7.3 2.1 7.3 1.5 2.8 29.4 2.5 14.0 2.7 3.3 4.1 4.2 1.3 2.8 7.9 4.4 5.4 5.1 1.5 0.0 2.4 6.8 7.1 0.8 0.0 2.7 3.9 2.0 1.0 0.9 33.7 5.3 1.0 7.2 2.8 0.3 7.5 0.0 0.5 1.1 2.9 3.6 3.8 1.7 3.7 37.0 39.4 3.5 1.9 0.0 28.1 4.0 5.4 8.0 4.9 1.6 3.4 1.6 3.9 5.7 4.7 OR7A5 HTPCR2 ENSG00000188269 "Olfactory receptor family 7 subfamily A member 5" Q15622 19 14826241-14835185 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 9.7;epididymis: 4.5;parathyroid gland: 7.1" "Cell type enhanced" "Detected in single" "Spermatocytes: 1.3" "Cancer enriched" "Detected in single" 8 "melanoma: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053823 Uncertain NA NA "HPA053823: AB_2682274" "unprognostic (3.26e-4)" "unprognostic (1.44e-1)" "unprognostic (7.46e-2)" "unprognostic (6.19e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (6.78e-2)" "unprognostic (2.01e-7)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (6.44e-2)" "unprognostic (2.47e-3)" 0.0 0.1 1.2 0.0 3.3 0.0 0.7 3.1 4.8 0.1 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.3 3.1 0.0 0.0 0.0 0.0 3.9 4.3 1.0 0.0 0.0 7.1 1.3 0.0 3.7 0.5 0.0 0.0 0.2 0.6 0.0 0.7 0.0 0.0 1.2 0.0 0.0 1.3 3.0 0.0 0.0 0.0 0.0 0.0 0.2 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.3 3.1 4.8 1.3 3.1 3.9 4.3 1.0 3.7 1.2 3.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 C15orf62 LOC643338 ENSG00000188277 "Chromosome 15 open reading frame 62" A8K5M9 15 40769980-40772449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.2;skin 1: 15.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 3.6;Club cells: 5.0;Glandular and luminal cells: 6.3;Ionocytes: 6.1;Prostatic glandular cells: 5.5;Squamous epithelial cells: 4.7;Urothelial cells: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.7;SK-BR-3: 5.7" "Region enriched" "Detected in single" 5 "olfactory bulb: 1.2" "Low region specificity" "Detected in all" HPA044636 Approved NA NA "HPA044636: AB_10794052" "unprognostic (9.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.52e-1)" "unprognostic (2.83e-2)" "unprognostic (5.56e-2)" "unprognostic (2.24e-2)" "unprognostic (5.37e-3)" "unprognostic (7.68e-3)" "unprognostic (1.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "unprognostic (3.40e-1)" 1.7 1.3 0.8 1.6 0.9 1.7 2.3 4.0 1.6 3.1 0.0 1.8 1.9 1.7 0.1 26.2 2.1 1.3 1.4 0.8 0.1 2.0 4.0 1.8 2.1 0.8 0.7 0.3 2.5 2.0 0.1 2.1 0.4 1.9 2.4 0.1 2.4 8.4 0.1 2.0 15.1 2.6 0.0 0.1 2.3 1.9 0.6 0.6 0.7 2.0 0.1 5.0 1.8 7.0 1.3 0.5 0.4 1.6 2.0 0.6 0.1 0.4 0.7 0.1 0.0 0.2 1.9 2.2 1.0 1.8 0.0 1.3 4.1 0.7 0.0 0.0 1.5 1.6 1.0 4.4 0.6 0.0 0.9 1.2 0.2 0.8 0.0 0.1 1.8 0.6 0.7 0.9 1.2 0.0 0.5 1.3 1.6 0.7 2.8 0.8 1.4 0.3 0.5 17.7 1.5 3.6 0.8 0.6 5.7 0.2 0.6 2.0 1.3 0.8 2.0 0.9 1.8 0.6 1.4 1.0 0.9 0.6 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 4.0 1.6 0.8 0.1 0.8 0.7 0.3 1.9 0.1 0.6 1.3 0.2 0.0 0.0 0.3 0.3 0.0 3.6 2.1 0.6 0.3 1.7 0.6 0.7 0.0 5.0 0.0 0.0 0.1 0.2 0.1 0.0 0.5 0.0 1.6 0.9 0.3 0.0 0.0 0.1 0.2 0.0 0.2 0.0 6.3 0.0 0.1 0.0 0.8 0.2 3.3 0.1 0.1 6.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.1 0.0 0.0 5.5 0.3 0.3 1.3 0.5 0.0 0.0 0.3 0.0 0.0 4.7 1.0 0.0 0.2 0.0 0.3 11.6 RUFY4 "FLJ46536, ZFYVE31" ENSG00000188282 "RUN and FYVE domain containing 4" Q6ZNE9 2 218034960-218090581 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;lymphoid tissue: 2.2" "Group enriched" "Detected in some" 4 "Granulosa cells: 9.5;Langerhans cells: 4.0;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "Karpas-707: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA037980 Uncertain NA NA "HPA037980: AB_10672501" "unprognostic (1.27e-3)" "unprognostic (4.60e-3)" "unprognostic (9.39e-3)" "unprognostic (6.79e-2)" "unprognostic (5.92e-2)" "unprognostic (6.57e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-2)" "unprognostic (1.31e-3)" "unprognostic (1.50e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-1)" "unprognostic (2.41e-14)" "unprognostic (1.36e-2)" "unprognostic (1.13e-3)" "unprognostic (3.45e-1)" "unprognostic (1.43e-5)" 0.1 0.2 0.5 0.9 0.6 0.8 0.1 0.4 1.8 0.1 0.4 0.2 0.7 0.0 0.0 0.4 0.2 0.5 0.0 0.9 0.4 0.1 0.2 0.4 1.1 0.4 0.4 0.4 0.1 0.0 0.0 0.2 0.0 0.5 1.1 0.5 0.1 0.5 0.1 0.0 0.3 0.7 0.0 0.4 2.2 0.6 0.1 0.4 1.7 0.1 0.0 0.9 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.4 1.8 0.9 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.0 0.0 0.0 2.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 9.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.3 4.0 0.3 0.0 0.9 0.0 1.0 2.0 0.0 0.0 13.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 ZNF383 "FLJ35863, Zfp383" ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA063945: AB_2685158" "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favorable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favorable (3.71e-4)" 3.6 3.2 2.5 3.4 4.4 3.5 5.1 7.8 3.6 4.1 1.4 3.2 3.6 3.8 3.6 3.6 3.7 2.9 4.9 2.7 2.6 4.5 3.2 3.6 6.1 3.2 3.1 2.0 5.8 3.0 4.5 2.8 3.2 3.7 4.2 3.5 5.4 4.0 4.0 7.5 5.4 3.5 3.8 2.1 5.1 3.9 4.0 3.8 5.7 5.4 9.1 6.1 3.4 3.4 7.0 2.9 6.8 4.6 7.1 5.7 5.8 3.1 4.1 5.6 4.0 5.9 3.1 3.6 4.0 5.9 3.9 3.8 3.0 3.6 5.5 5.9 5.4 4.2 5.7 5.2 2.6 6.1 6.9 6.2 7.1 4.6 3.9 7.6 5.1 3.7 5.5 3.2 2.1 5.0 1.4 6.3 3.2 4.2 5.8 1.9 4.4 8.4 3.7 3.6 8.2 5.2 4.1 6.6 3.8 5.7 5.8 4.6 4.1 2.3 5.0 3.5 3.7 4.0 6.5 6.4 7.9 0.7 3.2 4.7 3.7 3.2 5.3 5.8 3.9 8.2 8.0 5.4 7.1 3.3 10.7 8.6 6.9 3.5 4.8 4.9 3.1 6.0 3.9 2.5 4.4 7.8 3.6 2.7 2.6 3.2 3.1 2.0 3.7 2.1 3.8 7.0 7.2 3.2 4.4 7.5 10.2 2.7 4.0 3.4 5.7 9.8 3.7 5.2 12.8 7.2 2.5 1.8 14.6 3.8 7.5 3.8 1.9 3.5 8.9 3.6 5.4 5.1 2.4 11.0 7.4 3.6 4.8 5.8 4.6 3.7 5.7 7.8 6.4 2.2 3.8 15.2 8.7 3.8 2.0 6.3 3.5 3.0 6.5 4.5 8.8 4.7 5.5 6.2 10.3 9.5 10.4 2.7 3.6 7.5 3.8 5.1 5.8 3.9 2.5 9.9 13.1 9.9 6.1 5.8 5.2 3.9 3.3 4.9 8.5 6.6 4.8 4.1 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 345.1;Paneth cells: 397.4;Prostatic glandular cells: 286.6;Smooth muscle cells: 385.7;Urothelial cells: 494.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 10 "granulocytes: 12.4" "Cell line enriched" "Detected in many" 7 "HEK 293: 198.1" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA062465: AB_2684771" "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favorable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 8.5 2.0 13.7 0.7 12.1 0.5 9.1 8.3 30.2 8.2 2.7 9.2 1.2 10.6 0.4 7.5 10.4 0.1 22.5 6.8 11.7 6.4 3.0 10.9 0.2 23.9 15.5 9.2 4.0 5.6 0.9 8.4 1.5 15.3 11.5 0.3 0.8 7.8 2.2 4.1 7.2 4.0 1.2 5.3 4.4 5.7 2.7 17.3 1.4 6.0 0.9 0.3 10.1 8.5 17.1 14.3 1.6 1.5 0.2 0.2 0.1 17.6 8.6 1.0 5.2 5.4 2.3 4.5 0.0 20.0 0.7 2.3 25.3 2.1 0.3 0.2 0.1 198.1 0.1 2.4 2.9 1.7 0.0 1.7 0.1 2.0 0.3 0.4 0.7 0.6 2.5 4.1 0.3 0.0 7.6 11.7 0.6 0.2 3.1 19.2 0.2 1.9 4.4 2.0 0.0 1.1 4.6 5.8 14.3 29.1 0.7 10.5 0.0 1.1 1.6 0.6 0.0 4.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 12.4 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 13.7 12.1 8.3 30.2 6.8 11.7 23.9 15.5 9.2 15.3 5.3 17.3 17.1 90.1 0.0 0.0 18.6 15.3 52.1 345.1 1.7 6.8 8.9 158.9 149.4 13.3 20.0 4.0 58.8 0.0 1.5 22.3 88.3 31.3 44.1 1.0 74.7 30.0 63.4 10.7 2.7 12.9 2.9 43.9 65.5 11.2 153.3 53.5 3.1 37.5 0.8 4.8 0.0 25.9 25.4 4.1 10.0 120.5 1.5 7.5 70.8 115.6 11.2 5.2 129.7 12.3 8.5 1.7 10.7 397.4 15.4 2.3 286.6 1.5 0.8 1.1 11.3 164.3 157.8 385.7 3.2 29.6 43.0 82.7 3.4 27.4 2.0 56.9 494.9 IGFL1 UNQ644 ENSG00000188293 "IGF like family member 1" Q6UW32 19 46229742-46231243 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "esophagus: 113.9;salivary gland: 34.8;vagina: 31.8" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.7;Basal respiratory cells: 12.5;Prostatic glandular cells: 4.4;Squamous epithelial cells: 2.1;Suprabasal keratinocytes: 3.4" "Group enriched" "Detected in many" 7 "cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 6.9;RT4: 25.6;SK-BR-3: 8.6" HPA014001 Uncertain "Secreted in other tissues" NA NA "HPA014001: AB_2668919" "unprognostic (1.35e-1)" "unprognostic (9.70e-2)" "unprognostic (2.89e-1)" "unprognostic (1.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.67e-2)" "unprognostic (3.06e-1)" "unprognostic (4.50e-3)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (1.80e-1)" "unprognostic (1.64e-1)" "unprognostic (3.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 113.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 34.8 0.0 0.0 3.0 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.8 0.0 0.0 4.9 0.4 31.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 6.9 0.0 1.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.2 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 12.5 0.0 0.0 0.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.3 2.1 3.4 0.0 0.0 0.0 0.0 0.2 ZNF669 FLJ12606 ENSG00000188295 "Zinc finger protein 669" Q96BR6 1 247099962-247104372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044043 Uncertain NA NA "HPA044043: AB_10964039" "unprognostic (1.88e-1)" "unprognostic (6.57e-2)" "unprognostic (2.01e-2)" "unprognostic (1.32e-1)" "unprognostic (3.80e-2)" "unprognostic (6.04e-2)" "unprognostic (1.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (5.98e-2)" "unprognostic (1.09e-1)" "prognostic favorable (4.59e-7)" "unprognostic (2.60e-2)" "unprognostic (1.47e-1)" "unprognostic (3.11e-2)" "unprognostic (4.81e-2)" 3.4 1.9 1.9 2.6 1.8 11.8 5.6 4.7 2.3 3.8 1.6 3.7 2.9 4.8 3.2 2.5 4.0 3.0 2.5 1.6 1.7 3.8 2.2 3.4 5.5 1.9 1.8 2.0 4.6 4.3 4.3 1.6 2.8 2.4 3.1 3.6 5.2 3.0 3.2 2.0 2.8 2.4 3.7 1.3 4.1 3.4 4.7 1.9 8.9 5.0 3.7 5.7 2.7 1.6 3.4 4.2 2.9 9.4 10.9 5.4 4.8 9.6 6.1 6.2 8.1 8.3 7.1 4.3 5.9 8.9 4.2 5.8 5.3 9.2 7.2 9.0 3.1 2.2 0.4 6.4 5.2 4.3 5.7 6.9 4.5 7.4 6.6 4.8 3.9 4.9 15.1 10.4 4.1 8.6 3.7 14.6 5.7 22.1 8.7 5.9 11.6 9.1 4.3 6.0 12.0 10.1 17.9 7.8 4.1 3.1 10.5 8.0 20.3 5.6 5.7 6.4 5.3 11.4 10.2 20.1 12.0 1.5 2.9 5.8 10.7 2.4 8.9 4.4 1.6 5.8 6.4 5.2 4.2 3.1 5.1 5.9 5.8 5.8 4.3 2.4 4.2 6.2 2.9 1.9 1.8 4.7 2.3 1.6 1.7 1.9 1.8 2.0 2.4 1.3 1.9 3.4 10.2 3.2 8.3 1.6 17.5 9.7 6.2 4.8 7.4 27.1 5.1 5.6 1.6 12.8 4.5 1.8 12.5 3.6 11.3 2.3 7.9 5.1 11.5 9.0 7.2 8.3 7.8 8.6 3.0 7.7 4.9 5.4 3.6 11.5 15.2 9.7 8.6 2.5 4.8 16.8 3.3 2.6 2.0 6.0 19.8 7.4 7.2 7.3 12.4 3.7 4.7 9.9 18.6 3.0 2.4 8.1 1.2 3.8 8.1 3.3 2.8 3.6 7.5 31.1 0.0 5.9 6.2 10.4 9.5 5.1 8.5 2.3 10.5 9.7 2.5 4.1 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274631-2282175 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.3;lymphoid tissue: 4.1" "Cell type enhanced" "Detected in some" "dendritic cells: 1.5;Hofbauer cells: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 41.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 41.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 12.2" "Group enriched" "Detected in some" 5 "basal ganglia: 6.7;cerebellum: 3.1" HPA057806 Uncertain Uncertain Cytosol NA NA Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 0.5 0.4 0.5 1.3 0.7 2.3 0.3 0.6 1.3 0.2 0.3 0.3 0.2 0.2 0.0 0.2 0.5 0.2 0.5 0.3 0.8 0.3 0.2 1.1 0.4 1.2 0.9 0.2 0.1 0.2 0.0 0.2 0.1 1.1 0.3 0.2 0.0 0.2 0.0 0.3 0.3 0.8 0.1 0.8 4.1 0.3 0.1 0.8 0.1 0.2 0.0 0.3 0.3 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 10.5 4.4 11.7 1.6 5.7 0.2 0.2 0.1 0.2 1.8 0.4 0.1 0.3 41.0 4.5 1.9 0.2 0.0 1.1 0.5 0.7 0.6 1.3 0.3 0.8 1.2 0.9 0.2 1.1 0.8 0.8 1.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 LRRIQ4 LRRC64 ENSG00000188306 "Leucine rich repeats and IQ motif containing 4" A6NIV6 3 169821922-169837775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Group enriched" "Detected in some" 17 "Early spermatids: 42.8;Late spermatids: 27.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.6;T-47d: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036271, HPA036706" Uncertain Approved Mitochondria NA NA Mitochondria "HPA036271: , HPA036706: AB_2675264" "unprognostic (5.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-4)" "unprognostic (5.26e-3)" "unprognostic (2.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (9.72e-2)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "unprognostic (7.47e-2)" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (4.56e-3)" 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.1 0.7 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.3 0.0 0.0 0.0 1.6 0.6 0.2 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 42.8 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 27.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CENPP "CENP-P, RP11-19J3.3" ENSG00000188312 "Centromere protein P" Q6IPU0 9 92325953-92620529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 21.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 63.3;Excitatory neurons: 73.4;Inhibitory neurons: 70.5;Microglial cells: 94.6;Oligodendrocytes: 74.5;Suprabasal keratinocytes: 100.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021787, HPA058945" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA021787: AB_1846524, HPA058945: AB_2683860" "unprognostic (5.48e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.20e-1)" "unprognostic (2.43e-3)" "unprognostic (2.64e-2)" "prognostic favorable (3.65e-4)" "unprognostic (4.88e-5)" "unprognostic (8.06e-2)" "unprognostic (3.51e-3)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (6.68e-3)" "unprognostic (9.20e-8)" "unprognostic (1.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.11e-1)" "unprognostic (2.04e-1)" 3.4 3.1 1.5 3.6 2.0 12.4 3.0 5.6 2.2 3.1 0.8 2.4 2.8 3.0 0.7 4.4 2.0 2.8 2.6 2.0 1.5 2.0 1.9 1.9 5.6 1.7 1.6 1.4 2.3 2.2 2.4 1.8 3.1 2.4 2.4 2.7 2.4 2.2 1.5 9.1 21.6 1.9 3.0 0.8 2.8 1.8 4.5 1.8 7.2 1.4 4.6 6.4 2.3 4.0 1.8 14.2 8.7 12.0 8.8 4.9 5.3 11.7 14.6 8.2 17.9 14.3 4.0 7.9 18.5 6.7 4.7 16.5 16.8 11.6 8.0 16.6 26.3 15.1 18.6 7.2 5.7 2.6 38.2 17.0 5.8 4.5 17.3 11.1 2.5 9.2 17.5 20.8 25.2 13.8 9.0 53.4 11.6 10.1 26.6 17.9 17.9 20.3 20.0 2.7 14.1 27.8 9.6 16.8 10.5 5.4 8.7 5.6 11.4 4.4 17.4 8.7 26.6 21.2 16.7 21.6 23.9 19.5 18.9 16.1 1.8 1.8 2.6 2.6 6.4 4.7 4.6 3.0 2.3 2.3 3.6 2.7 2.7 0.5 3.5 3.3 3.0 3.5 2.0 1.5 2.0 5.6 2.2 2.0 1.5 1.7 1.6 1.4 2.4 0.8 1.8 1.8 3.7 0.0 0.5 17.3 4.5 63.3 4.0 4.5 5.2 6.2 4.0 2.7 2.1 2.8 1.3 0.0 8.4 6.2 3.3 1.6 1.9 1.7 17.5 2.4 4.2 4.4 1.2 11.2 73.4 2.3 9.2 5.8 5.6 2.3 0.0 6.4 2.5 0.9 17.1 1.7 70.5 1.5 0.0 2.1 11.7 4.7 4.4 4.0 14.2 94.6 0.5 2.8 1.0 38.2 74.5 1.1 0.4 4.9 11.9 2.8 0.4 1.8 0.3 7.8 6.6 20.8 9.2 30.2 16.2 9.8 100.9 3.8 3.6 4.4 2.6 2.7 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544856 "Predicted intracellular proteins, Transporters" "Antiviral defense, Host-virus interaction" "DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.0 23.3 12.6 87.4 12.9 65.0 46.3 12.2 17.8 24.1 12.7 65.6 40.2 28.4 31.3 48.3 40.4 66.6 24.2 11.1 17.3 43.3 49.7 49.7 40.9 17.3 12.7 9.9 35.3 38.6 16.9 15.5 56.8 15.1 23.9 60.1 9.9 49.5 50.1 10.9 13.2 45.8 42.3 13.8 65.1 44.4 17.2 14.8 30.3 28.0 17.7 39.7 68.8 29.8 19.4 106.2 41.5 26.4 12.1 40.9 65.0 40.5 32.6 88.4 319.8 418.6 34.0 88.1 8.4 75.6 20.6 245.9 86.2 21.2 32.7 56.6 32.9 21.6 66.1 12.5 25.2 292.9 40.3 35.4 106.3 53.3 36.6 182.3 52.6 49.4 19.1 44.7 104.0 66.9 41.0 30.6 16.1 25.8 71.6 37.6 27.4 28.1 2.9 95.9 29.6 16.3 0.0 42.6 20.9 569.9 35.8 20.7 46.8 30.6 26.9 22.7 59.1 55.8 79.2 15.6 0.4 27.0 29.0 23.3 41.1 157.6 44.3 20.8 159.6 30.0 25.2 13.5 18.5 105.8 19.7 9.3 13.9 100.0 57.8 94.8 28.5 8.3 79.3 12.6 12.9 12.2 17.8 11.1 17.3 17.3 12.7 9.9 15.1 13.8 14.8 19.4 191.4 35.3 43.0 12.7 28.2 37.0 106.5 92.1 26.2 0.7 36.0 22.6 7.3 124.4 110.4 95.6 0.0 53.7 25.4 134.2 74.3 291.6 2.0 56.1 24.5 135.2 33.1 18.3 7.1 217.4 114.1 74.8 47.9 58.2 28.4 60.5 100.6 29.7 139.9 0.0 9.0 71.5 79.3 86.2 162.9 6.8 114.9 185.5 48.0 35.6 72.3 64.3 32.0 7.1 0.3 157.6 110.3 45.9 18.2 79.6 40.7 75.0 133.5 1.6 39.5 63.4 59.2 1.5 2.4 21.8 28.6 44.5 25.9 42.6 69.4 211.9 C3orf62 FLJ43654 ENSG00000188315 "Chromosome 3 open reading frame 62" Q6ZUJ4 3 49268596-49277232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 40.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 40.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043328 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA043328: AB_10795613" "prognostic favorable (3.93e-4)" "unprognostic (4.87e-3)" "unprognostic (3.70e-3)" "unprognostic (2.35e-2)" "unprognostic (9.51e-2)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.20e-4)" "prognostic favorable (8.88e-4)" "unprognostic (1.28e-1)" "unprognostic (9.40e-3)" "prognostic favorable (8.15e-4)" "unprognostic (7.23e-2)" "unprognostic (3.27e-2)" "prognostic favorable (3.29e-5)" "unprognostic (2.46e-1)" "unprognostic (4.79e-1)" "prognostic favorable (1.62e-5)" 6.0 10.5 3.8 4.5 4.5 8.6 5.5 4.8 5.5 5.8 6.6 6.5 3.1 5.7 4.6 7.0 8.0 4.8 6.3 3.9 3.3 4.7 5.6 7.4 4.9 4.2 3.6 3.1 11.4 3.3 3.1 7.8 2.7 5.1 7.6 2.6 9.0 4.2 2.1 4.0 5.5 5.5 2.8 2.9 11.8 4.0 17.4 4.0 4.2 6.1 3.6 3.5 6.4 6.2 4.7 4.3 2.5 5.9 7.4 4.7 4.0 3.3 2.5 4.2 2.2 3.2 3.6 3.2 8.5 3.8 3.9 4.6 3.3 2.9 2.8 2.4 7.5 3.4 5.6 5.8 4.0 1.4 8.0 10.0 3.3 8.1 3.2 6.0 3.8 2.5 4.9 6.5 6.3 1.8 2.7 5.9 5.8 4.2 3.6 3.6 4.4 3.1 4.5 3.6 9.8 4.5 6.1 6.8 5.2 9.1 4.3 2.6 8.8 3.1 3.0 7.3 5.2 4.7 5.5 10.2 7.1 2.2 7.4 4.2 1.0 5.1 5.3 1.2 1.7 1.0 1.9 1.1 1.2 0.6 1.2 0.8 1.0 40.0 0.3 1.7 2.5 1.4 1.3 3.8 4.5 4.8 5.5 3.9 3.3 4.2 3.6 3.1 5.1 2.9 4.0 4.7 8.6 9.6 16.1 4.6 4.4 6.8 3.5 7.9 1.8 12.6 5.7 6.0 9.1 7.2 10.3 11.0 22.9 7.0 7.8 7.6 0.0 4.9 12.4 6.6 9.2 8.1 5.4 7.0 7.3 3.9 4.3 7.3 5.6 10.1 2.5 8.5 9.7 6.3 9.8 5.0 6.1 9.8 2.0 18.0 7.1 17.3 8.7 11.3 8.8 9.4 14.2 7.3 9.2 4.5 7.0 6.0 3.8 8.6 4.6 7.0 4.9 5.2 11.1 13.7 0.0 14.9 6.4 51.8 6.8 4.2 8.7 4.1 6.9 12.1 7.4 2.7 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase 4" A6NNW6 10 116849499-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.3;fallopian tube: 5.1" "Cell type enhanced" "Detected in some" "Astrocytes: 16.3;Cone photoreceptor cells: 22.9;Early spermatids: 15.5;Endometrial ciliated cells: 15.8;Inhibitory neurons: 18.4;Late spermatids: 15.8;Oligodendrocytes: 62.4;Respiratory ciliated cells: 30.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.1 0.3 2.0 0.0 4.5 0.0 0.4 1.9 3.6 0.4 3.4 0.2 0.0 0.7 1.3 0.1 5.1 0.3 0.1 1.6 3.7 0.6 1.4 0.6 0.1 3.4 3.0 1.1 0.5 0.6 1.0 1.0 0.0 4.6 0.4 0.1 2.0 0.2 0.4 0.0 0.2 0.2 0.2 2.0 0.2 0.3 2.5 2.9 0.1 0.7 0.0 0.0 0.1 0.2 11.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 4.5 1.9 3.6 1.6 3.7 3.4 3.0 1.1 4.6 2.0 2.9 11.3 0.0 0.0 0.0 16.3 0.0 0.1 0.3 0.8 0.6 4.9 0.4 0.3 0.3 0.0 0.4 0.0 22.9 0.3 0.0 0.2 0.0 0.5 15.5 15.8 0.7 0.1 1.8 0.0 12.2 0.2 0.2 0.7 0.0 1.1 0.0 0.5 0.0 0.0 0.0 5.0 18.4 0.0 0.0 0.0 0.6 15.8 1.2 0.2 0.0 8.4 0.6 1.3 0.0 4.5 62.4 0.2 0.1 0.7 0.0 0.1 0.3 0.8 30.2 8.4 0.0 1.0 0.5 9.4 2.9 0.1 0.0 0.1 0.0 1.0 0.3 0.1 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059632: AB_2684089, HPA065485: AB_2685497" "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favorable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 14.4 14.3 13.4 9.3 14.8 4.0 17.0 20.3 14.1 23.5 18.3 14.4 6.5 22.6 21.7 7.4 23.2 10.0 18.6 13.1 13.6 17.0 11.1 12.5 16.1 13.8 13.8 12.4 33.0 10.7 22.4 26.1 12.2 15.1 20.6 11.1 20.6 12.4 13.0 4.8 10.8 15.0 19.3 12.4 22.2 13.0 16.5 14.0 22.9 19.8 10.7 13.3 17.1 15.7 20.4 15.4 8.3 15.6 19.3 9.2 8.3 4.2 9.3 18.6 13.3 11.4 3.8 1.8 12.4 10.8 13.7 18.4 5.4 9.5 8.8 16.9 19.9 13.5 16.2 14.0 5.7 16.0 15.0 18.3 17.3 15.6 14.7 18.7 11.4 11.3 18.8 12.7 42.8 8.7 0.0 20.4 46.8 25.4 2.6 13.4 10.0 18.8 16.7 8.1 21.5 17.8 14.7 17.9 2.9 22.6 22.9 12.7 11.5 9.6 24.6 5.6 20.1 14.2 3.5 0.1 12.6 4.6 9.4 16.0 40.7 4.8 11.4 12.1 4.7 16.4 17.4 13.0 13.3 7.7 17.0 21.0 17.2 2.7 20.9 6.5 6.4 12.6 9.0 13.4 14.8 20.3 14.1 13.1 13.6 13.8 13.8 12.4 15.1 12.4 14.0 20.4 9.8 3.2 3.3 0.0 12.9 3.8 6.7 6.2 5.7 30.2 7.0 7.1 8.8 10.0 5.1 3.7 27.1 7.0 12.4 2.2 1.9 7.3 9.1 6.1 8.3 11.0 3.0 3.0 0.0 3.2 5.3 9.8 1.5 3.8 2.5 17.8 12.8 2.7 4.9 26.9 0.0 4.0 2.0 7.0 3.7 2.9 12.8 4.7 3.6 0.0 7.7 17.3 29.9 0.0 0.0 3.2 3.0 13.5 1.8 4.6 2.2 3.4 5.7 27.2 6.6 14.1 10.1 27.0 40.4 2.9 3.0 2.9 10.0 8.5 4.1 2.8 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28259246-28323849 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6;skeletal muscle: 44.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Excitatory neurons: 38.2;Granulosa cells: 26.3;NK-cells: 36.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 28.8;AN3-CA: 20.9;NTERA-2: 29.6;REH: 32.6;SCLC-21H: 45.5;SH-SY5Y: 42.6" "Region enriched" "Detected in all" 5 "cerebellum: 275.9" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-2)" "prognostic favorable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.1 2.4 7.7 1.0 6.7 1.3 0.8 26.6 15.1 0.7 0.0 0.4 0.3 0.9 0.4 0.6 0.7 0.2 1.3 11.0 5.6 1.2 0.2 0.8 1.7 5.8 8.5 5.9 0.5 1.9 2.9 5.6 0.0 10.4 1.6 0.3 5.1 2.8 0.2 44.5 1.0 0.6 0.1 2.5 1.9 0.8 2.5 10.4 10.1 2.5 9.2 0.8 0.3 0.4 7.8 0.3 0.4 28.8 20.9 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.2 1.4 0.7 0.2 0.0 0.4 0.5 8.8 0.2 0.1 3.0 1.2 0.1 0.3 0.9 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.2 0.2 11.2 0.0 1.8 0.0 3.6 14.0 0.3 29.6 1.9 0.2 32.6 1.6 0.6 0.1 1.8 45.5 42.6 0.8 2.7 0.4 3.5 3.3 0.1 0.8 0.1 4.3 0.4 0.2 0.3 0.0 0.5 0.1 0.5 1.6 0.3 0.0 0.0 1.5 0.0 0.5 0.0 0.4 0.8 0.0 0.1 0.4 1.0 0.0 0.7 0.0 0.0 0.5 0.1 7.7 6.7 26.6 15.1 11.0 5.6 5.8 8.5 5.9 10.4 2.5 10.4 7.8 0.2 3.2 0.5 1.0 0.6 0.6 0.7 1.4 3.4 13.0 6.3 2.9 3.6 2.8 2.5 0.0 81.3 0.0 11.1 0.1 1.9 8.2 1.2 2.4 0.3 0.3 6.0 0.4 38.2 5.6 0.0 0.4 0.0 1.8 0.0 26.3 0.0 0.2 0.1 0.0 13.8 0.8 4.1 0.0 0.8 3.9 0.6 0.4 0.0 0.0 0.7 4.1 36.0 5.0 1.7 3.6 0.0 0.0 2.3 1.5 0.1 0.7 1.7 2.7 0.0 2.5 2.7 2.4 2.1 1.0 0.1 0.1 5.6 0.2 1.2 0.4 OR6C6 ENSG00000188324 "Olfactory receptor family 6 subfamily C member 6" A6NF89 12 55293988-55296569 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051090 Uncertain Approved "Lipid droplets,Plasma membrane" NA NA "Lipid droplets, Plasma membrane" "HPA051090: AB_2681341" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BSPH1 "BSP1, ELSPBP2" ENSG00000188334 "Binder of sperm protein homolog 1" Q075Z2 19 47968046-47992170 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "epididymis: 386.4" "Cell type enhanced" "Detected in single" "Bipolar cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048335 Enhanced "Secreted in male reproductive system" NA NA "HPA048335: AB_2732546" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 386.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 334.3;retina: 174.4" "Group enriched" "Detected in many" 6 "Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Group enriched" "Detected in some" 5 "Hep G2: 49.8;SCLC-21H: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA031871: AB_2674080" "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 1.4 0.1 32.1 0.1 33.2 1.0 1.4 40.9 41.5 0.5 27.3 0.2 1.3 0.3 0.4 1.1 0.6 0.4 5.6 30.2 34.2 5.0 334.3 0.2 0.5 37.9 37.7 25.1 6.4 37.5 8.0 4.7 1.2 35.6 0.5 0.1 174.4 1.8 0.1 36.2 0.6 0.6 0.2 32.8 0.2 2.0 1.9 36.3 0.0 1.3 36.1 0.3 0.1 0.4 35.3 0.0 0.0 1.2 7.0 0.1 0.0 1.7 0.0 0.0 1.3 0.6 4.1 0.0 0.1 1.1 0.0 0.3 0.0 1.9 0.0 0.9 0.1 0.6 0.0 1.0 49.8 0.1 0.5 0.0 0.1 0.0 0.1 0.0 5.6 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.5 0.5 0.0 0.2 0.2 15.4 1.3 0.7 0.2 0.0 2.1 2.0 0.3 0.0 0.2 1.2 0.0 1.0 0.3 0.0 0.1 0.2 0.3 0.1 2.9 0.2 0.3 0.2 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.2 0.2 0.8 0.4 0.0 0.2 0.1 0.1 32.1 33.2 40.9 41.5 30.2 34.2 37.9 37.7 25.1 35.6 32.8 36.3 35.3 0.3 0.0 0.0 17.6 0.4 0.0 0.1 0.0 0.6 88.3 3.2 1.7 3.3 17.2 0.0 0.0 187.7 0.2 0.0 0.0 0.0 1.8 0.3 0.4 0.0 3.9 3.5 2.7 0.2 2.2 0.1 0.2 0.0 0.5 0.0 0.1 2.2 114.6 0.1 8.4 0.6 0.2 0.0 2.6 0.0 0.0 2.1 0.1 0.0 7.5 0.6 80.1 0.0 4.5 3.7 0.6 0.0 0.4 0.0 0.0 0.0 4.2 0.0 124.0 0.0 0.6 0.3 2.9 3.3 0.9 0.0 1.4 0.2 0.0 0.2 0.0 OR6N2 ENSG00000188340 "Olfactory receptor family 6 subfamily N member 2" Q8NGY6 1 158774222-158781204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056637 Uncertain NA NA "HPA056637: AB_2683198" 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTF2F2 "BTF4, RAP30, TFIIF" ENSG00000188342 "General transcription factor IIF subunit 2" P13984 13 45120510-45284893 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006912 Supported Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "HPA006912: AB_1080256" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (3.67e-2)" "unprognostic (3.17e-1)" "unprognostic (3.36e-2)" "unprognostic (2.53e-3)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.53e-3)" "unprognostic (3.94e-2)" "unprognostic (6.44e-3)" 10.9 16.8 13.0 11.1 13.9 18.5 13.1 13.2 15.1 12.6 17.9 16.1 10.5 11.7 15.5 16.6 10.1 8.5 20.2 13.6 14.2 11.4 11.4 9.7 13.5 13.1 13.7 12.5 12.2 10.8 14.2 13.0 11.1 13.1 10.8 14.3 10.0 12.3 13.1 25.2 24.2 10.1 13.0 13.8 10.3 11.4 13.4 13.7 14.9 11.5 15.9 14.5 15.6 14.9 16.4 43.2 15.9 29.3 21.8 17.6 25.8 24.3 46.2 30.2 46.1 44.9 26.8 65.7 42.9 25.4 33.9 44.8 46.9 44.3 37.1 66.7 32.6 38.4 50.8 20.7 35.2 28.1 57.0 27.9 21.8 55.9 34.4 57.8 52.0 29.9 32.9 36.6 15.8 125.6 24.2 42.0 65.2 34.8 68.6 38.3 39.0 22.2 24.8 101.4 15.0 15.6 26.0 23.5 22.9 39.8 27.5 18.6 45.9 23.7 38.6 33.1 30.8 79.9 10.0 14.6 42.7 44.9 36.1 41.2 16.2 15.9 29.9 10.3 16.7 12.4 17.3 12.1 12.4 18.8 17.8 13.5 13.5 22.5 18.9 18.9 14.7 14.7 10.1 13.0 13.9 13.2 15.1 13.6 14.2 13.1 13.7 12.5 13.1 13.8 13.7 16.4 21.6 41.7 32.1 41.1 36.0 75.1 82.8 80.2 35.9 19.2 27.3 30.2 79.4 10.0 41.6 11.0 4.2 33.0 25.7 29.0 49.0 49.7 93.0 34.9 37.5 27.6 28.2 32.6 23.7 33.6 49.4 28.9 13.7 56.8 39.3 25.6 18.2 21.4 49.1 8.4 35.1 26.4 50.8 27.1 38.2 82.3 24.2 32.0 76.5 36.5 38.2 36.8 27.8 57.8 48.9 48.5 30.3 31.6 30.4 88.3 22.6 42.7 29.4 21.5 6.6 35.6 32.3 68.6 83.9 34.5 72.7 33.8 28.8 33.5 40.7 75.1 CIBAR1 "FAM92A, FAM92A1, FLJ38979" ENSG00000188343 "CBY1 interacting BAR domain containing 1" A1XBS5 8 93698561-93731527 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 111.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 13.3;Extravillous trophoblasts: 14.1;Fibroblasts: 8.4;Hofbauer cells: 6.4;Syncytiotrophoblasts: 3.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034760, HPA058942" Enhanced Approved Mitochondria NA NA Mitochondria "HPA034760: AB_10599947, HPA058942: AB_2732628" "unprognostic (2.65e-3)" "unprognostic (6.81e-2)" "unprognostic (2.48e-3)" "unprognostic (2.44e-1)" "unprognostic (1.62e-2)" "unprognostic (2.93e-1)" "unprognostic (3.56e-1)" "unprognostic (3.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (2.28e-3)" "unprognostic (1.97e-1)" "unprognostic (1.71e-1)" "unprognostic (6.85e-3)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (3.07e-2)" 13.3 24.1 17.9 5.6 19.0 3.6 11.0 19.2 25.2 14.7 20.9 11.5 3.2 16.1 26.5 5.1 13.2 14.3 22.6 17.6 16.3 20.1 18.7 10.0 5.7 13.8 14.9 17.0 18.1 21.2 21.7 21.0 10.2 13.9 12.2 5.9 14.2 5.7 11.7 10.3 6.7 7.8 15.1 14.0 5.8 9.9 111.2 15.1 5.1 14.6 11.2 3.1 14.8 9.3 17.7 37.8 20.0 52.9 54.6 55.8 78.9 14.0 34.2 49.8 45.2 43.5 3.5 8.6 3.2 42.7 50.7 52.0 26.6 54.0 32.5 41.0 1.2 29.5 21.5 20.8 18.7 64.1 1.0 5.5 50.4 14.3 44.3 36.0 64.9 49.0 18.1 13.4 1.7 35.8 14.2 23.8 4.1 22.2 0.8 1.1 2.3 39.7 0.8 35.3 8.7 15.3 18.7 24.4 0.5 41.6 23.7 8.2 11.8 27.2 44.2 17.4 46.3 28.0 2.6 2.7 1.2 38.8 3.0 15.8 0.1 1.7 0.0 0.1 1.2 0.2 0.4 0.4 0.1 2.9 0.0 0.1 0.3 0.0 1.3 0.1 0.3 0.8 0.5 17.9 19.0 19.2 25.2 17.6 16.3 13.8 14.9 17.0 13.9 14.0 15.1 17.7 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 14.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "choroid plexus: 124.6" "Cell type enhanced" "Detected in all" "Excitatory neurons: 529.1;Inhibitory neurons: 314.2;Oligodendrocyte precursor cells: 140.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Approved Uncertain Mitochondria NA NA Mitochondria "HPA055015: AB_2682673" "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favorable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 6.5 19.5 11.5 6.1 14.4 5.2 7.8 12.5 21.6 8.6 124.6 9.6 4.6 9.1 11.3 9.0 13.3 5.2 12.6 23.3 16.3 8.1 5.0 8.6 5.4 10.7 8.4 14.5 7.5 12.9 12.4 25.3 8.3 12.0 10.6 10.5 7.1 12.0 7.1 11.3 8.5 6.4 9.1 5.0 6.2 8.2 7.7 12.5 14.6 20.6 11.9 6.2 7.4 7.8 17.3 32.8 22.2 23.7 17.8 21.7 24.7 12.5 19.1 30.2 13.3 15.1 14.8 11.0 13.4 9.9 27.4 11.1 11.2 20.8 37.8 23.0 59.8 15.4 10.5 25.3 18.5 11.2 17.5 13.0 22.9 25.5 13.2 21.6 18.5 51.3 11.1 0.3 19.2 22.3 12.6 13.3 33.0 18.7 17.4 22.2 0.1 10.7 9.0 20.6 13.9 15.7 7.9 12.6 21.3 5.2 31.5 13.3 10.2 31.7 0.1 8.7 14.7 17.5 4.7 28.3 15.0 0.0 24.3 8.0 6.8 1.6 4.9 2.9 3.3 3.8 1.5 2.5 2.8 4.0 2.6 2.2 2.7 1.2 2.7 1.9 1.6 2.6 1.7 11.5 14.4 12.5 21.6 23.3 16.3 10.7 8.4 14.5 12.0 5.0 12.5 17.3 7.0 9.6 14.7 85.8 5.2 2.9 2.8 4.5 6.8 5.8 5.8 5.1 14.9 4.3 8.6 16.5 4.2 4.7 4.1 7.9 1.9 8.1 16.6 21.2 6.7 6.0 17.5 5.5 529.1 8.6 7.6 8.7 12.8 6.8 5.1 13.9 9.7 4.0 5.1 11.8 314.2 10.1 10.2 4.4 3.5 5.0 5.0 5.3 8.8 74.9 2.8 7.9 2.1 140.8 59.0 8.9 3.4 3.8 10.7 5.8 2.5 4.8 25.0 4.0 6.6 11.2 6.7 13.7 7.5 11.2 3.7 3.3 5.7 7.0 10.4 3.0 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 21.8" "Group enriched" "Detected in some" 9 "Early spermatids: 26.7;Late spermatids: 60.1;Spermatocytes: 37.9;Spermatogonia: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: AB_2686259" "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.3 1.1 1.9 0.7 2.3 2.4 0.5 1.9 2.4 0.7 1.3 0.4 0.4 0.6 0.4 1.1 0.5 0.5 0.2 1.9 1.6 0.7 0.7 0.3 0.5 1.9 1.5 1.9 0.5 0.4 0.4 0.9 0.4 2.0 0.7 0.2 0.5 0.7 0.4 0.3 0.8 0.5 0.3 1.3 0.5 0.4 21.8 1.8 0.6 0.4 0.1 0.5 0.4 0.7 1.9 2.7 3.9 2.2 2.9 0.1 0.2 2.2 1.2 1.2 3.5 3.5 1.6 2.5 0.5 4.5 1.3 2.6 0.8 1.0 1.0 0.7 1.8 1.0 2.8 2.0 1.0 0.8 0.7 1.6 1.1 1.6 2.3 0.4 0.7 0.6 2.9 1.5 1.3 1.6 6.2 2.7 1.3 2.3 2.5 0.0 1.0 0.4 0.2 1.1 2.1 4.9 1.9 2.1 1.5 0.6 0.6 2.0 1.0 0.8 2.3 3.4 0.5 2.1 0.2 1.0 0.8 2.4 2.0 2.4 0.4 0.4 0.1 0.4 0.4 0.1 0.6 0.3 0.5 0.5 0.4 0.4 0.2 0.4 0.5 0.1 0.3 0.5 0.2 1.9 2.3 1.9 2.4 1.9 1.6 1.9 1.5 1.9 2.0 1.3 1.8 1.9 1.2 0.0 0.5 0.0 0.7 0.6 0.9 1.9 4.0 0.4 2.7 2.8 0.5 0.0 0.6 0.0 0.0 0.9 0.3 0.8 1.9 0.9 26.7 1.0 0.7 1.2 0.0 0.0 0.4 1.2 0.6 0.6 1.1 1.5 0.0 0.3 0.0 0.4 0.8 1.7 0.4 0.1 0.0 0.0 0.3 60.1 1.2 0.4 0.0 1.0 0.1 0.0 1.0 1.0 0.3 0.4 1.2 1.2 0.6 0.4 0.6 0.6 2.3 0.2 0.0 0.8 0.7 37.9 22.5 2.1 0.9 0.5 0.4 0.6 0.4 0.7 ZP3 "ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC" ENSG00000188372 "Zona pellucida glycoprotein 3" P21754 7 76397518-76442071 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 78.4;Early spermatids: 45.6;Late spermatids: 89.7;Spermatocytes: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 35.2;hTCEpi: 37.8;Karpas-707: 52.0;MCF7: 71.6;OE19: 30.2" "Not detected" "Not detected" "HPA054061, HPA071198" Supported "Secreted in female reproductive system" NA NA "HPA054061: AB_2682363, HPA071198: " "unprognostic (6.48e-2)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (1.59e-1)" "unprognostic (9.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (3.10e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (6.72e-2)" "unprognostic (2.13e-1)" 1.0 2.9 1.0 0.8 1.7 2.3 3.1 1.2 1.7 1.0 1.6 2.4 2.0 0.8 2.3 4.2 4.0 0.6 0.2 0.9 0.9 0.9 0.8 0.5 0.8 1.2 0.8 0.9 2.9 4.1 0.6 1.2 0.6 1.1 1.4 2.6 0.5 1.5 0.7 1.4 4.1 1.1 1.1 0.8 1.8 1.1 1.3 1.1 0.5 0.8 0.4 0.9 0.7 2.4 1.0 17.6 35.2 0.2 18.4 0.9 1.0 0.9 1.2 2.8 0.3 3.3 1.3 15.2 0.1 0.6 4.6 0.5 4.3 3.8 1.2 0.3 9.5 8.5 2.8 10.5 0.1 8.0 0.7 5.2 1.5 37.8 3.9 1.1 0.1 0.7 9.1 4.0 52.0 0.0 71.6 1.6 9.1 3.8 30.2 10.0 0.1 1.5 3.9 1.6 0.2 7.6 0.0 4.6 23.9 0.6 0.4 15.6 3.0 2.2 0.1 1.8 0.1 0.1 15.4 13.4 0.1 1.5 20.2 3.2 0.6 9.4 0.1 0.1 4.0 0.4 2.4 1.1 0.5 9.6 1.1 4.5 3.2 0.8 0.2 4.5 2.0 0.1 3.1 1.0 1.7 1.2 1.7 0.9 0.9 1.2 0.8 0.9 1.1 0.8 1.1 1.0 2.6 3.2 3.6 1.3 2.9 8.5 5.8 78.4 9.6 1.5 9.3 12.6 0.8 4.3 21.1 1.8 0.0 5.8 2.7 5.3 0.0 2.9 45.6 1.6 1.4 2.8 4.2 3.0 3.3 4.3 3.6 1.9 1.1 3.0 0.0 5.0 2.9 0.8 7.0 1.7 2.7 4.7 6.1 7.2 4.6 89.7 4.4 5.7 3.6 2.8 5.4 4.4 0.0 1.5 1.7 3.3 8.6 5.7 4.2 5.5 0.6 3.7 20.4 2.0 6.6 3.1 2.5 34.9 12.4 9.0 9.9 9.3 2.2 2.7 7.6 17.1 C10orf99 "AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833" ENSG00000188373 "Chromosome 10 open reading frame 99" Q6UWK7 10 84173801-84185294 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 194.8;intestine: 277.5;vagina: 116.2" "Group enriched" "Detected in some" 11 "Distal enterocytes: 853.2;Intestinal goblet cells: 267.6;Paneth cells: 815.9;Proximal enterocytes: 364.8;Undifferentiated cells: 402.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 91.5;head and neck cancer: 102.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 52.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050920 Enhanced "Secreted in other tissues" NA NA "HPA050920: AB_2681274" "unprognostic (3.13e-2)" "unprognostic (1.43e-1)" "unprognostic (6.04e-2)" "unprognostic (1.78e-2)" "unprognostic (7.46e-3)" "unprognostic (2.05e-1)" "unprognostic (7.98e-2)" "unprognostic (2.04e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (3.70e-1)" "unprognostic (4.67e-2)" 0.4 0.0 0.0 17.0 0.0 0.0 0.5 0.0 0.0 22.4 0.0 271.0 0.0 0.6 0.0 194.8 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 277.5 0.1 21.9 2.7 0.0 28.2 21.7 13.2 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.0 17.6 33.8 116.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 6.8 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 853.2 0.0 0.0 0.4 3.3 0.8 0.1 28.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 267.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 815.9 0.0 0.0 1.0 364.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 46.0 2.3 0.0 1.4 0.0 402.8 46.4 H3-5 "H3.5, H3F3C" ENSG00000188375 "H3.5 histone" Q6NXT2 12 31791185-31792298 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 22.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 83.8;Endothelial cells: 16.8;Fibroblasts: 23.8;Smooth muscle cells: 31.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 73.0" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.3" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.82e-1)" "unprognostic (2.80e-4)" "unprognostic (2.60e-2)" "unprognostic (9.21e-2)" "unprognostic (3.77e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "unprognostic (1.45e-1)" "unprognostic (7.56e-2)" "unprognostic (2.39e-1)" "unprognostic (4.06e-2)" "unprognostic (3.53e-2)" "unprognostic (2.73e-3)" "unprognostic (4.02e-2)" "unprognostic (2.99e-2)" "unprognostic (2.80e-2)" "unprognostic (3.86e-2)" 0.5 0.3 0.1 1.1 0.1 3.1 0.5 0.1 0.4 0.5 0.1 0.3 0.5 0.5 0.2 0.6 0.6 0.1 0.3 0.1 0.2 0.3 0.4 0.5 0.4 0.1 0.1 0.1 1.0 0.5 0.1 0.3 0.4 0.1 0.3 0.0 0.7 0.5 0.0 0.4 0.9 0.9 0.1 0.1 1.4 0.6 22.0 0.1 0.0 0.4 0.0 0.7 0.4 0.5 0.1 1.6 0.3 0.7 0.3 0.1 0.0 0.5 0.2 0.1 0.4 0.1 0.5 0.6 0.2 0.6 0.0 0.3 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 1.2 1.6 0.3 0.1 0.0 0.8 0.3 1.0 0.1 0.2 1.2 2.3 0.0 0.9 2.0 0.2 0.5 1.5 0.1 0.8 1.5 0.5 2.0 1.1 0.4 0.6 0.7 0.7 0.7 36.7 14.5 41.6 10.2 15.5 9.1 16.0 10.3 10.1 13.2 13.2 10.9 10.4 73.0 15.0 14.0 12.7 14.0 40.9 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 2.7 23.8 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 IFNA2 "IFN-alphaA, IFNA" ENSG00000188379 "Interferon alpha 2" P01563 9 21384255-21385398 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "brain: 1.3" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 2.5;Granulosa cells: 1.7;Oligodendrocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA 253000 "HPA047557: AB_2680087" 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.7 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.1 0.7 0.5 0.5 0.7 0.6 0.4 0.9 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JAKMIP3 "bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2" ENSG00000188385 "Janus kinase and microtubule interacting protein 3" Q5VZ66 10 132036336-132184858 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 20.2" "Cell type enhanced" "Detected in some" "Astrocytes: 14.4;Excitatory neurons: 39.4;Inhibitory neurons: 32.3;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 92.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.0;RPMI-8226: 2.0;U-266/84: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022872 Uncertain NA NA "HPA022872: AB_2249331" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (4.55e-3)" "unprognostic (8.90e-2)" "unprognostic (2.72e-1)" "unprognostic (9.39e-2)" "unprognostic (2.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.22e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-5)" "unprognostic (1.55e-2)" "unprognostic (5.71e-6)" "unprognostic (1.43e-1)" "unprognostic (2.11e-1)" "unprognostic (7.19e-4)" "unprognostic (1.59e-2)" 0.1 1.0 2.3 0.1 4.2 0.1 0.2 1.7 5.0 0.3 0.0 0.4 0.1 0.6 0.2 0.2 0.5 0.4 0.6 1.2 2.7 0.0 0.0 0.1 0.0 8.6 4.5 0.9 1.7 0.4 0.1 3.1 0.0 10.4 1.5 0.1 0.7 0.3 0.5 1.4 0.1 0.2 0.4 3.7 0.1 0.2 0.7 4.8 0.1 0.3 0.1 0.0 0.5 0.3 20.2 0.0 3.0 0.1 1.4 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.1 1.1 0.1 1.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.9 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 8.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.2 1.7 5.0 1.2 2.7 8.6 4.5 0.9 10.4 3.7 4.8 20.2 0.2 0.0 0.0 14.4 0.0 0.0 0.2 0.0 0.0 3.7 0.4 0.4 6.2 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.3 0.6 0.0 0.0 39.4 0.2 0.0 1.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 3.3 32.3 0.1 0.0 0.3 0.0 0.8 2.1 0.1 0.0 3.7 0.1 1.4 1.0 27.2 92.8 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.5 0.0 2.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 1.3 0.0 0.0 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591604-101595021 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 153 "testis: 81.5" "Group enriched" "Detected in some" 38 "Early spermatids: 399.2;Late spermatids: 198.3;Spermatocytes: 600.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047157: AB_2679960" "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 81.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.2 0.1 0.3 0.2 0.3 0.5 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 399.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.3 10.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.2 600.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDCD1 "CD279, hSLE1, PD-1, PD1, SLEB2" ENSG00000188389 "Programmed cell death 1" Q15116 2 241849884-241858894 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.2" "Group enriched" "Detected in some" 4 "Plasma cells: 9.5;T-cells: 34.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.3" "Group enriched" "Detected in many" 5 "gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3" "Lineage enriched" "Detected in single" 55 "T-cells: 12.4" "Cell line enhanced" "Detected in some" "JURKAT: 1.5;MOLT-4: 2.4;RPMI-8226: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035981, CAB038418, CAB076386" Enhanced NA NA "CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664" "unprognostic (2.90e-3)" "unprognostic (4.50e-3)" "unprognostic (7.78e-2)" "prognostic favorable (9.44e-5)" "unprognostic (7.18e-3)" "unprognostic (1.31e-3)" "unprognostic (3.83e-2)" "unprognostic (7.33e-2)" "unprognostic (5.82e-3)" "unprognostic (3.75e-2)" "unprognostic (6.57e-2)" "unprognostic (3.94e-1)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (5.06e-3)" 0.9 0.3 0.1 3.2 0.1 0.9 0.4 0.0 0.2 0.5 0.2 0.6 0.3 0.4 0.0 0.8 0.6 0.3 4.6 0.1 0.3 0.7 0.4 1.8 16.2 0.1 1.3 0.0 0.2 0.3 0.0 1.5 0.0 0.2 0.7 0.1 0.0 1.0 0.2 0.1 0.2 3.9 0.2 0.2 7.0 1.9 0.3 0.3 3.2 1.5 0.0 4.0 1.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.8 0.2 8.7 12.4 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 4.3 2.1 0.1 0.1 0.0 0.2 0.1 0.3 0.1 1.3 0.0 0.2 0.2 0.3 0.2 0.4 0.0 0.6 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.6 0.0 34.7 0.0 0.0 0.1 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932370 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "skin 1: 58.0" "Group enriched" "Detected in some" 11 "Basal keratinocytes: 18.7;Suprabasal keratinocytes: 37.1" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 22.0;U-937: 54.6" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA048530: AB_2680429, HPA072407: AB_2686518" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 3.6 1.9 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.2 58.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.9 0.2 0.1 0.3 0.4 0.2 0.0 0.9 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 37.1 0.0 0.1 0.0 0.0 0.1 GPR21 ENSG00000188394 "G protein-coupled receptor 21" Q99679 9 123033667-123035665 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041651 Uncertain NA NA "HPA041651: AB_10794673" "unprognostic (9.22e-3)" "unprognostic (1.46e-1)" 0.6 0.0 0.0 0.5 0.7 0.1 0.3 0.0 1.5 0.6 0.0 0.2 0.1 0.9 0.2 0.5 0.4 0.5 0.3 0.5 0.2 0.2 0.0 0.2 0.9 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.8 0.6 0.1 0.5 0.4 0.1 0.2 0.1 0.2 0.1 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.5 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCTEX1D4 ENSG00000188396 "Tctex1 domain containing 4" Q5JR98 1 44805893-44807351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 17.8;fallopian tube: 10.3" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 94.5;Respiratory ciliated cells: 129.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "neutrophil: 7.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.9" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.7;TIME: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA062652 Enhanced NA NA "HPA062652: AB_2684818" "unprognostic (3.12e-1)" "unprognostic (3.13e-1)" "unprognostic (1.81e-1)" "prognostic favorable (1.58e-4)" "unprognostic (5.28e-2)" "unprognostic (3.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.26e-1)" "unprognostic (3.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.26e-2)" "unprognostic (4.92e-2)" "unprognostic (4.70e-3)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.83e-3)" 0.7 2.0 2.1 1.2 1.5 2.5 0.4 1.7 2.2 0.8 17.8 0.3 0.4 1.4 2.2 0.7 10.3 1.8 0.6 0.9 4.8 0.6 0.6 2.8 0.3 4.9 3.2 0.3 0.4 0.9 0.4 0.9 0.1 2.5 0.3 0.2 0.0 1.1 0.3 0.4 0.5 0.5 0.1 3.3 0.4 1.0 0.4 3.3 0.0 0.9 0.2 0.0 0.4 0.3 4.0 0.5 0.9 0.3 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.7 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 1.1 0.0 0.1 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.5 0.9 0.0 0.0 1.8 0.1 0.7 0.2 0.3 0.7 0.4 0.0 0.2 0.2 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.2 2.1 1.5 1.7 2.2 0.9 4.8 4.9 3.2 0.3 2.5 3.3 3.3 4.0 0.2 0.0 0.5 0.0 0.3 0.3 0.4 11.4 0.0 0.0 0.6 0.8 0.2 1.5 10.6 1.8 0.0 0.2 0.1 0.9 0.0 1.2 0.0 94.5 0.9 0.4 0.0 0.0 0.0 4.0 0.2 0.4 0.0 1.5 0.0 0.2 0.0 1.2 0.8 0.0 0.0 1.7 10.2 1.2 0.9 0.1 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 2.4 0.0 0.0 0.4 2.3 1.3 129.4 0.0 0.0 0.8 3.8 0.1 0.6 0.0 0.0 0.3 0.3 0.5 0.6 0.5 IGHV1OR15-9 "IGHV1/OR15-9, IGHV1OR159, VSIG7" ENSG00000188403 "Immunoglobulin heavy variable 1/OR15-9 (non-functional)" 15 19964666-19965101 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "breast: 4.1;intestine: 8.6;lymphoid tissue: 8.7;stomach 1: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "lung cancer: 5.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "prognostic favorable (1.79e-4)" "unprognostic (8.93e-2)" "unprognostic (2.97e-3)" "unprognostic (9.34e-2)" "prognostic favorable (6.84e-4)" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (3.79e-1)" "unprognostic (1.07e-4)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (2.66e-1)" "unprognostic (2.11e-1)" 0.0 0.0 0.0 8.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 8.6 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 8.3 0.0 0.0 1.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690665-169711702 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 151.8;lymphoid tissue: 233.3" "Group enriched" "Detected in many" 5 "B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 4700000000 Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 29.6 2.3 2.9 119.9 4.3 151.8 2.6 8.5 5.5 3.7 5.3 6.8 3.2 2.6 1.7 5.6 4.8 24.3 3.2 3.3 10.5 3.0 12.2 19.6 233.3 6.6 4.8 2.5 1.0 3.7 28.2 14.0 11.3 6.0 3.7 7.2 1.1 3.8 1.9 3.4 0.6 17.2 14.6 6.1 168.2 5.6 1.1 5.0 133.4 2.8 13.7 203.7 38.2 1.4 8.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.7 0.0 0.3 11.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 7.7 1.3 0.5 0.0 0.0 0.0 0.0 1.8 29.4 0.1 1.4 0.0 1.8 21.2 0.3 0.1 0.4 0.3 7.8 0.2 0.7 6.1 0.3 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.0 0.0 0.6 0.2 0.0 0.0 38.8 0.0 19.4 2.0 11.1 0.3 3688.4 992.6 1696.7 284.3 211.6 78.1 613.0 528.9 294.2 756.3 734.4 1169.2 683.6 4201.4 2551.1 93.1 622.9 1011.2 2052.5 2.9 4.3 8.5 5.5 3.3 10.5 6.6 4.8 2.5 6.0 6.1 5.0 8.1 1.8 9.6 13.7 0.7 221.4 0.4 0.3 0.0 0.6 0.1 0.5 0.3 0.6 2.8 1.8 11.0 0.0 13.9 206.0 0.1 0.0 0.2 0.0 0.1 0.0 3.4 0.0 25.2 0.2 0.0 0.6 3.3 2.6 0.1 10.1 0.5 3.9 1.1 5.6 0.0 0.1 0.1 0.0 68.9 2.7 0.2 0.6 86.3 1.8 1.0 208.7 2.5 110.2 0.0 0.8 0.1 0.0 0.0 25.8 0.0 0.0 0.9 1.5 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.1 28.5 104.9 0.5 0.0 0.6 MAGEB5 "CT3.3, MAGE-B5" ENSG00000188408 "MAGE family member B5" Q9BZ81 X 26216169-26218270 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Early spermatids: 6.0;Late spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052627 Uncertain NA NA "HPA052627: AB_2681890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHM "DXS540, REP-1, TCD" ENSG00000188419 "CHM Rab escort protein" P24386 X 85861180-86047561 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003231, CAB016171" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB016171: AB_2229397, HPA003231: AB_1078518" "unprognostic (6.50e-3)" "unprognostic (1.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.40e-1)" "unprognostic (6.20e-3)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-2)" "unprognostic (6.15e-2)" "unprognostic (2.44e-1)" "unprognostic (7.60e-3)" 9.4 11.2 2.6 7.3 3.6 2.4 7.8 2.8 4.4 9.3 3.3 6.1 4.7 8.9 4.7 6.7 11.1 7.3 7.2 3.8 2.4 12.2 7.8 7.1 7.2 2.9 2.3 2.7 7.9 5.9 14.3 3.8 9.6 3.3 7.7 6.5 9.4 5.7 7.1 6.4 4.2 4.7 8.8 0.7 8.2 7.3 4.6 3.6 8.6 11.0 10.6 6.4 7.7 3.5 3.2 16.8 10.9 10.9 7.2 17.4 18.4 6.9 19.3 16.2 13.2 14.4 8.8 15.0 5.7 24.3 14.0 46.1 9.4 23.9 10.9 22.5 10.9 11.4 3.4 14.6 8.4 13.8 14.3 23.8 14.1 10.1 21.4 26.9 14.6 22.9 9.4 11.9 19.0 20.7 4.8 8.8 5.2 16.2 11.6 17.5 9.0 19.5 8.8 12.2 9.5 9.6 14.8 23.3 7.1 18.3 14.9 6.0 6.7 16.4 16.7 11.0 59.0 9.7 7.2 27.7 7.9 18.0 11.9 14.9 2.2 1.9 0.9 1.6 2.3 1.5 1.8 1.3 1.7 1.5 2.1 1.7 1.8 1.0 1.6 1.9 1.4 1.7 1.2 2.6 3.6 2.8 4.4 3.8 2.4 2.9 2.3 2.7 3.3 0.7 3.6 3.2 34.5 3.2 11.0 33.6 22.3 6.9 17.6 18.9 15.9 35.2 14.2 10.3 11.9 15.7 15.9 16.5 8.4 9.6 26.5 10.2 19.6 16.3 0.7 13.8 29.5 22.2 18.7 12.6 82.5 12.4 9.6 21.6 15.3 18.4 16.5 18.2 14.6 12.5 15.5 23.5 94.7 11.8 10.2 23.0 9.1 2.1 15.5 21.4 5.4 52.5 19.6 27.5 18.6 78.4 76.5 15.7 11.4 12.4 17.3 18.9 7.5 35.2 17.7 20.9 46.0 28.0 27.8 3.7 12.2 12.8 7.4 18.3 22.1 28.7 9.4 15.6 NANOS2 "NOS2, ZC2HC12B" ENSG00000188425 "Nanos C2HC-type zinc finger 2" P60321 19 45913214-45914778 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 3.6" "Cell type enriched" "Detected in single" 16 "Spermatogonia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014190 Approved NA NA "HPA014190: AB_2668950" "unprognostic (2.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.69e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.6 0.4 0.3 0.5 0.3 0.2 0.6 0.3 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLOC1S5 "dJ303A1.3, MU, MUTED" ENSG00000188428 "Biogenesis of lysosomal organelles complex 1 subunit 5" Q8TDH9 6 8013567-8064396 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025613, HPA077525" Uncertain Supported Vesicles NA NA Vesicles "CAB025613: , HPA077525: AB_2686843" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.12e-4)" "unprognostic (4.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.47e-2)" "unprognostic (2.87e-2)" "unprognostic (1.00e-1)" "unprognostic (1.62e-3)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.16e-2)" "unprognostic (7.60e-3)" 6.3 7.1 3.7 6.4 4.2 3.9 10.6 4.0 4.7 8.1 3.7 6.5 4.3 7.1 7.0 6.7 6.5 6.1 6.0 3.4 4.9 15.8 11.5 6.0 10.0 4.4 4.2 2.9 9.9 4.8 9.7 3.1 6.9 4.3 6.5 5.9 5.2 4.7 9.2 6.5 6.4 5.0 6.7 4.3 7.4 6.1 3.7 4.1 15.7 10.2 8.7 10.7 6.3 5.3 4.7 6.1 7.0 14.7 18.9 15.7 18.8 9.6 6.7 9.4 9.5 9.4 13.6 5.8 21.8 43.9 8.6 10.8 5.4 10.8 5.4 13.6 20.6 11.5 13.1 4.8 25.8 13.4 23.2 14.8 8.4 13.4 9.6 14.4 14.5 17.3 17.3 27.7 3.9 13.6 6.7 26.6 15.1 7.9 14.3 9.4 21.5 17.0 33.8 17.6 5.4 13.5 7.2 6.8 10.3 21.3 26.4 12.9 11.8 7.2 15.1 10.7 8.9 5.9 16.5 37.3 19.7 6.2 17.9 15.9 16.2 9.4 18.3 11.8 12.3 15.7 18.9 15.3 15.2 16.6 17.7 15.2 15.9 2.3 19.6 6.7 7.2 15.2 11.8 3.7 4.2 4.0 4.7 3.4 4.9 4.4 4.2 2.9 4.3 4.3 4.1 4.7 18.1 12.8 6.9 0.0 14.6 6.0 8.3 6.8 8.6 7.0 7.1 9.9 7.3 0.0 7.9 25.8 2.1 12.5 15.6 5.9 35.2 9.9 7.5 11.5 12.4 10.7 1.8 7.2 0.0 8.7 9.2 10.6 7.7 19.5 16.5 14.5 0.0 0.0 7.8 6.7 0.0 6.9 2.0 0.0 6.1 7.8 9.6 11.0 3.6 0.0 10.7 13.2 12.3 0.0 0.0 10.1 3.9 12.4 7.3 8.4 6.7 41.8 7.7 8.4 0.0 12.4 9.3 5.8 14.4 8.9 7.5 8.2 12.7 22.5 6.6 7.5 CERKL RP26 ENSG00000188452 "Ceramide kinase like" Q49MI3 2 181536672-181680665 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.3;retina: 16.8" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 43.5;Proximal tubular cells: 13.4;Respiratory ciliated cells: 38.7;Rod photoreceptor cells: 22.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 10.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 28 "SCLC-21H: 58.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.5" "HPA035443, HPA035444, HPA043203" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: " "unprognostic (7.52e-3)" "unprognostic (6.13e-3)" "unprognostic (2.09e-1)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (2.71e-3)" "unprognostic (2.59e-1)" "unprognostic (1.39e-2)" "unprognostic (2.76e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.25e-4)" "unprognostic (4.54e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (3.07e-2)" "unprognostic (8.45e-2)" 1.2 0.5 1.5 0.2 0.7 0.0 1.0 10.0 0.5 2.8 4.8 1.8 0.2 0.9 0.3 0.5 7.8 0.8 0.4 0.8 2.6 8.1 1.3 5.1 0.9 1.4 2.0 0.2 0.3 0.7 0.6 0.7 0.1 3.5 1.0 0.3 16.8 1.0 0.2 0.4 0.4 6.9 0.2 2.1 17.3 1.2 0.5 0.5 0.4 0.9 0.3 2.0 1.3 1.2 1.8 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.4 0.0 0.3 0.2 0.0 0.3 2.0 0.0 0.4 0.3 0.4 0.0 0.0 0.6 0.5 0.1 0.3 0.6 0.0 0.5 0.9 0.3 0.7 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.8 0.4 0.0 0.4 1.2 0.0 0.0 0.9 0.0 58.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.8 0.0 0.0 0.3 0.0 0.0 0.9 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.7 10.0 0.5 0.8 2.6 1.4 2.0 0.2 3.5 2.1 0.5 1.8 0.0 3.2 0.5 0.3 0.0 0.0 0.1 1.0 0.0 0.5 0.0 0.0 0.7 1.5 4.9 0.0 18.8 0.0 1.5 0.0 9.8 0.0 4.6 43.5 0.7 0.3 1.8 0.0 6.8 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 2.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.1 2.5 0.0 0.5 0.2 0.0 0.0 0.0 0.4 0.0 2.7 13.4 38.7 22.8 0.0 0.2 0.5 0.4 0.9 0.0 0.0 0.0 0.6 0.0 1.2 0.0 SLC24A5 "JSX, OCA6" ENSG00000188467 "Solute carrier family 24 member 5" Q71RS6 15 48120990-48142672 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" Albinism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 8.3" "Group enriched" "Detected in some" 7 "Early spermatids: 20.7;Melanocytes: 76.5" "Cancer enriched" "Detected in single" 162 "melanoma: 8.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 800 "SK-MEL-30: 251.8" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.0;pons and medulla: 4.1;thalamus: 1.5" "Low region specificity" "Detected in all" NA NA "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.1 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 251.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.1 0.5 0.3 1.2 0.0 0.3 0.1 0.8 0.2 0.3 0.0 0.5 0.7 0.2 2.4 0.0 0.0 0.0 6.4 0.0 0.1 0.3 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 20.7 1.5 0.1 0.1 0.0 0.4 2.9 0.0 0.0 0.5 0.0 0.9 0.0 0.1 0.0 0.0 0.1 5.0 2.7 0.0 0.0 0.0 0.7 6.6 0.0 0.0 76.5 1.0 0.0 0.9 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 4.6 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 177.5;Breast myoepithelial cells: 110.2;dendritic cells: 121.9;Endometrial stromal cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 24.7;SiHa: 34.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 16.0 10.7 5.4 1.2 4.4 0.4 10.8 3.3 7.3 36.7 2.0 8.3 0.8 14.0 2.1 9.5 16.7 1.9 17.5 5.0 7.6 21.5 14.7 13.2 0.7 6.1 3.4 2.8 19.0 4.8 0.6 10.8 1.4 3.8 12.4 0.4 0.5 7.6 3.3 3.5 7.4 5.7 1.0 3.2 6.4 9.2 4.7 4.4 0.3 12.5 0.9 0.3 16.3 19.7 9.5 8.6 24.7 6.9 13.3 5.0 7.9 20.9 12.6 1.1 1.9 1.9 1.3 13.8 0.2 4.9 2.9 5.5 18.6 0.3 1.5 0.3 1.2 1.8 0.0 5.7 2.4 3.8 0.3 0.2 8.6 1.9 1.4 0.2 10.8 0.9 0.2 0.7 4.4 0.3 22.1 0.3 1.1 0.6 2.2 12.9 1.2 0.5 3.8 7.6 1.2 3.1 4.1 34.8 11.1 15.7 2.8 3.4 2.2 5.1 11.7 7.0 7.9 18.3 2.4 1.7 0.3 14.9 2.5 5.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.4 4.4 3.3 7.3 5.0 7.6 6.1 3.4 2.8 3.8 3.2 4.4 9.5 177.5 16.0 1.7 12.7 25.5 6.8 9.2 11.1 27.9 6.1 52.7 110.2 1.6 25.8 10.7 47.8 0.0 3.9 121.9 34.7 9.8 14.5 0.7 87.1 218.9 42.6 10.7 0.8 13.1 27.1 11.8 41.4 19.9 102.7 0.0 2.2 30.0 11.7 31.0 3.3 4.3 20.6 26.4 17.0 17.2 1.6 10.8 64.7 14.2 15.0 7.4 13.9 0.0 2.0 1.4 20.0 12.5 7.2 11.2 9.8 8.4 17.3 13.4 2.8 26.3 41.8 99.0 0.1 3.6 37.6 4.5 8.1 55.1 3.9 15.4 7.7 H2AX H2AFX ENSG00000188486 "H2A.X variant histone" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes Yes Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 9.9 20.9 34.1 12.7 31.9 25.1 8.1 34.2 42.5 12.0 17.1 14.5 13.4 14.1 2.1 43.9 13.3 3.1 11.8 29.3 29.8 13.4 14.0 14.4 16.1 39.1 34.4 24.5 18.8 11.7 3.4 24.5 11.1 37.1 15.8 4.4 6.7 11.5 4.8 12.5 15.9 19.0 3.5 36.8 24.2 16.3 15.5 31.6 30.8 10.5 3.6 12.1 11.9 15.8 47.7 132.1 77.9 120.3 72.3 10.9 7.9 126.4 146.0 44.0 80.3 70.4 124.0 55.1 89.7 85.9 34.0 60.5 134.0 57.5 41.7 21.5 133.4 161.0 182.2 20.7 129.8 11.4 90.5 108.9 6.7 9.0 34.2 21.0 13.1 40.7 115.4 149.9 143.1 38.9 335.6 207.8 269.9 87.5 60.0 162.6 200.7 141.6 42.7 37.5 56.3 127.6 152.0 116.0 66.6 20.6 20.6 99.8 68.2 50.9 77.7 204.2 63.8 110.2 38.7 40.8 92.3 17.9 145.2 155.0 3.8 1.3 4.2 1.6 0.6 0.8 0.9 1.7 1.7 1.8 0.8 1.1 1.0 0.6 2.2 0.8 0.8 1.6 1.2 34.1 31.9 34.2 42.5 29.3 29.8 39.1 34.4 24.5 37.1 36.8 31.6 47.7 43.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 83.2 34.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 106.6 9.4 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 64.2 7.2 0.0 0.0 0.0 INSC ENSG00000188487 "INSC spindle orientation adaptor protein" Q1MX18 11 15112424-15247208 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "parathyroid gland: 25.5" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Early spermatids: 4.6;Exocrine glandular cells: 3.1;Oligodendrocyte precursor cells: 8.0;Pancreatic endocrine cells: 10.9;Proximal tubular cells: 8.9" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;hTERT-HME1: 6.0;Karpas-707: 3.3;LHCN-M2: 3.6;TIME: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039769 Uncertain NA NA "HPA039769: AB_10697556" "unprognostic (1.64e-2)" "unprognostic (6.54e-2)" "unprognostic (1.45e-3)" "unprognostic (1.59e-1)" "unprognostic (6.00e-2)" "unprognostic (4.59e-3)" "unprognostic (6.88e-2)" "unprognostic (3.44e-3)" "unprognostic (3.69e-1)" "unprognostic (3.59e-2)" "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (3.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-2)" "unprognostic (5.00e-2)" 0.2 0.8 0.1 1.0 0.1 0.6 0.2 0.0 0.2 1.1 0.1 4.0 2.1 0.1 0.1 0.5 0.3 0.6 0.8 0.1 0.2 0.3 0.2 0.9 0.0 0.3 0.1 0.1 0.1 0.9 25.5 0.2 0.0 0.2 1.1 1.8 0.0 0.5 1.0 0.0 0.1 3.0 0.5 0.1 0.1 2.5 0.7 0.1 0.2 0.3 0.1 0.0 0.8 0.8 0.2 0.0 0.0 0.0 0.0 0.3 11.7 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.6 6.0 0.0 0.0 0.0 0.0 3.3 3.6 0.0 0.0 0.2 0.0 0.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 1.0 0.0 0.0 1.5 0.2 0.0 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.1 4.6 0.2 0.0 0.1 1.8 0.0 0.5 3.1 0.0 0.9 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 0.0 10.9 0.0 0.0 0.1 0.2 0.0 8.9 0.0 0.0 0.0 0.0 1.1 1.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 SERPINA5 "PAI3, PCI, PLANH3, PROCI" ENSG00000188488 "Serpin family A member 5" P05154 14 94561442-94593118 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Fertilization, Lipid transport, Transport" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 488.5;liver: 792.0;testis: 436.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 400.4;Endometrial ciliated cells: 175.2;Glandular and luminal cells: 345.3;Hepatocytes: 198.2;Late spermatids: 277.8;Peritubular cells: 144.4" "Cancer enhanced" "Detected in many" "liver cancer: 121.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 261.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA078846 Enhanced "Secreted to blood" NA NA 2100000000 "HPA078846: " "unprognostic (5.94e-3)" "unprognostic (2.64e-4)" "unprognostic (1.13e-1)" "prognostic favorable (7.72e-4)" "unprognostic (3.34e-3)" "unprognostic (6.10e-3)" "unprognostic (3.94e-2)" "unprognostic (1.39e-3)" "unprognostic (5.36e-1)" "unprognostic (1.50e-1)" "unprognostic (6.16e-2)" "unprognostic (1.87e-2)" "unprognostic (8.39e-3)" "unprognostic (3.38e-3)" "unprognostic (9.92e-2)" "unprognostic (8.08e-2)" "unprognostic (3.23e-1)" 4.8 488.5 2.2 3.4 2.2 0.0 19.8 2.6 1.7 29.8 3.6 4.7 5.5 32.1 1.2 0.8 26.5 162.0 11.3 1.6 13.5 152.8 792.0 1.0 3.7 3.5 3.6 0.9 30.3 175.4 0.2 3.2 0.1 6.2 6.9 1.9 14.1 9.5 154.7 46.9 3.2 3.6 2.1 2.1 113.1 12.2 436.4 4.0 0.9 4.2 153.9 4.8 2.4 4.0 4.0 0.8 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 12.0 12.2 0.0 8.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 261.3 0.3 0.4 0.0 1.7 0.3 0.1 0.0 2.3 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.0 0.1 0.5 0.2 3.9 0.1 0.4 17.4 0.2 0.1 7.9 0.9 0.1 0.0 0.5 0.0 0.6 0.4 1.5 0.2 0.1 0.2 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.2 2.6 1.7 1.6 13.5 3.5 3.6 0.9 6.2 2.1 4.0 4.0 0.9 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.2 18.9 14.1 0.8 400.4 0.1 33.1 2.1 0.0 0.1 0.0 64.6 103.2 78.7 175.2 19.7 40.3 0.0 2.7 0.0 122.2 0.0 18.2 0.5 345.3 0.0 78.2 2.5 198.2 0.0 8.4 0.0 0.0 0.0 3.2 0.7 277.8 57.2 1.9 0.0 0.0 0.6 5.4 0.0 0.0 0.2 18.3 0.0 144.4 0.0 0.1 0.0 7.5 0.0 1.4 6.6 11.6 1.5 11.1 2.9 0.0 0.6 0.3 1.8 58.7 0.0 0.1 C19orf54 FLJ41131 ENSG00000188493 "Chromosome 19 open reading frame 54" Q5BKX5 19 40740856-40751553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059043, HPA059628" Approved Approved "Intermediate filaments,Centriolar satellite" NA NA "Intermediate filaments" "Centriolar satellite" "HPA059043: AB_2683886, HPA059628: AB_2684087" "unprognostic (3.18e-3)" "unprognostic (2.09e-2)" "unprognostic (5.19e-2)" "unprognostic (7.21e-2)" "unprognostic (8.44e-2)" "unprognostic (1.22e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-1)" "unprognostic (3.00e-2)" "unprognostic (3.16e-1)" "unprognostic (2.70e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "unprognostic (1.03e-2)" "unprognostic (6.33e-2)" 5.8 10.2 6.9 7.0 7.5 6.0 5.8 7.6 6.6 4.7 6.9 7.2 10.6 5.2 6.5 6.1 4.9 6.2 6.1 6.0 6.4 8.1 15.5 8.8 5.5 8.6 7.4 5.2 3.9 8.7 5.8 4.7 4.8 7.9 6.2 7.1 5.3 5.6 4.5 15.5 5.8 10.8 4.1 7.2 9.8 7.5 8.5 7.0 5.5 7.9 10.4 6.1 6.3 5.0 9.1 7.6 16.6 13.9 12.4 7.4 10.0 10.2 5.4 7.0 9.5 8.9 11.3 11.3 16.5 13.6 6.4 4.7 12.0 23.0 9.2 7.8 11.5 20.7 10.3 24.4 14.3 22.5 7.1 8.8 15.2 4.8 9.3 19.9 11.7 5.7 22.1 13.3 22.8 6.7 9.0 10.0 8.2 10.5 17.4 6.0 18.9 14.2 14.3 9.6 14.5 11.3 7.0 19.5 8.1 8.4 15.3 8.4 9.6 4.8 11.7 11.7 6.1 3.7 25.6 18.9 13.0 11.3 15.4 8.3 0.4 4.5 1.3 1.3 3.8 0.5 1.2 1.1 0.7 5.7 0.9 1.1 1.0 1.0 0.8 5.1 3.5 1.9 1.9 6.9 7.5 7.6 6.6 6.0 6.4 8.6 7.4 5.2 7.9 7.2 7.0 9.1 2.9 3.2 8.9 6.2 2.9 1.7 3.7 3.3 5.2 1.6 4.2 3.0 8.0 2.8 1.2 5.5 2.1 7.9 2.5 5.5 3.9 3.4 6.7 3.3 3.7 3.5 1.2 4.6 0.4 2.5 6.6 2.3 7.7 3.1 0.0 4.1 1.8 6.4 8.4 0.0 0.7 5.0 4.1 10.7 1.6 2.9 2.5 7.2 0.0 1.0 8.2 2.2 1.0 1.5 3.4 2.0 4.8 1.2 5.4 2.4 12.3 6.7 2.9 3.8 0.0 1.9 2.3 17.8 12.0 4.4 1.7 5.6 2.8 6.1 5.5 2.8 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Early spermatids: 5.8;Late spermatids: 9.0" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;hTERT-RPE1: 6.7;NTERA-2: 5.2;SuSa: 6.0;U-2 OS: 14.3;U-251 MG: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" NA NA "Plasma membrane" "Endoplasmic reticulum" "HPA071640: AB_2686428" "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.0 0.1 1.4 0.2 1.6 0.4 0.1 1.3 1.5 0.1 1.0 0.2 0.2 0.1 0.1 0.1 0.0 0.2 0.0 1.3 1.7 0.0 0.1 0.0 0.2 2.1 1.4 1.2 0.1 0.1 0.0 0.1 0.0 1.6 0.1 0.0 0.3 0.1 0.0 0.7 0.5 0.1 0.0 1.7 0.1 0.1 0.3 1.3 0.0 0.1 0.0 0.0 0.0 0.1 2.7 0.3 0.2 2.8 0.2 0.1 0.1 0.7 0.7 0.0 0.0 0.3 0.3 0.4 0.4 5.6 0.2 0.5 0.6 0.0 0.0 0.1 0.2 0.1 0.7 0.9 1.4 0.0 0.2 0.3 0.3 0.0 0.3 0.0 6.7 0.0 0.2 0.3 0.3 0.1 0.1 0.2 0.4 5.2 0.4 0.1 0.2 3.1 0.3 0.0 0.3 0.3 0.2 0.1 0.3 1.6 6.0 0.4 0.5 0.2 1.4 14.3 0.5 6.4 0.1 0.2 0.2 1.9 0.6 2.7 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.0 1.4 1.6 1.3 1.5 1.3 1.7 2.1 1.4 1.2 1.6 1.7 1.3 2.7 0.0 0.0 0.0 2.9 0.7 0.4 0.6 0.0 0.0 0.6 0.1 0.1 0.3 1.5 0.1 0.0 0.0 0.1 0.6 0.2 0.0 0.1 5.8 0.2 0.3 0.2 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.3 9.0 0.6 0.1 0.0 0.0 0.0 1.4 2.1 0.5 1.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.4 0.0 0.6 0.4 1.6 2.1 0.0 0.3 0.3 0.9 0.3 0.1 0.4 NCCRP1 "FBXO50, LOC342897, NCCRP-1" ENSG00000188505 "NCCRP1, F-box associated domain containing" Q6ZVX7 19 39196964-39201884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 457.0;lymphoid tissue: 126.0;skin 1: 257.3;vagina: 183.2" "Cell type enriched" "Detected in some" 12 "monocytes: 563.9" "Group enriched" "Detected in many" 4 "cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 30.8" "Region enhanced" "Detected in single" "olfactory bulb: 1.6" "Low region specificity" "Detected in some" HPA052812 Approved NA NA 400000 "HPA052812: AB_2681960" "unprognostic (3.56e-3)" "unprognostic (3.69e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.59e-3)" "unprognostic (3.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.37e-3)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (2.04e-2)" "unprognostic (1.90e-1)" "unprognostic (6.37e-6)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" 0.3 0.2 1.8 2.1 1.1 1.0 6.3 1.8 1.9 46.5 0.0 0.4 2.0 0.6 0.8 457.0 1.1 0.8 0.4 1.2 1.0 2.8 0.2 0.4 2.8 1.2 1.1 0.8 0.4 8.9 1.4 0.4 1.1 1.6 1.4 1.9 1.7 54.4 1.2 0.9 257.3 0.7 0.5 0.9 1.4 0.5 0.5 1.1 4.2 0.6 0.0 126.0 5.2 183.2 1.6 0.2 0.2 1.1 0.2 0.1 0.7 2.4 0.1 0.0 0.1 0.2 0.5 0.5 0.7 2.3 0.4 0.2 1.0 1.7 0.7 0.5 0.0 0.4 0.2 0.9 0.1 0.2 0.5 0.3 0.5 0.5 0.1 0.3 0.3 0.3 0.5 0.4 0.2 0.3 0.1 0.2 0.2 0.7 0.2 0.2 0.2 0.4 0.4 0.1 0.6 0.6 1.0 2.9 30.8 0.2 0.9 0.4 0.9 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.6 0.6 0.2 0.5 1.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 1.8 1.1 1.8 1.9 1.2 1.0 1.2 1.1 0.8 1.6 0.9 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.6 1.6 8.5 0.0 0.3 4.7 2.4 0.3 0.0 30.8 3.7 0.0 0.4 0.2 0.1 0.0 2.7 0.0 0.7 0.4 0.2 0.0 0.0 0.0 2.3 3.1 1.0 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 6.1 0.0 4.7 0.2 0.0 0.7 1.8 0.0 563.9 0.3 0.0 0.0 0.0 4.2 0.7 0.0 1.2 1.1 0.0 0.1 1.6 0.0 0.0 0.1 2.0 0.1 0.5 7.3 7.1 11.1 0.2 0.1 0.0 46.4 KRTDAP "KDAP, UNQ467" ENSG00000188508 "Keratinocyte differentiation associated protein" P60985 19 35487324-35495558 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skin 1: 5823.9;vagina: 1749.8" "Cell type enriched" "Detected in some" 15 "Suprabasal keratinocytes: 5277.0" "Group enriched" "Detected in many" 7 "head and neck cancer: 486.4;melanoma: 207.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 56 "hTCEpi: 100.2" "Region enriched" "Detected in single" 6 "white matter: 1.6" "Not detected" "Not detected" HPA063474 Enhanced "Secreted in other tissues" NA NA 34000000 "HPA063474: AB_2685019" "unprognostic (4.55e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-1)" "unprognostic (6.11e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (3.80e-2)" "unprognostic (1.50e-1)" "unprognostic (2.76e-1)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (1.16e-2)" 3.8 1.0 1.0 0.0 1.4 1.8 411.0 0.9 1.9 404.4 0.9 1.5 0.1 0.8 0.7 111.9 1.4 0.0 2.3 0.9 0.9 0.8 3.1 1.7 0.0 1.1 0.9 0.8 1.7 3.4 0.7 1.3 0.0 1.3 1.6 0.0 0.1 206.9 0.3 22.7 5823.9 1.3 0.1 0.9 0.8 1.5 3.3 0.9 20.2 2.5 0.3 90.9 0.7 1749.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.2 0.0 0.0 0.4 100.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.9 1.9 0.9 0.9 1.1 0.9 0.8 1.3 0.9 0.9 0.9 0.3 0.0 0.0 0.0 0.0 348.5 0.8 0.4 0.0 0.0 0.5 1.5 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.4 0.2 0.1 3.6 0.0 0.0 0.1 0.2 0.0 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.7 63.4 0.9 0.1 42.7 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 2.4 42.9 19.1 0.0 5277.0 0.0 1.5 0.0 0.0 0.5 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 80.4;retina: 25.0" "Cell type enhanced" "Detected in some" "Early spermatids: 107.1;Inhibitory neurons: 275.3;Late spermatids: 39.2;Rod photoreceptor cells: 71.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 80.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HeLa: 47.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 6.2 0.5 14.4 0.1 8.1 0.0 2.8 0.3 32.3 1.1 0.3 0.3 2.9 0.6 1.6 0.4 0.9 2.3 0.4 16.3 80.4 1.9 2.3 0.2 0.1 7.0 9.5 2.4 1.0 0.2 1.4 7.1 0.3 2.2 0.5 0.3 25.0 4.9 0.5 1.0 0.7 2.5 0.8 3.3 0.8 0.3 19.2 6.9 0.5 2.8 0.3 0.1 0.7 1.0 2.2 0.0 0.0 5.3 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 2.7 0.0 0.1 0.0 3.2 5.9 47.6 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.2 0.0 0.1 1.2 0.2 5.6 0.0 0.8 0.0 1.6 0.0 0.1 0.0 2.6 0.0 0.0 0.0 1.1 0.0 0.0 0.2 1.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 8.1 0.3 32.3 16.3 80.4 7.0 9.5 2.4 2.2 3.3 6.9 2.2 8.2 0.0 0.0 12.4 0.1 0.0 0.1 0.0 2.2 2.1 0.4 0.6 1.0 0.0 0.6 1.8 4.2 0.0 0.0 0.0 0.0 0.0 107.1 6.5 2.0 1.6 0.0 0.0 20.5 0.0 0.0 0.7 0.0 18.9 0.0 0.5 0.7 0.0 0.0 1.7 275.3 0.0 0.0 0.0 0.4 39.2 0.6 0.2 0.0 10.3 0.0 2.8 0.0 16.6 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 71.5 0.0 4.7 24.6 7.8 1.6 0.0 0.1 0.0 0.1 0.3 0.0 0.0 FAM83G "FLJ41564, PAWS1" ENSG00000188522 "Family with sequence similarity 83 member G" A6ND36 17 18968789-19004764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.7;skin 1: 63.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 77.8;Basal squamous epithelial cells: 39.3;Distal enterocytes: 46.5;Squamous epithelial cells: 55.3;Suprabasal keratinocytes: 68.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 22.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023369, HPA023940" Enhanced Approved Cytosol NA NA Cytosol "HPA023369: AB_1848415, HPA023940: AB_1848416" "unprognostic (2.12e-2)" "unprognostic (5.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.48e-2)" "unprognostic (1.42e-3)" "unprognostic (2.04e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.07e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-2)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.58e-6)" "unprognostic (9.68e-2)" "unprognostic (5.13e-2)" "unprognostic (3.74e-2)" 1.7 2.2 1.0 2.9 0.8 1.4 2.8 0.7 1.1 6.2 1.9 8.3 10.9 2.5 0.9 51.7 1.6 6.4 9.6 0.7 2.9 5.3 21.9 3.2 3.0 1.4 1.2 0.5 1.4 9.6 6.4 4.4 0.8 2.1 3.5 5.3 0.2 11.0 2.2 7.0 63.1 11.4 1.5 0.8 2.0 9.8 1.0 1.6 3.7 5.6 0.8 5.7 2.5 17.1 1.8 24.7 22.4 0.2 0.0 0.7 2.0 35.9 25.2 11.0 21.0 15.7 28.7 8.8 16.1 15.1 16.7 17.1 28.6 3.6 21.1 9.6 13.2 8.1 0.4 11.2 15.9 15.3 2.9 7.9 2.8 38.9 13.6 22.3 7.9 7.6 2.5 7.7 0.5 6.0 15.0 0.7 6.0 11.0 34.1 0.1 0.1 0.0 7.8 10.1 6.2 11.2 0.0 8.7 5.3 1.5 29.1 9.2 3.6 14.2 12.9 21.6 6.1 29.8 2.2 4.0 4.1 10.1 0.1 8.6 1.1 0.0 0.0 0.7 0.0 0.3 0.3 0.4 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.2 1.0 0.8 0.7 1.1 0.7 2.9 1.4 1.2 0.5 2.1 0.8 1.6 1.8 0.6 3.2 2.2 0.0 2.5 77.8 12.2 9.9 39.3 0.2 7.1 2.9 5.1 11.5 6.3 7.3 0.0 0.4 0.7 46.5 0.0 15.8 0.1 2.4 1.0 1.9 7.1 2.7 0.1 10.0 9.7 2.6 17.3 5.0 8.9 3.5 1.1 20.9 1.2 0.0 0.1 17.7 8.2 0.3 7.8 1.9 0.0 1.0 5.4 0.0 1.0 0.2 3.1 0.5 0.0 24.3 22.8 0.0 3.0 13.2 15.3 4.4 2.5 0.4 0.0 1.3 2.0 0.1 1.0 55.3 68.5 1.9 2.6 0.0 17.1 9.1 CFAP77 "C9orf171, FLJ46082" ENSG00000188523 "Cilia and flagella associated protein 77" Q6ZQR2 9 132410043-132573319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "choroid plexus: 9.5;fallopian tube: 30.0;testis: 19.5" "Cell type enhanced" "Detected in some" "Early spermatids: 127.1;Endometrial ciliated cells: 58.4;Late spermatids: 47.6;Respiratory ciliated cells: 36.5;Spermatocytes: 25.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021329, HPA024647, HPA061069" Enhanced Approved Cytosol NA NA Cytosol "HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657" "unprognostic (7.28e-4)" "unprognostic (5.68e-2)" "unprognostic (5.25e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.70e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (2.31e-2)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (1.77e-1)" "unprognostic (2.41e-3)" "unprognostic (2.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" 0.0 0.0 3.7 0.0 1.1 0.0 0.0 2.2 0.7 0.6 9.5 0.0 0.0 0.5 0.2 0.0 30.0 0.0 2.1 0.7 3.7 0.1 0.0 2.1 0.0 3.3 4.1 0.0 0.0 0.1 0.0 0.6 0.0 3.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 19.5 1.5 0.2 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.1 2.2 0.7 0.7 3.7 3.3 4.1 0.0 3.0 4.2 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 58.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.3 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 36.5 3.8 0.0 0.0 0.0 25.5 3.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 SRSF10 "FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2" ENSG00000188529 "Serine and arginine rich splicing factor 10" O75494 1 23964347-23980927 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053805, HPA053831" Uncertain Supported Nucleoplasm NA Yes 49000 Nucleoplasm "HPA053805: AB_2682269, HPA053831: AB_2682275" "unprognostic (2.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.34e-2)" "unprognostic (1.77e-1)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.05e-2)" "unprognostic (1.68e-3)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.74e-4)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.69e-2)" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (2.40e-2)" 51.7 60.4 24.9 46.7 25.3 120.7 47.3 28.7 30.3 51.9 31.2 48.6 38.4 50.0 41.1 44.1 56.8 29.5 39.9 25.1 28.7 42.5 57.2 50.0 61.5 25.8 26.2 23.3 61.6 50.5 37.5 43.9 42.6 26.1 48.3 45.4 46.9 45.7 32.4 38.0 37.0 50.6 41.6 27.8 49.4 48.2 35.0 26.1 56.3 61.8 24.6 57.6 43.3 45.4 30.8 110.7 89.6 142.9 92.9 88.6 68.2 98.0 133.4 53.5 116.8 102.3 83.5 112.8 239.5 82.7 63.5 73.8 99.7 163.4 89.7 140.7 140.9 122.7 134.5 160.3 115.1 62.2 164.3 107.9 44.2 68.5 74.3 72.9 66.8 89.1 92.1 187.2 83.4 99.3 77.2 167.9 118.1 196.2 139.6 84.4 162.9 99.7 127.6 102.1 86.4 104.9 85.5 98.7 88.2 100.1 97.4 94.2 129.5 89.2 94.7 99.5 89.2 126.4 94.6 134.6 189.1 83.4 185.9 112.8 112.8 67.7 74.0 51.3 84.1 65.1 80.2 58.5 60.3 58.1 68.8 62.9 55.8 43.9 74.5 82.0 69.6 75.9 72.3 24.9 25.3 28.7 30.3 25.1 28.7 25.8 26.2 23.3 26.1 27.8 26.1 30.8 115.8 112.2 112.1 39.2 188.4 42.6 115.5 23.2 183.2 159.1 104.4 103.4 59.1 97.2 85.5 79.1 160.6 116.8 150.5 85.6 78.2 94.2 115.4 96.7 138.3 109.8 122.0 154.2 54.7 89.2 164.1 111.3 93.8 106.7 93.6 181.0 86.0 63.8 82.0 99.3 50.9 92.4 36.7 51.2 41.3 118.5 127.7 83.4 26.6 44.0 101.5 131.6 111.2 54.8 67.2 78.6 85.9 110.6 169.4 122.6 67.4 74.6 94.6 287.5 105.2 121.8 125.8 188.1 150.5 140.0 45.5 63.3 142.6 335.7 106.3 100.1 HBA2 HBA-T2 ENSG00000188536 "Hemoglobin subunit alpha 2" P69905 16 172876-173710 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 38528.1" "Cell type enriched" "Detected in many" 22 "Erythroid cells: 198314.0" "Cancer enhanced" "Detected in all" "glioma: 59.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7" "Group enriched" "Detected in all" 7 "dendritic cells: 486.7;granulocytes: 955.3" "Group enriched" "Detected in some" 18 "HEL: 1196.2;K-562: 328.3" "CAB038417, HPA043780" Enhanced NA NA 14000000000 "CAB038417: , HPA043780: AB_2678667" "unprognostic (1.57e-1)" "unprognostic (7.02e-2)" "unprognostic (2.59e-2)" "unprognostic (2.13e-1)" "unprognostic (3.59e-1)" "unprognostic (3.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (4.99e-2)" "unprognostic (4.43e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.72e-3)" "unprognostic (1.36e-1)" "unprognostic (2.11e-1)" "unprognostic (4.73e-2)" "unprognostic (8.92e-2)" 1006.7 325.2 160.4 187.9 285.2 38528.1 550.0 276.4 1058.3 361.2 3417.4 238.4 21.8 86.6 5.9 436.0 575.4 148.9 2186.1 104.8 185.3 2287.2 1868.7 4241.2 9.8 263.7 502.8 81.6 291.0 142.5 11.5 814.1 3649.4 321.6 305.4 26.9 4.1 308.1 133.1 574.0 189.2 155.6 13.0 320.5 8190.8 266.3 186.5 360.5 34.9 1202.5 1760.1 10.1 328.1 638.2 487.2 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.4 0.1 0.0 0.0 3.2 0.0 1.9 4.9 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.6 1196.2 0.5 0.0 0.0 0.2 1.7 0.4 0.1 0.4 0.0 0.0 0.0 0.1 328.3 0.0 0.1 0.6 0.0 0.3 0.1 0.5 0.0 0.0 0.0 43.4 0.0 0.9 11.9 9.7 1.1 0.0 0.0 0.1 1.4 0.2 5.6 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.2 119.6 28.1 315.1 99.6 1.7 3.7 39.2 8.5 7.1 42.5 19.1 22.8 73.9 955.3 49.5 3.3 486.7 1.0 15003.3 160.4 285.2 276.4 1058.3 104.8 185.3 263.7 502.8 81.6 321.6 320.5 360.5 487.2 184.7 3.2 1.5 0.0 97.6 44.4 0.4 0.1 0.6 1.7 20.2 22.2 6.8 70.1 0.7 0.0 0.0 0.0 162.2 6.9 54.8 0.0 3.4 0.6 0.8 50.9 3.0 198314.0 0.0 0.0 0.0 241.0 4.1 0.9 1.3 0.3 142.8 131.2 0.0 0.0 0.0 7.5 4.1 770.6 149.6 16.9 0.0 402.9 8790.3 0.0 37.5 2.3 954.7 0.0 0.0 0.0 3.6 0.0 0.3 0.2 0.1 29.6 2.5 58.6 0.0 25.2 171.5 1.0 9.9 1.1 44.6 0.0 306.3 0.1 5.0 0.1 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240565256 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 39.7;Spermatocytes: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 8.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "U-266/70: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.5 2.4 1.4 1.3 1.7 5.5 1.8 2.8 1.8 2.2 0.5 2.3 1.1 2.1 1.7 3.1 2.6 0.8 2.9 1.4 1.3 2.8 3.2 2.2 1.9 1.7 1.1 1.6 2.2 3.0 0.9 3.9 0.6 1.9 3.6 1.0 1.2 2.8 0.8 9.9 2.0 3.6 0.6 1.1 4.7 2.7 6.2 1.4 1.1 3.6 4.0 1.5 2.3 2.2 1.7 1.0 0.8 1.1 1.4 0.7 0.4 1.3 1.0 0.6 0.8 0.5 0.5 2.4 1.7 0.6 0.6 1.3 3.1 0.9 0.3 0.7 2.2 4.0 2.1 2.2 1.3 0.5 1.6 3.7 1.0 0.9 0.6 0.6 1.6 0.4 2.3 1.6 1.9 0.7 1.1 1.7 2.5 0.9 1.4 0.9 2.3 2.4 2.1 0.6 1.6 2.8 1.5 0.9 1.1 1.3 0.7 1.2 2.2 1.0 1.9 1.6 1.3 1.0 8.2 2.1 2.8 1.2 1.0 1.5 8.9 1.1 0.5 1.2 0.7 1.4 1.0 1.2 1.3 0.6 1.8 1.4 1.2 1.9 1.5 0.7 1.9 0.9 0.9 1.4 1.7 2.8 1.8 1.4 1.3 1.7 1.1 1.6 1.9 1.1 1.4 1.7 5.7 0.0 4.5 1.3 11.4 3.7 7.7 4.7 6.2 6.7 12.3 10.0 13.8 10.0 3.8 12.9 4.2 7.8 18.4 11.0 15.6 5.1 35.2 11.2 5.5 4.1 8.4 8.8 3.8 5.8 4.8 4.3 14.8 10.2 7.0 6.2 3.3 8.6 11.5 8.4 4.9 9.8 6.1 10.0 6.1 39.7 3.1 13.6 7.2 1.9 10.5 9.9 23.7 2.5 3.6 4.4 10.4 1.5 16.8 8.0 15.7 15.6 11.7 6.8 6.6 4.1 7.2 45.8 18.7 10.7 5.4 7.0 14.9 7.6 11.2 8.7 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.0;Collecting duct cells: 20.2;Ductal cells: 30.0;Pancreatic endocrine cells: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 4.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "HaCaT: 122.5;hTERT-RPE1: 110.8;WM-115: 138.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol NA NA 77000 "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 4.6 10.4 11.8 7.8 13.3 2.9 8.1 13.1 11.6 11.3 15.5 53.7 10.0 24.1 7.4 33.5 10.9 12.1 53.5 10.3 14.0 9.0 5.0 12.4 3.3 14.6 14.0 9.3 4.0 25.5 11.3 10.3 4.0 16.9 16.4 12.6 4.3 28.6 22.9 68.0 13.7 18.3 24.4 13.1 5.7 22.5 8.3 13.2 1.3 45.6 65.7 5.9 26.1 16.8 13.7 50.0 6.8 0.0 0.4 1.1 4.6 2.5 14.8 14.6 16.1 15.6 0.5 44.7 0.3 20.1 47.8 58.6 122.5 0.2 40.4 15.1 0.0 0.3 14.9 64.4 4.7 8.5 0.2 2.8 5.7 9.0 6.9 20.3 110.8 11.6 0.8 0.1 0.7 27.9 0.0 0.5 0.0 0.2 23.1 12.7 0.0 4.2 0.2 48.0 2.8 0.1 3.6 8.8 19.1 8.4 0.2 1.9 2.3 62.1 29.7 47.2 7.9 39.8 0.0 0.1 0.6 36.2 2.8 138.3 4.3 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.5 0.4 0.1 0.2 0.0 0.2 11.8 13.3 13.1 11.6 10.3 14.0 14.6 14.0 9.3 16.9 13.1 13.2 13.7 2.7 12.8 10.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 3.0 0.0 0.0 1.3 20.2 0.0 0.0 0.2 0.0 1.9 30.0 0.0 1.8 0.4 0.6 0.0 0.0 0.0 3.7 0.1 0.6 0.0 2.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1 autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 276.9;Late spermatids: 909.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favorable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 46.1 52.8 48.6 39.8 54.5 20.3 56.5 53.0 48.6 52.5 50.1 66.8 70.8 49.4 40.2 40.7 53.8 44.9 68.0 43.7 49.8 85.4 92.0 47.7 41.4 52.9 51.2 40.3 70.3 44.3 97.9 29.0 60.7 52.6 65.3 71.1 80.8 49.8 52.5 113.1 43.2 74.4 49.8 54.3 53.5 53.1 142.3 50.3 59.6 68.8 117.1 45.8 47.8 34.8 66.5 42.3 49.8 42.6 44.6 93.5 95.2 41.0 77.1 147.2 60.5 50.4 26.6 65.1 22.7 77.8 105.1 62.6 46.1 48.5 97.4 90.3 70.0 51.2 27.1 62.0 60.0 89.4 23.2 40.1 108.4 111.6 67.2 133.7 127.3 96.0 50.8 58.1 58.7 83.7 23.9 48.9 17.7 13.6 50.0 32.8 16.5 65.6 73.3 81.6 48.0 25.9 45.8 53.1 26.1 79.8 70.7 70.7 38.0 82.2 89.9 34.1 42.7 31.5 69.9 61.8 29.1 61.8 31.5 63.6 41.6 25.7 40.1 20.3 23.3 20.7 13.7 18.1 19.6 19.3 9.4 17.0 16.6 34.4 24.3 36.4 12.0 26.4 25.0 48.6 54.5 53.0 48.6 43.7 49.8 52.9 51.2 40.3 52.6 54.3 50.3 66.5 36.9 41.7 44.1 24.5 21.9 23.8 29.2 28.1 54.1 37.3 33.8 27.4 86.4 35.8 40.4 36.8 39.6 28.0 34.6 94.2 19.6 25.4 276.9 40.5 30.4 39.0 40.2 53.2 24.7 21.9 19.4 37.6 31.1 33.0 25.9 53.1 45.3 67.8 22.0 20.2 28.2 56.4 20.3 62.9 19.9 909.9 58.7 35.7 26.6 29.0 35.6 49.3 44.3 33.2 41.4 25.8 64.5 44.4 26.1 41.1 100.3 57.4 63.4 56.9 39.5 33.9 36.2 49.6 30.9 26.7 27.3 15.7 31.9 68.6 52.4 38.7 OR2G6 ENSG00000188558 "Olfactory receptor family 2 subfamily G member 6" Q5TZ20 1 248508073-248527337 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.8;granulocytes: 1.3;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.4 0.1 0.5 0.9 0.1 0.9 0.9 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.2 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.4 0.0 0.0 0.1 0.5 0.2 0.0 0.6 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.4 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.9 0.9 0.4 0.2 0.3 0.3 0.4 0.5 0.0 0.2 0.8 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 RALGAPA2 "AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2" ENSG00000188559 "Ral GTPase activating protein catalytic subunit alpha 2" Q2PPJ7 20 20389530-20712644 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 212.2;Microglial cells: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 91.5;SCLC-21H: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042707, HPA043622" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042707: AB_2678124, HPA043622: AB_2678585" "unprognostic (7.40e-2)" "unprognostic (1.71e-1)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.34e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-2)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "prognostic favorable (3.77e-5)" "unprognostic (6.52e-2)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (5.33e-2)" 15.9 6.5 5.2 6.2 6.6 20.8 15.1 10.5 7.4 9.7 5.9 12.4 10.4 8.8 3.7 8.8 10.9 11.4 7.5 4.3 4.6 9.4 27.6 25.4 6.5 6.6 8.3 3.3 7.4 17.1 13.2 14.6 17.8 8.2 13.2 12.7 13.5 15.3 5.6 34.8 16.8 10.6 7.1 3.6 7.6 18.5 10.2 11.7 8.1 21.3 21.2 5.4 12.7 8.5 9.6 7.0 4.4 9.2 4.7 5.1 3.6 10.1 1.8 2.0 2.1 3.0 3.8 9.5 3.2 6.1 3.0 10.6 7.1 9.4 8.6 4.0 16.1 4.6 11.1 2.5 6.7 1.8 14.0 6.4 3.1 6.4 3.5 1.7 3.9 13.1 14.9 2.2 6.0 3.8 4.9 5.6 18.5 3.8 22.8 3.9 7.6 6.2 4.5 7.4 91.5 51.4 4.5 6.9 5.2 6.1 8.9 3.6 13.7 3.3 3.7 3.6 2.7 2.6 3.5 2.6 1.8 3.1 9.1 5.4 4.4 1.1 3.6 0.8 0.4 1.2 1.1 0.5 0.8 0.5 0.8 1.0 1.1 4.4 2.7 1.0 1.2 1.0 0.3 5.2 6.6 10.5 7.4 4.3 4.6 6.6 8.3 3.3 8.2 3.6 11.7 9.6 90.7 6.4 42.5 212.2 9.7 10.6 10.1 25.9 6.8 47.8 13.5 7.7 9.1 41.5 27.0 14.7 27.1 10.6 14.6 24.7 1.9 23.9 28.9 61.0 16.4 80.1 24.6 10.7 87.3 24.9 4.9 7.6 51.5 123.0 8.2 97.3 67.1 47.4 12.8 52.2 122.0 20.7 40.7 18.3 10.3 7.3 1.8 13.0 8.8 145.2 18.2 8.8 10.3 122.2 111.1 19.5 21.0 6.8 4.8 20.5 20.6 12.5 43.1 13.5 13.1 16.4 9.7 12.3 11.1 15.3 16.6 11.2 14.3 19.7 30.6 25.0 NDOR1 "bA350O14.9, CIAE1, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 13.4;Oligodendrocytes: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 6.4 8.3 6.8 9.9 7.5 17.3 6.9 6.1 12.6 8.0 3.8 7.7 9.7 7.8 2.0 8.3 8.0 4.6 6.1 6.5 6.1 9.1 7.1 8.6 11.6 8.8 7.2 5.6 7.0 8.9 4.1 8.3 4.0 9.2 9.7 3.0 4.0 8.7 5.3 4.1 9.6 10.7 3.7 6.3 14.4 8.8 10.6 7.2 9.0 10.1 1.5 5.5 7.9 7.2 10.5 14.2 21.2 13.8 21.8 5.7 5.6 42.7 20.4 9.1 19.1 13.0 21.6 16.3 19.9 15.6 7.7 15.3 52.1 10.0 14.3 3.8 25.9 16.3 17.6 59.7 11.6 9.6 19.9 36.2 7.8 9.7 21.6 7.9 5.3 8.9 25.9 29.2 20.6 7.0 25.8 21.0 35.8 22.5 12.9 26.0 38.0 16.5 28.2 6.0 12.4 17.6 17.5 16.8 17.0 10.6 6.1 27.2 22.8 12.0 35.3 22.9 41.7 23.2 12.5 26.8 20.7 15.4 18.1 20.7 1.1 2.1 3.1 1.3 2.2 1.1 0.5 1.2 1.2 1.7 1.0 0.6 0.6 2.9 0.7 1.7 1.1 1.8 1.5 6.8 7.5 6.1 12.6 6.5 6.1 8.8 7.2 5.6 9.2 6.3 7.2 10.5 1.4 0.0 2.6 13.4 3.9 0.5 0.7 1.0 5.2 0.4 1.5 1.3 1.6 1.5 1.6 3.7 0.0 4.5 1.4 3.3 1.9 1.1 0.8 1.3 1.9 1.8 2.4 1.3 8.6 1.1 3.5 1.6 5.1 2.1 1.3 2.0 1.1 0.8 2.5 0.0 7.5 1.9 2.0 3.2 1.3 1.1 0.6 2.7 1.8 6.5 5.4 0.1 5.2 3.5 10.5 1.6 1.5 0.4 6.9 0.7 2.6 1.2 0.3 0.9 0.0 0.9 1.4 1.9 1.2 3.2 0.3 3.7 3.8 1.6 2.2 0.8 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529305-168530634 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 35.7;pituitary gland: 15.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 24.2;SH-SY5Y: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049546, HPA077724" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA049546: AB_2680811, HPA077724: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.2 3.1 17.4 0.1 20.0 0.0 0.6 11.6 35.7 0.4 3.8 0.7 0.4 0.2 0.0 0.2 0.4 0.2 0.3 18.2 25.4 0.4 0.7 0.1 0.0 20.9 18.9 20.2 0.7 0.9 0.4 15.6 0.2 24.6 1.0 0.1 1.4 0.9 0.3 0.1 0.5 0.5 0.2 11.1 0.2 0.5 5.9 20.2 0.0 0.2 0.0 0.0 0.3 0.3 30.3 0.0 0.5 1.8 0.3 0.1 0.0 0.9 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.5 0.0 1.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 20.2 2.1 0.0 1.2 0.0 0.0 1.5 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 20.0 11.6 35.7 18.2 25.4 20.9 18.9 20.2 24.6 11.1 20.2 30.3 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.6 8.5 1.4 1.8 1.2 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.4 1.7 0.9 1.4 0.2 6.7 0.0 4.3 0.2 0.1 0.8 0.0 2.4 0.0 1.6 0.0 0.0 0.1 6.7 6.6 0.4 0.0 0.0 0.0 2.3 0.0 0.1 3.6 1.0 0.0 0.7 0.0 3.0 1.1 0.2 0.0 0.0 0.0 0.3 1.0 0.4 0.0 2.8 6.6 0.2 0.4 3.1 0.4 0.2 0.1 0.0 0.1 1.2 0.3 0.0 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123803865-124825640 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 60.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1721.6;Inhibitory neurons: 636.4;Oligodendrocytes: 2869.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "basophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Daudi: 3.0;HEL: 6.4;Karpas-707: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol NA NA Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 0.9 0.4 27.8 0.1 35.1 0.7 0.3 32.7 34.6 0.2 14.4 0.7 0.0 0.1 0.3 0.2 0.3 0.2 1.1 32.9 29.7 0.1 0.2 0.2 0.2 40.0 32.1 28.5 0.1 0.1 0.0 1.8 0.1 38.5 0.3 0.1 6.7 0.3 0.2 2.9 0.1 0.3 0.3 45.2 0.1 0.2 0.4 34.3 0.5 0.1 3.4 0.2 0.5 0.3 60.4 0.0 0.0 1.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.4 0.0 0.0 0.4 0.0 0.0 1.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 35.1 32.7 34.6 32.9 29.7 40.0 32.1 28.5 38.5 45.2 34.3 60.4 0.5 0.0 0.0 97.3 0.0 0.1 0.0 0.2 0.0 3.0 0.0 0.1 1.3 0.0 0.1 0.0 2.1 0.2 0.0 0.0 0.0 0.1 1.7 0.2 0.1 0.3 1.8 2.1 1721.6 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 47.1 636.4 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.0 47.8 0.0 15.8 0.0 19.1 2869.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.8 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 KRTAP1-1 "HB2A, KAP1.1, KAP1.1A, KAP1.1B" ENSG00000188581 "Keratin associated protein 1-1" Q07627 17 41040541-41041450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "skin 1: 48.4" "Group enriched" "Detected in some" 6 "Basal prostatic cells: 7.5;Ductal cells: 6.0;Prostatic glandular cells: 2.3;Urothelial cells: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.90e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963674 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.6;retina: 9.7;testis: 20.6" "Cell type enhanced" "Detected in some" "Early spermatids: 42.1;Erythroid cells: 28.2;Hepatocytes: 18.4;Late spermatids: 98.3;Syncytiotrophoblasts: 36.5" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;AF22: 1.0;U-266/70: 3.3;U-266/84: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052798 Uncertain NA NA "HPA052798: AB_2681955" "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.0 0.1 1.2 0.0 1.7 5.3 0.0 1.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 2.5 2.0 0.0 13.6 0.0 0.0 1.0 2.0 1.5 0.0 0.0 0.2 0.9 0.2 1.2 0.0 0.0 9.7 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 20.6 3.8 0.1 0.0 1.4 0.0 0.1 0.0 1.9 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 1.0 5.3 2.5 2.0 1.0 2.0 1.5 1.2 0.2 3.8 1.9 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 5.8 0.0 0.0 6.7 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 42.1 0.7 0.0 0.2 0.0 28.2 0.8 0.0 0.1 0.3 0.0 0.2 0.0 1.0 0.0 18.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 98.3 1.2 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.1 2.6 5.4 0.0 0.1 36.5 0.0 0.1 0.0 0.0 CLEC20A "FLJ44005, LINC00083, NCRNA00083, RP4-593C16.2" ENSG00000188585 "C-type lectin domain containing 20A" Q6ZU45 1 178479247-178499634 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.2;testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.2;naive B-cell: 10.7" "Lineage enriched" "Detected in many" 6 "B-cells: 10.7" "Cell line enriched" "Detected in single" 5 "REH: 1.0" NA NA 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.1 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.3 10.7 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.3;choroid plexus: 25.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Alveolar cells type 2: 80.1;Club cells: 42.7;Endometrial ciliated cells: 65.8;granulocytes: 37.8;Oligodendrocytes: 47.7;Respiratory ciliated cells: 106.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 7.7;TIME: 9.4" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 0.8 0.7 18.3 1.3 8.9 2.8 0.9 10.0 11.6 0.6 25.8 0.8 1.8 1.6 1.6 0.7 5.0 0.8 0.5 8.1 9.8 0.9 0.9 1.4 1.2 14.8 12.0 7.0 1.0 0.3 0.6 1.0 0.7 7.3 0.9 1.1 6.3 0.9 0.6 1.3 1.6 1.2 0.6 12.7 1.5 1.0 5.4 4.7 0.5 1.3 0.2 1.1 0.4 0.1 13.5 1.4 0.6 0.8 1.1 0.4 0.6 0.9 0.7 0.2 0.2 0.4 0.6 1.9 1.0 1.6 0.4 0.9 1.0 0.3 0.3 0.3 2.0 0.6 0.9 2.3 0.7 0.1 1.5 1.5 0.2 0.3 1.1 0.5 1.8 7.7 0.9 0.6 3.5 0.8 0.7 1.2 1.5 1.7 0.6 1.0 1.2 1.1 1.3 2.2 1.3 1.6 1.2 0.8 0.7 1.0 0.9 2.1 0.7 9.4 1.7 2.2 1.8 1.5 4.2 2.1 0.6 1.3 0.9 1.3 2.4 0.7 0.6 0.7 0.6 0.5 0.7 0.5 0.6 0.3 1.1 0.6 0.6 1.3 0.7 0.7 0.6 0.4 0.1 18.3 8.9 10.0 11.6 8.1 9.8 14.8 12.0 7.0 7.3 12.7 4.7 13.5 2.1 70.5 80.1 27.1 2.6 0.0 0.3 0.0 0.0 3.9 0.3 0.6 1.0 1.5 42.7 0.0 22.9 0.3 2.2 0.0 0.0 0.2 33.2 65.8 2.9 6.8 1.2 1.3 21.9 0.0 0.3 6.4 0.5 1.9 37.8 0.6 0.4 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 15.4 0.3 3.2 0.0 1.9 0.1 8.1 0.0 4.0 47.7 0.3 0.1 0.0 5.0 0.5 0.0 0.3 106.4 7.8 0.0 1.7 0.5 16.8 7.0 0.0 0.0 0.0 4.2 1.9 0.1 0.3 CLN3 "BTN1, BTS, JNCL" ENSG00000188603 "CLN3 lysosomal/endosomal transmembrane protein, battenin" Q13286 16 28474111-28495575 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 178.0;SK-BR-3: 186.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063280 Uncertain NA NA "HPA063280: AB_2684975" "unprognostic (2.38e-3)" "unprognostic (2.41e-2)" "unprognostic (7.06e-2)" "unprognostic (8.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (2.36e-2)" "unprognostic (1.69e-2)" "unprognostic (6.38e-3)" "unprognostic (8.16e-2)" "unprognostic (6.27e-2)" "unprognostic (5.26e-1)" "unprognostic (9.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.05e-2)" 18.0 30.8 13.3 19.8 13.7 13.5 21.6 13.6 16.1 16.7 15.1 38.7 22.1 16.0 10.0 22.4 16.1 15.3 11.7 12.4 14.2 21.3 32.2 23.8 13.9 14.1 13.0 12.0 17.0 28.0 30.2 8.3 37.2 14.0 17.5 29.5 3.2 34.8 21.2 14.6 23.8 25.9 13.5 13.5 20.6 26.3 7.9 14.7 14.2 24.9 13.9 12.2 19.5 15.7 16.5 23.1 39.2 15.4 38.4 41.1 19.9 178.0 14.8 40.7 28.3 34.9 19.7 52.9 16.0 45.8 24.8 52.0 23.5 25.8 24.7 12.9 38.0 38.5 15.6 24.1 60.6 60.5 23.3 64.7 28.0 66.8 21.9 14.7 26.3 32.9 24.9 30.9 55.0 28.8 61.9 20.7 45.1 21.8 35.3 26.0 37.2 13.4 54.5 30.2 53.0 20.8 19.6 5.7 186.5 18.3 14.0 62.2 32.4 20.2 19.2 10.1 24.9 22.5 58.3 64.2 15.9 28.4 47.3 11.9 63.4 59.8 98.4 57.6 47.6 42.7 24.3 43.6 53.6 63.8 29.3 38.3 40.6 23.8 41.2 38.7 68.1 53.5 46.6 13.3 13.7 13.6 16.1 12.4 14.2 14.1 13.0 12.0 14.0 13.5 14.7 16.5 1.2 22.4 15.9 11.1 10.8 0.1 17.2 0.0 23.9 10.9 1.7 0.6 0.0 38.6 6.2 1.8 12.5 315.9 25.8 46.4 0.0 2.2 1.1 1.8 1.3 11.2 17.0 17.5 7.5 0.5 106.9 9.3 20.9 2.6 2.5 7.6 21.0 39.0 70.1 13.5 8.1 39.3 0.0 36.7 0.4 2.5 19.0 17.7 0.0 2.8 17.5 25.0 40.2 7.1 11.4 1.5 43.7 12.4 13.1 10.6 53.1 0.8 1.5 12.1 13.1 9.9 3.5 3.2 8.4 17.1 0.1 451.4 15.9 3.6 50.2 13.3 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.2;lymphoid tissue: 10.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 7.3;Early spermatids: 11.3;Erythroid cells: 5.9;Hepatic stellate cells: 6.4;Spermatocytes: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 0.8 0.6 1.0 3.8 1.2 6.2 0.8 1.8 1.2 0.4 1.1 1.1 1.3 0.5 0.4 1.6 0.4 1.0 0.3 1.0 1.2 0.4 0.4 0.7 8.2 1.3 1.1 0.7 0.4 0.2 0.7 0.2 1.4 1.6 0.3 1.2 0.1 0.4 0.2 0.1 1.9 1.1 0.7 1.1 2.0 1.0 2.4 1.1 10.4 0.3 0.2 6.7 0.8 0.7 1.7 28.6 10.3 16.5 8.2 1.6 2.4 13.3 14.7 6.2 16.8 14.1 0.1 14.5 62.9 19.9 2.7 16.4 17.1 23.1 8.3 25.9 41.1 17.3 27.2 12.0 12.5 1.0 47.7 23.2 1.3 0.9 13.0 26.5 4.2 10.3 51.0 36.1 37.3 12.4 12.1 24.1 39.1 31.6 14.9 20.6 35.8 35.8 28.7 6.7 3.2 18.0 10.4 11.1 8.6 8.6 16.9 11.4 36.5 3.6 13.8 23.5 27.3 26.6 32.6 44.1 61.3 12.4 50.8 32.6 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.4 0.3 1.0 1.2 1.8 1.2 1.0 1.2 1.3 1.1 0.7 1.6 1.1 1.1 1.7 1.3 0.0 0.0 0.0 1.6 1.0 0.1 0.2 0.0 0.0 0.3 0.6 0.4 0.0 0.1 0.0 0.0 0.8 0.1 7.3 0.0 0.2 11.3 0.2 0.4 2.5 0.0 5.9 0.1 0.2 2.3 0.6 1.1 0.2 0.0 0.5 6.4 0.0 1.1 0.0 0.3 4.9 0.0 1.9 2.8 3.0 0.6 1.6 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.1 2.3 0.0 2.5 0.0 2.1 0.0 0.7 0.0 0.0 0.3 0.9 17.0 3.1 3.5 1.0 0.1 1.2 0.2 3.6 0.0 ASAH2 ENSG00000188611 "N-acylsphingosine amidohydrolase 2" Q9NR71 10 50182778-50279720 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 82.3" "Cell type enhanced" "Detected in some" "Late spermatids: 12.5;Muller glia cells: 9.0;Proximal enterocytes: 17.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebellum: 8.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061171 Supported Approved "Focal adhesion sites" "Intracellular and membrane" NA NA 2200000 "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (3.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-2)" "unprognostic (3.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (4.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.86e-2)" "unprognostic (5.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" 0.3 0.8 0.5 0.2 0.7 0.0 0.5 8.2 0.4 0.6 0.1 0.8 82.3 0.8 0.5 0.7 0.8 0.3 0.8 0.1 0.3 0.5 2.9 0.6 0.3 3.2 2.9 0.1 0.8 1.4 0.6 0.6 0.6 2.3 0.4 0.4 7.4 0.6 0.2 0.8 0.7 65.2 1.2 1.6 0.2 5.1 0.8 0.6 0.5 0.7 0.4 0.1 0.5 0.4 0.8 1.2 0.9 1.0 1.4 1.8 0.7 1.3 1.2 0.9 2.5 2.2 0.7 3.0 0.0 1.4 1.9 2.0 1.1 1.4 0.4 3.0 1.6 2.5 0.9 2.2 1.9 1.1 0.3 0.1 0.2 1.7 4.3 4.8 0.3 0.5 0.0 1.7 0.8 1.7 1.1 1.0 0.0 3.2 0.0 2.7 0.0 4.2 1.1 1.3 0.2 1.8 4.8 1.7 1.2 2.1 2.4 1.0 0.7 1.4 1.2 2.8 3.2 4.0 1.2 0.1 0.0 3.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.7 8.2 0.4 0.1 0.3 3.2 2.9 0.1 2.3 1.6 0.6 0.8 0.1 0.0 0.0 0.7 0.0 0.4 0.3 0.4 0.0 2.8 0.4 0.3 3.8 0.0 0.9 0.0 2.1 0.4 1.4 0.5 0.0 0.9 4.8 0.1 0.2 0.5 0.0 3.2 1.1 1.6 0.3 0.6 0.0 0.2 0.0 0.2 0.4 2.1 0.2 1.7 1.5 1.8 0.0 0.0 0.0 12.5 1.2 0.0 0.0 0.0 0.0 9.0 1.0 0.0 0.2 1.6 0.1 1.5 0.0 0.3 17.1 1.0 0.7 2.1 6.6 0.6 0.9 1.9 0.9 0.0 0.1 0.3 0.5 0.2 1.2 0.2 SUMO2 "SMT3B, SMT3H2" ENSG00000188612 "Small ubiquitin like modifier 2" P61956 17 75165586-75182959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037314, HPA042123, HPA048064" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (6.49e-2)" "unprognostic (1.01e-2)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.32e-1)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.12e-4)" "unprognostic (9.80e-2)" "unprognostic (6.02e-3)" "unprognostic (2.58e-3)" "unprognostic (5.07e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (5.23e-6)" "unprognostic (2.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.14e-2)" "unprognostic (4.89e-3)" 199.9 207.0 171.8 205.5 180.4 231.8 176.0 207.9 241.8 211.3 170.0 176.8 162.9 207.4 159.9 242.9 188.5 135.2 152.3 176.9 201.5 180.5 187.3 173.0 216.4 169.1 175.6 167.9 233.2 162.4 131.7 147.6 131.2 174.6 159.5 145.3 207.7 161.7 123.4 231.6 176.7 170.6 156.1 180.9 176.2 207.1 183.8 175.8 274.4 150.4 153.3 230.5 190.0 206.8 184.6 742.5 299.1 1035.7 534.4 296.8 283.6 486.1 571.2 276.9 384.5 354.5 343.6 396.0 641.8 398.1 327.9 503.0 353.4 470.3 351.7 451.6 373.6 712.4 644.0 282.1 597.4 194.1 856.1 555.7 290.1 195.9 343.9 187.2 615.6 403.8 628.3 540.7 508.7 288.3 317.8 1310.8 734.0 632.8 552.5 445.5 903.2 987.1 539.5 391.9 612.0 633.4 739.0 691.1 566.8 481.4 796.9 614.6 663.0 458.1 557.2 581.7 429.4 931.3 355.4 348.1 986.8 351.2 500.6 457.3 831.1 436.4 781.2 390.9 498.9 408.8 515.7 486.8 456.8 451.6 443.6 444.0 437.1 380.1 452.3 548.3 616.0 701.6 851.5 171.8 180.4 207.9 241.8 176.9 201.5 169.1 175.6 167.9 174.6 180.9 175.8 184.6 522.1 163.5 160.6 25.5 453.3 705.4 647.4 717.6 602.2 216.4 492.1 524.1 62.3 337.5 368.2 355.0 50.1 522.8 485.0 278.1 968.5 602.7 281.8 348.6 429.0 458.5 441.9 519.9 35.7 531.7 948.9 451.1 274.2 343.5 349.0 465.0 491.2 273.4 616.3 233.9 33.0 397.9 472.0 676.9 637.0 488.6 604.9 481.5 462.4 21.5 743.4 535.4 517.0 25.1 42.6 666.5 397.3 605.2 443.0 822.3 348.7 847.5 322.6 161.3 571.9 409.5 716.6 872.2 683.2 795.2 742.7 565.2 480.3 476.1 437.0 977.2 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029714-119033730 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.9" "Cell type enhanced" "Detected in many" "Breast glandular cells: 10.2;Cardiomyocytes: 11.3;Cone photoreceptor cells: 10.4;Muller glia cells: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 80.4;SK-BR-3: 46.7;SK-MEL-30: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 7.9 11.4 7.0 0.3 7.1 0.2 8.4 7.2 7.7 1.9 4.5 2.1 0.4 2.1 1.8 1.0 1.0 0.2 6.6 5.6 9.6 2.2 0.3 1.1 0.4 8.7 7.5 5.9 0.3 2.2 0.3 2.8 6.4 7.4 1.0 0.4 4.2 1.3 0.9 38.9 1.5 0.9 1.9 6.7 0.3 3.4 1.9 8.2 0.3 7.1 1.7 0.3 3.3 1.0 10.8 16.4 1.3 2.2 0.4 7.4 1.1 9.7 0.4 0.5 0.4 0.2 2.0 5.6 8.7 2.2 0.1 0.0 5.8 2.7 2.9 0.7 2.6 6.6 0.2 3.8 1.8 3.5 1.0 0.0 1.5 11.7 0.1 1.6 2.4 0.4 3.0 1.7 1.0 0.5 2.3 2.2 2.8 7.1 3.4 1.3 0.0 2.7 5.9 3.1 1.3 6.3 80.4 4.7 46.7 37.4 12.2 7.4 4.7 0.5 0.0 3.4 0.1 0.8 2.4 8.6 3.2 0.7 2.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 7.0 7.1 7.2 7.7 5.6 9.6 8.7 7.5 5.9 7.4 6.7 8.2 10.8 5.7 6.4 1.1 2.0 1.3 0.8 5.0 1.3 0.6 4.1 10.2 6.1 11.3 1.5 1.2 1.8 10.4 6.5 6.3 4.4 0.0 0.6 0.2 3.9 2.8 1.7 3.0 0.0 0.5 0.2 0.4 4.0 1.1 3.7 0.0 2.6 0.7 0.1 0.7 1.7 2.3 3.8 0.0 0.0 2.1 0.1 1.8 0.9 0.0 0.0 0.0 14.7 1.0 2.0 0.2 0.3 0.1 0.7 1.6 2.9 0.2 0.5 1.2 2.1 0.0 7.7 3.9 0.4 1.0 0.8 1.3 1.0 2.9 0.7 2.1 1.3 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135970-123139423 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 5.8" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Region enhanced" "Detected in many" "hypothalamus: 5.8" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7" "Region enriched" "Detected in single" 4 "hypothalamus: 1.1" "Group enriched" "Detected in some" 5 "basal ganglia: 1.4;hypothalamus: 4.8" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA069659: AB_2686165" "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 0.9 0.1 0.6 0.1 0.2 0.1 0.0 0.2 0.2 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.1 1.4 2.0 0.1 0.0 0.1 0.0 0.2 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 8.1 0.0 0.0 0.7 0.4 6.1 7.0 0.2 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 17.9 0.1 0.0 0.0 0.0 13.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 7.0 0.0 0.1 0.0 0.0 5.7 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.3 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.3 0.9 0.4 0.2 0.4 0.2 0.1 0.6 0.2 0.2 0.2 0.0 5.8 1.4 2.0 0.1 1.0 0.1 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGFL3 UNQ483 ENSG00000188624 "IGF like family member 3" Q6UXB1 19 46120067-46124688 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 26.6" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 3.1;Basal respiratory cells: 1.7;Exocrine glandular cells: 6.5;Melanocytes: 1.8;Suprabasal keratinocytes: 8.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.7;CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 1.3;U-87 MG: 2.4" HPA062776 Uncertain "Secreted in other tissues" NA NA "HPA062776: AB_2684866" "unprognostic (8.61e-2)" "unprognostic (6.26e-2)" "unprognostic (2.69e-1)" "unprognostic (4.78e-2)" "unprognostic (7.45e-3)" "unprognostic (2.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.90e-1)" "unprognostic (1.86e-4)" "unprognostic (2.86e-2)" "unprognostic (1.90e-1)" "unprognostic (3.69e-2)" 0.0 0.0 0.6 0.0 1.3 0.1 1.5 0.0 1.1 0.0 0.0 0.1 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.9 0.8 0.3 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.1 0.5 0.1 0.0 0.3 26.6 0.0 0.1 0.2 0.0 0.0 0.3 0.5 0.2 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.2 1.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.2 1.2 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.0 1.1 0.6 0.4 0.9 0.8 0.3 1.4 0.2 0.5 2.7 0.0 0.0 0.0 0.0 0.0 3.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 1.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 GOLGA8M ENSG00000188626 "Golgin A8 family member M" H3BSY2 15 28701954-28738384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.4;thyroid gland: 14.0" "Cell type enhanced" "Detected in some" "Astrocytes: 8.8;Early spermatids: 24.7;NK-cells: 7.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "HEL: 2.6;U-937: 6.4" NA NA "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (2.04e-1)" "unprognostic (2.00e-2)" "unprognostic (5.25e-3)" "unprognostic (1.28e-1)" "unprognostic (2.05e-1)" "unprognostic (6.16e-3)" "unprognostic (8.16e-4)" "unprognostic (4.32e-2)" "unprognostic (2.66e-4)" "unprognostic (8.24e-3)" "unprognostic (4.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.60e-1)" 3.0 0.7 0.3 0.0 0.4 0.6 2.6 0.1 0.5 1.4 0.1 0.3 0.0 0.7 0.5 0.2 1.2 0.3 0.8 0.2 1.2 1.4 3.4 0.7 0.1 0.8 0.4 0.1 4.2 0.7 0.0 1.9 1.8 0.5 0.6 0.0 0.0 0.3 0.2 0.3 0.3 0.3 0.1 0.2 0.4 0.3 6.4 0.2 0.0 14.0 0.0 0.0 0.6 1.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.5 0.2 1.2 0.8 0.4 0.1 0.5 0.2 0.2 0.7 1.7 3.2 2.2 8.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.5 1.5 0.0 0.0 0.0 0.0 3.0 0.0 1.9 0.0 24.7 0.3 0.2 0.5 0.0 0.0 2.2 0.0 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.1 3.3 1.5 0.0 0.0 0.0 0.3 2.9 0.0 0.4 0.0 1.9 0.5 0.2 7.2 3.0 2.9 0.0 0.0 0.7 0.3 0.0 0.0 0.8 0.7 0.1 0.0 0.8 0.3 3.9 0.8 0.0 0.0 0.1 1.4 0.2 0.0 0.1 ZNF177 ENSG00000188629 "Zinc finger protein 177" Q13360 19 9363020-9382617 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 12.7;Late spermatids: 7.6;Spermatocytes: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 11.4" "Low region specificity" "Detected in all" HPA003141 Uncertain NA NA "HPA003141: AB_1859102" "unprognostic (1.66e-1)" "unprognostic (2.88e-1)" "unprognostic (8.86e-3)" "unprognostic (1.74e-1)" "unprognostic (1.75e-2)" "unprognostic (2.71e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (3.80e-2)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (4.04e-2)" "unprognostic (1.97e-2)" 3.1 4.9 9.2 0.9 9.0 0.5 3.7 10.8 11.8 6.9 7.9 3.9 0.7 5.7 8.2 1.2 6.6 1.4 4.5 9.2 8.7 5.2 2.7 2.9 1.3 8.8 8.3 9.0 8.1 2.3 2.7 7.5 1.9 9.2 5.8 1.7 10.0 2.2 3.0 1.3 1.9 2.6 2.7 7.9 4.1 2.5 10.5 8.5 2.9 5.1 1.6 1.0 3.9 3.4 9.8 0.4 0.6 6.1 3.8 2.8 3.0 2.1 1.1 0.8 1.6 2.3 0.3 0.2 0.4 3.3 0.7 2.1 0.2 1.3 1.1 2.5 1.2 6.0 2.0 0.6 0.5 1.6 2.1 4.2 1.2 2.4 0.9 3.2 4.9 0.8 5.1 0.1 4.1 2.4 0.0 3.4 11.4 1.1 0.1 1.9 2.2 2.0 0.5 1.2 3.1 4.8 1.1 1.8 0.1 0.9 4.6 1.2 4.0 0.7 1.7 1.2 3.5 1.8 0.2 0.0 1.8 0.6 1.7 1.7 0.6 0.0 0.4 0.4 0.1 0.2 0.2 0.0 0.4 0.4 0.0 0.4 0.2 0.3 0.8 0.0 0.2 0.1 0.2 9.2 9.0 10.8 11.8 9.2 8.7 8.8 8.3 9.0 9.2 7.9 8.5 9.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 7.6 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492583-44498233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 11.1;Collecting duct cells: 12.9;Ductal cells: 8.4;Endometrial stromal cells: 12.9;Granulosa cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 10.6 12.2 20.9 7.2 19.6 3.3 9.0 15.8 18.9 11.3 8.2 11.3 8.9 15.9 12.2 8.3 16.7 11.1 15.5 20.3 17.8 9.3 3.3 9.5 6.3 20.0 19.9 18.8 19.3 11.1 18.0 8.8 5.2 17.3 9.9 9.2 9.6 7.3 13.7 15.7 3.4 8.5 17.0 18.7 7.6 9.8 11.3 19.6 14.3 10.3 18.2 4.8 10.5 5.4 17.2 13.8 18.9 23.9 31.9 18.3 14.8 6.3 17.9 21.1 24.6 19.2 6.3 8.0 0.0 10.9 33.5 18.5 11.8 16.3 17.7 15.1 6.5 31.8 0.0 35.8 0.0 22.6 1.8 8.7 16.2 16.8 22.5 17.3 33.4 22.3 21.6 7.8 0.1 16.9 24.3 44.4 4.1 14.7 15.1 20.0 12.1 12.7 0.0 21.1 15.8 25.6 30.0 29.2 14.0 18.1 11.5 14.0 19.3 23.1 19.2 25.7 25.7 14.5 8.3 3.5 0.0 28.5 4.5 29.2 0.0 0.7 0.0 1.8 0.3 1.9 0.0 1.0 1.5 0.5 0.0 0.4 1.0 0.0 0.4 0.4 0.0 0.2 1.1 20.9 19.6 15.8 18.9 20.3 17.8 20.0 19.9 18.8 17.3 18.7 19.6 17.2 5.8 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.1 6.5 0.0 0.0 2.5 12.9 0.0 2.9 4.8 0.0 0.0 8.4 0.0 7.4 12.9 4.0 0.0 0.0 0.0 6.5 2.7 3.5 0.0 8.1 0.0 13.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.7 0.0 0.0 5.7 7.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.2 1.8 5.2 0.0 0.0 DPYD DPD ENSG00000188641 "Dihydropyrimidine dehydrogenase" Q12882 1 97077743-97995000 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 1712.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033241, HPA045210" Uncertain NA NA 1600000 "CAB033241: AB_2094323, HPA045210: AB_2679256" "unprognostic (2.33e-2)" "unprognostic (1.69e-1)" "unprognostic (9.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.13e-2)" "unprognostic (8.81e-2)" "unprognostic (2.86e-1)" "unprognostic (3.05e-1)" "unprognostic (1.56e-1)" "unprognostic (9.29e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (6.54e-2)" "unprognostic (5.32e-2)" "unprognostic (1.43e-1)" "unprognostic (3.43e-2)" "unprognostic (3.71e-1)" "unprognostic (2.25e-1)" 22.4 13.3 6.5 22.8 12.0 10.4 16.8 5.2 8.8 19.0 3.5 10.3 22.1 15.0 8.4 17.3 14.4 25.9 8.6 7.3 18.0 12.7 69.0 29.8 16.7 11.9 9.5 6.0 24.2 11.9 9.3 6.2 4.6 12.0 10.0 10.2 3.3 15.1 13.6 5.8 7.2 19.6 18.4 7.4 24.9 8.5 3.7 11.0 17.2 10.4 10.1 12.1 18.4 14.3 24.5 22.2 6.2 7.8 0.2 42.4 72.5 0.1 35.2 31.9 32.1 23.6 0.0 9.2 11.7 50.6 32.9 5.1 5.2 0.0 8.3 58.7 11.6 7.3 10.0 11.1 0.2 18.8 4.5 0.6 57.5 3.0 25.7 29.3 67.7 26.8 6.8 0.4 36.4 17.0 0.0 23.6 6.4 0.9 0.2 7.5 0.1 37.1 18.6 39.4 0.1 11.1 8.8 30.1 2.5 0.3 0.8 0.0 10.2 30.9 69.2 5.0 56.4 70.6 3.0 0.1 0.2 10.2 12.6 56.2 18.2 61.1 4.1 11.6 29.5 14.8 2.2 13.3 11.0 32.7 4.9 12.5 11.1 59.8 13.3 27.1 0.9 15.8 21.9 6.5 12.0 5.2 8.8 7.3 18.0 11.9 9.5 6.0 12.0 7.4 11.0 24.5 25.5 16.0 39.1 23.8 15.4 7.6 8.8 9.4 18.8 2.5 8.4 8.3 5.3 40.0 11.5 7.3 0.0 0.2 19.2 3.3 5.9 2.5 7.0 1.5 15.2 14.7 3.0 13.3 258.6 6.4 0.2 30.0 10.7 1.7 9.5 4.5 17.2 54.2 17.1 0.0 30.5 5.5 6.1 130.4 27.0 4.0 33.5 73.7 3.6 105.9 98.1 4.8 27.8 34.2 1712.3 5.3 2.1 18.8 17.0 4.9 21.0 6.6 8.6 0.1 13.1 16.0 17.7 1.2 3.1 19.7 5.5 0.1 31.4 5.1 6.8 9.3 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 2497.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 1369.9;SK-BR-3: 1618.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 190000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 163.2 79.8 77.8 62.4 73.5 0.8 161.1 75.9 98.8 199.1 69.0 126.9 122.6 79.1 20.0 2497.6 68.8 82.3 112.3 76.6 110.1 157.3 211.7 162.7 28.7 101.0 75.9 69.5 84.1 41.4 77.3 42.3 72.3 79.1 78.5 106.0 7.0 441.6 38.5 52.1 442.8 110.7 79.7 81.0 119.5 101.3 60.8 92.0 25.2 73.0 52.6 206.8 164.8 719.2 85.5 670.4 318.1 16.0 36.7 102.5 386.8 42.8 367.9 341.4 302.7 265.2 315.4 366.1 0.3 577.5 553.0 69.0 479.6 1.1 839.2 175.3 1.9 0.6 0.4 260.5 90.8 117.5 0.2 0.9 182.7 787.6 731.6 567.9 390.9 1369.9 0.0 8.5 0.8 677.3 918.7 0.9 1.4 69.0 1171.0 887.9 0.9 187.4 1.8 1150.3 236.1 0.8 1.9 267.6 1618.0 55.7 140.5 504.7 3.5 743.9 178.2 289.5 171.5 848.6 0.5 3.5 2.4 525.0 0.9 122.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 77.8 73.5 75.9 98.8 76.6 110.1 101.0 75.9 69.5 79.1 81.0 92.0 85.5 275.6 38.5 25.5 10.4 6.8 633.9 995.4 531.6 157.6 0.5 225.4 191.3 33.0 124.4 290.6 108.5 2.1 20.3 4.4 500.7 72.4 610.9 4.9 50.9 172.5 293.5 139.0 16.0 0.0 193.9 8.7 112.2 96.8 128.5 19.1 154.1 365.9 132.7 5.0 0.0 0.1 286.4 164.8 15.7 95.4 17.4 67.1 7.4 112.1 5.6 7.2 72.5 0.0 7.5 0.7 1307.3 610.0 61.3 5.6 1141.1 353.3 169.7 48.6 2.1 6.6 70.9 91.2 8.0 1.3 1028.7 908.8 8.2 12.9 1528.4 320.2 1522.5 PTAR1 ENSG00000188647 "Protein prenyltransferase alpha subunit repeat containing 1" Q7Z6K3 9 69709522-69760011 "Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021248 Uncertain Approved "Centriolar satellite,Rods & Rings" NA NA "Centriolar satellite" "Rods & Rings" "HPA021248: AB_1855872" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (9.40e-2)" "unprognostic (1.71e-1)" "unprognostic (4.16e-1)" "unprognostic (6.99e-2)" "prognostic favorable (4.65e-4)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 9.6 6.7 12.0 9.8 10.8 34.1 12.9 10.5 11.3 10.9 11.6 10.6 6.9 11.3 7.5 8.3 9.8 8.1 8.4 11.2 10.5 14.2 13.4 11.4 11.6 12.9 12.6 7.0 12.7 11.1 15.5 6.7 9.9 9.4 7.2 12.9 21.6 10.5 5.8 14.5 9.6 10.7 8.5 10.8 11.4 7.6 9.7 16.4 20.3 10.0 11.8 9.0 9.3 10.9 14.6 11.8 11.9 18.7 9.1 16.4 21.2 10.4 27.2 17.5 8.1 8.9 3.8 7.7 12.2 12.5 20.9 8.1 18.0 39.4 10.2 19.3 11.1 10.7 18.8 24.3 10.8 18.0 16.7 16.2 14.1 9.4 14.4 22.7 16.9 14.6 19.9 11.7 24.7 23.3 3.2 14.5 6.5 24.9 12.2 9.9 13.1 29.6 9.2 23.4 10.3 13.7 17.2 16.6 8.0 15.5 17.4 5.5 8.3 27.3 22.3 20.4 18.5 22.3 17.2 18.2 7.4 15.0 16.1 41.6 5.6 2.3 4.2 2.8 3.3 2.6 1.9 2.5 2.2 2.0 1.6 2.8 2.9 7.3 2.9 2.0 1.1 4.3 1.4 12.0 10.8 10.5 11.3 11.2 10.5 12.9 12.6 7.0 9.4 10.8 16.4 14.6 26.0 35.3 21.6 104.8 26.3 16.7 19.4 17.7 21.6 29.1 21.1 18.5 19.1 40.0 17.9 33.1 81.3 20.1 28.5 29.2 15.6 13.3 19.2 17.0 24.8 24.5 11.4 23.8 21.7 7.7 14.6 21.6 12.2 16.8 17.7 28.7 20.0 32.6 12.7 33.7 33.0 28.6 36.7 31.1 18.3 22.1 31.1 22.9 32.0 51.5 28.6 31.8 26.8 82.0 62.2 12.5 21.3 23.0 22.1 23.2 14.7 41.4 18.8 56.2 26.3 26.1 21.1 57.0 10.3 19.5 15.3 9.6 26.0 21.6 22.2 25.5 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96033745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 8.8" "Cell type enhanced" "Detected in some" "Astrocytes: 25.8;Early spermatids: 10.8;Microglial cells: 15.0;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044091, HPA072122" Enhanced Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA044091: AB_2732514, HPA072122: AB_2686489" "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.7 1.9 0.8 1.9 2.7 2.5 0.5 1.2 2.0 0.7 2.9 0.9 1.0 1.5 0.4 0.8 0.9 1.5 1.1 0.6 1.7 0.9 0.6 0.8 1.4 2.5 1.7 0.3 1.1 0.4 0.7 0.3 1.1 2.9 0.6 0.3 2.8 1.1 0.4 2.3 2.4 0.6 1.2 1.5 1.2 1.0 8.8 1.7 0.2 3.1 0.2 0.2 0.8 0.8 5.5 1.1 4.4 3.7 7.4 0.2 0.4 4.1 3.8 0.4 0.7 0.1 3.3 0.8 4.4 3.0 0.0 3.8 3.0 0.3 0.3 0.0 4.9 8.5 9.7 3.5 2.8 0.0 9.8 0.7 0.7 0.0 0.4 0.1 1.3 0.3 1.4 7.8 2.9 0.9 2.6 4.6 3.1 7.9 3.3 6.8 12.1 3.4 3.8 0.7 0.8 6.5 3.2 3.9 1.0 2.5 4.4 6.8 4.9 3.7 4.3 4.5 3.0 5.7 2.6 11.7 0.2 3.3 8.4 2.8 0.0 0.3 0.0 0.5 0.1 0.9 1.2 0.4 0.3 0.3 1.2 0.4 0.1 0.3 0.2 0.2 0.3 0.2 0.1 0.8 2.7 1.2 2.0 0.6 1.7 2.5 1.7 0.3 2.9 1.5 1.7 5.5 1.1 0.0 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.8 0.2 0.4 1.1 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 15.0 0.2 0.0 0.0 13.6 7.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 RNASE9 "h461, RAK1" ENSG00000188655 "Ribonuclease A family member 9 (inactive)" P60153 14 20556093-20560931 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 994 "epididymis: 99.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 18.0;fallopian tube: 60.4;testis: 21.8" "Group enriched" "Detected in many" 4 "Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.1 3.9 0.3 2.4 0.6 3.3 2.4 3.0 1.9 6.9 1.1 0.7 2.2 18.0 0.6 60.4 1.0 1.3 2.7 2.5 2.4 0.9 8.1 1.2 3.0 2.9 1.7 1.7 1.6 4.7 5.0 0.4 2.5 2.6 2.0 6.9 2.8 1.2 1.3 2.1 1.6 0.6 3.3 1.2 2.5 21.8 1.7 2.6 3.5 0.8 1.6 1.3 1.1 3.9 1.4 1.9 1.1 4.1 0.9 1.8 0.5 0.5 0.3 0.8 1.5 0.2 2.3 1.4 1.0 0.0 2.2 10.5 1.8 1.6 1.8 1.0 6.8 0.5 3.4 0.0 0.1 0.3 0.4 1.2 2.2 1.4 1.2 2.3 1.7 2.9 10.0 0.7 1.0 1.0 0.5 0.0 2.7 0.5 0.8 1.4 0.5 0.9 0.8 0.9 7.8 1.2 1.1 0.0 1.5 0.6 4.0 0.4 0.2 2.0 1.1 4.2 0.8 2.1 2.6 0.9 1.9 0.5 1.3 0.0 0.0 3.0 0.5 0.0 0.8 1.3 0.2 1.5 0.1 3.3 0.9 0.4 0.0 2.0 0.1 0.8 0.0 0.3 3.9 2.4 2.4 3.0 2.7 2.5 3.0 2.9 1.7 2.5 3.3 1.7 3.9 1.8 0.0 2.7 9.1 1.5 0.0 2.0 0.0 2.8 2.7 4.5 4.1 2.7 1.5 24.1 3.7 4.2 0.5 0.9 0.1 1.9 0.7 90.9 71.5 1.5 0.9 2.4 0.8 21.1 0.5 0.4 1.5 10.2 2.0 1.3 3.7 0.4 0.3 0.1 0.0 16.4 1.9 0.0 0.6 0.0 175.4 2.5 0.5 0.0 3.7 0.0 3.7 0.0 9.0 8.0 0.3 0.1 2.2 1.9 1.5 0.3 4.6 201.9 5.0 6.6 1.0 1.0 57.7 12.7 0.9 0.0 0.3 0.7 3.0 0.5 1.6 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 48.8" "Cell type enriched" "Detected in some" 67 "Erythroid cells: 511.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HEL: 81.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.2 0.6 1.9 0.1 2.4 48.8 0.3 2.1 3.3 0.3 1.6 0.2 0.2 0.2 4.3 0.6 1.0 0.3 1.1 2.0 2.1 0.4 1.7 0.4 0.5 2.3 2.0 1.9 0.5 1.2 0.1 3.4 1.1 2.2 1.0 0.3 2.3 5.5 0.2 1.5 0.6 0.1 0.0 2.1 1.1 0.4 2.2 2.0 0.8 0.6 0.9 0.3 0.1 0.5 2.8 0.2 0.1 0.2 0.5 0.9 0.6 0.1 0.3 0.3 0.4 0.1 0.1 1.5 0.7 1.1 1.0 0.1 0.3 0.0 0.2 0.2 0.4 0.1 81.3 0.0 0.0 1.1 0.0 0.6 1.9 1.5 0.6 0.5 0.0 0.0 0.6 17.5 0.4 0.5 0.8 0.0 0.6 1.7 0.7 0.5 0.2 0.2 2.6 0.0 0.0 0.7 0.8 0.3 0.3 1.0 0.8 0.5 0.0 0.1 0.2 0.0 0.9 0.0 5.1 1.4 1.0 2.9 0.9 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.9 2.4 2.1 3.3 2.0 2.1 2.3 2.0 1.9 2.2 2.1 2.0 2.8 0.8 0.0 0.0 5.5 0.8 0.5 0.5 0.3 0.6 4.2 1.1 2.5 0.7 1.5 0.2 0.0 0.0 0.8 1.2 0.5 0.0 0.3 1.1 1.2 0.7 0.4 0.0 511.8 2.9 0.2 0.7 0.4 3.6 0.8 4.5 0.6 0.0 0.7 0.2 6.7 2.3 0.0 0.0 0.6 0.4 0.5 0.6 1.7 0.0 0.0 0.0 4.7 1.0 2.0 2.7 0.5 0.0 0.7 3.0 0.3 0.1 0.0 0.9 2.4 6.6 0.5 0.5 3.0 7.6 0.6 1.4 0.8 0.8 0.7 0.3 0.7 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "brain: 29.7;choroid plexus: 9.4" "Group enriched" "Detected in some" 8 "Excitatory neurons: 25.8;Inhibitory neurons: 11.7;Oligodendrocyte precursor cells: 31.7" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in single" "NTERA-2: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.0 0.1 19.8 0.4 29.7 1.2 0.0 8.1 28.8 0.0 9.4 0.2 0.2 0.1 0.0 1.0 0.1 0.2 0.1 27.8 24.6 0.1 0.3 0.0 0.2 13.7 15.2 26.3 0.2 0.0 0.1 1.0 0.1 15.4 0.2 0.2 1.4 0.3 0.4 0.3 0.4 0.3 0.1 11.5 0.1 0.2 0.6 17.6 0.0 0.1 0.0 0.0 0.0 0.0 19.5 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.5 1.7 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.3 3.2 0.6 0.5 0.3 0.4 0.2 0.5 0.3 0.3 0.2 0.7 0.3 0.3 4.6 0.5 0.3 0.8 0.1 0.1 19.8 29.7 8.1 28.8 27.8 24.6 13.7 15.2 26.3 15.4 11.5 17.6 19.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 1.0 0.0 31.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IDO2 INDOL1 ENSG00000188676 "Indoleamine 2,3-dioxygenase 2" Q6ZQW0 8 39934614-40016391 "Metabolic proteins, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "liver: 5.5;placenta: 4.0" "Cell type enhanced" "Detected in some" "Early spermatids: 21.0;Endometrial ciliated cells: 18.4;Glandular and luminal cells: 51.3;Late spermatids: 6.9;monocytes: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054911 Approved Cytosol NA NA Cytosol "HPA054911: " "unprognostic (2.00e-3)" "unprognostic (2.34e-5)" "unprognostic (2.22e-3)" "unprognostic (4.41e-3)" "unprognostic (5.37e-2)" "unprognostic (3.69e-5)" "unprognostic (1.19e-1)" "unprognostic (4.73e-3)" "unprognostic (1.20e-2)" "unprognostic (2.78e-1)" "unprognostic (4.11e-3)" "unprognostic (2.25e-1)" "unprognostic (6.47e-7)" "unprognostic (3.25e-2)" "unprognostic (1.96e-3)" "unprognostic (3.35e-2)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.5 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.1 21.0 18.4 4.4 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 51.3 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.0 0.0 0.0 1.9 6.9 0.3 0.8 0.0 0.0 14.6 0.0 0.0 0.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.1 PARVB CGI-56 ENSG00000188677 "Parvin beta" Q9HBI1 22 43999211-44172939 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 197.8;tongue: 172.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 113.2;Hofbauer cells: 90.6;Macrophages: 78.7" "Cancer enhanced" "Detected in all" "melanoma: 20.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 158.0;RPMI-8226: 159.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062601, HPA072217" Enhanced Approved Cytosol NA NA 24000000 Cytosol "HPA062601: AB_2684803, HPA072217: " "unprognostic (2.41e-1)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (2.10e-3)" "unprognostic (7.65e-3)" "unprognostic (1.28e-1)" "unprognostic (1.73e-2)" "unprognostic (2.28e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-2)" "unprognostic (6.45e-2)" "unprognostic (1.28e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-2)" "unprognostic (4.19e-2)" "unprognostic (7.05e-3)" 40.6 30.9 24.8 21.5 17.5 43.8 33.3 16.7 26.6 20.9 22.9 19.2 7.5 22.4 13.6 12.0 19.4 10.8 69.3 32.2 21.8 22.7 14.5 29.9 19.4 21.5 21.5 17.2 27.3 12.0 18.6 24.5 21.6 23.8 17.1 8.7 10.5 11.5 13.8 197.8 13.8 18.8 23.1 17.7 35.6 15.1 6.7 23.9 9.5 12.9 172.1 16.3 24.1 16.8 19.7 23.5 27.7 0.4 19.1 28.1 35.5 0.1 32.4 20.1 20.9 15.6 28.9 13.8 0.2 17.5 87.2 16.4 0.9 45.9 2.1 11.5 33.1 28.5 100.4 45.8 0.2 46.5 76.5 86.7 55.4 24.0 15.2 0.2 15.0 158.0 0.4 36.6 67.0 22.9 15.9 0.4 50.4 9.8 20.4 18.7 0.2 0.8 159.5 0.5 0.6 24.6 17.1 8.6 1.6 84.9 3.3 15.9 30.7 99.2 19.0 20.0 29.4 3.4 16.2 15.3 0.7 82.8 22.1 106.0 6.9 6.8 1.6 1.0 7.1 1.6 6.2 1.7 1.5 7.2 6.4 0.4 0.9 4.7 0.8 2.9 14.9 2.4 9.5 24.8 17.5 16.7 26.6 32.2 21.8 21.5 21.5 17.2 23.8 17.7 23.9 19.7 70.3 0.0 10.6 5.2 48.2 5.2 3.4 1.3 4.0 11.2 8.3 9.4 55.0 4.3 0.9 1.8 16.7 1.0 29.0 0.3 27.4 1.5 6.6 8.0 12.6 63.7 1.2 113.2 15.1 3.1 10.8 18.4 4.1 11.7 64.7 20.2 53.2 12.5 90.6 6.7 12.5 0.7 6.1 49.7 39.5 21.6 19.9 78.7 19.6 28.1 44.7 8.9 9.2 2.5 5.9 4.7 0.0 10.9 58.1 5.1 0.0 30.0 3.8 15.2 6.6 18.2 14.2 1.9 5.8 0.7 4.4 1.8 16.7 2.3 0.6 1.5 SLC4A5 NBC4 ENSG00000188687 "Solute carrier family 4 member 5" Q9BY07 2 74216242-74343414 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Sodium transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 62.0;retina: 42.4;thyroid gland: 26.9" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 168.2" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 3.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-266/70: 8.8" "Group enriched" "Detected in many" 5 "basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5" "Low region specificity" "Detected in many" HPA036621 Uncertain NA NA "HPA036621: AB_10696779" "unprognostic (1.30e-1)" "unprognostic (3.78e-2)" "unprognostic (2.75e-2)" "unprognostic (1.83e-4)" "unprognostic (3.38e-1)" "unprognostic (2.36e-2)" "unprognostic (2.56e-3)" "unprognostic (5.37e-4)" "unprognostic (1.39e-1)" "unprognostic (2.55e-1)" "unprognostic (1.55e-3)" "unprognostic (3.24e-2)" "unprognostic (1.72e-5)" "unprognostic (1.57e-1)" "unprognostic (1.06e-2)" "unprognostic (8.47e-2)" "unprognostic (9.27e-4)" 1.3 0.7 3.7 1.2 5.4 2.4 1.5 12.3 4.4 1.3 62.0 1.0 0.8 1.4 2.3 0.9 2.1 1.0 1.4 6.6 3.0 1.0 1.0 2.6 1.8 6.0 5.2 2.3 1.6 1.5 12.5 2.4 0.6 7.2 1.2 0.7 42.4 1.7 1.3 1.9 5.0 1.0 1.5 2.7 1.3 0.9 16.3 4.6 1.0 26.9 1.6 0.8 1.1 1.1 8.8 0.3 0.5 0.9 0.9 0.9 1.6 0.9 0.2 0.9 0.5 0.7 0.3 0.7 1.5 0.2 0.0 0.3 0.1 1.0 0.1 0.2 1.2 0.6 2.2 0.7 0.5 0.1 0.5 1.3 0.4 1.3 0.0 0.2 0.5 0.3 1.0 0.5 1.5 0.2 3.5 0.3 1.5 0.4 0.5 0.3 0.8 0.7 0.0 0.2 0.6 0.6 1.2 0.3 1.1 1.6 0.7 0.8 1.5 0.0 0.9 1.6 0.9 0.3 8.8 1.4 1.0 0.6 0.8 0.2 4.3 0.3 0.3 0.6 0.3 0.4 0.7 1.0 0.9 0.3 0.9 0.8 1.0 1.9 0.7 0.1 2.5 1.2 0.2 3.7 5.4 12.3 4.4 6.6 3.0 6.0 5.2 2.3 7.2 2.7 4.6 8.8 1.1 3.2 10.8 16.0 0.5 0.6 0.6 0.3 0.0 13.9 0.6 0.5 0.4 1.5 2.6 0.0 35.5 0.1 3.3 0.3 0.0 0.4 0.6 1.0 0.7 0.9 0.0 0.4 7.3 0.6 0.0 0.8 0.0 0.8 0.0 1.1 0.7 0.0 0.1 168.2 10.6 0.5 0.0 0.0 0.4 0.6 1.2 0.4 1.8 4.7 0.1 3.3 2.1 4.0 31.1 0.5 0.3 0.4 0.1 0.6 0.3 0.1 4.1 40.4 0.0 2.5 1.1 1.7 1.3 0.0 0.4 0.0 0.6 0.3 0.2 0.7 UROS ENSG00000188690 "Uroporphyrinogen III synthase" P10746 10 125784980-125823258 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 231.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044038 Approved Approved Nucleoplasm,Cytosol NA NA 69000 Nucleoplasm Cytosol "HPA044038: AB_10966692" "unprognostic (8.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.77e-1)" "unprognostic (7.19e-2)" "unprognostic (1.90e-1)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (5.82e-2)" "unprognostic (1.27e-1)" "unprognostic (4.35e-3)" "unprognostic (4.23e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (3.93e-1)" 28.1 41.6 51.4 13.5 49.9 68.1 27.1 37.7 65.0 15.6 30.7 27.1 21.1 21.5 57.4 25.1 19.4 15.7 69.6 52.2 44.6 40.9 60.2 20.7 18.9 40.8 45.8 50.6 22.7 33.1 30.3 30.2 11.4 42.9 27.6 16.7 26.5 29.9 19.3 84.6 22.7 24.4 18.3 37.0 28.3 29.8 31.4 49.4 18.7 32.8 80.7 19.3 27.6 17.2 47.8 45.5 56.3 29.8 74.9 38.5 42.2 51.9 51.4 94.5 39.0 34.6 22.9 54.0 58.4 24.7 72.9 24.3 23.5 18.5 43.1 31.3 78.1 39.9 125.3 27.9 40.1 67.3 50.7 29.7 59.3 20.7 25.8 66.0 47.5 34.4 48.5 24.4 54.1 63.5 65.2 51.2 72.8 37.7 31.8 54.0 33.1 34.1 37.3 53.9 28.2 26.2 46.8 51.6 41.8 80.7 30.8 40.4 59.1 33.8 52.3 19.6 38.1 48.2 50.7 36.8 40.6 75.6 23.1 26.3 4.9 31.9 4.6 30.1 33.1 33.9 30.1 29.3 38.6 53.5 37.5 38.1 29.6 2.1 53.6 31.9 25.3 29.8 38.1 51.4 49.9 37.7 65.0 52.2 44.6 40.8 45.8 50.6 42.9 37.0 49.4 47.8 19.0 19.2 23.1 20.5 34.3 9.3 12.0 31.8 9.6 49.3 36.2 39.5 70.5 40.0 28.6 36.8 45.9 60.8 36.3 19.1 101.8 59.7 57.0 11.2 25.5 22.2 14.5 231.5 23.9 59.6 47.4 33.3 23.9 16.9 11.4 112.3 28.2 53.4 79.3 47.1 25.2 25.6 40.7 47.8 20.8 123.7 35.8 31.6 62.2 9.4 58.7 77.0 69.0 13.6 29.6 42.7 15.8 40.6 46.9 27.3 52.9 142.6 20.4 42.3 6.6 22.8 36.7 55.7 100.9 28.5 12.8 20.0 37.8 55.0 38.8 21.3 OR56A5 OR56A5P ENSG00000188691 "Olfactory receptor family 56 subfamily A member 5" P0C7T3 11 5967177-5968494 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.82e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP24-1 KAP24.1 ENSG00000188694 "Keratin associated protein 24-1" Q3LI83 21 30281309-30282950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "skin 1: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017604 Enhanced NA NA "HPA017604: AB_2669625" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZDHHC9 "CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type palmitoyltransferase 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 66.0;Oligodendrocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavorable (9.77e-5)" "prognostic unfavorable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 27.3 12.1 38.5 10.3 62.0 5.5 24.5 44.1 51.5 19.2 22.8 22.2 31.9 12.0 11.8 15.7 12.2 15.4 14.0 37.5 59.8 37.4 40.4 27.0 3.3 57.4 58.2 32.5 11.3 26.1 25.4 11.5 17.3 57.1 18.9 25.2 6.1 21.3 11.4 13.5 32.7 34.3 15.4 44.1 3.9 19.7 4.1 53.8 3.7 14.0 11.4 6.6 24.0 14.6 79.8 45.9 23.8 33.2 67.5 112.4 87.7 27.0 44.3 50.6 20.9 26.0 37.6 58.4 1.6 73.7 47.6 54.0 30.4 38.0 44.6 30.0 2.6 23.7 9.2 24.0 50.1 44.4 6.1 15.7 96.0 71.1 34.0 50.1 36.5 39.9 15.0 10.1 17.6 34.0 40.0 8.8 11.4 18.0 102.3 40.4 8.2 21.4 27.1 30.1 25.2 26.3 22.0 12.7 64.7 20.5 38.9 27.6 10.1 32.8 21.1 7.3 50.0 36.3 16.5 12.7 5.5 37.9 25.1 10.8 0.0 2.2 1.8 3.0 2.0 3.7 2.7 3.6 2.9 2.4 1.5 4.5 2.6 0.0 2.5 5.2 5.1 1.8 2.1 38.5 62.0 44.1 51.5 37.5 59.8 57.4 58.2 32.5 57.1 44.1 53.8 79.8 66.0 22.4 28.6 4.6 2.8 18.6 12.4 12.8 13.1 9.1 16.8 15.1 4.6 17.2 15.9 46.0 2.1 5.6 2.7 20.1 3.9 18.6 1.8 23.8 16.9 16.6 18.0 4.2 10.5 19.8 19.1 32.7 18.3 59.7 2.5 11.5 7.9 43.7 4.9 1.7 11.8 23.2 10.2 3.5 12.2 2.0 12.2 3.9 10.6 7.5 0.3 1.5 1.0 9.5 118.2 33.5 14.6 7.5 7.7 39.1 51.0 25.8 7.2 2.8 0.0 9.5 11.1 8.4 8.7 16.9 19.2 10.3 5.1 7.5 27.2 22.1 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150322639-150332721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 72.9;parathyroid gland: 25.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4;Exocrine glandular cells: 13.3;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 85.2;K-562: 34.5" "Low region specificity" "Detected in all" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 1.3 72.9 1.3 5.3 0.9 3.8 2.1 0.6 0.8 2.7 2.6 3.9 3.4 4.4 1.2 3.0 4.1 1.6 1.1 1.2 1.0 4.5 12.2 3.1 7.0 1.0 0.9 0.8 6.1 7.3 25.8 5.5 0.8 0.8 3.5 3.1 1.7 2.8 2.1 0.5 3.7 5.1 1.8 0.7 5.0 4.2 1.1 1.0 5.7 4.0 0.3 6.8 2.7 2.1 1.0 8.1 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.3 0.9 10.9 8.4 4.8 4.0 0.1 0.0 3.5 0.0 0.0 0.7 85.2 5.4 6.3 13.3 17.6 2.1 0.0 8.4 1.4 3.9 0.0 0.0 0.3 0.4 16.2 34.5 11.8 0.0 3.3 14.5 2.8 5.3 3.4 0.0 0.0 0.5 10.2 3.2 16.4 15.1 8.4 14.9 3.2 0.5 2.4 1.0 3.6 0.2 0.0 0.0 0.0 0.1 10.0 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.2 0.8 0.5 0.6 0.9 0.2 0.8 0.8 0.8 0.8 0.7 0.0 0.2 0.6 0.7 1.3 0.9 0.6 0.8 1.2 1.0 1.0 0.9 0.8 0.8 0.7 1.0 1.0 0.0 0.0 1.5 0.0 0.6 0.3 0.5 1.0 0.0 1.0 1.2 0.9 0.9 2.8 1.6 1.8 8.4 1.5 2.2 2.2 5.9 2.8 0.0 3.1 0.4 0.9 4.8 0.8 0.0 13.3 0.8 0.6 1.5 3.3 1.3 1.3 0.4 3.7 0.6 0.0 0.0 2.4 4.1 1.2 0.0 0.4 2.8 0.7 0.0 0.0 3.4 1.2 3.1 0.0 0.0 13.4 1.2 1.2 0.2 0.4 1.3 0.9 0.6 0.6 0.0 0.9 0.2 0.4 0.9 0.9 0.1 1.9 1.4 1.1 2.3 0.4 QRFP "26RFa, P518" ENSG00000188710 "Pyroglutamylated RFamide peptide" P83859 9 130892707-130896812 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;Bipolar cells: 1.0;Rod photoreceptor cells: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 11 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "U-138 MG: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043377 Uncertain "Secreted in other tissues" NA NA "HPA043377: AB_10959754" "unprognostic (1.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-3)" "unprognostic (4.14e-3)" "unprognostic (7.78e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-3)" "unprognostic (5.11e-3)" "unprognostic (1.77e-1)" "unprognostic (2.28e-1)" "unprognostic (5.43e-3)" "unprognostic (1.02e-1)" "unprognostic (2.52e-2)" "unprognostic (2.48e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (7.04e-3)" 0.5 0.2 0.2 0.2 0.3 0.2 0.4 0.3 0.3 0.7 0.2 1.9 0.2 0.7 0.0 1.1 0.5 0.3 0.5 0.2 1.1 0.3 0.2 0.5 0.1 0.4 0.3 0.2 0.6 1.3 0.0 1.0 0.1 0.3 1.2 0.0 0.1 0.3 0.0 0.2 0.4 0.9 0.0 0.0 0.3 1.0 1.2 0.2 0.0 0.7 0.0 0.0 1.9 0.7 0.4 0.6 0.3 0.2 1.6 0.0 0.0 0.8 0.6 0.0 0.0 0.0 1.0 0.4 0.2 0.2 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 2.2 0.2 1.5 1.4 0.2 0.2 1.5 0.9 0.6 0.0 0.5 0.5 0.7 0.5 0.2 0.7 0.4 0.8 0.5 0.2 3.5 0.9 1.4 1.7 0.1 0.6 0.7 0.6 0.4 1.8 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.3 0.3 0.3 0.2 1.1 0.4 0.3 0.2 0.3 0.0 0.2 0.4 0.0 3.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 DUSP29 "DUPD1, DUSP27" ENSG00000188716 "Dual specificity phosphatase 29" Q68J44 10 75037836-75058514 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 71.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042964 Uncertain NA NA "HPA042964: AB_10795764" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.9 0.0 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM15 "C5orf43, DKFZP686E2158" ENSG00000188725 "Small integral membrane protein 15" Q7Z3B0 5 61157704-61162468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-1)" "unprognostic (2.56e-1)" "unprognostic (2.33e-2)" "unprognostic (3.82e-1)" "unprognostic (3.32e-2)" "unprognostic (6.03e-2)" "unprognostic (9.83e-3)" "unprognostic (4.43e-2)" "unprognostic (2.44e-2)" "unprognostic (4.09e-1)" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (5.34e-3)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "prognostic favorable (9.23e-4)" 19.1 23.8 14.2 24.8 15.4 22.7 29.4 15.2 16.7 27.1 13.5 49.6 42.9 22.5 23.7 32.8 31.1 25.3 16.0 13.5 17.9 32.1 43.7 24.5 27.0 15.3 14.3 13.3 33.4 27.7 36.7 16.2 30.6 15.1 31.0 41.8 21.6 27.3 27.9 11.3 18.6 41.1 23.9 16.3 19.7 47.0 15.4 14.4 28.0 35.9 15.7 29.2 40.7 21.7 18.2 95.3 79.6 51.4 84.1 48.8 58.0 52.9 78.5 86.0 77.1 103.2 69.4 141.4 46.2 133.4 82.6 101.3 54.5 0.0 94.3 90.3 97.4 42.1 72.9 60.7 67.9 95.4 54.2 65.9 69.0 85.9 95.7 108.6 58.9 62.9 57.1 87.0 61.7 87.4 99.5 27.9 0.7 63.4 38.7 92.7 9.8 63.8 106.2 83.3 112.6 71.0 67.9 90.4 48.2 99.4 35.9 90.9 58.3 72.4 46.1 73.9 58.9 100.9 62.6 117.3 85.9 63.2 29.6 96.7 33.2 56.4 20.2 34.7 70.5 38.7 41.6 38.3 39.9 51.4 33.9 46.0 32.1 11.3 58.8 57.8 41.2 55.9 39.4 14.2 15.4 15.2 16.7 13.5 17.9 15.3 14.3 13.3 15.1 16.3 14.4 18.2 26.8 57.7 37.1 4.9 39.4 86.8 122.1 58.1 60.3 25.7 45.2 33.4 21.2 35.8 53.2 42.3 8.4 71.9 34.6 79.9 135.0 70.8 23.3 35.6 40.3 25.7 55.2 29.2 3.9 61.3 62.9 50.0 57.1 40.9 23.5 35.4 25.7 40.4 73.4 40.4 4.3 74.0 42.7 40.8 30.5 24.5 46.3 40.5 40.9 2.8 33.8 59.3 44.3 4.5 8.7 75.2 116.1 42.2 41.9 108.6 73.2 93.0 37.0 20.8 26.3 28.2 37.6 18.7 12.3 78.6 82.7 47.5 34.9 45.7 82.8 152.6 OSTN ENSG00000188729 Osteocrin P61366 3 191199241-191265615 "Predicted secreted proteins" Differentiation "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Early spermatids: 4.2;Excitatory neurons: 1.0;Inhibitory neurons: 5.9;Late spermatids: 1.4;Oligodendrocyte precursor cells: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.0;naive B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 4.0" "Cell line enriched" "Detected in some" 24 "U-2197: 39.1" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in single" "CAB024997, CAB025649, HPA030878" Uncertain "Secreted in other tissues" NA NA "CAB024997: , CAB025649: , HPA030878: AB_2673642" "unprognostic (2.35e-2)" "unprognostic (9.12e-2)" "unprognostic (6.30e-2)" "unprognostic (2.34e-1)" "unprognostic (2.51e-1)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (8.11e-3)" "unprognostic (2.90e-1)" "unprognostic (1.45e-1)" 0.3 0.1 0.5 0.7 0.9 0.0 0.2 0.1 1.1 1.2 0.2 0.1 0.0 0.1 1.6 0.0 0.7 0.8 0.3 0.7 0.9 0.1 0.6 0.2 0.6 0.5 0.3 0.5 0.2 0.0 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.2 0.1 0.8 1.2 0.1 0.0 0.5 0.2 0.3 0.4 0.2 0.1 0.1 1.0 0.0 1.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 1.6 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.9 0.1 1.1 0.7 0.9 0.5 0.3 0.5 0.6 0.5 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VWC2 "PSST739, UNQ739" ENSG00000188730 "Von Willebrand factor C domain containing 2" Q2TAL6 7 49773638-49921950 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.8;heart muscle: 5.0;ovary: 5.0" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 361.7;Oligodendrocyte precursor cells: 163.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055243 Approved "Secreted to extracellular matrix" NA NA 39000 "HPA055243: AB_2682755" "unprognostic (3.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-4)" "unprognostic (8.97e-2)" "unprognostic (8.77e-2)" "unprognostic (1.56e-3)" "unprognostic (3.41e-2)" "unprognostic (4.11e-1)" "unprognostic (6.65e-2)" "unprognostic (1.69e-4)" "unprognostic (1.60e-2)" "unprognostic (2.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.94e-1)" "unprognostic (9.70e-3)" 0.0 0.0 2.4 0.0 2.0 0.0 0.0 8.8 1.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 5.0 0.8 1.5 0.0 0.0 0.1 0.0 0.7 2.3 0.9 5.0 0.0 0.1 0.1 0.0 2.9 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.1 0.4 0.2 0.1 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.0 8.8 1.7 0.8 1.5 0.7 2.3 0.9 2.9 0.2 3.9 1.6 0.0 0.0 0.0 3.3 0.0 0.5 0.1 0.0 10.8 22.6 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 18.4 0.5 0.0 0.0 65.2 0.0 0.0 1.6 0.0 0.4 0.0 47.6 0.0 0.0 0.0 1.7 361.7 0.2 0.0 0.0 1.6 0.0 0.0 0.3 0.0 10.3 0.0 0.9 0.0 163.3 1.7 0.0 7.3 0.0 0.1 0.2 0.1 0.0 0.0 13.5 0.0 0.1 2.7 0.0 0.4 0.7 2.0 0.0 0.3 0.6 0.3 0.2 FAM221A "C7orf46, DKFZp686F0810, FLJ45875, MGC72075" ENSG00000188732 "Family with sequence similarity 221 member A" A4D161 7 23680130-23703249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 69.2;Respiratory ciliated cells: 51.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 19.3;GAMG: 26.5;MOLT-4: 27.4;SCLC-21H: 23.4;SH-SY5Y: 41.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019719, HPA026748, HPA026752" Enhanced Approved Cytosol NA NA Cytosol "HPA019719: AB_1853910, HPA026748: AB_1853911, HPA026752: AB_1853912" "unprognostic (1.28e-1)" "unprognostic (7.28e-3)" "unprognostic (6.03e-3)" "unprognostic (2.54e-1)" "unprognostic (3.33e-2)" "unprognostic (8.04e-2)" "unprognostic (8.51e-3)" "unprognostic (2.18e-3)" "unprognostic (3.10e-2)" "unprognostic (5.69e-2)" "unprognostic (3.75e-1)" "unprognostic (2.42e-2)" "unprognostic (9.30e-3)" "unprognostic (4.26e-2)" "unprognostic (1.11e-2)" "unprognostic (2.40e-1)" "unprognostic (1.81e-2)" 4.2 3.6 14.6 3.2 17.3 1.8 4.4 18.0 24.6 3.5 15.0 6.6 10.0 2.6 3.4 7.3 9.4 3.4 4.1 14.2 16.2 6.5 9.8 4.8 3.9 17.1 16.1 13.9 3.9 20.6 2.7 5.3 1.6 18.0 4.9 8.6 4.9 7.6 2.4 2.7 4.0 7.4 1.9 17.0 2.6 12.0 19.8 16.0 7.8 6.0 4.4 5.0 4.9 4.1 23.8 0.0 1.0 11.1 8.9 0.4 0.0 5.4 0.6 0.8 1.4 1.6 11.6 5.5 1.5 19.3 0.3 26.5 2.4 0.0 0.1 2.2 0.0 15.3 3.3 1.1 0.0 3.0 0.0 17.3 0.7 0.7 0.2 0.1 2.4 3.4 11.7 0.0 0.0 0.4 5.5 27.4 0.0 0.0 0.0 5.8 10.8 1.1 0.0 5.8 5.4 23.4 41.3 1.9 0.0 0.0 2.6 5.6 8.0 0.5 0.1 4.2 2.4 1.1 0.1 0.1 0.0 1.1 0.0 2.0 0.0 3.1 4.2 5.1 2.0 10.7 6.6 8.6 6.4 5.4 6.8 9.8 5.5 0.1 7.8 6.0 4.7 12.2 3.3 14.6 17.3 18.0 24.6 14.2 16.2 17.1 16.1 13.9 18.0 17.0 16.0 23.8 7.2 16.0 7.2 13.4 7.2 16.2 9.5 10.0 14.8 6.9 17.8 7.7 5.5 20.0 20.0 7.3 2.1 3.5 5.3 8.2 9.8 15.4 8.5 24.7 2.0 6.9 14.9 3.8 13.7 10.6 0.3 12.3 36.7 11.2 5.1 10.2 6.1 16.0 6.7 6.7 16.3 25.7 18.3 4.1 10.8 10.4 4.7 6.1 8.8 12.2 2.1 8.5 2.1 11.6 69.2 11.5 25.2 3.8 7.1 11.7 15.2 12.3 51.6 8.0 19.7 8.5 5.3 45.2 27.6 14.6 18.9 0.8 7.6 4.4 22.5 11.8 TMEM120B ENSG00000188735 "Transmembrane protein 120B" A0PK00 12 121712752-121783001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 93.1;NK-cells: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014066 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA014066: AB_1845296" "unprognostic (8.80e-3)" "unprognostic (3.31e-2)" "unprognostic (1.95e-2)" "unprognostic (1.40e-2)" "unprognostic (3.10e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (3.62e-1)" "unprognostic (3.29e-1)" "unprognostic (5.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (5.86e-2)" "unprognostic (8.02e-3)" "unprognostic (2.31e-1)" "unprognostic (2.13e-3)" "unprognostic (4.72e-2)" 6.6 11.0 5.5 2.7 14.0 7.7 7.0 16.5 8.1 26.4 3.4 6.3 3.5 13.8 2.4 4.4 18.8 2.1 7.0 9.8 4.3 11.5 7.9 6.5 3.1 4.7 3.2 5.4 8.7 16.9 4.4 20.1 1.7 7.6 9.1 2.0 4.3 11.1 2.7 14.0 5.2 5.4 5.6 0.6 6.8 8.8 5.7 3.7 1.3 13.9 4.9 1.7 6.7 11.8 4.3 5.4 17.3 4.1 11.7 5.0 6.6 8.5 7.0 7.8 6.4 5.2 11.0 5.6 5.6 4.3 7.0 6.3 8.9 9.6 8.1 3.4 3.4 9.7 7.9 6.1 7.1 6.8 5.5 5.9 6.1 7.2 7.3 5.2 11.0 4.0 12.2 7.2 3.8 3.9 8.1 9.6 7.6 7.7 3.4 10.9 11.4 16.9 7.4 3.4 5.7 15.6 11.1 7.2 5.4 6.1 7.4 12.8 4.4 5.3 8.7 10.0 5.5 6.1 9.5 3.8 3.9 10.9 7.0 8.8 1.0 0.3 0.3 0.7 0.3 0.5 0.6 0.7 0.5 0.4 1.1 0.5 0.5 0.7 0.6 0.3 0.9 0.6 0.3 5.5 14.0 16.5 8.1 9.8 4.3 4.7 3.2 5.4 7.6 0.6 3.7 4.3 3.3 25.6 12.2 12.1 14.0 6.5 5.3 6.5 4.6 35.4 9.2 5.5 5.9 8.6 9.9 11.0 22.9 6.4 45.9 36.7 7.9 7.8 19.7 30.6 12.6 4.8 6.6 16.6 29.8 12.3 6.9 9.1 8.2 42.9 4.5 29.8 1.8 4.6 5.7 13.5 40.7 4.9 4.1 4.7 93.1 39.9 6.5 17.6 1.8 10.3 32.1 3.6 76.2 7.1 6.6 30.3 33.6 6.4 19.8 7.2 29.4 7.0 15.7 20.6 6.6 10.3 8.6 8.4 7.5 2.9 7.0 11.4 28.0 16.8 5.4 10.0 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738804-185833290 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 18.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 137.8;Alveolar cells type 2: 93.8;Early spermatids: 289.6;Gastric mucus-secreting cells: 68.3;Spermatocytes: 124.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.0 0.2 0.3 0.2 0.6 0.0 0.2 0.3 0.5 0.2 0.0 1.4 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.9 0.4 0.1 0.3 0.2 0.2 0.4 0.1 0.6 0.2 0.9 0.6 0.2 0.0 0.0 0.2 0.2 0.0 0.5 0.0 2.6 18.5 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.5 0.2 0.6 0.9 0.4 0.1 0.6 0.5 0.3 0.8 1.7 137.8 93.8 5.2 2.6 0.5 0.1 1.4 1.8 16.3 3.0 1.7 3.9 0.0 31.5 0.0 10.4 0.3 1.0 26.0 0.0 0.7 289.6 3.3 3.3 5.6 7.7 0.0 4.5 0.2 0.1 7.3 68.3 2.1 40.4 2.7 1.8 0.1 0.4 18.5 5.4 19.7 0.0 0.8 1.0 50.8 2.1 5.9 1.8 3.7 0.7 3.9 2.1 23.6 14.0 5.4 5.5 3.8 1.3 0.2 0.5 0.2 46.0 7.2 0.0 4.0 0.8 124.4 5.4 0.2 0.3 0.3 6.0 2.6 5.2 0.2 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161283 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 12.3 10.4 12.5 15.1 12.7 35.8 17.2 12.5 13.8 10.1 12.6 12.6 18.0 11.6 15.7 14.0 11.0 12.3 15.6 12.1 12.5 17.3 14.9 12.0 23.4 13.9 12.8 11.1 12.9 13.2 9.3 8.8 13.4 13.6 12.1 14.2 6.3 20.1 7.5 19.9 18.4 15.9 11.7 13.6 12.8 14.4 21.5 12.9 16.5 15.8 12.4 20.7 15.8 9.7 13.9 28.6 20.9 23.8 28.8 17.9 33.3 52.8 29.3 24.6 29.4 30.1 26.9 33.7 49.4 29.9 21.0 22.1 40.5 29.0 28.9 28.2 44.4 47.8 35.7 17.0 20.1 35.1 60.4 34.5 28.0 33.2 26.5 19.6 26.5 26.8 50.5 54.5 23.7 38.7 18.0 49.9 48.3 65.3 43.8 15.8 48.0 23.2 57.3 29.5 22.7 26.2 47.1 39.2 27.0 66.4 17.0 55.2 63.5 21.0 26.2 23.0 36.1 59.9 27.8 47.5 47.4 30.8 38.0 40.8 113.9 36.0 44.1 46.1 42.5 55.6 74.1 53.0 59.8 37.2 54.5 49.0 57.4 18.3 58.2 46.4 59.5 77.5 51.5 12.5 12.7 12.5 13.8 12.1 12.5 13.9 12.8 11.1 13.6 13.6 12.9 13.9 4.3 19.2 12.8 12.1 11.9 3.2 10.0 7.3 10.2 2.6 6.3 3.7 3.4 7.2 9.1 3.7 10.4 6.2 19.3 4.1 5.9 6.6 7.2 3.2 5.1 6.9 7.8 3.8 10.6 6.2 4.5 10.3 4.6 6.0 23.4 8.0 6.1 3.6 3.3 0.0 11.5 2.7 8.2 5.4 3.2 7.9 4.1 7.1 3.6 15.9 9.4 4.0 23.7 10.1 11.9 8.6 9.6 5.7 10.2 5.3 5.3 12.8 10.7 5.7 0.0 5.0 4.4 7.1 5.3 8.0 3.8 6.2 16.2 3.3 4.5 7.7 NOXA1 "FLJ25475, NY-CO-31, SDCCAG31" ENSG00000188747 "NADPH oxidase activator 1" Q86UR1 9 137423350-137434406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 37.5;Gastric mucus-secreting cells: 54.6;Paneth cells: 34.7;Proximal enterocytes: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 12.6;EFO-21: 11.3;MCF7: 19.8;T-47d: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA044781 Uncertain Approved Vesicles NA NA Vesicles "HPA044781: AB_10960532" "unprognostic (2.15e-1)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.42e-3)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (1.69e-1)" "unprognostic (5.45e-3)" "unprognostic (1.97e-3)" "prognostic favorable (2.65e-4)" "unprognostic (4.97e-3)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-2)" 3.5 6.6 8.7 3.5 8.9 3.0 7.0 4.1 24.6 7.4 2.2 9.6 19.5 6.2 1.2 9.7 9.3 6.9 3.9 8.9 7.7 12.9 12.6 4.6 2.6 10.5 8.0 11.1 10.1 17.3 6.2 15.5 1.2 9.3 10.5 3.9 2.6 20.0 7.1 10.4 18.6 13.4 1.3 4.7 7.1 17.8 3.9 6.5 2.7 13.0 1.4 1.4 5.7 8.8 8.0 2.0 5.0 0.1 3.8 0.4 0.0 2.6 0.4 0.6 0.2 0.3 0.8 12.6 0.0 11.3 0.1 0.8 8.6 0.2 0.2 0.0 5.5 4.2 0.0 3.6 1.9 1.2 0.1 2.4 0.4 2.7 0.0 0.1 2.2 0.3 0.0 0.7 0.8 0.0 19.8 0.0 1.1 0.2 5.2 1.7 0.1 0.0 7.8 3.3 4.3 1.0 0.3 0.3 2.0 2.0 0.2 18.8 1.6 1.3 0.2 2.6 2.9 0.4 0.8 0.0 0.1 0.3 0.7 0.6 0.0 0.4 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.7 0.1 0.1 0.4 0.0 0.6 2.5 0.0 0.0 0.2 8.7 8.9 4.1 24.6 8.9 7.7 10.5 8.0 11.1 9.3 4.7 6.5 8.0 4.0 0.0 5.4 6.5 4.0 3.4 6.1 2.8 3.4 9.8 16.2 11.2 1.3 14.3 7.2 12.9 8.4 0.4 2.3 37.5 7.9 7.4 0.3 11.2 2.1 2.4 6.7 2.7 22.4 11.0 0.4 1.7 54.6 20.0 2.5 3.8 0.7 6.5 5.4 3.3 17.0 20.5 4.1 3.8 9.0 0.5 1.2 6.1 8.8 6.5 3.8 10.7 4.1 8.0 3.8 7.0 34.7 0.7 2.1 4.4 39.5 19.9 5.9 8.2 6.6 3.2 3.8 5.1 5.0 12.8 4.1 0.3 3.5 1.0 24.6 7.4 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 19.2;Horizontal cells: 21.9;Muller glia cells: 10.9;Proximal enterocytes: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.0;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles NA NA Vesicles "HPA042385: AB_2677972, HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favorable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 2.7 8.2 10.8 1.4 9.9 0.1 3.0 10.9 20.0 4.1 2.5 2.6 9.0 5.3 1.0 2.0 3.6 1.8 4.1 21.0 8.0 4.1 4.3 3.2 0.7 8.0 8.2 10.4 14.8 12.1 3.1 18.4 1.1 7.7 4.3 0.6 2.6 3.8 1.8 2.8 1.5 4.4 1.6 7.2 2.3 4.6 5.9 9.2 0.5 4.0 2.0 0.7 3.9 2.1 8.9 0.6 0.1 5.6 9.6 1.1 1.0 4.9 2.8 1.5 2.3 2.0 12.5 1.6 2.6 2.7 1.8 5.8 3.5 2.0 1.4 0.4 8.7 2.4 2.0 2.9 10.4 1.6 0.7 4.7 2.4 0.8 1.1 2.7 2.5 0.0 1.8 7.8 8.1 1.4 1.2 0.1 0.6 7.3 1.0 0.9 0.2 3.4 2.9 1.4 1.4 20.0 17.4 0.7 2.0 5.0 1.0 0.2 4.0 0.1 2.5 1.0 2.3 1.2 7.7 2.4 2.7 2.3 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 10.8 9.9 10.9 20.0 21.0 8.0 8.0 8.2 10.4 7.7 7.2 9.2 8.9 0.3 0.0 1.1 2.0 0.8 0.1 1.4 1.4 1.2 9.3 3.5 4.3 1.8 4.3 0.6 0.0 2.1 1.0 0.4 0.4 1.9 3.9 0.8 0.3 2.6 0.4 19.2 0.0 4.9 7.9 0.9 3.9 1.5 0.6 0.0 1.6 0.0 1.6 0.3 21.9 4.8 2.4 2.0 0.3 0.9 1.4 2.8 0.0 1.8 0.0 0.6 10.9 0.0 3.0 1.2 1.5 4.0 4.9 1.1 0.8 12.4 1.8 0.6 7.4 0.0 1.6 2.8 8.4 4.2 0.4 0.1 2.9 0.4 5.5 0.5 0.4 BCL2L15 "Bfk, C1orf178, FLJ22588" ENSG00000188761 "BCL2 like 15" Q5TBC7 1 113876816-113887581 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.6;stomach 1: 18.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 67.6;Exocrine glandular cells: 115.9;Intestinal goblet cells: 39.3;Pancreatic endocrine cells: 74.9;Proximal enterocytes: 133.2;Undifferentiated cells: 54.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 16.9;EFO-21: 5.4;OE19: 15.2;RPTEC TERT1: 5.5" "Region enriched" "Detected in some" 32 "cerebellum: 32.9" "Low region specificity" "Detected in all" "HPA029732, HPA029733" Enhanced NA NA "HPA029732: AB_10599615, HPA029733: AB_10600422" "unprognostic (5.96e-2)" "unprognostic (6.41e-3)" "unprognostic (5.82e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.16e-1)" "unprognostic (6.23e-3)" "unprognostic (4.97e-4)" "unprognostic (1.74e-1)" "unprognostic (2.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.27e-2)" "unprognostic (1.49e-1)" "unprognostic (2.42e-7)" "unprognostic (5.20e-2)" "unprognostic (2.24e-2)" "unprognostic (9.04e-3)" "unprognostic (4.27e-2)" 0.2 0.1 1.2 3.1 1.2 13.3 0.6 2.6 1.9 3.9 0.5 32.8 43.6 1.1 5.3 2.2 0.6 8.4 0.2 1.3 1.2 0.7 0.2 0.5 0.2 1.2 0.9 1.2 0.1 9.7 0.1 0.1 0.1 1.5 0.3 27.1 1.3 0.3 0.2 0.3 0.2 42.1 0.9 0.7 0.5 18.6 0.8 1.1 1.2 0.1 0.0 0.2 0.5 0.6 1.5 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 2.2 0.3 0.1 0.0 15.2 0.0 0.1 0.3 0.6 5.5 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.3 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 1.2 2.6 1.9 1.3 1.2 1.2 0.9 1.2 1.5 0.7 1.1 1.5 0.6 0.0 1.3 2.0 0.9 0.4 5.0 3.4 2.2 1.6 0.3 0.3 0.4 4.3 12.2 23.9 6.2 0.1 1.0 67.6 0.0 4.1 1.4 4.3 0.5 1.2 2.4 0.0 2.3 115.9 0.0 1.2 29.6 5.5 0.0 0.4 0.0 0.3 0.8 1.7 1.8 39.3 6.1 0.6 5.0 0.2 0.0 1.6 0.0 0.0 2.5 0.3 0.0 0.5 1.6 74.9 23.3 0.0 1.0 2.7 133.2 0.4 6.3 2.6 0.0 6.6 2.2 0.6 0.6 2.0 1.1 0.1 1.8 0.4 54.9 14.9 FZD9 "CD349, FZD3" ENSG00000188763 "Frizzled class receptor 9" O00144 7 73433778-73436120 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;skeletal muscle: 7.1;testis: 4.7" "Group enriched" "Detected in some" 4 "Early spermatids: 8.0;Late spermatids: 14.2;Muller glia cells: 5.2;Oligodendrocyte precursor cells: 15.1;Sertoli cells: 6.6" "Cancer enriched" "Detected in many" 5 "melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.5;MCF7: 2.0;NTERA-2: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (9.60e-2)" "unprognostic (4.03e-2)" "unprognostic (3.16e-2)" "unprognostic (9.15e-3)" "unprognostic (1.10e-1)" "unprognostic (6.91e-2)" "unprognostic (2.29e-2)" "unprognostic (2.26e-1)" "unprognostic (2.04e-1)" "unprognostic (7.17e-3)" "unprognostic (1.20e-1)" "unprognostic (7.24e-2)" "unprognostic (5.90e-5)" "unprognostic (8.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.22e-1)" "unprognostic (5.21e-2)" 1.2 0.3 3.0 0.0 2.2 0.5 0.5 2.2 3.9 0.1 1.5 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.1 2.2 2.3 0.1 0.1 0.2 0.0 4.0 3.3 2.1 0.0 0.9 0.4 3.1 0.3 2.6 2.3 0.0 0.1 1.1 0.1 7.1 0.6 0.8 0.0 1.7 0.3 0.3 4.7 3.9 0.1 0.4 0.5 0.0 0.2 0.2 3.1 0.3 1.4 1.5 1.7 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.0 0.6 0.1 0.7 0.0 0.0 0.0 4.5 0.0 0.3 0.5 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 2.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.4 1.3 0.9 1.0 0.2 0.9 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.2 2.2 3.9 2.2 2.3 4.0 3.3 2.1 2.6 1.7 3.9 3.1 0.0 0.0 0.0 1.0 0.0 0.6 0.7 0.2 1.2 0.3 0.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 8.0 0.1 0.2 0.9 0.0 0.0 0.2 0.4 0.3 0.3 0.0 0.9 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.4 2.0 0.3 0.4 14.2 0.0 0.2 0.0 1.9 0.6 5.2 0.0 15.1 0.7 0.1 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.7 6.6 0.1 0.4 0.3 0.4 0.5 1.1 0.0 0.0 0.0 0.3 0.4 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 13.0;pituitary gland: 5.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 6.6;Enteroendocrine cells: 10.8;Excitatory neurons: 9.8;Inhibitory neurons: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.9;TIME: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 0.7 0.4 4.7 1.1 4.2 0.3 0.5 0.8 5.3 0.5 1.1 0.4 1.8 0.5 0.3 0.4 0.6 0.7 0.7 4.8 8.7 1.0 0.2 0.7 0.2 5.4 3.1 3.9 0.3 1.1 1.7 5.7 0.3 4.5 1.0 0.2 1.5 0.5 0.3 0.9 0.9 1.3 0.9 1.4 0.1 0.4 1.1 4.5 0.1 0.6 0.0 0.2 0.7 0.5 13.0 0.3 1.2 4.0 3.3 0.6 1.9 2.3 8.1 5.3 2.6 2.4 0.4 0.8 0.2 2.9 2.7 2.1 0.1 0.7 1.0 2.4 0.8 1.5 0.1 0.3 0.5 1.4 2.2 0.1 1.3 0.9 6.2 1.8 12.9 8.3 0.6 0.7 1.5 8.1 0.4 0.0 0.1 1.8 0.5 4.0 1.0 1.4 0.1 5.7 0.7 0.2 3.1 0.2 0.2 0.4 1.7 0.7 0.1 15.9 2.9 9.0 2.4 4.5 0.6 0.3 0.6 9.8 0.3 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 4.7 4.2 0.8 5.3 4.8 8.7 5.4 3.1 3.9 4.5 1.4 4.5 13.0 1.1 0.0 0.0 2.0 0.4 0.0 1.3 0.4 1.2 6.6 1.5 2.4 1.2 0.0 0.3 1.8 2.1 0.5 0.3 0.5 0.0 1.0 2.0 0.7 1.1 1.5 10.8 0.0 9.8 0.6 0.3 0.5 0.0 1.6 0.0 0.3 0.7 0.0 0.1 1.7 10.4 1.2 0.0 0.0 0.0 0.2 0.3 0.5 0.0 1.0 0.0 1.9 1.0 5.0 2.2 3.0 0.1 0.0 0.0 1.2 2.7 0.1 0.1 0.3 0.0 2.3 1.2 1.5 1.0 0.5 0.1 0.8 0.4 0.2 0.8 0.7 OPTC ENSG00000188770 Opticin Q9UBM4 1 203494153-203508949 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Oligodendrocyte precursor cells: 1.5;Spermatocytes: 1.5" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034951, HPA034952" Enhanced "Secreted in other tissues" NA NA "HPA034951: AB_10669852, HPA034952: AB_2674379" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" "unprognostic (7.69e-2)" "unprognostic (3.19e-2)" "unprognostic (1.70e-3)" "unprognostic (8.24e-2)" "unprognostic (3.65e-2)" 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.2 0.4 0.9 0.7 0.1 0.8 0.3 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLET1 C11orf34 ENSG00000188771 "Placenta expressed transcript 1" Q6UQ28 11 112248153-112260860 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Excitatory neurons: 1.7;Inhibitory neurons: 2.0;Microglial cells: 1.0;Oligodendrocytes: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.8" HPA040237 Uncertain NA NA "HPA040237: AB_10793960" "unprognostic (8.70e-2)" "unprognostic (1.75e-1)" "unprognostic (8.51e-3)" "unprognostic (5.19e-2)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.2 0.1 0.2 0.3 0.2 0.0 0.7 0.1 0.3 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADRB3 ENSG00000188778 "Adrenoceptor beta 3" P13945 8 37962990-37966599 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.8;ovary: 11.8" "Cell type enhanced" "Detected in some" "Fibroblasts: 2.8;Hofbauer cells: 1.1;Langerhans cells: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "white matter: 21.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA061969 Uncertain NA NA "HPA061969: AB_2732674" "unprognostic (1.70e-1)" "unprognostic (2.24e-1)" "unprognostic (6.64e-3)" "unprognostic (5.41e-1)" "unprognostic (1.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-2)" "unprognostic (2.29e-8)" "unprognostic (1.10e-3)" "unprognostic (2.81e-2)" "unprognostic (5.37e-2)" "unprognostic (6.06e-3)" 0.2 0.0 6.0 0.4 0.9 0.2 0.3 0.4 0.8 0.2 1.4 1.6 0.2 0.7 1.1 0.1 4.1 1.7 0.0 0.8 2.5 0.0 0.0 0.1 0.1 9.2 2.2 0.3 11.8 0.0 0.0 0.0 2.9 3.4 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.6 1.0 0.7 0.0 2.1 0.0 2.3 0.0 0.0 0.0 0.0 4.7 0.4 21.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.9 0.4 0.8 0.8 2.5 9.2 2.2 0.3 3.4 0.7 2.3 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834582 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.6;Early spermatids: 20.5;Late spermatids: 36.2;Spermatocytes: 8.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.0;U-266/70: 2.4;U-266/84: 2.0;U-698: 2.1" "Group enriched" "Detected in some" 11 "cerebellum: 3.7;pons and medulla: 1.2" "Region enriched" "Detected in single" 5 "cerebellum: 5.0" HPA071150 Enhanced NA NA "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 0.5 0.4 0.4 0.0 0.5 0.3 0.5 5.4 1.1 0.7 0.0 0.6 0.2 0.7 0.1 0.2 0.6 0.1 0.3 0.4 0.9 0.3 0.2 0.4 0.0 2.4 0.4 0.1 0.9 0.4 0.0 1.2 0.2 1.7 0.5 0.0 0.5 0.3 0.1 0.4 0.8 0.5 0.1 1.3 0.4 0.4 1.1 0.8 0.3 0.4 0.0 0.0 0.5 0.5 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.1 0.5 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.1 2.4 2.0 2.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 5.4 1.1 0.4 0.9 2.4 0.4 0.1 1.7 1.3 0.8 0.8 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.6 0.7 0.2 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 20.5 0.0 0.1 0.4 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 36.2 0.9 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.6 0.0 0.0 0.7 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.5 0.3 8.0 0.3 0.1 0.4 0.0 0.0 0.2 0.1 0.1 CATSPER4 ENSG00000188782 "Cation channel sperm associated 4" Q7RTX7 1 26190561-26202968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 53 "testis: 11.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 65.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045257 Enhanced NA NA "HPA045257: AB_10968995" "unprognostic (7.20e-2)" "unprognostic (2.06e-2)" "unprognostic (4.56e-2)" "unprognostic (2.69e-2)" "unprognostic (3.49e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-2)" "unprognostic (2.16e-1)" "unprognostic (3.06e-1)" "unprognostic (6.78e-2)" "unprognostic (6.98e-2)" "unprognostic (6.67e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRELP "prolargin, SLRR2A" ENSG00000188783 "Proline and arginine rich end leucine rich repeat protein" P51888 1 203475806-203491352 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Fibroblasts: 206.6;Leydig cells: 100.6;Melanocytes: 192.1;Muller glia cells: 152.4;Peritubular cells: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.1" "Group enriched" "Detected in some" 5 "ASC diff: 18.0;BJ: 7.7;fHDF/TERT166: 11.7;SuSa: 5.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 82.4" HPA059225 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 450000 "Endoplasmic reticulum" "HPA059225: " "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.83e-2)" "unprognostic (6.56e-2)" "unprognostic (2.75e-2)" "unprognostic (1.61e-1)" "unprognostic (2.84e-2)" "unprognostic (3.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (5.62e-6)" "unprognostic (2.81e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.02e-4)" 115.1 23.6 11.3 4.2 11.6 0.5 78.1 6.8 21.1 108.5 36.7 103.9 6.7 149.0 7.7 41.7 109.5 40.7 143.0 10.6 17.4 18.3 15.8 125.8 8.0 9.4 7.4 9.0 129.3 13.2 2.5 22.8 12.1 10.1 74.2 9.0 21.7 33.0 77.8 35.9 51.3 61.5 51.9 6.7 44.5 41.6 7.3 9.1 3.2 60.9 37.2 16.0 149.0 93.7 8.5 0.2 0.2 0.5 0.1 18.0 0.5 0.4 7.7 1.0 0.2 0.2 0.0 0.1 1.2 0.6 11.7 0.1 0.6 0.2 0.3 0.3 0.0 0.1 0.2 0.5 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.2 2.1 0.0 0.4 0.2 0.4 1.3 0.1 0.1 0.5 0.4 0.3 0.1 0.4 0.2 0.4 0.0 0.3 1.0 0.2 0.2 0.2 0.8 5.2 0.2 0.1 0.6 0.5 0.2 0.3 0.1 0.2 0.3 1.2 0.1 0.2 0.5 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 11.3 11.6 6.8 21.1 10.6 17.4 9.4 7.4 9.0 10.1 6.7 9.1 8.5 8.8 0.0 5.8 5.2 0.9 18.2 1.0 0.0 2.2 3.6 4.2 5.1 7.4 1.5 0.6 0.0 2.1 0.1 0.3 0.1 0.0 0.0 1.1 0.6 1.7 15.6 0.0 2.7 1.6 0.0 0.1 206.6 4.6 1.6 5.1 0.2 22.9 0.3 0.3 1.7 0.2 0.0 0.0 0.3 19.2 5.3 100.6 0.9 192.1 22.5 0.0 152.4 0.0 7.5 0.5 0.0 0.0 199.7 0.4 0.6 0.0 0.1 1.5 8.9 26.3 9.6 38.3 3.1 2.4 1.6 9.9 0.3 1.6 0.1 0.0 1.3 PLA2G2E ENSG00000188784 "Phospholipase A2 group IIE" Q9NZK7 1 19920009-19923617 "Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "lymphoid tissue: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064085 Uncertain "Secreted - unknown location" NA NA "HPA064085: AB_2685188" "unprognostic (9.56e-2)" "unprognostic (3.71e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF548 FLJ32932 ENSG00000188785 "Zinc finger protein 548" Q8NEK5 19 57389850-57402992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 55.6" HPA066042 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066042: AB_2685602" "prognostic favorable (7.85e-4)" "unprognostic (4.61e-2)" "unprognostic (5.53e-2)" "unprognostic (8.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (1.61e-2)" "unprognostic (6.77e-2)" "unprognostic (3.01e-2)" "unprognostic (1.59e-2)" "unprognostic (4.66e-2)" "unprognostic (2.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (5.85e-2)" 13.8 6.9 5.8 17.1 6.2 26.5 12.4 12.0 11.5 8.0 6.8 9.0 6.9 10.9 6.9 8.2 10.3 11.4 9.7 7.1 7.4 6.5 6.8 12.1 24.0 5.7 4.9 5.7 11.9 6.9 8.6 7.1 8.5 6.2 7.8 8.2 12.7 7.1 7.2 7.6 10.4 14.7 11.7 4.3 19.1 7.3 6.5 5.8 13.5 11.9 5.5 18.1 8.5 7.8 7.6 7.5 6.8 12.1 8.7 5.7 6.2 2.5 5.4 8.0 8.4 14.0 1.7 20.5 7.4 3.4 4.3 5.6 3.3 5.1 5.9 7.6 3.5 17.4 7.7 55.6 8.8 4.1 8.1 16.3 7.2 8.5 8.0 11.7 8.1 4.2 15.1 0.5 0.1 7.6 2.0 12.8 3.1 3.4 0.2 7.6 15.6 13.3 10.1 4.4 12.7 7.5 9.1 6.6 3.5 4.0 10.2 7.6 6.1 6.9 10.0 9.7 3.3 9.8 18.7 13.1 10.3 6.9 4.5 10.1 1.3 1.5 2.6 4.0 1.7 5.6 3.9 3.7 5.2 3.1 8.4 5.5 5.8 1.4 5.1 2.2 2.6 7.0 2.6 5.8 6.2 12.0 11.5 7.1 7.4 5.7 4.9 5.7 6.2 4.3 5.8 7.6 10.2 3.2 6.7 4.6 9.5 6.6 4.9 4.3 4.6 5.0 9.1 7.1 5.7 7.2 4.0 7.3 6.2 4.4 8.9 1.9 3.9 4.4 12.7 5.3 4.4 9.1 6.0 1.7 3.0 2.4 2.9 5.9 2.0 4.5 9.5 7.6 11.0 8.4 4.2 1.7 3.9 3.8 4.1 4.8 2.9 5.1 5.6 4.3 0.0 1.9 3.2 6.3 8.2 4.0 4.6 2.5 1.1 4.1 8.8 3.5 3.3 2.7 5.8 9.4 0.0 7.7 7.8 11.7 7.1 4.5 5.7 4.4 9.4 4.2 2.3 2.2 MTF1 ENSG00000188786 "Metal regulatory transcription factor 1" Q14872 1 37809574-37859592 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 20.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028604, HPA028689" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA028604: AB_10600304, HPA028689: AB_10611384" "unprognostic (5.74e-2)" "unprognostic (2.10e-1)" "unprognostic (2.56e-2)" "unprognostic (2.89e-1)" "unprognostic (8.33e-2)" "unprognostic (8.15e-3)" "unprognostic (1.34e-2)" "unprognostic (5.07e-2)" "unprognostic (1.91e-1)" "unprognostic (4.58e-2)" "unprognostic (3.20e-2)" "unprognostic (2.30e-2)" "unprognostic (3.70e-2)" "unprognostic (4.37e-3)" "unprognostic (2.98e-1)" "unprognostic (6.32e-2)" "unprognostic (2.19e-1)" 4.8 3.5 4.8 5.2 5.9 20.7 4.1 4.9 5.3 4.7 5.2 4.5 2.8 4.2 2.7 8.4 5.6 3.5 2.6 4.3 5.1 3.8 2.5 4.3 4.0 5.5 5.7 3.7 5.5 4.0 6.1 3.4 3.3 5.1 3.3 4.6 4.8 3.2 3.1 5.3 4.5 3.1 4.7 5.0 4.6 3.3 6.6 5.0 4.4 3.9 6.5 5.8 5.4 4.0 6.3 7.5 4.5 4.4 3.9 11.0 7.6 8.4 7.2 7.4 8.4 8.0 4.9 4.2 7.9 5.4 8.2 5.5 6.8 7.6 6.0 9.7 27.5 4.7 7.5 6.4 3.8 6.2 8.9 8.0 7.1 10.4 11.9 12.0 6.0 5.4 5.6 4.9 6.2 6.3 4.2 4.5 4.6 6.2 3.9 4.4 4.7 10.4 4.8 5.6 7.3 6.7 4.9 8.6 6.9 6.2 6.1 4.2 7.3 7.7 5.2 5.9 6.0 9.6 11.4 13.8 4.4 7.1 9.1 4.6 2.8 3.7 2.4 1.8 3.6 1.5 1.3 1.5 1.3 2.3 1.6 1.6 1.3 3.7 1.1 6.0 0.8 1.1 1.8 4.8 5.9 4.9 5.3 4.3 5.1 5.5 5.7 3.7 5.1 5.0 5.0 6.3 9.7 9.6 10.3 10.7 15.4 20.6 11.4 11.0 15.9 0.0 13.2 10.8 12.7 8.6 8.8 7.3 0.0 10.0 11.2 20.4 1.9 11.8 50.0 30.0 14.2 13.0 23.8 9.9 16.3 15.6 23.2 10.7 9.2 30.4 16.5 9.2 13.2 7.2 10.2 0.0 14.3 8.8 16.2 20.1 9.1 18.2 9.6 22.6 7.2 8.4 26.8 0.0 11.3 9.5 20.7 12.9 8.6 11.7 15.7 14.8 11.5 6.2 28.8 0.0 6.6 18.2 12.1 33.7 22.5 23.2 29.7 17.1 12.9 7.1 9.2 16.0 TMCO2 dJ39G22.2 ENSG00000188800 "Transmembrane and coiled-coil domains 2" Q7Z6W1 1 40245947-40251684 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 473 "testis: 123.6" "Group enriched" "Detected in some" 44 "Early spermatids: 2649.9;Late spermatids: 1104.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.30e-2)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.25e-1)" "unprognostic (3.93e-2)" "unprognostic (2.70e-5)" "unprognostic (6.16e-2)" "unprognostic (2.29e-1)" "unprognostic (1.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2649.9 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1104.1 16.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.1 0.0 0.0 0.0 0.1 1.5 0.0 19.7 0.2 0.0 41.9 9.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241213-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5;cervix: 17.0" "Cell type enhanced" "Detected in some" "Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "OE19: 52.0" "Low region specificity" "Detected in all" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 1.7 0.6 16.0 0.0 9.9 0.0 1.1 22.3 25.8 17.0 0.9 0.5 0.2 6.2 0.7 0.8 1.8 0.3 0.5 41.5 17.1 1.9 0.0 0.2 0.0 41.3 23.9 6.3 0.6 1.0 3.5 0.2 0.1 23.8 4.3 0.4 1.1 0.2 7.4 0.7 0.7 0.3 0.5 40.7 0.0 4.3 2.9 31.2 0.0 0.5 1.3 0.0 1.1 3.4 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 52.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 9.9 22.3 25.8 41.5 17.1 41.3 23.9 6.3 23.8 40.7 31.2 27.7 0.9 0.0 0.0 50.3 0.0 0.1 0.1 0.0 1.2 4.0 1.8 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.5 16.9 1.6 1.2 0.0 27.4 0.0 0.0 2.1 0.0 0.5 0.0 5.6 0.4 0.0 0.1 0.0 181.4 0.0 0.0 0.0 0.3 15.2 5.0 0.0 1.8 12.2 0.0 0.8 0.0 77.4 2.4 0.0 0.0 29.0 0.0 0.8 0.0 0.2 0.0 0.2 0.0 0.2 1.7 0.4 2.5 0.1 0.1 0.0 0.1 4.4 0.2 0.2 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588911-9614877 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favorable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 5.2 6.1 7.7 3.6 7.7 7.8 5.2 6.9 9.8 7.1 5.2 5.4 3.2 7.4 2.0 7.0 6.3 2.2 12.6 8.5 7.7 7.2 3.4 4.1 3.2 9.9 8.8 6.9 9.5 6.2 4.5 16.1 2.5 8.9 6.4 1.3 6.2 5.6 3.0 43.6 6.2 4.7 2.7 6.8 5.5 4.7 10.5 7.7 3.3 5.5 24.5 2.0 5.3 5.5 7.5 13.6 18.2 11.1 26.3 4.6 3.1 9.9 15.7 4.8 18.3 12.9 33.1 12.0 23.5 19.4 5.5 9.0 27.9 12.4 12.4 6.2 15.7 31.2 16.7 17.4 17.0 8.4 20.4 16.6 5.7 5.5 24.6 3.9 3.9 7.3 10.9 21.7 6.6 7.5 16.0 17.8 14.8 11.2 10.3 16.4 37.1 19.0 19.3 6.6 7.3 26.6 19.9 12.3 29.9 13.5 3.8 9.1 12.7 6.7 21.7 18.8 24.0 30.0 11.0 9.9 21.0 15.0 33.0 19.6 0.0 0.2 0.0 0.3 0.2 0.1 0.5 0.3 0.5 0.3 0.2 0.2 0.2 0.0 0.1 0.1 1.3 0.5 0.3 7.7 7.7 6.9 9.8 8.5 7.7 9.9 8.8 6.9 8.9 6.8 7.7 7.5 5.2 3.2 2.0 4.9 2.2 7.0 2.5 1.8 4.6 16.0 5.3 4.7 12.1 2.8 2.1 0.0 27.1 4.1 0.8 2.6 1.9 2.3 2.0 4.2 4.9 4.9 6.7 5.2 4.1 1.0 2.5 4.0 2.6 4.4 4.5 11.7 3.6 1.6 3.6 10.1 6.0 3.7 2.0 2.5 3.5 1.8 4.1 2.4 3.6 0.0 0.9 5.0 1.0 7.1 5.9 1.7 0.9 4.5 2.8 3.2 0.6 1.9 2.4 16.9 0.0 7.3 4.2 6.8 5.4 7.9 5.5 0.8 2.8 4.6 4.3 2.3 NHLRC3 ENSG00000188811 "NHL repeat containing 3" Q5JS37 13 39038306-39050109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013738 Uncertain "Secreted to blood" NA NA 310000 "HPA013738: AB_1854455" "unprognostic (7.92e-2)" "unprognostic (3.51e-2)" "unprognostic (5.96e-2)" "unprognostic (3.90e-1)" "unprognostic (2.92e-2)" "unprognostic (1.22e-1)" "unprognostic (2.99e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-1)" "unprognostic (8.88e-2)" "unprognostic (2.28e-2)" "unprognostic (4.83e-2)" "unprognostic (3.21e-1)" "unprognostic (1.58e-2)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (7.81e-2)" 18.7 12.1 8.9 11.0 9.9 7.5 15.4 9.1 10.6 11.6 10.7 13.0 11.7 13.7 20.8 7.5 10.8 13.1 10.3 9.1 11.4 16.9 26.1 14.0 14.4 11.3 9.4 8.9 16.0 13.5 8.5 11.5 19.6 10.3 11.1 16.7 13.0 12.3 9.9 10.9 12.1 12.4 11.9 9.5 16.2 16.9 8.8 9.5 8.1 17.1 10.5 12.1 10.1 9.8 11.7 5.1 3.1 13.5 6.5 15.4 16.0 20.9 7.8 9.7 8.2 10.9 9.8 22.6 13.9 14.5 5.2 10.3 10.5 5.4 4.5 7.1 20.3 5.8 11.1 6.9 11.2 9.8 11.1 15.8 13.0 5.8 5.7 5.5 12.3 5.2 11.2 4.0 16.9 7.6 3.8 8.7 17.2 3.7 11.8 3.2 9.2 36.2 7.8 12.6 10.1 3.1 5.6 5.0 6.9 18.4 7.5 9.0 17.5 6.0 11.2 5.4 14.7 8.3 13.5 12.3 5.5 14.9 11.9 8.2 1.5 6.8 0.8 4.5 6.9 5.0 4.1 3.2 3.7 6.0 3.0 3.3 4.8 0.6 4.5 6.8 5.4 4.1 3.7 8.9 9.9 9.1 10.6 9.1 11.4 11.3 9.4 8.9 10.3 9.5 9.5 11.7 20.6 12.8 20.2 22.9 36.7 8.4 16.9 40.8 15.9 70.8 22.2 13.5 13.0 18.6 35.8 35.0 56.3 78.4 52.5 22.5 9.8 21.0 6.7 14.1 25.3 22.4 13.8 23.3 37.4 16.5 14.9 21.8 17.9 14.6 15.8 76.7 42.5 34.5 43.6 79.1 45.8 28.6 42.7 57.6 27.0 4.6 61.2 35.2 17.8 27.2 47.7 33.5 102.0 40.2 131.7 17.2 25.0 41.8 30.7 10.2 34.8 16.3 32.1 93.1 59.2 14.2 18.7 51.1 41.0 9.0 8.9 24.2 30.5 50.2 28.4 11.7 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148136-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 1.2;kidney: 1.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "REH: 38.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.3" "CAB013268, CAB022752" Approved NA NA "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.6 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 SNTN "FLJ44379, S100AL" ENSG00000188817 "Sentan, cilia apical structure protein" A6NMZ2 3 63652675-63679020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 174.9" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 410.9;Respiratory ciliated cells: 726.5" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "MOLT-4: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA043322, HPA058399" Enhanced NA NA "HPA043322: AB_10793945, HPA058399: AB_2683705" "unprognostic (9.70e-3)" "unprognostic (3.67e-1)" "unprognostic (4.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.34e-3)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (8.43e-3)" 0.1 0.2 0.4 0.6 0.6 0.8 0.2 3.7 2.1 3.2 0.0 0.3 0.4 3.0 0.4 0.2 174.9 0.5 0.0 0.7 0.4 0.1 0.1 13.6 0.8 0.9 0.2 0.6 0.3 0.9 0.1 0.0 0.2 1.7 0.4 0.5 1.0 0.3 0.2 0.3 1.2 0.5 0.3 0.0 0.3 0.8 0.3 0.4 0.1 17.9 0.1 0.2 0.1 0.0 1.1 0.2 0.1 0.2 0.4 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.2 1.0 0.2 0.1 0.7 0.1 0.2 0.6 0.1 0.0 0.2 0.5 0.9 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.3 1.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.0 0.4 0.6 3.7 2.1 0.7 0.4 0.9 0.2 0.6 1.7 0.0 0.4 1.1 0.0 3.2 4.2 0.3 0.0 0.0 0.1 34.0 0.0 0.0 0.3 0.1 0.3 0.0 60.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.6 410.9 2.3 0.3 0.0 0.0 0.1 0.4 0.0 1.4 0.0 4.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 38.7 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 726.5 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.5 0.2 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Early spermatids: 17.0;Endometrial ciliated cells: 26.2;Excitatory neurons: 21.4;Inhibitory neurons: 16.4;Oligodendrocytes: 18.3;Respiratory ciliated cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.5 1.0 8.7 0.4 8.9 0.6 2.1 8.1 13.9 2.3 7.1 3.1 6.2 1.1 1.8 4.0 6.5 0.9 8.5 7.9 5.2 4.1 5.2 4.7 0.6 11.4 9.5 7.8 1.7 2.9 0.6 12.1 0.9 11.0 2.8 0.8 4.3 2.7 1.0 2.0 2.6 2.9 0.5 2.2 3.3 4.4 10.5 7.3 0.7 2.4 2.2 0.7 2.5 2.2 15.6 0.4 7.4 4.1 0.9 1.3 0.3 5.4 0.3 0.1 0.2 0.1 1.0 0.3 3.1 0.8 0.0 0.9 7.1 2.6 0.0 0.0 9.6 4.9 0.3 3.0 3.9 0.4 4.5 0.3 0.4 0.3 0.9 1.0 0.3 0.0 1.2 0.7 1.7 0.2 3.5 0.4 2.5 7.3 0.0 2.8 4.6 2.7 4.3 0.2 1.5 4.2 0.8 0.2 0.1 3.5 8.0 11.5 0.8 0.4 0.2 6.9 3.9 0.1 5.6 8.3 0.9 0.3 9.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 8.9 8.1 13.9 7.9 5.2 11.4 9.5 7.8 11.0 2.2 7.3 15.6 0.7 19.2 13.1 8.5 0.0 1.9 0.4 0.6 0.0 3.4 1.6 2.0 7.7 1.5 13.4 0.0 0.0 0.2 0.3 1.2 0.0 0.5 17.0 26.2 3.8 1.5 1.8 0.4 21.4 0.0 0.1 3.6 4.1 4.2 3.8 0.1 1.1 2.7 0.4 6.7 16.4 3.9 0.0 0.0 0.3 9.1 0.6 0.9 0.0 0.0 0.1 0.3 0.0 7.5 18.3 0.2 1.7 0.0 1.4 0.3 6.0 1.3 25.8 2.2 6.6 0.9 1.0 9.5 3.7 0.7 1.6 0.3 1.1 0.1 1.6 0.4 CALHM6 "C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5" ENSG00000188820 "Calcium homeostasis modulator family member 6" Q5R3K3 6 116461370-116463771 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 137.7" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 724.6;non-classical monocyte: 861.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 28.0;Karpas-707: 45.1;RPMI-8226: 159.8;U-937: 59.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.14e-2)" "unprognostic (2.31e-2)" "unprognostic (6.46e-3)" "unprognostic (7.15e-3)" "unprognostic (9.53e-3)" "unprognostic (4.10e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (8.19e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.31e-10)" "unprognostic (1.69e-1)" "unprognostic (2.12e-2)" "unprognostic (3.85e-3)" "unprognostic (9.25e-3)" 6.1 7.3 4.9 60.7 5.3 41.8 10.1 4.5 6.6 4.4 5.5 10.5 12.3 2.4 3.6 4.1 4.1 7.2 3.8 4.8 5.7 4.1 24.9 10.9 73.6 7.1 4.8 4.6 4.6 1.8 1.7 4.9 12.6 5.4 5.5 7.1 1.1 5.7 3.0 1.6 1.9 21.1 11.9 5.0 137.7 7.9 8.2 5.2 14.2 2.5 2.6 23.2 11.5 3.0 5.9 6.4 0.0 0.6 0.4 0.5 2.0 11.7 0.2 1.3 2.0 1.3 0.0 1.0 0.2 3.5 1.5 0.0 0.0 0.3 0.2 4.2 0.7 0.4 28.0 0.0 0.0 2.8 0.1 0.1 2.2 0.0 0.2 0.2 0.5 0.7 0.0 0.0 45.1 5.5 0.0 2.7 4.8 3.6 0.0 0.0 2.4 0.0 159.8 2.2 0.3 2.7 0.1 14.9 0.1 11.7 1.6 0.2 7.3 0.1 0.0 0.2 0.1 0.9 11.4 0.2 0.0 0.3 59.7 3.9 22.0 205.7 50.1 16.6 724.6 16.6 231.8 23.0 15.5 193.8 308.9 28.9 15.2 115.8 27.4 861.9 86.5 2.7 175.6 4.9 5.3 4.5 6.6 4.8 5.7 7.1 4.8 4.6 5.4 5.0 5.2 5.9 0.6 0.0 1.7 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.0 0.0 0.0 0.0 1.7 2.7 0.0 0.0 0.6 0.0 0.2 0.3 0.8 0.0 0.0 0.0 10.0 9.0 0.7 0.0 0.1 0.0 1.4 0.0 0.0 138.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.2 1.2 1.8 0.0 0.0 CNR2 CB2 ENSG00000188822 "Cannabinoid receptor 2" P34972 1 23870515-23913362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.4;lymphoid tissue: 8.8" "Cell type enriched" "Detected in some" 5 "B-cells: 27.8" "Cancer enriched" "Detected in single" 6 "testis cancer: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4" "Group enriched" "Detected in many" 9 "B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4" "Cell line enhanced" "Detected in some" "Daudi: 5.3;HEL: 4.4;HMC-1: 19.7;U-698: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB009719 Uncertain NA NA "CAB009719: AB_2082784" "unprognostic (9.45e-4)" "unprognostic (5.40e-3)" "unprognostic (8.50e-3)" "unprognostic (8.19e-3)" "unprognostic (3.55e-3)" "unprognostic (9.34e-6)" "unprognostic (5.58e-3)" "unprognostic (6.96e-3)" "unprognostic (1.74e-1)" "unprognostic (7.87e-2)" "unprognostic (1.53e-1)" "unprognostic (4.93e-2)" "unprognostic (1.04e-3)" "unprognostic (3.67e-1)" "unprognostic (1.80e-1)" "unprognostic (3.75e-2)" "unprognostic (4.91e-2)" 0.1 0.0 0.2 2.4 0.1 1.5 0.0 0.4 0.3 0.0 0.2 0.3 0.2 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 7.4 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 1.6 0.2 3.4 0.1 0.0 8.8 0.4 0.1 0.1 1.0 0.2 0.0 7.5 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.2 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 13.4 0.0 0.1 0.0 49.3 0.1 35.1 3.2 0.1 3.8 29.6 0.1 3.0 0.4 27.9 0.2 1.8 1.2 19.4 0.2 1.7 0.2 2.0 0.2 0.1 0.4 0.3 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 0.1 3.2 3.9 0.3 27.8 0.6 0.8 0.0 0.0 0.8 0.2 0.0 0.3 0.0 1.8 0.0 0.0 0.1 2.1 0.5 0.0 0.0 0.2 0.1 0.3 0.3 0.0 3.2 0.4 0.0 0.0 0.9 0.0 0.2 3.8 0.1 0.4 0.3 0.2 0.0 0.4 0.0 0.0 0.6 0.9 0.0 0.0 0.8 0.0 0.0 0.5 0.2 5.2 0.0 0.5 0.1 2.0 0.0 0.5 0.5 0.0 0.1 0.7 0.7 0.0 0.9 0.4 0.3 0.2 0.0 0.3 0.3 2.4 0.2 0.0 0.8 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611606 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.7" "Cell type enhanced" "Detected in many" "Spermatocytes: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 1.7 2.1 2.0 2.9 1.7 3.0 1.7 6.4 2.6 2.0 0.2 2.2 2.2 2.1 1.3 2.4 2.0 1.1 1.7 2.1 1.7 1.9 2.0 2.1 4.1 2.0 1.9 1.7 1.6 1.7 1.1 3.9 1.1 3.6 2.3 0.9 1.7 1.6 1.0 2.8 1.8 2.8 1.2 0.9 3.4 2.2 10.7 1.7 2.7 1.8 1.3 2.9 2.2 2.0 1.9 2.7 8.4 5.3 6.7 2.0 2.1 5.6 4.3 2.2 4.9 5.4 4.2 3.3 10.0 4.2 2.2 3.8 6.0 3.6 3.0 2.9 8.4 4.6 6.8 6.5 2.7 1.8 6.7 9.3 1.5 2.2 4.6 2.6 1.2 3.6 5.6 6.7 5.3 3.9 4.7 4.2 5.9 4.5 1.7 3.1 8.2 8.9 2.8 1.9 1.9 4.5 4.1 3.8 2.6 1.3 2.8 6.5 5.2 4.3 5.6 7.8 4.9 5.1 4.8 4.0 11.4 1.8 6.7 5.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 2.0 1.7 6.4 2.6 2.1 1.7 2.0 1.9 1.7 3.6 0.9 1.7 1.9 2.7 0.0 2.3 4.6 4.5 0.8 0.8 1.1 4.0 8.7 2.0 1.4 1.7 1.5 3.2 0.0 2.1 1.7 3.4 2.0 0.0 1.5 6.5 5.5 4.2 1.8 0.0 6.5 9.5 2.4 1.6 2.4 3.6 4.6 0.0 4.8 1.1 1.4 2.9 0.0 9.3 2.4 2.0 2.9 1.6 2.3 2.1 5.1 0.0 4.7 2.2 2.7 4.1 7.1 5.5 2.0 0.3 1.9 4.0 0.4 2.3 0.6 2.3 10.1 0.0 4.9 2.5 20.0 9.1 2.3 0.6 1.0 4.4 3.0 2.1 0.6 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 27.9;liver: 14.6;stomach 1: 9.0" "Group enriched" "Detected in some" 5 "Distal enterocytes: 194.5;Intestinal goblet cells: 181.0;Paneth cells: 174.3;Proximal enterocytes: 167.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.0;OE19: 1.7;RPMI-8226: 5.3;T-47d: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favorable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 1.4 0.0 0.4 0.4 0.1 0.2 0.6 0.0 21.5 27.9 0.1 0.0 0.3 0.7 3.7 0.0 0.0 0.0 3.0 14.6 0.1 0.1 0.1 0.0 0.0 0.1 3.1 0.1 5.1 0.1 0.0 0.4 11.3 0.0 6.4 0.2 0.0 0.1 27.4 0.1 0.0 0.2 9.0 0.5 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.1 5.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 1.7 0.2 0.0 0.0 5.3 0.7 0.0 0.2 0.5 0.1 0.0 0.1 0.4 2.8 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.7 1.5 0.4 11.5 0.3 20.2 0.0 0.0 0.1 194.5 0.0 1.3 0.0 3.0 0.4 0.1 3.6 0.0 0.0 7.5 0.2 0.1 31.6 4.7 0.0 0.1 0.4 10.1 0.1 0.0 0.0 181.0 8.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 174.3 0.0 0.2 0.6 167.3 5.9 1.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.3 0.1 15.6 1.7 RPL14 "CTG-B33, hRL14, L14, RL14" ENSG00000188846 "Ribosomal protein L14" P50914 3 40457292-40468587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004136 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 270000 "Endoplasmic reticulum, Cytosol" "HPA004136: AB_1079839" "unprognostic (1.36e-3)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (2.54e-1)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (2.11e-1)" "unprognostic (1.54e-1)" "unprognostic (2.90e-2)" "unprognostic (6.14e-3)" "unprognostic (1.15e-1)" 193.3 126.9 49.4 29.4 50.8 64.7 200.9 53.1 66.9 282.0 49.3 172.0 39.4 175.2 28.7 180.0 205.2 25.5 85.8 48.4 52.6 157.2 134.1 159.0 45.7 52.9 50.3 47.3 405.0 238.4 45.9 162.4 41.1 51.4 182.0 40.2 37.4 175.4 58.7 166.8 222.8 126.4 33.8 53.1 127.1 194.8 28.0 51.4 59.6 162.5 63.5 56.4 212.1 216.3 49.2 53.1 23.4 116.6 55.7 103.6 281.6 80.4 85.8 140.4 152.1 110.9 48.9 18.5 205.9 64.9 64.6 76.4 17.2 78.1 103.7 104.9 79.7 80.6 115.3 43.1 44.7 149.4 153.1 53.2 172.9 301.8 70.6 143.1 220.9 168.3 179.7 111.7 30.1 117.1 38.1 53.4 111.8 44.8 172.9 75.7 26.9 65.6 95.4 140.3 33.2 46.3 75.2 43.2 40.2 102.6 128.0 58.5 74.5 93.3 50.8 41.5 67.4 102.5 90.9 129.3 125.0 22.9 106.1 47.5 15.4 49.1 19.2 76.5 46.0 118.9 98.6 110.8 98.1 62.1 89.8 133.6 126.9 6.5 56.9 38.0 54.4 97.1 236.2 49.4 50.8 53.1 66.9 48.4 52.6 52.9 50.3 47.3 51.4 53.1 51.4 49.2 1374.3 830.1 1146.4 29.7 2884.7 3113.4 5120.8 2595.4 3076.6 225.8 3891.2 6163.2 346.3 1634.2 1633.6 676.8 102.2 3352.5 2285.9 971.2 2529.8 2063.4 290.0 898.3 1997.2 1471.6 1228.6 2245.7 39.0 4163.8 4729.5 1652.6 1184.6 1362.2 1565.2 1640.0 1678.7 1340.0 2207.8 101.0 45.7 2528.3 805.6 2102.2 2691.6 617.6 2160.3 1804.6 1782.2 32.8 2894.7 491.4 2368.7 23.1 41.3 2772.7 2061.9 1084.8 1855.0 4343.4 2359.1 3658.8 667.3 328.8 966.3 2109.4 2212.8 265.0 405.3 4161.2 3418.2 3314.5 2819.7 1921.9 2787.9 4891.9 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110853-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.2;prostate: 3.3;testis: 9.5" "Cell type enhanced" "Detected in some" "B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.0 0.0 0.8 1.1 0.8 0.8 0.0 0.0 1.5 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 1.4 0.9 0.0 0.1 0.2 2.1 1.2 3.2 0.7 0.1 0.0 0.0 1.0 0.3 2.1 3.3 0.2 1.1 0.0 0.0 0.0 0.0 1.2 0.1 0.2 1.2 0.2 9.5 1.1 1.1 0.0 0.0 1.6 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 33.2 0.0 0.0 0.0 7.9 21.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 7.0 0.0 0.1 0.0 0.0 13.1 0.0 6.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 4.7 0.8 0.0 0.0 0.0 15.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 1.5 1.4 0.9 1.2 3.2 0.7 2.1 0.2 1.1 1.6 0.4 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.0 3.4 4.4 0.0 0.0 0.3 0.0 0.0 0.0 4.8 2.5 0.0 0.0 3.3 6.2 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.1 10.7 0.0 3.5 0.2 0.0 0.0 0.0 3.9 1.7 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.6 38.3 0.0 0.0 0.0 1.5 2.2 0.0 0.0 FAM78B ENSG00000188859 "Family with sequence similarity 78 member B" Q5VT40 1 166057426-166167001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.7" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 87.6;Excitatory neurons: 55.4;Horizontal cells: 82.4;Inhibitory neurons: 85.0;Oligodendrocyte precursor cells: 45.8" "Cancer enhanced" "Detected in many" "melanoma: 3.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 8.6;RT4: 4.9;SK-MEL-30: 10.1;U-2 OS: 2.6;WM-115: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052789, HPA073246" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA052789: AB_2681949, HPA073246: AB_2686588" "unprognostic (7.38e-3)" "unprognostic (1.14e-3)" "unprognostic (7.96e-2)" "unprognostic (3.16e-2)" "unprognostic (3.77e-2)" "unprognostic (3.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-3)" "unprognostic (3.25e-2)" "unprognostic (1.69e-3)" "unprognostic (3.87e-2)" "unprognostic (1.87e-11)" "unprognostic (7.41e-2)" "unprognostic (2.09e-1)" "unprognostic (5.41e-2)" "unprognostic (2.69e-2)" 0.6 0.2 1.0 0.0 0.8 0.0 0.5 0.5 2.7 1.1 0.0 0.4 0.2 0.7 0.0 0.4 0.2 0.1 0.5 1.1 0.3 0.2 0.7 0.2 0.1 0.8 0.1 0.7 0.3 0.5 0.1 0.5 0.0 0.8 0.4 0.1 0.8 0.3 0.1 0.7 0.4 0.1 0.2 0.0 0.2 0.2 0.7 0.2 0.0 0.4 0.1 0.1 0.8 0.5 0.7 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 8.6 0.0 0.0 0.1 0.3 0.2 0.0 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 4.9 0.8 0.5 0.0 0.1 10.1 0.0 0.3 0.2 0.1 0.6 2.6 0.0 0.1 0.0 0.0 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.5 2.7 1.1 0.3 0.8 0.1 0.7 0.8 0.0 0.2 0.7 1.2 0.0 1.7 5.5 0.4 0.5 0.5 0.0 1.8 15.5 1.0 0.8 9.9 2.8 0.0 0.0 87.6 0.0 0.0 0.4 1.9 0.7 2.5 0.1 1.7 1.6 0.0 0.0 55.4 0.2 0.0 1.6 0.0 0.1 0.0 1.1 0.4 1.6 0.0 82.4 85.0 0.6 0.0 0.3 0.6 2.6 1.2 0.1 1.8 5.6 0.6 2.2 0.0 45.8 5.7 0.3 0.3 0.7 0.0 0.2 0.1 1.3 0.0 12.9 0.0 4.5 1.0 0.6 4.4 0.6 0.1 0.0 0.7 0.4 1.1 0.2 ZNF563 FLJ34797 ENSG00000188868 "Zinc finger protein 563" Q8TA94 19 12317477-12333720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 14.6" "Cell type enriched" "Detected in many" 6 "Early spermatids: 200.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.2;T-cells: 8.9" "Cell line enhanced" "Detected in many" "Hep G2: 9.0" HPA042136 Uncertain Approved Vesicles NA NA Vesicles "HPA042136: AB_10795395" "unprognostic (1.40e-1)" "unprognostic (3.61e-1)" "unprognostic (1.02e-1)" "unprognostic (8.81e-2)" "unprognostic (9.88e-2)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (9.16e-4)" "unprognostic (1.02e-2)" "unprognostic (5.38e-2)" "unprognostic (3.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-3)" "unprognostic (9.90e-2)" "unprognostic (2.12e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-2)" 2.3 2.8 2.0 2.0 1.9 1.1 3.8 2.8 1.9 3.2 1.4 1.9 1.4 2.2 2.3 2.5 3.2 1.5 3.5 1.9 1.2 3.8 10.1 1.9 2.9 1.7 1.5 1.6 3.6 2.1 2.5 2.2 1.1 2.1 4.9 2.1 2.8 2.7 2.6 1.9 3.8 2.2 2.0 1.0 2.7 1.8 14.6 1.6 3.0 5.5 3.0 3.0 2.7 3.2 2.8 2.0 0.2 0.7 2.7 2.8 1.8 0.2 2.3 4.5 2.8 4.1 2.6 0.7 4.6 2.4 2.9 3.1 1.6 2.4 5.4 2.5 0.1 0.4 0.6 0.5 9.0 2.2 0.4 2.8 3.0 3.7 2.8 1.9 2.1 0.1 2.5 0.9 1.0 2.5 1.3 2.5 0.9 1.1 1.0 2.0 0.1 2.0 0.1 3.0 2.7 0.7 1.3 0.3 0.5 0.3 3.1 2.2 0.2 0.3 4.4 0.8 5.1 1.4 4.4 3.8 0.3 0.8 0.4 1.6 0.8 1.1 0.7 2.7 1.2 1.6 3.2 4.6 2.5 1.4 4.2 8.9 5.2 0.8 1.5 1.4 1.4 3.9 2.2 2.0 1.9 2.8 1.9 1.9 1.2 1.7 1.5 1.6 2.1 1.0 1.6 2.8 3.2 3.2 1.7 2.3 4.6 1.3 2.0 3.0 4.6 8.4 2.4 3.4 5.5 5.7 2.1 1.8 0.0 0.3 2.6 1.1 1.9 4.7 200.4 3.6 2.3 3.7 0.0 19.4 4.2 4.9 0.2 2.6 2.0 2.0 0.0 9.5 3.3 8.3 2.2 5.0 2.6 2.4 2.0 1.9 0.4 32.3 7.8 1.7 5.4 3.7 1.8 13.9 8.2 3.5 2.7 2.6 4.5 5.7 1.5 2.0 2.6 7.8 4.9 3.4 13.1 3.1 3.3 15.8 6.3 2.8 2.0 0.1 4.7 3.3 2.5 0.9 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331088-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 34 "parathyroid gland: 84.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.1 0.2 0.7 0.4 0.7 0.8 0.4 2.4 0.9 0.2 0.2 0.3 0.6 0.4 1.6 0.1 0.9 0.6 0.2 0.6 0.3 0.2 0.3 0.1 0.4 0.7 0.7 0.5 0.4 0.2 84.2 0.1 0.2 1.8 0.4 0.1 0.7 0.7 0.5 0.2 0.4 0.4 0.1 0.3 0.3 0.2 0.7 0.5 0.1 0.8 0.1 0.1 0.1 0.8 1.4 0.3 0.3 0.1 0.9 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.2 0.6 0.8 0.0 0.0 0.8 0.2 0.1 0.0 0.0 0.5 0.5 0.6 0.3 0.3 0.1 0.5 0.3 0.1 0.0 0.1 0.1 0.4 0.0 0.9 0.2 1.0 0.0 0.3 0.3 0.4 0.5 0.3 0.3 0.2 0.3 1.5 0.0 0.2 0.3 0.6 0.2 0.3 0.6 0.2 0.7 0.3 0.1 0.5 0.6 0.4 0.2 1.5 0.6 0.5 0.3 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.7 0.7 2.4 0.9 0.6 0.3 0.7 0.7 0.5 1.8 0.3 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.1 0.6 0.1 0.6 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBF1 "ALB, FBF-1, FLJ00103, KIAA1863" ENSG00000188878 "Fas binding factor 1" Q8TES7 17 75909574-75941140 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.6" "Cell type enhanced" "Detected in many" "Late spermatids: 43.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023677 Supported Centrosome NA NA Centrosome "HPA023677: AB_1848440" "unprognostic (7.40e-3)" "unprognostic (9.90e-3)" "unprognostic (6.62e-2)" "unprognostic (1.38e-3)" "unprognostic (3.14e-3)" "unprognostic (7.88e-4)" "unprognostic (5.76e-4)" "unprognostic (6.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.24e-3)" "unprognostic (6.31e-5)" "unprognostic (6.76e-2)" "unprognostic (1.08e-9)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "unprognostic (3.59e-1)" "unprognostic (1.77e-1)" 3.6 6.9 7.7 3.6 9.0 5.2 3.9 7.5 8.3 5.5 5.6 4.2 2.7 4.6 8.0 8.8 6.3 3.1 3.4 7.5 7.1 5.2 2.6 4.2 4.2 8.4 8.3 6.3 6.0 4.4 4.2 13.1 2.0 9.1 9.7 1.9 4.3 5.8 4.5 3.3 13.2 4.4 1.7 7.7 5.6 4.0 32.6 8.3 4.5 19.0 1.3 2.7 5.2 8.8 8.7 11.2 14.6 4.3 8.0 3.9 2.7 11.7 6.3 1.2 4.3 3.1 3.7 6.3 5.4 4.0 3.0 6.1 6.9 2.5 4.5 3.1 3.1 4.8 4.9 9.9 2.8 1.9 1.6 7.4 2.7 5.3 7.1 4.7 2.2 3.3 19.2 9.1 6.2 2.9 12.5 14.1 5.5 3.6 3.4 6.2 11.1 7.0 4.8 2.2 1.8 4.9 4.5 9.0 6.7 3.5 3.2 18.7 3.9 2.0 9.3 7.4 4.9 5.8 10.6 2.9 2.3 5.9 3.6 9.2 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.3 0.3 0.0 0.2 0.1 0.4 0.5 0.1 7.7 9.0 7.5 8.3 7.5 7.1 8.4 8.3 6.3 9.1 7.7 8.3 8.7 2.4 0.0 2.6 9.1 3.7 3.1 4.9 3.1 12.0 5.4 3.9 3.9 1.6 0.0 7.0 3.7 10.4 6.4 4.4 2.8 3.9 1.3 15.7 8.1 4.4 2.3 1.2 3.4 8.0 0.7 2.1 4.1 6.1 3.9 2.5 7.6 0.0 0.0 2.2 5.0 8.9 2.5 0.0 0.0 2.1 43.1 6.5 1.5 3.6 1.9 1.2 2.7 8.2 3.5 5.7 0.7 1.7 6.0 3.2 2.3 6.2 1.4 9.4 8.0 0.0 4.7 3.2 27.1 9.1 5.2 2.6 3.6 5.9 4.3 3.0 2.4 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483673 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.0;salivary gland: 4.4;thyroid gland: 4.1" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 5.2;Collecting duct cells: 7.3;Squamous epithelial cells: 14.2;Syncytiotrophoblasts: 7.7" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.7;HAP1: 15.7;NTERA-2: 8.2;SCLC-21H: 7.4;SK-BR-3: 31.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.0 0.0 0.6 2.3 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.1 2.8 0.3 0.4 0.1 0.1 0.1 0.0 4.4 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.9 4.1 0.1 0.7 0.1 1.1 0.2 0.0 1.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.1 0.0 2.0 0.0 0.0 4.3 0.0 0.0 2.2 15.7 0.0 0.0 0.0 3.9 0.0 0.6 0.0 0.1 0.0 0.3 0.0 6.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 2.8 2.5 0.0 8.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 7.4 0.4 2.3 31.9 0.0 6.1 7.1 1.5 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.3 0.0 0.5 0.8 0.3 5.2 0.0 1.3 1.4 0.5 0.0 0.1 7.3 0.0 1.5 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 1.6 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 14.2 1.0 7.7 0.0 0.0 0.3 0.5 ASTL "ovastacin, SAS1B" ENSG00000188886 "Astacin like metalloendopeptidase" Q6HA08 2 96123850-96138436 "Predicted intracellular proteins" Fertilization "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 4.1;brain: 4.4" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 1.0;Macrophages: 1.2;T-cells: 1.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Region enriched" "Detected in single" 5 "cerebral cortex: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA015620 Uncertain "Intracellular and membrane" NA NA "HPA015620: AB_1845121" "unprognostic (3.21e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-2)" "unprognostic (3.45e-4)" "unprognostic (1.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.53e-2)" "unprognostic (5.12e-2)" "unprognostic (3.62e-1)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (2.61e-5)" "unprognostic (3.41e-3)" "unprognostic (1.08e-1)" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" 0.1 0.0 0.9 0.3 0.3 4.1 0.1 0.9 4.4 0.0 0.3 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.0 0.2 1.0 0.0 0.9 0.4 0.0 0.0 0.7 0.2 0.3 0.2 0.7 0.0 0.0 0.3 0.5 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.9 4.4 0.7 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.9 0.1 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "MSL complex subunit 1" Q68DK7 17 40121971-40136917 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 358.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 56.9 52.5 35.5 48.4 35.0 57.2 57.2 27.3 40.0 75.3 17.5 58.9 52.2 75.7 56.4 48.5 78.2 39.0 46.6 33.2 27.6 57.3 44.2 62.0 51.2 27.6 27.2 32.5 58.8 59.7 48.1 79.4 48.9 26.5 60.3 47.2 41.4 56.9 52.4 64.1 60.9 62.1 54.2 22.4 88.9 57.6 66.7 29.9 62.9 80.5 52.0 52.1 53.8 62.5 28.6 35.9 42.2 88.3 57.9 78.5 67.6 45.0 61.6 65.3 76.1 68.4 42.4 37.8 78.8 45.6 65.0 48.4 65.2 74.7 40.5 78.2 68.0 59.6 43.6 60.5 50.6 40.9 59.7 81.6 56.9 63.6 56.1 46.5 77.4 71.0 47.2 69.3 62.8 61.4 22.8 95.0 64.8 37.6 39.4 27.2 77.1 48.7 72.1 55.4 38.9 80.9 48.0 57.5 358.8 46.5 80.1 83.5 81.0 58.7 51.0 56.4 37.8 52.3 98.5 58.5 77.7 52.0 43.7 60.7 0.0 1.0 0.8 1.7 0.6 0.8 1.1 0.9 1.3 0.7 0.9 0.9 0.8 8.7 0.7 0.8 1.4 0.6 0.5 35.5 35.0 27.3 40.0 33.2 27.6 27.6 27.2 32.5 26.5 22.4 29.9 28.6 44.1 28.9 40.7 42.7 22.7 50.0 37.8 21.7 69.4 55.2 41.6 32.3 29.5 25.8 25.8 11.0 12.5 15.4 43.8 36.4 3.9 17.2 16.1 35.8 53.9 43.3 31.2 22.3 39.8 20.7 15.4 37.4 20.4 48.1 3.8 24.8 36.4 35.9 25.2 52.2 33.4 29.1 8.2 36.4 42.8 28.5 58.4 34.2 32.0 33.7 30.6 31.3 30.9 25.1 32.4 24.7 32.1 39.9 26.8 72.7 35.4 9.0 32.7 28.4 39.5 29.2 40.7 71.8 49.2 57.5 65.8 17.0 29.9 27.5 31.4 58.7 AC099489.1 ENSG00000188897 "Novel lipoprotein amino terminal region containing protein" 16 11359845-11527245 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 5.3;Glandular and luminal cells: 2.3;granulocytes: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 12 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "Daudi: 3.1;HDLM-2: 3.4;U-266/70: 1.7" "Not detected" "Not detected" HPA042154 Uncertain NA NA "HPA042154: AB_2677877" "unprognostic (4.69e-2)" "unprognostic (3.80e-2)" "unprognostic (7.24e-2)" "unprognostic (5.91e-2)" "unprognostic (1.21e-3)" "unprognostic (7.91e-2)" "unprognostic (9.18e-2)" "unprognostic (6.08e-2)" "unprognostic (8.04e-2)" "unprognostic (5.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.04e-1)" "unprognostic (3.72e-6)" "unprognostic (3.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (4.33e-5)" 1.4 0.5 0.9 3.8 0.7 1.5 0.9 0.9 1.7 1.7 0.9 0.7 0.1 0.9 0.3 0.5 3.4 0.5 1.4 0.7 0.6 1.7 2.3 5.2 0.8 0.8 0.6 0.6 0.7 0.9 0.5 1.0 0.3 1.1 1.9 0.2 0.2 3.1 0.4 2.4 3.6 1.1 0.1 0.6 18.7 1.2 4.9 0.6 0.2 0.9 0.4 0.3 1.6 1.1 0.9 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 3.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.1 1.0 0.3 0.0 0.0 0.2 0.1 1.1 0.0 0.2 0.3 0.2 0.0 0.4 0.4 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.9 1.7 0.7 0.6 0.8 0.6 0.6 1.1 0.6 0.6 0.9 0.4 9.6 5.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 1.5 0.0 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 0.5 0.0 1.6 0.9 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.0 2.3 3.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lung: 52.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9" "Cancer enhanced" "Detected in many" "renal cancer: 17.1;thyroid cancer: 22.7" "Region enhanced" "Detected in many" "hypothalamus: 8.1" "Immune cell enriched" "Detected in many" 8 "neutrophil: 58.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 58.2" "Cell line enhanced" "Detected in some" "A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Supported Vesicles NA NA Vesicles "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 4.8 3.1 0.9 10.2 1.7 9.1 2.6 0.9 2.5 5.1 1.4 3.4 0.6 4.8 2.0 7.1 4.1 6.3 3.3 1.3 8.1 11.0 5.6 52.9 6.9 1.8 1.2 0.9 5.5 3.7 8.5 2.1 1.2 1.3 2.6 1.8 1.5 3.6 2.1 5.5 2.1 3.6 4.0 1.2 10.9 2.1 0.8 1.3 2.6 2.9 8.0 5.4 4.5 5.5 1.6 0.0 4.6 0.0 0.0 2.3 5.6 0.0 1.3 3.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.6 0.4 0.0 2.1 0.4 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.3 0.0 0.5 2.7 0.1 3.1 1.5 1.0 0.4 0.5 0.6 0.4 0.0 0.0 0.0 1.3 0.0 1.7 0.0 7.2 2.2 0.0 5.2 0.0 1.8 0.0 0.0 2.1 1.7 0.0 0.0 58.2 0.0 6.9 0.3 0.0 1.3 0.9 1.7 0.9 2.5 1.3 8.1 1.8 1.2 0.9 1.3 1.2 1.3 1.6 7.4 32.1 502.2 17.3 29.9 2.4 1.8 0.4 2.8 8.6 1.3 1.4 7.8 5.7 17.3 27.6 0.0 0.0 1.9 0.0 1.9 1.3 0.5 0.4 2.6 7.0 0.0 2.1 92.0 2.7 0.1 16.1 0.5 0.4 13.9 2.7 13.2 8.2 4.6 47.1 28.0 0.0 0.0 55.8 8.7 1.2 19.0 52.2 12.4 73.1 133.1 8.6 3.1 256.9 3.1 0.8 1.1 12.0 2.8 0.6 0.0 22.5 3.4 1.0 0.0 22.5 4.8 0.3 1.0 12.6 3.1 0.4 3.4 11.2 0.0 0.7 BSX BSX1 ENSG00000188909 "Brain specific homeobox" Q3C1V8 11 122977570-122981834 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "brain: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hypothalamus: 9.6;pons: 4.5;thalamus: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "hypothalamus: 4.5" "Region enriched" "Detected in single" 10 "hypothalamus: 3.4" HPA015654 Uncertain NA NA "HPA015654: AB_1845470" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 9.6 0.0 1.1 0.0 4.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781214-34786369 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 78.4;skin 1: 141.7" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 138.4;Basal prostatic cells: 71.9;Basal respiratory cells: 43.6;Pancreatic endocrine cells: 119.8;Prostatic glandular cells: 63.4;Squamous epithelial cells: 91.9;Suprabasal keratinocytes: 170.6;Urothelial cells: 171.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 58.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 88.8;CAPAN-2: 121.7;HaCaT: 99.4;HBEC3-KT: 84.9;hTCEpi: 136.8;OE19: 54.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA074472: AB_2686694" "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavorable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.2 0.2 1.4 1.7 0.6 0.0 5.6 1.2 1.2 4.6 0.0 4.2 0.2 0.3 2.8 78.4 1.1 7.0 0.1 0.7 0.2 0.5 1.5 0.6 0.5 0.6 0.1 0.8 0.1 0.3 0.0 0.1 1.4 0.5 4.1 5.0 0.0 9.0 1.7 0.6 141.7 1.3 0.1 0.1 0.0 6.0 0.8 0.4 0.8 0.2 0.0 13.0 12.0 26.6 0.4 88.8 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 121.7 0.0 11.6 0.1 0.1 99.4 0.0 84.9 0.0 0.1 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 35.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.4 54.2 22.3 0.0 0.0 0.0 40.8 33.0 0.0 0.0 13.1 0.9 0.0 0.1 1.0 0.1 0.0 0.1 5.7 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 1.2 1.2 0.7 0.2 0.6 0.1 0.8 0.5 0.1 0.4 0.4 0.0 3.2 0.0 0.0 0.0 138.4 71.9 43.6 16.5 0.0 2.0 1.3 0.4 1.5 15.5 5.5 0.0 0.3 0.0 18.3 0.0 14.6 0.0 4.1 0.4 1.7 1.8 0.0 0.2 7.3 0.2 1.7 3.1 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 6.1 0.0 12.5 0.0 0.0 0.4 14.2 0.0 0.0 0.0 0.0 0.0 0.0 119.8 8.1 0.0 0.0 63.4 0.5 0.0 10.1 0.0 0.0 0.0 2.1 0.1 0.3 91.9 170.6 0.1 0.5 0.0 19.1 171.0 INSYN2A "C10orf141, FAM196A, FLJ45557, INSYN2" ENSG00000188916 "Inhibitory synaptic factor 2A" Q6ZSG2 10 127135426-127196591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 7.8" "Cell type enhanced" "Detected in single" "Endothelial cells: 1.4" "Group enriched" "Detected in some" 13 "breast cancer: 3.4;glioma: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 2.7;U-87 MG: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035898, HPA035899" Uncertain NA NA "HPA035898: AB_10964352, HPA035899: AB_10961723" "unprognostic (4.00e-2)" "unprognostic (9.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.66e-3)" "unprognostic (2.18e-1)" "unprognostic (4.70e-2)" "unprognostic (7.30e-2)" "unprognostic (3.62e-1)" "unprognostic (2.18e-2)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (5.47e-2)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" 0.0 0.0 4.6 0.1 5.5 0.0 0.6 2.8 4.7 0.0 0.9 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.1 3.4 5.8 0.2 0.0 0.2 0.0 4.3 5.0 2.9 0.7 0.1 0.0 0.2 0.0 5.6 0.8 0.1 1.6 0.2 0.1 0.0 0.1 0.3 0.1 2.2 0.3 0.2 0.6 7.8 1.1 0.1 0.1 0.1 0.2 0.1 4.7 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.6 5.5 2.8 4.7 3.4 5.8 4.3 5.0 2.9 5.6 2.2 7.8 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRMT2B "CXorf34, FLJ12687" ENSG00000188917 "TRNA methyltransferase 2 homolog B" Q96GJ1 X 101009346-101052116 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003745, HPA035120, HPA040814" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: " "prognostic unfavorable (1.58e-5)" "unprognostic (6.72e-3)" "unprognostic (3.28e-1)" "unprognostic (1.54e-2)" "unprognostic (4.44e-1)" "unprognostic (8.74e-2)" "unprognostic (3.52e-2)" "unprognostic (8.16e-3)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-2)" "prognostic favorable (2.30e-7)" "unprognostic (4.58e-2)" "unprognostic (4.82e-1)" "unprognostic (5.03e-2)" "unprognostic (1.60e-2)" 5.5 6.5 3.2 7.1 3.3 7.9 6.3 3.7 3.9 6.8 5.4 7.9 6.2 4.7 4.0 8.2 5.4 5.4 8.4 3.3 3.5 8.8 6.2 6.5 10.3 4.0 3.7 2.9 6.8 6.4 14.8 5.9 4.0 4.8 6.6 9.3 2.4 10.0 5.4 15.1 6.7 9.3 5.0 3.3 10.6 8.8 2.5 4.3 14.8 8.7 14.6 11.4 5.2 6.2 4.2 22.4 18.9 3.8 8.9 8.7 4.5 11.6 11.4 15.4 12.6 18.7 20.6 17.5 19.9 22.3 10.6 25.6 13.7 17.5 16.0 15.7 17.2 10.9 12.6 15.6 9.9 7.6 22.5 19.6 5.8 9.3 18.2 8.4 8.8 24.8 21.2 13.0 18.3 11.7 22.5 28.5 11.6 5.2 27.7 14.0 22.8 18.2 19.1 9.2 12.8 5.5 7.4 19.4 14.0 11.7 10.4 9.1 10.8 14.5 15.7 9.4 14.8 10.3 11.5 18.7 18.1 12.2 25.3 12.4 14.9 10.0 18.8 15.8 8.0 17.0 18.7 18.6 15.8 9.3 20.4 21.8 18.3 5.7 18.7 9.5 10.0 16.8 14.8 3.2 3.3 3.7 3.9 3.3 3.5 4.0 3.7 2.9 4.8 3.3 4.3 4.2 3.0 6.4 6.3 22.2 10.5 2.3 5.5 4.1 6.2 0.8 3.0 1.5 10.3 1.5 5.0 14.7 2.1 6.1 5.7 5.4 7.9 4.0 0.1 3.3 1.9 4.0 6.7 5.7 17.2 3.4 3.0 3.4 6.1 2.9 13.3 6.9 3.6 4.1 3.6 1.7 18.5 6.8 2.0 5.3 0.6 0.8 3.4 3.4 1.8 18.7 5.6 4.8 14.4 9.5 11.6 5.3 4.8 3.8 4.2 3.8 5.5 5.7 6.0 1.8 0.0 5.3 3.0 0.2 3.8 6.2 1.6 5.1 8.7 4.4 6.1 5.3 HACD4 "Em:AL662879.1, PTPLAD2" ENSG00000188921 "3-hydroxyacyl-CoA dehydratase 4" Q5VWC8 9 20999509-21031640 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.1" "Cell type enhanced" "Detected in many" "Hofbauer cells: 60.7;Kupffer cells: 78.8;Macrophages: 99.3;monocytes: 87.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 17.2;HDLM-2: 10.8;TIME: 8.6;U-937: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058666 Uncertain NA NA "HPA058666: AB_2683793" "unprognostic (1.71e-1)" "unprognostic (2.58e-2)" "unprognostic (5.47e-2)" "unprognostic (1.70e-2)" "unprognostic (7.66e-2)" "unprognostic (1.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.28e-2)" "unprognostic (1.11e-4)" "prognostic favorable (3.14e-4)" "unprognostic (8.72e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.89e-3)" "unprognostic (7.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-3)" 1.9 2.8 1.3 3.6 1.2 12.1 2.4 1.9 2.4 5.3 2.7 3.6 2.0 3.5 1.1 2.7 4.0 3.1 0.8 1.2 0.8 2.0 1.1 8.4 4.4 1.1 0.9 1.0 3.9 0.5 1.1 0.6 6.5 1.0 2.8 3.1 1.3 1.4 2.2 0.4 2.5 2.9 4.3 0.7 3.9 2.0 1.0 0.8 5.2 2.1 1.5 4.0 2.7 1.8 1.4 4.2 1.2 0.4 0.1 0.0 0.1 0.1 3.8 17.2 3.0 3.4 0.0 0.0 3.7 2.1 7.4 0.0 1.1 0.2 1.6 3.8 10.8 0.1 0.0 1.3 0.0 2.3 3.1 3.2 6.6 6.7 2.7 0.0 0.0 1.0 4.3 0.0 2.1 0.6 0.1 0.0 4.3 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.7 0.0 0.9 0.3 0.0 2.4 3.0 5.9 8.6 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 13.4 0.1 21.4 8.8 14.4 2.5 10.9 2.4 1.4 2.7 2.8 10.2 1.3 1.9 2.7 12.4 3.7 11.3 1.1 3.7 5.0 1.3 1.2 1.9 2.4 1.2 0.8 1.1 0.9 1.0 1.0 0.7 0.8 1.4 6.3 48.1 6.1 2.3 15.8 0.0 10.7 0.0 16.5 1.6 5.4 5.8 2.1 2.8 11.2 12.9 0.0 12.2 26.1 0.1 5.9 0.6 0.5 33.0 8.4 5.6 0.0 27.1 4.3 0.5 37.9 23.1 4.1 5.6 3.8 17.7 11.7 1.0 60.7 0.0 2.4 0.1 0.0 78.8 0.0 0.4 3.7 99.3 0.0 11.2 87.7 11.0 36.0 0.0 0.4 0.1 0.1 1.2 20.1 3.7 0.0 9.3 48.8 1.6 13.1 4.6 13.4 0.3 7.8 11.7 0.0 5.1 33.1 11.9 0.3 4.5 CFAP126 "C1orf192, Flattop, Fltp" ENSG00000188931 "Cilia and flagella associated protein 126" Q5VTH2 1 161364733-161367876 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 152.9;skeletal muscle: 85.0" "Group enriched" "Detected in some" 6 "Early spermatids: 120.4;Endometrial ciliated cells: 242.9;Respiratory ciliated cells: 201.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045904 Enhanced NA NA "HPA045904: AB_10960411" 11.7 13.5 11.3 5.2 9.5 3.0 0.7 14.6 7.8 2.8 24.1 5.0 10.5 10.5 0.7 18.6 152.9 11.8 39.8 2.9 8.0 16.8 10.0 14.1 7.8 9.9 15.8 0.2 12.3 9.8 0.1 3.6 3.7 12.8 6.8 0.0 33.1 12.8 0.9 85.0 19.0 11.2 0.1 11.4 6.4 7.7 24.4 10.9 0.8 26.6 0.1 0.2 5.4 0.0 16.4 9.2 16.2 18.4 16.8 0.4 0.2 12.5 14.9 0.0 0.0 0.0 37.0 13.6 2.2 34.8 0.0 2.8 20.2 0.1 0.0 0.0 19.8 16.9 7.9 16.4 12.8 0.1 10.4 6.0 0.4 0.0 0.0 0.0 30.1 0.0 12.4 26.1 1.3 0.0 12.5 7.8 4.4 12.9 32.0 7.4 4.0 12.9 12.0 0.9 17.0 17.7 19.3 28.8 24.2 17.5 45.6 34.3 15.9 26.1 9.5 4.9 31.6 9.1 16.8 40.1 19.6 19.7 13.5 10.2 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.3 0.3 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.2 0.0 0.1 11.3 9.5 14.6 7.8 2.9 8.0 9.9 15.8 0.2 12.8 11.4 10.9 16.4 0.0 6.4 4.1 0.7 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.4 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 120.4 242.9 1.4 0.8 0.0 0.0 0.2 0.0 0.1 0.7 0.0 2.5 2.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 29.6 0.3 0.5 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.0 1.0 0.0 2.5 201.9 0.3 0.0 0.6 0.1 27.3 0.7 0.0 0.0 0.0 0.4 0.2 0.0 0.4 NYX "CLRP, CSNB1, CSNB1A, CSNB4" ENSG00000188937 Nyctalopin Q9GZU5 X 41447343-41475710 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "HDLM-2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (3.27e-2)" "unprognostic (6.72e-2)" "unprognostic (4.21e-2)" "unprognostic (4.10e-4)" "unprognostic (1.83e-1)" "unprognostic (3.96e-2)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 FAM120AOS C9orf10OS ENSG00000188938 "Family with sequence similarity 120A opposite strand" Q5T036 9 93431441-93453581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 155.5;Syncytiotrophoblasts: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021475 Approved NA NA "HPA021475: AB_2670718" "unprognostic (1.20e-1)" "unprognostic (2.33e-1)" "unprognostic (1.56e-1)" "unprognostic (1.48e-2)" "unprognostic (1.10e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.10e-1)" "unprognostic (3.42e-1)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.93e-1)" "prognostic favorable (6.04e-4)" "unprognostic (2.33e-1)" "unprognostic (7.91e-2)" "unprognostic (8.45e-3)" "unprognostic (1.42e-1)" 21.7 19.1 27.1 14.9 26.5 12.3 23.7 26.4 34.5 18.2 26.0 25.0 14.6 18.2 35.7 16.8 16.5 16.9 21.5 26.7 28.2 22.4 18.5 17.9 17.3 27.9 26.1 26.1 19.0 23.7 28.1 32.5 23.8 26.5 23.7 24.6 23.8 20.3 20.5 21.0 20.1 16.7 16.1 26.6 14.5 24.5 8.6 26.9 18.7 29.4 20.0 18.9 21.3 15.7 28.2 31.3 29.0 20.2 22.5 28.1 12.1 31.6 19.1 19.8 20.7 15.8 21.5 24.1 26.7 23.8 21.8 29.8 39.1 20.2 20.1 18.9 43.5 16.0 27.6 26.5 24.5 28.6 22.3 17.1 15.6 28.1 20.6 33.2 23.2 22.5 23.5 29.1 37.5 20.0 74.4 30.6 12.1 27.3 42.9 31.0 24.5 27.5 27.8 28.3 27.8 42.1 20.3 28.7 30.8 28.9 22.9 33.0 18.0 15.0 13.1 21.0 45.6 27.2 26.1 37.6 11.6 21.2 13.5 27.6 12.9 9.0 6.7 4.1 8.9 5.8 11.8 6.5 5.8 7.3 8.8 7.9 6.0 10.5 8.0 11.3 8.0 6.8 4.4 27.1 26.5 26.4 34.5 26.7 28.2 27.9 26.1 26.1 26.5 26.6 26.9 28.2 29.8 35.3 45.4 22.2 30.8 12.6 45.8 21.6 40.5 25.4 47.6 37.6 38.9 14.3 46.1 18.4 14.6 100.9 25.8 60.6 39.2 37.5 0.5 31.0 31.2 28.4 28.3 26.1 22.2 47.8 155.5 37.3 55.0 45.1 22.8 15.1 24.3 22.3 41.2 6.7 17.5 42.8 14.2 31.8 20.0 3.4 23.9 29.7 12.4 12.2 36.6 30.8 19.6 7.5 17.5 37.9 41.0 33.4 37.0 38.9 33.2 33.9 24.7 32.7 26.3 31.6 36.0 13.7 17.1 34.8 25.9 249.0 30.6 21.3 30.6 59.4 UTS2B "U2B, URP, UTS2D" ENSG00000188958 "Urotensin 2B" Q765I0 3 191267168-191330536 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 15.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 2.8;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 2.8" "Cell line enhanced" "Detected in some" "PC-3: 3.3" "Region enriched" "Detected in some" 9 "pons and medulla: 11.3" "Region enriched" "Detected in single" 46 "spinal cord: 6.0" HPA026992 Uncertain "Secreted - unknown location" NA NA "HPA026992: AB_1858703" "unprognostic (1.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.17e-2)" "unprognostic (2.77e-2)" "unprognostic (2.14e-2)" "unprognostic (3.09e-1)" "unprognostic (2.63e-2)" "unprognostic (3.39e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (7.58e-2)" "unprognostic (2.08e-1)" "unprognostic (1.29e-1)" "unprognostic (3.10e-2)" 1.0 1.2 1.0 0.8 0.7 0.5 1.2 4.3 1.6 0.2 0.0 0.5 5.4 0.7 0.5 0.7 1.0 1.2 0.7 0.9 0.7 0.6 3.2 0.5 1.0 0.7 0.7 0.6 1.1 0.5 0.2 0.0 0.4 1.8 0.6 0.4 15.1 0.6 0.2 0.6 1.1 3.2 0.5 0.0 0.6 1.6 2.4 0.6 0.1 0.5 0.0 0.3 0.4 0.1 1.1 0.4 1.0 1.3 0.6 0.3 1.6 0.4 1.0 0.5 0.3 0.2 0.7 0.5 0.7 0.5 0.4 2.6 0.5 0.4 0.0 1.6 0.6 0.5 0.6 1.4 2.9 0.3 0.8 0.4 0.6 0.2 0.2 0.3 0.9 0.3 0.6 0.4 0.6 0.5 0.6 0.2 0.5 0.7 1.3 3.3 0.9 1.5 0.2 0.2 1.6 0.7 0.5 0.6 0.7 0.4 0.5 0.5 0.5 1.4 0.7 0.4 1.3 0.4 1.1 0.6 0.6 0.9 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.7 4.3 1.6 0.9 0.7 0.7 0.7 0.6 1.8 0.0 0.6 1.1 0.2 3.2 1.1 0.7 2.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 8.3 1.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.1 0.0 0.7 1.6 0.0 0.2 0.1 1.5 0.0 0.0 0.1 0.2 2.6 2.1 0.0 0.3 0.3 0.0 0.1 0.0 0.1 C9orf152 bA470J20.2 ENSG00000188959 "Chromosome 9 open reading frame 152" Q5JTZ5 9 110190048-110208159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 42.0;salivary gland: 25.6;stomach 1: 33.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8" "Cancer enhanced" "Detected in many" "prostate cancer: 27.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "OE19: 149.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA050769 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050769: AB_2681230" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "prognostic favorable (7.22e-5)" "unprognostic (2.28e-1)" "unprognostic (1.79e-3)" "unprognostic (6.86e-2)" "unprognostic (1.34e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (5.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (4.57e-1)" "unprognostic (2.49e-1)" "unprognostic (1.06e-2)" 0.1 0.0 0.5 2.2 0.4 0.0 12.5 0.2 0.4 10.5 0.1 33.1 19.2 2.3 0.0 3.0 3.8 5.5 0.0 0.4 0.2 0.2 0.8 5.9 0.0 0.5 0.4 0.2 0.0 5.1 0.0 0.1 0.0 0.6 17.2 42.0 0.0 25.6 1.4 0.0 5.0 15.2 1.2 0.3 0.1 33.2 0.0 0.3 0.1 0.1 0.0 0.2 1.2 0.4 0.7 0.0 1.3 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.0 149.2 0.2 0.0 0.0 0.2 0.0 0.6 0.1 0.1 0.0 9.3 0.0 0.0 18.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.4 0.2 0.5 0.4 0.2 0.6 0.3 0.3 0.7 0.4 9.6 16.3 0.3 0.2 0.3 3.4 5.9 6.2 0.0 20.5 10.8 0.1 20.0 14.5 0.0 0.0 0.0 0.1 35.4 0.0 6.0 0.0 4.0 2.0 0.5 25.9 0.0 0.1 11.1 0.0 0.2 25.0 13.9 0.0 0.0 0.0 3.3 0.1 0.0 0.1 139.7 40.7 0.0 1.0 0.0 0.0 0.6 10.6 0.0 0.0 0.0 0.0 0.0 0.1 3.9 40.0 0.0 0.0 12.4 4.4 0.0 5.2 0.0 0.0 0.4 0.9 0.0 0.0 10.9 0.4 0.0 0.4 0.0 79.8 5.5 NOC2L "DKFZP564C186, NET15, NET7, NIR, PPP1R112" ENSG00000188976 "NOC2 like nucleolar associated transcriptional repressor" Q9Y3T9 1 944203-959309 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044258, HPA062195" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 310000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044258: AB_10961284, HPA062195: AB_2684707" "unprognostic (3.18e-2)" "unprognostic (5.84e-2)" "unprognostic (1.59e-1)" "unprognostic (9.54e-3)" "unprognostic (6.75e-2)" "unprognostic (2.31e-3)" "unprognostic (1.94e-3)" "unprognostic (1.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.17e-1)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (6.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.52e-1)" 26.3 23.8 15.1 23.2 15.4 30.3 26.6 14.6 21.4 29.2 12.1 28.0 18.1 30.6 10.4 47.7 27.9 14.2 31.2 16.9 15.7 25.2 33.9 23.8 23.3 16.9 16.2 16.3 26.2 35.9 21.4 24.6 16.0 17.7 27.0 11.7 9.7 26.7 16.2 73.6 45.1 25.4 15.1 13.7 28.3 28.6 36.3 16.8 20.3 24.5 26.7 16.1 33.0 32.0 18.5 112.8 110.4 19.8 129.5 34.5 31.0 70.2 82.3 38.9 114.4 62.1 148.5 110.5 126.3 113.3 56.0 94.0 102.2 147.6 122.8 49.2 79.2 161.5 67.0 141.2 132.0 77.4 151.1 63.8 50.3 35.0 125.3 84.3 35.3 56.4 44.6 190.8 58.2 51.6 182.1 98.7 92.6 112.0 82.3 128.8 120.0 81.5 155.9 53.6 47.4 136.0 133.0 109.3 166.3 105.1 30.3 74.8 81.1 64.1 68.3 95.9 75.2 143.0 97.6 112.5 225.7 84.3 209.1 57.7 21.3 30.9 22.2 23.9 46.4 31.3 23.9 23.3 23.4 36.8 19.3 23.3 18.6 2.8 34.5 57.5 23.6 19.9 31.7 15.1 15.4 14.6 21.4 16.9 15.7 16.9 16.2 16.3 17.7 13.7 16.8 18.5 21.5 16.0 23.1 12.4 42.7 69.3 90.8 42.9 47.8 54.6 33.4 34.7 4.5 28.6 29.8 36.8 62.6 63.7 24.7 27.4 17.6 49.9 10.2 34.8 40.9 27.8 30.0 23.8 12.6 46.2 65.5 29.9 28.1 36.9 13.9 36.4 24.7 24.0 39.6 45.4 12.4 27.6 36.7 24.6 29.2 10.3 29.5 24.4 24.9 12.2 35.7 20.6 60.8 9.5 10.6 39.2 21.4 21.4 42.6 71.9 22.9 19.6 27.1 77.0 32.9 41.2 34.6 43.0 83.9 47.4 82.0 58.8 36.6 51.8 53.1 69.3 MSANTD1 "C4orf44, LOC345222" ENSG00000188981 "Myb/SANT DNA binding domain containing 1" Q6ZTZ1 4 3244369-3271738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.6;testis: 3.8" "Group enriched" "Detected in some" 4 "Early spermatids: 38.5;Late spermatids: 28.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-3)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (3.99e-1)" "unprognostic (5.50e-2)" "unprognostic (2.34e-3)" "unprognostic (6.36e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-2)" "unprognostic (8.57e-2)" "unprognostic (5.96e-2)" "unprognostic (1.24e-1)" 0.2 0.2 2.5 0.1 2.8 0.1 0.3 1.1 2.3 0.4 0.1 0.3 0.1 0.3 0.2 0.4 0.3 0.0 0.3 2.4 3.6 0.5 0.5 0.5 0.1 1.1 1.2 2.5 0.4 1.1 0.0 1.1 0.0 1.4 0.6 0.0 0.7 0.3 0.0 0.7 0.3 0.4 0.0 0.4 0.8 0.8 3.8 3.2 0.0 1.0 0.0 0.0 0.4 0.5 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.8 1.1 2.3 2.4 3.6 1.1 1.2 2.5 1.4 0.4 3.2 1.6 0.5 0.0 0.0 1.3 0.1 1.0 0.1 0.1 0.0 2.4 0.5 0.3 1.4 0.0 0.1 0.0 4.2 0.1 0.5 0.1 1.9 0.0 38.5 0.7 0.3 0.3 0.0 0.0 3.0 6.8 0.5 0.2 0.0 0.8 0.0 2.2 0.0 0.2 0.3 1.7 3.0 0.2 0.0 0.0 0.7 28.4 0.0 0.3 0.0 1.9 0.0 0.8 1.0 1.0 1.8 0.3 1.1 0.4 0.0 0.2 0.0 0.3 0.2 2.0 0.0 0.4 0.3 4.5 1.3 0.4 0.3 0.0 0.2 0.1 0.1 0.1 AADACL3 ENSG00000188984 "Arylacetamide deacetylase like 3" Q5VUY0 1 12716110-12728760 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "placenta: 1.6;skin 1: 1.2" "Cell type enhanced" "Detected in single" "Extravillous trophoblasts: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.01e-1)" "unprognostic (2.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NELFB "COBRA1, KIAA1182, NELF-B" ENSG00000188986 "Negative elongation factor complex member B" 9 137255327-137273542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020259 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA020259: AB_1847072" "unprognostic (2.56e-2)" "unprognostic (5.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.14e-2)" "unprognostic (3.27e-1)" "unprognostic (4.06e-1)" "unprognostic (5.58e-3)" "unprognostic (7.74e-3)" "unprognostic (2.04e-1)" "unprognostic (1.46e-1)" "unprognostic (5.03e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.31e-6)" "unprognostic (6.74e-3)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-2)" 24.9 24.7 34.7 22.0 31.6 24.1 25.3 29.9 52.5 28.2 23.8 28.7 24.1 25.1 7.0 34.9 23.4 15.9 32.2 34.2 30.6 33.0 30.5 25.3 27.6 37.4 35.8 33.9 28.4 37.7 18.3 20.8 18.6 32.4 30.8 11.6 7.6 29.9 16.2 36.6 36.2 26.8 13.2 31.4 31.8 30.6 28.6 35.7 21.8 24.2 21.4 16.9 29.2 28.2 31.2 50.4 79.5 41.1 53.1 34.8 24.8 62.1 42.0 28.4 48.0 33.9 84.7 56.9 70.2 60.8 40.0 56.3 96.0 41.0 47.8 14.0 68.2 64.9 45.4 97.9 69.7 35.3 66.5 54.2 29.7 47.2 44.3 25.8 28.9 45.0 46.9 77.8 57.7 28.6 116.8 51.0 106.2 67.2 88.8 92.9 83.6 76.1 114.7 27.1 43.9 60.8 57.2 56.7 59.7 40.6 21.4 79.3 79.7 59.9 71.1 56.1 113.4 65.9 32.1 55.2 59.1 56.9 47.4 64.6 1.1 3.3 5.5 4.3 2.8 2.9 3.5 3.6 3.3 2.9 3.5 3.3 3.5 1.9 4.0 2.7 4.7 4.3 2.2 34.7 31.6 29.9 52.5 34.2 30.6 37.4 35.8 33.9 32.4 31.4 35.7 31.2 31.6 6.4 17.9 16.6 11.7 14.9 11.8 12.7 5.7 19.7 21.8 20.6 12.4 17.2 14.1 23.9 18.8 24.3 24.7 40.0 13.7 27.9 3.7 14.7 18.1 19.8 28.2 13.0 8.9 38.5 27.8 17.4 13.3 21.8 18.4 39.1 20.3 19.5 26.5 43.7 8.4 37.2 12.2 14.0 15.6 5.6 23.3 17.6 7.2 11.2 37.7 33.8 22.6 9.5 11.7 33.5 18.7 20.7 13.8 18.9 29.2 13.9 9.9 17.1 39.5 15.5 20.6 10.7 23.6 12.6 13.9 15.6 15.4 35.0 31.5 13.5 SLC15A5 ENSG00000188991 "Solute carrier family 15 member 5" A6NIM6 12 16188485-16277685 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Astrocytes: 2.0;Early spermatids: 4.2;Excitatory neurons: 1.1;Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041638 Uncertain NA NA "HPA041638: AB_2677590" "unprognostic (3.68e-3)" "unprognostic (1.64e-1)" "unprognostic (4.89e-6)" "unprognostic (1.34e-1)" "unprognostic (1.72e-3)" 0.2 0.0 0.3 0.0 0.4 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.4 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIPI "CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5" ENSG00000188992 "Lipase I" Q6XZB0 21 14108813-14210955 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 166 "epididymis: 424.7" "Group enriched" "Detected in some" 4 "Early spermatids: 1.7;Excitatory neurons: 1.5;Inhibitory neurons: 2.0;Microglial cells: 1.9;Oligodendrocyte precursor cells: 2.0" "Cancer enriched" "Detected in single" 6 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049665 Supported "Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" "HPA049665: " "unprognostic (2.60e-2)" "unprognostic (3.49e-1)" "unprognostic (1.12e-3)" "unprognostic (1.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.53e-2)" "unprognostic (2.90e-1)" "unprognostic (3.64e-13)" "unprognostic (2.82e-1)" "unprognostic (4.14e-2)" "unprognostic (2.90e-1)" "unprognostic (7.87e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.5 424.7 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.1 0.6 0.1 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC66 ENSG00000188993 "Leucine rich repeat containing 66" Q68CR7 4 51993702-52017620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 22.7;skeletal muscle: 8.1" "Cell type enhanced" "Detected in some" "Astrocytes: 5.9;Distal enterocytes: 9.0;Excitatory neurons: 9.4;Gastric mucus-secreting cells: 6.1;Inhibitory neurons: 7.3;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 8.8;Paneth cells: 7.3;Proximal enterocytes: 21.8" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;CAPAN-2: 2.0;OE19: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014549, HPA027839" Uncertain NA NA "HPA014549: AB_1853062, HPA027839: AB_10602705" "unprognostic (1.10e-1)" "unprognostic (4.87e-2)" "unprognostic (8.62e-2)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-1)" "unprognostic (2.57e-2)" "unprognostic (4.83e-3)" "unprognostic (2.93e-1)" "unprognostic (4.09e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (6.31e-3)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-1)" "unprognostic (4.06e-1)" 0.3 0.3 1.0 0.9 1.1 0.0 0.3 1.5 1.5 0.5 0.6 6.2 22.7 0.5 0.2 0.1 0.5 1.9 0.8 1.0 1.0 1.1 0.5 0.2 0.1 1.3 1.0 1.0 0.4 0.3 0.3 2.4 0.0 1.3 0.5 5.9 0.8 0.3 0.2 8.1 0.2 18.9 0.6 0.9 0.3 5.1 0.8 1.3 0.1 0.2 2.1 0.0 0.5 0.3 1.3 0.0 0.0 0.1 0.2 0.6 1.5 0.0 0.2 0.4 0.1 0.3 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.3 0.1 0.5 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 1.5 1.5 1.0 1.0 1.3 1.0 1.0 1.3 0.9 1.3 1.3 0.2 0.0 0.0 5.9 0.1 0.0 0.0 0.2 0.0 1.6 0.1 0.4 1.1 1.5 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.2 1.3 0.4 0.2 0.1 0.0 0.0 9.4 1.2 0.0 0.6 6.1 0.2 0.0 0.1 0.7 0.1 0.0 0.0 7.3 4.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.9 0.6 0.1 0.0 8.0 8.8 0.5 7.3 0.4 0.0 0.0 21.8 0.4 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87265943 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: AB_2681190" "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 6.2 6.4 4.2 7.9 4.6 25.6 9.7 17.6 8.0 8.8 1.9 6.9 8.0 10.4 9.5 6.6 6.2 6.7 5.8 4.0 2.6 6.4 6.4 5.7 11.0 3.1 3.3 4.1 13.9 7.0 13.9 8.5 8.9 5.9 8.3 6.9 26.6 8.4 7.3 5.5 8.6 8.9 6.5 1.7 8.1 8.1 6.2 3.6 14.4 9.7 5.7 9.2 7.2 7.4 10.4 8.3 4.7 16.1 14.2 9.0 8.1 16.8 6.4 8.1 7.4 10.1 8.2 5.7 12.8 9.0 8.4 10.4 8.4 10.1 9.6 15.9 29.3 7.6 17.3 6.4 6.8 6.7 14.0 7.6 8.1 9.2 7.3 9.4 11.8 6.9 13.6 12.8 19.1 8.1 4.6 8.1 12.0 8.1 2.9 4.4 16.9 15.9 4.9 6.2 17.8 11.9 16.8 8.0 5.3 6.1 9.2 5.4 16.0 7.8 9.8 6.8 7.2 10.1 17.5 12.3 8.6 10.8 11.8 7.2 60.3 16.9 20.0 15.7 5.4 14.8 46.6 16.8 17.3 8.0 42.8 18.7 16.1 83.6 11.2 5.7 25.0 18.3 8.3 4.2 4.6 17.6 8.0 4.0 2.6 3.1 3.3 4.1 5.9 1.7 3.6 10.4 64.2 60.9 72.4 147.2 99.0 66.2 31.2 46.1 70.0 167.7 48.0 47.9 76.8 48.6 51.8 25.8 123.0 27.0 89.9 64.9 9.8 122.3 44.4 119.3 89.6 55.6 47.3 43.5 176.6 38.5 36.6 52.3 66.3 203.1 29.1 135.6 40.0 19.0 26.8 186.7 225.7 52.7 40.7 29.2 53.1 12.4 60.0 46.3 32.0 124.6 53.0 62.5 65.9 210.6 209.8 52.2 49.5 66.2 90.8 49.4 72.5 14.5 50.1 99.4 32.9 84.6 59.5 56.3 34.1 36.7 51.4 211.8 90.8 66.8 44.5 58.5 HUS1B ENSG00000188996 "HUS1 checkpoint clamp component B" Q8NHY5 6 655939-656963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.2" "Group enriched" "Detected in some" 4 "Sertoli cells: 6.6;Spermatocytes: 19.3;Spermatogonia: 8.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;U-266/84: 2.2;WM-115: 2.2" "Not detected" "Not detected" "HPA034511, HPA063449" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034511: AB_2674203, HPA063449: AB_2685014" "unprognostic (3.56e-4)" "unprognostic (3.68e-2)" "unprognostic (4.81e-2)" "unprognostic (1.95e-1)" "unprognostic (3.45e-2)" "unprognostic (1.36e-1)" "unprognostic (4.95e-2)" "unprognostic (6.53e-2)" "unprognostic (9.44e-2)" "unprognostic (8.46e-2)" "unprognostic (8.76e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-10)" "unprognostic (7.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" 0.3 0.3 0.3 0.1 0.3 0.7 0.3 0.1 0.4 0.8 0.4 0.3 0.2 0.4 0.1 0.6 0.3 0.1 0.4 0.2 0.2 0.5 0.6 0.6 0.0 0.3 0.2 0.2 0.5 0.1 0.0 0.5 0.1 0.3 0.8 0.0 0.2 0.4 0.0 0.2 0.5 0.3 0.1 0.0 0.6 0.2 2.2 0.2 0.1 0.4 0.1 0.0 0.4 0.7 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.5 1.8 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.7 0.4 0.2 0.0 0.2 1.0 1.1 0.0 0.6 0.3 0.3 1.0 0.1 0.2 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.3 0.6 0.1 0.9 2.2 0.4 0.0 0.2 2.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.3 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.5 1.1 0.0 0.0 0.0 0.8 0.6 0.8 1.0 0.6 0.7 1.3 1.3 0.2 1.5 0.2 0.0 0.0 1.5 1.7 0.3 0.0 1.3 0.6 0.5 0.4 1.2 0.0 0.0 0.0 0.6 1.1 0.5 0.0 0.9 0.0 0.5 2.2 0.2 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.6 0.9 0.5 0.0 0.0 2.6 0.4 2.1 0.0 0.0 1.3 0.1 1.2 0.1 0.7 0.3 0.1 0.1 1.4 6.6 0.7 1.3 19.3 8.0 0.2 1.7 1.5 1.5 0.8 0.3 0.5 KCTD21 KCASH2 ENSG00000188997 "Potassium channel tetramerization domain containing 21" Q4G0X4 11 78171249-78188626 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041964 Uncertain Approved Cytosol NA NA Cytosol "HPA041964: AB_10795647" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (3.74e-3)" "unprognostic (6.40e-3)" "unprognostic (8.06e-2)" "unprognostic (2.48e-2)" "unprognostic (1.52e-1)" "unprognostic (6.82e-2)" "unprognostic (8.85e-2)" "unprognostic (1.37e-3)" "unprognostic (2.49e-1)" "unprognostic (1.31e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "unprognostic (4.70e-1)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" 7.4 13.5 14.5 6.2 13.9 3.5 4.4 13.1 14.0 5.8 8.9 5.7 5.0 5.1 9.3 9.6 6.3 7.9 6.4 13.6 14.1 5.6 16.0 6.7 5.4 15.0 16.0 14.1 13.9 3.6 5.7 5.9 7.8 15.4 4.3 4.8 4.4 5.9 5.3 8.6 5.0 4.5 7.1 12.9 4.6 4.5 4.1 14.5 6.0 11.3 7.0 6.3 7.2 5.9 18.4 5.2 11.8 6.7 5.0 23.8 16.9 4.1 10.1 9.6 7.1 7.1 11.1 7.8 5.0 9.9 11.4 9.5 10.1 6.5 8.4 7.3 6.9 3.9 3.8 15.4 9.8 13.2 2.4 4.7 16.4 15.4 15.5 8.8 14.8 11.0 6.1 8.1 4.5 9.7 7.3 3.8 7.3 3.0 19.0 8.9 5.0 5.1 3.1 8.3 9.3 4.6 7.1 6.4 4.6 4.9 12.1 10.6 2.6 12.9 11.3 11.0 30.0 3.9 8.6 9.2 4.8 5.9 3.9 6.4 2.0 5.4 7.5 0.9 6.0 1.4 0.6 1.4 1.7 3.7 1.4 1.3 1.0 8.3 1.4 5.1 0.8 1.1 2.2 14.5 13.9 13.1 14.0 13.6 14.1 15.0 16.0 14.1 15.4 12.9 14.5 18.4 1.9 0.0 2.7 4.6 0.7 1.8 1.2 1.5 0.6 1.7 2.4 2.2 3.5 5.7 2.0 0.0 0.0 1.2 0.6 2.8 1.9 1.5 0.3 1.4 2.5 2.3 0.0 0.0 4.1 2.2 1.1 2.8 1.1 1.9 5.7 7.0 3.6 7.4 2.3 6.7 3.4 1.3 0.0 3.1 1.1 0.5 4.4 1.3 1.8 4.7 2.8 1.0 0.0 4.0 4.2 2.5 1.7 9.1 1.0 1.9 2.3 2.7 1.1 0.9 0.0 1.2 2.9 1.5 2.7 3.6 1.4 1.9 1.8 3.8 1.7 2.1 SBSN "HLAR698, UNQ698" ENSG00000189001 Suprabasin Q6UWP8 19 35523367-35528351 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 1064.7;skin 1: 2395.8;vagina: 762.7" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 1017.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 355.2;melanoma: 153.1" "Region enhanced" "Detected in some" "basal ganglia: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 62.2;ASC TERT1: 107.5;HSkMC: 146.1;U-2197: 51.6;U-87 MG: 119.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA062568, HPA067734" Enhanced Approved Vesicles "Secreted - unknown location" NA NA 89000000 Vesicles "HPA062568: AB_2684794, HPA067734: AB_2685894" "unprognostic (1.10e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (1.23e-3)" "unprognostic (3.45e-3)" "unprognostic (2.56e-1)" "unprognostic (4.83e-4)" "unprognostic (4.31e-4)" "unprognostic (6.97e-2)" "unprognostic (9.08e-14)" "unprognostic (6.37e-2)" "unprognostic (6.51e-3)" "unprognostic (2.09e-1)" "unprognostic (1.36e-3)" 2.4 0.6 0.4 0.1 3.7 0.8 95.4 0.4 1.1 222.6 0.2 0.8 0.0 0.5 0.0 1064.7 0.2 0.3 1.3 0.5 0.6 0.4 1.7 0.9 0.0 0.8 0.4 0.5 0.7 1.6 0.0 0.9 0.3 0.6 0.6 0.0 0.0 354.6 0.0 13.2 2395.8 0.7 0.2 0.4 0.5 1.1 1.0 0.4 6.6 0.7 0.0 170.4 1.2 762.7 0.5 0.1 0.1 0.0 0.1 62.2 107.5 0.1 5.1 7.2 2.4 0.9 0.0 0.1 0.1 1.2 4.8 1.7 0.3 0.0 1.8 1.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.1 146.1 8.2 30.0 7.1 2.1 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.3 0.2 0.0 0.4 18.4 3.8 51.6 1.4 0.5 0.3 0.0 119.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 0.4 1.1 0.5 0.6 0.8 0.4 0.5 0.6 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 89.3 0.1 0.6 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.4 0.8 1.8 0.0 0.0 0.2 0.6 0.2 3.1 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 25.2 4.0 0.0 0.2 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.2 0.2 13.4 1017.6 0.3 0.7 0.0 0.0 0.4 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase tRNA specific 2" Q7Z6V5 6 143422832-143450695 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 6.6 8.9 1.4 3.1 1.3 5.4 6.3 1.8 1.6 5.7 1.7 6.6 3.1 4.9 1.5 10.4 6.2 1.2 3.4 1.3 1.2 6.3 12.1 8.5 4.3 1.4 1.2 1.5 5.9 10.6 1.5 6.7 1.1 1.5 7.3 4.1 1.4 5.4 1.1 3.2 8.1 8.9 1.7 0.9 10.8 8.9 2.8 1.3 1.9 8.7 0.7 3.5 6.6 8.0 1.6 1.8 1.6 2.2 7.2 1.7 5.3 2.7 2.6 1.1 1.6 2.2 4.0 4.4 7.0 2.7 1.7 1.7 5.8 4.3 4.1 3.4 3.5 9.2 10.4 7.3 8.3 2.1 15.0 4.6 2.4 6.0 3.2 6.3 1.8 3.7 6.5 11.3 5.4 2.7 2.5 6.0 7.6 2.5 2.6 2.8 7.0 5.7 5.6 3.0 1.9 4.7 3.1 2.1 6.0 1.8 1.2 2.4 5.0 3.4 2.6 1.9 5.6 4.8 5.9 4.2 4.9 2.7 13.0 2.8 0.0 0.2 0.0 0.6 0.3 0.8 0.5 0.5 0.5 0.6 0.3 0.7 1.0 0.1 0.4 0.0 0.6 1.3 0.4 1.4 1.3 1.8 1.6 1.3 1.2 1.4 1.2 1.5 1.5 0.9 1.3 1.6 4.6 6.4 12.9 8.8 6.9 6.6 4.3 4.1 6.2 3.7 5.6 6.3 4.0 5.7 4.1 1.8 0.0 2.4 11.9 4.3 3.9 5.6 1.2 2.7 11.1 4.8 4.2 14.9 11.2 4.1 2.6 5.3 12.2 5.9 7.6 7.1 3.9 5.2 4.9 1.7 10.4 6.0 4.1 4.3 6.1 1.6 6.8 5.3 5.4 7.5 2.1 1.9 8.2 12.5 4.2 6.6 2.4 3.4 4.2 6.8 1.6 1.4 2.1 4.3 0.0 5.1 5.1 2.4 5.6 9.8 9.2 0.8 8.9 6.2 8.8 4.5 KIR2DL4 "103AS, 15.212, CD158D" ENSG00000189013 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4" Q99706 19 54803535-54814517 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "lymphoid tissue: 4.6" "Group enriched" "Detected in some" 6 "dendritic cells: 23.6;NK-cells: 6.2;T-cells: 20.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 28 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 28 "NK-cells: 2.8" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.84e-2)" "unprognostic (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (5.95e-4)" "unprognostic (1.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.92e-5)" "unprognostic (5.15e-2)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.53e-8)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (6.10e-4)" "unprognostic (3.59e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.2 2.5 0.0 0.7 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.1 0.0 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 33 "testis: 3.3" "Group enriched" "Detected in some" 35 "Spermatocytes: 7.4;Spermatogonia: 13.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA055743: AB_2682902, HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 59.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.4 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VHLL "VHLP, VLP" ENSG00000189030 "VHL like" Q6RSH7 1 156298624-156299307 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.61e-1)" "unprognostic (2.45e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.5 1.2 0.8 0.3 0.4 0.3 0.2 0.8 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP21 ENSG00000189037 "Dual specificity phosphatase 21" Q9H596 X 44844021-44844888 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "testis: 10.8" "Group enriched" "Detected in some" 99 "Early spermatids: 82.4;Late spermatids: 277.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 277.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF567 MGC45586 ENSG00000189042 "Zinc finger protein 567" Q8N184 19 36687612-36727701 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 86.7;Late spermatids: 153.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023937 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023937: AB_1859351" "unprognostic (4.39e-3)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.03e-2)" "unprognostic (2.36e-2)" "unprognostic (6.57e-2)" "unprognostic (2.40e-2)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (1.54e-1)" "unprognostic (9.93e-2)" "unprognostic (1.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (7.24e-2)" "unprognostic (9.03e-2)" 3.3 3.7 3.0 3.0 3.0 3.5 5.9 5.4 4.1 4.2 3.4 3.1 2.3 5.1 4.2 3.1 4.0 3.2 3.1 3.0 3.4 3.4 4.8 3.4 4.8 2.5 3.2 3.0 4.6 2.7 5.5 4.8 5.7 3.2 5.2 2.9 5.0 3.7 5.0 2.3 3.3 3.0 4.5 2.9 4.5 3.4 9.6 3.1 6.7 4.8 3.1 5.0 4.2 3.6 3.5 7.1 5.5 9.8 8.7 5.5 5.4 9.3 5.1 7.8 5.7 9.1 3.1 2.5 4.4 6.0 4.6 4.2 1.8 9.1 5.3 7.7 8.8 4.7 8.4 6.0 3.0 5.0 10.8 6.2 8.4 6.2 5.4 10.5 7.4 6.7 8.9 3.3 2.3 6.9 4.5 13.9 4.1 9.4 4.8 4.3 6.8 13.5 6.4 3.8 10.7 7.3 7.8 9.5 4.7 4.9 10.9 5.9 7.2 4.2 7.5 7.6 3.8 5.8 8.8 7.8 14.9 0.0 4.3 6.7 5.0 1.8 5.8 5.7 1.5 4.8 5.7 6.2 5.4 3.2 7.0 6.0 6.1 0.9 6.8 1.6 2.2 5.5 2.5 3.0 3.0 5.4 4.1 3.0 3.4 2.5 3.2 3.0 3.2 2.9 3.1 3.5 15.5 6.4 6.9 4.6 15.3 11.7 12.5 7.4 7.4 9.0 13.4 14.7 5.8 5.7 8.8 9.2 10.4 15.3 13.3 3.8 3.9 8.6 86.7 13.4 7.8 9.9 4.2 11.6 12.8 5.1 13.5 7.7 8.2 11.1 17.2 11.7 12.8 6.5 7.5 11.8 11.2 4.6 4.1 5.1 3.7 153.0 9.9 4.7 7.2 11.2 6.7 8.1 14.4 8.5 11.9 4.4 6.2 15.1 5.9 13.1 3.7 6.7 4.8 6.1 6.6 11.5 10.1 42.2 13.4 6.1 17.6 27.5 13.2 12.2 4.4 13.3 NDUFA4 "CI-9k, COXFA4, MLRQ" ENSG00000189043 "NDUFA4 mitochondrial complex associated" O00483 7 10931943-10940153 "Disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 530.0;tongue: 658.3" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 4615.5;Distal tubular cells: 3960.0;Proximal tubular cells: 3331.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Approved Supported Mitochondria NA NA 50000 Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favorable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 73.4 90.8 190.3 41.2 194.6 68.1 76.8 190.1 265.5 55.2 188.2 77.8 74.9 74.8 81.9 67.5 70.1 36.5 489.3 198.1 200.4 141.8 141.5 63.4 42.8 192.4 190.3 192.6 60.6 61.8 254.2 23.4 31.9 196.4 66.5 57.1 129.5 109.6 85.2 530.0 56.2 59.3 61.5 192.3 60.1 107.9 24.5 191.0 64.5 66.9 658.3 46.5 74.3 54.5 200.1 55.3 90.9 155.0 176.8 84.0 78.4 70.3 68.2 63.2 61.3 53.6 115.2 144.7 104.6 63.0 96.7 168.0 94.1 102.1 79.4 66.5 52.2 74.0 88.2 93.4 108.6 73.2 123.3 84.3 84.8 78.4 75.4 66.0 116.7 86.6 92.7 133.2 139.0 129.8 103.8 56.2 109.3 169.2 364.2 181.6 74.7 108.6 118.6 158.0 115.4 95.2 99.7 106.9 303.7 64.7 210.3 191.6 149.6 76.8 73.3 102.0 107.0 115.0 84.6 115.8 120.5 101.3 130.8 232.5 236.7 110.2 160.6 74.3 135.8 88.3 95.7 103.3 93.9 138.9 74.6 106.1 93.3 25.3 79.4 146.4 131.2 131.6 192.8 190.3 194.6 190.1 265.5 198.1 200.4 192.4 190.3 192.6 196.4 192.3 191.0 200.1 422.2 490.4 470.7 52.9 366.9 407.1 605.8 1642.7 307.9 521.0 742.3 936.0 4615.5 843.6 879.3 952.7 266.9 875.9 357.5 543.8 3960.0 865.1 160.6 626.2 471.6 447.0 209.7 358.3 54.1 955.5 763.9 557.9 404.7 477.7 576.4 507.5 656.1 1887.5 964.5 158.2 72.7 780.8 1373.2 589.0 589.8 106.8 493.6 517.6 916.0 49.6 596.6 721.5 374.9 36.7 57.9 776.6 626.7 784.3 467.9 696.6 596.2 3331.1 803.0 666.0 335.2 546.5 846.5 172.7 295.5 581.7 482.9 658.8 389.1 443.5 712.4 803.2 ANKDD1B ENSG00000189045 "Ankyrin repeat and death domain containing 1B" A6NHY2 5 75611182-75681773 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Endometrial ciliated cells: 13.6;Gastric mucus-secreting cells: 8.6;Intestinal goblet cells: 8.4;Proximal tubular cells: 8.4;Respiratory ciliated cells: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;PC-3: 1.0;RPMI-8226: 1.5;RPTEC TERT1: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059722 Uncertain NA NA "HPA059722: AB_2684112" "unprognostic (5.11e-3)" "unprognostic (2.46e-2)" "unprognostic (3.06e-2)" "unprognostic (6.16e-2)" "unprognostic (3.26e-1)" "unprognostic (2.42e-1)" "unprognostic (2.39e-1)" "unprognostic (7.84e-3)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" "unprognostic (7.36e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.30e-7)" "unprognostic (1.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-1)" "unprognostic (1.27e-2)" 0.1 0.4 1.4 1.0 1.9 0.1 1.0 1.3 1.4 0.4 3.0 3.4 0.1 0.6 0.6 0.1 4.3 0.5 0.2 1.3 1.6 3.6 0.1 1.1 0.6 1.8 1.9 1.0 0.1 0.7 0.7 0.2 0.5 1.2 0.8 3.4 0.2 0.1 0.1 0.0 1.7 0.9 0.2 1.9 0.3 1.9 0.6 1.6 0.2 0.3 0.0 0.5 0.2 0.2 1.4 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.3 0.1 0.6 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 1.5 2.6 0.2 0.3 0.6 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 1.4 1.9 1.3 1.4 1.3 1.6 1.8 1.9 1.0 1.2 1.9 1.6 1.4 0.3 0.0 2.4 2.0 0.6 0.5 0.7 1.4 0.0 0.0 1.0 0.6 0.4 0.0 2.5 3.7 0.0 2.5 0.3 2.9 9.8 1.0 0.6 13.6 0.6 1.1 0.0 0.8 6.8 1.0 0.5 0.2 8.6 0.6 0.0 0.5 2.2 0.1 0.4 0.0 4.9 8.4 0.0 0.8 0.7 0.2 2.1 1.3 1.8 3.7 0.1 0.0 2.1 2.0 3.5 0.4 1.4 1.5 0.1 0.5 0.0 8.4 23.4 0.0 0.0 0.1 0.3 0.5 0.5 0.0 0.6 0.5 0.8 2.1 4.3 0.2 ALKBH2 "ABH2, MGC90512" ENSG00000189046 "AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase" Q6NS38 12 109088188-109093631 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011198, HPA045392, HPA051976" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680" "prognostic favorable (6.67e-5)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (4.55e-2)" "unprognostic (4.71e-2)" "unprognostic (1.69e-1)" "unprognostic (9.60e-2)" "unprognostic (3.63e-1)" "unprognostic (1.85e-1)" "unprognostic (6.39e-2)" "unprognostic (6.43e-3)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.01e-2)" "unprognostic (7.88e-2)" "unprognostic (6.24e-2)" "prognostic favorable (8.67e-4)" 20.9 14.9 17.8 13.3 19.3 8.5 22.4 18.6 19.1 19.5 15.9 15.4 8.0 21.7 9.4 18.1 20.6 8.3 14.5 18.3 19.1 12.8 32.0 12.4 16.9 19.1 19.2 17.9 22.0 19.3 6.2 9.9 7.2 19.7 15.6 9.2 4.5 15.7 11.4 25.5 26.6 15.1 13.9 18.9 15.2 17.0 11.4 19.9 11.4 15.2 12.2 14.1 19.3 18.7 21.7 35.1 58.6 33.0 74.1 22.7 30.3 52.2 22.9 15.2 23.7 26.7 62.3 24.6 53.5 22.1 13.3 11.1 25.1 55.9 23.0 13.8 48.0 50.0 26.8 35.3 57.9 30.1 37.2 23.9 31.4 48.9 22.2 56.5 28.7 9.1 50.5 40.3 31.0 16.3 61.6 34.8 74.5 45.6 36.6 59.1 30.4 32.0 57.7 31.5 48.1 33.8 58.0 24.2 77.4 50.9 12.3 47.5 22.1 9.6 26.0 28.5 25.0 34.1 43.1 54.6 119.2 22.4 31.8 42.7 2.9 8.1 1.4 12.4 11.2 21.8 27.4 18.4 17.5 8.5 27.6 27.1 16.2 1.5 16.7 7.6 21.6 15.8 10.4 17.8 19.3 18.6 19.1 18.3 19.1 19.1 19.2 17.9 19.7 18.9 19.9 21.7 23.7 9.6 6.3 4.2 15.9 50.9 52.2 19.4 42.1 3.6 25.2 44.3 6.2 12.8 16.3 9.2 2.1 17.5 12.5 3.1 15.6 26.5 12.2 7.2 27.9 17.3 8.4 10.9 3.5 24.0 25.0 20.6 14.3 8.6 6.3 9.5 6.1 21.4 9.8 5.0 3.6 11.6 18.3 8.2 11.7 5.4 26.8 6.8 26.6 3.7 4.9 11.2 7.2 6.0 7.6 24.1 5.1 17.3 13.1 46.7 7.4 20.2 10.0 7.4 0.0 44.5 26.0 7.9 32.0 35.9 60.0 5.1 12.6 24.5 14.8 25.3 RNFT1 PTD016 ENSG00000189050 "Ring finger protein, transmembrane 1" Q5M7Z0 17 59952240-59964761 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 65.5" "Cell type enhanced" "Detected in many" "Early spermatids: 174.8;Spermatocytes: 256.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013739 Approved Nucleoli NA NA Nucleoli "HPA013739: AB_1856382" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "prognostic favorable (6.57e-4)" "unprognostic (3.04e-2)" "unprognostic (6.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "prognostic favorable (7.48e-4)" "unprognostic (5.42e-2)" "unprognostic (3.45e-1)" "unprognostic (8.26e-3)" "unprognostic (9.44e-3)" "unprognostic (1.19e-3)" "unprognostic (1.44e-2)" "unprognostic (2.05e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.60e-1)" 6.5 7.2 1.4 6.5 1.5 5.7 4.2 1.7 1.6 4.1 2.0 6.1 8.1 2.6 11.4 3.4 2.7 4.1 3.5 1.4 1.5 5.0 17.5 6.7 6.7 1.9 1.6 1.1 2.6 5.6 7.0 1.7 6.2 1.5 4.5 7.1 1.6 4.8 2.2 3.6 3.2 7.1 4.4 1.6 4.0 3.7 65.5 1.7 5.0 5.5 2.2 7.5 7.4 1.8 1.6 7.1 3.2 3.5 4.4 12.6 8.3 6.3 8.6 5.5 8.1 9.3 9.5 2.7 10.9 14.2 8.1 16.0 8.0 11.7 6.9 11.9 9.7 11.2 9.2 7.2 9.3 8.0 13.3 13.1 9.6 3.9 7.0 3.3 3.7 7.7 3.0 23.7 6.3 6.1 8.5 6.0 6.2 1.2 10.9 7.6 7.6 24.1 5.7 5.5 4.9 2.0 3.8 12.0 3.0 17.2 4.9 14.3 25.8 4.8 12.6 11.1 7.2 7.7 9.3 26.4 6.0 8.8 7.7 6.5 32.5 17.3 31.4 7.6 21.8 10.7 14.3 7.2 8.8 15.5 8.8 9.1 8.3 8.6 13.9 28.0 9.9 9.9 11.9 1.4 1.5 1.7 1.6 1.4 1.5 1.9 1.6 1.1 1.5 1.6 1.7 1.6 12.5 0.0 7.4 5.5 23.3 11.3 14.5 15.1 9.6 9.5 13.4 10.2 6.3 4.3 12.4 9.2 20.9 36.1 23.2 17.0 5.9 14.0 174.8 12.5 9.3 7.5 4.2 13.3 24.7 14.4 36.4 16.6 12.8 8.4 19.0 24.5 13.2 29.5 44.5 18.5 19.7 7.6 12.2 24.5 16.6 77.3 9.0 26.6 17.8 23.4 35.1 4.9 16.5 14.6 8.0 13.3 25.0 11.7 14.1 9.3 17.2 10.4 23.0 8.6 19.7 8.2 11.0 256.4 44.2 15.8 9.7 28.9 16.8 12.5 11.4 10.2 RNF222 ENSG00000189051 "Ring finger protein 222" A6NCQ9 17 8390704-8397826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 17.0;skin 1: 6.7;vagina: 6.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.3;NK-cells: 2.1;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 1.4;Syncytiotrophoblasts: 1.2;Urothelial cells: 1.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SK-BR-3: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048916 Uncertain NA NA "HPA048916: AB_2680555" "unprognostic (2.49e-1)" "unprognostic (4.19e-2)" "unprognostic (2.32e-2)" "unprognostic (8.19e-4)" "unprognostic (2.81e-1)" "unprognostic (5.30e-2)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (9.55e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-3)" "unprognostic (5.82e-2)" "unprognostic (6.70e-2)" "unprognostic (5.98e-3)" "unprognostic (3.97e-2)" 0.0 0.0 0.2 0.1 0.2 1.2 0.3 0.6 0.2 1.6 0.1 0.0 0.0 0.0 0.1 17.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 1.9 0.0 0.1 6.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.0 6.0 0.5 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.2 0.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.5 0.2 0.0 1.3 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.7 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.0 0.0 0.4 0.2 0.2 0.1 0.0 1.4 1.2 0.7 0.1 0.0 1.7 CGB5 HCG ENSG00000189052 "Chorionic gonadotropin subunit beta 5" P0DN86 19 49043848-49045311 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "pituitary gland: 8.7;placenta: 25.8" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 19.7" "Cancer enhanced" "Detected in some" "pancreatic cancer: 10.0;testis cancer: 5.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "BEWO: 120.1;U-251 MG: 53.2" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.38e-1)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "prognostic unfavorable (1.18e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.47e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 8.7 25.8 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.4 0.0 0.0 0.0 0.0 120.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.1 2.2 0.0 53.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 RELN "PRO1598, RL" ENSG00000189056 Reelin P78509 7 103471381-103989658 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein, Hydrolase, Protease, Serine protease" "Disease variant, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 63.3" "Group enriched" "Detected in some" 8 "Hepatic stellate cells: 128.5;Inhibitory neurons: 372.4" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Group enriched" "Detected in all" 7 "cerebellum: 63.3;pons: 16.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.2;PC-3: 8.6;SCLC-21H: 11.1;SH-SY5Y: 13.7;TIME: 33.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 110.0" HPA077891 Approved "Golgi apparatus,Vesicles" "Secreted in brain" NA NA 30000000 "Golgi apparatus" Vesicles "HPA077891: " "unprognostic (1.42e-1)" "unprognostic (2.93e-3)" "unprognostic (4.31e-2)" "unprognostic (1.29e-4)" "unprognostic (1.30e-1)" "unprognostic (6.95e-2)" "unprognostic (1.85e-1)" "unprognostic (8.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-2)" "unprognostic (3.31e-3)" "unprognostic (3.86e-1)" "unprognostic (2.02e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.06e-2)" 1.3 1.8 1.9 0.6 1.7 0.0 2.7 63.3 3.5 1.5 0.4 0.7 0.2 0.4 0.1 0.8 2.9 0.7 1.2 3.1 5.5 0.3 13.5 0.5 0.4 2.1 4.9 1.7 0.4 0.1 0.0 0.5 0.0 16.8 0.6 0.9 2.9 0.8 0.9 0.2 0.6 0.9 0.7 1.8 0.3 0.5 0.7 3.6 0.0 1.7 1.1 0.2 0.7 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.3 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 1.9 0.0 0.0 0.0 11.1 13.7 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 63.3 3.5 3.1 5.5 2.1 4.9 1.7 16.8 1.8 3.6 2.5 1.0 0.0 0.0 9.1 0.5 0.6 0.0 0.0 0.6 30.2 0.5 0.4 5.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 13.6 0.1 0.0 8.3 0.0 7.0 2.6 1.2 0.1 7.5 0.0 0.1 0.0 0.0 128.5 3.3 0.2 0.0 372.4 0.0 0.0 5.3 2.2 6.1 0.0 0.1 0.0 2.8 0.0 0.2 0.0 3.0 10.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.8 0.7 0.1 0.8 0.0 0.6 0.3 0.4 0.0 0.0 0.0 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127412 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.2" "Cell type enhanced" "Detected in many" "B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.3;naive B-cell: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 0.9 0.5 0.8 5.9 0.9 4.8 2.7 3.0 2.1 1.0 0.1 5.6 3.5 1.0 0.5 3.4 0.5 0.8 0.3 0.8 0.7 0.4 2.5 1.1 12.4 0.6 0.6 0.2 0.2 0.6 0.9 0.0 1.7 1.3 1.0 5.9 1.3 0.8 0.4 0.4 4.4 4.0 2.1 0.2 1.9 3.2 0.8 0.7 18.2 0.9 0.1 13.4 1.7 1.0 2.4 72.6 18.5 26.6 0.4 2.7 4.9 0.3 53.5 26.7 31.2 46.1 38.7 28.0 89.8 35.4 15.7 26.3 54.7 39.5 36.2 55.2 46.8 9.5 9.8 32.3 16.9 0.1 0.3 11.1 1.2 1.2 30.3 2.4 6.0 16.9 24.1 2.8 81.9 37.2 27.3 57.7 0.6 0.3 43.2 21.0 60.1 39.7 34.7 16.8 61.2 5.2 16.9 44.4 50.8 8.7 9.7 56.2 5.0 9.4 24.1 52.4 73.5 49.6 62.6 48.4 0.6 35.0 0.4 35.4 0.2 0.1 0.1 0.1 0.0 0.1 3.3 0.2 0.3 0.1 2.6 0.1 0.1 1.6 0.0 0.1 0.1 0.7 0.1 0.8 0.9 3.0 2.1 0.8 0.7 0.6 0.6 0.2 1.3 0.2 0.7 2.4 0.7 0.0 0.0 0.0 12.8 4.2 2.2 4.2 1.8 0.0 2.5 4.2 0.3 0.0 1.4 0.0 0.0 1.1 1.4 4.0 0.0 0.8 0.0 0.9 1.6 1.2 0.0 9.1 0.0 0.0 0.4 1.5 3.6 1.9 0.0 6.3 0.0 0.2 3.9 0.0 0.0 4.4 2.0 0.3 1.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 1.3 0.0 8.8 0.7 0.5 0.1 1.6 0.0 0.0 1.3 1.8 0.1 1.0 7.1 2.7 0.1 3.2 1.1 10.4 1.6 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568705-195584033 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 5088.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 4485.3;Leydig cells: 2077.4;Melanocytes: 1028.1;Peritubular cells: 994.5" "Cancer enriched" "Detected in all" 4 "melanoma: 925.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "memory B-cell: 5.0" "Lineage enriched" "Detected in single" 14 "B-cells: 5.0" "Group enriched" "Detected in many" 6 "ASC diff: 3507.4;ASC TERT1: 1918.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 98900000000 90000000000 "Plasma membrane" "HPA040520: AB_2677020" "prognostic favorable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.71e-3)" 1649.2 85.5 984.8 14.0 1171.7 0.9 5088.3 1189.5 1375.8 606.5 1503.3 142.6 56.5 500.8 157.1 161.3 757.2 215.3 600.3 973.3 1016.2 49.7 7.1 185.1 24.8 1172.5 1090.4 911.8 132.3 214.1 62.4 193.7 353.4 1146.7 423.4 57.8 0.8 1282.7 185.6 1164.4 881.5 89.2 97.0 1063.6 8.3 406.0 76.3 1080.6 114.5 835.7 630.8 21.0 438.1 596.7 1384.5 0.0 2.2 0.5 0.7 3507.4 1918.1 6.1 31.3 7.6 0.1 0.2 222.4 0.4 0.4 0.9 1.8 0.0 0.9 0.4 10.5 0.3 0.3 2.4 0.3 0.2 0.1 12.5 0.3 0.5 91.4 21.0 0.2 17.0 0.3 4.3 0.2 0.2 0.9 5.3 1.3 0.1 0.7 0.5 38.9 0.5 0.1 0.0 0.6 0.0 2.8 0.7 0.5 0.0 34.8 31.8 1.3 67.2 0.1 0.4 0.5 1.4 0.4 0.1 0.2 0.3 9.2 1.0 0.4 420.3 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 984.8 1171.7 1189.5 1375.8 973.3 1016.2 1172.5 1090.4 911.8 1146.7 1063.6 1080.6 1384.5 543.2 0.0 11.0 2.9 7.5 145.0 16.0 25.4 46.7 0.0 121.6 138.7 26.9 1.5 81.8 5.5 0.0 5.4 15.9 1.4 0.0 0.4 9.7 16.3 393.7 114.1 46.3 0.0 3.3 0.0 4.2 4485.3 7.7 7.0 0.0 0.0 21.4 0.0 13.3 0.0 2.1 0.7 10.2 0.3 193.2 51.0 2077.4 31.8 1028.1 279.2 1.0 0.0 0.0 300.6 221.5 2.3 0.3 994.5 19.2 25.7 0.0 0.2 128.9 0.0 19.7 100.3 210.7 10.5 4.0 24.1 102.6 5.9 23.5 7.0 0.6 47.3 H1-0 "H1.0, H1F0, H1FV" ENSG00000189060 "H1.0 linker histone" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 666.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7" "Cell line enhanced" "Detected in many" "OE19: 662.8;U-2 OS: 823.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No 120000 "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 79.0 54.0 59.8 37.0 58.4 666.3 122.4 72.6 64.6 172.0 45.8 142.4 131.0 169.6 43.9 232.4 120.7 56.8 87.3 58.9 65.3 108.1 180.8 73.1 24.6 59.7 57.4 50.1 121.7 127.0 94.0 58.6 80.6 62.4 153.0 121.1 40.2 156.6 40.6 218.3 229.7 138.3 98.6 53.1 37.0 132.2 42.8 60.1 137.5 94.8 94.4 47.0 86.3 196.5 63.8 159.6 67.9 206.0 91.8 53.4 48.4 291.6 126.9 262.3 362.6 512.6 278.1 247.3 0.2 31.1 106.3 84.1 303.8 0.0 87.2 256.0 0.9 15.3 268.2 25.3 187.4 185.8 0.1 0.7 45.4 152.4 182.3 203.2 4.0 97.8 60.4 0.1 0.5 28.5 263.3 45.4 26.5 80.2 662.8 329.9 74.6 122.6 56.1 58.0 42.7 47.3 263.9 349.9 235.4 473.9 91.8 184.2 167.1 65.4 27.4 823.3 122.7 25.9 0.7 18.5 1.2 33.5 95.9 80.3 17.1 9.9 15.7 0.1 11.7 0.1 0.0 1.0 0.2 8.1 0.1 2.8 0.4 5.4 0.1 10.3 7.4 0.2 6.9 59.8 58.4 72.6 64.6 58.9 65.3 59.7 57.4 50.1 62.4 53.1 60.1 63.8 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 125.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 93.3" "Group enriched" "Detected in some" 17 "Spermatocytes: 108.0;Spermatogonia: 358.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 86.8;T-47d: 289.7;WM-115: 325.3" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (1.29e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 86.8 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 289.7 0.0 0.0 47.3 10.6 0.1 0.0 1.2 13.8 0.0 2.9 0.0 325.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 108.0 358.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 701.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 2578.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 2578.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 140.6 44.1 56.6 167.3 77.3 208.8 96.5 79.1 66.4 122.2 76.5 122.3 46.7 101.4 78.5 63.2 109.1 115.1 56.6 50.0 81.0 125.4 108.6 193.8 113.2 94.5 78.9 40.9 68.2 65.1 56.9 39.3 71.9 88.9 106.9 117.2 64.4 117.5 84.1 36.6 70.6 58.4 94.3 84.5 120.6 71.4 10.7 75.1 69.3 117.8 37.9 124.7 216.2 83.8 111.1 79.2 157.8 89.4 43.8 13.9 11.0 90.7 100.2 309.0 93.6 139.1 62.6 206.3 39.9 126.8 86.1 108.7 95.5 40.1 186.4 88.4 304.2 45.8 2.8 117.1 310.3 212.9 12.5 12.9 35.0 320.8 79.6 210.7 84.4 0.3 2.7 25.3 149.5 1.5 75.8 1.8 183.3 146.4 104.0 0.6 12.1 19.6 228.2 79.0 110.4 22.2 68.0 172.9 219.4 183.9 136.3 122.5 66.7 0.8 38.7 65.3 23.0 24.2 59.2 140.6 100.5 45.1 95.8 225.5 508.8 149.5 284.0 459.6 130.2 277.2 174.0 284.0 412.7 178.0 173.9 318.9 381.4 2578.1 274.5 81.9 220.1 350.3 584.9 56.6 77.3 79.1 66.4 50.0 81.0 94.5 78.9 40.9 88.9 84.5 75.1 111.1 297.5 44.8 70.0 7.5 176.7 157.4 336.2 365.4 68.3 2.2 180.5 157.6 48.8 148.7 222.2 163.7 0.0 56.4 505.5 305.4 485.2 245.8 2.3 112.2 151.9 76.3 17.5 18.3 1.1 72.9 471.9 156.7 39.8 108.1 214.9 1.1 94.2 52.9 227.8 0.0 1.6 153.1 175.0 156.9 701.0 11.3 56.2 422.0 156.5 7.5 391.8 232.7 433.5 11.6 59.5 123.3 236.1 68.4 186.3 239.8 23.3 104.3 150.3 5.4 52.6 89.6 176.1 0.2 5.4 37.1 132.1 37.1 278.7 16.6 88.9 368.6 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 43.6" "Cell type enhanced" "Detected in some" "Early spermatids: 3.4;Late spermatids: 20.3;Macrophages: 4.5;monocytes: 12.4;NK-cells: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 16 "eosinophil: 129.2" "Lineage enriched" "Detected in many" 16 "granulocytes: 129.2" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;hTERT-HME1: 1.0;U-2 OS: 1.0" "Low region specificity" "Detected in all" HPA059365 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.1 0.1 0.0 0.2 0.0 43.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 129.2 0.0 6.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 8.1 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 3.4 0.2 0.1 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 2.1 0.0 0.4 0.0 0.0 2.5 0.0 20.3 0.0 4.5 0.0 0.0 12.4 0.0 3.1 0.5 0.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 TMEM120A "NET29, TMPIT" ENSG00000189077 "Transmembrane protein 120A" Q9BXJ8 7 75986831-75994656 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 289.1;Late spermatids: 1002.1;Proximal enterocytes: 414.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 223.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (1.78e-2)" "unprognostic (3.35e-2)" "unprognostic (1.71e-2)" "unprognostic (4.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.99e-1)" "unprognostic (3.26e-1)" "unprognostic (2.75e-3)" "unprognostic (6.16e-2)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.02e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (1.71e-1)" "unprognostic (5.15e-2)" 49.2 95.8 31.7 11.1 31.3 14.0 44.7 34.5 40.9 32.2 29.9 30.6 51.1 22.8 21.7 32.1 32.3 16.7 87.3 30.1 32.5 38.6 85.4 25.2 10.2 50.8 37.6 29.4 56.6 43.5 17.5 20.2 15.8 59.0 26.7 15.0 6.1 24.9 23.5 80.0 18.6 63.9 11.1 28.9 28.5 44.7 77.7 32.7 8.0 19.6 95.3 12.1 33.2 27.5 45.0 10.3 15.3 7.7 61.7 52.1 35.1 16.9 10.0 27.8 13.7 17.2 26.8 14.3 4.8 7.6 30.4 39.1 11.8 7.6 10.3 4.7 9.0 8.5 5.2 10.6 38.2 50.6 2.1 32.6 37.5 9.2 10.1 12.2 14.3 22.4 8.7 9.8 7.9 24.5 18.5 3.3 32.6 3.5 23.7 16.3 3.5 7.8 23.6 28.2 9.3 3.8 18.0 11.4 32.5 16.7 19.1 22.7 15.4 12.8 38.1 12.0 22.1 8.6 8.5 7.0 2.2 20.7 5.3 8.9 106.6 58.0 109.5 26.4 53.7 20.0 15.8 21.7 20.5 27.2 17.9 15.1 14.8 223.0 31.2 55.2 10.7 50.9 46.5 31.7 31.3 34.5 40.9 30.1 32.5 50.8 37.6 29.4 59.0 28.9 32.7 45.0 22.4 22.4 12.3 12.7 14.1 0.0 18.1 0.0 18.8 5.6 36.2 22.2 112.7 51.5 8.6 27.6 6.2 20.9 17.6 133.9 25.4 50.3 289.1 9.8 29.3 21.4 8.4 11.4 4.1 38.9 16.2 36.0 31.1 18.1 24.6 172.6 29.3 115.6 36.1 11.8 7.2 40.5 0.0 34.2 0.0 1002.1 40.4 36.0 0.0 3.7 23.7 12.8 18.6 4.0 7.3 40.0 108.9 30.9 24.6 17.4 414.8 118.0 4.4 7.0 39.5 46.0 31.2 113.4 15.4 33.1 0.0 10.9 20.0 31.0 43.6 28.1 ARID2 "BAF200, DKFZp686G052, FLJ30619, KIAA1557" ENSG00000189079 "AT-rich interaction domain 2" Q68CP9 12 45729706-45908040 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 525.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063044 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA063044: AB_2684929" "unprognostic (8.41e-2)" "unprognostic (1.03e-1)" "unprognostic (4.02e-2)" "unprognostic (3.94e-2)" "unprognostic (4.15e-2)" "prognostic favorable (5.75e-4)" "unprognostic (1.26e-2)" "unprognostic (9.71e-2)" "unprognostic (9.04e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.47e-1)" "unprognostic (1.12e-2)" "unprognostic (9.21e-2)" "unprognostic (3.02e-1)" "unprognostic (2.00e-1)" "unprognostic (6.53e-2)" 6.0 5.3 5.7 6.8 7.8 12.7 7.6 13.6 6.7 7.7 10.0 6.6 5.0 7.0 6.6 8.4 6.5 5.5 5.8 5.4 6.9 6.4 5.4 7.8 7.5 7.5 6.8 4.0 8.4 7.3 11.8 5.1 7.2 7.7 7.5 6.1 13.3 6.8 6.3 6.0 9.9 6.7 6.2 6.4 6.9 6.3 26.3 6.6 18.9 8.8 7.8 9.0 6.9 8.1 10.3 10.3 14.5 25.3 11.1 10.5 7.3 13.7 7.0 9.9 9.6 8.9 20.7 10.4 19.8 12.7 9.8 7.0 12.1 20.6 11.8 13.6 8.8 9.8 26.1 15.9 10.1 7.2 20.7 11.5 6.0 8.8 12.1 19.1 13.4 10.0 29.1 22.4 19.9 8.6 13.4 29.9 14.7 15.1 0.0 7.7 22.9 18.0 19.0 9.1 16.9 13.6 17.4 11.4 13.0 11.1 14.5 20.0 40.8 11.8 10.3 12.3 7.0 9.2 13.2 11.8 53.6 7.9 53.2 7.4 9.4 1.1 2.7 2.4 1.3 2.5 1.0 2.1 2.5 1.5 1.1 2.0 1.9 1.4 2.1 3.4 3.3 2.0 0.9 5.7 7.8 13.6 6.7 5.4 6.9 7.5 6.8 4.0 7.7 6.4 6.6 10.3 23.3 28.9 28.4 110.4 30.8 33.8 14.4 16.3 36.5 51.6 21.7 15.4 15.6 14.3 17.3 29.5 68.8 15.5 49.0 21.3 7.9 13.2 525.4 23.2 23.8 21.1 21.0 35.1 56.7 10.0 10.5 22.0 24.5 27.7 22.1 29.3 19.2 17.3 11.2 32.0 60.3 19.0 22.4 29.8 36.7 149.3 24.8 25.6 14.2 128.4 22.4 19.9 45.3 144.3 157.9 18.8 24.6 22.6 33.8 23.7 19.1 7.4 15.4 66.2 26.3 27.0 27.2 80.2 17.0 39.3 41.3 23.4 34.8 16.4 17.9 21.0 FAM25G bA301J7.4 ENSG00000189090 "Family with sequence similarity 25 member G" B3EWG6 10 47487219-47491693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 18.8;skin 1: 38.7;vagina: 10.0" "Group enriched" "Detected in some" 4 "Pancreatic endocrine cells: 57.1;Spermatogonia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 13.8" HPA044808 Uncertain NA NA "HPA044808: AB_2679096" "unprognostic (1.97e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 4.9 0.0 0.2 0.2 0.0 0.0 18.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.7 38.7 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 10.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.1 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 19.8 3.9 0.0 0.4 0.0 0.0 0.1 0.1 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523791-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No 50000 "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 15.8 11.3 7.6 19.4 8.4 22.4 14.0 16.3 9.3 15.9 11.4 17.3 13.7 17.2 10.2 20.1 16.6 11.7 12.3 8.8 9.1 12.7 12.4 11.8 24.5 7.2 7.0 9.2 22.4 13.9 17.0 7.9 14.3 8.9 11.7 13.3 16.5 12.7 10.8 23.8 20.1 13.1 16.1 6.6 14.0 13.3 10.3 9.0 23.9 14.6 11.8 26.8 14.3 14.5 11.5 72.4 72.6 93.4 65.3 45.5 41.6 74.0 66.3 55.5 84.5 67.3 75.6 55.8 97.1 52.6 51.8 49.9 81.4 98.0 55.7 133.0 31.5 71.1 75.1 56.7 81.0 30.6 106.1 83.9 39.8 40.1 93.9 68.8 54.1 50.9 55.3 104.6 34.2 67.4 87.5 92.9 51.6 85.2 44.8 41.9 163.2 73.3 109.7 26.9 96.4 81.4 59.8 217.7 33.8 33.8 39.2 73.9 53.0 52.7 61.9 67.8 49.2 71.6 37.4 90.4 260.7 40.9 66.9 61.3 23.4 26.1 28.1 35.8 30.8 39.3 28.4 33.1 37.5 35.3 34.3 38.8 33.7 8.3 35.5 31.2 19.1 40.2 37.4 7.6 8.4 16.3 9.3 8.8 9.1 7.2 7.0 9.2 8.9 6.6 9.0 11.5 18.9 25.6 25.7 16.6 33.0 22.4 23.2 23.4 13.1 35.5 20.5 18.3 29.3 14.3 25.4 23.9 14.6 33.6 21.6 19.7 7.9 20.7 6.3 17.8 31.9 25.4 21.1 36.8 23.2 23.2 34.7 24.2 20.4 17.5 17.7 52.3 17.5 23.6 23.6 40.4 26.5 21.8 24.4 20.6 12.8 10.3 33.8 19.2 17.8 24.4 22.7 19.4 25.7 26.2 26.7 24.9 14.0 33.1 25.1 30.2 18.1 15.7 18.8 26.7 6.6 30.2 18.8 28.7 33.3 37.6 26.1 25.4 28.3 48.2 31.6 24.7 PRSS48 ESSPL ENSG00000189099 "Serine protease 48" Q7RTY5 4 151277171-151291453 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "choroid plexus: 15.1" "Group enriched" "Detected in some" 4 "Excitatory neurons: 2.2;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 3.7;Sertoli cells: 6.6;Spermatocytes: 3.1;Spermatogonia: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053801 Uncertain "Secreted - unknown location" NA NA "HPA053801: AB_2682267" "unprognostic (9.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.76e-2)" "unprognostic (4.10e-2)" 0.0 0.0 1.5 0.0 1.5 0.0 0.0 2.4 1.1 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.0 0.0 2.7 2.1 0.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 2.4 1.1 0.8 1.6 2.7 2.1 0.3 3.4 0.6 1.3 2.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.1 0.0 3.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL1RAPL2 "IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1" ENSG00000189108 "Interleukin 1 receptor accessory protein like 2" Q9NP60 X 104566199-105767829 "Enzymes, Predicted membrane proteins" "Hydrolase, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.4;parathyroid gland: 1.0" "Group enriched" "Detected in some" 22 "Excitatory neurons: 191.3;Inhibitory neurons: 117.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.4;hTERT-HME1: 5.6;NTERA-2: 1.0;RT4: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.62e-1)" "unprognostic (1.50e-1)" "unprognostic (1.66e-2)" "unprognostic (3.09e-1)" "unprognostic (1.48e-4)" "unprognostic (9.32e-3)" "unprognostic (1.67e-1)" "unprognostic (6.80e-5)" "unprognostic (1.78e-2)" "unprognostic (2.79e-3)" "unprognostic (5.91e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.84e-2)" 0.0 1.4 0.1 0.0 0.1 0.0 0.4 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.3 0.2 0.0 0.4 0.2 0.2 0.0 0.5 0.7 0.1 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 2.4 0.1 0.2 0.1 0.0 0.0 191.3 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 117.4 0.0 0.0 0.0 0.0 0.2 5.9 0.0 0.0 2.8 0.0 0.0 0.0 3.0 4.6 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 2.6 0.0 1.4 0.0 0.4 BLOC1S3 "BLOS3, HPS8" ENSG00000189114 "Biogenesis of lysosomal organelles complex 1 subunit 3" Q6QNY0 19 45178784-45216933 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050111, HPA070609" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050111: AB_2681019, HPA070609: " "unprognostic (1.17e-1)" "unprognostic (3.97e-2)" "unprognostic (6.94e-3)" "unprognostic (6.26e-2)" "unprognostic (3.14e-1)" "unprognostic (3.04e-2)" "unprognostic (1.75e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-1)" "unprognostic (9.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.89e-9)" "unprognostic (1.92e-2)" "unprognostic (1.93e-1)" "unprognostic (3.29e-1)" "prognostic favorable (6.86e-4)" 6.0 6.3 7.6 6.0 7.6 12.5 5.7 6.9 8.3 5.5 4.7 5.6 5.4 5.6 5.9 6.4 4.7 3.3 4.6 7.5 6.8 5.0 7.8 5.5 7.7 9.2 8.0 7.2 5.6 6.1 4.8 4.5 3.9 8.4 5.7 4.4 3.3 5.7 4.5 4.4 13.0 6.8 4.1 7.2 11.0 7.6 7.3 8.3 4.8 4.7 3.4 7.5 6.7 6.0 8.8 10.4 11.6 3.2 8.1 10.8 7.3 9.7 5.1 8.2 9.5 9.8 7.0 6.6 9.0 12.2 11.9 10.8 16.0 8.5 11.6 6.8 7.9 17.3 12.3 5.5 8.0 15.4 6.0 19.5 10.8 16.3 12.3 17.3 5.4 10.6 5.9 13.2 18.2 5.6 17.8 6.2 9.2 1.8 14.9 14.5 8.9 4.3 7.5 7.0 13.2 6.3 6.0 13.6 22.8 5.1 5.6 9.4 11.1 5.7 9.7 5.5 10.4 8.2 12.7 14.0 6.1 10.6 11.1 7.5 51.1 34.4 30.2 37.4 42.8 31.0 18.4 31.6 28.3 21.4 24.8 25.5 25.5 35.2 24.2 39.9 18.5 29.8 17.8 7.6 7.6 6.9 8.3 7.5 6.8 9.2 8.0 7.2 8.4 7.2 8.3 8.8 3.4 0.0 1.7 1.0 5.4 12.7 2.6 1.7 2.2 5.7 4.2 3.2 2.3 1.5 1.5 3.7 0.0 3.7 5.9 4.6 1.9 4.4 17.7 1.9 3.2 5.2 7.2 1.7 2.7 3.7 4.0 3.2 2.0 2.7 8.2 3.0 6.1 6.3 6.1 5.0 2.8 5.0 0.0 8.8 8.9 39.3 6.2 4.7 3.6 1.0 6.8 3.4 11.3 3.5 2.9 5.1 3.2 7.9 4.0 4.9 4.6 4.2 1.7 2.0 0.0 1.9 3.1 1.5 5.1 2.7 13.9 4.5 6.7 3.0 4.1 1.9 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 23.0;skin 1: 14.4" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 57.5;Syncytiotrophoblasts: 98.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 11.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "BEWO: 92.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.7 0.9 0.1 0.6 0.2 0.0 3.9 0.5 0.3 0.9 0.1 1.0 1.6 0.3 3.9 5.5 1.1 0.1 0.3 0.1 0.3 0.7 0.0 3.1 0.6 0.6 0.4 0.1 0.9 0.4 6.2 0.2 23.0 1.0 1.8 0.7 0.1 0.9 10.3 0.1 14.4 4.8 0.3 0.4 0.9 0.3 0.2 0.2 1.1 1.1 0.1 1.9 2.7 3.9 0.6 6.8 0.8 0.0 0.0 0.0 0.0 92.3 0.4 0.4 1.8 0.4 20.1 1.9 0.0 0.6 0.0 1.3 2.8 0.1 3.4 0.5 0.2 0.7 0.1 1.5 0.6 0.1 0.0 0.0 0.1 1.8 0.0 1.8 0.2 0.2 0.2 4.7 0.1 0.1 1.8 0.0 0.1 0.0 8.2 1.6 0.0 0.0 0.2 0.5 11.9 2.9 0.1 0.1 11.9 0.0 16.8 4.8 0.0 6.3 0.4 2.6 0.0 0.5 0.8 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.1 0.3 0.6 0.4 0.1 1.0 0.4 0.2 0.6 1.3 0.0 0.0 1.0 0.2 0.1 2.6 4.6 4.0 0.0 6.0 6.1 0.5 0.0 0.8 1.8 0.0 57.5 0.3 5.2 0.0 0.7 0.1 0.4 0.1 2.7 1.8 0.0 0.2 0.8 3.9 0.7 0.0 0.7 0.0 0.2 0.7 0.1 4.1 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 3.2 0.0 0.1 3.8 13.4 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.6 1.1 0.9 98.8 0.3 0.1 3.3 6.3 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 27.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.0;Collecting duct cells: 3.7;Enteroendocrine cells: 1.8;Inhibitory neurons: 6.0;Kupffer cells: 1.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enhanced" "Detected in many" "thalamus: 27.2" "Immune cell enriched" "Detected in single" 5 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 97.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.0 0.0 3.1 0.4 14.1 1.7 0.0 3.6 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.6 0.7 0.0 0.1 0.9 5.1 1.4 0.9 0.0 0.0 0.1 0.1 0.1 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.2 27.2 0.0 0.0 0.0 1.3 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 97.9 0.1 0.3 0.4 0.0 0.3 0.0 0.1 3.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.1 3.1 14.1 3.6 2.9 1.1 5.6 5.1 1.4 0.9 4.1 1.4 27.2 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.0 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 1.8 0.0 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 6.0 0.0 0.0 1.2 0.0 0.7 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PLAC9 ENSG00000189129 "Placenta associated 9" Q5JTB6 10 80131682-80145359 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "spinal cord: 37.9" HPA043469 Uncertain "Secreted - unknown location" NA NA "HPA043469: AB_10795770" "unprognostic (1.72e-1)" "unprognostic (4.22e-2)" "unprognostic (5.01e-3)" "unprognostic (1.78e-2)" "unprognostic (2.76e-1)" "unprognostic (3.93e-1)" "unprognostic (5.57e-3)" "unprognostic (5.88e-3)" "unprognostic (8.45e-2)" "prognostic unfavorable (6.60e-4)" "unprognostic (1.30e-2)" "unprognostic (1.09e-1)" "unprognostic (4.23e-3)" "unprognostic (4.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (2.82e-3)" 99.5 18.6 9.0 6.7 8.2 1.3 86.5 9.5 14.9 66.2 43.4 21.4 4.0 27.1 5.1 21.6 30.6 9.1 97.1 13.2 5.2 13.8 6.4 56.6 2.8 5.8 5.9 7.8 11.6 5.8 4.1 4.9 12.6 7.2 36.2 4.6 0.6 20.3 7.7 17.0 43.8 19.9 6.5 5.2 5.0 21.6 15.0 5.4 2.2 45.0 19.4 2.0 54.5 76.4 7.6 0.2 0.0 0.8 0.0 98.5 85.3 32.1 10.3 8.7 0.9 1.2 0.0 0.7 0.0 0.2 6.0 0.1 0.8 0.1 0.0 0.0 0.8 0.3 0.0 0.5 0.0 16.4 0.0 2.3 28.7 0.0 2.1 1.2 10.6 3.4 0.4 0.0 0.4 0.0 0.3 0.1 0.6 1.9 0.4 1.5 0.0 0.1 1.5 0.0 0.6 0.0 1.8 0.0 1.2 0.7 0.2 0.1 0.2 3.6 6.6 3.6 21.0 0.2 0.7 0.9 0.1 1.9 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 9.0 8.2 9.5 14.9 13.2 5.2 5.8 5.9 7.8 7.2 5.2 5.4 7.6 246.2 3.2 1.8 0.0 1.6 126.4 0.7 1.1 8.0 0.4 7.4 14.0 24.4 0.0 0.3 0.0 0.0 7.0 3.6 0.1 0.0 0.3 4.6 3.1 75.7 102.5 1.8 0.0 0.5 0.2 17.7 926.5 5.6 4.4 1.3 0.1 115.6 0.3 14.1 0.0 0.5 0.0 0.0 0.0 191.3 26.7 873.5 7.9 136.9 7.5 0.0 50.2 0.0 0.0 0.2 0.7 0.0 659.7 2.1 1.0 0.0 0.2 0.9 1.7 295.9 89.7 446.6 2.6 2.9 4.6 126.3 11.5 14.1 1.1 0.0 1.8 FAM47B FLJ35782 ENSG00000189132 "Family with sequence similarity 47 member B" Q8NA70 X 34942796-34944915 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "testis: 9.3" "Group enriched" "Detected in some" 9 "Early spermatids: 58.1;Late spermatids: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046829, HPA050996" Uncertain NA NA "HPA046829: AB_2679828, HPA050996: AB_2681301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKAPL "bA424I5.1, C6orf194" ENSG00000189134 "NFKB activating protein like" Q5M9Q1 6 28259297-28260958 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 12.7;testis: 32.6" "Group enriched" "Detected in many" 4 "Early spermatids: 401.2;Spermatocytes: 307.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;BJ: 1.4;fHDF/TERT166: 2.2;HHSteC: 4.6;HSkMC: 3.0;HUVEC TERT2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.93e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (9.73e-2)" "unprognostic (2.47e-1)" "unprognostic (7.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.88e-2)" "unprognostic (3.84e-3)" "unprognostic (5.78e-2)" "unprognostic (5.83e-5)" "unprognostic (6.65e-3)" "unprognostic (2.38e-1)" "unprognostic (2.08e-2)" "unprognostic (2.47e-2)" 1.9 1.3 6.9 0.7 6.4 0.2 1.5 6.9 9.0 0.7 5.5 1.6 0.3 1.1 1.1 0.9 0.7 0.7 5.1 6.1 6.4 1.0 0.8 0.7 0.7 7.1 6.7 5.8 2.0 1.6 0.3 2.1 0.8 7.5 1.4 0.4 12.7 1.6 2.5 5.7 0.7 0.7 1.4 6.7 1.4 1.1 32.6 7.2 0.5 1.0 4.0 0.5 2.0 0.5 8.3 0.0 0.0 0.0 0.0 3.2 0.9 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 1.6 0.1 1.3 0.3 1.2 0.0 0.2 0.9 0.1 0.2 0.2 2.2 0.3 1.0 2.5 0.0 0.2 6.9 6.4 6.9 9.0 6.1 6.4 7.1 6.7 5.8 7.5 6.7 7.2 8.3 4.2 0.0 0.0 2.6 1.1 1.0 1.6 2.5 0.0 29.5 1.8 3.7 13.0 1.5 2.6 1.8 43.8 0.1 4.7 0.0 9.8 2.1 401.2 0.4 2.5 4.8 0.0 0.0 3.3 0.7 0.0 4.1 0.0 0.2 0.0 1.4 3.9 3.5 3.2 33.7 3.3 0.1 10.2 5.1 3.1 49.2 5.6 2.7 5.4 1.9 3.6 15.7 2.1 1.0 2.1 1.4 0.0 6.4 0.4 1.6 0.1 4.1 1.3 77.4 0.0 3.1 5.7 307.1 28.1 1.1 0.9 0.3 1.9 3.2 0.1 0.6 FSCB "C14orf155, DKFZP434F1017" ENSG00000189139 "Fibrous sheath CABYR binding protein" Q5H9T9 14 44504149-44507283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 32.8" "Group enriched" "Detected in some" 69 "Early spermatids: 339.4;Late spermatids: 655.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003546 Supported NA NA "HPA003546: AB_1845561" "unprognostic (8.13e-2)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 339.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 655.2 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832690 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 307.4;urinary bladder: 306.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB002610 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favorable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 2.7 0.4 0.2 23.3 0.1 0.2 69.6 0.8 0.3 38.5 4.0 231.8 128.0 27.0 24.7 307.4 76.4 49.3 0.4 0.2 0.7 117.1 4.8 64.5 1.0 0.4 0.9 0.0 1.2 117.1 52.4 13.2 36.6 0.6 82.9 124.5 0.3 206.3 39.5 0.5 177.3 192.2 7.4 0.0 0.7 13.4 0.6 0.2 10.8 112.6 0.3 37.8 306.5 106.6 0.1 358.1 4.4 0.0 1.5 0.0 0.4 395.0 3.3 0.2 0.3 0.4 184.9 761.4 0.6 28.0 0.1 2.6 193.3 0.0 0.5 0.4 0.7 0.4 0.2 20.3 127.0 0.1 0.1 0.9 0.0 1.9 0.1 0.4 0.3 0.0 0.2 0.3 0.7 0.0 400.2 0.7 1.9 0.7 402.0 495.0 0.5 6.9 7.6 92.4 340.2 79.5 1.7 0.4 636.8 0.8 21.6 250.9 0.9 0.5 0.9 13.7 3.1 3.5 0.9 0.7 0.7 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.3 0.2 0.7 0.4 0.9 0.0 0.6 0.0 0.2 0.1 5.1 275.7 230.2 0.0 12.2 16.2 3149.1 641.6 31.3 0.4 1255.2 548.4 0.8 287.4 954.3 218.8 0.0 771.7 18.7 1985.0 13.7 1026.1 0.0 1201.7 231.0 41.3 675.5 0.0 0.2 447.1 739.7 27.0 94.8 2298.8 27.3 0.2 0.4 0.5 76.3 0.0 0.1 1266.9 905.3 0.6 8.6 0.0 2.5 29.3 14.2 0.0 15.6 0.8 0.0 0.0 0.0 950.2 2081.0 0.0 2.5 2184.8 1906.1 21.6 635.6 0.0 0.0 0.1 68.2 0.0 0.2 1068.1 54.0 956.1 40.7 0.1 965.1 8033.4 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 1.6 1.7 0.7 1.1 1.3 2.1 2.0 3.8 1.9 1.0 0.4 0.9 1.3 2.0 2.7 0.7 1.2 1.7 0.9 1.0 1.2 1.3 0.7 1.4 1.2 0.8 0.6 0.8 2.1 1.3 1.4 0.8 1.5 1.3 1.3 1.2 2.7 0.8 0.9 0.9 2.1 1.0 0.9 0.5 1.7 2.0 1.3 0.6 1.1 2.5 0.7 1.6 0.7 0.8 2.6 0.5 1.8 1.4 1.3 0.7 1.5 0.6 1.2 1.3 0.4 1.0 1.8 1.2 1.8 1.1 1.0 0.5 1.1 1.4 1.9 1.7 0.4 1.2 2.0 2.8 0.9 0.6 1.7 1.6 1.4 0.6 2.5 1.0 0.9 1.3 1.0 0.8 0.8 0.3 0.7 1.4 1.0 2.0 0.5 0.2 1.4 2.8 0.6 0.0 1.3 1.8 1.6 2.2 0.6 0.2 0.9 1.7 1.5 0.5 1.6 1.5 1.4 1.9 2.1 2.8 2.6 0.3 0.2 1.3 2.1 0.4 1.6 1.9 0.6 1.5 1.5 1.6 2.1 0.9 2.8 2.6 2.0 0.2 1.7 1.3 1.5 1.0 0.5 0.7 1.3 3.8 1.9 1.0 1.2 0.8 0.6 0.8 1.3 0.5 0.6 2.6 3.1 0.0 3.9 7.2 7.4 1.8 2.6 2.1 1.8 15.7 2.1 2.4 11.8 2.8 1.9 3.7 12.5 4.0 7.1 0.8 1.9 2.5 37.9 1.4 3.8 4.7 1.2 3.4 22.2 0.7 3.2 4.0 1.1 1.3 0.0 7.6 5.0 1.4 4.0 16.8 28.1 1.3 0.0 1.3 2.5 16.8 8.7 2.2 3.6 12.2 3.2 7.3 7.2 21.1 22.9 1.3 1.6 6.4 1.8 1.9 2.6 2.9 2.4 12.0 0.0 5.2 3.8 7.7 7.6 2.8 2.6 1.6 5.7 3.6 2.1 1.2 GRAPL ENSG00000189152 "GRB2 related adaptor protein like" Q8TC17 17 19127535-19159187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 1.6;B-cells: 3.0;Endothelial cells: 2.0;Hepatic stellate cells: 2.5;Microglial cells: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 9.1" "Lineage enriched" "Detected in many" 6 "B-cells: 9.1" "Group enriched" "Detected in some" 6 "Daudi: 40.5;HUVEC TERT2: 15.6;TIME: 41.5;U-698: 34.6" "HPA051796, HPA066654" Uncertain Approved Centrosome NA NA Centrosome "HPA051796: AB_2681613, HPA066654: AB_2685699" "unprognostic (2.85e-1)" "unprognostic (3.37e-1)" "unprognostic (5.09e-4)" "unprognostic (4.49e-2)" "unprognostic (6.45e-2)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.76e-1)" "unprognostic (5.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.28e-2)" "unprognostic (8.29e-2)" "unprognostic (2.14e-1)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" 2.6 1.7 3.9 14.9 2.9 2.1 1.7 2.3 3.5 1.6 1.6 1.2 1.3 3.6 0.2 0.9 2.6 3.6 1.2 2.1 2.5 2.9 1.7 4.9 25.3 3.7 3.1 1.3 1.0 0.3 0.1 0.9 2.9 3.3 1.2 2.0 0.2 0.6 2.3 1.6 0.9 10.3 2.0 2.5 25.9 1.5 1.2 4.2 9.0 2.6 0.4 25.9 1.7 1.0 5.8 0.0 2.1 2.8 0.0 0.3 0.1 0.7 0.4 0.0 0.0 0.0 1.0 0.5 40.5 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 5.2 0.0 0.0 0.0 0.0 1.7 0.2 0.4 1.3 0.0 5.2 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.1 0.2 41.5 0.0 0.3 1.9 0.0 0.0 0.0 34.6 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 9.1 1.1 0.2 0.1 3.8 1.6 0.5 0.0 0.0 0.0 0.0 0.8 0.7 3.9 2.9 2.3 3.5 2.1 2.5 3.7 3.1 1.3 3.3 2.5 4.2 5.8 0.9 3.2 0.0 1.6 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.0 2.5 0.0 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 11.2 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.7 0.0 0.0 0.0 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283783 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 47.3;Endometrial ciliated cells: 34.0;Respiratory ciliated cells: 91.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 5 "OE19: 28.0" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 6.3 5.0 8.4 0.4 8.2 1.0 6.9 7.5 8.8 2.9 7.1 2.6 3.3 1.7 11.1 1.3 19.7 4.1 2.0 7.8 8.0 7.3 9.2 4.0 0.5 8.2 8.1 7.7 0.8 9.2 7.6 8.6 1.5 7.9 4.2 2.9 8.9 4.4 2.7 6.4 1.3 3.6 1.1 7.9 1.2 5.2 8.0 8.3 0.7 9.8 3.2 0.4 1.9 0.7 8.9 0.6 2.1 2.1 0.6 1.6 0.2 0.5 0.2 2.0 0.4 0.4 2.6 2.2 0.1 0.6 0.7 4.5 0.6 0.9 0.5 0.7 2.1 0.1 0.1 1.3 3.6 0.9 0.5 0.3 1.0 0.5 0.6 0.5 0.9 0.2 0.3 0.2 1.5 0.6 3.1 0.2 0.2 0.4 28.0 1.0 0.3 0.5 0.3 3.4 1.8 3.7 2.9 1.0 1.6 0.3 0.5 1.7 0.2 0.5 0.4 0.5 1.2 0.5 5.5 1.2 0.1 1.6 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 8.4 8.2 7.5 8.8 7.8 8.0 8.2 8.1 7.7 7.9 7.9 8.3 8.9 1.6 9.6 2.6 4.2 0.4 0.6 2.5 5.1 0.0 12.9 7.7 9.1 7.9 8.6 8.4 0.0 12.5 3.3 0.1 6.2 9.8 7.5 47.3 34.0 0.6 1.8 7.7 0.8 1.0 7.8 1.6 1.5 3.1 2.0 0.0 1.5 1.8 3.6 0.8 1.7 1.1 5.7 14.2 1.0 0.0 6.2 0.6 0.7 1.8 1.0 0.0 4.7 0.0 0.0 2.9 5.8 3.0 0.4 0.4 2.8 13.0 10.3 91.4 7.4 0.0 2.0 2.2 8.8 4.3 0.3 0.3 3.4 0.2 0.8 3.1 1.9 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 410.1" "Cell type enhanced" "Detected in many" "Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 767.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA 40000 Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 24.4 75.5 43.0 88.3 46.7 84.2 21.5 52.6 55.1 28.3 33.6 141.4 120.2 18.2 7.4 226.9 15.6 64.3 22.0 45.3 51.2 61.5 49.5 49.7 88.3 41.3 40.6 45.5 13.5 22.8 6.8 24.5 66.9 46.2 28.6 71.1 17.2 62.6 28.0 96.9 37.4 142.7 23.6 36.0 101.3 135.4 410.1 51.0 88.8 16.2 24.5 92.3 94.8 76.4 49.2 775.3 743.0 371.8 384.7 75.5 75.2 309.5 391.8 111.5 364.6 278.0 614.8 449.1 210.1 247.4 303.0 401.7 446.5 344.3 481.9 278.5 215.7 438.3 336.1 275.2 624.8 177.5 256.3 318.3 117.1 218.4 307.3 308.7 107.1 672.2 388.7 197.3 431.3 335.4 561.4 845.0 248.7 216.9 627.8 979.0 520.8 447.5 326.8 392.7 479.1 465.4 373.8 553.8 293.3 213.4 393.8 786.0 154.9 395.1 214.3 615.7 305.0 469.0 165.9 298.1 332.5 186.9 233.4 254.4 241.7 127.0 372.6 79.6 187.8 57.2 102.3 109.3 96.8 100.7 57.2 51.6 76.1 767.6 74.5 206.7 67.4 202.6 118.4 43.0 46.7 52.6 55.1 45.3 51.2 41.3 40.6 45.5 46.2 36.0 51.0 49.2 61.6 25.6 18.1 0.0 36.2 0.0 0.0 0.0 0.0 0.0 81.8 133.2 0.0 0.0 18.0 246.5 0.0 137.6 171.2 0.0 99.7 371.3 0.0 113.2 79.7 32.9 0.0 0.0 0.0 437.2 1344.2 40.4 0.0 194.0 7.6 179.6 0.0 0.0 319.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.5 0.0 0.0 375.7 0.0 0.0 0.0 0.0 1434.1 0.0 0.0 13.9 0.0 0.0 203.3 16.8 0.0 0.0 0.0 76.2 0.0 0.0 0.0 0.0 96.9 73.9 95.0 0.0 0.0 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: AB_2675642" "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 2.0 2.1 1.9 1.4 1.8 2.5 2.0 2.0 2.4 2.7 1.5 2.2 0.8 2.2 1.7 1.5 2.2 1.3 2.2 1.7 1.8 1.9 1.7 1.5 2.1 1.9 1.5 1.3 3.3 1.7 2.7 2.3 1.2 1.9 2.3 1.5 3.2 1.9 1.7 2.4 1.7 1.7 1.9 1.6 2.0 1.7 2.5 1.7 2.5 2.5 3.0 1.6 2.4 2.3 2.2 2.3 2.3 2.1 2.8 1.6 3.3 0.8 2.2 2.2 1.9 2.6 2.1 0.6 2.1 2.6 2.1 1.4 0.9 3.1 1.9 2.5 4.9 1.4 1.7 2.8 0.2 2.3 4.1 2.5 2.6 2.7 2.1 3.6 2.3 2.0 3.4 0.9 1.5 2.4 0.8 2.7 2.2 1.6 2.6 1.0 3.4 2.6 1.7 1.7 2.3 4.1 1.8 3.4 1.0 1.5 1.8 2.3 3.6 3.6 2.0 2.7 2.5 2.4 4.0 5.4 6.4 0.1 3.1 1.7 2.2 1.0 3.4 3.3 1.4 2.9 3.5 2.1 3.0 1.3 2.8 3.0 3.7 1.0 2.4 0.9 1.5 2.3 2.3 1.9 1.8 2.0 2.4 1.7 1.8 1.9 1.5 1.3 1.9 1.6 1.7 2.2 2.6 9.6 4.8 5.2 2.5 2.7 1.9 3.3 3.4 6.1 2.4 1.8 8.7 1.5 3.5 0.0 12.5 2.3 5.8 1.2 3.9 1.9 1.3 2.0 2.9 3.0 1.2 2.5 5.8 1.5 1.3 3.5 1.1 2.4 1.3 4.5 2.2 1.9 1.7 6.7 6.9 1.9 4.1 0.8 1.3 0.8 2.5 2.0 0.0 2.8 1.7 3.8 6.2 6.6 7.0 0.5 0.6 1.5 1.8 1.9 1.4 2.4 4.0 10.2 0.0 4.1 3.7 5.3 2.7 2.0 1.6 2.1 4.6 3.3 1.9 1.3 ZAR1L Z3CXXC7 ENSG00000189167 "Zygote arrest 1 like" A6NP61 13 32303699-32315363 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Spermatocytes: 2.1;Spermatogonia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041319 Uncertain NA NA "HPA041319: AB_10794407" "unprognostic (4.03e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (8.33e-3)" "unprognostic (6.08e-2)" "unprognostic (1.47e-2)" "unprognostic (1.66e-1)" "unprognostic (8.34e-2)" "unprognostic (3.73e-1)" "unprognostic (7.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 1.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 KRTAP10-12 "KAP10.12, KRTAP18-12, KRTAP18.12" ENSG00000189169 "Keratin associated protein 10-12" P60413 21 44697172-44698044 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "skin 1: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 3084.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 28.3" "Group enriched" "Detected in all" 5 "dendritic cells: 11.9;NK-cells: 28.3" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 811.3;SuSa: 896.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 36000 "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 248.2 138.4 227.1 48.1 232.8 4.4 224.3 231.0 350.4 129.1 210.0 163.6 30.9 112.7 72.7 92.4 130.9 104.8 275.3 222.9 227.1 182.6 66.7 139.2 49.2 249.7 237.9 216.3 139.4 76.3 320.1 74.4 70.7 240.6 101.8 60.3 26.0 157.3 65.2 252.7 103.0 117.4 69.5 242.0 112.6 95.2 41.5 238.5 21.4 321.3 222.6 50.0 122.2 123.7 254.3 188.7 153.7 174.5 111.4 150.7 437.5 62.7 254.7 400.0 150.6 172.2 150.4 203.7 4.9 471.6 435.5 22.3 174.7 73.5 158.7 132.7 0.8 68.1 12.0 178.0 129.6 99.8 5.9 39.2 355.3 59.4 135.3 145.0 441.9 346.5 1.3 61.4 0.3 475.2 663.4 0.4 3.4 141.0 161.1 460.2 30.0 180.4 1.4 811.3 141.9 53.4 2.0 544.7 277.2 576.7 896.9 226.4 6.8 495.0 103.3 57.9 139.5 312.0 2.0 5.3 9.3 185.5 3.2 62.1 4.1 2.0 0.2 0.4 0.9 0.9 4.1 0.4 0.3 7.0 2.0 0.6 0.5 0.3 28.3 1.4 11.9 1.4 1.1 227.1 232.8 231.0 350.4 222.9 227.1 249.7 237.9 216.3 240.6 242.0 238.5 254.3 331.0 28.9 106.1 29.7 9.3 110.5 177.4 105.0 103.0 2.1 311.2 345.6 141.9 164.5 104.0 465.3 0.0 132.4 15.3 148.7 248.4 323.3 8.4 399.3 449.1 251.9 124.7 17.3 1.2 323.6 202.1 450.0 58.6 573.8 23.5 185.5 372.3 51.8 162.3 0.0 0.5 167.5 61.1 31.7 107.7 36.3 771.7 37.1 238.3 13.1 14.8 308.1 1.0 0.0 8.8 488.4 164.7 314.1 6.3 240.0 128.7 521.7 77.1 6.9 0.0 234.2 132.5 12.8 23.4 80.3 75.7 74.7 20.5 3084.7 100.6 244.3 ZNF33A "FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK" ENSG00000189180 "Zinc finger protein 33A" Q06730 10 38010650-38065088 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (1.85e-2)" "unprognostic (1.19e-1)" "unprognostic (7.68e-3)" "unprognostic (1.48e-1)" "unprognostic (3.42e-2)" "unprognostic (1.69e-3)" "unprognostic (7.96e-3)" "unprognostic (4.89e-3)" "unprognostic (6.73e-2)" "unprognostic (9.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (6.83e-2)" "unprognostic (7.39e-3)" 9.0 12.7 6.3 12.3 7.1 12.3 18.0 17.3 8.0 14.6 9.5 12.3 13.5 15.2 11.0 9.3 15.0 11.9 9.1 5.7 7.7 15.5 16.4 10.2 14.9 9.4 8.2 4.8 14.9 17.0 17.3 14.1 11.5 10.1 15.2 16.0 20.8 15.0 14.5 14.0 14.0 13.8 10.4 6.9 14.4 16.8 4.4 7.1 14.1 15.9 15.9 16.4 11.1 10.4 8.9 16.3 9.1 16.2 14.1 7.8 9.8 12.8 7.3 7.1 9.1 10.2 9.7 14.5 31.5 7.7 9.8 5.2 10.6 19.3 12.6 8.5 18.9 22.0 25.2 18.6 13.2 7.9 36.0 20.2 8.6 22.5 6.9 10.1 17.0 7.5 17.7 13.5 16.5 9.3 10.6 15.0 8.2 16.4 8.2 10.5 12.9 11.2 14.8 12.8 15.0 12.6 19.8 11.3 12.3 6.4 11.2 14.8 9.5 7.3 8.0 11.7 9.0 5.8 13.0 17.1 18.5 7.4 19.7 3.7 12.7 3.6 6.1 5.4 5.0 4.7 6.4 4.7 3.6 3.4 6.2 5.8 4.6 15.9 4.7 6.6 6.3 3.6 3.1 6.3 7.1 17.3 8.0 5.7 7.7 9.4 8.2 4.8 10.1 6.9 7.1 8.9 28.4 60.9 73.0 39.8 47.5 11.9 33.0 25.6 19.4 38.2 33.4 28.6 70.6 31.5 49.0 27.6 33.3 28.4 43.1 27.1 25.4 34.9 4.6 62.8 19.3 31.6 34.1 30.3 47.4 29.2 20.0 23.5 25.5 37.7 33.6 47.6 21.4 39.6 19.4 30.3 63.9 28.2 18.3 22.8 16.8 6.7 23.9 26.1 10.6 58.1 46.9 21.1 38.1 56.3 81.5 32.0 29.6 24.0 32.1 38.9 22.0 39.3 80.8 31.8 26.3 32.7 22.7 15.3 18.9 18.7 12.8 35.6 34.6 33.2 27.5 38.4 OR14I1 "OR5BU1, OR5BU1P" ENSG00000189181 "Olfactory receptor family 14 subfamily I member 1" A6ND48 1 248681322-248682328 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "Excitatory neurons: 29.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.68e-1)" "unprognostic (1.63e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.8 0.5 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703524 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 257.0" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 20.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HaCaT: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" NA NA 1200000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.3 0.0 0.0 0.0 0.0 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 257.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.2 0.0 0.0 0.0 0.0 0.0 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" No NA 5900000 Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.71e-4)" 22.4 5.2 3.2 8.0 2.7 0.1 13.6 2.9 3.2 25.5 3.8 11.1 9.4 30.7 11.3 6.4 11.8 22.7 6.5 2.3 4.0 7.2 2.1 7.3 1.7 4.0 4.6 2.2 21.2 1.5 2.0 2.5 44.6 3.5 17.6 13.9 2.1 6.6 13.7 2.6 3.6 8.8 18.5 3.3 6.5 6.7 4.5 3.7 3.6 5.2 23.4 1.4 10.9 8.5 4.4 0.0 0.3 148.2 0.0 175.0 190.8 0.1 27.4 86.8 5.0 7.7 0.3 0.0 0.0 0.1 143.3 0.4 0.4 34.2 0.7 2.6 0.2 1.0 0.0 0.0 0.0 129.4 0.0 0.1 195.9 0.3 9.4 3.8 4.7 1.0 0.7 0.0 0.6 2.8 0.0 3.9 0.1 0.3 0.0 2.7 11.7 4.1 0.0 0.0 0.1 0.0 9.6 0.0 0.0 0.2 38.3 0.9 0.0 0.0 69.3 4.2 13.9 0.5 0.2 0.0 0.0 3.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.7 2.9 3.2 2.3 4.0 4.0 4.6 2.2 3.5 3.3 3.7 4.4 3.4 0.0 0.5 1.3 0.0 4.1 0.4 0.1 2.2 2.5 1.1 1.7 1.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 1.9 72.3 3.0 0.0 0.0 0.2 0.0 0.3 56.3 0.0 1.7 0.0 6.4 2.5 0.0 3.1 0.0 9.0 0.0 0.0 0.0 7.8 1.3 37.9 0.9 1.8 10.3 0.0 6.8 0.0 0.0 0.6 0.0 0.0 58.6 0.1 0.0 0.0 0.1 0.0 0.2 19.7 6.6 25.5 0.6 0.1 1.2 2.6 0.8 0.7 18.5 0.0 0.1 DCAF8L2 WDR42C ENSG00000189186 "DDB1 and CUL4 associated factor 8 like 2" P0C7V8 X 27590382-27748821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 21.6" "Cell type enhanced" "Detected in some" "Smooth muscle cells: 1.3;Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 9.4" NA NA "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 ZNF600 "DKFZp686F06123, KR-ZNF1" ENSG00000189190 "Zinc finger protein 600" Q6ZNG1 19 52749942-52786807 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 45.5" "Group enriched" "Detected in all" 5 "NK-cells: 45.5;T-cells: 18.9" "Cell line enhanced" "Detected in many" "RT4: 24.6" NA NA "unprognostic (6.36e-2)" "unprognostic (1.67e-1)" "unprognostic (8.41e-2)" "unprognostic (2.12e-2)" "unprognostic (1.85e-1)" "unprognostic (6.54e-2)" "unprognostic (5.19e-6)" "unprognostic (1.34e-1)" "unprognostic (2.75e-3)" "unprognostic (2.19e-1)" "unprognostic (6.73e-2)" "unprognostic (2.61e-3)" "prognostic unfavorable (4.98e-7)" "unprognostic (2.07e-2)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "prognostic favorable (1.11e-5)" 4.1 3.2 1.6 3.5 1.7 5.6 4.4 9.2 2.0 5.1 2.3 4.9 5.6 3.9 2.6 6.1 4.4 3.0 2.3 1.5 1.7 3.7 4.1 4.9 6.3 1.7 2.1 1.3 3.9 5.3 2.5 2.6 3.8 3.7 6.5 5.7 0.7 4.2 3.7 1.2 6.0 8.5 3.1 1.7 9.3 6.1 1.9 1.9 3.4 4.2 1.6 6.3 5.3 6.6 2.1 6.1 0.0 0.1 2.6 3.6 3.4 14.5 4.6 3.8 3.1 7.7 4.8 5.5 6.9 2.0 3.2 6.0 7.1 0.0 4.2 5.3 1.4 2.9 3.9 3.5 3.9 4.3 0.0 9.1 4.7 6.7 3.3 5.4 2.5 1.6 0.1 5.6 0.0 3.4 2.3 0.0 3.6 1.4 5.8 6.6 0.0 0.0 5.4 5.6 24.6 2.6 3.2 6.3 5.0 0.8 9.5 3.1 5.5 4.4 0.8 1.8 0.7 4.5 3.3 5.5 8.3 0.0 0.0 3.4 3.6 2.2 2.9 18.9 1.7 11.2 6.8 6.4 9.9 4.0 6.4 6.2 10.9 0.5 45.5 4.1 0.9 4.0 6.0 1.6 1.7 9.2 2.0 1.5 1.7 1.7 2.1 1.3 3.7 1.7 1.9 2.1 4.8 25.6 9.6 1.3 13.3 20.3 18.3 4.9 15.9 0.8 4.9 4.4 3.4 5.7 5.9 5.5 0.0 9.2 25.8 8.9 0.0 6.7 7.4 10.8 4.1 7.1 4.2 5.7 1.6 9.7 9.7 5.0 16.8 23.9 31.7 6.0 3.3 2.2 3.2 0.0 1.3 6.5 2.0 1.9 6.0 1.4 2.8 4.3 1.8 4.7 4.0 1.5 51.5 1.0 4.7 11.6 8.2 1.9 17.0 14.0 12.9 2.9 13.2 1.7 0.0 2.6 4.0 0.5 2.6 13.1 24.3 14.6 19.1 3.3 9.9 27.9 BTBD8 ENSG00000189195 "BTB domain containing 8" "Q5XKL5, Q9UPP5" 1 92080305-92184725 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 13.6;retina: 18.2;testis: 5.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 21.9;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 29.7;Oligodendrocytes: 46.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 0.9 1.5 2.6 0.5 5.1 0.1 1.2 7.4 13.6 0.7 0.0 0.8 0.5 1.3 1.1 0.4 1.5 0.8 0.9 5.6 4.3 0.9 0.5 1.1 0.5 1.1 2.7 4.2 2.0 0.5 1.5 0.3 0.9 3.3 1.2 0.8 18.2 0.4 1.0 0.4 0.4 0.7 0.6 0.5 0.5 0.9 5.2 2.1 0.7 1.6 0.7 0.3 0.8 0.2 7.3 1.3 0.8 0.6 0.0 1.1 3.5 2.8 0.6 1.1 0.6 0.7 0.3 0.9 0.4 2.2 0.7 2.5 0.3 0.5 1.2 1.1 1.2 0.7 1.2 0.3 0.4 0.1 0.5 0.5 2.3 1.0 0.4 0.7 2.3 0.7 1.0 1.1 0.3 1.0 0.9 0.3 0.4 0.7 1.6 0.7 0.9 0.5 0.1 0.9 0.9 0.3 0.3 1.0 0.5 0.5 1.1 0.9 0.8 0.6 0.6 0.5 0.3 0.2 1.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.6 5.1 7.4 13.6 5.6 4.3 1.1 2.7 4.2 3.3 0.5 2.1 7.3 5.9 0.0 4.1 19.9 0.9 0.4 1.0 0.3 0.0 9.5 6.0 2.7 0.7 2.8 3.6 5.5 6.2 2.4 2.5 1.2 1.9 4.7 7.6 10.3 5.9 2.8 0.0 2.5 21.9 2.9 1.2 3.7 2.0 8.1 0.0 13.8 1.4 1.1 0.7 3.3 38.3 2.4 6.1 1.5 0.6 1.7 5.9 1.8 1.8 10.3 2.6 4.7 5.2 29.7 46.0 3.8 4.4 3.8 2.1 1.7 3.1 1.7 4.3 15.3 0.0 2.4 2.8 8.1 9.0 0.6 0.6 1.4 2.0 9.4 2.0 1.4 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 232.3" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 819.8;Proximal tubular cells: 569.9;Undifferentiated cells: 285.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 162.1;HHSteC: 302.9;HSkMC: 76.1;hTCEpi: 87.2;RT4: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970" "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 145.2 28.0 24.4 8.7 26.4 0.4 72.2 26.2 26.8 24.2 13.8 117.4 164.9 24.2 14.2 47.1 39.5 17.0 48.4 20.7 31.1 77.6 120.1 64.1 2.4 26.2 29.4 19.9 41.0 39.5 31.7 4.0 30.4 42.2 46.7 119.0 28.4 78.0 35.3 33.8 36.8 232.3 24.2 19.5 6.4 56.4 3.8 33.9 10.0 119.5 34.6 5.4 65.6 39.2 20.9 0.0 3.7 0.6 9.9 162.1 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 4.6 17.2 6.1 22.3 0.1 0.0 2.5 6.9 0.5 18.6 302.9 0.0 16.9 76.1 87.2 0.2 45.2 0.1 20.0 0.0 0.3 0.4 5.7 2.9 0.1 0.8 1.6 20.7 5.0 0.0 0.3 0.5 22.3 131.8 3.1 7.8 0.0 0.0 0.3 0.4 0.5 0.0 8.7 0.0 8.2 0.7 0.0 0.3 0.0 0.0 9.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 26.4 26.2 26.8 20.7 31.1 26.2 29.4 19.9 42.2 19.5 33.9 20.9 35.2 70.5 146.9 23.2 4.6 11.0 177.7 32.3 116.7 5.0 13.6 10.2 101.3 94.4 49.3 60.7 22.9 11.5 0.2 248.0 121.3 36.7 25.2 50.4 42.5 43.6 38.0 4.8 4.0 13.4 21.3 24.3 40.2 175.1 5.7 7.3 53.6 193.7 6.6 3.3 5.0 137.5 67.1 12.2 2.1 33.9 5.6 6.7 10.6 21.5 17.1 25.4 0.0 7.5 1.3 49.5 140.5 0.0 2.6 64.6 819.8 569.9 32.8 27.4 6.6 4.4 30.5 1.3 0.8 120.6 14.3 207.0 3.7 3.5 285.1 129.0 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521131-67530146 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 24.0" "Cell type enhanced" "Detected in all" "Early spermatids: 222.6;Spermatocytes: 258.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 3.9 3.8 2.5 1.6 6.1 5.4 3.6 7.5 4.5 2.7 0.0 2.2 2.8 2.4 1.9 2.1 2.9 1.5 5.0 3.8 2.6 3.1 2.5 2.3 1.3 1.3 3.0 3.8 2.8 4.2 4.4 5.1 2.0 2.3 2.5 2.2 10.9 2.6 2.1 24.0 4.0 1.9 1.4 0.6 1.7 2.4 7.8 1.8 1.4 2.8 8.4 1.0 2.3 2.4 2.5 4.2 4.4 1.1 4.9 5.0 7.2 3.1 1.8 3.2 3.3 2.6 3.4 2.9 3.5 3.8 2.0 3.9 4.9 4.4 1.2 2.7 2.1 10.4 3.7 3.3 4.6 3.2 4.6 3.0 7.5 3.4 1.1 4.0 2.4 1.6 10.6 4.3 7.6 1.0 2.4 3.8 7.6 1.8 3.3 5.6 5.1 2.5 13.0 2.3 2.9 6.4 4.8 3.2 3.0 6.1 2.1 2.7 7.1 1.6 4.4 6.8 5.5 4.7 7.1 11.2 8.5 1.9 9.0 2.2 7.9 4.3 7.8 4.5 3.7 5.2 5.3 5.9 4.5 4.8 3.6 6.2 5.0 0.5 3.8 3.2 4.9 4.0 3.5 2.5 6.1 7.5 4.5 3.8 2.6 1.3 3.0 3.8 2.3 0.6 1.8 2.5 28.0 22.4 13.5 4.9 23.1 67.2 32.6 32.3 120.7 75.5 55.7 82.3 74.5 18.6 14.3 16.5 37.5 42.6 23.8 38.6 80.3 25.1 222.6 17.5 24.2 26.8 27.1 11.8 14.8 29.8 31.9 56.8 15.8 17.1 34.8 15.2 22.9 44.7 30.5 13.5 15.7 47.5 48.8 24.8 25.6 42.6 41.0 19.9 37.4 3.7 15.6 97.1 23.7 5.0 8.5 27.6 48.4 25.6 37.4 63.3 49.0 77.1 8.4 93.9 32.9 38.2 38.7 258.9 52.1 62.7 60.9 20.5 34.4 28.9 39.2 20.0 NUGGC "C8orf80, HMFN0672, SLIP-GC" ENSG00000189233 "Nuclear GTPase, germinal center associated" Q68CJ6 8 28021964-28083936 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "liver: 20.8;lymphoid tissue: 23.1" "Cell type enhanced" "Detected in some" "Hepatocytes: 15.7;Plasma cells: 35.1;Proximal tubular cells: 7.8" "Cancer enriched" "Detected in many" 5 "liver cancer: 3.8" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 4.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 116.5;Karpas-707: 38.6;U-698: 84.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.23e-2)" "unprognostic (2.17e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (2.15e-2)" "unprognostic (1.83e-4)" "unprognostic (2.08e-3)" "unprognostic (6.19e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-3)" "unprognostic (2.45e-1)" "unprognostic (1.95e-1)" "unprognostic (3.39e-3)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (6.14e-2)" 0.3 0.3 1.3 6.3 0.7 0.9 0.9 1.1 1.8 0.1 2.9 1.9 1.9 0.2 0.2 0.4 0.3 0.4 0.2 1.2 1.0 5.1 20.8 0.8 18.8 1.9 1.2 0.7 0.5 0.2 0.0 0.0 0.1 1.7 0.3 1.5 0.3 1.3 0.2 0.3 0.5 2.3 0.1 0.2 2.7 2.6 0.4 0.7 0.6 2.1 0.0 23.1 1.6 0.1 3.8 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 1.0 0.3 116.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.3 1.1 0.0 0.2 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 38.6 0.0 0.1 2.4 0.2 0.1 0.3 0.0 1.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.6 0.0 0.1 0.3 0.1 0.1 15.2 1.4 84.8 0.2 0.2 0.0 1.0 0.4 0.2 4.0 0.3 0.5 1.6 1.8 2.6 0.1 0.6 0.3 1.0 0.8 0.5 0.1 0.3 0.1 0.5 1.3 0.7 1.1 1.8 1.2 1.0 1.9 1.2 0.7 1.7 0.2 0.7 3.8 0.2 0.0 2.2 0.0 5.0 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.7 0.0 3.7 1.8 0.0 0.0 2.2 0.0 1.9 0.0 1.1 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.5 3.1 0.1 1.3 0.0 0.0 15.7 0.0 0.0 0.5 0.0 0.0 0.6 1.1 1.5 0.0 0.4 0.0 0.0 0.1 0.1 2.1 0.5 0.2 0.0 0.0 0.0 35.1 0.2 0.0 7.8 0.0 0.3 0.0 0.4 0.3 0.1 0.0 0.0 1.0 0.0 4.6 0.1 0.0 0.3 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116267760-116279930 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031970 Supported Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favorable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favorable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 24.2 74.4 45.2 17.3 68.8 34.7 23.6 47.7 87.8 22.7 34.5 30.0 24.6 28.6 33.2 34.3 31.7 20.7 36.9 67.5 60.7 50.9 41.3 21.6 21.6 36.5 35.3 66.2 35.2 33.6 64.4 40.4 16.1 44.6 42.4 17.9 26.3 30.5 34.2 116.0 28.1 30.3 24.5 24.8 29.8 35.8 29.1 40.6 22.5 40.0 92.7 25.8 31.6 22.9 66.5 22.2 21.5 27.3 50.3 47.2 30.9 22.7 35.2 34.7 31.3 35.8 27.7 15.9 47.3 43.0 40.8 28.2 38.5 21.6 59.8 33.2 19.4 56.0 19.1 29.9 50.8 29.8 31.9 11.2 36.2 46.0 32.5 31.2 32.9 30.3 20.7 34.3 36.1 44.2 48.9 21.5 18.9 13.6 21.3 19.8 19.1 23.5 26.3 54.9 42.9 23.7 23.6 29.2 38.8 18.0 30.6 51.0 39.1 37.3 21.2 18.7 17.2 38.7 19.8 22.7 25.2 35.1 20.3 14.1 121.0 30.1 51.5 40.5 51.0 61.4 46.4 52.4 45.4 26.1 52.2 51.1 50.0 24.1 33.2 57.7 44.9 44.8 34.0 45.2 68.8 47.7 87.8 67.5 60.7 36.5 35.3 66.2 44.6 24.8 40.6 66.5 29.4 35.3 45.9 15.7 65.2 166.1 100.6 37.6 70.6 81.0 91.7 47.5 100.0 61.5 40.5 104.8 27.1 54.8 54.2 49.3 154.6 40.8 33.0 40.5 42.0 40.4 74.6 49.7 65.4 43.9 25.5 63.1 41.3 34.9 31.7 67.5 73.9 81.3 42.4 38.7 50.5 59.3 46.8 82.1 116.0 20.2 75.5 40.2 87.2 22.5 38.3 82.6 42.2 15.6 20.2 48.8 52.5 95.5 24.1 77.0 60.3 218.9 41.4 58.1 131.5 87.6 63.5 61.9 39.8 55.5 162.0 59.7 69.1 101.3 70.2 75.8 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 49.3" "Group enriched" "Detected in some" 19 "Early spermatids: 456.5;Late spermatids: 271.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 1.8" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 49.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 456.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 271.5 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64B ENSG00000189253 "Tripartite motif containing 64B" A6NI03 11 89869282-89876017 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 332 "basophil: 33.2" "Lineage enriched" "Detected in single" 332 "granulocytes: 33.2" "Not detected" "Not detected" HPA045370 Approved NA NA "HPA045370: AB_2679298" "unprognostic (2.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNRC2 ENSG00000189266 "Proline rich nuclear receptor coactivator 2" Q9NPJ4 1 23956839-23963462 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027820, HPA045837" Uncertain Supported "Nucleoplasm,Golgi apparatus" No No Nucleoplasm "Golgi apparatus" "HPA027820: AB_10602147, HPA045837: AB_2679467" "prognostic favorable (6.02e-4)" "unprognostic (5.99e-2)" "unprognostic (3.15e-3)" "unprognostic (2.10e-2)" "unprognostic (3.58e-1)" "unprognostic (4.45e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (4.05e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.92e-3)" "unprognostic (1.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-1)" "unprognostic (4.44e-2)" "prognostic favorable (4.05e-4)" 73.5 83.3 50.8 81.3 53.1 142.2 79.3 54.7 62.5 70.2 58.0 99.0 100.4 88.2 69.2 63.3 58.8 81.2 75.9 50.6 58.9 100.5 67.4 76.6 138.1 54.3 53.6 48.7 80.0 52.6 95.0 35.1 104.2 55.6 71.1 93.1 56.7 55.5 57.5 50.2 46.5 84.9 72.4 52.7 88.3 82.6 34.0 52.5 134.7 123.3 64.2 110.4 101.0 51.8 59.1 107.8 42.0 179.5 124.9 121.5 110.7 68.6 116.7 103.7 132.7 106.1 122.7 132.5 291.7 111.5 74.8 49.9 93.5 121.6 101.8 146.7 208.6 78.7 277.5 131.8 130.2 103.3 272.1 122.3 83.9 125.8 109.2 101.0 86.8 130.3 148.4 239.6 159.5 79.0 87.5 169.4 103.3 243.8 101.7 76.5 189.7 116.7 125.0 134.8 113.8 107.4 93.5 101.0 85.7 123.7 130.9 93.6 168.6 105.3 85.6 82.2 84.6 75.4 133.7 164.8 197.6 58.0 259.0 89.8 230.8 112.7 126.8 103.5 115.0 108.8 129.1 112.5 112.2 109.1 131.1 124.9 106.8 74.2 108.6 112.2 77.4 129.4 178.3 50.8 53.1 54.7 62.5 50.6 58.9 54.3 53.6 48.7 55.6 52.7 52.5 59.1 119.0 185.9 109.2 11.4 122.5 13.3 231.7 2.0 99.0 33.6 110.5 109.6 84.8 58.6 62.2 62.5 18.8 129.8 104.7 160.5 238.7 90.5 6.9 86.0 96.1 97.3 100.4 157.0 7.9 127.8 101.4 128.7 66.3 130.9 76.5 84.1 86.7 30.0 68.6 20.2 6.4 109.3 0.0 82.3 10.9 14.2 78.9 109.0 1.8 13.1 81.8 66.9 127.7 6.0 11.8 119.2 157.7 81.3 48.8 187.6 90.3 112.0 56.1 28.7 46.0 104.3 104.5 21.2 24.4 97.8 12.6 141.7 104.0 203.9 110.2 314.0 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 17.2;testis: 46.7" "Group enriched" "Detected in some" 44 "Early spermatids: 405.5;Late spermatids: 589.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 11.1" HPA020446 Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.8 1.4 1.2 1.1 1.3 3.8 2.2 3.0 1.9 0.9 2.0 1.3 1.1 3.3 17.2 0.6 1.8 1.8 0.4 1.1 1.1 2.6 0.7 1.3 2.4 1.3 1.4 0.6 3.0 2.4 9.3 1.4 0.8 3.2 1.4 1.3 3.9 1.5 2.0 0.2 3.4 1.1 1.5 0.7 2.0 0.8 46.7 1.3 1.4 1.7 0.0 0.8 0.6 0.7 1.9 0.5 0.6 1.5 0.4 1.8 0.4 1.3 0.0 0.0 0.0 0.0 11.1 0.4 0.7 0.1 0.4 0.3 1.1 2.1 0.1 0.3 0.1 1.0 0.4 1.1 0.5 0.6 0.2 1.6 0.8 0.9 0.3 0.0 0.6 0.3 0.3 0.9 0.2 0.1 0.5 0.2 0.5 0.1 0.5 0.6 1.2 0.0 0.0 0.3 1.2 0.6 0.5 0.0 0.9 0.7 0.3 0.2 0.0 0.3 0.0 1.8 1.7 0.2 0.6 1.1 0.1 1.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 3.0 1.9 1.1 1.1 1.3 1.4 0.6 3.2 0.7 1.3 1.9 0.1 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.3 0.1 0.0 0.1 405.5 0.4 0.0 0.3 1.8 0.0 9.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 11.3 0.4 0.0 0.0 0.0 589.5 4.1 0.2 0.0 3.7 0.0 0.0 0.0 1.5 1.4 0.1 1.2 1.5 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 4.4 2.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 GJB5 CX31.1 ENSG00000189280 "Gap junction protein beta 5" O95377 1 34755047-34758512 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 101.8;skin 1: 92.4;vagina: 35.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 48.6;Basal prostatic cells: 38.0;Basal respiratory cells: 49.6;Squamous epithelial cells: 63.8;Suprabasal keratinocytes: 83.5;Urothelial cells: 66.2" "Cancer enhanced" "Detected in many" "cervical cancer: 36.7;head and neck cancer: 57.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 29.1;HaCaT: 90.8;HBEC3-KT: 40.7;hTCEpi: 147.4;RT4: 50.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA038146 Uncertain NA NA "HPA038146: AB_10697242" "unprognostic (2.62e-1)" "unprognostic (1.63e-1)" "unprognostic (3.48e-1)" "unprognostic (5.71e-2)" "unprognostic (8.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.89e-2)" "unprognostic (2.76e-2)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.30e-2)" "unprognostic (1.09e-3)" "unprognostic (2.36e-1)" "unprognostic (2.41e-3)" "unprognostic (5.59e-2)" "unprognostic (5.67e-3)" 0.2 0.1 1.1 0.0 0.9 0.0 4.0 0.7 1.3 6.4 0.1 0.1 0.0 0.1 3.4 101.8 0.6 3.4 0.1 1.5 0.4 0.1 0.4 0.3 0.0 0.5 0.4 0.8 0.1 1.1 0.0 0.9 0.7 0.6 5.2 0.1 0.0 14.0 3.2 0.3 92.4 0.2 0.0 0.6 0.1 0.1 2.4 0.5 1.5 0.9 0.1 12.7 7.2 35.2 1.0 29.1 0.3 0.1 0.5 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 2.2 0.0 1.2 0.0 0.3 90.8 0.0 40.7 0.0 0.1 0.0 7.0 0.9 0.0 0.0 0.0 0.0 0.1 147.4 0.0 23.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 50.9 0.1 0.0 3.6 1.5 0.0 0.4 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.7 1.3 1.5 0.4 0.5 0.4 0.8 0.6 0.6 0.5 1.0 0.0 0.0 1.1 0.3 0.0 48.6 38.0 49.6 12.5 0.0 2.8 1.9 0.5 0.0 17.2 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 4.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 19.5 0.0 0.0 12.4 0.0 0.0 0.0 1.4 0.0 0.0 63.8 83.5 0.4 0.2 0.0 0.3 66.2 FHIT "AP3Aase, FRA3B" ENSG00000189283 "Fragile histidine triad diadenosine triphosphatase" P49789 3 59747277-61251459 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 80.3" "Cell type enhanced" "Detected in many" "Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "naive CD4 T-cell: 87.6" "Lineage enriched" "Detected in all" 12 "T-cells: 87.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.5;U-266/70: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002684, HPA018840, HPA018909" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 12000 "Nucleoli fibrillar center, Plasma membrane" "CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537" "unprognostic (2.36e-3)" "unprognostic (6.38e-2)" "unprognostic (1.59e-1)" "unprognostic (4.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.16e-2)" "unprognostic (2.77e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-1)" "unprognostic (6.77e-2)" "prognostic favorable (1.36e-4)" "unprognostic (1.54e-1)" "unprognostic (5.96e-2)" "unprognostic (1.29e-2)" "unprognostic (1.80e-2)" 5.4 24.6 14.1 6.2 18.8 8.0 9.0 13.3 17.5 5.5 80.3 6.7 6.5 3.6 7.0 5.0 6.6 9.9 15.3 20.0 16.8 25.1 9.7 4.7 7.6 19.2 17.2 12.2 6.9 13.1 18.3 7.9 3.0 19.2 5.3 5.9 7.7 8.6 4.7 10.7 7.5 5.3 4.8 15.2 5.1 8.7 5.6 16.0 12.2 11.8 7.2 5.4 6.7 4.2 20.1 0.1 0.0 1.4 0.0 0.6 0.1 2.5 0.1 0.2 0.1 0.0 2.7 4.2 4.0 0.7 0.1 3.0 0.0 12.7 3.2 0.0 2.2 5.0 3.3 2.0 6.4 3.3 8.7 0.1 9.1 5.2 0.2 6.9 0.3 0.0 3.7 2.5 11.9 0.2 3.6 15.2 6.7 1.2 12.2 0.9 11.3 0.0 17.5 15.3 2.0 2.9 4.3 1.5 9.9 10.1 5.3 0.4 0.2 0.0 1.7 0.4 0.1 2.4 34.6 11.3 0.0 4.0 0.1 1.9 6.8 4.6 0.5 2.2 2.9 1.4 4.1 17.2 1.8 5.7 3.1 87.6 15.6 0.8 7.2 1.3 5.8 20.5 11.9 14.1 18.8 13.3 17.5 20.0 16.8 19.2 17.2 12.2 19.2 15.2 16.0 20.1 4.1 6.4 10.6 609.8 19.7 7.6 20.7 30.0 46.7 12.6 41.2 31.2 10.0 38.6 17.5 27.6 58.4 42.0 12.4 6.9 78.2 19.1 45.8 14.6 7.9 7.0 7.7 17.7 276.6 4.7 8.5 10.1 18.3 19.0 5.7 25.7 14.6 23.4 20.9 30.3 450.5 12.9 22.4 10.2 7.1 163.0 19.3 12.9 12.4 337.3 8.6 19.7 6.2 1086.7 1111.0 9.7 15.0 9.8 23.8 12.0 20.7 126.6 12.4 20.7 0.0 10.7 6.2 19.1 7.5 33.7 11.2 32.7 11.5 23.0 20.1 18.8 ALKAL2 "AUGA, FAM150B" ENSG00000189292 "ALK and LTK ligand 2" Q6UX46 2 279558-288851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 207.1" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 20.3;Ductal cells: 37.0;Endometrial ciliated cells: 24.0;Glandular and luminal cells: 50.3;Granulosa cells: 64.3;Proximal tubular cells: 28.1" "Cancer enhanced" "Detected in many" "renal cancer: 5.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "AF22: 138.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "amygdala: 4.3;basal ganglia: 3.0;cerebral cortex: 2.5;hippocampal formation: 3.4;spinal cord: 2.3" "Secreted - unknown location" NA NA "unprognostic (1.39e-3)" "unprognostic (1.44e-2)" "unprognostic (2.41e-2)" "unprognostic (2.03e-3)" "unprognostic (2.88e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.35e-1)" "unprognostic (9.29e-3)" "unprognostic (5.19e-2)" "unprognostic (3.68e-1)" 24.4 207.1 4.9 2.0 7.0 0.7 26.9 3.9 2.9 4.8 4.2 8.2 3.8 26.7 13.5 2.0 26.5 10.8 1.8 3.3 4.4 21.3 4.5 34.3 0.9 4.0 2.8 3.0 75.0 64.9 2.3 8.7 9.7 3.7 6.6 6.6 0.4 5.4 2.6 1.5 14.3 7.8 10.0 2.7 12.4 17.5 35.8 5.3 1.7 10.5 0.5 1.7 4.8 5.4 5.6 0.0 0.0 138.8 0.1 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.4 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.3 0.0 0.1 0.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.1 0.1 0.2 0.2 0.3 0.7 0.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 4.9 7.0 3.9 2.9 3.3 4.4 4.0 2.8 3.0 3.7 2.7 5.3 5.6 2.5 0.0 11.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 14.6 20.3 0.0 0.0 0.0 1.8 0.0 0.1 1.4 0.0 3.9 37.0 0.0 24.0 6.3 4.5 0.0 0.0 0.0 0.7 0.1 3.1 0.0 50.3 0.0 64.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.1 0.6 0.9 0.0 0.0 ZKSCAN3 "ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35" ENSG00000189298 "Zinc finger with KRAB and SCAN domains 3" Q9BRR0 6 28349947-28369172 "Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA009637, HPA060116" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA009637: AB_2668244, HPA060116: AB_2732641" "unprognostic (2.71e-2)" "unprognostic (1.94e-1)" "unprognostic (8.12e-2)" "unprognostic (2.67e-1)" "prognostic favorable (4.93e-4)" "unprognostic (6.42e-2)" "unprognostic (4.63e-3)" "unprognostic (2.50e-2)" "unprognostic (8.65e-2)" "unprognostic (4.37e-3)" "unprognostic (7.09e-3)" "unprognostic (1.29e-1)" "unprognostic (8.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.41e-2)" "unprognostic (3.10e-3)" 2.2 2.6 1.8 2.2 2.0 1.1 4.0 3.3 2.4 3.9 2.5 3.0 2.2 3.5 4.6 2.4 3.6 2.0 2.4 2.0 2.0 3.3 2.8 3.1 3.0 2.0 2.1 2.0 5.7 2.3 4.8 2.7 4.0 2.2 4.2 3.9 3.8 2.4 4.4 2.5 3.8 2.4 4.7 1.6 3.4 4.1 2.5 2.1 4.3 4.4 2.5 3.9 2.9 2.7 2.9 3.0 1.8 6.9 12.4 6.2 4.3 2.5 2.6 2.8 4.4 5.8 2.4 1.7 4.6 6.0 2.8 4.7 4.1 7.6 3.4 4.4 4.3 3.2 6.1 4.9 3.9 4.3 6.0 1.9 3.8 3.0 4.8 4.1 5.2 7.0 5.8 15.7 2.9 5.3 0.9 3.1 5.9 3.1 1.7 1.8 8.7 5.4 6.7 4.6 2.1 5.5 6.1 4.6 2.4 4.1 8.9 3.5 6.1 4.2 4.6 3.0 3.0 3.4 3.8 6.2 4.2 1.5 7.9 3.2 1.9 1.2 5.1 2.2 2.1 2.3 2.2 1.5 1.7 1.7 2.1 1.4 2.3 1.4 1.6 1.3 2.0 2.2 1.1 1.8 2.0 3.3 2.4 2.0 2.0 2.0 2.1 2.0 2.2 1.6 2.1 2.9 1.7 0.0 3.4 4.9 1.2 0.5 0.5 0.8 1.2 1.5 1.9 1.8 2.1 0.0 0.5 3.7 8.4 2.6 0.8 1.0 0.0 1.3 0.6 1.3 2.3 3.0 0.0 3.8 6.6 1.0 1.9 1.7 0.5 1.4 2.5 3.5 3.9 2.3 2.0 0.0 7.2 1.5 4.1 3.8 1.0 2.9 2.8 1.1 0.0 1.9 2.7 2.4 2.1 5.0 4.6 1.6 0.5 1.5 0.7 0.6 1.7 1.9 3.5 2.3 0.0 2.1 1.8 0.9 1.1 1.8 0.3 1.0 2.0 2.7 2.6 0.4 FOXR2 "FOXN6, MGC21658" ENSG00000189299 "Forkhead box R2" Q6PJQ5 X 55623400-55626192 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 110 "NTERA-2: 10.8;SH-SY5Y: 9.9;U-266/70: 6.2;U-266/84: 16.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA034487, HPA057358" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034487: AB_10795354, HPA057358: AB_2683418" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42508344-42519796 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: AB_2679796" "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 13.3 16.7 14.9 9.9 16.7 12.4 15.5 13.1 16.6 13.6 10.5 13.3 6.2 13.8 28.4 18.9 14.0 4.7 14.4 15.8 13.6 17.9 18.6 13.1 14.3 14.0 14.4 15.9 17.4 14.6 11.2 11.3 6.7 15.0 22.5 6.1 5.2 15.7 7.6 13.9 15.7 13.9 6.5 12.1 18.6 15.1 12.9 14.4 10.4 13.7 5.3 10.2 14.9 14.1 18.0 23.9 34.6 21.1 24.7 13.7 8.8 35.9 21.0 13.7 27.0 22.8 47.4 14.3 41.4 10.6 15.5 13.4 29.3 25.4 28.1 11.1 11.2 50.3 21.8 26.4 23.6 11.2 57.1 19.4 12.1 16.4 35.6 17.7 10.5 15.6 21.6 30.7 12.1 15.9 51.5 54.8 23.0 17.9 20.5 25.5 88.9 19.9 17.6 13.7 31.5 9.8 8.4 14.8 50.5 20.7 8.9 18.2 23.9 12.4 22.9 25.1 16.4 21.1 18.5 16.0 48.8 18.2 20.3 31.2 16.1 28.0 22.4 21.2 33.2 20.4 26.1 18.4 19.7 21.8 32.5 20.0 18.8 5.7 20.4 37.2 37.6 17.1 26.2 14.9 16.7 13.1 16.6 15.8 13.6 14.0 14.4 15.9 15.0 12.1 14.4 18.0 32.2 22.4 36.6 5.9 48.6 43.8 95.1 41.4 12.5 26.6 28.6 28.3 16.0 31.5 37.2 22.0 16.7 93.0 50.3 48.4 17.6 71.3 55.8 24.2 25.4 38.6 26.4 64.6 7.5 27.2 133.8 31.0 34.7 28.8 47.5 46.3 37.5 32.6 94.8 26.9 6.8 39.8 28.5 43.3 47.4 118.3 22.1 39.5 33.8 6.5 116.5 24.8 68.0 1.0 7.9 52.1 46.0 18.4 51.4 94.3 38.5 42.1 34.4 28.5 6.6 30.2 37.0 33.5 24.7 27.3 37.8 120.4 40.2 45.2 59.4 106.3 LIN54 "CXCDC1, DKFZp686L1814, JC8.6, MIP120, TCX1" ENSG00000189308 "Lin-54 DREAM MuvB core complex component" Q6MZP7 4 82909973-83012926 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 37.2;Oligodendrocytes: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 117.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056606 Approved NA NA "HPA056606: AB_2683187" "unprognostic (2.01e-2)" "unprognostic (1.47e-2)" "unprognostic (2.52e-2)" "unprognostic (7.11e-2)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (3.56e-3)" "unprognostic (6.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.06e-1)" "unprognostic (3.03e-1)" "unprognostic (2.60e-2)" "prognostic favorable (1.06e-4)" "unprognostic (3.02e-2)" "unprognostic (1.51e-1)" "unprognostic (9.17e-2)" "unprognostic (1.81e-2)" 3.9 3.4 3.0 5.0 4.6 13.2 4.9 5.8 5.2 5.4 1.0 6.0 5.4 4.5 3.8 10.6 3.7 3.9 4.4 3.7 3.7 7.0 8.2 4.0 6.6 4.7 4.0 2.5 5.0 2.7 6.0 2.1 6.3 4.5 3.9 7.0 10.1 3.4 4.4 4.4 5.5 4.4 4.5 3.8 4.7 4.5 7.0 3.8 12.9 10.4 5.9 8.7 4.7 3.4 8.1 16.8 9.8 15.1 17.3 7.8 7.5 11.2 26.7 18.5 19.8 18.9 11.7 18.9 18.3 14.4 27.6 13.0 12.9 20.8 8.7 24.1 19.9 9.1 16.8 14.7 13.2 6.8 20.7 117.8 6.3 5.0 21.7 10.4 6.1 12.2 17.0 18.6 35.5 19.4 11.9 44.3 8.6 6.3 20.6 6.5 23.9 16.8 12.8 9.4 14.3 15.7 8.3 16.2 25.7 10.6 9.4 11.2 13.3 9.6 23.6 17.6 22.1 12.2 17.6 14.0 30.6 13.1 12.8 18.9 3.5 2.5 5.5 3.7 2.0 4.2 1.6 3.7 4.2 1.5 2.1 4.6 3.9 5.4 4.7 6.6 1.1 4.7 2.4 3.0 4.6 5.8 5.2 3.7 3.7 4.7 4.0 2.5 4.5 3.8 3.8 8.1 7.5 6.4 5.5 10.7 7.2 12.1 3.6 2.4 9.6 8.5 5.5 5.2 6.1 4.3 3.3 5.5 2.1 4.3 8.9 11.3 0.0 3.1 37.2 7.1 6.0 4.9 4.2 15.2 23.4 3.6 4.8 4.9 6.6 12.9 2.5 5.7 5.7 7.5 6.5 5.0 22.1 4.9 2.0 6.3 7.8 14.2 2.5 8.2 8.8 12.2 4.4 7.3 7.2 18.1 60.3 4.0 3.4 4.9 17.2 3.8 4.7 6.2 4.4 8.6 13.1 6.4 6.9 3.1 3.1 14.0 12.5 3.4 9.1 3.5 5.2 8.2 FAM53B "bA12J10.2, KIAA0140, smp" ENSG00000189319 "Family with sequence similarity 53 member B" Q14153 10 124619292-124744378 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037751, HPA037752" Approved Approved Cytosol NA NA Cytosol "HPA037751: AB_2675645, HPA037752: AB_10672285" "unprognostic (7.88e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.73e-2)" "unprognostic (2.92e-1)" "unprognostic (4.91e-1)" "prognostic favorable (1.97e-4)" "unprognostic (2.52e-2)" "unprognostic (5.03e-3)" "unprognostic (1.51e-2)" "unprognostic (4.02e-2)" "prognostic favorable (7.00e-6)" "unprognostic (1.93e-1)" "prognostic favorable (4.81e-7)" "prognostic favorable (3.26e-4)" "unprognostic (3.41e-1)" "unprognostic (2.03e-1)" "unprognostic (2.45e-2)" 12.7 19.3 19.2 14.4 28.9 26.0 8.3 15.7 23.9 11.1 7.6 12.4 15.5 23.8 3.9 13.3 11.3 5.8 17.3 18.2 17.0 10.5 4.2 10.7 31.3 25.9 24.3 13.0 19.2 7.3 12.5 12.8 5.0 32.7 8.9 7.2 6.4 15.3 7.1 55.4 14.3 17.2 12.9 17.3 20.2 9.6 15.7 27.9 33.2 16.3 22.5 21.8 8.7 8.1 49.9 10.7 12.5 9.6 27.5 11.3 5.8 26.2 4.8 6.7 5.6 4.9 6.6 6.7 37.2 9.7 6.5 5.5 20.8 12.7 15.4 2.4 44.6 13.2 18.1 6.3 16.7 7.6 16.6 11.8 5.6 16.2 5.2 8.3 7.0 9.1 21.2 13.2 17.0 5.5 20.4 18.7 22.4 5.9 9.5 10.9 32.9 3.6 18.2 4.6 19.3 12.8 12.2 4.7 17.8 60.2 3.8 7.2 21.8 5.0 6.7 5.5 6.6 10.7 2.7 5.3 23.8 5.1 13.6 3.8 0.8 2.2 2.2 6.9 2.1 3.3 3.5 3.0 3.7 1.4 6.0 1.2 2.0 3.2 0.7 2.6 1.9 3.6 3.4 19.2 28.9 15.7 23.9 18.2 17.0 25.9 24.3 13.0 32.7 17.3 27.9 49.9 13.4 9.6 12.6 14.0 22.4 3.6 5.9 8.5 12.5 6.1 4.3 2.4 17.9 1.5 6.7 3.7 10.4 4.7 31.5 25.9 1.9 3.1 19.4 12.9 18.6 8.7 15.0 8.6 27.1 4.0 4.9 6.0 6.6 8.3 5.1 9.0 16.8 3.7 13.3 1.7 15.0 17.4 10.2 27.8 5.1 6.2 5.6 16.4 8.8 24.4 14.5 4.5 30.9 16.1 79.4 2.8 12.2 10.5 20.0 3.7 22.4 4.3 14.1 25.6 0.0 9.8 4.6 7.0 8.6 12.1 5.7 0.8 21.4 6.9 15.3 6.7 FAM180A "HWKM1940, UNQ1940" ENSG00000189320 "Family with sequence similarity 180 member A" Q6UWF9 7 135728348-135748813 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.2;heart muscle: 16.1" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.5;Cardiomyocytes: 6.6;Fibroblasts: 19.7;Hepatic stellate cells: 4.6;Langerhans cells: 9.5;Melanocytes: 7.2;Suprabasal keratinocytes: 4.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2197: 259.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA021224 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA021224: AB_1851352" "unprognostic (3.85e-2)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.27e-1)" "unprognostic (5.05e-2)" "unprognostic (1.97e-3)" "unprognostic (5.62e-2)" "unprognostic (7.55e-2)" "unprognostic (8.88e-4)" "unprognostic (3.14e-3)" "unprognostic (1.82e-1)" "unprognostic (4.35e-4)" "unprognostic (6.62e-4)" 3.1 2.8 0.0 0.5 0.1 0.1 3.5 0.1 0.3 2.6 3.7 1.8 0.9 4.7 0.4 4.1 2.0 16.2 16.1 0.3 0.0 4.2 10.3 2.5 0.1 0.0 0.0 0.0 7.9 1.3 0.2 0.1 0.3 0.0 0.6 2.0 0.0 1.2 0.2 0.3 3.1 1.3 4.7 0.0 0.6 1.0 0.4 0.0 0.2 2.7 1.4 0.6 4.4 1.3 0.1 0.0 0.1 0.0 0.0 27.8 28.4 0.0 14.9 56.2 0.3 0.2 0.0 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.6 0.0 35.6 4.6 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.6 57.1 0.0 259.7 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.8 6.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.8 0.0 0.0 0.3 0.0 0.0 19.7 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 2.8 0.1 7.2 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 1.8 0.0 0.0 0.1 4.8 0.7 0.2 0.0 0.0 0.0 BNIP5 "C6orf222, DKFZp779B1540" ENSG00000189325 "BCL2 interacting protein 5" P0C671 6 36315761-36336888 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 24.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA038407, HPA058189" Uncertain Approved Cytosol NA NA Cytosol "HPA038407: AB_10669644, HPA058189: AB_2683634" "unprognostic (1.97e-5)" "unprognostic (5.46e-3)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (7.52e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (6.75e-2)" "unprognostic (3.04e-2)" "unprognostic (4.55e-2)" "unprognostic (3.16e-2)" "unprognostic (3.98e-1)" "unprognostic (1.66e-4)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 24.9 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.1 0.0 5.8 0.0 0.0 0.0 0.0 0.2 23.7 0.1 0.0 0.0 4.2 1.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN4 "CT11.9, SPANX-N4" ENSG00000189326 "SPANX family member N4" Q5MJ08 X 143025918-143034702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 26.1" "Group enriched" "Detected in some" 165 "Early spermatids: 97.7;Late spermatids: 298.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045730, HPA059094" Uncertain Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nuclear membrane" "HPA045730: AB_10961036, HPA059094: " 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 298.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 3749.4;vagina: 1184.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA 260000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 1.8 0.8 1.4 25.1 1.4 0.2 79.1 1.3 2.0 257.2 1.2 243.2 267.8 5.4 14.9 3749.4 20.6 18.7 4.3 1.4 1.8 31.8 16.5 83.5 0.6 1.4 1.3 1.2 1.4 17.8 126.3 5.1 1.1 1.3 19.8 242.3 0.0 554.7 39.4 2.2 554.6 210.7 13.2 1.3 1.3 120.2 0.7 1.4 150.4 99.4 0.0 453.7 33.2 1184.0 1.4 798.6 0.2 0.1 0.2 0.2 0.3 7.4 0.2 0.1 0.2 0.1 97.6 140.1 0.6 2.3 0.2 0.5 1072.9 0.0 1527.6 0.1 0.5 0.3 0.1 10.8 7.3 0.0 0.0 0.9 0.6 2232.0 0.5 20.7 0.3 0.3 0.1 0.6 1.1 0.2 140.0 0.7 1.1 0.4 1675.1 1.9 0.6 0.6 2.8 8.1 51.2 0.7 0.7 2.2 1579.1 2.1 36.5 3.9 1.7 0.0 0.7 0.8 1.1 2.0 0.4 0.8 0.9 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 1.3 2.0 1.4 1.8 1.4 1.3 1.2 1.3 1.3 1.4 1.4 2.7 60.9 162.6 2.3 4.2 2340.8 448.6 770.5 657.9 0.0 256.2 178.3 5.3 270.2 387.7 35.0 0.0 2.7 2.2 1058.2 49.0 197.5 0.0 37.3 6.4 21.5 153.4 0.0 0.0 65.8 1.5 22.8 85.6 80.3 28.0 0.2 1.1 9.5 0.3 0.0 0.0 660.1 126.1 0.3 213.7 0.0 0.0 3.0 241.9 0.0 2.0 0.0 0.0 0.0 0.1 343.0 1098.9 0.0 7.5 619.3 1549.1 4.9 56.2 0.0 0.0 1.3 27.1 0.0 0.0 3205.8 3612.0 0.3 8.7 13.6 580.9 824.9 KAZN "C1orf196, FLJ43806, KAZRIN, KIAA1026" ENSG00000189337 "Kazrin, periplakin interacting protein" Q674X7 1 13892792-15118043 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 92.2" "Group enriched" "Detected in many" 12 "Excitatory neurons: 1065.9;Inhibitory neurons: 2872.7;Oligodendrocyte precursor cells: 1360.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 23 "granulocytes: 3.4" "Cell line enhanced" "Detected in many" "AN3-CA: 85.6;SK-BR-3: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032095, HPA032096" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA032095: AB_2674146, HPA032096: AB_10670826" "unprognostic (2.81e-1)" "unprognostic (5.82e-2)" "unprognostic (1.12e-1)" "unprognostic (2.42e-3)" "unprognostic (5.34e-2)" "unprognostic (2.15e-3)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (1.10e-1)" "unprognostic (5.55e-2)" "prognostic favorable (1.20e-6)" "unprognostic (3.61e-2)" "unprognostic (7.93e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-2)" 11.7 17.8 32.4 3.0 33.8 0.6 11.5 46.2 38.2 13.0 23.4 5.1 5.1 4.3 12.4 35.2 12.7 7.7 5.5 27.7 29.1 18.9 5.9 16.6 1.0 37.0 32.2 24.8 16.9 9.3 29.8 5.2 6.4 38.2 7.6 4.0 13.0 21.5 7.5 1.4 23.2 5.3 3.7 33.4 92.2 5.1 4.6 36.4 1.9 10.3 1.6 5.6 9.0 21.5 50.0 17.7 3.0 18.5 85.6 7.9 8.2 6.3 8.3 6.9 15.0 10.8 4.0 9.3 0.0 21.1 17.8 2.7 6.3 4.3 13.5 7.5 0.5 8.4 10.1 10.2 26.6 5.8 0.0 5.0 11.6 17.7 3.5 2.3 6.8 0.1 2.5 4.2 19.8 12.2 12.8 0.1 1.1 5.1 7.9 2.6 6.0 0.4 10.6 25.5 5.4 9.8 7.1 1.5 46.3 33.0 10.5 2.8 6.7 0.0 12.4 11.6 19.8 10.1 3.3 3.0 0.0 11.6 17.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 32.4 33.8 46.2 38.2 27.7 29.1 37.0 32.2 24.8 38.2 33.4 36.4 50.0 17.6 3.2 1.8 124.1 0.9 50.3 16.6 9.7 31.3 12.4 23.0 27.9 3.4 4.3 9.1 49.7 8.4 1.5 0.9 12.3 17.6 2.0 6.8 51.4 15.8 19.4 7.1 0.0 1065.9 1.6 8.1 27.0 3.6 16.8 3.8 9.7 31.1 0.1 0.8 0.0 2872.7 5.2 18.3 0.9 11.4 9.1 19.0 1.1 46.2 93.7 0.0 74.2 4.1 1360.7 143.5 1.5 1.6 17.3 0.3 19.4 2.0 12.9 30.3 3.2 6.6 33.5 23.6 0.3 3.2 26.2 90.4 46.4 1.4 41.6 3.5 24.8 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692795 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 21.1 29.9 38.7 21.1 36.4 17.4 26.0 31.6 40.3 34.9 30.7 29.8 32.2 32.1 34.5 21.0 29.5 19.7 18.8 39.7 29.6 24.3 26.3 23.1 32.7 30.1 31.6 37.5 39.3 30.9 20.4 43.5 20.6 35.6 30.4 22.4 42.9 29.3 22.7 29.4 29.7 34.3 30.9 26.5 40.4 28.9 11.0 33.2 34.8 31.0 14.7 28.2 26.3 26.7 36.4 13.0 17.4 58.3 49.8 42.3 40.0 16.9 15.6 35.8 16.9 19.7 12.8 33.6 22.6 24.2 33.7 20.9 16.9 23.0 14.9 16.8 28.4 20.1 30.6 37.2 21.7 31.5 24.6 26.2 35.0 31.2 21.4 30.5 47.3 35.5 40.9 31.1 30.8 19.4 9.2 32.3 29.2 19.0 11.2 18.5 28.3 15.9 29.5 29.1 13.1 50.9 46.8 26.4 31.5 50.8 23.8 38.9 34.8 33.5 29.9 12.6 11.7 8.6 25.0 19.6 35.2 22.8 45.2 16.5 1.8 3.7 2.8 7.0 3.3 7.6 3.9 5.9 8.1 2.4 3.9 6.8 5.9 5.5 4.0 2.4 7.6 6.0 5.0 38.7 36.4 31.6 40.3 39.7 29.6 30.1 31.6 37.5 35.6 26.5 33.2 36.4 8.2 12.8 28.3 9.8 19.8 7.4 7.1 14.1 18.8 35.5 12.0 8.6 17.1 34.3 24.6 3.7 77.2 14.1 26.0 28.3 0.0 5.7 1.1 9.1 14.8 16.8 25.4 21.5 12.0 6.1 9.6 18.4 30.5 6.8 23.4 13.9 25.4 22.2 10.5 30.3 12.1 24.3 18.3 31.5 8.2 3.9 30.4 13.8 12.4 9.4 21.8 12.3 29.9 14.6 12.9 6.2 17.8 26.7 28.0 9.3 38.1 3.4 23.4 66.5 6.6 16.8 12.0 8.5 16.1 16.3 9.7 8.8 23.1 10.1 26.4 8.7 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29052230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 24.9;choroid plexus: 22.2;fallopian tube: 20.3" "Group enriched" "Detected in some" 4 "dendritic cells: 20.1;Endometrial ciliated cells: 65.4;Respiratory ciliated cells: 30.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 2.3;JURKAT: 1.2;NB-4: 1.3" "Low region specificity" "Detected in many" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.1 1.3 24.9 0.6 11.0 2.0 0.2 17.9 2.8 0.5 22.2 0.3 0.5 0.6 0.1 0.4 20.3 0.3 2.8 5.2 12.4 0.1 0.2 2.9 0.8 15.5 17.7 1.8 0.5 0.3 0.0 1.1 0.3 17.8 0.2 0.2 0.2 0.2 0.1 1.2 0.3 0.4 0.5 19.7 2.0 1.0 1.3 10.5 0.2 0.1 3.0 0.7 0.2 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.0 0.6 0.1 0.2 0.6 2.3 0.1 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.3 0.3 0.0 0.3 1.3 1.0 0.4 0.1 0.0 0.3 0.6 0.3 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.6 0.5 24.9 11.0 17.9 2.8 5.2 12.4 15.5 17.7 1.8 17.8 19.7 10.5 6.2 0.3 0.0 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 65.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.2 30.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 3.6 0.5 0.0 0.0 SPATA31D4 "FAM75D4, FLJ43859" ENSG00000189357 "SPATA31 subfamily D member 4" Q6ZUB0 9 81928514-81934948 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 62 "testis: 6.1" "Cell type enriched" "Detected in some" 14 "Early spermatids: 57.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504338-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 10.8;NK-cells: 14.4;Spermatocytes: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA057719 Approved Nucleoplasm NA NA Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 1.5 1.7 0.5 2.5 0.8 1.9 1.5 2.7 1.0 1.4 0.1 1.3 0.9 1.3 1.0 1.5 1.1 1.1 1.0 0.6 0.3 1.3 1.8 1.7 3.7 0.7 0.8 0.3 0.9 1.2 1.0 1.3 1.1 0.9 1.3 0.9 1.3 2.1 0.7 0.5 1.8 1.7 1.2 0.5 2.4 1.9 3.1 0.7 4.7 2.0 0.7 3.0 1.3 1.6 1.2 5.0 2.7 1.8 2.3 1.0 2.7 4.7 3.5 3.0 3.4 4.3 4.0 6.8 7.3 2.3 1.8 2.4 8.7 2.8 7.6 6.9 5.4 2.4 5.2 2.6 2.8 2.6 5.7 1.7 2.8 3.1 15.9 4.1 3.2 1.6 8.0 4.6 8.3 6.8 2.3 6.3 2.7 1.9 2.7 2.9 2.6 3.9 3.4 3.1 3.7 3.2 2.7 5.6 0.6 5.6 3.0 1.4 6.1 2.9 7.7 6.0 1.5 3.9 4.5 5.4 3.8 6.0 5.8 5.7 0.0 0.4 0.0 1.5 0.4 2.0 1.3 1.7 1.3 0.5 1.9 2.7 2.3 0.1 1.3 0.3 1.9 3.1 1.2 0.5 0.8 2.7 1.0 0.6 0.3 0.7 0.8 0.3 0.9 0.5 0.7 1.2 4.5 0.0 0.6 0.0 5.9 0.0 2.1 0.0 4.0 5.5 2.0 1.3 1.6 0.0 0.0 1.8 0.0 3.0 10.8 0.2 0.0 2.0 4.5 0.9 3.3 4.0 0.0 4.6 0.0 2.0 3.1 4.1 2.0 1.2 1.3 5.4 3.9 3.4 2.9 3.3 0.0 1.0 0.0 3.3 0.0 6.2 2.8 3.1 0.0 0.0 2.4 2.5 14.4 0.0 0.0 0.7 1.8 1.2 9.5 2.1 0.6 2.3 0.0 2.0 0.0 4.9 5.1 17.0 6.1 3.9 0.0 1.2 6.4 5.3 1.7 2.2 ALG1L ALG1L1 ENSG00000189366 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 10.9;urinary bladder: 9.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7" HPA036108 Uncertain NA NA "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favorable (6.24e-4)" 0.4 1.1 2.5 1.1 2.7 0.3 1.4 2.1 3.0 1.5 1.5 1.3 0.4 1.4 10.9 1.6 2.2 0.8 0.6 2.4 2.6 1.2 1.4 1.0 0.4 2.7 2.7 2.7 2.4 1.3 0.6 1.9 1.6 3.0 1.8 0.8 0.6 1.9 0.9 6.8 5.8 0.5 0.5 2.0 0.3 1.5 1.3 2.3 1.1 1.6 2.6 2.7 9.5 1.6 2.5 1.1 0.8 0.4 0.0 0.0 0.2 1.8 0.1 0.0 0.2 0.4 15.9 14.3 4.4 6.8 0.0 0.3 15.2 0.4 0.0 0.8 0.6 3.6 0.8 2.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 4.1 1.2 1.4 0.0 30.1 1.0 0.3 6.4 19.1 3.8 0.1 0.1 7.4 0.0 0.9 2.4 0.9 0.5 0.2 0.7 3.2 19.7 0.4 0.3 0.2 2.2 0.2 0.1 10.9 1.7 5.9 0.2 0.0 1.0 2.5 0.0 0.1 2.0 0.1 1.1 1.6 1.0 2.2 0.0 0.9 1.2 0.7 0.4 3.2 0.0 1.3 2.7 0.9 2.5 2.7 2.1 3.0 2.4 2.6 2.7 2.7 2.7 3.0 2.0 2.3 2.5 0.2 0.0 0.5 0.3 0.7 3.3 1.7 33.6 0.6 0.3 2.1 2.4 0.0 0.0 15.2 1.8 0.0 3.5 0.5 0.3 1.9 0.4 1.7 10.5 0.8 0.3 1.8 0.0 1.2 0.4 2.0 1.1 0.0 0.4 1.3 1.4 0.0 0.1 0.3 0.0 1.7 0.2 12.2 0.0 1.2 1.8 1.8 0.1 1.8 0.0 0.2 1.5 2.1 1.0 0.6 0.6 1.4 3.0 0.4 0.5 0.0 1.0 46.0 0.0 0.0 2.7 2.6 1.4 1.6 0.3 5.1 1.4 0.5 2.4 0.4 8.2 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127438406-127459389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.2;skeletal muscle: 28.5" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: AB_2732578" "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 17.0 2.4 22.9 0.9 24.5 0.0 3.8 26.1 29.2 4.3 14.3 7.1 0.9 2.9 1.8 6.3 2.0 1.6 1.6 24.4 22.9 1.2 0.7 13.4 0.4 22.4 23.1 22.3 2.5 0.8 0.0 14.0 0.4 24.7 4.3 3.6 8.8 1.9 1.1 28.5 0.9 4.3 1.8 24.3 2.0 5.5 4.0 24.6 0.3 0.9 10.5 0.2 6.0 3.6 24.3 0.0 2.1 10.4 0.0 0.8 1.7 0.0 0.2 1.3 1.1 2.7 0.0 0.0 0.0 0.0 0.2 7.0 0.0 1.0 0.0 1.6 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 4.3 0.0 0.9 0.0 1.2 0.0 0.0 1.2 0.0 4.7 0.0 4.8 0.0 0.0 0.0 2.6 0.0 0.2 0.0 33.3 17.8 0.0 0.0 0.2 0.0 0.0 1.1 0.0 5.3 0.8 0.0 1.9 0.0 0.0 0.0 4.7 0.3 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 24.5 26.1 29.2 24.4 22.9 22.4 23.1 22.3 24.7 24.3 24.6 24.3 0.4 93.0 27.1 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.7 0.0 0.3 8.4 0.0 0.0 0.0 0.3 0.3 0.6 0.9 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.1 3.6 1.1 0.0 34.3 0.5 1.0 0.1 0.0 0.0 0.1 0.1 3.4 0.0 0.0 GSPT2 "eRF3b, FLJ10441" ENSG00000189369 "G1 to S phase transition 2" Q8IYD1 X 51743442-51746232 "Predicted intracellular proteins" "Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 95.5;Late spermatids: 189.0;Muller glia cells: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 47.6;PC-3: 53.8;SuSa: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044769, HPA074588" Approved Enhanced Cytosol NA NA 130000 Cytosol "HPA044769: AB_10963577, HPA074588: " "unprognostic (8.55e-3)" "unprognostic (1.76e-1)" "unprognostic (2.81e-1)" "unprognostic (2.71e-3)" "unprognostic (3.39e-1)" "unprognostic (4.12e-2)" "unprognostic (1.54e-2)" "unprognostic (3.43e-1)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.21e-1)" "unprognostic (3.01e-1)" "unprognostic (1.72e-1)" "unprognostic (2.08e-2)" "unprognostic (1.54e-2)" "unprognostic (9.76e-3)" "unprognostic (1.07e-1)" 6.3 6.5 6.8 5.8 7.6 2.8 6.3 6.1 7.5 4.4 5.4 5.1 3.3 5.4 7.5 2.8 5.7 5.1 6.9 7.2 9.3 6.4 11.3 5.5 9.3 5.5 6.0 6.4 9.9 4.9 6.2 6.5 2.5 5.8 6.9 3.6 7.8 6.4 6.2 5.9 2.7 5.0 5.4 5.2 5.9 4.0 13.4 8.5 10.5 6.1 5.4 8.7 4.9 2.3 6.1 0.0 9.9 19.7 0.0 13.6 11.8 0.0 11.3 1.9 8.0 10.0 6.3 10.0 29.3 0.0 9.7 24.6 3.2 0.0 5.3 9.1 0.0 12.7 0.4 0.0 0.0 10.1 0.0 12.3 15.7 2.5 7.0 7.1 13.6 11.7 13.4 7.9 2.2 14.2 0.0 2.6 1.8 47.6 0.0 53.8 14.0 18.6 0.0 14.5 10.6 0.0 16.6 0.0 0.0 10.5 38.9 0.0 9.5 7.5 7.9 16.0 7.4 7.5 0.0 17.3 0.0 10.5 1.9 8.9 2.9 2.5 1.6 4.5 3.6 4.5 7.9 3.9 4.3 8.2 8.1 6.3 5.5 0.3 6.5 2.7 6.9 5.6 3.6 6.8 7.6 6.1 7.5 7.2 9.3 5.5 6.0 6.4 5.8 5.2 8.5 6.1 6.4 12.8 11.8 3.6 10.1 1.8 5.3 8.9 3.4 17.0 4.2 7.0 17.9 14.3 8.0 14.7 8.4 9.6 11.5 2.0 5.9 14.2 95.5 1.4 10.7 8.3 3.0 4.2 3.9 8.7 4.3 11.2 3.1 1.3 10.8 6.3 6.1 20.3 6.2 11.8 4.3 3.5 2.0 7.6 2.1 189.0 12.8 4.9 3.6 1.9 9.8 61.4 14.4 3.5 2.6 5.6 5.5 18.8 7.6 6.5 0.8 11.5 10.0 10.4 26.3 8.2 7.6 11.6 10.4 2.5 1.4 3.4 7.5 15.7 3.2 3.9 TBC1D28 FLJ40244 ENSG00000189375 "TBC1 domain family member 28" Q2M2D7 17 18634247-18644427 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "testis: 22.3" "Group enriched" "Detected in some" 66 "Early spermatids: 63.0;Late spermatids: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.56e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219967-123241377 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 164.9" HPA023708 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavorable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 10.1 14.2 12.3 9.6 12.6 12.8 10.9 13.6 15.1 9.3 13.3 10.7 9.5 7.8 11.5 15.5 8.9 8.8 11.5 12.3 13.7 8.7 18.6 9.5 14.2 12.4 12.7 11.9 8.4 10.9 7.8 17.5 12.3 12.6 10.6 11.9 11.1 12.6 8.2 15.4 8.2 11.2 7.8 12.9 14.4 10.1 7.3 12.7 14.0 9.9 7.9 14.0 10.6 10.4 13.7 24.7 22.4 20.3 14.3 19.5 17.8 13.9 22.7 22.0 26.0 26.1 20.5 17.5 16.8 24.4 21.9 19.4 18.4 22.9 12.4 29.3 27.0 31.9 19.7 10.1 28.0 35.0 10.5 15.6 13.1 23.3 23.3 19.4 15.2 23.4 25.9 28.6 12.8 21.9 72.3 30.7 23.1 16.6 59.4 37.6 16.1 10.4 19.3 22.4 20.1 26.7 24.8 22.7 164.9 25.0 20.6 20.2 24.7 12.9 14.8 28.3 16.1 19.0 16.8 19.8 18.2 15.9 23.7 16.3 19.9 18.3 28.3 13.6 21.4 14.4 11.7 14.8 17.6 19.2 14.8 14.0 14.1 10.9 15.0 18.1 16.8 21.3 13.2 12.3 12.6 13.6 15.1 12.3 13.7 12.4 12.7 11.9 12.6 12.9 12.7 13.7 12.4 12.8 2.0 7.2 17.7 13.5 17.8 29.0 17.1 8.2 13.8 13.8 5.9 7.2 25.4 1.8 10.4 27.4 23.4 21.3 5.9 16.4 5.1 10.7 15.4 11.7 24.7 8.6 6.8 11.8 31.5 15.1 8.2 11.5 22.2 10.8 8.9 11.1 22.6 136.3 8.2 12.5 32.6 14.5 17.7 4.0 12.8 16.3 14.2 3.7 21.7 12.9 20.6 3.5 8.8 14.8 13.8 7.5 19.1 21.6 19.4 11.2 48.3 7.7 19.7 11.5 28.7 14.4 17.1 12.6 11.5 40.2 18.1 8.8 15.7 39.9 CXCL17 "Dcip1, DMC, UNQ473, VCC1" ENSG00000189377 "C-X-C motif chemokine ligand 17" Q6UXB2 19 42428278-42442946 "Predicted secreted proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 121.5;lung: 150.3;salivary gland: 146.8;stomach 1: 361.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 513.8;Basal respiratory cells: 988.1;Club cells: 1743.3;Respiratory ciliated cells: 383.0;Urothelial cells: 1584.1" "Cancer enhanced" "Detected in many" "cervical cancer: 170.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 8.7;RT4: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.74e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.03e-2)" "unprognostic (4.46e-3)" "unprognostic (3.77e-1)" "prognostic favorable (4.92e-5)" "unprognostic (6.68e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.70e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-1)" "unprognostic (1.88e-1)" "unprognostic (8.13e-3)" "unprognostic (2.29e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 2.3 0.2 0.1 19.4 0.0 0.4 0.7 1.0 22.5 121.5 27.3 6.6 0.1 0.1 0.0 0.2 0.1 150.3 0.0 0.0 0.0 0.0 0.3 43.3 0.0 0.6 0.0 0.1 8.3 0.0 0.0 146.8 0.4 0.0 0.2 0.0 0.1 0.0 0.2 361.8 0.1 0.0 1.1 0.5 0.0 24.4 48.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 35.3 513.8 0.3 0.1 0.0 225.5 988.1 1.2 0.4 21.5 10.3 0.0 4.3 1743.3 5.5 0.0 0.0 0.2 0.2 0.0 8.7 0.4 3.0 0.6 3.5 0.0 0.0 1.5 187.4 0.0 4.3 302.2 8.4 16.4 0.1 0.0 0.0 0.0 0.0 1.2 0.0 227.9 0.0 0.0 1.5 0.0 3.9 0.0 0.0 2.6 0.2 0.0 0.5 0.5 339.6 0.0 0.0 0.5 221.2 0.0 0.2 383.0 0.6 0.0 0.0 67.6 0.1 0.6 91.6 0.0 0.0 2.4 0.0 0.2 1584.1 OTUD6A "DUBA2, FLJ25831, HSHIN6" ENSG00000189401 "OTU deubiquitinase 6A" Q7L8S5 X 70062457-70064179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 4.8" "Group enriched" "Detected in some" 17 "Spermatocytes: 64.1;Spermatogonia: 25.1" "Cancer enriched" "Detected in single" 57 "testis cancer: 2.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053304 Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA053304: AB_2682107" "unprognostic (1.58e-1)" 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.5 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 4.8 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.5 0.3 0.3 0.3 0.2 0.1 0.3 0.3 0.1 0.2 0.4 0.1 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.4 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.4 0.3 0.6 0.0 0.0 0.1 0.0 0.1 2.6 0.0 0.3 1.3 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.9 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.3 0.0 0.3 0.0 1.8 0.0 0.4 0.4 64.1 25.1 0.0 0.6 0.3 1.0 0.2 0.0 0.2 HMGB1 "DKFZp686A04236, HMG1, HMG3, SBP-1" ENSG00000189403 "High mobility group box 1" P09429 13 30456704-30617597 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB005873, HPA073663" Supported Supported Nucleoplasm "Secreted to blood" NA NA 2800000 Nucleoplasm "CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: " "unprognostic (9.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-2)" "unprognostic (1.07e-1)" "unprognostic (4.44e-2)" "unprognostic (4.29e-2)" "unprognostic (3.16e-2)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" "unprognostic (1.73e-1)" "unprognostic (2.64e-2)" "unprognostic (2.30e-2)" "unprognostic (4.28e-3)" "unprognostic (5.22e-3)" "unprognostic (4.67e-1)" "unprognostic (9.13e-3)" "unprognostic (1.97e-2)" 314.8 226.4 295.5 358.3 310.6 1030.1 321.4 298.3 335.8 314.2 262.4 330.9 284.4 367.0 272.5 299.7 267.8 229.0 244.5 283.0 310.7 246.0 363.8 244.3 670.3 309.0 304.2 276.1 257.1 190.9 228.0 164.5 254.3 315.9 268.2 384.9 176.3 226.4 282.7 392.1 246.1 311.8 322.2 313.3 287.3 271.4 155.2 302.2 908.5 269.8 367.9 744.8 285.3 276.4 340.1 816.7 617.4 1402.5 1054.0 384.5 380.1 551.4 1012.6 547.9 957.3 643.5 983.6 1328.6 1639.3 515.5 924.0 880.6 886.5 1484.7 817.4 1639.6 869.6 622.4 1727.4 455.4 913.5 210.3 2513.6 1009.8 253.4 426.0 713.3 656.6 497.8 1302.2 1350.8 1167.9 571.7 855.6 1508.3 3224.3 2682.1 1184.3 1424.3 683.7 2673.3 1927.8 965.8 908.1 792.8 1264.0 1139.8 928.6 682.0 541.0 672.3 668.5 1857.9 814.7 637.2 921.8 689.7 1197.1 513.9 714.8 3508.3 261.1 1634.0 1369.3 1036.6 503.7 926.1 467.3 410.9 522.1 582.6 532.3 530.7 520.1 590.7 477.4 459.7 631.7 615.4 411.0 512.5 702.6 1072.0 295.5 310.6 298.3 335.8 283.0 310.7 309.0 304.2 276.1 315.9 313.3 302.2 340.1 948.9 458.3 496.6 188.4 920.7 791.1 986.7 942.7 752.4 414.3 471.9 630.0 172.5 561.9 561.3 603.2 131.3 998.9 759.9 408.1 766.9 941.3 113.4 611.2 1040.2 766.0 423.0 1808.9 58.5 967.2 1441.4 676.5 486.3 728.3 546.8 772.2 589.0 749.5 728.8 196.9 47.2 675.6 710.1 549.9 884.4 107.2 720.1 694.2 674.1 81.5 578.7 609.9 879.5 99.5 149.3 1212.3 554.8 666.9 1252.9 811.2 506.7 827.5 418.7 252.8 650.8 588.9 1005.9 549.1 1211.0 1045.8 691.9 465.7 797.9 515.7 839.1 867.9 MMP23B "MIFR, MIFR-1, MMP22" ENSG00000189409 "Matrix metallopeptidase 23B" O75900 1 1632163-1635263 "Enzymes, Predicted intracellular proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 30.1" "Cell type enhanced" "Detected in many" "Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "plasmacytoid DC: 11.3" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.3" "Cell line enhanced" "Detected in some" "HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9" "Region enriched" "Detected in some" 5 "cerebellum: 7.8" "Low region specificity" "Detected in some" NA NA "unprognostic (2.19e-2)" "unprognostic (6.31e-2)" "unprognostic (6.70e-3)" "unprognostic (1.29e-1)" "unprognostic (3.99e-2)" "unprognostic (9.31e-2)" "unprognostic (6.94e-2)" "unprognostic (1.20e-1)" "unprognostic (8.06e-2)" "unprognostic (8.37e-2)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.26e-11)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-2)" "unprognostic (6.66e-2)" 4.9 2.8 0.7 0.3 0.5 1.3 4.1 0.3 1.0 13.6 0.0 4.4 1.9 15.5 0.0 2.8 11.1 2.9 14.0 0.5 0.0 3.2 3.3 14.4 1.1 0.7 0.1 0.1 30.1 1.6 0.0 5.7 2.9 0.7 11.9 0.1 0.1 1.0 1.1 0.5 3.1 3.4 1.2 0.3 3.0 4.4 5.2 0.7 0.0 2.4 0.0 0.1 12.0 11.0 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.4 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.2 1.2 4.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.4 0.0 0.2 2.7 0.0 1.9 0.9 0.0 1.1 0.0 0.0 0.4 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.1 0.3 0.0 3.9 0.2 1.1 0.0 0.2 0.1 0.0 0.2 0.0 1.5 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.0 0.7 0.1 2.2 0.1 11.3 0.3 1.7 0.7 0.5 0.3 1.0 0.5 0.0 0.7 0.1 0.1 0.7 0.3 0.7 0.6 2.2 0.0 0.5 1.0 1.1 13.4 0.8 0.7 0.6 1.3 1.7 1.5 9.6 1.5 0.4 1.8 0.0 4.0 27.4 3.0 0.0 1.2 1.0 4.0 3.5 2.2 3.0 2.7 0.3 0.5 2.2 90.5 4.6 1.0 0.0 1.4 12.1 1.0 5.7 3.3 0.6 1.9 4.1 1.0 18.5 6.2 98.2 1.3 19.6 0.0 1.2 0.5 64.9 0.0 0.2 4.3 0.9 177.9 4.3 0.5 2.7 1.0 0.5 7.7 0.0 0.7 5.3 2.1 10.5 0.7 15.8 10.3 8.1 2.1 1.7 0.9 SH2D5 ENSG00000189410 "SH2 domain containing 5" Q6ZV89 1 20719731-20732837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 21.2;testis: 8.0" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.8;Excitatory neurons: 9.9;Inhibitory neurons: 5.3;Syncytiotrophoblasts: 5.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 47.0;hTERT-HME1: 59.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030182 Approved Cytosol NA NA Cytosol "HPA030182: AB_10670431" "unprognostic (2.32e-1)" "unprognostic (2.80e-2)" "unprognostic (3.85e-2)" "unprognostic (5.37e-3)" "unprognostic (1.20e-4)" "unprognostic (4.41e-2)" "unprognostic (1.80e-6)" "unprognostic (1.11e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-3)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-2)" 0.0 0.2 6.2 0.5 21.2 0.0 0.0 0.0 12.0 0.8 0.0 0.2 0.4 0.6 0.0 0.2 0.2 0.1 0.1 7.6 4.3 0.5 0.2 0.1 0.0 4.7 0.4 13.1 0.8 0.0 0.2 0.3 3.6 7.4 0.6 0.0 0.4 0.1 0.7 0.0 0.2 0.1 0.5 0.0 0.0 0.2 8.0 3.4 0.0 0.7 0.0 0.1 0.2 0.3 3.6 18.8 7.4 1.6 0.0 0.0 0.0 0.2 9.0 11.8 8.3 5.6 3.2 2.9 0.0 2.2 2.7 18.1 0.8 6.1 47.0 3.5 0.1 3.4 0.0 1.1 2.2 6.3 0.0 0.1 0.5 10.0 15.6 59.0 3.0 0.1 1.5 0.0 0.0 3.7 1.7 1.0 0.0 2.9 1.0 9.4 0.2 0.3 0.4 8.2 1.1 2.8 0.4 0.6 0.2 2.8 1.3 0.0 0.0 0.0 9.6 17.6 14.7 4.2 0.0 0.1 0.8 3.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 21.2 0.0 12.0 7.6 4.3 4.7 0.4 13.1 7.4 0.0 3.4 3.6 0.0 0.0 0.0 1.3 0.0 4.8 1.4 0.7 0.0 1.8 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.4 0.1 0.1 0.1 0.0 0.0 9.9 0.2 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 1.9 0.0 0.0 0.0 1.0 0.8 1.9 0.0 0.0 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.9 0.8 0.0 2.3 5.1 0.1 0.0 0.1 0.3 ZFP92 ZNF897 ENSG00000189420 "ZFP92 zinc finger protein" A6NM28 X 153418322-153426481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "Sertoli cells: 19.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2" "Region enhanced" "Detected in many" "hypothalamus: 8.8" "Low region specificity" "Detected in all" HPA003030 Uncertain NA NA "HPA003030: AB_2666758" "unprognostic (6.94e-2)" "unprognostic (2.54e-2)" "unprognostic (7.85e-2)" "unprognostic (2.57e-4)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.62e-2)" "unprognostic (6.51e-3)" "unprognostic (6.71e-2)" "unprognostic (1.84e-1)" "unprognostic (8.49e-4)" "unprognostic (1.81e-1)" "unprognostic (2.71e-2)" "unprognostic (6.66e-3)" 1.5 2.3 1.7 0.5 2.1 3.0 1.1 2.3 1.9 1.1 2.0 0.7 0.3 1.2 2.6 0.2 3.3 0.4 1.0 1.5 1.6 0.7 0.6 2.6 0.4 1.3 1.9 1.7 3.8 0.7 4.4 2.6 0.7 1.6 0.9 0.2 0.5 0.2 1.6 0.3 0.2 0.9 1.1 0.7 1.1 0.6 0.7 2.1 0.2 0.7 0.6 0.5 0.3 0.3 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.8 0.8 0.4 0.0 0.0 0.5 0.6 0.2 0.4 0.3 0.4 0.6 3.8 0.0 1.4 0.0 0.0 1.4 0.4 3.5 0.2 0.5 0.0 0.0 0.0 1.4 0.9 1.1 0.0 0.0 0.0 0.9 0.3 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.9 0.0 0.0 0.9 0.0 0.0 2.4 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.9 0.0 6.2 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.1 2.3 1.9 1.5 1.6 1.3 1.9 1.7 1.6 0.7 2.1 1.5 3.4 0.0 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.1 3.1 0.5 0.0 0.0 1.5 0.0 0.0 0.7 0.0 2.2 0.0 1.1 0.4 0.1 0.8 0.0 1.7 0.0 0.0 0.8 0.0 0.2 2.5 0.5 0.0 0.0 0.5 0.2 1.0 2.0 0.1 0.2 0.0 3.4 0.2 0.0 0.0 0.3 0.0 0.2 19.7 0.8 1.4 0.4 0.8 0.0 0.0 0.0 0.3 0.8 0.0 0.0 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906148-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 3.6" "Group enriched" "Detected in some" 7 "dendritic cells: 30.2;NK-cells: 110.2" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049311 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049311: AB_2680707" "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 0.2 0.0 0.0 0.2 0.0 0.7 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 6.6 0.4 0.0 0.0 0.1 1.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 1.8 0.0 1.9 0.1 0.0 110.2 0.5 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009316-13012119 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.0;salivary gland: 4.6;skin 1: 6.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 64.3;Distal tubular cells: 25.4;Gastric mucus-secreting cells: 17.9;Squamous epithelial cells: 60.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 8.9;CAPAN-2: 7.8;HaCaT: 12.6;HMC-1: 6.2;RPTEC TERT1: 11.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.6 0.0 0.5 0.0 1.3 0.4 0.5 0.6 0.2 0.4 1.2 0.1 0.1 6.0 3.0 0.3 0.3 0.3 0.9 2.8 0.0 1.2 0.0 0.6 0.9 0.2 0.0 0.0 2.1 0.1 0.0 0.6 0.6 0.4 0.0 4.6 0.2 0.7 6.1 0.5 0.0 1.0 0.0 3.6 0.5 0.2 0.5 0.1 0.2 0.5 1.1 1.5 0.5 0.4 8.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.8 0.0 0.5 0.0 0.3 12.6 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 2.2 0.0 1.3 0.0 0.0 11.9 1.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.5 0.3 0.9 0.6 0.9 0.2 0.6 1.0 0.2 0.5 2.0 0.0 5.1 0.7 0.1 0.0 6.3 0.0 64.3 0.0 5.8 8.0 0.9 0.0 2.5 1.8 0.0 0.2 0.0 0.9 25.4 0.6 0.0 6.0 1.1 1.4 2.4 0.0 0.0 0.2 0.0 0.2 17.9 11.1 1.3 0.0 3.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.3 0.5 0.0 1.9 0.0 0.9 0.0 0.0 0.0 11.5 1.2 0.0 0.0 1.9 0.0 4.5 7.3 0.0 0.0 0.5 0.3 0.0 0.8 60.0 0.0 0.0 0.2 0.0 5.5 3.5 GJB4 CX30.3 ENSG00000189433 "Gap junction protein beta 4" Q9NTQ9 1 34759740-34762327 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 43.5" "Group enriched" "Detected in some" 4 "Basal prostatic cells: 31.1;Pancreatic endocrine cells: 37.0;Urothelial cells: 102.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.0;HaCaT: 12.2;HBEC3-KT: 8.3;hTCEpi: 5.7;OE19: 4.5;RPTEC TERT1: 4.8;RT4: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055112, HPA073904" Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA055112: AB_2682699, HPA073904: " "unprognostic (3.30e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.57e-1)" "unprognostic (2.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.18e-2)" "unprognostic (5.40e-2)" "unprognostic (3.65e-1)" "prognostic unfavorable (3.24e-5)" "unprognostic (3.73e-2)" "unprognostic (5.81e-3)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.52e-4)" "unprognostic (5.42e-2)" 0.0 0.0 0.0 0.3 0.1 0.0 2.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 5.6 2.3 0.2 4.8 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.3 0.0 0.5 1.1 0.2 43.5 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.4 0.1 0.0 2.3 8.0 1.4 0.2 9.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 0.1 12.2 0.0 8.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 4.8 5.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.8 31.1 13.9 1.2 0.0 0.3 0.1 0.1 0.0 5.7 0.0 0.0 0.1 0.1 0.3 0.0 3.7 0.0 0.3 0.0 0.2 1.8 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 37.0 1.3 0.0 0.0 12.9 0.1 0.0 6.8 0.0 0.0 0.0 0.7 0.0 0.0 3.5 6.0 0.3 0.1 0.0 0.4 102.6 OR2L13 OR2L14 ENSG00000196071 "Olfactory receptor family 2 subfamily L member 13" Q8N349 1 248095184-248101103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.8;retina: 2.2" "Group enriched" "Detected in some" 19 "Excitatory neurons: 140.4;Inhibitory neurons: 106.7;Oligodendrocyte precursor cells: 68.3;Oligodendrocytes: 139.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.39e-2)" "unprognostic (1.53e-1)" "unprognostic (9.89e-2)" "unprognostic (3.66e-1)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.14e-1)" 0.0 0.6 2.9 0.0 4.0 0.0 0.2 3.7 6.4 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.3 4.4 0.0 0.0 0.0 0.1 5.4 5.2 3.3 0.0 0.0 0.0 0.6 0.0 6.1 0.5 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.4 0.0 0.7 4.0 0.0 0.3 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.0 3.7 6.4 3.3 4.4 5.4 5.2 3.3 6.1 3.6 4.0 6.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 140.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.8 0.0 0.8 0.0 68.3 139.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLOC1S2 "BLOS2, BORCS2, FLJ30135, MGC10120" ENSG00000196072 "Biogenesis of lysosomal organelles complex 1 subunit 2" Q6QNY1 10 100273280-100286680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048088, HPA055010" Approved NA NA "HPA048088: AB_2680259, HPA055010: AB_2682670" "unprognostic (3.64e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-2)" "unprognostic (1.71e-1)" "unprognostic (8.75e-2)" "unprognostic (4.37e-2)" "unprognostic (8.64e-3)" "unprognostic (3.10e-1)" "unprognostic (8.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.79e-1)" "unprognostic (1.21e-1)" "unprognostic (7.57e-2)" "unprognostic (2.90e-1)" "unprognostic (2.44e-1)" "unprognostic (2.08e-2)" "unprognostic (3.53e-1)" 25.8 34.9 36.7 26.1 38.8 74.0 24.7 36.7 41.8 20.9 32.3 18.0 15.7 14.7 22.9 58.4 16.1 14.6 23.9 38.1 41.4 33.9 41.2 30.9 38.5 40.1 40.2 37.1 18.2 26.1 25.6 36.4 16.2 40.5 23.7 18.6 19.0 28.1 9.9 75.1 39.8 23.6 11.6 40.2 44.5 22.5 21.2 40.2 23.2 23.1 23.1 34.8 20.0 33.7 43.3 36.5 36.5 49.2 56.1 52.3 47.8 44.5 62.0 60.5 31.4 39.6 24.9 30.6 34.4 34.1 38.0 25.2 37.2 25.0 78.9 31.7 53.9 36.9 20.4 33.3 62.5 45.9 59.9 62.3 37.2 86.7 30.6 98.9 51.7 55.0 42.7 28.2 56.7 68.3 44.2 50.5 36.6 26.6 38.4 29.2 13.6 45.1 30.0 47.9 49.2 23.5 31.4 27.9 15.6 68.2 47.7 57.3 33.4 43.7 19.0 37.1 33.3 57.9 56.0 69.1 67.0 56.6 61.4 19.7 63.1 51.6 81.1 26.5 70.6 39.3 74.7 33.3 30.2 59.7 94.0 28.9 32.5 106.8 35.0 70.7 38.4 47.3 44.6 36.7 38.8 36.7 41.8 38.1 41.4 40.1 40.2 37.1 40.5 40.2 40.2 43.3 33.4 25.6 31.4 10.1 103.6 66.4 45.0 171.3 57.5 27.3 40.3 39.0 22.6 18.6 50.9 35.0 12.5 85.1 68.1 19.5 92.0 61.8 33.3 20.8 26.5 36.7 28.8 42.5 16.8 70.9 71.6 38.9 27.5 25.4 86.3 21.5 30.4 30.3 133.3 21.9 14.8 19.7 85.5 108.0 71.9 36.2 22.7 82.3 40.9 14.0 127.1 29.1 74.2 14.1 17.4 94.4 23.1 17.7 32.3 38.9 26.3 72.5 38.0 24.0 6.6 51.1 29.4 84.4 54.7 102.4 77.3 45.7 68.3 27.3 26.1 31.4 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863564-59933655 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.5" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 468.5" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 3.3 0.8 2.5 1.5 3.2 2.4 14.1 10.2 4.7 2.1 0.2 1.3 1.7 1.6 1.2 1.0 1.3 2.4 2.0 2.6 2.0 4.4 1.1 2.2 2.6 3.3 3.1 1.8 0.7 6.7 0.7 1.9 4.0 5.3 3.8 1.1 1.5 4.4 1.0 1.3 2.8 2.4 0.7 1.6 3.1 6.2 43.5 2.2 1.3 2.4 1.0 1.7 1.8 1.5 4.2 0.3 1.3 0.2 1.4 0.6 0.8 1.4 4.1 1.1 1.8 0.2 25.9 2.6 0.1 4.0 1.8 0.8 0.6 0.5 0.1 1.0 8.5 0.6 0.2 6.1 0.4 0.2 0.4 19.0 0.4 0.4 0.4 0.0 0.9 0.0 47.2 0.2 0.0 0.9 12.5 54.4 2.9 0.4 1.5 0.3 0.0 0.1 0.2 2.1 6.1 0.2 4.5 92.2 13.3 3.3 1.6 82.6 4.7 0.5 0.1 2.8 11.2 0.0 0.0 0.0 0.0 0.0 1.7 5.2 0.7 0.1 0.7 0.8 0.0 0.8 0.2 0.4 0.5 0.0 0.2 0.2 0.4 0.7 0.0 0.0 0.0 0.3 0.2 2.5 3.2 10.2 4.7 2.6 2.0 3.3 3.1 1.8 5.3 1.6 2.2 4.2 11.5 0.0 1.1 24.5 1.4 1.0 1.1 1.0 0.0 1.9 12.7 9.4 3.6 2.8 6.3 1.8 2.1 0.8 3.0 0.1 1.9 0.9 82.3 0.4 5.0 6.5 0.0 0.0 27.5 3.6 0.4 2.1 2.6 0.5 2.5 1.2 2.9 0.0 0.5 0.0 14.6 0.1 0.0 1.2 0.8 21.8 4.7 1.6 5.4 13.1 1.4 2.3 5.2 28.6 11.1 1.2 1.2 1.9 0.4 1.8 0.3 5.4 8.6 1.1 52.6 1.7 3.8 468.5 92.4 0.6 0.0 0.4 4.1 0.2 0.3 1.2 ZNF724 ZNF724P ENSG00000196081 "Zinc finger protein 724" A8MTY0 19 23221599-23250394 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.5;esophagus: 2.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 2.1;Extravillous trophoblasts: 5.0;Glandular and luminal cells: 3.0;granulocytes: 2.5;Granulosa cells: 3.4;Syncytiotrophoblasts: 2.7;Theca cells: 3.1" "Cancer enhanced" "Detected in many" "testis cancer: 2.5" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 13.6" NA NA "unprognostic (2.02e-1)" "unprognostic (1.65e-1)" "unprognostic (1.78e-2)" "unprognostic (3.80e-2)" "unprognostic (2.27e-2)" "unprognostic (2.33e-1)" "unprognostic (1.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (5.34e-2)" "unprognostic (3.07e-2)" "unprognostic (2.73e-2)" "unprognostic (3.20e-1)" "unprognostic (3.76e-1)" "unprognostic (3.30e-2)" 0.3 0.2 0.6 0.6 0.4 2.5 0.4 1.9 0.8 0.3 0.4 0.5 0.1 0.5 0.4 2.6 0.3 0.3 0.1 0.6 0.9 0.3 0.4 0.2 0.6 0.6 0.6 0.5 0.4 0.3 0.2 0.0 0.6 0.9 0.3 0.6 0.8 0.5 0.1 0.6 0.6 0.4 0.3 0.4 0.7 1.7 1.0 0.7 0.8 0.5 0.1 0.8 0.1 0.2 0.9 3.4 1.6 5.7 7.1 0.5 0.6 6.6 1.6 1.4 4.2 5.1 3.7 1.1 3.4 3.8 1.7 1.5 2.2 6.2 2.4 7.8 0.4 5.5 3.4 1.2 1.4 0.1 0.1 3.2 0.4 0.3 5.1 3.6 0.5 0.2 4.8 5.4 0.3 2.6 5.1 8.5 2.1 13.6 0.1 4.5 4.8 7.4 2.6 0.6 3.6 3.2 2.8 0.0 0.1 0.8 4.5 2.0 2.2 0.1 1.6 0.2 4.8 4.6 0.0 1.5 7.4 0.0 1.0 1.4 2.2 0.6 0.3 1.0 0.6 0.5 1.6 0.6 0.7 0.5 1.9 0.8 1.0 2.6 2.0 0.5 1.4 0.4 0.2 0.6 0.4 1.9 0.8 0.6 0.9 0.6 0.6 0.5 0.9 0.4 0.7 0.9 1.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.6 0.0 0.0 2.1 0.8 0.0 0.0 0.8 0.0 1.2 1.9 0.7 0.0 0.0 0.0 0.2 5.0 0.6 0.0 3.0 2.5 3.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.7 0.4 3.1 0.0 0.0 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 227.7" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 23.8;neutrophil: 95.0" "Lineage enriched" "Detected in many" 15 "granulocytes: 95.0" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 350000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 6.3 2.9 3.8 11.5 0.9 20.5 4.4 0.1 8.5 4.4 0.5 2.3 1.8 4.0 2.6 13.2 5.5 12.2 4.0 4.4 8.8 3.4 227.7 8.3 2.7 2.4 3.1 0.1 3.1 3.9 1.5 1.2 37.3 2.6 3.9 2.2 2.5 5.2 3.4 1.3 12.0 2.2 6.4 1.5 5.5 4.6 1.4 4.9 4.7 4.1 2.1 4.8 9.5 5.6 6.7 13.3 3.0 5.5 0.8 9.5 7.7 10.0 5.8 11.9 13.4 13.2 5.8 29.3 2.2 59.2 16.4 31.1 34.1 3.0 57.6 18.7 2.5 3.6 2.9 5.3 14.5 19.6 20.2 9.5 10.3 23.1 19.7 59.2 27.8 6.0 5.9 0.4 0.2 6.4 6.5 1.7 9.4 8.5 6.0 6.0 9.5 8.2 4.8 5.3 14.8 1.0 0.0 26.3 15.0 247.1 5.2 9.6 14.6 7.9 10.3 10.4 32.1 26.6 5.0 0.2 0.5 17.2 18.0 60.9 11.7 3.8 23.8 1.8 4.3 3.3 2.1 2.1 2.3 3.8 2.1 2.0 1.3 95.0 0.3 6.3 0.6 2.1 1.4 3.8 0.9 0.1 8.5 4.4 8.8 2.4 3.1 0.1 2.6 1.5 4.9 6.7 3.5 0.0 14.7 6.5 6.8 44.7 16.5 45.8 68.9 6.5 2.5 4.7 5.5 40.0 22.8 3.7 8.4 8.5 3.6 1.8 0.0 7.7 4.4 8.6 3.8 8.0 5.4 4.4 44.3 7.5 109.2 7.3 7.1 12.3 7.6 0.7 7.5 295.8 7.8 0.0 63.3 1.4 4.1 33.7 17.7 0.6 4.4 28.8 8.8 53.4 5.0 1.0 6.2 298.6 1.5 19.7 0.8 2.6 5.3 11.5 0.7 1.1 8.7 0.6 0.0 18.0 5.1 0.1 0.6 30.9 37.2 24.2 5.2 1.4 1.1 14.3 PTPRT "KIAA0283, RPTPrho" ENSG00000196090 "Protein tyrosine phosphatase receptor type T" O14522 20 42072752-43189970 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.9;fallopian tube: 10.9" "Group enriched" "Detected in some" 14 "Excitatory neurons: 500.7;Inhibitory neurons: 700.2;Oligodendrocyte precursor cells: 418.7" "Group enriched" "Detected in many" 5 "breast cancer: 5.1;prostate cancer: 1.9" "Region enhanced" "Detected in many" "cerebral cortex: 22.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017336, CAB069423" Approved NA NA "CAB069423: AB_1622602, HPA017336: AB_1855943" "unprognostic (7.17e-3)" "unprognostic (1.02e-1)" "unprognostic (5.61e-3)" "unprognostic (1.08e-2)" "unprognostic (5.95e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (6.93e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-6)" "unprognostic (3.16e-1)" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" 0.1 0.2 5.1 0.1 9.4 0.0 2.7 0.0 22.9 0.7 0.0 0.1 0.5 0.0 0.2 0.0 10.9 0.1 0.2 5.7 4.8 0.1 0.2 1.1 0.4 0.3 0.5 7.3 0.0 0.4 0.0 3.0 2.8 3.2 0.2 0.0 3.7 1.0 2.6 0.0 0.3 0.3 0.0 0.0 0.1 0.8 1.6 0.5 6.4 0.0 0.1 0.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 9.4 0.0 22.9 5.7 4.8 0.3 0.5 7.3 3.2 0.0 0.5 4.9 0.4 0.0 1.1 13.1 0.0 0.9 0.0 0.0 0.0 36.2 2.6 6.9 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 3.2 0.1 0.2 0.0 0.0 500.7 0.0 0.0 1.2 0.0 0.2 0.0 3.3 6.4 0.2 0.2 5.0 700.2 0.0 0.0 0.3 0.3 12.6 0.0 0.1 0.0 8.4 0.0 10.3 0.0 418.7 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 18.5 2.1 0.0 0.5 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 MYBPC1 ssMyBP-C ENSG00000196091 "Myosin binding protein C1" Q00872 12 101568353-101686028 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 87 "skeletal muscle: 11397.7;tongue: 5253.9" "Cell type enhanced" "Detected in some" "Astrocytes: 34.6;Breast glandular cells: 102.4;Breast myoepithelial cells: 81.4;Cardiomyocytes: 64.7;Skeletal myocytes: 184.6" "Cancer enhanced" "Detected in many" "prostate cancer: 33.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "HAP1: 6.8" "Group enriched" "Detected in many" 9 "cerebellum: 39.6;olfactory bulb: 10.6" "Region enhanced" "Detected in many" "thalamus: 6.9" "HPA021004, HPA027614" Enhanced NA NA 240000 "HPA021004: AB_1854232, HPA027614: AB_10602711" "prognostic favorable (4.76e-5)" "unprognostic (7.72e-2)" "unprognostic (1.09e-1)" "unprognostic (1.81e-2)" "unprognostic (3.33e-2)" "unprognostic (4.63e-2)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (9.98e-3)" "unprognostic (2.56e-1)" "unprognostic (2.55e-1)" "unprognostic (1.19e-2)" "unprognostic (4.10e-2)" "unprognostic (7.96e-2)" "unprognostic (6.13e-2)" "unprognostic (5.55e-3)" 1.2 0.3 55.5 0.1 63.8 0.0 64.4 63.0 72.2 1.9 37.2 3.0 0.1 0.2 1.1 95.5 0.8 0.3 1.7 50.8 56.2 0.3 0.7 0.7 0.0 55.9 61.3 48.4 0.5 1.1 0.0 0.3 0.0 54.0 84.3 0.8 0.0 48.8 0.3 11397.7 4.6 7.5 0.0 49.5 0.4 1.3 3.4 65.7 2.7 1.2 5253.9 4.0 0.3 0.7 50.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 63.8 63.0 72.2 50.8 56.2 55.9 61.3 48.4 54.0 49.5 65.7 50.7 1.3 0.0 0.0 34.6 0.3 0.0 2.2 0.0 0.0 0.0 102.4 81.4 64.7 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 16.5 0.1 0.1 1.2 0.0 0.0 5.3 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.2 0.0 0.8 0.3 23.7 0.6 1.2 1.8 1.0 0.0 0.0 0.0 0.5 0.5 0.1 1.6 0.4 0.0 16.3 0.3 0.1 0.0 0.0 0.0 184.6 2.7 1.4 1.4 0.0 0.0 0.0 0.7 0.0 0.3 2.9 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833269-37034268 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 40.0" "Cell type enriched" "Detected in some" 29 "B-cells: 91.3" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "medulla oblongata: 4.4;midbrain: 4.9;pons: 3.7;thalamus: 3.6;white matter: 1.3" "Group enriched" "Detected in some" 43 "memory B-cell: 39.0;naive B-cell: 26.0" "Lineage enriched" "Detected in single" 52 "B-cells: 39.0" "Group enriched" "Detected in some" 9 "Daudi: 66.6;REH: 194.1;U-698: 87.1" "Region enriched" "Detected in single" 11 "midbrain: 3.9" "Low region specificity" "Detected in all" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997" "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.3 0.1 0.3 15.1 0.3 9.5 0.1 0.3 0.7 0.0 0.2 0.9 0.5 0.2 0.1 0.2 0.0 0.8 0.2 0.3 0.5 0.1 0.2 0.3 40.0 4.4 4.9 0.3 0.0 0.0 0.0 0.2 0.1 3.7 0.3 0.8 0.5 1.0 0.0 3.2 0.0 6.7 0.0 0.7 18.8 1.7 0.6 3.6 2.8 0.2 0.0 36.5 1.1 0.0 1.3 0.1 0.3 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 66.6 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.1 0.3 1.9 0.3 0.4 194.1 0.4 0.3 0.0 0.0 13.2 2.9 0.1 0.7 0.0 0.0 0.0 7.5 0.2 0.0 0.2 0.1 0.0 0.2 0.1 87.1 0.0 1.5 0.1 0.7 0.0 0.1 0.0 0.1 0.1 39.0 0.0 0.0 0.1 26.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.7 0.3 0.3 0.3 0.7 0.3 0.5 4.4 4.9 0.3 3.7 0.7 3.6 1.3 0.0 0.0 0.0 0.7 91.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.4 0.6 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.3 0.0 3.1 0.0 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.0 2.7 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.2 0.0 0.0 2.0 0.0 0.0 0.3 OR5K4 ENSG00000196098 "Olfactory receptor family 5 subfamily K member 4" A6NMS3 3 98353854-98354819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6M1 ENSG00000196099 "Olfactory receptor family 6 subfamily M member 1" Q8NGM8 11 123805335-123806387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048674 Uncertain NA NA "HPA048674: AB_2680489" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPOCK3 testican-3 ENSG00000196104 "SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3" Q9BQ16 4 166733384-167234796 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 156.3;parathyroid gland: 176.1;prostate: 74.6" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 1010.6;Oligodendrocyte precursor cells: 399.1;Oligodendrocytes: 1851.1" "Cancer enhanced" "Detected in many" "prostate cancer: 7.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Group enriched" "Detected in many" 12 "dendritic cells: 1.8;monocytes: 1.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.2;hTERT-RPE1: 6.5;PC-3: 2.7;RH-30: 7.1;SCLC-21H: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (3.54e-2)" "unprognostic (8.69e-2)" "unprognostic (2.90e-3)" "unprognostic (1.20e-1)" "unprognostic (4.09e-4)" "unprognostic (3.75e-1)" "unprognostic (1.97e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-1)" "unprognostic (3.94e-4)" "unprognostic (8.92e-2)" "unprognostic (4.18e-3)" "unprognostic (2.62e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-3)" "unprognostic (1.64e-1)" 0.3 24.9 60.4 0.6 97.4 0.1 0.3 79.9 87.5 0.9 30.9 0.9 0.8 2.9 19.0 0.2 1.1 0.3 0.3 59.1 80.0 0.2 0.4 0.4 0.5 87.7 76.2 51.0 17.5 0.7 176.1 0.3 0.0 90.0 74.6 0.5 14.5 0.3 35.2 0.2 0.0 1.3 2.8 78.2 0.4 0.7 0.5 80.8 0.3 0.2 24.2 0.3 1.7 0.2 156.3 0.0 1.6 0.2 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.4 0.1 0.2 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 6.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 2.7 0.0 7.1 0.4 0.0 1.1 2.8 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.5 60.4 97.4 79.9 87.5 59.1 80.0 87.7 76.2 51.0 90.0 78.2 80.8 156.3 0.0 0.0 0.0 12.7 0.1 0.0 1.5 8.1 0.0 43.7 0.0 0.0 1.6 0.0 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 15.0 0.0 0.2 1.6 0.0 1.3 106.7 0.0 0.1 15.7 2.0 0.0 1.3 3.2 0.0 0.0 0.1 15.2 1010.6 0.0 6.1 0.0 0.0 2.9 0.9 0.5 0.0 98.4 0.2 1.3 0.0 399.1 1851.1 0.1 0.0 0.4 0.0 3.3 0.0 0.1 6.7 6.3 0.0 0.0 2.5 0.5 0.7 0.0 0.0 0.1 0.0 55.4 0.0 0.8 ZNF676 ENSG00000196109 "Zinc finger protein 676" Q8N7Q3 19 22179089-22215801 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 19.6;Early spermatids: 23.9;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 37.1;Spermatocytes: 18.9" "Cancer enriched" "Detected in some" 7 "testis cancer: 9.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 12.5" NA NA "unprognostic (7.77e-2)" "unprognostic (2.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (8.33e-2)" "unprognostic (1.36e-2)" "unprognostic (1.64e-1)" "unprognostic (5.45e-1)" "unprognostic (6.76e-3)" "unprognostic (9.98e-3)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-3)" 1.0 0.2 0.7 0.1 1.3 0.0 1.4 0.7 1.1 0.7 0.6 0.7 0.1 1.6 1.0 0.2 1.5 0.4 1.4 1.0 2.3 1.0 0.1 0.3 0.1 1.8 1.6 0.1 2.0 1.0 3.8 1.1 0.0 2.2 0.5 0.3 0.3 0.3 0.4 0.1 0.3 0.3 1.0 0.7 0.6 0.2 3.8 1.5 0.0 3.3 0.3 0.0 0.4 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.7 1.1 1.0 2.3 1.8 1.6 0.1 2.2 0.7 1.5 1.6 3.7 0.0 0.0 8.1 0.0 0.0 0.6 0.0 0.0 1.5 1.4 1.3 3.5 0.0 0.0 5.5 0.0 1.3 0.0 0.0 19.6 8.6 23.9 0.0 1.0 2.8 0.0 0.0 0.8 2.7 0.6 4.6 0.0 0.0 0.0 1.2 3.6 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.3 5.0 0.9 0.0 0.0 7.5 0.0 1.4 0.0 17.6 37.1 1.0 0.0 0.4 0.0 0.2 0.0 1.2 0.0 0.0 6.6 2.1 1.3 18.9 10.3 0.4 0.3 0.8 0.1 0.0 0.0 0.4 ZNF699 "FLJ38144, hang" ENSG00000196110 "Zinc finger protein 699" Q32M78 19 9291140-9309838 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cells: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 12.4;hTERT-HME1: 12.3;U-138 MG: 14.1" HPA058287 Uncertain NA NA "HPA058287: AB_2683669" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (1.26e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-3)" "unprognostic (2.83e-3)" "unprognostic (2.75e-1)" "unprognostic (5.93e-2)" "unprognostic (3.16e-1)" "unprognostic (6.58e-2)" "unprognostic (1.20e-1)" "unprognostic (8.37e-2)" "unprognostic (2.10e-5)" "unprognostic (1.02e-1)" "unprognostic (2.23e-1)" "unprognostic (6.69e-2)" "unprognostic (3.07e-1)" 1.5 1.4 1.3 1.7 1.2 2.1 2.2 2.7 1.2 2.2 1.2 1.2 1.6 2.7 2.0 1.4 1.7 1.6 1.4 1.4 1.4 1.6 1.0 1.9 2.5 1.3 1.2 1.0 3.8 1.2 3.0 0.8 1.4 1.5 1.9 1.4 3.3 1.2 1.7 0.7 1.7 1.1 1.9 0.9 2.2 1.5 1.0 1.5 2.7 2.3 1.4 2.4 1.4 0.9 1.6 2.0 0.8 3.0 3.2 1.9 2.5 1.5 2.5 3.2 6.3 6.5 0.8 0.7 1.6 1.3 3.4 2.0 1.0 2.0 7.8 12.4 2.0 0.8 2.0 1.3 0.5 2.1 0.5 2.4 3.3 2.1 6.7 12.3 3.2 1.5 3.7 1.2 3.6 8.8 0.6 2.6 2.7 0.9 0.1 2.2 1.2 8.2 0.4 1.1 3.1 1.5 1.4 6.1 0.3 2.7 1.9 1.0 1.2 1.5 14.1 11.2 1.8 6.5 1.1 0.3 2.6 1.4 1.5 3.3 0.7 0.3 1.9 1.0 0.5 0.8 1.0 0.9 0.8 0.6 0.7 1.3 0.8 0.8 0.6 0.8 0.3 0.5 0.5 1.3 1.2 2.7 1.2 1.4 1.4 1.3 1.2 1.0 1.5 0.9 1.5 1.6 5.0 3.2 0.5 2.0 8.3 2.0 6.2 2.3 6.8 8.3 2.2 3.3 1.6 1.5 6.4 1.8 8.4 0.6 13.6 1.2 0.0 1.0 0.1 1.1 5.0 3.4 1.2 1.3 4.4 1.0 1.2 3.9 2.6 2.8 1.3 3.4 3.9 0.7 1.2 5.0 4.3 0.2 8.2 1.9 2.9 0.4 2.1 4.1 3.6 5.6 3.7 5.1 15.5 6.0 3.8 1.6 1.5 4.1 6.1 3.2 2.4 0.8 0.4 13.5 0.0 3.8 4.7 3.7 2.3 3.2 2.4 1.0 12.2 1.9 0.7 4.1 TDRD7 PCTAIRE2BP ENSG00000196116 "Tudor domain containing 7" Q8NHU6 9 97412096-97496125 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 63.6" "Cell type enhanced" "Detected in many" "Early spermatids: 44.7;Microglial cells: 33.7;Rod photoreceptor cells: 44.4;Spermatocytes: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 56.5;HDLM-2: 55.6;THP-1: 54.4" "Low region specificity" "Detected in all" "CAB020800, HPA022250, HPA024529" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "CAB020800: , HPA022250: , HPA024529: AB_1857869" "unprognostic (8.22e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-3)" "unprognostic (1.03e-1)" "unprognostic (2.88e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (5.91e-4)" "unprognostic (2.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "prognostic favorable (4.76e-5)" "unprognostic (4.03e-2)" "unprognostic (2.90e-1)" "unprognostic (1.17e-2)" "unprognostic (2.67e-1)" 6.8 6.3 12.4 8.1 13.8 11.2 6.7 13.6 12.6 6.5 10.8 14.5 16.0 7.0 6.4 9.0 8.9 10.3 6.5 11.5 13.3 7.0 8.2 9.8 8.1 14.8 12.8 11.0 7.5 5.7 9.9 5.9 9.0 14.7 6.2 14.0 63.6 7.6 7.4 4.7 5.5 13.8 9.9 14.7 9.1 8.6 37.2 13.1 11.1 7.9 5.5 8.5 8.2 6.8 16.6 17.1 11.7 0.0 4.0 8.7 11.2 9.8 10.6 26.7 35.8 39.9 15.2 14.1 1.1 5.1 15.1 56.5 12.8 9.8 5.4 9.6 55.6 8.3 7.8 5.5 11.1 7.9 17.6 18.0 3.8 10.7 11.9 1.2 10.7 15.7 8.2 4.4 0.8 9.5 10.2 8.8 8.6 1.7 20.1 6.2 3.8 5.9 0.2 8.8 11.4 1.8 4.8 14.8 6.5 41.6 6.2 3.9 54.4 16.1 4.5 4.4 11.4 8.2 5.5 6.9 1.0 10.6 9.4 11.8 1.7 2.2 7.2 1.1 4.3 1.6 3.0 1.5 1.1 3.2 2.5 1.2 1.9 4.2 1.2 4.2 0.7 1.1 1.2 12.4 13.8 13.6 12.6 11.5 13.3 14.8 12.8 11.0 14.7 14.7 13.1 16.6 7.0 0.0 3.0 10.4 5.7 1.7 2.6 2.2 2.8 8.2 2.7 2.4 6.4 1.5 4.0 3.7 18.8 1.7 3.0 14.2 5.9 4.4 44.7 11.1 5.2 6.0 6.0 1.7 18.5 4.9 2.2 4.3 10.2 8.0 0.0 5.4 2.9 2.5 4.8 5.0 19.0 7.9 2.0 6.4 1.8 23.9 4.4 7.3 1.8 33.7 10.8 8.6 1.0 21.1 29.9 6.1 7.6 3.8 4.3 2.2 8.9 2.8 12.9 44.4 6.6 3.7 4.2 36.4 15.7 4.4 2.3 0.7 4.7 2.6 7.2 4.3 CCDC189 "C16orf93, MGC104706" ENSG00000196118 "Coiled-coil domain containing 189" A1A4V9 16 30757423-30762221 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Group enriched" "Detected in many" 4 "Early spermatids: 208.2;Late spermatids: 318.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 12.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041806, HPA046289, HPA075094" Approved Approved Cytosol NA NA Cytosol "HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: " "unprognostic (5.84e-2)" "unprognostic (3.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.45e-4)" "unprognostic (3.60e-2)" "unprognostic (5.41e-3)" "unprognostic (7.76e-5)" "unprognostic (1.66e-2)" "unprognostic (1.82e-2)" "unprognostic (5.11e-3)" "unprognostic (2.15e-4)" "unprognostic (1.22e-3)" "unprognostic (1.06e-7)" "unprognostic (1.75e-3)" "unprognostic (2.14e-1)" "unprognostic (6.63e-2)" "unprognostic (3.41e-2)" 1.0 5.2 7.1 1.6 6.7 7.9 2.7 6.0 8.8 2.4 10.9 1.6 1.1 1.8 4.3 1.7 10.5 1.6 0.6 7.4 6.8 6.6 1.3 4.0 1.1 6.7 7.8 6.2 2.2 3.8 2.3 12.7 0.6 7.8 4.1 1.7 3.6 3.4 1.9 0.3 1.2 1.8 0.7 6.8 2.1 2.0 18.6 6.5 1.7 6.6 0.1 2.1 1.4 1.2 7.4 7.1 5.2 1.1 5.3 1.5 1.7 0.3 2.6 1.2 2.8 2.1 0.3 5.0 0.2 4.3 2.1 1.4 8.2 0.8 4.3 1.2 0.7 9.8 1.9 10.1 2.5 0.3 2.4 1.8 0.4 0.4 5.1 4.4 4.0 2.2 1.8 2.6 1.2 2.2 4.3 2.9 4.6 1.9 2.2 2.5 2.8 1.6 5.2 6.2 0.0 4.2 1.5 3.0 7.7 1.6 1.3 7.5 3.6 1.8 1.3 1.0 2.2 2.6 3.6 2.2 2.1 8.3 7.3 0.4 1.9 1.1 6.0 0.1 1.3 0.9 1.0 0.0 0.2 1.8 0.1 0.0 0.2 0.4 1.9 3.3 12.2 0.1 0.8 7.1 6.7 6.0 8.8 7.4 6.8 6.7 7.8 6.2 7.8 6.8 6.5 7.4 0.6 0.0 3.1 0.0 4.3 0.0 4.0 0.0 4.6 1.0 6.8 4.2 0.0 0.0 3.7 7.3 4.2 2.9 16.1 1.6 5.9 3.9 208.2 42.9 2.3 1.4 2.4 14.3 0.0 3.0 1.1 3.5 12.8 4.0 1.3 2.3 0.7 1.1 4.5 0.0 0.0 2.0 0.0 2.2 0.0 318.0 7.5 5.4 0.0 0.0 4.8 3.7 1.0 0.0 0.0 1.9 1.6 4.9 11.9 3.6 1.0 8.6 49.6 15.0 0.0 1.0 1.5 52.7 15.7 2.0 0.0 2.5 2.1 7.0 1.8 3.7 OR8A1 OST025 ENSG00000196119 "Olfactory receptor family 8 subfamily A member 1" Q8NGG7 11 124566660-124582942 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Group enriched" "Detected in some" 7 "Early spermatids: 1.7;Excitatory neurons: 1.1;granulocytes: 3.8;Late spermatids: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.5 0.2 0.5 0.9 0.4 1.0 0.8 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.4 0.3 0.1 0.8 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.1 0.5 0.2 0.1 0.5 0.2 0.0 0.0 0.6 0.3 0.1 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 1.0 0.8 0.4 0.3 0.4 0.2 0.2 0.5 0.1 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175599-67184040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 74.3;Early spermatids: 84.9;Horizontal cells: 107.7;Late spermatids: 198.4;Rod photoreceptor cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA065996: AB_2685593" "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favorable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 11.4 25.3 19.5 5.0 21.0 3.4 11.6 26.6 26.8 20.3 13.5 10.8 6.6 21.2 7.6 12.5 31.1 6.0 11.5 22.1 19.1 19.2 9.4 14.6 2.1 21.8 18.6 20.9 40.0 11.8 6.7 46.4 5.8 22.3 17.2 5.3 29.5 10.9 4.2 5.1 8.4 11.3 7.1 16.0 16.3 14.5 23.7 17.8 4.2 25.5 2.2 1.7 15.6 13.4 21.3 3.1 5.0 19.0 11.9 3.6 8.2 12.3 7.9 1.6 3.6 3.4 5.1 3.1 5.7 5.0 3.3 3.0 11.6 5.4 4.5 2.3 5.2 7.1 8.3 15.6 4.7 2.8 3.8 16.2 4.7 2.0 4.5 1.7 13.4 6.0 12.2 8.6 5.3 4.6 5.1 8.6 6.4 4.1 3.1 8.2 23.0 9.1 11.1 6.3 7.3 21.6 18.0 9.4 4.7 2.6 9.0 10.2 6.4 7.0 11.8 8.4 5.8 3.4 6.6 5.9 6.0 15.3 5.7 6.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 19.5 21.0 26.6 26.8 22.1 19.1 21.8 18.6 20.9 22.3 16.0 17.8 21.3 5.3 3.2 7.9 29.4 1.3 2.9 3.8 7.0 7.4 74.3 6.3 6.9 3.3 8.6 8.8 7.3 43.8 3.9 2.3 6.6 3.9 5.6 84.9 6.7 14.9 5.8 13.1 1.7 23.6 2.5 6.7 5.4 10.7 10.8 4.5 18.6 7.1 4.3 4.2 107.7 28.9 4.6 10.2 0.6 2.1 198.4 6.8 2.3 5.4 5.6 1.7 13.8 0.0 20.1 14.9 3.4 5.4 10.9 1.2 4.5 2.1 1.9 5.1 68.0 19.7 2.8 8.8 6.9 10.9 5.9 2.4 3.0 2.0 16.3 6.6 4.8 HLA-DRB1 HLA-DR1B ENSG00000196126 "Major histocompatibility complex, class II, DR beta 1" P01911 6 32578769-32589848 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 586.3;lymphoid tissue: 657.1" "Cell type enhanced" "Detected in many" "B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "myeloid DC: 749.2" "Group enriched" "Detected in all" 9 "B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3" "Cell line enhanced" "Detected in many" "HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9" "CAB015400, CAB034021, HPA043151" Enhanced NA NA "CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342" "unprognostic (3.69e-3)" "unprognostic (3.66e-3)" "unprognostic (1.80e-2)" "unprognostic (2.40e-3)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.22e-3)" "unprognostic (8.56e-2)" "unprognostic (3.00e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-3)" "unprognostic (6.16e-2)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.53e-1)" 274.2 163.5 6.0 222.8 8.6 62.0 241.5 5.2 29.9 107.6 12.0 114.6 2.4 91.1 141.8 72.2 120.4 67.4 122.6 6.9 14.2 217.1 101.5 586.3 657.1 9.9 16.4 3.9 40.7 51.2 0.0 80.9 13.7 17.1 89.2 136.7 5.3 94.6 0.4 58.8 122.2 356.2 11.2 8.0 520.3 234.3 25.7 8.4 256.6 130.6 0.0 259.5 117.2 92.3 11.0 0.6 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 2.4 17.1 0.0 0.0 1.9 0.0 4.7 0.0 1181.9 12.9 0.1 0.5 0.0 0.0 0.4 159.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 12.3 0.0 28.5 0.4 2.3 0.4 0.0 0.0 4.4 0.4 0.1 0.0 0.0 0.1 0.2 6.5 0.0 26.7 1.5 4.8 140.4 0.1 0.0 0.9 2.1 0.7 150.3 4.4 202.5 308.9 5.8 0.5 2.5 323.0 53.7 12.2 371.3 2.2 225.4 9.0 27.2 749.2 257.9 1.1 12.2 8.9 21.0 223.8 147.6 35.4 411.8 6.0 8.6 5.2 29.9 6.9 14.2 9.9 16.4 3.9 17.1 8.0 8.4 11.0 1241.9 147.4 609.1 0.0 2149.9 173.6 14.1 78.2 51.8 2.0 96.0 150.9 30.5 90.1 277.5 141.6 0.0 3.7 484.0 92.2 25.4 272.8 4.6 23.9 4.0 721.5 36.0 120.8 0.0 73.8 7.0 77.9 131.0 21.6 124.0 47.9 179.9 5.0 1417.7 0.0 0.0 92.7 30.5 1755.3 11630.1 12.3 14.9 3622.3 217.1 0.0 3104.1 7.7 55.6 0.0 0.0 89.1 308.9 26.7 120.2 21.0 1849.6 218.2 357.1 10.7 26.3 16.6 47.9 2.4 3.6 27.2 147.9 6.8 245.6 52.5 152.2 125.5 VN1R2 V1RL2 ENSG00000196131 "Vomeronasal 1 receptor 2" Q8NFZ6 19 53258292-53261837 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "Early spermatids: 15.8;Late spermatids: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044551 Uncertain NA NA "HPA044551: AB_2678982" "unprognostic (9.54e-2)" "unprognostic (3.17e-1)" "unprognostic (1.06e-1)" 0.2 0.2 0.2 0.3 0.2 0.3 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.4 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.3 0.0 0.1 0.3 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.5 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.2;pituitary gland: 5.5;retina: 8.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 17.5" HPA006303 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.2 3.5 6.2 0.2 4.2 1.1 0.1 23.2 3.9 0.0 0.0 0.2 0.8 0.1 0.2 0.0 0.2 0.1 0.1 4.1 5.4 0.1 0.2 0.1 0.1 5.1 5.9 3.0 0.1 0.6 0.3 5.5 0.1 10.4 0.1 0.2 8.3 0.0 0.1 0.0 0.1 0.3 0.1 2.7 0.2 0.6 0.7 5.7 0.1 0.6 0.0 0.1 0.1 0.0 4.8 0.0 0.1 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.7 0.3 0.1 0.3 0.0 2.4 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.2 1.7 0.0 0.1 1.8 0.1 0.9 0.0 0.5 7.6 0.2 0.2 0.0 0.1 23.1 6.0 0.0 0.2 0.1 0.3 0.1 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 2.2 0.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 4.2 23.2 3.9 4.1 5.4 5.1 5.9 3.0 10.4 2.7 5.7 4.8 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 31.9 0.1 0.0 1.2 4.3 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.1 1.6 0.2 0.0 0.4 2.4 2.7 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.2 0.5 26.9 5.8 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.9 0.0 5.0 0.0 112.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 29.0 0.0 0.4 0.1 1.6 8.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 SERPINA3 "AACT, ACT" ENSG00000196136 "Serpin family A member 3" P01011 14 94612384-94624055 "Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 9252.3;pancreas: 4951.4" "Cell type enhanced" "Detected in some" "Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 7 "Hep G2: 449.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000893, HPA002560, CAB016647" Enhanced "Secreted to blood" NA NA 697000000000 94000000000 "CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717" "prognostic favorable (8.92e-4)" "unprognostic (3.33e-3)" "unprognostic (9.21e-2)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (2.00e-2)" "unprognostic (1.00e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" "unprognostic (1.20e-2)" "unprognostic (9.92e-2)" "unprognostic (3.74e-12)" "unprognostic (6.47e-2)" "unprognostic (1.33e-2)" "unprognostic (2.02e-2)" 78.3 58.5 120.0 43.8 129.1 2.1 374.3 144.7 295.9 371.8 129.3 70.8 11.8 45.3 11.6 42.8 117.6 147.3 203.4 113.2 743.5 211.1 9252.3 171.4 5.0 225.8 161.5 94.4 183.0 4951.4 1.0 273.4 14.8 155.6 585.3 13.4 132.6 1518.1 55.4 179.2 45.4 92.4 83.9 163.0 32.0 292.9 67.5 324.8 2.6 73.2 39.3 6.4 209.2 71.0 174.9 0.2 0.5 0.0 0.3 0.2 0.8 0.3 0.1 0.1 0.0 0.0 1.2 4.9 0.6 4.5 0.0 3.3 0.9 0.0 4.4 0.0 2.7 0.0 1.0 0.2 449.9 56.9 1.9 0.7 52.0 63.9 0.0 2.5 5.4 0.0 0.0 0.3 0.2 0.0 17.1 0.5 0.5 0.8 1.6 0.0 0.6 2.2 0.2 3.8 0.2 0.1 0.0 1.8 2.5 65.6 0.4 2.4 0.0 0.6 0.0 8.5 0.1 19.4 1.1 2.0 2.1 0.4 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.0 129.1 144.7 295.9 113.2 743.5 225.8 161.5 94.4 155.6 163.0 324.8 174.9 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.5 1.8 0.0 5.6 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 20.9 3.7 0.2 0.1 0.3 0.0 0.0 0.0 33.0 0.0 68.6 9.7 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 18.7 0.0 0.4 0.3 0.5 0.0 0.1 1.5 0.0 0.0 1.7 0.8 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 445.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8" "Cancer enhanced" "Detected in all" "liver cancer: 83.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 244.0;gdT-cell: 102.6" "Group enriched" "Detected in many" 4 "granulocytes: 244.0;T-cells: 102.6" "Cell line enhanced" "Detected in many" "A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 19000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 165.9 50.6 29.4 25.6 30.5 42.7 116.2 31.1 42.7 22.1 28.6 129.0 445.3 26.1 4.4 53.6 42.4 263.5 35.9 29.2 42.7 179.3 270.2 48.7 7.6 31.1 30.8 27.7 18.0 36.7 22.7 10.5 4.8 31.3 10.4 98.9 19.3 40.8 19.6 117.9 24.8 273.1 39.5 28.2 3.8 239.6 10.1 31.5 37.8 26.6 35.1 6.7 85.5 22.3 32.8 0.1 1615.1 1.1 413.0 811.9 292.2 1.0 0.0 21.4 0.4 1.4 47.6 24.5 0.2 78.7 19.4 45.0 11.5 1.5 28.8 1.1 3.0 0.5 3.2 438.4 699.6 4.3 0.7 0.2 160.9 57.1 20.0 0.7 25.8 28.1 3.4 10.8 0.0 42.6 3.8 9.8 2.6 0.7 3025.3 4.3 3.3 9.6 43.7 149.0 639.2 1.0 2.9 232.2 0.0 0.3 0.9 0.5 0.2 221.7 5.2 4.7 87.8 3.1 0.7 0.7 0.3 45.8 62.8 4.4 244.0 2.9 4.8 102.6 0.9 6.9 0.0 19.0 18.7 2.1 0.5 11.6 8.9 7.3 21.1 1.4 39.6 21.4 42.4 29.4 30.5 31.1 42.7 29.2 42.7 31.1 30.8 27.7 31.3 28.2 31.5 32.8 144.2 44.8 5.3 4.9 4.3 12.0 3.7 393.1 2.8 2.0 15.8 5.5 3.9 0.0 172.9 36.8 0.0 0.4 64.4 133.8 43.0 114.6 3.3 67.5 4.5 67.5 19.2 34.9 2.5 722.5 0.0 44.3 158.0 66.4 5.7 0.1 0.0 0.0 1.6 1.7 3.2 65.9 61.1 0.0 14.0 4.9 78.3 14.8 21.4 7.5 4.1 132.7 202.9 14.6 0.0 266.1 219.6 106.8 3.1 1.3 576.9 601.8 112.8 5.3 26.3 15.5 20.3 0.5 4.3 20.2 10.7 0.0 14.4 7.8 196.9 46.4 SPATS2L "DNAPTP6, SGNP" ENSG00000196141 "Spermatogenesis associated serine rich 2 like" Q9NUQ6 2 200305881-200482264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 478.4;Paneth cells: 467.4;Proximal tubular cells: 568.2;Skeletal myocytes: 470.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 48.0" "Group enriched" "Detected in all" 5 "dendritic cells: 16.8;granulocytes: 48.0;T-cells: 31.6" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 475.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055427, HPA066310" Uncertain Enhanced Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA055427: AB_2682813, HPA066310: AB_2685655" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (9.35e-2)" "unprognostic (1.78e-2)" "unprognostic (4.39e-3)" "unprognostic (3.58e-2)" "unprognostic (2.17e-3)" "unprognostic (3.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (3.95e-1)" "unprognostic (7.84e-3)" "unprognostic (3.71e-2)" "unprognostic (5.67e-2)" "unprognostic (6.01e-2)" "unprognostic (2.99e-1)" 41.6 27.2 39.1 37.5 37.4 10.5 31.9 36.1 47.7 78.2 43.2 86.3 82.9 37.9 26.9 65.9 82.3 115.8 118.4 39.4 75.5 69.6 111.2 48.0 24.3 40.5 40.5 35.5 66.6 61.1 42.2 40.7 69.3 40.7 51.2 84.0 16.7 167.5 68.5 71.3 33.8 83.5 51.8 38.3 39.4 102.3 29.1 40.3 41.2 43.3 36.6 23.1 82.0 46.1 54.9 174.8 94.6 113.0 13.8 74.0 96.4 43.4 299.6 100.1 193.2 143.8 262.6 190.0 1.0 69.1 197.4 108.5 167.5 35.2 186.9 130.4 109.5 47.2 1.4 80.0 315.2 138.8 28.9 12.3 121.4 182.5 134.3 128.3 138.0 75.4 21.6 41.1 119.0 280.0 55.4 4.4 8.3 28.2 303.4 226.7 0.6 388.2 11.1 475.5 134.2 3.1 31.9 77.0 45.5 127.0 165.3 23.9 39.5 120.9 131.3 129.3 41.4 170.9 34.9 36.3 2.2 104.1 14.1 179.5 48.0 5.2 7.6 5.8 5.9 14.0 2.8 6.3 6.0 16.8 3.3 2.6 3.1 4.2 6.8 4.7 12.8 31.6 2.8 39.1 37.4 36.1 47.7 39.4 75.5 40.5 40.5 35.5 40.7 38.3 40.3 54.9 83.4 86.6 26.2 104.5 11.2 91.1 262.5 123.6 67.7 21.4 63.2 51.4 127.8 403.2 70.3 172.9 12.5 19.4 9.5 478.4 111.6 157.7 75.9 129.8 59.4 64.2 55.1 15.1 116.4 147.0 38.2 101.8 151.9 56.9 56.5 51.4 94.2 230.0 82.5 60.6 202.9 246.6 54.9 139.6 98.1 22.4 165.6 56.1 128.1 68.4 18.0 8.7 2.1 79.9 106.5 210.8 467.4 142.1 9.4 284.9 153.2 568.2 167.1 56.4 78.9 470.9 89.3 38.0 82.6 68.4 77.9 9.9 28.2 6.6 78.4 198.8 ZNF250 "MGC9718, ZFP647, ZNF647" ENSG00000196150 "Zinc finger protein 250" P15622 8 144876497-144902168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020853 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA020853: AB_1859152" "unprognostic (1.16e-3)" "unprognostic (9.56e-2)" "unprognostic (2.63e-1)" "unprognostic (2.60e-3)" "unprognostic (1.03e-1)" "unprognostic (5.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.72e-2)" "unprognostic (6.27e-2)" "unprognostic (7.37e-2)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.43e-7)" "unprognostic (2.23e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-2)" "prognostic favorable (8.26e-4)" 4.7 3.9 3.1 3.4 3.1 3.0 5.6 10.3 4.7 9.8 2.1 6.3 4.8 7.4 2.8 6.4 7.6 3.4 4.9 2.5 3.7 7.7 4.0 5.1 3.1 3.0 2.9 2.6 9.8 4.9 6.0 7.3 5.5 5.0 7.6 3.7 7.9 6.1 5.2 4.8 10.3 5.2 4.2 1.3 5.5 4.9 4.5 3.0 4.5 10.1 5.8 3.4 6.3 8.7 3.9 5.1 2.9 13.4 11.1 6.8 5.9 4.3 5.6 6.4 9.4 7.7 2.4 3.9 12.0 9.8 6.5 3.8 6.6 5.3 4.8 6.0 3.8 7.8 10.8 14.9 3.5 2.0 1.8 3.6 3.9 6.5 5.6 4.5 7.2 3.9 7.1 8.6 11.5 7.9 6.8 12.6 4.1 4.0 6.0 12.5 14.4 5.9 5.0 7.8 3.7 13.2 10.1 11.8 4.4 5.3 5.3 6.3 6.1 5.1 9.2 8.8 7.3 5.3 5.6 5.1 8.0 4.7 6.2 4.1 3.2 5.1 5.8 10.5 2.7 8.1 10.3 7.7 5.8 6.6 9.7 8.9 7.3 2.9 6.0 3.7 2.6 11.7 4.5 3.1 3.1 10.3 4.7 2.5 3.7 3.0 2.9 2.6 5.0 1.3 3.0 3.9 5.8 12.8 3.0 10.7 10.7 5.5 3.2 7.5 10.2 8.4 4.3 6.6 4.3 1.5 3.9 5.5 0.0 2.3 18.6 2.4 3.9 7.5 7.4 5.1 6.0 5.5 4.2 1.7 11.9 1.9 1.3 5.2 2.6 4.9 2.5 6.3 5.0 2.1 1.7 8.4 17.5 1.9 12.2 2.2 8.0 3.0 4.1 3.0 5.4 4.7 2.0 3.3 5.2 11.1 7.8 2.6 1.0 5.3 8.2 3.3 3.7 3.4 5.0 9.9 13.1 4.1 6.1 14.3 8.7 4.4 5.5 1.9 10.9 4.9 3.4 2.3 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235798-159286703 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: AB_2683628" "unprognostic (1.37e-2)" "prognostic favorable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 6.8 11.0 9.8 4.6 10.7 10.7 12.1 11.3 12.1 7.8 11.7 6.8 5.0 8.2 17.7 7.5 9.8 5.9 10.2 9.5 9.8 23.8 7.0 9.1 7.9 10.2 10.3 9.7 13.6 10.7 14.0 9.1 9.8 10.8 9.2 7.7 11.2 10.5 6.8 6.7 7.0 5.8 6.7 9.6 8.6 7.5 6.8 10.1 7.1 17.5 6.5 5.9 6.2 6.3 12.3 8.4 6.3 5.4 9.0 10.1 11.4 19.1 6.7 13.0 11.4 20.4 13.7 13.6 11.7 6.9 9.9 20.3 5.2 15.9 5.9 16.1 4.5 13.4 12.1 6.8 14.0 12.2 10.2 15.6 6.7 21.5 14.4 12.0 22.2 9.8 14.9 16.0 8.5 11.1 8.8 7.3 18.5 7.5 14.3 13.6 11.3 8.3 6.2 13.6 12.2 10.3 6.8 7.0 8.6 15.9 26.0 6.7 17.3 4.1 8.2 6.2 11.8 6.5 4.2 7.7 10.7 14.4 12.6 5.3 3.9 11.1 3.5 14.3 8.6 10.9 11.8 5.6 9.1 12.2 9.9 6.7 8.0 0.8 20.8 7.9 11.6 3.3 7.8 9.8 10.7 11.3 12.1 9.5 9.8 10.2 10.3 9.7 10.8 9.6 10.1 12.3 8.2 12.8 6.8 28.4 10.7 5.4 8.7 13.0 11.4 6.9 9.3 8.0 11.3 10.0 11.3 20.2 2.1 25.4 11.2 5.1 35.2 9.5 4.5 13.7 6.9 7.0 5.4 6.7 42.4 3.6 9.2 9.9 10.2 16.1 12.0 13.2 6.4 2.0 17.3 5.0 52.0 4.5 12.2 14.8 4.8 2.9 12.8 10.2 5.4 29.0 9.2 6.6 14.4 31.7 34.6 4.0 7.0 11.3 3.8 6.8 6.9 23.7 15.0 9.7 0.0 12.0 7.8 10.1 22.5 11.1 6.3 23.0 9.1 12.7 7.1 7.3 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 5.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favorable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favorable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favorable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 2.5 3.6 2.3 3.3 3.0 3.4 3.6 5.8 2.6 3.1 2.5 3.2 2.6 3.5 4.5 2.9 4.1 2.0 3.2 2.2 2.1 2.9 3.3 2.9 4.2 2.5 2.3 1.7 3.9 3.0 4.9 2.6 3.1 3.1 3.6 3.6 3.2 3.4 3.5 4.7 3.6 2.8 3.7 1.9 3.7 3.0 6.2 2.5 5.6 3.8 5.3 4.8 4.3 2.2 3.2 2.5 5.0 6.5 3.9 7.1 4.2 18.2 6.1 7.4 7.2 8.2 5.3 2.3 5.4 2.4 4.6 9.5 7.7 4.9 7.5 5.7 5.4 3.2 3.7 8.4 6.0 8.4 8.9 5.7 4.2 8.3 8.9 7.2 4.6 7.5 6.1 6.4 7.9 6.9 5.5 7.0 3.3 5.2 6.2 6.4 5.7 9.0 7.7 3.1 3.6 7.4 5.0 11.7 5.9 3.5 5.6 7.9 5.0 5.3 4.6 4.2 4.6 4.8 10.5 24.1 6.8 5.9 2.7 7.8 2.2 3.3 5.1 6.0 4.1 6.7 5.1 3.9 7.6 4.7 5.8 5.2 5.7 4.5 7.2 2.8 4.9 5.5 3.6 2.3 3.0 5.8 2.6 2.2 2.1 2.5 2.3 1.7 3.1 1.9 2.5 3.2 0.8 0.0 0.5 2.6 2.4 1.5 1.2 0.8 1.8 0.8 1.0 0.9 2.5 2.8 1.7 0.0 0.0 2.0 0.9 0.9 1.9 2.0 4.5 0.4 1.9 1.1 0.0 4.8 3.1 0.6 0.6 1.2 2.6 0.5 0.0 1.1 1.1 1.2 2.1 1.7 3.2 0.5 0.0 0.8 1.2 4.7 0.6 0.6 0.0 1.0 0.1 0.9 2.1 4.0 2.9 0.5 0.3 1.9 3.0 0.7 0.9 1.0 0.7 1.2 0.0 0.4 1.3 5.8 1.6 2.3 1.0 2.6 1.5 1.3 1.1 0.9 S100A4 "18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98" ENSG00000196154 "S100 calcium binding protein A4" P26447 1 153543613-153550136 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1100.2" "Cell type enhanced" "Detected in many" "Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "spinal cord: 39.6" "CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 9600000 "Nucleoplasm, Cytosol" "CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858" "unprognostic (1.56e-1)" "unprognostic (6.10e-2)" "unprognostic (2.84e-2)" "unprognostic (8.20e-2)" "unprognostic (6.21e-2)" "prognostic favorable (4.03e-5)" "unprognostic (8.35e-2)" "unprognostic (4.81e-2)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "unprognostic (2.78e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.05e-1)" "unprognostic (3.05e-1)" "unprognostic (2.76e-2)" "unprognostic (3.16e-2)" 764.0 77.7 24.2 357.1 24.7 1100.2 566.7 26.5 53.6 571.1 39.9 265.8 92.5 179.3 125.6 226.1 219.5 169.1 232.6 23.4 31.0 122.3 64.8 881.8 222.9 30.6 25.9 23.0 51.4 54.2 18.2 25.0 184.5 28.6 225.7 334.7 10.1 247.4 157.2 164.6 338.0 236.2 300.3 29.1 446.6 134.5 32.5 30.1 113.6 193.5 428.4 318.0 395.3 459.1 29.9 11.8 2614.3 13.2 77.0 3300.1 2410.9 3.7 1664.4 6738.6 32.1 148.4 20.0 180.3 0.8 299.7 4819.1 3.5 65.3 8.8 20.9 23.6 405.2 2.3 1186.8 529.0 59.4 4.3 106.9 1924.6 364.2 21.5 62.2 13.0 4.9 2.6 0.7 9.9 4.2 2468.1 10.6 3.8 1273.9 7.2 189.7 1050.4 64.1 3.7 2700.2 103.5 71.3 108.5 11.6 24.9 1286.6 9.4 412.5 77.1 1493.7 3.1 8.5 13.7 2159.5 9.3 82.8 647.5 14.3 6.1 1367.9 127.2 2789.7 13536.2 1408.0 5800.5 9099.6 6077.0 761.6 5167.7 4700.0 9268.4 282.5 882.4 2641.3 12129.7 837.1 11862.4 1626.0 7406.7 24075.8 24.2 24.7 26.5 53.6 23.4 31.0 30.6 25.9 23.0 28.6 29.1 30.1 29.9 226.0 490.4 398.4 0.0 266.1 772.9 19.5 159.0 93.9 0.7 44.9 65.9 14.9 35.8 273.8 893.8 0.0 52.4 1345.4 8.9 111.6 21.9 7.3 53.0 473.0 209.1 4.8 730.9 0.0 23.5 255.5 1378.8 54.0 41.9 1395.8 0.6 96.4 18.6 1966.1 45.4 0.0 10.0 345.8 2708.8 5952.7 24.0 235.8 2786.0 1193.5 12.2 3172.6 3.6 2130.8 0.0 0.1 35.7 17.0 45.9 266.5 12.9 3.2 19.7 154.9 2.3 151.2 2034.0 1309.6 1.9 5.5 77.6 694.0 53.4 2111.1 32.5 11.3 73.1 PLEKHG4 "ARHGEF44, DKFZP434I216, SCA4" ENSG00000196155 "Pleckstrin homology and RhoGEF domain containing G4" Q58EX7 16 67277510-67289499 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 42.6" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 13.6;Granulosa cells: 13.3;Spermatocytes: 33.2;Spermatogonia: 21.5;Theca cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.3" "Not detected" "Not detected" HPA055696 Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055696: AB_2682889" "unprognostic (2.63e-1)" "unprognostic (1.98e-3)" "unprognostic (1.16e-1)" "unprognostic (9.90e-2)" "unprognostic (3.40e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-1)" "unprognostic (7.88e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-3)" "unprognostic (4.48e-2)" "unprognostic (7.92e-2)" "prognostic unfavorable (6.72e-9)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (9.35e-3)" "unprognostic (5.01e-2)" 6.5 4.7 1.6 3.2 2.3 1.6 9.6 2.3 2.0 6.2 1.2 4.4 4.2 6.0 1.2 4.8 4.1 4.4 1.2 1.5 2.0 2.5 0.4 4.6 4.4 2.6 2.5 1.0 17.5 5.8 1.8 3.3 5.1 2.5 2.9 3.0 1.8 6.1 1.8 1.7 9.0 4.4 3.0 2.3 8.5 2.7 42.6 2.3 4.2 4.4 1.9 3.0 3.2 5.7 3.6 6.1 11.4 0.7 6.7 5.7 53.7 8.7 13.9 18.6 13.8 22.7 32.9 5.4 17.1 39.5 13.0 4.7 0.2 8.4 0.8 9.9 3.0 4.5 33.8 30.8 8.2 17.5 20.3 26.2 40.5 6.6 46.3 0.5 11.6 27.5 54.6 27.6 0.4 0.2 4.7 26.0 6.8 5.1 5.0 12.0 0.1 0.1 17.6 6.5 1.4 3.6 20.4 46.9 3.6 19.7 2.1 2.6 14.4 41.9 6.7 24.0 48.8 0.4 39.3 43.0 16.3 27.8 0.6 8.4 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.2 0.3 0.1 0.0 0.5 0.3 0.0 0.1 0.1 1.1 0.4 0.3 1.6 2.3 2.3 2.0 1.5 2.0 2.6 2.5 1.0 2.5 2.3 2.3 3.6 2.7 3.2 2.6 1.0 0.7 2.8 0.6 0.9 3.4 0.8 9.5 13.6 4.2 1.5 3.3 1.8 0.0 0.4 3.1 1.5 0.0 0.9 1.4 0.6 4.1 1.9 1.2 0.8 0.6 0.4 0.4 6.6 1.1 0.6 3.8 13.3 1.4 0.1 0.8 0.0 0.9 2.7 0.0 1.0 0.5 2.7 6.2 0.9 0.0 3.7 0.2 3.2 1.0 0.0 3.6 1.1 2.5 1.5 0.6 1.2 1.2 0.1 1.0 6.5 6.6 4.0 2.4 33.2 21.5 2.0 1.3 0.3 2.7 17.6 4.1 0.5 KRTAP4-3 KAP4.3 ENSG00000196156 "Keratin associated protein 4-3" Q9BYR4 17 41167231-41168221 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 116 "skin 1: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HDLM-2: 1.1" "Not detected" "Not detected" NA NA 1400000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FAT4 "CDHF14, CDHR11, FAT-J" ENSG00000196159 "FAT atypical cadherin 4" Q6V0I7 4 125314918-125492932 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Endothelial cells: 18.0;Fibroblasts: 17.9;Hepatic stellate cells: 33.2;Inhibitory neurons: 35.0;Microglial cells: 23.4;Oligodendrocytes: 54.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.5;ASC TERT1: 11.2;fHDF/TERT166: 11.4;HSkMC: 13.6;HUVEC TERT2: 14.3;TIME: 21.9" "Low region specificity" "Detected in many" HPA052819 Approved Approved Cytosol NA NA 2300000 Cytosol "HPA052819: AB_2681963" "unprognostic (1.18e-1)" "unprognostic (1.77e-1)" "unprognostic (7.99e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (2.81e-4)" "unprognostic (6.17e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (2.78e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.89e-4)" "unprognostic (2.38e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-3)" 3.1 1.0 3.2 1.4 3.6 0.0 2.8 1.1 2.5 4.1 2.5 4.8 0.9 3.0 1.3 2.3 1.9 4.4 3.9 3.8 2.2 2.8 2.5 4.6 0.8 3.0 2.4 1.5 5.0 0.9 3.0 0.6 2.9 2.7 3.7 2.3 0.5 1.1 2.6 1.6 1.2 2.2 3.5 2.3 2.7 2.0 0.7 2.9 1.1 4.0 4.8 0.8 2.5 1.8 4.9 0.0 0.9 7.4 0.8 15.5 11.2 0.0 2.6 3.0 1.2 1.2 0.0 0.4 0.0 3.1 11.4 1.5 0.0 2.8 3.2 0.7 0.0 1.3 1.7 3.3 0.1 5.4 1.1 0.0 13.6 1.9 0.7 7.0 9.1 14.3 0.0 0.0 1.9 6.7 0.1 0.5 0.0 0.5 0.0 0.3 0.9 1.5 0.0 0.1 0.0 0.2 1.5 0.4 0.0 0.0 0.4 0.0 0.0 21.9 7.8 2.2 2.7 1.1 0.3 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 3.6 1.1 2.5 3.8 2.2 3.0 2.4 1.5 2.7 2.3 2.9 4.9 19.3 6.4 0.0 8.8 0.0 1.7 0.2 1.5 0.0 3.7 0.3 1.3 6.9 0.0 0.3 5.5 0.0 0.1 0.9 0.0 0.0 0.7 0.9 0.6 8.8 18.0 0.0 0.0 9.4 0.2 0.0 17.9 1.1 1.0 0.0 1.2 33.2 7.4 0.2 0.0 35.0 0.0 0.0 2.2 2.2 0.2 5.9 0.3 3.6 23.4 0.0 1.1 1.0 6.0 54.4 0.3 0.0 4.9 1.4 0.4 0.0 0.7 0.1 0.2 0.0 5.3 4.1 0.1 0.6 0.5 0.6 0.0 0.3 5.7 0.0 0.1 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9;fallopian tube: 12.1;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 44.4;Enteroendocrine cells: 23.8;Hepatic stellate cells: 15.4;Intestinal goblet cells: 14.1;Plasma cells: 15.6;Respiratory ciliated cells: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: AB_2686593" "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.3 0.1 7.2 0.4 9.8 0.2 1.2 4.3 11.4 1.9 3.6 1.2 3.0 0.3 0.0 0.5 12.1 0.4 0.3 6.9 7.3 0.2 0.9 1.9 0.1 11.7 8.5 5.7 0.2 1.1 0.0 0.3 0.0 10.8 0.9 0.7 0.1 1.0 0.2 0.4 0.5 2.3 0.4 6.1 13.6 0.7 0.6 8.3 1.0 1.9 0.6 0.1 1.6 1.5 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.3 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.4 7.2 9.8 4.3 11.4 6.9 7.3 11.7 8.5 5.7 10.8 6.1 8.3 16.9 1.3 0.0 0.0 2.0 1.3 0.0 0.4 2.5 0.0 1.1 0.1 0.0 1.6 0.0 6.3 0.0 0.0 0.0 3.5 0.8 0.0 0.0 0.5 44.4 0.2 4.2 23.8 0.4 0.0 0.0 3.1 1.0 1.1 0.7 0.0 0.0 15.4 0.1 0.1 0.0 0.1 14.1 4.1 0.6 1.6 0.3 0.0 0.3 3.6 0.0 0.1 5.7 3.1 4.0 3.7 0.0 0.1 0.0 15.6 0.3 0.2 0.0 57.6 0.3 0.0 1.8 1.3 0.2 1.6 0.0 0.1 0.0 2.5 0.2 1.9 0.2 OR6K2 ENSG00000196171 "Olfactory receptor family 6 subfamily K member 2" Q8NGY2 1 158699678-158700652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF681 FLJ31526 ENSG00000196172 "Zinc finger protein 681" Q96N22 19 23739195-23758891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 13.2;Spermatogonia: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 16.2;RPMI-8226: 10.7" NA NA "unprognostic (1.48e-1)" "unprognostic (4.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (6.22e-2)" "unprognostic (1.01e-1)" "unprognostic (2.45e-3)" "unprognostic (8.55e-2)" "unprognostic (1.61e-2)" "unprognostic (5.24e-2)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (7.98e-2)" "unprognostic (2.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.55e-2)" 0.6 1.3 0.6 0.9 0.8 0.7 2.0 2.2 1.0 1.4 0.1 1.6 1.0 1.1 1.6 1.9 1.3 0.7 0.5 0.8 1.2 0.7 0.2 0.9 2.8 0.8 0.8 0.6 2.0 1.9 0.9 0.4 1.1 1.1 1.1 1.9 0.9 0.6 0.7 0.1 2.2 0.7 0.8 0.4 1.9 1.0 2.5 1.0 3.9 1.9 0.2 2.2 1.6 1.0 1.5 0.8 0.0 5.0 9.7 0.3 0.0 2.7 0.6 0.1 1.5 1.6 1.4 2.6 1.3 4.5 0.9 2.2 2.4 4.6 0.2 2.5 16.2 1.7 2.5 0.0 0.0 0.7 0.0 0.6 1.1 0.9 0.6 0.6 0.3 0.0 3.5 7.0 0.0 2.6 2.2 8.8 2.2 7.2 0.1 2.2 6.8 3.5 10.7 1.3 4.9 0.4 5.1 0.0 0.0 0.8 6.9 5.3 0.4 0.0 1.0 0.1 3.1 3.6 0.0 9.7 7.9 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 1.6 1.2 1.8 1.5 0.6 2.1 3.6 3.2 0.2 0.9 0.2 0.9 2.0 0.8 0.6 0.8 2.2 1.0 0.8 1.2 0.8 0.8 0.6 1.1 0.4 1.0 1.5 2.9 3.2 0.0 3.3 5.8 1.1 1.2 0.2 1.8 3.4 4.0 4.6 1.1 2.8 3.4 1.8 0.0 3.6 3.8 3.9 1.9 1.9 9.7 1.9 3.6 2.6 2.4 2.5 5.9 2.3 4.2 2.5 1.5 2.8 0.0 9.1 1.4 0.0 2.4 1.7 7.4 2.5 0.0 2.6 0.8 5.2 0.6 1.3 1.8 2.8 1.1 2.7 11.3 12.1 5.4 1.2 1.9 3.0 0.6 1.1 0.4 1.8 5.4 1.2 0.0 1.9 2.1 13.2 16.7 3.3 1.3 3.7 3.8 4.9 2.2 1.1 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058290 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 363.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 499.5;Proximal tubular cells: 137.9" "Cancer enhanced" "Detected in all" "liver cancer: 32.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041458, HPA063555" Enhanced Supported Mitochondria NA NA 37000 Mitochondria "HPA041458: AB_2677491, HPA063555: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favorable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favorable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 14.9 27.7 7.9 7.2 8.7 3.8 24.1 14.1 10.5 7.5 11.0 16.0 52.8 10.0 7.8 12.8 9.8 7.7 38.8 8.3 7.5 91.1 363.0 12.8 8.3 7.0 8.0 7.9 12.9 15.9 33.7 8.8 5.1 8.2 22.9 17.0 12.5 15.9 11.3 42.7 9.8 11.1 8.5 4.2 6.4 14.1 8.4 7.1 7.5 12.4 69.7 10.4 10.9 8.2 8.6 15.4 10.9 7.9 14.5 10.6 13.1 7.0 9.3 18.8 9.2 9.1 9.6 4.9 16.0 6.3 7.9 5.6 6.3 12.5 6.5 15.1 10.6 12.9 8.3 3.3 54.8 7.5 12.0 7.6 9.7 6.5 5.8 5.3 13.5 9.0 13.2 8.1 11.5 11.5 7.1 11.4 9.8 4.8 8.5 6.7 13.4 16.6 5.1 13.1 16.9 1.4 9.1 14.3 4.2 14.4 7.5 12.9 5.8 9.5 4.9 4.4 11.4 11.4 12.9 15.5 8.5 7.6 11.1 3.8 17.4 4.5 11.8 8.8 4.7 10.2 5.5 8.1 7.6 6.4 5.7 7.4 8.3 2.9 8.5 2.9 3.8 7.1 5.7 7.9 8.7 14.1 10.5 8.3 7.5 7.0 8.0 7.9 8.2 4.2 7.1 8.6 7.7 28.9 53.1 29.4 11.6 9.3 9.2 8.2 14.2 17.4 58.6 27.8 80.7 37.1 21.1 11.0 10.4 20.1 8.7 11.2 46.9 7.3 7.0 6.8 9.1 8.2 12.1 21.4 39.8 4.8 3.5 10.6 10.7 18.8 3.8 29.1 15.4 499.5 7.3 21.9 49.6 13.7 26.4 17.4 5.9 8.1 13.4 7.1 7.2 12.2 7.9 12.0 7.2 15.6 38.3 4.6 13.1 10.9 9.1 19.8 9.2 137.9 15.2 7.7 19.7 12.3 11.0 8.5 3.7 14.7 13.8 30.1 13.3 18.9 18.3 12.0 STK40 "MGC4796, SgK495" ENSG00000196182 "Serine/threonine kinase 40" Q8N2I9 1 36339624-36385924 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 116.7;Late spermatids: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 25.2" "Group enriched" "Detected in all" 5 "granulocytes: 25.2;monocytes: 12.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008026 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA008026: AB_1857603" "unprognostic (3.32e-1)" "unprognostic (3.00e-1)" "unprognostic (6.47e-2)" "unprognostic (4.55e-1)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (2.69e-3)" "unprognostic (6.09e-2)" "unprognostic (2.09e-1)" "unprognostic (5.96e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.19e-1)" "unprognostic (2.75e-2)" "unprognostic (7.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" 33.6 15.6 19.8 23.3 16.4 15.3 24.8 15.3 20.0 23.7 12.9 38.6 13.6 23.8 8.1 44.2 24.9 20.6 42.0 15.8 26.9 33.7 45.6 36.7 24.5 23.7 17.3 13.5 40.6 46.1 21.9 30.3 13.6 20.3 28.7 12.8 7.5 32.2 23.3 126.3 38.6 23.9 20.2 19.1 35.7 35.8 53.0 19.2 15.8 25.5 40.0 21.5 42.1 26.9 24.9 17.4 7.4 36.6 38.3 25.3 14.7 20.5 17.2 23.1 20.3 21.8 41.3 24.2 73.0 13.8 16.1 21.5 17.1 33.5 7.4 14.9 32.0 26.4 47.7 7.5 53.3 25.1 28.1 60.9 13.3 27.7 15.6 8.2 10.9 12.9 55.2 59.7 25.7 12.9 27.0 29.3 37.1 23.5 31.2 10.2 33.3 24.9 49.1 12.7 19.2 44.6 22.7 13.2 20.5 58.5 23.1 13.9 32.7 21.6 12.7 26.5 37.7 38.3 26.6 16.2 61.3 66.3 24.3 42.8 1.2 3.8 6.8 3.1 8.6 3.6 2.8 2.1 2.2 3.5 2.9 1.2 1.8 25.2 2.1 12.0 3.3 1.3 3.5 19.8 16.4 15.3 20.0 15.8 26.9 23.7 17.3 13.5 20.3 19.1 19.2 24.9 10.7 12.8 15.3 11.8 22.0 61.3 54.0 9.4 16.5 11.8 28.3 15.4 25.3 8.6 11.1 11.0 4.2 6.5 15.8 34.8 17.6 21.2 116.7 23.9 11.2 15.2 23.4 7.8 24.8 31.6 10.7 19.2 33.1 36.5 13.3 4.9 14.3 23.7 24.7 10.1 17.3 15.5 12.2 23.3 69.5 236.8 23.0 32.2 30.2 21.5 19.2 4.9 18.6 7.5 12.3 28.5 16.3 33.4 17.0 57.1 6.2 14.9 25.6 10.5 26.3 20.6 18.6 14.9 11.1 28.7 75.4 57.2 17.3 17.6 15.1 51.3 OR10J1 "HGMP07J, HSHGMP07J" ENSG00000196184 "Olfactory receptor family 10 subfamily J member 1" P30954 1 159437845-159443078 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 7.1" "Group enriched" "Detected in some" 45 "Early spermatids: 47.4;Late spermatids: 51.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 51.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882380 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 353.4;salivary gland: 122.1" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 112.2;SK-BR-3: 119.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057" "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favorable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 23.3 18.1 43.8 27.3 132.7 43.1 29.3 108.8 99.0 30.4 10.8 30.4 26.5 26.0 22.9 15.3 28.4 27.6 20.9 48.6 86.3 32.9 40.6 31.5 35.9 159.4 118.7 24.0 28.6 57.2 18.0 11.9 24.4 199.4 58.1 37.3 3.7 122.1 37.6 16.7 21.6 34.8 18.3 103.7 31.9 48.1 5.3 107.4 28.0 19.1 13.8 27.2 26.6 23.4 353.4 27.6 8.3 7.0 20.2 54.1 18.7 47.7 20.6 22.2 22.5 22.6 29.7 20.0 7.7 37.1 25.2 13.3 41.4 7.5 12.5 10.3 25.8 13.4 33.4 21.0 18.0 12.6 12.5 84.1 19.5 7.8 13.5 8.1 31.1 14.8 17.0 28.2 6.3 18.0 17.4 11.2 12.7 37.8 87.5 13.2 11.1 21.3 112.2 34.1 71.8 0.6 3.7 15.2 119.3 14.5 16.0 27.7 11.9 17.8 12.9 8.9 12.1 18.9 2.5 10.4 2.0 11.9 7.0 24.3 6.3 3.9 3.6 10.3 3.1 11.4 5.8 13.1 9.8 2.9 5.5 11.4 6.9 5.5 10.2 5.3 11.5 19.8 6.9 43.8 132.7 108.8 99.0 48.6 86.3 159.4 118.7 24.0 199.4 103.7 107.4 353.4 11.0 6.4 9.2 45.7 23.3 3.3 24.9 5.7 2.2 0.8 30.0 16.8 6.5 34.3 14.0 20.2 2.1 38.7 37.0 34.7 1.9 36.3 9.1 43.1 10.6 8.6 19.2 6.3 1.0 25.5 6.6 8.9 48.9 49.8 17.2 44.8 10.8 22.2 16.7 0.0 1.7 35.0 24.4 11.7 5.3 13.5 18.3 14.2 3.6 26.2 10.4 12.9 40.2 5.5 323.2 18.4 29.0 13.2 9.1 41.6 13.0 14.8 23.1 1.8 26.3 8.8 10.8 0.6 5.3 4.2 4.1 22.4 23.3 7.2 57.6 35.1 CTSE ENSG00000196188 "Cathepsin E" P14091 1 206008535-206023909 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "stomach 1: 1178.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 105.8;Exocrine glandular cells: 262.8;Gastric mucus-secreting cells: 553.5;Pancreatic endocrine cells: 260.0;Paneth cells: 208.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 297.4;stomach cancer: 200.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 46 "OE19: 1799.1" "Not detected" "Not detected" "HPA012674, HPA012940, CAB032687" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "CAB032687: AB_637901, HPA012674: , HPA012940: AB_2668773" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-2)" "unprognostic (2.72e-2)" "unprognostic (1.35e-2)" "unprognostic (2.52e-3)" "unprognostic (1.45e-1)" "unprognostic (3.29e-2)" "unprognostic (2.87e-2)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "unprognostic (6.37e-3)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (2.61e-2)" "prognostic favorable (5.26e-5)" 0.1 0.0 0.2 9.6 0.1 30.3 0.1 0.4 0.3 0.0 0.1 15.5 231.9 0.3 1.7 0.8 1.2 15.1 0.2 0.1 0.1 0.2 0.2 50.2 0.5 0.3 0.1 0.1 0.1 3.7 0.0 1.2 1.3 0.3 0.2 26.0 0.1 0.0 1.6 0.0 0.1 56.0 0.3 0.1 0.6 1178.9 0.1 0.2 0.5 9.0 0.0 10.8 5.8 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.8 0.8 0.0 3.8 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 2.4 0.0 1.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.8 1.5 0.7 1799.1 0.1 0.4 0.0 0.8 0.7 39.4 0.2 0.5 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.6 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.4 0.3 0.1 0.1 0.3 0.1 0.1 0.3 0.1 0.2 0.5 0.0 105.8 27.9 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.5 10.0 42.3 0.0 0.0 0.0 0.0 34.1 0.0 52.0 0.0 0.3 0.0 0.3 2.4 60.6 0.0 262.8 0.1 14.7 553.5 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 21.1 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.0 0.0 0.0 0.1 260.0 208.9 0.0 0.7 0.1 4.0 0.1 7.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 10.4 0.4 SEMA4A "CORD10, FLJ12287, SEMAB, SemB" ENSG00000196189 "Semaphorin 4A" Q9H3S1 1 156147366-156177752 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis" "Developmental protein" "Cone-rod dystrophy, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 51.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 63.7;Plasma cells: 61.2;Skeletal myocytes: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 123.9;eosinophil: 120.2;intermediate monocyte: 132.7;myeloid DC: 183.0;neutrophil: 210.7;non-classical monocyte: 76.1" "Group enriched" "Detected in all" 13 "dendritic cells: 183.0;granulocytes: 210.7;monocytes: 132.7" "Cell line enhanced" "Detected in many" "Karpas-707: 151.8;U-698: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069136 Supported NA NA 3300000 "HPA069136: AB_2686093" "unprognostic (1.90e-1)" "unprognostic (2.39e-2)" "unprognostic (4.24e-1)" "unprognostic (5.20e-2)" "unprognostic (8.04e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (3.51e-1)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (8.20e-4)" "unprognostic (8.77e-2)" "unprognostic (4.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.28e-2)" 6.2 1.0 22.5 25.1 21.4 37.9 9.2 5.8 23.4 8.0 4.2 6.9 3.6 3.0 51.7 32.8 8.0 8.9 2.5 25.2 17.2 11.7 2.1 15.3 31.8 14.1 15.4 21.5 5.3 4.0 1.5 3.6 1.8 14.8 16.5 6.2 2.0 19.4 12.7 3.1 32.5 4.9 3.7 9.0 27.1 10.7 4.2 23.0 8.2 23.3 2.2 33.4 10.9 17.5 15.4 12.6 0.0 0.5 0.0 0.0 0.9 0.3 0.2 0.4 0.1 0.2 0.1 0.3 8.1 0.3 0.6 0.1 11.7 0.9 10.0 0.4 3.5 0.0 0.4 0.2 0.4 0.4 18.5 1.1 0.6 9.2 0.2 0.4 2.3 0.9 2.8 1.3 151.8 0.5 15.2 0.1 6.5 3.6 12.4 0.0 0.6 0.3 5.4 17.9 24.1 0.1 0.3 0.0 19.2 1.0 1.7 22.3 23.3 0.9 0.0 0.1 0.0 0.0 29.3 3.0 67.6 0.5 17.5 0.4 16.0 123.9 120.2 4.0 132.7 8.5 13.2 1.3 8.0 183.0 10.9 0.2 1.3 210.7 4.3 76.1 25.7 1.4 66.4 22.5 21.4 5.8 23.4 25.2 17.2 14.1 15.4 21.5 14.8 9.0 23.0 15.4 13.6 19.2 63.7 25.8 13.9 23.5 22.5 25.8 24.5 1.9 28.3 27.6 5.9 14.3 13.8 40.5 0.0 0.9 9.8 6.5 1.9 6.1 6.4 12.9 21.6 9.5 3.6 1.3 7.5 0.7 0.4 20.9 22.4 33.5 17.7 0.6 9.3 0.6 15.4 0.0 5.2 24.1 8.2 22.8 42.1 4.3 1.8 37.8 16.0 1.0 32.6 6.3 2.1 1.0 1.0 1.1 7.2 1.2 61.2 14.2 0.8 0.7 9.6 0.4 0.0 100.1 11.3 3.1 0.7 39.0 27.6 1.8 10.0 1.4 17.6 15.6 HRCT1 "LGLL338, PRO537, UNQ338" ENSG00000196196 "Histidine rich carboxyl terminus 1" Q6UXD1 9 35906202-35907136 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.9;breast: 25.1" "Cell type enhanced" "Detected in many" "Adipocytes: 72.4;Distal enterocytes: 232.3;Intestinal goblet cells: 57.8;Paneth cells: 316.5;Proximal enterocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 18.0;HBEC3-KT: 10.3;HeLa: 15.9;Hep G2: 11.7;U-2197: 27.0;U-251 MG: 13.1" "Low region specificity" "Detected in some" HPA067038 Approved Nucleoplasm NA NA Nucleoplasm "HPA067038: AB_2685767" "unprognostic (2.48e-2)" "unprognostic (4.88e-2)" "unprognostic (2.43e-2)" "unprognostic (2.49e-1)" "unprognostic (5.69e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.63e-2)" "unprognostic (2.53e-2)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-1)" "unprognostic (2.00e-1)" "unprognostic (9.41e-2)" "unprognostic (2.80e-1)" "unprognostic (9.43e-2)" 23.9 1.8 3.6 1.9 3.8 0.0 25.1 3.3 4.9 4.0 2.9 14.8 9.0 6.1 1.0 1.8 5.5 0.3 7.9 3.6 3.2 7.2 1.6 4.9 0.6 4.2 4.4 2.9 2.7 1.3 0.6 1.2 2.9 4.1 4.7 11.9 1.1 6.7 2.8 5.5 5.4 11.1 1.8 3.3 0.8 3.7 2.4 3.7 0.1 4.9 3.8 0.2 7.5 4.4 3.3 0.4 0.2 0.0 0.2 0.8 5.9 0.0 0.2 0.5 0.1 0.0 0.2 1.7 0.0 18.0 0.4 3.4 0.0 0.0 10.3 0.0 0.0 0.0 0.0 15.9 11.7 2.3 0.0 0.0 5.8 5.2 2.0 1.2 0.8 6.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 4.8 2.4 0.0 0.3 0.1 3.4 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.2 5.3 0.2 5.3 27.0 13.1 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.8 3.3 4.9 3.6 3.2 4.2 4.4 2.9 4.1 3.3 3.7 3.3 72.4 6.4 1.5 0.3 0.3 2.2 0.4 0.4 0.6 2.0 2.4 11.0 1.2 4.3 2.1 0.0 0.0 23.3 0.5 232.3 1.9 1.9 0.1 2.1 0.4 40.8 1.2 0.0 0.4 0.2 6.2 7.4 0.0 0.8 0.0 1.0 50.7 0.6 1.8 0.0 0.2 57.8 0.0 0.9 2.0 0.5 10.8 0.4 1.8 0.0 0.0 10.8 0.0 0.0 0.1 4.6 316.5 9.4 0.0 0.8 64.6 13.0 0.9 2.5 13.1 3.5 4.7 0.1 0.2 0.1 1.8 2.6 0.6 0.3 24.0 0.4 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633659-19673441 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 28.2 32.8 35.5 30.2 34.0 28.1 28.9 38.6 49.1 38.6 33.8 35.4 22.7 36.5 31.9 23.6 34.3 23.6 36.4 34.8 35.1 23.1 21.2 29.0 39.5 34.7 35.2 31.5 51.9 28.4 26.5 31.8 25.6 34.9 31.4 24.7 37.2 32.6 31.5 23.6 33.9 33.6 26.8 30.0 40.2 28.6 21.7 36.0 23.4 33.2 18.7 26.6 32.5 32.0 39.8 26.0 16.4 23.9 39.0 30.3 38.2 42.2 38.2 27.5 23.6 20.1 25.1 44.5 40.8 29.7 23.1 36.6 42.2 44.4 26.7 30.2 51.1 22.7 65.7 27.8 30.8 27.0 47.8 51.4 22.8 33.8 18.6 26.1 35.8 31.6 32.5 32.5 25.5 22.2 25.1 36.8 39.9 23.4 48.0 18.1 29.3 55.2 32.6 40.7 19.8 32.7 20.0 35.7 32.3 35.3 39.8 19.7 39.1 37.3 18.1 16.4 34.8 19.6 17.2 19.2 40.1 13.8 43.4 28.7 133.6 23.4 42.5 31.5 18.2 28.1 64.3 35.6 31.1 11.4 54.1 42.5 34.8 69.2 30.4 27.8 35.8 30.9 9.9 35.5 34.0 38.6 49.1 34.8 35.1 34.7 35.2 31.5 34.9 30.0 36.0 39.8 117.3 93.0 110.6 42.1 129.7 69.0 102.1 99.0 97.3 201.0 74.8 95.0 94.4 110.1 92.2 103.0 83.4 151.1 132.0 95.1 49.0 57.6 84.3 82.3 129.2 109.0 58.8 78.9 94.7 54.6 83.7 118.8 62.7 118.8 144.2 101.0 133.2 81.3 72.9 210.3 89.4 113.2 67.1 74.5 55.5 37.9 179.3 71.4 67.6 51.5 99.8 114.9 166.9 56.3 78.7 48.2 99.7 157.2 118.5 80.8 100.5 61.6 66.6 219.0 177.5 111.5 118.5 211.0 203.7 57.9 74.0 58.7 142.7 105.3 86.8 65.3 GREB1 KIAA0575 ENSG00000196208 "Growth regulating estrogen receptor binding 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "ovary: 280.7" "Cell type enriched" "Detected in many" 9 "Granulosa cells: 545.2" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.8 3.4 8.3 0.7 8.8 0.4 13.8 2.3 10.5 49.7 0.7 0.9 0.7 61.8 7.0 0.6 53.9 2.8 4.5 8.0 16.4 1.8 3.1 1.4 0.6 8.9 7.6 5.5 280.7 7.7 0.7 9.0 3.0 5.0 64.0 0.2 1.5 1.1 3.8 4.0 2.6 0.9 12.9 3.4 0.2 3.0 15.1 9.0 0.3 0.6 4.8 0.3 1.7 21.7 7.0 0.1 1.0 40.3 0.5 0.2 0.2 1.8 0.0 0.1 0.1 0.3 0.3 0.2 2.5 0.3 0.0 6.9 0.2 3.1 0.2 0.1 5.1 3.6 0.4 0.3 39.6 0.5 0.3 2.1 0.5 2.2 0.6 0.4 0.4 0.0 3.9 0.5 1.0 0.3 61.8 1.2 2.0 13.0 0.1 0.1 29.1 0.0 1.9 0.1 0.0 11.8 40.5 0.9 1.1 30.4 5.2 138.0 0.7 0.0 4.1 2.0 0.4 0.1 6.0 4.4 24.7 6.8 11.9 1.2 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.0 8.3 8.8 2.3 10.5 8.0 16.4 8.9 7.6 5.5 5.0 3.4 9.0 7.0 0.4 0.0 0.5 20.2 0.7 0.8 1.9 0.0 0.6 4.8 24.7 13.7 8.3 5.7 0.6 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.8 35.7 36.0 1.3 0.0 0.0 15.0 0.2 3.6 16.9 0.0 23.4 3.8 545.2 0.7 8.9 3.2 3.3 46.9 0.0 0.0 0.0 1.2 2.5 20.2 1.4 5.4 1.0 0.0 0.2 0.0 11.6 20.9 0.4 0.0 55.3 5.0 14.3 0.0 2.5 2.9 0.5 0.0 7.2 14.8 1.1 2.9 0.3 0.3 0.3 1.1 33.1 0.0 2.5 SIRPB2 "dJ776F14.2, PTPN1L, PTPNS1L3" ENSG00000196209 "Signal regulatory protein beta 2" Q5JXA9 20 1470741-1491587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.2" "Cell type enhanced" "Detected in some" "Hofbauer cells: 5.1;Kupffer cells: 20.0;Macrophages: 9.5;Microglial cells: 14.0;monocytes: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "classical monocyte: 51.1;eosinophil: 31.7;intermediate monocyte: 30.4;myeloid DC: 21.1;neutrophil: 69.5;non-classical monocyte: 24.4" "Group enriched" "Detected in many" 329 "dendritic cells: 21.1;granulocytes: 69.5;monocytes: 51.1" "Cell line enhanced" "Detected in some" "A-431: 4.7;HBEC3-KT: 4.0;HMC-1: 7.8;hTCEpi: 8.5;HUVEC TERT2: 4.3;THP-1: 7.7;TIME: 3.7;U-937: 8.3" "Low region specificity" "Detected in all" "HPA011548, HPA048032" Uncertain Approved "Nuclear bodies" NA NA 250000 "Nuclear bodies" "HPA011548: AB_2668514, HPA048032: AB_2680236" "unprognostic (3.22e-2)" "unprognostic (5.57e-2)" "unprognostic (2.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (3.50e-5)" "unprognostic (3.59e-3)" "unprognostic (9.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" 5.7 2.4 1.0 12.1 1.4 6.6 1.6 1.3 1.6 1.9 2.1 1.5 0.9 0.9 0.1 1.8 1.6 3.7 1.4 1.0 3.3 1.1 1.8 7.3 7.1 2.3 1.5 0.6 0.5 0.7 0.6 0.6 7.6 2.1 0.9 1.7 0.2 1.3 0.6 0.5 0.9 2.0 4.1 1.5 13.2 1.2 0.5 2.4 1.4 0.8 1.8 3.2 3.9 0.9 2.6 4.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.8 0.0 8.5 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.7 3.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 8.3 0.0 3.0 51.1 31.7 0.1 30.4 0.0 0.0 0.0 0.0 21.1 0.1 0.0 0.0 69.5 0.0 24.4 0.6 0.0 18.9 1.0 1.4 1.3 1.6 1.0 3.3 2.3 1.5 0.6 2.1 1.5 2.4 2.6 0.0 0.0 1.1 0.0 0.5 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.6 0.6 0.0 0.1 1.3 0.0 1.4 0.2 5.1 0.0 0.1 0.0 0.0 20.0 3.3 0.0 0.0 9.5 0.0 14.0 8.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.1 0.7 0.3 0.1 0.0 0.6 ZNF766 ENSG00000196214 "Zinc finger protein 766" Q5HY98 19 52269587-52296046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 83.6;Late spermatids: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044882, HPA063496" Uncertain Supported Centrosome NA NA Centrosome "HPA044882: AB_10965173, HPA063496: AB_2685024" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (4.15e-1)" "unprognostic (1.20e-1)" "unprognostic (9.45e-2)" "unprognostic (9.28e-3)" "unprognostic (6.85e-3)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (6.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (2.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.75e-1)" "unprognostic (3.85e-3)" 7.6 5.8 5.3 8.6 5.6 16.3 12.6 6.9 5.6 9.6 5.7 9.3 6.3 9.8 7.5 7.3 9.7 6.5 7.1 4.8 5.3 8.0 5.6 8.8 12.7 6.0 6.3 5.0 14.7 5.7 9.4 6.2 6.5 6.2 9.5 8.4 5.7 8.4 7.2 7.0 8.7 7.1 6.8 4.7 11.3 8.5 24.0 5.0 14.2 14.1 7.2 11.4 8.1 6.4 7.6 11.8 18.8 13.8 16.0 13.5 19.4 10.2 11.2 11.0 7.2 14.2 5.0 9.2 19.4 10.4 11.9 11.1 11.5 13.0 11.1 12.7 15.1 17.6 20.2 11.0 5.7 7.9 22.7 13.3 15.3 15.8 8.3 19.5 14.0 11.3 25.4 13.7 10.7 12.7 8.0 29.9 9.5 15.6 16.9 20.8 20.7 23.8 17.3 9.2 34.2 17.0 14.1 17.3 13.4 9.7 20.9 15.9 14.2 13.8 6.7 9.5 5.7 11.9 18.6 56.9 29.4 6.4 11.6 13.2 51.4 14.8 30.1 26.1 21.3 36.3 32.7 27.8 29.8 15.1 29.2 43.7 34.6 15.4 31.7 22.9 10.6 32.3 20.9 5.3 5.6 6.9 5.6 4.8 5.3 6.0 6.3 5.0 6.2 4.7 5.0 7.6 12.0 22.4 8.7 3.9 17.7 5.5 17.0 13.1 5.2 15.1 8.6 12.2 20.2 14.3 12.7 14.7 4.2 13.3 11.4 4.4 15.6 18.7 83.6 8.9 16.1 12.8 9.1 17.9 8.4 10.3 10.7 12.6 4.1 9.3 10.1 21.1 11.7 5.9 6.5 15.2 10.0 10.5 18.3 8.2 6.4 53.2 11.5 7.6 3.6 7.5 16.5 11.2 21.6 8.5 11.7 11.3 11.2 10.5 5.8 19.2 4.7 8.9 9.7 10.5 0.0 15.7 10.6 13.7 30.8 4.5 7.7 11.9 15.7 12.7 7.5 18.2 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433691-38587564 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 1634.3" "Cell type enhanced" "Detected in many" "Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 8 "dendritic cells: 2.9;monocytes: 3.8" "Cell line enhanced" "Detected in some" "A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4" "Low region specificity" "Detected in single" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 46000 "Golgi apparatus, Vesicles" Cytosol "HPA056416: AB_2683121" "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 1.4 2.5 10.8 1.7 7.7 0.4 2.1 8.0 9.4 1.7 1.3 1.1 0.6 0.7 1.3 17.3 1.7 1.1 0.9 8.0 15.0 1.3 0.4 2.6 2.1 7.8 8.0 6.5 0.9 0.4 2.0 1.5 1.8 7.0 3.8 0.3 10.7 14.2 1.4 1634.3 13.4 1.3 0.8 2.7 1.7 1.0 9.0 15.3 1.5 1.3 289.2 2.6 1.0 3.4 5.8 0.0 7.7 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.4 0.5 6.3 0.0 0.0 18.9 0.2 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 1.7 7.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.5 1.0 0.0 0.0 15.3 1.5 0.8 0.0 0.0 1.5 30.7 0.0 0.0 0.6 0.7 5.9 0.0 0.0 12.4 0.3 0.0 0.4 1.4 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.2 1.8 0.2 0.2 0.1 0.3 2.9 0.3 0.0 0.0 0.0 0.0 3.8 0.0 0.4 0.3 10.8 7.7 8.0 9.4 8.0 15.0 7.8 8.0 6.5 7.0 2.7 15.3 5.8 0.3 0.0 1.1 29.4 1.4 11.3 3.8 6.6 22.8 8.9 0.5 7.9 3.6 0.0 1.1 0.0 2.1 0.2 1.2 0.0 5.9 0.1 6.7 0.2 0.9 1.0 0.0 0.4 10.2 0.0 0.4 0.9 0.0 0.5 0.0 0.3 0.7 0.0 8.8 1.7 17.2 0.0 2.0 2.9 15.2 5.9 3.1 6.2 0.0 49.6 1.3 50.6 0.0 13.6 2.0 0.0 0.0 1.9 0.9 0.8 0.0 0.2 0.4 1.8 0.0 41.7 1.2 6.3 7.4 7.5 4.7 0.3 2.6 0.4 0.0 0.7 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;retina: 14.9" "Cell type enhanced" "Detected in many" "Astrocytes: 201.8;Bipolar cells: 217.5;Cone photoreceptor cells: 273.1;Endometrial ciliated cells: 166.0;Excitatory neurons: 223.1;Horizontal cells: 228.8;Inhibitory neurons: 281.2;Oligodendrocyte precursor cells: 159.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.3;HBEC3-KT: 8.2;hTCEpi: 7.8;RT4: 10.9;T-47d: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Approved Cytosol NA NA Cytosol "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 0.7 3.3 12.6 0.7 14.4 0.3 1.5 22.5 17.3 5.2 0.3 1.0 0.7 2.3 1.6 2.3 11.0 1.0 1.3 14.4 9.5 2.4 0.5 1.0 1.1 7.3 10.0 12.2 3.8 1.1 0.6 6.2 0.7 10.5 4.5 1.1 14.9 4.2 1.5 1.3 3.7 0.9 0.7 4.2 0.7 1.5 3.6 9.7 1.8 2.7 2.1 0.9 4.1 1.7 11.2 0.5 0.5 9.3 0.4 0.6 1.2 1.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.1 4.8 0.2 8.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.0 0.7 7.8 0.6 0.8 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.2 2.0 0.9 1.6 0.7 1.1 0.0 0.0 3.8 10.9 1.0 1.2 0.2 2.8 0.1 2.2 10.5 0.0 0.0 0.0 0.3 0.1 0.1 2.7 0.1 0.0 0.8 1.7 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 12.6 14.4 22.5 17.3 14.4 9.5 7.3 10.0 12.2 10.5 4.2 9.7 11.2 1.0 3.2 5.6 201.8 2.3 4.1 28.7 36.3 23.3 217.5 7.9 9.8 9.6 0.0 40.6 77.3 273.1 2.4 3.5 1.4 5.9 3.2 24.1 166.0 6.0 4.2 3.0 0.8 223.1 0.5 0.8 4.9 8.2 93.8 1.3 5.4 0.7 2.1 13.2 228.8 281.2 6.2 12.2 18.6 6.0 20.2 2.5 9.4 1.8 37.5 3.3 80.6 1.0 159.8 132.2 0.6 0.5 1.2 1.4 12.3 0.5 1.4 59.4 94.8 0.0 2.9 3.9 6.1 7.1 17.2 5.8 1.4 14.7 12.0 3.1 31.2 KRTAP5-3 "KRTAP5-9, KRTAP5.3" ENSG00000196224 "Keratin associated protein 5-3" Q6L8H2 11 1607565-1608463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "skin 1: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM217B "C20orf177, dJ551D2.5" ENSG00000196227 "Family with sequence similarity 217 member B" Q9NTX9 20 59933764-59948680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041021, HPA056698" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA041021: AB_10959734, HPA056698: AB_2683212" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (9.43e-2)" "unprognostic (5.05e-2)" "unprognostic (9.04e-8)" "unprognostic (2.78e-3)" "unprognostic (4.51e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-1)" "unprognostic (9.89e-2)" "unprognostic (1.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" 4.8 4.0 8.4 6.3 11.0 13.7 5.0 6.5 17.6 4.8 0.2 4.3 5.2 6.9 5.6 4.6 5.6 4.1 10.0 10.7 7.9 5.3 2.0 5.3 9.4 7.7 7.9 8.9 10.8 3.1 3.8 7.0 6.4 7.7 7.6 3.6 8.3 4.3 9.1 15.6 3.5 5.9 4.5 4.8 6.4 4.6 9.6 7.7 9.5 6.9 17.6 8.9 3.6 3.1 12.5 9.1 6.1 14.0 9.6 6.6 9.8 11.2 12.7 10.8 13.8 9.9 31.9 19.4 20.0 21.0 5.3 11.1 21.9 15.2 10.6 13.4 11.1 9.6 18.7 15.5 18.5 4.2 30.2 24.3 5.7 12.9 10.2 3.3 5.6 4.1 23.8 13.6 8.2 9.0 16.6 53.0 16.4 13.6 8.5 12.5 12.7 13.8 19.5 5.3 14.1 14.2 16.9 17.0 21.8 18.9 12.9 21.2 21.1 5.8 11.4 13.3 11.8 6.8 14.0 25.7 23.9 15.8 19.4 7.6 9.3 5.9 8.2 8.5 3.7 10.3 4.9 8.0 7.7 6.5 5.7 8.2 8.8 11.1 8.0 3.6 5.2 7.6 6.0 8.4 11.0 6.5 17.6 10.7 7.9 7.7 7.9 8.9 7.7 4.8 7.7 12.5 16.0 16.0 19.4 25.5 18.5 5.4 5.4 13.6 10.2 35.6 16.4 16.0 34.9 10.0 12.1 11.0 22.9 23.4 22.2 11.7 17.6 5.5 29.9 8.4 15.5 16.7 8.4 11.3 33.5 8.2 12.0 18.0 7.1 6.6 29.1 19.3 17.2 5.0 19.1 60.6 32.6 5.3 8.2 34.0 13.4 24.9 17.4 13.2 12.4 12.2 32.4 24.4 44.3 22.6 27.9 8.1 5.1 10.1 16.8 9.6 26.3 14.5 17.5 32.0 32.9 36.2 16.6 52.4 16.2 11.0 5.4 6.8 23.3 13.1 9.5 9.7 SULT1C3 ENSG00000196228 "Sulfotransferase family 1C member 3" Q6IMI6 2 108239971-108265351 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 83 "breast: 372.0" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 4 "breast cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 36.7" HPA060368 Approved Cytosol NA NA Cytosol "HPA060368: " "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (4.13e-1)" "unprognostic (6.64e-2)" 0.1 0.0 0.2 0.0 0.1 0.0 372.0 0.0 0.2 0.1 1.4 0.4 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TUBB "M40, MGC16435, OK/SW-cl.56, Tubb5" ENSG00000196230 "Tubulin beta class I" P07437 6 30717435-30725538 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 2296.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005417, CAB012406, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes 170000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (1.01e-1)" "unprognostic (2.33e-1)" "unprognostic (2.17e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (2.18e-3)" "unprognostic (1.27e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.62e-8)" "unprognostic (8.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" 229.6 166.2 58.6 245.7 77.3 545.4 188.5 39.3 237.6 222.1 78.9 226.7 88.4 335.8 176.0 248.3 229.0 159.9 223.9 63.7 88.3 119.8 238.6 207.1 372.2 82.2 69.4 59.7 471.7 139.3 75.0 97.8 196.0 81.7 146.5 196.3 83.1 161.6 196.4 187.2 213.6 160.7 374.3 48.1 196.6 174.2 78.4 82.9 626.3 143.6 99.5 491.5 224.4 215.6 82.1 2281.7 1027.3 2650.0 1458.4 733.2 1265.2 568.2 396.9 469.5 943.3 863.5 1329.2 703.9 1494.1 1105.1 1408.1 1877.8 805.3 2160.6 1968.0 160.3 892.5 1321.1 461.4 207.3 1306.7 345.8 2550.0 1223.9 943.6 455.9 416.0 443.6 967.1 1493.3 2058.1 1270.4 294.1 1844.8 1398.2 2719.0 249.3 377.3 604.1 948.6 102.6 708.5 911.6 1564.5 1071.4 940.8 1516.7 969.0 911.2 354.7 1625.5 1148.3 422.4 880.6 2712.0 1526.0 614.5 917.7 835.3 1735.4 2101.3 538.8 2494.6 3548.7 119.8 115.6 122.8 187.3 182.5 218.8 166.1 152.3 188.8 111.7 113.0 143.2 163.3 46.8 165.1 222.4 227.7 180.8 342.5 58.6 77.3 39.3 237.6 63.7 88.3 82.2 69.4 59.7 81.7 48.1 82.9 82.1 215.8 131.4 47.3 21.5 214.9 576.2 358.4 698.6 434.2 72.7 234.2 312.8 114.9 244.5 238.7 171.0 39.6 811.9 198.7 133.4 311.0 1091.0 9.1 69.1 261.6 370.8 163.6 1322.1 28.2 1061.1 2296.1 471.5 95.3 140.2 207.3 643.6 298.4 267.8 955.2 109.4 25.0 185.3 376.4 454.5 689.6 24.4 402.6 295.8 321.9 30.9 774.0 192.6 246.1 20.1 23.0 1087.0 90.7 237.3 304.6 199.5 117.9 245.9 66.6 65.4 118.3 124.0 838.6 58.0 126.5 447.0 430.6 220.4 244.0 224.9 253.2 229.0 LCOR "C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2" ENSG00000196233 "Ligand dependent nuclear receptor corepressor" Q96JN0 10 96832254-96995956 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 264.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031429, HPA057621, HPA077000" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824" "unprognostic (5.61e-2)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (2.23e-1)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (2.19e-1)" "unprognostic (2.40e-1)" "unprognostic (1.54e-1)" "unprognostic (4.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (4.40e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.16e-4)" 3.6 3.1 5.1 6.2 8.8 25.7 5.1 20.8 7.8 4.1 2.9 8.7 11.3 4.2 4.7 7.1 3.9 4.0 3.6 4.6 9.5 5.3 5.9 4.9 6.3 7.8 6.1 1.8 6.4 8.2 4.3 5.3 4.9 9.4 4.7 8.6 15.9 5.6 3.5 9.3 4.1 10.8 3.4 4.8 5.6 8.4 4.7 7.5 6.1 5.5 5.1 6.0 6.8 4.8 16.6 14.7 9.3 16.5 8.9 4.4 6.2 7.9 6.2 6.0 7.5 8.5 12.0 10.0 15.4 7.3 6.4 7.0 12.2 16.5 8.6 13.3 7.4 8.0 17.7 6.0 15.2 8.4 22.1 8.8 4.9 7.5 11.5 20.4 7.7 8.1 7.8 12.7 7.2 11.9 6.7 9.2 8.4 6.3 7.9 4.0 11.2 12.7 4.3 8.6 30.7 7.5 6.6 7.0 4.4 8.8 7.1 8.3 6.9 12.5 5.8 13.0 5.2 11.6 9.4 6.7 17.9 6.1 13.9 3.1 1.7 5.0 8.0 5.8 4.1 4.7 4.6 4.4 5.3 3.7 8.6 4.7 3.7 16.7 5.0 2.0 5.4 3.6 2.5 5.1 8.8 20.8 7.8 4.6 9.5 7.8 6.1 1.8 9.4 4.8 7.5 16.6 26.4 19.2 26.8 72.1 36.1 15.4 16.7 31.3 25.6 45.2 37.0 20.3 17.8 37.1 38.2 31.3 77.2 18.8 46.5 85.3 11.7 27.0 0.8 34.6 26.8 23.1 46.9 17.7 138.3 33.9 8.2 17.1 28.1 35.9 26.6 67.1 20.3 22.2 14.1 40.4 151.6 31.2 52.9 30.5 29.7 2.3 10.2 40.0 21.4 103.0 28.1 11.7 24.7 143.2 264.9 41.5 62.0 13.9 36.8 26.9 67.1 25.4 54.1 58.9 19.7 21.6 26.8 21.7 26.3 29.2 12.9 38.6 34.0 22.0 33.6 34.4 SUPT5H "FLJ34157, SPT5, SPT5H" ENSG00000196235 "SPT5 homolog, DSIF elongation factor subunit" O00267 19 39436156-39476670 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029273, CAB034370" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034370: AB_2196394, HPA029273: AB_10603896" "unprognostic (3.96e-2)" "unprognostic (3.51e-1)" "unprognostic (1.32e-2)" "unprognostic (5.53e-3)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (7.00e-5)" "unprognostic (7.30e-2)" "unprognostic (4.35e-1)" "unprognostic (1.68e-2)" "unprognostic (1.94e-2)" "unprognostic (6.42e-2)" "unprognostic (1.37e-3)" "unprognostic (1.74e-1)" "unprognostic (2.68e-1)" "unprognostic (3.32e-1)" "unprognostic (2.38e-1)" 41.6 46.6 43.4 45.3 46.6 107.1 42.1 38.0 48.0 45.3 34.6 46.2 40.7 50.1 29.9 43.1 46.6 34.9 41.1 42.6 38.8 39.1 52.5 45.8 52.0 41.3 40.6 38.5 56.3 49.9 49.6 73.2 38.5 46.5 48.9 30.2 33.3 55.1 36.5 88.1 50.0 51.8 34.0 37.6 47.1 47.3 102.9 43.7 40.5 51.5 35.9 41.7 45.4 40.6 48.8 134.1 209.5 75.2 76.4 70.7 50.4 64.8 115.4 70.5 66.0 73.2 137.9 80.1 159.7 106.4 104.7 55.0 50.8 101.9 73.5 51.6 161.6 100.3 179.2 99.7 84.5 64.0 148.5 117.4 78.9 54.6 83.9 86.2 72.2 64.0 137.3 137.9 80.4 66.2 132.5 108.5 44.5 94.0 109.8 52.3 108.8 111.0 80.5 68.3 214.1 72.7 98.1 134.0 104.6 71.7 63.3 63.6 80.1 137.6 67.1 77.8 84.1 145.5 130.9 240.8 196.0 81.8 84.1 84.7 49.0 22.1 19.0 13.7 11.5 13.9 23.0 9.6 11.5 11.1 16.2 10.6 9.0 46.3 15.3 17.2 42.6 11.4 15.6 43.4 46.6 38.0 48.0 42.6 38.8 41.3 40.6 38.5 46.5 37.6 43.7 48.8 45.1 44.8 82.7 26.4 51.9 51.6 26.8 34.1 43.3 47.4 40.2 51.9 58.8 30.0 51.6 44.1 85.5 36.5 79.6 62.6 13.7 37.4 69.9 73.2 57.2 43.8 89.2 40.4 16.6 35.1 45.3 39.1 72.9 92.2 46.2 36.0 32.5 62.5 36.7 48.8 17.6 62.4 26.4 32.2 68.9 79.1 45.1 51.4 40.9 15.0 41.2 28.4 47.4 15.1 23.1 53.5 46.3 41.3 86.5 32.8 58.1 22.9 67.9 57.6 19.7 57.3 38.1 84.4 80.4 41.0 49.6 54.0 72.6 31.0 50.4 31.2 XPNPEP3 "APP3, ICP55, NPHPL1" ENSG00000196236 "X-prolyl aminopeptidase 3" Q9NQH7 22 40857077-40932815 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 232.9;Late spermatids: 306.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000527 Approved Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA000527: AB_1079266" "prognostic unfavorable (8.19e-4)" "unprognostic (6.77e-2)" "unprognostic (3.22e-3)" "unprognostic (5.03e-3)" "unprognostic (6.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (2.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.24e-1)" 2.6 5.0 5.9 1.3 5.9 1.6 2.6 7.8 6.9 2.9 6.5 2.5 14.8 4.7 5.0 2.8 3.8 4.4 4.7 7.2 5.6 3.7 8.3 2.4 2.5 6.7 6.2 4.9 3.8 3.6 2.2 3.7 1.5 6.2 2.8 2.2 4.4 3.5 2.5 5.5 5.5 10.2 2.4 5.8 2.9 2.8 3.7 6.4 5.9 3.2 3.6 1.9 3.7 2.8 8.2 2.7 4.1 2.5 5.5 6.3 4.6 2.1 3.3 2.5 1.7 1.7 3.1 1.6 5.2 1.8 6.5 7.8 7.3 4.7 2.4 2.7 3.5 9.7 3.3 9.7 7.5 3.2 6.0 0.5 4.0 3.9 5.7 3.3 2.7 3.3 3.8 2.9 4.8 4.3 4.1 3.1 3.2 1.5 5.0 8.3 3.9 3.3 3.0 5.9 3.6 2.3 1.9 3.9 4.8 3.3 2.6 6.1 2.7 3.2 3.6 3.4 3.4 2.1 4.7 4.0 7.4 5.6 8.5 2.5 2.8 2.5 2.9 2.1 2.5 1.0 3.7 1.2 1.2 1.9 1.9 2.4 1.9 3.6 0.7 6.9 3.8 1.9 2.8 5.9 5.9 7.8 6.9 7.2 5.6 6.7 6.2 4.9 6.2 5.8 6.4 8.2 9.6 6.4 17.6 32.0 12.7 13.3 8.0 15.6 9.6 16.0 12.9 13.2 22.5 15.7 14.0 9.2 18.8 21.7 11.0 6.2 15.6 12.2 232.9 37.5 16.6 11.7 13.8 12.0 22.0 17.1 18.7 13.1 12.2 12.0 14.0 17.8 10.8 36.0 14.7 16.8 24.0 9.5 12.2 12.6 15.7 306.8 19.9 11.9 17.8 18.7 7.8 13.0 9.2 19.6 42.3 10.4 9.5 15.4 11.8 7.8 3.5 25.3 38.5 19.8 32.9 14.0 12.7 65.6 34.2 12.2 16.3 20.0 11.0 19.5 8.7 7.6 OR2T2 OR2T2P ENSG00000196240 "Olfactory receptor family 2 subfamily T member 2" Q6IF00 1 248445512-248455725 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "Proximal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.1;testis: 1.1" "Cell type enhanced" "Detected in some" "Early spermatids: 2.4;granulocytes: 1.3;Late spermatids: 3.7;Spermatocytes: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "basophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA058578 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 1.1 0.4 0.2 0.1 0.2 0.1 0.1 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ZNF107 "smap-7, ZFD25, ZNF588" ENSG00000196247 "Zinc finger protein 107" Q9UII5 7 64666083-64711582 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.4" "Cell type enhanced" "Detected in many" "B-cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 47.0;REH: 49.5;U-698: 51.2" NA NA "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.50e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-2)" "unprognostic (4.13e-3)" "unprognostic (1.62e-2)" "unprognostic (2.34e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (5.49e-2)" "unprognostic (7.15e-3)" 2.3 6.0 1.5 8.9 2.7 8.7 8.4 3.0 2.0 6.9 0.8 2.7 2.8 2.9 2.3 2.7 2.7 2.5 1.3 1.8 2.1 2.2 1.6 2.4 16.4 2.4 2.2 1.0 4.5 1.6 2.1 1.8 3.1 2.6 3.3 3.5 3.3 4.8 2.6 0.8 7.6 7.8 2.1 1.9 8.6 3.7 2.8 2.0 13.5 5.1 1.9 14.3 3.2 3.7 3.8 6.8 4.1 11.3 19.8 2.6 2.7 8.3 5.0 3.3 7.4 9.8 6.3 6.3 39.6 8.9 3.3 10.0 5.2 12.6 5.1 11.1 9.7 8.5 7.8 6.6 3.5 1.1 14.9 13.3 4.6 3.5 6.4 3.7 3.7 3.7 36.1 13.8 20.2 6.6 5.7 47.0 15.9 22.0 4.2 4.5 49.5 9.1 8.8 3.7 13.3 12.6 10.1 7.8 8.0 5.1 15.6 12.6 9.7 3.2 12.3 5.0 4.7 7.4 9.4 9.1 51.2 2.8 10.0 8.1 12.0 0.7 1.5 3.4 1.7 3.6 9.0 4.6 4.8 1.1 10.1 6.0 5.8 13.7 2.6 1.3 2.8 4.3 1.8 1.5 2.7 3.0 2.0 1.8 2.1 2.4 2.2 1.0 2.6 1.9 2.0 3.8 7.9 12.8 4.2 10.4 45.2 2.2 3.2 3.2 8.6 6.2 13.9 5.8 3.8 5.7 5.4 7.3 2.1 2.7 9.0 1.3 1.9 2.6 8.2 5.1 5.7 6.9 6.6 5.9 6.2 3.1 2.4 6.7 5.1 5.9 0.0 15.0 4.2 0.6 1.9 3.3 9.7 2.9 2.0 3.8 1.5 7.8 4.4 4.8 0.0 10.3 1.7 4.1 10.3 22.6 22.1 3.9 2.4 3.4 22.8 3.5 2.0 1.9 3.3 5.7 6.6 4.0 3.9 4.3 4.7 5.5 4.1 2.5 17.9 17.5 3.6 3.8 OR10S1 ENSG00000196248 "Olfactory receptor family 10 subfamily S member 1" Q8NGN2 11 123976661-123977781 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019038 Uncertain NA NA "HPA019038: AB_1854785" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SFTA2 SFTPG ENSG00000196260 "Surfactant associated 2" Q6UW10 6 30931353-30955636 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 49.5;lung: 180.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 535.2;Alveolar cells type 2: 806.4" "Cancer enhanced" "Detected in many" "lung cancer: 121.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "CACO-2: 12.0;CAPAN-2: 5.5" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (5.82e-2)" "unprognostic (1.16e-1)" "unprognostic (7.20e-3)" "unprognostic (6.64e-2)" "unprognostic (3.12e-1)" "unprognostic (1.34e-1)" "unprognostic (6.37e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (1.16e-1)" "unprognostic (3.96e-4)" "unprognostic (8.84e-2)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" "unprognostic (7.95e-2)" 0.2 0.2 0.5 0.1 0.6 0.0 0.3 0.6 0.7 2.8 0.5 0.1 0.0 0.4 0.0 49.5 0.6 0.8 0.2 0.6 0.7 4.0 0.4 180.6 0.2 0.7 0.6 0.5 0.4 4.4 0.3 0.1 0.2 0.6 0.2 0.0 0.1 4.1 0.1 0.6 0.1 0.2 0.1 0.7 0.3 7.9 1.7 0.6 0.1 2.1 0.1 0.2 0.2 21.8 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.7 0.6 0.7 0.7 0.6 0.5 0.6 0.7 0.6 0.6 0.2 535.2 806.4 0.0 1.0 0.1 0.1 0.0 0.0 0.5 0.9 0.3 0.0 140.2 111.8 53.3 0.0 0.1 0.0 0.0 3.9 22.7 3.8 76.1 2.5 2.1 0.0 0.0 0.0 35.6 0.0 0.8 13.7 23.0 12.6 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 13.7 0.3 1.3 0.0 0.0 0.1 2.8 0.0 0.0 0.1 94.2 0.0 0.4 0.5 0.3 0.0 0.8 8.1 0.1 0.0 1.1 0.4 7.5 1.7 2.8 0.0 0.0 1.7 0.1 0.1 1.1 PPIA CYPA ENSG00000196262 "Peptidylprolyl isomerase A" P62937 7 44796680-44824564 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004655, HPA058345" Uncertain "Secreted to blood" NA NA 230000000 "CAB004655: AB_425607, HPA058345: AB_2683685" "unprognostic (3.10e-1)" "unprognostic (2.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.86e-2)" "unprognostic (9.27e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.12e-3)" "unprognostic (3.30e-2)" "unprognostic (3.92e-2)" "unprognostic (8.68e-3)" "unprognostic (2.52e-1)" "unprognostic (6.35e-3)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" "unprognostic (7.84e-2)" "unprognostic (1.16e-1)" 1096.2 1094.5 1819.2 720.8 1882.2 1061.8 1381.9 1844.4 2264.1 873.2 1847.1 1365.4 609.1 862.0 990.2 2166.3 778.0 553.7 755.5 1899.0 1888.7 1310.9 1329.5 1108.7 1075.9 1940.8 1851.7 1826.8 806.2 975.8 1297.2 675.3 812.7 1973.8 772.6 1207.6 501.0 1028.7 790.3 570.7 1505.6 961.3 951.7 1898.6 1143.5 904.1 368.8 1893.8 2354.7 892.1 522.4 1660.8 1352.2 1218.8 2147.2 2141.8 3020.1 3731.1 2509.6 2798.6 4154.8 1115.0 3173.6 4588.0 5531.3 5393.2 3414.3 3127.1 4614.1 1893.1 3828.8 6554.2 3209.5 4495.7 5727.5 5062.6 2674.3 3204.3 1883.6 3911.6 4682.5 2255.3 3890.0 2246.2 3103.5 3820.5 3988.9 4295.5 2888.1 5717.2 3277.9 3933.2 3789.6 5790.6 3665.7 4667.5 7562.4 4612.9 7628.9 3689.2 3554.4 2050.1 5969.7 8018.9 4215.4 2548.3 2218.7 2500.5 7185.8 2493.3 4091.8 4303.8 5202.3 2587.0 2865.0 3656.5 2027.1 4050.5 3861.7 6522.3 9409.0 2614.0 4314.6 4455.2 475.6 1239.3 594.8 1421.6 1449.2 1534.2 2104.8 1500.3 1491.1 2196.1 1769.5 1217.2 1394.4 133.3 1349.0 1374.8 2618.5 2085.4 3631.4 1819.2 1882.2 1844.4 2264.1 1899.0 1888.7 1940.8 1851.7 1826.8 1973.8 1898.6 1893.8 2147.2 713.8 794.9 759.9 37.2 1037.1 866.6 867.8 1097.5 1878.1 94.3 1226.2 1628.0 47.6 526.1 743.6 603.2 18.8 852.7 1067.7 658.4 1414.6 1172.4 78.2 539.3 770.8 719.7 529.6 1120.3 57.3 1218.7 1683.7 672.4 820.1 862.1 622.1 650.0 669.7 766.9 1582.1 111.0 50.4 1003.5 587.9 1110.0 786.1 81.4 582.2 988.1 691.9 41.2 1283.2 221.6 995.9 27.2 79.8 1222.6 715.0 613.1 1215.3 922.1 831.6 1636.8 481.4 101.5 394.4 588.7 942.7 366.7 246.1 2608.3 990.4 609.2 924.5 1157.5 1262.6 947.0 ZNF471 "KIAA1396, Z1971, Zfp78" ENSG00000196263 "Zinc finger protein 471" Q9BX82 19 56507850-56530221 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 24.8;Oligodendrocytes: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 8.5;hTERT-RPE1: 12.6;SuSa: 9.0" "Low region specificity" "Detected in all" HPA066695 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA066695: AB_2685704" "unprognostic (2.89e-2)" "unprognostic (2.79e-4)" "unprognostic (1.58e-1)" "unprognostic (2.90e-2)" "unprognostic (2.22e-1)" "unprognostic (2.42e-3)" "unprognostic (1.45e-1)" "unprognostic (8.44e-2)" "unprognostic (1.01e-2)" "unprognostic (4.14e-2)" "unprognostic (4.47e-4)" "unprognostic (9.36e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-2)" "unprognostic (3.44e-3)" 5.8 6.4 16.0 2.4 17.5 2.8 7.2 15.1 16.7 10.0 7.7 6.8 1.8 13.4 16.0 4.9 10.6 6.9 5.6 14.6 13.2 5.3 2.4 5.7 3.0 15.5 14.0 15.0 22.6 3.6 10.5 8.5 6.3 17.8 8.3 4.6 28.8 6.1 7.5 4.9 9.5 3.2 8.0 11.1 4.5 4.6 8.6 14.7 2.7 9.9 6.3 2.0 7.0 7.7 27.1 0.4 0.5 4.8 0.6 4.1 4.5 0.5 4.5 1.6 2.1 1.8 0.6 0.6 0.6 3.0 5.0 4.0 0.3 0.6 0.4 2.0 1.0 1.8 3.6 1.3 0.5 4.0 1.0 3.1 8.5 1.6 2.6 0.2 12.6 0.2 0.5 1.1 1.3 2.3 0.5 0.4 0.6 1.1 0.3 1.9 0.4 3.1 0.4 3.5 3.7 0.6 2.9 0.4 0.1 0.2 9.0 0.6 0.7 0.7 7.6 3.2 0.6 3.5 1.0 1.1 0.3 0.6 0.5 0.4 1.5 0.4 0.3 0.6 0.3 0.4 0.4 0.5 0.4 0.2 0.9 0.5 0.7 1.8 1.0 0.4 0.5 0.3 0.1 16.0 17.5 15.1 16.7 14.6 13.2 15.5 14.0 15.0 17.8 11.1 14.7 27.1 5.7 19.2 18.4 24.8 0.6 0.6 2.4 1.6 2.2 11.2 4.1 4.6 10.9 2.8 7.8 5.5 6.2 1.0 1.7 0.9 3.9 2.1 10.2 8.2 5.9 6.0 1.2 0.4 15.0 1.0 0.4 4.6 1.5 6.7 2.5 8.4 5.0 0.8 0.5 6.7 14.4 0.9 0.0 0.6 0.3 3.6 5.0 1.9 1.8 5.6 0.6 7.9 2.1 20.1 32.3 0.7 0.2 7.2 0.0 2.5 0.5 1.6 11.9 9.5 6.6 7.9 6.7 9.9 8.2 1.6 0.6 0.8 0.9 3.6 1.2 1.6 ZNF836 FLJ16287 ENSG00000196267 "Zinc finger protein 836" Q6ZNA1 19 52153864-52171643 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 34.0" "Cell type enhanced" "Detected in many" "Urothelial cells: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.12e-3)" "prognostic favorable (5.11e-4)" "unprognostic (9.68e-2)" "unprognostic (2.83e-1)" "unprognostic (3.10e-1)" "unprognostic (1.42e-2)" "unprognostic (3.01e-3)" "unprognostic (8.52e-2)" "unprognostic (2.23e-2)" "unprognostic (5.22e-2)" "unprognostic (2.49e-2)" "unprognostic (1.37e-1)" "prognostic favorable (3.77e-4)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 5.8 34.0 3.5 4.8 4.0 5.2 6.9 8.5 5.6 8.1 4.3 7.2 5.6 6.5 6.5 7.4 6.8 4.6 5.7 4.0 4.1 6.8 3.3 8.0 7.8 3.6 3.8 3.2 12.9 4.7 12.2 11.4 4.3 4.5 8.4 5.0 6.5 6.7 6.0 3.9 7.3 6.3 4.9 3.1 8.7 5.8 2.5 4.0 8.8 6.4 5.0 7.0 7.7 8.7 4.2 6.8 1.0 4.0 9.4 4.8 8.1 3.2 3.2 7.9 3.0 10.8 2.5 3.1 0.8 2.1 4.9 4.1 5.4 5.4 6.2 3.8 5.6 12.8 2.6 9.3 4.9 3.4 0.0 5.6 7.4 5.8 3.5 4.7 11.6 6.4 2.7 0.5 0.7 7.6 2.0 12.3 3.8 1.4 2.0 5.5 6.2 2.6 4.7 3.1 17.0 6.3 4.5 6.3 4.8 3.8 6.3 4.7 2.1 5.8 3.2 3.7 1.9 2.6 8.6 14.5 7.8 4.7 0.4 4.7 10.3 2.0 2.5 4.4 1.2 4.2 4.0 4.6 5.2 1.8 5.0 3.7 3.6 2.6 6.3 0.8 2.8 4.3 1.9 3.5 4.0 8.5 5.6 4.0 4.1 3.6 3.8 3.2 4.5 3.1 4.0 4.2 6.2 12.8 4.6 5.9 11.3 5.6 15.0 4.9 9.6 5.1 6.5 8.0 2.1 2.8 8.1 9.2 2.1 2.8 11.8 3.3 7.9 5.5 0.8 5.0 3.8 8.5 6.7 3.0 3.6 5.3 5.3 6.0 3.1 5.3 10.8 5.9 8.6 2.7 4.6 3.3 3.8 3.0 8.2 4.9 5.3 0.2 4.1 4.1 5.4 5.6 4.4 8.1 9.2 2.5 4.3 5.3 3.7 2.6 3.7 10.0 3.0 4.9 7.8 5.3 19.7 5.2 4.7 1.6 2.5 9.0 5.7 1.4 10.0 3.9 3.9 25.7 ZNF493 FLJ36504 ENSG00000196268 "Zinc finger protein 493" Q6ZR52 19 21397119-21427577 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 21.7" NA NA "unprognostic (3.49e-1)" "unprognostic (5.80e-3)" "unprognostic (1.28e-1)" "unprognostic (2.83e-2)" "unprognostic (2.54e-2)" "unprognostic (2.71e-3)" "unprognostic (5.90e-2)" "unprognostic (1.75e-3)" "unprognostic (2.30e-2)" "unprognostic (1.82e-3)" "unprognostic (4.13e-3)" "unprognostic (6.03e-3)" "unprognostic (2.08e-1)" "unprognostic (1.34e-2)" "unprognostic (4.80e-1)" "unprognostic (3.55e-1)" "unprognostic (6.00e-4)" 5.1 7.6 7.5 6.2 11.2 11.2 8.7 31.8 11.1 8.2 3.9 6.1 5.7 9.1 8.9 4.6 8.0 5.5 6.2 7.5 6.2 8.0 3.9 7.6 11.6 11.1 8.9 6.9 22.4 9.6 10.8 9.9 5.1 15.5 8.2 6.9 17.8 8.5 5.1 6.2 9.3 6.7 5.6 3.5 9.5 9.1 6.1 7.0 13.7 20.5 3.9 8.7 6.7 6.7 14.7 0.9 0.3 7.4 11.6 4.8 4.7 9.0 2.8 3.0 3.9 5.5 1.5 5.2 9.0 5.5 2.5 2.9 2.2 5.8 1.9 4.0 0.7 9.7 5.0 6.0 3.6 2.9 0.1 0.8 4.1 2.2 2.9 2.0 5.3 1.0 17.9 6.3 2.3 4.6 1.5 21.7 10.4 8.5 0.1 2.6 11.2 6.0 3.8 4.0 7.8 10.2 5.6 0.4 0.8 2.7 11.2 8.1 5.0 2.8 3.1 0.6 5.2 2.6 7.1 11.0 7.4 0.4 0.5 1.4 10.4 3.7 10.4 11.6 3.1 11.6 16.4 10.7 12.9 3.1 16.3 15.2 14.0 34.1 14.1 4.7 9.1 8.8 2.0 7.5 11.2 31.8 11.1 7.5 6.2 11.1 8.9 6.9 15.5 3.5 7.0 14.7 16.2 41.7 16.8 37.9 33.1 9.9 12.0 10.4 31.3 41.1 19.6 15.4 7.4 17.2 18.6 29.5 41.7 10.3 26.6 10.5 7.9 11.0 1.6 9.9 14.0 17.1 13.1 32.2 65.4 8.2 10.6 18.8 14.3 14.3 5.7 56.5 20.7 4.0 4.9 50.5 74.3 9.2 20.3 11.1 9.6 2.7 22.1 8.1 8.8 30.9 7.4 17.7 41.2 69.9 81.5 7.7 6.7 15.4 13.0 15.1 11.3 6.1 17.9 24.0 26.3 22.4 12.4 10.9 12.8 19.7 11.8 10.0 24.7 43.8 13.1 19.2 GTF2IRD2 "FLJ37938, GTF2IRD2A" ENSG00000196275 "GTF2I repeat domain containing 2" Q86UP8 7 74796144-74851551 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 59.0" "HPA056679, HPA056680" Supported Nucleoplasm NA NA Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "unprognostic (7.91e-5)" "unprognostic (3.90e-3)" "unprognostic (1.43e-2)" "unprognostic (5.35e-2)" "unprognostic (2.02e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" "unprognostic (6.80e-3)" "unprognostic (1.22e-1)" "unprognostic (6.11e-2)" "unprognostic (4.43e-5)" "unprognostic (3.18e-2)" "unprognostic (8.97e-3)" "unprognostic (2.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.59e-4)" 10.6 12.8 6.6 4.6 7.4 8.6 12.7 7.4 7.0 16.8 7.4 14.1 6.0 13.1 5.0 9.7 15.7 4.7 15.9 6.4 8.1 12.9 17.5 9.2 5.8 9.8 7.8 5.7 19.8 15.4 6.7 13.1 3.8 8.8 15.5 6.6 7.7 12.0 6.9 39.1 9.0 9.7 7.5 7.1 9.0 15.2 7.4 7.2 8.3 13.6 17.9 5.5 14.1 11.4 10.2 16.6 5.4 7.3 10.6 10.2 6.6 5.6 5.6 5.7 6.4 7.3 1.5 13.9 4.3 1.3 9.1 11.0 3.3 0.1 3.4 5.5 2.1 1.3 3.5 8.3 7.9 9.6 5.8 0.7 6.3 5.3 1.8 4.9 8.0 6.6 3.3 10.3 8.8 5.8 14.6 2.3 16.5 11.5 18.2 3.8 4.3 2.6 15.8 15.7 14.6 5.1 16.7 22.8 59.0 13.3 6.3 12.5 11.3 6.0 9.8 2.5 1.7 8.9 6.6 3.0 4.7 8.0 3.9 20.9 12.3 7.1 7.8 3.2 4.1 4.7 18.9 7.2 9.5 7.3 11.6 8.7 5.5 1.0 5.5 3.6 13.0 7.1 7.6 6.6 7.4 7.4 7.0 6.4 8.1 9.8 7.8 5.7 8.8 7.1 7.2 10.2 6.7 19.2 27.4 23.5 20.7 3.2 11.7 6.9 15.4 27.4 15.8 13.1 11.7 21.5 15.5 12.9 56.3 7.2 11.2 18.1 3.9 21.4 20.3 15.5 10.6 7.2 27.0 3.8 4.5 28.1 7.4 14.3 17.9 11.1 14.0 32.0 18.5 9.6 4.7 37.0 8.5 19.9 6.1 7.9 4.6 5.2 43.8 6.8 10.6 3.7 11.7 12.4 26.8 14.6 20.5 28.8 18.0 25.9 8.5 12.3 15.0 6.7 22.5 40.7 13.1 29.2 13.2 2.8 2.6 11.2 4.3 6.4 12.0 18.2 21.1 8.0 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cardiomyopathy, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;parathyroid gland: 4.4" "Group enriched" "Detected in some" 14 "Excitatory neurons: 773.1;Inhibitory neurons: 597.7;Oligodendrocyte precursor cells: 1189.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SH-SY5Y: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.1 2.0 2.8 0.0 3.2 0.0 0.1 0.2 4.2 0.9 0.0 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 4.1 4.3 0.0 0.1 0.1 0.0 2.3 2.1 3.6 0.1 0.0 4.4 0.0 0.1 1.5 0.3 0.1 1.1 0.7 0.3 0.0 0.0 0.0 2.3 2.2 0.1 0.0 1.1 4.0 0.3 0.1 0.0 0.0 0.2 0.1 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.2 0.2 4.2 4.1 4.3 2.3 2.1 3.6 1.5 2.2 4.0 2.9 0.1 0.0 0.0 29.4 0.0 0.1 1.2 0.1 0.0 24.1 0.1 0.5 1.1 4.3 0.7 0.0 8.4 0.0 0.1 0.0 1.9 0.0 32.7 0.1 2.7 0.2 0.0 0.0 773.1 0.0 0.1 1.6 0.0 0.1 1.3 0.1 0.0 0.0 0.1 1.7 597.7 0.0 0.0 0.0 1.2 41.7 0.3 0.4 0.0 13.1 0.1 1.3 0.0 1189.3 56.9 0.0 0.0 0.0 0.0 0.7 0.0 0.1 8.0 3.5 6.6 0.7 0.4 2.7 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.7 SUPT3H "SPT3, SPT3L" ENSG00000196284 "SPT3 homolog, SAGA and STAGA complex component" O75486 6 44809317-45377953 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in all" 6 "Astrocytes: 110.7;Early spermatids: 142.2;Excitatory neurons: 286.4;Inhibitory neurons: 405.2;Late spermatids: 183.4;Microglial cells: 124.6;Oligodendrocyte precursor cells: 182.9;Oligodendrocytes: 192.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024371 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024371: AB_1857660" "unprognostic (5.72e-3)" "unprognostic (7.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.55e-4)" "unprognostic (1.07e-2)" "unprognostic (6.15e-5)" "unprognostic (7.46e-2)" "unprognostic (1.75e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.49e-1)" "unprognostic (2.30e-1)" "unprognostic (2.05e-2)" "unprognostic (3.08e-2)" "unprognostic (1.23e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-2)" 2.4 5.1 3.5 1.2 3.8 1.2 2.4 4.6 4.5 4.4 0.1 3.0 2.3 3.5 4.2 2.9 4.2 2.0 1.7 3.5 3.7 4.3 1.6 2.4 1.8 4.3 3.3 3.3 5.3 3.8 3.9 3.2 3.4 3.4 4.4 2.3 4.3 7.2 2.1 1.6 1.4 2.4 2.5 1.9 1.8 2.2 9.0 4.4 2.7 4.5 0.5 1.9 3.2 2.5 5.8 5.2 2.4 12.9 6.8 2.7 7.8 4.3 3.2 4.0 7.2 8.9 4.0 4.0 2.0 3.0 1.5 6.2 2.2 9.0 7.1 13.2 5.0 3.6 1.4 1.9 10.4 6.4 3.9 1.5 4.2 5.7 3.7 10.0 20.5 3.7 7.2 4.7 3.7 6.6 1.5 4.0 8.2 4.6 11.2 1.1 8.8 5.7 2.2 10.2 4.2 6.4 3.1 0.7 0.8 10.2 16.7 3.3 3.8 1.3 6.4 0.1 4.6 7.3 7.2 2.2 12.3 5.0 7.9 6.0 0.1 0.3 0.1 2.9 0.5 5.1 1.2 4.4 3.4 1.4 1.6 5.1 4.3 0.2 2.3 0.7 3.9 1.9 1.6 3.5 3.8 4.6 4.5 3.5 3.7 4.3 3.3 3.3 3.4 1.9 4.4 5.8 4.5 3.2 4.8 110.7 11.5 1.8 14.5 10.0 8.6 7.4 5.1 6.7 3.0 2.8 7.2 7.3 6.2 11.7 19.7 1.2 11.7 8.4 142.2 5.4 4.5 5.7 8.4 5.9 286.4 3.2 12.3 7.2 6.6 6.3 3.8 16.0 7.1 3.0 8.7 3.3 405.2 2.3 2.0 2.9 5.0 183.4 7.8 4.5 5.4 124.6 10.5 2.8 20.6 182.9 192.9 4.0 2.1 5.3 14.7 11.3 1.9 10.7 8.3 13.5 13.1 6.8 16.0 26.8 22.0 6.2 1.3 8.2 30.7 7.8 3.7 9.3 BECN2 BECN1P1 ENSG00000196289 "Beclin 2" A8MW95 1 241957767-241959062 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.50e-1)" "unprognostic (2.97e-1)" "unprognostic (2.59e-1)" "unprognostic (7.16e-3)" "unprognostic (7.95e-2)" "unprognostic (8.19e-2)" "unprognostic (9.27e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NIF3L1 "ALS2CR1, CALS-7, MDS015" ENSG00000196290 "NGG1 interacting factor 3 like 1" Q9GZT8 2 200889327-200903938 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036335, HPA036336, HPA061466" Supported Approved Vesicles NA NA 9800000 Vesicles "HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: AB_2684532" "unprognostic (6.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (9.52e-5)" "unprognostic (2.48e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.51e-6)" "unprognostic (1.94e-1)" "unprognostic (8.53e-3)" "unprognostic (6.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.65e-2)" "unprognostic (6.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-1)" "unprognostic (6.04e-3)" "unprognostic (8.61e-2)" 12.0 19.3 15.6 15.4 17.9 11.1 24.6 17.7 24.0 17.8 15.3 22.0 16.7 16.1 26.5 16.8 22.7 13.3 21.7 16.5 16.6 24.5 23.1 15.7 26.7 17.2 16.7 16.1 21.6 15.6 27.2 9.8 19.3 17.8 17.4 28.3 33.0 20.0 20.0 23.7 21.8 15.8 19.2 16.8 18.3 20.3 18.6 16.5 26.8 19.5 30.9 32.7 17.3 12.8 18.6 39.5 42.1 66.9 41.3 29.8 37.1 45.9 42.6 45.4 88.6 71.3 66.1 44.7 31.8 40.2 36.5 64.1 42.7 96.8 56.0 94.6 42.4 90.8 47.4 73.6 70.9 27.0 56.8 31.3 31.7 52.3 58.6 55.8 39.9 29.9 65.6 70.2 31.4 52.7 51.4 69.9 71.1 79.1 44.7 73.5 41.1 37.1 61.6 46.8 40.6 42.3 49.5 36.6 36.8 51.9 94.4 36.5 50.5 15.6 42.2 39.8 38.3 39.0 28.4 58.3 68.4 41.4 45.6 41.6 70.1 23.0 30.7 27.8 34.9 29.1 31.4 31.8 35.3 28.8 23.7 35.4 29.1 7.8 33.6 31.1 29.8 32.0 24.2 15.6 17.9 17.7 24.0 16.5 16.6 17.2 16.7 16.1 17.8 16.8 16.5 18.6 6.0 0.0 7.0 2.6 11.7 3.7 7.7 43.1 12.5 90.5 6.9 9.3 13.9 10.0 26.5 5.5 14.6 34.3 8.0 7.5 15.6 20.3 16.2 10.2 9.3 7.0 1.8 23.2 6.2 18.2 35.6 9.8 9.7 7.8 9.5 12.7 6.8 9.3 17.2 18.5 5.7 10.5 26.4 7.3 2.2 6.5 16.1 9.5 5.4 5.6 17.2 18.8 8.2 2.5 5.7 13.2 9.2 19.2 23.9 6.3 10.1 21.3 24.9 27.4 6.6 7.2 14.5 30.9 24.4 12.9 8.2 22.6 10.0 11.1 11.4 6.2 ATP2A1 "ATP2A, SERCA1" ENSG00000196296 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" O14983 16 28878405-28904466 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 85 "skeletal muscle: 8320.7;tongue: 3228.0" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 65.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 30.0" "Region enriched" "Detected in some" 8 "thalamus: 13.1" "Group enriched" "Detected in some" 6 "basal ganglia: 1.3;cerebral cortex: 1.4;hippocampal formation: 1.2" "CAB002310, CAB032706" Enhanced Approved "Endoplasmic reticulum" NA NA 2800000 "Endoplasmic reticulum" "CAB002310: AB_564139, CAB032706: AB_2061286" "unprognostic (2.37e-1)" "unprognostic (6.81e-2)" "unprognostic (2.23e-5)" "unprognostic (5.35e-2)" "unprognostic (2.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.87e-1)" "unprognostic (5.22e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-4)" "unprognostic (1.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-2)" 1.3 1.1 1.3 1.6 0.8 1.9 1.8 0.9 2.6 0.8 0.0 1.2 1.6 1.5 0.4 28.0 1.4 0.5 1.1 0.8 0.6 1.3 3.1 1.3 2.9 1.2 0.6 0.3 1.6 1.0 0.5 3.2 0.7 1.4 9.6 0.4 8.0 67.8 3.5 8320.7 2.2 2.3 0.4 0.7 1.5 1.1 10.7 0.9 1.5 2.3 3228.0 0.4 1.2 1.3 2.3 7.7 8.0 14.4 8.7 0.7 2.3 13.3 3.5 2.0 0.6 0.6 4.5 6.7 11.9 4.1 0.6 4.8 7.9 3.6 0.2 1.0 5.9 30.0 4.2 19.0 14.4 0.3 1.8 3.8 5.9 1.6 0.9 0.7 7.3 0.4 21.8 8.2 9.8 0.4 15.2 17.3 9.5 14.4 2.8 11.2 26.4 10.2 9.1 0.1 0.9 9.2 7.3 5.0 6.8 5.2 5.2 5.1 4.2 3.1 4.5 9.4 8.5 4.5 14.2 9.5 12.0 8.7 23.4 4.4 0.0 0.0 0.2 0.3 0.0 0.4 0.5 0.3 0.3 0.0 0.2 0.4 0.4 0.0 1.6 0.0 1.0 0.5 0.2 1.3 0.8 0.9 2.6 0.8 0.6 1.2 0.6 0.3 1.4 0.7 0.9 2.3 0.3 0.0 0.0 0.7 0.2 0.1 0.0 0.3 0.6 2.1 0.5 0.5 0.5 0.0 0.2 0.0 14.6 0.4 0.0 0.6 0.0 0.1 1.3 0.4 0.4 0.3 0.0 0.0 2.3 0.2 0.2 0.5 1.5 0.7 0.0 0.7 0.0 0.6 0.1 0.0 2.3 0.3 0.0 0.6 0.0 3.9 0.3 0.3 0.0 1.0 0.0 0.3 0.0 0.5 2.3 0.2 1.2 0.0 0.1 0.2 0.7 0.1 0.4 4.7 0.0 65.2 0.6 5.7 3.4 0.3 0.1 0.7 0.4 0.7 0.6 0.1 IARS1 "IARS, ILRS" ENSG00000196305 "Isoleucyl-tRNA synthetase 1" P41252 9 92210207-92293756 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029806 Approved Approved Nucleoplasm,Cytosol NA NA 100000 "Nucleoplasm, Cytosol" "HPA029806: AB_10601818" "unprognostic (1.32e-3)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (8.23e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (2.00e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (4.96e-2)" "unprognostic (3.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.88e-2)" "unprognostic (4.71e-2)" "unprognostic (2.21e-1)" "unprognostic (7.76e-3)" 22.4 24.6 5.6 29.1 5.2 13.3 27.7 8.4 10.9 26.6 8.9 29.3 18.1 32.8 15.2 32.1 27.9 16.2 32.4 5.3 5.6 28.6 19.8 19.0 28.5 5.8 5.5 4.0 20.6 40.4 52.7 11.8 27.9 7.9 28.0 33.6 25.4 25.7 31.9 43.6 21.8 16.3 43.0 2.7 19.8 31.7 20.2 5.8 27.7 65.1 47.6 37.9 28.5 11.8 7.6 150.7 154.9 83.3 132.2 110.5 142.2 126.8 156.4 146.2 118.8 138.5 52.2 99.0 216.0 54.9 231.4 130.5 194.9 254.4 197.9 149.3 126.1 97.9 135.3 128.3 62.8 235.6 181.3 90.6 134.1 194.9 208.9 348.9 78.3 123.6 230.1 229.2 189.8 145.0 79.3 173.2 31.6 139.7 294.5 143.3 116.2 129.3 103.0 72.9 72.6 110.2 91.5 118.2 117.0 128.8 87.8 95.2 94.4 101.3 89.5 104.6 149.3 119.1 134.8 156.4 99.5 218.7 133.3 173.3 2.8 5.9 0.7 11.9 7.0 16.4 13.9 11.8 11.9 12.7 9.7 12.8 12.7 0.5 19.5 6.3 4.8 10.9 9.0 5.6 5.2 8.4 10.9 5.3 5.6 5.8 5.5 4.0 7.9 2.7 5.8 7.6 7.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.0 0.0 0.0 0.0 29.8 7.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 31.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 17.4 1.1 0.0 0.0 0.0 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 22.8 20.6 10.1 18.9 9.9 45.1 21.2 6.6 14.4 18.4 2.6 19.5 21.8 19.8 9.5 20.2 18.9 13.7 15.5 11.9 6.6 16.6 23.7 17.5 21.4 8.6 5.3 9.1 24.0 25.8 16.2 21.6 17.2 8.0 19.4 12.3 17.6 19.5 11.3 25.9 21.6 23.0 13.1 1.9 23.0 22.0 18.9 7.0 18.0 20.2 16.2 17.3 19.0 18.3 8.8 49.6 35.4 43.5 98.0 23.0 18.8 36.0 34.6 29.2 33.8 29.3 63.0 30.6 67.7 11.0 30.1 37.5 37.0 43.5 33.6 37.6 59.2 86.5 50.6 36.6 42.4 23.5 106.1 61.8 24.8 23.3 44.9 41.0 21.9 25.5 38.5 141.2 49.3 33.7 37.8 63.7 67.0 45.5 27.4 42.3 57.4 33.8 57.1 17.2 42.8 61.7 54.3 30.3 57.3 31.1 28.8 48.1 55.0 36.2 60.2 36.8 48.0 70.5 58.8 58.8 96.0 35.2 66.6 61.0 0.0 0.8 1.4 1.7 0.5 1.0 1.0 1.1 1.3 0.9 1.1 0.9 1.4 0.9 1.6 1.4 1.5 0.6 1.1 10.1 9.9 6.6 14.4 11.9 6.6 8.6 5.3 9.1 8.0 1.9 7.0 8.8 31.8 38.5 28.9 33.0 28.6 25.2 10.1 17.5 29.0 34.6 19.5 19.7 4.4 20.0 19.9 18.4 98.0 17.1 30.6 19.7 5.9 12.3 13.2 14.6 24.7 18.3 18.0 30.7 55.6 17.1 13.2 19.2 32.1 21.3 16.5 31.1 17.2 24.9 16.2 40.4 58.9 21.7 16.2 18.9 21.7 6.3 14.9 23.3 19.6 23.4 13.8 18.2 32.0 30.2 38.6 21.8 14.1 17.7 37.6 22.2 19.1 8.4 17.6 26.6 13.1 27.0 17.6 19.2 13.1 29.6 31.0 19.4 27.9 24.7 23.2 21.9 ZBTB44 "BTBD15, HSPC063, ZNF851" ENSG00000196323 "Zinc finger and BTB domain containing 44" Q8NCP5 11 130226677-130314917 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052589 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052589: AB_2681874" "unprognostic (4.04e-2)" "unprognostic (1.33e-1)" "unprognostic (8.03e-2)" "unprognostic (7.60e-2)" "unprognostic (4.13e-2)" "unprognostic (5.63e-2)" "unprognostic (2.19e-1)" "unprognostic (2.47e-2)" "unprognostic (1.93e-2)" "unprognostic (3.56e-2)" "unprognostic (1.38e-3)" "unprognostic (3.34e-1)" "unprognostic (8.45e-3)" "unprognostic (6.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.78e-2)" 12.3 11.3 13.8 10.6 16.1 12.9 15.8 21.9 13.9 12.7 9.2 10.2 8.9 12.1 17.7 11.6 14.7 8.8 11.0 12.8 12.3 25.6 14.2 11.6 15.8 10.9 13.5 11.9 16.0 11.5 16.1 8.3 12.7 11.0 10.6 9.9 16.8 14.3 11.7 37.2 13.9 11.0 9.5 10.9 14.4 10.5 37.2 13.8 25.6 13.5 31.7 16.5 12.4 12.1 15.8 14.0 9.1 13.6 12.4 18.9 18.4 14.9 8.3 14.7 7.5 9.4 15.7 42.5 44.0 42.8 14.0 18.4 14.0 19.1 18.0 12.7 37.8 11.6 65.3 10.2 9.7 11.2 34.2 47.2 12.3 19.2 12.8 27.8 15.9 11.5 26.3 18.6 63.8 8.5 11.1 33.4 24.2 12.0 21.1 13.6 21.8 12.1 15.0 21.4 14.2 28.4 12.1 24.4 16.3 6.5 12.9 29.8 26.9 12.8 15.3 13.5 6.9 9.5 12.2 19.4 40.0 4.0 42.4 14.1 0.7 0.7 0.9 2.0 0.8 1.3 1.1 1.2 1.2 0.8 1.3 1.0 1.2 2.0 1.5 0.6 1.6 1.6 0.4 13.8 16.1 21.9 13.9 12.8 12.3 10.9 13.5 11.9 11.0 10.9 13.8 15.8 32.6 25.6 39.4 33.0 42.9 72.1 33.9 33.8 46.7 44.4 56.6 41.4 49.3 40.0 28.6 77.3 58.4 34.0 61.6 18.3 19.6 26.6 56.5 47.9 38.7 33.8 19.3 55.2 50.5 20.4 18.6 40.2 16.3 85.3 10.2 56.6 38.6 43.4 14.9 20.2 48.5 26.8 24.4 42.5 29.9 58.3 73.7 30.0 23.2 39.4 33.6 23.2 104.0 64.3 125.7 21.4 16.9 79.0 27.1 51.7 27.7 69.7 30.5 37.6 39.5 64.4 26.5 103.4 61.6 39.8 82.1 26.8 40.2 42.3 33.1 40.9 GIMAP5 "HIMAP3, IAN4L1, IAN5" ENSG00000196329 "GTPase, IMAP family member 5" Q96F15 7 150722253-150750033 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 107.1" "Cell type enhanced" "Detected in some" "Adipocytes: 22.1;Basal keratinocytes: 11.1;Endothelial cells: 29.7;Langerhans cells: 13.9;Suprabasal keratinocytes: 10.7;T-cells: 31.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "MOLT-4: 41.7" NA NA "unprognostic (6.77e-2)" "unprognostic (8.83e-3)" "unprognostic (1.61e-1)" "unprognostic (4.68e-2)" "unprognostic (2.49e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-3)" "unprognostic (6.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.61e-2)" "unprognostic (2.96e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.13e-1)" "unprognostic (7.15e-3)" "unprognostic (1.86e-1)" "unprognostic (1.47e-2)" 34.7 13.8 13.5 45.2 13.2 5.3 25.8 13.1 16.9 16.0 13.6 16.8 10.7 17.3 8.8 12.5 19.1 18.0 24.4 12.1 12.8 12.8 23.5 40.1 107.1 14.6 13.5 11.0 6.0 8.7 9.2 4.1 26.6 13.8 6.7 16.7 0.8 7.3 9.1 12.5 6.8 22.3 30.8 13.3 64.7 15.7 3.6 14.1 25.3 18.4 44.3 67.0 26.9 6.7 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.3 0.0 1.4 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 3.6 70.5 1.1 260.4 106.3 337.2 1.1 436.3 334.0 8.0 0.6 521.5 280.6 8.3 188.3 43.6 1.6 176.9 510.2 13.5 13.2 13.1 16.9 12.1 12.8 14.6 13.5 11.0 13.8 13.3 14.1 13.9 22.1 0.0 1.7 0.0 1.4 11.1 0.3 0.0 1.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.1 5.8 0.2 0.0 0.0 0.1 0.0 0.1 29.7 0.0 0.4 0.0 0.0 0.4 2.6 0.5 0.1 2.5 0.0 8.9 0.6 3.1 0.0 0.0 0.2 0.0 5.3 13.9 0.1 0.0 7.1 3.6 0.0 2.2 0.0 9.2 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.1 0.1 0.0 0.1 0.0 0.7 3.2 0.2 0.1 0.1 10.7 0.3 31.5 0.1 0.1 0.1 STK31 "SgK396, TDRD8" ENSG00000196335 "Serine/threonine kinase 31" Q9BXU1 7 23710203-23832513 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 64.6" "Group enriched" "Detected in some" 5 "Spermatocytes: 161.5;Spermatogonia: 75.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "CACO-2: 20.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023194, HPA072896" Enhanced NA NA "HPA023194: AB_1857590, HPA072896: " "unprognostic (4.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.50e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.42e-3)" "unprognostic (2.92e-1)" "unprognostic (1.29e-6)" "unprognostic (7.83e-2)" "unprognostic (9.21e-3)" "unprognostic (1.46e-1)" "unprognostic (3.65e-1)" 0.1 0.1 0.3 0.0 0.4 0.0 0.2 1.0 0.4 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.2 0.1 0.0 0.2 0.3 0.2 0.3 0.4 0.0 0.5 0.3 0.1 0.2 0.4 0.0 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.4 64.6 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 20.5 2.3 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.4 0.2 0.3 0.5 0.3 0.1 0.6 0.2 0.4 0.5 0.4 3.2 1.1 2.9 0.3 0.1 0.2 0.5 0.0 2.0 1.0 0.1 0.6 1.5 2.8 0.0 0.0 0.6 0.1 0.3 0.0 0.2 21.1 0.6 0.0 0.4 1.2 0.0 2.9 0.6 0.1 0.6 2.0 0.2 0.0 0.3 0.0 0.5 0.2 0.0 4.6 0.4 2.0 0.0 0.0 19.6 3.4 0.5 0.0 2.8 0.0 1.0 0.0 2.5 12.7 0.4 5.3 3.0 0.5 0.3 0.8 0.1 4.3 1.2 0.0 0.6 0.1 161.5 75.0 0.0 0.1 0.5 0.5 0.1 0.5 0.5 CGB7 CG-beta-a ENSG00000196337 "Chorionic gonadotropin subunit beta 7" P0DN87 19 49054275-49058860 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 3.2;skin 1: 3.7" "Group enriched" "Detected in some" 5 "Pancreatic endocrine cells: 16.5;Syncytiotrophoblasts: 58.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HaCaT: 3.1;hTCEpi: 3.2;U-251 MG: 7.5" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (9.53e-2)" "unprognostic (1.99e-1)" "unprognostic (1.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.60e-5)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (8.37e-2)" "unprognostic (2.88e-2)" "unprognostic (4.80e-2)" "unprognostic (8.83e-4)" "unprognostic (1.54e-1)" "unprognostic (3.89e-8)" "unprognostic (1.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.05e-1)" "unprognostic (9.28e-2)" 0.1 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.3 0.7 0.1 0.0 0.1 0.1 0.1 2.4 0.6 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.1 0.2 0.1 0.1 0.7 0.0 1.5 0.4 0.1 3.2 0.0 0.0 1.2 0.4 2.2 3.7 0.0 0.0 0.1 0.1 0.0 1.1 0.1 0.2 0.2 0.1 0.0 1.1 1.8 0.1 2.2 0.3 0.1 1.0 0.0 0.0 2.7 0.3 0.0 0.6 0.8 0.5 1.8 0.0 0.1 0.5 1.2 3.1 0.0 2.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 3.2 0.2 0.4 1.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 1.0 0.0 0.0 1.1 0.6 0.1 0.0 1.5 1.5 0.0 7.5 0.2 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.6 0.1 0.6 1.8 0.0 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.0 58.7 0.0 0.0 0.0 0.1 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.2;seminal vesicle: 12.6" "Cell type enhanced" "Detected in some" "Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" NA NA "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: AB_2732397" "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 0.5 6.7 8.4 0.8 7.4 1.4 0.4 4.8 11.2 1.9 0.0 1.4 0.2 2.8 6.4 0.6 4.3 1.4 1.1 9.2 4.3 0.3 0.1 0.6 0.4 8.5 5.8 6.3 4.4 0.3 0.5 1.0 0.6 5.9 6.0 0.5 1.9 0.7 12.6 0.1 0.7 0.7 1.9 2.8 0.6 0.6 2.6 6.4 0.4 0.4 0.4 0.3 0.7 1.2 8.7 0.0 0.5 6.7 0.2 1.6 0.6 1.2 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.5 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.9 0.4 0.4 0.0 0.0 0.1 0.4 0.4 0.1 0.2 0.0 0.3 0.1 2.0 0.5 1.5 0.0 0.3 0.5 1.2 5.3 0.0 0.0 0.6 0.2 0.3 0.0 0.8 1.7 2.5 0.2 0.0 0.6 0.8 0.0 0.3 0.1 0.1 0.8 0.2 0.0 1.1 1.1 0.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.4 7.4 4.8 11.2 9.2 4.3 8.5 5.8 6.3 5.9 2.8 6.4 8.7 0.3 0.0 0.0 19.6 0.0 0.6 0.3 0.2 1.2 2.6 0.3 0.9 0.4 0.0 0.1 0.0 0.0 1.0 0.2 0.2 0.0 0.1 1.3 0.2 1.1 0.5 0.0 0.0 11.3 0.0 0.2 1.3 0.0 0.4 0.0 1.0 0.7 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.8 3.9 2.1 0.2 0.0 2.8 0.1 2.5 0.0 92.0 43.7 0.2 0.1 17.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.0 0.1 0.4 0.3 0.2 4.5 0.1 0.3 OR8D1 "OR8D3, OST004" ENSG00000196341 "Olfactory receptor family 8 subfamily D member 1" Q8WZ84 11 124302831-124315099 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059510 Uncertain NA NA "HPA059510: AB_2684045" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 198.1" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1" "Cancer enhanced" "Detected in some" "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC TERT1: 1.0;HaCaT: 1.2" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 198.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.3 0.0 0.0 38.4 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 89.0 21.1 0.0 0.0 0.0 0.2 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 7.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.6 0.0 0.0 26.2 0.0 0.0 0.0 2.3 0.0 0.0 209.1 0.0 0.0 0.0 0.0 0.0 1.0 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458" "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 1.4 2.7 0.9 1.0 0.9 0.3 1.6 1.9 1.0 2.6 1.2 1.7 0.4 2.8 2.3 0.8 2.5 0.9 2.1 0.8 0.8 2.0 2.2 1.3 1.3 0.7 0.9 0.6 4.2 3.1 0.8 4.2 0.7 1.1 2.4 0.7 3.0 1.6 1.3 1.0 0.6 1.7 1.4 0.5 2.1 1.7 4.2 0.7 2.2 2.6 0.6 1.2 2.4 1.6 1.0 0.0 0.0 2.6 4.0 0.8 0.3 0.0 1.3 1.1 1.4 1.5 0.0 0.0 0.0 0.4 0.9 0.4 0.0 0.0 0.8 1.7 0.0 0.0 0.1 0.9 1.1 2.4 0.0 0.0 1.8 0.9 0.7 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.2 0.0 0.7 0.3 1.9 4.8 0.0 0.1 0.0 2.9 0.0 1.9 0.4 0.8 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.2 0.3 0.8 0.1 0.2 0.3 0.5 0.6 0.2 0.7 0.3 0.7 0.4 0.6 0.3 0.6 0.5 0.3 0.9 0.9 1.9 1.0 0.8 0.8 0.7 0.9 0.6 1.1 0.5 0.7 1.0 0.3 0.0 0.5 5.2 1.4 0.1 0.4 0.9 0.6 6.6 0.9 1.1 4.8 0.0 0.4 1.8 0.0 0.0 3.3 0.2 0.0 2.1 15.4 0.6 1.8 0.9 3.0 1.3 4.3 0.5 0.1 2.1 0.0 0.4 0.0 3.1 0.4 1.4 1.1 3.3 4.7 0.3 0.0 0.3 0.4 17.1 0.9 0.7 0.0 1.0 1.4 3.8 6.2 10.6 6.4 0.9 0.0 2.6 0.4 0.5 0.4 1.3 0.3 4.2 0.0 1.0 1.1 10.8 3.6 0.5 0.4 0.1 1.0 2.9 0.6 0.2 ZNF729 ENSG00000196350 "Zinc finger protein 729" A6NN14 19 22286441-22317176 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 2.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.9;Distal tubular cells: 1.9;Early spermatids: 1.1;Late spermatids: 1.9;Oligodendrocyte precursor cells: 1.0;Spermatocytes: 4.4;Spermatogonia: 4.3" "Cancer enriched" "Detected in single" 41 "testis cancer: 5.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.7;SuSa: 1.4" NA NA "unprognostic (1.84e-1)" "unprognostic (2.14e-3)" "unprognostic (3.05e-4)" "unprognostic (1.30e-1)" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CD55 "CR, CROM, DAF, TC" ENSG00000196352 "CD55 molecule (Cromer blood group)" P08174 1 207321532-207386804 "Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 2227.6;Syncytiotrophoblasts: 847.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 662.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 472.3;HMC-1: 665.7;PC-3: 395.0;U-2197: 405.3" "Low region specificity" "Detected in many" "HPA002190, CAB010454, HPA024386" Enhanced "Secreted to blood" NA No 32300000 360000000 "CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319" "unprognostic (4.08e-2)" "unprognostic (3.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (1.08e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-2)" "unprognostic (1.55e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (9.36e-4)" "unprognostic (3.41e-2)" "unprognostic (2.04e-1)" "unprognostic (9.70e-2)" "unprognostic (2.33e-2)" 65.5 163.0 14.9 100.5 21.8 135.2 59.6 15.1 26.6 104.2 24.8 48.2 48.1 58.8 17.5 58.9 28.2 49.8 45.5 15.4 25.0 20.7 28.2 226.1 27.0 22.3 21.1 13.6 68.3 24.7 29.1 26.6 93.3 25.3 16.2 43.3 9.3 127.2 18.2 109.8 86.2 51.2 47.0 16.1 43.5 44.3 36.3 19.9 16.0 48.0 60.1 41.7 185.0 42.1 35.3 33.2 43.6 0.1 14.6 54.2 55.1 220.7 62.5 100.1 31.3 33.1 139.5 44.3 60.8 50.3 35.8 123.3 17.4 65.2 12.9 29.1 29.0 26.4 79.9 472.3 23.3 162.3 50.5 665.7 25.9 150.5 40.8 171.8 133.8 169.7 9.6 89.6 29.3 19.4 35.6 5.3 37.8 43.2 78.9 395.0 7.4 42.3 50.7 54.3 30.7 17.7 0.4 321.2 64.3 53.9 95.1 54.4 41.5 80.4 17.6 33.2 405.3 23.8 24.7 31.4 42.7 44.8 19.6 78.9 317.7 181.2 247.6 35.0 174.4 51.8 108.2 46.0 36.4 121.7 115.2 102.6 101.9 662.2 134.5 223.7 64.8 34.6 159.3 14.9 21.8 15.1 26.6 15.4 25.0 22.3 21.1 13.6 25.3 16.1 19.9 35.3 95.9 2227.6 405.3 2.3 529.8 705.1 214.1 143.6 59.2 3.1 69.9 53.8 72.7 7.2 542.6 23.9 0.0 217.5 201.7 196.1 3.9 98.6 324.6 345.6 101.9 143.4 17.3 79.8 7.6 180.2 411.7 244.7 387.9 709.3 146.9 88.9 46.8 9.1 70.0 1.7 10.7 155.7 77.3 177.5 449.2 66.3 32.6 377.3 160.1 7.5 122.6 4.8 69.0 6.0 54.3 388.9 241.2 9.1 305.4 334.9 138.4 3.2 259.5 3.3 6.6 56.1 98.0 8.9 13.7 273.4 765.9 847.7 215.4 281.5 145.1 578.6 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 26.1;prostate: 25.5" "Cell type enriched" "Detected in some" 10 "Excitatory neurons: 351.2" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: AB_2732377" "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 0.6 0.5 3.9 0.1 26.1 0.0 0.2 0.0 14.0 0.2 0.0 0.3 0.7 0.2 0.6 0.3 0.4 0.0 0.9 15.8 5.8 1.0 0.1 0.4 0.0 8.5 5.1 15.4 0.0 0.2 1.9 3.0 0.0 1.9 25.5 0.2 2.0 0.4 3.8 0.0 0.3 0.5 0.3 0.0 0.9 0.6 1.4 14.2 0.0 0.3 0.1 0.0 0.1 0.4 7.0 0.0 6.2 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 0.4 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.8 0.4 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.7 1.4 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.9 26.1 0.0 14.0 15.8 5.8 8.5 5.1 15.4 1.9 0.0 14.2 7.0 0.9 0.0 0.0 8.8 0.0 0.3 0.4 0.1 0.0 0.8 0.0 0.0 17.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.6 0.1 0.6 4.9 0.0 351.2 0.0 0.0 0.6 3.6 0.6 0.0 0.2 0.0 0.0 0.1 1.7 33.0 0.1 0.0 0.0 0.3 5.6 0.3 1.1 0.0 8.4 0.6 0.3 0.0 8.5 7.1 0.1 0.0 0.0 0.0 17.0 0.0 2.6 0.3 0.6 0.0 0.0 0.4 1.4 1.1 0.3 0.1 0.0 0.0 0.1 0.0 0.9 ZNF565 FLJ36991 ENSG00000196357 "Zinc finger protein 565" Q8N9K5 19 36182276-36246257 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.3;Late spermatids: 16.1;Oligodendrocytes: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 16.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044123 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA044123: AB_10794395" "unprognostic (1.51e-1)" "unprognostic (3.77e-2)" "unprognostic (6.80e-2)" "unprognostic (7.46e-3)" "unprognostic (6.08e-3)" "unprognostic (7.97e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.90e-2)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-3)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (3.35e-2)" "unprognostic (1.55e-3)" "unprognostic (1.93e-4)" 2.9 2.6 4.8 2.1 7.3 3.7 3.4 5.8 5.8 2.6 3.0 2.5 2.1 3.2 3.1 2.4 3.1 2.2 2.4 5.1 5.6 2.5 3.0 2.2 2.3 6.8 6.7 4.8 5.0 2.5 2.9 2.7 2.2 7.0 3.1 2.7 3.5 3.8 2.6 4.2 3.1 2.0 2.9 5.9 2.3 3.0 6.8 5.7 2.2 3.2 4.6 2.9 2.7 2.6 12.4 2.7 4.1 4.7 3.2 7.2 4.9 1.3 2.8 4.5 3.3 5.6 2.2 2.4 2.2 3.4 3.6 1.5 1.6 2.4 2.0 5.3 3.7 0.9 3.8 3.6 3.2 3.0 2.7 2.5 5.4 5.8 2.1 5.5 3.5 3.9 2.5 2.6 2.6 4.0 3.6 3.2 0.7 1.8 6.4 1.8 2.5 2.8 2.0 3.3 3.8 3.5 3.7 2.3 2.5 2.6 2.9 1.6 2.7 3.3 4.3 2.6 3.4 3.9 0.8 1.3 1.4 4.4 2.1 2.2 16.3 2.7 4.3 2.7 2.7 3.0 2.1 3.2 2.7 3.1 2.0 3.6 2.7 1.2 3.1 3.3 1.6 1.8 1.9 4.8 7.3 5.8 5.8 5.1 5.6 6.8 6.7 4.8 7.0 5.9 5.7 12.4 3.3 3.2 1.1 5.9 1.6 2.2 7.1 2.3 4.6 4.2 2.0 1.8 2.9 0.0 1.0 1.8 6.2 1.4 1.9 1.1 0.0 2.5 23.3 2.6 3.8 3.4 1.2 0.0 10.2 2.9 2.1 3.8 7.1 3.9 0.0 3.7 2.9 1.1 1.6 1.7 12.4 0.9 2.0 2.7 0.6 16.1 5.3 1.6 0.0 5.6 1.7 2.9 6.2 5.5 21.2 2.6 0.4 2.6 1.5 5.2 1.6 1.6 3.2 4.6 6.6 7.7 3.3 10.8 8.1 2.7 1.4 2.1 2.8 2.5 1.8 4.3 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244526 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 40.8;brain: 57.4;retina: 27.0" "Cell type enhanced" "Detected in many" "Astrocytes: 34.9;Bipolar cells: 69.6;Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "HL-60: 6.8;HMC-1: 16.2;NB-4: 39.0;U-937: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071290 Approved "Intracellular and membrane" NA NA "HPA071290: AB_2686381" "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favorable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 0.6 1.9 18.0 1.1 57.4 40.8 0.2 12.3 17.4 0.7 0.0 0.5 1.2 0.5 0.3 0.3 0.5 0.8 3.6 16.7 4.7 0.6 0.3 2.9 1.4 26.9 9.5 23.5 0.2 1.0 4.4 1.8 0.5 13.6 6.2 0.2 27.0 0.8 1.1 0.4 0.4 0.8 0.3 4.8 3.9 0.6 2.1 6.6 0.5 0.4 1.4 0.4 0.8 0.6 13.1 0.0 0.5 0.2 0.6 0.6 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.2 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.9 6.8 16.2 0.1 0.0 0.2 0.1 1.4 0.0 1.3 0.0 0.0 0.5 0.2 0.3 39.0 1.4 0.0 0.2 0.4 0.4 0.2 0.0 0.0 4.6 4.2 0.2 0.0 0.1 0.0 0.0 0.6 0.1 0.9 2.8 3.6 0.1 0.1 0.0 0.0 1.3 10.0 1.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 18.0 57.4 12.3 17.4 16.7 4.7 26.9 9.5 23.5 13.6 4.8 6.6 13.1 0.8 0.0 0.6 34.9 0.5 0.3 0.6 0.0 0.6 69.6 0.1 1.0 3.0 0.0 0.6 0.0 171.0 0.1 5.0 0.0 0.0 0.3 1.4 0.6 2.4 1.3 0.0 0.4 8.1 0.0 0.0 1.9 0.0 1.1 1.3 0.9 0.7 0.1 0.7 1.7 3.6 0.2 0.0 0.3 0.3 1.3 0.6 1.2 1.8 8.4 0.9 20.3 3.1 11.1 21.5 0.1 0.0 1.2 2.0 2.3 0.0 0.1 0.0 108.3 6.6 2.4 1.8 0.5 0.2 0.2 0.3 0.1 1.2 4.3 0.1 0.3 ELAVL3 "DKFZp547J036, HUC, HUCL, MGC20653, PLE21" ENSG00000196361 "ELAV like RNA binding protein 3" Q14576 19 11451326-11481046 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 103.6" "Cell type enhanced" "Detected in some" "Astrocytes: 36.9;Bipolar cells: 26.9;Excitatory neurons: 78.1;Inhibitory neurons: 91.0;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 120.1" "Cancer enriched" "Detected in some" 10 "glioma: 11.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 80.9;SH-SY5Y: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013066 Enhanced NA NA "CAB013066: AB_221448" "unprognostic (1.47e-2)" "unprognostic (2.29e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-3)" "unprognostic (8.76e-2)" "unprognostic (2.95e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (1.86e-2)" "unprognostic (2.15e-3)" "unprognostic (2.26e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (9.60e-3)" 0.0 1.2 47.7 0.5 53.4 0.0 0.0 84.0 70.7 0.0 0.0 0.5 0.1 0.1 0.5 0.1 0.0 0.0 0.5 54.5 49.3 0.1 0.1 0.1 0.0 57.1 54.2 48.6 0.1 0.1 0.1 5.6 0.0 68.3 0.5 0.2 6.0 0.0 0.2 3.3 0.0 0.2 0.2 44.5 0.1 0.2 1.0 52.6 0.0 0.0 0.1 0.0 0.0 0.1 103.6 0.0 0.2 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 80.9 46.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 53.4 84.0 70.7 54.5 49.3 57.1 54.2 48.6 68.3 44.5 52.6 103.6 1.0 0.0 0.0 36.9 0.0 0.6 0.4 0.0 0.6 26.9 1.3 3.3 12.4 0.0 0.0 0.0 4.2 0.2 0.1 0.2 0.0 0.0 3.5 0.2 0.5 1.8 0.0 0.0 78.1 0.0 0.1 0.6 0.0 0.6 0.0 0.1 0.0 0.0 0.1 5.0 91.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 4.7 0.0 3.0 1.0 36.2 120.1 0.1 0.0 0.0 0.0 0.5 0.2 0.2 0.0 7.4 0.0 1.7 2.2 2.9 4.2 1.1 0.1 0.0 0.1 0.5 0.2 0.3 WDR5 "CFAP89, SWD3" ENSG00000196363 "WD repeat domain 5" P61964 9 134135365-134159968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 152.7;Spermatocytes: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047182 Supported Nucleoplasm NA NA Nucleoplasm "HPA047182: AB_2679971" "unprognostic (9.28e-2)" "unprognostic (1.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (1.05e-3)" "unprognostic (2.26e-3)" "unprognostic (1.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.31e-3)" "unprognostic (4.63e-2)" "unprognostic (7.06e-2)" "unprognostic (5.91e-3)" "unprognostic (1.47e-1)" "unprognostic (3.22e-2)" "unprognostic (2.88e-2)" 16.6 18.5 16.5 14.1 17.2 20.5 16.8 19.7 21.2 16.9 15.6 19.3 17.8 18.9 9.0 25.1 19.1 8.3 17.6 17.2 16.9 17.0 34.3 15.5 16.3 15.5 16.4 17.3 22.1 27.9 13.6 25.6 14.8 18.0 19.1 13.8 9.1 18.2 12.8 34.1 22.3 19.6 13.7 14.2 20.2 20.8 39.0 16.8 17.9 17.8 18.4 18.1 18.6 16.4 17.3 43.6 52.4 49.0 56.1 26.1 28.7 77.4 43.0 28.3 57.5 39.1 61.3 34.9 68.8 26.7 35.2 50.5 105.9 66.9 44.1 46.6 46.4 45.6 39.7 85.6 49.9 27.9 90.0 40.2 27.7 41.0 43.1 52.6 23.7 38.7 67.5 75.3 37.6 40.5 116.1 77.4 73.6 62.3 98.3 65.2 83.4 99.2 65.2 28.3 42.0 81.7 42.5 64.8 50.2 29.7 32.5 69.1 78.3 33.9 58.7 53.8 54.5 70.5 19.6 40.0 74.0 34.1 60.4 48.2 0.9 9.3 1.6 6.7 6.0 6.6 4.6 6.6 6.9 10.0 5.8 6.8 5.4 0.8 4.9 5.1 8.3 6.4 7.1 16.5 17.2 19.7 21.2 17.2 16.9 15.5 16.4 17.3 18.0 14.2 16.8 17.3 8.2 9.6 8.6 10.7 11.8 11.9 14.9 7.0 16.5 9.6 13.6 12.8 9.5 11.5 5.0 5.5 22.9 27.4 8.9 9.1 9.8 14.7 152.7 8.6 14.4 9.6 6.6 17.5 16.4 20.9 42.5 12.2 15.3 10.0 8.9 17.6 5.3 21.9 19.1 8.4 16.6 13.7 8.2 6.3 9.8 41.4 11.5 10.9 5.4 11.2 10.0 6.8 10.3 10.1 14.3 16.7 9.7 11.7 26.6 30.4 17.6 10.2 3.9 7.4 6.6 9.7 10.9 99.9 42.3 25.6 16.3 17.8 9.7 32.5 22.2 18.0 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 197.8" "Cell type enhanced" "Detected in all" "Theca cells: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria No No 7900 Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 29.2 197.8 30.1 22.4 29.8 23.9 27.4 31.1 43.2 24.5 32.1 27.7 22.8 25.4 14.2 27.9 22.8 15.6 60.8 26.9 31.2 43.1 79.8 25.8 24.3 32.6 32.1 25.5 26.8 38.6 35.5 41.8 18.7 35.7 26.6 13.3 13.1 31.0 16.7 70.0 29.0 25.7 14.9 26.4 29.7 34.0 24.4 34.8 17.7 34.9 41.1 14.6 28.5 22.6 32.2 108.4 111.0 35.6 114.0 41.4 29.2 110.4 67.2 52.7 71.0 86.0 96.3 37.7 134.3 91.4 70.6 68.0 45.0 92.1 81.1 34.2 80.0 78.0 74.5 97.5 127.6 190.4 169.7 74.9 55.0 114.6 67.5 132.6 34.1 57.5 183.9 200.9 259.4 33.0 71.8 85.5 101.6 127.6 43.6 143.1 89.4 50.9 146.6 39.3 63.9 94.2 94.1 59.4 85.2 242.2 24.9 50.3 211.9 41.2 36.0 39.2 100.7 99.2 272.3 182.6 121.4 161.7 185.0 66.2 4.5 2.4 0.5 3.4 3.7 2.3 4.0 3.1 3.4 2.6 3.7 3.8 2.6 0.3 2.7 1.5 3.9 2.7 1.7 30.1 29.8 31.1 43.2 26.9 31.2 32.6 32.1 25.5 35.7 26.4 34.8 32.2 12.6 6.4 13.1 18.3 14.1 8.3 11.1 14.9 11.4 26.9 14.2 12.7 19.8 15.7 14.3 27.6 6.2 28.8 8.4 40.1 46.9 33.9 6.5 24.0 16.3 15.3 11.4 17.1 13.5 28.0 31.9 13.3 29.6 25.6 5.7 51.1 11.4 47.0 30.8 21.9 17.4 26.4 22.4 14.6 8.6 6.3 12.8 16.4 14.2 9.4 17.8 24.9 8.2 10.6 15.7 26.0 16.8 17.3 17.6 16.8 27.5 50.2 17.0 26.5 19.7 17.9 24.7 12.0 14.4 11.0 10.7 35.0 10.7 85.0 35.1 11.4 TRRAP "PAF400, TR-AP, Tra1" ENSG00000196367 "Transformation/transcription domain associated protein" Q9Y4A5 7 98877933-99050831 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054376 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA054376: AB_2682467" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (2.21e-1)" "unprognostic (4.35e-2)" "unprognostic (2.02e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.40e-2)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "unprognostic (9.45e-2)" "unprognostic (7.02e-2)" "unprognostic (2.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" 6.0 8.2 3.2 7.5 3.5 11.2 6.3 9.7 3.5 8.1 4.7 7.5 5.3 8.7 3.6 6.8 8.5 5.0 6.6 2.6 1.8 6.2 6.8 7.1 9.3 2.6 2.0 2.1 11.0 8.4 10.4 14.1 6.2 4.4 7.2 5.0 7.5 7.2 5.2 7.7 11.0 8.5 6.3 0.3 8.6 7.1 11.1 2.3 16.0 8.9 7.3 8.7 7.3 7.0 4.7 24.0 27.2 27.7 23.4 12.9 13.8 13.7 10.3 13.6 15.8 15.1 21.2 10.3 32.8 15.9 19.1 30.3 12.2 29.1 14.0 17.7 19.2 28.3 20.2 20.3 11.7 9.4 36.9 14.3 12.6 8.0 25.8 21.7 10.9 20.5 29.2 35.4 59.8 14.8 44.0 45.0 13.5 21.1 14.1 16.6 32.7 16.0 25.2 7.7 26.6 21.6 27.1 26.1 16.6 8.4 22.7 8.5 15.7 22.0 21.1 30.6 28.3 24.2 24.7 30.2 47.8 14.9 18.3 21.3 2.8 0.3 0.2 0.5 0.2 0.9 0.6 0.8 0.4 0.3 0.8 0.6 0.6 1.0 0.5 0.3 1.0 0.7 0.1 3.2 3.5 9.7 3.5 2.6 1.8 2.6 2.0 2.1 4.4 0.3 2.3 4.7 12.8 16.0 14.2 30.3 16.4 15.8 4.2 8.2 13.1 15.2 13.7 10.0 10.9 5.7 9.4 14.7 27.1 8.9 15.0 7.9 0.0 7.7 3.6 16.6 20.1 11.1 12.6 12.4 43.7 6.5 5.2 11.1 11.2 24.1 5.7 26.5 8.6 11.0 8.0 21.9 45.5 10.4 8.2 10.4 7.4 5.4 8.7 12.3 8.8 29.0 9.8 6.1 6.2 36.7 42.4 8.3 5.8 8.6 25.3 7.6 6.2 5.2 8.3 9.2 0.0 12.8 12.4 14.8 8.4 18.5 21.3 10.9 17.1 12.1 10.1 7.5 NUDT11 "DIPP3b, FLJ10628, hDIPP3beta" ENSG00000196368 "Nudix hydrolase 11" Q96G61 X 51490011-51496592 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.3;testis: 36.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 15.3;Late spermatids: 17.1;Peritubular cells: 20.7;Spermatocytes: 14.6;Spermatogonia: 20.3" "Group enriched" "Detected in many" 4 "glioma: 12.1;prostate cancer: 10.6;testis cancer: 17.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 69.3;NTERA-2: 42.9" "Low region specificity" "Detected in many" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.01e-1)" "unprognostic (2.57e-1)" "unprognostic (8.21e-2)" "unprognostic (1.93e-3)" "unprognostic (6.61e-2)" "unprognostic (1.13e-3)" "unprognostic (5.52e-3)" "unprognostic (1.25e-1)" "unprognostic (2.25e-2)" "unprognostic (2.18e-1)" "unprognostic (8.41e-2)" "unprognostic (1.33e-1)" "unprognostic (7.80e-12)" "unprognostic (4.34e-4)" "unprognostic (1.17e-2)" "unprognostic (2.78e-1)" "unprognostic (3.94e-4)" 1.0 4.6 11.8 0.9 16.3 1.4 2.2 6.5 13.7 4.0 4.4 2.3 1.1 5.2 3.5 1.3 2.0 1.6 0.3 14.5 25.3 0.5 0.1 0.5 0.6 8.7 9.4 14.8 9.0 4.9 0.2 4.3 0.0 8.8 9.2 0.8 2.2 0.7 10.5 0.1 1.2 1.0 4.4 6.5 0.3 1.1 36.5 20.1 2.7 0.6 0.5 0.6 1.9 2.4 10.7 0.0 1.0 20.6 0.0 17.5 22.0 0.1 9.8 2.7 0.5 0.5 0.0 0.0 0.0 0.5 11.9 11.4 1.5 69.3 23.9 0.3 0.0 4.7 0.0 0.0 0.0 8.2 0.0 4.6 13.5 9.3 6.2 22.4 3.9 16.4 21.6 0.1 0.0 19.6 0.5 27.6 0.1 42.9 0.0 17.5 0.0 14.4 0.0 4.3 0.0 0.0 13.4 4.2 0.0 4.0 10.2 0.0 0.1 9.6 4.8 22.4 1.4 0.0 9.0 4.5 15.2 3.1 0.0 1.9 0.0 0.0 0.0 1.2 0.0 0.5 0.1 0.3 0.6 0.1 0.1 0.0 0.9 0.0 0.7 0.1 0.0 0.0 0.3 11.8 16.3 6.5 13.7 14.5 25.3 8.7 9.4 14.8 8.8 6.5 20.1 10.7 0.4 0.0 0.0 0.3 0.3 15.3 6.4 12.8 12.0 1.6 0.5 3.9 0.6 0.0 1.6 0.0 0.0 0.3 3.5 0.0 0.0 0.2 11.3 0.5 9.0 0.9 0.0 1.3 6.3 1.5 1.0 7.7 0.0 0.3 0.0 3.4 0.4 0.0 0.1 0.0 3.8 0.0 0.0 0.3 3.8 17.1 8.7 0.6 5.4 2.8 0.0 1.4 3.1 4.0 0.6 1.4 0.0 20.7 0.3 10.4 0.0 0.2 0.2 0.2 0.0 3.0 5.3 14.6 20.3 1.6 9.1 0.3 0.8 7.5 0.0 1.3 SRGAP2B SRGAP2P2 ENSG00000196369 "SLIT-ROBO Rho GTPase activating protein 2B" P0DMP2 1 144887265-145095528 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Cell type enriched" "Detected in many" 4 "Microglial cells: 239.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;granulocytes: 3.9;monocytes: 7.9" "Low cell line specificity" "Detected in all" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (1.13e-2)" "unprognostic (2.76e-1)" "unprognostic (1.48e-3)" "unprognostic (3.52e-3)" "unprognostic (1.66e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (4.60e-2)" "unprognostic (3.13e-1)" "unprognostic (2.89e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-5)" "unprognostic (3.12e-1)" "unprognostic (5.43e-1)" "unprognostic (8.54e-2)" "unprognostic (2.38e-1)" 9.2 10.6 9.4 6.9 9.1 7.8 6.2 44.8 10.0 6.0 5.8 4.1 2.8 6.2 4.2 5.7 6.8 5.8 4.7 10.2 11.6 8.1 4.2 8.7 5.6 14.9 13.1 6.6 8.7 3.7 13.2 3.1 10.9 17.8 3.7 2.8 3.7 3.3 4.6 9.0 19.0 3.6 7.1 15.7 12.5 3.0 3.5 16.1 6.4 4.3 5.8 3.7 5.1 6.5 16.0 13.4 28.5 60.3 12.5 28.3 24.3 19.0 14.6 12.8 12.2 14.0 8.7 24.1 6.7 19.1 8.7 21.7 22.8 15.6 8.5 15.0 6.3 15.8 9.8 20.6 12.1 19.8 8.8 12.5 17.3 12.6 30.1 26.4 18.4 24.8 5.7 5.3 23.1 6.7 15.1 3.8 10.3 11.2 6.7 10.2 10.3 12.9 11.6 10.5 5.8 7.5 9.5 19.3 6.9 31.6 14.9 14.4 22.1 45.3 26.1 26.7 23.3 17.1 9.6 12.7 4.1 9.5 11.6 37.7 1.2 3.8 0.5 0.6 5.4 0.5 0.9 1.0 1.2 2.7 0.9 0.6 0.7 3.9 0.4 7.9 3.6 1.1 0.9 9.4 9.1 44.8 10.0 10.2 11.6 14.9 13.1 6.6 17.8 15.7 16.1 16.0 37.3 25.6 7.7 5.5 14.0 0.0 3.5 0.0 6.8 17.6 3.1 3.4 3.3 5.7 2.5 9.2 2.1 4.7 20.3 0.5 0.0 6.8 1.1 13.8 14.0 35.1 2.4 29.3 37.5 3.0 21.5 15.3 3.1 6.0 1.3 3.3 54.3 4.3 12.9 0.0 55.6 2.0 0.0 58.7 0.0 2.7 15.2 40.1 0.0 239.8 38.4 8.1 16.5 24.6 9.5 6.0 0.2 9.8 8.4 4.8 0.8 1.2 8.0 2.9 6.6 16.9 12.3 4.5 6.9 19.9 0.0 2.9 6.9 8.6 1.8 4.2 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 101.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 22.8;Ductal cells: 19.3;Gastric mucus-secreting cells: 21.9;Intestinal goblet cells: 23.7;Pancreatic endocrine cells: 22.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 11.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 37.4;NB-4: 24.2;THP-1: 46.6;U-937: 32.9" "Low region specificity" "Detected in single" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 3.7 1.2 1.2 4.8 1.2 101.7 2.5 1.2 1.3 2.3 0.4 9.2 12.4 2.8 1.2 1.8 2.1 3.8 1.5 1.6 1.1 1.9 1.5 2.2 3.7 1.2 1.0 1.2 2.9 6.8 0.5 1.3 3.1 1.1 1.6 8.8 1.7 6.8 2.2 0.9 0.8 10.9 2.6 1.3 3.7 10.9 1.3 1.3 3.7 1.3 1.1 2.8 2.1 1.3 2.0 2.9 1.4 1.7 0.0 5.3 4.8 8.9 2.6 1.3 2.3 2.5 12.5 4.0 0.0 6.1 4.4 1.2 1.4 2.9 0.3 2.1 19.1 2.9 9.4 2.2 0.3 2.7 37.4 8.0 4.1 0.1 2.9 0.0 0.5 3.6 8.3 9.7 0.0 2.7 1.4 7.9 24.2 3.4 11.6 3.4 6.9 0.0 0.0 2.4 1.9 2.4 0.9 1.5 3.7 1.5 5.1 2.1 46.6 3.3 1.8 4.9 0.0 1.0 1.1 0.6 0.0 1.6 32.9 1.1 0.5 0.8 0.7 0.2 0.4 0.1 0.1 0.2 0.3 0.4 0.1 0.2 0.1 0.3 0.2 1.2 0.5 0.5 0.2 1.2 1.2 1.2 1.3 1.6 1.1 1.2 1.0 1.2 1.1 1.3 1.3 2.0 2.9 0.0 0.0 1.3 1.8 1.7 3.0 0.9 1.2 1.0 1.8 1.8 0.9 22.8 1.9 1.8 4.2 15.6 2.6 12.1 0.0 19.3 0.3 1.1 2.8 2.3 10.2 3.4 1.5 17.9 3.2 6.0 21.9 3.3 0.0 2.6 3.9 1.0 9.0 0.0 1.9 23.7 0.0 12.9 3.5 0.8 4.4 5.2 3.6 3.7 13.6 0.4 0.0 3.0 3.4 22.5 5.8 1.2 0.5 2.9 11.6 2.4 1.7 7.9 0.0 3.1 2.6 1.7 3.5 2.1 0.6 2.2 3.1 2.0 17.9 1.4 ASB13 "FLJ13134, MGC19879" ENSG00000196372 "Ankyrin repeat and SOCS box containing 13" Q8WXK3 10 5638867-5666595 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1" "Cell line enhanced" "Detected in many" "Daudi: 66.7;RPMI-8226: 68.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048293, HPA061742" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA048293: AB_2680344, HPA061742: AB_2684599" "unprognostic (3.64e-2)" "unprognostic (3.60e-1)" "unprognostic (7.39e-2)" "unprognostic (2.21e-2)" "unprognostic (4.83e-2)" "unprognostic (2.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.87e-1)" "unprognostic (6.93e-2)" "unprognostic (3.42e-2)" "unprognostic (4.58e-3)" "unprognostic (1.16e-2)" "unprognostic (3.03e-1)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" 9.9 19.8 4.2 7.2 3.6 3.5 16.0 5.4 6.7 9.9 3.8 12.4 25.7 9.3 1.8 10.3 12.9 7.7 9.0 2.9 3.7 21.5 44.4 6.6 18.4 5.4 5.2 2.8 14.9 10.8 4.8 8.2 3.4 6.5 9.6 6.7 6.8 8.9 6.6 12.0 11.4 25.6 5.7 4.2 9.8 8.7 3.4 7.7 3.9 6.2 10.2 13.0 11.8 9.1 4.2 10.6 13.7 5.5 24.6 21.5 5.8 9.5 1.9 4.1 6.1 7.0 11.4 19.4 66.7 16.2 3.9 2.2 17.3 12.2 13.6 0.8 3.4 24.0 10.0 7.7 8.5 14.4 8.5 0.9 9.6 20.7 3.2 5.3 6.1 5.0 18.0 12.1 1.3 1.7 7.6 11.0 7.8 12.0 28.6 8.0 4.5 0.8 68.8 7.9 16.3 11.5 27.2 12.9 8.7 21.5 1.6 25.9 10.6 2.1 3.5 6.2 14.6 5.7 3.6 8.6 44.0 10.8 22.9 2.8 0.0 12.9 0.3 1.5 8.3 2.6 1.8 3.9 1.7 13.6 2.4 4.1 2.0 0.4 1.2 6.6 0.4 1.2 7.5 4.2 3.6 5.4 6.7 2.9 3.7 5.4 5.2 2.8 6.5 4.2 7.7 4.2 4.7 0.0 5.8 9.1 1.7 1.7 1.9 2.5 2.2 45.0 8.8 7.4 7.8 8.6 4.7 1.8 18.8 5.8 0.4 21.3 5.9 5.3 2.7 3.2 7.9 5.3 4.2 1.7 6.7 4.5 1.6 9.1 1.5 2.3 3.8 20.1 5.3 55.9 7.0 16.8 13.3 5.7 4.1 12.6 2.6 0.7 13.4 7.3 8.8 6.5 7.0 8.5 0.0 7.1 8.1 4.5 12.6 21.4 0.4 3.3 41.1 39.5 4.9 14.2 6.6 7.2 10.7 0.2 1.6 5.7 1.7 2.1 2.1 16.5 12.4 1.5 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907264-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.5;retina: 13.3" "Group enriched" "Detected in some" 17 "Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6" "Cancer enriched" "Detected in some" 4 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 47.8;WM-115: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 1.4 1.2 13.6 0.9 20.1 0.0 0.6 7.0 21.5 1.0 1.5 3.6 0.4 1.3 3.0 0.6 1.8 0.6 3.5 16.9 12.5 0.5 0.0 0.1 0.0 9.3 13.3 15.7 0.3 0.4 0.1 0.5 0.0 12.2 1.2 0.9 13.3 0.5 1.3 0.3 0.4 1.4 1.1 9.5 0.7 1.1 0.6 11.7 0.0 0.6 0.3 0.0 0.8 0.9 16.7 0.0 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.3 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.6 0.0 0.9 0.0 0.0 0.4 0.0 6.1 6.9 0.0 0.0 0.3 0.0 81.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 20.1 7.0 21.5 16.9 12.5 9.3 13.3 15.7 12.2 9.5 11.7 16.7 0.9 0.0 0.0 380.0 0.1 0.4 0.1 0.0 0.0 15.8 0.1 0.0 6.9 0.0 1.3 0.0 2.1 0.0 0.3 0.0 0.0 0.0 17.9 0.0 0.2 0.2 0.0 0.0 394.8 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 16.8 503.6 0.0 0.0 0.0 0.0 38.3 0.6 0.3 14.2 27.2 0.0 27.6 0.0 1344.6 10.3 0.0 0.0 1.2 0.1 1.0 0.0 0.1 0.0 2.2 0.0 1.1 5.4 3.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 ZNF34 KOX32 ENSG00000196378 "Zinc finger protein 34" Q8IZ26 8 144772224-144787345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053925, HPA060755, HPA066805" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725" "unprognostic (2.54e-1)" "unprognostic (3.50e-1)" "unprognostic (5.01e-2)" "unprognostic (7.60e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-2)" "unprognostic (2.85e-2)" "unprognostic (1.40e-2)" "unprognostic (9.84e-3)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (5.80e-2)" "unprognostic (2.09e-3)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" 8.8 4.2 9.5 2.8 9.8 3.3 8.7 13.0 10.6 10.3 8.9 8.2 2.2 9.2 4.7 3.9 10.1 3.6 5.7 9.2 9.6 5.9 5.0 5.6 3.9 9.6 9.8 8.9 10.9 5.2 6.2 9.8 4.7 10.7 7.6 3.6 12.5 4.5 7.4 6.3 8.1 5.7 6.6 9.0 4.9 5.7 6.5 9.6 5.4 8.3 6.5 3.0 9.2 7.5 11.5 2.1 3.0 5.7 4.7 4.7 4.8 1.4 1.8 4.1 4.6 3.8 0.8 3.3 3.1 3.4 4.9 2.6 2.0 3.4 3.9 3.6 2.9 2.8 6.3 5.4 2.7 4.3 1.8 3.4 4.8 4.4 3.5 7.7 5.0 3.2 2.0 4.2 2.6 4.1 5.0 3.8 2.7 3.9 4.7 3.3 3.3 2.1 4.1 2.6 2.2 5.6 4.0 4.1 3.0 3.1 3.6 3.2 2.3 2.0 4.3 3.9 3.4 3.9 3.4 1.2 3.9 3.1 2.7 5.1 8.2 6.7 12.9 6.6 6.5 5.7 7.2 6.2 7.8 10.2 7.4 4.3 6.5 1.0 6.1 16.3 4.8 5.1 4.8 9.5 9.8 13.0 10.6 9.2 9.6 9.6 9.8 8.9 10.7 9.0 9.6 11.5 17.2 6.4 5.1 3.3 5.5 3.7 2.8 3.9 5.2 7.8 4.6 9.1 3.0 1.5 3.9 0.0 0.0 2.7 2.4 1.4 5.9 3.0 10.6 3.2 7.7 7.9 0.0 1.7 4.8 1.3 3.1 6.7 1.1 4.9 5.1 3.8 2.9 2.1 1.8 13.5 6.2 1.7 6.1 1.2 4.5 7.9 7.2 4.1 3.6 2.8 8.2 6.2 2.1 3.0 8.2 1.1 3.2 4.9 2.7 2.0 2.8 2.3 1.1 9.1 6.6 8.5 7.5 16.4 9.9 8.4 4.8 2.3 4.9 4.2 2.3 0.9 ZNF781 FLJ37549 ENSG00000196381 "Zinc finger protein 781" Q8N8C0 19 37667751-37692315 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 71.1;Late spermatids: 65.7;Oligodendrocyte precursor cells: 42.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;ASC diff: 2.3;HSkMC: 2.1;SH-SY5Y: 2.2;U-266/84: 2.8" "Low region specificity" "Detected in all" HPA062512 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA062512: AB_2684788" "unprognostic (3.01e-1)" "unprognostic (8.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.82e-2)" "unprognostic (1.76e-3)" "unprognostic (2.68e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-1)" "unprognostic (1.84e-3)" "unprognostic (1.67e-1)" "unprognostic (1.23e-2)" "unprognostic (2.11e-2)" "unprognostic (8.12e-2)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" 1.5 1.7 3.1 0.5 3.2 0.0 1.0 5.5 3.2 2.2 2.3 2.0 0.3 2.2 1.3 0.5 2.0 0.7 1.8 2.8 2.9 1.2 0.3 1.0 1.0 3.1 3.0 2.9 3.1 0.5 1.1 4.0 1.4 3.3 1.6 0.8 3.9 0.5 1.4 0.3 0.5 1.2 2.5 1.9 2.1 1.0 1.3 2.8 0.5 2.0 0.5 0.7 1.8 1.2 3.5 0.0 0.0 0.9 2.3 2.3 0.5 0.5 0.8 0.0 0.8 0.5 0.1 0.0 0.1 0.0 0.5 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 2.1 0.0 0.6 0.0 0.3 0.2 0.1 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 1.6 0.0 0.3 0.6 0.0 2.2 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.7 0.0 0.2 0.7 0.9 0.0 0.0 0.0 0.0 0.2 0.2 3.1 3.2 5.5 3.2 2.8 2.9 3.1 3.0 2.9 3.3 1.9 2.8 3.5 10.4 0.0 0.6 13.7 2.8 0.5 0.5 0.5 1.2 6.3 2.0 1.0 14.9 2.8 0.1 0.0 20.9 7.5 2.5 0.0 0.0 0.8 71.1 0.4 2.6 5.5 7.8 0.8 18.0 0.0 3.1 4.7 0.5 0.1 3.8 5.3 10.4 0.1 3.9 3.3 22.2 0.0 2.0 1.6 0.4 65.7 4.7 0.5 1.8 3.7 0.1 5.3 11.3 42.3 19.9 0.1 0.0 6.8 0.5 0.2 0.0 0.5 0.5 8.5 13.1 1.5 6.4 17.4 5.1 0.1 0.0 1.4 2.2 2.4 0.0 0.2 ZNF140 pHZ-39 ENSG00000196387 "Zinc finger protein 140" P52738 12 133080474-133107526 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003655, HPA048332" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003655: , HPA048332: AB_2680362" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.90e-2)" "unprognostic (3.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (5.76e-3)" "unprognostic (7.67e-2)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.96e-2)" "unprognostic (9.13e-3)" 6.3 8.5 7.7 3.9 6.9 3.0 11.1 8.2 8.0 9.9 6.9 6.5 7.5 11.3 8.5 6.3 10.1 8.0 5.7 6.6 6.9 8.2 8.3 5.8 7.1 6.4 6.5 6.7 11.6 9.9 9.5 11.8 7.0 6.5 8.7 5.5 11.2 8.1 7.4 5.6 7.3 6.5 7.2 6.3 6.6 7.3 9.1 6.3 9.2 12.9 4.6 6.5 7.4 8.0 8.5 5.8 6.0 9.3 0.1 7.6 12.7 12.0 7.0 4.5 6.0 6.2 2.9 2.9 3.5 7.9 6.9 7.3 5.2 8.4 5.1 5.0 0.4 11.5 9.4 4.9 5.7 10.8 7.7 13.3 13.4 11.6 6.9 16.2 12.3 7.0 9.0 4.4 4.4 10.5 9.0 13.1 12.0 10.0 3.5 3.3 11.5 1.1 7.7 7.7 12.9 10.8 13.7 11.3 7.5 8.3 5.9 11.8 14.6 11.0 0.2 6.5 5.1 5.2 2.7 0.1 6.8 0.6 7.0 5.8 11.0 7.3 19.1 13.1 11.4 18.9 18.0 15.4 15.8 12.6 15.1 22.3 17.9 11.5 19.2 7.5 7.3 19.4 10.9 7.7 6.9 8.2 8.0 6.6 6.9 6.4 6.5 6.7 6.5 6.3 6.3 8.5 11.1 0.0 16.4 7.5 13.5 7.1 12.0 7.9 12.5 7.6 10.9 9.5 7.2 5.7 15.3 0.0 10.4 8.8 7.4 5.4 13.7 9.5 16.0 11.1 10.2 8.1 13.8 4.2 13.4 5.8 7.9 8.9 12.8 10.8 7.6 9.7 7.5 4.4 5.8 6.7 13.8 6.6 16.2 7.2 6.4 5.2 9.0 5.5 8.8 12.2 4.2 7.4 7.2 18.6 15.0 6.8 9.1 8.2 5.5 9.7 5.4 7.4 9.7 7.2 0.0 10.0 8.5 16.5 13.4 8.5 6.0 14.9 11.3 9.9 6.2 10.2 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.1" "Group enriched" "Detected in many" 19 "Early spermatids: 130.0;Late spermatids: 306.6;Spermatocytes: 211.3;Spermatogonia: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: AB_2681816" "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favorable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 2.9 3.7 3.2 6.3 3.4 1.6 2.1 4.1 4.3 3.6 1.6 3.1 10.9 5.3 0.8 5.2 3.2 7.2 6.6 2.9 3.4 3.4 3.8 4.6 8.6 3.9 3.4 2.8 8.2 3.9 1.6 2.2 3.0 4.6 4.6 1.2 4.5 5.8 1.7 10.7 8.1 8.0 2.2 3.4 7.4 5.1 48.1 4.1 0.4 8.1 4.9 0.4 2.7 2.4 3.9 5.0 5.6 3.9 3.7 2.6 1.0 4.7 5.3 0.5 1.4 1.5 4.0 5.9 23.9 3.5 1.4 4.6 14.0 0.7 0.3 0.8 10.0 5.9 5.2 7.6 2.7 1.8 0.8 12.2 1.5 0.0 0.8 0.4 8.5 0.5 8.4 6.6 10.9 1.0 2.6 7.4 1.7 1.7 2.3 1.5 9.0 2.0 2.2 0.9 1.6 11.7 3.5 2.6 3.4 3.1 4.1 7.0 1.1 10.8 4.9 1.8 4.7 4.1 1.8 1.0 1.1 4.8 12.6 2.5 0.2 0.8 0.0 0.2 1.5 0.6 0.4 0.4 0.5 0.3 0.2 0.7 0.6 0.2 0.0 1.2 0.4 0.2 0.2 3.2 3.4 4.1 4.3 2.9 3.4 3.9 3.4 2.8 4.6 3.4 4.1 3.9 1.0 0.0 1.1 1.0 0.6 1.1 1.5 1.2 0.6 0.5 0.9 0.8 1.0 1.5 1.2 3.7 2.1 0.6 0.1 9.3 0.0 0.7 130.0 0.6 0.8 1.3 0.0 2.7 0.8 1.6 0.7 1.3 1.5 0.6 4.5 2.5 0.7 1.4 1.2 0.0 0.9 2.0 2.0 0.0 1.5 306.6 7.2 1.1 1.8 1.0 0.7 6.1 0.0 1.0 1.1 1.2 9.3 1.2 0.1 0.4 5.2 2.2 1.5 0.8 6.6 2.0 1.9 211.3 87.1 0.3 0.9 0.8 0.2 0.7 2.9 0.8 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352284-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.0" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" No No "Intermediate filaments" Cytosol "HPA030839: AB_2673630, HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 0.7 2.7 2.3 1.2 3.4 1.0 3.4 4.1 3.7 2.7 0.0 4.6 2.3 2.8 4.1 1.4 3.0 2.9 2.2 2.0 2.2 1.4 1.1 1.1 0.7 1.2 1.1 1.6 1.1 4.0 3.1 3.0 0.7 2.5 2.4 7.1 4.1 3.9 5.8 6.2 3.1 2.1 1.8 0.2 0.6 2.6 2.2 1.8 1.6 2.7 7.3 0.9 1.9 1.6 3.4 1.7 0.7 2.1 2.4 0.9 0.5 5.0 1.0 1.7 1.3 1.6 2.7 2.0 0.6 2.0 1.3 3.7 2.5 2.2 3.7 1.3 1.2 4.2 1.8 9.0 1.3 1.6 1.0 1.3 0.5 4.4 1.9 1.8 3.6 2.3 3.4 2.0 0.8 2.1 1.6 1.4 0.9 0.6 4.5 2.5 1.3 1.8 0.5 2.6 4.6 4.8 2.0 2.0 3.1 0.8 2.4 2.1 0.2 1.1 1.4 1.3 1.1 2.2 5.2 3.8 0.4 2.3 2.8 0.7 1.4 0.3 0.7 0.2 0.1 0.1 0.2 0.2 0.3 0.6 0.4 0.2 0.2 1.2 0.7 0.2 0.3 0.1 0.1 2.3 3.4 4.1 3.7 2.0 2.2 1.2 1.1 1.6 2.5 0.2 1.8 3.4 0.6 6.4 3.2 0.3 0.7 0.8 2.5 1.0 2.2 6.4 2.4 2.4 4.9 0.0 1.1 0.0 0.0 1.7 0.2 6.8 1.9 2.8 15.4 1.7 2.3 1.0 2.4 0.0 2.5 2.0 1.1 0.9 4.1 3.2 0.0 45.3 0.0 1.5 0.8 8.4 2.3 3.3 0.0 0.3 0.7 11.0 0.3 0.8 0.0 0.0 0.2 2.0 0.0 1.5 1.1 1.7 5.5 2.2 0.7 1.4 1.9 1.1 0.7 5.3 0.0 1.7 1.9 11.8 4.5 1.3 0.3 1.4 0.5 0.3 5.5 2.0 PTPN1 PTP1B ENSG00000196396 "Protein tyrosine phosphatase non-receptor type 1" P18031 20 50510321-50585241 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 227.6;monocytes: 207.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009329, HPA012542, CAB015217" Approved Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915" "unprognostic (1.67e-1)" "unprognostic (7.78e-2)" "unprognostic (1.48e-1)" "unprognostic (1.05e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-3)" "unprognostic (3.95e-2)" "unprognostic (2.40e-2)" "unprognostic (6.47e-3)" "unprognostic (5.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.66e-2)" "unprognostic (6.70e-2)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (2.58e-2)" 26.0 31.0 13.3 44.9 14.3 55.9 22.2 12.6 15.0 22.6 26.5 24.4 14.0 23.2 18.8 29.8 22.2 23.3 28.6 17.4 18.0 46.9 21.1 55.7 53.3 16.8 14.6 13.1 25.9 16.0 48.7 19.9 34.4 14.0 25.2 19.0 9.9 19.1 18.4 35.7 23.6 28.5 22.1 14.3 46.9 21.1 18.4 14.2 35.9 18.9 21.8 53.1 36.2 23.7 15.4 66.1 32.4 38.4 26.6 24.6 33.6 54.5 43.2 40.8 123.8 44.9 96.1 134.3 32.5 74.8 40.0 48.7 56.9 30.8 123.8 78.2 48.5 27.6 45.9 30.9 51.3 49.0 48.2 60.2 39.6 84.9 55.9 68.2 54.3 72.3 38.5 81.5 28.9 68.3 36.5 52.1 38.1 20.4 36.2 44.2 45.6 44.6 31.1 71.2 48.4 30.8 35.3 62.0 77.6 71.3 32.1 50.4 50.9 108.2 107.3 43.1 48.8 54.2 31.4 27.3 38.9 67.1 32.3 40.6 19.8 7.1 25.2 12.9 12.1 9.5 19.2 10.8 10.0 7.1 17.4 8.9 9.8 15.4 5.3 22.8 11.8 9.4 8.7 13.3 14.3 12.6 15.0 17.4 18.0 16.8 14.6 13.1 14.0 14.3 14.2 15.4 34.0 227.6 83.6 22.9 147.8 86.0 61.7 37.1 56.3 25.1 23.9 24.4 30.0 11.5 40.0 36.8 47.9 54.0 68.7 26.1 23.5 26.2 67.7 45.0 44.0 36.3 18.6 32.0 61.6 19.3 20.9 52.1 32.1 65.9 70.8 14.2 41.4 20.8 37.4 43.7 43.3 16.4 20.3 40.6 169.5 37.4 14.0 100.7 37.4 32.8 207.8 12.1 38.1 27.6 42.1 41.7 14.5 12.0 178.7 26.6 8.9 65.2 30.2 27.5 19.7 55.5 57.7 20.8 24.5 48.7 47.2 54.3 83.8 44.3 14.6 53.5 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 291.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favorable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 37.5 31.6 112.8 92.8 131.7 50.5 58.7 98.8 187.0 42.2 66.6 39.2 29.4 65.4 50.0 30.8 64.2 42.4 48.4 131.3 113.6 42.4 91.0 63.7 160.3 99.8 108.4 126.3 52.1 41.2 19.8 99.3 29.3 112.3 52.5 24.4 206.4 41.5 32.3 33.5 38.1 70.5 62.5 88.0 108.7 43.6 31.8 105.3 181.0 38.2 29.1 127.2 43.5 33.1 119.4 15.2 14.2 107.1 30.3 22.4 58.5 59.7 18.9 26.5 14.2 18.7 0.8 11.4 30.9 24.9 19.2 10.5 0.4 49.0 36.3 16.8 30.4 32.6 51.9 11.5 8.4 18.0 16.2 116.7 31.6 18.9 9.1 35.8 29.3 38.3 117.3 25.5 2.3 15.7 22.7 291.7 89.6 19.7 13.1 21.8 65.4 58.7 5.5 17.2 0.6 120.8 73.1 14.3 22.0 7.2 24.6 17.7 47.4 27.7 11.2 16.5 66.9 12.8 55.3 44.1 87.9 14.9 27.1 19.7 2.3 2.6 27.4 20.2 13.9 15.1 9.6 22.6 19.2 4.3 13.2 26.3 24.4 0.6 18.0 16.5 0.8 41.4 10.6 112.8 131.7 98.8 187.0 131.3 113.6 99.8 108.4 126.3 112.3 88.0 105.3 119.4 26.4 28.9 42.3 45.1 155.2 20.8 22.2 10.8 12.0 125.4 70.4 50.5 4.7 22.8 14.2 12.9 402.4 22.6 215.3 1.0 31.3 12.9 4.2 40.1 51.9 47.5 8.4 31.1 119.9 14.0 12.0 30.5 20.4 26.2 17.1 45.1 39.3 102.2 144.8 77.4 121.1 3.7 8.2 82.5 76.6 12.0 24.8 92.5 26.6 100.2 42.0 89.1 591.2 86.0 66.1 11.6 2.9 49.7 53.3 17.4 2.6 14.2 41.9 438.0 6.6 29.8 33.9 14.1 28.4 8.7 31.4 14.6 373.3 13.5 3.8 15.9 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "testis: 23.4" "Group enriched" "Detected in some" 148 "Early spermatids: 491.4;Late spermatids: 1560.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 1.2;U-2 OS: 3.9" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 491.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1560.9 5.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THEM5 FLJ37964 ENSG00000196407 "Thioesterase superfamily member 5" Q8N1Q8 1 151847101-151853712 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "skin 1: 152.6" "Cell type enriched" "Detected in some" 18 "Suprabasal keratinocytes: 34.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 2.1;cerebral cortex: 3.8;hippocampal formation: 2.8;pons: 1.4;white matter: 1.3" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 6 "T-cells: 1.7" "Cell line enriched" "Detected in some" 7 "HDLM-2: 57.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "basal ganglia: 13.8" NA NA "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (3.41e-2)" "unprognostic (2.58e-3)" "unprognostic (9.55e-3)" "unprognostic (1.27e-1)" "unprognostic (1.93e-1)" "unprognostic (1.83e-1)" "unprognostic (7.86e-3)" "unprognostic (3.07e-3)" "unprognostic (9.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.34e-2)" "unprognostic (1.62e-2)" 0.3 1.9 2.1 2.0 0.2 0.5 4.3 0.0 3.8 0.8 0.4 0.5 1.4 0.5 0.0 6.6 0.7 3.1 1.9 2.8 0.0 1.1 0.6 1.3 6.4 0.5 0.3 0.1 0.3 1.3 0.0 0.5 0.6 1.4 0.4 0.0 0.7 3.2 0.0 1.3 152.6 0.8 0.0 0.0 1.1 1.9 1.2 0.3 0.1 1.0 0.0 0.3 1.3 3.2 1.3 6.6 0.0 0.1 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 57.6 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 1.7 0.2 0.0 7.1 1.2 0.6 0.0 0.2 0.7 0.0 0.0 0.4 0.1 8.6 2.1 1.1 1.4 1.4 2.4 0.0 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.1 1.7 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.9 1.7 2.1 0.2 0.0 3.8 2.8 0.0 0.5 0.3 0.1 1.4 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.8 34.7 1.1 0.0 0.0 0.0 0.0 NOXO1 "P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28" ENSG00000196408 "NADPH oxidase organizer 1" Q8NFA2 16 1978917-1984192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 7.5;lymphoid tissue: 4.7;testis: 4.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 52.1;Intestinal goblet cells: 34.7;Paneth cells: 20.5;Undifferentiated cells: 42.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;HaCaT: 1.6;OE19: 4.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA071540 Enhanced NA NA "HPA071540: AB_2686415" "unprognostic (3.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.73e-2)" 0.1 0.2 0.6 4.7 0.8 0.3 0.4 0.5 1.5 0.6 1.0 7.5 3.2 0.3 1.1 0.9 0.2 0.3 0.1 0.6 0.3 0.6 2.3 0.3 0.4 1.0 0.5 0.6 0.3 0.4 0.1 0.9 0.1 1.3 0.6 6.0 0.3 2.4 0.2 0.5 0.6 3.5 0.5 0.0 0.3 0.3 4.9 0.4 1.0 0.2 0.0 1.6 0.4 0.3 1.3 0.1 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 2.7 0.2 0.1 0.0 0.0 1.6 0.0 0.1 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.4 0.1 0.4 0.1 0.4 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.0 4.3 0.0 0.2 0.4 0.0 0.3 0.0 1.4 0.0 0.6 0.5 0.1 0.1 1.0 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.3 0.6 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.5 1.5 0.6 0.3 1.0 0.5 0.6 1.3 0.0 0.4 1.3 0.1 0.0 0.0 0.3 0.4 0.3 1.3 9.0 2.8 0.1 7.1 1.8 0.0 1.5 10.6 5.5 0.0 0.8 0.1 52.1 0.0 1.0 6.2 2.9 0.3 0.1 6.6 0.0 1.1 1.9 2.9 0.1 4.6 2.0 0.0 0.2 0.4 0.4 0.3 0.0 0.9 34.7 6.1 0.3 0.3 1.5 0.6 0.1 0.0 0.0 0.6 0.6 0.0 0.0 0.2 1.0 20.5 0.4 0.0 3.3 14.4 1.0 10.6 0.0 0.0 0.0 0.6 3.2 3.3 1.5 0.4 1.5 0.2 0.2 42.4 5.7 EPHB4 "HTK, Tyro11" ENSG00000196411 "EPH receptor B4" P54760 7 100802565-100827523 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Angiogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.0;neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB013537 Uncertain NA NA 1400000 "CAB013537: " "prognostic unfavorable (8.56e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.33e-1)" "unprognostic (5.23e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.84e-1)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (9.51e-3)" "unprognostic (6.63e-2)" "unprognostic (3.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (8.84e-4)" 25.7 50.2 4.8 8.1 4.0 5.7 32.9 4.5 4.8 44.2 6.7 19.1 8.4 62.0 3.8 24.9 27.4 18.2 21.3 3.8 4.3 24.0 33.5 28.4 5.8 5.2 4.8 2.9 36.3 27.0 10.2 6.3 35.8 4.8 29.1 10.3 0.3 24.4 22.6 7.8 34.9 17.6 22.3 4.7 48.3 21.5 12.4 6.1 3.1 17.7 13.4 4.9 17.5 28.4 5.2 37.7 33.1 32.5 94.2 20.4 13.0 94.7 14.1 31.2 22.3 29.0 27.4 28.3 4.8 63.6 15.3 31.3 38.2 14.3 38.3 11.9 6.2 25.6 1.3 19.0 43.2 11.8 0.7 0.9 15.3 56.7 14.2 33.1 24.8 84.0 1.5 71.9 1.8 18.4 66.4 0.7 15.0 54.7 56.3 47.5 51.4 15.6 8.9 28.6 19.9 0.2 27.4 22.0 10.4 22.1 45.1 26.1 6.7 71.3 27.6 42.6 51.3 21.4 0.2 0.8 1.7 4.0 12.0 51.2 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.3 0.0 0.1 0.1 0.0 0.7 4.8 4.0 4.5 4.8 3.8 4.3 5.2 4.8 2.9 4.8 4.7 6.1 5.2 47.1 9.6 12.6 1.6 1.9 20.5 10.3 13.9 15.9 0.1 22.0 19.7 5.7 7.2 8.5 5.5 0.0 68.5 1.1 9.1 0.0 12.3 28.5 4.8 21.8 51.2 3.0 10.8 0.3 6.6 11.2 6.5 12.8 8.0 1.3 10.7 113.2 22.4 9.0 0.0 0.2 17.4 8.2 4.1 3.4 9.9 8.1 1.3 3.6 1.9 1.5 1.7 0.0 0.0 1.0 20.6 7.6 4.1 1.4 13.3 1.3 4.0 4.2 0.2 6.6 5.7 6.3 1.4 10.2 12.1 17.8 206.5 1.2 2.9 19.9 8.0 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840999-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "bone marrow: 2115.4" "Cell type enriched" "Detected in some" 17 "Erythroid cells: 26.5" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.0" "Cell line enriched" "Detected in some" 6 "THP-1: 2054.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced Approved Vesicles,Cytosol "Secreted to blood" NA NA 390000 Cytosol Vesicles "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.5 0.2 0.5 0.0 0.7 2115.4 0.4 0.2 1.3 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.6 0.4 0.3 2.8 11.8 0.4 0.3 0.4 0.5 0.1 0.1 0.2 1.3 0.6 0.4 0.3 0.0 0.0 1.6 0.0 0.3 1.3 0.0 0.0 0.2 38.5 0.1 0.2 0.5 7.2 0.4 0.0 0.0 0.0 0.1 0.4 1.2 0.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 343.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2054.4 0.0 0.0 0.0 0.2 0.9 0.0 0.2 0.3 0.0 14.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.9 0.5 0.7 0.2 1.3 0.6 0.4 0.3 0.4 0.5 0.4 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.8 1.3 0.4 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 26.5 0.4 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.5 0.0 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 ZNF765 ENSG00000196417 "Zinc finger protein 765" Q7L2R6 19 53389793-53430413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 27.8;Granulosa cells: 36.9;Leydig cells: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "prognostic unfavorable (9.11e-4)" "unprognostic (4.56e-2)" "unprognostic (1.66e-1)" "unprognostic (7.05e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.17e-4)" "unprognostic (7.38e-2)" "unprognostic (6.76e-3)" "unprognostic (5.78e-2)" "unprognostic (1.75e-1)" "unprognostic (6.84e-2)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.31e-1)" "unprognostic (1.16e-1)" "unprognostic (2.89e-2)" 2.7 3.8 1.9 2.7 2.8 4.2 3.6 2.6 2.1 2.7 2.7 3.4 3.2 2.7 2.9 2.6 2.8 2.4 1.8 1.9 2.6 2.9 2.0 3.1 3.9 2.7 2.5 1.6 8.8 4.6 8.9 2.0 4.7 2.8 4.3 3.8 2.1 2.8 1.8 1.8 4.2 2.8 2.2 1.9 3.4 2.9 3.6 2.4 4.4 3.3 1.6 3.8 2.7 2.9 4.5 6.0 5.4 2.9 8.8 3.4 3.1 8.6 3.9 5.5 3.1 4.3 4.3 3.8 12.0 4.2 4.1 4.3 4.8 7.9 4.2 6.6 5.4 10.9 12.9 5.6 3.6 3.8 0.7 7.7 6.0 6.8 5.3 3.6 3.8 3.7 6.5 9.2 9.0 8.3 3.7 9.7 4.2 5.3 7.5 5.7 6.5 11.0 7.9 4.2 22.5 4.6 4.2 10.8 5.7 2.6 8.2 4.7 6.5 7.8 7.6 4.5 3.2 5.2 6.1 13.5 13.5 2.4 1.0 6.0 3.6 2.5 5.4 3.6 3.3 5.1 5.0 3.7 4.4 3.3 4.0 3.9 3.8 2.5 4.0 2.3 2.0 3.2 2.8 1.9 2.8 2.6 2.1 1.9 2.6 2.7 2.5 1.6 2.8 1.9 2.4 4.5 9.1 0.0 3.1 0.7 5.9 2.2 7.1 2.1 5.7 7.2 4.8 3.7 4.4 10.0 1.6 1.8 0.0 9.2 5.7 6.5 1.9 4.5 3.2 4.7 5.0 7.4 7.3 6.3 0.8 2.8 27.8 7.1 4.1 5.8 5.7 36.9 22.9 3.1 5.2 8.4 2.2 6.4 0.0 4.8 1.6 1.4 37.3 4.3 1.8 4.7 5.6 5.0 4.1 2.5 5.6 3.4 4.8 17.0 4.7 11.8 4.4 3.4 1.7 2.6 13.1 8.9 4.7 6.4 11.3 4.1 3.4 23.0 4.8 15.2 7.1 9.3 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 43.0" "Group enriched" "Detected in many" 16 "Early spermatids: 343.2;Late spermatids: 1250.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favorable (1.03e-4)" 2.4 2.3 1.2 4.2 3.2 6.0 3.6 12.8 5.6 2.5 2.1 7.1 6.4 4.3 3.9 2.0 2.2 3.6 2.0 2.7 4.7 4.7 3.2 4.0 6.1 3.2 3.2 0.9 3.2 3.4 1.6 1.0 4.4 4.0 2.9 7.0 4.8 43.0 2.5 1.9 4.3 6.0 3.6 1.2 5.5 4.4 4.0 3.9 6.8 3.8 1.5 6.3 3.3 1.9 6.9 5.8 4.3 12.0 15.8 4.4 2.5 29.9 5.8 3.5 6.0 6.0 6.5 5.1 11.6 6.8 4.7 4.0 6.2 14.4 4.6 8.6 0.7 3.8 10.0 5.6 14.0 4.3 18.5 11.3 3.5 3.7 5.9 5.7 2.9 8.8 13.4 14.6 8.0 7.5 5.1 18.9 11.8 31.1 11.1 9.9 19.9 9.7 8.2 5.7 17.0 18.5 18.9 8.7 6.7 6.0 14.0 4.8 28.8 10.0 4.5 6.8 5.0 10.7 6.8 9.0 16.8 1.9 18.6 9.6 8.1 7.9 9.2 5.8 9.1 8.2 9.3 7.4 7.1 11.2 5.1 9.9 9.8 1.8 9.5 14.5 8.7 6.2 5.5 1.2 3.2 12.8 5.6 2.7 4.7 3.2 3.2 0.9 4.0 1.2 3.9 6.9 8.2 16.0 8.9 5.5 14.9 3.6 5.8 10.2 6.2 3.7 4.1 6.5 4.6 7.2 11.2 3.7 4.2 3.6 13.8 8.6 1.9 5.3 343.2 7.2 6.8 8.9 7.8 5.5 13.5 5.0 6.6 4.5 13.3 7.9 11.4 10.7 3.3 0.7 7.9 0.0 47.8 5.1 12.2 26.8 5.3 1250.3 12.2 16.7 7.2 18.7 10.5 2.3 5.2 25.6 12.7 5.0 10.6 12.0 9.3 6.8 7.7 6.2 4.5 5.6 6.6 9.3 5.1 8.8 12.3 3.7 1.6 1.4 10.6 4.7 9.0 5.5 XRCC6 "D22S671, D22S731, G22P1, KU70, ML8" ENSG00000196419 "X-ray repair cross complementing 6" P12956 22 41621163-41664048 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 579.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004254, HPA047549, HPA062226" Enhanced Enhanced Nucleoplasm No No 700000 Nucleoplasm "CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716" "unprognostic (5.55e-2)" "unprognostic (2.39e-2)" "unprognostic (1.82e-3)" "unprognostic (2.39e-1)" "unprognostic (2.47e-2)" "unprognostic (9.17e-2)" "unprognostic (1.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.89e-2)" "unprognostic (1.33e-1)" "unprognostic (2.06e-3)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" "unprognostic (4.77e-2)" "unprognostic (7.95e-2)" 143.3 184.9 81.9 154.8 86.3 220.1 144.8 84.6 101.6 148.0 84.7 155.9 138.1 155.1 112.3 193.7 152.8 106.5 171.2 84.4 92.8 138.1 143.6 134.4 198.1 86.5 85.0 81.1 171.3 120.0 157.8 123.5 156.3 87.8 133.8 166.5 116.6 131.9 145.8 275.2 168.8 144.0 162.4 88.7 144.3 139.7 233.3 85.9 226.2 139.0 186.0 224.0 164.1 143.1 93.7 554.6 388.0 527.9 455.5 313.5 279.5 413.8 394.7 464.6 794.9 656.4 570.4 335.7 886.2 319.8 478.1 357.4 400.6 739.2 486.8 803.2 493.4 921.2 478.8 435.2 559.5 281.5 1142.2 520.5 252.7 323.1 501.2 275.0 319.8 505.6 371.6 470.2 360.1 523.1 589.9 589.0 390.6 482.1 1138.4 452.1 660.0 562.3 695.6 440.4 404.4 243.3 174.6 644.1 328.2 455.7 392.9 382.2 439.0 366.2 394.3 546.2 354.0 522.4 354.0 671.9 896.1 369.4 441.3 476.4 146.0 264.3 227.6 243.6 296.5 258.4 256.5 269.5 269.2 324.1 246.9 293.2 262.5 69.2 253.2 307.0 191.7 325.9 600.8 81.9 86.3 84.6 101.6 84.4 92.8 86.5 85.0 81.1 87.8 88.7 85.9 93.7 96.6 96.1 142.5 18.6 132.6 124.0 201.0 219.0 83.1 107.1 80.1 83.4 89.4 115.8 160.4 82.8 62.6 422.3 104.9 97.3 166.3 205.4 119.6 86.1 87.0 117.0 98.6 125.4 24.5 182.7 317.2 123.9 73.4 105.9 119.7 156.4 70.3 103.7 170.2 87.5 29.5 114.7 166.8 98.1 116.7 62.9 126.8 110.4 88.9 17.8 182.8 149.7 89.6 26.2 30.5 150.9 106.6 126.7 116.0 112.0 113.7 140.3 112.6 103.6 164.3 102.4 127.4 579.8 314.4 91.5 102.1 362.2 136.9 150.6 166.8 137.5 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.7;thyroid gland: 5.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 11.7" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6" "Cell line enhanced" "Detected in many" "OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3" "Region enriched" "Detected in many" 86 "olfactory bulb: 980.0" "Region enriched" "Detected in single" 15 "olfactory bulb: 5.6" HPA064184 Approved Nucleoplasm Yes NA Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.2 0.1 0.3 0.1 0.2 0.8 0.2 0.8 0.8 0.3 0.1 0.2 1.5 0.6 0.2 0.9 0.5 1.0 0.1 0.2 0.3 0.9 0.0 0.5 1.5 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.1 3.7 0.3 0.0 0.2 0.4 1.2 0.1 0.3 0.7 5.3 0.1 0.4 1.1 0.3 0.4 2.2 5.7 0.0 0.0 0.6 0.4 0.4 1.0 1.3 0.7 1.4 0.6 4.2 0.0 3.7 2.1 0.4 1.7 0.1 1.0 0.9 0.5 0.0 2.7 2.6 0.2 0.4 0.0 3.5 0.0 1.1 2.7 0.8 0.5 0.5 0.0 0.7 0.2 3.0 0.2 0.5 1.3 0.2 34.3 9.7 0.0 1.8 1.1 11.9 19.9 17.3 0.0 0.2 9.0 0.8 1.5 0.0 0.5 0.4 0.1 1.3 2.6 1.7 0.0 0.9 0.0 0.5 0.7 0.4 0.0 0.7 1.4 1.2 0.1 4.6 0.5 2.6 1.3 1.8 0.3 1.4 0.6 1.2 0.0 0.4 3.0 3.9 0.7 0.3 0.2 0.8 0.8 0.2 0.3 0.3 0.2 0.1 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.2 3.7 0.0 0.1 0.2 0.1 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 8.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.0 0.6 3.1 0.0 0.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.3 0.6 6.8 0.3 0.6 C20orf204 "DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17" ENSG00000196421 "Chromosome 20 open reading frame 204" A0A1B0GTL2 20 64034344-64039962 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Cell type enhanced" "Detected in some" "Adipocytes: 4.5;Breast glandular cells: 1.3;Endometrial stromal cells: 2.0;Endothelial cells: 4.3;Glandular and luminal cells: 1.8;T-cells: 1.1" "Cancer enriched" "Detected in some" 6 "ovarian cancer: 7.2" "Group enriched" "Detected in some" 5 "cerebellum: 4.0;pons: 1.1" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 2.6;naive CD4 T-cell: 5.8;naive CD8 T-cell: 4.7;T-reg: 1.4" "Lineage enriched" "Detected in single" 9 "T-cells: 5.8" "Cell line enriched" "Detected in some" 7 "Hep G2: 49.0" "Low region specificity" "Detected in single" NA NA "unprognostic (2.84e-1)" "unprognostic (4.02e-2)" "unprognostic (2.36e-2)" "unprognostic (2.49e-1)" "unprognostic (9.66e-2)" "unprognostic (3.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (3.50e-1)" "unprognostic (9.20e-3)" "unprognostic (4.43e-3)" "unprognostic (4.34e-2)" "unprognostic (2.49e-6)" "unprognostic (5.83e-2)" "unprognostic (4.58e-2)" "unprognostic (1.88e-2)" "unprognostic (2.79e-4)" 0.3 0.1 0.3 0.1 0.3 0.0 0.3 4.0 0.4 0.4 0.1 0.2 0.0 0.3 0.0 0.4 0.8 0.0 0.3 0.2 0.3 0.4 0.2 0.2 0.0 0.3 0.5 0.2 0.4 0.3 0.1 0.9 0.0 1.1 0.5 0.0 0.0 0.1 0.0 0.2 0.2 0.7 0.0 0.2 0.3 0.1 0.6 0.2 1.0 0.3 0.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.2 0.0 0.0 49.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.8 0.0 0.0 5.8 4.7 0.2 0.6 0.0 0.0 1.4 0.4 0.3 0.3 4.0 0.4 0.2 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.8 2.0 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 PPP1R26 KIAA0649 ENSG00000196422 "Protein phosphatase 1 regulatory subunit 26" Q5T8A7 9 135479079-135488893 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044686, HPA063817" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA044686: AB_10795987, HPA063817: " "unprognostic (1.79e-1)" "unprognostic (8.80e-3)" "prognostic unfavorable (3.98e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.67e-1)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-2)" "unprognostic (1.50e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.93e-4)" "unprognostic (9.23e-2)" "prognostic favorable (6.20e-13)" "unprognostic (4.46e-3)" "unprognostic (8.31e-2)" "unprognostic (3.94e-1)" "unprognostic (2.07e-3)" 4.8 8.3 9.8 2.4 9.5 0.8 6.1 6.1 12.9 6.3 7.1 8.6 6.3 6.4 3.3 7.1 7.3 3.6 11.3 10.2 8.7 11.9 10.3 9.4 1.7 8.5 8.9 9.5 7.3 13.0 14.5 15.8 4.1 8.6 9.6 3.3 4.6 10.6 7.1 6.2 4.3 6.4 2.5 7.2 5.6 11.6 7.4 9.1 1.4 10.6 5.1 2.1 9.1 5.8 7.4 12.0 17.9 9.2 9.6 3.9 3.3 0.1 6.5 8.7 8.6 5.6 17.5 20.3 0.0 12.0 6.3 21.9 43.7 8.5 8.3 2.7 0.6 9.7 0.2 28.0 13.0 9.1 5.8 21.3 2.4 15.3 4.3 10.2 9.3 5.4 0.0 12.2 0.1 4.9 27.5 0.2 1.9 13.6 24.4 24.3 0.0 16.3 19.9 8.1 15.8 14.2 20.8 11.4 15.7 12.2 7.0 12.1 5.3 6.7 3.2 14.4 15.5 7.4 8.8 22.3 0.4 6.7 1.2 8.3 0.0 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.1 9.8 9.5 6.1 12.9 10.2 8.7 8.5 8.9 9.5 8.6 7.2 9.1 7.4 3.1 3.2 7.7 10.1 0.7 2.2 1.9 4.9 2.8 10.0 8.4 5.7 10.4 15.7 3.8 7.3 8.4 0.6 0.3 8.9 5.9 5.7 0.3 7.5 2.9 3.1 6.6 1.7 3.5 3.3 0.9 2.2 4.1 9.0 2.5 13.6 3.9 5.9 6.0 1.7 4.8 8.9 4.1 3.5 1.6 0.9 1.2 2.3 3.6 1.0 0.9 8.3 2.1 3.5 1.4 7.4 7.1 1.9 1.0 4.7 6.4 5.1 5.8 7.1 0.0 3.4 3.6 0.5 4.0 4.6 1.7 0.3 0.4 5.1 8.3 2.6 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.3;testis: 3.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;K-562: 10.2;Karpas-707: 3.1;MCF7: 12.6;THP-1: 3.8" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.6 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.2 3.1 0.0 12.6 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.0 0.1 3.8 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.1 0.4 0.2 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSC22D2 "KIAA0669, TILZ4a, TILZ4b, TILZ4c" ENSG00000196428 "TSC22 domain family member 2" O75157 3 150408335-150466431 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004926 Approved Approved Cytosol NA NA 100000 Cytosol "HPA004926: AB_1080401" "unprognostic (4.65e-2)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (2.49e-1)" "unprognostic (2.65e-2)" "unprognostic (1.89e-1)" "unprognostic (1.09e-2)" "unprognostic (7.63e-2)" "unprognostic (2.59e-1)" "unprognostic (2.28e-3)" "unprognostic (8.32e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.10e-2)" "unprognostic (4.86e-1)" "unprognostic (1.10e-2)" "unprognostic (3.49e-1)" 21.0 11.9 9.2 10.8 9.6 35.3 13.3 10.0 15.1 15.1 4.6 14.3 6.1 23.6 14.6 24.0 15.5 22.7 18.9 9.5 12.9 16.1 29.9 15.1 10.4 9.3 9.0 8.1 15.3 11.5 10.8 9.8 17.0 10.4 11.5 12.5 16.9 10.7 7.4 17.1 11.1 12.0 26.5 7.5 13.9 16.4 18.0 9.0 11.9 13.0 14.5 10.0 20.8 23.5 11.5 45.7 6.2 19.6 18.8 25.1 12.2 56.4 44.6 16.9 32.1 39.5 25.0 22.4 14.9 25.1 33.7 65.7 18.9 19.8 16.2 63.7 11.8 11.1 16.0 11.6 12.7 28.5 9.8 10.6 22.6 12.4 20.9 31.4 19.4 20.4 7.1 27.7 23.9 22.6 16.1 10.5 12.1 25.1 13.6 12.3 11.0 35.8 17.7 20.7 26.6 11.3 10.1 20.5 10.8 45.8 23.5 10.3 13.0 33.0 21.1 21.9 25.3 41.6 31.9 6.6 20.6 14.3 29.2 12.7 0.5 1.7 2.0 1.1 1.6 1.8 1.1 1.4 1.2 1.1 1.4 1.1 1.1 2.2 2.0 2.9 1.2 0.6 1.5 9.2 9.6 10.0 15.1 9.5 12.9 9.3 9.0 8.1 10.4 7.5 9.0 11.5 97.4 64.1 30.8 160.3 52.5 148.9 81.5 12.6 111.0 18.6 65.1 28.4 46.9 20.0 18.2 12.9 29.2 28.6 53.7 77.6 17.6 13.8 23.2 85.5 107.6 48.3 31.6 10.3 78.7 13.8 33.0 59.6 50.0 166.6 65.4 10.9 29.3 40.1 18.4 16.8 70.9 45.4 22.4 24.1 94.9 29.6 18.6 58.9 42.7 86.2 20.2 31.8 16.5 59.3 86.5 26.0 82.2 15.1 37.3 42.6 16.0 10.6 10.8 21.3 13.1 79.0 48.9 51.6 29.3 77.0 108.3 54.9 48.7 17.9 34.8 83.5 CRYBA4 ENSG00000196431 "Crystallin beta A4" P53673 22 26621963-26630669 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.1" "Cell type enhanced" "Detected in some" "Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0;testis cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 7.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 4.3;hippocampal formation: 4.0" HPA071178 Supported NA NA "HPA071178: AB_2686354" "unprognostic (6.69e-2)" "unprognostic (3.94e-3)" "unprognostic (5.61e-5)" "unprognostic (1.74e-2)" "unprognostic (5.57e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-6)" "unprognostic (2.86e-1)" "unprognostic (1.20e-6)" "unprognostic (1.87e-2)" "unprognostic (7.23e-2)" "unprognostic (7.71e-2)" "unprognostic (3.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.2 0.0 0.0 0.3 0.1 0.0 0.5 0.1 ASMT "ASMTY, HIOMT, HIOMTY" ENSG00000196433 "Acetylserotonin O-methyltransferase" P46597 X 1615059-1643081 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Melatonin biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.8;Early spermatids: 1.1;Excitatory neurons: 1.5;Extravillous trophoblasts: 1.0;Inhibitory neurons: 1.3;Oligodendrocytes: 1.3;Theca cells: 3.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 3.4" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.84e-2)" "unprognostic (1.63e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (8.55e-4)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (4.30e-3)" "unprognostic (1.56e-1)" "unprognostic (1.43e-3)" "unprognostic (2.64e-1)" "unprognostic (4.04e-3)" "unprognostic (1.49e-1)" "unprognostic (3.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" 0.3 0.8 0.5 0.3 0.6 0.7 0.4 0.5 0.9 0.7 1.2 0.4 0.0 0.6 1.8 0.2 0.5 0.2 0.3 0.6 0.9 0.3 0.3 0.3 0.2 0.5 3.4 0.5 0.4 0.4 0.1 1.4 0.1 0.5 0.5 0.0 0.4 0.3 0.2 0.2 0.4 0.4 0.2 0.3 0.6 0.4 0.4 0.4 0.1 0.5 0.1 0.1 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.0 2.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.9 0.6 0.9 0.5 3.4 0.5 0.5 0.3 0.4 0.6 0.2 0.0 1.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.0 1.5 0.0 1.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.5 3.4 0.0 0.1 NPIPB15 "LOC440348, NPIPL2" ENSG00000196436 "Nuclear pore complex interacting protein family member B15" A6NHN6 16 74377878-74392080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 56.4" "Group enriched" "Detected in many" 9 "Early spermatids: 394.8;Late spermatids: 241.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 5 "B-cells: 1.0" "Cell line enhanced" "Detected in many" "T-47d: 11.7" "HPA011188, HPA053611" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (2.23e-2)" "unprognostic (3.48e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-1)" "unprognostic (9.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" "unprognostic (5.53e-2)" "unprognostic (2.41e-2)" "unprognostic (7.73e-2)" "unprognostic (4.58e-3)" "unprognostic (1.53e-1)" "unprognostic (2.81e-2)" "unprognostic (1.97e-1)" "unprognostic (7.34e-3)" "unprognostic (2.53e-1)" "unprognostic (1.14e-3)" 8.7 8.0 1.7 0.8 2.2 4.2 10.6 2.2 4.4 9.7 1.4 14.6 4.6 4.6 0.1 13.6 9.3 2.5 7.0 1.6 2.5 16.3 35.6 11.2 3.5 2.3 2.3 1.7 8.6 20.0 1.6 19.7 3.2 3.8 26.8 12.1 3.1 26.5 1.5 4.5 11.4 20.4 1.8 1.6 13.4 19.2 56.4 2.1 2.0 17.2 0.0 2.7 11.4 9.6 4.2 2.5 0.0 2.3 1.3 2.7 1.9 0.4 1.5 2.3 1.9 5.1 1.3 0.1 4.2 0.0 3.3 0.0 4.5 0.0 2.0 1.4 0.0 2.6 0.1 6.6 2.5 1.3 1.7 8.1 2.7 3.9 3.7 2.7 2.7 0.0 0.1 0.3 1.6 1.6 3.9 0.9 0.0 0.5 1.2 0.0 0.8 2.1 2.8 0.0 1.6 3.2 0.0 6.2 0.0 4.4 0.0 11.7 2.0 0.1 1.7 4.6 0.0 0.9 5.4 1.7 1.0 2.3 1.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.7 2.2 2.2 4.4 1.6 2.5 2.3 2.3 1.7 3.8 1.6 2.1 4.2 5.7 3.2 5.9 6.2 3.8 2.0 1.8 2.5 4.0 3.5 8.0 5.0 1.3 7.2 6.1 7.3 8.4 1.9 5.3 17.4 0.0 1.7 394.8 6.0 3.1 4.1 17.5 0.4 3.6 3.8 1.0 4.5 29.6 11.3 0.0 11.7 2.9 3.3 1.3 0.0 4.2 32.8 6.1 1.5 1.3 241.9 11.5 3.1 3.6 2.8 2.8 0.8 1.0 4.5 7.9 2.6 20.4 7.5 5.8 9.6 27.4 1.4 4.6 2.6 0.0 4.3 2.7 28.4 5.3 3.1 2.7 2.5 3.5 4.7 16.2 9.7 ZNF569 "FLJ32053, ZAP1, Zfp74" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 137.7;Late spermatids: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: AB_2682007" "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 3.3 4.2 4.4 2.8 4.6 4.7 3.6 7.6 4.8 3.3 4.2 1.9 1.7 3.8 4.7 2.2 3.3 2.3 4.3 3.7 4.8 3.6 3.3 2.5 4.0 3.9 4.4 3.7 5.7 1.9 4.5 3.3 3.0 4.8 3.0 1.8 13.9 2.3 2.8 4.4 3.2 1.8 3.4 3.5 3.5 2.3 10.9 5.5 5.2 5.7 4.7 3.2 2.2 1.8 6.9 3.3 6.2 7.6 12.2 6.0 5.5 3.7 5.9 3.4 6.1 6.5 2.3 1.5 4.0 8.4 4.5 6.0 1.2 8.4 2.0 6.6 9.0 5.1 10.3 1.8 3.8 3.6 1.9 4.0 3.8 1.4 6.3 0.2 6.3 5.2 11.7 3.3 0.8 8.7 2.0 12.0 4.1 8.0 0.2 4.4 8.1 9.6 4.1 4.4 3.3 6.4 9.8 0.2 1.3 3.4 7.1 5.3 8.1 5.3 4.9 10.1 3.9 9.6 10.2 18.6 15.0 0.2 4.2 7.8 3.7 1.8 5.9 6.4 2.6 5.5 4.6 5.7 6.1 2.2 5.4 8.0 6.5 1.8 4.8 3.3 2.4 6.1 2.4 4.4 4.6 7.6 4.8 3.7 4.8 3.9 4.4 3.7 4.8 3.5 5.5 6.9 5.1 0.0 1.7 14.0 7.8 1.7 1.7 2.0 2.8 16.1 3.5 4.2 16.3 0.0 5.2 1.8 31.3 3.2 8.1 0.5 1.9 1.5 137.7 5.1 3.9 6.5 0.0 2.1 14.5 2.0 4.0 4.0 1.5 2.3 2.5 5.3 5.3 2.5 2.9 3.3 17.4 0.4 0.0 3.8 3.9 41.8 4.7 4.0 0.0 8.4 3.0 9.3 8.2 20.6 23.4 1.6 0.4 7.5 2.4 0.9 1.0 4.7 5.3 30.2 0.0 6.9 6.3 32.3 13.1 3.4 2.0 0.8 9.1 4.2 0.7 0.9 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing X-linked 4" Q5H9R4 X 101418287-101533459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 66.6;Excitatory neurons: 59.1;Inhibitory neurons: 87.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: AB_2681665" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favorable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 2.0 4.0 1.9 1.1 2.3 0.7 2.7 1.6 2.2 2.7 0.3 2.3 0.9 3.7 2.6 1.0 3.0 1.3 1.5 2.1 2.9 1.5 1.0 1.9 0.9 2.1 2.2 2.1 7.1 2.0 4.5 4.5 1.7 2.2 3.6 1.6 1.6 1.9 4.7 1.9 2.1 2.1 2.7 1.4 1.7 1.8 0.9 2.4 0.9 2.7 1.0 0.8 2.3 1.9 2.6 2.4 0.6 7.9 0.0 3.7 3.9 0.8 5.5 4.3 4.4 8.5 1.9 0.7 0.0 2.1 8.2 0.1 0.9 0.0 0.1 7.2 0.0 0.9 0.6 2.5 0.0 2.2 0.0 3.0 2.4 0.4 9.6 0.0 0.0 7.8 0.0 0.0 0.7 2.0 0.0 0.3 0.3 5.8 0.8 0.0 0.4 6.5 0.0 1.1 1.4 5.3 4.9 0.8 0.0 3.0 1.3 0.6 1.2 2.9 2.0 1.2 6.1 0.0 0.0 0.0 0.0 3.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.3 1.6 2.2 2.1 2.9 2.1 2.2 2.1 2.2 1.4 2.4 2.6 8.7 3.2 6.8 66.6 2.2 2.4 7.7 1.7 5.7 24.5 9.1 7.1 10.5 2.8 7.9 27.6 8.4 1.7 2.6 2.3 17.6 2.7 0.2 5.6 8.9 8.0 3.0 1.3 59.1 2.3 0.7 11.0 2.0 8.3 3.8 13.3 5.3 2.5 2.3 23.5 87.5 2.3 6.1 3.8 5.1 0.7 10.5 2.4 17.8 63.7 2.8 11.6 4.1 78.4 75.6 2.0 3.9 12.4 2.2 5.3 4.7 4.8 9.8 7.8 0.0 8.1 10.9 1.3 1.3 1.8 3.4 1.5 2.2 8.4 4.0 4.5 YRDC "FLJ23476, IRIP, SUA5" ENSG00000196449 "YrdC N6-threonylcarbamoyltransferase domain containing" Q86U90 1 37802945-37808208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 50.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 77.8;Prostatic glandular cells: 87.8;Urothelial cells: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "basophil: 8.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030147 Approved Approved Mitochondria NA NA Mitochondria "HPA030147: AB_10603327" "unprognostic (2.98e-2)" "unprognostic (6.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.08e-3)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.43e-2)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (3.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-2)" 10.7 11.2 8.4 9.9 8.9 50.5 11.3 10.2 9.5 6.7 8.1 9.9 8.2 7.6 8.1 16.3 8.1 8.7 7.0 9.1 9.2 10.6 14.3 9.0 10.5 9.0 8.9 8.8 7.3 14.3 10.9 10.6 13.4 9.1 8.7 12.0 8.2 9.8 6.1 8.7 15.2 8.7 9.5 8.8 9.2 10.6 17.1 9.4 8.4 9.2 5.8 11.0 16.6 9.8 9.4 25.2 17.6 18.7 23.9 12.7 14.6 53.6 20.3 16.5 31.5 19.9 23.7 23.3 60.3 32.6 20.4 36.1 20.0 35.6 32.8 29.2 36.3 35.1 42.1 21.3 24.9 27.9 55.5 41.7 15.2 48.1 35.0 50.3 20.6 22.5 45.7 66.5 26.4 25.4 17.6 32.7 32.4 70.2 36.3 37.1 32.3 30.1 39.3 26.1 25.2 48.5 49.7 22.0 28.0 72.8 33.2 15.3 24.2 20.9 26.8 28.3 29.6 67.8 53.2 81.2 50.3 23.6 35.4 43.8 8.8 0.6 0.5 0.6 0.6 0.6 0.5 0.9 0.5 0.5 0.8 1.0 1.0 0.7 0.5 0.4 0.9 1.0 0.4 8.4 8.9 10.2 9.5 9.1 9.2 9.0 8.9 8.8 9.1 8.8 9.4 9.4 31.3 0.0 9.2 3.9 21.0 50.6 77.8 6.3 29.6 10.8 28.3 25.9 3.6 10.0 5.5 5.5 6.2 24.3 23.6 7.6 23.5 7.7 3.5 16.2 15.7 22.5 15.6 17.2 3.5 9.2 48.5 14.4 10.2 25.4 7.0 13.0 10.8 12.5 12.7 21.9 3.8 10.2 4.1 9.4 19.1 1.8 4.1 15.3 5.4 3.7 6.3 10.9 4.1 3.0 5.0 15.9 7.1 4.1 25.6 87.8 6.1 16.8 4.9 8.8 6.6 12.5 22.0 19.4 37.4 28.6 49.3 40.6 20.2 14.2 11.7 92.7 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461062 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 7.1 6.7 5.3 4.5 4.7 8.0 7.8 5.2 7.1 8.7 1.8 8.0 4.6 10.4 3.4 6.3 8.5 3.7 6.8 5.2 5.1 6.2 7.4 5.3 5.2 5.3 4.5 4.8 10.0 7.6 6.5 8.6 5.0 4.8 8.9 3.4 3.4 7.5 5.2 14.0 11.7 6.3 5.2 4.0 6.7 7.4 6.7 4.7 5.7 7.4 7.1 3.9 9.1 8.0 4.8 14.9 18.0 11.9 17.3 8.7 7.0 15.3 9.4 9.9 12.5 10.8 11.3 9.3 9.4 18.5 10.7 7.7 9.7 11.7 14.3 6.8 15.3 17.8 9.2 5.0 11.4 14.7 13.2 12.9 8.3 16.1 10.1 14.6 6.6 6.8 12.4 30.2 0.0 7.2 19.2 27.9 18.0 14.5 6.6 10.5 22.7 6.1 19.8 7.7 11.4 12.9 18.1 16.2 16.5 15.7 4.3 7.8 21.7 10.7 10.4 4.1 20.8 15.5 8.6 8.2 4.4 7.8 9.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.7 5.2 7.1 5.2 5.1 5.3 4.5 4.8 4.8 4.0 4.7 4.8 4.0 0.0 1.7 5.9 3.8 1.1 1.4 0.3 2.8 6.5 3.9 5.5 2.9 2.8 0.1 1.8 6.2 2.0 4.2 3.1 0.0 1.2 2.6 2.9 4.8 2.9 1.8 6.6 6.9 1.0 3.8 2.8 2.0 4.5 0.0 8.2 2.9 5.7 1.6 1.7 6.7 3.1 0.0 2.2 1.3 3.8 2.8 2.0 0.0 4.7 0.2 5.5 2.1 3.0 3.5 1.1 3.1 3.4 1.6 2.4 1.4 1.6 0.8 5.5 0.0 5.2 3.7 1.5 4.6 2.5 1.8 3.8 3.5 6.6 2.8 1.0 PIK3R4 "p150, VPS15" ENSG00000196455 "Phosphoinositide-3-kinase regulatory subunit 4" Q99570 3 130678934-130746829 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036032, HPA036033" Approved Approved Vesicles,Microtubules NA NA Vesicles Microtubules "HPA036032: AB_10610281, HPA036033: AB_2674911" "unprognostic (7.50e-2)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (4.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (1.02e-3)" "unprognostic (7.26e-2)" "prognostic favorable (4.40e-6)" "unprognostic (8.25e-2)" "unprognostic (3.72e-1)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" 8.9 8.6 3.3 7.8 4.2 9.0 10.2 5.3 4.6 9.4 4.9 8.2 7.6 10.2 7.9 8.0 9.2 7.2 7.6 3.8 4.5 10.6 21.3 9.7 9.4 3.5 4.0 3.2 12.5 7.0 17.8 6.1 9.7 3.7 9.9 8.2 16.7 7.6 9.7 7.3 7.7 8.0 10.4 2.8 10.1 7.6 11.5 3.6 11.5 13.2 8.6 10.5 9.1 6.5 7.1 20.7 12.9 18.5 13.4 26.6 21.1 12.8 15.0 17.9 20.2 23.3 16.7 17.1 24.2 18.4 15.2 16.1 28.7 30.7 23.3 31.6 14.7 11.3 19.7 13.8 11.7 12.2 30.3 9.5 14.7 16.4 21.7 13.6 12.6 19.0 13.8 23.3 11.9 18.1 18.1 24.9 9.2 23.3 18.6 12.4 17.2 21.4 21.9 13.2 16.7 17.0 12.4 21.6 13.4 15.3 21.5 18.6 13.1 15.2 15.5 13.3 17.6 12.2 13.8 13.5 31.2 17.0 11.3 14.7 9.7 5.3 7.0 6.3 6.0 9.3 5.6 5.7 4.7 6.9 3.5 6.6 6.0 4.4 8.5 6.6 2.4 6.8 5.3 3.3 4.2 5.3 4.6 3.8 4.5 3.5 4.0 3.2 3.7 2.8 3.6 7.1 8.3 6.4 8.7 18.6 8.8 3.8 3.9 5.7 10.8 8.1 5.7 4.7 7.7 8.6 9.6 11.0 14.6 5.6 7.2 5.5 1.9 5.0 4.4 8.9 7.5 8.9 3.0 9.2 28.5 5.8 3.4 6.9 13.3 9.9 9.5 9.5 7.5 18.2 5.9 5.0 30.3 6.8 8.2 6.4 2.6 3.1 9.6 7.3 5.4 20.6 7.1 9.0 6.2 22.1 32.9 6.6 4.3 11.7 6.9 4.8 6.2 4.2 12.6 12.6 6.6 8.9 6.2 17.0 13.9 9.5 4.4 4.2 7.5 9.6 6.1 3.4 ZNF775 MGC33584 ENSG00000196456 "Zinc finger protein 775" Q96BV0 7 150368790-150398630 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 21.2;Granulosa cells: 26.5;Horizontal cells: 30.3;Muller glia cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 18.9;RPMI-8226: 23.0" "Not detected" "Not detected" NA NA "unprognostic (9.67e-3)" "unprognostic (6.96e-2)" "unprognostic (1.06e-2)" "unprognostic (8.47e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (5.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (1.49e-1)" "prognostic favorable (2.84e-4)" "unprognostic (1.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.84e-2)" "unprognostic (1.28e-2)" 3.0 3.8 8.2 2.7 10.3 1.7 3.2 9.2 9.1 6.2 3.7 9.8 3.0 7.4 1.9 2.3 6.3 1.1 4.1 6.9 7.1 3.3 1.7 3.3 3.0 10.2 9.1 6.3 8.8 3.8 2.1 7.2 1.4 11.2 6.4 1.9 2.5 3.1 2.5 5.4 2.9 4.2 1.4 8.5 4.2 4.0 6.3 8.6 3.5 3.6 1.0 2.0 6.4 4.1 12.8 1.4 4.4 4.7 4.5 1.6 1.6 1.2 1.9 2.5 2.4 3.1 1.4 3.7 6.3 4.8 1.2 4.3 1.7 1.5 1.7 0.2 10.1 6.5 4.4 1.0 2.6 3.6 1.1 1.8 1.8 2.2 2.9 0.5 2.6 4.2 7.8 9.9 4.7 1.4 1.2 18.9 4.9 14.4 2.6 6.9 8.9 7.4 23.0 0.4 1.5 13.8 18.3 1.7 0.5 6.9 3.7 1.0 3.8 3.8 5.1 2.9 3.9 3.7 9.5 3.6 4.5 5.0 4.3 5.7 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.1 8.2 10.3 9.2 9.1 6.9 7.1 10.2 9.1 6.3 11.2 8.5 8.6 12.8 3.9 0.0 0.0 9.4 8.9 2.7 0.8 2.8 0.6 21.2 2.2 4.7 8.1 0.0 1.4 0.0 10.4 1.3 2.4 7.1 0.0 0.9 2.5 2.9 3.8 4.3 15.6 0.4 1.4 0.6 1.0 3.2 1.5 2.0 4.5 26.5 1.4 1.2 3.1 30.3 2.1 7.1 2.0 1.2 6.2 1.3 4.1 1.7 5.4 3.7 1.6 29.0 3.1 5.0 11.5 1.0 2.5 4.9 1.2 1.3 1.6 1.1 2.5 13.7 0.0 4.4 6.4 1.4 2.1 0.2 3.8 0.4 2.5 12.8 7.7 0.1 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918306-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061970: AB_2684649, HPA062655: AB_2684820" "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 2.7 4.2 5.9 2.6 6.0 1.4 5.3 7.5 7.1 4.6 6.2 4.6 2.9 4.3 5.4 3.5 4.6 2.7 4.3 5.9 4.9 4.4 4.4 2.9 3.2 5.9 5.3 5.4 5.4 4.0 6.2 6.8 3.3 6.7 5.3 2.8 8.5 4.5 3.8 4.2 5.0 4.2 3.2 4.6 3.9 4.0 2.1 5.4 4.0 6.9 5.2 2.9 4.4 4.2 6.7 4.8 3.8 9.7 9.2 5.2 10.7 7.2 6.5 3.7 2.9 2.1 0.6 0.6 2.0 3.4 5.6 3.6 2.6 4.2 1.6 3.6 1.6 7.2 9.2 3.4 3.0 3.9 3.9 9.7 6.8 7.0 2.0 4.4 9.0 2.2 4.7 1.4 0.1 7.4 1.3 5.1 5.4 7.5 1.3 5.2 4.7 6.3 1.4 5.0 8.1 6.2 7.1 2.9 1.7 4.5 5.7 10.6 11.1 4.4 3.6 5.8 5.4 2.6 0.0 0.0 1.6 0.1 3.2 2.2 0.4 0.2 0.2 0.2 0.1 0.1 0.5 0.2 0.3 0.1 0.3 0.5 0.3 0.3 0.3 0.1 0.2 0.0 0.1 5.9 6.0 7.5 7.1 5.9 4.9 5.9 5.3 5.4 6.7 4.6 5.4 6.7 8.4 19.2 33.5 21.9 9.3 3.4 8.1 3.3 18.8 33.6 10.5 11.2 22.5 15.7 25.1 9.2 29.2 7.5 5.0 7.3 9.8 7.2 2.2 8.1 15.0 12.7 6.1 7.6 24.9 3.3 3.6 12.6 15.3 7.1 10.1 20.2 13.6 4.9 3.9 40.4 25.2 10.1 6.1 7.3 2.7 2.5 15.8 6.1 0.0 11.2 8.9 16.4 13.4 28.1 15.8 7.5 4.5 13.5 5.8 9.5 5.8 5.2 13.7 35.2 13.1 16.2 11.5 6.8 7.9 9.4 4.5 5.6 10.8 23.0 7.1 6.2 TRAPPC2 "hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L" ENSG00000196459 "Trafficking protein particle complex 2" P0DI81 X 13712244-13734635 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004665, HPA063308" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "CAB004665: AB_425678, HPA063308: AB_2684982" "unprognostic (1.97e-1)" "prognostic favorable (8.09e-4)" "unprognostic (2.13e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "unprognostic (2.70e-2)" "unprognostic (1.04e-2)" "unprognostic (2.08e-3)" "unprognostic (1.76e-2)" "prognostic favorable (6.35e-4)" "unprognostic (3.50e-2)" "unprognostic (8.24e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (2.36e-1)" "prognostic favorable (7.89e-5)" 5.7 5.8 13.3 6.8 14.3 7.7 6.8 13.8 14.3 9.6 11.3 9.8 6.1 11.1 6.3 8.4 9.5 5.6 5.2 14.2 13.5 7.2 8.3 7.6 12.8 13.2 12.0 14.7 11.2 9.3 5.3 7.8 5.3 13.6 8.4 6.5 10.3 7.3 5.2 4.4 7.4 9.7 8.9 11.6 10.4 9.7 3.2 14.5 9.1 7.8 2.7 11.9 9.0 10.0 13.9 9.1 6.2 10.5 26.1 8.0 5.9 3.7 8.5 7.8 6.7 6.9 5.8 11.0 14.8 13.2 6.9 8.8 11.0 13.8 12.4 8.6 15.3 20.4 11.3 16.0 5.2 6.4 15.9 20.8 8.0 7.0 14.7 17.1 13.4 6.3 11.1 15.0 26.3 7.3 16.0 16.0 21.7 10.6 7.2 11.4 15.3 14.3 14.6 10.8 5.5 10.6 13.6 14.5 12.1 11.0 16.3 13.5 10.6 7.9 6.7 6.2 11.4 5.5 13.3 13.8 19.6 6.0 10.5 6.4 19.3 6.0 11.0 18.1 8.4 18.2 13.2 14.3 17.8 5.5 12.8 11.8 16.6 11.7 22.9 6.9 13.0 18.7 11.1 13.3 14.3 13.8 14.3 14.2 13.5 13.2 12.0 14.7 13.6 11.6 14.5 13.9 8.9 9.6 6.5 7.8 22.0 15.2 10.0 14.8 9.6 16.5 16.5 13.6 11.0 15.7 14.6 9.2 12.5 14.1 49.8 14.6 21.5 10.0 17.7 17.3 11.0 9.3 12.1 12.4 20.7 13.4 19.9 11.5 14.8 21.2 9.5 16.9 16.8 12.2 11.6 20.2 20.2 14.0 8.2 12.9 14.4 6.1 12.8 13.6 8.8 10.3 12.0 8.8 44.3 31.7 17.3 15.7 18.6 11.3 17.6 9.8 15.4 23.8 8.5 14.5 6.6 8.6 18.5 4.3 4.0 11.3 17.6 17.9 28.8 16.6 13.2 12.5 RFX8 FLJ42986 ENSG00000196460 "Regulatory factor X8" Q6ZV50 2 101397359-101475112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8" "Cell type enhanced" "Detected in some" "Early spermatids: 16.6;Excitatory neurons: 11.5;Inhibitory neurons: 4.5;Late spermatids: 10.2;Spermatocytes: 8.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.6;hTEC/SVTERT24-B: 16.8;LHCN-M2: 6.9;U-87 MG: 9.6;U-937: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA059745: AB_2684120" "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 0.6 0.1 0.0 0.1 0.0 3.8 0.8 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.7 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 5.6 0.0 2.1 1.7 1.3 1.7 0.0 3.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 2.0 0.0 16.8 0.1 0.0 0.0 0.6 0.0 0.0 6.9 0.0 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.2 0.2 0.0 1.9 3.1 0.0 0.0 0.0 9.6 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 16.6 1.4 0.1 1.0 0.0 0.0 11.5 0.0 0.7 2.6 0.0 0.5 0.0 0.1 0.7 0.0 0.1 0.0 4.5 0.0 0.0 0.3 1.6 10.2 0.3 0.4 0.0 2.8 0.0 0.0 0.0 0.5 1.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 1.3 8.5 1.5 0.0 0.0 1.4 0.1 0.0 0.0 0.1 MYL6B MLC1SA ENSG00000196465 "Myosin light chain 6B" P14649 12 56152256-56159647 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 640.3;tongue: 393.9" "Group enriched" "Detected in all" 4 "Early spermatids: 340.7;Late spermatids: 1215.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 18.4" "Group enriched" "Detected in all" 5 "B-cells: 6.3;dendritic cells: 18.4;T-cells: 14.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038887, HPA046859, HPA063034" Enhanced NA NA 7200000 "HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (5.25e-2)" "unprognostic (3.18e-1)" "unprognostic (6.29e-3)" "unprognostic (7.39e-2)" "unprognostic (5.37e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (1.02e-3)" "unprognostic (3.48e-1)" "unprognostic (1.53e-1)" "unprognostic (3.56e-3)" "unprognostic (3.42e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-2)" 20.2 27.6 129.5 13.9 130.3 17.2 24.0 122.7 178.4 38.6 107.4 19.6 7.6 27.3 34.8 23.6 36.6 27.8 42.8 130.5 129.4 36.8 17.1 16.4 22.1 123.4 124.8 130.1 54.8 12.8 78.1 72.5 14.2 124.0 36.5 10.3 23.8 23.3 21.4 640.3 20.3 14.6 23.0 120.5 16.3 18.4 141.1 126.7 43.5 29.6 393.9 26.0 19.1 26.6 123.3 34.1 57.4 152.1 146.4 31.6 112.7 106.0 39.0 170.0 150.8 146.4 41.3 55.4 56.6 83.6 83.9 57.8 19.1 72.2 94.4 80.6 102.9 104.9 59.6 54.8 73.6 99.5 43.7 40.0 189.4 37.6 140.0 54.1 320.2 165.6 134.8 64.2 56.6 126.0 44.5 121.0 145.3 128.3 32.1 97.5 125.7 94.4 75.1 117.0 22.7 139.3 204.6 43.1 52.6 80.4 110.6 43.0 74.0 93.2 88.3 75.1 46.1 84.8 79.9 49.2 47.5 94.7 43.9 98.8 0.9 2.8 0.9 2.0 2.7 1.1 6.3 4.0 3.3 6.4 4.0 3.0 2.5 2.1 2.3 1.1 18.4 14.9 4.3 129.5 130.3 122.7 178.4 130.5 129.4 123.4 124.8 130.1 124.0 120.5 126.7 123.3 29.4 67.3 32.4 13.4 28.2 33.1 54.6 72.4 67.7 59.6 67.4 101.7 17.6 38.6 30.6 110.3 25.0 34.2 24.1 21.5 150.6 50.4 340.7 83.0 58.9 44.0 157.4 24.6 18.9 20.2 68.3 55.3 26.0 93.1 12.7 134.9 53.9 32.2 43.5 33.7 23.7 35.0 46.8 22.3 25.0 1215.9 80.8 19.1 40.9 6.5 47.7 149.9 4.1 11.6 7.6 26.9 19.5 66.5 44.2 39.4 28.0 156.4 23.9 51.4 52.6 63.2 53.0 126.4 54.4 71.3 25.4 22.6 15.6 52.2 32.7 47.9 ZNF799 "HIT-40, MGC71805, ZNF842" ENSG00000196466 "Zinc finger protein 799" Q96GE5 19 12390016-12401271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" "unprognostic (2.96e-1)" "unprognostic (1.10e-1)" "unprognostic (8.84e-2)" "prognostic favorable (2.39e-4)" "unprognostic (3.63e-2)" "unprognostic (5.18e-3)" "unprognostic (3.02e-1)" "unprognostic (8.83e-3)" "unprognostic (4.47e-5)" "unprognostic (1.45e-1)" "unprognostic (5.56e-3)" "unprognostic (6.55e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.04e-1)" "unprognostic (8.91e-3)" "unprognostic (1.23e-3)" 2.7 3.0 2.5 1.5 2.6 1.6 3.8 3.3 2.7 3.4 2.4 2.6 2.2 2.9 2.1 1.8 3.9 2.1 1.8 2.6 2.3 2.9 3.8 2.9 2.7 2.7 2.5 2.3 4.5 2.2 2.4 1.1 4.8 2.7 2.6 2.7 1.6 2.2 2.3 1.9 2.2 2.5 2.4 2.5 3.0 2.0 2.7 3.0 3.2 2.0 2.4 2.3 2.7 2.7 2.9 3.0 2.4 3.0 7.2 1.6 1.5 6.0 1.6 2.2 3.9 3.7 4.6 1.2 3.8 2.8 1.9 1.9 2.1 2.4 2.8 3.7 0.0 2.2 3.0 2.0 7.5 0.5 2.3 5.3 1.8 1.7 2.8 2.2 1.2 1.9 3.6 3.1 0.0 2.5 4.2 4.8 3.3 1.6 3.9 6.1 0.5 4.5 3.9 4.0 7.2 1.9 2.2 2.9 0.7 0.9 2.2 3.2 4.2 1.8 4.0 2.3 4.8 1.8 2.6 4.4 3.0 0.4 2.4 1.7 3.1 2.6 2.9 3.9 2.6 4.5 4.7 3.6 5.7 2.1 4.4 3.4 2.7 2.5 2.8 1.6 2.7 4.5 2.3 2.5 2.6 3.3 2.7 2.6 2.3 2.7 2.5 2.3 2.7 2.5 3.0 2.9 7.5 6.4 1.5 5.2 3.8 2.4 3.1 1.4 4.6 1.8 5.6 4.3 5.4 1.5 2.0 3.7 0.0 15.2 3.0 3.2 5.9 4.6 8.6 8.0 2.4 7.3 4.2 0.8 5.4 1.3 2.9 2.9 2.6 8.5 3.8 2.9 3.3 1.4 4.4 0.0 4.0 5.7 6.1 1.2 2.6 2.3 2.5 2.2 0.0 10.3 2.1 1.3 6.2 8.0 4.7 2.5 2.3 1.2 2.0 2.1 3.6 2.9 4.7 3.1 13.1 2.8 4.6 4.5 5.6 4.0 1.4 4.5 3.7 1.9 4.0 2.6 FGF16 MF4 ENSG00000196468 "Fibroblast growth factor 16" O43320 X 77447389-77457278 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "choroid plexus: 1.4" "Cell type enhanced" "Detected in some" "Fibroblasts: 1.5;Melanocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 22.5" "Group enriched" "Detected in some" 6 "basal ganglia: 3.6;hippocampal formation: 2.0;olfactory bulb: 6.7" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (4.01e-2)" "unprognostic (5.30e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.31e-1)" "unprognostic (6.57e-2)" "unprognostic (1.49e-2)" 0.5 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Cytotrophoblasts: 187.4;Syncytiotrophoblasts: 746.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 23.1 14.2 13.2 10.9 14.5 28.5 23.0 17.2 16.1 19.2 14.8 16.0 16.1 19.6 15.7 14.1 17.5 15.9 15.1 13.3 14.0 14.8 22.8 17.8 14.1 14.5 13.4 12.9 19.4 14.2 14.7 10.4 50.5 14.9 16.9 14.7 19.3 16.3 14.0 21.7 21.7 16.4 14.6 13.6 13.5 15.8 23.5 17.0 14.2 17.7 17.5 13.2 14.2 17.3 17.9 15.5 13.7 29.1 26.3 24.5 21.3 29.6 14.2 19.2 20.6 10.1 10.5 19.7 20.1 15.3 18.0 14.4 17.6 20.3 20.7 25.3 8.1 16.4 10.8 10.6 27.8 34.2 10.7 15.8 25.8 36.5 12.1 27.9 23.1 17.5 18.5 17.7 18.4 17.0 10.6 29.1 21.9 35.5 17.1 21.0 33.3 43.7 21.3 19.5 19.3 33.1 29.3 42.0 20.9 37.7 24.8 13.3 24.4 18.8 22.0 19.8 12.0 15.4 24.0 10.7 36.8 16.3 13.1 20.2 13.7 8.1 35.4 4.1 3.6 4.5 20.4 4.4 6.3 13.0 19.2 8.7 6.6 4.7 8.7 2.2 12.5 2.5 5.8 13.2 14.5 17.2 16.1 13.3 14.0 14.5 13.4 12.9 14.9 13.6 17.0 17.9 43.0 12.8 9.7 8.8 24.7 85.7 55.7 45.0 71.2 22.3 43.5 32.0 13.3 20.0 20.5 16.5 8.4 187.4 15.3 27.3 31.3 24.5 70.5 21.9 26.7 35.7 22.6 27.0 20.1 22.7 34.0 42.5 21.9 34.5 4.5 37.8 33.9 23.6 34.3 35.3 20.9 17.8 40.7 20.3 99.2 71.3 22.7 31.1 49.8 23.4 27.0 38.3 4.1 25.6 40.2 22.3 18.2 19.5 17.9 49.7 23.5 28.9 17.0 18.6 19.7 36.2 34.4 70.0 51.0 67.7 75.7 746.2 17.3 17.4 20.6 50.8 GK2 "GKP2, GKTA" ENSG00000196475 "Glycerol kinase 2" Q14410 4 79406361-79408228 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 90.3" "Group enriched" "Detected in some" 92 "Early spermatids: 589.0;Late spermatids: 163.3;Spermatocytes: 194.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "SCLC-21H: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060687 Uncertain NA NA "HPA060687: AB_2684343" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 90.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 589.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.3 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf96 dJ1103G7.2 ENSG00000196476 "Chromosome 20 open reading frame 96" Q9NUD7 20 270863-290778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 109.6;Endometrial ciliated cells: 89.2;Respiratory ciliated cells: 106.2;Spermatocytes: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048649, HPA056227" Approved Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA048649: AB_2680476, HPA056227: " "unprognostic (1.59e-2)" "unprognostic (4.15e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (6.12e-5)" "unprognostic (4.62e-2)" "unprognostic (5.12e-1)" "unprognostic (3.24e-1)" "prognostic favorable (4.12e-5)" "unprognostic (2.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "prognostic favorable (1.05e-4)" 6.3 10.6 16.5 5.3 12.9 8.2 10.3 14.4 13.6 15.5 18.3 11.1 9.7 16.7 20.9 4.5 33.8 8.9 7.7 12.9 15.7 13.7 6.2 10.3 5.4 15.9 16.4 11.3 20.5 9.3 8.5 17.5 3.8 16.2 14.0 8.4 11.3 9.9 7.8 3.6 3.6 9.3 10.4 17.2 9.7 9.8 30.3 14.6 6.7 17.3 2.4 4.7 9.0 8.2 14.6 7.5 23.3 23.9 21.1 6.2 6.0 10.6 5.3 6.8 7.7 10.3 4.5 14.3 18.7 3.4 6.4 13.4 6.4 8.9 4.1 8.9 4.7 13.9 12.5 0.2 25.6 17.2 10.3 5.2 8.3 3.5 13.2 1.6 19.4 15.6 23.6 25.9 9.1 6.7 3.7 12.2 39.9 7.9 7.4 10.1 36.9 4.2 15.4 12.1 11.5 2.5 21.3 6.3 9.0 15.3 11.0 15.6 22.7 10.5 7.6 13.1 6.8 4.4 20.7 22.5 12.8 4.2 31.9 7.2 0.0 1.3 0.0 0.6 1.0 0.4 1.6 0.4 0.5 3.0 1.7 0.9 1.2 0.0 1.3 0.7 1.4 0.6 0.8 16.5 12.9 14.4 13.6 12.9 15.7 15.9 16.4 11.3 16.2 17.2 14.6 14.6 7.2 3.2 3.6 13.4 4.1 3.7 5.5 9.9 9.1 3.8 21.8 19.2 0.8 11.5 12.5 18.4 6.2 5.1 2.8 5.0 39.2 11.4 109.6 89.2 11.0 10.4 8.4 9.7 5.1 6.9 3.1 9.1 15.8 7.1 14.7 18.6 9.7 3.4 9.1 6.7 4.0 8.1 26.4 3.8 3.3 35.8 10.8 7.7 3.6 4.7 3.7 7.7 4.1 2.0 4.6 8.5 1.9 18.0 10.7 4.9 4.6 23.1 106.2 9.8 6.6 6.5 8.7 60.8 45.1 4.3 1.6 2.7 4.1 9.8 9.3 4.2 ESRRG "ERR-gamma, ERRg, NR3B3" ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.6;parathyroid gland: 46.7;retina: 36.5;stomach 1: 35.5" "Group enriched" "Detected in many" 4 "Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 23.0;SH-SY5Y: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.4 6.5 3.6 0.2 4.3 0.0 3.6 16.5 14.4 1.5 5.8 0.5 5.3 0.4 1.0 1.6 2.5 0.7 10.7 6.4 6.1 29.3 0.8 0.5 0.2 38.1 16.1 1.6 0.7 5.8 46.7 1.5 10.7 50.6 3.2 0.3 36.5 16.1 0.7 5.8 0.8 5.0 0.2 1.7 1.1 35.5 1.1 8.9 0.6 6.0 10.3 0.3 0.7 0.2 36.3 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.0 0.0 23.0 3.4 2.5 8.1 42.4 0.0 0.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 4.3 16.5 14.4 6.4 6.1 38.1 16.1 1.6 50.6 1.7 8.9 36.3 0.2 0.0 1.8 330.7 0.2 0.3 3.8 0.6 0.6 29.5 9.5 5.2 51.2 10.0 1.8 23.9 58.4 35.4 0.0 0.0 54.8 5.0 5.1 15.9 2.0 1.3 8.3 0.0 415.2 2.4 4.7 3.0 70.3 3.5 0.0 0.5 1.1 0.6 4.8 48.8 495.5 1.7 14.2 0.3 0.4 8.1 0.3 0.5 8.8 36.5 0.0 13.3 0.0 391.6 218.7 0.4 1.3 0.7 0.1 4.9 16.3 29.0 16.0 41.3 0.0 10.3 0.4 1.6 0.3 0.8 0.3 214.9 0.3 1.1 2.6 1.7 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188869 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.7" "Group enriched" "Detected in many" 4 "Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA 17000 Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 7.7 13.3 1.4 4.8 1.0 4.2 8.1 1.2 1.6 6.8 3.6 6.9 3.2 7.8 2.0 14.1 8.1 1.1 6.7 1.1 1.7 14.1 14.9 6.8 2.9 1.4 1.2 0.8 6.9 27.9 2.6 9.5 2.6 1.4 6.8 1.4 0.3 8.8 3.6 21.1 10.6 5.9 1.9 1.2 7.4 8.7 40.7 1.7 2.2 7.0 1.0 1.8 8.7 7.1 1.9 21.9 49.2 6.0 36.0 4.1 8.6 28.4 14.8 6.3 23.5 12.5 39.2 22.4 31.3 16.1 10.6 12.2 25.6 20.4 28.8 2.6 12.1 29.8 20.4 18.6 77.0 8.7 45.4 18.1 7.5 12.3 24.3 6.0 5.3 11.8 15.8 37.5 8.5 15.0 76.6 21.8 21.2 29.1 28.5 41.7 24.4 17.3 23.2 12.6 25.7 29.3 21.1 19.7 31.8 13.9 2.9 27.1 14.7 12.4 22.9 30.8 21.0 32.4 19.8 27.1 34.2 10.8 19.3 31.8 0.0 1.1 0.4 3.3 1.9 3.8 1.8 2.8 2.7 2.4 2.6 2.3 2.9 0.0 2.7 2.4 3.2 1.7 1.9 1.4 1.0 1.2 1.6 1.1 1.7 1.4 1.2 0.8 1.4 1.2 1.7 1.9 3.5 0.0 7.9 0.7 4.9 5.9 3.8 5.0 4.6 0.8 11.1 9.7 1.6 8.6 8.7 5.5 4.2 12.1 5.5 3.1 0.0 13.3 80.5 8.3 3.9 5.6 4.2 3.4 1.3 11.0 11.1 4.5 1.1 5.0 0.0 3.1 2.9 5.8 7.9 1.7 1.1 5.9 2.0 2.2 2.6 118.0 5.0 1.3 0.0 0.0 1.7 1.6 2.1 1.0 0.8 6.8 2.5 5.7 2.9 6.1 0.7 11.7 15.1 2.7 6.6 7.0 4.7 52.1 18.8 3.9 6.3 5.9 3.1 6.1 10.4 2.7 NCOR2 "CTG26, SMRT, SMRTE, TNRC14, TRAC-1" ENSG00000196498 "Nuclear receptor corepressor 2" Q9Y618 12 124324415-124567589 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.0;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 4 "granulocytes: 6.0;monocytes: 2.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001928 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA001928: AB_1079454" "unprognostic (9.51e-3)" "unprognostic (7.37e-3)" "unprognostic (4.66e-2)" "unprognostic (2.55e-3)" "unprognostic (2.14e-1)" "unprognostic (7.37e-2)" "unprognostic (3.19e-2)" "unprognostic (8.86e-2)" "unprognostic (2.21e-2)" "unprognostic (2.90e-3)" "unprognostic (6.42e-3)" "unprognostic (1.96e-1)" "unprognostic (9.86e-2)" "unprognostic (6.26e-2)" "unprognostic (1.59e-1)" "unprognostic (7.56e-2)" "unprognostic (8.90e-2)" 45.3 51.6 42.2 34.6 16.5 30.1 50.1 24.4 47.6 58.0 12.0 47.8 25.4 59.1 9.1 33.5 49.4 21.6 56.1 63.5 7.8 34.5 27.7 63.4 19.7 50.1 29.6 6.3 71.4 49.7 18.3 84.8 20.3 52.7 58.2 11.0 20.9 55.5 22.2 110.2 54.9 37.1 22.7 5.8 35.9 46.2 26.3 24.2 20.1 40.8 20.1 11.3 47.8 44.2 26.3 78.6 143.6 40.4 38.7 23.0 31.1 120.4 79.3 39.0 45.2 20.1 76.9 56.3 78.7 57.0 65.1 40.7 72.6 16.2 84.7 18.5 83.6 31.5 63.6 142.1 48.0 46.0 48.3 77.5 50.1 30.9 56.6 33.4 69.2 43.7 35.5 83.3 22.9 41.2 67.4 174.3 55.5 56.4 29.8 139.0 55.8 67.1 40.2 21.6 89.9 106.0 77.1 97.3 81.1 47.7 30.2 66.3 59.8 212.0 104.5 178.9 104.3 170.5 43.5 48.0 48.1 59.4 35.4 100.1 6.0 0.4 1.0 1.0 0.2 0.3 0.3 0.3 0.8 0.2 0.1 0.3 0.2 0.9 0.1 2.5 0.9 0.0 0.3 42.2 16.5 24.4 47.6 63.5 7.8 50.1 29.6 6.3 52.7 5.8 24.2 26.3 30.6 115.4 58.9 46.4 14.7 33.3 24.6 22.2 33.0 95.3 33.3 28.3 30.4 18.6 38.8 18.4 39.6 8.8 27.4 39.1 3.9 22.1 2.2 28.0 53.4 28.2 18.7 11.6 61.9 27.2 39.7 50.6 37.8 32.4 42.3 43.5 18.5 19.0 28.4 121.1 37.0 20.3 4.1 50.0 48.7 7.1 62.1 44.8 16.0 51.5 27.0 28.0 20.6 70.9 65.9 38.0 22.2 65.1 22.6 23.7 25.4 8.0 16.8 65.9 6.6 63.0 35.5 1.8 11.6 17.7 24.4 12.6 25.1 69.4 21.9 23.1 SULT1A1 "P-PST, STP, STP1" ENSG00000196502 "Sulfotransferase family 1A member 1" P50225 16 28603944-28623625 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 136.2;liver: 250.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 321.6;Hepatocytes: 229.6;Kupffer cells: 214.1;Paneth cells: 309.3;Proximal enterocytes: 926.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 257.6;intermediate monocyte: 212.2;myeloid DC: 116.3;neutrophil: 246.7;non-classical monocyte: 122.6" "Group enriched" "Detected in all" 33 "dendritic cells: 116.3;granulocytes: 246.7;monocytes: 257.6" "Group enriched" "Detected in many" 4 "EFO-21: 171.0;Hep G2: 353.6" "HPA049500, HPA051051" Supported NA NA "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (2.57e-2)" "unprognostic (2.80e-2)" "unprognostic (8.40e-2)" "unprognostic (1.30e-1)" "unprognostic (5.60e-3)" "unprognostic (7.63e-2)" "unprognostic (4.17e-2)" "prognostic favorable (7.02e-4)" "unprognostic (1.30e-1)" "unprognostic (2.40e-1)" "unprognostic (6.71e-2)" "unprognostic (2.07e-1)" "unprognostic (3.70e-3)" "unprognostic (1.49e-1)" "unprognostic (4.10e-2)" "unprognostic (7.39e-2)" "unprognostic (1.89e-2)" 24.9 100.9 19.2 10.7 19.0 23.9 15.4 19.2 23.7 8.8 27.4 53.6 136.2 7.3 32.6 5.1 14.3 11.0 22.4 20.2 24.1 30.9 250.9 47.0 15.3 20.5 19.4 18.0 7.3 17.9 23.6 24.4 12.5 20.0 9.0 42.1 6.0 26.4 20.5 11.4 2.9 105.2 11.2 18.7 66.8 22.4 13.9 19.7 7.7 35.6 4.8 4.2 13.8 5.1 22.3 6.6 1.5 2.7 10.9 0.0 0.0 23.2 0.0 0.2 0.1 0.0 0.9 42.2 0.3 171.0 0.2 1.6 0.4 3.1 12.1 0.3 0.7 30.8 7.2 13.1 353.6 18.3 0.0 12.6 1.1 0.9 0.0 0.0 0.2 2.9 11.9 4.4 4.2 3.0 39.9 0.7 11.0 2.5 1.8 0.1 11.6 1.3 20.5 2.9 2.9 6.9 0.4 0.4 55.7 1.1 14.1 32.8 32.2 22.5 0.5 7.8 0.4 0.0 5.8 5.5 1.6 2.7 63.1 0.0 32.4 257.6 5.0 1.4 212.2 1.2 1.2 1.9 1.4 116.3 0.3 2.9 1.4 246.7 4.3 122.6 8.6 6.3 129.1 19.2 19.0 19.2 23.7 20.2 24.1 20.5 19.4 18.0 20.0 18.7 19.7 22.3 7.1 192.3 97.0 25.1 4.6 1.1 8.0 13.2 9.6 21.8 14.4 9.9 14.2 80.1 17.8 16.5 10.4 2.4 3.0 321.6 129.1 13.4 107.8 18.2 5.9 17.0 19.9 20.2 34.4 19.9 1.4 29.2 23.0 5.2 49.9 15.9 43.9 229.6 38.5 8.4 27.5 63.9 14.2 214.1 8.9 34.4 51.3 45.3 1.8 5.6 37.8 67.8 3.1 18.1 3.6 6.2 309.3 34.6 3.6 3.9 926.9 80.9 40.2 3.8 19.7 11.2 15.2 22.8 5.8 9.6 0.3 1.9 9.0 13.1 79.2 6.8 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56524959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.0" "Group enriched" "Detected in many" 17 "Early spermatids: 100.7;Late spermatids: 292.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 2.8;REH: 7.5;SCLC-21H: 7.0" "Region enhanced" "Detected in single" "cerebellum: 1.4" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA072942: AB_2686561" "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 0.2 1.1 2.0 0.2 1.4 2.2 0.8 1.5 1.6 1.1 3.6 0.8 0.3 1.4 0.4 0.5 0.5 1.0 0.1 1.4 1.3 0.2 0.1 0.2 0.2 2.1 1.5 1.2 1.4 0.1 0.1 1.2 0.0 1.7 1.0 0.2 0.4 0.8 1.7 0.2 1.8 0.5 1.8 1.5 0.1 0.4 13.0 1.6 0.4 0.4 0.0 0.2 0.6 2.0 1.6 0.0 0.1 0.3 0.2 0.6 1.7 0.0 0.6 0.3 1.3 1.2 0.1 0.5 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.3 2.8 0.4 1.2 0.1 0.4 1.3 0.0 0.0 0.3 1.1 0.0 0.1 0.0 1.6 0.0 0.8 7.5 0.0 0.0 0.0 0.0 7.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.0 1.4 1.5 1.6 1.4 1.3 2.1 1.5 1.2 1.7 1.5 1.6 1.6 0.4 0.0 1.1 0.3 0.0 6.0 1.3 3.6 1.8 0.1 2.6 2.5 0.1 1.5 0.3 1.8 0.0 0.1 0.1 0.0 0.0 0.6 100.7 2.5 2.0 0.7 0.0 0.0 3.3 0.2 0.1 3.0 0.0 2.9 0.0 2.0 0.4 0.0 0.1 0.0 2.4 0.8 0.0 0.8 0.3 292.4 1.5 0.2 5.4 0.0 0.0 0.9 0.0 3.0 1.7 0.8 0.1 1.2 0.0 1.6 0.1 0.7 0.4 0.1 0.0 1.3 0.9 11.5 1.2 0.0 1.6 0.0 0.2 1.6 0.6 0.3 PRPF40A "FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40" ENSG00000196504 "Pre-mRNA processing factor 40 homolog A" O75400 2 152651593-152717997 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038272, HPA038273" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA038272: AB_2675923, HPA038273: AB_10671526" "unprognostic (1.81e-1)" "unprognostic (2.91e-1)" "unprognostic (4.31e-3)" "unprognostic (4.49e-3)" "unprognostic (1.55e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.62e-2)" "unprognostic (3.61e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.80e-2)" "unprognostic (2.32e-1)" "unprognostic (3.24e-2)" "unprognostic (2.05e-2)" 16.9 16.8 9.4 24.9 10.4 45.4 21.7 15.0 10.1 17.0 10.8 24.4 23.2 18.7 15.8 27.9 18.2 17.5 15.4 9.2 12.6 19.1 21.9 17.6 30.7 10.2 9.5 7.2 19.0 19.8 24.2 10.6 22.4 11.4 18.6 21.1 16.8 16.8 15.1 23.0 21.2 23.2 17.5 10.6 20.9 22.4 25.7 9.9 31.8 24.9 20.2 28.3 27.3 15.3 13.0 63.4 62.9 68.9 70.8 39.1 51.8 95.5 61.8 55.2 86.0 78.9 120.0 57.8 130.9 88.0 62.7 49.2 63.8 90.8 74.3 91.6 72.4 78.6 121.8 55.7 79.9 50.7 135.4 81.6 41.7 61.9 113.8 127.3 52.4 67.5 60.8 133.2 60.6 52.9 38.4 57.2 63.4 102.9 41.2 75.8 110.4 73.3 86.9 43.7 99.8 82.2 56.0 73.9 53.5 67.6 50.6 46.8 85.4 79.1 90.3 56.6 51.9 81.4 38.8 67.7 130.6 57.9 78.2 56.1 87.6 70.1 91.7 66.7 86.5 62.3 65.5 62.1 60.7 79.4 70.3 65.5 58.8 61.1 70.4 101.1 84.8 58.8 80.1 9.4 10.4 15.0 10.1 9.2 12.6 10.2 9.5 7.2 11.4 10.6 9.9 13.0 98.5 112.2 118.5 48.3 120.3 141.0 120.0 117.9 101.3 65.0 73.6 70.6 64.4 55.8 122.1 53.3 73.0 123.1 123.7 67.2 49.0 110.0 150.3 101.0 126.6 97.4 78.3 105.6 56.4 111.5 155.9 96.4 74.9 121.0 123.4 111.0 53.9 72.5 109.2 60.6 53.3 81.5 87.5 95.7 114.5 36.4 69.3 125.5 55.2 44.0 184.1 62.7 107.1 44.7 71.3 128.3 86.8 79.7 112.1 131.7 69.5 75.7 152.6 75.2 98.6 104.8 132.1 239.0 121.4 141.6 151.7 132.2 119.9 164.9 103.7 148.4 GDAP2 "dJ776P7.1, FLJ20142, MACROD3" ENSG00000196505 "Ganglioside induced differentiation associated protein 2" Q9NXN4 1 117863485-117929621 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046185 Approved Approved "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA046185: AB_10960897" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-2)" "unprognostic (4.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (4.26e-3)" "unprognostic (2.26e-3)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (3.28e-2)" "unprognostic (8.68e-2)" "unprognostic (1.68e-1)" 2.9 2.4 2.1 3.2 2.1 8.0 3.3 3.4 2.6 3.5 2.9 3.8 4.1 2.9 4.0 3.1 2.5 3.2 2.5 1.9 2.5 4.8 5.1 3.4 3.6 2.1 2.4 1.5 2.4 4.5 4.9 2.3 4.2 2.3 3.4 4.4 2.9 3.0 3.4 1.8 2.9 4.7 3.0 2.4 4.2 4.4 4.8 2.5 4.1 4.7 2.1 4.5 4.5 3.1 2.6 9.2 5.1 6.1 5.1 6.5 3.1 9.0 5.2 6.8 10.3 9.9 5.4 6.2 3.6 6.2 7.1 7.8 5.3 8.1 6.8 12.6 7.2 4.7 5.4 6.7 5.9 7.7 6.8 6.6 2.5 8.5 12.9 9.9 4.7 6.9 8.1 5.7 7.6 8.6 9.6 6.0 5.5 10.6 6.9 8.8 3.2 16.7 5.3 5.8 9.1 4.6 5.1 6.3 10.7 8.2 18.3 3.7 6.8 4.3 7.3 8.5 8.5 7.1 7.9 6.1 5.1 9.4 4.8 9.1 11.4 6.7 12.6 2.4 7.2 3.8 2.3 2.7 2.9 6.5 2.2 2.4 2.3 6.5 4.1 7.6 1.5 3.6 3.2 2.1 2.1 3.4 2.6 1.9 2.5 2.1 2.4 1.5 2.3 2.4 2.5 2.6 9.2 9.6 8.6 27.7 13.5 13.5 6.5 8.1 8.6 13.1 8.1 5.5 7.8 8.6 10.8 3.7 18.8 12.4 11.6 13.4 7.9 10.6 21.2 12.8 9.0 7.6 4.2 13.9 36.7 6.2 11.4 7.7 18.3 11.5 0.0 10.4 6.4 9.0 13.8 15.2 39.1 14.0 14.2 17.2 15.8 5.7 5.9 20.0 10.6 34.7 16.2 9.2 8.2 31.7 35.8 10.7 7.5 7.2 21.0 9.8 17.8 10.2 10.5 13.7 0.0 8.6 10.2 28.4 14.5 14.3 13.8 21.1 13.8 6.7 8.3 9.6 TCEAL3 "MGC15737, WEX8" ENSG00000196507 "Transcription elongation factor A like 3" Q969E4 X 103607451-103629690 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 165.3;Peritubular cells: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045564, HPA058982" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (2.55e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.05e-4)" "unprognostic (2.26e-1)" "prognostic favorable (8.33e-4)" "unprognostic (6.35e-3)" "unprognostic (2.30e-1)" "unprognostic (2.22e-3)" "unprognostic (7.19e-3)" "unprognostic (1.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" 42.0 62.4 121.5 15.3 117.2 15.0 43.2 115.9 131.5 101.4 115.4 58.3 11.9 172.6 32.7 25.7 121.7 21.4 53.5 113.0 116.6 47.1 9.8 47.9 10.4 124.1 121.4 108.7 164.5 34.3 48.1 109.4 17.9 131.6 98.4 9.6 46.3 35.0 70.7 21.7 32.8 32.5 43.4 119.7 44.0 58.0 34.5 125.4 7.1 51.1 10.8 8.1 127.8 68.9 131.5 81.5 8.6 21.5 17.6 72.6 36.8 0.7 118.4 56.4 53.1 70.0 0.0 7.8 0.0 14.3 87.1 94.5 31.3 15.5 46.6 38.9 0.1 3.9 6.0 35.4 0.2 69.8 0.0 25.6 47.9 14.3 37.6 53.9 75.3 36.0 27.6 0.0 23.1 73.6 68.4 3.9 0.6 9.2 0.0 21.9 28.5 13.5 0.3 25.6 16.2 32.7 26.3 5.3 6.9 29.5 10.5 32.4 18.9 47.1 27.6 14.1 56.9 37.5 24.2 12.0 0.1 68.6 0.1 61.9 5.7 8.3 5.1 13.2 4.7 14.3 9.3 11.4 10.4 9.6 10.5 11.1 13.7 1.4 20.0 0.5 12.2 15.9 6.3 121.5 117.2 115.9 131.5 113.0 116.6 124.1 121.4 108.7 131.6 119.7 125.4 131.5 39.1 16.0 47.9 6.2 15.9 25.9 91.4 37.8 20.5 57.0 69.8 73.4 50.2 40.0 39.4 75.4 18.8 3.1 19.9 5.1 142.8 41.3 3.3 61.1 165.3 46.2 43.4 6.3 10.0 39.0 3.3 56.3 19.4 40.6 95.8 55.5 58.2 3.8 63.5 18.5 13.8 32.1 36.7 35.1 32.9 17.2 157.2 31.3 16.0 4.7 29.7 137.8 17.5 9.0 12.3 25.3 9.6 256.1 33.0 78.9 0.7 30.6 62.4 35.6 26.3 26.0 62.4 4.4 1.9 10.2 16.9 2.7 21.1 32.9 6.2 45.6 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 14.0 19.1 12.7 14.2 14.1 12.7 15.9 13.1 16.3 18.6 12.2 17.6 10.7 21.6 16.8 36.5 18.2 11.5 20.5 13.3 13.3 18.8 13.5 13.8 18.1 12.9 12.6 12.3 16.8 14.2 25.1 14.8 8.6 13.0 18.6 16.3 13.3 20.7 17.7 34.1 17.5 14.7 21.2 12.5 16.8 15.9 30.3 12.7 24.3 20.4 25.1 20.9 19.2 25.0 13.4 49.7 66.8 47.8 40.9 48.8 24.6 27.4 33.9 30.6 61.1 42.2 68.5 30.8 78.6 33.5 45.8 35.2 49.1 71.8 46.5 61.8 42.0 57.8 69.3 46.0 57.3 35.5 62.5 31.6 27.0 32.7 53.0 35.0 43.6 60.1 55.2 110.7 16.4 48.7 53.0 95.6 46.7 42.0 48.1 57.6 72.8 47.2 93.1 41.4 62.5 61.8 35.4 53.2 41.2 57.3 41.9 87.1 56.0 38.2 36.3 34.1 32.6 40.6 27.4 59.5 105.6 40.5 52.6 42.9 20.2 12.1 20.5 18.2 17.2 21.7 14.3 19.6 17.7 20.1 18.7 16.1 17.5 9.3 24.3 15.9 10.9 26.1 14.4 12.7 14.1 13.1 16.3 13.3 13.3 12.9 12.6 12.3 13.0 12.5 12.7 13.4 13.1 16.0 18.4 17.6 12.9 10.1 19.6 16.5 13.1 18.5 12.8 11.6 17.5 10.0 22.6 12.9 20.9 12.4 10.7 9.2 11.7 16.9 7.6 22.8 18.6 15.7 10.8 33.6 28.1 15.2 10.1 16.9 16.3 15.3 15.8 42.5 11.7 13.4 22.4 21.9 22.6 10.8 32.6 17.9 6.6 12.7 18.3 12.5 17.8 13.1 14.7 16.1 11.3 22.6 29.3 16.2 8.9 21.8 11.4 20.0 7.3 15.0 18.4 22.9 13.1 15.9 16.2 74.1 42.2 38.3 13.4 7.3 14.0 32.4 14.9 17.5 TPK1 "HTPK1, PP20" ENSG00000196511 "Thiamin pyrophosphokinase 1" Q9H3S4 7 144451941-144836395 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 14.4" "Cell type enhanced" "Detected in many" "Early spermatids: 83.0;Excitatory neurons: 82.6;Inhibitory neurons: 76.3;Late spermatids: 95.8;Microglial cells: 110.5" "Cancer enhanced" "Detected in many" "renal cancer: 3.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 70.6;CACO-2: 17.2;EFO-21: 21.2;TIME: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021545, HPA021849" Approved Approved Vesicles NA NA 210000 Vesicles "HPA021545: AB_1858209, HPA021849: AB_1858210" "unprognostic (4.05e-2)" "unprognostic (3.28e-2)" "unprognostic (2.38e-2)" "unprognostic (3.32e-2)" "unprognostic (2.42e-1)" "unprognostic (1.63e-1)" "unprognostic (7.62e-2)" "unprognostic (6.08e-2)" "unprognostic (2.37e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (6.06e-2)" "unprognostic (1.45e-3)" "unprognostic (3.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (9.22e-3)" 4.0 3.5 2.7 6.0 3.3 2.8 4.3 2.1 4.2 2.7 3.4 6.4 14.4 2.2 1.5 2.0 2.0 3.6 3.5 2.8 4.4 3.9 4.5 5.3 5.8 3.1 2.8 2.6 2.3 2.0 1.8 1.5 5.2 3.6 1.9 6.2 2.4 3.6 2.6 1.6 1.2 7.5 3.6 2.9 8.2 2.2 3.4 3.1 2.9 3.1 3.0 5.0 4.2 1.6 3.4 0.7 0.7 0.7 70.6 0.5 0.7 5.8 0.3 0.3 0.2 0.2 17.2 2.8 1.3 21.2 1.2 1.4 0.0 1.4 0.8 0.6 4.3 1.0 0.3 0.2 0.3 1.8 5.5 1.7 1.4 1.4 0.8 1.0 2.0 13.6 2.8 1.5 3.2 0.3 2.1 1.6 8.2 1.8 2.1 5.9 0.7 1.6 2.5 10.9 6.3 0.7 0.2 1.1 0.2 1.3 1.3 1.0 10.4 16.3 0.7 1.8 1.3 0.9 1.6 4.2 1.7 2.5 13.8 0.7 0.4 10.2 0.3 5.0 7.4 5.2 6.7 5.5 4.6 13.2 7.2 6.5 5.4 4.7 5.8 10.8 3.1 7.7 5.6 2.7 3.3 2.1 4.2 2.8 4.4 3.1 2.8 2.6 3.6 2.9 3.1 3.4 8.5 9.6 2.8 43.1 23.8 2.3 2.6 3.0 0.6 3.9 4.4 2.9 5.9 8.6 1.3 3.7 8.4 41.2 8.3 20.1 19.6 4.3 83.0 5.3 2.3 8.9 1.2 2.1 82.6 6.7 14.3 6.3 7.1 8.6 7.6 6.5 6.1 5.2 17.0 1.7 76.3 5.0 0.0 18.9 19.2 95.8 5.0 17.9 8.8 110.5 15.7 3.4 17.5 55.8 38.4 9.8 15.9 1.2 9.9 1.8 20.4 8.6 3.2 5.4 0.0 3.6 2.9 14.9 10.5 2.1 1.7 32.0 12.1 4.0 8.1 4.1 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.7;skin 1: 43.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3" "Cancer enhanced" "Detected in all" "glioma: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 62.3;hTCEpi: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 3.6 31.2 21.9 4.9 39.2 10.9 4.6 51.6 19.3 8.9 4.9 10.5 2.4 7.5 1.1 23.3 9.6 4.8 2.0 13.7 27.4 2.9 2.3 11.7 1.2 57.3 41.6 11.1 2.9 8.2 2.8 1.7 1.4 58.5 4.0 6.4 17.3 11.6 5.6 1.2 43.6 6.0 9.2 50.5 1.9 7.4 1.1 40.9 1.4 5.3 0.6 4.3 12.4 25.3 74.7 19.7 13.7 7.1 18.0 11.2 3.7 15.6 14.7 41.0 24.3 30.1 4.8 7.5 0.3 1.6 42.9 0.0 62.3 11.0 12.5 5.0 0.1 1.8 17.1 33.9 5.8 50.3 3.8 0.7 11.3 106.6 11.9 28.5 15.3 0.6 12.3 13.0 48.5 1.0 10.4 2.9 0.1 5.4 7.4 19.1 2.2 0.0 22.9 2.3 2.2 4.4 4.2 7.4 35.3 7.0 1.7 9.1 10.3 0.2 2.8 11.0 2.4 8.0 53.1 39.2 4.4 9.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 39.2 51.6 19.3 13.7 27.4 57.3 41.6 11.1 58.5 50.5 40.9 74.7 1.5 0.0 2.0 5.9 1.1 7.5 0.9 3.2 8.0 30.7 2.2 0.9 0.7 4.3 2.2 1.8 16.7 0.5 0.5 17.8 0.0 3.7 5.9 4.8 0.4 0.7 0.0 33.1 2.2 8.9 1.0 0.9 1.5 2.7 0.0 0.0 0.0 0.3 0.3 1.7 1.5 2.7 20.3 0.0 1.0 0.8 1.5 0.1 3.6 0.0 1.0 1.2 0.0 3.0 16.4 4.2 3.0 1.5 1.3 2.0 9.1 1.1 12.5 11.1 6.6 0.1 10.0 0.1 0.4 8.9 12.9 0.5 0.3 1.2 2.6 3.2 AFAP1 "AFAP, AFAP-110" ENSG00000196526 "Actin filament associated protein 1" Q8N556 4 7758714-7939926 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 170.5;Extravillous trophoblasts: 116.3;Inhibitory neurons: 117.2;Late spermatids: 373.8;Oligodendrocyte precursor cells: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.9" "Group enriched" "Detected in many" 5 "granulocytes: 2.9;T-cells: 1.2" "Cell line enhanced" "Detected in many" "TIME: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015642, CAB024712" Enhanced Supported "Actin filaments,Focal adhesion sites,Cytosol" NA NA "Actin filaments, Cytosol" "Focal adhesion sites" "CAB024712: , HPA015642: AB_1844632" "unprognostic (1.12e-1)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (7.29e-2)" "unprognostic (2.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (2.00e-1)" "unprognostic (3.39e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (1.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.44e-2)" 12.2 3.1 7.0 8.8 5.9 0.7 9.8 4.4 6.1 8.7 3.5 14.5 5.7 15.5 2.0 11.1 8.6 9.5 8.0 5.7 5.0 4.7 1.2 8.6 4.5 3.7 2.8 6.3 7.1 3.8 14.8 7.9 12.7 3.2 7.8 9.9 3.4 8.7 10.3 3.5 5.0 7.7 15.5 3.4 4.0 6.7 22.1 3.3 3.2 7.4 2.5 4.8 14.3 8.4 3.8 31.9 23.2 16.2 12.9 15.4 27.8 21.3 46.4 68.1 43.6 40.0 7.4 7.2 0.1 15.2 75.5 72.3 15.1 8.6 18.7 28.6 0.9 5.7 0.0 33.2 4.5 43.0 0.0 0.4 17.2 13.8 54.4 35.5 72.2 53.0 4.8 0.7 6.8 23.0 10.3 0.6 0.0 7.0 13.2 44.3 0.0 12.1 1.5 4.7 4.1 31.8 53.0 15.9 10.9 12.4 21.4 4.1 0.3 126.7 53.0 11.8 69.6 23.0 0.0 0.2 0.0 18.9 0.1 61.9 0.0 0.4 2.9 0.4 0.1 0.5 0.0 0.6 0.6 0.0 0.0 1.2 0.5 1.0 0.0 0.0 0.0 0.5 0.7 7.0 5.9 4.4 6.1 5.7 5.0 3.7 2.8 6.3 3.2 3.4 3.3 3.8 22.5 6.4 2.0 4.6 0.2 2.9 9.7 16.2 7.4 1.2 10.2 8.9 5.9 10.0 12.7 11.0 4.2 5.6 2.3 14.8 0.0 19.2 170.5 7.5 17.6 20.1 14.5 0.0 24.7 7.7 116.3 21.1 11.2 8.8 0.0 4.4 14.3 0.0 8.5 0.0 117.2 20.6 0.0 0.3 3.6 373.8 11.1 6.0 1.8 30.9 0.6 10.2 0.0 125.2 5.4 29.9 8.6 12.4 0.6 13.5 6.4 4.2 6.4 0.7 6.6 8.0 13.4 12.5 10.0 6.2 4.3 8.8 7.3 2.6 13.9 9.9 NACA NACA1 ENSG00000196531 "Nascent polypeptide associated complex subunit alpha" "E9PAV3, Q13765" 12 56712305-56731628 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Activator, Chaperone, DNA-binding" Allergen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073152, HPA073648" Approved Cytosol NA Yes Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (3.35e-2)" "unprognostic (9.98e-3)" "unprognostic (1.56e-1)" "unprognostic (2.30e-3)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.24e-3)" "unprognostic (1.55e-1)" "unprognostic (3.92e-2)" "unprognostic (2.95e-2)" "unprognostic (5.64e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (4.58e-11)" "unprognostic (9.47e-2)" "unprognostic (6.28e-2)" "unprognostic (7.00e-2)" "unprognostic (9.79e-2)" 1335.4 1073.7 461.8 612.7 471.2 1537.0 1475.4 474.4 619.8 1577.4 457.9 1130.5 624.2 1076.0 1093.5 1524.1 1227.4 549.9 940.5 446.8 510.9 1045.1 901.1 846.4 1034.9 480.3 469.7 436.2 2411.0 1396.4 770.8 817.9 612.8 484.9 1149.4 853.3 457.0 1024.3 705.6 1202.2 1630.8 897.9 695.8 515.7 909.2 1043.6 366.9 477.3 1053.2 925.6 380.2 1443.7 1193.1 1459.3 511.9 1128.5 1333.7 1555.7 1198.7 1795.5 3053.1 1489.5 1117.9 1619.4 1509.9 1051.6 1602.0 1220.7 2014.8 1191.0 1019.4 599.8 963.6 1324.0 1814.9 1600.2 1002.6 2111.7 1463.4 890.3 1640.8 1607.2 2139.1 899.1 2430.3 2204.4 1226.9 2477.6 2669.6 1628.2 1184.8 1896.0 2594.7 1445.5 1118.9 1341.7 2670.1 1528.3 1072.6 1440.8 1543.1 1268.7 2180.1 2124.9 1157.6 1130.2 1197.4 835.8 1977.1 1774.5 1027.8 2109.8 2398.2 1085.4 770.4 933.2 834.0 1127.0 1217.9 1475.1 1768.0 1134.0 1422.3 997.9 462.6 987.0 503.8 581.4 1371.7 851.7 969.7 823.0 726.5 1006.8 812.1 941.6 834.7 350.2 748.7 1842.6 1082.7 944.3 1951.8 461.8 471.2 474.4 619.8 446.8 510.9 480.3 469.7 436.2 484.9 515.7 477.3 511.9 1444.2 445.5 645.8 38.8 1822.8 2027.4 2219.5 2022.2 2405.1 325.2 2494.6 5365.8 722.7 1159.6 1095.8 395.4 66.7 1867.2 2037.7 656.8 1778.5 1368.9 701.0 899.4 1625.1 1206.0 647.6 1213.0 31.4 2023.3 2894.2 1085.3 649.4 1079.9 735.9 1600.7 993.4 881.6 1594.4 183.4 35.5 1461.3 801.5 1436.7 1664.7 589.5 2409.8 1430.9 1239.8 40.3 2261.1 1195.0 1528.3 26.7 35.1 1574.8 1306.2 1431.2 1160.8 2248.0 1444.7 2734.4 523.2 455.2 802.0 1977.5 1718.3 542.4 479.1 2363.5 2231.6 2323.4 1549.8 2175.1 1762.0 2618.2 MYO18A "KIAA0216, MysPDZ" ENSG00000196535 "Myosin XVIIIA" Q92614 17 29071122-29180398 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 407.6;tongue: 125.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 33.6;Oligodendrocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "OE19: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019646 Supported NA NA 3400000 "HPA019646: AB_1854249" "unprognostic (2.54e-2)" "unprognostic (1.08e-1)" "unprognostic (5.36e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.48e-1)" "unprognostic (1.72e-1)" "unprognostic (3.31e-2)" "unprognostic (8.70e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.18e-4)" "unprognostic (6.94e-2)" "unprognostic (2.12e-2)" "unprognostic (6.95e-3)" "unprognostic (1.95e-1)" 8.8 4.0 13.1 7.5 31.3 13.0 10.6 9.8 18.2 12.0 0.0 14.6 14.2 15.4 2.9 19.2 10.7 10.5 96.1 10.0 11.5 5.7 20.5 7.3 6.6 31.8 24.7 2.4 7.1 14.9 8.4 5.4 4.5 50.1 10.7 5.9 3.8 16.1 6.0 407.6 20.1 14.5 7.7 7.7 6.4 14.5 5.2 26.6 4.1 7.8 125.1 4.9 12.5 14.5 52.9 29.6 40.9 15.5 8.0 4.0 7.0 24.8 13.8 13.7 11.8 8.2 10.3 20.5 3.1 15.2 10.0 17.3 33.2 6.0 23.1 4.6 34.4 11.4 2.6 12.9 11.3 6.1 3.7 3.6 8.1 13.2 7.2 3.2 19.5 4.3 12.3 37.1 5.3 5.9 10.2 10.8 2.9 3.2 60.1 9.0 37.3 17.3 9.1 9.0 21.7 8.1 8.3 13.7 45.5 9.8 10.2 10.6 4.4 5.0 7.7 9.3 5.2 9.6 10.0 18.1 5.9 9.7 2.6 20.9 0.6 0.2 0.4 0.3 0.3 0.4 0.1 0.3 0.3 0.3 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.2 0.1 13.1 31.3 9.8 18.2 10.0 11.5 31.8 24.7 2.4 50.1 7.7 26.6 52.9 14.8 12.8 7.0 13.4 5.4 1.0 1.0 0.5 10.8 7.1 3.7 3.3 33.6 2.8 8.3 1.8 10.4 0.4 2.8 8.6 0.0 2.9 1.4 1.9 4.4 8.1 2.4 9.0 13.6 1.4 2.7 4.9 21.4 2.3 1.3 15.3 2.2 5.0 1.1 1.7 13.3 4.0 0.0 0.6 1.3 0.6 2.1 6.1 0.0 9.4 2.0 2.6 2.1 14.6 38.8 4.2 5.1 3.0 6.8 1.0 5.0 1.7 1.7 4.2 0.0 4.7 2.0 1.3 1.3 9.5 0.9 0.3 5.5 3.2 4.1 1.1 OR2T3 ENSG00000196539 "Olfactory receptor family 2 subfamily T member 3" Q8NH03 1 248473351-248474307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 43.4;stomach 1: 62.0;urinary bladder: 50.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 28.5;Exocrine glandular cells: 46.0;Gastric mucus-secreting cells: 37.2;Melanocytes: 46.2;Prostatic glandular cells: 74.6;Suprabasal keratinocytes: 36.4;Urothelial cells: 65.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 13 "NK-cell: 353.6" "Lineage enriched" "Detected in many" 13 "NK-cells: 353.6" "Group enriched" "Detected in some" 10 "MCF7: 1167.1;RT4: 304.2" HPA047712 Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA047712: AB_2680127" "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.9 0.1 3.9 0.6 2.3 0.4 8.4 5.5 8.0 4.9 2.4 0.8 0.3 1.0 0.1 8.7 0.4 1.3 0.4 2.8 1.9 0.6 0.5 0.1 1.2 2.7 6.4 2.1 0.2 0.8 0.1 0.4 0.0 5.1 14.8 0.7 2.5 11.5 0.1 0.1 43.4 0.3 0.2 0.5 1.3 62.0 0.0 7.4 0.4 0.3 1.5 2.0 50.0 11.1 4.9 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.9 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.1 0.1 2.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1167.1 0.0 0.0 4.3 71.5 13.4 0.0 0.0 0.5 0.0 304.2 1.9 11.9 0.0 40.6 0.0 0.1 64.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.2 26.2 0.1 0.9 2.5 0.0 0.1 0.3 0.4 0.9 353.6 0.0 0.2 0.0 2.5 3.9 2.3 5.5 8.0 2.8 1.9 2.7 6.4 2.1 5.1 0.5 7.4 4.9 0.2 0.0 0.0 4.2 0.1 3.8 16.6 19.6 1.8 1.4 16.6 8.4 0.4 1.5 22.5 3.7 0.0 0.0 3.6 0.1 0.0 1.3 0.0 0.5 0.2 0.8 0.0 0.0 28.5 46.0 0.0 0.7 37.2 1.2 0.0 4.3 0.0 0.0 0.2 0.0 14.2 2.5 6.1 0.0 0.8 0.0 0.0 0.4 46.2 1.0 0.1 0.6 7.2 5.0 1.5 27.6 0.0 0.0 0.4 74.6 0.0 0.0 4.1 1.4 0.0 0.1 2.2 0.0 0.0 6.8 36.4 0.1 3.2 0.0 0.0 65.6 BORCS6 "C17orf59, FLJ20014" ENSG00000196544 "BLOC-1 related complex subunit 6" Q96GS4 17 8188345-8190180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045415, HPA060791" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 11000 "Golgi apparatus, Vesicles" "HPA045415: AB_10964575, HPA060791: AB_2684367" "unprognostic (2.11e-1)" "unprognostic (7.22e-3)" "unprognostic (3.25e-2)" "prognostic favorable (2.78e-4)" "unprognostic (3.84e-2)" "unprognostic (9.91e-3)" "unprognostic (7.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.60e-4)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (2.18e-2)" "unprognostic (4.38e-2)" "unprognostic (3.28e-1)" "unprognostic (3.10e-2)" 5.7 8.5 9.8 5.0 9.3 4.2 5.8 9.6 10.5 5.6 7.2 7.8 7.3 6.7 3.7 11.0 5.2 2.3 9.3 8.9 8.6 7.8 8.1 5.4 6.8 11.3 9.5 8.3 4.1 14.6 6.2 4.8 4.0 10.9 6.2 2.7 3.1 6.3 4.9 15.1 12.1 8.7 2.8 9.5 11.7 8.3 5.6 9.2 5.3 5.7 6.1 5.0 7.2 6.6 10.3 6.3 7.5 2.5 5.1 5.3 3.9 10.0 4.6 5.1 4.4 4.7 4.2 4.2 5.9 9.9 3.7 4.2 9.2 3.9 5.4 1.5 17.8 16.3 4.5 7.0 6.5 6.0 2.7 9.5 4.0 5.7 4.0 4.6 3.9 7.2 8.6 5.1 12.0 2.7 6.7 9.0 7.7 1.8 4.0 8.3 10.6 3.2 8.9 6.1 3.5 3.0 6.9 4.7 3.5 4.2 2.5 5.1 4.2 5.8 2.7 2.4 4.2 5.0 18.0 8.8 2.7 3.9 9.5 3.3 46.4 18.6 50.7 27.8 18.7 22.7 23.5 23.4 29.6 20.9 23.3 22.0 24.9 17.0 28.5 23.1 18.3 23.5 21.4 9.8 9.3 9.6 10.5 8.9 8.6 11.3 9.5 8.3 10.9 9.5 9.2 10.3 13.5 9.6 6.4 0.0 21.6 0.0 2.6 0.0 14.2 23.1 9.0 9.5 0.0 11.5 0.6 5.5 6.2 20.4 22.3 12.2 7.9 9.7 2.4 5.6 3.8 10.9 1.2 11.4 0.0 17.7 12.0 4.4 4.1 5.7 3.8 5.2 12.5 9.4 20.9 18.5 0.0 8.6 0.0 21.1 0.0 3.2 5.9 21.5 0.0 0.0 25.6 23.8 45.3 0.0 0.0 11.3 18.3 6.8 18.5 3.5 29.8 10.3 0.0 19.7 32.9 4.3 6.7 9.0 1.3 17.3 0.0 6.2 18.7 9.4 7.5 1.5 MAN2A2 "HsT19662, MANA2X" ENSG00000196547 "Mannosidase alpha class 2A member 2" P49641 15 90902218-90922584 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.6;Rod photoreceptor cells: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.8;neutrophil: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 100.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077930 Approved "Cytoplasmic bodies" NA NA 43000000 "Cytoplasmic bodies" "HPA077930: AB_2732363" "unprognostic (5.17e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (3.41e-1)" "unprognostic (2.27e-1)" "unprognostic (5.06e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (7.55e-3)" "unprognostic (1.13e-1)" "unprognostic (8.36e-2)" "unprognostic (2.33e-2)" 24.7 18.4 32.3 13.0 48.5 78.9 23.1 40.5 46.3 12.1 12.0 17.8 13.4 11.1 9.5 9.3 14.8 9.7 36.9 30.1 37.2 15.2 34.8 23.0 14.2 51.3 48.4 26.0 15.9 44.7 13.5 25.2 11.5 55.5 14.4 9.0 75.5 28.3 13.0 61.5 17.0 21.1 7.8 40.8 35.3 24.6 15.5 44.7 12.5 22.1 44.4 10.0 13.4 10.7 85.3 14.4 15.4 9.6 22.3 27.7 7.0 20.2 11.3 9.6 11.9 8.6 13.2 9.6 2.1 24.6 12.0 9.2 16.0 11.0 6.5 6.0 35.2 29.5 100.7 23.8 8.8 8.4 16.4 55.4 5.4 10.9 13.1 9.7 20.2 13.4 26.8 41.7 11.7 4.7 20.4 8.8 30.9 3.2 22.3 5.0 12.5 10.1 13.8 12.1 35.1 25.1 15.6 15.0 24.2 20.3 9.2 11.5 42.5 11.9 8.5 9.3 10.4 12.8 19.6 62.3 5.2 9.8 21.0 14.5 8.8 1.2 0.5 1.0 0.8 0.7 0.8 0.4 0.6 0.2 0.9 0.3 0.3 7.9 0.1 2.9 1.6 1.1 1.4 32.3 48.5 40.5 46.3 30.1 37.2 51.3 48.4 26.0 55.5 40.8 44.7 85.3 22.3 12.8 22.6 20.2 5.5 6.0 3.4 2.8 4.0 26.4 9.9 8.8 14.7 12.8 7.7 9.2 27.1 10.0 10.6 12.2 0.0 5.0 9.1 6.6 9.6 9.5 4.2 19.1 27.3 6.5 2.3 7.5 13.3 12.9 15.8 7.1 7.1 22.5 6.0 25.2 26.6 6.4 2.0 13.9 14.1 7.1 6.8 17.9 30.2 11.2 11.7 17.4 3.1 29.7 92.6 3.8 4.3 4.9 6.9 5.3 8.7 2.9 4.5 74.5 13.1 12.0 11.4 12.4 9.6 5.2 4.7 7.5 10.2 1.6 9.3 3.6 MME "CALLA, CD10, NEP" ENSG00000196549 "Membrane metalloendopeptidase" P08473 3 155024124-155183704 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 336.5;kidney: 305.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0" "Cancer enhanced" "Detected in many" "prostate cancer: 17.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 122 "neutrophil: 139.4" "Lineage enriched" "Detected in many" 122 "granulocytes: 139.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1" "Region enhanced" "Detected in many" "basal ganglia: 28.1" "Group enriched" "Detected in many" 4 "basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9" "CAB000013, HPA052583, HPA056072" Enhanced NA NA 320000 "CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027" "unprognostic (1.36e-1)" "unprognostic (1.02e-3)" "unprognostic (8.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.78e-2)" "unprognostic (6.52e-3)" "unprognostic (1.20e-1)" "unprognostic (1.67e-2)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (7.30e-3)" "unprognostic (1.31e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-1)" "unprognostic (7.29e-2)" "unprognostic (1.06e-2)" "unprognostic (1.37e-2)" 104.8 1.0 0.6 4.6 13.6 11.6 38.9 1.4 2.5 22.9 0.6 2.0 336.5 13.5 22.7 2.3 1.9 13.5 4.4 0.1 1.6 305.3 56.5 27.9 10.3 7.5 3.7 0.5 0.9 1.2 0.5 0.6 73.6 11.0 80.3 3.5 0.1 6.2 45.0 20.5 1.9 292.1 1.5 0.4 8.0 1.6 1.4 3.0 16.8 1.2 23.7 12.4 6.0 7.6 9.0 0.1 0.0 0.9 0.3 280.1 684.4 1.6 160.3 1116.9 82.2 209.8 0.0 0.3 172.9 0.1 130.1 107.4 0.5 5.2 6.1 201.3 0.0 0.8 0.0 0.1 0.2 229.6 0.0 0.0 651.1 1.0 40.4 308.1 89.4 59.5 0.4 0.2 0.3 135.1 0.7 0.4 1.0 6.1 0.5 1.1 303.3 139.9 1.6 5.2 1.9 0.5 1.5 0.1 0.5 31.9 68.3 0.2 0.2 165.8 356.4 0.8 115.7 27.9 0.1 0.0 217.3 42.5 0.1 7.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 139.4 0.0 0.0 1.1 0.0 0.0 0.6 13.6 1.4 2.5 0.1 1.6 7.5 3.7 0.5 11.0 0.4 3.0 9.0 5.9 9.6 13.0 0.3 2.3 0.8 74.1 2.5 0.0 0.0 1.5 64.1 1.6 21.5 11.2 22.0 0.0 82.1 6.9 0.0 9.8 0.2 0.5 6.2 273.3 6.6 0.0 0.0 2.2 0.0 57.8 40.6 0.0 5.7 2.5 0.0 2.9 53.2 8.9 0.0 8.1 9.9 2.0 3.1 1.2 0.5 4.1 10.7 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.6 13.8 1.2 0.1 40.0 372.4 125.7 1.6 0.0 0.0 17.4 11.1 0.2 0.5 0.1 0.3 126.0 2.5 0.1 12.6 33.6 FAM72A "LMPIP, MGC57827, p17, RP11-312O7.1, UGENE" ENSG00000196550 "Family with sequence similarity 72 member A" Q5TYM5 1 206186179-206204414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.0" "Cell type enhanced" "Detected in many" "Early spermatids: 29.5;Kupffer cells: 18.2;Late spermatids: 30.2;Spermatocytes: 28.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (3.61e-2)" "unprognostic (1.58e-1)" "unprognostic (1.80e-1)" "unprognostic (5.20e-5)" "unprognostic (3.61e-1)" "unprognostic (1.19e-3)" "unprognostic (1.01e-5)" "unprognostic (7.70e-3)" "unprognostic (1.45e-2)" "unprognostic (5.58e-3)" "unprognostic (2.87e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-16)" "unprognostic (1.82e-1)" "unprognostic (1.94e-2)" "unprognostic (4.83e-2)" "unprognostic (3.89e-1)" 3.9 3.1 2.5 5.9 2.9 8.5 3.6 8.1 2.9 1.3 1.3 2.3 3.1 0.9 0.4 2.5 1.8 2.7 1.1 3.1 3.7 1.3 2.0 2.7 11.0 4.1 4.5 1.9 1.1 1.4 1.6 0.8 3.5 4.9 1.1 2.4 0.2 1.0 0.7 0.6 5.9 2.9 2.0 4.8 6.3 1.6 7.1 5.2 8.6 0.9 1.0 7.5 1.5 1.5 4.6 21.1 16.4 17.7 7.7 2.6 3.1 21.1 14.6 6.3 17.1 12.7 9.9 31.1 54.2 12.3 3.8 18.8 24.7 20.9 8.1 20.2 29.5 16.3 24.3 16.4 13.9 1.8 42.9 27.0 4.4 1.4 15.1 26.7 5.1 10.7 45.7 50.1 36.7 10.7 12.9 26.9 38.3 32.1 15.1 22.1 29.5 30.6 41.4 9.8 3.2 17.7 10.2 10.6 9.7 9.3 20.1 20.5 23.2 5.5 13.5 15.5 17.7 24.9 29.1 44.8 48.4 11.1 34.9 18.8 0.0 5.9 0.0 0.7 8.0 0.2 1.7 1.4 1.4 4.6 0.5 0.1 0.3 1.0 0.6 4.8 1.9 2.9 2.1 2.5 2.9 8.1 2.9 3.1 3.7 4.1 4.5 1.9 4.9 4.8 5.2 4.6 5.9 0.0 1.5 0.0 2.4 1.8 0.4 1.2 1.2 0.3 0.8 0.6 1.5 0.0 0.9 0.0 0.0 0.8 3.7 4.9 0.0 1.0 29.5 1.5 1.5 8.4 0.0 0.4 0.1 0.8 3.8 1.8 0.5 0.7 0.0 0.3 7.1 0.4 9.4 0.0 0.2 3.6 0.0 18.2 5.8 30.2 0.0 6.9 3.6 0.0 9.6 0.6 2.1 0.0 0.1 0.6 0.0 0.0 1.6 0.4 1.3 0.3 2.1 0.2 0.0 0.9 2.2 28.0 4.1 2.0 1.0 0.7 1.4 0.8 1.6 0.8 CCDC196 "C14orf53, LINC00238, NCRNA00238" ENSG00000196553 "Coiled-coil domain containing 196" A0A1B0GTZ2 14 66411704-66498677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 5.4" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 1.0;Proximal tubular cells: 2.0" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.96e-2)" "unprognostic (6.53e-2)" "unprognostic (6.56e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (4.47e-1)" "unprognostic (7.20e-2)" "unprognostic (9.22e-2)" "unprognostic (3.60e-6)" "unprognostic (5.72e-2)" "unprognostic (7.10e-2)" "unprognostic (6.03e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153106-1221771 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 80.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favorable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 12.5 28.2 14.7 5.2 20.7 0.1 7.7 2.4 13.1 24.4 0.6 75.8 6.5 57.8 2.6 7.2 38.2 10.4 8.3 10.3 8.8 10.0 13.5 11.9 0.7 5.9 3.8 6.9 80.8 4.7 3.6 46.2 2.1 6.3 28.2 2.4 1.8 2.0 27.7 6.3 16.3 22.5 15.7 1.6 0.7 27.7 19.5 9.6 0.5 11.1 3.1 0.2 57.4 17.2 2.2 0.0 17.9 3.0 25.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 10.4 0.1 0.0 11.0 3.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.0 3.0 4.9 0.0 0.0 48.3 0.0 0.0 9.4 16.0 3.6 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.9 1.0 13.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 20.7 2.4 13.1 10.3 8.8 5.9 3.8 6.9 6.3 1.6 9.6 2.2 1.3 0.0 0.0 1.0 0.0 1.5 0.1 0.0 0.0 22.8 0.3 0.1 2.7 4.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.7 7.2 0.2 5.3 2.2 10.8 0.0 2.6 0.0 0.1 1.3 0.5 0.2 4.5 0.0 0.4 7.8 0.1 0.0 0.7 1.0 2.0 0.0 0.3 15.5 8.4 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.4 0.4 25.9 0.0 7.2 0.0 0.7 0.0 1.5 26.3 0.4 22.4 3.4 5.1 0.0 3.4 0.0 0.2 0.3 0.1 1.3 SULF2 "HSULF-2, KIAA1247, SULF-2" ENSG00000196562 "Sulfatase 2" Q8IWU5 20 47656348-47786616 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 205.8;Oligodendrocyte precursor cells: 247.8;Theca cells: 265.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "basophil: 27.2;classical monocyte: 19.6;intermediate monocyte: 17.2;myeloid DC: 21.3;neutrophil: 31.5;non-classical monocyte: 9.0;plasmacytoid DC: 27.1" "Group enriched" "Detected in many" 84 "dendritic cells: 27.1;granulocytes: 31.5;monocytes: 19.6" "Cell line enhanced" "Detected in many" "EFO-21: 338.0;HaCaT: 230.1;HBEC3-KT: 259.4;hTCEpi: 815.1;MCF7: 695.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002325 Approved "Intracellular and membrane" NA NA 340000 "HPA002325: AB_1080126" "unprognostic (4.06e-2)" "prognostic unfavorable (6.43e-5)" "unprognostic (4.39e-1)" "unprognostic (8.99e-2)" "unprognostic (2.65e-1)" "unprognostic (9.08e-2)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" "unprognostic (1.81e-2)" "unprognostic (3.04e-2)" "unprognostic (1.53e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (7.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.09e-1)" "unprognostic (7.14e-3)" 54.3 12.5 27.6 43.1 28.5 11.6 43.9 19.2 28.7 114.0 23.8 48.4 29.7 153.9 9.9 78.2 74.2 64.8 31.2 42.8 37.6 56.3 39.0 16.6 28.0 47.7 32.7 23.4 140.5 9.9 7.2 40.7 26.5 56.5 23.5 44.4 13.7 34.3 22.6 14.9 31.8 27.1 87.2 20.7 15.3 20.8 21.5 26.2 18.4 43.0 22.6 25.3 37.0 63.2 36.8 0.5 20.6 93.4 0.1 19.2 2.3 8.5 16.3 0.0 1.7 2.9 36.7 48.7 3.7 338.0 17.0 5.5 230.1 27.2 259.4 0.7 0.4 20.0 0.0 24.2 82.7 17.4 0.1 4.9 104.1 815.1 1.7 11.2 0.2 18.4 0.0 0.0 151.5 1.9 695.2 0.0 1.4 18.8 0.0 209.0 0.2 0.2 39.8 198.6 1.1 8.2 2.1 32.9 0.3 0.1 122.1 1.3 2.6 17.8 0.0 2.1 0.2 22.5 5.4 1.7 1.6 0.4 0.1 2.8 27.2 19.6 2.2 0.0 17.2 0.2 0.3 0.0 0.1 21.3 0.2 0.0 0.0 31.5 0.1 9.0 27.1 0.0 6.2 27.6 28.5 19.2 28.7 42.8 37.6 47.7 32.7 23.4 56.5 20.7 26.2 36.8 62.7 9.6 7.2 2.0 21.9 10.5 7.6 25.4 18.8 8.5 14.0 8.3 8.6 20.0 9.0 16.5 0.0 12.0 34.9 38.4 0.0 5.3 2.7 19.7 205.8 59.2 27.4 7.8 10.3 2.2 10.1 37.0 10.2 30.6 1.3 28.1 62.2 19.0 5.2 35.3 10.8 7.6 16.2 20.6 46.2 6.7 28.9 44.4 10.6 12.2 85.8 8.8 6.2 247.8 1.1 4.9 62.0 76.3 6.2 9.9 3.5 14.1 2.7 6.2 0.0 4.1 13.7 1.2 3.5 24.7 8.4 16.4 11.2 265.0 25.8 12.3 HBG2 HBG-T1 ENSG00000196565 "Hemoglobin subunit gamma 2" P69892 11 5253188-5505605 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 132 "placenta: 10396.8" "Group enriched" "Detected in some" 17 "Erythroid cells: 66.1;Macrophages: 74.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 192 "HEL: 8197.4;K-562: 8088.4" "CAB016143, HPA043234" Approved NA NA "CAB016143: AB_2295004, HPA043234: AB_2678378" "unprognostic (4.48e-3)" "unprognostic (2.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.41e-1)" "unprognostic (8.94e-2)" "unprognostic (4.22e-1)" "unprognostic (5.29e-1)" "unprognostic (3.95e-2)" "unprognostic (2.99e-1)" "unprognostic (3.52e-2)" "unprognostic (4.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-5)" "unprognostic (1.64e-1)" "unprognostic (2.65e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" 4.6 1.6 2.6 0.5 3.0 78.8 2.5 2.6 3.8 2.5 3.0 2.9 1.4 1.1 0.5 2.0 2.0 5.3 7.0 2.8 2.3 5.9 6.2 16.6 0.3 2.3 2.1 2.5 2.2 9.4 0.8 3.2 10396.8 2.1 1.5 0.1 0.4 3.7 0.2 4.2 1.0 0.9 4.4 1.7 27.5 3.3 0.8 2.1 2.4 4.9 0.6 0.4 0.4 3.1 2.9 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 1.4 0.0 0.2 23.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8197.4 0.5 0.4 0.0 1.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 8088.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.0 8.9 1.9 0.1 0.3 0.2 0.0 0.0 42.3 0.1 0.6 3.0 0.1 0.6 1.9 1.9 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 6.5 2.6 3.0 2.6 3.8 2.8 2.3 2.3 2.1 2.5 2.1 1.7 2.1 2.9 2.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 66.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.6 0.3 74.6 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.3 0.2 1.5 0.9 0.0 0.0 0.0 0.6 0.3 0.0 0.1 LAMA2 LAMM ENSG00000196569 "Laminin subunit alpha 2" P24043 6 128883138-129516566 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 106.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 363.1;Fibroblasts: 151.1;Leydig cells: 184.2;Microglial cells: 692.3;Oligodendrocytes: 160.9;Peritubular cells: 224.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "hypothalamus: 37.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 255.1;ASC TERT1: 184.5;HHSteC: 55.5;HSkMC: 156.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB040310, CAB078182" Enhanced "Secreted to extracellular matrix" NA NA 55000000 "CAB040310: , CAB078182: AB_2665829" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (2.17e-2)" "unprognostic (3.17e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (9.73e-2)" "unprognostic (3.67e-2)" "unprognostic (2.44e-3)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (4.04e-2)" "unprognostic (1.24e-3)" "unprognostic (6.16e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (3.65e-5)" 35.6 9.3 2.6 2.6 8.6 0.0 25.2 3.4 6.5 22.3 15.6 13.5 1.7 17.2 4.1 8.1 35.2 18.1 64.6 1.3 37.4 4.0 4.5 26.8 1.0 12.9 4.3 0.7 53.8 8.1 2.8 6.9 106.8 8.4 7.4 4.8 2.5 15.1 9.1 22.1 12.6 13.9 14.4 4.4 5.1 17.6 9.3 4.4 2.7 14.7 43.2 0.7 18.2 18.3 5.2 0.0 0.1 2.8 0.1 255.1 184.5 0.0 26.1 9.5 0.6 0.6 0.0 0.2 0.0 0.3 28.2 0.2 0.1 1.6 0.1 0.6 0.1 0.0 0.1 0.0 0.0 55.5 0.0 0.3 156.4 0.1 13.5 0.3 0.2 0.3 0.0 0.0 1.0 44.1 0.0 0.0 0.1 0.5 0.8 0.0 0.0 14.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 22.2 1.4 0.1 0.3 8.9 0.3 0.0 1.7 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 2.6 8.6 3.4 6.5 1.3 37.4 12.9 4.3 0.7 8.4 4.4 4.4 5.2 7.7 0.0 0.5 24.8 0.0 3.7 2.2 0.5 1.2 1.3 1.1 0.8 90.7 0.0 0.9 0.0 0.0 2.1 0.5 0.0 0.0 1.4 7.5 6.5 75.1 8.5 0.0 0.0 363.1 0.2 1.9 151.1 11.7 6.5 0.0 1.0 3.6 0.0 3.0 0.0 8.6 0.0 0.0 0.0 4.4 11.7 184.2 1.9 1.8 692.3 0.1 11.1 3.1 8.0 160.9 0.9 0.0 224.2 0.5 1.0 0.0 0.6 4.5 1.1 118.3 122.1 8.8 2.6 1.9 1.2 2.8 3.8 1.7 44.5 0.0 1.1 PFN3 ENSG00000196570 "Profilin 3" P60673 5 177400109-177400661 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 25.9" "Group enriched" "Detected in some" 176 "Early spermatids: 666.2;Late spermatids: 1589.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038274 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA038274: " "unprognostic (1.03e-2)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 666.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1589.2 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PLXNB2 "KIAA0315, MM1, PLEXB2" ENSG00000196576 "Plexin B2" O15031 22 50274979-50307646 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Gastric mucus-secreting cells: 296.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 11.1;intermediate monocyte: 16.4;myeloid DC: 8.3;non-classical monocyte: 21.2;plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 25 "dendritic cells: 8.3;monocytes: 21.2" "Cell line enhanced" "Detected in many" "SK-BR-3: 306.0" "Low region specificity" "Detected in all" HPA003100 Uncertain NA NA 78000000 "HPA003100: AB_1079638" "unprognostic (4.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.28e-2)" "unprognostic (4.96e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (8.47e-3)" "unprognostic (9.84e-2)" "unprognostic (3.05e-2)" "prognostic favorable (4.75e-4)" "unprognostic (1.61e-2)" "unprognostic (9.41e-3)" "unprognostic (6.05e-2)" 28.3 43.3 13.8 31.5 12.0 14.8 25.2 40.9 14.8 37.9 51.8 46.2 45.4 44.4 7.8 49.0 51.1 52.0 18.7 9.3 30.7 37.6 33.4 40.6 23.0 19.5 18.8 8.2 50.0 47.9 22.7 34.0 36.0 24.2 40.4 16.5 9.4 53.5 46.0 7.0 50.6 50.7 20.4 16.1 74.9 88.2 18.8 13.5 7.9 54.2 3.2 15.4 33.6 41.6 13.4 77.0 125.0 58.2 78.7 35.2 43.2 98.9 104.8 55.8 36.8 36.1 87.0 102.0 59.9 114.1 86.8 22.6 145.9 10.2 77.5 9.1 10.8 50.3 11.2 233.2 64.3 79.2 2.0 54.6 67.8 117.5 39.1 29.9 64.8 30.0 0.1 15.9 14.3 38.7 132.4 1.1 21.0 15.5 45.9 31.3 64.2 97.8 18.8 39.4 237.5 29.6 53.6 103.0 306.0 22.6 16.9 119.9 72.0 64.9 76.1 112.6 39.7 37.9 8.1 1.5 11.0 60.4 3.5 101.5 0.0 11.1 0.0 0.0 16.4 0.2 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.4 0.1 21.2 6.6 0.5 7.7 13.8 12.0 40.9 14.8 9.3 30.7 19.5 18.8 8.2 24.2 16.1 13.5 13.4 15.2 64.1 54.5 33.0 6.2 22.9 22.7 70.6 23.9 15.5 48.2 40.8 15.5 62.9 94.4 136.1 16.7 3.1 11.8 172.0 3.9 93.1 9.0 87.8 33.4 24.8 49.7 2.1 13.5 57.5 29.3 28.7 296.2 72.6 5.1 43.2 21.4 58.8 36.3 13.5 9.3 77.9 40.7 46.8 38.2 4.3 24.2 49.9 14.2 24.4 45.1 54.1 2.1 4.5 1.6 117.5 111.4 19.2 4.9 54.3 110.5 36.4 154.6 10.4 26.3 18.9 35.8 2.2 2.4 34.5 25.1 6.4 4.1 48.5 56.5 45.1 OR5AC2 HSA1 ENSG00000196578 "Olfactory receptor family 5 subfamily AC member 2" Q9NZP5 3 98087173-98088102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "Early spermatids: 2.2;Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AJAP1 "MOT8, SHREW-1, SHREW1" ENSG00000196581 "Adherens junctions associated protein 1" Q9UKB5 1 4654609-4792534 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.6;ovary: 4.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.3;Excitatory neurons: 52.0;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 18.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "eosinophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 7.4;EFO-21: 6.3;hTERT-HME1: 3.8;RPTEC TERT1: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-2)" "unprognostic (2.75e-2)" "unprognostic (7.52e-2)" "unprognostic (6.81e-2)" "unprognostic (2.57e-2)" "unprognostic (6.54e-2)" "unprognostic (1.16e-1)" "unprognostic (8.87e-2)" "unprognostic (4.04e-2)" "unprognostic (3.58e-1)" "prognostic favorable (1.89e-7)" "unprognostic (2.57e-1)" "unprognostic (1.70e-1)" "unprognostic (2.50e-1)" "unprognostic (5.49e-2)" 0.5 0.4 8.4 0.1 7.7 0.1 0.4 0.0 10.2 1.8 0.0 0.4 0.2 1.2 0.7 0.2 1.2 0.1 0.1 10.6 1.5 3.0 0.2 0.9 0.2 2.9 2.6 7.6 4.9 2.1 0.6 0.5 0.3 5.8 1.0 0.1 1.8 0.2 2.2 0.2 0.3 0.3 0.3 1.1 1.8 0.5 1.0 0.8 0.2 0.7 0.0 0.1 0.5 0.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 1.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.9 0.0 0.0 0.0 0.0 0.8 24.1 0.0 1.2 0.7 0.0 2.3 0.0 2.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.4 7.7 0.0 10.2 10.6 1.5 2.9 2.6 7.6 5.8 1.1 0.8 3.4 0.6 0.0 0.0 3.6 0.1 3.7 0.0 1.6 0.0 23.3 0.0 0.5 1.2 11.5 1.5 1.8 0.0 2.1 8.1 0.0 0.0 1.4 5.0 0.1 1.6 0.6 0.0 0.0 52.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 52.6 0.0 0.0 0.0 0.3 4.9 0.3 0.2 1.8 6.5 0.0 1.4 0.0 20.6 18.6 0.2 0.0 6.0 0.0 0.0 0.0 5.2 2.3 1.1 0.0 0.5 4.3 0.2 1.1 0.0 2.4 1.8 0.2 0.1 0.0 0.1 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644776-152676141 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA065153: AB_2685422" "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 0.2 0.3 0.9 2.3 0.6 5.3 1.5 1.5 2.8 0.3 0.0 1.1 1.7 1.1 0.9 1.0 0.5 0.4 1.0 0.6 0.8 0.4 0.4 0.5 3.0 0.9 1.3 0.9 1.0 0.0 0.6 0.0 2.2 1.8 0.7 1.7 1.9 0.2 0.4 0.1 2.0 1.5 0.5 0.4 1.0 1.0 3.0 1.1 3.6 0.6 0.0 2.5 0.5 0.1 1.7 16.5 10.4 18.3 15.8 1.1 1.8 15.0 11.8 3.9 8.2 10.3 14.7 12.8 24.8 9.5 3.5 13.7 13.7 12.8 7.1 19.3 8.9 17.3 16.8 15.5 10.0 0.3 27.3 9.3 0.9 1.1 15.6 3.6 2.0 3.8 15.5 34.2 22.8 8.3 12.6 32.4 21.2 21.6 10.8 12.9 22.8 19.3 15.3 3.1 10.3 16.7 18.1 11.7 7.6 5.0 11.3 5.4 8.3 4.2 17.2 6.9 13.3 23.0 8.8 14.5 19.0 11.0 20.9 20.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.6 1.5 2.8 0.6 0.8 0.9 1.3 0.9 1.8 0.4 1.1 1.7 0.2 0.0 1.1 1.6 1.9 1.3 1.0 1.0 0.0 4.9 0.8 0.4 2.9 0.0 1.4 1.8 0.0 11.2 0.4 0.9 0.0 1.1 11.7 0.9 1.9 1.1 0.0 14.1 2.3 0.2 21.2 2.5 3.1 1.4 0.0 20.2 1.1 0.2 2.4 0.0 2.0 1.7 2.0 0.6 0.8 4.9 0.9 0.8 0.0 0.0 0.6 1.1 3.1 4.5 2.0 0.5 0.1 1.2 6.1 0.6 0.3 0.3 0.1 2.3 0.0 1.9 1.8 31.3 19.1 2.7 1.4 12.6 2.2 1.2 2.3 1.0 MYO6 "DFNA22, DFNB37, KIAA0389" ENSG00000196586 "Myosin VI" Q9UM54 6 75749192-75919537 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Hearing, Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 409.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9" "Group enriched" "Detected in many" 7 "NK-cells: 2.9;T-cells: 5.5" "Cell line enhanced" "Detected in many" "RT4: 103.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010762, HPA035482, HPA035483" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647" "unprognostic (6.29e-2)" "unprognostic (6.34e-2)" "unprognostic (3.63e-3)" "unprognostic (1.30e-1)" "unprognostic (8.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.41e-3)" "unprognostic (1.23e-2)" "unprognostic (1.23e-2)" "unprognostic (2.66e-2)" "unprognostic (7.78e-2)" "unprognostic (2.78e-2)" "prognostic favorable (1.27e-12)" "unprognostic (1.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.49e-2)" 9.3 9.5 19.0 7.2 28.3 0.3 28.5 22.5 32.3 18.6 29.5 22.3 33.3 7.7 23.1 32.2 11.6 27.2 5.1 18.9 19.5 51.8 15.3 23.4 4.7 23.7 24.8 14.2 4.7 21.8 40.7 14.6 7.6 23.7 17.3 19.4 49.4 26.1 20.0 3.4 15.9 34.2 5.7 17.8 7.7 27.8 14.7 22.6 5.2 16.1 3.1 12.9 24.2 15.9 35.4 52.2 13.0 12.3 8.9 29.7 23.7 42.6 20.7 23.6 12.3 18.3 22.2 44.2 0.1 16.1 25.7 14.0 40.0 15.3 29.2 18.6 17.0 30.3 17.4 5.6 14.1 25.0 0.0 22.2 17.5 21.6 19.3 14.5 24.0 43.3 7.9 22.4 7.2 15.4 48.3 0.2 0.8 7.7 44.1 3.8 0.7 29.1 1.6 51.1 103.6 26.8 14.8 5.6 46.6 6.8 28.3 16.5 35.8 59.4 13.7 9.3 0.6 20.0 13.2 16.1 0.3 10.9 0.2 5.3 0.2 0.1 0.1 5.5 0.0 3.0 0.2 1.8 3.1 0.0 0.1 0.4 3.0 0.6 2.9 0.1 0.1 0.2 0.8 19.0 28.3 22.5 32.3 18.9 19.5 23.7 24.8 14.2 23.7 17.8 22.6 35.4 74.8 141.1 207.0 286.3 4.7 30.1 87.5 49.2 18.2 83.6 99.6 35.9 8.1 38.6 91.3 150.8 120.9 32.0 14.7 112.2 54.8 128.9 7.0 86.9 26.9 57.2 85.0 0.0 147.8 120.3 23.8 30.5 91.7 169.2 26.0 81.0 37.9 33.8 6.3 95.9 167.2 76.4 116.0 2.9 6.1 9.6 30.1 6.7 30.2 105.9 2.7 307.3 12.3 179.4 409.1 197.0 99.7 43.2 11.4 165.9 105.7 97.6 109.5 188.4 13.1 26.5 32.7 14.4 32.1 28.3 34.1 78.4 13.4 191.8 77.5 199.7 MRTFA "BSAC, KIAA1438, MAL, MKL, MKL1, MRTF-A" ENSG00000196588 "Myocardin related transcription factor A" Q969V6 22 40410281-40636719 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Actin-binding "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 4.5;Cardiomyocytes: 8.7;Cytotrophoblasts: 8.9;Extravillous trophoblasts: 8.7;Fibroblasts: 4.3;Hofbauer cells: 12.7;Syncytiotrophoblasts: 7.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 189.4" "Group enriched" "Detected in all" 5 "dendritic cells: 93.1;granulocytes: 189.4;monocytes: 58.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030782 Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA030782: AB_10600930" "unprognostic (7.90e-3)" "unprognostic (4.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (9.37e-2)" "unprognostic (4.38e-3)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-2)" "prognostic unfavorable (1.58e-7)" "unprognostic (9.05e-2)" "unprognostic (8.15e-2)" "unprognostic (1.30e-2)" "unprognostic (3.98e-1)" 19.6 15.5 13.8 27.6 17.4 81.4 20.0 9.1 23.0 25.3 11.6 19.0 11.8 33.4 7.4 16.7 22.8 11.8 20.7 18.4 23.0 14.4 12.4 24.7 27.7 8.6 7.5 16.8 21.0 16.3 8.9 13.9 18.4 9.9 19.6 8.9 11.2 18.4 15.3 19.2 23.9 18.7 16.4 5.7 29.9 19.2 36.1 8.8 21.9 22.3 8.1 23.0 22.2 19.8 14.5 26.5 33.9 14.5 17.5 21.6 15.9 27.8 25.6 16.6 23.1 22.8 19.1 7.9 27.2 10.2 27.0 20.3 35.5 12.7 31.9 13.8 32.0 29.2 46.3 39.9 24.7 17.8 53.5 79.8 15.5 36.7 22.4 15.1 17.5 18.3 15.0 12.9 12.3 11.5 25.3 20.7 57.4 11.7 14.2 12.1 35.4 17.5 16.4 16.9 22.1 8.7 8.7 43.7 19.4 13.8 18.3 16.0 59.0 27.8 14.7 38.7 21.4 20.9 16.1 16.5 39.1 12.1 25.6 26.5 49.0 53.5 189.4 18.5 43.7 16.9 13.0 15.8 13.6 64.3 18.6 21.1 18.1 57.2 16.8 58.8 93.1 22.0 34.2 13.8 17.4 9.1 23.0 18.4 23.0 8.6 7.5 16.8 9.9 5.7 8.8 14.5 4.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 8.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.7 4.3 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 7.8 0.6 0.0 0.0 0.0 MBD3L2B ENSG00000196589 "Methyl-CpG binding domain protein 3 like 2B" A0A1B0GVZ6 19 7018969-7021432 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HDAC2 "KDAC2, RPD3, YAF1" ENSG00000196591 "Histone deacetylase 2" Q92769 6 113933028-114011308 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005054, HPA011727" Supported Supported Nucleoplasm NA NA 25000 Nucleoplasm "CAB005054: AB_562295, HPA011727: AB_1850540" "prognostic unfavorable (7.07e-4)" "unprognostic (1.44e-1)" "unprognostic (2.67e-1)" "unprognostic (2.56e-2)" "unprognostic (2.61e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.39e-10)" "unprognostic (2.03e-1)" "unprognostic (2.63e-2)" "unprognostic (9.00e-2)" "unprognostic (2.01e-1)" "unprognostic (3.92e-1)" "unprognostic (1.84e-2)" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (9.80e-2)" "unprognostic (3.51e-1)" 36.3 43.1 30.0 37.7 35.1 64.0 55.4 36.2 40.3 45.5 26.2 48.4 34.7 57.9 53.8 43.6 49.2 34.9 41.5 31.0 33.5 46.7 34.9 33.3 42.9 33.7 33.0 29.0 53.8 37.4 46.1 36.2 56.5 34.7 47.4 54.2 37.5 34.5 45.7 49.0 46.5 37.0 54.7 31.9 36.2 40.9 77.4 33.6 69.2 46.0 43.8 52.5 63.8 37.8 41.0 126.7 84.9 387.1 224.3 97.7 110.5 162.6 146.6 119.0 168.5 200.1 226.3 90.1 103.6 119.0 132.5 173.1 96.6 266.0 148.1 281.4 148.9 185.0 249.2 102.1 131.8 129.7 256.1 107.7 90.0 97.6 180.0 167.2 164.4 199.6 179.2 326.4 101.6 282.7 105.5 231.9 229.6 220.0 133.4 116.3 155.0 193.0 95.2 174.4 148.9 258.3 219.1 115.9 107.5 127.7 231.4 78.6 294.0 163.2 107.0 122.9 113.7 246.9 80.6 113.9 244.6 90.9 242.6 185.3 43.5 39.0 42.1 28.0 38.6 37.3 37.0 34.0 30.3 51.0 31.4 41.8 39.1 23.1 39.8 50.2 44.2 36.0 37.2 30.0 35.1 36.2 40.3 31.0 33.5 33.7 33.0 29.0 34.7 31.9 33.6 41.0 40.2 57.7 57.8 13.4 51.4 192.1 91.3 152.6 85.4 31.0 61.0 54.6 64.0 25.8 116.4 53.3 4.2 157.7 42.6 43.5 43.0 154.9 86.8 74.3 91.6 73.8 100.5 129.4 29.9 105.0 140.7 76.2 53.5 63.2 55.1 103.9 50.0 31.9 102.0 15.2 26.3 73.4 175.0 64.1 89.8 109.1 83.0 63.3 83.6 26.2 107.7 30.9 33.0 29.1 34.0 133.6 51.3 67.4 56.2 90.0 37.4 71.7 98.7 28.1 39.5 94.7 88.0 199.0 215.5 96.5 193.1 207.7 45.5 53.9 94.6 100.5 ZNF782 FLJ16636 ENSG00000196597 "Zinc finger protein 782" Q6ZMW2 9 96816269-96875623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 10 "Astrocytes: 96.3;Excitatory neurons: 105.1;Inhibitory neurons: 126.8;Microglial cells: 70.3;Oligodendrocyte precursor cells: 117.1;Oligodendrocytes: 166.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011013 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA011013: AB_1080758" "unprognostic (5.51e-2)" "unprognostic (5.29e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.48e-2)" "unprognostic (2.82e-2)" "unprognostic (9.89e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-2)" "unprognostic (4.68e-3)" "unprognostic (3.63e-3)" "unprognostic (4.84e-2)" "unprognostic (3.55e-1)" "unprognostic (4.95e-1)" "unprognostic (2.61e-2)" "unprognostic (4.39e-2)" 1.4 1.6 1.9 2.3 1.3 1.3 3.0 8.2 3.8 2.4 0.0 2.0 2.3 3.0 3.5 1.6 2.4 1.9 1.1 1.4 0.4 2.6 1.7 1.5 2.6 1.3 1.0 0.7 3.3 4.6 3.2 1.8 2.0 3.3 3.0 2.8 9.1 2.2 2.3 2.3 3.9 2.9 2.1 0.1 2.2 2.8 6.2 0.8 3.2 3.3 2.0 3.0 1.6 1.9 3.3 2.1 1.7 4.2 5.9 1.0 1.0 2.5 1.8 1.5 2.4 1.8 1.8 3.3 3.7 2.3 1.4 3.5 3.6 2.9 1.1 2.8 4.2 1.7 3.2 3.8 1.8 1.4 5.3 3.2 0.6 2.5 2.6 1.6 1.9 1.3 5.7 4.8 5.0 2.0 3.6 4.7 2.4 3.0 3.4 2.7 5.4 4.9 1.3 2.2 1.1 3.8 2.7 2.5 1.6 1.8 2.7 2.8 2.5 2.0 3.5 2.6 3.8 2.1 4.9 3.5 2.2 2.2 2.0 2.7 0.0 0.2 0.0 0.3 0.1 0.5 0.1 0.1 0.2 0.0 0.4 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.0 1.9 1.3 8.2 3.8 1.4 0.4 1.3 1.0 0.7 3.3 0.1 0.8 3.3 3.4 0.0 4.1 96.3 3.3 1.9 1.4 0.6 4.0 5.9 2.3 2.2 1.6 1.5 0.3 1.8 8.4 0.9 5.1 1.7 0.0 1.4 7.5 2.9 3.9 3.6 0.0 7.4 105.1 1.7 0.4 2.3 2.0 5.2 5.7 6.0 3.6 1.1 1.2 3.3 126.8 1.9 0.0 0.6 0.7 9.2 1.8 1.7 0.0 70.3 4.0 1.7 1.0 117.1 166.0 1.0 0.3 3.0 4.6 1.9 2.4 1.8 1.2 7.6 0.0 5.0 3.1 10.6 2.3 2.1 1.0 0.7 2.9 3.3 1.1 2.0 SLC22A25 "HIMTP, MGC120420, UST6" ENSG00000196600 "Solute carrier family 22 member 25" Q6T423 11 63163776-63229652 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "liver: 11.4" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.4;Hepatocytes: 6.4;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.2" "Cancer enriched" "Detected in single" 66 "liver cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039390 Uncertain NA NA "HPA039390: AB_10671996" "unprognostic (3.19e-2)" "unprognostic (2.38e-1)" "unprognostic (4.51e-1)" "prognostic favorable (7.04e-4)" "unprognostic (1.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.4 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEF "A26C1B, POTE2alpha, POTEACTIN" ENSG00000196604 "POTE ankyrin domain family member F" A5A3E0 2 130073535-130129222 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.5;testis: 1.7" "Cell type enhanced" "Detected in some" "Melanocytes: 1.8;NK-cells: 1.0;Smooth muscle cells: 1.3;Spermatocytes: 2.2;Spermatogonia: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.7;BEWO: 2.0;CACO-2: 2.3;MCF7: 1.8;U-2 OS: 5.6;U-266/70: 2.7" "HPA041264, HPA041271, HPA043260" Uncertain NA NA 1900000000 "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (8.13e-3)" "unprognostic (1.44e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-1)" "unprognostic (3.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.50e-1)" "unprognostic (1.02e-1)" "unprognostic (4.48e-1)" "unprognostic (1.05e-2)" "unprognostic (9.35e-2)" 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 2.7 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.1 2.7 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 1.6 0.3 0.2 0.1 0.1 0.1 0.7 0.7 0.5 0.0 0.4 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 2.2 1.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 ZNF846 ENSG00000196605 "Zinc finger protein 846" Q147U1 19 9751993-9793180 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 242.1;Late spermatids: 91.0;Spermatocytes: 177.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA034617, HPA034618" Approved Approved "Actin filaments" NA NA "Actin filaments" "HPA034617: AB_10603942, HPA034618: AB_2674249" "unprognostic (1.36e-1)" "unprognostic (4.70e-2)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (6.73e-2)" "prognostic favorable (5.25e-8)" "unprognostic (2.57e-1)" "unprognostic (2.62e-2)" "unprognostic (2.96e-2)" "unprognostic (2.33e-3)" "unprognostic (1.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.31e-2)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (1.32e-1)" "unprognostic (9.05e-3)" 7.2 6.7 9.4 6.3 9.4 4.6 7.1 7.1 9.2 8.1 7.2 7.2 4.3 11.2 9.7 9.3 8.5 9.8 7.9 8.0 8.0 5.0 4.7 7.0 8.2 10.6 8.6 7.3 13.0 3.9 7.4 5.6 6.4 10.2 11.9 7.2 7.4 7.2 18.9 5.5 8.1 5.3 10.7 9.7 6.5 6.6 14.1 8.9 8.1 7.3 5.7 6.4 13.2 9.0 9.9 3.8 0.8 11.6 2.8 12.8 16.4 2.6 5.8 4.0 4.1 8.2 2.1 3.1 1.5 2.3 6.9 4.8 1.4 0.8 4.5 4.5 3.4 2.5 8.6 0.3 3.1 4.6 0.8 8.9 16.9 5.9 3.1 2.4 9.4 3.4 4.6 1.5 0.0 4.4 1.5 3.1 7.2 1.7 3.1 4.8 4.5 0.9 0.4 5.2 14.6 1.8 3.5 3.1 0.3 4.4 4.0 1.9 6.0 1.8 3.3 2.4 2.8 0.5 6.5 7.3 8.3 0.4 1.1 2.9 1.1 2.1 1.3 1.7 1.7 3.5 4.2 2.6 4.3 6.9 5.2 2.0 4.2 0.8 2.2 1.2 4.5 3.3 1.6 9.4 9.4 7.1 9.2 8.0 8.0 10.6 8.6 7.3 10.2 9.7 8.9 9.9 4.4 9.6 5.4 18.3 4.7 7.9 15.0 14.5 20.5 1.7 7.3 10.0 6.8 5.7 11.9 0.0 2.1 1.6 5.5 5.4 9.8 6.5 242.1 6.4 7.7 5.1 1.2 4.8 25.8 4.9 2.1 7.8 5.1 4.5 5.1 7.8 5.7 5.4 7.5 0.0 13.7 4.9 6.1 13.9 9.1 91.0 6.8 10.2 7.2 41.2 9.2 3.2 1.0 14.6 14.6 7.0 3.9 9.1 3.7 7.3 3.1 6.1 12.5 2.4 6.6 3.7 8.2 177.1 8.6 8.0 8.8 1.2 5.2 7.8 4.1 16.4 MMP1 CLG ENSG00000196611 "Matrix metallopeptidase 1" P03956 11 102789401-102798160 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation, Host-virus interaction" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 76.3;stomach 1: 48.0;urinary bladder: 52.7" "Cell type enriched" "Detected in many" 10 "Pancreatic endocrine cells: 2239.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 344.2" "Region enriched" "Detected in single" 9 "cerebral cortex: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1139.1;HBF TERT88: 1094.4;HUVEC TERT2: 2954.4;WM-115: 1454.1" "Not detected" "Not detected" HPA004920 Approved Vesicles "Secreted to extracellular matrix" NA NA 7730000 55000 Vesicles "HPA004920: AB_2667293" "unprognostic (4.11e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (4.20e-3)" "unprognostic (1.19e-3)" "unprognostic (6.46e-2)" "unprognostic (6.50e-2)" "prognostic unfavorable (4.22e-6)" "unprognostic (7.83e-3)" "unprognostic (2.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.86e-10)" "unprognostic (1.67e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-2)" "unprognostic (5.11e-2)" 0.3 0.1 0.0 26.9 0.0 0.3 0.2 0.0 1.1 0.1 0.0 4.1 8.0 10.8 0.0 4.3 0.1 76.3 0.3 0.0 0.1 0.9 0.8 6.8 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 7.2 0.0 0.4 6.9 0.0 6.9 0.2 0.0 0.6 13.1 1.2 0.0 2.1 48.0 0.1 0.1 0.3 0.2 0.0 1.7 52.7 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 517.1 1139.1 456.6 118.2 9.1 1.0 0.0 5.2 275.5 175.2 4.6 0.0 160.0 1094.4 0.0 1.0 0.0 0.0 0.0 2.9 0.0 0.5 0.3 0.8 470.1 39.6 0.1 2954.4 0.0 1.5 0.5 0.3 0.0 0.0 0.0 0.4 189.3 20.8 0.0 0.1 0.0 0.7 2.2 0.0 0.1 4.8 0.0 1.6 0.1 0.5 0.0 155.0 374.1 0.6 16.8 1.3 0.1 0.0 0.0 8.8 0.0 1454.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 3.2 2.6 0.0 0.2 2.3 22.4 90.4 0.0 0.0 0.0 0.0 0.1 30.0 15.8 3.7 0.0 0.0 0.0 0.2 0.0 143.7 0.0 0.1 0.2 113.2 0.0 0.0 0.1 204.8 0.1 11.5 25.5 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.9 0.4 0.0 0.0 15.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 2239.5 1.2 0.0 0.0 30.9 0.7 0.2 1.3 0.0 0.0 1.8 10.5 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 44.3 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304971-99352760 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1514.9;liver: 5906.7" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 4153.7" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "ASC diff: 6574.3" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" NA NA 39000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 1514.9 141.5 2.7 36.7 3.0 0.1 932.4 2.3 8.1 40.9 17.5 197.2 38.8 162.8 75.5 106.6 388.3 146.5 146.7 2.2 2.1 67.3 5906.7 376.5 26.0 5.1 3.0 2.1 118.7 49.5 7.9 24.4 6.8 4.2 27.0 115.8 0.1 68.5 26.9 67.1 147.3 239.2 74.0 4.7 73.3 142.3 2.8 2.5 20.0 95.3 230.2 16.1 290.3 119.7 2.8 0.0 0.0 0.0 0.0 6574.3 956.7 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.1 1.1 0.0 0.0 0.5 1.4 0.0 0.1 0.0 1.1 0.1 0.0 26.9 3.0 0.0 216.8 0.1 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.1 3.2 0.1 0.0 0.0 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.2 0.3 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.0 2.3 8.1 2.2 2.1 5.1 3.0 2.1 4.2 4.7 2.5 2.8 29.0 0.0 3.4 0.0 8.1 22.3 0.5 0.1 6.8 0.1 1.1 2.5 12.2 110.1 2.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.6 0.1 0.9 14.7 0.0 115.0 0.0 0.0 0.1 633.1 11.2 0.0 1.3 0.0 96.8 4153.7 0.1 0.0 0.0 0.0 0.0 98.8 25.4 0.6 55.3 3.5 28.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 7.1 0.7 0.0 0.1 0.2 0.1 6.6 15.0 47.9 0.0 0.1 10.4 13.1 0.1 8.9 0.1 0.0 0.2 UGT2B15 UGT2B8 ENSG00000196620 "UDP glucuronosyltransferase family 2 member B15" P54855 4 68646597-68670652 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "gallbladder: 78.4;liver: 293.6" "Group enriched" "Detected in some" 6 "Cholangiocytes: 168.7;Hepatocytes: 142.8" "Cancer enriched" "Detected in many" 10 "liver cancer: 120.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (2.22e-2)" "unprognostic (3.86e-1)" "unprognostic (1.94e-1)" "prognostic favorable (9.82e-4)" "unprognostic (6.73e-2)" "unprognostic (3.49e-2)" "unprognostic (7.84e-2)" "unprognostic (5.81e-3)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "prognostic favorable (4.50e-4)" 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 12.0 5.2 0.0 0.0 0.0 0.1 78.4 0.0 0.0 0.0 0.0 293.6 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 13.1 0.0 0.0 0.1 17.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 4.4 0.9 0.1 168.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 24.2 3.0 0.2 0.0 0.2 0.0 2.7 0.1 3.6 0.1 0.1 0.0 0.0 0.0 0.0 2.9 142.8 0.0 0.0 0.1 3.3 0.0 3.2 0.0 0.6 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 14.6 1.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.9 0.1 0.6 1.0 0.0 0.0 0.0 0.4 0.0 0.5 0.9 TCF4 "bHLHb19, E2-2, ITF2, SEF2-1B" ENSG00000196628 "Transcription factor 4" P15884 18 55222185-55664787 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.7" "Cell type enhanced" "Detected in many" "Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 58.7" "Group enriched" "Detected in many" 14 "memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8" "Group enriched" "Detected in many" 33 "B-cells: 173.6;dendritic cells: 559.8" "Cell line enhanced" "Detected in many" "HDLM-2: 140.4;SH-SY5Y: 157.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020722, HPA025958" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB020722: , HPA025958: AB_1857849" "unprognostic (2.11e-1)" "unprognostic (9.10e-2)" "unprognostic (8.69e-2)" "unprognostic (7.89e-3)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (3.03e-2)" "unprognostic (8.64e-2)" "unprognostic (1.79e-2)" "unprognostic (3.29e-2)" "unprognostic (2.77e-1)" "unprognostic (8.44e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (1.99e-3)" "unprognostic (2.68e-2)" "unprognostic (2.76e-3)" "prognostic unfavorable (9.95e-4)" 20.5 9.7 4.6 12.9 12.1 9.6 11.7 58.7 25.2 28.7 1.8 7.5 5.2 23.2 2.1 9.8 13.5 17.6 17.7 28.8 1.8 4.4 4.4 15.7 14.8 8.7 2.6 5.1 26.2 5.9 8.0 6.6 29.1 18.7 6.6 8.0 14.1 6.9 10.3 6.1 6.4 5.1 24.3 2.0 13.2 6.1 15.6 3.4 9.9 13.4 16.8 14.8 13.2 7.4 13.5 0.1 4.1 36.8 11.4 8.5 14.4 0.1 18.4 40.6 13.2 17.2 23.1 3.6 28.8 0.1 41.9 2.7 4.5 17.9 17.1 9.2 140.4 13.9 12.1 0.1 0.0 4.0 5.3 2.8 19.6 5.3 18.5 0.7 9.1 45.8 1.6 19.5 22.0 11.0 0.0 7.6 0.0 10.4 0.1 2.4 41.6 14.9 65.4 0.0 0.9 12.6 157.7 0.0 1.5 0.0 11.1 1.6 1.3 49.1 48.5 17.4 2.1 14.6 16.3 32.2 25.7 11.0 5.2 15.5 0.9 7.4 0.8 0.9 8.3 0.7 173.6 0.2 0.5 20.6 146.8 0.5 0.3 1.8 11.2 7.4 559.8 0.7 11.3 4.6 12.1 58.7 25.2 28.8 1.8 8.7 2.6 5.1 18.7 2.0 3.4 13.5 820.0 6.4 13.1 501.1 217.4 117.0 37.8 34.0 80.8 293.0 6.5 23.4 35.5 4.3 32.6 22.0 83.4 1.8 446.8 0.1 0.0 1.5 103.2 17.5 201.4 574.5 5.4 34.2 503.8 7.1 1.5 296.7 1.5 12.2 13.9 105.7 316.3 6.6 39.6 25.2 1177.6 0.3 26.4 112.4 129.2 116.3 205.3 80.4 64.0 474.1 32.7 372.8 13.4 719.8 573.6 2.1 0.1 182.1 131.7 20.8 0.0 2.3 25.9 54.7 236.7 304.5 221.0 8.7 14.5 47.5 84.4 2.6 15.1 164.8 0.2 17.8 WNK3 PRKWNK3 ENSG00000196632 "WNK lysine deficient protein kinase 3" Q9BYP7 X 54192823-54358642 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 11.8;testis: 10.0" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 193.3;Granulosa cells: 199.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.5;AN3-CA: 3.4;HAP1: 5.2;NTERA-2: 9.1;SiHa: 4.5;SuSa: 3.8;U-2 OS: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077678 Approved Approved Vesicles NA NA Vesicles "HPA077678: AB_2686850" "unprognostic (1.86e-1)" "unprognostic (1.68e-3)" "unprognostic (2.44e-1)" "unprognostic (7.87e-5)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (1.85e-2)" "unprognostic (3.32e-2)" "unprognostic (3.38e-1)" "unprognostic (3.03e-2)" "unprognostic (5.78e-4)" "unprognostic (2.22e-1)" "unprognostic (2.64e-2)" "unprognostic (5.61e-2)" "unprognostic (9.99e-2)" "unprognostic (7.63e-2)" "unprognostic (8.74e-2)" 0.2 2.5 1.7 0.1 1.8 0.1 0.6 0.3 1.8 0.6 0.0 0.2 0.2 0.6 11.8 0.2 0.8 0.3 0.5 0.9 3.9 1.0 3.6 0.3 0.1 1.8 2.1 0.8 3.0 0.3 0.9 2.4 0.3 2.1 0.9 0.0 3.4 0.3 0.8 0.1 0.3 0.2 0.5 0.6 0.2 0.6 10.0 3.7 0.1 0.6 0.1 0.1 0.5 0.4 1.8 0.0 0.0 4.5 3.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 5.2 0.1 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.2 0.6 0.0 0.9 0.1 1.4 1.3 4.5 0.0 0.5 3.8 0.4 0.0 0.2 0.0 3.9 0.0 1.0 0.0 3.3 0.0 1.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 0.3 1.8 0.9 3.9 1.8 2.1 0.8 2.1 0.6 3.7 1.8 1.9 0.0 2.3 18.3 0.7 3.7 4.3 0.3 9.1 24.9 5.8 6.9 193.3 2.8 3.2 7.3 14.6 0.2 0.0 0.1 5.9 1.7 6.4 2.0 7.8 8.5 0.0 0.8 14.5 0.0 0.3 6.7 0.0 4.9 6.3 199.5 20.3 48.3 0.1 35.3 29.7 0.0 2.0 0.8 1.5 20.4 15.8 0.6 0.0 3.7 0.0 19.5 0.0 48.2 19.2 0.2 0.0 43.6 0.0 6.0 0.0 3.9 0.2 43.3 6.6 4.8 10.5 43.8 46.3 2.1 1.1 0.1 1.5 9.8 0.0 1.4 SDHAF3 "ACN9, DC11, LYRM10, Sdh7" ENSG00000196636 "Succinate dehydrogenase complex assembly factor 3" Q9NRP4 7 97117698-97181763 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 148.7;Early spermatids: 136.0;Proximal tubular cells: 150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020515, HPA020523" Approved Approved Mitochondria NA NA Mitochondria "HPA020515: , HPA020523: AB_2670464" "unprognostic (3.94e-2)" "unprognostic (9.11e-2)" "unprognostic (6.51e-2)" "unprognostic (2.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.61e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-2)" "unprognostic (3.74e-2)" "unprognostic (3.07e-3)" "unprognostic (4.27e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-3)" "unprognostic (2.82e-1)" "unprognostic (3.79e-3)" "unprognostic (2.34e-1)" "unprognostic (8.45e-2)" 12.5 17.6 10.0 12.5 10.5 16.9 18.9 11.3 13.4 15.2 13.3 20.9 20.1 12.5 22.4 15.1 14.7 13.1 27.3 10.0 12.3 33.8 32.4 8.4 18.6 11.2 11.5 9.3 10.8 18.5 12.3 3.7 9.7 11.3 15.0 20.5 16.6 22.2 12.1 29.3 14.3 17.6 12.3 11.3 11.3 18.4 14.6 10.7 24.7 19.2 25.9 14.7 13.0 3.7 13.1 36.6 27.6 24.5 82.3 15.8 12.8 14.8 15.8 7.6 15.6 22.8 5.0 30.7 57.4 40.1 14.1 20.7 13.4 49.6 38.8 33.7 44.2 59.6 34.6 24.8 54.8 23.8 89.4 16.0 24.3 30.3 25.7 32.0 11.6 14.5 57.2 99.5 1.6 34.8 0.0 94.5 126.7 37.3 74.1 34.6 21.0 14.0 83.7 26.0 24.9 63.8 40.7 38.5 47.9 55.5 33.9 0.4 31.6 16.0 4.2 53.2 88.6 10.7 41.4 87.0 139.5 14.6 144.7 51.9 30.0 21.4 8.0 26.5 26.3 36.3 36.3 33.3 39.1 27.9 32.1 45.9 44.4 20.2 23.9 26.7 82.6 33.2 37.9 10.0 10.5 11.3 13.4 10.0 12.3 11.2 11.5 9.3 11.3 11.3 10.7 13.1 24.4 19.2 12.5 8.5 34.4 0.0 23.1 0.0 29.0 13.8 38.6 44.4 37.9 18.6 6.8 25.8 4.2 35.2 31.3 7.2 148.7 30.6 136.0 31.3 20.6 17.3 13.3 32.6 16.6 39.1 30.0 20.1 29.0 21.4 5.1 22.2 16.4 55.9 31.1 10.1 14.3 24.2 0.0 20.1 0.0 20.7 22.7 20.2 0.0 9.4 13.9 44.8 36.0 14.6 18.5 24.0 29.1 24.8 30.9 17.0 35.1 150.9 16.0 19.5 32.9 19.5 20.4 32.7 49.3 53.5 0.0 9.6 26.3 45.6 39.8 25.0 HRH1 ENSG00000196639 "Histamine receptor H1" P35367 3 11137093-11263557 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 14.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.1;Distal enterocytes: 44.9;Glandular and luminal cells: 41.6;Suprabasal keratinocytes: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029740 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA029740: AB_10601578" "unprognostic (4.60e-3)" "unprognostic (3.41e-2)" "unprognostic (6.37e-3)" "unprognostic (9.55e-2)" "unprognostic (3.32e-2)" "unprognostic (1.07e-2)" "unprognostic (9.60e-3)" "unprognostic (4.00e-3)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-1)" 5.2 3.0 5.3 3.2 5.9 0.1 3.5 1.6 6.6 5.1 2.9 6.8 2.7 4.3 4.8 3.3 7.4 7.1 1.5 5.6 4.2 1.6 0.7 4.2 1.2 4.6 2.9 5.3 5.9 0.6 0.9 0.5 4.0 4.2 2.4 5.2 0.2 1.8 3.5 0.9 4.9 4.4 5.4 3.1 1.0 1.7 0.8 4.5 1.2 1.2 2.3 1.4 14.4 5.1 4.2 2.6 6.1 0.0 0.0 2.7 28.5 4.2 4.6 15.3 13.3 8.8 1.1 21.8 0.0 13.4 10.6 13.5 17.3 0.0 6.3 17.7 10.1 0.0 1.4 9.7 0.0 8.4 4.5 2.4 10.0 3.7 30.4 10.5 18.4 19.1 0.2 0.0 0.1 5.8 0.0 0.0 1.9 0.0 2.6 5.4 0.4 1.6 0.6 23.2 3.6 0.2 0.0 6.6 4.6 0.0 0.2 0.0 3.5 28.8 14.8 9.4 15.3 23.4 0.0 1.7 0.1 22.5 3.9 13.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 5.3 5.9 1.6 6.6 5.6 4.2 4.6 2.9 5.3 4.2 3.1 4.5 4.2 11.5 6.4 1.1 33.3 0.1 46.1 8.9 7.4 6.8 0.0 0.5 0.5 0.5 0.0 19.3 1.8 0.0 0.2 0.0 44.9 0.0 0.6 0.3 20.5 6.9 20.2 3.5 0.0 34.6 0.7 1.0 16.7 8.6 41.6 2.5 28.8 2.5 0.0 27.2 0.0 19.1 15.1 4.1 12.5 12.3 0.2 3.7 9.8 0.0 2.8 0.1 0.0 0.0 2.0 1.1 14.0 21.0 0.0 0.0 6.2 29.1 0.7 5.0 0.2 0.0 6.8 2.8 1.8 3.3 2.2 41.5 0.5 1.0 0.2 15.8 19.3 RABL6 "bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1" ENSG00000196642 "RAB, member RAS oncogene family like 6" Q3YEC7 9 136807943-136841187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044037 Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA044037: AB_10966437" "unprognostic (3.10e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "prognostic favorable (4.00e-4)" "unprognostic (9.23e-2)" "unprognostic (2.44e-2)" "unprognostic (1.90e-3)" "unprognostic (7.55e-3)" "unprognostic (1.65e-1)" "unprognostic (4.92e-2)" "prognostic favorable (1.46e-4)" "unprognostic (5.23e-2)" "unprognostic (1.03e-3)" "prognostic favorable (9.14e-4)" "unprognostic (4.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.15e-1)" 37.3 45.9 45.5 30.1 57.4 52.3 36.2 40.6 69.7 33.5 24.3 57.3 40.1 38.8 10.8 57.9 36.7 15.5 74.1 43.3 32.6 55.4 24.5 42.0 27.1 43.9 37.8 42.5 39.9 102.3 22.9 70.4 21.1 46.5 68.0 21.4 15.5 43.1 20.2 156.0 45.6 52.0 16.3 30.6 50.7 62.2 50.4 43.4 28.5 42.5 61.4 18.3 44.1 35.3 42.2 75.2 97.9 68.4 80.3 27.5 30.7 178.5 65.8 42.2 63.1 45.9 109.7 77.2 104.7 40.5 52.0 66.4 159.9 76.8 58.6 21.5 110.1 97.5 64.5 127.2 129.9 49.4 120.6 79.4 34.2 59.6 39.0 42.8 38.3 66.4 88.8 142.0 50.0 43.9 149.5 130.2 82.9 128.0 91.3 82.4 167.4 81.6 103.1 41.5 65.7 223.5 92.5 117.2 135.6 83.5 36.1 116.8 120.1 81.1 80.9 69.8 86.5 109.1 42.3 51.8 85.5 68.2 57.8 77.5 0.5 1.8 1.2 1.4 2.4 1.5 2.2 1.5 1.4 1.3 2.0 1.2 1.5 0.9 2.3 0.8 1.7 2.3 0.6 45.5 57.4 40.6 69.7 43.3 32.6 43.9 37.8 42.5 46.5 30.6 43.4 42.2 36.2 28.9 41.2 24.5 25.5 18.0 17.7 12.6 38.7 39.5 38.7 33.4 35.3 0.0 13.8 25.8 20.9 25.2 35.3 172.7 31.3 34.9 13.4 42.6 40.6 25.7 52.0 25.6 37.7 58.2 33.2 28.1 43.3 43.8 15.2 85.2 0.0 0.0 31.0 38.7 34.3 78.5 20.3 0.0 26.5 18.5 19.6 37.0 40.9 8.4 27.5 22.2 24.7 18.1 26.9 62.5 80.9 26.7 67.7 36.6 59.4 55.8 18.3 38.3 0.0 19.0 33.3 18.1 28.0 55.3 19.5 28.3 29.6 41.0 94.9 26.5 ZNF136 pHZ-20 ENSG00000196646 "Zinc finger protein 136" P52737 19 12163064-12189871 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054120 Approved Nucleoli NA NA Nucleoli "HPA054120: AB_2682389" "unprognostic (1.40e-1)" "unprognostic (5.90e-2)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" "unprognostic (6.22e-2)" "unprognostic (4.68e-3)" "unprognostic (2.36e-1)" "unprognostic (9.39e-3)" "unprognostic (5.97e-3)" "unprognostic (1.71e-1)" "unprognostic (4.33e-2)" "unprognostic (5.46e-3)" "prognostic favorable (4.75e-5)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 5.3 5.6 1.8 5.9 2.7 15.7 7.6 5.8 3.8 5.8 2.7 4.3 2.7 8.4 6.1 4.2 6.5 5.5 4.0 1.7 3.0 5.8 3.9 6.1 7.6 2.5 2.6 1.6 12.1 4.6 7.2 3.1 7.1 3.1 6.8 5.5 7.3 4.5 5.2 2.3 4.5 4.6 6.5 2.0 8.0 6.8 7.5 2.8 7.9 9.0 4.4 7.1 5.3 4.7 3.9 2.7 1.6 9.3 9.8 4.9 5.6 5.5 5.2 5.4 5.3 5.1 1.8 1.0 13.4 6.8 3.7 4.7 3.0 4.3 3.0 6.0 6.8 6.8 7.4 4.5 3.0 3.6 15.6 13.1 5.9 5.5 4.4 5.6 7.0 3.4 11.5 6.0 20.6 6.1 3.6 11.4 7.5 11.0 1.0 5.8 10.1 12.0 5.1 5.1 9.6 9.8 8.7 7.8 1.7 6.1 7.7 4.1 8.9 7.3 12.9 4.6 5.6 5.2 14.6 26.1 14.7 5.2 6.0 6.6 15.3 3.4 7.9 6.3 3.3 7.9 7.8 7.5 7.3 3.9 8.1 8.1 7.0 9.4 8.2 3.9 4.4 5.4 3.8 1.8 2.7 5.8 3.8 1.7 3.0 2.5 2.6 1.6 3.1 2.0 2.8 3.9 9.3 6.4 7.0 4.6 16.4 5.5 10.5 4.7 4.0 18.6 6.3 5.8 3.1 8.6 8.2 9.2 18.8 7.6 16.5 5.4 5.9 6.0 2.2 5.9 6.4 9.0 10.2 10.8 5.0 3.8 6.8 10.1 4.1 6.6 8.2 23.4 8.9 3.1 5.7 20.2 6.7 5.6 4.1 10.0 6.9 3.1 13.4 7.8 1.8 2.8 11.6 14.3 22.6 8.0 6.0 4.2 7.4 14.7 6.1 8.9 5.0 4.1 3.5 15.9 6.6 11.3 9.5 31.5 23.7 2.4 3.1 9.9 12.5 13.6 3.9 11.2 ZKSCAN5 "ZFP95, ZNF914, ZSCAN37" ENSG00000196652 "Zinc finger with KRAB and SCAN domains 5" Q9Y2L8 7 99504662-99534700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003201 Uncertain Approved "Intermediate filaments" No No "Intermediate filaments" "HPA003201: AB_10610701" "unprognostic (2.47e-1)" "unprognostic (2.34e-2)" "unprognostic (2.99e-2)" "unprognostic (2.18e-1)" "unprognostic (4.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.59e-6)" "unprognostic (1.12e-1)" "unprognostic (2.15e-2)" "unprognostic (2.62e-1)" "unprognostic (5.35e-2)" "unprognostic (8.07e-2)" "unprognostic (1.18e-2)" "unprognostic (6.82e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.42e-1)" 2.7 3.2 4.9 2.9 5.1 3.2 3.4 5.9 5.7 3.0 4.2 2.8 1.7 3.3 3.5 2.3 3.0 2.6 3.2 4.8 4.9 3.0 3.1 3.0 3.5 4.6 4.9 4.5 3.6 1.6 3.8 2.9 3.3 5.0 3.3 2.7 5.5 2.0 3.5 4.7 2.3 2.4 4.2 4.4 3.2 2.6 8.4 4.9 6.1 3.7 6.9 3.8 3.1 2.6 5.3 6.6 10.6 12.4 16.5 8.5 6.4 5.3 11.1 10.6 12.7 12.4 7.6 5.9 11.3 9.9 8.3 15.5 5.2 11.1 7.2 12.7 6.5 6.6 7.2 6.9 7.1 8.9 10.8 11.4 5.7 10.2 10.9 16.7 8.1 9.1 9.9 14.8 15.0 13.7 8.5 15.0 11.8 10.9 5.9 8.6 9.4 10.6 9.4 8.1 6.5 8.8 14.0 10.0 9.4 7.4 9.8 5.7 7.5 8.7 16.2 11.7 13.1 9.5 9.6 14.6 16.9 7.5 7.5 14.6 0.8 0.8 2.4 2.0 1.2 1.6 0.7 0.7 1.0 1.6 0.6 1.6 1.6 0.7 1.7 0.8 1.1 1.4 1.0 4.9 5.1 5.9 5.7 4.8 4.9 4.6 4.9 4.5 5.0 4.4 4.9 5.3 6.9 6.4 3.2 7.8 5.8 2.7 1.9 2.3 4.6 5.8 4.7 4.4 6.1 0.0 4.8 3.7 14.6 3.8 5.6 4.3 0.0 3.3 6.2 3.8 5.8 6.4 6.0 6.5 8.5 3.5 3.4 3.7 5.6 4.4 5.7 7.5 4.6 4.2 3.4 10.1 8.6 3.0 8.2 3.9 4.0 2.9 4.1 4.9 0.0 9.4 3.5 8.7 2.1 6.0 8.4 4.3 0.8 5.7 4.4 2.4 4.1 2.5 3.0 6.3 6.6 6.5 4.1 18.0 6.6 5.9 2.8 2.6 4.4 5.9 3.3 1.8 ZNF502 "FLJ12515, FLJ14855" ENSG00000196653 "Zinc finger protein 502" Q8TBZ5 3 44712643-44723831 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 16.2;Spermatogonia: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024761, HPA029557" Uncertain NA NA "HPA024761: AB_10599830, HPA029557: AB_10601448" "unprognostic (1.80e-1)" "unprognostic (3.10e-2)" "unprognostic (4.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.25e-2)" "unprognostic (1.31e-2)" "unprognostic (6.75e-2)" "unprognostic (1.35e-3)" "unprognostic (8.23e-2)" "unprognostic (1.51e-1)" "unprognostic (8.72e-3)" "unprognostic (5.49e-2)" "prognostic favorable (4.51e-5)" "unprognostic (1.88e-1)" "unprognostic (3.14e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.06e-4)" 3.0 3.1 1.5 0.9 1.6 0.8 3.5 2.7 1.8 4.2 1.2 3.5 0.8 4.6 1.3 2.6 4.1 0.9 2.5 1.6 1.8 2.6 2.1 1.9 1.2 1.6 1.6 1.4 5.3 4.0 1.3 4.3 1.8 1.8 5.0 1.5 5.3 3.2 2.2 3.2 3.4 2.6 1.9 1.5 3.4 3.1 5.0 1.6 1.4 3.8 2.4 1.1 4.0 3.5 1.8 0.0 0.7 1.9 0.0 2.1 3.0 0.0 1.6 0.4 1.9 1.1 0.1 0.9 0.0 0.5 1.5 2.0 1.0 0.0 2.4 1.6 0.0 0.9 0.0 0.0 0.0 2.3 0.0 0.9 2.4 0.9 2.2 0.0 0.5 1.4 0.0 0.0 0.0 1.9 0.0 0.0 0.5 3.1 0.5 0.0 0.0 1.2 0.0 2.2 2.4 2.0 2.5 0.9 1.6 0.0 2.2 0.0 0.0 1.8 0.0 1.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.4 0.6 0.3 1.0 0.8 1.0 0.8 0.5 1.2 1.5 1.2 0.0 1.2 0.3 0.3 0.2 0.3 1.5 1.6 2.7 1.8 1.6 1.8 1.6 1.6 1.4 1.8 1.5 1.6 1.8 4.0 6.4 5.1 3.3 3.9 1.7 3.3 3.2 4.0 12.0 2.4 3.6 4.5 2.8 4.4 3.7 14.6 2.5 3.3 1.4 0.0 3.2 3.1 1.0 3.4 5.4 4.9 1.7 3.0 3.0 1.3 3.2 1.5 1.5 2.5 5.6 4.2 1.6 1.1 10.1 5.9 1.6 4.1 0.8 0.7 2.9 4.7 1.0 0.0 3.7 2.1 11.5 2.1 3.0 2.6 2.7 1.1 6.8 0.5 3.4 2.0 1.6 3.1 16.2 0.0 4.6 2.8 14.1 17.8 2.6 2.6 1.5 1.9 4.3 3.0 1.9 TRAPPC4 "PTD009, SBDN, TRS23" ENSG00000196655 "Trafficking protein particle complex 4" Q9Y296 11 119018763-119025454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 335.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039752, HPA041371" Approved Approved Cytosol NA NA Cytosol "HPA039752: AB_2676664, HPA041371: AB_2677439" "unprognostic (5.26e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (1.18e-2)" "unprognostic (9.42e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (1.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-2)" "unprognostic (7.49e-3)" "unprognostic (3.64e-1)" "unprognostic (1.17e-1)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" 20.6 38.2 14.6 4.3 14.4 8.3 20.3 15.0 18.8 17.0 15.2 21.7 8.5 18.0 12.0 21.5 18.2 5.3 23.4 14.2 15.9 36.7 26.3 19.6 8.1 15.2 14.6 14.0 15.6 25.7 13.6 29.4 5.6 14.9 21.0 6.1 9.2 19.0 12.4 38.6 19.6 23.8 4.1 15.1 22.2 22.8 31.8 14.6 17.1 17.7 18.4 6.2 19.4 16.2 15.8 15.5 14.1 16.9 20.2 25.2 19.3 8.7 59.6 44.3 45.6 40.0 35.1 6.4 18.6 40.3 27.2 23.6 14.5 32.0 25.9 32.9 31.5 15.3 28.5 14.2 40.0 33.4 25.3 14.8 25.1 29.2 40.1 30.1 23.5 42.3 20.7 34.7 7.3 28.8 38.6 30.0 24.9 13.7 30.0 44.4 26.3 13.1 25.9 34.7 20.2 7.4 16.2 10.5 13.1 15.4 19.8 58.5 21.5 24.9 10.5 18.8 13.1 19.7 9.2 18.9 45.9 11.8 20.1 18.5 68.3 37.0 77.0 50.8 45.8 53.5 59.1 59.6 59.8 37.2 55.5 54.7 59.6 32.6 54.6 58.3 52.4 96.4 61.2 14.6 14.4 15.0 18.8 14.2 15.9 15.2 14.6 14.0 14.9 15.1 14.6 15.8 50.3 38.5 34.4 7.5 38.8 51.4 59.1 166.1 37.5 60.1 38.4 38.7 30.8 41.5 83.4 71.7 14.6 90.7 61.1 30.4 140.8 107.6 41.9 46.0 39.1 47.7 67.6 45.3 9.0 76.2 56.5 45.1 15.3 33.2 62.1 335.0 46.1 21.8 80.4 38.7 11.7 33.5 152.5 27.3 30.7 16.4 44.4 33.1 30.2 10.3 76.3 88.5 41.2 10.1 15.0 103.4 44.3 60.9 26.9 51.1 83.0 206.1 89.0 61.2 46.0 21.6 82.2 78.2 67.0 28.7 59.0 87.3 52.7 49.1 36.8 52.4 TTC30B "fleer, FLJ30990, IFT70B" ENSG00000196659 "Tetratricopeptide repeat domain 30B" Q8N4P2 2 177548998-177552796 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 43.3;Spermatocytes: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (2.15e-2)" "unprognostic (9.10e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.89e-2)" "unprognostic (3.26e-1)" "unprognostic (5.45e-2)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (5.27e-2)" "unprognostic (9.77e-2)" "unprognostic (9.61e-2)" "unprognostic (9.25e-3)" "unprognostic (1.65e-1)" 1.7 1.6 2.5 1.8 1.9 0.8 5.4 2.1 1.9 3.5 3.0 3.3 2.6 3.3 6.9 2.0 10.4 2.1 1.7 1.6 2.0 5.0 2.5 3.2 2.2 2.4 2.2 1.6 3.4 2.4 5.1 1.6 1.7 2.1 2.8 3.0 5.3 3.7 3.2 0.4 2.5 2.9 2.5 2.8 2.3 3.9 7.1 1.9 3.3 8.2 0.5 2.5 1.9 0.8 2.7 2.5 3.7 4.7 0.9 4.1 4.8 3.2 1.4 4.5 3.9 4.1 2.1 6.1 0.9 3.9 2.8 4.5 6.0 5.7 6.2 3.7 1.4 2.8 1.7 2.2 1.8 3.5 2.2 2.9 4.0 5.7 3.8 2.9 4.7 3.1 4.5 2.3 0.8 2.3 4.2 4.4 3.4 2.2 3.3 0.9 3.4 4.1 1.0 5.9 2.7 11.4 6.2 1.8 4.1 2.9 6.4 4.2 4.2 2.7 2.1 1.1 2.8 1.2 2.1 2.6 0.3 4.9 0.9 3.7 2.7 1.4 1.2 0.6 1.3 0.4 0.5 0.4 0.7 1.6 1.4 0.8 0.8 0.8 0.9 1.0 1.1 0.4 0.7 2.5 1.9 2.1 1.9 1.6 2.0 2.4 2.2 1.6 2.1 2.8 1.9 2.7 1.8 3.2 4.6 1.3 2.8 0.6 0.6 5.0 2.8 2.2 3.1 2.8 1.4 5.7 7.9 0.0 2.1 2.5 0.4 4.8 5.9 4.8 10.8 12.8 3.7 2.5 1.2 1.3 0.7 2.7 1.1 3.3 5.1 1.9 1.3 3.2 2.5 2.8 1.2 5.0 0.8 2.4 6.1 1.3 0.6 6.6 1.5 1.3 1.8 1.9 1.4 7.2 4.1 1.5 1.1 2.6 0.5 2.2 4.1 0.6 2.6 5.3 43.3 11.5 0.0 2.7 1.8 24.5 3.7 2.3 0.9 0.5 1.3 5.4 1.8 0.2 SLC30A10 "DKFZp547M236, ZnT-10, ZNT8, ZRC1" ENSG00000196660 "Solute carrier family 30 member 10" Q6XR72 1 219685427-219958647 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.1;liver: 33.8" "Cell type enhanced" "Detected in some" "Astrocytes: 20.2;Distal enterocytes: 44.3;Early spermatids: 38.3;Hepatocytes: 21.1;Late spermatids: 36.1;Paneth cells: 14.4;Proximal enterocytes: 13.6" "Cancer enriched" "Detected in some" 14 "liver cancer: 7.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.0;HEL: 1.5;K-562: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064547 Enhanced NA NA "HPA064547: AB_2732715" "unprognostic (7.88e-2)" "unprognostic (1.07e-2)" "unprognostic (1.02e-1)" "unprognostic (7.25e-2)" "unprognostic (1.75e-2)" "unprognostic (3.74e-3)" "unprognostic (6.96e-2)" "unprognostic (3.72e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-2)" "unprognostic (5.10e-2)" "unprognostic (3.10e-3)" "unprognostic (4.47e-7)" "unprognostic (3.16e-1)" "unprognostic (6.11e-2)" "unprognostic (6.19e-3)" "unprognostic (5.72e-2)" 0.0 0.0 5.9 0.0 6.3 0.3 0.0 4.6 7.7 0.0 6.9 3.9 24.1 0.0 0.0 0.0 0.0 0.4 0.0 5.9 5.6 0.0 33.8 0.0 0.0 5.5 5.9 5.5 0.2 0.0 0.0 0.0 0.0 5.8 0.1 5.0 0.4 0.0 0.0 0.7 0.1 9.0 0.0 4.6 0.0 0.0 0.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.3 0.2 0.1 0.1 5.9 6.3 4.6 7.7 5.9 5.6 5.5 5.9 5.5 5.8 4.6 6.1 5.6 0.0 0.0 0.0 20.2 0.2 0.3 0.0 0.2 0.0 0.3 0.2 0.0 1.2 1.5 0.1 0.0 0.0 0.1 0.0 44.3 0.0 0.2 38.3 0.0 0.0 1.0 0.0 2.7 4.3 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.4 21.1 0.1 0.0 4.3 0.6 0.0 0.6 0.3 36.1 1.2 0.0 1.8 9.4 0.0 3.1 0.0 3.0 3.3 0.0 14.4 1.5 0.0 0.0 13.6 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.9 0.0 0.1 0.3 0.0 1.3 0.8 0.0 TECPR2 KIAA0329 ENSG00000196663 "Tectonin beta-propeller repeat containing 2" O15040 14 102362941-102502477 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 57.5;Excitatory neurons: 59.1;Oligodendrocytes: 150.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 7.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000658 Enhanced Approved Nucleoplasm,Nucleoli,Centrosome NA NA Nucleoplasm "Nucleoli, Centrosome" "HPA000658: AB_1079191" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.77e-2)" "unprognostic (2.62e-1)" "unprognostic (4.46e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (5.66e-5)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (1.64e-1)" "unprognostic (5.76e-3)" "unprognostic (3.78e-2)" "prognostic favorable (6.53e-9)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-3)" 5.4 5.1 10.7 5.5 16.7 5.8 5.5 10.9 13.8 5.9 4.6 7.0 3.9 8.0 6.7 5.0 6.4 4.6 7.2 12.2 10.5 4.4 4.1 5.1 2.7 14.5 14.1 12.0 6.0 4.6 9.1 7.3 5.7 15.0 6.4 3.2 9.8 10.2 7.3 11.2 5.5 4.7 8.7 10.4 5.7 5.4 11.0 13.2 5.6 5.7 7.9 2.9 7.3 5.1 20.7 4.7 9.4 8.9 7.4 18.0 13.6 4.9 10.4 12.0 10.3 8.6 2.0 3.4 3.5 6.4 10.9 7.6 8.4 6.2 7.8 8.6 13.0 4.1 4.2 4.9 4.1 8.5 2.3 3.9 9.0 6.8 9.3 6.1 9.7 10.2 3.9 2.1 7.8 9.6 8.9 2.1 2.5 3.4 4.9 9.7 5.0 6.2 1.1 5.2 7.8 7.1 6.6 9.0 2.3 5.7 5.7 10.5 3.1 10.6 7.9 2.0 21.4 4.4 8.0 5.1 0.7 7.6 6.1 8.3 0.3 0.5 0.9 0.2 0.3 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.1 7.3 0.1 0.1 0.1 0.4 0.4 10.7 16.7 10.9 13.8 12.2 10.5 14.5 14.1 12.0 15.0 10.4 13.2 20.7 9.1 9.6 6.9 57.5 3.5 2.0 3.1 4.7 8.0 17.0 10.1 8.0 13.0 4.3 5.6 3.7 50.1 7.1 5.7 7.2 5.9 8.2 31.2 7.4 10.3 8.7 4.2 5.7 59.1 7.1 5.7 8.4 5.6 6.3 0.0 8.6 8.2 6.1 4.9 13.5 34.4 3.8 10.2 4.7 3.4 27.9 14.3 12.7 3.6 26.2 8.5 21.6 5.2 28.6 150.4 6.8 2.5 18.8 8.0 4.0 5.9 6.0 7.0 44.7 19.7 9.1 8.3 24.6 15.0 7.7 1.6 6.0 4.6 8.4 4.6 3.2 TLR7 ENSG00000196664 "Toll like receptor 7" Q9NYK1 X 12867072-12890361 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 6.4" "Cell type enhanced" "Detected in some" "B-cells: 10.1;dendritic cells: 24.1;Hofbauer cells: 24.6;Macrophages: 20.2;Microglial cells: 14.0;monocytes: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 20.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.3;U-266/70: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059613 Supported NA NA "HPA059613: AB_2684083" "unprognostic (1.22e-1)" "unprognostic (1.09e-2)" "unprognostic (2.36e-3)" "unprognostic (9.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (8.27e-2)" "unprognostic (6.20e-3)" "unprognostic (3.75e-1)" "unprognostic (6.91e-2)" "unprognostic (3.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (4.17e-3)" "unprognostic (1.19e-3)" "unprognostic (1.53e-3)" "unprognostic (1.34e-1)" 1.1 1.6 1.2 4.4 1.7 0.6 4.1 1.7 1.8 1.3 1.6 1.9 1.9 0.9 0.5 0.7 0.8 2.9 0.7 1.1 3.3 0.6 0.6 4.6 4.4 3.6 1.8 0.8 0.7 0.3 0.9 0.2 6.4 3.4 0.8 2.3 0.1 1.4 1.0 0.1 0.1 1.8 2.0 4.0 3.8 1.8 0.6 2.4 3.8 0.4 0.3 5.6 2.5 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 16.3 0.0 3.1 0.0 0.3 0.0 0.4 10.0 4.5 0.0 11.6 0.0 8.7 0.0 0.0 4.9 7.2 0.0 0.0 0.5 0.1 9.7 20.7 0.0 3.3 1.2 1.7 1.7 1.8 1.1 3.3 3.6 1.8 0.8 3.4 4.0 2.4 5.4 0.2 0.0 3.9 0.0 10.1 1.3 1.3 0.0 0.0 0.0 0.2 0.6 0.5 0.0 0.6 0.0 2.1 0.3 24.1 0.0 0.0 0.0 0.0 0.3 0.2 1.3 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.5 1.3 0.0 0.7 0.2 24.6 0.0 0.1 0.0 0.0 6.2 8.1 0.7 0.6 20.2 1.8 14.0 11.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 5.7 0.9 0.0 0.0 2.2 0.7 0.0 4.5 0.5 0.0 0.1 0.1 1.0 0.3 2.5 0.1 0.0 1.6 FAM180B LOC399888 ENSG00000196666 "Family with sequence similarity 180 member B" Q6P0A1 11 47586678-47589194 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;breast: 5.2;skin 1: 5.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.4;Fibroblasts: 20.4;Langerhans cells: 11.9;Melanocytes: 5.4;Peritubular cells: 4.1;Suprabasal keratinocytes: 6.3" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029408 Uncertain "Secreted in other tissues" NA NA "HPA029408: AB_10601319" "unprognostic (1.28e-2)" "unprognostic (4.99e-3)" "unprognostic (7.48e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.64e-2)" "unprognostic (1.21e-3)" "unprognostic (1.04e-1)" "unprognostic (2.69e-1)" "unprognostic (3.87e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-5)" "unprognostic (5.65e-2)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" 4.2 0.1 0.7 0.0 1.7 0.1 5.2 5.0 1.6 0.4 3.9 0.5 0.0 0.2 0.0 0.1 0.4 0.4 0.5 0.6 0.6 0.0 0.0 0.2 0.0 2.2 1.6 0.6 0.1 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.1 1.1 0.0 1.0 5.4 0.2 0.1 0.8 0.1 0.5 0.5 1.5 0.7 4.3 3.0 0.1 0.4 0.2 1.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 5.0 1.6 0.6 0.6 2.2 1.6 0.6 2.1 0.8 1.5 1.8 0.8 0.0 0.0 1.0 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 20.4 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 11.9 0.3 2.5 0.3 5.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 6.3 0.1 0.3 0.0 0.0 0.0 ZFP62 "FLJ34231, ZET, ZNF755" ENSG00000196670 "ZFP62 zinc finger protein" Q8NB50 5 180847611-180861285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048629 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA048629: AB_2680467" "unprognostic (2.77e-2)" "unprognostic (1.77e-1)" "unprognostic (9.18e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (1.89e-2)" "unprognostic (9.49e-2)" "unprognostic (7.11e-3)" "unprognostic (7.29e-2)" "unprognostic (3.44e-2)" "unprognostic (1.05e-2)" "unprognostic (2.14e-1)" "unprognostic (4.34e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-2)" "unprognostic (2.29e-3)" 7.7 7.2 8.5 12.7 9.6 4.5 13.9 13.1 10.6 11.8 7.1 14.4 13.5 13.7 15.1 13.3 15.6 9.7 9.5 8.0 7.8 10.0 6.7 9.6 18.8 9.5 8.2 6.2 19.9 11.2 13.8 8.6 9.8 9.9 13.0 17.4 18.5 11.7 11.5 14.3 15.8 13.6 10.5 6.4 14.0 16.1 9.0 8.4 25.2 23.8 14.2 20.4 10.9 11.3 11.5 13.7 10.5 21.2 28.4 14.9 13.5 26.4 13.8 10.4 11.0 15.3 24.9 33.5 34.2 21.7 6.2 12.9 20.0 10.2 24.7 16.6 58.2 19.0 19.3 30.8 8.4 10.2 17.2 11.0 10.6 20.0 11.5 20.8 17.1 10.2 19.6 16.0 18.0 15.2 31.8 25.2 9.5 14.8 12.5 24.6 22.2 22.3 19.3 9.3 24.4 28.1 19.1 20.1 15.3 15.1 15.0 23.0 15.4 14.6 17.0 14.8 8.3 14.0 18.7 23.4 16.8 14.1 22.9 13.5 6.9 2.1 2.6 2.5 2.9 4.8 4.4 3.4 3.6 2.2 4.8 6.1 5.5 1.0 3.4 3.5 2.5 3.7 2.9 8.5 9.6 13.1 10.6 8.0 7.8 9.5 8.2 6.2 9.9 6.4 8.4 11.5 10.5 9.6 11.0 5.5 12.2 7.1 8.9 10.8 11.4 8.2 9.4 11.9 11.4 8.6 7.2 0.0 2.1 6.2 6.8 12.9 15.6 9.7 24.3 9.5 5.8 8.3 10.3 12.4 9.1 16.5 6.7 6.7 7.1 7.9 8.8 16.3 9.7 5.0 6.4 1.7 9.3 17.6 8.2 5.9 4.0 28.0 17.1 5.4 5.4 6.5 7.8 11.4 9.2 9.0 10.1 14.9 7.8 11.7 11.8 8.3 15.3 9.8 6.6 13.1 13.1 7.4 8.2 30.0 14.8 7.2 4.7 5.6 9.9 11.0 15.8 8.5 ERI2 "EXOD1, KIAA1504, MGC16943, ZGRF5" ENSG00000196678 "ERI1 exoribonuclease family member 2" A8K979 16 20780193-20900349 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 13.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035384, HPA035385" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA035384: AB_10602316, HPA035385: AB_2674600" "unprognostic (1.25e-1)" "unprognostic (1.47e-1)" "unprognostic (2.01e-3)" "unprognostic (4.36e-2)" "unprognostic (8.64e-2)" "unprognostic (2.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.99e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-2)" "unprognostic (1.08e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.05e-2)" "unprognostic (9.28e-3)" 4.7 6.9 4.6 3.7 5.3 6.5 9.3 4.9 5.6 3.9 5.3 7.5 8.1 4.2 7.7 6.8 5.8 4.6 4.4 4.5 4.7 5.7 12.2 4.8 3.8 5.4 4.9 4.3 4.6 7.5 14.1 5.1 5.4 5.2 7.6 10.3 4.2 5.1 4.8 5.1 7.2 7.9 4.6 5.0 3.6 8.5 13.2 4.7 7.6 6.3 3.7 4.4 4.6 4.7 6.1 17.1 7.9 21.6 9.5 6.5 8.3 13.0 13.3 7.9 11.8 14.9 10.2 17.0 4.8 14.6 7.3 8.2 12.7 21.8 13.7 21.8 15.3 11.4 11.5 9.7 17.6 6.0 22.3 9.0 7.5 16.7 15.9 13.2 6.3 7.2 0.0 37.1 13.5 20.0 15.3 3.2 19.8 13.4 17.5 4.5 25.5 17.7 10.5 11.0 13.4 11.0 13.5 8.5 16.0 10.3 11.4 33.7 24.7 5.5 12.5 7.0 12.2 17.9 8.3 13.4 2.9 11.9 17.9 17.6 13.8 1.8 1.7 0.4 1.3 0.3 0.5 0.4 0.4 1.9 0.0 0.3 0.2 0.1 0.5 2.6 0.6 0.8 0.4 4.6 5.3 4.9 5.6 4.5 4.7 5.4 4.9 4.3 5.2 5.0 4.7 6.1 4.0 16.0 6.7 18.3 1.0 5.0 5.3 5.6 8.0 5.3 11.3 5.8 7.3 5.7 8.5 9.2 0.0 8.3 0.9 8.0 9.8 4.1 22.5 6.9 5.5 3.0 0.0 22.7 10.4 5.2 9.1 4.3 9.7 6.0 0.0 7.1 2.9 10.9 8.4 3.3 10.6 9.6 6.1 8.2 4.1 14.7 6.2 5.8 1.8 5.6 6.7 5.0 3.1 10.6 20.3 4.7 6.6 5.3 2.8 4.5 7.5 6.8 12.6 3.5 0.0 5.6 3.5 39.3 20.0 9.7 3.7 3.7 2.5 4.5 8.5 5.7 TOMM7 Tom7 ENSG00000196683 "Translocase of outer mitochondrial membrane 7" Q9P0U1 7 22812628-22822852 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.69e-2)" "unprognostic (1.93e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.30e-4)" "unprognostic (2.25e-2)" "unprognostic (7.63e-2)" "unprognostic (1.52e-1)" "unprognostic (6.36e-2)" "unprognostic (2.49e-3)" "unprognostic (1.36e-1)" "unprognostic (1.75e-1)" "unprognostic (3.69e-3)" "unprognostic (2.08e-1)" "unprognostic (3.86e-2)" "unprognostic (1.01e-2)" 553.1 568.7 933.1 277.9 958.2 506.9 890.5 940.6 1292.9 645.7 969.4 625.3 359.8 499.6 542.6 432.2 592.4 244.3 676.9 917.4 942.4 450.3 495.3 447.5 500.3 939.7 931.8 915.7 982.6 688.4 527.6 543.4 250.2 941.1 485.9 425.2 422.8 531.9 513.1 1769.9 565.1 470.7 412.0 968.6 487.9 559.3 225.3 940.5 432.0 393.4 1310.8 680.3 529.2 529.0 963.5 712.5 403.3 257.7 530.0 951.1 1090.9 303.8 501.7 813.4 382.9 337.6 295.1 454.1 556.3 592.0 704.4 1148.1 457.9 672.4 540.6 415.7 303.3 695.0 269.6 942.9 386.3 811.1 638.0 289.4 1368.6 1222.6 575.7 862.1 1434.9 637.3 418.4 951.4 470.7 696.7 572.4 335.1 899.0 900.4 1002.6 960.5 282.0 302.0 782.7 353.7 367.6 241.7 416.3 367.6 886.3 1339.5 1009.6 658.7 1079.9 405.1 292.7 469.8 533.7 578.4 969.8 1141.0 783.5 389.4 658.3 1061.3 264.1 588.8 556.9 665.4 489.8 831.8 1233.9 1126.6 806.9 566.8 1053.9 1488.5 1059.0 199.4 567.6 525.1 868.7 919.5 1759.4 933.1 958.2 940.6 1292.9 917.4 942.4 939.7 931.8 915.7 941.1 968.6 940.5 963.5 483.9 259.6 350.4 25.1 883.6 886.1 805.5 698.9 570.8 279.7 998.5 1129.9 1223.2 622.0 372.1 349.4 66.7 477.2 670.5 558.3 1328.5 434.1 385.9 473.8 382.6 503.8 531.4 351.7 13.3 935.5 735.0 535.1 270.1 386.9 504.1 461.8 745.0 1228.2 699.6 151.4 12.7 1021.7 280.8 934.6 818.0 344.0 993.2 536.6 788.0 12.2 781.9 1059.7 784.8 8.5 19.5 534.9 823.7 759.8 360.8 828.6 1052.8 1386.2 362.6 311.9 486.4 996.5 557.8 448.0 204.1 691.9 926.6 406.1 811.4 292.2 879.5 820.9 HSH2D "ALX, FLJ14886, HSH2" ENSG00000196684 "Hematopoietic SH2 domain containing" Q96JZ2 19 16134028-16158575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.4;lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" "B-cells: 78.5;dendritic cells: 101.3;Gastric mucus-secreting cells: 40.2;NK-cells: 82.4;Plasma cells: 134.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in all" "basophil: 232.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 41.0;HL-60: 43.5;HMC-1: 56.4;NB-4: 140.1;RPMI-8226: 63.2;U-266/84: 41.9;U-937: 137.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036616 Approved "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA036616: AB_10671962" "unprognostic (1.69e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (9.46e-6)" "unprognostic (1.06e-1)" "unprognostic (5.50e-3)" "unprognostic (5.21e-3)" "unprognostic (9.35e-2)" "unprognostic (4.78e-2)" "unprognostic (4.21e-3)" "unprognostic (9.96e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (6.49e-6)" "unprognostic (9.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.21e-2)" "prognostic favorable (3.47e-5)" 1.7 0.7 0.5 17.0 0.9 47.4 3.3 1.0 0.9 3.0 1.1 9.9 12.8 1.3 1.8 1.7 3.3 5.4 0.4 0.4 0.4 1.5 2.3 5.7 27.4 1.0 0.7 0.3 0.5 4.3 2.3 4.1 1.5 1.2 5.1 9.4 0.3 9.6 2.9 0.4 0.4 20.7 1.0 0.7 38.0 12.8 0.4 0.8 8.8 2.6 1.2 36.0 7.6 0.7 2.6 15.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 2.2 21.3 41.0 0.6 0.0 0.8 0.7 0.0 0.6 0.0 2.3 0.1 0.6 0.5 2.6 0.0 43.5 56.4 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.1 37.4 0.0 9.0 0.1 140.1 0.0 5.5 0.0 3.0 0.0 63.2 0.4 5.6 0.1 0.1 0.0 1.3 0.3 0.0 0.3 15.9 0.2 0.1 0.1 0.2 0.2 5.7 41.9 23.6 0.2 137.3 0.0 232.1 15.5 100.9 17.1 22.0 15.8 56.4 7.6 11.2 25.5 35.8 6.9 9.2 182.6 85.2 38.8 7.6 13.0 16.7 0.5 0.9 1.0 0.9 0.4 0.4 1.0 0.7 0.3 1.2 0.7 0.8 2.6 1.0 3.2 8.9 0.0 78.5 0.3 1.2 3.0 0.6 0.0 3.6 1.9 0.6 5.7 11.3 5.5 0.0 2.6 101.3 18.9 0.0 6.7 0.0 4.5 1.5 0.8 8.4 32.2 0.5 5.1 4.1 0.7 40.2 7.9 6.3 0.1 1.4 0.6 1.1 0.0 0.4 19.1 2.0 3.4 2.4 0.1 0.0 7.3 10.6 1.0 10.7 0.0 82.4 1.0 0.3 9.7 18.0 0.0 134.0 2.6 17.9 0.3 7.9 0.0 0.0 1.1 0.7 0.1 0.5 0.1 0.1 3.4 31.0 0.2 9.3 4.1 TRPV1 VR1 ENSG00000196689 "Transient receptor potential cation channel subfamily V member 1" Q8NER1 17 3565444-3609411 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 24.8" "Cell type enhanced" "Detected in many" "Astrocytes: 20.2;Cone photoreceptor cells: 16.7;Oligodendrocytes: 18.8;Rod photoreceptor cells: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.96e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "unprognostic (6.83e-2)" "unprognostic (3.21e-4)" "unprognostic (9.90e-2)" "unprognostic (2.95e-1)" "unprognostic (2.03e-1)" "unprognostic (2.56e-2)" "unprognostic (3.43e-3)" "unprognostic (6.17e-3)" "unprognostic (6.97e-4)" "unprognostic (4.25e-1)" "unprognostic (4.78e-1)" "unprognostic (3.81e-2)" "unprognostic (5.12e-3)" 5.5 5.0 7.7 1.6 8.3 1.0 6.0 8.0 8.6 9.6 5.5 5.2 7.4 4.7 2.2 3.3 6.9 1.8 7.2 7.2 6.9 8.1 24.8 3.2 2.4 7.7 8.2 6.7 10.3 7.9 1.2 5.9 2.0 8.6 6.1 2.4 13.1 4.3 1.7 6.6 5.4 8.7 1.6 6.7 4.4 5.9 5.0 7.4 2.0 4.7 1.7 1.7 5.0 6.9 11.2 2.3 4.1 3.1 3.7 3.5 3.4 2.9 1.1 1.8 2.0 1.8 0.8 1.1 0.9 1.6 1.4 1.3 9.8 2.0 0.5 1.3 5.6 4.7 0.5 2.1 4.3 1.6 0.3 3.8 4.2 2.0 2.7 1.2 1.8 0.4 2.1 0.3 1.6 1.2 2.2 1.6 0.7 2.3 0.4 2.1 4.6 2.1 0.7 1.6 1.6 1.4 3.0 1.7 3.2 1.7 2.3 6.0 1.6 1.3 0.7 1.8 2.8 1.6 1.3 0.8 0.3 1.2 1.6 1.5 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.2 0.0 0.0 7.7 8.3 8.0 8.6 7.2 6.9 7.7 8.2 6.7 8.6 6.7 7.4 11.2 1.8 0.0 2.6 20.2 0.7 0.0 0.5 0.0 2.8 9.5 3.2 2.3 0.3 4.3 1.3 5.5 16.7 1.2 0.6 2.3 0.0 0.5 2.5 3.3 1.7 1.3 1.2 0.4 10.5 0.7 0.3 1.7 11.2 2.9 0.0 5.4 2.5 7.9 0.8 6.7 10.3 1.9 0.0 0.6 0.0 0.5 4.7 1.4 0.0 4.7 0.9 2.3 4.1 8.5 18.8 0.5 0.5 3.8 0.5 0.6 6.6 2.2 2.2 26.0 0.0 5.9 1.9 0.8 1.2 1.8 0.0 0.8 0.6 9.5 2.1 0.4 ZNF33B "KOX2, KOX31, ZNF11B" ENSG00000196693 "Zinc finger protein 33B" Q06732 10 42574185-42638570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (3.01e-3)" "unprognostic (2.20e-1)" "unprognostic (2.93e-2)" "unprognostic (8.34e-2)" "unprognostic (5.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.90e-3)" "unprognostic (3.71e-1)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (1.61e-2)" 4.6 9.9 4.2 5.9 5.1 3.1 20.8 10.2 5.1 9.6 8.5 9.2 9.0 11.8 7.7 7.5 18.8 8.7 5.3 4.6 6.3 18.7 10.4 9.0 9.5 4.7 4.4 4.1 23.7 34.4 15.4 10.1 7.3 5.2 12.7 10.5 10.5 18.8 10.5 3.9 12.3 9.8 5.3 2.9 10.4 14.4 4.7 4.4 8.1 18.5 5.0 9.0 9.1 9.1 5.4 13.2 3.3 8.5 8.8 3.1 0.4 10.6 8.1 6.2 5.1 7.1 7.3 14.9 19.9 4.8 3.1 7.7 10.9 16.5 5.6 5.7 11.8 12.4 7.9 12.7 11.9 3.6 18.8 6.2 5.1 20.1 3.1 17.0 13.4 4.4 10.8 10.9 14.7 3.1 5.7 7.5 4.5 9.3 6.5 7.7 8.0 8.5 8.5 13.4 17.2 15.3 14.9 5.1 10.5 5.1 7.7 13.4 5.7 5.3 2.6 12.3 4.5 8.6 9.5 15.5 6.1 1.8 13.9 2.4 19.4 7.5 7.1 10.7 6.7 15.1 20.1 15.4 10.8 6.7 15.4 19.5 13.7 2.4 8.3 5.5 11.1 13.4 9.0 4.2 5.1 10.2 5.1 4.6 6.3 4.7 4.4 4.1 5.2 2.9 4.4 5.4 10.0 80.1 37.8 14.0 17.7 4.8 18.0 5.5 18.2 15.4 26.0 27.8 31.5 34.3 30.0 20.2 10.4 18.6 13.4 9.7 21.5 27.0 2.4 37.2 6.0 14.1 25.3 17.1 25.6 36.1 16.8 10.0 14.8 14.5 8.2 23.8 16.4 10.8 8.4 10.1 48.2 17.6 4.1 13.6 3.6 3.8 20.5 9.3 7.2 36.5 17.9 10.2 21.6 30.7 14.1 25.8 21.4 11.7 15.2 13.0 21.2 27.0 47.6 9.6 0.0 9.0 8.5 9.0 11.3 11.8 4.0 11.5 17.0 22.6 18.5 12.8 ZNF512B "GM632, MGC149845, MGC149846" ENSG00000196700 "Zinc finger protein 512B" Q96KM6 20 63956704-63969930 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.4;Cone photoreceptor cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006688, HPA008731" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006688: AB_10963053, HPA008731: " "unprognostic (7.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-3)" "unprognostic (7.19e-3)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (5.30e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (6.99e-3)" "unprognostic (5.03e-3)" "unprognostic (2.12e-1)" "unprognostic (7.72e-2)" "unprognostic (5.52e-2)" "unprognostic (1.95e-3)" "unprognostic (3.72e-2)" 8.5 11.5 7.6 5.5 7.7 6.0 10.5 4.1 11.5 12.6 0.2 8.7 4.4 13.9 2.9 17.3 12.3 5.9 9.4 8.0 5.2 12.4 21.5 8.5 6.3 4.4 4.7 8.0 14.3 15.1 9.2 21.0 8.0 5.1 13.1 1.4 4.5 12.7 7.8 12.2 14.4 7.3 5.9 1.5 10.4 10.4 10.3 4.7 8.4 19.8 5.3 4.1 11.5 11.0 5.1 10.2 16.8 18.6 19.8 8.1 5.9 17.0 14.4 11.2 42.3 13.8 33.1 16.8 6.6 34.5 12.6 7.8 12.8 14.1 21.4 10.1 11.0 20.3 16.4 26.4 31.9 12.9 8.9 18.9 12.5 17.3 14.7 8.4 11.1 13.3 29.4 23.1 9.9 8.5 24.3 43.6 19.2 12.9 12.9 21.8 19.8 1.7 20.1 7.6 16.9 27.2 15.8 11.9 19.4 9.8 8.8 40.9 21.4 18.8 40.4 6.2 10.3 12.6 23.6 12.1 18.3 14.5 0.1 17.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 7.7 4.1 11.5 8.0 5.2 4.4 4.7 8.0 5.1 1.5 4.7 5.1 6.7 3.2 5.6 1.6 3.1 5.4 3.5 5.3 4.6 22.4 10.3 9.5 2.9 5.7 6.5 1.8 22.9 7.8 6.1 0.1 1.9 3.7 0.1 5.2 12.0 5.8 6.0 3.4 1.1 6.1 2.9 6.7 3.6 9.6 0.0 14.0 8.6 19.4 3.9 13.5 1.4 0.8 8.2 1.9 2.5 1.3 6.5 1.7 5.4 1.0 2.3 7.3 4.1 1.5 0.6 3.2 0.2 6.8 5.2 3.5 2.2 5.7 2.6 10.6 0.0 8.7 5.6 6.5 4.1 11.1 7.0 5.1 3.6 14.3 1.2 2.8 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68205481-68257712 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: AB_2681818" "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 52.8 52.3 59.3 32.9 68.1 36.7 45.4 60.6 87.9 41.3 54.0 48.4 26.4 44.8 53.9 38.7 52.9 38.2 77.8 63.8 59.5 59.7 38.4 33.2 54.4 62.3 59.5 58.5 49.1 45.7 64.9 59.6 29.7 62.4 42.0 33.3 79.2 40.4 51.7 96.5 43.2 37.2 42.0 58.6 43.7 40.0 196.2 59.8 53.7 53.8 87.6 52.1 48.9 36.8 64.9 94.6 98.9 87.5 72.9 65.6 113.4 140.0 71.0 88.3 116.1 93.7 42.3 60.4 142.6 74.9 104.8 107.0 46.0 68.6 198.5 154.0 50.2 67.7 52.8 38.6 83.1 124.9 49.8 86.9 96.9 213.9 107.5 206.2 113.0 118.9 121.7 54.6 86.5 150.9 67.3 110.2 45.4 43.5 51.1 98.5 41.3 238.9 106.7 71.2 50.1 85.7 67.2 64.8 125.5 130.9 184.6 100.7 33.5 65.2 143.8 72.0 55.8 74.8 121.9 121.9 255.7 105.1 69.0 79.1 76.6 25.2 35.3 34.8 30.3 46.2 30.7 43.2 46.0 30.3 41.3 37.8 40.4 45.1 63.7 40.9 28.1 58.3 36.9 59.3 68.1 60.6 87.9 63.8 59.5 62.3 59.5 58.5 62.4 58.6 59.8 64.9 18.5 12.8 15.6 477.3 38.7 18.6 31.6 58.4 30.1 13.8 29.7 34.3 81.4 21.5 32.8 23.9 8.4 64.0 58.0 9.4 109.5 28.8 736.8 28.4 17.2 24.4 21.1 21.0 36.4 26.0 66.9 28.2 14.8 18.5 34.1 28.9 21.4 15.5 41.8 18.5 30.0 16.7 40.7 26.1 71.0 1665.0 36.1 39.0 56.9 27.2 46.4 65.7 69.0 56.8 47.7 25.4 10.8 32.7 46.2 17.7 15.2 69.0 61.8 12.8 19.7 26.5 26.8 274.4 59.4 26.4 22.6 34.2 49.3 26.1 15.1 24.5 ZNF431 KIAA1969 ENSG00000196705 "Zinc finger protein 431" Q8TF32 19 21142024-21196053 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 121.8;Granulosa cells: 132.7;Theca cells: 185.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (1.37e-2)" "unprognostic (9.08e-2)" "unprognostic (2.30e-2)" "unprognostic (7.86e-2)" "unprognostic (1.97e-3)" "unprognostic (2.93e-3)" "unprognostic (5.91e-2)" "unprognostic (9.37e-3)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.29e-2)" "unprognostic (3.01e-3)" 4.8 10.4 2.3 6.2 3.3 14.7 7.3 6.9 3.4 6.8 1.0 3.8 3.4 5.8 6.9 19.4 4.9 3.2 7.6 1.8 2.8 3.3 1.2 6.7 9.5 3.2 3.0 0.8 22.1 7.2 5.0 3.5 5.6 4.0 5.2 5.0 7.1 6.7 3.3 5.2 11.7 4.8 4.6 1.5 6.7 6.4 8.3 2.4 9.7 12.4 5.8 8.3 4.6 11.4 5.7 11.0 3.1 9.7 11.4 2.7 5.4 14.7 5.6 4.9 10.5 10.4 6.0 7.7 13.9 9.6 3.8 4.9 7.2 8.5 6.1 12.8 5.0 10.7 10.6 8.3 3.7 2.6 5.3 10.7 3.9 10.9 6.6 6.3 5.9 8.2 12.3 19.5 8.1 6.3 4.7 16.9 5.9 11.3 4.2 9.2 9.2 12.4 3.9 4.1 12.6 9.3 7.8 14.5 0.1 5.1 15.3 6.0 9.3 5.0 6.6 0.5 9.1 8.2 6.4 12.9 18.1 1.6 9.2 4.5 4.1 3.4 7.1 2.8 3.1 4.1 8.1 4.9 3.8 2.4 8.0 6.0 4.7 5.0 8.6 4.3 5.8 4.1 1.8 2.3 3.3 6.9 3.4 1.8 2.8 3.2 3.0 0.8 4.0 1.5 2.4 5.7 17.5 121.8 22.1 7.2 32.0 12.6 15.0 8.0 15.4 32.8 13.6 13.7 17.3 12.8 20.1 23.9 37.5 17.6 34.4 9.0 3.9 12.6 3.7 23.2 30.5 16.5 16.9 19.3 12.5 8.8 18.4 19.9 24.5 52.5 20.3 132.7 17.5 0.6 10.7 15.2 12.5 10.2 12.2 17.9 11.3 5.4 32.6 16.4 3.6 19.7 16.0 11.3 43.3 16.6 24.0 14.0 3.1 21.4 21.2 17.8 5.5 4.5 11.9 30.8 19.7 25.2 23.2 26.7 16.1 26.0 15.5 11.6 27.1 185.6 10.4 31.7 ALKAL1 "AUGB, FAM150A, UNQ9433" ENSG00000196711 "ALK and LTK ligand 1" Q6UXT8 8 52534037-52565430 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 2.4;thyroid gland: 2.4;urinary bladder: 1.6" "Cell type enriched" "Detected in some" 4 "Distal tubular cells: 5.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027368 Uncertain "Secreted - unknown location" NA NA "HPA027368: AB_10602317" "unprognostic (1.18e-1)" "unprognostic (1.13e-4)" "unprognostic (9.47e-2)" "unprognostic (9.64e-2)" "unprognostic (1.52e-1)" "unprognostic (6.60e-2)" "unprognostic (1.70e-4)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (9.58e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 1.2 0.0 0.8 0.6 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.8 0.0 0.0 0.0 0.5 0.7 0.2 0.0 0.4 0.1 0.1 0.0 2.4 0.0 0.0 1.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.2 0.0 0.5 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NF1 ENSG00000196712 "Neurofibromin 1" P21359 17 31094927-31382116 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 254.0;Excitatory neurons: 325.3;Inhibitory neurons: 412.5;Oligodendrocyte precursor cells: 428.2;Oligodendrocytes: 317.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045502 Uncertain Approved Mitochondria No No Mitochondria "HPA045502: AB_2679352" "unprognostic (6.69e-2)" "unprognostic (8.73e-2)" "unprognostic (8.26e-2)" "unprognostic (1.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (1.30e-2)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (3.70e-1)" 7.4 8.5 8.8 7.1 10.6 3.4 11.6 13.3 11.9 10.0 1.5 8.6 6.8 10.3 10.1 6.2 9.1 8.0 11.4 9.5 10.4 12.2 9.5 7.4 7.7 10.9 9.5 7.9 13.6 10.4 16.0 7.9 12.5 9.3 9.6 8.9 21.1 9.2 9.6 8.2 7.5 7.5 8.8 7.1 7.2 8.3 10.1 10.6 13.6 19.6 10.7 7.9 10.5 6.8 14.4 15.8 20.3 24.2 13.1 20.1 25.8 12.2 13.4 24.1 19.5 21.8 18.4 10.5 15.2 3.8 25.1 22.9 26.8 22.2 18.7 32.6 7.5 14.1 13.4 18.8 9.5 14.2 24.4 10.6 20.7 11.8 20.8 25.1 21.8 9.5 15.7 19.8 14.8 18.8 12.4 20.4 8.8 7.1 9.7 6.8 15.8 36.8 12.3 14.7 22.5 10.0 14.9 25.4 8.3 13.8 16.8 25.0 15.3 14.1 15.3 21.5 18.8 5.1 13.2 6.9 16.3 12.6 10.0 16.2 4.4 0.3 0.6 1.5 0.1 1.0 1.4 2.8 2.5 0.4 1.2 2.0 2.0 0.7 0.7 0.3 0.4 5.9 0.6 8.8 10.6 13.3 11.9 9.5 10.4 10.9 9.5 7.9 9.3 7.1 10.6 14.4 30.9 32.1 31.1 254.0 18.3 38.6 48.1 38.9 31.9 62.7 33.7 24.9 43.9 41.5 29.8 40.5 137.6 57.5 23.8 37.8 23.5 27.1 210.4 27.4 39.4 35.8 19.8 9.7 325.3 22.5 26.6 39.1 39.3 45.8 10.8 44.0 33.2 35.7 22.5 70.7 412.5 24.3 38.7 27.6 34.1 94.6 37.3 28.2 21.4 215.5 20.9 47.5 21.6 428.2 317.4 33.3 43.0 50.4 30.8 54.2 32.1 28.6 36.9 62.8 46.0 51.9 43.3 30.5 28.7 19.8 34.0 49.3 19.8 36.1 27.4 64.5 VKORC1L1 ENSG00000196715 "Vitamin K epoxide reductase complex subunit 1 like 1" Q8N0U8 7 65873074-65959563 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053954 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053954: AB_2682319" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (4.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-3)" "unprognostic (7.15e-3)" "unprognostic (1.30e-3)" "unprognostic (8.84e-3)" "unprognostic (5.12e-2)" "unprognostic (5.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.07e-1)" "unprognostic (1.59e-2)" "unprognostic (1.17e-1)" "unprognostic (7.03e-3)" "unprognostic (4.30e-1)" "unprognostic (5.06e-2)" 54.5 11.2 7.6 11.3 9.4 4.3 23.9 8.2 11.6 12.1 4.0 12.5 11.2 12.4 10.7 12.6 10.1 10.1 12.2 9.8 9.5 10.1 23.1 18.6 8.8 18.7 10.0 8.9 17.5 9.7 33.8 6.8 12.1 9.9 12.1 12.6 11.6 11.0 12.5 21.8 12.5 11.7 11.7 8.8 7.5 12.9 9.2 8.6 9.8 14.1 15.4 8.8 12.0 9.7 10.7 46.8 29.5 23.4 29.5 72.6 28.6 42.3 49.5 31.8 29.0 29.1 28.7 44.9 40.4 39.0 35.7 43.9 31.2 33.6 20.1 47.9 25.5 33.1 27.6 25.4 24.7 35.4 38.7 20.3 23.2 25.3 29.5 40.7 22.5 29.2 22.6 59.0 30.0 34.9 18.3 31.8 44.8 56.1 43.8 22.0 34.5 34.0 50.5 28.0 18.5 28.0 39.8 38.3 68.5 21.8 32.8 34.5 29.5 33.3 46.6 32.0 29.5 51.0 26.9 47.1 46.1 28.6 43.0 41.6 2.0 1.1 2.7 1.2 1.1 1.0 1.3 1.5 1.4 1.3 1.1 0.9 0.9 1.3 2.9 2.2 3.5 1.5 0.7 7.6 9.4 8.2 11.6 9.8 9.5 18.7 10.0 8.9 9.9 8.8 8.6 10.7 19.5 73.7 41.7 16.6 5.5 24.9 18.6 16.2 9.6 21.8 18.6 15.9 21.5 27.1 24.2 16.5 12.5 12.5 10.0 27.1 5.9 18.1 39.0 13.7 23.8 17.1 13.8 26.1 42.7 24.8 21.2 22.6 19.4 25.3 5.1 24.1 10.8 46.9 16.0 30.3 36.6 26.4 20.3 6.6 10.2 9.1 17.7 12.9 7.2 28.1 10.0 11.6 7.2 26.7 34.6 31.6 8.2 18.4 15.6 36.3 14.4 11.4 11.7 20.2 6.6 24.9 26.4 18.5 7.2 17.9 32.0 8.8 6.6 10.8 20.3 22.6 ZNF418 "FLJ31551, KIAA1956" ENSG00000196724 "Zinc finger protein 418" Q8TF45 19 57921882-57935402 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 9.1;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 11.1;SuSa: 7.6;T-47d: 6.9" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.41e-2)" "unprognostic (3.20e-1)" "unprognostic (1.91e-1)" "unprognostic (4.27e-1)" "unprognostic (2.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-1)" "unprognostic (2.20e-1)" "unprognostic (2.96e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.63e-2)" "unprognostic (4.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" "unprognostic (1.36e-3)" 2.2 2.9 5.7 2.5 5.9 2.0 5.9 11.2 5.6 2.9 0.7 3.5 1.0 4.2 5.3 2.0 4.7 2.5 8.8 5.3 3.2 4.1 2.3 2.6 5.2 3.7 4.0 5.2 6.3 4.5 6.3 5.3 5.8 5.6 4.8 1.5 12.5 3.5 5.6 3.3 9.1 2.6 4.0 2.1 5.2 3.6 4.4 5.5 4.6 6.7 5.0 4.5 3.7 3.0 10.1 0.3 1.3 11.1 3.6 1.7 3.6 1.2 3.4 1.1 2.5 0.2 0.2 1.2 0.4 2.3 1.7 3.3 1.0 0.0 2.8 3.0 0.3 1.0 0.2 0.7 0.1 1.0 0.3 2.3 3.0 0.8 3.1 0.0 0.0 0.5 1.0 0.9 0.8 2.1 0.4 0.6 0.4 5.7 0.1 0.4 0.5 0.8 4.0 2.1 1.4 0.2 0.5 0.1 2.0 0.1 7.6 6.9 1.2 0.0 0.7 0.5 0.4 0.6 1.8 4.7 2.9 0.3 1.3 2.2 1.3 0.5 0.5 0.1 1.3 0.4 3.2 1.1 0.7 1.0 5.5 1.8 0.5 0.6 4.3 0.5 1.8 0.0 0.8 5.7 5.9 11.2 5.6 5.3 3.2 3.7 4.0 5.2 5.6 2.1 5.5 10.1 1.7 0.0 0.6 4.2 2.9 0.4 0.8 0.4 0.6 4.3 1.8 1.4 9.1 1.5 1.0 0.0 4.2 1.0 0.8 0.0 1.9 1.2 0.1 1.8 0.9 1.9 0.0 2.5 4.1 0.6 0.6 1.9 1.1 1.1 5.7 2.5 2.5 0.8 0.8 3.3 3.5 0.0 0.0 0.3 0.7 0.9 0.3 0.6 0.0 1.9 0.2 4.3 1.0 4.0 6.3 0.2 1.2 1.5 0.1 1.1 0.0 1.1 5.6 5.9 13.1 0.7 1.3 2.6 5.6 0.7 0.4 0.8 0.7 0.3 0.2 0.8 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708634 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 139.1;Excitatory neurons: 120.2;Inhibitory neurons: 155.9;Kupffer cells: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.7;eosinophil: 8.7;intermediate monocyte: 14.0;myeloid DC: 4.8;non-classical monocyte: 15.2;plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 56 "dendritic cells: 6.2;granulocytes: 8.7;monocytes: 15.2" "Cell line enhanced" "Detected in many" "HMC-1: 97.6;HUVEC TERT2: 56.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome NA NA Centrosome "CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390" "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 14.8 5.9 11.5 11.9 15.4 5.4 6.0 3.1 20.6 9.7 11.1 20.5 10.2 7.9 19.0 5.5 15.4 28.2 3.4 22.6 9.4 18.4 27.8 37.9 12.6 7.1 7.7 12.0 46.3 29.4 6.7 23.6 27.6 8.5 5.3 9.3 11.6 13.8 8.5 1.8 4.8 14.6 9.5 7.3 23.0 19.7 8.1 7.9 42.1 9.9 2.3 6.8 14.7 3.9 10.2 0.0 47.5 22.5 15.8 0.7 0.3 35.4 3.1 4.4 18.3 20.4 6.8 0.3 0.4 4.7 1.0 0.2 43.9 13.9 1.0 7.9 0.4 11.4 23.4 6.6 23.7 19.5 0.0 97.6 1.4 7.5 3.5 1.4 28.5 56.3 6.5 17.8 9.6 15.4 1.5 7.0 0.0 25.4 44.4 0.0 2.0 19.8 0.1 50.6 47.6 10.2 11.3 0.0 4.6 20.1 32.7 0.0 15.2 0.4 0.1 0.3 0.1 0.1 36.9 8.1 0.0 0.2 6.4 3.0 1.7 6.7 8.7 0.0 14.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 0.1 2.0 0.1 15.2 6.2 0.0 3.0 11.5 15.4 3.1 20.6 22.6 9.4 7.1 7.7 12.0 8.5 7.3 7.9 10.2 8.8 51.3 72.2 139.1 2.7 3.6 0.8 1.2 0.6 19.4 1.3 2.3 2.4 31.5 24.3 22.0 2.1 6.8 9.5 1.1 1.9 33.8 1.8 30.2 7.9 17.3 0.0 12.8 120.2 23.0 19.0 12.3 26.5 58.6 24.1 22.1 68.9 20.8 22.7 18.5 155.9 9.3 0.0 85.7 18.3 3.1 14.9 57.1 12.4 18.7 41.2 14.6 2.1 6.6 4.7 35.8 1.9 13.5 6.2 3.2 9.6 7.0 10.2 2.9 0.0 1.5 3.9 3.4 7.2 1.6 3.1 14.2 2.8 3.4 3.7 14.9 LCE1B "LEP2, SPRL2A" ENSG00000196734 "Late cornified envelope 1B" Q5T7P3 1 152811971-152813108 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 159.2" "Cell type enriched" "Detected in some" 18 "Suprabasal keratinocytes: 18.9" "Cancer enriched" "Detected in some" 10 "melanoma: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 2.0" NA NA "unprognostic (1.79e-1)" "unprognostic (1.24e-2)" "unprognostic (6.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 159.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 HLA-DQA1 "CELIAC1, HLA-DQA" ENSG00000196735 "Major histocompatibility complex, class II, DQ alpha 1" P01909 6 32628179-32647062 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 336.9;lymphoid tissue: 338.7" "Cell type enriched" "Detected in many" 4 "Langerhans cells: 4114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 666.6" "Group enriched" "Detected in all" 19 "B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6" "Cell line enriched" "Detected in some" 7 "HDLM-2: 1419.1" HPA012315 Enhanced NA NA 200000 "HPA012315: AB_1853930" "unprognostic (4.24e-3)" "unprognostic (1.47e-2)" "unprognostic (1.43e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (3.26e-1)" "unprognostic (5.81e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (5.36e-2)" "unprognostic (6.74e-2)" "unprognostic (2.27e-1)" "unprognostic (7.43e-2)" "unprognostic (1.57e-1)" 47.7 46.2 1.9 112.0 2.1 7.2 42.0 2.0 3.2 50.3 6.6 77.6 0.1 27.9 32.5 32.4 29.4 128.5 20.9 1.8 9.1 31.4 95.9 336.9 338.7 3.7 4.1 1.1 18.8 15.1 2.6 15.3 13.8 3.8 15.2 117.0 1.9 35.2 7.9 7.6 29.7 74.6 19.4 4.6 181.5 104.2 12.3 2.4 236.5 26.3 0.0 324.8 177.5 16.4 10.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 213.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1419.1 0.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 2.4 0.4 0.0 0.1 0.6 0.6 63.2 1.5 156.1 24.4 0.0 0.0 1.9 105.8 0.5 2.4 257.6 1.0 287.6 3.3 16.5 666.6 274.1 0.4 4.3 3.0 8.2 68.3 162.7 21.6 129.0 1.9 2.1 2.0 3.2 1.8 9.1 3.7 4.1 1.1 3.8 4.6 2.4 10.6 67.9 12.8 86.3 0.0 972.8 50.2 0.4 4.3 4.6 0.1 9.8 28.6 2.1 7.2 19.4 0.0 2.1 0.8 179.8 0.9 1.9 4.6 0.6 0.5 0.4 97.4 0.0 38.3 0.1 4.6 2.4 14.7 10.7 0.9 50.4 0.8 12.8 0.6 381.0 0.0 0.1 0.4 2.0 518.6 4114.3 1.3 3.1 874.3 71.2 12.2 957.1 1.0 4.1 0.0 0.2 2.1 0.1 0.0 96.1 1.5 1.8 6.5 27.3 2.5 6.6 1.2 5.3 0.0 0.7 2.5 41.6 2.1 56.0 1.2 2.7 7.6 COL27A1 "FLJ11895, KIAA1870, MGC11337" ENSG00000196739 "Collagen type XXVII alpha 1 chain" Q8IZC6 9 114155537-114312511 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 93.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 60.1;Extravillous trophoblasts: 75.5;Gastric mucus-secreting cells: 43.8;Hepatocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 54.8;Hep G2: 48.7" "Low region specificity" "Detected in some" "Region enriched" "Detected in all" 19 "cerebellum: 71.0" "HPA021884, HPA048471" Uncertain "Secreted to extracellular matrix" NA NA "HPA021884: AB_2670857, HPA048471: AB_2680407" "unprognostic (4.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (7.11e-4)" "unprognostic (4.13e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (6.25e-2)" "unprognostic (1.71e-1)" "unprognostic (1.09e-3)" "unprognostic (3.31e-1)" "unprognostic (3.41e-2)" "unprognostic (2.97e-2)" "unprognostic (9.48e-2)" "unprognostic (6.21e-3)" "unprognostic (3.50e-3)" 8.1 8.8 4.4 3.5 3.3 0.3 9.2 26.0 4.8 93.0 3.0 9.4 3.9 40.1 16.3 8.1 16.9 7.9 8.6 3.7 5.3 26.9 43.0 7.1 3.2 7.2 6.7 2.2 27.8 21.4 1.0 4.2 11.8 16.3 22.7 1.4 1.5 5.4 13.8 5.8 15.8 7.0 10.6 4.9 4.8 12.0 6.5 7.1 9.3 13.6 2.8 2.2 8.2 38.0 10.2 3.8 7.8 17.9 6.6 1.3 1.9 54.8 8.7 5.9 6.3 5.2 8.1 0.2 0.0 2.1 4.3 4.7 9.2 6.2 8.1 3.4 0.0 0.7 0.0 7.5 48.7 1.9 0.0 19.8 4.9 2.3 7.6 3.4 3.6 9.4 7.4 0.0 1.9 3.6 1.8 0.1 3.5 6.5 15.1 2.1 25.9 18.1 3.7 14.6 4.2 0.3 0.2 0.4 0.2 1.1 6.8 1.6 5.8 8.9 5.5 11.1 0.7 13.9 1.0 0.0 0.0 4.5 0.1 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 3.3 26.0 4.8 3.7 5.3 7.2 6.7 2.2 16.3 4.9 7.1 10.2 2.9 3.2 23.0 15.0 0.8 27.1 4.9 14.2 18.2 1.2 24.3 22.1 34.4 60.1 6.1 9.2 6.2 1.0 2.0 0.5 3.9 12.8 3.7 3.3 25.3 7.1 4.8 0.0 11.0 5.1 75.5 15.0 43.8 11.5 0.0 6.9 3.6 43.6 6.5 1.7 4.6 1.8 0.0 1.0 4.1 1.6 19.3 0.8 23.2 8.4 0.1 5.6 0.0 25.6 0.8 4.7 2.5 4.5 0.4 10.6 0.3 9.8 0.6 1.4 26.3 4.9 40.1 0.5 2.0 5.8 22.4 2.3 1.4 23.8 2.4 3.2 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4" "Cell line enhanced" "Detected in all" "BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 19000000 "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 17.5 20.6 29.5 30.2 38.6 20.8 28.3 40.5 32.0 21.7 20.0 19.9 15.9 15.2 31.1 56.6 15.6 23.6 26.4 27.3 36.7 11.6 25.0 39.3 61.9 42.1 38.8 21.7 21.5 15.0 28.6 6.6 58.4 42.8 21.3 26.5 11.8 17.1 18.1 7.3 82.5 16.4 20.2 41.8 36.3 15.9 11.7 36.8 73.0 13.1 10.6 78.5 40.7 49.9 49.6 22.3 14.8 15.1 71.7 98.0 48.2 207.1 35.0 75.1 19.0 25.6 30.3 26.1 71.9 35.1 26.9 51.1 60.0 16.7 291.8 27.2 41.4 10.5 11.7 16.8 37.9 23.7 19.1 117.1 65.4 287.0 24.4 16.4 26.0 27.6 85.1 11.4 30.7 30.1 9.6 38.4 18.0 10.2 11.4 32.3 17.7 7.1 46.3 18.4 43.3 3.9 13.4 29.1 133.0 58.3 52.0 30.7 22.5 24.6 46.0 17.6 38.3 10.6 75.2 96.8 187.0 53.1 30.1 19.4 7.6 40.4 2.4 3.7 13.6 2.7 30.9 4.3 3.9 39.6 29.8 6.1 4.8 8.7 4.4 3.4 28.0 5.4 18.6 29.5 38.6 40.5 32.0 27.3 36.7 42.1 38.8 21.7 42.8 41.8 36.8 49.6 5.8 16.0 23.0 5.5 25.0 14.9 18.5 63.2 26.7 5.8 5.4 15.5 30.9 0.0 29.7 18.4 2.1 53.6 8.3 4.4 1.9 7.2 0.5 5.7 6.8 7.3 3.6 5.0 2.2 8.1 224.7 10.2 10.7 7.7 69.6 16.3 8.6 24.2 100.8 6.7 2.7 5.4 10.2 55.7 32.5 1.6 8.1 67.8 8.8 2.8 52.5 8.0 7.2 3.5 9.5 6.0 4.7 13.9 28.8 6.7 6.2 5.4 19.9 3.7 0.0 7.9 6.9 1.8 4.2 45.6 23.9 52.5 5.6 6.4 6.7 36.5 H2AC13 "H2A/c, H2AFC, HIST1H2AI" ENSG00000196747 "H2A clustered histone 13" P0C0S8 6 27808199-27808701 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.3;brain: 3.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 42.1;U-266/84: 118.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (6.82e-2)" "unprognostic (5.57e-3)" "unprognostic (1.38e-1)" "unprognostic (4.48e-2)" "unprognostic (9.11e-3)" "unprognostic (1.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (9.54e-5)" "unprognostic (5.50e-2)" "unprognostic (1.50e-5)" "unprognostic (1.43e-1)" "unprognostic (1.85e-1)" "unprognostic (1.89e-1)" "unprognostic (6.24e-2)" 0.1 0.1 1.0 0.2 0.6 5.3 0.1 0.7 0.7 0.2 2.7 2.6 1.0 0.0 0.1 0.7 0.5 0.3 0.0 0.6 1.9 0.1 0.2 0.6 1.5 1.3 1.5 0.2 0.4 0.0 0.7 0.0 0.7 1.6 0.2 2.2 0.0 0.1 0.0 0.0 0.2 1.1 0.1 2.3 1.1 0.9 0.5 2.4 2.5 0.1 0.0 0.6 0.4 0.5 3.6 2.4 8.5 2.0 1.4 0.9 0.5 0.8 1.6 0.3 2.7 2.0 2.8 1.5 2.4 5.1 0.7 1.5 1.8 0.0 1.5 1.2 8.6 11.0 3.7 12.6 8.0 0.9 0.9 1.9 3.7 0.6 0.8 0.2 2.3 0.6 3.0 42.1 9.9 0.0 11.8 6.5 7.0 2.2 7.2 3.2 3.4 0.0 16.6 3.0 1.6 11.7 2.3 23.6 3.4 0.8 0.7 14.2 1.1 0.4 1.2 4.6 1.0 1.0 9.1 118.9 5.0 1.1 9.8 0.7 0.0 0.2 1.5 0.3 0.3 0.3 0.8 1.4 0.3 1.1 1.1 0.3 0.2 2.1 1.0 0.3 1.0 1.8 1.0 1.0 0.6 0.7 0.7 0.6 1.9 1.3 1.5 0.2 1.6 2.3 2.4 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 CLPSL2 "C6orf126, dJ510O8.5, UNQ3045" ENSG00000196748 "Colipase like 2" Q6UWE3 6 35776594-35779552 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "epididymis: 536.8" "Group enriched" "Detected in some" 4 "Breast glandular cells: 3.4;Breast myoepithelial cells: 2.2;Enteroendocrine cells: 1.8;Exocrine glandular cells: 4.0;Pancreatic endocrine cells: 2.1;Spermatogonia: 2.2" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "T-47d: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA051655 Approved "Secreted in male reproductive system" NA NA "HPA051655: " "unprognostic (2.38e-1)" "unprognostic (3.65e-1)" "unprognostic (6.39e-3)" "unprognostic (9.38e-2)" "unprognostic (4.03e-2)" "unprognostic (2.47e-1)" "unprognostic (4.85e-3)" "unprognostic (8.69e-2)" "unprognostic (3.17e-2)" "unprognostic (3.95e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.2 0.0 0.4 0.1 0.4 0.2 0.8 0.0 0.2 0.0 0.0 0.0 536.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 5.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.7 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.2 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.1 6.3 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.4 0.2 0.8 0.5 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.2 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.8 0.0 0.2 4.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 3603.4;urinary bladder: 1108.4" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7" "Cancer enhanced" "Detected in all" "cervical cancer: 848.8;head and neck cancer: 1229.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 10.1" "Group enriched" "Detected in many" 5 "HBEC3-KT: 21286.9;RT4: 8382.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA 27000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: AB_2684767" "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 3.2 2.1 2.6 4.1 2.6 1.0 17.5 2.5 3.6 142.0 2.1 2.7 0.8 2.5 16.2 3603.4 5.7 1.8 3.9 2.4 3.7 348.7 1.7 12.1 0.5 4.1 2.9 2.2 1.9 2.1 0.1 5.5 0.8 3.0 48.5 1.6 0.4 380.2 17.1 3.4 353.0 1.7 1.9 3.3 1.5 3.7 2.8 3.1 6.3 12.0 1.4 419.6 1108.4 753.5 3.6 827.0 9.3 1.1 0.9 10.8 4.2 1.2 10.4 11.5 9.0 7.8 2.1 26.8 1.2 418.3 17.8 18.3 2001.4 1.3 21286.9 9.9 5.4 3.7 3.8 56.2 5.0 4.5 0.7 1.9 8.8 2777.8 24.1 3135.5 21.7 13.2 0.0 0.8 1.5 47.7 3.4 0.2 0.2 2.2 22.3 155.4 1.3 497.9 2.1 502.4 8382.8 16.5 0.5 34.9 5.8 9.0 5.9 3.2 5.7 6.0 12.5 692.6 92.4 280.6 1.9 2.4 4.7 26.5 1.8 24.2 10.1 0.4 0.0 2.3 0.0 1.4 0.4 1.6 1.3 0.3 0.0 0.4 0.3 4.3 0.0 0.5 2.2 1.6 0.7 2.6 2.6 2.5 3.6 2.4 3.7 4.1 2.9 2.2 3.0 3.3 3.1 3.6 1.4 9.6 17.3 2.6 1.0 11464.4 4796.7 10600.9 4741.9 0.0 22.2 35.4 2.9 1.5 3331.1 218.8 0.0 0.7 0.8 3.2 1226.7 24.8 4.5 16.3 2.5 108.2 1.8 3.0 0.1 27.6 1.0 130.8 1.5 24.5 17.1 1.2 0.4 0.1 1.8 0.0 0.0 1.6 789.4 0.8 676.4 8.1 0.6 18.0 759.5 0.0 5.3 1.1 0.0 2.0 0.1 668.7 2.5 0.7 25.9 9446.4 0.8 11.8 560.8 0.1 0.0 5.5 207.0 0.6 3.0 9013.7 3626.5 0.3 37.8 8.9 2.0 5382.7 ZNF700 DKFZp434I1610 ENSG00000196757 "Zinc finger protein 700" Q9H0M5 19 11925068-11950773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.92e-1)" "unprognostic (1.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.27e-4)" "unprognostic (8.63e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (9.02e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (2.01e-5)" "unprognostic (8.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.53e-5)" 11.1 12.3 4.2 6.5 4.3 17.2 12.5 5.8 5.3 12.4 5.0 12.6 6.1 9.4 8.7 13.8 10.4 4.8 7.7 4.1 4.6 16.2 21.2 14.0 10.5 4.6 4.6 4.0 14.1 19.2 8.0 11.3 5.1 4.7 13.9 10.9 9.6 12.3 4.7 5.3 16.3 18.2 4.7 4.4 23.5 14.2 11.4 4.5 8.5 12.4 3.1 11.3 11.7 13.9 4.9 8.0 0.4 8.4 8.7 5.2 5.7 8.5 8.4 7.2 7.4 9.7 6.6 3.9 10.6 7.2 5.4 5.0 6.2 6.9 6.1 10.2 6.0 3.6 11.0 8.2 5.9 4.4 15.6 15.5 4.7 7.1 6.3 7.1 5.0 4.7 6.9 12.4 23.0 10.8 6.5 8.7 14.3 8.6 4.8 7.7 7.3 11.1 8.2 10.5 9.2 4.9 5.9 7.6 5.0 10.1 7.6 8.7 17.7 6.8 18.9 4.9 13.0 9.8 15.9 9.0 10.9 5.0 12.7 6.3 4.8 2.3 4.7 3.2 2.5 3.7 3.2 2.6 4.0 3.2 1.9 2.5 3.2 3.7 3.2 4.4 2.1 3.4 1.9 4.2 4.3 5.8 5.3 4.1 4.6 4.6 4.6 4.0 4.7 4.4 4.5 4.9 5.4 9.6 14.1 12.1 7.6 3.1 1.7 2.2 3.4 2.3 5.0 3.9 4.1 8.6 7.4 1.8 2.1 5.2 7.4 9.4 1.9 5.8 0.6 2.2 2.9 5.1 3.0 3.8 15.0 4.5 4.6 2.7 8.2 2.6 16.4 6.5 6.1 7.3 4.5 0.0 13.4 7.7 6.1 7.8 5.0 1.5 4.4 6.8 5.4 30.0 3.9 2.4 9.2 13.0 17.9 5.3 9.7 1.9 3.0 1.9 5.5 2.1 3.7 4.8 0.0 2.6 5.5 11.5 6.8 3.0 1.7 3.7 6.5 3.0 9.1 1.4 POU3F4 "BRN4, DFN3, DFNX2, OTF9" ENSG00000196767 "POU class 3 homeobox 4" X 83508290-83512127 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "brain: 11.6" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 11.0" "Cancer enriched" "Detected in single" 21 "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 99 "AF22: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062295 Supported Nucleoplasm NA NA Nucleoplasm "HPA062295: AB_2732681" "unprognostic (5.73e-2)" "unprognostic (2.00e-1)" 0.0 0.0 2.2 0.0 11.6 0.0 0.0 3.1 3.9 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 2.6 0.6 0.0 0.0 0.0 3.5 5.3 2.2 0.1 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 11.6 3.1 3.9 1.4 2.6 3.5 5.3 2.2 5.0 2.5 3.2 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14A16 OR5AT1 ENSG00000196772 "Olfactory receptor family 14 subfamily A member 16" Q8NHC5 1 247814660-247824119 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043091-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 589.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" NA NA 49000 "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favorable (7.29e-5)" "unprognostic (1.83e-1)" 52.3 65.6 42.0 117.4 52.5 234.3 90.2 68.0 64.0 57.9 34.4 89.8 75.3 53.5 93.2 94.7 101.4 87.5 60.1 47.9 61.3 44.8 72.0 156.0 139.0 57.0 48.0 46.8 46.5 41.8 27.4 34.9 80.8 52.0 123.3 100.3 288.2 106.2 56.2 58.5 60.3 79.9 55.9 48.1 101.0 105.2 59.5 49.6 79.8 92.0 23.0 163.0 111.1 52.9 77.1 303.3 49.9 108.0 62.1 130.3 122.6 147.9 106.0 139.4 70.8 126.0 2.1 159.1 129.6 180.0 90.7 216.5 201.0 52.2 98.7 91.7 81.5 35.8 311.6 45.9 3.9 73.8 227.4 467.6 85.7 58.1 71.6 53.6 118.5 73.4 132.6 85.1 323.6 108.5 148.1 268.5 77.0 46.7 298.4 133.6 154.2 69.3 187.8 185.3 115.8 69.7 37.9 63.6 111.7 124.4 56.5 227.4 85.8 76.5 210.9 40.9 120.7 79.4 124.2 100.8 208.0 131.5 119.8 65.6 185.2 119.2 232.8 178.1 244.2 155.6 191.6 209.7 192.0 181.6 188.7 149.2 169.0 145.4 232.6 339.2 133.3 334.5 296.9 42.0 52.5 68.0 64.0 47.9 61.3 57.0 48.0 46.8 52.0 48.1 49.6 77.1 72.3 368.6 157.4 98.6 192.9 165.3 311.7 504.4 101.3 102.9 119.0 93.1 51.9 110.1 205.7 93.8 95.9 169.9 218.6 36.5 15.6 589.6 81.5 157.2 17.0 76.5 63.8 112.6 219.2 412.5 85.5 119.1 36.2 120.4 57.7 250.0 83.6 34.2 186.4 122.8 129.3 70.8 148.5 79.6 200.7 52.2 34.2 121.5 117.4 39.4 100.5 51.7 219.4 107.1 150.4 344.7 92.6 48.5 143.8 439.0 53.7 16.3 162.2 229.7 65.7 47.1 85.4 111.5 19.6 97.1 140.1 121.2 160.8 80.6 94.3 321.3 OR52K1 ENSG00000196778 "Olfactory receptor family 52 subfamily K member 1" Q8NGK4 11 4482646-4493497 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.1;RT4: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.3 0.3 0.2 1.0 0.1 0.7 0.6 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.3 0.1 0.1 0.6 0.1 0.0 0.2 0.3 0.2 0.0 0.0 0.3 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.7 0.2 0.3 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.4 0.3 0.3 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.3 1.1 0.5 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.6 0.3 0.1 0.0 0.3 0.2 0.0 0.2 0.4 0.2 0.2 0.1 1.3 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.5 0.1 0.1 0.5 0.3 0.2 0.2 0.1 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.7 0.6 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLE1 "ESG, ESG1, GRG1" ENSG00000196781 "TLE family member 1, transcriptional corepressor" Q04724 9 81583683-81689547 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 205.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011482, HPA071396" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011482: AB_443210, HPA071396: AB_2686392" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (3.71e-1)" "unprognostic (8.49e-2)" "unprognostic (2.62e-1)" "unprognostic (4.18e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "unprognostic (3.59e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (3.65e-1)" "prognostic favorable (8.07e-4)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.60e-4)" "unprognostic (4.09e-1)" 43.4 40.5 36.0 11.9 30.0 40.4 39.3 22.3 33.9 53.5 14.1 37.8 7.7 50.5 27.3 20.5 43.3 27.5 18.7 40.9 22.6 19.2 81.4 23.8 12.8 22.0 32.9 29.2 42.3 60.4 6.3 19.2 19.4 25.4 31.3 21.8 11.2 47.9 17.6 91.6 31.0 30.5 33.6 18.5 45.0 38.5 26.0 25.7 6.6 25.1 22.7 13.6 30.4 35.8 25.6 69.9 50.6 49.7 0.2 50.3 28.3 99.6 3.9 12.4 8.6 11.3 8.8 26.2 0.0 43.1 27.6 69.0 40.9 1.0 22.3 8.3 0.2 40.0 0.0 12.0 74.8 24.5 0.0 1.3 12.4 47.2 26.2 57.1 22.6 35.1 20.0 0.3 22.4 25.8 74.2 9.8 0.4 88.6 48.0 26.1 66.9 35.2 4.9 46.1 38.2 25.2 31.0 4.8 39.6 22.2 53.3 27.9 31.4 27.6 21.7 22.5 10.5 30.8 0.5 0.3 1.6 28.0 0.2 41.0 8.4 0.0 4.6 2.1 0.0 2.9 6.6 0.2 0.9 0.6 5.8 0.0 0.2 0.0 4.3 0.1 1.7 0.0 0.6 36.0 30.0 22.3 33.9 40.9 22.6 22.0 32.9 29.2 25.4 18.5 25.7 25.6 66.6 0.0 6.5 121.5 52.4 54.6 22.3 9.8 18.8 36.6 33.5 18.4 5.7 41.5 15.8 14.7 16.7 67.2 63.5 49.5 15.6 40.8 1.7 85.9 76.2 38.2 28.8 13.9 36.5 23.8 71.9 27.5 23.9 205.8 0.0 30.1 27.1 65.3 7.8 16.8 23.5 24.0 36.7 6.4 20.5 3.6 22.7 9.6 46.2 46.9 8.1 39.5 68.0 22.6 14.5 54.8 41.0 34.3 35.1 40.5 12.2 3.0 17.1 6.0 118.3 12.8 47.4 2.2 102.4 29.3 43.8 50.8 18.6 71.4 48.6 69.4 MAML3 "CAGH3, GDN, KIAA1816, MAM2, TNRC3" ENSG00000196782 "Mastermind like transcriptional coactivator 3" Q96JK9 4 139716753-140154184 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 125.6;Microglial cells: 355.1;Oligodendrocytes: 150.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 15.8" "Immune cell enhanced" "Detected in many" "basophil: 12.2" "Group enriched" "Detected in many" 5 "granulocytes: 12.2;NK-cells: 3.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.0;SCLC-21H: 15.7;SH-SY5Y: 23.9;WM-115: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037717 Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA037717: AB_10794323" "unprognostic (1.83e-1)" "unprognostic (1.28e-1)" "unprognostic (1.17e-1)" "unprognostic (7.83e-3)" "unprognostic (4.73e-2)" "unprognostic (2.63e-1)" "unprognostic (3.36e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.89e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "prognostic favorable (7.60e-5)" "unprognostic (3.38e-1)" "unprognostic (1.20e-1)" "unprognostic (7.22e-2)" "unprognostic (2.88e-1)" 3.2 3.4 1.3 2.4 0.9 3.2 3.5 15.8 1.8 5.0 0.2 3.9 4.8 6.8 5.3 5.9 5.6 4.2 2.0 2.0 3.0 2.0 2.6 3.9 2.7 2.6 2.0 0.1 8.7 6.9 3.3 4.6 5.1 3.8 4.9 3.9 1.7 6.0 4.5 1.7 7.8 4.5 6.1 1.7 3.4 3.5 3.0 1.3 6.0 4.3 2.1 2.4 3.6 5.2 4.7 0.5 8.1 5.4 2.7 2.1 4.4 4.9 1.0 4.4 0.5 0.3 3.2 2.2 1.8 0.4 0.8 0.3 0.1 2.1 1.8 0.3 0.0 1.2 5.9 1.9 0.3 0.4 2.8 8.7 4.3 1.5 0.1 0.9 3.3 15.0 0.1 1.6 0.0 0.3 0.9 0.5 1.2 1.4 3.6 3.5 3.5 0.5 3.6 2.5 11.2 15.7 23.9 0.0 4.2 5.5 4.2 2.3 0.8 13.1 0.6 1.3 0.1 1.7 2.9 3.5 0.1 0.8 9.2 20.2 12.2 1.5 2.9 0.0 1.1 0.1 0.0 0.0 0.0 1.5 0.4 0.4 0.4 3.6 3.4 0.9 1.2 0.0 1.2 1.3 0.9 15.8 1.8 2.0 3.0 2.6 2.0 0.1 3.8 1.7 1.3 4.7 21.2 3.2 11.5 39.5 3.1 8.0 8.1 4.2 7.4 4.6 12.6 9.3 3.0 11.5 8.7 5.5 18.8 5.8 3.9 13.6 5.9 5.1 3.6 12.6 9.4 11.7 14.9 9.4 60.2 5.1 7.3 5.3 8.6 19.9 19.6 34.4 13.2 17.5 7.5 11.8 125.6 12.1 2.0 22.6 13.3 9.0 4.1 19.6 3.6 355.1 18.3 3.1 1.0 7.5 150.8 3.0 14.0 3.8 2.1 5.7 8.2 6.1 7.2 3.7 0.0 2.9 13.7 0.5 2.2 19.0 13.5 8.2 5.3 8.5 11.0 8.9 H2AC11 "H2A.1b, H2A/p, H2AFP, HIST1H2AG, pH2A/f" ENSG00000196787 "H2A clustered histone 11" P0C0S8 6 27133042-27135291 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 2.8;testis: 3.2" "Group enriched" "Detected in some" 10 "Cardiomyocytes: 1.2;Cytotrophoblasts: 2.0;dendritic cells: 1.5;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 9.5" "Group enriched" "Detected in many" 5 "B-cells: 2.8;granulocytes: 9.5;T-cells: 2.9" "Cell line enhanced" "Detected in many" "K-562: 15.5;SiHa: 17.3;U-266/84: 48.8" "Low region specificity" "Detected in many" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.86e-2)" "unprognostic (6.89e-2)" "unprognostic (1.66e-1)" "unprognostic (3.94e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.95e-1)" "unprognostic (5.78e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-2)" "unprognostic (5.98e-2)" "unprognostic (6.48e-2)" "unprognostic (8.22e-3)" "unprognostic (9.54e-2)" 0.3 0.3 1.1 0.3 0.8 2.4 2.8 0.6 0.8 0.5 0.8 0.9 1.3 0.1 0.6 0.6 0.2 0.3 0.2 0.6 1.4 0.1 0.5 0.3 1.0 1.3 1.2 0.3 0.1 0.2 0.0 0.1 0.4 1.3 0.7 0.7 0.1 0.1 0.4 0.2 0.2 1.1 0.2 1.4 0.9 0.5 3.2 2.1 2.0 0.3 0.3 0.4 0.4 0.4 2.7 2.1 2.8 2.3 2.0 7.1 1.5 1.5 0.7 1.1 2.4 0.3 1.2 2.1 0.7 3.0 0.9 2.3 4.2 2.8 1.2 1.6 3.7 1.6 1.1 5.2 0.0 1.5 1.1 2.2 2.7 0.5 0.7 0.8 1.2 0.8 2.0 15.5 6.9 0.1 2.7 2.9 1.8 1.3 3.1 1.9 1.9 2.3 8.0 0.4 0.5 9.0 2.1 17.3 2.7 1.0 1.1 0.0 0.7 0.9 2.6 5.8 2.1 1.1 12.4 48.8 4.9 0.5 1.7 1.6 9.5 0.3 0.6 0.4 0.2 0.9 2.3 1.7 1.1 0.5 2.8 1.4 1.3 2.3 0.9 0.6 1.0 2.9 5.3 1.1 0.8 0.6 0.8 0.6 1.4 1.3 1.2 0.3 1.3 1.4 2.1 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favorable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 19.1 13.5 9.8 9.4 9.7 10.1 11.7 16.5 11.3 14.1 9.7 14.2 7.4 12.5 13.9 15.5 9.9 12.5 18.6 9.1 12.5 14.0 21.7 10.1 7.6 9.9 9.2 7.0 10.1 12.7 14.0 9.4 12.0 9.8 13.9 12.7 14.3 10.4 14.2 39.6 11.8 9.8 18.2 7.2 10.5 11.3 21.1 10.7 9.5 13.8 28.7 9.1 14.9 11.7 12.1 33.7 29.2 31.0 22.0 27.4 20.4 25.8 33.0 23.2 24.9 26.3 37.7 22.4 18.4 22.0 23.2 12.6 18.2 33.5 18.1 37.7 17.5 12.3 19.2 19.6 73.6 28.8 15.6 19.8 19.9 20.8 19.5 24.8 23.9 21.5 16.7 22.8 17.8 25.4 21.5 21.3 16.3 15.3 24.1 25.5 15.0 35.5 4.9 39.2 47.7 19.1 15.5 32.8 23.6 17.7 28.4 27.7 14.5 28.0 24.8 21.3 14.7 12.4 15.7 21.4 17.8 12.7 11.2 20.5 4.1 3.5 4.7 3.3 4.3 4.4 3.4 4.2 3.7 3.1 3.2 4.1 4.8 4.3 4.2 3.5 5.7 3.6 1.3 9.8 9.7 16.5 11.3 9.1 12.5 9.9 9.2 7.0 9.8 7.2 10.7 12.1 37.1 22.4 22.4 82.3 19.5 98.1 57.5 17.9 23.9 27.2 37.1 25.1 51.7 28.6 22.1 31.3 27.1 22.1 17.5 34.1 11.7 38.9 21.8 32.7 48.0 36.0 31.9 43.8 110.9 26.3 19.9 39.6 20.4 46.9 8.8 21.7 35.0 43.1 12.8 37.0 119.0 18.8 16.2 23.9 45.7 13.4 26.8 22.9 44.4 92.8 18.9 24.6 11.3 102.1 139.2 40.3 13.2 27.8 31.3 49.6 13.2 43.3 25.2 30.2 26.3 52.3 51.9 59.8 53.6 31.4 96.5 33.2 21.4 26.1 16.3 53.6 ZNF239 "HOK-2, MOK2" ENSG00000196793 "Zinc finger protein 239" Q16600 10 43556344-43574618 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 49.2;Late spermatids: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 2.8;T-cells: 6.4" "Cell line enhanced" "Detected in many" "NTERA-2: 24.4;T-47d: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030843, HPA046679" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA030843: AB_2673632, HPA046679: AB_10960498" "unprognostic (1.74e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.45e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-7)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.90e-3)" "unprognostic (4.13e-2)" "unprognostic (5.59e-3)" "prognostic unfavorable (4.70e-7)" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" 2.4 2.3 4.1 1.9 4.3 0.3 5.4 4.1 4.5 3.3 3.0 2.7 1.3 4.4 2.1 1.1 4.3 1.4 1.4 4.0 4.0 2.6 1.5 1.4 2.9 3.8 3.7 3.9 4.0 5.1 4.4 4.5 0.9 4.0 5.2 2.8 1.5 1.9 4.5 2.9 0.7 2.0 4.9 3.6 1.5 2.5 8.3 4.0 1.7 3.2 2.8 2.7 4.3 1.8 4.1 0.0 4.3 5.0 4.9 6.8 5.2 0.0 8.9 1.0 10.6 9.3 11.1 9.7 0.0 3.3 4.9 3.9 0.3 0.0 0.5 13.5 0.1 7.2 0.0 8.0 0.0 5.3 0.0 3.2 5.7 0.2 8.3 0.0 3.2 0.4 0.0 14.7 0.0 8.8 4.9 1.4 1.5 24.4 4.8 5.0 0.0 0.0 0.3 8.8 3.9 9.3 12.7 4.0 0.1 0.6 6.9 19.1 6.1 1.1 0.0 10.8 0.3 11.6 1.2 8.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.5 0.0 3.7 2.6 3.5 2.4 0.0 2.8 6.4 3.8 0.0 0.4 0.0 0.0 2.0 1.4 4.1 4.3 4.1 4.5 4.0 4.0 3.8 3.7 3.9 4.0 3.6 4.0 4.1 0.5 0.0 0.5 3.6 1.4 0.0 1.7 0.3 4.0 3.1 1.8 2.4 0.7 0.0 1.3 3.7 0.0 0.3 0.2 0.2 1.9 2.0 49.2 0.5 2.2 0.3 0.0 0.4 5.6 0.4 1.2 1.6 1.5 0.7 0.0 2.1 0.4 0.2 0.4 0.0 6.7 0.9 0.0 0.0 0.3 16.4 0.3 0.2 0.0 1.0 0.6 1.3 3.1 7.5 4.3 0.9 0.2 1.5 0.1 0.9 0.0 1.5 0.0 0.5 0.0 1.9 1.6 6.1 8.2 0.4 0.0 0.1 0.8 2.8 1.1 0.2 SPINK14 SPINK5L2 ENSG00000196800 "Serine peptidase inhibitor Kazal type 14 (putative)" Q6IE38 5 148169733-148175398 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;intestine: 1.0;liver: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "OE19: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (4.98e-2)" "unprognostic (3.44e-1)" "unprognostic (1.94e-2)" "unprognostic (2.96e-2)" "unprognostic (5.69e-1)" "unprognostic (1.48e-3)" 0.0 0.0 1.4 0.0 1.0 0.0 0.8 0.4 3.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.8 0.0 1.1 0.1 0.0 1.6 2.0 0.9 0.0 0.0 0.0 0.0 0.2 2.1 0.1 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.4 3.0 0.8 0.8 1.6 2.0 0.9 2.1 1.2 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPRR2B ENSG00000196805 "Small proline rich protein 2B" P35325 1 153070224-153070840 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "esophagus: 50.5;lymphoid tissue: 15.3;salivary gland: 16.4;skin 1: 31.1;vagina: 16.6" "Group enriched" "Detected in some" 13 "Granulosa cells: 5.8;Leydig cells: 6.2;Theca cells: 3.9" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 77.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.52e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 15.3 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 CHRNG ACHRG ENSG00000196811 "Cholinergic receptor nicotinic gamma subunit" P07510 2 232539692-232548115 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skeletal muscle: 32.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "HSkMC: 2.7;RH-30: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.26e-1)" "unprognostic (8.97e-2)" "unprognostic (5.61e-2)" "unprognostic (1.92e-2)" "unprognostic (4.38e-1)" "unprognostic (4.86e-3)" "unprognostic (2.32e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (4.18e-2)" "unprognostic (4.32e-1)" "unprognostic (4.19e-6)" "unprognostic (6.13e-2)" "unprognostic (8.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.2 0.1 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSCAN16 "dJ265C24.3, FLJ22191, ZNF392, ZNF435" ENSG00000196812 "Zinc finger and SCAN domain containing 16" Q9H4T2 6 28124609-28130082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 69.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007290 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA007290: AB_1080721" "unprognostic (1.50e-1)" "prognostic favorable (5.73e-4)" "unprognostic (3.29e-2)" "unprognostic (8.93e-2)" "unprognostic (3.05e-3)" "unprognostic (1.00e-2)" "unprognostic (3.07e-2)" "prognostic favorable (3.19e-4)" "unprognostic (1.23e-2)" "prognostic favorable (1.14e-5)" "unprognostic (2.50e-1)" "unprognostic (1.98e-1)" "unprognostic (2.50e-1)" "unprognostic (1.55e-2)" "unprognostic (2.14e-1)" "unprognostic (3.37e-3)" "prognostic favorable (3.41e-5)" 3.0 3.9 6.0 5.6 6.9 3.2 7.1 8.5 7.2 4.0 5.6 7.2 8.7 3.9 7.1 3.7 4.2 4.0 2.9 6.2 6.6 5.5 4.4 5.0 8.4 6.7 7.0 5.7 2.5 5.0 7.0 3.2 2.3 7.1 4.8 9.1 7.3 6.7 5.8 3.2 7.0 8.4 4.7 6.3 7.4 7.1 2.2 6.7 8.0 4.6 2.8 9.1 4.2 2.7 9.8 0.1 8.8 11.1 8.2 3.0 0.7 9.1 3.0 6.4 7.8 8.4 6.1 5.7 8.8 8.0 2.8 5.4 6.8 7.8 4.4 7.4 12.8 10.8 9.1 7.4 8.7 4.8 6.8 7.4 1.0 7.3 6.6 3.6 8.3 14.7 0.2 1.3 7.3 2.1 10.0 0.0 10.7 2.3 7.4 5.3 10.9 8.4 12.2 9.3 12.6 15.0 16.5 1.5 9.2 10.9 7.2 12.2 3.2 4.6 2.9 6.7 4.4 7.9 3.7 12.5 2.4 1.3 3.4 1.6 69.0 8.6 10.2 13.8 11.8 17.7 19.3 12.0 10.6 9.0 14.6 14.5 11.8 15.6 17.7 11.6 19.6 14.7 8.6 6.0 6.9 8.5 7.2 6.2 6.6 6.7 7.0 5.7 7.1 6.3 6.7 9.8 5.6 6.4 2.6 0.3 5.6 1.8 0.8 4.9 1.2 3.8 5.2 5.6 1.6 10.0 7.5 7.3 4.2 2.2 12.6 4.7 5.9 12.8 3.3 4.2 0.8 4.0 1.8 8.2 1.4 12.6 1.2 1.4 4.6 3.3 2.5 4.8 4.2 2.0 2.1 1.7 1.1 6.0 14.2 3.8 1.3 1.5 0.6 4.3 1.8 1.0 6.1 5.6 11.3 3.5 3.7 9.6 6.1 3.4 4.2 1.3 10.3 8.3 7.7 6.6 0.0 1.7 3.7 1.7 6.3 2.7 1.3 1.8 6.1 2.2 7.0 1.1 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326829-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 100.8" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 505.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA043683: AB_2678616, HPA049383: AB_2680737" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favorable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.8 5.2 36.9 4.6 59.8 12.5 4.9 57.7 38.9 6.1 27.0 7.7 3.8 6.9 3.1 4.2 10.0 3.8 5.1 30.5 40.3 4.0 4.2 18.1 6.9 71.1 59.3 23.3 6.5 3.2 7.8 8.4 15.1 64.2 6.6 6.2 6.3 3.1 8.4 24.8 4.8 5.6 6.5 68.2 11.2 6.4 5.7 56.5 8.5 5.8 13.1 2.6 7.9 5.1 100.8 4.8 6.5 34.6 19.1 1.2 0.4 20.4 4.0 3.1 7.0 1.3 5.6 0.3 0.0 2.4 3.8 10.3 2.1 10.7 1.9 4.3 8.0 6.7 1.7 1.1 24.6 2.7 3.2 1.5 2.6 3.5 1.4 0.1 5.8 5.4 25.5 0.0 0.0 5.2 3.9 5.3 10.0 7.6 0.8 8.6 7.6 18.9 0.0 0.3 19.5 8.7 15.9 6.4 4.6 4.1 14.4 4.6 19.2 7.9 7.8 5.8 4.4 8.2 0.1 0.0 1.9 2.2 14.2 4.2 0.0 0.8 0.1 1.4 0.2 2.5 0.1 0.6 2.3 1.0 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.0 0.9 36.9 59.8 57.7 38.9 30.5 40.3 71.1 59.3 23.3 64.2 68.2 56.5 100.8 6.3 6.4 7.3 75.4 1.8 3.6 3.2 1.0 6.8 9.4 3.3 3.6 3.6 4.3 1.3 1.8 4.2 12.4 4.7 8.8 0.0 1.6 0.8 6.2 3.0 5.8 2.4 1.7 64.5 1.4 2.6 3.1 2.6 2.4 7.0 5.5 2.2 6.2 1.6 10.1 58.2 2.5 6.1 23.3 6.2 2.7 2.8 10.2 0.0 74.9 3.9 9.1 2.1 56.8 505.6 1.0 5.5 6.4 2.2 1.2 0.9 0.3 6.9 5.3 0.0 2.6 2.7 3.4 6.4 2.9 2.6 3.4 10.9 0.8 3.0 1.6 ILRUN "C6orf106, dJ391O22.4, FLJ22195" ENSG00000196821 "Inflammation and lipid regulator with UBA-like and NBR1-like domains" Q9H6K1 6 34587288-34696859 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 213.7" "Cell type enhanced" "Detected in some" "Adipocytes: 9.9;Cardiomyocytes: 73.7;Cytotrophoblasts: 13.7;dendritic cells: 11.8;Hofbauer cells: 15.6;Syncytiotrophoblasts: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034489, HPA034490" Approved Supported "Nuclear speckles,Centrosome,Cytosol" NA NA "Nuclear speckles" "Centrosome, Cytosol" "HPA034489: AB_10669991, HPA034490: AB_2674186" "unprognostic (3.76e-2)" "unprognostic (2.51e-1)" "unprognostic (7.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (8.40e-2)" "unprognostic (9.94e-2)" "unprognostic (7.57e-2)" "unprognostic (5.68e-2)" "unprognostic (3.55e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" 57.5 35.6 42.1 31.7 40.0 28.8 35.5 48.6 53.0 25.5 38.7 37.9 30.4 29.8 29.2 42.4 27.5 29.6 68.3 40.0 40.5 43.5 77.7 42.9 34.3 43.1 51.5 37.4 26.0 30.5 47.7 24.7 30.7 47.1 30.9 30.1 47.1 34.2 32.7 213.7 36.8 36.0 39.7 40.4 31.8 35.3 68.4 45.4 33.2 37.7 189.0 45.1 40.6 28.3 44.0 94.0 41.8 40.3 59.8 95.7 51.9 48.5 63.5 72.3 72.1 89.4 83.0 42.1 107.0 46.1 62.3 99.5 90.7 120.0 52.6 90.3 151.4 47.0 89.2 47.3 80.0 93.4 76.0 96.2 35.4 108.0 73.3 66.4 49.5 58.6 43.9 103.0 43.6 41.7 56.3 52.7 52.7 37.7 152.0 37.3 40.6 52.2 57.0 57.0 91.2 48.6 38.0 93.3 44.9 91.8 82.1 56.5 63.3 60.1 59.1 45.6 63.0 62.7 63.2 154.3 81.8 21.3 66.7 70.1 23.9 3.7 8.1 8.9 6.6 4.7 6.7 6.4 7.1 4.4 8.1 3.5 5.5 4.6 6.2 8.3 2.2 10.0 5.7 42.1 40.0 48.6 53.0 40.0 40.5 43.1 51.5 37.4 47.1 40.4 45.4 44.0 9.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.0 0.0 0.0 0.0 13.7 11.8 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 8.6 7.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 21.6 1.6 0.0 0.0 0.0 AC008758.1 ENSG00000196826 "Novel zinc finger protein" 19 12461559-12551474 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.2 1.1 0.2 0.4 0.1 0.2 1.2 0.5 0.2 0.3 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.5 0.3 0.1 0.1 0.4 0.2 0.5 0.4 0.2 0.2 0.1 0.0 0.1 0.6 0.0 0.1 0.1 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.4 0.5 0.0 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.6 0.5 0.0 0.5 0.1 0.0 0.3 0.4 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.6 0.3 0.6 0.1 0.7 0.1 0.5 0.0 0.0 0.3 0.4 0.2 0.2 0.4 0.2 0.3 0.4 0.2 0.4 0.1 0.3 0.3 0.3 0.2 0.9 0.2 0.2 0.4 0.2 1.1 0.4 1.2 0.5 0.5 0.5 0.2 0.5 0.4 0.6 0.2 0.5 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11G2 ENSG00000196832 "Olfactory receptor family 11 subfamily G member 2" Q8NGC1 14 20190894-20201075 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 4.8;Club cells: 3.1;granulocytes: 6.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.2" "Cell line enriched" "Detected in single" 15 "HEL: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 POTEI POTE2beta ENSG00000196834 "POTE ankyrin domain family member I" P0CG38 2 130459455-130509707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 3.7;prostate: 2.5;testis: 3.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 2.3;Breast myoepithelial cells: 1.5;Cardiomyocytes: 1.9;Prostatic glandular cells: 1.9;Spermatocytes: 5.8;Spermatogonia: 1.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "spinal cord: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;BEWO: 1.4;K-562: 2.0;MCF7: 1.2;RPMI-8226: 1.2;U-2 OS: 3.7;U-266/70: 1.2" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (2.52e-3)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.37e-1)" "unprognostic (2.99e-1)" "unprognostic (8.59e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" "unprognostic (5.52e-2)" "unprognostic (1.47e-1)" "unprognostic (3.38e-2)" 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.1 0.0 0.1 0.1 0.6 2.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.2 3.3 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.1 1.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 1.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.3 0.5 0.0 0.0 0.0 3.7 0.1 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.1 0.1 0.6 1.4 1.0 0.0 0.6 3.7 0.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.3 1.5 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.9 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.1 0.7 0.0 0.0 0.0 0.2 5.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 ADA ADA1 ENSG00000196839 "Adenosine deaminase" P00813 20 44619522-44652233 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Nucleotide metabolism" Hydrolase "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 511.8;lymphoid tissue: 261.4" "Cell type enhanced" "Detected in many" "dendritic cells: 76.4;Extravillous trophoblasts: 128.2;NK-cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 168.5;NK-cell: 94.5;non-classical monocyte: 362.8;plasmacytoid DC: 218.6" "Group enriched" "Detected in all" 4 "dendritic cells: 218.6;monocytes: 362.8;NK-cells: 94.5" "Group enriched" "Detected in many" 5 "JURKAT: 570.9;MOLT-4: 1915.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001399, CAB004307, HPA023884" Enhanced Supported "Plasma membrane,Cytosol" No No 470000 "Plasma membrane" Cytosol "CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573" "unprognostic (4.30e-2)" "unprognostic (6.89e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (9.33e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (6.77e-5)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (2.94e-14)" "unprognostic (2.29e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-1)" 14.8 6.4 8.5 18.6 9.5 20.3 11.0 8.5 9.6 6.4 7.8 5.6 511.8 3.9 1.7 9.1 5.7 9.3 16.7 8.8 9.3 3.2 4.4 6.2 33.7 9.3 9.9 8.2 2.1 5.3 1.5 1.3 4.6 9.9 4.4 3.7 0.3 4.8 2.8 5.4 5.8 18.1 5.8 7.8 17.6 46.3 2.5 9.8 261.4 5.9 6.5 26.6 9.4 5.4 10.3 14.0 37.7 19.2 13.2 35.6 48.7 30.5 13.7 7.8 13.2 9.3 17.5 14.8 38.4 15.8 17.9 24.7 2.2 13.2 55.1 7.3 2.9 17.2 7.8 6.6 13.5 15.0 6.3 20.3 234.3 23.2 5.1 9.0 12.6 50.3 570.9 20.4 30.7 6.0 33.1 1915.5 28.9 5.2 17.2 13.5 102.3 25.8 95.0 2.3 0.0 0.7 9.3 20.2 4.4 24.2 24.0 4.5 19.1 16.9 10.1 18.6 20.5 2.8 40.1 27.3 82.3 3.5 32.5 9.0 0.5 9.8 1.2 43.3 168.5 27.8 7.5 35.5 51.0 35.2 7.6 27.3 38.6 2.5 94.5 362.8 218.6 29.8 57.4 8.5 9.5 8.5 9.6 8.8 9.3 9.3 9.9 8.2 9.9 7.8 9.8 10.3 18.2 0.0 1.9 2.9 13.5 12.9 3.4 10.0 13.6 0.0 2.7 3.2 2.1 0.0 4.8 1.8 0.0 2.9 76.4 0.8 0.0 3.7 0.4 0.7 9.1 17.0 0.0 10.7 0.2 19.7 128.2 19.7 14.8 0.8 0.0 3.5 7.1 3.6 28.5 0.0 0.2 1.5 10.2 20.8 25.5 1.8 42.3 27.6 8.8 3.7 37.4 3.8 56.7 0.5 9.4 10.7 0.3 2.6 31.4 6.0 0.7 3.0 2.4 0.0 13.1 1.9 14.1 0.3 6.2 12.9 13.9 3.7 30.9 6.8 4.9 2.7 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552634 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 295.3;RPMI-8226: 117.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favorable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 28.7 4.6 8.5 19.6 7.1 11.9 39.1 6.8 11.2 18.4 7.1 21.5 5.0 25.4 2.0 7.9 24.3 12.4 25.8 6.0 19.4 8.0 8.6 48.5 19.2 12.7 7.5 5.7 10.9 7.0 2.2 9.4 9.7 10.6 23.4 2.3 2.2 10.3 2.6 23.6 10.8 19.9 7.4 8.3 22.9 14.7 5.6 8.9 10.4 13.2 2.3 10.0 20.1 15.5 12.9 3.4 1.9 1.6 5.4 2.7 3.0 7.5 5.1 17.2 6.1 5.3 3.1 0.9 1.1 3.8 2.9 9.1 4.6 1.4 0.3 2.1 295.3 4.1 6.9 1.1 5.8 3.4 4.7 4.9 2.1 5.7 5.0 0.9 5.3 5.4 8.1 5.4 38.5 2.4 2.9 8.7 16.1 3.3 1.5 0.2 12.2 11.3 117.5 0.7 2.5 2.2 1.1 0.5 0.6 4.3 1.3 0.2 10.0 6.0 5.4 6.7 6.2 4.6 24.7 21.5 3.1 3.0 11.1 4.9 10.5 7.9 32.8 15.3 6.9 14.9 5.9 13.1 14.6 10.3 6.5 14.1 14.4 21.5 27.5 5.5 18.4 16.0 14.9 8.5 7.1 6.8 11.2 6.0 19.4 12.7 7.5 5.7 10.6 8.3 8.9 12.9 97.1 3.2 18.3 3.9 59.9 52.4 46.5 17.0 5.7 24.8 80.3 44.7 14.7 8.6 14.7 3.7 31.3 4.9 121.1 10.8 3.9 33.7 14.2 16.7 26.8 82.2 0.0 3.4 1.5 30.9 9.0 41.2 11.2 32.4 61.9 2.1 38.6 28.7 72.6 0.0 1.6 10.7 20.3 41.5 137.1 36.7 3.7 61.6 58.7 15.9 66.6 6.5 123.6 3.5 1.3 29.1 23.9 6.4 54.5 28.2 0.6 10.6 8.3 25.7 46.0 49.1 120.1 3.2 17.9 1.1 32.5 4.0 98.2 2.1 7.8 26.9 PATE2 "C11orf38, LVLF3112, PATE-M, UNQ3112" ENSG00000196844 "Prostate and testis expressed 2" Q6UY27 11 125776113-125778828 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "epididymis: 454.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Early spermatids: 4.4;Excitatory neurons: 2.7;Inhibitory neurons: 3.1;Late spermatids: 13.7;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (3.28e-1)" "unprognostic (7.26e-2)" "unprognostic (2.95e-1)" "unprognostic (1.18e-2)" "unprognostic (2.63e-1)" "unprognostic (6.84e-3)" "unprognostic (1.55e-2)" "unprognostic (5.08e-1)" "unprognostic (2.55e-1)" 0.0 0.1 0.3 0.0 0.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 454.5 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.4 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.7 0.4 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.2 1.1 0.4 0.3 0.1 0.0 0.5 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PPTC7 TA-PP2C ENSG00000196850 "Protein phosphatase targeting COQ7" Q8NI37 12 110533245-110583318 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 141.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.43e-5)" "prognostic unfavorable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favorable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 18.9 25.8 7.6 16.3 7.7 52.8 13.6 12.8 11.6 14.7 8.7 15.8 13.5 14.4 6.4 21.8 11.4 15.1 38.3 7.1 13.9 21.7 21.2 15.7 20.9 12.1 12.5 5.7 13.2 13.4 30.9 8.5 10.8 12.7 12.4 16.9 15.8 18.0 13.5 89.4 20.4 13.3 16.2 9.4 15.4 12.0 14.2 12.1 18.5 11.7 141.2 18.6 19.2 19.2 13.8 24.3 13.6 11.4 12.0 27.8 24.3 16.3 10.9 14.3 11.7 11.7 15.4 9.3 42.2 11.1 10.8 16.7 23.0 23.1 25.3 23.5 30.9 19.1 37.5 14.4 16.7 26.3 41.8 29.6 21.0 40.7 16.6 48.4 17.4 22.5 28.8 28.3 11.7 19.2 6.3 37.2 35.7 16.1 13.0 25.0 30.7 15.3 25.8 48.7 26.7 18.4 14.2 20.6 28.2 24.4 11.0 13.4 22.1 25.9 10.7 11.5 32.8 18.6 33.5 40.0 46.7 18.0 22.6 21.4 0.0 0.6 0.5 0.8 0.5 0.8 0.4 0.6 0.6 0.4 0.7 0.7 0.6 2.1 0.6 0.4 0.5 0.5 0.2 7.6 7.7 12.8 11.6 7.1 13.9 12.1 12.5 5.7 12.7 9.4 12.1 13.8 14.1 22.4 28.3 16.0 35.7 91.9 53.1 33.9 56.9 8.6 20.2 12.8 105.4 12.8 36.0 9.2 14.6 7.5 28.2 36.7 17.6 7.7 29.7 34.4 20.4 22.3 16.8 7.8 15.5 8.2 8.4 26.1 12.8 63.3 23.5 8.6 15.4 29.5 17.4 13.5 19.8 15.2 30.5 28.3 97.6 33.2 11.5 30.8 33.8 21.5 31.9 4.8 20.6 19.1 11.7 14.6 15.1 9.8 28.2 57.3 16.5 13.1 35.4 23.8 13.1 22.8 22.4 15.9 24.1 57.1 104.3 6.7 28.7 8.2 17.2 77.5 KRT39 KA35 ENSG00000196859 "Keratin 39" Q6A163 17 40958417-40966948 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skin 1: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 210000 "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (4.92e-1)" "unprognostic (3.85e-1)" "unprognostic (9.03e-3)" "unprognostic (9.89e-3)" "unprognostic (5.00e-2)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (9.42e-10)" "unprognostic (3.95e-1)" "unprognostic (3.04e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395928-58408702 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 11.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 154.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA076397 Enhanced NA NA "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.0 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.1 0.2 0.1 0.5 0.3 0.4 0.2 0.3 0.0 0.2 0.3 0.1 0.0 0.2 0.4 11.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.4 0.1 0.2 0.1 0.4 0.5 0.2 0.1 0.1 0.1 1.0 0.7 0.1 0.1 0.2 0.3 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 1.3 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 154.1 0.8 0.2 0.1 0.0 0.0 2.5 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.0 0.0 28.6 0.9 0.2 0.0 0.0 0.0 0.8 0.0 4.5 2.1 0.1 0.3 0.7 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.4 0.1 27.6 1.6 0.0 0.4 0.0 0.1 0.2 0.2 0.2 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2 like and GRIP domain containing 4" Q7Z3J3 2 107826892-107892544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.8" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 5.8;Early spermatids: 10.4;Late spermatids: 3.1;Spermatocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.3 0.2 0.8 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.3 3.8 0.4 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.0 0.3 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 NHLRC2 "DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492" ENSG00000196865 "NHL repeat containing 2" Q8NBF2 10 113854661-113917194 "Disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038493, HPA057564" Approved Approved Nucleoplasm NA NA 120000 Nucleoplasm "HPA038493: AB_10672519, HPA057564: AB_2683469" "unprognostic (7.09e-2)" "unprognostic (7.33e-2)" "unprognostic (3.00e-1)" "unprognostic (4.74e-2)" "unprognostic (5.15e-2)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.49e-1)" "unprognostic (1.36e-1)" "unprognostic (4.88e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (8.60e-2)" "unprognostic (1.68e-2)" 5.8 5.7 4.5 5.0 5.3 4.2 6.2 6.0 5.1 6.7 7.4 6.1 5.5 6.3 6.9 4.7 5.8 4.1 16.6 3.9 6.0 5.5 8.8 6.6 5.9 5.3 5.4 3.3 7.2 8.0 10.5 5.3 6.4 5.0 8.9 5.9 10.2 6.7 4.9 10.7 7.1 6.3 5.2 4.6 7.2 6.4 3.9 4.6 4.6 7.7 7.6 5.6 6.2 6.3 6.4 10.8 6.8 13.1 10.8 4.7 8.4 8.3 7.4 8.8 6.3 6.9 4.7 10.3 5.8 5.2 7.5 5.5 9.4 10.8 6.1 10.7 7.0 5.4 6.2 5.7 6.7 7.1 8.9 6.8 5.8 7.4 7.0 14.4 12.2 7.7 4.1 7.4 6.5 8.6 5.0 5.1 6.9 3.9 6.6 3.4 4.7 18.8 3.4 7.8 5.9 3.4 6.9 5.8 7.3 9.1 6.1 5.3 6.6 9.9 7.5 7.6 4.8 11.3 4.4 2.3 5.7 6.2 14.0 5.1 0.9 0.5 0.7 0.6 0.4 0.6 0.6 0.4 0.7 0.6 0.6 0.4 0.5 0.3 0.6 0.9 0.8 0.5 0.3 4.5 5.3 6.0 5.1 3.9 6.0 5.3 5.4 3.3 5.0 4.6 4.6 6.4 22.4 19.2 21.3 40.5 13.7 7.9 13.1 8.9 11.4 20.8 15.2 9.7 74.4 18.6 18.8 36.8 14.6 16.8 8.3 8.5 7.9 10.9 5.4 15.6 24.1 19.4 10.3 27.6 45.5 12.3 12.9 19.3 16.3 14.4 10.8 23.3 19.2 28.2 10.1 28.6 34.7 15.8 10.2 17.6 6.7 8.6 18.0 13.7 7.2 44.0 13.2 20.6 13.4 58.3 55.2 11.1 15.4 26.4 9.1 17.3 12.4 11.8 8.9 25.7 65.7 29.1 19.1 16.0 11.4 9.9 8.4 18.2 10.9 18.7 12.3 14.1 H2AC7 "H2A.3, H2A/g, H2AFG, HIST1H2AD" ENSG00000196866 "H2A clustered histone 7" P20671 6 26198784-26199293 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 17.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 17.5;U-266/84: 6.3" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.03e-2)" "unprognostic (1.11e-2)" "unprognostic (7.27e-2)" "unprognostic (3.56e-1)" "unprognostic (9.17e-2)" "unprognostic (1.45e-1)" "unprognostic (9.09e-3)" "unprognostic (6.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.34e-1)" "unprognostic (1.81e-1)" "unprognostic (2.88e-2)" "unprognostic (1.10e-9)" "unprognostic (2.00e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" 0.4 0.2 0.2 0.3 1.3 2.9 0.6 3.7 1.8 2.0 2.8 0.4 0.0 0.1 0.0 2.5 0.6 0.3 0.3 0.8 1.1 0.6 1.2 2.1 0.5 2.6 1.3 0.0 0.7 0.1 0.0 0.3 0.2 1.2 2.1 0.1 0.0 0.5 0.0 0.0 0.7 0.5 0.0 4.5 1.2 0.6 0.3 3.3 1.8 0.3 0.0 0.3 0.3 2.9 4.8 1.1 0.0 0.2 0.2 0.0 0.0 0.2 0.7 0.1 1.1 0.0 1.3 0.4 0.7 1.2 0.2 0.1 0.3 0.0 0.1 0.2 0.0 1.0 0.3 1.4 1.3 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.7 2.5 1.3 0.0 0.0 3.7 1.5 1.1 0.0 1.1 1.0 0.4 0.9 0.4 0.1 1.4 0.2 0.6 0.8 0.1 0.0 1.4 0.3 0.0 1.1 3.1 0.0 1.0 17.5 6.3 2.2 1.0 1.3 0.4 2.3 0.3 3.8 1.3 1.9 1.3 2.7 2.0 4.0 1.1 7.6 1.9 1.9 17.9 1.8 2.2 6.2 2.7 0.8 0.2 1.3 3.7 1.8 0.8 1.1 2.6 1.3 0.0 1.2 4.5 3.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZFP28 "KIAA1431, mkr5" ENSG00000196867 "ZFP28 zinc finger protein" Q8NHY6 19 56538948-56556808 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028879 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028879: AB_10603841" "unprognostic (5.02e-3)" "unprognostic (3.67e-3)" "unprognostic (1.78e-1)" "unprognostic (1.90e-1)" "unprognostic (1.89e-1)" "unprognostic (4.24e-3)" "unprognostic (1.73e-1)" "unprognostic (7.00e-2)" "unprognostic (4.26e-3)" "unprognostic (3.16e-2)" "unprognostic (3.32e-4)" "unprognostic (1.15e-3)" "unprognostic (2.36e-5)" "unprognostic (6.77e-3)" "unprognostic (1.53e-1)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" 4.1 4.3 7.0 2.3 7.4 1.3 4.5 8.4 7.9 5.3 5.5 3.9 1.9 6.4 4.8 3.0 4.6 4.0 4.7 8.1 7.5 4.2 0.9 4.4 2.6 7.6 7.1 7.3 10.8 3.6 6.2 6.2 3.8 7.8 4.9 2.2 11.1 3.2 4.6 3.0 3.6 2.7 5.2 6.6 3.8 3.3 7.5 7.3 3.4 5.3 4.0 2.7 4.7 4.4 8.9 0.0 1.7 7.9 2.4 2.6 2.5 4.1 5.2 5.0 4.1 6.7 0.0 1.1 0.0 2.6 6.2 7.9 0.2 3.9 1.7 6.2 0.0 6.7 5.4 0.3 0.0 7.4 0.2 6.0 6.9 2.2 6.2 0.1 8.1 0.8 2.8 1.1 0.1 5.3 0.0 2.7 1.0 3.6 0.0 1.7 4.2 10.3 0.0 5.5 3.4 0.0 7.2 0.0 0.3 1.2 7.2 3.0 5.4 2.0 3.8 4.1 0.4 6.4 0.1 0.2 0.5 0.1 0.1 0.4 0.0 0.1 1.4 0.1 0.1 0.8 0.6 0.8 0.6 0.4 1.1 0.6 0.5 0.1 0.8 0.1 0.5 1.3 0.3 7.0 7.4 8.4 7.9 8.1 7.5 7.6 7.1 7.3 7.8 6.6 7.3 8.9 5.1 9.6 3.6 6.2 1.0 5.7 2.8 2.0 4.0 7.6 3.3 2.5 5.6 1.5 2.1 5.5 4.2 0.8 1.2 0.6 7.9 2.7 4.2 2.7 3.5 4.3 2.4 1.7 6.7 0.8 0.8 3.5 1.1 3.6 3.8 3.8 2.2 0.5 0.7 10.1 6.7 0.4 4.1 0.3 3.1 2.0 4.1 1.6 5.4 3.7 1.7 6.0 0.0 6.0 8.1 1.1 1.8 4.9 0.2 3.1 0.1 2.7 2.5 5.9 0.0 6.7 4.6 9.7 5.7 2.1 3.8 0.7 3.0 3.9 0.8 1.8 CRACDL "C2orf55, KIAA1211L, MGC42367" ENSG00000196872 "CRACD like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3;epididymis: 31.9" "Cell type enriched" "Detected in some" 9 "Adipocytes: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" Yes No "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: AB_2681337, HPA061678: AB_2684584" "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favorable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favorable (1.33e-5)" "unprognostic (2.22e-2)" 4.4 0.9 14.8 1.5 21.1 0.5 5.2 0.0 33.3 5.2 0.0 6.0 8.1 2.1 31.9 11.3 22.8 2.9 2.8 31.8 7.5 2.9 0.3 6.1 0.8 8.3 1.6 26.0 0.6 4.8 7.8 6.6 4.6 10.6 2.3 4.6 0.1 11.1 4.6 1.7 6.3 7.5 2.3 0.0 1.3 8.3 6.2 1.9 1.0 5.0 1.5 1.8 2.2 5.5 13.4 8.4 0.4 0.2 3.2 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.4 4.9 0.0 10.4 0.0 0.2 7.4 0.3 0.4 0.0 61.7 1.2 0.0 0.5 0.5 0.0 0.0 0.1 0.3 2.3 0.1 1.2 0.1 2.5 0.0 0.0 17.4 0.0 16.3 0.2 1.3 0.1 8.3 0.9 0.0 0.0 0.8 3.2 6.5 5.8 0.9 17.3 22.5 0.1 0.0 8.7 1.4 10.7 0.0 1.3 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.8 21.1 0.0 33.3 31.8 7.5 8.3 1.6 26.0 10.6 0.0 1.9 13.4 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300035 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 11.8 19.5 5.8 18.9 6.3 13.6 17.5 8.9 8.6 9.3 4.2 14.1 13.1 10.0 7.4 17.4 9.8 6.7 13.1 8.0 6.9 21.4 28.7 10.3 17.1 7.4 5.8 5.9 12.1 27.4 8.7 18.5 15.7 8.0 10.6 9.9 18.1 13.6 10.3 17.6 13.0 20.8 8.9 3.6 12.8 17.6 12.4 5.8 12.8 14.4 13.5 13.1 19.0 12.3 9.7 73.0 52.6 25.1 41.2 18.9 6.7 34.3 35.6 14.1 15.2 17.4 15.0 69.4 84.1 33.9 26.1 67.5 86.7 48.0 70.5 39.8 128.2 31.0 31.9 137.8 73.6 24.8 60.9 38.3 15.6 21.3 27.0 35.3 30.5 35.6 93.1 60.4 66.1 22.3 47.4 71.8 81.9 38.5 86.4 88.7 32.6 78.7 94.0 17.3 32.8 40.3 25.7 58.0 36.2 46.3 46.6 26.7 71.5 16.6 22.6 58.1 38.4 70.1 38.3 165.4 102.3 68.8 92.3 41.6 29.8 86.1 66.2 27.8 71.5 24.0 52.5 25.2 28.7 62.0 52.3 27.6 25.5 86.5 16.1 52.0 46.5 37.9 59.8 5.8 6.3 8.9 8.6 8.0 6.9 7.4 5.8 5.9 8.0 3.6 5.8 9.7 4.3 25.6 30.0 2.0 15.9 14.5 16.2 6.0 12.0 25.2 14.5 9.7 28.7 7.2 21.0 11.0 29.2 13.2 5.6 9.7 1.9 7.1 4.7 4.0 2.4 9.0 4.2 5.2 10.8 11.6 7.9 8.9 8.6 3.8 12.6 12.4 6.1 8.2 5.0 11.8 8.9 9.1 2.0 11.0 10.1 2.4 5.0 6.8 5.4 6.5 19.7 5.9 8.2 10.1 5.6 8.8 17.4 3.0 20.3 12.6 28.9 7.1 24.1 36.2 6.6 5.3 6.3 16.7 7.8 7.3 21.5 15.5 10.6 7.6 10.7 12.9 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 34.3" "Group enriched" "Detected in many" 8 "Excitatory neurons: 336.7;Inhibitory neurons: 280.1;Oligodendrocyte precursor cells: 104.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 34.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.7;ASC TERT1: 13.5;WM-115: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 0.2 1.0 3.6 0.4 9.6 0.7 0.5 2.9 34.3 0.3 0.0 0.7 0.2 0.4 0.7 0.1 0.2 0.9 0.1 12.5 7.8 0.9 2.7 0.1 0.4 5.4 0.6 8.4 0.5 1.6 0.5 6.8 0.1 8.2 0.6 0.9 7.9 0.6 0.2 0.3 0.3 0.2 0.1 0.0 0.6 1.0 1.7 2.9 0.5 0.5 0.1 0.2 0.2 0.2 14.0 1.7 1.3 13.7 0.2 1.8 13.5 0.3 8.0 12.5 9.1 8.5 2.8 1.6 0.4 1.9 9.9 4.4 0.1 2.3 0.0 10.5 1.6 0.8 0.1 0.3 0.3 0.1 0.2 1.1 1.8 0.0 6.5 1.4 3.4 9.8 3.5 0.2 0.2 5.5 1.0 2.5 0.2 4.9 0.9 4.8 0.1 0.7 0.0 0.0 0.5 5.6 2.2 4.5 2.1 0.3 2.1 0.4 0.2 2.8 8.9 6.3 3.3 5.2 0.2 0.1 0.0 1.8 1.9 13.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.0 3.6 9.6 2.9 34.3 12.5 7.8 5.4 0.6 8.4 8.2 0.0 2.9 14.0 1.2 0.0 0.0 27.1 0.0 0.0 0.5 0.0 3.4 16.7 2.6 1.8 1.4 1.5 0.0 0.0 10.4 0.0 0.3 1.0 0.0 0.5 0.6 0.0 0.7 1.3 11.4 0.0 336.7 0.5 0.0 0.1 3.1 0.0 0.0 0.7 1.1 4.3 0.0 5.0 280.1 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 20.6 0.0 4.7 0.0 104.5 14.2 0.7 0.5 0.7 0.0 0.4 0.0 0.7 0.0 11.2 0.0 0.4 0.3 3.8 10.2 0.1 0.0 0.0 0.3 0.0 0.9 0.3 LAMB3 "BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa" ENSG00000196878 "Laminin subunit beta 3" Q13751 1 209614870-209652425 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Amelogenesis imperfecta, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 73.9;urinary bladder: 73.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 370.0;Basal respiratory cells: 447.6;Pancreatic endocrine cells: 853.8;Urothelial cells: 392.7" "Cancer enhanced" "Detected in all" "head and neck cancer: 223.9" "Region enriched" "Detected in all" 7 "cerebral cortex: 23.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 353.8;HaCaT: 538.2;HBEC3-KT: 1315.0;hTCEpi: 412.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA007584, HPA008069, CAB078183" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 20000 Vesicles "CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228" "prognostic favorable (8.43e-4)" "unprognostic (3.08e-2)" "unprognostic (1.46e-2)" "unprognostic (2.88e-2)" "unprognostic (8.00e-2)" "unprognostic (1.60e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.55e-4)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.43e-5)" "unprognostic (1.02e-1)" "unprognostic (2.38e-1)" "unprognostic (6.01e-2)" "unprognostic (4.92e-3)" 9.1 16.1 2.0 13.2 2.8 10.8 20.9 1.0 23.4 12.1 0.8 26.4 31.8 18.2 2.7 47.6 16.5 12.0 6.9 2.6 2.2 11.7 9.3 28.7 1.2 1.5 1.6 2.3 1.1 4.3 0.1 1.7 5.8 2.0 26.2 16.8 0.2 41.9 24.3 6.9 42.2 44.0 2.3 1.5 1.0 73.9 1.0 1.8 5.8 1.3 0.3 13.4 73.8 32.8 3.1 178.4 25.8 0.0 0.4 18.1 11.7 1.0 5.1 15.4 6.0 9.1 68.9 353.8 0.1 15.1 3.7 8.9 538.2 0.1 1315.0 9.1 13.1 1.4 1.1 86.9 1.1 2.4 1.0 1.3 2.6 412.8 19.1 253.4 11.7 6.4 0.1 2.5 6.7 1.9 0.3 0.2 1.2 0.6 81.0 74.0 0.2 17.1 165.4 70.9 109.0 0.5 0.5 73.9 8.5 15.4 1.0 2.0 9.7 138.3 29.1 61.3 1.0 104.6 1.7 3.4 0.4 42.2 0.8 2.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.0 2.8 1.0 23.4 2.6 2.2 1.5 1.6 2.3 2.0 1.5 1.8 3.1 0.4 221.2 67.7 1.6 1.2 109.7 370.0 447.6 159.9 0.3 11.5 64.4 8.4 4.3 168.5 47.8 0.0 1.1 0.4 247.5 0.0 180.5 6.0 50.8 10.0 3.5 7.8 0.4 2.5 153.0 1.4 7.5 195.7 135.0 18.4 0.2 0.4 3.9 2.0 3.3 2.3 71.7 18.3 0.3 30.0 10.9 1.8 9.9 8.8 0.0 2.1 0.4 0.0 1.0 1.7 853.8 229.1 0.7 2.1 185.0 111.9 2.3 52.2 0.3 0.0 5.3 10.4 0.3 0.6 51.7 26.0 0.5 4.0 0.0 63.1 392.7 H2BU1 HIST3H2BB ENSG00000196890 "H2B.U histone 1" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;vagina: 3.5" "Cell type enhanced" "Detected in single" "Syncytiotrophoblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "T-47d: 3.0;U-266/70: 15.1;U-266/84: 3.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 0.3 0.7 0.7 0.0 0.5 0.2 0.2 3.5 0.6 2.5 0.1 0.2 0.1 0.1 0.1 1.4 1.0 0.0 0.5 0.4 1.4 0.5 0.1 0.9 0.1 0.8 0.7 0.7 0.6 0.1 0.0 0.9 0.0 1.0 0.8 0.0 0.5 0.3 0.0 0.1 1.0 0.3 0.0 0.6 0.8 0.4 0.2 1.5 0.0 0.4 0.0 0.1 0.4 3.5 1.2 0.2 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.8 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.6 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.7 0.0 0.1 1.2 0.4 0.8 0.3 0.2 0.0 3.0 0.0 0.0 0.0 0.0 0.4 0.0 15.1 3.8 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.3 0.2 0.1 0.1 0.7 0.5 3.5 0.6 0.4 1.4 0.8 0.7 0.7 1.0 0.6 1.5 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 TEX43 "C5orf48, FLJ27505, MGC163367, MGC163369, Tseg7" ENSG00000196900 "Testis expressed 43" Q6ZNM6 5 126631705-126636284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 23.5" "Group enriched" "Detected in some" 197 "Early spermatids: 430.2;Late spermatids: 121.4" "Cancer enriched" "Detected in single" 7 "colorectal cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "unprognostic (4.06e-2)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.6 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 23.5 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.6 0.2 0.2 0.2 0.3 0.2 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 430.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 121.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KPNA5 "IPOA6, SRP6" ENSG00000196911 "Karyopherin subunit alpha 5" O15131 6 116681187-116741867 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 227.6;Alveolar cells type 2: 240.9;granulocytes: 129.3;Respiratory ciliated cells: 143.6;Spermatocytes: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026464, HPA054037" Enhanced Supported Cytosol NA NA Cytosol "CAB026464: , HPA054037: AB_2682351" "unprognostic (9.64e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-2)" "unprognostic (3.56e-1)" "unprognostic (6.60e-3)" "unprognostic (6.98e-2)" "unprognostic (1.75e-3)" "unprognostic (5.19e-2)" "unprognostic (1.10e-1)" "unprognostic (6.12e-2)" "unprognostic (1.51e-3)" "unprognostic (3.02e-1)" "unprognostic (6.12e-2)" "unprognostic (8.00e-2)" "unprognostic (4.79e-1)" "unprognostic (7.89e-2)" "unprognostic (1.43e-1)" 4.2 5.5 6.7 5.1 9.0 7.1 6.2 17.0 13.7 6.4 2.7 2.8 3.2 9.5 3.7 5.0 8.2 5.2 4.7 8.0 7.9 5.0 2.5 6.1 9.0 9.3 7.3 7.5 19.1 2.6 6.4 4.8 4.5 9.8 6.8 3.3 19.1 4.1 5.4 14.0 3.5 3.6 6.9 4.0 6.6 3.6 44.4 5.6 9.0 10.3 12.8 6.3 4.8 3.6 12.3 2.9 1.7 12.0 7.5 4.4 8.5 4.9 4.2 11.7 7.4 10.5 8.1 3.0 10.8 5.6 4.6 8.4 4.7 6.3 3.7 9.2 6.8 18.1 10.1 5.6 4.5 5.5 7.8 6.0 7.7 2.2 9.0 5.6 8.6 8.3 10.3 15.0 4.6 8.3 3.9 12.5 5.5 5.4 2.0 4.7 10.1 3.9 3.0 5.5 5.5 12.8 11.9 3.2 2.7 4.6 7.7 5.3 7.9 6.8 3.0 6.2 3.2 7.5 11.6 13.4 12.2 3.8 5.6 6.4 27.6 4.7 6.4 13.1 5.1 16.3 25.3 14.8 15.7 2.7 26.6 24.1 17.9 1.3 11.2 6.9 16.7 12.1 4.1 6.7 9.0 17.0 13.7 8.0 7.9 9.3 7.3 7.5 9.8 4.0 5.6 12.3 12.5 227.6 240.9 63.0 35.2 13.6 7.1 8.9 13.6 50.9 12.8 13.3 17.1 10.0 118.6 9.2 29.2 4.2 24.2 1.6 9.8 6.1 80.3 22.0 13.0 28.8 33.7 7.6 63.7 5.6 1.8 30.5 6.1 7.9 129.3 18.8 20.3 4.7 4.4 47.1 70.9 7.1 8.2 9.1 9.5 15.2 17.7 21.5 10.6 41.2 7.6 34.7 10.3 64.3 56.7 6.0 1.5 16.6 15.8 8.9 2.4 6.5 143.6 38.8 13.1 16.8 15.4 173.4 10.6 8.8 8.9 3.3 31.9 15.9 4.2 3.8 ANKRD36B "FLJ21281, KIAA1641" ENSG00000196912 "Ankyrin repeat domain 36B" Q8N2N9 2 97492663-97589965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 73.4;Oligodendrocytes: 71.1;Plasma cells: 81.7;Spermatocytes: 76.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "unprognostic (2.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-1)" "unprognostic (8.72e-3)" "unprognostic (5.03e-2)" "unprognostic (7.17e-3)" "unprognostic (4.20e-2)" "unprognostic (4.00e-2)" "unprognostic (2.13e-6)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (7.71e-3)" "unprognostic (6.98e-2)" 3.9 1.8 2.5 1.6 3.9 21.7 4.8 13.5 5.8 4.5 0.0 3.2 1.0 4.2 2.3 1.8 5.1 1.7 2.6 2.9 2.0 2.0 1.1 3.0 2.7 5.2 3.9 2.4 5.3 6.2 1.0 2.9 0.8 6.7 3.4 2.8 10.2 4.4 1.4 1.3 3.8 3.5 2.9 0.7 3.1 3.3 13.2 2.5 3.0 2.8 0.2 1.9 3.1 3.1 7.1 2.9 1.4 1.4 1.7 1.1 2.8 1.8 1.5 1.2 1.0 1.1 1.8 3.2 4.7 1.1 1.5 1.0 0.4 1.1 1.1 1.1 1.5 2.2 3.6 3.5 1.3 0.8 2.6 1.6 1.5 1.5 1.5 2.4 2.8 1.4 7.1 3.8 5.0 1.2 0.5 3.0 3.3 0.9 0.5 1.4 3.2 0.6 0.7 1.4 2.1 1.8 2.3 1.2 0.7 0.9 3.1 1.6 2.0 2.6 1.5 1.8 2.5 2.8 3.9 5.7 3.3 1.9 3.9 1.3 1.9 0.1 0.2 0.6 0.1 0.6 0.6 0.8 0.5 0.1 1.0 0.9 0.6 0.1 0.8 0.0 0.8 0.4 0.1 2.5 3.9 13.5 5.8 2.9 2.0 5.2 3.9 2.4 6.7 0.7 2.5 7.1 14.6 12.8 15.0 27.1 28.3 0.0 6.9 0.0 20.5 36.7 5.4 7.4 15.4 5.7 17.3 9.2 20.9 1.4 15.4 5.9 0.0 9.4 48.9 29.6 10.1 12.5 14.4 16.4 68.5 14.0 3.9 11.4 73.4 14.1 22.8 23.4 4.2 0.7 3.4 16.8 68.7 12.6 0.0 1.2 0.0 7.3 12.8 9.5 0.0 19.7 7.3 6.8 12.3 42.3 71.1 9.7 3.6 7.5 81.7 5.0 2.5 1.3 16.8 34.1 6.6 25.2 9.9 76.4 11.1 24.0 0.0 0.1 35.2 7.1 6.7 12.4 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336413-120489937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 274.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favorable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 25.8 30.9 28.3 14.4 28.4 11.5 32.3 28.4 31.6 33.2 26.5 27.9 25.3 28.1 25.6 27.8 29.6 28.7 40.7 30.4 29.2 68.0 66.9 37.1 12.0 19.5 27.3 24.6 25.4 26.4 68.9 14.7 43.3 19.1 26.8 29.4 48.2 25.2 31.2 32.5 49.9 25.7 30.5 18.8 21.7 32.5 9.8 29.1 13.6 51.9 32.1 18.8 29.0 22.2 22.8 38.1 31.6 41.9 39.8 55.0 54.5 16.7 43.8 49.8 26.1 33.1 37.5 27.2 3.2 51.7 79.8 46.6 27.5 54.1 56.0 51.3 31.1 25.8 61.8 34.0 29.2 49.2 0.1 43.7 52.4 39.7 57.8 63.8 58.0 80.7 32.7 52.4 122.5 67.0 26.6 0.1 0.1 11.4 49.3 26.1 13.4 47.4 11.9 65.1 66.1 30.0 36.4 61.5 51.0 16.2 25.0 43.1 5.1 80.1 57.2 24.2 37.6 32.4 35.1 15.4 20.2 23.6 7.9 44.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 28.3 28.4 28.4 31.6 30.4 29.2 19.5 27.3 24.6 19.1 18.8 29.1 22.8 86.2 73.7 88.4 274.9 8.6 90.5 69.1 47.2 42.1 134.6 55.1 26.9 87.6 68.6 57.8 97.5 185.6 16.7 11.5 59.7 35.2 45.6 6.4 61.4 55.7 94.0 37.8 69.7 239.0 50.9 10.4 44.0 34.7 140.3 11.4 44.9 85.6 118.3 7.3 90.9 192.4 39.6 18.3 31.2 25.6 14.8 29.8 18.2 51.6 118.0 8.7 41.0 13.4 143.2 55.0 53.5 52.1 33.4 9.3 85.6 48.1 76.3 48.7 80.9 26.3 58.4 60.3 16.3 13.8 55.3 85.1 28.7 16.1 43.1 41.3 99.1 HCAR1 "FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR" ENSG00000196917 "Hydroxycarboxylic acid receptor 1" Q9BXC0 12 122726076-122730844 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.6;parathyroid gland: 40.7" "Group enriched" "Detected in some" 4 "Breast glandular cells: 8.7;Breast myoepithelial cells: 5.2;Club cells: 3.2;Early spermatids: 9.6;Extravillous trophoblasts: 3.7;Late spermatids: 6.5" "Cancer enhanced" "Detected in many" "breast cancer: 7.9" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.1;MCF7: 8.1;RT4: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "prognostic unfavorable (3.61e-5)" "unprognostic (8.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-2)" "unprognostic (3.80e-4)" "unprognostic (5.43e-4)" "unprognostic (1.41e-1)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.85e-3)" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (2.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.38e-1)" "unprognostic (1.87e-2)" 5.6 0.3 0.5 0.2 0.5 1.0 11.6 1.6 0.8 0.6 0.5 0.1 0.3 0.4 1.2 0.2 1.7 0.2 0.2 0.6 0.2 0.8 0.1 0.4 0.4 0.4 0.2 0.6 0.4 0.1 40.7 0.3 1.0 0.6 1.1 0.1 0.6 5.0 5.1 1.2 0.7 0.3 0.2 0.1 2.3 2.0 0.8 0.3 0.4 1.3 0.1 0.1 1.2 0.3 1.3 0.1 0.3 0.2 0.3 0.0 0.0 1.9 0.1 0.0 0.0 0.1 2.5 12.1 0.3 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.6 1.8 0.2 0.3 0.2 0.6 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.6 0.1 8.1 0.2 0.4 0.3 3.0 0.6 0.3 0.2 0.3 0.1 35.3 2.6 0.2 0.1 4.2 0.0 0.3 3.4 0.1 0.3 0.4 0.2 0.2 0.2 0.4 0.1 0.4 0.2 0.2 0.3 2.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 1.2 0.4 0.1 0.3 0.1 0.1 0.5 0.5 1.6 0.8 0.6 0.2 0.4 0.2 0.6 0.6 0.1 0.3 1.3 1.3 0.0 0.5 0.0 0.0 0.1 1.4 0.2 0.0 0.3 8.7 5.2 0.4 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 9.6 0.2 0.2 0.3 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 6.5 0.3 0.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 1.0 PDLIM7 ENIGMA ENSG00000196923 "PDZ and LIM domain 7" Q9NR12 5 177483394-177497606 "Predicted intracellular proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 493.6;skeletal muscle: 667.9" "Cell type enhanced" "Detected in many" "Ductal cells: 164.8;Exocrine glandular cells: 242.1;Pancreatic endocrine cells: 320.1;Peritubular cells: 223.0;Sertoli cells: 164.3;Smooth muscle cells: 157.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 177.1;eosinophil: 121.2;neutrophil: 438.7" "Lineage enriched" "Detected in all" 9 "granulocytes: 438.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018794, HPA048815" Approved Enhanced "Actin filaments,Focal adhesion sites" NA NA 1700000 "Actin filaments, Focal adhesion sites" "HPA018794: AB_1855155, HPA048815: AB_2680530" "unprognostic (7.70e-3)" "unprognostic (3.75e-2)" "unprognostic (9.27e-3)" "prognostic unfavorable (5.45e-4)" "unprognostic (1.40e-1)" "unprognostic (3.48e-2)" "unprognostic (9.18e-3)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.01e-2)" "unprognostic (3.10e-1)" "unprognostic (7.24e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (6.19e-10)" "unprognostic (6.72e-3)" "unprognostic (3.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.68e-2)" 68.4 26.9 19.4 75.2 22.1 50.8 58.7 15.4 40.1 166.4 28.5 399.8 31.8 493.6 29.1 65.0 238.1 45.4 79.6 18.7 24.5 52.9 16.1 85.4 15.2 20.2 18.8 19.2 95.0 15.2 9.7 66.8 33.5 20.0 247.4 25.1 5.7 42.6 202.6 667.9 35.7 112.6 179.2 17.2 85.2 157.5 37.9 22.7 11.6 37.4 71.1 7.6 318.1 126.1 20.7 115.8 25.8 120.7 89.4 32.5 59.9 118.9 232.4 132.8 128.9 89.0 50.9 109.6 20.4 220.4 156.4 69.5 59.5 19.7 160.6 30.3 27.5 27.6 73.6 92.2 52.6 83.6 38.8 237.3 132.0 29.1 115.6 51.5 191.9 85.4 18.3 52.4 15.3 102.5 103.9 7.0 88.6 75.7 23.2 108.8 144.4 101.3 14.0 89.1 29.6 17.5 35.8 91.5 16.9 44.6 39.9 24.3 31.3 292.9 153.8 168.1 60.5 211.7 4.0 4.7 24.1 73.3 44.2 35.7 177.1 46.7 121.2 5.3 22.9 6.3 9.6 3.1 7.2 26.7 5.3 3.0 4.0 438.7 2.3 29.3 1.9 7.0 23.9 19.4 22.1 15.4 40.1 18.7 24.5 20.2 18.8 19.2 20.0 17.2 22.7 20.7 36.6 0.0 0.6 11.1 7.5 14.5 47.1 106.8 6.2 6.3 7.6 65.3 21.0 4.3 20.9 25.8 14.6 12.5 4.4 5.5 25.4 164.8 27.0 7.5 44.8 51.0 3.5 9.4 13.9 242.1 53.3 65.0 9.7 7.3 17.2 18.6 51.0 1.6 64.0 8.4 7.4 2.1 36.7 16.6 18.3 49.3 44.7 44.9 10.6 5.6 31.0 16.2 1.0 2.0 1.7 320.1 33.6 223.0 3.2 30.4 1.0 15.7 13.2 22.6 164.3 24.6 157.7 11.6 38.7 12.2 15.8 14.1 10.8 18.2 3.1 25.3 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374634 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 1213.8" "Cell type enhanced" "Detected in many" "Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" NA NA 730000000 "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.88e-4)" 232.8 56.4 17.2 225.1 15.5 159.2 165.6 16.7 38.9 370.5 73.8 1057.4 90.7 1213.8 35.8 459.0 614.7 139.2 95.9 14.4 54.5 64.8 21.3 241.0 65.6 39.1 17.2 5.0 238.7 51.0 13.5 30.7 79.9 21.7 372.3 87.7 9.0 81.0 622.9 50.1 110.3 357.7 713.0 22.3 103.6 512.3 33.9 30.1 48.5 86.3 31.5 38.4 1062.6 288.9 23.6 947.2 719.2 246.7 316.1 209.8 278.4 400.9 614.0 680.1 552.5 489.8 469.2 169.4 80.5 1551.4 966.4 970.1 528.3 224.0 538.1 152.7 333.6 77.8 262.2 914.9 159.7 375.9 309.3 324.9 266.1 126.1 825.5 327.0 533.8 417.1 94.9 74.7 538.7 401.3 210.7 148.5 93.1 258.3 97.9 470.9 147.8 221.2 71.6 197.2 193.4 52.9 119.7 515.8 80.2 381.1 187.3 79.1 96.3 1016.6 625.2 586.8 640.0 1147.1 333.7 212.8 162.3 580.3 202.4 638.7 7.6 24.9 11.8 32.6 23.1 21.2 10.2 15.6 29.2 22.4 4.6 6.0 14.3 3.6 10.5 34.2 2.7 20.7 56.2 17.2 15.5 16.7 38.9 14.4 54.5 39.1 17.2 5.0 21.7 22.3 30.1 23.6 105.1 57.7 38.7 30.0 76.9 124.3 85.9 127.8 85.4 3.5 40.9 153.5 34.5 38.6 26.1 35.0 0.0 24.6 257.7 2.6 1.9 272.0 2.1 33.8 186.3 107.0 1.8 39.7 11.8 133.1 90.9 137.9 13.3 55.8 26.0 334.5 81.8 4.3 120.3 11.8 8.6 2.5 22.4 141.0 263.0 13.7 122.4 227.7 88.9 30.9 207.9 39.4 270.8 8.0 2.6 347.4 1.5 500.6 98.7 96.1 1.9 3.0 9.1 4.3 420.7 118.3 459.3 4.1 8.9 48.8 73.6 20.0 172.3 134.7 3.3 35.3 TMEM26 "Em:AC068892.1, MGC35010" ENSG00000196932 "Transmembrane protein 26" Q6ZUK4 10 61406642-61453381 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.2;Endometrial stromal cells: 5.4;Excitatory neurons: 5.3;Hepatic stellate cells: 4.6;Inhibitory neurons: 4.8;Kupffer cells: 12.2;Late spermatids: 5.6;Theca cells: 15.0" "Group enriched" "Detected in some" 4 "breast cancer: 2.5;endometrial cancer: 1.0;prostate cancer: 1.8;renal cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;fHDF/TERT166: 1.1;HSkMC: 2.0;HUVEC TERT2: 1.5;MOLT-4: 2.3" "Region enhanced" "Detected in some" "hypothalamus: 2.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.21e-3)" "unprognostic (2.84e-1)" "unprognostic (7.34e-2)" "unprognostic (7.83e-2)" "unprognostic (1.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.69e-2)" "unprognostic (3.13e-1)" "unprognostic (9.41e-2)" "unprognostic (5.38e-2)" "unprognostic (5.24e-2)" "unprognostic (2.29e-5)" "unprognostic (2.55e-2)" "unprognostic (1.51e-2)" "unprognostic (8.53e-2)" "unprognostic (1.95e-1)" 0.4 0.5 1.3 0.9 1.6 0.1 5.3 0.3 1.0 2.3 0.2 0.7 1.4 4.0 0.1 0.6 0.4 1.0 0.1 1.1 0.7 2.2 2.5 1.4 0.7 1.8 1.0 0.9 0.5 0.0 1.4 0.2 1.5 0.6 2.6 0.9 0.0 0.0 2.4 0.8 0.0 0.8 2.0 0.3 8.9 0.2 3.7 1.2 2.1 0.4 0.2 0.2 0.7 0.5 0.8 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 4.7 0.4 0.6 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.0 0.0 0.5 0.0 0.5 1.5 0.5 0.0 0.0 0.1 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 0.3 1.0 1.1 0.7 1.8 1.0 0.9 0.6 0.3 1.2 0.8 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.7 5.4 1.7 0.0 0.0 5.3 0.0 0.0 1.4 0.0 1.6 0.0 0.1 4.6 0.2 0.3 0.0 4.8 0.0 0.0 12.2 0.0 5.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 1.2 0.5 0.2 0.0 0.1 0.0 0.1 15.0 0.0 0.0 SRGAP1 "ARHGAP13, KIAA1304" ENSG00000196935 "SLIT-ROBO Rho GTPase activating protein 1" Q7Z6B7 12 63844700-64162217 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 159.0;Early spermatids: 192.4;Microglial cells: 151.8;Muller glia cells: 136.2;Oligodendrocyte precursor cells: 159.8;Oligodendrocytes: 135.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 30.4;hTERT-HME1: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052416, HPA078079" Uncertain Approved Cytosol NA NA Cytosol "HPA052416: AB_2681824, HPA078079: " "unprognostic (3.05e-3)" "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (2.22e-3)" "unprognostic (2.24e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.45e-3)" "unprognostic (1.43e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (3.54e-3)" "unprognostic (8.56e-2)" "unprognostic (1.41e-3)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (8.31e-2)" "unprognostic (1.56e-2)" 4.0 3.8 6.9 1.8 8.6 0.4 3.9 8.4 4.1 4.5 1.3 3.0 1.4 4.3 1.4 2.9 3.6 2.5 2.0 3.9 7.7 3.1 0.8 6.3 1.0 11.5 10.5 3.3 4.8 4.8 6.5 1.4 1.9 8.6 2.3 2.7 6.2 4.7 1.0 1.6 1.9 2.5 2.5 7.6 2.4 1.9 3.9 9.2 0.7 4.4 1.0 0.9 2.8 3.3 10.5 5.3 11.2 17.6 1.7 13.3 23.2 3.7 16.4 14.7 6.0 5.2 5.9 4.3 0.1 6.6 30.4 14.9 3.3 1.5 9.4 6.1 4.2 1.7 0.2 7.9 6.0 16.4 0.1 0.2 21.6 8.8 16.8 46.8 8.2 5.5 0.3 0.1 0.2 8.0 3.2 0.1 0.1 1.5 2.8 6.5 0.1 3.3 0.1 7.4 2.8 2.8 5.3 6.5 6.7 4.4 2.8 1.8 0.1 11.8 12.4 2.3 13.2 7.6 0.1 0.1 0.1 10.4 1.3 5.0 0.4 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 6.9 8.6 8.4 4.1 3.9 7.7 11.5 10.5 3.3 8.6 7.6 9.2 10.5 19.1 0.0 3.3 159.0 3.5 7.8 53.3 20.4 0.0 7.8 19.7 15.1 6.4 37.1 21.7 9.2 6.2 31.7 0.9 42.5 11.7 37.3 192.4 8.3 33.3 24.8 16.7 0.0 19.6 26.0 8.6 43.5 26.0 26.0 1.3 26.8 25.0 2.0 12.2 3.3 38.4 26.6 44.7 34.3 22.2 58.4 22.1 43.5 17.8 151.8 25.1 136.2 0.0 159.8 135.8 41.7 39.8 15.8 0.8 50.5 5.2 14.7 22.1 8.1 0.0 55.1 19.7 5.5 29.1 11.6 3.8 7.3 3.6 2.0 19.6 50.7 FAM3C "GS3876, ILEI" ENSG00000196937 "FAM3 metabolism regulating signaling molecule C" Q92520 7 121348878-121396364 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "memory B-cell: 22.5;naive B-cell: 19.9" "Lineage enriched" "Detected in many" 7 "B-cells: 22.5" "Cell line enhanced" "Detected in all" "CAPAN-2: 1257.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043376, HPA050548" Enhanced Enhanced "Golgi apparatus" "Secreted in other tissues" NA NA 48000000 "Golgi apparatus" "HPA043376: AB_2678452, HPA050548: AB_2681169" "unprognostic (9.44e-2)" "unprognostic (3.91e-1)" "unprognostic (1.75e-1)" "unprognostic (8.11e-3)" "unprognostic (1.26e-2)" "unprognostic (3.09e-3)" "unprognostic (3.38e-3)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (1.22e-2)" "unprognostic (2.15e-3)" "unprognostic (1.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.48e-1)" "unprognostic (9.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" 37.4 46.4 29.9 38.9 34.1 9.7 42.5 27.5 44.0 97.3 23.5 46.9 178.6 51.9 58.0 32.3 34.8 35.7 64.6 38.1 32.4 63.4 49.9 34.8 45.0 34.4 29.0 31.1 37.0 74.6 57.8 29.8 44.9 37.8 32.0 54.5 48.2 38.4 32.6 19.2 32.5 159.5 44.7 25.5 47.8 62.4 24.7 30.5 17.3 112.1 24.7 45.2 57.2 31.6 47.3 133.1 33.2 60.7 64.9 100.3 164.2 55.6 139.7 61.5 41.2 52.1 26.4 1257.1 125.4 65.4 72.5 116.7 85.2 35.1 77.7 87.3 15.3 72.5 35.6 19.3 27.4 73.5 59.0 65.3 165.7 52.1 58.9 57.1 110.4 74.8 24.6 23.3 152.3 326.6 22.3 24.6 45.2 108.1 45.4 45.3 34.2 63.8 51.1 256.7 75.1 38.6 38.1 41.4 167.4 80.6 126.2 24.0 32.5 178.8 105.1 37.7 236.1 96.9 148.0 71.3 48.7 114.0 60.6 192.5 0.0 1.1 0.8 2.1 1.2 2.0 22.5 0.9 1.7 1.0 19.9 1.3 0.9 0.2 3.0 0.9 1.5 0.7 0.8 29.9 34.1 27.5 44.0 38.1 32.4 34.4 29.0 31.1 37.8 25.5 30.5 47.3 49.8 9.6 33.3 17.3 103.0 71.8 257.1 183.0 61.5 137.3 47.5 28.8 65.7 71.4 134.4 55.2 22.9 88.1 44.8 66.8 60.7 182.2 3.5 76.0 81.8 58.9 52.3 10.3 64.6 191.0 188.6 104.3 46.4 170.1 19.7 33.3 50.0 37.0 43.6 45.4 64.3 49.1 101.7 29.6 88.4 6.7 96.0 30.9 99.6 24.4 31.7 49.4 58.7 42.3 24.7 415.8 71.9 95.9 129.8 325.0 327.0 66.8 63.9 67.1 72.3 93.6 68.7 23.8 22.4 61.7 66.3 120.4 44.3 35.6 86.7 425.8 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299850-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 9.4 13.1 6.7 5.5 6.8 7.1 9.4 6.7 6.3 8.6 4.9 10.9 7.8 9.9 3.5 16.2 9.6 3.3 11.2 6.2 6.5 7.7 14.0 8.8 6.3 7.1 6.9 5.6 11.8 12.7 6.7 7.9 4.1 7.0 9.1 5.5 7.5 10.7 4.4 27.4 12.6 11.5 4.9 7.3 17.4 10.6 7.7 7.2 5.9 8.7 11.3 6.8 9.9 9.4 6.7 6.5 12.8 10.2 12.8 8.7 7.3 9.8 11.4 8.5 13.2 10.2 9.7 11.3 16.7 6.3 10.5 10.7 16.6 20.4 14.2 13.7 10.6 7.8 12.3 18.3 22.4 7.0 28.4 13.5 7.4 10.9 9.7 8.9 7.0 12.4 9.3 10.6 8.0 9.3 11.3 13.2 10.7 4.6 22.9 16.2 16.0 6.1 10.6 8.1 14.8 10.2 7.8 16.1 18.4 3.5 7.3 6.9 7.4 12.8 8.7 7.2 6.9 10.9 11.1 10.6 12.2 4.8 12.7 7.1 0.3 0.6 0.5 0.4 0.7 0.4 0.3 0.3 0.2 0.5 0.4 0.2 0.2 0.1 0.1 1.2 0.3 0.3 0.4 6.7 6.8 6.7 6.3 6.2 6.5 7.1 6.9 5.6 7.0 7.3 7.2 6.7 4.0 3.2 3.3 2.6 6.2 12.5 3.2 4.9 6.2 8.1 5.3 3.9 1.2 7.2 8.5 9.2 8.4 6.3 6.7 15.2 0.0 7.3 3.1 5.2 4.8 5.6 10.7 9.9 3.6 10.3 5.8 4.5 6.1 5.0 1.3 9.6 6.1 18.1 7.3 6.7 4.3 7.6 0.0 10.7 6.3 1.3 6.5 5.8 0.0 1.0 7.6 5.5 2.1 3.0 5.0 11.6 8.5 4.5 5.5 5.2 12.5 6.6 7.7 8.0 6.6 5.4 5.4 4.6 5.7 8.1 13.5 6.4 4.9 5.5 14.3 4.6 OR2T4 OR2T4Q ENSG00000196944 "Olfactory receptor family 2 subfamily T member 4" Q8NH00 1 248361581-248362627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705A FLJ16353 ENSG00000196946 "Zinc finger protein 705A" Q6ZN79 12 8157034-8188537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.4" "Group enriched" "Detected in some" 12 "Early spermatids: 4.4;Late spermatids: 3.9;Sertoli cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.8;BJ hTERT+: 6.7;HDLM-2: 5.8;HSkMC: 5.2;NTERA-2: 6.4" NA NA "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (8.16e-2)" "unprognostic (4.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.52e-3)" "unprognostic (4.31e-6)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (1.41e-2)" 0.8 0.8 7.6 0.2 7.4 0.3 1.6 6.8 8.0 3.2 0.6 0.7 0.4 2.6 5.3 1.1 3.2 1.6 1.6 7.8 6.9 0.8 0.0 1.6 1.2 8.4 6.3 7.1 4.6 2.2 3.4 0.0 1.9 7.1 2.2 0.6 2.3 0.9 2.7 0.4 0.5 0.4 2.2 7.6 0.9 0.3 2.2 7.3 1.3 4.4 2.9 1.2 0.9 0.0 8.4 0.0 2.2 0.5 5.8 2.0 4.3 0.2 0.9 6.7 0.7 3.0 0.0 0.8 0.2 0.0 1.6 3.2 0.0 1.1 0.5 1.8 5.8 2.2 0.0 0.0 0.0 1.4 0.0 0.2 5.2 0.4 0.4 1.1 1.5 0.0 1.5 0.0 0.2 0.7 3.3 0.4 0.0 6.4 0.1 0.0 1.1 0.7 0.0 1.4 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.3 0.5 0.1 0.8 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.4 6.8 8.0 7.8 6.9 8.4 6.3 7.1 7.1 7.6 7.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 48.9" "Cell type enhanced" "Detected in all" "Excitatory neurons: 170.8;Microglial cells: 362.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 250000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 8.2 9.8 7.7 6.3 9.2 4.6 7.1 0.0 18.5 10.9 0.0 4.4 3.9 11.1 3.8 3.6 9.6 8.9 4.3 14.1 6.5 8.8 2.0 7.5 8.4 0.8 1.7 7.0 8.0 4.8 5.2 1.1 12.9 3.6 19.3 4.3 5.1 3.7 6.7 1.3 7.1 4.0 7.8 1.5 18.5 5.0 9.4 9.7 10.7 48.9 3.1 7.6 6.3 2.1 6.7 7.3 27.1 46.8 13.0 9.5 21.1 24.3 34.8 16.4 16.1 8.1 38.4 26.4 10.4 51.3 19.6 12.4 10.4 28.6 31.6 19.9 5.4 21.8 11.7 37.1 34.0 10.8 45.4 4.9 12.9 5.1 17.7 20.2 56.9 37.3 10.5 34.9 14.3 26.7 7.3 12.7 14.0 53.8 44.1 18.8 28.9 16.6 27.0 74.8 12.7 17.5 24.7 34.4 65.1 18.7 81.2 11.2 26.5 36.1 28.7 33.6 19.0 18.7 4.6 3.7 6.3 24.5 19.9 29.9 41.5 4.7 3.7 7.5 4.4 6.1 12.3 6.8 6.7 6.4 15.8 6.0 7.8 0.8 21.7 3.3 32.8 7.6 2.6 7.7 9.2 0.0 18.5 14.1 6.5 0.8 1.7 7.0 3.6 1.5 9.7 6.7 72.1 3.2 12.8 40.8 42.0 25.6 12.1 51.3 13.1 23.0 16.9 23.1 7.6 5.7 33.2 36.8 8.4 49.3 60.2 4.3 1.9 17.7 28.5 13.2 48.7 75.4 15.6 26.9 170.8 11.3 66.0 35.3 11.2 16.5 13.3 25.7 26.4 2.8 24.5 8.4 78.3 5.9 26.4 20.7 27.1 16.0 19.0 31.8 7.2 362.6 16.2 17.0 20.6 49.3 49.5 24.3 2.8 18.8 21.3 20.1 4.5 14.7 9.5 20.0 13.1 41.9 29.1 61.3 33.6 7.5 20.5 23.4 35.4 30.8 6.2 7.8 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969366 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavorable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 46.1 21.8 6.1 70.0 6.7 48.9 44.9 6.4 12.5 26.6 8.9 27.9 62.9 18.5 33.4 48.0 35.2 50.5 17.3 6.5 9.3 25.1 54.6 61.8 80.8 8.8 6.7 5.9 43.6 52.9 4.7 11.1 70.8 7.6 21.9 31.0 2.0 55.6 15.6 7.6 47.0 59.3 32.5 7.4 71.7 42.8 4.9 7.9 57.8 15.8 18.3 82.8 77.2 30.7 9.2 33.8 9.5 0.0 12.9 58.2 140.4 27.8 68.0 103.2 80.5 117.0 22.4 128.5 22.3 123.1 71.5 110.4 52.7 0.0 94.3 78.8 22.4 0.4 53.1 7.4 55.8 158.2 48.5 19.2 122.6 127.0 97.9 144.4 104.7 143.8 0.5 1.3 0.0 64.4 2.8 26.1 46.7 0.0 71.6 28.2 21.4 21.5 14.2 64.9 46.2 0.6 0.4 60.8 31.6 49.3 0.7 11.9 62.5 93.2 84.4 30.4 80.8 40.5 0.0 0.0 0.3 42.2 105.5 63.4 136.4 292.0 50.6 208.9 312.9 224.8 141.9 155.6 193.9 205.5 144.4 93.4 138.5 667.2 226.2 255.4 35.4 257.9 410.9 6.1 6.7 6.4 12.5 6.5 9.3 8.8 6.7 5.9 7.6 7.4 7.9 9.2 78.1 60.9 60.8 0.3 87.4 55.8 63.3 130.1 21.1 0.0 40.8 48.4 5.6 47.1 107.0 22.0 0.0 129.1 80.4 12.4 15.6 157.5 0.6 35.9 27.7 73.0 20.9 12.4 0.0 189.9 103.0 53.6 33.1 45.7 34.8 32.6 82.1 34.7 116.7 0.0 0.2 37.8 73.2 168.0 81.2 2.1 29.2 105.2 30.2 23.4 141.5 1.9 177.1 1.5 0.2 148.5 8.6 20.7 50.5 31.1 85.4 41.1 86.1 0.4 6.6 38.1 34.2 0.2 0.5 25.8 45.9 115.9 102.1 36.8 32.9 80.0 AP2A1 "ADTAA, CLAPA1" ENSG00000196961 "Adaptor related protein complex 2 subunit alpha 1" O95782 19 49767001-49807114 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 165.0;Syncytiotrophoblasts: 241.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 20.5" "Lineage enriched" "Detected in all" 4 "monocytes: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004306 Approved Supported Vesicles NA NA 61000 Vesicles "CAB004306: AB_2274034" "unprognostic (4.33e-2)" "unprognostic (1.52e-1)" "unprognostic (4.61e-1)" "unprognostic (7.18e-2)" "unprognostic (1.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (5.85e-3)" "unprognostic (4.84e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.82e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (2.83e-9)" "unprognostic (2.63e-1)" "unprognostic (1.45e-1)" "unprognostic (7.90e-2)" "unprognostic (1.72e-3)" 47.0 88.1 34.6 25.4 37.9 54.8 41.5 17.0 45.3 46.5 5.8 39.8 25.0 57.1 7.4 46.8 48.6 19.7 50.7 37.9 26.9 33.2 51.6 37.5 19.7 40.6 32.6 41.9 57.6 34.1 14.0 34.5 31.7 42.9 33.3 10.0 14.0 29.1 18.8 90.3 52.5 34.3 21.6 13.7 48.0 36.6 89.4 47.4 15.5 30.7 27.1 13.3 46.4 43.9 44.1 70.9 100.3 33.8 78.7 59.5 72.2 69.0 82.0 55.3 49.7 51.8 52.0 43.5 31.5 30.6 85.2 41.9 62.8 25.7 59.0 21.1 50.1 58.4 46.6 66.1 56.8 65.3 37.7 75.0 113.6 42.3 55.4 28.7 44.2 59.5 51.3 118.5 42.7 47.6 55.8 41.6 50.2 34.6 66.6 101.8 46.6 79.7 40.4 29.6 88.1 25.7 34.7 90.1 61.1 34.3 36.1 52.1 52.9 82.9 128.4 70.6 54.6 59.3 63.1 83.5 33.1 90.5 54.8 55.1 0.3 5.3 3.4 2.0 12.8 1.4 1.2 1.2 1.2 4.6 1.0 0.9 1.3 4.0 2.3 20.5 1.4 1.6 4.8 34.6 37.9 17.0 45.3 37.9 26.9 40.6 32.6 41.9 42.9 13.7 47.4 44.1 22.9 0.0 2.3 19.6 18.5 13.8 19.0 18.5 14.8 45.1 26.7 19.0 2.9 14.3 11.7 14.7 43.8 90.8 21.8 39.1 11.7 16.1 129.9 23.0 57.1 22.4 2.4 106.5 24.2 29.4 35.3 36.0 22.4 16.0 8.9 33.2 39.3 36.6 31.3 50.5 25.5 17.4 8.2 56.2 21.3 165.0 53.4 34.0 19.6 14.0 40.4 31.5 63.8 14.1 21.8 27.3 19.0 61.7 28.1 16.3 41.2 50.4 14.9 30.2 59.2 23.2 28.5 54.7 59.2 22.1 13.9 241.6 23.2 48.6 23.9 24.3 ZNF585A "FLJ23765, Zfp27" ENSG00000196967 "Zinc finger protein 585A" Q6P3V2 19 37106734-37172741 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (3.22e-2)" "unprognostic (1.50e-2)" "unprognostic (3.01e-2)" "unprognostic (4.12e-2)" "unprognostic (6.36e-4)" "unprognostic (1.65e-1)" "unprognostic (3.41e-2)" "unprognostic (3.71e-2)" "unprognostic (3.53e-2)" "unprognostic (1.76e-1)" "unprognostic (2.37e-2)" "unprognostic (3.45e-1)" "unprognostic (9.34e-3)" "unprognostic (1.20e-1)" "unprognostic (1.58e-2)" 7.9 10.5 6.0 6.8 6.2 5.9 12.2 7.1 9.0 8.4 5.3 7.7 7.1 5.4 7.5 9.0 7.2 6.2 8.6 5.8 6.4 11.4 7.6 6.8 12.8 5.8 6.4 5.6 7.6 8.3 13.8 10.0 10.2 6.2 7.0 7.6 9.7 8.7 5.4 7.2 7.4 7.6 5.6 5.5 9.4 8.9 9.3 6.2 13.0 10.7 8.3 9.7 8.6 8.3 7.3 9.5 7.4 11.2 13.9 13.8 11.9 8.2 8.7 19.0 17.0 18.9 5.8 8.3 1.5 20.9 16.1 18.5 3.3 5.1 14.9 15.6 11.0 7.2 5.7 6.2 6.8 33.6 0.0 13.8 19.9 14.2 14.1 4.5 14.6 8.1 1.7 3.7 0.1 12.9 8.5 13.6 7.2 10.7 13.1 6.8 0.0 12.3 18.6 11.9 13.6 6.9 14.6 12.3 5.6 16.2 13.5 10.0 7.1 2.5 5.6 7.5 8.8 22.7 37.5 35.0 18.5 0.3 2.5 18.7 75.9 18.4 65.4 28.0 23.4 30.7 28.3 29.7 32.8 17.3 26.0 31.4 30.7 38.4 29.9 20.0 27.2 45.3 18.1 6.0 6.2 7.1 9.0 5.8 6.4 5.8 6.4 5.6 6.2 5.5 6.2 7.3 4.3 6.4 5.4 15.7 12.1 1.3 1.5 2.5 9.6 21.6 4.9 3.4 14.0 7.2 4.3 3.7 16.7 4.0 2.5 4.6 1.9 3.5 38.8 5.5 4.7 6.3 3.0 7.2 11.7 0.8 3.1 6.6 8.6 4.3 19.6 7.0 6.4 1.8 3.6 25.2 12.3 3.2 6.1 3.5 2.3 14.8 4.1 5.7 0.0 5.6 4.7 11.6 6.2 13.0 26.6 2.5 7.3 4.9 8.4 2.6 2.9 3.3 9.9 13.4 0.0 4.5 4.9 18.9 6.9 17.6 1.6 3.4 10.6 5.6 2.1 0.9 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772276-73780251 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 1200000 "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavorable (6.78e-4)" "prognostic unfavorable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 9.4 5.2 2.7 6.8 2.7 6.4 5.3 3.7 2.8 9.0 1.9 4.5 3.2 6.1 3.3 7.0 4.7 9.0 9.5 1.6 3.5 4.7 5.2 8.7 6.4 4.6 3.8 0.9 6.4 4.2 3.7 3.1 17.5 3.6 4.4 3.8 10.1 4.2 6.5 4.2 4.5 3.7 8.4 4.0 10.3 4.9 10.3 6.3 4.4 7.0 4.9 6.3 7.0 4.8 4.5 26.4 14.2 9.9 20.8 19.2 22.2 2.9 13.1 31.3 16.3 31.7 4.7 13.8 6.1 9.3 21.7 5.5 10.9 5.2 13.3 18.1 14.4 10.9 8.1 11.4 7.6 7.5 11.6 24.5 14.8 3.0 15.5 15.9 50.3 30.1 2.7 8.1 10.5 16.4 3.2 2.0 6.0 4.7 2.5 35.1 2.8 6.1 7.2 5.9 4.7 3.0 9.6 11.5 12.0 7.5 8.4 8.2 5.0 31.3 21.1 9.0 10.6 16.4 13.8 5.1 1.4 29.6 10.2 7.0 5.4 1.4 1.4 20.0 1.6 14.2 2.1 5.9 14.3 1.7 1.8 4.3 8.9 0.3 10.9 1.8 3.5 2.6 6.9 2.7 2.7 3.7 2.8 1.6 3.5 4.6 3.8 0.9 3.6 4.0 6.3 4.5 22.4 16.0 13.1 6.2 12.1 13.6 5.6 22.7 5.2 14.6 6.1 6.1 12.2 7.2 9.8 11.0 14.6 10.7 23.1 4.9 0.0 13.3 171.6 6.7 12.0 28.0 4.8 15.8 6.0 6.8 25.2 15.8 2.6 10.5 14.0 7.1 38.2 5.2 12.5 20.2 5.7 4.6 2.0 18.1 16.7 234.7 16.1 11.0 17.8 11.2 11.4 8.3 69.0 5.0 6.5 10.3 5.2 14.7 10.2 8.9 2.6 3.4 9.8 13.0 6.6 14.3 11.7 20.7 19.0 5.5 11.5 9.7 19.9 6.8 3.1 6.4 SMIM10L2B "LINC00087, NCRNA00087, RP11-85L21.2" ENSG00000196972 "Small integral membrane protein 10 like 2B" P0DMW5 X 135094985-135098712 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.1;Cardiomyocytes: 4.8;Horizontal cells: 11.8;Muller glia cells: 5.0;Peritubular cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;GAMG: 2.1;HHSteC: 1.8;HSkMC: 2.9;NTERA-2: 1.6" NA NA "unprognostic (2.60e-2)" "unprognostic (3.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.18e-3)" "unprognostic (7.25e-3)" "unprognostic (9.55e-2)" "unprognostic (5.90e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (7.05e-2)" "unprognostic (4.69e-2)" "unprognostic (1.13e-2)" "prognostic favorable (2.41e-5)" "unprognostic (2.03e-3)" "unprognostic (1.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.98e-2)" 1.2 3.4 15.9 0.5 19.5 0.0 1.3 6.1 24.4 3.1 0.7 1.2 0.4 2.8 2.1 2.0 3.1 0.8 9.4 18.0 20.8 3.6 1.3 1.4 0.4 18.8 24.6 19.6 4.5 1.0 5.9 3.7 0.4 23.9 3.5 0.4 2.2 3.0 2.1 0.8 1.6 0.8 1.4 7.0 1.0 1.6 5.6 16.1 0.1 2.2 0.8 0.3 1.2 2.3 26.6 0.0 0.0 1.3 1.2 1.8 0.2 0.6 0.4 0.2 0.2 0.3 0.5 0.0 0.0 0.2 0.2 2.1 0.1 0.4 0.4 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 2.9 0.2 0.0 0.1 0.3 0.1 0.6 0.0 0.0 0.1 0.0 0.4 0.0 1.6 0.3 0.1 0.0 0.3 0.0 0.7 0.2 0.6 0.2 0.2 0.1 0.0 1.3 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 19.5 6.1 24.4 18.0 20.8 18.8 24.6 19.6 23.9 7.0 16.1 26.6 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.1 1.0 1.8 4.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.3 0.1 0.1 1.2 0.7 1.2 0.0 0.0 0.7 0.1 1.1 0.0 0.2 0.0 1.3 0.7 1.7 0.0 11.8 0.0 0.3 0.0 0.3 0.0 0.8 3.1 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.5 0.0 3.8 0.0 0.4 0.1 1.7 0.0 1.5 0.0 0.6 2.3 1.0 0.5 0.8 0.0 0.3 0.0 0.9 0.1 0.4 ANXA4 ANX4 ENSG00000196975 "Annexin A4" P09525 2 69644425-69827112 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 575.1;pancreas: 359.8" "Cell type enhanced" "Detected in all" "Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005076, HPA007393, CAB017560" Enhanced Approved Cytosol NA NA 550000 Cytosol "CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168" "prognostic unfavorable (8.55e-4)" "unprognostic (3.37e-2)" "unprognostic (4.82e-2)" "unprognostic (9.03e-2)" "unprognostic (1.62e-3)" "unprognostic (1.66e-1)" "unprognostic (3.57e-1)" "unprognostic (3.21e-1)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (7.23e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.79e-1)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (3.97e-2)" 43.7 21.8 16.4 33.9 17.1 31.0 46.4 17.0 17.7 62.9 48.7 102.7 273.7 51.4 30.6 43.4 69.2 575.1 25.4 16.3 22.1 105.0 121.9 82.4 21.3 17.4 16.9 15.4 39.1 359.8 78.7 11.9 53.1 17.3 46.8 93.2 30.3 39.5 52.6 17.3 61.5 234.3 52.4 17.7 24.4 109.1 9.8 16.7 23.3 44.0 20.5 24.2 61.8 50.6 18.6 69.6 249.4 3.4 31.0 185.0 158.3 11.3 66.0 101.5 27.1 38.0 37.9 121.7 22.8 414.2 109.5 78.9 104.7 23.8 108.1 27.6 65.2 20.3 35.0 20.5 456.9 131.2 12.5 43.0 95.9 104.8 36.5 87.3 62.9 71.1 11.0 2.0 20.1 74.7 63.8 18.3 22.8 6.1 280.0 34.3 19.4 6.8 28.3 623.2 99.1 5.1 22.9 72.9 99.5 103.8 35.6 33.3 156.3 100.9 49.2 23.8 65.5 37.7 8.2 9.7 1.3 75.8 59.7 34.1 80.4 34.7 29.6 23.1 42.5 17.5 40.6 11.7 17.5 50.6 46.7 2.0 12.5 4.9 9.5 58.7 15.5 14.5 24.2 16.4 17.1 17.0 17.7 16.3 22.1 17.4 16.9 15.4 17.3 17.7 16.7 18.6 66.4 205.1 154.8 47.3 27.3 74.2 98.5 148.2 68.9 8.2 36.8 36.4 10.6 2344.8 139.4 84.6 6.2 86.4 27.2 315.1 221.1 1469.8 14.6 257.9 79.0 49.1 18.6 12.6 29.9 344.4 370.1 103.6 196.7 488.8 111.5 24.3 33.9 68.5 227.6 8.4 17.7 193.8 240.1 46.1 80.4 11.2 64.7 54.5 92.5 63.7 87.2 48.7 45.3 17.6 106.0 245.7 268.6 92.2 6.9 55.6 657.1 400.4 230.2 59.9 6.6 27.6 64.6 15.8 3.7 61.3 79.6 439.6 32.5 19.1 174.1 96.9 LAGE3 "CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1" ENSG00000196976 "L antigen family member 3" Q14657 X 154477769-154479257 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036122, HPA036123" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA036122: AB_2674951, HPA036123: AB_10601926" "unprognostic (1.70e-1)" "prognostic favorable (5.29e-6)" "unprognostic (1.09e-2)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" "unprognostic (3.04e-2)" "unprognostic (4.88e-3)" "unprognostic (6.73e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (7.37e-2)" "unprognostic (3.57e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" 11.4 29.3 36.7 7.8 39.0 19.6 12.2 37.2 52.8 16.4 32.6 13.8 6.9 12.4 8.4 15.1 11.2 6.0 21.4 40.3 36.4 13.2 21.1 10.9 10.3 35.8 34.5 37.5 18.6 25.3 9.0 34.3 5.5 36.6 16.9 4.7 4.7 16.6 6.5 24.6 19.5 12.3 4.1 36.6 16.4 15.3 9.7 36.0 13.6 9.8 10.3 9.0 17.4 13.7 38.6 44.7 41.6 15.1 32.1 16.0 13.3 44.7 13.3 9.4 19.7 22.0 27.0 23.4 94.2 118.6 17.5 34.9 19.1 37.5 13.2 6.8 53.9 59.9 34.4 38.3 15.6 27.2 46.1 49.1 20.5 8.6 29.6 7.7 15.0 14.1 44.9 34.2 44.4 27.3 104.6 61.9 134.3 28.5 59.5 99.7 54.0 26.0 106.4 11.6 12.0 41.8 38.8 31.0 73.8 57.1 10.4 32.0 33.5 15.8 14.1 41.9 59.6 51.3 104.2 117.5 145.0 24.8 81.8 33.3 27.1 25.8 10.9 26.4 25.5 33.9 40.4 36.5 38.6 35.6 33.7 82.0 41.7 2.8 47.0 20.8 66.5 31.7 40.0 36.7 39.0 37.2 52.8 40.3 36.4 35.8 34.5 37.5 36.6 36.6 36.0 38.6 41.7 9.6 14.7 8.5 57.1 58.0 50.1 68.4 70.6 54.9 84.5 107.8 30.8 58.6 34.2 35.0 8.4 62.4 58.5 40.0 127.2 50.7 2.0 15.3 22.4 46.5 56.4 79.7 10.9 93.4 119.9 40.0 27.5 14.8 46.9 75.7 33.5 49.6 126.3 23.5 8.3 50.8 67.1 37.4 93.1 6.3 41.7 55.6 92.5 3.7 63.4 87.2 74.2 4.5 9.3 40.9 28.4 36.9 65.0 46.1 38.5 72.6 33.0 18.4 6.6 35.3 31.0 43.5 100.9 61.4 56.0 56.8 51.8 56.8 54.3 45.2 WDR5B FLJ11287 ENSG00000196981 "WD repeat domain 5B" Q86VZ2 3 122411846-122416062 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042994 Approved NA NA "HPA042994: AB_10960397" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (2.09e-1)" "unprognostic (3.31e-1)" "unprognostic (1.12e-1)" "unprognostic (3.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-2)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (7.45e-3)" 2.6 3.5 2.1 3.6 2.7 1.9 6.3 3.0 2.6 4.1 2.6 2.2 3.4 3.0 9.6 2.1 7.0 2.2 3.0 2.2 2.3 3.5 5.3 2.9 5.6 2.5 2.4 1.8 4.8 6.0 3.9 3.7 3.0 2.6 4.5 2.7 7.3 4.8 3.3 1.7 3.5 3.6 2.5 2.4 5.1 4.6 3.7 2.3 5.0 6.8 1.7 5.4 2.5 2.1 3.6 5.3 3.2 4.9 5.6 8.8 7.2 3.0 3.9 5.9 5.4 4.6 2.9 4.6 3.2 5.3 3.7 4.4 7.3 3.9 2.9 7.0 2.0 3.3 4.7 3.8 2.9 5.7 2.6 5.0 4.9 7.9 4.0 9.2 6.2 4.2 5.6 2.1 2.7 4.5 6.3 4.2 4.8 2.4 7.9 5.3 4.0 4.8 2.8 5.1 2.2 5.5 5.9 4.0 2.6 8.1 5.5 7.5 5.6 3.4 4.1 5.1 2.0 2.6 2.3 1.0 6.2 5.5 2.5 5.3 3.0 2.0 1.3 1.2 2.1 1.6 1.3 1.9 1.1 1.0 1.8 2.8 2.1 0.7 1.1 4.3 0.6 2.3 1.2 2.1 2.7 3.0 2.6 2.2 2.3 2.5 2.4 1.8 2.6 2.4 2.3 3.6 2.7 3.2 4.8 4.2 2.7 0.5 2.8 4.0 2.8 4.1 5.0 3.9 2.6 5.7 4.0 12.9 6.2 5.6 1.2 0.9 7.9 4.3 14.9 5.8 3.6 3.0 0.0 6.1 1.2 4.0 1.6 3.1 4.1 2.3 0.0 3.3 6.1 4.9 2.5 6.7 1.2 3.8 0.0 4.3 0.6 1.0 4.7 1.8 0.0 0.0 2.1 6.2 9.2 3.5 7.6 2.5 2.0 3.0 1.6 3.7 3.2 6.5 16.3 7.1 0.0 3.2 3.3 11.9 4.9 1.6 2.0 2.9 2.7 2.2 2.5 1.8 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133577081-133609389 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 63.4" "Group enriched" "Detected in some" 6 "Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "SH-SY5Y: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 10.1 16.7 0.0 46.1 0.0 0.0 0.0 63.4 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.4 2.7 36.6 10.3 0.4 8.8 0.3 1.7 5.9 9.3 45.2 0.4 0.1 0.0 0.5 0.8 18.7 0.2 0.5 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.2 0.4 2.4 0.0 0.2 0.2 0.0 0.0 1.1 0.1 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.7 0.2 0.1 0.0 0.0 2.4 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 46.1 0.0 63.4 36.6 10.3 5.9 9.3 45.2 18.7 0.3 0.0 35.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "testis: 15.0" "Cell type enhanced" "Detected in some" "Early spermatids: 1.4;Oligodendrocytes: 1.0;Plasma cells: 1.5;Respiratory ciliated cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 4.4;U-266/70: 2.8" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 1.1 0.6 1.9 0.4 1.5 1.0 1.2 1.9 3.1 1.6 1.0 1.5 0.0 1.2 1.1 0.7 2.1 0.4 0.8 1.7 1.3 0.9 1.2 1.4 0.8 1.5 1.4 1.2 2.9 1.1 0.1 1.6 0.2 1.9 1.8 0.4 1.7 0.9 0.4 1.0 2.8 1.7 0.4 1.2 1.7 1.0 15.0 1.6 0.1 1.9 0.0 0.6 1.3 1.4 2.4 0.2 1.8 0.5 0.3 0.2 0.7 1.5 0.0 0.1 0.0 0.0 0.2 1.0 0.7 0.5 0.0 0.2 0.1 0.2 0.0 0.1 0.2 0.9 0.3 0.0 0.4 0.0 1.3 1.2 0.1 4.4 0.3 0.8 0.2 0.0 1.4 0.2 1.2 0.1 1.2 0.4 1.7 0.7 0.1 0.4 1.7 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.2 0.1 1.0 1.1 0.5 0.0 0.0 1.3 0.9 0.3 2.8 1.4 1.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.9 1.5 1.9 3.1 1.7 1.3 1.5 1.4 1.2 1.9 1.2 1.6 2.4 0.0 0.0 0.5 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.1 WDR45 "JM5, NBIA5, WDRX1, WIPI4" ENSG00000196998 "WD repeat domain 45" Q9Y484 X 49074433-49101170 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027562 Uncertain NA NA "HPA027562: AB_10610565" "unprognostic (1.39e-1)" "prognostic favorable (1.21e-4)" "unprognostic (1.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (4.30e-2)" "unprognostic (6.66e-3)" "unprognostic (7.12e-2)" "unprognostic (3.57e-1)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (5.06e-3)" "unprognostic (2.85e-1)" "unprognostic (5.27e-1)" "unprognostic (3.60e-2)" "unprognostic (1.11e-3)" 58.1 75.3 53.7 22.6 55.7 43.6 54.8 55.3 58.2 54.3 54.4 47.0 27.9 51.9 210.3 38.8 46.1 30.0 77.4 53.0 52.5 61.9 69.1 47.0 25.9 64.9 58.0 49.6 49.4 59.1 55.3 43.7 22.1 55.7 49.4 19.8 21.3 51.2 34.7 116.8 47.0 38.6 24.9 54.0 45.3 59.4 10.1 59.2 32.6 53.3 88.3 23.4 46.3 43.4 57.4 36.3 41.9 23.4 23.7 50.1 63.7 45.7 39.0 80.6 30.1 42.1 22.1 51.5 25.1 21.6 77.1 38.6 30.8 35.3 31.6 21.6 27.6 61.0 15.6 79.5 33.5 114.2 12.1 34.5 57.2 54.9 49.4 52.1 47.8 30.7 23.8 33.3 42.8 40.3 40.9 25.6 31.0 23.8 15.9 36.3 20.4 34.8 85.7 53.2 32.8 31.3 46.8 49.2 37.5 120.5 29.9 23.9 43.4 41.8 32.8 29.4 65.6 16.6 66.2 48.9 18.1 60.1 19.5 24.1 125.4 89.0 82.0 54.5 81.6 54.3 49.1 41.0 51.4 67.1 48.4 32.0 36.5 88.9 83.7 97.9 68.0 65.3 72.0 53.7 55.7 55.3 58.2 53.0 52.5 64.9 58.0 49.6 55.7 54.0 59.2 57.4 36.5 32.1 34.6 15.0 34.0 46.5 54.2 49.3 36.5 18.8 43.7 41.8 35.8 35.8 42.6 35.0 12.5 30.6 56.5 37.9 56.7 71.3 1.3 22.5 35.0 30.5 28.8 71.8 8.9 98.5 56.8 50.8 43.3 26.1 27.3 27.5 35.0 49.7 42.1 26.9 9.3 32.2 10.2 38.8 44.1 3.8 40.4 47.1 35.6 6.5 74.8 38.7 68.0 4.5 11.0 109.6 44.0 32.4 86.5 67.9 68.5 131.2 23.4 24.0 19.7 42.4 44.5 2.6 5.0 24.8 47.3 62.1 33.4 48.3 28.7 73.4 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 414.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 59.8 101.5 43.4 31.4 50.1 119.8 55.0 41.6 53.7 60.2 53.9 43.7 28.6 46.7 71.1 68.4 42.7 33.2 41.4 45.1 48.1 142.1 16.6 49.6 36.4 45.7 44.8 42.8 49.1 40.0 68.7 45.1 37.1 41.8 46.0 31.4 38.9 50.2 28.3 78.0 51.6 39.6 33.4 51.6 55.1 44.6 11.1 46.8 57.4 53.1 53.4 44.5 49.9 57.9 47.2 50.8 41.8 95.3 77.0 99.5 156.2 36.1 85.7 103.8 58.8 68.5 30.4 79.9 92.4 64.8 132.6 53.3 33.0 61.1 71.4 71.2 70.5 72.0 41.1 34.1 120.6 75.1 35.8 81.0 111.6 76.6 54.3 81.1 119.4 111.4 97.8 61.8 57.6 112.3 60.2 93.7 71.2 87.6 60.8 64.0 124.8 80.8 82.7 116.3 44.5 61.8 116.0 66.1 53.1 195.0 65.6 44.5 16.7 75.0 96.9 43.9 62.2 49.5 72.8 102.8 71.4 107.6 80.8 66.3 111.0 75.7 33.4 11.4 14.3 13.5 18.3 19.0 21.1 42.5 20.6 20.4 16.2 36.1 17.0 12.0 14.3 20.4 28.8 43.4 50.1 41.6 53.7 45.1 48.1 45.7 44.8 42.8 41.8 51.6 46.8 47.2 82.4 19.2 26.1 32.3 66.9 71.8 89.5 143.8 51.2 52.6 77.7 61.7 53.6 34.3 81.3 86.5 45.9 79.4 94.3 49.6 281.8 119.5 7.8 56.4 68.9 89.2 84.9 146.9 48.2 122.9 124.2 67.6 42.8 64.7 47.7 70.0 98.6 11.2 95.8 45.4 37.8 80.4 101.7 181.7 103.3 6.3 63.3 124.2 104.9 40.3 270.1 92.9 109.2 34.2 28.3 114.9 51.5 65.1 58.0 149.4 81.1 414.2 50.4 43.7 65.7 48.9 108.8 17.1 25.1 74.7 77.0 139.1 111.4 57.4 80.5 142.9 ZNF138 pHZ-32 ENSG00000197008 "Zinc finger protein 138" P52744 7 64794388-64833681 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.3;Inhibitory neurons: 75.9;Oligodendrocytes: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.12e-2)" "unprognostic (3.25e-1)" "unprognostic (1.10e-2)" "unprognostic (3.12e-3)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (5.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.81e-3)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (1.23e-3)" "unprognostic (5.04e-2)" 2.6 4.9 4.5 3.6 5.4 2.9 7.4 8.9 7.3 3.3 0.2 2.9 2.6 2.0 3.6 2.9 1.9 2.5 2.2 4.6 4.0 3.9 4.4 2.3 5.8 5.8 4.5 4.3 2.8 2.2 1.8 2.2 2.5 5.9 3.3 3.8 3.9 3.9 2.4 3.1 7.3 2.7 2.1 2.6 3.3 4.0 4.8 4.4 5.2 3.5 2.7 5.6 2.4 2.5 8.1 5.0 3.7 7.6 14.4 4.9 5.7 7.9 4.0 3.4 4.9 7.7 6.9 8.2 22.3 7.3 2.1 9.4 3.1 12.9 3.5 8.7 6.9 8.0 6.1 5.5 4.5 2.7 12.8 6.0 3.3 3.3 7.5 6.1 5.7 4.0 14.4 16.9 7.7 5.2 8.7 12.5 8.4 17.4 6.0 7.7 9.7 7.8 7.4 5.8 11.5 12.1 12.4 5.7 9.1 7.2 20.4 14.3 11.5 2.0 5.0 5.8 4.4 7.7 11.1 14.3 24.8 3.2 8.3 3.7 11.7 1.6 3.2 4.0 3.2 4.3 7.4 6.2 6.3 2.2 7.4 6.5 6.3 2.7 3.7 3.1 5.6 6.3 2.4 4.5 5.4 8.9 7.3 4.6 4.0 5.8 4.5 4.3 5.9 2.6 4.4 8.1 9.8 0.0 5.1 37.5 15.8 9.2 6.6 12.1 9.1 18.6 15.6 11.7 12.9 0.0 9.0 5.5 6.2 10.4 14.8 4.9 7.9 8.3 13.3 10.2 9.3 7.3 4.2 13.7 75.3 14.0 10.2 8.8 9.7 11.2 14.5 16.2 6.1 6.8 7.7 23.5 75.9 7.4 8.2 5.7 7.0 12.6 6.8 8.3 1.8 24.4 7.0 10.8 19.6 52.8 90.4 9.9 9.4 4.9 7.3 3.4 4.6 7.2 3.3 13.5 0.0 7.8 7.8 22.5 14.8 8.2 10.5 5.6 14.2 23.5 7.4 5.9 ZNF429 ENSG00000197013 "Zinc finger protein 429" Q86V71 19 21496682-21556270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004139 Approved Nucleoplasm NA NA Nucleoplasm "HPA004139: AB_2667147" "unprognostic (1.06e-1)" "unprognostic (1.88e-1)" "unprognostic (2.77e-1)" "unprognostic (1.75e-2)" "unprognostic (1.45e-2)" "unprognostic (3.13e-1)" "unprognostic (3.39e-2)" "unprognostic (1.95e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.96e-8)" "prognostic favorable (7.30e-4)" "unprognostic (5.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.48e-1)" 2.8 4.8 5.5 2.8 5.1 2.5 5.3 7.7 6.2 4.3 5.4 3.2 2.6 3.3 6.2 2.2 4.9 2.8 2.1 4.9 3.2 5.4 5.6 3.3 5.0 4.8 4.4 5.3 6.9 5.1 5.4 3.5 3.6 5.4 4.3 4.1 5.5 3.7 2.9 2.2 6.8 3.1 2.2 2.9 5.9 4.4 4.5 4.0 5.8 7.9 2.2 3.5 2.2 2.6 7.8 0.3 0.6 3.7 5.2 2.7 2.4 4.0 2.0 1.5 2.7 3.6 0.4 2.7 3.5 5.6 1.3 2.4 1.3 2.1 0.9 4.9 0.9 2.7 0.8 0.9 1.3 1.5 3.6 1.4 2.5 1.2 1.7 0.6 2.5 0.2 4.9 5.5 0.9 4.4 2.4 8.5 3.4 4.1 0.1 1.3 4.1 2.1 1.8 3.2 4.2 6.5 2.9 0.3 0.2 1.6 7.1 4.9 3.2 0.6 0.4 0.9 3.5 1.7 0.7 3.0 4.4 0.2 0.4 1.4 8.9 1.3 6.7 3.5 1.7 3.8 5.5 4.8 4.7 1.2 4.9 6.7 6.2 6.9 7.1 2.2 1.9 3.2 1.9 5.5 5.1 7.7 6.2 4.9 3.2 4.8 4.4 5.3 5.4 2.9 4.0 7.8 6.1 28.9 13.6 14.7 13.6 2.8 6.5 3.8 8.6 15.9 8.6 8.0 6.0 18.6 10.8 7.3 6.2 9.1 5.1 3.8 21.5 8.7 39.2 9.6 8.7 7.7 6.7 10.1 17.5 4.9 6.9 9.5 9.2 7.8 3.8 19.0 7.1 8.5 3.4 3.3 20.8 5.1 8.2 3.1 4.0 7.6 11.5 5.4 5.4 12.2 4.5 11.4 23.7 20.6 20.4 4.4 6.1 6.0 3.7 5.0 10.9 13.6 12.2 8.1 19.7 6.0 7.5 14.0 17.3 9.4 2.0 6.8 10.3 37.2 5.8 4.6 ZNF470 "CZF-1, FLJ26175" ENSG00000197016 "Zinc finger protein 470" Q6ECI4 19 56567468-56588911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatogonia: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 11.0" "Low region specificity" "Detected in all" HPA029000 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA029000: AB_10603843" "unprognostic (1.40e-2)" "unprognostic (5.51e-2)" "unprognostic (5.91e-2)" "unprognostic (9.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.40e-2)" "unprognostic (7.11e-2)" "unprognostic (4.58e-2)" "unprognostic (6.91e-3)" "unprognostic (2.39e-2)" "unprognostic (3.45e-3)" "unprognostic (3.33e-3)" "unprognostic (3.89e-2)" "unprognostic (2.82e-2)" "unprognostic (4.68e-1)" "unprognostic (2.76e-3)" "unprognostic (2.88e-3)" 2.0 3.0 9.2 1.0 9.2 0.4 1.9 9.7 12.3 2.8 6.7 3.1 1.0 2.8 3.1 1.9 2.4 1.6 3.5 9.5 8.9 3.3 3.3 1.8 1.4 9.3 8.9 8.4 2.6 2.0 2.3 5.4 1.7 9.4 3.8 1.1 12.4 1.7 2.4 1.3 1.8 2.0 1.9 8.8 2.1 2.3 4.6 9.3 1.9 2.5 1.2 1.7 3.5 2.3 10.6 0.0 1.6 5.4 2.3 2.8 2.6 4.5 2.6 1.2 2.0 3.8 0.3 1.3 0.0 1.6 2.9 3.5 0.1 2.3 1.2 2.4 0.0 11.0 4.8 0.1 0.4 2.7 1.0 5.4 3.2 1.8 2.3 0.6 2.1 1.2 0.2 0.0 0.1 3.0 0.0 1.1 1.8 4.4 0.0 0.6 0.2 3.8 0.9 2.2 3.3 2.0 5.1 0.0 0.4 0.7 3.7 1.8 3.0 1.2 0.2 2.2 1.8 3.5 1.7 2.5 0.2 0.0 3.2 0.9 0.5 0.2 0.9 0.6 0.1 1.2 0.7 0.6 0.3 0.4 0.8 0.8 0.8 0.6 0.7 0.3 0.6 0.4 0.3 9.2 9.2 9.7 12.3 9.5 8.9 9.3 8.9 8.4 9.4 8.8 9.3 10.6 3.4 3.2 3.6 10.4 1.1 1.0 1.4 1.0 1.2 8.6 2.1 2.0 7.4 2.8 1.7 0.0 10.4 1.1 0.8 0.7 1.9 2.6 2.1 2.1 3.1 4.2 0.0 2.1 10.1 0.6 0.9 3.1 0.5 1.9 7.0 4.1 3.6 2.4 1.2 11.8 9.6 0.8 0.0 0.6 2.1 1.7 2.1 1.6 1.8 2.8 1.8 4.2 1.0 6.6 11.9 1.2 1.5 3.0 0.4 1.9 2.1 2.7 1.5 7.1 6.6 3.9 2.6 7.4 13.4 1.5 0.6 0.3 1.4 2.5 1.9 0.9 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421589-40425992 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 480.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA063323: AB_2684984" "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 18.0 9.4 7.8 7.3 6.9 29.0 10.8 8.1 11.5 8.8 7.9 12.1 6.8 11.4 2.1 19.0 15.4 12.8 19.7 8.1 11.3 14.5 14.2 22.5 5.9 7.8 7.1 6.4 6.9 15.2 4.4 9.0 6.7 7.7 11.1 3.0 0.9 8.5 4.2 15.2 14.3 10.9 7.1 7.4 10.1 18.9 3.8 9.0 5.6 11.7 13.3 3.5 11.1 12.0 7.9 18.5 21.4 3.0 7.4 8.3 5.9 8.0 29.0 8.7 15.4 15.1 9.5 14.6 3.6 13.4 9.8 4.4 7.4 2.4 26.2 4.7 10.1 5.1 3.2 5.0 8.3 9.4 1.1 11.0 9.6 15.8 16.8 3.1 7.4 8.7 3.1 6.8 5.6 14.1 27.7 1.7 5.6 2.3 13.2 14.2 2.2 4.8 9.3 8.2 12.8 0.9 1.4 15.3 14.0 14.5 3.4 14.0 3.1 16.2 15.2 17.2 12.3 19.8 8.1 3.6 4.8 21.3 4.8 7.2 22.5 21.9 15.0 9.7 19.8 5.8 13.3 9.5 9.3 26.1 12.7 10.9 7.8 17.5 15.9 19.4 23.8 14.2 13.6 7.8 6.9 8.1 11.5 8.1 11.3 7.8 7.1 6.4 7.7 7.4 9.0 7.9 480.2 73.7 52.3 2.3 138.2 126.2 196.5 83.4 243.6 5.0 221.4 299.7 83.2 32.9 51.5 31.3 0.0 46.0 203.8 246.0 23.5 62.6 1.4 100.0 72.1 156.1 106.1 6.1 1.1 61.7 72.8 159.7 169.7 126.7 132.9 27.9 86.7 12.8 53.9 3.3 0.6 152.3 46.8 28.9 98.3 4.2 16.4 102.6 94.3 4.7 30.0 17.9 6.2 1.5 0.8 91.6 300.8 10.9 69.7 130.9 158.9 18.5 31.7 2.4 39.5 292.5 201.5 1.7 5.4 174.7 130.4 130.2 150.4 24.2 102.0 111.9 ZNF100 ENSG00000197020 "Zinc finger protein 100" Q8IYN0 19 21722771-21767579 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.7;Late spermatids: 68.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 30.7" HPA059135 Uncertain NA NA "HPA059135: AB_2683918" "unprognostic (2.20e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-2)" "unprognostic (6.03e-3)" "unprognostic (2.67e-2)" "unprognostic (3.78e-2)" "unprognostic (1.64e-2)" "unprognostic (2.51e-2)" "unprognostic (7.02e-4)" "unprognostic (1.94e-3)" "unprognostic (9.27e-2)" "unprognostic (2.47e-3)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.84e-1)" "unprognostic (3.22e-2)" "prognostic favorable (5.47e-4)" 3.1 2.8 1.1 3.0 1.8 5.6 3.6 4.6 1.1 3.1 1.0 2.6 1.0 3.4 3.6 1.8 3.2 1.9 1.7 0.4 1.3 2.0 1.5 3.0 5.4 1.7 1.9 0.1 6.1 2.7 1.7 2.0 3.2 1.9 2.9 3.4 2.0 2.5 2.5 3.0 2.0 2.9 2.4 1.6 4.0 2.5 8.4 1.5 6.2 3.0 3.7 4.7 2.8 2.3 3.3 0.3 0.1 10.8 4.2 2.2 2.3 10.0 4.2 3.2 7.2 10.8 3.6 2.6 6.5 7.4 2.3 4.6 2.9 11.0 3.4 13.7 0.0 8.0 7.8 3.4 1.9 1.3 0.0 4.8 2.6 0.5 5.4 0.2 2.0 3.2 15.1 13.6 0.2 5.4 4.0 30.7 8.5 9.8 0.1 5.1 12.4 13.0 4.7 3.6 11.1 6.7 4.9 6.9 0.2 3.6 8.3 4.1 5.6 3.6 3.0 2.2 6.1 5.6 0.2 4.3 13.2 0.0 7.8 3.3 4.8 3.0 3.4 1.0 3.0 1.2 2.8 1.9 1.7 3.4 4.6 3.0 2.4 3.5 2.8 2.1 1.6 2.0 1.2 1.1 1.8 4.6 1.1 0.4 1.3 1.7 1.9 0.1 1.9 1.6 1.5 3.3 10.1 3.2 4.5 14.0 10.0 3.1 6.0 2.2 4.6 7.1 7.3 5.2 5.7 2.8 5.5 9.2 2.1 7.6 9.0 4.0 3.9 5.0 77.7 6.2 8.6 6.6 3.0 5.5 11.2 5.8 7.8 6.8 6.6 12.3 10.1 16.3 5.3 1.0 5.5 1.7 12.0 3.8 4.1 10.4 6.1 68.7 11.5 10.3 8.8 13.1 9.8 3.2 8.2 20.6 25.9 6.8 5.8 4.5 7.2 5.7 2.9 2.3 7.4 5.1 26.3 8.2 6.2 21.7 11.3 3.1 2.8 8.8 7.9 15.4 4.6 11.4 EOLA2 CXorf40B ENSG00000197021 "Endothelium and lymphocyte associated ASCH domain 2" Q96DE9 X 149929527-149938700 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 47.3;Extravillous trophoblasts: 21.8;Hofbauer cells: 12.5;Syncytiotrophoblasts: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA060897 Approved NA NA "HPA060897: AB_2684381" "unprognostic (5.44e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-1)" "unprognostic (8.49e-2)" "unprognostic (2.33e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-3)" "unprognostic (1.36e-1)" "unprognostic (5.35e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-2)" "unprognostic (7.57e-2)" "unprognostic (6.38e-2)" "unprognostic (5.94e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.14e-3)" 27.5 72.1 18.9 18.4 20.3 60.9 37.1 19.4 20.7 25.7 22.5 23.2 18.9 24.6 25.9 29.2 26.4 18.9 32.8 20.0 19.7 34.7 41.6 29.0 25.8 19.5 20.2 18.7 43.0 41.3 23.2 39.1 25.7 19.6 32.3 19.1 25.1 30.7 19.4 23.0 38.4 27.8 19.0 19.9 36.6 30.9 18.7 19.5 18.6 30.1 16.5 26.3 28.1 27.4 21.5 32.8 46.6 26.6 22.8 24.3 35.1 28.1 32.9 34.3 39.3 48.6 35.6 27.1 43.5 88.2 34.7 33.6 17.3 37.8 35.3 28.8 27.3 38.8 19.9 58.1 36.4 45.3 39.8 36.1 36.1 48.2 48.0 47.6 27.7 39.9 26.6 23.8 53.9 36.1 86.9 31.3 41.7 19.1 41.3 55.7 28.6 26.4 53.1 24.5 45.3 20.8 18.0 14.5 34.9 39.1 23.9 23.4 27.0 30.9 31.3 19.1 53.3 67.3 40.3 22.8 105.9 34.3 51.7 28.7 38.6 25.9 36.2 35.7 21.4 32.9 27.7 26.6 34.5 28.3 27.4 25.9 31.5 10.9 58.6 18.3 36.8 36.5 30.4 18.9 20.3 19.4 20.7 20.0 19.7 19.5 20.2 18.7 19.6 19.9 19.5 21.5 3.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 47.3 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 21.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 91.4 0.8 0.0 0.0 0.0 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149183042 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 32.3;Inhibitory neurons: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073151 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA073151: " "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 3.8 3.4 0.8 3.6 1.3 7.7 4.4 5.9 3.7 4.8 0.3 4.1 3.7 4.2 4.4 6.4 4.3 3.0 3.3 1.4 1.1 3.6 3.6 3.8 4.7 0.3 0.2 0.9 4.5 4.5 5.0 5.0 3.8 1.8 4.8 3.7 7.7 4.8 5.1 4.4 6.8 3.7 4.0 0.0 4.5 4.6 8.6 0.9 5.3 3.6 4.6 5.6 4.8 5.0 2.0 9.8 9.5 7.1 13.8 10.4 7.4 8.4 5.8 8.6 7.3 8.2 7.9 5.0 12.5 6.8 10.6 6.5 8.0 12.0 8.2 5.3 7.3 14.4 8.3 7.2 5.3 7.3 9.8 8.1 8.3 12.1 8.2 8.4 5.4 5.2 4.9 11.9 4.7 8.3 13.9 13.6 10.3 47.1 9.4 8.9 10.3 7.9 9.1 5.7 19.0 9.8 10.9 9.2 11.2 5.7 7.7 6.8 10.6 6.2 7.4 1.9 13.3 7.6 12.7 6.6 9.6 9.6 8.0 7.4 2.4 0.6 2.3 1.1 0.7 1.4 1.0 0.8 1.2 0.5 0.8 1.2 1.3 1.2 0.7 0.6 0.7 1.1 0.4 0.8 1.3 5.9 3.7 1.4 1.1 0.3 0.2 0.9 1.8 0.0 0.9 2.0 3.9 6.4 4.6 19.2 6.6 7.8 4.5 4.0 5.7 8.8 5.6 3.7 5.9 0.0 5.5 5.5 6.2 4.2 7.7 4.4 0.0 3.9 23.5 7.0 8.6 5.9 1.8 8.6 32.3 2.8 4.9 5.1 12.2 7.5 4.5 7.1 3.9 2.8 3.7 3.3 31.3 3.7 2.0 5.0 3.3 25.2 7.2 3.9 8.8 21.5 4.8 4.5 3.1 20.6 28.6 4.6 2.1 9.1 10.9 6.6 3.8 3.1 6.9 11.6 0.0 6.4 4.5 21.4 13.5 10.1 8.5 3.1 5.2 4.7 3.8 9.9 ZSCAN25 "FLJ32468, ZNF498" ENSG00000197037 "Zinc finger and SCAN domain containing 25" Q6NSZ9 7 99616946-99632408 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 34.6;Excitatory neurons: 48.1;Inhibitory neurons: 44.9;Microglial cells: 32.8;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055127, HPA057173" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA055127: AB_2682706, HPA057173: AB_2683360" "unprognostic (2.21e-3)" "unprognostic (3.96e-2)" "unprognostic (4.45e-1)" "unprognostic (3.92e-2)" "unprognostic (5.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (1.57e-3)" "unprognostic (3.97e-2)" "unprognostic (8.44e-2)" "unprognostic (3.82e-3)" "unprognostic (9.98e-2)" "unprognostic (1.10e-2)" "unprognostic (5.21e-2)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (7.19e-3)" 4.0 4.0 2.7 4.8 2.6 6.5 5.0 3.3 3.1 4.7 2.9 4.3 3.3 5.1 2.3 4.8 5.1 3.3 2.9 2.6 2.6 4.0 3.3 3.8 6.1 2.8 2.4 2.4 7.8 4.5 5.8 3.1 4.1 2.6 4.8 3.6 2.7 4.5 5.5 4.5 5.9 4.1 4.8 2.3 5.1 4.0 5.3 2.7 9.6 4.6 4.0 5.4 4.4 4.3 3.1 7.6 3.5 10.0 11.5 4.3 3.3 9.8 8.2 6.9 9.3 9.6 9.3 6.1 10.6 9.3 6.9 8.5 9.7 11.0 9.5 11.5 6.1 9.4 7.1 5.8 8.1 7.4 16.6 6.3 5.2 11.7 7.4 7.7 3.7 6.0 11.7 20.4 8.3 6.6 8.4 24.0 23.4 18.4 4.2 8.3 10.0 10.3 11.4 4.0 10.3 6.8 16.8 10.8 16.2 11.7 11.8 4.5 11.2 4.3 14.4 11.6 8.3 14.0 7.4 12.8 18.2 7.8 10.2 21.6 3.5 2.4 3.2 4.3 2.6 5.3 1.9 3.0 4.2 1.9 1.6 5.0 5.1 2.9 2.8 2.4 1.6 4.7 3.3 2.7 2.6 3.3 3.1 2.6 2.6 2.8 2.4 2.4 2.6 2.3 2.7 3.1 3.9 0.0 6.2 34.6 4.6 3.4 1.8 2.6 2.8 4.9 4.0 4.4 4.2 2.8 1.5 1.8 8.4 4.3 5.1 5.2 1.9 2.9 5.2 2.3 4.6 3.9 2.4 5.5 48.1 2.8 3.4 3.3 3.6 3.5 5.1 4.5 4.2 3.6 3.6 5.0 44.9 4.4 6.1 6.0 1.4 2.7 3.7 2.0 1.8 32.8 3.9 2.3 4.1 47.7 44.4 2.1 3.1 6.0 5.5 3.0 3.7 2.4 2.5 4.7 6.6 4.0 3.9 10.0 7.6 4.0 2.3 1.9 6.2 4.7 3.7 1.7 ANXA6 ANX6 ENSG00000197043 "Annexin A6" P08133 5 151100706-151157785 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 343.8;monocytes: 445.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 861.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002462, CAB005077, HPA009650, HPA009977" Enhanced Approved Cytosol NA NA 1800000 Cytosol "CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: " "unprognostic (1.74e-1)" "unprognostic (5.85e-2)" "unprognostic (1.03e-1)" "unprognostic (5.81e-2)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (9.63e-2)" "unprognostic (1.60e-2)" "unprognostic (1.08e-3)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.31e-5)" "unprognostic (6.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (1.38e-3)" 295.6 136.5 100.8 165.7 112.9 110.7 189.9 105.1 157.4 148.3 151.4 157.6 44.9 183.1 105.9 95.5 151.3 109.7 190.5 112.4 119.0 81.9 216.2 132.7 163.1 145.4 119.9 107.2 183.4 78.9 29.9 163.1 142.3 157.5 126.0 79.0 134.7 70.9 210.6 334.5 56.5 120.9 302.7 100.3 152.1 112.4 53.0 137.5 162.3 87.4 374.8 177.9 208.2 108.3 177.8 3.0 30.4 212.8 317.1 861.2 417.8 55.1 397.4 526.4 323.5 477.6 106.7 15.6 26.9 138.5 578.6 268.1 0.5 165.9 200.2 300.3 110.5 52.1 15.3 62.1 204.7 295.0 97.6 94.7 508.6 1.5 282.3 42.0 476.9 420.6 197.5 22.0 396.1 737.6 100.4 181.8 151.7 56.2 1.2 92.4 120.4 592.9 31.0 42.2 0.3 12.2 49.3 39.9 282.7 175.6 308.4 488.3 201.1 326.8 296.6 84.2 19.4 107.1 205.4 289.5 4.5 154.5 459.7 46.2 89.7 89.4 82.9 290.4 54.7 190.4 175.4 213.4 263.3 118.3 179.0 145.8 181.6 17.6 261.9 25.0 30.2 190.9 331.7 100.8 112.9 105.1 157.4 112.4 119.0 145.4 119.9 107.2 157.5 100.3 137.5 177.8 90.3 16.0 17.3 19.2 146.8 11.0 11.5 2.2 1.8 16.5 30.7 24.0 59.5 12.8 1.1 23.9 6.2 64.3 110.3 0.3 25.4 6.5 56.9 1.8 38.5 45.6 21.4 36.4 36.5 17.8 33.7 105.9 9.2 1.7 57.5 343.8 57.1 147.1 85.4 15.2 36.3 2.4 0.0 41.0 77.8 46.8 123.3 41.2 55.2 10.3 445.2 45.6 187.4 18.6 5.6 12.1 1.2 211.4 120.3 7.3 1.0 48.4 4.7 125.8 230.1 55.3 150.6 2.5 1.5 0.6 8.1 177.2 143.4 149.4 2.5 1.5 ZNF441 FLJ38637 ENSG00000197044 "Zinc finger protein 441" Q8N8Z8 19 11767000-11784078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 19.0;Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA063338 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA063338: AB_2684989" "unprognostic (1.97e-1)" "unprognostic (1.96e-1)" "unprognostic (2.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (6.42e-4)" "unprognostic (2.60e-2)" "unprognostic (1.92e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-2)" "unprognostic (1.33e-3)" "unprognostic (1.80e-1)" "unprognostic (1.75e-1)" "unprognostic (1.68e-2)" "unprognostic (2.70e-3)" 2.9 2.9 3.4 3.1 4.0 0.9 6.0 6.9 4.0 3.4 2.4 3.1 2.3 4.6 6.1 1.7 3.9 2.1 3.9 3.7 3.4 6.5 4.4 3.5 4.9 3.0 3.4 3.3 6.4 3.5 7.2 7.1 3.2 4.0 4.5 3.2 7.2 3.8 5.0 3.6 3.2 4.2 3.2 2.9 4.7 3.3 2.7 3.1 3.7 7.1 2.7 4.5 4.0 2.5 4.0 2.1 0.0 2.5 2.1 3.0 3.2 2.7 5.0 2.8 3.7 3.6 2.3 0.7 4.4 2.6 3.2 1.8 1.5 1.6 3.0 4.2 0.0 1.8 2.0 1.7 3.7 2.7 0.0 3.6 3.9 3.3 2.6 2.0 2.5 2.1 1.8 3.3 0.0 5.8 0.0 4.7 1.3 0.4 0.9 3.6 1.7 5.0 1.3 3.0 3.4 1.9 3.0 3.3 1.0 1.8 2.4 3.3 4.5 1.0 8.0 1.9 7.0 3.4 4.4 6.9 1.9 0.4 0.0 3.2 0.0 0.3 0.8 1.0 0.3 0.7 1.4 1.1 1.5 0.6 1.6 1.4 1.6 0.5 0.9 1.6 0.4 0.8 0.6 3.4 4.0 6.9 4.0 3.7 3.4 3.0 3.4 3.3 4.0 2.9 3.1 4.0 5.6 16.0 8.7 8.5 9.5 0.4 0.8 1.2 0.6 11.7 2.7 2.3 14.5 0.0 4.5 11.0 14.6 2.1 5.1 1.9 3.9 1.7 0.2 2.5 3.8 5.3 0.0 1.7 12.3 1.2 0.6 3.6 1.1 1.8 2.5 6.4 3.6 1.9 0.8 6.7 9.5 1.6 2.0 0.8 1.2 0.8 2.5 2.2 3.6 2.8 1.8 7.0 8.2 4.0 4.2 1.1 1.5 7.2 1.9 0.9 1.5 3.0 0.9 19.0 19.7 6.7 6.2 7.6 6.0 1.4 0.0 0.8 3.4 4.9 0.8 0.4 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489026 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 240000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 25.4 22.0 77.3 23.7 79.0 29.0 26.3 75.4 80.7 18.7 53.3 35.4 33.8 19.5 14.1 16.0 14.3 16.6 17.4 73.8 83.8 33.9 26.1 24.5 25.5 85.7 77.6 65.8 16.2 12.9 20.3 12.4 26.7 82.0 15.0 35.5 18.6 10.8 13.0 7.1 13.8 29.7 18.3 98.1 18.6 19.2 11.2 84.8 16.3 22.1 10.3 24.6 22.5 11.5 102.5 92.7 36.9 71.8 53.2 75.8 94.5 53.9 93.2 67.9 66.2 82.1 42.6 79.4 85.2 42.4 92.0 39.5 33.4 73.7 64.0 104.4 30.9 25.4 42.5 37.4 39.9 64.7 59.9 35.5 72.0 58.8 57.1 56.0 67.9 60.8 38.4 31.4 28.8 106.1 45.7 36.8 22.9 46.4 52.1 38.9 36.9 84.7 24.4 84.4 86.3 42.4 65.5 64.6 54.4 71.4 59.0 59.8 46.4 48.1 94.9 71.9 48.7 58.4 10.4 19.4 52.0 80.0 36.3 61.5 6.8 10.2 9.1 5.0 13.3 7.0 6.6 5.9 5.1 12.6 7.8 6.2 6.6 16.1 8.0 14.0 4.4 8.5 6.2 77.3 79.0 75.4 80.7 73.8 83.8 85.7 77.6 65.8 82.0 98.1 84.8 102.5 23.3 25.6 16.2 8.1 39.3 59.9 50.2 33.6 48.9 18.4 28.0 18.0 17.3 20.0 22.6 25.8 4.2 39.3 33.7 61.8 21.5 38.7 27.3 21.5 29.5 22.2 29.9 14.5 16.8 23.3 84.5 35.1 23.9 36.1 21.6 25.4 16.8 24.5 45.4 21.9 13.6 33.6 26.4 34.6 36.4 7.5 20.2 43.0 46.2 8.4 37.8 25.7 25.7 14.1 16.5 37.3 32.1 15.8 16.9 56.0 26.0 60.5 16.4 15.4 13.1 77.0 54.5 16.0 11.4 33.5 43.8 58.3 26.2 18.8 36.2 56.2 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825675-45844094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 1.7;intestine: 3.0;urinary bladder: 1.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.6;Hofbauer cells: 10.1;Macrophages: 3.7;Pancreatic endocrine cells: 3.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.0;myeloid DC: 1.0" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;monocytes: 3.0" "Cell line enriched" "Detected in some" 5 "U-87 MG: 124.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053509 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.14e-5)" 0.0 0.4 0.1 0.3 0.3 0.0 1.7 0.5 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.0 0.0 0.2 0.1 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.0 1.0 1.3 0.0 0.0 0.2 0.0 0.0 0.6 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 10.9 2.1 0.3 0.0 22.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 5.5 0.0 0.1 1.3 0.0 0.0 0.0 124.2 2.9 0.2 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.3 0.5 0.6 0.3 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.0 1.0 3.6 0.9 0.8 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.5 0.4 0.2 1.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.7 0.0 0.0 2.2 0.4 10.1 1.7 0.1 0.2 0.0 1.6 2.5 0.0 0.0 3.7 0.0 0.0 1.6 0.0 1.0 0.0 0.0 3.5 0.1 0.0 0.0 1.1 1.2 0.1 0.0 1.0 0.0 1.5 0.4 1.2 0.1 0.0 0.3 0.0 0.3 0.0 0.1 2.8 ZNF420 FLJ32191 ENSG00000197050 "Zinc finger protein 420" Q8TAQ5 19 37007857-37130368 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059675 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059675: AB_2684101" "unprognostic (1.00e-2)" "unprognostic (5.00e-2)" "unprognostic (2.30e-2)" "unprognostic (5.40e-3)" "prognostic favorable (3.57e-5)" "unprognostic (7.94e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.14e-3)" "unprognostic (1.64e-1)" "unprognostic (5.24e-2)" "unprognostic (7.59e-2)" "prognostic favorable (1.83e-4)" "unprognostic (2.42e-1)" "unprognostic (7.23e-2)" "unprognostic (7.35e-3)" "unprognostic (1.63e-2)" 3.0 4.2 5.0 2.5 5.3 1.6 5.6 6.9 6.2 5.1 5.1 3.3 2.5 4.6 3.9 3.0 5.2 2.7 3.3 5.0 5.1 4.2 3.3 2.8 4.3 4.7 5.1 4.7 8.1 3.2 6.4 3.4 3.3 5.7 4.3 2.5 7.4 3.4 4.1 5.5 3.5 2.8 4.2 5.0 4.5 3.1 9.9 5.4 5.8 6.7 6.6 4.7 3.4 3.3 5.6 0.0 6.8 6.4 6.7 5.8 3.8 3.2 4.2 4.1 4.7 7.1 1.5 1.4 3.3 8.1 2.9 2.9 1.2 6.6 2.1 5.5 10.8 5.0 7.5 3.6 2.8 6.0 6.3 3.2 4.0 4.5 5.1 3.5 5.4 2.7 5.6 4.1 0.3 5.5 2.3 10.7 2.4 7.4 2.7 4.1 6.1 12.9 6.8 2.7 4.5 8.7 9.7 6.1 2.5 3.4 4.5 4.0 4.9 3.1 5.0 7.7 4.6 4.9 9.9 12.9 8.2 0.0 1.3 4.4 2.1 2.9 6.8 9.9 4.0 10.6 9.8 11.0 10.4 5.6 13.7 11.1 12.3 0.5 12.3 4.3 3.0 14.3 5.9 5.0 5.3 6.9 6.2 5.0 5.1 4.7 5.1 4.7 5.7 5.0 5.4 5.6 7.1 12.8 8.6 11.1 11.0 9.9 3.3 4.0 7.4 18.7 7.4 6.3 6.1 4.3 6.6 3.7 0.0 9.2 6.2 2.1 7.9 4.1 31.4 4.6 4.1 6.7 6.0 4.2 32.8 1.3 4.1 7.0 0.5 2.9 12.7 15.3 10.0 4.2 4.2 16.8 24.2 2.8 8.2 3.8 2.3 34.5 9.6 3.5 7.2 26.2 2.8 5.9 12.3 28.1 26.4 1.9 2.9 9.4 5.9 4.2 2.7 5.3 10.7 9.0 26.3 10.5 6.5 15.5 7.4 6.4 8.7 4.0 10.4 6.6 4.3 2.6 ZNF763 ZNF440L ENSG00000197054 "Zinc finger protein 763" Q0D2J5 19 11965037-11980617 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 10.4;Microglial cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 5.2" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (4.09e-3)" "unprognostic (6.15e-4)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.43e-4)" "unprognostic (1.43e-1)" "unprognostic (8.26e-3)" "unprognostic (9.36e-3)" "unprognostic (1.93e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (6.07e-6)" "unprognostic (1.47e-1)" "unprognostic (3.08e-1)" "unprognostic (1.11e-1)" "unprognostic (8.89e-3)" 3.3 3.1 2.4 2.2 3.0 1.9 4.4 3.1 3.0 3.2 2.1 3.1 2.3 3.6 2.9 2.0 3.6 1.8 4.0 2.3 2.3 4.3 2.4 2.9 3.7 3.0 2.6 2.2 6.1 4.6 4.9 2.9 3.1 2.9 3.6 3.0 7.0 3.3 2.4 2.0 2.8 4.4 2.2 2.2 5.3 3.6 4.8 2.5 4.4 4.9 1.6 3.4 3.5 2.8 4.0 0.2 0.0 1.7 1.8 1.0 0.3 5.2 1.6 1.0 1.2 0.9 0.5 0.3 1.5 1.2 1.2 0.4 0.5 0.0 0.7 0.4 0.3 0.0 0.7 0.1 0.1 0.2 0.9 1.8 2.5 1.1 0.3 0.1 0.4 0.2 2.4 0.3 0.6 0.8 0.1 2.0 0.5 0.5 0.1 0.2 0.1 0.0 0.6 2.4 1.6 0.3 0.5 0.1 0.1 0.3 3.0 3.1 0.7 0.2 1.7 0.1 1.3 0.3 2.3 3.3 0.5 0.4 0.4 0.3 8.5 1.4 4.4 2.2 1.9 1.7 2.2 2.0 3.1 2.5 7.6 2.2 2.6 7.4 3.8 4.1 1.9 1.2 1.6 2.4 3.0 3.1 3.0 2.3 2.3 3.0 2.6 2.2 2.9 2.2 2.5 4.0 1.1 3.2 4.8 6.2 2.1 0.1 0.4 0.4 2.2 2.5 1.1 0.6 1.1 0.0 2.7 0.0 10.4 5.7 2.1 0.6 1.9 0.9 5.3 0.7 0.6 0.7 1.2 0.0 4.9 0.4 1.7 1.4 1.1 0.7 1.3 4.3 0.4 0.7 1.4 0.0 4.0 1.9 0.0 1.9 0.2 0.8 1.5 1.2 0.0 7.5 1.1 3.3 3.1 4.0 6.0 0.5 0.5 1.9 0.1 0.3 2.1 1.6 1.9 6.6 0.0 0.9 0.8 4.0 1.6 0.6 0.0 1.8 0.9 1.3 0.9 0.2 ZMYM1 "FLJ23151, MYM" ENSG00000197056 "Zinc finger MYM-type containing 1" Q5SVZ6 1 35032172-35115859 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064019 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA064019: AB_2685178" "unprognostic (7.82e-2)" "unprognostic (1.80e-2)" "unprognostic (5.72e-2)" "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.21e-6)" "unprognostic (2.18e-1)" "unprognostic (9.85e-3)" "unprognostic (5.51e-2)" "unprognostic (3.03e-3)" "unprognostic (1.72e-2)" "unprognostic (2.85e-3)" "unprognostic (1.01e-2)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.73e-1)" 2.8 2.0 1.6 2.1 1.8 1.0 4.5 2.2 1.7 3.6 2.7 2.7 2.4 3.3 4.4 2.7 2.7 2.0 1.3 1.3 1.7 2.8 2.2 2.3 3.4 1.8 1.9 1.1 4.9 1.7 2.8 0.7 3.5 1.7 3.0 2.8 3.7 2.9 2.8 1.6 4.3 2.9 2.8 1.7 3.5 2.7 4.0 1.6 4.1 4.0 2.8 2.8 1.9 1.6 2.4 11.8 6.2 9.6 8.6 9.8 11.3 5.5 10.5 7.9 8.9 9.7 6.4 13.0 7.6 4.4 5.9 5.0 11.9 9.0 8.3 15.9 2.0 3.6 7.9 5.7 5.7 6.0 6.0 3.7 8.4 7.1 14.1 13.2 7.0 13.8 7.4 7.3 3.2 10.2 5.8 7.9 2.7 14.6 4.6 5.4 5.1 10.1 0.0 4.7 6.8 4.7 6.1 9.9 7.7 9.7 13.0 6.7 3.7 7.3 7.4 8.9 5.9 10.9 0.2 0.6 1.2 4.3 4.1 6.4 5.6 0.7 1.1 1.8 1.1 2.0 1.0 1.5 1.3 1.0 0.8 1.3 1.5 0.6 3.1 2.7 1.1 1.4 0.7 1.6 1.8 2.2 1.7 1.3 1.7 1.8 1.9 1.1 1.7 1.7 1.6 2.4 16.4 12.8 8.9 16.6 9.2 1.7 10.3 11.2 19.9 8.1 6.7 10.4 4.8 2.8 7.4 14.7 0.0 6.5 9.5 1.8 9.8 6.0 7.0 8.9 16.1 10.3 1.8 11.6 7.1 3.5 6.1 11.4 3.6 6.2 6.3 17.9 5.0 3.6 4.4 11.8 10.8 3.5 4.1 5.8 1.4 5.7 7.5 7.6 1.8 17.8 6.2 6.6 9.2 11.1 19.9 3.8 0.8 7.9 6.6 9.6 3.7 6.0 8.6 4.2 13.1 12.4 9.9 24.7 12.4 12.2 1.4 3.7 10.1 14.7 4.5 7.5 DTHD1 FLJ16686 ENSG00000197057 "Death domain containing 1" Q6ZMT9 4 36281616-36347511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;fallopian tube: 13.9" "Cell type enhanced" "Detected in some" "dendritic cells: 37.9;Early spermatids: 87.2;Endometrial ciliated cells: 109.2;NK-cells: 53.5;Respiratory ciliated cells: 199.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (9.79e-6)" "unprognostic (4.04e-2)" "unprognostic (1.15e-2)" "unprognostic (5.54e-3)" "unprognostic (2.85e-1)" "unprognostic (5.45e-5)" "unprognostic (5.12e-3)" "unprognostic (9.11e-2)" "unprognostic (1.82e-2)" "unprognostic (7.59e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.05e-5)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.65e-2)" "unprognostic (7.12e-3)" 0.2 0.1 12.1 1.2 2.1 0.5 0.1 2.9 1.2 0.5 1.3 0.1 0.4 0.6 0.2 0.3 13.9 0.6 0.1 1.4 3.8 0.0 0.3 3.5 4.0 10.2 6.9 0.1 0.0 0.1 0.0 0.0 0.0 5.9 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.5 0.1 14.8 2.2 0.5 1.2 3.5 0.3 0.2 0.0 1.3 0.3 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.3 1.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.4 12.1 2.1 2.9 1.2 1.4 3.8 10.2 6.9 0.1 5.9 14.8 3.5 5.2 0.4 3.2 4.1 0.7 1.4 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 0.0 24.2 0.0 0.0 0.0 37.9 0.0 0.0 0.1 87.2 109.2 0.6 0.1 0.0 0.8 0.2 0.0 0.0 0.4 3.1 1.7 1.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 8.2 0.8 0.0 24.1 0.3 1.2 0.0 1.9 0.1 0.0 53.5 0.0 2.9 0.1 0.0 0.0 12.4 0.1 0.0 0.2 199.1 0.0 0.0 0.5 0.9 1.8 0.3 0.5 0.1 0.0 27.4 0.0 0.0 0.1 H4C3 "dJ221C16.1, H4/g, H4FG, HIST1H4C" ENSG00000197061 "H4 clustered histone 3" P62805 6 26103933-26104337 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "brain: 243.9" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 200.9;Cytotrophoblasts: 584.5;Extravillous trophoblasts: 700.1;Hofbauer cells: 264.1;Syncytiotrophoblasts: 220.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 12.8" "Region enriched" "Detected in all" 4 "cerebellum: 243.9" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 39.5;PC-3: 21.4" HPA042201 Supported NA Yes 25000000 "HPA042201: AB_2677898" "unprognostic (1.28e-1)" "unprognostic (5.91e-4)" "unprognostic (6.95e-2)" "unprognostic (8.93e-3)" "unprognostic (5.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (4.31e-3)" "unprognostic (3.79e-1)" "unprognostic (1.01e-2)" "unprognostic (2.30e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (5.74e-6)" "unprognostic (2.42e-2)" "unprognostic (3.02e-1)" "unprognostic (2.82e-1)" "unprognostic (2.79e-3)" 0.2 0.2 27.5 0.9 55.1 5.0 0.2 243.9 34.5 0.4 1.6 1.0 0.3 0.6 0.0 0.7 0.5 0.1 0.1 22.5 39.6 0.6 0.6 0.2 2.1 30.7 41.5 18.0 0.4 0.4 0.1 0.2 0.4 43.1 0.2 1.1 0.5 1.8 0.3 0.1 0.3 0.5 0.0 26.0 1.0 0.4 0.6 39.1 3.7 1.2 0.0 1.7 0.8 0.1 41.1 2.3 2.1 0.8 3.3 0.0 0.4 0.0 1.3 1.0 0.7 1.6 3.3 0.6 0.8 1.0 0.4 0.9 1.2 2.5 0.7 0.6 1.9 39.5 1.5 4.5 5.0 1.0 1.8 1.3 1.7 0.0 0.5 0.0 0.0 0.9 0.6 2.3 1.6 0.6 1.1 8.9 4.4 2.1 1.5 21.4 2.5 1.2 3.7 1.4 0.2 2.2 1.4 1.1 1.5 0.9 0.9 1.0 5.4 0.6 2.3 2.4 1.1 1.9 3.1 3.2 4.4 1.4 3.3 1.2 605.5 279.8 218.0 343.5 117.8 331.0 645.7 432.0 285.4 218.9 559.1 496.9 378.6 509.7 325.0 128.7 317.6 322.8 2335.9 27.5 55.1 243.9 34.5 22.5 39.6 30.7 41.5 18.0 43.1 26.0 39.1 41.1 25.3 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 200.9 0.0 0.0 0.0 0.0 584.5 76.4 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.0 0.0 700.1 54.9 0.0 0.0 0.0 0.0 0.0 0.0 264.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 220.3 13.0 0.0 0.0 0.0 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267058-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 9.9 11.2 19.5 10.4 20.1 6.8 15.2 25.3 23.2 19.5 15.7 13.7 9.0 19.1 13.6 9.7 14.4 12.9 12.8 20.4 19.6 11.4 10.0 10.4 11.1 19.9 19.9 19.5 30.5 12.0 14.1 16.5 9.4 20.8 17.2 10.1 26.9 10.3 18.3 12.0 9.9 11.7 16.4 17.6 17.6 10.9 7.9 19.2 11.5 14.5 10.5 12.3 13.8 12.3 23.5 8.1 6.6 18.8 16.2 19.0 18.5 4.2 16.2 15.0 19.9 19.8 4.9 5.7 4.6 22.9 10.1 15.1 5.7 8.6 11.3 21.5 9.8 9.6 12.2 10.6 9.9 13.2 10.1 7.1 15.5 10.7 15.4 14.0 25.8 20.5 7.0 10.2 9.2 16.0 6.7 10.9 13.3 5.6 4.3 10.5 10.7 16.1 7.8 17.2 7.9 13.6 10.3 9.6 4.0 13.2 15.2 6.5 6.9 13.7 16.3 11.7 5.8 19.2 9.9 14.5 8.7 5.8 11.0 14.3 17.9 7.9 14.0 16.1 6.4 19.0 16.3 16.0 17.6 12.5 19.9 19.4 16.0 5.8 22.5 5.5 6.0 15.6 12.5 19.5 20.1 25.3 23.2 20.4 19.6 19.9 19.9 19.5 20.8 17.6 19.2 23.5 8.8 0.0 5.6 15.3 9.2 0.0 2.7 0.0 4.0 8.9 4.7 8.3 10.4 2.8 6.2 0.0 4.2 4.9 9.2 1.8 3.9 5.6 5.9 3.8 7.8 7.0 6.7 7.8 23.5 5.0 2.8 8.1 2.0 3.1 6.3 11.1 4.6 1.8 5.9 1.7 26.1 2.6 0.0 5.1 0.0 2.5 9.0 4.3 0.0 8.4 2.3 12.8 14.4 30.7 28.8 3.6 4.0 13.2 3.5 2.2 4.9 4.6 1.5 9.6 19.7 7.7 7.5 7.5 8.7 2.9 0.0 1.4 7.2 8.1 3.4 0.8 MAFG "MGC13090, MGC20149" ENSG00000197063 "MAF bZIP transcription factor G" O15525 17 81918270-81927735 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 12.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025573 Approved NA NA "CAB025573: " "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (3.00e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (9.77e-3)" "unprognostic (1.27e-1)" "unprognostic (8.05e-2)" "unprognostic (5.97e-3)" "unprognostic (4.91e-2)" "unprognostic (7.46e-2)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-2)" "unprognostic (4.54e-3)" 11.9 13.0 26.0 9.9 22.9 41.0 9.7 18.4 22.2 10.7 13.8 16.4 11.2 15.4 5.1 19.3 13.5 10.8 17.9 24.9 23.2 13.0 11.1 22.3 8.0 26.3 27.4 24.5 14.1 10.1 13.8 13.1 8.3 28.1 11.7 6.9 4.9 10.5 9.6 45.3 11.6 15.0 10.9 24.6 15.6 15.3 14.1 27.3 7.1 14.7 19.8 6.8 18.4 11.5 26.9 18.2 61.2 13.0 12.9 22.5 17.1 23.1 20.6 21.8 17.2 15.9 20.1 30.7 8.1 20.6 16.0 52.4 21.1 13.9 9.7 11.4 14.3 18.5 37.1 85.5 25.8 33.9 33.4 61.8 14.1 20.7 24.1 22.2 26.9 21.2 16.9 49.9 38.8 17.3 8.0 15.9 37.4 15.6 37.7 21.2 19.9 20.6 15.0 7.6 18.7 22.4 26.7 15.1 18.9 47.1 21.8 8.0 91.0 26.3 37.6 29.9 32.1 27.7 27.2 18.2 12.7 31.0 35.7 49.8 12.2 2.8 1.5 0.2 0.9 0.4 0.7 0.3 0.0 2.3 0.4 0.2 0.3 3.2 0.3 1.1 1.7 0.3 1.2 26.0 22.9 18.4 22.2 24.9 23.2 26.3 27.4 24.5 28.1 24.6 27.3 26.9 33.4 22.4 9.8 19.2 19.8 74.4 108.5 12.6 27.3 29.4 63.0 33.8 18.0 32.9 12.4 11.0 22.9 8.8 12.0 52.5 5.9 17.3 88.0 41.1 23.1 53.8 45.2 49.9 14.6 19.8 13.9 47.8 36.2 74.3 18.4 22.0 30.0 16.7 26.5 43.7 14.5 22.3 12.2 50.8 90.1 97.6 24.5 55.2 33.8 12.2 29.1 24.0 2.1 11.1 9.5 29.4 37.6 19.9 11.8 116.6 37.6 12.4 16.6 28.2 13.1 37.2 41.6 8.7 14.1 38.8 89.4 35.3 19.0 12.4 32.4 132.8 ARRDC1 MGC40555 ENSG00000197070 "Arrestin domain containing 1" Q8N5I2 9 137605685-137615360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 204.5;T-47d: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044345 Uncertain NA NA "HPA044345: AB_10965181" "unprognostic (3.25e-2)" "unprognostic (1.41e-2)" "unprognostic (6.03e-3)" "unprognostic (4.32e-3)" "unprognostic (8.21e-2)" "unprognostic (8.01e-2)" "unprognostic (7.95e-2)" "unprognostic (2.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.26e-1)" "unprognostic (3.55e-1)" "unprognostic (5.52e-2)" "prognostic favorable (3.59e-4)" "unprognostic (5.01e-3)" "unprognostic (1.51e-1)" "unprognostic (8.70e-2)" "unprognostic (1.11e-3)" 19.2 25.4 6.9 9.1 7.0 23.5 28.5 5.6 15.2 22.7 9.1 27.2 22.9 13.2 3.2 60.9 21.7 4.7 21.3 7.5 6.8 35.8 43.3 35.6 11.1 7.4 6.6 6.4 10.4 43.3 9.5 31.0 7.9 7.4 43.8 5.4 3.1 52.4 11.3 13.7 35.5 44.1 2.5 6.1 55.1 54.2 21.2 6.9 8.4 32.0 4.0 5.0 23.8 36.2 7.0 39.4 25.4 2.4 8.3 3.9 4.2 38.7 10.2 8.8 5.5 4.2 21.4 53.1 9.5 25.7 7.2 10.5 79.5 2.8 32.9 0.9 8.9 15.6 6.4 23.1 19.4 9.3 11.2 15.4 1.7 49.2 4.9 20.4 7.4 7.9 14.7 13.8 5.6 2.4 204.5 13.6 72.0 5.1 43.9 31.6 16.3 4.2 43.1 20.4 29.2 10.3 7.8 7.1 83.0 11.4 2.5 89.9 26.5 18.8 3.2 4.7 21.8 8.8 11.1 9.0 8.3 8.5 24.9 3.7 108.7 99.2 214.7 35.7 132.5 26.4 23.3 32.7 32.8 121.8 39.9 28.9 28.4 92.9 28.3 122.3 46.1 49.7 56.1 6.9 7.0 5.6 15.2 7.5 6.8 7.4 6.6 6.4 7.4 6.1 6.9 7.0 39.4 19.2 22.3 11.1 29.2 17.0 58.5 78.0 29.0 7.2 52.5 35.3 5.4 45.8 67.1 58.8 62.6 85.4 43.1 71.7 37.2 50.2 12.1 30.9 8.2 22.5 17.4 11.1 10.6 46.0 41.8 10.1 85.6 32.9 18.4 22.1 23.2 23.7 48.1 3.3 6.1 56.1 57.0 54.0 29.8 14.8 10.8 41.3 7.2 16.9 57.0 10.7 46.4 2.5 3.5 69.1 72.8 10.5 20.6 58.6 81.6 27.4 53.9 46.0 0.0 4.1 13.7 21.3 13.7 33.7 21.3 73.3 38.8 6.7 47.1 69.0 KIAA1671 ENSG00000197077 KIAA1671 Q9BY89 22 24952730-25197448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 74.4;Excitatory neurons: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "OE19: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018135 Approved Approved Microtubules NA NA Microtubules "HPA018135: AB_1859551" "unprognostic (1.67e-1)" "unprognostic (1.65e-3)" "unprognostic (1.14e-2)" "unprognostic (1.46e-2)" "unprognostic (7.34e-2)" "unprognostic (3.52e-2)" "unprognostic (8.71e-3)" "unprognostic (1.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (2.66e-2)" "unprognostic (7.68e-2)" "prognostic favorable (3.19e-6)" "unprognostic (6.72e-2)" "unprognostic (1.14e-1)" "unprognostic (7.54e-2)" "unprognostic (7.87e-2)" 9.3 13.9 12.2 5.2 12.2 0.8 22.7 3.9 18.3 10.3 9.8 16.2 14.5 6.7 5.2 26.1 20.2 14.9 11.4 19.5 13.8 11.1 34.4 12.4 5.5 7.3 8.3 9.0 8.5 10.1 10.3 11.3 4.1 6.1 13.3 14.4 15.7 26.1 15.6 25.3 28.2 16.9 6.9 5.5 3.8 12.5 4.9 10.6 15.8 26.9 22.3 8.9 9.0 18.9 6.6 25.2 15.7 3.3 5.9 0.1 0.1 2.6 0.1 0.1 1.4 0.1 12.6 9.0 0.1 11.7 1.1 6.9 29.8 25.5 25.2 1.0 0.2 10.6 0.1 16.7 16.9 3.3 0.1 1.3 0.6 22.4 7.9 24.3 16.6 28.9 0.5 0.3 0.1 3.4 11.6 0.1 0.1 5.2 39.9 8.3 1.1 26.6 4.9 16.3 10.8 8.0 6.7 20.3 14.0 1.3 10.8 7.6 0.2 19.5 1.4 27.0 16.6 4.5 0.1 0.4 0.1 10.0 0.0 4.3 0.2 0.0 0.0 1.8 0.0 0.2 0.0 0.5 1.3 0.0 0.1 0.2 0.8 0.2 0.4 0.0 0.1 0.1 0.3 12.2 12.2 3.9 18.3 19.5 13.8 7.3 8.3 9.0 6.1 5.5 10.6 6.6 27.7 12.8 21.9 74.4 1.1 10.8 21.1 16.2 18.2 4.2 25.4 16.5 11.9 25.8 19.2 5.5 22.9 0.2 3.0 62.9 0.0 18.9 2.6 31.2 3.5 28.5 7.2 5.3 67.8 18.9 0.1 4.9 22.4 30.2 1.3 4.2 29.6 47.8 2.4 16.8 22.9 12.3 6.1 1.9 5.9 3.5 7.2 1.6 10.6 43.1 0.6 21.6 0.0 12.5 3.4 21.4 34.1 9.1 0.6 18.2 34.1 8.8 32.0 17.6 0.0 11.0 9.3 6.8 8.8 27.3 14.5 1.0 6.6 6.6 20.1 29.2 KRT35 "Ha-5, KRTHA5" ENSG00000197079 "Keratin 35" Q92764 17 41476689-41481140 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "skin 1: 39.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025750, HPA078713" Enhanced Approved "Intermediate filaments" NA NA 220000000 "Intermediate filaments" "HPA025750: , HPA078713: " 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 39.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969082-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" "NK-cells: 264.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" NA NA 190000000 "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.08e-4)" 19.9 22.0 2.4 11.5 3.4 13.4 16.1 3.9 3.9 14.4 10.2 15.9 7.4 19.5 4.8 16.8 14.0 10.8 18.5 3.0 5.5 14.8 24.1 22.4 8.3 4.4 3.7 2.0 17.2 16.7 14.4 9.6 15.5 4.0 11.1 11.7 3.2 18.6 6.8 70.1 16.5 14.8 16.2 4.1 23.4 15.6 7.8 4.5 16.1 14.6 27.4 7.9 15.4 16.7 5.5 20.8 18.1 32.6 44.6 108.4 76.4 36.9 30.1 80.4 30.3 52.8 28.3 37.2 7.3 30.9 38.4 101.7 25.4 27.0 140.0 52.0 47.7 19.4 3.6 30.0 32.1 49.2 20.7 31.2 52.7 45.4 57.6 144.8 65.4 19.2 36.0 42.2 48.2 46.4 10.1 8.8 13.4 13.1 19.3 23.2 23.2 20.6 46.1 29.9 20.8 11.3 25.4 45.0 34.5 44.8 41.4 15.7 49.4 25.3 27.0 27.9 57.3 60.4 16.7 40.2 9.1 49.0 23.7 38.9 0.5 1.0 0.8 1.1 0.3 0.4 0.2 0.5 0.4 0.2 0.2 0.5 0.7 4.4 0.7 0.4 1.3 0.2 0.3 2.4 3.4 3.9 3.9 3.0 5.5 4.4 3.7 2.0 4.0 4.1 4.5 5.5 44.7 48.1 47.3 34.6 16.7 22.2 10.0 16.0 17.1 13.0 20.2 14.7 33.6 24.3 22.1 16.5 20.9 7.5 107.0 46.2 0.0 29.3 7.5 25.8 38.7 29.6 22.3 9.5 33.0 19.4 12.3 29.9 16.8 39.7 3.8 41.7 28.9 63.4 22.2 15.2 34.2 18.4 12.2 59.4 12.8 5.2 47.5 37.6 12.4 31.9 65.9 11.7 264.7 30.7 40.0 40.8 17.2 38.4 35.9 17.1 23.2 23.6 12.2 15.1 65.7 63.7 32.6 10.9 10.4 28.9 19.7 9.3 38.8 38.8 20.9 16.7 LCE1C LEP3 ENSG00000197084 "Late cornified envelope 1C" Q5T751 1 152804835-152806628 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 489.0" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 83.0" "Cancer enriched" "Detected in some" 6 "melanoma: 17.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+: 1.0;HBEC3-KT: 2.2;hTEC/SVTERT24-B: 1.1;hTERT-HME1: 2.8" NA NA "unprognostic (3.35e-2)" "unprognostic (5.95e-2)" "unprognostic (3.46e-2)" "unprognostic (3.35e-2)" 0.2 0.1 0.0 0.0 0.0 0.3 34.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 4.1 489.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 3.5 2.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 83.0 0.0 0.2 0.0 0.0 0.0 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168617 "Metabolic proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 27.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7" "Group enriched" "Detected in many" 29 "dendritic cells: 4.7;T-cells: 15.0" "Cell line enhanced" "Detected in many" "WM-115: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol NA NA 35000 Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: AB_2675854" "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 4.2 4.9 8.1 4.0 9.4 0.7 3.8 7.9 12.7 9.5 7.0 6.2 3.9 9.2 3.2 7.8 6.1 5.6 4.3 8.3 12.1 1.4 0.9 5.2 2.9 12.5 8.3 6.3 6.4 1.4 3.0 4.2 5.1 9.9 4.8 6.4 0.5 25.9 3.7 1.9 27.6 5.0 10.0 9.9 2.7 2.5 4.9 11.5 22.5 1.9 1.9 3.2 6.8 10.7 12.2 0.1 0.9 5.4 2.3 4.7 9.6 10.9 3.2 3.2 1.8 2.6 0.6 0.2 1.1 0.7 10.4 3.3 12.2 0.3 1.8 0.6 0.1 0.6 0.4 0.2 0.4 3.4 0.3 2.7 11.7 4.6 5.5 0.6 4.0 3.7 4.3 1.6 0.2 3.4 0.4 4.2 0.2 1.9 11.5 1.3 2.7 2.4 0.2 0.0 0.4 0.3 2.2 1.0 0.0 6.7 1.0 0.0 0.3 3.4 0.3 1.6 0.5 0.1 0.2 0.2 2.5 1.9 0.4 43.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 4.5 0.3 0.0 0.1 15.0 4.6 0.3 0.2 0.1 4.7 1.3 2.2 8.1 9.4 7.9 12.7 8.3 12.1 12.5 8.3 6.3 9.9 9.9 11.5 12.2 0.7 0.0 0.5 2.9 0.1 4.2 2.0 3.3 7.4 0.0 2.2 2.4 1.0 1.5 0.9 0.0 0.0 0.3 0.3 1.5 0.0 0.6 0.2 0.2 2.1 1.2 0.0 2.7 0.5 0.0 0.4 7.5 0.0 0.3 0.0 1.2 1.4 0.0 37.2 0.0 0.3 1.3 4.1 1.3 0.8 0.0 4.7 9.6 5.4 23.4 0.7 0.4 0.0 24.6 0.5 0.3 2.5 5.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 3.7 3.3 0.6 0.3 4.2 8.1 0.8 0.7 0.1 4.1 1.4 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964573-102056443 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol NA NA 490000 "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 20.8 19.5 4.7 5.0 7.5 9.3 18.3 15.8 11.0 17.2 0.0 25.6 3.7 24.8 5.1 18.7 17.7 4.0 27.1 8.1 3.2 12.6 9.5 20.1 4.4 5.3 5.4 6.6 21.2 15.9 2.1 21.1 3.0 9.5 14.6 3.1 13.3 20.0 2.9 53.5 26.5 19.3 3.1 0.7 14.3 19.9 13.1 3.1 2.0 17.7 1.2 2.4 23.6 18.2 9.8 3.3 6.6 5.0 4.6 3.0 5.0 3.2 3.0 1.8 5.1 4.5 2.6 4.5 4.2 3.4 5.4 4.9 4.0 8.2 5.3 3.6 3.4 3.5 4.1 15.1 3.3 2.7 3.6 6.4 6.4 6.3 14.1 4.9 3.2 3.9 8.0 3.0 8.9 4.5 4.2 5.6 4.1 5.1 2.1 10.2 4.6 3.3 1.6 5.2 7.6 8.4 2.8 3.2 2.2 3.4 4.9 2.5 1.5 11.5 6.8 4.1 11.5 5.1 4.3 7.6 4.9 9.1 2.9 3.0 1.3 0.6 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.5 0.3 0.5 1.2 0.4 0.6 0.6 0.4 0.3 4.7 7.5 15.8 11.0 8.1 3.2 5.3 5.4 6.6 9.5 0.7 3.1 9.8 102.1 125.0 84.7 83.9 55.9 52.4 46.4 75.0 51.2 126.4 63.1 55.5 182.9 31.5 89.1 77.3 139.7 49.6 106.3 94.2 13.7 112.6 14.8 123.6 131.0 93.7 71.3 38.1 127.3 81.2 42.9 86.5 86.6 134.6 33.5 117.9 46.1 36.7 40.2 183.4 131.0 68.0 75.3 52.7 123.6 16.8 70.5 90.7 71.2 51.5 99.2 63.3 73.2 51.8 93.3 131.3 73.6 71.5 100.0 47.6 82.6 48.5 90.7 115.4 85.5 81.4 106.1 87.1 72.2 59.2 64.1 37.4 91.3 86.1 64.4 46.5 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150494-110202202 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.0;pituitary gland: 25.5" "Group enriched" "Detected in some" 5 "Excitatory neurons: 60.6;Inhibitory neurons: 59.4" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008043, HPA008044" Enhanced Approved Mitochondria NA NA Mitochondria "HPA008043: , HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 0.4 6.0 13.0 0.2 26.2 0.1 0.3 1.5 52.0 0.1 0.0 0.2 0.0 0.1 1.0 0.4 0.1 0.1 0.1 17.6 13.0 1.3 0.0 0.1 0.0 14.6 10.0 26.6 0.0 1.5 8.9 25.5 0.8 27.7 0.1 0.1 6.1 0.6 0.1 0.1 6.2 0.1 0.1 0.0 0.0 0.7 1.8 29.2 0.0 0.3 0.1 0.0 0.1 0.1 26.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 5.5 0.5 2.1 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.8 6.2 1.9 36.0 1.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 7.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 26.2 1.5 52.0 17.6 13.0 14.6 10.0 26.6 27.7 0.0 29.2 26.8 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.1 0.0 5.1 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.9 0.0 1.2 0.0 0.0 0.5 0.0 0.0 60.6 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 59.4 0.0 4.1 0.0 0.0 0.7 0.0 0.0 10.6 3.7 0.0 0.7 0.0 4.5 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.7 0.4 0.0 1.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 IFNL3 "IL-28B, IL28B, IL28C" ENSG00000197110 "Interferon lambda 3" Q8IZI9 19 39243553-39245129 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 1700 "unprognostic (2.67e-1)" "unprognostic (9.19e-2)" "unprognostic (4.17e-1)" "unprognostic (6.86e-2)" "unprognostic (1.89e-2)" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCBP2 "hnRNP-E2, HNRNPE2, HNRPE2" ENSG00000197111 "Poly(rC) binding protein 2" Q15366 12 53452102-53481162 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038356, HPA073145" Approved Supported Nucleoplasm,Cytosol NA NA 970000 Nucleoplasm Cytosol "HPA038356: AB_10697248, HPA073145: " "unprognostic (1.44e-1)" "unprognostic (2.08e-1)" "unprognostic (9.89e-2)" "unprognostic (2.92e-3)" "unprognostic (4.34e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.82e-5)" "unprognostic (2.52e-1)" "unprognostic (2.05e-2)" "prognostic favorable (8.23e-4)" "unprognostic (3.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.35e-1)" "unprognostic (1.99e-1)" "unprognostic (8.20e-2)" 435.8 432.9 212.0 265.4 221.7 870.7 399.5 257.4 242.3 385.3 251.4 310.4 337.9 347.9 369.6 316.9 411.4 304.2 343.4 197.2 259.0 539.9 513.2 354.0 383.5 231.5 219.9 191.8 511.9 505.7 440.8 222.4 302.2 229.6 267.8 328.7 671.1 324.9 267.0 485.6 415.3 327.2 336.7 230.8 326.6 393.6 366.8 233.4 548.6 418.6 405.2 459.3 315.9 326.2 259.9 527.6 809.2 755.8 614.7 1068.5 809.3 582.3 547.0 722.3 844.6 605.4 951.9 760.5 916.9 518.6 796.7 398.6 501.2 830.1 720.1 830.0 579.1 617.4 917.3 597.0 946.0 1071.1 922.5 592.1 937.8 593.9 719.6 1147.1 1451.3 819.3 583.5 810.8 1621.9 762.9 1444.3 856.8 1030.1 975.1 447.8 559.7 690.0 686.4 1098.4 667.5 814.6 742.4 655.6 736.2 656.2 553.9 767.2 918.2 791.8 615.9 443.9 614.0 412.7 561.7 908.2 666.0 840.7 523.9 572.6 494.4 19.1 34.5 25.9 27.7 34.0 44.6 38.1 42.3 35.7 41.6 34.3 48.1 41.8 30.8 23.9 33.3 57.2 52.3 30.1 212.0 221.7 257.4 242.3 197.2 259.0 231.5 219.9 191.8 229.6 230.8 233.4 259.9 306.1 115.4 179.2 64.9 433.6 390.7 302.9 352.6 569.1 88.0 361.5 389.9 73.7 253.1 193.0 296.1 110.5 329.2 313.6 242.9 493.1 233.0 68.3 264.2 289.3 285.1 206.5 525.1 54.6 240.0 365.1 285.8 326.2 298.1 155.0 360.3 283.4 302.2 368.2 102.6 58.1 279.1 223.8 437.6 473.8 65.6 309.1 376.0 233.1 74.0 476.5 152.9 292.5 58.8 101.4 250.8 266.5 229.0 483.8 256.3 446.8 714.4 159.5 188.3 190.7 346.6 435.1 292.8 183.4 511.3 382.3 443.3 341.6 240.4 325.7 345.0 ZGPAT "dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP" ENSG00000197114 "Zinc finger CCCH-type and G-patch domain containing" Q8N5A5 20 63707465-63736142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 124.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 14.2;Gastric mucus-secreting cells: 13.7;Plasma cells: 26.9;Squamous epithelial cells: 11.1;T-cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056705 Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056705: AB_2683213" "unprognostic (4.50e-2)" "unprognostic (2.74e-1)" "unprognostic (5.30e-2)" "unprognostic (4.42e-2)" "unprognostic (8.58e-2)" "prognostic favorable (6.17e-5)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.54e-1)" "unprognostic (9.31e-3)" "unprognostic (1.60e-2)" "unprognostic (3.43e-3)" "unprognostic (1.37e-1)" "unprognostic (4.11e-2)" "unprognostic (1.24e-1)" "unprognostic (9.86e-3)" 14.2 17.1 4.8 8.9 4.8 15.0 14.7 4.5 8.9 15.5 5.9 16.8 10.1 16.2 3.4 16.7 14.3 5.6 14.9 4.7 4.4 22.0 124.6 13.1 11.6 6.6 4.4 4.4 12.0 14.2 8.4 14.5 6.5 5.1 15.0 3.0 1.4 13.8 6.8 16.8 18.7 14.9 4.9 3.5 20.5 15.4 20.4 4.6 9.6 13.9 4.3 4.1 16.1 15.2 6.6 15.3 19.3 7.4 12.0 6.0 4.2 17.1 15.5 10.1 24.0 10.0 41.6 20.4 15.6 28.9 8.8 23.3 27.4 5.0 18.3 3.0 10.7 13.3 14.8 16.9 43.3 11.7 9.4 25.2 10.7 15.3 9.9 3.9 6.5 13.2 18.5 16.5 13.9 8.0 15.3 22.6 22.1 12.1 22.3 24.0 23.9 5.7 15.7 13.5 14.0 14.0 17.4 22.1 24.7 14.2 3.7 16.9 26.0 15.2 37.2 13.3 14.3 20.1 13.9 24.3 22.2 23.5 9.3 17.0 8.6 21.0 26.5 28.3 21.5 28.1 19.2 24.6 26.3 19.7 16.2 23.9 24.7 21.8 26.4 18.4 28.2 26.2 18.6 4.8 4.8 4.5 8.9 4.7 4.4 6.6 4.4 4.4 5.1 3.5 4.6 6.6 0.3 3.2 3.4 4.6 8.0 0.0 0.0 0.1 14.2 1.0 0.2 0.3 0.3 0.0 1.3 0.0 0.0 0.2 0.7 0.4 0.0 0.1 0.1 0.4 1.1 2.1 1.8 6.3 7.4 0.2 0.3 3.3 13.7 0.6 2.5 0.5 0.4 2.3 0.2 0.0 5.8 0.2 0.0 1.3 0.0 0.0 0.0 5.4 1.8 8.4 0.0 0.2 0.0 5.5 4.6 0.4 0.1 0.0 26.9 0.2 0.3 0.5 0.1 1.1 0.0 0.5 1.4 0.3 0.1 11.1 0.3 0.3 8.9 0.5 0.2 0.1 SLC25A29 "C14orf69, FLJ38975" ENSG00000197119 "Solute carrier family 25 member 29" Q8N8R3 14 100291116-100306547 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "thyroid gland: 423.1" "Cell type enhanced" "Detected in many" "Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 47.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030781 Uncertain NA NA "HPA030781: AB_10603029" "unprognostic (8.64e-3)" "unprognostic (1.20e-3)" "unprognostic (2.39e-2)" "unprognostic (1.32e-1)" "unprognostic (2.23e-1)" "unprognostic (3.63e-3)" "unprognostic (3.39e-3)" "unprognostic (2.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.00e-1)" "prognostic favorable (2.90e-4)" "unprognostic (1.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.97e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "prognostic favorable (5.26e-4)" 24.7 45.0 61.6 5.3 67.2 13.6 34.7 73.9 74.7 40.1 70.8 18.7 8.2 32.3 37.8 36.6 85.1 12.3 29.0 58.6 64.6 102.4 36.2 44.4 8.1 86.9 71.6 57.9 50.3 22.4 6.7 63.2 6.7 80.9 69.6 5.4 47.8 45.9 12.7 12.0 39.8 18.7 8.3 77.7 20.6 26.8 45.1 67.1 8.9 423.1 6.1 5.7 27.1 27.2 100.0 11.0 23.2 29.7 39.0 6.8 2.5 17.4 8.2 8.9 16.8 9.9 5.4 6.7 0.0 20.4 2.8 8.6 11.5 12.7 4.2 5.6 4.2 5.4 10.4 35.8 9.9 16.1 6.1 13.0 7.4 12.9 7.7 7.1 25.5 23.3 35.7 3.4 1.2 4.9 34.8 37.9 33.6 14.8 9.7 22.5 49.1 12.4 0.8 55.5 7.7 42.9 52.8 19.3 13.2 15.4 12.5 33.0 10.2 24.5 6.1 11.7 8.6 12.9 2.9 1.3 1.4 6.9 14.9 7.6 1.5 1.1 2.1 0.9 0.2 0.0 0.1 0.4 0.9 1.2 0.5 0.1 0.6 1.2 0.1 0.0 0.5 0.6 0.2 61.6 67.2 73.9 74.7 58.6 64.6 86.9 71.6 57.9 80.9 77.7 67.1 100.0 23.5 9.6 26.5 108.7 5.8 6.5 16.3 14.8 22.8 17.9 57.1 38.5 1.4 11.5 23.3 123.2 75.0 6.2 17.8 9.4 17.6 31.4 19.7 136.7 24.8 20.9 20.9 3.8 26.4 11.8 0.7 10.9 12.2 136.0 14.5 22.6 31.8 9.5 7.4 21.9 22.4 8.8 12.2 2.8 30.0 62.4 2.5 11.7 10.6 30.9 8.8 21.0 12.3 42.7 78.5 14.2 17.0 6.0 4.1 39.6 4.6 13.1 45.1 82.7 13.1 7.0 12.6 4.2 5.0 24.5 6.5 18.6 6.4 6.3 14.3 13.8 PGAP1 "Bst1, FLJ12377, SPG67" ENSG00000197121 "Post-GPI attachment to proteins inositol deacylase 1" Q75T13 2 196833004-196927796 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "brain: 164.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 89.6;Inhibitory neurons: 104.5;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 11 "hypothalamus: 164.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.21e-1)" "unprognostic (9.15e-2)" "unprognostic (5.89e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-2)" "unprognostic (6.95e-2)" "unprognostic (6.51e-2)" "unprognostic (1.41e-2)" "unprognostic (2.59e-3)" "unprognostic (9.61e-2)" "unprognostic (7.16e-3)" "unprognostic (1.21e-1)" "unprognostic (7.88e-2)" "unprognostic (9.03e-3)" "unprognostic (1.91e-2)" 3.7 8.5 10.2 1.1 12.5 2.0 3.9 9.7 12.3 3.1 4.4 3.0 3.7 3.0 3.1 3.5 2.8 1.5 2.7 8.1 164.6 1.6 1.2 4.6 1.1 7.0 7.7 8.1 9.4 4.4 2.8 9.2 3.3 6.9 3.3 2.8 13.1 2.2 2.2 1.4 12.4 4.4 2.2 4.5 1.4 2.0 1.5 14.9 1.7 2.1 1.4 1.1 3.1 4.0 7.5 1.5 0.6 15.2 8.3 6.8 4.1 2.5 1.9 1.4 1.1 1.3 0.8 1.6 1.8 2.4 2.8 2.4 2.8 4.0 4.3 1.7 9.0 5.2 1.2 4.0 4.1 1.8 2.6 2.0 3.0 3.0 1.9 2.2 7.9 6.6 5.9 0.3 3.0 4.2 0.6 2.4 3.3 7.1 2.4 3.5 3.7 3.8 0.5 2.4 13.8 12.6 10.0 1.3 1.9 2.4 9.0 1.9 1.0 7.6 5.1 2.2 2.5 2.6 2.7 1.5 2.4 3.9 1.2 5.1 0.1 0.1 0.1 0.2 0.0 0.2 0.2 0.7 0.7 0.1 0.2 0.6 0.5 0.2 0.1 0.0 0.0 0.9 0.0 10.2 12.5 9.7 12.3 8.1 164.6 7.0 7.7 8.1 6.9 4.5 14.9 7.5 9.3 3.2 2.6 37.9 12.7 34.4 13.5 21.4 30.1 43.3 5.4 5.6 6.8 2.8 6.9 25.8 25.0 37.4 4.6 5.8 0.0 1.4 8.3 11.9 14.5 9.7 38.9 3.2 89.6 3.7 9.1 15.8 14.3 4.3 4.5 8.8 4.2 4.4 6.2 13.5 104.5 13.6 8.2 1.9 14.9 4.8 14.3 3.0 7.2 23.4 1.3 17.5 3.1 130.2 58.7 0.9 8.2 15.8 8.2 11.4 12.4 1.6 16.7 41.1 6.6 12.0 33.8 11.0 8.2 23.4 30.0 15.9 18.5 8.1 24.0 11.9 SRC "ASV, c-src, SRC1" ENSG00000197122 "SRC proto-oncogene, non-receptor tyrosine kinase" P12931 20 37344685-37406050 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell adhesion, Cell cycle, Host-virus interaction, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 6 "dendritic cells: 1.4;monocytes: 2.4" "Cell line enhanced" "Detected in many" "A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004023, HPA030875" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA 3200000 "Plasma membrane, Cell Junctions" "Nucleoplasm, Cytosol" "CAB004023: AB_2106059, HPA030875: AB_2673640" "unprognostic (5.58e-2)" "unprognostic (9.83e-2)" "unprognostic (3.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.52e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.90e-5)" "unprognostic (3.89e-2)" "unprognostic (7.04e-2)" "unprognostic (8.13e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.63e-4)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.33e-2)" "unprognostic (4.72e-2)" "unprognostic (3.65e-2)" "prognostic favorable (5.22e-5)" 9.3 25.5 5.6 13.4 5.4 8.5 10.2 0.4 6.2 24.8 1.3 29.7 40.2 32.1 3.3 26.3 24.0 28.1 6.6 6.4 4.6 20.5 4.3 16.2 6.3 2.7 3.3 5.0 23.8 31.0 11.2 16.1 8.2 3.3 31.0 17.2 5.5 11.9 27.6 2.4 12.8 39.1 17.4 2.2 14.3 40.3 25.4 5.4 6.2 9.8 1.5 8.2 35.9 24.8 2.9 24.6 110.8 24.9 22.6 9.3 14.7 51.6 22.0 18.9 26.3 16.6 41.9 21.5 0.7 13.4 40.2 29.9 43.5 15.1 102.6 10.3 0.1 13.7 6.2 3.9 65.9 22.0 0.3 9.3 15.7 34.2 17.3 22.8 29.4 24.3 14.2 0.6 0.2 4.4 16.7 6.0 0.8 11.7 67.3 98.8 26.5 6.6 0.7 11.0 106.3 23.1 83.6 25.0 34.5 27.2 19.1 31.1 9.0 35.8 31.4 20.9 11.7 20.1 0.3 0.8 0.3 22.1 0.1 24.0 0.0 1.6 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 2.3 1.4 0.0 1.0 5.6 5.4 0.4 6.2 6.4 4.6 2.7 3.3 5.0 3.3 2.2 5.4 2.9 1.0 3.2 1.7 3.3 4.1 8.2 12.5 9.5 10.8 6.5 6.2 7.5 2.2 18.6 4.7 12.9 2.1 2.3 4.9 42.0 1.9 12.2 1.8 6.4 10.7 1.4 16.8 0.4 9.5 18.7 8.3 7.2 43.8 12.4 0.0 14.8 1.1 1.6 5.7 3.3 9.1 29.2 8.2 9.4 46.3 3.3 10.8 22.8 1.8 9.4 9.7 4.4 1.0 9.0 0.6 39.1 19.2 17.3 4.3 18.0 36.7 9.3 5.6 5.2 13.1 1.8 6.7 0.3 1.1 11.2 9.1 2.3 1.0 2.9 16.9 36.6 ZNF679 MGC42415 ENSG00000197123 "Zinc finger protein 679" Q8IYX0 7 64228474-64266931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 1.1" "Group enriched" "Detected in some" 20 "Early spermatids: 7.8;Late spermatids: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.27e-1)" "unprognostic (8.09e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 ZNF682 BC39498_3 ENSG00000197124 "Zinc finger protein 682" O95780 19 19997058-20039505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 22.2" "Cancer enhanced" "Detected in many" "testis cancer: 7.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 14.4;AN3-CA: 21.8" HPA055998 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA055998: AB_2683002" "unprognostic (8.96e-2)" "unprognostic (3.93e-2)" "unprognostic (4.78e-2)" "unprognostic (1.10e-1)" "unprognostic (6.16e-2)" "unprognostic (6.95e-3)" "unprognostic (1.69e-2)" "unprognostic (1.71e-2)" "unprognostic (6.44e-2)" "unprognostic (1.24e-3)" "unprognostic (7.70e-4)" "unprognostic (1.77e-3)" "unprognostic (4.06e-7)" "unprognostic (2.07e-1)" "unprognostic (2.10e-1)" "unprognostic (1.19e-1)" "prognostic favorable (3.51e-4)" 2.0 2.5 4.6 2.5 5.0 2.1 3.4 5.0 7.1 2.5 2.7 2.4 1.5 2.5 3.5 3.3 3.0 2.2 4.6 5.1 5.2 3.1 4.2 3.7 4.0 4.9 5.0 4.1 2.0 3.0 3.0 4.1 3.0 5.0 4.9 2.5 3.2 1.9 4.1 3.4 6.6 2.9 1.3 4.1 4.1 3.1 3.3 4.7 3.1 8.0 1.6 4.5 3.6 3.1 6.4 0.0 0.0 14.4 21.8 1.1 1.5 0.6 3.1 1.4 5.1 8.1 2.5 3.1 0.1 5.2 4.4 1.5 2.6 5.9 0.5 5.7 0.0 6.3 0.0 0.1 1.6 2.0 0.0 5.1 2.1 1.7 2.8 0.0 0.8 0.0 5.7 0.0 0.1 3.9 4.3 8.7 1.3 7.9 0.0 1.9 5.3 7.5 0.1 2.7 9.7 7.9 8.5 0.0 2.8 0.0 7.8 5.4 2.9 0.0 7.5 1.2 12.7 5.4 0.0 9.0 1.4 0.0 0.0 2.4 7.1 0.4 0.9 2.5 0.5 1.8 4.1 3.7 2.0 1.5 2.7 4.0 4.1 1.5 1.4 0.7 1.3 4.2 1.3 4.6 5.0 5.0 7.1 5.1 5.2 4.9 5.0 4.1 5.0 4.1 4.7 6.4 5.2 9.6 15.1 7.2 7.0 3.4 2.1 0.6 5.2 5.4 4.6 5.2 10.3 4.3 4.6 3.7 0.0 6.8 8.2 2.7 5.9 4.0 1.8 1.8 2.9 4.4 1.2 4.4 9.8 7.5 6.8 3.5 2.6 3.0 2.5 5.9 5.0 3.0 2.9 3.3 10.1 2.8 0.0 3.5 2.7 0.9 1.8 2.3 1.8 6.5 0.6 4.0 5.2 6.6 22.2 4.8 1.2 4.5 3.1 1.5 1.7 3.8 1.5 2.3 0.0 3.1 3.4 4.3 4.2 3.7 3.4 2.5 6.9 9.2 2.1 2.5 OR8B8 TPCR85 ENSG00000197125 "Olfactory receptor family 8 subfamily B member 8" Q15620 11 124437445-124445696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.8 0.1 0.4 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF772 DKFZp686I1569 ENSG00000197128 "Zinc finger protein 772" Q68DY9 19 57466663-57477570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" HPA031312 Uncertain Approved Cytosol NA NA Cytosol "HPA031312: AB_10603941" "unprognostic (2.30e-2)" "unprognostic (5.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.82e-1)" "unprognostic (1.83e-1)" "unprognostic (3.73e-2)" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (6.31e-3)" "unprognostic (1.27e-1)" "unprognostic (2.50e-2)" "unprognostic (5.01e-2)" "prognostic favorable (1.02e-6)" "unprognostic (7.99e-2)" "unprognostic (3.75e-1)" "unprognostic (1.43e-1)" "unprognostic (7.93e-2)" 1.8 3.8 3.2 1.8 3.4 1.5 4.8 13.5 3.6 2.9 4.9 1.4 1.8 2.3 5.6 2.5 5.3 2.6 7.0 3.1 3.1 4.1 2.6 3.0 3.4 3.7 2.7 2.7 6.2 3.0 11.0 4.5 4.4 5.0 4.6 1.6 14.2 4.2 4.1 5.6 4.4 2.0 2.0 1.5 4.9 2.6 3.8 2.0 6.1 9.2 8.0 4.1 2.0 1.4 4.0 2.9 1.9 11.7 4.9 3.0 6.3 4.8 5.1 6.0 7.8 26.4 0.8 2.6 0.3 3.7 4.4 3.4 0.4 2.5 6.4 9.5 0.0 18.5 9.6 1.1 3.1 4.0 1.2 9.7 4.8 3.0 5.5 10.2 7.1 5.7 3.8 2.9 1.8 7.4 2.1 1.4 2.5 7.4 0.7 5.2 2.6 14.4 9.6 3.7 7.5 12.1 7.5 0.2 2.6 3.7 7.9 7.6 6.2 2.7 7.1 4.6 1.6 5.1 11.5 22.2 3.4 1.5 0.2 7.3 0.2 1.2 1.1 0.3 0.8 1.3 2.1 1.0 0.4 1.5 3.7 1.9 1.0 0.6 1.6 0.9 0.8 0.2 1.0 3.2 3.4 13.5 3.6 3.1 3.1 3.7 2.7 2.7 5.0 1.5 2.0 4.0 1.5 6.4 2.6 6.5 2.7 0.6 0.5 0.9 0.6 7.0 2.2 1.5 5.3 2.8 1.6 16.5 6.2 2.3 0.4 1.0 0.0 2.0 0.0 1.0 0.8 2.6 2.4 1.7 4.3 0.4 0.9 1.3 1.1 1.2 2.5 3.8 4.2 3.3 2.6 6.7 4.2 1.4 4.1 4.1 0.5 1.2 0.6 1.6 0.0 1.0 1.2 5.4 1.0 7.5 4.5 0.7 0.5 2.2 0.8 1.2 1.0 2.1 1.7 8.8 0.0 1.1 1.9 0.6 1.3 2.3 1.1 1.8 0.7 1.9 1.5 0.8 ZNF257 BMZF-4 ENSG00000197134 "Zinc finger protein 257" Q9Y2Q1 19 22052430-22091480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Spermatocytes: 19.9;Spermatogonia: 13.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 5.1;NB-4: 4.4;NTERA-2: 12.1;RH-30: 5.2;U-698: 4.4" NA NA "unprognostic (8.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (5.45e-2)" "unprognostic (3.29e-3)" "unprognostic (1.99e-3)" "unprognostic (9.40e-3)" "unprognostic (7.00e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (7.13e-2)" "unprognostic (2.34e-3)" "unprognostic (2.21e-1)" "unprognostic (2.15e-1)" "unprognostic (6.62e-4)" 0.6 0.5 0.5 1.0 0.9 4.1 1.2 1.2 1.2 1.5 0.3 0.7 0.5 1.4 1.6 0.3 0.9 0.5 0.6 0.5 0.9 0.6 0.4 0.8 2.6 1.0 1.3 0.2 2.4 2.1 1.1 0.2 2.0 1.1 1.4 0.6 0.7 0.3 0.9 0.2 0.8 0.4 0.8 0.8 1.6 1.4 2.7 0.7 1.6 2.3 0.0 1.3 1.1 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 2.3 0.6 3.6 2.9 0.0 0.5 0.0 1.4 0.1 5.1 0.0 0.0 0.0 3.7 0.0 0.1 3.6 0.4 0.0 0.1 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 3.8 4.4 12.1 0.0 1.0 0.0 5.2 3.0 0.5 0.8 0.0 1.4 0.0 0.0 0.9 1.7 0.0 2.5 0.0 0.0 0.1 0.4 0.0 0.1 2.6 4.4 0.1 0.0 0.2 2.7 0.3 1.4 0.6 0.5 0.8 2.6 1.2 0.9 0.3 2.1 1.4 0.7 1.8 1.3 0.5 0.7 0.6 0.3 0.5 0.9 1.2 1.2 0.5 0.9 1.0 1.3 0.2 1.1 0.8 0.7 1.2 1.7 0.0 0.0 1.0 3.9 1.3 1.4 0.0 1.2 1.4 2.1 1.5 1.9 0.0 1.3 7.3 0.0 4.1 1.3 0.4 9.8 1.8 4.6 1.0 1.5 2.3 0.0 0.4 2.0 2.0 5.5 1.7 1.5 1.1 2.5 9.2 3.9 0.0 1.2 5.0 1.1 0.5 2.0 0.3 1.9 2.6 1.5 1.1 0.0 5.6 0.6 1.1 3.1 8.0 4.6 0.8 0.2 1.5 0.7 1.0 0.0 3.5 1.5 0.4 0.0 1.1 1.3 19.9 13.5 0.4 1.7 3.4 2.4 2.4 0.4 1.3 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Endometrial ciliated cells: 13.5;Glandular and luminal cells: 20.4;Granulosa cells: 17.7;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 5.0 6.6 3.1 8.1 2.3 10.5 5.5 1.7 3.9 5.8 1.1 6.9 8.3 7.9 1.6 7.7 6.5 4.5 4.4 2.3 0.7 5.4 5.2 6.8 7.4 4.0 2.4 1.8 6.1 8.1 4.6 6.6 5.1 3.8 6.2 3.2 2.6 7.9 5.0 4.2 7.6 9.1 4.0 1.2 8.7 7.2 9.0 2.6 7.3 7.4 2.1 4.4 6.3 5.6 3.8 19.5 28.6 10.3 25.6 7.9 6.1 23.3 13.5 11.5 12.9 9.4 13.8 21.5 14.2 25.4 12.0 17.5 31.2 11.0 15.6 3.8 12.1 19.4 18.6 28.6 11.4 8.8 18.3 21.9 11.6 7.7 12.7 10.0 5.8 12.7 14.7 21.7 11.7 7.6 28.8 15.6 14.1 20.9 8.4 18.2 21.6 9.2 18.6 5.6 30.9 12.7 19.0 14.3 18.6 15.7 4.5 32.8 12.4 18.3 22.3 20.7 18.6 13.6 19.1 12.2 12.7 17.8 8.8 19.9 3.5 0.9 0.6 1.2 0.4 1.0 0.5 0.7 0.7 0.5 0.8 0.5 0.7 1.3 0.6 0.7 1.2 0.2 0.6 3.1 2.3 1.7 3.9 2.3 0.7 4.0 2.4 1.8 3.8 1.2 2.6 3.8 10.8 6.4 6.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 11.3 8.4 0.0 0.0 0.6 12.9 0.0 6.8 10.7 0.0 0.0 9.1 0.0 13.5 9.1 5.1 0.0 0.0 0.0 8.9 5.6 3.2 0.0 20.4 5.1 17.7 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 5.9 0.0 0.0 4.3 0.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 8.3 3.0 10.2 0.0 0.0 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 27.6" "Cell type enhanced" "Detected in many" "Early spermatids: 189.0;Excitatory neurons: 37.3;Late spermatids: 50.5;Spermatocytes: 99.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.1;U-2 OS: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: AB_2684699" "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.8 1.0 0.9 0.2 1.0 0.4 1.0 2.8 1.5 0.6 0.1 0.4 0.0 0.5 0.6 0.2 0.5 0.4 0.5 0.9 1.1 0.2 0.0 0.4 0.1 0.3 0.9 1.0 0.6 1.8 0.0 0.4 0.1 0.8 0.6 0.4 0.9 0.5 0.4 0.2 0.7 0.2 0.1 0.5 0.7 0.3 27.6 0.9 0.0 0.3 0.1 0.1 0.5 0.4 1.4 0.2 0.4 0.0 0.2 0.6 0.0 0.0 0.4 0.1 0.4 0.2 0.1 0.9 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.2 0.5 1.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.9 1.0 2.8 1.5 0.9 1.1 0.3 0.9 1.0 0.8 0.5 0.9 1.4 1.0 0.0 0.0 11.8 0.0 0.9 1.1 0.7 0.6 8.2 2.5 2.3 1.7 1.5 0.4 1.8 18.8 0.3 0.1 0.4 0.0 0.4 189.0 5.7 3.6 1.0 4.2 0.0 37.3 1.3 0.2 2.4 0.0 9.8 0.0 3.3 0.7 0.4 0.5 0.0 29.8 1.1 0.0 0.0 1.0 50.5 2.8 0.6 0.0 9.4 0.1 1.0 0.0 18.6 17.6 2.8 0.1 3.0 0.1 1.7 0.0 0.2 1.4 3.8 0.0 3.4 0.9 99.9 2.9 0.5 0.0 0.1 0.2 3.7 1.4 1.5 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 219.7;intestine: 421.4;liver: 166.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 87.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 20.7 4.2 12.7 29.2 12.1 16.4 21.5 12.4 15.7 51.9 10.8 112.7 362.1 30.6 219.7 8.0 45.4 21.7 8.2 11.5 12.7 7.8 166.8 35.9 28.3 13.8 12.5 10.2 17.2 5.6 2.2 2.6 8.7 13.8 12.4 117.7 1.5 5.6 20.5 3.9 3.2 421.4 15.6 13.1 25.9 44.6 9.7 15.1 16.5 7.3 8.9 28.3 77.0 7.7 13.3 38.6 0.9 0.7 0.1 2.5 0.4 3.3 1.1 7.3 0.3 0.6 34.8 138.8 46.7 8.4 1.9 6.8 0.3 0.0 0.2 0.8 39.4 0.0 36.5 1.3 60.9 8.8 57.3 59.2 5.9 0.0 0.8 0.0 2.7 2.8 0.0 0.1 20.6 0.1 0.0 0.1 26.3 0.1 32.2 1.3 12.9 0.2 28.6 3.8 143.3 0.1 0.9 55.8 21.0 0.1 0.1 0.1 31.7 40.5 0.5 0.4 2.2 2.5 14.8 0.1 22.6 1.2 70.5 0.1 27.4 15.1 27.5 25.2 27.9 24.9 16.3 20.4 27.8 31.1 13.1 13.8 21.4 3.9 26.1 27.7 9.8 41.5 21.1 12.7 12.1 12.4 15.7 11.5 12.7 13.8 12.5 10.2 13.8 13.1 15.1 13.3 23.4 12.8 51.3 0.0 20.1 3.8 10.3 10.7 8.6 0.1 7.0 4.6 1.7 12.8 23.6 0.0 4.2 1.8 10.5 164.9 0.0 13.3 92.6 159.9 37.6 24.7 40.8 10.7 1.3 6.4 2.6 5.7 41.8 292.3 17.2 0.5 16.1 88.6 18.9 0.0 1.1 79.0 0.0 22.4 57.8 42.6 15.8 24.9 3.6 17.8 11.5 0.1 16.5 1.0 1.0 48.0 122.4 12.0 20.3 7.1 462.5 0.2 8.2 1.2 0.0 0.8 3.3 4.0 1.9 3.3 1.7 0.7 24.0 6.4 103.3 50.0 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524829-89597861 "Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 97.0;Excitatory neurons: 177.4;Inhibitory neurons: 197.3;Oligodendrocytes: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain NA NA "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favorable (7.15e-4)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 6.7 14.8 4.4 3.8 10.3 3.0 5.4 1.4 14.4 2.8 0.0 4.4 6.1 1.9 5.5 4.0 3.2 5.1 2.3 12.8 2.7 3.7 3.8 4.7 4.5 2.1 2.0 10.8 1.6 6.7 5.4 3.3 1.8 3.3 4.3 5.3 13.1 4.2 1.1 4.0 5.9 4.1 2.7 1.9 3.6 5.2 15.5 1.2 3.8 4.9 3.2 5.0 5.0 2.3 17.7 13.0 4.7 3.8 13.2 18.5 10.8 15.3 0.4 4.0 1.7 2.3 7.9 8.4 1.2 4.8 1.9 5.0 6.7 35.6 2.8 1.9 6.4 6.3 28.9 3.7 7.4 1.9 13.6 17.7 5.6 11.5 1.5 5.6 0.6 18.7 10.6 30.3 9.3 2.1 7.9 5.3 6.2 20.7 6.1 7.1 13.0 1.7 5.3 4.5 16.8 10.6 17.5 7.2 18.3 12.7 4.6 10.7 6.1 6.0 1.5 8.4 3.8 4.1 5.9 4.7 6.7 2.1 3.0 3.3 0.7 0.7 0.5 0.4 0.3 0.3 0.8 0.6 0.4 0.7 0.6 0.9 0.8 0.3 0.3 0.4 0.6 1.0 0.5 4.4 10.3 1.4 14.4 12.8 2.7 2.1 2.0 10.8 3.3 1.9 1.2 17.7 5.8 16.0 13.9 15.7 11.4 33.0 12.4 13.6 14.8 32.9 15.2 8.4 7.0 17.2 17.7 7.3 47.9 3.2 2.8 8.9 1.9 13.0 97.0 13.5 1.9 12.7 26.9 3.8 177.4 18.9 18.2 4.4 10.2 8.4 2.5 13.3 16.1 6.7 7.0 0.0 197.3 14.2 8.2 12.8 17.3 72.7 2.5 9.8 1.8 26.2 7.9 5.8 1.0 45.2 140.7 15.4 6.0 2.6 11.1 18.6 4.3 5.7 26.8 22.4 6.6 9.4 14.8 7.3 3.8 13.9 27.6 2.5 8.0 8.0 13.2 12.4 ABCB8 "EST328128, M-ABC1, MABC1, MITOSUR" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 81.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favorable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favorable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favorable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 9.1 20.6 7.6 8.5 8.7 8.2 8.7 8.1 13.8 15.6 8.0 11.6 11.0 15.0 8.0 18.5 11.1 6.1 11.8 7.9 6.9 15.0 22.5 10.9 7.6 10.3 8.7 7.6 11.7 10.1 11.6 19.7 8.5 9.9 11.1 5.3 8.8 8.9 6.7 7.9 10.7 11.4 7.1 6.5 11.3 12.3 12.5 8.6 7.2 15.7 5.8 6.2 8.9 10.6 12.7 26.1 40.1 10.1 32.3 15.8 9.2 20.0 13.6 13.8 20.6 21.9 16.1 42.7 13.8 17.7 14.4 25.2 27.1 15.0 28.1 9.3 17.2 16.5 10.9 16.2 19.7 10.3 8.5 25.9 15.7 20.8 25.1 10.3 7.8 21.4 29.5 57.8 18.3 16.1 58.4 32.3 15.9 6.9 19.6 45.8 14.8 6.4 49.0 14.2 10.9 9.8 19.6 14.5 40.4 13.0 7.9 15.6 11.0 13.3 19.3 5.1 14.1 20.6 18.7 9.8 9.8 27.6 19.9 20.2 11.8 3.2 2.5 4.9 4.7 3.4 2.8 3.4 3.9 4.3 2.1 3.1 4.4 0.7 3.0 3.3 7.1 3.8 2.8 7.6 8.7 8.1 13.8 7.9 6.9 10.3 8.7 7.6 9.9 6.5 8.6 12.7 7.3 12.8 1.1 16.6 12.1 3.7 6.6 10.6 6.2 24.9 6.4 4.7 7.0 7.2 7.2 11.0 37.5 36.2 12.0 28.5 3.9 15.9 3.1 14.8 12.8 4.8 0.0 13.7 15.9 20.0 22.5 9.8 36.7 12.1 49.6 57.8 6.1 25.2 28.0 30.3 17.8 14.0 18.3 6.0 3.9 2.8 6.5 8.2 8.8 2.8 9.7 9.0 17.5 7.1 11.8 21.5 8.5 12.4 22.9 7.0 20.6 14.3 8.8 36.6 26.3 8.9 9.5 9.9 13.5 12.0 7.4 81.8 11.3 28.1 18.7 7.6 H3C12 "H3/j, H3FJ, HIST1H3J" ENSG00000197153 "H3 clustered histone 12" P68431 6 27890315-27893106 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 1.2;brain: 3.5;choroid plexus: 1.3;lymphoid tissue: 1.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.4;U-266/84: 11.7" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.15e-1)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (3.18e-1)" "unprognostic (1.71e-4)" "unprognostic (2.91e-2)" "unprognostic (4.09e-3)" "unprognostic (6.37e-3)" "unprognostic (6.67e-2)" "unprognostic (4.68e-3)" "unprognostic (1.34e-1)" "unprognostic (2.63e-8)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.82e-3)" "unprognostic (8.04e-2)" 0.0 0.0 1.0 0.0 0.3 1.2 0.1 0.6 0.4 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.1 0.1 1.0 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.4 0.0 0.3 0.8 1.1 0.0 0.0 0.2 0.1 0.1 3.5 0.9 0.3 1.3 0.6 0.5 0.2 0.6 0.3 0.0 0.7 0.1 0.0 0.2 4.4 0.7 0.2 0.5 0.1 0.9 0.5 0.0 0.2 0.4 0.8 1.8 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.5 1.9 1.0 0.0 0.5 2.0 2.5 1.7 0.8 0.2 1.0 0.3 0.4 0.0 0.0 2.3 1.0 1.5 1.4 0.0 0.2 0.4 0.5 0.0 0.5 0.0 0.1 0.2 3.1 11.7 1.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.7 0.9 0.7 0.5 0.1 0.2 0.0 0.3 0.2 0.1 0.7 0.1 1.0 0.3 0.6 0.4 0.2 1.5 0.7 1.9 0.0 0.9 0.8 0.8 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SND1 "p100, TDRD11" ENSG00000197157 "Staphylococcal nuclease and tudor domain containing 1" Q7KZF4 7 127652194-128092609 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002529, HPA002632, CAB019323" Enhanced Enhanced Cytosol NA NA 1800000 Cytosol "CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316" "unprognostic (2.06e-1)" "unprognostic (8.27e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.95e-4)" "unprognostic (5.10e-3)" "unprognostic (6.83e-2)" "unprognostic (1.17e-2)" "unprognostic (2.91e-2)" "unprognostic (4.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.30e-1)" "unprognostic (1.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.42e-2)" "unprognostic (2.26e-3)" 49.0 52.9 20.7 58.4 22.6 66.4 57.3 26.4 21.6 77.5 39.8 51.8 54.7 67.8 91.4 48.1 65.6 37.6 42.0 20.2 35.7 34.2 68.1 47.1 53.5 30.0 27.5 19.8 88.1 180.5 51.2 53.1 87.4 29.2 59.6 49.9 32.4 103.0 58.2 42.2 43.3 45.7 67.1 27.9 46.2 66.2 38.9 26.1 68.1 66.6 40.3 65.8 50.4 42.2 34.9 160.0 141.8 106.3 193.5 156.6 162.7 145.3 183.5 214.8 163.8 182.5 184.6 134.6 210.6 90.4 225.7 137.8 130.4 150.7 198.1 158.6 116.1 127.2 116.1 153.0 177.9 284.2 181.9 109.6 241.3 216.3 140.0 232.3 185.7 206.2 85.1 131.3 204.9 165.0 118.6 199.5 135.6 119.5 159.7 173.6 136.8 94.6 476.1 128.1 110.5 133.0 143.7 132.8 606.6 217.5 157.8 76.2 127.2 207.3 132.3 86.4 243.3 144.7 250.1 101.1 217.0 265.6 153.6 245.2 49.7 86.4 17.1 67.0 76.6 78.0 70.1 50.0 54.0 87.4 44.6 34.9 39.8 6.2 59.7 66.1 92.9 43.4 92.9 20.7 22.6 26.4 21.6 20.2 35.7 30.0 27.5 19.8 29.2 27.9 26.1 34.9 20.3 16.0 44.7 60.4 56.7 19.6 24.7 32.9 22.2 17.1 41.0 28.6 29.2 35.8 28.9 29.5 20.9 255.0 44.3 28.8 17.6 62.8 20.1 21.9 51.9 30.3 73.1 47.5 128.0 96.7 106.1 40.7 54.6 39.5 34.9 54.4 25.0 49.8 81.9 30.3 116.0 59.4 18.3 52.8 36.7 68.1 45.7 50.8 33.8 78.7 72.5 16.7 32.0 84.9 89.9 58.6 29.8 41.3 124.6 42.8 38.2 33.1 19.0 32.7 32.9 27.0 34.4 23.4 28.0 37.6 27.4 267.6 37.2 74.0 58.3 27.0 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585769 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004010 Approved Cytosol NA NA Cytosol "HPA004010: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favorable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 4.9 5.7 5.9 5.0 6.4 3.1 6.1 8.5 8.5 10.9 2.6 8.1 8.5 9.7 5.5 6.3 8.9 4.4 5.6 5.8 4.2 7.1 5.9 5.9 5.6 6.1 4.8 5.5 11.1 8.3 5.8 9.5 3.6 7.0 10.3 4.7 6.6 8.2 5.1 6.1 7.4 8.2 4.2 2.8 7.7 7.6 3.3 5.2 4.4 8.1 3.7 3.9 9.1 8.6 9.1 5.7 0.5 5.4 7.1 6.5 7.2 1.7 4.9 4.3 5.0 3.7 7.5 8.9 5.9 5.6 4.7 0.3 8.0 0.1 3.2 2.9 4.0 1.4 7.2 17.4 1.8 4.8 0.6 11.8 4.8 6.7 3.3 3.1 4.2 5.3 1.0 6.9 7.1 4.6 9.8 7.3 6.7 3.0 2.2 3.2 18.8 6.1 2.9 4.6 5.8 14.7 10.4 4.0 5.0 3.0 3.2 6.3 6.1 8.1 1.9 5.2 4.4 0.4 0.9 3.3 2.4 6.3 4.3 8.1 2.8 1.1 0.4 0.9 0.6 0.9 2.7 1.1 0.7 0.8 1.1 1.3 1.0 1.9 1.3 2.4 2.3 1.5 0.5 5.9 6.4 8.5 8.5 5.8 4.2 6.1 4.8 5.5 7.0 2.8 5.2 9.1 5.3 0.0 3.4 11.1 5.3 1.0 7.6 3.4 6.8 10.7 4.1 2.4 1.8 4.3 2.5 7.3 20.9 1.3 14.3 4.7 5.9 3.9 0.1 3.5 11.1 7.1 12.0 3.4 14.1 3.7 1.1 5.2 3.6 4.5 0.0 14.8 3.6 3.5 2.6 13.5 13.6 5.2 0.0 5.0 3.1 0.8 13.4 3.3 5.4 6.5 6.0 5.8 15.5 6.6 11.4 4.2 8.1 13.2 1.4 7.0 6.6 2.4 4.0 12.0 0.0 6.2 4.6 5.3 3.1 3.1 2.6 0.8 4.7 6.8 7.4 5.1 SULT1A2 "HAST4, STP2" ENSG00000197165 "Sulfotransferase family 1A member 2" P50226 16 28591943-28597050 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 48.7;liver: 50.5" "Group enriched" "Detected in many" 4 "Distal enterocytes: 204.8;Paneth cells: 146.1;Proximal enterocytes: 505.6" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 9.1;intermediate monocyte: 7.7;myeloid DC: 3.3;neutrophil: 12.4;non-classical monocyte: 3.9" "Group enriched" "Detected in many" 24 "dendritic cells: 3.3;granulocytes: 12.4;monocytes: 9.1" "Cell line enriched" "Detected in many" 4 "Hep G2: 50.2" "HPA049500, HPA051051" Supported NA NA "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (4.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.53e-1)" "unprognostic (6.13e-2)" "unprognostic (5.35e-2)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.05e-1)" "unprognostic (2.49e-4)" "unprognostic (5.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (2.74e-1)" "unprognostic (2.98e-1)" "unprognostic (1.44e-1)" "unprognostic (8.52e-3)" 1.5 2.9 1.2 0.7 1.0 1.2 1.1 2.2 1.4 0.2 0.5 13.7 48.7 0.4 1.3 0.3 1.0 1.0 1.8 1.2 0.5 3.2 50.5 6.9 0.9 0.8 0.7 1.1 0.7 2.2 2.9 1.9 1.7 1.4 0.5 13.1 0.7 1.5 1.0 0.9 0.8 45.7 0.7 0.6 4.3 1.1 0.7 0.7 0.4 7.3 0.2 0.7 2.1 0.2 1.4 1.9 1.1 1.0 0.7 0.3 0.4 9.7 1.0 0.0 0.1 0.1 2.0 5.1 0.3 12.2 0.3 0.1 2.9 0.5 0.6 0.2 1.0 0.5 1.5 2.4 50.2 0.7 1.0 1.9 0.3 0.7 0.8 0.2 0.6 0.3 0.8 1.0 2.3 0.4 1.8 0.3 2.6 1.4 0.3 0.3 1.6 0.3 1.0 0.2 1.5 0.6 1.4 0.3 3.9 0.1 1.6 3.2 0.7 0.6 2.5 1.4 1.9 0.8 2.2 1.6 0.4 0.6 0.7 0.8 1.0 9.1 0.1 0.1 7.7 0.0 0.1 0.1 0.1 3.3 0.1 0.1 0.2 12.4 0.2 3.9 0.8 0.3 4.6 1.2 1.0 2.2 1.4 1.2 0.5 0.8 0.7 1.1 1.4 0.6 0.7 1.4 0.6 28.9 15.1 2.0 0.5 0.3 0.4 1.9 0.0 0.3 1.9 3.7 2.4 5.7 7.1 3.7 0.0 0.1 0.1 204.8 15.6 7.8 0.2 2.5 0.5 3.8 3.0 0.0 2.8 4.5 0.2 5.4 4.1 0.8 11.4 1.2 7.5 69.5 1.6 0.0 1.8 20.9 0.0 7.6 0.4 1.4 1.5 1.1 0.0 1.0 1.2 4.4 0.0 1.5 0.6 4.2 146.1 1.5 0.1 0.3 505.6 38.2 2.9 0.5 0.0 0.4 0.8 0.7 0.3 0.1 0.1 0.3 0.5 1.6 14.3 0.9 NEK5 ENSG00000197168 "NIMA related kinase 5" Q6P3R8 13 52033611-52129092 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.4;choroid plexus: 6.1;fallopian tube: 8.9;testis: 10.9" "Group enriched" "Detected in many" 4 "Early spermatids: 57.9;Endometrial ciliated cells: 75.8;Late spermatids: 32.0;Respiratory ciliated cells: 98.6;Spermatocytes: 32.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;OE19: 2.4;T-47d: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035565, HPA041399" Enhanced NA NA "HPA035565: AB_10672095, HPA041399: AB_2677453" "unprognostic (4.14e-2)" "unprognostic (1.49e-1)" "unprognostic (1.89e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-2)" "unprognostic (2.47e-1)" "unprognostic (3.57e-2)" "unprognostic (6.50e-2)" "unprognostic (8.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.94e-1)" "unprognostic (2.06e-3)" "unprognostic (1.83e-3)" "unprognostic (1.10e-1)" "unprognostic (1.19e-3)" "unprognostic (9.44e-3)" 0.1 0.1 7.4 0.2 1.6 0.3 0.4 1.2 0.8 0.3 6.1 0.1 0.1 0.5 0.3 0.0 8.9 0.1 0.4 1.4 2.3 0.4 0.0 1.3 0.1 4.3 4.2 0.6 0.1 0.1 0.7 0.1 0.4 2.5 0.5 0.2 1.6 0.1 0.1 0.3 0.2 0.1 0.2 4.4 0.2 0.1 10.9 2.1 0.3 0.3 0.1 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.6 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.4 0.6 0.1 0.2 0.0 0.1 0.1 0.0 1.2 0.4 0.2 0.0 0.5 0.1 0.3 0.2 2.4 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.3 0.2 0.0 0.2 0.3 1.1 0.4 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 7.4 1.6 1.2 0.8 1.4 2.3 4.3 4.2 0.6 2.5 4.4 2.1 2.8 1.4 0.0 2.0 2.6 1.5 0.0 1.9 0.3 0.0 9.2 3.0 1.8 2.0 2.8 12.1 7.3 14.6 2.6 2.5 0.5 1.9 1.3 57.9 75.8 1.9 3.0 1.8 0.8 3.8 2.9 2.4 1.6 0.0 2.8 2.5 1.2 0.4 1.2 1.2 13.5 3.1 0.4 2.0 0.3 0.4 32.0 2.1 0.6 0.0 4.7 1.4 2.1 3.1 1.0 6.6 0.8 0.7 2.2 0.5 3.7 1.3 1.5 98.6 13.2 6.6 4.6 1.3 32.2 12.9 0.3 0.1 1.9 1.0 1.2 1.1 1.3 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366605 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA 73000 Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavorable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 14.9 14.0 13.2 11.5 13.9 12.6 12.0 16.6 21.1 9.5 11.3 10.5 8.3 10.6 11.0 12.6 7.7 9.7 13.4 13.6 18.6 15.0 28.2 9.5 10.9 18.5 19.1 12.2 9.2 15.8 14.9 7.7 11.1 20.4 10.8 11.7 9.0 10.1 7.8 36.1 10.3 8.8 11.4 15.4 9.5 11.3 14.5 17.8 12.2 10.4 29.4 15.3 14.9 8.1 24.0 63.8 38.5 29.2 32.2 21.9 26.3 40.6 44.2 27.9 47.8 42.0 40.4 27.4 36.6 28.0 35.9 37.4 37.0 51.1 45.1 70.7 17.8 38.5 43.2 29.9 41.1 28.6 44.7 25.0 29.6 29.4 45.3 35.2 21.2 47.6 27.8 57.4 21.0 45.0 43.5 41.0 42.6 35.7 30.0 50.1 20.9 75.6 32.5 36.1 52.0 28.0 40.6 32.9 62.6 45.2 34.1 45.0 36.9 49.5 50.5 34.4 38.6 81.4 21.4 35.2 30.5 59.8 46.5 29.9 14.0 9.9 8.9 8.7 16.7 12.3 8.0 11.5 9.9 10.3 8.9 10.1 10.7 7.3 10.9 19.6 7.0 12.1 8.7 13.2 13.9 16.6 21.1 13.6 18.6 18.5 19.1 12.2 20.4 15.4 17.8 24.0 59.6 48.1 58.8 9.8 37.9 112.3 119.5 109.0 43.3 40.8 37.9 33.0 108.1 25.8 97.7 46.0 25.0 88.3 47.9 29.7 70.5 80.7 158.1 99.1 62.3 73.8 32.9 67.3 21.0 78.7 88.8 64.0 33.1 125.3 50.6 39.9 41.0 84.1 56.0 92.5 22.0 28.6 65.1 44.7 90.6 197.0 46.3 50.6 48.0 10.3 59.8 58.6 37.0 14.6 15.0 84.9 22.7 44.0 58.2 93.4 26.0 77.2 68.1 44.6 26.3 78.6 146.8 126.2 108.0 52.9 94.8 123.0 53.8 53.8 34.1 123.2 MAGEA6 "CT1.6, MAGE-3b, MAGE3B, MAGE6" ENSG00000197172 "MAGE family member A6" P43360 X 152766136-152769747 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 7.2" "Group enriched" "Detected in some" 5 "Spermatocytes: 29.8;Spermatogonia: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 210.0;HMC-1: 156.5;K-562: 136.8;OE19: 272.9;PC-3: 148.1;SK-BR-3: 138.3;U-266/70: 176.3;U-266/84: 119.7" NA NA "unprognostic (3.09e-1)" "unprognostic (5.94e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.50e-2)" "unprognostic (1.74e-1)" "unprognostic (5.33e-2)" "unprognostic (8.33e-2)" "unprognostic (6.00e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 17.6 0.0 0.3 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 210.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 50.8 1.1 0.0 0.0 156.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.8 75.4 0.0 0.2 0.4 0.0 0.2 272.9 148.1 0.1 0.0 8.5 0.0 0.0 7.8 58.3 0.0 138.3 20.2 0.1 2.2 10.1 0.7 64.2 100.7 3.7 19.9 176.3 119.7 0.2 1.2 0.0 77.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 29.8 49.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 34.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "RH-30: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042773 Approved NA NA "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.0 3.8 15.8 0.0 13.7 0.0 0.0 3.9 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 18.7 11.9 0.3 0.2 0.1 0.0 10.1 16.2 14.1 0.0 0.1 0.0 2.8 0.0 11.2 0.0 0.0 0.9 1.8 0.0 0.1 0.0 0.0 0.0 3.6 0.2 0.0 0.7 34.3 0.0 0.1 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 13.7 3.9 27.2 18.7 11.9 10.1 16.2 14.1 11.2 3.6 34.3 15.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 2.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.5 0.0 29.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIWIL2 "CT80, FLJ10351, HILI, Mili" ENSG00000197181 "Piwi like RNA-mediated gene silencing 2" Q8TC59 8 22275316-22357568 "Predicted intracellular proteins" "Biological rhythms, Differentiation, Meiosis, Oogenesis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 29.0" "Group enriched" "Detected in many" 4 "Spermatocytes: 62.4;Spermatogonia: 48.9" "Cancer enriched" "Detected in some" 6 "testis cancer: 6.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 24 "NTERA-2: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.91e-2)" "unprognostic (1.77e-2)" "unprognostic (6.51e-2)" "unprognostic (2.18e-1)" "unprognostic (8.29e-2)" "unprognostic (3.58e-3)" "unprognostic (2.60e-1)" "unprognostic (2.37e-1)" "unprognostic (7.59e-2)" "unprognostic (6.68e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.16e-7)" "unprognostic (1.27e-1)" "unprognostic (7.83e-2)" "unprognostic (1.05e-3)" "unprognostic (2.61e-2)" 0.9 0.2 0.9 0.5 0.9 0.2 1.1 0.9 0.7 1.2 0.5 0.8 6.1 0.9 0.3 0.2 1.2 0.1 0.4 1.2 1.4 0.3 1.1 0.3 0.3 0.7 1.0 0.5 1.9 2.4 0.0 1.5 0.1 0.9 0.8 0.9 0.9 0.8 0.6 2.5 0.7 1.9 0.5 0.4 0.3 1.4 29.0 1.5 0.1 0.5 1.1 0.2 0.8 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 38.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.9 0.7 1.2 1.4 0.7 1.0 0.5 0.9 0.4 1.5 1.2 1.0 6.4 3.0 3.9 0.2 1.0 1.0 0.3 1.8 6.6 0.6 0.6 1.2 0.0 0.0 1.8 8.4 0.1 0.4 5.9 0.0 0.1 4.5 5.8 1.8 0.8 0.0 0.0 2.5 1.6 0.4 2.3 5.1 8.9 1.3 0.7 0.7 3.6 0.1 0.0 3.4 5.1 0.0 0.3 0.7 5.9 2.8 0.7 1.8 5.6 0.8 0.6 1.0 2.5 4.2 1.3 3.2 2.2 0.1 1.5 13.2 0.4 2.3 3.0 0.0 3.5 1.6 62.4 48.9 0.1 1.6 0.3 0.6 1.0 7.1 0.9 NOL4L "C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424" ENSG00000197183 "Nucleolar protein 4 like" Q96MY1 20 32443059-32585074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 49.7;testis: 50.4" "Cell type enhanced" "Detected in many" "Early spermatids: 107.4;Late spermatids: 171.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 73.4;HEL: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041768, HPA043600" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA041768: AB_10964172, HPA043600: AB_10961001" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.10e-1)" "unprognostic (7.88e-2)" "unprognostic (2.75e-3)" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (3.88e-2)" "unprognostic (9.32e-2)" "unprognostic (3.42e-1)" "unprognostic (6.08e-3)" "prognostic favorable (2.63e-4)" 9.2 9.1 14.0 8.8 17.4 21.0 10.2 21.2 19.0 8.2 4.4 15.4 18.8 6.7 12.1 2.5 8.6 8.6 5.5 14.4 11.6 13.4 7.1 13.5 8.0 17.2 14.6 13.9 4.0 11.2 4.3 22.5 11.2 16.8 8.8 13.7 49.7 9.8 8.3 1.6 3.4 20.0 6.5 12.1 13.0 13.3 50.4 13.5 15.2 9.8 1.7 5.9 9.7 5.2 20.3 9.1 27.4 16.9 11.6 3.6 5.4 2.3 5.7 4.6 7.1 4.9 73.4 20.8 0.6 16.6 7.5 11.0 2.5 5.4 15.9 3.2 2.1 4.3 58.2 14.5 53.2 9.3 0.9 3.3 13.6 2.2 5.2 3.4 16.1 43.1 12.5 17.7 7.6 3.4 5.1 19.3 17.8 9.9 27.7 25.3 8.2 2.1 3.0 12.0 1.6 22.3 18.1 17.9 0.4 9.8 17.4 3.7 17.8 45.5 6.6 22.6 6.1 5.9 5.6 2.1 4.0 7.2 31.4 20.3 2.9 2.0 1.2 5.8 4.5 5.1 1.6 3.8 3.4 2.1 1.1 7.6 6.4 6.5 8.3 12.1 0.2 6.9 4.9 14.0 17.4 21.2 19.0 14.4 11.6 17.2 14.6 13.9 16.8 12.1 13.5 20.3 23.1 6.4 3.3 7.2 4.1 0.0 10.8 0.0 2.2 49.9 20.8 18.3 8.8 11.5 1.3 12.9 66.7 0.3 29.5 57.9 9.8 8.0 107.4 9.4 2.9 25.3 17.5 4.6 29.7 7.8 2.1 5.8 20.4 8.7 12.0 11.1 21.8 4.7 9.8 8.4 22.0 36.6 0.0 3.3 0.0 171.5 5.6 8.6 0.0 33.7 6.1 17.2 24.7 14.1 51.2 14.0 36.6 4.9 9.0 15.2 59.4 24.0 2.2 57.3 19.7 1.7 5.0 75.3 3.8 0.8 0.0 0.4 16.5 16.9 29.5 28.7 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" A8MQ03 9 137224635-137226315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 241.4" "Group enriched" "Detected in some" 10 "Pancreatic endocrine cells: 58.0;Squamous epithelial cells: 66.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.1;CAPAN-2: 28.9;HaCaT: 33.3;HeLa: 30.6;MCF7: 49.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" Yes No "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.5 1.2 0.5 0.2 0.7 0.4 1.5 0.5 1.6 20.9 0.0 0.6 0.4 0.5 0.5 241.4 1.9 0.7 0.7 0.6 0.9 3.7 1.7 1.1 0.7 1.0 1.2 0.2 0.3 1.5 0.6 7.3 0.3 0.7 2.6 0.1 0.6 30.2 0.6 0.4 32.2 0.8 0.0 1.0 0.7 2.0 4.1 0.6 0.3 2.4 0.0 14.5 1.3 58.2 0.9 25.1 2.4 1.8 3.9 0.0 0.1 5.3 0.4 0.4 0.5 0.2 1.3 28.9 1.3 1.2 0.3 0.7 33.3 0.5 7.0 0.0 2.7 1.8 0.3 30.6 16.8 0.9 0.2 1.4 0.4 3.5 0.9 0.2 1.3 0.3 1.4 0.6 3.1 1.6 49.5 0.7 1.0 0.7 4.8 3.0 2.4 2.8 3.5 0.6 1.6 0.4 1.8 4.5 3.5 0.9 1.5 7.7 0.4 1.0 1.1 0.9 3.2 0.6 1.9 1.7 1.2 1.4 1.3 1.4 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.5 0.7 0.5 1.6 0.6 0.9 1.0 1.2 0.2 0.7 1.0 0.6 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.5 0.4 1.5 2.5 5.5 0.0 0.6 0.1 0.4 0.0 4.6 0.5 2.1 0.2 0.3 0.0 0.0 0.3 5.8 0.2 0.1 3.1 1.7 0.0 0.6 0.7 0.8 0.2 0.0 0.3 0.6 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 58.0 1.1 0.4 0.1 0.2 1.6 0.9 0.0 0.6 0.0 0.3 0.3 3.0 1.1 66.0 0.0 0.0 0.1 0.9 0.5 1.7 SLC22A4 "DFNB60, MGC34546, OCTN1" ENSG00000197208 "Solute carrier family 22 member 4" Q9H015 5 132294394-132344190 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.9" "Group enriched" "Detected in many" 5 "Erythroid cells: 57.0;Proximal enterocytes: 25.6;Respiratory ciliated cells: 78.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 36.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.1;U-138 MG: 24.4" "Region enhanced" "Detected in all" "cerebellum: 64.5" "Low region specificity" "Detected in all" "CAB015468, HPA036974" Approved Approved Mitochondria NA NA Mitochondria "CAB015468: , HPA036974: AB_2732474" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (8.42e-3)" "unprognostic (6.17e-2)" "unprognostic (6.22e-3)" "unprognostic (4.17e-3)" "unprognostic (3.33e-1)" "unprognostic (1.30e-1)" "unprognostic (9.79e-2)" "unprognostic (1.95e-3)" "unprognostic (7.82e-2)" "unprognostic (1.74e-2)" "unprognostic (2.31e-3)" "unprognostic (1.20e-1)" "unprognostic (1.95e-2)" "unprognostic (4.06e-2)" 1.9 3.0 2.3 3.0 1.9 20.9 2.2 3.5 2.1 1.3 1.2 2.0 3.6 1.4 1.4 0.4 11.4 1.9 1.6 2.0 6.0 7.1 0.8 2.9 0.3 4.0 3.5 1.5 2.1 0.6 2.6 2.6 1.0 4.9 4.0 2.3 2.2 1.7 1.5 7.3 1.1 9.2 1.0 3.7 5.2 1.5 0.6 2.6 0.4 0.7 2.7 0.2 1.4 0.9 2.7 1.9 3.0 0.2 0.7 1.3 1.0 0.9 12.9 59.1 9.7 10.1 1.1 3.3 0.6 3.6 7.6 7.2 3.2 0.0 2.1 6.8 2.6 0.3 0.1 5.6 0.2 1.0 4.1 0.0 2.3 0.4 5.3 4.9 3.5 4.3 0.3 5.3 6.7 7.6 1.1 0.0 9.5 0.3 0.3 3.2 0.0 0.8 0.4 1.5 0.2 0.8 0.4 14.0 0.9 0.4 0.4 0.6 2.4 5.2 24.4 2.4 9.7 3.3 0.0 2.7 0.0 7.2 4.7 2.9 0.0 5.6 5.8 0.0 1.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 36.2 0.0 0.4 0.3 0.0 1.2 2.3 1.9 3.5 2.1 2.0 6.0 4.0 3.5 1.5 4.9 3.7 2.6 2.7 1.1 3.2 0.0 5.5 0.1 0.8 1.0 3.8 1.8 2.0 1.9 1.3 0.8 1.5 10.0 0.0 0.0 1.0 0.1 8.8 0.0 3.2 0.0 4.7 1.8 3.8 1.2 57.0 7.2 0.4 2.3 3.1 0.5 2.2 0.0 0.6 1.4 0.0 4.0 3.3 8.0 0.8 4.1 0.8 0.8 0.3 0.6 3.7 0.0 1.9 2.2 1.6 0.0 4.5 2.3 1.9 1.7 0.0 0.1 1.7 25.6 8.6 78.5 0.4 0.0 9.3 1.8 0.3 0.4 0.2 0.4 2.5 0.2 0.1 1.0 0.9 ZSCAN5B "ZNF371, ZNF495B" ENSG00000197213 "Zinc finger and SCAN domain containing 5B" A6NJL1 19 56189570-56197920 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.3" "Cell type enriched" "Detected in single" 8 "Spermatogonia: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043123, HPA046836, HPA059494, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: " "unprognostic (4.73e-2)" "unprognostic (9.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (5.79e-2)" "unprognostic (2.88e-2)" "unprognostic (2.44e-1)" "unprognostic (5.15e-1)" "unprognostic (1.98e-1)" "unprognostic (7.01e-2)" "unprognostic (2.90e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.83e-2)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENTPD4 "KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase" ENSG00000197217 "Ectonucleoside triphosphate diphosphohydrolase 4" Q9Y227 8 23385783-23457695 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017655 Supported Approved Vesicles NA NA 82000 Vesicles "HPA017655: AB_1848181" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (7.86e-3)" "unprognostic (2.00e-2)" "unprognostic (2.99e-3)" "unprognostic (2.07e-2)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-1)" "unprognostic (6.62e-2)" "unprognostic (3.72e-2)" 15.2 11.6 8.6 24.4 10.9 30.8 14.9 11.0 16.3 16.8 7.8 20.0 18.2 17.0 17.5 12.7 13.8 14.7 21.4 10.6 11.9 12.2 13.8 20.1 29.5 12.6 10.4 10.1 13.6 21.6 27.4 18.5 17.4 14.2 16.9 20.5 33.0 22.2 13.5 15.3 12.5 26.4 16.6 8.5 25.6 20.4 20.1 13.1 14.7 14.8 16.0 30.0 16.9 16.7 15.6 20.8 28.7 34.0 23.5 29.0 36.8 35.0 33.1 30.4 21.3 33.2 40.3 26.4 35.5 22.9 32.8 32.9 24.5 15.8 29.0 40.3 8.6 11.5 18.4 18.1 14.2 23.7 9.8 34.8 22.8 34.7 28.4 29.9 51.9 31.2 26.7 13.2 30.6 36.4 9.3 14.8 11.9 20.1 26.2 10.2 14.3 34.6 10.8 27.0 24.1 27.2 26.6 12.0 17.0 23.7 67.0 12.9 13.6 38.6 39.1 38.3 43.7 24.1 24.7 11.5 45.5 51.3 11.5 39.4 17.0 5.7 13.4 7.4 8.6 8.8 8.7 7.3 8.1 7.5 6.5 9.2 7.3 14.4 4.8 7.0 6.8 6.3 6.9 8.6 10.9 11.0 16.3 10.6 11.9 12.6 10.4 10.1 14.2 8.5 13.1 15.6 15.9 19.2 34.5 10.7 25.8 6.5 12.0 17.6 8.6 32.1 11.4 8.6 24.6 7.2 27.3 14.7 14.6 16.1 33.4 25.1 0.0 15.6 8.6 13.6 21.6 15.8 17.3 10.3 31.4 16.9 16.9 16.9 23.9 23.9 17.7 18.9 12.1 11.5 12.3 47.1 37.4 19.7 20.3 14.2 15.5 19.2 7.2 18.2 12.4 19.7 19.4 15.2 18.6 23.1 23.1 21.8 13.3 8.6 46.9 18.9 18.8 5.0 15.0 35.9 13.1 14.3 14.6 21.5 22.8 9.5 5.5 20.2 21.3 11.7 12.4 18.9 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037413: AB_2675463, HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 21.8 25.5 14.0 17.1 14.2 48.6 21.5 14.2 19.2 18.8 15.1 19.1 16.8 20.2 17.1 19.4 18.4 14.9 22.1 14.2 15.2 31.8 33.7 19.1 21.6 13.8 14.5 13.6 19.5 16.0 24.3 15.4 17.6 13.9 19.6 14.9 16.8 18.9 15.6 47.4 16.6 18.7 13.8 14.2 21.9 21.6 14.9 14.2 17.7 19.8 32.2 16.7 17.6 28.5 16.2 36.6 20.3 22.0 21.0 22.2 27.0 29.6 48.7 28.1 29.3 22.4 40.8 45.0 45.2 27.2 28.9 28.1 18.0 24.7 20.4 43.1 43.0 36.6 43.5 17.6 46.3 22.3 68.1 54.4 25.0 32.4 22.1 20.9 36.3 22.0 41.4 44.8 41.1 26.6 22.2 51.3 69.6 25.4 29.8 24.4 29.6 28.3 39.9 28.2 29.2 20.5 25.4 15.1 30.0 51.6 26.7 22.2 41.2 30.9 27.9 34.5 34.0 38.9 38.0 40.8 58.6 38.9 41.3 34.2 45.3 17.6 43.7 19.0 23.3 22.5 24.2 22.0 16.6 20.6 21.3 23.4 24.3 34.9 30.3 25.2 19.2 25.3 15.2 14.0 14.2 14.2 19.2 14.2 15.2 13.8 14.5 13.6 13.9 14.2 14.2 16.2 65.2 76.9 47.9 13.1 70.7 85.0 83.2 132.8 33.6 34.3 52.9 58.4 36.5 64.3 86.3 64.4 22.9 98.9 76.2 48.1 234.8 83.4 52.4 53.7 47.2 42.9 51.6 121.2 17.7 59.4 82.7 60.2 44.9 46.6 44.3 32.8 43.5 81.7 87.5 35.3 15.9 42.6 109.9 61.9 46.1 21.7 55.6 66.9 56.9 8.4 80.1 57.4 88.6 14.1 21.9 65.6 63.3 59.0 58.5 78.1 57.0 251.4 95.4 36.8 98.6 54.2 65.3 164.5 100.3 44.5 86.2 107.8 62.9 52.2 32.8 109.0 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907897 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (8.22e-2)" 51.5 62.3 54.7 21.0 58.1 23.0 46.7 58.0 49.7 39.5 37.6 33.5 23.0 39.2 12.1 44.2 34.4 24.1 30.6 51.6 49.7 44.6 55.4 32.0 24.1 63.5 60.1 44.3 39.4 46.8 27.2 29.4 17.3 66.7 33.9 12.2 9.2 37.3 25.2 46.3 44.2 34.6 21.3 65.6 39.8 35.8 20.7 55.4 13.2 36.6 18.8 15.4 35.4 36.0 68.4 42.7 64.0 27.4 62.4 69.9 49.0 66.8 51.0 47.2 50.1 48.4 43.8 41.9 29.3 60.2 57.8 56.6 39.6 28.3 115.9 9.8 98.0 39.1 26.0 47.3 27.9 41.5 35.1 85.0 50.6 42.6 39.2 18.9 22.6 48.4 55.3 17.7 28.1 39.5 104.2 22.7 24.5 20.3 17.4 36.5 38.7 22.1 27.8 35.1 66.8 40.1 30.4 48.2 54.5 54.9 11.0 45.0 48.8 57.2 71.2 31.9 34.8 45.2 16.8 23.3 22.7 68.0 41.7 51.7 5.0 7.8 5.5 6.1 9.2 4.8 6.3 4.2 4.9 9.3 5.1 3.9 3.5 0.9 4.2 9.2 9.5 4.0 7.1 54.7 58.1 58.0 49.7 51.6 49.7 63.5 60.1 44.3 66.7 65.6 55.4 68.4 24.9 22.4 19.2 20.2 19.7 16.6 10.2 14.6 15.4 27.8 23.9 21.6 9.5 12.8 14.0 27.6 8.4 19.8 20.4 28.4 13.7 21.1 2.4 18.2 20.2 21.0 18.0 17.5 32.1 18.0 23.6 21.1 21.9 27.0 11.4 30.0 24.3 35.2 30.7 62.2 23.6 23.9 10.2 33.5 15.7 8.2 32.3 28.6 16.0 15.9 21.4 17.8 24.7 14.6 27.0 25.2 24.3 28.6 16.4 15.3 24.4 22.6 13.3 18.0 26.3 26.7 16.4 11.1 18.5 25.0 15.6 14.1 17.9 57.1 20.5 13.7 OR1J2 "OR1J3, OR1J5, OST044" ENSG00000197233 "Olfactory receptor family 1 subfamily J member 2" Q8NGS2 9 122510802-122511743 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 9 "Excitatory neurons: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C11 "H4/e, H4F2iv, H4FE, HIST1H4J" ENSG00000197238 "H4 clustered histone 11" P62805 6 27824092-27824480 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 20.8" "Cell type enhanced" "Detected in some" "dendritic cells: 2.5;Extravillous trophoblasts: 8.0;Hofbauer cells: 4.4;Syncytiotrophoblasts: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 6 "basophil: 80.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 80.9" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.0;U-266/70: 2.4;U-266/84: 1.1;U-937: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (3.79e-2)" "unprognostic (2.05e-2)" "unprognostic (7.65e-2)" "unprognostic (8.35e-2)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" "unprognostic (2.99e-1)" "unprognostic (7.30e-2)" "unprognostic (3.77e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.79e-3)" "unprognostic (3.50e-1)" "unprognostic (2.77e-1)" "unprognostic (2.08e-1)" "unprognostic (4.24e-3)" 3.4 10.1 0.0 0.0 0.4 0.0 4.1 0.0 0.5 4.3 0.1 4.8 0.0 4.1 0.0 4.9 5.0 1.2 3.1 0.1 1.0 4.2 20.8 4.4 0.0 1.6 0.1 0.0 4.9 1.2 0.0 4.2 0.0 1.3 8.7 0.0 0.0 1.9 0.0 0.4 2.5 5.4 1.4 0.0 11.6 3.3 2.7 0.2 0.0 8.8 0.0 0.0 3.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.1 0.0 0.0 6.3 0.0 80.9 2.3 13.5 8.6 9.9 3.0 6.1 8.1 9.9 0.0 6.0 3.6 4.4 0.2 13.6 14.3 6.7 9.0 8.6 0.0 0.4 0.0 0.5 0.1 1.0 1.6 0.1 0.0 1.3 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 8.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 SLC2A7 GLUT7 ENSG00000197241 "Solute carrier family 2 member 7" Q6PXP3 1 9003300-9026345 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "intestine: 3.0" "Cell type enhanced" "Detected in some" "Astrocytes: 1.6;Microglial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039931 Uncertain NA NA "HPA039931: AB_10671046" "unprognostic (4.19e-2)" "unprognostic (3.68e-1)" "unprognostic (1.96e-2)" "unprognostic (2.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.43e-1)" "unprognostic (9.05e-2)" "unprognostic (5.69e-4)" "unprognostic (5.09e-2)" "unprognostic (7.12e-2)" "unprognostic (1.60e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FAM110D "FLJ14050, GRRP1" ENSG00000197245 "Family with sequence similarity 110 member D" Q8TAY7 1 26159079-26163962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Adipocytes: 82.7;Endothelial cells: 63.5;Hepatic stellate cells: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "TIME: 1.2;U-2 OS: 1.4;U-937: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA013664 Approved NA NA "HPA013664: AB_1234332" "unprognostic (7.53e-2)" "unprognostic (4.45e-3)" "unprognostic (4.80e-4)" "unprognostic (1.84e-2)" "unprognostic (1.07e-3)" "unprognostic (3.16e-3)" "unprognostic (7.67e-5)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (4.51e-2)" "unprognostic (7.29e-3)" "unprognostic (6.63e-2)" "unprognostic (9.87e-2)" "unprognostic (6.94e-2)" "unprognostic (2.91e-1)" "unprognostic (1.51e-1)" "unprognostic (2.96e-1)" 9.8 1.3 3.3 0.6 2.7 0.8 8.5 2.8 3.3 4.6 1.9 2.7 1.1 8.0 0.8 1.9 7.4 2.3 4.6 2.8 3.1 2.9 0.4 4.2 1.1 4.3 3.3 2.6 1.3 2.2 1.2 1.4 0.6 3.7 3.1 0.5 0.3 2.4 0.7 4.3 2.8 3.1 2.9 3.9 0.8 3.3 0.6 4.2 0.9 4.7 2.1 0.4 4.1 3.6 3.7 0.1 0.1 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.5 0.1 0.0 0.1 0.4 0.1 0.2 1.2 0.1 1.4 0.1 0.0 0.0 0.2 0.1 0.0 1.0 0.0 1.3 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.2 1.0 0.4 0.1 0.2 0.0 0.0 3.3 2.7 2.8 3.3 2.8 3.1 4.3 3.3 2.6 3.7 3.9 4.2 3.7 82.7 0.0 3.4 0.3 0.9 1.0 0.9 0.0 2.2 2.3 1.3 1.8 3.1 2.8 1.3 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.4 0.2 0.5 63.5 0.0 2.7 0.4 0.0 0.0 2.5 0.0 0.2 0.0 0.3 34.6 0.0 0.0 1.7 0.7 0.0 0.0 1.3 1.8 0.5 0.6 0.4 0.0 4.7 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.4 0.0 1.4 1.8 0.2 0.7 0.8 0.9 0.3 0.3 0.5 0.0 0.3 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 45 "liver: 34304.0" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 42919.3" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8" "Group enriched" "Detected in all" 5 "granulocytes: 2823.2;monocytes: 4518.8" "Cell line enriched" "Detected in many" 10 "Hep G2: 4769.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 130.6" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 2070000000000 140000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favorable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 49.6 9.7 7.8 227.0 11.7 158.6 101.7 10.2 19.9 106.6 14.6 152.4 281.1 42.7 5.3 10.1 22.6 355.5 12.2 7.8 19.1 511.1 34304.0 575.7 37.4 22.4 13.0 6.9 5.5 202.7 5.3 9.1 26.8 16.7 12.7 180.6 2.6 33.9 141.7 3.7 6.1 767.2 76.4 14.1 316.1 284.8 3.0 20.5 15.2 23.2 12.0 25.4 56.4 9.1 29.9 25.9 0.3 0.0 0.5 1.0 0.0 1.5 0.6 1.7 0.6 1.1 187.8 500.8 2.6 15.6 0.0 1.4 1.9 0.0 10.9 1.2 70.1 0.0 4.3 2.0 4769.1 0.3 16.8 2.3 4.1 5.4 0.3 18.5 1.9 0.0 0.0 3.2 0.4 0.0 0.8 1.1 12.1 2.0 5.5 8.0 1.9 16.7 2.4 300.8 3.0 0.6 1.3 6.4 1.6 1.4 0.4 262.1 2.7 1.6 2.1 59.4 1.9 7.1 3.3 1.8 7.0 4.4 41.8 0.6 10.6 2482.1 634.3 5.5 3411.9 6.8 7.7 3.6 4.1 683.6 3.6 4.3 3.6 2823.2 5.3 4518.8 14.9 4.5 2770.7 7.8 11.7 10.2 19.9 7.8 19.1 22.4 13.0 6.9 16.7 14.1 20.5 29.9 2.2 35.3 285.9 0.0 137.4 2.3 1.0 36.3 0.0 0.2 100.8 31.5 5.3 4520.9 165.5 150.8 0.0 1.6 3.9 52.0 68.4 3787.9 0.2 70.0 2.8 57.0 12.1 1227.4 0.0 225.8 4.5 3.6 36.2 51.3 1.3 0.1 938.8 42919.3 167.6 0.0 0.0 742.4 30.5 1454.0 74.1 1.1 0.0 413.3 1.8 1.0 291.7 0.3 9.2 0.0 0.0 2161.6 137.0 0.0 1.5 6.8 5270.0 745.9 108.3 0.2 0.0 0.6 17.4 0.0 0.2 0.6 1.7 6.4 75.5 0.0 83.2 6.7 TPSB2 ENSG00000197253 "Tryptase beta 2" P20231 16 1227272-1230184 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 25 "granulocytes: 8966.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 50 "basophil: 5.0" "Lineage enriched" "Detected in single" 50 "granulocytes: 5.0" "Cell line enriched" "Detected in some" 7 "HMC-1: 297.5" "HPA049153, HPA049554" Supported "Secreted to blood" NA NA 16000000 "HPA049153: AB_2680656, HPA049554: AB_2680815" "unprognostic (9.05e-2)" "unprognostic (8.46e-3)" "unprognostic (2.42e-3)" "unprognostic (2.27e-2)" "unprognostic (4.97e-3)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (8.55e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (1.95e-1)" "unprognostic (8.30e-3)" "unprognostic (1.91e-2)" "unprognostic (5.76e-2)" "unprognostic (2.41e-2)" "unprognostic (4.65e-2)" "unprognostic (3.17e-2)" 77.8 2.5 0.3 20.4 0.4 4.3 48.2 0.3 0.9 53.7 0.7 61.1 35.8 72.4 9.9 65.1 30.6 104.9 12.8 0.4 0.4 15.2 12.3 128.9 26.4 0.4 0.3 0.3 3.5 19.1 1.5 3.9 1.3 0.7 67.5 20.0 0.0 65.0 13.4 10.0 107.0 147.3 22.2 0.4 5.2 103.0 10.0 0.3 4.9 4.7 10.5 10.0 119.6 53.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.2 0.4 297.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 4.7 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.9 0.4 0.4 0.4 0.3 0.3 0.7 0.4 0.3 0.5 0.1 38.5 275.3 0.0 2.8 0.0 4.4 0.0 0.0 0.0 1.5 0.0 1.5 0.0 16.7 0.0 0.0 0.1 0.6 0.7 0.0 2.4 0.6 0.0 0.0 3.2 0.0 18.9 0.0 0.0 0.2 6.0 2.0 0.0 8966.1 0.0 0.0 0.0 3.8 0.0 0.1 0.7 0.0 0.0 0.0 1.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.8 5.4 0.7 0.1 3.6 0.0 0.0 0.4 1.1 0.0 0.7 0.0 0.0 0.1 345.1 0.0 1.0 6.1 KANK2 "ANKRD25, KIAA1518, MXRA3" ENSG00000197256 "KN motif and ankyrin repeat domains 2" Q63ZY3 19 11164270-11197791 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 402.5;Endometrial stromal cells: 149.6;Leydig cells: 126.2;Peritubular cells: 225.7;Smooth muscle cells: 131.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "ASC diff: 327.8;ASC TERT1: 365.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015643 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA015643: AB_1844839" "unprognostic (2.37e-1)" "unprognostic (8.03e-2)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" "unprognostic (3.23e-3)" "unprognostic (1.54e-1)" "unprognostic (8.63e-2)" "unprognostic (8.98e-2)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (8.73e-5)" "unprognostic (4.01e-2)" "unprognostic (1.37e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-2)" 134.1 56.0 26.1 50.9 26.1 18.0 98.5 23.7 25.8 272.7 31.9 299.0 37.1 380.1 65.2 140.4 224.0 126.1 200.8 20.2 35.8 52.5 51.7 135.7 20.8 30.7 26.4 18.0 215.8 35.7 14.4 30.0 62.8 30.8 141.6 59.2 19.2 39.6 175.2 57.3 44.5 109.0 280.1 23.8 58.2 124.8 25.2 29.6 15.9 72.3 51.6 12.5 257.4 149.7 28.0 42.4 91.1 28.3 30.3 327.8 365.1 20.2 188.9 161.0 92.1 76.2 36.3 27.0 177.2 88.1 234.3 59.6 40.0 25.6 13.7 61.3 9.3 18.4 77.2 105.6 37.5 123.9 11.8 21.4 158.7 20.1 67.3 9.0 237.2 37.8 5.5 51.5 14.3 143.6 75.7 2.3 9.9 31.4 27.5 95.1 59.7 234.8 42.2 65.4 22.7 16.6 51.7 188.2 16.4 22.4 32.7 25.1 41.2 139.1 131.5 52.6 170.1 75.2 13.7 32.9 61.3 111.0 66.3 136.4 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 26.1 26.1 23.7 25.8 20.2 35.8 30.7 26.4 18.0 30.8 23.8 29.6 28.0 34.1 57.7 28.3 7.8 1.3 6.2 5.5 5.2 2.2 2.0 5.2 7.1 402.5 27.1 12.0 20.2 20.9 6.9 0.6 2.5 3.9 8.1 2.4 12.7 149.6 41.2 0.0 76.2 0.9 4.4 4.9 69.2 13.3 11.9 7.6 7.7 32.5 28.2 22.5 0.0 4.1 2.6 4.1 10.6 15.1 3.8 126.2 6.3 8.8 42.2 0.5 34.9 4.1 1.0 1.4 11.9 1.2 225.7 0.8 6.7 1.6 3.7 8.0 23.4 92.1 79.2 131.0 1.8 7.2 2.8 7.7 2.3 2.3 7.7 5.2 8.4 C6orf141 MGC46457 ENSG00000197261 "Chromosome 6 open reading frame 141" Q5SZD1 6 49550646-49561907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 41.3;Basal prostatic cells: 38.8;Distal enterocytes: 41.0;Ductal cells: 39.2;Enteroendocrine cells: 106.3;Gastric mucus-secreting cells: 50.4;Glandular and luminal cells: 61.7;Paneth cells: 39.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 7.6;HaCaT: 8.7;HeLa: 8.4;PC-3: 11.7;T-47d: 7.3" "Not detected" "Not detected" HPA036199 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA036199: AB_2675002" "prognostic favorable (3.92e-6)" "unprognostic (1.58e-1)" "unprognostic (9.87e-2)" "prognostic favorable (1.15e-4)" "unprognostic (4.95e-2)" "unprognostic (2.15e-2)" "unprognostic (1.39e-3)" "unprognostic (8.13e-2)" "unprognostic (7.02e-2)" "unprognostic (2.85e-2)" "unprognostic (6.37e-3)" "unprognostic (1.41e-1)" "unprognostic (1.89e-8)" "unprognostic (2.33e-2)" "unprognostic (5.81e-1)" "unprognostic (3.77e-1)" "unprognostic (4.43e-1)" 3.5 0.1 0.1 0.5 5.0 0.0 4.3 1.2 1.3 2.5 0.0 1.3 6.4 1.9 0.5 2.8 2.2 6.1 0.3 0.3 3.9 0.1 1.1 0.5 0.3 2.0 0.5 0.1 0.5 3.2 0.0 1.6 0.1 2.4 0.4 0.8 0.0 4.3 0.3 0.7 2.8 1.0 0.4 0.0 0.0 5.5 1.8 0.9 0.0 1.3 0.4 0.4 0.9 3.5 1.1 4.8 3.1 0.0 0.0 0.0 0.0 1.6 0.9 0.9 0.0 0.0 0.2 3.2 0.0 0.5 1.5 7.6 8.7 0.9 2.3 0.0 0.0 5.5 0.0 8.4 0.0 0.2 0.0 0.0 0.3 6.6 0.0 4.7 2.6 1.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.2 1.2 11.7 0.0 0.0 0.0 1.5 5.3 0.3 0.0 2.1 0.0 0.0 0.4 7.3 0.0 2.7 0.4 0.0 0.0 5.8 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 1.2 1.3 0.3 3.9 2.0 0.5 0.1 2.4 0.0 0.9 1.1 19.9 0.0 3.1 0.0 0.0 41.3 38.8 2.9 13.1 0.0 8.1 3.7 2.1 8.6 7.6 0.0 0.0 3.9 0.4 41.0 0.0 39.2 0.3 36.9 3.8 11.9 106.3 0.0 1.9 9.0 18.5 2.3 50.4 61.7 0.0 0.8 0.4 0.3 0.9 0.0 0.4 3.1 4.1 0.0 2.1 0.7 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.2 39.6 0.4 0.1 8.2 0.7 0.1 3.9 0.0 0.0 0.4 0.9 0.5 1.1 25.7 35.9 2.1 0.4 0.1 7.6 19.3 GTF2E2 "FE, TF2E2, TFIIE-B" ENSG00000197265 "General transcription factor IIE subunit 2" P29084 8 30578318-30658236 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004816, CAB009603, HPA025065" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658" "unprognostic (4.84e-2)" "unprognostic (7.38e-3)" "unprognostic (6.20e-3)" "unprognostic (9.09e-2)" "unprognostic (6.30e-2)" "unprognostic (4.38e-1)" "unprognostic (6.05e-3)" "unprognostic (8.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.72e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (5.82e-7)" "unprognostic (8.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.05e-3)" "unprognostic (1.24e-1)" 24.1 29.3 16.0 18.0 16.5 9.5 20.1 20.4 19.4 22.7 17.6 19.4 19.6 19.6 17.3 26.6 16.5 13.3 16.3 16.4 20.1 20.8 28.3 17.9 26.2 15.4 16.1 15.2 30.6 52.3 15.5 20.3 16.9 16.5 18.8 16.1 11.7 16.0 14.8 13.5 20.3 17.7 18.6 15.6 20.6 24.7 32.9 16.6 22.6 17.6 11.1 26.8 24.4 24.3 16.4 53.7 43.7 29.2 31.2 77.4 68.2 22.0 57.7 52.4 46.5 58.6 26.2 38.2 70.0 48.0 51.9 67.0 37.8 49.1 53.8 61.5 31.8 28.2 34.9 28.9 63.0 75.4 17.1 29.5 50.6 70.7 49.7 50.7 46.3 65.3 51.2 68.7 42.1 74.5 37.3 83.7 42.9 33.1 66.0 51.9 43.2 31.6 35.4 50.9 36.7 22.4 29.1 32.1 21.5 46.5 38.3 20.8 20.9 49.9 30.6 31.4 25.9 39.8 42.6 62.7 77.0 48.2 28.8 41.3 4.3 4.2 6.4 3.6 3.5 4.1 18.8 5.7 7.6 7.3 11.7 5.6 5.5 2.2 9.7 3.7 8.2 7.0 2.8 16.0 16.5 20.4 19.4 16.4 20.1 15.4 16.1 15.2 16.5 15.6 16.6 16.4 20.2 0.0 8.4 16.6 48.7 47.9 48.1 44.3 48.3 9.2 19.1 17.5 9.9 17.2 28.2 14.7 10.4 43.0 32.3 26.5 19.6 31.5 96.7 42.2 33.8 22.9 13.2 14.1 30.2 33.1 51.4 30.0 31.1 29.0 11.4 17.7 26.4 27.0 34.1 5.0 30.1 24.2 22.4 21.6 39.3 58.9 39.4 28.4 21.4 13.1 58.8 9.0 46.4 17.1 21.8 43.3 23.4 70.7 35.9 72.7 46.5 48.2 40.0 14.9 26.3 17.5 28.0 74.3 87.9 38.3 46.5 62.1 36.9 26.1 24.5 91.8 IL27 "IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28" ENSG00000197272 "Interleukin 27" Q8NEV9 16 28499362-28512051 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antiviral protein, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 26.9" "Group enriched" "Detected in some" 5 "Hepatocytes: 18.1;Syncytiotrophoblasts: 23.1" "Cancer enriched" "Detected in some" 8 "liver cancer: 4.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.6;intermediate monocyte: 3.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "BEWO: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB024722 Approved "Secreted to blood" NA NA 521000 "CAB024722: " "unprognostic (4.79e-3)" "unprognostic (2.66e-3)" "unprognostic (4.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-3)" "prognostic favorable (1.30e-4)" "unprognostic (3.76e-2)" "unprognostic (8.23e-3)" "unprognostic (1.29e-2)" "unprognostic (6.07e-3)" "unprognostic (4.57e-2)" "unprognostic (2.41e-7)" "unprognostic (6.44e-2)" "unprognostic (1.04e-3)" "unprognostic (2.13e-1)" "unprognostic (2.83e-2)" 0.2 0.2 0.2 1.2 0.2 0.9 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 26.9 0.5 0.4 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.7 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.2 1.7 0.1 0.7 0.5 0.1 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 3.6 0.8 0.0 3.8 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 2.1 1.5 0.1 0.0 0.2 1.0 0.2 0.2 0.3 0.4 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 18.1 0.9 0.0 0.4 0.0 0.0 3.5 1.2 0.1 0.0 2.3 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.0 GUCA2A "GUCA2, STARA" ENSG00000197273 "Guanylate cyclase activator 2A" Q02747 1 42162690-42164745 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "intestine: 935.3" "Cell type enhanced" "Detected in some" "Distal enterocytes: 3728.7;Paneth cells: 17085.1;Proximal enterocytes: 12113.5" "Group enriched" "Detected in many" 7 "colorectal cancer: 31.6;urothelial cancer: 8.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 52.1" "Not detected" "Not detected" HPA018215 Enhanced "Secreted to blood" NA NA 18000000 "HPA018215: AB_1850443" "unprognostic (7.98e-3)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (9.07e-2)" "unprognostic (1.14e-1)" "unprognostic (8.06e-2)" "unprognostic (2.89e-1)" "unprognostic (3.10e-1)" "unprognostic (9.15e-2)" 0.8 0.1 0.0 3.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 723.6 57.0 0.9 0.0 0.2 0.5 0.3 0.1 0.0 0.0 0.4 0.3 1.2 0.7 0.0 0.0 0.0 0.1 1.2 0.0 0.2 7.3 0.0 0.1 732.7 0.0 0.1 2.0 0.1 0.0 935.3 17.4 0.0 0.2 0.7 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3728.7 0.0 2.6 0.1 0.0 0.0 0.0 47.7 0.0 0.0 1.1 4.4 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 421.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17085.1 0.0 0.0 0.0 12113.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 3.8 0.0 206.6 0.2 RAD54B RDH54 ENSG00000197275 "RAD54 homolog B" Q9Y620 8 94371960-94475115 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 7.0" "Cell type enhanced" "Detected in many" "Astrocytes: 29.0;Cone photoreceptor cells: 27.1;Excitatory neurons: 45.8;Inhibitory neurons: 19.0;Oligodendrocyte precursor cells: 39.7;Oligodendrocytes: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA007087 Enhanced NA NA "HPA007087: AB_1856040" "unprognostic (1.68e-3)" "unprognostic (2.51e-1)" "unprognostic (2.31e-2)" "unprognostic (8.84e-3)" "unprognostic (4.15e-2)" "unprognostic (1.44e-1)" "unprognostic (5.56e-8)" "unprognostic (1.96e-2)" "unprognostic (1.77e-2)" "unprognostic (5.39e-2)" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (2.04e-12)" "unprognostic (5.86e-2)" "unprognostic (5.23e-1)" "unprognostic (9.08e-2)" "unprognostic (6.68e-5)" 0.6 0.7 1.3 1.7 1.7 2.0 1.9 2.1 2.1 2.4 1.5 1.5 1.4 1.1 2.1 1.4 5.1 0.8 0.6 1.3 1.6 0.8 1.4 0.7 2.7 1.6 1.9 1.2 1.0 0.8 0.7 1.2 1.4 1.6 1.6 2.1 7.0 0.8 2.0 0.3 1.9 1.2 1.1 1.3 1.0 1.5 3.6 1.8 4.2 1.1 0.3 3.0 1.2 0.9 1.7 20.5 15.7 20.9 11.2 1.6 2.5 11.0 16.2 8.9 22.7 23.1 8.1 14.8 14.5 25.3 4.3 11.7 12.7 18.7 7.7 24.6 17.5 11.9 23.2 8.1 7.7 1.5 8.4 8.5 0.8 1.8 11.7 14.9 4.5 8.3 14.7 16.6 8.9 24.6 10.6 28.5 5.7 13.5 23.4 14.4 7.1 21.3 8.7 8.9 9.8 12.0 8.0 11.6 2.8 9.7 17.9 14.9 6.1 5.8 14.8 7.6 16.7 18.1 4.5 12.2 7.8 7.7 15.9 15.4 0.0 0.0 0.0 0.5 0.0 1.9 0.7 0.9 0.4 0.0 1.0 0.8 1.1 0.0 0.1 0.1 0.0 0.6 0.3 1.3 1.7 2.1 2.1 1.3 1.6 1.6 1.9 1.2 1.6 1.3 1.8 1.7 0.5 0.0 0.5 29.0 1.7 0.4 0.9 1.7 1.2 9.1 1.1 1.1 1.8 1.5 0.6 3.7 27.1 2.0 0.5 0.7 1.9 0.8 0.3 11.5 1.6 1.3 1.2 3.8 45.8 0.8 3.2 1.3 3.1 5.6 0.0 3.3 3.3 2.0 1.5 0.0 19.0 1.1 0.0 0.6 0.6 0.4 3.4 0.9 0.0 9.4 0.6 4.4 1.0 39.7 25.9 0.7 0.4 2.2 3.9 0.4 0.2 1.4 3.3 17.5 0.0 1.0 1.7 9.4 13.1 3.7 0.6 0.3 2.6 3.0 2.3 0.7 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080568-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 94.6;Early spermatids: 152.7;Glandular and luminal cells: 75.8;Paneth cells: 120.3;Syncytiotrophoblasts: 79.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 14.4;BEWO: 22.9;GAMG: 16.9" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" NA NA "Nuclear speckles, Microtubules" "HPA007247: AB_2797217" "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favorable (9.82e-5)" 0.4 0.8 0.6 1.0 0.5 1.4 2.1 0.7 0.8 1.4 1.7 2.4 2.3 1.1 5.1 2.2 1.8 0.9 0.5 0.6 0.5 4.5 2.5 1.9 1.3 0.9 0.6 0.5 0.7 4.6 4.8 3.8 3.1 1.0 1.0 3.4 1.7 2.0 1.2 0.7 1.0 1.8 0.5 0.5 0.9 2.5 17.3 0.5 0.5 3.0 0.1 1.7 2.5 1.1 0.9 14.4 0.9 0.8 1.1 0.3 0.5 22.9 0.5 0.5 0.9 0.8 9.0 10.3 1.2 3.9 0.2 16.9 5.4 2.0 6.2 0.6 0.4 3.6 0.7 1.5 9.7 0.3 2.3 2.0 0.3 3.2 0.7 8.8 0.6 0.3 0.8 2.3 1.1 0.5 3.9 0.6 2.7 1.9 12.2 1.4 1.9 0.8 7.7 4.7 6.5 9.6 0.7 1.2 11.1 1.3 2.5 5.5 0.5 0.4 0.8 1.1 0.4 1.0 3.4 9.6 3.6 0.5 2.6 0.4 5.8 1.7 3.4 1.3 1.4 1.6 7.0 1.5 1.0 1.8 8.6 2.5 2.0 2.5 1.4 1.7 5.5 0.7 0.9 0.6 0.5 0.7 0.8 0.6 0.5 0.9 0.6 0.5 1.0 0.5 0.5 0.9 0.8 6.4 7.0 0.0 23.2 8.5 16.5 2.3 2.8 0.8 24.5 9.4 0.4 4.3 5.0 3.7 0.0 9.4 4.2 94.6 3.9 18.2 152.7 55.4 5.9 1.3 53.9 0.0 1.2 12.3 9.0 0.6 13.7 75.8 0.0 0.6 0.0 0.4 1.5 0.0 0.9 53.7 6.1 0.6 3.2 19.5 0.9 2.8 5.4 0.0 1.6 1.5 0.0 0.0 0.1 17.5 120.3 2.2 12.4 6.5 9.0 2.0 12.0 2.6 0.0 0.6 1.5 33.6 4.4 8.5 11.8 79.6 8.5 0.3 34.9 40.8 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33453689 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 40.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 34.5;Horizontal cells: 38.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.1;HMC-1: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavorable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 8.0 8.4 11.4 7.0 12.1 3.4 7.5 0.0 22.1 17.5 4.8 10.7 3.2 18.5 2.4 8.0 19.6 3.0 6.9 27.3 4.7 6.9 3.0 11.8 6.0 1.7 0.3 11.9 22.0 5.7 4.4 40.5 3.2 6.1 9.9 2.2 5.9 5.9 3.5 2.1 7.3 11.3 5.9 0.0 11.8 8.0 10.8 1.6 7.9 10.4 2.0 3.7 11.8 12.1 4.3 2.7 1.0 26.1 10.1 5.7 6.0 3.4 7.1 4.6 3.8 3.0 11.9 1.0 8.3 1.6 3.5 3.5 4.0 3.4 3.9 2.5 4.6 2.0 20.8 3.6 0.7 4.9 3.3 22.9 4.1 1.1 7.2 3.3 14.4 2.9 6.5 6.7 3.4 2.8 6.0 5.1 4.2 14.5 1.2 3.0 19.2 0.6 3.1 2.9 2.2 6.7 5.4 2.6 5.0 2.2 6.1 11.1 3.1 0.8 7.8 7.7 3.1 1.5 4.0 1.4 5.9 4.5 3.4 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 12.1 0.0 22.1 27.3 4.7 1.7 0.3 11.9 6.1 0.0 1.6 4.3 7.0 0.0 2.0 28.1 7.4 3.6 2.4 3.1 17.1 23.5 4.6 5.7 1.4 4.3 4.0 3.7 10.4 0.8 7.3 1.4 1.9 2.2 6.3 18.7 21.2 7.2 9.6 4.6 34.5 1.4 1.3 8.8 2.6 3.2 5.1 6.3 10.0 0.8 1.8 38.7 21.1 1.6 6.1 2.8 7.5 1.6 11.5 2.4 3.6 7.5 2.7 4.2 6.2 12.1 6.2 1.5 0.6 13.5 3.8 1.6 1.6 8.5 21.9 7.9 19.7 3.2 9.2 9.3 8.2 9.2 4.3 0.8 12.8 11.8 2.8 1.8 FITM2 "C20orf142, dJ881L22.2, FIT2" ENSG00000197296 "Fat storage inducing transmembrane protein 2" Q8N6M3 20 44302840-44311202 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Deafness, Disease variant, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 59.8" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 153.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.92e-2)" "unprognostic (7.61e-2)" "unprognostic (2.27e-2)" "unprognostic (2.10e-3)" "unprognostic (1.02e-1)" "unprognostic (3.57e-3)" "unprognostic (1.63e-2)" "unprognostic (3.90e-2)" "unprognostic (8.43e-2)" "unprognostic (5.19e-2)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "prognostic favorable (8.98e-12)" "unprognostic (2.07e-1)" "unprognostic (2.54e-1)" "unprognostic (3.38e-3)" "unprognostic (2.49e-3)" 11.5 11.2 4.5 3.0 4.9 1.2 7.1 5.7 6.3 4.2 5.1 5.2 4.4 4.0 8.8 3.4 3.7 3.2 59.8 4.5 5.6 7.9 6.4 4.1 2.3 6.4 5.9 4.7 4.7 7.5 13.7 5.2 1.9 6.9 6.5 6.0 6.7 6.5 4.4 9.3 5.6 4.0 5.3 4.3 2.6 4.6 3.9 5.2 1.7 6.3 16.9 2.6 4.6 3.1 6.8 7.2 10.9 4.5 6.6 31.4 12.8 4.6 11.5 8.4 8.9 4.9 13.5 5.1 4.9 6.5 13.0 14.3 15.8 5.7 7.7 9.6 1.4 2.7 1.6 6.5 22.9 6.6 3.1 4.0 9.7 17.2 6.2 4.7 4.9 6.4 3.1 2.7 14.2 9.1 22.4 1.2 3.4 1.1 10.8 13.9 1.9 8.4 4.9 5.1 6.7 2.7 3.2 24.4 13.5 10.3 2.0 16.5 2.4 7.9 28.2 12.6 16.6 6.8 5.2 14.4 1.3 12.6 4.9 14.4 0.7 1.0 0.6 1.1 1.0 1.2 0.6 1.2 0.9 1.0 0.6 2.0 1.6 0.4 1.4 0.8 0.6 1.2 0.9 4.5 4.9 5.7 6.3 4.5 5.6 6.4 5.9 4.7 6.9 4.3 5.2 6.8 2.8 6.4 9.7 1.3 3.6 6.9 3.5 2.8 1.2 6.4 5.0 3.4 153.9 11.5 4.3 5.5 6.2 2.0 1.0 5.1 1.9 5.2 4.6 2.2 5.0 4.4 9.1 0.8 2.3 8.6 3.5 9.4 4.1 2.1 0.0 4.4 8.2 14.1 3.4 6.7 2.1 4.8 0.0 3.8 2.2 1.2 7.8 1.7 7.2 1.0 2.3 6.6 2.1 4.0 0.9 5.7 4.1 7.5 3.1 3.1 5.9 6.2 4.0 5.9 0.0 5.6 6.3 9.1 6.0 2.7 8.1 1.5 2.1 16.3 9.2 2.2 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "BLM RecQ like helicase" P54132 15 90717346-90816166 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;lymphoid tissue: 8.0;salivary gland: 7.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 0.3 0.2 0.9 3.7 1.0 5.7 0.5 2.3 0.8 0.1 0.3 1.4 1.0 0.4 0.4 0.6 0.3 0.3 0.3 0.8 1.0 0.1 0.1 0.4 6.5 1.1 1.1 0.8 0.1 0.2 0.0 0.6 1.2 1.2 0.1 1.7 2.5 7.8 0.0 0.5 0.4 1.6 0.4 1.0 1.7 1.1 2.2 0.9 8.0 0.3 0.1 6.3 1.0 0.2 1.4 13.0 14.4 20.4 12.6 0.1 0.9 14.6 9.4 3.2 11.1 13.4 11.7 10.1 35.1 5.9 2.6 14.1 20.4 25.7 7.1 15.1 19.1 20.5 36.4 14.8 3.9 0.0 33.7 17.3 0.3 0.1 10.6 4.7 1.3 7.9 16.9 32.7 9.9 11.0 7.4 28.3 14.5 22.2 24.9 4.2 25.4 39.1 14.7 2.3 18.9 14.6 14.7 8.5 11.5 4.8 18.1 7.2 23.4 3.7 8.6 13.6 9.6 21.0 6.4 30.4 39.5 5.6 25.8 15.7 1.7 0.6 2.6 1.6 0.8 2.6 4.6 1.4 2.1 0.7 2.3 1.0 1.1 0.7 3.1 1.0 0.7 3.2 0.9 0.9 1.0 2.3 0.8 0.8 1.0 1.1 1.1 0.8 1.2 1.0 0.9 1.4 0.9 3.2 8.9 1.0 12.9 0.3 0.5 0.5 0.6 3.6 1.3 1.0 7.9 0.0 4.2 0.0 2.1 5.5 6.9 2.2 1.9 1.0 2.7 1.3 1.3 2.0 0.0 18.3 0.7 0.7 6.8 1.8 3.6 1.7 13.3 8.1 2.2 0.6 5.7 0.0 8.6 1.3 0.0 7.7 1.3 1.6 0.0 7.7 0.0 7.5 2.7 1.7 10.3 58.3 2.6 1.2 0.3 0.4 20.6 0.7 0.2 0.0 5.4 7.1 0.0 0.9 1.7 17.1 12.9 2.2 0.6 1.0 10.2 0.7 4.0 0.4 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041570 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 5.9 6.9 6.1 6.8 6.0 6.5 7.3 11.1 6.7 5.1 6.0 7.4 4.2 6.2 9.5 7.9 7.1 6.0 4.7 5.9 7.3 6.5 6.8 6.1 11.1 7.0 7.5 5.5 4.4 7.3 7.2 7.4 9.3 7.4 8.0 8.0 6.1 5.8 7.1 6.4 10.1 5.3 6.2 7.1 8.3 8.4 8.3 6.9 7.5 7.8 4.4 10.9 6.3 5.7 6.6 15.1 10.5 12.6 10.7 10.9 16.5 12.4 15.9 10.1 7.6 10.1 7.9 15.8 7.3 27.2 5.3 11.2 10.2 12.7 6.2 11.3 32.7 6.6 4.1 5.7 21.8 16.4 8.8 21.6 11.1 16.7 5.3 7.3 15.1 14.3 17.4 13.8 9.4 8.3 24.5 8.9 11.6 12.5 10.4 8.2 17.0 5.7 11.5 8.5 9.4 5.6 8.6 15.9 6.8 15.4 19.9 13.5 17.3 9.5 5.5 4.3 11.1 4.9 15.5 18.3 21.0 4.9 13.3 8.8 21.2 6.7 33.7 18.6 7.6 14.3 19.9 13.0 17.2 7.4 20.3 12.2 15.1 8.8 20.2 8.5 12.9 18.1 6.8 6.1 6.0 11.1 6.7 5.9 7.3 7.0 7.5 5.5 7.4 7.1 6.9 6.6 19.4 16.0 21.0 25.8 19.8 9.1 16.9 23.4 6.8 25.6 15.0 18.4 12.2 5.7 19.4 5.5 6.2 35.4 24.5 10.3 23.5 16.9 7.3 20.6 19.2 21.5 17.4 9.9 32.0 13.5 12.3 16.4 15.3 20.1 21.5 25.8 15.7 10.6 16.8 23.5 28.7 13.5 22.4 9.5 14.5 4.1 13.4 13.0 10.6 24.4 14.5 18.1 40.2 40.2 31.0 19.0 10.8 18.4 13.9 28.4 7.2 15.7 19.5 9.8 32.9 21.3 15.3 28.2 19.3 9.4 11.5 71.0 20.9 25.7 10.6 24.3 OR10D3 "HTPCRX09, OR10D3P" ENSG00000197309 "Olfactory receptor family 10 subfamily D member 3" Q8NH80 11 124183219-124188780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDI2 MGC14844 ENSG00000197312 "DNA damage inducible 1 homolog 2" Q5TDH0 1 15617458-15669044 "Plasma proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043119, HPA043225" Approved Enhanced Nucleoplasm,Cytosol NA NA 630000 "Nucleoplasm, Cytosol" "HPA043119: AB_2678326, HPA043225: AB_2678369" "unprognostic (1.93e-1)" "unprognostic (8.03e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-3)" "unprognostic (3.04e-2)" "unprognostic (1.63e-2)" "unprognostic (3.31e-3)" "unprognostic (8.31e-3)" "unprognostic (1.02e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-3)" "unprognostic (7.56e-2)" "unprognostic (1.84e-1)" "unprognostic (7.63e-2)" "unprognostic (3.77e-2)" 9.6 6.1 3.4 6.4 3.9 10.8 10.3 4.4 4.7 7.2 4.5 6.5 8.0 8.8 6.6 15.9 6.0 5.2 6.8 4.3 3.6 8.0 22.0 7.9 8.7 4.1 3.9 3.7 5.8 7.0 10.3 3.9 7.4 4.3 10.1 6.6 10.3 10.3 5.4 27.0 11.0 7.2 6.5 3.6 7.0 5.9 3.1 3.8 7.7 6.4 11.8 9.8 7.9 10.5 5.5 11.4 6.5 11.6 12.1 15.5 12.2 11.2 7.0 5.3 6.0 5.2 16.1 10.1 28.4 8.0 7.7 4.4 11.8 25.4 11.3 10.1 13.2 17.0 22.3 10.7 15.8 6.6 29.8 10.8 12.1 13.1 11.3 12.0 7.5 12.4 18.2 36.5 10.2 7.5 7.6 17.3 9.8 11.1 16.8 5.3 16.1 16.3 16.8 8.5 9.4 14.1 7.8 13.1 20.9 19.2 12.9 10.9 7.7 10.9 8.6 7.4 9.8 8.6 9.5 12.4 22.3 6.7 21.4 6.9 0.3 0.8 0.1 1.1 0.7 0.9 0.8 0.8 0.8 0.8 1.1 0.8 1.1 0.2 0.7 0.5 1.8 0.8 0.5 3.4 3.9 4.4 4.7 4.3 3.6 4.1 3.9 3.7 4.3 3.6 3.8 5.5 8.9 9.6 21.0 6.2 18.1 15.3 14.0 11.7 23.3 25.6 23.4 11.6 28.0 15.7 24.6 3.7 14.6 22.6 22.8 16.5 1.9 7.7 1.7 40.7 25.2 17.5 15.0 82.9 12.8 7.7 19.2 16.7 14.8 39.1 1.3 13.7 15.7 61.7 15.1 35.3 15.1 21.3 22.4 27.1 6.8 1.0 12.8 17.6 16.0 10.3 16.8 8.2 6.2 8.5 17.6 16.4 9.4 6.8 10.9 24.9 28.1 20.5 33.0 41.3 6.6 14.7 11.3 11.1 9.1 38.6 20.2 40.2 13.6 8.6 20.4 13.8 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736959 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 815.8;tongue: 586.7" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 259.3" "Lineage enriched" "Detected in all" 9 "granulocytes: 259.3" "Cell line enhanced" "Detected in many" "HaCaT: 146.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 210000 "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 26.6 13.5 3.8 22.9 3.1 37.5 22.8 1.4 8.0 42.7 6.8 221.8 14.9 117.2 24.3 93.0 56.0 52.4 166.5 2.2 11.7 15.5 10.5 23.1 12.7 7.0 4.0 2.2 84.1 18.7 32.1 8.6 18.1 4.3 70.9 37.5 10.4 40.9 100.9 815.8 27.1 60.6 107.9 4.6 7.7 78.2 11.8 4.4 19.3 35.3 586.7 10.9 174.6 40.6 6.1 71.4 27.9 12.4 5.4 32.1 84.4 22.1 12.6 24.1 4.3 4.7 34.4 63.1 2.4 43.0 4.9 31.9 146.8 8.6 25.6 5.2 1.4 17.6 0.1 33.6 19.9 21.4 8.0 1.5 72.7 24.5 44.2 19.1 71.9 69.6 14.7 0.1 0.4 6.7 19.9 7.7 4.0 7.0 27.8 15.1 15.5 32.1 0.9 40.2 20.1 18.1 14.1 12.3 1.4 34.3 39.8 12.9 7.9 46.3 21.9 23.4 94.4 34.4 0.6 0.8 0.3 64.5 14.0 65.4 43.4 12.1 58.2 11.1 14.0 10.9 0.6 11.2 7.6 7.3 1.0 17.1 10.9 259.3 14.6 29.6 3.0 4.3 3.7 3.8 3.1 1.4 8.0 2.2 11.7 7.0 4.0 2.2 4.3 4.6 4.4 6.1 31.3 48.1 30.5 2.3 3.7 70.2 108.0 41.1 204.9 11.7 36.6 67.1 469.6 18.6 53.5 38.6 25.0 29.7 11.3 39.7 7.9 94.1 4.0 26.3 65.8 61.1 23.9 1.7 8.3 42.3 18.5 68.1 7.7 43.6 10.1 35.7 32.2 11.8 10.4 5.0 43.9 31.3 28.5 7.5 45.7 6.8 109.6 25.3 28.4 146.1 16.7 30.6 13.4 28.1 6.6 63.4 40.2 260.7 3.3 131.8 18.4 10.8 42.2 15.0 46.0 90.6 92.9 6.5 11.1 103.8 60.0 24.8 14.6 27.9 39.2 98.3 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392790-114511203 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 237.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favorable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 8.7 8.2 11.3 10.8 12.5 25.6 13.6 19.2 17.5 12.6 9.4 9.1 8.8 15.3 30.0 11.8 9.2 11.0 9.0 12.1 10.3 13.7 12.3 11.0 13.4 9.6 10.6 10.7 14.6 12.3 15.4 7.4 16.1 11.0 12.8 10.2 18.9 10.8 11.1 8.9 14.9 9.0 11.9 8.1 12.8 11.4 25.6 9.8 17.9 14.3 10.8 12.9 11.6 9.9 12.3 30.9 16.3 30.1 22.6 12.5 13.1 51.0 15.4 16.3 20.9 22.1 18.5 12.8 32.8 15.5 18.1 13.6 17.4 27.6 18.0 28.6 24.9 16.4 31.6 21.7 21.6 13.8 40.3 25.3 12.5 12.9 24.9 25.2 16.0 17.8 27.3 40.1 22.5 20.2 115.4 40.9 17.0 40.7 11.7 16.3 34.8 45.9 10.8 14.9 47.7 20.8 21.9 29.2 34.7 27.4 19.3 15.8 21.7 20.1 14.5 23.4 33.8 21.7 15.7 15.6 33.4 20.4 23.0 42.0 13.2 1.2 6.1 2.5 1.5 2.2 3.0 2.6 2.7 1.5 1.4 2.0 3.1 3.6 4.1 2.4 3.0 1.6 0.8 11.3 12.5 19.2 17.5 12.1 10.3 9.6 10.6 10.7 11.0 8.1 9.8 12.3 31.0 19.2 33.3 70.5 35.4 52.8 28.9 28.6 25.6 75.6 35.9 23.9 29.2 30.0 32.3 55.2 98.0 64.9 53.9 33.3 1.9 21.0 237.3 50.4 37.5 33.2 52.1 37.9 120.7 23.6 34.0 28.7 30.1 90.0 37.4 55.6 40.7 44.3 29.6 26.9 108.5 30.4 30.5 50.3 47.9 97.9 49.0 37.2 19.6 79.6 42.9 31.5 54.6 116.6 101.8 31.4 34.9 36.9 31.6 47.3 26.6 17.3 31.4 58.3 32.9 38.3 32.5 60.0 31.9 31.2 55.4 87.7 42.8 48.1 31.2 55.3 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871740-22881713 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 367.2;Pancreatic endocrine cells: 314.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 59.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 59.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (3.54e-7)" "prognostic unfavorable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favorable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 78.0 49.1 26.1 68.0 30.1 81.0 75.6 30.0 25.6 79.6 49.5 107.7 95.6 101.2 26.7 174.7 76.7 109.7 64.7 22.3 44.6 78.9 45.5 80.6 50.1 51.3 29.2 16.9 77.4 75.2 88.4 29.1 57.5 31.1 70.6 56.4 10.5 96.0 96.0 46.0 89.8 92.1 76.8 36.4 63.0 100.7 15.6 35.0 39.3 63.9 36.4 54.3 105.5 100.8 39.0 78.9 94.3 20.4 53.4 269.9 155.4 68.6 121.6 228.6 75.1 103.4 29.1 272.4 41.2 59.5 275.8 85.9 109.8 13.3 139.2 29.5 67.5 14.3 14.4 48.4 20.5 120.0 33.0 125.4 170.8 159.4 112.7 57.9 207.3 138.8 18.7 17.9 153.8 102.8 90.3 9.3 10.0 4.4 75.8 125.6 20.8 20.6 41.5 79.1 137.8 1.8 22.1 67.3 127.5 52.4 15.2 67.1 23.5 146.3 114.9 32.5 60.4 51.1 71.6 45.6 18.7 59.6 13.2 50.2 15.3 4.7 34.6 9.7 4.7 9.5 7.3 11.9 11.3 4.6 4.9 10.1 5.8 59.1 5.4 5.5 3.8 12.4 7.3 26.1 30.1 30.0 25.6 22.3 44.6 51.3 29.2 16.9 31.1 36.4 35.0 39.0 78.4 105.8 60.9 13.1 60.5 38.5 95.8 69.1 40.9 2.3 68.0 51.7 30.4 115.8 100.4 82.8 0.0 67.9 60.7 367.2 9.8 173.3 14.1 45.5 35.3 64.2 66.5 69.7 0.2 238.5 96.5 71.8 86.6 80.6 34.9 40.2 81.4 43.2 58.7 0.0 0.2 125.4 57.0 55.0 46.8 16.5 56.8 44.1 55.2 10.3 82.2 91.4 127.7 3.5 7.3 314.0 289.6 73.0 89.8 127.3 259.8 47.6 85.8 8.8 65.7 38.8 70.4 5.4 7.9 74.6 47.5 132.4 58.2 24.6 109.1 154.1 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144420 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 230.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 76.9" "Group enriched" "Detected in all" 4 "granulocytes: 76.9;monocytes: 23.2" "Cell line enhanced" "Detected in many" "CACO-2: 58.8;U-698: 146.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 25.8 7.9 11.3 28.4 16.2 230.7 25.9 13.2 13.7 15.2 11.6 18.8 17.7 17.5 8.7 43.3 12.8 26.3 11.3 14.2 18.3 10.7 13.6 31.3 24.9 12.9 12.4 11.1 5.5 9.3 38.2 15.9 15.7 13.0 8.9 20.3 5.1 19.1 7.8 7.2 27.2 23.4 14.0 14.2 22.0 18.2 10.8 12.3 28.5 9.8 10.1 29.3 22.6 23.9 15.9 3.6 2.8 36.5 24.6 4.2 3.2 8.3 4.8 5.4 4.3 6.8 58.8 4.1 48.3 11.3 1.7 1.6 5.8 11.1 10.5 8.6 12.2 8.9 4.4 1.7 9.5 12.4 4.8 8.3 4.2 8.1 6.4 21.6 4.5 24.3 18.2 2.7 11.7 3.7 0.3 10.6 6.9 23.8 11.1 1.7 13.2 12.6 28.1 17.7 10.8 16.7 23.3 3.6 5.5 12.9 11.3 3.0 3.3 17.5 4.0 5.7 4.0 7.1 27.0 2.8 146.7 2.1 4.3 10.9 15.0 15.6 15.0 0.9 14.1 1.7 8.5 4.8 1.9 5.4 6.6 5.6 2.5 76.9 3.0 23.2 0.5 11.6 6.6 11.3 16.2 13.2 13.7 14.2 18.3 12.9 12.4 11.1 13.0 14.2 12.3 15.9 94.5 28.9 49.2 4.6 84.4 224.1 74.6 48.2 105.9 1.7 60.9 50.3 5.7 15.7 52.0 5.5 0.0 1.7 16.9 57.9 1.9 5.3 10.6 34.6 26.4 52.1 25.7 3.4 23.4 26.7 8.6 24.5 75.4 58.7 15.2 6.3 37.5 7.5 22.8 3.3 19.1 23.4 30.5 67.6 103.7 11.2 1.5 107.0 112.1 119.9 30.6 5.5 3.1 82.9 67.9 20.9 45.9 1.9 318.8 44.7 32.7 9.6 43.6 2.0 0.0 10.1 51.9 8.4 9.6 208.0 217.5 4.0 49.4 3.2 32.4 145.8 ZNF655 "VIK, VIK-1" ENSG00000197343 "Zinc finger protein 655" Q8N720 7 99558406-99576453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029534, HPA050750" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA029534: AB_10603008, HPA050750: AB_2681225" "prognostic favorable (7.12e-4)" "unprognostic (3.03e-2)" "unprognostic (9.62e-2)" "unprognostic (5.00e-1)" "unprognostic (1.51e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (3.93e-3)" "prognostic unfavorable (7.24e-4)" "unprognostic (2.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-2)" "unprognostic (1.12e-1)" 11.7 12.0 7.4 14.4 6.6 9.0 13.0 8.7 8.4 13.3 6.2 14.9 16.0 10.2 11.1 27.1 11.6 10.3 8.5 6.4 6.4 13.9 15.0 15.4 19.8 6.1 6.2 5.4 14.0 21.3 14.5 8.3 12.6 6.5 11.5 11.9 8.5 16.9 11.5 12.8 18.5 14.0 11.8 6.5 14.3 18.1 7.5 7.0 22.8 11.9 13.6 17.4 19.0 15.0 10.1 40.5 35.9 16.5 23.9 15.8 25.4 12.4 24.0 45.8 40.7 37.8 20.1 37.0 31.8 0.4 33.2 52.0 25.2 18.0 29.6 40.6 34.5 23.6 18.9 16.0 27.8 24.1 38.1 35.9 21.1 32.8 35.8 50.6 21.4 17.3 26.4 54.4 39.7 24.4 0.1 53.9 36.6 21.1 0.1 0.0 19.9 14.0 52.9 25.9 42.8 17.4 37.6 25.1 0.7 27.2 24.0 12.2 20.2 13.3 24.3 60.2 43.4 43.6 47.3 72.7 63.4 23.5 18.2 39.9 147.8 43.2 74.4 47.8 47.2 45.1 32.7 44.1 55.7 40.3 31.3 35.0 43.8 50.3 37.0 55.2 23.3 61.3 55.4 7.4 6.6 8.7 8.4 6.4 6.4 6.1 6.2 5.4 6.5 6.5 7.0 10.1 19.5 96.1 82.8 51.2 53.2 44.7 46.5 36.5 42.1 48.8 34.4 25.1 36.1 31.5 44.3 23.9 41.7 31.6 76.3 46.3 33.2 31.6 12.8 25.8 33.9 20.4 41.5 12.8 53.4 36.2 42.7 32.7 37.2 33.0 18.9 70.8 19.2 24.6 37.4 50.5 57.4 40.4 18.3 63.4 31.6 9.7 25.4 56.0 23.2 44.0 59.2 24.9 106.1 61.3 75.3 48.2 55.2 25.2 55.4 44.5 48.1 41.1 26.0 45.8 13.1 39.9 31.7 39.0 29.8 55.6 48.9 73.6 62.5 30.0 28.1 64.0 MRPL21 ENSG00000197345 "Mitochondrial ribosomal protein L21" Q7Z2W9 11 68891276-68903835 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051657 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Nucleoplasm, Mitochondria" "HPA051657: AB_2681565" "unprognostic (1.80e-1)" "unprognostic (6.09e-2)" "unprognostic (4.80e-2)" "unprognostic (8.96e-3)" "unprognostic (9.25e-3)" "prognostic unfavorable (5.97e-4)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.84e-2)" "unprognostic (7.36e-2)" "unprognostic (1.26e-2)" "unprognostic (3.73e-2)" "unprognostic (1.72e-1)" "unprognostic (4.36e-2)" "unprognostic (3.12e-1)" 43.8 44.7 55.4 34.3 56.1 61.0 53.0 61.3 72.5 45.1 56.1 65.3 39.0 50.8 48.8 58.9 45.6 27.3 102.5 56.2 56.8 66.5 66.6 31.8 44.2 58.5 55.7 55.0 49.0 54.1 56.8 45.0 33.3 58.4 44.4 42.9 30.0 100.4 39.4 132.3 50.3 46.4 35.4 56.4 37.3 53.4 47.4 56.5 37.6 45.1 110.1 43.2 50.2 45.3 57.4 105.2 145.6 86.0 82.3 59.1 63.5 101.4 71.8 77.2 132.8 90.4 297.3 132.7 163.5 157.2 78.0 122.0 129.9 143.8 138.6 102.8 109.7 112.6 114.4 102.4 181.0 116.6 201.4 83.4 95.0 69.4 134.1 156.0 64.7 93.7 115.1 229.2 119.4 80.7 196.7 95.5 210.5 78.0 307.6 210.3 135.2 102.9 253.0 134.0 120.8 139.3 111.3 91.1 181.6 302.7 68.7 188.7 115.4 79.3 90.6 90.6 201.3 135.5 88.9 149.5 232.3 120.6 120.4 125.7 79.6 113.0 61.6 72.4 122.8 77.1 162.2 94.5 78.8 124.2 105.8 89.3 74.1 32.1 93.3 114.2 92.0 113.2 114.0 55.4 56.1 61.3 72.5 56.2 56.8 58.5 55.7 55.0 58.4 56.4 56.5 57.4 38.9 35.3 38.7 5.5 47.4 50.2 76.8 145.1 68.9 36.3 56.5 65.4 179.8 67.2 82.0 80.9 8.4 122.8 34.6 127.7 299.3 106.7 176.9 72.2 59.8 50.4 61.7 56.0 5.6 105.3 114.8 53.9 42.8 63.0 65.2 31.8 40.7 115.9 110.4 11.8 6.4 115.6 85.5 56.3 41.3 227.3 74.9 47.0 78.2 1.0 69.8 69.0 34.0 2.0 5.1 86.3 93.0 72.2 63.8 79.6 150.6 272.9 72.8 51.4 26.3 59.3 85.8 86.6 60.5 83.2 51.9 81.3 44.2 55.0 141.6 75.0 LYPD2 "LYPDC2, RGTR430, UNQ430" ENSG00000197353 "LY6/PLAUR domain containing 2" Q6UXB3 8 142750150-142752532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "esophagus: 350.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 97.0;Club cells: 378.7;Ionocytes: 71.2;Respiratory ciliated cells: 77.4" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9;ovarian cancer: 46.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 13 "non-classical monocyte: 440.1" "Lineage enriched" "Detected in many" 22 "monocytes: 440.1" "Cell line enhanced" "Detected in some" "EFO-21: 10.2;HaCaT: 2.8;OE19: 1.9" "Low region specificity" "Detected in many" HPA028599 Uncertain "Intracellular and membrane" NA NA "HPA028599: AB_10603777" "prognostic favorable (2.00e-4)" "unprognostic (3.10e-2)" "prognostic favorable (2.63e-4)" "unprognostic (3.85e-3)" "unprognostic (3.75e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-2)" "unprognostic (3.11e-3)" "unprognostic (1.53e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.12e-1)" "unprognostic (2.04e-1)" 0.2 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.3 7.2 0.0 0.0 0.0 0.0 0.0 350.6 0.3 0.2 2.5 0.1 0.0 0.0 1.3 1.6 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.3 0.1 0.0 0.0 27.2 0.0 0.1 28.1 0.1 0.0 0.0 0.2 23.4 0.0 0.1 2.5 0.0 0.0 26.5 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 33.7 0.4 2.0 0.1 0.2 20.1 0.0 0.2 0.1 0.0 0.0 440.1 1.6 0.1 10.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 97.0 0.0 0.0 0.1 0.0 0.0 0.0 378.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 5.7 0.4 0.4 0.0 0.0 0.0 71.2 1.3 0.0 0.1 0.0 25.3 0.0 0.0 11.2 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 77.4 0.0 0.0 0.0 22.3 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.2 UAP1L1 ENSG00000197355 "UDP-N-acetylglucosamine pyrophosphorylase 1 like 1" Q3KQV9 9 137077517-137084539 "Metabolic proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 21.7;Horizontal cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044356 Approved Approved "Intermediate filaments,Cytosol" No No "Intermediate filaments" Cytosol "HPA044356: AB_10959902" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (2.49e-2)" "unprognostic (3.80e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (3.01e-2)" "unprognostic (2.33e-1)" "unprognostic (5.65e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (1.67e-2)" "unprognostic (6.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.64e-3)" 10.8 14.2 14.3 5.5 18.2 3.2 9.6 14.9 16.5 14.0 15.5 7.2 5.7 6.8 5.1 6.1 7.7 5.4 10.2 14.3 14.8 13.9 2.8 12.6 7.9 16.8 16.2 13.3 3.9 9.7 8.0 15.5 6.4 22.3 13.1 3.6 2.9 11.0 5.7 2.7 9.8 10.9 3.6 13.9 22.2 10.3 3.2 17.9 2.5 14.2 2.8 6.0 10.1 9.2 24.7 0.8 5.8 0.0 15.7 26.4 12.1 4.5 8.1 21.1 22.4 15.4 11.7 2.6 3.7 4.7 8.3 40.6 12.1 29.6 2.0 4.6 10.0 2.7 7.9 9.5 11.3 58.5 0.1 31.5 8.9 2.1 12.7 10.4 10.4 17.7 7.3 2.4 18.0 15.2 13.5 0.8 8.1 2.6 28.3 8.3 12.8 0.2 11.3 8.9 1.1 9.3 5.8 2.0 44.3 18.7 3.7 23.9 21.8 14.1 40.2 8.6 28.3 3.9 19.6 30.1 7.9 34.9 8.6 11.7 0.1 1.0 0.0 0.2 0.5 0.8 0.5 0.1 0.3 0.5 0.2 0.2 0.3 0.1 0.0 0.0 0.3 0.5 0.4 14.3 18.2 14.9 16.5 14.3 14.8 16.8 16.2 13.3 22.3 13.9 17.9 24.7 2.4 0.0 8.4 16.0 6.9 6.1 0.6 2.0 4.0 6.8 4.8 3.9 4.0 5.7 1.5 0.0 2.1 0.4 7.1 2.1 11.7 1.4 0.2 2.2 4.9 3.1 1.8 0.4 3.3 0.9 5.0 4.0 1.1 3.4 4.5 0.8 7.1 0.7 21.7 20.2 5.1 1.8 6.1 10.9 9.9 0.2 2.5 11.2 8.8 6.5 9.1 4.7 3.1 6.6 18.4 0.8 1.9 3.8 5.6 2.0 0.5 3.4 1.1 5.1 0.0 3.0 16.5 0.6 1.5 3.5 4.4 1.4 4.5 1.0 3.1 0.2 ZNF98 "F7175, ZNF739" ENSG00000197360 "Zinc finger protein 98" A6NK75 19 22391019-22532485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 12.0;pancreas: 37.5" "Cell type enhanced" "Detected in many" "Astrocytes: 34.0;Distal tubular cells: 15.6;Early spermatids: 14.7;Granulosa cells: 12.9;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 15.7;Spermatogonia: 21.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.8;GAMG: 5.4;NB-4: 4.8;RPMI-8226: 1.9;SuSa: 2.1;T-47d: 3.4;U-2197: 3.6" NA NA "unprognostic (1.11e-1)" "unprognostic (1.31e-2)" "unprognostic (6.95e-3)" "unprognostic (1.36e-3)" "unprognostic (3.07e-3)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.63e-1)" "unprognostic (1.81e-1)" "unprognostic (3.81e-2)" "unprognostic (1.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.56e-2)" 1.0 0.6 1.3 0.2 4.1 0.2 3.8 0.8 10.4 3.4 0.0 0.2 0.1 1.2 5.7 0.2 2.2 0.4 0.6 2.8 3.7 2.1 0.0 0.2 0.4 2.3 2.4 0.9 12.0 37.5 3.9 0.3 0.5 2.7 0.8 0.1 0.7 0.8 0.6 0.0 0.1 0.1 1.3 0.2 0.2 0.3 7.6 1.4 0.0 4.7 0.2 0.0 0.5 0.2 6.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 5.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 4.8 1.0 0.0 0.2 0.3 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 3.4 1.1 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 4.1 0.8 10.4 2.8 3.7 2.3 2.4 0.9 2.7 0.2 1.4 6.0 1.2 0.0 0.0 34.0 0.1 0.0 0.4 0.0 0.0 1.4 2.9 2.5 1.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 15.6 3.1 14.7 0.3 1.6 0.4 0.0 0.0 2.5 1.4 0.4 1.2 0.0 0.5 0.0 12.9 0.0 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.0 3.5 1.2 0.1 0.0 1.9 0.0 1.0 0.0 10.6 5.2 0.3 0.0 1.9 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 1.0 15.7 21.1 0.0 0.0 0.4 0.0 8.2 0.0 0.4 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 60.9;intestine: 40.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 2.4 0.9 1.5 2.8 1.7 0.3 1.8 2.7 2.0 15.3 0.2 40.2 2.9 60.9 3.6 7.1 21.4 8.9 16.8 1.6 1.2 1.0 0.5 1.1 0.9 0.9 1.2 1.6 4.5 0.7 0.6 0.7 0.9 1.3 17.1 4.9 0.6 3.3 29.7 4.9 1.2 7.4 29.1 0.4 0.6 11.2 3.1 1.3 0.4 1.5 1.8 0.2 26.5 10.2 1.0 0.7 1.2 0.2 0.8 0.5 0.5 0.1 0.2 0.0 0.3 0.0 0.8 0.9 0.3 0.7 0.2 0.4 0.8 0.6 0.4 0.0 0.8 0.6 0.3 1.1 2.2 0.1 0.4 0.1 0.2 0.2 0.1 0.5 0.1 0.2 2.2 0.0 1.1 0.0 4.9 0.7 0.7 1.7 0.8 0.4 0.7 0.0 2.4 0.3 0.3 5.3 0.2 0.6 1.0 0.3 0.0 1.9 0.6 0.8 0.3 1.0 0.5 0.2 0.7 1.5 0.8 0.5 3.7 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.6 0.6 0.6 0.0 0.4 1.0 0.4 0.1 0.7 0.0 1.6 0.0 0.2 1.5 1.7 2.7 2.0 1.6 1.2 0.9 1.2 1.6 1.3 0.4 1.3 1.0 1.4 0.0 0.0 1.0 3.4 0.1 1.8 0.4 0.6 10.1 4.7 8.6 7.7 2.8 0.7 7.3 4.2 0.7 2.7 2.3 9.8 1.2 0.9 3.2 5.8 1.3 4.9 2.5 1.5 1.1 1.2 3.4 7.7 5.8 0.0 0.9 3.9 4.0 0.7 0.0 1.8 6.1 0.0 1.6 0.4 0.5 0.3 1.7 0.0 0.0 0.7 10.6 2.1 1.5 0.5 0.8 3.0 11.3 9.1 1.7 1.9 4.0 0.1 3.8 0.0 6.2 8.1 3.8 3.2 4.4 0.9 0.5 4.4 2.7 4.0 0.8 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069641-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.8;Horizontal cells: 18.5;Inhibitory neurons: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA021518: AB_2670734, HPA053459: AB_2682159" "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favorable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 2.0 2.3 2.3 2.8 2.7 1.5 2.7 4.0 4.4 3.4 0.9 3.0 2.0 3.3 2.5 3.8 3.2 2.1 1.9 2.8 2.2 2.4 3.2 1.9 3.9 1.6 1.7 2.9 3.3 2.7 2.3 3.9 1.6 2.4 3.7 1.4 1.9 3.0 2.3 2.0 5.7 3.1 1.9 0.8 4.0 2.3 1.6 2.3 3.6 2.9 2.3 2.8 3.3 3.5 2.8 4.5 8.1 6.1 10.4 3.7 1.5 8.7 2.7 2.8 2.9 2.3 4.3 4.0 6.3 6.3 1.9 5.1 5.0 3.8 3.6 1.9 6.9 5.9 3.2 5.1 5.4 3.1 6.3 4.1 2.2 4.0 3.6 2.6 3.0 2.7 4.5 5.6 3.5 2.7 13.9 10.7 10.5 11.4 4.1 6.0 7.7 3.0 4.1 2.4 6.1 7.3 11.5 6.6 6.1 5.0 3.8 3.9 3.0 3.6 3.4 2.0 6.0 3.9 12.7 10.0 3.5 5.7 3.9 3.8 1.8 3.4 2.9 10.4 4.7 8.8 6.4 7.5 9.4 4.3 5.9 9.7 8.3 1.1 8.5 4.0 3.7 5.0 5.0 2.3 2.7 4.0 4.4 2.8 2.2 1.6 1.7 2.9 2.4 0.8 2.3 2.8 2.4 0.0 1.1 3.6 3.5 2.7 2.6 4.2 2.8 10.1 2.3 1.3 2.7 1.5 1.6 3.7 2.1 2.4 5.9 2.0 3.9 4.1 0.4 0.9 2.1 3.1 4.8 0.8 18.8 1.5 2.5 2.6 6.6 1.1 4.5 4.5 1.8 2.4 2.2 18.5 15.8 1.6 2.0 1.9 2.6 0.4 3.1 2.1 0.0 3.7 3.6 2.8 13.4 7.1 5.4 1.8 3.3 4.1 2.9 1.4 1.7 2.5 2.3 6.0 0.0 3.3 2.5 4.9 8.3 2.3 1.7 1.9 6.0 1.8 2.7 1.7 ZNF517 ENSG00000197363 "Zinc finger protein 517" Q6ZMY9 8 144798876-144811169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055337 Approved Nucleoplasm NA NA Nucleoplasm "HPA055337: AB_2682788" "unprognostic (9.54e-3)" "unprognostic (4.72e-2)" "unprognostic (3.20e-2)" "unprognostic (3.06e-2)" "unprognostic (1.81e-1)" "unprognostic (1.55e-2)" "unprognostic (2.22e-2)" "unprognostic (3.13e-1)" "unprognostic (4.83e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.66e-4)" "unprognostic (1.83e-1)" "unprognostic (4.23e-2)" "unprognostic (2.75e-1)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "unprognostic (9.57e-2)" 2.7 6.0 2.2 2.1 1.7 1.0 3.3 1.8 3.0 5.5 0.2 4.1 2.2 6.9 0.4 3.3 5.6 2.0 3.0 3.2 0.8 4.1 3.6 2.6 2.3 2.0 1.5 1.8 7.2 3.6 1.9 5.0 1.4 2.8 5.1 0.3 2.2 4.2 1.0 6.3 6.4 3.5 0.6 0.7 3.4 3.7 4.0 1.5 1.1 4.8 0.8 0.9 4.9 4.1 2.1 1.7 3.2 5.2 5.1 0.8 1.5 2.7 1.4 0.4 0.3 0.2 1.0 1.9 0.9 3.6 0.5 2.2 1.7 0.2 0.6 0.7 3.8 1.4 2.2 2.0 11.7 1.9 0.5 2.2 1.1 1.3 0.2 1.0 2.9 1.2 2.7 2.6 1.4 0.9 2.8 2.3 1.3 3.6 3.5 3.5 3.2 1.6 0.8 0.5 2.1 2.3 6.6 4.3 1.7 1.7 2.5 4.2 2.0 1.5 3.5 5.3 1.8 1.6 2.2 0.4 0.7 3.7 0.9 2.9 0.1 0.3 0.0 0.5 0.7 0.3 1.4 0.4 0.3 0.3 0.1 0.3 0.3 0.1 0.3 0.4 0.1 0.6 0.4 2.2 1.7 1.8 3.0 3.2 0.8 2.0 1.5 1.8 2.8 0.7 1.5 2.1 1.8 0.0 0.5 1.3 1.2 0.5 5.8 0.9 0.6 3.9 1.6 1.3 3.3 2.8 1.1 0.0 8.4 0.8 1.2 0.8 1.9 0.8 1.3 1.8 1.5 1.5 1.2 0.8 0.9 0.5 0.7 1.7 1.1 1.3 0.0 2.2 2.2 2.3 1.5 3.3 1.3 1.5 2.0 2.2 0.5 0.0 0.9 1.4 0.0 1.0 0.5 2.5 4.1 1.5 0.6 0.9 0.3 1.2 0.9 1.6 1.3 3.3 0.8 3.6 0.0 1.8 1.5 4.3 3.0 0.9 1.1 0.4 1.5 2.2 0.9 4.1 S100A7L2 s100a7b ENSG00000197364 "S100 calcium binding protein A7 like 2" Q5SY68 1 153437058-153439949 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057828 Uncertain NA NA "HPA057828: AB_2683540" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF675 "TBZF, TIZ" ENSG00000197372 "Zinc finger protein 675" Q8TD23 19 23525631-23687220 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 65.0;Late spermatids: 108.1;Spermatocytes: 36.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 58.0" NA NA "unprognostic (3.75e-2)" "unprognostic (6.67e-2)" "unprognostic (3.73e-2)" "unprognostic (2.03e-3)" "unprognostic (4.62e-2)" "unprognostic (1.68e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (8.50e-4)" "unprognostic (9.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.16e-2)" "unprognostic (4.54e-1)" "unprognostic (3.57e-3)" "unprognostic (9.55e-2)" "unprognostic (2.60e-2)" "unprognostic (2.11e-2)" 7.0 4.9 6.1 5.8 5.4 11.1 8.1 7.9 8.7 6.8 2.6 7.7 5.9 4.5 11.1 5.7 5.9 4.8 3.0 6.1 4.4 4.7 6.1 5.7 11.7 4.0 2.9 6.1 5.8 6.7 7.0 2.0 5.7 4.9 5.0 11.7 7.3 5.9 4.4 3.0 8.7 5.2 3.8 1.4 8.4 8.4 12.7 3.3 9.9 8.1 3.5 11.3 5.2 4.9 7.7 6.7 7.8 15.1 14.7 4.6 4.8 12.8 7.1 10.4 17.8 23.2 4.8 5.4 14.7 17.1 5.1 9.0 8.9 15.2 8.7 17.7 58.0 10.1 11.0 12.1 4.6 1.8 10.6 8.3 7.2 7.4 8.9 17.2 5.9 6.5 17.4 12.8 21.1 13.7 8.0 28.6 13.7 17.5 4.6 10.0 21.4 9.1 18.6 16.7 20.9 8.3 10.6 23.1 0.8 6.1 17.3 9.7 12.2 7.3 8.7 3.9 10.9 15.4 4.7 10.7 24.7 0.6 13.1 4.1 2.8 4.5 9.0 6.6 5.6 6.6 9.8 8.2 7.8 4.9 11.0 10.9 9.6 2.5 8.2 3.7 6.4 9.5 4.0 6.1 5.4 7.9 8.7 6.1 4.4 4.0 2.9 6.1 4.9 1.4 3.3 7.7 6.6 19.2 7.3 2.9 15.2 1.5 2.9 3.8 2.8 8.4 4.7 6.5 5.0 1.5 4.5 1.8 0.0 3.5 18.0 6.2 3.9 4.9 65.0 4.7 8.9 6.1 3.5 4.6 9.8 3.4 5.0 6.1 4.1 6.3 9.5 8.7 2.9 0.9 5.4 1.7 10.4 4.1 10.2 3.8 2.4 108.1 5.0 7.4 0.0 10.3 11.0 6.0 12.3 14.1 10.5 4.3 6.4 3.8 4.4 2.0 2.2 2.9 6.1 3.3 6.6 5.1 5.4 36.1 16.0 7.2 2.7 4.4 14.9 8.8 3.5 4.8 SLC22A5 "CDSP, OCTN2, SCD" ENSG00000197375 "Solute carrier family 22 member 5" O76082 5 132369710-132395613 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 56.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 63.9;Proximal enterocytes: 56.2" "Cancer enhanced" "Detected in all" "renal cancer: 8.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 34.7;SiHa: 37.8" "Low region specificity" "Detected in some" HPA063062 Approved Mitochondria NA NA Mitochondria "HPA063062: AB_2684934" "unprognostic (3.88e-1)" "unprognostic (1.69e-1)" "unprognostic (2.19e-2)" "prognostic favorable (2.87e-5)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.50e-2)" "unprognostic (9.24e-2)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.53e-2)" "prognostic favorable (8.36e-4)" "unprognostic (1.12e-2)" "unprognostic (2.98e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-2)" 3.8 6.7 7.3 2.0 7.6 0.9 4.9 7.6 7.8 4.9 12.7 12.5 13.9 4.0 11.2 3.9 8.4 4.1 10.7 7.1 8.1 27.0 7.8 3.3 1.2 7.5 7.5 6.5 5.6 8.3 18.0 11.1 4.3 7.7 9.2 9.5 3.7 6.5 11.3 56.6 6.0 17.0 2.6 7.2 2.6 6.0 3.8 7.4 2.1 5.5 22.5 1.8 5.1 5.0 7.7 6.1 14.4 0.9 11.3 4.4 2.1 19.3 2.7 2.9 4.5 6.2 10.7 12.2 2.9 6.0 2.6 13.1 14.3 9.4 7.0 5.3 3.6 11.6 1.5 34.7 4.9 7.3 2.4 2.4 2.0 12.9 3.1 15.8 7.6 1.2 5.2 6.8 1.8 4.4 10.4 3.6 2.4 1.0 10.5 6.2 1.3 0.0 15.9 13.5 15.2 4.8 3.3 37.8 28.9 7.6 2.9 13.5 3.1 0.7 0.7 3.9 9.5 3.3 6.0 12.8 0.1 2.9 5.9 2.7 0.0 2.0 0.0 1.1 1.0 1.2 0.6 1.1 1.4 3.1 0.6 1.1 1.4 0.2 0.8 0.3 0.2 2.1 1.0 7.3 7.6 7.6 7.8 7.1 8.1 7.5 7.5 6.5 7.7 7.2 7.4 7.7 3.0 9.6 8.2 23.5 3.8 7.6 7.5 4.7 13.1 6.7 16.9 5.3 5.6 21.5 5.5 16.5 12.5 23.6 3.2 63.9 1.9 9.8 2.0 13.7 10.3 2.6 7.2 1.7 11.9 5.2 5.5 5.6 16.3 26.6 0.0 6.1 2.9 8.6 4.2 10.1 11.1 14.3 8.2 6.7 1.6 2.8 6.5 5.9 5.4 17.8 1.3 9.4 0.0 7.1 4.2 6.4 26.3 4.1 4.8 14.2 56.2 22.2 9.4 7.1 0.0 17.7 3.8 8.4 2.8 9.6 6.3 8.2 4.0 0.3 18.0 9.0 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647551-46661182 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.6" "Cell type enhanced" "Detected in many" "Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 10.5;SH-SY5Y: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.66e-4)" 8.1 3.3 42.0 6.0 43.0 1.5 5.5 42.7 56.5 29.1 8.2 38.9 3.9 48.6 14.5 7.4 37.7 7.3 19.3 50.2 34.2 5.9 2.6 14.1 1.1 47.6 41.9 48.1 17.2 1.1 1.9 4.2 1.7 53.8 19.9 6.7 5.9 1.7 24.8 2.2 3.3 13.1 31.9 39.6 6.8 18.1 18.8 48.8 0.5 4.8 2.9 0.9 39.3 16.0 59.6 0.2 0.2 5.6 5.3 1.9 1.5 0.5 3.1 5.2 1.0 1.5 0.2 0.3 0.5 2.0 10.5 1.0 0.3 3.6 0.1 1.0 0.3 1.9 1.2 0.8 0.2 2.7 0.1 2.1 4.9 0.1 1.3 0.1 0.6 0.4 0.7 1.8 1.8 0.9 0.4 0.2 1.4 2.2 0.0 0.8 4.6 1.3 0.3 0.2 0.3 2.1 24.6 0.4 0.2 0.4 5.7 0.4 0.5 0.4 2.6 3.2 2.6 0.5 1.6 0.5 0.8 0.5 0.8 1.9 2.6 0.3 0.3 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.5 0.2 0.2 1.6 0.7 0.2 0.3 0.2 0.1 42.0 43.0 42.7 56.5 50.2 34.2 47.6 41.9 48.1 53.8 39.6 48.8 59.6 1.9 6.4 5.5 13.7 0.2 2.3 1.5 0.0 0.0 16.5 1.0 2.4 17.8 1.5 0.7 0.0 2.1 5.4 0.5 0.3 0.0 0.0 23.9 0.4 9.3 3.1 1.8 0.0 9.2 0.0 2.6 7.4 0.0 0.8 6.3 0.5 1.8 0.2 1.1 1.7 16.7 0.2 2.0 1.6 9.2 8.6 7.8 1.4 3.6 7.5 1.2 9.2 2.1 15.1 27.2 0.1 1.2 14.7 0.1 1.0 0.2 0.3 0.2 6.3 6.6 2.3 22.9 2.3 2.5 0.4 3.3 9.9 1.0 4.3 0.2 1.0 ADARB1 "ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1" ENSG00000197381 "Adenosine deaminase RNA specific B1" P78563 21 45073853-45226560 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing" "Hydrolase, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 60.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 65.8;HHSteC: 65.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029645 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029645: AB_10602106" "unprognostic (2.69e-1)" "unprognostic (7.65e-2)" "prognostic unfavorable (8.16e-5)" "unprognostic (1.82e-2)" "unprognostic (1.07e-2)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (6.97e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.57e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-2)" "unprognostic (2.38e-2)" 14.5 7.1 14.8 10.4 12.8 5.2 11.4 36.8 25.2 14.5 26.0 26.8 3.0 23.2 6.3 7.5 13.7 8.1 9.6 18.9 16.5 8.5 7.1 35.5 13.5 26.0 19.9 12.0 7.9 6.1 9.3 6.1 12.4 31.0 18.1 4.9 28.9 6.9 8.2 13.8 14.7 10.9 11.8 9.1 16.2 19.1 4.5 22.9 5.7 6.7 11.9 8.8 60.9 12.0 31.6 7.0 1.0 5.3 6.2 6.3 4.3 7.2 4.6 7.6 14.4 9.0 10.9 1.1 2.2 12.1 22.6 7.9 0.6 7.8 19.1 15.9 1.7 7.0 15.2 65.8 7.2 65.7 10.5 7.2 23.7 8.1 5.1 14.9 5.4 15.4 20.4 3.5 0.8 42.2 5.1 6.8 10.0 8.6 3.4 10.1 2.0 5.0 7.1 3.2 2.3 30.6 8.2 36.4 1.6 11.6 8.5 3.5 8.2 16.3 4.7 5.7 19.4 17.5 6.6 3.1 1.8 4.3 24.1 25.8 0.7 0.0 2.4 0.4 0.2 0.8 1.0 1.1 0.7 0.0 2.6 0.7 0.6 0.1 0.3 0.2 1.0 0.8 0.2 14.8 12.8 36.8 25.2 18.9 16.5 26.0 19.9 12.0 31.0 9.1 22.9 31.6 29.0 0.0 1.1 10.7 12.0 11.1 2.9 3.4 2.8 62.9 6.2 7.1 21.6 1.5 1.9 0.0 12.5 0.5 5.9 0.9 0.0 1.3 2.7 1.6 8.8 21.2 0.0 2.1 54.1 0.5 1.2 9.4 2.6 1.6 8.2 5.5 14.3 6.3 5.9 69.0 85.7 0.9 0.0 3.4 4.9 2.9 3.7 3.2 5.4 37.5 5.0 34.2 2.1 16.1 4.8 1.0 0.1 5.7 4.0 5.5 0.3 2.7 0.7 16.0 0.0 32.9 12.7 11.4 17.7 1.5 7.2 1.0 13.7 1.4 1.2 2.3 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981750-31991723 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.2" "Cell type enhanced" "Detected in some" "B-cells: 14.0;Extravillous trophoblasts: 3.8;Respiratory ciliated cells: 4.3;Syncytiotrophoblasts: 4.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "memory B-cell: 7.0;naive B-cell: 5.2" "Lineage enriched" "Detected in single" 56 "B-cells: 7.0" "Cell line enriched" "Detected in many" 4 "BEWO: 44.8" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 0.3 0.2 0.1 1.4 0.2 0.1 1.4 0.0 0.2 1.5 0.5 0.6 0.2 0.9 2.3 1.7 1.0 0.6 0.2 0.4 0.3 1.0 0.0 0.7 3.1 0.1 0.5 0.1 0.7 0.1 0.0 1.4 1.3 0.2 2.8 0.8 0.7 1.4 1.2 0.1 1.2 1.2 0.7 0.0 1.6 0.6 1.0 0.2 0.4 0.9 0.2 4.2 1.1 0.8 0.1 3.0 0.9 0.0 2.3 0.0 0.1 44.8 0.2 0.1 0.2 0.3 3.0 3.5 3.3 3.3 0.0 1.4 2.8 1.0 4.5 0.3 0.0 0.4 0.0 4.4 1.5 0.0 0.0 0.0 0.2 2.0 0.3 8.6 0.3 0.8 0.0 0.0 0.0 0.4 2.6 0.0 0.0 1.2 8.1 4.7 0.0 0.0 0.1 10.2 1.2 0.2 0.0 0.6 5.3 0.0 2.1 4.0 0.0 1.7 0.3 3.5 0.0 0.3 0.0 0.0 5.2 0.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.4 0.3 0.1 0.5 0.1 0.2 0.0 0.2 0.1 0.5 0.0 0.0 0.0 14.0 0.9 0.5 0.7 0.6 0.6 1.9 0.8 0.6 0.0 3.1 0.0 0.0 1.7 0.1 0.2 0.0 0.1 0.1 1.2 0.7 1.1 3.5 0.0 1.6 0.5 3.8 0.7 1.5 1.6 0.0 0.0 0.4 0.0 0.3 0.0 1.7 0.5 2.0 0.0 0.5 0.3 0.6 0.3 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.3 0.2 0.4 0.7 0.8 0.5 1.2 4.3 0.0 0.0 0.2 0.7 0.1 0.2 2.4 0.3 4.2 0.4 0.0 0.5 0.6 HTT "HD, IT15" ENSG00000197386 Huntingtin P42858 4 3041363-3243960 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002756, HPA026114" Uncertain Supported Nucleoplasm,Cytosol NA NA 36000 Nucleoplasm Cytosol "CAB002756: , HPA026114: AB_1851330" "unprognostic (2.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.52e-2)" "unprognostic (8.33e-2)" "unprognostic (8.06e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-2)" "unprognostic (6.04e-2)" "prognostic favorable (2.41e-12)" "unprognostic (9.46e-3)" "unprognostic (1.99e-1)" "unprognostic (6.53e-2)" "unprognostic (3.84e-2)" 7.9 9.4 8.8 8.3 10.0 8.2 7.6 6.1 11.4 6.1 5.8 8.1 6.1 7.2 8.4 10.5 6.8 5.2 6.5 13.2 4.7 7.9 9.0 10.2 11.6 7.1 4.7 9.8 7.3 21.4 12.4 9.1 6.9 6.6 7.0 6.6 10.3 7.3 5.8 15.4 15.3 9.7 5.8 1.8 11.6 8.9 10.2 5.9 11.4 9.1 12.5 8.9 7.3 7.0 9.3 19.5 14.2 17.6 10.3 30.9 20.2 17.7 9.0 10.4 13.0 12.6 17.3 12.2 28.6 8.9 20.9 21.6 10.7 20.6 15.3 12.0 7.8 15.4 27.4 18.0 18.8 7.5 17.7 37.9 11.1 9.5 25.4 10.7 9.3 14.3 13.0 17.7 9.9 11.4 17.9 22.4 17.1 21.2 9.7 20.7 17.7 16.9 5.7 14.2 18.1 18.5 13.9 15.0 5.7 14.6 12.9 16.1 10.8 20.6 16.8 11.1 12.4 19.0 7.6 8.8 22.9 13.4 16.4 13.3 0.0 0.7 0.9 1.0 1.1 0.7 0.8 0.8 1.3 1.1 0.6 0.4 0.7 0.1 0.9 1.5 0.7 1.2 0.7 8.8 10.0 6.1 11.4 13.2 4.7 7.1 4.7 9.8 6.6 1.8 5.9 9.3 15.8 25.6 14.8 41.1 20.7 13.8 8.0 12.4 9.1 48.1 20.4 15.4 10.4 17.2 14.6 14.7 181.4 11.8 26.1 22.4 5.9 12.0 9.4 23.1 20.8 17.2 18.5 18.5 88.8 17.5 11.7 13.9 20.9 25.3 11.4 54.9 22.1 17.1 26.7 45.4 75.1 13.3 4.1 23.4 15.4 10.3 16.1 25.4 8.8 40.3 18.2 20.8 24.7 59.8 52.4 20.0 21.2 11.7 15.3 15.7 20.9 12.2 12.0 50.7 13.1 19.2 13.6 13.0 21.3 21.9 20.0 8.3 19.5 16.8 20.9 11.6 OR6N1 ENSG00000197403 "Olfactory receptor family 6 subfamily N member 1" Q8NGY5 1 158747814-158772195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "Distal tubular cells: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 25 "basophil: 5.1" "Lineage enriched" "Detected in single" 52 "granulocytes: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C5AR1 "C5A, C5AR, C5R1, CD88" ENSG00000197405 "Complement C5a receptor 1" P21730 19 47290023-47322066 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 126.6;lymphoid tissue: 85.5" "Group enriched" "Detected in many" 4 "Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 394.0" "Group enriched" "Detected in many" 42 "granulocytes: 394.0;monocytes: 115.9" "Cell line enhanced" "Detected in some" "A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB002720, HPA014520, HPA048012" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB002720: , HPA014520: AB_1846337, HPA048012: " "unprognostic (5.95e-2)" "prognostic favorable (4.71e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (4.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-2)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (9.55e-4)" "unprognostic (2.02e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.96e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.82e-2)" "unprognostic (6.54e-2)" 73.3 18.4 4.8 85.5 4.8 126.6 8.6 3.5 8.8 11.9 20.0 8.7 2.5 7.6 1.4 8.4 24.1 39.1 8.6 4.2 27.1 9.7 18.1 43.5 11.6 9.6 6.5 2.6 5.0 8.9 4.9 52.2 32.1 5.8 5.4 4.3 4.5 5.1 2.5 1.9 2.2 5.9 28.4 8.7 38.5 7.2 2.6 9.2 7.2 3.6 5.8 4.3 37.4 4.6 11.2 1.0 3.9 0.1 0.1 0.7 0.2 0.6 0.7 0.5 0.2 0.1 0.2 4.1 0.3 0.7 0.9 0.4 1.4 0.2 0.5 0.2 0.7 0.5 0.1 3.8 0.6 0.4 1.5 4.7 0.3 2.2 0.4 0.3 0.6 0.0 0.2 0.2 1.7 0.1 1.1 0.2 2.5 1.2 0.2 0.3 0.2 0.1 0.3 1.3 0.9 0.0 0.0 0.3 0.3 0.6 0.5 0.2 2.2 0.0 0.1 2.1 0.3 0.1 0.2 0.3 0.3 6.2 6.5 0.2 41.6 53.8 38.8 0.4 80.4 0.3 0.4 0.3 0.2 6.1 0.6 0.3 0.3 394.0 0.5 115.9 1.1 0.3 19.3 4.8 4.8 3.5 8.8 4.2 27.1 9.6 6.5 2.6 5.8 8.7 9.2 11.2 4.4 3.2 20.8 0.0 5.1 5.1 1.0 3.4 2.8 1.0 2.1 4.4 2.9 1.5 15.3 1.8 2.1 0.8 1.5 1.6 3.9 0.0 1.3 17.3 1.8 6.3 0.0 0.4 1.5 0.0 1.5 5.3 1.1 4.6 25.2 0.1 2.9 8.3 130.9 0.0 0.6 0.8 4.1 228.3 122.4 1.3 0.6 446.7 5.4 5.6 56.3 0.2 0.0 1.0 0.3 0.1 0.1 0.0 4.9 0.5 0.7 1.3 40.7 4.3 13.1 4.1 2.8 0.5 0.9 1.4 3.0 1.5 3.3 0.0 1.3 0.5 DIO3 TXDI3 ENSG00000197406 "Iodothyronine deiodinase 3" P55073 14 101561351-101563452 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 19.8;placenta: 17.9" "Cell type enhanced" "Detected in some" "Endothelial cells: 7.8;Fibroblasts: 27.9;Leydig cells: 10.8;Muller glia cells: 8.1;Peritubular cells: 7.5;Skeletal myocytes: 16.3;Syncytiotrophoblasts: 28.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "hypothalamus: 13.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "AF22: 54.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "amygdala: 4.4;hippocampal formation: 5.6" HPA073684 Supported Vesicles NA NA Vesicles "HPA073684: " "unprognostic (4.52e-3)" "unprognostic (1.80e-1)" "unprognostic (3.04e-3)" "unprognostic (3.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.24e-2)" "unprognostic (8.11e-2)" "unprognostic (2.58e-1)" "unprognostic (6.24e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-1)" "unprognostic (7.46e-5)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (1.11e-4)" "unprognostic (9.80e-3)" 5.0 0.4 0.5 1.8 1.2 0.0 3.2 0.2 1.2 19.8 0.3 1.7 0.0 6.5 0.6 1.9 6.8 3.0 0.4 0.5 13.7 0.3 3.9 2.6 1.3 1.2 0.3 0.8 13.7 1.5 0.0 0.7 17.9 0.4 3.3 0.4 0.7 1.7 2.3 1.6 3.1 1.7 0.9 0.2 0.6 1.6 1.3 2.6 0.2 4.2 3.0 0.1 5.3 15.6 0.4 0.0 0.2 54.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 1.0 1.3 0.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.2 1.2 0.5 13.7 1.2 0.3 0.8 0.4 0.2 2.6 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.0 1.9 0.0 5.9 0.0 0.6 0.3 0.4 4.9 7.8 0.0 0.0 0.1 0.0 2.5 27.9 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.0 0.7 0.6 10.8 0.1 0.0 0.0 0.6 8.1 0.0 0.0 0.0 0.9 1.1 7.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 16.3 0.7 0.1 0.2 0.2 0.1 28.3 0.2 0.1 0.3 0.4 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991282-41018398 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "liver: 538.2" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 420.9" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;OE19: 1.8" "Region enhanced" "Detected in single" "spinal cord: 2.3" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.0 0.0 0.3 0.2 0.2 0.5 0.1 0.6 0.3 0.0 0.3 4.8 5.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.3 15.2 538.2 0.4 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 1.8 0.9 0.0 0.1 0.2 0.0 6.8 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.0 2.6 0.1 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.5 0.2 1.8 0.1 0.0 0.1 0.1 0.6 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.3 0.2 0.1 0.2 0.2 0.1 0.3 0.3 0.0 0.4 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.1 0.0 0.4 0.1 0.0 0.3 0.2 0.6 0.3 0.2 0.3 0.3 0.2 0.1 0.4 0.1 0.2 0.4 0.0 0.0 1.1 0.0 0.8 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.2 7.2 1.4 1.8 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 16.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.4 420.9 0.0 0.0 0.1 1.6 0.0 11.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 0.0 0.1 38.3 16.9 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.1 4.3 0.7 H3C4 "H3/b, H3FB, HIST1H3D" ENSG00000197409 "H3 clustered histone 4" P68431 6 26196784-26197286 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.3;brain: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.7;MOLT-4: 5.4;U-266/70: 11.7;U-266/84: 6.9" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (8.64e-2)" "unprognostic (1.27e-2)" "unprognostic (9.06e-3)" "unprognostic (2.00e-1)" "unprognostic (6.59e-2)" "unprognostic (1.43e-2)" "unprognostic (8.62e-2)" "unprognostic (1.56e-1)" "unprognostic (2.95e-1)" "unprognostic (2.69e-2)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.78e-6)" "unprognostic (2.44e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" 0.3 0.8 1.7 0.1 2.6 12.3 0.6 14.7 2.5 1.5 4.5 0.8 0.6 0.2 0.0 2.0 1.0 0.5 0.4 0.7 2.0 0.9 1.5 1.4 0.4 3.5 4.5 1.1 0.8 0.2 0.0 0.6 0.2 3.2 2.8 0.0 0.1 1.0 0.1 0.0 0.5 0.7 0.1 6.8 1.8 0.6 0.8 4.1 1.8 0.6 0.0 0.3 0.7 2.8 7.0 1.5 0.0 0.2 1.2 0.8 0.3 0.7 0.0 0.3 1.6 1.1 2.9 0.6 2.7 1.3 0.4 0.0 0.4 0.7 0.1 0.0 1.5 0.2 0.1 1.3 2.0 0.1 0.9 1.8 0.1 0.1 1.2 0.3 0.0 0.5 1.1 1.2 5.7 0.0 0.6 5.4 4.6 0.2 0.1 0.9 2.7 0.3 3.1 0.0 0.0 0.8 0.1 0.0 1.0 0.8 0.0 0.6 1.6 1.4 0.3 2.9 0.0 1.5 11.7 6.9 0.6 1.5 0.3 0.4 14.8 1.6 4.2 3.4 1.6 8.6 8.3 2.5 3.5 3.9 13.0 2.6 4.6 22.2 3.2 3.5 5.1 3.3 0.9 1.7 2.6 14.7 2.5 0.7 2.0 3.5 4.5 1.1 3.2 6.8 4.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" Q6V1P9 4 154231742-154491799 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1" "Cell type enhanced" "Detected in some" "Astrocytes: 63.0;Early spermatids: 20.7;Excitatory neurons: 30.3;Horizontal cells: 25.2;Inhibitory neurons: 13.2;Late spermatids: 19.4;Microglial cells: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-2 OS: 4.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA064159: AB_2685201" "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.0 0.1 0.4 0.0 0.8 0.0 0.1 0.4 0.5 0.6 0.0 1.3 0.0 1.4 0.0 0.0 0.9 0.1 0.0 0.4 2.1 0.1 0.0 0.1 0.0 0.5 1.3 0.5 0.7 0.0 0.0 0.6 0.0 0.4 0.4 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.2 0.8 0.0 1.3 1.1 0.7 0.0 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.4 0.5 0.4 2.1 0.5 1.3 0.5 0.4 0.8 0.7 1.4 0.0 0.0 0.0 63.0 0.0 0.4 0.2 0.8 0.0 0.4 0.8 0.6 1.9 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.7 0.1 0.5 0.3 6.7 0.0 30.3 0.0 0.0 1.8 3.6 0.0 0.0 1.2 0.0 0.0 0.1 25.2 13.2 0.1 0.0 0.0 0.7 19.4 0.6 0.0 0.0 13.1 0.0 0.2 0.0 6.6 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.2 0.0 0.3 0.5 1.7 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;kidney: 27.3;lung: 29.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 266.0;Alveolar cells type 2: 175.9;Distal tubular cells: 46.9;Early spermatids: 64.5;Late spermatids: 84.7" "Cancer enhanced" "Detected in many" "melanoma: 4.3;renal cancer: 4.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 92.0;hTERT-RPE1: 96.7;HUVEC TERT2: 245.1;TIME: 147.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.4 20.4 0.4 0.1 0.3 2.3 1.9 0.8 0.6 3.1 9.1 0.8 0.7 0.3 17.7 0.0 5.5 1.0 0.2 0.8 0.4 27.3 0.5 29.7 0.0 2.5 1.2 0.1 0.2 13.2 2.1 17.2 1.3 3.0 1.4 0.8 0.4 2.5 2.9 0.1 1.5 0.1 0.2 0.6 4.0 0.9 2.9 0.4 0.1 2.1 0.1 0.0 0.4 0.3 1.4 7.3 0.8 16.0 0.0 9.2 33.8 0.0 41.9 92.0 12.2 17.7 1.1 6.4 0.0 16.0 45.3 1.9 0.3 0.5 1.0 67.2 0.2 0.0 7.3 0.8 0.0 2.9 0.0 0.1 9.9 0.7 51.9 10.3 96.7 245.1 0.0 2.5 0.0 33.4 0.9 0.0 0.0 6.6 1.9 6.2 0.0 1.2 0.0 6.1 3.6 0.6 0.0 1.3 1.9 17.0 0.2 70.7 0.1 147.2 48.0 1.6 16.8 58.0 0.0 0.0 0.0 38.6 0.0 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.4 0.3 0.8 0.6 0.8 0.4 2.5 1.2 0.1 3.0 0.6 0.4 1.4 0.1 266.0 175.9 1.6 0.5 1.8 0.2 0.0 0.0 0.2 4.5 3.7 0.5 22.8 14.3 31.3 2.1 1.8 0.2 1.2 46.9 6.9 64.5 11.1 0.5 0.9 0.0 0.0 2.8 10.1 0.1 0.9 0.0 4.4 0.0 0.8 0.0 0.0 0.2 0.0 3.3 0.4 0.0 0.0 0.3 84.7 1.5 2.3 28.4 0.0 0.7 1.5 0.0 0.0 0.9 1.8 3.2 0.4 0.0 0.3 0.0 28.7 8.1 0.5 0.0 0.1 1.3 0.3 0.9 0.0 0.4 0.0 0.6 0.9 0.8 0.2 FABP12 ENSG00000197416 "Fatty acid binding protein 12" A6NFH5 8 81524981-81531378 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 72.7" "Group enriched" "Detected in some" 4 "Early spermatids: 83.1;Late spermatids: 150.3" "Cancer enhanced" "Detected in single" "cervical cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044041 Enhanced NA NA "HPA044041: AB_10962213" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 72.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 83.1 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 150.3 0.6 0.0 0.0 0.0 0.0 4.1 0.0 2.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.5 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 SHPK "CARKL, SHK" ENSG00000197417 Sedoheptulokinase Q9UHJ6 17 3608240-3636250 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 19.1;Proximal enterocytes: 18.9;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024361, HPA064939" Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA 350000 "Nucleoplasm, Nuclear speckles" "HPA024361: AB_1846030, HPA064939: AB_2685388" "unprognostic (1.75e-2)" "unprognostic (1.51e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (3.57e-3)" "unprognostic (1.54e-2)" "unprognostic (1.95e-2)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" "unprognostic (3.64e-2)" "unprognostic (1.08e-2)" "unprognostic (1.42e-1)" "unprognostic (3.82e-2)" "unprognostic (6.75e-2)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" 6.8 10.0 3.4 3.9 4.4 4.8 7.0 3.7 3.7 8.5 2.3 6.2 13.6 4.9 2.9 9.5 6.2 3.7 4.5 2.8 2.9 10.3 23.5 4.8 3.9 3.5 3.8 2.4 7.5 11.0 8.7 4.6 6.3 4.2 5.8 6.0 7.2 7.1 5.5 3.4 9.3 11.6 3.5 2.6 4.4 8.5 4.2 3.7 4.5 5.6 3.4 5.3 5.6 7.8 8.4 6.7 13.5 14.0 9.1 5.7 5.7 7.8 4.4 4.0 8.5 5.0 23.3 6.2 7.9 9.5 8.6 7.9 12.8 18.8 14.3 6.1 12.8 18.3 8.6 11.6 17.0 6.9 7.6 11.8 9.7 6.8 9.4 6.3 7.2 16.1 6.2 11.6 9.8 8.3 12.0 9.8 5.9 7.0 15.3 8.9 13.3 7.3 12.6 12.0 8.5 4.1 10.7 16.2 14.7 4.6 8.4 13.2 4.4 11.6 12.8 6.1 12.5 10.9 3.3 4.5 5.2 13.9 6.7 6.7 1.5 2.2 2.5 1.9 2.3 2.0 2.1 1.8 1.6 3.0 1.5 3.0 1.9 0.4 3.2 1.8 3.2 1.6 2.5 3.4 4.4 3.7 3.7 2.8 2.9 3.5 3.8 2.4 4.2 2.6 3.7 8.4 2.6 0.0 3.2 11.1 2.0 0.0 1.0 0.1 3.4 5.9 3.2 2.3 1.0 4.3 0.8 5.5 16.7 10.0 1.1 9.2 1.9 3.3 0.5 2.6 2.5 2.9 3.5 5.2 4.5 4.7 10.1 3.3 4.6 2.9 0.0 5.0 3.6 19.1 8.4 15.2 5.3 6.0 0.0 2.2 0.4 0.4 4.1 2.2 0.0 8.4 2.7 2.5 1.0 4.0 8.2 5.3 6.7 2.6 2.0 2.2 18.9 8.5 1.0 18.2 0.0 4.8 1.8 0.6 1.2 3.0 0.4 5.6 2.1 16.9 6.5 1.8 OR51D1 OR51D1Q ENSG00000197428 "Olfactory receptor family 51 subfamily D member 1" Q8NGF3 11 4637477-4643060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061240 Uncertain NA NA "HPA061240: AB_2684457" "unprognostic (1.90e-1)" 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.7 0.4 0.3 0.5 0.4 0.4 0.5 0.4 0.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IPP KLHL27 ENSG00000197429 "Intracisternal A particle-promoted polypeptide" Q9Y573 1 45694324-45750653 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075545 Approved NA NA "HPA075545: " "unprognostic (8.45e-3)" "unprognostic (1.35e-1)" "prognostic favorable (9.11e-4)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (5.84e-3)" "prognostic unfavorable (2.27e-4)" "unprognostic (2.99e-1)" "unprognostic (1.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.77e-1)" "unprognostic (7.03e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.68e-2)" "unprognostic (6.44e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-1)" 5.6 4.5 3.1 3.8 4.6 3.4 6.2 4.0 2.9 4.9 3.4 5.7 4.9 6.6 5.4 6.3 6.6 5.0 7.1 2.6 4.8 7.1 6.9 4.3 4.4 4.0 3.9 2.5 7.6 6.6 9.6 2.3 4.0 3.6 7.1 5.7 7.4 5.7 6.5 14.4 5.1 5.4 5.7 3.7 3.8 5.1 10.2 3.7 6.6 9.8 9.1 5.0 3.8 2.9 5.0 9.6 9.1 8.0 11.8 9.8 18.2 6.2 9.9 7.1 6.9 7.0 5.6 6.8 5.2 10.1 12.3 7.9 6.7 8.8 7.3 9.9 12.2 5.2 7.3 7.7 6.9 9.8 2.1 6.2 15.5 8.3 15.0 8.1 8.0 6.8 9.4 9.0 10.3 12.2 6.4 7.3 0.4 4.8 7.0 4.9 3.1 14.7 4.3 5.7 10.4 11.5 7.5 19.1 10.3 9.5 9.1 10.0 1.8 7.9 7.5 9.2 5.3 7.9 8.3 10.4 9.2 12.0 3.1 11.9 4.1 0.6 3.5 4.6 0.4 3.4 3.1 2.7 3.7 0.7 2.6 3.4 4.0 2.6 3.7 0.8 0.6 4.7 2.5 3.1 4.6 4.0 2.9 2.6 4.8 4.0 3.9 2.5 3.6 3.7 3.7 5.0 7.6 12.8 10.0 11.1 7.9 2.5 5.6 7.6 6.8 12.4 6.5 4.8 18.8 5.7 8.1 5.5 12.5 7.8 4.7 10.1 3.9 6.5 26.0 10.7 10.1 5.2 5.4 3.0 5.4 7.3 6.9 9.6 9.7 6.7 12.7 15.9 3.3 5.9 1.4 18.5 7.1 6.8 6.1 1.3 1.1 7.6 7.2 2.8 1.8 4.7 3.4 19.0 18.6 6.0 11.9 5.8 4.6 6.4 7.4 3.9 9.5 8.4 10.1 16.8 0.0 14.0 9.3 40.8 14.7 6.7 4.7 7.7 8.4 23.5 5.8 4.9 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343221-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 640 "brain: 149.9;choroid plexus: 61.5" "Cell type enriched" "Detected in some" 304 "Oligodendrocytes: 304.5" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "REH: 1.0" "Region enhanced" "Detected in all" "white matter: 240.1" "Low region specificity" "Detected in all" HPA014372 Supported NA NA "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 0.0 0.0 116.3 0.0 141.1 0.0 0.0 72.2 147.1 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.7 100.5 0.0 0.0 0.0 0.0 134.0 119.8 96.3 0.0 0.0 0.0 0.1 0.0 117.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.0 105.7 0.0 0.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.3 141.1 72.2 147.1 113.7 100.5 134.0 119.8 96.3 117.2 83.2 105.7 149.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 304.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13G1 ENSG00000197437 "Olfactory receptor family 13 subfamily G member 1" Q8NGZ3 1 247670812-247679739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAP3K5 "ASK1, MAPKKK5, MEKK5" ENSG00000197442 "Mitogen-activated protein kinase kinase kinase 5" Q99683 6 136557046-136792477 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 88.9" "Cell type enhanced" "Detected in many" "Astrocytes: 383.6;Excitatory neurons: 170.4;Inhibitory neurons: 204.8;Microglial cells: 216.4;Oligodendrocyte precursor cells: 210.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007824, HPA063245" Supported Supported Cytosol NA NA Cytosol "CAB007824: AB_598175, HPA063245: AB_2684969" "unprognostic (1.37e-1)" "unprognostic (3.21e-2)" "unprognostic (2.85e-2)" "unprognostic (1.38e-1)" "unprognostic (3.19e-1)" "prognostic favorable (6.08e-4)" "unprognostic (8.76e-2)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.91e-4)" "unprognostic (3.97e-1)" "unprognostic (3.75e-2)" "unprognostic (1.37e-1)" "unprognostic (2.72e-1)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 12.7 88.9 22.6 11.8 23.3 14.3 9.6 22.8 19.1 7.6 9.7 8.7 7.3 11.4 7.8 10.1 13.0 7.5 9.6 19.1 34.1 10.7 9.1 12.0 12.2 18.8 20.8 17.0 49.7 31.2 1.9 16.4 5.4 17.4 18.1 9.8 14.6 7.1 7.2 6.4 8.0 9.1 5.2 18.5 11.8 14.9 12.1 20.6 8.3 12.9 6.1 12.4 18.6 9.3 16.5 5.6 3.4 0.0 0.0 7.6 20.2 1.9 8.0 42.6 4.0 3.8 0.3 5.6 3.3 11.5 11.1 3.0 7.6 13.6 4.1 10.5 4.6 10.6 28.9 7.6 0.0 36.3 13.6 0.1 26.8 5.3 6.3 17.9 15.4 13.6 4.1 7.3 31.2 28.7 10.9 0.3 11.6 1.3 10.9 4.5 7.6 8.9 13.2 16.2 35.3 9.7 6.4 6.6 6.3 1.8 1.4 1.4 12.0 12.0 6.7 2.1 0.4 7.5 25.3 18.0 0.0 5.3 18.6 6.0 3.5 1.8 2.1 1.5 1.4 2.9 1.1 2.5 2.2 1.5 1.5 0.2 0.8 5.2 2.3 1.4 1.5 4.6 0.9 22.6 23.3 22.8 19.1 19.1 34.1 18.8 20.8 17.0 17.4 18.5 20.6 16.5 11.9 6.4 22.0 383.6 14.3 5.0 20.5 32.0 3.4 18.2 10.0 5.0 21.2 4.3 35.1 11.0 6.2 1.0 25.9 12.3 3.9 3.0 6.4 17.3 31.4 7.7 34.8 14.9 170.4 23.1 1.1 12.1 20.9 62.5 5.7 67.7 9.7 11.2 8.0 0.0 204.8 18.2 14.2 23.5 10.2 4.2 23.6 26.6 0.0 216.4 21.7 43.3 12.3 210.1 4.2 17.8 8.7 14.3 13.5 18.8 7.2 8.3 20.5 2.6 13.1 5.3 17.9 3.4 15.5 13.1 10.1 2.7 18.5 16.2 11.2 23.4 OGDHL FLJ10851 ENSG00000197444 "Oxoglutarate dehydrogenase L" Q9ULD0 10 49734641-49762379 "Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 79.6;kidney: 122.9;liver: 80.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7" "Group enriched" "Detected in many" 5 "liver cancer: 14.7;renal cancer: 44.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043716, HPA052497" Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043716: , HPA052497: AB_2681853" "unprognostic (9.05e-2)" "unprognostic (3.93e-3)" "unprognostic (5.30e-2)" "unprognostic (2.50e-1)" "unprognostic (3.70e-3)" "unprognostic (2.03e-1)" "unprognostic (1.46e-3)" "unprognostic (4.19e-1)" "unprognostic (2.07e-1)" "unprognostic (1.46e-2)" "unprognostic (1.52e-3)" "unprognostic (4.60e-1)" "prognostic favorable (1.21e-14)" "unprognostic (3.25e-2)" "unprognostic (1.85e-1)" "unprognostic (1.59e-3)" "unprognostic (8.38e-2)" 0.1 11.7 20.4 0.3 22.4 0.0 0.0 22.5 41.3 0.7 79.6 1.3 1.0 2.2 0.6 0.1 1.0 0.4 5.9 23.9 34.1 122.9 80.7 0.0 0.2 34.4 26.7 20.3 1.7 4.4 51.0 29.6 0.1 38.3 1.6 0.3 18.8 17.2 6.4 0.1 0.1 1.1 0.7 13.1 0.3 1.0 2.3 30.7 0.5 23.1 0.8 0.6 0.5 0.5 44.4 0.0 0.0 4.7 21.3 0.0 0.0 2.7 0.1 0.1 1.1 0.2 10.5 2.3 0.0 11.4 0.0 3.4 0.4 7.4 0.2 0.4 0.0 0.4 0.0 0.2 5.3 0.2 0.0 1.6 0.3 0.0 0.0 0.0 0.6 0.0 5.4 0.5 0.0 0.0 3.2 8.2 7.3 2.0 0.8 1.0 0.0 0.0 0.0 43.4 0.7 12.0 16.3 0.1 16.2 1.1 6.1 4.5 2.9 0.0 0.0 10.6 0.0 0.7 0.2 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 22.4 22.5 41.3 23.9 34.1 34.4 26.7 20.3 38.3 13.1 30.7 44.4 0.0 0.0 0.0 20.2 0.8 0.0 0.9 0.4 0.0 30.4 0.1 0.1 4.4 2.8 0.1 29.5 31.3 0.0 0.0 0.4 92.0 1.1 0.2 0.9 0.2 0.3 4.8 0.0 16.8 0.0 0.1 0.3 0.0 1.6 0.0 0.7 1.4 55.3 0.1 30.3 21.4 0.5 2.0 1.3 0.0 0.5 0.0 0.5 0.0 1.0 0.0 5.4 0.0 3.5 1.8 0.1 1.1 0.0 0.0 0.3 0.0 84.7 0.0 18.1 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.1 0.6 0.4 0.3 0.3 CYP2F1 CYP2F ENSG00000197446 "Cytochrome P450 family 2 subfamily F member 1" P24903 19 41114432-41128381 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 1.4;salivary gland: 1.0;testis: 2.1" "Cell type enriched" "Detected in some" 4 "Club cells: 67.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "HMC-1: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.04e-1)" "unprognostic (8.79e-2)" "unprognostic (4.63e-1)" "unprognostic (4.60e-2)" "unprognostic (2.54e-1)" "unprognostic (7.29e-3)" "unprognostic (6.23e-3)" "unprognostic (2.87e-2)" "unprognostic (3.91e-2)" "unprognostic (1.58e-6)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.5 0.0 67.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 16.5 0.0 0.0 0.0 1.6 8.0 5.3 1.5 0.0 0.0 0.6 0.0 0.0 0.1 GSTK1 GST13 ENSG00000197448 "Glutathione S-transferase kappa 1" Q9Y2Q3 7 143244093-143270854 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1160.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006311, HPA022904" Supported Supported Peroxisomes NA NA 110000 Peroxisomes "HPA006311: AB_1849786, HPA022904: AB_1849787" "prognostic favorable (4.41e-6)" "unprognostic (2.40e-1)" "unprognostic (6.53e-2)" "unprognostic (4.49e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-2)" "unprognostic (1.37e-1)" "unprognostic (2.99e-1)" "unprognostic (1.43e-1)" "unprognostic (3.76e-3)" "unprognostic (1.99e-2)" "unprognostic (7.27e-2)" "prognostic favorable (2.10e-6)" "unprognostic (2.66e-2)" "unprognostic (2.94e-1)" "unprognostic (9.13e-2)" "unprognostic (2.15e-2)" 152.3 182.4 80.0 137.2 84.5 188.7 160.4 86.6 89.9 155.8 134.0 219.9 320.0 96.0 111.6 155.3 146.0 141.8 274.3 78.6 92.8 256.4 453.0 126.2 186.5 87.6 85.4 76.7 71.7 139.2 310.8 80.3 105.1 86.5 112.3 233.0 27.1 214.9 97.3 240.9 131.3 279.4 107.5 81.7 238.4 164.9 85.7 85.3 97.1 161.4 326.9 185.2 130.7 113.4 91.2 150.7 106.1 14.7 130.1 224.2 319.7 68.8 87.0 148.4 76.3 150.8 64.5 375.2 85.4 120.8 126.7 114.5 222.4 57.5 136.2 66.0 165.0 62.3 69.6 80.9 102.9 154.1 84.7 108.4 290.4 164.3 88.0 62.0 113.1 205.3 109.5 99.3 100.9 207.2 116.2 87.3 152.9 34.7 291.3 158.6 73.9 2.4 169.6 266.1 81.6 59.7 81.4 159.4 256.3 137.4 88.3 123.6 117.0 122.2 41.0 37.7 108.5 75.2 171.0 86.5 20.0 148.5 336.0 86.6 351.1 537.1 210.7 298.5 597.9 289.7 254.5 554.6 386.4 445.2 183.2 281.3 274.6 165.0 188.3 641.7 187.0 800.5 917.1 80.0 84.5 86.6 89.9 78.6 92.8 87.6 85.4 76.7 86.5 81.7 85.3 91.2 181.9 70.5 95.6 17.0 134.1 114.2 174.9 244.0 118.4 11.6 181.9 198.2 172.9 211.6 219.5 121.4 12.5 295.3 151.4 301.6 291.6 160.5 561.3 102.7 95.8 117.0 153.6 63.3 25.8 120.3 132.0 96.4 185.5 92.9 145.1 47.4 155.3 322.1 304.2 8.4 28.8 252.8 154.6 288.3 174.1 1160.2 72.7 195.8 151.2 16.9 228.5 85.9 194.7 16.6 14.3 104.5 505.2 50.8 130.0 82.9 670.0 620.2 154.0 15.4 85.5 65.9 121.7 6.9 10.3 166.3 116.4 183.7 250.7 150.7 366.5 218.9 HNRNPAB "ABBP1, FLJ40338, HNRPAB" ENSG00000197451 "Heterogeneous nuclear ribonucleoprotein A/B" Q99729 5 178204533-178211163 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046688 Approved Enhanced Nucleoplasm NA NA 460000 Nucleoplasm "HPA046688: AB_10964924" "unprognostic (2.23e-1)" "unprognostic (6.21e-2)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (8.69e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (4.09e-2)" "unprognostic (6.17e-3)" "prognostic favorable (9.79e-4)" "unprognostic (9.12e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.35e-7)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (3.53e-1)" "unprognostic (2.08e-1)" 76.8 104.0 36.4 93.4 37.7 140.9 64.4 39.3 38.6 62.5 40.9 146.0 99.1 76.1 44.2 123.0 65.0 51.5 77.1 35.7 45.5 69.9 89.1 69.7 96.4 40.6 38.7 34.0 57.2 55.9 76.8 46.6 64.5 40.3 60.3 120.1 27.3 68.6 54.5 120.0 116.3 89.7 75.0 40.1 80.6 86.3 38.5 42.1 118.1 52.5 59.2 103.5 123.5 73.3 41.7 347.4 282.5 424.1 414.7 153.8 134.6 613.2 378.5 174.3 296.9 317.2 525.4 251.8 555.2 340.3 204.7 361.1 223.2 373.1 516.7 363.8 865.9 439.5 349.8 223.7 325.1 153.7 446.1 285.6 134.0 239.2 267.3 266.8 122.3 270.3 218.4 290.1 245.7 302.0 934.2 542.6 429.7 389.5 354.0 401.7 436.3 255.6 329.8 254.2 364.8 389.5 302.4 295.2 407.9 278.8 264.0 244.7 270.7 244.0 359.7 305.2 256.2 527.8 285.4 360.2 649.3 145.2 488.2 298.8 3.2 4.4 15.7 5.1 7.0 5.7 5.9 4.1 6.0 4.4 5.2 3.9 4.7 0.8 5.8 7.5 10.9 4.8 2.2 36.4 37.7 39.3 38.6 35.7 45.5 40.6 38.7 34.0 40.3 40.1 42.1 41.7 124.7 32.1 41.0 4.6 115.4 281.6 212.1 42.7 243.0 26.5 129.6 141.3 45.9 41.5 42.7 49.7 18.8 106.3 148.5 251.2 50.9 118.9 9.3 112.4 225.6 107.1 119.2 273.2 3.5 151.7 208.9 110.1 167.7 124.7 44.5 102.0 53.6 101.2 101.0 16.8 4.3 219.0 48.8 67.0 129.9 11.1 74.0 109.9 67.6 8.4 56.2 34.7 76.2 3.5 6.1 204.2 138.2 88.0 179.6 275.0 90.5 116.8 25.8 28.3 78.9 149.7 173.6 81.6 122.4 362.5 339.8 114.4 129.7 238.1 247.9 235.5 OR2L5 "OR2L11, OR2L5P" ENSG00000197454 "Olfactory receptor family 2 subfamily L member 5" Q8NG80 1 248013660-248024276 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.2 0.4 0.1 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 293.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 5 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 21.0 50.1 183.7 21.5 191.0 11.5 20.1 103.2 293.9 27.7 16.4 22.1 5.5 30.3 5.1 11.7 28.2 11.0 16.8 210.4 151.2 24.9 3.7 23.8 26.0 233.0 160.8 209.1 50.9 16.6 17.6 103.0 10.1 262.8 24.6 5.2 39.1 11.8 12.9 4.4 20.2 25.0 14.8 85.5 48.6 15.2 9.0 154.0 43.9 64.4 3.7 12.5 22.1 19.2 242.9 10.4 11.6 74.4 125.1 1.9 7.3 5.1 12.0 0.4 35.8 16.8 73.6 13.7 0.5 36.3 4.6 2.0 68.6 52.2 1.3 11.1 5.2 14.0 5.1 17.0 27.6 9.9 3.9 42.0 15.3 0.3 11.5 2.9 1.5 1.3 34.4 98.8 2.2 9.6 11.7 142.0 17.7 76.5 2.4 81.7 143.8 12.1 58.0 60.9 2.0 192.5 146.6 5.7 3.4 14.9 5.9 2.1 25.9 1.9 0.8 20.4 0.8 2.6 4.9 10.4 3.6 2.1 14.3 48.8 1.1 0.0 1.1 2.5 0.1 2.7 0.2 5.2 4.5 0.1 0.6 6.2 5.3 0.1 0.0 0.1 1.1 0.9 2.0 183.7 191.0 103.2 293.9 210.4 151.2 233.0 160.8 209.1 262.8 85.5 154.0 242.9 5.8 6.4 2.5 16.3 17.1 8.2 6.9 11.9 8.6 108.5 4.7 14.7 2.3 4.3 3.2 3.7 52.1 11.7 13.4 1.1 13.7 4.0 10.0 1.6 17.9 7.8 37.2 4.6 56.9 2.5 4.0 25.4 2.0 2.7 4.5 254.2 6.8 0.0 2.3 109.4 67.1 0.6 4.1 2.2 7.6 18.8 30.1 3.5 7.2 7.5 4.6 37.2 16.5 21.1 11.3 2.2 0.1 35.7 5.3 4.5 0.1 5.0 0.8 44.5 13.1 3.0 20.9 3.3 6.7 1.6 4.3 8.8 28.6 51.0 0.6 2.7 PDGFA "PDGF-A, PDGF1" ENSG00000197461 "Platelet derived growth factor subunit A" P04085 7 497258-520296 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 11.3" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "WM-115: 311.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005579, HPA065024" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 580000 "Golgi apparatus" "CAB005579: AB_2161916, HPA065024: " "unprognostic (2.22e-1)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.63e-3)" "unprognostic (4.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.85e-1)" "unprognostic (8.26e-2)" "unprognostic (1.07e-2)" "unprognostic (5.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (8.67e-4)" 14.8 8.5 31.2 8.0 34.7 1.7 17.1 35.4 33.4 17.9 21.1 26.8 20.4 26.3 11.3 9.7 21.4 11.5 18.3 27.3 30.4 18.2 8.6 25.1 3.5 46.4 37.2 24.7 7.8 72.2 6.7 10.2 27.1 45.0 23.5 14.9 5.3 20.5 11.3 96.1 12.6 26.1 10.3 38.7 16.4 32.4 4.5 34.6 6.7 10.1 15.2 2.4 18.0 16.0 58.8 22.9 15.3 1.5 21.6 4.1 0.7 50.7 5.0 2.9 6.4 4.4 23.8 25.3 0.6 8.7 4.3 2.9 56.6 1.5 69.0 3.4 12.9 2.3 0.3 13.3 8.7 26.9 2.4 2.2 3.0 26.8 3.3 21.3 8.5 12.5 1.3 2.3 3.1 15.8 28.7 3.5 5.0 40.1 8.9 3.3 11.6 1.5 2.5 9.0 5.3 2.1 1.8 76.5 4.2 13.3 47.5 10.7 2.6 37.3 13.6 37.8 8.0 31.0 0.9 1.4 0.8 12.3 7.1 311.4 11.3 1.6 2.4 1.6 1.9 2.2 1.9 1.6 1.5 1.5 1.8 1.9 2.0 4.9 3.4 3.3 2.1 1.8 2.1 31.2 34.7 35.4 33.4 27.3 30.4 46.4 37.2 24.7 45.0 38.7 34.6 58.8 15.2 89.8 11.9 11.1 1.5 28.0 20.2 12.1 59.7 15.7 12.7 154.9 29.9 15.7 11.0 14.7 8.4 8.8 1.7 76.9 5.9 15.8 0.3 49.0 4.2 19.4 13.1 0.0 7.7 53.3 5.4 12.3 41.8 35.7 10.8 18.1 21.0 1.0 2.0 32.0 5.9 40.5 2.0 1.3 10.4 0.1 2.1 14.8 14.2 6.5 1.5 0.7 1.0 5.0 27.5 72.6 97.0 6.4 4.4 29.4 47.2 8.5 4.5 2.1 39.5 48.9 110.3 0.5 1.8 9.4 9.8 2.9 3.9 0.2 32.1 18.2 GYPE "GPE, MNS" ENSG00000197465 "Glycophorin E (MNS blood group)" P15421 4 143870864-143905563 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "bone marrow: 13.4" "Cell type enriched" "Detected in some" 11 "Erythroid cells: 188.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "HEL: 120.9;K-562: 39.8" NA NA "unprognostic (2.17e-1)" "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.00e-2)" "unprognostic (4.71e-2)" "unprognostic (1.09e-4)" "unprognostic (2.05e-2)" "unprognostic (1.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-2)" "unprognostic (2.81e-3)" "unprognostic (1.10e-4)" "unprognostic (7.81e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (3.49e-2)" 1.1 0.3 0.1 1.4 1.0 13.4 0.7 0.0 1.6 0.7 0.0 0.2 0.0 0.3 0.7 0.3 0.2 0.7 0.9 0.6 0.4 0.4 0.1 2.9 1.1 0.1 0.0 1.2 0.0 0.1 0.2 0.2 0.8 0.4 0.3 0.4 0.2 0.3 0.6 0.1 0.3 0.9 0.4 0.0 3.2 0.3 0.5 0.0 1.1 0.8 0.0 2.6 0.7 0.2 0.3 0.0 0.0 0.0 0.0 6.8 6.6 0.0 2.8 6.4 1.4 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.0 1.6 0.0 0.0 120.9 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 39.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.6 0.6 0.4 0.1 0.0 1.2 0.4 0.0 0.0 0.3 0.2 16.0 1.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.0 188.4 5.3 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.8 0.5 0.3 0.0 0.3 3.6 1.0 0.0 0.0 1.0 6.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.3 0.0 0.0 0.1 0.3 0.7 0.0 0.0 COL13A1 ENSG00000197467 "Collagen type XIII alpha 1 chain" Q5TAT6 10 69801880-69964275 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Osteogenesis" "Developmental protein, Heparin-binding" "Congenital myasthenic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 30.7" "Cell type enhanced" "Detected in some" "Fibroblasts: 10.1;granulocytes: 20.3;Melanocytes: 5.4;Microglial cells: 6.5;NK-cells: 9.2;Smooth muscle cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 63.6;BJ hTERT+: 61.6;hTERT-RPE1: 83.7;HUVEC TERT2: 102.2;PC-3: 93.1;TIME: 137.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050392 Approved NA NA "HPA050392: AB_2681110" "unprognostic (2.79e-2)" "unprognostic (2.82e-3)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (4.67e-4)" "unprognostic (3.13e-1)" "unprognostic (1.69e-1)" "unprognostic (7.43e-2)" "unprognostic (6.16e-3)" "unprognostic (1.22e-1)" "unprognostic (2.60e-1)" "unprognostic (2.53e-2)" "unprognostic (1.36e-5)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.52e-2)" "unprognostic (3.93e-2)" 1.1 1.9 1.5 2.6 1.5 0.3 2.0 9.0 3.5 5.0 2.2 4.6 3.0 1.8 30.7 1.9 2.9 2.4 2.6 1.3 1.5 2.0 0.8 11.0 0.9 1.5 1.7 1.2 0.9 2.2 0.8 3.7 1.8 4.2 13.8 3.4 0.0 0.7 8.1 0.9 5.2 3.8 2.9 1.4 8.0 6.2 0.7 1.6 0.3 1.5 1.4 0.8 3.8 1.8 1.4 1.5 0.6 22.1 0.0 0.1 4.3 0.1 63.6 61.6 10.9 5.5 0.0 1.4 0.2 10.5 30.1 1.0 2.3 0.0 0.2 18.9 0.0 1.6 0.0 0.0 0.0 2.9 0.0 0.1 9.8 0.1 27.5 9.0 83.7 102.2 0.0 0.0 0.1 10.4 0.4 0.0 0.2 5.3 0.0 93.1 0.1 0.0 10.3 0.4 0.0 2.4 0.0 0.0 0.2 3.4 0.9 0.0 0.2 137.4 0.3 17.1 5.7 45.7 13.4 0.0 0.1 37.2 0.1 51.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.5 1.5 9.0 3.5 1.3 1.5 1.5 1.7 1.2 4.2 1.4 1.6 1.4 0.9 0.0 0.6 0.3 0.0 3.4 0.3 0.3 0.6 0.2 0.1 2.0 2.1 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.2 3.4 0.0 0.0 1.4 0.0 0.0 10.1 0.0 0.1 20.3 1.8 1.1 0.0 0.1 0.0 0.3 0.0 0.0 0.3 2.3 0.0 0.0 0.3 5.4 6.5 0.0 0.1 9.2 0.0 0.3 0.1 0.0 0.4 0.3 0.5 0.9 0.0 0.1 0.0 0.0 1.1 5.6 0.5 0.5 0.2 3.0 0.1 0.6 0.5 0.1 0.1 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 72.5;lung: 28.5;lymphoid tissue: 51.6" "Cell type enhanced" "Detected in many" "dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 218.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA 270000 "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 4.0 0.7 0.8 14.6 1.4 72.5 1.8 1.0 1.8 1.5 0.4 4.0 5.6 1.6 1.1 3.0 2.0 4.4 2.8 0.8 1.5 0.8 2.6 28.5 26.5 2.3 1.2 0.2 0.6 1.0 0.6 0.3 0.9 2.4 1.3 5.4 0.3 2.3 1.1 0.9 2.9 6.4 2.3 2.8 19.2 5.1 0.4 2.1 51.6 0.8 0.3 23.2 4.3 0.5 2.9 0.2 0.2 0.1 0.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.9 0.1 0.6 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 278.8 0.2 2.0 0.0 281.5 158.3 0.0 0.0 0.1 0.0 0.1 0.0 68.0 96.1 76.9 0.5 0.2 122.2 70.1 0.1 0.0 0.0 98.4 1.1 2.2 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.3 0.1 164.1 0.4 0.0 0.2 0.2 0.2 0.3 5.8 40.7 0.3 205.4 0.3 13.6 23.2 14.6 96.3 96.3 51.4 3.7 38.5 65.5 34.0 1.1 26.3 47.6 3.6 69.4 218.0 27.2 34.7 52.1 0.8 1.4 1.0 1.8 0.8 1.5 2.3 1.2 0.2 2.4 2.8 2.1 2.9 1.2 9.6 16.9 0.0 10.8 2.2 0.9 0.0 0.0 0.6 1.0 0.8 5.3 1.5 2.5 1.8 0.0 0.2 131.6 0.1 0.0 0.1 0.1 0.5 0.6 3.0 0.0 125.9 0.0 0.0 0.4 3.0 5.1 0.7 43.7 0.8 4.6 1.5 27.0 1.7 0.0 0.3 0.0 28.8 30.3 0.0 0.0 65.8 1.8 1.9 66.4 0.5 352.2 1.5 0.0 0.0 0.1 0.0 60.3 0.5 0.1 0.6 1.5 1.9 0.0 0.8 1.0 0.2 0.6 0.1 2.0 0.3 94.8 0.1 0.2 0.6 ZNF695 SBZF3 ENSG00000197472 "Zinc finger protein 695" Q8IW36 1 246945547-247008093 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 3.2;Extravillous trophoblasts: 4.7;Spermatocytes: 3.5;Spermatogonia: 2.8" "Cancer enhanced" "Detected in many" "testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA024743 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024743: AB_1859419" "unprognostic (8.46e-3)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (2.57e-4)" "unprognostic (4.51e-2)" "unprognostic (1.72e-1)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (5.71e-5)" "unprognostic (7.42e-4)" "unprognostic (2.81e-3)" "unprognostic (2.21e-2)" "unprognostic (1.05e-9)" "unprognostic (2.22e-1)" "unprognostic (2.07e-1)" "unprognostic (2.72e-1)" "unprognostic (3.87e-1)" 0.0 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.5 7.1 0.8 4.2 10.7 0.1 0.1 11.1 2.4 0.1 3.2 4.3 7.3 0.4 5.6 4.4 1.2 2.8 2.2 12.2 0.6 3.7 0.0 4.0 3.8 1.5 4.5 0.0 0.0 1.4 0.2 0.0 3.6 2.9 0.9 1.3 7.3 5.2 0.0 3.4 2.7 8.2 4.1 7.8 6.8 4.3 4.5 9.7 0.0 0.8 3.8 3.7 6.5 3.4 2.8 1.2 4.0 3.0 5.2 0.6 0.5 6.0 3.2 0.0 0.7 2.2 0.1 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.6 0.0 0.8 1.1 0.5 0.0 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.3 0.9 0.9 0.5 0.3 0.0 2.1 0.0 0.0 4.7 0.4 1.5 1.4 0.0 2.0 0.4 0.2 1.4 0.0 0.0 2.1 0.0 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.5 3.5 2.8 2.0 0.1 1.1 0.0 0.3 1.7 0.2 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199610-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 4.9;Endometrial stromal cells: 3.5;Fibroblasts: 4.8;Peritubular cells: 3.4;Sertoli cells: 6.6;Skeletal myocytes: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.6;EFO-21: 8.9;U-2 OS: 3.0" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 1.3 0.6 0.3 0.5 0.6 0.2 0.9 0.9 1.4 1.1 0.0 0.8 0.3 1.5 0.5 0.7 0.9 0.9 0.6 0.7 0.1 0.7 0.2 0.8 0.1 0.4 0.3 0.5 1.6 2.6 2.6 0.7 0.6 0.6 0.9 0.3 0.6 0.8 1.0 0.4 0.7 0.4 1.2 0.3 0.6 0.6 0.4 0.1 0.3 0.6 0.6 0.1 0.9 0.6 0.6 0.0 0.1 1.8 5.6 0.1 0.1 1.1 0.1 0.5 0.0 0.0 0.0 0.1 0.0 8.9 0.5 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.8 0.0 0.1 0.0 1.4 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 2.2 0.0 0.0 0.2 2.2 0.3 1.3 0.1 0.7 0.3 1.3 0.0 0.3 0.1 3.0 2.4 0.0 0.1 0.0 0.0 1.4 0.1 1.5 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.3 0.6 0.9 1.4 0.7 0.1 0.4 0.3 0.5 0.6 0.3 0.1 0.6 1.9 3.2 0.5 0.0 0.0 0.0 0.7 0.0 0.0 4.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 3.5 1.9 2.4 0.0 0.0 1.8 0.0 4.8 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 3.4 0.1 0.9 0.0 0.9 0.0 0.2 6.6 4.1 1.7 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.7 ZNF628 "ZEC, Zfp628" ENSG00000197483 "Zinc finger protein 628" Q5EBL2 19 55476617-55484487 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.3" "Group enriched" "Detected in many" 5 "Early spermatids: 35.4;Late spermatids: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044451 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044451: AB_10962507" "unprognostic (8.70e-2)" "unprognostic (5.08e-1)" "unprognostic (8.30e-2)" "unprognostic (1.81e-1)" "unprognostic (4.65e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-2)" "unprognostic (5.19e-2)" "unprognostic (3.10e-1)" "unprognostic (7.15e-2)" "unprognostic (4.58e-3)" "unprognostic (3.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (4.88e-3)" 4.6 4.7 0.5 1.6 0.5 3.1 5.0 0.2 1.3 4.7 0.0 5.5 2.2 6.5 0.4 5.0 5.2 0.4 4.6 0.9 0.0 4.2 4.7 4.5 1.1 0.6 0.2 0.1 5.2 4.8 0.7 5.4 0.7 0.8 5.3 0.3 0.2 5.0 1.0 13.9 7.9 4.8 0.7 0.0 5.4 5.0 23.3 0.2 0.7 4.8 0.7 0.3 5.3 4.5 0.4 7.0 4.3 1.0 2.9 0.5 1.2 7.9 4.7 0.9 1.6 1.3 2.7 3.0 6.4 4.4 0.9 1.3 4.0 0.5 2.6 0.2 6.6 16.7 4.5 4.1 2.4 1.8 3.6 11.3 1.0 1.8 1.2 0.7 0.8 1.2 3.8 6.8 3.5 0.6 4.5 5.0 2.5 4.4 2.1 8.7 9.5 1.4 6.3 1.4 4.3 5.1 5.6 3.6 4.0 6.1 0.3 4.0 5.5 2.7 3.0 4.3 2.9 4.9 7.9 7.4 4.8 3.8 2.6 2.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.5 0.2 1.3 0.9 0.0 0.6 0.2 0.1 0.8 0.0 0.2 0.4 3.0 0.0 1.1 0.7 8.3 5.0 7.6 2.5 12.0 4.7 5.9 2.7 2.2 5.7 1.8 3.7 4.2 3.2 3.7 9.4 9.8 2.6 35.4 6.5 3.5 3.9 7.2 6.1 0.7 3.6 3.5 2.8 5.1 9.1 13.4 3.9 3.6 3.3 3.1 5.0 0.7 5.7 2.0 3.8 3.1 119.7 5.6 4.2 3.6 0.0 2.5 4.4 5.2 1.0 0.7 4.9 4.1 4.5 5.7 4.1 4.5 3.3 2.0 2.6 13.1 4.6 3.4 8.9 5.5 6.4 4.5 5.5 5.8 3.6 6.7 5.2 GALP ENSG00000197487 "Galanin like peptide" Q9UBC7 19 56176008-56185775 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Hormone, Neuropeptide" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 1.8;Glandular and luminal cells: 1.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053938 Uncertain "Secreted in brain" NA NA "HPA053938: AB_2682315" "unprognostic (8.51e-3)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (7.02e-2)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709649-46736347 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 43.6;Intestinal goblet cells: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 75 "basophil: 20.9" "Lineage enriched" "Detected in single" 75 "granulocytes: 20.9" "Cell line enhanced" "Detected in many" "ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041015, HPA055673" Approved Supported Cytosol NA NA Cytosol "HPA041015: AB_2677252, HPA055673: AB_2682879" "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 6.9 6.0 4.3 3.5 3.8 1.2 15.5 3.7 3.9 19.6 16.7 12.8 5.5 8.0 8.8 5.2 10.0 10.4 4.6 3.8 5.1 3.5 41.8 6.9 1.8 5.3 4.5 3.1 10.0 17.5 19.7 6.3 11.7 3.6 31.6 16.2 1.6 24.2 10.0 1.5 3.4 5.4 8.6 3.6 2.6 23.0 2.6 3.9 1.7 19.7 2.7 2.1 9.4 8.5 4.6 0.0 0.1 11.3 11.7 45.8 38.9 34.2 22.2 30.2 10.1 12.0 0.9 38.9 0.0 16.3 40.6 0.0 0.2 0.0 1.1 4.8 0.0 0.3 3.3 0.0 18.6 32.2 0.0 0.0 56.6 1.0 6.2 0.0 11.8 4.2 0.0 0.2 0.1 17.5 41.3 0.0 1.2 4.3 49.8 2.9 0.0 1.6 0.1 0.0 10.6 0.0 1.8 4.3 7.2 60.3 8.1 5.4 9.2 2.6 21.7 9.1 17.2 2.9 0.3 0.1 0.0 0.1 0.0 4.6 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 4.3 3.8 3.7 3.9 3.8 5.1 5.3 4.5 3.1 3.6 3.6 3.9 4.6 4.2 6.4 6.3 12.4 0.8 0.6 6.1 7.8 5.2 0.0 29.6 14.4 6.4 7.2 15.8 1.8 0.0 2.7 0.4 11.4 0.0 7.4 0.2 3.2 17.8 4.6 3.6 6.1 0.1 5.6 16.3 16.7 23.4 4.0 6.3 10.7 8.6 43.6 1.1 0.0 0.4 56.6 12.2 1.9 1.3 1.6 26.4 0.4 1.8 2.8 0.0 5.5 0.0 10.1 0.3 5.1 10.3 17.3 2.8 23.9 1.7 0.8 27.5 0.5 13.1 5.1 6.3 0.8 0.3 4.2 1.0 2.1 0.5 3.6 14.6 10.9 ZNF665 "FLJ14345, ZFP160L" ENSG00000197497 "Zinc finger protein 665" Q9H7R5 19 53159213-53193386 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA023437 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA023437: AB_2671205" "unprognostic (8.01e-2)" "unprognostic (2.44e-1)" "unprognostic (1.73e-1)" "unprognostic (8.04e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (1.26e-1)" "unprognostic (3.27e-2)" "unprognostic (5.81e-4)" "unprognostic (2.26e-1)" "unprognostic (1.04e-2)" "unprognostic (2.45e-1)" "unprognostic (9.27e-2)" 0.7 0.6 0.8 0.7 0.8 0.8 1.3 2.2 1.0 1.1 0.4 0.6 0.3 1.4 1.3 0.6 1.8 0.8 0.5 0.6 0.6 0.6 0.2 1.0 1.4 0.7 1.2 0.5 3.3 0.5 1.5 0.4 0.7 1.1 1.2 0.6 0.9 0.8 0.9 0.3 1.0 0.4 1.0 0.5 1.1 0.6 0.9 0.5 1.5 1.6 0.2 0.6 0.8 0.7 2.0 0.7 0.1 0.6 2.1 0.6 1.1 1.4 1.4 0.9 1.4 2.0 0.2 0.6 1.2 1.2 1.0 1.0 0.2 0.4 0.1 2.4 0.0 0.0 0.0 0.4 0.0 1.3 0.2 0.6 1.2 0.0 1.3 0.0 0.5 0.1 0.0 0.2 0.3 0.0 0.2 3.0 0.9 1.1 0.0 0.3 0.0 0.0 0.4 0.3 3.0 0.3 1.2 0.1 0.2 0.1 1.4 0.9 0.5 0.4 1.0 1.3 0.9 0.6 0.2 2.7 3.0 0.1 0.7 1.3 0.8 0.2 0.5 0.3 0.1 0.4 1.2 0.4 0.9 0.4 2.1 0.8 0.8 0.6 2.0 0.6 0.7 0.3 0.2 0.8 0.8 2.2 1.0 0.6 0.6 0.7 1.2 0.5 1.1 0.5 0.5 2.0 3.0 19.2 8.4 4.9 4.9 1.1 2.5 0.4 0.6 6.0 1.7 2.2 0.9 4.3 4.0 5.5 0.0 2.4 1.2 0.5 3.9 1.2 2.2 2.8 2.9 4.2 2.4 2.5 3.2 0.7 2.5 4.9 0.0 3.7 5.1 8.0 1.8 0.3 1.3 11.8 4.0 0.5 0.0 0.8 1.1 1.7 2.1 1.9 1.8 4.7 2.5 6.4 5.2 3.5 4.5 0.6 0.3 3.0 0.4 2.9 0.3 0.8 4.6 4.0 0.0 4.4 2.5 2.7 6.7 0.9 0.6 0.8 3.9 4.9 1.0 2.1 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 234.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 15.7 12.3 7.6 9.6 8.1 10.9 15.1 8.0 8.8 12.0 8.0 11.2 6.7 11.3 5.4 15.3 12.6 9.2 15.3 7.8 10.0 11.5 17.3 9.7 10.5 8.0 7.7 7.5 13.3 20.0 9.7 8.1 10.3 7.9 11.5 8.9 5.6 9.9 7.2 22.4 13.6 8.2 8.2 8.0 9.3 11.8 13.7 7.9 7.7 13.2 14.1 11.0 15.5 12.6 8.7 23.3 16.6 12.7 50.5 26.4 34.7 32.6 32.5 23.6 32.3 32.6 39.2 18.5 50.2 29.4 22.8 38.8 27.0 51.5 37.6 84.2 19.4 38.7 29.5 14.2 27.4 35.9 45.9 16.6 26.5 31.4 46.5 83.5 20.3 24.9 22.1 99.0 29.9 52.2 23.4 39.2 45.5 45.2 37.7 20.2 40.2 22.4 43.6 37.4 22.9 20.3 28.7 14.1 23.7 61.3 16.8 18.8 47.3 17.5 24.7 21.2 234.1 81.4 13.4 22.0 65.0 36.4 60.8 55.2 0.2 4.4 0.7 4.1 5.5 8.5 6.6 6.1 5.0 5.8 5.7 6.8 7.0 0.3 8.8 3.5 5.8 5.0 4.0 7.6 8.1 8.0 8.8 7.8 10.0 8.0 7.7 7.5 7.9 8.0 7.9 8.7 40.0 19.2 26.9 6.5 25.0 78.4 119.6 90.1 35.9 14.1 33.6 52.3 71.9 47.1 67.6 18.4 0.0 44.9 18.0 15.8 68.4 48.2 105.7 49.8 57.6 35.2 11.4 26.1 15.7 47.4 53.8 50.0 17.3 60.9 46.2 18.9 23.6 83.6 56.0 18.5 14.0 30.3 36.7 27.7 19.5 32.1 34.5 28.2 37.4 5.6 21.8 21.0 19.6 9.0 13.5 42.2 18.7 27.1 18.8 80.4 15.2 87.2 55.0 8.9 13.1 61.7 49.9 76.8 28.4 33.0 66.2 34.6 22.9 29.8 44.0 70.2 SLC28A3 CNT3 ENSG00000197506 "Solute carrier family 28 member 3" Q9HAS3 9 84275457-84340758 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 18.3;salivary gland: 12.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 10.7;Breast glandular cells: 9.5;Cholangiocytes: 8.6;Ductal cells: 24.9;Endometrial ciliated cells: 9.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 58.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023311, HPA024729" Approved NA NA "HPA023311: AB_1857067, HPA024729: AB_1857069" "prognostic favorable (3.37e-4)" "unprognostic (1.28e-2)" "unprognostic (3.01e-1)" "unprognostic (2.50e-1)" "unprognostic (2.79e-1)" "unprognostic (1.82e-3)" "unprognostic (3.74e-1)" "unprognostic (2.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-7)" "unprognostic (1.03e-1)" "unprognostic (9.87e-2)" "unprognostic (8.75e-2)" "unprognostic (4.03e-2)" 2.5 0.0 0.1 0.4 0.1 9.5 9.0 0.2 0.2 1.0 18.3 0.7 1.0 0.5 0.5 4.2 2.3 7.3 0.3 0.9 0.4 0.0 0.3 1.1 0.1 0.7 0.6 0.0 0.0 8.2 0.1 1.2 0.3 0.3 0.1 2.5 0.0 12.1 2.8 0.0 9.9 2.0 0.1 0.4 0.3 0.8 0.4 0.3 0.5 0.1 0.0 1.3 0.3 1.5 0.1 0.7 0.0 0.0 0.0 0.0 0.1 6.2 0.7 1.5 0.8 0.7 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.4 0.2 58.1 0.1 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.0 0.1 0.0 0.5 0.1 9.3 0.0 0.1 6.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.9 0.4 0.7 0.6 0.0 0.3 0.4 0.3 0.1 0.0 0.0 0.5 1.6 0.1 0.3 0.0 10.7 0.0 0.0 9.5 3.8 0.8 8.6 4.2 1.8 0.0 0.2 0.3 0.7 0.0 24.9 1.4 9.2 0.8 0.2 3.0 0.0 0.4 3.1 0.1 0.5 2.0 6.7 1.3 1.5 0.0 0.0 2.1 0.0 0.4 5.4 2.0 1.2 0.0 2.5 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.0 0.1 4.5 0.3 0.0 0.4 0.1 1.0 0.0 4.2 0.0 0.0 0.0 0.4 0.6 0.3 3.4 0.9 0.1 0.1 0.0 4.8 0.2 FAM177B "FLJ43505, RP11-452F19.2" ENSG00000197520 "Family with sequence similarity 177 member B" A6PVY3 1 222737207-222750805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 50.1" "Cell type enhanced" "Detected in some" "B-cells: 22.8;Cardiomyocytes: 19.0;Gastric mucus-secreting cells: 53.5;Intestinal goblet cells: 58.6;Microglial cells: 32.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 3.1" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 20 "memory B-cell: 40.9;naive B-cell: 53.6" "Lineage enriched" "Detected in many" 22 "B-cells: 53.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA063059 Uncertain NA NA "HPA063059: AB_2684933" "unprognostic (8.19e-2)" "unprognostic (1.72e-1)" "unprognostic (4.88e-3)" "unprognostic (3.09e-2)" "unprognostic (7.70e-3)" "unprognostic (1.57e-3)" "unprognostic (2.65e-2)" "unprognostic (1.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.56e-6)" "unprognostic (5.13e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-2)" "unprognostic (4.29e-2)" 0.2 1.6 1.1 3.1 0.7 0.2 0.3 0.1 0.8 0.3 0.3 6.7 4.9 0.2 0.2 0.3 0.2 10.2 0.2 1.1 0.3 0.2 0.1 0.4 8.5 1.4 0.6 0.1 0.1 0.2 0.2 0.2 2.5 0.8 0.4 9.4 0.1 8.7 0.2 0.0 0.0 12.3 0.9 0.3 2.2 50.1 1.8 1.2 1.0 0.2 0.0 8.4 0.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 40.9 0.0 0.0 0.1 53.6 0.0 0.1 0.8 0.0 0.1 2.4 0.0 1.4 1.1 0.7 0.1 0.8 1.1 0.3 1.4 0.6 0.1 0.8 0.3 1.2 0.7 0.1 0.0 0.0 0.7 22.8 0.4 0.8 0.3 0.0 0.0 0.5 0.3 19.0 8.6 0.3 0.0 0.0 0.0 1.4 1.1 0.0 0.3 8.6 0.1 0.1 0.7 0.0 0.4 0.8 0.4 0.0 1.5 53.5 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.8 58.6 0.0 1.9 0.8 11.9 0.0 3.5 0.0 32.8 0.1 0.0 0.0 1.0 0.2 0.2 0.1 0.0 0.1 2.2 3.0 0.1 0.1 0.0 0.0 1.2 0.8 0.4 0.3 0.2 0.1 0.0 0.9 0.0 1.0 0.5 MIB2 "FLJ39787, skeletrophin, ZZANK1, ZZZ5" ENSG00000197530 "Mindbomb E3 ubiquitin protein ligase 2" Q96AX9 1 1615415-1630610 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 44.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 130.9;Late spermatids: 242.0;Suprabasal keratinocytes: 126.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.2;SCLC-21H: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068322 Enhanced NA NA "HPA068322: AB_2685973" "unprognostic (3.93e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (6.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.17e-2)" "unprognostic (2.22e-3)" "unprognostic (1.29e-1)" "unprognostic (3.58e-2)" "unprognostic (2.49e-1)" "unprognostic (1.01e-2)" 4.0 7.4 1.8 1.1 2.1 0.9 3.9 0.2 7.8 6.2 2.0 7.4 1.2 6.9 0.1 20.0 7.0 0.4 11.6 3.3 1.7 8.5 9.7 4.1 0.4 6.3 0.4 3.4 8.3 8.8 0.8 15.7 0.5 2.5 6.9 0.4 0.4 5.7 1.5 44.3 17.1 5.7 0.4 0.0 6.6 6.6 9.7 1.9 0.5 6.2 2.2 0.0 7.4 7.2 3.0 7.6 1.1 0.5 1.7 1.9 0.7 10.2 3.5 1.6 1.1 2.5 1.5 1.9 0.8 4.9 1.0 0.5 15.2 0.5 2.3 0.0 4.0 6.3 0.6 2.5 1.5 2.6 1.0 2.5 1.5 1.6 0.7 0.2 0.7 0.6 3.4 3.1 1.3 0.3 1.2 4.2 9.7 1.3 1.9 11.8 7.1 2.1 10.8 0.1 0.9 15.7 5.7 5.9 0.8 6.5 0.3 1.1 3.7 0.7 1.0 2.4 5.7 1.0 7.6 2.4 2.2 2.6 3.1 1.3 0.0 0.1 1.7 3.2 0.1 3.2 2.6 2.4 3.5 0.0 3.3 2.9 2.2 0.3 6.3 0.0 7.3 2.0 0.8 1.8 2.1 0.2 7.8 3.3 1.7 6.3 0.4 3.4 2.5 0.0 1.9 3.0 15.2 0.0 8.4 21.5 20.0 130.9 16.2 17.1 86.0 35.1 18.5 18.4 11.2 18.6 11.3 23.9 12.5 11.1 61.2 50.8 9.8 7.9 75.9 19.0 12.2 12.1 15.0 5.7 18.5 1.3 10.3 16.0 34.7 13.1 20.3 32.5 17.5 10.6 6.6 26.9 13.5 35.7 8.2 11.6 22.2 242.0 21.1 12.4 17.8 4.7 8.9 30.0 110.2 10.1 11.9 5.8 50.3 15.8 19.5 12.1 44.6 20.8 10.2 35.7 0.0 17.0 20.1 22.3 45.6 85.6 126.0 15.1 43.3 20.6 38.2 18.3 OR6Y1 OR6Y2 ENSG00000197532 "Olfactory receptor family 6 subfamily Y member 1" Q8NGX8 1 158544550-158554405 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.3;retina: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.2 0.9 0.3 1.1 1.1 0.3 2.3 2.1 0.2 0.0 0.2 0.4 0.2 0.5 0.1 0.3 0.3 0.2 1.0 0.4 0.2 0.4 0.2 0.4 0.3 0.0 1.1 0.3 0.1 0.4 0.0 0.2 1.2 0.2 0.2 1.7 0.4 0.1 0.4 1.0 0.3 0.1 0.0 0.3 0.4 0.5 0.4 0.2 0.3 0.1 0.2 0.1 0.0 1.9 0.3 0.1 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.4 0.3 0.1 0.2 0.2 0.3 0.1 0.3 0.7 0.2 0.1 0.3 0.3 0.1 0.2 0.5 0.2 0.2 0.0 0.3 0.3 0.7 0.1 0.3 0.3 0.3 0.4 0.2 0.1 0.2 1.4 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.3 0.3 0.5 0.4 0.1 0.4 0.3 0.2 0.3 0.3 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 1.1 2.3 2.1 1.0 0.4 0.3 0.0 1.1 1.2 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYO5A "GS1, MYH12, MYO5, MYR12" ENSG00000197535 "Myosin VA" Q9Y4I1 15 52307283-52529050 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 47.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 353.0;Inhibitory neurons: 241.0;Oligodendrocyte precursor cells: 330.8;Oligodendrocytes: 404.2" "Cancer enhanced" "Detected in all" "melanoma: 25.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 201.0;RPMI-8226: 140.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001356 Enhanced Approved "Focal adhesion sites,Centriolar satellite" NA NA "Focal adhesion sites, Centriolar satellite" "HPA001356: AB_1079441" "unprognostic (1.54e-1)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (2.29e-2)" "unprognostic (1.97e-2)" "unprognostic (3.91e-2)" "unprognostic (2.30e-2)" "unprognostic (6.65e-2)" "unprognostic (7.89e-2)" "unprognostic (4.74e-2)" "unprognostic (9.36e-3)" "unprognostic (1.71e-1)" "unprognostic (5.63e-3)" "unprognostic (3.79e-3)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (4.22e-4)" 10.2 8.4 9.3 12.2 18.5 22.0 6.6 2.5 35.6 6.8 0.0 5.3 3.9 5.0 3.7 5.3 4.0 8.5 4.7 14.6 12.3 5.4 2.9 8.9 15.1 9.5 4.1 15.4 5.8 5.3 47.8 8.9 6.4 12.4 5.2 5.9 26.3 5.3 3.6 5.5 11.9 5.1 9.5 0.0 9.6 4.7 5.9 7.1 11.1 8.5 5.1 13.2 9.8 5.3 17.5 19.5 33.7 17.6 21.3 16.2 19.3 19.0 34.7 31.1 18.1 14.0 3.2 7.8 18.7 8.9 41.8 26.5 15.7 40.7 35.6 22.3 105.5 9.6 16.7 8.8 4.2 8.3 9.0 16.3 13.0 21.9 26.6 52.4 17.6 106.8 12.0 0.7 201.0 34.8 34.4 8.2 1.2 8.1 0.5 26.6 14.5 27.8 140.8 15.1 14.0 12.7 7.8 32.3 26.2 59.4 13.1 14.0 9.1 52.0 36.4 15.7 17.1 34.1 20.9 49.9 22.0 39.4 25.1 53.5 0.4 2.4 3.1 1.4 1.7 2.1 1.1 1.3 0.9 2.7 0.7 0.2 0.4 3.0 0.3 1.4 1.5 2.2 1.1 9.3 18.5 2.5 35.6 14.6 12.3 9.5 4.1 15.4 12.4 0.0 7.1 17.5 11.2 12.8 11.4 68.2 19.8 20.8 9.3 10.5 7.4 75.1 6.7 5.5 12.1 2.8 19.8 14.7 39.6 0.6 18.4 0.3 0.0 5.4 18.0 9.3 8.0 12.7 1.2 2.5 353.0 6.3 0.4 7.5 3.1 6.7 22.8 5.0 2.5 1.3 24.4 26.9 241.0 0.2 2.0 27.1 28.0 10.8 3.7 50.2 97.8 52.5 36.7 6.0 15.5 330.8 404.2 6.1 2.5 1.9 32.4 10.2 0.0 2.8 11.1 28.7 6.6 16.7 10.8 14.0 9.4 3.9 11.6 1.1 23.7 2.1 0.3 7.3 GZMM "LMET1, MET1" ENSG00000197540 "Granzyme M" P51124 19 544034-549924 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.8;lymphoid tissue: 22.9" "Group enriched" "Detected in many" 13 "dendritic cells: 385.8;NK-cells: 810.5;T-cells: 243.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "gdT-cell: 583.9" "Group enriched" "Detected in all" 33 "NK-cells: 194.9;T-cells: 583.9" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;HDLM-2: 1.7;HMC-1: 2.1;JURKAT: 3.5;MOLT-4: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015624 Enhanced "Secreted to blood" NA NA "HPA015624: AB_2669245" "unprognostic (2.97e-3)" "unprognostic (2.29e-3)" "unprognostic (7.53e-2)" "prognostic favorable (1.89e-4)" "unprognostic (1.07e-1)" "prognostic favorable (1.87e-7)" "unprognostic (2.35e-1)" "unprognostic (7.46e-2)" "unprognostic (1.67e-1)" "unprognostic (4.98e-2)" "unprognostic (4.53e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.32e-1)" "unprognostic (9.51e-2)" "unprognostic (2.69e-3)" "unprognostic (9.94e-2)" 1.7 1.1 1.0 10.1 0.8 21.8 1.1 3.2 2.0 1.3 0.1 1.1 2.1 0.8 0.2 0.8 1.3 1.8 0.8 0.8 0.7 1.0 3.3 5.3 19.4 0.9 0.8 0.6 0.8 0.4 0.0 0.9 0.4 0.9 1.3 0.3 0.2 2.9 0.4 0.7 0.8 6.3 0.2 0.7 22.9 3.7 1.8 0.9 8.8 1.6 0.1 3.9 1.5 1.4 1.1 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.1 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.1 0.0 0.4 1.3 0.6 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.1 0.5 0.1 0.3 0.1 9.1 1.4 1.3 583.9 1.7 366.5 0.9 189.2 471.3 1.5 4.0 182.8 379.2 11.9 194.9 2.3 3.6 99.1 227.5 1.0 0.8 3.2 2.0 0.8 0.7 0.9 0.8 0.6 0.9 0.7 0.9 1.1 3.4 0.0 0.0 0.3 5.7 3.1 0.1 0.0 0.6 0.5 2.4 2.2 0.1 1.5 0.0 0.0 0.0 0.2 385.8 0.1 0.0 0.4 0.9 0.6 1.5 1.4 0.0 12.0 0.3 0.4 0.4 2.2 13.3 1.1 0.0 0.1 3.6 1.4 0.2 0.0 0.2 0.4 0.0 3.7 4.7 1.6 0.0 5.9 1.8 1.0 8.6 1.6 810.5 0.5 0.3 0.3 0.0 0.0 35.8 0.1 0.0 1.2 0.0 1.4 0.0 1.5 1.2 0.5 1.1 0.9 1.4 0.5 243.6 0.2 0.1 0.1 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8" "Group enriched" "Detected in all" 5 "dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 33000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favorable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favorable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 16.9 13.6 10.1 25.2 12.7 48.1 18.2 6.8 20.6 14.6 18.1 17.5 13.1 15.1 16.8 16.9 18.8 16.7 10.9 12.2 11.6 13.9 13.3 21.1 24.1 12.1 14.1 9.8 12.3 11.0 21.4 7.6 21.1 14.3 11.7 19.4 10.4 12.3 12.0 13.1 17.4 13.9 20.2 12.4 16.6 14.5 22.7 13.6 13.2 13.1 13.6 25.2 20.5 12.1 17.0 48.5 37.1 16.7 9.2 28.0 36.7 80.4 44.5 56.8 43.1 49.9 16.0 42.5 22.1 26.5 39.2 45.1 14.5 18.3 62.0 73.8 19.8 23.5 16.0 33.6 19.6 36.9 46.8 50.8 38.0 28.2 83.6 52.0 45.4 60.5 14.0 24.1 17.9 60.6 31.3 13.7 21.3 13.0 22.2 47.9 17.1 19.6 19.9 32.5 34.2 14.6 14.5 31.6 26.4 17.5 20.1 28.8 44.7 42.5 36.0 25.7 23.6 63.2 11.1 31.8 38.1 57.8 43.1 49.9 60.1 136.6 88.4 15.9 79.4 12.3 13.0 12.9 15.1 82.4 12.3 11.7 13.7 107.4 21.3 60.8 14.7 12.4 56.8 10.1 12.7 6.8 20.6 12.2 11.6 12.1 14.1 9.8 14.3 12.4 13.6 17.0 6.4 0.0 9.8 160.0 11.4 11.1 7.3 21.6 9.6 18.1 7.4 3.6 4.2 4.3 12.5 7.3 18.8 16.5 7.9 8.3 7.9 12.3 44.2 10.6 9.5 14.6 11.4 9.5 178.7 12.9 16.8 11.0 10.7 13.2 14.7 12.4 19.6 9.0 57.6 20.2 176.4 7.6 22.4 25.8 12.1 119.1 10.2 28.8 3.6 132.1 30.6 8.1 13.4 99.0 137.2 17.4 7.3 9.8 10.8 6.4 8.4 6.8 16.5 12.5 6.6 11.7 10.6 22.4 11.9 9.8 7.7 19.2 10.1 9.9 7.6 7.4 SIPA1L1 "E6TP1, KIAA0440, SPAR1" ENSG00000197555 "Signal induced proliferation associated 1 like 1" O43166 14 71320449-71741229 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 575.1;Inhibitory neurons: 447.6;Oligodendrocyte precursor cells: 221.2;Oligodendrocytes: 251.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 22.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 101.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002875, HPA077689" Approved Enhanced "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA002875: AB_1079974, HPA077689: " "unprognostic (1.50e-3)" "unprognostic (2.99e-1)" "unprognostic (3.34e-2)" "unprognostic (5.64e-3)" "unprognostic (4.19e-2)" "unprognostic (4.14e-1)" "unprognostic (7.89e-2)" "unprognostic (4.86e-2)" "unprognostic (3.09e-1)" "unprognostic (8.62e-2)" "unprognostic (2.61e-1)" "unprognostic (5.27e-2)" "prognostic favorable (6.80e-8)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.42e-1)" "unprognostic (7.03e-2)" 6.2 14.6 31.5 11.7 31.4 11.8 9.1 8.4 28.4 9.5 27.5 12.2 10.4 7.2 11.1 14.5 13.9 15.7 3.3 33.1 71.6 15.0 12.4 11.6 11.1 8.1 3.2 30.1 4.7 12.8 19.3 16.1 5.2 10.3 7.9 11.8 13.4 10.8 8.6 3.0 8.6 11.2 10.6 1.1 25.6 18.3 19.9 8.6 12.6 14.4 2.9 16.0 12.8 6.1 14.9 27.0 8.3 18.9 14.2 5.6 16.0 34.2 35.9 42.4 14.3 18.1 48.1 14.8 12.6 9.1 59.1 12.9 26.1 13.9 32.3 27.1 11.4 6.5 26.5 55.3 11.3 46.3 3.2 9.8 11.7 26.7 22.1 52.0 16.3 15.5 17.5 11.8 30.7 19.8 40.5 10.8 3.0 10.8 24.6 22.4 15.7 20.4 13.4 10.2 41.1 23.2 61.9 36.8 28.6 2.6 12.1 17.0 1.4 43.3 101.4 37.2 11.6 20.8 25.0 30.3 18.3 17.3 8.6 34.6 6.9 5.2 1.1 1.7 5.8 3.8 3.2 1.5 2.4 1.3 7.4 1.0 1.1 22.9 2.2 7.1 0.4 1.6 2.3 31.5 31.4 8.4 28.4 33.1 71.6 8.1 3.2 30.1 10.3 1.1 8.6 14.9 14.4 67.3 30.5 163.9 53.8 11.9 15.2 20.2 30.7 19.6 13.0 21.2 5.3 21.5 23.6 14.7 18.8 7.8 23.9 19.3 13.7 24.6 74.4 28.8 18.8 12.9 32.4 1.3 575.1 19.9 8.5 11.3 46.9 35.3 13.9 26.4 5.0 17.5 5.1 58.9 447.6 16.8 10.2 21.4 67.2 31.2 7.8 49.2 5.4 120.9 34.6 58.2 9.2 221.2 251.3 23.0 15.5 35.3 24.9 16.2 18.3 28.4 34.4 15.9 0.0 5.4 18.2 22.4 36.8 17.3 8.4 9.4 24.3 102.0 22.5 27.2 TTC30A "FAP259, FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612999-177618742 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 50.1;Respiratory ciliated cells: 29.0;Spermatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.2 1.8 2.8 1.2 2.1 0.4 4.3 2.3 2.1 3.0 3.6 2.6 1.7 3.2 7.9 1.6 6.3 2.3 3.4 1.9 2.6 5.0 2.9 2.6 1.3 2.6 2.4 1.6 2.5 3.3 5.7 2.1 0.9 2.6 2.9 2.5 8.3 3.2 2.9 1.5 1.2 1.7 2.7 2.9 1.2 2.8 10.0 2.1 1.7 7.2 1.2 1.3 1.2 0.6 2.8 5.1 2.9 2.8 0.0 5.7 4.7 2.1 2.4 7.1 4.3 4.5 0.9 3.6 1.1 4.6 4.3 5.8 4.2 1.9 5.4 4.7 0.3 1.6 1.0 1.4 1.3 2.3 1.2 1.1 2.9 3.5 2.4 0.9 4.1 2.0 2.5 0.7 0.5 3.0 2.6 4.0 2.4 1.6 1.8 1.0 2.5 7.5 0.5 5.4 1.3 9.2 6.2 2.2 4.2 2.6 6.6 2.4 1.3 1.8 2.6 1.5 2.9 2.0 1.9 1.9 0.3 6.6 0.1 2.6 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.5 0.2 0.1 0.0 0.3 0.1 0.2 0.2 2.8 2.1 2.3 2.1 1.9 2.6 2.6 2.4 1.6 2.6 2.9 2.1 2.8 2.3 9.6 3.1 1.6 1.2 0.8 0.8 3.6 1.8 3.0 3.8 2.4 3.6 2.8 4.7 7.3 2.1 1.0 0.4 5.0 1.9 5.5 50.1 10.8 3.1 2.0 7.2 0.4 1.2 4.0 0.7 3.2 1.5 1.6 0.0 2.8 3.6 3.8 0.8 16.8 1.6 2.5 8.2 0.6 0.4 10.9 2.1 0.8 1.8 0.0 0.3 10.6 0.0 0.5 1.0 2.9 1.0 2.2 1.2 1.1 1.7 4.7 29.0 11.7 0.0 4.1 2.1 51.7 4.3 2.8 0.4 0.3 0.9 4.1 1.9 0.3 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 91 "bone marrow: 3927.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 4.0;neutrophil: 12.1" "Group enriched" "Detected in many" 9 "granulocytes: 12.1;monocytes: 4.0" "Cell line enriched" "Detected in some" 91 "THP-1: 3105.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015409, HPA066836, HPA073774" Enhanced "Secreted to blood" NA NA 370000 "CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: " "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 3.3 1.0 0.2 0.1 0.3 3927.4 3.4 0.1 0.8 0.4 0.1 1.9 0.4 1.0 0.0 1.1 1.5 0.1 3.8 0.2 0.1 0.7 3.4 19.6 0.6 0.1 0.2 0.2 0.5 0.5 0.0 1.2 0.8 0.2 2.9 0.0 0.0 2.4 0.1 1.5 5.4 1.8 0.1 0.1 43.0 1.5 0.4 0.2 6.4 3.1 0.0 0.0 2.2 1.0 0.2 2.0 0.1 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3105.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.0 34.0 0.0 0.0 4.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 27.2 0.2 0.3 0.1 0.8 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.9 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.0 4.2 0.1 0.0 1.3 16.2 0.0 0.1 0.0 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.0 3.4 11.1 0.0 6.2 1.1 7.2 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 0.0 0.0 7.4 0.0 0.7 0.2 0.0 0.0 RAB40C "RARL, RASL8C" ENSG00000197562 "RAB40C, member RAS oncogene family" Q96S21 16 589357-629272 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 57.5" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (8.04e-2)" "unprognostic (3.63e-1)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (5.38e-3)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (5.78e-2)" "unprognostic (3.45e-2)" "unprognostic (2.90e-1)" "unprognostic (1.37e-3)" "unprognostic (3.89e-2)" "unprognostic (6.20e-2)" "unprognostic (7.48e-2)" "unprognostic (4.00e-3)" 10.2 8.0 7.0 4.5 9.1 5.8 11.7 7.1 16.8 12.5 0.0 19.1 13.5 13.1 5.2 20.5 12.3 4.5 11.9 9.5 2.5 14.0 12.9 13.4 4.1 3.5 2.9 10.4 12.2 38.8 5.2 21.5 6.6 6.6 17.6 4.4 1.9 14.4 6.0 18.9 57.5 13.7 4.4 1.1 7.9 19.4 13.9 3.4 10.3 10.7 6.2 2.6 18.5 16.3 8.4 7.7 16.3 9.4 13.2 5.3 6.6 12.6 10.1 4.7 8.0 6.5 14.7 13.7 8.8 10.5 6.0 7.1 17.1 5.8 8.3 1.6 9.3 9.8 4.9 11.3 10.5 9.4 9.9 8.9 5.6 17.9 6.4 6.7 5.6 6.6 10.3 11.2 8.8 3.5 22.7 9.6 18.0 10.9 13.5 9.4 15.4 6.7 14.1 4.7 10.9 12.8 10.3 11.1 24.1 9.4 4.3 17.8 19.6 8.2 8.4 11.8 11.3 6.1 8.4 8.6 11.0 5.5 13.4 8.9 1.1 2.8 14.0 0.4 1.8 1.9 1.1 1.4 1.5 1.6 0.7 1.0 0.7 4.8 0.8 0.8 0.7 0.6 1.3 7.0 9.1 7.1 16.8 9.5 2.5 3.5 2.9 10.4 6.6 1.1 3.4 8.4 7.1 9.6 15.7 20.5 4.3 17.5 9.9 11.3 18.2 11.4 9.8 7.9 6.3 8.6 10.4 11.0 8.4 26.6 7.7 33.2 7.9 6.2 4.0 12.1 7.1 5.4 10.8 5.2 44.5 12.5 15.3 4.7 23.4 12.7 7.0 11.2 7.5 16.2 9.4 16.8 18.6 16.5 24.4 6.1 4.1 6.6 5.0 4.5 7.2 10.3 7.5 8.4 7.2 10.6 14.8 10.4 21.3 6.4 2.5 10.8 38.2 9.7 11.2 3.3 0.0 5.6 5.8 17.1 13.9 24.8 31.1 56.8 4.6 7.2 18.7 8.6 PIGN "MCD4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 323.7;Alveolar cells type 2: 372.2;Club cells: 138.4;granulocytes: 159.0;Oligodendrocytes: 123.2;Respiratory ciliated cells: 145.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favorable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 10.0 10.4 10.8 11.0 18.9 17.0 16.1 54.7 54.5 11.9 3.1 16.4 14.1 11.2 12.0 22.9 9.0 12.8 13.7 19.6 7.0 12.0 18.2 10.0 10.5 12.1 15.7 4.0 12.2 16.0 16.1 4.3 17.7 18.7 17.5 18.6 39.2 14.9 7.5 13.6 20.3 13.4 9.0 0.2 10.1 21.3 20.0 2.9 12.5 17.0 10.9 13.0 15.0 7.8 53.4 31.6 19.0 18.4 23.0 23.1 31.4 24.3 32.3 25.7 21.2 24.9 24.4 31.9 36.0 44.0 25.0 18.3 44.6 26.0 27.8 32.9 30.3 16.9 21.6 29.6 19.7 16.8 46.0 24.6 18.5 18.1 21.0 24.5 22.3 27.0 25.3 26.1 50.8 23.3 28.2 22.8 13.5 29.9 25.3 17.3 24.1 35.1 35.7 25.5 48.5 20.8 21.4 42.5 29.0 13.6 50.9 46.1 28.6 29.8 41.0 28.2 15.4 23.5 54.3 53.8 17.4 22.5 25.7 40.9 10.1 7.5 6.1 6.9 6.6 7.2 7.9 7.1 6.9 8.9 8.8 8.0 8.4 9.6 12.1 7.8 10.2 6.5 3.7 10.8 18.9 54.7 54.5 19.6 7.0 12.1 15.7 4.0 18.7 0.2 2.9 53.4 8.9 323.7 372.2 52.5 9.7 8.0 8.9 8.4 10.2 7.2 16.3 9.4 10.4 12.8 138.4 11.0 4.2 9.6 14.1 11.6 1.9 11.0 6.4 9.1 16.2 24.7 6.7 16.6 54.5 9.5 11.5 26.6 10.2 11.5 159.0 19.3 10.0 12.0 10.1 6.7 41.3 11.6 10.2 9.2 4.0 6.5 7.2 26.9 3.6 44.0 7.9 7.3 3.1 57.8 123.2 10.9 9.4 3.8 8.2 11.7 5.6 5.0 145.5 6.6 6.6 6.8 6.7 20.7 7.3 17.4 17.0 10.4 18.5 10.5 12.3 12.1 COL4A6 ENSG00000197565 "Collagen type IV alpha 6 chain" Q14031 X 108155607-108439497 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cell adhesion" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 32.9;urinary bladder: 41.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 24.5;Basal respiratory cells: 16.0;Cardiomyocytes: 13.1;Prostatic glandular cells: 12.1;Urothelial cells: 15.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "hypothalamus: 4.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.0;HeLa: 40.1;HHSteC: 59.2;hTERT-HME1: 44.1;HUVEC TERT2: 41.7;TIME: 94.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA065393 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum" "HPA065393: AB_2685483" "unprognostic (8.47e-3)" "unprognostic (4.50e-3)" "unprognostic (9.75e-3)" "unprognostic (9.80e-3)" "unprognostic (1.18e-1)" "unprognostic (5.99e-2)" "unprognostic (1.78e-2)" "unprognostic (3.78e-2)" "unprognostic (1.72e-1)" "unprognostic (9.84e-2)" "unprognostic (1.40e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (1.32e-2)" "unprognostic (2.06e-1)" "unprognostic (8.54e-3)" "unprognostic (3.51e-1)" 2.3 0.5 0.5 0.4 0.2 0.0 2.0 0.5 0.3 12.6 1.2 1.9 1.4 32.9 17.2 5.6 15.0 13.4 5.4 0.2 4.8 2.3 0.1 1.0 0.1 0.7 1.1 0.0 9.4 0.1 5.6 7.2 3.2 0.9 12.6 2.1 1.2 1.4 21.7 1.5 6.5 1.5 24.7 0.5 1.4 13.4 1.2 0.4 0.9 0.7 1.3 0.1 41.1 9.3 0.6 0.1 31.1 9.9 0.0 24.2 1.7 0.0 0.0 1.8 0.3 0.2 17.9 0.0 0.0 0.0 0.0 3.9 5.8 10.3 46.0 0.8 0.4 8.8 0.8 40.1 0.3 59.2 0.0 0.0 2.6 27.8 6.5 44.1 0.1 41.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 14.0 0.0 3.8 0.0 0.0 0.0 1.9 3.4 0.0 0.0 2.4 0.0 0.0 18.2 0.9 0.0 94.2 0.0 0.1 5.5 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.5 0.3 0.2 4.8 0.7 1.1 0.0 0.9 0.5 0.4 0.6 0.1 0.0 0.0 6.2 0.0 6.4 24.5 16.0 3.4 0.2 2.3 6.1 13.1 0.0 2.6 1.8 0.0 0.1 0.0 0.0 1.9 0.0 2.1 0.7 6.0 0.4 0.0 0.0 0.4 0.0 0.0 6.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 2.0 0.0 0.3 0.3 4.1 0.0 0.0 8.4 0.0 5.5 0.0 0.0 0.6 0.1 0.0 9.1 0.0 12.1 0.0 0.0 2.2 0.4 0.0 0.4 7.2 0.2 0.2 0.1 3.7 0.0 0.1 0.8 0.0 15.2 ZNF624 KIAA1349 ENSG00000197566 "Zinc finger protein 624" Q9P2J8 17 16620734-16653856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 12.1" "Low region specificity" "Detected in all" "HPA023157, HPA023244" Uncertain Approved Vesicles NA NA Vesicles "HPA023157: AB_2671094, HPA023244: AB_2671117" "unprognostic (2.47e-1)" "unprognostic (8.75e-2)" "unprognostic (3.51e-2)" "unprognostic (3.97e-3)" "unprognostic (1.64e-1)" "unprognostic (3.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.18e-1)" "unprognostic (1.10e-2)" "unprognostic (4.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (7.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.97e-1)" 1.7 0.7 1.4 1.5 2.3 1.2 1.8 1.4 2.2 2.3 0.4 1.8 1.3 2.5 1.2 1.3 2.0 1.3 1.5 1.2 2.2 1.9 0.8 2.0 2.4 2.6 2.1 1.1 3.6 0.8 2.5 0.4 3.0 2.7 1.0 1.8 2.6 0.9 1.5 0.4 1.5 1.4 2.0 1.9 3.5 1.9 4.9 2.6 3.1 2.3 0.9 2.2 1.4 0.9 4.2 1.1 1.8 5.3 1.8 2.6 3.1 1.4 1.8 3.1 3.4 3.1 0.9 1.0 2.7 1.5 2.4 1.1 1.5 1.5 1.9 3.7 2.9 1.8 3.0 0.9 0.8 2.5 2.1 2.9 3.5 4.4 1.9 3.8 1.8 3.1 3.4 1.9 0.7 4.5 1.6 5.2 0.8 0.9 3.8 0.8 5.5 9.0 0.8 2.3 2.2 1.6 3.2 2.0 1.5 2.1 12.1 1.2 0.9 4.4 3.2 1.2 1.2 1.3 1.2 0.9 0.0 1.5 0.0 2.7 1.0 1.0 2.0 1.7 3.3 2.5 1.6 2.0 2.0 1.9 2.9 2.2 1.3 0.2 2.8 1.5 0.5 1.5 1.1 1.4 2.3 1.4 2.2 1.2 2.2 2.6 2.1 1.1 2.7 1.9 2.6 4.2 4.2 0.0 0.0 5.9 2.9 0.5 0.4 1.1 0.6 5.1 1.4 1.0 2.6 1.5 2.2 0.0 2.1 1.3 2.4 1.9 3.9 1.3 11.2 1.3 4.1 3.0 0.0 1.7 5.6 1.0 1.5 2.7 1.5 1.4 3.8 4.1 4.6 0.3 2.6 8.4 9.6 1.3 0.0 4.6 1.6 2.1 1.5 2.3 0.0 8.4 1.2 2.8 2.1 16.6 21.1 1.5 0.8 2.6 0.6 0.5 0.8 2.0 3.6 3.2 0.0 2.4 4.1 12.0 8.4 0.9 0.9 1.5 2.3 4.6 0.9 1.1 HOXA4 "HOX1, HOX1D" ENSG00000197576 "Homeobox A4" Q00056 7 27128507-27130780 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1" "Region enriched" "Detected in single" 46 "pons and medulla: 11.3" HPA060088 Approved Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA060088: AB_2684200" "unprognostic (3.37e-2)" "unprognostic (6.27e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.32e-1)" "unprognostic (4.22e-1)" "unprognostic (1.31e-1)" "unprognostic (7.39e-2)" "unprognostic (4.23e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (3.38e-1)" "unprognostic (3.59e-4)" "unprognostic (3.93e-2)" 10.3 10.1 2.2 2.1 3.3 0.7 10.6 0.1 3.0 4.8 0.0 11.5 4.9 5.9 13.1 15.4 22.3 3.6 1.7 0.0 0.9 14.8 1.5 14.8 1.3 18.4 4.1 0.0 6.8 1.9 26.1 0.0 0.1 15.4 5.9 2.5 0.0 0.6 5.9 18.9 4.9 8.3 4.7 14.1 6.9 13.5 1.6 4.8 2.0 3.7 8.3 0.4 7.8 4.6 15.1 9.5 3.1 0.0 29.0 0.0 0.0 1.9 0.9 0.9 3.0 3.0 5.9 1.9 2.5 0.1 2.8 2.7 4.0 1.1 0.4 2.3 0.1 22.2 0.0 0.9 13.7 3.3 3.3 5.4 3.2 2.4 10.2 0.8 0.0 10.3 0.8 0.0 0.0 10.0 2.5 0.0 11.2 0.0 3.3 7.2 21.0 4.4 0.2 14.6 2.2 1.4 0.0 2.9 0.0 11.2 1.0 0.7 1.7 13.5 0.0 4.6 7.6 0.2 0.0 0.0 1.0 6.1 5.1 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 3.3 0.1 3.0 0.0 0.9 18.4 4.1 0.0 15.4 14.1 4.8 15.1 11.6 0.0 0.0 0.0 0.1 0.9 3.1 0.0 31.9 0.0 3.6 7.7 0.4 0.0 0.0 0.0 0.0 0.0 0.4 1.7 15.6 0.0 0.4 0.2 2.6 5.2 3.0 0.8 0.0 0.0 0.9 5.4 0.5 0.1 0.0 0.4 16.8 0.0 0.2 0.0 0.0 0.9 0.0 0.6 0.3 0.4 0.0 0.9 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.7 1.4 0.7 1.0 13.1 0.0 0.0 0.0 8.3 5.8 0.4 3.2 12.5 1.3 0.1 0.8 1.4 2.0 2.5 TOPORS "LUN, RP31, TP53BPL" ENSG00000197579 "TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase" Q9NS56 9 32540544-32552586 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 67.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 67.6" "Cell line enhanced" "Detected in all" "HEL: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060640, HPA065661" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA060640: AB_2684334, HPA065661: AB_2685527" "unprognostic (1.75e-1)" "unprognostic (1.73e-1)" "unprognostic (1.20e-2)" "unprognostic (1.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-2)" "unprognostic (9.94e-2)" "prognostic favorable (7.07e-4)" "unprognostic (2.70e-1)" "unprognostic (3.61e-1)" "prognostic favorable (6.64e-6)" "unprognostic (1.22e-1)" "unprognostic (5.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.92e-1)" 9.9 9.9 5.9 8.5 6.9 25.4 12.6 11.1 8.6 10.4 7.6 9.3 8.4 11.5 10.1 10.0 7.7 8.8 6.8 5.9 6.7 13.4 16.3 9.4 9.4 6.5 6.8 5.7 15.5 8.7 14.1 6.9 10.1 7.0 11.3 9.4 11.6 7.6 9.4 7.2 9.6 8.9 11.3 6.6 10.6 9.0 14.9 6.9 14.6 14.2 10.5 10.2 10.4 7.2 8.9 16.6 15.1 20.4 17.9 24.4 21.8 12.9 20.7 19.5 16.9 19.5 9.5 8.3 26.8 11.7 20.8 14.8 10.9 24.2 23.5 23.6 22.5 13.3 90.8 25.2 11.9 15.1 26.1 24.0 17.9 25.8 24.4 17.1 20.9 20.8 20.1 16.1 13.6 27.9 8.9 23.5 47.6 27.2 12.3 15.2 23.9 18.1 12.2 22.5 17.2 10.1 16.1 20.7 11.2 13.8 22.9 11.3 14.7 22.0 18.4 18.6 9.6 15.5 9.5 16.2 28.5 17.0 14.8 8.4 38.8 10.0 21.3 9.6 9.8 10.3 9.4 10.4 11.4 10.2 10.8 13.9 13.8 67.6 15.0 13.6 8.2 13.5 7.3 5.9 6.9 11.1 8.6 5.9 6.7 6.5 6.8 5.7 7.0 6.6 6.9 8.9 69.2 54.5 32.0 10.7 49.1 47.2 45.3 33.7 61.5 46.8 32.7 28.6 18.4 25.8 37.0 25.8 37.5 31.9 63.4 26.3 19.6 25.1 169.9 36.2 38.1 48.8 45.9 66.5 14.5 18.4 16.9 42.0 25.0 45.5 41.8 43.6 26.4 24.3 17.7 55.5 15.5 22.9 44.7 19.1 35.3 21.8 33.2 31.8 19.6 7.5 30.4 43.5 36.0 13.0 22.4 21.1 24.3 32.7 39.5 39.0 24.3 22.7 22.3 42.0 19.7 54.0 48.2 54.4 53.7 39.0 47.6 50.8 55.4 43.1 24.0 49.8 BCO2 "B-DIOX-II, BCDO2, FLJ34464" ENSG00000197580 "Beta-carotene oxygenase 2" Q9BYV7 11 112175510-112224699 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.1;liver: 52.8;retina: 56.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 410.8;Horizontal cells: 134.6;Rod photoreceptor cells: 254.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.9;HHSteC: 12.3;U-937: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061542 Supported NA NA "HPA061542: " "unprognostic (2.92e-1)" "unprognostic (1.89e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-2)" "unprognostic (7.60e-3)" "unprognostic (1.88e-1)" "unprognostic (3.18e-2)" "unprognostic (6.40e-2)" "unprognostic (2.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.36e-4)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (1.07e-2)" "unprognostic (1.34e-1)" 2.1 21.5 7.0 0.3 5.8 0.2 0.8 5.2 7.2 2.1 9.1 2.1 0.5 1.6 1.0 3.5 9.8 5.1 39.1 5.2 6.2 2.5 52.8 1.7 0.4 7.2 6.8 4.1 1.3 1.1 0.3 4.5 3.8 7.8 2.0 0.5 56.4 0.9 0.9 21.6 1.0 1.7 1.1 6.7 1.1 0.9 3.0 6.1 0.3 2.5 14.4 0.8 2.3 4.6 8.5 0.1 1.0 0.4 0.6 0.4 0.4 0.0 0.3 0.2 0.1 0.5 0.0 5.9 0.4 0.5 0.6 0.6 1.2 0.0 0.2 0.4 0.1 0.1 0.7 0.5 0.4 12.3 0.4 0.2 0.1 2.3 0.1 0.3 1.1 0.0 0.1 0.1 0.3 0.1 0.0 0.5 1.3 0.1 0.6 0.2 0.3 0.1 0.2 0.2 0.2 0.5 0.2 0.4 0.2 0.0 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.0 2.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 7.0 5.8 5.2 7.2 5.2 6.2 7.2 6.8 4.1 7.8 6.7 6.1 8.5 1.7 3.2 3.1 10.1 2.0 3.3 20.3 8.6 6.8 12.6 2.2 1.5 51.3 58.6 8.2 5.5 410.8 0.3 4.4 5.0 0.0 3.7 3.1 26.5 3.0 4.5 8.3 0.0 50.7 2.1 0.4 16.3 1.1 1.2 5.7 4.0 16.4 83.1 1.0 134.6 51.5 1.6 2.0 2.8 3.8 2.4 4.1 7.9 1.8 47.8 3.7 13.9 7.2 7.1 51.3 1.6 2.6 3.8 1.2 10.3 18.2 1.3 67.6 254.6 0.0 5.0 3.8 8.3 2.5 1.8 3.1 0.7 5.2 6.8 3.5 8.7 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 35.7;fallopian tube: 14.0;ovary: 12.8" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.4;SCLC-21H: 3.3" CAB022649 Uncertain NA NA "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.2 5.2 2.8 0.0 3.4 0.0 0.7 1.7 4.4 1.4 1.2 0.9 0.5 3.0 35.7 0.4 14.0 0.5 5.9 4.1 2.6 3.4 0.2 1.1 0.0 3.5 2.8 3.6 12.8 4.0 0.2 1.7 0.1 2.6 0.5 0.3 0.2 0.2 1.1 0.2 0.3 0.5 1.9 2.6 1.3 3.0 0.2 2.2 0.0 0.3 0.2 0.0 0.2 0.7 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.5 3.3 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.4 1.7 4.4 4.1 2.6 3.5 2.8 3.6 2.6 2.6 2.2 3.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.1 8.7 0.2 0.0 13.8 0.0 311.8 0.0 0.0 2.7 0.0 1.9 0.0 12.7 1.8 0.0 0.0 0.0 791.1 0.0 4.1 0.0 0.0 0.1 2.8 0.1 0.0 12.2 0.0 0.0 0.0 1982.5 6.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 10.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.1 ENTPD6 "CD39L2, dJ738P15.3, IL6ST2, NTPDase-6" ENSG00000197586 "Ectonucleoside triphosphate diphosphohydrolase 6" O75354 20 25195693-25228075 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 289.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015491, HPA069555" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 41000 "Golgi apparatus" "HPA015491: AB_2669200, HPA069555: AB_2686152" "unprognostic (3.24e-1)" "unprognostic (1.27e-2)" "unprognostic (5.91e-2)" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (4.44e-1)" "unprognostic (2.10e-3)" "unprognostic (7.41e-3)" "unprognostic (2.74e-3)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (8.14e-3)" "unprognostic (1.78e-2)" "unprognostic (2.74e-1)" "unprognostic (4.86e-2)" "unprognostic (4.48e-2)" 25.0 55.9 47.8 23.0 60.5 15.4 28.0 39.0 66.4 22.8 23.6 61.6 60.6 22.0 18.5 25.5 23.4 26.7 72.1 54.3 44.6 40.4 39.2 25.6 16.3 29.7 33.8 54.2 36.5 50.1 23.7 60.4 25.4 35.6 56.2 45.4 15.9 71.8 17.4 39.0 19.4 63.6 18.7 22.5 20.0 47.6 36.6 42.7 30.1 29.1 22.1 13.1 24.7 22.0 44.4 78.8 122.8 32.9 64.0 41.0 50.8 70.8 63.0 45.0 54.0 48.3 65.5 60.0 47.6 91.4 60.9 104.7 100.3 40.1 96.2 35.5 29.2 36.2 38.3 18.2 150.4 60.7 52.7 57.3 47.4 53.1 67.7 51.4 39.4 43.7 46.1 51.5 78.8 40.0 75.6 49.2 32.6 20.8 63.9 96.0 27.1 102.9 108.4 67.8 46.3 52.0 26.7 17.7 105.1 289.4 29.6 75.3 43.4 48.6 61.9 63.7 51.6 75.7 50.5 43.8 21.0 44.5 34.1 116.3 0.1 25.2 4.9 18.8 17.0 25.6 8.7 16.5 15.0 26.4 11.0 16.9 15.5 1.1 14.1 7.6 18.5 17.2 22.1 47.8 60.5 39.0 66.4 54.3 44.6 29.7 33.8 54.2 35.6 22.5 42.7 44.4 6.4 19.2 28.5 12.4 9.9 9.8 16.2 23.6 6.2 19.2 25.8 21.8 5.8 25.8 14.8 18.4 10.4 63.2 11.0 81.4 9.8 42.5 22.1 10.5 7.6 7.6 34.0 4.2 18.6 40.1 21.7 12.8 52.5 15.4 3.8 65.2 14.3 15.0 26.7 25.2 19.4 57.5 26.4 17.7 17.4 65.2 20.5 17.6 10.6 11.2 16.0 4.2 10.3 13.0 9.2 33.8 59.8 42.2 16.5 27.9 68.4 13.5 10.7 9.1 6.6 6.3 9.6 3.0 8.8 8.6 6.0 59.8 12.0 25.8 72.6 12.1 DMBX1 "OTX3, PAXB" ENSG00000197587 "Diencephalon/mesencephalon homeobox 1" Q8NFW5 1 46489836-46516216 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.3;Cone photoreceptor cells: 2.1;Spermatogonia: 2.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "thalamus: 5.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 12.1;CAPAN-2: 4.0;GAMG: 3.1;K-562: 4.0;SiHa: 4.1;T-47d: 3.1" "Group enriched" "Detected in some" 7 "midbrain: 1.5;pons and medulla: 1.0" "Region enhanced" "Detected in some" "thalamus: 4.0" NA NA "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (7.13e-5)" "unprognostic (2.33e-2)" "unprognostic (8.92e-3)" "unprognostic (1.07e-1)" "unprognostic (5.90e-2)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (2.00e-4)" "unprognostic (1.19e-2)" "unprognostic (2.12e-12)" "unprognostic (7.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (3.35e-2)" 0.0 0.0 1.4 0.0 0.3 0.1 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 2.8 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 5.5 0.0 0.2 0.0 0.0 0.2 0.0 0.3 1.8 1.0 0.0 12.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.6 0.0 3.1 1.0 2.3 0.0 0.0 0.8 1.3 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.3 2.8 0.1 0.0 0.8 0.9 2.8 0.0 0.5 0.0 5.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 OR11L1 ENSG00000197591 "Olfactory receptor family 11 subfamily L member 1" Q8NGX0 1 247840928-247841896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENPP1 "M6S1, NPPS, PC-1, PCA1, PDNP1" ENSG00000197594 "Ectonucleotide pyrophosphatase/phosphodiesterase 1" P22413 6 131808016-131895155 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins" Biomineralization Hydrolase "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032904, HPA062066" Enhanced "Secreted - unknown location" NA NA 4400000 "CAB032904: AB_2099635, HPA062066: AB_2684674" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.60e-3)" "unprognostic (2.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.00e-1)" "unprognostic (1.60e-2)" "unprognostic (7.22e-3)" "unprognostic (8.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-1)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" "unprognostic (1.84e-1)" "unprognostic (3.28e-3)" 6.8 3.1 0.5 1.4 0.6 0.1 7.2 0.7 0.6 6.6 0.8 2.3 1.8 22.2 7.4 2.3 6.9 1.2 1.4 0.4 0.9 4.2 32.2 0.8 1.4 1.1 1.3 0.3 8.3 28.8 28.1 11.0 44.4 0.9 3.4 2.0 0.5 4.2 5.8 2.7 1.4 1.3 10.3 0.9 1.9 1.8 1.6 0.8 2.2 20.3 3.3 0.9 2.7 4.9 0.8 0.0 1.3 1.2 0.1 34.1 5.3 0.0 9.2 9.4 3.5 9.5 4.1 1.1 0.0 0.8 5.9 7.2 0.0 1.3 0.2 14.8 0.3 1.8 0.0 1.1 12.0 1.0 0.0 4.2 8.8 0.4 9.6 0.4 4.1 4.3 0.7 0.0 1.8 21.1 2.6 0.0 0.0 7.9 1.6 1.3 0.0 10.2 0.3 0.2 0.4 3.4 0.0 0.2 1.3 4.2 5.7 3.9 0.0 2.9 27.6 1.0 1.9 9.1 3.4 0.0 0.0 12.6 0.0 3.5 0.6 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.7 0.2 0.0 0.0 0.3 1.6 0.1 0.1 0.0 0.0 0.5 0.6 0.7 0.6 0.4 0.9 1.1 1.3 0.3 0.9 0.9 0.8 0.8 2.6 0.0 1.7 0.3 1.5 1.5 9.9 0.0 0.6 4.5 28.7 19.9 6.4 5.7 0.1 1.8 0.0 3.0 1.2 16.7 5.9 0.3 4.8 3.9 80.2 4.1 0.0 8.0 3.5 10.6 2.1 56.9 6.1 3.2 0.0 9.4 3.3 111.6 4.6 1.7 10.5 12.7 0.0 2.9 5.9 6.7 25.1 3.9 1.8 12.2 0.2 3.6 0.0 21.6 1.6 5.2 3.9 70.0 0.4 2.3 6.7 25.2 0.1 0.5 13.1 12.6 18.8 4.1 2.2 0.1 1.3 6.2 2.6 1.9 2.5 1.7 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 11.7" "Cell type enriched" "Detected in some" 4 "Early spermatids: 51.6" "Cancer enhanced" "Detected in many" "prostate cancer: 4.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.5;NB-4: 4.7;SCLC-21H: 33.2;U-266/70: 5.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.9" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 0.8 1.8 0.9 1.6 1.0 0.8 1.6 2.2 1.7 0.5 0.9 1.4 1.0 0.3 0.4 1.9 0.5 0.6 1.4 1.1 1.3 0.7 0.8 1.5 1.7 1.3 1.0 1.5 1.2 0.1 3.8 0.4 2.1 1.6 0.1 0.8 0.7 0.4 0.8 1.6 1.2 0.2 1.0 2.2 2.0 11.7 1.6 0.4 2.8 0.1 0.4 0.8 0.9 2.4 9.5 0.4 0.3 0.6 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.3 0.8 0.1 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.4 0.3 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.0 0.1 1.2 0.5 0.0 0.7 0.0 4.7 0.2 0.0 0.1 2.8 0.1 0.2 0.0 0.2 33.2 0.5 0.1 0.2 1.4 0.1 1.0 2.4 0.0 0.4 0.1 0.4 0.0 5.8 1.6 0.1 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.6 1.6 2.2 1.4 1.1 1.7 1.3 1.0 2.1 1.0 1.6 2.4 0.2 0.0 0.0 9.8 1.4 0.0 0.5 0.2 0.0 3.2 0.5 0.6 0.6 1.5 0.1 3.7 8.4 0.0 0.4 0.1 0.0 0.1 51.6 0.3 0.3 0.1 0.0 0.0 3.9 0.4 0.0 0.3 1.1 0.3 1.3 1.5 0.4 0.2 0.8 6.7 4.8 0.5 0.0 0.3 0.8 11.1 1.5 0.6 1.8 7.5 0.8 2.4 0.0 2.0 3.8 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.8 4.2 0.0 0.3 0.6 10.1 1.2 0.0 0.4 0.0 0.7 0.4 0.0 0.2 FAR1 "FLJ22728, MLSTD2, SDR10E1" ENSG00000197601 "Fatty acyl-CoA reductase 1" Q8WVX9 11 13668668-13732346 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Cataract, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 437.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017322 Approved Supported Peroxisomes NA NA Peroxisomes "HPA017322: AB_1848424" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (4.62e-2)" "unprognostic (3.66e-1)" "unprognostic (3.30e-1)" "unprognostic (2.79e-1)" "unprognostic (3.60e-2)" "unprognostic (2.59e-2)" "unprognostic (1.84e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-3)" 21.3 16.3 22.4 23.2 38.0 75.6 20.8 35.1 38.8 23.3 27.4 33.2 39.1 24.9 25.1 51.3 17.8 13.8 20.2 25.5 34.7 14.1 5.0 20.4 20.7 46.1 38.4 22.4 20.0 21.4 29.3 15.7 24.8 44.5 20.7 38.0 32.9 18.3 15.5 15.4 12.3 21.3 31.0 45.3 20.7 62.6 21.0 36.9 16.6 19.9 18.7 24.1 28.7 30.2 98.4 79.5 50.6 49.1 38.4 45.9 52.6 26.7 69.2 27.6 50.0 52.7 53.5 66.4 100.9 30.2 55.5 74.3 84.3 73.2 69.9 76.1 30.0 59.4 43.4 44.8 0.2 44.1 87.9 33.7 40.2 70.3 36.2 107.7 36.9 49.6 50.2 68.9 29.3 41.5 39.9 65.5 26.3 25.8 100.1 72.6 56.9 62.6 28.4 48.4 126.4 37.7 27.3 65.5 61.6 34.4 56.2 37.8 54.1 62.1 68.5 58.2 63.7 58.4 16.4 59.6 84.7 43.4 26.4 42.4 10.4 24.9 28.0 7.7 21.3 5.4 3.5 3.7 6.6 28.5 5.5 3.3 5.5 38.9 9.1 18.2 4.4 5.3 7.7 22.4 38.0 35.1 38.8 25.5 34.7 46.1 38.4 22.4 44.5 45.3 36.9 98.4 38.6 35.3 21.1 80.0 24.2 32.2 24.2 21.5 41.5 46.0 27.6 20.3 24.1 5.7 26.2 22.0 41.7 25.7 40.2 59.8 5.9 12.8 100.8 21.1 36.5 31.4 36.0 38.5 146.0 25.9 18.5 26.8 114.7 26.2 38.7 23.3 29.6 2.5 33.9 47.1 113.5 28.8 26.4 53.5 57.0 181.3 26.8 48.8 35.6 71.2 54.8 20.6 20.6 93.5 437.2 29.3 43.4 25.6 36.1 30.8 23.3 8.7 18.7 50.4 26.3 29.3 29.3 41.6 32.3 116.9 19.9 9.9 25.8 17.0 47.7 42.0 CPLANE1 "C5orf42, FLJ13231, Hug, JBTS17" ENSG00000197603 "Ciliogenesis and planar polarity effector 1" Q9H799 5 37106228-37249376 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.4;Collecting duct cells: 22.0;Endometrial ciliated cells: 50.3;Endometrial stromal cells: 42.9;Glandular and luminal cells: 20.6;Granulosa cells: 40.8;Theca cells: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 21.9;SiHa: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036775, HPA036776" Approved Approved Cytosol NA NA Cytosol "HPA036775: AB_10669914, HPA036776: AB_2675308" "unprognostic (3.06e-1)" "unprognostic (2.00e-1)" "unprognostic (4.96e-2)" "unprognostic (4.13e-3)" "unprognostic (1.65e-1)" "unprognostic (1.44e-2)" "unprognostic (1.38e-3)" "unprognostic (5.88e-2)" "unprognostic (3.13e-2)" "unprognostic (6.20e-3)" "unprognostic (3.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.44e-2)" "unprognostic (2.09e-1)" 2.5 3.1 1.4 1.4 1.8 1.0 3.8 2.5 2.6 3.4 2.0 1.9 1.0 4.2 3.7 2.4 4.3 3.2 1.8 1.2 1.1 3.6 1.6 3.3 1.7 1.6 1.0 1.1 5.4 2.5 5.5 2.2 3.3 1.1 4.4 2.0 5.8 3.0 3.6 1.4 2.4 1.1 3.3 0.1 2.3 2.2 4.8 1.6 6.4 7.0 3.3 1.7 2.7 1.4 2.7 5.7 3.5 8.4 6.4 11.4 10.3 3.7 5.8 4.2 6.6 5.2 4.0 7.6 1.4 3.7 5.2 10.4 2.7 2.4 3.5 6.5 3.8 2.6 3.3 21.9 2.4 5.8 0.0 1.8 7.8 4.7 6.7 3.5 7.8 6.5 3.6 0.0 1.2 11.8 0.0 4.2 4.8 2.2 0.0 2.7 4.0 14.9 0.0 6.0 1.7 4.7 3.3 48.7 0.3 3.1 6.8 2.6 3.5 8.0 10.0 6.2 2.7 4.5 1.7 0.0 1.6 2.4 0.1 3.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 1.4 1.8 2.5 2.6 1.2 1.1 1.6 1.0 1.1 1.1 0.1 1.6 2.7 19.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 11.3 8.9 0.0 0.0 0.0 22.0 0.0 7.4 8.8 0.0 0.0 8.8 0.0 50.3 42.9 4.8 0.0 0.0 0.0 5.3 5.8 7.6 0.0 20.6 0.0 40.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 2.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 3.6 3.2 18.9 0.0 0.0 ZNF841 LOC284371 ENSG00000197608 "Zinc finger protein 841" Q6ZN19 19 52064466-52095765 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.8;Gastric mucus-secreting cells: 30.1;Oligodendrocyte precursor cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.94e-1)" "unprognostic (1.94e-1)" "unprognostic (3.57e-2)" "unprognostic (1.73e-2)" "unprognostic (5.16e-2)" "prognostic favorable (2.93e-4)" "unprognostic (5.79e-2)" "unprognostic (2.35e-1)" "unprognostic (7.37e-2)" "unprognostic (5.70e-2)" "unprognostic (9.21e-2)" "unprognostic (3.62e-3)" "prognostic unfavorable (3.56e-6)" "unprognostic (2.06e-1)" "unprognostic (2.47e-1)" "unprognostic (2.64e-2)" "prognostic favorable (8.92e-5)" 8.4 9.6 4.1 7.8 5.5 7.6 9.9 10.0 5.8 14.5 5.6 7.1 5.9 13.3 12.7 9.2 11.2 8.0 7.1 4.4 5.8 7.0 7.9 11.2 11.5 4.3 3.7 4.1 15.5 11.1 7.1 13.3 10.1 6.1 14.3 10.0 15.5 9.2 9.6 3.3 12.2 7.7 9.2 1.7 10.6 9.7 4.9 4.5 6.9 10.4 2.7 10.1 8.4 12.4 7.8 8.6 4.5 7.5 10.5 7.9 13.3 0.5 8.0 7.5 4.9 8.2 4.0 5.0 0.3 3.8 11.1 10.8 6.8 1.0 6.2 6.2 0.2 12.0 14.5 17.8 7.1 9.5 0.3 12.7 9.2 7.5 8.9 20.3 11.5 7.3 0.1 6.6 25.7 13.7 2.9 10.7 11.0 4.5 5.5 10.4 1.8 13.1 7.3 4.1 18.0 8.6 5.9 15.2 7.0 3.2 11.9 8.3 7.3 13.9 8.2 7.1 7.2 8.4 12.2 9.1 10.5 6.4 0.0 10.9 3.2 1.2 4.0 3.5 1.1 4.1 4.0 2.1 2.2 0.8 2.5 1.9 2.5 1.7 2.1 0.7 2.6 2.9 1.2 4.1 5.5 10.0 5.8 4.4 5.8 4.3 3.7 4.1 6.1 1.7 4.5 7.8 5.8 0.0 3.9 8.8 10.9 2.3 3.5 1.8 5.7 4.1 2.7 2.2 1.8 0.0 4.0 0.0 8.4 1.3 4.4 1.5 1.9 2.4 0.9 2.2 5.3 5.5 3.0 6.9 18.8 1.0 3.7 7.3 30.1 6.0 2.5 5.0 2.2 1.7 0.5 5.0 12.3 2.4 0.0 0.6 2.2 0.2 0.9 3.2 0.0 12.2 2.4 1.5 3.1 20.6 15.9 1.7 0.5 1.5 16.6 3.7 1.1 0.7 6.1 7.2 6.6 3.0 2.7 3.9 2.8 8.2 2.6 3.0 6.3 2.4 1.0 5.6 MFAP5 "MAGP2, MP25" ENSG00000197614 "Microfibril associated protein 5" Q13361 12 8637346-8662888 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 244.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 140.5;Extravillous trophoblasts: 1015.1;Fibroblasts: 579.7;Syncytiotrophoblasts: 252.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 32.4" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 172.2;BJ: 63.7;EFO-21: 150.4;HeLa: 55.9;SuSa: 137.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 8 "spinal cord: 42.6" HPA010553 Enhanced "Secreted to extracellular matrix" NA NA 3200000 "HPA010553: AB_1853843" "unprognostic (1.80e-1)" "unprognostic (1.11e-2)" "unprognostic (4.25e-2)" "unprognostic (4.84e-2)" "unprognostic (1.44e-1)" "unprognostic (6.05e-2)" "unprognostic (2.15e-3)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (8.79e-2)" "unprognostic (8.63e-3)" "unprognostic (3.05e-1)" "unprognostic (4.41e-7)" "prognostic unfavorable (6.87e-4)" "unprognostic (8.81e-2)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.81e-4)" 127.6 11.0 4.4 5.5 6.1 3.6 80.6 32.4 10.5 60.4 1.8 31.8 7.3 244.2 11.2 35.3 26.0 28.5 48.0 5.3 3.8 3.1 12.8 8.7 4.8 4.4 2.7 5.3 2.4 5.5 2.4 3.8 95.3 13.9 6.4 42.4 8.0 17.4 50.2 28.8 32.2 19.2 143.2 0.0 1.9 23.8 6.9 1.5 3.3 14.5 119.2 3.4 43.5 61.3 9.7 1.4 5.7 1.6 2.6 29.4 12.4 172.2 63.7 1.2 0.8 1.1 2.3 1.0 0.6 150.4 19.8 1.6 9.1 0.6 13.1 0.0 0.5 0.4 1.6 55.9 1.9 0.4 1.3 0.6 8.7 4.4 7.3 0.0 3.3 0.0 2.0 2.7 3.7 52.7 0.8 1.9 0.8 3.2 0.9 2.9 1.2 1.3 6.5 6.5 2.6 0.7 0.9 1.9 0.7 1.0 137.1 24.0 0.8 2.3 10.7 21.5 45.7 3.0 2.1 1.9 2.3 6.0 0.7 0.1 2.9 0.8 0.7 0.2 0.7 0.4 0.1 0.1 0.1 0.4 0.3 0.4 0.1 1.1 0.2 0.5 0.3 0.0 0.3 4.4 6.1 32.4 10.5 5.3 3.8 4.4 2.7 5.3 13.9 0.0 1.5 9.7 61.5 12.8 5.8 0.3 0.5 23.1 0.4 1.8 0.6 0.2 0.6 0.9 7.0 0.0 2.0 0.0 0.0 140.5 0.5 0.0 0.0 0.5 0.3 5.1 3.9 20.1 0.0 0.0 0.2 0.0 1015.1 579.7 3.6 28.0 0.0 0.2 4.2 0.0 27.7 0.0 0.1 0.0 0.0 9.5 36.3 0.5 61.2 8.8 12.4 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 1.6 0.1 0.0 0.2 1.6 0.9 0.0 40.2 35.2 0.1 0.2 0.6 18.0 252.3 5.3 0.1 0.0 0.3 MYH6 ENSG00000197616 "Myosin heavy chain 6" P13533 14 23381982-23408273 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "heart muscle: 2909.5" "Cell type enriched" "Detected in some" 17 "Cardiomyocytes: 8051.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "NTERA-2: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB075723, CAB075724, CAB075725" Enhanced Uncertain "Focal adhesion sites" NA NA 25000000 "Focal adhesion sites" "CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (2.09e-2)" "unprognostic (8.53e-4)" "unprognostic (1.80e-2)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.09e-1)" "unprognostic (1.66e-1)" "unprognostic (5.73e-2)" "unprognostic (1.44e-2)" "unprognostic (5.34e-3)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-2)" 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2909.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 5.9 0.0 0.0 0.5 0.1 0.9 0.0 0.0 1.9 0.0 53.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 51.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8051.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 31.7 0.0 2.7 0.1 0.0 0.0 449.6 0.0 0.0 0.0 0.3 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 60.3 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ZNF615 FLJ33710 ENSG00000197619 "Zinc finger protein 615" Q8N8J6 19 51991332-52008230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "prostate cancer: 11.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052422 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA052422: AB_2681825" "unprognostic (2.20e-1)" "unprognostic (4.66e-2)" "unprognostic (4.56e-1)" "unprognostic (2.64e-1)" "unprognostic (4.08e-3)" "unprognostic (7.28e-2)" "unprognostic (5.23e-2)" "unprognostic (3.68e-1)" "unprognostic (4.44e-3)" "unprognostic (2.44e-2)" "unprognostic (4.41e-2)" "unprognostic (4.80e-2)" "unprognostic (1.77e-1)" "unprognostic (8.16e-3)" "unprognostic (3.03e-1)" "unprognostic (1.82e-1)" "prognostic favorable (2.98e-4)" 5.3 3.7 3.7 3.0 6.0 5.7 6.7 9.4 5.4 4.9 4.0 4.2 3.5 7.9 4.8 4.2 6.5 5.1 6.0 4.6 3.7 6.1 3.9 5.2 4.4 3.9 4.2 4.4 10.2 3.8 10.2 4.6 5.7 4.5 17.7 3.7 9.9 5.5 6.4 3.8 4.7 3.2 6.6 1.6 5.3 4.2 3.7 4.2 4.8 7.7 6.8 4.3 4.2 3.5 8.5 1.5 6.2 5.8 12.4 11.2 8.1 4.7 4.5 6.9 6.4 5.7 1.2 1.7 2.2 2.4 5.0 3.9 1.5 4.7 3.1 5.2 0.3 10.0 7.5 5.6 4.3 8.6 0.0 4.1 6.8 3.7 10.2 10.2 10.6 3.0 2.7 0.0 0.0 4.3 0.5 0.0 3.8 6.1 0.2 9.6 4.7 10.2 4.0 3.9 10.3 5.4 4.7 5.4 4.7 3.2 6.3 7.1 3.4 5.9 5.4 6.2 3.3 3.3 4.3 12.3 2.8 3.0 0.0 8.7 5.8 2.2 4.2 2.5 3.2 5.3 2.8 4.5 3.6 3.3 2.9 4.3 3.1 2.5 8.2 2.0 2.0 4.2 2.9 3.7 6.0 9.4 5.4 4.6 3.7 3.9 4.2 4.4 4.5 1.6 4.2 8.5 5.1 6.4 7.2 7.5 4.5 2.8 2.1 1.0 1.8 6.4 4.4 3.4 6.9 5.7 1.4 3.7 6.2 4.1 5.9 2.4 3.9 2.2 2.6 2.3 4.4 3.5 9.0 2.1 10.2 1.2 2.9 5.3 2.0 2.4 0.0 6.2 4.2 2.1 3.0 3.3 7.8 2.7 2.0 3.5 3.6 1.0 2.5 4.1 7.2 5.6 3.8 3.2 7.2 8.0 12.0 1.2 3.9 4.1 3.4 4.3 2.2 3.1 3.1 7.0 6.6 5.2 6.7 3.8 2.2 2.6 4.0 5.1 3.9 2.8 2.8 2.0 EOLA1 "CXorf40, CXorf40A" ENSG00000197620 "Endothelium and lymphocyte associated ASCH domain 1" Q8TE69 X 149540355-149550510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 27.2;Cytotrophoblasts: 26.9;Extravillous trophoblasts: 8.5;Hofbauer cells: 10.9;Syncytiotrophoblasts: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060897 Approved NA NA "HPA060897: AB_2684381" "unprognostic (1.37e-1)" "unprognostic (1.36e-3)" "unprognostic (1.93e-2)" "unprognostic (7.19e-2)" "unprognostic (5.16e-3)" "unprognostic (5.67e-2)" "unprognostic (3.09e-2)" "unprognostic (3.18e-3)" "unprognostic (2.73e-1)" "unprognostic (6.82e-2)" "unprognostic (1.96e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-3)" "unprognostic (8.98e-3)" "unprognostic (3.02e-1)" "unprognostic (8.73e-2)" "unprognostic (1.06e-2)" 14.8 53.5 18.1 15.9 19.4 29.4 21.4 19.8 23.0 13.0 21.3 17.8 16.0 12.8 31.8 15.7 13.5 10.8 27.4 21.9 19.0 26.0 24.9 13.6 17.7 18.8 18.8 18.0 21.3 24.0 38.7 34.6 16.0 18.8 17.9 20.7 23.5 22.7 16.6 32.6 16.3 17.6 13.3 19.0 25.7 22.4 8.1 18.9 17.9 19.2 27.3 19.2 14.2 14.0 21.0 17.4 22.7 10.9 15.8 18.4 19.1 11.4 16.6 16.5 17.1 22.1 7.7 13.6 35.9 48.8 16.6 18.8 19.0 26.5 15.1 15.7 31.0 26.0 8.8 38.9 10.5 21.0 25.6 25.0 19.7 24.3 19.3 19.3 21.9 19.8 18.2 7.7 29.6 15.5 70.2 20.3 31.7 4.5 30.7 35.2 16.3 17.5 36.2 16.6 21.3 22.1 11.8 7.6 22.6 21.7 8.5 10.9 18.4 15.3 10.2 7.1 29.3 32.4 21.7 17.2 52.1 21.0 35.4 12.7 31.5 14.4 10.0 21.6 15.1 17.0 15.5 16.7 17.7 15.1 11.5 20.3 14.5 13.4 34.5 13.8 42.3 22.0 16.7 18.1 19.4 19.8 23.0 21.9 19.0 18.8 18.8 18.0 18.8 19.0 18.9 21.0 1.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 26.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 8.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 54.2 0.6 0.0 0.0 0.0 CDC42SE1 "SCIP1, SPEC1" ENSG00000197622 "CDC42 small effector 1" Q9NRR8 1 151050971-151070325 "Predicted intracellular proteins" "Cell shape, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 320.7;NK-cells: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 453.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027634 Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA027634: AB_10600861" "unprognostic (1.59e-2)" "unprognostic (5.76e-2)" "unprognostic (8.93e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (5.76e-2)" "unprognostic (2.85e-2)" "unprognostic (1.71e-1)" "unprognostic (6.96e-3)" "unprognostic (2.19e-1)" "unprognostic (2.59e-2)" "unprognostic (3.04e-1)" "prognostic unfavorable (2.19e-6)" "unprognostic (9.94e-2)" "unprognostic (4.89e-2)" "unprognostic (2.86e-3)" "unprognostic (4.12e-2)" 46.4 48.4 40.4 64.4 41.4 82.3 42.2 41.8 49.1 43.5 40.2 40.4 20.2 35.3 27.1 98.2 44.4 37.5 43.9 39.9 51.3 45.1 30.3 73.9 85.0 43.9 42.9 38.8 44.4 36.8 72.1 37.5 49.0 44.3 56.6 34.0 20.8 54.6 33.5 22.1 60.2 59.2 37.6 44.0 123.3 45.0 11.2 42.8 57.0 46.3 19.4 85.2 66.4 64.7 44.8 61.5 28.5 48.4 30.5 37.0 35.5 73.9 45.6 47.1 51.1 43.5 27.6 64.3 44.2 36.2 51.3 27.4 74.9 51.6 79.8 44.6 69.9 27.7 71.6 30.2 13.6 49.1 64.1 110.0 39.8 125.7 64.3 49.6 71.8 64.6 43.9 114.1 100.8 58.2 91.3 46.8 46.1 54.5 56.2 30.5 41.1 40.8 49.6 64.5 97.2 20.7 49.3 39.4 83.6 82.8 75.9 93.1 113.1 61.7 49.5 36.6 38.5 84.2 65.6 56.1 453.9 35.8 47.8 111.8 124.6 43.9 228.5 88.5 80.7 70.0 44.0 75.5 81.0 58.3 44.9 62.9 78.4 369.7 91.1 82.7 21.9 123.2 38.1 40.4 41.4 41.8 49.1 39.9 51.3 43.9 42.9 38.8 44.3 44.0 42.8 44.8 76.4 38.5 56.2 22.2 110.5 66.2 54.4 41.0 42.1 28.3 94.1 64.1 8.1 27.1 44.8 55.2 25.0 57.9 320.7 36.1 21.5 41.3 85.0 23.4 38.0 50.5 35.3 24.4 30.5 37.0 72.1 40.0 33.1 35.1 71.7 19.0 65.0 33.9 73.2 26.9 29.1 29.9 50.8 138.8 204.1 16.6 11.5 115.0 55.2 32.8 159.8 23.0 233.8 36.7 44.9 66.7 39.3 24.0 93.8 41.9 19.4 27.5 21.8 24.2 32.9 47.9 46.5 35.0 18.7 59.6 93.6 114.8 142.7 22.2 21.4 73.4 MPEG1 MPG1 ENSG00000197629 "Macrophage expressed 1" Q2M385 11 59208510-59212927 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.2" "Group enriched" "Detected in some" 4 "dendritic cells: 156.0;Kupffer cells: 409.8;Macrophages: 174.6;monocytes: 218.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 290.5;intermediate monocyte: 209.9;myeloid DC: 144.7;non-classical monocyte: 245.2;plasmacytoid DC: 204.9" "Group enriched" "Detected in many" 6 "dendritic cells: 204.9;monocytes: 290.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA046801 Approved "Secreted to blood" NA NA "HPA046801: AB_2679814" "unprognostic (1.24e-1)" "unprognostic (2.17e-3)" "unprognostic (1.05e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-2)" "unprognostic (2.79e-3)" "unprognostic (7.82e-2)" "unprognostic (1.41e-2)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (5.48e-2)" "unprognostic (3.51e-1)" "unprognostic (1.48e-1)" "unprognostic (9.38e-2)" "unprognostic (2.48e-2)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" 29.5 16.0 1.4 113.4 1.9 21.5 13.6 1.6 4.3 11.7 3.3 33.2 41.3 11.0 3.7 12.8 7.0 36.5 10.4 1.3 1.9 6.1 41.4 35.7 97.1 2.4 1.8 0.9 5.0 4.6 4.6 1.6 36.1 3.3 8.1 43.9 0.3 7.4 9.4 3.9 7.2 53.2 28.4 2.6 209.2 19.4 4.5 2.7 43.2 5.9 8.4 75.8 43.1 2.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 290.5 8.4 0.5 209.9 0.5 12.6 0.3 0.2 144.7 14.0 0.2 0.1 38.5 1.2 245.2 204.9 0.6 214.5 1.4 1.9 1.6 4.3 1.3 1.9 2.4 1.8 0.9 3.3 2.6 2.7 4.1 0.7 0.0 7.9 0.0 33.8 1.1 0.0 0.0 1.2 0.0 0.3 0.9 1.7 1.5 0.6 0.0 0.0 0.3 156.0 0.1 0.0 0.0 0.2 0.0 0.1 1.7 0.0 4.4 0.0 0.0 0.6 0.8 0.5 0.1 2.5 0.0 4.6 3.7 52.4 0.0 0.0 0.0 0.0 409.8 48.0 0.6 0.0 174.6 1.8 10.3 218.2 0.2 7.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.7 0.1 6.6 0.7 0.4 0.0 0.0 0.3 1.6 0.3 2.7 0.0 0.0 0.1 SERPINB2 "HsT1201, PAI2, PLANH2" ENSG00000197632 "Serpin family B member 2" P05120 18 63871692-63903888 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Plasminogen activation" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 241.3;lymphoid tissue: 81.9;skin 1: 89.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 2243.9;Suprabasal keratinocytes: 1053.6;Syncytiotrophoblasts: 439.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.5" "Region enhanced" "Detected in some" "hypothalamus: 2.9" "Immune cell enhanced" "Detected in some" "basophil: 22.0;eosinophil: 10.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.0" "Cell line enhanced" "Detected in many" "GAMG: 282.7;HaCaT: 699.1;U-138 MG: 807.0;U-2197: 1243.9" "Region enriched" "Detected in single" 15 "cerebellum: 2.6" "Not detected" "Not detected" "HPA015480, HPA076596, HPA076608" Enhanced "Intracellular and membrane" NA NA 2200000 "HPA015480: AB_1855456, HPA076596: , HPA076608: " "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.46e-2)" "unprognostic (1.36e-4)" "unprognostic (1.17e-1)" "unprognostic (1.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (9.69e-2)" "unprognostic (3.76e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-6)" "unprognostic (3.89e-2)" "unprognostic (3.94e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.55e-5)" 10.0 0.3 0.0 8.7 0.0 36.8 8.8 0.0 1.2 10.0 0.0 0.3 0.1 0.7 0.0 241.3 8.5 0.7 0.6 0.0 2.9 0.1 0.3 2.8 0.0 0.0 0.1 0.0 0.3 1.1 0.2 0.1 50.5 0.1 0.2 0.0 0.0 31.5 0.0 0.3 89.9 0.1 1.7 0.0 0.3 0.8 0.0 0.9 2.7 0.1 0.2 81.9 6.7 45.8 0.1 1.4 0.0 0.0 0.8 1.3 0.6 0.2 169.2 179.2 6.0 13.1 0.9 0.4 0.2 0.0 6.1 282.7 699.1 0.0 143.7 118.6 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.5 1.5 13.9 81.7 37.0 1.8 0.6 0.0 0.6 0.4 2.8 0.0 0.2 0.4 0.3 0.2 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 1.1 0.0 0.6 0.7 15.7 13.9 807.0 0.4 1243.9 0.0 0.2 0.1 0.0 21.6 1.8 96.7 22.0 4.9 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 1.2 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.9 0.1 0.2 0.0 0.5 0.0 0.2 2243.9 4.1 82.1 0.0 0.0 0.6 0.1 0.7 0.0 153.4 0.0 0.0 6.2 0.1 0.0 0.0 92.6 0.0 0.1 0.1 5.5 0.0 0.0 0.0 7.1 1.7 11.0 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 26.4 2.9 86.4 0.0 0.0 73.1 94.3 0.0 3.9 0.0 0.0 0.0 0.0 167.2 0.0 0.0 1.0 18.9 0.0 0.0 94.5 0.0 0.0 0.3 14.8 0.0 0.0 94.7 1053.6 439.3 2.5 0.0 0.0 52.0 DPP4 "ADCP2, CD26, DPPIV" ENSG00000197635 "Dipeptidyl peptidase 4" P27487 2 161992245-162074394 "CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 139.1;parathyroid gland: 156.7;placenta: 135.2;prostate: 108.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0" "Cancer enhanced" "Detected in all" "prostate cancer: 55.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 52.3" "Lineage enriched" "Detected in many" 10 "T-cells: 52.3" "Cell line enhanced" "Detected in many" "ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB045970, HPA068778, HPA071236" Enhanced "Secreted to blood" NA NA 190000000 "CAB045970: AB_11140529, HPA068778: , HPA071236: " "unprognostic (4.47e-2)" "unprognostic (4.47e-2)" "unprognostic (8.89e-2)" "unprognostic (3.36e-1)" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-1)" "unprognostic (3.54e-2)" "unprognostic (3.58e-1)" "unprognostic (4.73e-1)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.98e-4)" "prognostic favorable (1.35e-6)" "unprognostic (4.68e-2)" "unprognostic (6.33e-2)" "prognostic favorable (4.99e-4)" "unprognostic (1.21e-2)" 12.0 3.1 0.2 5.3 0.3 0.7 8.5 0.2 0.6 11.0 0.2 14.7 108.0 3.6 4.0 3.0 7.4 6.8 2.1 0.2 0.4 95.7 57.6 16.1 5.9 0.3 0.3 0.2 3.5 3.5 156.7 0.1 135.2 0.3 108.2 17.1 0.1 85.2 23.7 1.6 5.1 139.1 3.0 0.3 11.3 7.7 1.3 0.7 12.5 5.0 4.0 4.5 5.8 3.6 0.5 0.2 0.2 1.0 0.0 194.4 212.6 0.6 37.7 207.0 10.9 37.2 38.0 1.0 0.0 13.6 71.0 30.2 1.1 0.4 0.0 6.2 12.3 0.0 0.0 0.0 57.1 77.0 0.0 0.0 22.0 0.1 66.3 0.5 9.1 6.6 0.7 0.0 0.0 3.6 0.0 3.6 0.5 2.0 1.3 72.7 0.0 0.0 0.6 263.3 0.0 0.1 0.4 0.0 0.0 0.0 4.4 0.0 0.3 37.0 21.8 1.1 0.7 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 52.3 0.2 16.2 10.7 1.2 0.0 15.7 6.6 0.4 5.3 0.0 4.0 2.0 4.7 0.2 0.3 0.2 0.6 0.2 0.4 0.3 0.3 0.2 0.3 0.3 0.7 0.5 10.8 6.4 26.0 0.3 2.1 4.1 0.4 0.1 0.0 1.8 0.2 0.8 3.3 12.8 2.8 14.7 10.4 140.3 10.4 27.4 1.9 3.0 15.0 2.3 7.1 9.4 55.2 0.4 31.6 0.0 59.1 35.3 2.0 68.0 13.9 5.3 9.3 34.5 14.5 0.0 6.3 16.4 0.0 0.9 7.6 7.9 0.0 4.8 5.4 3.7 1.1 0.0 1.0 2.5 0.7 1.4 23.8 0.0 2.1 32.7 291.1 101.4 2.2 0.1 0.0 2.1 1.5 4.0 1.1 0.1 4.1 172.0 25.8 29.2 29.1 0.3 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 181.9;vagina: 136.1" "Group enriched" "Detected in some" 4 "Basal respiratory cells: 58.8;Club cells: 54.8;Squamous epithelial cells: 148.6" "Group enriched" "Detected in many" 5 "cervical cancer: 45.9;head and neck cancer: 27.6;lung cancer: 12.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 129 "HaCaT: 198.9;hTCEpi: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 210000 "Nuclear speckles, Cytosol" "HPA052630: AB_2681891, HPA057129: AB_2683347" "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 27.2 0.0 0.0 0.0 0.0 0.0 181.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 36.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 23.1 3.3 136.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.7 1.9 58.8 13.1 0.0 0.0 0.1 0.1 0.0 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 0.0 8.5 0.0 0.0 0.0 1.0 0.0 0.0 148.6 1.3 0.5 0.0 0.0 0.0 19.9 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510531-5571282 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Uncertain Cytosol "Secreted - unknown location" NA NA 31000000 Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 4.5 0.8 0.6 7.0 0.7 0.3 4.4 0.5 1.0 2.5 0.8 1.7 0.7 2.2 1.3 2.0 2.4 3.4 2.7 0.5 1.4 1.2 4.2 7.1 10.5 0.9 0.8 0.3 1.6 0.6 0.4 0.2 4.8 1.2 1.0 2.1 0.0 1.3 1.4 1.5 1.3 1.5 3.1 0.8 15.3 1.4 0.6 0.7 5.1 1.0 2.2 6.2 4.3 2.2 1.4 6.0 0.0 0.0 0.0 4.7 5.4 0.1 71.4 111.6 33.7 40.4 0.0 0.3 0.0 0.2 29.2 4.8 0.5 0.1 9.7 33.3 88.1 0.0 0.0 0.0 0.0 26.5 0.0 0.0 5.0 0.1 15.8 18.5 9.7 22.4 0.0 0.0 8.5 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.7 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 0.0 0.1 49.7 24.0 1.4 11.8 20.1 1.2 0.1 0.1 13.6 0.0 3.0 1.5 0.3 0.0 0.5 1.4 0.6 0.2 0.7 0.3 0.3 0.1 0.0 0.3 0.7 0.0 0.1 0.0 1.1 0.3 0.6 0.7 0.5 1.0 0.5 1.4 0.9 0.8 0.3 1.2 0.8 0.7 1.4 6.1 6.4 0.5 1.6 0.4 1.0 0.1 0.7 1.8 0.0 0.2 1.5 0.1 0.0 0.7 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.4 2.2 0.0 0.0 1.6 0.2 17.9 6.7 0.5 0.0 3.8 0.2 6.8 0.0 2.9 0.0 1.4 0.0 0.0 5.3 13.1 0.0 5.9 2.5 1.8 12.2 26.4 0.0 0.0 1.0 2.4 3.7 0.0 2.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 2.2 3.1 0.0 0.0 0.3 1.0 0.8 1.1 0.1 0.0 0.1 ZNF433 FLJ40981 ENSG00000197647 "Zinc finger protein 433" Q8N7K0 19 12014732-12035741 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.8" "Group enriched" "Detected in many" 4 "Early spermatids: 198.4;Late spermatids: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA073724 Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA073724: AB_2686631" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "unprognostic (9.90e-2)" "unprognostic (6.84e-2)" "unprognostic (2.67e-1)" "unprognostic (3.92e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-2)" "unprognostic (3.66e-3)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (1.36e-3)" "prognostic favorable (8.33e-15)" "unprognostic (1.06e-2)" "unprognostic (6.95e-2)" "unprognostic (9.20e-2)" "unprognostic (2.69e-2)" 3.7 3.8 4.9 2.4 4.6 11.9 7.9 10.3 5.4 5.3 4.8 3.1 2.1 5.0 9.5 6.9 4.7 3.8 5.4 5.6 6.0 9.5 5.3 4.0 3.2 4.7 4.9 4.4 5.7 9.3 9.2 4.9 5.2 6.2 6.3 3.6 10.0 7.2 4.8 5.6 9.1 2.5 3.2 4.3 4.6 4.9 27.8 6.1 1.9 9.2 3.9 2.9 4.6 5.3 5.8 5.5 0.4 4.1 11.5 3.9 3.7 6.0 4.8 3.5 5.3 5.6 3.1 1.1 1.7 2.6 4.1 3.6 2.2 0.0 5.3 5.0 0.8 1.4 4.0 1.1 3.4 4.1 3.7 9.0 4.3 4.9 3.7 1.8 3.3 0.0 6.4 1.0 0.8 5.9 2.3 4.9 4.7 1.6 0.1 4.5 2.6 2.8 0.4 7.7 11.3 3.4 2.8 0.0 3.0 2.3 4.4 6.2 5.5 3.4 6.0 2.5 10.3 3.4 8.1 10.6 4.8 1.1 4.2 3.7 6.5 1.1 5.1 1.3 0.9 1.1 1.5 1.2 1.7 4.1 2.6 1.8 2.2 2.0 5.9 1.4 3.9 0.9 1.1 4.9 4.6 10.3 5.4 5.6 6.0 4.7 4.9 4.4 6.2 4.3 6.1 5.8 3.8 3.2 2.8 7.5 1.7 1.8 3.4 3.7 1.8 4.9 4.8 4.3 7.2 5.7 4.1 5.5 16.7 10.5 1.7 0.8 7.9 4.2 198.4 7.1 3.8 2.2 0.0 3.6 6.7 3.8 4.5 3.1 3.6 9.5 3.8 3.3 1.4 3.1 6.9 6.7 5.9 0.5 4.1 2.2 1.6 134.4 3.1 1.5 5.4 0.0 0.0 4.7 1.0 10.1 3.7 3.0 1.1 4.1 0.6 2.1 0.0 6.1 6.1 8.1 6.6 1.9 2.9 35.1 5.7 4.5 2.6 3.4 0.9 2.4 0.8 2.5 CCER1 "C12orf12, MGC26598" ENSG00000197651 "Coiled-coil glutamate rich protein 1" Q8TC90 12 90905622-90955176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 386 "testis: 38.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 480.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 480.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.4 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAH10 FLJ43808 ENSG00000197653 "Dynein axonemal heavy chain 10" Q8IVF4 12 123762188-123935720 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;fallopian tube: 4.1;testis: 3.0" "Group enriched" "Detected in many" 5 "Early spermatids: 35.5;Endometrial ciliated cells: 88.5;Late spermatids: 68.9;Respiratory ciliated cells: 88.0" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039066 Enhanced NA NA "HPA039066: AB_10673237" "unprognostic (1.37e-1)" "unprognostic (1.78e-1)" "unprognostic (6.08e-3)" "unprognostic (9.90e-3)" "unprognostic (2.16e-1)" "unprognostic (8.91e-2)" "unprognostic (3.39e-2)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" "unprognostic (1.08e-2)" "unprognostic (7.28e-3)" "unprognostic (5.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (7.23e-2)" "unprognostic (1.22e-2)" "unprognostic (9.11e-3)" 0.1 0.0 3.9 0.0 1.0 1.2 0.0 1.3 0.5 0.5 2.1 0.0 0.1 0.1 0.0 0.0 4.1 0.0 0.1 0.7 1.5 0.1 0.0 1.2 0.0 3.7 3.6 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 4.3 0.1 0.0 3.0 1.9 0.0 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.5 0.9 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.0 1.3 0.5 0.7 1.5 3.7 3.6 0.0 2.5 4.3 1.9 1.2 0.0 0.0 5.5 2.0 0.7 0.0 0.0 1.6 0.0 1.2 0.1 0.3 2.3 0.0 12.9 0.0 0.0 0.0 0.6 0.0 1.9 0.0 35.5 88.5 1.2 0.3 0.0 0.4 7.2 0.0 0.0 0.8 0.0 2.1 0.0 0.1 0.4 0.0 0.1 0.0 6.1 0.2 0.0 0.0 0.0 68.9 0.0 0.3 0.0 0.0 0.4 1.0 1.0 2.0 5.0 0.1 0.0 0.0 0.0 0.0 1.2 2.9 88.0 1.4 13.1 0.6 1.0 9.9 2.1 0.0 0.0 0.0 0.4 0.9 0.4 0.1 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins" "Ion transport, Lipid metabolism, Steroid metabolism, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.2;kidney: 4.4" "Group enriched" "Detected in some" 5 "Excitatory neurons: 5.9;Proximal tubular cells: 11.8" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain NA NA "HPA045015: AB_2679183" "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 4.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.8 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51C1P "OR51C2P, OR51C3P, OST734" ENSG00000197674 "Olfactory receptor family 51 subfamily C member 1 pseudogene" 11 4690423-4697831 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Enteroendocrine cells: 1.8" "Cancer enriched" "Detected in single" 65 "prostate cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP26-1 ENSG00000197683 "Keratin associated protein 26-1" Q6PEX3 21 30319124-30320315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPTAN1 ENSG00000197694 "Spectrin alpha, non-erythrocytic 1" Q13813 9 128552558-128633662 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 296.6;Cone photoreceptor cells: 310.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004581, HPA007927" Enhanced Approved Vesicles,Microtubules NA NA 1600000 "Vesicles, Microtubules" "CAB004581: AB_671135, HPA007927: AB_1857435" "unprognostic (1.46e-2)" "unprognostic (2.73e-2)" "unprognostic (1.56e-1)" "unprognostic (9.06e-2)" "unprognostic (3.24e-1)" "unprognostic (4.02e-2)" "unprognostic (2.56e-3)" "unprognostic (2.20e-1)" "unprognostic (1.81e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.84e-12)" "unprognostic (2.94e-2)" "unprognostic (1.60e-1)" "unprognostic (4.18e-3)" "unprognostic (2.19e-3)" 49.3 31.7 71.8 39.0 91.1 28.4 36.9 65.2 102.6 38.6 4.3 43.4 25.0 57.6 33.2 37.1 54.4 32.8 66.3 88.0 48.4 34.7 22.9 55.5 38.8 131.9 59.4 76.4 52.1 24.2 47.4 32.8 57.6 163.2 33.0 36.6 104.0 32.1 47.0 24.1 70.0 35.2 59.3 63.8 44.7 31.4 45.3 67.9 45.8 38.7 22.5 38.4 40.4 36.8 99.9 108.1 116.9 75.2 83.4 107.6 121.0 61.5 90.2 75.2 99.4 74.1 167.3 74.6 94.3 78.3 137.0 69.8 193.3 80.7 90.4 61.1 53.2 47.9 15.9 324.4 94.4 61.3 70.9 51.0 58.3 71.6 166.3 55.8 83.9 134.4 87.2 9.1 107.6 98.6 74.6 136.3 29.5 96.1 125.9 72.1 91.0 90.2 59.7 80.2 91.1 58.1 91.1 296.1 40.3 42.9 91.8 70.0 19.8 232.5 68.5 102.2 100.0 71.2 65.3 82.6 51.8 83.5 31.5 65.9 3.3 1.6 3.9 9.7 1.3 13.5 6.3 12.4 9.2 2.4 5.8 7.6 7.9 1.5 7.1 1.2 3.0 15.3 5.8 71.8 91.1 65.2 102.6 88.0 48.4 131.9 59.4 76.4 163.2 63.8 67.9 99.9 144.9 70.5 27.5 123.7 56.3 37.3 27.8 34.3 25.6 296.6 69.8 83.2 68.5 68.6 33.9 101.2 310.6 27.5 112.6 145.4 7.9 67.6 18.0 108.2 71.4 103.8 56.9 13.7 159.5 59.2 16.0 77.8 76.5 87.5 12.0 47.9 96.8 36.2 29.2 124.5 183.8 54.1 30.5 22.2 29.4 40.5 85.1 32.8 35.6 74.9 24.4 97.7 48.4 87.4 17.4 102.2 93.0 94.8 70.5 45.9 62.4 22.8 71.3 156.5 26.3 53.0 60.0 33.0 44.5 43.7 45.5 18.2 95.4 22.0 73.6 65.7 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.9;brain: 47.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 319.5;Club cells: 164.2;Ductal cells: 123.9" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 90.1" "Region enriched" "Detected in all" 16 "olfactory bulb: 168.0" "Group enriched" "Detected in all" 5 "olfactory bulb: 43.3;pons: 14.1" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 68.9 24.2 20.6 4.1 18.0 6.0 30.9 19.1 23.7 7.3 16.1 4.7 3.2 7.6 4.9 7.0 8.7 4.8 5.3 21.6 47.5 10.4 3.2 6.3 5.7 29.0 23.4 14.6 7.2 8.4 4.5 9.8 1.9 31.6 5.0 2.9 3.0 7.5 2.5 2.5 4.6 4.1 4.7 25.9 4.8 5.6 12.0 24.0 4.5 17.8 3.2 3.1 8.6 6.5 33.4 90.1 35.3 6.1 1.3 17.1 7.7 0.8 4.7 10.5 12.5 16.6 12.9 23.5 3.4 12.9 14.7 0.1 15.0 34.0 7.0 7.4 30.3 36.7 12.4 13.2 59.7 4.4 8.2 13.6 7.6 2.8 18.2 7.2 7.6 17.9 23.3 0.2 1.4 6.9 55.2 8.8 30.0 22.9 18.0 8.9 25.7 0.1 38.7 11.5 7.3 3.1 34.6 8.2 5.1 40.5 6.0 5.9 33.8 4.0 2.4 10.3 10.3 7.9 0.7 9.9 8.2 26.3 52.9 14.1 0.0 1.0 7.8 7.9 0.7 2.9 5.9 5.9 7.7 4.5 11.3 5.8 4.1 1.6 1.8 0.5 13.4 7.6 3.4 20.6 18.0 19.1 23.7 21.6 47.5 29.0 23.4 14.6 31.6 25.9 24.0 33.4 39.0 3.2 2.7 5.5 13.6 15.6 29.5 319.5 21.6 1.9 30.7 37.6 3.5 20.0 164.2 31.3 0.0 2.4 25.3 5.3 13.7 123.9 33.7 21.3 7.3 19.6 18.6 7.4 0.6 58.2 14.1 19.7 11.2 15.6 5.7 12.0 7.5 3.7 32.3 5.0 1.2 6.5 18.3 8.8 86.4 29.0 4.4 26.0 33.8 1.9 18.5 6.5 25.7 2.0 1.0 45.2 5.1 3.8 32.5 39.3 0.8 32.0 57.8 4.1 13.1 22.5 28.6 24.0 21.6 29.5 12.8 3.1 19.7 8.2 9.1 60.6 PARVA "FLJ10793, FLJ12254, MXRA2" ENSG00000197702 "Parvin alpha" Q9NVD7 11 12377563-12535356 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 229.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005964 Approved Supported "Actin filaments,Focal adhesion sites,Cytosol" NA NA 7300000 "Actin filaments, Focal adhesion sites" Cytosol "HPA005964: AB_1079569" "unprognostic (3.87e-2)" "unprognostic (7.38e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.76e-4)" "unprognostic (7.37e-3)" "unprognostic (1.38e-2)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (1.76e-2)" "unprognostic (2.80e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-2)" "unprognostic (6.73e-2)" "unprognostic (6.58e-3)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.82e-2)" 62.4 17.7 9.6 22.9 8.8 0.1 41.3 7.5 10.2 54.4 17.2 70.1 17.6 72.4 16.8 43.2 39.2 32.2 34.0 9.4 11.6 23.2 17.0 29.0 6.4 10.7 6.9 7.5 32.2 36.3 17.0 11.7 36.2 7.9 51.1 38.7 9.0 21.1 69.6 8.2 13.2 26.4 96.3 11.2 11.4 42.9 6.8 8.2 4.6 18.0 11.8 9.2 55.5 28.5 11.1 34.0 33.1 30.2 39.4 147.8 110.6 69.1 126.5 130.1 87.7 81.6 24.7 51.8 0.0 41.1 229.5 9.9 20.7 0.4 66.4 104.0 0.6 14.9 0.1 42.4 18.7 114.7 0.1 0.9 91.3 22.3 37.1 57.4 107.5 110.9 0.0 0.1 0.3 131.8 20.4 0.0 0.2 14.2 20.2 26.4 0.0 75.2 0.2 44.9 32.8 4.8 0.1 97.6 39.1 65.5 66.9 18.4 0.9 138.2 105.1 43.8 57.2 35.4 0.1 0.1 0.2 58.5 0.1 118.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 8.8 7.5 10.2 9.4 11.6 10.7 6.9 7.5 7.9 11.2 8.2 11.1 37.0 99.3 33.0 47.3 1.1 13.8 25.0 29.3 20.5 4.3 24.4 24.8 45.1 18.6 27.0 27.6 0.0 39.9 0.7 39.6 39.2 56.1 0.9 26.9 62.5 33.3 27.1 0.0 31.4 67.1 92.2 59.1 24.5 35.9 5.1 34.8 39.7 19.1 6.5 0.0 34.9 26.2 18.3 1.8 8.8 2.5 41.0 2.0 46.2 36.5 1.0 25.3 0.0 30.7 1.0 51.7 25.4 51.9 0.2 33.5 23.1 38.1 54.8 2.5 52.6 32.6 60.6 1.1 3.4 20.2 8.9 19.0 2.3 25.1 32.4 25.1 KLHL14 KIAA1384 ENSG00000197705 "Kelch like family member 14" Q9P2G3 18 32672673-32773023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 12.8;thyroid gland: 13.9" "Cell type enhanced" "Detected in some" "B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7" "Group enriched" "Detected in many" 10 "endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 90 "memory B-cell: 10.5;naive B-cell: 7.3" "Lineage enriched" "Detected in single" 106 "B-cells: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "hippocampal formation: 14.9;olfactory bulb: 8.1" HPA024777 Uncertain Supported "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA024777: AB_1852576" "unprognostic (3.93e-2)" "unprognostic (7.87e-2)" "unprognostic (7.09e-2)" "unprognostic (5.61e-3)" "unprognostic (1.87e-1)" "unprognostic (2.16e-6)" "unprognostic (2.14e-1)" "unprognostic (4.30e-2)" "unprognostic (4.81e-2)" "unprognostic (2.32e-3)" "unprognostic (2.32e-1)" "unprognostic (7.64e-2)" "unprognostic (8.91e-2)" "unprognostic (8.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.65e-2)" "unprognostic (1.43e-2)" 0.4 0.2 0.2 1.9 0.3 2.5 0.5 0.0 0.6 2.9 0.0 0.2 0.2 1.7 1.0 0.2 6.6 0.3 0.1 0.3 0.3 4.0 0.0 0.3 7.2 1.4 1.0 0.2 0.3 0.0 7.0 0.3 0.9 0.6 1.4 0.2 4.7 0.4 12.8 0.0 0.1 2.0 0.8 0.8 8.7 0.2 1.0 0.7 0.3 13.9 0.0 5.4 0.6 0.5 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 15.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.2 1.3 0.0 8.4 0.0 3.2 0.4 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.6 0.3 0.3 1.4 1.0 0.2 0.6 0.8 0.7 0.2 1.3 0.0 0.0 0.3 21.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 7.3 0.0 0.0 0.1 0.0 3.9 0.0 4.5 7.1 0.3 2.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.7 0.0 0.1 1.7 9.8 0.0 0.0 0.6 0.0 1.1 0.0 0.2 0.0 0.0 0.0 19.4 0.0 1.5 0.2 0.0 0.0 0.0 45.7 0.0 0.5 1.1 0.0 0.8 0.0 0.0 0.1 0.7 0.6 0.0 0.3 0.0 0.2 4.7 0.1 0.0 OR6C74 ENSG00000197706 "Olfactory receptor family 6 subfamily C member 74" A6NCV1 12 55247198-55248302 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 96000 "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 28.6 48.6 7.5 23.8 11.0 2.0 20.5 7.7 8.1 48.8 21.9 34.9 23.1 29.5 17.9 35.5 19.6 36.7 23.9 9.8 14.1 11.9 54.7 21.4 8.9 14.5 11.9 5.6 41.8 25.8 22.6 18.7 35.9 12.8 35.8 34.0 3.1 61.7 28.1 16.7 14.8 24.6 62.2 9.0 8.9 34.7 12.6 11.9 4.3 17.7 22.9 19.7 36.0 26.6 11.9 43.5 30.7 18.5 21.9 197.4 204.7 6.1 167.9 244.1 69.7 105.8 8.1 33.0 0.0 23.0 273.8 118.8 11.9 0.1 53.7 80.1 0.2 4.6 3.1 30.3 40.6 70.6 0.1 5.8 122.1 17.0 101.2 23.3 157.2 101.4 0.1 3.4 0.2 102.9 11.0 0.1 2.3 3.8 18.3 15.6 0.8 90.9 3.2 23.4 8.7 0.7 9.4 33.8 0.7 33.8 42.8 20.8 3.8 156.3 75.4 34.8 95.3 39.5 0.7 0.2 0.3 123.3 3.3 63.0 0.6 3.2 0.0 0.1 3.6 0.0 0.4 0.1 0.1 2.6 0.1 0.1 0.1 2.4 0.0 1.4 0.3 0.0 0.9 7.5 11.0 7.7 8.1 9.8 14.1 14.5 11.9 5.6 12.8 9.0 11.9 11.9 28.1 16.0 13.2 5.9 2.2 12.2 47.4 43.7 15.4 0.3 29.9 21.2 17.2 14.3 56.0 7.3 0.0 2.2 0.2 46.8 9.8 45.6 1.0 17.5 88.6 35.2 15.7 3.6 1.0 61.0 47.0 94.9 35.7 39.1 1.3 30.4 31.1 68.3 16.1 0.0 1.8 78.7 83.4 7.2 15.0 6.3 110.9 8.7 21.4 17.8 6.4 12.2 0.0 14.6 31.0 47.6 41.6 116.2 8.5 92.6 39.0 11.7 47.8 1.2 19.7 49.4 44.3 1.2 5.5 23.6 10.2 3.4 3.1 94.1 32.0 82.7 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 130000 Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 22.1 27.8 13.8 20.3 21.2 19.6 25.7 18.9 21.1 19.9 12.7 24.2 22.0 22.8 22.5 29.4 21.2 20.0 13.1 15.5 14.4 30.2 27.6 18.1 25.3 12.9 14.6 15.3 25.6 15.3 21.2 17.3 29.7 13.6 22.7 32.1 17.9 20.7 31.3 11.1 19.9 20.0 29.6 13.8 19.3 24.4 15.5 16.8 23.1 29.8 27.7 29.7 27.7 17.5 21.9 62.4 81.0 47.5 47.9 71.3 68.0 85.4 80.2 60.9 67.9 93.1 118.7 92.1 39.9 50.6 58.8 104.1 59.9 69.7 81.9 103.3 49.7 47.8 78.2 112.3 112.3 98.8 80.7 56.1 51.7 75.4 83.2 107.5 60.2 94.8 39.1 79.7 57.2 55.5 106.7 43.5 63.5 68.2 121.4 59.8 52.4 58.4 56.7 78.6 94.7 56.6 31.4 70.2 63.7 52.3 85.6 54.4 85.2 80.0 96.7 66.9 47.5 73.8 31.9 49.5 88.6 69.6 76.0 62.5 20.2 40.2 19.1 23.1 51.0 19.8 20.2 17.7 21.7 69.5 21.6 23.4 21.0 3.7 77.2 34.8 25.4 26.7 28.8 13.8 21.2 18.9 21.1 15.5 14.4 12.9 14.6 15.3 13.6 13.8 16.8 21.9 14.9 6.4 7.5 14.4 13.1 16.6 15.2 21.6 13.1 13.2 13.2 10.3 6.2 10.0 20.1 18.4 20.9 35.4 18.1 14.0 31.3 24.5 10.7 13.5 17.4 14.3 10.2 17.2 61.9 17.5 42.8 17.4 14.3 11.2 6.3 18.1 18.2 17.5 37.0 10.1 44.7 14.6 14.2 19.4 45.8 11.8 11.1 17.2 14.2 15.0 19.7 8.9 26.8 27.2 39.2 19.4 11.6 14.7 12.2 19.9 14.2 48.6 15.9 12.7 6.6 11.1 16.1 14.7 17.4 20.1 20.3 25.6 10.5 24.8 21.3 14.8 ZNF460 "HZF8, ZNF272" ENSG00000197714 "Zinc finger protein 460" Q14592 19 57280051-57294069 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 21.5" "Cancer enhanced" "Detected in many" "stomach cancer: 3.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 13.5" "HPA053004, HPA066506" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053004: AB_2682012, HPA066506: AB_2685681" "unprognostic (2.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-2)" "unprognostic (1.58e-2)" "unprognostic (3.20e-1)" "unprognostic (8.04e-2)" "unprognostic (2.52e-1)" "unprognostic (2.19e-1)" "unprognostic (2.86e-1)" "unprognostic (2.89e-2)" "unprognostic (1.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (2.08e-2)" "unprognostic (4.10e-2)" 1.6 5.0 4.8 0.7 7.4 6.0 1.6 7.7 8.0 1.2 4.0 0.8 0.3 1.0 0.8 1.3 1.0 1.0 1.3 3.1 37.8 1.1 1.5 1.4 0.9 7.6 7.6 4.4 2.3 1.0 1.3 1.7 1.4 11.2 1.1 0.6 2.6 1.3 1.1 1.5 1.7 0.7 1.1 5.7 1.4 0.9 1.8 5.6 1.0 1.4 1.3 1.0 1.1 1.3 19.5 1.2 1.9 1.5 2.1 1.5 1.3 3.8 0.8 1.2 0.9 2.8 2.4 0.7 1.9 0.9 1.0 0.8 0.8 2.0 1.0 1.6 1.4 3.9 1.8 1.6 1.2 1.7 3.2 2.0 0.7 1.8 2.5 2.8 0.7 0.6 2.0 1.8 13.5 1.1 0.9 1.9 0.5 2.1 1.0 1.8 1.4 2.1 0.9 0.6 2.4 1.9 1.0 2.1 1.1 1.2 1.0 0.9 2.2 0.9 2.8 3.3 0.4 1.7 5.7 2.7 3.1 1.0 1.2 0.9 0.0 0.5 1.0 0.7 1.1 0.8 0.8 0.5 0.4 0.1 2.2 1.2 0.5 1.2 0.8 0.7 0.0 1.1 0.7 4.8 7.4 7.7 8.0 3.1 37.8 7.6 7.6 4.4 11.2 5.7 5.6 19.5 7.9 3.2 1.5 3.9 11.6 3.1 3.6 0.7 22.2 4.3 4.1 2.8 5.9 1.5 2.0 0.0 0.0 1.4 6.6 1.3 0.0 1.5 3.4 7.0 9.5 4.9 0.0 11.2 6.2 0.4 2.0 7.3 10.2 13.1 0.0 4.7 7.1 2.0 1.1 8.4 5.9 1.2 4.1 1.9 2.2 0.7 1.8 3.3 1.8 1.9 4.0 2.4 4.1 2.5 13.3 1.7 0.2 1.5 16.3 3.0 0.7 0.8 2.4 3.2 0.0 8.1 8.4 3.6 1.4 21.5 2.4 2.6 7.8 3.6 1.3 4.4 CR1L ENSG00000197721 "Complement C3b/C4b receptor 1 like" Q2VPA4 1 207645113-207738416 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "bone marrow: 1.5" "Cell type enriched" "Detected in some" 18 "Erythroid cells: 128.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 1.3;HMC-1: 2.9;K-562: 1.6" HPA049348 Approved "Secreted in other tissues" NA NA "HPA049348: AB_2680723" "unprognostic (2.35e-2)" "unprognostic (8.27e-2)" "unprognostic (1.99e-1)" "unprognostic (8.89e-2)" "unprognostic (1.31e-2)" "unprognostic (5.50e-2)" "unprognostic (2.01e-1)" "unprognostic (7.45e-2)" "unprognostic (5.27e-2)" "unprognostic (8.21e-3)" "unprognostic (7.94e-2)" "unprognostic (3.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (9.68e-2)" 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.5 0.0 0.3 1.8 0.0 0.1 0.0 0.0 5.9 0.4 0.2 6.9 0.2 1.8 0.0 128.6 0.4 0.0 0.1 0.2 0.0 1.0 0.0 0.0 3.6 0.2 1.2 0.0 0.4 0.0 2.0 0.3 0.3 0.4 0.0 0.5 0.0 1.0 1.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.2 3.3 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.2 PHF2 "CENP-35, JHDM1E, KDM7C, KIAA0662" ENSG00000197724 "PHD finger protein 2" O75151 9 93576584-93679587 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 12 "Early spermatids: 155.2;Late spermatids: 575.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010831 Approved Supported "Nucleoplasm,Nucleoli rim" NA No "Nucleoli rim" Nucleoplasm "HPA010831: AB_1855294" "unprognostic (9.42e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.30e-1)" "unprognostic (2.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.44e-1)" "unprognostic (8.48e-2)" "unprognostic (1.07e-1)" "unprognostic (5.89e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.17e-1)" "unprognostic (4.19e-2)" 21.7 15.9 28.8 11.7 30.2 17.5 23.7 31.9 27.0 31.1 23.9 25.1 10.2 29.8 13.4 19.5 27.7 12.1 26.3 26.2 27.9 15.2 14.4 24.2 13.6 30.7 30.1 24.3 34.5 21.9 17.3 29.9 16.0 29.5 25.1 9.4 13.9 21.2 18.0 28.9 23.2 18.9 14.7 28.1 24.1 23.1 15.2 28.4 18.8 25.9 21.4 10.0 24.7 26.5 34.8 16.1 13.6 27.9 22.6 17.4 13.5 14.0 12.8 17.0 18.2 12.9 6.4 9.3 11.7 9.0 16.7 16.3 30.6 17.7 12.3 9.6 31.8 11.5 9.6 15.9 9.7 15.0 18.8 31.3 13.7 20.2 8.6 14.4 17.7 14.6 17.7 14.2 19.6 12.5 36.1 35.9 20.3 7.2 28.3 11.5 40.4 21.4 4.6 11.4 20.5 36.4 17.6 13.4 21.1 11.7 8.0 14.4 31.9 17.2 16.9 14.3 18.6 18.3 15.3 2.7 8.6 9.3 11.3 19.6 0.4 0.8 0.8 0.9 0.4 0.9 0.5 1.0 0.6 0.8 0.8 1.0 1.2 1.6 0.3 0.6 1.2 0.6 0.7 28.8 30.2 31.9 27.0 26.2 27.9 30.7 30.1 24.3 29.5 28.1 28.4 34.8 18.4 16.0 13.7 13.7 7.5 7.6 6.6 7.1 4.6 14.4 13.3 11.0 15.5 4.3 16.0 5.5 8.4 7.3 9.8 7.5 0.0 5.6 155.2 13.2 14.0 15.0 16.3 9.9 11.9 5.6 3.5 13.3 10.2 13.3 17.1 8.4 13.2 7.6 5.8 10.1 16.0 7.3 8.2 12.4 10.0 575.3 19.9 10.2 3.6 12.2 9.0 9.6 5.2 20.1 28.8 6.1 3.8 20.3 3.9 8.7 4.1 3.2 16.4 7.9 19.7 15.0 13.4 1.8 3.4 7.8 8.0 6.0 9.6 4.9 7.6 8.2 RPS26 "eS26, S26" ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044697 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "ovarian cancer: 494.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: AB_2682927" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 665.7 1275.5 393.5 274.2 387.2 399.2 696.1 375.2 460.9 699.3 376.7 692.4 178.7 574.5 414.3 882.5 730.4 124.4 673.6 372.9 395.4 679.2 934.2 526.4 517.0 400.2 379.6 368.8 1129.9 1180.0 276.6 480.4 253.7 392.4 632.6 407.1 70.4 597.2 339.2 784.6 819.4 750.3 309.9 376.9 838.7 723.4 210.4 408.2 622.6 548.6 394.1 721.3 740.6 703.8 436.5 639.2 763.3 853.6 319.5 1153.3 1696.4 852.0 633.4 929.5 1027.7 596.0 1182.7 281.7 1408.3 383.5 670.6 339.5 293.2 970.5 544.0 698.1 558.9 1552.8 743.9 482.1 719.0 1062.3 490.5 392.2 1036.9 1705.6 544.3 614.0 404.0 794.3 989.6 517.2 458.1 845.1 983.2 371.8 886.0 839.7 766.7 1710.8 496.7 254.8 884.3 871.4 634.9 318.2 552.4 245.8 542.2 372.2 252.1 479.4 538.6 260.8 255.0 524.3 328.0 518.0 369.3 810.2 770.9 284.0 969.2 334.4 334.8 394.8 262.5 650.7 410.2 723.2 872.3 841.4 711.8 508.4 720.3 898.4 863.6 154.8 607.5 373.0 643.6 963.7 1264.1 393.5 387.2 375.2 460.9 372.9 395.4 400.2 379.6 368.8 392.4 376.9 408.2 436.5 1114.5 224.4 237.7 5.2 2483.4 1760.6 852.7 2533.9 3266.8 131.0 1968.1 2542.2 29.2 1425.5 985.7 430.4 62.6 1237.2 1377.0 1803.5 972.4 1031.5 85.4 862.0 876.0 992.0 860.5 1977.9 5.2 2625.0 2835.4 1006.2 1666.7 861.2 514.4 1242.7 1647.4 2125.4 1369.2 75.7 5.1 1406.6 732.4 1557.8 1925.7 57.3 295.4 1146.8 1462.1 6.5 754.7 706.4 563.4 6.6 7.1 1806.8 1756.4 221.5 2590.7 1221.2 2448.3 1503.0 557.4 193.1 309.0 719.1 935.9 305.9 304.0 4236.6 1814.2 1708.2 2103.6 1318.5 1411.0 1000.6 SCGB1D4 IIS ENSG00000197745 "Secretoglobin family 1D member 4" Q6XE38 11 62296281-62299075 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix: 52.7;endometrium 1: 15.7;epididymis: 44.1;fallopian tube: 54.2" "Cell type enriched" "Detected in some" 6 "Endometrial ciliated cells: 3089.4" "Cancer enriched" "Detected in some" 57 "endometrial cancer: 100.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in female reproductive system" NA NA "unprognostic (2.26e-3)" "unprognostic (3.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 52.7 0.0 0.0 0.0 15.7 44.1 0.0 54.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 3089.4 111.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 457.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 PSAP "GLBA, SAP1, SAP2" ENSG00000197746 Prosaposin P07602 10 71816298-71851325 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Lipid metabolism, Sphingolipid metabolism" "Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "intermediate monocyte: 11615.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 5104.0;hTERT-RPE1: 6978.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004426, CAB004647" Supported Supported Vesicles "Intracellular and membrane" NA NA 88000000 Vesicles "CAB004647: AB_425625, HPA004426: AB_1079701" "unprognostic (4.43e-3)" "unprognostic (2.69e-1)" "unprognostic (1.64e-2)" "unprognostic (8.00e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-3)" "unprognostic (2.79e-1)" "unprognostic (3.31e-2)" "unprognostic (3.25e-2)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (2.34e-1)" "unprognostic (2.06e-1)" 1078.2 1202.0 832.1 882.1 928.4 841.7 690.9 892.8 936.8 1083.0 965.6 673.5 479.9 886.6 959.5 611.1 731.1 1125.4 1426.0 784.5 1316.1 868.4 913.9 1128.6 964.2 940.2 882.9 718.5 1116.8 549.4 1177.0 567.9 876.5 861.3 780.8 631.6 671.0 585.7 945.6 1421.1 513.0 491.8 1148.4 1082.1 1055.0 670.1 493.5 961.7 678.6 883.8 996.2 565.0 950.1 583.2 1307.9 455.9 847.4 540.4 1121.0 5104.0 2910.1 1900.2 799.9 2368.3 620.8 735.9 795.4 1131.9 245.6 1608.1 1321.6 1038.9 964.1 207.5 659.1 434.8 481.4 381.8 288.9 352.3 459.6 1970.7 188.8 1596.0 1871.8 1479.1 625.7 1177.6 6978.9 1128.1 345.8 420.5 1158.1 777.0 294.9 843.8 290.1 249.5 575.4 404.0 172.9 301.3 696.7 730.3 764.4 584.4 515.8 751.1 2248.3 3122.2 700.4 454.4 431.1 1467.0 861.8 610.0 587.1 670.5 1289.0 1038.7 435.4 1375.5 374.4 650.0 863.2 10095.9 1127.5 424.2 11615.6 349.8 466.7 342.9 368.8 3481.1 425.5 370.1 350.6 2890.4 365.8 10148.2 1758.2 422.8 15009.0 832.1 928.4 892.8 936.8 784.5 1316.1 940.2 882.9 718.5 861.3 1082.1 961.7 1307.9 263.2 253.2 339.0 136.8 173.9 228.3 253.4 487.0 108.1 193.8 254.6 158.7 664.1 253.1 318.9 476.3 127.2 891.6 260.2 434.8 70.5 1043.6 19.3 147.0 246.6 311.4 261.9 160.5 86.1 456.1 872.6 623.8 187.6 195.2 398.1 210.8 426.9 509.2 2792.8 333.1 93.7 242.2 343.8 2427.0 779.7 54.1 458.6 1916.9 663.5 105.9 1528.9 495.6 182.3 92.5 117.6 357.7 298.3 551.8 503.0 244.8 370.6 311.6 297.2 164.3 276.1 273.6 263.8 55.2 126.3 137.2 198.0 1073.2 138.9 624.1 228.3 223.9 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151993859 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 1774.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0" "Cell line enhanced" "Detected in all" "OE19: 4936.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria Yes No 270000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.33e-4)" "prognostic unfavorable (1.00e-4)" "prognostic unfavorable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavorable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.84e-4)" 707.6 379.9 68.5 247.0 73.2 134.9 524.0 75.1 140.9 331.3 83.0 875.4 465.6 111.0 57.2 1774.6 190.3 214.3 342.4 68.9 169.9 402.1 159.0 695.9 134.4 142.6 98.1 59.9 236.0 146.2 36.6 71.6 329.7 114.0 166.3 933.0 51.8 426.2 105.9 106.9 472.0 451.7 290.7 104.0 112.1 190.6 146.9 112.6 119.4 144.7 146.7 292.2 341.7 809.8 110.9 1251.3 1085.9 3.4 241.6 1351.4 1711.3 972.5 730.1 912.1 613.8 606.5 1975.4 1671.4 2.3 689.1 1208.0 661.7 2227.5 337.0 2786.6 495.3 242.5 127.1 163.8 461.5 468.1 507.0 60.2 126.7 470.8 2195.5 660.6 738.6 487.6 1326.0 78.9 2.9 3.6 753.8 940.0 11.0 376.5 163.6 4936.7 1671.4 1.6 242.4 27.1 2348.3 317.0 11.1 9.5 1259.2 374.3 539.8 1213.0 882.2 130.5 1654.9 285.5 737.2 1362.3 459.2 34.4 7.8 225.2 1709.5 51.7 977.8 359.5 1235.2 299.7 425.7 758.7 443.3 232.4 652.3 539.0 2005.4 140.1 237.7 363.1 43.6 355.0 664.7 329.6 1180.0 1313.4 68.5 73.2 75.1 140.9 68.9 169.9 142.6 98.1 59.9 114.0 104.0 112.6 110.9 1197.3 2554.5 537.7 3.9 244.0 1594.8 1171.4 2183.2 795.6 11.6 241.1 281.4 111.2 693.4 994.6 950.9 4.2 1271.5 476.2 3820.4 1524.1 1811.7 314.2 901.0 104.6 1061.2 1078.1 114.2 0.4 2105.0 527.4 1751.3 432.8 1270.7 289.5 840.0 864.5 206.9 1023.1 16.8 0.9 1723.1 272.6 795.2 3945.6 274.2 647.1 1338.1 1632.8 28.1 1544.2 24.8 285.3 4.0 0.6 4570.5 3391.8 64.7 244.5 2782.5 2146.1 495.6 620.3 32.5 144.7 801.6 529.5 30.4 115.9 1940.1 1242.0 375.8 801.0 38.5 1998.0 2290.6 CFAP43 "bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96" ENSG00000197748 "Cilia and flagella associated protein 43" Q8NDM7 10 104129888-104232364 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 32.4;choroid plexus: 68.2;fallopian tube: 49.4;testis: 57.8" "Cell type enhanced" "Detected in many" "Early spermatids: 103.0;Endometrial ciliated cells: 161.0;Late spermatids: 58.4;Respiratory ciliated cells: 231.0;Spermatocytes: 53.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 5.9" NA NA "unprognostic (1.20e-2)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "unprognostic (6.46e-3)" "unprognostic (2.03e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.78e-1)" "unprognostic (1.56e-1)" "unprognostic (2.80e-1)" "unprognostic (6.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.41e-1)" "unprognostic (3.35e-2)" "unprognostic (9.11e-4)" "unprognostic (6.67e-2)" 0.2 1.0 26.7 0.2 8.7 0.2 2.6 12.1 5.2 3.8 68.2 0.3 0.4 2.9 7.8 0.2 49.4 0.9 0.2 9.0 19.2 4.0 0.4 8.3 0.3 29.1 26.0 3.1 1.9 2.2 3.8 10.2 0.3 23.3 1.5 0.2 10.8 0.9 1.3 0.1 1.0 0.6 0.2 32.4 0.2 0.6 57.8 12.7 0.4 5.4 0.0 0.2 0.2 0.5 16.1 1.7 0.6 0.6 1.1 0.0 0.3 0.1 0.0 0.5 0.3 0.2 0.0 4.3 0.0 0.0 0.0 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.5 0.4 0.3 0.9 0.1 0.3 1.2 0.1 0.0 1.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 1.5 0.0 0.9 0.9 0.4 0.0 0.8 0.5 0.5 0.0 0.0 0.1 0.3 0.5 0.2 3.3 2.9 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.7 8.7 12.1 5.2 9.0 19.2 29.1 26.0 3.1 23.3 32.4 12.7 16.1 0.3 3.2 8.4 16.6 0.1 0.0 0.6 0.0 0.6 0.8 1.9 1.7 0.8 0.0 38.4 1.8 10.4 0.1 0.0 0.0 0.0 1.2 103.0 161.0 2.1 1.0 3.6 0.8 16.6 0.0 0.2 1.2 1.1 3.6 6.3 0.6 0.4 0.1 0.1 0.0 23.5 0.1 0.0 0.0 0.0 58.4 1.5 0.7 0.0 1.9 0.6 1.3 0.0 1.5 6.1 0.2 0.1 2.2 0.2 0.6 0.1 1.2 231.0 8.8 0.0 0.6 0.1 53.7 4.4 0.3 0.0 0.0 0.7 0.4 0.2 0.3 LHFPL5 "DFNB67, dJ510O8.8, MGC33835, Tmhs" ENSG00000197753 "LHFPL tetraspan subfamily member 5" Q8TAF8 6 35797206-35845397 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;epididymis: 12.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029421, HPA055110" Uncertain Approved Vesicles NA NA Vesicles "HPA029421: , HPA055110: AB_2682697" "unprognostic (2.35e-1)" "unprognostic (6.45e-2)" "unprognostic (2.41e-2)" "unprognostic (1.22e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.89e-3)" "unprognostic (2.96e-3)" "unprognostic (2.46e-2)" "unprognostic (1.47e-8)" "unprognostic (5.53e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.41e-1)" 0.9 1.1 2.6 2.7 4.5 19.0 0.8 5.0 5.9 0.3 0.3 0.9 3.1 1.5 12.5 1.3 0.6 1.7 0.7 3.2 1.9 0.6 0.8 1.0 2.8 1.6 0.4 4.4 1.1 5.7 0.3 0.5 1.3 2.9 1.0 0.7 8.3 2.5 0.4 1.4 7.7 2.5 0.3 0.0 2.2 1.7 1.5 1.6 0.5 1.4 0.2 0.6 0.6 0.0 5.1 2.3 1.5 3.0 3.1 0.2 0.6 4.6 1.6 0.3 0.1 0.4 2.7 2.0 3.6 1.2 0.6 1.9 2.9 0.2 0.8 0.3 1.6 2.6 3.2 5.3 4.0 0.0 3.4 2.2 0.5 0.3 0.3 0.4 2.1 0.2 3.6 3.1 5.1 0.9 1.9 2.5 6.2 2.6 0.7 1.5 2.2 1.1 2.0 0.7 5.6 3.4 1.9 1.6 2.3 1.0 2.9 2.4 1.9 2.6 3.1 1.7 2.5 2.4 3.2 3.0 3.1 1.1 3.6 1.6 2.9 0.6 0.5 0.3 0.3 0.3 0.5 0.3 0.3 0.1 0.9 0.4 0.5 3.3 0.6 0.4 0.7 0.4 0.1 2.6 4.5 5.0 5.9 3.2 1.9 1.6 0.4 4.4 2.9 0.0 1.6 5.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.7 0.3 0.0 0.4 8.0 0.2 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 RPL37A L37A ENSG00000197756 "Ribosomal protein L37a" P61513 2 216498825-216579180 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065327 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 87000 "Endoplasmic reticulum, Cytosol" "HPA065327: AB_2685469" "unprognostic (9.94e-3)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.19e-1)" "unprognostic (5.12e-3)" "unprognostic (6.92e-2)" "unprognostic (1.76e-2)" "unprognostic (2.67e-1)" "unprognostic (8.26e-2)" "unprognostic (2.33e-1)" "unprognostic (2.62e-1)" "unprognostic (8.84e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.49e-1)" "unprognostic (4.92e-2)" "unprognostic (1.05e-2)" "unprognostic (1.67e-1)" 2765.5 2505.6 3543.0 1240.9 3581.4 2561.7 3485.2 3463.7 5606.9 3369.7 3442.3 2592.7 1121.1 2532.2 1621.4 3615.9 2996.1 478.0 2563.8 3437.2 3570.4 2089.1 2081.5 1922.1 1496.7 3547.0 3524.9 3387.2 5538.2 4276.7 2124.8 2045.6 979.5 3560.4 2548.6 1554.1 1247.5 2404.8 1391.1 5283.3 4300.9 2087.5 1308.9 3655.0 2393.6 2589.8 1267.3 3589.3 3042.8 1926.0 4192.8 2264.8 2781.7 3106.6 3653.8 2117.5 1757.0 3750.8 2542.5 3820.2 6666.2 2783.2 2804.7 3711.8 2778.8 2362.0 4478.9 2000.9 2310.8 3821.8 3450.3 3000.1 2165.8 3570.4 4118.4 2861.6 2653.7 3779.3 3786.9 3130.5 6449.1 6532.0 4206.8 2285.8 7292.0 8500.4 2410.8 6755.9 7614.5 3897.7 4509.9 3008.0 3296.4 3653.4 4222.0 4025.0 8611.8 4350.4 4680.8 1985.4 2874.3 2818.9 2846.9 3975.2 3650.5 2425.5 2719.7 1032.7 3199.3 6926.2 5291.2 2027.5 7146.0 2649.0 2006.9 2201.6 1991.6 3119.4 3471.7 5348.9 4515.3 2242.4 2876.4 2081.6 1025.7 2303.5 546.8 2463.3 1720.1 3379.1 4446.9 3801.3 3078.0 3061.9 4258.4 4343.3 4006.9 281.8 2725.4 1469.9 4230.5 3011.4 6099.2 3543.0 3581.4 3463.7 5606.9 3437.2 3570.4 3547.0 3524.9 3387.2 3560.4 3655.0 3589.3 3653.8 1310.3 1198.7 1865.0 20.2 3813.1 4936.9 3370.7 3086.2 2318.0 513.1 5676.7 3353.1 1482.9 2713.7 2139.1 1265.3 185.6 3021.4 2978.5 1879.2 3155.8 2994.2 3958.3 1634.1 3979.9 2334.0 2623.6 2835.7 16.8 8453.9 5257.7 1903.5 1194.2 2334.1 2170.9 3057.7 3945.8 4967.1 3060.4 200.2 18.2 4863.9 935.8 4892.5 4112.7 7778.0 5740.1 2453.8 2853.1 15.9 3968.7 2304.7 3980.5 11.1 24.2 6102.8 5240.6 2969.2 2205.6 3694.1 3198.7 3898.4 964.1 755.8 2005.0 4215.6 2775.8 2230.8 1623.5 4320.7 7355.8 3208.5 2814.6 1760.7 5273.7 3405.9 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.3;ovary: 26.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6" "Region enriched" "Detected in single" 14 "pons and medulla: 1.4" "Region enriched" "Detected in single" 32 "spinal cord: 9.7" HPA054981 Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 12.7 15.0 0.1 1.1 0.4 0.0 13.5 0.0 1.0 1.0 0.0 1.0 0.3 5.3 19.4 3.0 27.3 0.1 0.4 0.1 0.2 17.8 0.0 0.7 4.3 3.3 0.7 0.0 26.4 0.4 0.3 0.0 5.7 4.3 1.3 0.2 0.5 0.2 0.5 17.5 12.5 11.5 8.9 2.9 0.2 0.7 3.6 0.4 0.1 1.0 0.0 0.0 1.3 1.5 2.2 6.6 4.5 0.0 94.4 34.1 32.0 1.0 4.9 4.7 7.9 7.1 4.1 7.4 3.0 6.3 47.9 2.3 10.7 3.8 0.5 6.7 80.6 27.3 5.2 14.6 0.0 3.8 0.5 12.0 30.7 5.0 15.7 5.6 0.0 0.3 0.3 3.5 0.0 27.4 1.5 0.0 3.3 0.0 0.8 4.1 0.0 3.6 0.0 24.1 0.2 0.0 11.8 7.3 7.0 21.7 8.2 16.6 1.3 0.0 9.7 21.1 10.7 7.0 0.7 0.9 0.2 3.7 0.8 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.0 0.1 0.2 3.3 0.7 0.0 4.3 2.9 0.4 2.2 3.9 0.0 0.0 0.0 0.3 6.2 0.0 0.0 9.1 0.0 3.2 5.8 0.6 0.0 0.0 3.7 0.0 0.4 0.2 0.0 17.6 0.0 1.6 0.0 0.6 1.1 0.0 0.0 0.0 0.0 3.0 14.0 0.0 0.0 0.0 13.2 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 1.8 1.0 22.4 0.4 12.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.8 9.6 0.0 2.1 6.6 13.5 11.8 34.0 2.7 5.1 4.0 0.3 0.4 7.4 0.2 0.0 TXNRD3 "TGR, TR2, TR2IT1, TRXR3, TXNRD3IT1, TXNRD3NB, TXNRD3NT1" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126571779-126655124 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020802: , HPA036109: AB_2674945" "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favorable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 5.0 4.0 2.5 2.2 2.3 1.1 6.2 3.5 2.1 4.8 2.8 2.5 1.3 5.1 5.9 4.8 3.6 3.6 3.2 1.8 3.3 5.7 8.7 4.2 1.1 3.2 2.8 2.0 6.8 6.4 8.3 1.8 2.9 2.9 3.8 3.0 1.9 3.7 4.1 5.7 3.2 1.4 4.9 3.0 2.6 3.7 20.6 2.6 4.7 6.1 5.9 1.4 3.2 1.9 3.0 16.0 3.8 4.9 8.3 8.7 13.1 2.7 6.7 5.8 5.4 7.4 7.6 8.7 0.0 8.5 9.7 3.4 6.4 6.3 7.1 6.4 0.0 5.1 1.5 3.7 5.9 7.8 6.4 0.6 13.1 5.9 1.8 12.1 7.0 3.8 5.2 3.7 0.0 9.0 12.2 1.4 3.4 7.3 4.3 3.4 0.5 4.2 2.6 6.0 8.0 8.9 5.1 19.9 5.7 10.3 3.7 8.0 2.6 6.9 6.8 1.8 9.3 3.3 4.0 1.9 0.0 3.5 2.2 5.6 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 2.5 2.3 3.5 2.1 1.8 3.3 3.2 2.8 2.0 2.9 3.0 2.6 3.0 1.3 3.2 7.2 14.4 0.4 1.0 5.7 1.6 6.2 2.0 2.9 2.4 4.1 4.3 3.0 3.7 2.1 9.4 0.1 0.5 3.9 5.1 18.2 1.5 4.0 1.7 4.2 3.0 7.5 3.8 5.4 5.3 4.1 1.0 5.7 6.1 2.9 8.0 2.9 0.0 5.8 2.4 0.0 0.8 0.7 4.0 4.7 1.0 0.0 3.7 0.0 3.2 0.0 11.1 4.7 3.8 0.3 8.6 0.1 5.5 0.1 4.5 3.3 0.9 0.0 5.7 2.8 71.5 18.2 6.1 0.6 7.3 0.6 6.6 1.5 3.2 CFD "ADN, DF, PFD" ENSG00000197766 "Complement factor D" P00746 19 859664-863641 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1339.6;breast: 1001.7" "Group enriched" "Detected in many" 6 "Fibroblasts: 9365.5;Leydig cells: 5032.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 297.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 297.6" "Group enriched" "Detected in many" 5 "ASC diff: 197.4;THP-1: 342.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 732000000 4400000000 "unprognostic (3.00e-2)" "unprognostic (6.09e-2)" "unprognostic (2.44e-1)" "unprognostic (1.22e-3)" "unprognostic (6.92e-2)" "unprognostic (5.28e-2)" "unprognostic (8.11e-3)" "unprognostic (2.48e-1)" "unprognostic (1.46e-2)" "unprognostic (8.10e-2)" "prognostic favorable (1.77e-4)" "unprognostic (9.53e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (1.23e-1)" "unprognostic (4.55e-2)" "unprognostic (1.92e-2)" "unprognostic (9.75e-2)" 1339.6 33.5 1.7 9.7 2.1 10.8 1001.7 1.2 5.4 442.3 3.6 291.4 23.8 58.9 2.4 214.6 260.3 9.7 660.4 1.7 5.0 18.2 8.7 366.5 2.1 3.0 1.5 1.2 74.9 41.7 1.7 9.1 14.6 2.4 280.1 11.0 0.6 249.3 6.4 198.7 484.6 250.6 4.0 4.0 28.8 266.0 52.2 2.7 3.6 335.0 27.1 0.8 855.5 736.1 5.9 3.9 5.2 0.6 2.2 197.4 26.2 9.5 0.8 0.0 0.0 0.0 0.8 0.4 0.2 5.7 0.0 0.5 3.0 1.8 0.5 0.0 5.7 14.5 0.5 12.3 3.8 3.6 2.5 4.9 8.7 0.2 0.1 0.0 0.8 0.0 4.5 11.9 0.9 0.0 2.6 0.6 49.2 1.0 4.5 16.1 1.3 0.5 5.2 0.3 1.2 1.8 1.8 5.5 1.9 0.5 0.6 7.5 342.2 0.4 0.2 5.1 2.9 0.6 7.8 4.7 0.4 0.2 20.8 0.2 297.6 41.2 127.8 8.4 55.5 13.2 5.7 4.2 10.2 14.5 1.4 9.7 9.7 112.0 1.3 57.3 1.8 4.7 37.8 1.7 2.1 1.2 5.4 1.7 5.0 3.0 1.5 1.2 2.4 4.0 2.7 5.9 857.8 9.6 23.3 0.0 19.2 785.5 49.0 10.1 17.1 2.9 107.3 120.1 55.5 21.5 30.9 18.4 2.1 36.6 40.0 33.1 11.7 7.7 27.1 23.1 593.3 114.8 4.2 8.2 0.2 0.0 32.9 9365.5 113.6 15.9 17.1 0.9 30.4 2.6 272.4 1.7 0.4 8.7 0.0 424.7 1145.2 89.6 5032.4 442.5 642.1 4.7 303.6 1.3 21.6 0.0 0.1 2.9 64.8 283.2 41.0 19.7 4.3 3.4 28.4 6.5 0.0 414.3 530.2 11.4 21.3 28.6 735.9 34.3 82.8 1.2 21.0 233.2 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 42.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.3;RPMI-8226: 1.4;SK-BR-3: 1.2;T-47d: 2.0;U-266/70: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA044352 Uncertain Vesicles NA NA Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.9 0.5 0.2 0.4 0.0 0.3 0.3 0.2 0.1 0.2 0.0 0.1 4.0 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.0 1.1 1.6 0.1 0.4 0.1 0.1 0.0 0.0 1.3 0.0 0.7 0.2 0.1 0.3 0.0 1.5 1.3 0.0 0.0 0.6 3.0 0.0 0.1 0.4 0.5 42.9 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.9 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.4 0.0 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.4 0.2 0.1 1.2 0.0 0.2 2.0 0.0 0.0 0.3 0.6 0.1 0.0 1.2 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 MAP1LC3C ATG8J ENSG00000197769 "Microtubule associated protein 1 light chain 3 gamma" Q9BXW4 1 241995490-241999098 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.0;breast: 14.0" "Cell type enhanced" "Detected in some" "Fibroblasts: 2.4;granulocytes: 1.3" "Cancer enhanced" "Detected in many" "glioma: 2.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SuSa: 28.0" "Low region specificity" "Detected in all" HPA072670 Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA072670: AB_2686546" "unprognostic (2.27e-2)" "unprognostic (1.74e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (1.08e-1)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.89e-3)" "unprognostic (6.17e-3)" "unprognostic (1.26e-1)" "unprognostic (8.65e-2)" "unprognostic (7.73e-2)" 12.0 0.6 0.8 0.7 0.8 0.1 14.0 0.7 1.7 0.2 1.2 1.8 0.2 0.5 0.2 1.7 4.6 0.5 0.7 0.8 1.3 0.4 0.3 5.9 4.7 0.8 0.7 0.7 3.2 0.4 0.6 0.7 10.8 0.9 0.2 0.3 0.0 7.7 0.1 3.8 5.4 2.8 0.7 0.5 0.9 4.7 0.3 0.8 0.5 1.7 3.5 3.8 2.3 1.0 0.9 0.1 0.1 5.9 0.0 0.2 5.4 3.8 0.1 0.0 0.0 0.2 0.5 0.0 0.0 3.3 1.3 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.2 0.2 0.2 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 1.8 0.1 0.0 0.0 1.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.3 28.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.8 0.8 0.7 1.7 0.8 1.3 0.8 0.7 0.7 0.9 0.5 0.8 0.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 30.6 14.3 9.8 16.9 11.1 10.1 26.3 13.7 12.1 23.3 10.8 24.0 13.4 27.0 10.9 25.2 23.9 12.2 18.2 10.0 12.1 14.7 18.8 25.1 19.1 12.1 11.0 9.3 22.3 17.2 16.3 11.1 25.5 11.9 15.3 16.8 12.4 20.7 13.8 30.3 25.4 19.7 18.4 12.0 19.7 20.5 11.9 10.7 20.9 17.6 16.1 19.8 25.3 24.3 13.2 54.4 28.6 49.6 40.3 24.0 27.1 27.0 49.2 55.9 62.2 63.3 42.5 32.9 69.7 20.3 34.8 20.7 46.8 65.1 46.8 74.1 46.0 50.3 34.7 20.8 38.3 35.7 71.3 80.6 24.1 25.8 47.4 60.7 27.6 38.9 37.5 35.3 43.9 41.7 28.5 77.4 52.6 33.3 34.7 26.5 49.8 104.0 30.8 29.0 30.0 25.0 28.7 32.9 33.1 39.3 33.0 20.4 50.2 34.3 26.5 24.1 29.8 56.3 36.1 37.7 71.1 35.5 46.1 16.2 9.8 2.3 1.4 2.0 4.2 2.0 2.0 2.0 1.9 3.2 0.9 2.0 2.2 3.0 1.8 2.5 1.5 1.9 1.1 9.8 11.1 13.7 12.1 10.0 12.1 12.1 11.0 9.3 11.9 12.0 10.7 13.2 39.0 16.0 16.5 11.8 26.2 42.8 35.0 12.3 24.5 11.4 18.1 14.2 18.6 25.8 15.6 20.2 4.2 40.5 35.4 23.7 13.7 11.7 4.6 18.8 31.7 38.3 10.8 25.0 14.0 13.7 52.6 27.4 12.2 26.2 18.3 18.2 26.7 25.6 38.5 32.0 17.3 20.8 12.2 35.5 35.0 6.2 30.1 35.9 23.2 15.0 34.2 18.3 26.8 17.6 25.3 15.8 11.9 22.6 28.0 32.8 15.6 18.7 12.5 18.3 19.7 32.8 27.4 42.5 68.7 29.9 42.8 39.7 31.6 12.7 29.1 29.1 EME2 "FLJ00151, SLX2B" ENSG00000197774 "Essential meiotic structure-specific endonuclease subunit 2" A4GXA9 16 1772810-1781708 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 3.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.1;Gastric mucus-secreting cells: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.5;REH: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045770 Uncertain NA NA "HPA045770: AB_2679447" "unprognostic (2.67e-2)" "unprognostic (1.77e-1)" "unprognostic (2.07e-1)" "unprognostic (2.94e-1)" "unprognostic (5.83e-2)" "prognostic favorable (2.86e-4)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (6.76e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "prognostic favorable (6.32e-5)" 0.7 1.1 0.6 0.5 0.8 0.2 0.8 0.4 1.0 0.7 0.2 0.8 0.6 1.1 0.2 1.2 0.9 0.0 0.4 0.9 0.2 0.8 0.4 0.7 0.2 1.0 0.3 0.9 0.6 0.8 0.1 3.9 0.1 0.5 2.1 0.0 0.0 1.0 0.4 0.4 0.9 1.2 0.0 0.0 1.1 1.1 0.9 0.7 0.1 1.7 0.0 0.0 0.9 0.8 0.6 0.5 0.1 0.0 0.4 0.1 0.0 1.1 1.8 0.0 0.1 0.1 0.4 0.8 1.8 1.1 0.0 0.0 1.9 0.0 0.0 0.0 2.4 7.5 0.4 0.8 0.1 0.0 0.9 2.1 0.0 0.3 0.0 0.0 0.0 0.2 0.7 2.4 0.1 0.0 0.2 0.5 0.6 1.0 0.1 1.0 4.1 0.3 2.1 0.1 0.1 3.4 0.6 1.7 0.8 0.2 0.0 1.2 0.7 1.2 0.2 1.1 0.5 0.9 2.5 0.8 2.1 0.0 0.4 0.5 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.2 0.6 0.8 0.4 1.0 0.9 0.2 1.0 0.3 0.9 0.5 0.0 0.7 0.6 2.8 3.2 8.2 0.3 4.5 2.7 1.2 2.4 2.2 14.1 4.3 3.9 1.3 0.0 6.0 3.7 8.4 2.1 3.3 8.9 0.0 1.6 2.1 2.7 2.8 2.2 6.7 0.8 0.0 2.2 1.2 2.7 15.3 3.1 0.0 4.2 2.5 2.7 3.6 5.0 0.0 3.6 0.0 5.5 2.3 1.4 1.2 4.6 3.6 0.0 4.4 2.4 3.1 0.0 0.1 3.6 1.7 1.5 2.7 2.0 5.6 1.5 3.0 7.1 0.0 4.0 2.4 1.5 1.9 4.6 2.8 2.5 3.6 8.5 6.7 1.4 KLHDC1 MST025 ENSG00000197776 "Kelch domain containing 1" Q8N7A1 14 49693105-49753150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 46.4;Excitatory neurons: 41.7;Inhibitory neurons: 51.1;Microglial cells: 49.6;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 90.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;ASC TERT1: 5.3;HSkMC: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020461 Approved Supported Cytosol No No Cytosol "HPA020461: AB_1852556" "unprognostic (2.97e-2)" "unprognostic (6.30e-2)" "unprognostic (8.49e-3)" "unprognostic (1.26e-2)" "unprognostic (5.46e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (1.95e-2)" "unprognostic (1.01e-1)" "unprognostic (2.53e-1)" "prognostic favorable (1.94e-4)" "unprognostic (3.42e-1)" "unprognostic (5.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" 4.8 4.2 4.0 2.4 6.0 1.5 4.8 5.2 6.0 6.1 2.2 4.6 1.9 6.0 5.7 2.2 5.8 3.1 4.6 3.5 4.5 3.0 3.5 3.1 3.6 5.0 5.0 3.1 9.4 3.9 4.1 6.2 2.6 5.0 4.7 2.3 6.1 3.4 4.4 7.2 5.2 3.9 3.5 3.9 3.8 3.9 4.8 4.3 2.0 5.6 4.7 2.7 4.4 4.9 8.1 0.7 0.3 0.6 0.3 5.7 5.3 0.0 1.5 2.1 0.5 0.3 0.0 1.8 0.3 0.3 0.6 0.5 0.5 0.1 0.0 0.4 1.5 0.5 0.2 0.1 0.0 2.9 0.1 0.7 4.5 0.2 0.2 0.2 2.9 1.2 1.0 0.3 0.0 2.2 0.2 0.4 0.8 0.0 0.2 0.2 0.4 0.5 0.0 1.1 0.2 0.2 1.5 0.2 0.0 0.6 0.7 0.6 1.2 1.7 1.3 1.4 0.5 0.1 0.5 0.0 0.4 1.2 0.2 0.7 0.5 0.4 1.0 0.7 0.8 1.4 1.2 1.0 0.9 0.4 0.8 1.7 1.4 0.0 0.6 0.4 1.4 0.3 0.7 4.0 6.0 5.2 6.0 3.5 4.5 5.0 5.0 3.1 5.0 3.9 4.3 8.1 7.6 22.4 6.5 46.4 6.1 3.6 3.4 1.5 4.0 10.4 3.3 2.3 10.1 5.7 5.7 0.0 4.2 1.5 2.7 1.7 9.8 0.8 2.1 3.5 5.4 5.7 1.8 5.2 41.7 0.8 0.8 7.3 2.6 1.9 1.3 4.5 4.6 3.2 2.6 13.5 51.1 2.4 2.0 2.2 3.3 3.3 18.0 2.9 5.4 49.6 2.2 15.0 4.1 45.2 90.5 0.4 2.7 10.1 2.9 1.6 4.2 2.5 3.1 15.8 0.0 9.5 6.1 17.9 7.6 1.3 3.3 0.3 3.7 4.2 1.2 1.8 ZNF81 "HFZ20, MRX45" ENSG00000197779 "Zinc finger protein 81" P51508 X 47836902-48002561 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Excitatory neurons: 17.7;Inhibitory neurons: 19.3;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 37.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 16.5" "Low region specificity" "Detected in all" HPA001689 Approved NA NA "HPA001689: AB_2666416" "unprognostic (1.61e-1)" "unprognostic (8.70e-2)" "unprognostic (7.26e-2)" "unprognostic (7.99e-2)" "unprognostic (4.63e-3)" "unprognostic (1.82e-4)" "unprognostic (5.20e-2)" "unprognostic (4.85e-3)" "unprognostic (6.37e-2)" "unprognostic (6.49e-2)" "unprognostic (5.00e-1)" "unprognostic (3.98e-2)" "unprognostic (1.99e-1)" "unprognostic (2.28e-1)" "unprognostic (5.25e-2)" "unprognostic (1.16e-1)" "unprognostic (2.65e-2)" 1.7 1.9 3.1 2.5 4.1 3.3 1.8 2.6 3.6 2.1 2.1 2.4 1.5 2.6 2.3 2.2 1.7 1.7 3.7 2.8 3.5 2.6 1.5 2.0 2.3 3.6 3.0 2.5 2.1 1.8 3.5 2.3 2.0 3.4 1.8 2.9 4.4 1.5 1.6 1.8 3.6 1.7 2.3 2.6 2.8 1.8 1.1 3.5 3.0 2.9 1.0 3.0 2.1 2.0 4.2 2.1 8.0 4.3 3.7 4.4 4.6 2.2 3.2 2.3 3.2 2.7 3.6 2.2 4.4 1.9 2.4 4.5 3.1 6.2 3.0 2.8 6.2 5.7 5.8 5.9 0.8 2.8 7.2 4.5 2.9 2.6 5.0 3.5 2.8 2.9 3.9 6.0 3.2 3.6 3.9 4.9 2.0 5.0 1.8 3.0 3.3 5.9 3.1 1.5 2.6 4.1 6.4 8.1 1.5 2.2 4.7 3.4 2.1 7.1 2.8 5.2 5.4 2.4 4.4 16.5 3.6 4.3 5.1 2.7 1.4 1.5 3.0 1.2 1.8 0.4 0.5 1.0 0.9 1.6 0.8 1.1 0.5 1.8 2.7 1.3 1.0 0.8 1.1 3.1 4.1 2.6 3.6 2.8 3.5 3.6 3.0 2.5 3.4 2.6 3.5 4.2 1.7 0.0 2.6 22.5 1.8 1.3 1.9 2.0 1.8 3.0 1.7 1.4 4.3 4.3 1.4 5.5 8.4 1.1 1.8 3.0 1.9 1.2 0.2 1.4 3.1 3.6 3.6 0.0 17.7 1.0 1.5 2.0 1.5 1.6 0.0 4.8 2.5 1.8 1.5 1.7 19.3 1.8 4.1 1.3 2.1 0.7 0.6 3.4 5.4 13.1 1.6 2.0 2.1 22.1 37.0 1.4 3.7 1.9 2.6 2.0 2.0 2.3 3.4 2.9 0.0 2.9 2.9 0.8 1.1 1.6 3.7 1.1 2.1 4.9 2.2 2.3 TAF13 "TAF2K, TAFII18" ENSG00000197780 "TATA-box binding protein associated factor 13" Q15543 1 109062486-109076003 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044492 Approved Enhanced Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044492: AB_10962871" "unprognostic (8.54e-2)" "unprognostic (2.02e-2)" "unprognostic (2.82e-2)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.74e-6)" "unprognostic (1.73e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "unprognostic (1.91e-1)" "unprognostic (7.61e-3)" "unprognostic (7.22e-3)" 37.3 17.7 25.8 23.5 26.7 50.1 22.6 26.4 25.9 25.8 17.8 26.6 16.2 21.3 22.1 34.2 12.4 27.5 30.7 22.7 27.3 34.7 32.2 18.4 15.1 28.0 27.1 19.3 7.1 17.1 26.0 8.8 33.7 28.3 25.4 28.0 9.3 15.2 17.4 67.5 19.0 17.1 35.2 31.0 12.9 21.1 17.1 29.6 13.0 28.2 48.8 24.5 35.0 9.3 28.6 74.5 19.3 28.7 42.0 80.7 75.2 47.6 172.3 72.5 68.7 69.0 30.6 16.4 28.1 64.2 115.6 40.8 30.7 50.9 62.2 102.8 48.6 11.5 28.5 43.0 31.9 63.8 50.7 41.5 67.5 73.0 115.4 62.3 36.8 59.6 25.8 55.5 26.7 93.9 42.8 26.7 13.6 57.6 34.4 39.2 20.7 51.7 11.5 80.0 63.6 29.8 37.2 84.6 54.2 63.7 50.8 18.5 35.5 78.5 112.7 43.1 80.3 95.5 32.4 88.5 36.9 119.8 26.2 171.2 2.0 2.3 2.0 0.8 1.7 0.7 0.7 0.5 0.8 0.8 0.6 0.5 0.8 4.0 0.2 1.6 1.5 1.3 0.5 25.8 26.7 26.4 25.9 22.7 27.3 28.0 27.1 19.3 28.3 31.0 29.6 28.6 46.4 19.2 24.6 1.0 10.3 70.2 10.7 12.3 8.6 5.5 14.7 10.2 63.6 10.0 20.3 7.3 0.0 16.7 21.2 35.6 13.7 16.2 55.2 29.4 24.0 21.4 31.8 9.3 4.5 20.9 30.1 20.9 11.7 48.8 14.5 5.1 25.7 37.9 18.2 6.7 3.8 30.2 18.3 28.3 37.6 6.6 9.3 26.5 14.2 1.9 14.5 13.8 5.2 3.0 3.6 31.8 21.7 12.8 9.8 21.9 25.4 31.1 16.8 7.5 6.6 23.6 20.1 10.8 18.2 10.7 82.3 54.9 13.8 6.8 17.9 29.0 ZNF780A ZNF780 ENSG00000197782 "Zinc finger protein 780A" O75290 19 40069152-40090938 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 48.9;Hepatocytes: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (1.92e-1)" "unprognostic (9.25e-2)" "unprognostic (7.38e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (1.46e-2)" "unprognostic (1.19e-2)" "unprognostic (2.17e-1)" "unprognostic (4.47e-3)" "unprognostic (1.13e-1)" "unprognostic (9.49e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.30e-4)" 2.4 3.1 1.6 3.2 1.7 1.4 2.6 3.0 2.1 2.6 1.7 2.6 1.9 2.7 3.5 3.6 2.5 2.2 2.2 1.6 1.4 2.5 4.3 2.4 4.3 1.3 1.3 1.6 2.8 3.9 3.7 2.8 2.4 1.6 2.7 1.9 3.7 3.5 3.0 1.5 2.7 3.4 1.5 0.9 4.2 3.0 1.8 1.3 2.7 3.7 1.8 4.0 2.7 2.9 1.8 3.4 6.4 4.1 3.8 3.6 3.3 2.9 3.9 3.1 3.1 4.8 4.2 2.3 3.1 2.5 1.9 3.1 2.8 2.6 2.2 3.5 5.3 3.6 4.8 5.5 4.0 3.2 5.0 3.8 3.4 2.4 3.2 2.6 4.2 3.3 3.3 5.5 5.0 2.7 2.0 2.0 1.6 3.3 3.3 2.0 1.6 7.2 1.8 2.6 7.0 2.5 4.8 5.8 2.2 2.5 3.6 2.7 6.0 2.5 3.8 5.1 3.5 3.2 4.9 4.6 3.0 2.4 3.4 2.6 1.4 2.4 4.0 1.6 2.3 2.3 1.8 1.8 1.5 2.1 1.4 2.5 2.1 2.1 1.6 3.8 1.6 2.1 1.1 1.6 1.7 3.0 2.1 1.6 1.4 1.3 1.3 1.6 1.6 0.9 1.3 1.8 8.5 9.6 10.2 6.2 8.1 3.8 4.5 15.2 6.2 5.8 9.4 5.7 4.0 8.6 11.6 9.2 2.1 5.9 7.0 7.0 9.8 14.5 25.0 4.1 5.5 8.4 3.5 3.4 7.8 48.9 8.5 6.0 2.0 4.5 16.5 4.2 12.8 37.7 15.0 5.0 5.7 7.4 4.1 25.4 11.5 3.6 4.4 11.4 12.4 9.4 12.0 3.9 17.5 4.0 6.5 32.6 7.1 5.3 5.8 3.2 14.1 21.7 13.5 7.3 6.6 4.4 5.1 9.8 4.0 5.2 2.6 5.9 11.8 5.7 7.6 3.4 ATAD3A FLJ10709 ENSG00000197785 "ATPase family AAA domain containing 3A" Q9NVI7 1 1512162-1534685 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058968, HPA064867, HPA065305" Approved Enhanced Mitochondria NA NA 27000 Mitochondria "HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459" "unprognostic (8.42e-2)" "unprognostic (1.67e-1)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.50e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (6.62e-2)" "unprognostic (9.53e-2)" "unprognostic (5.81e-2)" "unprognostic (4.09e-2)" "unprognostic (7.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (3.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.87e-3)" 10.7 13.7 6.9 12.5 6.4 18.2 10.8 7.1 11.2 10.2 7.4 10.6 11.5 12.9 2.0 17.4 10.5 4.4 14.1 7.6 6.5 10.6 18.6 10.1 10.5 6.9 6.9 6.7 8.5 19.7 5.2 14.7 6.7 6.8 9.6 3.0 2.0 13.5 5.6 29.0 14.3 9.9 3.8 6.0 11.8 13.0 9.4 6.7 6.2 9.7 8.4 4.7 11.5 10.8 6.9 79.2 47.9 18.0 49.3 8.3 10.6 45.6 62.9 16.8 52.7 32.1 127.2 52.8 45.9 41.5 24.9 19.7 65.8 27.5 36.5 9.2 42.7 110.3 75.0 131.9 97.0 17.3 112.5 42.7 12.8 11.2 44.2 16.2 6.1 23.2 44.2 120.1 27.3 19.7 64.5 83.1 95.2 40.9 25.9 91.5 88.5 35.7 91.9 14.7 40.3 91.8 35.3 39.8 58.1 53.0 5.9 24.8 55.7 32.6 52.5 45.0 85.8 79.2 45.6 52.6 172.7 54.2 160.5 25.4 0.5 1.8 0.6 1.5 1.5 1.0 1.4 1.5 1.7 2.2 1.5 1.3 0.6 0.1 2.5 3.4 2.2 1.5 1.1 6.9 6.4 7.1 11.2 7.6 6.5 6.9 6.9 6.7 6.8 6.0 6.7 6.9 8.5 3.2 9.0 10.7 11.7 20.4 11.2 5.9 8.0 10.5 11.6 8.3 9.5 8.6 6.4 7.3 6.2 21.6 10.0 18.8 7.9 22.5 9.5 14.7 9.3 11.8 13.8 28.4 8.8 21.3 43.4 10.4 13.7 8.7 8.9 21.9 4.6 12.5 22.4 23.5 8.3 19.6 14.2 7.5 12.5 10.1 5.6 7.7 16.0 6.5 5.9 10.9 6.2 4.5 6.1 25.3 5.2 7.9 27.5 38.3 13.8 12.8 7.9 9.4 0.0 9.4 14.8 5.8 20.1 17.4 24.3 19.7 7.7 35.6 27.7 15.7 OR5B17 OR5B20P ENSG00000197786 "Olfactory receptor family 5 subfamily B member 17" Q8NGF7 11 58358124-58359069 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52M1 OR52M1P ENSG00000197790 "Olfactory receptor family 52 subfamily M member 1" Q8NGK5 11 4545191-4546144 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM118B FLJ21103 ENSG00000197798 "Family with sequence similarity 118 member B" Q9BPY3 11 126211724-126262984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041644, HPA042100" Approved NA NA "HPA041644: AB_10794303, HPA042100: AB_10795394" "unprognostic (8.11e-2)" "unprognostic (9.87e-3)" "unprognostic (4.05e-3)" "unprognostic (3.13e-2)" "unprognostic (9.55e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (6.67e-7)" "unprognostic (1.85e-2)" "unprognostic (3.03e-3)" "unprognostic (1.43e-1)" "unprognostic (7.12e-2)" "unprognostic (1.64e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (9.49e-2)" "unprognostic (3.82e-1)" "unprognostic (7.44e-2)" 9.4 10.6 15.0 10.4 18.7 4.3 7.6 15.5 20.6 10.4 18.7 24.2 18.7 10.0 12.4 7.7 6.8 10.6 15.0 15.4 21.8 10.3 9.0 16.4 12.8 15.6 15.0 15.3 6.3 5.7 7.7 9.1 11.1 15.0 7.4 23.9 9.1 8.1 9.4 22.2 5.4 13.2 14.3 15.9 10.6 15.0 21.6 15.1 14.2 10.3 16.5 14.1 13.7 6.3 16.0 11.7 14.3 31.5 23.6 43.4 28.5 14.0 18.5 33.2 20.4 21.2 29.0 18.5 13.0 19.2 23.5 42.4 15.2 33.5 19.7 24.8 21.2 14.5 41.3 6.8 19.5 33.7 20.7 13.0 23.7 19.9 25.0 23.0 20.5 46.8 24.9 25.8 17.8 29.6 10.9 27.8 16.2 25.6 63.3 26.4 24.1 25.1 11.6 34.4 18.3 14.5 15.2 21.5 14.0 26.8 36.8 27.3 12.4 29.2 20.7 15.2 17.9 16.3 9.3 11.7 22.0 8.9 31.0 26.9 33.8 43.4 21.9 14.6 58.8 18.6 15.2 14.4 18.9 48.1 15.9 12.9 16.0 9.0 18.9 59.6 21.9 18.0 25.2 15.0 18.7 15.5 20.6 15.4 21.8 15.6 15.0 15.3 15.0 15.9 15.1 16.0 8.6 3.2 16.4 14.4 5.6 4.1 4.2 21.9 1.2 3.1 3.3 3.6 10.4 4.3 9.6 12.9 4.2 9.3 5.0 21.9 5.9 16.0 7.5 5.0 6.0 12.4 3.6 8.6 19.1 17.2 12.4 8.3 21.4 4.1 10.8 9.1 9.7 5.5 24.2 1.7 17.6 11.4 12.2 16.7 9.4 9.2 7.8 11.0 3.6 12.2 16.9 13.5 13.4 16.1 12.7 14.0 12.8 21.8 9.5 4.1 11.4 12.9 6.8 5.7 6.6 3.4 10.2 46.0 20.6 3.5 3.4 13.0 5.3 11.0 16.6 5.7 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36636618-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Alveolar cells type 2: 23.8;Early spermatids: 43.5;granulocytes: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 2.1 3.6 3.3 2.1 3.4 3.0 3.1 6.5 5.3 2.0 1.9 2.0 0.5 3.4 2.5 2.1 3.1 2.0 2.3 3.5 3.6 2.7 2.0 2.0 3.2 2.8 3.0 3.5 4.5 1.3 3.2 3.0 3.4 3.8 2.8 1.9 6.7 1.6 2.2 2.3 3.0 2.0 3.2 2.2 3.5 2.5 3.7 3.4 2.5 4.1 2.1 3.2 2.0 2.1 4.0 2.9 4.7 3.5 4.8 2.6 4.9 2.4 2.9 3.0 4.2 5.8 0.8 1.4 0.4 6.2 3.8 4.2 0.6 2.5 3.0 4.6 5.6 3.4 4.9 0.7 1.9 4.1 3.7 5.5 3.5 5.6 1.5 4.3 5.6 2.6 2.4 0.2 0.5 4.3 2.7 6.1 1.7 2.3 0.4 2.1 0.4 3.6 1.0 1.8 6.3 4.6 6.1 0.3 2.1 3.8 3.5 2.2 1.5 3.2 2.5 3.4 2.1 3.7 7.6 12.2 1.6 0.0 0.8 3.6 0.8 0.5 0.5 1.3 1.1 1.7 1.5 2.1 2.8 1.2 2.0 1.6 1.3 0.1 1.4 0.2 0.5 2.0 0.9 3.3 3.4 6.5 5.3 3.5 3.6 2.8 3.0 3.5 3.8 2.2 3.4 4.0 2.3 28.9 23.8 8.1 4.1 3.3 2.0 2.3 4.6 5.4 4.7 2.5 2.2 7.2 12.9 3.7 0.0 2.5 2.6 0.9 1.9 1.7 43.5 4.6 2.9 5.2 3.0 0.8 16.3 0.9 2.9 6.2 1.5 4.6 33.5 3.1 2.9 1.2 1.7 3.3 14.0 1.1 0.0 2.5 3.2 8.3 0.9 3.2 0.0 4.7 0.9 1.6 1.0 9.0 12.4 0.8 0.5 1.9 1.2 2.3 0.8 1.8 9.9 3.6 0.0 4.9 3.9 10.2 4.0 3.1 3.4 2.9 6.1 1.9 1.3 1.8 CCDC180 "BDAG1, C9orf174, CFAP76, DKFZp434I2420, FAP76, KIAA1529" ENSG00000197816 "Coiled-coil domain containing 180" 9 97307304-97378751 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.8;testis: 13.2" "Cell type enhanced" "Detected in many" "Early spermatids: 133.5;Late spermatids: 297.4;Respiratory ciliated cells: 81.2;Spermatocytes: 48.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6;U-266/70: 4.1;U-266/84: 3.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (9.92e-2)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-3)" "unprognostic (2.94e-2)" "unprognostic (3.52e-2)" "unprognostic (2.94e-1)" "unprognostic (1.52e-1)" "unprognostic (5.53e-5)" "unprognostic (2.33e-2)" "unprognostic (7.34e-3)" "unprognostic (1.64e-1)" "unprognostic (2.54e-1)" "unprognostic (1.41e-2)" "unprognostic (7.50e-3)" 0.7 0.9 4.1 0.6 2.5 0.7 1.2 4.0 2.8 1.2 9.8 0.7 0.4 1.7 2.0 0.5 6.4 0.9 0.9 2.2 1.8 1.0 0.5 2.0 0.9 3.5 4.4 1.6 2.4 1.1 1.0 1.2 0.5 2.7 1.1 0.8 6.5 0.8 1.1 1.0 0.5 0.6 1.3 3.2 1.1 0.6 13.2 2.5 0.6 1.8 0.9 0.7 0.5 0.4 2.6 0.0 0.4 0.6 0.3 0.4 1.3 0.0 0.1 0.4 0.4 0.3 0.7 0.4 0.0 0.6 0.0 0.3 0.0 0.4 0.0 0.1 2.6 0.3 0.8 0.9 0.3 0.1 1.0 1.3 0.6 0.4 0.0 0.1 1.5 0.0 1.2 0.6 0.4 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.3 0.0 0.4 0.1 1.2 0.6 4.1 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.5 4.0 2.8 2.2 1.8 3.5 4.4 1.6 2.7 3.2 2.5 2.6 3.0 0.0 10.5 0.0 3.4 0.4 0.5 1.8 1.2 12.6 1.9 2.3 0.8 1.5 11.7 0.0 20.9 0.2 2.0 0.4 1.9 0.4 133.5 39.0 3.7 2.7 1.2 0.8 0.0 1.4 0.0 2.8 0.5 1.4 9.5 11.4 2.9 0.1 0.5 13.5 0.0 1.2 2.0 0.8 0.9 297.4 1.8 1.6 1.8 0.0 3.4 2.7 4.1 0.0 0.0 0.2 0.5 3.0 5.1 0.4 1.7 15.9 81.2 25.0 0.0 6.7 3.0 48.0 6.0 0.5 0.1 0.4 2.7 5.7 1.2 0.4 SLC9A8 "KIAA0939, NHE8" ENSG00000197818 "Solute carrier family 9 member A8" Q9Y2E8 20 49812713-49892242 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "SK-BR-3: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033682 Approved NA NA "CAB033682: AB_2270441" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (6.11e-2)" "unprognostic (2.73e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-2)" "unprognostic (4.49e-2)" "unprognostic (3.22e-1)" "unprognostic (3.96e-2)" "unprognostic (5.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.19e-2)" "unprognostic (1.96e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (5.28e-2)" 5.4 6.8 3.4 7.1 3.4 20.5 4.5 2.7 3.4 4.4 1.6 5.4 5.8 4.2 4.0 8.7 4.8 4.8 3.9 3.0 3.7 4.0 6.4 5.6 6.7 4.7 3.7 2.5 3.9 5.7 5.6 5.1 3.8 4.1 5.1 5.1 4.0 6.6 4.2 11.5 4.3 5.7 3.3 3.6 8.2 7.7 6.8 4.0 6.9 6.6 4.8 5.9 5.5 4.5 3.6 5.7 10.3 4.5 4.5 5.6 3.5 11.4 5.8 7.8 10.8 5.1 7.3 12.7 6.8 7.3 8.3 8.9 12.5 4.8 5.9 5.5 6.0 2.7 3.4 7.1 3.8 7.8 6.1 8.0 6.7 6.6 5.7 11.5 5.6 4.7 8.9 6.7 6.9 6.7 6.3 5.6 4.1 3.7 8.6 4.8 4.1 5.3 4.9 6.4 6.1 4.5 3.9 9.6 35.3 7.0 3.0 11.5 9.8 7.1 14.7 8.1 7.2 5.7 10.5 4.9 4.9 20.1 8.0 6.2 1.9 0.6 1.6 0.9 0.4 0.9 0.7 0.7 0.8 0.6 0.8 0.7 0.4 2.9 0.4 0.7 0.3 0.5 0.7 3.4 3.4 2.7 3.4 3.0 3.7 4.7 3.7 2.5 4.1 3.6 4.0 3.6 6.3 12.8 8.8 24.5 9.9 2.5 4.4 9.2 4.0 5.7 5.7 5.0 4.9 7.2 14.8 3.7 14.6 6.1 10.6 17.9 1.9 7.1 2.7 12.3 6.5 5.4 6.7 9.3 13.8 6.4 4.1 5.1 19.4 18.7 22.2 7.0 8.6 15.5 5.1 6.7 20.0 7.0 6.1 9.2 4.1 8.4 3.7 11.8 1.8 19.7 5.8 5.7 5.2 15.1 25.3 9.4 9.0 4.9 8.0 5.2 7.6 3.4 21.5 9.6 0.0 5.9 5.2 8.9 6.7 10.2 1.8 3.4 9.8 4.7 7.3 9.4 OCLN PPP1R115 ENSG00000197822 Occludin Q16625 5 69492292-69558104 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 31.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 109.0;Glandular and luminal cells: 119.7;Urothelial cells: 224.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "A-431: 23.3;CAPAN-2: 39.8;HaCaT: 33.4;RPTEC TERT1: 25.7;SK-BR-3: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005933, CAB013075, CAB068212, CAB068213, CAB068214" Enhanced Supported "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA "Plasma membrane, Cell Junctions" "CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520" "unprognostic (2.28e-1)" "unprognostic (1.88e-1)" "unprognostic (2.50e-2)" "unprognostic (9.94e-2)" "unprognostic (3.65e-1)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.08e-2)" "unprognostic (8.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.58e-2)" "unprognostic (3.48e-1)" "prognostic favorable (6.59e-11)" "unprognostic (2.83e-1)" "unprognostic (4.01e-1)" "unprognostic (1.33e-1)" "unprognostic (3.35e-1)" 1.2 0.7 8.6 1.6 6.4 1.8 7.9 7.5 6.7 5.3 19.5 11.1 10.4 2.1 4.0 11.7 7.5 8.6 1.3 6.2 6.1 11.1 18.9 15.2 0.6 9.5 6.5 4.7 2.3 20.4 8.4 3.4 4.0 8.1 3.6 11.3 2.3 6.7 4.7 0.6 10.8 10.1 0.6 6.0 2.2 15.4 2.4 7.0 0.9 31.7 0.6 2.9 5.0 8.0 11.7 23.3 4.5 0.6 0.9 0.6 0.9 15.1 0.3 1.6 2.5 3.3 20.7 39.8 0.5 5.9 1.1 8.3 33.4 7.2 4.3 7.8 0.3 12.2 2.4 1.1 9.8 0.3 1.2 2.5 0.1 6.4 4.1 1.0 1.6 1.4 3.1 0.1 0.4 0.1 22.4 1.5 1.2 3.1 8.0 2.1 0.2 6.0 1.1 25.7 22.2 2.7 2.8 0.3 27.2 0.9 5.0 14.7 4.0 1.2 0.4 7.7 1.8 2.7 0.5 0.4 0.3 0.3 0.3 0.6 1.0 0.2 0.5 0.2 0.1 0.2 0.3 0.2 0.1 0.1 0.4 0.2 0.2 2.7 0.5 0.1 0.4 0.1 0.1 8.6 6.4 7.5 6.7 6.2 6.1 9.5 6.5 4.7 8.1 6.0 7.0 11.7 4.8 109.0 67.3 1.6 3.2 3.7 60.8 7.6 1.8 5.7 49.7 16.9 1.4 64.3 51.0 25.8 14.6 30.3 3.6 94.1 9.8 65.6 1.9 78.5 12.1 10.7 26.3 2.5 1.3 61.6 2.5 5.8 46.4 119.7 2.5 6.5 18.2 48.3 3.0 6.7 1.1 45.1 16.2 12.9 1.2 1.6 3.1 2.4 1.8 16.9 3.9 2.8 1.0 0.5 1.5 64.6 61.8 1.5 1.1 101.5 42.3 10.5 63.0 6.3 13.1 3.3 4.4 4.7 8.2 29.5 15.5 16.4 4.3 0.7 47.9 224.0 CFAP299 C4orf22 ENSG00000197826 "Cilia and flagella associated protein 299" Q6V702 4 80335730-80963750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 20.0;testis: 27.6" "Cell type enriched" "Detected in some" 54 "Endometrial ciliated cells: 54.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.0 1.6 0.0 1.0 0.0 0.1 1.5 0.6 0.4 2.1 0.0 0.1 0.2 0.0 0.0 20.0 0.1 0.0 0.7 1.1 0.3 0.0 1.4 0.1 4.4 3.3 0.0 0.1 0.0 0.0 0.1 0.0 2.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 27.6 1.3 0.1 0.6 0.0 0.0 0.0 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.7 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 1.0 1.5 0.6 0.7 1.1 4.4 3.3 0.0 2.3 4.1 1.3 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 54.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 H4-16 "HIST4H4, MGC24116" ENSG00000197837 "H4 histone 16" P62805 12 14767999-14771131 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.7;Cytotrophoblasts: 1.0;dendritic cells: 2.6;Hofbauer cells: 1.6;Syncytiotrophoblasts: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 4.7;HeLa: 3.7" "Low region specificity" "Detected in all" "CAB011503, CAB037279, HPA042201" Supported Supported Nucleoplasm NA NA 25000000 Nucleoplasm "CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.16e-2)" "unprognostic (4.86e-2)" "unprognostic (3.67e-2)" "unprognostic (9.69e-3)" "unprognostic (4.54e-2)" "unprognostic (3.25e-2)" "unprognostic (5.35e-2)" "unprognostic (6.62e-3)" "unprognostic (4.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.28e-3)" 0.4 1.0 4.0 1.2 10.4 0.6 0.9 3.4 4.4 1.3 2.1 0.7 1.3 0.9 1.8 2.2 1.5 1.4 0.8 1.7 9.1 0.7 0.4 0.8 1.5 6.0 3.7 2.4 1.2 1.2 0.2 0.5 1.7 4.0 4.3 1.2 1.2 1.4 0.9 0.5 1.7 1.0 0.6 5.2 1.9 2.7 1.7 11.4 1.4 1.7 0.0 1.2 0.8 1.1 3.2 1.3 0.5 0.0 1.5 1.6 0.0 0.9 0.8 0.0 0.6 0.5 0.8 4.7 1.2 0.3 0.4 0.0 0.8 0.0 0.6 0.3 1.5 0.6 0.0 3.7 1.2 0.4 0.3 1.1 1.1 0.3 0.1 0.6 0.0 0.0 0.4 0.0 1.5 0.0 0.6 0.3 0.4 1.6 0.4 0.2 1.3 0.0 2.3 0.0 3.4 0.5 0.8 3.1 0.8 0.2 0.3 0.5 0.6 1.0 0.2 2.4 0.6 1.0 1.6 1.1 3.6 1.1 0.0 0.8 0.0 2.5 0.3 2.3 2.4 4.1 5.3 2.7 2.6 2.7 5.7 2.4 2.8 24.1 3.0 1.0 4.6 4.0 1.6 4.0 10.4 3.4 4.4 1.7 9.1 6.0 3.7 2.4 4.0 5.2 11.4 3.2 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 CYP2A13 "CPAD, CYP2A" ENSG00000197838 "Cytochrome P450 family 2 subfamily A member 13" Q16696 19 41088451-41096195 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "liver: 2.0" "Group enriched" "Detected in some" 8 "Club cells: 2.0;Early spermatids: 4.2;Late spermatids: 3.7" "Cancer enriched" "Detected in single" 5 "liver cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (9.79e-2)" "unprognostic (1.00e-1)" "unprognostic (4.51e-3)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ZNF181 "HHZ181, MGC44316" ENSG00000197841 "Zinc finger protein 181" Q2M3W8 19 34734155-34745378 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043701, HPA062305" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043701: AB_10960859, HPA062305: AB_2684743" "unprognostic (2.00e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-4)" "unprognostic (1.06e-1)" "unprognostic (4.83e-3)" "unprognostic (5.60e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.01e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.06e-1)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (9.34e-2)" "prognostic favorable (5.45e-4)" 7.5 8.9 11.4 6.0 13.2 3.6 10.5 14.7 13.3 8.4 11.1 8.5 9.8 9.1 6.4 6.6 9.0 7.3 13.9 10.9 12.2 9.2 14.8 8.1 7.9 12.4 12.2 10.7 18.4 11.9 13.3 6.8 5.6 12.2 8.6 7.1 17.9 8.1 10.7 23.0 5.1 8.9 8.2 12.1 9.9 7.6 7.1 12.2 8.9 10.6 24.0 9.2 7.9 5.9 15.0 4.4 7.0 8.5 11.2 13.4 10.5 2.7 5.3 9.4 5.7 6.5 5.0 4.6 6.8 14.8 8.2 7.6 4.1 5.9 5.8 4.3 14.5 6.0 12.9 9.1 7.0 15.8 7.6 4.3 8.1 9.2 4.0 7.8 14.4 5.5 15.0 10.6 0.1 11.4 3.0 15.1 5.4 5.4 10.0 5.7 10.3 10.7 8.9 7.5 5.1 5.9 10.8 11.6 3.2 12.4 7.0 6.7 12.1 7.2 14.6 7.3 3.6 5.8 10.2 16.4 5.7 5.8 2.0 7.5 3.0 4.1 6.6 8.3 5.6 8.5 8.8 11.0 11.3 6.0 15.2 17.1 12.3 0.7 10.9 16.1 6.6 7.6 6.3 11.4 13.2 14.7 13.3 10.9 12.2 12.4 12.2 10.7 12.2 12.1 12.2 15.0 11.5 16.0 5.3 8.5 5.7 1.7 3.7 4.0 3.4 15.9 6.5 9.0 40.8 2.8 9.4 5.5 4.2 3.6 3.1 5.3 17.6 6.3 3.3 4.6 7.3 8.9 4.2 1.7 6.8 4.9 1.0 11.2 5.6 4.0 2.5 13.1 7.5 8.5 3.8 13.5 7.8 6.5 4.1 5.4 2.0 2.5 9.3 3.3 5.4 2.8 3.0 16.1 15.5 8.0 11.7 2.6 4.6 12.0 2.6 2.7 6.9 8.0 14.5 15.5 0.0 22.3 14.6 18.9 8.9 3.2 0.9 1.1 6.2 13.1 4.4 1.5 OR8G1 "HSTPCR25, OR8G1P, TPCR25" ENSG00000197849 "Olfactory receptor family 8 subfamily G member 1" Q15617 11 124241095-124254364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Early spermatids: 3.6;Late spermatids: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INKA2 "C1orf183, FAM212B, FLJ31105" ENSG00000197852 "Inka box actin regulator 2" Q9NTI7 1 111680630-111755824 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "Hofbauer cells: 4.0" "Cancer enhanced" "Detected in many" "glioma: 6.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 13 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 13 "granulocytes: 25.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 35.6;U-87 MG: 73.0;WM-115: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027809, HPA027810, HPA027811" Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872" "unprognostic (1.92e-1)" "unprognostic (9.70e-3)" "unprognostic (1.84e-1)" "unprognostic (1.85e-2)" "unprognostic (2.81e-2)" "prognostic favorable (4.51e-5)" "unprognostic (9.96e-4)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (9.50e-3)" "unprognostic (9.92e-5)" "unprognostic (8.66e-2)" "unprognostic (1.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-3)" "unprognostic (5.07e-2)" 7.4 1.1 9.5 3.1 11.8 2.9 4.1 5.4 16.8 2.3 3.1 2.9 1.2 4.0 1.7 6.7 5.1 2.9 12.4 15.3 5.6 2.7 0.9 4.8 1.0 5.9 5.3 12.6 2.1 1.3 2.3 0.7 6.2 7.1 3.0 2.4 1.4 2.3 4.0 7.8 5.5 2.5 5.9 4.0 5.4 3.9 2.6 5.1 2.1 2.6 9.0 1.8 2.8 3.4 10.6 2.5 2.3 5.1 3.2 20.5 7.3 1.7 1.8 4.0 3.3 7.8 4.1 0.1 2.0 0.9 1.8 1.6 2.2 2.2 4.9 3.2 4.6 1.9 15.0 1.8 4.0 8.1 1.1 2.3 6.0 20.9 35.6 1.6 0.9 8.9 2.6 0.1 3.3 5.3 2.8 1.1 1.2 1.2 2.4 2.0 2.2 19.4 0.7 0.9 3.5 10.2 3.4 1.1 0.1 9.8 5.6 2.8 3.3 3.5 7.1 11.4 3.9 1.5 20.7 3.8 2.1 73.0 4.5 28.0 0.2 1.8 1.4 0.0 1.4 0.0 0.2 0.1 0.1 1.0 0.4 0.0 0.0 25.2 0.6 2.0 0.5 0.0 0.6 9.5 11.8 5.4 16.8 15.3 5.6 5.9 5.3 12.6 7.1 4.0 5.1 10.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 95.9;Early spermatids: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favorable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favorable (9.21e-6)" 6.4 5.7 2.5 2.7 2.7 9.7 6.8 3.5 3.2 7.5 3.5 5.9 3.3 5.5 5.3 6.9 6.3 2.1 4.7 2.4 3.0 8.4 11.1 6.2 4.5 2.6 2.7 2.4 9.5 6.8 4.1 7.2 2.7 3.0 7.5 5.0 5.0 5.7 3.1 3.5 7.9 7.5 2.6 2.3 9.5 5.0 9.8 2.8 3.2 6.8 2.4 4.3 7.1 7.0 3.7 3.0 0.9 1.8 4.3 2.1 1.9 9.6 4.2 1.7 6.5 5.9 4.2 1.7 3.0 5.0 3.4 1.9 3.2 3.0 2.6 5.6 0.0 2.7 2.9 4.4 11.3 2.9 0.0 7.4 2.5 3.9 4.1 4.9 2.6 2.6 3.8 1.9 0.6 4.2 3.2 4.6 5.7 1.8 3.0 5.2 3.2 4.7 3.8 3.7 7.1 2.6 2.9 5.4 2.2 1.4 6.2 4.5 4.6 2.8 8.3 2.3 8.3 3.7 6.5 7.5 2.8 0.2 2.7 2.4 11.9 1.7 15.8 7.3 3.2 8.5 4.2 7.9 7.9 1.3 3.4 8.4 8.4 5.6 11.5 3.2 3.2 6.1 3.4 2.5 2.7 3.5 3.2 2.4 3.0 2.6 2.7 2.4 3.0 2.3 2.8 3.7 14.6 28.9 19.9 16.6 16.1 9.1 6.6 8.2 8.0 16.1 10.6 8.3 16.9 17.2 13.9 64.4 37.5 17.2 21.5 17.9 95.9 9.9 113.1 21.1 11.6 11.8 15.6 6.5 13.8 9.3 6.8 8.3 6.1 25.1 24.1 14.4 11.0 12.4 8.5 16.8 16.1 12.9 10.2 11.1 8.7 34.1 14.0 10.9 10.6 25.3 8.8 9.8 27.8 17.6 21.7 9.6 13.0 6.0 13.7 6.2 17.1 13.6 24.8 36.7 19.7 11.6 9.8 36.5 24.8 16.4 11.6 8.6 19.2 8.4 12.9 9.6 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 275.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved Approved "Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Centrosome, Mitochondria" "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 46.1 76.1 30.0 21.4 31.4 48.7 47.1 34.6 44.0 50.9 49.4 44.0 36.1 57.4 19.0 52.1 46.3 25.3 70.4 29.1 30.5 61.9 70.5 43.0 23.6 36.1 32.5 29.1 50.3 66.8 47.9 37.5 20.2 35.6 51.3 13.2 11.5 61.0 40.9 72.3 47.3 47.2 19.0 37.8 48.8 56.3 41.2 31.5 18.7 60.6 28.7 13.0 43.3 43.2 43.1 67.3 117.2 26.9 84.7 60.8 51.5 92.8 68.5 66.5 55.8 57.4 49.0 108.9 36.6 94.1 73.9 26.4 82.5 17.9 67.2 8.1 60.4 59.0 58.0 53.1 36.3 58.6 28.5 83.2 56.8 61.6 56.9 39.4 45.0 46.4 61.5 42.1 125.7 54.1 237.6 55.9 26.5 27.2 79.3 275.8 38.1 34.2 176.9 48.4 46.8 45.7 63.2 88.8 112.4 51.1 14.7 73.2 79.3 31.6 51.8 88.6 29.5 77.2 70.0 57.5 24.9 91.2 34.8 72.0 35.7 64.4 59.0 84.2 78.1 57.2 37.4 41.7 66.7 59.6 40.1 40.6 57.7 14.8 69.1 91.9 107.1 40.1 76.7 30.0 31.4 34.6 44.0 29.1 30.5 36.1 32.5 29.1 35.6 37.8 31.5 43.1 41.0 38.5 40.0 13.7 46.7 28.8 54.9 84.6 37.0 60.8 74.9 59.9 42.7 55.8 58.0 44.1 64.6 123.4 72.5 100.2 25.4 125.8 5.7 30.8 30.7 37.3 56.9 48.0 12.8 89.9 152.9 57.1 56.6 37.3 64.8 45.1 42.5 74.9 86.6 55.5 14.6 52.6 79.3 53.6 25.6 10.9 40.4 41.2 72.9 6.5 57.4 98.0 98.9 15.6 20.4 76.0 91.0 37.6 85.5 58.0 155.1 90.3 46.8 73.2 59.2 50.8 50.5 194.8 109.9 55.9 22.3 109.3 38.9 66.5 85.3 48.1 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 42.0;liver: 36.1" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" NA NA 170000000 Vesicles "HPA045634: AB_2679399, HPA053812: AB_2682271" "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.0 28.7 7.0 1.0 6.1 0.1 1.5 10.8 10.1 2.1 0.6 2.5 1.4 3.1 3.2 1.9 3.2 2.6 42.0 4.8 6.6 25.8 36.1 23.4 3.4 15.3 10.9 5.9 5.0 7.2 1.3 16.0 1.6 19.5 8.5 0.4 0.3 3.4 2.2 4.4 0.8 3.3 0.9 6.5 6.5 2.3 3.2 9.8 0.6 12.2 0.6 0.6 5.3 1.6 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.5 0.0 1.1 0.7 10.1 0.0 0.0 1.4 30.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 6.1 10.8 10.1 4.8 6.6 15.3 10.9 5.9 19.5 6.5 9.8 17.4 1.4 0.0 0.5 4.9 0.1 0.1 0.1 0.0 0.0 4.2 0.0 0.1 2.3 0.0 0.0 1.8 0.0 0.1 0.0 1.4 5.9 0.2 0.1 0.1 0.1 5.7 5.3 0.0 5.0 0.0 0.1 8.5 0.0 0.0 0.0 0.1 4.6 0.9 0.3 0.0 3.8 0.4 0.0 0.3 0.8 1.1 4.7 0.6 0.0 12.2 0.0 0.4 0.0 2.5 4.0 0.2 0.5 3.0 0.0 0.2 0.0 0.7 0.0 0.2 6.6 1.1 1.6 0.1 0.8 0.4 0.3 0.0 0.6 0.7 1.1 0.2 SGTB "FLJ39002, Sgt2" ENSG00000197860 "Small glutamine rich tetratricopeptide repeat containing beta" Q96EQ0 5 65665928-65723035 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.5;Horizontal cells: 70.7;Langerhans cells: 40.0;Muller glia cells: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "granulocytes: 10.0;monocytes: 6.7;T-cells: 13.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044689, HPA063674" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044689: AB_10960838, HPA063674: AB_2685084" "unprognostic (9.94e-2)" "unprognostic (2.28e-1)" "unprognostic (9.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (5.92e-5)" "unprognostic (4.27e-2)" "unprognostic (2.86e-1)" "unprognostic (2.41e-1)" "unprognostic (1.64e-2)" "unprognostic (5.35e-2)" "unprognostic (2.54e-3)" "unprognostic (6.82e-2)" "unprognostic (1.87e-1)" "unprognostic (6.34e-2)" "unprognostic (3.05e-3)" 4.4 2.6 4.7 7.6 10.5 10.1 2.5 4.3 18.7 3.0 0.3 2.3 1.5 4.7 2.0 3.0 2.4 3.0 4.2 10.4 8.9 2.5 2.5 3.9 7.0 7.8 7.5 8.1 2.9 1.8 2.6 3.1 3.7 9.8 4.8 2.6 16.5 1.7 2.1 2.8 2.0 2.2 5.5 2.8 4.7 1.8 1.9 7.5 4.1 4.2 4.7 5.0 4.0 2.4 14.6 7.6 4.8 9.0 9.2 13.3 17.3 8.9 31.4 9.7 10.3 14.0 6.5 3.2 10.3 16.5 24.5 18.1 7.6 12.9 11.9 16.7 7.7 12.7 4.6 13.0 13.2 34.3 3.4 7.3 13.0 10.3 22.3 29.3 7.2 10.0 8.0 7.9 6.9 16.3 2.8 7.5 5.4 6.0 0.6 2.5 8.7 15.7 10.7 4.6 2.8 14.1 7.5 12.9 2.2 14.8 8.9 3.1 5.0 15.2 13.5 14.5 14.5 7.0 5.4 8.8 13.9 6.9 9.7 5.4 10.0 5.5 1.4 2.6 6.7 2.5 1.4 6.3 3.6 2.3 1.2 6.7 3.9 5.9 1.0 5.7 0.5 13.6 3.1 4.7 10.5 4.3 18.7 10.4 8.9 7.8 7.5 8.1 9.8 2.8 7.5 14.6 11.3 16.0 5.5 10.4 7.4 6.4 3.3 2.7 4.6 8.8 2.0 2.8 4.3 2.8 4.1 1.8 0.0 1.5 8.5 0.4 0.0 3.5 2.0 2.7 8.0 8.5 1.8 7.0 43.5 2.0 5.1 9.7 3.6 5.8 21.0 4.4 3.3 3.9 23.5 70.7 38.0 1.4 2.0 19.9 40.0 1.7 4.1 18.5 12.4 3.7 27.3 67.5 4.1 10.6 16.3 4.9 1.7 4.1 9.9 3.7 0.1 2.9 1.9 5.2 13.1 18.5 10.4 4.4 5.3 3.4 4.5 1.2 24.0 2.4 0.4 1.8 ZNF790 "FLJ20350, MGC62100" ENSG00000197863 "Zinc finger protein 790" Q6PG37 19 36817428-36850787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA056134, HPA060288" Uncertain Approved Nucleoli NA NA Nucleoli "HPA056134: AB_2683049, HPA060288: AB_2797260" "unprognostic (1.14e-1)" "unprognostic (3.79e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (1.55e-1)" "unprognostic (5.10e-2)" "unprognostic (1.05e-1)" "unprognostic (1.03e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.48e-2)" "unprognostic (5.54e-2)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (2.85e-2)" 3.7 4.9 4.5 3.8 6.0 2.2 4.3 9.7 5.3 4.3 4.4 2.9 3.9 3.4 3.0 4.5 3.2 5.0 5.6 4.1 5.3 6.1 8.8 3.8 5.4 7.6 5.7 3.3 4.6 4.5 5.8 3.0 3.7 6.2 4.0 2.6 8.1 3.1 3.4 5.0 9.8 3.8 3.4 4.2 4.8 5.0 11.4 5.1 4.4 8.1 5.0 3.5 3.7 3.0 7.4 0.0 0.8 6.7 12.2 4.6 4.8 4.3 4.8 6.4 3.8 6.8 0.0 1.5 1.5 9.4 3.5 4.6 1.8 5.4 4.3 3.4 11.4 4.8 8.1 0.7 1.9 3.9 3.6 5.8 6.2 3.6 3.2 0.0 4.4 6.5 6.1 0.3 0.1 8.5 3.8 9.4 2.9 4.6 0.0 0.9 1.6 5.6 6.2 4.1 9.0 8.4 7.6 4.5 0.1 2.6 7.6 5.5 6.7 7.2 5.2 4.0 4.7 6.4 9.5 14.5 5.6 0.0 0.2 4.2 4.5 2.6 5.1 3.9 4.3 4.1 6.8 5.6 5.6 4.8 7.8 5.8 4.9 0.7 4.8 1.6 4.0 4.9 2.3 4.5 6.0 9.7 5.3 4.1 5.3 7.6 5.7 3.3 6.2 4.2 5.1 7.4 5.0 3.2 1.1 14.7 7.5 1.8 3.4 8.3 5.2 24.9 3.7 3.0 4.0 7.2 4.3 7.3 31.3 6.9 8.7 4.3 5.9 5.3 109.1 3.8 5.3 7.9 2.4 10.1 12.4 5.1 3.5 4.5 4.1 4.8 4.5 10.6 5.7 5.6 4.3 11.8 14.6 3.5 10.2 4.6 4.0 33.7 8.4 2.3 3.6 16.9 5.0 10.1 24.7 21.1 17.9 4.6 2.4 4.9 1.5 3.5 6.3 10.6 4.3 28.2 0.0 4.9 5.1 6.9 2.9 3.3 4.1 5.9 7.4 8.7 3.1 6.8 PRB3 PRG ENSG00000197870 "Proline rich protein BstNI subfamily 3" Q04118 12 11265924-11269805 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1915 "salivary gland: 14330.6" "Cell type enhanced" "Detected in some" "Early spermatids: 8.8;Endometrial ciliated cells: 1.7;Glandular and luminal cells: 1.7;Late spermatids: 3.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0;lung cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 2.2" "Secreted to digestive system" NA NA 27000000 "unprognostic (4.12e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.51e-1)" "unprognostic (7.46e-3)" "unprognostic (4.12e-2)" "unprognostic (9.65e-2)" "unprognostic (1.94e-2)" "unprognostic (8.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 14330.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.8 1.7 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 CYRIA "CYRI-A, DKFZP566A1524, FAM49A, FLJ11080" ENSG00000197872 "CYFIP related Rac1 interactor A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 46.4;Extravillous trophoblasts: 102.6;Hofbauer cells: 37.1;Macrophages: 24.0;Syncytiotrophoblasts: 150.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 18.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 53.1;HUVEC TERT2: 43.1;RH-30: 95.6;SK-BR-3: 28.2;TIME: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB017847: , HPA060398: AB_2684275" "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (4.46e-4)" 14.0 11.1 22.0 21.3 34.4 23.4 8.9 4.8 31.2 15.9 3.3 6.7 3.4 10.2 2.2 5.1 9.2 11.0 4.0 34.5 22.6 1.9 7.7 13.1 19.3 11.9 20.0 33.6 12.0 2.8 1.1 6.5 20.2 12.9 8.3 6.3 6.4 4.2 8.6 8.5 3.5 6.5 10.8 10.3 28.0 4.3 2.0 20.9 5.1 41.3 7.4 18.3 10.4 9.5 26.2 0.5 0.0 6.1 0.3 6.2 1.8 18.0 0.0 0.1 0.0 0.0 0.1 0.0 2.9 1.0 0.0 4.2 3.7 1.5 2.4 0.0 6.8 0.2 3.8 0.1 0.0 3.3 0.1 53.1 3.1 2.3 0.5 0.0 4.9 43.1 0.1 0.4 4.8 3.8 0.4 0.1 12.9 2.7 0.3 0.0 2.1 95.6 0.4 5.1 24.4 1.0 3.6 0.0 28.2 0.0 7.4 1.1 1.7 34.1 0.4 5.4 0.0 0.2 2.8 0.1 3.4 13.9 2.8 2.0 0.2 100.1 140.5 21.6 129.7 2.5 37.2 1.0 11.3 66.4 32.3 0.8 8.1 195.4 58.1 159.2 33.0 0.4 43.2 22.0 34.4 4.8 31.2 34.5 22.6 11.9 20.0 33.6 12.9 10.3 20.9 26.2 12.2 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 46.4 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 102.6 4.7 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 150.0 0.7 0.0 0.0 0.0 MYO1C myr2 ENSG00000197879 "Myosin IC" O00159 17 1464186-1492686 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001768, HPA005924, CAB037023" Enhanced Enhanced "Nuclear bodies,Plasma membrane" NA NA 3800000 "Nuclear bodies, Plasma membrane" "CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469" "unprognostic (3.60e-1)" "unprognostic (4.71e-3)" "unprognostic (2.89e-1)" "unprognostic (2.96e-3)" "unprognostic (1.38e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-2)" "unprognostic (1.99e-2)" "unprognostic (5.02e-2)" "unprognostic (4.66e-2)" "unprognostic (4.93e-2)" "unprognostic (3.47e-2)" 170.9 27.2 12.6 34.7 10.5 5.0 116.9 12.9 12.8 74.0 17.0 97.5 47.8 98.0 21.7 65.3 67.0 46.5 87.0 9.2 13.4 57.1 39.8 88.0 24.2 12.8 10.3 6.8 44.0 69.9 34.6 23.1 57.4 13.9 70.5 42.1 2.1 92.5 58.8 49.9 56.4 66.1 66.3 10.6 31.1 76.9 17.3 12.3 21.5 61.1 36.2 25.3 87.0 68.4 13.1 169.8 182.1 19.3 79.5 88.8 87.6 74.2 168.6 138.9 108.7 91.0 122.3 90.7 16.9 118.7 261.1 72.7 139.9 29.2 117.2 56.3 75.2 74.5 16.2 96.4 46.2 131.7 1.6 81.5 68.7 57.3 100.2 57.3 99.5 141.7 10.5 13.1 13.7 93.5 129.5 1.9 1.4 12.4 105.8 34.0 6.9 26.4 30.7 100.5 86.9 7.8 43.0 105.9 152.6 67.4 47.5 125.3 8.7 187.9 156.6 119.1 77.7 147.8 10.7 9.1 7.2 124.7 4.1 138.8 0.1 0.9 0.0 0.9 2.0 0.4 4.8 2.1 0.9 1.1 3.8 0.7 0.4 0.5 0.0 1.7 1.0 1.9 1.5 12.6 10.5 12.9 12.8 9.2 13.4 12.8 10.3 6.8 13.9 10.6 12.3 13.1 133.7 125.0 35.9 5.5 20.8 39.8 38.2 27.8 31.9 4.1 44.0 33.0 75.4 48.6 36.3 86.5 0.0 57.8 2.5 159.0 21.5 62.3 17.4 26.3 44.4 78.0 39.5 13.5 2.5 52.0 28.4 51.8 66.3 75.5 12.0 25.4 83.6 38.5 20.0 5.0 3.8 111.8 14.2 14.5 43.4 11.4 42.3 16.7 64.0 15.0 20.3 5.6 0.0 2.5 1.0 92.8 88.7 48.5 12.8 64.7 92.8 15.4 12.9 2.1 118.3 37.7 90.6 9.4 7.5 39.5 42.6 47.6 10.0 10.6 88.1 39.2 NKIRAS1 "kappaB-Ras1, KBRAS1" ENSG00000197885 "NFKB inhibitor interacting Ras like 1" Q9NYS0 3 23889951-23946591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6;Rod photoreceptor cells: 59.7;Spermatocytes: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077387 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA077387: " "unprognostic (1.36e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (1.08e-2)" "unprognostic (4.25e-2)" "unprognostic (5.30e-2)" "prognostic favorable (3.69e-4)" "unprognostic (3.69e-3)" "unprognostic (8.07e-3)" "unprognostic (1.19e-2)" "unprognostic (3.37e-2)" "prognostic favorable (7.71e-13)" "unprognostic (1.98e-1)" "unprognostic (4.90e-2)" "unprognostic (1.18e-1)" "unprognostic (2.63e-3)" 10.1 13.5 24.1 4.6 26.4 8.0 8.8 26.9 28.6 9.1 19.0 7.5 3.4 8.7 8.5 8.4 7.9 6.2 16.6 25.9 28.5 16.6 25.2 6.3 4.4 25.2 25.1 24.8 12.0 5.3 38.1 15.0 6.3 26.5 9.6 4.0 47.7 7.0 13.2 33.1 5.0 4.1 9.2 23.3 5.9 6.2 23.1 26.1 3.8 9.9 27.4 4.6 6.7 6.1 33.8 13.3 12.9 11.0 11.7 31.6 14.6 11.4 32.4 19.8 23.5 18.9 10.9 3.6 7.0 14.4 18.8 13.9 7.0 20.4 14.1 20.0 28.7 13.8 3.4 10.2 10.5 17.1 6.0 3.4 12.1 19.1 30.3 13.9 21.3 7.0 6.6 6.7 26.6 26.1 6.4 4.5 5.5 15.2 8.2 15.6 6.7 17.3 6.0 16.2 5.2 4.3 21.6 11.0 14.5 23.4 11.4 11.7 9.9 12.6 10.9 11.8 28.2 26.5 57.1 64.0 4.2 14.4 10.3 9.0 13.9 5.1 6.7 8.9 4.1 9.8 6.1 6.2 8.5 5.1 8.1 9.6 7.8 2.4 4.3 4.3 3.6 5.3 4.5 24.1 26.4 26.9 28.6 25.9 28.5 25.2 25.1 24.8 26.5 23.3 26.1 33.8 5.7 6.4 8.2 7.5 5.3 11.2 10.3 18.0 13.6 34.1 9.0 8.3 22.3 4.3 13.1 5.5 64.6 12.2 6.0 3.0 15.6 7.5 27.5 18.0 12.0 5.5 1.2 3.0 15.3 4.5 9.7 11.6 3.1 21.0 7.0 5.7 6.1 13.3 7.3 13.5 16.9 2.2 14.2 3.2 12.9 7.7 7.5 6.8 10.6 5.6 4.6 44.0 3.1 11.6 10.7 5.3 2.4 9.1 4.2 8.1 4.1 23.2 17.2 59.7 13.1 7.3 12.9 68.6 41.1 7.9 9.9 10.4 6.7 10.7 3.0 7.2 OR1S2 ENSG00000197887 "Olfactory receptor family 1 subfamily S member 2" Q8NGQ3 11 58203202-58204181 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain NA NA "HPA049304: AB_2680704" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B17 ENSG00000197888 "UDP glucuronosyltransferase family 2 member B17" O75795 4 68537184-68568527 "Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 463.8;liver: 137.2" "Group enriched" "Detected in some" 6 "Distal enterocytes: 130.1;Paneth cells: 35.1;Undifferentiated cells: 100.6" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.3;liver cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "memory B-cell: 2.8;naive B-cell: 8.8" "Lineage enriched" "Detected in single" 61 "B-cells: 8.8" "Cell line enhanced" "Detected in some" "BEWO: 1.0;NB-4: 1.1;RPMI-8226: 1.7" HPA045108 Supported NA NA "HPA045108: AB_2679218" "unprognostic (1.66e-1)" "unprognostic (2.97e-2)" "unprognostic (2.96e-2)" "unprognostic (2.41e-1)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.36e-1)" "unprognostic (8.44e-3)" "unprognostic (9.67e-2)" "unprognostic (4.80e-3)" "unprognostic (8.52e-2)" "unprognostic (2.45e-1)" "unprognostic (6.44e-2)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" 0.3 0.0 0.0 39.2 0.1 0.0 0.7 0.1 0.1 1.5 0.0 369.1 367.6 1.4 1.5 0.1 0.2 0.6 0.0 0.0 0.1 0.2 137.2 0.2 1.5 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 127.1 0.0 0.2 0.7 0.0 0.0 463.8 9.2 0.1 0.6 0.8 0.0 0.1 0.4 0.0 0.0 2.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 1.3 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 130.1 0.0 0.0 0.0 11.1 0.1 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 2.8 0.0 0.0 0.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.3 0.1 35.1 0.0 1.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 100.6 0.2 MEIG1 "bA2K17.3, SPATA39" ENSG00000197889 "Meiosis/spermiogenesis associated 1" Q5JSS6 10 14959388-14988050 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.7;testis: 10.3" "Cell type enhanced" "Detected in some" "Early spermatids: 128.5;Endometrial ciliated cells: 28.9;Late spermatids: 21.4;Respiratory ciliated cells: 31.7;Spermatocytes: 52.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 6.1;SK-MEL-30: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (5.51e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (3.75e-6)" "unprognostic (6.89e-2)" "unprognostic (1.36e-5)" "unprognostic (2.97e-1)" "unprognostic (3.74e-3)" "unprognostic (8.40e-3)" "unprognostic (3.15e-1)" 0.2 0.4 1.8 0.0 1.5 0.0 0.0 1.5 1.9 0.2 1.6 0.1 0.0 0.1 0.0 0.1 3.7 0.0 0.1 1.5 1.7 0.2 0.2 0.4 0.2 1.7 1.6 1.4 0.0 0.2 0.2 0.8 0.1 1.5 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 1.7 0.2 0.1 10.3 1.5 0.3 0.1 0.0 0.1 0.1 0.0 1.7 0.8 0.7 1.2 0.6 0.3 0.2 0.0 0.2 0.3 0.4 0.4 0.0 1.1 0.2 0.0 0.2 0.6 0.1 0.8 0.1 0.1 6.1 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.4 0.1 0.3 0.6 0.6 1.2 0.2 0.0 0.6 0.6 0.9 1.2 0.2 0.4 0.6 0.0 0.9 1.6 0.3 0.3 3.3 0.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 1.9 1.7 1.7 0.7 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.2 1.4 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.3 0.2 0.7 0.0 1.8 1.5 1.5 1.9 1.5 1.7 1.7 1.6 1.4 1.5 1.7 1.5 1.7 0.2 0.0 0.5 1.3 0.2 0.0 0.5 2.8 0.0 0.2 0.8 1.0 0.8 0.0 3.2 1.8 0.0 0.8 0.1 0.1 1.9 0.4 128.5 28.9 0.3 0.1 0.0 0.0 1.3 0.9 0.4 0.2 0.0 0.8 0.0 0.3 0.0 1.4 0.6 0.0 1.4 0.5 4.1 0.3 0.3 21.4 2.1 0.5 0.0 0.0 0.3 2.6 1.0 0.5 1.4 0.2 0.0 0.0 0.1 0.5 0.0 0.7 31.7 0.3 0.0 0.2 0.7 52.2 3.7 0.0 0.4 0.3 0.5 0.1 0.3 0.4 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 185 "kidney: 106.5" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 173.1" "Cancer enriched" "Detected in some" 4 "renal cancer: 16.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA024575 Enhanced NA NA "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favorable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 106.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 173.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KIF13B "GAKIN, KIAA0639" ENSG00000197892 "Kinesin family member 13B" Q9NQT8 8 29067278-29263124 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 63.7;parathyroid gland: 162.8" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 140.2;Oligodendrocytes: 371.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025023, HPA049655" Enhanced NA NA "HPA025023: AB_1852471, HPA049655: AB_2732555" "unprognostic (1.37e-1)" "unprognostic (4.31e-1)" "prognostic favorable (8.92e-4)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "prognostic favorable (6.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (9.69e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (9.76e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" 7.1 11.8 27.9 6.9 42.6 5.1 9.3 33.2 22.5 8.8 14.7 18.4 16.3 6.8 9.5 8.4 7.2 8.5 5.1 17.1 29.0 18.7 10.3 8.5 4.3 45.4 41.9 10.0 7.3 11.0 162.8 10.1 3.9 46.8 11.0 13.9 8.0 15.8 8.6 4.7 18.2 15.8 5.5 34.1 9.0 19.4 6.7 35.0 5.1 9.1 3.0 4.6 9.6 6.1 63.7 12.4 13.2 4.6 3.8 7.5 4.3 6.7 0.7 2.9 3.9 6.2 8.3 6.9 2.6 6.9 0.8 7.1 8.2 3.7 2.1 5.1 3.9 3.6 6.6 1.8 8.4 7.2 1.8 19.2 5.0 3.9 8.9 3.6 8.3 17.1 4.9 8.6 9.5 12.9 3.8 9.7 3.1 2.3 17.4 2.2 5.5 10.6 4.9 17.0 13.2 1.3 9.1 2.4 8.0 11.7 4.8 5.9 3.7 22.8 2.8 7.6 0.8 5.6 6.9 11.1 4.4 16.4 3.4 13.2 0.1 1.5 1.7 1.5 1.1 0.7 1.4 0.6 0.9 0.5 0.8 0.5 0.6 0.7 0.9 0.6 2.2 0.6 0.5 27.9 42.6 33.2 22.5 17.1 29.0 45.4 41.9 10.0 46.8 34.1 35.0 63.7 22.2 44.8 24.8 30.0 16.5 4.5 13.8 17.2 5.2 13.3 23.5 11.2 5.3 20.0 36.8 35.0 60.5 6.4 35.8 95.8 11.7 25.7 8.0 55.3 12.7 14.2 25.2 7.4 26.7 25.0 0.9 10.0 55.0 140.2 41.0 10.6 13.9 18.6 8.9 16.8 35.3 44.1 36.7 25.7 6.3 3.5 8.1 24.4 7.2 41.2 12.1 9.5 12.3 47.3 371.1 39.7 58.0 20.3 42.5 28.1 34.7 17.8 34.9 26.2 6.6 36.4 7.4 6.3 7.7 9.8 6.8 5.1 31.8 5.9 36.0 32.5 NRAP ENSG00000197893 "Nebulin related anchoring protein" Q86VF7 10 113588714-113664070 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 2386.3;tongue: 1155.0" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 534.1" "Group enriched" "Detected in some" 7 "head and neck cancer: 8.2;prostate cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037953, HPA037954, HPA075074" Enhanced Approved "Vesicles,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Vesicles, Cytosol" "HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: " "unprognostic (1.13e-1)" "unprognostic (2.95e-1)" "unprognostic (3.61e-2)" "unprognostic (2.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.97e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-3)" "unprognostic (3.72e-2)" "unprognostic (4.20e-2)" "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (5.39e-4)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (3.16e-1)" 0.3 0.1 0.1 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 25.0 0.0 0.2 331.9 0.1 0.1 0.1 0.5 0.4 0.1 0.4 0.2 0.3 0.1 0.4 0.0 0.3 0.0 0.1 20.6 1.0 0.0 22.2 0.0 2386.3 0.6 0.1 0.0 0.0 0.1 0.3 0.6 0.2 0.0 0.4 1155.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.1 0.1 0.4 0.2 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 534.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.4 0.1 0.0 3.7 0.0 0.0 0.3 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.3 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 57.3 3.3 1.0 2.3 0.0 0.1 0.0 0.2 0.0 0.5 0.0 ADH5 "ADH-3, ADHX, FDH, GSNOR" ENSG00000197894 "Alcohol dehydrogenase 5 (class III), chi polypeptide" P11766 4 99070978-99088801 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044578, HPA061919" Approved NA NA 5300000 "HPA044578: AB_2679002, HPA061919: AB_2684638" "unprognostic (1.05e-1)" "unprognostic (1.63e-2)" "unprognostic (1.14e-3)" "prognostic favorable (9.90e-5)" "unprognostic (2.63e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (9.48e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (1.22e-1)" "prognostic favorable (4.58e-10)" "unprognostic (1.79e-3)" "unprognostic (9.05e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" 131.0 71.9 50.0 53.0 50.0 28.7 112.9 50.5 56.5 92.6 56.8 144.0 95.1 135.9 143.4 115.5 96.8 69.9 125.4 47.2 59.1 177.0 266.2 74.1 51.7 49.7 48.8 46.6 119.5 49.9 50.5 41.7 61.5 49.1 117.2 101.7 36.3 66.0 125.8 81.5 51.3 95.1 119.1 49.7 52.0 92.1 52.7 49.6 84.1 80.0 76.4 56.0 160.3 74.5 53.7 84.0 66.9 194.8 110.0 344.7 316.0 116.6 136.6 237.6 143.8 125.2 77.1 96.7 96.5 77.5 197.8 92.8 69.8 135.0 188.7 137.7 69.9 56.6 67.1 83.3 306.7 332.2 118.4 51.9 287.3 143.1 108.3 84.7 151.0 112.8 99.8 125.8 53.3 192.3 94.9 160.4 105.4 156.7 20.6 79.8 115.4 108.9 50.9 230.2 96.0 74.0 97.0 82.7 96.6 155.9 141.8 78.2 82.2 85.4 130.5 82.9 86.4 95.2 55.9 74.4 135.4 134.2 77.4 135.7 21.8 21.2 35.8 32.6 18.9 29.5 26.0 35.3 30.4 23.8 26.2 34.0 31.9 3.0 51.3 14.1 20.5 49.5 32.8 50.0 50.0 50.5 56.5 47.2 59.1 49.7 48.8 46.6 49.1 49.7 49.6 53.7 69.0 105.8 78.2 22.9 48.1 39.6 85.9 257.5 109.3 31.8 32.1 74.3 127.4 78.6 94.3 55.2 10.4 290.1 51.8 80.4 197.6 94.8 24.0 146.9 159.1 56.3 79.7 45.8 14.3 83.8 277.2 131.2 37.8 113.0 26.6 83.3 47.2 188.0 118.1 38.7 12.0 101.8 87.5 48.6 27.1 22.0 187.4 43.4 53.4 15.9 63.2 152.4 77.2 27.6 13.9 78.4 86.0 255.1 41.5 34.9 95.2 316.0 56.8 46.5 111.7 55.6 127.7 30.5 48.5 74.9 23.0 83.0 58.5 147.0 104.8 68.1 SLC22A6 "OAT1, PAHT, ROAT1" ENSG00000197901 "Solute carrier family 22 member 6" Q4U2R8 11 62936385-62984967 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "kidney: 198.3" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 310.4" "Cancer enriched" "Detected in single" 102 "renal cancer: 18.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074559, CAB075704" Enhanced NA NA "CAB075704: , HPA074559: AB_2732260" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (4.43e-1)" 0.0 0.0 2.0 0.0 2.3 0.0 0.0 3.9 2.4 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.8 198.3 0.0 0.0 0.0 7.1 4.8 0.9 0.0 0.0 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 3.9 2.4 1.5 3.8 7.1 4.8 0.9 3.1 3.0 5.5 3.1 0.0 0.0 0.0 4.9 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 7.3 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 310.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 H2BC12 "H2BFAiii, H2BFT, HIST1H2BK" ENSG00000197903 "H2B clustered histone 12" O60814 6 27146361-27146855 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.4;Hofbauer cells: 1.1;Syncytiotrophoblasts: 3.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 1269.7;SiHa: 771.0;U-2 OS: 949.9;U-266/84: 1355.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 35.6 29.1 8.5 36.2 12.2 46.8 31.5 6.6 11.7 42.5 16.0 46.1 42.0 35.5 28.0 64.7 60.5 38.1 27.1 9.9 15.4 17.3 94.8 47.5 60.1 11.3 10.1 5.9 29.1 60.5 15.0 16.4 45.1 10.4 75.7 26.6 0.4 43.5 21.9 8.6 28.5 45.1 22.3 17.7 67.4 56.5 44.9 15.5 66.4 49.6 6.7 24.4 35.3 43.1 15.7 64.6 153.7 25.7 41.2 116.0 37.0 84.7 118.1 70.5 157.9 99.1 133.1 68.9 28.1 338.6 64.2 94.1 78.3 29.8 35.8 19.7 95.1 201.2 42.0 91.0 4.4 46.2 29.9 183.4 205.0 26.8 29.5 28.1 38.8 27.6 14.1 1269.7 194.4 66.5 166.3 49.1 52.6 20.2 204.6 98.8 27.9 24.2 265.9 55.2 23.4 124.1 74.2 771.0 178.6 56.9 18.9 473.7 29.8 41.6 57.6 949.9 54.0 18.8 293.6 1355.8 207.7 34.7 314.1 34.5 244.6 49.0 329.3 21.6 45.3 19.6 112.1 21.3 21.9 53.1 141.9 25.7 20.4 308.2 28.5 96.3 120.8 65.7 68.3 8.5 12.2 6.6 11.7 9.9 15.4 11.3 10.1 5.9 10.4 17.7 15.5 15.7 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 TEAD4 "EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1" ENSG00000197905 "TEA domain transcription factor 4" Q15561 12 2959330-3040676 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 128.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 78.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 364.1" "Region enriched" "Detected in single" 5 "cerebellum: 3.1" "Low region specificity" "Detected in all" HPA056896 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA056896: AB_2683268" "unprognostic (3.68e-1)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (1.33e-1)" "unprognostic (3.68e-1)" "unprognostic (9.20e-3)" "unprognostic (2.21e-3)" "unprognostic (3.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.50e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (9.78e-9)" "unprognostic (5.05e-3)" "unprognostic (8.43e-2)" "unprognostic (2.42e-2)" "unprognostic (1.23e-3)" 13.5 5.2 4.8 7.1 3.3 0.4 12.1 4.8 5.6 8.9 4.7 7.4 4.9 9.8 1.0 7.9 8.4 4.6 18.5 3.2 6.7 17.4 4.6 26.3 1.6 5.0 4.1 2.3 4.6 51.5 1.7 3.4 11.0 5.6 8.6 4.1 0.5 8.1 5.1 128.4 15.5 8.5 9.0 3.7 9.1 8.1 3.8 6.2 1.6 23.8 47.1 2.4 11.4 7.2 10.2 37.6 51.5 13.0 36.2 4.0 8.7 137.8 29.5 15.6 49.7 27.8 99.6 39.0 0.3 22.2 22.5 34.0 52.5 51.2 364.1 46.1 0.2 41.2 59.1 43.7 87.7 18.8 12.8 10.7 12.2 14.8 43.3 66.7 20.8 42.9 23.4 38.4 0.5 17.5 53.2 0.7 0.3 99.5 48.0 30.0 27.4 73.7 28.9 23.6 15.3 7.4 13.2 36.4 89.9 27.1 93.8 61.2 21.8 49.4 28.7 100.1 20.2 15.7 0.1 0.2 0.4 23.3 0.0 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 3.3 4.8 5.6 3.2 6.7 5.0 4.1 2.3 5.6 3.7 6.2 10.2 17.1 12.8 4.7 0.0 0.1 12.2 12.6 6.1 9.1 0.1 6.6 3.7 2.4 5.7 2.3 7.3 0.0 50.3 0.4 3.7 5.9 17.7 0.3 3.0 5.1 25.9 0.0 0.0 1.6 38.3 18.3 6.6 4.1 5.0 5.7 3.4 32.2 0.4 5.2 0.0 0.5 3.7 2.0 0.8 1.5 2.3 0.0 0.5 8.8 3.7 0.0 0.0 0.0 0.0 0.4 21.1 0.9 0.4 1.2 28.9 37.9 21.1 1.5 0.1 0.0 9.3 12.2 0.5 6.4 5.4 7.7 34.6 0.5 0.4 7.1 4.9 SPG7 "CAR, CMAR, SPG5C" ENSG00000197912 "SPG7 matrix AAA peptidase subunit, paraplegin" Q9UQ90 16 89490719-89557766 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.42e-1)" "unprognostic (1.72e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (2.33e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.56e-2)" "unprognostic (7.01e-2)" "unprognostic (1.44e-2)" "unprognostic (2.58e-1)" "unprognostic (1.71e-1)" "prognostic favorable (4.25e-4)" 27.6 45.2 20.9 7.1 20.1 8.3 28.1 22.1 28.8 30.4 20.0 33.2 10.0 32.1 4.1 28.4 26.6 6.9 45.4 20.9 19.9 32.5 47.4 25.1 9.0 21.1 20.5 20.9 39.3 32.2 13.9 39.0 6.0 22.4 31.4 8.2 10.0 29.2 9.8 57.2 31.4 35.8 9.1 18.3 34.3 31.3 32.1 20.4 10.6 53.5 31.3 8.0 30.3 27.2 21.6 11.5 28.3 17.3 26.6 33.2 24.2 10.9 27.3 24.6 21.0 10.4 23.0 22.3 16.5 32.5 20.1 16.2 30.5 21.5 24.4 14.7 11.7 25.3 11.4 12.0 43.4 16.2 5.5 10.3 15.2 20.1 12.8 14.1 27.9 25.6 22.0 23.1 5.5 21.7 21.0 14.4 22.5 21.9 23.8 21.4 31.8 26.2 10.8 15.9 17.3 16.4 10.5 44.9 8.3 9.5 15.2 22.6 17.0 33.7 13.9 17.2 12.0 12.2 13.7 19.8 12.8 17.7 19.8 17.7 4.5 2.5 3.9 2.7 2.4 2.6 1.6 1.7 1.3 2.8 3.4 3.1 2.0 2.9 3.7 1.7 2.3 1.8 1.0 20.9 20.1 22.1 28.8 20.9 19.9 21.1 20.5 20.9 22.4 18.3 20.4 21.6 53.9 48.1 49.4 39.2 45.6 15.9 27.9 30.1 44.9 57.8 31.2 37.2 45.8 22.8 41.5 35.0 95.9 39.9 47.6 42.3 19.6 40.0 66.0 50.5 41.7 49.9 37.2 27.3 58.5 25.8 28.8 35.9 67.2 54.1 21.5 95.3 51.0 38.1 32.2 40.4 53.1 43.8 30.5 34.8 21.8 22.1 42.9 35.2 21.4 35.6 42.6 30.5 51.5 87.0 46.2 39.5 39.5 33.4 43.5 29.5 68.2 23.8 37.7 73.7 6.6 36.9 36.2 57.5 36.5 36.7 18.0 25.9 45.5 68.3 51.0 28.7 HRNR "FLG3, S100A16, S100a18" ENSG00000197915 Hornerin Q86YZ3 1 152212076-152224193 "Plasma proteins, Predicted intracellular proteins" Keratinization "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.0;Horizontal cells: 1.7;Rod photoreceptor cells: 3.5" "Cancer enriched" "Detected in single" 4 "melanoma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.9" "Not detected" "Not detected" HPA031469 Uncertain Approved Mitochondria No No 180000000 Mitochondria "HPA031469: AB_10603771" "unprognostic (1.34e-1)" "unprognostic (4.51e-2)" "unprognostic (3.01e-2)" "unprognostic (8.72e-4)" "unprognostic (1.61e-2)" "unprognostic (1.45e-1)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (6.09e-2)" "unprognostic (3.38e-2)" "unprognostic (1.87e-2)" "unprognostic (1.59e-2)" "unprognostic (1.65e-2)" "unprognostic (2.49e-2)" "unprognostic (1.71e-1)" "unprognostic (2.07e-1)" "unprognostic (3.64e-2)" 0.1 0.2 1.0 0.0 0.5 0.0 0.1 0.1 0.7 0.2 0.3 0.1 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.8 1.2 0.3 0.1 0.1 0.0 1.3 0.9 0.1 0.4 0.4 0.0 0.2 0.0 1.0 0.2 0.0 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.3 0.1 0.1 0.4 0.7 0.0 0.3 0.0 0.0 0.1 0.3 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.5 0.1 0.7 0.8 1.2 1.3 0.9 0.1 1.0 0.3 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 IFNA1 "IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13" ENSG00000197919 "Interferon alpha 1" P01562 9 21440439-21441316 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.2;hTERT-RPE1: 2.2" HPA047557 Uncertain "Secreted to blood" NA NA 10000 "HPA047557: AB_2680087" "unprognostic (3.14e-1)" "unprognostic (1.55e-1)" "unprognostic (9.75e-2)" "unprognostic (5.88e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530263 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 17.0;skin 1: 4.2" "Cell type enhanced" "Detected in some" "Adipocytes: 24.8;Astrocytes: 53.5;Muller glia cells: 113.4;Oligodendrocyte precursor cells: 15.6" "Cancer enriched" "Detected in some" 5 "glioma: 3.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 0.3 0.0 8.5 0.0 14.1 0.0 0.3 0.4 9.5 0.4 0.0 0.3 0.0 0.2 0.0 0.8 0.2 0.0 2.3 3.0 7.8 0.1 0.3 0.3 0.0 3.8 1.6 4.3 0.1 0.0 0.0 2.5 0.0 17.0 0.4 0.0 0.0 0.1 0.0 0.1 4.2 0.2 0.0 0.0 0.2 0.1 0.9 11.4 0.0 0.5 0.0 0.0 0.7 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 14.1 0.4 9.5 3.0 7.8 3.8 1.6 4.3 17.0 0.0 11.4 1.7 24.8 0.0 0.0 53.5 0.2 0.1 0.3 0.2 1.8 2.9 1.1 2.8 1.4 0.0 0.3 0.0 0.0 0.0 0.4 4.0 0.0 0.0 0.0 5.4 0.8 5.1 0.0 0.0 0.7 0.0 0.0 0.3 0.0 8.9 0.0 0.1 0.0 0.0 0.0 3.3 0.8 4.9 0.0 0.0 0.8 0.0 0.0 0.3 0.0 1.9 0.0 113.4 0.0 15.6 0.3 0.0 2.9 0.0 0.0 0.5 0.1 0.0 0.0 7.7 0.0 1.0 6.2 0.0 0.4 6.2 1.4 0.0 0.5 0.0 3.0 0.2 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.1" "Group enriched" "Detected in many" 11 "Early spermatids: 602.9;Late spermatids: 408.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 30.4;SuSa: 25.5" HPA023106 Approved Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.2 6.4 4.9 5.6 6.2 5.6 11.1 9.3 5.4 7.0 5.2 5.5 3.6 10.3 4.3 5.6 11.2 7.5 11.5 5.0 5.1 6.5 2.8 6.4 6.5 5.2 4.8 4.2 16.3 5.4 9.7 4.8 9.2 5.7 10.2 4.1 11.8 8.0 7.1 5.3 9.2 3.5 9.4 5.5 9.0 5.5 45.1 5.2 9.4 12.0 7.1 6.2 7.9 5.8 8.2 0.4 0.4 17.5 0.6 5.9 9.0 3.2 11.8 8.8 11.9 10.6 0.0 0.6 0.1 8.5 10.3 15.0 1.1 0.1 9.1 3.5 0.3 6.2 0.5 1.0 0.3 14.6 0.2 11.7 15.7 0.1 11.4 0.2 0.4 5.3 0.2 0.2 0.6 8.1 0.4 10.2 0.2 30.4 0.1 4.0 0.2 0.0 0.2 3.3 4.7 0.3 16.7 0.3 4.4 0.2 25.5 0.6 0.5 3.4 18.6 0.4 0.3 7.8 0.4 0.1 0.4 0.3 0.5 0.1 18.3 2.8 9.0 6.6 3.9 9.4 15.7 9.4 7.2 8.4 23.3 19.8 13.0 3.0 15.7 2.6 20.0 6.6 5.1 4.9 6.2 9.3 5.4 5.0 5.1 5.2 4.8 4.2 5.7 5.5 5.2 8.2 27.6 25.6 2.8 9.8 10.0 11.5 25.9 15.7 5.7 24.4 14.2 20.4 19.3 11.5 14.8 20.2 14.6 12.6 7.1 0.7 35.2 15.0 602.9 8.2 12.5 24.3 0.0 12.2 4.0 6.9 21.9 20.6 3.1 11.1 14.0 19.9 31.1 0.3 7.7 28.6 4.7 2.8 12.2 7.2 12.1 408.1 27.4 7.2 14.2 5.6 7.2 21.1 12.3 20.6 10.8 7.5 0.7 17.3 1.8 36.2 1.4 3.3 7.4 18.6 19.7 19.2 22.0 45.3 38.7 7.0 14.6 11.8 8.2 19.7 2.4 27.8 ERO1A "ERO1-alpha, Ero1alpha, ERO1L" ENSG00000197930 "Endoplasmic reticulum oxidoreductase 1 alpha" Q96HE7 14 52639915-52695900 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 173.9" "Cell type enhanced" "Detected in many" "Ductal cells: 221.3;Extravillous trophoblasts: 215.8;Pancreatic endocrine cells: 264.7;Prostatic glandular cells: 171.4;Urothelial cells: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026653, HPA030053, CAB034294" Enhanced "Intracellular and membrane" NA NA 110000 "CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467" "unprognostic (8.64e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.86e-2)" "unprognostic (5.89e-2)" "unprognostic (5.69e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (7.59e-4)" "prognostic unfavorable (1.10e-5)" "unprognostic (4.98e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.54e-9)" "unprognostic (9.19e-2)" "unprognostic (2.78e-2)" "unprognostic (4.58e-1)" "unprognostic (5.03e-2)" 17.7 8.7 11.5 20.6 12.4 47.4 16.6 12.5 13.9 33.5 11.8 18.6 18.0 12.1 15.2 173.9 10.1 19.0 13.7 12.3 14.8 14.5 31.5 15.3 15.0 12.5 12.6 11.9 8.6 19.0 11.1 12.7 44.8 12.2 9.7 18.0 30.9 37.7 14.1 9.2 18.0 16.7 12.1 11.2 14.7 29.2 5.5 17.2 8.4 13.5 8.2 30.6 32.9 62.9 15.6 100.6 24.2 19.9 21.4 54.4 61.3 38.0 42.4 52.7 34.1 56.9 33.4 158.0 26.3 50.7 28.3 42.0 61.1 27.1 84.1 84.9 22.0 14.5 3.6 25.1 42.1 46.2 60.2 72.1 54.5 54.2 43.9 44.5 79.9 48.2 32.3 18.1 50.8 46.2 15.8 36.0 37.8 11.8 46.5 15.5 21.5 59.8 38.1 52.3 97.1 18.5 49.6 28.9 17.8 39.4 25.7 24.8 22.3 40.0 60.7 29.5 49.6 37.4 26.9 28.8 22.7 88.0 30.3 28.7 20.6 5.9 11.7 5.0 6.9 11.0 4.6 9.4 6.3 4.9 3.1 5.5 5.5 14.7 6.7 9.4 3.7 11.9 2.5 11.5 12.4 12.5 13.9 12.3 14.8 12.5 12.6 11.9 12.2 11.2 17.2 15.6 33.8 16.0 27.6 0.0 18.8 0.0 79.2 0.0 19.4 23.4 29.7 11.8 0.0 38.6 15.5 38.6 16.7 24.3 23.3 33.4 3.9 221.3 0.6 32.4 23.8 32.6 10.9 9.9 0.0 130.6 215.8 20.5 56.1 64.0 6.3 10.9 21.0 62.5 42.9 42.1 0.0 10.7 0.0 42.7 0.0 1.6 6.2 49.7 0.0 0.0 45.0 12.2 15.5 0.0 0.0 264.7 18.1 12.8 60.0 171.4 29.0 15.1 13.1 26.4 19.7 14.6 20.9 0.6 3.6 25.7 0.0 91.4 32.1 10.4 20.3 145.8 ZNF823 HSZFP36 ENSG00000197933 "Zinc finger protein 823" P16415 19 11721265-11739009 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 18.6;Syncytiotrophoblasts: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.76e-5)" "unprognostic (2.50e-1)" "unprognostic (1.65e-1)" "unprognostic (8.69e-2)" "unprognostic (1.02e-2)" "unprognostic (5.50e-1)" "unprognostic (2.36e-2)" "prognostic favorable (4.49e-4)" "prognostic favorable (5.05e-4)" "unprognostic (7.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.47e-3)" 3.2 2.0 2.0 2.0 3.2 1.9 7.5 12.0 2.7 4.3 0.2 6.0 3.7 4.1 3.5 8.3 4.0 3.1 2.4 2.1 2.1 5.3 6.1 3.3 2.4 2.4 2.6 1.3 4.7 4.4 6.1 1.1 5.0 4.2 3.3 5.9 2.0 5.1 3.8 2.0 4.3 3.7 2.8 2.1 2.5 4.3 1.4 2.8 4.0 2.9 2.8 3.2 4.2 5.0 3.2 6.3 3.2 5.0 5.9 3.1 1.1 9.6 6.8 5.6 9.0 8.5 10.8 2.0 7.4 7.3 5.6 2.8 5.2 5.4 4.2 8.9 0.0 3.5 5.6 2.2 9.6 1.2 2.6 7.7 1.9 4.4 5.9 4.4 3.4 4.3 5.8 4.0 0.1 8.6 4.1 7.4 2.1 3.3 5.1 6.8 3.2 8.9 2.0 8.9 16.5 3.2 4.2 6.6 6.9 2.4 9.1 5.2 7.0 4.7 8.6 3.0 12.8 4.8 4.7 12.7 3.8 2.0 0.0 1.5 2.2 1.4 10.3 2.6 1.7 4.2 2.4 3.4 2.8 1.9 1.6 5.9 4.3 0.8 5.3 1.0 3.3 1.2 1.9 2.0 3.2 12.0 2.7 2.1 2.1 2.4 2.6 1.3 4.2 2.1 2.8 3.2 4.3 3.2 1.7 6.5 1.5 5.2 3.7 2.7 9.1 1.3 6.1 4.6 3.3 7.2 4.0 1.8 0.0 18.6 5.7 10.0 9.8 5.9 0.4 5.1 2.8 3.1 0.0 2.5 6.5 4.5 14.9 2.3 6.6 6.9 1.3 3.6 5.7 3.2 4.6 0.0 5.6 7.3 0.0 2.6 5.1 0.8 2.8 1.9 3.6 9.4 2.4 1.2 3.1 4.5 7.1 4.0 9.0 2.2 2.0 2.9 6.3 3.9 2.2 1.5 0.0 1.8 3.7 4.3 4.0 10.3 4.0 21.5 4.3 0.9 7.0 6.1 ZNF311 ENSG00000197935 "Zinc finger protein 311" Q5JNZ3 6 28994785-29005316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.5" "Cell type enhanced" "Detected in some" "Melanocytes: 3.6;Spermatocytes: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.0;HEL: 1.4;K-562: 2.0;SK-MEL-30: 1.1;WM-115: 1.0" "Low region specificity" "Detected in many" HPA050541 Approved NA NA "HPA050541: AB_2681164" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (1.23e-1)" "unprognostic (7.03e-4)" "unprognostic (1.79e-1)" "unprognostic (3.14e-1)" "unprognostic (1.68e-1)" "unprognostic (8.41e-2)" "unprognostic (4.24e-3)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (2.57e-1)" "unprognostic (3.05e-4)" "unprognostic (9.70e-2)" "unprognostic (1.82e-1)" "unprognostic (3.11e-1)" "unprognostic (1.14e-1)" 0.5 0.5 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.7 0.0 0.7 0.7 0.6 0.9 0.2 0.3 0.1 0.1 0.5 0.7 0.4 0.1 0.0 0.1 0.0 1.1 0.6 0.0 0.3 0.0 0.0 1.1 0.2 0.0 0.6 0.1 0.1 0.6 0.5 0.0 0.0 0.6 0.5 2.5 0.0 0.0 1.2 0.0 0.1 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.4 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 2.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.3 0.0 0.4 0.6 0.5 1.2 0.7 1.1 1.0 0.4 1.5 0.1 1.8 0.0 0.4 0.0 0.7 1.9 0.8 0.1 1.1 1.0 0.6 0.0 1.3 0.2 0.7 0.3 0.5 0.0 0.5 0.0 1.8 2.5 0.8 0.5 0.0 0.3 1.7 0.0 0.8 0.0 1.3 0.6 0.2 3.6 1.0 0.8 1.4 0.0 0.0 1.8 1.0 1.7 0.0 0.0 0.6 0.6 0.1 0.1 0.8 0.0 0.4 0.6 6.5 2.8 0.6 0.1 0.0 0.1 0.7 1.1 0.3 ZNF347 ZNF1111 ENSG00000197937 "Zinc finger protein 347" Q96SE7 19 53124072-53159075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023448 Uncertain Approved Microtubules NA NA Microtubules "HPA023448: AB_1859214" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (6.48e-2)" "unprognostic (3.01e-3)" "unprognostic (6.20e-2)" "unprognostic (3.82e-2)" "unprognostic (3.65e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (8.39e-2)" "unprognostic (3.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (7.59e-3)" 4.9 4.8 7.5 5.7 5.9 19.5 5.2 17.3 7.2 4.4 0.7 3.7 2.7 6.2 5.6 3.9 4.0 6.1 4.5 6.2 5.1 3.5 2.0 5.0 5.8 7.1 7.1 4.3 6.4 5.3 4.7 2.9 5.0 9.2 4.4 3.7 15.1 4.4 4.9 3.7 6.8 3.1 4.9 2.4 9.6 4.2 3.8 4.9 5.7 6.8 3.6 4.1 3.7 3.5 16.8 0.8 0.8 7.9 13.2 5.0 5.4 7.4 8.6 8.6 10.0 11.8 1.3 2.2 7.6 3.3 7.3 11.2 3.7 0.9 1.5 12.8 1.5 5.8 1.4 5.1 2.4 3.1 1.7 7.7 6.1 0.6 7.4 0.0 3.5 2.5 4.6 6.4 2.3 5.2 0.9 12.9 3.9 9.6 0.4 4.0 3.5 0.3 1.7 4.0 20.1 5.7 5.9 1.3 2.6 3.4 10.1 7.1 3.5 4.2 12.5 8.1 6.8 12.4 1.1 7.1 13.4 2.0 1.4 7.1 3.8 1.1 1.6 1.8 0.9 1.8 1.9 1.5 1.6 1.1 3.0 1.9 1.6 6.8 3.7 1.5 1.9 1.8 0.8 7.5 5.9 17.3 7.2 6.2 5.1 7.1 7.1 4.3 9.2 2.4 4.9 16.8 16.2 19.2 12.4 5.9 6.0 2.0 4.9 1.0 3.4 10.5 3.5 4.2 7.3 4.3 6.8 3.7 4.2 3.1 1.5 3.8 1.9 2.9 0.3 5.5 7.8 15.9 1.2 3.0 7.7 4.0 3.7 6.5 4.6 6.1 3.8 11.7 11.7 1.3 2.7 8.4 10.8 2.5 2.0 3.8 2.8 0.8 5.3 3.5 1.8 4.7 3.4 4.0 8.2 8.5 14.9 3.5 1.1 3.8 2.0 4.6 2.9 1.4 18.6 14.3 0.0 11.4 5.9 3.0 5.4 4.2 2.0 3.4 3.9 16.9 2.8 3.0 OR5H2 ENSG00000197938 "Olfactory receptor family 5 subfamily H member 2" Q8NGV7 3 98282888-98283832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962685 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 562.2;choroid plexus: 281.6" "Cell type enhanced" "Detected in many" "Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2" "Cancer enhanced" "Detected in all" "renal cancer: 9.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 8200 "Vesicles, Cytosol" Nucleoplasm "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 8.6 4.3 98.3 33.3 97.6 30.6 8.5 562.2 114.7 5.0 281.6 8.7 17.4 8.7 22.7 4.6 5.5 13.6 4.4 34.4 57.4 23.0 14.4 9.5 67.4 285.9 57.0 15.7 1.6 3.9 2.8 1.2 8.3 205.0 2.8 7.1 0.6 7.1 3.4 1.9 4.0 19.5 8.9 201.5 35.1 8.8 2.0 202.3 10.0 6.9 3.6 72.6 10.2 3.9 405.3 1.4 3.2 0.6 2.9 0.2 0.2 4.0 0.3 0.4 2.3 0.8 0.9 8.1 183.3 30.1 0.2 7.4 4.2 4.0 0.5 1.4 1.4 2.1 22.1 0.4 0.3 1.2 22.3 84.2 0.3 1.8 1.3 1.0 0.3 4.2 8.1 2.5 15.0 0.4 5.7 2.6 55.5 3.1 2.3 1.3 75.1 0.1 23.7 0.5 3.9 1.4 0.4 5.0 1.6 1.5 3.9 3.3 67.7 1.1 0.4 3.2 0.4 0.6 35.2 61.4 403.4 0.3 30.0 1.6 9.4 12.1 76.2 1.9 16.1 0.9 51.1 0.6 2.9 10.7 49.6 0.8 1.9 65.7 41.3 36.8 7.0 0.5 6.9 98.3 97.6 562.2 114.7 34.4 57.4 285.9 57.0 15.7 205.0 201.5 202.3 405.3 187.0 12.8 54.0 0.0 138.3 2.9 1.6 2.3 1.8 224.8 139.5 113.0 7.2 28.6 13.1 16.5 104.3 13.6 94.0 0.4 13.7 2.6 20.5 65.5 88.0 61.7 21.5 23.2 0.7 0.0 2.2 30.6 16.8 86.6 40.4 29.0 37.1 43.2 27.7 101.0 0.8 2.7 65.1 47.4 9.4 30.7 11.1 46.7 8.8 95.5 21.8 221.7 47.4 2.0 1.3 0.1 9.8 4.9 138.6 3.5 5.5 5.9 6.9 196.2 6.6 28.0 51.9 4.8 2.9 3.0 2.3 11.1 48.2 8.7 1.9 6.5 FCHSD1 FLJ00007 ENSG00000197948 "FCH and double SH3 domains 1" Q86WN1 5 141639302-141651418 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 51.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043795 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043795: AB_10963435" "prognostic favorable (8.62e-4)" "unprognostic (4.08e-2)" "unprognostic (6.17e-2)" "unprognostic (5.28e-2)" "unprognostic (3.50e-3)" "unprognostic (8.56e-3)" "unprognostic (5.34e-2)" "unprognostic (9.61e-3)" "unprognostic (2.17e-2)" "unprognostic (2.66e-2)" "unprognostic (1.88e-3)" "unprognostic (1.50e-2)" "prognostic unfavorable (6.19e-6)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.77e-4)" "unprognostic (4.12e-3)" "prognostic favorable (1.21e-4)" 8.1 6.7 4.6 19.7 5.0 19.9 8.9 4.8 5.3 14.9 2.8 9.2 11.2 12.6 3.5 9.1 11.1 11.4 4.7 2.2 6.4 5.9 2.8 10.8 23.2 5.7 5.4 1.5 17.6 7.8 51.3 13.2 6.7 8.6 10.6 5.3 3.6 11.3 6.3 2.0 21.5 17.3 6.1 3.5 22.4 11.8 3.9 5.7 11.1 11.2 1.9 17.0 11.8 14.5 10.3 13.5 8.3 11.0 23.1 9.2 11.5 19.3 28.5 14.5 25.1 39.3 15.7 28.1 5.6 14.0 22.1 4.0 7.5 3.5 15.8 11.2 23.9 6.0 11.7 12.9 5.8 7.0 3.7 38.1 14.2 12.3 19.8 6.4 21.1 14.6 0.4 7.4 10.3 2.9 11.8 3.0 7.1 3.2 4.7 7.6 0.1 0.1 5.5 8.6 19.8 1.2 12.2 0.5 10.6 16.5 8.3 12.9 11.0 29.8 0.4 6.9 10.3 12.1 12.2 4.4 2.9 21.8 13.1 12.2 5.8 1.2 4.0 4.3 1.3 3.3 3.3 2.4 4.6 1.2 1.7 2.2 3.1 6.5 1.6 2.1 1.2 3.5 2.4 4.6 5.0 4.8 5.3 2.2 6.4 5.7 5.4 1.5 8.6 3.5 5.7 10.3 4.0 0.0 2.2 5.5 11.6 2.7 3.7 4.7 9.6 4.9 3.5 4.1 0.6 2.8 3.6 3.7 12.5 1.1 11.4 6.3 0.0 4.7 7.1 1.8 2.9 3.8 4.2 1.3 1.7 6.5 4.3 5.3 9.2 3.4 8.9 4.9 3.9 0.6 5.6 53.8 3.9 4.6 8.2 1.9 1.9 6.6 4.1 5.6 3.6 4.7 3.5 1.9 15.5 0.5 8.6 7.4 3.4 3.8 8.2 2.4 4.3 0.7 3.6 1.7 6.6 2.4 3.8 2.3 4.0 4.4 2.8 1.4 14.4 3.5 2.6 2.3 ZNF71 "Cos26, EZFIT" ENSG00000197951 "Zinc finger protein 71" Q9NQZ8 19 56595300-56626481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.6" HPA018124 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018124: AB_1848339" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" "unprognostic (7.72e-2)" "unprognostic (5.03e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.39e-1)" "unprognostic (1.12e-3)" "unprognostic (1.90e-3)" "unprognostic (3.91e-2)" "unprognostic (4.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "unprognostic (6.97e-3)" 3.2 2.2 3.0 2.0 2.7 1.1 3.1 2.1 4.7 3.2 0.0 3.2 1.3 4.3 1.3 2.5 3.2 1.9 3.5 4.8 1.5 2.3 1.0 2.4 3.0 1.7 2.2 3.1 3.6 2.6 2.4 2.9 2.1 2.3 3.2 1.1 3.3 2.6 2.7 3.5 2.8 2.3 2.5 0.9 2.7 2.5 3.2 1.9 3.3 2.3 2.7 1.5 3.6 2.8 2.7 3.1 7.9 9.1 8.7 3.1 3.3 5.7 3.2 3.9 3.6 4.0 1.5 1.4 3.3 3.2 3.5 3.3 1.1 2.0 3.5 2.1 0.0 20.6 5.4 0.9 3.0 3.7 6.4 4.3 4.7 3.4 3.1 2.6 4.0 4.6 7.2 2.3 0.0 3.4 0.0 12.5 2.3 9.0 0.0 7.9 4.8 6.9 3.0 2.1 5.8 9.0 10.5 2.9 4.5 4.4 3.7 3.4 6.3 5.3 10.5 5.1 2.6 6.4 2.2 3.0 5.0 3.0 3.8 3.1 2.9 1.7 3.5 4.3 1.4 4.5 3.2 3.3 3.6 2.8 3.5 3.4 3.6 0.6 6.1 2.6 2.3 3.7 2.6 3.0 2.7 2.1 4.7 4.8 1.5 1.7 2.2 3.1 2.3 0.9 1.9 2.7 8.9 3.2 1.7 3.9 4.5 2.9 2.8 3.8 2.8 9.3 4.8 4.3 3.9 4.3 2.0 7.3 4.2 4.9 5.5 0.6 3.9 10.1 2.7 2.5 3.5 9.8 2.4 2.5 7.4 4.9 6.8 4.6 1.5 2.1 0.0 7.8 3.6 1.0 5.7 11.8 6.6 2.1 4.1 2.4 5.2 3.6 6.2 3.5 3.6 1.9 4.2 3.4 12.3 5.0 4.8 6.3 1.9 5.7 1.4 2.4 1.0 5.8 0.9 8.1 0.0 5.1 6.3 7.4 10.7 2.3 4.3 1.5 5.5 5.5 2.3 1.4 AADACL2 MGC72001 ENSG00000197953 "Arylacetamide deacetylase like 2" Q6P093 3 151733916-151761339 "Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 26 "skin 1: 35.6" "Cell type enriched" "Detected in some" 7 "Suprabasal keratinocytes: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.20e-2)" "unprognostic (3.10e-3)" "unprognostic (2.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (3.00e-1)" "unprognostic (2.91e-4)" 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 35.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 30.7 0.1 0.1 0.0 0.0 0.0 S100A6 "2A9, CABP, CACY, PRA" ENSG00000197956 "S100 calcium binding protein A6" P06703 1 153534599-153536244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 37545.1;Urothelial cells: 17431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 17071.6;RPTEC TERT1: 20988.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002601, HPA007575, CAB040549, CAB047354" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 7000000 "Plasma membrane, Cytosol" "CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859" "unprognostic (8.80e-3)" "unprognostic (6.96e-2)" "unprognostic (2.31e-1)" "unprognostic (2.47e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-1)" "unprognostic (6.86e-3)" "unprognostic (1.66e-1)" "unprognostic (3.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.88e-1)" "unprognostic (1.46e-2)" "prognostic favorable (7.56e-4)" 1606.2 672.9 423.7 1139.9 433.4 2021.9 1514.8 453.7 554.4 2325.6 458.5 2899.3 1517.7 1067.3 408.4 1310.9 887.6 1499.0 1056.2 416.9 607.4 1239.3 92.7 2236.4 368.1 514.5 467.1 409.1 561.4 205.9 69.0 313.6 715.1 477.7 834.7 2273.7 36.9 1132.7 1180.2 482.1 799.2 1378.4 973.5 504.6 523.2 1600.3 171.6 533.3 193.3 978.0 1019.7 509.1 3904.5 1286.8 520.9 3666.6 4412.8 4.3 330.6 7597.2 10482.0 9.3 4560.1 13403.9 2582.7 3352.7 273.3 8022.5 4.5 1319.7 7774.8 2078.7 1589.3 80.7 7340.5 1322.0 1340.0 1.6 731.2 2579.1 255.8 2730.2 28.1 458.7 4550.0 6406.8 2638.7 4734.2 3259.1 6078.3 0.7 3.2 12.3 7052.7 589.4 11.4 292.3 9.6 17071.6 7563.4 5.5 463.0 1250.1 20988.4 3918.8 1019.8 142.6 6251.9 6380.9 4628.4 3.7 835.3 1095.9 7473.3 2228.2 489.8 4463.8 7452.6 8.8 11.9 15.5 8619.0 728.4 4773.0 5517.3 6053.2 2413.8 1806.1 3258.0 1983.1 937.8 1664.9 1773.1 4240.8 583.7 1037.2 1378.3 9637.7 297.4 3066.5 2145.0 2217.6 8320.4 423.7 433.4 453.7 554.4 416.9 607.4 514.5 467.1 409.1 477.7 504.6 533.3 520.9 1177.8 4708.3 2663.1 17.6 343.0 1488.3 6868.7 7856.4 2416.5 4.9 1494.4 1445.2 326.6 1474.1 7013.9 8165.9 0.0 1368.2 999.9 8832.0 7446.5 6206.3 21.3 1148.6 3473.2 1801.5 2035.6 637.5 14.7 9903.1 2440.0 4102.1 2276.3 814.3 1817.4 126.3 946.3 21.6 2430.3 58.9 7.1 6823.9 5706.7 2853.5 7378.0 115.0 3013.4 3110.9 3070.0 30.0 6073.8 168.0 926.9 7.5 23.0 37545.1 9094.3 1143.8 346.6 9900.7 8570.5 224.3 4962.3 8.7 131.5 3234.0 2978.8 28.7 13.2 1718.7 997.6 1573.4 1283.0 5881.5 3218.9 17431.0 RPL12 L12 ENSG00000197958 "Ribosomal protein L12" P30050 9 127447674-127451406 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 16277.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003403 Approved Approved "Golgi apparatus" NA NA 710000 "Golgi apparatus" "HPA003403: AB_1856432" "unprognostic (5.89e-3)" "unprognostic (3.27e-1)" "unprognostic (1.08e-1)" "unprognostic (5.75e-3)" "unprognostic (4.93e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (4.98e-2)" "unprognostic (3.05e-1)" "unprognostic (6.82e-2)" "unprognostic (3.22e-3)" "unprognostic (1.03e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-3)" "unprognostic (4.80e-2)" 1899.7 1241.4 857.3 1047.5 867.5 2784.3 2944.7 861.8 1079.7 1950.0 919.8 1541.8 1024.1 1379.2 2217.0 1913.9 2199.9 1067.9 1043.0 837.3 932.1 1220.5 1193.5 1206.1 2135.2 907.0 865.8 824.0 3046.0 2726.4 706.6 895.1 886.5 908.1 1651.0 1397.9 363.8 1800.4 1007.1 2184.5 2515.0 1247.6 1213.2 913.1 1360.7 1412.9 341.9 892.4 1712.4 1436.2 1329.8 2442.7 1867.4 1803.0 924.0 1511.6 1359.5 1474.8 2976.3 2773.6 6171.2 2266.6 1317.9 3562.5 2315.3 1802.2 2949.5 1529.4 2855.4 1745.3 2256.0 1161.2 1774.7 1887.1 3068.4 1578.4 1451.5 1731.1 1678.1 1705.9 2724.4 5881.5 2596.8 1735.1 6766.3 6013.6 1628.4 6142.1 4589.1 3178.6 1755.1 2307.8 2371.9 2920.2 5170.1 2464.7 3988.0 2166.2 4448.6 2519.6 2073.6 2828.6 3141.2 3458.6 1497.1 1295.6 1882.9 989.8 3291.6 4287.8 1727.6 2707.1 3536.1 1796.2 866.3 1546.2 1504.9 2645.1 1223.5 1630.1 2951.4 901.8 2447.8 1351.3 354.9 961.6 274.4 997.8 982.9 1845.3 2714.4 1857.1 1366.2 1536.6 2602.0 2177.6 1891.8 114.3 1265.6 973.6 1398.4 1772.9 3151.7 857.3 867.5 861.8 1079.7 837.3 932.1 907.0 865.8 824.0 908.1 913.1 892.4 924.0 2021.8 695.5 1593.2 9.1 5219.3 6047.5 4680.5 5696.6 6688.2 186.4 9458.0 16277.6 445.0 2522.1 2427.5 1272.7 85.5 3455.7 2702.3 1424.3 4073.5 2502.6 320.6 1210.9 3910.1 2415.0 2095.3 2939.8 7.4 7126.9 5794.1 2409.3 2320.1 1688.1 1876.4 1940.1 3301.1 2861.4 3348.2 95.9 7.5 4283.6 1810.7 5716.7 5579.1 839.4 5405.5 2945.4 3601.9 13.1 4509.5 782.7 2582.9 5.5 13.4 4166.6 2911.7 2389.9 2741.9 4582.4 3159.4 6003.0 879.7 309.3 986.1 3458.1 2319.6 334.8 584.2 7183.3 6963.2 3724.4 3677.5 3289.4 4446.0 4896.3 DNM3 KIAA0820 ENSG00000197959 "Dynamin 3" Q9UQ16 1 171841498-172418466 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 66.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9" "Cancer enhanced" "Detected in many" "glioma: 2.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064121 Approved "Golgi apparatus" NA NA 70000 "Golgi apparatus" "HPA064121: AB_2685193" "unprognostic (8.21e-2)" "unprognostic (6.80e-3)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (8.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.52e-3)" "unprognostic (6.46e-2)" "unprognostic (5.52e-2)" "unprognostic (2.96e-2)" "unprognostic (2.45e-2)" "unprognostic (3.37e-1)" "unprognostic (6.10e-4)" "unprognostic (1.60e-3)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (2.70e-3)" 4.2 12.0 18.9 1.0 26.3 1.3 4.0 58.5 33.7 5.0 0.0 2.1 0.6 3.2 1.3 1.3 3.3 2.7 1.9 12.6 31.1 3.6 0.4 4.4 1.1 40.8 33.0 10.4 2.6 1.1 1.3 6.3 0.4 46.1 2.6 1.1 13.6 2.2 1.6 1.2 2.4 1.4 3.1 15.8 1.9 2.7 3.2 29.9 1.8 3.3 1.3 0.8 2.2 5.1 66.8 0.8 2.5 2.0 0.4 1.5 1.0 0.0 0.5 1.2 1.0 1.3 0.0 3.7 0.0 7.5 1.1 1.2 0.3 1.5 2.9 0.9 1.0 2.9 22.9 3.7 0.0 0.1 0.5 10.2 0.7 0.5 1.2 0.7 1.1 0.5 2.0 0.0 0.3 0.4 0.0 1.5 0.1 5.8 9.5 1.7 1.5 9.9 0.0 19.0 0.1 3.9 0.8 2.7 0.7 0.2 0.7 0.0 0.9 0.3 2.8 3.8 2.3 14.3 3.8 0.7 0.2 2.7 1.2 1.0 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.2 0.0 0.3 0.5 0.3 0.3 0.1 0.0 1.4 1.2 18.9 26.3 58.5 33.7 12.6 31.1 40.8 33.0 10.4 46.1 15.8 29.9 66.8 21.8 0.0 6.8 207.3 1.5 2.4 1.5 0.7 3.4 25.1 1.4 1.3 2.4 0.0 0.4 0.0 29.2 0.1 0.7 0.2 3.9 0.3 8.2 7.3 1.3 19.5 0.0 0.8 365.7 0.4 0.1 3.2 7.1 1.0 1.3 0.8 8.2 0.2 0.7 8.4 631.8 0.7 0.0 0.6 3.1 3.9 1.8 13.4 0.0 178.0 0.3 5.9 0.0 976.1 1970.9 2.5 0.1 2.6 0.3 0.7 0.0 0.8 2.2 29.0 0.0 4.5 2.2 5.3 0.4 1.1 1.7 0.3 0.9 10.3 0.8 0.7 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560329-9584504 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 68.2;RT4: 72.3" "Low region specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 6.2 4.8 5.5 5.3 5.9 14.5 7.3 8.8 6.5 4.8 8.0 5.1 3.6 4.7 5.7 9.3 5.5 4.0 5.6 5.7 6.0 5.3 8.6 7.5 6.2 6.2 6.0 5.8 4.6 6.3 8.7 6.7 4.3 6.4 7.2 5.8 7.3 6.7 3.5 4.5 9.9 6.5 4.9 5.8 7.4 5.7 3.7 6.2 6.1 5.6 3.2 6.9 5.4 7.1 9.7 14.9 8.7 10.3 23.7 4.6 5.4 16.4 5.3 5.3 7.3 10.0 17.7 6.6 16.1 13.3 4.6 4.1 13.6 18.8 15.0 9.2 8.4 32.4 43.2 29.2 15.7 6.1 26.0 25.6 7.2 11.2 7.2 16.3 6.1 5.4 17.4 16.9 27.7 5.4 11.8 17.9 68.2 27.1 5.2 13.9 10.9 13.0 11.8 8.0 72.3 19.6 10.2 7.6 10.6 6.2 20.7 7.8 8.2 6.1 21.7 12.0 7.6 12.1 26.6 17.6 18.4 6.0 14.4 9.1 1.6 1.5 0.9 2.1 1.9 2.8 1.5 2.0 1.9 1.6 2.3 2.3 2.6 1.2 3.1 2.0 2.0 2.0 0.9 5.5 5.9 8.8 6.5 5.7 6.0 6.2 6.0 5.8 6.4 5.8 6.2 9.7 16.0 6.4 10.5 3.9 14.7 22.6 36.9 15.6 10.8 7.3 12.7 11.7 11.2 5.7 15.7 9.2 12.5 12.3 25.8 5.6 7.9 11.4 1.5 12.3 16.9 11.8 13.7 11.6 6.2 5.3 11.3 11.7 11.7 18.3 15.2 16.7 10.8 9.9 5.3 6.7 5.3 10.2 8.2 10.4 13.8 0.6 6.2 9.7 8.8 1.0 6.9 3.1 12.3 7.5 6.7 11.4 5.6 8.2 12.6 26.2 4.1 5.3 11.0 7.8 6.6 17.0 10.3 11.0 12.5 21.3 31.7 10.5 14.5 11.9 14.6 35.9 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 183.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 183.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: AB_2685034" "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.27e-6)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (4.21e-2)" 63.1 34.4 22.4 49.7 21.0 8.4 92.5 22.1 21.9 63.6 38.8 60.7 41.2 50.5 27.6 53.3 60.6 68.3 42.5 21.6 35.6 28.3 23.1 42.7 35.5 24.8 28.1 19.4 46.8 27.7 28.6 33.2 69.5 27.8 42.1 60.0 12.8 73.7 39.2 14.8 33.6 41.4 63.2 25.2 29.5 44.2 48.6 27.3 29.5 39.8 27.1 46.3 75.4 51.7 25.8 88.5 126.3 96.9 75.8 303.4 137.2 304.8 134.5 172.7 86.3 106.4 234.4 119.5 31.0 152.9 171.6 76.1 144.2 97.5 149.0 72.6 70.9 52.8 25.5 63.5 56.7 188.5 30.2 16.1 126.1 183.5 137.8 153.4 121.4 116.4 93.6 97.1 63.5 103.0 29.3 103.6 36.2 61.9 176.7 53.5 62.5 82.7 137.5 131.4 84.6 55.7 91.8 119.6 122.4 69.7 221.9 66.6 16.0 132.8 97.9 44.1 127.5 73.8 94.0 157.2 142.8 140.8 35.3 15.8 7.7 29.1 20.0 2.8 24.8 1.3 14.7 2.8 4.1 38.5 8.8 7.7 2.6 183.8 10.4 34.6 43.9 0.5 11.0 22.4 21.0 22.1 21.9 21.6 35.6 24.8 28.1 19.4 27.8 25.2 27.3 25.8 52.9 28.9 30.0 31.0 15.1 76.3 78.5 57.6 35.9 8.8 75.9 73.9 6.3 20.0 49.6 20.2 6.2 128.7 21.1 67.1 5.9 63.2 1.8 14.5 40.4 56.7 47.8 10.1 32.8 75.6 145.2 118.2 41.3 23.0 3.8 75.3 24.3 23.3 37.7 10.1 27.9 39.7 20.3 28.2 31.9 4.9 69.9 23.5 16.0 60.0 84.0 11.8 3.1 141.8 1.7 81.0 41.6 83.8 23.5 141.7 55.5 10.1 28.3 13.9 19.7 18.6 48.6 8.9 26.8 41.2 55.5 76.9 8.6 49.4 61.0 57.7 VPS13A "CHAC, KIAA0986" ENSG00000197969 "Vacuolar protein sorting 13 homolog A" Q96RL7 9 77177445-77421537 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 228.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021652, HPA021662" Supported NA NA "HPA021652: AB_1858759, HPA021662: AB_1858760" "unprognostic (1.52e-1)" "unprognostic (4.19e-2)" "unprognostic (5.49e-3)" "unprognostic (2.96e-1)" "unprognostic (4.68e-1)" "unprognostic (8.54e-2)" "unprognostic (8.91e-3)" "unprognostic (1.69e-3)" "unprognostic (9.67e-2)" "unprognostic (9.74e-2)" "unprognostic (1.14e-1)" "unprognostic (9.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.53e-2)" "unprognostic (3.28e-1)" "unprognostic (2.05e-1)" "unprognostic (1.70e-2)" 4.7 7.7 3.3 7.2 5.5 17.8 7.3 12.4 10.2 4.4 3.9 9.4 16.4 6.0 8.0 7.7 4.7 9.1 9.6 5.8 2.6 10.0 7.5 6.4 8.8 1.0 0.6 4.0 3.7 8.8 9.4 6.5 3.7 3.9 6.7 11.5 7.3 8.1 6.7 14.7 15.8 13.9 7.3 0.0 10.7 12.4 16.9 1.0 10.4 8.6 9.8 7.7 6.5 6.3 4.9 21.0 10.4 9.1 7.9 8.5 7.4 13.7 11.4 10.3 9.8 11.1 4.2 9.3 16.4 5.2 10.6 11.9 27.9 13.7 11.3 17.4 15.5 11.0 21.7 21.3 10.3 8.3 28.3 13.9 4.7 16.6 14.5 17.7 17.3 14.1 15.7 14.3 17.4 6.0 9.8 21.7 9.7 10.2 11.9 8.3 15.7 17.4 6.8 14.1 20.2 13.3 13.3 14.3 9.2 6.3 16.6 6.3 6.3 18.6 10.4 11.3 14.4 14.6 9.7 9.6 8.4 10.8 13.2 4.2 3.8 0.2 2.0 1.2 0.1 1.2 0.9 0.9 0.9 0.1 1.2 0.7 0.8 0.2 1.2 0.1 2.2 0.7 0.2 3.3 5.5 12.4 10.2 5.8 2.6 1.0 0.6 4.0 3.9 0.0 1.0 4.9 29.7 64.1 46.5 48.3 32.2 33.0 26.6 28.0 27.3 29.1 25.4 22.1 87.2 27.1 41.2 29.5 58.4 15.2 42.3 78.9 3.9 18.2 90.5 33.8 28.2 38.6 87.8 48.4 228.3 18.4 4.8 18.9 86.6 42.6 19.0 32.4 37.5 34.1 8.6 11.8 101.1 47.4 30.5 10.6 14.4 55.0 13.7 13.3 23.2 43.1 11.9 16.4 41.2 72.4 23.0 46.2 42.9 15.8 42.7 31.0 98.5 21.7 38.9 18.2 32.9 33.1 30.5 74.3 64.5 36.6 31.3 8.9 43.2 38.0 39.8 25.7 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 160 "brain: 32454.4;choroid plexus: 13028.9" "Cell type enriched" "Detected in many" 11 "Oligodendrocytes: 2895.5" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 99.3;SK-MEL-30: 204.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" NA NA 54000 "Plasma membrane" "CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247" "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favorable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 23.3 7.2 22176.9 21.0 23170.9 43.4 21.1 22711.2 22942.9 16.3 13028.9 17.3 18.8 13.3 8.0 20.7 31.8 17.3 24.3 16046.8 18317.0 19.6 23.7 20.2 27.2 30153.0 25169.6 14249.6 22.5 23.0 47.9 26.9 4.8 30653.3 15.4 17.0 7.5 22.2 13.2 142.1 28.3 20.9 8.8 29096.5 28.2 17.6 6.2 23715.3 12.6 22.4 82.3 28.0 19.2 20.4 32454.4 26.1 22.4 0.2 0.8 35.8 53.1 8.5 0.6 0.6 0.8 0.6 3.2 39.2 15.9 4.4 1.7 0.2 49.9 3.8 22.1 0.7 60.7 5.3 10.4 3.9 5.2 22.5 99.3 65.3 7.7 18.4 19.8 30.3 16.4 6.5 37.9 0.0 3.6 0.0 3.2 4.1 50.6 2.2 15.6 18.1 1.5 0.4 35.9 34.5 34.3 1.8 0.3 3.2 0.0 204.7 6.1 0.6 60.5 0.1 0.2 0.5 0.2 2.8 0.1 0.5 16.9 5.8 62.0 2.5 21.7 8.5 32.4 21.6 8.1 13.1 5.9 15.4 28.1 9.2 5.1 9.1 17.0 39.5 28.0 8.1 11.9 14.9 11.6 22176.9 23170.9 22711.2 22942.9 16046.8 18317.0 30153.0 25169.6 14249.6 30653.3 29096.5 23715.3 32454.4 5.5 48.1 39.5 10.7 86.8 118.8 61.1 28.1 84.2 52.8 24.2 22.7 45.0 35.8 50.3 103.0 2.1 0.7 221.8 48.7 41.1 43.7 5.9 159.8 11.2 9.4 49.8 68.8 32.4 35.8 0.8 36.2 59.1 161.1 71.5 2.1 10.0 30.2 44.4 1.7 47.1 51.4 44.7 78.3 123.1 6.3 28.3 98.2 92.5 45.0 84.4 25.7 247.2 124.7 2895.5 60.4 25.5 14.3 45.3 117.6 37.5 36.0 54.0 6.1 0.0 88.7 8.4 7.7 1.1 75.6 154.7 0.7 151.6 0.0 42.1 103.7 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591604-1602520 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: AB_2681314" "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favorable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favorable (1.11e-5)" 33.9 47.3 13.1 34.1 14.4 45.0 37.6 12.2 14.4 43.0 14.6 35.8 31.2 35.5 20.2 38.9 39.9 16.6 33.6 13.0 12.6 39.3 70.6 51.9 36.3 16.2 14.0 11.6 73.6 66.9 12.7 47.0 17.4 16.8 51.1 10.0 7.5 41.9 16.0 17.6 33.4 49.8 7.7 12.2 83.7 41.7 32.0 14.6 27.5 63.2 9.3 20.3 32.5 38.3 17.2 23.8 29.8 23.4 26.5 11.3 14.4 57.1 25.1 10.2 19.8 16.6 33.3 21.3 35.5 15.8 12.6 27.9 20.4 14.3 12.6 11.8 29.3 49.2 44.3 32.6 31.3 24.1 17.3 71.3 12.8 22.8 14.8 16.4 23.6 13.8 17.7 28.2 21.8 11.7 15.6 38.5 74.4 35.0 5.5 25.6 28.9 27.9 30.0 13.2 16.3 26.1 38.1 19.7 31.5 31.5 19.2 20.6 31.3 26.9 30.8 14.0 26.9 22.1 93.7 17.0 49.1 12.5 27.7 8.4 4.5 0.5 0.9 0.3 0.2 0.4 0.9 0.4 0.7 0.3 0.5 0.3 0.3 1.9 0.7 0.4 0.8 0.2 0.2 13.1 14.4 12.2 14.4 13.0 12.6 16.2 14.0 11.6 16.8 12.2 14.6 17.2 41.2 25.6 25.3 1.3 53.5 44.4 36.1 10.6 36.5 24.1 41.5 29.8 12.0 12.8 19.4 12.9 10.4 25.1 67.0 39.9 13.7 21.2 52.1 29.6 32.7 35.1 22.6 14.5 0.8 15.5 32.4 31.5 39.3 41.1 25.4 49.8 32.2 21.3 22.8 16.8 0.8 38.7 12.2 25.7 54.5 18.9 38.8 37.4 40.9 0.0 38.0 21.5 54.6 2.0 2.7 24.4 35.9 31.6 65.0 41.9 22.6 7.9 14.4 15.4 0.0 28.4 23.2 20.6 27.6 31.7 47.2 72.7 51.1 131.7 28.6 46.2 ELOVL2 Ssc2 ENSG00000197977 "ELOVL fatty acid elongase 2" Q9NXB9 6 10980759-11044305 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.9;placenta: 35.6;retina: 28.1" "Cell type enhanced" "Detected in many" "Astrocytes: 95.0;Cone photoreceptor cells: 29.2;Extravillous trophoblasts: 19.7;Sertoli cells: 19.7;Spermatocytes: 23.0" "Group enriched" "Detected in many" 8 "breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 31.2;HBF TERT88: 29.0;Hep G2: 23.4;RH-30: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (6.73e-5)" "unprognostic (4.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.28e-5)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.89e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (6.92e-3)" "unprognostic (1.78e-2)" "unprognostic (1.04e-12)" "unprognostic (9.98e-4)" "unprognostic (8.86e-2)" "unprognostic (3.41e-1)" "unprognostic (9.47e-2)" 1.2 0.9 9.0 1.5 10.2 0.0 4.9 10.1 14.0 0.1 4.6 0.4 0.2 0.5 2.3 0.4 0.2 0.6 3.2 9.1 22.4 0.2 52.9 0.2 0.5 10.2 9.2 8.6 0.2 2.6 9.8 3.0 35.6 9.5 5.3 0.1 28.1 0.7 0.4 1.0 0.2 0.3 0.7 9.8 0.0 0.1 11.7 9.6 1.1 1.8 1.0 0.9 2.1 0.1 14.5 0.0 5.3 20.1 0.0 0.0 0.0 11.5 0.4 1.0 17.7 29.9 0.0 0.0 0.0 0.0 1.1 31.2 0.0 21.3 0.0 29.0 0.0 18.2 0.1 0.4 23.4 0.9 0.4 4.8 0.2 0.0 13.7 0.0 1.0 0.0 0.9 1.2 0.0 0.4 0.1 12.1 0.2 3.8 0.0 17.4 16.6 31.8 0.0 0.0 0.3 8.0 9.1 0.0 0.0 7.5 16.1 3.7 9.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 10.2 10.1 14.0 9.1 22.4 10.2 9.2 8.6 9.5 9.8 9.6 14.5 0.5 0.0 0.0 95.0 0.1 0.1 0.0 0.0 0.0 2.2 7.8 1.3 1.2 8.6 0.0 0.0 29.2 2.3 0.0 0.0 0.0 7.2 10.1 0.0 0.5 1.9 0.0 0.0 2.5 1.0 19.7 8.0 0.0 0.0 0.0 0.3 0.0 17.5 1.2 0.0 5.9 0.0 0.0 0.0 0.0 14.9 0.9 0.1 0.0 6.5 0.0 4.9 0.0 4.5 16.8 1.0 0.0 0.4 0.0 1.9 0.0 0.1 0.0 11.8 19.7 0.1 3.9 23.0 8.9 0.2 0.0 1.6 0.1 0.0 0.0 0.1 GOLGA6L9 GOLGA6L20 ENSG00000197978 "Golgin A6 family like 9" A6NEM1 15 82430018-82439153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 30.0;Astrocytes: 30.3;Early spermatids: 72.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;HDLM-2: 3.6;U-266/84: 3.3" NA NA "unprognostic (2.13e-1)" "unprognostic (1.51e-2)" "unprognostic (3.80e-1)" "unprognostic (7.40e-2)" "unprognostic (1.53e-1)" "unprognostic (9.09e-3)" "unprognostic (5.73e-2)" "unprognostic (2.48e-3)" "unprognostic (2.92e-2)" "unprognostic (4.76e-3)" "unprognostic (1.22e-2)" "unprognostic (6.63e-3)" "unprognostic (5.09e-5)" "unprognostic (4.78e-2)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.29e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.7 0.1 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.4 0.8 4.0 0.0 0.0 2.1 0.6 0.0 0.2 0.0 0.0 1.3 1.6 0.0 0.2 0.0 0.6 0.5 0.2 0.1 3.6 0.0 0.0 1.7 0.9 0.4 0.1 1.3 0.0 1.5 0.0 0.5 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.0 2.5 0.0 2.6 0.0 0.9 2.2 0.7 0.6 0.0 0.0 0.0 2.0 1.5 1.6 1.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.7 9.6 30.0 30.3 2.1 0.1 1.5 0.0 8.6 5.9 2.9 2.2 5.6 4.3 19.8 3.7 8.4 1.5 2.4 6.4 0.0 4.4 72.6 18.0 3.5 2.5 16.2 5.9 27.5 3.7 0.7 3.6 18.3 8.1 1.3 6.9 4.2 2.0 0.7 6.7 17.9 7.6 0.0 0.6 0.4 10.2 1.2 1.1 0.0 12.2 1.1 4.0 0.0 19.1 2.6 6.3 3.3 1.2 1.9 3.1 2.9 0.5 7.4 9.1 0.0 3.0 2.2 13.7 6.1 22.1 0.0 0.8 1.9 4.7 8.7 2.7 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 12.9" "Cell type enhanced" "Detected in many" "Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.3;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 0.9 1.0 1.2 0.3 0.9 0.2 1.6 1.0 0.7 0.4 1.6 0.6 1.1 0.7 3.4 0.3 3.9 0.4 0.9 0.9 1.7 1.4 0.7 0.6 1.1 1.7 1.6 0.6 0.9 1.0 1.5 1.5 0.2 1.4 0.9 0.6 1.8 0.6 0.6 0.2 0.4 0.6 0.4 2.0 0.5 0.9 12.9 0.9 0.7 2.4 0.2 0.4 0.5 0.2 1.0 3.3 1.2 0.0 0.7 0.4 0.2 0.1 0.1 0.5 0.6 0.5 0.1 1.7 0.0 0.9 0.4 1.2 1.2 0.0 0.3 1.3 0.5 0.3 1.0 0.1 0.0 0.0 1.0 0.2 1.5 0.8 0.1 0.9 0.3 0.3 0.0 0.7 0.6 1.2 1.2 0.0 0.7 1.0 0.9 0.7 0.0 0.8 0.8 1.0 0.2 1.9 0.7 1.0 0.7 0.0 0.2 2.2 1.8 0.0 0.1 0.3 0.2 0.5 2.9 0.5 0.0 0.5 0.7 1.0 0.6 0.0 0.0 0.2 0.0 0.4 0.8 0.4 0.0 0.3 0.9 0.4 0.2 0.0 0.7 0.0 0.5 0.6 0.1 1.2 0.9 1.0 0.7 0.9 1.7 1.7 1.6 0.6 1.4 2.0 0.9 1.0 0.5 0.0 1.1 19.9 6.3 1.3 1.1 1.4 2.8 1.2 2.7 3.9 1.5 1.5 2.8 3.7 2.1 0.3 0.7 1.5 3.9 0.7 96.8 20.7 1.4 0.6 0.0 2.1 6.5 1.6 0.1 1.1 9.7 2.8 1.3 1.4 0.0 1.8 0.2 3.3 11.8 0.9 0.0 1.6 1.3 47.7 1.5 1.8 1.8 3.7 1.1 1.7 0.0 8.0 8.0 1.0 0.6 1.9 2.5 0.7 1.2 5.4 28.0 4.8 0.0 0.6 1.4 65.2 4.3 2.2 0.9 0.1 2.3 1.1 0.9 0.8 C1orf122 FLJ45459 ENSG00000197982 "Chromosome 1 open reading frame 122" Q6ZSJ8 1 37806979-37809454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.83e-2)" "unprognostic (4.07e-3)" "unprognostic (1.46e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "unprognostic (1.39e-1)" "unprognostic (1.45e-3)" "unprognostic (7.12e-2)" "unprognostic (1.69e-1)" "unprognostic (4.44e-2)" "unprognostic (2.81e-3)" "unprognostic (3.89e-1)" "unprognostic (3.58e-2)" "unprognostic (9.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.81e-4)" 45.9 86.2 83.9 10.4 85.3 7.6 44.6 87.5 93.0 38.1 75.2 48.8 11.4 40.7 20.4 51.3 36.8 7.6 74.0 76.1 79.5 74.8 83.2 35.1 7.1 92.3 86.6 73.5 32.1 63.5 19.8 102.6 10.4 88.2 60.6 8.3 25.2 40.8 18.3 61.6 34.2 33.3 11.3 91.3 32.7 56.0 40.0 87.4 6.8 43.3 21.7 7.1 45.7 37.6 98.8 38.2 19.7 21.3 25.6 35.3 40.3 84.8 43.5 23.5 29.6 25.8 33.7 37.0 20.7 91.5 27.5 22.1 33.9 14.4 30.1 16.8 39.0 48.1 13.9 23.8 20.8 49.9 18.5 24.7 48.9 65.3 23.8 27.5 33.0 20.5 17.6 35.1 21.1 27.4 36.2 19.4 32.4 57.6 30.7 50.0 29.2 20.9 43.5 30.9 19.4 39.3 63.8 31.5 30.8 38.8 37.6 40.3 11.8 24.9 37.1 33.4 20.9 40.8 49.4 26.7 24.8 33.5 20.5 29.2 1.4 4.9 5.8 3.7 5.8 1.7 1.2 2.5 2.2 3.6 2.9 1.5 2.4 3.0 3.1 5.6 2.5 2.7 2.9 83.9 85.3 87.5 93.0 76.1 79.5 92.3 86.6 73.5 88.2 91.3 87.4 98.8 57.4 3.2 14.0 37.9 38.5 55.4 95.5 45.9 51.2 146.1 101.4 95.4 83.3 60.1 30.8 82.8 41.7 84.5 47.9 105.4 266.1 59.6 11.5 62.5 60.5 57.5 113.6 10.8 19.0 109.9 132.4 80.4 31.1 124.8 34.3 67.9 61.8 127.3 146.3 69.0 23.2 73.7 95.6 52.0 56.5 30.2 49.0 80.1 83.6 9.4 94.3 246.5 41.2 15.1 108.2 71.1 88.0 73.7 51.6 201.6 64.6 274.4 25.2 145.0 32.9 55.2 99.8 24.2 19.6 50.2 60.1 106.7 39.2 126.0 57.8 147.8 AL592490.1 ENSG00000197991 "Novel protein" 13 61409858-61427849 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Yes NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC9A "CD370, DNGR-1, HEEE9341, UNQ9341" ENSG00000197992 "C-type lectin domain containing 9A" Q6UXN8 12 10030678-10066031 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.6" "Group enriched" "Detected in some" 5 "Langerhans cells: 30.2;Macrophages: 19.5;Microglial cells: 15.9;Spermatocytes: 9.4" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 96 "myeloid DC: 22.0;neutrophil: 7.9" "Group enriched" "Detected in many" 96 "dendritic cells: 22.0;granulocytes: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.13e-3)" "unprognostic (1.21e-2)" "unprognostic (5.00e-3)" "unprognostic (7.85e-3)" "unprognostic (1.28e-2)" "unprognostic (1.56e-5)" "unprognostic (6.58e-4)" "unprognostic (4.73e-3)" "unprognostic (9.65e-2)" "unprognostic (7.45e-3)" "unprognostic (8.15e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (7.93e-2)" "unprognostic (3.45e-5)" "unprognostic (2.17e-1)" 0.3 0.2 1.1 1.6 1.5 0.5 0.6 2.0 1.9 0.3 1.1 0.7 0.9 0.5 0.2 0.2 0.2 0.9 0.2 1.4 1.7 0.3 0.8 0.6 7.6 2.3 2.0 0.9 0.7 0.3 0.2 0.3 0.2 2.0 0.6 0.6 0.1 1.1 0.4 0.1 0.3 1.5 0.7 2.4 4.8 0.4 3.0 1.9 5.0 0.2 0.2 2.2 1.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 7.9 0.1 0.0 0.0 0.0 0.4 1.1 1.5 2.0 1.9 1.4 1.7 2.3 2.0 0.9 2.0 2.4 1.9 2.5 0.8 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.2 30.2 1.8 0.0 19.5 0.0 15.9 2.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KEL "CD238, ECE3" ENSG00000197993 "Kell metallo-endopeptidase (Kell blood group)" P23276 7 142941114-142962363 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 56.7;testis: 32.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "HEL: 31.7;K-562: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.1 0.0 1.6 0.8 2.3 56.7 0.3 1.5 2.2 0.8 1.2 0.1 0.0 0.2 0.0 0.8 0.5 0.0 0.3 1.8 1.7 0.6 0.3 0.5 10.7 2.3 2.0 1.3 0.2 0.2 0.0 0.2 0.4 2.7 0.3 0.0 0.1 0.6 0.1 0.2 0.1 0.9 0.0 1.7 4.9 0.2 32.6 1.8 1.3 0.3 0.0 6.7 0.1 0.4 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.3 1.5 2.2 1.8 1.7 2.3 2.0 1.3 2.7 1.7 1.8 2.7 0.2 0.0 0.0 0.3 0.0 0.0 1.3 0.2 4.0 0.0 0.3 0.1 0.4 0.0 1.4 3.7 0.0 0.1 0.1 0.0 1.9 0.3 2.4 0.2 0.1 0.1 0.0 79.7 3.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 3.1 0.0 1.4 0.2 16.8 0.0 0.1 0.0 0.0 0.0 0.9 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 8.7 5.9 4.7 8.1 5.9 6.9 10.1 4.9 5.3 8.3 5.5 8.7 6.1 9.9 7.5 8.8 7.5 6.6 6.8 4.2 5.2 7.3 5.6 6.9 12.1 5.8 5.3 3.7 11.3 7.2 12.7 3.2 7.7 5.8 7.5 8.4 5.8 7.8 8.5 6.4 7.3 5.9 9.9 4.9 9.9 6.3 6.1 5.5 12.7 10.6 6.2 12.7 8.6 5.1 7.2 18.9 27.1 13.4 24.2 28.5 24.3 19.8 19.7 14.9 20.9 18.7 11.2 18.5 54.2 16.3 20.1 33.8 39.9 43.5 25.8 22.3 36.3 21.4 37.1 25.9 22.4 20.3 63.2 30.5 24.0 23.5 22.0 31.6 16.7 23.7 16.3 60.7 17.1 22.5 29.7 42.7 24.8 21.4 28.4 26.8 29.8 37.9 23.0 10.6 13.4 23.0 12.3 25.3 25.1 18.0 17.3 9.5 21.2 24.9 18.3 14.0 26.7 25.0 17.7 37.5 26.7 18.5 37.4 26.6 18.9 8.3 11.3 11.4 10.8 15.8 13.0 11.3 11.8 12.1 12.9 13.3 11.7 3.1 13.2 15.7 10.2 13.8 7.1 4.7 5.9 4.9 5.3 4.2 5.2 5.8 5.3 3.7 5.8 4.9 5.5 7.2 25.4 19.2 33.4 15.7 33.8 13.0 18.4 15.3 21.1 17.9 14.7 20.6 28.4 14.3 19.8 11.0 10.4 19.5 37.7 10.1 15.6 23.5 13.9 17.9 46.2 23.9 9.0 37.6 12.1 12.9 20.1 25.8 23.9 20.8 52.4 30.6 16.1 11.5 26.5 28.6 12.5 16.9 6.1 17.7 12.1 9.4 32.0 23.9 10.6 18.7 34.5 12.4 43.3 15.6 25.9 16.1 11.2 23.7 36.5 23.3 10.3 15.8 21.2 17.7 6.6 29.3 21.5 73.3 50.2 25.4 15.9 14.6 30.1 33.4 20.3 12.2 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 56.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol NA NA Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favorable (4.42e-5)" 8.2 6.5 4.4 13.7 5.0 10.1 9.0 5.0 5.1 7.7 5.7 7.5 9.1 6.9 7.0 10.6 7.0 8.9 5.0 4.3 5.5 7.5 9.2 8.6 17.7 5.9 5.1 4.0 5.6 15.2 7.0 6.2 8.3 5.6 7.6 8.5 12.4 8.4 7.0 3.0 13.4 12.0 7.3 5.2 18.8 10.6 5.8 5.1 18.6 11.0 3.2 16.4 7.8 8.0 5.8 9.3 6.8 4.7 6.2 16.5 27.6 6.7 12.9 9.1 10.0 9.1 5.8 8.7 15.8 12.4 10.7 6.6 7.5 5.3 8.3 14.2 22.8 4.9 15.2 5.2 3.7 9.4 21.2 17.7 14.7 12.7 12.7 7.4 17.4 15.0 15.1 14.4 11.6 27.8 5.1 18.6 11.7 1.7 0.0 7.9 12.2 5.8 8.4 7.8 8.8 3.4 3.3 6.3 7.9 6.2 6.4 9.9 18.5 13.4 12.2 2.3 15.1 9.0 14.0 19.4 13.7 12.7 56.2 6.9 20.8 4.0 8.7 6.1 4.6 6.3 3.3 4.9 5.3 3.7 4.4 4.4 4.8 7.9 7.9 5.9 5.1 6.7 4.6 4.4 5.0 5.0 5.1 4.3 5.5 5.9 5.1 4.0 5.6 5.2 5.1 5.8 24.1 19.2 15.6 5.2 36.5 10.8 11.3 10.7 17.1 5.8 15.2 11.2 4.5 17.2 11.3 33.1 20.9 14.9 52.1 15.7 21.5 12.7 18.4 14.1 12.4 17.3 3.6 12.0 2.9 17.8 8.4 13.7 33.6 15.2 22.1 10.7 16.1 8.7 16.9 8.4 3.4 11.9 14.2 24.7 20.2 23.2 12.5 25.1 10.6 20.6 28.2 9.9 60.8 2.5 14.7 13.3 7.2 11.3 33.2 8.9 18.6 13.8 9.5 27.2 6.6 9.5 11.0 28.2 12.5 17.2 11.8 27.9 41.1 15.0 9.2 13.5 CCDC151 "MGC20983, ODA10" ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.3;parathyroid gland: 9.8;testis: 10.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Kupffer cells: 51.6;Muller glia cells: 58.9;Respiratory ciliated cells: 29.6;Spermatocytes: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;T-47d: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054626 Enhanced NA NA "HPA054626: AB_2682547" "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.4 2.8 6.1 0.0 4.1 0.0 0.4 5.1 6.5 1.2 12.3 0.3 0.0 0.6 0.3 0.2 8.5 0.0 1.5 4.7 6.2 2.8 0.7 2.3 0.0 5.5 6.0 3.4 0.6 0.4 9.8 7.0 0.4 5.2 0.8 0.0 0.9 1.7 0.5 0.1 0.5 0.2 0.0 5.9 2.6 0.4 10.5 5.5 0.0 3.0 0.0 0.0 0.3 0.8 6.0 0.2 0.0 0.6 0.2 0.1 0.2 0.5 0.2 0.1 0.3 0.4 0.0 0.0 0.1 0.2 0.1 1.2 0.1 0.5 0.2 0.0 0.5 0.5 0.2 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.5 0.1 0.4 0.0 0.1 0.2 0.1 1.0 0.2 0.0 0.7 0.3 0.0 2.0 1.3 0.6 0.1 0.1 0.1 4.8 0.2 0.0 0.8 0.1 1.7 0.0 1.7 1.4 0.1 1.8 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 4.1 5.1 6.5 4.7 6.2 5.5 6.0 3.4 5.2 5.9 5.5 6.0 1.1 0.0 0.0 6.5 5.7 0.9 0.7 1.0 0.6 1.1 0.8 1.3 2.2 1.5 2.6 12.9 0.0 0.5 0.0 0.0 29.4 0.2 12.4 20.3 4.2 2.9 0.0 0.0 2.3 0.2 0.5 3.8 0.5 1.1 4.5 1.6 14.3 1.2 4.7 1.7 1.7 0.5 2.0 51.6 1.7 14.5 2.8 7.8 7.2 1.0 2.6 58.9 0.0 1.0 0.8 0.1 0.0 0.7 0.8 0.1 0.1 1.1 29.6 3.2 6.6 15.2 6.8 22.7 6.6 0.1 0.4 1.2 1.5 1.0 0.0 0.5 DLGAP2 "C8orf68, DAP-2, ERICH1-AS1" ENSG00000198010 "DLG associated protein 2" Q9P1A6 8 737628-1708476 "Nuclear receptors, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;testis: 12.2" "Group enriched" "Detected in some" 8 "Excitatory neurons: 645.0;Inhibitory neurons: 467.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "cerebral cortex: 5.0;hippocampal formation: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030320 Uncertain NA NA "HPA030320: AB_10600904" "unprognostic (8.86e-2)" "unprognostic (2.32e-1)" "unprognostic (5.32e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" "unprognostic (1.23e-3)" "unprognostic (1.07e-1)" "unprognostic (2.71e-2)" "unprognostic (5.01e-2)" "unprognostic (2.16e-2)" "unprognostic (1.90e-3)" "unprognostic (2.53e-1)" "unprognostic (1.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.96e-1)" "unprognostic (3.85e-1)" "unprognostic (3.81e-1)" 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 5.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.6 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 12.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 2.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.4 0.0 0.0 16.0 0.0 0.4 0.3 0.0 0.0 4.1 0.7 0.9 1.7 0.0 1.8 0.0 16.7 0.0 0.0 0.0 1.9 0.1 64.1 0.1 0.0 0.6 0.0 0.0 645.0 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 40.4 467.8 0.0 0.0 0.0 0.3 31.9 0.9 0.2 1.8 35.6 0.0 1.9 0.0 12.1 9.1 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.7 2.5 0.0 0.3 0.2 8.2 6.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467514-93516214 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" NA NA "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favorable (8.12e-4)" 14.2 26.9 7.0 8.9 8.1 14.0 15.1 11.7 9.0 15.7 9.5 17.1 13.6 14.7 11.0 19.5 14.3 8.2 17.3 8.3 10.1 21.5 20.6 12.9 12.3 7.5 8.0 7.0 14.4 13.9 23.6 15.5 11.4 8.8 16.0 17.0 6.2 14.1 10.6 12.1 14.3 13.6 14.0 6.6 10.9 16.0 14.6 8.3 19.4 14.1 14.5 15.0 16.7 16.8 11.8 30.5 42.3 53.5 33.8 25.5 36.8 36.5 43.0 33.0 45.4 32.9 51.8 11.6 49.9 16.3 32.1 29.8 22.4 61.5 48.0 74.3 50.6 40.5 45.0 26.8 61.9 41.9 74.0 21.3 31.0 44.4 48.4 60.5 42.2 46.5 53.0 61.3 19.0 54.0 36.1 67.2 49.3 65.1 52.8 55.9 48.1 25.5 40.4 49.2 77.0 39.8 32.0 36.0 39.3 41.3 42.0 35.5 33.4 29.1 26.5 22.1 21.3 49.6 31.2 49.0 46.1 12.2 45.7 41.5 21.0 14.4 20.4 14.7 21.2 18.9 25.9 19.4 16.6 16.4 23.7 21.3 21.8 8.3 27.0 20.4 11.2 28.1 16.3 7.0 8.1 11.7 9.0 8.3 10.1 7.5 8.0 7.0 8.8 6.6 8.3 11.8 55.0 28.9 35.5 13.4 59.9 67.3 97.6 131.6 50.1 34.9 48.7 38.1 82.6 42.9 82.5 46.0 60.5 96.7 41.4 38.2 213.2 86.2 397.6 87.5 61.3 48.7 93.2 66.7 16.2 77.4 133.1 54.5 48.9 48.6 58.4 50.7 32.9 48.4 54.0 47.1 22.1 66.8 107.8 34.1 47.9 165.0 51.6 32.6 60.5 6.5 35.2 22.1 54.6 20.1 20.3 89.8 49.9 56.1 59.8 109.8 44.9 146.5 96.7 41.6 52.6 42.3 59.8 230.5 66.6 59.7 75.0 95.5 51.7 100.1 82.1 115.4 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659509-99711241 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 14.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 17.5;Urothelial cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 65000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 1.8 3.8 0.5 4.2 0.4 7.1 2.2 1.7 0.7 3.2 3.1 3.7 14.8 2.2 2.2 4.5 1.8 4.5 1.2 0.6 1.9 2.7 6.3 1.9 2.2 0.3 0.4 0.2 1.0 6.9 3.0 1.7 6.6 0.5 2.7 3.8 2.7 3.0 2.3 0.5 3.0 14.7 2.7 0.4 2.1 4.0 1.4 0.3 1.7 2.2 0.4 2.7 10.3 2.6 0.5 5.4 5.9 8.0 14.4 4.0 3.6 8.4 10.0 19.1 11.4 9.2 11.1 5.2 4.8 5.4 14.0 3.6 13.6 6.0 4.0 9.6 2.3 5.6 4.0 4.4 11.2 5.8 13.4 7.8 3.5 6.7 14.1 15.3 14.1 11.8 5.1 6.1 4.7 4.8 4.6 2.6 3.9 4.7 6.0 2.4 0.3 6.2 2.4 15.8 16.7 3.4 6.9 6.7 2.7 9.5 5.4 7.1 5.9 8.5 11.0 6.2 7.0 8.4 4.7 7.3 4.1 11.0 4.4 2.7 0.3 0.6 0.9 0.6 0.7 0.5 0.2 0.3 0.5 1.3 0.1 0.4 0.3 0.5 0.8 0.4 2.3 0.2 0.3 0.5 0.4 1.7 0.7 0.6 1.9 0.3 0.4 0.2 0.5 0.4 0.3 0.5 1.2 0.0 0.0 2.9 1.3 8.2 17.5 4.6 10.8 0.7 2.0 1.1 0.8 1.5 2.2 5.5 2.1 6.3 3.2 3.7 0.0 2.3 1.5 6.0 2.8 1.7 5.4 1.3 9.5 5.0 5.3 2.4 9.2 5.3 0.0 0.7 0.7 4.7 1.9 0.0 7.9 4.2 0.0 0.6 2.7 2.7 0.9 2.6 0.0 6.5 4.9 0.4 0.0 10.1 3.2 4.5 3.1 0.7 7.6 2.6 11.4 1.3 3.6 1.9 0.0 1.1 1.7 1.2 0.8 6.9 7.4 5.1 1.2 3.9 2.4 23.6 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121097161 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 52.0;lymphoid tissue: 19.0" "Cell type enhanced" "Detected in some" "Hofbauer cells: 86.5;Kupffer cells: 51.5;Late spermatids: 14.6;Macrophages: 36.6;monocytes: 16.4;Sertoli cells: 19.7" "Cancer enriched" "Detected in single" 4 "glioma: 1.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 31.2;neutrophil: 36.3" "Group enriched" "Detected in many" 4 "granulocytes: 36.3;monocytes: 31.2" "Group enriched" "Detected in some" 6 "NB-4: 19.8;THP-1: 73.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 5.0 3.0 5.3 19.0 5.5 6.6 1.8 5.4 7.9 1.0 4.7 0.7 0.5 0.7 52.0 0.7 0.8 1.9 0.9 5.5 6.9 1.0 1.7 6.9 2.2 6.9 6.2 4.9 0.6 2.7 0.7 1.0 11.1 6.9 0.8 0.8 0.8 0.9 0.7 0.4 0.2 0.7 5.8 6.9 7.3 0.9 0.7 6.5 0.4 2.1 0.1 0.3 4.1 0.4 7.6 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 19.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.3 1.0 73.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.2 0.6 0.0 19.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 36.3 0.0 12.4 0.3 0.0 8.8 5.3 5.5 5.4 7.9 5.5 6.9 6.9 6.2 4.9 6.9 6.9 6.5 7.6 0.4 0.0 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.6 2.2 0.0 0.6 0.0 2.1 0.8 0.1 0.1 0.0 0.0 7.7 0.2 0.2 2.0 0.0 0.8 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.4 0.4 0.3 86.5 3.3 0.1 0.0 0.0 51.5 4.1 14.6 1.2 36.6 0.0 11.2 16.4 0.1 1.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 19.7 0.6 0.1 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.1 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.2 0.1 0.3 0.1 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF335 "bA465L10.2, NIF-1" ENSG00000198026 "Zinc finger protein 335" Q9H4Z2 20 45948660-45972203 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063999, HPA071230" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063999: AB_2685170, HPA071230: AB_2686369" "unprognostic (1.50e-1)" "unprognostic (8.05e-2)" "unprognostic (8.29e-3)" "unprognostic (7.85e-2)" "unprognostic (1.35e-2)" "prognostic favorable (4.48e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.74e-2)" "unprognostic (1.01e-1)" "unprognostic (7.91e-2)" "unprognostic (1.30e-3)" "prognostic unfavorable (7.04e-4)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.44e-1)" "unprognostic (2.88e-3)" 12.1 12.2 7.3 11.7 7.3 29.8 13.3 10.2 10.1 14.4 4.5 13.1 10.3 14.0 4.2 14.4 14.2 6.6 9.2 7.8 5.4 11.7 12.2 13.2 14.6 6.3 5.6 7.3 18.1 15.4 8.4 17.5 6.5 7.3 16.3 5.7 4.9 13.1 7.5 14.7 20.9 17.8 6.7 4.3 22.3 14.5 13.9 5.8 13.5 17.9 7.8 10.3 12.6 12.8 7.7 12.6 12.6 11.0 11.9 5.7 7.2 23.2 11.0 7.6 10.7 7.7 27.3 13.8 15.0 16.0 10.9 9.8 17.7 10.7 16.6 4.9 10.3 14.6 12.6 20.0 14.6 8.8 16.4 20.5 11.6 13.8 14.1 10.0 7.7 9.3 15.5 12.0 19.6 7.5 25.7 19.4 15.8 7.5 8.4 20.4 15.8 7.3 12.7 9.5 19.5 11.0 9.7 16.4 22.7 11.6 6.5 17.2 13.4 9.8 23.0 10.0 14.8 15.2 22.7 12.6 15.4 18.6 10.0 12.9 1.2 1.7 2.4 3.3 2.2 1.6 1.4 1.6 2.2 1.7 1.5 1.3 1.5 1.7 4.2 1.8 1.2 1.8 2.0 7.3 7.3 10.2 10.1 7.8 5.4 6.3 5.6 7.3 7.3 4.3 5.8 7.7 16.9 12.8 15.0 16.6 17.3 18.7 12.1 5.3 14.8 19.3 13.7 14.2 3.8 5.7 5.9 1.8 27.1 8.1 21.5 22.7 0.0 4.4 32.1 10.0 12.3 10.9 21.5 5.7 14.8 5.9 8.5 9.5 22.4 15.4 7.0 15.2 7.1 5.1 6.1 13.5 12.4 11.7 6.1 10.0 11.3 24.8 7.5 14.5 8.8 9.4 6.7 6.0 21.6 7.1 12.4 7.9 12.7 5.3 18.5 10.5 14.6 2.7 4.6 11.6 0.0 21.7 10.3 3.8 7.2 12.9 22.4 11.9 23.1 7.8 12.3 12.8 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466355-9498616 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 2.0;testis: 6.2" "Group enriched" "Detected in some" 5 "Early spermatids: 79.2;Late spermatids: 20.1" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 20.5;HMC-1: 4.8;NTERA-2: 19.7;SuSa: 9.2" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA045439: AB_2732520, HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.8 2.5 0.0 1.5 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 1.1 20.5 0.0 0.0 1.4 0.0 4.8 2.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 79.2 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 20.1 0.3 0.2 0.0 0.0 0.0 0.2 0.0 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 9.5 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUBA3C "bA408E5.3, TUBA2" ENSG00000198033 "Tubulin alpha 3c" P0DPH7 13 19173772-19181824 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 714 "testis: 408.0" "Group enriched" "Detected in some" 25 "Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9" "Cancer enhanced" "Detected in many" "liver cancer: 2.7;testis cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA Yes Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.76e-3)" "unprognostic (1.33e-1)" "unprognostic (3.00e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-1)" 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 408.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 107.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.4 256.9 0.2 0.3 84.2 109.7 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 703.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 250.4 21.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.6 947.8 255.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 RPS4X "CCG2, DXS306, FLJ40595, RPS4, S4, SCAR, SCR10" ENSG00000198034 "Ribosomal protein S4 X-linked" P62701 X 72255679-72277248 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 16435.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000857 Supported NA NA 980000 "HPA000857: AB_1079849" "unprognostic (1.09e-2)" "unprognostic (4.15e-2)" "unprognostic (2.20e-1)" "unprognostic (7.53e-3)" "unprognostic (7.05e-3)" "unprognostic (1.32e-2)" "unprognostic (5.86e-3)" "unprognostic (1.96e-2)" "unprognostic (9.65e-2)" "unprognostic (7.49e-2)" "unprognostic (4.19e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.50e-6)" "unprognostic (1.03e-2)" "unprognostic (9.78e-3)" "prognostic favorable (4.22e-4)" "unprognostic (6.87e-2)" 856.3 553.9 357.0 434.2 363.9 1267.4 1435.2 349.8 564.0 1352.5 381.4 795.2 604.8 976.3 1447.3 920.2 1175.6 414.0 534.4 345.0 385.7 669.2 564.0 581.4 1110.5 364.3 369.0 336.3 2141.1 1679.3 427.0 826.7 441.0 368.8 765.6 660.8 267.9 848.9 566.4 859.5 1395.1 695.6 719.7 380.0 734.0 770.2 140.8 367.9 1174.1 780.3 439.4 1058.3 839.8 1188.3 371.2 824.3 739.2 978.8 721.5 1348.9 2149.0 712.1 558.1 1459.1 1258.7 996.5 1211.2 569.5 2612.6 1327.0 527.8 931.7 464.3 958.1 1188.4 1312.8 543.5 2220.1 451.1 868.8 902.3 1721.6 1110.2 1087.7 2272.6 1372.4 541.6 1732.2 1232.7 1089.7 840.1 744.8 1579.2 1236.8 1205.1 1334.9 1776.2 969.4 2272.0 857.4 801.1 1371.1 2103.2 827.3 1083.2 911.3 1105.5 920.3 2068.4 1790.3 583.4 413.6 1715.2 586.9 296.5 830.9 619.4 542.5 594.3 598.6 815.8 516.1 2034.5 625.5 307.3 853.9 161.2 1093.0 761.1 1737.7 2010.7 1780.2 1421.2 1240.9 1781.6 2191.8 1787.8 76.4 1291.3 725.8 1413.6 1556.5 3744.0 357.0 363.9 349.8 564.0 345.0 385.7 364.3 369.0 336.3 368.8 380.0 367.9 371.2 2558.8 541.7 1356.5 33.0 4448.1 7308.4 7295.0 5549.2 4584.9 274.3 11267.1 16435.1 373.2 2240.4 2347.4 958.2 64.6 4734.2 3564.6 1259.3 5636.8 2116.8 40.7 1732.9 3743.4 2920.8 2538.3 2604.8 30.8 6446.6 7517.1 2559.8 1270.6 1992.9 1314.0 3898.1 2557.6 2057.1 3296.7 67.3 32.6 4050.7 1755.7 2881.5 4938.2 172.0 3729.8 2563.0 3656.9 35.6 3293.0 890.5 2435.7 18.1 46.7 3064.4 3542.1 2188.7 3329.3 5760.5 3103.2 4152.2 995.8 383.9 1216.2 3044.3 3471.7 48.8 229.8 5478.7 9764.3 5159.5 3869.0 4946.8 5023.8 7162.0 ZNF273 HZF9 ENSG00000198039 "Zinc finger protein 273" Q14593 7 64870172-64930966 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 44.0;Inhibitory neurons: 51.2;Respiratory ciliated cells: 82.0" "Cancer enhanced" "Detected in many" "testis cancer: 4.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA077549 Approved Nucleoplasm NA NA Nucleoplasm "HPA077549: AB_2732352" "unprognostic (7.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.80e-2)" "unprognostic (5.87e-4)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-2)" "unprognostic (1.65e-2)" "unprognostic (2.02e-5)" "unprognostic (2.54e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (1.04e-2)" "unprognostic (3.14e-1)" "unprognostic (9.48e-2)" "unprognostic (1.85e-2)" 0.3 0.1 0.2 0.2 0.2 2.4 1.2 1.1 0.7 0.8 0.1 0.2 0.3 0.6 0.1 0.5 0.8 0.1 0.1 0.2 0.2 0.2 0.1 0.4 1.1 0.5 0.3 0.2 0.9 0.3 0.2 0.0 0.5 0.4 0.4 0.4 0.4 0.4 0.3 0.3 3.4 0.1 0.2 0.3 0.4 0.2 2.1 0.2 1.2 1.6 0.4 1.0 0.4 0.6 0.3 1.8 1.3 2.8 4.1 0.4 0.9 2.3 0.8 0.5 1.2 2.2 2.0 1.6 4.7 2.4 0.4 2.2 0.6 5.6 1.1 1.0 2.3 2.1 2.5 0.6 0.7 0.2 2.4 1.7 0.7 0.7 2.0 1.8 0.8 1.1 6.9 6.7 1.8 1.4 1.6 5.3 2.7 5.7 1.0 2.0 5.5 4.2 2.8 0.6 1.1 2.6 2.7 2.2 1.1 1.3 5.4 2.1 3.5 0.5 1.4 1.5 1.0 1.7 1.7 2.4 6.8 0.3 2.4 1.0 2.0 0.2 1.2 0.3 0.3 0.6 1.2 0.7 0.5 0.6 1.0 0.5 0.9 0.4 0.2 0.2 0.6 0.8 0.3 0.2 0.2 1.1 0.7 0.2 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.3 8.2 3.2 2.3 22.5 12.9 25.0 6.2 8.8 6.8 5.5 7.6 4.7 4.3 1.5 11.1 1.8 0.0 6.8 4.9 0.5 7.9 3.4 25.0 27.1 4.7 7.1 0.0 30.7 44.0 2.9 13.1 7.8 3.6 4.4 3.8 13.4 6.4 1.1 3.6 5.0 51.2 2.0 8.2 3.1 3.5 13.5 6.2 4.1 5.4 15.0 3.9 3.6 7.2 20.1 11.6 2.6 6.1 3.4 2.8 3.6 0.6 1.6 82.0 3.2 0.0 4.8 4.4 21.6 11.4 9.7 18.9 2.9 7.2 5.2 3.5 3.1 ZNF84 HPF2 ENSG00000198040 "Zinc finger protein 84" P51523 12 133037292-133063304 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028860 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028860: AB_10604102" "unprognostic (2.39e-1)" "unprognostic (5.11e-3)" "unprognostic (3.09e-2)" "unprognostic (8.66e-2)" "unprognostic (8.16e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (5.96e-3)" "unprognostic (9.73e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-3)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (7.30e-3)" 10.6 11.2 17.2 9.0 18.2 9.4 16.8 20.1 30.5 15.5 17.3 12.4 7.6 18.2 23.2 8.7 15.9 11.4 11.2 16.5 16.4 13.7 13.2 10.6 13.8 15.6 16.6 16.0 21.0 12.8 13.6 23.3 11.7 16.5 17.2 12.1 24.9 11.9 12.4 10.4 12.4 11.7 13.4 15.9 13.7 11.4 14.1 16.0 15.0 18.4 11.8 14.5 13.6 12.3 24.3 18.4 14.3 38.0 25.0 16.1 25.3 33.1 16.5 14.2 12.0 11.5 8.7 5.5 22.0 14.4 14.3 14.6 8.2 15.4 13.4 18.7 6.2 26.0 32.8 18.2 12.4 19.8 35.8 14.0 17.9 16.1 18.3 19.7 38.9 18.9 15.4 16.8 10.8 30.8 10.8 24.8 33.6 51.5 6.9 11.7 34.4 17.7 15.2 16.8 39.5 31.7 34.5 31.8 9.6 13.9 21.3 31.5 21.0 23.2 13.6 15.2 12.8 11.7 5.2 0.0 50.2 7.9 27.8 17.8 1.5 3.5 4.4 8.1 5.2 12.2 9.5 9.0 10.4 5.9 7.9 11.9 9.8 0.8 10.1 3.8 7.4 5.4 5.0 17.2 18.2 20.1 30.5 16.5 16.4 15.6 16.6 16.0 16.5 15.9 16.0 24.3 16.6 9.6 9.6 27.4 21.8 3.1 13.4 2.7 17.6 18.6 14.0 14.4 24.1 10.0 8.1 16.5 6.2 10.3 11.7 3.2 3.9 13.4 14.9 15.5 15.4 16.1 9.6 20.8 33.7 7.1 5.6 16.3 7.1 9.6 13.9 23.2 15.7 8.6 10.5 20.2 36.2 9.6 0.0 7.3 2.4 15.2 13.4 8.6 1.8 14.0 5.1 14.6 17.5 45.2 47.5 9.7 9.1 15.1 9.1 12.9 5.4 11.2 17.6 17.3 13.1 16.9 14.3 13.1 24.2 11.5 2.7 6.4 14.2 12.0 7.5 9.3 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33485182-33501262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 10.0 6.3 5.2 9.4 5.5 9.3 9.0 5.6 5.7 6.6 4.8 5.8 5.4 7.2 5.1 8.1 6.0 6.5 7.0 5.1 6.3 6.8 9.1 5.7 11.2 5.7 6.0 4.9 7.5 9.4 5.9 4.5 7.9 6.3 6.1 6.5 4.0 5.7 5.7 8.5 7.5 5.1 7.8 5.8 6.6 5.4 5.6 5.9 8.8 8.6 8.0 10.9 12.3 5.1 6.5 14.1 19.3 13.2 30.6 15.2 18.1 19.9 25.0 16.2 26.4 24.6 28.5 12.0 49.7 23.8 22.1 22.5 18.3 45.6 27.8 35.0 10.8 12.3 46.9 13.2 25.6 22.9 19.3 27.4 19.1 24.8 34.8 40.4 9.4 19.6 33.5 59.5 27.5 22.0 16.1 68.9 22.4 71.4 34.4 13.2 23.9 20.1 22.2 22.2 23.7 33.6 26.7 15.5 21.1 30.4 16.2 14.7 19.5 17.8 24.9 19.3 32.6 28.9 13.8 16.4 50.4 15.3 39.7 27.0 0.0 2.4 0.6 3.2 5.0 3.6 2.0 3.2 2.8 2.9 2.5 4.0 4.3 0.4 4.4 7.9 3.0 2.6 2.3 5.2 5.5 5.6 5.7 5.1 6.3 5.7 6.0 4.9 6.3 5.8 5.9 6.5 12.8 16.0 9.7 3.6 12.8 15.6 15.2 5.6 13.1 5.1 7.9 9.0 12.9 10.0 11.3 9.2 2.1 11.5 7.8 3.9 7.9 10.6 1.8 9.8 19.8 12.7 1.8 15.8 5.8 7.8 15.8 15.8 8.2 10.5 9.5 10.8 5.3 7.3 8.7 10.1 6.0 6.7 6.1 5.3 4.7 1.3 9.0 7.8 1.8 2.8 7.7 2.9 10.3 7.1 4.7 11.5 5.0 7.5 12.1 15.3 4.1 10.2 10.5 5.1 6.6 17.6 14.4 13.8 19.2 12.7 14.9 7.5 9.9 13.8 7.4 12.3 ZNF667 FLJ14011 ENSG00000198046 "Zinc finger protein 667" Q5HYK9 19 56439325-56478065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 24.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.6;Excitatory neurons: 29.2;Horizontal cells: 32.0;Rod photoreceptor cells: 29.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.0;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.3;hTERT-RPE1: 17.5;U-138 MG: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030731, HPA046673" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030731: AB_2673584, HPA046673: AB_2679746" "unprognostic (6.10e-2)" "unprognostic (7.87e-3)" "unprognostic (2.91e-2)" "unprognostic (4.81e-2)" "unprognostic (6.38e-2)" "unprognostic (2.26e-3)" "unprognostic (8.55e-2)" "unprognostic (5.37e-2)" "unprognostic (1.05e-1)" "unprognostic (5.67e-2)" "unprognostic (3.77e-4)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (8.34e-3)" "unprognostic (3.54e-2)" "unprognostic (7.62e-2)" "unprognostic (1.55e-2)" 1.9 5.5 10.7 1.2 12.6 5.2 4.9 6.3 11.2 4.3 4.4 2.6 1.1 4.6 8.0 1.6 4.9 3.1 3.3 13.9 9.6 3.3 1.1 1.4 1.9 8.1 6.8 11.6 7.6 2.5 5.3 24.4 2.2 7.5 4.7 0.5 9.5 3.2 3.0 1.6 2.0 1.3 3.8 4.8 1.9 1.6 4.4 8.9 2.6 9.0 1.7 1.3 3.9 2.8 10.3 0.1 0.2 10.4 0.1 0.0 0.0 0.2 4.6 3.4 3.9 3.1 0.2 0.1 0.6 6.0 1.6 6.0 0.1 0.0 0.1 6.0 0.0 2.3 12.3 0.1 0.2 3.0 7.3 5.4 6.6 0.1 0.8 0.0 17.5 0.0 0.4 0.1 0.2 3.1 0.2 0.1 0.2 7.6 0.1 2.0 0.1 3.9 8.6 3.9 0.6 0.3 5.9 0.2 0.1 0.0 9.2 2.8 0.0 0.0 14.7 4.0 0.2 7.9 0.2 6.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.2 0.2 0.2 3.0 0.8 1.9 0.2 2.7 0.0 1.1 0.1 0.4 10.7 12.6 6.3 11.2 13.9 9.6 8.1 6.8 11.6 7.5 4.8 8.9 10.3 4.3 0.0 0.0 10.4 2.9 3.3 6.8 0.5 6.2 30.6 6.0 9.4 6.4 1.5 2.9 5.5 25.0 0.3 1.8 0.1 0.0 3.6 3.0 10.3 8.9 4.0 1.2 3.0 29.2 0.2 0.0 7.4 0.0 5.6 9.5 18.1 2.9 0.2 0.2 32.0 24.4 0.1 0.0 0.0 1.2 2.5 5.3 0.8 3.6 6.5 0.1 8.4 1.0 22.6 23.9 0.4 0.1 7.2 0.5 8.1 0.0 1.4 3.7 29.2 0.0 11.7 5.0 13.6 14.0 1.0 4.1 0.1 1.1 16.7 0.3 2.6 AVPR1B AVPR3 ENSG00000198049 "Arginine vasopressin receptor 1B" P47901 1 206106936-206117699 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "pituitary gland: 6.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA075404 Enhanced NA NA "HPA075404: AB_2732291" "unprognostic (4.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.82e-1)" "unprognostic (2.82e-1)" "unprognostic (2.87e-1)" "unprognostic (1.08e-2)" "unprognostic (3.33e-1)" "unprognostic (2.96e-2)" "unprognostic (6.23e-2)" "unprognostic (7.65e-2)" "unprognostic (1.86e-1)" "unprognostic (6.66e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 6.9 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIRPA "BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2" ENSG00000198053 "Signal regulatory protein alpha" P78324 20 1894167-1940592 "CD markers, Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 158.5" "Cell type enhanced" "Detected in many" "Astrocytes: 138.1;Excitatory neurons: 87.4;Hofbauer cells: 100.8;Macrophages: 82.5;monocytes: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 24.1;eosinophil: 48.7;myeloid DC: 13.9;neutrophil: 50.8" "Group enriched" "Detected in many" 150 "dendritic cells: 13.9;granulocytes: 50.8;monocytes: 24.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 142.7;RPTEC TERT1: 100.3;SK-MEL-30: 120.2" "CAB002776, CAB015122, HPA054437, HPA058511" Enhanced NA NA 130000000 "CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738" "unprognostic (9.78e-2)" "unprognostic (2.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (5.56e-2)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (4.19e-3)" "unprognostic (3.48e-2)" "unprognostic (2.84e-3)" "unprognostic (3.69e-1)" "unprognostic (3.33e-2)" "unprognostic (2.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.55e-2)" "unprognostic (3.55e-2)" "unprognostic (2.24e-2)" 44.3 40.7 144.2 49.6 144.7 44.5 41.5 101.2 158.5 24.3 64.6 15.1 27.3 15.1 20.0 13.2 23.5 27.6 25.8 149.0 107.1 27.2 53.9 42.7 22.7 106.8 128.6 138.4 19.7 12.7 4.9 16.0 26.5 110.9 15.7 15.0 40.1 30.1 15.4 17.5 29.5 22.5 21.8 103.7 28.3 11.9 7.0 134.3 7.1 12.3 9.1 17.1 35.7 22.0 125.9 11.8 25.2 12.5 23.2 29.4 27.5 1.8 60.5 51.1 16.2 4.9 16.2 0.3 0.0 14.3 142.7 43.6 11.6 10.0 70.6 6.7 0.1 7.1 0.0 2.8 9.0 35.4 24.4 28.5 24.9 32.5 13.8 16.6 46.1 50.8 0.2 1.4 15.4 22.0 0.7 0.0 33.9 13.9 0.0 11.2 0.1 22.2 16.1 100.3 0.0 1.7 3.7 8.2 0.0 120.2 4.5 4.0 76.9 76.6 71.1 36.7 46.4 30.5 0.1 0.1 0.2 22.2 77.3 8.2 0.3 24.1 48.7 0.0 6.0 0.0 0.1 0.0 0.0 13.9 0.0 0.0 0.0 50.8 0.0 2.2 0.9 0.1 10.0 144.2 144.7 101.2 158.5 149.0 107.1 106.8 128.6 138.4 110.9 103.7 134.3 125.9 60.6 3.2 6.5 138.1 4.3 14.3 12.8 28.3 6.2 13.2 18.8 27.7 12.7 34.3 10.1 9.2 14.6 20.2 0.6 2.8 1.9 26.8 0.5 1.5 2.2 13.7 9.6 4.4 87.4 2.1 2.1 23.7 1.1 4.8 17.7 1.6 20.3 29.3 100.8 15.2 44.2 3.5 2.0 57.2 54.3 1.2 5.0 82.5 23.2 33.7 85.0 23.7 0.0 40.7 51.1 25.1 9.9 1.9 1.6 9.7 17.7 16.1 5.1 26.8 6.6 3.4 7.8 0.2 8.3 2.8 6.7 36.5 2.1 0.0 2.6 7.7 GRK6 GPRK6 ENSG00000198055 "G protein-coupled receptor kinase 6" P43250 5 177403204-177442901 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 135.3" "Cell type enhanced" "Detected in many" "Late spermatids: 90.6;NK-cells: 123.6;Plasma cells: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015327, HPA018903" Approved Approved Mitochondria NA NA 170000 Mitochondria "HPA015327: AB_1850334, HPA018903: AB_1850335" "unprognostic (1.06e-1)" "unprognostic (3.39e-2)" "unprognostic (4.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.66e-6)" "unprognostic (2.63e-1)" "unprognostic (6.45e-2)" "unprognostic (8.96e-2)" "prognostic favorable (1.22e-4)" "unprognostic (1.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.83e-3)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.47e-1)" 12.8 10.9 10.4 37.0 11.1 135.3 12.8 7.1 16.1 11.1 8.3 18.1 18.7 14.9 2.4 21.7 13.4 12.5 11.6 12.3 9.2 11.0 13.7 22.0 62.1 12.8 10.2 11.1 11.2 13.4 5.6 10.6 6.9 11.3 16.0 8.9 2.3 18.0 7.5 15.9 15.4 29.4 9.3 8.1 63.8 16.0 22.5 9.3 36.2 10.3 6.3 30.5 16.7 13.3 13.1 41.1 44.2 15.7 67.8 4.6 7.4 66.4 29.4 15.1 36.2 35.5 103.0 34.1 48.7 44.0 15.6 53.5 29.1 24.3 67.0 14.3 133.9 77.3 43.5 36.2 36.0 24.1 58.6 52.8 11.7 16.1 36.2 21.4 8.8 20.5 87.8 45.6 170.9 11.2 117.4 61.3 61.4 26.7 20.4 48.1 57.1 25.5 71.2 10.7 32.9 36.0 48.6 24.3 42.5 56.8 7.1 32.6 63.4 26.3 29.6 43.8 31.2 75.1 48.8 64.2 40.7 20.0 95.0 29.2 12.7 20.9 74.5 23.6 36.5 17.0 19.3 19.6 21.9 11.9 19.5 20.3 18.0 50.6 40.3 51.9 12.5 26.4 22.6 10.4 11.1 7.1 16.1 12.3 9.2 12.8 10.2 11.1 11.3 8.1 9.3 13.1 9.2 0.0 2.2 2.6 71.7 23.7 60.3 4.9 5.7 10.5 14.7 17.3 3.0 10.0 4.6 3.7 6.2 13.9 70.8 18.2 15.6 6.0 37.2 7.4 8.2 6.6 11.4 41.7 3.7 8.3 12.6 9.7 16.8 6.4 14.7 13.9 10.0 6.5 20.4 16.8 3.5 14.3 4.1 29.8 18.8 90.6 6.2 41.2 14.2 2.8 26.4 9.0 123.6 2.0 3.3 10.3 14.0 5.3 112.2 61.1 11.8 8.5 2.0 8.6 13.1 8.4 10.7 3.9 4.2 11.9 20.3 12.7 66.5 12.1 17.1 56.6 PRIM1 ENSG00000198056 "DNA primase subunit 1" P49642 12 56731296-56752374 "Predicted intracellular proteins" "DNA replication, Transcription" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 56.4;Spermatocytes: 118.2;Spermatogonia: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040010 Uncertain NA Yes "HPA040010: AB_10805599" "unprognostic (3.04e-3)" "unprognostic (1.67e-2)" "unprognostic (2.12e-2)" "unprognostic (1.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (2.40e-8)" "unprognostic (4.68e-2)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (1.82e-1)" "unprognostic (1.98e-3)" "unprognostic (3.94e-1)" "unprognostic (2.16e-1)" "unprognostic (5.35e-2)" "unprognostic (6.53e-2)" 3.7 3.2 2.1 7.1 2.8 28.4 10.0 5.5 3.0 3.7 1.4 8.0 4.6 5.0 4.3 4.4 5.4 3.0 2.3 2.0 2.1 3.0 7.6 4.9 12.4 2.6 2.5 1.8 9.0 6.1 6.2 2.1 4.9 2.9 3.6 11.3 8.4 3.9 3.9 4.6 7.9 7.8 5.9 2.2 6.9 5.5 14.6 2.4 19.0 5.0 5.7 14.5 3.8 3.1 4.4 43.0 37.9 52.1 29.2 5.1 9.1 57.8 34.7 28.7 62.1 59.8 42.0 54.4 83.0 27.4 15.8 26.0 40.4 60.3 39.9 68.8 40.7 40.4 106.2 22.6 36.8 1.2 129.3 43.2 4.2 7.2 55.8 22.1 8.8 22.6 92.1 105.5 123.8 35.4 33.6 76.8 54.4 53.5 32.0 47.1 85.0 81.4 70.9 15.0 35.4 51.0 46.0 41.4 20.6 19.9 36.2 67.2 52.8 10.9 32.2 70.7 33.1 46.4 45.1 94.5 45.3 19.4 55.4 40.9 2.5 1.9 4.4 9.1 4.0 9.5 11.3 11.2 8.5 3.9 12.2 14.0 10.7 1.0 6.8 7.1 7.5 10.0 5.3 2.1 2.8 5.5 3.0 2.0 2.1 2.6 2.5 1.8 2.9 2.2 2.4 4.4 6.9 6.4 6.8 4.6 10.4 3.8 10.7 10.0 4.6 5.1 7.0 7.2 3.2 2.8 6.1 7.3 6.2 14.9 8.7 2.5 0.0 5.8 6.2 4.1 3.9 6.4 1.2 56.4 5.7 7.2 27.0 5.4 5.6 3.3 3.8 10.0 5.7 4.7 11.8 20.2 10.6 4.6 2.0 8.1 3.1 4.3 7.2 6.5 3.6 2.8 7.9 5.7 8.2 8.0 7.8 2.7 2.2 4.9 9.7 2.2 2.0 2.5 6.0 12.7 13.1 8.2 8.8 118.2 107.2 5.1 4.0 4.5 12.8 3.0 9.4 5.0 MARCHF5 "FLJ20445, MARCH-V, MARCH5, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291167-92353964 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.8;Cardiomyocytes: 28.6;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 44.0;Hofbauer cells: 34.9;Syncytiotrophoblasts: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria NA NA Mitochondria "HPA056596: AB_2683181" "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 13.7 14.1 10.4 7.7 10.5 17.5 15.1 10.2 12.0 11.2 11.3 9.9 11.4 13.4 12.7 19.5 10.2 10.8 12.0 10.5 10.8 15.3 20.3 10.5 9.0 10.2 10.4 10.1 14.2 9.3 12.6 7.1 7.9 9.9 15.3 10.2 8.9 13.9 7.9 18.4 9.7 11.7 10.8 10.6 8.9 10.6 8.9 10.3 12.6 17.3 16.2 9.9 10.8 12.3 10.7 28.0 14.8 28.7 33.1 19.2 19.8 14.8 24.5 26.7 29.8 30.4 10.0 19.6 16.2 16.5 24.1 13.0 22.4 20.3 20.5 42.5 12.3 23.9 13.1 13.6 23.7 23.2 21.1 12.4 20.4 27.0 19.7 40.9 39.6 26.6 17.0 14.5 19.7 24.2 17.7 18.7 24.1 6.7 18.1 22.1 20.0 29.4 9.8 30.8 17.8 13.3 24.5 21.3 15.5 26.7 13.7 27.1 16.1 26.0 13.9 15.3 15.3 34.0 19.9 16.2 14.2 12.7 28.7 9.5 4.2 6.0 7.0 5.1 7.5 5.2 5.2 5.7 5.5 6.9 4.5 5.7 5.5 12.2 5.0 6.7 4.6 5.9 5.0 10.4 10.5 10.2 12.0 10.5 10.8 10.2 10.4 10.1 9.9 10.6 10.3 10.7 23.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 39.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 44.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 65.3 2.8 0.0 0.0 0.0 POTEH "A26C3, ACTBL1, CT104.7, POTE22" ENSG00000198062 "POTE ankyrin domain family member H" Q6S545 22 15690026-15721631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "prostate: 2.2;testis: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.66e-2)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB13 ENSG00000198064 "Nuclear pore complex interacting protein family, member B13" A6NJU9 16 30222937-30254510 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 16.0;Alveolar cells type 2: 10.6;Club cells: 7.4;granulocytes: 12.6;Respiratory ciliated cells: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.11e-3)" "unprognostic (4.08e-2)" "unprognostic (1.83e-1)" "unprognostic (1.89e-3)" "unprognostic (4.87e-2)" "unprognostic (2.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.69e-2)" "unprognostic (3.67e-1)" "unprognostic (1.41e-1)" "unprognostic (3.09e-7)" "unprognostic (1.86e-2)" "unprognostic (2.98e-1)" "unprognostic (3.17e-1)" "unprognostic (2.58e-2)" 3.1 2.2 3.6 2.1 1.4 6.1 3.0 3.5 5.9 3.8 0.0 3.7 1.6 2.2 4.6 2.5 3.8 1.6 3.0 3.2 0.4 3.0 4.2 4.1 3.6 2.4 1.0 0.0 3.9 2.6 1.8 4.2 1.5 7.6 4.1 2.0 3.9 2.8 1.5 3.8 7.2 4.8 0.5 0.0 5.1 2.9 2.9 1.6 1.1 4.1 0.6 2.1 3.3 3.4 2.1 2.2 5.4 1.3 4.4 0.6 1.4 2.6 0.4 0.0 0.2 0.2 0.6 2.9 3.3 2.1 0.8 0.5 2.5 2.4 1.2 0.7 1.9 1.1 3.5 6.3 2.8 0.2 4.4 2.7 2.0 1.7 1.9 1.1 0.6 0.9 1.4 1.5 4.5 1.0 4.5 2.0 4.3 1.8 0.5 1.3 4.1 0.7 1.8 1.2 3.6 1.5 1.6 0.6 1.6 0.8 1.7 1.3 1.1 2.1 2.5 2.6 2.4 1.3 1.8 2.3 4.1 2.4 2.0 1.3 0.0 0.3 0.0 0.6 0.1 0.3 0.0 0.2 0.2 0.1 0.2 0.3 0.1 0.1 0.4 0.4 0.1 0.0 0.1 3.6 1.4 3.5 5.9 3.2 0.4 2.4 1.0 0.0 7.6 0.0 1.6 2.1 0.8 16.0 10.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 7.4 1.8 0.0 0.5 0.8 0.0 0.0 0.6 0.0 0.3 0.4 1.7 0.0 0.0 0.0 1.5 0.1 1.3 0.0 0.7 12.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.3 10.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.5 0.2 0.0 0.0 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527567-134541412 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 226.3;intestine: 620.4;stomach 1: 436.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 104 "A549: 2959.1;Hep G2: 835.6;OE19: 3141.0" "Low region specificity" "Detected in all" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted to digestive system" NA NA 67000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.9 5.5 0.1 8.0 0.1 0.2 0.4 0.3 0.1 35.6 0.0 74.0 620.4 0.5 0.1 226.3 0.9 177.8 0.1 0.1 0.1 11.8 40.3 0.4 0.3 0.0 0.0 0.1 0.2 0.7 0.0 4.8 0.1 0.1 1.3 46.0 0.1 32.7 0.2 3.8 7.6 357.7 3.3 0.0 0.1 436.4 0.6 0.0 5.6 0.6 5.9 7.8 66.3 146.8 0.1 0.0 2959.1 0.0 0.0 0.7 2.3 9.0 0.3 1.1 0.2 0.0 5.9 0.9 0.0 1.1 1.6 4.6 6.2 0.0 4.0 0.2 0.1 0.0 0.0 1.9 835.6 0.7 0.0 0.6 0.1 13.8 0.7 0.0 4.0 0.5 0.0 0.0 0.0 0.6 5.4 0.1 1.3 0.5 3141.0 2.3 0.3 0.0 2.7 1.5 2.7 1.0 1.5 1.8 1.3 0.1 0.1 0.0 0.1 1.9 1.2 1.2 0.2 1.0 0.4 0.1 0.0 22.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 2.8 2.1 52.1 3.4 0.0 0.1 0.0 0.7 193.0 13.5 0.0 0.0 0.3 0.0 201.0 0.0 31.5 0.7 2.9 0.1 0.2 3.5 2.7 0.0 27.5 0.1 4.4 542.3 1.0 0.0 0.0 2.2 62.9 0.0 0.0 0.1 29.5 4.1 0.6 0.3 0.7 3.4 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 66.9 42.5 1.9 1.7 1.0 327.1 3.8 4.8 0.0 0.0 3.7 1.5 0.0 0.1 96.0 10.4 0.3 0.5 0.0 73.0 11.4 SULT1C4 "SULT1C, SULT1C2" ENSG00000198075 "Sulfotransferase family 1C member 4" O75897 2 108377911-108388989 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6" "Group enriched" "Detected in many" 6 "glioma: 7.1;renal cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6" "Low region specificity" "Detected in many" HPA034530 Approved Cytosol NA NA Cytosol "HPA034530: AB_10670170" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-1)" "unprognostic (2.89e-1)" "unprognostic (5.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-2)" "unprognostic (5.77e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-3)" "prognostic favorable (9.99e-7)" "unprognostic (1.79e-2)" "unprognostic (2.96e-2)" "unprognostic (1.85e-2)" "unprognostic (1.38e-1)" 6.3 2.1 15.9 1.1 15.1 0.5 5.2 17.2 17.4 22.1 12.5 2.8 1.5 11.2 8.0 2.4 9.4 27.4 11.0 13.0 22.9 18.3 3.7 10.4 1.8 17.9 23.8 10.8 28.2 2.9 1.0 5.3 13.1 19.0 6.6 2.2 8.7 1.6 8.9 3.1 0.7 3.2 5.5 16.9 1.4 2.0 1.4 19.1 5.1 4.6 6.3 1.3 3.9 5.4 15.5 0.0 0.1 9.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 1.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.0 0.0 0.0 0.0 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.9 15.1 17.2 17.4 13.0 22.9 17.9 23.8 10.8 19.0 16.9 19.1 15.5 13.3 0.0 0.5 10.4 0.0 0.3 0.7 0.0 0.0 2.0 0.4 0.3 0.7 37.1 0.0 9.2 0.0 0.3 0.0 0.0 0.0 0.3 5.9 10.9 3.1 13.2 0.0 2.7 0.6 0.2 0.1 4.9 0.0 3.8 0.0 15.3 17.9 0.0 0.9 1.7 0.5 0.0 0.0 1.3 1.0 1.1 1.5 0.4 0.0 7.5 0.1 12.3 0.0 17.6 0.4 0.1 0.0 4.5 1.4 0.7 0.0 7.7 0.0 1.0 0.0 1.4 1.8 0.6 0.7 0.0 0.4 0.3 0.2 7.2 0.0 0.2 CYP2A7 CYP2A ENSG00000198077 "Cytochrome P450 family 2 subfamily A member 7" P20853 19 40875439-40882752 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 101 "liver: 153.7" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 195.3" "Group enriched" "Detected in some" 238 "breast cancer: 9.2;liver cancer: 25.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033510, HPA046713, HPA047262" Enhanced "Intracellular and membrane" NA NA "CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (2.65e-3)" "unprognostic (8.89e-2)" "unprognostic (1.39e-2)" "unprognostic (3.95e-1)" "unprognostic (9.21e-2)" "unprognostic (8.71e-2)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.0 0.6 1.5 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 153.7 0.1 0.0 0.4 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 24.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.2 11.0 195.3 0.0 0.0 0.1 0.8 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.9 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 10.4 8.7 9.9 14.9 11.1 9.7 12.6 12.3 11.4 9.6 8.4 10.5 8.8 10.0 16.6 12.5 10.7 12.1 8.6 9.4 10.0 11.3 13.5 11.2 24.9 10.4 11.3 8.6 15.7 14.5 12.1 4.8 9.2 10.9 9.9 10.1 7.3 12.3 12.2 8.6 14.1 9.4 8.8 11.2 16.4 12.0 6.0 10.3 22.0 15.7 8.4 22.0 9.6 5.2 12.4 9.0 11.8 15.1 11.2 11.0 14.5 10.0 8.8 13.0 12.0 10.5 11.3 11.5 31.2 7.6 10.7 13.9 8.2 11.2 13.2 12.2 6.0 6.0 12.4 11.1 10.5 7.8 15.8 14.4 11.6 10.9 8.5 7.9 13.0 19.2 22.3 8.1 10.1 12.4 9.9 23.8 10.5 13.4 11.1 6.0 14.0 9.7 9.2 10.0 10.8 13.3 13.0 13.4 8.8 14.3 15.0 10.5 17.9 10.7 15.6 12.8 12.2 13.3 6.4 6.9 19.9 16.4 13.3 14.0 9.8 5.5 14.1 8.7 7.8 8.6 7.5 11.0 10.0 8.2 10.4 11.6 11.1 1.2 7.6 7.5 6.1 7.6 7.3 9.9 11.1 12.3 11.4 9.4 10.0 10.4 11.3 8.6 10.9 11.2 10.3 12.4 8.8 6.4 6.7 5.9 8.5 2.4 1.6 2.9 5.2 7.4 5.6 4.3 3.6 1.5 2.2 5.5 0.0 5.3 6.3 5.5 5.9 4.9 0.8 4.3 5.5 7.4 1.2 9.1 2.9 3.3 5.5 4.6 0.5 3.7 15.9 6.0 11.7 6.9 7.1 5.0 3.1 5.1 8.2 7.5 4.5 2.8 5.9 6.3 1.8 1.0 7.8 10.8 6.2 2.5 6.6 3.5 4.0 5.7 2.2 2.4 5.7 5.5 2.5 5.9 0.0 6.0 5.7 1.0 9.3 4.2 3.0 2.2 8.8 5.1 5.2 1.5 KRTAP9-9 "KAP9.5, KAP9.9, KRTAP9-5" ENSG00000198083 "Keratin associated protein 9-9" Q9BYP9 17 41255384-41256364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 153 "skin 1: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD2AP CMS ENSG00000198087 "CD2 associated protein" Q9Y5K6 6 47477789-47627263 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 204.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003267, HPA003326, CAB004352" Enhanced Supported "Plasma membrane,Centriolar satellite" NA NA 58000 "Plasma membrane" "Centriolar satellite" "CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457" "unprognostic (5.98e-2)" "unprognostic (1.08e-2)" "unprognostic (1.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.31e-1)" "unprognostic (1.77e-2)" "unprognostic (1.74e-3)" "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (2.21e-1)" "unprognostic (3.09e-3)" "unprognostic (6.12e-3)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "prognostic favorable (7.57e-5)" 14.1 10.6 3.6 15.2 4.1 14.4 18.0 6.7 4.7 18.2 8.6 40.3 57.4 12.1 13.3 19.4 14.3 15.1 7.8 3.1 5.7 34.4 20.4 17.3 16.1 4.6 4.2 2.6 6.5 20.4 35.9 6.0 21.8 5.0 19.9 37.3 7.0 17.1 13.7 6.9 18.1 60.0 11.0 4.4 13.9 40.7 9.5 4.8 34.3 18.3 10.4 17.6 30.4 10.2 4.9 58.0 22.5 6.9 14.3 9.4 13.6 54.8 13.9 16.9 18.5 23.3 37.3 39.9 74.5 56.9 18.2 24.0 21.2 23.0 34.7 29.9 29.9 37.2 41.3 18.4 33.6 12.5 23.3 15.4 9.7 32.1 17.7 25.5 35.7 30.1 24.4 73.5 23.2 16.9 18.2 44.6 8.7 20.3 69.6 8.1 23.6 17.6 34.1 115.6 101.7 20.9 8.1 27.9 36.9 27.7 31.1 35.0 14.8 36.2 36.9 30.8 12.0 39.9 17.5 31.3 52.6 39.4 12.4 19.2 1.8 0.5 3.2 1.2 0.4 1.8 0.9 1.0 1.1 1.2 1.0 0.9 1.5 0.1 3.1 0.4 9.9 0.9 0.5 3.6 4.1 6.7 4.7 3.1 5.7 4.6 4.2 2.6 5.0 4.4 4.8 4.9 81.7 96.1 67.1 32.0 40.5 32.2 52.1 26.5 39.9 10.0 40.4 26.4 17.2 35.8 68.9 71.7 16.7 53.0 96.1 204.1 21.5 84.6 10.4 97.9 25.0 56.6 55.8 42.9 40.7 98.0 17.1 20.6 101.4 136.7 24.1 28.5 37.5 24.2 17.4 15.2 45.3 97.3 40.7 26.2 12.6 10.5 16.8 30.6 14.2 83.4 18.0 12.5 22.6 28.6 30.8 151.3 114.0 10.9 27.7 89.0 182.3 67.4 60.0 13.0 26.3 34.9 27.8 38.9 27.2 44.2 41.1 40.9 29.4 48.0 68.8 143.6 NUP62CL FLJ20130 ENSG00000198088 "Nucleoporin 62 C-terminal like" Q9H1M0 X 107123427-107206433 "Metabolic proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 17.4;fallopian tube: 17.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 21.5;Endometrial ciliated cells: 26.6;Respiratory ciliated cells: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 21.9;CAPAN-2: 23.5;HeLa: 30.7;K-562: 23.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001884 Approved NA NA "HPA001884: AB_1079512" "unprognostic (1.62e-2)" "prognostic favorable (5.66e-5)" "unprognostic (8.80e-2)" "unprognostic (4.23e-2)" "unprognostic (1.44e-1)" "unprognostic (8.19e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-2)" "unprognostic (6.47e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.82e-3)" "unprognostic (4.52e-3)" 0.1 14.0 3.0 1.6 1.0 2.2 3.2 1.3 0.6 1.3 6.4 2.7 3.0 1.8 17.4 1.3 17.4 1.5 1.8 0.6 2.0 6.0 1.9 1.6 1.3 3.0 2.3 0.2 1.4 4.3 4.2 2.6 0.4 2.0 0.9 3.3 1.0 2.1 2.9 0.1 1.5 3.0 0.3 3.2 0.2 1.8 12.1 1.2 2.1 10.1 0.5 2.3 0.9 0.9 1.3 13.5 21.9 1.9 0.0 0.0 0.1 9.4 0.0 0.8 0.5 0.5 2.1 23.5 7.7 2.5 0.0 11.9 11.9 13.9 4.8 0.1 0.0 17.8 0.8 30.7 3.9 0.0 0.0 0.0 0.2 6.3 0.1 3.3 0.0 0.0 11.8 23.0 1.9 0.0 6.6 3.0 0.0 2.8 19.1 7.9 0.0 0.0 0.7 7.1 3.6 5.5 6.4 7.8 2.4 0.0 7.8 0.0 0.4 0.0 0.0 7.0 0.1 0.0 2.5 9.4 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.2 2.0 0.9 0.0 0.0 1.0 0.4 0.5 0.0 0.7 0.2 0.0 0.4 0.2 3.0 1.0 1.3 0.6 0.6 2.0 3.0 2.3 0.2 2.0 3.2 1.2 1.3 0.3 3.2 0.0 0.3 1.7 1.9 3.9 6.3 1.8 0.5 2.8 1.7 1.0 2.8 3.5 9.2 0.0 2.0 0.8 1.7 21.5 2.1 8.8 26.6 0.3 0.4 0.0 3.8 0.4 3.4 1.0 0.2 1.5 4.2 0.0 1.7 0.0 2.2 0.9 1.7 0.5 3.5 6.1 0.0 1.1 3.3 0.3 0.3 5.4 2.8 0.2 1.2 0.0 0.0 0.3 1.4 0.7 0.7 2.4 1.1 1.1 5.7 21.6 0.2 6.6 0.4 0.9 9.6 9.7 1.6 2.8 1.0 1.1 0.0 2.4 2.6 SFI1 "KIAA0542, PISD, PPP1R139" ENSG00000198089 "SFI1 centrin binding protein" A8K8P3 22 31488688-31618588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 119.5;Rod photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.82e-3)" "unprognostic (3.51e-2)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "prognostic favorable (5.80e-4)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (2.11e-2)" "prognostic favorable (1.31e-4)" 3.3 6.2 2.4 7.9 1.7 13.1 4.8 9.7 4.7 4.9 1.0 5.6 8.7 4.1 4.1 4.1 5.5 3.4 2.3 1.7 2.5 5.1 2.9 4.6 12.3 1.7 1.7 1.6 5.3 5.0 4.0 10.1 2.7 4.6 5.6 2.7 8.6 5.3 3.3 1.4 5.7 9.5 2.2 0.3 9.5 5.6 10.1 2.1 10.7 6.4 0.7 6.6 4.8 4.5 2.7 11.3 7.0 6.4 7.9 3.5 3.3 4.0 8.9 3.7 6.1 7.5 6.4 7.7 17.3 3.4 2.8 3.9 10.4 3.2 5.6 4.2 14.2 10.1 4.2 16.9 7.8 4.6 16.9 13.5 2.5 3.7 6.9 4.5 5.1 5.5 16.0 5.4 8.4 5.1 17.0 11.8 10.3 2.4 8.1 4.2 12.8 7.5 12.5 3.7 11.8 9.6 5.4 7.6 10.8 7.4 2.4 8.1 7.2 10.4 8.6 7.8 7.5 6.4 9.9 7.8 9.2 8.6 8.8 6.9 8.5 1.2 3.1 9.1 1.3 4.1 4.1 7.3 10.6 1.4 3.5 9.9 8.9 5.5 9.3 5.0 1.7 5.9 5.5 2.4 1.7 9.7 4.7 1.7 2.5 1.7 1.7 1.6 4.6 0.3 2.1 2.7 7.2 6.4 26.2 17.6 17.6 4.0 7.9 6.8 5.7 45.7 9.7 8.0 2.7 8.6 17.3 16.5 35.5 8.8 21.8 21.7 1.9 7.3 14.2 16.1 5.7 8.9 11.4 17.9 30.5 5.1 2.3 5.6 17.9 18.0 20.3 15.5 7.1 2.9 4.9 119.5 30.9 25.0 6.1 9.1 8.2 5.1 5.3 9.4 3.6 19.7 8.6 7.1 34.0 10.6 17.1 7.6 15.5 1.9 19.1 7.0 34.6 3.2 31.3 68.7 0.0 9.6 5.7 28.9 27.6 2.7 3.3 18.9 35.2 2.6 10.0 6.3 KRTAP4-6 "KAP4.15, KAP4.6, KRTAP4-15" ENSG00000198090 "Keratin associated protein 4-6" Q9BYQ5 17 41139433-41140487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 211 "skin 1: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 15000000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS11F "FLJ16046, HATL4" ENSG00000198092 "Transmembrane serine protease 11F" Q6ZWK6 4 68053198-68129869 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "esophagus: 15.3;lymphoid tissue: 4.1;skin 1: 9.3;vagina: 4.8" "Cell type enriched" "Detected in some" 4 "Squamous epithelial cells: 6.9" "Group enriched" "Detected in some" 7 "cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA026911 Uncertain NA NA "HPA026911: AB_2205589" "unprognostic (9.46e-2)" "unprognostic (5.30e-1)" "unprognostic (7.16e-2)" "unprognostic (8.79e-3)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "unprognostic (5.08e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.1 0.0 0.1 1.0 0.0 0.1 9.3 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 4.1 0.0 4.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.5 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 6.9 0.0 0.3 0.0 0.1 0.0 0.5 ZNF649 FLJ12644 ENSG00000198093 "Zinc finger protein 649" Q9BS31 19 51889235-51905040 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 29.1" "Low region specificity" "Detected in all" HPA026541 Uncertain NA NA "HPA026541: AB_1859390" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (8.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.15e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-1)" "unprognostic (4.23e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (2.24e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" "prognostic favorable (4.60e-5)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.07e-2)" "unprognostic (1.41e-2)" 5.7 4.7 5.0 5.2 5.6 6.6 10.2 8.4 7.5 5.5 0.6 5.7 4.2 8.7 7.1 6.5 7.2 5.6 6.6 5.0 5.2 6.3 4.7 5.6 8.0 5.6 4.8 4.4 10.0 6.0 9.6 3.4 9.0 6.0 21.3 6.1 12.9 5.0 7.1 4.1 8.2 4.4 7.7 3.4 6.6 5.6 8.0 5.9 7.9 8.2 7.0 6.4 6.9 3.8 13.4 4.1 0.6 18.3 13.4 7.1 5.7 0.8 7.7 5.4 7.8 7.2 3.5 3.2 3.9 1.8 5.9 5.4 5.6 9.4 7.4 7.3 1.8 22.5 18.4 1.7 4.3 5.5 5.9 8.2 7.1 5.1 9.9 3.3 6.0 4.7 1.0 4.4 0.2 6.6 1.2 16.1 8.2 29.1 0.1 1.7 9.5 10.1 6.6 7.3 15.2 8.2 8.4 9.4 4.8 6.1 10.0 5.9 8.1 3.6 7.0 6.7 2.7 9.5 5.2 0.7 4.9 2.6 1.6 15.3 3.1 4.4 7.7 6.0 4.6 11.6 4.8 7.2 6.7 5.6 9.1 7.4 5.5 1.6 7.7 4.3 4.5 10.1 4.2 5.0 5.6 8.4 7.5 5.0 5.2 5.6 4.8 4.4 6.0 3.4 5.9 13.4 5.1 0.0 3.2 0.3 5.9 6.5 10.6 4.2 1.8 8.0 5.4 6.5 5.5 10.0 3.0 3.7 0.0 6.2 4.1 2.5 13.7 5.3 1.2 2.7 6.1 5.6 3.0 6.9 2.0 2.4 7.1 6.1 5.6 3.5 12.0 7.3 5.3 2.9 4.1 15.2 2.2 3.7 0.0 3.5 3.3 1.5 5.3 3.4 5.4 1.9 1.9 6.8 7.2 4.0 6.1 3.5 1.0 9.1 2.4 7.2 1.2 3.8 0.5 6.2 6.6 7.2 5.7 4.4 3.3 4.9 8.1 7.0 3.4 4.1 2.6 8.4 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 5193.5" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 975.2" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Hep G2: 22.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 20000000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favorable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 1.6 0.8 0.5 0.4 0.5 0.5 4.4 1.2 1.2 1.0 0.0 0.6 165.6 0.2 0.5 0.8 0.3 0.4 0.1 0.6 0.5 1.5 5193.5 0.2 0.2 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.2 0.5 0.3 0.6 0.8 2.7 0.5 0.6 0.6 23.1 0.1 0.0 0.6 0.6 1.0 0.3 0.0 0.4 2.2 0.1 0.4 3.4 0.8 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.4 22.2 0.0 1.6 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.8 0.0 0.1 0.1 0.5 0.3 0.0 0.1 0.1 1.6 0.5 0.0 0.1 0.1 0.2 1.5 0.3 0.0 0.1 0.4 0.0 0.1 0.4 0.1 0.3 0.0 0.4 0.4 0.6 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 1.2 1.2 0.6 0.5 0.3 0.1 0.2 0.5 0.0 0.3 0.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 21.5 0.2 1.8 0.0 0.0 0.0 0.8 0.0 0.0 26.9 0.7 0.6 1.1 0.0 45.5 0.1 0.6 0.0 1.0 0.0 0.3 0.0 0.0 16.1 975.2 0.0 0.0 0.0 1.1 0.0 27.0 0.0 3.7 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.8 0.0 OR2T6 "OR2T6P, OR2T9, OST703" ENSG00000198104 "Olfactory receptor family 2 subfamily T member 6" Q8NHC8 1 248375746-248391811 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF248 bA162G10.3 ENSG00000198105 "Zinc finger protein 248" Q8NDW4 10 37776526-37858106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 110.0;Excitatory neurons: 145.0;Inhibitory neurons: 135.1;Oligodendrocyte precursor cells: 101.6;Oligodendrocytes: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018237, HPA018287, HPA018455" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869" "unprognostic (6.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.20e-2)" "unprognostic (6.51e-3)" "unprognostic (2.50e-4)" "prognostic favorable (1.04e-4)" "unprognostic (6.37e-3)" "unprognostic (2.05e-2)" "prognostic favorable (1.22e-4)" "prognostic unfavorable (6.71e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (2.70e-1)" "unprognostic (1.62e-1)" "unprognostic (9.51e-2)" "unprognostic (8.68e-3)" 5.3 7.2 12.1 6.7 13.0 0.8 7.9 21.3 16.6 15.7 7.2 14.0 5.6 15.3 14.2 5.8 12.4 6.7 7.9 12.0 12.9 7.3 6.0 6.3 6.8 10.8 11.5 11.1 15.6 6.9 12.4 19.0 6.5 11.8 12.3 9.0 17.2 6.9 16.3 8.5 7.3 8.0 10.9 8.2 8.0 7.7 7.1 12.0 5.6 13.5 9.8 6.6 9.6 9.8 17.4 7.0 5.8 1.2 16.1 11.3 9.4 7.0 7.1 3.6 7.2 7.7 7.2 8.7 9.2 6.1 5.0 5.5 8.7 9.4 5.0 6.2 16.2 10.3 11.5 12.9 8.8 5.6 9.6 7.5 3.8 9.4 3.8 3.1 14.3 6.6 9.9 5.1 6.5 10.7 3.4 9.7 6.2 4.9 4.6 31.1 8.9 16.2 6.6 8.9 3.4 6.7 12.7 6.1 3.3 4.2 9.8 8.8 2.7 6.5 6.5 6.8 5.2 4.3 10.1 11.6 7.7 8.7 12.5 3.2 0.8 1.3 1.2 4.0 0.9 4.5 4.2 3.5 3.5 2.9 5.1 6.0 5.3 0.2 3.4 1.2 2.6 2.0 2.2 12.1 13.0 21.3 16.6 12.0 12.9 10.8 11.5 11.1 11.8 8.2 12.0 17.4 7.1 12.8 14.4 110.0 10.0 2.0 7.6 4.4 10.2 47.4 6.7 7.6 24.4 8.6 7.2 5.5 47.9 6.3 7.7 4.0 7.9 4.1 1.0 15.7 15.4 8.3 5.4 7.2 145.0 1.6 3.1 11.1 6.1 24.7 5.1 26.3 5.0 4.1 4.3 42.1 135.1 4.4 0.0 1.6 2.9 1.8 9.9 3.3 1.8 52.5 4.0 16.1 6.2 101.6 106.8 3.8 5.9 12.0 8.2 4.8 4.2 4.4 5.2 36.9 0.0 17.0 14.2 9.0 10.5 5.9 2.7 2.6 6.4 17.1 5.1 4.2 CHSY3 "CHSY-2, CSS3" ENSG00000198108 "Chondroitin sulfate synthase 3" Q70JA7 5 129904465-130186634 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Excitatory neurons: 509.1;Inhibitory neurons: 349.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 13.1;ASC TERT1: 11.5;HSkMC: 7.6;TIME: 7.4;U-138 MG: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044612 Uncertain "Intracellular and membrane" NA NA "HPA044612: AB_10795883" "unprognostic (3.43e-2)" "unprognostic (6.28e-3)" "unprognostic (1.76e-2)" "unprognostic (5.83e-2)" "unprognostic (5.88e-2)" "unprognostic (8.17e-2)" "unprognostic (3.37e-2)" "unprognostic (1.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (9.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.08e-6)" "unprognostic (5.22e-3)" "unprognostic (9.93e-2)" "unprognostic (4.61e-3)" "unprognostic (1.74e-2)" 4.3 0.5 1.3 1.0 2.8 0.0 2.8 0.0 3.2 4.6 0.2 0.6 0.5 1.5 0.1 0.6 1.1 2.8 1.0 2.7 1.3 0.2 1.7 1.8 0.5 0.5 0.9 2.9 0.3 0.3 0.4 0.3 2.2 1.0 0.5 0.5 1.0 0.5 0.6 1.0 1.1 0.5 2.1 0.1 0.7 0.5 0.7 0.5 0.2 1.2 0.5 0.4 1.7 1.9 2.3 0.0 0.1 1.2 0.0 13.1 11.5 1.0 3.0 0.1 0.4 0.4 0.0 0.1 0.0 0.3 4.6 0.0 0.0 0.0 0.1 0.0 0.0 1.6 1.9 5.6 0.5 1.2 0.0 0.0 7.6 0.0 0.1 1.2 0.6 3.2 0.0 0.0 1.9 5.2 0.0 0.0 0.0 0.7 0.0 1.2 0.4 5.7 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.3 1.1 0.2 0.5 7.4 14.2 3.0 0.2 2.0 0.0 0.0 0.0 0.3 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.8 0.0 3.2 2.7 1.3 0.5 0.9 2.9 1.0 0.1 0.5 2.3 2.0 9.6 1.1 20.2 0.0 0.5 0.0 0.0 1.2 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.5 14.8 2.4 0.0 0.0 509.1 0.0 0.1 2.9 0.0 0.3 0.0 4.1 3.6 1.8 1.9 0.0 349.5 0.0 0.0 1.3 0.7 0.1 1.2 0.1 3.6 87.1 0.0 1.3 0.0 76.9 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 6.6 0.9 6.3 1.6 0.7 0.3 0.3 0.4 0.2 0.6 0.0 0.1 TOR4A "C9orf167, FLJ20245" ENSG00000198113 "Torsin family 4 member A" Q9NXH8 9 137277726-137282641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 45.6;Undifferentiated cells: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 45.4;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA044913 Enhanced Approved Nucleoplasm NA NA 260000 Nucleoplasm "HPA044913: AB_10965030" "unprognostic (1.95e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.99e-1)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (2.24e-1)" "unprognostic (5.20e-2)" "unprognostic (2.00e-3)" "unprognostic (4.39e-3)" "unprognostic (7.93e-3)" "unprognostic (2.56e-1)" 3.9 2.9 2.3 5.0 1.9 2.8 2.5 1.7 2.1 4.5 2.0 9.2 9.7 3.6 0.8 7.6 4.3 5.3 9.2 1.4 2.4 7.1 2.9 11.0 4.1 2.6 2.1 0.9 5.1 3.8 1.9 1.9 1.9 2.3 2.4 4.3 0.0 1.6 2.5 1.4 1.6 11.1 1.3 2.3 15.5 12.6 0.6 2.7 0.9 4.3 0.8 3.0 3.9 3.8 2.9 16.7 21.6 0.2 0.6 0.2 1.7 1.7 27.0 18.5 12.3 6.5 2.7 30.8 1.6 37.4 9.7 0.9 34.0 0.1 9.0 4.2 1.4 1.4 18.2 15.4 14.8 25.9 8.0 45.4 0.9 9.3 2.5 4.8 13.9 16.8 0.1 27.8 2.1 2.1 1.8 0.0 22.0 2.6 18.0 23.9 4.4 5.8 11.3 14.7 0.1 0.8 0.2 19.7 0.1 0.5 0.5 1.6 24.7 41.7 0.6 14.6 2.9 4.6 0.2 1.2 10.5 4.6 7.3 6.0 0.5 0.7 1.3 0.1 0.7 0.2 0.2 0.1 0.0 0.5 0.4 0.0 0.0 0.4 0.2 1.2 0.0 0.2 0.3 2.3 1.9 1.7 2.1 1.4 2.4 2.6 2.1 0.9 2.3 2.3 2.7 2.9 10.5 0.0 5.9 0.0 6.2 2.7 3.0 4.9 2.2 0.1 1.9 4.6 8.1 22.8 6.3 12.9 0.0 0.2 4.1 45.6 0.0 10.4 0.1 4.6 2.4 8.4 7.2 5.2 0.0 2.2 0.2 1.9 21.4 9.6 10.2 0.0 27.8 1.0 15.0 0.0 0.0 24.7 2.0 22.0 17.7 0.1 2.5 16.2 0.0 2.8 16.1 0.7 15.5 0.0 0.0 22.9 29.4 4.1 2.4 1.7 17.9 0.6 7.5 0.6 19.7 1.5 3.1 0.0 0.7 2.2 2.4 0.0 2.9 4.3 34.7 15.4 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 339.6;choroid plexus: 153.0" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 9.1;eosinophil: 19.0" "Group enriched" "Detected in many" 6 "granulocytes: 19.0;monocytes: 9.1" "Cell line enhanced" "Detected in many" "ASC diff: 582.0;ASC TERT1: 337.0;BJ hTERT+: 426.7;HSkMC: 246.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 27.3 13.5 306.6 19.0 318.5 0.2 26.1 235.1 274.8 58.2 153.0 21.8 14.0 17.2 17.3 15.3 15.9 14.3 16.7 220.9 231.0 7.8 2.6 16.5 17.8 300.0 304.1 187.2 12.2 6.6 2.2 5.0 39.1 310.8 21.1 18.5 0.8 16.8 23.8 6.7 19.1 18.4 20.7 262.5 14.9 11.9 6.9 276.0 6.8 16.6 17.7 17.4 27.9 31.9 339.6 11.7 22.2 30.4 0.1 582.0 337.0 0.0 151.6 426.7 104.1 46.8 3.0 1.8 0.0 0.1 157.7 18.6 45.5 0.4 118.5 85.0 0.0 4.1 0.0 1.1 0.0 157.1 0.1 0.2 246.6 6.8 51.4 96.9 62.3 1.8 0.2 0.0 0.2 80.8 0.1 0.0 0.1 5.9 0.0 121.6 0.1 22.4 0.0 23.5 20.6 0.9 7.2 3.1 0.0 0.0 6.2 10.4 0.5 0.1 48.9 1.3 35.3 0.1 1.5 0.0 0.0 7.4 0.0 54.9 1.5 9.1 19.0 0.0 3.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.9 2.1 1.3 0.2 0.0 2.1 306.6 318.5 235.1 274.8 220.9 231.0 300.0 304.1 187.2 310.8 262.5 276.0 339.6 1.9 0.0 1.1 6.2 0.2 13.0 15.5 8.5 4.0 0.0 3.4 6.0 1.4 1.5 9.1 0.0 0.0 0.5 0.3 6.6 1.9 1.8 1.4 3.6 40.4 1.9 0.0 0.0 1.0 2.9 0.4 61.4 6.1 8.7 0.0 0.0 2.5 0.0 3.3 0.0 15.6 3.7 4.1 4.1 15.1 2.7 38.8 3.6 14.2 141.5 12.0 1.0 1.0 1.0 626.8 2.0 2.9 70.7 0.7 12.7 4.5 0.2 3.0 0.2 0.0 13.3 6.3 0.3 2.4 15.2 9.2 0.8 1.2 0.2 4.2 6.7 MB PVALB ENSG00000198125 Myoglobin P02144 22 35606764-35637951 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 37 "heart muscle: 11523.2;skeletal muscle: 41097.5;tongue: 29343.1" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 5182.1" "Group enriched" "Detected in many" 7 "breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.3" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 175.6" "Low region specificity" "Detected in many" "CAB000060, HPA003123" Enhanced NA NA 13500000 140000000 "CAB000060: , HPA003123: AB_1079442" "unprognostic (7.51e-2)" "unprognostic (3.92e-3)" "unprognostic (1.07e-1)" "unprognostic (7.71e-2)" "unprognostic (2.35e-1)" "unprognostic (4.66e-3)" "unprognostic (5.78e-3)" "unprognostic (1.18e-1)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (2.74e-3)" "unprognostic (1.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.51e-2)" "unprognostic (2.35e-1)" "unprognostic (3.44e-3)" "unprognostic (1.19e-2)" 6.6 4.6 1.0 1.5 1.0 0.3 43.9 1.0 2.3 2.9 0.7 14.7 1.9 2.3 0.3 742.4 18.8 4.1 11523.2 0.8 1.7 2.7 5.9 15.0 5.4 1.2 1.2 0.7 5.4 27.1 16.3 10.7 3.1 1.1 216.1 13.0 0.2 370.1 0.5 41097.5 16.3 11.2 1.4 0.9 2.1 3.8 4.6 1.3 0.8 8.6 29343.1 1.9 1.3 4.5 1.0 1.9 7.6 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 4.6 0.7 0.1 0.3 1.0 0.8 0.2 0.0 0.0 5.4 0.3 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.5 0.5 0.0 19.2 0.1 0.6 0.0 1.9 2.3 0.9 0.5 8.0 0.0 6.4 1.5 0.2 19.0 175.6 0.0 0.3 39.4 0.1 0.4 0.5 1.2 2.2 0.2 0.0 0.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.0 1.0 1.0 2.3 0.8 1.7 1.2 1.2 0.7 1.1 0.9 1.3 1.0 0.3 0.0 0.0 0.3 0.1 0.3 4.3 12.5 0.0 0.0 30.7 23.9 5182.1 0.0 30.8 0.0 0.0 0.1 0.5 3.8 0.0 4.7 20.1 20.2 0.1 40.7 11.5 0.0 0.0 0.2 0.0 145.2 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.0 0.1 114.6 14.2 0.0 0.4 70.0 0.0 2.1 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.7 0.0 21.8 2.6 0.1 19.9 0.0 0.0 420.9 42.0 0.3 0.7 0.6 0.1 0.3 2.8 0.1 2.9 15.1 OR2L3 ENSG00000198128 "Olfactory receptor family 2 subfamily L member 3" Q8NG85 1 248046836-248063407 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.2 0.2 0.8 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.1 0.3 0.5 0.6 0.0 0.8 0.1 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107B HsT21816 ENSG00000198129 "Defensin beta 107B" Q8IZN7 8 7495911-7509311 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5424 "epididymis: 542.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 542.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIBCH ENSG00000198130 "3-hydroxyisobutyryl-CoA hydrolase" Q6NVY1 2 190189735-190344193 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 230.2;Proximal tubular cells: 376.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036540, HPA036541, HPA067080" Enhanced Enhanced Mitochondria NA NA 74000 Mitochondria "HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: " "unprognostic (3.60e-3)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.36e-3)" "unprognostic (3.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.96e-1)" "unprognostic (1.89e-1)" "unprognostic (2.88e-1)" "prognostic favorable (1.22e-4)" "unprognostic (7.32e-2)" "unprognostic (1.37e-2)" "prognostic favorable (1.04e-10)" "unprognostic (1.34e-1)" "unprognostic (3.73e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-3)" 34.3 60.6 51.7 17.6 49.4 14.6 28.8 42.6 72.2 33.7 51.5 37.8 56.5 28.4 29.3 35.2 22.7 22.5 29.0 58.0 41.7 143.5 130.1 14.1 20.7 49.3 47.4 35.7 18.8 27.5 58.7 19.2 18.8 59.8 25.8 41.3 38.8 21.1 23.4 49.7 59.2 34.2 18.4 49.4 18.0 25.9 21.9 52.0 17.0 31.9 38.9 22.1 24.0 26.8 75.0 23.5 16.1 37.0 23.8 29.9 27.6 16.9 23.1 11.4 20.8 22.1 46.8 20.2 33.3 36.1 18.1 17.0 44.4 33.2 30.7 29.5 47.0 25.1 44.5 37.7 41.4 10.7 31.8 16.7 19.8 17.8 24.3 4.8 32.3 31.6 30.4 55.2 30.3 20.8 18.2 34.3 33.6 11.1 30.2 30.2 42.4 24.8 83.8 43.8 68.4 27.9 24.0 18.0 27.2 66.8 47.2 32.0 21.3 26.5 22.8 20.8 16.1 15.8 18.7 45.2 30.9 20.7 27.4 18.6 27.8 11.9 26.4 19.5 14.2 21.3 43.5 21.8 21.0 20.9 34.7 22.9 29.6 6.0 32.0 11.3 26.7 37.0 12.7 51.7 49.4 42.6 72.2 58.0 41.7 49.3 47.4 35.7 59.8 49.4 52.0 75.0 23.3 22.4 25.8 129.3 29.8 56.0 131.4 74.9 34.1 35.3 39.1 24.1 28.6 42.9 51.3 36.8 102.2 53.6 18.8 53.5 115.4 27.4 230.2 48.0 21.4 33.3 37.8 13.0 46.4 29.4 22.3 27.7 29.6 39.3 10.2 41.1 89.3 117.4 35.3 25.2 51.5 31.4 71.2 15.7 11.7 62.9 34.8 15.9 46.2 52.5 14.1 35.5 39.1 104.0 141.1 15.6 26.6 45.5 23.3 27.9 32.4 376.2 47.6 50.5 39.5 29.9 26.2 18.0 29.4 45.5 40.6 20.0 30.7 61.7 62.7 67.8 ZNF544 AF020591 ENSG00000198131 "Zinc finger protein 544" Q6NX49 19 58228594-58277495 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 164.2" "Low region specificity" "Detected in all" HPA002732 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA002732: AB_1080735" "unprognostic (5.28e-2)" "unprognostic (9.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.24e-2)" "unprognostic (4.32e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (3.61e-3)" "prognostic unfavorable (3.65e-5)" "unprognostic (4.94e-2)" "unprognostic (2.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (2.49e-1)" 8.3 10.5 15.7 7.0 14.7 10.0 15.8 23.7 14.1 13.5 21.6 10.4 5.4 11.8 39.0 11.2 25.6 10.2 18.9 15.6 12.6 11.7 9.7 9.1 14.1 13.5 13.0 12.9 15.6 13.4 26.4 13.0 12.8 15.7 12.4 10.6 23.0 10.9 11.7 3.8 14.7 8.0 13.2 14.3 10.3 12.1 25.0 12.7 19.4 21.3 8.6 15.9 10.2 8.5 13.8 49.6 18.2 12.8 13.5 12.8 23.1 29.7 23.3 9.9 42.0 29.5 14.4 19.5 65.8 11.1 27.0 0.0 16.1 15.2 50.1 59.4 29.7 164.2 49.3 38.6 6.9 35.7 30.2 36.1 15.7 71.9 28.7 76.2 41.4 36.6 0.4 28.0 0.0 24.0 15.6 64.0 19.3 29.5 10.0 8.9 21.3 13.8 50.7 26.9 73.3 68.8 0.1 26.6 13.1 8.9 21.7 19.4 18.8 32.0 7.0 25.5 7.5 24.9 56.2 118.2 0.2 0.0 0.1 18.7 4.4 2.3 15.4 8.0 4.6 7.5 11.7 7.0 10.2 5.9 13.4 8.6 11.9 2.9 17.2 1.0 9.7 6.4 5.8 15.7 14.7 23.7 14.1 15.6 12.6 13.5 13.0 12.9 15.7 14.3 12.7 13.8 9.8 6.4 11.3 15.0 14.3 5.9 11.8 11.9 8.6 25.2 12.6 13.0 12.3 17.2 17.7 7.3 45.9 15.7 9.6 3.9 19.6 7.7 43.7 17.6 8.0 9.5 11.5 21.5 21.5 4.5 10.4 5.8 9.7 9.0 10.8 18.9 11.0 9.3 13.6 21.9 23.5 7.9 10.2 4.1 3.3 62.7 5.6 5.0 8.8 9.4 2.9 18.6 20.6 26.7 8.8 9.4 1.9 3.8 15.2 12.9 7.0 12.4 16.3 34.4 19.7 7.4 8.1 55.9 28.0 13.1 7.7 11.8 12.4 11.1 8.6 11.7 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Late spermatids: 25.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 19.1" "Cancer enhanced" "Detected in all" "melanoma: 12.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 12.9;MCF7: 13.6;SK-MEL-30: 11.6;U-937: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved NA NA "HPA046562: AB_10960265" "prognostic favorable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.79e-5)" 1.5 15.4 13.4 5.6 7.5 1.8 3.7 20.7 15.7 10.9 0.2 4.4 15.8 1.4 11.0 1.3 2.1 4.1 1.2 10.6 10.1 1.9 1.1 3.5 9.2 22.2 13.0 6.5 1.1 5.0 12.7 7.0 0.8 27.2 2.7 3.3 5.4 4.0 10.5 0.5 1.4 14.3 3.3 11.2 9.9 4.2 6.2 14.6 11.9 8.4 0.9 6.1 5.1 1.5 17.0 3.2 0.4 0.0 0.8 0.3 0.0 1.2 0.5 0.7 0.8 3.3 0.0 10.1 12.9 0.1 0.3 2.8 0.0 0.2 0.7 0.1 4.2 1.0 7.8 0.0 0.0 1.0 8.5 1.5 0.2 0.4 0.1 0.0 0.2 0.0 0.8 0.1 0.5 0.0 13.6 5.2 3.2 0.1 6.7 0.6 4.7 0.1 1.9 0.1 6.7 1.9 0.4 0.0 4.9 11.6 0.5 10.3 8.1 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.6 34.5 7.0 5.8 5.7 9.1 9.9 6.5 9.5 1.3 5.9 8.0 2.7 0.9 5.0 6.5 0.1 5.5 6.9 1.5 2.5 5.8 13.4 7.5 20.7 15.7 10.6 10.1 22.2 13.0 6.5 27.2 11.2 14.6 17.0 1.2 0.0 0.5 1.3 2.6 0.3 0.3 3.6 0.0 4.8 3.5 2.5 1.8 2.8 2.5 0.0 14.6 0.1 8.3 3.6 0.0 2.0 12.6 2.3 0.3 1.4 2.4 0.4 7.1 3.6 0.0 0.6 1.1 0.3 0.0 11.0 2.9 0.2 1.8 0.0 10.6 5.3 0.0 6.2 1.0 25.7 0.0 2.6 7.2 3.7 5.5 0.3 15.5 19.1 6.1 0.5 5.7 0.7 0.4 0.4 11.3 2.2 2.4 4.1 0.0 0.2 0.7 0.7 0.3 0.1 0.1 0.1 4.1 4.9 3.9 1.1 SOWAHC "ANKRD57, C2orf26, FLJ21870" ENSG00000198142 "Sosondowah ankyrin repeat domain family member C" Q53LP3 2 109614364-109618990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 147.6;Granulosa cells: 151.0;Squamous epithelial cells: 137.1;Suprabasal keratinocytes: 199.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 160.4;hTCEpi: 50.8;RT4: 66.2" "Low region specificity" "Detected in all" HPA056131 Enhanced Approved Cytosol No No Cytosol "HPA056131: AB_2683047" "unprognostic (6.76e-2)" "unprognostic (6.96e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.87e-1)" "unprognostic (8.91e-3)" "unprognostic (1.63e-2)" "unprognostic (1.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (5.11e-3)" "prognostic favorable (3.56e-5)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (3.50e-1)" "unprognostic (2.54e-2)" 6.4 3.7 3.1 3.6 3.2 0.6 9.5 3.3 2.7 6.1 6.8 11.4 5.2 5.1 3.9 33.6 4.5 8.4 1.9 2.9 4.3 14.1 29.6 7.0 2.9 5.0 4.2 2.1 13.1 3.6 5.2 1.9 4.3 4.1 7.1 8.8 5.6 8.4 7.4 1.1 19.5 7.4 6.3 4.6 3.3 5.9 6.5 4.3 4.4 8.0 2.1 7.5 23.3 12.1 5.0 19.3 3.6 10.8 5.9 5.3 8.8 35.1 41.3 24.1 7.1 7.4 17.0 6.0 0.0 16.6 6.3 13.4 18.1 2.5 27.1 7.7 160.4 18.0 0.0 8.6 24.3 4.9 0.0 4.8 4.7 50.8 15.3 10.9 5.9 1.8 0.0 0.3 0.1 5.5 6.4 0.0 1.7 7.6 17.5 16.2 0.0 2.4 0.3 10.7 66.2 13.5 5.8 14.2 2.5 11.3 10.5 5.3 0.4 2.7 5.6 21.6 3.3 3.0 5.3 5.5 0.1 6.6 0.6 13.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 3.2 3.3 2.7 2.9 4.3 5.0 4.2 2.1 4.1 4.6 4.3 5.0 18.9 16.0 9.8 2.9 1.2 147.6 43.2 32.0 93.9 15.7 30.5 22.7 3.6 20.0 14.7 12.9 10.4 4.3 0.7 61.1 3.9 15.9 37.8 28.7 21.1 10.8 15.6 2.7 0.2 7.1 28.6 15.6 13.3 76.9 0.0 151.0 6.8 53.2 8.0 0.0 1.2 32.7 10.2 7.0 15.1 13.7 11.8 6.2 19.6 0.0 3.4 7.3 2.1 1.5 2.4 14.2 34.2 15.1 0.6 21.0 21.5 25.1 5.5 20.7 13.1 12.1 20.8 20.8 13.2 137.1 199.3 10.0 2.2 5.3 36.7 80.9 ZNF770 "FLJ20582, PRO1914" ENSG00000198146 "Zinc finger protein 770" Q6IQ21 15 34978341-34988287 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024518 Approved NA NA "HPA024518: AB_1859449" "unprognostic (1.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.75e-2)" "unprognostic (2.79e-1)" "unprognostic (2.32e-2)" "unprognostic (1.17e-1)" "unprognostic (3.11e-1)" "unprognostic (6.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.67e-3)" "unprognostic (4.24e-2)" "unprognostic (2.09e-3)" "unprognostic (1.20e-1)" "unprognostic (1.41e-1)" "unprognostic (5.06e-2)" "unprognostic (2.10e-3)" 12.8 13.1 13.4 12.8 17.1 9.0 18.8 18.2 16.4 13.3 12.2 9.8 12.3 15.3 45.3 29.2 17.8 9.1 14.9 14.4 12.8 21.8 29.6 9.9 17.8 11.8 13.9 13.0 18.0 10.8 22.4 5.5 22.7 11.5 13.3 10.0 19.9 15.1 12.1 18.7 35.6 11.7 10.8 12.7 15.6 11.8 13.8 13.1 16.8 44.5 20.0 22.1 12.3 12.9 13.2 18.9 23.1 31.8 40.5 25.1 23.9 17.9 22.0 21.0 21.1 23.1 20.5 12.7 18.0 29.6 21.8 20.8 44.7 37.9 30.1 29.5 23.1 16.1 41.9 33.2 23.5 50.7 44.1 26.7 16.3 74.1 19.0 52.8 28.0 24.7 13.4 48.0 26.5 29.0 11.1 30.6 21.9 26.2 29.2 23.6 35.1 29.9 24.8 28.2 34.4 45.3 26.1 32.9 37.3 19.9 25.4 26.8 26.3 21.6 37.1 15.6 21.1 21.3 16.6 28.2 28.7 30.6 32.2 27.5 2.1 3.8 1.3 3.9 3.2 5.5 4.9 4.1 3.4 3.2 4.9 6.0 4.9 4.5 4.2 3.6 3.3 4.8 2.6 13.4 17.1 18.2 16.4 14.4 12.8 11.8 13.9 13.0 11.5 12.7 13.1 13.2 20.5 16.0 29.3 26.8 40.3 64.6 40.1 25.4 39.9 25.6 27.5 25.8 13.4 20.0 28.8 33.1 22.9 17.5 32.8 9.8 31.3 21.1 15.8 29.2 30.5 24.9 27.1 13.5 21.6 24.0 14.2 24.2 20.9 26.3 22.1 26.6 27.5 68.1 13.9 25.2 24.8 24.4 14.2 22.9 18.8 8.7 25.4 18.6 39.2 12.2 38.9 29.4 32.0 22.1 19.8 25.3 11.1 23.0 19.8 42.1 12.1 54.3 19.8 21.1 0.0 32.3 18.3 63.8 52.5 64.1 91.1 19.8 26.4 33.3 23.5 39.8 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 40.0" "Group enriched" "Detected in some" 19 "Early spermatids: 300.0;Late spermatids: 151.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.1;hTCEpi: 3.0;NB-4: 3.1;RPMI-8226: 3.4" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 1.2 0.6 5.6 0.3 5.7 0.7 1.3 5.9 8.8 2.6 4.8 1.8 0.3 1.3 1.0 0.9 3.0 0.2 0.9 5.5 5.2 1.1 1.2 1.4 0.5 5.5 5.6 5.1 3.2 1.5 0.2 2.5 0.2 5.9 2.4 0.6 1.3 1.1 0.6 1.4 2.1 2.1 0.4 5.2 1.9 1.2 40.0 5.4 0.4 2.4 0.1 0.3 1.5 1.7 7.0 0.1 3.1 1.4 0.3 0.7 0.0 2.7 0.2 0.3 0.0 0.2 0.1 1.3 1.1 0.2 0.1 0.3 0.4 0.3 0.3 0.1 0.7 0.2 0.8 0.7 0.0 0.0 1.0 0.2 0.4 3.0 0.2 0.6 0.5 0.0 1.7 0.1 2.4 0.0 0.7 0.3 3.1 0.7 0.3 0.1 1.6 1.1 3.4 0.0 0.0 0.4 0.6 0.1 0.1 0.3 1.5 0.6 0.3 0.2 0.4 1.0 0.2 0.2 1.0 1.1 0.3 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 5.7 5.9 8.8 5.5 5.2 5.5 5.6 5.1 5.9 5.2 5.4 7.0 0.2 0.0 1.1 0.0 0.1 0.5 0.4 0.0 0.0 0.5 1.6 1.7 0.5 0.0 0.8 0.0 0.0 0.5 0.1 0.4 0.0 0.0 300.0 0.7 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.4 0.0 1.5 0.0 1.4 1.1 0.2 0.2 0.0 0.0 0.1 0.0 0.3 0.3 151.0 1.2 0.6 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 1.4 1.9 0.0 0.6 0.3 0.2 6.0 0.2 0.0 1.7 0.4 11.7 3.1 0.0 1.3 1.4 0.4 0.3 0.5 0.7 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113699-81201913 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 108.4" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 209.6;Karpas-707: 298.5" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria NA NA 41000 Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favorable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 13.3 24.9 34.5 6.2 33.8 34.3 14.6 32.1 61.1 11.9 30.0 16.7 23.2 17.3 65.8 14.9 17.7 11.1 8.4 32.2 33.4 27.9 23.2 8.8 5.4 38.4 35.4 30.5 20.6 12.8 20.4 30.0 4.8 36.8 15.5 16.5 7.4 13.1 19.6 9.5 12.1 21.7 10.9 35.5 13.0 13.9 108.4 34.8 31.0 18.1 8.8 6.6 12.2 11.7 34.6 1.1 9.6 26.4 130.0 22.2 6.8 5.5 7.4 11.5 2.2 3.2 3.1 49.6 209.6 22.7 3.1 2.1 8.9 158.6 19.2 4.8 123.5 62.9 87.6 97.0 1.6 2.6 147.9 83.1 5.6 4.9 8.1 7.9 7.3 10.4 132.2 118.2 298.5 13.3 4.4 135.2 51.8 117.9 29.5 34.5 5.1 110.1 98.3 32.0 3.5 1.1 3.1 0.9 2.9 9.1 22.6 16.3 34.6 12.2 4.2 33.5 20.4 28.5 20.7 9.4 33.8 12.4 57.5 7.4 1.3 3.1 1.2 7.5 1.6 6.6 3.8 4.4 4.0 5.2 6.0 8.7 7.6 1.4 3.4 2.2 10.0 1.7 2.9 34.5 33.8 32.1 61.1 32.2 33.4 38.4 35.4 30.5 36.8 35.5 34.8 34.6 18.1 9.6 16.4 19.9 9.0 15.9 27.6 12.8 17.6 3.5 18.9 17.5 11.1 27.1 16.2 46.0 0.0 0.6 6.4 22.7 68.4 12.8 24.5 44.0 11.0 18.1 17.4 64.8 11.6 18.7 0.4 15.4 16.8 31.1 13.3 39.4 22.1 87.2 15.7 1.7 16.5 34.2 28.5 11.3 10.8 79.7 29.5 10.2 8.8 13.1 2.9 25.8 7.2 25.6 8.5 7.1 19.6 41.0 9.6 15.0 27.4 113.6 55.9 1.7 46.0 13.3 19.6 18.9 8.7 32.8 14.9 0.4 8.3 31.0 45.0 24.4 MIER1 "hMI-ER1, KIAA1610, MI-ER1" ENSG00000198160 "MIER1 transcriptional regulator" Q8N108 1 66924895-66988619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 98.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019589, HPA050306" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA019589: AB_1853953, HPA050306: AB_2681080" "unprognostic (3.38e-3)" "unprognostic (1.34e-1)" "prognostic favorable (4.96e-4)" "unprognostic (1.63e-1)" "prognostic favorable (3.44e-8)" "unprognostic (1.61e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-3)" "unprognostic (4.48e-3)" "unprognostic (2.57e-2)" "unprognostic (2.81e-2)" "unprognostic (2.25e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (2.45e-2)" 18.7 21.0 11.8 18.5 13.5 98.8 16.6 14.3 13.4 19.8 13.1 27.7 15.6 18.8 13.6 16.8 13.2 19.0 11.5 10.3 12.7 16.3 24.8 16.5 20.9 12.6 12.2 9.4 20.9 9.2 12.4 7.8 20.4 13.2 14.6 23.7 19.0 11.4 17.3 8.2 12.7 16.3 18.0 12.8 20.1 19.0 18.3 12.5 24.6 14.2 13.2 19.8 18.6 11.9 16.2 29.7 16.8 20.4 36.8 41.9 27.2 22.7 30.3 33.5 29.7 32.1 13.7 17.7 29.8 11.1 34.3 26.7 19.2 24.9 33.1 42.5 34.6 19.3 65.2 44.0 21.8 33.2 52.5 36.9 28.2 24.5 33.3 34.3 34.5 32.9 35.6 34.6 25.6 35.6 9.4 76.0 18.8 29.2 13.4 10.8 32.7 49.1 20.4 25.5 32.6 12.0 23.7 45.5 27.9 29.8 19.3 14.4 34.2 39.7 34.5 24.2 33.7 28.4 31.8 31.6 42.5 28.1 22.5 21.2 43.7 10.9 26.8 18.5 12.4 21.5 11.2 16.4 16.5 8.6 13.1 16.6 16.3 37.1 15.8 20.8 11.7 15.1 8.7 11.8 13.5 14.3 13.4 10.3 12.7 12.6 12.2 9.4 13.2 12.8 12.5 16.2 77.4 16.0 45.7 40.8 65.7 48.3 40.5 37.3 51.2 37.7 45.9 44.7 32.9 35.8 35.0 27.6 25.0 41.6 92.1 125.7 45.0 36.8 55.3 54.3 56.8 54.7 42.1 50.1 50.6 40.6 26.8 62.8 34.1 70.6 92.4 48.9 40.4 50.3 22.2 40.4 48.6 54.6 34.6 45.6 38.3 49.3 81.4 56.1 14.2 46.9 69.8 68.7 86.5 40.7 83.8 54.1 77.7 93.3 48.1 52.4 41.3 34.1 35.2 48.5 78.9 64.7 77.5 53.0 62.9 42.0 34.7 34.3 97.1 35.7 53.5 60.4 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 2000000 "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 15.7 11.8 7.5 13.1 10.7 6.4 13.0 10.1 12.8 17.7 7.0 12.7 11.2 16.6 13.9 15.3 14.4 12.4 11.1 7.2 6.0 15.4 21.3 10.9 14.2 2.8 6.4 5.5 14.4 36.5 33.2 6.7 21.9 4.5 14.5 12.6 18.4 14.1 13.2 8.5 10.4 11.7 18.2 1.4 12.3 14.3 10.9 5.8 14.8 25.7 10.2 13.9 18.0 7.7 11.0 32.4 13.8 23.2 20.1 29.8 35.7 74.2 26.3 40.9 11.6 10.9 10.7 18.2 24.2 47.4 33.9 10.8 18.7 11.0 22.3 26.0 30.3 16.4 14.4 18.5 11.8 18.1 22.7 31.6 24.2 23.5 17.8 15.5 21.3 35.0 16.7 23.5 36.1 24.5 62.6 14.0 7.2 11.9 16.4 14.4 12.5 50.5 16.7 15.9 43.3 12.6 18.4 26.2 27.6 21.1 30.1 13.8 14.2 33.6 26.0 21.4 18.6 27.2 24.4 18.0 15.9 34.4 17.8 63.1 0.9 1.5 2.6 3.0 1.2 3.6 1.9 2.4 2.5 1.4 1.9 2.0 2.9 1.2 3.8 1.1 2.7 6.3 1.5 7.5 10.7 10.1 12.8 7.2 6.0 2.8 6.4 5.5 4.5 1.4 5.8 11.0 40.3 38.5 33.4 71.5 45.1 31.0 34.8 26.7 39.3 63.5 43.3 46.0 101.8 35.8 39.1 44.1 22.9 55.1 52.6 24.7 17.6 32.3 33.1 43.2 52.0 40.6 21.7 43.8 188.5 60.4 236.1 50.7 28.5 54.7 16.4 32.3 42.1 88.7 29.4 43.7 238.0 37.1 20.3 36.2 22.0 22.5 53.7 37.2 40.9 101.2 39.2 51.3 55.6 136.7 149.1 37.5 25.1 65.5 120.2 43.0 28.6 22.1 40.9 42.2 39.5 69.1 53.5 72.9 56.2 53.0 34.5 380.5 45.8 68.3 30.8 47.3 SVIP DKFZp313A2432 ENSG00000198168 "Small VCP interacting protein" Q8NHG7 11 22813799-22830299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 406.9;Early spermatids: 945.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.2" "Low region specificity" "Detected in all" HPA039807 Approved NA NA "HPA039807: AB_10795232" "unprognostic (1.18e-2)" "unprognostic (2.05e-1)" "unprognostic (2.21e-1)" "unprognostic (2.72e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (8.80e-2)" "unprognostic (2.02e-2)" "unprognostic (9.31e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.77e-8)" "unprognostic (2.18e-2)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (1.16e-2)" 3.3 8.5 14.1 5.7 16.6 17.7 10.8 15.3 18.2 7.0 11.4 7.8 10.5 7.2 18.3 5.7 8.2 7.3 5.6 14.1 16.9 15.7 4.1 6.7 7.9 16.9 16.6 12.9 8.2 13.4 14.2 12.0 2.7 17.2 12.9 8.3 9.3 11.9 8.1 5.5 5.5 11.2 3.6 18.6 8.3 18.7 4.8 17.6 6.2 23.9 4.2 7.3 6.4 3.3 21.4 0.1 4.5 10.0 0.3 1.2 0.4 5.9 4.1 3.0 5.6 4.5 2.9 3.8 0.1 6.3 3.1 6.0 2.6 14.6 4.1 7.3 28.9 11.3 14.5 4.2 7.2 2.9 24.3 20.3 0.6 5.5 0.0 3.6 6.9 21.3 26.3 29.9 31.2 5.6 7.2 26.4 3.2 5.7 24.8 11.5 22.7 10.0 21.8 10.4 12.8 50.2 11.2 0.0 12.3 13.9 2.5 20.8 4.6 14.9 2.4 8.7 34.9 7.0 7.8 0.0 8.4 16.2 0.0 10.4 9.6 1.3 23.3 8.0 0.7 10.6 12.4 12.8 9.1 1.7 12.5 15.8 11.3 4.4 6.6 0.9 24.0 9.6 6.3 14.1 16.6 15.3 18.2 14.1 16.9 16.9 16.6 12.9 17.2 18.6 17.6 21.4 68.8 80.1 66.9 4.9 80.1 26.8 69.0 61.6 12.5 48.9 141.2 110.4 157.7 82.9 71.4 161.8 22.9 34.8 89.6 63.8 406.9 89.9 945.7 64.2 9.3 79.4 112.5 187.8 4.8 143.5 7.4 24.9 57.6 80.2 125.4 36.4 79.9 100.7 24.2 26.9 3.8 105.9 111.9 22.1 64.8 319.1 34.8 55.6 55.2 7.5 62.0 67.0 65.9 6.0 62.0 156.5 63.4 47.0 67.1 77.3 100.8 224.4 59.2 79.3 13.1 23.7 32.5 201.7 87.6 28.6 77.4 32.8 89.2 23.2 84.6 92.8 ZNF251 ENSG00000198169 "Zinc finger protein 251" Q9BRH9 8 144720907-144756417 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 31.6;Excitatory neurons: 49.1;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018290 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA018290: AB_1859153" "unprognostic (1.16e-3)" "unprognostic (1.50e-1)" "unprognostic (1.47e-1)" "unprognostic (1.77e-1)" "unprognostic (6.87e-2)" "unprognostic (1.20e-1)" "unprognostic (4.26e-3)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (2.30e-1)" "unprognostic (5.75e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.42e-9)" "unprognostic (5.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (2.33e-3)" 16.0 10.5 13.0 6.3 12.8 3.6 16.7 18.0 13.4 20.7 10.8 15.9 6.9 17.6 24.7 9.9 18.3 10.6 18.4 13.3 12.8 15.5 11.5 10.6 12.3 12.4 12.8 13.0 20.2 14.6 12.3 22.8 8.9 14.2 18.0 11.5 17.7 12.3 13.6 10.2 13.2 15.8 12.7 11.2 15.0 13.3 14.2 12.8 11.3 28.2 8.6 11.2 16.7 15.7 13.4 9.9 6.0 23.0 10.8 13.5 17.7 8.7 9.9 14.9 11.3 15.8 2.5 11.6 14.6 9.0 12.9 6.3 13.5 6.8 6.1 15.3 4.1 5.0 11.1 25.1 6.8 7.8 4.1 5.9 13.4 9.1 6.9 13.2 22.0 9.2 10.3 7.4 4.1 13.3 4.7 12.3 2.4 6.9 7.3 10.5 12.7 3.3 5.9 7.6 5.5 10.7 13.9 9.5 4.8 11.0 10.4 12.2 9.6 7.4 9.4 14.4 16.4 8.7 4.4 1.3 8.5 10.5 6.0 7.5 0.0 0.3 1.0 0.9 0.5 1.5 1.3 1.4 1.4 0.7 1.0 1.9 1.4 0.0 1.2 0.5 0.7 1.6 0.8 13.0 12.8 18.0 13.4 13.3 12.8 12.4 12.8 13.0 14.2 11.2 12.8 13.4 9.3 0.0 5.3 31.6 4.8 2.2 3.8 1.7 5.7 5.5 4.0 4.1 3.9 1.5 8.9 1.8 6.2 2.0 3.1 1.0 5.9 1.6 20.2 4.5 7.1 7.7 1.2 3.8 49.1 1.5 1.4 5.6 6.6 5.0 1.3 6.8 1.8 0.9 1.6 5.0 50.2 2.1 0.0 3.0 3.0 9.5 7.8 2.0 1.8 22.5 2.9 2.8 3.1 37.7 40.7 2.0 1.8 4.5 5.7 3.0 2.0 3.2 5.3 5.9 13.1 5.2 6.1 11.9 10.3 3.9 3.1 1.4 5.0 5.4 1.9 2.0 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 24000 "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: AB_2668872" "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favorable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 43.0 89.8 44.5 24.0 44.4 25.0 45.9 40.3 66.3 49.7 36.6 42.5 43.8 43.9 20.2 46.4 49.4 22.6 38.5 43.6 37.9 51.2 78.5 52.0 23.7 41.0 38.2 42.4 49.3 84.8 55.1 36.9 26.1 42.5 46.1 19.4 43.6 62.3 32.5 58.7 51.9 45.3 20.1 35.9 36.6 63.5 35.1 39.0 18.8 51.7 14.3 17.2 43.9 45.0 50.0 108.5 133.3 32.3 60.6 71.7 27.2 46.6 67.2 31.9 40.6 44.1 105.7 76.7 64.3 53.6 37.5 77.9 118.2 33.5 100.6 14.8 44.0 62.8 54.4 45.6 186.1 97.9 62.1 56.6 42.8 96.2 77.8 55.2 44.8 37.5 45.3 77.0 74.8 26.4 59.2 42.9 115.5 40.1 73.6 60.8 55.9 28.7 98.6 66.7 99.8 71.4 44.1 69.2 192.7 65.6 19.2 82.0 37.6 57.2 64.9 28.8 46.3 104.2 55.8 67.7 27.3 18.0 51.6 38.9 23.1 36.9 45.6 33.3 25.3 32.7 26.9 35.0 35.6 36.8 26.3 30.8 30.5 9.5 24.6 23.2 57.3 36.2 25.9 44.5 44.4 40.3 66.3 43.6 37.9 41.0 38.2 42.4 42.5 35.9 39.0 50.0 57.3 44.8 53.9 19.9 35.1 26.3 68.8 119.0 44.3 47.9 77.1 72.3 31.3 91.5 114.3 69.9 64.6 127.5 50.9 105.8 19.6 147.0 42.2 54.8 42.6 54.1 53.4 26.5 28.6 178.8 65.1 49.3 54.0 79.0 27.3 34.8 50.0 125.6 119.3 52.2 13.9 72.2 154.6 60.9 36.0 21.1 55.9 54.2 39.2 7.5 67.8 73.7 64.9 6.0 28.4 145.0 125.3 68.8 60.5 75.7 216.3 80.5 81.6 108.3 65.7 39.1 115.6 38.7 23.6 64.0 38.8 146.0 44.7 70.0 92.7 75.0 FAM47C ENSG00000198173 "Family with sequence similarity 47 member C" Q5HY64 X 37008366-37011664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 2.9" "Cell type enhanced" "Detected in some" "Early spermatids: 10.5;Late spermatids: 3.3;Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFDP1 "DILC, Dp-1, DP1, DRTF1" ENSG00000198176 "Transcription factor Dp-1" Q14186 13 113584721-113641473 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 165.4" "Cell type enhanced" "Detected in all" "Erythroid cells: 344.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 31.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 31.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033605, HPA044754, HPA068909, HPA077304" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: " "unprognostic (4.28e-2)" "unprognostic (9.50e-3)" "unprognostic (1.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.01e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (5.50e-3)" "unprognostic (1.68e-2)" "unprognostic (3.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.43e-2)" "prognostic favorable (7.57e-4)" "prognostic favorable (6.17e-4)" "unprognostic (2.30e-1)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" 28.5 23.7 25.8 39.0 25.6 165.4 27.5 26.3 25.7 33.8 31.9 38.1 30.8 27.9 19.5 50.5 33.1 24.8 34.6 25.5 27.9 23.4 26.1 22.0 67.6 29.4 26.2 23.3 19.5 18.6 28.7 21.4 41.0 26.6 26.4 42.8 20.3 26.3 31.1 58.7 43.1 32.6 34.5 28.6 31.1 31.6 50.1 26.8 53.9 33.4 59.5 68.8 37.8 30.3 28.5 343.2 82.5 104.4 89.5 138.4 122.7 118.5 187.8 168.7 238.1 218.6 173.3 155.9 314.6 61.3 181.3 130.3 160.3 183.0 167.1 232.2 215.9 212.8 184.4 129.2 109.8 86.8 468.3 155.7 102.1 147.3 151.3 87.4 85.0 162.7 116.2 154.1 82.6 215.5 117.7 207.0 181.4 96.6 322.7 105.0 138.9 93.0 181.1 91.3 129.1 268.2 79.3 84.8 228.8 58.7 75.1 157.9 371.7 114.4 77.2 122.9 165.6 210.8 69.5 92.4 326.4 171.9 285.2 133.2 31.9 3.0 4.6 3.1 3.8 3.4 4.4 4.1 3.7 5.9 3.6 6.3 3.2 3.8 2.3 5.5 3.0 5.3 2.5 25.8 25.6 26.3 25.7 25.5 27.9 29.4 26.2 23.3 26.6 28.6 26.8 28.5 21.4 9.6 15.8 12.7 38.8 59.8 32.1 16.1 33.6 10.3 45.6 35.2 26.6 28.6 14.7 29.5 14.6 83.2 33.8 29.8 80.3 12.3 5.5 34.4 28.2 25.8 40.2 344.3 22.5 11.9 128.0 30.8 38.7 31.0 21.0 23.3 34.6 58.7 49.2 6.7 19.5 36.1 12.2 49.1 51.2 10.7 28.6 41.1 35.6 5.6 24.8 14.7 16.5 9.5 10.2 19.0 24.2 28.2 67.3 35.7 29.4 66.5 21.0 22.5 6.6 20.0 32.7 76.7 52.7 74.6 60.0 66.6 32.1 30.3 47.4 35.8 CLEC4C "BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL" ENSG00000198178 "C-type lectin domain family 4 member C" Q8WTT0 12 7729383-7751605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.5" "Cell type enriched" "Detected in some" 21 "dendritic cells: 107.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 16 "plasmacytoid DC: 468.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 468.0" "Cell line enriched" "Detected in single" 5 "HDLM-2: 2.1" HPA029432 Approved NA NA "HPA029432: AB_10601259" "unprognostic (3.55e-3)" "unprognostic (3.01e-2)" "unprognostic (1.03e-1)" "unprognostic (3.70e-2)" "unprognostic (7.37e-5)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-2)" "unprognostic (6.98e-2)" "unprognostic (1.39e-1)" "unprognostic (1.88e-3)" "unprognostic (2.82e-2)" "unprognostic (3.18e-3)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" 0.3 0.1 0.0 1.4 0.1 1.6 1.4 0.4 0.2 0.1 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.2 0.0 0.1 0.0 0.1 0.2 0.6 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 3.8 0.2 0.9 0.0 2.1 0.1 0.0 5.3 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 5.3 0.7 30.0 0.1 0.1 0.1 0.6 0.1 0.1 4.1 2.6 0.1 0.0 14.7 2.9 0.0 468.0 0.2 3.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 107.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.0 0.1 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 4.9 0.0 0.3 0.0 0.8 0.0 0.0 0.0 ZNF607 "FLJ14802, MGC13071" ENSG00000198182 "Zinc finger protein 607" Q96SK3 19 37696371-37719761 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 33.0;Late spermatids: 26.7;Smooth muscle cells: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA049465, HPA055018" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049465: AB_2680778, HPA055018: AB_2682674" "unprognostic (6.70e-2)" "unprognostic (8.00e-2)" "unprognostic (1.77e-3)" "unprognostic (2.69e-3)" "unprognostic (1.58e-1)" "unprognostic (9.23e-2)" "unprognostic (9.86e-3)" "unprognostic (2.15e-1)" "unprognostic (4.86e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-3)" "unprognostic (1.68e-1)" "unprognostic (6.43e-3)" "unprognostic (3.86e-1)" "unprognostic (4.30e-2)" "unprognostic (5.03e-2)" "prognostic favorable (5.23e-5)" 1.7 2.9 4.8 1.5 5.2 0.6 3.4 5.5 4.6 3.3 3.9 2.9 1.7 3.4 3.4 3.1 4.7 1.8 2.6 4.2 4.6 3.0 0.8 2.1 2.7 6.4 4.4 4.4 5.2 2.8 5.4 5.5 2.7 5.0 3.3 2.1 5.0 2.4 2.5 2.0 3.6 2.7 2.4 4.8 3.1 2.5 9.1 4.7 2.8 4.0 2.0 3.3 3.0 3.1 6.4 5.1 5.3 8.0 8.4 4.3 4.9 5.6 3.7 3.6 3.3 5.9 8.0 2.8 7.1 5.2 3.9 4.4 2.4 7.9 2.8 5.0 3.7 8.1 3.5 4.6 4.4 3.5 0.1 2.1 3.2 5.3 4.1 3.8 4.8 1.7 4.7 7.3 0.0 3.7 4.4 7.1 3.9 9.4 3.6 2.1 3.2 12.3 1.9 3.5 6.6 2.3 7.0 0.2 2.1 0.6 5.8 5.7 0.6 0.4 2.4 1.7 2.9 4.2 6.9 8.0 9.8 0.0 0.0 3.2 0.0 0.2 1.6 1.3 0.2 0.9 3.0 2.2 2.8 0.8 2.0 1.9 2.3 0.0 2.4 0.3 1.6 0.8 0.8 4.8 5.2 5.5 4.6 4.2 4.6 6.4 4.4 4.4 5.0 4.8 4.7 6.4 1.3 3.2 0.5 4.9 3.0 1.3 0.8 1.5 2.8 2.7 2.1 2.5 4.1 2.8 1.9 1.8 2.1 2.5 1.1 1.2 0.0 1.7 33.0 3.2 1.5 1.3 0.0 0.4 5.5 1.2 2.3 1.6 2.6 1.6 0.0 3.2 1.8 0.2 1.4 1.7 7.1 1.9 0.0 0.6 0.4 26.7 0.9 0.7 3.6 1.0 0.6 1.2 2.1 3.0 10.6 0.7 0.5 1.9 0.6 1.2 1.0 1.2 7.2 1.5 0.0 1.1 13.9 5.4 5.2 2.9 1.1 0.8 1.4 1.6 1.5 0.9 BPIFA1 "bA49G10.5, LUNX, PLUNC, SPLUNC1" ENSG00000198183 "BPI fold containing family A member 1" Q9NP55 20 33235995-33243311 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 6.2;lung: 18.5;pituitary gland: 12.2" "Cell type enriched" "Detected in some" 6 "Club cells: 1205.8" "Cancer enriched" "Detected in many" 27 "lung cancer: 262.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "cerebellum: 2.0" "Not detected" "Not detected" CAB025669 Supported "Secreted in other tissues" NA NA 1200000 "CAB025669: " "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (3.65e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 129.5 0.0 0.0 0.0 0.0 0.0 0.0 1205.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 126.1 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.0 0.0 0.0 0.0 80.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 ZNF334 bA179N14.1 ENSG00000198185 "Zinc finger protein 334" Q9HCZ1 20 46499630-46513559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 43.1;Inhibitory neurons: 29.1;Oligodendrocyte precursor cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.5;BEWO: 19.4;NTERA-2: 10.4;SCLC-21H: 12.9;SuSa: 22.0" "Low region specificity" "Detected in all" HPA050022 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050022: AB_2680994" "unprognostic (3.04e-2)" "unprognostic (1.28e-2)" "unprognostic (3.68e-1)" "unprognostic (2.74e-4)" "unprognostic (9.08e-2)" "unprognostic (5.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (3.62e-2)" "unprognostic (8.25e-2)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.55e-3)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "unprognostic (1.71e-3)" 2.3 8.0 11.5 0.9 10.4 1.4 6.9 15.1 10.4 7.4 9.7 3.5 2.0 6.7 9.4 2.1 9.6 4.1 2.3 8.5 10.2 6.8 5.5 3.4 1.4 11.9 11.1 8.4 16.0 8.9 1.7 16.2 5.1 11.4 12.8 2.3 15.8 6.4 5.9 0.9 2.0 3.6 3.3 9.3 3.2 5.2 7.8 9.6 2.9 12.4 1.7 1.1 5.1 5.5 11.3 0.1 0.0 15.5 0.1 1.0 0.1 19.4 1.4 0.1 1.2 0.1 0.0 4.0 0.0 0.0 0.4 4.8 0.0 0.0 0.3 0.6 0.0 3.3 5.1 0.1 5.7 4.1 0.1 0.0 4.9 0.0 1.3 0.0 0.7 0.1 0.1 3.5 0.0 0.1 0.0 0.0 9.1 10.4 2.6 1.3 0.0 0.0 0.1 4.2 3.9 12.9 7.3 0.0 0.4 0.2 22.0 0.1 4.5 0.0 0.2 6.9 0.1 0.0 1.2 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 11.5 10.4 15.1 10.4 8.5 10.2 11.9 11.1 8.4 11.4 9.3 9.6 11.3 1.2 9.6 4.5 43.1 0.2 0.1 3.5 1.1 2.8 11.0 5.6 4.3 1.9 1.5 5.5 3.7 2.1 4.1 0.0 0.4 5.9 4.5 0.6 2.5 6.2 1.7 0.0 2.1 15.7 1.3 3.7 3.9 7.7 1.3 2.5 11.1 2.2 0.9 1.7 10.1 29.1 1.2 0.0 0.0 0.3 1.4 2.8 1.2 0.0 3.7 0.0 7.8 0.0 33.2 7.5 1.7 0.3 1.9 0.2 2.2 0.6 3.4 7.9 12.3 0.0 5.1 2.4 5.7 7.5 1.4 0.0 1.0 0.2 6.5 1.8 1.6 HSD17B11 "17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2" ENSG00000198189 "Hydroxysteroid 17-beta dehydrogenase 11" Q8NBQ5 4 87336515-87391188 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 291.0;liver: 243.6" "Cell type enhanced" "Detected in all" "Paneth cells: 498.6;Proximal enterocytes: 1134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 768.7" "Group enriched" "Detected in all" 4 "granulocytes: 768.7;monocytes: 202.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 295.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021608 Enhanced Supported "Lipid droplets" "Intracellular and membrane" NA NA "Lipid droplets" "HPA021608: AB_1847660" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (4.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.92e-1)" "unprognostic (3.35e-1)" "unprognostic (3.70e-2)" "unprognostic (1.78e-1)" "unprognostic (8.53e-2)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (2.65e-3)" "unprognostic (5.53e-2)" "unprognostic (2.13e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-2)" 55.9 64.8 15.5 33.3 16.2 110.9 45.9 19.9 18.8 44.4 21.2 140.9 218.6 58.1 28.5 21.7 44.6 108.7 21.2 15.9 22.2 76.6 243.6 105.3 41.9 20.3 17.3 15.2 61.2 55.0 10.9 13.2 47.6 18.9 25.7 147.2 8.2 14.9 34.5 12.2 13.8 291.0 49.9 20.1 43.0 36.9 10.2 16.7 36.6 19.5 26.5 35.2 42.2 33.8 21.7 1.0 45.4 22.2 56.1 66.5 92.4 31.2 23.4 39.3 16.1 29.9 38.2 295.2 0.0 45.8 26.2 14.8 0.9 65.6 5.2 18.0 72.1 13.8 63.3 22.9 131.0 37.6 114.8 114.0 65.3 1.7 22.5 7.4 51.3 31.5 27.4 67.9 32.7 30.1 1.8 24.0 144.8 37.8 146.7 7.6 63.2 20.4 77.7 45.5 70.0 7.2 69.3 47.5 1.6 87.0 28.2 0.1 112.7 24.9 11.0 47.9 43.1 13.0 15.0 6.6 7.1 20.1 80.6 77.0 591.1 202.0 442.9 62.5 142.7 74.8 57.1 62.6 64.6 108.2 47.6 55.8 64.2 768.7 82.3 125.8 36.8 77.4 171.6 15.5 16.2 19.9 18.8 15.9 22.2 20.3 17.3 15.2 18.9 20.1 16.7 21.7 169.0 314.1 179.5 13.4 89.0 28.0 77.0 16.0 10.8 1.8 5.0 6.2 5.3 368.9 83.7 44.1 2.1 30.6 63.1 356.8 25.4 53.9 1.2 9.0 28.1 101.8 93.7 68.8 16.8 58.6 59.7 77.3 28.1 18.8 100.1 34.1 112.5 337.3 129.1 18.5 14.7 180.8 18.3 220.4 176.2 5.1 104.1 139.1 67.6 43.1 197.3 36.3 113.3 16.6 19.0 65.9 498.6 59.5 60.8 39.5 1134.9 173.6 62.2 3.9 72.3 77.9 43.0 2.7 15.4 10.4 21.5 14.9 93.8 65.4 281.0 93.9 SZT2 "C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B" ENSG00000198198 "SZT2 subunit of KICSTOR complex" Q5T011 1 43389882-43454247 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029012 Approved Approved "Nucleoplasm,Vesicles,Actin filaments" NA NA "Nucleoplasm, Vesicles, Actin filaments" "HPA029012: AB_10600817" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.14e-1)" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.47e-7)" "prognostic unfavorable (2.53e-4)" "prognostic favorable (6.20e-4)" "unprognostic (1.54e-1)" "unprognostic (1.81e-2)" "unprognostic (5.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (1.84e-3)" "unprognostic (8.28e-2)" "unprognostic (7.19e-2)" "unprognostic (2.61e-2)" 5.9 5.4 0.7 4.3 1.8 6.1 6.3 2.3 2.5 6.0 0.4 6.5 3.4 7.2 2.6 6.0 7.0 2.7 5.2 0.6 1.1 4.7 4.5 6.4 4.2 2.2 1.8 0.4 8.0 6.5 5.7 8.9 2.7 3.1 6.6 3.4 4.0 6.6 3.2 6.7 7.6 8.0 3.6 0.8 7.2 6.4 9.7 2.0 4.4 9.1 4.0 4.1 6.2 5.8 4.5 4.5 4.4 3.7 3.4 9.1 4.5 5.7 3.7 4.4 4.5 4.1 1.5 5.0 4.1 4.1 5.9 3.2 5.1 3.7 6.3 3.9 5.1 3.4 7.5 8.1 2.7 3.4 6.1 6.2 4.8 4.2 7.7 7.5 5.0 5.2 4.7 3.4 6.8 3.2 2.1 4.1 1.6 3.3 2.7 4.5 4.5 5.1 4.9 2.6 6.2 3.8 3.4 7.8 5.9 4.0 4.8 3.2 8.8 6.5 4.8 6.8 6.4 6.5 7.3 2.8 3.4 4.9 3.8 3.1 1.4 0.5 1.4 0.3 0.4 0.8 0.3 0.1 0.1 0.4 0.3 0.4 0.3 1.1 0.3 0.5 0.9 0.4 0.2 0.7 1.8 2.3 2.5 0.6 1.1 2.2 1.8 0.4 3.1 0.8 2.0 4.5 8.3 25.6 19.3 19.6 10.5 1.9 3.5 5.1 6.2 16.8 7.7 7.0 4.8 5.7 6.8 5.5 62.6 6.5 9.2 10.0 0.0 6.1 14.2 5.8 10.1 7.6 3.6 5.5 20.4 6.4 5.2 7.0 13.7 6.9 14.5 19.0 12.8 13.1 5.4 13.5 20.2 7.0 4.1 7.0 3.1 15.8 9.3 9.4 5.4 15.9 11.6 5.8 13.4 11.1 29.1 6.8 3.7 6.0 9.5 4.2 10.5 9.2 8.0 22.2 19.7 9.1 7.1 8.1 8.6 4.2 1.8 5.5 11.4 12.6 7.0 3.8 SULT1C2 "ST1C1, SULT1C1" ENSG00000198203 "Sulfotransferase family 1C member 2" O00338 2 108288639-108309915 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 70.6;stomach 1: 164.8" "Cell type enriched" "Detected in many" 7 "Gastric mucus-secreting cells: 553.0" "Cancer enhanced" "Detected in many" "renal cancer: 10.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "RPTEC TERT1: 25.4;RT4: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007190 Approved NA NA "HPA007190: AB_1857647" "unprognostic (3.31e-2)" "unprognostic (1.63e-2)" "unprognostic (3.41e-1)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (3.61e-2)" "unprognostic (3.78e-1)" "unprognostic (3.62e-2)" "unprognostic (8.74e-2)" "unprognostic (2.76e-1)" "unprognostic (3.19e-2)" "unprognostic (9.27e-2)" "unprognostic (6.28e-2)" "unprognostic (4.63e-2)" "unprognostic (9.96e-5)" 0.7 0.0 0.4 0.6 0.4 0.0 0.9 0.3 1.1 2.4 6.2 2.5 29.5 0.5 16.0 0.3 2.0 6.2 1.0 0.5 0.4 70.6 2.9 2.2 1.9 0.3 0.4 0.1 0.2 5.4 6.0 2.9 1.3 0.3 0.5 5.2 0.0 1.4 0.9 0.6 0.1 3.3 0.8 0.8 0.5 164.8 0.1 0.6 0.4 19.6 0.6 0.8 0.7 0.5 1.3 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.8 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.2 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.3 0.0 25.4 7.3 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 1.1 0.5 0.4 0.3 0.4 0.1 0.3 0.8 0.6 1.3 7.0 3.2 14.1 0.3 1.0 1.5 1.6 0.0 0.0 0.9 0.3 0.1 2.2 15.7 3.1 20.2 2.1 0.3 0.0 3.9 58.7 7.6 0.1 5.7 0.8 4.8 0.0 0.0 0.4 0.2 0.3 2.6 553.0 5.6 1.3 0.2 3.3 0.9 18.6 1.7 0.2 6.4 12.2 0.3 5.4 0.2 0.0 2.7 0.0 3.7 0.1 0.1 0.0 0.0 0.1 6.2 6.8 0.0 2.0 2.8 9.6 73.4 1.0 1.5 0.0 2.9 1.2 0.7 0.3 0.0 1.8 0.1 1.1 0.1 4.9 1.3 ZXDA ZNF896 ENSG00000198205 "Zinc finger X-linked duplicated A" P98168 X 57905430-57910458 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.53e-1)" "unprognostic (3.71e-1)" "unprognostic (1.01e-1)" "unprognostic (3.61e-3)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.22e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.85e-3)" "unprognostic (6.50e-2)" "prognostic favorable (8.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.15e-1)" "unprognostic (3.27e-2)" 2.2 2.0 2.0 1.7 2.6 2.9 2.5 4.5 2.1 2.5 0.2 1.7 1.4 2.9 2.1 1.4 3.1 1.9 2.2 1.7 1.9 2.1 1.8 1.9 3.0 2.3 2.3 1.4 4.5 2.4 2.7 1.1 1.0 2.9 2.8 1.6 1.8 1.7 2.4 3.1 1.6 1.4 2.1 2.0 3.2 2.5 0.9 2.2 2.3 3.1 3.0 2.5 1.8 1.2 4.0 1.8 1.6 0.5 2.0 2.1 2.9 1.2 1.1 2.0 1.3 1.5 0.3 1.3 4.2 2.5 2.7 1.5 1.7 1.9 2.2 1.3 3.0 3.0 0.5 1.4 0.0 3.1 0.0 0.2 2.4 4.6 2.0 4.3 2.5 2.5 2.4 0.6 0.1 3.0 1.5 1.9 1.0 2.1 0.3 1.3 2.0 1.5 1.1 1.4 1.6 0.2 1.7 2.3 1.6 1.8 2.6 2.1 1.5 1.7 2.2 4.7 0.6 1.1 0.0 0.0 2.2 1.6 1.8 1.4 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.1 0.2 0.0 2.0 2.6 4.5 2.1 1.7 1.9 2.3 2.3 1.4 2.9 2.0 2.2 4.0 4.1 0.0 0.5 1.0 5.6 9.3 4.2 1.5 8.0 2.8 1.6 1.4 2.3 2.8 1.4 1.8 4.2 0.9 1.7 0.6 0.0 1.6 0.0 1.5 1.6 3.3 1.2 0.0 2.6 0.8 0.7 2.8 3.6 1.9 1.3 1.5 0.7 0.7 1.1 3.3 3.7 1.4 2.0 1.9 2.9 0.0 2.5 1.3 3.6 3.7 0.7 1.9 0.0 2.5 5.8 0.9 0.8 1.2 4.7 2.2 0.5 1.6 1.2 2.4 0.0 2.9 2.4 0.0 0.4 1.4 6.5 0.8 3.2 1.4 1.1 2.8 RPS6KL1 "MGC11287, RSKL2" ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903951-74923302 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.3;Cone photoreceptor cells: 83.4;Horizontal cells: 40.4;Rod photoreceptor cells: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 17.5;SCLC-21H: 25.1;SK-BR-3: 19.7;U-266/70: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 3.5 4.6 24.6 1.1 26.2 3.0 4.1 24.7 29.6 1.8 20.6 5.7 2.2 4.1 4.8 2.9 2.5 1.8 11.7 26.4 24.2 4.8 4.2 2.5 1.4 24.0 24.6 26.2 0.9 8.0 1.3 18.9 0.5 24.4 3.8 3.3 20.7 3.1 3.0 19.2 1.9 3.1 4.0 22.0 3.2 2.6 14.0 24.5 0.6 4.4 4.2 1.1 3.4 1.7 26.5 3.3 0.5 1.3 4.4 0.2 0.0 6.3 0.7 0.2 1.6 0.4 5.8 2.4 0.1 4.5 1.1 0.7 0.4 1.9 0.1 1.6 0.0 0.6 2.7 1.2 4.8 5.7 3.2 17.5 0.5 3.5 2.3 0.0 0.0 7.9 0.0 3.2 0.9 0.1 10.7 0.1 1.1 1.3 1.0 5.1 2.0 0.1 9.7 2.3 0.0 25.1 3.8 0.4 19.7 3.4 2.7 1.5 2.1 5.8 0.1 0.2 4.0 0.0 13.8 8.1 6.9 1.8 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.7 0.8 0.0 0.0 0.0 2.3 0.0 0.1 24.6 26.2 24.7 29.6 26.4 24.2 24.0 24.6 26.2 24.4 22.0 24.5 26.5 2.6 0.0 0.0 10.4 0.9 0.8 2.7 1.2 0.6 72.3 4.3 3.9 6.1 0.0 0.8 3.7 83.4 1.7 2.0 2.4 1.9 1.3 7.7 0.8 0.6 2.6 6.7 5.2 24.5 6.2 1.7 1.0 0.5 0.7 0.0 0.7 1.1 2.6 3.7 40.4 19.7 2.1 4.1 0.3 1.3 7.4 2.1 1.0 3.6 3.7 0.0 5.0 3.1 15.6 15.1 3.8 1.6 2.6 0.5 2.1 1.5 1.9 4.5 73.6 6.6 3.8 3.1 27.0 22.9 1.2 1.3 1.4 1.0 1.5 3.1 1.6 AC092143.1 ENSG00000198211 "Novel protein (MC1R-TUBB3 readthrough)" 16 89919165-89936092 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 6.6" "Cell type enriched" "Detected in single" 15 "Fibroblasts: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 10.7" "CAB011512, HPA043640, HPA046280" Uncertain Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.90e-4)" "unprognostic (6.87e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 48.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.0 1.0 37.2 0.6 31.7 1.2 0.0 0.0 38.6 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.7 0.0 0.2 48.5 9.4 1.3 0.0 0.1 0.4 7.8 7.4 36.3 0.0 0.0 0.0 0.1 0.1 8.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.4 0.1 1.0 5.1 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.2 31.7 0.0 38.6 48.5 9.4 7.8 7.4 36.3 8.2 1.4 5.1 14.6 0.0 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.4 0.0 0.0 188.7 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 116.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.5 0.0 0.2 0.0 73.9 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 QRICH1 "AB-DIP, FLJ20259, VERBRAS" ENSG00000198218 "Glutamine rich 1" Q2TAL8 3 49029707-49094363 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Unfolded protein response" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037677, HPA037678" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA037677: AB_10671883, HPA037678: AB_2675603" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.29e-2)" "unprognostic (1.67e-1)" "unprognostic (2.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.77e-3)" "unprognostic (6.94e-2)" "unprognostic (2.82e-2)" "prognostic favorable (7.46e-4)" "unprognostic (1.12e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-3)" "unprognostic (5.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.76e-1)" "unprognostic (1.06e-1)" 27.3 28.1 13.6 30.8 16.4 61.6 28.0 24.0 20.5 26.1 14.7 25.9 26.6 28.9 26.1 30.3 27.8 25.4 26.2 15.6 15.0 21.4 23.7 28.0 40.4 14.3 13.2 15.3 34.3 26.2 33.4 25.0 27.2 15.6 26.1 25.5 30.7 28.5 26.5 35.1 35.6 31.2 29.1 11.8 36.1 26.2 44.9 12.7 52.3 26.0 32.7 42.3 27.1 23.9 16.1 41.4 39.6 78.6 35.6 48.2 45.8 48.2 48.4 60.3 75.6 70.7 44.3 50.8 65.6 29.1 58.9 62.8 33.5 69.0 63.0 64.8 57.8 45.1 65.5 52.9 37.8 43.1 57.9 75.0 53.3 47.4 74.8 46.6 46.2 60.3 62.7 45.0 58.6 51.6 31.8 84.9 41.4 62.3 43.7 48.9 43.3 40.3 55.4 47.6 63.2 29.9 58.9 54.9 47.7 39.7 59.3 42.4 65.5 52.5 49.0 55.1 43.7 69.8 54.2 66.6 82.2 44.0 55.2 57.2 21.3 15.6 19.1 18.1 18.9 21.5 16.6 17.3 20.6 18.5 16.6 18.3 22.0 11.7 18.1 33.0 13.5 19.8 14.3 13.6 16.4 24.0 20.5 15.6 15.0 14.3 13.2 15.3 15.6 11.8 12.7 16.1 21.8 9.6 18.9 19.6 30.5 22.2 13.7 16.0 17.1 13.6 20.6 17.7 21.1 14.3 17.9 20.2 22.9 25.7 28.2 16.6 1.9 15.9 15.8 19.8 20.7 19.6 25.9 22.5 37.9 14.0 27.8 20.3 23.9 27.5 16.5 20.0 18.9 20.4 19.7 11.8 39.1 20.6 10.2 25.3 18.3 10.9 22.4 19.5 12.4 14.0 22.3 12.5 15.5 24.6 25.5 18.6 10.5 30.9 39.7 18.0 14.4 10.1 15.2 17.6 6.6 21.9 25.3 52.4 27.8 24.5 22.6 36.8 28.5 17.0 16.8 15.5 CSF2RA "alphaGMR, CD116, CSF2R" ENSG00000198223 "Colony stimulating factor 2 receptor subunit alpha" P15509 X 1268800-1310381 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 248.5;Extravillous trophoblasts: 124.6;Langerhans cells: 365.1;Macrophages: 114.5;monocytes: 575.2;Syncytiotrophoblasts: 312.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 320.2" "Group enriched" "Detected in all" 30 "dendritic cells: 170.7;granulocytes: 320.2;monocytes: 161.1" "Group enriched" "Detected in some" 7 "BEWO: 194.0;HMC-1: 58.3;SK-MEL-30: 142.0" "Low region specificity" "Detected in single" CAB016148 Uncertain "Secreted to blood" NA NA 13000000 "CAB016148: AB_626868" "unprognostic (4.19e-2)" "prognostic favorable (2.38e-5)" "unprognostic (5.47e-2)" "unprognostic (4.33e-2)" "unprognostic (4.88e-2)" "prognostic favorable (2.81e-4)" "unprognostic (8.24e-2)" "unprognostic (2.17e-1)" "unprognostic (5.55e-2)" "unprognostic (8.48e-2)" "unprognostic (8.89e-2)" "unprognostic (3.80e-1)" "unprognostic (2.89e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (5.53e-4)" "unprognostic (3.60e-1)" "unprognostic (9.44e-2)" 10.1 5.6 3.5 25.7 4.9 21.9 6.9 5.2 5.5 5.1 5.7 5.8 5.9 2.6 1.7 5.4 4.1 12.8 2.5 3.5 7.4 2.3 4.7 14.3 21.1 7.6 5.5 2.2 1.8 3.4 3.1 1.5 64.9 8.4 2.5 7.5 0.7 3.1 3.0 0.6 4.0 6.6 7.2 7.8 15.1 5.0 1.1 6.3 9.5 1.6 2.0 23.7 12.8 1.5 9.3 0.3 11.5 0.5 0.0 0.0 0.0 194.0 0.3 0.5 0.4 0.1 4.2 1.0 0.2 12.6 0.0 10.3 0.2 0.1 0.0 0.0 3.9 0.1 0.2 8.0 0.1 0.0 4.6 58.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.4 18.8 1.6 1.8 0.4 0.2 0.5 0.3 0.0 0.5 0.1 0.3 3.7 0.1 142.0 15.1 9.4 16.8 0.0 0.2 5.5 0.1 0.0 0.1 0.1 0.6 0.0 18.5 0.1 17.4 161.1 200.3 0.4 94.9 1.0 2.3 0.3 0.3 170.7 0.6 0.4 0.3 320.2 7.3 48.7 164.0 1.1 65.5 3.5 4.9 5.2 5.5 3.5 7.4 7.6 5.5 2.2 8.4 7.8 6.3 9.3 1.2 0.0 7.3 1.3 5.5 7.8 0.9 0.1 0.6 0.6 6.3 2.5 1.2 2.8 3.6 1.8 0.0 248.5 38.3 0.0 0.0 0.3 0.6 7.8 1.2 5.3 0.0 1.3 1.4 1.8 124.6 3.4 0.0 14.7 10.1 0.5 0.7 0.1 75.5 0.0 1.7 0.0 2.0 74.8 365.1 0.3 0.9 114.5 8.8 66.5 575.2 0.3 0.0 1.5 0.9 0.2 0.0 0.4 1.0 0.5 0.0 0.1 2.7 1.5 6.6 1.8 1.4 0.2 0.4 0.0 5.3 312.5 3.3 0.1 0.0 2.5 FKBP1C bA184C23.2 ENSG00000198225 "FKBP prolyl isomerase 1C" 6 63211446-63213024 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 9.9;Cardiomyocytes: 11.7;Langerhans cells: 12.0;Melanocytes: 8.8;Suprabasal keratinocytes: 15.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.0;granulocytes: 4.4;monocytes: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051798 Uncertain NA NA "HPA051798: AB_2681615" "unprognostic (6.64e-2)" "unprognostic (1.25e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.19e-1)" "unprognostic (4.91e-5)" "unprognostic (4.78e-2)" "unprognostic (3.58e-1)" "unprognostic (1.98e-1)" "unprognostic (9.79e-2)" "unprognostic (8.54e-2)" "unprognostic (9.95e-2)" "unprognostic (9.46e-2)" "unprognostic (3.48e-1)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" 1.3 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.4 0.0 0.6 0.0 0.8 0.0 0.9 0.5 0.0 0.8 0.0 0.0 0.8 0.4 1.3 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.7 0.6 0.5 0.0 0.0 0.8 0.6 0.2 0.0 0.0 1.0 0.0 0.0 0.5 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.2 0.8 0.0 0.1 0.1 0.4 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 1.3 3.3 4.4 0.4 5.1 0.4 0.6 0.5 0.5 3.0 0.6 0.6 0.7 2.7 0.7 4.7 1.2 1.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.3 9.9 3.1 3.4 0.0 0.0 0.1 0.0 11.7 1.5 0.9 1.8 0.0 1.5 0.0 1.0 0.0 0.1 1.2 0.2 0.5 6.1 0.0 0.0 0.0 0.0 3.3 3.3 0.0 0.3 1.3 0.1 3.3 0.6 3.9 0.0 0.0 0.0 6.1 3.1 12.0 1.8 0.9 1.5 8.8 0.0 1.4 0.0 1.0 0.0 0.0 0.2 2.4 0.4 0.0 2.0 0.5 0.6 2.5 0.0 0.0 1.0 3.9 3.0 2.1 0.0 15.9 0.8 0.6 0.3 0.4 2.0 DDX42 "RHELP, RNAHP, SF3b125, SF3B8" ENSG00000198231 "DEAD-box helicase 42" Q86XP3 17 63773603-63819317 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023447, HPA023571, HPA025941" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562" "unprognostic (3.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.44e-2)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.06e-1)" "unprognostic (4.73e-2)" "unprognostic (1.90e-1)" "unprognostic (2.54e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (7.35e-2)" "unprognostic (1.55e-2)" 43.9 32.9 28.5 30.8 28.5 37.6 43.1 27.1 29.9 38.9 21.9 39.4 31.6 42.8 39.3 32.9 44.3 30.5 35.6 26.3 30.9 30.2 35.1 36.1 41.0 30.7 30.4 23.2 55.2 54.9 40.2 29.5 36.8 31.1 39.7 36.7 39.6 47.7 41.1 59.7 40.0 33.8 43.5 28.9 37.5 37.4 40.2 29.5 40.5 34.5 43.0 47.5 39.8 30.9 27.2 87.4 89.9 79.2 81.3 78.2 62.7 85.0 83.4 74.6 74.7 72.9 84.7 55.9 120.8 32.0 94.3 62.4 68.2 90.3 74.3 98.5 35.9 59.1 91.0 92.0 104.2 77.1 106.9 59.7 80.3 69.2 67.9 81.6 63.5 75.2 61.6 103.2 49.7 77.0 71.3 102.8 59.3 75.8 69.4 47.4 88.7 135.8 62.3 68.2 101.3 49.5 93.9 63.2 112.3 74.1 110.7 77.2 87.1 80.5 109.9 67.0 45.3 99.4 55.6 47.9 109.5 56.4 58.1 58.9 1.9 2.2 6.9 3.7 2.2 4.2 2.8 3.0 3.7 2.9 5.3 3.6 3.7 2.0 4.5 4.3 1.8 2.1 1.9 28.5 28.5 27.1 29.9 26.3 30.9 30.7 30.4 23.2 31.1 28.9 29.5 27.2 41.5 80.1 60.4 24.2 34.7 31.2 24.4 24.5 48.9 40.9 37.0 38.0 49.5 30.0 49.0 36.8 37.5 33.3 29.3 27.0 13.7 30.4 9.2 64.9 68.0 41.8 40.7 33.0 33.6 27.1 24.4 42.2 32.1 72.0 30.4 82.1 30.0 34.5 23.2 50.5 30.3 37.8 28.5 32.7 26.1 12.7 48.7 29.6 14.2 21.5 55.5 46.6 32.0 18.1 26.7 41.1 25.3 50.4 36.7 39.0 26.5 23.5 65.5 46.7 39.5 63.2 51.8 68.5 63.1 52.7 29.7 27.4 32.7 71.3 33.8 32.4 RPL23A L23A ENSG00000198242 "Ribosomal protein L23a" P62750 17 28719985-28724359 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA051754, HPA077474" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 86000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA051754: AB_2681593, HPA077474: AB_2686841" "unprognostic (1.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (9.79e-2)" "unprognostic (7.76e-2)" "unprognostic (1.91e-3)" "unprognostic (1.23e-1)" "unprognostic (9.64e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (3.91e-2)" "unprognostic (1.54e-1)" "unprognostic (3.98e-3)" "unprognostic (2.68e-1)" 1496.8 1122.3 659.5 677.7 677.4 1406.1 1583.9 652.9 1030.6 2090.5 647.3 1401.0 618.1 1405.7 724.9 1584.6 1648.4 540.1 1168.4 620.0 665.1 1102.0 890.2 1102.5 1445.1 676.8 667.4 613.2 3463.9 1798.9 529.9 1107.0 680.1 679.2 1330.8 829.3 346.6 1366.9 645.7 2023.6 2095.9 1352.6 676.0 732.6 1634.7 1376.3 397.4 693.5 979.1 1107.1 894.9 1541.9 1529.4 1739.2 705.2 1011.7 2016.2 1187.9 1478.2 1541.3 2460.3 1167.5 919.9 1609.3 1530.9 1285.0 2069.6 945.7 2272.0 842.9 1288.6 794.8 1336.2 1604.1 2059.1 1570.9 1207.4 4393.8 1090.0 1875.4 2228.4 1393.9 2286.0 1078.5 2415.4 2592.8 1218.4 1907.0 2198.5 1679.1 1024.9 1440.9 1494.0 1555.3 1668.7 2566.5 3014.5 1145.8 2554.4 1212.9 1485.1 2158.1 2703.9 1672.0 2029.6 1233.6 1432.9 656.5 4676.5 2224.2 1655.3 2336.4 2637.5 1009.1 833.0 1177.1 985.4 1663.8 1819.6 1831.8 1323.2 1314.2 1241.1 939.6 1095.3 1931.7 552.4 4031.6 2107.3 5926.1 6793.2 5786.8 5255.4 2964.7 5683.7 6315.4 5951.4 244.7 4162.0 1738.1 3784.3 4293.0 7336.1 659.5 677.4 652.9 1030.6 620.0 665.1 676.8 667.4 613.2 679.2 732.6 693.5 705.2 987.8 862.2 1387.4 42.1 4276.8 5192.7 5364.3 4497.6 1889.4 237.4 3483.7 2581.2 292.2 2254.7 2254.3 864.4 70.9 4486.2 3010.4 1253.0 3083.4 2444.1 968.0 1089.8 2060.3 2031.0 1846.3 1943.9 13.5 4593.6 6595.0 1928.4 821.6 1503.9 1512.6 1814.9 2939.2 2626.6 2651.7 163.2 17.2 3659.6 1310.2 3406.8 5015.0 360.5 4557.4 1983.9 3066.4 14.0 3997.3 1072.1 4293.5 16.1 23.3 2801.3 3326.6 2366.6 1803.5 5056.3 2925.9 3669.2 886.9 363.6 1709.2 3461.4 2748.7 674.8 779.0 2554.1 6196.5 4927.6 3651.6 2266.4 3979.8 5957.0 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319259-71381423 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.8;Hep G2: 35.9;RT4: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550" "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.43e-3)" 4.6 2.6 3.2 4.1 3.7 1.1 4.8 3.7 4.4 6.5 2.6 4.2 2.1 6.9 2.5 2.3 5.9 4.5 2.2 3.1 4.0 2.5 9.5 6.7 7.2 4.7 3.6 2.9 9.7 5.3 3.6 1.7 11.3 4.2 5.1 3.5 0.3 4.9 2.9 1.4 2.5 3.7 5.1 4.3 6.5 6.1 3.7 4.0 3.8 3.9 0.6 3.8 9.9 4.4 4.7 2.1 12.3 1.8 7.8 6.8 5.3 31.8 2.3 2.2 0.7 0.4 13.8 8.8 7.4 6.4 4.7 3.2 18.3 5.7 2.9 0.1 5.6 5.6 2.2 1.0 35.9 3.3 1.8 4.5 5.2 12.9 0.3 0.6 1.5 3.2 8.5 6.5 6.8 0.9 19.1 4.2 3.8 4.2 19.2 4.5 5.7 0.6 5.9 2.3 29.5 8.5 9.6 6.4 20.3 1.7 5.2 3.2 4.0 5.2 0.2 3.8 2.3 0.1 1.8 3.1 4.0 7.6 24.0 1.3 4.2 19.3 2.2 5.4 15.3 4.6 4.9 4.5 5.1 29.1 1.9 3.5 5.0 1.5 9.4 10.3 20.2 5.5 9.5 3.2 3.7 3.7 4.4 3.1 4.0 4.7 3.6 2.9 4.2 4.3 4.0 4.7 2.0 3.2 1.1 2.0 3.1 0.3 1.5 4.0 1.8 2.3 2.7 3.8 0.8 1.5 3.8 0.0 0.0 46.1 6.3 2.6 0.0 6.1 3.6 1.8 3.2 1.8 1.8 4.2 2.4 8.9 45.3 4.7 7.1 2.4 2.5 10.2 3.3 5.4 34.7 0.0 1.3 2.5 8.2 11.8 4.4 15.2 2.8 10.9 1.8 16.9 8.5 3.0 3.1 2.5 2.7 7.9 13.1 1.5 6.0 3.2 0.1 2.0 2.6 0.4 0.0 0.2 2.5 0.6 5.0 0.7 0.0 31.7 2.9 10.0 2.5 1.7 STYX ENSG00000198252 "Serine/threonine/tyrosine interacting protein" Q8WUJ0 14 52730166-52774989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 117.1;Late spermatids: 92.5;Spermatocytes: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040290 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA040290: AB_10963686" "unprognostic (5.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.22e-1)" "unprognostic (9.56e-2)" "unprognostic (2.43e-1)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.37e-1)" "unprognostic (3.00e-3)" "unprognostic (1.91e-2)" "unprognostic (3.21e-2)" "unprognostic (2.26e-1)" "unprognostic (1.57e-3)" "unprognostic (6.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.48e-2)" "unprognostic (6.84e-3)" 9.5 3.7 3.8 8.9 4.9 5.8 7.7 5.2 4.4 5.6 3.6 6.0 5.8 6.9 4.7 9.1 4.7 5.8 8.8 3.2 4.0 5.9 26.9 5.9 14.1 5.0 5.0 2.9 6.9 5.9 4.9 2.2 9.6 5.0 6.4 6.5 3.9 5.8 5.9 11.5 8.2 5.7 7.0 4.6 9.2 6.7 11.0 4.4 9.5 5.7 13.0 12.5 7.5 4.9 6.1 14.4 7.8 10.5 12.7 17.5 24.9 20.0 16.9 12.6 12.1 12.2 11.3 10.3 17.7 14.1 16.0 10.2 11.1 13.1 13.8 21.3 16.0 5.0 9.1 8.3 15.0 14.5 14.5 11.5 17.9 16.4 16.0 16.4 10.9 22.2 15.7 11.0 16.6 16.9 19.9 16.3 9.5 12.7 16.1 15.9 13.6 14.1 10.5 15.8 16.1 2.4 7.0 17.3 11.5 11.4 14.6 28.1 14.5 20.8 21.1 13.4 23.1 10.7 6.1 8.8 10.8 6.8 9.6 18.3 7.7 4.4 3.7 5.6 6.1 7.4 6.1 9.2 7.6 4.8 3.8 10.6 8.2 2.2 4.9 5.8 3.6 10.8 5.6 3.8 4.9 5.2 4.4 3.2 4.0 5.0 5.0 2.9 5.0 4.6 4.4 6.1 15.2 6.4 9.2 6.2 18.3 16.6 10.7 10.2 9.6 5.1 14.1 8.0 23.1 8.6 11.4 5.5 6.2 13.8 19.7 7.6 13.7 12.4 117.1 9.1 10.9 16.0 4.8 15.6 7.7 18.2 32.8 11.8 11.2 8.9 20.8 5.9 16.1 54.7 15.4 5.0 7.6 6.1 8.2 21.2 20.4 92.5 9.6 20.2 3.6 10.3 27.6 8.7 15.5 6.6 15.9 14.5 7.9 11.3 16.2 19.6 8.1 12.0 14.6 6.9 26.3 8.7 19.6 73.1 25.7 16.9 19.6 21.1 25.6 5.9 8.2 13.6 UBL5 ENSG00000198258 "Ubiquitin like 5" Q9BZL1 19 9827892-9830115 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 3183.1" "Low region specificity" "Detected in all" NA NA "unprognostic (2.53e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (4.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.96e-1)" "unprognostic (7.30e-2)" "unprognostic (7.85e-2)" "unprognostic (8.51e-2)" "unprognostic (3.14e-3)" "unprognostic (2.04e-2)" "unprognostic (4.79e-2)" "unprognostic (1.05e-2)" "unprognostic (3.64e-1)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (2.23e-3)" 286.8 453.7 488.4 204.2 497.1 326.6 289.9 499.6 618.1 280.2 527.0 315.5 220.5 266.0 518.1 378.8 263.8 215.7 610.4 488.5 529.6 471.7 405.0 265.3 283.1 492.2 492.8 483.0 271.8 228.9 490.7 442.9 217.6 492.7 303.2 266.6 277.1 281.3 287.6 537.8 258.3 261.9 250.6 512.1 306.1 306.0 277.5 493.1 431.2 306.8 572.1 324.9 300.6 280.5 524.6 609.5 633.1 536.4 508.8 755.8 589.0 320.0 434.9 519.8 557.0 687.0 800.0 338.5 374.8 745.6 651.7 475.1 380.9 562.1 634.2 532.7 629.4 1032.4 1110.5 783.3 1328.0 508.8 1105.1 471.2 612.2 658.5 406.4 437.8 569.2 630.0 798.3 697.9 888.0 669.8 1016.8 758.8 3183.1 534.7 758.8 1046.3 444.4 435.8 972.4 1054.9 1138.9 474.9 616.1 380.3 358.4 568.1 612.2 397.3 1029.3 517.3 608.9 277.1 787.5 579.1 1046.1 1812.3 800.4 540.0 713.6 370.6 865.4 497.7 1271.3 424.7 488.1 410.8 445.4 468.2 464.3 466.7 352.4 395.3 430.8 818.7 395.9 529.2 780.2 618.9 756.0 488.4 497.1 499.6 618.1 488.5 529.6 492.2 492.8 483.0 492.7 512.1 493.1 524.6 387.5 256.4 330.2 8.1 329.4 397.7 342.1 779.0 236.2 177.4 479.0 535.4 763.9 446.1 491.5 662.1 62.6 549.6 422.1 970.8 1486.9 574.3 168.8 613.3 370.8 335.4 433.4 400.4 6.8 519.7 598.4 336.7 284.4 523.3 400.8 305.2 327.7 932.9 705.0 126.2 6.7 693.1 571.7 447.8 548.4 130.6 472.5 423.9 499.8 8.4 729.1 591.6 503.6 6.6 11.9 645.8 1081.0 495.0 427.5 460.5 1117.0 1610.2 642.1 230.1 355.0 284.4 417.4 622.6 596.8 420.5 519.0 585.7 395.1 235.8 555.7 495.3 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070444-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 6.2 6.7 4.2 8.6 4.9 12.6 6.6 11.7 5.8 7.7 8.7 5.8 4.9 7.4 6.1 4.8 6.1 7.1 6.1 4.1 5.4 7.0 11.0 6.8 9.9 5.1 5.0 2.1 12.4 7.8 12.0 6.1 11.3 5.5 6.1 6.6 14.4 6.3 6.3 9.2 4.4 6.0 7.6 3.6 9.2 6.6 10.9 4.8 15.5 8.8 14.2 9.0 6.7 5.0 7.7 10.3 10.0 12.3 12.3 14.8 8.4 18.7 9.0 8.8 11.8 12.4 14.7 7.9 21.2 7.2 12.0 7.4 10.5 23.3 11.3 18.4 8.2 7.3 27.2 10.7 12.5 7.1 22.3 15.6 9.8 10.5 11.4 14.1 8.8 18.1 15.6 19.1 12.9 9.8 13.0 29.0 7.6 7.4 9.2 9.7 19.3 21.6 9.2 9.1 14.3 12.0 11.0 14.3 11.5 15.2 16.9 13.7 13.7 16.1 14.5 16.6 8.0 8.1 10.7 13.4 15.5 7.2 13.7 15.5 2.3 3.3 2.8 5.1 2.8 6.3 1.7 3.1 3.2 2.8 2.8 1.9 2.6 2.3 2.6 1.9 2.2 3.0 2.3 4.2 4.9 11.7 5.8 4.1 5.4 5.1 5.0 2.1 5.5 3.6 4.8 7.7 42.9 19.2 37.1 89.1 44.3 32.1 24.6 30.2 29.6 50.8 32.8 23.6 31.1 24.3 30.2 27.6 93.8 32.9 95.8 29.4 7.9 19.1 5.2 49.4 55.8 32.3 38.3 48.8 93.1 14.2 42.8 30.9 38.7 118.5 33.7 51.9 61.8 52.1 31.9 67.3 112.1 30.2 16.2 79.4 28.8 10.5 38.8 55.4 14.2 107.7 62.0 24.0 104.0 134.2 72.6 19.2 23.1 42.9 67.1 29.3 27.7 14.6 26.1 54.9 13.1 45.9 34.0 36.0 26.0 33.6 20.2 18.3 71.0 32.6 26.3 45.8 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 60.2" "Cell type enhanced" "Detected in many" "Early spermatids: 67.8;Spermatocytes: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 19.3" "Cell line enhanced" "Detected in many" "RT4: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.5 8.9 6.9 2.3 7.9 1.2 11.5 9.4 8.5 6.0 23.4 3.6 11.2 2.7 7.1 4.2 4.9 6.8 17.7 6.4 6.6 31.1 12.4 8.6 4.6 6.9 7.4 6.2 5.3 4.3 60.2 6.5 3.0 7.2 3.9 3.8 7.1 13.4 6.0 6.6 11.2 6.3 2.1 7.0 3.5 10.3 27.3 7.3 5.4 6.4 5.8 6.9 7.4 3.3 8.7 6.2 6.4 8.9 9.7 8.3 6.6 6.0 5.1 7.5 6.1 6.6 4.6 5.1 6.9 2.9 3.5 7.6 5.9 4.8 5.1 5.4 17.1 4.1 4.4 5.4 5.1 13.2 1.6 0.7 7.8 8.5 7.7 13.5 6.7 2.2 13.2 8.7 5.0 6.5 9.4 2.3 14.2 10.6 14.5 3.9 7.0 3.8 12.2 18.9 33.1 8.1 5.6 5.3 4.4 8.3 11.7 16.0 22.9 1.6 5.8 1.8 5.1 2.2 6.5 12.1 6.6 7.9 5.5 8.0 1.1 2.6 4.5 8.1 4.5 6.8 2.9 18.5 15.6 2.9 3.6 9.6 10.8 0.4 2.4 3.5 4.2 19.3 4.0 6.9 7.9 9.4 8.5 6.4 6.6 6.9 7.4 6.2 7.2 7.0 7.3 8.7 4.0 3.2 18.5 17.3 6.2 5.5 6.2 8.8 7.4 11.2 14.0 12.8 21.7 7.2 10.1 29.5 16.7 18.6 10.2 5.7 23.5 4.2 67.8 7.0 4.3 3.5 0.0 3.4 28.3 4.0 5.9 5.9 7.7 3.7 5.7 7.0 2.2 5.4 5.1 10.1 25.6 4.6 24.4 4.1 4.5 33.5 9.3 3.9 7.2 7.5 3.6 13.4 11.3 13.0 33.3 2.7 3.2 4.9 5.5 4.2 20.9 10.3 18.6 17.3 6.6 6.5 6.6 123.5 37.4 6.2 5.4 40.1 17.4 7.0 6.0 7.6 KRTAP4-5 KAP4.5 ENSG00000198271 "Keratin associated protein 4-5" Q9BYR2 17 41148924-41149825 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 80 "skin 1: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UCKL1 "FLJ20517, URKL1" ENSG00000198276 "Uridine-cytidine kinase 1 like 1" Q9NWZ5 20 63939829-63956416 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004722, HPA004769" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA004722: AB_1080455, HPA004769: AB_1080453" "unprognostic (1.03e-1)" "unprognostic (2.77e-2)" "unprognostic (2.64e-1)" "unprognostic (8.34e-2)" "unprognostic (7.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.45e-1)" "unprognostic (1.29e-1)" "prognostic favorable (4.42e-4)" "unprognostic (5.87e-2)" "unprognostic (3.18e-2)" "unprognostic (9.11e-2)" "unprognostic (2.81e-1)" "unprognostic (3.01e-1)" "unprognostic (5.26e-3)" 41.9 47.7 17.5 17.6 18.6 25.0 44.4 26.4 33.4 52.7 19.4 46.0 33.8 42.3 7.3 50.8 50.2 12.0 54.2 16.4 16.6 54.5 56.1 40.9 21.3 19.5 17.8 15.5 75.5 46.7 17.3 52.7 18.0 21.7 49.9 8.8 56.3 43.8 17.7 61.7 42.0 52.2 9.7 16.1 65.2 37.5 25.9 18.1 16.1 59.5 36.9 11.1 40.4 54.4 27.6 29.2 30.3 25.5 34.2 18.4 15.6 40.9 22.8 15.4 46.2 23.0 72.8 22.0 29.3 37.5 14.9 31.6 46.7 20.0 31.4 9.2 12.3 33.6 22.2 67.8 108.1 20.3 38.2 40.8 21.9 27.6 18.5 15.1 18.3 21.5 28.4 32.1 30.3 14.6 37.4 45.1 66.3 18.9 23.0 70.0 45.4 19.2 51.0 19.1 41.4 60.3 35.3 32.9 31.8 36.2 12.7 33.4 34.1 24.2 48.7 18.2 32.1 30.1 31.5 18.1 13.6 25.0 27.1 18.8 8.0 11.4 9.9 18.3 19.7 21.0 31.0 17.8 15.8 13.3 17.1 10.1 12.4 1.8 8.5 22.2 7.6 20.8 12.1 17.5 18.6 26.4 33.4 16.4 16.6 19.5 17.8 15.5 21.7 16.1 18.1 27.6 31.7 25.6 8.3 17.0 24.1 18.9 21.4 29.9 14.8 30.7 13.5 17.3 20.3 18.6 17.7 9.2 83.4 31.2 16.8 24.7 23.5 19.4 2.4 18.2 17.0 19.4 21.5 5.5 7.8 11.1 23.6 17.5 25.0 22.7 13.3 21.1 13.6 12.4 17.6 20.2 9.7 21.2 32.6 11.4 16.4 3.7 17.7 14.5 10.6 4.7 17.0 18.5 12.3 10.1 12.2 17.5 27.4 20.7 21.4 17.8 38.7 16.1 11.3 148.0 26.3 16.2 30.1 12.7 12.4 22.5 19.0 33.4 22.0 28.4 24.3 19.2 OR5B21 ENSG00000198283 "Olfactory receptor family 5 subfamily B member 21" A6NL26 11 58507175-58508105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CARD11 "BIMP3, CARMA1" ENSG00000198286 "Caspase recruitment domain family member 11" Q9BXL7 7 2906142-3043867 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" Immunity "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7" "Cell type enhanced" "Detected in many" "B-cells: 34.9;dendritic cells: 47.2;Microglial cells: 49.6;NK-cells: 28.8;Pancreatic endocrine cells: 24.9;Plasma cells: 26.7;T-cells: 28.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "thalamus: 15.5" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 31.4" "Lineage enriched" "Detected in many" 4 "dendritic cells: 31.4" "Cell line enhanced" "Detected in many" "Daudi: 122.7;K-562: 50.1;RT4: 91.4;U-698: 108.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052984 Approved NA NA "HPA052984: AB_2682005" "unprognostic (3.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (4.81e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-1)" "unprognostic (2.31e-1)" "unprognostic (5.65e-2)" "unprognostic (5.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (6.68e-8)" "unprognostic (3.74e-2)" "unprognostic (4.75e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.10e-4)" 1.3 3.1 5.0 22.0 1.6 18.6 1.2 1.1 1.6 2.3 1.0 2.4 3.8 1.3 0.2 1.3 2.2 8.8 1.0 0.6 4.1 1.5 1.6 4.8 47.7 2.8 7.3 0.0 1.3 1.4 0.7 0.9 0.5 3.5 1.4 2.4 0.2 3.4 1.6 0.6 0.7 18.4 0.6 2.2 31.7 7.6 1.8 15.5 21.1 1.5 0.2 29.8 17.3 1.3 2.7 16.7 2.6 0.1 0.1 0.0 0.0 12.2 0.1 0.0 0.5 0.0 32.4 35.5 122.7 29.2 0.0 0.0 27.2 0.0 0.4 0.3 42.1 1.1 0.1 3.1 0.3 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.8 23.1 13.3 50.1 0.0 0.0 0.3 4.7 0.0 44.9 20.6 0.1 5.9 0.1 30.7 11.4 91.4 0.3 1.5 0.1 0.2 0.1 17.7 0.2 2.5 15.4 0.2 11.8 0.1 0.1 12.3 0.1 108.0 0.0 0.0 0.2 0.5 0.0 0.0 7.7 0.0 7.2 5.4 4.4 5.2 0.9 6.2 2.9 5.3 0.2 5.5 0.0 31.4 3.5 2.9 5.0 1.6 1.1 1.6 0.6 4.1 2.8 7.3 0.0 3.5 2.2 15.5 2.7 0.5 0.0 0.0 0.7 34.9 0.0 0.3 0.3 0.6 0.6 0.3 0.4 2.0 0.0 0.3 1.8 0.0 0.0 47.2 0.7 0.0 4.6 0.2 0.4 0.3 0.6 0.0 0.8 2.1 5.3 0.0 1.6 14.3 0.7 5.7 8.6 0.4 0.2 1.5 0.0 1.6 0.3 0.0 2.4 1.8 0.4 0.3 5.4 3.6 49.6 1.0 0.1 28.8 1.0 0.6 24.9 0.0 0.0 26.7 0.3 0.0 0.1 1.0 0.2 0.0 0.3 0.9 1.5 0.2 0.0 0.3 0.0 28.6 4.5 0.4 8.1 ZNF485 ENSG00000198298 "Zinc finger protein 485" Q8NCK3 10 43606419-43617904 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 8.9;Spermatocytes: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA059356 Uncertain NA NA "HPA059356: AB_2683988" "prognostic unfavorable (5.24e-4)" "unprognostic (1.34e-1)" "unprognostic (4.18e-1)" "unprognostic (1.08e-1)" "unprognostic (5.12e-3)" "unprognostic (3.21e-1)" "unprognostic (1.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (4.56e-3)" "unprognostic (4.12e-2)" "unprognostic (2.40e-2)" "unprognostic (3.46e-6)" "unprognostic (8.45e-2)" "unprognostic (1.61e-1)" "unprognostic (1.30e-1)" "unprognostic (1.41e-2)" 1.2 1.7 2.3 2.2 2.9 0.7 3.8 2.5 2.8 1.7 2.0 2.1 1.7 2.3 1.7 1.9 2.7 1.1 1.4 2.1 2.6 1.4 1.8 1.3 3.4 2.7 2.7 2.3 3.9 4.1 1.5 1.0 1.0 3.0 2.6 2.0 1.8 1.9 1.8 3.1 3.9 1.6 1.6 2.2 2.3 2.4 4.0 2.6 2.1 1.9 2.5 3.4 1.8 1.7 3.6 3.3 2.4 1.9 7.1 3.7 4.3 0.1 3.6 1.0 4.0 5.6 6.8 5.1 11.1 3.7 1.4 1.6 3.3 4.2 3.5 6.5 4.9 3.3 0.1 3.0 3.1 2.8 1.8 5.2 3.1 5.8 2.5 4.7 1.8 1.6 1.9 10.4 0.2 7.9 5.4 5.8 5.4 9.7 5.2 3.0 3.1 1.3 2.6 3.6 3.1 7.0 5.5 1.7 5.9 2.2 2.9 9.7 3.8 2.2 2.9 4.3 4.4 5.8 7.3 8.5 2.2 0.6 2.7 2.8 0.1 1.9 0.9 4.3 3.8 6.7 6.0 5.5 4.8 2.6 4.8 9.2 5.7 0.3 13.8 1.3 1.5 4.8 3.3 2.3 2.9 2.5 2.8 2.1 2.6 2.7 2.7 2.3 3.0 2.2 2.6 3.6 1.2 0.0 1.1 0.3 2.4 0.6 1.8 1.7 2.8 1.7 2.0 2.3 2.6 1.5 1.8 0.0 0.0 0.9 1.5 0.7 3.9 2.0 8.9 0.6 2.2 1.0 0.0 2.5 2.1 2.0 0.9 1.3 0.5 0.6 0.0 2.5 1.4 1.3 1.5 1.7 2.7 1.9 0.0 0.6 0.4 4.6 0.6 1.1 0.0 1.0 1.0 0.6 2.1 2.0 3.4 1.7 2.1 1.2 0.6 1.6 0.2 1.6 0.2 0.6 0.0 2.4 1.1 19.9 4.7 2.6 0.6 0.3 2.1 2.6 2.4 0.9 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810077-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 77.6;brain: 171.0;choroid plexus: 144.9;ovary: 262.4;placenta: 136.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026070 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.68e-3)" 2.4 77.6 73.4 1.5 55.8 0.1 11.0 4.9 44.2 8.7 144.9 3.8 0.6 23.0 5.9 2.2 13.0 1.9 3.5 27.3 171.0 3.4 4.6 1.8 0.5 54.5 72.9 32.2 262.4 2.6 10.0 29.0 136.2 70.4 3.0 1.7 18.1 5.4 5.0 0.7 1.5 1.4 9.2 12.8 0.8 2.1 33.9 110.0 1.0 5.7 1.8 6.3 3.5 3.3 89.5 0.0 0.0 4.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 218.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.6 0.0 71.7 0.1 0.1 0.1 0.2 6.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 7.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 73.4 55.8 4.9 44.2 27.3 171.0 54.5 72.9 32.2 70.4 12.8 110.0 89.5 4.1 0.0 4.6 0.0 0.2 4.8 1.9 0.0 4.0 31.0 10.9 17.8 17.2 1.5 1.8 1.8 8.4 345.8 1.6 0.0 1.9 0.9 32.0 1.3 35.0 3.5 0.0 0.0 0.0 0.0 45.4 56.9 0.0 1.6 0.0 224.1 4.6 4.3 34.3 148.0 0.0 0.0 0.0 0.6 1.7 19.4 58.7 1.2 14.2 0.0 0.0 17.0 0.0 0.0 0.0 0.3 0.0 109.9 0.0 2.0 0.0 1.1 2.2 13.7 13.1 29.5 17.0 53.0 36.2 2.0 2.6 477.1 0.2 395.9 0.0 0.7 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Human disease related genes, Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favorable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 14.7 13.6 10.2 15.0 11.4 7.3 18.1 9.0 12.4 13.7 9.5 14.4 12.0 17.8 19.1 15.4 12.8 8.8 14.4 11.3 11.0 15.1 15.9 12.7 21.4 10.2 9.2 10.2 13.9 17.9 17.9 9.0 13.0 10.2 14.3 15.3 6.8 15.1 16.4 23.1 15.0 11.2 17.3 8.9 15.6 14.1 21.5 11.2 16.6 21.4 16.5 20.4 19.0 11.8 10.7 29.8 11.8 28.5 38.9 33.1 29.8 30.6 41.3 35.9 34.0 29.1 36.6 42.0 46.7 30.2 38.1 32.4 29.7 44.5 40.5 42.3 41.2 23.0 39.9 24.4 30.6 32.7 68.5 43.9 26.4 45.0 36.3 40.4 21.1 30.0 31.2 72.7 37.8 36.4 33.1 69.6 25.1 47.4 48.3 18.1 41.8 53.5 39.3 32.7 32.6 43.3 35.6 28.1 57.0 48.9 31.1 26.4 39.6 29.1 36.6 36.7 44.4 34.8 33.9 37.6 62.0 40.7 31.1 46.0 10.4 14.5 4.1 19.1 19.1 23.8 17.8 23.0 21.1 15.3 20.1 23.0 19.5 2.3 23.4 27.5 13.0 21.5 15.9 10.2 11.4 9.0 12.4 11.3 11.0 10.2 9.2 10.2 10.2 8.9 11.2 10.7 36.2 19.2 34.7 15.0 45.7 27.5 26.8 45.1 35.3 21.1 21.3 29.1 12.3 14.3 46.0 22.0 6.2 30.6 35.7 14.5 35.2 37.7 109.0 12.1 29.9 25.2 22.8 35.3 34.0 24.9 32.2 27.4 20.9 18.7 49.4 26.3 18.9 22.1 37.9 13.5 31.8 22.6 36.7 24.3 16.3 106.7 25.4 30.0 24.9 30.9 40.3 23.7 42.2 23.6 29.9 33.4 18.3 33.1 49.0 37.1 17.1 46.6 26.1 20.0 19.7 33.2 38.7 75.6 100.7 47.5 33.1 25.0 38.1 33.2 27.9 22.4 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141883-28159460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 9.8 7.7 5.1 8.2 6.1 15.0 11.6 9.0 7.3 11.3 6.9 10.4 6.7 16.0 13.4 5.7 11.1 7.6 7.7 4.8 5.6 7.7 7.4 9.3 10.6 5.3 5.5 4.1 17.7 10.0 13.0 8.5 9.5 6.1 10.4 8.5 17.8 9.1 11.7 8.2 8.0 10.8 10.7 5.2 10.9 9.3 9.2 5.3 13.2 10.7 8.9 11.0 10.3 8.0 9.4 9.0 5.6 26.1 25.4 15.8 14.9 8.2 9.7 18.3 12.6 15.7 6.3 5.3 19.4 15.7 9.4 10.5 7.4 16.7 6.2 17.9 11.2 14.1 17.7 11.7 13.6 14.4 21.8 12.7 15.4 10.4 12.9 19.2 21.5 12.5 16.9 27.9 7.1 12.9 4.4 15.5 18.2 9.5 2.1 6.4 17.0 16.5 15.2 8.6 10.9 19.5 24.7 11.6 5.3 11.9 14.3 5.9 11.7 10.9 18.1 10.5 6.1 13.2 17.3 13.2 15.6 5.1 14.8 9.9 2.2 0.5 0.6 1.0 1.2 1.1 0.5 0.6 0.4 0.4 1.7 1.0 0.8 0.1 1.1 2.1 0.7 0.6 0.6 5.1 6.1 9.0 7.3 4.8 5.6 5.3 5.5 4.1 6.1 5.2 5.3 9.4 6.9 3.2 9.3 11.8 9.8 4.8 2.6 3.8 14.8 9.5 8.5 5.1 8.0 7.2 5.0 7.3 6.2 4.2 11.0 2.0 0.0 3.1 3.7 5.9 10.0 8.8 7.2 9.4 11.1 2.9 2.0 9.5 4.6 7.4 5.1 12.7 8.6 10.2 4.1 6.7 12.5 4.6 4.1 11.1 6.8 5.2 9.0 6.0 1.8 15.9 5.9 6.5 4.1 26.7 17.1 3.0 2.4 9.1 9.0 4.3 2.3 3.5 6.1 9.2 0.0 9.9 7.3 11.9 8.6 8.5 2.8 2.3 7.1 7.4 3.7 1.9 PHETA1 "FAM109A, FLJ32356, IPIP27A, SES1" ENSG00000198324 "PH domain containing endocytic trafficking adaptor 1" Q8N4B1 12 111360651-111369121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 32.6;Granulosa cells: 9.6;Hofbauer cells: 10.6;Pancreatic endocrine cells: 33.8;Theca cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.1" "Group enriched" "Detected in many" 4 "B-cells: 1.0;dendritic cells: 3.1;monocytes: 1.9" "Cell line enhanced" "Detected in many" "Hep G2: 43.5;OE19: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.26e-1)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.05e-1)" "unprognostic (6.02e-2)" "unprognostic (1.15e-3)" "unprognostic (6.18e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (5.51e-2)" "unprognostic (9.42e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" 6.9 17.2 6.3 3.7 5.6 1.6 6.8 4.9 7.6 10.2 4.6 11.6 28.9 9.9 2.2 12.7 7.9 5.2 13.9 5.0 6.3 9.8 19.6 11.0 2.2 7.0 6.2 5.3 14.1 29.2 2.9 5.1 2.6 6.4 9.4 5.5 1.1 9.6 3.6 10.2 19.4 28.2 3.6 5.4 23.4 22.9 11.0 6.7 1.2 6.5 4.6 2.0 7.1 8.7 5.2 8.5 7.4 6.2 9.5 8.5 7.4 16.5 5.4 4.7 4.2 2.2 11.7 5.7 0.2 11.5 8.2 5.9 4.6 3.3 3.5 1.8 3.4 7.6 5.7 2.7 43.5 5.0 1.1 7.4 6.1 8.8 6.3 2.0 8.3 6.3 2.8 13.4 0.6 5.2 8.0 1.4 6.8 9.7 34.3 17.6 5.6 4.2 2.5 4.3 4.7 1.4 18.6 8.4 12.8 3.7 5.2 8.7 2.1 7.6 6.2 12.4 7.2 4.2 5.5 5.0 1.0 6.2 3.8 7.1 0.0 1.2 0.2 0.3 1.9 0.4 0.2 0.1 0.1 3.1 1.0 0.0 0.4 0.0 0.3 1.9 0.3 0.0 0.9 6.3 5.6 4.9 7.6 5.0 6.3 7.0 6.2 5.3 6.4 5.4 6.7 5.2 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.3 3.2 0.0 0.0 0.0 3.7 0.0 1.3 1.4 0.0 3.9 6.8 0.0 2.8 5.2 1.3 0.0 0.0 0.0 32.6 5.5 1.8 0.0 4.0 0.0 9.6 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.2 0.2 8.9 0.0 0.0 TMEM239 ENSG00000198326 "Transmembrane protein 239" Q8WW34 20 2816302-2820284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 107.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 127.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HDLM-2: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.12e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HYLS1 FLJ32915 ENSG00000198331 "HYLS1 centriolar and ciliogenesis associated" Q96M11 11 125883614-125900646 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.8" "Cell type enhanced" "Detected in many" "Early spermatids: 80.8;Late spermatids: 54.9;Spermatocytes: 92.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 2.9 2.4 6.5 3.0 6.6 2.4 4.3 9.3 8.0 4.3 6.0 4.8 6.1 3.9 6.7 3.7 4.2 2.6 5.1 6.5 6.8 5.5 5.8 2.5 6.3 6.3 6.2 6.6 3.9 2.2 2.7 2.4 4.4 6.7 5.1 5.0 4.3 3.2 6.1 2.8 4.8 3.3 6.5 5.7 3.6 5.4 26.8 6.9 5.2 2.5 4.4 9.1 3.9 2.3 7.0 11.2 23.9 8.4 5.9 16.5 11.6 14.8 27.3 10.9 24.8 16.9 0.3 17.2 5.0 11.3 25.4 8.4 15.8 12.2 10.0 28.7 27.1 9.2 3.5 2.3 4.9 12.9 12.4 16.9 7.2 11.0 25.2 28.3 5.1 18.4 11.0 6.1 27.3 33.6 18.6 9.1 36.2 18.4 46.2 40.8 19.0 0.1 16.5 27.3 17.9 11.6 7.2 29.6 22.2 11.0 10.5 53.6 26.9 16.7 1.8 20.9 19.4 4.6 10.1 11.4 11.4 5.1 26.7 22.2 5.7 7.6 1.5 10.6 8.7 10.2 16.1 13.8 12.6 10.0 16.1 13.2 9.7 1.1 6.8 6.3 20.4 15.5 7.1 6.5 6.6 9.3 8.0 6.5 6.8 6.3 6.2 6.6 6.7 5.7 6.9 7.0 3.9 0.0 0.5 2.6 9.3 4.2 2.8 8.0 4.6 7.1 4.1 5.3 5.5 1.5 2.2 1.8 4.2 18.6 11.5 4.0 11.7 5.5 80.8 5.8 3.4 3.7 4.9 9.1 14.3 4.2 13.0 5.9 8.6 2.1 0.0 7.1 6.8 5.4 7.6 0.0 13.8 3.2 8.2 3.2 4.0 54.9 8.4 2.5 7.2 6.5 11.9 5.8 12.3 6.0 5.8 3.6 5.8 6.0 4.2 3.3 5.2 12.1 4.8 6.5 6.6 2.3 5.7 92.1 32.3 6.2 4.3 4.4 4.9 7.5 5.5 1.5 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "heart muscle: 3302.6" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2426.3" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 11.7" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 9 "dendritic cells: 1.8" "Cell line enriched" "Detected in some" 4 "HEL: 552.8" "Group enriched" "Detected in all" 6 "amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9" "Not detected" "Not detected" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" NA NA 3100000 "Plasma membrane" "HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927" "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 2.0 0.5 0.3 0.4 0.3 135.7 2.8 0.2 0.4 0.3 0.4 0.7 0.8 0.8 0.0 0.6 0.5 1.1 3302.6 0.3 0.3 1.3 1.4 9.5 0.9 0.3 1.1 0.2 0.8 8.7 0.3 0.5 9.2 0.4 1.1 0.3 42.5 3.0 0.2 3.6 1.1 1.3 0.8 0.3 3.1 3.5 15.6 0.3 2.4 11.1 6.5 0.4 0.9 0.8 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.3 0.0 0.2 0.0 0.9 0.1 1.6 0.9 0.0 0.4 0.0 0.1 0.0 0.0 3.0 0.2 552.8 0.1 0.0 0.0 0.0 0.3 21.2 0.0 0.3 0.1 0.0 1.0 1.4 133.3 0.3 0.2 0.0 10.0 0.1 0.3 0.0 0.4 0.3 12.9 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 24.3 0.0 0.2 4.5 0.0 0.3 0.1 0.0 0.3 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.3 0.3 0.2 0.4 0.3 0.3 0.3 1.1 0.2 0.4 0.3 0.3 0.4 3.2 3.2 0.0 0.0 0.7 0.8 0.0 0.0 0.0 5.5 0.0 0.0 2426.3 0.0 0.0 0.0 64.6 0.5 2.7 0.1 0.0 0.1 23.3 0.1 0.0 23.2 0.0 412.8 0.1 0.0 3.9 150.7 1.5 0.1 0.0 0.3 1.8 0.5 1.9 1.7 0.0 0.8 0.0 0.6 0.6 54.6 3.4 34.0 12.4 0.0 1.5 7.9 4.1 0.0 0.1 0.1 0.0 1.5 0.8 0.0 10.9 0.2 0.0 24.4 0.0 0.6 36.5 9.9 0.5 0.0 0.9 1.4 0.3 0.2 1.0 0.0 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345944-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.2" "Cell type enhanced" "Detected in many" "Adipocytes: 7.7;Granulosa cells: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 5.5" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: AB_2682138" "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 1.5 1.0 5.5 1.0 4.2 0.5 1.7 3.2 3.2 1.8 5.3 1.1 0.6 1.9 1.1 0.9 2.1 0.6 1.2 2.3 6.3 2.0 2.0 1.2 1.3 10.3 4.3 0.8 5.0 1.7 1.3 0.9 1.0 8.1 1.7 1.3 1.3 0.9 2.1 0.8 1.2 0.8 1.6 4.5 1.7 0.9 1.3 6.1 1.2 2.0 1.5 1.0 1.8 1.5 14.2 0.2 0.0 1.7 2.2 1.0 0.5 0.1 2.3 0.6 2.0 1.6 1.6 0.5 2.0 0.7 1.2 0.8 0.4 1.4 1.1 1.9 0.0 0.2 0.1 3.2 1.5 0.8 0.0 1.9 0.9 1.2 0.8 0.3 0.1 0.2 1.4 2.9 0.2 1.8 1.5 2.4 0.3 1.4 0.3 1.0 0.1 2.5 0.1 0.8 1.3 0.1 0.4 0.0 0.0 0.0 1.9 2.2 1.5 0.0 2.6 1.3 3.3 1.4 2.0 5.5 0.0 0.1 0.0 1.0 0.5 0.3 2.2 0.8 0.5 0.5 2.5 0.5 0.5 0.5 0.4 1.3 0.8 0.6 0.4 0.4 0.5 0.0 0.3 5.5 4.2 3.2 3.2 2.3 6.3 10.3 4.3 0.8 8.1 4.5 6.1 14.2 7.7 0.0 2.6 1.0 2.4 0.4 1.1 2.2 1.8 1.6 1.9 1.9 2.8 1.5 0.6 1.8 6.2 0.4 1.6 0.7 1.9 0.9 1.0 0.9 1.6 3.2 1.2 0.4 0.9 0.9 0.4 2.5 0.0 1.2 2.5 7.0 3.6 1.6 1.5 0.0 1.5 0.7 2.0 2.4 0.6 0.5 0.6 1.5 3.6 1.9 1.6 2.2 3.1 0.5 1.3 0.2 0.1 0.4 2.7 0.8 0.3 3.7 1.8 1.7 0.0 4.8 3.9 2.4 2.5 1.2 0.6 0.4 1.3 0.6 0.5 0.6 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467733-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 18.1" HPA056406 Uncertain Approved Vesicles NA NA Vesicles "HPA056406: AB_2683119" "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 1.3 1.1 1.0 1.5 1.3 1.4 2.3 1.0 1.0 1.1 1.3 1.8 1.8 1.3 4.0 1.2 1.8 1.4 0.7 0.9 1.1 1.3 0.7 1.4 2.2 1.3 1.2 0.7 1.8 1.3 2.4 0.6 3.6 1.3 4.9 1.7 0.6 1.2 1.1 0.4 2.0 1.7 1.0 0.9 1.9 1.9 1.6 1.2 2.2 1.9 0.5 2.1 1.4 1.2 1.8 0.9 0.8 2.6 4.3 2.2 2.6 6.0 2.4 2.4 1.6 2.3 4.6 2.7 6.9 2.3 2.3 3.0 1.4 6.3 2.7 3.0 0.0 9.9 6.9 1.8 5.2 1.1 0.0 7.1 2.2 2.2 1.8 1.3 0.9 1.4 4.9 3.8 0.1 2.6 1.3 9.2 3.8 3.3 0.8 2.4 5.6 5.7 3.4 1.5 18.1 1.1 2.5 0.0 4.5 1.6 5.6 1.8 3.4 2.3 0.9 3.1 0.1 2.3 3.6 5.5 7.5 0.0 0.0 4.7 1.8 1.1 0.8 1.7 1.6 1.7 1.6 1.6 1.9 1.2 2.4 3.0 2.3 0.5 3.6 3.0 1.1 1.3 1.4 1.0 1.3 1.0 1.0 0.9 1.1 1.3 1.2 0.7 1.3 0.9 1.2 1.8 3.4 6.4 1.8 0.3 4.4 1.8 3.1 1.4 4.6 0.7 1.9 1.8 1.9 5.7 2.6 0.0 0.0 5.0 4.3 2.5 1.9 2.2 1.7 2.6 3.2 4.0 0.0 3.4 0.3 1.2 10.1 4.1 3.6 2.6 0.0 7.0 13.6 1.2 2.8 3.3 1.0 3.2 2.0 3.0 1.7 0.9 2.5 2.6 3.6 1.0 3.7 1.1 3.1 2.0 2.8 1.5 3.4 2.2 1.5 5.0 1.2 0.8 2.0 0.6 0.0 4.0 3.4 0.9 4.1 2.2 1.6 8.9 2.8 2.6 3.9 2.3 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 9.1;Endometrial ciliated cells: 12.3;Granulosa cells: 10.5;Sertoli cells: 6.6;Squamous epithelial cells: 8.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 12.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 23.8;HDLM-2: 31.2;HEK 293: 33.0;SH-SY5Y: 27.3" "Region enriched" "Detected in single" 24 "pons and medulla: 9.4" "Group enriched" "Detected in some" 49 "medulla oblongata: 4.9;pons: 3.7;spinal cord: 6.0" HPA053910 Supported Nucleoplasm NA NA Nucleoplasm "HPA053910: AB_2682305" "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 6.3 4.5 0.4 2.1 1.9 0.1 5.2 0.2 3.0 0.7 0.1 1.9 1.1 4.7 7.3 8.2 27.3 0.4 0.3 0.2 1.0 13.6 0.1 0.8 3.6 13.4 4.1 0.0 11.2 0.3 0.1 0.1 6.3 15.6 1.6 0.2 0.0 0.3 0.9 9.2 6.1 6.8 4.8 6.4 1.8 5.2 3.3 1.9 0.4 1.0 0.0 1.9 0.8 0.8 7.6 5.3 5.1 0.0 23.8 9.4 4.9 0.0 2.4 2.5 2.4 1.7 0.2 4.3 20.5 0.2 18.5 0.1 4.7 0.4 0.6 1.5 31.2 33.0 0.2 2.9 0.0 1.1 2.5 0.7 12.5 2.3 13.7 2.4 0.0 0.3 6.7 1.1 0.0 8.9 0.3 2.8 0.5 0.1 0.9 0.1 6.7 7.2 0.0 10.2 0.0 0.0 27.3 3.8 1.2 13.7 1.1 18.0 1.2 0.0 12.0 6.9 1.0 12.8 5.3 6.0 10.6 0.7 2.3 12.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 3.0 0.2 1.0 13.4 4.1 0.0 15.6 6.4 1.9 7.6 1.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 9.1 0.0 1.4 3.4 0.5 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.9 0.0 4.1 12.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.6 0.1 0.0 10.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 2.9 3.1 0.2 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.1 0.0 1.5 3.7 0.0 0.1 2.9 0.0 0.0 6.6 3.9 3.6 2.7 0.5 8.2 0.0 0.3 1.6 2.7 0.1 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0;epididymis: 21.6" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 0.5 0.9 1.7 0.0 2.1 0.0 0.4 0.2 2.3 1.4 0.0 0.5 0.0 2.4 21.6 0.1 2.3 0.1 0.0 2.5 2.6 0.2 0.0 0.0 0.1 10.0 1.6 1.7 1.4 0.0 2.5 1.3 0.0 3.0 1.5 0.0 0.2 0.3 4.3 0.1 0.2 0.2 1.3 1.5 0.0 0.3 5.5 2.5 0.0 0.1 0.9 0.2 1.2 0.5 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.1 0.2 2.3 2.5 2.6 10.0 1.6 1.7 3.0 1.5 2.5 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PIM3 ENSG00000198355 "Pim-3 proto-oncogene, serine/threonine kinase" Q86V86 22 49960768-49964072 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 408.4;Syncytiotrophoblasts: 389.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 20.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 163.3;SK-BR-3: 144.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068758 Supported Cytosol NA Yes Cytosol "HPA068758: AB_2686026" "unprognostic (3.67e-2)" "unprognostic (7.69e-3)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-2)" "unprognostic (5.83e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.09e-4)" "unprognostic (5.59e-3)" "unprognostic (1.71e-1)" "unprognostic (3.92e-3)" "unprognostic (7.27e-3)" 89.0 48.8 26.7 31.6 29.1 115.3 80.8 30.6 37.2 46.4 26.2 45.7 24.0 41.1 12.8 81.4 54.4 26.1 62.7 23.6 31.2 112.7 93.7 108.0 28.5 38.8 34.7 21.1 36.0 73.7 21.7 51.7 21.5 39.4 88.0 10.5 3.1 94.3 22.8 112.9 116.1 52.0 10.0 29.6 81.3 119.1 34.2 32.0 19.2 55.3 35.3 13.1 71.6 69.2 39.0 26.8 17.7 11.6 21.9 9.0 6.7 65.5 16.5 26.7 19.4 14.0 29.5 22.3 47.3 20.1 4.6 39.1 22.5 22.3 12.6 6.9 35.8 92.1 19.5 46.3 36.0 41.8 42.5 36.0 12.8 41.0 11.9 20.2 10.5 63.5 31.7 27.0 163.3 5.9 60.6 21.7 76.4 24.2 28.1 27.8 100.3 19.2 57.6 10.6 20.3 41.1 28.6 32.2 144.7 109.2 10.7 19.0 56.4 16.8 12.1 51.5 19.8 27.1 82.2 56.9 41.4 30.1 24.1 33.2 0.0 4.0 0.1 2.2 4.1 2.5 4.3 5.0 4.4 3.1 7.5 4.8 1.9 20.7 1.7 5.2 7.0 5.8 2.7 26.7 29.1 30.6 37.2 23.6 31.2 38.8 34.7 21.1 39.4 29.6 32.0 39.0 120.2 64.1 85.9 6.5 107.7 227.3 236.8 79.1 96.8 31.5 99.2 67.3 32.8 121.5 72.8 80.9 2.1 56.9 79.5 57.9 84.1 50.9 5.1 114.2 76.3 167.7 97.7 10.8 10.2 54.5 346.5 69.0 202.3 170.5 69.3 16.8 98.6 45.9 69.7 62.2 6.7 101.7 81.4 41.1 408.4 4.8 32.3 134.8 108.5 6.5 35.8 14.0 11.3 6.6 20.5 71.0 94.6 11.3 95.1 298.4 58.1 88.5 40.9 16.5 26.3 39.4 57.3 26.1 37.7 95.3 204.7 389.9 90.4 11.6 79.0 266.0 GET3 "ARSA-I, ASNA1, TRC40" ENSG00000198356 "Guided entry of tail-anchored proteins factor 3, ATPase" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli NA NA 37000 Nucleoli Nucleoplasm "HPA045951: AB_2679511, HPA048087: AB_2680258" "unprognostic (2.87e-1)" "prognostic favorable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavorable (8.47e-4)" 47.8 62.1 53.7 39.7 54.7 66.8 46.9 55.7 73.4 47.2 55.9 42.0 40.3 50.2 41.4 58.6 47.4 39.6 62.6 54.8 54.2 61.7 38.7 41.2 48.7 53.2 53.2 52.1 42.2 48.6 73.9 48.5 28.3 54.3 34.6 29.0 36.7 47.7 31.7 68.2 58.7 39.0 34.2 51.1 43.7 51.3 60.7 55.4 47.3 56.8 59.1 38.4 46.7 43.7 53.6 143.7 116.5 60.7 132.3 118.6 72.4 74.6 72.4 99.7 137.5 107.6 90.3 69.6 64.8 111.0 95.4 157.5 75.2 84.5 97.6 65.4 100.9 132.7 54.3 82.4 105.3 125.8 83.5 104.9 83.6 84.1 111.3 66.1 89.2 99.4 75.9 71.3 86.8 109.5 320.4 112.9 68.1 154.6 92.0 215.6 82.2 93.6 128.4 130.2 120.7 111.6 95.5 97.3 131.3 119.8 51.5 108.2 80.5 85.5 193.3 65.4 217.1 172.4 153.9 279.4 61.7 136.2 137.0 109.0 33.6 44.3 26.3 24.8 34.3 21.2 20.3 22.0 22.2 44.8 17.0 15.7 19.5 15.6 16.7 42.9 29.4 34.2 35.8 53.7 54.7 55.7 73.4 54.8 54.2 53.2 53.2 52.1 54.3 51.1 55.4 53.6 14.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 106.6 13.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 80.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 110.7 1.7 0.0 0.0 0.0 ASPH "BAH, CASQ2BP1, HAAH, JCTN" ENSG00000198363 "Aspartate beta-hydroxylase" Q12797 8 61500556-61714640 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Dioxygenase, Oxidoreductase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 390.4" "Cell type enhanced" "Detected in all" "Muller glia cells: 468.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 34.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 890.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055161, HPA059303" Uncertain Enhanced "Endoplasmic reticulum" NA NA 1100000 "Endoplasmic reticulum" "HPA055161: AB_2682721, HPA059303: AB_2683973" "unprognostic (8.07e-2)" "prognostic unfavorable (8.07e-5)" "unprognostic (1.73e-2)" "unprognostic (4.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (6.39e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.57e-5)" "unprognostic (8.96e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (2.74e-2)" 390.4 161.8 68.3 51.0 65.7 17.0 108.0 107.2 95.6 66.2 83.5 79.6 46.0 49.7 45.1 72.0 47.3 61.5 112.3 69.6 101.5 60.0 75.5 74.8 20.4 55.8 67.6 53.4 62.8 45.1 39.0 36.5 48.3 68.3 48.7 85.8 221.4 102.8 70.9 361.0 34.6 45.9 68.1 46.9 28.8 106.0 16.7 74.7 16.8 97.9 184.3 28.7 113.2 44.1 65.7 460.3 652.3 89.9 55.1 392.1 370.1 31.2 804.0 741.3 336.3 350.1 113.1 594.2 35.3 54.3 474.6 270.3 167.5 56.2 281.1 570.0 13.6 57.0 81.1 372.5 310.3 251.2 12.5 12.9 306.5 61.9 187.6 237.4 657.2 144.8 18.0 22.2 32.1 300.2 97.4 3.3 16.6 51.7 441.6 383.4 22.3 97.0 7.3 206.2 374.0 93.1 32.1 249.9 116.1 101.7 49.0 47.7 22.2 456.7 338.0 174.3 313.0 288.0 20.2 27.1 1.5 890.1 7.5 231.4 1.9 8.3 0.3 2.5 2.9 4.7 5.5 3.5 2.4 10.0 5.0 4.9 2.5 25.4 8.7 1.8 34.0 4.0 4.1 68.3 65.7 107.2 95.6 69.6 101.5 55.8 67.6 53.4 68.3 46.9 74.7 65.7 79.1 195.5 244.0 366.6 13.8 47.0 160.7 126.0 68.9 138.3 83.7 58.4 228.6 37.1 157.5 86.5 294.0 118.1 40.3 57.0 15.6 144.2 1.6 51.4 65.8 85.9 116.5 13.0 93.1 180.4 107.1 132.0 73.9 115.4 8.2 34.5 42.8 62.6 72.2 127.9 98.9 215.1 52.9 26.6 44.1 3.1 70.8 48.1 42.7 61.8 20.0 468.8 2.1 154.8 53.5 257.7 32.3 57.6 15.9 148.2 34.3 34.6 66.6 158.8 46.0 114.4 92.7 3.4 16.8 101.7 50.3 48.0 13.6 131.2 67.3 254.2 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 108.7;Excitatory neurons: 138.5;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "NK-cell: 1.9;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 4 "dendritic cells: 4.2;NK-cells: 1.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038256: , HPA064394: AB_2732712" "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 22.2 11.5 13.1 9.8 16.2 7.0 21.9 12.4 23.0 13.5 7.4 16.6 15.1 16.6 8.6 11.0 13.4 13.3 14.8 15.3 11.9 13.6 25.0 18.5 14.1 15.3 12.7 13.4 14.2 18.2 16.8 11.6 15.9 13.6 12.4 16.2 11.0 16.1 10.9 8.0 10.8 13.9 11.6 11.4 8.6 20.0 7.4 13.4 29.0 18.0 14.1 15.5 15.6 14.2 13.7 60.4 32.9 32.2 32.4 41.1 40.9 22.2 16.1 25.2 10.9 14.5 43.4 16.4 41.2 9.2 20.8 29.2 18.7 18.2 37.2 21.9 52.3 11.6 9.7 9.1 45.2 21.0 25.7 18.8 33.1 22.2 37.2 36.9 22.9 6.9 24.9 39.1 16.9 17.7 40.9 22.6 26.7 16.1 43.4 35.4 17.1 28.6 24.2 34.1 52.3 13.1 45.1 18.1 14.8 44.2 20.1 15.1 23.7 11.4 27.6 35.8 23.8 27.4 33.2 13.8 73.7 44.7 27.1 54.2 0.0 0.2 0.0 0.6 0.7 0.0 0.0 0.1 0.5 0.4 0.0 0.1 0.1 0.6 1.9 0.3 4.2 0.0 0.7 13.1 16.2 12.4 23.0 15.3 11.9 15.3 12.7 13.4 13.6 11.4 13.4 13.7 49.7 19.2 16.0 108.7 1.8 39.9 29.0 12.0 41.5 17.8 22.7 17.7 7.5 14.3 6.6 9.2 6.2 11.0 3.3 32.0 13.7 11.0 1.5 16.8 11.4 18.6 11.4 1.7 138.5 8.6 8.4 21.0 14.8 35.0 1.3 2.8 13.9 14.1 6.7 25.2 122.4 24.1 8.2 7.5 67.6 4.1 17.1 10.2 19.6 68.4 26.0 7.9 0.0 124.1 23.2 13.9 21.5 12.4 0.5 23.4 17.1 7.4 7.2 9.8 26.3 17.0 17.4 3.9 10.4 16.6 16.8 3.0 3.8 4.7 10.9 24.0 WWP2 AIP2 ENSG00000198373 "WW domain containing E3 ubiquitin protein ligase 2" O00308 16 69762328-69941741 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-3)" "unprognostic (2.86e-1)" "unprognostic (1.73e-1)" "unprognostic (1.14e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (7.50e-2)" "unprognostic (2.08e-2)" "unprognostic (9.81e-2)" "prognostic favorable (5.87e-11)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.62e-1)" 24.3 31.5 21.3 18.3 21.8 34.4 23.0 18.7 22.5 22.7 22.1 22.8 23.6 22.8 10.2 26.4 23.7 15.2 15.5 18.9 20.3 32.0 18.6 23.6 22.2 22.1 21.0 19.8 23.6 29.8 26.1 17.9 16.3 21.7 20.7 20.0 15.7 32.1 17.4 21.7 28.5 23.7 14.5 19.9 30.5 26.5 16.2 20.9 19.9 22.7 9.3 19.5 19.0 21.1 25.8 25.0 24.8 15.7 16.3 12.9 10.7 24.1 16.3 18.6 27.4 28.3 23.1 18.5 28.4 17.4 29.2 14.9 28.6 20.8 24.7 20.4 13.4 17.9 15.9 15.1 39.4 24.1 28.3 22.4 15.7 17.9 37.4 25.9 15.4 25.6 24.1 24.5 15.5 17.6 43.2 15.5 30.9 22.1 20.6 10.5 34.6 13.1 49.5 26.6 23.6 19.3 21.3 69.1 19.8 15.4 10.2 30.9 34.6 25.6 21.3 30.8 29.9 19.8 36.3 26.0 42.7 22.9 23.6 38.2 35.9 19.0 29.8 16.3 23.5 12.2 10.8 12.1 13.0 14.9 12.4 12.3 8.7 49.7 8.5 30.8 7.0 11.7 17.1 21.3 21.8 18.7 22.5 18.9 20.3 22.1 21.0 19.8 21.7 19.9 20.9 25.8 11.9 9.6 31.0 16.0 18.7 7.4 7.0 5.4 9.1 9.0 10.0 8.3 8.7 21.5 12.8 14.7 10.4 10.0 13.1 47.2 1.9 12.3 22.6 13.9 7.5 13.1 16.8 13.9 20.3 20.0 9.2 8.2 31.1 14.4 21.5 12.7 13.2 13.3 12.8 10.1 26.0 16.1 6.1 22.7 13.6 38.5 10.2 18.8 10.6 42.2 18.8 12.3 19.6 79.4 56.4 16.8 23.6 8.6 12.4 6.1 22.6 10.0 24.1 6.5 13.1 6.9 17.7 8.1 6.0 9.6 6.0 20.0 14.6 7.0 20.4 9.9 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319780-69387250 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 184.2;Intestinal goblet cells: 244.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA 93000 "Nucleoplasm, Nucleoli" "Nucleoli fibrillar center" "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favorable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 31.5 18.1 7.0 21.6 6.8 15.2 22.6 5.8 7.7 38.2 27.3 75.0 38.8 15.8 42.0 16.6 24.5 32.8 25.0 6.6 10.6 21.8 23.3 17.2 10.7 5.2 7.7 5.8 12.1 34.0 26.4 19.1 36.3 9.1 37.1 77.4 10.5 42.8 26.1 10.3 6.0 41.6 23.4 5.4 9.6 64.9 47.0 8.4 10.3 92.5 14.0 16.0 22.0 9.3 9.2 46.6 42.7 34.7 20.9 107.7 75.8 73.5 97.1 94.5 44.7 59.3 109.5 50.5 31.7 31.9 92.9 61.4 22.6 47.1 28.6 73.6 38.4 18.4 38.2 25.0 94.5 123.0 27.9 17.9 47.8 132.5 88.7 158.8 55.5 43.4 29.8 34.8 58.3 85.2 30.9 31.3 22.9 37.0 116.7 27.4 28.2 79.1 18.3 70.6 42.0 25.2 11.9 35.2 52.4 93.7 73.5 22.7 17.2 61.8 37.2 62.3 64.6 47.5 39.5 32.2 25.4 65.7 18.3 46.9 9.2 3.5 4.9 7.5 4.3 7.0 6.4 6.5 8.3 4.7 3.6 6.3 6.2 1.2 5.2 5.2 4.4 5.0 4.2 7.0 6.8 5.8 7.7 6.6 10.6 5.2 7.7 5.8 9.1 5.4 8.4 9.2 14.6 51.3 49.5 15.7 29.8 28.4 21.6 31.7 26.7 13.7 50.6 16.5 43.1 42.9 54.5 44.1 12.5 28.6 30.3 184.2 17.6 34.1 123.9 54.4 54.1 17.2 75.1 3.8 49.2 89.5 70.3 37.6 110.1 60.0 24.1 19.2 17.9 53.6 17.0 6.7 56.3 244.0 16.2 10.0 31.4 23.7 23.3 16.0 53.4 27.2 28.1 10.6 13.4 42.7 43.8 66.0 83.3 28.2 82.1 72.3 62.5 30.0 89.7 14.0 19.7 21.6 41.8 134.1 45.3 20.3 21.0 34.3 33.4 15.7 135.3 56.3 UVRAG VPS38 ENSG00000198382 "UV radiation resistance associated" Q9P2Y5 11 75815210-76144232 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 144.6;Microglial cells: 178.9;Oligodendrocytes: 361.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016932 Uncertain NA NA "HPA016932: AB_1858707" "unprognostic (3.92e-2)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (4.22e-3)" "unprognostic (2.29e-1)" "unprognostic (1.02e-1)" "unprognostic (1.15e-2)" "unprognostic (2.89e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (7.89e-2)" "unprognostic (2.18e-2)" "unprognostic (6.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.94e-2)" "unprognostic (3.03e-1)" 32.4 12.9 12.4 18.0 17.9 34.2 20.9 14.0 16.1 13.8 32.9 12.2 10.7 13.4 14.5 10.2 13.4 15.4 10.8 12.4 13.8 11.7 15.4 15.6 26.7 15.8 16.8 12.3 12.5 8.2 21.5 7.3 18.4 18.0 10.5 12.6 19.3 8.0 11.5 14.7 11.6 10.7 15.0 17.3 21.6 12.8 8.0 14.2 25.5 13.0 14.9 25.7 13.3 9.0 26.3 10.3 14.4 11.2 9.7 27.2 20.2 16.3 15.0 27.5 17.4 13.8 19.7 18.9 49.5 30.5 20.5 30.7 10.8 19.5 17.5 19.9 27.2 7.8 18.3 12.2 16.8 24.2 30.6 19.1 17.4 14.6 23.8 42.6 13.1 51.0 22.0 19.6 29.7 16.5 24.1 20.9 19.6 11.1 32.1 15.7 17.3 28.5 40.9 14.8 35.0 15.3 10.8 16.6 16.7 13.2 17.1 20.9 27.4 45.3 16.8 12.7 62.4 10.3 18.4 23.3 51.0 7.6 16.0 21.3 5.8 9.9 8.4 7.0 8.8 6.4 23.4 6.1 6.9 16.8 26.6 8.2 6.6 13.9 8.1 11.4 24.0 6.3 4.7 12.4 17.9 14.0 16.1 12.4 13.8 15.8 16.8 12.3 18.0 17.3 14.2 26.3 97.3 12.8 21.3 53.8 97.0 9.2 9.4 9.8 26.7 52.2 17.5 19.4 16.1 10.0 11.3 7.3 68.8 37.6 41.6 9.5 7.9 11.5 6.2 13.6 28.1 36.5 5.4 24.6 144.6 8.7 10.3 24.7 34.1 18.5 10.8 16.0 20.0 9.2 17.3 53.8 124.6 10.0 8.2 22.0 50.8 2.6 21.5 46.3 8.8 178.9 45.8 19.0 34.0 89.0 361.8 10.5 11.4 16.1 40.4 12.1 10.8 11.0 6.5 53.1 13.1 27.2 28.6 13.5 19.1 19.4 12.6 32.8 28.1 25.1 10.1 9.1 KRTAP13-1 KAP13.1 ENSG00000198390 "Keratin associated protein 13-1" Q8IUC0 21 30396031-30396822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "skin 1: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1400000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF26 "FLJ20755, KOX20" ENSG00000198393 "Zinc finger protein 26" P17031 12 132986365-133032952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018329, HPA042406" Uncertain Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA018329: AB_1859157, HPA042406: AB_2677982" "unprognostic (7.31e-3)" "unprognostic (7.60e-3)" "unprognostic (7.26e-4)" "unprognostic (5.52e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.52e-3)" "unprognostic (3.00e-2)" "unprognostic (9.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-3)" "unprognostic (2.66e-12)" "unprognostic (8.24e-2)" "unprognostic (7.20e-2)" "unprognostic (1.94e-3)" "unprognostic (7.64e-4)" 0.7 0.7 1.3 1.0 1.1 1.6 0.8 1.8 1.6 0.9 1.7 0.7 0.8 0.9 1.5 0.6 1.2 0.5 0.5 1.4 0.7 0.6 0.6 1.0 0.9 1.3 0.7 1.6 0.9 0.9 0.4 0.7 0.5 1.0 0.7 0.6 1.4 0.8 0.5 1.2 1.4 0.8 0.6 0.7 1.0 0.8 1.1 1.0 0.6 0.8 0.2 0.8 0.7 0.8 1.9 1.3 0.3 1.0 2.0 0.4 0.5 3.4 0.9 0.7 0.9 0.5 0.4 1.0 0.9 1.8 0.8 0.6 1.4 0.4 0.4 0.5 1.1 3.1 2.0 1.2 0.4 0.2 2.7 3.2 0.8 0.7 0.6 1.3 0.8 0.4 1.4 1.3 0.3 0.6 1.4 2.5 1.7 2.2 0.4 2.4 3.0 2.6 2.7 0.3 2.5 2.6 4.2 0.8 1.3 1.1 0.5 2.9 2.4 2.4 1.5 1.1 0.7 1.2 0.7 0.1 3.5 0.9 1.6 1.8 5.9 1.2 3.2 4.0 1.4 4.0 2.1 3.4 2.9 1.8 3.8 4.3 3.8 0.9 3.4 1.3 1.5 3.3 2.8 1.3 1.1 1.8 1.6 1.4 0.7 1.3 0.7 1.6 1.0 0.7 1.0 1.9 10.7 22.4 16.0 6.5 15.7 0.0 9.0 0.1 7.4 26.6 9.1 6.7 5.2 11.5 8.2 5.5 25.0 6.4 18.9 3.3 3.9 7.5 1.1 8.8 9.5 10.1 8.4 3.8 11.6 5.7 4.2 8.2 9.2 8.4 9.5 20.3 11.4 5.6 5.3 26.9 8.8 7.0 0.0 6.6 0.0 1.5 8.1 7.5 0.0 11.2 6.5 5.6 17.5 9.5 10.3 8.4 4.9 6.0 10.7 8.1 5.9 2.8 3.0 23.2 0.0 19.1 7.4 12.1 10.9 5.3 0.0 4.8 15.8 14.0 7.2 7.8 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449901 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "kidney: 17.9" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 68.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain NA NA "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 68.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360536 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 23.3 21.6 13.8 36.1 13.0 74.3 15.4 7.7 17.9 18.1 22.7 18.2 17.7 19.7 13.0 37.0 15.6 19.1 20.2 11.7 19.2 21.4 27.6 27.3 53.8 13.0 13.6 9.3 16.6 67.5 18.9 16.4 24.9 13.1 18.0 20.3 16.1 18.6 15.2 23.5 26.7 22.5 18.2 10.4 43.7 24.9 15.3 15.9 30.3 51.1 19.0 51.3 22.4 24.7 19.4 41.2 19.7 4.8 14.2 13.6 18.1 43.5 24.5 22.8 11.1 13.2 19.2 21.4 63.6 21.2 20.4 32.7 18.2 21.9 15.5 18.3 50.8 21.0 86.1 12.6 21.4 22.9 44.7 47.6 14.2 17.7 19.4 33.7 21.1 35.3 23.7 25.0 46.7 17.6 16.9 18.4 21.7 8.9 24.9 19.1 22.8 55.7 19.0 19.6 76.0 3.3 9.9 19.4 20.6 29.5 19.2 14.1 23.7 49.1 23.6 20.6 19.6 22.9 50.6 60.4 65.0 18.8 40.4 21.0 69.6 30.4 56.2 31.1 37.0 32.8 68.7 26.8 27.7 28.7 73.1 27.4 24.6 112.8 26.5 59.3 18.9 31.2 20.3 13.8 13.0 7.7 17.9 11.7 19.2 13.0 13.6 9.3 13.1 10.4 15.9 19.4 62.6 96.1 103.3 64.6 143.2 51.7 82.0 21.7 41.5 23.7 21.9 20.2 70.5 22.8 48.5 29.5 20.9 26.1 88.6 42.5 17.6 53.0 4.3 42.8 21.5 62.8 24.5 33.2 114.7 75.5 35.3 40.7 53.0 62.1 103.9 30.4 39.3 27.8 42.4 13.5 98.2 28.6 26.4 93.1 111.1 7.6 30.1 102.2 24.9 132.1 107.1 16.0 105.0 104.0 140.5 88.3 48.4 18.0 85.2 74.9 40.1 27.0 35.3 33.2 13.1 54.2 40.3 95.6 58.8 36.4 58.1 24.2 94.9 28.3 24.6 116.6 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 7.1;brain: 22.3" "Group enriched" "Detected in some" 10 "Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 116 "basophil: 94.5" "Lineage enriched" "Detected in single" 768 "granulocytes: 94.5" "Cell line enriched" "Detected in some" 4 "HMC-1: 82.1" "Region enhanced" "Detected in many" "basal ganglia: 8.4" "Region enriched" "Detected in single" 6 "basal ganglia: 4.1" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol NA NA 79000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 0.5 7.1 0.6 0.4 2.7 0.8 0.2 1.7 6.1 0.6 0.6 0.5 0.5 1.0 0.0 0.1 0.5 0.4 1.0 0.3 3.2 2.9 0.0 0.5 0.1 17.9 6.5 1.1 0.1 0.2 0.0 0.7 0.3 22.3 1.4 0.0 1.9 0.5 0.3 0.4 0.1 0.3 0.6 0.1 0.1 0.5 1.6 1.6 0.3 0.2 0.2 0.0 0.3 0.6 11.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 11.9 0.0 14.0 0.0 0.0 0.0 0.0 82.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 1.6 0.0 0.2 0.0 2.4 0.2 0.0 1.5 2.5 0.0 0.2 0.0 0.5 1.5 18.2 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 1.1 0.0 0.0 3.5 0.6 0.0 0.0 0.0 0.1 94.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.6 2.7 1.7 6.1 0.3 3.2 17.9 6.5 1.1 22.3 0.1 1.6 11.8 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 4.2 0.7 0.0 0.0 4.3 0.0 0.1 55.9 0.0 0.0 0.0 0.1 57.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.9 3.2 2.7 0.0 0.1 0.0 1.0 0.1 0.0 0.0 OGA "MEA5, MGEA5, NCOAT" ENSG00000198408 O-GlcNAcase O60502 10 101784443-101818465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;dendritic cells: 89.3;Glandular and luminal cells: 83.7;Granulosa cells: 69.4;Pancreatic endocrine cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036141, HPA076501" Approved Supported Cytosol NA NA Cytosol "HPA036141: AB_10672079, HPA076501: AB_2686802" "unprognostic (4.34e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (4.63e-1)" "unprognostic (2.06e-1)" "unprognostic (2.57e-2)" "unprognostic (2.65e-1)" "unprognostic (1.79e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-3)" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.90e-1)" "unprognostic (9.23e-3)" 60.5 34.4 80.6 47.1 82.0 89.8 59.7 103.2 83.4 61.3 60.8 59.8 28.4 50.4 56.0 57.8 53.4 30.0 57.4 83.5 78.3 45.9 46.4 53.3 70.4 71.2 74.1 75.4 67.4 43.3 61.0 45.2 41.4 73.5 53.1 41.1 100.7 50.9 39.3 57.1 72.8 63.3 35.7 68.3 75.0 46.8 38.9 80.9 68.2 52.2 29.8 65.3 57.5 59.1 81.1 89.8 44.7 63.7 124.6 40.0 96.6 44.4 61.7 61.8 28.1 48.0 33.1 56.0 59.6 43.7 73.7 48.2 62.9 60.3 77.5 59.2 87.9 41.2 59.6 65.0 26.0 43.1 44.4 32.3 93.9 85.1 48.1 113.7 80.0 53.0 53.1 42.8 107.3 48.3 45.6 47.2 46.1 35.4 19.4 44.8 64.8 70.5 44.0 47.2 80.0 27.7 48.8 55.2 29.4 78.2 58.0 77.9 47.7 80.9 43.0 41.6 63.0 71.6 53.1 91.0 47.2 54.0 74.6 24.0 14.4 2.1 7.2 6.4 2.0 5.1 6.6 4.5 5.8 1.3 7.5 6.1 5.2 14.1 6.6 6.3 3.3 4.6 1.5 80.6 82.0 103.2 83.4 83.5 78.3 71.2 74.1 75.4 73.5 68.3 80.9 81.1 66.3 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 66.5 47.0 0.0 0.0 0.0 86.5 0.0 41.9 89.3 0.0 13.7 38.0 0.0 61.6 68.3 18.1 0.0 0.0 0.0 40.9 34.3 20.3 0.0 83.7 0.0 69.4 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 48.6 0.0 0.0 0.0 0.0 82.4 0.0 0.0 44.3 0.0 0.0 34.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 50.9 34.6 44.8 0.0 0.0 MT1F MT1 ENSG00000198417 "Metallothionein 1F" P04733 16 56657731-56660698 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 590.1;kidney: 579.1;liver: 566.6;thyroid gland: 1194.1" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 10399.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 61.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 55.6;classical monocyte: 30.2;gdT-cell: 47.0;MAIT T-cell: 41.8;memory B-cell: 25.7;memory CD4 T-cell: 48.9;memory CD8 T-cell: 80.3;naive CD4 T-cell: 49.4;naive CD8 T-cell: 85.5;T-reg: 89.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 143.4;NB-4: 238.9;NTERA-2: 137.1;RPTEC TERT1: 754.6;THP-1: 131.9;U-937: 126.2" NA NA 160000 "unprognostic (4.15e-2)" "unprognostic (3.60e-2)" "unprognostic (6.78e-2)" "unprognostic (2.78e-2)" "unprognostic (1.95e-3)" "unprognostic (1.88e-3)" "unprognostic (2.70e-1)" "unprognostic (4.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.14e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.02e-7)" "unprognostic (2.78e-1)" "unprognostic (3.50e-2)" "unprognostic (2.65e-2)" "unprognostic (2.85e-1)" 28.7 60.9 318.7 30.2 324.1 10.3 16.6 374.2 590.1 8.1 283.4 159.8 82.9 8.7 2.7 10.7 20.0 19.3 7.9 307.5 310.0 579.1 566.6 11.6 23.6 362.4 332.2 300.1 2.8 315.0 5.1 23.4 4.0 339.8 71.1 124.1 52.9 18.5 14.1 2.9 8.3 224.0 16.7 318.6 20.7 89.1 4.5 349.8 6.4 1194.1 1.8 14.7 14.9 6.1 326.4 4.9 7.4 0.0 0.2 0.4 0.3 10.0 6.1 15.6 5.6 9.5 2.0 29.5 0.1 19.3 1.3 8.8 26.5 51.5 6.0 5.8 143.4 7.1 8.9 1.4 2.6 3.7 0.2 100.9 1.5 1.7 6.1 1.7 2.5 0.8 2.1 0.4 0.1 0.3 14.7 0.4 238.9 137.1 1.2 12.9 0.0 0.6 4.4 754.6 5.3 75.1 8.3 6.1 2.4 2.6 19.8 3.5 131.9 0.0 0.0 1.7 0.9 0.7 0.4 0.0 0.0 87.5 126.2 1.1 55.6 30.2 8.9 47.0 2.8 41.8 25.7 48.9 80.3 8.2 10.7 49.4 85.5 4.8 8.1 1.4 3.3 89.2 64.1 318.7 324.1 374.2 590.1 307.5 310.0 362.4 332.2 300.1 339.8 318.6 349.8 326.4 25.9 0.0 9.3 18.6 55.4 8.5 28.1 18.6 18.2 0.0 42.0 77.1 9.5 181.6 15.1 327.4 0.0 6.7 27.5 652.8 1119.2 194.4 0.6 376.6 79.5 16.8 170.9 95.6 0.1 123.2 379.6 22.5 57.1 946.3 11.4 77.8 48.9 1365.5 29.6 0.0 0.0 631.0 4.1 70.3 9.4 1.9 31.4 115.6 92.5 2.8 53.4 0.0 27.8 1.0 0.3 126.5 1252.2 5.3 65.9 107.0 2028.8 10399.1 22.6 0.0 6.6 26.4 41.6 3.2 1.5 3.9 8.0 19.4 68.6 6.9 851.3 19.2 TCAF1 "FAM115A, KIAA0738" ENSG00000198420 "TRPM8 channel associated factor 1" Q9Y4C2 7 143851375-143902198 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011732 Approved Approved "Nuclear bodies,Vesicles,Cell Junctions" NA NA "Cell Junctions" "Nuclear bodies, Vesicles" "HPA011732: AB_2668526" "unprognostic (1.57e-1)" "unprognostic (7.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" "unprognostic (7.00e-2)" "unprognostic (5.70e-3)" "unprognostic (3.07e-2)" "unprognostic (4.93e-2)" "prognostic favorable (5.93e-4)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (3.95e-3)" "unprognostic (6.45e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.89e-1)" 29.2 46.8 17.6 13.1 48.8 4.7 21.9 15.7 30.2 27.7 3.4 19.0 12.3 32.5 15.4 15.2 22.4 19.5 23.9 30.9 33.8 15.0 29.5 19.2 8.5 15.4 14.8 25.7 40.3 19.5 35.4 27.4 81.8 17.5 36.5 20.5 28.2 16.0 20.0 17.6 17.1 15.9 30.9 8.2 11.8 21.9 9.5 27.7 17.3 27.0 56.2 9.1 14.9 13.5 26.4 47.2 29.0 90.1 93.7 57.9 55.7 55.1 54.3 64.9 42.4 56.3 60.5 33.0 0.2 25.2 63.3 54.5 29.7 34.8 35.7 46.5 25.7 26.0 25.7 15.7 54.0 39.7 0.3 16.2 58.2 31.5 50.0 18.4 66.8 53.4 32.2 43.2 4.5 83.2 70.7 42.3 15.9 27.6 52.0 17.4 26.0 60.7 6.2 33.7 37.5 25.6 153.1 55.5 34.2 25.7 63.7 51.5 4.0 48.8 44.6 28.5 42.2 32.7 14.0 19.2 0.4 81.9 7.6 62.3 0.4 1.5 0.9 4.7 1.8 3.3 1.6 2.8 3.1 2.9 1.6 2.4 3.0 0.4 4.4 3.1 1.4 2.3 2.5 17.6 48.8 15.7 30.2 30.9 33.8 15.4 14.8 25.7 17.5 8.2 27.7 26.4 36.3 44.8 37.1 30.3 7.3 0.0 15.0 0.0 16.5 47.7 29.4 38.6 43.0 31.5 14.9 3.7 25.0 251.7 15.2 18.7 0.0 30.9 2.4 27.6 62.7 35.1 19.4 22.1 71.2 35.6 43.7 54.6 20.9 40.5 7.6 167.5 34.6 83.6 32.9 30.3 63.1 29.3 0.0 10.5 0.0 3.5 53.1 12.2 0.0 29.0 10.8 27.5 20.6 57.3 43.7 49.9 15.4 56.4 8.4 27.3 20.1 8.9 8.0 26.7 13.1 72.1 53.3 13.3 11.7 14.1 0.0 521.5 10.4 377.5 23.5 24.3 ZNF69 Cos5 ENSG00000198429 "Zinc finger protein 69" Q9UC07 19 11887782-11914329 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 18.6;Late spermatids: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 12.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.8" HPA047845 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (1.08e-1)" "unprognostic (4.58e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.55e-4)" "unprognostic (2.45e-2)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (1.37e-2)" "unprognostic (3.08e-3)" "unprognostic (3.97e-2)" "unprognostic (2.09e-1)" "unprognostic (4.83e-3)" "unprognostic (4.12e-2)" "unprognostic (2.54e-1)" "unprognostic (1.26e-1)" "unprognostic (7.97e-2)" "unprognostic (1.93e-2)" 2.5 5.0 2.5 2.7 2.0 2.6 3.4 2.2 2.4 5.1 7.3 7.9 2.3 2.7 2.5 0.9 5.6 4.4 2.6 2.4 2.0 9.5 8.9 3.3 2.2 3.0 2.7 1.9 6.9 7.6 14.7 2.0 2.5 3.1 4.8 8.1 1.5 4.2 2.2 1.0 1.2 3.6 1.2 1.7 2.2 9.0 4.8 2.2 3.6 3.4 0.9 1.9 3.8 2.1 2.3 5.6 0.1 13.8 8.0 1.5 0.1 4.8 8.2 5.7 4.4 5.5 3.7 2.2 3.5 4.7 4.7 3.5 0.1 0.1 3.1 4.6 0.1 0.1 1.6 0.2 8.0 1.1 0.0 3.3 2.2 0.0 1.6 0.2 2.1 0.1 4.9 0.0 0.2 9.2 0.1 4.3 0.8 8.6 0.5 0.0 0.1 3.1 0.1 10.4 3.9 1.3 3.9 0.0 0.2 1.8 6.6 7.3 2.3 0.4 3.6 2.4 3.7 4.6 3.7 3.6 0.1 0.1 0.0 11.3 12.6 1.5 1.1 1.7 1.5 1.7 0.8 1.2 0.7 1.7 0.5 3.2 3.3 0.7 2.5 0.9 1.2 1.0 1.5 2.5 2.0 2.2 2.4 2.4 2.0 3.0 2.7 1.9 3.1 1.7 2.2 2.3 1.4 3.2 10.9 11.8 0.6 0.3 1.3 2.5 1.2 0.7 2.6 2.3 2.4 18.6 4.9 5.5 0.0 3.6 1.1 2.9 3.9 6.8 8.8 6.5 2.4 2.6 0.0 10.7 11.4 3.5 3.2 1.6 13.3 2.4 7.6 8.3 5.0 11.9 2.8 0.0 5.6 5.7 0.0 3.1 1.2 24.2 2.5 2.6 5.4 8.4 0.9 0.9 0.0 14.6 6.0 10.1 3.7 1.9 1.6 1.2 2.0 11.3 3.9 0.2 13.1 0.9 1.8 4.3 4.3 0.5 0.1 1.9 1.4 2.1 4.9 2.8 TXNRD1 "GRIM-12, Trxr1, TXNR" ENSG00000198431 "Thioredoxin reductase 1" Q16881 12 104215779-104350307 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 1452.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001395, CAB004607, CAB015834, HPA043871" Approved Supported Nucleoplasm NA NA 6100000 Nucleoplasm "CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709" "unprognostic (2.52e-2)" "unprognostic (1.16e-1)" "unprognostic (5.48e-2)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-2)" "unprognostic (8.80e-2)" 39.2 149.3 22.6 41.0 21.0 65.3 28.3 22.0 23.0 28.2 34.6 47.1 58.9 48.3 21.2 31.0 39.4 56.4 61.4 22.0 62.5 38.2 46.8 63.5 34.6 56.3 24.4 19.8 34.4 19.1 34.0 21.4 39.4 28.8 41.4 46.1 20.3 20.9 61.2 68.4 12.3 39.7 52.1 27.0 28.1 52.5 38.1 24.6 43.2 30.6 64.6 34.4 142.8 30.3 30.9 228.4 1032.6 118.1 111.3 553.5 308.0 409.8 412.4 259.3 182.7 186.8 110.5 329.4 169.3 187.0 1452.6 682.1 77.7 235.7 158.6 214.1 82.7 101.8 143.1 765.8 468.0 885.7 226.3 149.9 176.9 159.8 403.7 128.1 557.1 634.0 227.9 200.5 77.5 276.8 109.1 233.4 102.7 114.4 453.0 1053.1 227.3 82.1 146.5 211.2 123.1 182.6 110.6 333.3 519.1 325.2 222.6 123.2 131.4 854.5 89.3 183.7 201.3 341.2 84.8 179.9 254.5 186.8 122.5 538.0 109.4 29.9 69.7 23.6 39.0 26.9 21.3 21.6 23.9 39.5 14.5 19.1 16.7 102.6 24.4 48.4 25.2 19.8 27.6 22.6 21.0 22.0 23.0 22.0 62.5 56.3 24.4 19.8 28.8 27.0 24.6 30.9 26.0 64.1 67.5 50.3 27.6 104.0 459.7 41.3 40.9 28.1 19.4 16.3 66.2 32.9 79.3 16.5 22.9 26.1 40.4 93.4 41.1 79.6 45.0 100.9 36.8 116.2 20.4 46.3 48.2 80.7 34.3 90.1 69.8 119.6 53.2 35.2 49.2 68.2 42.0 28.6 56.7 18.8 44.7 43.5 100.5 19.1 68.0 62.2 19.6 49.6 51.9 24.8 26.8 29.1 55.3 197.7 40.5 29.3 28.4 557.4 24.6 37.5 105.5 20.9 0.0 43.4 84.0 14.4 33.8 24.3 72.9 51.3 28.5 98.4 33.0 488.0 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137299631-137302271 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 48.4" "Cell type enhanced" "Detected in many" "Adipocytes: 75.3;Basal keratinocytes: 97.0;Langerhans cells: 97.9;Squamous epithelial cells: 101.8;Suprabasal keratinocytes: 381.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 45.1;MCF7: 23.3;NTERA-2: 31.9;OE19: 30.8;T-47d: 23.1;TIME: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.4 1.7 8.4 7.7 7.1 1.5 6.9 9.2 8.6 4.2 5.1 48.4 22.2 4.4 1.2 22.8 3.6 12.1 10.9 7.1 10.2 3.7 2.7 7.2 1.6 11.5 11.6 5.5 2.1 16.9 2.7 7.7 10.4 10.2 9.6 30.8 1.5 3.0 2.1 2.9 20.6 18.0 3.4 8.9 4.3 8.8 10.3 11.8 2.8 4.9 6.5 4.2 10.5 13.6 9.5 4.8 1.0 8.0 8.8 0.0 0.0 2.6 0.1 0.2 0.0 0.1 6.8 3.0 0.0 10.2 0.0 0.4 45.1 13.9 0.4 0.1 0.3 20.6 1.4 2.1 7.6 0.8 2.8 4.3 0.0 2.3 0.0 0.6 0.2 11.8 0.1 11.8 0.3 0.0 23.3 0.2 6.4 31.9 30.8 6.7 8.4 1.5 17.7 1.2 0.6 4.9 8.1 1.4 2.4 0.1 1.7 23.1 5.8 31.9 0.0 0.1 0.1 1.9 0.3 0.2 3.0 0.1 5.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.1 9.2 8.6 7.1 10.2 11.5 11.6 5.5 10.2 8.9 11.8 9.5 75.3 0.0 0.0 33.3 17.6 97.0 5.9 20.1 15.9 0.6 24.4 39.2 4.4 5.7 14.3 0.0 0.0 0.1 9.7 22.4 0.0 0.5 17.3 35.2 4.4 21.9 10.2 0.0 2.5 1.1 0.0 2.1 19.4 43.0 0.0 0.3 8.9 0.1 0.4 0.0 0.4 20.5 8.2 0.6 97.9 5.2 0.0 18.6 17.8 9.4 0.0 6.8 0.0 2.0 0.6 0.6 28.3 0.4 3.9 6.2 5.0 0.1 3.2 2.8 6.6 4.0 32.1 0.1 0.6 101.8 381.0 0.0 6.7 3.7 23.4 6.0 ZNF583 FLJ31030 ENSG00000198440 "Zinc finger protein 583" Q96ND8 19 56397966-56436035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 60.5;Late spermatids: 43.0;Spermatocytes: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023805, HPA023957" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023805: AB_2671318, HPA023957: AB_2671383" "unprognostic (9.89e-3)" "unprognostic (5.52e-3)" "unprognostic (8.14e-2)" "unprognostic (2.89e-2)" "unprognostic (1.15e-1)" "unprognostic (6.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "unprognostic (2.31e-2)" "unprognostic (1.79e-2)" "unprognostic (8.43e-3)" "unprognostic (5.00e-2)" "unprognostic (9.54e-5)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" 3.3 2.4 4.1 1.7 4.2 1.0 2.0 5.9 4.5 2.2 1.7 1.7 1.3 2.6 2.2 1.5 2.4 2.3 2.1 3.9 4.2 2.8 2.6 2.9 1.8 4.7 4.1 3.4 4.7 2.6 4.0 2.7 2.0 4.0 2.5 1.4 4.1 1.0 1.9 2.2 0.8 1.3 2.6 4.7 2.4 1.7 7.4 4.2 2.8 3.4 3.3 1.8 2.1 1.3 4.6 0.0 2.1 4.9 0.0 3.4 2.7 0.0 6.2 6.2 2.8 2.3 0.3 0.7 4.7 3.0 5.7 5.1 0.3 2.0 1.9 3.0 2.2 10.8 6.2 0.0 1.1 3.9 5.2 5.4 3.8 3.0 4.0 2.0 4.1 2.8 4.8 2.3 1.7 9.3 0.0 6.5 1.7 1.2 0.0 2.0 3.2 9.3 3.5 2.2 4.5 2.8 4.2 0.0 0.6 1.6 2.5 3.1 6.6 1.9 14.5 4.0 2.8 12.4 6.2 12.3 7.4 0.3 1.4 5.2 9.7 1.5 3.3 3.1 2.2 4.6 4.5 2.5 2.9 1.7 3.5 4.6 2.8 0.6 6.1 3.7 2.4 3.6 1.9 4.1 4.2 5.9 4.5 3.9 4.2 4.7 4.1 3.4 4.0 4.7 4.2 4.6 7.7 3.2 1.5 4.6 7.9 1.8 3.2 2.8 0.6 17.5 3.5 1.8 5.3 0.0 1.9 1.8 6.2 1.8 4.9 0.6 9.8 5.7 60.5 2.1 6.2 6.6 0.0 9.1 14.6 2.7 0.5 6.5 1.1 2.9 10.8 10.5 7.5 2.4 3.9 10.1 12.1 1.6 0.0 3.3 4.3 43.0 6.8 3.3 3.6 4.7 3.8 12.2 16.5 15.1 12.0 2.5 1.8 13.5 1.6 3.0 1.2 5.2 1.7 15.1 6.6 13.8 7.1 30.6 17.2 0.6 1.7 1.1 6.8 6.9 1.4 2.4 KRTAP4-1 "KAP4.1, KAP4.10, KRTAP4-10" ENSG00000198443 "Keratin associated protein 4-1" Q9BYQ7 17 41184102-41185342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "skin 1: 16.6" "Cell type enhanced" "Detected in single" "Enteroendocrine cells: 1.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.1;A549: 1.7;CAPAN-2: 1.2;HDLM-2: 4.9;SCLC-21H: 1.2;SK-BR-3: 1.0" NA NA "unprognostic (1.21e-1)" "unprognostic (3.57e-1)" "unprognostic (1.64e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.49e-2)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 CCT8L2 CESK1 ENSG00000198445 "Chaperonin containing TCP1 subunit 8 like 2" Q96SF2 22 16590751-16592810 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 217 "testis: 21.6" "Group enriched" "Detected in some" 53 "Early spermatids: 182.6;Late spermatids: 87.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 182.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.2 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14L1P "OR5AV1, OR5AV1P" ENSG00000198452 "Olfactory receptor family 14 subfamily L member 1 pseudogene" 1 247617143-247622372 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 53 "basophil: 5.2" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.2" "Group enriched" "Detected in some" 9 "HEL: 2.0;HMC-1: 5.8" NA NA "unprognostic (3.03e-2)" 0.0 0.0 0.1 0.1 0.2 0.6 0.1 1.0 0.3 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 2.0 0.2 0.1 0.0 0.1 5.8 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.4 0.1 0.1 0.2 0.2 0.2 0.2 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.3 0.2 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF568 DKFZp686B0797 ENSG00000198453 "Zinc finger protein 568" Q3ZCX4 19 36916329-36998700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 40.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024541, HPA052061" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024541: , HPA052061: AB_2681713" "unprognostic (3.62e-2)" "unprognostic (2.73e-1)" "unprognostic (9.97e-2)" "unprognostic (1.99e-3)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (8.64e-2)" "unprognostic (2.65e-2)" "unprognostic (5.83e-5)" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (2.05e-5)" "unprognostic (2.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.06e-3)" "unprognostic (9.98e-3)" 3.9 6.6 6.0 3.6 6.0 3.8 5.7 11.6 6.5 6.4 6.5 3.7 2.4 7.4 5.0 3.5 6.0 3.4 5.3 5.6 6.7 4.6 3.3 4.2 4.1 5.9 6.2 5.3 9.4 4.4 8.4 5.4 5.2 7.2 4.9 2.9 11.9 4.9 5.4 5.5 4.1 3.2 6.0 4.2 6.2 4.3 6.1 6.1 4.9 7.8 5.7 4.5 4.4 4.1 10.2 0.2 5.0 8.4 2.5 7.8 8.8 2.6 7.4 7.4 6.0 8.1 0.6 2.9 0.3 8.3 9.3 4.3 1.4 0.1 4.3 6.3 1.1 6.5 2.8 0.9 1.0 10.1 0.4 6.5 10.7 5.1 6.1 0.2 7.3 2.9 3.7 0.3 0.8 9.2 0.2 1.6 1.3 6.9 0.0 0.3 0.7 6.7 2.6 5.7 11.0 8.2 10.7 0.3 0.2 6.2 8.3 6.7 1.1 4.7 3.5 11.9 6.1 4.8 9.0 13.1 6.0 0.2 0.2 12.5 19.6 1.7 6.4 7.1 1.3 6.3 9.0 6.8 5.9 2.9 6.9 8.4 6.4 1.4 7.4 2.1 2.7 6.4 3.0 6.0 6.0 11.6 6.5 5.6 6.7 5.9 6.2 5.3 7.2 4.2 6.1 10.2 7.7 3.2 7.0 12.7 7.5 5.1 3.4 4.5 2.8 18.9 5.7 6.5 6.6 10.0 3.1 9.2 14.6 5.0 6.3 0.5 3.9 7.1 28.9 5.1 7.1 7.4 0.0 1.3 22.4 3.7 4.1 7.8 2.6 3.8 16.5 13.9 6.4 1.4 3.5 40.4 22.6 1.4 14.2 2.5 3.4 19.5 6.5 3.5 1.8 10.3 3.5 9.4 12.3 25.6 25.7 2.8 0.3 9.8 3.4 3.9 0.7 5.1 5.2 17.0 6.6 13.6 6.6 18.1 12.6 3.4 4.1 2.9 7.9 7.2 1.0 2.6 ZXDB ZNF905 ENSG00000198455 "Zinc finger X-linked duplicated B" P98169 X 57592011-57597477 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 31.7;Suprabasal keratinocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 34.8" HPA043789 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043789: AB_2678673" "unprognostic (1.87e-1)" "unprognostic (3.22e-1)" "unprognostic (1.88e-1)" "unprognostic (8.61e-3)" "unprognostic (4.29e-2)" "unprognostic (2.80e-1)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (4.36e-1)" "unprognostic (9.04e-2)" "unprognostic (6.73e-2)" "unprognostic (2.16e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (4.02e-3)" "unprognostic (2.87e-3)" 3.6 3.1 3.8 3.4 3.8 8.2 4.9 4.8 4.1 4.6 2.9 3.6 2.9 5.3 3.1 3.3 5.5 4.2 3.6 3.7 4.2 3.6 14.6 3.4 4.8 4.1 3.8 3.7 5.9 6.1 6.1 2.3 2.6 4.3 4.9 3.7 3.4 3.3 4.3 4.2 4.3 3.4 5.8 4.2 4.2 4.2 1.5 4.1 3.3 5.3 4.9 4.5 4.4 2.8 4.6 5.5 6.4 4.1 5.5 6.8 6.7 5.6 3.9 4.8 3.1 3.2 2.7 4.0 4.8 5.6 7.0 4.9 6.1 11.9 20.5 6.0 11.7 6.4 2.6 8.3 7.3 8.8 4.5 2.9 5.9 34.8 8.0 21.4 6.8 9.4 5.2 3.0 5.0 8.4 3.9 4.0 3.7 16.5 2.2 8.0 5.0 14.9 2.7 4.2 8.7 3.5 6.5 7.7 5.6 6.1 9.2 5.8 4.9 8.3 6.7 12.9 5.8 3.9 0.0 2.1 6.4 4.8 3.9 3.1 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.2 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.1 3.8 3.8 4.8 4.1 3.7 4.2 4.1 3.8 3.7 4.3 4.2 4.1 4.6 4.6 6.4 2.6 1.0 6.4 31.7 11.4 3.7 12.5 3.5 10.6 4.8 6.1 8.6 3.5 1.8 0.0 2.4 7.3 2.8 3.9 2.9 0.0 9.8 6.1 5.6 0.0 4.0 2.8 3.7 1.6 6.0 7.1 14.5 0.0 4.4 3.9 12.0 1.1 6.7 3.7 7.8 0.0 2.2 8.1 0.2 5.0 2.7 7.2 1.9 1.4 1.0 2.1 4.0 3.6 4.0 1.7 5.7 7.3 17.1 2.2 2.9 3.5 3.5 0.0 7.1 4.6 0.2 0.2 9.7 38.1 2.9 4.8 1.8 4.6 16.1 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297169-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 7.7 7.3 6.5 10.5 7.1 9.6 6.7 9.3 7.8 7.6 6.0 10.5 9.9 6.0 3.3 6.6 5.6 4.6 11.2 6.2 6.2 8.8 8.6 6.3 12.7 7.0 7.1 5.6 7.0 4.6 7.4 5.9 5.8 7.2 6.2 10.2 10.5 7.2 5.2 10.9 5.6 8.2 6.0 5.7 9.9 9.2 3.3 6.9 15.3 7.3 15.0 15.6 11.2 5.4 9.7 7.2 28.4 18.2 21.2 21.1 19.7 14.1 18.3 26.7 12.8 14.9 12.9 10.0 36.0 11.2 15.1 23.4 15.3 19.9 18.5 18.5 0.3 33.1 37.0 15.2 12.5 20.3 52.7 29.0 18.1 23.4 17.8 20.7 26.7 18.8 31.0 27.0 12.0 29.0 11.7 48.3 10.5 13.7 23.7 22.8 24.5 19.5 30.0 18.8 51.0 17.2 15.0 26.6 18.9 7.4 37.3 15.7 38.1 32.4 12.7 15.8 7.3 28.6 28.4 56.9 74.3 5.7 28.2 23.1 10.1 9.6 11.2 12.6 9.4 14.5 19.7 12.8 15.1 11.9 19.1 12.0 16.3 3.6 17.8 11.4 19.3 15.9 7.8 6.5 7.1 9.3 7.8 6.2 6.2 7.0 7.1 5.6 7.2 5.7 6.9 9.7 13.1 35.3 11.8 8.5 20.1 5.5 15.3 22.1 5.7 4.7 6.7 6.1 43.0 8.6 18.2 3.7 2.1 8.7 17.8 11.7 17.6 18.6 2.5 12.7 11.9 17.0 12.6 14.9 1.7 27.6 16.8 11.1 9.7 14.1 12.6 15.4 14.3 15.4 17.6 6.7 4.7 18.0 20.3 15.8 14.3 2.4 9.0 12.3 7.2 6.5 19.0 6.1 26.8 9.5 10.2 36.3 11.8 8.2 9.2 25.4 13.5 24.2 16.8 7.4 0.0 10.6 12.0 1.9 6.1 10.5 8.4 14.8 19.7 12.1 16.1 22.6 ZNF587 "FLJ14710, FLJ20813, UBF-fl, ZF6" ENSG00000198466 "Zinc finger protein 587" Q96SQ5 19 57849859-57865117 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "RT4: 41.5" "HPA042125, HPA043288, HPA056213" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042125: AB_2677862, HPA043288: AB_2678410, HPA056213: AB_2683069" "unprognostic (1.61e-2)" "unprognostic (5.39e-2)" "unprognostic (3.92e-2)" "unprognostic (1.91e-1)" "unprognostic (2.42e-1)" "unprognostic (2.12e-2)" "unprognostic (6.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (7.30e-2)" "unprognostic (3.68e-3)" 4.7 5.2 3.9 6.5 3.7 6.8 10.2 4.4 5.3 6.3 5.1 8.1 8.3 6.0 5.6 6.2 6.0 3.7 6.0 3.7 3.4 5.7 6.3 6.2 5.5 3.0 2.9 3.3 7.2 9.2 5.0 11.6 8.1 3.6 9.7 13.3 11.5 12.2 6.6 4.5 5.7 8.0 5.6 2.0 6.2 9.0 4.4 3.1 5.4 7.8 4.2 6.9 6.3 7.4 4.8 8.6 7.8 7.0 5.7 7.5 10.9 10.5 7.5 9.5 11.2 9.8 11.2 5.7 5.7 3.9 5.9 4.4 5.1 10.1 11.1 20.8 5.3 21.5 11.1 28.6 8.0 4.3 11.1 10.6 10.8 5.1 11.0 10.4 8.6 12.1 7.8 14.1 7.5 8.4 3.6 6.7 4.1 2.1 2.2 7.1 5.3 6.6 3.8 6.7 41.5 11.1 5.2 8.7 7.9 2.7 9.2 6.8 6.3 5.7 8.3 5.1 2.1 10.7 12.0 9.8 6.0 3.8 4.7 5.0 1.4 0.5 0.4 0.4 0.4 0.4 0.5 0.5 0.4 0.5 0.7 0.4 0.7 1.2 0.5 0.4 0.4 0.7 0.3 3.9 3.7 4.4 5.3 3.7 3.4 3.0 2.9 3.3 3.6 2.0 3.1 4.8 6.9 3.2 6.8 13.1 8.4 9.2 13.6 7.3 1.8 20.0 10.4 5.8 7.1 30.0 9.6 7.3 31.3 10.8 7.4 12.2 11.7 9.1 9.5 16.9 10.0 7.8 23.4 3.8 19.9 3.7 9.8 7.3 19.4 22.6 12.7 18.3 12.5 9.4 6.5 20.2 19.3 18.2 4.1 7.1 5.5 1.3 4.7 7.0 0.0 10.3 7.2 7.6 7.2 17.6 14.1 7.6 15.9 9.1 8.7 13.4 14.8 8.5 13.3 24.7 0.0 9.2 6.3 4.2 6.7 5.4 6.7 10.1 8.7 9.5 15.5 15.4 TPM2 "AMCD1, DA1, NEM4" ENSG00000198467 "Tropomyosin 2" P07951 9 35681992-35690056 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 11 "skeletal muscle: 39384.7;tongue: 16922.4" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 812 "plasmacytoid DC: 398.6" "Lineage enriched" "Detected in single" 920 "dendritic cells: 398.6" "Cell line enhanced" "Detected in many" "BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1" "HPA047089, HPA053624" Approved NA NA 140000000 "HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (5.56e-2)" "unprognostic (5.37e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (3.34e-2)" "unprognostic (2.70e-1)" "unprognostic (1.75e-2)" "unprognostic (1.18e-3)" "unprognostic (6.56e-3)" "unprognostic (2.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.51e-10)" "unprognostic (1.43e-2)" "unprognostic (8.33e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-2)" 315.3 287.3 80.1 414.7 76.5 16.8 263.0 84.9 118.3 598.8 132.6 2452.6 219.7 1944.3 203.7 1027.4 857.1 446.5 730.1 77.0 73.6 144.0 41.3 285.6 62.7 79.7 72.0 70.3 391.7 74.4 24.3 83.3 143.5 73.5 1229.3 240.2 8.0 396.9 2007.5 39384.7 125.5 641.6 2362.4 71.7 141.2 1263.2 83.5 74.2 26.5 140.0 16922.4 21.4 1643.8 458.8 76.8 375.4 291.2 213.9 33.6 335.4 893.3 129.3 2309.6 934.4 983.0 667.9 12.2 24.2 0.4 213.0 1289.0 144.6 9.2 3.7 291.2 457.0 716.2 10.8 9.1 1054.1 11.8 540.2 2.3 102.7 1067.7 44.9 738.8 0.4 1399.1 235.7 25.3 5.6 0.8 1052.1 15.3 2.7 29.1 269.6 1.5 17.0 18.5 391.5 3.0 31.1 7.2 3.8 13.3 470.0 7.9 18.2 273.8 6.8 27.7 30.0 16.5 585.7 11.6 730.6 0.6 2.7 2.9 34.0 6.5 29.2 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.4 0.2 0.0 398.6 0.0 2.1 80.1 76.5 84.9 118.3 77.0 73.6 79.7 72.0 70.3 73.5 71.7 74.2 76.8 110.0 3.2 4.1 10.4 5.9 57.1 81.2 274.1 24.5 0.8 29.9 1066.2 619.5 4.3 42.1 7.3 0.0 12.1 116.7 1.4 0.0 21.4 4.3 20.3 488.3 80.3 2.4 4.0 2.5 5.7 104.8 332.6 99.4 18.7 2.5 142.0 181.3 1.4 32.4 1.7 4.6 1.9 48.8 3.1 77.9 32.4 283.0 24.2 67.6 9.4 6.5 11.7 1.0 3.0 0.4 8.4 0.1 2072.1 2.9 169.8 0.4 1.3 23.5 0.9 2222.0 594.8 2341.4 2.5 27.3 6.7 42.8 14.6 16.0 106.7 2.8 28.7 RTP2 "MGC78665, Z3CXXC2" ENSG00000198471 "Receptor transporter protein 2" Q5QGT7 3 187698259-187702557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 2.0;testis: 1.2" "Group enriched" "Detected in some" 5 "Early spermatids: 15.8;Late spermatids: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SK-BR-3: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.86e-2)" "unprognostic (1.12e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SH3BGRL2 ENSG00000198478 "SH3 domain binding glutamate rich protein like 2" Q9UJC5 6 79631329-79703655 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 163.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 50.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 11.1" "Lineage enriched" "Detected in many" 10 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "CACO-2: 81.6;HEL: 41.8;OE19: 99.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047486 Approved Supported Nucleoplasm NA NA 2000000 Nucleoplasm "HPA047486: AB_2680065" "unprognostic (3.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (2.28e-2)" "unprognostic (4.21e-1)" "unprognostic (7.77e-2)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (6.92e-2)" "unprognostic (6.53e-3)" "unprognostic (2.78e-1)" "unprognostic (7.94e-2)" "prognostic favorable (2.24e-4)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.33e-1)" 26.6 6.9 21.5 7.6 20.0 1.7 21.8 18.0 28.4 22.5 15.4 51.0 35.5 10.0 24.9 55.7 17.9 23.4 6.9 23.0 28.1 15.8 53.6 12.8 5.5 27.0 23.7 17.5 4.2 23.5 31.8 16.7 24.2 30.5 26.4 48.3 26.3 163.1 11.5 4.8 11.0 35.9 15.9 24.8 6.6 69.5 2.1 26.2 4.8 59.7 10.2 10.7 12.8 19.9 28.0 8.5 1.5 7.6 1.6 6.7 5.6 18.0 0.5 5.6 1.9 4.0 81.6 16.3 0.1 11.4 0.5 1.6 3.9 7.0 9.2 6.7 0.0 10.2 41.8 1.8 15.8 2.8 1.7 1.1 3.1 7.3 5.8 3.3 2.7 23.8 0.0 16.8 0.0 0.7 1.3 0.0 0.2 6.5 99.7 2.8 0.0 2.2 0.2 2.0 27.3 20.3 22.3 0.5 2.4 0.6 10.3 0.4 3.5 13.6 5.2 3.4 0.1 4.9 12.0 6.0 0.0 0.9 0.0 1.6 11.1 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.0 2.2 0.0 0.0 0.1 0.0 8.8 21.5 20.0 18.0 28.4 23.0 28.1 27.0 23.7 17.5 30.5 24.8 26.2 28.0 83.2 6.4 24.8 20.9 0.9 2.2 4.6 3.3 2.2 13.5 14.8 9.9 6.1 52.9 21.4 22.0 8.4 40.4 1.7 156.3 0.0 14.8 18.1 14.3 3.7 33.8 12.6 7.4 86.5 13.0 3.7 4.6 81.1 21.0 0.0 2.0 44.6 69.6 4.1 13.5 38.1 87.8 4.1 2.9 2.1 20.3 0.6 21.6 16.0 11.2 4.6 8.6 0.0 33.7 24.9 15.0 76.0 4.5 1.3 19.7 48.7 11.3 24.6 12.2 0.0 3.7 4.7 2.5 1.2 21.5 0.9 52.7 1.0 1.8 67.2 29.9 ZNF808 ENSG00000198482 "Zinc finger protein 808" Q8N4W9 19 52527652-52564464 "Predicted intracellular proteins, Transcription factors" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 13.1" NA NA "unprognostic (4.11e-2)" "unprognostic (8.36e-2)" "unprognostic (1.93e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-1)" "unprognostic (2.04e-2)" "unprognostic (2.83e-2)" "unprognostic (2.05e-2)" "unprognostic (2.80e-3)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (1.54e-1)" "unprognostic (7.14e-3)" "unprognostic (7.19e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.82e-4)" "prognostic favorable (3.88e-4)" 1.6 1.1 2.6 2.4 3.3 6.6 2.2 3.4 2.8 2.9 7.0 2.9 2.4 2.8 3.2 1.5 3.1 2.2 3.1 2.9 1.9 3.4 1.5 2.8 2.8 3.0 2.2 1.5 3.9 1.2 4.3 0.9 2.9 3.6 2.5 3.7 4.0 2.1 2.3 3.1 2.2 2.4 2.4 1.1 4.2 3.2 3.6 2.3 3.7 5.2 6.1 2.3 2.4 1.6 3.3 2.3 0.2 1.7 5.0 2.9 5.3 4.5 2.3 2.8 2.4 4.8 4.6 2.5 4.3 1.8 3.0 4.1 1.8 4.2 2.9 4.1 1.1 3.9 5.1 6.0 0.2 1.2 0.2 6.1 3.1 1.0 3.2 2.6 4.1 3.2 5.3 2.9 0.0 2.1 1.4 5.4 1.9 2.3 3.0 1.2 1.6 3.4 2.2 1.0 13.1 1.9 2.3 5.9 2.9 2.0 5.7 3.7 2.4 2.9 2.2 2.2 2.2 2.8 0.7 11.6 9.1 0.0 1.3 3.5 12.6 4.6 10.0 5.4 4.0 6.4 7.1 4.6 5.3 3.4 5.9 5.4 5.1 10.9 7.3 3.3 4.8 3.8 2.1 2.6 3.3 3.4 2.8 2.9 1.9 3.0 2.2 1.5 3.6 1.1 2.3 3.3 7.9 6.4 6.5 19.6 8.4 1.9 5.5 2.7 8.0 8.4 3.0 3.0 19.8 4.3 7.6 0.0 6.2 6.4 11.6 9.8 7.9 2.9 3.8 14.2 6.6 7.5 4.2 4.2 13.1 1.5 5.4 5.1 11.7 7.9 2.5 6.4 4.2 2.5 3.5 8.4 13.5 6.7 8.2 6.6 3.9 1.8 1.2 6.0 3.6 12.2 6.0 3.6 21.6 15.6 16.9 2.0 6.8 2.6 7.0 5.2 8.0 3.8 8.3 11.4 0.0 5.8 6.7 5.3 8.2 6.7 2.7 3.6 9.1 3.9 5.0 6.5 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 59.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 3.5 1.3 7.8 1.1 7.4 0.3 4.6 7.2 9.8 20.8 6.0 4.6 0.5 5.8 1.4 24.9 6.7 1.3 2.4 7.1 8.0 0.7 2.6 2.3 0.5 8.2 8.4 7.2 4.5 0.7 0.0 2.0 0.1 7.9 6.6 0.8 1.3 11.5 2.7 8.3 59.4 2.5 2.1 7.7 0.6 4.0 1.6 8.5 0.5 1.7 3.9 6.8 7.3 20.7 7.3 0.1 0.0 0.0 0.0 2.2 9.6 0.2 1.4 3.6 0.4 1.2 0.4 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.1 2.9 0.1 3.3 0.4 0.3 0.0 0.1 0.4 0.0 0.0 0.0 2.2 0.0 0.0 3.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 8.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.5 0.0 0.0 2.1 0.0 0.7 0.8 0.1 0.0 0.3 1.1 0.3 0.0 0.2 0.7 0.1 0.7 0.2 0.5 0.7 0.7 7.8 7.4 7.2 9.8 7.1 8.0 8.2 8.4 7.2 7.9 7.7 8.5 7.3 1.6 0.0 0.0 6.8 0.3 4.6 16.8 10.2 0.0 1.1 6.3 13.5 1.5 2.8 9.5 1.8 0.0 0.1 2.2 0.0 0.0 0.0 3.5 56.4 10.9 1.3 0.0 2.7 5.6 0.4 0.1 31.2 0.5 17.2 19.1 0.0 2.2 13.9 11.0 0.0 2.1 0.0 14.2 1.2 4.6 5.9 36.4 1.1 5.4 1.0 1.1 57.7 5.2 3.0 0.6 0.1 0.0 50.8 0.4 5.3 0.0 0.1 9.8 2.7 0.0 29.5 6.4 0.1 1.0 10.4 12.4 0.3 5.5 1.1 0.0 13.6 B3GNT6 B3Gn-T6 ENSG00000198488 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6" Q6ZMB0 11 77034398-77041973 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 22.0;salivary gland: 6.5;stomach 1: 25.1" "Group enriched" "Detected in some" 20 "Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 60.8" "Group enriched" "Detected in some" 14 "colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039805 Enhanced "Intracellular and membrane" NA NA "HPA039805: AB_2676690" "unprognostic (1.71e-1)" "prognostic favorable (2.31e-4)" "unprognostic (4.79e-2)" "unprognostic (5.42e-2)" "unprognostic (7.64e-2)" "unprognostic (1.95e-1)" "unprognostic (2.72e-1)" "unprognostic (1.23e-2)" "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-1)" 0.1 0.0 0.1 2.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 22.0 5.5 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 17.0 0.0 6.5 0.0 0.0 0.1 7.1 0.3 0.0 0.0 25.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.5 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.0 0.0 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 23.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 60.8 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.6 1.4 0.0 0.0 0.3 1.2 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.5 0.2 YTHDF2 "CAHL, HGRG8, NY-REN-2" ENSG00000198492 "YTH N6-methyladenosine RNA binding protein 2" Q9Y5A9 1 28736621-28769775 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030063, HPA054080, HPA059621" Approved Enhanced "Cytosol,Cytoplasmic bodies" NA NA Cytosol "Cytoplasmic bodies" "HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084" "unprognostic (8.75e-2)" "unprognostic (1.90e-2)" "unprognostic (4.66e-3)" "unprognostic (1.63e-1)" "unprognostic (3.03e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.14e-9)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (4.18e-2)" "unprognostic (1.69e-1)" "unprognostic (4.11e-2)" "unprognostic (2.07e-1)" "unprognostic (1.21e-1)" "unprognostic (6.38e-2)" "unprognostic (9.29e-2)" "unprognostic (6.97e-3)" 33.8 33.3 21.8 26.9 23.2 64.4 38.7 24.3 24.9 27.8 29.6 32.3 29.7 28.1 44.0 37.8 27.9 27.2 27.3 22.8 25.0 32.1 42.5 35.9 35.9 22.0 22.3 22.6 29.6 27.6 37.4 18.2 34.7 22.7 23.1 34.1 20.4 40.2 24.1 44.3 40.4 26.4 33.2 23.6 32.3 27.8 29.6 23.0 44.5 28.3 34.0 44.2 33.1 26.3 24.5 68.8 46.3 99.6 96.8 75.5 58.1 117.8 66.1 80.7 80.0 80.4 42.8 78.1 117.8 64.4 84.4 47.8 62.2 117.3 105.7 94.0 76.0 91.9 98.7 60.7 78.4 90.0 105.1 74.4 78.5 106.4 86.1 121.1 70.0 99.0 70.0 101.9 55.6 89.7 53.3 112.1 80.8 161.8 61.1 61.1 95.4 74.2 96.8 111.3 95.8 85.7 91.2 68.6 102.1 181.7 82.6 67.8 95.8 69.4 55.4 57.8 52.5 93.5 68.2 47.7 133.3 63.3 81.2 89.9 108.3 78.4 78.7 66.1 91.1 88.3 80.3 72.7 80.3 96.7 59.0 77.9 73.2 26.5 92.4 94.4 62.6 92.3 109.5 21.8 23.2 24.3 24.9 22.8 25.0 22.0 22.3 22.6 22.7 23.6 23.0 24.5 70.8 51.3 61.2 13.7 70.8 152.7 104.9 111.0 109.8 45.4 110.2 101.3 52.8 77.2 85.3 44.1 31.3 149.6 79.5 46.4 66.5 102.0 16.3 65.8 78.2 78.5 75.7 52.8 22.5 69.6 108.3 64.5 49.5 76.6 72.3 63.6 77.4 102.3 77.3 58.9 20.4 76.0 105.8 65.4 75.4 19.3 71.1 56.7 37.4 21.5 74.1 66.4 73.2 14.1 23.5 80.7 43.8 75.2 71.0 78.6 42.4 96.0 53.8 45.9 92.1 61.5 83.0 142.2 115.5 95.3 161.7 260.2 69.2 69.5 65.9 118.7 TMA16 "C4orf43, FLJ11184" ENSG00000198498 "Translation machinery associated 16 homolog" Q96EY4 4 163494442-163520539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.6;Late spermatids: 179.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041571, HPA052688" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA041571: AB_10794381, HPA052688: AB_2681916" "unprognostic (6.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.63e-2)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.70e-5)" "prognostic unfavorable (4.40e-4)" "unprognostic (2.30e-3)" "unprognostic (1.33e-2)" "unprognostic (1.17e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (6.98e-2)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-2)" 16.5 12.0 4.5 18.0 5.1 12.6 18.1 5.7 6.8 10.9 5.3 13.2 11.1 15.9 7.0 14.5 11.5 10.0 9.3 4.8 4.9 12.2 13.7 9.0 22.2 5.1 5.0 4.2 17.0 14.9 9.6 5.3 14.1 5.4 11.9 11.9 5.8 14.5 10.0 9.7 14.5 10.1 13.1 5.0 16.2 12.9 26.9 4.9 19.3 11.7 7.6 20.1 14.0 10.9 6.2 49.1 24.1 43.0 37.3 20.1 32.6 41.3 56.3 29.8 34.2 28.5 23.4 65.4 108.1 22.7 34.0 27.0 25.2 54.6 43.0 43.0 58.1 42.6 154.3 23.3 41.3 39.6 120.2 46.7 22.6 40.0 27.1 36.4 29.5 34.5 39.4 55.1 79.9 39.7 47.2 74.9 68.4 45.6 28.4 43.0 67.7 38.3 68.9 26.2 23.8 22.5 35.2 36.8 46.3 43.4 25.7 30.3 51.3 59.3 23.5 46.0 22.9 61.2 55.8 75.8 124.7 47.3 64.0 72.3 11.7 37.0 3.5 18.4 58.8 26.1 55.6 32.4 23.5 42.3 51.7 29.8 26.1 1.3 35.3 48.4 74.8 31.3 19.4 4.5 5.1 5.7 6.8 4.8 4.9 5.1 5.0 4.2 5.4 5.0 4.9 6.2 25.7 22.4 31.2 3.3 51.2 32.9 36.3 52.0 29.6 15.4 42.9 40.5 37.6 47.1 31.7 33.1 4.2 53.8 25.6 16.4 64.6 53.2 165.6 19.0 61.4 30.0 30.5 28.8 8.8 71.0 92.3 37.9 15.3 17.9 29.1 41.6 36.0 55.6 36.4 15.2 7.3 37.5 20.3 43.3 23.4 179.2 55.6 25.4 26.6 6.5 44.4 15.8 16.5 11.6 11.0 54.9 30.6 32.0 30.0 57.8 11.9 71.7 19.0 14.3 39.5 30.4 33.7 103.9 42.1 28.5 39.6 30.5 24.1 43.7 44.0 28.9 HLA-DRB5 ENSG00000198502 "Major histocompatibility complex, class II, DR beta 5" Q30154 6 32517353-32530287 "Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 359.3;lymphoid tissue: 427.0" "Cell type enriched" "Detected in many" 4 "Langerhans cells: 4068.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "myeloid DC: 61.9" "Group enriched" "Detected in all" 10 "B-cells: 26.1;dendritic cells: 61.9;monocytes: 35.2" "Cell line enhanced" "Detected in some" "HDLM-2: 641.1;HMC-1: 154.2;U-698: 189.9;U-87 MG: 238.6" HPA043151 Supported NA NA "HPA043151: AB_2678342" "unprognostic (1.97e-3)" "unprognostic (4.74e-2)" "unprognostic (3.30e-2)" "prognostic favorable (7.89e-4)" "unprognostic (2.28e-2)" "unprognostic (4.68e-3)" "unprognostic (9.09e-3)" "unprognostic (2.08e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.87e-1)" "unprognostic (2.89e-2)" "unprognostic (1.45e-1)" "unprognostic (7.60e-3)" "unprognostic (9.72e-2)" "unprognostic (5.48e-2)" 97.6 63.5 1.0 140.3 1.4 23.3 83.3 1.0 2.8 50.2 2.6 70.7 13.3 40.1 110.7 49.0 61.5 2.5 42.7 0.9 6.2 65.2 42.9 359.3 427.0 1.2 5.2 0.6 25.6 28.1 0.0 27.4 6.7 6.6 32.9 53.5 3.0 27.8 0.0 22.5 48.3 186.2 0.2 8.7 230.3 216.0 11.9 2.6 167.3 46.5 0.0 164.1 56.6 29.2 1.6 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.7 0.0 0.0 0.0 641.1 6.2 0.0 0.0 0.0 0.0 0.6 154.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.2 0.2 1.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 6.6 0.0 0.0 56.0 0.1 3.3 0.8 1.9 0.4 41.4 0.8 189.9 238.6 1.8 0.1 0.2 28.6 3.8 0.9 35.2 0.1 23.0 0.8 2.4 61.9 26.1 0.1 1.1 0.7 2.1 20.3 13.3 4.1 51.9 1.0 1.4 1.0 2.8 0.9 6.2 1.2 5.2 0.6 6.6 8.7 2.6 1.6 467.2 16.0 84.9 0.0 632.7 104.3 3.1 9.3 23.9 0.6 9.9 15.2 9.5 88.6 35.6 14.7 4.2 1.4 140.9 17.5 1.9 2.8 2.7 1.5 1.1 285.3 1.8 72.3 0.1 8.1 2.9 30.3 75.4 2.0 60.1 1.5 88.5 3.4 475.2 0.0 0.1 35.4 12.2 516.2 4068.5 7.4 15.8 978.8 120.9 8.4 246.9 0.5 9.2 0.0 0.1 31.5 52.3 34.3 46.2 6.7 661.5 37.0 71.6 1.8 19.7 8.9 17.3 0.8 1.3 11.2 90.6 3.1 68.0 0.3 50.8 65.7 ATL1 "AD-FSP, FSP1, SPG3, SPG3A" ENSG00000198513 "Atlastin GTPase 1" Q8WXF7 14 50532509-50634017 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 22.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 22.9" "Cell line enhanced" "Detected in many" "HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027550 Enhanced NA NA "HPA027550: AB_10600983" "unprognostic (2.06e-2)" "unprognostic (7.57e-3)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-1)" "unprognostic (7.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (4.95e-2)" "unprognostic (1.23e-2)" 3.8 5.7 29.1 3.4 38.3 0.2 11.5 23.4 41.6 5.7 8.0 6.9 3.9 9.1 2.9 5.3 6.5 4.8 1.8 39.5 33.6 4.1 0.3 4.4 1.7 30.9 26.5 38.7 10.6 3.7 1.9 7.8 0.6 31.3 8.4 5.6 9.6 13.3 8.7 1.1 9.7 4.9 15.7 23.9 1.1 4.6 8.7 29.5 1.2 2.5 2.3 1.8 6.7 5.4 39.8 1.2 1.1 4.8 4.6 0.3 0.0 3.4 5.7 9.6 6.2 7.4 0.0 4.1 3.7 2.5 0.1 4.5 1.4 8.4 1.1 2.4 19.8 1.8 1.2 0.8 0.3 0.2 0.2 3.1 3.6 1.9 8.6 1.6 0.3 0.4 4.2 0.1 0.5 8.7 0.4 1.2 0.6 4.4 1.4 1.5 0.6 12.1 0.4 1.7 2.5 17.1 15.4 18.9 1.1 0.6 0.0 0.0 2.1 1.3 6.0 4.6 0.0 2.9 0.9 4.7 1.7 3.9 0.2 0.2 22.9 0.1 4.9 2.5 0.0 0.5 3.8 0.9 2.1 1.2 1.1 2.1 4.2 0.3 0.6 0.5 2.8 0.4 2.0 29.1 38.3 23.4 41.6 39.5 33.6 30.9 26.5 38.7 31.3 23.9 29.5 39.8 3.0 6.4 2.6 31.6 3.7 5.1 6.2 10.3 6.2 27.8 18.1 16.3 1.9 5.7 6.6 5.5 0.0 0.4 6.7 9.3 0.0 10.6 31.4 4.2 5.4 4.8 7.2 0.4 138.6 13.1 1.1 14.6 5.6 2.3 6.3 1.2 5.0 0.0 1.6 11.8 95.5 1.9 2.0 0.0 3.6 5.7 13.4 5.5 8.8 20.6 1.3 23.0 2.1 81.4 136.7 7.2 6.0 17.0 5.2 3.9 13.2 3.4 14.2 8.6 19.7 4.5 10.8 31.9 5.7 4.1 5.5 0.1 3.8 0.2 3.6 3.3 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel subunit alpha 1" P29973 4 47935977-48016681 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "retina: 266.7" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 1139.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: AB_2686781" "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 3.3 0.4 0.5 0.8 1.3 0.3 1.5 1.6 0.9 1.0 0.6 3.6 2.3 0.4 9.4 9.1 4.1 1.1 0.4 0.8 0.7 2.4 23.7 0.3 0.1 0.6 0.5 0.6 0.1 0.8 4.2 0.3 1.0 0.8 2.6 2.4 266.7 4.4 1.7 5.1 5.2 6.3 0.3 0.1 3.4 2.8 0.4 0.7 0.3 0.7 1.3 0.5 3.7 1.9 0.7 2.3 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 2.0 9.2 0.1 0.5 0.0 2.7 1.4 0.2 0.3 0.1 0.0 0.6 0.0 0.2 0.8 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.9 0.0 0.8 0.7 0.5 0.2 0.9 0.0 0.1 0.4 1.1 2.2 0.1 0.0 0.1 0.4 7.2 0.3 0.0 0.2 0.5 0.1 0.2 0.9 0.0 0.3 0.2 3.0 0.1 0.1 0.7 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.5 0.0 0.0 0.5 1.3 1.6 0.9 0.8 0.7 0.6 0.5 0.6 0.8 0.1 0.7 0.7 7.3 0.0 0.0 0.7 0.1 0.1 1.8 0.5 0.6 97.7 8.7 1.8 0.7 5.7 3.4 62.5 91.8 0.0 0.0 10.6 0.0 10.1 0.4 2.5 0.4 8.7 0.0 2.7 1.2 6.6 0.0 0.3 0.0 3.6 0.0 0.0 0.0 38.0 1.7 45.4 1.1 4.0 0.0 0.8 0.0 0.1 0.3 0.5 0.0 7.5 0.0 163.9 0.0 0.0 0.2 2.1 16.4 0.0 0.0 3.7 24.5 0.4 0.8 1139.7 0.0 0.6 17.1 0.6 1.3 10.3 2.7 0.3 0.2 0.1 4.7 35.1 MAFK "NFE2U, P18" ENSG00000198517 "MAF bZIP transcription factor K" O60675 7 1530702-1543043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 94.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2 OS: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026820, HPA060841" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB026820: , HPA060841: AB_2684377" "unprognostic (6.82e-2)" "unprognostic (3.71e-3)" "unprognostic (1.49e-2)" "unprognostic (2.55e-1)" "unprognostic (6.44e-3)" "unprognostic (1.19e-1)" "unprognostic (9.44e-2)" "unprognostic (2.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" 40.7 31.3 39.3 13.1 30.9 19.6 34.7 25.5 31.9 30.3 34.4 49.5 18.4 35.0 1.8 30.3 33.9 11.7 74.4 25.4 28.0 36.8 33.1 60.5 9.5 34.1 31.6 21.5 21.9 40.0 4.2 25.8 25.6 34.7 49.6 4.7 2.5 25.8 10.8 79.3 37.4 31.3 6.8 29.1 21.1 37.5 9.8 32.3 23.1 27.6 13.3 5.0 39.7 36.0 36.9 50.0 35.0 1.2 5.2 3.9 4.8 26.2 32.3 18.3 7.7 5.4 25.2 13.4 11.6 11.7 8.2 51.8 38.1 2.9 9.2 3.3 17.9 25.2 6.8 50.8 18.7 8.7 16.2 20.7 4.8 11.8 12.9 9.6 9.5 7.1 35.7 17.8 6.2 3.6 32.7 18.2 57.6 11.2 12.2 35.2 27.1 1.2 19.5 7.3 20.2 14.8 5.4 19.5 56.4 14.6 7.5 22.0 21.3 16.8 11.8 82.3 59.5 17.9 11.8 3.9 19.8 15.5 22.0 17.1 0.5 0.4 1.2 0.6 0.2 0.6 0.3 0.3 0.7 0.2 0.5 0.7 0.5 0.6 0.5 0.5 1.5 0.7 0.4 39.3 30.9 25.5 31.9 25.4 28.0 34.1 31.6 21.5 34.7 29.1 32.3 36.9 33.0 41.7 17.6 2.0 8.8 63.9 52.2 21.3 37.0 2.2 33.7 20.2 2.8 11.5 25.7 31.3 2.1 11.0 13.2 45.8 1.9 15.2 2.9 57.3 13.3 24.6 23.2 8.2 8.8 14.9 9.0 16.6 20.4 94.3 9.5 6.6 9.7 14.8 10.9 11.8 3.7 24.4 16.2 13.2 27.9 6.0 4.7 18.0 19.6 9.4 8.7 7.1 8.2 0.5 3.1 46.2 38.9 3.0 6.0 60.8 27.4 2.5 29.6 1.6 13.1 33.2 27.1 0.9 4.0 25.8 57.7 78.0 11.0 2.0 19.8 73.5 ARMH1 "C1orf228, MGC33556, NCRNA00082, p40" ENSG00000198520 "Armadillo like helical domain containing 1" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.2;testis: 11.8" "Cell type enhanced" "Detected in some" "B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.4 1.1 3.0 0.2 2.3 2.2 0.7 1.6 2.6 0.8 3.8 0.4 0.2 1.7 3.5 0.5 8.2 0.7 0.1 2.4 1.2 0.7 4.2 1.0 0.6 2.5 3.0 1.8 2.6 0.5 1.9 3.3 0.3 2.4 0.8 0.3 4.3 0.7 0.6 0.1 0.8 0.3 0.3 1.9 0.3 0.7 11.8 1.9 0.4 0.6 0.0 0.3 0.3 0.3 2.3 0.2 0.3 1.8 0.1 0.5 2.1 0.5 0.0 0.2 0.5 0.3 0.4 3.8 0.2 0.2 0.8 0.9 0.5 0.0 0.0 0.0 1.0 0.2 0.9 2.6 0.6 0.2 6.9 4.1 1.7 0.2 0.7 0.0 1.3 0.2 0.3 0.1 0.7 0.2 0.0 4.9 7.5 0.1 0.5 0.0 2.7 0.1 2.2 0.7 0.0 1.2 0.8 0.0 1.2 0.9 1.2 0.3 3.6 0.0 0.3 0.3 0.3 0.0 0.3 0.1 0.2 0.3 9.9 0.4 8.7 2.1 6.1 0.2 0.7 0.1 0.6 1.1 0.8 1.0 0.9 1.6 1.5 1.0 0.4 0.0 4.8 0.0 1.4 3.0 2.3 1.6 2.6 2.4 1.2 2.5 3.0 1.8 2.4 1.9 1.9 2.3 0.5 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 3.7 0.0 0.4 1.3 0.0 1.9 0.7 0.0 13.1 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.7 0.0 6.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 5.2 0.9 0.0 0.0 ZNF43 "HTF6, KOX27, ZNF39L1" ENSG00000198521 "Zinc finger protein 43" P17038 19 21804946-21852125 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 37.8" HPA050271 Uncertain NA NA "HPA050271: AB_2681070" "unprognostic (9.25e-3)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-2)" "unprognostic (1.25e-1)" "unprognostic (4.16e-3)" "unprognostic (3.61e-2)" "unprognostic (2.47e-3)" "unprognostic (4.45e-3)" "prognostic favorable (3.16e-5)" "unprognostic (2.73e-2)" "unprognostic (1.01e-1)" "unprognostic (3.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-3)" "unprognostic (1.43e-3)" 3.9 4.1 2.2 5.5 4.2 10.8 7.9 10.6 4.0 5.0 0.9 4.5 3.6 6.4 4.7 3.7 6.8 4.0 4.5 1.6 2.7 5.1 1.5 4.2 8.4 2.5 1.9 0.8 11.3 3.1 6.7 2.6 4.8 4.7 7.3 5.3 6.7 3.5 4.9 3.1 7.4 4.3 4.5 0.8 6.6 4.8 8.8 2.3 10.2 8.7 4.2 6.8 3.7 3.1 7.8 0.4 3.7 25.0 19.8 2.7 5.9 10.4 6.6 2.7 8.3 11.4 0.3 3.8 5.9 7.5 4.2 7.7 0.5 0.3 0.7 13.8 0.8 6.5 0.3 1.6 2.9 1.3 0.2 7.2 5.6 0.9 8.9 0.4 2.1 1.9 21.8 0.4 1.1 6.3 4.3 37.8 9.1 18.0 0.5 5.4 22.0 9.8 6.6 5.4 18.9 16.7 12.6 0.1 0.1 2.2 11.3 9.6 5.1 0.4 0.7 0.8 6.0 7.0 1.5 11.3 10.2 0.3 0.8 0.8 30.7 4.5 6.2 8.8 4.6 8.4 18.8 11.5 9.9 4.6 19.1 18.6 12.7 4.5 9.0 4.0 8.5 8.1 3.9 2.2 4.2 10.6 4.0 1.6 2.7 2.5 1.9 0.8 4.7 0.8 2.3 7.8 17.0 12.8 15.1 19.2 14.4 2.0 8.1 1.4 2.8 16.0 10.6 12.2 13.2 8.6 9.9 3.7 10.4 9.4 10.6 3.7 17.6 11.0 36.3 11.6 13.6 16.0 11.4 16.2 9.5 9.4 7.6 12.8 5.1 16.6 16.4 52.0 16.8 0.4 4.8 8.4 14.1 4.2 6.1 4.4 4.4 9.8 14.0 6.6 1.8 18.7 6.5 12.5 20.6 26.7 23.1 7.6 4.0 9.4 7.7 8.8 2.4 7.4 6.6 9.6 6.6 13.8 13.3 21.3 15.7 3.3 2.0 5.9 10.8 41.0 7.1 4.4 GPN1 "ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1" ENSG00000198522 "GPN-loop GTPase 1" Q9HCN4 2 27628247-27651511 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036793, HPA036794, CAB037303" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230" "unprognostic (9.42e-2)" "unprognostic (1.44e-1)" "unprognostic (5.64e-2)" "prognostic unfavorable (2.88e-5)" "unprognostic (2.57e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.50e-2)" "unprognostic (8.27e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-3)" "unprognostic (2.34e-1)" "unprognostic (1.21e-2)" "unprognostic (2.51e-1)" "unprognostic (1.13e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" 22.3 22.9 19.9 20.5 19.7 34.4 26.7 19.8 26.3 17.8 19.5 22.9 20.0 19.2 20.1 25.7 21.2 18.8 19.6 19.5 24.6 26.5 24.8 18.8 29.0 22.8 20.1 18.6 18.6 23.0 26.1 16.8 26.7 22.0 17.9 25.9 25.1 21.7 17.1 32.7 24.5 19.8 22.6 21.3 22.4 20.8 25.7 21.7 30.4 23.0 27.4 30.5 24.2 19.6 22.9 94.6 53.3 48.8 35.4 44.3 44.8 48.7 52.0 50.5 70.7 52.1 58.0 47.4 58.8 49.2 56.4 65.4 39.5 67.6 63.4 71.5 55.4 47.6 66.8 38.3 70.7 57.3 100.0 33.7 46.7 54.8 72.6 67.1 49.4 75.2 51.5 84.7 53.5 84.1 54.2 60.3 75.1 83.4 70.9 50.7 60.2 144.4 61.0 57.9 53.5 42.9 67.6 57.2 61.5 58.4 44.7 37.1 56.0 62.9 61.5 91.1 30.9 122.7 60.8 71.8 156.9 88.0 85.0 51.8 92.4 61.3 55.1 79.1 71.6 86.0 74.6 72.2 92.0 89.7 68.7 63.8 78.2 9.3 106.1 72.1 46.8 79.2 82.3 19.9 19.7 19.8 26.3 19.5 24.6 22.8 20.1 18.6 22.0 21.3 21.7 22.9 17.6 12.8 10.4 2.3 18.7 21.7 21.7 28.2 10.8 9.2 14.8 11.8 11.8 14.3 19.7 14.7 4.2 43.5 28.8 9.5 23.5 46.4 86.3 20.5 14.1 17.3 17.4 18.7 6.6 36.3 46.2 14.3 9.7 21.7 24.7 17.7 17.5 10.2 33.4 11.8 6.6 13.0 20.3 20.1 26.8 76.0 14.9 17.6 23.2 2.8 28.9 15.0 27.8 5.0 5.0 46.3 13.5 10.9 11.2 20.1 16.2 20.8 14.3 10.9 13.1 13.2 19.0 36.6 23.4 13.6 18.6 33.1 31.0 20.2 20.0 18.9 PLN "CMD1P, PLB" ENSG00000198523 Phospholamban P26678 6 118548296-118561716 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 1578.1;skeletal muscle: 512.0" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 2452.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005597, HPA026900" Enhanced NA NA "CAB005597: AB_2252716, HPA026900: AB_1855314" "unprognostic (2.49e-1)" "unprognostic (5.67e-2)" "unprognostic (1.96e-3)" "unprognostic (4.81e-2)" "unprognostic (1.20e-1)" "unprognostic (5.54e-2)" "unprognostic (2.35e-3)" "unprognostic (4.66e-2)" "unprognostic (3.97e-1)" "unprognostic (8.98e-2)" "unprognostic (8.98e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.11e-4)" "unprognostic (2.98e-3)" "unprognostic (1.80e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.59e-4)" 40.5 12.5 1.5 12.5 2.2 0.6 16.0 2.8 3.5 31.1 3.7 110.8 13.8 122.7 22.0 44.3 82.6 93.0 1578.1 1.6 2.0 15.1 1.2 15.6 2.7 2.0 1.9 1.2 20.6 3.3 1.3 1.5 0.3 2.0 35.4 24.6 0.2 5.3 37.4 512.0 6.4 41.9 129.5 1.5 3.0 34.3 4.3 2.1 1.0 12.8 232.3 0.9 44.5 23.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 2.8 3.5 1.6 2.0 2.0 1.9 1.2 2.0 1.5 2.1 2.1 4.5 0.0 0.0 0.3 0.2 4.2 0.2 0.0 1.2 1.8 0.4 0.6 2452.8 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 108.2 0.2 0.7 21.4 0.0 0.0 1.0 0.0 0.0 49.1 0.5 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.9 0.0 0.0 0.0 4.7 25.0 0.9 0.4 3.6 1.0 0.0 0.0 0.0 2.0 1.1 0.1 0.0 11.7 0.0 0.7 0.0 0.0 0.0 0.3 276.1 16.7 248.0 9.2 0.8 0.3 1.6 0.0 0.8 0.0 0.0 0.4 C2CD4A "FAM148A, NLF1" ENSG00000198535 "C2 calcium dependent domain containing 4A" Q8NCU7 15 62066977-62070917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 13.6" "Cell type enriched" "Detected in many" 5 "Glandular and luminal cells: 107.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "OE19: 34.4;RPTEC TERT1: 29.9" HPA078864 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA078864: " "unprognostic (3.85e-2)" "unprognostic (6.68e-2)" "unprognostic (5.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.32e-1)" "unprognostic (5.38e-3)" "unprognostic (5.49e-3)" "unprognostic (3.85e-1)" "unprognostic (1.67e-1)" "unprognostic (9.21e-2)" "unprognostic (3.89e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.72e-2)" "unprognostic (2.07e-2)" "unprognostic (6.26e-2)" "unprognostic (3.35e-1)" 0.2 0.4 0.2 0.6 0.2 0.2 0.2 0.1 1.9 0.4 0.3 0.5 1.0 1.3 0.0 0.1 0.0 0.4 0.1 0.3 1.7 2.0 2.5 0.5 0.2 0.9 0.2 0.2 0.1 4.0 0.0 13.6 0.1 0.7 0.6 0.6 0.2 1.2 0.1 0.3 0.5 0.5 0.0 0.1 0.1 2.0 0.1 0.3 2.1 0.2 0.0 0.5 3.7 0.0 0.9 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 34.4 0.2 0.1 0.0 0.2 29.9 0.7 1.3 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.1 1.9 0.3 1.7 0.9 0.2 0.2 0.7 0.1 0.3 0.9 0.6 0.0 0.0 0.3 0.3 0.5 1.8 3.8 0.0 0.9 4.3 6.2 1.4 0.0 2.7 0.0 0.0 0.0 0.0 1.2 1.9 2.8 0.0 11.7 14.6 3.9 20.8 0.0 0.0 6.6 0.0 1.2 3.6 107.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.2 14.2 0.0 0.8 0.0 0.0 0.8 0.0 0.0 1.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.8 2.2 0.3 0.0 1.1 0.2 0.0 1.0 1.4 0.0 0.0 0.0 1.1 0.0 1.1 0.1 1.0 1.1 ZNF28 "DKFZp781D0275, KOX24" ENSG00000198538 "Zinc finger protein 28" P17035 19 52797408-52857600 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "prognostic unfavorable (9.29e-4)" "unprognostic (2.11e-1)" "unprognostic (7.05e-2)" "unprognostic (3.40e-2)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-2)" "unprognostic (6.91e-3)" "unprognostic (5.38e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (6.57e-2)" "unprognostic (1.06e-2)" "unprognostic (7.09e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-1)" "unprognostic (5.68e-2)" 4.5 3.8 2.3 5.1 2.4 1.5 7.3 5.2 2.5 6.0 2.9 7.3 6.6 4.9 5.5 5.6 7.5 5.7 3.8 1.9 2.5 6.8 2.1 5.2 6.4 3.0 2.3 1.5 5.3 4.3 6.5 1.8 6.7 3.0 6.6 8.6 8.1 3.4 5.3 1.2 3.8 6.3 4.8 2.4 6.3 6.7 5.9 2.4 7.8 10.7 2.5 6.9 6.5 3.5 3.4 11.7 1.4 6.7 12.6 10.5 8.3 23.5 10.2 7.9 9.9 13.7 9.7 11.0 19.4 11.5 7.8 10.1 8.7 11.1 6.7 13.7 0.1 11.6 15.8 6.4 2.8 10.7 0.1 15.4 7.0 10.1 13.1 12.9 7.4 10.0 10.7 18.4 0.2 11.8 3.6 16.2 6.6 8.4 12.6 9.6 10.4 16.6 11.5 10.6 39.5 10.9 8.3 21.8 10.2 7.5 17.5 15.0 14.3 8.6 5.0 10.0 4.5 10.5 4.0 18.0 21.0 0.3 2.4 20.1 20.9 5.9 9.3 9.3 4.3 8.2 5.8 6.5 7.7 7.7 6.1 7.3 8.7 2.9 25.1 5.0 4.0 5.9 7.6 2.3 2.4 5.2 2.5 1.9 2.5 3.0 2.3 1.5 3.0 2.4 2.4 3.4 4.9 3.2 4.7 0.0 6.3 3.2 3.8 5.5 4.6 1.4 7.7 5.2 6.7 11.5 11.5 11.0 2.1 7.1 6.3 13.7 7.9 7.0 0.9 10.2 5.9 6.8 14.5 5.5 0.0 5.1 9.7 3.4 3.6 13.5 8.2 6.5 6.4 6.5 9.6 5.0 0.0 12.8 8.2 10.6 3.0 1.3 2.5 6.1 3.6 0.0 5.7 2.2 9.2 0.0 0.0 6.9 14.0 1.9 5.6 7.8 17.8 8.2 9.8 1.6 0.0 3.4 3.4 2.0 3.9 7.6 2.3 7.0 6.2 4.2 10.4 8.8 ITGBL1 "OSCP, TIED" ENSG00000198542 "Integrin subunit beta like 1" O95965 13 101452593-101720856 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Fibroblasts: 76.1;Skeletal myocytes: 93.0" "Cancer enhanced" "Detected in many" "pancreatic cancer: 7.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 208.3;ASC TERT1: 138.7;fHDF/TERT166: 345.3;LHCN-M2: 311.8" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 12 "spinal cord: 56.9" "Secreted - unknown location" NA NA 37000 "unprognostic (1.70e-1)" "unprognostic (2.12e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.12e-4)" "unprognostic (1.45e-1)" "unprognostic (3.18e-1)" "unprognostic (2.54e-1)" "unprognostic (1.86e-1)" "unprognostic (8.84e-2)" "unprognostic (2.16e-2)" "unprognostic (9.50e-2)" "unprognostic (1.13e-5)" "unprognostic (1.44e-2)" "unprognostic (2.55e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.70e-4)" 10.7 9.2 1.8 0.7 1.7 0.1 18.2 2.7 4.3 24.0 8.1 1.4 0.5 2.0 0.5 9.8 5.0 38.7 14.7 1.9 7.9 2.8 7.8 25.7 1.4 3.9 2.2 0.9 5.3 8.0 5.6 10.4 33.6 4.1 4.0 2.5 0.1 11.8 4.4 4.5 11.1 0.5 4.1 3.8 4.0 7.2 2.5 2.3 0.9 8.5 15.0 4.4 18.0 10.1 7.0 4.2 0.3 0.0 0.0 208.3 138.7 0.0 65.8 67.7 29.3 18.7 0.0 2.4 0.0 0.3 345.3 13.9 70.9 0.0 24.1 46.0 0.0 0.0 21.3 0.6 0.0 21.7 0.0 0.0 59.3 1.5 16.8 46.6 55.3 76.8 0.0 1.5 0.7 311.8 0.0 0.0 0.0 0.0 0.0 24.0 0.1 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 8.8 24.0 33.2 27.3 0.1 8.3 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.7 2.7 4.3 1.9 7.9 3.9 2.2 0.9 4.1 3.8 2.3 7.0 1.9 3.2 0.5 5.5 0.1 4.0 0.1 1.3 0.6 1.8 4.2 19.0 0.5 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.5 4.5 0.5 7.7 1.2 0.0 0.0 3.6 0.2 0.8 76.1 5.6 1.1 0.0 0.0 8.6 0.5 0.7 5.0 6.7 0.0 0.0 0.0 4.7 2.1 0.0 0.8 5.4 13.1 0.0 0.5 0.0 2.0 5.0 1.1 0.0 8.2 0.6 0.2 0.0 0.1 0.0 0.7 0.0 93.0 4.8 11.6 8.4 0.7 2.4 0.8 0.4 1.2 0.0 0.2 ZNF511 "MGC30006, Zfp511" ENSG00000198546 "Zinc finger protein 511" Q8NB15 10 133308914-133313162 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035360 Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Intracellular and membrane" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931" "unprognostic (3.35e-2)" "unprognostic (2.19e-1)" "unprognostic (1.91e-1)" "unprognostic (8.84e-2)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (3.04e-1)" "unprognostic (1.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (1.40e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.94e-2)" "unprognostic (3.91e-2)" "unprognostic (2.55e-1)" "unprognostic (4.52e-2)" 12.8 11.7 15.4 8.7 15.6 17.2 11.4 15.3 17.4 15.8 16.7 16.2 16.3 15.8 10.8 10.9 15.5 9.4 21.4 15.0 17.0 10.5 21.5 11.5 12.7 16.3 15.3 14.8 20.6 15.7 14.8 12.8 8.8 15.7 16.3 12.9 5.9 16.8 10.8 49.6 8.0 13.3 11.2 16.0 12.6 12.6 9.7 16.1 11.5 11.0 32.2 9.8 13.8 12.6 15.9 54.1 54.0 30.3 43.8 25.6 21.6 32.6 25.2 39.3 53.3 44.4 88.0 50.9 48.2 24.4 29.5 33.9 48.8 41.9 36.0 23.2 38.8 92.1 29.1 22.1 53.4 21.0 57.5 52.1 22.0 19.2 43.7 26.5 30.6 24.3 22.7 40.0 22.4 18.6 71.2 27.5 76.1 37.3 50.2 74.6 37.1 37.1 12.4 28.3 18.6 16.9 37.0 16.8 30.0 38.2 18.7 23.2 33.1 23.3 23.1 35.4 26.5 68.5 31.3 36.4 66.1 37.5 26.8 12.9 40.2 61.1 68.6 45.4 52.6 35.6 66.6 37.0 46.6 61.0 51.8 41.6 40.8 8.5 41.0 51.1 65.9 36.2 47.3 15.4 15.6 15.3 17.4 15.0 17.0 16.3 15.3 14.8 15.7 16.0 16.1 15.9 16.3 16.0 14.5 7.5 33.6 29.6 45.6 40.7 39.3 19.5 37.3 52.6 23.6 25.8 21.9 22.0 8.4 61.2 36.7 33.3 70.5 39.5 29.5 18.5 22.4 20.9 53.4 40.2 10.7 41.2 62.9 34.0 20.4 15.2 78.1 40.6 20.3 54.4 47.4 21.9 7.6 128.8 22.4 33.9 38.0 8.8 41.7 39.9 16.0 5.6 64.3 27.4 41.2 3.5 12.3 38.6 44.0 30.5 40.4 43.0 60.8 72.1 23.2 23.6 26.3 27.3 34.5 58.1 48.0 36.3 35.9 28.2 33.0 38.6 65.9 41.5 C20orf203 FLJ33706 ENSG00000198547 "Chromosome 20 open reading frame 203" Q8NBC4 20 32631625-32673941 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.1;Excitatory neurons: 4.8;Horizontal cells: 15.2;Inhibitory neurons: 5.0;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "basophil: 1.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "HEL: 3.3;HMC-1: 3.3;U-2 OS: 2.0" NA NA "unprognostic (6.24e-2)" "unprognostic (3.39e-3)" "unprognostic (8.39e-3)" "unprognostic (2.06e-1)" "unprognostic (1.19e-2)" "unprognostic (6.70e-3)" "unprognostic (7.53e-2)" "unprognostic (2.52e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (1.00e-2)" "unprognostic (1.39e-3)" "unprognostic (1.25e-10)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (7.46e-5)" 0.1 0.2 0.3 0.1 0.7 0.1 0.5 0.5 1.4 0.3 0.1 0.1 0.0 0.6 0.9 0.2 0.5 0.2 0.2 0.3 0.3 0.1 0.3 0.1 0.3 0.9 0.3 0.4 0.8 0.1 0.2 0.2 0.6 0.3 0.3 1.4 0.1 0.5 0.0 0.6 0.1 0.3 0.0 0.3 0.1 0.3 0.5 0.5 0.5 0.3 0.5 0.1 1.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.1 0.0 0.2 3.3 0.0 0.0 0.3 0.0 3.3 0.4 0.2 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.9 0.0 0.3 0.8 0.2 0.0 0.0 0.3 0.1 0.3 0.5 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 2.0 0.0 0.0 0.8 0.2 0.2 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.5 1.4 0.3 0.3 0.9 0.3 0.4 0.6 0.0 0.5 1.1 0.1 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 4.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 15.2 5.0 0.0 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 1.5 0.0 2.5 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ZNF627 FLJ90365 ENSG00000198551 "Zinc finger protein 627" Q7L945 19 11559374-11619161 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA049770, HPA073463" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA049770: AB_2680871, HPA073463: AB_2686606" "unprognostic (1.81e-1)" "unprognostic (9.89e-2)" "unprognostic (1.64e-2)" "unprognostic (3.14e-2)" "unprognostic (7.89e-3)" "prognostic favorable (8.12e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.83e-3)" "unprognostic (3.17e-2)" "unprognostic (2.03e-1)" "unprognostic (1.67e-2)" "prognostic favorable (6.93e-7)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-1)" "unprognostic (6.39e-3)" 4.9 4.2 5.6 4.3 5.7 7.7 11.3 7.3 6.8 8.3 5.7 6.0 5.7 10.7 8.8 4.6 12.3 5.0 5.2 5.5 6.2 9.7 7.2 6.2 6.8 6.1 6.0 5.1 13.2 7.5 9.0 5.9 6.3 5.9 8.1 6.8 8.4 6.0 6.5 4.0 5.4 5.1 6.3 6.2 6.6 6.0 8.0 5.9 9.4 13.2 5.7 5.6 6.5 5.7 7.9 6.0 5.2 15.0 18.8 6.7 6.9 8.5 8.4 10.0 9.5 9.5 3.9 4.0 4.6 8.4 6.6 4.8 5.1 6.0 8.2 10.5 8.3 2.8 12.8 2.8 7.6 12.5 6.9 6.9 8.4 11.6 6.2 14.3 14.5 10.6 10.9 11.9 6.0 12.5 12.3 11.3 6.9 11.3 4.0 10.4 12.6 11.3 6.3 10.8 9.2 20.8 15.5 11.5 6.1 12.6 12.7 11.1 19.6 9.2 10.0 4.8 6.2 5.9 8.6 9.0 4.8 4.6 11.3 8.4 14.2 4.5 7.4 4.6 4.9 5.3 9.0 5.6 5.8 7.2 5.8 7.4 6.7 2.4 7.3 4.8 2.7 3.2 4.2 5.6 5.7 7.3 6.8 5.5 6.2 6.1 6.0 5.1 5.9 6.2 5.9 7.9 2.9 12.8 5.9 6.2 11.2 1.3 3.4 4.0 6.2 4.5 6.2 5.8 15.0 7.2 3.1 9.2 4.2 5.2 5.4 3.7 17.6 5.4 7.9 7.0 4.9 4.3 5.3 8.0 4.5 2.6 4.3 4.3 10.2 3.7 1.3 6.1 6.1 6.1 3.2 6.7 4.8 3.2 10.2 4.4 4.4 4.0 5.3 3.1 0.0 3.7 3.2 4.9 3.1 6.6 7.3 4.1 3.1 5.3 6.7 4.9 3.5 7.3 11.6 5.8 0.0 3.1 4.7 15.5 4.4 3.6 2.7 4.7 4.8 3.1 4.3 3.3 KCNRG ENSG00000198553 "Potassium channel regulator" Q8N5I3 13 50015254-50020922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 36.0" "Cell type enhanced" "Detected in some" "Early spermatids: 19.4;Endometrial ciliated cells: 46.0;Late spermatids: 12.6;Respiratory ciliated cells: 88.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001027 Uncertain Vesicles NA NA Vesicles "HPA001027: " "unprognostic (1.85e-3)" "unprognostic (1.66e-2)" "unprognostic (1.08e-2)" "prognostic favorable (2.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.39e-3)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (1.71e-1)" "unprognostic (5.91e-1)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (4.69e-2)" "unprognostic (1.52e-1)" "unprognostic (9.16e-2)" 0.5 0.4 0.4 0.6 1.9 1.9 0.8 3.1 1.1 1.0 0.2 0.5 0.5 1.3 0.5 0.8 36.0 0.4 0.6 0.3 1.1 0.8 0.4 3.2 0.6 1.4 0.8 0.1 0.5 0.4 1.1 0.5 0.2 1.3 0.6 0.8 0.8 0.5 0.4 0.7 0.9 0.6 0.5 0.7 0.6 0.5 2.0 1.1 0.6 0.5 0.5 0.6 0.7 0.5 3.4 0.4 0.3 1.1 0.4 0.4 0.5 0.2 0.0 0.9 0.8 0.0 1.3 0.4 0.8 0.2 1.1 0.5 0.5 0.8 0.3 0.6 0.6 0.5 1.7 0.5 0.7 1.0 1.5 0.4 0.6 0.8 0.5 1.4 0.7 1.6 3.1 0.7 0.1 1.0 0.5 1.6 1.5 0.9 1.0 0.6 1.0 0.0 0.0 0.7 1.0 1.0 2.2 0.3 0.7 0.8 0.6 0.6 0.4 0.5 0.7 0.3 0.4 0.3 0.1 0.2 0.9 0.2 0.5 0.2 1.0 0.3 0.2 0.1 0.3 0.2 0.4 0.1 0.3 0.3 0.6 0.2 0.2 1.2 0.4 0.2 0.3 0.4 0.1 0.4 1.9 3.1 1.1 0.3 1.1 1.4 0.8 0.1 1.3 0.7 1.1 3.4 1.1 0.0 2.7 0.7 0.9 0.1 0.9 3.8 0.0 1.0 0.6 0.9 0.5 0.0 6.2 0.0 2.1 0.8 0.5 0.8 0.0 0.5 19.4 46.0 1.0 0.8 4.2 0.0 0.7 1.4 0.5 0.8 0.0 1.0 0.0 0.5 0.0 0.3 0.5 3.3 0.7 0.9 0.0 0.0 0.3 12.6 0.6 1.3 0.0 0.0 1.3 0.7 0.0 1.0 0.5 0.6 0.3 0.7 0.0 0.9 0.8 2.1 88.6 1.2 0.0 1.4 1.5 11.4 1.5 0.0 0.1 0.7 0.5 0.5 0.7 1.3 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938949-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 1.3 0.8 0.5 3.8 1.0 7.2 2.2 1.0 0.8 1.2 0.1 2.9 1.9 2.1 0.6 2.5 1.6 1.3 0.9 0.8 0.4 1.1 1.2 1.3 5.5 0.3 0.3 0.6 1.4 0.9 1.5 0.3 2.8 0.6 1.0 4.1 1.8 0.7 0.9 0.6 2.1 1.7 2.6 0.3 1.7 1.6 5.3 0.3 8.1 0.9 0.9 6.7 1.7 1.1 0.6 39.6 24.7 48.4 21.4 4.6 11.2 28.1 37.5 16.1 29.6 36.0 16.6 25.9 44.9 18.6 10.8 21.4 32.8 72.9 21.5 61.7 30.0 12.7 29.8 23.7 16.2 1.9 56.7 21.8 5.9 3.8 36.6 14.3 7.1 19.6 28.8 37.8 22.0 28.7 21.7 53.5 11.1 38.6 21.1 25.7 49.5 69.7 17.3 8.4 26.0 28.1 19.8 39.8 10.0 12.8 35.1 26.8 11.3 12.8 37.3 43.9 27.5 32.1 6.5 14.4 58.8 17.1 27.4 30.0 1.7 0.3 0.6 0.9 0.2 1.2 1.2 1.0 1.3 0.5 1.8 1.3 1.8 0.4 2.0 0.4 0.7 1.6 0.6 0.5 1.0 1.0 0.8 0.8 0.4 0.3 0.3 0.6 0.6 0.3 0.3 0.6 2.3 0.0 2.0 3.9 5.1 3.8 2.2 3.5 3.4 2.9 1.8 1.9 1.7 0.0 4.0 3.7 0.0 8.7 3.6 1.8 0.0 1.8 0.8 1.9 3.1 2.0 0.0 15.5 10.3 1.0 8.4 3.4 2.6 2.5 0.0 12.4 0.7 0.9 4.1 3.3 6.5 2.4 6.1 2.1 1.2 1.1 0.0 2.4 1.8 5.6 1.4 1.4 2.1 4.5 10.1 1.1 0.3 3.0 7.8 0.6 0.5 6.2 3.5 3.1 0.0 2.4 3.0 15.0 19.3 6.1 2.4 2.6 3.6 2.8 5.2 1.7 ZNF789 ENSG00000198556 "Zinc finger protein 789" Q5FWF6 7 99472890-99503650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029500, HPA050793" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029500: AB_10603009, HPA050793: AB_2681240" "unprognostic (6.84e-3)" "unprognostic (5.75e-2)" "unprognostic (5.71e-2)" "unprognostic (2.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (1.25e-3)" "unprognostic (4.38e-3)" "unprognostic (5.16e-2)" "unprognostic (1.56e-1)" "prognostic favorable (7.14e-4)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (6.63e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "prognostic favorable (5.31e-6)" 4.9 5.7 8.5 4.7 8.6 7.7 5.6 11.1 10.0 7.2 8.4 7.6 8.6 6.2 7.3 5.0 7.2 2.6 4.3 8.6 8.7 9.9 8.8 4.9 6.2 9.0 9.0 8.2 7.9 7.6 3.3 11.9 2.6 9.3 16.5 7.4 11.8 6.2 4.3 5.8 7.3 9.9 3.7 8.4 10.8 6.2 13.5 8.7 4.5 8.5 2.9 5.9 5.2 5.3 9.5 12.0 3.8 6.1 11.0 1.9 1.8 8.4 5.8 2.2 3.7 7.9 6.0 7.7 8.6 4.8 2.7 3.7 5.0 3.2 3.3 5.0 4.0 6.0 6.6 10.3 11.8 3.1 4.3 14.5 2.1 2.8 7.2 3.5 2.2 3.9 11.1 10.2 7.7 3.3 11.6 5.7 12.0 6.1 5.7 5.6 7.0 6.2 9.4 4.9 3.4 5.9 6.6 4.2 11.8 7.3 3.4 3.0 7.5 6.1 6.4 8.0 9.9 5.9 5.0 7.6 11.9 10.8 8.2 6.9 2.0 1.5 1.5 2.3 1.0 2.7 2.3 3.0 2.6 5.2 3.6 6.0 3.7 0.3 4.2 1.3 13.5 5.1 1.8 8.5 8.6 11.1 10.0 8.6 8.7 9.0 9.0 8.2 9.3 8.4 8.7 9.5 8.2 0.0 6.3 11.8 9.5 5.5 4.2 4.0 4.6 18.3 6.3 6.7 2.4 1.5 4.6 1.8 14.6 4.4 14.0 6.3 1.9 3.8 33.9 5.2 4.8 7.2 5.4 8.6 10.4 5.4 3.2 4.7 9.2 5.6 3.8 11.8 1.8 3.5 6.9 6.7 12.7 6.3 4.1 3.1 6.5 8.4 3.4 4.6 7.2 10.3 3.8 12.0 5.2 12.5 10.6 4.3 5.4 4.5 6.1 2.7 5.2 4.6 4.9 14.7 0.0 6.5 4.8 20.8 4.8 6.7 5.3 2.2 6.9 8.5 6.6 3.4 CTNND1 "CTNND, KIAA0384, p120, p120cas, p120ctn" ENSG00000198561 "Catenin delta 1" O60716 11 57753243-57819546 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 305.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6" "Group enriched" "Detected in many" 19 "dendritic cells: 6.3;monocytes: 9.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003837, HPA015954, HPA015955" Enhanced Enhanced "Plasma membrane" NA NA 200000 "Plasma membrane" "CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068" "unprognostic (1.06e-2)" "unprognostic (1.60e-2)" "unprognostic (5.17e-3)" "unprognostic (4.87e-2)" "unprognostic (7.81e-2)" "unprognostic (2.30e-1)" "unprognostic (2.98e-2)" "unprognostic (3.52e-3)" "unprognostic (4.17e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.75e-1)" "prognostic favorable (3.54e-4)" "unprognostic (7.17e-2)" "unprognostic (4.09e-2)" "unprognostic (3.34e-1)" "unprognostic (7.33e-2)" 72.8 49.2 28.8 35.1 27.0 5.9 84.1 28.8 33.2 71.9 49.3 106.8 98.7 71.4 49.7 211.4 58.9 56.8 48.2 26.3 31.4 78.6 83.3 84.6 19.2 35.1 30.8 24.5 49.7 121.0 76.7 58.2 106.9 31.2 79.6 103.0 23.7 122.8 57.7 27.0 128.0 105.8 55.3 31.3 51.9 106.3 44.7 38.0 24.6 99.4 20.1 48.8 84.3 112.9 38.9 156.6 106.4 70.2 63.3 46.1 71.6 141.7 65.1 78.8 58.5 55.6 88.5 163.9 1.0 113.2 72.5 50.9 201.7 58.8 97.4 71.1 1.0 21.9 32.0 35.8 109.9 52.6 5.0 52.7 70.0 133.5 67.1 73.5 103.8 197.2 1.7 55.1 0.4 55.1 48.0 1.7 13.9 54.7 101.2 56.5 0.7 67.4 1.3 90.2 171.0 4.9 40.1 91.5 133.6 113.1 176.3 138.9 6.1 166.0 59.6 50.3 53.2 34.6 1.2 0.9 2.3 53.2 3.4 111.5 0.0 4.9 0.1 0.0 9.5 0.2 0.2 0.0 0.1 6.3 0.3 0.0 0.0 0.2 0.4 5.6 1.4 0.1 1.1 28.8 27.0 28.8 33.2 26.3 31.4 35.1 30.8 24.5 31.2 31.3 38.0 38.9 116.2 147.4 84.0 0.0 8.8 117.1 96.9 82.9 126.9 21.0 101.5 70.5 17.5 125.8 96.6 141.6 39.6 94.0 2.3 305.5 13.7 106.7 14.1 91.1 58.5 98.6 86.2 21.3 0.0 97.2 85.6 34.5 165.1 139.4 32.4 61.1 91.8 127.6 44.4 15.2 0.0 160.7 52.9 64.3 55.5 10.5 28.3 46.4 48.0 0.0 28.5 30.2 2.1 0.0 0.0 141.8 169.3 38.4 5.0 116.9 179.6 57.6 88.2 26.4 26.3 32.3 38.1 37.0 21.1 285.1 200.5 90.8 6.2 39.9 127.0 194.6 DDX39B "BAT1, D6S81E, UAP56" ENSG00000198563 "DExD-box helicase 39B" Q13838 6 31530219-31542448 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034012, HPA055334, HPA058450" Enhanced Enhanced "Nuclear speckles" NA NA 270000 "Nuclear speckles" "CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721" "unprognostic (2.78e-2)" "unprognostic (1.30e-2)" "unprognostic (6.86e-3)" "unprognostic (3.44e-2)" "unprognostic (3.22e-2)" "unprognostic (5.13e-3)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.85e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-2)" "prognostic favorable (1.43e-5)" 121.1 139.5 13.7 23.9 13.9 5.5 126.1 14.5 15.7 145.6 14.1 123.1 3.0 128.6 104.4 106.8 135.0 6.3 138.8 13.0 16.3 123.9 126.9 118.6 34.8 16.8 18.8 13.1 174.4 189.0 8.0 125.9 14.7 16.0 143.0 16.7 34.6 103.9 30.6 183.1 101.4 135.2 9.6 15.3 179.5 117.9 60.3 13.8 40.5 134.5 61.0 26.6 119.6 114.1 16.2 9.0 130.9 37.7 19.7 121.4 78.1 24.7 9.6 11.5 28.8 25.4 13.3 17.8 24.3 75.0 145.0 106.3 16.5 42.8 223.1 26.7 8.1 352.9 19.9 14.3 28.7 13.2 35.1 18.8 129.0 117.8 28.9 244.9 131.0 18.3 157.0 255.5 7.1 24.1 6.3 22.7 254.1 17.2 18.3 13.0 17.9 41.6 10.8 143.5 11.8 18.4 151.2 26.3 9.0 15.6 35.7 6.5 36.5 10.3 3.7 13.9 3.6 26.7 68.2 78.9 229.9 2.3 39.5 16.6 2.5 6.4 4.8 4.8 7.6 6.4 4.2 6.9 6.7 9.3 6.2 10.2 8.8 4.3 5.2 4.6 7.7 7.1 5.6 13.7 13.9 14.5 15.7 13.0 16.3 16.8 18.8 13.1 16.0 15.3 13.8 16.2 31.5 22.4 36.9 0.0 43.9 14.4 41.9 13.2 35.9 21.3 21.8 15.7 4.0 5.7 22.2 3.7 22.9 13.9 58.1 15.2 5.9 9.7 1.4 23.0 37.8 26.5 17.3 26.3 0.0 8.2 11.8 28.0 64.2 32.4 37.2 58.3 13.2 6.9 9.8 15.2 0.0 11.7 12.2 14.8 14.4 2.6 16.1 34.9 8.8 0.0 17.1 8.5 66.9 0.0 0.0 10.4 11.7 11.7 44.5 23.0 17.5 5.1 31.5 27.2 26.3 57.9 35.2 6.4 6.7 44.2 13.5 17.0 50.3 79.6 12.7 33.9 SLC34A3 "FLJ38680, NPTIIc" ENSG00000198569 "Solute carrier family 34 member 3" Q8N130 9 137230757-137236555 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.8;kidney: 13.4" "Group enriched" "Detected in some" 9 "Proximal enterocytes: 83.7;Proximal tubular cells: 40.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA023776 Enhanced NA NA "HPA023776: AB_1857102" "unprognostic (2.69e-1)" "unprognostic (4.16e-1)" "unprognostic (9.08e-3)" "unprognostic (1.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-3)" "unprognostic (1.75e-2)" "unprognostic (1.05e-2)" "unprognostic (9.84e-3)" "unprognostic (2.05e-2)" "unprognostic (2.20e-2)" "unprognostic (5.94e-2)" "unprognostic (1.94e-2)" "unprognostic (9.12e-2)" "unprognostic (5.80e-2)" "unprognostic (2.20e-1)" 0.1 0.1 1.6 0.1 0.7 0.3 0.0 0.4 0.9 0.1 0.0 0.1 0.5 0.2 0.0 2.9 0.4 0.5 0.2 0.1 1.9 13.4 0.0 0.3 0.2 1.1 1.6 0.1 0.0 0.6 0.0 1.2 0.0 1.2 0.3 0.0 0.3 1.6 0.0 0.1 0.4 9.8 0.0 0.9 0.2 0.4 0.4 0.8 0.0 0.3 0.0 0.0 0.1 0.5 0.9 0.6 1.2 0.7 1.5 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.5 4.0 0.5 0.1 0.0 0.1 1.8 0.0 0.0 0.1 2.8 0.3 0.1 3.3 1.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.3 0.6 0.0 7.6 0.0 0.1 0.3 0.7 0.8 0.9 0.5 0.0 0.0 0.6 0.0 1.3 0.4 0.9 0.2 0.6 2.2 0.0 0.3 0.3 0.3 1.5 0.1 0.7 0.3 0.3 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.4 0.9 0.1 1.9 1.1 1.6 0.1 1.2 0.9 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 83.7 40.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 RD3 "C1orf36, LCA12" ENSG00000198570 "Retinal degeneration 3, GUCY2D regulator" Q7Z3Z2 1 211476522-211492162 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "retina: 47.6" "Group enriched" "Detected in some" 10 "Bipolar cells: 82.7;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.6;HMC-1: 14.4;SH-SY5Y: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029941, HPA029943" Enhanced NA NA "HPA029941: AB_2732449, HPA029943: AB_2732450" "unprognostic (1.42e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-2)" "unprognostic (6.07e-2)" "unprognostic (2.96e-2)" "unprognostic (2.18e-1)" "unprognostic (9.54e-2)" "unprognostic (7.87e-2)" "unprognostic (1.15e-1)" "unprognostic (4.80e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-2)" 0.0 0.7 0.1 0.0 0.2 0.2 0.0 0.5 0.3 0.2 0.7 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 47.6 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.7 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.5 0.0 1.5 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 0.0 0.5 0.0 0.0 0.0 100.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 31.3" "Group enriched" "Detected in some" 209 "Early spermatids: 468.6;Late spermatids: 1668.9" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 11.8;U-2 OS: 6.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 6.2 0.0 0.3 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.3 0.3 0.1 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 468.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1668.9 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SH2D1B EAT2 ENSG00000198574 "SH2 domain containing 1B" O14796 1 162395268-162412138 "Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.6;skeletal muscle: 12.2;tongue: 6.7" "Group enriched" "Detected in some" 7 "dendritic cells: 47.3;NK-cells: 154.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 8 "NK-cell: 376.5;non-classical monocyte: 149.2" "Group enriched" "Detected in many" 38 "monocytes: 149.2;NK-cells: 376.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;EFO-21: 2.7;Karpas-707: 4.4;TIME: 1.3" "Not detected" "Not detected" HPA054791 Uncertain NA NA "HPA054791: AB_2682600" "unprognostic (7.82e-3)" "unprognostic (6.06e-3)" "unprognostic (1.41e-1)" "unprognostic (2.52e-2)" "unprognostic (1.43e-3)" "unprognostic (2.55e-3)" "unprognostic (1.89e-2)" "unprognostic (6.54e-2)" "unprognostic (5.96e-2)" "unprognostic (4.35e-1)" "unprognostic (1.12e-1)" "unprognostic (4.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-1)" "unprognostic (3.80e-1)" "unprognostic (8.45e-2)" "unprognostic (1.15e-3)" 0.5 0.0 0.4 0.8 1.1 4.5 0.2 0.0 0.9 0.1 0.2 0.5 0.9 0.7 0.1 1.4 0.2 0.5 0.1 0.6 0.2 0.4 1.0 2.2 1.2 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.5 0.0 0.3 0.6 12.2 0.0 1.1 0.2 0.1 7.6 0.1 0.3 0.2 0.2 0.1 6.7 1.0 0.3 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 1.1 6.7 31.0 0.4 0.3 0.1 1.8 6.8 0.1 0.4 1.3 3.0 376.5 149.2 0.5 0.4 67.3 0.4 1.1 0.0 0.9 0.6 0.2 0.4 0.3 0.4 0.2 0.1 0.2 1.2 0.1 3.2 0.6 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.3 0.0 0.0 0.0 47.3 0.2 0.0 0.0 0.1 1.4 0.3 0.2 0.0 5.3 4.3 0.0 0.0 0.2 0.0 2.1 0.0 0.0 1.8 0.6 0.1 0.0 0.5 0.0 0.0 1.6 0.3 0.5 0.0 2.0 0.0 1.0 1.6 0.0 154.5 0.0 0.7 0.5 0.0 0.0 3.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 13.9 0.0 0.1 0.0 ARC "Arg3.1, KIAA0278" ENSG00000198576 "Activity regulated cytoskeleton associated protein" Q7LC44 8 142611049-142614479 "Predicted intracellular proteins" "Endocytosis, Transport" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 294.5" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 57.0;Endometrial stromal cells: 47.8;Enteroendocrine cells: 164.2;Skeletal myocytes: 57.7" "Cancer enriched" "Detected in many" 12 "glioma: 36.1" "Group enriched" "Detected in all" 8 "cerebral cortex: 127.2;hypothalamus: 294.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 8.1;HEK 293: 10.0;SCLC-21H: 23.6;U-2 OS: 11.5;U-87 MG: 12.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basal ganglia: 20.7;cerebral cortex: 75.1;hippocampal formation: 42.4;olfactory bulb: 22.9" "HPA056430, CAB079013" Supported Approved Vesicles,Microtubules NA NA "Vesicles, Microtubules" "CAB079013: , HPA056430: AB_2683130" "unprognostic (1.40e-3)" "unprognostic (2.95e-2)" "unprognostic (4.35e-3)" "unprognostic (4.87e-4)" "unprognostic (6.83e-2)" "unprognostic (8.12e-2)" "unprognostic (5.13e-2)" "unprognostic (1.77e-1)" "unprognostic (5.07e-2)" "unprognostic (9.43e-2)" "unprognostic (4.15e-3)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.01e-2)" "unprognostic (7.42e-2)" "unprognostic (1.54e-1)" "unprognostic (3.35e-2)" 12.1 10.3 5.9 0.4 7.1 0.2 1.2 3.4 127.2 1.9 3.3 1.5 0.2 0.9 0.9 1.6 1.9 2.0 1.5 27.8 294.5 1.9 0.3 8.2 0.0 6.0 3.5 5.7 0.6 4.1 0.0 68.1 0.9 8.2 0.8 0.1 0.8 0.8 3.9 0.4 9.8 1.1 0.3 3.2 0.7 8.8 0.6 7.2 0.1 1.0 0.4 0.1 0.7 4.6 15.2 0.0 0.1 0.4 8.1 0.1 0.8 0.0 1.7 0.0 0.4 0.2 0.2 0.0 0.0 1.1 0.3 0.3 0.1 0.5 0.0 0.0 0.0 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.1 0.0 0.0 0.1 3.5 0.0 0.0 3.7 1.4 1.8 0.0 0.8 0.0 0.0 0.0 23.6 5.5 0.6 0.0 0.3 0.0 0.1 0.1 0.0 1.3 11.5 0.9 0.2 2.2 0.1 0.0 12.8 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.1 3.4 127.2 27.8 294.5 6.0 3.5 5.7 8.2 3.2 7.2 15.2 19.7 0.0 3.0 1.6 1.9 5.1 16.6 2.6 1.2 8.4 33.2 57.0 4.5 4.3 0.8 0.0 0.0 0.1 5.8 6.0 0.0 1.6 0.1 9.2 47.8 9.8 164.2 0.0 17.0 0.0 0.4 24.1 21.9 10.3 0.0 0.5 7.5 0.0 1.6 3.3 0.8 6.2 4.1 0.8 7.0 0.0 0.3 8.2 7.2 1.0 0.1 15.2 0.0 3.5 0.8 0.1 0.0 1.9 1.1 10.3 0.3 0.0 0.3 2.8 0.0 57.7 27.0 0.2 0.6 4.7 6.5 0.1 4.2 0.5 4.1 2.7 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 179.8;Proximal enterocytes: 334.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4" "Group enriched" "Detected in all" 4 "dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli NA NA 38000 "Nucleoplasm, Nucleoli" "HPA060452: AB_2684279, HPA062492: AB_2684781" "unprognostic (4.85e-3)" "prognostic favorable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favorable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 30.9 19.2 44.7 15.3 43.1 10.5 23.1 40.8 44.0 16.2 32.8 22.3 22.4 19.6 11.0 11.2 22.9 9.9 27.5 38.8 42.5 27.9 34.1 26.4 12.4 45.7 43.9 36.0 25.4 14.8 49.0 16.0 8.2 46.2 18.0 19.7 18.9 16.2 13.7 24.9 11.3 58.0 12.7 46.3 36.3 21.4 12.2 45.1 6.7 24.6 24.7 10.2 21.1 14.2 44.5 20.8 10.8 17.5 9.2 34.3 31.0 8.1 16.5 15.1 10.9 11.3 16.8 9.0 3.4 14.1 15.4 21.5 14.8 15.7 10.4 17.3 10.4 11.5 8.7 15.3 16.4 22.0 14.9 15.4 27.8 9.0 7.2 19.5 9.7 17.2 0.0 10.2 17.4 10.7 21.5 0.0 4.0 13.6 20.6 16.0 11.6 12.6 26.1 10.8 16.6 8.6 15.0 9.9 9.9 15.6 14.7 21.6 11.7 17.1 17.7 7.6 32.8 13.0 17.1 18.1 0.5 11.5 11.2 10.0 7.2 41.7 47.0 6.0 54.6 6.2 11.2 6.0 5.5 32.4 10.5 5.3 5.4 34.0 9.8 63.4 4.3 10.7 17.4 44.7 43.1 40.8 44.0 38.8 42.5 45.7 43.9 36.0 46.2 46.3 45.1 44.5 56.1 16.0 41.1 4.6 13.0 8.4 12.3 21.1 10.8 22.8 22.2 20.2 85.2 44.3 23.9 20.2 8.4 21.0 11.5 58.8 68.4 24.7 77.8 27.2 25.5 33.0 25.3 17.9 5.6 36.9 26.1 27.8 36.2 33.1 19.6 23.0 78.1 107.5 65.1 43.7 3.0 74.7 18.3 179.8 25.3 37.5 26.4 73.6 17.8 3.7 64.6 14.2 17.5 3.0 4.6 31.1 66.7 39.5 14.3 19.5 334.3 109.4 19.8 19.2 26.3 22.1 30.7 28.2 6.3 15.4 5.4 7.3 15.1 68.2 48.5 16.0 TLK1 "KIAA0137, PKU-BETA" ENSG00000198586 "Tousled like kinase 1" Q9UKI8 2 170990823-171231314 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, DNA damage" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016043 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016043: AB_1858027" "unprognostic (2.13e-2)" "unprognostic (3.87e-1)" "unprognostic (7.36e-2)" "unprognostic (6.00e-3)" "unprognostic (2.00e-1)" "unprognostic (6.78e-2)" "unprognostic (2.47e-2)" "unprognostic (7.60e-2)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (2.57e-1)" "unprognostic (1.11e-1)" "unprognostic (6.13e-2)" "unprognostic (2.08e-1)" "unprognostic (1.55e-1)" "unprognostic (2.63e-1)" "unprognostic (1.53e-1)" 7.7 10.3 8.0 10.8 10.0 11.2 12.4 5.6 11.6 12.8 7.0 13.1 9.5 10.7 5.4 9.4 9.6 9.7 7.1 10.4 9.4 13.1 14.9 8.5 15.1 5.2 8.7 6.9 14.2 10.5 18.2 6.3 15.3 5.4 11.9 12.4 15.9 9.2 14.8 16.4 8.5 11.9 11.8 6.3 13.3 13.6 17.8 12.9 13.9 17.8 5.6 15.8 11.8 8.4 8.8 16.6 15.6 22.0 17.3 15.4 15.3 24.7 22.5 31.9 21.8 18.2 21.8 25.9 34.2 18.7 33.4 23.6 13.7 28.5 24.6 23.8 42.1 14.9 39.1 18.5 28.0 16.5 50.3 19.0 16.7 24.6 43.4 28.4 23.0 24.3 21.2 42.3 27.4 13.2 20.3 43.8 15.5 20.6 15.5 8.9 31.9 26.9 34.7 17.7 30.9 25.0 19.7 24.7 16.7 16.1 14.9 13.8 17.0 33.2 19.3 24.0 12.7 17.8 24.5 43.0 59.7 23.9 20.1 19.9 11.1 3.1 5.7 5.2 2.6 7.3 8.3 8.3 5.7 3.0 8.3 9.3 6.2 4.2 8.1 5.3 4.4 8.5 5.2 8.0 10.0 5.6 11.6 10.4 9.4 5.2 8.7 6.9 5.4 6.3 12.9 8.8 34.2 51.3 27.8 135.8 76.7 41.3 33.2 27.1 30.7 34.8 45.9 28.4 32.1 37.1 29.2 51.5 60.5 82.7 42.6 55.8 88.0 29.2 58.1 29.5 33.9 34.5 23.9 33.7 196.2 32.7 52.7 30.3 37.8 38.4 27.3 39.5 27.5 40.0 27.4 45.4 161.0 36.7 36.7 29.0 30.4 32.0 43.2 54.7 37.4 74.0 29.1 26.6 49.4 84.9 92.0 35.6 36.5 44.8 66.3 51.0 33.4 58.0 30.7 77.5 0.0 41.6 29.6 31.1 54.9 24.5 39.1 174.9 66.4 59.2 33.9 43.0 LRBA "BGL, CDC4L, LAB300, LBA" ENSG00000198589 "LPS responsive beige-like anchor protein" P50851 4 150264435-151015727 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019366, HPA023597" Approved Approved "Golgi apparatus,Cytosol" NA NA 340000 "Golgi apparatus" Cytosol "HPA019366: AB_2138441, HPA023597: AB_1853256" "unprognostic (2.60e-1)" "unprognostic (4.70e-2)" "unprognostic (1.64e-3)" "unprognostic (4.49e-3)" "unprognostic (4.38e-1)" "unprognostic (8.65e-2)" "unprognostic (5.88e-2)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (6.92e-2)" "unprognostic (2.29e-2)" "unprognostic (5.88e-2)" "prognostic favorable (2.22e-16)" "unprognostic (7.15e-2)" "unprognostic (2.36e-1)" "unprognostic (4.79e-1)" "unprognostic (3.00e-1)" 7.4 10.8 3.5 9.4 6.9 11.2 22.9 11.0 4.0 13.2 16.0 16.9 13.5 7.0 14.4 14.0 15.4 10.0 8.4 3.0 4.2 23.7 13.5 11.1 16.0 5.3 4.9 2.7 9.0 13.6 34.5 6.6 7.1 6.4 20.1 17.6 15.1 13.9 9.0 7.3 19.5 11.6 6.7 3.9 9.7 17.1 9.5 3.2 18.9 19.3 9.0 17.9 12.4 7.0 6.6 27.6 14.3 11.9 11.1 12.2 18.5 17.0 6.0 15.8 10.9 10.2 30.9 35.6 33.7 7.2 8.6 7.5 13.7 22.1 36.6 15.3 25.9 15.8 20.8 19.8 19.0 7.5 29.0 16.2 14.6 21.1 16.0 24.6 23.9 32.9 14.8 22.4 24.3 12.9 21.9 21.9 7.7 10.7 23.7 10.3 18.4 12.0 12.6 42.0 33.7 39.3 13.0 15.1 32.1 7.4 18.1 32.4 6.1 17.2 16.8 12.2 8.7 11.4 20.9 20.5 20.5 26.2 16.0 6.6 5.7 0.6 1.2 5.0 0.2 3.3 4.9 3.3 4.7 1.0 2.1 2.3 4.0 0.1 3.2 2.1 2.1 4.6 1.8 3.5 6.9 11.0 4.0 3.0 4.2 5.3 4.9 2.7 6.4 3.9 3.2 6.6 10.4 16.0 14.9 148.5 42.5 17.5 16.4 21.0 28.5 33.5 30.8 18.2 55.9 21.5 21.5 51.5 148.0 23.7 37.7 19.7 9.8 15.2 25.5 51.2 11.0 13.3 42.0 40.2 213.7 13.5 10.6 12.8 56.6 61.8 6.3 22.4 10.0 20.5 6.1 30.3 192.6 23.8 24.4 11.1 12.8 5.5 9.6 17.7 16.0 161.1 8.2 17.7 46.4 239.8 217.4 17.2 20.2 10.1 38.3 22.4 22.0 15.8 36.7 72.6 6.6 13.7 9.8 16.6 22.3 37.3 23.7 24.2 45.6 25.9 27.2 24.0 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 79.2" "Group enriched" "Detected in some" 9 "Inhibitory neurons: 506.0;Oligodendrocytes: 794.4" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.0;HAP1: 11.0;SH-SY5Y: 29.5;U-937: 7.5;WM-115: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA077341: AB_2732340" "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 0.3 2.6 19.9 0.7 36.1 0.0 0.2 27.1 29.1 1.6 13.6 2.9 1.0 0.5 0.3 3.1 0.3 0.3 1.6 15.5 22.8 0.1 0.0 0.2 0.0 37.2 30.8 9.6 0.1 0.2 0.3 4.3 0.0 39.8 2.1 1.7 13.9 0.4 0.8 0.4 0.3 1.9 0.3 21.4 0.5 1.1 2.3 29.1 0.0 3.2 0.8 0.0 2.1 1.1 79.2 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 11.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 29.5 0.0 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 7.5 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 36.1 27.1 29.1 15.5 22.8 37.2 30.8 9.6 39.8 21.4 29.1 79.2 0.0 0.0 0.0 11.1 0.0 0.4 0.2 0.0 0.0 33.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.8 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.0 0.0 2.3 0.0 0.0 0.7 70.7 506.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 13.1 0.0 48.6 0.0 46.8 794.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 9.7 0.0 9.1 1.6 0.3 0.6 0.1 0.3 0.0 0.1 0.0 0.0 0.3 MMP17 MT4-MMP ENSG00000198598 "Matrix metallopeptidase 17" Q9ULZ9 12 131828393-131851783 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.6" "Group enriched" "Detected in many" 5 "Excitatory neurons: 47.0;Inhibitory neurons: 14.3;Melanocytes: 28.4;Oligodendrocyte precursor cells: 26.7" "Cancer enriched" "Detected in many" 10 "melanoma: 29.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "REH: 29.6;SK-MEL-30: 60.4;WM-115: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (9.11e-2)" "unprognostic (1.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.71e-3)" "unprognostic (5.62e-2)" "unprognostic (1.85e-2)" "unprognostic (8.90e-3)" "unprognostic (2.14e-2)" "unprognostic (2.60e-1)" "unprognostic (2.66e-4)" "unprognostic (7.68e-2)" "unprognostic (5.88e-2)" "unprognostic (9.26e-10)" "unprognostic (1.15e-2)" "unprognostic (2.65e-1)" "unprognostic (1.21e-3)" "unprognostic (2.81e-2)" 3.7 0.8 7.1 1.2 11.1 0.9 4.0 0.0 37.6 9.9 0.0 4.9 0.3 3.7 0.0 1.7 2.5 1.0 1.9 28.8 4.0 0.8 1.0 2.0 0.9 4.9 0.4 15.2 11.7 2.0 0.1 1.5 0.1 7.9 2.9 0.1 0.1 3.1 0.5 0.9 4.8 2.7 0.3 0.0 1.8 1.6 3.3 2.2 0.0 1.7 0.0 0.2 2.7 4.8 6.9 0.3 11.5 0.0 0.5 2.3 2.9 0.1 7.2 7.9 2.1 3.3 0.0 1.4 0.0 5.2 1.8 1.4 3.8 1.3 1.5 0.0 0.0 0.7 1.1 3.8 0.0 3.6 0.0 7.2 2.7 1.2 2.4 0.0 0.5 4.0 0.0 2.0 0.0 1.0 8.3 0.0 11.5 4.6 1.6 7.3 29.6 0.0 3.9 0.0 0.0 3.7 2.0 1.0 0.2 60.4 0.5 7.4 12.8 5.8 0.7 0.9 6.3 0.6 0.0 0.0 0.0 2.4 0.3 87.5 0.0 0.4 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 7.1 11.1 0.0 37.6 28.8 4.0 4.9 0.4 15.2 7.9 0.0 2.2 6.9 0.6 0.0 0.0 2.9 2.3 2.5 0.1 1.7 0.6 1.0 2.3 1.8 1.2 1.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 5.4 0.5 0.0 0.0 47.0 0.2 0.2 5.4 0.0 0.4 0.0 0.7 1.1 0.0 0.6 3.3 14.3 0.0 2.0 2.6 1.0 0.4 0.9 3.4 28.4 3.7 2.4 0.1 0.0 26.7 2.9 0.0 0.0 1.9 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.8 1.4 0.4 0.4 0.1 1.1 0.0 0.2 5.3 0.0 0.2 OR2M2 "OR2M2Q, OST423" ENSG00000198601 "Olfactory receptor family 2 subfamily M member 2" Q96R28 1 248174821-248181067 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BAZ1A "ACF1, hACF1, WALp1, WCRF180" ENSG00000198604 "Bromodomain adjacent to zinc finger domain 1A" Q9NRL2 14 34752731-34875647 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 428.6;Early spermatids: 555.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 29.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002730 Supported NA NA "HPA002730: AB_1078269" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (2.76e-2)" "unprognostic (1.84e-2)" "unprognostic (4.24e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (4.11e-2)" "unprognostic (3.99e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-3)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.31e-7)" "unprognostic (2.44e-1)" "unprognostic (7.83e-2)" "unprognostic (2.90e-2)" "unprognostic (4.37e-2)" 14.5 6.0 5.9 22.7 6.4 75.3 11.8 5.3 6.4 8.2 6.8 12.6 10.5 7.6 7.4 16.7 9.0 13.6 5.7 5.3 6.8 5.3 12.0 19.5 25.4 6.9 6.3 4.2 7.8 7.2 6.3 3.6 12.8 6.7 8.9 13.0 1.7 11.6 5.9 9.7 21.8 12.5 9.0 5.8 20.4 13.2 31.1 6.8 21.9 7.7 6.4 20.8 28.2 11.3 7.4 46.4 24.1 39.7 30.5 16.9 19.6 49.2 36.7 20.0 33.6 33.6 23.9 32.8 92.1 28.0 26.3 18.7 47.0 68.4 23.8 58.2 33.4 29.5 60.0 22.6 66.9 19.9 99.6 69.8 18.2 24.2 36.3 48.1 13.5 49.3 41.2 56.4 23.0 28.5 52.9 95.3 31.3 19.1 36.4 34.1 72.4 40.9 25.7 21.0 44.2 50.4 41.2 49.6 67.4 20.2 13.5 34.5 68.7 44.6 31.0 22.7 33.6 37.2 12.7 13.5 77.1 10.0 45.9 36.0 7.6 5.7 7.7 3.5 6.2 2.5 5.3 3.6 3.9 3.4 4.7 3.6 2.9 29.3 2.7 7.1 4.2 4.2 1.5 5.9 6.4 5.3 6.4 5.3 6.8 6.9 6.3 4.2 6.7 5.8 6.8 7.4 68.5 60.9 77.9 24.5 103.5 428.6 237.6 96.9 174.2 2.6 79.7 54.0 14.7 28.6 82.8 16.5 2.1 68.6 135.4 89.2 0.0 86.8 555.2 87.5 72.3 103.8 30.5 85.2 12.2 74.7 118.0 76.1 66.3 112.1 101.6 33.1 27.8 28.6 87.9 0.0 9.4 69.9 77.3 96.7 263.7 373.0 40.4 158.7 72.9 47.8 165.8 2.4 129.8 26.7 35.8 121.7 133.6 13.5 90.5 213.2 51.6 15.3 89.2 2.0 6.6 106.8 76.1 199.9 38.7 141.8 389.6 196.9 152.1 23.8 62.1 372.5 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 723.4" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 613.3" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.6;OE19: 2.9" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 3800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: AB_2679058, HPA068265: AB_2685966" "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.2 0.0 0.4 42.2 0.0 0.0 0.1 0.3 723.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.3 0.2 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.2 0.0 0.8 0.0 13.5 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 13.6 613.3 0.0 0.0 0.0 0.6 0.0 14.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 1.0 1.5 0.0 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 COPS8 "COP9, CSN8, MGC1297, SGN8" ENSG00000198612 "COP9 signalosome subunit 8" Q99627 2 237085882-237100474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 451.5;U-138 MG: 536.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036485 Uncertain Supported Nucleoplasm,Cytosol NA NA 110000 Nucleoplasm Cytosol "HPA036485: AB_10670720" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (8.74e-2)" "unprognostic (1.07e-3)" "unprognostic (1.20e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (4.70e-5)" "unprognostic (1.34e-2)" "unprognostic (8.03e-2)" "unprognostic (2.04e-1)" "unprognostic (6.85e-2)" "unprognostic (2.70e-1)" "unprognostic (2.41e-2)" "unprognostic (7.36e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" 48.8 48.3 58.8 36.3 65.5 41.5 42.4 64.6 67.8 43.0 56.0 31.8 17.2 44.5 38.4 27.0 37.7 42.8 84.5 66.8 72.9 52.4 34.7 29.7 32.8 62.1 62.7 60.9 48.6 22.8 64.6 37.8 44.1 63.6 34.4 25.0 92.6 27.9 36.3 174.3 29.9 24.0 54.6 60.9 24.3 30.6 47.7 64.8 49.1 37.6 119.1 33.1 52.5 32.8 70.6 58.9 48.6 103.5 51.8 289.5 226.1 69.2 100.7 99.0 100.3 110.7 31.9 57.9 39.9 37.6 110.0 159.5 43.3 102.4 136.1 138.8 94.9 66.2 58.0 57.5 113.8 199.4 76.3 33.3 376.9 153.0 101.2 451.5 124.6 119.4 84.7 81.9 37.4 320.9 55.7 94.7 77.7 91.7 63.0 70.2 71.7 123.3 79.9 124.7 46.4 50.8 87.3 60.3 51.2 155.4 82.4 59.5 61.4 127.4 536.9 91.1 106.1 110.7 71.1 64.0 127.9 167.4 46.0 138.7 59.1 45.2 56.1 57.1 53.3 70.9 68.3 60.4 65.8 55.7 56.9 58.3 60.7 14.1 72.2 58.0 40.2 70.7 70.5 58.8 65.5 64.6 67.8 66.8 72.9 62.1 62.7 60.9 63.6 60.9 64.8 70.6 46.8 32.1 24.4 13.1 38.5 75.5 50.0 97.1 39.9 55.2 32.3 26.8 114.2 31.5 44.4 33.1 27.1 61.6 32.5 12.5 142.8 65.1 34.7 45.0 41.2 52.2 21.0 39.6 20.6 40.8 79.3 85.7 23.0 28.7 42.6 38.9 38.9 23.5 61.0 35.3 20.1 16.5 95.6 29.6 59.3 21.1 72.7 24.2 126.3 11.2 44.6 98.2 39.1 15.1 20.6 52.6 16.7 75.6 44.4 44.9 22.6 96.9 55.3 63.0 59.2 44.7 69.8 98.1 116.1 33.6 64.5 44.5 44.5 50.0 21.0 41.8 CCDC69 "DKFZP434C171, FLJ13705" ENSG00000198624 "Coiled-coil domain containing 69" A6NI79 5 151181052-151224093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 355.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 124.5;dendritic cells: 106.9;Granulosa cells: 138.2;NK-cells: 197.8;Plasma cells: 133.6;Theca cells: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 129.2;Daudi: 199.9;U-266/70: 120.5;U-698: 119.1" "Region enhanced" "Detected in some" "cerebellum: 4.8" "Low region specificity" "Detected in all" "HPA043648, HPA052896" Uncertain Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Golgi apparatus, Actin filaments" "HPA043648: AB_10795877, HPA052896: AB_2681983" "prognostic favorable (3.21e-4)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (5.62e-2)" "unprognostic (8.63e-3)" "unprognostic (3.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.00e-1)" "unprognostic (9.29e-2)" "unprognostic (3.85e-2)" "unprognostic (1.55e-2)" "unprognostic (3.67e-1)" "unprognostic (4.31e-2)" "unprognostic (3.69e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 109.8 90.4 7.8 46.3 7.1 46.7 61.0 12.4 7.7 15.3 11.9 102.8 19.8 33.2 13.4 54.6 37.4 19.5 97.8 5.4 8.5 7.8 24.2 39.3 71.0 13.2 12.8 4.2 27.4 47.9 32.3 8.5 15.0 13.3 23.2 20.7 1.8 14.6 29.7 355.3 13.3 45.1 46.0 11.5 55.9 37.3 13.3 9.7 38.1 11.7 165.2 67.4 88.4 22.1 10.2 8.0 1.6 0.4 6.4 129.2 13.1 4.2 1.5 13.1 2.6 2.4 2.1 1.1 199.9 6.3 0.5 3.3 1.0 3.0 2.8 0.9 0.1 2.7 27.0 0.0 17.5 21.1 9.9 34.4 33.0 0.2 1.0 0.0 2.5 13.1 0.0 23.7 44.0 0.1 0.6 43.8 23.3 7.5 0.1 15.2 36.0 1.0 12.1 0.5 5.9 0.2 0.8 2.4 3.2 1.7 3.2 2.0 24.0 32.0 1.0 6.1 0.6 1.5 120.5 60.1 119.1 1.4 22.2 0.0 30.9 12.4 13.5 11.3 10.9 10.3 5.4 8.8 10.8 10.0 10.4 6.1 6.6 9.6 14.3 10.3 19.3 8.5 11.5 7.8 7.1 12.4 7.7 5.4 8.5 13.2 12.8 4.2 13.3 11.5 9.7 10.2 51.0 12.8 78.4 0.7 68.8 2.5 3.0 3.5 1.2 0.4 4.8 2.4 124.5 1.5 13.5 1.8 0.0 7.3 106.9 0.2 0.0 2.9 0.5 26.8 2.7 58.9 1.8 32.2 1.8 20.0 9.6 18.4 7.1 1.3 34.8 138.2 28.2 39.7 7.3 6.7 2.7 0.0 4.1 64.0 12.2 2.4 5.6 46.5 10.6 11.2 73.5 4.9 197.8 1.0 0.6 8.8 0.1 7.9 133.6 3.6 4.5 3.2 51.3 1.4 13.1 4.7 14.8 1.2 1.0 0.7 1.3 35.4 65.7 132.1 0.9 23.5 MDM4 "HDMX, MDMX" ENSG00000198625 "MDM4 regulator of p53" O15151 1 204516379-204558120 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018919, HPA048821" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018919: AB_1853694, HPA048821: AB_2680531" "unprognostic (4.63e-2)" "unprognostic (3.73e-1)" "unprognostic (6.38e-2)" "unprognostic (1.50e-1)" "unprognostic (3.84e-2)" "unprognostic (1.68e-3)" "unprognostic (2.33e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-2)" "unprognostic (2.34e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.87e-4)" "prognostic unfavorable (7.06e-6)" "unprognostic (1.20e-1)" "unprognostic (1.73e-1)" "unprognostic (2.49e-2)" "prognostic favorable (2.49e-4)" 13.8 10.6 9.7 13.5 16.8 56.6 14.5 15.8 12.3 16.9 30.9 12.5 5.9 12.1 18.8 11.6 13.7 6.8 11.3 9.2 12.4 11.8 14.9 16.5 18.9 15.2 13.9 4.5 19.1 18.9 5.3 16.5 10.2 16.1 14.8 9.7 25.4 12.0 7.4 10.6 20.0 16.8 7.2 10.5 22.8 13.3 20.1 13.7 30.7 15.9 4.3 17.5 12.2 13.8 36.0 6.5 12.7 12.5 17.3 8.6 9.4 58.7 4.8 4.9 6.1 8.9 6.6 8.7 22.4 4.5 6.7 5.1 6.8 8.5 7.2 8.2 6.8 6.0 17.8 32.0 7.6 6.5 14.0 16.9 9.4 4.5 9.9 17.4 6.3 6.0 14.2 10.4 31.5 5.4 21.9 8.6 12.3 17.3 2.4 5.3 10.1 10.2 7.5 6.0 31.1 5.6 12.6 4.9 9.1 9.1 12.4 18.0 8.1 6.1 6.8 12.1 4.5 7.9 15.8 6.2 18.2 4.7 5.9 10.1 7.5 4.3 5.8 5.7 4.2 4.9 7.9 4.4 4.1 3.6 11.9 6.1 5.4 6.4 4.1 3.8 7.8 2.6 2.5 9.7 16.8 15.8 12.3 9.2 12.4 15.2 13.9 4.5 16.1 10.5 13.7 36.0 73.6 28.9 56.9 76.0 118.1 61.6 48.2 31.0 22.8 96.0 55.2 33.7 38.5 47.1 51.2 69.9 168.9 52.0 135.7 35.5 13.7 29.9 82.3 39.6 74.2 54.5 65.0 64.4 61.8 26.7 26.1 53.0 36.7 63.2 65.9 82.6 87.1 61.0 35.5 42.1 65.7 48.3 54.9 96.4 128.3 160.2 80.2 62.0 42.7 83.4 81.8 40.1 90.6 106.6 170.3 26.5 42.3 54.2 81.0 66.3 49.0 18.6 32.0 192.7 52.6 99.6 50.5 75.7 64.8 23.0 68.3 60.9 73.7 58.2 51.1 48.3 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042184-237833988 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 133.3" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 0.6 0.7 5.5 0.8 12.3 0.0 0.6 10.3 24.5 1.5 0.0 1.5 0.2 0.8 0.4 2.9 0.7 1.9 133.3 10.7 3.4 0.1 0.1 1.9 0.1 2.2 0.5 6.7 2.9 8.5 0.0 1.8 1.2 3.8 2.9 0.5 6.6 0.5 1.7 0.1 0.3 0.5 0.7 0.0 1.3 1.5 1.1 2.8 0.1 4.5 0.3 0.0 1.2 0.4 13.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.9 0.3 0.0 0.0 7.7 8.5 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.0 0.0 0.0 2.7 3.1 0.6 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.5 12.3 10.3 24.5 10.7 3.4 2.2 0.5 6.7 3.8 0.0 2.8 13.9 0.2 0.0 0.5 17.0 0.0 0.4 0.0 0.0 0.0 74.2 0.3 0.1 2180.6 0.0 1.3 1.8 10.4 0.1 0.1 0.0 0.0 0.0 21.1 0.2 3.4 10.6 3.5 0.0 1320.5 2.9 0.1 53.6 0.0 0.5 0.0 0.5 1.1 0.0 0.1 1.7 790.6 0.0 0.0 0.0 0.2 15.3 1.2 1.3 8.8 48.7 0.0 1.3 0.0 29.7 140.6 0.4 0.0 0.0 0.1 0.0 1.0 0.2 0.7 5.3 0.0 0.5 21.6 5.8 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 ZNF534 "FLJ25344, KRBO3" ENSG00000198633 "Zinc finger protein 534" Q76KX8 19 52429187-52452315 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;retina: 1.1;testis: 1.8" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Excitatory neurons: 6.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 3.7;Spermatocytes: 5.4;Spermatogonia: 12.1" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.1" NA NA "unprognostic (2.66e-1)" "unprognostic (3.35e-1)" "unprognostic (2.35e-1)" "unprognostic (2.35e-1)" "unprognostic (7.65e-4)" "unprognostic (7.25e-2)" "unprognostic (9.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.36e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (9.57e-4)" "unprognostic (3.04e-2)" "unprognostic (4.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.80e-2)" 0.1 0.1 0.9 0.0 1.2 0.0 0.2 0.6 1.3 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.0 0.3 1.3 0.3 0.1 0.0 0.1 0.0 0.5 0.1 0.9 0.3 0.0 0.0 0.2 0.2 0.7 0.2 0.0 1.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.1 0.2 0.1 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.2 0.6 1.3 1.3 0.3 0.5 0.1 0.9 0.7 0.0 0.2 1.0 0.1 0.0 0.0 4.6 0.1 0.4 0.8 0.1 0.0 1.2 0.1 0.0 1.8 0.0 0.0 0.0 2.1 0.1 0.1 0.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 6.4 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 4.4 0.0 0.0 0.0 0.7 0.8 0.3 0.0 0.0 1.9 0.1 1.0 1.0 3.5 3.7 0.0 0.0 0.4 0.3 0.5 0.0 0.2 0.3 0.7 0.0 0.5 0.3 5.4 12.1 0.0 0.4 0.0 0.1 0.0 0.0 0.3 KLHL9 "FLJ13568, KIAA1354" ENSG00000198642 "Kelch like family member 9" Q9P2J3 9 21329665-21335404 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (7.82e-2)" "unprognostic (4.36e-1)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.89e-1)" "unprognostic (1.87e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-2)" "unprognostic (8.23e-2)" "unprognostic (2.95e-1)" "unprognostic (4.52e-2)" "unprognostic (9.06e-2)" "prognostic favorable (9.43e-10)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (2.91e-1)" "unprognostic (3.33e-3)" 11.3 10.3 8.2 11.0 8.7 9.0 17.0 10.6 9.2 15.0 8.7 12.1 7.2 15.6 14.7 10.5 13.4 10.3 8.0 7.6 9.3 14.4 11.0 11.3 12.2 8.4 9.1 7.9 19.8 10.9 12.9 5.3 16.9 8.4 15.8 12.2 17.9 12.3 11.4 4.7 8.4 10.5 14.3 8.8 15.3 13.5 7.2 8.5 14.5 16.1 8.5 11.6 11.0 7.1 12.5 12.3 14.7 32.6 17.7 41.3 40.7 7.1 22.5 22.9 16.7 18.8 5.6 9.5 5.5 14.2 33.1 16.8 6.6 19.2 22.0 20.6 30.7 14.0 0.0 27.4 14.5 28.7 9.8 6.5 40.2 23.3 13.1 21.1 27.3 25.8 0.0 0.0 7.0 38.6 7.8 20.4 33.9 13.4 12.7 12.4 0.0 14.3 6.6 20.8 15.1 10.3 19.6 13.0 11.6 14.3 30.0 21.0 0.0 31.2 0.1 11.7 9.4 13.2 7.6 11.2 5.7 0.0 10.1 11.5 8.4 6.0 16.5 4.8 6.8 5.5 3.1 5.9 4.4 4.7 2.3 7.1 4.9 1.9 6.2 7.2 3.5 4.5 4.6 8.2 8.7 10.6 9.2 7.6 9.3 8.4 9.1 7.9 8.4 8.8 8.5 12.5 20.3 25.6 20.5 9.1 12.2 10.3 34.3 15.4 22.8 27.3 14.8 12.4 17.9 17.2 25.9 16.5 18.8 16.4 12.7 19.5 11.7 14.8 0.8 12.1 26.2 20.2 27.6 10.5 14.2 15.3 7.8 22.6 25.5 12.7 12.0 24.6 37.9 23.1 15.4 18.5 17.0 22.0 22.4 22.8 8.4 1.9 21.5 14.7 17.8 20.6 14.7 20.1 9.2 15.1 23.8 12.2 13.9 24.0 16.3 25.2 13.7 19.3 20.8 21.4 13.1 20.1 22.0 13.4 9.7 19.5 10.4 10.0 17.2 18.7 16.9 21.0 FAM3D "EF7, OIT1" ENSG00000198643 "FAM3 metabolism regulating signaling molecule D" Q96BQ1 3 58633946-58666834 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 266.9;intestine: 493.4;salivary gland: 472.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 794.8;Intestinal goblet cells: 1150.1;Paneth cells: 776.7;Proximal enterocytes: 353.1;Undifferentiated cells: 760.0" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 151.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 3.7" "Lineage enhanced" "Detected in single" "granulocytes: 3.7" "Cell line enriched" "Detected in some" 65 "OE19: 68.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013844 Approved "Secreted to digestive system" NA NA 15000 "HPA013844: AB_2668897" "prognostic favorable (7.51e-4)" "unprognostic (1.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.67e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.89e-4)" "unprognostic (7.97e-2)" "unprognostic (6.54e-2)" "unprognostic (7.43e-2)" "unprognostic (5.48e-2)" "unprognostic (2.23e-2)" "unprognostic (1.42e-1)" "unprognostic (8.68e-2)" "unprognostic (1.64e-1)" "unprognostic (2.00e-1)" "unprognostic (6.97e-4)" "unprognostic (2.34e-2)" 0.9 0.1 0.2 29.9 0.2 0.0 18.6 0.1 0.5 31.6 0.2 365.4 90.0 0.6 0.2 266.9 0.8 82.4 0.2 0.2 0.2 1.1 0.2 4.8 0.6 0.2 0.2 0.2 0.1 1.7 0.0 0.4 1.0 0.2 14.9 493.4 0.0 472.5 69.1 0.1 2.6 91.1 8.4 0.2 0.2 78.9 0.3 0.3 0.4 1.5 0.0 41.5 12.9 59.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.2 68.5 0.0 0.1 0.1 0.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.2 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.3 0.0 0.0 0.4 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.6 0.0 1.1 0.3 3.4 0.0 9.9 223.1 0.0 0.0 29.5 53.8 0.2 47.1 133.4 14.7 0.0 0.0 1.3 794.8 0.0 1.3 0.5 0.0 0.0 2.5 152.1 0.0 0.1 0.0 0.0 0.8 114.2 0.2 8.9 0.0 0.4 0.2 0.3 0.0 0.1 1150.1 18.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 776.7 0.0 0.2 68.2 353.1 1.2 43.1 0.0 0.0 0.0 4.9 0.1 0.6 7.9 0.1 0.4 2.0 0.0 760.0 245.0 NCOA6 "AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP" ENSG00000198646 "Nuclear receptor coactivator 6" Q14686 20 34689097-34825651 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 130.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004198, HPA050211" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004198: AB_1078228, HPA050211: AB_2681052" "unprognostic (2.48e-1)" "unprognostic (4.81e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.87e-2)" "unprognostic (1.51e-1)" "prognostic favorable (8.78e-5)" "unprognostic (9.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.42e-2)" 10.3 9.0 4.7 9.2 6.1 14.1 9.2 11.8 12.5 10.9 3.4 12.5 13.3 10.8 12.3 11.8 11.4 8.9 9.3 5.6 4.2 10.0 8.5 10.5 9.0 6.6 4.3 3.3 11.7 12.7 22.2 10.1 13.6 5.2 9.9 14.6 26.9 13.0 11.4 12.8 13.6 12.1 13.3 1.2 9.5 11.5 19.0 5.0 18.3 13.9 13.2 10.4 10.5 10.6 9.1 25.2 14.7 32.6 19.7 17.5 19.4 21.3 12.0 15.3 21.1 16.9 37.9 17.2 17.7 12.9 21.5 25.8 30.0 29.3 20.2 23.9 9.0 13.2 41.6 16.7 22.4 19.3 23.5 29.4 14.8 36.5 19.8 24.5 14.6 20.2 20.1 21.5 23.7 17.7 16.3 37.5 14.8 6.7 21.0 21.1 24.9 39.3 15.9 15.6 16.6 27.2 18.5 22.0 52.5 20.5 15.0 22.2 18.5 20.0 34.1 20.7 25.6 20.2 26.9 24.3 20.0 22.5 13.5 15.5 1.1 0.6 2.5 0.9 0.5 0.8 1.0 0.8 0.8 1.1 0.8 0.7 0.5 1.5 0.7 0.7 1.0 0.5 0.5 4.7 6.1 11.8 12.5 5.6 4.2 6.6 4.3 3.3 5.2 1.2 5.0 9.1 17.3 25.6 16.0 54.9 11.0 17.0 9.1 10.6 13.6 28.8 14.3 10.9 20.1 18.6 11.6 16.5 29.2 13.0 12.2 31.9 5.9 12.5 23.5 16.4 21.3 14.0 10.8 13.3 50.9 12.4 12.1 14.5 15.8 23.3 6.3 18.5 13.9 12.1 10.8 33.7 58.8 17.4 20.3 12.2 10.3 17.3 18.0 13.0 10.6 45.9 17.6 11.5 13.4 54.3 130.4 15.4 12.4 13.5 14.2 16.9 20.3 9.3 17.5 29.8 26.3 16.6 16.9 25.6 27.1 19.2 20.9 15.9 13.1 13.6 17.6 14.6 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168247595 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 159.9;Inhibitory neurons: 142.9;Oligodendrocyte precursor cells: 153.3;Oligodendrocytes: 359.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA 80000 Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870" "prognostic favorable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 19.5 6.7 22.1 14.1 25.6 5.1 8.4 24.7 24.7 12.1 44.7 26.6 32.3 7.4 14.6 36.6 6.4 18.2 15.9 18.2 20.3 9.1 1.9 7.7 22.4 28.2 28.0 11.8 6.6 25.8 13.8 8.3 2.3 33.9 29.0 32.7 28.0 68.5 11.6 2.8 5.7 18.8 11.8 25.1 8.7 32.1 49.0 26.3 29.4 7.0 7.6 23.7 25.1 9.6 38.8 19.1 10.9 40.9 12.9 28.1 37.5 4.0 45.0 33.8 29.6 27.8 0.2 59.9 51.1 12.2 30.5 25.5 46.6 26.7 34.4 37.1 16.2 16.4 21.2 11.8 42.9 52.3 30.5 2.1 29.1 52.8 35.1 36.5 38.5 21.2 41.3 0.5 0.0 67.0 11.4 51.6 13.0 30.3 41.0 24.3 72.1 16.0 4.8 27.9 47.6 65.7 27.0 15.7 2.6 21.8 20.3 8.0 25.9 20.2 36.6 11.1 26.5 32.2 0.1 0.0 41.5 29.7 28.5 25.1 0.0 0.3 0.0 1.1 0.2 0.6 0.2 0.9 1.6 0.5 0.5 0.2 0.8 0.0 1.0 0.1 0.1 1.8 0.2 22.1 25.6 24.7 24.7 18.2 20.3 28.2 28.0 11.8 33.9 25.1 26.3 38.8 6.1 3.2 14.0 64.6 6.4 3.8 34.4 6.5 5.7 14.8 5.5 6.5 26.2 18.6 15.2 5.5 16.7 0.1 30.0 47.7 21.5 10.9 29.4 11.9 11.6 5.6 22.8 5.7 159.9 23.1 0.1 9.2 28.1 18.9 0.0 5.8 2.9 0.4 3.5 20.2 142.9 17.3 14.2 6.7 6.7 16.2 10.2 6.7 17.8 64.6 5.5 28.9 12.3 153.3 359.4 36.0 20.1 11.3 9.5 74.8 14.5 7.9 17.5 30.0 6.6 7.7 18.2 25.4 8.1 7.5 4.4 0.3 19.4 15.8 22.4 50.6 TAT ENSG00000198650 "Tyrosine aminotransferase" P17735 16 71565660-71577092 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Aminotransferase, Transferase" "Disease variant, Mental retardation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 1283.0" "Cell type enriched" "Detected in some" 43 "Hepatocytes: 4164.8" "Cancer enriched" "Detected in some" 10 "liver cancer: 152.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.66e-3)" "unprognostic (1.29e-1)" "unprognostic (8.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic favorable (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-3)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.1 59.5 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.4 1283.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 6.7 0.0 0.1 0.0 0.0 0.6 95.3 18.7 0.5 72.9 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.3 1.0 0.3 0.0 3.1 0.0 45.5 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.1 49.6 4164.8 0.0 0.0 0.0 0.0 0.0 72.3 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 2.7 0.2 0.3 1.0 0.0 0.0 0.1 1.3 1.3 0.0 0.0 0.0 3.9 0.0 0.1 0.0 C6orf89 "BRAP, FLJ25357" ENSG00000198663 "Chromosome 6 open reading frame 89" Q6UWU4 6 36871870-36928964 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 340.1;Late spermatids: 699.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 351.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012548 Uncertain NA NA "HPA012548: AB_1845748" "unprognostic (2.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.94e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "unprognostic (1.69e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.77e-5)" "unprognostic (3.75e-3)" "unprognostic (3.85e-1)" "unprognostic (9.94e-3)" "unprognostic (8.42e-3)" 37.7 37.8 24.5 27.5 28.4 37.9 32.3 25.8 24.6 46.2 22.4 34.1 28.4 37.1 50.4 35.7 38.8 33.4 50.2 25.7 33.0 33.2 34.4 33.1 24.9 28.3 27.4 23.7 45.3 46.6 54.8 28.4 33.6 28.6 37.3 37.5 13.6 42.6 48.1 36.9 24.4 27.7 45.4 28.2 25.1 33.7 47.9 30.3 30.5 58.7 44.7 31.7 31.9 26.7 34.3 37.9 22.9 31.1 44.8 111.0 76.2 18.3 73.1 91.6 50.5 55.2 23.7 39.2 33.6 55.5 150.6 54.1 40.3 38.3 46.0 72.9 60.4 33.2 48.8 23.3 26.8 55.5 39.6 48.3 66.0 56.2 62.0 58.9 60.4 44.5 60.1 93.8 90.1 79.0 37.7 43.5 15.0 11.6 43.1 25.7 21.1 30.9 61.1 33.7 33.2 54.9 39.5 48.8 23.5 50.8 25.8 56.0 53.3 52.7 72.3 41.2 57.6 57.4 48.4 63.8 351.0 32.6 55.8 77.3 28.1 16.7 20.9 18.1 16.4 17.9 9.8 14.8 16.8 14.7 9.1 10.2 11.2 27.2 11.2 22.5 9.2 16.4 14.4 24.5 28.4 25.8 24.6 25.7 33.0 28.3 27.4 23.7 28.6 28.2 30.3 34.3 31.2 38.5 56.8 22.9 24.6 6.8 23.9 28.8 19.4 15.5 24.6 19.0 67.1 41.5 31.6 38.6 10.4 34.0 26.6 39.2 19.6 41.2 340.1 24.9 36.1 36.1 17.4 56.0 38.4 58.1 41.6 37.7 27.5 33.7 30.4 52.6 25.0 45.5 40.0 23.5 35.3 27.9 32.6 29.8 12.5 699.2 45.1 27.2 10.6 29.0 24.9 53.9 28.8 31.7 54.5 56.3 27.9 50.8 44.1 26.6 30.5 20.1 28.3 12.8 19.7 35.8 36.9 33.7 38.5 23.5 8.9 46.0 28.5 50.8 25.9 26.1 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408268 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018558, HPA044999" Supported Supported Cytosol NA NA 75000000 Cytosol "CAB018558: AB_2069454, HPA044999: AB_2679177" "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favorable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.38e-5)" 266.6 144.8 463.7 153.7 587.8 352.2 124.1 489.5 854.6 135.3 279.8 306.3 292.2 106.1 211.5 307.4 253.6 155.1 289.6 682.8 493.6 329.3 212.7 211.0 167.0 482.1 416.4 501.7 105.3 122.7 227.4 145.0 209.1 499.0 171.0 315.2 243.7 189.6 217.3 593.7 104.8 281.5 229.2 339.1 168.1 203.8 124.7 485.4 147.8 119.1 187.2 212.3 193.4 126.3 632.4 189.3 256.3 308.0 115.7 332.2 286.5 256.9 347.4 295.3 260.0 283.2 278.1 320.9 200.8 171.1 413.0 123.4 309.4 194.6 490.1 431.0 398.3 119.7 212.4 211.0 264.1 185.9 327.6 167.2 188.0 232.7 261.6 93.1 173.6 592.9 140.3 101.3 270.0 353.9 653.7 112.4 316.2 178.4 521.1 351.6 216.9 264.9 134.4 215.3 574.5 621.2 259.1 292.3 507.7 195.5 254.0 335.6 112.0 363.1 212.9 137.7 224.8 289.0 149.5 371.0 222.2 335.9 267.6 301.5 1289.6 356.8 826.7 1005.3 420.4 1230.3 496.8 1039.1 1079.6 483.1 400.2 745.7 882.7 513.3 1036.9 647.3 453.3 1168.3 1477.9 463.7 587.8 489.5 854.6 682.8 493.6 482.1 416.4 501.7 499.0 339.1 485.4 632.4 1812.3 387.8 374.4 119.8 573.2 567.1 572.2 604.2 543.5 1729.1 343.7 514.8 867.5 346.0 523.1 399.1 123.0 427.7 1471.8 828.8 459.7 550.8 154.9 1026.1 249.0 996.0 599.8 143.5 367.6 444.7 984.2 521.4 317.0 377.6 490.3 148.5 652.5 333.7 795.1 604.0 258.9 513.9 730.4 286.5 837.4 101.5 210.6 639.9 627.9 131.2 856.3 1061.8 1100.9 108.0 188.9 534.2 615.8 500.2 591.8 287.7 1637.2 1430.5 1618.4 321.1 315.5 387.5 901.6 128.8 199.8 553.8 580.4 1147.6 1139.3 247.8 666.6 458.5 LPA "LP, Lp(a)" ENSG00000198670 Lipoprotein(a) P08519 6 160531482-160664275 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Hydrolase, Protease, Serine protease" Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 77.3" "Cell type enriched" "Detected in some" 28 "Hepatocytes: 80.7" "Cancer enriched" "Detected in single" 38 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "RT4: 1.0" "CAB016072, HPA060604" Supported "Secreted to blood" NA NA 78800000000 1800000000 "CAB016072: AB_2135240, HPA060604: AB_2684330" "unprognostic (2.16e-1)" "unprognostic (5.10e-1)" "unprognostic (7.75e-3)" "unprognostic (6.70e-2)" "unprognostic (1.60e-1)" "unprognostic (4.17e-3)" "unprognostic (1.59e-1)" "unprognostic (6.38e-3)" "unprognostic (3.63e-2)" "unprognostic (3.18e-1)" "unprognostic (7.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (3.72e-2)" 0.0 0.1 1.7 0.0 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.8 0.0 0.0 0.9 4.7 0.5 77.3 0.1 0.0 1.5 1.5 1.2 0.2 0.6 0.0 0.0 0.0 1.0 0.6 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 3.3 1.1 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.0 1.1 0.9 4.7 1.5 1.5 1.2 1.0 0.2 3.3 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.2 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 80.7 0.0 0.0 1.3 0.0 0.0 2.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 TAFA2 "FAM19A2, TAFA-2" ENSG00000198673 "TAFA chemokine like family member 2" Q8N3H0 12 61708259-62279150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.6;seminal vesicle: 7.3" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.7;Cytotrophoblasts: 1.3;Extravillous trophoblasts: 1.4;Hofbauer cells: 1.8;Plasma cells: 1.0;Syncytiotrophoblasts: 2.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 31.6;neutrophil: 12.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 31.6" "Cell line enhanced" "Detected in some" "hTCEpi: 5.7;SCLC-21H: 2.1;WM-115: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.89e-3)" "unprognostic (9.33e-2)" "unprognostic (1.02e-1)" "unprognostic (1.37e-2)" "unprognostic (2.78e-1)" "unprognostic (4.83e-1)" "unprognostic (6.62e-2)" "unprognostic (4.16e-3)" "unprognostic (4.08e-1)" "unprognostic (1.80e-1)" "unprognostic (3.22e-5)" "unprognostic (1.05e-1)" "unprognostic (2.22e-2)" "unprognostic (3.31e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" 1.0 1.0 4.4 0.7 9.8 3.0 0.8 0.0 20.6 1.7 0.0 1.0 1.0 1.1 0.5 0.4 0.7 0.6 0.4 11.9 4.2 0.4 0.4 0.4 0.5 4.4 1.0 9.1 2.7 1.1 0.6 1.5 3.3 7.0 1.4 0.8 0.9 0.7 7.3 0.2 0.7 0.7 0.5 0.0 1.2 0.7 3.0 1.6 0.8 0.5 0.5 0.3 1.1 1.8 9.4 0.1 0.0 1.1 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.4 0.1 0.0 0.1 0.2 0.2 0.4 0.2 0.8 1.6 0.0 0.2 0.8 1.3 0.0 5.7 0.0 0.0 0.1 0.0 1.5 1.1 0.6 0.0 0.0 1.5 0.3 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.1 0.5 0.0 0.4 0.4 0.2 0.2 0.0 0.2 0.6 0.1 0.3 0.4 0.5 0.3 0.0 0.3 4.7 31.6 2.4 5.2 0.5 0.8 0.2 0.5 1.0 0.5 0.3 0.2 0.8 0.3 12.0 0.6 0.2 0.5 3.9 0.5 4.4 9.8 0.0 20.6 11.9 4.2 4.4 1.0 9.1 7.0 0.0 1.6 9.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 OR10G6 "OR10G6P, OR10G6Q" ENSG00000198674 "Olfactory receptor family 10 subfamily G member 6" Q8NH81 11 123994163-123995161 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTC37 "KIAA0372, THES" ENSG00000198677 "Tetratricopeptide repeat domain 37" Q6PGP7 5 95461755-95554977 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037905 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037905: AB_10673034" "unprognostic (5.99e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.62e-4)" "unprognostic (8.48e-2)" "unprognostic (9.49e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-2)" "unprognostic (2.18e-1)" "unprognostic (6.88e-2)" "unprognostic (5.97e-2)" "unprognostic (6.81e-3)" "unprognostic (2.51e-1)" "unprognostic (3.30e-3)" "unprognostic (6.88e-3)" "unprognostic (3.91e-1)" "unprognostic (3.98e-2)" "unprognostic (7.90e-3)" 23.8 24.4 11.5 18.0 13.9 10.6 26.0 22.0 16.0 24.0 15.1 20.4 21.6 23.0 19.9 20.0 17.1 18.6 24.5 12.6 12.4 27.8 23.4 17.2 20.6 16.1 14.7 11.2 22.8 26.9 46.5 20.4 26.1 16.8 27.5 22.3 22.0 20.9 21.6 34.8 32.9 19.4 22.4 13.4 19.6 26.4 7.8 13.3 26.0 26.4 31.2 21.7 17.1 16.9 19.2 33.1 34.6 43.0 14.9 70.3 94.9 38.2 61.8 49.6 39.3 58.6 37.1 23.6 58.0 39.7 59.0 41.0 31.7 54.5 74.5 65.4 34.0 44.6 39.1 68.8 24.6 60.1 25.7 27.1 63.6 37.3 50.1 69.5 60.3 63.0 19.0 31.2 37.1 75.1 19.0 33.5 20.6 24.3 15.1 28.2 28.1 60.0 61.5 43.2 25.7 53.5 41.8 50.8 24.8 57.0 35.7 38.8 21.7 87.4 53.3 30.5 42.5 47.9 35.4 48.3 53.0 54.0 36.9 70.0 6.1 6.4 2.4 10.1 7.8 12.2 10.3 9.8 8.5 8.1 10.0 10.0 10.6 0.2 9.3 8.0 16.2 9.7 4.4 11.5 13.9 22.0 16.0 12.6 12.4 16.1 14.7 11.2 16.8 13.4 13.3 19.2 51.4 76.9 56.1 68.6 38.5 19.5 20.4 26.5 8.6 57.8 33.2 31.8 84.9 25.8 40.9 27.6 50.1 32.5 52.0 22.4 15.6 41.5 2.4 44.8 70.9 39.9 32.5 20.2 146.8 40.5 41.8 43.4 42.8 57.3 41.1 64.6 32.9 36.0 26.9 58.9 130.6 34.3 16.2 28.8 16.7 4.3 62.4 32.2 8.8 68.4 55.4 21.0 41.2 99.5 145.0 38.1 20.2 64.7 41.1 19.0 32.2 30.7 38.2 33.6 39.5 55.1 39.5 10.5 10.0 30.9 32.8 19.8 34.8 52.3 34.2 18.2 OR5BS1P OR5BS1 ENSG00000198678 "Olfactory receptor family 5 subfamily BS member 1 pseudogene" 12 48559882-48562956 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA051426: AB_2681481" "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 15.2 10.7 8.7 2.9 8.5 1.7 14.9 7.5 9.4 12.9 9.3 13.6 5.3 18.4 6.2 9.2 16.1 2.9 12.0 9.0 8.9 12.1 11.0 9.9 1.6 10.0 10.3 9.2 13.4 9.9 5.6 9.1 3.8 9.0 11.8 3.7 2.8 10.9 6.1 8.4 12.8 9.1 5.5 9.2 6.8 11.6 22.0 9.4 3.2 12.0 4.7 2.0 12.8 10.8 9.6 10.0 2.1 2.1 0.0 7.0 5.8 0.1 7.5 0.0 2.8 3.4 0.1 3.5 0.0 2.2 8.9 7.6 0.0 5.3 9.4 1.7 0.0 10.3 38.6 11.2 0.0 3.4 0.0 0.0 7.1 13.0 3.1 7.3 0.0 3.1 0.0 0.0 0.1 3.3 5.0 0.0 0.1 1.8 8.0 9.5 0.0 1.4 0.1 3.9 4.6 0.7 16.8 9.3 7.6 8.2 4.1 6.7 10.8 6.6 0.0 13.6 0.1 0.0 0.0 0.0 0.0 8.8 2.6 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.7 8.5 7.5 9.4 9.0 8.9 10.0 10.3 9.2 9.0 9.2 9.4 9.6 46.5 12.8 6.4 2.3 2.1 60.8 46.1 14.7 47.3 24.8 45.4 55.0 12.2 20.0 5.9 16.5 4.2 29.5 2.4 14.8 66.5 7.9 85.7 11.0 26.6 24.4 13.1 4.8 7.3 12.4 13.8 33.0 7.1 17.2 0.0 15.7 22.9 18.5 9.7 21.9 7.6 11.8 10.2 4.8 13.0 16.2 30.7 5.2 28.4 3.7 1.2 42.9 0.0 4.0 9.3 8.1 9.5 21.8 0.5 45.5 8.1 23.1 3.5 14.3 32.9 52.8 36.9 164.0 12.8 16.8 37.8 29.0 1.3 16.3 14.3 19.8 MAGEA1 "CT1.1, MAGE1, MGC9326" ENSG00000198681 "MAGE family member A1" P43355 X 153179284-153183880 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 4.6" "Group enriched" "Detected in some" 36 "Spermatocytes: 26.2;Spermatogonia: 38.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 74.4;HMC-1: 123.9;RPMI-8226: 64.3;U-2 OS: 117.8;U-266/70: 177.4;U-266/84: 305.3" CAB002620 Enhanced Supported Cytosol NA NA Cytosol "CAB002620: " "unprognostic (8.65e-2)" "unprognostic (1.33e-1)" "unprognostic (6.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (2.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.0 74.4 12.9 0.0 0.0 0.0 123.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.2 0.0 0.1 0.0 1.7 0.1 0.0 64.3 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 7.8 0.5 0.0 0.0 117.8 0.5 0.7 177.4 305.3 0.1 8.3 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAPSS2 ATPSK2 ENSG00000198682 "3'-phosphoadenosine 5'-phosphosulfate synthase 2" O95340 10 87659613-87747705 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 136.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 7 "dendritic cells: 2.1;monocytes: 7.7" "Cell line enhanced" "Detected in many" "BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071224, HPA075267" Enhanced Approved Mitochondria No No 16000 Mitochondria "HPA071224: AB_2686366, HPA075267: " "unprognostic (3.98e-3)" "unprognostic (7.06e-2)" "unprognostic (4.95e-3)" "unprognostic (1.02e-1)" "unprognostic (2.67e-1)" "unprognostic (1.61e-2)" "unprognostic (4.96e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (3.50e-2)" "prognostic favorable (6.58e-4)" "unprognostic (1.14e-1)" "unprognostic (4.90e-2)" "unprognostic (6.72e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.21e-5)" "unprognostic (3.46e-3)" 33.5 136.3 6.9 26.9 6.9 2.0 21.1 6.7 9.6 17.9 7.9 80.6 29.8 8.6 3.1 10.3 12.5 20.9 10.6 6.1 7.3 24.0 77.6 71.0 11.1 7.3 6.9 5.8 27.7 26.3 2.1 3.0 58.9 7.6 6.8 65.0 2.3 16.5 3.4 4.7 3.2 62.3 16.9 7.1 8.6 9.3 11.8 8.5 3.1 21.5 8.8 14.9 16.8 11.6 9.9 19.9 20.0 6.4 0.3 129.4 164.8 0.3 189.8 157.7 110.4 79.9 1.0 4.1 0.1 9.8 473.2 3.5 8.5 13.9 13.3 125.2 0.2 10.0 8.8 13.4 0.1 196.5 0.2 3.8 58.7 0.3 63.7 5.2 135.6 94.2 1.4 0.0 89.4 79.2 74.1 0.1 0.7 7.4 4.8 24.1 0.4 0.1 0.4 117.5 8.7 0.9 1.6 92.5 3.3 1.1 12.6 13.5 5.3 120.0 38.2 22.5 131.5 13.9 0.3 1.0 0.3 18.3 0.2 0.2 0.0 1.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 7.7 0.0 0.0 0.8 6.9 6.9 6.7 9.6 6.1 7.3 7.3 6.9 5.8 7.6 7.1 8.5 9.9 49.5 240.4 38.2 3.6 2.6 2.3 0.9 18.0 1.8 0.2 11.5 4.7 4.4 8.6 13.8 9.2 0.0 0.5 0.8 202.4 13.7 6.4 1.2 2.6 18.7 23.2 12.6 5.2 22.2 30.2 0.8 36.1 15.3 11.6 0.0 20.3 36.0 111.5 11.5 0.0 27.6 26.5 4.1 29.8 50.7 0.8 17.4 51.0 1.8 30.0 5.2 1.3 0.0 21.6 1.0 19.4 46.1 5.3 3.1 2.1 181.3 9.8 3.4 0.0 13.1 1.0 20.4 1.2 0.7 1.1 1.3 1.4 1.7 96.4 74.3 1.1 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles NA NA Vesicles "HPA059445: AB_2684021, HPA059590: AB_2684075" "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 5.1 6.4 7.7 5.7 12.3 4.7 3.3 0.9 11.0 5.7 0.0 6.1 8.6 6.4 3.4 6.3 5.7 5.5 8.7 12.6 31.4 7.0 4.6 6.8 5.7 8.0 8.0 13.5 8.1 3.8 10.5 2.3 4.8 9.3 4.0 6.2 14.6 4.2 4.9 7.6 4.7 7.9 7.5 2.5 5.8 5.8 5.9 11.4 5.6 6.8 7.1 6.7 5.6 1.6 19.8 20.0 10.5 9.1 3.8 14.8 14.2 17.3 15.9 16.9 13.3 27.9 9.2 15.5 14.8 35.2 18.4 19.8 11.6 14.3 14.0 19.1 11.7 12.9 4.0 15.3 5.3 7.9 11.6 13.3 7.7 11.6 22.0 10.8 9.4 11.2 12.5 7.5 20.5 14.9 8.7 15.5 3.4 6.0 7.1 14.0 10.4 16.0 15.2 9.4 9.8 9.5 7.2 11.4 1.2 8.9 8.8 4.5 8.7 16.4 16.5 10.9 24.5 20.7 9.6 23.8 12.7 10.0 19.4 9.4 2.0 5.0 3.0 6.4 7.0 11.1 4.1 7.1 5.9 5.8 2.6 7.6 5.7 2.0 5.1 6.0 3.5 6.9 5.4 7.7 12.3 0.9 11.0 12.6 31.4 8.0 8.0 13.5 9.3 2.5 11.4 19.8 4.3 3.2 5.4 22.9 5.9 7.5 1.4 6.2 7.4 14.2 2.7 3.4 11.2 12.8 4.0 12.9 8.4 2.5 6.1 8.9 0.0 4.3 0.8 4.2 4.1 4.9 10.7 5.0 40.3 6.0 2.4 5.1 8.6 6.8 1.3 4.6 8.2 9.6 9.9 48.8 42.0 4.0 8.2 13.0 7.0 1.4 5.6 9.8 8.8 15.9 8.2 12.9 4.1 19.6 22.7 6.1 6.0 4.5 3.8 2.0 10.3 6.0 3.1 7.8 0.0 5.1 8.4 9.0 11.9 7.0 6.8 2.9 8.9 3.1 6.0 3.1 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30890559-30943108 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 6.1 8.6 9.4 0.9 9.6 0.5 6.8 9.6 9.8 9.9 9.3 9.7 0.9 9.2 6.6 6.5 9.1 1.3 8.6 9.1 9.7 7.8 9.7 5.5 0.8 9.9 9.9 8.9 11.9 12.8 6.0 11.5 3.0 10.2 11.6 2.0 2.8 9.9 1.4 18.8 10.1 7.4 2.5 10.0 6.8 8.7 9.0 9.8 4.4 10.1 7.3 0.7 9.4 9.8 10.2 5.2 9.9 3.6 1.9 12.4 9.3 0.8 4.4 2.1 4.7 5.0 4.5 1.7 0.6 7.6 3.6 7.4 9.2 4.7 9.4 5.0 4.2 1.4 1.3 5.5 1.9 4.8 1.2 1.9 2.8 7.3 3.0 7.3 7.2 3.4 5.7 4.7 6.1 4.7 0.6 8.6 3.1 2.2 11.5 2.8 7.0 12.0 2.3 6.7 2.3 4.5 4.6 9.2 5.6 3.0 8.8 4.4 3.3 3.3 9.4 3.0 5.0 3.4 7.4 8.7 1.1 4.1 1.9 1.1 0.0 0.1 0.0 1.4 0.3 2.0 1.2 1.2 0.7 0.9 1.5 1.8 1.1 0.0 1.8 4.3 1.1 1.4 0.7 9.4 9.6 9.6 9.8 9.1 9.7 9.9 9.9 8.9 10.2 10.0 9.8 10.2 9.1 16.0 8.4 21.2 5.4 4.1 5.8 4.9 9.6 17.0 11.2 9.8 17.0 0.0 10.7 9.2 20.9 6.5 3.5 7.6 9.8 4.5 11.9 10.2 12.9 8.8 7.8 6.9 23.7 2.9 2.2 8.4 8.6 9.0 8.8 15.5 6.8 13.4 3.7 26.9 25.5 11.0 8.2 5.4 2.5 7.1 10.5 3.9 5.4 15.0 3.4 14.9 7.2 13.6 44.2 3.6 6.4 6.8 7.0 6.0 4.2 8.0 13.6 23.5 6.6 9.4 7.6 20.9 16.4 7.2 2.4 4.1 5.3 9.2 10.3 3.7 ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992834-94121148 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "choroid plexus: 116.3;retina: 465.0" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in many" 6 "hippocampal formation: 9.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.4 0.0 0.4 0.1 0.3 0.0 0.8 1.1 1.6 0.5 116.3 0.2 2.6 0.1 8.5 0.2 0.4 0.1 0.1 9.6 0.1 3.5 0.9 0.3 0.4 0.3 1.0 0.2 0.2 0.0 0.0 0.1 0.6 0.4 0.2 0.1 465.0 0.0 1.4 0.1 1.4 2.9 0.0 0.1 0.1 0.1 1.0 1.1 0.3 0.4 0.0 0.1 0.2 0.1 0.5 0.3 0.0 0.1 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 6.8 0.3 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.4 2.3 0.7 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.9 0.5 0.0 1.2 0.0 0.1 0.1 0.2 0.2 0.3 0.3 0.0 0.0 0.6 3.0 0.1 3.1 0.3 0.0 0.1 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.6 9.6 0.1 0.3 1.0 0.2 0.4 0.1 1.1 0.5 1.2 0.0 1.1 1.3 0.0 0.1 0.2 1.7 0.0 27.9 0.5 1.3 1.1 0.0 1.8 7.3 450.4 0.3 0.0 0.0 0.0 0.0 8.8 0.3 0.1 3.1 0.0 0.0 0.4 0.0 1.5 0.2 0.0 0.9 0.0 0.2 1.4 0.3 0.1 10.1 0.6 16.2 0.0 0.3 0.0 21.9 0.0 0.0 0.0 19.7 0.0 37.3 0.0 0.5 0.0 0.0 0.0 0.4 0.0 2.6 1.3 0.4 2.3 482.9 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.6 0.7 EIF1AY ENSG00000198692 "Eukaryotic translation initiation factor 1A Y-linked" O14602 Y 20575776-20593154 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 105.3;tongue: 132.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 378.0;Erythroid cells: 538.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 180.2;HEL: 220.6;U-266/84: 161.1;U-698: 349.8" "Low region specificity" "Detected in all" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (4.31e-2)" "unprognostic (3.74e-1)" "unprognostic (2.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (2.89e-2)" "unprognostic (4.18e-2)" "unprognostic (2.17e-2)" "unprognostic (4.10e-2)" "unprognostic (8.53e-3)" "unprognostic (2.89e-1)" "unprognostic (6.03e-2)" 16.2 22.4 15.9 11.5 15.0 60.3 14.8 14.0 29.2 0.0 13.7 19.2 14.7 0.0 20.8 14.9 0.0 8.9 105.3 15.0 14.6 26.3 25.5 15.0 9.8 16.1 13.8 13.4 0.0 13.8 13.4 28.0 16.3 18.0 27.2 25.4 11.7 13.8 20.4 85.9 11.1 29.1 0.0 14.2 32.1 16.7 21.6 18.5 0.0 11.3 132.7 27.9 18.6 0.0 27.6 0.5 26.4 0.0 0.0 0.0 0.0 52.7 57.4 39.1 39.5 39.1 0.0 0.1 180.2 0.2 32.0 0.0 0.0 0.0 0.0 55.0 97.4 0.0 220.6 0.0 65.8 38.4 0.4 0.0 21.1 44.2 0.0 0.0 0.0 0.0 59.4 0.3 0.0 65.1 0.0 144.7 0.2 37.8 0.0 0.0 0.0 70.9 71.9 56.5 67.6 50.1 0.1 0.1 0.3 42.4 71.9 0.0 30.9 56.8 29.9 0.9 0.3 63.1 103.9 161.1 349.8 11.6 0.1 0.0 48.8 20.4 28.3 14.2 21.8 19.7 53.2 25.9 16.8 16.7 55.3 31.2 25.2 125.8 21.6 22.1 66.2 31.7 21.5 15.9 15.0 14.0 29.2 15.0 14.6 16.1 13.8 13.4 18.0 14.2 18.5 27.6 0.0 32.1 49.9 2.9 122.1 54.7 68.5 123.8 26.7 19.6 0.0 0.0 378.0 35.8 63.3 53.3 10.4 123.0 51.8 6.8 88.0 47.7 59.6 0.0 0.0 31.3 17.8 538.5 2.0 0.4 45.6 33.1 27.5 0.1 91.7 0.0 57.8 16.5 38.9 6.7 2.4 23.3 61.1 67.9 43.7 16.7 42.9 43.0 67.6 1.0 88.7 92.2 59.8 3.0 2.5 21.5 9.6 43.6 101.2 63.3 28.9 123.6 64.2 26.3 39.5 23.5 31.7 85.0 90.4 29.9 50.6 92.8 48.3 0.0 18.8 73.2 MT-ND6 "MTND6, NAD6, ND6" ENSG00000198695 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6" P03923 MT 14149-14673 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 36141.3;skeletal muscle: 58428.6" "Cell type enriched" "Detected in many" 13 "Cardiomyocytes: 15756.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 20826.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-1)" "unprognostic (3.27e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.03e-3)" "unprognostic (6.02e-3)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (6.06e-3)" "unprognostic (2.91e-1)" "prognostic favorable (8.91e-6)" "unprognostic (3.64e-2)" "unprognostic (1.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.92e-2)" 8016.0 6362.1 7658.3 3215.6 7735.1 3280.3 3122.5 3655.9 8795.7 1760.9 11735.7 5344.7 7912.0 3171.3 55.0 5876.4 5494.9 3464.6 36141.3 5505.2 4454.4 9498.0 11793.1 4637.9 2523.5 17376.5 4986.4 1025.0 2144.9 4187.6 69.8 1383.5 961.1 17708.2 2530.8 98.7 4351.6 4119.9 41.0 58428.6 15347.2 8073.3 52.3 1809.8 4239.4 10112.5 2011.3 12608.0 41.3 2583.4 245.7 43.5 5279.8 1913.2 10185.4 3305.7 2595.3 2255.7 2869.4 371.0 34.6 1614.6 4329.1 8.9 13.9 14.2 3553.8 3233.4 6999.5 2873.3 117.5 423.7 4781.1 25.1 79.1 23.3 4178.5 1966.3 4217.6 20826.9 10361.0 29.7 2704.1 3805.1 64.4 103.3 103.9 86.4 2123.1 23.2 1445.3 1855.2 2671.0 94.5 6976.5 836.0 3680.9 492.5 1868.7 1267.3 2002.7 1440.3 3034.3 60.9 9493.6 926.2 1476.3 2250.2 3898.6 1876.3 3559.0 3037.2 5182.3 8822.6 2473.6 2088.6 3550.5 1766.8 906.6 2600.9 1705.0 1682.9 2680.8 1473.8 2089.0 1092.3 645.1 733.4 881.5 840.2 1047.3 776.1 800.0 582.8 1016.1 760.2 870.6 453.3 752.2 963.0 790.6 635.2 365.4 7658.3 7735.1 3655.9 8795.7 5505.2 4454.4 17376.5 4986.4 1025.0 17708.2 1809.8 12608.0 10185.4 31.2 83.3 62.2 0.0 328.4 16.8 55.8 75.1 1210.0 0.0 52.2 31.2 15756.5 273.1 107.1 128.8 0.0 0.0 78.9 125.6 17.6 32.6 8.2 154.1 132.5 478.6 30.1 797.7 0.0 35.3 0.0 396.2 886.9 247.7 98.0 130.6 385.8 699.5 0.0 0.0 0.0 59.8 44.7 518.3 20.1 33.4 62.4 214.3 33.8 0.0 66.3 0.0 48.4 0.0 0.0 25.6 69.9 45.1 1055.4 152.0 76.1 175.7 111.0 0.0 59.2 121.6 423.9 31.7 60.5 1160.0 20.5 0.0 266.3 58.1 78.4 117.0 IPO9 "FLJ10402, Imp9" ENSG00000198700 "Importin 9" Q96P70 1 201829149-201884291 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059540 Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 70000 Cytosol Vesicles "HPA059540: " "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.44e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (8.92e-3)" "unprognostic (2.23e-3)" "unprognostic (2.52e-1)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (5.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (5.78e-4)" 17.1 18.3 18.1 12.1 18.2 10.2 16.6 18.5 22.6 18.6 16.4 15.3 9.3 19.4 18.4 15.9 15.3 9.3 14.6 18.8 17.6 15.0 27.1 18.0 13.8 17.7 17.1 18.3 17.4 18.0 14.9 20.9 14.6 17.4 17.6 14.1 23.9 12.4 10.9 14.1 17.8 15.3 16.8 14.5 19.7 14.4 14.5 17.4 16.3 19.5 10.8 16.9 16.8 15.2 18.0 45.4 46.9 63.0 51.4 35.7 24.1 47.1 34.2 34.3 55.6 53.8 75.6 38.4 26.8 18.9 32.9 48.8 41.0 43.0 47.2 47.9 24.5 38.1 20.0 75.2 57.2 27.2 26.2 31.4 26.7 21.3 60.2 48.5 37.1 56.7 36.0 40.5 24.6 40.4 45.1 30.5 34.2 63.4 40.6 15.2 32.2 65.8 26.6 30.7 71.0 53.3 60.5 37.5 58.7 30.8 96.6 43.1 32.8 31.1 52.1 46.6 29.5 63.5 18.1 12.0 31.5 25.9 30.5 39.8 10.1 10.1 8.7 9.9 13.2 8.6 9.5 9.5 10.9 12.6 8.5 7.6 8.3 2.3 10.2 13.8 6.6 9.5 7.8 18.1 18.2 18.5 22.6 18.8 17.6 17.7 17.1 18.3 17.4 14.5 17.4 18.0 25.7 22.4 45.6 48.0 22.1 15.8 14.9 14.3 13.6 57.9 14.5 14.7 23.6 10.0 20.4 7.3 60.5 27.8 17.6 7.5 1.9 16.9 8.0 9.2 28.9 27.3 11.3 28.6 60.1 18.7 20.8 25.4 16.3 11.2 11.4 32.6 23.2 18.1 19.5 75.7 60.7 16.3 10.2 17.6 21.5 8.8 20.2 13.3 14.2 36.5 21.6 38.1 26.8 46.8 50.6 17.6 10.6 28.2 18.2 16.4 8.9 9.0 10.5 56.5 39.5 35.4 26.1 42.0 37.3 16.4 14.2 22.6 17.0 26.0 17.0 12.5 GPX6 GPXP3 ENSG00000198704 "Glutathione peroxidase 6" P59796 6 28503296-28528215 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "epididymis: 3.3" "Group enriched" "Detected in some" 6 "Early spermatids: 3.3;Late spermatids: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 16 "basal ganglia: 23.8" "Low region specificity" "Detected in single" "Secreted in male reproductive system" NA NA "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEP290 "3H11Ag, BBS14, CT87, FLJ13615, JBTS5, KIAA0373, LCA10, MKS4, NPHP6, POC3, rd16, SLSN6" ENSG00000198707 "Centrosomal protein 290" O15078 12 88049016-88142099 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" Activator "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Leber congenital amaurosis, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 150.5;Spermatocytes: 143.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB029995, HPA043918, HPA064397" Approved Supported Centrosome NA NA Centrosome "CAB029995: , HPA043918: AB_2678730, HPA064397: AB_2685255" "unprognostic (7.42e-2)" "unprognostic (4.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "unprognostic (3.26e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-4)" "unprognostic (2.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.94e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.21e-6)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (2.44e-2)" "unprognostic (3.84e-3)" 5.0 5.1 2.9 4.0 3.6 2.8 5.0 3.3 3.8 7.7 2.0 5.5 1.5 6.5 2.7 2.4 8.1 2.6 4.4 3.0 2.9 5.9 3.6 5.1 3.7 3.2 3.4 2.2 12.4 4.7 9.1 8.5 3.3 3.6 6.9 2.6 7.2 3.5 2.1 3.0 3.5 4.7 2.9 2.7 4.6 4.8 8.6 2.9 4.3 7.4 1.2 2.6 6.1 5.0 4.5 8.3 4.9 9.8 2.0 4.2 16.1 3.8 8.2 6.6 5.8 5.0 7.3 3.3 7.6 3.6 6.1 9.1 6.4 2.7 5.2 9.1 4.2 4.7 7.5 4.5 4.7 7.6 10.0 3.4 8.3 3.3 12.5 10.4 11.3 11.3 6.5 15.4 1.4 11.0 3.8 5.7 6.2 2.5 1.3 8.5 4.5 11.6 5.1 4.9 6.1 4.7 8.3 5.0 2.5 6.4 7.6 11.3 3.3 10.0 9.5 5.5 8.1 10.7 6.0 10.4 8.2 3.5 3.7 3.9 0.0 0.0 0.1 0.6 0.1 0.8 0.2 0.7 0.5 0.0 0.3 0.7 0.5 0.0 0.5 0.2 0.6 0.5 0.0 2.9 3.6 3.3 3.8 3.0 2.9 3.2 3.4 2.2 3.6 2.7 2.9 4.5 29.0 86.6 32.1 56.2 22.5 6.4 16.9 17.5 17.1 65.9 15.1 16.5 50.0 25.8 35.2 29.5 102.2 13.0 28.6 8.4 7.9 26.0 70.6 89.0 57.0 24.6 4.9 12.4 91.8 13.1 8.8 26.1 14.3 32.1 19.0 56.2 13.9 5.7 13.9 65.6 93.7 17.4 34.6 6.3 7.4 29.4 28.6 13.5 14.2 30.9 11.4 35.0 33.0 67.3 100.4 19.0 6.5 37.6 22.5 9.2 6.9 11.0 81.8 150.5 32.9 42.5 32.2 143.9 53.5 6.4 5.5 5.6 23.7 46.1 15.8 9.4 MT-CO2 "CO2, COX2, MTCO2" ENSG00000198712 "Mitochondrially encoded cytochrome c oxidase II" P00403 MT 7586-8269 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 161733.2" "Cell type enriched" "Detected in many" 13 "Cardiomyocytes: 709929.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 73985.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016243, HPA051505, HPA054758" Enhanced NA NA 240000 "CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (2.77e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.06e-1)" "unprognostic (3.39e-1)" "unprognostic (2.72e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.25e-1)" "unprognostic (9.30e-2)" "unprognostic (3.05e-1)" "unprognostic (1.70e-1)" "unprognostic (9.50e-2)" "unprognostic (3.72e-3)" 23809.4 50528.2 113718.8 6015.2 115560.3 9289.0 23308.7 103093.1 161733.2 8633.9 116564.9 39379.1 18405.0 10129.1 10907.7 24728.2 11110.3 5966.5 141681.1 108498.6 100947.0 110468.7 106309.0 14153.9 6365.2 128597.3 109871.0 94676.1 8017.4 24721.3 30045.5 16993.0 10484.6 134367.9 25907.3 25229.1 9061.9 21555.4 13030.0 94136.6 21618.8 36423.0 9779.8 99835.0 18340.6 45780.6 14629.6 122532.6 6089.9 17016.6 110904.6 7955.3 21246.9 13295.2 112398.4 6276.2 9796.4 12777.6 12396.3 25548.5 9745.3 9393.2 7927.6 6429.8 4420.4 6584.3 10616.0 13681.5 12924.1 6467.6 11751.8 4522.1 23074.6 1724.1 16319.1 5925.8 10089.3 8726.0 9297.7 73985.8 20756.8 5543.0 7919.2 9987.0 14433.8 23568.7 2276.3 8072.8 14337.8 4979.3 12668.7 8862.9 12216.0 12212.6 13490.3 5804.8 22519.7 3353.4 12256.7 6160.6 5998.2 3899.6 10866.7 17578.2 17096.2 4758.2 7830.6 6527.3 15842.4 11881.3 18742.2 11084.6 31596.4 12345.0 10576.0 9043.3 10116.0 5740.6 6151.2 6563.0 7590.8 5638.0 15586.1 7129.7 20953.0 13541.7 15753.7 5586.8 8887.6 6782.0 11844.8 6189.5 6338.9 6316.7 10947.0 6386.1 7947.1 5329.9 6846.5 10055.3 8426.1 5367.4 7670.7 113718.8 115560.3 103093.1 161733.2 108498.6 100947.0 128597.3 109871.0 94676.1 134367.9 99835.0 122532.6 112398.4 4337.7 1445.5 1999.8 0.0 11825.3 6754.0 8961.4 22171.6 22140.9 0.0 11994.6 16742.4 709929.9 18464.2 10323.3 18597.6 0.0 0.0 7569.1 29582.2 3709.5 3684.4 1119.7 12108.5 6979.9 16215.0 6396.9 27238.9 0.0 4873.7 0.0 10942.5 19089.4 20683.3 2144.6 17185.5 15141.7 53416.5 0.0 0.0 0.0 17158.1 14290.0 26774.7 4814.0 5284.9 7663.3 9292.7 5140.4 0.0 7967.0 0.0 6828.1 0.0 0.0 4709.1 15133.6 5123.0 14109.6 5949.4 40280.5 22569.2 7617.1 0.0 7060.4 9361.8 14171.2 7120.5 8965.1 26952.2 6702.8 0.0 8863.0 13639.8 19371.4 14261.8 GLMP "C1orf85, MGC31963, NCU-G1" ENSG00000198715 "Glycosylated lysosomal membrane protein" Q8WWB7 1 156290089-156295689 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 224.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029121 Uncertain NA NA "HPA029121: AB_10600794" "unprognostic (2.46e-2)" "unprognostic (1.19e-2)" "unprognostic (5.68e-2)" "unprognostic (4.22e-3)" "unprognostic (3.71e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.35e-5)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (9.21e-3)" "unprognostic (1.33e-1)" "unprognostic (7.66e-3)" "unprognostic (7.68e-3)" "unprognostic (3.90e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" 31.3 68.9 11.0 17.3 11.2 19.6 25.9 11.9 15.5 31.1 18.5 22.8 30.5 24.6 23.4 30.1 21.3 45.1 16.6 10.6 14.7 51.6 60.3 29.1 22.7 12.5 12.3 9.9 22.2 27.2 29.7 19.9 48.4 12.8 57.8 21.3 2.7 35.5 20.6 7.4 29.1 27.1 24.7 11.6 32.5 29.0 6.4 13.8 12.3 23.8 9.7 15.6 36.3 27.0 14.0 22.7 40.8 3.9 27.0 224.8 121.7 27.5 40.8 172.0 58.1 79.0 50.9 68.7 0.0 83.2 59.0 1.9 14.6 0.6 30.0 18.4 4.6 41.8 7.0 22.9 60.6 101.4 19.7 58.1 119.9 36.0 55.9 17.9 85.1 89.0 17.6 32.8 3.1 34.6 28.5 10.1 0.1 46.5 56.9 20.9 17.4 0.0 74.3 53.7 24.5 12.9 42.2 27.1 76.4 120.6 45.6 38.3 54.2 45.7 25.7 5.0 46.2 26.9 24.9 45.9 11.3 44.0 15.7 36.3 35.0 71.3 12.2 23.4 74.5 21.7 13.1 23.0 20.5 31.8 7.7 22.7 21.7 19.4 18.0 55.6 21.3 43.4 36.9 11.0 11.2 11.9 15.5 10.6 14.7 12.5 12.3 9.9 12.8 11.6 13.8 14.0 11.7 3.2 19.1 3.3 7.3 0.0 16.4 0.0 10.8 2.0 12.3 11.6 5.8 31.5 5.0 31.3 0.0 70.3 7.6 13.8 27.4 51.3 0.6 8.5 19.1 17.5 10.9 18.5 1.6 38.3 68.5 33.4 18.8 14.2 8.8 14.9 42.8 69.8 197.7 1.7 1.9 19.4 0.0 66.8 0.0 1.4 16.4 41.1 0.0 1.0 29.8 21.0 13.4 2.0 3.9 29.8 22.2 13.9 23.0 28.9 44.9 67.3 5.8 1.5 13.1 11.9 17.1 0.9 1.9 17.8 0.0 69.6 9.3 17.6 11.8 18.7 TOGARAM1 "crescerin, Crescerin-1, FAM179B, KIAA0423" ENSG00000198718 "TOG array regulator of axonemal microtubules 1" Q9Y4F4 14 44962190-45074431 "Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.7;Endometrial stromal cells: 28.6;Granulosa cells: 30.1;Respiratory ciliated cells: 38.6;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 4.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050849, HPA053559" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA050849: AB_2681257, HPA053559: AB_2682190" "unprognostic (2.91e-1)" "unprognostic (4.07e-2)" "unprognostic (2.04e-2)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (2.67e-2)" "unprognostic (2.69e-1)" "unprognostic (1.21e-1)" "unprognostic (5.63e-2)" "unprognostic (6.49e-2)" "prognostic favorable (8.38e-4)" "unprognostic (1.62e-1)" "unprognostic (2.15e-1)" "unprognostic (3.02e-2)" "unprognostic (1.60e-1)" 4.5 6.6 9.3 3.0 13.2 3.9 5.2 10.3 13.1 6.8 9.5 4.4 2.8 6.0 5.2 4.6 10.5 4.8 8.4 11.7 8.6 8.0 4.7 4.0 3.9 8.8 9.3 10.3 7.7 6.4 8.5 7.2 5.9 9.7 5.6 3.7 16.9 4.8 6.4 12.5 4.1 3.9 5.5 6.8 4.4 4.3 6.5 8.7 8.5 9.1 12.2 4.0 5.4 4.4 20.0 3.5 5.7 5.3 1.4 12.2 14.2 3.8 4.9 10.4 9.1 10.8 2.3 3.7 3.3 5.6 7.9 4.9 6.4 9.8 3.3 10.0 3.0 3.6 2.7 2.8 2.7 8.6 4.6 2.7 8.3 5.6 5.2 8.8 10.8 7.4 1.8 1.9 3.7 9.2 5.0 5.9 2.5 1.8 5.2 4.3 2.9 12.9 2.2 8.6 12.0 5.5 2.1 5.8 8.4 9.1 5.5 6.2 3.6 5.5 6.1 4.9 7.8 3.7 3.8 3.0 3.7 3.5 0.9 5.2 4.8 0.4 1.0 0.4 0.4 0.5 0.4 0.6 0.4 0.6 0.6 0.5 0.3 0.0 0.8 0.4 0.7 0.6 0.3 9.3 13.2 10.3 13.1 11.7 8.6 8.8 9.3 10.3 9.7 6.8 8.7 20.0 15.8 16.0 14.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 15.2 10.9 0.0 0.0 20.4 16.5 0.0 11.9 13.2 0.0 1.9 10.2 0.0 65.7 28.6 6.6 0.0 0.0 0.0 5.6 8.1 8.8 0.0 16.0 10.1 30.1 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 3.8 0.0 0.0 10.4 38.6 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 9.9 6.3 34.4 0.0 0.0 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.3" "Cell type enhanced" "Detected in many" "Adipocytes: 88.8;Basal keratinocytes: 66.9;Basal squamous epithelial cells: 82.0;Enteroendocrine cells: 51.9;Intestinal goblet cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "NK-cell: 3.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 3.3" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;HBEC3-KT: 4.5;NB-4: 14.2;THP-1: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001255 Approved "Plasma membrane" NA NA 690000 "Plasma membrane" "HPA001255: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 18.3 8.7 2.9 2.2 5.3 0.7 19.3 2.8 3.8 18.2 0.2 11.3 3.9 10.1 0.3 22.0 11.6 0.8 15.3 1.5 4.0 12.5 6.4 13.2 1.9 5.6 4.7 0.7 4.2 17.0 0.3 6.2 1.3 6.0 29.0 0.9 0.4 17.9 1.1 5.4 26.3 19.4 0.8 1.8 54.3 11.0 1.6 3.8 0.2 12.5 0.7 0.4 9.7 23.1 10.7 0.7 0.1 3.3 2.0 0.1 0.1 1.5 0.3 0.2 0.2 0.3 1.0 0.1 0.0 0.3 0.1 0.6 6.8 1.4 4.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.6 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.1 0.8 0.0 14.2 0.2 0.1 0.0 1.1 2.8 0.0 0.0 0.4 1.6 0.2 0.1 0.0 0.0 1.1 0.4 14.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.3 0.4 0.0 0.0 0.1 2.9 5.3 2.8 3.8 1.5 4.0 5.6 4.7 0.7 6.0 1.8 3.8 10.7 88.8 0.0 0.5 26.1 2.7 66.9 14.9 31.2 82.0 1.4 5.4 14.7 11.8 0.0 7.2 1.8 22.9 3.1 3.0 3.0 0.0 0.3 0.4 5.1 10.1 28.5 51.9 0.4 6.9 1.8 5.9 19.2 1.5 5.3 5.7 0.2 21.4 0.2 1.3 0.0 6.4 80.3 16.2 4.8 6.6 1.9 0.3 2.7 7.2 4.7 0.2 1.1 0.0 28.6 26.7 0.7 2.5 1.2 0.3 4.8 2.5 0.1 9.0 0.6 13.1 12.3 8.2 0.5 2.0 8.5 12.8 3.7 4.7 0.1 3.6 1.1 ANKRD13B FLJ25555 ENSG00000198720 "Ankyrin repeat domain 13B" Q86YJ7 17 29589769-29614761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 27.4;Endometrial stromal cells: 24.2;Excitatory neurons: 19.4;Horizontal cells: 16.8;Late spermatids: 44.7;Oligodendrocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 52.0;SH-SY5Y: 57.6;SK-BR-3: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051886, HPA063748" Uncertain Supported Vesicles NA NA Vesicles "HPA051886: AB_2681652, HPA063748: AB_2685112" "unprognostic (1.61e-1)" "unprognostic (2.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (3.10e-4)" "unprognostic (1.84e-1)" "unprognostic (1.84e-1)" "unprognostic (1.03e-2)" "prognostic favorable (7.58e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (9.93e-2)" "unprognostic (1.18e-1)" "unprognostic (3.94e-2)" "unprognostic (5.36e-3)" 9.8 3.7 11.7 1.7 12.6 0.7 7.6 11.5 15.5 16.0 0.5 8.3 0.8 13.7 0.8 6.5 12.1 3.7 9.4 14.1 8.8 2.7 1.2 5.6 1.6 13.3 9.9 14.5 15.3 3.7 1.6 14.7 0.9 12.2 7.7 0.6 2.0 4.4 1.8 9.6 7.1 4.6 2.9 8.3 2.6 4.9 19.1 9.2 0.9 5.9 1.3 0.3 10.1 11.6 23.2 6.6 11.5 13.3 35.4 8.2 8.0 5.1 2.0 1.2 1.4 2.7 6.1 1.4 7.4 6.4 2.8 4.9 24.3 7.2 7.8 0.2 14.8 23.5 2.3 22.3 5.3 3.5 2.4 4.6 7.9 10.2 2.2 5.8 6.4 10.1 12.8 6.0 6.1 1.9 5.9 16.0 7.5 11.4 6.8 9.7 33.4 9.5 23.4 3.0 2.2 52.0 57.6 3.9 48.0 4.3 1.2 7.4 4.4 6.7 7.4 7.2 5.2 7.2 11.4 15.7 9.2 5.2 12.1 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 12.6 11.5 15.5 14.1 8.8 13.3 9.9 14.5 12.2 8.3 9.2 23.2 2.6 0.0 0.0 6.8 0.1 1.7 1.0 0.7 3.4 4.5 1.8 2.7 2.3 0.0 0.4 0.0 2.1 0.1 0.6 0.6 1.9 1.6 27.4 0.9 24.2 2.4 3.0 1.7 19.4 0.6 0.2 5.5 2.6 1.0 0.0 3.8 1.4 0.6 0.1 16.8 14.6 0.8 0.0 0.3 1.6 44.7 14.6 0.3 0.0 0.0 0.0 1.8 0.0 11.1 17.8 0.5 0.0 7.5 0.5 3.2 0.1 0.2 0.0 5.2 0.0 2.4 2.5 6.0 4.7 2.6 1.7 0.1 0.7 1.0 1.1 1.5 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115693-4135597 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 426.2" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria NA NA "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favorable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 54.1 124.6 43.8 21.2 47.0 21.6 65.7 46.8 64.2 60.5 49.6 53.8 64.6 45.3 103.0 26.9 49.6 40.5 135.5 42.4 47.1 238.2 426.2 28.9 20.2 45.1 44.4 41.3 72.1 161.2 53.7 53.0 38.0 44.4 45.6 56.0 32.1 30.2 36.6 200.2 22.7 60.1 35.8 45.7 30.4 104.3 31.2 47.5 33.8 37.3 238.5 22.0 31.8 27.0 45.6 82.8 45.1 72.8 161.0 89.7 131.4 8.8 114.0 116.7 122.1 107.7 34.0 12.4 3.6 139.6 126.0 111.0 41.6 83.6 67.4 179.5 30.4 95.8 44.0 59.7 186.8 51.3 40.4 20.7 90.6 40.6 106.2 58.4 166.0 262.9 136.2 146.2 31.1 118.6 33.4 113.9 100.7 49.5 8.1 158.7 108.8 90.8 1.5 67.2 16.8 1.8 33.7 6.8 48.2 107.6 131.0 109.8 18.9 268.6 92.4 49.8 82.7 69.8 46.8 88.7 8.4 47.9 34.7 73.0 19.2 36.4 17.4 41.5 28.4 57.1 45.8 48.8 58.3 58.9 51.9 59.8 59.2 1.2 66.0 43.3 45.3 57.9 41.1 43.8 47.0 46.8 64.2 42.4 47.1 45.1 44.4 41.3 44.4 45.7 47.5 45.6 61.0 28.9 25.2 17.0 24.4 18.2 48.6 50.3 22.2 14.3 33.3 41.0 165.8 78.6 40.1 36.8 12.5 293.6 29.3 32.0 428.4 53.2 63.1 60.8 43.1 48.0 52.1 77.6 10.7 175.5 29.0 55.2 34.7 57.0 23.4 68.6 53.9 162.2 64.3 18.5 11.9 41.6 20.3 22.0 19.2 50.6 63.3 23.5 35.6 14.0 34.7 77.7 21.6 8.5 18.2 80.4 37.5 50.8 28.3 24.7 120.6 577.0 83.6 46.4 26.3 46.8 33.9 46.5 35.6 24.9 12.8 101.9 41.2 224.0 60.8 22.3 UNC13B "hmunc13, Munc13-2, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Yes No Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: AB_2684742" "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favorable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favorable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favorable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favorable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 12.8 12.9 9.7 5.7 12.3 1.1 10.4 7.1 13.0 12.0 14.7 22.4 11.7 10.1 7.8 17.6 10.5 11.6 12.2 12.0 9.3 22.0 12.9 39.2 1.9 9.2 10.1 10.4 7.4 21.5 15.1 11.6 6.1 9.0 22.8 25.3 41.5 18.0 23.6 24.4 12.3 13.5 12.0 7.5 4.8 18.0 15.8 10.1 3.0 12.3 10.4 5.0 10.3 12.8 10.9 9.8 12.8 13.9 22.6 26.3 14.6 11.8 15.7 7.1 11.4 15.3 10.7 4.5 0.0 7.0 20.6 20.1 4.7 35.4 18.2 14.5 0.0 11.3 5.9 36.6 13.9 12.7 2.2 6.4 11.6 14.0 18.0 18.5 18.2 37.3 15.8 13.5 8.1 13.5 7.5 2.1 0.2 12.6 30.2 13.3 0.1 8.6 3.4 15.5 12.6 14.9 15.7 11.0 6.8 11.4 23.0 11.6 7.5 34.5 7.8 7.2 12.3 12.2 12.7 16.2 0.0 8.5 18.4 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 12.3 7.1 13.0 12.0 9.3 9.2 10.1 10.4 9.0 7.5 10.1 10.9 6.7 57.7 80.7 28.7 0.8 3.1 1.1 2.1 3.4 42.3 7.3 4.4 11.4 18.6 16.7 9.2 95.9 3.7 0.1 24.4 3.9 6.0 6.9 8.2 5.1 8.5 24.6 1.7 60.4 12.2 2.1 4.8 16.3 13.9 2.5 8.7 5.7 12.5 4.9 6.7 17.7 31.9 0.0 2.4 3.0 12.3 2.1 3.7 7.2 73.1 0.1 5.7 0.0 42.3 36.7 7.8 11.9 3.0 4.2 11.7 10.5 7.8 10.0 40.8 6.6 8.4 6.5 8.7 7.5 14.3 7.4 2.9 1.0 5.7 19.5 5.7 TEX45 "C19orf45, FLJ35784" ENSG00000198723 "Testis expressed 45" Q8NA69 19 7492976-7508450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 20.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 1.0;Exocrine glandular cells: 1.1;Glandular and luminal cells: 3.0;Granulosa cells: 1.4;Pancreatic endocrine cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (7.96e-3)" "unprognostic (3.90e-2)" "unprognostic (5.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.44e-2)" "unprognostic (1.50e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (6.42e-2)" "unprognostic (4.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (4.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-3)" 0.1 0.6 0.4 0.2 0.9 1.7 0.1 0.2 0.9 0.0 0.0 0.2 0.2 0.3 0.1 0.2 0.2 0.4 0.0 0.5 0.3 0.0 0.1 0.2 0.2 0.7 0.6 0.5 0.2 0.2 0.1 1.0 0.2 0.9 0.1 0.2 1.4 0.4 0.0 0.2 1.5 0.8 0.1 0.0 0.1 0.2 20.7 0.4 0.0 0.2 0.0 0.1 0.1 0.0 2.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.3 0.5 0.0 0.5 0.4 0.2 0.0 0.5 0.1 0.0 0.0 0.1 0.1 0.3 0.7 0.1 0.2 0.3 0.0 0.1 0.4 0.5 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.9 0.2 0.9 0.5 0.3 0.7 0.6 0.5 0.9 0.0 0.4 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 3.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 92388.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 87067.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 14365.7;HeLa: 18945.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400, HPA074796" Approved Supported Mitochondria NA NA Mitochondria "CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favorable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 16181.5 25280.8 40535.4 2660.4 41053.5 2951.8 15251.1 38162.5 54788.5 6334.8 44666.3 17442.5 9022.5 7179.0 6612.8 10678.4 7563.2 3463.7 92388.4 39753.4 35393.8 59731.8 59615.6 6605.9 2550.2 48667.6 39550.7 33306.2 6119.6 15547.8 9184.6 11641.5 5365.1 47274.9 15271.5 8876.8 8588.1 12305.5 7400.7 53121.2 12444.7 17667.0 5855.4 34314.0 7421.8 25469.8 7429.6 42445.9 1753.2 9838.6 64316.6 3612.1 12952.9 7684.2 40607.6 2322.4 3039.1 3687.6 3950.3 14365.7 2287.8 2963.8 2587.3 1076.5 668.0 1136.3 3013.8 4943.2 5840.7 1240.7 3087.3 794.6 7063.3 556.2 3180.7 1613.0 2880.4 2458.9 3277.0 18945.0 5461.7 2697.8 1862.5 3828.3 4981.3 4631.2 1257.6 2679.7 4457.1 1715.5 2341.4 1709.0 3565.6 3417.2 6354.8 1735.3 3789.4 824.1 2230.7 2036.7 2028.2 1449.8 3681.4 5134.1 5275.9 1308.0 2302.7 1802.1 3352.1 2587.4 5497.2 4911.1 6332.5 5398.3 2302.7 2984.2 4256.3 2037.2 972.6 1390.1 2557.4 1385.7 2822.6 1485.0 8811.6 3750.4 4806.7 1834.1 1738.1 2355.1 2806.2 2123.9 2376.2 1485.5 3034.9 2241.0 2781.9 2755.9 1680.5 1944.8 1468.0 1511.0 1612.6 40535.4 41053.5 38162.5 54788.5 39753.4 35393.8 48667.6 39550.7 33306.2 47274.9 34314.0 42445.9 40607.6 3091.7 1185.9 1390.0 0.0 5710.5 3319.9 7605.2 9945.0 8512.3 0.0 4026.8 5510.1 87067.0 11564.1 5338.9 7470.6 0.0 0.0 3723.1 10971.1 2163.9 2555.0 789.7 9063.7 5550.2 5673.6 2863.2 16130.5 0.0 3523.1 0.0 4692.6 4895.1 15794.2 1889.0 16261.2 9871.2 17132.6 0.0 0.0 0.0 9502.4 5486.9 14290.0 2254.1 3983.1 7943.2 4269.6 2612.9 0.0 4118.1 0.0 2612.8 0.0 0.0 2977.1 8823.6 5402.0 5725.9 4425.8 25108.7 14736.3 4210.2 0.0 5798.2 9579.6 5914.9 4807.6 4136.3 9142.3 3422.9 0.0 5502.2 11093.2 10319.6 9796.7 LDB1 "CLIM2, NLI" ENSG00000198728 "LIM domain binding 1" Q86U70 10 102106489-102120368 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034488 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA034488: AB_10669783" "unprognostic (8.83e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-3)" "unprognostic (4.54e-2)" "unprognostic (1.35e-1)" "unprognostic (5.01e-3)" "unprognostic (1.55e-2)" "unprognostic (1.04e-3)" "unprognostic (2.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-3)" "unprognostic (8.25e-2)" "unprognostic (2.54e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (1.26e-2)" 38.4 38.3 45.7 43.3 48.8 123.5 44.4 42.1 57.9 86.6 50.9 61.6 31.4 82.2 38.4 54.6 69.5 49.6 61.1 48.0 42.5 40.8 20.7 47.0 62.0 43.1 39.9 46.2 118.9 29.6 56.0 52.7 49.5 41.9 58.9 27.8 42.0 66.2 72.2 53.0 151.1 52.1 53.3 36.6 61.3 44.8 30.8 42.2 59.8 49.9 31.8 55.8 66.0 73.0 46.1 42.6 53.5 105.8 128.0 41.3 44.6 52.7 43.8 70.2 48.7 42.3 38.3 36.3 64.8 60.8 56.7 23.0 85.8 48.9 87.3 25.9 55.7 46.9 208.2 62.7 38.6 49.0 56.1 67.8 97.4 70.0 40.2 46.3 177.3 52.0 59.7 128.3 69.1 38.6 41.9 101.1 89.5 52.1 20.4 26.4 112.0 68.4 46.9 46.7 47.3 42.6 103.8 30.9 34.1 51.6 69.0 162.5 36.3 53.8 29.5 60.0 26.8 37.3 58.7 54.4 44.3 49.7 125.7 27.2 2.9 2.0 1.9 2.1 2.9 1.3 2.0 1.5 2.1 1.3 2.4 2.0 1.6 4.8 2.0 4.9 1.4 1.6 1.3 45.7 48.8 42.1 57.9 48.0 42.5 43.1 39.9 46.2 41.9 36.6 42.2 46.1 6.4 32.1 11.0 5.2 8.1 22.8 2.8 4.6 17.6 18.5 8.4 7.9 9.1 2.8 6.9 3.7 4.2 4.8 11.7 3.2 0.0 7.7 2.1 7.7 11.1 6.9 8.3 17.0 9.8 5.6 6.3 7.0 5.6 9.3 9.5 9.5 5.3 2.2 8.9 15.2 10.4 1.4 4.1 5.4 7.5 3.0 6.2 7.3 3.6 12.2 4.0 11.8 6.2 5.5 6.6 7.5 2.0 6.4 7.7 2.7 1.9 1.4 3.5 6.1 0.0 6.9 8.2 7.6 7.3 10.7 21.2 7.8 10.0 10.3 2.6 2.0 PPP1R14C "CPI17-like, KEPI, NY-BR-81" ENSG00000198729 "Protein phosphatase 1 regulatory inhibitor subunit 14C" Q8TAE6 6 150143044-150250392 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 76.2;skeletal muscle: 67.1;skin 1: 92.9;thyroid gland: 59.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 53.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB044667, HPA047907" Approved NA NA "CAB044667: , HPA047907: " "unprognostic (1.81e-3)" "unprognostic (7.65e-2)" "unprognostic (4.25e-3)" "unprognostic (6.92e-2)" "unprognostic (3.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.81e-3)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (5.13e-2)" "unprognostic (4.50e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.98e-1)" "unprognostic (7.49e-3)" "unprognostic (6.77e-2)" 0.3 0.2 5.4 1.4 6.4 0.2 6.1 6.9 8.6 5.1 5.7 12.7 10.5 1.4 0.9 18.5 16.1 0.1 76.2 8.1 4.9 9.6 0.0 12.4 0.3 6.2 5.3 5.9 0.1 0.7 5.1 1.7 3.4 6.4 1.3 8.7 0.6 3.2 0.2 67.1 92.9 2.7 0.9 5.0 0.1 0.8 6.8 5.0 0.5 59.3 8.5 5.9 0.5 22.2 7.8 27.9 0.1 11.7 0.1 0.1 0.6 0.0 3.7 0.0 0.0 0.1 1.3 3.8 0.7 8.0 5.3 1.8 40.7 6.1 86.1 0.0 0.0 36.2 0.3 0.0 0.0 0.0 0.0 1.1 0.0 103.0 0.2 41.1 0.0 0.0 0.5 23.6 0.0 0.0 3.8 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 35.5 1.5 6.2 0.0 0.6 37.7 2.2 0.7 0.2 1.9 0.0 0.1 20.4 32.5 9.5 0.0 0.0 0.0 14.2 16.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.4 6.9 8.6 8.1 4.9 6.2 5.3 5.9 6.4 5.0 5.0 7.8 0.3 19.2 41.1 1.3 0.5 280.2 17.9 19.6 12.0 1.1 6.5 4.3 79.5 0.0 17.1 14.7 0.0 0.1 0.4 24.5 1.9 3.8 0.2 37.9 0.6 3.0 28.2 0.0 28.0 0.2 0.1 6.7 0.0 5.1 1.3 4.1 0.0 0.0 3.0 1.7 13.3 3.1 14.2 0.0 19.7 1.6 0.0 0.6 30.2 2.8 1.1 0.0 0.0 37.2 2.5 12.8 41.5 0.4 0.0 16.6 5.0 38.6 61.5 0.5 0.0 80.9 4.3 0.5 1.8 14.7 336.6 1.9 1.4 0.5 8.7 1.9 CTR9 "KIAA0155, p150TSP, SH2BP1, TSBP" ENSG00000198730 "CTR9 homolog, Paf1/RNA polymerase II complex component" Q6PD62 11 10751246-10801625 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 186.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061027, HPA068122" Supported Enhanced Nucleoplasm No No Nucleoplasm "HPA061027: AB_2684418, HPA068122: AB_2685959" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.89e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.58e-1)" "unprognostic (6.27e-2)" "unprognostic (2.42e-1)" "unprognostic (5.26e-2)" "unprognostic (2.80e-1)" "unprognostic (2.63e-1)" "unprognostic (7.27e-2)" "prognostic favorable (3.65e-6)" "unprognostic (6.88e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" 15.6 20.8 10.3 21.2 10.4 23.9 19.0 10.3 11.4 20.0 13.3 17.1 16.3 22.4 48.4 17.7 17.0 15.5 17.3 10.4 11.4 22.7 25.4 17.3 26.5 10.4 10.3 9.3 22.2 13.4 30.3 12.6 20.4 10.4 17.7 18.2 29.4 18.5 16.2 18.1 19.4 17.0 16.6 10.2 22.7 17.4 27.3 10.8 30.6 23.4 15.3 26.2 22.0 11.9 11.3 40.5 30.9 43.5 41.4 93.1 37.0 21.2 43.9 29.2 34.8 36.5 51.1 83.9 36.7 23.6 36.6 42.3 40.9 54.0 36.2 56.7 56.7 64.6 186.6 31.0 29.2 29.7 74.1 98.8 34.6 28.8 22.5 30.1 32.1 40.6 34.5 77.0 43.2 42.6 18.3 47.5 28.9 36.0 48.7 38.2 43.6 52.9 25.1 29.9 54.8 19.9 47.4 39.6 38.9 31.3 41.5 34.6 32.3 40.2 29.2 30.0 51.7 24.0 23.6 59.8 39.5 31.2 49.5 30.5 54.4 15.4 31.3 20.0 17.7 26.3 16.7 21.4 19.7 18.1 17.0 20.1 19.6 11.3 26.7 18.3 9.0 19.4 15.8 10.3 10.4 10.3 11.4 10.4 11.4 10.4 10.3 9.3 10.4 10.2 10.8 11.3 51.5 57.7 48.8 14.7 49.0 87.2 46.2 29.7 64.3 34.0 30.2 31.6 49.2 31.5 41.7 25.8 56.3 37.9 42.7 30.7 19.6 26.9 28.5 34.0 38.0 37.7 26.9 25.5 16.5 24.5 24.8 36.4 15.8 52.4 85.9 33.2 28.5 38.6 29.1 63.9 21.4 45.1 32.6 32.3 23.6 13.1 33.5 36.1 12.4 15.0 31.8 31.1 29.9 20.6 18.6 26.9 17.5 31.2 37.2 26.1 22.8 18.3 33.7 45.9 26.3 47.8 33.1 100.3 71.3 51.1 81.1 45.7 48.0 56.4 25.3 31.5 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Human disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.2;liver: 68.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 104.4;Oligodendrocyte precursor cells: 372.4;Oligodendrocytes: 81.1;Peritubular cells: 133.2" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 50.3;HeLa: 122.6;HSkMC: 38.3;SiHa: 72.1;SK-BR-3: 30.6;U-266/70: 42.3;U-87 MG: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 140000 "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 9.9 10.4 30.8 0.5 32.1 0.1 6.3 59.2 32.1 8.5 19.7 1.3 1.9 2.2 7.8 0.3 6.7 0.5 4.6 31.1 32.7 2.0 68.4 0.6 0.9 41.8 39.7 25.0 1.4 10.4 0.3 4.4 8.1 40.8 33.7 1.0 2.4 5.9 39.1 12.8 2.3 1.4 1.0 43.4 27.5 3.8 36.0 32.0 0.4 4.3 2.7 0.5 1.3 6.4 56.2 0.0 3.3 50.3 0.0 9.8 6.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 2.9 0.0 0.0 20.4 0.0 122.6 17.4 0.1 0.0 0.0 38.3 11.9 1.4 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.0 0.2 72.1 30.6 0.0 0.3 0.0 0.0 0.4 0.3 2.9 0.0 0.0 42.3 0.0 0.0 51.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 30.8 32.1 59.2 32.1 31.1 32.7 41.8 39.7 25.0 40.8 43.4 32.0 56.2 0.3 0.0 0.0 12.1 2.5 0.3 0.0 0.7 0.0 2.1 1.3 3.8 2.0 7.2 0.1 0.0 16.7 24.2 4.0 0.0 0.0 0.3 4.7 11.9 0.6 2.9 15.6 0.0 1.0 2.3 0.8 6.0 3.6 1.5 0.0 1.4 3.3 104.4 2.8 0.0 13.5 0.1 14.2 2.5 0.4 19.0 7.8 0.3 0.0 1.0 0.1 0.3 0.0 372.4 81.1 3.7 0.1 133.2 12.4 0.0 0.0 0.0 1.1 0.3 0.0 0.7 2.3 2.1 3.9 0.0 0.4 40.2 0.4 0.4 0.0 0.1 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169511951-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "choroid plexus: 116.7;liver: 177.6;placenta: 47.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2" "Group enriched" "Detected in many" 13 "granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2" "Group enriched" "Detected in some" 23 "Hep G2: 32.8;OE19: 125.5" "Group enriched" "Detected in many" 5 "basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4" "Group enriched" "Detected in all" 7 "amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6" HPA002036 Approved "Golgi apparatus" "Secreted to blood" NA NA 7670000000 13000000000 "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.0 0.8 3.2 1.3 3.7 0.6 4.9 2.4 0.1 116.7 0.3 0.9 0.1 0.2 0.2 3.5 17.8 2.4 4.7 5.0 1.5 177.6 0.9 2.2 1.7 2.9 0.1 0.0 0.8 0.0 1.6 47.3 3.2 1.3 0.6 1.0 6.2 0.0 0.2 1.1 0.3 1.1 0.8 1.8 4.9 0.5 1.9 0.5 0.4 0.2 2.4 3.8 0.1 4.3 0.0 0.6 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 32.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 125.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.1 8.1 0.0 0.2 0.0 0.0 1.4 0.2 0.4 0.0 0.3 0.0 7.0 0.0 0.0 0.0 6.2 1.1 0.8 1.3 4.9 2.4 4.7 5.0 1.7 2.9 0.1 3.2 0.8 1.9 4.3 0.0 3.2 0.6 1.6 0.7 0.1 6.1 0.0 0.0 0.3 0.7 0.3 9.4 74.4 1.9 0.0 2.1 82.7 0.1 0.3 0.0 2.4 2.4 0.9 0.0 2.4 25.2 0.0 5.4 0.2 2.3 5.3 4.1 0.2 0.0 2.8 3.6 253.4 5.3 0.0 2.6 0.1 0.0 12.3 0.4 0.3 0.0 7.1 3.6 0.0 18.2 1.0 2.1 0.5 1.0 1.9 0.0 0.0 0.1 1.8 0.0 0.2 3.1 0.1 0.0 2.4 0.2 0.5 0.5 0.0 0.0 59.5 2.5 0.0 0.0 11.8 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938229-1943293 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 236.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1414.9;neutrophil: 3051.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 3051.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 25.7 15.2 23.7 32.0 24.6 97.2 21.5 25.5 28.6 16.4 23.6 33.9 29.7 29.8 11.3 45.7 33.8 23.4 47.8 23.2 24.9 79.1 236.2 30.6 17.9 26.5 25.1 22.0 16.5 150.8 14.9 14.6 13.3 24.8 32.3 17.6 2.7 16.7 29.5 76.6 29.4 27.7 37.1 24.9 67.5 33.6 17.8 25.3 13.9 12.6 94.5 12.3 41.1 20.2 24.8 23.6 59.1 21.3 50.4 39.9 17.0 36.4 27.8 36.0 41.2 35.6 96.2 25.5 22.7 90.6 33.5 36.0 37.9 36.3 25.2 12.8 127.7 41.1 17.5 20.5 154.9 36.1 49.3 40.3 32.0 21.9 29.6 6.0 12.9 41.9 28.8 28.2 12.3 22.3 131.2 28.2 82.7 29.2 42.7 33.5 40.3 29.3 106.0 66.0 37.2 20.5 26.9 32.3 35.6 17.3 13.9 38.7 87.9 24.8 12.3 33.7 24.3 16.7 32.0 53.4 42.4 12.5 47.4 22.0 493.5 412.0 1414.9 31.9 194.8 32.2 28.0 26.5 26.7 171.2 28.3 20.5 22.7 3051.8 42.2 182.9 73.2 45.9 226.7 23.7 24.6 25.5 28.6 23.2 24.9 26.5 25.1 22.0 24.8 24.9 25.3 24.8 24.9 9.6 13.4 3.9 10.0 6.5 9.1 21.5 8.0 6.5 27.9 21.3 36.1 32.9 14.9 33.1 4.2 33.3 12.3 69.1 93.9 65.9 5.9 23.9 13.4 15.4 60.3 21.5 0.8 111.2 121.4 13.7 11.7 17.0 4.5 12.2 20.7 275.6 63.5 8.4 1.2 38.6 34.6 59.2 21.2 13.9 9.3 37.9 16.0 2.8 178.7 22.5 25.7 1.5 2.9 66.0 62.8 23.0 13.0 16.3 97.3 496.8 37.9 4.2 0.0 8.1 22.8 28.9 8.7 11.1 9.5 38.6 10.6 14.8 33.5 21.9 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926036-67101551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;brain: 5.1;ovary: 2.7;pituitary gland: 3.4" "Group enriched" "Detected in some" 22 "Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;HAP1: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.0 2.6 1.6 0.0 3.3 0.0 0.0 0.9 4.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.2 0.0 0.1 0.8 3.0 2.7 1.1 0.0 3.4 0.0 1.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.3 0.9 4.3 3.3 0.9 0.1 0.8 3.0 1.1 0.2 1.1 5.1 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.0 0.0 0.2 0.2 0.0 0.0 485.6 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 577.7 0.0 0.0 0.0 0.0 178.7 8.7 0.1 0.0 8.4 0.0 0.4 0.0 601.7 253.5 0.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.3 2.5 1.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 ZNF652 KIAA0924 ENSG00000198740 "Zinc finger protein 652" Q9Y2D9 17 49289206-49362473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 17.7" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044408 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA044408: AB_2678932" "unprognostic (1.33e-2)" "unprognostic (5.54e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (7.31e-3)" "unprognostic (2.34e-1)" "unprognostic (4.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-1)" "unprognostic (4.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.30e-2)" 2.1 2.3 3.9 2.8 9.9 3.8 9.7 5.7 5.8 3.2 1.0 2.8 2.6 2.1 2.0 2.0 2.1 2.2 1.6 2.9 6.2 2.6 4.1 2.8 3.0 8.9 7.7 1.2 2.8 2.4 3.6 1.0 2.7 10.1 3.3 3.0 4.5 4.4 2.4 10.6 6.7 2.1 2.8 5.4 4.6 3.4 3.7 7.6 3.4 3.6 2.5 3.1 2.1 1.1 17.7 4.3 2.9 3.2 4.1 4.3 2.3 4.3 1.6 2.6 1.8 2.1 6.8 2.7 9.7 5.0 3.3 1.4 3.0 2.9 3.1 2.9 3.3 2.6 3.5 5.0 4.7 1.6 2.9 5.3 3.2 2.8 1.6 2.9 1.8 2.2 4.8 2.7 8.1 1.8 6.0 4.3 1.6 3.2 2.5 2.1 3.4 6.6 4.6 2.4 5.7 5.9 4.0 2.8 3.9 4.2 4.8 7.1 4.1 3.6 5.9 4.4 2.6 2.6 10.3 7.6 6.3 3.2 2.6 2.2 7.7 3.0 3.2 2.6 2.6 3.5 1.9 1.9 2.0 2.1 2.6 1.8 1.9 5.9 2.1 3.4 1.9 0.9 2.5 3.9 9.9 5.7 5.8 2.9 6.2 8.9 7.7 1.2 10.1 5.4 7.6 17.7 28.8 19.2 19.8 37.5 38.6 16.4 14.2 7.8 18.8 56.5 63.7 50.2 16.6 21.5 15.2 29.5 64.6 24.0 60.6 22.7 13.7 18.6 19.2 56.6 45.1 24.3 12.1 22.3 49.2 19.6 18.2 24.4 16.8 59.1 5.1 24.0 29.6 41.6 12.8 43.7 70.9 20.4 14.2 41.6 32.4 17.3 48.4 25.1 26.6 65.6 37.0 30.1 45.3 76.9 152.6 18.4 18.5 44.4 21.9 24.6 17.9 12.4 21.3 47.1 0.0 30.0 22.8 60.4 29.9 15.6 24.3 13.4 33.7 27.7 24.0 12.6 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027440-99144108 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 100.2;Microglial cells: 89.9;Oligodendrocytes: 211.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 9.2;BJ: 15.2;EFO-21: 12.8;HDLM-2: 8.1;PC-3: 18.2;U-2 OS: 8.3;U-251 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019671: , HPA055245: AB_2682757" "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 16.0 14.0 0.5 0.3 0.8 1.1 14.4 0.5 1.3 13.1 0.9 12.3 0.0 12.4 0.0 22.2 12.3 0.0 8.9 0.9 0.7 11.6 11.7 18.7 0.0 1.2 1.5 0.7 20.8 15.7 0.0 11.3 0.0 1.6 13.4 0.0 0.7 15.2 0.0 12.8 20.3 11.8 0.0 0.2 10.0 16.2 21.1 0.7 0.0 8.5 0.0 0.0 12.5 15.7 1.8 9.2 0.0 0.1 0.2 0.0 0.0 1.3 15.2 0.1 0.4 0.0 0.0 0.4 1.6 12.8 0.0 0.3 4.5 0.0 0.1 0.0 8.1 2.3 0.0 0.7 0.7 0.1 0.1 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.9 0.1 0.8 0.1 1.3 1.9 2.8 0.0 18.2 2.5 1.2 0.0 0.0 0.4 0.3 1.5 0.7 0.5 0.9 0.3 0.3 0.0 1.4 0.0 8.3 1.3 9.4 2.0 4.9 1.3 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.5 1.3 0.9 0.7 1.2 1.5 0.7 1.6 0.2 0.7 1.8 9.7 19.2 27.5 59.4 8.9 25.9 25.5 10.0 25.0 28.2 10.3 7.2 4.4 20.0 18.5 12.9 8.4 7.7 4.6 17.1 1.9 14.7 6.2 13.3 8.8 12.8 11.4 0.4 100.2 16.0 10.3 10.8 46.9 23.3 2.5 6.8 9.7 9.3 6.6 26.9 77.0 11.0 4.1 4.1 10.9 8.5 6.2 8.8 8.8 89.9 5.5 3.3 5.2 70.4 211.9 34.8 14.9 13.9 5.4 37.9 7.1 5.5 22.1 7.6 6.6 10.4 15.1 32.8 2.4 19.3 22.0 21.1 8.8 6.5 8.1 77.5 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073578-34106260 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0;choroid plexus: 76.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 129.1;Collecting duct cells: 138.0;Granulosa cells: 148.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 22.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 5.5 5.9 10.5 4.5 9.5 1.9 6.6 5.8 28.8 3.5 76.5 4.5 2.7 6.9 5.3 3.1 4.8 2.6 2.0 15.5 34.0 29.2 6.0 4.0 4.9 9.4 9.5 5.6 3.9 1.9 3.2 4.2 10.7 9.5 2.9 5.3 5.7 2.9 3.6 2.5 5.8 3.8 2.9 10.2 2.4 3.9 6.3 15.4 4.0 25.4 2.6 4.9 3.8 3.5 17.0 10.5 9.3 19.0 13.4 15.5 12.7 9.1 11.8 35.7 7.2 10.9 15.5 22.5 16.9 9.3 24.0 13.5 5.3 23.3 6.7 12.2 17.7 6.0 17.5 9.0 5.2 4.1 7.6 7.1 6.1 17.0 19.7 7.8 22.0 4.4 13.7 17.6 3.9 18.7 7.1 8.1 6.1 9.6 4.0 9.0 8.1 3.4 7.7 28.1 14.5 9.9 4.6 24.5 6.4 5.6 11.3 3.9 8.0 4.2 14.0 10.7 27.1 4.8 20.1 18.5 12.4 28.2 10.9 9.6 0.0 0.2 0.0 0.6 0.2 0.5 0.1 0.3 0.4 0.2 0.1 0.4 0.6 0.1 0.2 0.1 0.5 0.1 0.1 10.5 9.5 5.8 28.8 15.5 34.0 9.4 9.5 5.6 9.5 10.2 15.4 17.0 18.8 16.0 10.2 0.0 33.3 0.0 46.5 0.0 129.1 33.8 37.4 34.9 11.4 10.0 13.0 138.0 20.9 27.4 43.0 39.1 21.5 4.0 9.0 38.7 59.9 16.4 49.3 17.0 0.0 5.5 19.7 42.3 18.3 42.5 41.3 148.6 5.0 20.7 15.2 37.0 0.0 69.3 0.0 14.4 0.0 7.2 6.5 41.0 0.0 0.0 23.3 6.7 16.5 0.0 0.0 7.6 49.7 20.7 54.1 88.4 16.3 9.4 8.7 20.9 13.1 15.4 33.7 14.8 18.5 39.7 0.0 28.2 48.3 14.0 36.3 69.5 GPATCH3 "FLJ12455, GPATC3" ENSG00000198746 "G-patch domain containing 3" Q96I76 1 26890488-26900467 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032078, HPA054973" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA032078: AB_10603671, HPA054973: AB_2682656" "unprognostic (2.93e-2)" "unprognostic (1.33e-2)" "unprognostic (7.34e-2)" "unprognostic (9.63e-2)" "unprognostic (1.42e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (4.37e-2)" "unprognostic (7.75e-2)" "unprognostic (6.46e-2)" "prognostic favorable (6.42e-4)" "unprognostic (3.77e-1)" "unprognostic (3.22e-3)" "unprognostic (2.31e-2)" "unprognostic (3.81e-2)" "unprognostic (2.59e-1)" "unprognostic (6.82e-2)" 7.9 11.6 11.7 6.3 13.2 23.4 8.2 12.5 13.1 7.9 10.7 8.5 8.5 8.7 9.0 9.5 6.9 5.7 8.2 11.5 11.9 9.2 12.6 6.8 9.1 12.0 12.3 11.2 7.1 9.0 8.0 7.7 8.1 13.6 8.3 6.3 5.4 8.0 6.1 18.2 12.8 9.3 6.4 12.1 11.9 10.0 10.9 12.2 9.4 7.6 12.5 7.5 8.6 7.7 14.2 12.5 9.9 9.4 14.5 8.9 8.5 12.7 9.4 10.9 18.6 16.2 12.1 14.6 11.4 10.3 9.6 9.7 12.6 15.8 17.8 9.9 13.0 18.1 22.5 22.3 25.2 11.9 15.2 14.6 12.5 15.7 18.3 10.1 8.2 12.1 14.9 26.7 15.0 7.8 9.2 13.5 28.2 21.5 14.4 12.2 16.6 13.5 18.0 9.2 6.5 12.2 14.6 18.8 16.0 27.9 10.1 14.3 14.5 12.9 11.8 13.9 16.2 10.7 19.0 27.4 15.2 10.6 21.6 10.6 30.3 17.9 22.3 16.2 14.6 13.1 12.5 13.3 14.2 18.7 11.9 13.6 13.0 7.8 9.8 19.0 14.2 12.6 14.4 11.7 13.2 12.5 13.1 11.5 11.9 12.0 12.3 11.2 13.6 12.1 12.2 14.2 5.4 3.2 3.9 1.6 11.7 9.7 4.8 5.6 8.0 6.4 7.0 4.7 4.0 1.5 3.7 0.0 12.5 15.5 10.3 11.6 5.9 10.9 2.2 4.5 4.1 8.1 11.3 6.9 3.5 12.5 10.0 5.3 11.2 6.1 5.7 7.8 8.2 6.2 11.2 5.0 3.0 4.7 6.1 9.4 7.5 1.4 5.3 10.0 8.8 1.9 15.3 6.6 12.3 3.5 3.5 10.6 7.5 7.2 8.3 4.3 10.4 7.4 3.1 5.5 6.6 6.6 5.9 12.5 25.3 8.3 9.8 30.1 11.2 6.6 6.2 4.9 CDC42BPB "KIAA1124, MRCKB" ENSG00000198752 "CDC42 binding protein kinase beta" Q9Y5S2 14 102932380-103057549 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022821 Approved NA NA 12000 "HPA022821: AB_1846376" "unprognostic (6.73e-2)" "unprognostic (2.19e-2)" "unprognostic (6.99e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (3.46e-2)" "unprognostic (2.28e-1)" "prognostic favorable (8.67e-10)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (7.56e-2)" 39.1 31.6 40.8 18.0 39.6 3.7 31.5 30.3 38.7 32.8 20.9 34.2 30.4 38.3 18.0 38.1 31.6 29.7 36.5 42.9 35.6 32.5 29.1 33.2 9.9 39.7 39.2 38.3 33.7 33.4 34.5 32.7 29.7 38.7 28.9 20.4 24.3 28.2 30.7 27.4 32.7 35.2 32.6 37.1 22.4 32.3 25.5 37.8 8.7 29.8 24.4 12.7 35.3 33.5 45.3 42.8 83.8 52.7 38.7 57.3 65.1 53.0 47.9 50.3 49.7 45.4 28.8 49.0 0.0 51.1 93.7 37.7 53.0 54.9 57.2 52.3 52.2 24.8 23.4 68.0 29.0 62.2 0.2 24.1 56.7 57.6 51.0 48.5 52.2 97.7 9.8 19.3 11.7 48.3 89.2 0.4 5.4 25.3 66.5 68.4 0.2 44.3 1.2 63.1 82.6 38.2 41.6 85.1 31.6 35.8 55.7 48.7 14.9 125.3 47.3 31.6 105.8 45.3 15.1 17.4 12.4 53.2 5.2 46.9 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 39.6 30.3 38.7 42.9 35.6 39.7 39.2 38.3 38.7 37.1 37.8 45.3 57.1 57.7 35.8 37.5 7.8 14.5 16.5 14.5 17.6 45.8 19.1 15.4 28.8 28.6 27.4 55.2 33.3 12.6 0.5 35.4 3.9 29.8 14.2 35.8 55.0 46.3 25.2 11.0 40.3 21.8 11.1 25.7 32.1 59.4 13.3 37.8 36.0 20.5 12.8 57.2 33.1 16.1 30.5 13.5 14.7 7.9 32.3 21.7 12.4 31.9 11.1 29.3 0.0 31.7 74.6 44.2 15.4 55.3 3.5 26.1 28.2 15.4 28.1 42.3 6.6 38.6 29.3 15.5 17.0 27.2 18.3 16.8 3.2 37.3 27.5 32.4 PLXNB3 "PLEXB3, PLEXR, PLXN6" ENSG00000198753 "Plexin B3" Q9ULL4 X 153764196-153779346 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 209.0" "Group enriched" "Detected in some" 8 "Astrocytes: 43.8;Oligodendrocytes: 72.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "WM-115: 70.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048046 Enhanced NA NA 390000 "HPA048046: AB_2680239" "prognostic unfavorable (6.13e-4)" "unprognostic (2.60e-1)" "unprognostic (9.10e-4)" "unprognostic (2.30e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-3)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-1)" "unprognostic (2.66e-1)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (9.73e-3)" "unprognostic (1.98e-2)" 10.8 29.0 65.3 2.1 110.9 0.7 16.2 81.0 92.2 10.1 25.9 40.2 2.3 23.8 3.9 7.1 12.0 4.9 6.3 68.2 75.4 1.8 1.1 2.8 0.5 111.6 98.5 52.1 1.8 6.6 0.2 3.2 0.5 157.0 16.8 2.1 2.4 26.5 8.6 0.8 10.1 9.4 6.6 75.2 0.7 13.7 11.6 98.7 0.1 1.7 0.4 0.3 21.0 13.1 209.0 9.3 1.1 1.1 0.7 1.2 0.7 0.7 8.5 1.7 1.1 3.0 0.0 0.1 0.0 5.4 2.4 1.6 1.0 0.0 7.2 0.9 0.1 0.0 5.8 12.0 6.6 2.3 0.0 0.6 1.8 5.2 5.2 3.2 19.8 3.4 0.2 0.5 3.1 2.3 7.6 0.1 1.4 0.2 6.3 14.0 2.8 0.9 0.1 1.4 4.2 2.4 7.5 0.4 7.8 20.2 0.2 10.4 0.0 15.0 8.6 4.4 6.8 10.9 3.0 0.8 0.2 18.6 0.5 70.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 65.3 110.9 81.0 92.2 68.2 75.4 111.6 98.5 52.1 157.0 75.2 98.7 209.0 0.0 0.0 0.0 43.8 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 6.6 72.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 OXCT2 "FKSG25, FLJ00030, SCOT-T" ENSG00000198754 "3-oxoacid CoA-transferase 2" Q9BYC2 1 39769523-39771348 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "testis: 73.6" "Group enriched" "Detected in some" 80 "Early spermatids: 420.5;Late spermatids: 1019.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 7.6;THP-1: 8.4;U-266/70: 6.2" "Not detected" "Not detected" HPA075423 Enhanced NA NA "HPA075423: AB_2732292" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (6.50e-2)" "unprognostic (7.16e-2)" "unprognostic (9.68e-2)" "unprognostic (1.13e-1)" "unprognostic (1.32e-1)" "unprognostic (1.93e-3)" "unprognostic (2.74e-1)" "unprognostic (3.16e-1)" "unprognostic (2.57e-3)" "unprognostic (4.18e-2)" "unprognostic (5.39e-5)" "unprognostic (3.24e-1)" "unprognostic (4.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.85e-1)" 0.3 0.8 0.8 0.4 1.0 0.5 0.3 1.6 1.6 0.5 0.0 0.8 0.7 1.2 0.9 0.7 0.8 0.7 4.6 0.9 0.8 0.4 0.6 0.5 0.6 1.6 1.3 0.6 2.3 1.3 0.2 1.1 0.2 1.8 1.3 0.4 0.0 0.3 1.3 0.4 2.3 1.1 0.6 1.3 1.1 0.7 73.6 0.7 3.9 1.8 0.0 0.2 0.4 0.5 3.9 0.4 0.2 0.0 0.9 0.3 1.1 0.0 1.1 0.0 1.0 0.5 3.9 0.4 0.0 0.7 1.6 0.1 0.4 1.2 0.1 0.5 0.0 2.5 0.7 3.0 0.2 1.8 0.0 0.4 0.5 0.3 0.1 0.1 0.0 0.8 0.3 0.2 7.6 0.1 1.1 0.0 1.2 0.1 0.0 1.0 1.1 1.2 1.2 0.3 0.8 1.3 0.6 3.3 0.2 1.1 0.0 0.4 8.4 0.9 0.0 0.2 3.7 0.0 6.2 3.6 0.4 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 1.0 1.6 1.6 0.9 0.8 1.6 1.3 0.6 1.8 1.3 0.7 3.9 0.3 0.0 0.6 0.0 2.3 0.3 0.3 0.1 0.0 0.2 0.3 0.5 3.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.7 420.5 0.2 2.1 0.8 0.0 0.0 0.0 0.7 0.1 1.5 0.0 0.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.3 8.3 1019.0 4.1 3.0 1.8 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.1 6.4 8.9 0.5 0.6 0.0 0.1 0.1 0.0 1.1 2.7 3.4 2.7 0.1 0.4 0.0 0.8 0.6 0.5 0.2 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468401-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 740000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: AB_2682268" "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 1290.8 947.6 615.4 832.4 613.6 2068.7 2112.8 592.3 770.5 1800.5 628.5 1338.0 783.5 1361.3 1266.9 1595.8 1927.8 727.0 817.7 595.3 640.2 963.4 847.8 842.5 1638.8 621.6 614.8 580.9 3209.0 1910.2 688.1 736.8 753.9 623.0 1333.6 1189.5 257.4 1282.7 1016.7 1423.1 2064.0 1084.0 1123.8 658.7 1072.5 1198.7 232.3 643.3 1599.6 1093.8 1018.4 1747.3 1446.1 1518.9 634.4 1205.5 1211.3 1349.6 1275.9 1967.9 3560.6 1522.8 1213.7 2475.5 1671.2 1320.9 1765.5 1126.2 3571.4 1089.8 1650.2 819.4 1036.0 1832.7 2764.1 1374.0 1249.1 1618.0 1375.9 1007.0 2501.0 2909.6 2031.3 1096.1 4179.2 3172.8 1225.0 4066.4 2689.3 2481.9 1760.1 1652.9 1712.2 1920.0 2112.5 2158.4 2452.2 1421.3 1879.5 1057.5 1681.9 1298.7 2801.6 2124.0 1949.5 945.6 1384.7 747.8 1688.0 3632.5 1076.1 1831.0 3628.9 1450.9 541.4 975.4 729.4 1559.5 1073.4 1889.4 2381.8 681.1 2322.7 992.7 215.5 1232.7 120.6 1478.3 1210.1 2629.7 3176.9 2436.2 1905.6 1990.0 2806.5 3252.5 2601.9 113.1 2069.4 1077.8 1875.3 2059.9 5496.8 615.4 613.6 592.3 770.5 595.3 640.2 621.6 614.8 580.9 623.0 658.7 643.3 634.4 973.2 535.2 1036.5 19.2 3101.2 5399.7 5910.9 3550.3 2636.7 221.4 4627.1 4144.2 270.8 1742.9 1828.0 597.7 73.0 4048.8 1980.0 867.3 2983.7 1701.7 243.5 992.0 2446.8 1604.3 1512.3 1533.0 23.1 3272.4 5396.6 1667.3 884.8 1150.5 917.2 2228.2 1601.0 1519.3 2201.2 109.4 23.8 2834.0 1084.4 1989.9 3307.5 430.7 2517.0 1457.1 2406.5 17.8 2486.8 530.4 1845.5 31.7 32.4 2092.1 2269.8 1479.8 1382.6 4479.8 1447.6 2791.4 790.8 252.3 769.2 3139.6 1955.7 236.4 357.1 3510.2 6623.0 4105.6 2341.0 2848.1 3482.8 5438.5 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 50.0" "Cell type enhanced" "Detected in many" "Astrocytes: 53.5;Excitatory neurons: 79.9;Inhibitory neurons: 71.5;Late spermatids: 76.2;Oligodendrocyte precursor cells: 115.1;Oligodendrocytes: 359.3" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 30 "basophil: 11.1" "Lineage enriched" "Detected in single" 30 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "Hep G2: 17.1;OE19: 13.8;SK-MEL-30: 18.6;U-251 MG: 18.0;WM-115: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 1.1 6.4 16.8 0.8 25.4 1.1 1.5 21.0 22.5 1.0 0.1 2.8 0.5 1.8 3.1 0.7 2.9 2.3 8.7 15.1 20.3 0.8 0.2 3.8 0.3 23.9 26.1 11.3 1.4 2.3 0.5 2.2 0.1 26.7 5.3 0.9 3.5 2.9 2.2 8.9 0.3 1.0 1.8 23.8 0.5 1.9 3.5 23.0 0.3 3.3 6.4 0.5 1.8 1.5 50.0 0.1 0.0 5.7 0.4 3.0 4.4 0.1 1.8 0.7 0.8 1.0 2.8 0.2 0.0 0.5 4.4 1.1 0.0 5.6 0.0 1.4 6.6 3.3 0.4 0.0 17.1 0.1 6.0 0.1 2.6 0.0 0.8 0.1 8.4 0.0 0.2 5.7 7.2 6.1 0.2 0.3 0.3 3.9 13.8 0.0 0.5 0.0 0.0 0.0 1.2 2.2 3.5 0.3 0.0 18.6 3.7 0.0 0.3 0.1 0.7 0.7 0.1 18.0 10.8 0.1 0.1 0.5 2.8 22.5 11.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 16.8 25.4 21.0 22.5 15.1 20.3 23.9 26.1 11.3 26.7 23.8 23.0 50.0 0.1 0.0 0.0 53.5 0.0 0.4 0.5 0.0 0.0 4.4 0.3 0.3 3.5 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.6 40.3 0.2 0.5 0.9 0.0 1.3 79.9 0.0 0.0 9.9 1.5 0.5 0.0 0.2 0.0 0.1 0.3 0.0 71.5 0.1 0.0 0.3 9.5 76.2 2.1 0.9 1.8 4.7 0.0 5.7 8.2 115.1 359.3 1.2 0.0 4.1 1.9 0.2 0.0 0.3 0.0 0.4 13.1 2.3 3.1 0.3 1.3 0.0 0.4 0.0 4.5 0.4 0.0 0.4 EPS8L3 "FLJ21522, MGC16817" ENSG00000198758 "EPS8 like 3" Q8TE67 1 109750080-109764027 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "gallbladder: 36.0;intestine: 143.3;stomach 1: 51.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 254.4;Gastric mucus-secreting cells: 80.5;Intestinal goblet cells: 103.4;Late spermatids: 144.6;Paneth cells: 257.8;Proximal enterocytes: 285.3;Undifferentiated cells: 112.6" "Group enriched" "Detected in many" 6 "colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 15.6;CAPAN-2: 14.4;Hep G2: 36.2;OE19: 67.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030998 Approved Approved Vesicles NA NA Vesicles "HPA030998: AB_2673691" "unprognostic (1.73e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.13e-5)" "unprognostic (5.55e-3)" "unprognostic (3.71e-2)" "unprognostic (2.09e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (5.87e-3)" "unprognostic (3.89e-1)" "prognostic favorable (1.82e-4)" 0.0 0.0 0.1 10.9 0.0 0.0 0.2 0.0 0.0 1.3 0.0 73.2 143.1 0.2 0.9 0.1 0.1 36.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 77.9 0.0 0.0 0.2 0.0 0.0 143.3 2.9 0.0 0.0 51.2 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.6 14.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 67.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 14.3 0.3 0.0 0.0 0.0 0.0 254.4 0.0 11.6 28.0 0.7 0.1 0.3 51.4 0.0 0.0 23.9 0.0 0.0 80.5 1.0 4.5 0.0 0.0 0.2 0.0 0.0 0.0 103.4 0.0 0.0 0.0 144.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 257.8 0.4 0.3 0.0 285.3 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.4 0.6 112.6 1.8 EGFL6 MAEG ENSG00000198759 "EGF like domain multiple 6" Q8IUX8 X 13569601-13633575 "Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 650.6" "Cell type enriched" "Detected in many" 8 "Fibroblasts: 214.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 4.3;NTERA-2: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001838 Enhanced "Secreted to extracellular matrix" NA NA "HPA001838: AB_2666457" "unprognostic (1.66e-1)" "unprognostic (1.32e-2)" "unprognostic (9.15e-3)" "unprognostic (3.76e-3)" "unprognostic (1.77e-2)" "prognostic favorable (9.73e-4)" "unprognostic (4.13e-3)" "unprognostic (1.37e-1)" "unprognostic (5.19e-3)" "prognostic favorable (4.95e-4)" "unprognostic (2.39e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-9)" "unprognostic (7.10e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.82e-3)" 13.6 0.0 0.4 0.6 0.5 0.0 3.3 0.1 0.2 0.8 0.1 0.2 0.5 1.8 0.0 4.4 2.3 1.1 0.3 0.2 1.0 0.7 0.0 25.8 0.3 0.7 1.0 0.2 0.3 1.2 0.6 2.6 650.6 0.3 1.1 0.3 2.3 0.4 0.1 0.0 0.5 0.4 0.5 1.1 0.3 1.3 0.3 0.6 0.2 0.3 1.7 1.6 10.8 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.2 0.2 1.0 0.7 1.0 0.2 0.3 1.1 0.6 0.4 1.3 0.0 2.0 0.0 0.0 1.0 1.2 22.0 1.2 6.3 0.1 0.5 0.4 0.0 11.9 0.0 0.0 12.4 0.0 0.5 0.0 0.0 0.3 4.2 5.6 6.0 0.0 0.0 0.3 0.0 9.8 214.7 0.0 3.7 0.0 0.0 0.0 0.0 17.3 0.0 2.0 0.1 4.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.4 1.0 0.0 0.0 23.9 0.1 1.1 14.9 0.4 26.4 0.9 4.9 0.1 3.7 MT-ND2 "MTND2, NAD2, ND2" ENSG00000198763 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2" P03891 MT 4470-5511 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102366.7;heart muscle: 96918.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 77734.8;Proximal enterocytes: 33797.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "basophil: 16754.8" "Lineage enriched" "Detected in all" 10 "granulocytes: 16754.8" "Cell line enhanced" "Detected in all" "HeLa: 23544.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.53e-2)" "unprognostic (1.36e-1)" "unprognostic (4.77e-1)" "unprognostic (4.79e-2)" "unprognostic (9.56e-3)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (3.38e-3)" "unprognostic (4.55e-3)" "unprognostic (3.79e-2)" "unprognostic (4.35e-2)" "unprognostic (3.94e-2)" "unprognostic (2.11e-1)" "unprognostic (5.92e-2)" "unprognostic (4.35e-2)" 23219.5 33461.5 71816.8 2752.8 74086.4 2896.5 21914.7 66484.2 102366.7 7436.3 67600.5 21646.7 7406.1 7359.6 8164.1 11180.5 9350.4 2888.8 96918.5 66218.0 64715.3 56339.8 54405.9 9543.3 2489.6 89788.0 69495.0 60215.1 7865.6 20815.6 9935.7 12484.6 5492.5 83260.5 17312.3 8219.5 5484.0 13579.4 5495.5 46282.1 14676.1 20503.3 3585.8 63049.2 9024.9 31438.0 11541.1 75510.3 2068.1 10792.8 50846.9 2855.1 14251.7 8499.3 75754.5 2964.9 3166.9 2774.5 4699.2 9795.6 1730.7 2618.5 2678.9 669.9 703.1 875.8 4014.2 3860.6 4185.9 2486.9 1936.7 1150.4 5147.5 444.4 3349.6 1504.2 3675.8 2270.9 4845.1 23544.1 6585.1 1999.7 4760.9 5392.4 2886.1 5969.8 1726.7 1692.0 2488.5 1049.4 2269.3 3606.2 3978.3 1701.5 3480.4 2711.2 7603.4 1396.2 3068.2 2045.4 2352.3 1554.8 3525.9 5071.4 4465.8 1728.4 2059.3 1159.0 3501.0 4372.7 4402.7 5412.1 5417.8 3333.0 2606.6 3230.5 3719.5 3483.2 2577.9 2356.8 3637.4 1695.0 4006.5 1196.1 16754.8 1658.1 2709.0 872.0 1066.1 1373.3 1568.7 1012.2 1099.7 632.5 1625.8 1212.2 1558.3 2355.9 1158.8 1341.7 1171.9 716.1 804.2 71816.8 74086.4 66484.2 102366.7 66218.0 64715.3 89788.0 69495.0 60215.1 83260.5 63049.2 75510.3 75754.5 1855.6 919.9 759.8 0.0 3886.7 2666.7 7962.2 3116.2 2155.8 0.0 2560.5 3948.5 77734.8 10211.5 2425.9 6232.9 0.0 0.0 2313.0 13115.0 1807.8 1793.7 1314.5 4100.0 2322.6 4025.7 3175.3 10585.1 0.0 3677.8 0.0 2629.4 2366.5 5225.2 1865.9 7033.2 9394.0 19067.5 0.0 0.0 0.0 10974.6 1947.0 14566.9 1814.8 6327.6 9064.4 3148.2 1657.8 0.0 4768.9 0.0 3602.5 0.0 0.0 2565.3 9271.1 4538.8 1959.6 4228.6 33797.5 12714.8 3449.0 0.0 7283.9 6341.5 3547.2 5465.6 4872.6 1826.5 2455.7 0.0 3694.7 2538.3 10272.4 7385.5 SYCP1 "CT8, HOM-TES-14, SCP1" ENSG00000198765 "Synaptonemal complex protein 1" Q15431 1 114854863-114995370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 40.5" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 1162.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 98 "THP-1: 17.2" "Region enriched" "Detected in single" 51 "cerebellum: 14.7" "Not detected" "Not detected" HPA021083 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA021083: AB_1857685" "unprognostic (2.91e-1)" "unprognostic (6.89e-3)" "unprognostic (4.87e-1)" "unprognostic (8.74e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.5 0.3 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 56.7 5.3 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1162.6 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515399 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 19.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.1;Breast myoepithelial cells: 7.7;Fibroblasts: 3.6;Oligodendrocyte precursor cells: 6.0;Skeletal myocytes: 8.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 94.5;hTEC/SVTERT24-B: 32.7;HUVEC TERT2: 33.6;TIME: 56.1;U-87 MG: 36.5" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria No No Mitochondria "HPA067015: AB_2685764" "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.4 0.5 0.2 0.2 0.0 0.0 4.9 0.4 0.1 1.1 0.0 0.7 0.1 1.8 0.0 0.5 0.0 0.7 1.4 0.1 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.2 0.5 0.6 0.0 19.4 1.3 0.6 0.8 0.4 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 16.8 0.1 1.9 1.4 0.0 5.6 0.0 0.0 94.5 0.5 1.1 0.0 3.3 3.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.6 0.0 32.7 0.5 6.8 33.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 56.1 12.6 0.9 0.0 16.5 0.0 0.0 0.0 36.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.1 0.0 0.3 0.4 0.0 0.0 9.1 7.7 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.7 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 6.0 0.5 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 8.4 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 RCSD1 "CapZIP, MGC21854, MK2S4" ENSG00000198771 "RCSD domain containing 1" Q6JBY9 1 167630093-167708696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 116.5;skeletal muscle: 149.3" "Cell type enhanced" "Detected in many" "B-cells: 258.0;Kupffer cells: 137.5;Macrophages: 80.7;Microglial cells: 78.7;monocytes: 121.6;NK-cells: 142.2;Sertoli cells: 78.9;T-cells: 97.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 195.2;HDLM-2: 91.0;REH: 224.0;RPMI-8226: 139.7;THP-1: 103.4;U-266/70: 132.0;U-698: 132.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016597, HPA073490" Enhanced Approved "Plasma membrane" NA NA 200000 "Plasma membrane" "HPA016597: AB_2669397, HPA073490: " "unprognostic (2.13e-2)" "unprognostic (7.38e-3)" "unprognostic (6.50e-3)" "unprognostic (1.37e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.97e-4)" "unprognostic (5.51e-2)" "unprognostic (8.90e-3)" "unprognostic (3.65e-1)" "unprognostic (8.48e-2)" "unprognostic (1.01e-1)" "unprognostic (6.33e-2)" "unprognostic (2.53e-3)" "unprognostic (3.19e-1)" "unprognostic (3.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.97e-2)" 14.3 5.9 5.5 43.3 6.4 56.2 11.7 5.9 6.4 5.7 7.1 12.1 8.9 4.7 2.5 8.7 4.1 11.8 25.9 5.0 7.5 5.3 8.0 16.9 89.5 9.8 5.5 3.4 2.8 1.5 2.4 2.1 17.6 8.5 3.7 12.0 0.6 4.8 3.9 149.3 2.5 29.5 8.7 7.0 52.8 12.5 3.7 8.1 116.5 6.2 51.1 74.3 14.2 3.5 9.5 0.3 0.0 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 195.2 0.6 0.2 0.0 0.2 0.0 0.0 0.0 91.0 0.3 1.6 0.1 0.1 0.2 34.4 3.7 0.5 0.3 0.4 0.0 0.0 0.0 76.0 67.8 56.7 25.4 0.0 69.3 49.8 1.7 0.0 0.0 224.0 0.8 139.7 0.0 0.1 0.1 0.1 0.2 0.6 0.1 2.7 0.1 103.4 0.5 0.2 0.6 0.2 0.4 132.0 42.5 132.0 0.1 64.6 0.0 249.3 170.3 271.3 63.5 119.8 76.9 216.4 81.7 80.0 103.4 201.7 68.1 64.7 165.7 130.0 122.7 54.3 129.4 148.9 5.5 6.4 5.9 6.4 5.0 7.5 9.8 5.5 3.4 8.5 7.0 8.1 9.5 18.7 3.2 6.7 0.3 258.0 1.1 1.2 0.0 3.4 0.7 6.2 10.7 46.8 0.0 3.1 1.8 0.0 0.5 73.9 0.1 0.0 0.2 0.8 0.4 2.1 18.8 0.0 30.1 4.2 0.0 0.5 12.4 4.1 0.3 13.9 0.2 19.2 1.5 44.2 0.0 0.7 0.0 0.0 137.5 26.9 1.7 0.9 80.7 5.4 78.7 121.6 0.2 142.2 2.0 0.6 0.1 0.0 0.4 55.1 0.8 0.0 0.5 0.0 0.8 78.9 5.8 39.7 0.0 0.3 1.0 1.7 1.2 97.2 0.6 0.1 0.3 RASSF9 "P-CIP1, PAMCI" ENSG00000198774 "Ras association domain family member 9" O75901 12 85800703-85836409 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 22.8;Club cells: 47.8;Endothelial cells: 27.5;Hepatic stellate cells: 32.9;Respiratory ciliated cells: 27.2;Squamous epithelial cells: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 4.1;hTERT-RPE1: 12.7;RPTEC TERT1: 3.8;U-138 MG: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039428, HPA039678" Approved NA NA "HPA039428: AB_10795251, HPA039678: AB_10796332" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-3)" "unprognostic (2.88e-3)" "unprognostic (7.78e-3)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" "unprognostic (1.93e-2)" "unprognostic (3.17e-1)" "unprognostic (1.12e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-1)" "unprognostic (6.10e-2)" "unprognostic (9.90e-5)" 1.9 2.7 5.1 0.8 1.8 0.0 1.8 3.5 1.0 3.0 1.8 0.7 1.8 3.5 0.9 5.7 6.5 1.4 4.5 1.1 5.9 2.4 1.0 5.6 1.3 9.8 4.9 0.2 1.3 1.8 0.5 0.6 0.3 5.7 1.8 1.1 1.0 1.4 1.6 1.5 3.1 1.1 3.1 9.1 2.2 1.3 0.4 3.9 2.1 4.4 3.5 2.0 1.2 1.1 5.2 0.0 1.3 0.0 0.0 0.1 0.9 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.7 0.2 0.1 0.0 2.2 0.0 0.0 0.3 0.0 4.1 0.0 0.2 0.0 0.0 1.5 2.1 0.7 0.1 12.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.0 2.8 1.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 1.8 3.5 1.0 1.1 5.9 9.8 4.9 0.2 5.7 9.1 3.9 5.2 9.6 16.0 16.4 0.7 0.0 4.8 5.8 22.8 16.5 0.1 1.4 6.7 4.0 21.5 47.8 3.7 0.0 0.0 0.1 0.0 1.9 7.3 0.4 8.7 0.4 27.5 0.0 2.7 0.1 1.5 0.0 4.6 2.0 6.1 0.0 4.4 32.9 0.1 0.1 0.0 0.1 0.4 8.2 1.9 1.1 0.4 2.5 0.4 0.0 5.6 0.0 12.3 0.0 0.0 0.0 4.5 1.2 0.4 0.1 8.2 0.3 0.2 27.2 0.3 0.0 2.9 4.2 0.0 1.8 38.9 3.3 0.0 0.7 0.7 0.3 5.4 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1;retina: 72.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 138.0;Cone photoreceptor cells: 141.8;Excitatory neurons: 103.4;Horizontal cells: 85.8;Inhibitory neurons: 101.3;Muller glia cells: 191.3;Rod photoreceptor cells: 179.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 31.9;Hep G2: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.1 2.9 14.7 0.7 16.3 1.1 0.5 5.7 12.6 1.0 0.0 1.3 0.3 2.5 18.1 0.3 2.6 2.1 1.3 10.7 23.1 4.7 2.2 0.3 1.5 13.7 12.1 10.8 2.1 1.3 5.1 2.1 0.7 10.5 4.6 2.0 72.0 1.4 4.6 0.1 0.2 0.3 0.3 15.4 1.7 1.4 12.5 15.1 5.1 7.2 0.1 1.7 3.2 0.2 17.5 8.0 7.2 4.8 6.7 0.0 0.0 31.9 1.3 2.5 5.1 5.1 3.0 5.2 0.0 3.4 0.1 13.9 5.4 10.2 15.3 5.5 5.7 11.9 2.2 1.3 23.4 0.2 0.0 0.1 0.1 16.2 1.3 7.2 0.8 0.0 7.3 0.0 0.1 3.0 2.2 7.4 0.1 12.8 1.8 4.1 10.9 3.2 0.5 4.8 12.8 2.8 3.8 12.9 5.5 1.0 21.5 5.6 1.4 0.0 0.3 4.8 0.0 5.5 17.7 18.5 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.0 0.0 1.4 0.2 0.6 0.9 0.0 0.4 1.2 1.3 0.0 0.3 0.0 0.2 0.3 0.6 14.7 16.3 5.7 12.6 10.7 23.1 13.7 12.1 10.8 10.5 15.4 15.1 17.5 0.3 0.0 0.0 32.0 5.7 0.3 6.5 2.8 1.2 138.0 1.2 1.5 1.6 1.5 3.5 49.7 141.8 5.4 14.2 1.6 3.9 1.9 15.5 8.5 1.9 2.6 3.5 1.3 103.4 0.0 0.5 1.5 6.6 10.9 1.3 24.7 0.0 4.1 0.5 85.8 101.3 1.3 2.0 1.9 0.0 29.0 5.0 0.7 1.8 14.0 0.9 191.3 11.3 67.3 58.2 2.9 0.5 4.1 4.8 8.1 2.2 2.8 2.8 179.7 0.0 0.3 1.5 25.2 13.4 1.4 0.1 0.3 7.8 5.7 1.4 4.4 ZNF830 "CCDC16, MGC20398, OMCG1" ENSG00000198783 "Zinc finger protein 830" Q96NB3 17 34961540-34963777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024754, HPA027211" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA024754: AB_1859464, HPA027211: AB_1859465" "unprognostic (2.87e-1)" "unprognostic (3.86e-2)" "unprognostic (2.47e-1)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (8.70e-2)" "unprognostic (2.37e-2)" "unprognostic (6.39e-2)" "unprognostic (6.39e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.01e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (8.63e-2)" 7.7 7.1 6.4 9.6 6.8 11.2 8.5 8.5 7.3 7.5 6.9 8.2 8.7 9.5 6.8 8.7 9.0 6.9 6.3 6.5 6.6 7.3 10.5 6.6 14.0 6.4 6.7 6.4 12.9 8.3 8.1 5.6 7.9 6.8 8.1 6.4 6.4 7.8 6.7 8.1 8.4 10.7 6.6 6.4 14.8 9.0 10.2 6.6 13.8 9.1 8.6 11.9 9.4 7.6 7.9 7.9 15.2 13.5 12.5 14.1 10.9 9.3 9.5 9.6 12.2 12.0 11.5 10.5 14.3 8.5 9.3 12.7 18.2 14.5 8.6 13.7 8.7 19.7 16.9 15.5 14.5 14.3 25.4 23.2 10.7 19.9 10.2 19.7 12.3 11.1 17.4 24.6 20.5 11.1 6.1 23.2 28.5 8.9 10.6 7.4 15.4 18.3 19.1 11.3 10.6 15.9 13.6 9.3 5.7 15.4 12.9 13.2 27.5 11.7 12.8 9.4 9.5 16.7 22.6 18.5 19.1 11.0 13.4 11.7 30.8 12.3 40.7 16.2 12.1 16.2 13.1 17.3 18.0 13.5 13.0 26.2 20.9 11.6 15.8 8.7 14.4 16.9 12.3 6.4 6.8 8.5 7.3 6.5 6.6 6.4 6.7 6.4 6.8 6.4 6.6 7.9 27.6 38.5 21.3 4.2 35.3 24.0 45.3 26.7 25.0 19.9 23.3 18.7 8.3 17.2 30.9 12.9 14.6 24.5 45.8 25.7 35.2 19.0 7.1 14.1 27.3 23.6 18.5 20.2 5.1 13.1 16.7 23.2 23.0 17.3 17.1 20.4 15.4 10.6 14.4 10.1 4.8 21.1 22.4 11.5 16.7 3.8 26.8 15.8 21.4 6.5 18.3 20.4 51.5 4.5 11.6 13.4 25.3 27.4 21.3 27.7 26.5 22.4 15.4 31.8 26.3 27.2 22.6 44.8 46.4 18.6 24.2 26.7 36.3 22.6 28.2 34.3 GRIN3A GluN3A ENSG00000198785 "Glutamate ionotropic receptor NMDA type subunit 3A" Q8TCU5 9 101569352-101738647 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 220.7" "Cancer enriched" "Detected in single" 7 "prostate cancer: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.29e-1)" "unprognostic (7.10e-3)" "unprognostic (3.01e-5)" "unprognostic (3.39e-2)" "unprognostic (6.32e-2)" "unprognostic (7.06e-4)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (7.56e-2)" "unprognostic (7.34e-3)" "unprognostic (1.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.87e-1)" "unprognostic (9.41e-2)" 0.1 0.1 2.5 0.2 4.3 0.1 0.2 0.0 3.1 1.5 0.0 0.3 0.1 0.3 0.3 0.1 0.1 0.0 0.4 2.7 2.0 0.1 0.2 0.2 0.4 1.2 1.8 3.6 0.8 0.1 0.0 0.1 0.0 1.5 0.6 0.2 0.9 0.2 0.9 0.2 0.3 0.2 0.1 0.4 0.7 0.1 0.3 3.6 0.1 0.1 0.1 0.2 0.1 0.1 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.5 4.3 0.0 3.1 2.7 2.0 1.2 1.8 3.6 1.5 0.4 3.6 3.1 0.2 0.0 0.0 5.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 1.8 0.2 0.1 0.6 0.0 0.0 37.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 220.7 0.0 0.0 2.4 1.1 0.8 0.9 0.2 0.0 0.0 0.1 0.1 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.6 0.0 0.8 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 MT-ND5 "MTND5, NAD5, ND5" ENSG00000198786 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5" P03915 MT 12337-14148 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26244.7;skeletal muscle: 25940.2" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 35040.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 10198.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.87e-1)" "unprognostic (3.18e-2)" "unprognostic (3.00e-1)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (5.09e-3)" "unprognostic (1.06e-2)" "unprognostic (3.01e-1)" "unprognostic (3.29e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.31e-5)" "unprognostic (9.93e-3)" "unprognostic (8.75e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" 5336.1 4816.9 20153.2 1757.9 19867.7 1538.5 2477.7 15855.2 21563.1 1426.2 20703.9 3747.8 4172.7 1989.2 2530.1 2742.9 3056.5 2058.5 20920.1 17658.5 15492.0 7914.0 10123.6 2706.6 1190.0 26244.7 17622.9 12481.6 1902.9 2653.6 4854.7 1540.7 1705.7 25702.0 2837.5 2905.7 3293.5 2843.6 2184.3 25940.2 6710.7 4820.6 2667.0 13941.7 2030.5 6728.6 1693.7 22479.6 802.1 2076.0 19616.6 1554.7 3587.2 1550.6 20825.5 1615.8 1671.5 1998.7 1937.9 5903.9 1530.3 1075.8 3208.3 492.5 355.1 583.1 2472.6 2051.0 3865.3 1590.5 1510.4 397.3 3350.6 191.2 1685.7 583.4 2182.3 1281.4 2840.4 10198.2 4239.2 678.8 2010.7 2824.3 2305.4 1315.5 401.6 951.8 1933.5 725.2 1233.3 1056.8 1794.8 1216.3 3046.1 757.3 2453.4 397.5 910.2 903.0 1432.9 938.2 1668.7 2083.2 3132.2 595.0 904.1 1496.1 2636.3 894.4 3001.9 1927.1 2979.2 5094.9 2013.2 1403.2 2409.7 1271.9 678.8 1246.0 1066.9 1077.4 1780.4 897.7 2851.8 1521.7 874.2 771.4 980.3 922.8 979.1 753.9 839.2 746.5 1096.6 729.2 869.0 446.2 785.1 1039.5 890.3 628.6 492.0 20153.2 19867.7 15855.2 21563.1 17658.5 15492.0 26244.7 17622.9 12481.6 25702.0 13941.7 22479.6 20825.5 773.3 628.2 594.2 0.0 1707.9 895.1 1050.1 1005.5 3261.6 0.0 1003.4 1025.1 35040.8 2566.4 934.5 1156.8 0.0 0.0 977.0 3181.2 283.7 804.1 109.5 3130.4 2025.6 1614.3 782.9 3776.6 0.0 936.6 0.0 1437.2 3609.6 5212.8 862.1 2987.5 2623.3 6597.7 0.0 0.0 0.0 1776.8 583.9 3664.2 661.9 528.9 1057.5 1364.5 608.3 0.0 1303.9 0.0 756.0 0.0 0.0 1327.8 2211.7 848.6 2674.2 753.3 4484.5 2410.8 1282.0 0.0 696.8 1941.5 1558.6 652.2 521.9 3002.4 973.6 0.0 1527.8 1560.9 1650.5 1506.6 MUC2 ENSG00000198788 "Mucin 2, oligomeric mucus/gel-forming" 11 1074875-1110511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 135.1" "Cell type enriched" "Detected in some" 12 "Intestinal goblet cells: 745.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 93.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB016275 Enhanced "Intracellular and membrane" NA NA "CAB016275: AB_627970" "unprognostic (6.37e-2)" "unprognostic (8.32e-2)" "unprognostic (5.76e-3)" "unprognostic (5.09e-2)" "unprognostic (6.18e-3)" "unprognostic (3.39e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-3)" "unprognostic (7.87e-2)" "unprognostic (2.04e-1)" "unprognostic (7.37e-3)" "unprognostic (4.20e-2)" "unprognostic (3.64e-5)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (3.10e-2)" 0.6 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.1 31.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.6 0.0 0.0 0.5 0.0 0.0 80.6 4.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 18.0 0.0 0.4 0.0 0.0 0.0 0.0 60.3 0.0 0.3 0.0 0.1 0.0 0.6 14.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 745.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 31.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 34.3 0.0 CNOT7 CAF1 ENSG00000198791 "CCR4-NOT transcription complex subunit 7" Q9UIV1 8 17224966-17246878 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069543 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA069543: AB_2686148" "unprognostic (1.55e-1)" "unprognostic (4.49e-2)" "prognostic favorable (4.99e-4)" "unprognostic (4.61e-2)" "unprognostic (8.45e-2)" "unprognostic (3.10e-2)" "unprognostic (1.44e-3)" "unprognostic (4.54e-2)" "unprognostic (6.83e-2)" "unprognostic (4.09e-3)" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-2)" "unprognostic (1.72e-1)" "unprognostic (4.51e-1)" "unprognostic (2.24e-1)" "unprognostic (2.52e-1)" 32.2 33.0 19.1 40.1 23.9 51.4 42.6 33.8 31.0 28.3 19.5 43.4 38.7 39.9 45.5 44.1 36.7 36.0 38.6 21.4 25.2 51.3 49.2 33.3 52.6 18.1 19.3 18.3 42.5 36.3 63.1 26.4 43.5 20.5 33.0 44.2 78.7 38.9 29.8 79.6 28.0 38.8 36.9 20.4 39.4 32.3 52.4 21.9 80.9 60.5 72.9 65.5 45.5 20.6 24.9 77.3 93.6 138.1 103.1 57.0 59.6 95.3 97.6 82.5 110.4 97.5 110.2 60.4 106.1 103.9 85.9 177.5 60.3 147.0 122.9 160.2 44.1 71.0 139.9 68.6 119.9 73.2 95.3 82.8 57.3 99.7 94.3 100.3 102.0 133.7 138.2 119.1 114.9 112.9 60.2 234.7 88.2 152.6 144.4 72.0 126.1 102.7 79.9 95.6 167.6 173.6 115.9 68.6 60.3 114.4 112.9 72.5 79.2 90.8 82.0 116.5 92.4 110.8 59.3 208.2 189.5 76.9 88.7 82.8 138.0 93.9 109.5 80.2 116.6 95.3 133.3 109.7 95.7 113.5 135.3 136.6 110.0 84.5 106.5 105.1 101.3 134.8 130.1 19.1 23.9 33.8 31.0 21.4 25.2 18.1 19.3 18.3 20.5 20.4 21.9 24.9 46.9 32.1 40.3 15.0 100.4 90.9 65.2 82.5 100.7 114.9 77.1 64.0 58.2 61.5 48.2 62.5 93.8 88.4 74.5 31.0 97.8 79.0 86.5 50.7 37.1 56.8 94.1 60.5 39.1 72.5 115.1 45.9 40.2 53.5 44.9 72.2 69.3 67.2 69.7 25.2 32.1 69.6 81.4 73.5 58.7 33.9 40.7 59.4 26.6 28.1 83.7 68.5 76.2 23.1 34.8 79.3 58.1 40.6 84.0 93.8 52.6 113.9 56.6 219.2 78.9 51.6 56.2 95.9 100.7 90.7 86.0 85.5 77.6 55.3 70.5 84.3 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273010 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 86.8;Oligodendrocytes: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 197.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 26.8 22.1 49.0 14.1 45.8 5.8 25.1 49.3 60.1 18.8 18.3 20.6 17.1 19.6 7.3 17.5 17.2 14.6 32.3 45.8 41.8 21.8 11.5 36.2 8.5 52.8 52.3 40.5 16.3 18.5 19.1 34.6 38.7 53.4 19.0 10.9 15.3 22.8 14.6 29.0 15.2 17.7 14.1 50.3 22.2 22.6 7.6 49.4 6.2 26.4 17.5 8.3 18.5 16.6 63.6 55.8 47.5 27.5 21.9 53.6 42.6 63.4 58.8 82.9 46.9 41.5 35.1 25.2 10.6 44.9 87.6 42.4 67.2 24.9 57.8 31.6 37.9 45.0 20.9 34.0 29.5 56.3 16.6 28.0 36.1 50.2 55.4 61.5 48.5 59.5 15.9 13.5 36.2 41.5 31.6 10.6 14.1 22.4 41.2 43.4 18.1 24.8 10.6 34.8 60.6 59.3 10.5 44.2 63.6 32.0 31.7 35.2 12.0 89.2 47.7 48.4 42.5 36.2 74.5 197.9 8.5 69.2 12.1 42.0 14.2 3.3 4.7 5.3 2.3 4.6 1.4 2.9 4.0 4.5 1.1 2.1 2.5 10.9 6.2 1.6 7.0 1.0 3.2 49.0 45.8 49.3 60.1 45.8 41.8 52.8 52.3 40.5 53.4 50.3 49.4 63.6 43.4 6.4 14.8 86.8 7.5 12.4 19.8 22.3 17.6 16.4 15.9 10.5 17.1 8.6 18.7 14.7 2.1 35.0 17.8 12.5 3.9 17.3 5.6 17.4 15.5 34.6 25.9 4.6 42.6 22.2 48.3 17.4 13.3 33.8 2.5 15.3 18.2 4.4 14.7 15.2 40.7 19.7 12.2 8.5 19.7 2.4 11.8 8.4 14.2 22.5 12.2 44.4 23.7 42.3 93.1 28.3 9.8 13.5 35.6 32.9 11.1 4.3 15.9 9.0 19.7 15.3 27.0 3.3 6.1 5.3 9.7 78.4 9.3 10.2 10.1 37.0 MTOR "FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1" ENSG00000198793 "Mechanistic target of rapamycin kinase" P42345 1 11106535-11262551 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB069425, HPA071227" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB069425: , HPA071227: AB_2686367" "unprognostic (3.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (2.45e-3)" "unprognostic (5.50e-2)" "unprognostic (2.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.24e-3)" "unprognostic (3.48e-2)" "unprognostic (1.88e-1)" "prognostic favorable (1.49e-5)" "unprognostic (1.27e-1)" "unprognostic (2.45e-1)" "unprognostic (6.60e-2)" "unprognostic (7.55e-2)" 16.2 19.5 17.7 13.7 18.7 14.1 17.0 18.5 20.4 15.2 17.5 21.3 11.1 17.6 22.0 18.5 14.8 9.1 21.1 19.3 17.9 20.1 27.8 15.3 15.4 16.6 21.5 18.7 14.3 18.5 20.7 22.0 11.9 18.1 20.0 16.2 27.1 16.6 13.9 36.7 17.0 19.8 14.0 14.5 21.4 18.9 34.2 22.6 19.3 17.9 18.0 16.0 17.2 15.0 18.9 28.5 25.2 33.3 25.4 39.4 18.6 16.6 23.4 22.3 30.6 29.9 26.0 25.5 31.4 19.6 27.8 18.8 33.1 45.3 35.8 39.3 25.2 33.2 41.7 53.8 33.4 24.7 41.1 29.7 24.0 26.8 43.7 44.0 14.5 39.3 29.6 47.4 26.1 21.6 32.4 28.5 31.2 25.3 29.6 23.5 28.2 39.2 21.0 27.2 25.3 33.4 24.5 50.1 26.8 31.2 36.5 21.8 24.0 42.3 26.5 23.9 20.5 31.8 25.5 25.5 60.5 19.1 43.6 28.6 0.3 1.1 1.3 1.9 2.4 1.6 1.4 1.1 1.0 1.6 1.1 1.3 1.1 0.8 1.1 1.3 1.2 2.4 1.0 17.7 18.7 18.5 20.4 19.3 17.9 16.6 21.5 18.7 18.1 14.5 22.6 18.9 9.2 16.0 11.8 40.8 10.0 3.4 5.2 7.6 8.6 0.0 7.7 7.5 25.1 2.8 10.3 9.2 0.0 7.9 9.8 9.4 1.9 8.5 42.0 13.8 16.1 11.0 10.3 14.3 43.8 6.2 7.2 9.2 16.8 18.6 13.3 12.9 5.3 13.4 6.9 0.0 49.2 7.8 6.1 8.2 4.1 36.1 7.8 9.1 8.8 36.5 9.2 0.0 10.3 38.2 37.4 10.4 5.4 8.2 17.2 8.9 7.0 4.5 6.3 0.0 39.5 11.4 12.1 49.3 37.4 15.6 5.7 9.9 9.8 15.3 10.0 5.7 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 189.0;parathyroid gland: 103.9;retina: 286.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 33 "plasmacytoid DC: 27.7" "Lineage enriched" "Detected in single" 33 "dendritic cells: 27.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced NA NA "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favorable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favorable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 3.1 20.8 95.5 4.3 134.4 2.6 3.1 85.5 189.0 2.4 21.1 5.9 42.0 5.8 3.7 1.5 5.1 5.6 4.8 127.4 96.2 16.8 4.3 2.8 7.9 119.9 87.3 131.5 6.1 53.9 103.9 68.3 6.7 135.0 4.6 5.0 286.2 7.3 2.7 0.6 2.1 30.6 3.2 40.8 8.6 15.7 10.7 105.6 4.4 6.6 0.8 10.1 5.9 1.8 133.4 1.5 17.8 3.8 12.6 0.3 0.2 0.5 0.4 0.6 4.0 1.4 4.9 8.9 28.0 8.5 1.1 3.3 1.2 15.6 1.1 1.4 4.4 2.0 3.5 2.1 25.8 2.7 0.4 11.5 1.3 2.1 1.0 0.3 2.8 1.7 10.1 0.2 22.1 1.0 15.1 1.1 10.2 13.4 2.1 7.1 0.4 3.2 6.7 1.0 8.6 88.1 49.3 19.8 13.6 27.6 2.7 7.7 34.0 1.1 1.2 8.2 1.6 1.3 1.8 2.4 2.6 3.0 21.2 4.3 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.8 0.4 0.1 27.7 0.0 0.4 95.5 134.4 85.5 189.0 127.4 96.2 119.9 87.3 131.5 135.0 40.8 105.6 133.4 2.2 0.0 1.1 14.7 2.5 0.3 0.5 0.4 2.8 113.3 3.2 2.7 3.0 7.2 0.4 5.5 125.1 0.1 35.5 2.9 1.9 4.4 0.5 0.4 0.7 3.6 62.5 0.0 75.1 43.3 0.3 1.9 12.8 0.3 0.0 4.1 6.8 0.6 13.8 70.7 99.3 5.0 0.0 6.9 0.2 0.7 2.1 2.0 1.8 6.5 0.4 29.9 0.0 32.2 26.2 6.8 5.3 6.4 8.9 0.8 34.0 13.0 2.7 168.0 0.0 0.9 2.8 1.8 4.7 1.7 0.1 0.1 0.6 2.0 2.7 0.3 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061924-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 94.4" "Cell type enhanced" "Detected in many" "Astrocytes: 170.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 221.7;Oligodendrocytes: 104.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 94.4;pons: 35.5" "Group enriched" "Detected in some" 6 "basophil: 11.4;plasmacytoid DC: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 8.8;granulocytes: 11.4" "Cell line enhanced" "Detected in many" "AF22: 67.6;fHDF/TERT166: 32.7;HUVEC TERT2: 46.9;THP-1: 38.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 49.7" "HPA023056, HPA023849" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 11.9 12.0 10.3 3.1 9.8 2.3 11.5 94.4 8.7 10.6 24.6 4.4 1.8 15.5 4.3 4.0 9.1 10.7 7.5 5.8 12.9 3.3 1.2 6.4 3.8 14.6 15.1 5.8 20.7 1.2 1.1 7.6 8.7 35.5 2.7 3.6 5.7 9.0 3.0 3.7 5.7 4.4 13.7 11.7 21.2 2.7 3.7 10.6 4.4 6.8 6.1 2.8 5.8 6.9 14.0 0.1 0.0 67.6 0.1 10.6 18.4 0.2 10.0 14.3 3.4 2.1 0.0 0.1 0.0 0.0 32.7 0.0 0.3 0.0 0.0 2.8 0.0 4.0 14.0 0.6 0.5 1.9 0.0 20.2 23.0 0.0 0.3 0.0 0.0 46.9 16.4 0.3 0.1 6.0 0.0 9.2 0.0 4.7 0.0 0.0 0.0 15.2 1.1 0.0 0.0 8.7 5.5 0.8 0.0 0.0 6.1 0.0 38.9 26.9 26.5 2.0 8.0 1.5 0.1 0.0 0.3 10.0 0.0 22.2 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 8.8 0.0 0.1 10.3 9.8 94.4 8.7 5.8 12.9 14.6 15.1 5.8 35.5 11.7 10.6 14.0 19.0 0.0 3.0 170.1 0.3 3.7 0.1 0.0 1.2 42.4 8.0 10.9 11.9 0.0 0.6 0.0 2.1 0.1 1.7 0.0 0.0 0.0 2.1 0.5 3.3 28.6 1.2 13.9 16.5 0.0 0.0 21.4 0.0 0.2 13.3 4.7 20.3 0.0 0.1 15.2 22.7 0.1 0.0 0.6 5.5 3.3 9.9 0.9 14.2 53.4 0.1 0.7 0.0 221.7 104.6 0.0 0.0 7.9 0.1 0.2 0.0 4.0 1.5 3.0 0.0 13.7 6.0 0.1 6.1 0.8 4.4 0.1 0.8 17.2 0.0 0.2 ALPK2 HAK ENSG00000198796 "Alpha kinase 2" Q86TB3 18 58481247-58629091 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 42.2;skeletal muscle: 38.6;tongue: 33.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 120.4;Cone photoreceptor cells: 47.9;Early spermatids: 15.9;Late spermatids: 24.3;monocytes: 18.1" "Cancer enriched" "Detected in some" 6 "renal cancer: 7.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 51.2;BJ hTERT+: 31.0;fHDF/TERT166: 46.6;U-138 MG: 25.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027377, HPA027976, HPA028084, HPA029801" Uncertain Approved Cytosol NA NA Cytosol "HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006" "unprognostic (7.35e-2)" "unprognostic (4.91e-2)" "unprognostic (1.64e-1)" "unprognostic (4.60e-3)" "unprognostic (2.64e-1)" "unprognostic (8.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (5.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-2)" 0.5 0.0 0.1 2.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.8 0.3 0.0 0.9 42.2 0.3 0.0 9.1 4.6 0.1 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.3 0.2 2.1 0.3 0.0 38.6 0.4 1.0 0.1 0.0 0.5 1.7 1.2 0.0 3.5 0.0 33.5 4.4 1.5 0.0 0.0 0.0 13.7 0.9 0.0 0.4 3.4 0.3 51.2 31.0 21.2 18.1 3.4 0.0 0.0 5.2 46.6 2.9 0.0 0.0 0.0 21.5 11.5 0.0 0.0 4.4 1.8 2.7 0.0 0.0 3.0 0.0 6.4 0.2 0.7 0.0 0.0 0.0 0.4 13.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 8.3 0.0 0.0 0.0 25.3 11.2 3.5 8.7 20.9 19.2 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.2 0.1 4.8 120.4 0.0 0.0 0.0 47.9 0.0 0.1 0.0 1.9 1.5 15.9 0.0 2.3 0.9 0.0 0.0 1.0 0.7 0.0 8.9 0.0 0.1 0.0 4.0 0.4 3.0 0.7 1.7 0.7 0.0 0.0 0.3 3.0 24.3 0.3 2.4 0.0 0.0 18.1 2.6 0.0 0.0 0.8 0.2 2.3 0.0 0.6 0.0 0.3 13.6 0.0 0.9 0.0 3.8 1.7 1.1 0.1 0.0 0.9 0.1 0.3 0.0 0.0 0.0 BRINP2 "DBCCR1L2, FAM5B" ENSG00000198797 "BMP/retinoic acid inducible neural specific 2" Q9C0B6 1 177170958-177282422 "Predicted secreted proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 9.7;brain: 18.7" "Group enriched" "Detected in some" 4 "Astrocytes: 121.1;Excitatory neurons: 116.8;Inhibitory neurons: 148.3;Oligodendrocyte precursor cells: 96.5" "Cancer enriched" "Detected in some" 5 "glioma: 11.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.7;PC-3: 1.3;REH: 2.1;SCLC-21H: 5.6;SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050681 Uncertain "Secreted in other tissues" NA NA "HPA050681: " "unprognostic (7.78e-2)" "unprognostic (4.49e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.43e-2)" "unprognostic (1.77e-1)" "unprognostic (5.77e-2)" "unprognostic (1.23e-2)" "unprognostic (1.95e-2)" "unprognostic (2.20e-4)" "unprognostic (8.95e-2)" "unprognostic (1.78e-2)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (2.60e-2)" "unprognostic (4.82e-3)" 0.3 9.7 17.1 0.0 16.0 0.0 0.9 0.9 18.7 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 16.6 8.9 0.0 0.1 0.0 0.0 4.6 9.9 15.8 0.0 0.0 0.0 4.3 0.5 7.8 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 2.1 14.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 2.1 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 16.0 0.9 18.7 16.6 8.9 4.6 9.9 15.8 7.8 3.2 14.1 12.9 0.0 0.0 0.0 121.1 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 3.4 0.2 0.3 0.0 0.0 0.0 116.8 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.1 15.2 148.3 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 25.3 0.0 0.5 0.0 96.5 15.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 MAGEB3 CT3.5 ENSG00000198798 "MAGE family member B3" O15480 X 30230436-30237492 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 115 "epididymis: 17.8;testis: 5.1" "Group enriched" "Detected in some" 8 "Spermatocytes: 13.0;Spermatogonia: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SuSa: 1.3;U-266/70: 2.1" "Not detected" "Not detected" HPA072203 Approved NA NA "HPA072203: AB_2686492" "unprognostic (3.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073198-113132260 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 2100000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 2.3 2.3 3.5 2.1 4.6 1.1 2.7 4.7 3.8 3.2 3.0 2.8 2.8 3.1 3.8 2.4 2.5 1.5 2.3 3.0 3.3 2.2 2.0 2.0 2.7 3.9 3.9 3.0 3.9 2.6 2.9 2.9 2.4 4.0 2.5 2.1 6.5 2.4 2.2 3.9 4.6 3.0 1.7 3.8 3.0 2.3 1.7 3.9 2.9 3.4 2.1 2.4 2.5 2.8 6.9 2.6 1.3 3.8 2.9 3.6 3.6 2.1 1.6 2.4 1.9 3.2 2.0 1.6 2.6 2.8 2.0 1.1 2.8 2.6 1.7 3.2 1.8 1.5 2.8 2.9 1.0 3.6 3.4 1.3 3.6 3.1 3.0 4.0 2.9 2.5 3.6 3.4 2.4 2.4 1.9 3.5 3.5 3.5 1.0 2.3 3.1 4.8 1.3 1.9 1.7 2.6 2.1 2.8 1.8 3.6 3.1 1.4 3.8 3.9 3.5 1.9 4.9 2.6 2.6 1.3 2.6 3.8 2.1 3.3 1.9 0.7 0.5 0.8 0.6 1.0 0.9 1.0 0.9 0.6 1.4 1.1 1.0 0.4 1.4 0.7 0.7 0.8 0.5 3.5 4.6 4.7 3.8 3.0 3.3 3.9 3.9 3.0 4.0 3.8 3.9 6.9 9.4 0.0 15.5 14.4 12.7 8.4 3.1 5.7 8.0 21.0 7.0 7.2 11.6 7.2 7.1 14.7 37.5 7.8 14.6 13.5 0.0 3.2 1.3 6.9 14.6 9.4 5.4 5.5 22.9 2.6 5.1 10.2 13.7 8.0 5.7 22.0 6.1 5.4 4.8 18.5 23.8 8.7 0.0 8.2 5.6 0.9 18.3 6.4 7.2 19.7 11.9 20.6 17.5 25.1 40.9 3.3 7.5 16.1 7.8 5.5 8.9 4.4 10.8 23.4 0.0 12.6 8.2 11.1 16.1 5.5 6.7 5.3 10.3 20.4 9.8 3.3 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Deafness, Disease variant, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 211969.7;heart muscle: 178858.5;tongue: 186224.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107039.5;Hepatocytes: 59794.3;Proximal enterocytes: 98329.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 54167.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria NA NA Mitochondria "CAB016241: AB_2229888, HPA069328: AB_2686122" "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 22203.3 47353.6 170009.7 8807.4 155228.5 11418.0 18105.0 136056.3 211969.7 10529.0 170017.9 31068.2 27755.6 11679.8 14350.5 20959.8 10793.4 11554.3 178858.5 157156.7 138633.6 61990.0 97362.4 12855.3 9185.5 183024.9 153188.2 130377.6 8196.3 19629.6 41596.6 7477.9 10615.8 192364.4 12532.3 28659.1 12612.8 23465.2 17921.5 148595.9 25048.1 35660.7 13262.5 136533.1 16415.1 45217.6 11017.6 173328.8 7529.7 14171.2 186224.0 8452.4 17561.7 10647.7 155906.2 5837.6 8554.3 11384.1 12431.0 25510.2 11563.1 12037.2 12867.2 4284.9 3189.4 5257.4 10383.6 18320.5 15138.9 6040.7 9857.6 3118.2 21430.9 1326.6 11407.4 4515.1 7226.0 8040.6 9130.6 54167.9 19725.4 3521.2 5336.1 11055.5 13603.9 11589.8 3149.9 6917.5 14668.4 3902.1 8485.5 5916.3 10551.1 9525.6 14037.0 4378.4 23591.9 2905.0 7814.2 6900.5 5664.0 3401.6 9177.9 15910.6 15016.1 5414.7 7189.1 4466.7 17018.9 8305.7 13626.1 9809.7 17703.3 15637.8 12617.8 8438.9 12565.9 6642.1 4951.2 5072.9 3542.6 6235.7 13711.8 6294.4 5305.8 9759.2 3824.6 3085.1 4907.9 3420.5 5374.6 3047.3 3425.6 3444.6 5567.3 3080.8 3911.2 1900.4 3759.1 5775.1 4847.5 2947.7 3929.0 170009.7 155228.5 136056.3 211969.7 157156.7 138633.6 183024.9 153188.2 130377.6 192364.4 136533.1 173328.8 155906.2 3924.0 2900.6 3897.1 0.0 13282.9 9769.7 9713.9 22625.0 20857.7 0.0 12033.2 11841.6 107039.5 30777.5 16135.4 19596.3 0.0 0.0 9288.4 40726.1 4255.4 7191.4 1555.3 13044.7 9033.9 7847.9 7514.7 45610.3 0.0 5089.4 0.0 6305.3 19235.7 25645.6 3832.6 20400.0 25951.4 59794.3 0.0 0.0 0.0 24302.1 19071.0 45533.4 7744.0 7398.4 11696.4 12124.7 6894.2 0.0 15180.0 0.0 8901.3 0.0 0.0 6410.5 23865.9 8490.1 13829.3 9441.3 98329.8 33652.6 10474.0 0.0 13614.6 11019.8 9403.5 12096.5 14338.7 27110.9 11475.1 0.0 11502.4 15179.6 27138.6 21770.7 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477089 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 336.8;epididymis: 600.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 531.3;U-937: 593.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 58000000 Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 55.8 25.0 16.6 47.2 17.3 336.8 34.9 22.7 21.4 17.1 20.3 52.7 121.4 14.3 600.0 88.2 18.3 57.3 25.0 17.4 26.2 208.7 98.8 49.0 47.1 19.8 18.9 14.6 5.0 23.4 32.3 20.0 133.7 19.9 15.1 62.4 27.3 22.8 27.6 7.4 28.1 60.8 39.0 22.8 44.8 51.0 7.4 21.2 33.8 18.0 10.1 65.0 101.4 41.8 20.3 86.1 113.4 24.0 53.9 26.0 21.0 71.8 85.2 40.3 68.2 67.0 66.1 76.5 227.1 96.8 45.5 81.5 89.9 125.2 159.8 89.5 75.0 109.6 189.1 89.9 109.3 24.2 531.3 94.7 14.4 57.4 206.0 91.0 37.8 295.9 141.0 95.4 137.4 86.7 79.1 157.6 311.3 67.5 215.7 186.1 130.2 35.9 88.3 243.7 79.6 101.9 22.6 163.4 205.0 13.2 32.6 75.5 92.5 240.0 46.1 62.6 105.1 148.4 63.1 113.3 258.9 39.3 593.0 4.6 12.0 30.6 10.3 39.8 27.3 73.6 25.7 44.2 45.0 48.1 28.8 27.6 35.9 3.7 38.5 26.6 27.3 16.7 31.1 16.6 17.3 22.7 21.4 17.4 26.2 19.8 18.9 14.6 19.9 22.8 21.2 20.3 149.6 0.0 23.5 5.9 50.3 84.6 67.4 12.6 112.7 4.7 56.3 62.6 3.5 27.1 13.4 82.8 14.6 360.6 45.2 61.1 39.2 43.2 1.3 36.0 12.7 139.4 46.4 227.3 0.6 51.5 41.8 32.4 106.5 65.3 57.7 5.0 24.3 30.6 70.9 16.8 1.1 51.3 18.3 18.1 58.4 0.8 0.3 83.3 30.2 3.7 13.2 78.8 29.9 3.0 0.9 130.8 83.9 0.7 88.6 27.5 41.2 118.9 10.5 18.1 0.0 23.9 41.3 0.4 0.7 114.7 63.9 646.2 62.3 3.1 51.4 77.1 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 81.6;lymphoid tissue: 20.7;parathyroid gland: 43.3;salivary gland: 52.2" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001572, CAB016239" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "CAB016239: AB_2159984, HPA001572: " "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 3.7 0.1 0.4 0.0 0.2 0.3 81.6 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 43.3 2.3 0.0 0.1 3.8 0.1 0.0 52.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.0 20.7 0.7 0.0 8.6 0.7 7.2 0.0 5.3 2.3 0.0 2.5 2.1 3.8 2.0 0.0 0.3 0.0 0.0 1.6 1.8 1.6 0.8 0.0 0.5 11.4 2.1 12.3 0.0 58.3 7.3 0.9 1.2 0.0 0.0 0.0 4.2 0.7 6.0 0.0 1.9 0.0 0.0 5.3 2.3 0.3 0.2 7.3 0.9 0.0 0.1 1.9 18.9 0.0 0.0 0.0 0.0 6.9 3.4 0.0 1.3 7.0 1.4 0.9 5.1 0.0 0.0 0.0 0.6 2.2 1.0 0.0 0.1 4.4 0.7 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.4 45.3 174.8 0.0 1.6 1.3 0.4 0.0 25.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.4 0.0 0.2 0.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.7 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 20.9 0.0 0.0 26.8 0.0 0.0 0.1 2.0 2.4 0.9 172.0 0.3 0.1 0.1 0.0 0.6 12.1 LRRC10 "HRLRRP, LRRC10A" ENSG00000198812 "Leucine rich repeat containing 10" Q5BKY1 12 69608564-69610907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "heart muscle: 40.4" "Cell type enriched" "Detected in some" 19 "Cardiomyocytes: 39.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.76e-4)" "unprognostic (4.59e-1)" 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 40.4 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GK "GK1, GKD" ENSG00000198814 "Glycerol kinase" P32189 X 30653359-30731462 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 91.4;kidney: 108.7;liver: 79.8" "Cell type enhanced" "Detected in many" "Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 8 "neutrophil: 178.4" "Lineage enriched" "Detected in all" 8 "granulocytes: 178.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 37.4;Hep G2: 46.4" "Low region specificity" "Detected in all" HPA060687 Supported NA NA "HPA060687: AB_2684343" "unprognostic (8.78e-3)" "unprognostic (8.41e-3)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (5.52e-2)" "unprognostic (1.42e-2)" "unprognostic (3.85e-1)" "unprognostic (8.56e-3)" "unprognostic (1.30e-2)" "unprognostic (1.58e-2)" "prognostic favorable (3.24e-9)" "unprognostic (1.59e-1)" "unprognostic (9.35e-2)" "unprognostic (4.57e-3)" "unprognostic (4.11e-3)" 8.9 9.9 3.6 51.9 3.6 6.6 4.8 3.7 15.9 4.8 9.1 13.1 87.4 3.6 12.4 9.7 7.8 24.0 4.2 2.9 13.6 108.7 79.8 19.8 10.7 8.1 4.2 2.1 2.6 4.6 14.1 5.4 8.2 7.2 3.6 11.0 10.4 11.2 2.2 2.6 6.4 91.4 4.5 4.7 10.2 6.3 2.9 11.8 5.4 6.6 3.1 14.6 30.5 2.7 7.1 4.5 3.5 4.5 7.7 2.7 10.4 1.8 10.6 37.4 7.6 8.6 5.8 4.1 12.6 1.7 4.1 6.9 0.3 8.5 3.5 10.1 8.2 9.6 7.5 6.6 46.4 17.2 14.2 15.4 6.3 4.9 24.2 22.3 1.9 6.0 9.6 4.0 17.3 2.1 6.2 11.0 14.6 7.5 4.9 4.0 15.0 7.1 13.1 5.7 14.8 4.8 6.1 9.4 9.4 21.5 4.5 10.6 10.1 2.3 5.5 2.3 0.3 4.9 9.1 10.7 12.5 9.5 9.1 5.6 5.0 22.8 7.9 1.7 7.2 1.3 3.1 3.1 2.2 14.2 5.6 1.8 1.9 178.4 4.8 9.1 4.2 11.5 6.2 3.6 3.6 3.7 15.9 2.9 13.6 8.1 4.2 2.1 7.2 4.7 11.8 7.1 2.0 16.0 27.4 19.6 15.8 6.9 12.3 12.6 4.6 3.2 9.4 3.9 4.3 12.8 22.5 7.3 16.7 1.2 5.6 54.7 35.2 21.9 61.5 15.1 2.7 3.8 12.1 6.3 41.5 11.1 1.1 12.4 20.9 1.7 14.5 6.9 3.6 38.1 34.8 5.0 37.2 14.7 0.0 26.6 139.2 29.9 1.2 133.4 14.2 10.3 42.6 29.1 3.1 28.6 19.6 10.6 39.9 2.2 12.4 17.0 144.2 161.1 47.7 17.7 0.0 9.2 7.0 15.3 1.7 14.7 16.9 0.8 15.7 3.7 11.0 26.8 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 126.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: AB_2685817" "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 22.1 13.1 15.1 15.1 18.8 30.4 22.4 29.3 20.4 22.1 15.0 17.5 15.9 20.4 14.9 15.6 18.1 13.2 20.3 20.2 21.9 13.5 16.4 18.7 17.9 14.5 14.4 16.0 23.3 19.1 21.5 17.2 18.5 16.5 17.2 18.3 19.5 17.0 14.7 42.4 22.8 17.8 17.9 11.3 17.3 17.7 16.5 15.7 22.5 19.4 29.4 17.5 18.4 19.3 21.0 24.8 20.5 22.1 23.0 23.3 28.5 31.7 18.4 27.1 24.2 26.8 19.0 28.9 37.8 19.1 25.8 20.7 23.1 31.1 30.2 40.8 28.5 17.5 41.7 26.3 16.3 20.1 38.7 27.4 21.3 29.3 36.2 44.6 25.7 26.7 29.6 25.7 26.6 29.2 14.1 39.3 22.0 34.4 19.8 18.3 36.4 57.9 25.9 20.5 35.4 30.6 28.8 33.1 37.8 33.1 31.4 19.0 56.9 25.0 25.1 33.5 25.7 30.8 26.2 34.8 30.2 22.7 31.6 20.7 5.1 4.9 5.5 7.2 4.3 8.9 6.4 8.9 7.9 4.0 9.2 9.3 10.7 9.3 9.9 8.9 8.3 6.2 4.2 15.1 18.8 29.3 20.4 20.2 21.9 14.5 14.4 16.0 16.5 11.3 15.7 21.0 47.5 12.8 21.3 75.4 29.5 35.4 10.9 16.7 40.5 21.4 22.9 18.3 39.9 10.0 18.5 16.5 18.8 13.9 28.8 33.2 17.6 10.7 23.7 30.6 32.0 26.7 27.0 27.3 110.8 14.7 30.8 22.6 31.6 38.1 12.7 19.3 16.4 17.0 11.7 21.9 112.6 26.5 8.2 18.6 15.3 18.4 22.4 18.7 10.6 87.1 16.0 15.0 27.8 102.5 126.6 15.9 18.9 19.9 29.2 21.4 22.6 14.8 15.1 31.3 6.6 38.3 22.0 32.1 22.5 28.2 33.4 27.9 27.7 12.6 18.9 20.8 ZNF358 "FLJ10390, ZFEND" ENSG00000198816 "Zinc finger protein 358" Q9NW07 19 7515292-7521025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 126.5;Granulosa cells: 178.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030887, HPA063624" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030887: AB_10602688, HPA063624: AB_2685064" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.34e-2)" "unprognostic (1.59e-2)" "unprognostic (9.89e-3)" "unprognostic (7.82e-2)" "unprognostic (7.40e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (6.52e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.30e-1)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.00e-1)" "unprognostic (9.72e-2)" "unprognostic (3.60e-2)" 64.6 57.8 82.9 12.1 71.9 2.2 58.9 64.5 110.7 73.5 49.3 85.6 29.7 70.4 28.2 32.1 62.6 32.2 108.9 76.7 70.0 52.9 67.6 51.1 10.6 83.3 80.2 72.9 89.4 51.0 50.0 61.4 18.4 80.3 79.3 18.5 11.9 51.7 44.2 177.2 37.2 48.3 37.7 67.4 39.9 68.5 12.7 83.0 14.2 60.4 148.3 8.0 89.1 54.7 73.1 32.5 21.4 39.7 63.3 83.2 91.8 33.9 12.0 78.2 53.7 47.0 9.4 22.6 0.0 45.7 64.8 8.5 12.4 16.5 30.8 17.2 0.1 35.0 6.2 24.9 13.3 91.0 0.9 0.3 80.3 57.2 25.4 22.0 80.0 57.1 0.0 16.7 0.0 48.2 16.0 0.1 23.5 40.9 13.4 37.4 35.8 21.2 3.5 28.2 13.8 43.8 87.1 15.1 12.5 43.8 25.5 9.5 16.9 27.1 34.4 24.8 51.6 18.4 41.8 24.8 0.1 31.7 0.0 48.6 1.5 0.5 0.4 0.6 0.5 0.4 0.1 0.1 0.3 0.2 0.7 0.4 0.7 0.0 0.2 0.1 0.4 0.0 0.2 82.9 71.9 64.5 110.7 76.7 70.0 83.3 80.2 72.9 80.3 67.4 83.0 73.1 29.5 9.6 11.1 11.8 4.6 7.8 11.8 7.1 2.2 20.8 32.8 37.1 126.5 20.0 5.5 16.5 14.6 3.3 6.5 38.8 5.9 13.0 3.8 9.4 28.2 22.1 36.5 0.8 5.8 16.8 5.1 29.2 8.6 14.2 14.7 178.1 32.5 43.0 10.9 50.5 8.5 27.8 8.2 21.1 10.8 7.7 37.9 13.3 5.4 7.5 3.8 48.8 1.0 8.5 14.9 16.0 21.7 37.2 3.4 11.3 48.3 30.7 3.3 20.7 13.1 22.1 27.6 0.7 1.2 3.2 3.7 3.0 3.6 23.9 24.7 12.8 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342576 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 39.8 44.2 58.8 35.9 64.7 36.1 46.4 65.9 76.9 35.7 58.4 52.6 39.6 26.7 68.8 36.9 34.1 34.7 30.7 58.0 62.7 51.5 24.7 37.3 51.3 67.8 63.5 56.7 32.2 51.6 36.4 17.5 49.3 67.7 47.9 50.6 13.0 71.3 28.3 22.4 23.7 39.3 25.0 66.9 42.3 51.1 27.2 62.5 42.1 46.7 27.7 48.3 40.8 29.6 76.3 47.1 39.9 41.9 86.3 76.1 65.9 56.4 70.7 69.6 56.8 85.5 80.2 103.3 43.9 55.7 68.8 90.2 59.7 62.5 67.0 88.3 58.8 88.4 53.0 35.4 133.4 65.9 134.9 106.5 61.1 78.9 65.5 58.3 81.8 31.3 73.1 96.1 46.8 90.3 68.5 42.1 241.5 40.2 154.5 36.2 28.6 45.0 105.4 141.6 46.1 8.0 34.3 45.6 87.8 73.0 48.1 46.4 252.3 28.6 33.4 60.4 87.4 79.7 40.7 32.3 50.6 70.4 84.8 85.5 141.1 90.7 126.3 62.1 98.6 38.7 88.1 47.3 52.3 103.4 72.5 50.3 51.7 166.0 58.9 107.3 204.9 79.4 92.7 58.8 64.7 65.9 76.9 58.0 62.7 67.8 63.5 56.7 67.7 66.9 62.5 76.3 45.6 41.7 66.5 25.1 103.4 86.5 127.8 262.4 59.2 10.0 136.0 103.6 25.0 51.5 143.9 108.5 0.0 153.0 154.2 109.3 90.1 154.5 70.3 52.0 49.9 55.8 28.8 63.3 15.6 126.8 259.4 81.5 61.2 73.9 149.0 31.3 65.3 30.6 211.6 15.2 13.6 162.5 168.9 178.5 178.4 25.2 85.1 143.5 99.6 21.5 198.3 31.7 111.2 16.6 71.5 155.4 146.5 47.4 108.5 239.2 115.5 140.4 96.0 9.1 85.5 69.5 64.0 159.0 93.4 72.9 102.9 131.2 74.9 63.2 131.4 194.0 CD247 "CD3H, CD3Q, CD3Z" ENSG00000198821 "CD247 molecule" P20963 1 167430640-167518610 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 49.4;lymphoid tissue: 181.1" "Group enriched" "Detected in many" 9 "dendritic cells: 492.1;NK-cells: 727.1;T-cells: 247.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 25 "gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5" "Group enriched" "Detected in all" 32 "NK-cells: 225.3;T-cells: 376.4" "Group enriched" "Detected in some" 25 "HDLM-2: 155.9;JURKAT: 113.1;MOLT-4: 167.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004651, HPA008750" Enhanced NA NA "CAB004651: AB_425347, HPA008750: AB_1857863" "prognostic favorable (9.12e-4)" "unprognostic (3.21e-3)" "unprognostic (7.09e-3)" "prognostic favorable (8.63e-6)" "unprognostic (1.99e-2)" "prognostic favorable (3.98e-4)" "unprognostic (1.79e-2)" "unprognostic (1.11e-2)" "unprognostic (5.46e-3)" "unprognostic (9.73e-3)" "unprognostic (1.33e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (1.60e-1)" "unprognostic (5.33e-2)" "unprognostic (4.02e-2)" "unprognostic (5.94e-3)" 2.5 1.7 2.1 25.5 2.2 49.4 1.9 2.1 2.5 1.9 2.1 4.3 7.2 2.3 3.1 2.1 1.8 5.6 1.2 2.1 2.3 2.0 5.4 11.0 58.2 2.1 2.1 2.0 0.8 0.8 0.5 0.8 1.4 2.1 1.8 4.6 0.2 2.4 1.6 1.4 1.1 14.4 1.5 2.0 40.6 7.1 0.4 2.4 181.1 2.5 0.9 36.7 7.4 1.9 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 155.9 0.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 113.1 0.0 0.1 0.0 0.0 167.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.8 0.0 0.0 0.0 8.3 1.0 0.4 376.4 1.4 208.9 9.3 190.0 219.7 1.5 4.9 237.8 195.1 8.7 225.3 1.2 2.8 254.5 231.2 2.1 2.2 2.1 2.5 2.1 2.3 2.1 2.1 2.0 2.1 2.0 2.4 2.4 3.4 3.2 16.0 3.3 8.2 1.5 0.1 0.0 0.6 0.4 3.5 3.2 0.6 1.5 1.3 0.0 0.0 0.1 492.1 0.4 0.0 0.5 0.2 0.7 0.8 1.8 0.0 14.7 8.8 0.0 0.1 2.2 6.1 1.1 6.3 0.4 7.1 1.4 0.3 3.3 9.4 0.5 0.0 7.8 1.4 0.2 0.0 5.9 3.6 14.0 7.6 0.1 727.1 0.5 3.7 0.0 1.2 0.0 51.9 0.1 0.2 1.3 2.2 0.2 0.0 0.9 1.2 0.1 2.5 1.4 0.6 0.1 247.2 0.0 0.1 0.1 GRM3 "GPRC1C, mGlu3, MGLUR3" ENSG00000198822 "Glutamate metabotropic receptor 3" Q14832 7 86643914-86864884 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 79.7" "Group enriched" "Detected in some" 20 "Astrocytes: 410.7;Excitatory neurons: 272.0;Oligodendrocytes: 1028.4" "Cancer enriched" "Detected in single" 7 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.05e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-1)" "unprognostic (2.70e-3)" "unprognostic (3.16e-1)" "unprognostic (1.07e-3)" "unprognostic (6.99e-3)" "unprognostic (2.98e-1)" "unprognostic (2.71e-1)" "unprognostic (9.13e-3)" "unprognostic (1.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.91e-3)" "unprognostic (4.00e-2)" "unprognostic (9.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.12e-2)" 0.1 0.8 28.8 0.0 47.5 0.0 0.1 33.8 42.8 0.1 6.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 35.2 34.6 0.1 0.0 0.1 0.0 44.2 36.4 28.1 0.0 0.0 0.0 0.4 0.0 40.0 0.4 0.0 1.9 0.1 0.1 0.8 0.0 0.0 0.0 27.3 0.5 0.1 0.7 36.8 0.1 0.1 0.0 0.0 0.1 0.0 79.7 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 47.5 33.8 42.8 35.2 34.6 44.2 36.4 28.1 40.0 27.3 36.8 79.7 1.2 0.0 0.0 410.7 0.1 0.1 0.6 0.5 0.0 6.7 0.2 0.3 1.2 0.0 0.2 0.0 4.2 0.0 0.2 0.1 0.0 0.0 21.8 0.1 0.1 0.7 0.0 0.0 272.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 13.5 16.5 0.0 2.0 0.0 0.0 2.7 0.3 0.0 1.8 28.1 0.0 0.2 0.0 20.1 1028.4 0.1 0.1 0.4 0.0 0.5 0.0 0.0 0.1 2.2 0.0 1.0 0.3 1.3 0.2 0.0 0.0 0.0 0.2 0.3 0.1 0.4 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314482-114337626 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 10.0 7.2 3.2 9.9 3.3 14.4 9.6 6.5 5.3 8.2 3.3 8.8 10.1 8.5 8.1 6.4 9.9 7.6 6.3 3.1 3.2 8.9 15.4 9.0 15.8 3.1 2.9 2.9 12.2 15.5 9.3 3.7 9.9 3.9 10.0 10.0 9.2 8.4 9.4 7.9 9.3 8.1 10.2 2.0 9.7 7.8 7.0 2.7 16.6 10.8 9.7 17.4 7.6 4.5 3.2 36.9 15.8 56.6 24.2 20.1 30.9 24.3 38.2 32.0 35.6 39.4 23.5 22.0 75.2 15.1 30.0 22.3 23.0 41.8 30.6 52.7 29.8 50.0 49.7 21.8 20.7 22.5 73.3 28.3 30.4 18.8 27.8 27.3 12.6 17.4 25.8 32.1 20.3 46.1 14.6 48.6 21.4 43.1 45.2 20.2 48.1 26.9 26.0 27.0 22.2 27.5 32.8 22.2 49.2 36.7 39.1 28.2 61.3 19.3 19.5 30.8 20.7 23.6 25.7 27.9 80.4 38.6 42.7 38.1 7.5 3.3 4.4 3.7 4.0 4.6 5.4 3.3 3.7 3.9 5.8 2.6 3.0 0.8 3.5 6.6 12.5 2.4 2.1 3.2 3.3 6.5 5.3 3.1 3.2 3.1 2.9 2.9 3.9 2.0 2.7 3.2 11.2 9.6 9.6 3.6 13.9 3.3 6.6 7.6 10.8 12.5 11.3 10.8 5.7 11.5 4.1 12.9 4.2 14.2 18.1 9.3 13.7 11.7 1.0 8.5 14.8 10.9 10.8 24.4 6.1 11.4 18.1 11.5 10.2 8.3 10.1 13.1 13.9 21.6 21.7 15.2 7.8 12.5 6.1 20.7 7.8 1.6 11.8 13.0 12.4 7.5 18.4 8.8 17.5 4.0 8.0 10.9 7.8 11.3 17.6 13.2 12.5 17.0 7.6 10.9 6.6 11.7 10.5 10.6 20.7 13.1 3.8 7.9 11.4 12.4 11.4 3.5 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726042-119829147 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 132.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 79.5;Inhibitory neurons: 130.5;Late spermatids: 88.6;Oligodendrocytes: 70.5" "Cancer enhanced" "Detected in all" "testis cancer: 27.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 91.4;SK-MEL-30: 149.0;SuSa: 181.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles NA NA Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 9.2 17.0 55.3 10.0 55.6 4.8 7.7 51.6 65.9 15.4 18.4 13.1 4.6 15.5 23.0 9.3 8.4 6.9 5.9 52.7 113.6 10.6 3.2 9.2 10.8 73.7 68.9 47.5 12.4 6.7 7.4 57.6 11.0 82.1 11.0 8.1 33.2 10.9 10.1 11.1 13.8 9.6 13.3 57.8 7.6 8.6 14.9 73.3 7.0 10.6 3.8 13.1 9.3 12.6 132.8 13.5 8.2 91.4 14.3 6.9 10.6 8.5 18.4 9.3 8.4 8.4 12.0 15.2 8.3 7.6 19.7 10.6 14.4 7.9 9.8 11.9 6.0 10.3 6.5 3.9 11.0 13.5 4.4 19.0 9.7 8.6 14.2 13.5 15.7 23.2 6.1 5.7 13.8 20.8 7.0 5.5 15.7 9.2 9.9 12.0 7.0 18.8 2.3 12.5 5.3 6.5 70.2 19.8 7.2 149.0 181.5 4.3 3.4 19.6 9.9 12.2 11.0 17.5 15.2 7.7 4.5 11.0 12.8 32.3 0.9 3.4 1.3 1.0 3.0 1.3 6.7 2.2 1.3 6.2 9.1 2.2 1.1 0.8 3.4 3.6 1.4 5.3 1.9 55.3 55.6 51.6 65.9 52.7 113.6 73.7 68.9 47.5 82.1 57.8 73.3 132.8 7.8 6.4 4.8 52.5 21.5 9.1 11.7 7.5 10.2 24.2 6.9 9.5 5.4 1.5 7.8 12.9 16.7 9.3 7.9 15.1 11.7 3.6 58.7 4.3 18.3 8.6 1.2 5.2 79.5 4.5 10.6 7.9 5.1 6.9 2.5 9.7 4.2 3.5 9.9 42.1 130.5 5.6 10.2 6.0 27.8 88.6 5.3 13.1 19.6 34.7 16.3 21.7 6.2 52.8 70.5 6.8 6.6 3.8 4.7 8.2 6.5 24.7 4.0 21.6 6.6 7.8 13.8 22.4 41.0 13.1 10.4 13.3 7.7 19.3 6.5 13.1 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639941 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.4;lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.7 0.9 2.4 8.0 2.4 24.4 1.7 2.2 2.2 1.5 1.4 7.6 6.2 1.5 1.1 5.4 0.8 1.7 0.7 1.8 2.1 0.6 1.3 1.7 13.7 2.6 3.0 1.4 0.6 2.6 1.2 0.7 4.3 3.0 0.6 8.9 0.5 1.2 0.5 0.9 4.4 7.7 4.9 2.8 2.8 3.6 8.7 2.4 26.3 1.3 0.4 14.4 2.8 1.9 3.3 80.8 69.4 73.1 46.2 5.0 13.0 39.6 78.5 50.2 80.0 63.3 52.2 41.5 43.5 23.7 49.9 91.3 56.9 55.3 43.8 110.9 83.5 27.4 132.6 68.9 33.5 2.0 103.8 55.5 4.3 5.5 61.6 50.9 15.2 61.5 94.4 101.0 112.7 95.3 31.7 58.6 39.7 44.6 71.6 44.5 67.8 141.7 38.2 28.4 41.6 64.7 44.5 72.9 46.2 17.6 37.6 63.6 115.8 35.3 102.5 74.1 42.0 87.2 38.3 63.7 123.7 44.4 129.1 91.8 0.1 0.3 0.8 0.5 0.5 0.2 0.3 1.0 0.9 0.4 0.2 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 2.4 2.4 2.2 2.2 1.8 2.1 2.6 3.0 1.4 3.0 2.8 2.4 3.3 0.7 0.0 2.3 0.3 4.6 4.8 1.1 2.4 2.2 0.2 1.3 1.7 0.9 4.3 1.9 1.8 0.0 9.8 2.9 6.2 0.0 0.8 4.7 3.8 2.6 2.0 0.0 38.7 1.0 0.8 23.7 3.5 8.6 2.8 0.0 21.1 1.8 2.1 9.5 0.0 0.6 7.8 0.0 6.5 4.2 5.0 0.6 3.5 0.0 1.0 3.9 0.1 2.1 0.5 1.4 0.5 2.9 0.4 18.6 1.4 1.1 0.4 1.4 1.0 6.6 1.4 3.3 24.7 22.6 10.5 2.3 3.1 5.4 2.0 14.1 2.1 SUCNR1 GPR91 ENSG00000198829 "Succinate receptor 1" Q9BXA5 3 151873643-151884619 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 40.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 19.6;Hofbauer cells: 22.0;Kupffer cells: 32.0;Macrophages: 11.8;Proximal tubular cells: 46.3;Smooth muscle cells: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 53.3;NB-4: 31.0;U-937: 52.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB022745 Uncertain NA NA "CAB022745: " "unprognostic (1.54e-1)" "unprognostic (2.65e-2)" "unprognostic (3.45e-2)" "unprognostic (6.94e-2)" "unprognostic (1.58e-1)" "unprognostic (6.01e-2)" "unprognostic (3.17e-1)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (8.92e-2)" "unprognostic (2.59e-1)" "unprognostic (1.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.14e-2)" "unprognostic (7.49e-2)" "unprognostic (1.58e-1)" 3.5 0.8 0.1 1.3 0.1 8.2 1.0 0.1 0.3 0.2 0.0 0.5 1.2 0.1 0.1 0.2 0.1 0.5 0.7 0.0 0.4 40.3 5.3 2.7 1.9 0.2 0.1 0.0 0.1 0.0 3.4 0.0 0.2 0.2 0.1 0.8 0.0 0.6 0.1 0.0 1.1 1.1 0.7 0.3 7.0 7.9 0.1 0.3 0.9 9.4 0.1 0.6 0.6 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 8.7 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.4 0.2 0.1 0.0 0.2 0.3 0.3 0.5 8.4 0.0 1.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.5 0.1 3.7 0.0 0.1 1.4 0.0 19.6 0.0 0.5 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 4.3 22.0 0.0 0.0 0.2 8.2 32.0 8.1 0.4 0.0 11.8 0.0 8.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 46.3 1.5 0.0 0.0 0.1 11.2 0.0 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.1 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472440-26476642 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli NA NA 640000 Nucleoplasm Nucleoli "CAB018371: , HPA077364: AB_2686835" "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavorable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 217.0 227.4 179.0 256.8 186.5 1147.4 236.8 180.5 253.2 323.7 168.0 272.2 177.9 286.1 362.4 293.4 295.9 144.2 191.2 169.2 205.8 242.0 214.7 261.4 440.1 184.8 180.2 167.3 397.9 254.6 161.8 331.3 216.7 185.8 284.0 304.0 287.5 218.9 164.4 253.8 234.0 272.2 237.8 189.4 326.9 226.6 161.6 179.1 924.5 308.6 134.6 538.3 247.2 252.8 213.1 1074.5 304.8 1192.5 496.5 112.0 251.6 390.8 517.2 331.2 1089.4 835.7 305.8 1073.1 1107.2 443.1 482.3 338.4 627.8 1564.6 565.6 1001.7 684.2 906.7 1222.2 401.5 360.2 197.7 2793.6 738.7 254.9 303.4 602.1 369.1 245.1 541.7 866.8 964.3 643.0 623.0 690.8 1906.1 1363.3 922.7 1463.0 619.6 1384.3 1598.6 776.5 380.3 278.6 1064.5 641.1 1384.3 498.7 651.4 304.9 759.0 1508.9 322.3 536.9 920.4 977.1 943.6 641.2 899.2 1266.9 338.9 2989.0 1056.9 331.8 530.8 1430.5 279.2 622.3 267.3 532.2 379.7 343.3 531.5 505.6 412.4 337.7 462.4 355.5 690.4 704.7 746.7 1084.6 179.0 186.5 180.5 253.2 169.2 205.8 184.8 180.2 167.3 185.8 189.4 179.1 213.1 128.7 342.9 394.4 28.1 459.3 288.6 323.8 383.2 211.1 180.2 353.0 241.3 93.4 221.6 314.8 261.1 141.8 898.7 325.2 227.2 371.7 218.4 204.3 328.9 291.1 190.3 576.9 980.4 14.4 268.7 606.4 435.4 263.5 278.1 383.0 375.0 185.6 147.5 763.0 94.2 22.2 564.5 193.3 434.3 467.9 53.5 185.8 477.5 227.7 15.0 655.6 376.0 399.6 15.1 36.9 93.7 304.4 151.9 669.5 250.4 238.0 320.4 495.6 370.2 124.9 249.0 325.7 306.4 412.0 585.8 213.4 923.4 369.5 351.9 613.2 314.0 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 154.8;T-cells: 233.0" "Cell line enhanced" "Detected in many" "BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 170000 "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 216.8 96.2 103.5 56.2 103.2 2.9 241.9 103.4 172.1 448.6 157.8 431.3 37.5 605.2 14.9 86.8 441.6 28.9 169.8 104.8 137.8 157.8 37.0 158.8 26.1 117.0 116.8 90.5 264.6 155.6 95.5 243.0 32.4 110.0 342.5 16.6 8.2 200.5 141.4 110.8 103.9 195.5 86.1 111.4 98.4 288.0 42.5 119.5 10.3 227.7 18.8 15.4 466.2 293.2 117.1 12.8 25.7 7.4 42.7 68.8 80.5 82.2 152.2 143.8 69.2 50.0 0.8 2.0 1.6 30.9 89.9 31.2 1.2 6.9 9.2 4.7 7.0 25.6 2.7 7.8 13.3 183.7 0.0 13.1 78.5 27.1 33.1 12.6 33.1 9.0 2.2 2.4 14.7 17.9 6.6 0.5 1.4 9.6 11.8 27.3 0.1 0.1 18.1 11.1 0.1 16.2 35.7 47.3 41.6 0.7 2.5 57.5 0.9 30.9 20.8 59.0 77.8 0.1 13.2 6.5 1.0 83.1 0.2 13.8 18.3 10.5 5.1 105.3 19.9 137.9 154.8 174.5 127.0 6.4 129.5 233.0 137.8 8.2 39.1 40.1 2.5 179.0 102.6 103.5 103.2 103.4 172.1 104.8 137.8 117.0 116.8 90.5 110.0 111.4 119.5 117.1 168.6 54.5 126.5 0.0 38.8 0.0 0.0 0.0 0.0 0.0 373.6 436.2 0.0 0.0 32.2 309.0 0.0 11.7 23.2 0.0 309.1 101.2 0.0 22.8 349.5 61.8 0.0 0.0 0.0 586.6 149.5 161.3 0.0 18.1 30.3 30.8 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 42.9 0.0 0.0 0.0 0.0 166.2 0.0 0.0 22.3 0.0 0.0 152.5 20.4 0.0 0.0 0.0 225.6 0.0 0.0 0.0 0.0 23.4 24.8 30.5 0.0 0.0 UBE2J1 "CGI-76, HSPC153, NCUBE1, UBC6" ENSG00000198833 "Ubiquitin conjugating enzyme E2 J1" Q9Y385 6 89326625-89352722 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 498.7;Late spermatids: 1426.6;Plasma cells: 1003.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 294.1;Karpas-707: 247.4;U-266/70: 274.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003509, CAB073419" Enhanced NA NA "CAB073419: , HPA003509: AB_1858531" "unprognostic (1.82e-1)" "unprognostic (3.20e-2)" "unprognostic (1.55e-3)" "prognostic favorable (2.87e-4)" "unprognostic (3.41e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (6.90e-5)" "unprognostic (1.19e-1)" "unprognostic (9.36e-2)" "prognostic favorable (7.43e-4)" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (5.11e-2)" "unprognostic (2.83e-1)" "unprognostic (3.87e-2)" "unprognostic (9.38e-2)" 26.1 23.5 15.3 52.8 16.2 120.4 31.7 17.0 19.0 33.6 15.7 49.3 55.5 28.1 28.8 23.4 21.1 26.8 14.9 15.1 16.5 22.2 27.1 30.2 91.2 17.2 17.7 14.5 23.9 32.3 22.0 13.0 33.6 17.2 42.6 50.1 19.6 45.1 21.4 12.1 14.4 46.2 30.5 17.6 44.1 49.5 24.8 17.0 58.4 32.2 15.7 97.9 37.1 14.6 18.6 38.8 13.4 36.3 46.5 37.0 47.8 0.2 60.4 53.4 36.7 40.0 21.9 23.7 294.1 32.9 63.0 30.6 15.3 23.9 35.1 59.4 41.6 37.0 53.6 16.1 36.0 98.2 68.2 33.4 36.7 34.4 30.8 52.1 48.9 83.1 34.7 43.9 247.4 43.4 23.8 28.5 52.1 12.5 27.3 19.0 110.1 46.5 143.6 46.2 26.9 18.3 36.7 25.6 55.7 56.9 52.2 22.0 149.3 56.1 20.2 19.1 36.3 47.0 274.1 146.1 80.0 40.3 48.3 34.4 24.6 13.5 24.7 6.2 22.0 7.2 37.5 8.2 7.6 12.4 29.6 7.6 7.0 30.7 12.8 37.4 45.5 13.0 13.3 15.3 16.2 17.0 19.0 15.1 16.5 17.2 17.7 14.5 17.2 17.6 17.0 18.6 65.3 16.0 33.9 18.6 185.6 24.9 60.0 39.1 31.3 34.6 39.5 29.5 9.7 30.0 38.5 20.2 29.2 89.7 136.8 71.0 50.9 60.5 498.7 35.6 50.3 104.6 77.3 34.7 26.9 101.4 91.8 60.0 72.9 50.2 25.3 27.1 99.2 45.5 75.8 23.5 28.9 80.3 42.7 107.7 53.0 1426.6 54.7 105.5 72.9 23.4 65.4 18.6 30.9 26.2 31.0 112.0 74.3 47.8 1003.3 99.5 72.4 49.2 33.4 16.0 32.9 54.3 61.1 22.5 20.5 54.4 34.7 129.4 52.3 32.6 65.0 123.7 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149930-228159826 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 55.5" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 12.5;Oligodendrocytes: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;SCLC-21H: 2.9;TIME: 2.7" "Region enhanced" "Detected in all" "white matter: 105.5" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.5 0.9 18.0 0.6 29.8 0.2 1.7 39.2 23.9 4.0 7.7 4.3 0.2 4.7 0.9 1.4 5.5 0.7 1.7 15.1 22.8 0.8 0.5 3.0 0.6 40.1 33.7 12.3 3.9 0.5 0.8 1.4 0.5 35.9 3.0 0.3 0.5 0.8 1.7 0.8 1.7 1.7 1.9 38.3 1.4 2.4 1.2 27.5 0.5 2.0 0.9 0.3 4.2 3.5 55.5 0.2 0.2 0.1 0.3 0.8 0.4 1.0 0.8 0.2 0.3 0.4 0.5 0.7 0.1 5.4 1.5 0.4 0.5 0.2 0.2 0.1 0.2 0.9 0.2 1.4 1.2 1.4 0.0 0.0 0.2 0.1 0.5 0.3 0.7 0.1 1.0 0.6 0.1 0.2 0.3 1.1 0.3 0.3 0.0 1.1 0.2 0.1 0.0 0.4 0.0 2.9 1.7 0.2 0.0 0.2 0.1 0.1 0.2 2.7 0.7 2.1 2.5 0.9 0.1 0.4 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.0 29.8 39.2 23.9 15.1 22.8 40.1 33.7 12.3 35.9 38.3 27.5 55.5 2.8 0.0 0.6 0.7 0.2 3.4 1.3 0.6 1.8 2.6 1.3 0.6 1.8 0.0 0.0 0.0 12.5 0.0 0.4 0.2 0.0 0.1 0.2 1.0 1.1 4.3 0.0 0.0 0.8 0.5 0.0 2.2 0.0 1.6 0.0 0.3 3.6 0.0 0.1 3.3 1.1 0.3 0.0 0.6 3.8 0.0 2.5 1.3 1.8 0.0 0.0 0.3 0.0 0.0 26.9 1.1 0.0 4.1 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.6 1.8 0.0 0.0 0.5 1.7 0.0 0.8 0.6 0.3 1.0 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1 mitochondrial dynamin like GTPase" O60313 3 193593144-193697811 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria NA NA 10000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: AB_2675388" "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favorable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 15.1 12.1 14.3 7.6 17.7 25.8 12.9 15.3 20.3 10.5 10.3 19.1 17.0 11.0 9.2 14.8 8.1 10.3 39.7 18.5 17.6 18.5 21.0 8.6 11.9 16.8 16.4 16.3 8.5 10.1 23.3 3.9 11.8 18.2 12.4 16.8 9.7 11.8 13.4 24.4 12.0 13.9 13.6 11.7 9.4 14.7 6.3 15.8 12.8 14.0 44.9 12.5 13.1 5.1 19.5 58.9 18.8 18.2 20.2 15.8 25.0 19.3 27.5 26.2 30.0 29.0 45.2 19.3 38.6 58.1 27.0 27.3 37.3 32.7 31.7 53.5 46.5 25.7 67.9 16.7 23.1 24.9 55.8 29.8 28.4 27.6 30.0 40.9 18.5 26.2 15.7 28.4 37.0 30.2 46.5 21.9 30.9 25.8 33.9 59.9 27.8 40.1 41.6 22.7 36.1 39.8 24.2 41.8 46.3 29.5 14.1 60.3 43.5 26.3 27.7 20.8 29.3 58.7 33.1 41.3 74.0 30.5 43.7 28.4 9.7 7.3 7.1 5.8 8.2 5.5 6.8 5.5 5.6 7.8 5.1 5.6 6.0 2.7 4.7 17.3 4.0 6.6 5.2 14.3 17.7 15.3 20.3 18.5 17.6 16.8 16.4 16.3 18.2 11.7 15.8 19.5 24.8 16.0 24.0 72.1 27.5 15.9 16.4 17.4 24.5 19.5 20.9 13.5 135.2 22.8 20.1 18.4 31.3 19.0 24.6 31.4 17.6 19.3 7.7 20.3 25.2 23.8 23.4 86.3 106.8 24.0 14.9 24.6 31.1 26.1 19.6 25.6 14.3 39.1 17.9 21.9 106.7 20.6 10.2 25.6 14.7 13.5 15.8 28.1 21.4 58.1 22.9 14.6 11.3 87.4 98.1 28.9 12.1 14.7 29.3 18.7 24.6 34.1 19.6 23.4 6.6 21.3 26.2 15.1 16.6 34.3 22.4 17.9 22.3 28.2 26.7 22.1 DENND4B KIAA0476 ENSG00000198837 "DENN domain containing 4B" O75064 1 153929501-153946718 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040188, HPA071133" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040188: AB_10671168, HPA071133: AB_2732173" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (1.59e-2)" "unprognostic (9.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.58e-1)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.18e-5)" "unprognostic (2.21e-1)" "prognostic unfavorable (9.27e-9)" "unprognostic (4.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.56e-3)" 18.0 13.5 8.9 24.5 8.9 37.4 15.8 1.6 17.8 16.7 0.5 15.0 9.6 16.4 3.4 10.3 16.3 10.1 19.1 9.1 4.5 12.9 11.5 24.5 30.3 11.2 6.8 10.2 19.8 15.6 7.8 13.3 10.4 13.5 13.1 6.0 9.6 11.8 7.1 49.6 11.0 22.2 8.9 2.1 41.4 13.0 7.7 9.0 14.7 15.3 29.7 17.5 15.2 13.0 8.7 12.0 22.7 17.1 17.3 10.0 9.7 17.8 11.5 12.4 17.8 16.6 13.8 13.4 29.9 19.1 7.8 13.5 20.9 15.5 10.6 8.0 27.5 14.0 26.5 26.1 13.3 13.9 28.0 51.5 8.8 18.3 16.6 17.8 14.8 12.8 32.3 28.7 16.4 10.3 24.6 34.2 25.7 23.8 14.1 21.8 36.2 11.5 17.3 8.5 17.6 20.3 24.9 12.1 28.4 16.7 17.0 20.6 68.0 13.5 19.2 18.5 16.1 18.7 49.3 37.7 39.5 13.2 21.7 23.5 1.5 1.6 0.4 1.1 2.4 1.4 1.0 0.9 0.7 1.4 0.9 0.4 1.0 1.5 0.7 1.9 1.9 0.7 1.5 8.9 8.9 1.6 17.8 9.1 4.5 11.2 6.8 10.2 13.5 2.1 9.0 8.7 14.7 9.6 10.3 18.6 20.3 4.7 3.7 4.6 1.2 22.3 7.1 6.9 22.9 8.6 5.7 7.3 6.2 4.6 31.9 4.8 5.9 5.2 1.2 4.0 8.0 11.8 4.9 9.5 21.8 6.5 4.7 7.2 13.7 7.4 17.2 12.5 10.8 9.2 18.0 35.3 23.6 4.6 2.0 30.2 11.7 1.9 7.5 31.1 5.4 18.7 22.5 5.8 30.9 19.1 27.9 6.1 4.8 7.9 7.1 6.8 7.6 2.7 4.4 17.8 6.6 7.9 6.0 6.4 8.1 5.7 3.4 3.4 17.0 9.2 7.1 5.2 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310962-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 42.1;choroid plexus: 30.6;skeletal muscle: 24.4;tongue: 44.6" "Cell type enriched" "Detected in many" 4 "Astrocytes: 788.8" "Cancer enriched" "Detected in single" 4 "glioma: 1.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "basophil: 1.9" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "A549: 4.4;RH-30: 6.5;RPTEC TERT1: 3.1;SuSa: 2.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 23.4" HPA062004 Approved Vesicles NA NA Vesicles "HPA062004: AB_2797267" "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.3 0.7 35.4 0.2 42.1 1.4 2.1 34.3 40.0 4.0 30.6 7.0 0.5 7.2 0.1 1.3 5.4 0.5 0.2 33.9 26.7 2.0 0.0 0.3 0.1 35.7 28.5 31.1 0.9 0.1 6.1 1.4 0.1 32.9 1.4 1.3 2.2 0.5 2.0 24.4 1.0 1.8 4.4 23.1 0.6 2.1 0.5 36.4 0.6 0.3 44.6 0.4 4.0 2.8 29.4 0.2 4.4 0.9 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.1 0.1 0.2 0.4 0.0 1.4 0.1 0.0 0.0 0.0 0.2 0.1 0.9 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.6 0.0 0.2 0.1 0.1 0.7 0.2 0.1 0.3 6.5 0.1 3.1 0.3 0.1 0.3 0.4 0.0 0.1 2.8 0.0 0.2 0.5 0.1 0.1 0.0 0.4 0.2 0.9 0.4 0.3 1.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.4 42.1 34.3 40.0 33.9 26.7 35.7 28.5 31.1 32.9 23.1 36.4 29.4 2.9 0.0 1.1 788.8 0.2 0.4 0.0 0.0 0.0 8.0 0.2 2.5 2.2 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 15.5 7.7 1.4 1.8 0.0 8.4 162.5 0.0 0.7 0.6 0.0 8.0 14.0 0.2 0.0 0.0 1.0 69.0 115.2 0.0 0.0 0.0 1.0 41.9 0.3 0.3 0.0 36.5 0.6 0.3 0.0 22.1 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 5.9 0.8 0.0 51.3 0.4 0.1 1.5 0.0 0.6 0.1 0.4 2.5 0.0 0.0 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206695-112343934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favorable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 6.9 6.8 4.7 5.5 5.9 6.2 9.0 5.1 7.3 5.9 5.0 7.2 6.0 6.7 3.1 7.2 6.1 6.5 8.1 5.2 5.2 9.5 11.7 7.1 6.9 5.2 5.0 4.9 7.1 11.4 7.1 4.6 4.6 5.1 5.7 6.9 4.5 7.1 4.5 6.6 7.9 5.6 6.1 4.8 5.9 7.9 5.5 4.9 8.0 9.5 3.4 6.4 8.2 7.0 8.0 7.6 4.5 7.5 9.3 10.2 28.1 5.6 7.4 7.9 3.5 6.3 6.8 6.8 12.6 13.3 6.1 7.2 5.0 5.7 7.3 9.4 10.2 3.6 6.6 6.1 5.8 6.3 12.1 5.2 17.1 10.8 8.6 5.7 11.1 10.7 13.2 7.9 13.3 6.4 8.8 15.2 20.6 5.1 6.5 5.0 7.4 8.2 11.4 9.5 5.6 5.3 13.8 9.7 12.0 11.9 8.1 3.4 10.2 14.9 5.4 3.1 12.0 4.8 11.5 14.6 14.8 3.9 11.5 6.6 9.3 4.6 6.4 5.7 8.1 8.5 8.7 8.0 8.2 3.7 9.6 9.6 8.1 6.6 7.4 7.2 5.9 9.4 3.7 4.7 5.9 5.1 7.3 5.2 5.2 5.2 5.0 4.9 5.1 4.8 4.9 8.0 13.0 38.5 24.6 77.1 25.7 20.6 18.2 35.7 26.2 10.0 19.0 17.5 12.8 27.1 24.1 5.5 2.1 12.3 19.6 12.4 27.4 25.9 46.4 13.6 15.6 17.9 18.5 11.1 51.9 31.0 18.3 15.7 12.8 16.3 7.6 21.4 16.4 19.2 21.7 32.0 43.4 22.5 34.6 46.9 34.8 8.6 17.1 29.1 12.4 43.1 50.6 6.6 37.0 47.7 70.5 24.6 22.9 25.2 13.2 17.5 27.0 34.5 12.7 12.0 19.7 17.1 23.7 32.8 10.4 19.1 24.3 13.8 25.8 28.1 22.4 21.5 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 125777.4;heart muscle: 135096.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 37883.1;Proximal enterocytes: 23257.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 23280.2;HeLa: 21694.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 26454.8 42379.3 78523.3 3514.6 79416.7 4111.7 25584.5 75752.9 125777.4 8890.8 77016.6 25833.9 11583.3 8480.5 8289.7 12816.2 10585.1 3642.2 135096.6 74780.9 73530.6 83564.3 73583.9 9096.5 3640.8 95036.4 75650.4 67356.5 9518.5 26226.9 14327.9 13491.3 6333.6 86545.5 24200.5 10190.6 6373.8 14909.2 8434.7 70979.5 15605.3 21974.4 5005.0 69953.8 11499.9 36417.9 10900.0 82797.9 3688.8 14747.7 74017.9 3967.2 19001.6 10461.7 79224.4 3324.0 5255.7 3450.6 3399.1 23280.2 4613.0 2871.7 2717.2 1592.1 1441.9 1616.6 7973.2 5004.1 3408.8 4095.7 3519.2 2600.2 6710.1 1504.4 5941.5 2461.9 4945.3 7153.7 3371.4 21694.2 13369.3 3629.0 5018.8 4874.1 8076.0 10704.2 2416.7 2704.4 8547.3 2285.4 3853.4 2711.1 3864.5 2747.1 10748.2 2646.2 6609.3 1779.4 9407.1 4824.1 2262.5 3389.7 3164.0 8729.4 8962.3 1417.0 3058.9 1310.8 2587.7 5763.8 8928.3 6011.6 7960.5 3898.6 2207.0 3378.3 3876.8 2982.9 1492.1 2128.5 7735.7 1794.0 2976.6 1284.1 2263.7 612.4 386.5 336.6 346.8 441.9 672.5 393.0 417.4 321.5 686.4 568.4 769.3 968.2 447.0 335.5 312.1 262.5 353.1 78523.3 79416.7 75752.9 125777.4 74780.9 73530.6 95036.4 75650.4 67356.5 86545.5 69953.8 82797.9 79224.4 4254.0 701.9 879.1 0.0 6320.6 1987.5 2507.9 1722.8 5384.4 0.0 3350.4 5821.1 37883.1 9781.1 1560.8 5041.1 0.0 0.0 5039.9 14324.8 1164.1 1320.8 1023.5 11751.2 6030.4 3302.6 2852.4 14390.0 0.0 2870.2 0.0 3063.4 6039.9 17552.8 1453.7 17373.9 10407.8 20920.6 0.0 0.0 0.0 11328.3 870.8 16584.4 1757.6 5643.0 9133.7 4877.6 1858.7 0.0 4964.0 0.0 2775.5 0.0 0.0 2194.1 9034.9 4865.3 6343.6 1554.6 23257.1 8457.2 2113.9 0.0 7001.2 6561.9 3856.1 5442.6 3706.2 3801.0 1888.8 0.0 4844.1 3423.5 10381.8 2314.6 KTI12 "MGC20419, SBBI81, TOT4" ENSG00000198841 "KTI12 chromatin associated homolog" Q96EK9 1 52032103-52033810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031203, HPA031204, HPA031205" Approved Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles, Cytoplasmic bodies" "HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-3)" "unprognostic (3.36e-3)" "unprognostic (4.18e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.74e-1)" "unprognostic (2.94e-1)" "unprognostic (3.72e-2)" "unprognostic (4.06e-2)" "unprognostic (8.08e-3)" "unprognostic (6.59e-2)" "unprognostic (3.36e-3)" "unprognostic (2.39e-1)" "unprognostic (3.59e-2)" "unprognostic (1.64e-2)" 6.8 10.2 4.2 6.9 4.1 16.8 5.9 4.6 4.5 4.2 4.8 6.1 4.9 7.3 4.7 5.8 7.0 3.8 4.4 4.2 4.8 4.8 6.8 4.3 8.8 4.7 4.2 4.1 9.3 6.8 4.0 6.5 4.3 4.2 4.0 4.0 2.5 4.0 4.7 4.6 5.1 7.7 4.7 4.3 8.5 7.1 7.3 4.9 6.7 4.1 3.6 7.7 5.6 3.9 4.4 14.0 13.4 5.3 12.5 17.8 14.8 16.6 13.9 17.0 20.1 17.1 15.2 6.7 16.0 15.3 14.5 29.8 15.6 18.7 16.4 13.9 16.5 20.9 16.6 14.6 14.9 12.3 23.8 15.7 13.9 12.5 16.0 8.6 8.7 13.8 14.0 25.2 7.7 17.1 11.1 17.5 26.7 10.3 12.2 14.9 16.3 14.6 21.5 19.4 10.0 9.3 13.5 13.4 23.3 25.8 12.0 4.5 37.2 10.4 16.2 10.1 19.4 26.3 28.6 25.8 25.4 17.9 25.2 12.1 17.0 21.6 16.4 22.1 24.5 24.9 29.8 24.7 27.0 29.4 22.7 29.0 20.7 4.5 24.2 19.3 44.6 26.9 18.8 4.2 4.1 4.6 4.5 4.2 4.8 4.7 4.2 4.1 4.2 4.3 4.9 4.4 10.8 3.2 5.1 0.0 14.3 7.1 13.2 14.1 5.7 6.1 5.3 6.1 3.1 8.6 6.3 3.7 0.0 12.1 17.5 1.8 5.9 11.3 2.3 4.4 10.6 8.4 2.4 8.6 0.0 10.9 17.0 8.6 3.1 3.9 6.3 26.3 9.3 5.9 10.0 10.1 0.0 3.9 6.1 6.6 6.4 1.2 11.5 6.0 5.4 0.0 13.6 9.7 10.3 0.0 0.0 10.5 3.4 10.1 9.5 7.8 3.1 11.6 4.7 4.9 19.7 8.1 10.7 20.3 9.3 6.7 7.4 18.3 10.6 28.1 4.7 11.5 STYXL2 DUSP27 ENSG00000198842 "Serine/threonine/tyrosine interacting like 2" Q5VZP5 1 167094075-167129165 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 43 "heart muscle: 64.2;skeletal muscle: 115.7;tongue: 54.5" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 143.6" "Group enriched" "Detected in many" 6 "colorectal cancer: 12.8;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 14.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012912 Approved Nucleoplasm NA NA Nucleoplasm "HPA012912: AB_2668767" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.44e-3)" "unprognostic (1.22e-1)" "unprognostic (2.10e-3)" "unprognostic (4.65e-2)" "unprognostic (1.53e-1)" "unprognostic (8.19e-2)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.72e-1)" "unprognostic (7.65e-2)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.1 0.1 64.2 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.7 0.0 0.9 1.7 0.0 115.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 54.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 SELENOT SELT ENSG00000198843 "Selenoprotein T" P62341 3 150602875-150630445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 215.1;Extravillous trophoblasts: 230.6;Hofbauer cells: 238.8;Pancreatic endocrine cells: 206.0;Proximal tubular cells: 176.8;Syncytiotrophoblasts: 489.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039780 Approved NA NA "HPA039780: AB_10805594" "unprognostic (1.13e-1)" "unprognostic (4.03e-2)" "unprognostic (2.78e-1)" "unprognostic (1.92e-1)" "unprognostic (3.31e-1)" "unprognostic (1.34e-2)" "unprognostic (2.65e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-3)" "unprognostic (6.30e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-3)" "unprognostic (4.91e-2)" "unprognostic (4.08e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" 49.7 74.2 48.1 56.9 50.8 100.9 48.3 53.0 59.4 44.4 47.6 49.6 51.7 39.5 63.2 41.4 49.5 39.3 52.3 48.6 55.4 76.1 73.0 51.5 81.1 51.3 51.9 45.0 36.4 45.8 84.9 46.0 61.1 51.8 50.0 57.1 70.3 45.9 49.2 45.2 28.3 50.8 54.6 52.1 46.8 45.5 40.0 50.7 58.8 67.8 54.5 73.8 64.0 32.3 57.2 232.1 94.9 57.1 51.8 86.7 84.0 111.3 174.3 127.3 120.7 79.6 145.9 129.1 125.6 192.2 128.7 107.5 76.1 89.6 110.3 177.7 124.8 77.3 130.9 48.4 68.1 94.6 77.1 102.5 74.1 86.5 107.6 92.1 86.7 132.2 58.2 31.0 359.9 173.4 137.6 107.5 46.1 65.4 134.2 99.0 79.0 73.8 215.4 102.6 132.7 64.2 39.8 106.4 64.4 74.8 71.2 133.6 96.2 125.7 65.1 41.1 121.1 172.6 261.3 151.4 176.1 88.8 142.1 56.9 218.1 163.8 142.5 133.7 138.4 148.5 119.6 111.3 125.4 126.5 102.3 87.4 110.1 198.8 106.3 155.7 90.7 132.3 324.7 48.1 50.8 53.0 59.4 48.6 55.4 51.3 51.9 45.0 51.8 52.1 50.7 57.2 80.6 60.9 67.9 0.0 53.4 0.0 0.0 0.0 0.0 0.0 97.2 66.5 0.0 0.0 29.1 108.5 0.0 215.1 114.7 0.0 97.8 166.8 0.0 63.9 46.8 35.5 0.0 0.0 0.0 135.0 230.6 30.9 0.0 64.7 45.4 31.5 0.0 0.0 238.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 0.0 0.0 123.5 0.0 0.0 0.0 0.0 206.0 0.0 0.0 21.0 0.0 0.0 176.8 32.8 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 489.3 48.1 63.4 0.0 0.0 ARHGEF15 "ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF" ENSG00000198844 "Rho guanine nucleotide exchange factor 15" O94989 17 8310241-8322514 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 45.4;breast: 41.9" "Group enriched" "Detected in some" 4 "Adipocytes: 66.4;Endothelial cells: 48.9;Hepatic stellate cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 48 "HUVEC TERT2: 40.4;TIME: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044443, HPA063495" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044443: AB_10960424, HPA063495: AB_2685023" "unprognostic (3.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.18e-2)" "unprognostic (7.09e-3)" "unprognostic (3.82e-1)" "unprognostic (7.29e-4)" "unprognostic (1.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.40e-1)" "unprognostic (1.06e-2)" "unprognostic (1.45e-1)" "unprognostic (2.23e-3)" "unprognostic (4.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.89e-1)" "unprognostic (9.56e-3)" 45.4 5.9 4.9 4.1 3.7 0.0 41.9 3.8 4.8 8.6 3.0 6.6 3.1 11.0 1.6 4.8 9.9 7.3 25.0 3.7 3.8 15.8 2.9 22.3 3.2 4.4 4.2 2.6 3.8 4.3 3.4 4.1 14.8 4.3 8.0 2.0 0.2 5.2 3.6 13.4 7.2 6.5 7.2 3.5 8.0 6.9 2.2 4.7 1.6 12.5 11.0 1.8 12.4 8.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 49.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.7 3.8 4.8 3.7 3.8 4.4 4.2 2.6 4.3 3.5 4.7 4.6 66.4 0.0 3.0 0.3 0.5 2.8 0.3 0.0 0.6 0.8 0.5 0.4 8.9 2.8 0.0 1.8 0.0 0.0 0.2 0.1 0.0 0.0 3.3 0.4 0.2 48.9 0.0 0.0 0.2 0.0 0.1 1.0 0.0 1.3 0.0 0.0 37.1 0.0 0.1 0.0 0.5 0.0 0.0 1.4 2.8 4.4 0.0 0.5 7.2 11.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.1 0.0 1.6 1.5 0.4 0.2 0.2 1.0 0.1 0.3 0.7 0.0 0.3 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805412-59119147 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 52.9" "Group enriched" "Detected in many" 5 "Astrocytes: 316.3;Excitatory neurons: 198.3;Inhibitory neurons: 155.0;Oligodendrocyte precursor cells: 455.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 36.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.5;NK-cells: 18.4;T-cells: 36.6" "Cell line enhanced" "Detected in many" "JURKAT: 75.9;MOLT-4: 149.1;SH-SY5Y: 43.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: AB_2686584" "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 0.7 1.0 5.4 5.8 9.9 2.9 1.0 0.3 10.9 1.8 0.3 9.7 9.6 1.3 0.4 3.3 0.8 4.6 0.7 6.1 8.2 2.8 1.1 4.7 18.4 2.3 4.2 5.0 5.7 1.4 2.4 1.8 1.3 3.5 2.0 8.7 6.0 1.6 1.0 0.1 0.5 10.4 2.5 0.0 5.5 7.9 6.3 5.0 52.9 1.1 0.6 19.0 2.0 1.4 5.1 0.9 0.2 15.7 0.0 1.6 3.5 0.0 3.3 7.5 1.8 0.3 0.0 0.0 0.0 0.0 14.4 0.8 1.2 3.9 0.0 0.4 0.5 1.5 0.0 2.8 0.0 12.7 2.8 0.7 1.9 0.5 2.3 2.9 1.0 25.9 75.9 0.0 0.0 1.2 0.0 149.1 0.0 2.7 0.2 0.4 3.1 10.7 0.1 0.4 0.4 14.3 43.8 0.0 0.1 0.0 3.6 0.0 0.0 0.2 3.9 1.8 12.9 4.4 0.0 0.0 9.9 0.5 0.1 2.8 21.5 0.2 3.2 12.1 0.0 5.5 5.4 8.6 18.2 1.4 1.3 3.3 9.7 0.3 18.4 0.0 0.0 36.6 5.6 5.4 9.9 0.3 10.9 6.1 8.2 2.3 4.2 5.0 3.5 0.0 5.0 5.1 0.6 9.6 31.6 316.3 12.3 1.3 0.1 0.1 1.2 18.4 0.2 0.9 1.8 1.5 2.5 1.8 0.0 3.9 23.2 3.7 0.0 0.9 2.0 1.9 2.7 1.8 46.0 4.2 198.3 0.7 0.2 2.7 6.1 0.8 16.5 0.0 0.4 0.7 3.7 0.0 155.0 34.8 2.0 0.6 9.6 2.2 0.9 2.8 0.0 47.8 0.6 14.3 34.0 455.4 5.0 2.6 9.6 0.4 22.4 0.1 4.0 1.3 10.4 2.2 0.0 0.2 0.6 1.0 0.7 0.5 1.3 0.8 35.0 0.0 10.3 0.1 CES1 "CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1" ENSG00000198848 "Carboxylesterase 1" P23141 16 55802851-55833337 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 2537.7" "Group enriched" "Detected in many" 7 "Cholangiocytes: 613.4;Hepatocytes: 2420.8" "Cancer enriched" "Detected in all" 6 "liver cancer: 711.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 16 "classical monocyte: 109.6;myeloid DC: 114.5" "Group enriched" "Detected in many" 22 "dendritic cells: 114.5;monocytes: 109.6" "Group enriched" "Detected in some" 5 "Hep G2: 700.9;THP-1: 688.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012023, HPA046717" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" No NA 40000000 "Endoplasmic reticulum" "HPA012023: AB_1846554, HPA046717: AB_2679770" "unprognostic (1.04e-2)" "unprognostic (9.85e-2)" "unprognostic (2.94e-1)" "unprognostic (1.28e-1)" "unprognostic (1.55e-3)" "unprognostic (7.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (3.51e-1)" "unprognostic (5.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.29e-2)" "unprognostic (1.91e-2)" "unprognostic (5.32e-2)" "unprognostic (1.92e-1)" "unprognostic (2.87e-1)" "prognostic unfavorable (9.92e-4)" 95.7 14.2 0.8 3.3 0.8 27.2 43.9 0.7 1.9 22.8 3.6 62.9 24.2 60.9 7.5 41.4 55.1 275.5 48.1 0.7 3.1 4.8 2537.7 169.3 1.9 2.0 1.0 0.6 20.5 8.9 0.7 3.8 8.6 1.7 39.5 12.4 2.9 41.8 36.7 5.2 13.6 27.6 40.7 0.9 41.4 56.6 7.9 1.0 2.5 9.9 9.5 1.0 58.2 17.9 1.0 0.7 4.4 0.0 0.0 90.8 0.6 3.1 0.3 0.0 0.0 0.0 43.5 0.0 0.0 19.4 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.9 700.9 0.0 1.3 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 40.8 0.1 0.6 0.0 0.0 1.5 6.7 0.0 0.5 0.0 0.1 3.2 0.1 1.1 0.9 0.0 688.0 0.1 0.0 0.4 0.2 0.5 2.2 0.1 1.0 0.0 151.7 0.0 0.0 109.6 0.5 4.5 6.1 1.5 1.1 0.7 5.0 114.5 1.2 0.7 1.1 0.6 0.3 1.6 6.8 0.4 58.0 0.8 0.8 0.7 1.9 0.7 3.1 2.0 1.0 0.6 1.7 0.9 1.0 1.0 2.0 16.0 67.6 0.0 11.3 16.7 5.3 6.8 1.2 0.0 1.2 8.1 0.8 613.4 31.5 16.5 0.0 0.5 12.2 0.1 0.0 15.4 79.6 1.0 10.6 8.9 37.5 177.7 0.0 18.7 2.2 57.4 1.1 0.2 6.3 0.0 66.0 2420.8 18.1 0.0 0.0 12.2 4.1 107.3 26.7 197.8 18.6 58.7 39.2 1.0 39.6 10.4 7.2 0.0 0.0 0.9 1.3 98.9 1.8 1.5 0.6 0.9 169.0 0.9 0.0 9.8 9.8 1.0 2.3 20.6 11.6 0.8 16.9 0.9 0.7 2.6 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304730-118316175 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 646.3" "Group enriched" "Detected in many" 7 "dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 26 "gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3" "Group enriched" "Detected in all" 21 "NK-cells: 202.2;T-cells: 501.3" "Group enriched" "Detected in some" 67 "JURKAT: 544.9;MOLT-4: 764.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "Golgi apparatus" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 5.9 5.6 0.8 86.6 1.1 37.0 6.8 0.9 1.4 7.2 2.2 15.5 22.2 5.9 4.6 9.6 5.5 20.3 3.8 0.7 1.0 3.4 9.8 23.2 211.3 1.7 1.3 0.6 3.8 2.2 0.7 1.0 1.6 1.3 6.7 19.5 0.0 11.7 3.0 1.9 5.5 36.7 5.2 1.4 79.6 24.6 1.7 2.1 646.3 5.3 1.6 148.2 25.0 4.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 544.9 0.9 2.0 0.0 0.0 764.9 0.6 0.3 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 1.6 8.0 9.8 0.0 0.6 0.0 16.4 1.8 2.4 490.6 1.3 420.8 1.6 414.4 463.5 1.5 2.1 491.7 501.3 12.2 202.2 2.0 8.6 426.3 333.0 0.8 1.1 0.9 1.4 0.7 1.0 1.7 1.3 0.6 1.3 1.4 2.1 2.0 4.9 0.0 8.6 0.0 12.9 5.2 0.3 0.0 0.0 0.0 3.8 4.8 0.3 0.0 0.6 1.8 0.0 0.2 213.6 0.4 0.0 0.2 7.0 0.5 0.9 2.5 0.0 6.9 0.1 0.0 0.0 5.3 24.5 0.9 7.6 0.0 8.9 2.4 0.3 0.0 0.1 0.0 0.0 7.6 8.3 0.2 0.0 12.6 12.4 1.0 8.4 0.0 154.5 0.0 0.1 0.0 1.1 0.0 41.4 0.1 0.2 2.1 0.0 0.0 0.0 1.3 2.7 0.0 0.0 1.6 5.4 0.3 601.4 0.0 0.6 0.3 RUSC2 KIAA0375 ENSG00000198853 "RUN and SH3 domain containing 2" Q8N2Y8 9 35490111-35561898 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 33.6;Excitatory neurons: 61.5;Inhibitory neurons: 63.5;Microglial cells: 43.1;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "basophil: 3.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "TIME: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021297 Uncertain NA NA "HPA021297: AB_1856510" "unprognostic (4.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-3)" "unprognostic (3.46e-1)" "unprognostic (2.36e-1)" "unprognostic (1.24e-2)" "unprognostic (6.13e-2)" "unprognostic (3.88e-1)" "unprognostic (1.66e-2)" "unprognostic (1.45e-2)" "unprognostic (6.62e-3)" "unprognostic (2.46e-2)" "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (2.94e-2)" "unprognostic (9.38e-3)" 19.5 18.1 19.9 5.9 29.0 5.9 16.9 15.2 39.0 21.6 2.8 25.1 5.1 22.3 5.6 12.6 18.9 9.4 25.2 28.2 18.6 17.6 12.0 16.9 2.8 19.0 16.5 29.8 19.1 13.1 7.0 21.8 8.1 24.2 18.7 3.9 12.3 12.3 15.5 45.5 11.2 9.4 15.2 7.4 12.2 14.9 22.5 21.6 1.5 18.2 36.4 2.0 32.6 16.2 28.6 12.2 18.4 6.6 6.4 17.6 15.9 7.3 35.5 21.7 16.3 14.4 5.4 4.8 0.0 11.8 29.5 44.3 2.4 6.0 11.1 7.2 0.0 5.2 2.2 30.7 4.2 25.5 0.0 31.3 13.9 5.9 28.4 28.2 26.4 17.5 4.9 5.2 0.1 27.5 3.6 1.1 0.8 5.0 0.1 8.4 7.4 4.6 0.1 10.4 1.3 1.6 11.1 8.3 16.6 6.7 9.2 10.4 4.3 49.3 25.1 17.0 22.3 18.4 0.3 0.6 0.0 24.8 6.9 17.1 3.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 19.9 29.0 15.2 39.0 28.2 18.6 19.0 16.5 29.8 24.2 7.4 21.6 28.6 7.7 6.4 4.8 33.6 0.0 2.7 3.6 1.6 4.6 15.2 2.2 3.2 6.1 8.6 2.4 7.3 14.6 0.8 0.2 0.1 1.9 7.8 8.7 1.4 4.4 10.4 0.0 1.3 61.5 6.7 6.1 7.8 1.1 3.2 5.7 3.0 5.3 2.1 2.4 13.5 63.5 0.2 0.0 2.2 3.2 3.5 8.7 2.6 5.4 43.1 0.4 6.9 0.0 52.3 38.7 8.4 0.0 7.5 0.3 4.3 0.4 3.1 3.0 7.5 0.0 5.0 10.0 9.5 2.6 0.8 1.7 0.7 0.4 1.3 0.7 1.4 C1orf68 "LEP7, XP32" ENSG00000198854 "Chromosome 1 open reading frame 68" Q5T750 1 152719522-152720470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "skin 1: 683.7" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 78.3" "Group enriched" "Detected in some" 13 "head and neck cancer: 2.4;melanoma: 6.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HaCaT: 1.8" "Not detected" "Not detected" HPA057942 Approved "Plasma membrane,Cytosol" NA NA 220000 "Plasma membrane" Cytosol "HPA057942: " "unprognostic (1.73e-1)" "unprognostic (7.46e-2)" "unprognostic (9.34e-2)" 0.2 0.0 0.0 0.0 0.0 0.2 43.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 683.7 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.8 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 78.3 0.0 0.1 0.0 0.0 0.0 FICD "HIP13, HYPE" ENSG00000198855 "FIC domain protein adenylyltransferase" Q9BVA6 12 108515277-108525837 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" "Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 62.8;Late spermatids: 52.0;Syncytiotrophoblasts: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021390, HPA071134" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA021390: AB_1851340, HPA071134: AB_2686347" "unprognostic (1.00e-1)" "unprognostic (8.76e-2)" "unprognostic (1.76e-2)" "prognostic favorable (4.61e-5)" "unprognostic (6.92e-2)" "unprognostic (2.68e-2)" "unprognostic (5.73e-2)" "unprognostic (2.84e-2)" "unprognostic (8.68e-2)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (7.66e-2)" "unprognostic (1.56e-2)" "unprognostic (6.22e-2)" "unprognostic (3.12e-2)" "unprognostic (3.65e-2)" 3.5 7.5 5.3 5.3 6.5 3.0 3.6 6.3 5.8 6.3 4.5 3.2 3.3 3.3 12.3 1.9 3.2 3.0 2.6 5.5 6.6 3.1 8.3 3.9 4.1 6.8 6.8 5.1 2.6 12.8 4.7 11.7 3.7 6.3 4.8 2.9 2.4 9.0 6.0 2.0 2.9 2.7 3.9 6.6 3.5 4.4 7.6 6.5 2.5 11.0 2.0 5.4 3.3 1.6 7.8 2.5 6.3 2.5 5.0 5.9 4.1 6.8 16.5 8.7 7.6 5.3 3.9 2.4 3.5 6.0 8.0 9.0 3.2 2.7 1.8 6.7 6.1 4.0 2.0 4.6 5.6 23.0 3.0 7.2 1.9 3.8 10.7 15.2 9.4 5.5 3.3 1.4 11.6 6.9 5.9 4.0 3.1 2.7 2.7 10.2 2.3 3.4 8.7 3.6 4.9 2.4 1.6 7.4 3.4 8.3 3.7 5.4 2.9 6.2 7.8 2.8 13.8 6.4 22.9 4.0 1.2 10.7 2.6 5.5 11.5 2.7 4.5 6.3 4.8 7.7 4.7 4.6 5.9 2.7 2.9 2.7 5.2 5.4 3.3 5.8 15.3 3.1 1.9 5.3 6.5 6.3 5.8 5.5 6.6 6.8 6.8 5.1 6.3 6.6 6.5 7.8 3.8 0.0 3.7 6.5 6.5 0.8 4.5 4.4 1.2 5.5 5.9 3.4 2.9 4.3 3.3 7.3 2.1 6.2 4.3 2.3 5.9 5.8 62.8 2.7 6.9 4.2 1.8 2.7 2.3 9.5 5.5 6.5 5.6 7.3 13.4 3.2 4.6 5.1 6.1 13.5 2.9 4.0 0.0 2.9 3.5 52.0 3.4 4.6 7.2 1.9 2.8 11.8 5.2 3.5 4.5 7.6 1.4 9.8 15.0 8.9 1.9 2.4 4.4 7.8 13.1 4.2 4.7 9.6 9.3 1.7 3.3 31.1 4.7 5.0 2.5 4.8 OSTC DC2 ENSG00000198856 "Oligosaccharyltransferase complex non-catalytic subunit" Q9NRP0 4 108650585-108667820 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 628.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.05e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (6.46e-2)" "unprognostic (4.55e-2)" "unprognostic (3.13e-3)" "unprognostic (9.16e-3)" "prognostic unfavorable (2.31e-8)" "unprognostic (2.06e-1)" "unprognostic (1.68e-1)" "unprognostic (4.06e-2)" "unprognostic (1.55e-2)" 64.2 74.7 23.7 84.9 24.8 99.8 100.8 25.1 30.0 119.6 35.5 85.9 97.1 87.9 181.5 78.1 73.3 83.1 49.3 23.3 27.7 75.3 195.5 65.1 88.5 27.1 25.5 22.9 70.4 134.0 51.5 83.4 106.3 25.6 65.2 99.3 22.8 84.2 60.1 24.5 46.2 89.8 83.4 26.2 70.6 87.9 39.6 26.7 92.4 107.1 30.9 81.6 93.4 60.9 27.2 123.2 75.5 200.2 138.2 419.3 556.1 158.0 328.3 316.8 166.9 203.0 161.6 274.7 258.5 236.0 388.7 101.2 81.6 159.8 133.5 192.8 108.8 117.4 133.0 99.7 357.0 336.8 304.0 124.1 362.8 253.7 137.4 280.2 349.9 379.6 160.1 255.0 295.1 329.5 152.2 213.1 264.7 137.2 332.2 95.7 216.2 217.5 284.6 292.1 85.9 99.9 123.4 111.8 265.0 262.9 245.2 122.4 246.5 298.5 175.4 185.3 132.2 135.9 168.0 183.1 254.0 225.1 183.9 195.7 146.4 136.2 76.4 130.4 145.5 202.4 120.2 138.0 143.0 204.0 91.5 128.3 139.2 18.6 152.7 125.9 375.9 105.5 227.2 23.7 24.8 25.1 30.0 23.3 27.7 27.1 25.5 22.9 25.6 26.2 26.7 27.2 123.1 38.5 48.5 11.8 128.4 97.3 114.1 413.8 86.6 15.1 178.3 197.1 34.2 124.4 235.4 84.6 16.7 276.9 199.9 54.6 88.0 221.7 9.4 105.4 337.0 120.0 58.0 105.5 9.4 159.5 628.6 200.2 120.8 180.5 122.4 169.5 111.4 187.1 256.1 11.8 13.3 274.2 209.5 139.9 196.7 10.1 164.1 138.5 161.9 6.5 140.0 50.2 140.1 12.1 17.5 160.3 90.4 109.1 424.4 183.7 166.5 173.9 126.9 17.3 72.3 108.8 175.3 74.5 72.4 134.9 117.9 365.4 117.2 197.4 178.5 145.2 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 586.7" "Lineage enriched" "Detected in all" 12 "granulocytes: 586.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043025: AB_2678275, HPA048638: AB_2680472" "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favorable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 35.3 26.5 31.4 50.5 28.9 98.9 37.3 29.7 38.8 38.5 28.1 37.1 24.1 34.4 13.5 82.4 37.2 28.7 31.3 28.8 24.2 47.8 48.2 56.2 54.8 28.9 25.7 25.0 23.9 51.2 19.4 33.4 25.3 27.4 42.6 17.7 22.1 48.5 15.9 56.2 57.5 45.9 18.9 22.6 94.7 39.4 9.1 28.2 39.9 32.6 24.0 36.8 43.6 49.9 33.9 44.2 25.4 26.1 36.5 16.6 28.9 43.7 29.3 23.2 28.8 25.4 27.6 36.7 31.5 23.9 33.4 6.1 39.6 15.4 34.7 12.9 49.2 33.0 43.7 19.7 48.3 49.3 24.6 73.0 38.7 65.9 18.7 39.1 26.3 33.4 35.7 82.2 62.8 27.1 79.0 34.7 46.5 34.5 53.3 41.2 33.9 12.5 60.8 48.2 45.7 46.6 45.4 25.8 56.2 48.9 20.0 49.1 57.8 34.3 52.3 29.1 62.0 30.0 69.1 39.1 47.6 33.5 34.9 45.9 117.4 13.1 111.0 14.9 10.1 23.1 38.5 30.3 20.5 14.3 21.5 28.1 20.1 586.7 8.6 14.0 6.0 49.3 26.5 31.4 28.9 29.7 38.8 28.8 24.2 28.9 25.7 25.0 27.4 22.6 28.2 33.9 23.2 19.2 21.5 0.7 59.6 35.1 49.0 24.9 25.0 17.5 30.7 20.6 6.8 20.0 26.3 18.4 8.4 38.1 29.0 34.7 7.9 57.7 1.3 20.1 20.1 22.8 32.8 106.5 4.0 55.4 46.7 20.0 30.5 33.5 23.5 10.3 12.1 13.3 26.2 28.6 3.0 31.3 34.6 27.5 37.0 2.6 11.1 59.0 24.9 1.9 51.4 8.0 29.9 1.5 3.1 68.4 31.9 11.7 37.3 48.9 13.1 16.0 19.9 12.4 26.3 13.6 20.6 0.8 4.0 34.3 31.7 69.0 48.1 15.2 22.6 70.9 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 16.5 18.0 24.3 14.9 25.7 20.0 18.0 25.2 27.7 17.2 18.5 17.1 11.7 17.6 28.3 15.2 14.8 12.4 20.1 24.3 22.1 13.0 15.4 16.7 19.2 25.0 23.4 22.8 11.7 17.4 16.1 11.9 17.6 26.2 17.4 13.7 21.9 15.4 15.4 36.5 14.2 11.6 17.9 21.6 14.8 15.5 14.7 24.0 28.3 21.2 23.0 18.9 16.6 12.4 32.6 83.3 28.2 39.2 41.6 30.1 31.7 96.6 40.1 77.9 64.1 61.7 30.0 35.8 54.3 40.2 50.4 41.0 38.8 44.2 38.7 69.6 78.1 23.4 28.2 19.7 34.7 60.1 103.4 32.3 21.1 67.2 29.7 60.9 25.4 38.1 95.5 55.9 144.0 59.7 43.4 97.8 46.5 72.6 107.6 30.7 60.3 65.0 113.0 37.6 26.6 35.2 52.3 54.0 39.0 102.7 41.2 51.1 57.8 20.0 39.5 83.9 26.5 61.9 190.4 141.7 87.1 36.7 52.5 86.1 33.5 16.7 24.7 33.7 27.5 30.2 24.8 32.3 35.3 35.9 18.1 24.4 33.7 3.1 54.3 25.4 31.8 39.8 35.0 24.3 25.7 25.2 27.7 24.3 22.1 25.0 23.4 22.8 26.2 21.6 24.0 32.6 15.5 48.1 8.1 22.2 26.1 11.1 12.4 17.3 16.5 8.7 18.4 13.7 32.0 10.0 17.1 12.9 4.2 42.5 31.4 3.4 54.8 33.0 1.6 6.7 13.1 15.9 6.7 22.7 30.9 41.8 48.9 20.0 14.3 11.7 32.3 18.0 18.2 34.0 31.7 3.3 32.7 8.4 10.2 13.1 29.1 2.5 21.8 16.6 33.8 13.1 21.6 19.8 64.9 42.7 91.7 35.9 4.5 19.5 45.7 13.3 5.4 71.4 6.9 12.5 13.1 11.3 24.9 46.0 44.6 23.1 13.2 22.6 34.8 19.1 9.8 10.5 LTN1 "C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294" ENSG00000198862 "Listerin E3 ubiquitin protein ligase 1" O94822 21 28928144-28992956 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 213.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029143, CAB034164, HPA055604" Uncertain Enhanced Cytosol NA NA Cytosol "CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859" "unprognostic (3.67e-2)" "unprognostic (7.07e-2)" "unprognostic (7.78e-2)" "unprognostic (3.99e-1)" "unprognostic (1.42e-2)" "unprognostic (3.66e-3)" "unprognostic (5.38e-2)" "unprognostic (5.40e-2)" "unprognostic (9.98e-2)" "unprognostic (4.45e-2)" "unprognostic (2.85e-2)" "unprognostic (1.13e-1)" "unprognostic (9.87e-2)" "unprognostic (1.72e-1)" "unprognostic (8.22e-2)" "unprognostic (4.57e-2)" "unprognostic (1.52e-1)" 7.8 8.5 4.9 9.4 7.8 16.7 12.5 7.3 7.1 9.4 5.8 9.3 8.9 10.8 10.3 9.2 7.1 7.5 7.8 4.6 6.6 8.3 11.1 7.5 12.1 6.3 6.5 3.9 10.2 9.5 10.0 3.9 18.8 7.0 12.8 10.7 11.7 10.2 8.2 9.6 9.5 9.1 9.2 6.8 10.4 11.1 13.7 6.6 11.4 12.2 11.3 10.6 8.3 5.9 13.5 20.4 8.6 17.5 7.9 14.6 19.9 17.7 16.8 13.6 14.2 19.4 12.1 16.5 13.3 8.0 15.1 12.2 10.2 18.8 13.8 25.5 15.7 13.0 39.8 11.9 9.7 11.0 13.3 14.8 13.9 12.1 20.1 16.6 13.9 15.2 9.5 33.0 31.0 16.4 6.3 8.6 12.9 25.1 16.8 10.1 11.4 34.9 28.0 16.0 17.3 9.5 19.7 19.3 14.5 17.0 16.3 14.8 18.6 20.2 12.4 22.9 16.8 14.3 25.1 25.1 18.5 19.3 28.3 15.0 12.6 4.9 7.9 6.3 7.6 5.2 5.8 4.2 4.2 4.9 5.1 4.5 3.4 8.6 7.0 10.7 3.1 5.0 2.6 4.9 7.8 7.3 7.1 4.6 6.6 6.3 6.5 3.9 7.0 6.8 6.6 13.5 42.1 16.0 22.6 36.6 30.7 30.2 26.3 22.8 30.7 28.4 22.8 17.4 25.8 12.8 24.0 11.0 33.3 19.3 26.8 18.4 1.9 14.4 213.7 21.6 45.9 27.5 22.7 18.7 47.1 14.0 18.8 30.3 38.2 36.2 27.8 24.2 14.3 19.7 13.2 42.1 54.8 18.9 22.4 18.1 13.2 73.1 26.8 23.5 12.4 25.3 28.2 44.9 18.6 53.8 90.8 20.2 14.2 21.1 43.9 31.5 16.6 16.9 22.6 30.5 13.1 29.3 28.6 46.8 23.9 30.1 32.0 29.8 30.5 34.3 20.8 29.8 RUNDC1 DKFZp761H0421 ENSG00000198863 "RUN domain containing 1" Q96C34 17 42980565-42993690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023726 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023726: AB_2184078" "unprognostic (4.24e-2)" "unprognostic (1.26e-1)" "unprognostic (9.39e-2)" "prognostic favorable (6.93e-5)" "unprognostic (9.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.40e-2)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.53e-3)" "unprognostic (2.87e-3)" "unprognostic (1.25e-1)" "unprognostic (1.12e-2)" "unprognostic (4.77e-3)" 5.4 8.0 8.0 6.7 10.2 6.9 10.1 6.4 10.8 8.6 8.8 9.5 6.5 8.8 12.2 6.7 14.6 6.2 6.8 9.0 8.0 8.5 5.0 6.9 7.3 6.5 6.5 9.1 5.1 8.0 12.1 9.5 4.9 7.3 12.2 7.7 8.6 7.5 8.6 11.7 7.0 7.8 8.7 6.0 8.1 10.2 6.9 7.2 6.8 10.3 9.1 7.7 8.5 6.3 8.3 12.9 22.1 8.8 11.9 14.7 8.8 9.3 12.2 12.6 17.1 12.7 14.0 7.2 8.6 10.7 12.1 11.6 15.8 11.3 12.3 18.9 9.7 17.7 5.8 12.8 13.5 9.4 12.6 11.9 6.6 14.7 15.1 10.0 13.6 9.2 9.3 11.2 5.3 9.9 9.3 15.6 8.9 9.9 18.3 13.8 11.2 12.3 8.6 14.3 17.0 12.8 11.8 9.6 9.0 10.2 12.9 17.5 13.9 7.6 15.4 9.6 9.2 14.7 12.6 13.1 7.5 11.0 6.6 9.8 4.7 2.3 7.9 1.3 3.8 1.7 3.7 1.6 1.1 1.8 3.7 1.6 1.7 5.4 1.1 2.8 5.6 2.0 1.0 8.0 10.2 6.4 10.8 9.0 8.0 6.5 6.5 9.1 7.3 6.0 7.2 8.3 5.3 44.8 38.4 6.5 18.7 15.0 11.0 5.8 9.1 18.9 19.2 9.8 13.7 22.8 17.2 5.5 22.9 9.8 19.1 28.7 21.5 11.8 8.1 26.4 9.6 10.3 19.2 5.7 13.8 9.8 7.3 8.6 20.4 19.5 11.4 8.4 10.4 6.1 8.4 38.7 11.0 16.9 6.1 10.5 14.7 4.5 9.9 9.5 3.6 7.5 14.3 14.3 12.3 5.0 6.2 10.1 16.4 14.3 11.7 16.6 15.1 12.8 24.7 33.2 19.7 8.5 9.6 22.9 14.9 7.2 14.6 5.5 13.9 10.4 17.8 17.0 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756818-42802439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 179.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 60.9;Alveolar cells type 2: 43.4;Spermatocytes: 103.0;Spermatogonia: 37.8" "Cancer enhanced" "Detected in many" "liver cancer: 3.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 13.6;JURKAT: 13.3;U-2 OS: 23.5;U-266/84: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 7.0 5.7 2.7 2.2 5.1 1.5 6.6 4.6 3.3 6.0 2.9 4.2 3.9 3.0 0.6 2.3 4.2 4.9 6.6 2.2 4.1 8.4 179.5 6.1 7.4 6.1 4.9 1.6 8.4 4.1 0.0 7.8 2.3 6.1 4.7 0.3 2.2 2.7 0.3 1.8 2.9 13.4 0.4 5.0 15.0 4.5 5.0 4.5 4.0 3.3 0.6 2.6 2.7 5.0 7.3 0.4 0.1 1.0 0.1 3.2 4.1 0.0 5.7 0.1 0.0 0.4 0.0 0.3 0.0 0.3 2.6 4.3 4.6 0.0 0.0 0.5 0.1 0.4 0.2 13.6 5.5 3.2 0.1 0.0 5.3 0.0 2.3 0.0 8.5 1.8 13.3 0.6 1.2 0.1 0.0 0.1 0.2 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.4 6.5 0.0 0.1 0.0 4.7 0.4 0.1 0.1 0.2 23.5 5.2 0.2 0.1 16.8 0.2 6.9 0.2 0.1 0.0 0.1 0.1 3.1 0.6 3.7 2.0 2.3 3.9 0.6 2.7 3.0 4.7 0.2 5.1 0.3 8.3 1.6 1.0 2.7 5.1 4.6 3.3 2.2 4.1 6.1 4.9 1.6 6.1 5.0 4.5 7.3 4.9 60.9 43.4 3.9 10.2 3.7 0.3 0.7 2.2 15.8 1.9 1.5 11.7 2.8 7.6 1.8 0.0 1.6 6.0 2.4 0.0 0.8 14.9 2.3 11.1 4.3 1.2 10.3 2.6 1.1 1.0 17.7 0.0 3.1 9.5 5.3 7.1 5.1 2.6 33.7 9.3 2.9 2.0 14.4 5.6 7.4 6.5 8.0 3.6 1.0 0.9 34.2 21.6 7.5 13.0 1.9 3.0 7.5 3.4 0.3 6.4 0.7 3.9 2.7 0.0 13.0 5.0 103.0 37.8 3.5 4.0 1.8 9.1 10.5 1.3 0.3 STKLD1 "C9orf96, MGC43306, SGK071" ENSG00000198870 "Serine/threonine kinase like domain containing 1" Q8NE28 9 133376366-133406096 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 10.0" "Group enriched" "Detected in many" 4 "Early spermatids: 33.8;Late spermatids: 66.4;Spermatocytes: 20.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029902 Uncertain NA NA "HPA029902: AB_10603554" "unprognostic (6.65e-2)" "unprognostic (9.43e-3)" "unprognostic (7.54e-4)" "unprognostic (8.15e-2)" "unprognostic (9.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-3)" "unprognostic (6.05e-2)" "unprognostic (2.94e-4)" "unprognostic (1.92e-4)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "unprognostic (4.69e-2)" "unprognostic (3.65e-1)" "unprognostic (5.86e-2)" "unprognostic (4.52e-2)" 0.2 0.2 0.4 0.0 0.4 0.1 0.2 0.6 0.7 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.2 0.3 0.1 0.1 0.3 0.3 0.3 0.3 0.2 0.0 0.2 0.0 0.4 0.3 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.2 10.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.6 0.7 0.4 0.1 0.3 0.3 0.3 0.4 0.2 0.2 0.6 0.4 0.0 0.0 4.2 0.5 0.0 1.3 0.0 2.2 3.7 2.1 2.2 1.2 1.5 0.6 0.0 2.1 4.8 0.1 0.1 9.8 0.6 33.8 0.9 1.4 1.1 0.0 0.0 3.5 1.1 1.0 1.1 1.5 0.9 0.0 1.7 0.7 1.3 0.9 1.7 2.9 0.5 0.0 0.8 0.0 66.4 2.1 0.4 0.0 1.0 0.1 1.3 1.0 1.0 3.8 0.2 0.2 1.9 1.6 0.6 0.4 2.8 0.0 2.0 0.0 1.3 0.8 20.5 4.0 0.8 0.0 3.3 1.2 2.5 0.6 0.7 GRK5 GPRK5 ENSG00000198873 "G protein-coupled receptor kinase 5" P34947 10 119207571-119459745 "Enzymes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025579, HPA046838" Approved Supported "Nuclear membrane,Nuclear speckles,Plasma membrane" NA NA "Nuclear membrane, Nuclear speckles" "Plasma membrane" "CAB025579: , HPA046838: AB_2679833" "unprognostic (1.09e-1)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.02e-2)" "unprognostic (6.56e-2)" "unprognostic (3.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.69e-1)" "unprognostic (4.11e-1)" "unprognostic (1.06e-1)" "unprognostic (3.70e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" 35.2 18.1 4.2 6.0 5.0 2.7 24.8 4.8 5.0 18.8 4.7 24.2 10.1 21.2 3.5 12.7 19.7 5.7 47.7 3.9 5.0 9.9 13.0 66.2 7.9 3.9 3.6 3.2 35.3 4.7 21.4 13.4 8.3 3.8 14.2 5.0 1.0 7.9 4.1 12.0 10.0 26.0 7.4 3.3 37.3 27.8 4.1 4.5 6.3 19.8 9.8 6.9 19.6 18.2 3.5 3.7 2.3 5.4 5.7 11.8 11.0 1.6 7.1 32.1 4.1 2.3 1.7 5.4 3.9 1.6 11.1 7.5 0.9 2.3 7.7 2.7 15.4 2.0 0.7 4.6 7.0 8.2 0.2 2.0 1.5 1.1 8.5 1.2 5.2 24.9 2.4 0.4 3.7 1.5 0.7 3.8 3.5 0.8 25.8 5.2 1.3 0.8 0.9 0.6 1.5 1.8 4.9 2.4 1.1 7.0 3.0 0.1 0.9 7.8 2.3 1.6 14.6 2.8 0.9 4.4 2.4 4.9 4.4 2.4 0.4 1.5 2.9 2.0 1.4 0.1 3.8 3.0 1.6 0.9 4.0 4.5 2.0 2.1 0.1 0.5 0.0 4.0 1.7 4.2 5.0 4.8 5.0 3.9 5.0 3.9 3.6 3.2 3.8 3.3 4.5 3.5 32.6 57.7 3.7 3.6 19.7 1.7 0.7 0.5 1.2 3.9 2.3 2.0 19.4 0.0 1.3 3.7 0.0 3.7 13.3 0.4 0.0 1.1 18.7 0.4 5.1 28.4 4.8 0.0 17.7 3.1 15.8 35.7 18.8 1.0 4.5 7.8 24.7 2.2 4.4 1.7 36.5 0.8 6.1 15.5 6.3 4.9 4.4 14.2 7.2 56.2 3.6 0.0 19.6 14.1 5.7 2.4 1.2 4.5 10.2 0.7 4.9 0.6 0.8 0.9 59.2 18.2 46.5 1.3 2.1 0.7 2.4 13.1 14.1 4.6 0.5 0.9 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 57.8;Oligodendrocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 7.7 10.9 5.6 8.2 6.0 9.2 10.1 6.6 7.6 12.0 8.3 9.0 9.6 9.3 9.8 6.6 10.2 7.1 8.0 5.6 6.2 8.9 12.1 7.2 9.9 6.5 6.0 5.0 12.3 7.4 13.2 6.9 8.5 6.1 9.9 10.8 9.0 7.2 9.5 15.7 7.9 7.9 9.2 5.8 7.8 7.8 8.1 5.8 10.5 12.9 8.5 9.5 8.6 8.8 7.4 16.3 20.5 12.1 24.9 17.4 12.0 13.8 16.8 12.9 12.9 12.0 23.3 20.2 28.1 25.2 15.4 18.6 18.4 24.9 20.3 18.4 22.1 24.1 11.9 17.1 15.6 17.7 27.7 15.1 12.4 20.3 17.5 27.0 10.6 13.0 20.9 32.3 16.0 15.6 15.7 18.1 23.4 21.1 27.2 18.8 19.7 16.6 34.8 17.4 16.4 18.2 18.3 20.4 38.4 17.6 22.7 26.6 19.6 14.0 15.0 10.8 11.8 23.3 16.1 25.7 33.2 12.1 25.9 20.8 2.4 7.4 3.9 8.5 7.7 11.2 8.3 8.8 9.5 8.8 9.8 10.8 11.7 1.8 11.1 10.0 6.7 6.8 6.2 5.6 6.0 6.6 7.6 5.6 6.2 6.5 6.0 5.0 6.1 5.8 5.8 7.4 10.0 6.4 15.3 39.2 18.2 10.5 5.3 10.0 17.1 12.0 11.4 11.7 9.5 10.0 7.6 11.0 4.2 18.6 11.7 7.8 0.0 7.8 7.3 10.9 18.0 8.8 4.8 12.6 57.8 6.9 13.1 11.0 12.8 10.9 34.2 9.1 6.1 14.2 7.7 3.3 53.4 12.3 12.2 7.1 11.2 4.5 8.4 10.3 8.8 43.1 10.0 6.8 10.3 50.3 58.7 7.1 4.0 8.2 18.0 6.2 4.9 2.4 9.6 11.5 19.7 11.2 10.4 23.9 23.4 15.6 16.9 15.2 17.1 10.2 11.4 3.3 DCAF12 "CT102, DKFZP434O125, KIAA1892, MGC1058, TCC52, WDR40A" ENSG00000198876 "DDB1 and CUL4 associated factor 12" Q5T6F0 9 34086387-34127399 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.9;Erythroid cells: 315.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062279 Uncertain NA NA "HPA062279: AB_2684734" "unprognostic (9.56e-2)" "unprognostic (3.47e-2)" "unprognostic (3.92e-3)" "unprognostic (2.22e-2)" "unprognostic (6.61e-2)" "unprognostic (2.40e-1)" "unprognostic (6.34e-3)" "unprognostic (6.57e-2)" "unprognostic (2.86e-3)" "prognostic favorable (2.81e-5)" "unprognostic (1.77e-1)" "unprognostic (4.37e-1)" "unprognostic (2.21e-3)" "unprognostic (3.09e-2)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" 16.3 32.6 10.6 20.2 10.5 34.0 21.9 10.5 12.0 20.5 15.4 22.4 17.2 17.5 17.0 29.6 18.5 17.1 12.8 10.0 12.2 17.6 23.4 17.5 37.3 12.0 11.6 9.3 16.2 15.9 22.9 10.0 28.8 11.9 16.4 26.2 17.6 16.9 14.6 18.3 16.8 17.4 17.6 11.4 17.7 17.5 63.0 11.7 30.2 19.7 23.5 42.5 24.3 17.0 11.6 45.1 29.2 58.1 26.1 24.9 21.6 33.0 24.5 31.4 43.8 37.6 25.6 21.4 88.6 20.7 27.7 15.2 19.6 64.4 28.7 37.6 40.3 34.6 70.1 58.6 36.1 36.4 86.5 41.7 21.6 54.8 28.0 53.1 33.7 35.3 48.9 70.2 30.0 28.6 18.5 55.3 85.8 29.9 29.5 28.3 51.8 31.6 39.3 46.0 32.5 57.0 48.9 49.6 42.0 20.2 30.6 23.5 134.4 25.4 20.8 25.3 17.8 33.5 19.6 38.8 68.7 19.8 65.2 51.2 36.4 28.6 28.3 12.3 24.0 18.5 1.2 12.2 14.1 25.3 0.4 9.8 11.4 27.6 16.0 20.4 20.4 22.9 20.2 10.6 10.5 10.5 12.0 10.0 12.2 12.0 11.6 9.3 11.9 11.4 11.7 11.6 13.8 6.4 20.0 7.5 5.9 38.5 18.8 13.3 21.1 6.9 20.3 14.7 6.7 8.6 13.4 5.5 6.2 21.5 27.6 22.0 25.4 16.0 165.9 27.3 13.7 18.2 25.2 315.8 10.0 18.2 25.2 14.5 16.3 19.3 17.7 20.6 15.0 21.9 31.4 10.1 10.4 22.3 10.2 63.9 16.2 63.0 20.2 32.1 17.8 12.2 22.4 7.5 11.3 11.6 8.8 18.0 15.7 21.1 29.6 28.6 13.1 21.5 23.4 7.0 13.1 13.8 17.5 40.1 43.2 33.1 38.6 22.4 16.7 30.0 19.6 38.4 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Cell type enriched" "Detected in many" 4 "Microglial cells: 618.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.3 4.1 12.5 6.0 12.1 6.7 5.5 9.6 10.4 3.2 5.8 2.8 2.0 4.1 3.7 1.1 4.0 3.6 4.0 6.7 34.4 3.1 1.3 4.7 7.4 16.0 11.2 3.9 9.2 1.3 5.7 6.5 3.5 21.3 6.7 3.2 18.1 2.3 3.1 4.3 1.6 4.0 3.3 13.6 9.1 3.1 1.8 17.1 4.5 6.9 2.7 5.8 4.2 4.2 16.8 0.0 4.0 0.3 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 1.1 7.6 0.0 0.0 0.0 1.9 7.6 0.0 0.0 0.4 7.9 0.0 13.0 0.0 0.7 8.0 1.1 1.1 0.4 0.0 0.3 0.0 0.1 10.0 11.5 23.0 0.0 3.5 7.0 14.3 1.6 0.0 0.0 21.0 2.2 20.2 0.0 0.8 2.0 16.6 0.0 0.1 0.0 2.1 1.3 25.0 0.0 0.0 2.6 0.4 0.2 10.1 13.3 0.0 1.1 16.5 0.3 0.1 0.2 1.1 0.7 2.3 0.4 0.0 0.2 0.5 0.4 0.0 1.0 0.6 0.1 0.9 4.6 3.1 0.0 0.2 12.5 12.1 9.6 10.4 6.7 34.4 16.0 11.2 3.9 21.3 13.6 17.1 16.8 8.2 0.0 5.2 148.2 10.2 1.5 1.5 0.0 1.2 8.1 9.3 8.6 9.7 1.5 0.6 0.0 81.3 7.7 22.1 0.1 0.0 0.4 0.2 0.8 15.8 10.1 4.2 6.1 77.3 0.2 2.5 4.2 2.0 3.5 4.5 7.1 5.7 1.1 15.5 0.0 103.9 0.0 0.0 15.7 9.9 0.8 5.0 26.3 5.4 618.3 11.4 12.4 15.5 26.2 113.7 0.1 0.0 2.2 25.8 11.4 0.0 0.3 0.7 34.1 0.0 4.4 2.6 0.3 3.9 0.2 1.3 4.4 25.8 2.5 0.2 0.6 ASB12 FLJ39577 ENSG00000198881 "Ankyrin repeat and SOCS box containing 12" Q8WXK4 X 64224194-64230607 "Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 33 "skeletal muscle: 91.4;tongue: 52.6" "Cell type enriched" "Detected in some" 4 "Late spermatids: 21.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 1.2;THP-1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA049542 Uncertain NA NA "HPA049542: AB_2680810" "unprognostic (6.52e-2)" "unprognostic (2.31e-1)" "unprognostic (1.48e-2)" "unprognostic (1.06e-3)" "unprognostic (6.76e-2)" "unprognostic (4.23e-2)" "unprognostic (6.50e-2)" "unprognostic (8.25e-2)" "unprognostic (6.75e-2)" "unprognostic (9.69e-3)" "unprognostic (6.75e-3)" "unprognostic (5.18e-2)" "unprognostic (5.12e-2)" "unprognostic (5.15e-2)" "unprognostic (1.35e-1)" "unprognostic (4.32e-2)" "unprognostic (4.63e-2)" 0.2 0.3 0.3 0.1 0.3 0.2 0.2 0.3 0.4 0.3 0.3 0.4 0.0 0.4 0.5 0.9 1.4 0.2 2.1 0.3 0.3 0.3 0.1 0.2 0.1 0.3 0.2 0.3 0.6 0.2 0.3 0.2 0.0 0.3 0.4 0.5 0.2 0.7 0.6 91.4 0.3 0.2 0.3 0.2 0.2 0.3 1.7 0.2 0.1 0.2 52.6 0.2 0.6 0.3 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.6 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.2 0.7 0.7 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 4.6 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 21.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 PNMA5 KIAA1934 ENSG00000198883 "PNMA family member 5" Q96PV4 X 152988824-152994116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 17.3;testis: 8.8" "Group enriched" "Detected in some" 14 "Spermatocytes: 20.3;Spermatogonia: 71.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 578 "HMC-1: 356.2;U-266/70: 560.6;U-266/84: 355.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044690, HPA073946" Enhanced NA NA "HPA044690: AB_2679049, HPA073946: " "unprognostic (5.25e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (3.55e-2)" "prognostic favorable (3.16e-4)" "unprognostic (1.15e-1)" "unprognostic (1.16e-3)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.76e-9)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" 0.0 0.0 9.1 0.1 12.6 0.0 0.0 0.8 8.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 17.3 0.0 0.0 0.0 0.1 3.2 3.9 10.1 0.0 0.0 0.0 0.9 0.1 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1.8 0.5 0.1 8.8 15.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 356.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 560.6 355.8 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.1 12.6 0.8 8.2 8.9 17.3 3.2 3.9 10.1 3.1 1.8 15.0 4.6 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 1.7 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 2.6 0.4 1.3 0.3 1.2 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 71.9 0.0 0.0 0.3 0.9 0.1 0.0 0.0 ITPRIPL1 KIAA1754L ENSG00000198885 "ITPRIP like 1" Q6GPH6 2 96325317-96330517 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.0" "Group enriched" "Detected in many" 10 "Early spermatids: 170.7;Late spermatids: 145.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 12.9" "Lineage enriched" "Detected in many" 5 "T-cells: 12.9" "Cell line enhanced" "Detected in many" "HEK 293: 30.9;HEL: 32.0;MOLT-4: 34.5;RPMI-8226: 33.0;U-698: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (3.56e-3)" "unprognostic (4.78e-2)" "unprognostic (9.43e-2)" "unprognostic (2.22e-1)" "unprognostic (6.56e-4)" "unprognostic (3.04e-2)" "unprognostic (2.87e-1)" "unprognostic (6.50e-2)" "unprognostic (5.36e-2)" "unprognostic (8.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.41e-5)" "unprognostic (4.97e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (6.39e-2)" 3.4 0.4 0.5 3.0 0.9 1.1 3.8 2.9 0.8 1.0 0.4 1.0 1.2 0.5 0.5 1.6 0.8 1.6 1.0 0.5 0.6 0.4 0.5 1.5 3.9 1.0 0.5 0.5 0.4 1.4 0.5 0.4 1.2 1.5 2.0 0.9 1.0 7.6 1.5 1.5 0.8 1.7 1.0 0.7 2.6 1.2 28.0 0.6 5.2 0.7 2.0 4.3 1.5 1.3 0.8 0.0 0.0 7.3 0.1 0.8 1.9 8.3 1.6 8.7 7.2 14.1 3.3 0.3 0.0 0.1 3.1 0.1 0.7 25.4 0.0 8.1 15.7 30.9 32.0 0.2 14.4 3.9 0.1 0.0 5.4 0.0 8.3 0.0 0.0 4.7 20.4 0.0 10.6 0.2 0.0 34.5 5.0 10.5 0.0 0.0 22.7 23.1 33.0 0.3 0.0 21.2 14.2 0.0 0.0 0.1 4.4 0.0 5.3 2.4 0.0 0.8 0.1 0.1 15.4 21.4 35.3 4.1 0.0 6.8 0.4 0.2 0.0 10.2 0.2 12.9 1.6 3.3 9.7 1.2 0.4 0.7 4.1 0.1 2.7 0.0 0.5 6.3 2.3 0.5 0.9 2.9 0.8 0.5 0.6 1.0 0.5 0.5 1.5 0.7 0.6 0.8 9.4 3.2 0.0 0.0 2.3 0.3 4.8 1.8 2.2 0.7 3.6 2.9 0.7 2.8 3.5 0.0 4.2 0.9 6.9 1.0 0.0 0.1 170.7 0.2 0.6 2.7 0.0 1.7 0.2 0.2 2.3 0.9 0.5 0.1 0.0 0.8 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.3 2.4 145.2 1.2 1.8 1.8 0.0 0.3 4.3 11.3 0.0 0.0 0.3 0.1 0.7 7.6 3.3 0.0 0.3 0.8 1.7 6.6 0.6 2.9 3.6 2.8 1.7 1.0 0.4 14.8 0.3 0.4 1.3 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 137287.9" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 253563.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 13456.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 41594.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053928 Approved Supported Mitochondria NA NA Mitochondria "HPA053928: AB_2682313" "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 20658.1 43922.2 86296.9 4231.6 84800.0 3683.9 19527.9 76338.0 120140.6 8424.5 91101.6 26265.1 11121.8 10854.6 6855.4 16014.7 10715.8 4663.8 137287.9 78671.7 72792.5 75146.2 102227.7 11958.7 3851.1 100889.9 79118.2 67242.3 9032.7 21656.0 15848.4 12934.0 7756.8 98820.8 22403.6 15152.1 14235.8 17652.8 11801.9 62065.6 16809.5 25255.8 7178.8 71321.8 12885.4 39917.5 13676.8 89007.8 3263.7 14907.0 71231.6 4954.5 19582.1 10396.1 90827.3 4251.7 4285.9 5449.6 8075.1 12523.6 3123.1 3808.6 4184.0 1603.2 958.4 1834.2 6555.4 4688.4 7428.4 3608.7 3590.8 1396.3 7685.0 496.1 6777.9 1691.7 4330.2 2654.6 4592.7 41594.9 11166.3 1884.9 4672.8 5223.9 5330.2 7007.6 1403.3 4977.9 8925.4 2344.4 3683.1 3908.9 8930.2 3461.9 9508.0 1848.1 10481.0 1551.2 3650.3 2876.4 2481.0 1712.1 4518.2 6770.1 8938.3 1999.0 2694.8 2434.3 7967.3 4267.8 9600.3 5601.2 10888.7 6532.2 3851.7 3726.9 5232.7 3330.8 5307.6 2292.6 3407.7 2514.1 7881.4 2100.8 13456.8 3334.1 7103.1 1902.0 2192.8 2614.3 3555.5 2129.5 2285.7 1616.0 3624.4 2452.9 3095.1 2513.1 2106.5 2329.2 2112.6 1668.2 1840.0 86296.9 84800.0 76338.0 120140.6 78671.7 72792.5 100889.9 79118.2 67242.3 98820.8 71321.8 89007.8 90827.3 3065.0 1269.2 1516.1 0.0 6183.3 4404.5 9073.3 7719.8 2713.0 0.0 6210.4 6965.6 253563.4 15377.3 4975.3 12806.1 0.0 0.0 4005.7 20185.0 2435.8 2924.2 1109.7 6731.7 4298.6 9316.2 5090.0 20898.0 0.0 4058.3 0.0 5843.3 5601.5 11920.4 2188.6 15486.9 13931.3 35046.7 0.0 0.0 0.0 14557.8 5771.7 22254.8 3452.7 5132.5 8834.9 4749.3 3799.3 0.0 6280.7 0.0 4212.2 0.0 0.0 3710.0 12363.2 5788.3 3409.4 5872.9 28978.7 17714.1 4527.9 0.0 6310.9 8264.3 7732.9 6461.4 6003.0 3008.8 4937.6 0.0 5125.3 7671.5 15595.2 11405.7 SMC5 "KIAA0594, SMC5L1" ENSG00000198887 "Structural maintenance of chromosomes 5" Q8IY18 9 70258978-70354873 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054900 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA054900: AB_2682634" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (8.04e-3)" "unprognostic (2.15e-2)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.23e-1)" "unprognostic (3.36e-2)" "unprognostic (7.30e-2)" "unprognostic (1.71e-2)" "unprognostic (2.73e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" 10.3 7.7 5.6 15.1 5.4 26.2 16.8 10.5 6.0 11.8 8.8 15.1 13.7 15.4 12.9 10.9 12.4 13.0 9.0 4.9 10.8 8.1 14.9 12.9 18.6 5.9 5.9 3.7 25.4 19.5 10.5 9.6 14.9 6.1 11.5 17.1 8.3 17.2 8.8 13.9 9.0 14.0 10.8 5.1 12.1 14.7 13.6 5.4 18.4 14.4 8.3 16.2 16.6 11.4 8.6 43.9 10.8 26.6 16.2 15.1 28.3 20.9 29.8 25.8 15.9 17.3 4.1 23.3 43.7 9.5 22.5 13.9 39.3 28.9 19.8 31.7 19.9 10.3 25.5 18.3 13.1 19.2 41.8 25.3 19.9 13.5 21.5 24.5 25.4 16.9 25.8 19.1 17.1 29.9 6.7 55.4 14.7 20.4 33.5 14.9 32.4 43.6 13.7 16.1 21.3 18.9 14.2 29.5 18.7 8.3 19.2 11.2 17.6 18.6 21.3 22.4 29.2 41.2 20.9 29.9 29.9 17.9 21.6 25.9 14.1 5.6 10.4 8.5 6.3 8.0 8.4 7.3 8.1 4.6 8.2 8.0 7.4 3.7 8.1 7.6 8.7 8.4 4.0 5.6 5.4 10.5 6.0 4.9 10.8 5.9 5.9 3.7 6.1 5.1 5.4 8.6 48.9 57.7 70.3 61.7 54.6 45.6 102.0 30.3 59.7 26.8 39.2 34.0 34.6 41.5 62.0 20.2 29.2 32.1 65.2 38.8 9.8 61.3 47.9 65.3 58.9 37.6 28.1 29.0 72.2 54.8 37.5 62.1 40.8 89.1 51.8 52.5 16.1 25.9 16.4 38.7 66.4 34.8 20.3 22.9 30.8 15.9 53.4 37.9 24.9 74.0 65.4 17.2 54.6 85.5 94.6 68.3 37.9 59.5 40.6 105.5 23.6 11.7 51.0 35.7 26.3 66.2 52.2 80.0 55.0 52.5 41.9 35.6 56.7 58.4 45.0 105.8 MT-ND1 "MTND1, NAD1, ND1" ENSG00000198888 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1" P03886 MT 3307-4262 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease variant, Epilepsy, FDA approved drug targets, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 112263.5;heart muscle: 90921.1" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 101184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 9432.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 9432.2" "Cell line enhanced" "Detected in all" "HeLa: 28480.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033779, HPA066847" Approved NA NA "CAB033779: AB_2149736, HPA066847: " "prognostic favorable (3.63e-4)" "unprognostic (3.55e-1)" "unprognostic (3.77e-2)" "unprognostic (3.65e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.95e-3)" "unprognostic (5.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.26e-4)" "unprognostic (8.67e-2)" "unprognostic (8.66e-2)" "unprognostic (3.24e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-2)" "unprognostic (2.85e-2)" 18998.0 25141.1 73075.3 2707.2 73846.7 3486.3 18053.2 69171.1 112263.5 4392.8 72811.1 16638.9 6474.6 5979.3 6485.1 8432.9 6172.3 2871.9 90921.1 69327.8 65582.2 47460.2 45392.3 7945.4 2264.2 88943.4 69300.5 60576.1 4675.4 15652.8 12630.0 8056.0 5206.6 81982.0 11455.3 8875.7 6512.4 11523.4 7113.9 69755.1 14410.3 17076.6 3882.9 62244.9 8294.5 26245.9 12318.7 76272.4 2178.7 7290.5 62005.3 3011.5 10421.0 5489.5 75875.4 3533.6 3499.2 2812.3 2571.1 10434.4 1879.8 3604.8 2946.1 872.8 805.7 835.0 6132.0 3710.1 4259.8 1831.7 2239.3 810.9 2285.7 316.3 1774.7 1592.0 3064.7 2432.6 4755.7 28480.4 8841.6 2231.9 2279.1 4495.2 4494.5 4734.4 1241.1 1773.2 3240.7 877.2 1226.5 2235.4 2580.5 2400.4 4813.7 1841.1 9325.6 757.8 2191.3 2603.6 1916.7 1277.6 2295.7 4312.3 5574.2 1165.0 1844.2 1632.5 2572.1 2943.6 3403.7 2306.2 7771.2 4632.1 2652.3 2396.0 3427.2 2511.3 2841.3 1883.7 2015.4 1784.6 3937.3 744.7 9432.2 1265.2 2347.3 512.4 662.6 732.0 1155.4 614.6 683.5 439.9 1185.3 800.8 960.2 3270.7 759.6 733.2 677.2 480.0 507.7 73075.3 73846.7 69171.1 112263.5 69327.8 65582.2 88943.4 69300.5 60576.1 81982.0 62244.9 76272.4 75875.4 1754.9 1352.6 1511.3 0.0 3159.5 2265.8 3355.3 1632.2 2928.1 0.0 3174.3 3513.1 101184.9 9771.1 1985.3 4610.8 0.0 0.0 2175.7 12456.8 1033.1 1511.9 1087.5 3160.1 1985.1 4881.6 3135.6 8308.9 0.0 3595.1 0.0 2970.8 2347.6 5039.6 1402.2 7165.4 7745.2 16276.4 0.0 0.0 0.0 10835.1 927.7 12435.2 1651.4 5233.2 7049.5 2982.5 1497.7 0.0 4450.1 0.0 2385.2 0.0 0.0 2180.4 8080.9 3546.9 2046.0 3735.0 18353.7 8183.6 1760.8 0.0 6409.6 6534.6 4075.7 4806.0 5071.3 2061.1 2073.2 0.0 2839.0 4329.0 10735.4 5236.0 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;testis: 6.2" "Group enriched" "Detected in some" 4 "Early spermatids: 20.7;Late spermatids: 44.4;Spermatogonia: 14.4" "Cancer enhanced" "Detected in some" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "EFO-21: 15.2;U-2 OS: 8.4" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 2.5 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.8 6.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.7 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 3.8 14.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056674-107067636 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 308.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 5.0 10.0 6.2 7.3 6.0 4.3 8.1 6.0 5.8 6.2 12.2 7.9 6.2 7.1 8.1 6.8 8.9 6.0 3.9 5.6 6.6 12.1 7.1 4.6 9.7 6.6 6.9 5.8 8.7 11.0 9.7 8.4 7.4 6.2 8.6 7.2 6.4 6.6 7.9 1.9 5.6 7.2 5.9 5.9 8.3 7.5 6.7 7.3 10.4 7.1 3.2 8.8 7.9 5.1 6.7 13.6 0.2 25.7 11.3 16.6 18.4 7.0 17.8 13.2 16.9 17.2 17.2 9.2 33.1 24.1 16.5 9.2 18.9 23.9 26.2 13.3 0.0 25.4 20.0 35.6 25.0 16.5 41.6 11.9 17.4 14.2 15.2 15.5 11.4 14.8 18.5 27.1 5.0 15.4 308.1 24.5 14.6 11.1 10.6 24.6 30.8 56.0 12.6 41.3 27.1 47.8 58.3 24.2 34.5 12.1 15.5 24.0 30.7 17.2 12.5 25.5 26.3 26.8 5.4 4.0 5.7 18.4 19.3 10.2 2.1 10.4 1.9 7.9 11.9 9.5 7.4 8.3 7.6 14.1 10.3 11.5 11.9 0.6 17.4 12.0 17.2 9.2 9.3 6.2 6.0 6.0 5.8 5.6 6.6 6.6 6.9 5.8 6.2 5.9 7.3 6.7 3.0 0.0 4.4 1.3 6.2 4.5 6.9 9.7 8.6 14.2 8.9 5.0 2.6 5.7 5.8 14.7 0.0 18.3 8.5 3.3 27.4 10.3 1.2 5.2 6.2 4.7 17.5 15.8 1.5 7.4 14.6 6.7 4.6 4.9 1.3 9.4 7.5 2.4 10.0 15.2 2.2 7.4 8.2 7.0 1.6 3.0 8.7 3.8 1.8 3.7 3.9 6.9 3.1 2.0 2.2 4.7 8.5 9.1 2.0 5.1 4.1 18.4 7.4 5.1 13.1 5.9 6.3 9.1 8.1 8.9 6.1 7.1 5.0 13.7 10.3 5.4 SHISA4 "C1orf40, hShisa4, TMEM58" ENSG00000198892 "Shisa family member 4" Q96DD7 1 201888680-201892587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 221.9" "Cell type enhanced" "Detected in many" "Muller glia cells: 37.5" "Cancer enhanced" "Detected in all" "glioma: 49.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 24.6;intermediate monocyte: 8.1;neutrophil: 9.1;non-classical monocyte: 10.2" "Group enriched" "Detected in many" 10 "granulocytes: 24.6;monocytes: 10.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 23.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061273, HPA067885" Uncertain NA NA "HPA061273: AB_2684460, HPA067885: " "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (1.48e-3)" "unprognostic (2.12e-3)" "unprognostic (6.59e-2)" "unprognostic (8.29e-3)" "unprognostic (7.06e-2)" "unprognostic (5.00e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-1)" "unprognostic (8.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.63e-3)" "unprognostic (1.20e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" 6.3 27.1 66.7 2.0 67.7 0.5 6.0 62.4 58.9 9.1 30.0 6.2 0.4 11.0 3.5 2.7 7.0 3.6 38.8 57.6 55.4 5.9 3.2 5.2 0.9 67.0 67.4 54.3 10.8 5.1 3.9 9.2 2.3 69.5 8.5 0.9 4.7 15.9 4.0 221.9 3.5 3.5 3.7 59.6 2.8 6.8 5.8 67.5 0.3 11.5 58.8 0.6 8.6 6.4 57.9 1.3 10.5 1.6 7.8 12.7 7.7 1.3 9.1 19.3 5.2 6.5 2.0 4.1 0.0 10.6 12.6 17.2 3.4 0.1 1.4 3.0 1.3 0.6 0.1 2.8 1.3 8.2 0.1 6.7 7.6 4.3 6.5 3.0 23.2 8.0 0.1 0.2 0.7 8.1 1.3 0.0 0.0 0.8 0.9 11.3 0.4 0.0 2.1 5.0 4.1 0.5 6.6 3.3 1.6 10.9 7.6 4.4 1.0 7.5 6.3 5.5 3.9 4.4 2.4 2.9 0.1 9.2 0.0 11.2 0.0 1.7 24.6 1.7 8.1 0.8 0.0 0.3 0.4 0.9 0.0 0.0 0.3 9.1 0.0 10.2 0.0 0.0 0.7 66.7 67.7 62.4 58.9 57.6 55.4 67.0 67.4 54.3 69.5 59.6 67.5 57.9 12.8 0.0 1.7 14.4 0.3 14.1 4.5 7.4 6.8 11.7 8.2 14.4 20.9 8.6 3.7 11.0 4.2 2.0 0.9 0.1 33.2 24.9 0.7 2.4 10.0 11.1 1.8 0.0 8.4 15.4 27.2 19.2 3.6 2.7 1.3 10.4 12.5 12.1 3.2 5.0 6.5 0.1 6.1 6.9 25.1 2.3 15.8 3.7 23.2 1.0 4.6 37.5 0.0 17.6 19.2 9.5 0.0 29.3 0.2 7.4 0.0 6.3 1.3 3.8 19.7 9.2 18.0 1.4 0.8 0.9 6.8 2.7 1.5 2.3 0.1 2.1 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098126-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 133.4" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 13.4 9.7 41.7 8.5 50.2 4.3 15.9 50.1 42.8 17.0 23.1 22.9 10.4 14.7 13.6 22.3 30.7 9.1 40.2 45.7 42.9 14.4 15.5 11.2 8.5 48.4 49.0 34.2 9.2 9.7 29.8 13.6 9.1 44.2 25.8 20.1 41.6 20.7 25.0 133.4 15.0 11.5 16.6 45.5 9.2 11.5 11.8 52.7 10.4 20.6 83.1 10.2 17.4 15.6 50.9 9.4 12.6 25.4 16.8 10.1 8.0 15.4 6.0 9.4 10.9 9.8 10.3 19.4 23.3 5.9 9.7 9.6 14.3 23.7 9.4 14.3 12.3 6.4 14.9 9.8 9.5 9.7 8.4 10.7 9.4 17.9 10.6 6.5 14.1 12.7 19.2 14.0 8.8 8.1 21.4 20.2 10.2 10.6 21.3 10.9 20.2 11.3 14.0 11.0 16.1 35.9 13.4 11.0 17.4 14.9 10.7 27.2 8.6 14.9 7.0 15.1 10.0 7.6 8.4 7.1 11.1 13.2 7.1 14.8 4.3 4.5 1.6 2.6 5.1 4.1 7.9 3.6 2.7 5.4 7.1 3.8 2.8 5.5 5.5 3.8 2.0 4.1 3.6 41.7 50.2 50.1 42.8 45.7 42.9 48.4 49.0 34.2 44.2 45.5 52.7 50.9 8.5 16.0 18.4 33.6 4.7 9.1 8.2 5.3 12.5 29.3 18.3 12.6 49.9 8.6 12.6 11.0 58.4 7.4 5.5 43.5 9.8 4.2 11.0 39.8 9.2 7.0 17.4 6.5 16.4 5.6 5.0 5.6 9.2 20.3 1.3 5.8 7.1 29.5 15.2 11.8 20.2 14.8 30.5 16.0 6.6 15.8 4.1 7.2 8.8 9.4 5.8 22.8 2.1 21.1 58.7 5.1 12.4 14.3 4.2 8.3 18.1 6.0 30.5 36.4 13.1 7.9 9.3 19.9 9.1 10.4 9.8 13.5 3.1 7.1 13.7 7.1 CAPZA2 "CAPPA2, CAPZ" ENSG00000198898 "Capping actin protein of muscle Z-line subunit alpha 2" P47755 7 116811070-116922049 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007470, HPA007643" Uncertain Approved Cytosol No No 4500000 Cytosol "HPA007470: AB_1845985, HPA007643: AB_2667886" "unprognostic (1.37e-2)" "unprognostic (2.25e-3)" "unprognostic (4.16e-2)" "unprognostic (3.16e-1)" "unprognostic (1.53e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (9.34e-5)" "unprognostic (1.90e-2)" "unprognostic (1.80e-2)" "unprognostic (2.15e-1)" "unprognostic (2.08e-3)" "unprognostic (2.52e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.91e-3)" "unprognostic (6.58e-2)" 26.5 20.3 20.0 20.2 19.7 43.7 22.0 25.2 26.0 18.2 24.5 24.6 20.6 19.9 19.2 20.9 14.3 20.8 46.2 24.3 21.3 37.6 34.2 24.0 20.2 20.1 20.1 17.8 12.7 13.5 19.6 7.6 25.1 23.4 20.5 24.1 13.5 14.7 20.7 64.9 12.4 23.6 28.4 18.1 22.5 20.2 8.8 21.9 16.6 23.0 53.6 17.4 28.3 11.4 22.3 30.0 19.5 19.8 25.2 35.9 37.8 9.8 28.7 41.3 28.8 32.7 14.5 38.1 20.8 46.5 41.3 36.1 18.2 20.4 24.1 45.4 22.7 14.9 31.3 18.0 24.6 22.2 21.2 40.9 30.2 26.9 22.9 21.9 34.8 63.2 12.9 20.8 35.2 57.9 13.0 28.3 35.6 29.5 31.3 16.8 19.7 26.2 42.1 69.3 24.6 20.6 23.5 27.7 104.1 29.7 25.0 14.5 25.0 23.0 47.0 14.6 37.5 28.5 27.7 21.0 39.6 28.0 29.6 34.0 57.3 34.8 45.6 11.1 45.6 13.2 14.4 13.5 11.9 33.2 12.6 12.9 13.1 69.4 15.9 54.9 18.1 18.1 45.3 20.0 19.7 25.2 26.0 24.3 21.3 20.1 20.1 17.8 23.4 18.1 21.9 22.3 177.9 73.7 67.4 44.4 109.4 243.1 219.8 224.3 94.4 106.6 85.1 67.3 219.4 71.4 146.5 171.0 27.1 151.7 96.2 147.4 516.5 193.1 9.6 139.4 113.7 189.5 121.2 263.9 59.2 160.3 204.0 124.8 103.5 340.1 126.2 48.8 262.3 110.6 314.1 107.7 48.0 102.6 286.8 238.5 274.9 16.2 74.6 262.9 181.5 64.6 222.4 164.5 72.1 49.8 47.1 193.1 147.5 110.9 83.0 140.9 182.6 519.7 99.7 95.9 92.1 122.8 188.9 43.1 47.0 94.1 218.8 144.1 108.6 78.7 109.9 207.0 MT-ATP6 "ATP6, ATPase-6, MTATP6, RP, Su6m" ENSG00000198899 "Mitochondrially encoded ATP synthase membrane subunit 6" P00846 MT 8527-9207 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 172223.8" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 183462.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 15099.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 15099.8" "Cell line enriched" "Detected in all" 4 "HeLa: 81002.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (4.16e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" "unprognostic (8.45e-3)" "unprognostic (1.66e-1)" "prognostic favorable (3.79e-4)" "unprognostic (6.47e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-2)" "prognostic favorable (7.64e-4)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.37e-1)" "unprognostic (3.56e-1)" "unprognostic (2.52e-3)" 26129.7 50311.0 77728.6 5809.7 78792.2 5307.7 24910.8 72560.4 112900.1 10565.3 83902.2 30700.9 16104.6 12754.9 6279.1 19134.0 12236.5 5261.4 172223.8 72883.3 66558.6 96709.9 109278.1 13366.0 4651.1 94216.9 72799.7 60937.8 11094.0 26955.6 15420.6 17626.3 7398.6 90587.5 26760.3 12112.4 12790.0 19834.7 7128.3 111829.2 20121.2 29802.0 5877.4 63727.6 15614.0 42731.3 15126.7 82041.6 2907.2 17218.3 67707.6 4381.2 21390.0 13077.2 75847.4 5618.9 8971.4 6145.8 9667.8 11469.9 2606.5 4002.9 8017.4 1465.1 1068.3 1770.2 10629.5 5953.7 9842.8 3325.6 4356.6 1640.3 11849.7 653.2 6255.4 1954.9 7091.2 5605.0 8645.7 81002.5 18778.0 1945.0 5183.5 10726.9 4289.5 5409.3 1909.8 1824.4 7406.7 1920.7 5418.1 5810.5 6963.2 4174.7 15671.4 3204.2 13620.4 1620.4 4244.5 3674.4 3985.7 2622.4 6104.2 10727.8 13879.3 3495.2 4452.8 2870.3 6024.9 6026.0 10017.9 6477.5 17539.6 10178.1 4280.9 6317.4 7166.3 5880.9 3051.9 4303.3 7137.5 3739.9 10744.5 2455.0 15099.8 2475.3 4245.7 1346.3 1650.5 1689.2 2678.1 1534.6 1712.3 1211.4 2550.5 1774.0 2220.6 2427.2 1828.9 1841.1 1470.9 1232.4 1223.2 77728.6 78792.2 72560.4 112900.1 72883.3 66558.6 94216.9 72799.7 60937.8 90587.5 63727.6 82041.6 75847.4 4123.3 1487.2 1804.3 0.0 6867.9 2903.0 6184.5 4172.7 7102.6 0.0 4343.1 7054.0 183462.2 11539.8 3367.8 6422.4 0.0 0.0 6110.1 15211.0 1880.2 2059.0 908.9 7527.8 6522.7 7371.6 3995.8 17562.3 0.0 3405.9 0.0 6067.7 6569.9 13453.0 2064.3 20320.2 9969.1 26635.5 0.0 0.0 0.0 10468.7 2803.5 16148.3 2386.4 4627.8 7672.0 5539.3 2534.6 0.0 4773.4 0.0 4080.4 0.0 0.0 2818.6 9241.3 4966.1 7780.1 4657.8 24094.7 14129.0 3106.0 0.0 6304.4 11559.3 7641.7 5682.1 5225.7 5947.3 3034.9 0.0 6304.5 12298.1 10197.0 7899.3 TOP1 ENSG00000198900 "DNA topoisomerase I" P11387 20 41028822-41124487 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 801.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009058, HPA019039" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No Yes 7600 Nucleoplasm "Nucleoli fibrillar center" "CAB009058: AB_2303554, HPA019039: AB_1858187" "unprognostic (1.46e-1)" "unprognostic (8.65e-2)" "unprognostic (1.33e-2)" "unprognostic (1.92e-3)" "unprognostic (5.05e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.86e-2)" "unprognostic (1.51e-1)" "unprognostic (4.60e-2)" "unprognostic (3.74e-3)" "unprognostic (6.51e-2)" "unprognostic (8.65e-2)" "unprognostic (4.70e-2)" "unprognostic (5.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" 38.3 37.0 20.0 50.3 21.1 75.5 28.2 24.3 25.3 27.1 27.2 37.2 43.0 28.2 34.7 37.0 22.6 37.6 18.7 20.6 25.8 39.3 47.9 40.3 60.4 21.1 20.7 18.6 24.5 28.8 26.9 22.6 50.6 21.0 32.1 37.6 25.7 27.0 24.5 21.5 26.7 42.9 24.2 21.0 38.9 36.8 19.1 20.8 59.5 37.9 20.4 61.1 43.1 29.0 23.8 105.2 71.7 131.4 108.2 52.2 61.8 129.8 92.6 81.0 105.0 94.8 190.5 127.6 296.4 96.4 48.5 112.3 98.9 159.1 147.2 153.0 64.9 81.6 378.6 54.9 139.0 135.4 165.1 124.0 69.8 76.4 102.4 166.8 94.0 111.5 98.1 167.8 98.7 120.9 233.2 235.3 119.7 106.3 104.1 131.6 197.7 123.1 157.7 121.4 95.2 108.6 75.4 145.4 88.3 95.0 94.2 98.6 146.4 109.9 84.7 71.3 78.8 100.9 62.7 75.6 338.3 113.7 91.1 82.0 12.6 9.9 16.8 6.6 10.3 8.3 10.5 7.3 7.0 9.5 10.1 7.7 6.9 19.1 6.3 13.2 18.8 9.0 5.4 20.0 21.1 24.3 25.3 20.6 25.8 21.1 20.7 18.6 21.0 21.0 20.8 23.8 116.9 118.6 201.5 66.0 117.6 245.9 338.0 90.3 153.7 98.2 90.5 75.7 49.7 78.6 170.3 99.3 60.5 192.1 137.1 194.1 74.3 94.4 10.0 151.3 167.4 115.1 91.8 486.5 86.9 65.8 175.4 121.4 84.1 259.2 78.6 119.1 67.1 131.7 99.2 72.3 77.4 126.9 69.2 101.2 109.1 12.8 59.7 151.6 72.9 74.9 95.4 88.0 78.2 87.4 90.7 119.2 169.8 69.6 234.1 162.3 94.1 136.2 68.3 87.0 85.5 135.5 130.8 116.8 54.6 129.4 214.2 801.5 111.5 123.7 117.8 237.7 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966040-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.7;testis: 55.4" "Cell type enhanced" "Detected in many" "Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 34.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 34.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 6.6 6.3 5.6 10.1 6.4 90.7 6.5 10.2 8.7 6.5 5.0 16.5 10.7 5.7 2.3 37.9 6.0 3.0 6.7 5.9 5.6 4.6 4.8 9.0 17.1 5.1 5.6 5.7 8.2 9.0 2.6 3.6 15.4 6.9 4.9 16.6 5.0 9.6 1.5 4.2 20.0 13.1 9.5 5.1 12.6 11.8 55.4 4.8 43.4 4.4 2.3 25.1 4.9 13.8 6.2 167.9 199.9 164.8 113.6 16.8 28.7 87.5 237.8 139.3 257.2 195.3 134.6 158.5 65.5 91.4 151.9 156.9 220.9 188.8 101.2 240.6 118.7 206.4 135.6 263.5 123.5 4.1 71.4 109.0 7.7 12.8 145.8 146.9 56.6 146.4 100.5 114.0 132.4 241.1 144.4 66.9 98.5 66.6 216.4 84.9 69.7 205.1 86.3 115.3 123.6 151.2 118.9 225.4 121.9 82.7 112.3 149.1 127.1 91.2 168.2 146.0 140.5 345.1 43.5 127.7 80.0 74.5 162.0 265.3 34.4 0.6 2.9 0.6 0.1 0.4 1.1 1.3 1.3 2.4 0.5 1.2 0.4 0.4 3.0 0.3 2.6 8.0 1.0 5.6 6.4 10.2 8.7 5.9 5.6 5.1 5.6 5.7 6.9 5.1 4.8 6.2 2.5 0.0 3.1 1.3 6.8 16.6 6.6 8.0 2.2 6.4 3.4 4.3 3.2 0.0 7.6 3.7 0.0 45.5 2.8 16.5 0.0 3.2 41.5 4.5 4.0 4.7 5.4 142.9 5.0 2.9 68.3 7.2 16.3 6.8 8.9 13.2 9.3 2.1 21.5 3.3 5.2 17.0 10.2 8.7 15.0 15.4 3.7 5.2 3.6 1.9 5.5 3.8 4.1 2.0 1.7 2.3 3.2 1.9 17.5 5.9 2.0 0.1 3.2 4.6 6.6 7.4 10.9 136.4 74.2 38.0 14.2 14.6 6.8 0.4 24.1 6.7 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.6;Inhibitory neurons: 28.5;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA000887 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000887: AB_2666130" "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 1.5 3.0 5.7 0.8 7.8 1.8 1.9 5.1 7.0 3.3 2.2 2.0 1.2 3.6 2.6 1.3 2.3 1.4 2.4 6.9 8.1 3.4 2.2 1.3 0.8 6.5 4.6 5.4 4.5 1.8 3.4 4.5 2.6 7.3 3.7 1.4 6.9 2.0 3.9 3.0 1.7 1.3 3.5 4.5 1.5 1.4 2.5 6.7 2.4 3.2 2.4 1.0 2.4 2.3 9.7 0.4 3.1 8.6 2.6 2.4 1.4 4.1 2.8 3.7 4.7 8.6 2.9 2.0 0.0 2.9 3.3 2.3 2.3 4.7 3.4 5.4 0.0 2.8 0.9 1.8 0.4 5.5 0.6 0.6 3.1 2.4 1.9 0.3 3.5 4.6 0.1 2.6 3.1 3.6 1.9 1.9 0.2 6.0 0.8 1.9 0.9 2.5 0.0 3.2 5.0 4.6 4.1 2.8 0.8 0.2 3.4 2.7 1.5 4.9 0.8 2.8 1.4 2.6 1.6 4.2 0.0 2.0 0.5 1.7 0.4 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.6 0.0 0.1 0.3 0.5 0.2 1.7 0.0 0.0 0.5 0.1 5.7 7.8 5.1 7.0 6.9 8.1 6.5 4.6 5.4 7.3 4.5 6.7 9.7 3.4 6.4 1.5 12.1 0.6 1.8 1.2 0.7 4.6 11.3 1.9 1.7 6.9 2.8 1.0 3.7 12.5 4.3 0.5 0.7 7.9 1.2 0.2 1.2 5.3 3.5 4.8 0.8 24.6 0.8 0.8 5.4 0.5 1.0 0.0 7.3 3.9 1.4 1.4 3.3 28.5 0.7 0.0 1.3 0.0 0.9 2.8 0.2 0.0 1.9 0.7 12.5 2.1 17.6 16.9 0.4 0.5 2.6 0.1 1.4 0.8 1.9 0.3 5.8 6.6 3.7 2.8 9.1 7.5 2.1 1.1 1.4 1.6 3.6 1.1 0.6 MAP3K3 "MAPKKK3, MEKK3" ENSG00000198909 "Mitogen-activated protein kinase kinase kinase 3" Q99759 17 63622415-63696305 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007764, HPA035410, HPA035411" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615" "unprognostic (9.65e-3)" "unprognostic (1.33e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (4.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.33e-1)" "unprognostic (1.36e-1)" "unprognostic (9.37e-2)" "unprognostic (1.46e-3)" "unprognostic (5.51e-2)" "unprognostic (2.35e-1)" "unprognostic (2.79e-2)" "unprognostic (4.68e-2)" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" 28.3 12.4 10.9 23.9 11.6 31.8 23.8 12.9 12.4 21.3 13.5 23.9 8.7 24.0 6.5 17.9 24.4 22.0 41.3 9.8 11.3 20.9 14.0 28.9 22.5 13.4 12.1 9.0 24.2 13.0 15.4 13.9 23.1 12.2 22.4 8.6 6.9 15.2 18.6 24.0 18.3 18.9 22.2 12.3 34.8 18.9 17.3 13.0 15.2 18.2 30.6 14.6 23.6 19.3 12.9 22.6 16.3 20.4 20.1 37.7 30.2 9.4 22.0 24.4 27.0 21.2 7.8 4.5 24.2 15.0 43.2 18.7 8.3 13.4 15.5 16.9 21.7 29.3 19.6 22.6 11.0 19.5 15.6 20.1 22.3 10.4 33.6 17.1 16.3 65.7 17.4 12.2 31.1 21.4 15.9 27.3 15.9 12.5 4.5 16.8 14.3 53.0 15.6 9.4 10.3 10.6 25.3 14.6 17.1 17.9 24.9 17.3 14.8 60.5 67.8 17.8 37.3 26.9 30.3 33.6 8.9 14.4 12.0 18.0 15.0 11.4 15.3 2.8 11.8 3.0 2.0 3.4 2.8 4.9 2.4 3.3 3.2 25.1 1.9 12.5 1.9 2.9 3.5 10.9 11.6 12.9 12.4 9.8 11.3 13.4 12.1 9.0 12.2 12.3 13.0 12.9 31.6 19.2 14.5 23.5 11.0 7.8 5.4 3.9 5.7 15.8 9.5 8.9 10.3 12.8 5.1 16.5 14.6 3.2 25.8 3.3 9.8 4.5 8.3 10.0 12.3 33.0 4.2 2.1 39.8 8.1 3.3 13.6 3.1 9.3 3.8 7.1 48.2 10.1 16.3 18.5 34.2 3.9 2.0 47.1 13.0 6.4 14.9 35.1 23.2 54.4 42.7 8.8 24.7 31.2 36.1 5.2 1.9 13.2 8.3 8.2 3.7 2.4 5.4 14.0 19.7 21.9 12.9 23.9 17.8 6.1 11.2 1.4 15.6 6.2 4.5 3.8 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886173 "CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3;intestine: 35.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 67000000 "Nucleoplasm, Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 3.5 27.5 12.9 7.6 25.9 0.5 2.1 26.4 46.3 7.0 0.0 35.7 4.2 2.4 2.1 4.4 3.4 2.4 8.5 16.2 30.7 14.3 0.9 0.6 3.2 12.5 13.0 24.7 1.4 2.2 0.1 14.5 0.6 12.1 8.4 4.8 15.8 4.9 9.1 0.9 9.3 13.1 5.5 0.0 0.9 11.4 0.8 6.3 0.7 2.5 2.1 1.8 6.2 9.7 29.8 95.2 7.2 27.6 0.2 0.0 0.0 11.8 131.6 372.4 123.6 200.8 37.8 1.0 0.0 121.8 0.9 103.2 3.9 3.5 2.3 64.1 0.3 1.0 0.0 258.1 6.1 0.4 0.3 20.4 0.9 1.6 18.7 12.9 0.2 0.1 0.1 0.3 0.3 0.6 127.9 0.4 2.6 6.5 0.4 4.7 0.2 162.6 0.9 218.4 1.9 81.4 53.0 73.4 64.2 54.1 61.0 6.7 1.7 0.3 0.1 52.6 5.8 63.7 1.1 1.6 1.0 0.9 1.1 105.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 25.9 26.4 46.3 16.2 30.7 12.5 13.0 24.7 12.1 0.0 6.3 29.8 0.4 0.0 0.0 2.6 1.3 1.1 0.1 0.6 3.4 11.6 0.0 0.4 1.2 0.0 0.0 84.6 4.2 0.3 0.1 0.0 0.0 0.5 0.0 0.3 0.1 1.9 0.0 0.0 23.7 0.0 0.2 1.3 0.0 0.6 0.0 0.0 1.4 0.0 0.1 33.7 23.3 0.0 0.0 0.0 1.1 0.0 0.9 0.3 44.4 5.6 0.0 1.5 0.0 1.5 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 10.4 0.0 2.2 0.6 0.4 0.1 0.0 1.3 0.1 1.5 0.0 0.0 0.1 SREBF2 "bHLHd2, SREBP2" ENSG00000198911 "Sterol regulatory element binding transcription factor 2" Q12772 22 41833079-41907307 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031962, HPA031963" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "HPA031962: AB_10601266, HPA031963: AB_2674090" "unprognostic (6.53e-2)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (1.50e-3)" "unprognostic (3.41e-3)" "unprognostic (9.08e-2)" "unprognostic (5.04e-2)" "unprognostic (1.31e-1)" "unprognostic (4.78e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (9.85e-2)" "prognostic favorable (1.37e-4)" "unprognostic (4.68e-2)" "unprognostic (1.92e-2)" "unprognostic (3.22e-1)" "unprognostic (7.93e-3)" 22.1 81.4 48.4 31.3 50.0 32.6 24.8 20.5 58.6 25.8 0.9 43.3 41.2 34.6 61.1 82.7 27.6 25.5 54.3 50.3 27.6 30.6 36.5 43.5 35.5 34.3 39.3 48.1 36.1 46.2 51.8 30.8 24.7 46.3 33.8 31.9 21.2 49.5 23.1 34.4 57.3 36.2 30.4 14.0 26.3 54.2 20.5 37.7 25.3 23.5 33.8 36.5 29.9 39.3 43.3 65.5 45.8 119.4 111.6 68.4 90.9 66.7 21.4 71.1 24.8 50.5 54.3 84.2 115.8 29.7 52.6 91.1 109.6 68.7 141.8 17.5 32.9 75.0 58.0 79.7 54.6 113.8 85.7 37.9 85.8 78.7 65.1 80.6 56.7 49.2 64.2 60.6 135.9 26.4 83.1 62.5 64.5 75.7 81.2 34.9 71.3 68.1 189.0 103.3 67.6 48.2 36.3 49.1 89.3 91.7 69.5 56.3 150.2 53.0 33.2 61.0 15.9 25.8 98.3 54.3 91.7 32.4 64.0 51.9 0.0 4.7 1.6 4.6 3.6 3.1 7.0 2.5 3.3 5.0 4.8 2.2 2.6 0.7 1.4 3.1 6.3 1.5 4.8 48.4 50.0 20.5 58.6 50.3 27.6 34.3 39.3 48.1 46.3 14.0 37.7 43.3 14.5 44.8 43.3 100.6 35.4 16.3 13.5 52.2 30.7 41.0 36.3 23.1 30.3 37.1 38.0 58.8 10.4 25.4 23.5 67.0 3.9 20.3 15.9 25.2 10.5 16.8 49.1 14.1 72.6 44.3 22.6 16.3 42.8 59.2 12.7 43.2 8.2 34.3 14.8 57.2 75.1 39.4 52.9 10.3 14.8 7.0 31.4 16.3 7.2 67.5 18.1 18.6 20.6 90.5 129.5 38.4 30.5 27.4 29.2 27.9 26.3 4.8 30.0 18.7 19.7 13.7 20.5 8.4 13.8 55.7 28.1 36.5 19.0 43.0 40.3 30.2 C1orf174 RP13-531C17.2 ENSG00000198912 "Chromosome 1 open reading frame 174" Q8IYL3 1 3889125-3900293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008270, HPA065778" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA008270: AB_1845633, HPA065778: AB_2685557" "unprognostic (4.91e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.38e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (7.24e-2)" "unprognostic (5.36e-2)" "unprognostic (7.02e-2)" "prognostic unfavorable (2.73e-6)" "unprognostic (3.71e-2)" "unprognostic (3.95e-1)" "unprognostic (8.05e-2)" "unprognostic (1.46e-2)" 11.7 12.2 8.8 10.3 9.2 13.5 11.3 9.2 10.2 10.5 10.0 13.1 6.8 11.8 9.4 13.9 10.9 8.6 10.2 9.3 9.5 13.4 18.7 10.4 11.5 9.2 8.9 9.1 11.1 14.6 7.0 7.6 10.4 9.5 10.4 6.5 4.4 11.2 6.9 15.6 9.7 12.3 7.9 10.0 15.5 12.3 13.3 9.1 14.0 11.5 14.2 12.0 12.3 11.1 9.6 27.6 15.5 23.2 22.0 20.3 12.1 15.6 23.6 13.7 21.8 22.1 24.4 43.4 21.5 28.8 18.7 31.1 27.7 27.6 17.5 23.5 39.3 25.4 56.6 14.2 33.8 11.8 39.9 29.1 13.1 9.9 24.2 15.3 17.3 18.6 27.3 45.9 22.2 14.8 21.8 44.4 30.2 28.6 36.2 32.4 32.7 42.2 20.6 15.1 16.4 23.6 19.1 22.2 30.5 35.7 23.4 14.3 24.8 20.4 29.9 23.9 52.4 25.1 7.2 7.8 39.7 15.5 42.4 10.9 61.5 26.5 50.8 43.7 50.7 38.5 25.2 29.7 34.0 31.8 23.8 27.4 35.4 22.6 29.6 33.5 17.4 32.9 23.9 8.8 9.2 9.2 10.2 9.3 9.5 9.2 8.9 9.1 9.5 10.0 9.1 9.6 20.7 9.6 7.7 4.6 21.1 21.9 13.1 17.6 19.9 11.9 15.6 12.8 3.9 22.8 15.6 5.5 8.4 59.8 46.2 11.6 27.4 22.4 114.8 14.7 16.0 16.8 11.4 28.2 5.1 19.6 61.9 16.1 14.8 13.3 36.8 21.6 13.9 15.7 31.5 11.8 7.2 15.6 16.2 17.3 14.5 20.5 17.1 20.7 14.2 4.7 20.4 13.3 50.4 6.6 13.2 17.7 15.2 19.2 17.4 18.9 15.1 20.9 11.7 12.6 13.1 16.5 17.4 32.3 32.6 21.8 17.6 26.7 24.7 21.7 19.8 12.1 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104853287-104858574 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 47.4;epididymis: 32.7;kidney: 30.7;seminal vesicle: 15.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 58.8;Distal tubular cells: 27.4;Proximal tubular cells: 13.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 59.6;AN3-CA: 53.9;HEK 293: 21.2;RPTEC TERT1: 57.3;SH-SY5Y: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.8 0.1 25.2 0.1 36.1 0.0 0.3 35.5 37.1 0.0 0.0 0.6 0.0 0.0 32.7 0.0 0.0 0.0 0.0 26.0 21.0 30.7 0.0 0.0 0.0 37.5 35.8 17.3 0.1 0.0 0.0 0.1 0.0 39.6 0.2 0.2 0.3 1.3 15.3 0.0 1.2 0.1 0.0 24.8 0.0 0.6 0.2 32.0 0.2 0.0 0.0 0.1 0.0 0.0 47.4 0.0 0.0 59.6 53.9 0.6 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 6.5 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 1.8 1.7 0.0 0.0 0.9 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 6.4 1.4 0.0 57.3 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 36.1 35.5 37.1 26.0 21.0 37.5 35.8 17.3 39.6 24.8 32.0 47.4 0.0 0.0 0.0 1.0 0.5 0.8 0.1 0.0 0.0 3.8 0.0 0.6 1.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.2 5.4 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 13.2 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43267065 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;brain: 19.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 22.1;Inhibitory neurons: 16.3;NK-cells: 8.2;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 17.2;SCLC-21H: 15.6;SK-BR-3: 14.1;T-47d: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favorable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 0.8 1.7 18.9 1.3 17.0 14.8 3.3 11.8 18.0 1.6 5.5 0.8 0.9 1.2 0.4 1.1 2.5 2.3 1.2 19.5 16.6 1.8 0.4 1.7 5.3 15.4 15.2 19.0 1.2 3.7 4.3 4.4 0.7 14.8 1.5 0.4 1.3 3.5 1.7 0.8 0.9 1.3 1.2 12.2 3.8 0.7 2.4 16.6 1.1 0.8 0.7 3.7 1.2 2.6 17.7 9.7 8.2 0.0 0.1 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.2 5.2 8.4 8.6 0.8 0.0 0.1 1.3 7.7 0.0 0.0 6.3 0.0 0.1 0.4 3.7 0.0 3.0 2.0 8.7 0.7 0.0 0.0 0.0 0.4 17.2 0.0 0.0 1.9 0.0 0.2 0.8 4.3 0.0 0.0 0.0 0.2 0.6 4.5 15.6 0.0 0.0 14.1 0.1 7.1 15.6 0.1 0.1 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.1 2.9 0.5 1.1 0.2 0.7 2.2 2.9 2.6 0.2 1.4 9.4 6.3 0.4 5.1 0.0 1.2 18.9 17.0 11.8 18.0 19.5 16.6 15.4 15.2 19.0 14.8 12.2 16.6 17.7 0.2 0.0 0.0 3.6 1.1 0.5 0.3 2.4 0.6 2.0 4.3 4.1 2.2 0.0 0.2 3.7 0.0 0.4 6.7 0.2 0.0 0.3 1.3 1.8 0.5 1.0 0.0 0.0 22.1 1.3 1.1 1.0 0.5 2.3 0.0 1.9 1.1 0.1 0.9 1.7 16.3 0.3 0.0 0.9 1.7 0.7 0.0 1.4 0.0 1.0 1.4 0.3 8.2 1.5 1.0 2.1 0.1 0.0 0.7 1.2 0.2 0.6 0.6 0.3 0.0 0.9 0.4 0.7 7.7 0.5 0.3 0.3 5.0 0.5 0.6 0.1 SPOUT1 "C9orf114, CENP-32, HSPC109" ENSG00000198917 "SPOUT domain containing methyltransferase 1" Q5T280 9 128819651-128829794 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.0;Extravillous trophoblasts: 25.2;Granulosa cells: 32.5;Hofbauer cells: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076946 Approved NA NA "HPA076946: " "unprognostic (1.85e-1)" "unprognostic (3.51e-3)" "unprognostic (1.76e-2)" "unprognostic (3.32e-3)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (6.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.27e-1)" "prognostic favorable (4.09e-4)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (1.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (3.70e-2)" 16.6 19.2 20.1 14.4 20.8 13.6 18.4 19.7 25.8 20.0 18.3 18.3 11.3 17.7 5.7 25.9 20.0 9.2 18.5 19.5 20.3 24.2 45.4 17.0 19.1 20.1 20.4 18.7 20.2 23.1 9.2 20.7 9.6 20.3 33.0 5.5 6.6 18.9 8.7 20.8 22.9 20.7 8.1 19.2 31.0 23.1 13.3 20.7 13.5 23.0 6.1 10.4 23.0 19.9 21.1 13.7 31.2 25.2 37.2 14.1 14.2 44.5 14.5 8.7 26.3 14.2 44.1 24.1 27.5 15.6 14.9 26.8 56.3 23.3 22.6 8.7 26.3 24.2 21.8 51.6 36.6 15.4 32.6 39.2 14.8 18.9 18.2 18.9 11.2 19.6 40.3 44.7 24.0 14.9 88.1 40.8 66.5 33.2 63.5 39.5 44.0 24.1 48.7 17.5 25.4 29.6 28.7 27.7 40.7 19.0 14.0 40.3 36.5 20.0 37.3 16.6 25.6 38.2 26.1 47.0 28.9 23.7 28.3 30.8 5.5 11.7 6.1 24.7 12.6 25.5 19.1 19.9 22.8 13.9 19.3 19.5 19.7 2.9 25.2 10.3 15.7 19.8 17.4 20.1 20.8 19.7 25.8 19.5 20.3 20.1 20.4 18.7 20.3 19.2 20.7 21.1 9.3 3.2 10.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 19.2 12.2 0.0 0.0 8.1 9.2 0.0 34.0 10.8 0.0 11.7 15.7 0.0 6.4 10.2 6.1 0.0 0.0 0.0 17.6 25.2 4.3 0.0 7.7 13.9 32.5 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 15.5 0.0 0.0 0.0 0.0 15.7 0.0 0.0 1.8 0.0 0.0 19.3 4.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 10.4 5.4 12.1 0.0 0.0 RPL39 "L39, RPL39P42" ENSG00000198918 "Ribosomal protein L39" P62891 X 119786504-119791630 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047105 Uncertain NA NA "HPA047105: AB_2679933" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-2)" "unprognostic (5.03e-2)" "unprognostic (3.23e-3)" "unprognostic (5.05e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-1)" "unprognostic (2.72e-1)" "unprognostic (4.38e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (3.26e-2)" "unprognostic (5.77e-2)" "unprognostic (1.81e-2)" "unprognostic (7.31e-3)" 2744.1 1936.5 1364.5 1578.5 1382.5 4472.1 4833.1 1379.1 2235.5 2515.1 1384.6 2220.1 1377.4 1542.3 1781.8 2624.1 2098.3 1029.1 1846.7 1334.6 1408.2 1639.4 2231.3 1771.5 2906.4 1415.4 1374.0 1322.2 4433.0 3232.7 1243.8 933.2 1230.9 1405.8 1901.2 2016.3 677.0 2126.5 1119.6 2859.4 3665.2 2139.1 1221.8 1461.6 2718.0 1952.3 370.0 1397.4 2546.1 1559.0 2563.0 3236.7 2204.7 2452.6 1446.0 3790.9 2372.2 3355.8 2743.6 5777.8 7348.5 3178.2 3493.5 4019.6 3974.8 3532.9 2448.7 2820.6 5944.9 3525.9 3582.5 2637.3 3088.9 5379.6 4672.4 4104.6 2114.7 8156.7 2834.5 3244.6 3575.6 4849.7 4998.5 2254.4 7107.5 8225.4 3115.6 5824.5 5356.6 4678.2 3946.7 3572.9 4114.3 3734.8 5153.1 3507.5 9057.2 5322.7 8755.2 5275.2 3233.9 4361.7 7431.3 4643.9 3008.5 1991.1 4035.7 4464.5 4033.9 6372.9 3147.0 2124.6 5293.9 3527.2 1439.4 1421.9 3886.7 5654.4 2576.9 4797.0 6316.6 2145.5 7095.7 1744.6 1417.6 2604.1 867.7 1828.2 1821.3 2930.8 4593.5 4019.7 2791.2 2704.3 4082.4 4601.8 3724.8 584.5 2142.6 1686.8 3008.0 2822.1 6382.9 1364.5 1382.5 1379.1 2235.5 1334.6 1408.2 1415.4 1374.0 1322.2 1405.8 1461.6 1397.4 1446.0 3052.5 865.4 1237.9 15.7 9102.0 7445.1 4567.7 6856.6 8468.5 201.2 9097.0 13551.0 642.9 2480.7 2636.8 938.0 85.5 3985.6 4514.3 1526.9 2089.5 2510.9 62.3 2477.4 5388.1 2798.9 2432.4 3741.9 16.0 5763.7 7685.9 2812.1 3289.6 4119.0 1733.1 4292.9 4501.6 5863.2 3870.0 80.8 19.4 5577.5 1761.9 7840.8 7734.3 305.0 5968.4 4747.5 3858.0 20.6 6326.8 988.4 3492.3 9.0 20.0 4404.6 5124.9 2210.6 4802.9 3960.4 3756.8 2888.1 1088.6 368.1 1498.8 4028.0 2561.6 55.7 245.9 10630.2 8681.3 4615.1 6523.4 2580.5 6330.7 4299.6 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589705-108694840 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 327.4;Respiratory ciliated cells: 218.2;Spermatocytes: 351.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles No No Vesicles "HPA035066: AB_10601549, HPA049232: AB_2680684" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favorable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 5.2 9.8 17.7 4.9 20.6 4.0 5.4 12.4 19.4 5.3 19.7 4.6 3.1 8.0 10.2 3.9 18.9 6.0 11.8 17.9 18.0 11.0 4.3 6.6 10.3 16.3 14.4 16.4 10.6 5.4 7.8 24.7 4.9 11.4 9.8 4.7 30.1 3.6 7.0 12.5 3.7 4.0 5.2 13.9 8.4 6.6 34.9 13.9 8.6 12.9 16.3 8.1 5.3 3.4 17.6 9.8 8.2 24.8 14.7 10.7 10.8 8.6 6.1 12.2 10.1 13.9 12.1 6.8 18.0 12.8 6.6 20.9 3.5 13.7 5.3 21.0 6.6 6.1 8.1 3.4 8.5 6.3 3.3 4.5 11.8 2.8 9.4 11.4 10.2 6.4 10.9 8.0 8.7 19.6 8.6 8.2 3.5 15.5 5.0 6.2 10.4 20.5 1.8 8.4 4.7 17.0 16.2 9.8 1.0 11.1 21.6 15.1 2.8 7.6 9.0 13.7 1.8 5.3 9.6 6.0 34.7 6.8 2.7 11.3 6.5 0.5 1.2 4.1 0.8 5.0 6.3 4.2 5.1 0.5 4.6 3.6 4.8 0.1 10.6 1.5 1.5 6.0 1.5 17.7 20.6 12.4 19.4 17.9 18.0 16.3 14.4 16.4 11.4 13.9 13.9 17.6 7.3 12.8 12.8 86.8 14.8 7.5 8.6 16.3 9.1 67.8 9.6 8.3 45.0 4.3 26.6 33.1 327.4 21.9 17.1 4.1 13.7 12.9 28.4 106.1 16.0 8.7 52.8 11.1 145.2 9.0 8.8 18.2 9.2 9.2 8.8 30.9 7.5 4.4 9.4 77.4 103.4 6.9 34.6 5.7 7.5 59.9 17.4 5.7 7.2 37.5 10.5 32.9 11.3 79.4 80.6 8.9 4.6 17.7 9.0 6.9 4.5 20.6 218.2 33.7 19.7 16.6 17.7 351.3 112.5 4.4 7.4 14.8 29.4 35.4 7.4 5.6 KIAA0753 "MNR, OFIP" ENSG00000198920 KIAA0753 Q2KHM9 17 6578147-6640711 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9;Excitatory neurons: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA023057, HPA023494" Enhanced Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA023057: AB_1852338, HPA023494: AB_1852339" "unprognostic (3.72e-2)" "unprognostic (5.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.93e-2)" "unprognostic (5.17e-2)" "unprognostic (1.47e-1)" "unprognostic (4.19e-3)" "unprognostic (1.47e-1)" "unprognostic (3.01e-3)" "unprognostic (1.82e-1)" "unprognostic (6.10e-3)" "unprognostic (1.47e-2)" "unprognostic (9.57e-2)" "unprognostic (1.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" 4.8 5.8 7.2 4.6 7.0 3.6 7.4 4.2 7.8 7.8 9.6 6.6 3.6 8.6 11.1 7.1 10.2 5.2 3.9 7.7 6.2 6.6 3.8 5.4 5.1 4.9 4.9 7.6 10.2 5.7 14.1 8.9 5.4 4.3 7.8 6.9 10.9 5.7 8.4 2.2 5.8 5.5 8.5 4.1 7.7 6.6 16.7 5.2 8.5 9.1 2.7 5.2 6.5 6.4 6.8 19.9 16.1 19.4 13.2 7.2 11.9 7.7 10.5 10.0 15.1 14.0 11.1 4.8 7.9 7.1 10.4 9.9 18.4 17.8 10.1 23.9 8.1 15.1 4.3 14.8 8.7 12.0 6.9 9.3 7.1 12.9 13.7 13.0 15.5 11.8 9.1 9.9 1.0 12.3 5.9 7.7 6.2 11.8 9.7 8.1 11.1 6.8 2.5 13.9 12.9 7.3 12.7 13.2 3.9 8.9 12.5 6.5 4.5 11.1 13.1 6.7 7.6 16.8 1.8 2.6 2.8 9.8 4.5 10.6 0.0 0.7 0.6 0.5 0.7 0.6 0.8 0.5 0.5 0.4 0.4 0.3 0.3 1.9 0.4 0.4 0.6 0.4 0.2 7.2 7.0 4.2 7.8 7.7 6.2 4.9 4.9 7.6 4.3 4.1 5.2 6.8 5.4 6.4 12.3 25.8 3.4 3.2 2.9 2.6 4.6 3.8 5.9 5.2 3.6 7.2 8.3 0.0 16.7 2.4 2.9 5.2 0.0 4.1 90.9 13.2 9.5 5.7 7.2 3.0 46.6 3.8 1.1 6.3 9.7 5.8 1.3 12.9 3.9 2.1 2.5 10.1 29.2 3.9 4.1 3.1 0.6 15.4 4.4 3.2 0.0 25.3 2.8 2.1 2.1 27.2 14.7 3.9 4.9 3.4 5.6 3.6 2.2 2.9 29.3 12.1 0.0 5.9 5.4 15.1 7.8 5.0 2.4 1.2 3.1 9.3 4.4 2.7 DCLRE1A "hSNM1, KIAA0086, PSO2, SNM1" ENSG00000198924 "DNA cross-link repair 1A" Q6PJP8 10 113834725-113854383 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036907 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA036907: AB_10673626" "unprognostic (1.22e-1)" "unprognostic (7.55e-2)" "unprognostic (4.84e-2)" "unprognostic (3.82e-2)" "unprognostic (1.09e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.74e-5)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (4.05e-2)" "unprognostic (2.85e-1)" "unprognostic (3.07e-1)" "unprognostic (6.34e-2)" 2.1 3.8 4.1 3.9 4.2 4.7 5.2 4.4 5.6 4.0 4.1 4.3 4.2 2.9 5.5 3.3 4.2 2.8 4.4 4.2 4.4 6.1 9.8 3.6 5.3 4.0 4.0 3.9 5.3 7.4 8.5 2.9 4.2 4.3 5.9 5.2 8.0 5.0 4.0 3.7 3.7 4.1 3.2 3.9 4.1 5.2 4.7 4.2 5.1 5.2 3.3 5.3 3.2 1.9 4.2 15.8 13.0 19.3 19.7 2.5 4.2 11.0 9.4 9.5 12.5 14.3 10.2 21.1 12.2 10.4 4.8 9.7 12.9 18.6 8.2 16.1 24.2 16.0 20.7 8.0 13.1 8.2 21.9 18.8 2.8 9.8 10.5 18.5 8.3 7.7 16.3 24.1 12.9 7.1 9.4 10.6 8.8 9.4 12.5 6.9 6.1 23.0 8.0 8.3 7.3 8.4 13.9 5.4 9.2 13.8 13.2 11.0 10.5 6.8 7.2 14.1 9.8 15.6 14.9 18.2 18.6 10.7 31.5 10.5 1.3 0.3 0.7 2.8 0.2 1.8 0.6 1.2 1.9 1.1 0.3 0.8 1.4 0.1 1.0 0.5 0.4 3.2 1.2 4.1 4.2 4.4 5.6 4.2 4.4 4.0 4.0 3.9 4.3 3.9 4.2 4.2 0.9 6.4 4.1 4.9 1.3 0.6 0.6 2.8 0.6 4.2 2.9 1.9 9.6 5.7 3.6 1.8 0.0 3.0 2.0 2.2 7.9 1.9 0.7 2.9 1.8 1.6 3.5 6.5 4.9 1.1 1.8 2.5 1.5 2.0 1.3 3.6 1.8 7.7 3.2 6.7 4.7 2.5 4.1 3.8 0.6 0.5 1.5 10.3 0.0 2.8 3.6 3.9 2.1 8.0 4.1 1.6 2.3 1.5 3.0 1.3 1.6 3.7 5.1 3.9 0.0 1.7 1.2 6.0 5.4 2.5 0.6 0.7 3.1 2.4 3.4 0.7 ATG9A "APG9L1, FLJ22169" ENSG00000198925 "Autophagy related 9A" Q7Z3C6 2 219219380-219229717 "Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 83.8;Late spermatids: 105.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059551 Uncertain Supported Vesicles NA NA Vesicles "HPA059551: AB_2684060" "unprognostic (1.53e-2)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (4.80e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (8.99e-3)" "unprognostic (2.07e-1)" "unprognostic (3.55e-3)" "unprognostic (4.67e-2)" "unprognostic (4.21e-1)" "unprognostic (2.23e-2)" "unprognostic (4.84e-2)" "unprognostic (3.15e-1)" "unprognostic (5.61e-2)" "unprognostic (1.95e-2)" 25.8 23.8 23.3 17.4 26.6 45.1 19.3 25.6 36.9 19.2 8.3 25.7 31.7 24.3 14.4 31.7 19.0 22.0 41.5 27.1 22.3 20.2 26.1 23.9 19.6 26.7 25.6 27.0 20.6 28.3 31.5 17.8 30.9 26.9 21.8 22.0 24.8 24.1 23.0 117.7 31.1 29.9 28.3 23.9 21.8 23.0 62.8 25.7 15.8 18.6 63.3 21.4 22.9 22.9 26.2 29.4 35.7 26.9 64.0 50.3 55.1 35.9 52.1 56.1 67.3 60.2 52.9 38.8 7.7 43.7 79.8 54.7 58.0 43.2 56.9 49.6 22.6 70.7 55.7 90.1 63.9 54.9 14.1 40.6 56.7 91.4 68.7 63.0 60.9 68.2 18.6 75.6 27.0 46.2 38.3 12.2 33.4 19.5 28.5 26.9 16.9 36.7 30.2 40.0 38.6 42.6 25.7 52.0 46.7 46.5 52.0 17.3 39.3 52.5 67.0 32.3 28.7 47.1 15.5 14.7 11.2 55.7 33.9 37.2 6.5 12.4 6.3 7.2 18.0 7.2 5.6 5.6 9.1 8.5 3.6 5.4 6.1 11.2 9.7 22.6 4.1 7.1 11.6 23.3 26.6 25.6 36.9 27.1 22.3 26.7 25.6 27.0 26.9 23.9 25.7 26.2 0.3 0.0 4.5 12.7 8.2 7.8 7.6 10.6 8.6 18.9 0.3 0.3 33.2 17.2 7.1 0.0 14.6 26.8 4.1 44.0 0.0 0.2 83.8 0.6 1.5 10.0 13.8 34.7 15.2 0.5 24.4 9.1 11.7 0.8 10.2 0.3 16.8 37.1 11.5 21.9 14.1 17.6 6.1 13.3 7.0 105.9 14.0 4.8 10.6 5.6 7.0 20.5 9.2 9.5 12.5 0.3 27.6 8.6 6.7 13.4 39.3 0.3 4.7 15.7 13.1 7.1 5.5 54.9 13.8 14.2 11.1 34.8 7.5 0.8 18.5 10.5 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069691-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 22.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 204.3;Excitatory neurons: 142.3;Horizontal cells: 67.3;Inhibitory neurons: 107.6;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 82.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.9;HaCaT: 3.1;HEL: 4.6" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851" "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 0.4 2.8 9.0 0.1 18.6 1.8 1.2 7.6 16.0 0.5 0.0 1.2 0.6 0.5 0.2 0.7 0.6 0.6 0.6 22.0 6.0 0.9 3.1 0.4 0.0 2.8 3.1 13.1 0.2 0.9 0.5 0.8 0.4 4.6 0.7 1.1 3.7 1.5 1.4 0.2 1.1 0.7 0.4 0.0 0.0 1.4 1.9 5.6 0.1 0.1 0.2 0.2 0.6 0.4 19.4 3.9 0.0 1.8 1.1 0.0 0.0 0.2 0.3 0.4 0.5 0.4 0.9 1.0 0.0 2.2 0.1 0.6 3.1 0.6 0.1 0.1 0.1 1.7 4.6 0.6 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 1.0 0.6 0.4 0.0 0.1 2.1 0.3 0.0 1.3 0.6 1.5 0.0 0.7 0.1 0.9 1.4 1.4 0.9 0.8 0.1 0.6 0.5 1.1 0.2 0.4 0.0 0.4 0.0 0.6 2.2 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.0 18.6 7.6 16.0 22.0 6.0 2.8 3.1 13.1 4.6 0.0 5.6 19.4 4.4 0.0 0.5 5.9 0.4 2.9 6.1 0.7 0.6 11.6 14.1 21.5 2.3 2.8 1.5 22.0 204.3 0.2 0.4 7.9 9.8 1.0 36.8 4.5 3.5 3.6 6.7 2.7 142.3 1.2 0.3 1.3 9.7 7.9 0.0 8.0 3.3 21.2 0.1 67.3 107.6 10.2 0.0 0.8 0.4 12.4 4.4 0.2 0.0 43.1 0.0 13.4 1.0 79.9 82.9 0.7 5.3 7.2 0.1 6.8 3.9 0.6 1.7 3.8 6.6 0.9 1.1 2.0 2.2 2.3 2.0 0.5 0.5 1.9 5.3 7.8 CSAG1 "CSAGE, CT24.1" ENSG00000198930 "Chondrosarcoma associated gene 1" Q6PB30 X 152727484-152733735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;choroid plexus: 2.5" "Group enriched" "Detected in some" 4 "Spermatocytes: 5.4;Spermatogonia: 12.4" "Cancer enhanced" "Detected in many" "melanoma: 16.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 120.2;HMC-1: 64.4;K-562: 44.4;OE19: 140.6;PC-3: 58.8;U-266/70: 103.4" NA NA "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" "unprognostic (8.96e-3)" "unprognostic (4.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.83e-3)" "unprognostic (5.96e-2)" "unprognostic (4.21e-1)" "unprognostic (6.68e-3)" "unprognostic (3.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-6)" "unprognostic (5.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-3)" "unprognostic (8.70e-3)" 0.0 0.0 2.9 0.1 2.7 0.0 0.0 2.6 7.1 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 2.6 0.0 0.0 0.0 0.4 2.8 2.7 2.5 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 1.3 2.7 0.0 0.1 0.0 0.2 0.0 0.0 2.8 0.1 0.0 0.0 8.4 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.2 0.0 0.0 0.0 0.0 0.4 0.0 2.2 2.0 0.0 0.0 0.0 64.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 44.4 0.6 0.0 0.0 0.2 0.0 0.0 140.6 58.8 0.0 0.0 0.3 0.0 0.1 6.4 36.1 0.0 21.6 19.1 0.0 1.0 0.0 0.0 0.1 0.8 21.8 7.3 103.4 1.7 0.0 0.7 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.7 2.6 7.1 2.7 2.6 2.8 2.7 2.5 2.9 2.5 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.4 12.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811937 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Approved Nucleoplasm,Cytosol NA NA 1600000 "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 112.0 162.6 26.0 74.3 26.6 104.0 113.3 27.9 39.8 96.4 33.7 95.2 72.8 81.9 25.8 232.9 88.4 31.6 69.7 24.8 31.0 129.2 191.9 86.6 84.5 28.4 26.6 23.9 73.9 170.8 66.7 65.4 37.3 27.2 114.5 40.6 5.1 120.7 45.0 63.3 236.2 107.7 30.1 29.3 129.6 132.8 35.5 29.3 77.9 97.7 24.0 65.0 96.5 155.0 31.1 157.9 228.3 44.9 200.4 54.2 106.0 232.2 117.1 105.0 136.0 52.6 237.6 189.0 145.5 221.9 68.4 65.0 165.3 74.8 195.4 27.5 102.9 417.7 124.3 106.5 253.0 168.1 87.4 97.7 113.1 207.6 109.0 139.4 63.7 172.6 244.6 266.6 107.9 71.4 586.0 242.1 254.7 169.4 169.5 288.8 259.2 69.2 351.5 156.3 107.0 218.2 132.4 223.5 130.7 131.2 41.9 427.9 171.1 111.4 122.5 104.9 99.5 118.0 205.9 186.5 408.8 179.9 228.4 110.5 77.7 544.5 202.8 474.5 473.5 631.7 501.1 612.0 510.3 562.4 517.3 557.8 475.3 31.8 501.8 322.1 731.6 551.8 998.0 26.0 26.6 27.9 39.8 24.8 31.0 28.4 26.6 23.9 27.2 29.3 29.3 31.1 146.5 115.4 147.4 5.9 247.0 319.0 320.0 375.7 207.7 19.9 346.2 479.7 46.9 230.2 206.8 92.0 6.2 265.0 262.3 273.1 406.9 404.3 11.8 124.6 180.3 163.1 210.8 150.6 5.1 442.6 401.5 170.3 192.7 148.4 131.9 154.9 147.8 309.6 348.0 15.2 4.4 386.4 160.7 253.9 336.1 35.4 239.9 214.6 297.1 3.7 449.4 78.7 355.3 2.5 7.2 392.3 228.3 135.4 171.6 404.3 349.2 647.9 125.5 20.4 39.5 135.6 186.5 18.4 126.9 358.8 494.7 172.7 285.7 339.5 426.7 385.2 GPRASP1 "GASP, GASP1" ENSG00000198932 "G protein-coupled receptor associated sorting protein 1" Q5JY77 X 102651092-102659083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 42.6;Cardiomyocytes: 28.6;Cone photoreceptor cells: 37.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 4.5;REH: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000161, HPA031061" Approved Supported Cytosol NA NA Cytosol "HPA000161: AB_2247872, HPA031061: AB_2673718" "unprognostic (3.92e-3)" "unprognostic (1.10e-1)" "unprognostic (2.07e-4)" "unprognostic (1.42e-1)" "unprognostic (3.32e-2)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (2.33e-2)" "unprognostic (1.58e-1)" "unprognostic (2.82e-1)" "prognostic favorable (1.77e-5)" "unprognostic (3.34e-1)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.23e-2)" 8.0 22.8 24.7 5.5 27.7 3.8 10.0 23.4 34.6 30.9 7.2 18.1 2.5 25.8 10.8 4.4 26.9 7.6 15.6 24.9 31.2 8.9 2.9 7.3 9.5 19.7 18.8 25.1 53.8 5.7 17.4 43.8 2.9 23.9 20.6 4.5 30.1 8.8 17.9 6.1 5.0 12.5 15.5 12.6 11.4 9.7 5.3 23.3 6.9 26.3 4.2 7.7 18.7 17.1 23.5 0.2 0.5 1.7 1.1 1.7 1.7 1.0 1.8 0.1 2.7 4.5 0.2 0.3 0.0 0.4 3.8 0.3 0.5 0.5 0.1 3.9 0.0 0.2 0.1 0.6 0.5 1.4 0.2 0.2 2.2 0.7 3.3 0.3 0.4 0.2 1.8 0.3 0.1 4.3 0.4 3.7 0.1 1.2 0.3 0.6 5.6 1.7 0.0 0.2 0.4 1.7 2.7 0.6 0.2 0.5 1.4 0.2 0.9 0.5 0.8 1.0 0.5 0.3 0.3 0.5 0.0 0.4 0.2 1.1 0.0 0.0 0.0 0.5 0.0 1.3 0.2 1.1 0.4 0.0 0.7 2.3 2.3 0.0 0.1 0.0 0.3 0.8 0.5 24.7 27.7 23.4 34.6 24.9 31.2 19.7 18.8 25.1 23.9 12.6 23.3 23.5 5.1 0.0 3.6 0.0 4.4 3.6 4.1 0.8 1.8 42.6 1.8 3.0 28.6 1.5 3.5 5.5 37.5 0.4 3.5 0.1 0.0 0.2 0.3 0.6 6.5 7.3 6.0 0.4 0.0 0.2 0.2 9.9 1.1 0.7 2.5 13.9 7.1 0.7 0.3 6.7 0.0 0.7 0.0 0.3 2.0 1.7 15.2 1.3 1.8 0.0 0.5 12.9 3.1 0.0 0.0 0.6 0.1 15.4 2.2 3.8 0.4 1.7 1.2 18.8 6.6 16.9 8.5 7.0 2.4 0.4 0.9 0.1 7.3 6.5 0.8 1.6 TBKBP1 "KIAA0775, ProSAPiP2" ENSG00000198933 "TBK1 binding protein 1" A7MCY6 17 47694081-47712050 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062347, HPA064856" Approved Approved Nucleoplasm NA Yes Nucleoplasm "HPA062347: AB_2684744, HPA064856: AB_2685371" "unprognostic (2.14e-3)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.92e-2)" "unprognostic (2.39e-1)" "unprognostic (3.09e-2)" "unprognostic (3.72e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "prognostic favorable (8.14e-6)" "unprognostic (5.83e-2)" "unprognostic (1.14e-1)" "unprognostic (3.03e-1)" "unprognostic (4.22e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.59e-5)" 13.7 10.9 25.3 8.6 22.3 6.7 12.1 10.9 30.4 16.9 7.1 12.1 3.1 14.1 2.1 11.4 14.4 8.1 16.5 27.1 17.9 12.9 3.4 12.4 6.0 18.4 18.6 22.1 21.6 9.7 10.2 11.7 9.5 18.5 13.5 2.3 10.5 16.0 9.4 35.8 7.2 7.9 8.0 10.8 18.6 10.6 14.3 25.0 3.2 11.8 22.5 3.4 15.0 12.4 18.6 0.5 10.0 18.3 19.4 9.2 9.3 11.9 10.1 10.6 4.9 5.8 62.8 1.5 0.3 9.9 12.6 8.7 1.1 14.4 2.6 2.9 12.3 32.6 26.8 9.8 10.7 21.2 5.1 5.7 18.8 6.5 1.1 1.8 15.2 17.4 7.3 23.5 0.0 2.8 2.8 3.3 25.2 25.5 0.5 7.0 12.0 5.7 10.5 6.1 0.8 15.8 29.5 4.8 1.2 5.2 17.2 11.0 11.4 20.2 15.1 17.8 18.4 1.2 6.8 0.7 12.4 8.8 9.6 3.9 0.0 0.2 0.4 1.0 0.1 0.5 0.0 0.3 0.8 0.2 0.2 0.1 0.3 2.2 0.9 0.0 0.2 0.2 0.1 25.3 22.3 10.9 30.4 27.1 17.9 18.4 18.6 22.1 18.5 10.8 25.0 18.6 15.5 0.0 1.1 13.4 2.4 4.0 3.2 0.9 1.8 13.7 2.8 3.4 3.7 1.5 1.1 3.7 2.1 0.1 6.3 0.0 1.9 1.1 6.9 0.7 3.5 9.7 5.3 3.2 6.9 1.8 0.2 3.9 2.6 1.2 0.0 4.2 10.4 1.1 3.2 28.6 12.1 0.5 4.1 2.9 4.0 6.6 8.7 2.2 1.8 5.6 1.1 4.7 5.2 9.5 1.2 0.9 0.0 8.6 2.2 5.5 0.0 5.0 0.8 3.7 0.0 1.5 2.7 3.8 5.3 2.0 3.0 0.3 3.9 1.3 0.1 2.2 MAGEE1 "DAMAGE, KIAA1587" ENSG00000198934 "MAGE family member E1" Q9HCI5 X 76427710-76431342 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 7.8" "Low region specificity" "Detected in all" HPA003047 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA003047: AB_1079298" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-3)" "unprognostic (1.76e-1)" "unprognostic (3.94e-2)" "unprognostic (5.61e-3)" "unprognostic (8.72e-3)" "unprognostic (2.41e-3)" "unprognostic (1.43e-1)" "prognostic favorable (3.95e-4)" "unprognostic (7.91e-2)" "prognostic favorable (6.86e-6)" "unprognostic (4.60e-3)" "unprognostic (2.71e-1)" "unprognostic (6.03e-3)" "unprognostic (5.99e-3)" 1.4 3.2 7.9 1.6 12.1 0.4 1.7 4.2 21.9 2.6 0.0 1.8 0.5 3.3 1.8 1.0 2.5 1.1 2.2 11.7 13.4 2.1 0.4 1.3 2.5 8.8 7.4 13.0 4.8 2.6 6.2 6.1 0.0 10.2 3.3 0.9 6.5 1.8 4.0 1.2 1.7 1.8 2.6 0.3 2.7 1.6 0.4 9.0 2.9 2.1 0.9 1.9 2.2 1.8 23.0 0.2 3.8 3.9 7.5 2.7 1.5 3.4 2.9 2.9 2.4 1.3 0.8 0.6 0.8 1.4 2.5 7.8 2.9 5.8 5.4 1.9 1.9 0.1 0.0 0.0 2.5 0.5 1.5 0.5 1.1 2.4 0.6 0.6 0.1 0.9 4.2 0.3 0.0 3.6 0.5 4.3 0.2 4.7 0.0 5.8 3.4 2.9 0.0 3.1 0.0 0.0 2.0 0.0 0.4 0.6 3.9 1.7 0.1 0.5 3.6 4.5 3.8 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.2 0.5 0.0 0.2 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.1 7.9 12.1 4.2 21.9 11.7 13.4 8.8 7.4 13.0 10.2 0.3 9.0 23.0 0.8 3.2 2.6 3.3 1.7 0.5 0.7 1.2 1.2 11.2 0.9 1.9 1.9 1.5 1.1 1.8 4.2 0.2 1.4 0.3 1.9 1.4 0.0 0.4 1.3 2.4 0.0 0.4 12.2 1.5 0.4 1.3 1.1 0.4 1.3 1.5 1.8 0.2 0.1 28.6 12.2 0.4 0.0 0.3 0.0 0.1 1.5 0.1 0.0 3.7 0.1 5.5 2.1 5.5 5.0 0.7 0.0 4.5 0.3 0.3 0.0 1.3 0.3 5.0 19.7 2.7 3.6 0.3 0.2 0.6 0.1 0.1 2.5 0.8 0.1 0.2 CCDC167 "C6orf129, dJ153P14.2" ENSG00000198937 "Coiled-coil domain containing 167" Q9P0B6 6 37482938-37499893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 281.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 145.2;granulocytes: 140.2;T-cells: 423.5" "Cell line enriched" "Detected in all" 9 "U-698: 1553.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045215 Uncertain Approved Cytosol NA NA Cytosol "HPA045215: AB_10962866" "unprognostic (1.82e-1)" "prognostic favorable (7.59e-4)" "unprognostic (6.99e-2)" "unprognostic (3.66e-1)" "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.73e-1)" "unprognostic (7.67e-2)" "unprognostic (3.41e-3)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.71e-7)" "unprognostic (1.57e-1)" "unprognostic (4.06e-1)" "unprognostic (2.44e-1)" "unprognostic (1.95e-1)" 11.6 19.3 48.2 23.0 49.2 28.5 18.7 50.0 54.6 22.3 45.9 20.1 11.7 15.9 45.5 26.8 21.4 12.0 31.8 46.3 48.2 21.9 56.9 13.4 49.9 50.6 48.6 46.1 8.6 19.3 27.4 15.1 15.6 49.7 23.0 23.8 14.5 22.8 13.7 21.6 12.7 14.5 31.9 51.3 28.5 15.1 37.9 50.1 91.6 15.2 26.4 70.9 17.0 17.2 55.9 27.2 61.9 137.1 95.4 37.4 65.5 50.4 31.6 25.8 48.8 54.5 66.1 39.5 146.9 69.4 54.8 92.1 20.7 90.4 74.1 49.7 122.9 166.9 69.7 25.3 168.7 39.1 68.4 26.4 30.7 153.4 52.1 47.4 34.2 154.0 150.2 44.1 123.1 85.1 90.2 129.1 56.6 8.0 76.7 39.3 79.0 48.4 108.9 66.3 53.6 93.3 109.6 47.1 46.0 74.3 119.3 50.1 70.3 38.5 31.8 61.6 17.8 32.5 89.3 97.1 1553.2 30.8 147.9 90.8 34.9 32.6 140.2 140.0 35.6 169.2 145.2 230.0 177.9 56.3 122.6 105.5 99.7 10.0 55.8 29.5 35.8 423.5 165.8 48.2 49.2 50.0 54.6 46.3 48.2 50.6 48.6 46.1 49.7 51.3 50.1 55.9 18.6 6.4 10.3 5.2 50.6 14.1 26.5 62.1 10.8 9.4 22.4 30.4 50.0 24.3 36.0 14.7 8.4 67.1 33.4 31.8 31.3 69.3 108.2 19.1 31.8 23.4 25.2 86.7 2.2 50.4 108.7 26.4 16.3 31.7 15.2 61.9 25.0 141.9 89.8 15.2 3.2 56.2 48.8 18.8 31.4 281.6 13.1 23.8 55.2 1.9 25.2 56.5 29.9 2.0 7.3 57.9 13.6 18.8 100.2 35.9 10.8 89.0 30.3 11.8 6.6 14.0 28.7 96.8 118.9 26.2 15.2 29.7 59.7 38.1 36.6 31.9 MT-CO3 "CO3, COIII, COX3, MTCO3" ENSG00000198938 "Mitochondrially encoded cytochrome c oxidase III" P00414 MT 9207-9990 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 168609.8;heart muscle: 166512.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 98114.9;Proximal enterocytes: 47697.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 47821.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042788 Approved NA NA "HPA042788: AB_10793985" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.93e-1)" "prognostic favorable (2.01e-4)" "unprognostic (1.18e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-2)" "prognostic favorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (8.80e-3)" "unprognostic (2.75e-2)" "unprognostic (1.20e-1)" "unprognostic (9.29e-2)" "unprognostic (1.33e-2)" 26258.6 54119.7 109360.8 6462.1 102808.6 12015.0 27192.2 96197.8 168609.8 9878.6 118164.6 33900.0 21493.0 10203.5 12272.8 23325.8 10503.6 8207.2 166512.9 105841.1 94191.0 133629.1 94699.0 11840.3 7369.0 116719.3 99720.8 91342.8 9434.9 21485.5 31102.5 18238.7 9410.5 120506.6 25486.1 25649.1 14317.5 21403.4 16777.1 99274.2 27023.4 31275.8 10776.7 92906.3 14315.5 42113.8 19157.6 108723.5 6013.7 20302.9 140023.8 9445.7 19931.3 13649.8 100411.8 6374.2 7329.2 11033.5 15732.2 21484.7 8772.8 6020.3 8032.3 4753.9 3111.6 4736.6 9884.1 9176.0 14020.9 3392.6 6719.8 3380.0 16891.6 1769.9 9653.6 5455.7 4794.4 7644.1 7478.3 47821.5 16704.0 4327.8 4505.2 9419.7 8504.4 13400.6 3422.1 5046.7 10915.4 5848.3 7900.3 6047.2 13759.0 10367.7 12916.5 4589.9 25941.9 2461.0 9979.3 5226.1 4852.9 3482.9 10181.9 19232.2 10970.2 4917.9 6797.0 3741.8 4032.3 8135.9 15244.2 8471.0 19585.6 9432.2 5152.8 8782.1 9756.5 5388.8 5622.3 3881.6 8183.5 5151.5 14362.6 3475.8 2863.0 4714.1 2004.7 1562.3 1885.5 1896.8 2933.1 1703.2 1823.0 1927.4 3253.5 2137.7 2759.1 3629.6 2089.5 1920.3 1612.4 1186.9 2432.3 109360.8 102808.6 96197.8 168609.8 105841.1 94191.0 116719.3 99720.8 91342.8 120506.6 92906.3 108723.5 100411.8 2817.9 1910.3 2767.0 0.0 9010.7 8343.8 9724.5 21550.3 14394.8 0.0 8643.0 8027.7 98114.9 20354.3 11786.8 16547.0 0.0 0.0 5698.3 25285.3 4368.9 5152.0 1929.0 10274.3 6922.4 7282.3 6805.3 29321.2 0.0 6670.2 0.0 5902.5 8605.1 22503.2 2090.9 20302.5 15810.3 44494.8 0.0 0.0 0.0 19209.5 11157.0 28166.3 5603.1 9286.2 11579.8 7637.7 5553.1 0.0 9746.7 0.0 6001.1 0.0 0.0 5901.3 16542.9 7809.0 8204.1 6813.7 47697.3 33390.3 6427.3 0.0 12142.0 15068.6 7967.9 11927.7 12469.2 17772.8 8480.1 0.0 7584.6 21335.3 22667.3 15127.4 ZFP2 "FLJ21628, ZNF751" ENSG00000198939 "ZFP2 zinc finger protein" Q6ZN57 5 178895898-178933212 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 15.0;Excitatory neurons: 10.9;Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HAP1: 2.6;THP-1: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023364 Uncertain NA NA "HPA023364: AB_2671173" "unprognostic (2.07e-1)" "unprognostic (6.81e-2)" "unprognostic (6.63e-2)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (1.26e-3)" "unprognostic (4.33e-2)" "unprognostic (4.40e-3)" "unprognostic (2.98e-1)" "unprognostic (6.04e-2)" "unprognostic (2.40e-3)" "unprognostic (1.85e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.13e-1)" "unprognostic (1.79e-3)" 2.2 1.4 4.9 1.3 4.7 0.2 3.2 6.2 5.4 3.2 2.8 2.9 0.9 3.5 2.2 1.2 3.2 1.7 1.5 4.3 4.2 2.9 1.1 1.5 0.7 4.6 4.9 4.1 4.8 2.2 2.8 3.2 1.9 5.1 3.3 1.6 6.8 1.3 3.0 2.3 1.8 1.5 2.3 4.3 1.6 1.9 4.8 4.3 1.2 3.5 2.7 0.9 3.1 2.1 6.3 0.0 0.3 1.0 5.5 0.9 0.9 1.4 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.6 0.3 0.0 2.6 0.3 0.1 0.0 1.9 0.0 0.2 0.5 1.6 0.0 0.3 1.8 0.5 0.0 0.3 1.2 0.2 0.8 0.0 0.0 1.3 0.0 0.4 0.3 0.1 0.1 0.1 1.3 0.2 0.0 1.5 0.2 0.9 0.7 0.3 0.0 0.1 1.2 0.1 2.4 0.0 0.1 1.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.4 0.9 0.6 0.7 0.0 0.4 0.7 0.2 0.1 0.1 0.0 0.0 0.5 0.2 4.9 4.7 6.2 5.4 4.3 4.2 4.6 4.9 4.1 5.1 4.3 4.3 6.3 3.0 3.2 1.1 15.0 0.3 0.1 0.3 0.2 0.0 3.9 1.1 0.9 1.8 1.5 0.8 1.8 0.0 1.7 0.0 0.4 1.9 1.0 0.1 0.5 0.8 1.6 1.2 0.0 10.9 0.2 0.9 0.7 0.0 0.6 0.0 1.8 0.0 0.2 0.3 3.3 15.3 0.3 0.0 0.0 0.7 0.5 1.2 0.0 1.8 2.8 0.0 3.2 0.0 18.1 19.3 0.4 0.1 1.5 0.3 0.1 0.2 1.3 0.2 2.1 0.0 1.3 1.3 2.6 2.7 0.4 0.3 1.5 0.2 1.1 0.3 0.1 SOWAHA ANKRD43 ENSG00000198944 "Sosondowah ankyrin repeat domain family member A" Q2M3V2 5 132813302-132816786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 87.7;intestine: 39.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 39.5;Horizontal cells: 132.9;Muller glia cells: 26.8;Proximal enterocytes: 108.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 13.4;T-47d: 32.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 61.0" HPA064621 Approved NA NA "HPA064621: AB_2685302" "unprognostic (1.59e-1)" "unprognostic (5.58e-2)" "unprognostic (3.75e-3)" "unprognostic (5.34e-3)" "unprognostic (8.28e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-1)" "unprognostic (5.99e-2)" "unprognostic (1.27e-1)" "unprognostic (2.65e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.92e-2)" "prognostic favorable (9.38e-5)" "unprognostic (4.36e-1)" "unprognostic (3.00e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" 0.4 0.8 63.9 0.6 87.7 0.0 0.5 16.4 54.5 0.3 10.5 8.4 36.7 0.0 6.2 0.1 1.4 1.6 0.0 51.5 27.7 4.9 1.9 0.1 0.0 44.3 15.6 51.0 0.2 2.4 1.2 2.6 0.1 38.4 2.6 6.8 4.3 3.3 2.8 0.0 0.1 39.7 0.0 15.6 0.0 5.6 0.5 24.9 2.0 1.2 0.0 0.1 1.1 0.1 37.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.9 1.5 0.0 0.7 0.0 0.1 0.0 2.6 0.4 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 1.0 1.7 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.7 13.4 0.5 0.1 0.0 0.0 1.6 32.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 87.7 16.4 54.5 51.5 27.7 44.3 15.6 51.0 38.4 15.6 24.9 37.1 0.0 0.0 0.0 1.6 0.2 0.0 0.4 0.1 0.0 0.7 1.0 0.1 0.3 14.3 0.2 5.5 0.0 0.4 0.0 39.5 0.0 0.3 0.0 0.5 0.1 0.1 11.5 0.0 4.8 1.1 0.0 0.1 2.6 0.5 0.0 0.0 0.0 2.1 0.1 132.9 0.6 19.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 26.8 0.0 5.5 15.2 0.4 21.0 0.4 0.0 2.2 108.7 5.5 0.8 3.1 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.1 0.2 0.0 19.1 0.6 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL histone methyl-lysine binding protein 3" Q96JM7 6 130013699-130141449 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 4.4 11.1 3.6 10.0 3.6 7.8 4.8 2.1 3.8 9.5 8.9 4.6 2.8 11.3 11.9 2.4 5.5 5.4 2.2 4.5 12.2 4.8 5.8 4.1 11.2 2.8 3.3 3.0 10.2 2.3 5.7 5.5 5.8 2.6 7.0 5.0 2.1 5.0 6.2 2.5 2.7 5.2 8.4 2.7 12.7 3.3 7.6 4.0 7.7 6.1 2.2 9.0 5.8 5.3 3.2 1.7 6.5 15.2 2.4 10.4 13.4 3.1 7.8 15.9 3.0 5.5 8.0 8.1 2.7 11.0 9.9 9.3 6.5 8.7 13.6 4.6 6.1 8.8 18.3 3.2 2.0 5.2 10.8 63.5 8.8 9.6 3.6 10.2 15.1 62.5 8.3 13.3 7.1 7.7 0.7 23.2 1.9 7.0 1.7 3.3 8.7 4.2 0.0 9.8 2.5 0.5 2.0 2.9 0.7 6.1 18.2 16.4 9.3 43.0 5.1 6.9 0.9 5.3 1.4 0.1 4.7 2.5 4.5 5.2 8.2 4.9 4.8 3.7 5.5 3.2 10.7 3.5 4.7 1.9 13.4 3.2 4.1 4.9 2.1 22.7 14.8 5.9 1.0 3.6 3.6 2.1 3.8 4.5 12.2 2.8 3.3 3.0 2.6 2.7 4.0 3.2 9.1 3.2 6.5 6.5 20.5 5.1 5.1 2.4 10.2 4.2 5.3 2.8 3.9 1.5 3.8 9.2 2.1 13.4 20.7 2.8 1.9 5.6 24.2 6.1 12.8 9.4 3.6 5.0 20.8 5.4 7.1 7.3 4.6 16.1 40.4 24.7 8.9 6.3 4.0 0.0 10.5 9.3 6.1 8.2 4.0 3.1 9.6 9.5 1.8 11.2 12.9 5.3 13.4 15.6 8.5 10.9 5.2 6.0 5.2 4.7 0.5 5.9 4.1 0.7 6.6 11.2 8.6 5.8 7.6 4.0 4.4 6.2 15.6 9.5 5.0 5.5 DMD "BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85" ENSG00000198947 Dystrophin P11532 X 31097677-33339609 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Actin-binding "Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9" "Cancer enhanced" "Detected in many" "testis cancer: 8.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 7 "B-cells: 1.1;granulocytes: 4.3" "Cell line enhanced" "Detected in many" "AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000119, HPA002725, HPA023885" Enhanced NA NA "CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931" "unprognostic (3.91e-3)" "unprognostic (2.29e-1)" "unprognostic (1.83e-2)" "unprognostic (1.09e-1)" "unprognostic (2.17e-1)" "unprognostic (7.58e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-4)" "unprognostic (6.98e-2)" "unprognostic (1.25e-1)" "unprognostic (5.84e-3)" "unprognostic (2.38e-1)" "unprognostic (1.15e-2)" "unprognostic (8.76e-3)" "unprognostic (1.82e-1)" "unprognostic (9.83e-2)" "unprognostic (1.51e-2)" 15.2 14.9 13.3 5.3 13.6 0.6 17.0 0.8 16.0 6.8 8.1 27.8 5.5 18.2 11.3 9.2 17.0 21.7 38.2 16.8 3.2 5.5 50.4 7.2 4.8 3.8 2.3 10.7 14.0 53.3 4.4 4.4 15.3 3.7 13.6 8.4 80.7 30.5 31.0 74.0 11.6 9.5 22.2 0.1 2.3 15.6 8.3 3.4 3.3 7.3 68.0 6.4 21.2 7.2 11.1 0.3 0.2 27.9 0.3 0.3 0.3 7.6 6.1 0.6 2.8 3.1 13.3 0.6 0.4 0.2 12.5 2.3 8.5 10.5 15.0 4.2 7.4 8.6 3.3 10.5 30.3 14.7 1.2 3.7 3.3 9.5 4.6 17.1 15.3 6.1 2.0 2.9 0.4 8.3 0.5 4.4 0.6 13.3 0.1 9.8 0.3 25.0 0.1 0.3 3.3 0.5 8.5 0.1 2.3 2.8 27.7 2.2 0.1 1.6 0.3 0.5 1.1 4.6 0.4 23.8 0.6 1.0 2.3 14.4 0.8 0.1 2.0 0.1 0.1 0.1 1.1 0.1 0.1 0.3 0.9 0.1 0.1 4.3 0.1 0.1 0.4 0.2 0.1 13.3 13.6 0.8 16.0 16.8 3.2 3.8 2.3 10.7 3.7 0.1 3.4 11.1 8.5 28.9 25.3 164.9 6.7 20.1 7.0 6.3 3.4 78.0 26.5 50.0 452.8 7.2 15.0 3.7 308.6 33.7 0.7 0.8 3.9 3.8 22.4 22.5 1.4 9.9 8.4 0.0 1275.8 12.3 9.5 26.1 3.6 5.6 1.3 37.9 6.1 49.8 4.2 11.8 719.8 1.3 6.1 4.8 5.4 20.5 89.2 3.5 19.6 94.6 6.7 54.9 0.0 1161.6 610.2 6.0 0.1 118.8 0.2 3.6 3.6 2.1 60.4 375.9 118.3 95.2 50.3 4.0 8.8 1.8 11.5 5.1 1.0 33.1 4.2 4.8 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.9;choroid plexus: 73.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1840.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306, HPA077490" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842" "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favorable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.1 3.4 34.3 0.9 57.2 3.2 12.2 50.2 36.3 13.1 73.5 2.2 0.6 5.1 39.2 0.8 4.3 2.6 1.7 35.5 38.9 30.3 37.7 2.7 0.9 51.2 57.3 24.4 0.6 1.5 6.5 4.1 3.0 55.1 2.8 2.0 25.2 2.1 12.9 5.1 24.7 1.0 4.1 40.4 1.5 1.3 46.7 48.0 0.6 2.8 2.3 0.5 10.2 1.9 66.9 0.4 5.7 3.0 3.1 2.6 1.3 1.1 6.2 0.9 2.8 2.5 1.9 0.4 0.0 0.2 9.6 5.4 2.9 10.9 1.4 1.2 0.0 4.7 0.0 6.7 2.4 1.4 0.0 22.5 1.8 3.4 0.3 1.0 1.5 0.3 3.5 0.9 1.1 5.8 3.4 1.0 0.8 3.1 0.7 4.7 0.0 1.8 0.0 8.1 38.0 2.5 5.5 5.1 34.3 11.6 19.1 1.9 0.0 0.2 2.9 11.2 5.5 11.9 0.6 0.0 0.0 7.5 1.2 11.4 5.7 0.1 1.8 0.6 0.7 0.3 0.0 0.5 0.1 0.2 0.0 0.2 0.1 3.5 0.0 0.0 0.5 0.1 4.6 34.3 57.2 50.2 36.3 35.5 38.9 51.2 57.3 24.4 55.1 40.4 48.0 66.9 1.0 0.0 5.6 112.6 0.6 2.5 0.4 0.1 2.8 12.2 8.5 9.7 3.4 0.0 0.2 36.8 20.9 3.1 0.2 0.6 5.9 0.5 417.5 8.5 1.1 2.0 2.4 11.2 36.3 1.1 1.0 0.6 0.0 12.4 4.5 11.0 3.3 49.1 1.2 3.3 25.0 0.3 0.0 1.0 0.7 1840.0 5.3 13.5 7.2 3.7 1.5 2.9 2.1 53.8 127.6 1.4 0.3 9.1 0.5 0.9 0.3 24.0 0.3 15.8 19.7 1.7 4.2 17.6 13.2 0.3 8.4 9.4 0.6 1.4 0.8 2.2 NAGA D22S674 ENSG00000198951 Alpha-N-acetylgalactosaminidase P17050 22 42058334-42070842 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8" "Group enriched" "Detected in all" 6 "dendritic cells: 195.2;monocytes: 257.9" "Cell line enhanced" "Detected in all" "HMC-1: 190.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000649 Enhanced "Intracellular and membrane" NA NA 2200000 "HPA000649: AB_1079448" "unprognostic (3.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.45e-3)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (3.02e-2)" "unprognostic (4.27e-1)" "unprognostic (1.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.93e-1)" "unprognostic (3.64e-2)" "unprognostic (3.68e-2)" "unprognostic (1.92e-3)" "unprognostic (8.95e-2)" "unprognostic (2.53e-1)" 21.5 12.8 8.5 32.6 9.6 20.3 13.6 10.1 9.6 20.8 15.6 26.4 20.5 17.4 12.5 17.3 20.2 22.3 16.2 8.2 13.9 15.1 32.2 27.3 20.9 12.4 10.1 7.1 17.1 11.5 39.5 11.8 43.2 11.7 18.4 27.0 7.8 17.5 18.8 7.7 13.5 24.4 28.6 11.1 20.5 16.7 9.0 11.9 14.0 15.2 12.4 19.2 25.1 13.8 14.1 27.8 14.0 21.7 38.9 37.0 41.9 15.9 22.4 45.7 37.9 39.2 31.4 39.9 13.5 13.5 49.1 22.9 19.2 16.7 27.4 22.3 31.0 21.2 33.5 20.1 21.5 21.5 28.1 190.4 28.9 23.8 34.0 14.4 19.5 63.4 11.6 12.4 56.0 30.2 32.3 10.4 11.5 5.8 25.3 18.5 23.0 11.0 24.2 29.4 32.7 6.7 7.7 29.8 27.0 29.3 19.1 40.4 50.9 34.4 26.6 31.8 17.1 20.7 30.9 33.3 10.9 28.3 52.7 33.4 36.5 202.5 25.1 13.6 249.1 13.8 10.5 14.1 12.7 195.2 6.9 9.2 8.4 9.9 18.8 257.9 119.8 18.3 121.0 8.5 9.6 10.1 9.6 8.2 13.9 12.4 10.1 7.1 11.7 11.1 11.9 14.1 6.5 9.6 6.7 4.6 8.2 3.3 9.4 10.9 5.7 2.8 6.7 6.2 4.2 4.3 11.3 7.3 8.4 46.1 11.0 27.3 3.9 15.4 15.8 5.6 8.8 11.2 6.0 12.4 1.1 8.1 65.0 13.8 6.1 10.2 9.5 3.2 9.3 33.6 91.6 0.0 2.0 15.0 6.1 64.4 36.3 17.9 7.2 52.5 19.6 12.2 65.8 5.9 6.2 0.5 2.0 13.0 23.9 6.8 22.2 6.0 40.0 9.8 15.7 6.4 19.7 6.1 10.0 10.7 5.2 7.1 3.4 58.3 6.9 6.5 15.4 10.0 SMG5 "EST1B, KIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5" ENSG00000198952 "SMG5 nonsense mediated mRNA decay factor" Q9UPR3 1 156249224-156282825 "Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072651 Uncertain "Cytoplasmic bodies" No No "Cytoplasmic bodies" "HPA072651: AB_2686544" "unprognostic (2.09e-2)" "unprognostic (3.45e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (3.20e-1)" "unprognostic (4.06e-2)" "prognostic unfavorable (6.70e-9)" "unprognostic (1.28e-1)" "unprognostic (3.21e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (4.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.26e-2)" 24.1 43.5 44.9 22.2 44.9 47.1 23.9 41.1 44.9 25.6 38.6 34.8 27.5 27.8 24.8 37.6 27.4 19.0 51.5 39.7 40.2 43.7 47.9 32.9 26.0 47.4 45.6 39.3 26.0 28.5 46.7 39.3 26.7 48.1 35.5 22.2 35.6 27.1 24.0 63.3 36.7 32.6 28.2 43.1 34.1 33.7 27.9 46.0 29.7 30.1 43.7 25.0 31.5 26.1 51.2 53.4 45.8 54.8 40.9 52.2 29.5 79.0 54.0 48.2 80.0 67.7 116.2 67.4 48.1 61.6 64.8 63.7 62.8 97.3 68.3 51.4 54.5 80.9 55.6 45.8 64.2 67.6 58.8 54.5 37.4 66.7 76.9 81.5 41.2 52.1 70.4 77.0 47.1 56.9 54.5 48.3 47.5 110.9 97.0 94.6 77.2 41.8 51.1 52.1 63.4 73.4 61.1 68.5 100.6 61.8 71.9 86.8 124.3 44.0 55.4 61.6 59.1 79.6 71.7 17.9 89.1 48.8 57.8 71.7 1.6 3.7 5.2 3.8 3.9 3.1 2.9 2.9 2.8 2.4 2.5 2.5 2.7 4.1 3.0 4.2 2.4 2.0 3.6 44.9 44.9 41.1 44.9 39.7 40.2 47.4 45.6 39.3 48.1 43.1 46.0 51.2 9.1 16.0 13.4 21.9 16.8 14.7 7.8 7.3 17.6 12.8 14.7 9.8 39.5 18.6 9.6 20.2 33.3 17.8 10.4 44.8 7.9 12.3 2.8 14.1 9.1 12.9 22.7 9.9 23.9 14.5 10.7 9.4 35.2 16.1 12.7 18.4 9.7 21.6 12.4 18.5 21.4 20.3 8.2 14.4 8.6 5.5 8.4 11.1 5.4 19.7 13.5 11.2 7.2 12.1 24.2 17.9 24.2 7.2 17.9 14.3 23.7 15.5 12.8 12.6 6.6 9.2 10.5 8.5 7.8 16.9 12.1 17.1 14.0 11.4 23.6 15.4 KIFBP "DKFZP586B0923, KBP, KIAA1279, KIF1BP, TTC20" ENSG00000198954 "Kinesin family binding protein" Q96EK5 10 68988803-69043544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.5;Cardiomyocytes: 40.7;Cytotrophoblasts: 21.7;Extravillous trophoblasts: 19.5;Fibroblasts: 8.7;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035538, HPA035539" Uncertain NA NA "HPA035538: AB_10601130, HPA035539: AB_2674676" "unprognostic (4.28e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (4.19e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (4.23e-3)" "unprognostic (3.72e-2)" "unprognostic (3.52e-2)" "unprognostic (7.74e-2)" "unprognostic (6.23e-3)" "unprognostic (8.74e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.19e-2)" "unprognostic (9.45e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 20.1 22.3 21.6 6.8 24.1 1.3 11.3 23.6 32.7 14.1 18.8 11.3 6.4 12.6 16.1 12.3 11.9 12.7 37.6 23.3 23.1 19.7 13.9 10.0 6.8 23.5 23.1 21.2 12.4 8.6 34.0 13.8 14.9 24.2 16.8 10.4 25.9 9.9 17.4 30.7 8.8 8.1 15.4 23.7 7.6 11.5 16.4 22.2 7.7 19.4 43.7 9.2 15.3 9.4 27.6 49.1 36.9 33.3 36.1 48.3 42.5 0.2 63.2 58.0 63.4 71.9 40.4 24.7 0.1 20.7 57.3 39.5 40.2 57.0 37.9 63.6 27.5 48.8 9.5 22.0 24.0 32.4 13.3 11.5 26.4 30.4 42.3 37.7 60.5 46.6 15.1 13.1 14.0 78.4 23.3 13.0 15.8 20.7 25.4 84.1 15.5 27.7 7.2 67.4 12.4 25.0 18.1 36.0 48.9 34.8 32.2 60.3 10.2 46.3 28.0 25.7 24.6 64.0 2.8 0.3 9.0 35.9 19.8 15.7 1.8 4.3 2.4 7.3 7.5 8.8 5.1 8.4 7.2 5.5 4.1 9.6 7.8 1.6 6.9 12.9 2.8 8.0 5.0 21.6 24.1 23.6 32.7 23.3 23.1 23.5 23.1 21.2 24.2 23.7 22.2 27.6 9.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 0.0 0.0 0.0 21.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 19.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 8.3 0.9 0.0 0.0 0.0 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127385-38166578 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Hydrolase, Protease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 106.9 45.5 21.3 69.1 18.0 3.2 30.5 18.9 29.7 383.6 53.9 30.7 30.0 268.6 28.6 37.6 219.5 128.9 372.0 17.3 19.8 76.9 246.1 291.0 18.2 21.9 18.6 13.8 40.9 25.8 19.5 96.6 236.2 20.8 89.4 21.0 2.1 9.9 57.2 64.4 3.5 64.2 160.4 20.3 33.0 62.9 4.0 24.1 15.5 36.6 33.7 10.4 155.5 88.6 25.2 65.0 47.5 0.2 1.8 47.3 5.1 24.0 95.5 45.2 0.7 1.8 78.4 1546.7 0.1 505.5 1.0 105.4 1.7 0.1 221.7 3.4 0.7 0.2 10.3 2.6 35.0 191.9 0.0 0.5 5.2 0.4 40.2 0.3 994.3 695.3 0.0 21.4 0.1 16.0 0.3 0.0 0.6 0.8 0.9 4.6 0.0 0.1 0.3 69.0 0.0 0.0 1.3 224.4 0.2 7.6 31.6 2.2 0.6 924.2 1.6 57.6 7.8 46.3 0.0 0.6 0.8 60.7 0.1 18.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 18.0 18.9 29.7 17.3 19.8 21.9 18.6 13.8 20.8 20.3 24.1 25.2 58.0 9.6 18.3 0.0 7.4 0.5 10.4 41.0 0.6 0.0 8.5 8.8 204.5 31.5 55.3 14.7 2.1 311.1 0.1 11.7 3.9 226.7 3.2 16.7 459.1 183.8 0.0 74.5 0.1 145.7 38.6 37.7 0.5 13.1 2.5 2.8 408.0 205.7 54.4 0.0 0.1 1.8 6.1 23.7 2.1 5.0 1.2 35.5 0.0 28.1 6.5 0.4 0.0 0.0 0.3 326.5 1.1 6.0 0.0 68.6 63.0 27.6 23.6 0.5 0.0 5.2 49.1 0.4 4.0 0.9 0.0 374.2 3.9 2.1 3.3 26.4 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 8.9 14.7 12.2 9.7 12.0 8.2 11.8 13.0 14.0 14.0 12.1 10.1 6.3 16.0 22.9 9.4 12.7 10.6 15.5 11.6 12.9 11.9 7.7 9.7 12.9 14.0 12.1 10.7 19.2 17.6 26.5 17.2 15.8 13.9 13.8 8.2 5.4 24.7 18.4 6.8 10.8 9.1 15.0 13.3 19.4 9.6 4.4 13.0 13.9 14.4 8.3 13.9 11.3 11.4 14.4 13.7 15.7 24.2 13.8 48.4 28.6 4.8 28.0 27.0 24.5 47.5 9.4 12.8 14.4 28.0 26.4 25.5 13.9 23.8 11.3 19.1 12.6 14.4 13.5 22.6 12.8 22.2 13.4 16.4 17.9 11.3 15.1 7.8 34.3 25.4 7.4 11.3 18.0 37.3 33.0 19.8 0.2 17.5 17.7 3.1 20.0 32.5 5.5 17.7 1.8 13.3 12.5 16.4 0.1 21.0 18.3 11.4 6.4 19.8 29.7 13.4 41.8 6.6 22.1 12.6 0.0 8.9 3.5 9.9 11.3 3.7 6.1 5.8 6.7 7.5 13.2 6.1 6.4 7.6 9.0 7.3 6.9 0.4 8.3 5.1 13.2 3.6 6.2 12.2 12.0 13.0 14.0 11.6 12.9 14.0 12.1 10.7 13.9 13.3 13.0 14.4 23.9 9.6 9.1 5.2 28.5 13.4 14.4 28.3 26.2 5.5 39.3 44.4 9.7 14.3 16.3 31.3 16.7 37.8 40.6 2.2 23.5 44.2 0.6 21.9 23.7 27.2 16.4 13.0 1.9 27.7 17.3 24.6 19.9 38.0 14.5 30.2 25.4 15.7 67.9 10.1 3.3 14.2 16.2 29.0 32.3 2.2 18.6 40.8 37.4 5.6 28.5 30.3 36.0 8.5 4.9 26.5 11.2 19.9 23.8 18.3 7.6 25.0 5.5 4.6 26.3 13.1 22.4 2.6 2.3 32.7 16.1 34.5 26.0 29.5 11.7 20.8 PJA2 "KIAA0438, Neurodap1, RNF131" ENSG00000198961 "Praja ring finger ubiquitin ligase 2" O43164 5 109334713-109409974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040347, HPA057636" Supported Enhanced "Intermediate filaments" No No "Intermediate filaments" "HPA040347: AB_10795631, HPA057636: AB_2683485" "unprognostic (5.78e-2)" "unprognostic (1.25e-1)" "unprognostic (5.48e-3)" "unprognostic (1.17e-1)" "unprognostic (2.99e-1)" "unprognostic (7.83e-2)" "unprognostic (2.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.84e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (4.46e-2)" "unprognostic (6.03e-2)" "unprognostic (5.64e-3)" "unprognostic (1.47e-3)" "unprognostic (5.94e-2)" "unprognostic (7.59e-2)" "unprognostic (1.00e-2)" 59.8 68.5 61.9 44.8 82.6 88.7 57.6 54.1 87.1 69.5 34.0 51.7 33.7 75.2 62.8 51.3 46.6 48.7 66.4 81.2 82.8 61.7 77.9 51.8 41.8 64.8 63.5 68.3 88.6 39.1 88.8 37.1 58.6 66.9 79.1 53.0 64.7 49.6 92.7 39.4 30.8 41.0 77.8 64.2 55.2 33.4 47.4 66.9 54.3 93.0 54.7 45.0 54.2 37.2 87.6 36.0 24.6 96.2 74.6 93.4 101.3 52.4 57.9 86.5 44.6 72.6 22.9 47.6 46.0 78.1 111.8 71.8 20.5 57.0 71.3 81.1 39.5 21.7 53.5 47.4 31.1 66.2 40.2 75.8 70.4 58.1 59.7 85.1 80.0 72.4 40.8 37.2 84.0 73.0 21.9 48.8 36.9 19.2 21.9 16.3 31.1 84.6 77.5 69.5 31.9 18.4 47.1 59.8 21.5 70.5 64.2 48.6 58.7 84.6 63.4 30.7 58.8 27.5 56.4 51.6 53.5 66.8 54.8 42.6 32.9 19.2 29.3 14.4 19.7 14.4 16.5 14.1 13.4 19.3 11.7 18.0 13.4 49.0 17.8 27.7 8.0 20.5 18.5 61.9 82.6 54.1 87.1 81.2 82.8 64.8 63.5 68.3 66.9 64.2 66.9 87.6 85.2 67.3 58.4 71.2 76.9 63.5 56.2 59.8 58.1 102.1 53.0 58.5 127.5 51.5 51.7 57.0 62.6 24.1 78.2 85.9 49.0 40.8 22.5 42.8 97.5 70.3 67.6 32.1 159.0 33.3 31.0 86.7 32.1 68.2 47.5 99.3 70.6 94.8 54.5 77.4 126.0 53.1 36.7 91.5 78.5 20.7 85.1 77.1 60.5 66.5 73.4 93.0 68.0 60.8 111.6 30.9 30.4 92.6 72.0 59.2 46.8 58.7 48.4 91.3 78.9 105.0 110.1 73.4 42.9 43.7 58.2 26.3 68.7 61.6 39.3 44.0 RORB "NR1F2, ROR-BETA, RZRB" ENSG00000198963 "RAR related orphan receptor B" Q92753 9 74497335-74693177 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;retina: 56.1" "Cell type enhanced" "Detected in many" "Astrocytes: 393.7;Endometrial stromal cells: 436.8;Excitatory neurons: 190.0;Horizontal cells: 1399.8;Muller glia cells: 390.7;Rod photoreceptor cells: 190.3" "Group enriched" "Detected in some" 5 "glioma: 2.1;prostate cancer: 2.3" "Group enriched" "Detected in many" 6 "cerebral cortex: 17.7;hippocampal formation: 5.8;pons: 5.2;white matter: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HHSteC: 22.5;HSkMC: 12.4;JURKAT: 23.3;MOLT-4: 6.9;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008393 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008393: AB_1079830" "unprognostic (6.89e-3)" "unprognostic (4.06e-3)" "unprognostic (1.38e-1)" "unprognostic (3.97e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.28e-1)" "unprognostic (1.18e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (5.46e-2)" "unprognostic (8.81e-8)" "unprognostic (5.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.26e-2)" "unprognostic (4.00e-2)" 1.1 3.4 1.2 0.1 1.4 0.0 0.3 0.0 17.7 9.8 0.0 0.2 0.1 3.9 0.0 0.4 0.3 1.8 1.6 5.8 0.8 0.5 0.0 0.6 0.0 0.4 1.0 0.7 0.2 0.1 0.4 1.7 2.0 5.2 4.6 0.3 56.1 0.1 5.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.6 0.3 0.4 0.3 0.1 0.3 0.7 0.8 4.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 22.5 0.0 0.7 12.4 0.0 0.0 0.0 0.0 0.0 23.3 0.0 3.6 0.0 0.1 6.9 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.0 0.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.0 17.7 5.8 0.8 0.4 1.0 0.7 5.2 0.0 0.3 4.9 0.1 0.0 4.8 393.7 0.4 1.7 0.8 0.0 6.8 156.4 0.4 0.6 14.1 0.0 0.0 0.0 120.9 0.2 2.7 0.1 0.0 0.0 6.6 11.9 436.8 4.2 0.0 0.0 190.0 0.0 0.4 10.7 0.0 6.9 1.3 0.2 0.7 0.0 0.6 1399.8 6.4 0.0 0.0 0.3 2.1 1.9 0.0 1.8 1.8 10.3 0.1 390.7 1.0 12.5 28.6 0.1 0.0 0.0 0.8 2.8 0.0 8.9 0.7 190.3 0.0 8.7 9.9 3.0 0.7 1.4 0.4 0.1 3.0 0.3 0.1 0.9 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" Q86VZ5 10 50305586-50625163 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favorable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 15.9 19.5 22.6 10.8 27.0 24.2 14.7 21.3 20.6 17.0 30.8 9.8 13.6 12.0 20.1 15.5 16.7 15.6 13.3 17.0 22.8 20.4 28.1 22.1 15.1 27.1 25.0 13.3 18.8 13.4 53.3 6.5 24.8 27.8 19.7 11.9 20.4 18.2 16.9 9.9 25.5 16.2 15.9 27.9 11.8 14.4 11.4 25.5 12.1 24.9 10.6 14.6 21.1 13.2 42.3 30.2 14.0 4.0 9.0 14.2 18.6 18.8 19.6 19.7 13.5 12.6 11.7 30.3 22.1 11.3 25.9 12.2 18.7 9.5 20.6 14.0 19.4 10.2 32.7 17.9 9.0 16.5 7.5 7.6 12.1 23.6 18.0 21.7 8.7 19.3 7.9 62.6 32.2 14.6 12.7 3.3 4.2 9.2 13.7 13.7 5.5 18.4 8.8 19.7 31.2 6.2 4.9 14.4 14.2 7.5 11.3 21.4 2.7 27.1 14.6 17.8 14.1 14.6 11.0 9.5 6.3 18.2 12.0 12.1 3.4 9.3 28.4 4.6 4.9 10.3 7.0 6.2 6.8 5.2 6.5 8.2 5.4 16.7 10.1 4.0 3.2 15.6 6.3 22.6 27.0 21.3 20.6 17.0 22.8 27.1 25.0 13.3 27.8 27.9 25.5 42.3 17.1 44.8 40.0 106.7 19.9 54.4 28.9 15.6 23.9 20.1 15.8 8.9 26.3 10.0 30.0 29.5 4.2 10.9 15.6 6.2 15.6 17.6 17.0 20.9 10.5 19.6 14.9 32.0 153.1 21.6 7.7 19.8 30.5 32.4 20.8 12.1 17.9 16.0 29.0 5.0 117.2 11.1 4.1 46.5 17.6 30.6 16.1 34.5 12.4 229.5 12.4 17.4 10.3 313.1 422.0 10.7 6.4 10.5 13.7 32.3 18.4 9.3 25.1 36.4 0.0 20.5 27.1 12.8 2.3 18.7 83.4 4.9 20.0 11.8 12.4 25.4 OR10R2 OR10R2Q ENSG00000198965 "Olfactory receptor family 10 subfamily R member 2" Q8NGX6 1 158472220-158480936 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MOLT-4: 32.1" "Not detected" "Not detected" "HPA059775, HPA060399" Uncertain NA NA "HPA059775: AB_2684124, HPA060399: AB_2684276" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Z1 ENSG00000198967 "Olfactory receptor family 10 subfamily Z member 1" Q8NGY1 1 158605268-158612514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "bone marrow: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "K-562: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.5 0.0 0.5 7.6 0.0 0.6 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.7 0.5 0.5 0.4 0.5 0.5 0.5 0.4 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF525 KIAA1979 ENSG00000203326 "Zinc finger protein 525" 19 53365693-53392217 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 22.3;Granulosa cells: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.77e-2)" "unprognostic (7.10e-3)" "unprognostic (2.62e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "unprognostic (8.88e-3)" "unprognostic (6.96e-3)" "unprognostic (1.07e-3)" "unprognostic (2.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.95e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-1)" "unprognostic (7.18e-2)" "unprognostic (3.42e-2)" "unprognostic (1.13e-2)" 3.0 4.7 3.7 4.3 3.9 5.0 5.7 9.3 3.9 4.2 4.4 3.9 4.0 4.4 6.0 4.2 4.7 3.8 2.3 3.6 3.6 4.8 2.4 3.4 8.0 3.9 3.6 3.6 7.7 6.1 14.2 5.5 5.0 5.0 7.3 5.2 5.0 4.5 3.5 1.1 8.5 5.4 2.6 2.9 6.4 5.6 10.9 3.8 6.6 5.3 1.8 6.2 4.9 5.3 5.3 1.2 0.4 2.3 4.5 2.4 0.9 16.3 3.9 4.0 4.0 7.0 3.8 4.6 7.0 3.3 2.3 6.8 6.0 0.2 4.7 6.0 0.4 15.7 1.7 7.1 3.0 2.7 0.3 9.5 3.8 6.4 2.3 7.0 2.7 1.3 9.1 8.2 0.6 4.7 4.1 10.6 8.8 9.8 6.1 8.8 0.8 6.2 8.9 3.7 18.5 3.9 5.0 6.2 9.5 3.1 9.2 6.8 8.5 1.6 0.8 4.9 4.4 5.9 7.1 19.2 18.3 0.3 0.9 4.8 2.6 1.2 3.0 1.5 1.4 2.8 3.5 2.3 2.4 1.5 2.6 2.7 2.3 2.5 3.2 0.8 2.2 1.9 2.1 3.7 3.9 9.3 3.9 3.6 3.6 3.9 3.6 3.6 5.0 2.9 3.8 5.3 3.5 3.2 4.6 2.6 5.3 3.7 9.7 3.3 5.2 4.3 3.1 3.7 13.7 4.3 4.7 1.8 0.0 7.0 5.3 2.5 1.9 4.2 22.3 6.1 2.9 4.1 7.8 2.1 2.4 2.8 5.2 4.1 0.5 10.6 6.3 27.9 1.8 1.1 2.8 3.3 4.3 3.6 0.0 0.8 4.0 2.4 2.5 2.3 1.8 1.9 2.0 1.9 7.2 2.5 5.8 3.3 2.4 1.2 1.0 8.9 2.4 1.7 3.3 3.0 0.0 5.9 3.3 3.1 4.2 2.9 4.5 13.5 4.9 4.8 3.4 8.6 INF2 "C14orf151, C14orf173, MGC13251" ENSG00000203485 "Inverted formin 2" Q27J81 14 104681146-104722535 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 229.3;Gastric mucus-secreting cells: 183.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 100.8" "Region enhanced" "Detected in all" "basal ganglia: 224.1" "Low region specificity" "Detected in all" HPA000724 Approved Approved "Nuclear bodies,Endoplasmic reticulum" NA NA 3000000 "Endoplasmic reticulum" "Nuclear bodies" "HPA000724: AB_1078325" "unprognostic (1.42e-1)" "unprognostic (9.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.00e-2)" "unprognostic (1.49e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.18e-4)" "unprognostic (1.13e-2)" "unprognostic (9.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (1.36e-3)" "unprognostic (7.24e-2)" "unprognostic (4.01e-1)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.70e-2)" 41.7 21.6 13.3 8.4 26.3 7.6 35.5 14.2 23.1 27.9 0.9 37.5 21.4 24.5 2.3 20.5 21.1 9.0 23.3 10.2 15.6 27.1 30.5 34.6 6.9 23.9 22.4 4.8 13.7 15.9 2.0 8.3 11.8 29.1 23.4 4.8 3.4 18.1 7.6 13.8 26.8 31.9 4.5 13.3 31.6 35.0 32.5 18.6 2.1 21.0 1.5 3.4 30.5 28.8 68.0 26.3 92.1 9.9 16.0 7.6 12.2 84.2 49.0 14.5 21.9 14.0 35.5 40.2 3.7 46.6 17.9 17.0 43.3 9.4 22.7 9.5 18.5 26.6 22.0 59.9 23.9 16.5 6.8 21.0 11.4 14.5 15.8 6.8 15.0 24.1 9.1 10.7 10.5 18.0 30.0 10.2 17.9 17.1 18.3 100.8 29.8 19.2 9.4 12.6 38.0 20.5 12.8 26.4 36.7 11.7 8.0 8.0 4.9 49.9 29.4 22.1 45.7 22.5 6.9 3.7 3.7 41.2 12.1 25.1 0.5 2.1 0.1 0.9 0.7 0.7 1.6 3.2 0.6 2.4 1.5 2.5 1.6 1.6 1.2 0.1 5.1 4.0 3.2 13.3 26.3 14.2 23.1 10.2 15.6 23.9 22.4 4.8 29.1 13.3 18.6 68.0 48.8 64.1 13.4 10.1 22.5 22.7 17.5 19.0 17.1 0.3 16.5 14.6 14.3 28.6 15.0 3.7 0.0 54.8 5.2 229.3 5.9 24.1 1.2 7.8 8.6 29.8 17.4 17.2 16.7 25.5 87.8 17.9 183.0 18.2 14.7 8.4 25.4 29.8 32.6 0.0 1.9 86.2 12.2 21.8 35.6 2.1 5.6 25.5 8.8 20.6 14.0 55.3 1.0 11.1 89.6 58.1 110.7 4.5 7.8 26.6 90.4 7.3 9.4 2.0 32.9 5.7 36.1 1.1 4.5 8.5 18.8 31.6 9.3 12.9 66.9 38.2 IQANK1 ENSG00000203499 "IQ motif and ankyrin repeat containing 1" A8MXQ7 8 143734139-143790645 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 41.6;skin 1: 28.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.4;Breast myoepithelial cells: 6.3;Collecting duct cells: 7.3;Cytotrophoblasts: 8.8;Endometrial ciliated cells: 23.2;Extravillous trophoblasts: 6.0;Respiratory ciliated cells: 12.4;Syncytiotrophoblasts: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.5;HaCaT: 29.4;hTCEpi: 35.4;MCF7: 72.3;OE19: 68.6;RT4: 30.3;SK-BR-3: 30.0;T-47d: 64.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.45e-3)" "unprognostic (3.38e-1)" "unprognostic (7.46e-2)" "unprognostic (4.94e-3)" "unprognostic (4.31e-3)" "unprognostic (1.98e-1)" "unprognostic (5.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (2.22e-3)" "unprognostic (3.29e-2)" "unprognostic (4.49e-3)" "unprognostic (1.42e-2)" "unprognostic (1.47e-1)" "unprognostic (1.79e-1)" "unprognostic (9.40e-2)" 0.2 0.3 1.9 0.6 1.5 0.8 6.1 1.2 1.1 5.0 2.0 1.8 1.3 0.8 21.7 41.6 13.7 1.3 0.2 1.1 0.5 1.9 0.5 3.6 0.2 1.4 1.2 1.1 0.2 4.7 3.4 1.9 3.5 1.2 7.2 2.5 1.9 8.1 2.0 0.3 28.9 0.9 0.2 1.3 0.3 4.2 8.4 0.8 0.6 2.6 0.0 3.9 6.3 18.7 1.0 17.6 1.1 0.2 0.8 0.1 0.2 19.5 0.3 0.0 0.1 0.2 9.2 26.5 0.1 2.0 0.1 0.1 29.4 0.9 3.4 0.2 0.2 0.8 0.1 2.8 2.1 0.5 0.2 0.2 0.3 35.4 0.2 0.7 0.4 0.0 0.6 1.3 0.2 0.0 72.3 0.1 0.2 1.5 68.6 1.1 0.2 0.1 0.6 1.9 30.3 9.8 0.2 2.6 30.0 1.1 2.3 64.4 0.4 0.2 0.3 1.0 0.5 0.1 0.5 0.2 0.2 0.1 0.3 0.5 0.8 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.1 1.4 0.2 0.2 0.2 0.0 0.0 1.9 1.5 1.2 1.1 1.1 0.5 1.4 1.2 1.1 1.2 1.3 0.8 1.0 0.1 0.0 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.4 6.3 0.0 0.0 3.7 7.3 0.0 8.8 0.0 0.0 0.0 2.0 0.0 23.2 0.7 0.3 0.0 0.0 0.0 1.6 6.0 0.4 0.0 5.2 1.3 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.3 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.1 0.2 0.0 0.0 AL139353.1 ENSG00000203546 "Novel protein" 14 31334312-31457441 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.1;skeletal muscle: 1.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Breast glandular cells: 3.2;Breast myoepithelial cells: 5.8;Cytotrophoblasts: 4.6;Distal tubular cells: 3.9;Proximal tubular cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (2.86e-4)" "unprognostic (3.48e-1)" "unprognostic (3.52e-1)" "unprognostic (2.21e-1)" "unprognostic (2.52e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.18e-2)" "unprognostic (3.91e-2)" "unprognostic (3.13e-2)" "unprognostic (5.79e-3)" "unprognostic (1.47e-2)" "unprognostic (2.63e-3)" "unprognostic (8.26e-3)" "unprognostic (3.56e-2)" "unprognostic (4.57e-2)" "unprognostic (5.10e-2)" 1.1 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.1 0.7 0.2 0.1 0.0 1.3 0.0 0.6 0.5 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 1.2 3.2 2.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.2 5.8 0.0 0.0 0.6 1.8 0.0 4.6 0.4 0.0 3.9 1.5 0.0 2.5 1.6 0.6 0.0 0.0 0.0 1.3 1.6 1.1 0.0 0.7 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 6.5 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.3 1.1 0.0 0.0 GP1BB "CD42c, GPIbbeta" ENSG00000203618 "Glycoprotein Ib platelet subunit beta" P13224 22 19723539-19724771 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.9;heart muscle: 27.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 74.0;neutrophil: 74.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 74.5" "Cell line enriched" "Detected in some" 4 "K-562: 85.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA 4400000 2.6 2.0 26.6 0.2 25.6 2.7 2.5 17.8 45.9 7.5 3.6 2.5 0.0 4.8 0.0 11.3 4.4 0.0 27.3 45.0 11.0 2.9 1.2 4.2 0.2 22.4 8.5 28.5 6.3 2.2 2.5 22.3 0.2 26.4 3.4 0.0 0.6 2.4 0.0 1.4 22.2 1.4 0.1 0.7 10.2 2.3 4.2 23.5 0.1 3.1 0.5 0.1 1.6 7.3 15.7 0.0 1.1 1.6 0.7 0.0 0.0 0.2 1.5 0.0 0.1 0.4 0.0 0.1 0.2 0.3 0.0 0.3 0.8 0.1 0.1 0.0 0.0 7.7 4.1 0.1 0.0 0.0 0.0 10.3 0.2 0.1 0.3 0.0 0.0 0.0 0.2 85.4 0.1 0.5 0.1 0.3 19.2 0.4 0.1 2.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.9 1.3 0.2 0.0 2.9 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 74.0 8.5 12.5 1.6 3.1 0.8 0.5 0.5 0.2 3.6 0.9 1.0 0.8 74.5 1.1 0.6 12.6 2.2 417.7 26.6 25.6 17.8 45.9 45.0 11.0 22.4 8.5 28.5 26.4 0.7 23.5 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T5 ENSG00000203661 "Olfactory receptor family 2 subfamily T member 5" Q6IEZ7 1 248488589-248491113 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L2 "HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P" ENSG00000203663 "Olfactory receptor family 2 subfamily L member 2" Q8NH16 1 248030070-248042305 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;retina: 1.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.1;Club cells: 7.4;granulocytes: 11.4;Respiratory ciliated cells: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.37e-2)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (2.96e-2)" 0.2 0.1 0.6 0.2 1.0 1.0 0.1 2.0 3.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.9 0.6 0.1 0.5 0.1 0.2 1.2 1.0 0.6 0.1 0.0 0.0 0.0 0.1 2.1 0.1 0.1 1.8 0.1 0.0 0.4 0.2 0.4 0.0 0.2 0.3 0.4 1.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 2.6 0.3 0.1 0.2 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.6 0.0 0.1 0.1 0.3 0.3 0.2 0.3 0.2 0.3 0.1 0.0 0.4 0.3 0.5 0.3 0.2 0.2 0.3 0.3 0.1 0.3 0.2 0.4 0.4 0.3 0.5 0.3 0.2 0.3 0.2 0.3 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.6 1.0 2.0 3.0 0.9 0.6 1.2 1.0 0.6 2.1 0.2 0.5 2.6 0.0 19.2 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 112.3;Endometrial ciliated cells: 103.1;Late spermatids: 132.5;Respiratory ciliated cells: 177.2;Spermatocytes: 115.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 77.1;THP-1: 70.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (4.88e-2)" 13.1 10.7 18.3 6.7 17.5 14.5 16.2 18.0 19.2 8.2 26.4 6.9 3.3 21.4 17.7 10.6 36.5 14.8 15.2 14.3 15.8 11.2 5.6 12.7 9.7 20.6 18.1 13.1 11.4 9.0 15.5 8.6 17.0 17.2 8.9 12.5 17.9 8.9 13.2 19.9 7.0 7.5 11.5 19.3 7.6 12.5 28.3 17.6 7.5 27.0 7.5 10.8 8.2 5.0 19.7 7.3 9.1 20.3 5.2 7.2 16.7 24.7 9.2 9.7 11.5 10.6 23.5 19.5 25.3 19.2 11.6 12.2 5.7 8.2 5.3 7.1 2.7 5.0 12.4 41.3 10.7 15.2 12.8 77.1 14.6 11.0 15.5 14.4 13.7 18.0 0.7 48.0 20.1 10.0 7.6 2.6 34.6 26.0 10.4 6.9 48.4 3.1 6.8 29.0 12.3 15.9 21.4 16.0 6.1 13.6 22.7 5.9 70.5 2.8 14.1 5.3 7.9 33.7 6.9 12.4 17.2 11.2 35.9 11.7 0.9 1.3 2.3 0.4 1.4 0.5 3.1 0.5 0.3 4.3 3.3 0.4 0.4 3.8 2.3 1.1 8.7 0.6 1.0 18.3 17.5 18.0 19.2 14.3 15.8 20.6 18.1 13.1 17.2 19.3 17.6 19.7 13.3 3.2 14.5 76.0 11.5 5.1 11.8 17.2 10.2 12.6 11.6 11.0 58.6 8.6 23.0 23.9 14.6 16.3 9.3 5.4 50.9 8.2 112.3 103.1 18.5 11.7 18.8 17.2 54.6 10.8 46.3 15.5 11.2 11.1 0.0 13.6 12.5 7.3 11.2 5.0 90.3 6.5 22.4 21.3 6.5 132.5 9.0 13.2 7.2 42.2 6.6 19.2 1.0 74.9 75.9 5.6 6.6 6.4 12.0 7.1 2.7 35.6 177.2 19.1 6.6 15.5 15.8 115.9 30.6 5.4 3.0 34.2 7.5 8.3 6.9 10.6 COX20 "FAM36A, FLJ43269" ENSG00000203667 "Cytochrome c oxidase assembly factor COX20" Q5RI15 1 244835616-244845057 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 414.8;Proximal tubular cells: 464.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043617, HPA045490" Approved Enhanced Mitochondria NA NA Mitochondria "HPA043617: AB_10965694, HPA045490: AB_10962869" "unprognostic (5.84e-3)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (2.86e-1)" "unprognostic (3.62e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (2.54e-2)" "unprognostic (3.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.02e-3)" 17.7 44.6 27.6 23.5 30.9 20.2 22.3 37.8 49.6 14.0 23.5 24.1 24.5 25.0 30.1 21.7 17.4 15.5 43.3 28.0 29.9 50.6 29.9 15.9 21.5 30.2 30.1 25.3 35.7 23.4 22.9 11.2 17.8 29.7 28.9 18.9 58.8 17.3 18.8 43.7 15.3 25.3 20.7 29.6 15.2 23.3 25.2 29.1 16.5 37.3 37.7 16.6 20.6 9.7 30.2 132.6 34.1 33.5 100.4 22.5 17.3 75.2 54.0 35.7 31.0 27.2 93.9 88.9 21.3 65.7 36.6 58.3 36.1 17.8 43.0 40.8 56.0 15.6 38.6 47.6 85.7 28.7 95.7 57.5 16.0 20.2 44.5 30.8 44.9 35.2 22.7 81.2 80.2 63.0 33.0 53.5 43.5 84.2 94.9 68.6 38.5 42.0 121.5 59.5 33.1 19.6 54.2 68.1 36.1 79.6 32.1 67.0 28.7 69.3 67.3 88.7 59.9 120.1 128.0 188.7 43.7 90.9 108.2 65.3 14.5 15.3 21.4 27.1 36.4 26.3 34.2 31.3 30.2 26.5 32.6 21.2 28.7 3.9 24.2 34.5 26.1 43.4 20.4 27.6 30.9 37.8 49.6 28.0 29.9 30.2 30.1 25.3 29.7 29.6 29.1 30.2 66.7 19.2 52.1 44.1 77.7 85.1 115.1 144.3 38.1 111.5 104.4 110.1 68.6 183.0 90.5 191.3 45.9 231.5 74.4 97.7 414.8 154.1 38.6 78.4 74.1 61.4 61.8 82.0 16.6 188.9 164.6 56.1 57.6 119.5 73.4 53.1 42.5 294.8 122.1 89.2 24.4 91.7 77.3 64.8 79.6 75.9 69.6 73.4 72.9 9.4 97.6 195.2 110.2 27.6 34.1 178.6 87.0 80.1 51.9 75.9 134.8 464.0 67.7 133.4 65.7 83.2 85.0 67.1 122.4 61.6 75.6 264.5 81.4 63.6 115.3 87.8 CHML REP-2 ENSG00000203668 "CHM like Rab escort protein" P26374 1 241628851-241640369 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavorable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 2.8 1.8 0.8 3.5 1.8 7.5 3.7 0.0 3.4 3.1 0.2 3.1 2.2 4.3 2.7 3.3 2.8 3.2 3.0 1.6 0.9 2.9 2.4 3.9 3.8 0.3 1.2 1.1 7.5 2.0 4.2 1.5 11.5 1.0 1.9 3.5 3.4 2.3 1.5 2.6 3.2 2.8 3.2 0.0 3.9 3.2 6.1 1.7 6.5 4.4 3.4 3.1 2.1 2.3 1.9 31.3 9.5 14.6 11.7 4.3 12.8 28.4 12.1 6.0 10.3 7.0 17.5 5.6 8.6 18.1 8.1 8.4 6.3 20.6 13.1 19.0 16.5 19.2 11.3 39.4 12.3 8.7 27.2 14.0 10.7 5.8 13.6 14.0 7.2 8.2 22.7 31.0 10.2 12.3 12.2 18.1 18.1 19.4 11.8 30.6 27.3 18.0 28.8 10.4 19.2 18.6 30.6 15.2 11.5 13.3 14.2 13.5 17.4 16.7 20.9 40.8 10.6 23.3 11.9 31.2 9.0 20.3 16.0 33.0 1.1 0.2 0.1 0.1 0.3 0.1 0.3 0.0 0.0 0.2 0.3 0.3 0.2 0.0 0.1 0.2 0.7 0.0 0.0 0.8 1.8 0.0 3.4 1.6 0.9 0.3 1.2 1.1 1.0 0.0 1.7 1.9 14.0 48.1 7.0 0.0 17.2 8.5 6.1 3.8 3.4 3.6 9.9 11.7 19.6 4.3 7.9 0.0 0.0 23.5 26.4 6.2 5.9 14.8 12.3 14.4 15.1 8.1 6.7 10.3 0.0 21.3 26.7 6.5 6.6 34.8 3.8 21.3 4.2 2.1 7.1 5.0 0.0 4.2 6.1 17.6 31.0 30.9 10.5 34.7 17.8 0.0 18.6 3.1 4.1 0.0 0.0 22.5 4.3 18.0 5.8 3.9 4.3 2.2 2.0 4.7 13.1 11.4 20.7 9.0 12.6 7.6 7.2 20.1 5.8 9.9 5.0 4.3 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548764-226609230 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "brain: 220.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 9.8;Endometrial stromal cells: 3.8;Fibroblasts: 1.5;Glandular and luminal cells: 1.6;Smooth muscle cells: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "medulla oblongata: 220.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 29.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 70.3;basal ganglia: 76.6;cerebral cortex: 75.5;hippocampal formation: 74.0;thalamus: 21.3" HPA074381 Approved Cytosol NA NA Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 3.1 1.0 49.8 1.2 37.2 0.0 2.8 0.2 39.5 3.1 0.0 11.0 1.6 3.3 1.3 5.7 3.1 0.8 1.5 37.6 17.2 3.5 0.1 0.5 0.2 220.9 31.2 45.7 2.5 1.0 0.9 7.5 0.4 63.6 4.0 2.1 1.4 1.0 1.2 3.6 3.6 2.8 5.9 4.3 1.0 2.3 1.4 56.6 0.5 0.7 1.3 0.3 6.8 3.5 24.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 4.9 0.4 29.9 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.3 0.0 4.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 37.2 0.2 39.5 37.6 17.2 220.9 31.2 45.7 63.6 4.3 56.6 24.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.8 0.0 0.0 1.0 3.8 0.2 0.0 0.0 0.0 0.2 0.5 1.5 0.0 1.6 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665723 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "stomach 1: 293.7" "Cell type enriched" "Detected in many" 6 "Gastric mucus-secreting cells: 910.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "OE19: 125.9;RT4: 76.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" No NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: AB_2686646" "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.3 0.2 4.6 6.3 1.1 0.1 15.1 0.1 3.0 1.0 1.6 23.8 8.1 0.1 11.2 0.6 1.3 14.4 0.0 2.3 3.1 1.6 0.3 21.5 0.1 2.2 1.3 0.6 0.2 3.0 0.0 0.1 0.3 1.0 2.9 33.3 0.3 8.6 1.4 0.8 1.7 4.6 1.1 1.3 0.3 293.7 0.6 1.7 0.0 0.2 0.0 0.4 12.4 0.7 2.3 1.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.8 0.0 4.6 0.0 0.1 0.0 0.2 8.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.2 125.9 3.8 0.1 0.0 0.0 1.3 76.8 1.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 4.6 1.1 0.1 3.0 2.3 3.1 2.2 1.3 0.6 1.0 1.3 1.7 2.3 0.4 28.9 131.7 1.6 1.8 0.1 6.5 1.9 0.0 0.0 19.9 7.9 2.6 10.0 55.9 25.8 0.0 0.2 0.2 90.9 0.0 3.8 2.3 2.0 0.3 0.7 3.0 0.0 0.6 21.6 0.0 0.3 910.8 2.1 10.8 5.2 0.0 0.3 0.6 0.0 0.1 61.9 4.1 0.0 0.8 6.7 1.8 1.8 0.0 0.0 0.0 0.0 1.0 0.0 0.1 36.1 42.6 3.4 3.5 4.0 2.1 1.5 15.0 0.0 0.0 0.3 0.8 0.4 1.0 0.0 0.0 0.1 1.4 2.9 21.2 31.2 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816830 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.1 11.4 9.6 10.5 13.2 12.3 10.1 9.7 12.9 6.6 9.1 8.4 6.1 7.2 13.4 7.4 7.7 7.5 19.4 11.0 12.5 16.8 10.4 8.1 12.3 12.3 11.5 10.9 8.7 9.4 18.4 8.2 7.3 12.6 7.0 7.8 17.9 8.6 7.0 30.2 6.4 7.2 7.8 9.6 11.2 11.2 10.1 11.3 11.3 11.8 24.3 10.4 8.3 5.6 14.5 12.2 11.9 10.3 15.1 16.7 26.0 23.5 12.9 14.3 10.8 13.1 3.1 17.2 27.4 12.3 12.4 6.0 7.6 13.0 18.2 11.5 17.1 17.0 13.4 10.3 6.3 19.0 33.3 16.3 20.6 12.8 14.3 37.3 11.2 16.1 37.7 28.2 21.7 11.7 5.9 28.4 10.9 13.9 14.9 7.6 16.0 19.3 49.4 11.3 6.3 21.6 18.5 14.5 25.1 30.6 19.2 26.6 19.6 10.1 7.9 10.3 16.4 13.0 19.4 32.9 44.9 20.6 26.8 12.0 26.1 37.2 60.2 12.7 59.3 11.5 39.7 15.8 15.4 45.6 31.0 12.5 14.9 42.8 13.8 64.4 74.6 16.1 22.9 9.6 13.2 9.7 12.9 11.0 12.5 12.3 11.5 10.9 12.6 9.6 11.3 14.5 9.1 6.4 16.2 17.3 18.5 4.5 8.1 14.2 3.4 16.1 8.5 8.3 36.6 8.6 8.0 3.7 18.8 14.3 39.7 3.4 41.1 18.1 12.2 10.8 7.6 8.9 10.2 6.5 35.1 16.5 17.5 10.0 6.1 7.8 7.0 10.8 5.3 7.0 18.8 15.2 43.9 5.1 12.2 27.6 8.3 4.0 5.3 20.4 14.2 17.8 31.0 17.8 8.2 23.1 53.6 12.0 6.2 4.9 9.3 6.2 7.3 26.4 12.5 29.6 6.6 8.8 9.2 24.2 17.9 6.6 4.4 9.3 11.1 11.0 5.2 7.0 CR1 "CD35, KN" ENSG00000203710 "Complement C3b/C4b receptor 1 (Knops blood group)" P17927 1 207496147-207641765 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 13.4;lymphoid tissue: 27.5" "Cell type enhanced" "Detected in some" "B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6" "Lineage enriched" "Detected in many" 12 "granulocytes: 53.7" "Group enriched" "Detected in some" 9 "HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002491, CAB016271, HPA042455, HPA043579, HPA049348" Enhanced NA NA 33000000 "CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723" "unprognostic (1.74e-1)" "unprognostic (3.16e-2)" "unprognostic (2.75e-2)" "unprognostic (6.12e-2)" "unprognostic (1.58e-2)" "unprognostic (7.14e-2)" "unprognostic (2.84e-1)" "unprognostic (3.86e-2)" "unprognostic (2.02e-1)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-3)" "unprognostic (4.38e-2)" "unprognostic (3.32e-2)" "unprognostic (6.45e-2)" "unprognostic (3.50e-3)" 13.4 0.8 0.2 27.5 0.4 10.6 0.6 0.1 2.5 1.2 1.9 1.5 1.3 0.5 0.2 0.9 1.4 2.1 0.5 0.2 2.6 2.5 2.7 3.2 20.3 0.7 0.6 0.1 0.2 0.3 0.1 0.2 9.2 1.1 0.3 1.5 0.0 0.4 0.4 0.2 0.1 4.5 6.4 0.1 24.6 1.7 0.6 1.6 1.6 0.3 1.0 18.1 6.8 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 9.9 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.7 4.2 17.2 0.0 2.4 0.7 4.5 0.9 0.4 0.3 2.2 0.2 0.1 15.6 0.0 2.3 0.0 0.0 1.3 0.2 0.4 0.1 2.5 0.2 2.6 0.7 0.6 0.1 1.1 0.1 1.6 2.2 0.3 0.0 4.2 0.3 32.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.0 20.4 0.3 0.0 0.1 0.6 0.0 0.2 1.3 0.3 0.0 0.4 9.7 0.0 0.4 0.0 0.0 59.1 1.4 0.0 0.0 24.9 0.0 1.9 13.3 0.0 0.0 1.5 4.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.0 0.0 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.5;esophagus: 15.2" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1" "Group enriched" "Detected in many" 4 "cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3" "HPA062673, HPA066741" Supported "Vesicles,Plasma membrane" "Secreted - unknown location" NA NA "Vesicles, Plasma membrane" "HPA062673: , HPA066741: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 1.5 8.5 0.6 0.4 0.6 0.0 0.6 0.1 0.7 2.3 0.0 0.2 0.1 0.3 0.7 15.2 0.6 0.7 0.4 0.5 0.3 0.5 0.1 0.5 0.1 1.0 0.6 0.4 0.7 0.1 0.2 0.3 0.1 0.6 0.7 0.1 0.1 3.7 1.0 0.2 2.7 0.2 0.6 0.1 0.1 0.4 0.3 0.6 0.0 0.5 0.1 1.1 1.8 6.1 0.3 1.0 1.4 0.0 1.7 2.3 1.7 0.0 0.8 3.0 1.3 1.9 0.0 1.5 0.0 0.6 1.7 1.4 2.7 0.9 5.3 1.1 0.3 1.6 0.5 29.5 0.0 0.7 0.0 0.0 3.3 22.6 3.5 1.7 1.5 0.3 0.7 0.3 0.2 0.6 1.3 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 1.0 3.2 0.3 0.3 11.9 0.5 0.0 0.1 0.4 0.4 1.6 0.6 0.5 1.6 0.8 0.0 0.0 0.0 9.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.7 0.5 0.3 1.0 0.6 0.4 0.6 0.1 0.6 0.3 1.4 0.0 0.0 0.0 0.0 3.1 5.1 42.9 2.8 0.0 0.4 0.4 0.1 1.5 14.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.4 0.1 1.3 0.0 0.0 0.0 1.3 0.0 1.9 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 12.2 0.0 0.7 0.1 0.9 0.0 3.6 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 23.3 0.0 0.0 0.2 1.1 0.0 0.3 8.9 1.7 0.1 0.3 0.5 0.0 8.1 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902630-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 64.6;Theca cells: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 8.9" "Lineage enriched" "Detected in many" 4 "monocytes: 8.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065352 Approved Vesicles,Aggresome NA NA Vesicles Aggresome "HPA065352: AB_2685477" "prognostic favorable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 1.6 9.5 2.6 0.5 2.1 0.8 1.4 2.0 3.7 1.3 4.5 2.8 1.8 1.0 3.1 3.0 0.9 0.8 6.4 2.7 2.2 5.1 15.2 1.9 0.5 2.3 2.4 2.2 2.3 2.7 0.4 5.0 0.8 2.1 1.4 1.3 0.5 2.4 0.4 3.8 0.9 1.9 0.8 1.7 1.6 1.8 3.1 3.0 0.3 2.7 1.4 0.3 1.2 1.5 2.5 4.4 6.0 0.4 2.1 3.7 10.5 3.3 7.5 5.4 6.2 3.1 5.4 3.7 8.5 11.8 8.5 1.4 2.0 2.2 1.4 0.6 2.7 15.8 5.0 3.7 8.6 1.0 11.2 6.8 7.1 4.8 1.9 0.8 5.0 2.2 1.8 1.4 2.1 4.7 7.9 0.6 10.1 4.7 6.9 8.7 1.1 3.4 3.1 10.1 6.9 18.4 14.4 9.5 1.6 3.2 2.3 4.5 4.3 5.1 7.2 8.0 10.2 5.2 3.6 2.6 2.2 5.2 3.6 9.0 0.0 2.7 0.0 0.3 8.9 0.0 0.0 0.1 0.6 2.1 0.1 0.3 0.3 0.0 0.0 4.4 0.6 0.1 0.9 2.6 2.1 2.0 3.7 2.7 2.2 2.3 2.4 2.2 2.1 1.7 3.0 2.5 0.5 9.6 10.6 0.3 1.6 2.5 4.1 13.1 4.0 2.2 16.3 20.8 11.7 18.6 15.1 22.0 0.0 18.9 0.3 14.8 19.6 9.9 15.7 16.2 6.7 2.0 7.8 4.8 2.0 13.8 10.2 5.5 4.1 12.1 1.3 8.6 2.2 64.6 9.5 3.3 1.5 12.6 14.2 4.1 1.8 2.7 14.0 4.7 8.8 0.0 2.6 11.5 4.1 1.0 0.8 9.3 8.8 10.5 6.0 6.7 10.8 25.8 12.2 3.9 0.0 1.4 6.1 8.6 4.5 12.4 2.8 11.8 1.1 55.8 16.6 5.7 SAMD5 dJ875H10.1 ENSG00000203727 "Sterile alpha motif domain containing 5" Q5TGI4 6 147508690-147737547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Bipolar cells: 96.0;Inhibitory neurons: 276.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067811 Uncertain Supported Vesicles No No Vesicles "HPA067811: AB_2685901" "unprognostic (4.16e-2)" "unprognostic (4.52e-2)" "unprognostic (9.65e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (1.61e-2)" "unprognostic (8.55e-3)" "unprognostic (3.09e-2)" "unprognostic (5.40e-3)" "unprognostic (1.72e-1)" "unprognostic (4.51e-2)" "unprognostic (9.82e-3)" "unprognostic (1.50e-1)" 0.5 1.8 2.5 1.3 4.2 0.1 4.1 1.1 3.7 1.2 0.4 6.1 3.0 4.3 0.8 8.9 0.9 2.2 1.2 2.3 4.0 7.5 7.6 3.4 0.3 7.6 4.1 1.9 0.4 1.3 5.8 3.9 12.3 9.6 1.4 8.1 8.9 2.4 2.4 0.2 1.9 4.5 3.2 0.0 1.4 4.6 7.6 7.5 0.1 2.2 0.1 0.7 1.5 1.9 7.9 11.2 1.4 1.4 2.0 0.0 0.0 0.1 3.6 1.3 0.3 0.2 16.6 0.1 0.6 3.6 0.0 0.6 0.1 0.3 2.5 0.4 0.0 2.0 0.8 1.5 65.6 0.2 0.0 1.3 0.0 0.1 0.3 0.1 0.0 6.8 0.0 44.7 0.6 4.8 0.1 0.0 0.0 0.1 8.4 2.8 0.0 29.0 6.5 0.1 2.3 0.5 0.1 0.9 0.2 2.8 0.3 0.0 0.0 4.9 0.5 1.5 0.5 1.3 0.1 1.1 0.0 0.1 0.1 20.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 4.2 1.1 3.7 2.3 4.0 7.6 4.1 1.9 9.6 0.0 7.5 7.9 1.7 3.2 5.9 1.3 1.0 1.8 5.6 0.5 2.2 96.0 2.9 23.5 2.6 0.0 0.0 18.4 2.1 0.2 0.0 5.4 9.8 2.2 0.5 1.1 10.7 11.1 16.9 0.0 15.7 0.2 0.3 6.9 19.4 1.8 0.0 7.0 6.1 28.1 0.8 0.0 276.9 11.6 0.0 1.0 1.4 1.3 0.3 0.7 0.0 45.0 0.0 9.2 0.0 5.5 0.9 0.6 3.4 3.4 0.1 3.0 5.2 19.7 0.0 4.0 0.0 3.1 2.0 0.5 0.2 36.4 1.6 0.3 0.5 3.6 25.7 4.2 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 481 "epididymis: 580.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.0 0.0 0.5 0.0 0.2 0.1 0.0 1.2 0.3 0.1 0.0 0.0 0.0 0.0 580.8 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.5 0.2 1.2 0.3 0.2 0.1 0.1 0.1 0.3 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJE1 CX23 ENSG00000203733 "Gap junction protein epsilon 1" A6NN92 6 142133090-142135151 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014916 Uncertain NA NA "HPA014916: AB_1847134" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ECT2L "ARHGEF32, C6orf91, FBXO49, LFDH" ENSG00000203734 "Epithelial cell transforming 2 like" Q008S8 6 138795911-138904070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "fallopian tube: 8.7" "Cell type enriched" "Detected in some" 6 "Respiratory ciliated cells: 91.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035488 Uncertain NA NA "HPA035488: AB_10672865" "unprognostic (2.88e-2)" "unprognostic (7.88e-2)" "unprognostic (2.52e-2)" "unprognostic (5.53e-3)" "unprognostic (3.48e-2)" "unprognostic (8.45e-3)" "unprognostic (9.42e-2)" "unprognostic (2.44e-2)" "unprognostic (1.18e-1)" "unprognostic (7.03e-2)" "unprognostic (5.90e-4)" "unprognostic (2.32e-1)" "unprognostic (5.21e-2)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (7.07e-3)" "unprognostic (2.65e-3)" 0.0 0.3 1.2 0.1 0.4 0.3 0.3 0.8 0.9 0.4 1.3 0.0 0.0 0.2 0.0 0.1 8.7 0.0 1.7 1.2 0.5 0.0 0.0 1.5 0.1 1.6 1.3 0.2 0.1 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.4 0.2 0.0 0.2 0.4 0.0 0.1 1.6 0.1 0.1 0.4 0.5 0.0 0.1 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.8 0.9 1.2 0.5 1.6 1.3 0.2 0.6 1.6 0.5 0.7 0.2 0.0 1.1 2.3 0.1 0.5 0.7 1.6 0.0 2.1 0.3 0.1 2.3 0.0 12.7 0.0 2.1 0.1 0.6 0.1 0.0 0.0 5.1 15.0 0.5 0.8 0.0 0.0 6.1 0.0 0.0 0.9 0.0 1.4 0.0 0.3 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.0 0.4 5.4 0.0 0.1 0.0 1.0 0.0 2.0 0.0 2.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 91.4 3.2 0.0 1.2 0.5 0.5 0.1 0.0 0.0 0.3 0.6 0.2 0.0 0.3 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174447964-174449545 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 10.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 103.7" "Region enhanced" "Detected in all" "basal ganglia: 31.6" NA NA "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.0 0.0 0.7 0.0 10.1 0.5 0.0 3.4 3.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.5 0.0 0.0 0.0 0.0 1.4 0.4 1.7 0.0 0.0 0.0 0.6 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 10.1 3.4 3.1 0.8 1.5 1.4 0.4 1.7 3.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 METTL11B "C1orf184, HOMT1B" ENSG00000203740 "Methyltransferase like 11B" Q5VVY1 1 170145959-170168866 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 1.7;skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "NTERA-2: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028049 Uncertain NA NA "HPA028049: AB_10610139" "unprognostic (1.12e-1)" "unprognostic (2.57e-1)" "unprognostic (5.62e-2)" "unprognostic (7.59e-2)" "unprognostic (7.25e-2)" "unprognostic (1.19e-1)" "unprognostic (8.68e-2)" "unprognostic (5.24e-2)" "unprognostic (2.76e-3)" "unprognostic (5.43e-2)" "unprognostic (4.56e-1)" "unprognostic (5.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCGR3A "CD16, CD16a, FCG3, FCGR3" ENSG00000203747 "Fc fragment of IgG receptor IIIa" P08637 1 161541759-161550737 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 208.1;lymphoid tissue: 309.5" "Cell type enhanced" "Detected in many" "dendritic cells: 333.4;Hofbauer cells: 193.1;Kupffer cells: 807.9;Macrophages: 300.0;NK-cells: 579.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "intermediate monocyte: 1763.5;neutrophil: 1169.8;non-classical monocyte: 3948.7" "Group enriched" "Detected in all" 5 "granulocytes: 1169.8;monocytes: 3948.7" "Not detected" "Not detected" "CAB032435, HPA055431" Supported "Secreted to blood" NA NA "CAB032435: AB_626925, HPA055431: AB_2682815" "unprognostic (5.27e-2)" "unprognostic (9.95e-2)" "unprognostic (2.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.39e-1)" "unprognostic (1.82e-1)" "unprognostic (2.24e-2)" "unprognostic (6.06e-2)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.98e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-6)" "unprognostic (1.14e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" "unprognostic (7.51e-2)" 53.4 42.3 17.4 100.7 24.2 27.6 14.9 19.5 27.4 8.2 28.4 12.7 5.9 6.0 6.0 4.9 9.2 24.7 14.8 16.4 43.3 8.0 112.5 208.1 37.5 38.9 24.6 15.7 6.6 7.9 13.7 11.4 71.6 30.5 6.9 12.8 6.9 14.9 7.7 3.4 2.0 5.7 69.1 27.6 309.5 6.9 7.7 31.0 9.4 7.0 4.3 3.9 32.8 3.5 50.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.5 26.2 9.6 513.6 1763.5 4.9 3.7 4.7 205.9 175.8 1.4 3.0 184.0 1169.8 136.2 3948.7 4.6 2.6 734.1 17.4 24.2 19.5 27.4 16.4 43.3 38.9 24.6 15.7 30.5 27.6 31.0 50.0 2.7 22.4 24.6 0.7 6.5 0.5 0.1 0.0 0.0 0.2 1.4 3.4 0.7 8.6 10.5 3.7 2.1 1.2 333.4 0.0 0.0 0.2 1.4 0.1 0.0 18.9 0.0 16.4 0.0 0.0 1.4 3.9 0.0 0.1 18.9 0.1 8.6 5.3 193.1 0.0 0.1 0.1 0.0 807.9 7.4 3.7 0.3 300.0 0.0 20.6 77.2 0.1 579.9 0.0 0.1 0.0 0.0 0.0 22.1 0.0 0.0 0.8 5.8 1.5 19.7 1.1 0.4 0.0 0.5 0.2 0.0 2.1 88.0 0.0 0.0 0.3 TMEM244 "bA174C7.4, C6orf191" ENSG00000203756 "Transmembrane protein 244" Q5VVB8 6 129831244-129861547 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 35 "retina: 64.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 18.8;Excitatory neurons: 4.9;Oligodendrocytes: 7.0;Rod photoreceptor cells: 27.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 1.4;T-reg: 1.6" "Lineage enriched" "Detected in single" 9 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 4.3;LHCN-M2: 5.0;U-2 OS: 1.7;U-251 MG: 4.1;U-266/70: 3.6;WM-115: 2.4" "Not detected" "Not detected" NA NA "unprognostic (4.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-1)" "unprognostic (9.57e-2)" 0.0 0.0 0.4 0.1 1.2 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.4 0.1 0.0 0.1 0.5 0.5 0.6 0.6 0.0 0.0 0.0 1.6 0.0 0.6 0.2 0.1 64.7 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.4 0.1 0.0 0.2 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 5.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.6 4.1 3.6 0.0 0.0 1.0 0.0 2.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.1 0.4 1.2 0.0 1.3 1.4 0.4 0.5 0.6 0.6 0.6 0.3 0.4 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 3.7 0.0 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 OR6K3 ENSG00000203757 "Olfactory receptor family 6 subfamily K member 3" Q8NGY3 1 158716327-158720720 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "bone marrow: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 21 "basophil: 8.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA055949 Uncertain NA NA "HPA055949: AB_2682982" 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPW "C6orf173, CUG2" ENSG00000203760 "Centromere protein W" Q5EE01 6 126340115-126348875 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.0;testis: 39.8" "Cell type enhanced" "Detected in many" "Early spermatids: 329.7;Extravillous trophoblasts: 155.9;Spermatocytes: 148.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA067285 Supported Nucleoplasm NA NA Nucleoplasm "HPA067285: AB_2685818" "unprognostic (3.51e-3)" "unprognostic (2.35e-1)" "unprognostic (3.26e-3)" "unprognostic (9.61e-3)" "unprognostic (3.78e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.11e-2)" "unprognostic (2.82e-2)" "unprognostic (9.07e-2)" "unprognostic (5.86e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.22e-1)" 6.2 4.3 2.2 12.9 2.5 51.0 6.7 2.0 3.6 12.1 1.6 15.1 8.4 21.7 7.0 23.3 9.3 5.4 1.5 4.3 2.2 3.3 3.6 4.9 15.6 1.9 2.1 2.5 4.1 2.1 2.8 2.5 7.9 2.0 6.4 17.7 1.6 8.6 4.4 3.1 8.4 10.9 16.3 2.2 6.8 6.4 39.8 2.0 27.6 2.5 1.9 20.7 6.6 11.0 3.0 73.4 49.0 94.7 82.9 10.3 10.4 81.2 60.0 43.6 81.3 98.3 148.0 50.1 86.8 48.8 38.3 128.7 88.0 78.0 94.3 114.6 94.0 140.2 84.7 141.4 166.3 3.4 123.8 59.1 6.4 10.0 69.1 51.2 23.1 88.3 116.8 144.1 56.5 69.6 119.3 103.1 204.4 60.5 64.0 74.3 107.7 63.2 62.6 38.0 33.0 99.1 44.0 50.8 46.5 67.4 76.9 43.7 119.5 48.0 76.6 78.3 104.6 163.7 36.9 72.7 156.8 45.9 147.0 92.8 3.2 16.9 2.3 2.0 20.3 0.6 6.0 4.4 4.3 15.9 3.5 3.4 2.7 2.9 6.9 14.1 18.9 12.0 5.9 2.2 2.5 2.0 3.6 4.3 2.2 1.9 2.1 2.5 2.0 2.2 2.0 3.0 2.5 0.0 2.6 1.0 18.6 38.0 13.4 54.3 6.2 1.3 10.3 18.7 0.3 11.5 29.4 1.8 2.1 52.2 6.1 23.5 5.9 16.6 329.7 18.0 26.5 11.0 7.8 75.1 23.7 17.9 155.9 25.1 17.3 12.7 13.4 31.4 10.8 6.0 63.6 3.3 22.0 27.1 42.7 15.6 40.1 39.3 19.3 19.3 8.8 1.0 12.6 3.1 3.1 1.0 2.4 17.2 10.6 9.1 38.6 24.7 18.1 1.6 7.0 1.4 0.0 6.4 18.1 148.3 83.8 60.9 29.0 21.2 8.6 11.4 51.7 35.8 SPRN "bA108K14.1, FLJ41197, Shadoo" ENSG00000203772 "Shadow of prion protein" Q5BIV9 10 133420666-133424572 "Predicted intracellular proteins, Transporters" Prion "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.5;liver: 17.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.5;Hepatocytes: 22.5;Horizontal cells: 3.3;Inhibitory neurons: 5.1;Oligodendrocyte precursor cells: 5.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.66e-1)" "unprognostic (1.64e-3)" "unprognostic (3.38e-3)" "unprognostic (1.95e-1)" "unprognostic (1.35e-1)" "unprognostic (3.31e-2)" "unprognostic (1.07e-1)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.58e-7)" 1.3 4.1 6.4 0.3 7.6 0.0 1.6 5.6 13.5 2.1 0.0 2.0 0.5 1.6 0.0 3.0 1.8 0.2 1.5 8.3 1.5 4.5 17.8 1.7 0.1 1.9 2.2 8.6 2.1 3.0 0.2 5.2 0.2 2.7 3.7 0.0 0.7 2.1 0.0 2.0 1.8 3.3 0.3 0.0 4.8 3.6 3.1 3.5 0.0 3.5 0.0 0.0 1.7 2.0 5.1 0.6 0.2 0.4 0.9 0.0 0.0 1.2 1.6 0.0 0.7 0.1 1.2 0.5 1.2 0.3 1.6 0.0 0.9 0.5 0.0 0.0 0.6 1.3 0.3 2.3 0.8 0.2 1.6 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.6 0.4 0.4 0.8 0.6 1.2 0.5 0.0 0.3 2.2 0.4 0.4 0.0 0.4 0.2 0.8 0.0 0.1 0.8 0.2 0.4 0.3 0.6 0.6 1.1 0.8 0.9 0.8 0.7 1.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 7.6 5.6 13.5 8.3 1.5 1.9 2.2 8.6 2.7 0.0 3.5 5.1 0.1 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.7 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.4 22.5 0.0 3.3 5.1 0.0 0.0 2.1 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.5 0.0 5.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087591-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 451.6" "Group enriched" "Detected in many" 8 "Early spermatids: 3403.2;Late spermatids: 7607.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 16.4 21.9 66.0 3.6 72.3 3.8 17.1 73.0 86.1 19.1 68.7 16.1 3.6 26.0 36.8 7.3 53.8 19.3 64.8 64.7 75.9 26.1 25.2 15.4 3.5 73.1 71.2 61.6 26.2 8.6 43.9 66.6 10.7 74.1 19.4 5.4 35.7 9.0 22.8 13.8 7.4 7.5 18.5 78.2 5.2 18.8 451.6 71.0 11.0 21.3 15.4 3.3 19.2 11.4 80.9 4.0 9.9 39.9 19.5 34.3 34.0 1.9 14.9 56.6 21.0 44.0 1.7 9.4 3.1 43.0 27.7 21.9 2.5 8.4 21.7 33.4 1.0 27.7 3.7 4.1 15.7 21.3 8.1 1.8 20.7 14.3 34.8 5.9 48.6 20.9 35.2 4.9 7.8 26.0 1.0 15.1 12.9 10.4 2.9 23.2 23.3 10.0 3.2 31.3 0.6 37.0 15.5 11.9 1.3 23.9 21.4 19.1 7.4 12.0 17.5 7.4 67.1 20.2 5.8 0.3 28.6 27.7 6.8 23.5 0.1 0.0 2.1 3.0 0.0 3.9 1.8 2.6 2.4 0.4 2.6 5.6 5.1 0.2 4.6 0.2 2.5 0.3 1.9 66.0 72.3 73.0 86.1 64.7 75.9 73.1 71.2 61.6 74.1 78.2 71.0 80.9 53.7 3.2 11.4 10.4 4.7 8.4 18.8 48.6 12.0 31.3 23.6 34.7 93.9 21.5 42.1 51.5 12.5 1.5 1.9 0.3 133.1 31.7 3403.2 207.7 18.5 24.6 3.0 9.0 17.2 10.4 6.9 32.9 7.1 11.6 1.3 36.1 33.2 54.4 3.1 16.8 14.8 0.6 52.9 3.2 7.3 7607.9 72.7 6.2 24.9 6.5 2.1 83.5 4.1 12.1 35.8 6.7 0.1 90.7 5.0 11.6 0.1 93.0 409.9 36.9 59.2 26.5 32.6 663.2 51.1 5.5 8.7 0.5 4.4 64.0 0.7 12.2 FANK1 ENSG00000203780 "Fibronectin type III and ankyrin repeat domains 1" Q8TC84 10 125896564-126009592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 29.5;fallopian tube: 35.4;testis: 56.9" "Cell type enhanced" "Detected in many" "Early spermatids: 603.8;Late spermatids: 603.0;Respiratory ciliated cells: 222.2;Spermatocytes: 126.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 16 "T-reg: 61.2" "Lineage enriched" "Detected in single" 612 "T-cells: 61.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.3;hTCEpi: 9.8;hTERT-RPE1: 13.0;RPTEC TERT1: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038413 Supported Nucleoplasm NA NA Nucleoplasm "HPA038413: AB_10697249" "unprognostic (4.25e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.83e-4)" "unprognostic (1.17e-3)" "unprognostic (4.02e-2)" "unprognostic (6.29e-2)" "unprognostic (1.44e-1)" "unprognostic (3.12e-3)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (3.42e-2)" "unprognostic (9.53e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-2)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" 0.8 3.6 11.4 0.7 5.6 1.1 4.6 6.7 4.8 3.4 29.5 3.1 2.4 2.4 12.1 3.6 35.4 2.1 0.8 5.7 15.7 4.9 0.2 5.7 0.5 14.2 14.4 3.0 5.5 4.3 4.5 7.4 1.3 10.5 2.2 4.7 15.9 2.4 3.1 0.2 5.8 2.1 1.4 13.8 0.3 5.4 56.9 7.6 1.6 8.3 0.5 1.3 2.3 2.5 5.7 7.2 2.4 0.6 4.0 3.0 3.0 4.5 2.7 1.9 0.7 0.6 0.1 19.3 0.0 0.5 2.0 1.0 9.3 0.0 3.4 0.5 0.2 0.1 0.0 1.0 0.0 1.1 0.4 0.6 0.9 9.8 2.7 0.9 13.0 1.0 0.0 0.4 0.0 1.1 6.1 0.0 1.4 0.4 6.5 0.2 0.0 0.3 0.6 13.6 2.0 0.5 2.0 2.2 4.5 0.5 7.4 0.7 0.3 0.9 1.3 2.2 1.8 0.1 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.2 0.2 11.4 5.6 6.7 4.8 5.7 15.7 14.2 14.4 3.0 10.5 13.8 7.6 5.7 0.9 12.8 6.3 18.9 0.2 5.1 3.4 18.6 1.2 1.5 7.2 5.7 0.8 1.5 26.6 12.9 33.3 2.6 0.0 5.2 13.7 12.3 603.8 94.9 3.1 1.7 0.0 0.4 15.9 8.9 5.9 2.2 2.0 6.0 3.8 16.5 1.1 0.0 1.0 3.3 14.1 12.4 12.2 0.3 2.3 603.0 3.7 1.1 1.8 2.8 0.2 6.3 0.0 3.0 2.7 11.1 6.9 4.5 0.2 3.2 1.5 11.1 222.2 10.0 0.0 0.8 6.1 126.7 15.5 1.3 3.4 5.1 2.4 12.2 3.6 3.6 LORICRIN LOR ENSG00000203782 "Loricrin cornified envelope precursor protein" P23490 1 153259687-153262124 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Keratinization "Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "skin 1: 1627.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 11 "melanoma: 45.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 92 "HDLM-2: 35.2" "HPA076123, HPA077266" Enhanced NA NA 1800000 "HPA076123: AB_2732302, HPA077266: AB_2732338" "unprognostic (1.97e-2)" "unprognostic (1.93e-2)" "unprognostic (4.16e-2)" "prognostic favorable (8.53e-4)" "unprognostic (1.65e-1)" "unprognostic (2.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.41e-1)" "unprognostic (1.47e-1)" "unprognostic (3.03e-1)" "unprognostic (1.02e-2)" 0.8 0.3 0.5 0.2 0.4 0.0 24.4 0.2 0.4 0.5 0.0 0.4 0.0 0.2 0.0 0.7 0.0 0.0 0.6 0.4 0.7 0.2 0.8 0.5 0.1 0.6 0.4 0.4 0.5 0.6 0.0 0.2 0.0 0.5 0.2 0.0 0.0 1.7 0.0 11.0 1627.8 0.4 0.0 0.3 0.4 0.3 0.5 0.8 0.6 0.3 0.0 1.8 0.1 22.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.4 0.7 0.6 0.4 0.4 0.5 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR9 ENSG00000203783 "Proline rich 9" Q5T870 1 153217584-153219310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 37.9" "Group enriched" "Detected in some" 5 "Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9" "Group enriched" "Detected in many" 6 "cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SuSa: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA027714 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA027714: AB_10602194" "unprognostic (1.45e-1)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (3.48e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-2)" 0.7 0.0 0.1 0.0 0.1 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.1 0.0 0.0 2.9 0.1 0.7 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 LELP1 ENSG00000203784 "Late cornified envelope like proline rich 1" Q5T871 1 153203430-153205120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1197 "testis: 1126.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 21424.4" "Cancer enriched" "Detected in single" 10 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070231 Enhanced NA NA "HPA070231: AB_2686237" "unprognostic (1.77e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.4 0.3 0.3 0.0 0.0 0.1 0.1 1126.4 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3645.9 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21424.4 88.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.1 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 105.5 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPRR2E ENSG00000203785 "Small proline rich protein 2E" P22531 1 153093135-153106184 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 1789.6;lymphoid tissue: 507.8;skin 1: 978.8;vagina: 486.7" "Group enriched" "Detected in some" 6 "Basal respiratory cells: 26.2;Granulosa cells: 21.2;Squamous epithelial cells: 18.4;Suprabasal keratinocytes: 43.8" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 612.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "hTCEpi: 16.5" NA NA "unprognostic (2.27e-1)" "unprognostic (3.86e-2)" "unprognostic (5.04e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (9.47e-4)" 1.9 0.5 0.0 0.0 0.0 0.3 46.5 0.0 0.0 161.3 0.0 0.4 0.0 0.4 0.0 1789.6 0.3 0.4 0.8 0.0 0.0 0.4 1.0 0.4 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 341.4 0.0 1.2 978.8 0.4 0.4 0.0 0.4 1.0 0.6 0.0 1.9 0.3 0.0 507.8 0.3 486.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 16.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.2 18.4 43.8 0.0 0.1 0.1 0.0 0.0 KPRP C1orf45 ENSG00000203786 "Keratinocyte proline rich protein" Q5T749 1 152759561-152762052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 259.2" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 20.0" "Group enriched" "Detected in some" 22 "head and neck cancer: 6.9;melanoma: 13.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.9;U-2197: 1.1" "Not detected" "Not detected" "HPA031988, HPA031990" Enhanced NA NA 27000000 "HPA031988: AB_10671582, HPA031990: AB_2674102" "unprognostic (1.03e-1)" "unprognostic (2.67e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" 0.1 0.0 0.0 0.0 0.7 0.1 10.4 0.0 0.1 6.7 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 1.7 259.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 4.1 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791887 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050138 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Vesicles, Cytosol" "HPA050138: AB_2681030" "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.09e-2)" 4.6 3.9 3.0 2.1 3.3 3.6 5.3 4.7 4.2 4.4 2.9 3.5 1.8 4.1 4.6 4.0 3.8 2.1 4.1 3.0 3.0 5.0 5.3 3.3 2.6 2.8 3.1 3.0 5.6 4.4 4.6 4.3 2.7 3.4 4.4 3.8 2.5 5.1 2.8 4.0 5.0 3.5 2.6 2.7 3.6 3.8 5.7 2.9 3.3 5.2 3.3 3.1 3.5 4.2 3.2 12.6 3.3 4.8 8.0 3.1 8.0 3.1 5.8 7.6 7.4 6.5 4.3 7.1 8.4 3.0 4.7 2.5 3.8 6.8 4.2 11.5 7.0 2.5 6.8 4.2 3.9 6.0 10.9 4.1 3.9 3.9 4.1 9.9 6.2 4.7 7.0 7.6 9.3 9.3 3.7 5.2 8.5 5.9 4.6 4.8 2.3 5.7 2.6 4.6 2.7 1.5 3.8 3.7 6.2 8.7 3.3 5.4 8.5 5.8 2.7 2.9 4.5 8.8 4.3 3.7 6.8 4.9 5.7 3.9 0.8 1.0 1.6 1.6 1.1 2.5 1.9 1.6 2.0 1.2 1.3 2.2 1.6 0.1 4.4 0.8 1.5 1.9 1.1 3.0 3.3 4.7 4.2 3.0 3.0 2.8 3.1 3.0 3.4 2.7 2.9 3.2 23.2 3.2 11.3 0.0 8.9 0.0 0.0 0.0 0.0 0.0 20.5 22.4 0.0 0.0 2.5 11.0 0.0 29.1 13.4 0.0 66.5 20.0 0.0 11.4 11.8 7.5 0.0 0.0 0.0 20.4 29.8 10.4 0.0 10.5 2.5 17.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 11.4 0.0 0.0 0.0 0.0 19.8 0.0 0.0 2.8 0.0 0.0 30.5 3.6 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.1 7.1 14.7 0.0 0.0 FAM24A AC073585.4 ENSG00000203795 "Family with sequence similarity 24 member A" A6NFZ4 10 122910610-122913111 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "testis: 17.8" "Cell type enriched" "Detected in some" 10 "Early spermatids: 303.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052490 Supported "Secreted in male reproductive system" NA NA "HPA052490: AB_2681851" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 303.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DDO ENSG00000203797 "D-aspartate oxidase" Q99489 6 110391771-110415575 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.4;Muller glia cells: 8.2;Oligodendrocytes: 13.3;Paneth cells: 8.5;Proximal enterocytes: 8.5;Proximal tubular cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 3.3;myeloid DC: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.5;RPMI-8226: 15.9;U-937: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037525, HPA037526" Enhanced Enhanced Cytosol NA NA Cytosol "HPA037525: AB_2675523, HPA037526: AB_10672352" "unprognostic (1.37e-1)" "unprognostic (1.54e-1)" "unprognostic (6.51e-2)" "unprognostic (1.30e-2)" "unprognostic (2.00e-1)" "unprognostic (3.28e-2)" "unprognostic (3.71e-2)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.91e-1)" "unprognostic (6.97e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.69e-5)" "unprognostic (3.51e-4)" "unprognostic (3.36e-3)" "unprognostic (1.27e-3)" "unprognostic (9.06e-2)" 1.9 8.3 4.6 0.8 7.0 1.4 2.6 5.1 4.6 2.0 4.3 2.3 7.5 2.2 2.8 0.8 5.0 2.9 18.5 4.5 4.4 10.7 11.2 3.2 1.0 5.2 5.0 3.6 0.4 2.6 5.3 1.2 1.6 5.7 2.0 3.2 2.4 4.3 2.3 11.0 0.4 7.0 2.2 4.8 2.1 1.1 0.1 4.9 0.4 1.3 7.5 0.2 1.6 0.9 6.1 0.2 0.0 0.0 0.1 0.0 0.2 1.1 0.1 5.4 1.3 0.9 0.0 0.1 0.0 0.7 0.7 11.5 0.0 0.0 0.0 2.3 5.0 0.0 5.1 0.1 4.3 1.6 0.0 0.0 0.1 0.0 2.7 0.1 2.3 0.0 0.0 0.0 1.9 4.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.0 15.9 0.0 4.9 0.1 0.2 0.0 0.5 0.6 0.0 0.7 1.1 0.9 1.0 0.1 0.0 2.6 0.1 0.4 0.0 2.0 17.4 0.0 0.0 2.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 1.1 4.6 7.0 5.1 4.6 4.5 4.4 5.2 5.0 3.6 5.7 4.8 4.9 6.1 1.1 0.0 0.0 4.9 0.0 0.0 0.7 0.7 0.6 0.0 1.4 1.1 17.4 0.0 0.4 0.0 2.1 0.2 0.1 1.8 3.9 4.5 0.3 3.6 0.5 0.7 4.2 0.0 0.0 2.2 0.2 0.6 0.0 0.9 0.0 0.1 2.5 4.9 1.7 0.0 0.1 6.0 0.0 3.1 0.4 0.0 0.3 1.6 0.0 0.0 2.0 8.2 0.0 3.5 13.3 0.8 8.5 0.0 0.0 0.4 8.5 12.9 2.2 0.2 0.0 2.1 1.2 0.0 0.0 0.2 0.0 0.0 0.2 0.3 5.0 0.5 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120457227-120592065 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "brain: 12.0" "Cell type enhanced" "Detected in some" "Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 14.2;U-251 MG: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.0 0.0 3.9 0.1 3.1 0.4 0.1 6.1 3.5 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 4.6 7.3 0.8 0.1 0.0 0.0 9.3 4.8 1.6 0.0 0.0 0.0 0.0 0.0 12.0 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.1 4.0 0.0 0.0 0.9 3.8 0.1 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.3 0.2 0.0 0.3 0.1 0.0 1.7 1.4 0.0 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 14.2 1.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.1 0.9 0.2 0.0 2.8 1.7 1.2 0.1 10.4 0.0 0.0 0.0 2.3 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.9 3.1 6.1 3.5 4.6 7.3 9.3 4.8 1.6 12.0 4.0 3.8 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.0 3.7 0.0 0.0 0.0 0.0 7.9 0.3 10.9 0.1 2.5 0.0 0.0 9.7 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.2 1.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 19.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 7.9 0.0 0.5 0.0 9.0 0.0 0.0 0.0 0.0 4.9 1.5 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 H3C14 "H3, H3.2, H3/m, H3F2, H3FM, HIST2H3C, MGC9629" ENSG00000203811 "H3 clustered histone 14" Q71DI3 1 149839538-149841193 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 5.6;U-266/70: 4.8;U-266/84: 5.1" "HPA042570, CAB069990" Supported NA NA "CAB069990: AB_10804539, HPA042570: AB_2678056" "unprognostic (1.78e-1)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.36e-2)" 0.1 0.1 6.6 0.1 3.5 0.8 0.1 11.7 2.7 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.5 0.0 0.3 3.1 0.9 0.1 0.4 0.2 0.1 8.3 1.4 0.8 0.1 0.4 0.0 0.2 0.0 8.4 1.3 0.0 1.0 0.2 0.0 0.2 0.3 0.1 0.0 0.8 0.2 0.2 0.9 7.2 0.1 0.1 0.0 0.0 0.2 0.4 16.0 0.4 2.2 0.4 0.3 0.1 0.0 0.7 0.3 0.0 0.4 0.1 0.3 0.4 0.2 0.3 0.0 0.2 1.7 0.0 0.1 0.1 0.5 3.7 0.3 2.0 0.1 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 1.8 2.0 0.1 1.5 1.1 1.4 1.2 2.7 0.8 0.9 0.2 1.0 0.0 0.2 3.2 0.7 5.6 1.5 0.2 0.6 0.9 1.2 0.0 0.4 3.1 0.2 0.2 4.8 5.1 1.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 3.5 11.7 2.7 3.1 0.9 8.3 1.4 0.8 8.4 0.8 7.2 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AC18 "H2A.2, H2A/q, H2AFO, HIST2H2AA, HIST2H2AA3" ENSG00000203812 "H2A clustered histone 18" Q6FI13 1 149842188-149842736 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.5;Hofbauer cells: 1.0;Syncytiotrophoblasts: 2.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 116.8;U-266/70: 472.4;U-266/84: 300.7" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.89e-1)" "unprognostic (2.20e-1)" 46.4 38.1 5.7 16.7 7.7 177.3 47.6 7.0 18.7 89.2 40.6 40.0 11.5 14.0 7.8 80.2 50.9 14.7 52.1 6.3 37.3 73.4 75.3 154.0 12.8 16.0 11.4 4.9 55.1 24.2 0.1 31.7 22.0 11.1 202.2 3.5 0.0 47.3 6.6 43.0 89.4 32.0 5.6 12.9 128.6 60.3 118.4 11.5 15.3 31.3 3.8 2.3 43.1 137.0 9.6 14.7 0.0 1.1 0.0 11.1 7.8 0.0 29.8 12.3 17.3 14.5 0.3 7.3 7.5 20.5 11.7 0.7 4.6 1.6 5.5 2.0 15.3 0.0 3.7 31.7 8.8 11.4 0.0 7.9 55.0 9.9 4.2 4.8 0.0 4.5 0.0 43.6 116.8 6.0 21.6 0.0 28.9 0.0 30.1 31.4 6.1 0.0 47.8 7.4 11.8 2.7 1.2 50.4 10.1 1.6 0.0 41.2 12.8 10.1 7.8 58.3 1.5 2.6 472.4 300.7 11.5 26.3 59.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 7.7 7.0 18.7 6.3 37.3 16.0 11.4 4.9 11.1 12.9 11.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 H2BC18 HIST2H2BF ENSG00000203814 "H2B clustered histone 18" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 30.8" "Lineage enriched" "Detected in many" 14 "granulocytes: 30.8" "Cell line enriched" "Detected in many" 7 "U-266/70: 49.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.2 6.8 4.2 1.3 4.8 3.0 5.3 9.7 3.6 29.3 11.1 5.1 0.6 1.2 2.5 9.7 9.8 1.0 5.0 3.2 8.2 9.0 7.3 28.3 0.9 5.5 4.7 1.3 35.6 4.8 0.3 5.7 2.2 5.4 30.5 0.9 2.9 6.9 1.0 0.7 11.0 3.4 0.6 5.8 15.9 13.0 3.7 6.7 2.8 6.1 0.5 0.7 6.2 35.0 11.9 0.7 1.0 0.5 1.0 0.6 0.1 0.5 1.0 0.2 0.8 1.0 0.5 1.3 0.7 0.4 0.2 0.8 2.1 0.2 0.0 0.1 2.1 0.7 0.7 3.0 0.1 0.4 0.4 2.7 1.2 0.0 0.4 0.5 0.4 0.1 0.5 1.8 3.8 0.0 1.5 5.2 3.1 0.7 3.6 1.5 0.5 1.7 1.2 0.2 0.2 2.7 0.9 6.6 0.3 0.5 1.0 2.0 0.4 0.0 0.7 0.0 1.1 0.6 49.7 1.7 2.0 1.0 0.5 0.2 0.0 1.4 0.3 0.8 0.5 0.8 0.7 1.1 0.4 0.9 2.1 0.5 0.4 30.8 0.7 0.6 0.8 0.2 0.2 4.2 4.8 9.7 3.6 3.2 8.2 5.5 4.7 1.3 5.4 5.8 6.7 11.9 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 PNLIPRP3 ENSG00000203837 "Pancreatic lipase related protein 3" Q17RR3 10 116427847-116477957 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 9.1;skin 1: 14.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.1;Early spermatids: 1.5;Late spermatids: 1.9;Melanocytes: 1.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 4.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "hTCEpi: 320.3" "Not detected" "Not detected" "HPA046202, HPA052009" Uncertain "Secreted - unknown location" NA NA "HPA046202: AB_10959739, HPA052009: AB_2681692" "unprognostic (2.62e-4)" "unprognostic (1.60e-1)" "unprognostic (6.97e-2)" 1.3 0.1 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 320.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 H3C15 "H3/n, H3/o, HIST2H3A" ENSG00000203852 "H3 clustered histone 15" Q71DI3 1 149852619-149854274 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 5.6;U-266/70: 4.8;U-266/84: 5.1" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "unprognostic (3.99e-2)" 0.1 0.1 6.6 0.1 3.5 0.8 0.1 11.7 2.7 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.3 3.1 0.9 0.1 0.3 0.2 0.1 8.3 1.4 0.8 0.1 0.4 0.0 0.2 0.0 8.4 1.2 0.0 1.0 0.2 0.0 0.2 0.2 0.1 0.0 0.8 0.2 0.2 0.8 7.2 0.1 0.1 0.0 0.0 0.1 0.2 16.0 0.4 2.2 0.4 0.3 0.1 0.0 0.7 0.3 0.0 0.4 0.1 0.3 0.4 0.2 0.3 0.0 0.2 1.7 0.0 0.1 0.1 0.5 3.7 0.3 2.0 0.1 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 1.8 2.0 0.1 1.5 1.1 1.4 1.2 2.7 0.8 0.9 0.2 1.0 0.0 0.2 3.2 0.7 5.6 1.5 0.2 0.6 0.9 1.2 0.0 0.4 3.1 0.2 0.2 4.8 5.1 1.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 3.5 11.7 2.7 3.1 0.9 8.3 1.4 0.8 8.4 0.8 7.2 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 78.4" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 140.8;Syncytiotrophoblasts: 502.0" "Cancer enriched" "Detected in single" 4 "urothelial cancer: 1.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 64.1;SuSa: 26.5" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" Yes NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 1.2 0.3 0.0 1.0 0.0 1.5 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 1.2 0.0 0.0 78.4 0.2 0.1 0.5 0.0 0.1 0.0 0.2 2.5 8.7 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.2 0.0 0.0 0.0 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 7.0 0.7 0.8 26.5 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 1.3 0.3 0.4 0.4 0.0 0.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 140.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 502.0 0.0 0.1 1.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 56 "adrenal gland: 2192.7" "Group enriched" "Detected in some" 4 "Granulosa cells: 40.6;Proximal enterocytes: 38.8;Theca cells: 68.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.4" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" Yes NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.2 2192.7 0.4 2.1 0.8 0.0 0.1 0.0 0.8 0.2 0.0 4.2 0.0 0.2 0.0 0.2 0.4 0.0 0.2 0.3 0.2 0.9 1.0 0.5 0.0 0.3 0.0 0.7 0.9 0.5 0.0 0.1 3.6 0.2 0.4 1.0 0.0 1.0 0.0 0.1 0.2 39.0 0.1 0.0 0.2 0.3 3.0 0.1 0.5 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.8 0.3 0.2 0.3 0.0 0.7 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 3.5 0.0 0.0 0.0 40.6 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 38.8 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 68.9 1.7 0.0 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644336-110839468 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.1;pancreas: 20.4;skeletal muscle: 15.7" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 151.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2" "Low region specificity" "Detected in single" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge" Yes No "Nucleoplasm, Golgi apparatus" "Nucleoli, Cytokinetic bridge" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.1 0.1 0.8 0.2 2.1 0.1 2.5 0.5 0.8 1.4 1.7 3.0 0.1 2.9 0.6 5.6 2.6 0.4 41.1 0.8 0.7 0.7 0.1 0.9 0.1 1.2 0.9 0.4 2.8 20.4 1.2 1.7 1.7 1.1 1.4 0.5 1.2 7.3 0.7 15.7 1.1 0.8 2.2 0.4 0.1 1.0 0.8 0.7 0.5 1.0 3.8 0.6 1.0 5.6 0.7 0.0 1.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 2.5 6.0 5.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 16.2 0.0 0.0 0.0 0.1 15.0 0.1 0.0 0.6 4.9 9.2 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.5 0.8 0.8 0.7 1.2 0.9 0.4 1.1 0.4 0.7 0.7 0.3 0.0 0.0 0.7 0.2 0.1 0.2 0.4 1.2 1.4 0.8 0.5 151.5 0.0 0.1 0.0 2.1 1.6 0.0 0.7 1.9 0.0 0.8 0.5 1.2 1.5 0.0 0.0 14.8 0.2 0.2 3.3 0.0 0.1 0.0 14.6 1.4 0.0 0.1 0.0 15.4 0.7 2.0 0.0 0.0 0.8 4.4 0.0 0.0 17.8 0.0 0.1 0.0 1.5 0.6 0.0 0.1 13.5 1.0 0.0 2.0 1.5 12.4 2.7 6.6 3.7 5.4 0.5 0.8 3.7 0.0 3.1 0.2 1.7 0.2 0.3 SMIM9 CXorf68 ENSG00000203870 "Small integral membrane protein 9" A6NGZ8 X 154823348-154834662 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Early spermatids: 28.6;Late spermatids: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA060970 Uncertain NA NA "HPA060970: AB_2684399" "unprognostic (2.63e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 C6orf163 ENSG00000203872 "Chromosome 6 open reading frame 163" Q5TEZ5 6 87344813-87365463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 7.8" "Group enriched" "Detected in some" 7 "Early spermatids: 180.7;Late spermatids: 267.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in single" 4 "basal ganglia: 1.5" "Low region specificity" "Detected in all" "HPA044797, HPA052927" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044797: AB_10962365, HPA052927: AB_2681990" "unprognostic (4.98e-2)" "unprognostic (6.42e-2)" "unprognostic (1.65e-1)" "unprognostic (2.33e-2)" "unprognostic (4.18e-2)" "unprognostic (3.49e-2)" "unprognostic (7.55e-3)" "unprognostic (3.96e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (5.60e-4)" "unprognostic (6.66e-2)" "unprognostic (3.77e-3)" "unprognostic (1.46e-1)" "unprognostic (1.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" 0.5 0.6 1.2 0.3 0.9 2.3 0.9 0.6 1.7 0.9 1.2 0.6 0.2 0.9 1.4 0.4 1.5 0.4 0.8 1.3 0.5 0.5 0.7 0.4 0.7 1.0 0.9 0.6 1.2 0.8 0.7 1.2 0.4 1.5 0.9 0.8 1.2 0.9 0.3 1.3 1.6 0.8 0.4 0.0 1.2 0.6 7.8 0.5 0.5 0.8 0.6 0.6 0.5 0.5 1.5 0.0 0.2 1.0 1.6 0.1 1.1 1.3 0.0 0.0 0.2 0.3 0.4 0.3 0.6 0.1 0.1 0.6 0.3 0.4 0.9 0.0 0.6 0.7 0.8 0.4 0.3 0.0 0.4 0.2 0.5 0.5 0.3 0.3 0.4 0.2 0.6 1.3 0.5 0.1 0.2 0.1 0.5 0.2 0.0 0.0 1.4 0.3 0.0 0.7 1.0 0.8 0.4 0.1 0.2 0.5 1.0 0.2 0.4 0.3 0.6 0.5 0.3 0.5 0.2 0.3 0.1 0.0 0.8 0.4 0.2 0.1 0.0 0.4 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.3 0.8 0.2 0.2 0.0 0.2 0.1 1.2 0.9 0.6 1.7 1.3 0.5 1.0 0.9 0.6 1.5 0.0 0.5 1.5 0.7 0.0 0.5 28.4 0.4 0.4 0.5 0.5 0.0 0.6 0.5 0.3 2.5 1.5 0.2 0.0 0.0 0.6 0.3 0.6 0.0 0.3 180.7 1.8 1.2 1.3 0.0 1.3 31.4 0.0 0.4 0.5 1.5 0.4 0.0 1.6 0.4 0.5 0.2 0.0 25.1 0.4 0.0 0.8 0.0 267.1 2.5 0.4 1.8 12.2 0.2 0.2 0.0 14.1 16.0 0.1 0.2 1.9 0.5 0.4 0.4 0.5 1.1 0.5 6.6 1.4 0.9 2.3 1.8 0.2 0.1 0.8 0.7 1.6 0.2 0.4 RIPPLY2 "C6orf159, dJ237I15.1" ENSG00000203877 "Ripply transcriptional repressor 2" Q5TAB7 6 83853266-83857515 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.3;choroid plexus: 10.9;pituitary gland: 11.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.0;Excitatory neurons: 10.0;Horizontal cells: 11.8;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 13.0;Rod photoreceptor cells: 8.5" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 19.1;HEL: 6.2;SCLC-21H: 26.0;SH-SY5Y: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047454 Uncertain NA NA "HPA047454: AB_2680053" "unprognostic (2.09e-1)" "unprognostic (7.43e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-3)" "unprognostic (2.69e-3)" "unprognostic (3.66e-1)" "unprognostic (6.94e-3)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" 0.2 1.4 14.5 0.2 15.7 0.0 0.2 19.2 19.3 0.8 10.9 0.9 0.2 0.8 0.0 0.2 0.5 0.3 0.2 15.8 15.7 0.1 0.0 0.1 0.0 15.0 14.5 14.8 0.4 1.1 0.0 11.3 0.0 15.6 0.7 0.2 4.3 0.1 0.4 0.3 0.0 0.4 0.3 14.7 0.0 0.7 0.8 15.2 0.0 0.2 0.0 0.0 1.4 0.5 16.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 19.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 1.5 0.0 0.0 1.1 26.0 17.7 1.3 0.1 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 15.7 19.2 19.3 15.8 15.7 15.0 14.5 14.8 15.6 14.7 15.2 16.9 0.2 0.0 0.0 2.0 0.0 0.0 0.4 0.3 1.8 12.0 0.0 0.1 3.5 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.3 1.8 0.0 10.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 10.5 0.0 4.1 0.0 0.3 0.5 0.3 0.0 0.0 1.0 0.0 1.4 0.0 13.0 4.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 8.5 0.0 2.9 1.0 0.8 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 GDI1 "FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4" ENSG00000203879 "GDP dissociation inhibitor 1" P31150 X 154436913-154443467 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 441.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012979, HPA049290, HPA057668" Enhanced Approved Cytosol NA NA 31000000 Cytosol "CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498" "prognostic unfavorable (6.84e-4)" "unprognostic (1.13e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.53e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" "unprognostic (1.31e-3)" "unprognostic (1.36e-1)" "unprognostic (1.46e-2)" "unprognostic (1.30e-1)" "unprognostic (2.98e-3)" "unprognostic (3.86e-2)" "unprognostic (3.88e-3)" "unprognostic (1.70e-1)" "unprognostic (8.12e-2)" "unprognostic (1.92e-2)" "unprognostic (1.72e-1)" 74.1 86.6 317.4 55.4 376.6 41.6 68.0 298.7 441.9 99.6 208.5 80.7 37.0 93.0 46.6 57.9 95.5 47.7 94.7 369.4 357.7 75.0 54.4 90.8 54.3 334.2 311.1 347.6 121.1 55.2 64.0 177.4 60.9 355.4 75.6 42.1 132.0 50.1 70.2 63.4 61.1 68.1 79.6 291.2 90.1 69.1 54.5 326.2 59.3 63.5 71.4 51.5 90.0 81.9 377.6 100.2 88.9 195.9 164.6 77.7 91.4 64.5 149.6 91.1 140.4 146.0 52.6 51.1 79.5 149.3 139.4 213.2 79.7 172.7 83.9 96.5 147.5 93.8 25.0 142.6 35.5 113.5 24.6 90.5 94.7 101.3 163.4 99.6 154.6 92.4 95.7 31.1 120.5 169.4 99.2 77.9 62.1 53.0 106.1 168.8 77.6 51.6 45.0 98.8 46.5 272.5 210.3 67.6 86.1 109.0 150.3 50.9 42.5 110.4 131.9 116.8 138.4 212.0 182.1 202.0 128.3 140.7 54.5 162.5 23.7 8.4 26.9 12.1 12.6 18.0 9.9 13.0 12.0 7.0 10.1 10.0 10.1 30.0 8.7 21.3 12.1 16.2 7.3 317.4 376.6 298.7 441.9 369.4 357.7 334.2 311.1 347.6 355.4 291.2 326.2 377.6 39.3 16.0 27.4 30.3 35.9 27.1 24.8 48.3 33.6 71.3 24.1 25.7 62.6 24.3 29.0 27.6 25.0 22.7 27.0 31.4 31.3 39.4 2.9 33.1 41.1 35.3 90.8 9.2 48.8 31.3 39.3 37.5 37.8 34.3 33.7 29.7 30.4 17.7 36.3 60.6 43.2 24.8 65.1 35.9 40.9 6.0 37.6 35.5 17.8 22.5 59.0 37.7 19.6 33.2 46.4 50.2 25.9 39.9 35.7 27.4 24.3 25.5 46.8 37.1 52.6 29.5 49.8 33.9 66.6 20.7 30.3 49.5 43.2 22.0 15.0 26.2 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 182.1" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 138.2;Rod photoreceptor cells: 181.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA057849: AB_2683544" "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 29.2 34.0 30.5 23.1 34.6 18.0 37.9 42.3 41.0 34.7 30.0 23.2 23.6 39.5 49.6 23.0 29.3 32.7 42.9 30.3 29.6 34.5 32.4 24.3 41.9 32.7 29.3 29.2 57.5 27.3 27.9 32.1 41.5 32.6 29.8 20.5 182.1 32.6 18.5 45.0 66.5 25.2 19.2 26.3 36.7 21.9 24.9 29.8 39.9 27.3 33.2 29.8 20.8 28.3 42.5 22.9 8.5 32.0 25.0 30.1 37.1 30.1 13.6 15.1 19.7 12.0 19.4 35.9 33.8 23.5 16.6 15.6 27.6 17.6 22.4 26.5 7.4 23.0 16.4 42.1 32.9 25.3 16.9 24.0 52.7 30.5 10.4 17.9 35.1 29.1 34.0 30.4 29.8 16.3 14.8 39.8 56.7 23.5 31.6 31.7 32.6 12.6 41.1 30.0 26.1 50.0 58.9 26.1 30.1 37.2 49.4 32.2 34.1 21.2 29.4 10.3 18.9 11.3 35.8 31.3 32.9 19.5 17.9 16.1 10.1 7.9 9.4 9.4 5.4 11.2 10.2 14.0 10.7 9.0 10.7 19.2 14.2 10.2 17.4 5.3 5.4 22.6 9.8 30.5 34.6 42.3 41.0 30.3 29.6 32.7 29.3 29.2 32.6 26.3 29.8 42.5 40.8 22.4 26.9 25.8 21.0 20.4 15.6 10.2 31.3 118.5 27.5 18.0 67.4 28.6 17.5 29.5 93.8 33.7 21.9 6.7 23.5 8.4 13.2 21.3 23.2 36.6 22.8 35.3 34.8 9.1 7.0 34.8 17.9 26.4 12.7 33.5 45.0 36.7 14.4 37.0 29.5 15.9 14.2 28.8 10.7 9.5 42.9 17.3 48.0 21.5 19.2 61.3 20.6 138.2 64.6 9.9 15.7 30.9 20.2 14.6 12.0 23.3 24.3 181.9 26.3 25.0 27.7 51.7 37.7 24.9 21.3 21.9 21.6 63.1 15.2 11.3 SOX18 ENSG00000203883 "SRY-box transcription factor 18" P35713 20 64047582-64049639 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 9 "Adipocytes: 370.9;Endothelial cells: 212.4;Hepatic stellate cells: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 20.8;NB-4: 35.8;REH: 8.5;TIME: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073703 Approved Nucleoplasm NA NA Nucleoplasm "HPA073703: AB_2686628" "unprognostic (2.51e-1)" "unprognostic (3.23e-1)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.07e-1)" "unprognostic (2.88e-2)" "unprognostic (2.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.62e-1)" "unprognostic (3.45e-2)" "unprognostic (1.33e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-3)" "unprognostic (9.63e-3)" "unprognostic (1.41e-1)" "unprognostic (2.46e-1)" "unprognostic (5.40e-2)" 48.1 14.4 7.8 3.1 5.4 0.0 43.5 5.8 8.7 19.6 6.1 15.4 3.2 38.7 0.4 12.0 29.5 3.8 57.0 3.7 4.8 21.1 5.3 29.4 3.1 9.5 7.5 1.6 8.1 8.2 1.3 6.7 5.6 10.0 17.7 0.4 0.0 12.7 1.3 14.0 12.2 17.2 1.5 5.6 22.6 15.7 5.6 9.7 0.8 29.3 3.9 0.5 19.9 22.1 8.4 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.0 0.0 0.0 0.2 0.3 0.0 0.0 0.5 1.0 0.0 3.0 5.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 20.8 0.0 3.7 0.0 0.0 0.7 0.0 35.8 0.1 0.0 0.3 8.5 0.0 0.6 0.0 1.4 0.6 0.6 0.3 0.0 0.5 0.0 0.5 1.8 9.6 0.1 2.6 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 5.4 5.8 8.7 3.7 4.8 9.5 7.5 1.6 10.0 5.6 9.7 8.4 370.9 0.0 0.6 0.3 3.7 1.0 0.2 0.0 2.2 0.9 1.9 3.0 8.8 1.5 0.0 1.8 0.0 0.0 1.6 0.1 0.0 0.3 22.1 1.0 11.9 212.4 0.0 2.7 0.0 0.0 0.0 2.5 0.0 0.7 4.5 0.0 306.6 0.6 0.1 0.0 0.0 0.0 0.0 6.0 2.2 4.8 1.2 1.3 1.8 15.9 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 3.6 6.5 32.4 2.5 0.9 1.1 0.3 0.7 2.3 0.0 0.3 LIME1 "dJ583P15.4, FLJ20406, LIME" ENSG00000203896 "Lck interacting transmembrane adaptor 1" Q9H400 20 63736283-63739103 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 244.7" "Cell type enriched" "Detected in some" 5 "Plasma cells: 210.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 5 "gdT-cell: 314.8;MAIT T-cell: 285.2;memory CD4 T-cell: 437.6;memory CD8 T-cell: 412.5;naive CD4 T-cell: 289.4;naive CD8 T-cell: 319.4;plasmacytoid DC: 749.3;T-reg: 689.4" "Group enriched" "Detected in all" 8 "dendritic cells: 749.3;T-cells: 689.4" "Cell line enhanced" "Detected in many" "Karpas-707: 33.9;MOLT-4: 37.9;RPMI-8226: 144.4;U-266/70: 71.1" "Low region specificity" "Detected in many" CAB015363 Approved "Intracellular and membrane" NA NA "CAB015363: AB_629890" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.95e-3)" "unprognostic (3.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.06e-2)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (1.94e-1)" "unprognostic (1.05e-3)" "unprognostic (1.51e-3)" "prognostic unfavorable (5.04e-5)" "unprognostic (2.39e-2)" "unprognostic (4.25e-2)" "unprognostic (1.67e-1)" "prognostic favorable (6.92e-6)" 6.7 5.7 1.7 5.7 4.3 4.7 5.9 1.9 7.1 8.3 0.4 9.6 2.2 6.0 0.0 11.3 6.9 0.0 4.6 2.2 1.1 53.2 244.7 9.1 10.8 3.2 1.1 1.4 9.7 5.2 0.1 11.4 0.1 2.5 13.5 0.3 0.0 12.6 0.4 4.0 11.9 18.9 0.0 0.7 43.5 18.5 5.9 1.2 6.1 11.3 0.0 1.2 7.7 9.2 3.7 2.0 0.6 0.1 0.4 0.0 0.0 4.9 2.6 0.2 0.3 0.0 1.1 2.1 5.7 3.8 0.1 0.0 5.1 0.0 0.3 0.3 2.5 4.8 1.1 2.3 25.4 0.0 1.5 2.1 0.2 0.7 0.0 0.0 0.0 0.0 16.4 2.1 33.9 0.0 1.1 37.9 10.7 2.0 1.3 6.6 25.9 0.8 144.4 0.4 0.3 2.0 2.9 1.3 1.3 2.8 0.0 1.1 0.8 0.5 1.8 2.8 1.9 1.5 71.1 3.0 12.7 1.5 1.1 0.7 1.9 1.5 1.8 314.8 1.0 285.2 76.4 437.6 412.5 2.4 37.2 289.4 319.4 10.6 85.5 1.7 749.3 689.4 193.8 1.7 4.3 1.9 7.1 2.2 1.1 3.2 1.1 1.4 2.5 0.7 1.2 3.7 0.0 0.0 0.0 21.5 7.2 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 7.7 0.0 0.0 0.3 22.4 0.0 0.0 0.0 0.4 3.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.6 0.1 0.0 0.0 9.0 9.6 0.0 0.0 0.0 210.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.8 0.1 0.0 36.7 0.0 0.1 0.0 OOEP "C6orf156, Em:AC019205.2, KHDC2" ENSG00000203907 "Oocyte expressed protein" A6NGQ2 6 73368555-73395133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 14.3" "Group enriched" "Detected in some" 6 "Early spermatids: 29.4;Spermatocytes: 74.1;Spermatogonia: 56.8" "Cancer enriched" "Detected in single" 26 "testis cancer: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;CAPAN-2: 8.3;MCF7: 2.9;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA055165 Approved NA NA "HPA055165: AB_2682722" "unprognostic (7.95e-2)" "unprognostic (1.13e-1)" "unprognostic (2.63e-1)" "unprognostic (4.50e-1)" "unprognostic (4.68e-1)" "unprognostic (2.20e-3)" "unprognostic (6.86e-2)" "unprognostic (3.99e-2)" "unprognostic (7.22e-2)" "unprognostic (2.52e-1)" "unprognostic (6.04e-2)" "unprognostic (1.17e-2)" "unprognostic (1.86e-2)" "unprognostic (8.66e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (4.98e-2)" 0.2 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.2 0.0 0.2 0.9 0.0 0.1 1.4 0.2 0.2 0.0 0.0 1.8 0.4 0.0 0.9 0.1 0.0 0.1 0.2 0.5 14.3 0.2 0.0 0.4 0.2 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.1 0.2 0.0 8.3 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.3 0.5 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.6 0.2 0.2 0.3 0.2 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.3 1.1 0.3 3.8 0.0 0.0 0.4 0.6 0.0 1.5 0.5 0.0 0.0 8.6 0.2 0.2 0.0 0.1 29.4 1.8 0.1 0.7 0.0 2.7 0.0 0.6 2.4 0.5 0.0 0.8 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.5 2.0 0.3 0.7 7.2 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 1.2 0.4 0.3 0.2 1.2 0.5 0.6 0.0 0.5 0.2 74.1 56.8 0.0 1.0 4.5 0.4 0.0 0.0 0.3 KHDC3L "C6orf221, ECAT1" ENSG00000203908 "KH domain containing 3 like, subcortical maternal complex member" Q587J8 6 73362658-73364171 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 3156 "testis cancer: 254.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043699 Uncertain NA NA "HPA043699: AB_10960564" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (4.36e-1)" 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.4 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DPPA5 Esg1 ENSG00000203909 "Developmental pluripotency associated 5" A6NC42 6 73353063-73354276 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.1" "Group enriched" "Detected in some" 4 "Spermatocytes: 2.4;Spermatogonia: 1.4" "Cancer enriched" "Detected in single" 2209 "testis cancer: 347.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 43 "SuSa: 6.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA055016, HPA064505" Uncertain Uncertain "Cell Junctions" NA NA "Cell Junctions" "HPA055016: , HPA064505: AB_2685275" "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C1orf146 SPO16 ENSG00000203910 "Chromosome 1 open reading frame 146" Q5VVC0 1 92217915-92245813 "Predicted intracellular proteins" Meiosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "retina: 2.1;testis: 7.6" "Group enriched" "Detected in some" 20 "Spermatocytes: 79.3;Spermatogonia: 27.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074051 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA074051: " "unprognostic (2.89e-2)" "unprognostic (4.26e-3)" "unprognostic (1.81e-1)" "unprognostic (5.37e-3)" "unprognostic (8.77e-2)" "unprognostic (1.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" "unprognostic (1.90e-1)" "unprognostic (7.13e-2)" "unprognostic (4.17e-2)" "unprognostic (2.78e-7)" "unprognostic (3.36e-2)" "unprognostic (6.76e-2)" "unprognostic (3.17e-1)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.3 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN1 "CT11.6, SPANX-N1" ENSG00000203923 "SPANX family member N1" Q5VSR9 X 145247503-145256208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 1.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589708-141590762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 53 "testis: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;GAMG: 1.3;PC-3: 1.3;U-2197: 1.5" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXorf66 "RP11-35F15.2, SGPX" ENSG00000203933 "Chromosome X open reading frame 66" Q5JRM2 X 139955728-139965521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell type enriched" "Detected in some" 7 "Early spermatids: 129.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589721-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 184 "testis: 280.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 9848.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA072947 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA072947: AB_2686562" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.2 0.4 0.0 0.7 0.0 0.2 1.4 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.4 0.7 0.7 0.0 0.0 0.9 0.9 0.1 0.0 0.3 0.1 0.2 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.5 0.0 0.0 280.1 0.7 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.4 0.3 0.3 0.4 0.9 0.9 0.1 0.9 0.5 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1711.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9848.3 39.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.3 0.0 0.0 6.6 0.0 0.0 40.7 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAMD13 ENSG00000203943 "Sterile alpha motif domain containing 13" Q5VXD3 1 84298366-84389957 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9;choroid plexus: 31.9;intestine: 22.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 20.3;Intestinal goblet cells: 18.0;Oligodendrocytes: 16.4;Paneth cells: 33.2;Spermatocytes: 22.5;Undifferentiated cells: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "basophil: 12.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 12.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA058929 Enhanced Approved Mitochondria NA NA Mitochondria "HPA058929: AB_2683855" "unprognostic (3.78e-2)" "unprognostic (4.93e-2)" "unprognostic (8.51e-3)" "unprognostic (7.55e-2)" "prognostic favorable (1.14e-8)" "unprognostic (1.78e-1)" "unprognostic (1.65e-6)" "unprognostic (2.05e-1)" "unprognostic (5.50e-2)" "unprognostic (2.80e-3)" "unprognostic (9.42e-2)" "unprognostic (3.29e-1)" "unprognostic (1.98e-7)" "unprognostic (3.99e-2)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.56e-3)" 0.9 3.4 22.9 1.5 26.4 2.8 2.4 11.8 26.5 1.7 31.9 19.6 3.4 1.7 4.2 0.8 4.2 1.8 2.4 19.9 24.0 1.5 0.4 0.9 1.2 29.7 33.3 12.6 0.3 1.8 1.2 1.0 0.8 28.2 4.0 22.2 0.8 17.7 2.1 6.3 1.2 3.8 2.5 29.2 1.1 6.1 13.3 37.9 2.8 9.9 3.0 0.6 1.8 0.4 33.8 0.5 2.3 1.1 3.5 3.6 3.3 2.3 0.3 0.2 0.3 0.2 0.0 3.4 3.6 6.3 0.1 0.7 0.4 0.4 1.2 0.5 2.0 1.7 1.3 1.7 0.3 0.8 4.4 0.0 1.3 1.6 0.1 1.0 2.5 8.2 7.8 0.5 1.1 1.0 1.1 5.1 0.5 3.5 2.9 2.3 0.5 2.5 1.5 6.5 2.1 1.4 5.1 0.1 0.1 8.1 1.4 1.0 4.1 1.4 1.4 0.3 0.3 1.0 2.4 0.5 6.3 0.3 3.8 1.1 12.5 0.3 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.7 0.7 0.3 0.4 0.1 0.5 0.3 0.8 0.0 0.3 22.9 26.4 11.8 26.5 19.9 24.0 29.7 33.3 12.6 28.2 29.2 37.9 33.8 1.7 0.0 0.6 2.0 0.3 0.4 0.7 0.7 0.6 1.2 3.8 2.9 1.0 2.8 1.1 1.8 0.0 4.5 0.1 20.3 5.9 2.1 5.6 5.4 1.6 1.6 11.4 6.1 5.2 0.6 0.6 1.4 3.6 4.7 5.7 2.0 3.3 0.1 1.5 0.0 5.8 18.0 0.0 2.4 1.6 5.8 1.8 1.4 8.8 6.5 0.4 2.7 0.0 7.1 16.4 1.1 33.2 2.6 0.1 2.0 3.8 2.9 1.1 0.1 0.0 1.8 0.7 22.5 5.5 2.2 0.3 0.8 0.7 4.1 21.3 1.2 RTL8A "CXX1b, DKFZP564B147, FAM127B, MAR8A, SIRH6" ENSG00000203950 "Retrotransposon Gag like 8A" Q9BWD3 X 135050932-135052196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 109.5;Ductal cells: 71.3;Pancreatic endocrine cells: 78.2;Proximal tubular cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 174.7" NA NA "unprognostic (2.10e-2)" "prognostic favorable (5.35e-4)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (9.91e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (1.10e-5)" "unprognostic (2.16e-2)" "unprognostic (4.48e-1)" "prognostic favorable (2.71e-4)" "unprognostic (2.05e-2)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (3.35e-2)" "unprognostic (1.57e-2)" 36.0 30.6 19.1 7.0 21.2 4.8 36.6 20.6 38.4 46.3 8.9 40.3 10.3 45.4 4.9 57.9 41.4 9.3 38.9 17.5 20.8 38.0 19.3 32.5 6.7 20.8 19.1 17.7 47.9 20.3 10.2 51.4 10.7 21.0 42.3 5.9 7.8 31.8 17.5 20.0 38.3 29.0 10.4 18.7 26.7 30.8 12.2 20.4 6.1 38.4 8.7 4.1 45.1 43.8 21.6 47.9 57.1 28.4 62.8 29.5 25.3 40.9 18.8 17.8 45.3 49.4 59.1 20.1 0.0 50.4 29.4 50.3 29.9 14.8 32.8 14.5 16.4 52.1 9.4 59.7 0.0 71.6 3.0 13.6 48.0 55.7 46.6 20.9 17.6 33.9 9.4 15.0 0.0 21.4 174.7 3.3 30.4 14.7 12.5 57.0 10.4 29.4 0.1 9.0 26.5 52.3 67.2 21.7 15.9 50.6 10.7 17.5 8.5 35.0 34.4 29.3 66.4 46.8 7.1 12.6 0.2 20.0 13.4 27.9 31.7 19.5 21.0 6.9 27.8 6.0 4.4 7.3 8.7 14.0 5.5 8.1 9.2 4.6 4.6 34.1 10.8 5.0 8.6 19.1 21.2 20.6 38.4 17.5 20.8 20.8 19.1 17.7 21.0 18.7 20.4 21.6 43.9 60.9 19.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 52.6 63.5 0.0 0.0 26.0 62.5 0.0 60.1 7.4 0.0 109.5 71.3 0.0 39.3 49.6 21.7 0.0 0.0 0.0 63.5 60.7 22.6 0.0 38.1 11.4 34.8 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 78.2 0.0 0.0 1.8 0.0 0.0 110.5 14.6 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 28.2 5.0 54.1 0.0 0.0 CCDC160 ENSG00000203952 "Coiled-coil domain containing 160" A6NGH7 X 134237047-134246207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 16.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 45.0;Early spermatids: 14.8;Endometrial ciliated cells: 28.1;Respiratory ciliated cells: 36.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 29.7;RPTEC TERT1: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (7.45e-3)" "unprognostic (2.79e-2)" "prognostic favorable (2.31e-4)" "unprognostic (1.98e-1)" "unprognostic (5.11e-4)" "unprognostic (4.22e-2)" "unprognostic (2.07e-2)" "prognostic favorable (7.62e-6)" "unprognostic (3.32e-2)" "unprognostic (4.51e-2)" "prognostic favorable (2.21e-4)" "unprognostic (5.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.44e-3)" 0.2 0.0 2.5 0.1 2.3 0.2 3.9 3.0 2.9 2.9 3.5 0.1 0.0 0.7 1.7 0.4 3.3 1.2 0.1 2.3 2.3 6.0 0.0 0.4 0.5 2.7 2.5 2.2 1.3 0.5 5.2 0.6 0.2 2.8 1.8 0.1 1.0 16.6 2.6 1.0 0.2 0.0 0.0 2.3 0.4 1.0 2.1 2.5 0.0 0.2 0.0 0.1 0.5 0.3 3.0 0.0 0.0 29.7 2.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 8.3 2.4 0.0 0.1 0.0 0.3 0.4 2.9 3.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.3 3.0 2.9 2.3 2.3 2.7 2.5 2.2 2.8 2.3 2.5 3.0 0.2 0.0 0.0 5.5 0.0 0.0 1.0 9.3 0.6 0.3 9.6 9.0 0.5 1.5 10.2 9.2 0.0 0.0 0.0 0.0 45.0 3.2 14.8 28.1 0.5 0.3 0.0 0.0 0.4 0.0 0.3 0.8 0.0 2.5 0.0 0.8 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.6 0.1 1.8 1.0 0.0 6.9 0.0 6.0 5.6 0.2 0.0 0.4 0.0 1.8 0.0 7.7 36.0 0.6 0.0 0.7 0.6 6.7 10.1 2.3 0.0 0.0 0.1 0.1 0.0 1.4 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.8;testis: 15.6" "Cell type enhanced" "Detected in some" "Early spermatids: 117.8;Granulosa cells: 23.1;Late spermatids: 94.7;Muller glia cells: 63.0;Respiratory ciliated cells: 53.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "HEL: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA035316 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.3 0.6 0.2 2.2 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.2 0.5 0.0 0.0 1.1 0.0 1.0 1.0 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 15.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.4 0.3 0.6 0.2 0.5 1.0 1.0 0.1 0.5 1.4 0.6 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.2 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 117.8 3.8 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 23.1 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 94.7 1.8 0.2 0.0 0.0 0.0 63.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 53.8 2.1 0.0 0.0 1.4 8.8 0.9 0.0 0.0 0.1 0.0 4.0 0.0 0.0 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 55.3;Excitatory neurons: 58.9;Inhibitory neurons: 47.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 73.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favorable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 2.7 5.3 8.1 2.2 7.6 2.0 6.1 9.2 9.3 5.8 9.8 2.9 2.0 6.2 6.2 2.9 8.2 4.7 6.6 8.2 8.9 5.7 1.7 4.1 3.6 7.3 7.0 7.1 8.1 3.0 10.5 5.9 3.3 7.3 5.5 3.0 9.0 3.2 5.0 6.8 3.2 2.1 4.8 6.8 2.7 3.2 14.7 7.7 7.4 5.9 3.9 3.3 3.8 2.9 8.7 6.5 5.7 7.1 4.5 7.5 11.0 3.6 4.1 4.6 7.2 8.8 1.7 5.0 4.4 9.6 2.5 14.5 6.0 6.1 4.1 8.5 8.6 4.3 3.6 10.4 3.9 4.6 5.1 3.2 6.1 9.9 8.6 5.6 11.4 6.1 8.2 4.8 7.3 4.7 1.5 9.9 3.5 3.1 4.6 5.6 6.2 10.7 4.6 11.1 3.6 15.2 5.8 8.1 4.5 10.5 9.6 4.5 3.8 1.7 4.1 3.5 12.1 4.0 4.7 8.7 5.0 7.4 3.5 6.0 10.1 0.4 0.1 1.2 0.3 1.6 1.8 1.4 1.4 0.8 1.9 1.4 1.3 0.0 1.3 2.6 1.0 1.6 0.6 8.1 7.6 9.2 9.3 8.2 8.9 7.3 7.0 7.1 7.3 6.8 7.7 8.7 3.1 12.8 4.1 23.2 6.0 3.1 5.6 7.0 5.7 7.7 2.6 3.9 7.8 2.8 5.6 5.5 4.2 3.7 2.1 0.6 7.9 3.8 55.3 19.9 8.0 3.2 1.8 1.3 58.9 0.7 2.0 5.6 3.6 3.4 2.5 7.9 2.2 1.2 2.6 0.0 47.7 1.3 8.2 2.5 1.6 8.8 10.8 1.8 1.8 14.0 1.9 5.2 2.1 41.7 21.9 1.4 0.3 13.5 6.0 1.4 0.5 5.5 27.5 11.3 26.3 11.8 5.3 73.4 22.7 3.8 2.3 1.2 3.4 5.8 2.1 1.6 DEFB110 "DEFB-10, DEFB-11, DEFB111" ENSG00000203970 "Defensin beta 110" Q30KQ9 6 50009138-50021994 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4674 "epididymis: 879.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 879.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYATL3 "bA28H17.2, C6orf140" ENSG00000203972 "Glycine-N-acyltransferase like 3" Q5SZD4 6 49499923-49528078 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "liver: 1.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "T-47d: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA044044 Uncertain NA NA "HPA044044: AB_10960855" "unprognostic (3.57e-1)" "unprognostic (6.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007298-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "fallopian tube: 117.3" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 2.2;Hep G2: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.6 0.2 0.1 0.1 0.1 0.6 0.5 0.2 4.5 0.2 0.1 0.0 0.7 0.1 0.6 117.3 0.8 0.0 0.1 0.1 0.0 0.1 7.0 0.1 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.2 0.1 3.4 0.1 0.2 0.3 0.1 0.0 0.0 0.2 1.4 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.5 0.0 6.4 7.2 0.0 0.0 0.0 0.2 5.0 0.0 0.0 0.5 0.1 0.1 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 98.1 0.8 0.7 20.9 0.0 0.1 0.2 0.0 1.1 0.0 2.1 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 12.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.0 0.0 329.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120072264-120077690 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 21.4" "Cell type enriched" "Detected in single" 6 "Spermatogonia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HL-60: 596.6;K-562: 903.3;NB-4: 1129.0" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 596.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 903.3 0.0 0.0 0.0 0.0 1129.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 94.3 3.0 0.0 0.0 0.6 0.2 0.0 156.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZYG11A ZYG11 ENSG00000203995 "Zyg-11 family member A, cell cycle regulator" Q6WRX3 1 52842511-52894998 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 3.0;testis: 3.8;thyroid gland: 2.3" "Cell type enhanced" "Detected in some" "Prostatic glandular cells: 2.5;Spermatocytes: 3.5;Spermatogonia: 7.9" "Cancer enriched" "Detected in many" 7 "testis cancer: 11.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 12.5;hTEC/SVTERT24-B: 10.4;K-562: 10.7;SiHa: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030378, HPA030379" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030378: AB_10604159, HPA030379: AB_2673451" "unprognostic (7.94e-2)" "unprognostic (6.71e-3)" "unprognostic (1.04e-2)" "unprognostic (4.06e-3)" "unprognostic (1.59e-2)" "unprognostic (1.00e-4)" "unprognostic (1.87e-1)" "unprognostic (2.34e-1)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "unprognostic (4.01e-2)" "unprognostic (1.01e-1)" "unprognostic (6.15e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 0.3 0.1 0.1 0.5 0.7 0.1 0.1 0.3 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.1 3.0 1.2 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.7 0.1 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 3.8 0.1 0.3 2.3 0.0 0.7 0.1 0.4 0.4 0.0 2.0 0.3 0.0 0.0 0.0 4.5 1.2 1.4 5.8 4.7 0.1 0.0 0.0 3.0 1.8 0.0 0.1 3.8 0.1 6.8 0.3 7.5 0.0 12.5 0.0 2.7 0.0 0.9 0.0 0.3 10.4 0.0 0.3 1.3 0.0 10.7 5.6 0.2 5.6 0.0 5.6 1.4 0.0 1.0 0.0 1.2 4.9 3.5 0.2 1.4 2.1 10.8 0.4 0.0 4.3 6.0 3.0 0.0 0.0 0.1 0.0 0.0 2.7 4.9 0.0 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 0.5 1.6 0.5 0.7 0.0 0.1 0.0 0.0 1.1 0.3 0.4 0.0 0.0 0.3 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.5 0.0 0.1 0.4 0.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.0 0.0 0.9 2.5 0.0 1.3 0.2 1.3 0.0 0.6 0.3 3.5 7.9 1.5 0.1 0.3 0.1 0.0 0.1 0.3 LCN8 LCN5 ENSG00000204001 "Lipocalin 8" Q6JVE9 9 136754386-136758543 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 96 "epididymis: 84.4" "Group enriched" "Detected in some" 11 "B-cells: 17.9;Plasma cells: 5.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 60 "memory B-cell: 4.1;naive B-cell: 8.1" "Lineage enriched" "Detected in single" 79 "B-cells: 8.1" "Cell line enriched" "Detected in single" 6 "REH: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (6.71e-2)" "unprognostic (2.11e-2)" "unprognostic (2.92e-1)" "unprognostic (2.89e-1)" "unprognostic (2.00e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 84.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C1orf185 FLJ27485 ENSG00000204006 "Chromosome 1 open reading frame 185" Q5T7R7 1 51102221-51148086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 138 "testis: 25.7" "Cell type enriched" "Detected in some" 8 "Early spermatids: 616.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 616.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 71.7 4.7 0.3 0.0 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLT6D1 GLTDC1 ENSG00000204007 "Glycosyltransferase 6 domain containing 1" Q7Z4J2 9 135623648-135639540 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 4.8" "Group enriched" "Detected in some" 39 "Early spermatids: 26.8;Late spermatids: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023424 Uncertain "Intracellular and membrane" NA NA "HPA023424: AB_1849729" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 IFIT1B "bA149I23.6, IFIT1L" ENSG00000204010 "Interferon induced protein with tetratricopeptide repeats 1B" Q5T764 10 89378056-89385205 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 25.9" "Cell type enriched" "Detected in single" 320 "Erythroid cells: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062924 Approved NA NA "HPA062924: AB_2684906" "unprognostic (2.59e-1)" "unprognostic (3.13e-1)" "unprognostic (6.62e-3)" "unprognostic (4.55e-2)" "unprognostic (4.11e-2)" "unprognostic (9.34e-2)" "unprognostic (1.76e-1)" "unprognostic (6.86e-2)" 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT83 "CXorf61, FLJ20611, FLJ22913, KK-LC-1" ENSG00000204019 "Cancer/testis antigen 83" Q5H943 X 116461686-116462976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 64.5" "Group enriched" "Detected in some" 153 "Early spermatids: 817.7;Late spermatids: 3229.1" "Cancer enhanced" "Detected in many" "stomach cancer: 7.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 77.6;OE19: 77.0;RPMI-8226: 25.6;U-266/70: 108.5;U-266/84: 61.5" "Not detected" "Not detected" NA NA "unprognostic (1.59e-2)" "unprognostic (1.69e-2)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 64.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.2 0.0 0.0 0.0 0.0 0.0 77.0 0.8 0.0 0.0 25.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 108.5 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 817.7 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3229.1 8.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.2 7.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 LIPN "bA186O14.3, LIPL4" ENSG00000204020 "Lipase family member N" Q5VXI9 10 88759982-88779626 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase Ichthyosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "skin 1: 26.9" "Group enriched" "Detected in some" 4 "Macrophages: 7.5;monocytes: 2.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 2.9;eosinophil: 10.3;intermediate monocyte: 7.5;neutrophil: 5.4;non-classical monocyte: 8.5" "Group enriched" "Detected in many" 8 "granulocytes: 10.3;monocytes: 8.5" "Cell line enhanced" "Detected in single" "HL-60: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.03e-2)" "unprognostic (9.75e-2)" "unprognostic (2.54e-2)" "unprognostic (4.40e-2)" "unprognostic (5.77e-3)" "unprognostic (1.65e-1)" 1.3 0.3 0.0 2.8 0.0 2.8 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.4 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 26.9 0.1 0.3 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.9 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 2.9 10.3 0.0 7.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.4 0.0 8.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 7.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 LIPK "bA186O14.2, LIPL2" ENSG00000204021 "Lipase family member K" Q5VXJ0 10 88724544-88752756 "Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 32.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-BR-3: 2.6" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (7.65e-2)" "unprognostic (8.64e-2)" "unprognostic (3.57e-2)" "unprognostic (3.19e-7)" "unprognostic (1.25e-1)" "unprognostic (1.60e-2)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.0" "Cell type enriched" "Detected in some" 7 "Early spermatids: 67.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048594 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA048594: AB_2680456" "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.5 0.1 0.3 0.0 0.2 1.1 0.3 0.1 0.3 0.1 0.3 0.1 0.9 0.0 0.7 0.1 0.2 0.3 0.3 0.2 0.5 0.1 0.3 1.2 0.8 0.2 0.1 0.4 0.0 0.1 0.0 0.5 0.3 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.2 0.5 0.1 0.2 7.0 0.3 0.4 0.6 0.0 0.3 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.1 0.3 0.3 0.3 1.2 0.8 0.2 0.5 0.5 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.1 67.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.0 0.6 0.0 9.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TRPC5OS TRPC5-AS1 ENSG00000204025 "TRPC5 opposite strand" A6NMA1 X 111876051-111903990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 21.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.3;Inhibitory neurons: 2.0;Late spermatids: 2.2;Spermatogonia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-937: 1.3" "Not detected" "Not detected" NA NA "unprognostic (1.77e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.47e-2)" "unprognostic (9.90e-2)" "unprognostic (1.72e-1)" "unprognostic (1.40e-6)" "unprognostic (6.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.85e-3)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.3 0.2 0.4 0.2 0.4 0.3 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 2.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220571-84225544 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "retina: 59.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.5;Cone photoreceptor cells: 8.4;Rod photoreceptor cells: 24.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced NA NA "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 59.5 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.3 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 44.5" "Group enriched" "Detected in many" 4 "Early spermatids: 411.0;Spermatocytes: 121.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;MCF7: 3.2;OE19: 4.5;T-47d: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol NA NA Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 0.2 6.5 5.0 0.0 5.3 0.0 0.3 0.3 9.3 0.7 0.6 0.4 0.6 0.6 0.3 0.2 5.2 0.5 1.4 6.2 2.8 2.3 0.5 0.9 0.0 1.9 1.5 5.6 0.9 1.2 3.0 4.8 0.2 2.3 1.1 0.1 1.3 0.6 0.6 0.0 0.3 0.2 0.3 0.1 0.5 1.0 44.5 2.9 0.0 1.1 0.0 0.0 0.4 0.3 4.0 0.3 0.7 0.4 3.1 0.5 1.5 0.1 0.1 0.9 0.2 0.1 0.0 0.1 0.1 0.0 0.5 0.4 1.2 0.3 0.4 0.0 0.0 0.5 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.6 1.0 0.1 1.5 0.1 0.1 0.2 0.3 0.6 3.2 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.8 0.0 1.1 1.3 0.3 0.2 0.1 0.0 3.2 0.0 0.1 0.2 0.3 1.1 0.1 0.3 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 5.3 0.3 9.3 6.2 2.8 1.9 1.5 5.6 2.3 0.1 2.9 4.0 0.3 0.0 0.0 1.0 0.0 0.4 3.1 0.7 0.0 5.6 0.8 1.3 1.0 1.5 1.6 3.7 0.0 0.1 0.0 1.0 7.9 0.6 411.0 27.1 4.0 0.6 5.4 0.0 3.3 0.9 0.1 0.8 1.5 1.3 0.0 0.6 0.0 0.8 0.1 28.6 3.3 2.2 0.0 0.0 0.0 58.3 4.4 0.4 1.8 0.0 0.0 8.7 0.0 0.0 0.3 0.2 0.1 4.1 0.0 2.8 2.2 9.4 12.6 8.4 6.6 0.3 0.9 121.6 12.4 0.0 0.0 0.3 0.1 7.1 0.8 0.6 FOXO6 ENSG00000204060 "Forkhead box O6" A8MYZ6 1 41361922-41383590 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "Bipolar cells: 6.9;Late spermatids: 6.0;Muller glia cells: 7.8;Skeletal myocytes: 6.4;Theca cells: 11.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 10.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.70e-1)" "unprognostic (1.13e-1)" "unprognostic (7.35e-2)" "prognostic unfavorable (7.65e-6)" "unprognostic (5.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (2.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.71e-2)" "unprognostic (5.27e-2)" "unprognostic (6.55e-9)" "unprognostic (4.35e-2)" "unprognostic (4.28e-1)" "unprognostic (6.10e-2)" "unprognostic (8.10e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.3 0.3 0.1 0.1 0.2 0.9 0.0 0.0 0.3 0.1 0.3 3.1 0.1 0.0 6.9 3.3 2.2 3.4 2.8 0.1 1.8 0.0 3.6 0.3 0.6 0.0 0.8 4.1 1.1 0.6 0.4 1.2 0.0 0.7 0.2 2.3 2.3 4.6 0.8 0.0 2.0 0.4 0.2 0.4 0.0 0.6 1.0 0.0 0.0 0.3 6.0 4.1 0.2 0.0 1.0 0.0 7.8 0.0 1.5 1.6 0.1 0.0 4.1 1.3 1.5 0.2 0.7 0.1 0.7 0.0 6.4 1.3 0.2 0.5 0.9 0.0 4.4 0.6 11.2 0.5 1.3 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276750 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.6;choroid plexus: 42.2;pituitary gland: 62.7;retina: 23.7;testis: 60.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 9.0;SH-SY5Y: 28.0" "Low region specificity" "Detected in all" "HPA045564, HPA058982" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favorable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 0.7 10.6 58.0 0.9 61.6 0.0 2.2 62.1 74.6 5.9 42.2 1.8 0.6 5.7 6.8 0.3 2.5 0.8 1.7 59.6 58.0 0.3 0.1 0.3 0.0 57.0 53.7 57.5 5.2 0.9 0.0 62.7 0.0 59.2 3.3 0.7 23.7 1.1 4.2 0.1 0.3 1.2 3.4 50.3 0.1 1.0 60.5 55.6 0.6 2.3 0.7 0.0 1.5 3.9 62.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 61.6 62.1 74.6 59.6 58.0 57.0 53.7 57.5 59.2 50.3 55.6 62.3 0.1 0.0 0.0 2.9 0.0 0.1 0.5 0.0 1.8 43.4 0.3 9.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.3 7.5 0.6 0.0 0.0 7.0 0.0 0.4 7.6 0.0 0.2 0.0 16.5 0.0 0.0 0.3 1.7 7.7 0.0 0.0 0.0 1.7 22.1 8.4 0.7 0.0 2.8 0.0 75.5 0.0 7.1 2.8 0.0 0.0 35.7 0.0 0.2 0.0 0.3 0.0 6.8 0.0 6.9 1.4 7.6 1.9 0.1 0.3 0.4 0.1 0.2 0.0 0.2 SYS1 "C20orf169, dJ453C12.4" ENSG00000204070 "SYS1 golgi trafficking protein" Q8N2H4 20 45361937-45376798 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046716 Approved NA NA "HPA046716: AB_2679769" "unprognostic (8.24e-2)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.51e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.77e-1)" "unprognostic (4.66e-3)" "unprognostic (2.33e-1)" "unprognostic (4.28e-2)" "unprognostic (4.90e-2)" "unprognostic (4.38e-2)" "unprognostic (5.38e-3)" "unprognostic (2.01e-2)" 18.3 18.6 16.9 16.6 17.9 25.7 18.4 17.1 16.9 18.9 38.4 19.4 11.8 21.8 17.7 16.3 33.3 19.0 16.2 16.9 19.5 23.8 25.1 20.0 27.0 16.3 16.2 14.9 25.3 19.4 23.4 16.5 16.1 16.8 15.1 14.7 21.7 26.3 19.8 23.6 12.7 18.3 17.0 16.0 15.4 20.6 8.6 18.6 16.6 30.1 15.9 24.5 19.1 15.7 18.9 16.8 30.4 12.9 22.0 40.2 24.6 20.4 17.3 24.3 25.5 21.8 76.1 32.0 10.5 39.1 28.7 32.8 35.8 25.6 30.5 17.8 15.1 13.9 12.3 16.6 41.5 33.4 23.0 23.9 30.1 44.6 28.0 17.7 25.6 25.6 18.6 19.3 15.3 18.9 36.6 19.0 23.1 13.8 20.2 42.2 3.1 15.0 16.3 30.6 14.5 9.8 11.8 27.5 16.6 34.2 13.3 37.3 14.6 15.1 32.2 21.3 17.9 16.3 18.1 13.0 4.1 22.0 15.5 18.7 51.8 23.4 37.7 33.8 23.4 35.7 26.3 32.5 34.8 26.4 31.3 35.1 30.6 29.7 22.9 25.6 103.9 37.8 30.6 16.9 17.9 17.1 16.9 16.9 19.5 16.3 16.2 14.9 16.8 16.0 18.6 18.9 18.5 19.2 28.1 0.0 39.5 29.1 37.6 24.6 19.9 25.3 29.9 25.4 12.7 27.1 17.3 23.9 29.2 28.4 61.1 31.7 17.6 39.6 30.3 48.7 15.8 23.1 16.1 7.6 0.0 57.9 45.2 26.8 9.2 28.5 26.1 15.0 24.7 34.5 60.6 20.2 0.0 22.6 22.4 38.4 15.4 19.9 17.4 30.3 24.9 0.0 24.4 34.3 35.0 0.0 0.0 42.0 28.5 19.2 14.8 36.2 47.5 29.4 58.4 37.1 13.1 21.0 33.2 17.4 13.8 16.6 30.5 52.5 37.2 18.9 17.1 39.4 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.4;pituitary gland: 74.0;testis: 27.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 40.4;Excitatory neurons: 9.1;Horizontal cells: 15.2;Inhibitory neurons: 10.4;Late spermatids: 6.7" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045564, HPA058982" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 0.7 10.8 25.9 0.2 27.1 0.0 0.6 25.9 45.4 1.2 6.6 1.3 0.2 3.6 1.4 0.0 5.7 0.1 0.3 25.6 33.1 1.0 0.0 0.1 0.0 28.9 27.7 25.0 8.6 0.4 1.8 74.0 0.0 31.0 0.8 0.2 16.9 1.8 0.6 0.0 0.2 0.7 0.7 20.0 0.0 0.8 27.0 25.2 0.0 0.5 0.2 0.0 0.0 1.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.9 27.1 25.9 45.4 25.6 33.1 28.9 27.7 25.0 31.0 20.0 25.2 35.7 0.0 0.0 0.0 3.9 0.0 0.1 0.5 0.0 0.0 40.4 0.0 0.1 4.6 0.0 0.0 3.7 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 9.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 15.2 10.4 0.0 0.0 0.0 0.3 6.7 2.5 0.1 1.8 1.0 0.0 1.9 0.0 4.5 1.7 0.4 0.0 0.7 0.0 0.5 0.0 0.0 0.0 4.3 0.0 1.4 0.9 1.9 0.9 0.0 0.3 0.0 0.2 0.0 0.0 0.1 INPP5B ENSG00000204084 "Inositol polyphosphate-5-phosphatase B" P32019 1 37860697-37947057 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.5;Inhibitory neurons: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028803 Approved Supported Cytosol NA NA 8400 Cytosol "HPA028803: AB_10612121" "unprognostic (2.28e-2)" "unprognostic (8.91e-3)" "unprognostic (7.67e-2)" "unprognostic (2.27e-1)" "unprognostic (4.30e-2)" "prognostic favorable (1.11e-4)" "unprognostic (1.67e-2)" "unprognostic (1.52e-2)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "prognostic favorable (5.33e-4)" "unprognostic (8.27e-2)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.03e-1)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" 13.2 9.4 9.8 10.4 10.5 20.9 12.0 14.2 11.9 16.0 11.2 16.3 7.0 14.0 10.0 7.2 15.8 8.4 11.6 9.4 9.5 10.8 16.4 14.8 18.6 10.9 10.4 9.2 24.1 10.5 8.9 12.0 10.5 11.5 11.0 10.1 12.6 8.4 11.2 9.2 10.5 13.5 12.0 9.7 17.4 13.8 7.1 10.2 13.5 12.3 6.1 18.9 17.0 11.8 15.5 6.8 4.6 10.7 15.7 12.3 15.8 18.5 7.5 12.5 9.6 13.2 7.2 9.4 23.2 3.6 12.9 5.0 9.1 14.3 6.0 12.8 16.2 6.3 35.8 15.4 4.9 17.7 19.0 47.4 17.8 3.7 10.2 6.6 9.4 11.0 16.4 11.7 25.6 12.4 5.3 16.7 21.4 15.5 9.5 3.9 18.7 21.3 10.9 5.5 6.2 4.3 6.8 8.8 4.2 18.9 15.7 5.2 15.8 10.6 8.8 7.9 8.5 7.1 20.8 11.8 18.3 10.1 15.8 8.1 27.3 2.9 16.5 7.0 2.3 9.9 7.1 4.8 6.7 6.1 7.6 6.1 5.8 3.7 6.2 6.0 5.4 6.8 4.9 9.8 10.5 14.2 11.9 9.4 9.5 10.9 10.4 9.2 11.5 9.7 10.2 15.5 5.7 28.9 26.3 35.3 11.8 2.2 5.8 2.1 4.0 14.7 2.2 2.3 3.2 1.5 6.4 1.8 25.0 4.1 7.9 3.9 0.0 2.4 10.7 2.3 8.4 5.9 3.5 6.5 47.5 4.4 15.4 6.3 16.8 3.3 8.2 6.9 5.3 7.8 5.2 23.5 48.5 5.0 6.1 8.1 5.4 15.9 8.4 8.3 7.2 35.6 11.3 4.6 28.8 20.1 39.4 3.0 4.7 9.1 8.5 4.5 3.5 2.6 5.8 18.9 6.6 7.7 7.1 4.6 8.1 3.4 3.3 4.7 11.2 7.7 4.7 4.1 RPA4 HSU24186 ENSG00000204086 "Replication protein A4" Q13156 X 96883908-96885467 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 1.6;testis: 1.7" "Cell type enhanced" "Detected in many" "Spermatocytes: 20.6;Syncytiotrophoblasts: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" HPA066010 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066010: AB_2685596" "unprognostic (6.23e-2)" "unprognostic (2.55e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-6)" "unprognostic (1.33e-1)" "unprognostic (6.33e-2)" "unprognostic (9.75e-4)" "unprognostic (3.15e-1)" "unprognostic (7.61e-3)" "unprognostic (2.59e-3)" "unprognostic (1.55e-1)" "unprognostic (2.62e-1)" "unprognostic (2.47e-12)" "unprognostic (8.95e-3)" "unprognostic (6.05e-3)" "unprognostic (8.17e-2)" "unprognostic (4.59e-2)" 0.3 0.1 0.3 0.0 0.5 0.2 0.2 0.0 0.4 0.3 1.6 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.6 0.1 0.1 0.4 0.3 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 1.7 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.4 0.1 0.4 0.0 0.1 0.7 0.0 0.7 0.0 0.2 0.0 0.3 0.0 1.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.7 0.6 0.1 0.3 0.4 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.5 0.3 0.0 0.5 0.7 0.4 0.2 0.4 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.4 0.3 0.3 0.0 0.3 0.5 0.0 0.4 0.6 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 3.3 0.0 3.3 0.0 0.7 0.8 0.3 0.7 0.6 0.3 0.4 0.5 0.1 2.8 0.8 0.0 0.0 4.6 1.6 2.1 0.0 0.8 1.1 0.9 1.5 2.0 3.6 0.0 0.0 0.6 1.1 1.3 2.6 1.7 0.0 3.4 0.4 1.9 1.9 0.0 0.0 2.5 4.1 2.2 1.1 1.0 1.5 2.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 1.4 2.9 1.5 0.3 0.4 1.1 0.1 0.1 1.6 6.6 3.5 1.0 20.6 6.7 1.1 1.3 9.9 0.8 1.1 1.7 0.2 NEU4 ENSG00000204099 "Neuraminidase 4" Q8WWR8 2 241809065-241817413 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 76.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4" "Group enriched" "Detected in some" 7 "colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "Hep G2: 57.7;HMC-1: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037394 Enhanced NA NA "HPA037394: AB_2675455" "unprognostic (1.50e-1)" "unprognostic (2.39e-3)" "unprognostic (1.85e-1)" "unprognostic (3.68e-4)" "unprognostic (3.76e-2)" "unprognostic (1.57e-1)" "unprognostic (8.70e-2)" "unprognostic (8.62e-2)" "unprognostic (1.74e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-2)" "unprognostic (2.92e-1)" "unprognostic (8.11e-4)" "unprognostic (2.00e-2)" "unprognostic (3.82e-1)" "unprognostic (6.64e-3)" "unprognostic (1.55e-2)" 0.6 0.2 2.2 0.1 2.0 3.5 0.2 1.8 4.4 0.3 0.2 9.1 10.8 0.2 0.0 0.0 0.7 0.4 0.3 1.6 2.0 1.5 76.4 0.4 0.0 4.5 2.3 1.2 0.3 0.1 0.0 1.1 0.0 2.3 0.4 2.2 0.1 0.8 0.0 9.1 0.1 9.2 0.0 2.3 0.3 0.1 0.7 2.3 0.0 0.3 0.8 0.0 0.1 0.1 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 57.7 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.0 1.8 4.4 1.6 2.0 4.5 2.3 1.2 2.3 2.3 2.3 3.0 0.2 0.0 0.0 1.0 0.5 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.6 1.5 0.7 1.8 0.0 0.0 1.1 74.6 3.9 0.0 0.1 0.0 0.1 0.3 34.4 0.0 0.4 0.0 0.0 0.2 0.5 0.0 1.3 0.1 1.1 124.4 1.5 0.0 0.4 38.5 2.0 4.2 0.7 0.2 0.6 4.0 0.0 0.0 0.0 26.2 0.0 50.3 0.1 0.0 58.0 0.7 0.4 0.0 76.0 23.6 0.2 1.3 0.0 3.6 0.4 0.5 0.5 0.0 0.0 0.0 1.3 0.0 38.4 0.1 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689236 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 275.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 88.3;non-classical monocyte: 121.4" "Lineage enriched" "Detected in many" 15 "monocytes: 121.4" "Cell line enhanced" "Detected in some" "HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 35.7 14.0 4.7 37.6 7.0 59.8 27.6 4.5 15.2 13.1 8.4 9.3 7.8 9.4 5.5 33.3 11.4 24.6 9.4 3.9 10.1 17.2 29.5 21.0 28.0 9.5 5.2 2.5 6.9 15.9 275.2 3.1 13.3 9.6 8.3 7.3 0.6 18.5 4.8 16.0 71.1 13.3 14.3 7.8 97.0 11.1 3.9 8.4 6.7 50.6 16.8 12.8 14.0 22.1 11.5 0.0 0.0 0.0 2.6 1.5 0.2 0.4 0.3 0.1 0.3 0.1 0.4 0.2 0.0 1.9 0.4 0.0 3.8 0.0 0.0 0.0 0.0 1.4 0.0 1.2 0.2 0.9 0.0 0.1 28.6 61.2 0.2 2.1 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.3 7.4 2.6 6.2 0.0 0.0 0.0 0.0 0.5 0.4 16.7 1.4 15.6 1.5 3.9 5.4 1.5 0.3 0.5 16.4 0.3 24.4 0.0 0.0 0.0 0.0 16.0 0.6 0.0 0.4 24.3 0.0 0.0 88.3 0.0 0.0 0.0 0.1 7.9 0.1 0.0 0.0 2.1 0.0 121.4 0.1 0.0 10.6 4.7 7.0 4.5 15.2 3.9 10.1 9.5 5.2 2.5 9.6 7.8 8.4 11.5 70.0 22.4 37.9 1.6 7.8 68.6 50.5 17.1 264.0 12.0 112.2 217.8 208.9 7.2 16.8 51.5 25.0 9.8 7.6 117.1 1.9 2.3 0.8 15.7 64.4 39.1 57.7 4.0 0.8 3.4 2.8 172.7 49.5 27.6 10.8 0.9 34.6 36.1 377.6 3.3 25.4 50.7 6.1 672.8 91.7 2.8 29.5 456.7 21.4 6.5 65.3 21.9 3.1 2.0 1.3 4.9 30.9 24.5 5.6 29.7 89.5 1.3 2.4 8.3 13.1 160.6 102.4 0.8 1.7 361.5 88.2 12.4 9.5 114.6 39.0 19.2 TRAF3IP1 "DKFZP434F124, FAP116, IFT54, MIP-T3, MIPT3" ENSG00000204104 "TRAF3 interacting protein 1" Q8TDR0 2 238320441-238400897 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 75.3;Endometrial ciliated cells: 150.3;Late spermatids: 75.1;Respiratory ciliated cells: 105.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037857, HPA037858" Approved NA NA "HPA037857: AB_2675706, HPA037858: AB_10671724" "unprognostic (1.25e-1)" "unprognostic (9.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (3.38e-2)" "unprognostic (1.80e-3)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (9.04e-2)" "unprognostic (6.38e-3)" "unprognostic (7.44e-2)" "unprognostic (4.78e-3)" "unprognostic (7.48e-3)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.07e-1)" 6.5 5.1 10.2 4.3 8.7 2.0 6.7 8.8 8.9 7.2 10.5 8.5 5.2 8.4 12.4 6.6 19.5 5.8 5.3 8.7 10.4 7.0 5.6 6.7 4.7 11.1 10.7 7.9 7.3 5.4 12.3 5.9 5.0 10.5 7.2 6.1 6.7 6.4 8.2 11.5 5.5 4.9 7.4 10.7 4.9 5.9 14.3 9.5 4.0 10.8 7.6 5.4 7.1 6.2 9.4 8.6 10.4 9.4 11.4 9.2 11.4 6.9 6.9 10.4 8.9 8.3 3.7 6.6 0.2 3.6 9.9 10.3 8.5 10.5 7.9 13.7 5.2 10.7 2.2 9.2 12.7 9.7 10.4 5.8 8.8 12.3 11.3 9.1 8.3 9.1 7.6 10.5 1.9 9.6 10.8 8.3 5.7 10.5 6.8 5.4 13.0 17.1 3.4 12.1 4.0 12.8 6.9 11.7 9.0 9.0 5.7 7.6 7.8 10.4 10.8 8.4 11.0 9.1 4.9 2.8 3.3 10.6 3.7 7.3 0.2 0.2 0.1 0.3 0.1 0.6 0.3 0.3 0.4 0.1 0.2 0.3 0.3 0.3 2.0 1.5 0.4 0.0 0.2 10.2 8.7 8.8 8.9 8.7 10.4 11.1 10.7 7.9 10.5 10.7 9.5 9.4 10.9 32.1 18.1 20.5 5.0 7.9 7.8 5.2 9.6 20.3 15.6 11.0 14.6 2.8 21.7 1.8 37.5 7.1 7.4 10.5 0.0 8.1 75.3 150.3 25.2 10.4 10.7 6.1 37.9 9.1 6.0 11.6 9.2 24.5 6.3 16.0 8.2 16.0 4.5 47.1 36.9 9.9 8.2 2.5 6.0 75.1 11.1 4.9 3.6 15.0 3.2 14.5 4.1 16.1 18.1 8.4 7.1 17.0 4.2 7.0 7.8 8.2 105.3 37.8 6.6 17.9 12.4 48.1 44.1 9.1 8.0 3.7 5.1 18.1 11.4 5.9 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 47.0;Excitatory neurons: 62.7;Inhibitory neurons: 59.6;Microglial cells: 29.0;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 76.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" NA NA "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: AB_2681714" "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 2.8 7.0 5.2 3.0 5.8 0.6 3.7 5.7 9.4 7.1 3.1 4.4 2.3 5.7 3.8 2.4 4.3 4.7 5.5 6.3 6.9 6.4 1.6 2.8 4.0 6.6 5.6 4.6 5.8 2.2 6.0 5.7 2.1 7.2 4.9 4.3 5.5 2.8 5.1 2.7 3.0 3.5 5.4 5.6 4.1 2.5 1.5 7.0 2.8 6.6 5.3 3.5 4.3 3.4 9.3 4.6 4.7 2.3 3.0 6.5 8.7 0.0 5.1 6.8 4.1 4.9 3.1 5.8 2.1 6.9 4.6 8.1 1.4 3.3 2.5 9.0 5.3 4.1 3.2 4.0 0.0 4.2 0.0 6.0 6.1 2.9 7.7 4.1 5.2 5.9 2.1 0.8 20.3 8.1 0.7 1.9 0.0 7.3 0.0 4.6 1.8 5.9 1.3 5.1 2.3 1.3 1.9 5.8 2.7 6.3 3.9 2.3 1.3 6.9 4.7 4.6 9.4 3.1 5.7 15.3 0.0 6.9 3.4 3.7 0.2 0.0 0.0 0.4 0.0 0.7 0.2 0.3 0.4 0.0 0.2 0.3 0.4 0.0 0.3 0.0 0.0 0.3 0.1 5.2 5.8 5.7 9.4 6.3 6.9 6.6 5.6 4.6 7.2 5.6 7.0 9.3 8.3 3.2 9.1 47.0 9.4 2.7 4.6 2.7 4.6 10.0 4.2 3.6 12.7 5.7 4.1 3.7 6.2 0.2 7.5 2.1 0.0 3.5 4.1 10.9 5.6 9.4 0.0 4.4 62.7 3.5 0.0 8.2 1.5 7.3 5.1 5.3 5.3 1.6 1.6 13.5 59.6 7.5 2.0 2.2 1.8 1.8 3.1 2.3 5.4 29.0 1.6 5.7 8.2 66.9 76.1 2.4 6.1 9.1 6.7 5.4 1.4 11.4 3.9 7.5 0.0 8.3 5.0 2.0 2.4 2.4 4.5 0.0 8.8 5.9 3.4 4.6 GIGYF2 "GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15" ENSG00000204120 "GRB10 interacting GYF protein 2" Q6Y7W6 2 232697299-232860605 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 333.8;Late spermatids: 563.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050899, HPA054612, HPA059918, HPA065064" Approved Enhanced Cytosol NA NA Cytosol "HPA050899: AB_2681267, HPA054612: AB_2682542, HPA059918: AB_2684160, HPA065064: AB_2685417" "unprognostic (7.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-2)" "unprognostic (1.92e-2)" "unprognostic (8.61e-2)" "unprognostic (8.39e-3)" "unprognostic (2.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.27e-2)" "unprognostic (7.40e-3)" "unprognostic (8.01e-2)" "prognostic favorable (6.97e-5)" "unprognostic (7.53e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "unprognostic (1.66e-1)" 19.3 19.6 14.6 19.2 17.7 21.8 23.3 23.4 15.9 19.2 11.9 18.0 17.8 21.5 13.9 20.6 18.3 15.8 25.8 14.6 14.6 25.4 16.0 16.8 20.6 15.9 14.4 10.6 27.6 25.8 40.8 9.7 22.2 16.2 22.2 19.7 23.1 28.6 17.1 37.9 21.4 20.2 18.6 13.1 21.5 21.7 38.3 16.2 24.8 26.2 32.4 21.5 18.8 12.5 21.8 34.3 30.8 37.2 38.1 51.2 44.7 44.1 37.9 36.5 31.3 33.0 30.6 29.6 20.1 9.3 33.5 59.8 36.6 44.2 34.7 41.2 49.4 32.1 71.6 30.5 46.9 36.7 61.3 44.9 31.1 34.6 38.1 59.2 33.6 34.9 33.5 72.8 24.2 33.1 36.5 40.7 24.3 37.5 29.8 25.7 38.7 74.5 27.8 28.6 51.8 33.4 27.5 41.8 30.5 37.7 32.9 29.8 40.1 53.1 33.6 28.6 34.1 29.6 47.6 26.1 40.3 31.6 35.0 31.3 39.2 10.7 13.1 8.0 7.8 10.5 6.1 7.1 7.9 11.2 10.6 8.5 7.9 13.7 13.4 18.9 8.3 10.7 6.4 14.6 17.7 23.4 15.9 14.6 14.6 15.9 14.4 10.6 16.2 13.1 16.2 21.8 31.3 57.7 68.4 98.2 26.7 15.7 36.9 25.8 23.9 50.6 29.6 26.0 85.5 25.8 50.8 36.8 60.5 32.2 28.0 28.8 25.4 31.1 333.8 41.2 54.5 36.8 19.2 41.0 105.0 27.3 22.0 36.7 25.0 45.0 17.7 35.4 20.0 28.8 28.5 48.8 131.2 27.9 24.4 29.3 12.1 563.9 37.6 31.8 26.6 98.4 32.9 38.8 42.2 116.6 171.7 29.2 15.0 36.9 39.0 40.6 29.5 18.5 43.3 38.7 26.3 55.0 36.0 128.4 93.4 27.3 19.2 73.2 28.8 46.3 30.3 37.4 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037523-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 11.9;liver: 18.8" "Cell type enhanced" "Detected in many" "Astrocytes: 163.2;Cholangiocytes: 47.1;Hepatocytes: 129.1;Oligodendrocyte precursor cells: 45.8;Paneth cells: 51.3" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;CACO-2: 2.2;EFO-21: 3.3;OE19: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favorable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 0.0 0.0 6.8 0.0 6.2 0.0 0.3 5.0 9.4 0.0 0.0 3.1 0.6 0.0 0.1 0.0 0.0 0.4 0.0 8.2 6.8 0.2 18.8 0.1 0.0 8.9 11.9 4.1 0.0 1.4 0.2 1.1 0.9 7.5 0.5 0.7 0.0 0.1 0.0 0.0 0.1 1.1 0.0 4.8 0.0 1.5 0.1 10.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.5 0.4 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 4.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.1 1.0 0.5 0.5 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.2 5.0 9.4 8.2 6.8 8.9 11.9 4.1 7.5 4.8 10.6 5.8 0.0 0.0 0.0 163.2 0.5 0.1 0.1 0.0 0.0 1.9 5.9 6.0 0.5 47.1 0.0 0.0 0.0 1.8 0.2 32.8 1.9 3.9 13.6 0.1 0.2 0.2 4.9 10.7 33.4 2.0 11.9 0.2 4.6 0.1 0.0 0.1 3.6 129.1 0.6 0.0 15.0 14.8 0.0 2.9 0.0 30.8 0.3 0.2 1.8 6.5 0.0 15.7 0.0 45.8 20.1 0.8 51.3 4.1 0.2 0.7 10.7 1.8 0.0 0.3 0.0 0.0 0.1 0.5 0.9 0.0 0.0 5.2 0.3 0.0 28.8 0.3 RUFY2 "FLJ10063, KIAA1537, RABIP4R, ZFYVE13" ENSG00000204130 "RUN and FYVE domain containing 2" Q8WXA3 10 68341107-68407294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 93.1;Oligodendrocytes: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039792 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039792: AB_10673363" "unprognostic (1.23e-1)" "unprognostic (3.37e-1)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (2.48e-3)" "unprognostic (2.22e-2)" "unprognostic (4.36e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.92e-1)" "unprognostic (1.28e-2)" "unprognostic (2.00e-3)" "unprognostic (3.23e-1)" "unprognostic (3.82e-1)" "unprognostic (7.74e-2)" "unprognostic (3.40e-2)" 5.8 4.8 10.3 3.9 14.0 1.9 6.5 16.3 17.1 5.9 5.8 4.6 3.3 8.5 4.6 5.0 5.8 5.0 4.5 11.1 12.6 5.6 1.8 5.4 4.1 15.9 13.6 10.5 9.9 4.4 7.0 3.6 5.6 15.1 6.4 5.5 10.0 4.7 4.9 5.1 5.0 4.1 7.1 14.1 4.9 4.9 4.2 13.2 5.7 6.5 4.5 4.2 5.7 5.2 20.9 11.7 4.5 7.3 9.8 9.2 13.5 4.5 9.8 12.1 10.2 10.2 6.9 10.8 3.8 7.2 16.0 4.5 8.3 3.2 10.9 10.2 1.6 8.2 2.6 3.6 3.7 9.7 3.7 1.7 12.0 11.4 12.1 12.4 16.2 11.5 3.2 4.9 5.6 10.9 4.8 3.1 5.0 3.2 3.6 13.1 4.3 5.9 2.3 10.8 7.1 8.4 7.9 7.0 9.3 6.0 9.1 13.8 4.6 13.2 12.7 9.6 7.6 13.8 5.6 3.2 1.9 12.0 3.6 5.6 0.6 0.5 1.1 0.8 0.6 0.8 0.8 1.1 1.1 0.3 0.9 1.1 1.4 0.5 2.6 0.8 0.5 0.4 0.3 10.3 14.0 16.3 17.1 11.1 12.6 15.9 13.6 10.5 15.1 14.1 13.2 20.9 22.8 32.1 15.1 40.1 15.9 6.6 15.2 14.8 8.0 47.7 11.7 11.2 11.4 4.3 20.7 25.8 60.5 9.3 13.0 7.2 1.9 16.1 8.5 24.1 30.2 20.3 10.2 13.5 93.1 12.9 6.0 24.8 14.3 20.2 7.6 24.2 22.5 6.5 6.5 32.0 84.7 12.0 10.2 10.0 7.7 5.5 24.2 11.2 12.4 45.0 13.1 20.2 12.3 58.8 153.7 17.9 5.4 17.7 12.0 15.6 6.3 10.1 21.7 62.0 13.1 31.7 24.7 11.1 24.4 15.9 8.1 9.6 11.8 22.8 7.7 10.7 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 101.2;monocytes: 57.7;Prostatic glandular cells: 90.5;Urothelial cells: 80.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 14.3;neutrophil: 15.6" "Group enriched" "Detected in many" 4 "dendritic cells: 4.1;granulocytes: 15.6;monocytes: 7.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;EFO-21: 29.5;HUVEC TERT2: 27.8;TIME: 16.3;U-937: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049771, HPA075115" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA049771: AB_2680872, HPA075115: " "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 4.4 1.3 8.3 3.0 8.9 2.2 3.2 12.0 6.2 3.2 11.3 3.7 0.8 3.3 1.5 3.2 2.4 4.4 2.3 5.9 6.5 1.1 0.9 3.4 0.9 2.4 3.5 6.5 1.6 0.7 1.6 2.6 2.2 4.5 3.6 1.9 0.3 1.5 4.8 0.8 1.4 1.7 6.9 0.2 2.9 2.0 2.4 6.2 1.0 2.7 2.4 0.9 3.7 2.3 2.3 0.4 0.6 25.2 0.1 0.3 1.0 0.2 0.9 4.7 0.1 0.4 0.1 0.0 0.2 29.5 2.6 0.1 0.0 1.6 0.0 0.6 0.1 0.6 0.1 0.1 0.0 0.1 0.1 1.4 0.5 0.0 0.9 0.0 0.1 27.8 0.1 0.0 4.1 0.2 0.2 0.1 2.1 4.8 0.0 0.0 0.1 1.4 0.0 0.1 2.9 0.6 5.7 0.0 0.0 0.0 7.1 0.1 1.7 16.3 0.0 1.6 2.0 0.0 0.1 0.0 0.1 1.1 20.5 0.0 5.0 7.1 14.3 2.0 4.7 1.9 0.0 1.0 1.7 4.1 0.0 0.1 0.2 15.6 1.0 3.7 0.0 0.1 2.3 8.3 8.9 12.0 6.2 5.9 6.5 2.4 3.5 6.5 4.5 0.2 6.2 2.3 29.2 0.0 1.9 1.0 7.3 0.5 101.2 0.0 0.6 0.9 5.0 3.7 19.6 21.5 0.0 1.8 0.0 17.9 10.1 2.0 0.0 0.2 4.7 3.3 2.8 32.9 1.2 17.3 7.8 0.7 24.3 15.2 0.5 9.0 7.6 0.9 51.0 19.0 19.1 0.0 5.8 3.7 0.0 49.0 0.5 7.4 31.7 19.7 1.8 19.7 57.7 1.5 32.0 5.5 1.1 0.6 3.1 21.4 2.8 90.5 7.8 2.9 0.0 0.5 26.3 39.7 12.6 2.7 3.7 0.3 0.3 24.9 17.0 2.9 3.8 80.7 GGTA1 "GGTA, GGTA1P, GLYT2" ENSG00000204136 "Glycoprotein alpha-galactosyltransferase 1 (inactive)" Q4G0N0 9 121444991-121499844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 134.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Endothelial cells: 2.2;granulocytes: 3.8;Macrophages: 2.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "classical monocyte: 22.7;intermediate monocyte: 17.9;myeloid DC: 12.7;plasmacytoid DC: 27.5" "Group enriched" "Detected in many" 19 "dendritic cells: 27.5;monocytes: 22.7" "Group enriched" "Detected in some" 6 "AN3-CA: 4.3;HEL: 1.3;SH-SY5Y: 4.9" HPA023262 Approved NA NA "HPA023262: AB_1849651" "unprognostic (1.71e-1)" "unprognostic (9.98e-2)" "unprognostic (4.49e-2)" "prognostic favorable (5.33e-5)" "unprognostic (1.67e-2)" "unprognostic (2.85e-2)" "unprognostic (8.98e-2)" "unprognostic (1.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.29e-1)" "unprognostic (7.85e-2)" "unprognostic (1.63e-1)" "unprognostic (5.53e-3)" "unprognostic (9.24e-2)" "unprognostic (2.64e-2)" "unprognostic (1.44e-2)" "unprognostic (6.87e-2)" 33.7 18.7 15.5 10.2 18.4 68.8 40.8 13.0 20.0 17.4 17.7 15.1 12.1 10.8 7.5 24.4 10.2 23.3 18.9 16.4 14.9 5.8 15.1 22.1 25.9 15.1 15.3 14.0 7.6 5.1 4.8 42.1 15.4 6.6 15.6 0.5 134.4 15.5 5.1 13.7 16.2 12.6 14.4 40.8 8.7 4.1 15.6 10.0 5.2 13.5 10.5 21.6 15.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 17.9 0.0 0.7 0.0 0.0 12.7 0.0 0.0 0.0 1.2 0.1 0.4 27.5 0.0 7.2 15.5 18.4 13.0 20.0 16.4 14.9 15.1 15.3 14.0 15.4 14.4 15.6 15.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500364 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 212.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" NA Yes "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favorable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 7.2 6.6 5.9 8.7 7.4 12.0 10.2 7.6 6.9 12.5 10.8 13.1 9.2 13.9 7.1 33.3 13.3 9.0 8.9 5.1 7.4 14.3 16.4 12.5 7.9 8.1 6.3 3.9 13.2 11.8 15.2 4.0 10.5 9.0 11.9 14.2 5.1 11.4 8.3 12.0 16.3 10.3 13.9 4.8 12.1 10.8 8.7 7.5 12.0 12.5 18.5 12.3 9.4 14.9 8.5 26.0 17.2 37.8 27.5 9.6 10.2 5.8 18.1 18.3 38.5 40.0 16.4 28.1 24.5 15.9 21.6 24.3 17.7 26.3 17.4 33.9 18.1 14.9 51.6 28.2 26.5 14.3 31.2 56.7 9.9 16.4 24.7 42.7 14.0 52.0 19.5 26.0 16.9 24.5 8.0 22.3 7.8 28.3 14.0 11.8 23.2 35.7 18.5 20.2 22.8 20.1 26.0 41.0 16.9 20.9 14.9 22.5 11.1 33.3 18.8 34.6 13.4 35.8 12.4 19.7 20.1 18.4 26.2 20.3 1.9 2.0 2.0 3.3 2.0 2.9 1.4 2.6 3.3 2.2 2.2 1.8 2.6 1.4 2.4 3.3 2.6 1.2 1.5 5.9 7.4 7.6 6.9 5.1 7.4 8.1 6.3 3.9 9.0 4.8 7.5 8.5 65.9 70.5 49.8 60.7 38.9 38.6 23.6 24.1 46.7 34.6 37.0 35.8 38.5 40.0 53.7 23.9 20.9 17.6 36.7 59.9 17.6 32.4 6.1 125.6 58.6 56.2 49.3 32.2 65.8 36.5 17.3 29.1 35.2 212.6 48.0 38.8 42.5 63.3 22.8 23.5 82.6 57.0 24.4 33.6 32.3 8.5 19.3 40.3 17.8 92.8 33.7 19.8 51.5 117.1 148.1 48.2 33.5 29.7 30.8 24.4 40.0 45.5 63.3 39.8 39.5 45.6 31.0 47.1 39.4 62.1 54.1 15.2 35.7 15.3 50.6 30.9 CLPSL1 "C6orf127, dJ510O8.6" ENSG00000204140 "Colipase like 1" A2RUU4 6 35781019-35793675 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 90 "epididymis: 612.9;pancreas: 179.9" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 39.0" "Group enriched" "Detected in some" 6 "breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "T-47d: 8.4" HPA073155 Enhanced "Secreted in male reproductive system" NA NA "HPA073155: AB_2686576" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (4.75e-1)" "unprognostic (2.54e-1)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.60e-2)" "unprognostic (7.06e-3)" 0.1 0.3 0.8 0.0 2.2 0.0 4.3 0.3 2.3 0.0 0.2 0.0 0.0 0.0 612.9 0.0 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.8 0.5 1.2 0.1 179.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.3 2.3 2.9 0.4 0.8 0.5 1.2 0.6 0.3 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 39.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 ASAH2B "ASAH2C, ASAH2L, bA449O16.3, bA98I6.3" ENSG00000204147 "N-acylsphingosine amidohydrolase 2B" P0C7U1 10 50739318-50816495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "intestine: 17.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 25.8" "Low region specificity" "Detected in many" HPA061171 Supported Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (6.86e-3)" "unprognostic (1.91e-2)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "unprognostic (1.18e-2)" "unprognostic (5.42e-3)" "unprognostic (5.03e-3)" "unprognostic (2.21e-2)" "unprognostic (1.11e-1)" "unprognostic (3.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-3)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" 1.5 3.7 1.6 1.9 1.7 1.3 2.8 2.0 2.3 2.1 1.5 2.9 17.4 1.6 3.5 2.6 2.7 2.4 5.3 1.9 2.0 4.5 6.4 2.0 1.7 2.3 2.1 1.6 3.0 3.5 4.7 3.3 1.0 2.2 3.6 3.2 7.0 2.6 2.4 3.8 1.8 11.2 2.6 1.4 0.9 4.0 3.0 2.1 1.6 3.7 4.0 1.7 1.8 1.7 2.4 2.5 3.7 3.9 6.3 1.4 3.1 3.0 12.9 7.1 7.5 6.1 8.3 7.4 0.1 4.5 3.4 2.4 2.4 4.3 5.4 6.1 4.6 5.4 1.6 10.5 6.4 5.1 2.2 2.3 3.9 5.6 7.1 10.4 2.3 1.7 0.0 8.0 3.0 5.9 6.0 3.7 0.2 5.0 7.6 25.8 0.1 8.9 3.1 4.2 9.7 7.2 14.7 4.1 5.0 4.3 4.0 8.5 1.4 8.0 3.0 14.0 6.3 16.2 3.9 0.5 0.0 15.5 0.0 5.7 0.3 0.0 0.0 1.1 0.0 3.2 0.4 1.9 1.3 0.0 0.7 2.6 2.5 0.2 0.3 0.0 1.8 2.4 0.8 1.6 1.7 2.0 2.3 1.9 2.0 2.3 2.1 1.6 2.2 1.4 2.1 2.4 0.6 3.2 1.1 1.0 1.1 1.7 1.0 1.5 3.4 7.0 2.9 1.7 5.1 5.7 2.1 5.5 8.4 1.7 0.6 1.4 5.9 4.4 0.2 1.6 1.4 1.3 6.7 0.8 6.4 4.8 1.5 2.0 3.6 1.0 0.0 2.3 1.8 7.3 0.3 0.0 6.4 4.2 2.0 0.0 0.0 1.0 1.8 0.1 1.8 2.8 0.2 4.1 2.1 7.1 0.5 4.4 2.5 1.2 2.2 1.3 3.5 6.0 2.0 4.6 0.0 1.0 2.4 4.3 3.0 3.4 0.4 0.5 2.2 2.3 3.9 1.0 AGAP6 "bA324H6.1, CTGLF3" ENSG00000204149 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 6" Q5VW22 10 49982190-50011654 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 84.8;Late spermatids: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NB-4: 9.0" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.07e-3)" "unprognostic (2.96e-1)" "unprognostic (1.71e-1)" "unprognostic (7.60e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-2)" "unprognostic (5.51e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.66e-4)" "unprognostic (9.93e-3)" "prognostic unfavorable (9.70e-10)" "unprognostic (8.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.85e-2)" "prognostic favorable (1.83e-7)" 19.1 21.9 2.1 1.1 2.2 0.5 20.4 2.5 2.7 23.4 2.8 22.2 1.4 18.8 0.2 16.1 20.9 0.3 17.2 2.0 1.9 24.7 39.0 22.8 2.4 2.0 2.0 2.1 22.8 31.7 0.4 38.9 0.8 2.1 28.7 1.0 0.7 18.7 1.3 20.2 17.9 24.2 1.1 1.8 35.3 20.9 29.5 2.2 3.3 29.2 0.6 0.7 19.4 19.7 2.4 1.0 1.4 0.8 2.1 2.7 1.5 1.8 3.0 0.5 1.0 1.6 2.9 1.1 2.3 1.0 0.6 0.6 1.5 1.0 1.0 1.4 1.4 4.3 3.8 3.0 1.2 1.2 3.1 4.6 1.8 3.4 1.2 3.7 1.6 1.2 2.3 3.9 3.1 1.8 1.4 3.5 9.0 0.6 0.8 3.6 2.6 0.9 1.2 2.0 2.3 2.1 2.6 0.7 2.3 1.1 0.7 1.8 1.6 3.1 1.4 1.4 0.4 2.4 4.9 2.1 1.5 0.3 3.3 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 2.1 2.2 2.5 2.7 2.0 1.9 2.0 2.0 2.1 2.1 1.8 2.2 2.4 6.0 19.2 10.9 19.2 2.9 3.3 1.8 1.3 1.2 6.2 5.6 7.4 8.3 2.8 7.8 0.0 4.2 2.6 6.0 4.5 0.0 2.4 84.8 4.3 5.0 5.8 7.3 2.5 22.6 2.5 1.5 3.9 6.6 5.1 7.6 5.1 5.0 5.4 2.2 3.3 17.8 6.4 0.0 5.0 1.5 44.0 5.6 4.5 0.0 10.3 5.1 2.8 3.1 14.6 17.4 2.6 3.3 4.5 6.2 3.2 4.0 0.7 7.5 7.0 0.0 4.3 4.8 10.7 7.8 1.3 5.3 1.4 5.9 3.8 8.4 2.0 TIMM23B bA592B15.7 ENSG00000204152 "Translocase of inner mitochondrial membrane 23 homolog B" Q5SRD1 10 49942049-49974850 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.84e-2)" "unprognostic (2.67e-2)" "unprognostic (5.92e-2)" "unprognostic (4.19e-3)" "unprognostic (9.37e-2)" "unprognostic (7.64e-2)" "unprognostic (2.04e-1)" "unprognostic (1.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.43e-3)" "unprognostic (4.03e-2)" "unprognostic (3.30e-3)" "unprognostic (5.39e-2)" "unprognostic (9.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.90e-3)" "unprognostic (1.18e-1)" 5.1 4.5 3.3 4.2 4.4 15.2 6.0 4.3 4.9 3.0 2.5 3.4 6.0 4.7 4.5 4.2 3.1 2.7 9.1 3.1 4.5 3.3 5.5 3.9 3.8 6.8 4.6 3.5 4.0 5.1 3.2 4.1 3.6 5.9 4.4 3.8 5.9 3.9 3.6 18.5 6.4 3.9 4.4 4.0 3.5 4.1 3.9 4.4 3.5 3.9 14.8 3.6 5.3 2.9 5.2 4.0 2.2 2.1 4.6 5.1 7.7 2.2 4.8 10.9 4.0 2.2 3.2 5.6 5.8 2.9 14.6 4.0 3.3 1.8 4.8 8.2 6.8 0.3 0.7 0.0 5.8 8.3 11.6 1.0 11.7 2.6 5.4 13.5 3.6 5.7 5.0 5.3 4.4 7.8 0.6 4.9 4.0 5.3 1.2 3.4 3.7 4.4 4.5 3.7 4.4 4.6 10.6 2.5 7.2 5.6 5.0 5.1 4.1 4.9 3.8 3.5 7.5 8.6 5.4 2.6 13.4 9.1 2.6 3.0 1.5 0.9 1.2 1.2 1.1 2.0 1.5 1.1 1.2 1.4 1.0 1.9 1.3 0.3 2.6 2.4 1.2 0.6 1.3 3.3 4.4 4.3 4.9 3.1 4.5 6.8 4.6 3.5 5.9 4.0 4.4 5.2 8.2 19.2 10.9 27.4 11.4 0.0 10.1 0.0 10.2 15.2 5.0 4.3 7.1 7.2 5.6 5.5 29.2 5.0 7.7 2.5 1.9 6.1 1.1 9.2 10.8 6.1 0.0 10.3 30.5 8.2 5.4 7.5 10.7 8.3 7.0 8.7 5.3 10.5 5.6 20.2 39.8 2.8 0.0 3.2 0.0 2.3 5.6 5.8 0.0 19.7 9.2 8.0 7.2 24.6 33.3 9.8 1.1 8.6 13.4 9.1 2.9 3.5 2.9 17.5 6.6 9.4 6.7 15.5 9.1 8.0 0.0 5.9 9.3 9.1 3.7 9.7 ZDHHC18 DKFZp667O2416 ENSG00000204160 "Zinc finger DHHC-type palmitoyltransferase 18" Q9NUE0 1 26826688-26857604 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 115.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 48.8" "Lineage enriched" "Detected in many" 18 "granulocytes: 48.8" "Cell line enhanced" "Detected in all" "HDLM-2: 132.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040234 Approved Approved Microtubules NA NA Microtubules "HPA040234: AB_10805709" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (2.35e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" "unprognostic (2.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (1.36e-10)" "unprognostic (3.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 23.6 8.1 27.8 27.6 24.4 115.0 17.2 25.3 32.3 12.4 20.0 14.8 13.0 13.7 4.6 24.5 11.4 14.9 13.0 27.3 28.8 8.8 18.7 16.3 22.2 28.6 28.0 24.4 9.7 10.6 8.6 11.8 23.5 31.8 11.5 15.1 19.5 17.0 9.2 10.9 18.6 14.0 18.6 21.8 31.5 12.5 7.5 28.5 14.8 15.5 16.2 21.1 22.9 14.5 31.2 45.3 19.8 31.5 21.8 25.6 17.8 30.9 26.7 31.5 45.9 33.9 18.3 28.4 20.9 16.7 35.5 24.0 31.3 33.8 15.9 39.2 132.6 28.7 20.3 15.3 25.7 22.0 18.1 16.9 15.5 21.3 42.3 27.9 16.5 25.9 31.6 21.4 41.8 18.4 22.1 34.5 14.6 30.4 28.1 18.8 28.3 27.2 22.2 19.2 11.3 14.6 17.7 17.9 13.4 19.3 23.9 12.1 17.6 22.2 31.5 24.2 52.3 31.0 49.7 38.8 18.1 17.9 32.5 21.9 0.0 0.5 10.0 1.6 1.1 1.1 0.4 1.2 1.2 0.8 0.3 0.7 0.8 48.8 1.0 0.8 0.4 2.7 0.5 27.8 24.4 25.3 32.3 27.3 28.8 28.6 28.0 24.4 31.8 21.8 28.5 31.2 12.9 9.6 7.9 6.5 7.5 25.6 8.6 4.4 6.8 39.8 8.4 6.6 6.0 10.0 6.8 1.8 27.1 10.6 21.2 27.0 0.0 4.1 3.8 6.1 7.0 9.1 3.0 9.3 10.2 2.8 7.1 7.1 4.6 12.7 1.3 5.9 7.9 12.0 7.3 18.5 10.2 3.9 2.0 8.5 17.0 2.1 6.2 11.0 10.6 5.6 26.6 5.7 12.3 4.0 6.3 8.0 25.6 3.8 8.3 19.3 10.4 2.2 4.6 35.3 0.0 7.1 6.2 3.5 11.4 14.6 36.2 6.2 17.4 8.0 7.0 34.7 TMEM273 "C10orf128, Em:AC084727.5" ENSG00000204161 "Transmembrane protein 273" Q5T292 10 49154725-49188585 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 37.8;dendritic cells: 10.1;Hofbauer cells: 82.9;Macrophages: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "eosinophil: 269.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 269.0" "Cell line enhanced" "Detected in some" "HDLM-2: 214.8;HEL: 51.7;K-562: 101.4;U-266/84: 38.3;U-87 MG: 102.2;U-937: 91.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058166 Approved NA NA "HPA058166: AB_2683627" "unprognostic (1.33e-1)" "unprognostic (5.67e-4)" "unprognostic (1.34e-2)" "unprognostic (1.21e-1)" "unprognostic (4.50e-2)" "unprognostic (4.13e-2)" "unprognostic (5.86e-3)" "unprognostic (9.13e-3)" "unprognostic (2.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.11e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.86e-5)" "unprognostic (2.45e-2)" "unprognostic (2.22e-2)" "unprognostic (8.69e-3)" "unprognostic (1.24e-1)" 29.4 3.0 18.3 17.4 22.9 4.1 27.7 24.3 27.3 15.2 16.4 12.9 8.8 13.8 6.2 8.5 12.9 18.4 22.1 16.9 19.8 3.8 9.6 27.3 22.4 26.7 24.5 15.4 4.0 4.0 14.5 3.3 11.0 25.6 8.3 14.3 1.1 9.9 7.8 8.6 7.1 24.5 21.0 23.2 30.0 8.9 2.0 22.1 7.9 10.3 16.6 23.6 14.5 12.8 32.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 214.8 0.0 51.7 0.0 0.0 0.0 0.5 21.9 0.0 0.0 0.0 0.0 0.0 1.4 0.2 101.4 6.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.3 0.0 0.0 0.0 0.1 0.0 38.3 0.1 102.2 91.6 0.0 24.9 4.2 269.0 22.9 1.4 36.5 35.9 13.8 22.0 19.8 18.5 0.7 6.1 19.4 0.2 0.7 0.6 11.2 11.5 18.3 22.9 24.3 27.3 16.9 19.8 26.7 24.5 15.4 25.6 23.2 22.1 32.5 37.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.8 0.0 0.8 10.1 0.0 0.0 0.1 0.0 1.1 0.2 9.4 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.0 0.0 0.0 0.0 0.0 82.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.1 5.6 0.0 0.0 0.0 CXorf65 ENSG00000204165 "Chromosome X open reading frame 65" A6NEN9 X 71103889-71106788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 22.6" "Group enriched" "Detected in some" 154 "Early spermatids: 432.7;Late spermatids: 1481.8" "Cancer enhanced" "Detected in some" "melanoma: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047396 Uncertain NA NA "HPA047396: AB_2680028" "unprognostic (7.81e-3)" "unprognostic (8.43e-4)" "unprognostic (1.08e-2)" "unprognostic (1.87e-2)" "unprognostic (6.14e-2)" "unprognostic (3.06e-3)" "unprognostic (6.20e-2)" "unprognostic (2.62e-2)" "unprognostic (6.72e-2)" "unprognostic (1.84e-4)" "unprognostic (9.53e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-8)" "unprognostic (1.12e-1)" "unprognostic (3.49e-2)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 2.3 0.1 22.6 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.8 0.0 0.0 432.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.6 2.1 1481.8 4.4 0.5 1.8 1.0 0.2 0.0 6.2 0.0 0.0 0.0 0.2 6.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 2.7 0.0 0.0 1.1 3.2 0.0 0.1 0.1 AGAP9 "bA301J7.2, CTGLF6, FLJ00312" ENSG00000204172 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 9" Q5VTM2 10 47501854-47523638 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "HPA042490: AB_2678022" "unprognostic (6.26e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (9.98e-5)" "unprognostic (1.85e-1)" "unprognostic (6.80e-2)" "unprognostic (9.89e-4)" "unprognostic (1.13e-2)" "unprognostic (3.71e-2)" "unprognostic (1.13e-1)" "unprognostic (5.85e-2)" "unprognostic (4.51e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.02e-5)" "unprognostic (9.44e-2)" "unprognostic (3.42e-2)" "unprognostic (2.70e-3)" "prognostic favorable (7.04e-4)" 12.4 14.6 7.8 5.3 8.2 8.5 14.5 9.4 9.5 16.3 8.9 13.8 15.8 12.3 6.8 13.6 15.0 5.7 12.2 7.6 7.7 22.1 40.2 12.3 5.4 9.2 8.1 7.4 18.8 32.4 3.1 26.3 2.3 9.2 18.1 3.5 12.0 14.3 4.8 10.0 19.9 19.4 3.5 6.9 14.7 18.5 27.5 8.4 4.9 19.9 2.3 3.3 12.4 14.9 9.7 4.4 6.6 5.7 5.8 5.1 4.2 6.8 4.2 1.9 2.0 1.5 7.9 6.9 0.9 5.2 2.9 1.2 12.9 2.3 3.0 1.5 8.5 12.4 2.5 2.6 9.4 4.5 9.3 7.4 2.9 5.8 5.1 14.2 2.2 1.0 0.5 4.0 3.5 1.3 7.3 1.6 11.9 3.1 3.2 1.3 3.4 3.2 2.8 4.1 5.0 0.7 4.1 3.4 7.0 0.9 5.4 9.3 5.1 5.3 4.3 7.1 5.0 7.8 4.8 3.7 4.3 4.3 9.7 1.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 7.8 8.2 9.4 9.5 7.6 7.7 9.2 8.1 7.4 9.2 6.9 8.4 9.7 3.8 3.2 9.9 0.0 1.6 0.0 1.6 0.0 2.8 6.6 5.3 5.0 1.6 7.2 3.1 11.0 18.8 3.1 3.0 0.2 1.9 1.8 109.7 12.3 4.7 2.7 1.2 2.7 0.0 2.2 0.7 3.6 20.4 4.1 7.6 7.1 2.2 7.2 2.1 11.8 0.0 1.5 0.0 3.0 0.0 21.5 3.4 3.3 0.0 0.0 1.7 4.3 1.0 0.0 0.0 6.0 0.8 6.0 2.1 2.6 6.7 1.0 6.6 8.7 0.0 3.2 2.9 12.4 4.8 1.8 0.0 1.0 2.3 4.0 2.0 1.8 NPY4R "PP1, PPYR1, Y4" ENSG00000204174 "Neuropeptide Y receptor Y4" P50391 10 46461099-46465958 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 6.0;skin 1: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "A549: 28.6" HPA027863 Approved NA NA "HPA027863: AB_10602819" "unprognostic (2.26e-6)" "unprognostic (2.94e-1)" "unprognostic (8.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (1.77e-3)" "unprognostic (1.98e-1)" "unprognostic (2.64e-3)" "unprognostic (6.58e-2)" "unprognostic (9.79e-2)" 0.2 0.0 0.3 0.7 0.1 0.0 0.2 0.6 0.2 0.0 0.0 4.9 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.7 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.4 6.0 0.0 0.0 0.0 0.0 3.1 1.2 1.1 0.3 0.0 1.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 28.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.8 0.0 0.0 5.9 0.0 0.4 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.2 0.2 0.2 0.4 0.5 0.1 0.5 0.3 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 10.6;skin 1: 17.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.1 0.0 2.2 0.6 1.6 0.0 1.0 5.8 1.7 0.4 0.3 3.9 3.7 0.0 0.0 4.4 0.3 0.2 0.0 0.5 5.3 2.4 0.3 10.6 0.0 4.6 4.8 0.8 0.1 5.8 2.1 4.3 0.0 5.7 1.9 3.4 0.1 2.8 1.1 0.1 17.1 8.0 0.1 1.8 0.0 5.1 3.0 6.9 0.0 3.5 0.0 0.5 0.6 2.1 4.7 10.2 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.7 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.0 1.7 0.3 0.3 0.1 3.7 12.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.6 5.8 1.7 0.5 5.3 4.6 4.8 0.8 5.7 1.8 6.9 4.7 0.0 19.2 3.7 0.0 0.0 1.7 2.8 1.9 2.8 0.3 1.4 1.0 0.2 7.2 2.1 3.7 0.0 0.0 0.0 30.4 0.0 11.3 9.3 0.0 0.0 0.1 6.6 0.0 0.7 20.2 0.0 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 30.8 0.0 0.0 0.3 20.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 13.1 0.4 0.0 2.1 21.7 4.0 1.8 0.1 0.0 0.0 0.2 2.9 0.8 2.4 6.1 0.0 0.1 0.0 7.3 1.3 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 14.6" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 3.3 2.4 4.1 3.4 4.3 0.8 3.2 2.0 9.6 4.4 1.7 1.6 1.8 2.9 3.9 3.4 4.5 2.7 4.1 8.3 2.8 2.2 1.4 9.7 5.4 6.6 3.3 5.1 2.7 4.9 2.3 0.9 5.1 7.4 2.5 2.1 3.4 3.6 3.5 2.2 11.7 1.5 3.7 0.3 3.5 1.2 1.6 5.2 1.8 2.6 4.2 4.0 2.9 3.5 6.1 2.8 2.9 1.5 0.7 1.7 1.6 2.1 2.9 5.3 2.2 2.5 6.8 5.2 0.6 2.2 2.5 2.1 9.4 0.0 0.8 2.9 1.4 3.2 1.7 2.8 4.5 4.4 3.0 2.1 3.2 0.9 1.4 4.2 2.7 1.2 2.2 0.7 1.7 1.0 4.6 1.5 4.7 1.2 0.5 1.2 1.9 0.0 1.9 3.3 1.3 0.9 1.4 2.4 14.6 1.3 1.4 4.3 1.3 3.8 0.8 3.3 2.0 2.1 2.6 2.9 2.3 1.8 1.9 0.6 0.0 0.6 0.3 0.7 1.4 0.6 0.4 0.6 0.3 0.6 0.2 0.4 0.5 0.0 0.5 1.1 0.4 0.1 0.3 4.1 4.3 2.0 9.6 8.3 2.8 6.6 3.3 5.1 7.4 0.3 5.2 6.1 8.0 54.5 49.5 0.7 0.3 6.1 2.2 2.0 0.6 2.2 2.8 1.5 3.6 0.0 3.0 1.8 2.1 1.1 0.6 0.9 1.9 2.0 0.4 0.8 1.2 20.4 1.2 2.7 0.7 5.8 1.4 2.7 0.0 1.0 2.5 1.1 26.4 1.5 0.1 0.0 0.8 1.6 0.0 2.2 3.5 0.6 3.7 0.6 3.6 1.9 0.5 0.6 1.0 1.0 1.1 4.5 0.9 3.8 0.4 5.6 1.1 2.5 1.5 1.8 6.6 3.6 2.7 1.3 1.4 0.5 5.5 1.2 0.8 0.4 1.4 2.4 MACO1 "FLJ10747, TMEM57" ENSG00000204178 "Macoilin 1" Q8N5G2 1 25430858-25500209 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 38.8;Exocrine glandular cells: 62.3;Pancreatic endocrine cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019680 Approved Cytosol NA NA Cytosol "HPA019680: AB_1858125" "unprognostic (2.42e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.83e-2)" "unprognostic (2.16e-1)" "unprognostic (1.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.69e-2)" "unprognostic (6.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (7.02e-2)" "prognostic favorable (7.13e-4)" "unprognostic (2.54e-2)" "unprognostic (4.22e-2)" "unprognostic (5.22e-2)" "unprognostic (5.35e-3)" 8.4 15.2 11.6 5.4 12.2 28.6 8.8 21.3 13.9 8.2 13.5 8.4 6.3 8.0 12.6 16.2 7.0 7.5 8.2 12.2 12.1 11.9 26.5 8.4 7.9 12.0 12.2 12.7 16.4 25.1 9.3 9.0 6.9 13.9 12.4 7.9 11.1 16.4 8.0 30.5 9.2 9.1 7.5 11.4 8.8 11.8 14.3 12.2 11.5 12.5 15.3 9.0 7.3 9.7 13.8 8.6 3.6 9.3 18.0 16.4 10.1 4.3 9.0 11.1 9.2 8.6 2.6 11.0 20.1 10.1 11.9 5.2 8.0 8.8 9.2 10.4 9.4 7.9 26.8 5.7 7.7 9.3 10.1 15.3 10.3 13.3 12.5 8.9 9.7 11.6 12.4 15.8 7.5 9.3 5.0 19.0 13.8 13.2 10.1 7.1 12.1 11.0 15.0 15.0 3.7 15.2 15.5 7.5 19.3 10.9 7.3 7.7 14.3 13.8 9.3 6.2 12.9 6.2 12.1 7.2 10.6 10.5 13.1 7.9 0.5 0.3 1.6 0.3 0.2 0.5 0.4 0.5 0.5 0.2 0.5 0.4 0.7 0.1 0.3 0.3 1.1 0.3 0.2 11.6 12.2 21.3 13.9 12.2 12.1 12.0 12.2 12.7 13.9 11.4 12.2 13.8 31.3 19.2 23.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 27.8 17.8 0.0 0.0 11.2 7.3 0.0 13.7 27.0 0.0 5.9 38.8 0.0 19.4 23.8 12.9 0.0 0.0 0.0 62.3 22.7 9.2 0.0 32.5 10.1 26.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 48.6 0.0 0.0 9.8 0.0 0.0 19.6 13.8 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 10.4 11.0 22.7 0.0 0.0 PTPN20 "bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B" ENSG00000204179 "Protein tyrosine phosphatase non-receptor type 20" Q4JDL3 10 46911396-47002488 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 16.3;Distal tubular cells: 21.5;Early spermatids: 44.2;Late spermatids: 34.9;Proximal tubular cells: 17.7;Spermatocytes: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 50.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043337, HPA046896, HPA048310, HPA069148" Enhanced Supported "Centriolar satellite" NA NA "Centriolar satellite" "HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: " "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.04e-2)" "unprognostic (2.82e-3)" "unprognostic (6.78e-2)" "unprognostic (1.85e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-1)" "unprognostic (2.22e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-2)" "unprognostic (1.75e-1)" "unprognostic (8.34e-2)" 1.6 9.2 5.0 0.2 4.8 0.2 3.5 9.3 5.9 0.8 7.3 0.9 1.3 0.9 0.3 3.4 1.4 0.7 9.2 4.4 5.5 4.5 0.8 0.8 0.4 16.5 9.0 3.3 1.9 4.1 0.0 3.2 0.2 20.0 1.2 1.6 2.9 2.4 1.4 12.4 5.8 0.6 0.8 5.5 1.2 1.1 14.1 7.1 0.3 2.0 14.9 0.6 0.9 1.1 19.8 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.9 0.0 3.7 0.0 0.0 0.0 50.2 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 2.2 1.3 9.0 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.3 0.1 0.6 0.9 0.0 0.8 0.0 0.7 0.4 0.2 5.0 4.8 9.3 5.9 4.4 5.5 16.5 9.0 3.3 20.0 5.5 7.1 19.8 0.5 0.0 1.5 0.0 0.7 0.0 2.0 0.0 5.7 6.0 5.9 3.7 16.3 0.0 2.5 9.2 6.2 0.1 0.3 0.7 21.5 1.8 44.2 5.0 0.1 0.5 1.2 1.7 0.0 0.9 0.2 1.9 3.1 0.2 0.0 4.9 1.4 0.9 0.4 11.8 0.0 0.4 0.0 0.0 0.0 34.9 0.0 0.4 0.0 0.0 0.7 7.3 0.0 0.0 0.0 2.2 0.2 7.2 1.5 0.9 0.2 17.7 3.6 3.1 0.0 2.7 0.8 24.8 12.2 5.2 0.0 0.1 0.4 8.4 0.8 0.9 ZDBF2 "FLJ45338, KIAA1571" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.0;Granulosa cells: 44.4;Inhibitory neurons: 56.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039121: AB_2676357, HPA050311: AB_2681081" "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 1.7 4.1 1.7 0.9 3.7 0.6 1.6 3.8 2.1 3.0 6.5 2.0 0.4 2.6 1.8 1.1 3.2 1.2 2.1 2.2 3.1 1.5 1.6 1.3 1.2 1.5 1.1 1.8 9.5 5.0 1.5 8.1 2.3 1.1 1.8 0.6 5.5 1.7 1.4 2.7 1.1 1.7 1.3 0.4 1.4 2.0 1.7 2.8 0.9 2.0 1.5 0.9 1.8 2.0 1.6 1.4 0.2 4.4 0.8 1.7 1.4 6.9 1.4 1.5 0.7 0.9 0.4 1.2 0.0 0.6 1.5 2.6 0.3 3.0 1.1 1.3 1.4 2.9 0.0 3.4 0.1 2.2 1.3 2.9 1.4 1.9 1.4 2.7 5.1 2.1 1.1 0.2 1.9 2.1 0.2 0.4 0.0 6.2 0.1 1.6 0.0 4.6 0.0 0.8 0.6 2.4 5.6 2.6 0.0 2.5 10.0 0.1 0.0 2.6 0.7 2.3 0.5 1.1 4.1 1.1 0.2 3.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 3.7 3.8 2.1 2.2 3.1 1.5 1.1 1.8 1.1 0.4 2.8 1.6 6.9 3.2 3.9 15.7 19.3 4.0 1.9 3.1 7.4 26.9 4.4 3.3 9.2 1.5 4.4 11.0 14.6 5.2 9.7 0.6 0.0 2.8 4.1 1.9 7.5 5.1 7.8 0.8 75.0 2.2 6.9 11.7 4.6 0.6 12.7 44.4 3.3 3.4 0.5 8.4 56.5 1.3 4.1 0.3 4.2 5.1 4.4 2.3 1.8 18.7 0.1 8.7 0.0 26.2 3.1 1.2 0.5 5.3 23.4 3.5 1.0 2.3 10.6 18.1 0.0 19.2 9.2 4.4 9.0 6.0 3.3 9.0 13.5 24.5 0.5 0.8 TXNDC8 "bA427L11.2, SPTRX-3, TRX6" ENSG00000204193 "Thioredoxin domain containing 8" Q6A555 9 110303476-110337884 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 116 "testis: 22.0" "Group enriched" "Detected in some" 182 "Early spermatids: 357.8;Late spermatids: 590.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.50e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 357.8 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 590.4 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AWAT1 DGAT2L3 ENSG00000204195 "Acyl-CoA wax alcohol acyltransferase 1" Q58HT5 X 70234655-70240659 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skin 1: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063412 Enhanced NA NA "HPA063412: AB_2685009" "unprognostic (1.12e-1)" "unprognostic (1.78e-1)" "unprognostic (1.96e-2)" "unprognostic (4.90e-2)" "unprognostic (2.08e-1)" "unprognostic (6.78e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DAXX DAP6 ENSG00000204209 "Death domain associated protein" Q9UER7 6 33318558-33323016 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002224, HPA008736, HPA008797, CAB025546, HPA065779" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558" "prognostic favorable (6.05e-4)" "unprognostic (2.90e-1)" "unprognostic (9.66e-2)" "unprognostic (4.04e-2)" "unprognostic (8.55e-2)" "unprognostic (1.36e-1)" "unprognostic (1.46e-3)" "unprognostic (3.48e-1)" "unprognostic (1.92e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (6.32e-7)" "unprognostic (2.43e-1)" "unprognostic (5.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 25.7 33.9 6.8 4.0 6.7 8.2 25.5 5.3 9.8 27.5 3.5 27.6 8.1 28.1 19.0 31.0 28.9 7.3 21.7 6.9 6.3 21.5 25.2 24.3 8.8 11.0 6.6 4.8 24.0 23.3 19.5 22.3 8.0 7.7 25.3 10.9 5.2 24.4 9.4 35.7 28.5 30.6 10.7 5.9 44.7 25.2 37.0 6.8 23.7 24.4 12.6 27.5 27.4 26.1 8.5 20.8 0.1 38.0 15.6 16.0 16.0 30.1 27.4 76.7 61.5 43.6 1.6 11.8 58.5 14.8 33.3 65.5 11.8 0.3 46.1 62.5 29.9 39.6 52.0 29.9 39.9 26.5 37.0 17.0 27.0 32.5 25.8 31.0 22.7 15.5 16.2 39.1 21.2 32.1 23.2 29.7 54.1 1.2 0.2 9.1 35.2 5.6 41.8 11.7 1.6 49.7 20.2 0.0 0.9 22.7 14.8 17.5 0.5 22.9 26.3 29.1 0.5 0.3 35.4 58.3 66.4 23.3 23.0 27.7 24.1 22.5 47.3 55.6 28.9 54.9 58.8 48.3 61.3 28.2 56.8 44.5 49.6 22.9 62.9 35.1 27.0 59.0 70.5 6.8 6.7 5.3 9.8 6.9 6.3 11.0 6.6 4.8 7.7 5.9 6.8 8.5 18.4 6.4 22.8 5.2 45.3 58.5 23.5 36.2 48.3 19.2 25.8 19.4 7.9 18.6 27.6 12.9 18.8 25.2 41.3 23.3 23.5 38.5 15.7 14.5 54.8 23.9 21.0 27.1 3.7 38.3 35.9 25.2 16.8 23.6 37.9 12.9 16.4 14.5 24.3 15.2 3.8 21.2 12.2 17.2 42.5 7.6 17.7 19.7 24.9 6.5 48.8 29.9 52.5 5.0 4.6 45.4 21.8 23.3 38.7 31.8 20.3 14.4 15.6 111.1 13.1 18.7 19.9 63.8 41.5 45.9 60.9 24.8 42.8 24.1 22.0 35.7 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376327-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 202.2;Inhibitory neurons: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.7 21.8 7.3 11.0 15.2 2.3 13.3 3.6 17.2 22.8 7.6 11.7 8.6 20.2 11.4 12.5 15.0 17.4 21.7 14.2 13.6 17.5 15.7 29.4 7.3 6.2 7.7 9.0 16.9 10.5 17.7 8.6 34.3 8.6 17.3 13.1 26.9 11.1 14.0 11.0 10.6 8.7 24.5 3.6 13.3 11.8 11.4 9.5 9.1 18.3 23.3 9.5 20.8 12.5 12.7 13.3 12.3 12.6 19.7 34.2 31.9 23.8 27.2 28.3 23.6 23.9 10.8 19.6 4.7 30.7 58.2 19.9 24.5 16.8 21.4 41.6 13.8 11.2 14.2 12.6 16.8 22.7 4.0 10.7 24.2 21.5 17.1 22.8 40.6 73.9 5.6 9.3 22.5 33.8 24.8 3.4 3.6 6.9 6.6 11.1 9.1 24.3 7.1 21.3 27.9 12.6 12.7 28.9 17.7 32.7 32.0 13.2 9.5 75.9 48.0 24.4 16.3 16.7 3.1 4.1 1.3 11.3 9.0 13.9 0.1 0.6 0.2 0.9 0.5 0.6 0.3 0.3 0.5 0.6 0.4 0.7 0.3 0.1 0.3 0.9 0.7 1.0 0.3 7.3 15.2 3.6 17.2 14.2 13.6 6.2 7.7 9.0 8.6 3.6 9.5 12.7 116.9 105.8 40.3 104.5 15.2 33.4 18.0 34.9 13.6 54.3 29.2 29.7 55.5 15.7 38.8 20.2 81.3 16.9 17.8 25.2 1.9 27.2 2.8 23.1 54.5 152.2 25.1 6.9 202.2 28.1 22.6 47.7 16.8 36.4 23.5 155.1 143.1 19.9 18.7 35.3 190.2 16.3 20.3 24.2 31.7 4.6 33.8 23.5 42.7 170.5 20.2 39.9 16.5 152.8 55.1 46.8 21.1 42.9 9.5 23.9 16.4 12.4 28.0 31.7 65.7 48.8 62.4 33.2 25.0 21.2 35.9 20.0 13.1 0.8 15.5 24.8 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23380909-23424748 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 517.5" "Cell type enhanced" "Detected in many" "Granulosa cells: 214.8;Hepatocytes: 205.9;Intestinal goblet cells: 376.2;Proximal tubular cells: 260.9;Undifferentiated cells: 223.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 8.4;naive CD4 T-cell: 13.6" "Lineage enriched" "Detected in many" 5 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.3;Hep G2: 55.1;OE19: 28.7;SiHa: 18.2;T-47d: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: AB_2682932" "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favorable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 15.9 96.4 4.1 4.6 3.6 0.6 19.7 3.5 4.7 34.8 6.5 67.8 16.0 17.2 7.3 40.9 28.5 11.7 60.8 3.4 4.5 56.4 162.0 20.6 2.4 5.7 4.0 3.4 82.6 231.3 16.4 15.0 3.9 4.5 60.4 40.2 3.3 101.1 14.7 517.5 50.7 35.5 9.3 4.9 10.6 76.5 4.7 3.7 1.8 41.6 174.7 4.5 36.5 39.0 6.4 0.0 0.1 0.5 0.5 2.5 15.3 9.0 6.4 4.1 3.2 1.9 4.1 0.5 0.2 0.7 7.9 1.0 9.1 0.5 0.1 2.8 0.0 0.1 0.0 6.9 55.1 1.9 0.8 0.0 10.1 2.8 2.9 0.0 7.1 0.4 0.1 0.0 0.0 1.1 1.5 0.4 6.1 0.0 28.7 1.8 0.1 0.0 0.2 0.0 0.1 0.5 0.1 18.2 0.8 0.8 1.5 28.4 2.8 0.4 0.0 0.2 0.7 0.0 0.5 5.3 0.0 0.5 0.5 0.6 0.0 0.2 0.0 0.4 0.7 0.4 0.0 8.4 1.1 2.9 0.0 13.6 6.1 0.0 0.2 0.2 0.9 0.8 2.3 4.1 3.6 3.5 4.7 3.4 4.5 5.7 4.0 3.4 4.5 4.9 3.7 6.4 10.5 125.0 109.5 4.2 1.9 27.4 53.4 30.9 30.7 2.3 46.3 42.4 109.8 100.1 57.2 42.3 2.1 3.3 1.9 158.0 199.6 37.7 6.1 7.7 6.6 13.4 55.9 5.7 2.8 97.9 33.9 45.2 69.3 20.8 9.5 214.8 8.2 205.9 1.5 25.2 4.5 376.2 6.1 7.6 65.4 17.9 17.1 8.4 24.9 3.7 3.2 6.8 3.1 2.0 1.3 25.5 143.0 15.4 0.5 38.8 154.3 260.9 29.4 1.4 19.7 90.1 24.0 0.7 2.6 61.1 54.8 2.2 8.4 52.0 223.5 73.9 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 220.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 89000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 44.0 78.8 24.4 13.8 25.3 13.0 45.8 25.1 27.5 49.2 23.5 54.8 9.4 55.2 14.3 70.7 46.6 6.7 74.6 25.5 26.1 66.2 98.9 42.0 16.0 25.4 24.9 25.0 45.7 52.2 14.6 63.2 13.7 25.7 51.5 11.7 8.7 47.9 8.1 130.4 49.0 45.7 10.0 24.7 50.3 58.9 92.1 25.2 17.2 46.0 14.8 17.1 56.1 47.1 26.9 49.4 36.0 34.9 56.7 22.7 17.3 43.4 37.2 20.6 48.0 48.7 42.6 24.0 102.8 43.1 20.5 83.5 42.2 69.5 47.6 58.3 49.3 52.9 89.8 39.4 78.3 33.2 56.3 49.3 20.7 50.9 64.8 41.6 28.5 40.2 61.2 107.2 29.6 36.7 36.0 73.9 58.7 47.7 33.0 37.6 71.9 38.0 65.2 58.9 23.4 61.3 83.9 32.1 83.3 61.3 35.0 44.4 65.0 22.5 24.7 36.0 26.0 68.7 71.2 220.3 89.4 20.5 71.9 38.1 1.8 2.6 1.8 1.9 3.2 2.1 3.3 2.3 3.1 2.4 3.2 1.8 2.5 1.1 2.1 3.5 3.5 3.5 1.9 24.4 25.3 25.1 27.5 25.5 26.1 25.4 24.9 25.0 25.7 24.7 25.2 26.9 17.4 25.6 8.7 5.2 49.1 55.7 45.2 92.6 43.9 24.5 30.2 17.1 20.7 60.1 51.6 55.2 10.4 127.5 37.6 90.0 121.3 87.6 94.2 106.5 64.7 30.6 50.4 48.4 4.3 103.8 126.1 32.6 44.4 66.9 61.6 32.9 19.2 74.0 79.2 18.5 4.1 75.7 87.5 35.4 45.2 42.7 61.8 37.2 71.2 2.8 66.3 51.0 50.4 1.5 7.1 88.0 71.3 49.2 55.3 53.9 76.4 210.0 53.0 29.0 39.5 43.6 96.3 208.2 60.4 64.3 63.9 110.8 36.9 47.4 82.7 46.7 RING1 RNF1 ENSG00000204227 "Ring finger protein 1" Q06587 6 33208500-33212722 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008701 Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA008701: AB_1079814" "unprognostic (2.12e-3)" "unprognostic (7.98e-2)" "unprognostic (3.77e-2)" "unprognostic (1.37e-1)" "unprognostic (3.91e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (4.75e-2)" "unprognostic (7.76e-2)" "unprognostic (1.26e-2)" "unprognostic (3.70e-2)" "unprognostic (1.62e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.55e-1)" "unprognostic (2.13e-1)" "unprognostic (9.88e-2)" 34.7 42.7 36.9 21.8 39.5 18.3 37.1 38.8 45.5 59.7 39.4 41.1 21.5 51.9 20.9 37.7 52.3 19.5 36.9 38.0 38.1 47.1 51.6 39.7 21.0 37.0 38.4 36.9 59.9 45.0 34.4 81.4 19.6 39.0 56.3 7.3 15.8 37.3 23.4 37.6 32.6 37.3 29.8 37.5 41.5 37.8 47.2 40.4 34.8 67.7 25.6 17.5 41.7 42.6 44.4 38.8 24.9 38.2 33.3 35.0 13.2 15.5 36.5 55.1 32.7 40.5 35.2 22.9 30.1 19.0 41.2 45.8 21.0 31.6 29.7 24.5 69.5 16.5 60.2 50.4 40.2 75.9 37.7 57.0 0.0 26.7 34.4 53.6 38.1 16.5 30.4 49.2 37.2 37.2 0.0 6.3 22.1 13.6 24.5 17.0 18.1 27.1 59.6 42.9 41.5 43.6 32.4 26.3 34.8 62.9 11.6 40.2 56.7 26.1 37.6 29.7 5.6 43.8 56.4 37.1 32.6 25.5 36.0 28.7 0.0 0.4 1.6 0.0 0.2 0.6 0.8 0.5 0.6 0.4 0.2 0.6 1.3 0.6 0.5 0.5 1.1 0.8 0.4 36.9 39.5 38.8 45.5 38.0 38.1 37.0 38.4 36.9 39.0 37.5 40.4 44.4 27.5 0.0 20.2 22.5 23.6 27.5 40.6 28.6 51.2 32.1 26.8 25.3 23.9 21.5 22.1 22.0 16.7 41.9 30.8 23.7 15.6 32.8 34.7 28.4 29.0 26.8 30.6 16.8 23.2 34.7 35.2 32.2 31.6 29.5 19.7 19.7 35.0 36.9 29.1 25.2 23.0 24.1 8.2 26.5 23.5 21.5 40.0 22.3 17.8 12.2 21.0 44.8 21.6 12.5 20.3 31.2 25.1 29.7 32.2 29.4 36.6 34.8 25.9 21.6 26.3 38.3 30.9 33.4 18.9 32.7 30.5 63.1 27.6 32.6 21.8 30.2 HSD17B8 "D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1" ENSG00000204228 "Hydroxysteroid 17-beta dehydrogenase 8" Q92506 6 33204655-33206831 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 125.2;Proximal tubular cells: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 79.5;T-47d: 62.0;U-266/70: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042132 Enhanced NA NA 97000 "HPA042132: AB_10793978" "prognostic favorable (9.99e-4)" "unprognostic (4.24e-1)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (2.10e-1)" "unprognostic (8.11e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.50e-3)" "unprognostic (3.12e-1)" "unprognostic (1.34e-2)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "prognostic favorable (2.18e-12)" "unprognostic (2.82e-2)" "unprognostic (5.57e-1)" "unprognostic (3.09e-1)" "unprognostic (3.23e-2)" 9.7 24.8 10.2 6.6 10.2 9.7 17.1 10.4 10.6 13.8 11.0 18.2 19.9 7.3 29.7 25.7 23.8 8.0 20.0 9.5 10.5 30.8 68.0 11.3 10.6 11.3 12.1 9.0 8.7 55.7 42.6 14.2 5.6 11.8 11.4 16.3 11.9 25.3 16.7 21.0 25.2 18.9 7.4 11.2 12.2 15.2 5.9 10.9 13.4 33.2 25.2 15.3 9.9 12.9 11.8 7.0 15.0 6.8 9.3 2.3 4.4 1.3 0.8 4.7 0.1 0.1 5.8 17.5 45.4 11.2 1.2 2.2 29.1 7.2 11.7 1.0 8.6 0.0 2.6 14.0 27.1 20.0 0.0 3.8 5.0 28.9 0.2 49.4 0.4 2.1 13.6 0.3 46.2 4.1 9.4 31.2 1.3 2.1 23.3 2.9 11.0 1.2 79.5 27.8 1.3 12.1 7.6 2.9 34.3 7.6 4.6 62.0 1.8 1.3 0.7 7.3 0.6 0.4 65.5 42.4 16.6 3.1 1.0 1.7 0.1 5.8 2.0 18.7 13.4 30.0 16.6 24.0 29.2 11.6 13.1 26.4 28.5 0.7 16.8 14.6 20.8 21.8 26.7 10.2 10.2 10.4 10.6 9.5 10.5 11.3 12.1 9.0 11.8 11.2 10.9 11.8 12.5 19.2 21.6 3.3 18.6 29.7 28.3 55.0 21.6 12.4 31.3 34.8 31.8 48.6 25.9 22.0 6.2 29.9 9.7 21.2 125.2 27.9 6.3 20.0 6.0 10.1 18.0 12.8 0.3 32.4 12.9 9.1 16.3 13.7 7.0 9.8 10.0 83.2 17.4 1.7 0.5 26.6 20.3 10.3 16.4 18.1 7.5 7.9 49.8 1.0 8.1 32.6 6.2 1.0 0.7 21.9 21.1 6.0 47.6 15.4 74.8 137.2 33.3 14.8 0.0 11.3 9.8 8.1 8.5 40.0 37.2 17.4 18.0 29.8 44.4 31.5 RXRB "H-2RIIBP, NR2B2, RCoR-1" ENSG00000204231 "Retinoid X receptor beta" P28702 6 33193588-33200665 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002003, HPA063653" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB002003: , HPA063653: AB_2685076" "unprognostic (3.51e-1)" "unprognostic (8.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-2)" "unprognostic (2.00e-2)" "unprognostic (4.71e-3)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-3)" "unprognostic (8.13e-3)" "unprognostic (9.53e-3)" "unprognostic (8.30e-2)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" "unprognostic (8.53e-3)" 25.9 29.3 2.2 2.0 2.9 2.4 27.3 2.2 5.4 33.9 2.2 31.8 3.9 32.1 7.5 27.2 31.7 3.3 29.5 2.2 3.2 28.4 34.6 27.4 1.4 4.2 2.4 2.1 33.2 32.6 0.0 33.3 2.5 4.5 33.1 1.6 3.3 27.2 3.3 42.9 26.0 28.8 9.6 2.2 38.6 28.5 20.2 2.3 2.9 38.0 12.4 9.2 30.9 29.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 10.0 0.0 10.4 7.1 0.0 11.0 4.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 8.9 0.0 0.0 0.5 3.2 0.0 0.0 0.1 14.4 0.0 8.0 12.1 0.0 7.4 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 4.8 0.0 0.0 11.1 11.8 9.2 0.0 0.0 0.0 2.3 0.4 1.7 1.1 0.3 0.8 1.0 1.3 1.3 0.6 0.3 1.1 0.8 0.7 0.8 0.6 0.6 1.1 0.3 2.2 2.9 2.2 5.4 2.2 3.2 4.2 2.4 2.1 4.5 2.2 2.3 3.8 21.2 41.7 13.3 14.4 19.2 17.3 14.9 8.9 18.2 25.2 22.4 18.9 16.1 15.7 14.7 5.5 20.9 23.6 26.3 21.8 25.4 19.9 2.7 10.6 14.7 18.2 22.0 8.6 14.9 16.2 17.9 18.3 23.0 11.9 10.2 22.5 14.3 15.9 15.8 18.5 12.9 21.8 16.2 14.7 9.2 8.6 16.1 12.2 16.0 10.3 18.8 16.6 33.0 14.1 15.2 13.6 20.2 16.1 12.0 16.3 23.2 14.1 10.8 20.4 26.3 19.3 20.0 17.7 12.5 16.8 18.8 28.7 19.4 18.7 24.5 12.7 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol NA NA 12000 "Vesicles, Cytosol" "HPA056878: AB_2683265, HPA057019: AB_2683310" "unprognostic (1.08e-1)" "prognostic favorable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 11.3 16.8 6.3 3.2 6.2 6.3 12.7 6.5 15.3 7.2 5.8 9.9 4.6 7.9 0.0 11.1 8.4 1.2 13.5 6.0 6.6 14.1 18.1 7.5 3.9 6.9 6.9 6.2 5.5 14.9 1.5 6.7 1.7 6.6 11.2 0.2 0.1 10.6 1.9 16.6 13.8 9.9 1.3 6.8 11.8 15.5 29.9 6.9 0.6 8.9 0.0 0.7 10.1 7.6 7.3 15.2 56.0 0.5 12.6 3.2 0.3 9.5 7.3 0.2 0.1 1.4 14.9 14.1 4.7 12.6 0.0 7.8 13.1 0.0 10.0 0.0 7.7 29.4 4.2 26.1 37.2 22.9 3.0 11.1 4.8 6.8 2.9 3.1 0.7 5.3 22.3 7.3 7.2 1.1 38.3 10.7 12.4 6.9 7.9 24.9 9.7 0.4 20.5 2.9 8.2 2.4 11.2 3.1 19.0 27.6 0.2 27.4 17.1 4.5 10.8 7.2 12.2 8.4 19.8 7.9 6.5 14.6 11.3 11.0 18.6 23.6 18.4 23.5 20.8 25.1 26.4 31.9 27.0 22.9 28.6 33.5 26.0 17.1 35.5 22.6 31.2 30.6 23.8 6.3 6.2 6.5 15.3 6.0 6.6 6.9 6.9 6.2 6.6 6.8 6.9 7.3 17.9 32.1 17.1 7.5 26.1 8.5 21.5 48.6 21.6 19.9 40.3 40.0 16.2 30.0 26.1 23.9 6.2 37.1 24.8 43.4 72.4 38.1 85.7 29.9 25.6 19.2 21.7 38.1 8.3 47.9 28.8 20.6 28.1 26.9 14.0 26.1 23.6 55.0 44.2 23.5 7.7 35.5 50.8 34.2 11.1 34.6 33.2 21.0 16.0 5.6 41.2 41.3 47.4 7.5 12.6 43.9 41.5 23.7 19.7 40.4 63.4 89.3 36.0 30.9 26.3 11.9 18.5 95.7 20.4 35.8 8.5 27.9 29.5 56.5 31.6 26.6 OR13C3 ENSG00000204246 "Olfactory receptor family 13 subfamily C member 3" Q8NGS6 9 104535749-104536856 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053978 Uncertain NA NA "HPA053978: AB_2682330" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COL11A2 "DFNA13, DFNB53, HKE5" ENSG00000204248 "Collagen type XI alpha 2 chain" P13942 6 33162681-33192499 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Deafness, Disease variant, Dwarfism, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "pituitary gland: 23.6;testis: 8.1" "Cell type enhanced" "Detected in some" "Astrocytes: 8.5;Early spermatids: 10.8;Muller glia cells: 5.2;Oligodendrocytes: 6.7" "Cancer enriched" "Detected in many" 8 "melanoma: 13.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 2100000 "unprognostic (4.62e-1)" "unprognostic (8.69e-2)" "unprognostic (1.65e-4)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (1.04e-2)" "unprognostic (9.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.47e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-3)" "unprognostic (2.26e-6)" "unprognostic (8.27e-2)" "unprognostic (2.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.96e-2)" 0.8 0.3 0.2 0.0 0.6 0.0 0.9 0.5 0.6 1.3 0.0 0.6 0.2 1.2 0.2 0.5 0.9 0.1 1.6 0.3 0.3 1.3 0.8 1.0 0.0 0.5 0.4 0.2 1.1 0.6 0.1 23.6 0.0 0.7 1.3 0.0 0.1 0.8 0.1 1.3 0.5 0.7 0.1 0.4 1.2 0.7 8.1 0.3 0.3 3.5 0.7 0.0 0.6 0.9 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.5 0.6 0.3 0.3 0.5 0.4 0.2 0.7 0.4 0.3 0.8 2.6 0.0 0.0 8.5 0.1 1.5 0.2 0.1 1.8 2.8 1.2 1.8 2.3 0.0 0.1 0.0 4.2 0.0 0.6 0.3 0.0 0.1 10.8 0.2 0.6 1.5 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.5 0.0 0.6 4.6 0.2 0.2 0.0 3.7 0.1 0.0 0.6 0.4 1.9 0.0 0.3 1.8 1.0 0.0 5.2 0.0 3.5 6.7 0.1 0.6 0.4 0.8 0.2 0.0 0.1 0.0 1.1 0.0 0.7 1.8 0.9 2.1 0.7 1.1 0.0 0.4 0.2 0.5 0.1 HLA-DOA "HLA-D0-alpha, HLA-DNA, HLA-DZA" ENSG00000204252 "Major histocompatibility complex, class II, DO alpha" P06340 6 33004182-33009591 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 30.3;B-cells: 61.5;dendritic cells: 20.3;Kupffer cells: 29.4;Langerhans cells: 59.0;Macrophages: 37.7;monocytes: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "myeloid DC: 17.8;naive B-cell: 21.0" "Group enriched" "Detected in many" 11 "B-cells: 21.0;dendritic cells: 17.8;monocytes: 6.0" "Cell line enhanced" "Detected in some" "Daudi: 12.9;HDLM-2: 9.1;REH: 40.5;U-698: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045038, HPA076922" Enhanced NA NA "HPA045038: AB_10959457, HPA076922: " "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" "unprognostic (1.19e-1)" "unprognostic (3.01e-1)" "unprognostic (3.83e-2)" "unprognostic (2.60e-1)" "unprognostic (9.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (3.68e-1)" "unprognostic (4.39e-2)" "unprognostic (1.91e-1)" "unprognostic (9.95e-2)" "unprognostic (3.65e-2)" "unprognostic (8.70e-2)" "unprognostic (5.94e-2)" 6.0 6.2 0.1 7.8 0.9 1.5 6.5 0.4 0.9 4.8 0.7 3.2 5.0 3.1 1.2 2.3 5.0 2.2 1.9 0.3 1.2 8.0 2.8 12.8 15.3 1.9 0.8 0.1 2.8 2.4 0.9 3.5 0.0 1.3 5.1 4.2 0.4 3.2 2.1 0.8 2.8 15.4 1.1 1.0 29.0 4.1 0.4 2.5 7.1 4.5 1.0 20.0 3.1 3.7 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 40.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.1 8.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.0 0.0 14.6 0.1 0.3 17.8 21.0 0.3 1.3 0.7 0.2 4.7 5.0 1.0 2.4 0.1 0.9 0.4 0.9 0.3 1.2 1.9 0.8 0.1 1.3 1.0 2.5 4.3 7.5 3.2 30.3 0.0 61.5 1.9 0.6 0.1 0.6 0.0 0.5 2.4 1.6 1.5 2.0 3.7 0.0 0.1 20.3 0.3 0.0 6.6 0.1 0.3 0.2 8.5 0.0 2.5 0.0 0.2 0.1 1.2 0.5 0.3 5.1 3.5 1.1 0.0 13.4 0.0 0.0 0.1 2.0 29.4 59.0 0.2 0.3 37.7 0.0 6.5 41.9 0.6 4.1 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 2.9 1.4 0.2 0.0 0.7 0.6 0.0 0.2 0.5 1.1 0.1 4.1 1.0 0.3 1.2 BRD2 "BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3" ENSG00000204256 "Bromodomain containing 2" P25440 6 32968594-32981505 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042816 Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA042816: AB_10794766" "unprognostic (2.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.10e-1)" "unprognostic (4.60e-2)" "unprognostic (1.45e-1)" "unprognostic (9.89e-2)" "unprognostic (5.03e-2)" "unprognostic (2.54e-1)" "unprognostic (6.85e-3)" "unprognostic (1.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.42e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-2)" "unprognostic (1.44e-2)" 64.1 62.3 0.5 22.3 2.4 67.1 62.9 3.3 3.9 67.5 0.0 60.7 20.0 71.9 1.8 68.5 67.2 17.6 50.9 2.1 2.2 65.7 62.4 65.9 22.3 1.7 1.8 0.0 82.4 81.1 26.5 72.0 19.5 2.8 61.3 11.7 10.2 66.6 18.4 72.0 69.5 61.3 11.8 0.4 71.7 66.6 83.6 1.4 27.1 77.7 10.5 21.3 62.1 65.6 1.9 45.7 19.5 41.6 41.8 31.8 28.5 38.3 44.6 44.4 48.5 35.8 22.7 22.5 37.3 44.6 37.2 32.4 28.1 39.3 33.2 27.7 49.5 147.7 41.2 18.3 14.6 23.5 60.6 39.2 29.2 28.7 38.2 44.9 27.6 21.3 35.2 44.4 76.0 21.7 12.1 77.0 8.5 24.0 28.9 20.4 76.2 18.7 53.8 13.8 26.6 85.6 28.9 54.5 63.7 52.7 27.8 37.4 39.0 27.5 58.6 32.0 21.5 50.0 61.1 69.5 77.9 23.1 19.7 47.8 9.6 7.6 11.6 14.5 8.8 13.0 9.2 9.4 9.9 10.6 8.7 6.6 10.4 9.7 10.3 9.5 8.5 13.3 11.7 0.5 2.4 3.3 3.9 2.1 2.2 1.7 1.8 0.0 2.8 0.4 1.4 1.9 325.8 76.9 121.5 38.2 327.1 212.1 232.7 70.0 478.1 78.6 295.5 383.9 171.7 94.4 80.1 60.7 104.3 91.7 395.7 210.7 21.5 69.2 302.4 201.9 149.3 191.2 259.1 97.6 16.1 91.4 145.0 224.2 249.8 256.6 115.2 103.1 113.2 85.3 79.9 55.5 19.9 247.5 77.3 92.6 209.2 177.9 86.9 194.5 124.5 26.2 94.7 62.8 107.1 15.1 22.1 81.2 137.3 77.1 313.0 211.5 133.7 39.5 84.4 65.1 39.5 240.0 251.3 88.4 137.9 365.0 226.9 205.1 356.7 71.2 179.5 248.4 HLA-DMA "D6S222E, RING6" ENSG00000204257 "Major histocompatibility complex, class II, DM alpha" P28067 6 32948613-32969094 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 121.4" "Cell type enhanced" "Detected in many" "B-cells: 400.4;Hofbauer cells: 354.3;Kupffer cells: 411.6;Langerhans cells: 1350.5;Macrophages: 591.4;monocytes: 332.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 3.8;intermediate monocyte: 3.8;memory B-cell: 6.3;myeloid DC: 7.2;naive B-cell: 6.4;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 12 "B-cells: 6.4;dendritic cells: 7.2;monocytes: 3.8" "Group enriched" "Detected in some" 5 "U-266/70: 30.5;U-698: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012750, HPA017295" Enhanced Approved Vesicles NA NA Vesicles "HPA012750: AB_1853926, HPA017295: AB_2669575" "unprognostic (1.69e-3)" "unprognostic (3.52e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.99e-1)" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.59e-4)" "unprognostic (7.01e-2)" "unprognostic (9.69e-2)" "unprognostic (6.66e-2)" "unprognostic (1.89e-1)" "unprognostic (2.12e-3)" "unprognostic (1.41e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-1)" "unprognostic (2.14e-2)" 74.0 64.2 0.1 1.0 0.1 23.6 64.0 0.2 0.6 28.1 0.5 22.8 1.6 19.9 23.0 16.1 31.7 0.9 22.0 0.1 0.3 48.3 15.3 99.1 2.5 0.3 0.2 0.0 13.6 19.6 0.1 15.7 0.9 0.2 23.3 13.8 0.5 26.1 0.3 11.9 24.4 70.2 0.6 0.3 121.4 33.0 4.1 0.3 0.6 33.4 0.2 37.2 21.5 21.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.1 0.1 0.1 0.0 0.1 0.0 0.5 1.9 0.0 0.0 0.5 0.3 0.3 2.5 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.7 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 30.5 13.7 94.3 0.6 0.0 0.0 0.0 3.8 0.3 0.2 3.8 0.0 6.3 0.1 0.2 7.2 6.4 0.0 0.1 0.4 0.3 1.2 5.2 0.4 3.6 0.1 0.1 0.2 0.6 0.1 0.3 0.3 0.2 0.0 0.2 0.3 0.3 0.5 240.5 73.7 171.3 0.7 400.4 48.3 15.5 77.3 17.6 1.8 38.2 32.0 5.2 45.8 95.9 53.3 2.1 4.9 175.6 19.3 17.6 101.0 3.4 12.5 3.1 123.6 3.0 30.5 0.8 51.1 4.2 16.4 43.8 24.5 41.2 8.2 37.1 4.4 354.3 0.0 1.2 25.0 22.4 411.6 1350.5 5.3 16.1 591.4 80.0 14.0 332.4 4.3 33.0 1.5 1.3 26.6 46.2 18.8 68.9 19.1 267.0 47.1 77.6 1.3 19.7 5.4 15.6 4.1 4.8 7.0 41.9 4.0 44.7 4.3 42.6 60.9 COL5A2 ENSG00000204262 "Collagen type V alpha 2 chain" P05997 2 189031898-189225312 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 186.0;Excitatory neurons: 185.2;Fibroblasts: 145.7;Skeletal myocytes: 76.4;Smooth muscle cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 447.8;BJ hTERT+ SV40 Large T+ RasG12V: 382.4;fHDF/TERT166: 430.3;HSkMC: 340.2;SuSa: 373.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 820000 "unprognostic (7.45e-2)" "unprognostic (6.44e-3)" "unprognostic (1.22e-1)" "unprognostic (9.31e-2)" "unprognostic (2.01e-1)" "unprognostic (1.13e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (5.97e-2)" "unprognostic (1.78e-2)" "unprognostic (4.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.53e-10)" "unprognostic (4.57e-3)" "unprognostic (3.76e-2)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.58e-4)" 61.5 4.9 3.4 42.9 6.4 0.2 25.9 0.7 16.7 84.1 6.7 40.2 10.1 43.8 33.0 23.9 21.4 82.6 18.5 17.9 3.6 6.0 12.5 26.3 9.4 2.4 6.3 1.9 25.4 7.2 7.6 7.4 112.4 3.3 14.9 25.7 1.6 7.5 13.0 7.9 13.0 23.0 99.2 2.8 10.1 21.7 6.9 2.4 4.7 9.9 27.1 10.3 57.8 30.0 3.4 0.4 93.5 143.9 67.5 212.0 285.3 0.8 213.7 242.3 447.8 382.4 63.2 0.7 0.2 2.2 430.3 23.2 1.6 4.1 2.3 153.3 0.9 1.3 1.0 2.1 0.6 282.6 0.6 0.4 340.2 7.8 129.8 45.3 92.2 108.5 0.9 0.5 0.4 109.1 2.4 0.3 0.3 20.9 0.9 124.3 0.5 33.9 0.4 0.5 24.9 2.0 1.4 5.2 2.5 5.2 373.0 2.1 0.2 91.6 212.8 22.9 52.6 44.6 0.8 0.4 0.6 32.2 0.1 235.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 6.4 0.7 16.7 17.9 3.6 2.4 6.3 1.9 3.3 2.8 2.4 3.4 36.7 0.0 1.5 29.7 0.3 26.1 0.2 7.2 6.2 1.3 1.6 3.7 2.8 0.0 0.7 1.8 0.0 4.6 0.2 0.5 1.9 0.6 0.7 22.4 186.0 9.1 38.7 0.0 185.2 0.7 3.9 145.7 0.5 5.1 0.0 4.2 25.7 7.4 6.6 0.0 23.8 0.2 4.1 0.3 27.4 1.7 48.7 1.4 21.4 25.3 0.6 0.7 0.0 21.6 10.9 1.1 0.1 19.5 0.4 0.3 0.1 1.0 1.9 0.8 46.0 76.4 116.0 3.9 1.8 2.0 18.8 6.2 2.8 27.4 0.0 0.4 PSMB8 "beta5i, D6S216E, LMP7, PSMB5i, RING10" ENSG00000204264 "Proteasome 20S subunit beta 8" P28062 6 32840717-32844679 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046995, HPA050327" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No 2700000 Vesicles "Cytokinetic bridge" "HPA046995: AB_2679896, HPA050327: AB_2681088" "prognostic favorable (5.08e-4)" "unprognostic (4.22e-2)" "unprognostic (2.39e-2)" "prognostic favorable (7.16e-4)" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (7.78e-2)" "unprognostic (1.09e-1)" "unprognostic (5.71e-2)" "unprognostic (1.17e-2)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-3)" "unprognostic (7.11e-3)" 61.8 77.5 3.6 11.3 3.7 9.9 57.0 3.6 7.3 40.9 3.7 62.2 13.0 41.6 3.3 59.9 41.9 5.8 29.9 3.7 4.1 64.0 100.0 78.9 18.3 4.4 3.7 3.3 32.4 29.8 8.3 26.8 4.5 4.0 45.5 20.6 0.7 44.6 6.5 14.6 57.0 94.7 9.0 4.0 151.6 57.5 5.9 3.8 13.6 41.2 0.1 17.3 41.6 48.5 4.8 15.1 3.9 0.3 0.0 5.1 13.1 11.2 4.9 22.9 29.1 39.3 0.0 20.9 45.7 9.4 10.5 25.5 8.1 6.8 16.6 8.0 19.2 0.0 27.6 5.9 0.3 30.3 5.2 7.5 14.9 10.3 12.9 6.8 1.9 18.1 11.8 1.1 8.1 6.1 0.1 12.9 11.7 0.1 0.0 7.3 29.3 1.3 24.1 21.3 4.9 0.8 0.2 8.6 10.4 8.5 0.1 7.0 41.0 4.3 8.8 7.6 7.8 0.6 21.0 15.9 11.2 2.2 27.7 9.0 56.8 70.3 94.6 58.1 88.0 51.2 73.4 49.1 61.1 67.5 71.1 34.8 49.6 90.2 63.0 78.2 58.5 81.2 156.0 3.6 3.7 3.6 7.3 3.7 4.1 4.4 3.7 3.3 4.0 4.0 3.8 4.8 237.0 38.5 55.8 2.9 162.0 84.4 64.1 183.7 54.7 1.8 85.3 92.5 8.7 71.4 103.2 62.5 0.0 2.7 211.2 219.9 86.1 219.4 0.6 63.2 74.9 158.5 65.7 45.0 0.1 247.6 18.3 60.7 93.8 81.5 50.7 51.4 114.5 75.0 165.9 6.7 0.5 243.8 120.1 143.5 94.9 1.9 39.1 128.2 56.9 10.3 214.3 39.9 279.1 3.0 0.7 179.6 287.9 30.5 153.2 100.1 319.8 78.9 103.2 3.0 39.5 33.2 56.8 0.4 1.2 60.5 79.6 2.7 181.6 110.9 222.6 121.6 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838770 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "monocytes: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.4;U-251 MG: 52.0" HPA001312 Approved Supported "Nuclear speckles,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavorable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 16.7 11.8 0.8 4.3 0.8 8.9 14.8 0.7 1.2 14.0 0.4 12.5 10.3 13.8 1.1 26.2 12.0 1.1 12.3 1.1 2.6 12.2 11.6 25.9 8.0 1.8 3.1 0.5 9.3 9.1 3.7 8.3 3.2 2.4 10.0 5.6 2.5 11.3 2.1 8.7 14.5 25.5 4.1 0.6 30.0 11.5 2.5 2.9 9.8 12.4 5.9 8.1 10.7 17.3 4.2 4.4 2.0 0.5 5.0 6.1 6.5 0.0 2.3 3.3 13.1 17.7 3.9 41.0 36.5 7.5 9.1 37.1 38.8 15.8 61.4 6.9 43.8 1.9 20.3 11.6 1.3 8.5 0.0 29.5 0.6 2.6 10.3 24.8 0.0 12.1 0.0 20.0 12.2 0.4 1.6 5.8 2.4 0.5 0.0 11.7 25.8 0.0 12.8 10.9 1.1 0.0 0.0 16.0 37.3 4.1 1.0 7.4 1.9 5.7 25.7 6.9 3.9 52.0 17.9 31.4 33.3 19.5 25.7 10.9 1.8 1.3 1.6 3.0 3.2 1.7 0.4 0.8 1.7 0.8 0.3 0.6 0.7 3.8 1.9 2.8 1.3 1.2 0.8 0.8 0.8 0.7 1.2 1.1 2.6 1.8 3.1 0.5 2.4 0.6 2.9 4.2 48.2 0.0 7.5 7.5 20.7 0.0 15.6 0.0 3.4 5.0 9.2 8.0 3.5 4.3 3.7 14.7 2.1 1.9 37.9 21.0 1.9 34.1 0.1 18.0 19.4 32.0 3.6 4.0 6.6 33.4 45.8 8.0 10.7 41.9 5.1 8.7 16.4 8.3 23.9 18.5 14.6 14.9 0.0 18.9 0.0 0.0 5.6 20.3 0.0 14.0 69.3 17.7 47.4 10.6 6.5 35.1 12.6 6.0 18.0 29.7 55.9 4.8 1.5 5.8 0.0 8.6 10.3 0.7 2.5 11.1 0.0 1.6 24.0 20.3 14.3 16.7 SPIN3 TDRD27 ENSG00000204271 "Spindlin family member 3" Q5JUX0 X 56818298-56995827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 23.8;Inhibitory neurons: 23.3;Oligodendrocyte precursor cells: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 20.5" "Low region specificity" "Detected in all" HPA000727 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000727: AB_2196121" "unprognostic (3.12e-3)" "unprognostic (2.32e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.20e-2)" "unprognostic (1.67e-2)" "unprognostic (6.85e-4)" "prognostic favorable (6.79e-4)" "unprognostic (1.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.48e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-2)" "unprognostic (6.53e-2)" "unprognostic (8.51e-2)" "unprognostic (1.98e-2)" "prognostic favorable (6.30e-4)" 4.2 6.1 6.8 3.1 7.4 0.3 5.4 8.0 7.8 6.3 4.5 4.2 3.0 6.1 4.7 3.8 6.0 3.2 3.1 7.2 7.8 3.9 6.4 3.1 4.4 6.3 6.4 7.0 6.4 8.8 2.9 8.6 2.5 6.9 5.9 4.0 8.5 5.7 4.1 3.0 2.9 5.7 4.2 5.5 5.0 5.5 3.1 7.5 1.8 4.8 1.6 4.3 5.1 5.2 7.0 4.5 6.6 3.6 0.0 6.9 5.9 2.8 3.4 2.0 2.1 2.9 3.5 5.6 0.0 2.4 3.3 7.3 4.9 5.7 2.2 3.2 0.0 1.4 0.6 20.5 2.7 3.7 0.0 4.6 5.3 4.7 2.7 4.2 4.0 1.6 0.0 2.9 8.6 4.4 3.0 0.0 3.6 7.3 2.6 5.8 0.0 3.0 1.8 3.3 5.3 7.3 5.1 4.2 3.7 4.1 5.7 9.8 1.1 1.2 4.4 6.3 7.4 2.1 3.6 2.5 0.0 4.2 0.0 3.4 1.5 0.4 0.8 0.1 0.6 0.8 1.1 1.7 0.6 0.7 0.3 1.9 0.5 0.0 2.2 0.1 0.1 0.5 1.0 6.8 7.4 8.0 7.8 7.2 7.8 6.3 6.4 7.0 6.9 5.5 7.5 7.0 2.9 0.0 3.7 11.8 3.7 0.3 4.0 1.8 2.8 2.0 5.1 4.6 1.1 2.8 2.8 7.3 0.0 2.6 0.5 0.7 1.9 4.1 0.0 3.0 4.7 2.3 0.0 0.4 23.8 3.0 2.1 3.2 2.6 2.3 1.3 4.7 2.2 1.6 0.9 1.7 23.3 0.8 2.0 1.0 1.2 0.0 4.1 0.9 1.8 7.5 1.5 0.9 1.0 25.1 10.0 3.6 0.3 2.6 2.5 1.8 1.1 2.9 1.1 3.0 6.6 1.4 2.2 0.0 0.3 1.4 0.4 0.4 1.1 5.8 1.5 2.2 NBDY "LINC01420, NoBody" ENSG00000204272 "Negative regulator of P-body association" A0A0U1RRE5 X 56729241-56819179 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 336.5;Extravillous trophoblasts: 257.1;Proximal tubular cells: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.38e-3)" "unprognostic (2.46e-1)" "unprognostic (1.96e-3)" "prognostic unfavorable (3.14e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.01e-2)" "unprognostic (2.23e-1)" "unprognostic (2.83e-1)" "unprognostic (2.59e-2)" "unprognostic (2.77e-1)" "unprognostic (2.09e-1)" "unprognostic (2.01e-2)" "unprognostic (2.18e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-2)" 25.4 39.6 35.0 21.1 35.6 18.9 26.0 33.8 48.4 28.1 32.3 23.2 18.0 27.8 47.9 26.0 32.1 27.7 27.2 34.1 38.7 43.8 13.9 29.8 27.1 34.7 34.9 33.3 29.9 15.8 34.9 41.8 24.9 36.9 28.9 22.6 23.6 20.5 28.1 11.2 29.9 21.4 30.6 33.7 28.2 22.6 13.1 37.1 36.2 41.8 18.3 25.1 35.4 28.1 39.4 34.2 52.1 63.6 53.7 74.2 66.4 15.5 46.6 75.4 25.7 42.1 25.0 67.4 14.7 111.1 54.2 52.8 23.0 59.0 58.0 32.9 0.2 73.5 43.6 49.6 6.4 76.7 49.5 44.4 80.2 68.9 45.3 81.0 77.8 68.8 48.7 17.7 36.7 50.4 59.0 62.3 14.3 84.2 55.5 92.2 30.2 42.8 53.0 68.8 49.3 27.7 43.1 100.8 47.1 46.7 113.7 60.7 22.7 59.3 42.9 35.3 75.5 29.0 40.7 26.3 39.8 36.2 26.9 34.6 66.4 54.7 6.0 70.5 62.5 73.1 86.1 89.1 78.6 98.7 86.7 85.6 82.1 5.0 103.4 66.9 175.9 93.2 68.2 35.0 35.6 33.8 48.4 34.1 38.7 34.7 34.9 33.3 36.9 33.7 37.1 39.4 128.6 28.9 34.5 0.0 24.6 0.0 0.0 0.0 0.0 0.0 83.2 88.9 0.0 0.0 18.0 117.7 0.0 143.1 40.5 0.0 336.5 110.8 0.0 71.9 60.4 55.2 0.0 0.0 0.0 95.5 257.1 31.0 0.0 68.5 39.1 67.2 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 0.0 91.5 0.0 0.0 0.0 0.0 126.2 0.0 0.0 5.4 0.0 0.0 262.5 29.9 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 148.9 25.6 119.5 0.0 0.0 TMEM235 ENSG00000204278 "Transmembrane protein 235" A6NFC5 17 78231310-78240987 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 108.5" "Cell type enriched" "Detected in some" 23 "Oligodendrocytes: 107.8" "Cancer enriched" "Detected in single" 15 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053939 Uncertain NA NA "HPA053939: AB_2682316" "unprognostic (1.47e-1)" "unprognostic (6.91e-3)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" 0.0 0.0 44.3 0.0 67.7 0.0 0.0 44.8 48.7 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 44.6 0.0 0.0 0.0 0.0 62.9 58.7 30.5 0.0 0.0 0.0 0.3 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 51.5 0.3 0.0 0.0 0.0 0.0 0.0 108.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.3 67.7 44.8 48.7 36.8 44.6 62.9 58.7 30.5 57.3 38.8 51.5 108.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 107.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE3 "CT16.6, GAGED1, PAGE-3" ENSG00000204279 "PAGE family member 3" Q5JUK9 X 55258412-55264846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 7.7" "Group enriched" "Detected in some" 63 "Early spermatids: 107.9;Late spermatids: 312.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045032, HPA062248" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA045032: , HPA062248: AB_2684725" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 312.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLA-DRA HLA-DRA1 ENSG00000204287 "Major histocompatibility complex, class II, DR alpha" P01903 6 32439878-32445046 "Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 948.4;lymphoid tissue: 1288.8" "Cell type enhanced" "Detected in many" "B-cells: 4744.7;Kupffer cells: 4311.3;Langerhans cells: 24286.4;Macrophages: 6377.4;monocytes: 6924.4;Proximal enterocytes: 3639.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 209.3;intermediate monocyte: 408.8;memory B-cell: 379.6;naive B-cell: 418.5;non-classical monocyte: 255.2;plasmacytoid DC: 229.8" "Group enriched" "Detected in all" 5 "B-cells: 418.5;dendritic cells: 229.8;monocytes: 408.8" "Cell line enhanced" "Detected in some" "Daudi: 715.7;HDLM-2: 1623.6;REH: 277.1;U-266/70: 242.2;U-698: 730.2;U-87 MG: 258.0" "Low region specificity" "Detected in all" "CAB002798, CAB015402, HPA050162, HPA053176" Enhanced NA NA 950000 "CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070" "unprognostic (1.20e-3)" "unprognostic (4.70e-3)" "prognostic favorable (5.30e-4)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (2.77e-2)" "unprognostic (3.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (4.42e-2)" "unprognostic (5.67e-2)" "unprognostic (2.52e-2)" 428.7 297.2 13.7 307.3 25.7 1.0 373.9 14.2 30.4 156.5 13.8 166.0 119.0 125.0 262.7 130.1 146.4 62.0 124.6 14.0 13.8 292.0 96.6 948.4 1288.8 24.7 16.2 13.4 59.0 74.5 0.1 126.6 23.7 37.0 142.7 152.6 8.4 157.3 8.5 80.0 191.6 719.2 1.4 13.8 1100.7 391.4 25.8 14.1 200.8 177.0 0.0 812.5 174.1 144.5 16.5 0.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.5 715.7 6.3 0.0 0.0 1.5 0.0 0.0 0.0 1623.6 0.0 17.7 0.0 0.0 0.0 1.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 3.1 0.1 0.0 0.0 277.1 0.4 0.9 0.0 0.1 0.6 0.7 1.3 0.3 22.8 0.0 0.0 0.8 0.0 8.9 1.4 2.7 1.6 242.2 6.1 730.2 258.0 0.5 0.5 5.9 209.3 74.1 2.1 408.8 1.1 379.6 2.4 10.8 4.6 418.5 1.2 2.2 17.9 15.0 255.2 229.8 19.8 137.8 13.7 25.7 14.2 30.4 14.0 13.8 24.7 16.2 13.4 37.0 13.8 14.1 16.5 935.5 291.7 1070.1 0.3 4744.7 748.4 18.1 160.7 84.2 4.1 101.2 172.6 22.5 115.8 458.0 150.8 0.0 12.7 983.5 79.5 29.4 329.2 8.7 26.9 5.2 803.1 64.9 228.5 0.2 59.8 18.3 128.0 159.6 27.1 174.8 80.9 167.4 19.8 2809.0 1.7 0.2 175.0 146.5 4311.3 24286.4 25.8 30.1 6377.4 773.7 59.0 6924.4 8.4 81.4 0.0 0.1 46.3 182.5 4.5 107.5 32.9 3639.5 303.5 487.1 19.7 72.3 27.8 78.0 3.5 5.2 35.3 576.1 25.9 218.8 0.8 245.4 273.3 BTNL2 "BTL-II, BTN7, HSBLMHC1" ENSG00000204290 "Butyrophilin like 2" Q9UIR0 6 32393963-32407128 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-2)" "unprognostic (8.13e-4)" "unprognostic (3.74e-2)" "unprognostic (1.33e-1)" "unprognostic (1.21e-1)" "unprognostic (3.04e-1)" "unprognostic (9.36e-2)" "unprognostic (2.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.67e-1)" "unprognostic (8.03e-2)" 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COL15A1 ENSG00000204291 "Collagen type XV alpha 1 chain" P39059 9 98943179-99070792 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 231.1" "Cell type enhanced" "Detected in many" "Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "spinal cord: 44.3" "HPA017913, HPA017915" Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 28000000 "Endoplasmic reticulum" "HPA017913: AB_1847099, HPA017915: AB_1847100" "unprognostic (4.30e-1)" "unprognostic (1.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-2)" "unprognostic (2.09e-1)" "unprognostic (1.09e-2)" "prognostic favorable (5.47e-4)" "unprognostic (3.08e-2)" "unprognostic (1.05e-1)" "unprognostic (2.29e-1)" "unprognostic (1.84e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (3.66e-3)" "unprognostic (8.98e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (3.08e-4)" 85.5 37.2 0.7 51.1 0.9 0.1 47.1 0.8 1.2 31.4 4.3 35.2 13.1 54.3 19.4 27.2 17.5 43.2 57.4 0.5 1.7 10.0 1.0 11.2 10.5 0.7 0.9 0.4 23.4 27.0 11.9 6.1 231.1 0.7 21.8 16.5 0.0 36.2 14.4 57.0 15.2 17.8 109.9 0.6 3.7 27.5 27.2 1.8 13.1 21.2 34.7 8.6 42.4 15.2 1.5 0.0 0.0 0.1 0.0 4.6 2.6 0.1 26.4 55.6 1.4 0.5 0.0 0.0 0.2 0.7 5.8 0.2 0.1 0.0 0.0 0.2 24.5 0.0 0.3 12.9 0.0 1.1 0.4 2.5 7.6 0.0 6.0 0.2 0.0 0.0 0.0 18.8 0.0 2.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 14.7 0.2 0.0 0.0 0.1 0.1 0.8 3.9 7.4 0.3 0.2 0.6 0.0 0.1 0.6 45.6 0.5 0.2 0.0 0.0 20.6 0.2 31.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.9 0.8 1.2 0.5 1.7 0.7 0.9 0.4 0.7 0.6 1.8 1.5 307.0 0.0 0.0 0.7 0.5 19.5 0.1 0.0 5.2 0.0 2.6 4.1 8.1 0.0 0.0 0.0 0.0 3.8 1.8 0.0 0.0 2.4 5.7 3.9 103.4 190.5 0.0 0.0 0.4 0.8 3.7 202.3 0.5 2.2 0.0 0.3 0.0 0.0 7.6 0.0 2.9 0.0 0.0 0.3 27.2 22.5 326.8 3.1 17.8 46.9 0.6 0.0 1.0 1.0 0.3 0.6 0.0 483.3 0.3 1.2 0.0 0.5 0.0 0.0 13.1 107.8 52.8 1.9 1.2 1.3 16.3 7.7 2.1 333.4 0.0 0.7 TSBP1 "C6orf10, TSBP" ENSG00000204296 "Testis expressed basic protein 1" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 74 "testis: 35.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA047479, HPA057426" Approved Approved Cytosol NA NA Cytosol "HPA047479: , HPA057426: " "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.3 0.4 0.2 0.2 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM225 "PMP22CD, PPP1R154, SPATA47" ENSG00000204300 "Transmembrane protein 225" Q6GV28 11 123882920-123885670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 188 "testis: 22.1" "Cell type enhanced" "Detected in some" "Early spermatids: 113.4;Late spermatids: 28.0;Spermatocytes: 80.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOTCH4 INT3 ENSG00000204301 "Notch receptor 4" Q99466 6 32194843-32224067 "Human disease related genes, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 21.5;breast: 20.0" "Group enriched" "Detected in many" 4 "Adipocytes: 263.8;Endothelial cells: 121.0;Hepatic stellate cells: 188.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 6400000 "unprognostic (2.27e-1)" "unprognostic (2.27e-1)" "unprognostic (6.80e-3)" "unprognostic (9.50e-2)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.88e-2)" "unprognostic (3.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.56e-1)" "unprognostic (3.13e-1)" 21.5 4.1 0.0 0.5 0.0 0.0 20.0 0.0 0.0 5.5 0.0 3.5 0.5 7.2 3.3 2.7 5.8 0.0 12.3 0.0 0.0 8.6 2.5 18.7 0.4 0.0 0.1 0.0 2.8 2.6 0.0 3.1 1.4 0.0 6.0 0.1 0.0 2.6 0.0 5.7 2.8 3.9 0.0 0.0 2.6 3.9 0.9 0.0 0.0 9.7 0.0 0.1 5.1 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 263.8 0.0 6.1 0.0 6.0 5.2 32.1 9.9 13.6 2.7 2.6 6.6 8.7 0.0 4.2 5.5 4.2 0.4 11.9 0.6 0.0 2.6 46.0 2.6 3.1 121.0 6.0 12.0 0.2 1.1 0.3 4.7 0.0 1.0 0.0 1.8 188.8 2.3 1.7 6.7 0.2 0.8 4.1 9.3 5.2 35.6 7.2 6.8 3.6 10.3 1.6 21.0 0.0 0.0 0.5 0.4 0.3 5.3 0.7 18.0 1.0 0.9 3.1 3.6 0.0 7.8 9.3 5.5 1.9 1.9 1.6 0.3 3.6 3.7 0.9 5.6 PBX2 "G17, HOX12, PBX2MHC" ENSG00000204304 "PBX homeobox 2" P40425 6 32184733-32190202 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061478 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA061478: AB_2684535" "unprognostic (9.73e-3)" "unprognostic (2.16e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (4.98e-1)" "unprognostic (2.68e-2)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.81e-2)" "prognostic favorable (6.84e-4)" "unprognostic (3.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.06e-1)" "unprognostic (2.52e-2)" "unprognostic (2.27e-1)" 27.9 39.9 5.8 14.3 5.4 9.0 27.8 5.0 5.6 47.4 6.0 43.8 10.7 48.2 30.6 33.8 47.5 5.0 31.5 5.4 6.3 34.2 31.2 44.3 16.8 6.0 5.4 5.0 52.8 28.5 4.6 52.4 25.4 5.9 39.7 12.3 8.5 27.8 12.4 30.1 32.2 40.1 13.1 5.4 65.1 37.0 24.1 5.8 24.2 55.6 2.3 17.9 42.7 39.6 5.5 4.8 7.9 32.3 17.7 23.5 29.4 13.9 3.7 8.9 9.7 10.0 6.5 7.8 21.9 23.5 13.7 3.8 13.4 8.1 26.8 10.6 19.5 30.3 20.5 7.1 3.8 20.7 13.2 18.7 43.2 14.9 7.4 24.8 16.6 19.1 38.8 26.5 11.1 3.7 18.1 13.6 29.7 0.6 2.9 2.2 18.8 5.0 26.1 21.2 7.7 9.4 12.6 3.0 6.8 26.5 18.3 16.9 25.0 6.5 8.5 19.8 3.4 4.2 54.1 36.9 27.2 17.3 9.9 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.8 5.4 5.0 5.6 5.4 6.3 6.0 5.4 5.0 5.9 5.4 5.8 5.5 27.7 6.4 11.0 14.4 18.5 18.2 18.5 11.8 15.4 19.2 17.0 12.2 3.7 31.5 10.1 16.5 8.4 32.2 29.4 9.6 3.9 17.1 1.0 12.3 24.5 24.8 30.5 19.1 7.8 14.0 25.6 16.0 12.2 16.6 15.2 21.8 28.9 23.0 19.0 26.9 7.0 15.5 10.2 34.5 55.5 4.2 20.2 25.3 8.8 9.4 23.9 21.0 35.0 6.0 9.1 13.9 12.5 19.5 17.7 19.4 12.5 10.2 9.6 4.9 6.6 19.7 19.8 1.6 6.1 19.7 19.5 47.2 16.7 22.8 13.2 18.1 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184322 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lung: 734.6" "Cell type enriched" "Detected in many" 22 "Alveolar cells type 1: 2394.2" "Cancer enhanced" "Detected in all" "lung cancer: 27.2;thyroid cancer: 20.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" NA NA 5360000 100000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favorable (2.74e-6)" 1.8 1.8 0.1 1.1 0.1 0.5 1.7 0.2 0.4 4.2 0.2 3.2 0.6 2.5 2.0 2.1 4.5 0.1 2.4 0.1 0.1 5.5 2.7 734.6 0.6 0.2 0.1 0.1 4.8 1.8 0.0 5.1 0.4 0.2 4.9 0.8 0.4 1.6 0.0 1.0 1.8 3.2 0.1 0.0 7.0 2.1 2.2 0.1 0.8 39.5 0.1 0.5 2.9 3.3 0.1 0.1 0.0 0.0 0.3 0.1 0.9 1.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 1.0 0.2 0.0 1.0 0.1 0.3 0.2 0.2 2.5 0.7 0.0 0.0 0.0 0.3 1.1 0.0 0.1 0.0 0.1 0.2 0.1 3.0 0.0 0.3 0.1 1.3 0.1 0.9 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.5 0.0 0.1 0.0 0.6 0.8 0.1 2.4 2.0 0.9 1.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 5.4 2394.2 107.9 5.9 4.9 0.9 1.5 2.0 2.8 5.1 1.5 2.9 3.0 4.3 20.9 1.8 0.0 1.1 2.7 1.1 0.0 1.5 0.4 1.1 2.6 4.1 0.0 4.4 0.5 1.0 0.9 3.0 1.5 1.9 17.7 3.1 2.9 2.0 1.3 6.7 0.6 1.3 0.0 5.3 6.5 1.2 1.8 5.3 1.8 4.7 4.8 4.6 2.1 2.5 1.3 1.1 2.7 1.2 3.3 2.6 0.8 0.3 5.6 3.4 6.6 1.2 2.6 0.1 1.2 1.6 1.8 2.2 6.2 1.7 1.2 0.9 RNF5 "G16, NG2, RING5, RMA1" ENSG00000204308 "Ring finger protein 5" Q99942 6 32178405-32180793 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 371.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034107, HPA065032" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB034107: AB_2238618, HPA065032: AB_2685408" "unprognostic (1.94e-1)" "unprognostic (1.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.45e-3)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (4.07e-1)" "prognostic favorable (2.44e-4)" "unprognostic (1.95e-1)" "unprognostic (8.93e-3)" "unprognostic (2.91e-3)" "unprognostic (8.84e-2)" "unprognostic (9.17e-2)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" 38.5 76.6 58.5 29.5 62.4 40.7 44.9 61.8 65.7 44.4 56.3 58.0 62.2 45.1 46.2 37.8 54.6 46.5 73.5 57.0 59.0 116.6 127.2 39.0 43.5 62.2 60.4 56.0 61.0 41.9 56.0 17.3 30.3 64.8 44.3 63.0 43.3 44.3 32.0 90.4 44.9 77.1 30.8 60.5 39.1 55.8 29.7 59.1 61.2 49.0 77.2 43.7 45.4 39.1 64.8 51.2 66.1 43.7 167.5 46.9 31.3 34.0 20.6 26.5 44.4 48.7 89.1 42.1 65.2 70.8 47.9 62.5 41.7 80.3 45.1 45.2 41.8 107.5 53.9 69.5 184.4 55.0 0.2 101.2 32.3 60.3 73.3 53.6 77.2 89.1 115.0 136.6 67.8 63.8 71.9 66.5 151.5 0.3 71.8 28.7 44.4 48.2 88.2 124.0 32.6 44.8 92.1 39.9 42.4 46.7 39.9 87.0 183.0 40.3 48.1 44.7 0.5 79.1 38.6 63.5 79.3 33.2 116.4 29.6 64.8 45.7 75.8 64.8 65.9 55.6 64.6 52.5 57.6 64.7 56.2 57.5 58.3 22.1 79.6 46.7 264.6 58.2 75.0 58.5 62.4 61.8 65.7 57.0 59.0 62.2 60.4 56.0 64.8 60.5 59.1 64.8 38.3 19.2 41.1 2.9 52.7 95.7 70.0 146.6 52.3 23.6 61.8 56.5 62.9 87.2 79.5 92.0 0.0 78.1 70.3 151.9 283.7 110.8 21.6 47.2 31.7 50.9 73.2 126.3 3.4 91.3 101.7 44.6 28.5 31.7 56.3 41.5 47.8 131.5 68.9 33.7 3.5 83.0 132.2 51.1 171.7 22.6 59.4 43.3 85.4 1.0 69.5 91.3 65.9 1.5 10.0 78.5 173.0 72.6 45.5 58.4 270.6 371.6 73.4 27.6 65.7 50.6 63.0 55.7 37.7 44.4 84.4 84.1 53.8 42.8 100.3 56.5 AGPAT1 LPAAT-alpha ENSG00000204310 "1-acylglycerol-3-phosphate O-acyltransferase 1" Q99943 6 32168212-32178096 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048478, HPA073355" Approved Supported "Endoplasmic reticulum,Rods & Rings" NA NA "Endoplasmic reticulum" "Rods & Rings" "HPA048478: AB_2680411, HPA073355: AB_2686596" "prognostic unfavorable (1.93e-4)" "unprognostic (9.35e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (4.79e-2)" "unprognostic (7.05e-2)" "unprognostic (7.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.79e-1)" "unprognostic (4.24e-3)" "unprognostic (1.84e-3)" "unprognostic (1.77e-1)" "unprognostic (6.58e-2)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.92e-3)" "unprognostic (7.00e-2)" 43.0 60.8 16.7 6.0 16.5 6.6 42.9 4.3 40.7 57.8 3.6 56.1 28.4 64.8 43.3 34.2 57.0 19.0 66.9 21.3 18.9 61.9 60.6 44.6 11.0 17.8 21.9 3.9 67.7 37.8 9.4 54.2 16.0 26.9 53.6 20.3 12.6 34.3 0.0 68.2 31.9 53.4 1.5 13.2 40.1 58.9 79.9 30.3 18.6 54.6 33.8 12.6 58.7 43.1 70.2 0.0 0.4 51.2 0.3 127.5 85.2 49.4 0.0 0.0 0.0 0.0 104.5 0.0 0.0 46.1 128.0 36.4 13.4 108.5 39.4 0.0 0.4 83.6 0.0 0.0 111.7 0.0 0.0 101.5 51.0 47.6 0.0 46.0 105.9 31.6 86.7 78.5 66.0 109.2 28.8 0.4 26.8 0.0 0.1 18.0 0.6 0.0 0.5 32.8 0.0 0.0 0.1 51.3 16.1 70.4 51.6 63.4 0.0 25.9 0.0 20.3 0.0 0.2 45.9 41.1 18.0 64.3 0.1 0.3 3.4 5.6 12.4 7.6 8.2 7.4 5.3 5.0 8.6 9.3 5.0 4.3 6.4 9.4 8.7 5.8 11.6 7.2 6.9 16.7 16.5 4.3 40.7 21.3 18.9 17.8 21.9 3.9 26.9 13.2 30.3 70.2 32.1 16.0 18.6 11.1 14.3 9.1 14.0 20.6 16.5 26.1 26.2 21.6 4.0 14.3 12.0 36.8 12.5 35.2 24.5 28.7 5.9 17.9 63.9 14.1 24.9 21.3 29.4 12.0 13.8 14.3 29.9 19.6 16.3 11.4 12.7 22.7 27.1 31.2 24.7 32.0 17.7 24.3 18.3 22.3 20.6 91.7 13.4 24.9 8.8 11.2 13.0 38.5 21.6 10.1 14.8 17.0 22.3 21.4 16.9 10.2 73.6 29.4 12.9 17.9 0.0 18.3 22.9 44.8 22.1 9.5 3.7 15.3 13.8 21.5 20.8 12.1 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178462102 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "SuSa: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042621 Approved Mitochondria No No Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 3.0 1.8 8.8 1.3 8.8 1.4 4.9 8.5 10.3 2.5 8.4 1.5 1.2 3.9 7.4 1.2 2.9 2.9 1.3 8.5 8.7 2.7 2.8 1.5 1.9 9.2 8.6 8.2 7.1 1.4 1.1 4.2 1.3 9.1 2.8 1.2 6.4 2.7 3.0 3.5 4.2 1.4 2.0 8.8 1.5 1.2 20.9 8.6 1.2 2.5 0.9 1.7 1.9 1.4 9.2 0.2 1.8 2.3 1.9 3.0 3.1 1.2 1.5 1.4 1.2 2.0 0.7 3.1 2.1 1.5 0.9 1.0 0.9 1.7 1.0 0.9 0.7 0.6 0.7 2.9 0.4 3.0 0.6 0.2 3.2 2.2 1.4 3.2 3.8 1.5 4.1 0.4 1.3 1.5 0.5 2.1 1.3 2.8 0.2 0.8 2.7 1.7 1.3 2.0 1.0 1.6 1.3 0.5 0.3 0.6 6.8 0.7 0.7 1.0 1.5 0.6 0.4 0.1 4.3 2.8 0.7 0.7 1.1 0.6 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.0 0.5 0.5 0.3 0.4 0.2 0.0 2.8 0.0 0.0 8.8 8.8 8.5 10.3 8.5 8.7 9.2 8.6 8.2 9.1 8.8 8.6 9.2 1.6 6.4 9.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 2.4 0.0 0.0 1.8 1.8 0.0 1.1 0.5 0.0 3.9 1.4 0.0 1.8 2.6 0.4 0.0 0.0 0.0 0.9 0.5 1.4 0.0 1.6 0.0 6.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 PRRT1 "C6orf31, DSPD1, IFITMD7, NG5" ENSG00000204314 "Proline rich transmembrane protein 1" Q99946 6 32148359-32153083 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 35.4;ovary: 12.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 67.5;Cardiomyocytes: 125.5;Granulosa cells: 181.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 30.7;cerebral cortex: 35.4;hippocampal formation: 30.0;white matter: 10.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;SK-MEL-30: 1.6;U-2 OS: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055149, HPA059099" Enhanced NA NA "HPA055149: AB_2682717, HPA059099: AB_2732632" "unprognostic (1.40e-2)" "unprognostic (1.35e-1)" "unprognostic (2.10e-3)" "unprognostic (3.87e-3)" "unprognostic (2.89e-1)" "unprognostic (4.74e-2)" "unprognostic (5.51e-3)" "unprognostic (5.93e-2)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (8.08e-5)" "unprognostic (2.99e-1)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" 1.4 2.2 30.7 0.3 3.0 0.0 2.0 0.0 35.4 2.5 0.0 2.7 0.6 2.4 0.0 1.5 3.7 0.1 1.3 30.0 4.8 2.3 1.0 1.3 0.1 0.3 0.0 0.0 12.0 0.6 0.3 5.7 0.2 1.7 3.1 0.0 1.3 0.9 0.6 0.4 2.0 1.8 0.0 0.0 0.9 2.0 1.3 2.7 0.0 1.9 0.0 0.0 2.5 2.4 10.6 0.0 0.1 0.0 0.5 0.2 0.1 0.2 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.8 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 3.0 0.0 35.4 30.0 4.8 0.3 0.0 0.0 1.7 0.0 2.7 10.6 3.2 0.0 0.0 4.9 0.5 4.0 8.0 3.4 14.8 67.5 1.8 3.0 125.5 10.0 1.2 1.8 10.4 6.7 1.7 2.2 1.9 0.1 1.3 1.3 2.3 6.7 9.0 4.2 12.6 0.0 1.0 7.8 4.6 0.5 0.0 181.6 5.0 3.5 1.0 32.0 10.9 5.5 0.0 0.8 2.1 1.2 6.2 1.9 3.6 6.5 0.2 16.0 1.0 3.5 5.0 0.2 3.4 6.4 0.8 3.6 5.5 0.1 3.7 8.7 0.0 3.6 8.0 0.8 1.6 3.8 2.7 3.6 2.2 8.1 4.1 4.8 FKBPL "DIR1, NG7, WISp39" ENSG00000204315 "FKBP prolyl isomerase like" Q9UIM3 6 32128707-32130288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043478, HPA060158" Approved Approved "Nucleoplasm,Mitotic spindle" Yes No Nucleoplasm "Mitotic spindle" "HPA043478: AB_2678500, HPA060158: AB_2684213" "unprognostic (1.80e-1)" "unprognostic (6.80e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-3)" "unprognostic (1.02e-1)" "unprognostic (7.67e-2)" "unprognostic (8.22e-3)" "unprognostic (2.25e-2)" "unprognostic (1.22e-1)" "prognostic favorable (8.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-2)" "unprognostic (7.32e-2)" "unprognostic (4.39e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" 3.3 4.2 3.0 2.0 2.9 2.8 4.1 2.6 3.2 3.6 2.5 4.0 1.6 3.2 6.1 10.7 4.4 1.6 2.6 3.2 3.3 3.3 5.2 3.3 3.1 3.4 3.0 2.6 3.3 5.6 4.1 3.0 1.7 3.2 3.2 3.4 1.8 6.5 1.2 4.5 9.6 3.6 3.6 2.7 4.7 6.1 6.3 2.9 5.5 5.7 4.4 1.1 2.9 5.2 4.1 0.0 0.9 8.1 13.8 11.6 8.2 3.4 5.4 6.1 10.0 9.7 17.5 7.3 0.0 1.8 9.3 13.1 4.2 11.3 10.5 6.9 0.0 13.7 0.0 11.9 10.2 6.5 0.0 6.6 8.0 5.6 19.3 6.1 7.3 10.6 15.8 11.9 15.0 10.2 6.0 6.9 5.9 6.0 16.1 3.0 0.0 5.0 13.6 10.4 1.5 15.3 1.0 5.5 9.6 10.2 2.4 16.8 11.8 4.7 14.3 4.1 7.5 13.3 7.7 1.5 5.7 5.6 7.1 9.1 6.6 1.8 0.5 0.7 2.5 0.7 2.1 1.1 1.3 1.9 0.5 1.0 1.0 2.6 3.4 0.8 1.6 0.3 1.5 3.0 2.9 2.6 3.2 3.2 3.3 3.4 3.0 2.6 3.2 2.7 2.9 4.1 8.8 6.4 5.9 0.3 7.8 11.2 4.7 6.7 51.2 2.9 11.5 8.5 2.0 7.2 6.2 1.8 0.0 9.9 6.1 9.3 5.9 8.1 4.2 11.6 6.1 9.6 6.0 19.8 0.7 6.7 13.3 5.6 6.1 8.1 2.5 12.4 5.0 3.3 5.0 10.1 0.6 7.0 8.2 2.8 8.8 5.5 2.8 4.2 7.2 1.0 3.7 7.3 3.1 0.0 0.5 6.0 6.2 3.4 7.7 5.2 10.3 9.9 3.2 4.9 0.0 5.4 17.4 11.1 8.8 34.1 10.2 14.1 6.8 14.9 6.5 4.1 MRPL38 "HSPC262, MGC4810, MRP-L3, RPML3" ENSG00000204316 "Mitochondrial ribosomal protein L38" Q96DV4 17 75898644-75905093 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 34.7;Gastric mucus-secreting cells: 35.2;Plasma cells: 60.1;Squamous epithelial cells: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023054, HPA023135" Approved Supported Mitochondria NA NA Mitochondria "HPA023054: AB_1854109, HPA023135: AB_1854110" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.83e-1)" "unprognostic (3.68e-3)" "unprognostic (2.47e-2)" "unprognostic (1.50e-2)" "unprognostic (4.44e-2)" "unprognostic (1.61e-1)" "unprognostic (7.59e-2)" "unprognostic (5.24e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (5.58e-4)" "unprognostic (3.06e-2)" "unprognostic (2.40e-1)" "unprognostic (3.72e-1)" "prognostic favorable (9.21e-5)" 23.1 35.0 33.2 16.4 31.9 22.1 23.0 34.6 49.3 20.2 31.6 29.8 27.1 24.2 14.5 30.3 30.9 14.7 45.4 32.3 33.0 31.3 47.2 18.4 24.0 34.7 33.9 31.6 22.5 37.1 29.0 19.7 17.5 35.1 22.8 19.4 6.8 36.9 26.4 104.2 26.8 22.1 20.5 31.8 22.7 28.9 25.5 34.6 24.0 20.8 85.5 22.6 26.2 21.2 34.2 82.2 114.2 28.3 39.2 32.5 26.5 86.5 26.4 44.5 96.3 69.5 134.4 49.3 72.7 31.2 45.9 55.1 59.1 79.2 71.1 27.3 24.0 130.5 51.0 39.9 133.7 72.0 69.5 48.6 36.6 77.3 66.8 52.4 29.3 92.6 89.7 64.6 45.6 36.6 163.0 92.9 75.1 33.6 101.8 97.2 69.1 74.7 92.3 76.3 51.0 48.6 51.4 45.3 121.3 104.5 26.1 112.4 74.4 26.3 45.8 67.2 38.6 75.4 51.1 32.1 24.7 50.0 57.1 41.3 24.4 74.1 37.9 84.2 80.8 84.0 101.8 86.0 79.1 106.7 113.7 84.8 81.7 7.0 95.7 69.1 78.1 93.7 83.6 33.2 31.9 34.6 49.3 32.3 33.0 34.7 33.9 31.6 35.1 31.8 34.6 34.2 1.7 19.2 7.3 14.7 19.3 1.5 0.8 2.7 34.7 1.0 2.4 1.1 2.3 0.0 5.5 3.7 0.0 5.1 6.6 11.4 3.9 23.8 1.1 2.2 1.8 4.7 10.3 20.2 11.9 21.4 3.7 8.1 35.2 1.8 3.8 1.0 2.5 2.4 3.3 1.7 13.2 13.9 2.0 0.8 1.9 1.9 3.1 6.1 7.2 5.6 14.2 0.9 5.2 7.5 15.7 19.2 17.9 3.0 60.1 1.3 16.3 5.6 9.8 2.9 0.0 0.9 8.3 1.9 1.9 46.2 1.4 3.4 13.6 1.2 20.9 0.8 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.6;kidney: 28.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 56 "plasmacytoid DC: 207.6" "Lineage enriched" "Detected in many" 56 "dendritic cells: 207.6" "Cell line enhanced" "Detected in some" "HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 1.3 0.6 5.3 1.9 8.6 11.5 1.5 8.8 6.2 6.6 9.6 8.8 9.6 1.2 0.8 27.6 7.4 4.5 11.0 4.9 6.2 28.4 1.5 3.2 1.1 10.1 9.1 3.7 2.7 2.6 3.4 2.4 1.9 9.6 4.3 2.7 0.7 7.8 1.9 0.5 13.5 15.3 0.5 8.3 4.8 10.2 2.2 7.4 0.6 16.1 0.3 3.6 6.2 14.7 16.7 1.8 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.4 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 10.5 0.1 0.0 0.0 2.8 0.1 0.3 0.3 0.0 0.0 2.0 0.8 0.0 0.0 4.5 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.5 0.5 1.1 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 207.6 0.0 13.7 5.3 8.6 8.8 6.2 4.9 6.2 10.1 9.1 3.7 9.6 8.3 7.4 16.7 0.7 9.6 7.0 0.7 1.6 1.1 7.3 4.8 0.6 1.5 1.2 0.9 25.1 10.0 13.9 125.0 2.1 3.1 51.9 48.4 92.0 2.9 0.1 69.4 10.1 1.8 14.4 142.5 0.0 0.5 5.8 2.3 26.0 67.6 0.0 0.3 1.8 0.2 0.7 0.0 0.0 16.1 44.7 0.6 0.9 0.3 0.6 17.0 7.2 0.0 1.2 3.3 1.0 0.0 17.9 10.7 54.2 1.5 0.9 7.4 15.5 0.9 48.0 2.1 0.0 1.4 3.1 0.4 0.5 10.0 8.4 32.8 0.8 0.3 2.3 90.6 ERICH2 ENSG00000204334 "Glutamate rich 2" A1L162 2 170783786-170798971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 165.2" "Cell type enriched" "Detected in many" 7 "Early spermatids: 2216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "hTCEpi: 61.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory bulb: 33.1" HPA061010 Approved "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" Vesicles "HPA061010: " "unprognostic (1.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.26e-1)" "prognostic favorable (9.49e-4)" "unprognostic (7.57e-3)" "unprognostic (6.61e-2)" "unprognostic (9.62e-3)" "unprognostic (6.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-2)" "unprognostic (1.12e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (8.98e-7)" "unprognostic (1.03e-1)" "unprognostic (5.28e-3)" "unprognostic (7.35e-2)" "unprognostic (2.76e-1)" 1.4 1.8 6.0 0.2 6.0 0.0 4.4 5.7 7.3 6.3 13.1 0.6 0.1 4.9 3.6 0.7 9.5 1.8 3.9 5.2 6.1 3.6 5.5 12.2 0.3 5.0 5.3 4.8 2.2 2.9 8.0 1.4 0.4 5.0 2.3 0.7 6.9 2.5 2.2 1.1 0.6 0.3 1.3 4.7 0.1 3.9 165.2 5.4 0.3 18.8 3.5 0.6 1.1 0.9 5.1 9.5 0.0 0.1 7.7 0.0 0.0 0.4 0.0 0.0 1.5 3.1 7.9 1.9 0.0 0.3 0.0 3.4 0.2 2.0 0.7 0.1 1.3 2.0 4.1 0.0 0.1 7.8 0.4 0.5 1.2 61.5 0.0 14.1 0.2 0.0 1.5 9.2 0.0 0.0 3.3 0.0 0.8 9.5 11.3 1.6 0.0 1.5 0.0 4.4 0.2 1.1 2.0 5.6 0.1 2.4 1.8 1.3 1.3 0.0 2.0 1.7 0.0 0.9 0.0 0.0 0.0 7.7 3.8 6.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 6.0 5.7 7.3 5.2 6.1 5.0 5.3 4.8 5.0 4.7 5.4 5.1 0.2 6.4 24.4 8.1 0.1 0.3 0.6 1.7 0.0 1.6 1.0 2.0 2.0 2.8 2.3 1.8 0.0 0.0 0.0 0.1 13.7 0.9 2216.6 25.7 3.6 0.9 7.7 0.0 4.4 1.8 0.2 1.0 0.0 1.3 0.0 0.7 0.0 2.5 0.0 0.0 12.7 1.6 2.0 0.0 0.0 302.9 9.6 0.9 0.0 1.9 0.0 2.0 0.0 6.6 4.0 1.3 0.0 7.5 0.0 0.2 0.0 0.7 21.5 0.5 6.6 0.8 1.0 39.1 10.8 0.0 0.1 0.0 0.1 0.2 0.4 0.1 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715337-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 8.4" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 2.8;Cardiomyocytes: 3.1;Distal tubular cells: 3.9;Endometrial stromal cells: 7.1;Fibroblasts: 4.4;Intestinal goblet cells: 4.3;Spermatogonia: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 122.1" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Low region specificity" "Detected in some" HPA074123 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA074123: AB_2686664" "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 1.6 1.2 0.5 0.2 0.4 0.0 1.4 2.2 0.3 8.4 0.5 1.3 1.0 3.7 0.4 1.2 1.2 0.2 0.1 0.3 1.2 0.2 2.1 0.5 0.2 0.3 1.2 0.3 0.4 0.4 0.3 0.1 0.2 0.5 1.7 0.2 0.0 1.6 0.2 0.2 3.5 1.4 0.1 0.0 0.0 3.1 0.8 1.2 0.1 0.1 0.0 0.8 1.5 2.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.7 0.1 0.0 0.5 0.0 0.5 1.5 0.3 0.0 0.0 3.5 0.3 0.4 0.1 122.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.0 2.3 0.0 0.0 0.0 0.1 0.0 0.1 0.3 4.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.2 0.3 0.3 1.2 0.3 1.2 0.3 0.5 0.0 1.2 0.1 0.2 0.0 0.0 0.3 0.0 0.8 0.1 0.0 2.8 0.0 0.2 0.3 3.1 0.0 0.0 1.8 0.0 1.5 0.1 0.3 3.9 0.0 0.2 2.3 7.1 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.3 0.0 0.0 0.0 2.5 0.2 0.0 0.4 4.3 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 3.7 0.2 0.1 0.3 0.2 0.0 1.6 0.0 STK19 "D6S60, G11, RP1" ENSG00000204344 "Serine/threonine kinase 19" P49842 6 31971091-31982821 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in all" 4 "Proximal tubular cells: 348.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031511, HPA068559" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA031511: AB_2673915, HPA068559: AB_2686004" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.31e-1)" "unprognostic (1.86e-1)" "unprognostic (2.63e-1)" "unprognostic (1.67e-1)" "unprognostic (1.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" "unprognostic (2.25e-2)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.40e-1)" "unprognostic (4.10e-1)" 1.3 3.6 0.1 0.2 0.2 0.0 1.3 0.5 0.9 1.8 0.0 1.8 0.0 1.4 0.3 1.9 1.0 0.1 1.0 0.2 0.1 1.0 2.2 1.3 0.0 0.2 0.0 0.1 1.1 1.1 0.2 1.4 0.4 0.1 2.1 0.0 0.2 0.9 0.1 1.4 2.3 0.7 0.0 0.0 1.2 1.3 1.5 0.1 0.1 1.2 0.0 0.1 2.0 1.5 0.5 0.0 0.1 0.0 0.4 1.1 0.7 0.0 0.3 0.1 0.2 0.4 0.0 0.7 0.6 0.3 0.5 0.0 0.6 0.0 0.2 0.3 1.4 0.4 1.5 0.3 0.0 0.5 1.6 0.0 0.6 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.1 0.4 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.9 0.0 0.7 0.2 0.0 0.0 1.1 0.0 0.1 0.3 0.2 0.6 0.2 0.0 0.8 0.2 0.3 0.1 0.1 0.3 0.4 0.4 0.0 0.1 0.1 0.2 0.5 0.9 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.5 21.2 9.6 21.5 13.7 16.4 13.0 14.0 23.0 13.6 11.8 26.6 27.6 8.1 18.6 24.6 22.0 20.9 37.2 22.4 13.8 39.2 26.3 85.8 27.8 31.8 20.6 19.3 4.6 8.7 28.3 20.0 23.3 19.4 20.7 9.5 20.1 14.3 21.1 19.3 10.1 8.0 17.3 18.3 8.8 10.0 76.0 20.2 18.3 17.8 11.2 12.5 30.2 13.4 4.5 6.5 23.6 16.4 18.4 11.9 13.2 15.0 348.9 41.8 21.9 32.9 19.6 21.1 39.5 21.0 17.9 18.2 49.7 19.8 45.1 13.1 11.8 CD300LD "CD300D, CMRF35A4" ENSG00000204345 "CD300 molecule like family member d" Q6UXZ3 17 74579365-74592283 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "neutrophil: 4.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.9" "Cell line enhanced" "Detected in single" "HMC-1: 1.0" HPA027756 Uncertain NA NA "HPA027756: AB_10601097" "unprognostic (8.03e-2)" "unprognostic (3.30e-1)" 0.0 0.1 0.1 0.6 0.1 0.9 0.0 0.4 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.4 0.4 0.0 0.1 0.4 0.3 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.2 4.9 0.4 0.2 0.3 0.8 0.1 0.1 0.1 0.4 0.4 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTBD17 "BTBD17A, LGALS3BPL, TANGO10A" ENSG00000204347 "BTB domain containing 17" A6NE02 17 74356416-74361868 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 5.1" "Cell type enriched" "Detected in some" 6 "Horizontal cells: 28.6" "Cancer enriched" "Detected in some" 5 "glioma: 9.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "AF22: 2.9;NTERA-2: 3.8;SCLC-21H: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA025022 Approved "Secreted in brain" NA NA "HPA025022: AB_2067352" "unprognostic (2.63e-1)" "unprognostic (2.77e-1)" "unprognostic (4.82e-5)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (9.89e-3)" 0.0 0.5 2.6 0.0 2.5 0.0 0.0 1.8 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.4 0.0 0.0 0.0 0.0 2.3 3.0 1.6 0.0 0.2 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.3 5.1 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.5 1.8 3.3 2.1 4.4 2.3 3.0 1.6 2.9 1.5 5.1 2.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 0.0 0.0 4.2 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972290 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 467.9;Late spermatids: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 6.0 17.9 7.6 4.0 7.7 1.4 6.9 7.6 8.4 10.5 8.5 6.5 4.6 8.2 5.9 5.8 8.5 4.2 9.5 7.5 8.0 12.3 13.2 6.5 4.6 8.8 7.8 7.1 13.6 10.9 11.9 13.1 4.5 8.1 10.4 3.9 4.8 6.8 6.1 5.4 4.9 5.9 4.8 7.6 9.8 8.6 31.5 7.8 7.1 11.6 7.2 3.0 8.0 7.5 7.9 12.9 6.3 5.8 23.1 9.5 6.4 6.7 7.5 12.0 16.2 15.5 7.6 5.9 5.2 8.5 16.6 5.2 8.7 10.1 16.8 9.4 9.6 12.9 9.3 15.8 16.4 18.7 0.0 4.6 9.7 16.3 10.5 13.5 9.9 21.3 6.6 8.3 11.9 9.8 14.7 1.5 11.1 4.4 8.4 1.3 4.0 4.1 8.2 21.2 4.5 30.1 17.0 6.6 7.3 16.9 4.1 0.0 14.8 7.0 4.7 12.6 4.6 12.3 9.1 9.4 10.2 4.6 14.4 5.2 0.0 1.9 1.0 2.2 1.6 3.9 2.4 2.3 1.4 4.3 2.1 1.6 2.3 0.3 2.1 1.4 1.3 1.6 1.8 7.6 7.7 7.6 8.4 7.5 8.0 8.8 7.8 7.1 8.1 7.6 7.8 7.9 11.2 6.4 9.6 11.8 16.8 8.5 15.3 14.3 19.9 13.3 13.6 11.4 7.1 11.5 10.5 3.7 16.7 14.5 14.1 5.0 19.6 8.4 467.9 9.3 10.6 9.8 16.2 4.4 4.4 12.6 9.5 10.9 15.8 8.7 6.3 12.1 8.6 10.9 6.6 5.0 6.2 9.0 12.2 5.9 4.9 242.8 17.7 6.9 12.4 1.9 4.3 16.0 11.3 7.5 6.6 6.9 10.5 12.4 14.7 10.8 10.6 13.3 8.9 15.6 13.1 7.1 14.3 78.4 16.1 11.8 5.5 20.1 15.4 22.6 8.3 11.5 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959117-31969751 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "pons: 2.7" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047122, HPA051959, HPA054419" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol" Yes NA "Nucleoplasm, Nuclear bodies" "Mitotic spindle, Cytosol" "HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavorable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 20.3 33.4 0.0 5.3 0.3 4.2 21.8 0.0 0.4 25.3 0.0 25.3 10.6 22.8 9.5 23.1 25.2 0.0 22.0 0.0 0.6 24.1 55.2 22.4 3.4 2.2 1.5 0.0 24.8 25.9 2.5 40.0 2.6 2.7 32.2 2.4 2.1 22.6 3.3 20.5 19.3 31.5 5.8 0.0 40.9 27.8 16.7 0.1 4.3 27.9 5.3 2.7 23.8 21.0 0.0 0.2 12.7 13.3 0.0 16.5 11.8 27.1 10.9 11.7 13.6 13.2 0.4 0.0 0.0 26.0 25.5 13.2 11.9 0.0 30.8 9.9 14.8 15.7 0.0 0.0 0.2 0.0 0.1 0.2 28.3 17.9 0.1 0.0 12.7 0.0 19.3 0.0 13.6 0.0 0.0 0.0 0.3 20.6 0.0 0.0 0.3 0.0 0.0 11.2 0.0 0.0 0.0 23.6 0.0 17.6 11.5 0.0 15.7 12.8 16.0 7.2 18.7 0.2 42.2 35.7 12.0 20.4 0.1 0.0 0.3 0.5 0.2 1.5 1.4 1.1 0.2 0.7 0.3 1.1 0.9 0.8 0.8 0.1 0.0 2.2 0.5 0.2 0.4 0.0 0.3 0.0 0.4 0.0 0.6 2.2 1.5 0.0 2.7 0.0 0.1 0.0 6.4 16.0 11.3 10.1 13.3 2.8 5.0 7.9 11.4 5.0 9.3 5.1 8.5 10.0 8.8 7.3 8.4 12.6 12.7 19.7 1.9 9.5 3.1 7.7 7.9 7.9 12.6 6.5 7.2 8.6 7.9 7.4 28.1 6.3 8.2 10.8 8.6 19.4 9.2 0.0 5.0 13.2 8.2 6.3 4.1 1.5 9.3 7.8 7.2 2.8 10.2 4.9 18.6 3.0 4.8 9.4 16.0 6.0 20.2 5.9 25.5 6.9 16.5 8.3 0.0 4.1 10.2 4.7 7.5 6.6 3.7 12.4 14.4 12.3 11.0 5.2 NELFE "D6S45, NELF-E, RD, RDBP, RDP" ENSG00000204356 "Negative elongation factor complex member E" P18615 6 31952087-31959038 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 635.4;Late spermatids: 1699.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007187, HPA007594, HPA046502" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677" "unprognostic (1.09e-1)" "unprognostic (3.28e-1)" "unprognostic (1.45e-1)" "unprognostic (6.33e-3)" "unprognostic (4.43e-2)" "unprognostic (4.25e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.97e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (5.21e-2)" "unprognostic (1.07e-1)" "unprognostic (2.21e-1)" "unprognostic (3.68e-2)" 50.5 48.9 37.7 15.4 37.8 23.7 49.8 38.9 40.6 45.6 37.1 44.6 12.8 50.6 27.1 52.1 47.3 12.0 54.4 35.7 40.9 47.6 24.7 44.0 17.1 39.5 37.9 34.3 47.8 52.9 41.5 42.9 20.7 38.6 35.7 24.4 6.4 40.8 26.9 58.6 51.5 37.5 27.9 39.1 39.0 47.0 167.5 38.3 37.2 39.9 31.0 25.6 44.5 43.9 39.6 51.8 59.9 55.5 48.4 54.7 59.9 50.9 40.3 73.8 90.1 74.6 69.5 35.7 49.0 41.3 79.0 117.1 44.0 47.4 85.7 64.5 39.4 63.2 35.9 41.9 80.5 110.6 43.4 29.0 63.2 119.2 96.2 113.5 75.6 84.2 87.6 51.6 56.6 90.2 89.6 77.1 44.6 22.9 79.6 68.1 63.0 49.1 95.2 61.0 49.8 42.3 52.8 30.4 44.4 80.1 48.4 66.0 89.6 37.1 39.7 63.5 34.5 67.8 65.9 77.8 47.6 26.0 36.4 69.8 44.9 60.4 58.7 49.4 68.8 46.2 50.9 45.4 47.2 56.9 49.9 41.9 41.0 31.4 48.8 67.8 45.4 49.0 55.4 37.7 37.8 38.9 40.6 35.7 40.9 39.5 37.9 34.3 38.6 39.1 38.3 39.6 49.0 16.0 27.9 4.6 42.8 47.2 69.0 61.5 40.5 15.5 55.1 62.5 47.2 72.9 43.1 33.1 12.5 98.4 37.7 84.6 133.1 93.3 635.4 68.4 40.8 49.8 34.2 52.2 6.2 136.5 112.1 47.7 31.1 45.6 45.6 46.7 45.3 34.8 82.8 11.8 6.2 71.1 46.8 55.3 42.6 1699.6 71.1 45.0 49.8 3.7 73.2 65.5 51.5 6.6 9.9 113.1 99.1 45.1 68.6 79.6 124.8 107.7 112.5 25.6 32.9 48.7 84.9 224.7 91.0 54.2 41.8 114.4 41.7 41.0 72.4 64.6 NXPE2 "FAM55B, FLJ25224" ENSG00000204361 "Neurexophilin and PC-esterase domain family member 2" Q96DL1 11 114678527-114707069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "epididymis: 25.5;intestine: 10.0;salivary gland: 21.4" "Cell type enhanced" "Detected in some" "Astrocytes: 2.6;Distal enterocytes: 3.2;Early spermatids: 1.4;Enteroendocrine cells: 1.8;Intestinal goblet cells: 3.2;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.7;Paneth cells: 1.4;Prostatic glandular cells: 1.4;Undifferentiated cells: 1.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039744, HPA039876" Enhanced NA NA "HPA039744: AB_2676660, HPA039876: AB_2676721" "unprognostic (2.85e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.46e-2)" "unprognostic (9.35e-2)" "unprognostic (1.27e-1)" "unprognostic (6.40e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-4)" "unprognostic (9.00e-2)" "unprognostic (9.22e-2)" 0.1 0.0 0.1 1.1 0.1 0.0 0.4 0.0 0.2 0.1 0.0 10.0 0.6 0.2 25.5 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.1 9.2 0.0 21.4 0.2 0.0 0.1 2.7 0.8 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.1 0.1 1.8 0.0 1.3 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.7 0.0 1.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.5 SPANXN5 "CT11.10, SPANX-N5" ENSG00000204363 "SPANX family member N5" Q5MJ07 X 52796144-52797427 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 114 "testis: 16.8" "Group enriched" "Detected in some" 15 "Early spermatids: 311.7;Late spermatids: 93.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 311.7 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 93.1 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.1 6.8 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ZBTB12 "C6orf46, D6S59E, G10, NG35" ENSG00000204366 "Zinc finger and BTB domain containing 12" Q9Y330 6 31899613-31902086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.6;Erythroid cells: 2.5;Horizontal cells: 3.3;Oligodendrocytes: 2.2;Rod photoreceptor cells: 1.7;Squamous epithelial cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.5;HEK 293: 3.1;NTERA-2: 2.5;REH: 4.6;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047161, HPA070639" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA047161: AB_2679962, HPA070639: " "unprognostic (2.05e-1)" "unprognostic (3.15e-2)" "unprognostic (3.77e-1)" "unprognostic (2.93e-1)" "unprognostic (1.24e-1)" "unprognostic (8.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.55e-1)" "unprognostic (5.22e-2)" "unprognostic (8.16e-2)" "unprognostic (2.58e-1)" "unprognostic (5.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.87e-1)" "unprognostic (2.11e-1)" "unprognostic (6.39e-2)" "unprognostic (8.98e-3)" 1.6 2.8 0.6 0.0 0.5 0.0 1.9 0.5 0.6 5.5 0.0 2.5 0.0 5.1 0.0 2.7 4.1 0.1 1.7 0.4 0.3 1.5 1.3 1.5 0.0 1.4 0.8 0.4 6.4 2.1 0.0 2.2 0.0 0.8 3.2 0.0 0.0 2.4 0.0 2.0 1.4 2.5 0.0 0.7 2.4 2.1 2.3 0.7 0.0 2.5 0.0 0.0 4.2 3.1 1.3 1.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.1 1.1 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.5 0.2 2.5 0.0 1.2 4.6 0.3 0.2 0.0 0.0 1.1 1.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.1 1.4 3.1 0.6 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.5 0.6 0.4 0.3 1.4 0.8 0.4 0.8 0.7 0.7 1.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.8 0.3 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.6 0.4 0.0 2.5 0.4 0.0 0.0 0.2 0.5 0.2 0.0 1.0 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 1.7 0.0 0.3 1.1 0.0 0.0 1.5 0.0 0.0 0.2 0.5 0.1 0.1 SDHD "cybS, PGL, PGL1" ENSG00000204370 "Succinate dehydrogenase complex subunit D" O14521 11 112086824-112120016 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 530.2;Proximal tubular cells: 449.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045727 Approved "Intracellular and membrane" NA NA "HPA045727: AB_10963114" "unprognostic (9.13e-2)" "unprognostic (3.51e-2)" "unprognostic (4.47e-3)" "unprognostic (4.21e-2)" "unprognostic (1.93e-1)" "unprognostic (4.98e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-3)" "unprognostic (7.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.99e-10)" "unprognostic (5.14e-2)" "unprognostic (1.58e-2)" "unprognostic (1.56e-2)" "unprognostic (7.51e-2)" 118.6 96.6 61.1 85.3 63.7 73.5 103.6 69.8 77.0 93.3 65.3 187.0 210.0 89.0 97.5 127.8 93.4 86.4 257.1 61.0 69.6 322.9 395.0 80.0 132.8 65.9 64.8 58.2 92.4 78.5 153.6 37.3 95.8 64.0 88.7 192.6 37.7 113.6 101.9 358.1 64.8 177.1 99.0 66.4 85.8 102.0 34.4 64.6 103.5 138.0 453.6 125.8 119.0 77.0 69.0 84.0 67.3 58.1 89.4 212.0 170.7 97.3 97.5 147.6 106.8 132.2 244.8 222.1 155.5 288.4 131.0 156.1 203.5 175.4 139.8 129.8 129.9 92.4 142.8 51.9 140.1 165.6 222.4 107.5 189.6 160.2 110.5 189.1 124.6 153.0 109.6 156.0 208.7 135.0 95.2 143.9 215.0 77.4 333.8 211.6 126.2 145.8 294.4 221.6 175.2 83.5 55.8 135.3 194.8 107.0 81.8 198.9 164.2 108.0 103.8 132.3 114.7 95.0 59.1 73.2 270.7 58.8 297.0 100.5 233.7 293.3 208.8 158.4 390.1 173.1 235.2 170.8 168.8 308.7 198.1 204.3 191.8 257.5 207.9 322.9 151.7 189.9 348.9 61.1 63.7 69.8 77.0 61.0 69.6 65.9 64.8 58.2 64.0 66.4 64.6 69.0 104.3 80.1 51.1 12.4 78.0 81.6 102.2 262.2 83.6 12.2 61.0 78.4 216.5 120.1 108.1 90.1 8.4 154.3 55.2 203.8 530.2 82.9 9.9 41.6 67.6 76.4 50.4 70.2 9.6 58.9 124.1 104.6 75.4 41.2 65.9 32.3 76.8 169.7 162.9 11.8 11.2 129.1 154.6 97.1 74.4 37.0 104.1 94.2 76.5 9.4 118.6 52.9 75.2 8.0 9.7 54.1 134.2 99.6 80.9 61.6 253.1 449.9 60.5 18.9 92.1 78.3 110.7 70.4 55.8 127.1 74.4 179.0 71.4 86.2 176.0 98.6 EHMT2 "BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a" ENSG00000204371 "Euchromatic histone lysine methyltransferase 2" Q96KQ7 6 31879759-31897687 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050550, HPA060259" Supported Supported "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" Nucleoplasm "HPA050550: AB_2681170, HPA060259: AB_2684234" "unprognostic (3.11e-2)" "unprognostic (2.72e-1)" "unprognostic (4.39e-2)" "unprognostic (1.92e-2)" "unprognostic (5.44e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.89e-2)" "unprognostic (1.88e-1)" "unprognostic (9.78e-3)" "unprognostic (8.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.25e-1)" "unprognostic (9.03e-2)" 8.3 9.7 0.5 0.3 0.4 1.0 8.8 0.3 0.5 15.0 0.2 11.4 2.4 20.0 1.7 10.2 13.0 0.0 5.5 0.8 0.4 7.1 4.7 7.3 1.0 1.3 0.5 0.3 16.3 7.8 0.6 12.9 0.7 1.4 10.4 0.3 0.6 9.6 1.3 5.6 9.1 10.6 1.4 0.3 11.5 9.5 12.7 0.4 1.6 10.3 0.4 1.0 13.2 11.3 0.7 0.0 4.5 7.8 0.0 3.4 1.8 5.0 3.5 2.8 3.9 3.2 0.0 0.0 0.0 7.6 5.7 4.0 0.0 0.0 8.6 1.8 5.4 11.8 0.0 0.0 0.1 0.0 13.3 0.0 4.6 1.4 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 9.4 0.0 19.3 0.0 0.0 8.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.3 6.5 3.1 0.0 0.0 3.8 4.1 3.1 6.9 0.0 11.0 16.1 3.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.4 0.3 0.5 0.8 0.4 1.3 0.5 0.3 1.4 0.3 0.4 0.7 16.9 16.0 12.0 22.9 20.3 8.4 6.3 11.9 26.2 60.6 15.9 17.8 6.6 17.2 18.9 25.8 41.7 24.6 13.4 9.2 7.9 15.7 41.5 10.1 19.1 16.1 22.6 19.3 16.6 12.2 15.0 16.0 13.3 11.8 14.5 33.8 22.1 7.5 16.3 38.7 24.4 16.4 12.2 12.9 7.3 60.0 27.4 12.1 19.6 9.4 19.9 26.8 25.7 20.1 23.9 10.8 9.1 23.0 16.5 6.2 12.5 10.1 10.8 48.2 26.3 16.3 15.0 20.8 33.7 23.5 11.1 5.6 18.3 19.9 19.0 5.2 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495808-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "testis: 95.4" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 1443.3;NB-4: 1484.7;THP-1: 1390.5;U-2 OS: 1014.9;U-266/70: 649.2;U-266/84: 1967.0;U-937: 1201.1" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 95.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 5.7 235.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 6.5 2.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 1443.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 319.6 1.9 0.0 0.0 1.3 1484.7 0.2 0.0 0.0 0.7 0.0 5.3 0.0 0.0 0.6 156.7 0.0 2.6 3.7 0.0 96.1 1390.5 1.5 0.0 1014.9 0.3 187.7 649.2 1967.0 3.3 0.7 1201.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Prostatic glandular cells: 233.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "myeloid DC: 11.2;T-reg: 13.4" "Group enriched" "Detected in many" 123 "dendritic cells: 11.2;T-cells: 13.4" "Cell line enhanced" "Detected in many" "BJ: 150.7;BJ hTERT+: 153.7;BJ hTERT+ SV40 Large T+ RasG12V: 96.7;fHDF/TERT166: 95.1;HSkMC: 88.8;hTERT-RPE1: 94.0;U-138 MG: 108.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol NA NA 340000 Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 7.4 2.0 16.9 5.8 20.7 1.0 8.6 16.4 19.8 14.7 14.2 21.4 3.9 16.0 10.2 4.7 17.9 17.1 6.1 16.6 18.7 4.2 0.9 11.4 7.2 20.0 20.2 12.8 39.5 2.0 6.5 6.2 14.2 18.2 14.7 3.4 0.8 5.5 17.2 6.2 2.5 10.7 22.7 15.1 8.3 13.2 4.5 17.9 10.4 27.6 6.2 5.0 8.9 12.3 24.7 0.4 3.9 0.8 0.0 25.4 48.0 7.6 150.7 153.7 71.0 96.7 0.2 0.1 0.0 1.4 95.1 18.7 3.2 9.9 0.7 74.2 0.2 0.5 0.8 0.0 0.2 41.7 0.0 0.2 88.8 0.0 30.8 0.2 94.0 0.9 0.0 0.0 0.1 29.4 0.0 0.1 0.1 4.8 0.0 0.0 0.0 11.4 0.2 0.6 0.0 4.9 18.9 0.5 0.2 0.4 34.9 0.1 0.7 0.6 108.8 81.2 1.0 74.3 0.0 0.0 0.2 14.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.4 0.4 16.9 20.7 16.4 19.8 16.6 18.7 20.0 20.2 12.8 18.2 15.1 17.9 24.7 22.2 19.2 2.8 0.3 0.3 2.2 48.8 44.8 0.6 0.4 0.7 15.0 2.7 2.8 23.3 0.0 0.0 1.6 2.6 0.0 0.0 6.5 2.5 3.9 7.7 50.9 0.0 2.7 0.3 0.2 2.1 13.1 0.0 0.9 1.3 9.6 6.8 0.1 0.7 0.0 1.4 0.0 6.1 0.6 13.6 1.8 22.7 1.2 0.0 2.8 0.6 0.2 0.0 4.0 30.1 0.8 0.0 55.3 2.8 233.0 0.0 0.2 32.0 0.2 32.9 2.6 17.3 0.1 2.3 0.1 2.3 0.5 14.5 11.2 0.0 50.3 XAGE1B "CT12.1b, CT12.1c, CT12.1d, XAGE1C, XAGE1D, XAGE1E" ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.0" "Cell type enhanced" "Detected in some" "Spermatocytes: 1.5;Spermatogonia: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.6" "Cell line enhanced" "Detected in some" "HMC-1: 81.1;NB-4: 95.0;THP-1: 89.4;U-2 OS: 70.5;U-266/84: 143.5;U-937: 69.5" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 38.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 23.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 95.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 9.3 0.0 0.7 0.4 0.0 6.2 89.4 0.0 0.0 70.5 0.0 13.3 38.3 143.5 0.0 0.0 69.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC44A4 "C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT" ENSG00000204385 "Solute carrier family 44 member 4" Q53GD3 6 31863192-31879046 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 101.7;prostate: 83.7;stomach 1: 84.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6" "Cancer enhanced" "Detected in many" "prostate cancer: 222.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "OE19: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046977, HPA054176" Enhanced NA NA "HPA046977: AB_2679887, HPA054176: AB_2682404" "unprognostic (5.84e-2)" "unprognostic (4.90e-2)" "unprognostic (3.86e-3)" "unprognostic (4.85e-3)" "unprognostic (2.75e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.65e-3)" "unprognostic (2.44e-3)" "unprognostic (3.08e-1)" "unprognostic (2.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.06e-6)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (4.54e-2)" "prognostic favorable (6.06e-4)" 0.5 8.3 0.0 2.6 0.0 1.0 5.3 0.0 0.0 22.6 0.0 78.0 101.7 5.9 2.6 2.0 47.4 19.0 0.0 0.0 0.0 31.7 0.4 15.0 0.2 0.2 0.0 0.0 1.6 8.9 0.0 16.3 3.5 0.1 83.7 30.6 0.0 42.9 4.0 0.0 1.0 87.5 2.9 0.0 1.6 84.0 0.7 0.0 0.2 1.9 0.0 0.8 11.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 14.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 3.7 22.4 36.0 0.0 3.8 0.5 23.0 71.4 0.6 0.3 14.6 6.1 0.4 38.6 180.2 66.2 0.0 0.3 0.5 546.0 3.9 111.2 2.3 127.4 8.9 6.2 46.7 0.0 0.1 213.4 0.5 2.4 208.5 67.5 2.5 1.1 0.4 0.0 0.5 0.0 0.1 327.8 91.6 0.0 0.0 3.2 1.5 2.5 0.0 0.0 1.6 0.7 0.0 0.0 0.0 184.0 299.3 0.4 0.3 142.0 267.7 61.5 406.7 0.6 0.0 0.8 11.9 0.2 0.2 0.5 0.4 0.7 2.3 5.5 259.6 139.4 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862905 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 197.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "neutrophil: 3.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;U-266/84: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" NA NA 180000 Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 22.6 57.7 0.6 0.4 0.8 0.0 22.6 2.5 1.2 20.4 1.2 22.9 0.7 19.7 0.0 15.0 16.9 1.0 21.6 0.7 0.6 43.5 30.2 29.1 0.3 0.7 0.5 0.6 20.5 36.2 0.3 33.3 0.2 1.0 26.8 0.0 1.6 38.9 0.0 21.5 19.7 24.5 0.1 0.4 25.5 30.0 8.3 0.8 0.0 32.1 0.0 0.0 23.4 16.4 1.6 0.3 0.2 0.8 1.4 1.8 0.4 0.7 0.2 0.2 0.3 0.3 1.5 0.6 0.7 0.4 0.1 5.4 0.3 2.2 0.0 0.4 2.5 0.3 0.6 0.9 1.2 1.4 0.9 1.8 1.0 0.2 1.4 0.7 0.2 0.6 0.9 1.1 1.2 0.5 0.3 0.6 0.0 0.6 0.5 0.4 0.9 0.4 0.9 1.0 0.4 0.7 0.4 0.2 0.3 0.7 0.9 0.9 0.5 0.7 1.1 0.8 0.7 0.6 3.7 9.6 0.9 1.7 0.4 0.4 1.3 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.6 0.2 0.3 3.0 0.3 0.2 0.3 0.2 0.1 0.6 0.8 2.5 1.2 0.7 0.6 0.7 0.5 0.6 1.0 0.4 0.8 1.6 65.7 25.6 46.3 5.2 57.0 34.3 48.5 45.0 39.9 26.4 87.7 55.8 29.0 51.5 54.8 47.8 25.0 62.8 100.5 83.7 9.8 114.2 0.8 29.3 53.5 42.8 113.5 4.6 6.3 59.6 57.8 73.8 32.6 60.8 67.9 17.4 30.7 34.5 170.9 10.1 7.6 39.9 79.3 63.0 65.9 1.4 27.7 93.0 71.2 9.4 25.8 48.8 9.2 5.0 4.0 34.4 88.1 23.3 81.7 89.0 115.0 59.9 29.2 32.7 26.3 60.8 43.7 5.4 10.0 29.3 41.6 197.0 81.7 40.3 41.1 34.6 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827738-31830254 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 3007.4;Urothelial cells: 1619.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "hippocampal formation: 31.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 204.3" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: AB_2681854" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 286.7 342.9 4.4 0.4 1.5 0.0 127.1 1.5 20.4 315.9 1.0 331.9 0.1 155.3 9.2 378.2 233.4 2.3 624.8 31.5 1.8 558.6 690.9 852.8 0.0 3.3 1.0 0.1 688.0 339.3 3.4 441.6 0.0 5.4 306.3 0.5 2.6 95.6 0.3 161.2 222.9 140.3 0.0 0.3 277.0 375.1 94.5 4.7 0.0 292.3 0.0 0.0 418.9 507.5 6.7 0.4 24.1 0.4 0.2 1.1 0.0 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 8.4 0.0 0.0 3.3 0.0 0.0 0.0 0.0 15.4 0.0 0.5 2.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 204.3 0.0 3.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 1.6 0.0 0.0 0.3 3.2 0.0 0.4 41.5 0.4 0.4 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 1.5 1.5 20.4 31.5 1.8 3.3 1.0 0.1 5.4 0.3 4.7 6.7 563.2 112.2 75.0 140.7 242.7 239.2 3007.4 63.2 630.0 44.6 509.4 403.9 512.3 40.0 73.7 69.9 131.3 82.7 82.8 542.8 19.6 45.5 1.9 434.9 380.2 446.2 318.6 57.9 2.7 15.6 140.8 585.8 595.8 710.4 346.8 14.1 25.7 17.7 142.0 47.1 2.8 426.3 61.1 84.4 1140.4 9.8 220.6 627.1 642.1 126.5 17.7 192.4 1.0 5.5 61.8 21.4 524.1 54.9 967.0 584.2 159.1 38.3 75.0 144.2 105.2 226.4 846.5 15.2 46.4 904.0 221.9 259.7 604.6 116.7 400.5 1619.4 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815543-31817946 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 7514.5;Langerhans cells: 2690.4;Urothelial cells: 3444.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 39 "cerebral cortex: 245.6" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 6.8;monocytes: 3.6;T-cells: 3.0" "Cell line enriched" "Detected in some" 8 "HEK 293: 4450.4" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA Yes 47000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 364.4 353.4 3.7 12.8 4.0 0.0 168.6 6.1 245.6 293.8 3.9 422.2 0.0 211.4 16.1 456.5 196.3 5.9 873.4 4.3 3.9 746.9 1125.3 1064.2 9.2 5.5 5.3 3.4 372.8 310.8 1.1 478.0 12.1 4.2 431.5 4.2 6.5 112.4 0.5 296.8 202.2 175.9 2.2 4.4 455.7 487.3 98.8 3.8 2.6 343.0 0.3 2.4 574.1 558.4 6.3 0.2 524.1 0.0 0.1 20.1 14.4 0.0 0.3 0.0 0.0 0.0 1.6 0.7 0.0 122.9 28.7 0.0 0.4 0.0 34.1 0.0 6.9 4450.4 0.0 1.7 3.1 0.0 1.1 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.4 0.0 0.5 0.7 0.0 0.0 16.6 5.3 0.0 0.1 4.1 0.0 49.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 2.3 3.2 1.1 3.6 0.7 0.6 1.6 1.4 0.3 0.2 0.7 0.6 6.8 0.8 2.0 0.3 3.0 0.4 3.7 4.0 6.1 245.6 4.3 3.9 5.5 5.3 3.4 4.2 4.4 3.8 6.3 1537.0 147.4 97.0 427.4 312.4 362.4 7514.5 125.5 968.7 305.3 782.0 844.3 1010.7 81.5 109.3 126.9 379.5 43.2 148.1 634.6 41.1 86.8 81.0 534.7 488.1 1049.0 469.2 64.0 9.7 21.6 154.1 1208.6 592.8 753.4 445.4 18.1 123.5 95.2 270.4 205.3 11.4 560.1 114.0 319.0 2690.4 49.5 603.0 1715.2 839.6 398.2 126.6 768.2 15.5 17.1 207.0 39.5 668.8 160.6 1173.3 1404.1 68.4 72.9 177.2 690.2 151.2 443.4 1802.0 65.4 148.8 1105.8 336.3 104.3 1382.2 285.6 454.9 3444.4 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815283 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "testis: 63.7" "Group enriched" "Detected in many" 22 "Early spermatids: 212.5;Late spermatids: 560.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.1;EFO-21: 1.5;HEK 293: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles NA NA 53000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: AB_2681854" "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favorable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favorable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 1.0 1.4 0.2 0.0 0.3 0.1 0.9 1.6 1.1 1.5 0.1 1.5 0.1 1.8 0.0 0.6 2.4 0.0 1.3 0.8 0.2 1.2 1.2 1.4 0.0 0.2 0.3 0.0 2.2 0.9 0.0 1.7 0.0 0.4 1.1 0.0 0.1 1.0 0.0 3.9 0.9 1.5 0.0 0.2 2.5 1.3 63.7 0.4 0.0 1.5 0.1 0.0 1.6 1.1 0.6 0.1 1.1 0.1 0.4 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.4 0.4 0.1 0.0 0.1 0.3 4.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.6 1.1 0.8 0.2 0.2 0.3 0.0 0.4 0.2 0.4 0.6 4.2 0.0 1.1 2.9 3.5 0.9 1.3 0.4 2.2 2.6 1.9 2.0 4.5 0.0 0.9 0.0 8.4 0.6 1.4 1.4 0.0 0.7 212.5 2.0 0.7 2.2 1.8 3.2 0.6 0.2 0.6 1.3 0.0 1.3 0.0 0.9 1.8 1.1 1.3 3.3 0.8 1.4 0.0 4.4 2.5 560.9 5.0 2.1 5.4 2.8 4.1 3.6 1.0 0.5 2.0 0.4 1.4 2.2 1.9 0.9 0.9 0.6 2.2 2.8 0.0 0.8 2.9 17.0 8.7 1.7 0.1 0.4 3.8 0.9 1.5 0.3 LSM2 "C6orf28, G7b, YBL026W" ENSG00000204392 "LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y333 6 31797396-31806966 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052805, HPA066718" Supported Enhanced Nucleoplasm NA NA 97000 Nucleoplasm "HPA052805: , HPA066718: AB_2685710" "unprognostic (1.69e-1)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (6.14e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-3)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.59e-9)" "unprognostic (2.23e-1)" "unprognostic (8.48e-2)" "unprognostic (4.49e-2)" "unprognostic (9.59e-2)" 36.8 34.6 17.6 19.4 20.1 33.0 38.2 19.1 21.5 43.5 17.4 40.8 23.8 45.4 19.5 39.4 37.2 18.3 30.9 17.1 18.4 35.4 27.9 31.8 36.9 20.6 19.2 17.6 37.9 37.6 20.7 30.4 22.7 19.3 29.9 28.0 7.3 25.4 16.4 44.2 36.4 33.9 27.9 20.6 43.8 34.9 26.9 20.1 45.5 30.4 21.1 39.7 40.2 35.9 20.5 91.1 42.5 84.9 103.7 43.8 61.9 58.4 50.1 38.5 85.2 75.1 56.9 37.6 50.3 66.8 50.1 79.8 36.2 109.3 101.1 76.9 72.4 85.0 83.6 27.3 60.1 55.7 80.6 39.7 47.1 47.3 78.6 80.4 40.6 90.3 102.0 127.5 63.0 60.7 73.3 132.3 168.4 56.8 75.0 77.6 73.4 40.5 123.4 69.5 31.6 66.6 55.6 56.0 58.8 101.7 44.7 61.6 68.7 20.1 47.6 74.5 54.1 85.1 53.2 109.9 88.2 26.8 123.3 76.7 29.1 31.3 15.9 36.9 37.7 45.2 3.7 51.6 33.6 35.4 4.1 45.6 30.1 8.7 13.8 25.1 30.9 29.9 57.5 17.6 20.1 19.1 21.5 17.1 18.4 20.6 19.2 17.6 19.3 20.6 20.1 20.5 82.9 22.4 23.6 4.6 95.2 58.2 63.7 104.9 56.3 30.9 108.2 177.2 14.9 60.1 48.5 55.2 6.2 143.5 58.5 36.5 113.5 104.5 20.1 38.8 61.2 90.2 54.0 121.8 5.9 137.1 218.8 58.0 46.9 49.2 82.6 119.9 72.8 59.7 143.2 30.3 6.0 93.9 73.2 67.9 76.8 26.0 49.7 56.6 92.5 3.7 99.3 53.3 109.2 9.5 19.8 94.0 55.7 49.2 91.5 78.2 40.8 113.3 24.2 28.3 46.0 70.7 71.4 66.9 176.5 90.8 64.2 69.0 77.8 101.3 113.6 58.6 VARS1 "VARS, VARS2" ENSG00000204394 "Valyl-tRNA synthetase 1" P26640 6 31777518-31795752 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "U-266/84: 140.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046710 Approved Enhanced Cytosol NA NA 110000 Cytosol "HPA046710: AB_2679765" "unprognostic (1.86e-2)" "prognostic unfavorable (7.25e-4)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.86e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.20e-1)" "unprognostic (2.76e-1)" "unprognostic (4.72e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.85e-2)" "unprognostic (2.59e-1)" 21.9 24.8 1.2 6.6 1.3 3.3 22.1 0.2 1.8 19.4 0.0 20.0 5.7 29.6 0.9 32.7 22.3 1.2 18.8 1.4 0.9 18.8 29.5 20.0 3.0 1.7 1.0 0.4 19.8 37.6 2.6 33.9 2.2 1.7 17.7 1.8 1.4 20.7 1.2 58.7 33.3 22.1 3.5 0.4 30.2 23.5 64.1 2.6 3.0 18.6 3.2 2.8 23.6 20.9 5.2 36.2 11.6 12.4 36.9 9.1 8.5 84.0 52.2 10.8 25.2 13.3 11.5 9.9 58.3 60.2 18.4 18.9 22.0 33.5 32.4 8.8 46.0 74.0 31.7 18.4 21.3 18.3 75.7 60.6 12.5 8.2 14.8 16.5 6.2 13.5 22.9 92.2 48.8 12.7 13.2 51.0 16.2 35.0 11.9 32.5 55.5 20.5 132.7 13.0 12.4 42.1 26.2 12.0 31.0 19.5 5.8 23.2 34.0 31.2 24.2 37.8 28.2 72.5 87.9 140.4 44.1 14.6 31.1 29.0 0.0 0.3 0.1 0.2 0.3 0.3 0.5 0.3 0.3 0.5 0.3 0.3 0.1 0.1 0.5 0.3 0.6 0.1 0.5 1.2 1.3 0.2 1.8 1.4 0.9 1.7 1.0 0.4 1.7 0.4 2.6 5.2 4.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 23.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 48.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 16.6 0.4 0.0 0.0 0.0 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777328 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 21.5" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6" "Group enriched" "Detected in some" 5 "cerebellum: 7.0;pons and medulla: 3.9" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 9200 "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 0.2 0.3 1.1 0.1 0.2 0.0 0.7 0.1 2.5 0.6 0.0 1.1 1.1 4.6 0.0 0.4 7.3 0.7 4.2 0.6 5.9 5.7 1.4 1.4 0.1 4.8 1.1 0.4 0.5 2.6 1.7 21.5 0.0 4.9 0.8 0.4 0.2 1.5 1.3 6.6 0.7 2.3 0.0 0.0 0.5 3.0 0.7 4.7 0.0 1.8 0.0 0.1 0.6 0.7 6.0 0.8 1.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.7 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 0.1 2.5 0.6 5.9 4.8 1.1 0.4 4.9 0.0 4.7 6.0 0.0 0.0 1.1 0.0 0.6 0.1 0.4 0.5 1.2 0.5 0.1 0.3 0.8 0.0 0.3 1.8 0.0 0.0 0.2 1.4 1.9 0.6 0.0 1.5 0.1 0.1 4.2 0.0 1.5 0.5 0.0 0.1 8.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.4 0.3 5.0 2.4 1.6 0.8 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.4 0.0 0.5 0.4 MBD5 "FLJ11113, KIAA1461" ENSG00000204406 "Methyl-CpG binding domain protein 5" Q9P267 2 148021011-148516971 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 317.4;Excitatory neurons: 510.1;Inhibitory neurons: 456.0;Microglial cells: 288.6;Oligodendrocyte precursor cells: 604.2;Oligodendrocytes: 438.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035964 Supported Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA035964: AB_2674891" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.72e-4)" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.65e-1)" "unprognostic (9.86e-2)" "unprognostic (7.72e-2)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" "unprognostic (2.39e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (6.59e-2)" "unprognostic (1.82e-1)" 2.4 3.2 3.4 2.2 4.8 2.0 2.4 7.9 4.9 3.1 1.2 4.1 1.8 3.2 1.6 2.6 2.3 3.2 2.8 4.2 3.5 3.4 2.0 2.3 2.4 2.7 3.1 3.9 3.8 1.7 4.1 3.9 3.1 3.6 3.0 1.9 5.8 1.9 2.5 2.8 1.9 2.3 2.7 1.9 2.6 2.7 3.1 3.2 4.3 3.4 3.0 2.2 3.8 2.2 4.6 1.1 1.1 4.4 4.1 3.5 3.6 2.9 4.0 3.9 3.1 2.3 2.8 2.9 1.9 0.9 3.4 1.7 0.8 3.1 5.1 4.1 1.6 1.6 3.5 2.8 1.5 2.0 0.6 0.6 2.9 4.1 4.5 3.3 5.0 4.1 2.7 1.9 3.6 4.8 2.7 1.5 2.7 2.2 2.5 1.7 1.6 1.2 0.8 3.2 3.8 2.9 3.5 3.2 1.6 3.0 3.2 2.3 3.4 2.8 3.7 1.8 0.6 1.9 2.4 1.1 1.5 4.8 1.6 3.6 0.8 0.1 0.5 0.3 0.1 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.4 0.2 0.2 0.3 0.3 0.1 0.1 3.4 4.8 7.9 4.9 4.2 3.5 2.7 3.1 3.9 3.6 1.9 3.2 4.6 27.3 16.0 13.7 317.4 23.4 3.8 11.9 4.1 10.8 24.7 16.5 15.0 10.5 11.5 14.8 12.9 37.5 7.3 23.8 5.0 3.9 18.6 94.5 14.8 25.8 15.2 11.5 36.6 510.1 15.7 9.8 15.5 12.2 18.0 3.8 35.9 15.0 8.4 7.0 13.5 456.0 4.9 6.1 16.9 3.3 37.6 18.0 15.1 0.0 288.6 13.6 8.1 24.7 604.2 438.3 20.4 4.6 10.5 22.8 7.8 9.4 14.0 8.5 17.4 6.6 16.5 16.8 15.7 9.4 10.4 3.3 8.5 27.7 23.7 5.8 12.6 MSH5 G7 ENSG00000204410 "MutS homolog 5" O43196 6 31739677-31762676 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" DNA-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 3.1;NB-4: 5.2" HPA062688 Approved "Endoplasmic reticulum,Vesicles" NA NA Vesicles "Endoplasmic reticulum" "HPA062688: AB_2684835" "unprognostic (3.21e-3)" "unprognostic (2.32e-2)" "unprognostic (2.05e-1)" "unprognostic (4.37e-2)" "unprognostic (4.51e-1)" "unprognostic (9.20e-4)" "unprognostic (7.67e-3)" "unprognostic (2.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.05e-3)" "unprognostic (4.59e-3)" "unprognostic (2.28e-2)" "unprognostic (5.19e-5)" "unprognostic (3.75e-2)" "unprognostic (8.83e-2)" "unprognostic (9.21e-2)" "unprognostic (9.34e-4)" 1.3 1.3 0.1 0.5 0.1 0.7 1.5 0.1 0.4 1.7 0.1 1.4 0.0 1.4 0.0 2.2 1.9 0.0 1.0 0.1 0.1 5.6 2.0 1.4 0.6 0.1 0.2 0.1 2.3 1.6 0.0 2.2 0.0 0.2 3.0 0.0 0.1 1.7 0.0 0.6 1.8 1.8 0.0 0.1 2.5 1.6 14.1 0.1 0.0 1.5 0.0 0.0 1.6 1.7 0.2 0.3 1.1 0.4 0.9 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.1 1.0 3.1 0.4 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.7 1.1 0.1 0.6 0.0 0.3 1.3 0.0 0.0 0.1 0.3 0.5 0.9 1.2 1.9 1.6 0.0 2.1 0.5 5.2 0.9 0.9 0.0 2.1 0.1 2.4 0.3 0.5 0.2 0.8 0.3 0.2 0.0 0.0 0.3 1.8 0.0 0.3 1.6 0.1 0.6 0.3 2.1 1.7 0.0 0.5 0.8 2.5 0.4 0.0 0.4 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.1 0.1 0.6 0.1 0.6 0.8 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.4 0.0 2.3 0.0 3.6 0.5 0.5 0.3 3.4 0.7 0.5 0.5 0.3 2.8 0.8 3.7 18.8 0.6 0.5 1.0 0.0 0.2 0.1 1.6 1.3 0.6 1.2 8.0 0.0 0.2 0.4 0.9 10.7 2.8 3.8 3.1 0.4 0.3 0.5 0.0 0.0 1.2 0.0 0.8 1.3 0.5 1.2 1.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.5 0.7 10.7 0.5 2.0 0.8 0.9 7.3 0.0 1.0 1.4 10.9 8.3 6.2 0.4 0.5 2.5 0.9 1.9 0.4 CSHL1 "CS-5, CSHP1, CSL, hCS-L, MGC149868" ENSG00000204414 "Chorionic somatomammotropin hormone like 1" Q14406 17 63909597-63918838 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "placenta: 151.3" "Cell type enriched" "Detected in some" 12 "Syncytiotrophoblasts: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025646, HPA043715" Enhanced "Secreted to blood" NA NA "CAB025646: , HPA043715: AB_2678632" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 151.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 21.6 0.0 0.0 0.0 0.0 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 3.6;lymphoid tissue: 4.8;skin 1: 8.2" "Cell type enriched" "Detected in single" 14 "granulocytes: 10.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 14 "HEL: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 330000 "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.5 0.0 0.0 0.1 0.0 1.2 0.4 0.1 0.2 0.7 0.1 0.3 0.1 0.4 0.0 1.6 0.5 0.2 0.7 0.0 0.1 0.1 0.3 3.6 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.2 8.2 0.4 0.0 0.0 4.8 0.3 2.3 0.1 0.0 0.5 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.8 0.0 2.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 LY6G6C "C6orf24, G6c, NG24" ENSG00000204421 "Lymphocyte antigen 6 family member G6C" O95867 6 31718648-31721746 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 512.2" "Cell type enhanced" "Detected in some" "Early spermatids: 11.3;Late spermatids: 13.1;Suprabasal keratinocytes: 64.2;Syncytiotrophoblasts: 20.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 20.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;CACO-2: 1.0;HaCaT: 2.0;MCF7: 3.2;OE19: 1.5;SuSa: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-1)" "unprognostic (3.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.85e-3)" "unprognostic (2.59e-3)" "unprognostic (1.35e-1)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (4.13e-1)" "unprognostic (1.76e-3)" "unprognostic (2.85e-1)" "unprognostic (8.80e-7)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (6.09e-2)" "unprognostic (9.38e-2)" 0.9 0.1 0.1 0.2 0.3 0.0 16.0 0.1 0.4 6.5 0.1 0.3 0.0 0.4 0.2 48.1 1.5 0.0 0.5 0.2 0.1 0.2 0.4 0.7 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.3 7.7 0.1 0.5 0.1 0.1 12.1 0.0 1.6 512.2 0.2 0.1 0.1 0.6 0.5 1.9 0.1 1.2 0.6 0.0 12.2 0.3 31.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.1 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.6 0.0 0.0 0.3 0.1 4.7 0.7 0.5 0.6 0.0 3.5 2.0 0.1 0.0 0.1 0.0 0.0 7.5 0.0 2.3 0.0 0.1 11.3 1.3 1.3 0.6 0.0 0.0 0.0 0.0 1.2 0.7 0.0 3.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 2.0 0.0 0.0 0.7 13.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 2.1 0.2 0.0 0.9 0.0 0.0 0.4 0.5 0.0 0.1 6.1 64.2 20.4 0.2 0.1 2.0 3.2 LY6G6F "C6orf21, G6f, LY6G6D, NG32" ENSG00000204424 "Lymphocyte antigen 6 family member G6F" Q5SQ64 6 31706866-31710679 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;lymphoid tissue: 1.2;skin 1: 1.3" "Cell type enriched" "Detected in some" 9 "Macrophages: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enriched" "Detected in single" 379 "HEL: 37.8" "Low region specificity" "Detected in many" HPA008053 Uncertain NA NA 380000 "HPA008053: AB_1840160" "unprognostic (3.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.66e-3)" 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 0.0 0.0 0.5 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 9.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ABHD16A "BAT5, D6S82E, NG26" ENSG00000204427 "Abhydrolase domain containing 16A, phospholipase" O95870 6 31686955-31703356 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 41.2;OE19: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058606 Approved NA NA 37000 "HPA058606: AB_2683774" "unprognostic (1.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.26e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (3.14e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (6.17e-3)" "unprognostic (1.97e-3)" "unprognostic (6.02e-2)" "unprognostic (1.30e-2)" "unprognostic (9.35e-2)" "unprognostic (1.81e-1)" "unprognostic (5.11e-3)" "unprognostic (1.60e-3)" 14.0 22.3 1.0 11.8 3.5 6.8 13.4 1.2 3.9 19.5 0.9 21.1 0.0 21.7 19.2 21.3 19.0 10.0 17.0 1.1 1.3 17.0 30.2 16.1 13.1 1.6 3.8 1.4 15.2 18.8 5.9 40.3 7.9 3.7 19.8 7.3 6.7 17.6 4.3 35.3 12.9 17.7 0.0 5.1 18.7 21.7 31.8 1.6 4.6 21.5 0.0 0.0 20.8 15.1 1.6 0.0 15.7 0.0 41.2 29.0 11.7 0.0 14.5 16.2 16.5 15.6 0.0 26.1 16.5 33.7 21.2 0.0 0.0 0.0 19.7 9.0 16.0 12.7 0.0 0.0 0.0 34.7 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.3 0.0 0.0 0.0 0.5 0.0 42.4 0.0 0.7 0.0 29.3 21.0 0.0 0.2 20.0 0.9 0.5 0.4 0.0 0.0 0.0 14.9 19.6 14.5 0.0 0.0 10.5 21.1 8.5 13.6 0.1 16.1 2.5 6.8 8.4 4.1 8.9 1.9 2.8 1.2 4.2 6.2 2.8 3.5 2.7 13.3 5.9 0.5 4.1 4.1 6.3 1.0 3.5 1.2 3.9 1.1 1.3 1.6 3.8 1.4 3.7 5.1 1.6 1.6 1.2 0.0 8.2 11.4 10.7 0.4 0.3 1.7 15.4 1.2 1.5 1.0 0.5 0.0 1.6 0.0 0.0 3.9 2.2 12.0 3.9 18.3 1.3 1.4 1.7 2.7 12.5 14.9 13.4 13.3 1.5 5.3 12.2 1.2 1.3 0.5 0.7 0.8 3.3 0.0 14.6 9.7 2.0 2.2 2.1 0.4 0.9 8.8 3.6 13.1 8.1 1.0 5.2 15.6 21.1 12.7 16.0 0.4 16.4 0.4 16.5 0.7 1.7 1.4 0.0 0.7 4.9 2.5 1.6 16.8 1.0 5.3 7.6 0.2 12.1 0.3 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 1.7" "Cell type enhanced" "Detected in many" "Early spermatids: 21.4;Respiratory ciliated cells: 16.1;Spermatocytes: 15.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.2 0.2 0.0 0.6 0.4 0.3 0.2 0.2 1.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.5 0.5 0.3 0.0 0.1 0.3 0.3 0.5 0.3 0.1 0.1 0.0 0.2 0.6 0.0 0.9 0.1 0.3 0.4 0.0 0.6 0.2 0.0 0.8 0.1 0.3 0.0 0.1 0.6 0.3 1.7 0.1 0.1 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.8 0.4 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.5 0.0 0.1 0.1 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 7.8 3.2 1.5 0.3 1.4 1.7 1.8 2.0 0.0 2.8 7.7 8.0 1.2 1.5 2.1 1.8 2.1 0.5 4.2 3.8 3.9 2.1 21.4 6.9 1.4 5.6 3.5 3.0 0.8 4.9 0.2 1.6 3.1 1.8 5.1 1.4 10.4 2.2 6.2 0.0 1.2 2.0 8.2 5.5 3.1 7.5 1.2 11.6 1.8 0.0 3.7 6.0 2.1 1.0 0.6 3.4 3.1 1.5 3.2 2.1 3.0 4.6 16.1 1.1 0.0 2.6 1.7 15.9 13.9 2.0 0.9 0.3 5.2 1.3 3.1 1.9 CSNK2B "Ckb1, Ckb2" ENSG00000204435 "Casein kinase 2 beta" P67870 6 31665227-31670343 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004349, HPA005944, CAB013087, CAB016059" Approved NA NA 83000 "CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290" "unprognostic (1.61e-1)" "unprognostic (3.21e-2)" "unprognostic (8.88e-2)" "unprognostic (1.55e-3)" "unprognostic (9.51e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-3)" "unprognostic (1.60e-1)" "unprognostic (7.52e-2)" "unprognostic (1.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (5.88e-2)" "unprognostic (1.72e-1)" "unprognostic (9.67e-2)" "unprognostic (3.72e-2)" 154.0 158.7 17.6 32.2 32.3 62.7 151.4 18.9 54.7 144.3 18.1 141.4 28.1 127.7 185.3 168.0 131.2 33.4 170.4 17.1 33.5 173.1 165.0 134.2 73.1 18.1 18.6 15.8 162.5 143.5 70.0 131.0 68.8 45.3 121.3 50.9 41.8 132.9 58.1 233.9 284.6 127.6 66.8 31.8 147.1 147.9 259.9 55.7 57.0 133.4 95.7 30.3 127.2 141.0 84.0 0.9 95.5 2.5 164.9 97.4 158.0 120.8 200.9 350.2 407.6 377.9 0.2 129.3 302.5 127.9 196.8 146.0 0.1 1.0 374.5 409.4 153.1 322.6 4.3 0.6 1.1 260.0 341.5 0.9 257.8 1.5 0.8 0.2 0.2 4.7 208.3 1.7 1.7 0.8 2.9 237.1 2.2 102.0 240.0 0.0 221.1 2.3 247.7 222.3 136.5 1.2 243.0 1.8 0.9 175.8 101.0 7.4 1.3 118.8 210.3 203.9 198.0 1.3 167.3 285.9 267.6 122.3 1.6 196.1 87.3 114.8 121.8 80.1 125.9 80.5 113.7 81.7 85.1 111.0 99.1 71.4 61.9 95.2 90.8 83.2 131.7 113.4 95.0 17.6 32.3 18.9 54.7 17.1 33.5 18.1 18.6 15.8 45.3 31.8 55.7 84.0 114.3 51.3 67.0 11.1 124.4 186.1 125.1 196.1 138.9 56.8 135.5 196.3 91.3 105.8 116.5 101.2 12.5 211.8 106.4 185.6 270.1 184.7 452.7 75.1 71.7 122.7 125.7 103.5 14.1 175.2 252.7 118.3 93.3 68.2 129.5 102.3 125.7 126.6 296.2 48.8 14.3 175.4 138.4 204.4 218.5 270.7 153.7 146.2 152.9 8.4 181.1 168.3 121.5 14.6 19.1 182.9 248.1 125.3 152.1 154.3 283.1 397.5 91.3 47.8 138.1 107.9 152.2 485.6 186.5 142.7 186.3 282.1 111.5 116.8 184.3 150.6 GPANK1 "ANKRD59, BAT4, D6S54E, G5, GPATCH10" ENSG00000204438 "G-patch domain and ankyrin repeats 1" O95872 6 31661228-31666283 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 180.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006301 Approved Approved "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "HPA006301: AB_1078267" "unprognostic (2.03e-1)" "unprognostic (2.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (4.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-2)" "unprognostic (5.72e-2)" "unprognostic (1.10e-1)" "unprognostic (8.81e-2)" "prognostic favorable (5.89e-4)" "unprognostic (2.29e-1)" "unprognostic (2.46e-2)" "unprognostic (2.00e-1)" "unprognostic (1.86e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-1)" 13.8 11.9 1.5 2.7 1.7 4.0 14.8 3.6 2.6 14.9 1.2 14.8 1.6 16.1 2.6 11.5 15.1 2.1 19.4 1.5 1.4 14.6 16.1 13.3 3.8 2.4 2.5 1.4 17.4 15.2 3.3 13.6 1.8 2.8 14.1 2.4 2.4 13.9 2.0 28.7 15.6 15.7 1.1 1.4 16.8 15.6 36.7 1.6 6.7 12.9 2.8 2.3 15.1 13.4 2.3 3.3 3.3 1.7 5.6 8.3 6.6 4.4 3.2 5.2 3.1 4.2 0.2 4.8 10.8 5.2 3.4 4.2 3.9 0.0 8.1 2.3 6.4 5.6 11.3 0.0 3.7 5.7 3.7 4.3 3.2 4.3 10.4 6.9 6.1 3.8 10.9 3.0 8.8 4.2 2.6 13.1 4.4 0.0 5.1 1.2 5.4 7.5 7.9 5.1 2.6 12.6 8.4 4.3 1.9 5.4 4.6 5.1 9.2 4.8 7.3 7.0 0.5 0.0 6.5 10.8 4.1 8.6 7.9 4.2 11.8 3.1 9.9 4.1 2.5 4.1 2.0 3.2 2.5 3.1 2.9 3.7 3.3 9.5 4.5 2.6 3.8 4.6 2.7 1.5 1.7 3.6 2.6 1.5 1.4 2.4 2.5 1.4 2.8 1.4 1.6 2.3 22.6 38.5 21.7 5.9 30.5 25.0 24.2 27.6 23.3 29.1 25.0 23.4 35.9 30.0 21.6 18.4 35.5 30.1 28.3 26.4 45.0 31.6 55.4 21.9 21.4 29.1 27.1 33.0 3.2 23.6 39.7 23.8 13.3 22.9 35.4 21.9 27.8 30.3 27.7 11.8 3.5 29.9 22.4 27.0 18.5 51.5 34.5 21.0 19.6 3.7 43.5 37.8 47.4 5.0 7.3 21.9 43.3 24.8 29.2 32.3 90.5 74.5 20.1 47.3 19.7 21.6 29.7 180.8 87.2 16.2 34.2 47.1 26.9 17.3 26.9 19.9 C6orf47 "D6S53E, G4" ENSG00000204439 "Chromosome 6 open reading frame 47" O95873 6 31658298-31660778 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5;HBEC3-KT: 7.6;HDLM-2: 4.7;HEK 293: 6.1;U-2 OS: 5.5;U-266/84: 5.5" "Low region specificity" "Detected in all" HPA045281 Uncertain Approved Cytosol NA NA Cytosol "HPA045281: AB_10961000" "unprognostic (5.99e-2)" "unprognostic (5.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.09e-1)" "unprognostic (3.24e-2)" "unprognostic (3.27e-1)" "unprognostic (5.04e-2)" "unprognostic (2.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.66e-3)" "unprognostic (6.78e-3)" "unprognostic (2.38e-1)" "unprognostic (7.73e-2)" "unprognostic (3.59e-3)" 11.2 13.0 0.2 0.4 0.5 0.2 10.8 1.0 0.8 11.8 0.0 17.8 0.0 15.2 3.2 21.6 12.2 1.0 15.2 0.3 0.3 12.7 11.0 12.1 1.5 0.5 1.0 0.3 11.3 13.2 0.6 11.7 0.8 0.7 12.5 1.0 0.6 13.6 0.0 19.0 18.0 17.8 0.0 0.8 18.2 15.6 4.8 0.4 0.7 11.6 0.0 0.0 16.8 13.2 0.4 0.1 4.5 0.0 0.3 3.2 0.1 0.5 0.0 0.0 0.1 0.0 0.3 0.6 3.0 2.4 3.8 0.0 0.0 0.0 7.6 0.0 4.7 6.1 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.3 0.0 1.2 3.8 0.9 2.6 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.4 5.5 0.0 0.2 3.7 5.5 0.9 1.9 0.0 0.2 0.6 1.5 2.8 2.6 1.0 1.3 1.9 0.7 1.6 1.0 1.4 2.0 0.8 1.8 0.7 0.9 0.6 1.4 1.9 0.2 0.5 1.0 0.8 0.3 0.3 0.5 1.0 0.3 0.7 0.8 0.4 0.4 8.7 6.4 10.9 0.0 16.6 25.1 29.1 14.6 18.2 16.0 12.2 6.5 1.5 25.8 11.5 12.9 8.4 20.0 17.7 42.2 25.4 24.2 0.0 4.3 7.8 10.9 6.7 6.1 0.0 28.9 15.1 11.2 11.7 6.1 11.4 12.8 15.4 8.5 18.2 6.7 0.0 21.6 4.1 17.4 18.7 0.0 16.1 17.1 8.8 0.0 19.4 12.5 32.0 0.0 0.0 29.9 29.0 21.8 5.1 25.6 40.9 18.1 5.0 13.5 32.9 13.0 14.2 1.0 5.5 20.9 26.9 23.8 16.1 15.8 26.2 47.0 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107867496 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;pituitary gland: 5.5" "Group enriched" "Detected in many" 6 "Astrocytes: 918.7;Excitatory neurons: 3051.8;Inhibitory neurons: 2146.4;Oligodendrocyte precursor cells: 2307.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.3;RPTEC TERT1: 11.4;SCLC-21H: 7.2;SH-SY5Y: 16.6;U-87 MG: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039453 Enhanced NA NA "HPA039453: AB_10795290" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.3 1.1 7.3 0.1 8.7 0.0 0.2 6.0 10.8 0.5 1.6 0.2 0.1 0.6 1.7 0.2 0.2 0.4 0.2 9.3 9.2 0.1 0.0 0.4 0.1 6.0 6.7 7.9 0.2 0.1 0.0 5.5 0.4 7.2 1.1 0.2 2.0 0.0 1.6 0.0 0.0 0.2 0.4 4.6 0.1 0.2 1.0 7.7 0.0 0.4 0.0 0.3 0.5 0.3 8.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.6 0.0 2.4 0.0 5.3 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 4.5 0.0 0.0 0.2 0.0 11.4 1.9 7.2 16.6 0.0 0.0 0.0 0.2 4.2 0.0 0.2 5.0 2.1 1.7 0.2 0.0 0.0 0.0 10.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 8.7 6.0 10.8 9.3 9.2 6.0 6.7 7.9 7.2 4.6 7.7 8.4 2.8 3.2 24.6 918.7 0.0 0.1 0.3 0.0 0.0 19.7 0.9 0.3 0.8 0.0 1.9 3.7 0.0 0.0 0.0 0.0 0.0 1.3 62.3 8.9 39.5 4.4 0.0 0.0 3051.8 0.0 0.1 3.7 0.0 20.7 0.0 0.5 8.2 0.0 0.2 37.0 2146.4 0.0 0.0 0.0 0.4 22.7 1.8 0.2 0.0 306.3 0.0 6.8 0.0 2307.6 37.2 0.5 0.0 1.2 0.0 0.9 0.0 0.1 0.0 1.6 6.6 0.3 1.5 1.1 2.0 0.1 0.0 0.0 0.4 1.0 0.0 0.3 APOM "G3a, NG20" ENSG00000204444 "Apolipoprotein M" O95445 6 31652416-31658210 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 393.9" "Group enriched" "Detected in many" 8 "Hepatocytes: 665.9;Proximal tubular cells: 681.1" "Cancer enriched" "Detected in all" 13 "liver cancer: 185.9" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 12 "Hep G2: 38.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034086, HPA051006" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 7400000000 8200000000 "Golgi apparatus" "CAB034086: AB_1119033, HPA051006: AB_2681307" "unprognostic (2.76e-3)" "unprognostic (1.69e-2)" "unprognostic (8.66e-2)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (3.78e-1)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (6.04e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (7.28e-2)" "unprognostic (5.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-1)" "unprognostic (3.20e-2)" 4.4 5.3 0.5 0.1 0.6 2.5 5.3 1.0 0.9 3.6 0.5 3.7 0.6 4.0 1.0 4.1 4.2 0.5 3.3 0.6 1.0 91.5 393.9 2.6 0.6 0.7 0.6 0.5 6.2 6.1 0.7 4.7 0.1 0.7 3.9 0.4 0.4 3.6 0.5 7.2 6.3 9.0 0.5 0.7 4.2 5.3 16.1 0.6 1.2 5.5 0.7 1.1 3.4 3.3 0.8 0.5 0.3 0.6 0.7 0.6 0.8 0.0 0.4 1.1 0.4 0.9 3.2 1.0 1.4 0.2 1.1 0.2 0.6 0.4 0.6 0.8 0.8 0.7 0.8 0.3 38.2 1.3 1.7 0.1 1.2 0.4 0.3 1.0 0.5 0.3 0.9 1.2 0.4 1.1 1.1 1.1 0.9 0.5 0.6 0.2 0.8 0.4 1.5 1.1 0.6 0.5 0.2 0.4 0.0 0.5 0.2 1.5 1.2 0.4 0.2 0.1 0.3 0.3 1.1 1.2 1.5 0.2 1.8 0.1 3.0 0.6 0.6 0.3 0.3 0.5 1.1 0.4 0.3 0.5 0.5 0.5 0.6 0.4 0.3 0.7 0.3 0.7 0.3 0.5 0.6 1.0 0.9 0.6 1.0 0.7 0.6 0.5 0.7 0.7 0.6 0.8 1.5 0.0 7.4 2.3 9.0 6.4 6.7 6.7 9.1 1.5 6.6 12.4 1.6 12.8 3.0 14.7 4.2 2.0 1.6 4.1 76.3 4.3 60.2 5.2 3.1 2.0 4.2 11.4 0.3 6.9 0.9 4.3 5.1 1.6 5.1 1.8 8.9 665.9 5.4 0.0 0.4 4.9 2.0 14.5 4.2 38.4 9.3 6.1 5.4 0.0 2.5 14.6 1.0 0.5 1.3 6.4 4.9 6.4 7.4 4.2 81.4 681.1 4.6 2.5 0.0 6.2 3.1 33.1 6.6 5.3 6.5 1.2 5.6 4.6 6.5 6.1 TRIM49C TRIM49L2 ENSG00000204449 "Tripartite motif containing 49C" P0CI26 11 90031106-90042025 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64 "C11orf28, TRIM64A" ENSG00000204450 "Tripartite motif containing 64" A6NGJ6 11 89968502-89974072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 266 "basophil: 26.5" "Lineage enriched" "Detected in single" 266 "granulocytes: 26.5" "Not detected" "Not detected" HPA045370 Approved NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BAG6 "BAT3, D6S52E, G3, Scythe" ENSG00000204463 "BAG cochaperone 6" P46379 6 31639028-31652705 "Predicted intracellular proteins" "Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 261.8;Late spermatids: 483.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020704, HPA045116, HPA053291" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 26000 "Nucleoplasm, Cytosol" "CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103" "unprognostic (7.32e-2)" "unprognostic (2.96e-2)" "unprognostic (3.43e-1)" "unprognostic (7.67e-3)" "unprognostic (2.61e-1)" "unprognostic (6.00e-2)" "unprognostic (1.07e-3)" "unprognostic (2.14e-1)" "unprognostic (4.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.88e-2)" "unprognostic (9.98e-2)" "unprognostic (1.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.82e-2)" "unprognostic (6.05e-2)" "unprognostic (8.16e-2)" 67.8 77.9 9.7 18.2 12.2 24.3 68.3 11.4 14.5 68.0 20.6 68.9 38.4 72.8 26.6 74.2 67.6 15.4 89.0 10.6 10.9 58.4 66.0 71.9 24.8 18.6 10.9 8.8 76.7 64.7 24.1 65.9 22.0 19.6 62.7 25.0 16.1 71.3 12.4 206.3 82.7 77.0 17.5 9.2 77.0 65.9 137.9 11.9 23.3 75.3 52.2 28.2 70.4 65.2 17.5 28.3 47.3 63.7 63.0 28.7 47.8 49.0 33.1 34.1 49.1 42.5 121.2 26.5 44.0 98.2 101.2 72.1 22.3 17.3 110.7 19.1 45.4 139.8 62.2 18.8 77.5 42.5 47.4 125.6 37.2 52.8 27.0 24.0 52.9 47.9 76.3 85.7 46.1 82.6 34.4 25.4 46.7 20.1 16.7 23.8 37.0 26.3 52.1 38.3 31.2 29.4 41.6 22.7 27.3 42.0 16.8 112.6 91.2 31.8 57.8 40.0 28.2 53.6 59.9 87.0 88.4 56.0 45.8 40.2 3.3 2.5 2.8 2.2 3.0 1.7 1.4 1.0 1.1 2.2 1.3 1.2 1.4 1.5 1.6 3.4 1.6 0.9 1.9 9.7 12.2 11.4 14.5 10.6 10.9 18.6 10.9 8.8 19.6 9.2 11.9 17.5 39.0 48.1 39.9 11.1 39.0 32.1 39.0 44.5 23.3 28.4 34.5 30.2 77.7 42.9 51.3 36.8 18.8 62.2 33.0 82.4 31.3 66.0 261.8 39.1 22.4 40.8 76.7 52.2 7.6 50.0 67.1 38.4 40.8 34.1 48.2 41.4 38.6 45.4 55.9 50.5 8.6 56.4 61.1 39.9 29.9 483.4 33.2 40.5 28.4 12.2 38.5 34.0 44.3 5.0 10.8 64.0 63.4 39.5 51.6 35.0 105.6 47.9 54.6 48.3 39.5 35.4 65.8 115.0 87.9 33.3 35.5 119.4 34.8 31.7 68.8 40.1 PRRC2A "BAT2, D6S51E, G2" ENSG00000204469 "Proline rich coiled-coil 2A" P48634 6 31620715-31637771 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026383, HPA046791, HPA066501" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 5600 Cytosol "Nucleoplasm, Plasma membrane" "CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747" "unprognostic (2.07e-1)" "unprognostic (6.84e-2)" "unprognostic (3.82e-1)" "unprognostic (2.25e-3)" "unprognostic (5.04e-2)" "unprognostic (4.63e-1)" "unprognostic (2.42e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-3)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.57e-1)" "unprognostic (5.40e-2)" "unprognostic (3.10e-1)" 35.7 36.8 0.2 6.9 0.2 0.1 36.6 0.2 0.5 47.9 0.1 43.0 0.5 54.2 12.3 42.3 47.8 0.0 41.1 0.6 0.2 35.1 23.2 36.7 3.4 0.6 1.1 0.1 56.2 35.4 0.0 50.7 0.8 0.3 47.9 0.6 2.9 32.0 0.3 55.3 37.6 37.6 0.1 0.3 42.1 37.4 84.9 0.3 4.4 42.2 0.0 0.0 44.5 40.6 0.3 4.4 19.3 0.2 0.7 35.5 33.6 3.3 2.0 0.0 0.0 0.2 0.9 0.2 4.2 24.5 41.8 0.0 1.8 0.0 81.9 0.0 8.1 148.3 4.6 0.2 0.3 0.1 2.0 1.4 14.9 0.0 0.2 0.0 0.0 0.0 30.7 2.0 0.0 0.2 0.7 0.9 0.2 0.4 0.1 1.7 2.2 0.6 0.9 6.9 0.5 2.6 1.3 1.5 0.1 0.7 0.0 0.3 1.5 0.7 0.5 17.6 1.3 0.9 75.3 86.8 78.7 25.7 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.6 0.2 0.6 1.1 0.1 0.3 0.3 0.3 0.3 39.3 0.0 5.5 25.5 39.2 32.9 28.4 26.1 67.7 36.1 41.6 39.0 6.7 18.6 14.5 40.5 60.5 26.9 38.0 48.4 5.9 24.8 58.7 33.3 37.1 33.4 38.9 47.9 19.2 25.6 22.2 32.9 52.0 35.9 10.8 55.5 33.5 22.5 34.6 37.0 19.7 39.1 26.4 28.2 30.9 23.7 49.0 31.4 19.6 15.9 28.7 20.9 39.1 23.1 15.3 34.5 37.8 44.8 47.2 39.1 27.0 16.0 20.1 35.9 19.7 57.0 44.8 58.0 43.2 64.1 28.4 18.3 38.2 45.3 48.0 28.4 AIF1 "AIF-1, Em:AF129756.17, IBA1, IRT-1" ENSG00000204472 "Allograft inflammatory factor 1" P55008 6 31615217-31617021 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 237.0;lymphoid tissue: 349.4" "Group enriched" "Detected in many" 22 "Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 26 "classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5" "Group enriched" "Detected in all" 74 "dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5" "Group enriched" "Detected in some" 4 "HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049234, HPA062949" Enhanced Uncertain Cytosol NA NA Cytosol "HPA049234: AB_2680685, HPA062949: AB_2732694" "unprognostic (3.20e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-2)" "unprognostic (2.33e-2)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (6.98e-2)" "unprognostic (4.83e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.29e-1)" "unprognostic (1.02e-2)" "unprognostic (9.59e-2)" "unprognostic (4.89e-2)" 80.3 47.0 23.3 183.9 27.4 237.0 47.6 25.8 33.3 29.6 42.1 48.8 36.8 17.3 12.2 18.9 19.9 61.8 19.3 23.4 44.5 73.7 81.8 100.2 117.8 43.1 28.4 21.4 14.5 12.5 13.0 17.5 110.4 33.5 22.5 57.8 3.9 20.5 24.2 6.1 11.5 44.9 75.4 31.9 349.4 22.4 8.8 31.6 69.8 14.0 16.7 57.6 96.2 13.6 42.6 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 204.6 0.0 0.0 0.0 30.0 329.6 0.0 0.0 0.0 0.0 0.0 0.0 51.6 0.9 0.2 0.0 0.0 2.3 264.7 0.4 0.0 0.0 35.9 0.4 8.9 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 184.2 0.1 0.0 0.2 0.1 0.3 0.2 0.0 1.3 0.2 114.6 0.0 33.1 3823.3 177.9 10.2 6550.1 12.7 57.5 10.8 9.3 2043.3 6.3 33.1 26.2 2943.0 14.5 7744.5 144.2 10.7 4449.8 23.3 27.4 25.8 33.3 23.4 44.5 43.1 28.4 21.4 33.5 31.9 31.6 42.6 12.0 25.6 59.6 0.0 39.2 32.5 0.7 0.0 0.6 0.1 5.3 24.3 7.5 18.6 19.2 42.3 0.0 11.1 31.2 1.0 0.0 0.3 1.9 0.6 0.7 28.7 1.2 65.0 0.0 0.4 15.4 20.6 0.5 0.4 68.3 0.4 35.3 13.4 1777.1 0.0 0.0 0.1 0.0 2140.2 1359.1 4.9 7.5 1494.0 39.2 10.3 1022.6 0.0 32.0 0.5 0.1 0.2 11.1 0.7 7.2 0.4 0.3 4.2 10.2 0.1 52.6 4.7 6.5 0.5 1.5 2.1 28.3 22.7 46.1 1.9 0.6 0.3 NCR3 "1C7, CD337, LY117, NKp30" ENSG00000204475 "Natural cytotoxicity triggering receptor 3" O14931 6 31588895-31593006 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 4.1;intestine: 5.7;lymphoid tissue: 16.3" "Group enriched" "Detected in some" 10 "B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5" "Cancer enhanced" "Detected in many" "testis cancer: 2.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 274.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7" "Low region specificity" "Detected in many" NA NA "unprognostic (3.99e-3)" "unprognostic (9.23e-4)" "unprognostic (1.23e-3)" "unprognostic (2.49e-4)" "unprognostic (2.15e-1)" "unprognostic (2.57e-4)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-1)" "unprognostic (1.81e-1)" "unprognostic (2.21e-4)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (8.17e-2)" "unprognostic (1.43e-1)" 0.4 0.0 0.0 2.9 0.0 4.1 0.2 0.0 0.1 0.1 0.0 0.3 0.3 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 1.1 1.9 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.1 5.7 0.0 0.0 16.3 0.4 0.7 0.1 2.0 0.3 0.0 5.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.2 0.5 0.0 98.8 0.1 274.3 65.2 12.1 53.9 0.3 51.8 5.7 30.1 0.9 76.6 0.6 0.6 20.3 31.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 1.9 0.0 43.6 3.4 0.0 0.0 0.6 0.0 0.3 0.4 0.1 0.0 1.3 0.0 0.0 0.1 110.4 0.1 0.0 0.0 0.5 0.1 0.2 0.5 0.0 2.7 0.0 0.0 0.2 0.3 0.5 0.1 8.9 0.0 1.4 0.4 0.4 0.0 0.0 0.0 0.0 2.5 2.9 0.2 0.3 1.2 3.6 0.0 1.6 0.0 166.9 0.0 0.1 0.0 0.1 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.1 1.7 0.1 55.5 0.0 0.1 0.0 PRAMEF20 "OTTHUMT00000008157, PRAMEF21" ENSG00000204478 "PRAME family member 20" Q5VT98 1 13416351-13421328 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF17 ENSG00000204479 "PRAME family member 17" Q5VTA0 1 13389632-13392629 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF19 ENSG00000204480 "PRAME family member 19" Q5SWL8 1 13369067-13371900 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057423 Uncertain NA NA "HPA057423: AB_2683435" "unprognostic (2.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF14 ENSG00000204481 "PRAME family member 14" 1 13341892-13347134 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "Early spermatids: 14.9;Late spermatids: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LST1 "B144, D6S49E, LST-1" ENSG00000204482 "Leukocyte specific transcript 1" O00453 6 31586124-31588909 "Predicted intracellular proteins, Predicted membrane proteins" "Cell shape, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 101.2;lung: 49.3;lymphoid tissue: 183.3" "Group enriched" "Detected in many" 11 "Hofbauer cells: 407.1;Kupffer cells: 1326.9;Langerhans cells: 1240.5;Macrophages: 871.6;monocytes: 1096.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 1746.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 39.3;HMC-1: 73.6;MOLT-4: 39.6;NB-4: 76.2;THP-1: 179.9;U-937: 92.9" "Low region specificity" "Detected in all" HPA079451 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA079451: " "unprognostic (1.08e-2)" "prognostic favorable (7.89e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-3)" "unprognostic (3.13e-1)" "unprognostic (3.92e-2)" "unprognostic (3.65e-1)" "unprognostic (7.06e-3)" "unprognostic (2.81e-3)" "unprognostic (2.12e-1)" "unprognostic (1.70e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.97e-5)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (1.03e-1)" "unprognostic (1.95e-1)" 13.2 10.3 4.9 22.2 5.7 101.2 8.0 5.1 7.3 4.4 5.7 7.0 7.1 3.8 1.4 5.5 6.6 3.2 6.9 5.0 8.2 8.0 14.5 49.3 13.9 6.3 6.0 4.3 3.0 4.7 0.9 6.2 4.7 6.8 8.9 3.1 0.5 6.9 2.3 2.1 7.2 15.1 5.1 6.0 183.3 5.8 1.8 5.6 15.2 4.7 1.9 7.2 9.2 5.1 6.6 0.3 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 2.5 0.6 0.0 0.0 0.5 0.3 0.4 0.3 12.9 0.0 39.3 0.0 0.0 0.7 29.3 73.6 0.0 0.3 0.1 1.2 0.3 0.9 0.8 0.1 0.2 0.0 0.0 39.6 76.2 0.1 0.0 0.0 18.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 179.9 0.3 0.0 0.4 0.0 0.2 0.1 0.0 5.9 0.0 92.9 0.0 112.2 419.7 681.6 9.4 1273.9 80.7 32.8 15.9 20.2 392.9 21.9 10.9 9.0 1133.0 21.6 1746.7 69.9 12.0 541.6 4.9 5.7 5.1 7.3 5.0 8.2 6.3 6.0 4.3 6.8 6.0 5.6 6.6 5.4 35.3 86.7 0.7 43.7 35.2 0.3 0.2 0.0 0.3 3.2 12.2 1.9 7.2 13.0 11.0 0.0 2.9 42.8 1.0 0.0 0.6 1.5 0.4 1.9 12.9 0.0 15.1 0.2 0.2 3.8 9.2 1.5 0.4 70.3 0.1 22.9 5.8 407.1 0.0 0.3 0.0 2.0 1326.9 1240.5 5.4 3.7 871.6 44.4 24.4 1096.6 0.7 60.8 0.5 0.1 0.1 1.1 1.2 4.7 1.0 0.0 3.8 11.0 0.2 26.3 2.2 2.8 2.4 4.6 0.4 28.3 5.3 43.6 0.0 0.4 0.3 NFKBIL1 "IKBL, NFKBIL" ENSG00000204498 "NFKB inhibitor like 1" Q9UBC1 6 31546870-31558829 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.8;HBEC3-KT: 5.0;HEK 293: 20.2;JURKAT: 9.8;U-266/70: 10.8;U-266/84: 9.6;U-698: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006298 Supported Nucleoplasm NA NA Nucleoplasm "HPA006298: AB_1079480" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (2.51e-2)" "unprognostic (6.29e-2)" "unprognostic (5.41e-2)" "unprognostic (5.97e-3)" "unprognostic (5.54e-2)" "unprognostic (1.33e-1)" "unprognostic (2.16e-1)" "unprognostic (8.73e-2)" "unprognostic (9.92e-2)" "unprognostic (3.15e-1)" "unprognostic (7.50e-2)" 19.4 18.4 0.0 0.5 0.0 0.0 21.7 0.0 0.3 23.0 0.0 23.1 0.0 21.2 2.2 17.7 22.5 0.0 18.3 0.0 0.0 20.9 23.6 16.8 0.0 0.0 0.0 0.0 33.3 43.2 0.0 24.1 0.0 0.0 24.5 0.0 0.4 19.9 0.0 27.9 23.8 16.6 0.0 0.0 19.5 30.7 17.5 0.0 0.0 23.6 0.0 0.0 23.3 19.6 0.1 0.0 4.0 0.0 0.1 4.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 2.8 0.0 0.0 5.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 9.6 5.9 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.9 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.7 6.4 3.6 7.8 14.9 20.8 26.7 31.4 30.1 18.8 25.6 25.5 5.7 25.8 12.8 25.8 2.1 21.8 13.2 23.1 39.2 27.0 8.7 15.9 14.6 18.4 7.8 9.2 5.6 31.8 28.1 19.6 25.5 12.9 7.0 25.2 24.3 15.8 24.4 6.7 6.1 27.1 14.2 29.3 16.1 8.9 25.4 17.4 8.8 1.9 26.2 26.8 24.7 3.5 5.2 32.7 22.4 25.9 8.3 24.3 61.4 24.8 13.0 17.9 26.3 20.2 30.9 12.7 10.0 17.4 18.8 29.6 11.6 30.7 26.2 22.3 PRAMEF15 ENSG00000204501 "PRAME family member 15" Q5VWM5 1 13315581-13322598 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF9 ENSG00000204505 "PRAME family member 9" 1 13171848-13179459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "skeletal muscle: 33.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 33.6 0.3 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.3 0.1 0.6 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.8 0.2 0.0 0.5 0.1 0.0 0.5 0.0 0.3 0.4 0.2 0.0 0.5 0.2 0.0 0.1 0.2 0.2 0.2 0.4 0.4 0.1 0.0 0.5 0.2 0.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF7 ENSG00000204510 "PRAME family member 7" Q5VXH5 1 12916610-12920482 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049887, HPA051704" Uncertain NA NA "HPA049887: AB_2680935, HPA051704: AB_2681581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCCD1 ENSG00000204511 "Mitochondrial coiled-coil domain 1" P59942 6 31528962-31530232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 71 "kidney: 80.3" "Group enriched" "Detected in some" 44 "Distal tubular cells: 401.1;Proximal tubular cells: 414.8" "Group enriched" "Detected in some" 5 "breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (2.71e-1)" "unprognostic (3.22e-2)" "prognostic favorable (1.73e-4)" 0.0 0.0 0.1 0.0 0.2 0.1 1.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 80.3 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.2 0.4 0.2 0.1 0.4 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 401.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 414.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 ZNF814 ENSG00000204514 "Zinc finger protein 814" B7Z6K7 19 57848731-57889074 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 32.5;U-266/84: 33.4" "HPA043800, HPA053762, HPA072145" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (3.74e-2)" "unprognostic (1.24e-1)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (6.01e-2)" "unprognostic (2.12e-2)" "unprognostic (1.03e-1)" "unprognostic (4.69e-2)" "unprognostic (6.78e-4)" "unprognostic (5.05e-3)" "unprognostic (2.41e-4)" "unprognostic (1.56e-2)" "unprognostic (4.99e-4)" "unprognostic (3.94e-1)" "unprognostic (2.33e-1)" "unprognostic (1.08e-1)" "unprognostic (1.54e-5)" 5.2 14.6 10.2 4.5 8.6 10.5 8.2 22.6 9.5 5.0 6.5 7.1 6.7 5.2 6.9 5.3 8.6 4.5 11.5 10.3 5.6 14.6 13.5 6.3 8.8 7.0 6.2 8.2 7.5 7.2 9.8 14.3 5.0 13.2 12.7 4.9 13.9 8.8 5.5 10.1 9.6 9.3 4.1 1.6 13.2 5.4 11.3 6.6 9.6 14.8 5.7 8.2 6.4 5.5 8.3 1.6 4.0 11.6 16.6 1.2 1.1 3.0 4.1 2.7 4.4 0.6 2.0 1.6 8.9 2.7 3.8 4.5 1.3 0.7 8.8 5.4 1.6 7.9 6.6 7.0 2.4 4.8 7.8 8.2 7.3 7.9 1.6 1.7 7.8 1.1 3.6 1.8 3.6 7.3 1.7 25.2 3.6 32.5 0.9 5.1 3.1 1.3 15.6 3.8 6.2 4.7 11.8 1.4 3.2 6.1 23.5 8.0 2.5 2.5 10.3 3.5 2.4 2.2 10.1 33.4 22.5 2.6 4.3 12.9 4.6 8.2 9.7 5.4 9.7 14.0 37.4 14.2 11.7 11.9 38.7 22.4 18.5 5.4 24.8 6.0 27.9 4.2 7.4 10.2 8.6 22.6 9.5 10.3 5.6 7.0 6.2 8.2 13.2 1.6 6.6 8.3 6.2 0.0 1.5 4.6 15.6 6.8 10.5 7.3 4.0 22.7 11.5 9.8 12.9 21.5 10.1 12.9 47.9 13.2 10.8 5.0 17.6 8.0 46.5 13.9 6.6 7.6 4.9 5.9 10.9 1.4 18.6 5.5 6.1 20.4 16.5 12.6 14.6 15.3 13.0 20.2 12.3 8.7 14.2 2.8 7.9 19.5 4.1 6.5 10.6 4.7 5.9 9.4 13.4 7.5 10.1 1.7 17.8 7.2 5.9 8.4 10.5 44.0 8.4 35.9 19.7 5.7 6.6 14.1 10.9 3.5 13.1 11.6 9.2 8.9 22.1 12.6 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.0" "Cell type enhanced" "Detected in many" "dendritic cells: 10.3;Erythroid cells: 10.5;Hofbauer cells: 11.1;Kupffer cells: 17.8;monocytes: 13.2;T-cells: 11.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 15.2;U-266/84: 36.5" HPA064618 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA064618: AB_2685301" "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 2.5 1.2 0.2 1.4 0.2 2.2 2.3 0.2 0.5 1.3 0.4 1.4 0.2 1.7 0.3 1.4 1.2 0.4 2.3 0.3 0.2 1.8 1.2 6.2 2.9 0.2 0.3 0.1 0.7 0.8 0.1 0.6 0.2 0.2 1.1 0.5 0.0 1.3 0.0 0.5 1.0 4.5 0.4 0.2 10.0 1.4 1.3 0.3 0.7 1.7 0.7 1.6 1.4 1.5 0.3 3.4 1.3 0.0 0.0 1.9 3.2 0.1 2.3 2.2 2.9 3.7 0.0 0.4 3.9 5.9 4.3 8.1 0.8 1.0 4.1 1.0 3.4 2.3 4.6 0.6 1.3 0.7 1.4 3.5 4.1 0.8 5.0 3.5 3.1 1.9 6.0 4.2 7.8 3.5 0.0 1.3 5.9 0.4 0.0 0.5 4.7 0.0 8.2 3.8 0.2 0.0 0.0 1.5 0.0 0.7 1.2 2.0 1.6 1.9 2.2 0.0 1.9 0.1 15.2 36.5 8.3 0.5 12.0 4.9 1.8 0.9 1.2 0.8 1.1 1.0 0.6 0.8 1.1 0.6 0.5 0.4 0.9 0.9 0.6 1.6 0.4 1.4 0.7 0.2 0.2 0.2 0.5 0.3 0.2 0.2 0.3 0.1 0.2 0.2 0.3 0.3 3.0 3.2 1.5 0.0 8.2 2.9 0.5 0.3 0.0 0.0 3.1 1.9 0.5 1.5 0.8 0.0 0.0 0.1 10.3 0.8 1.9 1.6 0.0 3.1 1.6 3.0 0.0 10.5 0.6 0.7 0.3 1.5 2.0 5.2 0.0 0.1 3.9 0.1 11.1 0.0 0.1 0.6 0.0 17.8 8.2 0.4 0.3 8.0 1.8 3.7 13.2 0.0 7.2 0.0 0.1 1.9 1.9 0.4 8.7 2.1 0.5 0.3 0.9 0.0 0.0 0.6 2.2 4.6 5.2 0.1 1.1 0.1 11.3 0.5 2.1 1.1 AADACL4 ENSG00000204518 "Arylacetamide deacetylase like 4" Q5VUY2 1 12644085-12667076 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.20e-1)" "unprognostic (1.89e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038187: AB_2675884" "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favorable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 2.0 2.3 1.2 3.4 1.0 8.0 4.0 5.7 1.2 2.3 2.3 2.4 2.2 1.9 1.9 2.3 2.9 1.7 2.1 1.1 0.8 2.4 1.7 2.0 5.0 0.8 0.7 0.6 3.3 2.5 3.3 6.3 2.6 2.3 2.7 2.5 4.9 2.5 2.4 2.0 3.8 2.4 2.4 0.8 3.6 2.7 4.3 0.8 5.2 6.2 1.8 5.0 2.7 1.6 1.2 3.9 8.4 10.2 7.5 1.9 2.4 10.8 4.6 3.2 6.3 2.9 7.2 3.7 7.0 2.9 3.4 4.6 4.3 6.9 10.4 9.7 0.0 30.3 12.4 0.3 3.2 1.8 8.8 10.8 4.1 3.8 6.4 5.8 3.5 2.6 7.2 8.6 0.0 5.6 3.6 18.3 3.4 21.6 7.4 13.5 11.4 17.7 9.3 2.5 22.0 9.9 8.1 6.9 4.3 3.5 9.7 5.5 11.5 3.2 7.2 7.4 2.4 8.6 7.3 17.0 15.7 1.3 4.3 6.9 1.2 1.2 1.3 1.8 1.9 3.3 3.8 2.7 2.9 2.8 2.8 4.3 4.1 0.6 3.1 1.0 2.2 2.3 2.3 1.2 1.0 5.7 1.2 1.1 0.8 0.8 0.7 0.6 2.3 0.8 0.8 1.2 2.2 6.4 3.9 2.6 5.4 5.2 6.3 2.6 1.8 7.7 4.7 2.8 1.8 2.8 6.3 1.8 8.4 4.1 4.5 2.3 1.9 3.1 13.8 2.0 3.3 3.3 2.4 11.2 1.1 1.0 3.0 2.8 2.0 3.8 1.3 6.0 4.6 2.4 2.6 3.3 1.4 4.1 4.1 4.4 2.1 4.1 3.4 2.4 1.8 1.0 1.7 2.7 3.1 2.0 0.9 1.9 1.7 4.9 3.3 5.0 1.6 0.7 4.5 13.8 0.0 2.3 2.4 8.7 12.8 4.6 7.1 2.9 4.8 3.3 4.7 7.6 MICA PERB11.1 ENSG00000204520 "MHC class I polypeptide-related sequence A" 6 31399784-31415315 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 97.7;HSkMC: 65.6;hTERT-RPE1: 52.5;RPTEC TERT1: 44.6" NA NA "unprognostic (1.94e-1)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.66e-2)" "unprognostic (6.10e-2)" "unprognostic (5.19e-2)" "unprognostic (4.09e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (2.18e-1)" "unprognostic (1.12e-2)" 30.0 35.5 3.1 5.3 4.2 6.2 29.6 5.0 4.9 48.5 3.9 32.6 3.7 29.3 11.0 20.5 34.3 10.6 29.1 4.0 4.1 34.5 28.8 43.5 7.3 3.6 3.8 3.3 50.3 21.8 2.9 10.8 3.4 4.1 32.3 6.7 2.4 20.2 1.2 10.5 20.5 23.2 4.4 3.5 28.7 23.3 17.4 3.7 2.3 29.8 4.2 2.5 32.7 39.4 5.8 44.5 0.3 2.4 3.5 32.3 41.3 0.7 2.0 1.4 1.4 1.3 2.0 0.1 1.8 25.8 38.3 97.7 26.0 31.1 38.4 4.4 1.7 17.1 0.0 39.4 0.7 11.9 0.0 1.4 65.6 0.1 0.3 0.5 52.5 0.9 5.4 4.5 5.5 2.7 0.4 0.7 6.0 1.4 0.2 0.0 1.3 0.0 4.6 44.6 0.6 0.8 0.1 3.3 0.3 2.2 1.0 0.7 2.2 32.9 1.8 8.7 2.5 1.2 7.0 26.4 3.5 1.3 0.4 2.6 1.0 0.4 1.7 0.6 1.0 0.8 0.5 0.7 0.8 0.8 0.8 0.9 0.7 1.4 0.2 0.3 0.3 1.0 1.0 3.1 4.2 5.0 4.9 4.0 4.1 3.6 3.8 3.3 4.1 3.5 3.7 5.8 22.9 32.1 12.2 20.5 8.3 40.0 26.9 54.4 19.4 0.8 12.4 10.7 7.2 12.8 22.3 18.4 0.0 0.2 11.6 26.0 0.0 29.6 1.8 7.1 8.2 22.7 2.4 4.2 3.8 45.4 0.5 24.1 13.3 11.6 9.5 6.7 24.7 9.4 14.6 0.0 1.2 22.0 42.7 14.5 36.8 1.5 14.9 11.6 33.8 19.7 17.7 10.0 17.5 1.5 0.1 51.2 20.1 15.8 8.6 32.7 40.1 7.0 17.1 0.8 19.7 10.7 24.1 15.3 6.6 14.8 34.4 0.8 15.2 11.3 12.2 21.1 ZNF805 ENSG00000204524 "Zinc finger protein 805" Q5CZA5 19 57240632-57262728 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA046330, HPA058895" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046330: , HPA058895: AB_2683846" "unprognostic (2.18e-1)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.22e-1)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.20e-1)" "unprognostic (1.95e-1)" "unprognostic (1.58e-2)" "unprognostic (3.51e-1)" "unprognostic (3.68e-2)" "unprognostic (7.16e-3)" "unprognostic (1.64e-1)" 1.5 2.0 2.7 1.5 3.0 6.8 2.0 2.7 2.7 1.6 3.3 1.3 1.0 1.7 1.6 1.2 1.4 1.2 1.5 2.2 2.7 1.3 1.9 1.6 1.5 3.1 2.9 2.1 2.1 1.3 2.2 1.3 1.8 3.1 1.3 1.6 2.7 1.5 1.5 1.8 2.0 1.1 1.8 2.6 2.2 1.5 2.2 3.4 1.6 1.7 2.2 2.0 1.4 1.1 3.9 1.3 1.8 2.1 3.0 3.9 2.7 2.6 1.2 2.6 2.1 4.2 1.9 1.1 2.5 0.9 2.9 1.4 0.8 2.1 2.3 3.5 1.3 5.3 2.6 1.8 2.2 3.0 2.5 2.3 3.1 2.6 2.7 4.7 1.9 1.9 2.7 0.9 3.5 1.7 0.9 2.9 1.3 1.6 1.2 2.1 1.3 3.9 2.1 1.6 3.9 1.7 1.9 3.2 1.9 2.1 2.5 1.2 2.5 2.2 3.3 2.1 1.3 1.6 3.2 2.4 2.4 2.0 1.3 1.6 1.0 0.8 2.4 1.6 0.4 1.8 1.5 1.3 2.0 0.8 0.7 1.3 1.4 0.9 2.8 0.6 0.8 1.6 0.9 2.7 3.0 2.7 2.7 2.2 2.7 3.1 2.9 2.1 3.1 2.6 3.4 3.9 4.1 3.2 0.5 7.2 2.3 1.7 2.2 1.3 2.8 6.3 2.1 2.2 2.0 0.0 0.7 1.8 8.4 1.1 3.5 0.7 1.9 1.6 5.3 2.8 4.2 2.3 1.2 3.2 7.4 1.1 1.6 2.9 2.0 2.7 4.5 2.6 2.9 0.6 0.9 3.3 7.1 1.1 0.0 0.8 0.4 0.8 1.2 1.9 0.0 10.3 0.0 2.5 2.1 7.5 9.7 1.4 0.2 0.7 3.9 2.1 0.9 0.8 1.6 5.4 0.0 4.4 3.7 7.8 2.8 1.8 1.1 2.3 2.7 5.1 0.7 2.4 HLA-C "D6S204, HLA-JY3, PSORS1" ENSG00000204525 "Major histocompatibility complex, class I, C" P10321 6 31268749-31272130 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1457.4" "Cell type enhanced" "Detected in all" "NK-cells: 3899.1;Proximal enterocytes: 3582.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 760.0;EFO-21: 795.5;RPTEC TERT1: 462.7;U-266/70: 481.6;U-266/84: 401.0;U-698: 289.3" "Intracellular and membrane" NA NA 240000000 "unprognostic (2.17e-1)" "unprognostic (3.38e-1)" "unprognostic (3.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.56e-1)" "unprognostic (2.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-3)" "unprognostic (3.23e-3)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (8.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.16e-2)" 539.1 421.0 0.7 277.0 2.6 123.7 511.7 0.8 2.6 464.2 1.5 457.1 1.6 438.4 261.8 279.9 415.3 104.8 376.0 0.4 4.2 560.0 489.7 1087.6 336.9 2.8 11.1 0.0 268.5 247.4 0.2 271.7 34.8 9.4 347.2 27.9 13.8 392.7 0.4 192.2 451.9 756.2 51.3 1.1 1457.4 422.8 62.8 0.6 2.4 386.1 0.3 0.7 375.9 380.7 2.1 760.0 1.1 0.0 0.0 120.1 94.1 1.7 3.1 0.9 1.1 2.3 0.9 0.0 0.4 795.5 190.8 208.7 0.5 0.0 188.1 0.0 1.4 170.4 0.8 8.1 0.1 0.8 0.5 0.5 80.5 0.2 0.5 0.0 272.4 0.0 92.5 0.4 0.0 0.0 0.0 7.8 4.8 0.5 0.0 0.8 1.9 0.3 1.9 462.7 0.0 0.9 1.5 0.2 0.1 2.2 0.3 0.3 3.3 0.6 196.4 65.8 2.3 2.5 481.6 401.0 289.3 0.3 8.2 0.2 1.9 2.8 2.3 0.7 0.8 0.6 0.4 0.4 0.6 0.4 0.4 0.4 0.5 2.8 0.8 0.3 0.1 0.9 46.1 0.7 2.6 0.8 2.6 0.4 4.2 2.8 11.1 0.0 9.4 1.1 0.6 2.1 1903.4 227.6 328.1 13.1 1576.5 729.1 757.8 1082.3 236.8 33.4 457.0 342.8 61.2 807.8 662.7 483.7 10.4 39.5 2429.1 1994.0 84.1 1966.4 25.6 233.7 343.8 1466.2 482.2 301.2 3.9 1511.3 1010.7 608.5 648.8 557.2 344.1 256.3 1390.0 469.2 1579.0 99.3 5.8 1375.7 923.7 2050.7 1492.7 32.1 507.3 1595.9 836.0 76.8 2570.1 207.3 3899.1 18.6 3.8 1272.7 2195.7 333.6 2482.6 1038.0 3582.3 232.5 548.5 24.0 1203.0 336.7 558.8 142.0 43.5 192.6 651.7 121.6 2212.1 786.8 1003.1 1160.6 POU5F1 "MGC22487, OCT3, Oct4, OTF3" ENSG00000204531 "POU class 5 homeobox 1" Q01860 6 31164337-31180731 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 16.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8" "Cancer enriched" "Detected in many" 34 "testis cancer: 355.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 51 "SuSa: 287.4" "Not detected" "Not detected" "CAB025600, CAB026380, HPA058267, CAB079773" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659" "unprognostic (3.25e-2)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-2)" "unprognostic (2.11e-2)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (2.59e-1)" "unprognostic (9.27e-2)" "unprognostic (2.27e-2)" "unprognostic (4.79e-2)" "unprognostic (1.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.35e-1)" "unprognostic (3.86e-2)" "prognostic favorable (2.04e-5)" 1.0 0.3 1.4 1.0 1.3 1.5 1.2 1.7 1.4 3.9 0.6 3.3 4.4 2.3 2.4 1.8 7.2 2.1 2.7 1.1 0.8 16.4 8.1 3.7 1.0 1.1 1.0 0.9 0.5 13.1 0.0 0.3 0.3 1.6 7.7 1.1 0.7 0.8 2.5 1.0 2.2 8.0 0.3 0.6 2.0 10.1 1.3 1.3 0.2 0.9 0.3 0.3 10.3 2.1 1.9 3.6 1.8 0.4 0.7 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 1.3 0.3 5.6 0.1 0.4 2.9 0.7 3.1 0.0 0.6 1.4 0.6 3.3 2.5 0.2 0.9 0.8 0.3 0.6 0.3 0.9 0.2 0.0 0.7 0.1 1.0 1.0 0.2 0.3 1.0 2.9 0.6 0.1 0.8 0.6 0.7 4.8 3.8 0.6 0.1 1.0 0.2 0.3 287.4 0.6 0.4 0.0 0.7 0.5 1.8 0.3 1.3 1.3 1.6 0.5 1.3 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.2 0.1 0.3 0.0 0.1 1.4 1.3 1.7 1.4 1.1 0.8 1.1 1.0 0.9 1.6 0.6 1.3 1.9 1.0 0.0 1.1 0.0 0.9 5.2 2.7 5.3 2.8 0.5 0.7 0.8 0.4 10.0 2.3 9.2 2.1 0.0 0.1 9.2 0.0 6.7 0.0 27.9 5.9 1.2 1.2 0.0 0.2 6.6 0.1 0.7 11.2 67.8 0.0 0.1 0.4 2.4 0.1 0.0 0.1 6.4 2.0 0.0 1.5 0.2 0.0 0.7 1.8 1.0 0.7 0.1 1.0 0.5 0.1 12.6 12.5 0.7 0.2 5.6 10.1 2.0 1.6 1.0 0.0 1.4 1.2 0.1 0.8 0.8 3.8 0.1 0.8 0.0 4.1 4.3 ZSCAN5C "ZNF495C, ZSCAN5CP" ENSG00000204532 "Zinc finger and SCAN domain containing 5C" A6NGD5 19 56202273-56209200 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (3.74e-1)" "unprognostic (1.54e-1)" "unprognostic (3.29e-2)" "unprognostic (2.56e-2)" "unprognostic (9.17e-3)" "unprognostic (1.53e-1)" "unprognostic (1.47e-1)" "unprognostic (3.68e-2)" "unprognostic (4.01e-2)" "unprognostic (2.13e-2)" "unprognostic (7.45e-2)" "unprognostic (1.35e-1)" "unprognostic (8.51e-2)" "unprognostic (1.55e-1)" "unprognostic (7.89e-2)" "unprognostic (2.53e-1)" "unprognostic (9.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCHCR1 "C6orf18, HCR" ENSG00000204536 "Coiled-coil alpha-helical rod protein 1" Q8TD31 6 31142439-31158238 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 140.0" "Cell type enhanced" "Detected in many" "Early spermatids: 89.7;Endometrial ciliated cells: 68.0;Glandular and luminal cells: 161.9;Late spermatids: 160.7;Spermatocytes: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 38.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA054167 Supported Cytosol NA NA Cytosol "HPA054167: AB_2682403" "unprognostic (6.68e-2)" "unprognostic (7.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (3.11e-3)" "unprognostic (2.23e-3)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (5.36e-3)" "unprognostic (1.65e-1)" "unprognostic (2.07e-1)" "unprognostic (3.85e-3)" "unprognostic (1.06e-1)" "unprognostic (4.35e-2)" "unprognostic (3.57e-1)" "unprognostic (4.17e-2)" 9.6 7.6 2.2 2.8 1.8 1.3 11.9 1.8 2.2 18.3 1.5 14.1 10.2 12.5 5.8 15.2 18.9 1.7 11.2 1.7 1.6 16.7 12.3 9.1 7.0 2.0 2.0 1.2 19.2 14.6 1.4 9.3 0.9 2.5 20.1 3.3 1.2 11.5 4.0 19.5 17.1 14.8 1.6 1.5 13.4 14.0 140.0 2.3 2.2 16.3 1.1 1.7 13.5 15.5 3.8 38.9 3.0 9.8 1.6 6.1 7.4 8.8 3.3 1.1 0.5 1.2 14.9 0.7 5.1 17.6 8.5 23.1 1.6 0.6 15.4 1.5 5.8 23.9 18.1 13.2 11.7 3.7 0.4 11.5 9.7 1.8 6.9 1.5 7.2 8.1 27.2 7.3 10.3 4.1 2.8 6.7 19.9 0.6 1.4 0.2 12.0 13.8 9.6 9.6 3.8 29.2 4.9 11.7 0.0 2.8 6.0 4.2 9.3 1.0 14.5 4.8 0.3 9.4 23.7 14.7 20.7 3.1 4.4 1.5 0.2 0.6 0.5 0.9 0.3 0.8 0.3 0.8 1.4 0.5 0.6 1.3 1.3 0.0 1.0 0.4 1.2 1.5 0.6 2.2 1.8 1.8 2.2 1.7 1.6 2.0 2.0 1.2 2.5 1.5 2.3 3.8 8.0 3.2 5.1 10.4 7.7 9.7 13.0 12.8 8.6 9.6 8.2 10.9 8.7 11.5 11.0 3.7 0.0 3.1 5.4 41.9 11.7 8.9 89.7 68.0 19.0 6.7 29.3 6.3 5.2 10.5 7.5 7.7 28.5 161.9 0.0 15.0 5.7 7.5 6.8 15.2 4.3 27.6 0.0 5.0 3.7 160.7 9.9 5.4 7.2 1.9 8.4 5.1 9.2 0.5 1.8 8.4 17.3 11.7 6.7 9.0 36.2 7.6 15.9 2.3 6.6 9.2 8.6 68.6 21.1 7.3 5.8 1.4 6.0 14.7 35.9 8.3 PSORS1C2 "C6orf17, SPR1" ENSG00000204538 "Psoriasis susceptibility 1 candidate 2" Q9UIG4 6 31137534-31139066 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "skin 1: 166.8" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 3.3;Glandular and luminal cells: 9.0;Melanocytes: 8.8;Suprabasal keratinocytes: 7.0" "Cancer enhanced" "Detected in many" "testis cancer: 14.6;urothelial cancer: 20.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061228 Enhanced "Secreted in other tissues" NA NA "HPA061228: AB_2684455" "unprognostic (8.86e-2)" "unprognostic (7.73e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (5.20e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (3.78e-1)" "unprognostic (1.64e-2)" "unprognostic (1.06e-1)" "unprognostic (9.40e-5)" "unprognostic (2.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (2.66e-1)" 1.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.2 0.0 3.5 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 166.8 0.4 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.3 0.0 0.2 0.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.8 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.5 CDSN D6S586E ENSG00000204539 Corneodesmosin 6 31115087-31120446 "Human disease related genes, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 88 "skin 1: 590.5" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 2.6;Gastric mucus-secreting cells: 2.0;Glandular and luminal cells: 7.1;granulocytes: 4.5;Suprabasal keratinocytes: 5.3" "Group enriched" "Detected in some" 8 "head and neck cancer: 2.4;melanoma: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "A-431: 1.6" "Region enhanced" "Detected in some" "cerebral cortex: 1.5" "Not detected" "Not detected" "HPA044730, HPA054184" Enhanced "Secreted in other tissues" NA NA "HPA044730: AB_10964923, HPA054184: AB_2682409" "unprognostic (1.46e-1)" "unprognostic (6.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (8.80e-2)" "unprognostic (8.13e-2)" "unprognostic (3.92e-4)" "unprognostic (3.92e-3)" "unprognostic (1.74e-4)" "unprognostic (6.34e-2)" "unprognostic (2.75e-1)" "unprognostic (2.22e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 3.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 590.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 6.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.9 0.4 2.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.0 7.1 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.2 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 110.7" "Group enriched" "Detected in many" 4 "Early spermatids: 358.6;Late spermatids: 1285.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" HPA045049 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.7 0.4 0.1 0.0 0.1 0.0 0.8 0.0 0.1 0.7 0.0 1.4 0.0 1.0 2.3 0.9 0.5 0.0 0.4 0.1 0.0 0.8 0.0 1.7 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.9 0.2 0.0 0.9 0.1 0.0 3.2 1.8 0.0 0.0 0.2 1.4 110.7 0.0 0.0 1.0 0.0 0.0 0.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.5 0.1 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 19.2 3.2 0.7 0.0 8.8 3.8 5.4 3.4 0.0 7.5 3.4 3.3 12.8 2.7 9.2 0.0 0.2 0.1 55.1 0.0 17.7 358.6 3.6 3.3 4.6 3.0 0.0 0.4 2.2 0.6 5.8 20.9 11.6 0.0 0.0 3.6 0.1 0.4 0.0 0.3 4.9 0.0 0.0 3.0 1285.1 9.3 0.4 3.6 0.0 0.6 0.7 0.0 2.0 2.4 12.2 131.7 6.8 0.0 2.7 26.0 1.0 0.6 0.0 6.6 0.9 1.3 170.3 31.8 3.5 10.5 0.1 0.4 0.2 6.9 2.4 C6orf15 STG ENSG00000204542 "Chromosome 6 open reading frame 15" Q6UXA7 6 31111223-31112575 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix: 5.6;lymphoid tissue: 3.5;skin 1: 5.8" "Cell type enriched" "Detected in some" 14 "Breast glandular cells: 73.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "RH-30: 13.4;U-2 OS: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA001436 Uncertain "Secreted to extracellular matrix" NA NA "HPA001436: AB_2243752" "unprognostic (2.73e-2)" "unprognostic (5.39e-2)" "unprognostic (1.46e-2)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.35e-1)" "unprognostic (3.42e-2)" "unprognostic (1.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.5 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.3 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 1.3 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MUC21 "bCX31G15.2, C6orf205" ENSG00000204544 "Mucin 21, cell surface associated" Q5SSG8 6 30983718-30989903 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 701.9;vagina: 246.5" "Group enriched" "Detected in some" 5 "Club cells: 11.8;Squamous epithelial cells: 37.7;Urothelial cells: 32.0" "Group enriched" "Detected in many" 9 "cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052028 Enhanced NA NA "HPA052028: AB_2681700" "unprognostic (2.27e-2)" "unprognostic (4.85e-3)" "unprognostic (5.24e-3)" "unprognostic (1.68e-2)" "unprognostic (2.68e-2)" "unprognostic (2.98e-3)" "unprognostic (1.32e-4)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 64.9 0.0 0.1 0.0 0.1 0.0 701.9 0.2 0.0 0.1 0.0 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.6 0.0 0.0 0.3 0.0 0.0 107.7 0.0 0.3 0.2 0.1 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.1 0.0 13.6 0.2 246.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.2 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.3 0.1 0.0 32.0 DEFB121 DEFB-21 ENSG00000204548 "Defensin beta 121" Q5J5C9 20 31404845-31412838 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11882 "epididymis: 2628.1" "Group enriched" "Detected in some" 22 "Early spermatids: 14.5;Late spermatids: 5.4;Spermatocytes: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NB-4: 3.1" "Not detected" "Not detected" HPA079460 Enhanced "Secreted in male reproductive system" NA NA "HPA079460: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2628.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DHX16 "DBP2, DDX16, Prp2, PRPF2" ENSG00000204560 "DEAH-box helicase 16" O60231 6 30653119-30673006 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 92.7;Spermatocytes: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051455 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA051455: AB_2681491" "unprognostic (7.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.29e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.66e-2)" "unprognostic (3.11e-1)" "unprognostic (8.58e-2)" "unprognostic (1.24e-2)" "unprognostic (9.77e-3)" "unprognostic (4.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "unprognostic (8.73e-3)" 24.5 28.5 5.1 13.9 6.1 11.4 26.2 6.0 6.9 27.9 7.4 27.0 19.0 25.7 8.6 27.4 26.9 11.4 24.8 5.0 5.9 35.1 36.8 25.7 18.3 6.0 5.4 4.9 26.4 35.3 16.2 28.8 10.6 6.3 30.3 10.4 14.5 32.3 12.9 45.4 28.4 37.8 12.6 4.8 40.6 28.5 47.2 6.1 17.2 38.5 17.8 12.8 25.0 27.0 5.8 31.9 17.9 20.3 38.7 26.8 15.7 27.0 33.0 30.7 47.6 44.3 35.8 15.9 25.5 24.2 31.1 39.6 34.0 47.0 24.1 35.5 35.4 15.5 27.2 25.5 17.9 21.4 65.9 40.4 17.6 22.7 47.3 30.1 16.5 16.9 36.9 44.4 29.3 26.7 29.0 22.4 20.8 21.4 20.9 12.1 38.5 17.4 28.2 18.4 24.0 27.9 19.7 30.8 37.4 32.0 20.3 29.5 24.7 11.8 31.2 21.3 27.4 46.3 29.9 49.9 20.2 15.7 36.8 40.4 10.5 11.2 18.6 7.4 14.7 9.5 7.7 9.1 7.9 11.1 5.9 7.4 5.8 11.4 14.8 16.4 9.8 7.4 7.5 5.1 6.1 6.0 6.9 5.0 5.9 6.0 5.4 4.9 6.3 4.8 6.1 5.8 13.0 22.4 20.9 4.6 16.9 10.8 11.7 11.3 16.5 13.9 10.0 9.9 14.6 10.0 20.2 5.5 39.6 19.2 14.4 18.3 9.8 15.7 92.7 25.2 18.0 11.8 6.0 14.9 4.3 18.6 20.1 11.6 26.5 15.8 42.3 11.1 8.6 9.7 13.9 5.0 4.1 14.6 8.2 12.6 12.8 49.3 14.3 14.4 5.4 5.6 20.3 11.6 15.5 2.5 5.2 22.9 23.1 12.4 22.1 9.3 18.0 9.8 31.4 51.1 19.7 16.2 19.2 86.9 32.6 14.7 10.7 19.2 19.5 11.4 12.8 9.5 C6orf136 Em:AB023049.8 ENSG00000204564 "Chromosome 6 open reading frame 136" Q5SQH8 6 30647039-30653210 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046804 Uncertain NA NA "HPA046804: AB_2679815" "unprognostic (1.94e-2)" "unprognostic (1.71e-3)" "unprognostic (1.26e-1)" "unprognostic (8.01e-3)" "unprognostic (1.65e-2)" "unprognostic (2.76e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (4.72e-3)" "unprognostic (3.43e-1)" "prognostic favorable (9.16e-8)" "unprognostic (2.33e-2)" "unprognostic (4.54e-2)" "unprognostic (6.03e-2)" "prognostic favorable (7.51e-4)" 10.7 19.4 8.1 1.3 8.5 1.8 11.4 9.8 11.4 11.4 8.7 29.1 6.5 10.4 3.9 22.4 11.7 0.7 45.9 8.1 8.8 36.0 29.0 11.8 2.0 9.1 8.7 8.4 9.4 20.3 6.5 26.4 1.4 8.9 15.3 5.4 3.5 18.7 2.7 49.6 16.9 37.4 1.6 7.9 18.2 22.5 18.2 8.7 0.6 23.5 5.6 1.0 14.7 14.3 9.0 2.7 4.4 2.3 2.0 3.4 4.2 4.1 1.0 1.2 2.6 3.6 2.8 1.9 2.4 1.6 0.8 2.2 3.5 0.4 0.1 2.8 2.0 3.3 1.3 3.4 1.7 0.9 3.8 3.8 1.9 4.0 1.9 2.4 2.5 1.0 3.7 3.1 1.6 0.6 4.4 1.7 4.4 2.5 4.2 2.4 3.3 2.1 4.8 5.9 3.9 5.5 1.1 1.4 4.5 3.4 0.9 2.2 0.8 0.5 0.8 3.8 1.6 3.4 4.5 5.6 1.6 1.4 3.4 1.8 0.0 0.3 0.0 0.5 0.3 0.7 1.2 0.7 0.4 0.3 0.7 1.1 0.7 0.6 0.3 0.3 0.7 0.5 0.4 8.1 8.5 9.8 11.4 8.1 8.8 9.1 8.7 8.4 8.9 7.9 8.7 9.0 8.9 0.0 4.4 15.0 14.8 9.3 11.1 29.7 16.5 16.8 10.7 8.9 26.7 17.2 18.2 36.8 4.2 17.3 11.3 67.1 58.7 18.5 14.3 7.4 3.4 10.1 22.9 9.9 17.2 17.5 11.1 8.0 23.9 6.5 12.7 4.6 8.9 12.2 15.7 11.8 19.5 45.0 30.5 4.7 7.6 17.4 7.8 7.1 10.6 8.4 10.0 13.9 11.3 6.0 9.8 17.1 54.2 6.4 18.8 13.4 108.7 27.7 11.1 20.0 6.6 5.3 17.5 51.5 49.5 24.1 10.7 16.8 13.5 6.7 47.2 16.2 MRPS18B "C6orf14, HSPC183, MRPS18-2, PTD017" ENSG00000204568 "Mitochondrial ribosomal protein S18B" Q9Y676 6 30617840-30626395 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043485, HPA050334" Supported Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA043485: AB_2678506, HPA050334: AB_2681091" "unprognostic (8.18e-3)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (2.51e-2)" "unprognostic (4.20e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (2.98e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-2)" "prognostic favorable (3.99e-5)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.39e-2)" 37.6 52.4 43.1 27.9 44.9 20.5 61.6 46.5 44.7 41.5 42.4 52.8 50.2 31.6 58.1 39.6 63.1 27.6 109.2 40.4 43.2 78.6 100.6 39.7 44.0 45.0 45.2 39.6 63.6 47.4 74.6 29.5 38.8 45.3 32.3 62.9 42.0 58.5 42.8 181.9 45.5 39.7 38.5 45.7 39.6 44.8 22.2 44.8 44.1 54.6 231.0 64.1 33.3 29.7 48.1 112.7 68.3 51.1 73.5 72.9 101.8 92.6 39.8 92.6 122.8 75.5 117.7 51.8 112.6 91.5 61.7 91.3 86.1 115.0 109.9 122.0 68.7 122.9 107.9 45.1 124.2 67.2 105.7 45.4 88.8 139.4 99.5 273.8 82.7 72.4 104.7 171.3 107.7 112.2 83.1 70.6 111.4 40.6 86.1 81.8 91.2 69.8 220.7 114.8 49.5 111.3 38.4 34.7 147.1 163.0 46.0 190.6 58.4 39.6 79.2 80.8 47.3 70.8 89.5 114.1 99.2 38.3 154.6 121.7 79.2 72.4 42.5 77.0 94.4 104.7 153.5 104.3 86.3 79.8 140.3 129.6 103.5 7.2 120.3 101.4 74.3 108.1 108.4 43.1 44.9 46.5 44.7 40.4 43.2 45.0 45.2 39.6 45.3 45.7 44.8 48.1 59.4 60.9 56.1 7.2 58.4 36.8 65.9 114.0 58.6 47.4 56.6 73.0 175.5 117.2 75.0 47.8 64.6 121.2 43.7 39.1 193.7 103.8 54.2 37.5 42.8 59.4 31.3 45.4 6.0 92.1 124.9 47.4 39.3 30.8 37.4 53.1 61.8 121.6 81.4 43.7 7.9 59.5 75.3 53.2 30.4 37.4 70.2 39.7 60.5 1.9 80.0 46.9 70.0 4.5 14.4 69.5 49.9 44.8 56.8 53.2 89.6 201.6 60.4 69.4 52.6 50.0 53.0 29.6 57.4 61.7 44.9 96.5 43.9 144.4 85.3 50.1 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600413-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 7.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favorable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 18.0 27.7 0.2 12.1 0.1 1.0 15.9 0.3 1.3 23.1 0.2 21.5 9.0 21.4 1.1 23.3 22.2 10.8 13.9 0.5 0.4 19.5 33.9 17.6 5.0 0.7 1.2 0.1 23.0 28.2 4.9 26.5 5.0 0.6 23.0 6.4 5.3 20.3 7.9 23.1 20.0 21.1 7.1 0.3 25.3 25.4 21.8 0.3 10.2 23.1 1.3 5.7 22.7 22.0 0.2 9.1 20.0 30.9 16.8 17.0 2.2 8.9 15.9 7.0 5.6 23.3 5.0 9.7 11.5 9.6 16.0 10.5 23.6 24.3 35.7 9.7 13.1 0.0 19.8 14.1 0.2 7.6 16.3 27.3 14.2 4.0 28.0 30.9 13.2 9.7 3.9 18.4 3.7 14.4 5.4 5.5 2.4 9.1 1.9 2.3 25.4 39.3 19.8 1.4 8.0 19.3 9.1 29.5 28.3 8.8 13.0 13.8 21.8 2.6 12.7 9.0 18.5 10.7 26.9 5.1 11.3 15.8 19.9 15.8 7.9 1.2 2.0 0.9 2.1 1.6 2.9 0.4 1.7 3.3 0.7 0.5 1.1 1.0 1.0 0.8 1.2 1.9 0.4 0.2 0.1 0.3 1.3 0.5 0.4 0.7 1.2 0.1 0.6 0.3 0.3 0.2 243.9 32.1 40.3 20.5 152.7 69.8 64.9 41.1 167.9 72.7 165.1 163.8 59.1 28.6 34.2 27.6 131.3 44.0 178.9 120.5 35.2 27.2 32.0 138.2 103.8 102.6 71.3 30.5 26.1 23.0 21.8 103.2 107.0 151.4 44.9 143.0 38.2 33.6 33.1 35.3 27.0 102.2 54.9 35.5 70.6 11.3 46.3 123.4 37.4 30.0 46.4 59.0 72.1 21.1 29.7 29.8 58.3 30.1 140.1 51.9 88.1 40.3 46.9 102.2 32.9 211.5 114.9 45.9 23.4 125.7 77.9 88.5 144.1 99.9 77.0 34.5 KRTAP5-11 "KRTAP5-6, KRTAP5.11" ENSG00000204571 "Keratin associated protein 5-11" Q6L8G4 11 71579714-71603353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "skin 1: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.08e-1)" 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.5 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-10 KRTAP5.10 ENSG00000204572 "Keratin associated protein 5-10" Q6L8G5 11 71565563-71566735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.4;skin 1: 3.2" "Cell type enhanced" "Detected in some" "Early spermatids: 2.7;Late spermatids: 1.0;Respiratory ciliated cells: 1.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "RT4: 3.5" NA NA "unprognostic (4.05e-2)" "unprognostic (5.64e-3)" "unprognostic (1.39e-2)" "unprognostic (6.47e-2)" "unprognostic (7.81e-2)" "unprognostic (4.70e-2)" "unprognostic (5.55e-2)" "unprognostic (1.68e-1)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-4)" "unprognostic (9.43e-2)" "unprognostic (1.37e-1)" "unprognostic (6.21e-2)" "unprognostic (2.27e-4)" 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.0 0.2 0.1 0.0 0.0 1.4 0.1 0.2 0.1 0.0 0.3 0.3 0.3 0.2 0.1 0.0 0.2 0.2 0.2 0.0 0.5 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.1 0.3 0.2 3.2 0.1 0.0 0.2 0.2 0.1 0.6 0.3 0.0 0.2 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.6 ABCF1 "ABC50, EST123147" ENSG00000204574 "ATP binding cassette subfamily F member 1" Q8NE71 6 30571393-30597179 "Plasma proteins, Predicted intracellular proteins, Transporters" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017578 Approved Enhanced Cytosol NA NA 490000 Cytosol "HPA017578: AB_1844438" "unprognostic (5.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-3)" "unprognostic (4.31e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (5.50e-2)" "unprognostic (3.45e-2)" "unprognostic (1.70e-2)" "unprognostic (2.35e-1)" "unprognostic (2.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.65e-1)" "unprognostic (3.65e-1)" "unprognostic (1.68e-3)" "unprognostic (7.16e-2)" 30.5 27.7 4.8 6.8 5.2 25.7 28.6 4.7 6.0 28.5 3.6 33.3 2.0 34.6 7.4 32.7 24.8 6.9 32.3 4.3 6.6 28.3 32.9 30.2 7.4 6.3 5.8 3.8 26.5 32.9 13.7 24.9 10.6 10.6 28.5 11.5 11.2 30.6 5.5 107.9 39.8 32.6 10.3 5.1 31.0 32.6 35.3 5.3 14.8 29.5 4.2 11.3 32.7 30.3 5.6 46.2 33.5 29.4 39.7 40.0 24.5 4.2 30.1 37.6 49.0 53.6 104.8 16.4 33.8 27.1 34.3 51.9 33.3 61.7 39.5 56.2 34.2 65.2 43.0 47.6 14.5 5.5 9.4 5.6 33.6 33.7 68.6 6.4 4.0 5.6 16.9 77.2 4.5 35.3 8.5 9.3 15.5 7.5 31.2 9.4 64.5 7.5 63.3 32.2 52.4 10.2 42.9 20.1 55.3 6.6 5.0 6.1 24.4 28.2 59.0 6.9 3.8 6.2 35.7 47.5 52.8 1.3 43.3 62.2 1.7 5.5 1.5 10.1 4.7 9.3 6.2 7.2 10.2 4.7 5.1 6.3 6.3 1.8 8.0 4.9 5.4 4.1 6.1 4.8 5.2 4.7 6.0 4.3 6.6 6.3 5.8 3.8 10.6 5.1 5.3 5.6 42.5 51.3 84.4 7.2 67.9 86.2 100.3 54.2 49.5 48.9 45.5 30.1 87.3 42.9 65.2 58.8 66.7 100.3 77.5 103.3 60.7 93.9 105.0 67.0 95.4 57.2 50.7 50.9 6.8 87.6 139.4 52.6 53.5 115.2 86.9 27.0 36.0 125.4 49.5 55.5 7.4 80.6 28.5 47.4 43.0 176.4 38.8 52.1 35.6 2.8 63.2 39.3 116.4 2.0 9.2 105.9 73.8 51.9 61.8 92.1 66.2 99.0 44.0 112.9 72.3 58.7 54.3 132.5 104.2 50.2 84.8 166.1 70.5 48.2 72.3 87.1 PRR3 "CAT56, Em:AB014077.1, Em:AB023052.2" ENSG00000204576 "Proline rich 3" P79522 6 30557280-30563723 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 16.6;HAP1: 20.1;HEL: 15.1;JURKAT: 14.7;U-266/84: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064061 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064061: AB_2685185" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (8.90e-2)" "unprognostic (2.10e-3)" "unprognostic (1.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.65e-3)" "unprognostic (1.25e-2)" "unprognostic (3.73e-2)" "prognostic favorable (6.49e-6)" "prognostic favorable (5.61e-5)" "unprognostic (4.71e-2)" "prognostic unfavorable (7.84e-7)" "unprognostic (2.80e-1)" "unprognostic (2.82e-1)" "unprognostic (3.66e-1)" "unprognostic (1.21e-3)" 3.7 5.3 1.1 0.1 1.1 0.0 3.6 1.1 2.9 6.3 1.0 3.2 0.0 6.9 1.1 2.6 6.0 0.0 3.5 1.1 1.0 3.2 3.2 3.3 0.3 1.1 1.2 1.1 10.7 3.2 0.1 5.9 0.0 1.2 4.3 0.2 0.6 2.6 0.3 1.5 3.0 3.6 0.0 1.1 5.0 3.1 4.8 1.1 0.8 3.9 0.0 0.6 4.5 4.1 1.1 0.1 3.9 7.7 16.6 5.2 1.3 0.0 0.0 0.0 0.0 0.0 6.6 0.1 7.0 8.6 2.1 4.4 0.6 20.1 1.5 0.0 4.1 3.7 15.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.6 0.0 0.0 0.0 14.7 7.8 0.0 3.6 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 1.7 0.3 0.1 10.6 4.8 0.5 0.0 0.0 0.0 4.3 0.5 6.4 0.1 0.0 0.0 9.2 13.1 8.8 0.0 5.8 3.6 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.5 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.1 1.1 1.1 1.1 2.9 1.1 1.0 1.1 1.2 1.1 1.2 1.1 1.1 1.1 10.6 9.6 19.1 11.4 18.2 5.7 6.4 8.6 12.5 11.3 11.0 22.9 3.6 11.5 10.7 3.7 14.6 14.2 11.2 14.0 7.9 5.8 0.6 8.7 14.2 8.0 7.8 7.6 18.8 9.5 8.7 10.9 24.5 8.4 12.0 16.3 9.3 5.9 7.9 6.7 16.4 10.2 14.2 6.0 7.9 2.6 10.2 8.8 10.6 9.4 12.7 6.4 12.3 17.1 12.2 5.7 5.7 10.1 14.5 5.7 9.9 9.4 11.3 19.2 6.6 11.9 9.8 10.3 6.6 9.1 5.7 9.9 12.0 15.9 8.3 3.9 LILRB3 "CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB" ENSG00000204577 "Leukocyte immunoglobulin like receptor B3" O75022 19 54216278-54223506 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.2;lymphoid tissue: 50.3" "Group enriched" "Detected in many" 5 "Hofbauer cells: 63.4;Kupffer cells: 88.6;Macrophages: 88.8;monocytes: 71.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 44.8" "Group enriched" "Detected in many" 4 "granulocytes: 44.8;monocytes: 15.4" "Not detected" "Not detected" HPA026985 Approved "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane" Cytosol "HPA026985: " "unprognostic (7.51e-2)" "unprognostic (3.52e-2)" "unprognostic (9.59e-2)" "unprognostic (4.53e-1)" "unprognostic (1.83e-3)" "unprognostic (5.28e-3)" "unprognostic (2.91e-2)" "unprognostic (2.55e-1)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.92e-8)" "unprognostic (2.18e-1)" "unprognostic (2.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.75e-1)" 7.8 3.4 0.4 8.4 0.7 14.8 2.9 0.3 1.8 1.1 0.7 2.7 0.3 1.3 0.3 1.3 5.4 0.1 3.3 0.3 0.9 2.3 4.1 27.2 0.3 1.3 0.6 0.2 1.0 1.9 0.0 1.3 1.2 1.1 1.7 0.0 0.2 2.4 0.0 1.1 0.8 2.6 0.1 0.5 50.3 2.3 0.5 1.4 0.6 1.7 0.0 0.2 3.3 1.6 1.7 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 15.4 0.6 0.1 14.3 0.2 0.1 0.3 0.0 7.2 0.1 0.0 0.1 44.8 0.0 5.6 0.5 0.0 11.6 0.4 0.7 0.3 1.8 0.3 0.9 1.3 0.6 0.2 1.1 0.5 1.4 1.7 1.5 9.6 13.0 0.3 2.2 2.4 1.2 6.5 0.0 0.7 1.6 2.2 0.4 4.3 8.3 1.8 0.0 1.5 2.1 0.6 0.0 0.3 1.3 0.8 1.9 3.0 0.0 0.8 0.2 0.6 6.7 2.9 0.0 2.2 7.6 0.5 1.8 3.2 63.4 0.0 0.1 1.9 0.0 88.6 8.4 4.1 0.3 88.8 1.8 1.9 71.2 0.9 3.1 0.0 0.1 0.2 1.3 0.7 2.1 1.6 0.4 0.4 5.2 2.9 6.6 4.3 1.3 0.8 1.5 0.1 3.0 1.2 3.8 2.6 2.0 0.4 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 90.9;HBEC3-KT: 70.1;RT4: 93.5;T-47d: 103.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 4400000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favorable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 23.4 50.8 22.9 5.3 43.2 0.4 55.1 51.5 17.5 45.3 4.4 41.5 12.4 23.6 4.6 151.3 46.5 11.5 29.3 19.7 42.2 93.1 6.4 34.0 1.2 76.6 97.3 5.3 41.8 100.5 19.9 68.5 4.3 54.4 70.8 10.8 4.5 132.8 13.9 40.8 114.4 47.7 1.1 40.7 11.5 71.7 16.6 52.4 7.1 86.6 4.4 3.0 45.4 89.2 59.1 58.2 18.5 26.0 5.4 1.7 2.4 16.2 1.4 0.4 0.8 0.1 25.2 29.8 0.5 30.9 5.1 26.8 90.9 5.7 70.1 0.3 32.0 9.9 0.2 18.7 6.7 5.0 0.0 1.2 3.3 35.4 0.4 0.5 16.1 2.0 1.4 17.3 0.7 4.0 36.5 2.0 0.1 4.5 31.8 3.8 3.9 19.5 2.2 13.1 93.5 4.7 2.5 5.4 41.4 19.4 8.6 103.0 0.6 4.3 12.8 11.7 1.2 13.6 0.8 0.1 2.6 8.4 0.0 11.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 22.9 43.2 51.5 17.5 19.7 42.2 76.6 97.3 5.3 54.4 40.7 52.4 59.1 1.9 35.3 24.6 54.5 3.8 53.0 68.3 125.5 67.2 7.4 77.0 57.9 18.0 37.1 79.8 90.1 0.0 63.6 1.5 109.7 5.9 125.5 15.1 58.5 6.5 4.1 46.2 2.7 1.2 76.2 26.0 7.4 63.7 58.4 1.3 29.5 2.2 0.6 6.1 6.7 7.5 69.8 109.9 0.8 5.4 30.1 8.4 2.5 16.0 9.4 13.1 139.9 1.0 60.3 73.8 71.5 78.2 5.3 0.8 68.1 77.3 5.4 104.2 8.0 6.6 10.5 11.9 1.5 6.8 81.8 51.9 46.5 1.9 4.1 67.1 88.4 LRCOL1 ENSG00000204583 "Leucine rich colipase like 1" A6NCL2 12 132603150-132610582 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "epididymis: 50.5" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 33.2" "Group enriched" "Detected in some" 4 "endometrial cancer: 0.8;liver cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (5.09e-3)" "unprognostic (7.83e-3)" "unprognostic (3.26e-1)" "unprognostic (6.94e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-2)" "prognostic favorable (7.04e-4)" "unprognostic (4.54e-2)" "unprognostic (6.08e-2)" "unprognostic (5.29e-2)" "unprognostic (4.66e-3)" "unprognostic (1.52e-1)" "unprognostic (6.50e-6)" "unprognostic (1.46e-3)" "unprognostic (9.63e-2)" "unprognostic (3.31e-1)" "unprognostic (4.00e-3)" 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.2 50.5 0.1 0.4 0.0 0.0 0.0 0.0 0.1 2.3 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.6 1.9 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.0 0.1 3.3 33.2 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 1.5 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.0 GNL1 HSR1 ENSG00000204590 "G protein nucleolar 1 (putative)" P36915 6 30541377-30557174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 193.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033575, HPA043338, HPA050455" Uncertain Supported Vesicles NA NA 11000 Vesicles "CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132" "unprognostic (2.76e-2)" "unprognostic (3.68e-2)" "unprognostic (2.21e-1)" "unprognostic (3.53e-2)" "unprognostic (3.30e-2)" "unprognostic (2.75e-1)" "unprognostic (4.22e-2)" "unprognostic (8.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-2)" "unprognostic (3.95e-3)" "unprognostic (7.32e-2)" "unprognostic (5.67e-3)" "unprognostic (4.42e-2)" "unprognostic (2.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.78e-1)" 22.5 19.7 2.1 3.5 3.1 2.0 21.9 1.8 3.2 30.6 1.3 18.3 0.6 27.5 3.9 17.1 26.4 2.4 14.1 2.0 3.4 19.4 13.2 28.1 2.3 3.3 2.8 1.7 37.8 24.5 7.8 23.9 2.9 4.6 20.1 3.5 4.2 16.7 3.9 15.1 22.8 17.5 4.5 2.1 18.8 20.2 38.3 3.5 5.0 23.5 1.6 4.6 21.3 23.1 4.5 10.5 2.2 5.9 16.9 10.9 12.8 0.4 3.2 6.4 2.6 4.0 15.1 6.5 4.8 6.2 10.4 25.8 6.9 15.4 12.7 4.4 1.8 9.0 7.8 7.9 1.4 0.0 1.3 5.0 11.0 9.9 20.4 6.7 0.0 1.1 18.6 14.2 0.3 6.5 2.4 3.8 0.2 3.4 8.4 1.6 7.3 3.6 5.3 8.7 4.5 5.2 4.9 4.2 3.1 1.6 2.0 3.0 4.9 6.2 10.5 3.0 2.0 3.7 7.9 9.3 9.9 0.1 6.6 13.1 0.2 0.2 0.2 0.7 0.2 1.0 0.4 0.8 0.9 0.0 0.3 0.1 0.3 0.2 0.4 0.2 0.1 0.5 0.5 2.1 3.1 1.8 3.2 2.0 3.4 3.3 2.8 1.7 4.6 2.1 3.5 4.5 48.2 44.8 41.8 17.3 45.0 59.3 104.0 44.1 56.3 40.6 35.4 40.6 14.3 34.3 28.8 25.8 41.7 72.6 36.3 22.6 23.5 38.4 113.1 30.0 40.2 50.8 46.0 13.3 26.2 35.3 65.5 46.4 27.5 47.5 31.7 40.9 50.7 16.9 28.5 16.8 27.0 25.8 26.4 19.8 32.5 193.5 36.4 24.6 28.4 9.4 14.8 30.9 18.6 11.1 10.8 29.9 22.1 32.0 42.6 56.2 32.4 30.3 20.7 34.6 39.5 47.9 58.1 108.4 51.8 36.1 40.6 160.1 46.0 40.9 27.0 66.7 HLA-E ENSG00000204592 "Major histocompatibility complex, class I, E" P13747 6 30489509-30494194 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 2347.3;Hepatic stellate cells: 1647.8;NK-cells: 1874.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 212.3;U-266/70: 284.8" "CAB024589, HPA031454" Enhanced Approved Vesicles "Secreted to blood" NA NA 100000000 Vesicles "CAB024589: AB_324025, HPA031454: AB_2673891" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (9.20e-2)" "unprognostic (2.47e-3)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (1.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.90e-1)" "unprognostic (4.14e-2)" "unprognostic (1.75e-3)" "unprognostic (1.42e-3)" 667.5 219.0 27.5 175.1 70.1 413.9 583.9 17.3 103.3 343.1 13.2 303.2 0.6 316.1 120.4 333.6 339.4 187.8 329.6 18.1 18.4 374.6 335.5 1154.6 339.2 26.7 22.1 11.6 214.9 157.9 96.6 122.7 118.3 41.6 253.3 117.9 12.5 254.6 93.9 180.7 500.2 432.4 89.8 37.3 1015.3 261.7 41.4 21.6 86.8 385.0 0.0 138.6 297.5 369.4 92.7 100.7 16.7 6.8 57.0 212.3 166.4 0.9 0.0 0.0 0.1 0.3 40.0 189.1 65.6 98.7 92.7 148.3 121.6 12.8 53.1 0.0 67.6 32.7 78.6 18.7 0.0 0.0 0.2 38.3 135.4 94.4 67.7 0.0 0.0 0.2 34.6 9.8 0.9 54.5 0.2 0.3 0.8 0.5 32.0 0.0 20.6 0.2 97.4 82.7 58.4 0.3 4.8 63.3 56.9 0.3 1.2 0.0 132.7 102.0 60.7 0.1 0.5 14.7 284.8 171.6 29.4 0.3 62.1 149.2 1140.0 335.4 1153.0 723.3 550.2 602.2 449.1 539.9 709.2 158.5 450.3 531.5 547.8 1916.1 512.9 648.0 138.3 611.7 1441.6 27.5 70.1 17.3 103.3 18.1 18.4 26.7 22.1 11.6 41.6 37.3 21.6 92.7 2347.3 310.9 411.0 8.1 950.6 484.6 386.6 284.2 183.8 2.7 238.7 204.0 108.3 231.6 270.0 123.2 6.2 88.2 1304.6 603.0 17.6 484.9 5.0 157.7 157.9 1554.7 216.2 172.3 0.1 677.2 277.0 402.8 233.4 325.6 531.6 59.2 1647.8 120.1 700.6 5.0 0.1 545.3 248.2 1220.4 512.2 11.0 132.0 821.6 466.0 105.9 740.5 100.2 1874.4 2.0 0.5 682.2 559.1 76.3 716.6 436.9 473.9 79.9 214.7 9.5 177.5 535.1 350.1 10.6 7.0 170.0 426.5 359.0 1162.1 196.5 285.0 544.4 DPRX ENSG00000204595 "Divergent-paired related homeobox" A6NFQ7 19 53632056-53637009 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "placenta: 1.2;skeletal muscle: 1.2" "Cell type enhanced" "Detected in some" "Adipocytes: 1.6;Cytotrophoblasts: 1.2;Early spermatids: 1.1;Late spermatids: 2.0;Oligodendrocyte precursor cells: 1.0;Syncytiotrophoblasts: 5.6" "Cancer enriched" "Detected in single" 20 "thyroid cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043682 Uncertain NA NA "HPA043682: AB_10963073" "unprognostic (2.47e-1)" "unprognostic (1.89e-1)" 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 TRIM39 RNF23 ENSG00000204599 "Tripartite motif containing 39" Q9HCM9 6 30326479-30343729 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051120, HPA059496" Uncertain Supported Cytosol NA NA Cytosol "HPA051120: AB_2681348, HPA059496: AB_2684040" "unprognostic (2.90e-1)" "unprognostic (1.61e-2)" "unprognostic (2.79e-2)" "unprognostic (2.86e-2)" "unprognostic (6.38e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-1)" "unprognostic (9.44e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.30e-2)" "unprognostic (4.69e-2)" "unprognostic (6.35e-3)" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (2.39e-3)" 9.6 8.7 1.0 1.7 1.1 3.1 10.3 1.2 1.1 11.0 1.2 12.1 1.6 12.2 2.3 13.2 11.8 1.4 8.6 0.9 1.1 9.8 11.7 9.8 1.6 1.3 1.0 0.7 11.6 12.3 2.1 14.9 1.6 1.3 10.9 1.6 1.5 10.2 2.0 14.4 9.1 12.0 1.9 0.9 14.4 11.1 20.8 1.1 1.7 11.7 1.4 2.1 13.0 9.5 1.3 3.2 0.1 2.6 4.8 1.2 1.2 2.7 1.4 1.8 2.1 1.9 3.8 0.4 4.1 2.8 2.7 1.3 1.0 3.1 2.2 2.2 3.2 3.4 3.2 0.5 1.4 2.7 4.8 3.5 1.4 1.8 2.7 2.9 3.2 1.3 3.4 4.9 3.2 2.7 2.9 1.0 1.0 3.6 1.3 2.2 2.2 0.5 3.1 2.2 3.0 5.7 2.8 1.1 2.3 2.8 2.5 3.1 1.2 1.2 2.3 1.8 2.8 4.9 5.7 7.6 4.2 1.3 1.7 3.6 1.0 0.9 4.1 2.7 1.3 2.4 1.8 1.9 2.0 0.9 1.6 2.2 2.2 4.5 2.6 1.4 0.7 1.7 1.4 1.0 1.1 1.2 1.1 0.9 1.1 1.3 1.0 0.7 1.3 0.9 1.1 1.3 5.9 3.2 7.2 0.7 14.2 3.7 5.6 2.6 6.8 6.0 7.5 5.2 5.6 2.8 3.5 1.8 6.2 4.7 11.9 5.5 7.9 4.6 4.6 11.2 4.1 4.8 5.4 3.6 0.9 6.1 5.7 4.1 15.3 13.1 5.7 4.2 5.7 3.7 3.3 3.3 1.1 7.3 4.1 7.2 5.0 7.8 2.8 7.3 3.6 1.0 4.3 6.9 8.2 0.5 0.9 6.8 10.0 4.5 10.9 3.7 7.5 4.0 7.2 7.6 0.0 3.8 5.8 19.1 10.0 5.3 4.1 10.0 15.3 3.5 4.4 5.3 ZNF468 ENSG00000204604 "Zinc finger protein 468" Q5VIY5 19 52838010-52857649 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 44.4" NA NA "prognostic unfavorable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favorable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 2.9 4.3 2.5 4.3 2.1 7.4 6.4 4.0 2.5 4.6 2.5 6.7 3.5 3.5 6.5 4.0 5.9 4.4 2.2 1.9 1.9 6.3 2.2 4.1 6.0 2.2 2.4 1.7 3.1 5.9 6.8 1.8 9.5 2.6 7.3 7.4 3.2 4.0 4.7 1.5 4.3 5.4 3.1 1.7 4.6 7.2 3.3 1.9 6.6 12.3 3.2 6.5 4.7 3.8 2.8 9.7 0.5 4.3 10.7 5.8 5.4 26.9 6.3 9.0 8.6 13.2 8.3 6.9 14.0 6.1 7.2 9.7 6.1 8.1 6.6 12.0 0.0 10.6 10.5 4.8 5.5 20.4 0.2 12.2 8.0 10.3 11.6 12.4 4.8 6.6 9.0 9.4 0.1 7.6 3.0 11.5 8.4 5.4 9.7 8.8 7.3 12.2 7.8 11.5 44.4 5.6 6.1 13.1 9.3 3.1 12.2 11.0 9.9 4.7 2.4 6.5 4.3 9.6 4.6 13.3 14.0 0.2 1.5 11.5 7.5 5.7 11.2 10.1 9.0 10.5 6.9 6.7 8.2 6.1 8.2 8.1 7.3 5.3 16.5 8.0 3.9 8.9 8.4 2.5 2.1 4.0 2.5 1.9 1.9 2.2 2.4 1.7 2.6 1.7 1.9 2.8 3.9 3.2 4.8 1.3 5.9 3.3 5.3 4.6 7.4 0.8 6.3 4.3 3.9 8.6 6.5 9.2 0.0 9.0 7.1 8.2 17.6 6.8 3.1 8.9 5.8 4.0 8.5 7.4 2.1 9.7 12.8 4.1 6.6 18.4 17.2 5.5 5.0 3.5 6.4 0.0 2.0 11.3 6.1 9.4 4.9 1.3 0.9 4.5 1.8 3.7 5.4 0.6 5.2 1.0 3.3 9.7 6.7 2.6 3.9 12.1 4.7 6.1 2.9 0.2 0.0 1.9 3.2 0.5 3.4 7.3 5.4 24.1 6.5 2.8 8.5 14.0 TRIM15 "RNF93, ZNF178, ZNFB7" ENSG00000204610 "Tripartite motif containing 15" Q9C019 6 30163206-30172693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 17.2;kidney: 5.9;liver: 14.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0" "Group enriched" "Detected in many" 4 "colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "HEL: 16.5;Hep G2: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047527 Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA047527: " "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-1)" "unprognostic (1.71e-1)" "unprognostic (5.36e-2)" "unprognostic (1.92e-2)" "unprognostic (7.57e-4)" "unprognostic (5.27e-2)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (3.83e-1)" "unprognostic (1.63e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.7 17.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.9 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.7 12.3 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 11.5 0.0 0.0 0.0 0.0 0.0 139.1 1.9 1.8 0.0 0.0 0.1 0.0 0.0 2.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 41.5 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 332.0 0.0 0.0 0.0 80.0 21.5 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.5 0.0 29.1 0.0 ZNF616 MGC45556 ENSG00000204611 "Zinc finger protein 616" Q08AN1 19 52113091-52139938 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062639, HPA071539" Approved Approved Centrosome NA NA Centrosome "HPA062639: AB_2684815, HPA071539: AB_2686414" "unprognostic (5.98e-3)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (2.58e-2)" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (4.78e-3)" "unprognostic (1.97e-1)" "unprognostic (1.19e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (3.01e-2)" "unprognostic (1.32e-3)" 5.4 11.7 4.1 4.1 4.5 2.4 6.2 8.9 4.4 6.2 3.6 5.0 4.1 6.8 5.7 4.2 6.9 4.4 3.9 4.0 4.1 6.0 6.0 5.2 5.4 3.9 3.8 3.5 11.0 5.5 7.7 2.6 6.8 4.9 7.0 5.7 9.6 4.7 5.1 4.1 5.7 4.4 5.9 2.3 6.0 5.5 4.0 3.7 7.3 7.8 4.9 5.3 3.7 3.7 5.1 5.4 4.9 13.8 11.4 16.0 14.8 0.2 6.9 7.9 6.0 9.4 5.9 4.4 7.2 4.7 6.5 3.2 3.4 12.4 7.8 9.7 5.3 20.0 13.6 14.0 12.3 10.4 12.9 8.3 10.5 10.6 5.9 19.3 11.0 8.3 8.8 15.4 3.8 10.2 4.0 11.7 7.0 15.1 4.2 12.4 11.1 20.3 10.9 4.6 14.5 16.2 9.3 12.3 4.9 3.8 12.3 7.6 4.3 8.2 5.3 6.4 6.2 7.5 6.9 11.1 10.4 4.8 7.9 10.9 3.8 2.9 3.4 4.9 1.7 4.4 3.2 4.5 3.9 3.0 3.4 4.0 3.6 3.9 13.2 10.5 3.7 3.2 2.1 4.1 4.5 8.9 4.4 4.0 4.1 3.9 3.8 3.5 4.9 2.3 3.7 5.1 2.4 6.4 3.2 1.6 2.5 4.1 3.9 1.4 5.2 3.6 3.0 2.2 3.1 7.2 1.8 7.3 4.2 3.2 3.0 3.6 5.9 3.5 0.0 2.8 4.3 2.7 1.2 1.7 3.1 1.8 4.3 4.2 4.1 2.0 0.0 4.0 2.9 2.6 3.2 6.7 3.0 4.0 2.0 1.9 3.2 0.6 6.5 2.7 1.8 5.6 3.1 3.6 8.2 6.0 5.6 2.0 1.5 2.6 1.5 3.2 3.6 3.1 3.7 8.1 0.0 2.4 3.6 4.5 4.2 2.7 2.6 1.9 2.9 2.7 2.9 4.5 FOXB2 bA159H20.4 ENSG00000204612 "Forkhead box B2" Q5VYV0 9 77019655-77020953 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 48 "brain: 4.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.6" "Region enriched" "Detected in some" 5 "hypothalamus: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NTERA-2: 1.3" "Region enriched" "Detected in single" 11 "hypothalamus: 1.1" "Group enriched" "Detected in many" 4 "basal ganglia: 3.3;hypothalamus: 6.5;medulla oblongata: 2.8;midbrain: 2.8;spinal cord: 5.1" HPA067947 Approved NA NA "HPA067947: AB_2685930" "unprognostic (2.02e-1)" "unprognostic (8.58e-2)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 4.7 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM10 "HERF1, RFB30, RNF9" ENSG00000204613 "Tripartite motif containing 10" Q9UDY6 6 30151943-30161211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.9;kidney: 2.1;liver: 2.9" "Cell type enriched" "Detected in some" 21 "Erythroid cells: 126.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "HEL: 22.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hippocampal formation: 3.4" HPA043325 Uncertain NA NA "HPA043325: AB_2678428" "unprognostic (2.98e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (2.13e-1)" "unprognostic (2.98e-1)" "unprognostic (9.53e-3)" "unprognostic (6.32e-2)" "unprognostic (2.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.74e-3)" "unprognostic (1.46e-2)" "unprognostic (4.37e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.1 0.0 7.9 0.0 0.0 0.0 0.1 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 126.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 0.0 3.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 TRIM40 RNF35 ENSG00000204614 "Tripartite motif containing 40" Q6P9F5 6 30136124-30148735 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 3.0;liver: 1.6;testis: 1.4" "Group enriched" "Detected in some" 5 "Distal enterocytes: 20.1;Paneth cells: 24.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.7;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HEL: 1.1" "Region enriched" "Detected in single" 18 "thalamus: 3.1" "Low region specificity" "Detected in many" HPA043818 Uncertain Approved Cytosol NA NA Cytosol "HPA043818: AB_10963090" "unprognostic (2.88e-1)" "unprognostic (5.20e-2)" "unprognostic (4.11e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (4.84e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.7 0.0 0.0 0.0 3.8 0.5 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 TRIM31 "C6orf13, HCG1, HCGI, RNF" ENSG00000204616 "Tripartite motif containing 31" Q9BZY9 6 30102897-30113090 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.2;stomach 1: 6.0;urinary bladder: 8.6" "Group enriched" "Detected in some" 4 "Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9" "Group enriched" "Detected in many" 5 "cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 726 "RT4: 294.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA074175 Enhanced NA NA "HPA074175: " "unprognostic (1.37e-1)" "unprognostic (7.78e-3)" "unprognostic (1.83e-1)" "unprognostic (7.05e-3)" "unprognostic (1.75e-1)" "unprognostic (9.37e-2)" "unprognostic (6.13e-2)" "unprognostic (1.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-2)" "unprognostic (1.97e-2)" "unprognostic (1.92e-1)" "unprognostic (1.43e-3)" "unprognostic (5.84e-3)" "unprognostic (6.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 12.2 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.3 12.2 0.1 0.0 0.0 6.0 3.3 0.0 0.0 0.0 0.0 0.0 8.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 294.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.6 0.1 12.3 2.5 0.0 0.0 0.4 0.3 5.7 4.3 3.0 0.0 0.0 0.0 0.2 409.1 0.0 2.7 0.2 25.7 0.2 0.4 5.4 2.7 0.0 1.7 0.0 0.3 73.9 1.1 4.5 0.0 0.0 0.0 0.1 0.0 0.0 52.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 404.9 0.0 0.2 2.7 193.3 0.6 14.2 0.0 0.0 0.2 0.5 1.8 0.2 0.0 0.0 0.0 0.8 0.0 25.6 227.9 RNF39 "FAP216, HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 24.7;skin 1: 62.5;vagina: 21.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 79.9;Basal respiratory cells: 96.2;Club cells: 55.7;Prostatic glandular cells: 57.2;Urothelial cells: 233.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 4.5;U-266/84: 3.6" "Region enhanced" "Detected in many" "cerebral cortex: 8.1" "Group enriched" "Detected in many" 4 "cerebellum: 9.0;cerebral cortex: 8.0;hippocampal formation: 4.4" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: AB_2679938" "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.7 0.8 0.1 0.0 0.1 0.0 8.7 0.1 0.3 9.7 0.0 0.5 0.2 0.6 0.0 24.7 1.4 0.1 0.2 0.0 0.1 0.4 0.2 1.9 0.0 0.2 0.0 0.0 1.3 1.7 0.1 1.4 0.0 0.2 7.2 0.0 0.5 15.9 0.1 0.4 62.5 0.5 0.0 0.1 0.2 8.3 1.6 0.0 0.0 0.4 0.0 0.4 3.9 21.8 0.3 1.2 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.2 1.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.7 0.0 0.9 0.3 0.2 0.0 0.4 0.0 0.5 0.0 4.5 0.0 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.8 3.6 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.3 0.3 3.2 2.7 0.0 0.0 17.8 79.9 96.2 42.1 0.5 23.7 28.6 0.3 7.2 55.7 0.0 0.0 0.0 0.8 1.8 0.0 6.4 0.6 3.6 2.4 1.1 0.0 0.0 0.0 3.3 0.0 1.2 17.3 20.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 14.2 0.0 2.1 0.0 1.2 0.4 3.6 0.0 0.6 0.0 0.0 0.0 0.0 24.2 2.2 1.2 0.0 57.2 0.1 0.0 13.0 0.4 0.0 0.0 3.0 0.1 0.4 11.3 23.9 0.7 0.6 0.0 0.9 233.1 PPP1R11 "CFAP255, HCG-V, HCGV, TCTE5, Tctex5" ENSG00000204619 "Protein phosphatase 1 regulatory inhibitor subunit 11" O60927 6 30066709-30070333 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Late spermatids: 696.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 51.5;AN3-CA: 65.6;fHDF/TERT166: 48.6;GAMG: 47.4;HBEC3-KT: 53.6;JURKAT: 76.7;RPTEC TERT1: 47.4;U-266/84: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043266, HPA060174" Approved Approved Vesicles NA NA 43000 Vesicles "HPA043266: AB_2678400, HPA060174: AB_2684216" "unprognostic (2.00e-2)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (4.24e-2)" "unprognostic (3.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.77e-2)" "unprognostic (1.18e-1)" "unprognostic (2.81e-1)" "unprognostic (1.74e-3)" "unprognostic (3.33e-2)" "unprognostic (2.68e-1)" "unprognostic (8.36e-3)" "unprognostic (1.74e-1)" "unprognostic (3.31e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-3)" 41.9 41.5 1.7 0.0 3.9 1.9 41.7 1.7 8.7 41.8 1.7 55.0 11.7 50.0 33.4 52.5 37.6 11.9 48.9 1.8 1.7 54.7 47.9 44.0 5.5 1.9 1.8 1.7 42.2 45.5 2.3 29.4 5.9 3.3 46.7 0.7 7.9 43.1 0.0 50.8 42.4 51.1 0.0 1.7 40.1 60.0 41.8 3.0 9.8 42.6 0.0 11.9 52.0 43.1 2.2 51.5 0.0 0.0 65.6 29.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 48.6 47.4 0.0 0.0 53.6 0.0 1.0 34.5 42.6 0.0 0.0 0.0 3.0 3.9 0.0 0.0 0.0 0.7 0.0 0.0 76.7 0.5 2.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 47.4 29.0 0.0 0.0 0.7 35.5 4.8 26.8 0.0 0.0 0.0 0.0 0.3 4.1 1.5 30.7 64.9 26.7 0.7 0.0 0.0 11.5 4.1 12.4 4.7 9.3 4.5 6.8 5.3 6.5 2.2 7.2 4.9 7.0 2.8 3.9 7.9 3.2 8.4 6.8 1.7 3.9 1.7 8.7 1.8 1.7 1.9 1.8 1.7 3.3 1.7 3.0 2.2 38.2 19.2 20.2 2.6 57.8 52.8 80.0 77.2 29.0 29.3 47.7 32.8 18.8 52.9 49.7 40.5 6.2 56.0 39.2 111.5 95.9 142.2 242.1 19.8 24.2 44.3 53.7 32.4 10.1 136.3 119.9 27.0 53.5 31.8 78.6 21.4 45.7 28.0 65.7 13.5 9.0 83.8 77.3 49.7 53.8 696.0 32.3 43.5 62.2 3.7 75.4 58.4 92.7 6.0 7.6 136.5 114.1 40.3 42.2 66.6 139.6 93.3 38.7 33.1 39.5 27.2 89.4 61.9 23.2 39.0 66.5 75.2 52.4 16.5 51.8 94.9 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479155-11537551 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;pituitary gland: 3.5;retina: 4.6;testis: 6.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;NTERA-2: 2.1;SCLC-21H: 2.0;SH-SY5Y: 6.8;SiHa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.0 0.3 6.9 0.1 8.5 0.0 0.0 4.1 8.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 8.5 5.0 0.1 0.0 0.1 0.1 5.3 4.4 6.4 0.1 0.5 0.0 3.5 0.0 3.9 0.5 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.3 0.1 6.4 5.4 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 4.9 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.5 0.0 1.3 0.0 0.1 2.0 6.8 1.6 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 8.5 4.1 8.1 8.5 5.0 5.3 4.4 6.4 3.9 2.0 5.4 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RACK1 "Gnb2-rs1, GNB2L1, H12.3" ENSG00000204628 "Receptor for activated C kinase 1" P63244 5 181236897-181248096 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004288, HPA021676" Uncertain Supported Nucleoplasm,Cytosol NA NA 630000 Nucleoplasm Cytosol "CAB004288: AB_2247471, HPA021676: AB_1849868" "unprognostic (4.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.03e-2)" "unprognostic (1.07e-2)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (4.19e-1)" "unprognostic (3.04e-1)" "unprognostic (2.00e-1)" "unprognostic (2.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.05e-3)" "unprognostic (3.67e-1)" "unprognostic (1.78e-1)" "unprognostic (3.50e-1)" "unprognostic (2.62e-1)" 872.6 724.8 461.7 707.8 470.8 1603.9 1450.2 470.4 531.5 1088.8 513.2 1043.4 754.5 893.1 998.0 1165.5 1378.7 739.3 682.7 442.7 508.1 640.5 823.6 636.9 1369.7 507.0 471.1 428.7 2550.3 1517.4 727.6 587.1 770.2 495.0 722.4 931.4 289.0 1214.6 644.1 1176.7 1252.9 794.8 830.7 514.8 828.8 759.8 232.5 500.2 1718.9 827.7 1162.4 1603.1 1035.9 903.9 506.1 1606.0 1783.0 1498.7 2930.0 2671.8 4139.8 2576.4 1409.8 2832.1 2364.7 2463.4 3845.9 1671.3 3592.6 1735.5 2068.5 1668.5 1216.3 1867.9 6501.5 1729.1 3457.2 3068.4 1205.2 1939.5 2508.6 3610.1 3145.0 1193.1 4375.7 3664.7 1935.6 3427.8 2880.2 2705.8 2328.3 1610.6 2717.9 2117.6 3742.7 2435.7 2703.6 1535.1 1487.1 1504.9 2218.3 1536.5 3279.6 2733.5 2152.4 1969.8 2163.4 865.3 2682.2 4446.4 1015.6 1882.1 2802.9 2089.8 1297.4 1032.1 1029.1 2315.5 1767.8 2293.6 2063.5 1242.5 2470.7 1440.5 577.1 1163.9 290.3 829.2 908.1 1333.4 1732.3 1391.2 1062.0 1405.6 1689.0 1597.5 1348.6 138.6 1092.2 861.8 1037.0 1465.0 3377.9 461.7 470.8 470.4 531.5 442.7 508.1 507.0 471.1 428.7 495.0 514.8 500.2 506.1 896.6 576.9 935.7 0.0 698.1 0.0 0.0 0.0 0.0 0.0 3642.0 3742.9 0.0 0.0 452.5 498.4 0.0 3252.2 821.7 0.0 1749.1 1773.1 0.0 590.9 1560.3 523.7 0.0 0.0 0.0 3361.4 4389.3 783.3 0.0 818.8 671.1 1822.8 0.0 0.0 1964.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 669.4 0.0 0.0 1169.6 0.0 0.0 0.0 0.0 2097.2 0.0 0.0 200.2 0.0 0.0 2538.2 253.6 0.0 0.0 0.0 689.9 0.0 0.0 0.0 0.0 3206.0 503.5 2464.9 0.0 0.0 HLA-G ENSG00000204632 "Major histocompatibility complex, class I, G" P17693 6 29826967-29831125 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pituitary gland: 13.9;placenta: 11.2" "Cell type enriched" "Detected in many" 45 "Extravillous trophoblasts: 1850.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" CAB016158 Enhanced "Secreted to blood" NA NA 32800000 67000000 "CAB016158: AB_627938" "unprognostic (1.13e-2)" "unprognostic (9.95e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-3)" "unprognostic (2.51e-1)" "prognostic favorable (3.91e-5)" "unprognostic (6.34e-2)" "unprognostic (8.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (1.52e-2)" "unprognostic (3.19e-3)" 0.4 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.7 0.7 0.2 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.5 0.4 2.8 0.0 0.0 0.0 0.0 0.2 1.2 0.0 13.9 11.2 0.0 0.3 0.0 0.0 0.6 0.0 0.2 0.4 0.7 0.0 0.0 1.3 0.7 2.7 0.0 0.4 0.6 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 1.4 0.8 0.6 1.0 0.7 0.6 0.9 0.4 0.5 0.5 1.3 2.1 0.8 0.6 0.1 1.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 1.2 22.8 7.3 7.1 1.2 0.0 0.2 0.0 0.8 4.3 1.8 0.0 0.0 10.7 2.7 28.1 0.0 4.5 20.1 0.9 1.3 8.8 17.5 2.7 0.0 5.6 1850.2 5.5 1.5 2.6 0.0 0.7 6.4 1.2 25.5 0.0 0.0 34.3 2.0 8.1 27.3 13.0 2.5 4.8 12.4 0.0 1.4 0.0 3.1 0.0 0.0 24.9 19.9 2.6 0.9 14.3 0.2 0.3 0.6 0.0 0.0 4.8 3.8 5.9 2.8 0.1 35.2 40.5 6.8 1.9 18.2 15.0 TBC1D8 "AD3, GRAMD8, HBLP1, VRP" ENSG00000204634 "TBC1 domain family member 8" O95759 2 101007228-101252866 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 30.1;non-classical monocyte: 38.2" "Lineage enriched" "Detected in many" 5 "monocytes: 38.2" "Cell line enhanced" "Detected in many" "ASC diff: 82.9;ASC TERT1: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015211, HPA037496" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB015211: , HPA037496: AB_2675507" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (4.25e-3)" "unprognostic (3.98e-1)" "unprognostic (2.12e-2)" "unprognostic (1.08e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-2)" "unprognostic (2.38e-1)" "unprognostic (8.53e-2)" "unprognostic (1.82e-1)" "unprognostic (2.25e-2)" "unprognostic (8.02e-2)" "unprognostic (1.26e-1)" "unprognostic (6.73e-2)" "unprognostic (7.98e-3)" 14.2 6.4 4.3 9.0 5.0 12.8 22.0 8.0 4.8 13.6 8.2 7.8 7.2 10.7 7.9 15.6 20.1 18.3 39.0 5.1 5.7 17.0 25.0 23.4 7.3 6.2 5.0 4.4 8.5 34.6 17.7 13.1 3.1 6.9 44.4 6.0 6.6 19.2 30.5 84.4 26.3 28.9 6.9 3.8 14.6 27.4 18.2 5.5 6.5 9.7 80.4 6.9 13.2 17.6 6.3 5.1 30.1 2.6 8.6 82.9 57.8 24.4 3.1 51.8 2.1 2.6 10.8 8.0 2.6 27.1 2.3 42.5 15.5 5.0 23.5 1.4 1.5 4.6 1.5 11.1 37.7 5.7 0.3 26.0 27.4 21.8 2.8 21.6 1.7 30.2 4.5 0.7 2.6 2.7 13.3 2.8 15.8 6.7 3.6 32.3 6.4 7.5 0.6 17.0 32.3 18.7 9.2 4.2 7.4 10.8 4.0 2.1 23.1 26.0 1.3 4.5 4.4 2.1 5.0 0.4 0.2 10.9 7.7 8.0 0.0 9.7 0.4 0.2 30.1 0.3 0.4 0.3 0.2 5.0 1.5 0.6 0.4 0.3 0.0 38.2 7.2 0.2 4.1 4.3 5.0 8.0 4.8 5.1 5.7 6.2 5.0 4.4 6.9 3.8 5.5 6.3 4.3 3.2 4.6 10.7 2.8 4.1 38.3 7.2 23.9 6.4 15.0 3.9 12.2 18.6 14.4 5.5 4.2 4.6 4.8 1.1 0.0 8.2 6.0 42.6 4.7 9.8 3.0 0.8 43.5 3.0 2.8 4.3 31.6 23.7 7.0 0.9 11.7 5.6 3.7 1.7 42.8 2.2 10.2 13.8 17.7 10.9 3.1 27.7 5.4 22.5 28.1 1.0 0.0 23.6 6.5 2.6 2.4 1.9 1.4 35.0 4.8 1.2 31.9 3.7 6.6 24.7 4.3 3.6 4.0 29.8 6.3 3.4 1.6 2.7 1.1 29.7 NMS ENSG00000204640 "Neuromedin S" Q5H8A3 2 100470482-100483280 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HL-60: 8.4;HMC-1: 4.8" "Group enriched" "Detected in some" 4 "basal ganglia: 2.4;hypothalamus: 5.4;pons and medulla: 1.3" "Secreted in brain" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.7 1.8 0.1 0.0 0.3 1.2 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLA-F ENSG00000204642 "Major histocompatibility complex, class I, F" P30511 6 29722775-29738528 "Plasma proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 189.8" "Cell type enhanced" "Detected in many" "dendritic cells: 220.4;NK-cells: 339.8;Proximal enterocytes: 298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A-431: 36.3;GAMG: 13.5;HEK 293: 12.5;HEL: 8.9;HHSteC: 10.1;JURKAT: 7.6;U-266/70: 8.5;U-937: 13.6" NA NA 15000000 "unprognostic (3.07e-3)" "unprognostic (5.16e-2)" "unprognostic (3.05e-1)" "unprognostic (9.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (4.99e-2)" "unprognostic (2.68e-1)" "unprognostic (4.21e-3)" "unprognostic (2.43e-3)" "unprognostic (3.21e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (1.26e-1)" "unprognostic (2.95e-2)" "unprognostic (4.13e-2)" "unprognostic (1.30e-2)" 55.1 36.9 3.0 1.9 1.0 1.8 52.6 0.3 2.0 43.0 0.5 44.7 29.0 41.5 2.3 21.1 38.5 18.9 36.3 1.0 0.7 35.3 30.1 92.6 41.7 2.9 0.5 0.3 20.0 14.5 0.2 25.9 1.2 2.9 31.8 2.7 1.0 28.3 2.2 14.8 38.5 102.2 0.3 0.9 189.8 36.5 7.4 2.6 1.9 40.9 0.0 10.3 30.3 38.8 7.2 36.3 0.0 0.0 0.1 0.2 0.8 0.2 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.0 0.1 13.5 1.4 0.0 1.3 0.0 0.8 12.5 8.9 0.4 0.1 10.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 7.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.4 2.3 0.0 0.0 0.1 0.0 0.5 1.7 0.0 0.0 0.6 0.1 0.1 1.2 0.2 8.5 1.9 0.1 0.0 13.6 0.1 54.3 16.8 42.8 34.9 21.6 25.9 19.4 22.8 28.5 1.1 16.9 21.5 21.2 31.9 32.7 32.0 6.5 25.1 15.2 3.0 1.0 0.3 2.0 1.0 0.7 2.9 0.5 0.3 2.9 0.9 2.6 7.2 180.1 38.5 64.7 2.6 133.4 40.9 32.7 58.4 12.5 1.5 19.9 17.0 12.2 50.1 37.0 7.3 2.1 0.4 220.4 214.3 1.9 75.9 2.2 8.6 13.9 110.6 22.8 29.9 2.7 87.8 0.8 27.3 69.8 14.2 50.0 3.4 71.7 30.4 55.3 0.0 6.2 119.2 69.2 96.9 50.3 1.4 28.3 99.4 28.4 12.2 207.1 4.6 339.8 4.5 0.7 71.4 122.0 21.1 92.3 41.8 298.8 4.9 34.3 1.3 46.0 20.7 36.2 10.0 3.9 11.4 37.5 0.3 198.9 24.9 90.8 62.5 ZFP57 "bA145L22, bA145L22.2, C6orf40, ZNF698" ENSG00000204644 "ZFP57 zinc finger protein" Q9NU63 6 29672483-29681155 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "heart muscle: 9.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.8;Erythroid cells: 4.6;Extravillous trophoblasts: 4.4;Ionocytes: 8.2;Late spermatids: 5.9;Pancreatic endocrine cells: 4.0;Spermatogonia: 3.6" "Cancer enriched" "Detected in many" 10 "testis cancer: 18.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 5 "basophil: 11.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.1" "Group enriched" "Detected in some" 13 "BEWO: 40.3;SuSa: 12.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.35e-1)" "unprognostic (1.74e-1)" "unprognostic (5.02e-2)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.72e-3)" "unprognostic (4.65e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-4)" "prognostic favorable (1.95e-4)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (2.29e-2)" "unprognostic (8.56e-2)" "unprognostic (7.45e-2)" "unprognostic (6.11e-2)" 0.3 0.3 0.1 0.0 0.3 1.9 1.6 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.4 0.2 9.0 0.0 0.1 0.2 0.0 0.6 0.9 0.5 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.3 0.5 0.2 0.0 0.7 2.2 0.0 0.7 0.4 0.2 0.2 1.0 0.0 0.7 0.2 0.3 0.1 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 11.1 1.4 0.0 1.7 0.9 0.7 0.8 1.0 1.1 2.1 0.2 0.3 1.0 0.0 1.3 0.3 0.1 1.5 1.2 0.1 0.3 0.2 0.3 0.0 0.1 0.5 0.2 0.0 0.3 0.2 0.2 0.8 1.1 0.0 0.6 0.0 0.7 0.3 0.2 0.4 2.8 0.0 0.6 1.8 4.8 0.0 0.2 0.0 0.0 0.2 0.7 0.0 0.0 0.9 2.1 0.0 0.0 0.1 0.0 4.6 0.0 1.1 4.4 0.6 1.1 0.0 2.5 2.0 0.0 0.0 1.2 0.0 0.1 0.0 8.2 0.0 1.3 5.9 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 2.1 4.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 3.6 0.3 0.1 0.3 1.7 0.2 0.1 0.1 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.5;kidney: 38.0;liver: 133.5" "Group enriched" "Detected in some" 6 "Hepatocytes: 135.8;Proximal tubular cells: 487.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;MOLT-4: 16.5;SH-SY5Y: 9.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042631, HPA042654" Approved Approved Nucleoplasm,Cytosol NA NA 200000 Nucleoplasm Cytosol "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 0.5 2.5 15.4 1.0 16.8 0.5 0.0 21.2 40.5 0.0 4.9 0.2 6.6 0.2 0.0 0.3 0.0 1.7 0.3 17.4 14.4 38.0 133.5 0.2 1.0 14.8 15.2 14.8 0.0 0.8 0.0 19.8 0.0 16.9 0.3 0.0 5.5 1.6 0.0 0.3 1.1 2.5 0.0 11.4 0.6 0.3 0.2 19.6 2.4 0.9 0.0 0.0 0.1 0.1 19.2 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.6 0.0 0.7 3.8 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 1.7 0.0 1.6 16.5 0.1 0.0 0.6 0.2 0.4 0.3 1.1 0.0 0.2 1.7 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 3.6 0.8 1.8 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 16.8 21.2 40.5 17.4 14.4 14.8 15.2 14.8 16.9 11.4 19.6 19.2 0.0 0.0 0.0 3.3 2.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.4 1.5 0.0 9.2 4.2 0.0 0.0 0.1 45.0 0.0 0.7 0.0 0.0 0.1 7.1 10.7 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 135.8 0.0 0.0 4.4 0.1 0.0 1.9 0.0 2.5 0.0 3.4 0.0 2.8 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 8.8 487.2 0.0 4.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 MOG "BTN6, BTNL11" ENSG00000204655 "Myelin oligodendrocyte glycoprotein" Q16653 6 29657002-29672372 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 66.1" "Cell type enriched" "Detected in some" 49 "Oligodendrocytes: 472.3" "Cancer enriched" "Detected in single" 45 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "white matter: 1396.5" "Low region specificity" "Detected in all" HPA021873 Enhanced NA NA "HPA021873: AB_1854055" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (3.00e-4)" "unprognostic (4.89e-2)" "unprognostic (4.90e-2)" 0.0 0.0 17.7 0.0 23.1 0.0 0.0 20.9 66.1 0.0 15.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 19.0 21.9 0.0 0.0 0.0 0.0 27.8 21.4 17.2 0.1 0.0 0.0 0.3 0.0 53.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 23.1 20.9 66.1 19.0 21.9 27.8 21.4 17.2 53.2 20.1 21.6 35.2 0.0 0.0 1.1 0.7 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 9.5 472.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.3 OR2H2 hs6M1-12 ENSG00000204657 "Olfactory receptor family 2 subfamily H member 2" O95918 6 29585121-29590500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 4.8;testis: 2.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.95e-1)" "unprognostic (3.76e-1)" "unprognostic (2.33e-2)" "unprognostic (2.42e-1)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" 0.0 0.0 0.6 0.1 1.6 0.7 0.0 1.1 0.8 0.2 0.0 0.1 0.0 0.1 4.8 0.1 0.2 0.0 0.3 0.6 0.1 0.0 0.0 0.1 0.2 1.0 0.2 0.5 0.3 0.0 0.0 0.5 0.0 0.5 0.3 0.0 1.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.1 2.3 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 1.1 0.8 0.6 0.1 1.0 0.2 0.5 0.5 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CBY3 ENSG00000204659 "Chibby family member 3" A6NI87 5 179678560-179681034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.5" "Group enriched" "Detected in some" 117 "Early spermatids: 211.1;Late spermatids: 351.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.3;HeLa: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA069037 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069037: AB_2686069" "unprognostic (1.33e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (1.76e-1)" "unprognostic (8.68e-3)" "unprognostic (7.69e-3)" "unprognostic (5.71e-2)" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (6.10e-4)" "unprognostic (2.69e-2)" "unprognostic (1.67e-2)" "unprognostic (9.76e-3)" "unprognostic (7.85e-2)" "unprognostic (5.04e-3)" "unprognostic (4.98e-2)" 0.2 0.4 0.5 0.0 0.3 0.0 0.3 0.5 0.3 0.5 0.0 0.5 0.1 0.5 0.0 0.2 0.7 0.0 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.7 0.3 0.2 0.8 1.0 0.0 0.9 0.0 0.8 0.5 0.0 0.4 0.5 0.0 0.4 0.3 0.5 0.0 0.2 0.5 0.4 15.5 0.3 0.0 0.6 0.0 0.0 0.5 0.4 0.5 0.0 0.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.2 0.3 0.2 0.5 0.1 0.2 0.9 0.5 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.5 0.3 0.5 0.3 0.2 0.2 0.7 0.3 0.2 0.8 0.2 0.3 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 211.1 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 351.4 1.5 0.2 0.0 1.9 0.0 0.0 0.0 1.0 2.4 0.0 0.0 1.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C9orf57 ENSG00000204669 "Chromosome 9 open reading frame 57" Q5W0N0 9 72051376-72072721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 13.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.26e-2)" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL31 IL-31 ENSG00000204671 "Interleukin 31" Q6EBC2 12 122172029-122174221 "Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "Early spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB025657 Uncertain "Secreted to blood" NA NA 37800 "CAB025657: " "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKT1S1 "Lobe, MGC2865, PRAS40" ENSG00000204673 "AKT1 substrate 1" Q96B36 19 49869033-49878459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021903, HPA043590, HPA064427" Uncertain Supported Cytosol NA NA Cytosol "CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-1)" "unprognostic (2.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-1)" "prognostic favorable (6.60e-4)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.34e-6)" "unprognostic (3.20e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (3.65e-1)" 37.3 54.4 37.7 14.3 35.0 14.4 35.2 35.0 41.3 33.3 26.1 38.4 22.0 39.5 14.4 53.6 32.9 12.5 43.1 32.6 33.1 36.2 66.4 25.8 8.8 39.6 35.2 29.3 33.3 39.5 24.6 34.5 16.8 37.1 35.3 14.3 6.6 33.1 20.2 119.2 53.1 29.6 17.7 33.4 24.8 40.9 24.2 36.6 8.2 31.6 45.8 9.7 38.8 33.5 41.4 70.9 83.8 24.1 56.0 50.2 53.4 42.5 62.2 69.4 57.4 49.4 45.7 46.0 14.1 31.1 70.6 43.5 47.9 41.9 70.5 33.5 32.2 116.6 17.0 48.2 43.5 44.6 14.9 26.8 65.9 64.0 62.3 70.2 43.0 53.9 16.8 57.0 18.2 52.5 49.5 14.0 36.7 63.0 85.7 120.9 17.1 33.8 43.2 57.9 49.3 56.2 65.4 53.2 93.7 39.9 28.1 49.1 28.9 52.5 118.1 61.7 34.2 62.1 26.4 69.8 15.2 68.4 27.2 57.5 0.1 1.1 0.9 0.7 1.4 0.4 0.4 0.5 0.7 0.8 0.7 0.4 0.7 1.7 0.7 1.6 1.2 1.0 0.6 37.7 35.0 35.0 41.3 32.6 33.1 39.6 35.2 29.3 37.1 33.4 36.6 41.4 20.7 0.0 3.3 7.2 15.1 14.7 22.9 33.8 18.8 12.6 31.2 22.6 6.2 27.1 15.5 11.0 2.1 64.0 10.7 56.1 45.0 36.8 24.8 18.2 22.9 20.6 30.0 42.5 4.1 40.2 52.3 23.5 32.1 25.3 4.5 18.6 17.9 42.8 31.1 10.1 4.9 38.8 30.5 20.7 22.8 10.8 23.9 16.6 12.4 4.7 26.9 32.9 15.5 2.5 8.1 34.5 32.9 28.6 17.1 43.3 57.1 55.8 7.2 11.7 26.3 23.7 25.3 12.3 19.3 32.1 20.0 130.0 9.4 26.5 38.1 31.3 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 150.5;Excitatory neurons: 58.7;Inhibitory neurons: 68.1;Oligodendrocyte precursor cells: 72.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "cerebral cortex: 33.2;hippocampal formation: 13.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 6.3;HEL: 6.4;U-2 OS: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA050483: AB_2681140, HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavorable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 18.4 18.2 2.4 2.4 2.6 2.8 20.9 1.1 33.2 44.1 0.0 27.7 0.2 43.2 0.0 14.6 39.3 0.9 25.8 13.7 0.0 17.0 4.8 20.8 2.0 4.2 0.0 0.0 41.0 10.4 1.1 31.0 1.3 4.7 34.6 0.5 0.5 16.5 4.3 6.1 16.7 20.4 1.4 0.0 39.4 18.6 8.0 1.5 0.2 23.0 0.0 1.3 25.5 31.9 2.7 2.4 0.0 1.5 6.3 0.7 1.6 1.6 1.6 0.7 1.4 0.4 1.9 0.1 1.1 1.5 0.0 0.3 2.0 0.7 0.0 0.0 5.9 2.6 6.4 3.7 0.0 0.9 0.2 3.1 0.0 0.0 1.2 0.0 1.8 0.8 3.3 5.5 0.0 0.2 1.5 0.6 0.1 0.4 0.0 0.9 2.9 0.6 0.1 0.2 0.0 0.4 1.0 0.4 0.0 2.6 0.4 1.2 0.9 3.6 2.5 6.2 0.2 3.1 5.4 0.6 0.0 1.4 2.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 2.4 2.6 1.1 33.2 13.7 0.0 4.2 0.0 0.0 4.7 0.0 1.5 2.7 16.8 12.8 20.2 150.5 10.6 11.9 6.2 4.7 10.2 30.6 13.4 17.7 13.9 1.5 10.7 3.7 0.0 0.3 5.7 0.8 0.0 1.4 4.7 1.3 30.6 17.0 7.2 5.7 58.7 0.9 0.2 16.0 1.5 1.9 7.6 14.6 22.5 0.3 1.1 23.5 68.1 4.7 2.0 5.9 18.3 3.1 15.2 14.4 0.0 19.7 11.0 9.8 0.0 72.4 16.3 1.7 1.6 25.6 0.7 7.6 0.1 1.0 1.1 17.3 13.1 12.5 18.8 1.2 2.7 5.3 11.1 0.5 5.9 6.7 1.5 2.8 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 3.2;epididymis: 1.9" "Cell type enriched" "Detected in single" 62 "granulocytes: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 0.3 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.7 0.3 0.7 1.9 1.1 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.2 0.0 0.3 0.7 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2H1 "OR2H6, OR2H8, OR6-2" ENSG00000204688 "Olfactory receptor family 2 subfamily H member 1" Q9GZK4 6 29457181-29464328 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 128 "testis: 12.7" "Cell type enriched" "Detected in some" 4 "Early spermatids: 65.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11A1 "hs6M1-18, OR11A2" ENSG00000204694 "Olfactory receptor family 11 subfamily A member 1" Q9GZK7 6 29425504-29457071 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 93 "Early spermatids: 33.7;Late spermatids: 41.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.0 0.6 0.5 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14J1 "hs6M1-28, OR5U1" ENSG00000204695 "Olfactory receptor family 14 subfamily J member 1" Q9UGF5 6 29301701-29313017 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.4;retina: 2.0" "Group enriched" "Detected in some" 4 "Club cells: 1.3;granulocytes: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.2 1.7 0.5 2.3 1.2 0.2 5.4 5.0 0.1 0.0 0.2 0.3 0.3 0.5 0.2 0.1 0.3 0.2 1.7 0.5 0.2 0.6 0.2 0.4 1.3 0.9 0.8 0.3 0.1 0.0 0.0 0.3 2.2 0.2 0.2 2.0 0.4 0.1 0.5 0.8 0.4 0.1 0.1 0.5 0.3 0.6 0.6 0.1 0.3 0.0 0.2 0.1 0.0 4.7 0.5 0.3 0.4 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.4 0.5 0.5 0.6 0.1 0.3 0.3 0.0 0.0 0.0 0.6 0.1 0.5 1.2 0.5 0.0 0.4 0.4 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.4 1.5 0.1 0.3 0.3 0.6 0.7 0.1 0.2 0.3 0.4 0.3 0.1 0.7 0.4 0.5 0.5 0.3 0.2 0.5 0.5 0.4 0.7 0.6 0.5 0.9 0.4 0.9 0.5 0.3 0.4 0.3 0.5 1.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.7 0.2 0.2 0.2 0.1 0.0 1.7 2.3 5.4 5.0 1.7 0.5 1.3 0.9 0.8 2.2 0.1 0.6 4.7 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR2J2 "dJ80I19.4, hs6M1-6, OR6-8" ENSG00000204700 "Olfactory receptor family 2 subfamily J member 2" O76002 6 29170907-29175811 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.2 0.2 0.1 0.2 0.9 0.7 0.1 0.5 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2J3 OR6-6 ENSG00000204701 "Olfactory receptor family 2 subfamily J member 3" O76001 6 29108058-29114770 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.1 0.1 0.1 0.7 0.5 0.0 0.5 0.7 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2J1 "dJ80I19.2, hs6M1-4, OR2J1P, OR6-5" ENSG00000204702 "Olfactory receptor family 2 subfamily J member 1" Q9GZK6 6 29099657-29102701 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B3 "OR2B3P, OR6-4" ENSG00000204703 "Olfactory receptor family 2 subfamily B member 3" O76000 6 29086208-29087313 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W1 hs6M1-15 ENSG00000204704 "Olfactory receptor family 2 subfamily W member 1" Q9Y3N9 6 29044213-29045240 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYC Ringo2 ENSG00000204710 "Speedy/RINGO cell cycle regulator family member C" Q5MJ68 11 65170154-65173244 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "liver: 3.1;testis: 1.0" "Cell type enhanced" "Detected in some" "Early spermatids: 2.3;Extravillous trophoblasts: 4.6;Hepatocytes: 3.0;Late spermatids: 9.8;Macrophages: 1.8;Spermatogonia: 3.3;Syncytiotrophoblasts: 1.9" "Cancer enhanced" "Detected in many" "breast cancer: 6.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.2;HEL: 7.1;Hep G2: 3.1;K-562: 17.2" "Not detected" "Not detected" HPA039891 Uncertain NA NA "HPA039891: AB_10795260" "prognostic unfavorable (1.20e-5)" "unprognostic (7.35e-2)" "unprognostic (4.42e-2)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-2)" "unprognostic (1.31e-3)" "unprognostic (5.08e-2)" "unprognostic (1.85e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-1)" "unprognostic (4.75e-2)" "unprognostic (7.97e-2)" "unprognostic (2.53e-1)" "unprognostic (6.60e-4)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 7.1 0.0 3.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 9.8 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.0 1.9 0.0 0.0 0.1 0.0 C9orf135 ENSG00000204711 "Chromosome 9 open reading frame 135" Q5VTT2 9 69820817-69906227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 37.2;testis: 15.6" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 77.2;Early spermatids: 192.0;Endometrial ciliated cells: 198.0;Respiratory ciliated cells: 277.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 7.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.7;T-reg: 1.5" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 5 "HAP1: 11.7;NTERA-2: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021261, HPA021325" Uncertain NA NA "HPA021261: AB_1845811, HPA021325: AB_1845812" "unprognostic (1.05e-2)" "unprognostic (4.39e-1)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (1.90e-1)" "unprognostic (5.22e-3)" "unprognostic (5.72e-1)" "unprognostic (3.25e-3)" "unprognostic (4.11e-2)" "unprognostic (2.04e-1)" "unprognostic (7.60e-2)" 0.0 0.4 1.3 0.0 0.4 0.0 0.0 0.4 0.2 0.8 5.5 0.0 0.0 0.5 0.0 0.0 37.2 1.4 0.0 0.4 1.2 1.3 0.0 2.2 0.0 1.4 1.7 0.1 0.0 0.5 3.0 7.6 0.0 1.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 15.6 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 1.5 0.0 1.3 0.4 0.4 0.2 0.4 1.2 1.4 1.7 0.1 1.0 2.5 0.7 0.8 0.0 0.0 2.0 0.0 0.0 0.4 0.0 14.7 0.0 0.1 0.3 0.5 2.5 0.0 30.8 1.8 77.2 0.1 0.0 0.7 17.6 0.7 192.0 198.0 2.1 0.5 1.8 0.0 0.5 0.0 0.0 0.5 0.0 2.4 1.3 0.3 0.0 0.0 0.1 0.0 0.4 0.3 12.2 0.0 1.1 22.0 2.5 0.6 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.2 0.1 0.7 0.0 0.1 0.0 2.2 277.3 1.5 0.0 0.0 5.7 41.8 1.3 0.0 0.1 0.0 0.5 0.1 0.0 0.3 TRIM27 "RFP, RNF76" ENSG00000204713 "Tripartite motif containing 27" P14373 6 28903002-28923988 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048684, HPA053408" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA048684: AB_2680493, HPA053408: AB_2682139" "unprognostic (1.57e-1)" "unprognostic (1.48e-2)" "unprognostic (2.36e-1)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (2.56e-1)" "unprognostic (2.00e-3)" "unprognostic (1.17e-2)" "unprognostic (1.01e-2)" "unprognostic (1.12e-3)" "unprognostic (4.76e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.50e-6)" "unprognostic (1.27e-1)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "prognostic favorable (2.71e-4)" 22.1 28.3 1.6 7.3 1.3 1.2 23.5 0.8 2.8 31.7 1.7 21.8 8.8 24.7 0.0 20.6 31.3 0.5 22.8 1.4 2.3 27.4 59.9 27.1 2.2 1.5 1.9 1.0 31.1 53.5 0.6 34.0 4.6 1.8 35.4 0.6 0.2 26.0 6.5 21.4 17.7 27.0 2.3 1.2 46.2 27.6 14.5 1.8 0.9 26.5 0.0 1.0 28.9 22.8 1.8 2.4 8.2 1.2 21.7 2.8 6.2 0.3 16.1 0.8 5.1 6.2 6.1 1.7 1.6 1.1 4.8 1.3 17.5 4.0 9.2 0.5 1.3 2.6 20.3 2.5 9.3 4.3 2.0 5.7 0.1 1.0 4.1 1.3 0.6 4.5 5.8 2.1 12.1 1.3 4.9 11.1 0.9 0.0 3.4 13.5 20.1 4.6 49.7 3.9 2.3 4.9 18.7 19.9 11.6 4.1 0.6 11.6 12.2 13.1 6.3 9.3 14.7 5.1 31.7 2.7 17.9 6.8 24.8 20.0 5.2 4.4 2.5 7.0 12.5 11.3 7.0 10.6 5.5 8.5 1.8 4.1 7.6 2.7 6.4 7.0 5.6 5.2 9.9 1.6 1.3 0.8 2.8 1.4 2.3 1.5 1.9 1.0 1.8 1.2 1.8 1.8 21.4 16.0 24.8 11.8 32.2 28.4 41.9 27.4 33.6 11.7 32.2 24.6 18.3 24.3 24.0 29.5 16.7 46.4 25.4 15.9 21.5 39.5 12.9 27.1 27.0 32.0 27.6 24.6 13.5 43.4 55.5 25.5 26.5 27.2 21.5 36.9 27.8 42.1 41.1 8.4 13.4 38.5 26.4 28.3 23.5 6.8 23.9 29.0 8.8 16.9 46.5 10.4 29.9 19.1 19.7 48.9 18.7 18.4 51.2 53.3 19.3 27.6 23.9 13.6 19.7 14.8 31.0 8.0 16.1 25.8 19.6 45.6 28.9 43.7 28.3 30.9 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048801-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 31.4" "Group enriched" "Detected in some" 4 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3" "Cancer enhanced" "Detected in some" "breast cancer: 0.9;stomach cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Karpas-707: 44.2" "Not detected" "Not detected" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837" "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.7 1.8 0.2 1.8 0.4 0.6 1.1 1.3 0.6 1.2 0.4 30.9 0.6 2.2 0.2 0.2 0.4 0.9 1.7 3.6 1.5 0.1 0.9 0.1 1.4 1.1 1.2 1.2 0.1 0.0 1.5 0.4 1.4 0.6 0.1 0.3 0.1 0.3 0.6 0.2 31.4 0.4 1.5 0.2 0.3 2.1 1.4 1.9 0.5 0.1 0.0 0.6 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.8 0.0 2.6 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.2 0.0 4.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.8 1.8 1.1 1.3 1.7 3.6 1.4 1.1 1.2 1.4 1.5 1.4 1.6 0.0 0.0 1.8 37.9 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.9 0.1 7.9 0.1 0.3 0.1 0.0 4.2 11.6 0.0 0.8 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 11.0 9.5 0.0 0.0 0.3 1.8 0.0 0.0 0.0 5.6 0.0 1.4 0.0 76.4 4.9 0.0 13.8 0.7 0.0 0.2 69.3 0.2 0.0 0.0 0.0 0.1 0.2 9.0 4.1 0.1 0.1 0.3 0.0 1.9 9.7 0.0 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2" "Cell type enhanced" "Detected in many" "Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 4.0;SK-BR-3: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 0.2 0.8 0.3 0.1 0.2 0.1 0.2 2.2 0.6 0.2 0.6 0.2 0.2 0.5 0.2 0.0 0.4 0.5 0.2 0.1 0.8 0.4 0.3 0.8 0.3 0.8 0.9 0.1 0.2 1.4 0.8 0.4 0.8 1.2 0.4 0.4 0.8 0.8 0.5 0.0 0.0 0.3 0.3 0.7 0.0 0.4 1.4 0.5 0.2 1.0 0.0 0.1 0.1 0.1 1.0 0.0 0.7 4.0 3.3 1.3 0.3 2.4 2.6 1.2 1.8 1.1 1.5 0.0 0.1 2.0 2.5 0.0 0.0 0.0 1.2 3.5 0.0 2.4 0.7 1.4 0.0 1.1 0.0 0.0 2.6 0.2 0.2 0.0 0.2 1.7 0.0 0.3 0.0 1.0 1.7 0.0 0.0 0.3 0.6 0.2 0.0 2.4 0.0 0.6 1.0 0.2 1.4 0.0 3.9 1.5 1.7 0.7 1.2 2.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.2 0.6 0.1 0.8 0.8 0.9 0.1 1.2 0.7 0.5 1.0 9.4 9.6 2.0 12.7 0.0 0.3 6.2 5.8 1.8 24.8 6.1 2.8 1.3 7.2 4.8 0.0 14.6 10.4 1.7 2.3 0.0 7.3 112.7 22.4 17.5 7.9 5.4 5.5 100.6 1.4 3.2 4.9 5.1 59.5 0.0 15.6 4.2 1.6 1.9 0.0 152.9 3.7 2.0 0.6 1.4 46.5 2.8 1.0 1.8 9.4 1.2 5.5 5.2 65.4 87.1 5.3 2.9 3.0 0.8 13.0 3.9 0.9 2.4 26.9 0.0 3.0 5.1 27.2 26.7 1.4 0.0 2.5 0.8 7.5 6.3 7.6 INSYN2B "C5orf57, FAM196B" ENSG00000204767 "Inhibitory synaptic factor family member 2B" A6NMK8 5 169861303-169980495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.0;breast: 6.9;salivary gland: 5.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.0;HUVEC TERT2: 23.2;U-138 MG: 66.3;U-251 MG: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047227 Uncertain NA NA "HPA047227: AB_2679992" "unprognostic (5.30e-2)" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (1.26e-3)" "unprognostic (2.31e-2)" "unprognostic (1.98e-2)" "unprognostic (3.31e-5)" "unprognostic (5.16e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.37e-1)" "unprognostic (6.38e-2)" "unprognostic (3.73e-3)" 0.2 0.5 3.4 0.4 6.0 0.2 6.9 3.5 4.3 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 3.5 4.4 0.4 0.1 0.1 0.0 5.4 5.7 3.3 1.8 0.0 0.0 0.1 0.0 5.7 0.6 0.0 0.4 5.2 0.0 0.0 0.3 0.0 0.2 5.0 1.4 0.0 0.1 5.5 0.2 0.8 0.0 0.0 0.0 0.0 5.9 0.2 0.3 1.7 0.1 11.4 3.5 0.0 7.8 3.3 5.1 4.3 0.0 0.0 0.0 15.6 38.0 11.7 0.0 0.1 12.3 10.9 0.0 0.0 0.0 2.7 0.0 2.2 0.0 0.0 1.1 0.0 7.0 6.8 12.4 23.2 0.0 0.0 0.1 16.3 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 14.2 66.3 0.8 1.9 25.3 0.0 0.0 0.0 10.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.4 6.0 3.5 4.3 3.5 4.4 5.4 5.7 3.3 5.7 5.0 5.5 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L5 bA15J10.2 ENSG00000204779 "Forkhead box D4 like 5" Q5VV16 9 65282101-65285209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.26e-2)" "unprognostic (6.95e-3)" "unprognostic (1.58e-1)" "unprognostic (5.76e-2)" "unprognostic (2.57e-1)" 0.1 0.2 0.2 0.0 0.6 0.0 0.1 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.1 0.1 0.6 0.5 0.3 0.0 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.7 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.9 0.1 0.1 1.0 0.2 0.0 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.5 0.5 0.3 0.2 0.0 0.5 0.8 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.9 0.3 0.0 0.2 0.1 0.3 0.2 0.1 0.2 0.2 0.6 0.2 0.2 0.4 0.4 0.8 0.2 0.1 0.0 0.5 0.2 1.1 0.1 0.1 0.6 0.3 0.3 0.2 0.5 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 1.0 1.2 1.0 0.2 0.6 0.5 0.3 0.7 0.1 0.2 1.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 AL391987.2 ENSG00000204805 9 61861625-61863200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.8" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4" NA NA 1.4 1.5 15.0 1.1 13.9 0.6 1.6 16.0 14.7 0.8 11.2 1.5 2.6 1.3 0.8 1.2 4.9 1.0 1.3 18.2 12.6 3.3 0.6 0.8 1.0 13.2 12.2 13.0 1.6 2.2 3.8 1.7 13.6 2.5 2.0 6.0 1.4 1.3 1.0 2.7 2.3 0.9 11.7 1.8 2.2 8.5 12.2 3.3 1.5 0.5 0.6 0.8 12.2 6.6 1.7 3.7 7.5 2.4 0.7 0.0 1.0 0.6 0.7 1.2 0.3 3.8 1.1 0.1 0.5 3.8 7.4 8.1 3.8 0.8 2.0 7.6 1.3 7.0 5.7 3.2 2.8 4.5 1.9 11.5 0.7 2.5 1.0 2.7 6.6 14.3 16.4 1.4 0.2 4.9 4.0 0.6 7.5 13.6 1.1 1.6 4.9 10.6 0.5 14.8 5.1 2.1 1.6 4.3 0.7 2.3 2.9 2.1 1.0 7.9 2.0 2.3 1.8 0.2 2.4 1.3 4.7 6.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 15.0 13.9 16.0 14.7 18.2 12.6 13.2 12.2 13.0 13.6 11.7 12.2 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTC25 DKFZP434H0115 ENSG00000204815 "Tetratricopeptide repeat domain 25" Q96NG3 17 41930617-41966503 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 17.1;testis: 45.2" "Cell type enhanced" "Detected in many" "Early spermatids: 227.2;Endometrial ciliated cells: 65.3;Late spermatids: 43.5;Respiratory ciliated cells: 79.4;Spermatocytes: 98.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.0;U-87 MG: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023908 Enhanced Uncertain Vesicles,Centrosome NA NA Centrosome Vesicles "HPA023908: AB_2241243" "unprognostic (3.08e-3)" "unprognostic (4.51e-2)" "unprognostic (6.96e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (4.57e-2)" "unprognostic (4.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-4)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (2.10e-2)" "unprognostic (9.21e-3)" "unprognostic (3.76e-1)" "unprognostic (2.71e-1)" 0.5 0.6 2.8 0.0 1.7 2.8 0.8 1.5 1.7 1.8 5.6 0.8 0.1 1.5 1.3 0.1 17.1 0.5 0.6 1.6 2.5 1.7 0.4 2.9 0.1 2.7 2.9 1.4 1.3 0.7 1.9 5.7 0.3 2.1 0.9 0.1 1.7 0.3 0.4 0.5 0.4 0.3 0.5 2.4 0.2 0.5 45.2 1.9 0.3 2.0 0.2 0.0 0.9 0.5 1.6 0.1 1.2 1.4 1.4 0.3 0.3 0.2 0.0 0.6 0.2 0.3 0.2 1.0 0.1 0.5 0.2 0.4 0.3 0.2 0.1 0.3 0.2 0.3 0.3 0.3 0.0 0.4 0.0 0.7 0.2 0.2 0.6 0.0 0.8 0.0 0.7 0.1 0.8 0.2 0.8 0.8 0.1 0.4 0.0 0.1 0.0 0.1 1.0 1.3 0.1 3.0 2.0 0.1 0.4 1.1 0.4 0.5 0.3 0.0 0.1 0.6 0.5 0.3 1.0 0.9 0.1 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 1.7 1.5 1.7 1.6 2.5 2.7 2.9 1.4 2.1 2.4 1.9 1.6 0.4 3.2 4.8 2.9 0.0 0.0 0.5 0.0 0.0 2.7 0.5 1.1 1.6 1.5 14.9 3.7 8.4 0.5 0.0 0.3 1.9 2.3 227.2 65.3 2.6 0.9 0.0 18.7 5.2 0.8 0.7 3.0 0.5 3.1 3.8 0.6 0.7 0.2 0.4 3.3 4.6 0.2 0.0 0.0 0.0 43.5 3.4 0.4 0.0 1.0 0.2 2.8 0.0 1.0 0.7 0.4 0.1 1.9 0.0 0.2 0.0 3.4 79.4 5.2 13.1 4.1 0.6 98.4 3.5 0.0 0.0 0.1 0.2 1.5 0.2 0.3 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471982-74472687 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria NA NA Mitochondria "HPA034612: , HPA056185: AB_2683060" "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 61.4 83.7 58.9 47.3 61.3 62.3 39.3 66.8 99.7 31.0 67.5 41.9 48.4 29.0 39.4 41.4 50.6 34.3 115.5 56.8 65.2 55.0 65.7 34.5 79.0 63.0 59.4 54.7 62.0 119.0 72.7 35.3 35.1 62.4 46.4 20.5 27.3 108.0 36.6 171.3 25.7 46.3 24.7 65.6 55.2 55.5 23.3 62.5 50.8 47.5 89.8 42.6 45.1 27.3 67.3 101.5 271.0 60.0 58.5 77.9 69.7 103.4 79.8 73.7 70.5 60.9 224.7 130.1 87.6 78.8 61.4 97.3 76.3 32.5 105.7 24.5 174.6 188.3 77.7 115.6 133.7 70.7 88.4 85.6 96.7 75.1 90.4 59.0 82.3 75.3 109.0 93.0 156.6 63.8 316.5 118.6 163.3 57.5 166.0 204.5 89.1 196.0 212.9 88.9 115.6 103.5 128.0 74.1 195.6 137.3 40.8 102.3 111.1 83.6 115.9 119.6 101.7 135.2 292.3 260.6 141.1 116.4 94.8 125.8 244.9 293.8 133.8 168.2 277.6 188.5 350.0 215.9 173.1 250.3 367.5 282.0 211.4 185.5 167.6 271.8 360.3 275.3 345.5 58.9 61.3 66.8 99.7 56.8 65.2 63.0 59.4 54.7 62.4 65.6 62.5 67.3 5.2 9.6 23.2 4.6 18.0 17.2 6.0 9.7 12.0 2.0 24.0 16.4 1.6 4.3 12.1 11.0 0.0 14.7 10.5 29.5 21.5 32.8 8.9 7.2 4.3 11.2 39.7 18.9 3.4 56.9 17.5 10.9 15.3 4.7 33.6 3.0 16.1 23.8 18.0 1.7 3.5 27.2 6.1 25.9 23.9 2.3 8.7 15.6 26.6 2.8 35.8 4.6 15.5 2.0 7.1 35.8 43.5 4.5 34.8 4.9 41.8 45.3 46.1 4.0 6.6 7.7 11.2 11.2 6.8 16.6 25.1 15.7 14.6 3.3 21.7 6.9 MROH6 C8orf73 ENSG00000204839 "Maestro heat like repeat family member 6" A6NGR9 8 143566192-143572772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.6;skin 1: 13.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 13.8;Hepatocytes: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 11.6;HaCaT: 13.6;OE19: 14.8;SK-BR-3: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA068049 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068049: AB_2685945" "unprognostic (2.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-3)" "unprognostic (2.26e-3)" "unprognostic (8.04e-2)" "unprognostic (8.96e-2)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" "unprognostic (5.97e-2)" "unprognostic (2.81e-2)" "unprognostic (1.09e-2)" "unprognostic (9.04e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (1.44e-1)" "unprognostic (9.16e-3)" "unprognostic (1.18e-1)" 2.5 3.1 0.9 0.5 0.9 1.7 2.1 1.0 1.4 4.2 0.8 3.5 2.0 2.5 0.1 23.6 2.4 0.7 1.4 1.1 1.1 3.7 7.4 4.0 0.3 1.1 0.9 0.6 3.2 1.1 0.2 1.9 0.2 1.0 2.8 0.0 0.1 4.2 0.4 0.9 13.8 5.0 0.1 0.9 4.6 3.0 5.8 1.1 0.3 1.7 0.1 0.7 3.3 8.6 1.0 11.6 2.0 0.2 0.4 0.7 0.7 0.5 0.5 0.4 0.5 0.2 0.4 6.0 1.1 0.6 0.2 0.0 13.6 0.0 2.7 0.0 1.2 1.2 1.3 4.3 0.3 0.6 0.5 1.1 0.7 0.7 0.0 0.0 0.0 0.2 0.4 0.6 0.7 0.0 2.8 0.6 0.3 0.0 14.8 1.1 0.7 0.4 1.1 0.7 1.1 0.2 0.3 0.6 30.0 0.7 0.0 1.3 0.9 0.0 0.4 3.9 0.7 1.2 0.5 0.4 0.3 0.5 6.8 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.9 1.0 1.4 1.1 1.1 1.1 0.9 0.6 1.0 0.9 1.1 1.0 4.0 0.0 4.7 3.9 1.6 2.8 2.2 1.4 4.0 1.4 7.2 4.3 1.5 7.2 2.7 9.2 0.0 1.0 3.7 13.8 1.9 1.3 0.0 1.5 2.9 2.4 1.8 6.1 1.4 0.7 3.4 3.0 6.6 3.0 1.3 3.6 1.1 13.4 5.2 1.7 1.3 4.5 0.0 8.1 3.7 1.3 4.7 6.0 3.6 0.0 3.3 3.5 4.1 0.5 0.3 7.2 6.0 2.6 3.1 2.1 7.3 2.3 0.9 0.3 0.0 2.8 2.3 0.7 7.6 3.2 2.6 1.0 2.6 2.3 8.2 2.8 ATXN2 "ATX2, SCA2, TNRC13" ENSG00000204842 "Ataxin 2" Q99700 12 111443485-111599676 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018295, HPA020339, HPA021146" Enhanced Enhanced Cytosol NA NA 9600 Cytosol "HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132" "unprognostic (3.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (2.34e-1)" "unprognostic (2.77e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (5.28e-2)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (3.40e-2)" 19.1 23.7 20.1 11.3 20.2 8.1 17.6 22.7 30.5 21.0 17.8 20.2 11.3 21.9 14.0 14.3 20.6 12.1 21.7 20.7 19.8 17.6 20.3 19.8 9.6 25.1 23.1 16.9 26.1 13.9 18.7 22.1 16.5 24.6 19.5 11.8 15.9 14.6 15.8 26.0 15.0 15.0 18.4 16.7 14.3 16.5 23.3 22.7 12.9 17.3 21.0 8.9 19.8 18.5 28.3 31.0 38.0 30.3 38.2 35.9 29.0 29.4 35.8 25.9 28.8 23.4 25.2 25.7 25.8 14.2 47.7 23.8 25.5 45.0 18.2 36.0 23.3 33.9 38.2 22.8 42.4 49.7 27.1 21.4 32.4 20.1 38.0 42.6 48.0 27.8 20.2 46.8 13.1 37.2 24.7 23.2 24.2 30.1 19.4 24.6 21.8 18.6 19.2 30.1 34.5 28.7 25.2 38.5 49.3 24.7 29.1 30.9 16.5 34.9 36.9 21.6 30.4 20.6 23.4 30.0 22.5 19.0 20.9 23.5 4.5 3.6 5.8 3.9 3.4 5.2 5.1 4.9 5.3 5.0 2.7 4.1 3.6 3.5 5.6 6.4 2.7 2.2 2.8 20.1 20.2 22.7 30.5 20.7 19.8 25.1 23.1 16.9 24.6 16.7 22.7 28.3 43.0 80.1 72.6 175.3 26.7 35.3 34.3 18.4 35.9 101.0 33.6 26.3 36.6 30.0 36.6 36.8 135.5 32.5 28.9 25.6 3.9 26.0 11.1 87.2 72.2 43.9 41.4 34.9 146.7 25.3 25.4 40.0 23.9 50.3 23.5 67.2 63.5 38.1 24.5 65.6 171.8 26.7 24.4 35.9 35.9 11.9 65.6 30.6 32.0 106.8 35.1 32.6 48.4 128.7 209.6 32.6 16.0 47.4 24.2 43.0 22.7 16.9 56.0 90.4 32.9 41.5 46.6 78.0 70.7 25.7 35.2 46.9 27.4 68.7 31.5 42.2 DCTN1 ENSG00000204843 "Dynactin subunit 1" Q14203 2 74361154-74392087 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009108, HPA034635, HPA071875" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No 250000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: " "unprognostic (1.14e-1)" "unprognostic (7.19e-2)" "unprognostic (1.33e-3)" "unprognostic (4.08e-2)" "unprognostic (1.20e-1)" "unprognostic (2.67e-1)" "unprognostic (4.61e-3)" "unprognostic (2.11e-2)" "unprognostic (2.79e-1)" "unprognostic (3.73e-3)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.34e-7)" "unprognostic (5.41e-2)" "unprognostic (3.11e-1)" "unprognostic (7.86e-3)" "unprognostic (1.12e-3)" 41.5 40.3 90.4 27.3 88.9 23.9 37.7 74.2 113.2 42.8 23.2 46.4 22.4 51.8 17.2 43.0 39.1 28.5 75.1 97.5 80.5 27.7 18.3 36.3 23.0 107.0 87.6 89.6 39.5 28.9 118.9 61.6 32.9 112.2 30.2 25.7 43.9 56.8 38.3 88.3 43.5 32.4 50.3 76.5 26.7 39.8 51.7 107.1 35.0 31.6 63.9 24.8 48.0 39.4 116.2 65.0 74.7 68.4 71.9 122.5 90.7 55.2 102.0 105.2 127.0 89.9 99.9 48.6 88.8 40.8 213.0 70.1 63.5 84.3 129.5 96.1 111.2 85.0 92.5 55.6 84.7 94.4 50.7 109.3 109.6 62.0 138.3 82.3 86.9 110.3 79.4 40.3 61.4 97.3 55.6 92.8 52.5 74.0 78.6 78.3 82.3 120.1 63.8 70.2 39.6 83.3 74.1 57.1 67.7 60.6 59.0 43.5 36.5 84.3 115.0 82.7 50.0 77.2 37.8 32.7 78.9 107.6 81.4 82.5 8.3 11.3 12.7 14.4 13.0 11.7 10.1 8.2 10.8 11.2 6.8 5.6 6.3 9.2 9.2 15.6 8.8 7.7 16.5 90.4 88.9 74.2 113.2 97.5 80.5 107.0 87.6 89.6 112.2 76.5 107.1 116.2 28.6 32.1 25.4 9.8 23.2 10.1 10.3 19.1 25.6 27.2 19.6 17.8 56.4 18.6 20.0 29.5 25.0 29.8 19.4 41.0 19.6 22.5 7.3 21.5 32.8 26.6 16.7 27.3 28.4 19.9 27.1 25.1 49.5 27.8 29.2 30.8 29.6 19.9 28.8 90.9 26.7 31.8 24.4 21.0 11.3 9.3 44.7 21.2 16.0 8.4 27.3 14.9 23.7 12.1 29.7 26.6 33.6 51.9 24.7 9.6 34.2 19.6 19.4 45.5 19.7 28.3 30.0 40.6 38.5 29.0 11.8 25.2 20.0 33.9 24.9 10.7 SPATA31A1 "C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2" ENSG00000204849 "SPATA31 subfamily A member 1" Q5TZJ5 9 39355669-39361962 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 9.0" "Cell type enriched" "Detected in some" 6 "Early spermatids: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMA8B "KIAA1183, PNMAL2" ENSG00000204851 "PNMA family member 8B" Q9ULN7 19 46486906-46495879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 14.9;brain: 43.7" "Group enriched" "Detected in some" 4 "Adipocytes: 8.3;Granulosa cells: 5.3;Theca cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;AN3-CA: 1.8;SH-SY5Y: 1.4" "Low region specificity" "Detected in all" HPA054810 Enhanced NA NA "HPA054810: AB_2682609" "unprognostic (1.31e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-2)" "unprognostic (3.38e-3)" "unprognostic (2.90e-1)" "unprognostic (1.35e-1)" "unprognostic (4.15e-1)" "unprognostic (4.19e-3)" "unprognostic (4.26e-4)" "unprognostic (7.30e-2)" "unprognostic (5.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.38e-1)" "unprognostic (1.32e-2)" 2.6 14.9 25.1 0.3 33.0 0.0 2.4 0.0 43.7 1.7 0.0 1.3 0.3 1.7 0.5 0.5 1.6 1.0 1.5 22.3 27.0 0.6 0.4 0.7 0.4 26.2 19.5 31.2 4.0 0.9 0.3 7.3 0.3 22.4 1.6 0.1 2.2 1.5 1.0 0.5 2.2 0.9 0.6 0.6 2.0 0.9 0.8 14.7 3.5 0.8 0.4 0.1 1.1 1.6 41.4 0.0 0.0 1.4 1.8 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 33.0 0.0 43.7 22.3 27.0 26.2 19.5 31.2 22.4 0.6 14.7 41.4 8.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.3 0.0 0.5 0.9 0.8 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.1 0.0 5.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 TCTN1 "FLJ21127, JBTS13, TECT1" ENSG00000204852 "Tectonic family member 1" Q2MV58 12 110614027-110663431 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 98.9;Respiratory ciliated cells: 203.7;Spermatocytes: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039687, HPA040036" Approved Approved "Nucleoplasm,Vesicles,Actin filaments,Microtubules" "Intracellular and membrane" NA NA "Actin filaments" "Nucleoplasm, Vesicles, Microtubules" "HPA039687: AB_10795293, HPA040036: AB_10794759" "unprognostic (2.54e-1)" "unprognostic (7.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (1.13e-5)" "unprognostic (2.89e-2)" "unprognostic (6.53e-2)" "unprognostic (2.11e-1)" "unprognostic (3.05e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (9.60e-2)" "unprognostic (9.97e-2)" "unprognostic (2.15e-2)" "unprognostic (8.41e-2)" "unprognostic (1.24e-1)" "unprognostic (4.27e-2)" 7.7 14.1 6.4 2.0 5.2 1.0 8.5 9.5 7.6 9.1 15.1 6.2 1.5 9.1 10.8 4.6 15.4 5.6 14.5 5.9 4.7 19.0 9.2 8.3 2.5 5.2 6.0 4.5 12.9 10.9 15.3 26.4 4.1 6.3 10.0 1.0 3.1 9.6 6.1 10.4 5.2 4.1 3.6 3.8 4.6 7.0 21.3 4.8 1.3 17.8 1.9 0.8 7.8 7.0 6.9 11.6 11.7 6.7 17.6 24.9 18.0 4.3 6.3 16.2 5.9 4.4 1.2 2.7 2.0 6.9 18.6 7.2 6.1 4.7 4.6 5.0 4.7 8.7 0.3 4.1 3.6 8.6 1.2 1.3 14.8 7.8 7.7 7.9 34.7 3.3 3.0 7.4 2.5 9.7 9.4 0.9 2.2 4.1 3.5 16.7 2.4 2.9 14.6 16.8 1.8 5.5 11.7 13.1 1.6 5.3 5.5 22.7 16.0 4.0 8.2 2.4 3.5 6.0 4.2 2.6 2.6 11.1 1.3 9.3 0.0 2.0 0.0 0.8 3.6 2.2 4.9 1.5 2.5 3.4 9.1 2.2 1.6 6.4 1.0 1.9 4.3 0.5 2.0 6.4 5.2 9.5 7.6 5.9 4.7 5.2 6.0 4.5 6.3 3.8 4.8 6.9 6.5 3.2 18.8 25.5 24.0 13.8 28.4 38.4 18.2 10.7 22.8 19.3 13.0 24.3 26.0 16.5 31.3 30.9 5.8 1.0 9.8 24.3 82.7 98.9 29.0 11.5 18.0 1.3 15.0 4.7 8.5 30.5 8.2 9.8 3.8 27.1 9.3 6.9 11.8 3.3 12.1 4.8 32.6 3.8 12.4 18.7 17.1 7.0 23.2 7.5 1.7 30.5 0.0 12.5 9.3 4.2 2.4 28.6 9.6 20.0 0.4 42.5 203.7 34.1 6.6 16.2 18.3 96.9 30.1 8.5 11.2 18.3 4.2 38.1 4.7 16.6 FAM216A "C12orf24, HSU79274" ENSG00000204856 "Family with sequence similarity 216 member A" Q8WUB2 12 110468415-110490385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 16.6;testis: 59.9" "Cell type enhanced" "Detected in many" "Late spermatids: 54.7;Spermatocytes: 215.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038286 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA038286: AB_2675931" "unprognostic (7.91e-2)" "unprognostic (3.73e-2)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (3.04e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (8.49e-2)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (4.18e-10)" "unprognostic (7.60e-2)" "unprognostic (4.35e-2)" "unprognostic (6.66e-2)" "unprognostic (1.05e-1)" 3.2 7.5 9.9 6.7 10.8 4.1 3.9 14.3 16.6 4.8 6.1 3.0 1.1 5.9 2.0 3.2 4.5 4.3 9.2 11.0 13.7 3.0 3.2 2.1 7.4 11.2 10.9 9.1 7.1 2.0 5.5 5.2 3.6 11.7 3.9 2.2 8.9 1.7 4.5 3.4 1.4 3.3 6.0 9.4 4.0 2.3 59.9 12.0 7.3 3.3 4.4 4.5 4.9 3.2 13.9 31.1 25.8 21.6 28.5 13.7 25.9 3.5 57.3 14.4 63.9 28.3 27.5 8.5 101.2 13.1 24.2 18.1 19.9 38.1 33.3 77.9 30.0 72.8 49.9 17.6 23.4 22.8 68.3 39.1 25.1 7.8 32.5 71.6 47.8 20.5 39.5 63.1 26.7 48.4 11.2 50.4 106.4 64.6 13.6 41.9 24.4 29.6 68.9 24.7 0.9 77.4 27.5 24.4 18.4 14.2 7.8 43.6 49.2 18.9 22.4 7.5 19.9 58.8 41.7 38.9 79.7 31.7 61.0 37.7 0.9 3.6 1.0 1.9 3.1 3.7 7.3 3.7 3.6 4.5 8.2 9.3 5.6 2.9 2.8 2.6 2.4 2.4 3.9 9.9 10.8 14.3 16.6 11.0 13.7 11.2 10.9 9.1 11.7 9.4 12.0 13.9 2.4 0.0 1.5 7.8 9.6 1.7 6.0 8.7 7.4 11.6 3.0 7.5 20.1 0.0 3.6 3.7 2.1 0.7 1.4 0.1 0.0 4.1 38.6 3.2 17.5 4.4 1.2 17.2 20.4 0.9 3.0 10.8 1.1 0.7 10.2 6.6 3.9 3.4 8.1 13.5 21.6 0.1 2.0 4.4 2.1 54.7 9.6 3.7 3.6 5.6 4.2 4.2 6.2 14.1 8.9 2.8 0.0 5.7 3.9 8.0 0.1 4.4 5.1 5.1 13.1 8.4 9.3 215.9 21.6 5.1 2.0 0.5 3.6 12.2 0.4 1.5 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6579994-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favorable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 9.7 11.0 6.5 13.4 6.6 14.3 10.8 6.3 8.7 14.7 8.1 10.8 11.9 11.1 12.0 12.0 13.2 11.3 8.4 6.6 7.2 11.5 21.4 11.2 14.2 6.5 6.3 6.3 16.6 11.7 13.4 12.0 10.5 6.6 15.7 12.6 7.0 11.6 10.1 10.3 14.2 11.6 10.6 6.2 16.1 12.5 25.7 7.1 17.0 14.3 14.4 15.1 12.1 13.1 7.8 6.5 7.2 12.1 17.8 13.0 10.1 6.1 6.3 7.5 12.2 12.8 8.1 14.8 20.8 11.1 5.7 8.1 12.4 18.3 12.8 9.3 21.6 16.5 17.0 24.1 7.9 15.1 28.0 45.2 10.0 9.5 11.9 18.9 16.1 8.9 16.0 17.5 13.2 9.0 12.0 14.0 20.0 9.2 12.7 12.9 15.5 11.3 23.4 10.6 5.3 23.4 10.7 9.7 22.3 15.1 12.1 12.7 22.2 9.9 8.3 5.3 9.1 8.3 14.7 13.8 33.2 7.7 22.0 5.1 20.0 10.5 42.3 8.3 6.5 8.5 9.1 6.5 8.1 11.5 10.5 8.7 7.8 14.6 10.6 10.7 7.7 5.9 8.4 6.5 6.6 6.3 8.7 6.6 7.2 6.5 6.3 6.3 6.6 6.2 7.1 7.8 7.7 3.2 12.3 10.4 13.0 4.7 9.3 13.3 3.4 8.0 7.8 8.0 5.8 11.5 10.0 11.0 6.2 6.1 12.5 15.1 11.7 4.7 61.8 10.1 7.1 6.1 15.5 3.4 7.5 3.6 5.1 6.8 23.4 6.5 26.6 10.1 7.1 15.1 10.8 10.1 6.6 15.5 14.2 7.6 5.4 19.1 8.7 11.2 5.4 4.7 9.2 11.1 9.2 4.0 5.5 3.1 14.6 5.7 6.6 5.6 22.6 12.6 18.3 7.8 19.7 10.5 8.2 34.5 14.8 5.3 5.5 5.1 9.9 13.6 10.0 6.5 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 41.6" "Cell type enhanced" "Detected in some" "Astrocytes: 17.9;Excitatory neurons: 27.1;Inhibitory neurons: 29.3;Oligodendrocytes: 38.5;Spermatocytes: 9.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "CACO-2: 82.4;OE19: 166.9" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.1 0.0 0.2 0.0 0.3 0.0 2.0 0.1 0.7 0.0 0.0 0.5 0.0 0.2 0.5 1.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 2.0 0.6 0.3 0.2 0.0 0.0 1.5 0.3 0.9 0.7 0.0 0.8 0.4 1.0 0.0 0.0 41.6 0.1 0.2 0.2 0.0 0.0 4.2 0.3 1.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 1.7 0.5 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 82.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.0 1.6 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 166.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.2 0.2 0.6 0.3 0.2 0.7 0.2 0.3 2.1 0.0 0.0 0.0 17.9 0.0 2.2 0.0 1.1 0.0 1.7 2.0 1.5 0.6 0.0 0.7 0.0 0.0 4.3 0.0 0.7 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.0 27.1 0.2 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 29.3 0.4 0.0 0.0 0.3 5.4 0.0 0.0 1.8 0.0 0.0 0.2 0.0 6.0 38.5 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.0 1.9 0.0 0.0 0.7 9.8 8.7 0.0 4.7 2.6 0.2 0.0 1.4 0.0 IGFL4 ENSG00000204869 "IGF like family member 4" Q6B9Z1 19 46039748-46077118 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "retina: 19.7;skin 1: 7.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.2;Cone photoreceptor cells: 14.6;Excitatory neurons: 9.5;Inhibitory neurons: 10.1;Rod photoreceptor cells: 42.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.9;HaCaT: 3.5;OE19: 6.1" HPA047655 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA047655: AB_2680113" "unprognostic (1.22e-2)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" "unprognostic (7.96e-2)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.39e-1)" "unprognostic (8.25e-2)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (1.09e-2)" "unprognostic (3.59e-4)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" 0.0 0.3 0.9 0.1 1.3 0.1 0.1 1.1 2.2 0.0 0.0 0.1 0.4 0.4 1.3 1.0 0.2 0.5 1.0 1.4 0.3 0.1 0.1 0.3 0.4 0.4 0.5 1.5 0.9 0.0 0.5 1.6 0.1 1.2 0.4 0.2 19.7 0.5 0.0 0.3 7.0 0.3 0.0 0.0 0.2 0.3 0.4 0.2 0.0 0.8 0.0 0.0 0.3 0.0 2.0 0.0 3.9 0.1 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.0 0.1 0.5 3.5 0.0 0.0 0.0 0.4 0.6 0.0 0.6 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.4 0.0 0.4 0.0 0.3 0.2 6.1 0.2 0.0 1.7 0.9 0.0 0.2 0.2 0.3 0.0 0.1 0.9 0.4 0.2 0.7 0.4 0.3 0.7 0.2 0.2 0.4 0.3 0.1 0.1 0.6 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 1.3 1.1 2.2 1.4 0.3 0.4 0.5 1.5 1.2 0.0 0.2 2.0 0.0 0.0 0.0 2.6 0.0 1.0 0.0 0.8 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 10.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.0 3.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.1 0.8 2.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 KRTAP9-3 KAP9.3 ENSG00000204873 "Keratin associated protein 9-3" Q9BYQ3 17 41232449-41233454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 307 "skin 1: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-8 KAP4.8 ENSG00000204880 "Keratin associated protein 4-8" Q9BYQ9 17 41096981-41098142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 152 "skin 1: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 6900000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR20 ENSG00000204882 "G protein-coupled receptor 20" Q99678 8 141356470-141367286 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 72.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "intermediate monocyte: 2.6;non-classical monocyte: 4.3" "Lineage enriched" "Detected in single" 22 "monocytes: 4.3" "Cell line enriched" "Detected in single" 6 "EFO-21: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA071337 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA071337: " "unprognostic (4.47e-2)" "unprognostic (2.64e-3)" "unprognostic (5.18e-2)" "unprognostic (2.00e-2)" "unprognostic (7.47e-2)" "unprognostic (2.28e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (3.54e-1)" "unprognostic (2.13e-2)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (7.41e-2)" "unprognostic (5.50e-2)" "unprognostic (6.23e-2)" "unprognostic (4.07e-1)" 0.8 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.4 1.7 0.1 1.3 0.4 1.9 0.7 0.6 1.5 0.7 1.0 0.0 0.0 0.3 0.2 1.5 0.0 0.0 0.1 0.0 1.2 0.2 0.1 0.2 1.2 0.1 0.9 0.3 0.0 0.2 0.8 0.3 0.4 2.1 1.8 0.0 0.2 1.7 0.1 0.0 0.0 0.5 0.4 0.0 0.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.2 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 72.3 0.3 16.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 KRTAP1-4 KAP1.4 ENSG00000204887 "Keratin associated protein 1-4" P0C5Y4 17 41029697-41030104 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT40 "FLJ36600, KA36" ENSG00000204889 "Keratin 40" Q6A162 17 40977716-40987135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "pituitary gland: 2.5;retina: 1.8;skin 1: 1.6" "Group enriched" "Detected in some" 61 "Enteroendocrine cells: 22.1;Muller glia cells: 27.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075961 Supported NA NA "HPA075961: " "unprognostic (2.33e-2)" "unprognostic (9.35e-4)" "unprognostic (8.90e-2)" "unprognostic (1.73e-2)" "unprognostic (1.87e-1)" "unprognostic (1.92e-1)" "unprognostic (9.09e-3)" "unprognostic (2.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.08e-1)" "unprognostic (2.01e-4)" "unprognostic (1.47e-2)" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 22.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT25 KRT25A ENSG00000204897 "Keratin 25" Q7Z3Z0 17 40748021-40755331 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "skin 1: 71.2" "Cell type enhanced" "Detected in some" "Early spermatids: 7.8;Late spermatids: 9.2;Spermatogonia: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RPTEC TERT1: 1.3" "Region enriched" "Detected in some" 7 "cerebellum: 8.6" "Group enriched" "Detected in some" 5 "cerebral cortex: 7.3;hippocampal formation: 4.8" "HPA053977, HPA058943" Enhanced Approved Vesicles NA NA Vesicles "HPA053977: AB_2682329, HPA058943: AB_2683859" "unprognostic (8.19e-2)" "unprognostic (5.89e-8)" "unprognostic (1.79e-1)" 1.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MZT1 "C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2" ENSG00000204899 "Mitotic spindle organizing protein 1" Q08AG7 13 72708367-72727629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063299, HPA066715" Approved NA Yes "HPA063299: AB_2684980, HPA066715: AB_2685709" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.48e-1)" "unprognostic (4.89e-1)" "unprognostic (2.46e-1)" "unprognostic (2.38e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.65e-2)" "unprognostic (6.88e-2)" "unprognostic (5.28e-2)" "unprognostic (7.09e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.01e-5)" "unprognostic (9.01e-3)" "unprognostic (5.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" 9.1 15.2 14.3 11.7 17.4 26.6 11.7 15.1 18.6 8.7 12.6 8.9 8.4 8.3 9.1 9.9 6.1 6.1 12.1 14.7 15.3 11.2 5.5 8.1 17.4 13.8 14.0 14.3 7.4 5.9 8.3 6.7 10.7 12.9 10.4 10.1 10.0 9.6 6.4 19.4 9.6 7.4 7.2 13.3 9.9 9.3 6.4 14.6 17.7 12.2 15.1 13.3 9.3 6.1 14.0 97.5 15.4 53.1 39.4 10.8 18.0 43.5 77.1 31.9 47.7 54.8 28.9 62.3 66.9 57.5 30.9 30.1 30.8 53.6 28.7 86.1 80.6 54.5 86.9 30.0 44.0 15.0 147.1 68.1 9.8 28.8 28.9 59.4 28.8 49.1 76.7 48.7 51.1 95.1 17.5 75.2 81.9 40.5 58.7 28.7 52.6 60.7 33.2 42.9 23.8 62.3 56.9 32.7 47.8 48.4 29.0 36.1 72.1 33.5 41.9 47.7 59.5 94.8 46.5 77.0 53.1 98.2 88.8 87.6 16.2 3.8 8.5 4.8 6.9 6.0 7.7 6.5 6.0 4.8 7.3 8.3 6.7 2.0 7.2 7.6 6.3 9.9 3.8 14.3 17.4 15.1 18.6 14.7 15.3 13.8 14.0 14.3 12.9 13.3 14.6 14.0 29.3 0.0 15.2 5.5 49.9 55.1 27.6 32.2 30.7 29.3 32.8 24.5 17.8 12.8 18.7 31.3 14.6 57.3 38.3 10.3 58.7 25.9 4.5 20.5 18.0 26.5 21.7 122.3 15.2 24.4 98.8 23.1 18.3 18.8 18.4 27.0 20.7 8.8 41.3 63.9 17.1 17.6 38.7 32.3 46.4 4.2 19.9 33.1 60.5 3.7 36.0 31.1 23.7 6.0 10.0 25.1 15.2 16.6 47.9 33.7 8.1 46.5 12.9 27.7 32.9 21.4 26.8 52.0 38.2 51.9 57.4 30.2 43.8 17.6 24.2 32.3 SPINK9 ENSG00000204909 "Serine peptidase inhibitor Kazal type 9" Q5DT21 5 148321203-148339852 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 16.0;Alveolar cells type 2: 27.9;Club cells: 14.9;granulocytes: 10.1;Respiratory ciliated cells: 14.6" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 12.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.4;U-266/84: 26.9" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA 24000 "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.5 3.2 19.5 3.0 16.1 6.6 0.5 20.1 24.1 0.6 5.4 2.0 2.2 2.6 1.9 2.2 1.0 1.4 2.0 15.6 14.8 1.8 1.6 1.2 2.6 12.8 13.4 13.5 1.8 1.1 0.5 0.1 3.2 20.5 2.5 1.7 10.4 1.5 0.5 3.8 3.4 2.4 0.5 3.1 2.0 2.5 4.3 8.8 3.2 1.5 0.1 1.7 0.9 0.0 30.6 15.4 2.6 2.9 3.4 0.7 1.2 2.8 3.5 0.2 0.3 0.5 5.3 10.8 3.4 24.4 0.1 2.0 3.5 0.9 0.7 1.0 6.1 1.4 7.7 8.3 2.7 0.3 2.9 2.6 0.2 0.7 0.5 0.1 2.0 0.0 2.5 4.9 18.3 0.4 9.6 2.5 4.7 13.7 5.5 5.0 3.9 3.4 4.0 1.0 10.0 6.3 7.9 3.0 8.6 2.8 8.6 14.0 3.0 5.9 4.4 14.1 3.9 4.5 11.1 26.9 4.0 2.6 2.1 6.2 12.4 1.8 1.0 1.1 1.0 1.4 0.8 1.3 1.4 0.4 1.9 1.8 1.8 6.6 3.9 2.2 1.9 0.9 0.1 19.5 16.1 20.1 24.1 15.6 14.8 12.8 13.4 13.5 20.5 3.1 8.8 30.6 0.1 16.0 27.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 14.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 1.9 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.1 10.1 0.1 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 2.2 0.4 0.0 0.1 0.0 0.3 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.7 0.0 0.0 0.2 LRRC3C ENSG00000204913 "Leucine rich repeat containing 3C" A6NJW4 17 39941474-39944734 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Astrocytes: 11.4;Microglial cells: 3.7;Oligodendrocytes: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071271 Uncertain NA NA "HPA071271: AB_2686378" "unprognostic (1.59e-1)" "unprognostic (6.57e-2)" "unprognostic (6.17e-2)" "unprognostic (2.81e-1)" "unprognostic (3.16e-4)" "unprognostic (9.20e-2)" "unprognostic (4.27e-1)" "unprognostic (6.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.14e-1)" "unprognostic (1.90e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PRR20B ENSG00000204918 "Proline rich 20B" P86481 13 57147488-57150509 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20A "FLJ40296, PRR20" ENSG00000204919 "Proline rich 20A" P86496 13 57140918-57143939 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF155 pHZ-96 ENSG00000204920 "Zinc finger protein 155" Q12901 19 43967862-43998326 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 23.5;Excitatory neurons: 22.0;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003220 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003220: AB_1080675" "unprognostic (2.71e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" "unprognostic (1.99e-1)" "unprognostic (7.98e-3)" "unprognostic (4.36e-2)" "unprognostic (2.98e-1)" "unprognostic (1.90e-1)" "unprognostic (3.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (6.57e-2)" 3.8 5.6 4.5 3.3 5.1 3.0 5.6 7.3 5.1 4.7 4.3 3.8 3.3 4.7 6.1 3.6 3.7 3.7 6.1 4.3 4.5 5.2 6.5 4.4 4.4 4.2 4.5 4.2 6.1 3.0 8.3 4.5 4.4 4.7 5.1 4.7 8.7 3.8 4.6 3.2 5.4 4.0 5.8 3.9 6.0 5.2 3.3 4.8 6.6 7.9 3.5 4.3 4.0 2.9 5.7 5.1 4.2 10.4 9.5 5.6 6.5 3.0 4.1 3.9 2.8 4.1 2.8 2.5 0.0 5.1 6.4 4.0 3.9 3.5 8.7 4.7 5.7 8.7 10.8 9.8 3.1 5.8 3.9 6.0 9.2 7.0 5.8 8.5 8.2 6.6 0.2 0.2 0.1 7.8 4.5 4.9 3.9 6.4 2.1 3.7 0.0 11.1 3.8 7.5 16.3 7.0 9.3 10.1 0.6 4.0 9.1 6.7 9.3 5.0 6.3 9.2 4.1 6.0 11.5 9.1 0.0 5.3 0.7 5.9 8.1 2.7 9.8 6.5 2.9 6.3 4.0 4.5 7.0 4.1 5.2 5.5 5.0 2.4 5.5 2.2 2.4 4.2 4.2 4.5 5.1 7.3 5.1 4.3 4.5 4.2 4.5 4.2 4.7 3.9 4.8 5.7 2.4 0.0 1.3 23.5 2.7 1.5 1.1 2.2 1.2 3.6 2.4 2.2 0.4 1.5 1.9 0.0 0.0 1.8 1.8 2.3 1.9 1.8 0.5 0.8 1.3 2.6 0.0 0.8 22.0 1.5 0.6 2.0 2.0 1.2 1.3 3.2 2.5 1.5 1.6 6.7 16.1 1.3 2.0 0.8 1.3 0.9 2.8 1.3 1.8 9.4 0.9 4.2 1.0 24.6 24.1 0.9 0.8 5.7 1.0 1.2 1.9 1.9 0.8 3.2 0.0 2.2 2.4 1.3 1.4 1.4 1.3 1.1 2.2 3.0 1.5 1.0 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673686 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 209.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 7.2 12.3 6.4 3.7 6.2 5.8 7.5 6.8 9.7 7.2 7.4 8.7 8.1 6.6 1.7 12.4 6.1 1.2 9.3 6.1 5.9 10.7 12.0 4.7 4.2 6.4 6.1 5.6 6.5 9.1 3.5 6.8 2.2 7.2 9.5 2.0 4.0 11.6 3.4 15.9 8.8 8.3 1.5 5.7 7.5 9.7 3.5 6.7 2.5 6.3 5.0 1.6 6.4 8.2 7.0 26.9 52.9 7.7 12.0 4.7 4.6 6.5 10.4 3.5 7.7 7.6 31.4 22.8 17.4 21.1 3.6 10.4 26.1 7.4 12.3 2.4 8.8 27.4 9.8 28.7 20.3 6.3 16.0 7.6 4.4 10.3 6.8 7.6 4.8 6.0 8.1 21.3 12.2 4.3 82.4 15.7 39.2 8.6 10.6 29.8 17.9 11.7 31.1 6.1 13.2 15.5 15.7 11.5 41.7 16.2 2.4 39.7 14.9 7.9 16.8 19.7 17.6 23.6 18.7 11.0 18.3 13.8 13.7 12.3 14.6 25.0 20.1 21.3 19.1 20.4 30.8 21.1 19.0 20.0 29.9 19.2 15.3 11.0 19.6 17.2 26.7 25.8 20.0 6.4 6.2 6.8 9.7 6.1 5.9 6.4 6.1 5.6 7.2 5.7 6.7 7.0 49.0 44.8 25.0 3.6 32.3 0.0 42.2 0.0 47.3 21.8 77.5 86.4 35.8 70.1 16.1 64.4 16.7 53.1 22.9 65.2 140.8 56.6 1.7 50.3 40.6 32.9 35.2 32.2 2.4 78.4 53.1 32.4 54.6 41.1 5.1 28.0 44.6 125.4 54.8 18.5 4.2 75.2 0.0 39.7 0.0 3.7 48.4 29.2 0.0 7.5 47.2 59.7 66.9 5.0 5.2 67.4 66.9 36.1 38.4 85.1 209.3 170.6 12.4 37.0 39.5 28.3 31.8 4.2 32.0 91.0 0.0 29.0 25.3 35.1 79.0 57.0 FBXO48 ENSG00000204923 "F-box protein 48" Q5FWF7 2 68459422-68467294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Alveolar cells type 2: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049775, HPA054782" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA049775: AB_2680874, HPA054782: AB_2682599" "unprognostic (2.90e-1)" "unprognostic (2.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.75e-3)" "unprognostic (6.56e-3)" "unprognostic (2.90e-3)" "unprognostic (2.30e-1)" "unprognostic (4.74e-2)" "unprognostic (6.01e-3)" "unprognostic (3.92e-2)" "unprognostic (3.81e-2)" "unprognostic (2.33e-1)" "unprognostic (2.09e-2)" "unprognostic (6.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-3)" "unprognostic (1.89e-2)" 1.1 1.2 1.3 1.4 1.8 0.7 1.3 1.5 1.6 1.1 1.2 1.1 1.8 0.9 1.1 1.1 0.7 0.8 0.7 1.4 1.3 1.4 2.0 1.0 1.7 1.7 1.5 1.4 1.7 0.9 1.3 0.5 1.2 1.8 0.8 1.2 3.1 1.3 0.7 3.1 2.5 1.6 0.6 1.3 1.8 1.3 1.0 1.6 1.2 1.1 1.8 1.8 0.7 0.9 2.8 2.1 0.7 1.3 0.9 1.6 1.8 0.9 1.5 1.8 1.4 1.6 1.0 0.9 2.6 1.0 0.7 1.9 1.1 1.2 1.2 2.7 3.5 1.3 1.3 0.7 0.5 0.7 0.6 1.5 0.8 2.1 2.0 1.7 0.7 0.6 4.3 0.6 4.9 1.1 0.4 1.5 1.9 0.7 1.4 1.0 1.3 2.3 1.7 1.1 0.6 1.3 0.9 0.7 0.3 1.7 1.1 0.4 0.6 0.6 1.6 1.5 2.0 1.6 3.9 2.5 1.1 1.0 1.1 1.2 2.6 0.7 0.9 1.0 0.7 1.0 0.9 1.7 1.0 0.4 1.0 1.2 1.2 1.4 1.0 1.3 0.9 2.1 0.6 1.3 1.8 1.5 1.6 1.4 1.3 1.7 1.5 1.4 1.8 1.3 1.6 2.8 9.1 32.1 52.0 1.3 6.4 7.1 5.0 3.1 9.1 3.9 7.7 10.4 11.7 7.2 16.3 5.5 2.1 4.2 4.5 7.1 11.7 3.2 1.7 4.0 3.1 8.2 3.0 4.0 0.8 3.3 3.5 6.8 3.1 4.1 12.6 2.1 5.3 7.1 4.1 3.3 0.8 6.2 0.0 5.1 6.6 1.0 4.1 8.7 1.8 0.0 2.5 2.2 2.1 1.5 1.7 3.1 2.7 1.5 5.8 3.4 7.4 9.2 12.9 5.7 0.0 5.5 3.9 18.0 11.1 6.7 8.0 1.6 8.1 2.8 3.5 3.9 GRXCR2 DFNB101 ENSG00000204928 "Glutaredoxin and cysteine rich domain containing 2" A6NFK2 5 145858521-145937126 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Early spermatids: 15.1;Late spermatids: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "cerebral cortex: 1.2;hippocampal formation: 4.1" HPA059421 Uncertain NA NA "HPA059421: AB_2684010" "unprognostic (4.71e-2)" "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM221B C9orf128 ENSG00000204930 "Family with sequence similarity 221 member B" A6H8Z2 9 35816391-35828747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 2.9;testis: 9.9" "Group enriched" "Detected in some" 12 "Early spermatids: 266.3;Late spermatids: 122.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA026577 Enhanced NA NA "HPA026577: AB_1845810" "unprognostic (1.23e-1)" "unprognostic (5.32e-2)" "unprognostic (9.40e-2)" "unprognostic (3.59e-2)" "unprognostic (1.25e-1)" "unprognostic (9.81e-3)" "unprognostic (6.94e-2)" "unprognostic (2.44e-2)" "unprognostic (4.03e-1)" "unprognostic (2.67e-2)" "unprognostic (3.13e-3)" "unprognostic (4.22e-1)" "unprognostic (9.20e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-1)" "unprognostic (3.15e-2)" "unprognostic (1.25e-3)" 0.1 0.1 0.2 0.4 0.3 2.9 0.4 1.1 0.4 0.2 0.0 0.1 0.1 0.4 0.1 0.2 0.3 0.3 0.2 0.2 0.1 0.0 0.1 0.2 0.5 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.7 0.5 0.6 0.6 0.1 0.3 0.2 0.1 0.1 0.3 0.3 0.4 9.9 0.2 0.2 0.1 0.0 0.5 0.2 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.2 0.2 0.9 0.0 0.0 2.9 0.1 0.0 0.2 0.3 1.1 0.4 0.2 0.1 0.4 0.3 0.1 0.4 0.3 0.2 0.5 0.0 0.0 3.1 0.3 0.4 0.0 0.4 1.0 0.0 4.1 0.8 0.4 0.4 0.0 1.8 0.0 0.0 0.1 16.1 0.3 0.0 0.1 266.3 0.5 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.0 0.4 1.2 2.0 0.3 0.0 122.0 2.1 0.4 0.0 0.0 0.2 1.9 0.0 1.0 0.7 0.2 1.6 0.7 0.3 1.3 0.0 0.1 2.7 5.5 0.0 0.1 0.2 6.0 1.4 0.0 0.0 0.0 0.0 0.1 0.2 1.3 CD177 "HNA2A, NB1, PRV1" ENSG00000204936 "CD177 molecule" 19 43353686-43363172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 288.7;intestine: 166.2" "Group enriched" "Detected in some" 5 "Distal enterocytes: 632.4;Paneth cells: 314.8" "Cancer enhanced" "Detected in many" "prostate cancer: 27.6" "Group enriched" "Detected in some" 6 "cerebellum: 3.5;cerebral cortex: 6.7;midbrain: 2.3;pons: 2.4" "Immune cell enriched" "Detected in some" 7 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.7" "Cell line enriched" "Detected in some" 26 "RPMI-8226: 98.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041820, HPA046601, HPA077640" Enhanced "Intracellular and membrane" NA NA "HPA041820: AB_2677691, HPA046601: AB_2679716, HPA077640: " "unprognostic (4.32e-2)" "prognostic favorable (3.66e-4)" "unprognostic (1.04e-2)" "unprognostic (2.04e-3)" "unprognostic (1.61e-1)" "unprognostic (3.89e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (2.05e-1)" "unprognostic (1.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.90e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (1.24e-1)" 4.3 0.4 0.2 7.2 0.4 288.7 1.3 3.5 6.7 3.1 4.3 156.7 0.3 0.4 0.2 2.2 2.3 0.2 2.1 0.3 0.2 1.8 2.7 20.8 0.2 0.5 2.3 0.2 0.3 1.1 0.0 3.0 1.6 2.4 65.4 166.2 0.1 1.8 0.2 0.7 0.4 0.7 3.0 0.3 64.9 1.5 0.2 0.4 1.4 0.7 0.8 10.5 2.2 5.5 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 1.3 0.6 0.6 0.0 0.0 0.1 2.4 0.6 1.7 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.2 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 1.2 0.0 0.2 0.0 0.0 98.0 1.4 0.3 0.7 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.3 2.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 1.2 0.0 0.7 0.0 0.2 0.4 3.5 6.7 0.3 0.2 0.5 2.3 0.2 2.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.0 632.4 0.0 0.5 0.4 0.2 0.1 0.0 8.4 3.6 0.0 0.2 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 87.2 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 314.8 0.0 0.1 29.2 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 28.0 0.2 PSG5 "FL-NCA-3, PSG" ENSG00000204941 "Pregnancy specific beta-1-glycoprotein 5" Q15238 19 43166256-43186536 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "placenta: 112.8" "Cell type enriched" "Detected in some" 44 "Syncytiotrophoblasts: 724.4" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Region enhanced" "Detected in single" "cerebellum: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 427.9;fHDF/TERT166: 1485.4" HPA046327 Supported "Secreted in female reproductive system" NA NA 22000000 "HPA046327: AB_2679624" "unprognostic (1.59e-1)" "unprognostic (3.38e-2)" "unprognostic (4.69e-2)" "unprognostic (1.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.04e-1)" "unprognostic (1.75e-2)" "unprognostic (1.12e-2)" "unprognostic (2.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.92e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 112.8 0.8 0.0 0.0 0.3 0.1 0.1 0.1 0.6 0.0 0.9 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.3 0.0 0.0 0.2 0.6 0.1 427.9 122.3 7.0 57.8 0.0 0.3 0.0 0.0 1485.4 1.8 16.4 0.1 0.0 65.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.1 0.8 0.0 1.1 7.8 2.3 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 10.2 0.0 0.0 0.1 0.5 1.6 54.9 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.3 0.3 0.0 0.1 0.0 0.3 0.8 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.3 0.0 1.2 0.0 0.1 0.1 0.0 0.5 1.8 0.0 14.2 0.0 0.1 0.0 6.0 0.8 0.0 0.0 0.2 0.0 0.0 3.3 0.0 16.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 3.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.5 1.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 724.4 0.0 0.1 0.0 0.1 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 6.7 5.4 7.2 5.4 7.1 3.0 7.5 7.0 7.4 10.4 5.6 7.4 4.1 9.0 3.6 6.1 10.2 3.0 5.4 6.7 7.0 6.5 3.4 6.3 7.4 7.6 7.2 6.8 11.8 7.2 2.9 7.2 2.9 7.3 9.5 3.8 2.9 5.8 4.1 6.4 6.6 9.3 4.5 6.7 12.9 6.6 6.6 7.3 4.1 8.3 3.3 6.5 8.2 7.8 8.5 3.5 3.5 5.7 4.1 3.7 6.9 5.3 2.1 1.1 5.0 2.2 5.6 6.5 11.9 5.5 3.5 1.1 2.3 4.0 4.3 2.2 3.3 3.5 7.6 8.7 1.1 8.5 5.1 9.2 7.4 8.7 4.5 5.5 3.1 3.4 4.2 6.2 6.0 4.2 7.6 7.6 7.8 12.8 8.1 4.7 1.6 0.5 10.6 5.6 5.8 4.5 9.5 8.5 4.0 6.0 3.0 4.4 10.1 5.0 4.0 0.9 2.1 4.9 9.1 6.2 0.1 5.6 1.8 8.7 0.1 0.4 0.1 1.0 0.7 0.8 0.7 0.6 0.6 0.4 1.3 0.8 0.7 0.1 0.5 1.7 0.9 0.4 0.4 7.2 7.1 7.0 7.4 6.7 7.0 7.6 7.2 6.8 7.3 6.7 7.3 8.5 6.7 3.2 2.7 5.5 6.1 2.5 2.5 4.6 1.8 13.3 7.5 7.6 2.2 7.2 3.2 0.0 10.4 3.0 6.1 3.4 3.9 2.1 5.3 3.2 7.9 4.3 3.6 1.7 5.7 2.7 2.0 7.0 7.1 6.2 0.0 6.4 5.0 6.6 4.2 6.7 6.3 4.7 4.1 7.9 4.6 5.0 8.7 3.9 5.4 11.2 5.2 3.8 8.2 4.0 8.5 3.0 1.6 5.7 3.9 4.0 3.0 1.1 5.5 8.8 13.1 7.4 5.0 16.3 6.9 3.6 3.0 1.1 5.0 6.9 4.3 2.4 ZNF425 ENSG00000204947 "Zinc finger protein 425" Q6IV72 7 149102784-149126324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 8.5;Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA020087 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA020087: AB_2670358" "unprognostic (4.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-4)" "unprognostic (9.97e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-2)" "unprognostic (8.18e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-2)" "unprognostic (2.14e-1)" "unprognostic (8.21e-4)" "unprognostic (3.09e-1)" "unprognostic (1.25e-4)" "unprognostic (3.04e-2)" "unprognostic (2.32e-1)" "unprognostic (5.19e-3)" "unprognostic (1.58e-2)" 0.7 1.3 2.8 0.9 2.8 0.6 1.7 3.1 3.2 2.0 1.8 1.7 1.0 2.4 2.1 2.1 2.3 1.0 0.8 2.7 2.4 1.8 1.0 1.0 0.8 2.6 2.5 2.6 3.8 1.5 2.4 1.4 0.7 2.9 2.0 0.8 1.4 1.8 2.2 3.8 2.5 0.9 1.7 2.4 1.0 1.6 1.3 2.5 1.6 1.9 1.9 1.2 1.9 1.5 2.7 1.4 1.7 3.6 3.1 5.3 1.5 2.0 2.0 3.4 1.1 1.2 0.4 1.8 1.6 2.8 1.6 1.4 1.9 0.6 1.0 0.4 1.1 1.4 1.9 2.4 0.8 3.0 0.9 0.8 3.1 1.7 1.1 2.0 3.0 0.5 2.4 1.4 1.5 3.7 6.6 2.5 2.9 8.6 2.0 3.3 2.7 1.8 0.9 2.4 1.9 1.6 3.0 1.9 2.4 4.5 2.3 1.6 2.6 0.7 2.3 0.3 2.7 0.5 3.2 2.1 1.2 1.9 0.6 1.9 2.1 0.6 1.4 1.8 0.7 2.3 1.4 1.5 1.2 0.6 1.8 2.1 2.3 1.6 3.2 0.4 2.1 2.0 0.8 2.8 2.8 3.1 3.2 2.7 2.4 2.6 2.5 2.6 2.9 2.4 2.5 2.7 0.4 0.0 2.0 5.2 1.9 0.3 0.8 0.7 2.2 3.4 1.8 1.5 1.8 0.0 1.2 3.7 0.0 0.8 0.3 0.5 5.9 1.6 0.9 1.4 2.2 0.6 1.2 3.0 7.5 0.5 0.8 1.5 4.6 1.2 0.0 3.4 0.4 0.6 0.4 6.7 8.5 0.7 2.0 0.0 0.2 0.3 4.4 0.6 0.0 7.5 1.8 4.7 0.0 9.0 10.7 0.6 0.6 5.3 1.3 1.0 0.7 1.1 2.4 1.2 0.0 2.3 1.5 3.5 3.5 2.8 0.3 1.0 1.4 3.0 0.8 0.5 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508749-61511018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.7;fallopian tube: 29.0;pituitary gland: 34.0" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4" "Region enriched" "Detected in many" 7 "basal ganglia: 222.5" "Group enriched" "Detected in many" 5 "basal ganglia: 30.9;hippocampal formation: 24.2" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 3.2 0.9 11.3 0.4 34.7 0.0 3.0 1.0 11.1 5.0 3.3 2.1 0.3 4.9 1.9 0.5 29.0 0.3 1.4 14.1 3.9 0.9 0.1 4.9 0.0 5.4 3.5 8.8 2.3 1.3 2.2 34.0 0.5 11.0 1.6 0.3 0.1 1.3 0.5 0.7 0.9 1.4 1.6 2.7 0.4 2.9 5.9 5.4 2.7 1.6 0.9 0.0 1.1 2.6 3.5 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 5.4 0.5 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 34.7 1.0 11.1 14.1 3.9 5.4 3.5 8.8 11.0 2.7 5.4 3.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.6 0.4 1.1 0.0 3.5 1.8 0.0 0.0 0.0 0.1 0.0 0.0 3.2 49.3 0.5 0.4 4.2 0.0 1.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 6.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 37.2 0.2 19.7 0.7 20.6 0.8 1.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 FBXO47 ENSG00000204952 "F-box protein 47" Q5MNV8 17 38936432-38967403 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 3.9" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 74.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057438 Uncertain NA NA "HPA057438: AB_2683441" "unprognostic (1.53e-1)" "unprognostic (2.98e-1)" "unprognostic (2.82e-1)" "unprognostic (3.92e-1)" "unprognostic (6.04e-2)" "unprognostic (2.59e-2)" "unprognostic (2.29e-2)" "unprognostic (6.85e-2)" "unprognostic (4.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 74.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C12orf73 "BRAWNIN, DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103940763-103965708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 42.9" "Cell type enhanced" "Detected in many" "Early spermatids: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Intracellular and membrane" NA NA "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favorable (1.61e-4)" 6.0 11.5 15.1 7.7 15.2 4.5 8.0 16.6 16.2 8.6 12.5 7.0 7.0 8.3 10.4 6.5 7.4 4.6 9.3 15.0 15.3 9.1 8.4 5.8 9.3 14.4 14.3 14.6 10.2 7.8 10.1 10.9 6.2 14.8 8.8 7.7 13.3 7.3 7.4 42.9 8.4 6.8 6.6 14.0 7.0 9.0 11.0 14.8 8.3 13.0 27.9 8.9 7.4 6.9 16.9 11.8 21.2 31.8 19.4 8.9 11.6 20.7 12.6 7.4 13.4 10.8 23.2 9.9 13.7 15.9 7.5 11.7 18.3 19.1 15.6 10.1 19.7 38.4 20.9 32.9 29.1 13.1 30.8 18.2 10.3 17.6 6.9 11.9 32.5 12.5 39.5 27.0 9.2 12.5 13.2 34.5 46.1 15.6 11.0 35.9 19.7 11.9 13.7 17.8 16.6 51.8 18.5 13.0 21.9 29.7 14.1 36.4 16.7 6.5 16.4 9.3 12.4 12.8 24.5 40.6 28.8 22.4 17.4 14.5 10.1 5.6 10.6 11.7 5.0 11.4 14.6 10.6 11.1 8.6 11.3 15.7 14.8 1.7 14.5 4.5 13.3 17.0 4.2 15.1 15.2 16.6 16.2 15.0 15.3 14.4 14.3 14.6 14.8 14.0 14.8 16.9 6.8 6.4 6.8 7.5 7.8 6.0 9.4 16.3 18.8 16.3 9.0 11.0 16.5 7.2 10.0 9.2 0.0 11.6 8.6 7.1 27.4 20.3 87.1 8.7 10.3 8.3 11.4 18.5 5.0 12.1 11.7 7.9 15.3 9.1 9.5 13.8 8.9 15.5 17.5 8.4 6.0 13.2 20.3 7.9 5.1 36.6 8.7 8.7 1.8 2.8 12.4 17.1 22.6 7.5 9.0 19.9 5.6 8.6 13.7 13.7 16.0 25.9 10.9 15.2 6.6 5.6 11.7 31.1 25.6 16.0 5.3 8.9 8.8 6.4 12.3 8.6 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 2.4;Cardiomyocytes: 1.8;Horizontal cells: 3.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.5;T-47d: 7.3;WM-115: 3.3" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 0.3 0.2 1.3 0.2 2.3 0.2 0.2 3.2 2.1 0.5 0.0 0.4 0.2 0.6 0.9 0.2 0.4 0.1 1.0 2.2 0.8 0.2 0.1 0.3 0.2 1.4 1.3 1.0 0.6 0.5 0.5 0.9 0.5 1.0 0.3 0.2 1.0 0.2 0.2 0.7 0.3 0.1 0.4 1.4 0.2 0.1 0.7 1.7 0.1 0.2 0.4 0.1 0.4 0.3 1.8 0.0 0.2 0.3 1.1 0.7 1.3 0.1 1.1 0.7 0.3 0.6 0.3 0.1 0.2 1.8 0.7 0.5 0.1 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 1.1 0.3 0.0 0.4 2.1 0.0 0.1 0.1 0.5 4.5 0.0 0.1 0.5 0.1 0.0 0.2 2.0 1.6 0.2 0.2 0.2 1.0 1.3 0.1 0.6 1.1 0.3 7.3 0.2 0.5 2.0 0.3 1.0 0.2 0.1 0.6 0.1 2.4 0.1 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.3 3.2 2.1 2.2 0.8 1.4 1.3 1.0 1.0 1.4 1.7 1.8 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 PCDHA9 "KIAA0345, PCDH-ALPHA9" ENSG00000204961 "Protocadherin alpha 9" Q9Y5H5 5 140847772-141012347 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.2;testis: 1.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.9;Early spermatids: 1.7;Horizontal cells: 1.7;Rod photoreceptor cells: 1.7;Spermatocytes: 4.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 7.1" NA NA "unprognostic (1.53e-3)" "unprognostic (1.13e-1)" "unprognostic (7.54e-4)" "unprognostic (1.28e-2)" "unprognostic (4.65e-2)" "unprognostic (1.48e-1)" "unprognostic (5.20e-3)" "unprognostic (6.49e-3)" "unprognostic (1.31e-4)" "unprognostic (1.82e-1)" "unprognostic (8.79e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-1)" 0.1 0.1 0.4 0.0 0.5 0.2 0.0 3.2 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.6 0.0 0.7 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 3.2 0.7 0.4 0.2 0.7 0.3 0.6 1.2 0.3 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.9 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.7 0.2 0.7 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.7 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA8 ENSG00000204962 "Protocadherin alpha 8" Q9Y5H6 5 140841187-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 12.6;SCLC-21H: 3.6" HPA044585 Uncertain NA NA "HPA044585: AB_10793953" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (4.20e-2)" "unprognostic (9.67e-2)" "unprognostic (8.58e-3)" "unprognostic (7.87e-4)" "unprognostic (5.62e-3)" "unprognostic (2.22e-2)" "unprognostic (5.48e-1)" "unprognostic (1.20e-2)" 0.0 0.1 0.3 0.0 0.5 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.7 0.8 0.6 0.0 0.1 0.0 0.4 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.6 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 3.7 0.6 0.4 0.2 0.7 0.8 0.6 1.2 0.3 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA7 "CNR4, CNRS4, CRNR4" ENSG00000204963 "Protocadherin alpha 7" Q9UN72 5 140834248-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.2" "Cell type enhanced" "Detected in some" "Horizontal cells: 1.7;Spermatocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;SK-MEL-30: 1.2;WM-115: 1.1" NA NA "unprognostic (1.99e-1)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (5.28e-2)" "unprognostic (3.05e-1)" "unprognostic (7.08e-2)" "unprognostic (9.29e-3)" "unprognostic (4.11e-3)" "unprognostic (7.20e-2)" "unprognostic (3.18e-3)" "unprognostic (3.12e-4)" "unprognostic (9.54e-4)" "unprognostic (6.86e-5)" "unprognostic (5.34e-4)" "unprognostic (2.88e-1)" "unprognostic (3.72e-1)" "unprognostic (1.14e-1)" 0.1 0.1 0.4 0.0 0.6 0.0 0.2 3.2 0.9 0.2 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.4 0.5 0.2 0.0 0.2 0.0 1.2 0.9 0.5 0.3 0.3 0.1 0.4 0.0 1.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.9 0.2 0.0 0.1 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.8 1.2 0.3 0.2 0.0 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 3.2 0.9 0.4 0.5 1.2 0.9 0.5 1.0 0.5 0.2 2.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.0 0.0 0.2 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "brain: 3.4" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 6.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;EFO-21: 3.4;T-47d: 3.7;WM-115: 1.3" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" NA NA "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.1 0.1 0.3 0.0 1.0 0.0 0.1 3.4 1.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.8 0.1 0.2 0.0 0.5 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.0 3.4 1.1 0.8 0.3 0.1 0.2 0.8 1.0 0.3 0.1 0.8 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;granulocytes: 3.8;Respiratory ciliated cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.6;AF22: 5.6;EFO-21: 5.1;T-47d: 5.4" "Not detected" "Not detected" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.2 0.2 0.9 0.2 1.3 0.9 0.4 3.1 1.2 0.5 0.0 0.3 0.3 0.6 0.4 0.1 0.3 1.3 0.1 0.9 0.7 0.4 0.1 0.4 0.3 0.6 0.8 0.9 0.2 1.3 0.1 0.4 0.1 1.3 0.4 0.3 1.0 0.2 0.3 0.3 0.5 0.2 0.3 0.3 0.3 0.3 0.4 0.5 0.1 0.3 0.1 0.2 0.2 0.1 1.6 0.1 6.6 5.6 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 1.1 0.1 5.1 0.1 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.2 0.1 0.2 0.3 0.3 1.1 0.1 0.1 0.3 0.3 0.2 0.1 0.7 0.1 0.1 0.1 0.2 1.7 1.2 0.9 0.1 0.1 0.2 0.1 0.2 0.2 2.3 0.0 1.4 0.5 0.8 5.4 0.1 0.6 1.2 0.8 0.5 0.1 0.3 0.1 0.1 0.2 0.2 0.5 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.9 1.3 3.1 1.2 0.9 0.7 0.6 0.8 0.9 1.3 0.3 0.5 1.6 0.1 3.2 2.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.3 0.6 0.7 0.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.3 3.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.2 2.9 1.1 0.0 0.4 0.5 1.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.4 PCDHA2 ENSG00000204969 "Protocadherin alpha 2" Q9Y5H9 5 140794852-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;pituitary gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.9;SH-SY5Y: 1.2;T-47d: 1.2;WM-115: 1.0" "Low region specificity" "Detected in all" HPA035653 Uncertain NA NA "HPA035653: AB_10670969" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (3.27e-2)" "unprognostic (8.39e-3)" "unprognostic (4.61e-2)" "unprognostic (4.16e-3)" "unprognostic (1.23e-1)" "unprognostic (4.30e-2)" "unprognostic (3.35e-3)" "unprognostic (5.64e-6)" "unprognostic (2.17e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (3.42e-1)" 0.1 0.1 0.4 0.0 0.6 0.0 0.2 1.9 0.4 0.4 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.4 0.5 0.3 0.0 0.2 0.0 0.8 0.7 0.3 0.4 0.4 0.0 1.8 0.0 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.1 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.1 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.2 0.1 0.2 1.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 1.9 0.4 0.4 0.5 0.8 0.7 0.3 0.6 0.6 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;pituitary gland: 1.0;testis: 1.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;Hepatic stellate cells: 1.4;Sertoli cells: 6.6;Spermatogonia: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 9.1" "Low region specificity" "Detected in many" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.0 0.2 0.3 0.0 0.8 0.0 0.1 1.5 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.0 1.6 0.8 0.5 0.0 0.1 0.0 1.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.1 1.1 0.1 9.1 0.3 0.0 1.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.5 1.0 0.7 0.5 1.6 0.8 0.5 1.1 0.8 0.5 1.9 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM13 "DLEU5, Leu5, RFP2, RNF77" ENSG00000204977 "Tripartite motif containing 13" O60858 13 49995888-50020481 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 576.8;Spermatocytes: 211.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000367 Enhanced NA NA "HPA000367: AB_1856196" "unprognostic (1.14e-1)" "unprognostic (8.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.23e-3)" "unprognostic (4.75e-3)" "unprognostic (5.01e-2)" "unprognostic (4.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.44e-1)" "unprognostic (5.07e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-2)" "unprognostic (9.01e-2)" "unprognostic (2.37e-2)" "unprognostic (1.55e-2)" 16.3 13.8 12.8 14.9 17.5 65.8 21.2 22.0 14.0 16.7 11.5 17.7 12.9 16.7 15.0 26.8 17.3 12.7 16.1 11.6 14.4 22.2 14.4 20.9 20.4 15.4 14.5 11.7 19.5 15.6 20.3 15.8 15.0 15.0 20.3 20.3 15.9 19.2 13.2 25.1 26.7 18.8 14.1 14.5 21.1 15.4 79.8 14.9 24.3 16.1 24.5 23.4 15.6 19.1 24.5 10.6 12.0 41.3 32.1 22.7 35.3 18.7 17.0 24.5 13.5 9.4 16.6 23.7 38.9 5.2 18.6 12.2 16.2 18.4 22.5 16.6 15.1 16.2 38.7 9.9 18.9 25.3 37.5 21.7 25.9 32.5 12.4 20.6 34.0 30.3 32.9 21.0 12.0 27.0 9.6 31.5 58.5 37.5 24.3 9.0 37.7 1.9 11.7 28.8 17.2 16.5 26.9 15.4 15.8 24.8 29.1 17.9 46.9 28.5 13.9 12.8 11.5 9.7 8.6 7.8 28.6 6.2 16.9 19.2 24.8 17.7 28.4 19.0 15.8 24.1 46.4 25.5 25.2 22.7 45.4 22.3 20.9 35.0 27.0 23.5 34.8 30.0 14.4 12.8 17.5 22.0 14.0 11.6 14.4 15.4 14.5 11.7 15.0 14.5 14.9 24.5 34.2 25.6 29.1 20.9 47.7 27.5 37.0 48.8 21.1 24.5 24.8 19.2 20.1 22.8 39.8 27.6 20.9 33.4 31.7 24.2 19.6 25.4 576.8 21.3 25.3 29.8 44.9 20.6 30.6 20.1 16.5 26.2 15.8 15.3 38.7 34.1 20.3 15.1 18.3 11.8 29.6 27.5 30.5 21.3 62.3 83.6 25.7 24.3 17.8 35.6 27.1 14.5 28.8 45.8 57.5 20.3 22.7 29.7 13.8 34.5 21.5 32.8 51.8 54.3 19.7 25.2 29.9 211.2 25.2 29.9 33.4 32.2 29.0 21.3 28.6 31.1 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443156-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "intestine: 42.9;kidney: 16.7" "Group enriched" "Detected in some" 10 "Proximal enterocytes: 189.7;Proximal tubular cells: 90.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042632: AB_2678090, HPA048484: AB_2680415" "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.7 0.0 0.5 0.1 0.2 0.0 0.6 0.1 0.1 0.4 0.1 0.2 42.9 0.6 0.0 0.2 0.5 0.3 1.4 0.1 0.1 16.7 0.0 1.1 0.3 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.3 0.0 1.7 0.2 39.5 0.0 0.2 0.6 0.2 0.8 0.3 0.0 0.3 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.2 0.2 0.3 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 13.7 0.2 3.7 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 189.7 90.2 0.0 0.0 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.0 0.3 0.1 3.0 0.0 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515392-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 3.5" "Cell type enhanced" "Detected in some" "Early spermatids: 25.0;Late spermatids: 47.0;Spermatocytes: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045017, HPA063626" Uncertain NA NA "HPA045017: AB_10962976, HPA063626: AB_2685065" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 47.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1921 "pancreas: 344337.9" "Cell type enriched" "Detected in some" 28 "Exocrine glandular cells: 57138.3" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 100000000000 Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavorable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.12e-1)" 39.2 10.0 0.0 4.7 0.0 0.0 25.9 0.0 0.0 11.7 0.0 9.6 55.0 8.9 0.8 15.3 5.7 0.0 51.5 0.0 0.0 9.5 30.0 6.5 6.5 0.0 0.0 0.0 179.2 344337.9 0.1 10.4 14.0 0.0 15.3 0.0 0.0 44.6 4.3 9.0 10.1 12.8 0.0 0.0 13.5 77.7 6.9 0.0 0.0 6.4 0.0 0.0 4.7 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 100.7 0.0 0.1 0.0 3.6 0.0 0.0 0.0 57138.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 119.4 0.6 0.0 0.0 0.0 1985.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.2 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 21.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 54.9;Gastric mucus-secreting cells: 46.9;Intestinal goblet cells: 43.8;Paneth cells: 39.9;Syncytiotrophoblasts: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 29.5;T-47d: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: AB_2677464, HPA049415: AB_2680755" "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.3 2.2 8.6 1.2 9.2 1.2 1.9 12.1 12.6 2.1 4.3 10.7 7.9 1.7 1.8 3.0 6.2 2.0 0.8 9.3 7.5 3.1 6.6 2.4 0.5 9.6 7.9 10.3 1.8 2.2 3.6 21.6 4.6 10.8 4.8 8.2 3.1 2.6 3.1 0.6 1.9 9.3 1.0 6.0 1.0 14.6 5.0 8.1 0.4 7.0 0.0 0.4 6.1 2.3 10.0 0.4 8.4 5.2 4.2 1.4 0.9 17.5 2.7 1.6 3.9 1.6 3.2 9.0 5.8 1.2 0.8 4.0 9.0 2.2 0.3 1.1 2.2 10.1 1.3 7.1 8.9 1.4 0.3 1.8 1.8 2.0 1.2 1.0 0.5 0.2 0.5 9.2 1.4 1.1 12.8 0.1 2.2 5.7 29.5 5.3 4.6 1.9 1.3 2.0 8.6 13.6 7.0 11.6 5.0 5.1 4.4 18.8 3.0 0.4 2.3 4.9 3.3 2.5 0.7 3.7 0.5 3.5 2.1 4.9 2.4 0.5 0.3 0.4 0.3 0.2 0.4 0.3 0.2 0.1 0.7 0.4 0.4 2.0 0.5 0.5 0.6 0.2 0.3 8.6 9.2 12.1 12.6 9.3 7.5 9.6 7.9 10.3 10.8 6.0 8.1 10.0 0.7 6.4 4.8 10.7 0.6 0.9 5.1 1.7 2.2 13.0 4.3 2.8 2.4 14.3 2.4 12.9 4.2 15.7 2.1 54.9 3.9 1.5 3.1 11.9 2.6 1.1 15.7 0.0 20.2 0.4 3.6 1.4 46.9 3.2 0.0 4.2 0.0 2.4 2.7 23.5 23.6 43.8 2.0 1.0 1.1 2.5 0.9 1.4 0.0 1.9 0.2 2.8 1.0 7.1 4.1 1.5 39.9 1.9 0.7 5.0 29.8 0.8 13.5 10.7 0.0 2.8 1.6 6.0 8.8 3.8 0.6 70.5 1.3 5.7 33.5 30.2 AARD "C8orf85, LOC441376" ENSG00000205002 "Alanine and arginine rich domain containing protein" Q4LEZ3 8 116938207-116944487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.7;urinary bladder: 7.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 27.6;Breast glandular cells: 26.0;Breast myoepithelial cells: 29.0;granulocytes: 14.5;Late spermatids: 18.4;Proximal tubular cells: 14.9;Spermatocytes: 57.4" "Cancer enriched" "Detected in many" 8 "breast cancer: 27.0" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 21.7;JURKAT: 7.2;SK-BR-3: 11.8;U-2 OS: 5.5;U-266/84: 4.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 4 "midbrain: 4.4" HPA068290 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA068290: " "unprognostic (5.81e-2)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" "unprognostic (7.28e-8)" "unprognostic (3.42e-2)" "unprognostic (4.32e-3)" "unprognostic (4.34e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (8.29e-2)" "unprognostic (8.57e-3)" "unprognostic (4.20e-1)" "unprognostic (2.23e-6)" "unprognostic (1.67e-1)" "unprognostic (9.78e-3)" "unprognostic (3.77e-2)" "unprognostic (5.27e-4)" 0.3 0.9 0.5 0.4 0.8 0.2 4.3 0.4 0.8 0.2 0.8 3.7 0.1 0.8 0.2 2.4 0.1 0.2 0.0 0.6 0.8 1.0 0.0 2.5 0.8 1.2 1.0 0.6 0.0 0.0 0.0 0.0 0.4 0.9 0.6 0.5 0.1 2.0 0.1 0.1 1.3 1.0 1.0 0.8 0.1 6.9 22.7 0.6 0.0 0.1 0.0 0.4 7.8 0.2 1.4 0.0 0.0 0.5 0.0 0.0 0.0 0.2 1.8 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.5 0.0 0.2 0.1 2.4 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.0 7.2 0.0 2.4 0.1 0.5 0.9 0.1 1.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 1.9 0.3 0.0 11.8 0.1 0.2 0.5 0.0 0.0 0.1 5.5 0.2 0.0 1.6 4.5 0.0 3.0 0.0 0.3 1.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.3 0.1 0.2 0.6 0.0 0.5 0.8 0.4 0.8 0.6 0.8 1.2 1.0 0.6 0.9 0.8 0.6 1.4 0.2 12.8 27.6 0.0 0.1 0.8 0.6 0.2 0.0 0.4 26.0 29.0 0.9 0.0 5.0 7.3 0.0 0.2 0.8 0.1 1.9 0.1 9.3 0.1 1.7 0.9 0.0 0.0 0.8 0.0 0.9 1.4 0.0 0.0 14.5 0.1 0.0 0.1 0.0 1.7 2.1 0.0 0.0 0.0 0.3 18.4 4.1 0.5 0.0 0.0 0.1 0.1 4.1 0.0 0.2 0.1 0.0 0.7 0.0 0.6 0.0 14.9 0.7 0.2 0.0 0.5 1.1 57.4 7.3 0.0 0.6 0.3 0.8 2.0 0.0 0.4 PABPN1L ePABP2 ENSG00000205022 "PABPN1 like, cytoplasmic" A6NDY0 16 88863333-88866660 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "adrenal gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;NB-4: 1.8;SCLC-21H: 4.7;T-47d: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 1.6" HPA043415 Uncertain NA NA "HPA043415: AB_10981610" "unprognostic (2.19e-1)" "unprognostic (1.50e-2)" "unprognostic (1.40e-3)" "unprognostic (8.96e-3)" "unprognostic (1.57e-1)" "unprognostic (3.19e-1)" 0.1 2.4 0.2 0.0 0.3 0.8 0.1 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.3 0.2 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 2.6 0.3 1.8 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.5 0.2 0.0 0.2 0.1 0.2 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D16 ENSG00000205029 "Olfactory receptor family 5 subfamily D member 16" Q8NGK9 11 55838752-55839738 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046711 Uncertain NA NA "HPA046711: AB_2679766" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L2 "HSHTPCRX16, HTPCRX16" ENSG00000205030 "Olfactory receptor family 5 subfamily L member 2" Q8NGL0 11 55827219-55828154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKHD1L1 ENSG00000205038 "PKHD1 like 1" Q86WI1 8 109362461-109537207 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "thyroid gland: 69.4" "Cell type enhanced" "Detected in some" "B-cells: 24.4;Endometrial ciliated cells: 47.0;Endothelial cells: 14.0;Glandular and luminal cells: 49.9;Plasma cells: 28.2" "Group enriched" "Detected in some" 18 "endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HHSteC: 1.4;TIME: 1.6;U-266/70: 3.9" "Not detected" "Not detected" HPA044458 Uncertain NA NA 13000000 "HPA044458: AB_2678949" "unprognostic (9.07e-3)" "unprognostic (3.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.61e-4)" "unprognostic (5.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.91e-2)" "unprognostic (3.45e-2)" "unprognostic (3.31e-2)" "unprognostic (1.98e-1)" "unprognostic (9.65e-3)" "unprognostic (1.92e-1)" "unprognostic (7.76e-6)" "unprognostic (4.56e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-3)" "unprognostic (2.73e-2)" 12.8 2.7 0.2 0.5 0.1 0.4 2.6 0.1 0.3 13.9 1.4 2.4 1.1 6.0 0.3 1.7 14.2 0.4 5.3 0.1 0.4 1.9 0.6 7.0 1.2 0.2 0.1 0.1 2.6 0.5 0.0 0.8 0.0 0.1 0.7 1.6 0.0 0.7 0.2 0.2 1.7 4.3 0.4 0.2 0.5 1.6 0.5 0.1 0.1 69.4 0.6 1.1 1.2 1.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.4 0.2 0.1 0.1 0.1 0.2 0.1 0.4 1.3 0.0 2.8 0.7 24.4 0.3 0.0 0.0 0.6 0.0 0.1 0.0 1.9 1.5 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 47.0 3.4 14.0 1.8 0.4 0.2 0.0 0.1 6.6 1.1 49.9 1.3 0.0 10.4 0.6 0.0 0.0 0.2 0.0 0.0 0.9 0.3 0.5 0.6 0.3 1.8 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 28.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 1.9 0.0 0.1 0.0 SLFN12L ENSG00000205045 "Schlafen family member 12 like" Q6IEE8 17 35464249-35487857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.2" "Group enriched" "Detected in some" 8 "dendritic cells: 16.0;NK-cells: 42.2;T-cells: 31.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 3.6" "Group enriched" "Detected in many" 6 "granulocytes: 1.0;NK-cells: 3.6;T-cells: 1.9" "Cell line enhanced" "Detected in some" "HDLM-2: 9.7;Karpas-707: 5.5" HPA024447 Uncertain NA NA "HPA024447: AB_1856614" "unprognostic (1.93e-3)" "unprognostic (2.10e-4)" "unprognostic (3.77e-2)" "unprognostic (2.67e-2)" "unprognostic (8.18e-3)" "unprognostic (2.98e-5)" "unprognostic (4.59e-3)" "unprognostic (2.75e-2)" "unprognostic (6.82e-2)" "unprognostic (1.67e-2)" "unprognostic (9.51e-2)" "unprognostic (1.78e-1)" "unprognostic (2.25e-6)" "unprognostic (2.30e-1)" "unprognostic (3.88e-2)" "unprognostic (7.02e-2)" "unprognostic (8.88e-3)" 0.6 0.3 0.8 2.5 1.0 3.0 0.6 2.6 1.9 0.5 0.9 0.6 1.7 0.5 0.3 0.3 0.3 1.0 0.2 0.8 0.4 0.3 0.6 1.3 3.0 0.7 0.4 0.9 0.4 0.3 0.1 0.0 0.2 1.1 0.3 0.8 0.8 0.9 0.2 0.5 0.6 1.5 0.4 0.0 3.2 1.2 0.3 0.5 1.1 0.4 0.3 2.2 0.7 0.1 2.0 0.5 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.0 0.6 1.4 0.1 0.3 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.7 9.7 0.1 1.3 0.8 0.1 0.0 0.3 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.3 5.5 0.1 0.0 0.4 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.1 0.4 0.1 0.1 0.1 0.0 2.0 0.6 0.3 1.2 0.5 0.2 2.0 2.0 0.1 0.2 0.3 0.5 1.0 0.3 1.0 1.9 0.0 0.8 0.3 0.8 1.4 0.2 0.3 1.0 1.0 0.9 3.6 0.1 0.2 0.5 0.4 0.8 1.0 2.6 1.9 0.8 0.4 0.7 0.4 0.9 1.1 0.0 0.5 2.0 3.5 3.2 2.7 0.0 1.5 0.3 0.6 0.4 0.0 0.0 0.3 0.3 1.3 1.5 0.7 0.0 0.0 0.0 16.0 0.0 0.0 0.2 0.8 0.5 0.2 1.4 0.0 0.4 0.0 0.0 0.0 0.5 1.5 0.3 1.3 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 1.1 0.0 1.0 0.8 0.0 42.2 0.0 0.1 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.7 0.4 0.0 0.3 0.1 0.0 31.7 0.1 0.1 0.2 SLC35B4 "FLJ14697, YEA4" ENSG00000205060 "Solute carrier family 35 member B4" Q969S0 7 134289332-134316930 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 95.2;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049779 Approved NA NA "HPA049779: AB_2680878" "unprognostic (1.84e-1)" "unprognostic (1.94e-2)" "unprognostic (7.19e-2)" "unprognostic (2.49e-2)" "unprognostic (1.77e-3)" "unprognostic (3.47e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (6.88e-3)" "unprognostic (1.86e-1)" "unprognostic (2.24e-3)" "unprognostic (3.18e-2)" "unprognostic (2.86e-1)" "unprognostic (9.81e-2)" "unprognostic (1.00e-1)" 5.2 6.4 8.6 5.2 8.9 1.9 3.3 10.0 8.6 4.0 6.7 3.7 2.9 6.0 6.4 3.3 4.4 3.9 2.6 8.4 8.7 10.5 8.5 3.3 4.6 8.5 8.6 8.0 6.4 2.7 4.6 4.2 11.9 8.4 5.2 3.6 12.4 2.4 6.2 2.5 3.2 4.1 7.1 7.7 4.2 3.5 4.7 9.3 4.9 3.4 2.9 4.9 4.1 2.9 8.3 6.8 22.5 19.3 29.0 18.4 15.3 9.9 16.9 14.1 14.7 12.4 8.7 6.3 22.9 5.6 18.3 19.2 7.2 29.0 15.0 24.3 14.5 21.4 15.5 12.9 11.6 13.6 22.1 13.4 13.6 6.3 17.7 14.9 11.0 14.4 15.6 15.2 8.2 22.2 6.1 19.7 16.1 40.0 7.0 20.0 14.1 17.0 11.2 8.3 8.3 6.7 39.5 15.1 5.0 19.0 16.0 2.7 12.4 16.1 19.0 6.2 11.5 16.9 26.9 39.9 25.9 34.0 20.5 22.4 0.7 1.5 0.3 1.6 2.1 2.5 1.3 1.5 2.1 3.1 1.4 1.4 2.1 0.1 1.9 1.7 2.1 1.7 1.4 8.6 8.9 10.0 8.6 8.4 8.7 8.5 8.6 8.0 8.4 7.7 9.3 8.3 7.2 9.6 5.4 22.9 10.2 2.2 5.7 10.7 6.2 52.6 4.9 3.4 6.9 11.5 8.5 1.8 45.9 95.2 3.7 2.2 11.7 8.1 2.4 5.3 15.2 11.8 4.2 8.8 33.4 5.3 27.8 13.3 14.8 6.5 1.3 27.8 7.5 15.1 20.9 42.1 36.6 5.7 22.4 9.3 3.9 3.4 11.1 11.9 5.4 14.0 8.4 16.2 14.4 24.1 24.3 9.0 4.9 12.4 9.2 4.9 7.0 13.9 6.2 21.6 6.6 10.0 10.0 10.8 24.0 9.3 3.3 83.2 10.7 31.3 4.1 3.7 LGALS7 "GAL7, LGALS7A, PIG1, TP53I1" ENSG00000205076 "Galectin 7" P47929 19 38770971-38773492 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 396.2;skin 1: 779.8" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 275.1;Squamous epithelial cells: 639.7;Suprabasal keratinocytes: 725.7" "Group enriched" "Detected in many" 7 "cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 7.1;OE19: 2.2" "Low region specificity" "Detected in single" "HPA001549, CAB032606" Enhanced "Intracellular and membrane" NA NA 4000000 "CAB032606: AB_640852, HPA001549: AB_1078938" "unprognostic (1.56e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (4.86e-2)" "unprognostic (2.39e-1)" "unprognostic (2.38e-1)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.01e-2)" "unprognostic (3.37e-1)" "unprognostic (1.93e-1)" "unprognostic (3.31e-2)" "unprognostic (3.09e-2)" 0.7 0.2 0.0 0.0 0.0 0.0 13.8 0.0 0.0 30.5 0.0 0.2 0.0 0.4 0.0 396.2 0.4 0.2 0.5 0.0 0.0 0.7 0.3 0.4 0.0 0.1 0.1 0.0 0.3 0.4 0.0 0.4 0.0 0.0 2.0 0.0 0.0 25.7 0.2 10.8 779.8 0.3 0.0 0.0 2.3 0.5 1.5 0.0 0.5 0.7 0.4 2.3 0.3 156.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 275.1 0.9 124.3 89.4 0.0 0.3 2.8 0.2 0.0 57.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 7.5 1.1 0.0 0.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 1.6 0.0 0.4 10.7 0.0 0.0 1.7 3.8 1.5 0.8 639.7 725.7 0.0 0.5 0.1 0.0 1.5 SYCE1L MRP2 ENSG00000205078 "Synaptonemal complex central element protein 1 like" A8MT33 16 77199408-77213215 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.7" "Cell type enhanced" "Detected in many" "Breast glandular cells: 89.5;Breast myoepithelial cells: 125.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.1;U-698: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA062464, HPA066691" Enhanced "Intermediate filaments" No No "Intermediate filaments" "HPA062464: , HPA066691: AB_2685702" "unprognostic (5.54e-3)" "unprognostic (2.15e-1)" "unprognostic (1.65e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (2.00e-3)" "unprognostic (6.28e-3)" "unprognostic (1.02e-1)" "unprognostic (7.48e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (9.27e-2)" "unprognostic (4.27e-1)" "unprognostic (2.68e-2)" "unprognostic (1.73e-2)" 2.4 1.5 1.5 0.4 1.2 1.2 3.6 6.8 2.3 5.4 1.3 1.6 0.8 3.0 1.5 1.5 3.2 0.4 1.2 1.2 2.7 3.2 1.5 1.4 1.0 2.1 2.8 0.8 5.3 2.0 0.7 2.2 0.5 3.6 7.0 0.5 2.8 5.1 0.6 0.8 2.8 2.2 0.5 1.6 2.0 1.2 23.7 1.8 0.4 3.4 0.0 0.6 2.4 4.1 1.2 2.4 0.9 2.3 0.9 0.2 0.0 0.3 0.6 0.2 0.3 0.6 0.4 4.6 1.3 2.6 0.4 0.1 3.4 0.2 0.0 0.2 1.4 11.1 0.3 0.8 0.0 1.5 0.8 0.8 0.0 0.3 0.1 0.2 0.3 1.6 2.0 0.6 0.1 0.2 3.6 0.5 0.9 1.4 0.3 3.8 5.7 0.6 0.4 2.3 0.5 2.3 2.2 0.3 0.2 0.0 0.1 0.0 0.8 5.1 0.3 5.1 0.6 0.1 4.1 1.9 8.0 1.9 0.4 0.1 4.5 1.3 13.9 6.8 2.6 7.8 4.0 8.2 9.0 1.8 2.6 8.9 8.4 1.4 3.6 2.1 13.8 12.6 3.4 1.5 1.2 6.8 2.3 1.2 2.7 2.1 2.8 0.8 3.6 1.6 1.8 1.2 19.5 3.2 3.7 6.5 7.6 17.3 10.9 15.2 15.9 3.7 89.5 125.7 1.7 32.9 7.4 27.6 10.4 6.8 8.9 22.4 15.6 24.8 24.7 7.1 4.5 15.9 22.4 1.3 5.9 27.9 4.0 13.8 2.6 15.2 1.3 5.0 18.2 13.2 2.3 1.7 9.2 52.0 12.2 15.8 9.7 55.5 13.7 3.6 19.6 5.6 2.9 35.1 3.1 7.5 10.6 13.9 27.2 6.8 6.9 16.7 22.3 31.9 2.6 44.5 6.6 19.9 5.4 30.4 9.9 6.7 17.0 2.9 9.4 0.5 52.5 7.1 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536741-75556268 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "fallopian tube: 48.9" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 52.1;Endometrial ciliated cells: 121.2;Respiratory ciliated cells: 132.2;Rod photoreceptor cells: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042081 Enhanced Approved Vesicles NA NA Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 2.3 3.3 6.2 1.4 4.8 1.4 2.5 4.8 5.3 2.9 9.6 2.6 2.4 4.3 3.7 1.7 48.9 3.2 6.0 5.0 5.9 2.9 1.1 4.6 1.6 7.6 8.2 4.0 4.7 3.1 7.1 5.0 2.2 6.4 3.6 1.9 5.2 1.5 3.5 1.0 2.2 2.6 5.5 8.3 1.5 1.9 4.5 5.5 0.9 5.8 1.2 1.0 2.6 1.7 4.7 4.0 2.6 7.1 12.0 6.8 16.6 3.8 5.0 6.3 6.1 7.3 1.4 7.0 5.0 6.7 6.9 5.1 10.3 0.8 5.3 3.9 0.9 2.9 0.3 3.6 1.6 5.9 2.9 2.1 3.7 7.0 6.2 15.1 11.0 3.3 4.5 4.8 0.2 1.8 11.5 1.8 5.2 4.0 0.8 2.1 0.9 1.0 11.5 7.4 1.6 5.7 3.8 8.8 2.5 4.4 2.3 2.3 3.0 5.1 4.7 3.7 3.0 2.6 9.1 8.4 1.6 11.9 1.3 4.6 1.8 0.3 0.2 0.6 0.4 1.5 2.2 0.7 1.2 1.0 1.0 0.6 1.0 2.5 0.4 0.2 1.3 0.2 0.6 6.2 4.8 4.8 5.3 5.0 5.9 7.6 8.2 4.0 6.4 8.3 5.5 4.7 6.4 3.2 6.3 9.4 3.0 1.0 4.7 5.5 1.8 18.3 5.3 6.1 5.2 1.5 14.0 7.3 52.1 1.1 1.1 3.7 0.0 3.0 17.6 121.2 8.1 6.3 3.0 1.7 11.6 2.3 1.2 5.2 3.6 10.6 1.3 6.1 4.2 1.5 0.9 13.5 11.4 5.0 18.3 1.2 0.8 5.3 1.8 1.5 0.0 1.0 2.8 6.0 0.0 9.5 7.6 1.5 3.8 3.8 2.0 5.0 16.8 2.1 132.2 33.1 0.0 6.6 6.1 15.3 9.8 1.8 1.0 0.3 2.3 6.0 4.2 2.5 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 26.3" "Cell type enriched" "Detected in many" 4 "Late spermatids: 611.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020513: AB_1853077, HPA024248: AB_2671497" "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 2.0 2.3 0.4 2.1 1.1 1.3 1.5 2.5 1.2 1.1 0.9 0.3 0.9 0.9 0.9 0.9 0.5 2.0 2.1 1.1 1.7 1.0 0.8 0.4 2.0 1.2 2.3 1.2 1.3 0.2 2.9 0.3 1.7 1.3 0.4 2.7 1.7 0.4 1.3 1.0 0.9 0.5 0.6 1.7 1.1 26.3 1.6 0.2 1.4 0.1 0.3 1.0 0.8 2.7 0.2 0.3 0.4 0.6 0.4 0.6 0.2 0.2 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.5 0.1 0.5 0.0 0.2 0.2 0.1 0.1 0.2 0.9 0.0 0.2 0.2 0.6 0.5 0.2 0.4 0.1 0.6 0.1 0.2 0.1 0.4 0.2 0.4 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.1 0.3 1.1 0.3 0.2 0.2 0.2 0.4 0.5 0.2 0.1 1.3 0.5 0.1 0.8 0.3 0.9 0.4 0.3 0.3 0.2 0.3 1.6 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 1.1 0.4 0.1 0.4 0.1 0.0 2.3 2.1 1.5 2.5 2.1 1.1 2.0 1.2 2.3 1.7 0.6 1.6 2.7 0.5 3.2 2.2 17.0 0.4 0.0 1.8 0.3 0.6 12.2 1.3 0.8 1.4 2.8 0.2 3.7 52.1 0.6 0.1 0.5 0.0 1.5 138.7 2.1 2.0 1.5 1.2 0.0 11.9 0.7 0.7 1.4 3.1 5.6 2.5 2.0 2.2 0.8 0.9 0.0 10.2 1.1 0.0 1.3 0.4 611.8 4.1 1.4 0.0 2.8 1.1 2.7 1.0 6.6 10.6 1.6 1.8 3.0 2.0 2.5 0.5 0.3 0.2 19.0 0.0 6.5 1.4 13.1 4.0 0.4 0.1 2.5 1.1 4.0 1.4 1.1 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747426-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;intestine: 3.6" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 25.7" "Low region specificity" "Detected in all" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.2 0.3 1.3 0.9 1.7 0.1 0.2 1.3 1.2 0.5 0.0 2.7 3.6 0.1 0.3 0.1 0.3 0.4 0.3 0.9 0.7 2.0 0.0 0.5 0.8 1.8 1.3 0.7 0.2 1.2 0.0 0.6 0.1 1.8 0.9 2.7 1.1 2.7 1.4 0.3 0.3 2.2 0.1 1.3 0.4 2.5 0.7 1.3 1.6 0.4 0.0 0.9 0.9 0.2 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.4 0.0 0.6 25.7 0.1 0.4 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.3 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 4.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.3 1.7 1.3 1.2 0.9 0.7 1.8 1.3 0.7 1.8 1.3 1.3 4.3 0.2 0.0 0.5 0.0 0.9 0.1 0.4 0.8 0.0 0.1 0.4 0.1 0.6 0.0 0.4 0.0 0.0 0.4 0.1 3.4 3.9 0.4 2.2 0.4 0.0 0.1 1.2 0.0 0.6 1.5 0.2 0.3 7.1 0.5 1.3 0.0 0.0 0.0 0.1 1.7 0.5 3.5 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.0 4.9 0.0 1.0 2.4 1.5 2.3 0.0 4.8 0.6 1.8 0.3 1.0 0.2 0.0 0.1 0.2 0.2 0.7 0.0 0.1 0.0 1.9 0.1 4.2 0.6 TMEM240 "C1orf70, SCA21" ENSG00000205090 "Transmembrane protein 240" Q5SV17 1 1534778-1540624 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 6.5;Excitatory neurons: 15.5;Inhibitory neurons: 15.1;Oligodendrocyte precursor cells: 8.0;Sertoli cells: 6.6" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 8.5;SCLC-21H: 9.3;SH-SY5Y: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066721 Supported NA NA "HPA066721: AB_2732750" "unprognostic (2.24e-1)" "unprognostic (1.87e-1)" "unprognostic (5.52e-5)" "unprognostic (2.31e-1)" "unprognostic (2.47e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" "unprognostic (3.85e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "prognostic favorable (2.52e-4)" "unprognostic (9.13e-2)" "unprognostic (7.96e-3)" "unprognostic (9.50e-4)" "unprognostic (2.64e-1)" "unprognostic (8.38e-2)" "unprognostic (1.93e-1)" 4.1 3.6 9.4 0.6 11.0 0.1 3.9 16.0 23.0 13.9 1.2 12.7 0.4 15.2 0.9 3.0 10.7 1.0 7.7 11.7 7.8 2.8 1.2 4.3 0.4 6.0 7.5 11.8 16.3 1.3 1.4 15.3 1.6 9.1 9.6 0.5 1.3 2.5 3.3 3.8 2.6 4.9 2.2 3.7 4.0 5.7 3.0 8.0 0.3 5.4 1.2 0.2 10.8 8.6 8.5 0.9 1.0 5.7 0.7 0.8 3.8 1.4 3.8 2.1 3.5 2.0 0.0 0.4 0.7 0.7 1.9 0.2 2.2 0.0 0.2 0.5 3.5 8.5 0.5 3.6 1.3 7.5 0.0 0.8 5.2 1.8 1.4 0.3 4.3 3.5 0.6 1.1 0.3 0.0 0.2 0.6 0.9 3.9 0.1 1.2 3.3 1.1 0.7 0.4 0.0 9.3 11.2 1.4 0.4 4.0 0.1 0.6 0.0 1.9 0.5 1.7 0.7 1.7 1.6 0.4 0.4 1.9 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.0 16.0 23.0 11.7 7.8 6.0 7.5 11.8 9.1 3.7 8.0 8.5 0.7 0.0 0.0 6.5 0.2 0.0 0.3 0.0 1.2 3.1 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.2 1.6 0.4 0.0 0.0 15.5 0.0 0.1 0.8 0.0 0.2 0.0 1.6 0.7 0.0 0.1 3.3 15.1 0.6 0.0 0.0 0.0 0.0 1.2 0.2 0.0 1.0 0.0 4.5 1.0 8.0 4.4 0.1 0.2 2.2 0.3 0.2 0.1 0.1 0.0 0.5 6.6 0.2 0.9 0.1 0.5 0.1 0.0 0.0 0.2 1.4 0.3 0.1 FRG2 FRG2A ENSG00000205097 "FSHD region gene 2" Q64ET8 4 190024367-190027257 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723053-34729488 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 25.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 135.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071267 Enhanced Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA071267: AB_2686376" "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDKL4 ENSG00000205111 "Cyclin dependent kinase like 4" Q5MAI5 2 39175646-39229588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 1.7;testis: 3.0" "Cell type enhanced" "Detected in some" "Early spermatids: 11.8;Excitatory neurons: 5.4;Late spermatids: 6.8;Respiratory ciliated cells: 5.9;Spermatocytes: 8.7;Spermatogonia: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 2.1;RT4: 1.3;SH-SY5Y: 2.6" "Low region specificity" "Detected in all" HPA067895 Uncertain NA NA "HPA067895: AB_2685920" "unprognostic (3.57e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (3.29e-1)" "unprognostic (7.46e-3)" "unprognostic (3.26e-2)" "unprognostic (4.26e-1)" "unprognostic (3.82e-2)" "unprognostic (6.13e-3)" "unprognostic (1.77e-2)" "unprognostic (8.43e-2)" "unprognostic (8.45e-4)" "unprognostic (8.59e-2)" "unprognostic (4.95e-1)" "unprognostic (3.08e-1)" "unprognostic (3.26e-2)" 0.1 0.4 0.7 0.0 0.6 0.0 0.1 0.7 0.7 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.7 0.9 0.1 0.0 0.2 0.1 0.5 0.6 0.5 0.1 0.1 0.2 0.5 0.4 0.4 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 3.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 2.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.6 0.7 0.7 0.7 0.9 0.5 0.6 0.5 0.4 0.4 0.7 0.6 0.5 3.2 0.0 0.7 0.0 0.1 0.2 0.3 0.0 0.1 0.6 0.5 0.2 0.0 2.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 11.8 1.2 0.3 0.3 0.0 0.0 5.4 0.2 0.4 0.2 1.1 1.8 0.0 0.2 0.0 0.1 0.2 0.0 3.4 0.0 2.0 0.0 0.0 6.8 0.3 0.2 0.0 1.9 0.0 0.2 0.0 1.5 0.4 0.4 0.1 0.4 0.1 0.4 0.0 0.3 5.9 0.8 0.0 0.5 0.1 8.7 4.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 TMEM88B ENSG00000205116 "Transmembrane protein 88B" A6NKF7 1 1426128-1427787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 186 "brain: 416.1" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 4 "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 4.2;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065743 Enhanced NA NA "HPA065743: AB_2685552" "unprognostic (3.17e-2)" "unprognostic (1.42e-2)" "unprognostic (1.63e-4)" "unprognostic (1.11e-1)" "unprognostic (3.35e-2)" "unprognostic (2.67e-1)" "unprognostic (2.91e-2)" "unprognostic (5.30e-5)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (3.53e-2)" "unprognostic (7.19e-2)" "unprognostic (1.45e-1)" "unprognostic (7.95e-2)" 0.0 0.0 82.9 0.1 229.2 0.0 0.0 164.2 127.4 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 56.6 129.0 1.0 0.0 0.1 0.0 288.1 214.3 28.9 0.1 0.0 0.0 0.0 0.0 342.8 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 146.9 0.0 0.0 2.2 187.0 0.0 0.0 0.0 0.0 0.3 0.1 416.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.9 229.2 164.2 127.4 56.6 129.0 288.1 214.3 28.9 342.8 146.9 187.0 416.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACCSL ENSG00000205126 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like" Q4AC99 11 44047981-44059977 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 2.0;Excitatory neurons: 2.6;Inhibitory neurons: 2.7;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.8" "Cancer enriched" "Detected in single" 22 "melanoma: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA065042 Approved Cytosol NA NA Cytosol "HPA065042: " "unprognostic (2.37e-2)" "unprognostic (2.91e-1)" "unprognostic (9.76e-5)" "unprognostic (7.42e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 19.9;fallopian tube: 13.7;retina: 15.2;testis: 13.5" "Cell type enhanced" "Detected in many" "Early spermatids: 191.3;Endometrial ciliated cells: 50.0;Excitatory neurons: 36.6;Respiratory ciliated cells: 106.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 2.4;hTERT-RPE1: 4.9;U-87 MG: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.3 0.3 6.3 0.2 4.7 0.3 2.1 4.2 3.2 0.9 19.9 0.3 0.1 1.3 3.8 0.3 13.7 0.9 0.6 3.6 7.4 1.9 0.4 2.0 0.1 6.9 7.0 2.8 0.7 0.7 0.6 2.9 0.2 5.3 0.6 0.2 15.2 0.5 0.6 0.1 1.0 0.2 0.4 7.9 0.2 0.3 13.5 4.2 0.2 4.6 0.1 0.2 0.3 0.3 4.1 2.4 0.0 0.2 1.2 0.4 2.3 0.7 0.0 0.1 0.2 0.3 0.3 1.4 0.1 0.4 0.1 0.2 0.2 0.3 0.4 0.5 0.5 0.4 0.0 0.1 0.3 0.5 0.0 0.1 0.5 0.5 0.5 0.2 4.9 0.0 0.5 0.3 0.1 1.8 0.3 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.2 0.7 0.0 1.3 0.6 0.4 0.0 1.5 0.5 0.1 0.4 0.7 0.4 0.1 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.2 0.0 0.0 6.3 4.7 4.2 3.2 3.6 7.4 6.9 7.0 2.8 5.3 7.9 4.2 4.1 0.6 3.2 1.5 21.5 2.0 0.6 0.9 8.7 4.6 0.9 2.2 3.9 0.6 1.5 13.2 3.7 10.4 0.1 0.4 0.4 1.9 2.8 191.3 50.0 1.5 1.3 0.0 0.0 36.6 0.6 1.5 2.4 6.6 3.4 0.0 0.3 1.1 0.1 0.2 1.7 26.3 0.0 2.0 0.6 0.4 20.9 0.6 0.7 1.8 4.7 0.1 3.6 0.0 18.6 13.4 1.0 0.0 0.7 9.6 0.6 0.0 3.7 106.6 14.8 0.0 3.0 3.1 12.6 5.0 2.6 0.6 0.3 1.5 0.5 0.0 0.3 TRIQK "C8orf83, DKFZp779L1068, LOC286144, PRO0845" ENSG00000205133 "Triple QxxK/R motif containing" Q629K1 8 92883532-93017673 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 32.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.47e-3)" "unprognostic (3.09e-1)" "unprognostic (6.03e-3)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.13e-2)" "unprognostic (7.78e-2)" "unprognostic (2.50e-1)" "unprognostic (2.31e-1)" "unprognostic (1.56e-1)" "unprognostic (2.52e-1)" "unprognostic (1.79e-1)" "unprognostic (5.11e-3)" "unprognostic (9.23e-2)" "unprognostic (7.15e-2)" "unprognostic (2.79e-2)" 12.9 22.1 13.8 7.8 16.2 14.6 14.7 19.7 15.0 19.6 12.2 20.9 12.5 12.6 9.8 9.9 15.8 23.1 20.2 14.0 16.0 19.6 31.6 17.1 5.4 14.5 16.2 12.8 19.7 18.1 20.8 10.8 19.8 14.7 18.3 21.2 12.5 11.2 10.3 2.4 5.7 12.2 11.5 14.9 13.3 17.6 6.5 15.1 7.4 23.6 5.7 5.2 15.6 7.9 18.1 7.4 9.2 19.8 7.0 27.1 42.8 6.6 26.4 28.4 14.7 20.9 1.3 22.9 0.0 31.6 24.9 9.8 11.9 16.1 15.9 23.7 0.0 7.6 28.9 10.1 15.6 22.9 8.1 24.0 32.0 35.4 8.0 27.1 33.3 15.7 16.3 5.6 16.7 21.3 19.7 13.1 6.3 6.8 31.3 33.8 0.0 20.5 9.6 27.8 9.1 11.4 16.0 10.0 3.9 25.6 16.3 27.2 7.1 20.5 21.8 6.7 38.3 8.3 5.8 0.0 0.0 33.8 0.1 22.5 0.9 17.0 15.9 0.1 18.8 8.1 2.8 0.9 0.7 9.4 1.9 0.0 0.0 14.6 2.0 32.9 2.5 0.2 4.7 13.8 16.2 19.7 15.0 14.0 16.0 14.5 16.2 12.8 14.7 14.9 15.1 18.1 19.0 19.2 17.9 21.9 4.0 15.0 21.4 17.1 22.8 18.9 17.7 12.4 13.8 25.8 14.1 16.5 6.2 7.3 2.1 16.2 50.9 14.8 7.0 21.3 27.7 17.8 19.2 6.7 36.8 16.4 23.8 23.5 20.9 24.5 2.5 11.7 17.2 18.3 11.9 6.7 43.6 35.6 12.2 20.0 13.6 8.0 16.4 18.5 23.2 31.9 24.3 22.8 3.1 34.7 56.3 12.5 14.0 21.8 1.0 22.2 17.0 39.1 29.5 6.3 32.9 18.4 18.2 12.1 5.3 12.3 8.4 3.7 3.3 21.6 20.0 22.6 SDHAF1 LYRM8 ENSG00000205138 "Succinate dehydrogenase complex assembly factor 1" A6NFY7 19 35995188-35996312 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064277, HPA074563" Supported Mitochondria NA NA Mitochondria "HPA064277: AB_2685231, HPA074563: " "unprognostic (2.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.22e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-1)" "unprognostic (4.47e-2)" "unprognostic (5.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.24e-1)" "unprognostic (3.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.83e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.38e-2)" "unprognostic (2.59e-1)" "unprognostic (2.24e-1)" "unprognostic (3.59e-2)" 14.2 16.3 14.0 6.3 15.4 4.2 16.3 18.2 15.8 18.8 13.2 20.1 13.7 16.5 6.1 16.4 17.1 4.8 14.6 14.5 15.3 18.6 33.0 12.9 9.6 16.5 15.0 14.3 15.1 24.9 9.7 20.3 5.5 16.4 16.6 5.1 6.8 17.0 6.7 19.1 18.2 19.0 3.0 15.6 19.2 19.1 10.0 15.1 8.6 16.5 7.7 6.1 18.9 16.8 18.7 9.6 24.7 7.2 16.7 6.9 8.7 12.5 9.2 9.8 9.8 11.3 17.8 7.1 17.8 17.3 6.1 6.7 9.5 9.5 5.1 4.7 33.6 22.3 7.9 10.7 23.6 8.4 9.5 12.5 7.7 16.4 6.0 6.4 3.9 5.5 18.5 24.6 18.9 4.3 23.5 18.2 18.6 11.2 31.4 11.8 19.6 8.0 20.3 9.7 12.2 28.2 21.1 14.8 23.9 16.5 5.9 13.7 15.9 7.3 11.2 16.8 10.7 14.2 25.4 12.6 21.0 9.8 18.1 10.1 45.6 34.0 55.2 40.3 40.7 43.8 43.0 43.4 39.5 35.8 46.5 47.8 40.5 19.2 57.7 45.7 45.0 49.6 32.1 14.0 15.4 18.2 15.8 14.5 15.3 16.5 15.0 14.3 16.4 15.6 15.1 18.7 18.7 6.4 4.1 4.6 24.6 30.0 11.4 9.7 14.2 20.9 27.1 26.4 9.5 17.2 5.9 18.4 6.2 25.1 19.9 21.7 27.4 21.9 25.0 7.9 15.8 16.9 28.8 8.8 4.0 29.6 37.7 20.0 16.3 7.3 4.5 17.3 19.6 19.9 22.7 18.5 4.6 32.7 10.2 19.6 18.5 6.5 23.0 12.1 24.9 3.7 28.2 16.6 32.0 3.0 8.1 22.9 37.2 29.3 16.8 23.1 54.1 32.8 3.3 14.8 26.3 10.9 13.8 10.5 13.9 16.1 41.6 23.1 20.1 25.4 32.0 16.4 ARID3C ENSG00000205143 "AT-rich interaction domain 3C" A6NKF2 9 34621379-34628086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 11.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "liver cancer: 2.2;ovarian cancer: 0.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;Karpas-707: 2.6;T-47d: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.66e-2)" "unprognostic (2.38e-1)" "unprognostic (2.05e-3)" "unprognostic (4.42e-3)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.76e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.21e-2)" "unprognostic (7.79e-2)" "unprognostic (3.28e-14)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (7.91e-2)" "unprognostic (4.26e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.9 0.0 11.8 0.0 0.0 1.3 0.5 0.2 0.0 0.1 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.2 0.9 0.1 0.3 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.0 2.0 0.2 0.0 0.3 0.0 0.6 0.0 0.1 0.1 0.4 0.0 0.0 0.2 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.6 0.2 0.0 2.6 0.1 0.0 0.0 0.1 0.5 0.0 0.5 0.4 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.1 0.1 0.9 1.3 0.5 0.2 1.5 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSENEN PEN2 ENSG00000205155 "Presenilin enhancer, gamma-secretase subunit" Q9NZ42 19 35745600-35747519 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 573.3;Respiratory ciliated cells: 954.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047435 Enhanced NA NA "HPA047435: AB_2680047" "unprognostic (1.96e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.64e-1)" "unprognostic (2.01e-1)" "unprognostic (2.79e-1)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (3.51e-3)" "unprognostic (2.30e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (6.85e-2)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (5.41e-3)" 47.8 66.3 91.8 39.3 86.1 35.9 54.8 93.8 90.3 59.9 117.4 57.8 42.4 46.9 135.8 70.0 230.0 38.2 53.4 86.2 100.9 70.7 79.0 55.4 41.6 93.7 93.0 83.6 37.8 63.6 75.7 60.5 36.7 96.7 47.1 64.0 38.9 56.1 53.8 52.4 45.7 43.5 48.1 96.7 58.1 52.6 150.1 90.9 54.5 58.8 47.1 62.2 59.9 45.0 97.9 94.2 187.8 75.1 87.2 136.5 85.3 43.2 49.8 108.9 111.0 117.7 52.3 173.7 48.9 116.0 99.4 76.2 54.6 65.3 86.1 105.0 81.8 55.1 34.5 44.1 50.6 118.9 53.7 60.5 88.8 153.4 129.7 106.2 95.8 112.2 94.1 53.7 116.5 127.8 108.5 62.8 63.7 55.9 214.9 49.7 58.8 30.2 89.9 226.4 46.7 62.1 94.5 65.6 144.3 45.6 98.8 92.0 119.7 46.4 88.4 52.9 60.3 81.1 88.0 107.6 62.1 152.0 50.3 72.1 140.8 208.3 202.0 131.3 232.9 123.9 109.3 95.8 114.0 154.8 100.4 73.1 92.9 539.2 91.4 191.1 337.1 107.4 245.3 91.8 86.1 93.8 90.3 86.2 100.9 93.7 93.0 83.6 96.7 96.7 90.9 97.9 58.4 38.5 38.2 4.2 53.5 38.7 59.3 192.5 39.3 13.2 55.6 36.7 29.7 51.5 137.6 128.8 14.6 92.5 73.2 132.8 60.7 146.8 199.1 573.3 42.7 52.4 70.2 36.6 1.9 151.0 135.9 50.5 34.1 75.6 57.7 22.5 42.1 49.7 164.4 6.7 2.1 66.1 185.1 51.2 90.9 126.5 54.7 69.8 71.2 1.9 85.9 58.6 86.5 2.0 6.3 171.4 152.5 40.6 83.1 44.2 122.4 194.4 954.0 19.7 52.6 33.9 147.7 344.8 35.8 48.4 48.4 104.1 53.3 56.3 67.3 74.0 C11orf91 ENSG00000205177 "Chromosome 11 open reading frame 91" Q3C1V1 11 33698261-33700801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 4.8;testis: 9.6" "Cell type enhanced" "Detected in some" "Early spermatids: 16.6;Late spermatids: 4.0;Sertoli cells: 6.6;Spermatocytes: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 16.2;hTERT-HME1: 10.0;HUVEC TERT2: 8.2;TIME: 12.6;U-2197: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047064, HPA050487" Uncertain Supported Vesicles NA NA Vesicles "HPA047064: AB_2679920, HPA050487: AB_2681142" "unprognostic (9.22e-3)" "unprognostic (1.51e-2)" "unprognostic (1.76e-1)" "unprognostic (6.60e-2)" "unprognostic (1.62e-2)" "unprognostic (3.63e-2)" "unprognostic (2.31e-1)" "unprognostic (5.68e-3)" "unprognostic (7.41e-2)" "unprognostic (2.97e-2)" "unprognostic (1.99e-2)" "unprognostic (3.01e-1)" "unprognostic (8.33e-2)" "unprognostic (4.06e-2)" "unprognostic (3.95e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" 4.8 0.2 0.5 0.6 0.4 1.0 1.6 1.3 2.2 0.1 0.1 0.4 0.0 0.2 0.1 3.0 0.3 4.7 0.6 0.4 1.0 0.7 0.2 1.1 0.2 0.6 0.5 0.1 0.2 1.5 0.0 0.1 0.5 0.6 0.2 0.0 0.2 0.5 0.2 0.5 1.0 0.3 0.8 0.4 0.0 2.1 9.6 0.5 0.2 0.4 0.0 0.4 1.4 0.3 0.8 0.2 0.0 0.2 1.5 0.0 0.0 0.0 1.8 0.0 0.9 0.4 0.3 0.6 0.0 0.1 1.9 0.2 0.7 0.5 16.2 1.3 0.5 0.0 0.0 4.0 0.9 0.3 0.0 0.0 0.0 0.1 1.2 10.0 0.5 8.2 0.2 0.0 2.5 3.9 0.0 0.0 0.3 0.0 0.1 5.0 0.0 0.0 0.0 1.1 2.1 0.0 0.3 0.0 1.6 0.1 0.5 0.0 0.0 12.6 1.2 0.3 10.3 0.3 0.7 0.6 0.0 2.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.3 2.2 0.4 1.0 0.6 0.5 0.1 0.6 0.4 0.5 0.8 1.2 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 16.6 0.4 0.2 0.6 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 6.6 0.1 0.3 12.3 0.4 0.3 0.0 0.1 0.0 0.0 0.0 1.5 FABP9 "PERF, PERF15, T-FABP" ENSG00000205186 "Fatty acid binding protein 9" Q0Z7S8 8 81458253-81461579 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "skin 1: 23.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA073619 Enhanced NA NA "HPA073619: AB_2732229" "unprognostic (2.99e-1)" 0.9 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 23.6 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB10 "FLJ12752, RINZF" ENSG00000205189 "Zinc finger and BTB domain containing 10" Q96DT7 8 80485619-80526265 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021554, HPA050569" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021554: AB_1858937, HPA050569: AB_2681179" "unprognostic (7.97e-2)" "unprognostic (3.53e-1)" "unprognostic (2.26e-1)" "unprognostic (6.67e-2)" "unprognostic (9.28e-2)" "unprognostic (8.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (4.86e-1)" "unprognostic (3.66e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.65e-3)" "unprognostic (2.40e-1)" "unprognostic (7.15e-2)" "unprognostic (2.63e-2)" 8.0 7.9 4.5 4.8 5.2 23.9 8.2 12.7 4.7 8.8 4.4 6.9 2.0 11.3 6.2 3.7 11.9 7.5 7.6 3.7 6.5 10.2 18.6 6.3 5.3 5.5 4.7 3.7 12.9 14.1 7.2 3.6 17.9 5.7 14.2 7.9 7.4 7.6 6.4 5.5 1.9 2.2 9.0 4.8 7.0 4.6 11.3 5.2 8.7 10.2 8.1 3.4 5.6 3.4 6.2 0.0 4.2 21.1 10.7 9.1 6.9 28.5 3.9 0.0 3.0 3.0 9.2 3.4 12.7 11.0 5.8 9.2 0.9 16.7 5.3 3.5 0.0 26.8 6.5 2.8 7.3 5.3 2.2 2.9 6.5 4.6 3.7 10.6 2.5 7.7 10.5 5.9 24.2 2.5 6.7 12.6 5.5 5.3 1.3 6.6 14.7 11.1 4.5 8.4 12.5 12.6 14.6 5.2 48.5 14.8 23.6 9.4 9.1 9.9 7.3 13.5 0.1 3.6 7.0 3.7 14.0 2.8 0.0 9.1 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.0 0.5 0.2 0.9 0.0 0.0 4.5 5.2 12.7 4.7 3.7 6.5 5.5 4.7 3.7 5.7 4.8 5.2 6.2 37.1 25.6 17.0 18.9 55.3 28.4 21.1 8.1 44.3 13.4 48.8 39.8 36.1 25.8 11.8 12.9 16.7 38.3 34.1 38.9 3.9 13.1 83.7 82.4 60.6 34.5 60.4 3.0 12.8 6.9 41.0 29.3 40.8 142.6 9.5 37.0 16.8 31.7 13.3 32.0 11.1 43.0 20.3 21.3 79.6 29.7 19.3 32.0 49.8 13.1 11.2 20.8 8.2 19.6 13.4 8.3 14.8 21.1 24.5 82.1 0.4 14.5 19.4 10.6 26.3 46.6 49.5 14.6 10.6 13.6 12.6 105.2 28.4 19.6 34.7 19.6 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666675-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047287: AB_2680011, HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 2.5 2.4 2.2 4.2 2.6 14.6 3.0 2.7 2.7 2.8 1.6 3.3 3.0 5.0 2.1 2.9 2.4 2.8 3.7 2.2 2.3 2.0 1.5 2.6 6.1 2.4 2.5 2.0 4.2 2.4 1.7 1.2 4.6 2.4 2.4 4.2 9.5 1.8 2.2 2.1 2.9 2.8 4.1 2.5 3.2 2.6 12.9 2.4 10.3 4.3 6.0 5.4 2.6 2.1 3.2 16.6 9.9 23.7 35.0 10.3 10.6 11.8 27.5 18.9 31.5 27.4 8.9 14.6 29.3 4.3 14.0 11.6 9.0 20.6 14.2 40.3 40.5 10.7 44.5 10.4 11.9 3.5 33.9 23.7 6.2 5.0 25.6 11.2 10.4 22.7 29.3 19.7 72.1 43.2 8.9 65.8 29.7 16.3 10.6 13.0 47.0 13.5 13.0 9.6 8.1 12.8 38.5 12.1 10.9 10.1 11.9 9.3 26.9 12.0 48.0 22.1 27.0 23.2 16.5 22.3 37.0 12.1 29.8 18.9 2.4 1.9 1.7 1.9 1.6 1.4 1.7 1.5 1.9 2.1 1.4 2.1 2.3 0.6 3.4 2.2 1.8 1.8 1.3 2.2 2.6 2.7 2.7 2.2 2.3 2.4 2.5 2.0 2.4 2.5 2.4 3.2 10.3 3.2 1.8 1.3 7.8 24.1 5.1 5.8 14.2 7.5 6.5 5.2 7.6 1.5 3.2 1.8 4.2 9.8 8.2 2.9 7.9 3.6 0.8 7.6 10.8 6.9 7.7 11.2 1.2 3.0 11.8 14.5 4.6 15.0 7.0 8.7 5.0 2.0 9.7 10.1 1.8 5.1 6.1 10.3 25.8 1.8 4.7 7.6 19.6 0.0 18.9 6.5 5.2 1.0 6.2 3.8 3.1 6.0 18.1 6.6 3.2 2.8 3.3 28.2 6.6 7.7 10.6 49.1 15.2 30.1 15.6 3.3 9.6 2.5 5.8 7.2 SCGB2B2 "SCGB4A2, SCGBL" ENSG00000205209 "Secretoglobin family 2B member 2" Q4G0G5 19 34593329-34675699 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 8.7" "Cell type enhanced" "Detected in some" "Astrocytes: 63.6;Excitatory neurons: 32.8;Inhibitory neurons: 45.3;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 104.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;U-266/70: 1.0" HPA046806 Uncertain "Secreted in other tissues" NA NA "HPA046806: AB_10962373" "unprognostic (9.99e-2)" "unprognostic (3.62e-1)" "unprognostic (9.51e-2)" "unprognostic (1.38e-5)" "unprognostic (4.80e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-3)" "unprognostic (3.67e-1)" "unprognostic (3.52e-2)" "unprognostic (2.90e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" 0.3 0.4 0.7 0.0 0.8 0.1 0.9 0.3 0.8 0.1 0.0 0.2 0.1 0.3 2.7 0.9 0.3 0.2 0.3 0.6 0.5 0.2 0.5 0.5 0.3 0.9 0.8 0.3 0.2 8.7 0.3 0.3 0.2 0.9 0.3 0.2 0.6 0.3 0.5 0.7 2.4 0.2 0.1 0.4 0.4 0.3 2.0 0.7 0.1 0.5 1.1 0.3 0.4 0.2 0.8 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.2 0.4 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.4 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 1.0 0.4 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.8 0.6 0.5 0.9 0.8 0.3 0.9 0.4 0.7 0.8 0.0 0.0 0.0 63.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.1 0.0 0.2 0.0 0.0 32.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.3 0.0 0.0 0.0 0.0 31.0 0.0 0.0 3.6 17.8 0.0 0.0 0.0 52.8 104.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 LGR4 GPR48 ENSG00000205213 "Leucine rich repeat containing G protein-coupled receptor 4" Q9BXB1 11 27365961-27472790 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030267, HPA054350" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030267: AB_10610004, HPA054350: " "unprognostic (5.27e-3)" "unprognostic (5.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.59e-1)" "unprognostic (4.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-2)" "unprognostic (4.63e-2)" "unprognostic (5.84e-3)" "unprognostic (2.10e-1)" "prognostic favorable (2.00e-7)" "unprognostic (5.01e-1)" "unprognostic (3.59e-1)" "unprognostic (3.54e-2)" "unprognostic (1.76e-1)" 16.5 17.0 10.8 8.2 11.0 2.4 16.2 13.4 9.3 7.6 9.3 37.2 22.8 10.3 13.4 13.8 10.3 9.0 14.9 8.1 16.2 52.0 56.1 3.2 1.5 14.0 10.5 7.9 23.1 60.2 6.5 6.8 34.7 12.3 15.6 37.1 44.8 18.2 16.3 14.5 18.4 24.9 13.3 13.3 11.8 31.3 14.0 11.6 4.4 15.3 8.3 3.0 10.2 11.8 18.4 28.3 50.7 49.5 5.7 4.5 3.1 56.0 15.7 14.8 13.8 11.8 7.6 0.5 0.1 10.1 21.2 23.2 45.8 83.5 31.1 23.5 0.2 37.0 15.3 28.4 36.1 1.4 1.6 0.1 4.1 19.5 9.5 21.0 57.0 7.0 0.0 4.5 0.1 5.7 9.0 0.1 2.7 47.9 76.3 20.4 0.2 33.8 3.3 100.4 12.1 0.7 6.0 7.7 45.7 4.6 37.6 15.1 23.4 22.6 10.2 8.2 82.6 14.6 18.9 15.2 0.0 17.3 0.0 6.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 11.0 13.4 9.3 8.1 16.2 14.0 10.5 7.9 12.3 13.3 11.6 18.4 1.7 3.2 0.5 204.4 1.4 30.3 13.5 33.1 38.7 18.6 17.2 14.1 26.6 24.3 15.4 44.1 25.0 55.1 0.4 123.3 3.9 21.4 7.1 75.4 11.5 3.9 16.8 3.4 35.6 50.7 29.2 14.5 43.3 137.7 0.0 78.6 3.6 60.7 8.1 25.2 51.6 47.1 20.3 5.3 5.7 2.2 5.0 1.6 7.2 15.0 2.1 109.8 0.0 36.7 62.1 31.4 48.8 17.0 0.6 11.7 37.9 19.4 14.5 14.8 6.6 6.9 13.0 1.3 1.4 36.8 21.9 128.6 1.8 6.3 55.5 19.7 PSMB10 "beta2i, LMP10, MECL1, MGC1665" ENSG00000205220 "Proteasome 20S subunit beta 10" P40306 16 67934506-67936864 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 123.4" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 173.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 183.4;RPMI-8226: 169.4;THP-1: 171.3;U-266/70: 189.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030224, HPA030225, CAB034384" Enhanced Approved Vesicles,Cytosol NA NA 1400000 Cytosol Vesicles "CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231" "unprognostic (1.18e-2)" "unprognostic (1.90e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-3)" "unprognostic (2.00e-1)" "unprognostic (1.85e-2)" "unprognostic (7.22e-2)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (8.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-2)" "prognostic favorable (5.44e-4)" 26.3 27.1 4.8 82.5 6.1 71.9 25.1 6.2 8.9 18.1 6.5 51.1 111.5 18.6 5.8 23.0 30.7 31.5 15.1 4.7 11.0 32.7 37.4 42.6 123.4 9.2 6.1 3.6 14.7 15.1 6.4 13.3 23.3 7.7 29.1 23.1 0.4 65.7 22.6 6.8 18.2 96.6 14.1 8.4 103.5 63.0 5.3 7.7 62.4 23.8 3.5 37.8 36.7 18.8 11.9 31.8 26.9 0.7 2.2 6.7 17.2 99.6 10.8 42.3 38.5 50.6 13.9 148.5 111.9 23.4 13.2 12.9 47.9 0.0 13.4 2.9 50.3 1.9 39.2 7.6 16.4 65.7 78.5 115.2 26.9 8.4 15.2 1.5 12.1 20.6 32.1 3.6 48.2 9.0 42.6 140.7 84.9 1.0 1.1 10.2 183.4 8.3 169.4 31.6 52.5 0.9 2.3 31.1 67.5 17.2 0.4 14.5 171.3 32.0 21.2 6.6 9.7 15.3 189.8 43.9 88.4 57.1 97.9 47.0 539.5 714.6 571.1 511.7 787.1 376.4 402.6 397.9 437.3 594.8 390.2 326.2 364.6 786.2 588.6 607.4 604.4 495.9 1155.7 4.8 6.1 6.2 8.9 4.7 11.0 9.2 6.1 3.6 7.7 8.4 7.7 11.9 24.7 22.4 26.8 4.6 72.9 17.2 14.3 101.2 26.2 1.0 15.8 13.8 1.6 28.6 43.9 18.4 0.0 29.5 66.2 80.8 23.5 58.5 14.0 17.6 20.1 22.8 16.3 32.6 3.4 104.3 30.0 23.4 110.6 12.3 51.9 7.2 37.1 10.2 87.4 0.0 5.0 74.6 52.9 81.9 66.4 35.9 30.1 88.5 48.0 9.4 123.3 3.0 112.3 2.5 7.3 51.2 139.7 21.1 110.5 12.1 173.5 69.4 83.9 1.1 19.7 10.3 26.6 16.4 7.5 24.1 9.9 22.6 93.9 16.9 79.5 24.8 VIT ENSG00000205221 Vitrin Q6UXI7 2 36696690-36814792 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 41.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 68.3;Fibroblasts: 58.8;Granulosa cells: 45.1;Leydig cells: 115.2;Skeletal myocytes: 45.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.3;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 10 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "ASC diff: 33.6;ASC TERT1: 65.2;BJ: 32.9;fHDF/TERT166: 112.3;SuSa: 62.2;THP-1: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 140000 "unprognostic (5.34e-4)" "unprognostic (4.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.20e-1)" "unprognostic (7.78e-3)" "unprognostic (8.32e-2)" "unprognostic (1.81e-1)" "unprognostic (3.08e-1)" "unprognostic (3.35e-1)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (3.66e-6)" "unprognostic (2.09e-1)" "unprognostic (2.01e-1)" "unprognostic (3.62e-3)" "unprognostic (1.41e-2)" 25.9 0.9 0.3 0.5 0.6 0.9 15.5 0.9 0.9 5.0 1.3 3.3 0.4 1.0 0.6 8.8 7.9 2.3 18.6 0.4 0.4 0.2 0.0 1.2 2.3 0.3 0.3 0.4 29.0 1.0 0.6 3.1 2.2 0.3 7.0 1.5 0.0 11.7 2.4 12.6 11.8 2.7 0.2 0.2 0.1 4.7 3.0 0.3 1.0 8.9 41.5 2.3 15.1 14.8 0.3 0.0 0.0 0.0 0.0 33.6 65.2 0.0 32.9 7.7 10.4 4.3 0.0 0.0 0.0 0.0 112.3 0.1 0.2 6.2 0.0 6.9 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 3.3 1.6 0.0 0.0 0.0 2.5 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 62.2 0.0 35.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 2.5 2.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.6 0.9 0.9 0.4 0.4 0.3 0.3 0.4 0.3 0.2 0.3 0.3 4.1 0.0 0.0 0.7 0.0 4.2 0.9 0.0 68.3 0.0 0.2 10.0 3.2 0.0 0.0 0.0 0.0 10.6 0.9 0.3 0.0 0.0 1.2 0.4 0.4 1.1 0.0 0.0 1.8 0.0 11.0 58.8 0.0 0.0 0.0 45.1 0.4 0.0 1.1 0.0 0.7 0.4 0.0 0.0 3.5 2.7 115.2 0.5 7.2 20.6 0.0 0.0 4.1 0.5 0.3 0.0 0.1 23.3 0.8 0.1 0.0 0.0 0.0 0.0 6.6 45.2 6.1 1.1 0.6 1.6 3.4 4.2 1.1 0.1 0.3 0.2 SPDYE2 MGC119295 ENSG00000205238 "Speedy/RINGO cell cycle regulator family member E2" Q495Y8 7 102551232-102562308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.9;testis: 10.9" "Group enriched" "Detected in some" 4 "Astrocytes: 7.2;Excitatory neurons: 9.1;Inhibitory neurons: 7.0;Microglial cells: 6.5;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 6.2" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.5;Karpas-707: 10.5" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (2.04e-2)" "unprognostic (8.58e-2)" "unprognostic (5.12e-2)" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.54e-2)" "unprognostic (1.68e-1)" "unprognostic (5.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.37e-1)" "unprognostic (3.15e-2)" "unprognostic (6.49e-3)" "unprognostic (7.94e-4)" "unprognostic (2.32e-1)" "unprognostic (2.12e-1)" "unprognostic (2.52e-3)" "unprognostic (1.04e-1)" 0.8 0.9 2.9 2.6 2.1 5.2 0.8 1.4 3.7 1.0 0.8 1.0 1.1 1.2 0.0 1.2 0.9 0.5 1.1 2.1 0.2 1.0 0.9 1.2 2.6 2.3 2.3 0.5 1.2 1.5 0.0 1.3 0.7 7.9 1.2 0.0 2.3 1.2 0.1 5.0 3.8 1.7 0.0 0.1 2.5 1.3 10.9 1.4 0.0 1.7 0.1 0.0 1.0 1.2 4.9 3.0 4.9 2.1 2.9 0.0 0.0 3.9 2.3 0.0 0.0 0.0 2.3 2.0 3.5 1.8 0.0 0.6 3.1 0.0 0.0 0.0 2.2 2.4 1.5 14.5 1.3 0.0 4.2 1.1 0.0 0.0 0.0 0.0 0.6 0.0 1.8 4.6 10.5 0.0 6.0 2.2 2.3 1.8 0.9 0.6 3.5 0.8 3.5 0.0 5.5 2.0 1.2 8.0 1.0 0.7 3.2 2.0 1.1 1.9 6.9 1.7 3.5 3.5 2.4 1.8 2.3 1.1 4.8 2.7 2.6 2.0 0.4 1.7 0.8 1.2 1.6 1.5 1.1 0.6 2.2 1.2 1.1 3.1 0.5 0.9 2.5 0.8 0.6 2.9 2.1 1.4 3.7 2.1 0.2 2.3 2.3 0.5 7.9 0.1 1.4 4.9 0.0 0.0 1.1 7.2 0.3 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 9.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.5 0.0 0.0 0.0 4.5 6.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 E2F4 E2F-4 ENSG00000205250 "E2F transcription factor 4" Q16254 16 67192155-67198918 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054128 Supported Nucleoplasm NA NA Nucleoplasm "HPA054128: AB_2682392" "unprognostic (1.74e-1)" "unprognostic (1.81e-1)" "unprognostic (4.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.76e-1)" "unprognostic (4.39e-3)" "unprognostic (1.05e-3)" "unprognostic (7.50e-3)" "unprognostic (1.37e-1)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.04e-2)" "unprognostic (8.44e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-1)" 40.6 40.0 26.0 40.1 25.7 99.1 38.6 24.6 31.2 35.3 25.2 42.1 32.4 41.5 22.4 47.8 37.0 23.8 37.0 25.6 26.6 35.0 32.2 38.4 48.9 27.4 25.9 24.0 33.4 36.4 29.4 39.5 44.4 26.4 36.8 32.3 9.9 30.0 27.8 50.9 33.6 44.6 32.1 25.8 55.2 40.9 33.1 26.1 42.9 33.8 30.3 43.8 42.3 34.4 25.9 67.3 53.2 44.4 54.3 63.5 54.6 158.6 49.1 72.7 88.5 84.8 94.6 71.5 82.7 58.1 52.3 60.7 95.8 69.2 69.2 57.4 35.2 73.4 55.9 31.9 97.5 76.7 110.9 113.0 64.8 53.9 70.4 77.9 33.2 77.8 62.9 107.1 26.8 47.2 115.0 127.9 90.8 109.1 71.7 47.4 152.7 92.8 109.7 41.8 50.9 53.6 63.9 134.2 49.6 58.2 35.2 50.6 109.7 56.0 62.4 58.9 46.1 78.2 65.6 62.0 215.0 73.3 75.5 60.7 1.2 11.8 10.9 8.4 10.7 7.0 6.1 7.7 9.9 14.6 6.6 6.1 5.5 7.5 8.7 8.1 6.3 3.9 7.7 26.0 25.7 24.6 31.2 25.6 26.6 27.4 25.9 24.0 26.4 25.8 26.1 25.9 36.2 12.8 16.5 14.7 31.2 41.6 33.9 18.0 10.8 22.3 20.9 16.3 15.1 22.8 13.4 12.9 4.2 116.1 35.1 26.7 19.6 30.2 50.5 16.0 24.4 36.2 22.8 174.7 13.9 37.2 82.8 25.5 36.7 19.4 27.3 25.4 30.0 10.2 44.7 21.9 12.3 23.6 22.4 23.8 29.0 84.9 27.1 30.1 14.2 11.2 41.5 14.3 55.6 10.6 12.2 35.8 19.3 23.7 39.7 56.8 21.4 13.4 9.5 19.2 46.0 20.0 26.9 37.9 45.3 25.8 45.9 79.8 36.7 31.4 30.2 37.9 PDE7A HCP1 ENSG00000205268 "Phosphodiesterase 7A" Q13946 8 65714334-65842322 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 109.3;tongue: 76.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.4;Inhibitory neurons: 111.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 94.9;MOLT-4: 167.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018770, HPA027340" Approved NA NA "CAB018770: AB_677329, HPA027340: AB_1855127" "unprognostic (2.76e-1)" "unprognostic (2.94e-2)" "unprognostic (1.36e-1)" "unprognostic (1.17e-2)" "unprognostic (2.15e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (1.44e-2)" "unprognostic (6.94e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.08e-2)" "unprognostic (1.26e-1)" "unprognostic (5.06e-2)" "unprognostic (2.03e-2)" 8.4 3.2 5.3 28.8 8.0 26.9 20.0 8.5 7.9 13.5 7.8 7.5 11.5 6.4 14.1 6.7 7.9 11.6 45.1 5.6 7.5 19.0 5.5 19.2 59.2 6.6 5.5 5.7 6.0 14.4 3.1 13.5 8.4 7.0 13.8 9.9 14.1 21.0 8.7 64.2 8.2 26.6 5.6 4.5 29.6 13.1 10.4 7.7 109.3 23.1 76.6 43.4 10.0 9.0 11.6 12.5 10.8 47.2 22.2 6.7 5.8 20.0 9.3 7.9 11.5 11.0 12.8 8.1 35.0 2.2 5.8 10.2 13.8 17.5 19.7 12.0 41.3 8.9 25.6 18.5 9.6 3.4 20.3 9.8 8.3 32.0 7.4 22.3 9.9 11.4 84.0 19.1 94.9 7.9 6.8 167.6 23.0 50.3 10.1 4.8 61.8 7.2 9.2 7.8 24.6 22.9 26.5 9.8 4.9 4.8 32.2 26.1 52.2 7.4 15.9 19.6 11.3 7.6 45.6 21.3 60.3 16.1 42.1 8.9 2.5 0.7 5.5 3.4 0.6 5.5 6.5 5.2 3.4 1.5 7.5 11.9 9.2 2.5 2.3 0.2 2.1 4.7 1.8 5.3 8.0 8.5 7.9 5.6 7.5 6.6 5.5 5.7 7.0 4.5 7.7 11.6 8.6 19.2 22.7 41.4 95.1 18.1 13.6 8.8 7.4 27.3 23.1 21.8 46.6 20.0 17.3 3.7 56.3 14.1 93.4 3.7 0.0 8.2 32.1 11.8 12.6 7.9 9.6 31.6 102.4 5.3 8.4 17.2 8.2 13.5 9.5 14.2 6.8 4.3 10.4 18.5 111.3 6.5 12.2 17.3 34.9 15.0 7.5 26.2 16.0 48.7 19.7 10.1 47.4 89.0 86.2 6.1 5.6 7.5 56.3 19.4 5.9 21.3 20.3 66.1 0.0 18.4 11.1 10.3 10.9 6.0 18.8 8.6 81.3 6.8 6.5 10.8 TMEM170B ENSG00000205269 "Transmembrane protein 170B" Q5T4T1 6 11537749-11583524 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.5" "Cell type enhanced" "Detected in many" "Astrocytes: 39.2;Excitatory neurons: 57.3;Inhibitory neurons: 52.3;Kupffer cells: 36.8;Macrophages: 31.5;monocytes: 45.8;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "THP-1: 22.1;U-937: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055134 Uncertain Approved Centrosome NA NA Centrosome "HPA055134: AB_2682709" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.71e-4)" "unprognostic (6.67e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (4.62e-3)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (2.45e-5)" "unprognostic (3.49e-1)" "unprognostic (1.26e-1)" "unprognostic (4.27e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-4)" "unprognostic (3.97e-2)" 7.1 2.9 9.1 4.4 10.0 25.5 2.4 9.5 11.3 1.6 2.8 1.9 0.7 2.4 3.1 1.3 1.6 1.7 2.1 10.3 8.1 3.8 8.8 3.9 1.7 9.1 8.8 8.6 2.2 1.9 2.9 2.7 2.5 10.1 1.9 1.1 9.6 1.5 2.1 6.2 0.9 1.2 2.9 7.3 3.9 1.5 3.4 8.5 1.9 2.6 7.3 1.2 1.5 0.9 8.4 0.9 1.5 8.8 7.9 1.6 0.1 1.8 0.8 2.0 1.2 1.4 0.5 0.5 7.3 4.0 0.5 2.3 0.0 10.0 0.6 3.1 2.1 5.3 4.1 1.0 1.2 0.5 6.6 4.1 0.6 0.1 1.3 0.0 2.0 0.8 6.7 0.2 0.1 1.8 1.3 8.0 11.3 2.5 0.8 1.2 4.1 8.4 1.2 0.9 1.8 6.0 5.1 0.5 2.9 3.3 12.4 2.9 22.1 0.1 1.6 1.9 3.2 2.1 6.3 13.4 6.4 1.4 16.6 2.2 0.9 0.8 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.1 9.1 10.0 9.5 11.3 10.3 8.1 9.1 8.8 8.6 10.1 7.3 8.5 8.4 2.7 3.2 2.0 39.2 2.9 1.8 0.6 0.2 0.6 13.2 2.2 1.8 6.5 1.5 1.5 0.0 4.2 2.1 11.8 0.5 5.9 0.6 0.5 1.9 1.8 2.3 1.8 0.8 57.3 1.4 0.3 2.3 0.5 2.1 1.3 5.1 2.2 8.4 7.0 25.2 52.3 0.3 0.0 36.8 13.2 0.4 0.9 31.5 0.0 21.5 45.8 13.7 2.1 31.7 27.1 0.9 0.3 1.5 0.5 1.1 0.0 5.4 0.1 8.3 6.6 4.1 3.7 7.5 4.8 0.2 0.9 1.9 1.4 1.7 0.8 0.5 TRBV20OR9-2 "TCRBV20S2, TCRBV2O, TCRBV2S2O, TRBV20/OR9-2" ENSG00000205274 "T cell receptor beta variable 20/OR9-2 (non-functional)" 9 33617762-33618506 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 12.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 17.0" "Lineage enriched" "Detected in single" 31 "T-cells: 17.0" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HEL: 1.4;MOLT-4: 1.0;RH-30: 5.0;SuSa: 1.1" NA NA "unprognostic (1.53e-1)" "unprognostic (3.70e-2)" "unprognostic (3.01e-2)" "unprognostic (1.31e-1)" "unprognostic (1.51e-1)" 0.0 0.0 0.6 0.1 1.1 0.0 0.0 1.5 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 0.0 5.8 6.5 0.7 0.0 0.8 0.0 2.9 2.1 12.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 1.0 0.3 0.3 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 5.7 0.0 6.9 4.0 0.0 0.0 6.4 5.3 0.0 0.0 0.0 0.0 17.0 1.9 0.6 1.1 1.5 2.3 0.6 1.9 5.8 6.5 0.7 12.1 1.3 2.4 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC12 MUC11 ENSG00000205277 "Mucin 12, cell surface associated" Q9UKN1 7 100969623-101018949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 68.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1187.9;Intestinal goblet cells: 132.3;Paneth cells: 550.8;Undifferentiated cells: 265.8" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 13.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023835 Enhanced NA NA "HPA023835: AB_1854199" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-4)" "unprognostic (4.40e-2)" "unprognostic (1.30e-3)" "unprognostic (1.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.52e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (3.33e-7)" "unprognostic (8.42e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 50.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 68.6 0.0 0.0 0.1 0.0 0.0 2.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 8.2 3.8 13.1 2.2 0.0 0.0 0.1 0.0 2.7 0.0 2.7 1.8 0.0 0.4 1.4 1187.9 0.0 7.9 13.0 17.2 16.6 1.2 47.5 0.0 3.0 2.8 2.2 15.6 9.2 0.6 8.9 1.6 0.7 0.1 1.9 0.0 0.7 132.3 4.1 1.6 16.0 5.7 0.9 4.0 3.6 1.0 0.0 0.0 0.0 0.0 0.3 8.3 550.8 3.4 2.8 9.5 53.1 0.2 15.7 0.0 0.0 2.2 4.4 11.5 3.8 0.1 3.0 0.5 5.7 5.3 265.8 5.3 CTXN3 ENSG00000205279 "Cortexin 3" Q4LDR2 5 127649044-127658630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 80.6" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 201.3" "Cancer enriched" "Detected in single" 8 "renal cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (7.32e-2)" "unprognostic (9.88e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (6.20e-3)" 0.0 0.0 4.9 0.0 5.4 0.0 0.0 3.6 9.3 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 6.8 80.6 0.0 0.1 0.0 9.3 13.0 5.0 0.0 0.0 0.2 5.4 0.0 12.3 0.5 0.0 0.2 0.2 0.0 13.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 7.3 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 5.4 3.6 9.3 7.0 6.8 9.3 13.0 5.0 12.3 4.2 7.3 12.2 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 23.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 201.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "testis: 22.9" "Group enriched" "Detected in some" 19 "Early spermatids: 19.5;Late spermatids: 26.7;Spermatocytes: 64.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced NA NA "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNX2 ENSG00000205302 "Sorting nexin 2" O60749 5 122775079-122834543 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 349.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "memory B-cell: 290.2;naive B-cell: 289.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037400 Approved Supported Endosomes,Lysosomes NA NA 150000 "Endosomes, Lysosomes" "HPA037400: AB_10670381" "unprognostic (9.26e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "prognostic favorable (8.76e-7)" "unprognostic (8.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.07e-1)" "unprognostic (8.59e-2)" 38.7 31.3 6.8 18.1 7.4 14.4 34.1 10.5 8.6 27.7 7.8 32.5 13.5 28.5 12.6 30.4 29.2 12.9 21.9 7.1 7.6 37.8 28.2 34.0 26.7 7.4 6.9 6.5 37.4 31.6 14.2 23.4 19.3 7.5 24.4 14.7 7.2 29.4 10.2 27.3 28.6 35.1 18.1 7.8 52.8 33.2 17.2 7.9 10.5 38.6 7.7 24.2 33.9 26.3 9.5 18.9 14.1 18.7 13.1 27.8 19.0 79.6 6.2 21.1 15.1 24.2 27.1 27.2 18.8 18.5 14.9 37.4 6.1 24.6 16.2 18.0 13.4 12.2 23.3 15.8 29.7 19.7 7.7 10.8 16.1 12.8 9.6 16.6 17.6 16.8 15.4 10.1 14.9 14.0 16.1 5.5 11.6 6.3 22.2 10.7 20.2 14.3 25.4 17.3 33.9 12.0 13.3 16.0 19.8 17.0 46.4 24.2 16.0 10.7 13.7 6.9 19.1 11.7 4.4 14.9 24.4 13.6 32.1 15.6 77.9 78.5 57.0 15.4 89.1 18.3 290.2 25.7 24.2 66.5 289.1 23.6 21.0 34.7 18.5 86.6 20.1 48.7 72.7 6.8 7.4 10.5 8.6 7.1 7.6 7.4 6.9 6.5 7.5 7.8 7.9 9.5 48.4 35.3 42.8 33.0 260.8 40.7 46.9 82.3 45.5 43.1 23.8 29.3 34.4 40.0 62.4 80.9 8.4 153.9 36.2 19.9 131.0 69.1 25.5 71.5 44.7 49.0 31.8 34.3 38.5 51.8 244.9 62.1 52.5 52.2 65.1 41.8 89.6 31.4 349.2 26.9 42.2 32.6 69.2 125.8 75.8 15.0 53.4 133.0 33.8 61.8 215.8 71.7 23.7 51.8 51.4 35.7 37.0 53.0 37.5 28.1 57.8 114.7 77.8 38.0 46.0 42.8 74.5 89.1 75.9 32.9 38.9 122.9 47.2 92.4 39.8 37.5 SAP25 FLJ00248 ENSG00000205307 "Sin3A associated protein 25" Q8TEE9 7 100572228-100573900 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 57.8;Spermatogonia: 86.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 30.4;NB-4: 69.1;OE19: 117.4;U-937: 27.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062610 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA062610: AB_2684806" "unprognostic (1.70e-1)" "unprognostic (7.87e-2)" "unprognostic (1.09e-5)" "unprognostic (6.89e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-3)" "unprognostic (9.96e-2)" "unprognostic (4.26e-2)" "unprognostic (2.83e-1)" "unprognostic (5.04e-2)" "unprognostic (6.57e-3)" "unprognostic (1.71e-2)" "unprognostic (7.52e-6)" "unprognostic (7.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.39e-1)" "unprognostic (4.18e-3)" 6.9 4.5 14.7 18.0 16.5 29.2 4.7 15.4 26.4 10.0 14.3 5.4 6.6 4.8 0.3 4.4 9.4 5.0 5.5 14.1 15.5 15.9 7.1 14.8 28.9 18.0 15.2 12.6 23.4 6.6 1.1 13.0 5.4 16.7 11.1 1.7 13.6 8.4 2.4 3.9 6.2 20.1 2.0 15.1 47.7 5.6 25.6 16.3 17.8 15.9 1.1 8.2 5.0 7.5 20.9 4.0 1.4 2.8 1.6 0.2 0.4 6.4 3.0 0.6 1.9 0.9 3.1 4.1 2.0 1.8 0.0 0.2 4.2 0.5 0.9 0.2 3.9 2.3 3.7 3.6 1.0 0.6 4.2 30.4 0.8 1.9 1.1 0.4 1.5 0.6 8.0 4.7 7.7 0.4 9.2 7.8 69.1 4.3 117.4 1.5 16.7 0.9 3.1 0.3 1.2 1.6 5.0 0.4 3.7 4.5 3.1 5.6 15.8 3.2 2.9 6.1 2.7 2.9 13.1 3.4 1.6 0.9 27.4 3.0 0.9 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.2 0.3 0.0 0.0 14.7 16.5 15.4 26.4 14.1 15.5 18.0 15.2 12.6 16.7 15.1 16.3 20.9 2.2 0.0 4.1 11.1 6.7 0.0 1.3 0.0 1.2 23.7 4.6 5.3 0.0 7.2 1.3 0.0 70.9 2.6 8.7 3.1 0.0 1.9 1.4 2.1 2.0 1.7 0.0 3.4 0.9 0.7 0.7 1.3 4.1 3.2 1.3 6.0 2.5 1.1 3.1 21.9 0.9 2.3 0.0 8.5 0.0 4.6 3.4 10.7 0.0 9.4 6.5 8.0 5.2 2.5 8.2 2.0 1.9 1.2 4.1 2.8 4.9 0.3 0.0 57.8 6.6 1.5 1.8 17.2 86.6 1.5 0.0 3.6 8.2 0.9 1.5 1.8 NT5M "dNT-2, dNT2, mdN" ENSG00000205309 "5',3'-nucleotidase, mitochondrial" Q9NPB1 17 17303335-17347663 "Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 13.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 17.6;Erythroid cells: 31.2;Horizontal cells: 16.8;Inhibitory neurons: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "JURKAT: 8.5;RPMI-8226: 6.3;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043777 Uncertain NA NA "HPA043777: AB_10962842" "unprognostic (5.70e-2)" "unprognostic (3.20e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (8.61e-3)" "unprognostic (1.24e-1)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.42e-5)" "unprognostic (4.28e-5)" "unprognostic (2.27e-1)" "unprognostic (4.93e-2)" "unprognostic (3.89e-2)" "unprognostic (1.05e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" 1.0 0.6 5.2 0.2 4.8 4.7 1.0 5.5 7.6 2.2 3.8 2.1 0.4 2.1 0.4 0.9 1.7 0.4 5.2 4.8 4.9 2.0 1.0 0.8 0.3 5.4 5.5 4.9 1.9 1.1 1.9 4.5 0.2 5.6 1.9 0.1 0.5 0.8 0.7 13.4 0.8 0.8 0.4 4.7 0.9 1.1 6.9 6.5 1.1 0.8 4.6 0.2 2.1 1.1 5.6 0.3 0.7 0.3 2.9 1.7 1.9 1.2 0.6 0.2 0.2 0.4 0.0 0.2 3.3 1.8 0.0 0.5 0.0 0.1 0.1 0.0 2.9 1.8 2.3 0.1 0.3 1.7 0.6 4.3 1.4 1.5 0.3 1.1 0.6 0.0 8.5 2.0 0.0 0.0 0.8 2.8 2.6 1.8 1.0 2.5 2.1 0.2 6.3 1.0 0.0 3.6 5.9 1.0 0.1 2.6 2.1 1.0 0.9 0.0 0.9 1.0 0.2 0.8 9.3 1.3 0.5 0.5 0.4 2.4 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.2 4.8 5.5 7.6 4.8 4.9 5.4 5.5 4.9 5.6 4.7 6.5 5.6 1.1 0.0 0.5 11.1 0.5 1.7 2.1 0.1 2.2 5.5 3.4 6.1 7.9 1.5 0.6 9.2 2.1 1.0 2.6 0.4 17.6 0.3 0.9 0.3 3.3 1.7 1.2 31.2 7.6 0.6 1.2 2.5 1.1 0.9 0.0 5.2 0.7 1.3 1.5 16.8 13.2 0.8 0.0 0.8 0.6 4.4 0.6 3.4 0.0 3.7 0.3 4.7 2.1 4.0 5.4 0.0 0.1 1.2 2.3 3.2 0.1 2.9 0.0 1.8 0.0 7.4 1.8 1.5 6.0 1.8 0.4 0.5 2.3 3.2 0.5 1.3 SARNP "CIP29, Hcc-1, THO1" ENSG00000205323 "SAP domain containing ribonucleoprotein" P82979 12 55752463-55817724 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030902, HPA030903" Supported Supported "Nuclear speckles" NA NA 150000 "Nuclear speckles" "HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (1.83e-2)" "unprognostic (1.58e-2)" "unprognostic (2.22e-1)" "unprognostic (2.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.10e-1)" "unprognostic (2.36e-4)" "unprognostic (2.02e-2)" "unprognostic (4.29e-3)" "unprognostic (1.21e-2)" "unprognostic (5.03e-2)" "unprognostic (6.48e-2)" "unprognostic (2.31e-6)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (5.29e-3)" "unprognostic (1.19e-1)" 46.2 59.6 57.9 46.2 58.1 89.6 58.6 60.7 89.0 50.7 59.5 50.2 31.4 48.7 57.7 62.4 42.7 35.1 79.4 57.7 62.5 55.1 49.8 46.8 67.8 59.1 59.8 56.3 48.9 31.9 46.1 44.1 55.6 59.2 48.4 54.1 31.9 39.7 48.2 99.7 42.4 38.8 53.9 57.8 48.2 44.5 55.9 59.6 83.7 41.9 84.8 85.2 60.3 48.7 60.5 118.8 106.6 251.5 107.9 114.9 162.9 119.7 160.5 126.2 196.7 163.6 151.4 129.1 191.3 108.7 131.8 77.2 66.5 223.7 158.2 209.8 151.2 140.5 192.5 181.6 132.9 166.9 162.0 142.4 121.1 115.7 129.0 99.7 206.0 210.4 169.1 141.3 137.9 198.0 100.5 204.1 257.8 221.4 107.0 97.8 186.5 131.6 159.3 265.9 133.0 108.2 87.8 138.1 88.1 144.8 143.3 134.1 216.3 146.1 79.0 79.3 101.3 128.3 87.0 122.8 258.5 94.9 163.8 101.9 246.1 137.9 218.7 110.5 156.2 101.1 125.3 115.8 119.0 153.7 114.0 91.7 103.0 107.2 134.2 138.8 146.8 170.6 153.9 57.9 58.1 60.7 89.0 57.7 62.5 59.1 59.8 56.3 59.2 57.8 59.6 60.5 14.7 32.1 35.6 27.7 26.6 25.2 24.5 24.0 46.1 11.2 12.9 9.9 0.2 10.0 41.0 22.0 16.7 16.1 17.9 11.8 25.4 28.8 16.3 9.1 8.8 16.5 14.9 34.1 32.8 29.8 19.8 30.5 33.6 11.4 27.8 8.9 8.9 7.4 14.6 8.4 33.8 13.3 24.4 19.2 36.3 35.9 18.0 25.1 21.4 27.2 32.4 10.6 16.5 37.7 46.6 32.1 13.1 17.3 37.0 14.8 14.8 19.1 45.2 10.0 6.6 12.6 23.3 36.4 32.8 50.9 26.6 16.8 29.9 12.2 11.5 20.4 OR6C68 ENSG00000205327 "Olfactory receptor family 6 subfamily C member 68" A6NDL8 12 55492378-55493316 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C65 ENSG00000205328 "Olfactory receptor family 6 subfamily C member 65" A6NJZ3 12 55400430-55401505 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C3 OST709 ENSG00000205329 "Olfactory receptor family 6 subfamily C member 3" Q9NZP0 12 55330043-55332687 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C1 OST267 ENSG00000205330 "Olfactory receptor family 6 subfamily C member 1" Q96RD1 12 55314343-55322364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRG1 "GPR56, TM7LN4, TM7XN1" ENSG00000205336 "Adhesion G protein-coupled receptor G1" Q9Y653 16 57610652-57665580 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 218.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 222.5;Exocrine glandular cells: 170.7;NK-cells: 208.1;Syncytiotrophoblasts: 186.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 160.3" "Lineage enriched" "Detected in many" 5 "T-cells: 160.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 218.4;SK-BR-3: 277.7;SK-MEL-30: 297.8;TIME: 241.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046065 Uncertain "Secreted to blood" NA NA 32000 "HPA046065: AB_2679521" "unprognostic (4.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.69e-2)" "unprognostic (1.47e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (4.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.82e-2)" "unprognostic (6.77e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "prognostic favorable (5.52e-7)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.33e-1)" "unprognostic (1.98e-1)" 44.9 13.3 64.7 12.8 48.9 19.7 50.9 35.2 116.1 36.6 0.0 37.1 26.4 19.9 84.9 47.1 52.6 70.2 27.0 59.2 77.5 158.3 4.2 37.6 5.3 48.5 58.2 35.3 5.4 60.3 28.7 17.8 102.2 53.1 32.0 33.7 6.7 93.0 58.1 15.9 88.2 19.4 20.0 32.8 12.5 48.3 45.8 66.2 29.2 218.2 17.0 15.7 37.4 38.1 55.6 41.8 47.1 12.0 0.6 0.0 0.1 127.7 8.5 3.9 14.4 2.6 34.7 218.4 0.2 110.5 8.2 196.1 149.1 0.0 103.4 5.1 1.6 0.0 5.1 56.0 39.3 0.3 0.4 2.1 2.4 143.8 24.5 10.2 15.8 118.1 1.0 0.1 1.2 3.2 51.4 107.3 0.8 1.7 143.3 42.6 3.8 1.4 30.8 209.4 134.9 38.2 1.2 2.0 277.7 297.8 8.4 123.8 0.8 241.4 25.6 38.0 1.5 96.2 0.2 2.1 0.6 200.5 0.7 62.9 2.9 0.8 0.2 160.3 0.5 1.9 0.3 10.5 62.6 0.2 0.1 5.3 45.2 3.3 30.6 0.7 0.3 0.2 37.1 64.7 48.9 35.2 116.1 59.2 77.5 48.5 58.2 35.3 53.1 32.8 66.2 55.6 107.7 9.6 11.9 113.9 3.7 0.0 24.1 0.0 11.4 0.9 29.6 27.2 4.3 15.7 21.7 79.1 0.0 222.5 120.4 17.7 27.4 33.9 74.0 24.6 4.3 53.9 20.6 17.7 3.5 170.7 25.1 4.7 29.0 45.2 5.1 88.2 30.0 0.5 22.8 0.0 4.9 23.2 0.0 3.5 0.0 31.3 3.1 6.1 0.0 41.2 1.1 4.8 208.1 85.5 1.3 101.1 12.3 0.0 19.1 15.2 5.6 132.6 16.8 0.5 0.0 1.6 7.1 2.7 0.9 23.0 0.0 186.5 35.1 0.4 24.6 19.5 IPO7 "Imp7, RANBP7" ENSG00000205339 "Importin 7" O95373 11 9384652-9448127 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019002, HPA056590" Approved Approved Supported Nucleoplasm,Cytosol NA NA 220000 "Nucleoplasm, Cytosol" "HPA019002: AB_1856059, HPA056590: AB_2683180" "unprognostic (1.92e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (9.50e-2)" "unprognostic (1.27e-1)" "unprognostic (3.68e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.19e-2)" "unprognostic (7.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.38e-6)" "unprognostic (3.06e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.08e-2)" "unprognostic (2.17e-1)" "unprognostic (3.90e-3)" 38.2 29.4 25.7 31.5 28.2 22.9 40.8 30.9 29.4 36.0 30.7 30.9 27.4 34.3 29.5 38.2 31.6 32.1 50.9 26.2 31.8 41.7 38.8 29.2 30.3 31.3 30.2 23.1 33.4 34.1 39.2 13.1 41.4 30.7 32.4 34.5 48.2 33.6 33.5 111.2 25.6 26.2 43.8 31.6 23.1 25.8 12.9 30.6 32.1 54.5 94.2 35.1 52.3 23.0 33.5 148.7 110.8 130.6 104.4 129.4 165.7 104.4 176.0 112.4 127.1 136.4 99.1 132.6 138.1 62.5 136.3 115.5 113.5 187.5 136.7 210.7 66.3 154.5 114.3 118.8 100.1 80.7 177.0 83.3 106.7 144.8 84.0 195.6 129.5 152.8 46.7 174.7 80.5 167.9 60.3 107.5 86.3 129.0 136.3 130.2 111.4 205.5 63.0 105.3 137.5 51.7 101.5 78.6 153.5 129.1 103.2 70.7 87.6 120.9 155.6 107.4 162.0 190.9 23.2 95.3 93.6 102.0 93.6 86.4 0.1 1.5 0.3 1.4 2.6 2.7 1.9 1.5 2.0 3.2 1.4 1.9 1.7 0.7 3.5 3.8 1.4 1.5 1.0 25.7 28.2 30.9 29.4 26.2 31.8 31.3 30.2 23.1 30.7 31.6 30.6 33.5 41.3 67.3 71.5 19.6 46.4 144.0 103.3 44.8 68.9 40.1 65.5 42.4 131.9 25.8 59.7 35.0 58.4 52.8 39.7 27.2 33.2 34.2 4.6 55.9 92.5 55.7 31.1 50.9 43.9 42.2 63.8 58.0 47.4 99.5 37.9 56.5 25.0 46.8 35.3 35.3 49.7 38.8 32.6 48.0 92.2 7.1 28.0 56.6 39.2 17.8 39.2 31.8 13.4 28.1 44.9 45.5 32.9 35.7 47.6 150.6 26.5 45.7 48.4 39.8 13.1 96.2 71.0 21.6 19.8 82.2 147.9 36.7 37.7 49.0 50.9 127.4 PRR13 "DKFZP564J157, FLJ23818" ENSG00000205352 "Proline rich 13" Q9NZ81 12 53441678-53446645 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 884.9;Distal tubular cells: 1365.6;Paneth cells: 858.1;Proximal enterocytes: 1642.7;Proximal tubular cells: 1097.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039396, HPA046219" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA039396: AB_2676484, HPA046219: AB_10963936" "unprognostic (1.09e-1)" "prognostic favorable (9.08e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-1)" "unprognostic (8.97e-3)" "unprognostic (4.88e-3)" "unprognostic (1.86e-3)" "unprognostic (7.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.41e-2)" "unprognostic (6.81e-3)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "prognostic favorable (7.55e-4)" 143.1 209.5 115.7 160.6 111.7 281.7 140.4 112.7 148.9 114.5 111.0 319.1 455.7 105.5 111.8 144.6 140.4 148.4 107.6 105.9 131.2 458.6 194.3 165.8 186.8 130.6 119.9 98.6 119.8 134.4 76.6 115.4 96.0 129.2 140.8 268.3 44.4 116.5 87.4 132.7 108.2 436.2 92.2 114.4 232.1 249.8 46.7 120.2 140.3 132.9 60.1 192.0 144.9 112.6 150.7 171.7 339.6 82.6 89.4 135.3 185.3 178.4 142.5 213.0 185.6 179.4 623.1 373.6 265.1 453.5 206.8 225.4 146.6 167.8 225.0 217.9 263.1 124.6 382.4 166.4 294.6 340.7 573.2 489.5 232.6 221.2 326.5 223.6 192.6 195.3 166.1 340.1 254.6 285.1 472.5 325.8 563.8 127.5 229.2 230.7 287.6 67.8 273.9 406.2 283.8 72.3 56.5 202.5 276.7 237.2 169.5 394.0 436.2 196.3 117.2 114.0 201.3 138.0 190.7 241.6 386.4 153.3 345.1 220.2 851.3 824.0 1620.1 511.1 941.9 503.0 888.2 563.7 545.8 649.3 855.6 520.6 557.7 2095.7 584.5 1014.6 539.0 824.8 1573.1 115.7 111.7 112.7 148.9 105.9 131.2 130.6 119.9 98.6 129.2 114.4 120.2 150.7 66.8 83.3 110.4 6.8 219.1 47.5 147.8 204.8 82.6 11.1 114.3 95.2 26.4 198.8 145.1 187.6 29.2 225.3 159.1 884.9 1365.6 228.0 12.6 182.7 67.1 80.3 169.8 99.2 6.3 253.9 337.7 76.6 263.0 127.4 186.7 53.4 78.1 152.8 355.2 18.5 7.1 346.9 193.3 345.0 174.4 8.7 58.1 266.8 108.5 9.4 384.7 85.3 297.6 4.5 12.9 332.3 858.1 45.9 120.9 174.7 1642.7 1097.6 215.9 20.9 78.9 33.6 67.1 29.7 22.8 107.1 56.0 291.0 212.7 88.4 340.0 193.1 TECPR1 "DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358" ENSG00000205356 "Tectonin beta-propeller repeat containing 1" Q7Z6L1 7 98214624-98252232 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 85.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 106.3;Rod photoreceptor cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021061 Approved Supported Vesicles NA NA Vesicles "HPA021061: AB_1847687" "unprognostic (8.10e-3)" "unprognostic (7.89e-2)" "unprognostic (9.05e-3)" "unprognostic (5.00e-3)" "unprognostic (2.03e-1)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.45e-2)" "unprognostic (1.72e-1)" "unprognostic (1.88e-1)" "prognostic favorable (8.12e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (1.38e-1)" "unprognostic (3.24e-1)" "unprognostic (9.46e-2)" "unprognostic (6.12e-2)" 8.3 7.1 9.3 10.5 10.8 6.2 8.0 5.5 11.1 6.3 4.0 7.7 9.3 6.9 3.0 9.9 7.0 5.8 8.4 11.5 10.6 7.8 9.3 13.4 11.9 11.0 10.5 11.3 5.7 85.7 3.1 16.8 8.6 10.4 11.7 5.0 10.3 19.0 3.8 9.2 5.9 10.9 4.8 6.9 18.8 18.5 4.6 10.3 9.6 9.6 5.0 6.8 6.9 6.6 11.7 4.4 6.1 8.4 18.3 7.2 4.3 6.2 9.1 5.0 7.1 8.7 5.8 5.4 3.6 14.4 10.6 8.8 2.8 5.7 4.2 3.0 8.8 8.0 5.3 9.4 5.3 8.5 6.5 9.9 7.5 3.4 6.9 5.3 6.6 25.2 15.1 3.6 15.0 5.4 7.2 9.4 6.8 3.3 8.6 5.9 7.8 8.5 17.7 5.4 4.8 15.0 16.9 5.4 14.9 8.5 6.1 4.8 9.2 26.0 6.7 11.5 17.4 7.6 17.6 9.8 1.9 14.0 5.6 12.5 2.5 2.9 0.9 2.2 3.2 1.3 1.8 2.9 1.7 1.8 1.6 4.8 4.2 3.5 1.0 4.9 2.4 3.0 2.3 9.3 10.8 5.5 11.1 11.5 10.6 11.0 10.5 11.3 10.4 6.9 10.3 11.7 32.2 9.6 18.4 18.3 12.3 2.3 2.2 3.7 1.8 37.1 7.0 5.8 11.2 7.2 7.0 5.5 106.3 6.0 10.9 16.0 1.9 6.4 2.1 6.9 5.5 22.9 29.3 2.1 21.1 13.4 9.8 7.2 35.7 8.1 8.2 11.0 21.0 8.5 13.7 32.0 17.8 22.9 10.2 20.5 4.0 2.2 7.2 14.2 1.8 16.9 19.5 11.4 14.4 10.1 10.1 11.9 10.3 3.4 17.4 4.1 10.8 3.6 7.7 66.7 0.0 7.5 7.4 5.5 4.5 7.1 1.8 3.4 16.0 9.0 10.0 2.9 MT1H MT1 ENSG00000205358 "Metallothionein 1H" P80294 16 56669814-56671129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 845.9;liver: 1146.3" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 18797.6" "Cancer enhanced" "Detected in many" "testis cancer: 173.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 3.6;SuSa: 8.9" NA NA "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-1)" "unprognostic (8.65e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (8.48e-3)" "unprognostic (6.26e-2)" "unprognostic (7.44e-2)" "unprognostic (3.31e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.44e-5)" "unprognostic (5.77e-2)" "unprognostic (3.50e-2)" "unprognostic (2.37e-2)" "unprognostic (1.34e-1)" 3.9 0.2 30.6 6.8 43.0 0.0 0.8 32.7 98.9 1.9 27.5 120.3 51.6 1.7 0.7 29.4 2.1 1.1 0.6 31.2 31.3 845.9 1146.3 1.9 0.8 39.9 32.6 35.8 0.1 206.2 0.0 0.4 0.9 35.7 22.2 61.8 5.6 4.1 0.0 0.2 6.5 300.5 8.1 28.7 0.4 76.9 0.3 31.1 0.1 328.3 0.0 0.6 3.5 2.6 31.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.9 0.6 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 30.6 43.0 32.7 98.9 31.2 31.3 39.9 32.6 35.8 35.7 28.7 31.1 31.5 0.1 0.0 0.0 1.0 73.2 12.2 1.4 0.9 1.2 0.0 0.4 0.5 2.2 42.9 0.7 535.2 0.0 3.1 0.0 1181.8 1668.9 1.8 0.0 668.1 153.9 9.3 43.6 133.7 0.0 47.9 543.9 2.7 28.5 1793.8 4.5 0.4 54.7 3439.8 19.3 0.0 0.0 767.4 0.0 55.1 0.8 0.0 0.3 195.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 43.3 3282.6 0.0 0.1 27.8 3229.9 18797.6 0.0 0.0 0.0 1.6 5.5 0.1 0.4 5.5 18.9 66.9 55.5 0.0 851.8 1.3 SLCO6A1 "CT48, MGC26949, OATP6A1, OATPY" ENSG00000205359 "Solute carrier organic anion transporter family member 6A1" Q86UG4 5 102371774-102499016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "testis: 30.5" "Group enriched" "Detected in some" 5 "Early spermatids: 168.8;Spermatocytes: 127.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054126 Enhanced NA NA "HPA054126: AB_2682390" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (4.37e-2)" "unprognostic (4.65e-1)" "unprognostic (1.84e-1)" "unprognostic (2.60e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 26.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 127.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MT1A "MT1, MT1S" ENSG00000205362 "Metallothionein 1A" P04731 16 56638666-56640087 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 315.8;liver: 434.3" "Group enriched" "Detected in many" 6 "Adipocytes: 797.9;Fibroblasts: 244.1;Hepatocytes: 343.8;Skeletal myocytes: 561.9;Smooth muscle cells: 889.5" "Cancer enriched" "Detected in all" 4 "liver cancer: 33.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 18.4;ASC TERT1: 27.9;HHSteC: 19.7;HMC-1: 29.5;hTEC/SVTERT24-B: 80.2;NTERA-2: 40.1" "Low region specificity" "Detected in single" "CAB002161, CAB013056" Approved NA NA "CAB002161: AB_563878, CAB013056: " "unprognostic (1.36e-1)" "unprognostic (4.91e-3)" "unprognostic (1.22e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-3)" "unprognostic (9.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (6.67e-3)" "unprognostic (3.10e-2)" "unprognostic (1.86e-1)" "unprognostic (9.43e-2)" "unprognostic (1.35e-2)" 315.8 64.9 9.4 10.9 11.3 0.0 209.9 9.3 15.4 48.6 7.7 25.4 7.8 13.7 1.3 33.7 69.3 30.5 54.1 8.8 28.1 34.8 434.3 116.2 0.6 9.9 10.4 8.4 20.0 91.1 2.1 26.1 0.8 10.8 33.3 13.3 4.4 19.1 2.9 100.8 25.1 23.5 17.1 10.9 3.4 43.3 8.5 11.9 6.1 68.3 6.2 0.7 34.2 22.8 13.1 0.0 6.2 0.0 0.1 18.4 27.9 0.4 1.9 7.9 1.2 1.5 2.3 4.8 0.0 2.4 1.1 0.0 0.5 0.0 0.4 2.9 0.0 0.0 0.0 2.5 9.9 19.7 0.2 29.5 8.2 0.0 80.2 0.0 0.0 7.7 0.0 0.7 0.0 5.5 0.0 0.0 0.1 40.1 0.0 0.0 0.0 0.0 3.6 0.5 0.0 0.3 0.1 0.0 0.3 0.0 0.9 0.0 0.3 6.3 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 9.4 11.3 9.3 15.4 8.8 28.1 9.9 10.4 8.4 10.8 10.9 11.9 13.1 797.9 9.6 1.7 0.7 1.8 27.4 11.3 1.9 5.7 0.0 11.7 15.4 5.4 8.6 5.1 0.0 0.0 1.1 1.0 11.1 13.7 2.7 0.1 11.9 6.9 63.2 3.6 29.5 0.0 1.8 12.8 244.1 5.1 23.8 3.8 0.3 15.7 343.8 0.3 0.0 0.0 32.3 0.0 10.4 39.6 0.7 55.0 12.4 33.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 18.6 12.8 1.2 27.9 86.5 16.1 3.0 0.0 26.3 561.9 889.5 0.0 0.3 2.1 19.5 0.5 6.6 0.4 34.7 13.7 INSYN1 "C15orf59, LOC388135, MGC131524" ENSG00000205363 "Inhibitory synaptic factor 1" Q2T9L4 15 73735458-73753351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0;heart muscle: 41.7" "Cell type enriched" "Detected in single" 24 "Cardiomyocytes: 14.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favorable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 3.0 2.6 28.9 0.9 26.1 0.1 1.9 24.5 40.7 5.4 1.0 4.9 0.8 4.2 3.4 12.1 7.9 1.9 41.7 35.8 23.5 15.2 0.4 2.7 0.2 24.5 50.0 26.7 13.6 1.5 2.9 5.2 0.5 29.5 10.7 0.6 3.9 3.4 11.1 4.7 12.9 2.5 3.2 17.2 0.7 3.8 4.6 40.5 0.2 2.1 2.7 0.9 6.4 17.0 32.4 0.0 0.0 1.8 1.2 8.7 0.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.5 5.8 1.0 2.1 1.9 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.4 4.7 0.4 1.3 2.0 0.1 0.0 1.3 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.9 26.1 24.5 40.7 35.8 23.5 24.5 50.0 26.7 29.5 17.2 40.5 32.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MT1M "MT1, MT1K" ENSG00000205364 "Metallothionein 1M" Q8N339 16 56632659-56633981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 318.4;liver: 567.0" "Cell type enhanced" "Detected in many" "Adipocytes: 1333.5;Distal enterocytes: 906.4;Glandular and luminal cells: 1180.5;Hepatocytes: 1549.5;Paneth cells: 1204.8;Proximal enterocytes: 933.2;Smooth muscle cells: 680.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 181.8" NA NA "unprognostic (1.83e-2)" "unprognostic (2.49e-1)" "unprognostic (2.10e-2)" "unprognostic (3.10e-2)" "unprognostic (4.19e-3)" "unprognostic (7.73e-2)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (4.67e-2)" "unprognostic (3.10e-1)" "unprognostic (3.55e-1)" "unprognostic (3.68e-2)" "unprognostic (1.25e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-2)" "unprognostic (4.71e-2)" 282.9 27.9 176.2 33.1 190.0 0.1 146.9 206.0 318.4 31.1 145.8 135.2 21.4 14.9 4.2 84.2 96.3 43.0 31.2 170.0 178.3 46.0 567.0 117.5 4.6 188.4 183.6 167.0 16.2 147.0 2.6 10.5 2.7 195.4 58.0 142.1 24.9 31.7 6.8 48.6 42.4 114.6 37.6 175.3 7.8 99.3 3.9 198.3 5.2 64.9 4.0 2.5 33.7 26.3 203.2 0.0 0.0 0.0 0.0 39.1 27.3 0.5 1.2 9.9 1.2 2.4 0.4 0.6 0.0 7.9 6.3 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.1 3.1 0.0 14.8 0.0 23.7 0.0 0.0 0.0 0.0 19.6 0.0 0.1 0.2 13.4 0.0 1.3 0.0 0.1 0.2 181.8 0.0 0.2 0.5 0.0 0.0 0.0 1.7 0.0 2.7 5.5 0.1 0.0 1.8 0.0 0.1 0.0 0.2 4.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 176.2 190.0 206.0 318.4 170.0 178.3 188.4 183.6 167.0 195.4 175.3 198.3 203.2 1333.5 12.8 7.2 49.6 9.3 27.5 19.0 3.1 27.9 0.0 13.7 52.7 7.9 121.5 6.0 14.7 0.0 0.3 4.9 906.4 37.2 58.9 0.1 413.6 114.7 141.3 32.7 131.0 0.1 117.0 70.5 308.1 25.5 1180.5 15.9 11.9 82.8 1549.5 1.7 0.0 0.1 397.5 0.0 65.9 39.9 1.5 47.8 35.2 88.9 5.6 24.3 0.0 0.0 6.0 0.3 64.1 1204.8 12.0 29.4 152.4 933.2 258.6 5.2 0.0 78.9 587.1 680.1 0.0 0.5 4.7 20.2 1.0 15.5 1.2 559.6 7.9 CFI "C3b-INA, FI, IF, KAF" ENSG00000205403 "Complement factor I" P05156 4 109740694-109801999 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 1108.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6" "Cancer enhanced" "Detected in all" "liver cancer: 90.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6" "HPA001143, CAB016777, HPA024061" Supported "Secreted to blood" NA NA 12000000000 "CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129" "unprognostic (1.04e-1)" "unprognostic (5.79e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.55e-2)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" "unprognostic (3.00e-1)" "unprognostic (2.00e-2)" "unprognostic (5.42e-3)" "unprognostic (1.41e-1)" "unprognostic (3.61e-1)" "unprognostic (8.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.06e-4)" 29.8 50.7 7.1 12.7 7.3 0.1 17.5 7.3 13.3 37.1 10.7 7.5 38.3 39.5 81.0 9.4 74.6 73.6 18.4 7.3 10.7 226.9 1108.0 51.2 9.0 15.0 7.9 6.6 32.4 26.2 3.1 8.5 24.4 9.4 8.4 6.4 53.4 15.1 26.9 4.0 2.7 22.5 24.6 10.0 33.3 14.6 8.9 9.4 2.3 14.6 4.6 7.6 34.5 8.4 9.8 0.0 0.6 0.0 0.3 0.0 0.2 0.1 1.5 1.4 0.1 0.2 0.0 106.1 0.0 32.9 0.0 0.5 0.0 0.0 0.0 0.0 34.8 0.7 0.0 0.4 179.8 6.2 0.3 0.0 67.4 0.0 0.1 0.0 3.6 4.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 190.6 0.5 0.0 0.3 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.1 18.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 7.3 7.3 13.3 7.3 10.7 15.0 7.9 6.6 9.4 10.0 9.4 9.8 48.1 12.8 50.9 3.6 4.0 1.0 12.2 15.2 0.6 3.4 2.1 5.6 2.3 108.7 36.2 64.4 2.1 0.1 0.3 1.7 31.3 69.3 0.2 34.1 46.4 57.7 0.0 2.7 0.3 30.9 0.2 34.3 8.2 33.6 3.8 72.1 55.0 592.5 0.7 1.7 0.2 1.9 0.0 16.7 1.5 0.8 16.8 2.0 0.0 4.7 1.6 147.8 0.0 0.0 0.3 30.8 2.4 0.0 0.0 3.8 17.0 223.6 8.4 7.3 0.0 1.3 9.4 1.6 0.5 1.9 1.1 0.3 3.4 18.5 4.1 12.6 OR52E6 ENSG00000205409 "Olfactory receptor family 52 subfamily E member 6" Q96RD3 11 5840928-5841952 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.5" "Cell type enhanced" "Detected in many" "dendritic cells: 92.7;Distal enterocytes: 104.6;NK-cells: 109.2;Paneth cells: 171.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 28.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 66.7;GAMG: 66.0" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavorable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 4.2 3.6 1.5 13.3 1.5 10.0 3.5 1.1 1.2 4.7 1.9 11.1 7.5 3.6 2.9 39.5 3.0 7.2 2.4 1.1 1.6 3.2 3.8 7.8 15.9 2.5 1.3 0.6 5.9 1.6 1.0 0.9 7.0 2.0 2.1 11.4 0.3 4.3 2.4 0.7 1.9 7.8 4.0 1.8 17.8 10.8 1.0 2.4 20.9 2.0 2.3 16.0 7.1 8.4 3.6 28.5 3.6 1.0 0.2 12.0 15.2 0.3 10.9 45.2 51.0 66.7 0.2 30.9 11.9 16.8 27.1 66.0 32.6 0.1 10.0 17.1 40.5 1.3 17.3 18.0 0.0 5.4 19.5 23.1 6.8 14.1 16.8 4.6 2.8 7.7 13.1 1.2 28.6 10.9 0.1 29.2 15.9 0.1 0.0 7.9 9.5 9.2 13.5 0.3 3.6 4.4 0.4 8.4 3.3 9.1 0.1 1.0 9.5 33.8 11.8 4.2 36.0 6.0 16.9 3.4 10.8 12.3 11.2 12.1 21.8 4.2 15.7 8.3 8.1 7.7 5.6 6.4 7.3 3.6 5.9 6.7 6.1 17.8 8.8 12.8 2.5 8.8 3.2 1.5 1.5 1.1 1.2 1.1 1.6 2.5 1.3 0.6 2.0 1.8 2.4 3.6 43.9 9.6 3.7 0.7 53.4 2.3 8.2 40.2 4.0 1.4 4.4 5.1 1.2 5.7 33.7 14.7 0.0 1.9 92.7 104.6 0.0 23.5 0.1 21.1 18.5 29.0 3.0 19.4 0.4 12.3 7.1 14.6 37.8 7.0 43.6 21.8 12.1 1.2 11.5 6.7 1.5 34.9 20.3 29.9 9.6 0.7 15.2 32.7 3.6 21.5 41.6 2.2 109.2 2.0 2.4 50.4 171.0 12.4 35.9 7.0 12.6 2.3 37.5 0.1 13.1 14.4 12.6 0.2 0.0 21.1 1.8 0.4 69.4 25.4 5.6 34.3 KRT6A "CK6C, CK6D, K6C, K6D, KRT6C, KRT6D" ENSG00000205420 "Keratin 6A" P02538 12 52487176-52493257 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Allergen, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 7397.3;vagina: 4985.3" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 674.0;Club cells: 200.5;Squamous epithelial cells: 876.0;Suprabasal keratinocytes: 151.4;Urothelial cells: 306.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 3892.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 9761.7" "HPA045697, HPA061168" Supported Enhanced "Intermediate filaments" NA NA 4500000000 "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (8.10e-3)" "unprognostic (2.11e-1)" "unprognostic (2.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (2.43e-1)" "unprognostic (3.73e-2)" "unprognostic (1.31e-3)" "unprognostic (1.29e-1)" "unprognostic (2.89e-9)" "unprognostic (8.80e-2)" "unprognostic (7.20e-2)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" 2.9 1.5 0.0 2.0 0.0 0.1 7.0 0.0 0.0 1206.2 0.0 1.0 0.0 1.3 0.0 7397.3 9.2 0.9 1.6 0.0 0.0 1.1 2.6 3.4 0.0 0.0 0.0 0.0 2.3 3.3 0.0 3.1 8.8 0.0 5.0 0.0 0.0 1033.7 0.0 2.0 408.8 1.3 0.4 0.0 1.4 4.9 1.0 0.0 33.9 1.5 0.0 633.9 19.9 4985.3 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.9 0.0 0.0 1143.8 0.0 2414.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.6 0.3 9761.7 0.2 306.7 0.0 0.3 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 14.0 0.3 0.1 0.5 0.0 0.3 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.2 0.2 0.4 0.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.5 79.0 674.0 12.0 0.0 0.6 1.7 0.0 0.0 200.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 2.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 5.5 0.0 0.0 0.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 100.4 0.0 0.0 24.5 0.0 0.0 0.0 11.8 0.0 0.0 876.0 151.4 0.0 1.7 0.0 0.1 306.8 CNEP1R1 "C16orf69, FLJ38101, NEP1-R1, TMEM188" ENSG00000205423 "CTD nuclear envelope phosphatase 1 regulatory subunit 1" Q8N9A8 16 50024410-50037088 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042815, HPA077906" Uncertain Supported Cytosol NA NA Cytosol "HPA042815: AB_10794765, HPA077906: AB_2686868" "unprognostic (4.11e-2)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.43e-3)" "unprognostic (1.80e-1)" "unprognostic (3.42e-2)" "unprognostic (8.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (3.37e-3)" "unprognostic (5.09e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" 9.7 8.5 6.9 14.5 7.8 24.0 8.0 8.6 7.9 8.2 6.5 9.5 9.0 9.2 13.0 12.1 7.6 10.8 9.1 7.2 8.8 7.2 10.7 9.6 14.4 6.7 6.4 6.9 9.9 7.2 8.7 8.5 15.7 6.9 8.3 13.5 9.7 8.4 8.3 10.2 11.7 9.3 11.1 7.0 13.5 9.9 18.1 7.3 9.6 5.5 7.3 15.5 10.1 9.1 8.4 11.2 10.2 12.4 13.9 23.5 23.1 17.4 22.5 17.1 21.4 12.5 11.0 15.3 12.4 16.3 18.7 14.6 17.0 10.0 10.9 27.1 9.1 11.7 6.1 6.7 17.8 16.7 8.1 18.1 17.0 18.2 13.9 10.8 16.6 14.8 15.5 7.6 6.9 27.4 3.4 16.0 21.0 9.0 4.9 13.8 19.3 16.4 12.8 15.9 7.4 9.3 11.1 21.3 8.5 9.0 10.7 7.4 10.0 19.3 20.7 15.9 19.7 8.0 11.4 11.3 14.5 12.0 8.1 17.4 16.6 21.0 16.3 16.0 29.2 15.1 9.4 12.4 11.9 17.5 8.7 12.4 14.5 51.0 12.7 36.4 6.9 13.4 14.5 6.9 7.8 8.6 7.9 7.2 8.8 6.7 6.4 6.9 6.9 7.0 7.3 8.4 8.2 3.2 7.8 8.8 10.1 10.6 3.4 6.5 5.7 5.8 5.9 3.9 11.4 8.6 6.9 7.3 4.2 17.7 10.6 7.7 3.9 5.2 4.6 5.9 8.6 8.6 4.8 7.8 13.7 5.4 25.1 9.7 8.6 6.8 12.7 5.6 10.0 6.9 14.8 6.7 13.2 3.7 2.0 20.0 20.8 3.9 5.9 18.2 16.0 6.5 15.4 12.2 12.3 8.5 12.5 5.8 6.4 7.9 7.7 4.2 5.0 5.5 4.5 10.0 6.6 9.4 8.4 26.4 18.8 5.5 9.8 14.4 13.3 5.7 5.6 3.8 KRT81 "Hb-1, KRTHB1" ENSG00000205426 "Keratin 81" Q14533 12 52285913-52291534 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "skin 1: 86.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 41.0;Club cells: 20.4;Ductal cells: 67.3;Pancreatic endocrine cells: 27.2" "Cancer enhanced" "Detected in many" "breast cancer: 46.1;cervical cancer: 49.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 49 "basophil: 170.8" "Lineage enriched" "Detected in many" 49 "granulocytes: 170.8" "Cell line enhanced" "Detected in many" "A-431: 3086.0;A549: 2296.0;MCF7: 700.1;PC-3: 1088.7;U-251 MG: 2151.1" HPA049778 Supported NA NA 130000000 "HPA049778: AB_2680877" "unprognostic (1.69e-2)" "unprognostic (5.61e-2)" "unprognostic (6.57e-2)" "unprognostic (2.90e-1)" "unprognostic (5.64e-2)" "unprognostic (1.77e-1)" "unprognostic (2.00e-1)" "unprognostic (3.64e-3)" "unprognostic (1.87e-1)" "unprognostic (5.10e-2)" "unprognostic (4.89e-2)" "unprognostic (2.21e-1)" "unprognostic (2.64e-4)" "unprognostic (5.98e-2)" "unprognostic (1.86e-1)" "unprognostic (2.25e-1)" "unprognostic (7.31e-2)" 0.8 0.0 0.3 0.2 0.4 0.3 3.1 0.3 0.6 0.1 0.1 0.2 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.2 0.0 0.4 0.3 0.3 0.0 0.2 0.0 0.1 1.0 0.4 0.3 0.0 0.0 2.1 0.2 0.2 86.9 0.2 0.0 0.3 0.2 0.1 0.4 0.4 0.2 0.9 0.0 0.0 0.1 0.1 0.4 3086.0 2296.0 0.0 0.0 0.0 0.0 0.3 18.6 3.2 23.9 2.2 6.7 0.7 0.0 3.0 0.3 1.6 43.2 0.0 0.0 4.2 4.6 0.0 0.0 1.3 0.2 1.4 0.0 0.2 0.0 0.0 0.4 1.1 32.9 0.0 0.0 0.0 1.6 0.2 700.1 0.3 6.4 0.2 0.1 1088.7 0.5 0.0 10.4 0.6 0.2 0.7 0.0 1.0 179.1 11.1 0.1 0.5 12.9 0.2 0.4 564.4 0.2 2151.1 0.3 4.4 3.1 0.4 7.2 0.2 170.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.3 0.4 0.3 0.6 0.4 0.5 0.4 0.3 0.3 0.4 0.3 0.4 0.4 0.1 0.0 0.0 0.3 0.0 0.0 3.3 4.4 0.0 0.0 41.0 4.6 0.3 0.0 20.4 0.0 0.0 0.1 12.8 0.1 0.0 67.3 0.9 1.9 0.3 0.4 0.0 0.0 3.9 1.3 2.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 4.1 0.0 0.4 2.5 0.0 0.1 0.0 1.0 0.0 0.0 6.2 0.0 3.3 27.2 0.0 0.0 0.1 2.6 0.0 0.0 2.0 0.0 0.0 1.2 6.8 0.0 0.1 0.0 0.3 2.9 10.5 0.0 0.0 6.0 EXOC3L4 C14orf73 ENSG00000205436 "Exocyst complex component 3 like 4" Q17RC7 14 103100144-103110559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 19.3;liver: 41.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 8.6;Gastric mucus-secreting cells: 21.9;Hepatocytes: 25.1;Proximal enterocytes: 30.2;Proximal tubular cells: 12.3" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.4;HEL: 3.8;Hep G2: 2.7;RPMI-8226: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043661 Approved NA NA "HPA043661: AB_10965693" "unprognostic (8.71e-2)" "unprognostic (7.42e-3)" "prognostic unfavorable (1.43e-5)" "unprognostic (8.20e-2)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.64e-2)" "unprognostic (1.49e-1)" "unprognostic (6.98e-2)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.22e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.81e-4)" 0.6 0.3 0.0 2.8 0.0 0.2 0.2 0.0 0.1 0.5 0.1 1.8 19.3 0.2 0.0 0.5 0.4 3.1 0.8 0.0 0.0 3.8 41.4 1.8 6.5 0.0 0.0 0.0 0.3 1.6 0.0 0.2 0.9 0.0 1.3 1.4 0.0 0.7 0.3 0.3 0.1 9.8 0.2 0.0 5.1 4.6 0.2 0.0 3.8 0.3 0.0 2.9 0.8 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 3.8 0.0 2.7 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.2 1.3 0.0 0.0 0.2 0.1 1.1 8.6 0.6 0.0 0.0 0.0 0.0 6.3 0.0 2.3 0.1 0.3 0.2 0.3 1.2 0.0 0.0 4.1 3.2 2.2 21.9 0.3 0.0 0.8 0.4 25.1 0.2 0.0 0.0 5.3 0.0 0.8 0.3 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.6 1.5 2.1 0.2 30.2 12.3 1.5 0.0 0.0 6.4 0.8 0.1 2.0 0.0 0.4 0.3 0.2 2.2 5.1 0.7 KRTAP12-3 KRTAP12.3 ENSG00000205439 "Keratin associated protein 12-3" P60328 21 44657932-44658341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "skin 1: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IZUMO3 "bA20A20.1, C9orf134" ENSG00000205442 "IZUMO family member 3" Q5VZ72 9 24542952-24545946 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "testis: 13.8" "Group enriched" "Detected in some" 35 "Early spermatids: 248.7;Late spermatids: 103.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "SCLC-21H: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 248.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-2 "KAP10.2, KAP18.2, KRTAP18-2" ENSG00000205445 "Keratin associated protein 10-2" P60368 21 44550357-44551505 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "skin 1: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3D ENSG00000205456 "TP53 target 3D" Q9ULZ0 16 32252719-32255922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 3.4;testis: 2.2" "Group enriched" "Detected in some" 6 "Early spermatids: 77.5;Late spermatids: 21.1;Spermatocytes: 32.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;HEL: 1.1;HMC-1: 1.4;RH-30: 1.1;SCLC-21H: 1.2;U-2 OS: 1.2" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (5.98e-3)" "unprognostic (1.47e-2)" "unprognostic (2.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" 0.1 0.8 0.1 0.1 0.2 0.0 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.4 3.4 0.7 0.2 0.0 0.3 0.0 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.0 0.5 0.4 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.1 2.2 0.3 0.0 0.2 0.0 0.0 0.2 0.4 0.5 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.2 0.3 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 1.2 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.7 0.3 0.0 0.2 0.5 0.1 0.0 0.5 0.1 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.5 0.8 0.3 0.0 0.1 0.0 2.1 0.1 0.5 0.0 0.0 0.0 77.5 0.1 1.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.6 21.1 1.2 0.1 5.4 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.0 1.2 0.1 0.2 0.0 0.0 0.2 0.1 6.6 0.6 0.3 32.5 6.6 0.0 0.1 0.0 0.1 0.4 0.0 0.0 TP53TG3C ENSG00000205457 "TP53 target 3C" Q9ULZ0 16 33193659-33196858 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500190-99604207 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058346, HPA061922" Uncertain Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions" Yes No "Nucleoli rim, Cell Junctions" "Nucleoplasm, Nuclear bodies, Mitotic chromosome" "HPA058346: AB_2683686, HPA061922: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favorable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 4.0 22.1 27.7 4.3 30.1 9.7 7.2 66.0 27.3 5.2 17.8 26.7 18.9 15.5 14.4 28.5 11.4 5.4 14.9 23.8 20.3 14.2 18.3 8.2 2.5 29.3 27.4 25.0 5.1 18.7 16.5 17.1 8.7 37.9 15.1 11.2 35.0 26.7 16.3 20.9 18.9 17.8 13.3 22.3 3.6 19.3 8.6 26.7 5.1 9.4 5.7 7.5 16.2 9.0 22.4 48.4 43.4 52.7 31.7 0.7 0.2 48.9 16.0 16.2 31.4 18.1 52.9 49.8 0.3 61.7 18.2 8.6 63.3 39.2 38.4 19.5 79.2 23.3 2.5 43.6 36.1 4.2 0.5 4.9 0.1 19.9 9.0 25.9 18.6 9.9 27.9 11.8 7.2 3.9 80.3 21.8 6.6 19.3 55.4 44.7 32.1 22.1 10.8 22.3 18.8 26.0 32.6 40.7 21.5 9.5 19.9 46.9 9.8 22.6 6.2 51.5 22.4 16.2 11.2 15.8 0.4 1.0 4.3 4.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.4 0.1 27.7 30.1 66.0 27.3 23.8 20.3 29.3 27.4 25.0 37.9 22.3 26.7 22.4 8.5 22.4 5.6 15.7 6.7 8.8 8.7 4.0 13.6 35.2 12.1 9.3 3.0 5.7 7.3 1.8 62.6 6.3 3.9 21.2 0.0 7.6 3.1 18.8 8.1 9.2 9.6 3.4 2.8 9.4 4.5 6.2 17.3 35.6 6.3 14.1 5.3 16.7 1.8 1.7 5.4 9.6 6.1 1.6 1.2 2.1 0.6 5.0 8.8 4.7 0.4 30.6 1.0 1.5 11.7 17.4 13.2 0.7 10.4 11.0 23.3 6.5 3.0 51.7 0.0 5.7 4.1 1.4 3.5 20.4 14.1 4.9 8.3 2.3 13.0 12.0 OR52J3 ENSG00000205495 "Olfactory receptor family 52 subfamily J member 3" Q8NH60 11 5046526-5047461 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A2 ENSG00000205496 "Olfactory receptor family 51 subfamily A member 2" Q8NGJ7 11 4954772-4955713 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A4 ENSG00000205497 "Olfactory receptor family 51 subfamily A member 4" Q8NGJ6 11 4942831-4947605 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2CD4B "FAM148B, NLF2" ENSG00000205502 "C2 calcium dependent domain containing 4B" A6NLJ0 15 62163535-62165285 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 100.2" "Cell type enhanced" "Detected in many" "Adipocytes: 169.8;Endothelial cells: 116.2;Enteroendocrine cells: 214.4;Glandular and luminal cells: 128.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.9" HPA046880 Uncertain NA NA "HPA046880: AB_10959458" "unprognostic (6.60e-2)" "prognostic favorable (4.22e-4)" "unprognostic (2.24e-2)" "unprognostic (1.25e-1)" "unprognostic (4.15e-1)" "unprognostic (4.06e-3)" "unprognostic (2.29e-1)" "unprognostic (5.02e-2)" "unprognostic (3.36e-2)" "unprognostic (2.33e-1)" "unprognostic (5.30e-2)" "unprognostic (1.83e-1)" "unprognostic (6.16e-3)" "unprognostic (7.89e-2)" "unprognostic (5.24e-1)" "unprognostic (8.64e-3)" "unprognostic (1.48e-1)" 20.8 1.2 2.0 0.6 0.8 3.0 19.7 0.8 1.2 4.4 0.6 2.4 2.2 4.2 0.0 1.6 2.8 1.6 6.0 1.1 1.1 2.6 1.9 13.1 0.5 1.5 1.3 0.4 1.0 100.2 0.3 6.5 0.4 1.4 2.3 0.4 0.0 1.6 0.2 2.8 4.6 2.4 0.7 1.5 0.5 24.6 1.0 3.0 2.7 2.7 1.3 0.0 5.1 2.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.8 1.2 1.1 1.1 1.5 1.3 0.4 1.4 1.5 3.0 1.6 169.8 3.2 5.5 0.0 0.1 6.8 3.0 0.1 0.6 0.8 14.5 4.3 1.3 5.7 0.9 1.8 0.0 0.0 0.9 6.1 0.0 2.1 0.0 40.4 15.2 116.2 214.4 0.0 0.0 24.0 0.0 3.2 17.9 128.9 2.5 0.0 11.4 0.4 0.4 0.0 0.1 22.5 6.1 1.0 12.1 0.0 0.0 1.3 3.6 1.9 1.6 0.1 0.0 0.0 0.0 9.8 1.3 0.0 0.1 2.4 1.3 0.0 0.1 0.6 0.0 6.8 4.1 0.1 0.4 0.8 7.0 0.0 1.7 0.5 4.3 3.5 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419328 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 46.2;thyroid gland: 65.4" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Collecting duct cells: 51.5;Gastric mucus-secreting cells: 48.4;Sertoli cells: 39.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 26.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;CACO-2: 10.4;RT4: 22.0;SK-BR-3: 9.7;T-47d: 15.9" "Region enriched" "Detected in many" 6 "cerebellum: 9.0" "Low region specificity" "Detected in many" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favorable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favorable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 6.7 11.5 1.3 0.7 1.3 0.0 7.4 1.5 2.5 10.4 5.5 2.2 1.4 4.8 9.6 1.1 9.5 2.1 7.7 1.6 2.7 36.1 10.7 9.0 0.6 2.1 1.3 0.3 2.5 21.1 46.2 15.5 5.6 1.9 6.5 1.4 0.8 5.9 9.5 2.1 1.3 1.8 0.9 1.5 8.2 13.9 0.6 1.8 0.2 65.4 0.6 0.3 5.3 5.7 1.6 0.0 0.6 0.0 0.1 1.1 0.2 17.7 1.1 1.4 0.6 2.0 10.4 7.4 0.0 6.5 1.3 2.6 4.6 0.0 0.0 0.1 0.0 0.0 0.1 4.2 3.3 2.7 0.0 0.0 0.0 0.1 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.9 1.4 0.0 0.7 2.2 6.3 22.0 1.0 5.2 0.2 9.7 3.3 3.7 15.9 0.0 0.0 3.3 0.0 2.5 0.9 0.0 0.6 1.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.3 1.5 2.5 1.6 2.7 2.1 1.3 0.3 1.9 1.5 1.8 1.6 3.1 19.2 21.0 32.3 1.1 0.1 2.1 0.4 1.8 0.3 3.3 4.6 4.6 12.8 12.4 51.5 0.0 12.9 0.0 2.2 11.7 8.6 0.0 14.8 9.6 5.8 10.3 0.0 0.5 4.2 11.9 4.1 48.4 18.4 1.3 3.1 26.0 5.8 3.0 0.0 0.6 7.7 2.0 7.4 0.3 0.2 3.7 1.5 5.4 4.7 0.0 16.9 0.0 1.5 0.5 5.7 5.3 0.4 0.6 1.4 0.0 4.6 1.7 0.6 39.5 9.9 18.7 0.6 1.7 0.0 0.0 12.0 0.2 0.8 2.4 2.0 NAP1L4 NAP2 ENSG00000205531 "Nucleosome assembly protein 1 like 4" Q99733 11 2944431-2992377 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 346.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011567 Approved Supported Nucleoplasm NA NA 3100000 Nucleoplasm "CAB011567: AB_776638" "unprognostic (1.61e-1)" "prognostic favorable (9.77e-4)" "unprognostic (8.99e-2)" "unprognostic (9.64e-3)" "unprognostic (2.96e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.80e-1)" "unprognostic (6.44e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (2.31e-1)" "unprognostic (6.10e-3)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.55e-4)" "unprognostic (1.54e-1)" 39.6 43.9 122.7 36.4 71.2 50.7 41.7 46.5 117.7 46.1 57.7 56.7 20.2 45.8 17.4 80.2 41.5 32.8 100.6 61.0 48.3 64.0 56.7 40.8 66.2 112.4 59.0 35.7 43.2 38.3 64.0 61.9 37.1 127.0 52.3 34.5 38.9 66.9 32.4 147.3 47.1 54.3 39.4 49.6 59.5 57.1 88.0 87.2 79.5 44.9 111.7 76.4 62.4 52.5 346.4 82.8 59.9 81.7 65.7 83.9 92.4 37.7 159.8 104.1 145.4 132.5 129.7 208.4 149.5 95.3 98.0 15.1 140.0 21.9 136.3 166.8 159.2 57.5 106.7 151.4 168.2 57.7 93.0 110.5 77.8 65.1 78.6 59.1 12.0 88.9 77.6 139.3 150.7 128.0 74.5 206.4 4.2 199.8 98.9 75.2 101.4 98.1 117.0 12.2 131.7 121.4 104.3 80.5 118.1 78.3 82.5 7.3 7.4 67.8 112.5 104.4 152.4 13.8 79.3 136.5 201.5 8.4 66.0 75.3 67.5 22.9 32.6 42.3 24.0 39.9 24.7 51.9 53.0 27.2 28.4 45.7 52.1 14.5 57.6 30.4 25.0 70.5 48.0 122.7 71.2 46.5 117.7 61.0 48.3 112.4 59.0 35.7 127.0 49.6 87.2 346.4 53.6 44.8 49.8 56.2 64.3 70.1 67.4 76.9 83.1 80.4 54.6 48.3 200.4 42.9 69.0 75.4 45.9 103.8 99.4 37.2 97.8 78.7 97.0 107.7 65.9 55.4 45.4 168.7 36.9 50.4 109.2 56.6 54.0 91.1 74.6 100.6 43.5 50.0 47.3 65.6 56.6 41.4 67.1 30.8 44.7 142.6 48.1 49.7 35.6 38.4 65.3 67.5 95.8 60.8 125.3 74.1 26.8 50.0 100.7 76.1 39.8 76.9 92.6 68.1 46.0 58.8 64.7 166.1 129.0 102.3 66.9 91.3 123.8 79.7 55.1 83.7 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4 X-linked" P62328 X 12975110-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 30742.3;Langerhans cells: 57681.0;monocytes: 48133.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033806 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 6116.7 4257.1 3783.2 5135.2 4070.3 8800.5 4490.1 3954.1 4525.8 3593.3 3600.0 4368.0 1792.9 3762.5 2903.0 2088.7 2733.0 4166.0 2457.7 3728.0 4344.2 2947.7 2380.0 6279.7 10533.8 4420.5 4014.5 3500.4 2613.8 1868.1 487.3 1061.9 2470.6 4499.8 2355.6 3830.2 275.6 1903.5 2465.1 823.2 1962.8 3701.8 3369.1 4807.8 8004.6 4732.8 491.1 4128.8 6436.4 1662.4 1488.0 7293.2 5217.1 2931.8 5101.9 5980.6 4886.3 9387.7 14881.1 11264.5 12247.2 23.0 3083.9 8032.6 2344.3 4005.4 1016.1 4865.3 1417.1 2900.6 9443.7 4198.0 2564.2 1411.5 2072.7 3135.4 8343.4 80.9 1771.0 2621.8 12.9 2619.8 6994.8 14038.1 5755.3 2911.9 2781.9 2412.7 5704.5 14335.9 3714.1 230.0 22.0 8424.8 2121.5 8390.5 15083.5 3384.1 2853.1 3337.3 6352.0 3321.0 5858.5 14234.5 1720.4 994.2 422.9 4461.8 207.4 583.3 6898.2 5536.5 6961.4 11607.2 3383.5 1647.5 19441.4 3123.6 4432.5 3490.6 2774.8 5183.2 2860.5 2499.5 42940.3 34738.5 50992.6 21474.2 33907.1 18326.4 18757.1 23777.1 23343.2 31253.2 16919.4 19802.1 20330.2 35862.9 18444.5 37523.3 12797.6 34088.1 86809.5 3783.2 4070.3 3954.1 4525.8 3728.0 4344.2 4420.5 4014.5 3500.4 4499.8 4807.8 4128.8 5101.9 6885.8 5253.2 4939.6 35.9 6293.8 8836.3 2708.7 10515.3 296.5 332.9 2318.3 1124.2 106.9 3484.4 8003.6 6882.2 22.9 283.0 9136.2 9016.2 2181.5 17304.6 142.1 2613.2 4698.0 9239.4 1765.0 1339.1 54.3 23029.4 511.7 4800.1 2728.9 5047.4 4380.4 4646.7 6638.0 1088.5 30742.3 62.2 81.0 4883.9 14806.8 20982.2 57681.0 343.6 3932.0 17648.1 6349.9 212.7 48133.8 86.7 20882.8 19.6 102.1 25113.5 5826.4 6035.9 2541.8 3272.5 6888.7 835.1 2596.4 99.4 5732.4 1018.2 5450.7 58.2 126.3 933.7 9528.5 454.8 12719.6 3874.8 3140.6 9064.0 TMEM256 "C17orf61, MGC40107" ENSG00000205544 "Transmembrane protein 256" Q8N2U0 17 7402975-7404097 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 573.1;Proximal enterocytes: 972.0;Proximal tubular cells: 801.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062732 Approved Vesicles NA NA Vesicles "HPA062732: AB_2684852" "unprognostic (3.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.69e-2)" "unprognostic (5.73e-2)" "unprognostic (7.45e-2)" "unprognostic (2.12e-2)" "unprognostic (3.22e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.36e-4)" "unprognostic (1.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.19e-2)" 85.1 85.0 57.0 22.4 59.2 37.0 87.5 60.9 73.6 80.4 56.6 69.7 77.0 64.0 48.7 75.3 78.3 24.2 95.0 55.0 57.4 122.3 175.3 52.2 34.7 60.4 57.9 54.7 76.0 114.7 43.0 46.2 14.4 59.5 82.2 25.4 15.2 60.8 24.6 68.0 58.9 90.7 17.7 62.1 68.5 92.5 12.5 59.1 31.1 51.9 41.9 28.7 70.3 68.2 65.7 67.0 89.3 47.3 64.3 78.6 99.0 43.0 30.7 43.9 49.4 46.3 36.1 38.0 59.0 54.0 31.2 39.4 56.4 29.9 93.6 35.7 30.5 99.4 37.5 32.0 95.1 54.0 13.0 49.0 87.1 44.2 64.1 53.0 66.4 73.1 63.8 28.9 39.1 64.1 36.5 44.1 42.5 21.4 29.4 58.6 69.9 41.5 68.8 121.2 28.8 5.5 37.9 47.6 36.7 51.2 46.0 66.6 23.4 43.7 22.8 42.7 46.5 39.3 32.6 45.2 31.2 60.2 18.0 44.4 12.9 63.1 14.8 35.7 48.5 44.5 77.4 42.3 41.3 59.7 69.0 48.5 45.2 3.9 39.3 36.3 82.3 46.0 77.8 57.0 59.2 60.9 73.6 55.0 57.4 60.4 57.9 54.7 59.5 62.1 59.1 65.7 103.1 44.8 55.8 0.0 134.5 87.4 93.3 100.1 94.4 24.0 212.4 216.9 62.5 131.5 76.9 132.4 8.4 77.2 78.4 162.9 297.4 132.8 6.0 80.2 84.6 85.1 125.3 100.5 0.0 190.8 223.6 83.3 88.7 84.5 68.4 50.3 114.5 573.1 205.5 20.2 0.0 186.6 81.4 164.7 128.2 6.8 137.3 108.4 144.1 0.0 166.7 134.0 88.6 0.0 0.0 171.3 214.0 71.1 173.1 87.3 972.0 801.9 96.3 42.0 59.2 80.2 160.2 10.1 39.1 179.5 134.0 46.7 91.7 64.5 210.0 90.9 CPT1B "CPT1-M, M-CPT1" ENSG00000205560 "Carnitine palmitoyltransferase 1B" Q92523 22 50568861-50578465 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 197.4;skeletal muscle: 145.7;testis: 81.3;tongue: 230.0" "Group enriched" "Detected in many" 4 "Early spermatids: 45.4;Late spermatids: 109.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA079265 Enhanced NA NA "HPA079265: " "unprognostic (1.66e-1)" "unprognostic (2.99e-1)" "unprognostic (6.71e-3)" "unprognostic (2.53e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-3)" "unprognostic (8.89e-2)" "unprognostic (7.16e-2)" "unprognostic (5.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.10e-3)" "unprognostic (9.76e-3)" "unprognostic (7.37e-2)" "unprognostic (4.98e-3)" "unprognostic (1.14e-1)" "unprognostic (8.43e-2)" "unprognostic (3.15e-5)" 9.9 9.4 14.9 11.5 16.5 13.5 15.8 18.1 17.6 7.5 13.4 10.6 13.6 4.7 10.4 16.7 7.4 6.2 197.4 14.8 15.8 23.4 25.8 10.6 14.5 17.5 15.7 15.1 5.0 18.5 34.4 23.7 8.2 17.8 15.9 10.7 17.3 13.2 3.5 145.7 14.2 22.4 3.6 14.4 27.7 13.1 81.3 16.4 9.9 27.0 230.0 13.2 10.0 10.4 18.9 8.2 7.7 24.5 9.0 5.3 3.1 17.5 0.3 3.1 4.1 4.5 3.6 7.2 16.3 2.2 2.0 6.0 13.6 12.9 2.9 3.6 6.5 14.2 8.0 26.2 3.9 1.4 8.5 22.3 1.8 22.0 2.9 4.8 15.0 0.7 11.4 2.9 27.8 3.9 11.9 2.9 16.3 5.2 4.3 4.9 15.2 7.8 3.5 10.3 19.6 6.6 12.7 5.7 9.7 10.9 14.8 10.8 17.9 1.6 11.4 11.4 7.4 2.8 22.3 5.5 8.7 4.9 15.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.9 16.5 18.1 17.6 14.8 15.8 17.5 15.7 15.1 17.8 14.4 16.4 18.9 0.5 0.0 11.0 0.0 0.8 0.3 0.0 1.0 1.8 1.9 2.2 1.0 3.7 1.5 1.5 3.7 2.1 0.5 0.2 5.6 0.0 2.2 45.4 0.9 0.1 1.0 0.0 0.0 0.0 2.1 0.6 1.4 5.6 0.4 7.0 0.1 0.4 2.1 0.6 3.3 0.0 5.2 0.0 0.6 0.8 109.3 0.3 1.0 1.8 0.0 6.3 0.4 0.0 0.0 0.0 1.0 6.4 0.7 0.4 0.0 3.5 0.5 3.7 2.0 0.0 0.9 0.3 16.3 2.4 1.0 0.3 0.4 1.2 0.0 4.2 0.1 SMN2 "BCD541, GEMIN1, SMNC, TDRD16B" ENSG00000205571 "Survival of motor neuron 2, centromeric" Q16637 5 70049638-70078522 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 41.8;Club cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2" "CAB009344, HPA045271, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: " "unprognostic (2.07e-2)" "unprognostic (5.70e-3)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.77e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.21e-1)" "unprognostic (5.19e-2)" "unprognostic (2.98e-5)" "unprognostic (2.36e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (1.19e-1)" 19.0 15.8 1.8 4.5 1.6 13.9 19.5 0.9 4.6 20.3 1.0 17.6 0.5 20.1 17.0 17.2 15.3 13.7 15.8 1.9 5.5 14.5 23.4 16.6 13.9 1.8 3.6 0.9 26.1 18.5 8.4 20.7 3.8 5.5 18.9 5.6 3.0 15.2 5.9 26.3 16.6 13.7 14.1 3.1 14.8 14.6 16.6 1.8 0.1 17.5 0.0 0.1 16.1 21.0 6.2 61.3 0.6 0.6 0.4 16.1 20.9 122.7 31.7 21.1 42.0 44.0 0.4 0.4 1.2 86.6 31.8 1.1 28.8 0.9 0.0 50.1 0.8 1.2 68.6 0.0 2.1 0.0 1.1 0.0 0.3 36.0 0.0 1.1 14.3 0.7 0.0 0.0 0.6 0.0 0.6 125.1 106.2 0.5 0.0 0.5 0.0 45.8 55.3 31.5 0.3 30.5 70.7 60.2 6.7 89.7 0.0 41.4 25.2 53.4 27.2 1.3 0.4 0.7 0.6 1.1 72.4 0.4 0.0 76.2 8.0 9.9 5.2 12.1 16.5 14.6 16.8 14.4 10.1 16.6 20.0 17.0 14.8 1.8 10.9 11.4 16.3 12.7 13.4 1.8 1.6 0.9 4.6 1.9 5.5 1.8 3.6 0.9 5.5 3.1 1.8 6.2 2.0 6.4 7.8 0.0 2.7 13.6 3.4 9.7 1.8 0.3 2.7 2.8 41.8 0.0 20.2 1.8 0.0 6.9 4.0 1.1 5.9 2.7 14.1 3.3 4.0 6.6 1.8 3.4 0.0 1.0 3.3 10.1 2.6 3.2 8.2 1.2 2.5 3.1 2.6 1.7 0.0 3.1 6.1 2.6 6.8 8.9 7.2 3.3 1.8 0.0 2.9 0.6 2.1 0.0 0.0 2.3 1.6 5.3 2.5 1.7 2.7 3.8 14.0 1.1 0.0 5.3 6.4 12.0 11.4 3.1 12.6 7.1 5.0 1.0 2.5 2.8 SERF1B "FAM2B, H4F5C" ENSG00000205572 "Small EDRK-rich factor 1B" O75920 5 70025247-70043113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 155.6" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 40.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 11.3" HPA075271 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.00e-1)" "unprognostic (2.52e-4)" "unprognostic (2.60e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (5.98e-2)" "unprognostic (4.92e-3)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-4)" "unprognostic (1.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (6.74e-2)" "unprognostic (3.52e-1)" 26.1 27.3 0.6 1.6 1.3 1.7 30.6 1.4 3.2 34.1 0.2 41.6 0.7 32.2 0.5 28.8 25.7 1.0 39.3 1.3 1.8 32.3 15.0 30.8 2.1 0.8 1.7 0.7 27.3 27.9 1.4 38.3 1.0 2.4 30.7 1.2 11.5 25.3 2.1 46.9 21.6 31.1 3.0 1.0 23.5 28.6 155.6 1.3 1.3 34.0 1.2 1.6 28.5 32.7 0.9 2.6 0.7 4.1 6.0 3.8 1.5 1.1 1.0 1.8 1.7 3.7 0.6 3.0 3.1 11.3 1.1 3.8 1.3 2.6 1.9 1.6 8.0 0.9 3.0 1.3 1.6 1.5 0.1 2.9 1.2 5.3 1.9 0.3 1.3 1.7 0.9 1.2 2.5 0.5 0.2 4.7 2.1 3.6 0.0 0.4 2.4 6.3 5.0 1.3 1.5 7.8 5.1 2.7 0.1 3.7 1.8 2.6 1.1 6.3 1.6 1.8 1.0 1.7 2.0 3.4 3.5 1.6 0.2 3.2 0.3 0.2 1.8 4.1 1.5 4.8 3.3 5.9 2.9 2.9 6.3 7.0 4.9 0.5 2.6 1.5 4.6 2.8 1.9 0.6 1.3 1.4 3.2 1.3 1.8 0.8 1.7 0.7 2.4 1.0 1.3 0.9 0.4 9.6 2.2 0.0 1.0 0.4 0.7 0.3 1.2 0.1 0.5 0.5 40.3 0.0 3.2 0.0 2.1 0.1 0.4 0.6 1.9 0.2 1.6 0.3 0.7 4.4 0.0 0.4 0.0 0.0 0.1 3.4 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 1.0 1.8 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 1.1 5.2 1.4 0.0 0.5 8.8 1.6 0.6 0.9 0.6 0.0 0.7 0.1 0.4 0.4 HMGN1 "FLJ27265, FLJ31471, HMG14, MGC104230, MGC117425" ENSG00000205581 "High mobility group nucleosome binding domain 1" P05114 21 39342315-39349647 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012260, HPA048694" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012260: AB_304786, HPA048694: AB_2680496" "unprognostic (4.49e-2)" "unprognostic (5.52e-2)" "unprognostic (4.85e-2)" "unprognostic (6.28e-2)" "unprognostic (2.20e-1)" "unprognostic (5.21e-3)" "unprognostic (8.50e-3)" "unprognostic (1.32e-1)" "unprognostic (2.46e-3)" "unprognostic (5.68e-2)" "unprognostic (3.02e-2)" "unprognostic (5.24e-2)" "prognostic unfavorable (8.74e-7)" "unprognostic (3.20e-1)" "unprognostic (3.72e-2)" "unprognostic (3.84e-2)" "unprognostic (8.98e-3)" 56.6 74.4 52.4 121.6 51.0 204.2 122.6 51.6 64.3 116.8 53.9 127.2 122.4 79.5 189.3 125.8 101.1 73.5 39.5 52.1 65.8 115.5 101.7 73.1 220.9 55.8 54.1 47.2 73.6 92.9 133.2 74.4 112.5 54.3 94.0 137.5 247.6 97.9 75.9 16.4 83.2 134.7 65.9 56.8 101.8 114.2 65.3 55.3 240.9 118.3 26.5 297.3 115.3 74.4 61.1 517.7 135.9 450.3 316.3 74.5 131.1 299.7 266.6 191.8 261.0 233.0 262.6 420.6 1161.6 246.8 223.7 309.8 106.5 317.4 377.9 336.1 459.5 317.7 883.6 225.7 355.8 187.0 768.2 291.3 167.4 349.9 260.2 350.6 222.4 363.6 513.6 680.2 191.6 436.7 686.7 780.2 691.0 798.0 682.3 237.8 853.2 224.7 466.0 469.5 308.3 386.3 362.2 582.8 364.1 356.0 183.1 479.5 807.5 239.6 127.2 128.7 94.0 279.7 235.6 394.8 690.7 179.4 882.9 341.4 103.7 76.4 282.5 138.0 68.9 153.5 228.9 175.2 143.7 216.5 205.8 195.2 172.2 53.8 174.5 67.7 294.9 221.5 231.4 52.4 51.0 51.6 64.3 52.1 65.8 55.8 54.1 47.2 54.3 56.8 55.3 61.1 169.9 93.0 139.7 55.2 420.4 278.5 532.0 674.9 233.9 265.1 650.7 412.6 56.1 307.4 349.0 285.1 331.5 599.2 405.1 306.8 737.6 479.9 642.8 304.4 287.3 223.3 345.2 275.6 34.9 350.5 970.7 196.6 221.7 309.2 219.9 277.8 135.7 176.2 533.9 240.6 55.1 442.1 514.7 176.1 389.6 180.6 175.8 279.6 243.7 45.0 415.1 427.8 358.4 96.5 68.8 381.0 307.4 200.1 335.9 684.7 327.8 625.4 226.8 1301.8 32.9 122.0 179.5 81.9 149.1 399.7 313.7 602.1 326.1 289.2 537.1 699.9 MUC19 FLJ35746 ENSG00000205592 "Mucin 19, oligomeric" 12 40393395-40570832 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "salivary gland: 13.2;testis: 5.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.1;Excitatory neurons: 1.3;Microglial cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.4;HL-60: 2.0;SCLC-21H: 4.9;SK-BR-3: 2.2;SuSa: 1.8;U-937: 8.7" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (7.80e-3)" "unprognostic (2.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.53e-1)" "unprognostic (4.25e-3)" "unprognostic (8.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (8.63e-2)" "unprognostic (6.99e-2)" "unprognostic (8.64e-3)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-1)" "unprognostic (7.35e-3)" 0.0 0.0 0.1 0.0 0.2 1.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.2 0.1 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327012 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 42.1;Late spermatids: 58.7;monocytes: 39.4;Respiratory ciliated cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 6.9;RPMI-8226: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.41e-4)" "prognostic favorable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.3 3.9 11.4 2.4 10.0 1.0 3.4 7.3 14.5 5.6 7.0 3.4 1.1 5.3 2.6 2.5 13.5 3.3 1.5 9.7 8.6 7.4 1.8 4.7 2.9 8.1 8.4 10.8 4.0 5.5 2.7 13.7 1.0 8.8 5.5 1.0 4.3 3.7 3.6 0.7 2.6 3.9 1.7 6.4 4.5 3.4 6.8 7.5 0.8 6.7 0.6 1.7 2.7 3.5 7.7 0.5 1.8 3.9 4.3 1.0 3.7 0.0 0.8 1.9 0.5 0.3 0.1 2.8 6.9 1.7 1.9 0.2 3.4 0.1 0.1 0.2 1.7 1.0 1.2 3.5 0.2 0.9 0.2 3.0 3.1 4.2 0.1 0.6 3.8 0.8 0.1 1.5 1.2 0.9 3.0 0.0 0.6 0.3 2.0 0.2 1.0 0.0 10.0 4.9 1.6 1.7 3.1 2.1 2.7 0.3 0.2 4.3 1.0 0.9 0.7 0.6 0.6 0.1 1.0 0.2 1.0 1.7 0.8 0.8 0.2 0.8 0.0 0.1 1.0 0.2 0.2 0.1 0.2 0.5 0.2 0.1 0.2 0.1 0.3 1.3 0.4 0.1 0.3 11.4 10.0 7.3 14.5 9.7 8.6 8.1 8.4 10.8 8.8 6.4 7.5 7.7 4.5 3.2 4.1 16.3 14.9 1.1 3.6 6.1 5.7 6.2 5.4 5.8 1.3 11.5 8.3 5.5 22.9 0.3 9.5 3.9 3.9 6.5 24.7 42.1 4.6 5.7 10.2 4.4 20.3 1.8 0.6 4.2 9.2 5.7 5.7 2.8 4.2 1.0 13.7 1.7 13.7 3.3 4.1 24.2 7.8 58.7 2.5 20.0 5.4 2.8 39.4 5.6 5.2 9.0 2.5 2.6 2.1 2.6 33.2 2.4 14.0 17.8 65.5 17.5 0.0 2.5 3.0 24.7 22.2 1.6 0.6 1.0 8.4 3.1 3.6 2.3 EIF3CL ENSG00000205609 "Eukaryotic translation initiation factor 3 subunit C like" B5ME19 16 28379579-28403841 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.0;Cardiomyocytes: 35.1;Club cells: 37.9;Respiratory ciliated cells: 38.2" "Group enriched" "Detected in some" 5 "glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA047097, HPA049495, HPA050112" Supported Approved Cytosol NA NA Cytosol "HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (1.22e-1)" "unprognostic (4.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.48e-3)" "unprognostic (1.98e-1)" "unprognostic (4.59e-2)" "unprognostic (1.75e-5)" "unprognostic (6.56e-2)" "unprognostic (1.64e-1)" "unprognostic (7.58e-2)" "unprognostic (1.48e-1)" "unprognostic (1.18e-3)" "unprognostic (3.59e-2)" "unprognostic (9.52e-2)" "unprognostic (1.41e-1)" "unprognostic (9.00e-3)" "unprognostic (3.58e-2)" 40.3 35.7 21.9 1.0 19.0 6.3 41.6 19.5 33.8 35.8 15.5 35.8 1.3 29.6 3.5 44.7 34.1 1.9 45.4 21.1 18.9 43.2 40.2 31.0 1.6 20.4 19.1 19.5 50.9 73.5 4.0 32.4 2.5 22.7 35.9 2.3 5.5 38.9 3.4 99.4 52.5 30.5 2.0 17.6 32.3 43.4 30.9 19.5 1.8 41.0 6.9 3.0 38.1 36.1 22.1 3.0 6.9 6.6 5.5 9.1 5.2 4.3 3.8 4.6 9.5 8.2 7.7 3.5 4.1 6.8 5.8 7.6 5.5 11.0 10.9 14.1 1.9 6.5 4.7 12.7 15.3 2.7 6.9 8.3 5.7 7.3 5.7 6.0 5.7 3.6 6.8 7.6 7.8 3.6 9.4 8.2 17.3 15.1 5.7 4.0 10.9 8.0 7.4 8.1 5.1 13.1 8.5 3.2 6.4 6.0 1.8 16.4 6.8 5.2 4.2 7.9 5.2 7.6 4.2 3.8 7.2 7.3 7.2 7.7 2.9 1.3 0.7 1.1 1.8 1.3 0.9 1.4 1.2 1.7 0.9 1.2 1.6 0.1 1.1 2.3 0.8 1.2 1.3 21.9 19.0 19.5 33.8 21.1 18.9 20.4 19.1 19.5 22.7 17.6 19.5 22.1 0.1 22.4 44.0 0.7 2.2 1.3 2.0 0.3 1.8 0.0 0.5 0.6 35.1 0.0 37.9 0.0 0.0 0.8 0.0 0.4 0.0 0.5 0.1 0.2 0.2 4.9 0.0 8.4 0.5 1.2 0.6 10.5 3.1 0.1 10.1 0.0 1.8 0.2 0.5 0.0 0.6 0.7 0.0 1.3 2.3 0.7 0.3 5.2 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.1 1.7 0.4 5.2 1.1 0.9 1.7 38.2 0.0 0.0 0.5 7.4 0.3 0.6 2.5 1.6 0.8 2.6 0.1 0.7 1.0 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111731-25178231 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041559: AB_2677548, HPA043530: AB_2678532" "unprognostic (9.08e-2)" "prognostic favorable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 17.2 27.5 41.5 13.4 44.2 20.1 22.7 42.0 44.9 23.3 37.3 22.2 16.9 21.4 31.4 23.0 20.7 13.7 33.4 44.8 44.6 27.1 11.0 15.1 16.9 41.2 40.9 43.4 28.4 47.6 32.2 33.2 24.3 42.5 21.0 21.5 22.0 21.4 21.5 52.7 28.3 17.2 18.6 38.4 16.3 22.7 35.7 43.4 21.5 18.8 36.6 20.4 18.3 20.8 45.3 40.3 36.3 33.9 47.2 30.2 42.9 34.9 24.7 40.5 35.7 45.9 46.4 35.7 24.4 34.1 37.6 44.2 20.1 35.9 34.3 47.9 24.9 53.3 13.5 35.4 77.3 67.9 32.0 20.9 48.7 37.7 39.9 41.4 51.3 32.3 54.0 21.5 31.2 39.5 102.3 37.9 60.6 52.1 25.3 37.0 44.3 30.9 47.7 40.7 27.9 55.5 34.1 29.0 45.8 58.2 39.9 46.0 14.9 19.1 34.6 24.3 23.4 25.0 39.8 43.9 25.8 42.3 27.5 26.6 33.4 36.5 46.2 39.4 33.5 43.3 42.0 47.8 42.1 35.0 31.6 42.8 39.2 14.6 33.6 37.6 18.1 82.9 42.2 41.5 44.2 42.0 44.9 44.8 44.6 41.2 40.9 43.4 42.5 38.4 43.4 45.3 21.0 16.0 19.8 15.3 23.5 24.1 31.1 55.6 33.6 25.7 39.3 42.0 34.8 15.7 29.6 33.1 2.1 164.5 20.9 60.5 49.0 51.7 76.5 22.7 31.4 22.7 51.4 29.5 29.0 66.7 69.4 29.1 20.9 20.2 9.5 197.7 23.2 9.5 46.8 23.5 30.1 46.9 38.7 33.9 20.0 137.5 26.1 27.0 33.8 17.8 31.3 32.0 32.0 28.1 31.7 46.7 45.1 24.0 28.9 34.6 79.4 90.0 30.0 26.1 26.3 22.9 67.7 67.3 52.9 35.6 31.8 163.8 29.6 78.7 43.7 34.7 MFSD2B ENSG00000205639 "Major facilitator superfamily domain containing 2B" A6NFX1 2 24010081-24063321 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "bone marrow: 11.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 25.1;Erythroid cells: 65.2;Prostatic glandular cells: 41.0;Urothelial cells: 30.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "basophil: 2.9" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.9" "Group enriched" "Detected in some" 14 "HEL: 8.3;K-562: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044145 Enhanced NA NA "HPA044145: AB_2678833" "unprognostic (5.67e-2)" "unprognostic (1.25e-3)" "unprognostic (1.84e-1)" "unprognostic (5.35e-5)" "unprognostic (2.82e-1)" "unprognostic (1.74e-1)" "unprognostic (4.26e-2)" "unprognostic (7.47e-2)" "unprognostic (2.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.21e-3)" "unprognostic (1.90e-2)" "unprognostic (6.87e-6)" "unprognostic (7.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.72e-1)" 0.0 0.0 0.2 0.0 0.4 11.9 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.3 0.2 0.4 0.5 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.1 0.2 0.3 0.1 0.0 1.3 0.3 1.6 10.1 25.1 0.7 0.0 0.9 0.3 0.3 4.6 1.5 0.5 0.0 4.2 6.9 0.2 0.9 3.9 5.0 0.6 0.1 0.3 1.7 1.2 65.2 0.3 1.8 4.4 1.6 0.0 0.3 5.1 0.3 0.4 0.0 3.1 0.0 0.5 2.9 2.0 1.4 5.9 0.8 0.0 4.5 0.0 1.0 0.6 0.1 0.0 0.0 0.3 10.6 2.3 0.0 0.2 41.0 3.1 0.2 0.0 1.5 0.0 1.1 0.7 0.9 2.1 0.0 11.2 7.5 1.1 0.0 5.5 30.3 VCX3B VCX-C ENSG00000205642 "Variable charge X-linked 3B" Q9H321 X 8464830-8466510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 64 "testis: 33.1" "Group enriched" "Detected in some" 8 "Spermatocytes: 902.7;Spermatogonia: 1055.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "U-138 MG: 18.6" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-2)" "unprognostic (2.07e-1)" "unprognostic (4.19e-3)" "unprognostic (4.41e-2)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (3.58e-2)" 0.0 0.2 0.3 0.0 0.3 0.0 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.0 0.0 0.3 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 33.1 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 18.6 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.3 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 75.7 0.1 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.7 0.2 0.0 0.0 0.0 0.0 54.4 8.1 1.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 111.7 0.0 0.1 902.7 1055.5 0.0 0.3 0.1 0.0 0.1 0.0 0.0 CDPF1 "C22orf40, LOC150383" ENSG00000205643 "Cysteine rich DPF motif domain containing 1" Q6NVV7 22 46244011-46250311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018823 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA018823: AB_1853018" "unprognostic (1.98e-2)" "unprognostic (5.06e-3)" "unprognostic (1.42e-2)" "prognostic favorable (3.13e-5)" "unprognostic (2.20e-1)" "unprognostic (1.51e-1)" "unprognostic (1.85e-3)" "unprognostic (1.83e-3)" "unprognostic (2.09e-1)" "unprognostic (2.56e-3)" "unprognostic (4.69e-3)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" 5.9 9.6 6.6 4.2 6.9 2.6 6.1 6.6 8.6 7.7 6.2 8.6 4.2 7.9 3.0 5.0 7.3 4.1 7.8 6.6 7.0 7.6 7.6 4.6 6.4 7.4 6.8 6.0 7.8 6.8 6.2 6.4 3.9 7.0 9.0 2.9 2.6 6.8 5.1 8.0 5.0 6.4 4.8 6.2 9.2 6.8 3.3 6.9 7.5 8.1 5.8 4.1 7.8 5.8 7.3 5.5 7.2 6.5 9.8 4.7 6.9 6.7 3.3 4.5 6.6 6.3 1.8 7.0 5.1 4.0 2.7 5.3 7.7 3.8 2.8 3.9 7.3 10.3 3.1 5.2 6.3 7.0 9.3 4.3 7.4 7.8 5.8 7.4 7.5 5.8 13.0 5.2 6.9 6.2 3.8 12.1 5.8 5.2 8.0 6.7 8.9 4.3 11.7 5.8 2.1 3.1 7.8 4.2 7.8 9.4 3.8 8.9 5.1 3.7 10.7 7.4 5.9 4.7 7.9 4.0 5.9 5.8 6.3 11.1 1.4 6.4 10.5 10.4 9.1 9.9 6.9 10.0 9.0 6.3 8.3 11.3 8.5 1.6 10.0 9.9 10.9 8.7 8.0 6.6 6.9 6.6 8.6 6.6 7.0 7.4 6.8 6.0 7.0 6.2 6.9 7.3 6.9 6.4 3.9 1.0 7.1 1.8 2.9 8.1 1.2 4.5 4.7 6.7 6.1 5.7 4.0 7.3 0.0 12.8 4.5 1.3 7.9 10.7 1.0 2.5 3.3 8.9 4.2 3.4 1.1 11.2 10.0 5.8 3.1 1.9 14.5 6.9 6.8 4.8 9.3 0.0 1.8 3.7 6.1 5.0 2.0 1.2 5.0 4.2 5.4 0.0 8.1 5.7 19.6 1.5 2.5 8.3 1.4 7.9 3.8 5.1 3.4 8.1 6.9 5.4 13.1 4.5 6.5 4.3 8.1 3.1 2.0 4.5 6.1 9.1 5.3 2.1 HTN3 HIS2 ENSG00000205649 "Histatin 3" P15516 4 70028455-70036538 "Predicted secreted proteins, Transporters" Biomineralization "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1102 "salivary gland: 137171.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;HL-60: 1.7" CAB073541 Enhanced "Secreted to digestive system" NA NA "CAB073541: " 0.0 0.1 0.5 0.3 1.5 19.1 0.1 3.2 2.7 0.0 0.0 2.4 0.3 0.2 0.4 0.2 0.1 0.1 26.4 1.2 0.2 0.1 0.1 0.2 0.3 0.5 0.3 0.5 26.2 124.4 0.1 1.8 13.2 1.5 0.2 3.1 0.7 137171.1 0.1 0.1 10.0 0.1 0.2 0.0 0.2 0.3 0.5 0.1 0.0 0.2 0.0 0.1 0.1 0.0 2.4 0.4 0.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.5 0.6 0.2 0.0 0.2 0.2 0.0 0.1 0.0 1.6 0.2 0.1 0.3 0.1 0.0 1.7 1.1 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.7 0.2 0.2 0.4 0.9 0.4 0.1 0.4 1.0 0.2 0.1 0.1 0.1 0.6 0.4 0.4 0.2 0.3 0.3 0.7 0.4 0.0 0.3 0.6 0.4 0.3 0.5 0.9 0.2 0.3 0.5 0.8 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.5 1.5 3.2 2.7 1.2 0.2 0.5 0.3 0.5 1.5 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIN52 C14orf46 ENSG00000205659 "Lin-52 DREAM MuvB core complex component" Q52LA3 14 74084796-74201235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.5;Inhibitory neurons: 65.4;Oligodendrocyte precursor cells: 60.3;Oligodendrocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000900, HPA001777" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000900: AB_2135058, HPA001777: AB_2666431" "unprognostic (2.34e-2)" "unprognostic (6.51e-3)" "unprognostic (1.86e-1)" "unprognostic (1.94e-1)" "unprognostic (7.90e-3)" "prognostic favorable (6.60e-4)" "prognostic unfavorable (6.08e-5)" "unprognostic (2.48e-3)" "unprognostic (9.34e-2)" "unprognostic (8.65e-2)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (1.74e-3)" "unprognostic (1.20e-2)" "unprognostic (8.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.04e-1)" 8.1 7.9 8.2 5.5 8.3 3.5 6.4 8.6 10.2 5.8 7.8 4.5 6.6 7.1 5.7 5.0 5.5 4.9 10.3 8.2 9.4 19.5 6.7 5.0 6.1 9.0 8.6 8.5 8.6 3.5 6.8 5.8 5.0 9.1 6.5 5.7 10.8 3.9 5.7 5.6 3.8 5.8 6.8 7.6 5.2 4.4 7.6 8.7 10.8 5.2 10.1 6.3 5.9 3.9 9.3 10.5 7.7 26.8 12.8 15.5 6.6 10.5 17.5 16.7 23.0 25.7 14.0 9.6 5.9 5.3 8.6 9.2 9.2 20.4 6.9 35.1 49.1 8.1 9.1 8.9 20.0 16.6 9.4 12.7 8.2 7.7 12.2 15.9 6.3 11.0 18.6 9.7 27.8 11.4 13.4 14.9 12.3 7.7 13.8 12.3 19.0 25.1 9.6 6.0 6.2 19.0 15.5 16.4 12.0 13.7 9.9 16.3 13.5 6.3 10.8 20.3 11.5 14.8 18.2 41.8 13.2 12.5 10.7 18.4 6.2 6.4 20.6 10.7 6.6 16.6 8.7 9.3 10.7 8.6 9.4 13.7 12.5 3.2 11.4 4.8 7.9 13.9 10.1 8.2 8.3 8.6 10.2 8.2 9.4 9.0 8.6 8.5 9.1 7.6 8.7 9.3 5.6 9.6 9.0 39.8 10.4 4.8 3.2 3.2 11.4 8.8 7.6 5.3 10.0 10.0 6.6 5.5 8.4 6.3 8.8 3.5 7.9 3.1 0.8 5.9 6.6 7.4 3.0 16.4 47.5 2.4 5.2 8.1 6.1 6.7 2.5 9.0 6.4 12.2 6.3 16.8 65.4 6.0 4.1 4.3 3.7 1.6 5.3 4.5 0.0 26.2 6.6 10.8 10.3 60.3 60.4 2.4 5.0 9.8 27.3 3.3 10.9 22.4 6.2 7.5 6.6 8.1 6.4 16.3 10.4 10.3 5.5 8.8 8.2 3.7 4.7 1.4 ARSH ENSG00000205667 "Arylsulfatase family member H" Q5FYA8 X 3006546-3034111 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.43e-1)" "unprognostic (1.95e-1)" "unprognostic (2.01e-2)" "unprognostic (8.90e-2)" "unprognostic (6.79e-2)" "unprognostic (2.56e-2)" "unprognostic (1.83e-1)" "unprognostic (8.56e-4)" "unprognostic (3.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.63e-1)" "unprognostic (2.65e-2)" "unprognostic (6.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ACOT6 C14orf42 ENSG00000205669 "Acyl-CoA thioesterase 6" Q3I5F7 14 73610945-73619888 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;kidney: 3.7;liver: 3.1;skeletal muscle: 4.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2.3;Excitatory neurons: 2.7;Hepatocytes: 3.4;Inhibitory neurons: 2.8;Proximal tubular cells: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "T-47d: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058258 Uncertain NA NA "HPA058258: AB_2683656" "unprognostic (1.88e-1)" "unprognostic (1.77e-1)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.15e-2)" "unprognostic (6.52e-2)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (2.28e-1)" "unprognostic (5.04e-1)" 1.8 0.6 1.0 0.1 0.9 0.0 0.1 5.0 2.6 0.0 1.7 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.9 1.3 0.7 3.7 3.1 0.1 0.1 0.8 0.6 0.5 0.5 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.2 0.0 4.0 0.0 0.1 0.0 0.2 0.2 0.0 0.6 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 1.8 0.1 0.0 10.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 5.0 2.6 1.3 0.7 0.8 0.6 0.5 1.9 0.2 0.5 0.9 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM11A "C21orf51, FAM165B, SMIM11" ENSG00000205670 "Small integral membrane protein 11A" P58511 21 34375480-34416961 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 12.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051321 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA051321: AB_2681440" "unprognostic (2.62e-2)" "unprognostic (4.28e-2)" "unprognostic (1.27e-1)" "unprognostic (5.86e-3)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.04e-1)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" "unprognostic (8.84e-2)" "unprognostic (4.83e-3)" 10.3 9.0 22.2 12.2 22.7 13.2 6.7 22.3 32.8 10.4 25.9 7.6 15.0 9.8 14.6 9.4 9.3 13.7 22.1 22.0 22.5 17.9 14.7 8.2 15.9 23.0 22.2 21.3 16.9 11.7 11.3 3.7 5.9 23.6 10.6 6.6 13.4 14.4 4.8 36.3 6.3 11.8 11.4 24.0 11.5 30.8 6.4 22.7 6.7 20.8 11.5 6.5 12.9 2.7 25.9 24.7 9.8 11.1 33.0 21.0 6.5 22.6 9.0 4.3 12.5 25.1 12.7 22.7 57.4 11.8 11.6 16.5 15.1 18.8 0.7 11.9 32.0 8.9 33.1 23.0 12.7 19.0 55.6 7.8 15.5 10.8 13.6 31.1 24.5 14.2 12.1 51.4 65.7 13.2 13.2 2.2 43.5 52.2 15.5 34.5 31.1 25.2 82.5 10.8 6.2 28.3 20.4 14.8 18.5 39.0 20.3 18.2 25.1 18.1 18.1 13.4 8.0 16.9 25.1 28.3 54.0 33.6 70.0 33.0 5.6 6.3 14.9 6.9 10.1 11.4 6.5 11.7 16.8 8.5 17.1 8.5 11.4 3.6 14.4 9.2 7.6 14.1 9.5 22.2 22.7 22.3 32.8 22.0 22.5 23.0 22.2 21.3 23.6 24.0 22.7 25.9 0.1 3.2 2.6 0.0 0.4 0.0 0.4 0.0 0.0 0.8 0.8 0.3 0.0 0.0 0.6 0.0 0.0 0.3 0.1 0.3 1.9 1.5 0.4 0.1 0.4 0.7 1.2 0.0 0.0 0.7 0.3 0.7 12.8 0.2 0.0 0.2 0.7 1.4 0.7 0.0 0.0 0.8 0.0 0.6 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.9 0.3 0.4 0.6 0.3 1.4 2.2 2.2 0.4 0.0 0.3 0.3 0.6 0.5 0.0 0.0 0.1 0.4 0.1 0.6 0.1 TECRL "DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL" ENSG00000205678 "Trans-2,3-enoyl-CoA reductase like" Q5HYJ1 4 64275257-64409468 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "heart muscle: 559.4" "Cell type enriched" "Detected in some" 35 "Cardiomyocytes: 1775.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.3 0.1 0.1 0.3 1.0 0.6 0.8 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.1 559.4 0.1 0.5 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.4 1.7 0.0 0.5 0.3 0.0 56.8 1.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.7 2.0 0.0 0.3 0.0 1.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.4 0.1 0.5 0.2 0.2 0.0 0.4 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1775.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.2 0.0 0.0 50.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;retina: 18.1;skeletal muscle: 26.7" "Cell type enhanced" "Detected in many" "Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4" "Region enhanced" "Detected in all" "cerebellum: 49.5" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA066790: AB_2685724, HPA070601: AB_2686284" "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.3 1.4 3.4 0.6 6.2 2.7 0.4 31.6 5.6 0.3 0.0 1.8 0.2 0.2 0.0 0.6 0.3 0.3 14.4 10.5 4.0 1.4 3.1 0.2 0.8 10.7 7.3 2.0 13.8 0.3 5.2 0.6 0.3 13.7 0.1 1.5 18.1 0.4 0.2 26.7 0.5 1.3 0.5 4.1 1.0 0.5 3.5 6.6 0.3 0.4 9.2 1.0 0.2 0.2 7.9 2.1 0.0 1.6 0.1 0.2 2.9 17.7 5.4 5.1 12.2 4.7 0.1 0.2 0.2 0.3 1.7 0.2 0.1 1.7 0.8 7.4 0.3 0.6 31.5 0.2 0.0 0.5 0.2 0.5 0.7 0.3 2.8 2.0 2.0 4.0 3.4 2.8 12.4 3.9 0.1 2.7 0.3 0.0 0.0 1.8 6.9 0.8 0.4 2.1 0.0 1.2 0.7 0.0 0.1 0.0 0.5 0.0 0.0 8.7 6.0 0.0 2.2 0.6 4.3 1.2 0.4 0.5 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 6.2 31.6 5.6 10.5 4.0 10.7 7.3 2.0 13.7 4.1 6.6 7.9 0.8 0.0 0.0 104.5 6.0 0.6 0.1 0.0 0.0 10.5 1.1 0.9 38.4 1.5 0.0 0.0 108.4 2.6 2.6 7.5 1.9 0.1 58.5 0.1 0.8 2.9 0.0 8.6 17.7 0.4 1.3 2.8 0.0 0.1 4.5 43.2 1.1 4.4 0.4 6.7 21.7 3.4 0.0 0.8 0.7 34.3 0.3 1.7 0.0 8.4 0.1 8.6 2.1 123.1 115.7 0.7 5.1 4.9 2.6 0.1 2.7 10.7 0.0 85.5 0.0 2.6 3.5 4.5 1.2 0.3 0.3 0.1 3.8 14.5 7.4 0.0 MANSC4 ENSG00000205693 "MANSC domain containing 4" A6NHS7 12 27762427-27780236 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 2.1;Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039454, HPA039682" Uncertain NA NA "HPA039454: AB_2676515, HPA039682: AB_10805483" "unprognostic (1.13e-1)" "unprognostic (4.74e-2)" "unprognostic (2.34e-2)" "unprognostic (2.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-4)" "unprognostic (1.96e-1)" "unprognostic (2.49e-2)" "unprognostic (2.87e-3)" "unprognostic (2.50e-3)" "unprognostic (7.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.10e-2)" 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.4 0.0 0.2 0.5 0.3 0.1 0.1 0.2 0.2 0.0 0.7 0.5 0.4 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 1.5 0.3 0.1 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.7 0.4 0.2 0.3 0.3 0.1 0.1 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 LINC00634 ENSG00000205704 "Long intergenic non-protein coding RNA 634" 22 41952174-41958933 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "brain: 33.5;choroid plexus: 12.4" "Group enriched" "Detected in some" 35 "Astrocytes: 5.2;Excitatory neurons: 4.0;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.6" "Cancer enriched" "Detected in single" 13 "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 2.9;SCLC-21H: 2.7" HPA029815 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA029815: AB_10601803" "unprognostic (1.42e-1)" "unprognostic (8.80e-4)" "unprognostic (3.93e-4)" "unprognostic (9.78e-2)" "unprognostic (2.94e-2)" "unprognostic (1.53e-1)" "unprognostic (1.72e-4)" "unprognostic (6.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.10e-2)" "unprognostic (1.17e-2)" "unprognostic (6.00e-2)" "unprognostic (1.11e-6)" "unprognostic (5.40e-2)" "unprognostic (5.76e-2)" "unprognostic (2.99e-1)" "unprognostic (3.17e-1)" 0.0 2.2 28.7 0.0 27.2 0.1 0.0 17.9 33.5 0.0 12.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.1 22.9 0.0 0.0 0.0 0.0 21.1 24.5 27.9 0.0 0.0 0.0 0.0 26.8 0.1 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 16.6 0.0 0.2 1.0 32.0 0.0 0.0 0.0 0.1 0.0 23.3 0.3 0.0 1.3 1.3 0.0 0.7 0.8 0.0 0.0 0.2 0.3 0.4 1.0 2.4 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.9 2.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.6 0.6 0.0 0.0 2.5 0.1 1.5 0.0 0.6 1.0 1.4 0.3 0.3 2.0 2.9 0.5 0.1 0.0 0.1 2.7 1.8 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.2 1.1 0.0 0.3 0.8 1.7 2.4 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 27.2 17.9 33.5 30.1 22.9 21.1 24.5 27.9 26.8 16.6 32.0 23.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETFRF1 LYRM5 ENSG00000205707 "Electron transfer flavoprotein regulatory factor 1" Q6IPR1 12 25195216-25209645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 305.2;Proximal tubular cells: 183.8;Theca cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044255 Approved NA NA "HPA044255: AB_10967895" "prognostic favorable (9.63e-4)" "unprognostic (1.30e-1)" "unprognostic (2.01e-1)" "unprognostic (9.17e-2)" "unprognostic (5.96e-2)" "unprognostic (1.70e-1)" "unprognostic (3.57e-3)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (2.49e-2)" "unprognostic (3.41e-2)" "prognostic favorable (9.23e-5)" "unprognostic (1.55e-1)" "unprognostic (4.04e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-3)" 28.5 46.7 52.3 13.6 56.5 13.1 35.4 57.4 70.4 25.9 48.8 18.0 33.7 19.8 35.9 22.7 18.5 22.7 53.6 51.9 55.8 56.4 122.3 21.9 18.0 58.8 56.4 50.5 20.8 24.3 37.5 15.2 17.7 57.8 26.7 19.6 30.7 30.6 20.8 89.9 24.4 24.1 18.4 57.2 18.4 30.6 56.8 55.0 19.1 43.6 102.4 16.7 18.2 12.1 65.9 13.4 12.6 16.8 11.1 25.4 40.4 12.1 14.7 21.4 15.1 17.4 6.0 15.0 4.3 10.2 23.4 9.6 9.4 14.2 14.9 17.0 15.9 12.1 21.5 13.8 7.9 27.3 19.4 12.1 26.1 48.9 13.8 23.5 46.5 23.9 23.9 25.5 13.5 24.1 14.1 16.9 50.1 26.8 29.6 16.1 11.2 19.8 26.2 40.8 10.4 17.3 12.2 13.4 14.1 40.2 42.5 21.7 27.1 14.0 6.0 8.1 33.1 9.2 16.6 10.9 16.6 26.2 15.2 18.7 24.9 8.5 7.8 8.5 9.5 12.1 21.3 15.2 11.6 8.9 16.8 27.7 22.6 15.6 17.1 6.2 13.3 7.7 12.3 52.3 56.5 57.4 70.4 51.9 55.8 58.8 56.4 50.5 57.8 57.2 55.0 65.9 38.0 19.2 24.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 39.1 48.8 0.0 0.0 9.3 27.6 0.0 56.2 11.9 0.0 305.2 31.0 0.0 36.8 17.0 13.8 0.0 0.0 0.0 45.8 19.2 12.1 0.0 36.1 11.4 14.2 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 3.0 0.0 0.0 183.8 4.4 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 65.5 9.0 69.1 0.0 0.0 C17orf107 ENSG00000205710 "Chromosome 17 open reading frame 107" Q6ZR85 17 4899418-4902934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.2" "Cell type enriched" "Detected in many" 5 "Late spermatids: 288.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "neutrophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.6;HMC-1: 3.2;hTCEpi: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA069713 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069713: AB_2686181" "prognostic favorable (5.06e-5)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "unprognostic (1.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-3)" "unprognostic (9.61e-2)" "unprognostic (5.03e-2)" "unprognostic (4.15e-1)" "unprognostic (2.05e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.29e-2)" "unprognostic (2.65e-1)" "unprognostic (2.71e-1)" "unprognostic (3.12e-1)" 1.4 1.8 0.8 1.1 1.0 2.1 2.0 7.4 3.7 2.0 0.0 0.9 1.0 1.5 3.4 1.1 1.8 1.5 8.8 1.7 2.5 2.1 5.7 2.0 0.5 1.3 0.6 1.1 4.2 5.0 3.6 27.2 0.6 1.5 3.4 0.4 1.7 13.3 2.0 0.5 3.3 1.0 0.4 0.0 2.0 3.3 4.6 1.2 0.3 1.3 0.0 0.6 1.0 1.6 1.5 0.3 0.4 0.5 0.1 1.0 0.8 0.7 1.9 0.2 0.1 0.3 0.3 0.3 0.2 0.3 2.6 0.0 0.7 0.0 0.2 0.1 0.0 0.4 0.8 0.4 0.4 1.4 0.0 3.2 0.8 3.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.9 0.4 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.2 1.0 0.1 0.2 0.3 0.5 0.2 0.1 0.3 0.2 0.2 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 0.0 0.0 0.1 0.8 1.0 7.4 3.7 1.7 2.5 1.3 0.6 1.1 1.5 0.0 1.2 1.5 1.7 0.0 1.3 1.6 9.7 1.8 2.8 0.4 6.8 1.2 3.5 1.7 14.4 0.0 1.1 0.0 0.0 0.4 4.5 0.1 1.9 0.4 53.3 0.8 0.4 1.5 0.0 0.0 0.7 1.3 2.3 2.3 2.0 1.2 11.4 0.9 0.4 3.1 1.0 5.0 0.8 1.5 2.0 1.9 10.7 288.4 1.5 6.3 1.8 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.0 1.2 8.1 2.3 0.2 1.9 0.6 0.8 0.0 0.5 2.0 1.5 1.2 1.2 1.3 5.2 4.0 1.1 0.2 1.1 MBD3L4 ENSG00000205718 "Methyl-CpG binding domain protein 3 like 4" A6NDZ8 19 7037748-7040179 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITSN1 "ITSN, MGC134948, MGC134949, SH3D1A, SH3P17" ENSG00000205726 "Intersectin 1" Q15811 21 33642400-33899861 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 217.4;Inhibitory neurons: 151.9;Rod photoreceptor cells: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 5.5;non-classical monocyte: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 115.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018007 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA018007: AB_1851836" "unprognostic (2.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (3.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" "unprognostic (3.94e-2)" "unprognostic (7.33e-3)" "unprognostic (1.31e-2)" "unprognostic (3.23e-1)" "unprognostic (3.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.78e-3)" "unprognostic (2.37e-1)" "unprognostic (6.02e-2)" "unprognostic (5.64e-2)" 56.0 15.6 18.5 10.0 19.0 6.8 28.1 15.9 27.2 19.2 20.7 13.4 9.0 20.4 12.1 11.5 16.9 20.0 16.9 19.2 15.0 11.0 26.6 11.6 6.9 16.1 13.9 14.3 19.8 5.0 7.1 6.8 24.6 16.2 14.6 11.1 28.7 8.0 22.6 22.3 12.0 9.8 18.6 8.7 15.5 11.2 12.4 16.4 5.1 10.3 22.2 3.9 15.5 13.5 14.8 36.3 14.9 70.4 23.4 32.3 30.8 115.3 35.8 34.4 20.6 19.8 56.7 27.0 8.5 28.3 43.1 42.7 13.7 42.2 24.9 22.0 3.5 18.6 10.3 30.9 26.7 24.4 7.4 9.9 30.5 22.0 38.6 21.2 23.5 55.3 9.8 13.7 5.8 33.4 8.2 10.3 9.8 104.5 12.6 11.3 13.2 33.7 17.6 30.9 14.7 13.2 14.4 51.4 10.6 12.6 44.6 13.0 7.2 50.2 22.9 30.9 18.1 12.5 7.0 20.8 7.9 20.8 22.9 26.0 0.0 4.2 5.5 0.3 3.2 0.3 0.0 0.5 0.1 1.3 0.0 0.2 0.1 0.2 0.1 5.1 0.3 0.0 0.8 18.5 19.0 15.9 27.2 19.2 15.0 16.1 13.9 14.3 16.2 8.7 16.4 14.8 19.8 25.6 18.6 217.4 1.8 18.1 22.6 10.8 36.5 73.1 12.2 8.1 81.8 18.6 14.5 11.0 91.8 20.8 1.1 22.4 0.0 19.9 10.2 13.3 67.7 21.3 9.1 47.4 110.9 12.5 28.0 31.9 19.4 21.0 2.5 30.7 28.2 54.2 55.6 65.6 151.9 7.2 20.3 30.0 10.9 8.6 24.8 27.3 10.6 74.0 10.8 46.9 0.0 80.4 46.4 37.1 10.3 71.5 3.1 18.3 16.8 16.6 18.8 146.2 13.1 20.1 39.7 32.4 47.7 8.9 11.8 15.6 2.7 21.4 10.5 27.2 ITPRIPL2 "FLJ22994, LOC162073, MGC126798, MGC126800" ENSG00000205730 "ITPRIP like 2" Q3MIP1 16 19113932-19121629 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042011 Approved Centrosome NA NA Centrosome "HPA042011: AB_2677795" "unprognostic (1.07e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (9.64e-2)" "unprognostic (1.97e-1)" "unprognostic (2.20e-1)" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (5.60e-2)" "unprognostic (1.90e-2)" "unprognostic (5.26e-3)" "unprognostic (4.24e-2)" "unprognostic (1.53e-1)" "unprognostic (7.23e-2)" "unprognostic (6.37e-2)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" 16.7 7.5 4.8 9.4 4.6 1.6 8.8 4.7 4.8 10.5 6.2 8.1 6.9 8.4 5.3 11.7 6.4 9.4 6.6 4.1 5.7 5.4 5.7 11.7 4.2 6.1 5.5 3.3 9.6 8.7 7.6 2.7 12.2 6.0 9.1 6.7 0.5 5.6 9.4 6.9 21.8 6.1 9.0 5.8 5.9 10.1 2.5 6.5 1.6 5.2 7.4 5.1 11.7 8.1 6.4 17.3 10.1 4.3 13.7 36.0 54.3 23.0 28.0 20.9 8.4 7.8 4.6 31.9 0.0 25.9 23.7 9.6 19.3 6.0 8.9 11.2 0.1 5.9 1.5 23.2 7.8 23.3 0.2 0.2 36.3 24.9 16.4 18.7 15.3 11.3 0.1 2.6 0.2 20.5 12.8 0.1 0.6 4.1 4.0 12.3 0.0 0.6 0.1 12.9 31.5 0.3 5.0 23.2 2.4 14.3 6.9 13.3 3.0 21.8 28.7 10.8 14.3 10.7 0.1 0.1 0.1 16.3 0.6 14.1 0.6 1.2 0.1 0.2 1.5 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.4 0.3 0.0 0.2 4.8 4.6 4.7 4.8 4.1 5.7 6.1 5.5 3.3 6.0 5.8 6.5 6.4 38.0 51.3 37.7 13.1 3.3 12.7 25.0 20.0 26.7 0.5 18.8 12.6 7.1 11.5 31.1 25.8 2.1 16.6 3.6 22.0 1.9 15.4 0.4 18.5 76.6 37.5 14.4 4.0 1.1 31.6 10.5 36.7 25.5 27.9 5.7 12.0 35.7 26.9 22.3 5.0 1.6 19.3 26.4 57.8 23.2 1.7 26.8 28.8 14.2 22.5 40.6 2.0 1.0 6.6 0.2 41.6 12.7 30.1 10.0 36.0 8.3 0.2 23.4 0.4 39.5 54.4 36.4 0.2 1.8 23.1 17.3 14.4 4.9 18.9 18.9 35.9 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 21.4;intestine: 14.5;lymphoid tissue: 35.4" "Cell type enhanced" "Detected in many" "B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.0 1.0 1.2 21.5 1.2 21.4 1.0 1.3 1.7 0.8 1.7 2.4 4.9 0.9 0.0 1.9 1.3 2.8 1.1 1.2 2.0 1.6 2.1 5.8 32.4 2.1 1.4 0.8 0.3 1.3 0.1 0.8 1.9 1.7 1.7 1.2 0.0 3.0 0.5 0.8 1.4 14.5 1.3 1.7 35.4 5.3 0.4 2.2 20.7 1.7 0.3 15.0 3.0 1.3 2.2 0.2 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 22.5 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.0 0.0 15.1 0.0 1.6 0.0 7.5 44.7 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.3 9.4 0.1 0.0 14.7 11.5 0.0 0.5 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 13.8 0.1 0.0 0.0 0.0 0.0 0.4 2.0 10.6 0.1 31.3 0.0 18.3 19.9 32.8 40.1 32.4 35.0 23.8 28.6 35.0 19.5 18.7 35.7 32.1 27.8 23.8 35.0 11.2 35.6 37.1 1.2 1.2 1.3 1.7 1.2 2.0 2.1 1.4 0.8 1.7 1.7 2.2 2.2 0.3 3.2 3.0 0.0 27.5 0.4 0.1 0.0 1.2 0.0 0.6 0.6 1.3 2.8 0.0 1.8 0.0 0.2 30.1 0.5 1.9 0.4 0.7 1.5 0.2 0.4 0.0 5.7 0.4 0.0 0.2 0.7 1.5 0.3 15.9 0.5 1.1 0.7 14.6 0.0 0.5 0.9 0.0 11.6 9.2 0.6 0.0 13.8 3.6 2.8 10.9 0.0 35.0 0.0 0.5 0.3 0.4 0.0 13.5 0.2 2.9 6.2 1.6 0.0 0.0 0.0 0.3 0.3 1.2 1.6 0.1 0.3 34.5 0.7 1.0 0.1 CRLF2 "CRL2, TSLPR" ENSG00000205755 "Cytokine receptor like factor 2" Q9HC73 X 1187549-1212723 "Cancer-related genes, Human disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8;gallbladder: 1.3;lymphoid tissue: 1.5" "Cell type enriched" "Detected in some" 4 "monocytes: 100.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.2" "Cell line enriched" "Detected in some" 4 "HMC-1: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (7.84e-2)" "unprognostic (7.99e-4)" "unprognostic (6.02e-3)" "unprognostic (2.01e-2)" "unprognostic (1.15e-3)" "unprognostic (2.31e-6)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "unprognostic (4.59e-3)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (9.72e-3)" "unprognostic (6.88e-5)" "unprognostic (7.09e-3)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.62e-1)" 0.2 0.0 0.0 1.5 0.0 1.8 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.1 0.5 0.6 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.5 0.8 0.1 0.3 2.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.9 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.3 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 1.8 0.0 1.0 100.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 CRYZL1 "4P11, QOH-1" ENSG00000205758 "Crystallin zeta like 1" O95825 21 33589341-33643926 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 139.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019120, HPA029399, CAB034129" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865" "unprognostic (1.54e-1)" "unprognostic (4.69e-2)" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.55e-1)" "unprognostic (9.19e-2)" "unprognostic (2.73e-1)" "unprognostic (2.57e-3)" "unprognostic (2.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-2)" "unprognostic (8.16e-3)" "unprognostic (1.59e-1)" "unprognostic (1.28e-3)" 22.6 18.8 24.9 16.5 27.8 22.6 21.3 32.7 33.7 18.6 23.9 24.5 15.2 22.8 19.2 19.0 20.4 16.4 20.2 26.1 25.7 23.7 18.1 16.3 17.9 25.9 27.1 25.4 22.2 15.3 22.5 14.3 21.8 26.8 18.4 20.5 29.5 18.1 22.5 19.4 23.1 16.0 21.4 24.0 15.7 17.8 34.3 26.1 18.3 24.7 15.6 14.1 21.2 18.1 35.4 38.0 16.4 45.7 33.8 24.3 35.0 24.0 26.3 37.8 33.0 29.1 24.5 29.0 26.4 23.0 32.5 25.6 20.5 24.6 27.2 30.0 24.6 24.8 49.9 35.5 22.2 38.4 31.0 29.8 32.7 23.4 34.9 27.2 43.1 42.4 42.6 36.8 26.6 31.3 19.3 30.2 31.8 32.3 38.8 21.9 28.5 36.8 36.6 47.1 33.7 19.8 31.2 34.6 17.5 39.7 37.8 34.3 23.1 44.8 26.3 25.3 22.0 20.5 43.4 64.7 29.1 34.4 22.7 30.1 36.1 34.5 36.2 31.7 37.5 34.3 38.2 33.4 29.9 43.3 40.4 43.3 35.3 18.3 47.1 35.6 34.3 29.9 26.8 24.9 27.8 32.7 33.7 26.1 25.7 25.9 27.1 25.4 26.8 24.0 26.1 35.4 25.6 32.1 17.3 40.1 25.9 23.6 43.9 58.9 19.9 47.8 22.1 25.1 28.0 31.5 36.0 31.3 31.3 70.4 21.3 20.2 49.0 37.6 90.4 19.6 14.4 29.9 21.0 25.4 42.4 29.1 40.5 28.1 13.3 14.4 65.2 34.5 27.5 15.0 33.5 47.1 47.2 22.5 46.8 26.0 25.7 28.0 44.1 24.6 37.4 26.2 36.1 49.4 41.2 32.2 56.7 28.6 30.3 41.0 11.3 23.3 33.7 44.8 35.0 51.1 19.7 23.7 41.5 139.4 19.4 15.9 21.5 44.6 28.4 27.3 29.4 40.5 C5orf51 LOC285636 ENSG00000205765 "Chromosome 5 open reading frame 51" A6NDU8 5 41904188-41921636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 34.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043779, HPA063816" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043779: AB_2678666, HPA063816: AB_2685130" "unprognostic (6.64e-2)" "unprognostic (2.24e-2)" "unprognostic (9.92e-2)" "unprognostic (6.92e-3)" "unprognostic (3.93e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (4.98e-2)" "unprognostic (1.59e-1)" "unprognostic (4.90e-3)" "unprognostic (2.10e-2)" "unprognostic (4.58e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-1)" "unprognostic (3.75e-1)" "unprognostic (2.30e-2)" "unprognostic (1.67e-2)" 11.1 8.8 11.4 9.9 14.1 2.7 11.6 13.5 14.4 10.0 8.0 7.7 7.8 10.3 15.5 10.9 8.0 8.9 9.7 11.2 13.3 11.0 10.5 8.0 10.6 13.2 13.5 10.6 15.6 8.9 15.4 5.1 13.0 13.6 11.6 9.1 15.8 9.0 10.6 4.6 9.2 7.9 12.3 13.6 9.9 7.6 7.1 13.7 16.0 13.9 7.5 10.7 10.6 7.5 17.7 14.8 11.2 22.3 46.9 44.7 35.0 24.3 17.1 29.6 23.7 25.2 11.3 14.9 15.9 20.7 19.2 41.3 9.4 29.8 16.2 34.2 21.4 9.1 15.4 33.0 17.0 54.0 19.8 11.2 34.2 23.0 27.9 31.9 15.1 20.8 19.0 27.8 26.5 25.4 15.5 18.7 20.2 22.4 9.0 6.0 16.2 31.0 24.7 15.9 14.1 13.5 21.2 54.9 25.9 29.0 19.9 28.9 20.0 15.1 28.0 16.7 21.5 16.8 13.3 23.2 15.7 31.2 34.1 20.4 34.3 8.0 7.8 4.9 6.2 6.4 5.6 5.7 5.4 7.8 5.8 7.6 5.2 5.3 6.5 9.2 4.5 4.4 9.8 11.4 14.1 13.5 14.4 11.2 13.3 13.2 13.5 10.6 13.6 13.6 13.7 17.7 13.3 32.1 11.5 12.7 16.6 9.9 8.7 10.4 21.6 11.5 13.9 12.4 14.5 8.6 9.5 14.7 6.2 12.5 10.4 7.1 9.8 12.0 13.1 8.1 14.4 11.9 10.8 14.1 11.8 7.6 12.4 19.2 11.2 10.0 5.1 10.3 10.4 20.2 15.0 8.4 13.8 9.1 6.1 17.6 7.9 11.8 9.0 13.0 7.2 4.7 13.8 18.6 10.3 16.6 20.9 8.1 7.3 7.9 11.0 11.6 5.7 12.8 9.6 11.2 13.1 12.8 16.5 9.0 8.3 30.1 13.2 16.8 10.6 9.0 7.1 9.9 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" P0DTW1 X 49599025-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 9.1" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 113.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AN3-CA: 739.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 739.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 24.4 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARRDC5 ENSG00000205784 "Arrestin domain containing 5" A6NEK1 19 4890437-4902896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 17.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 292.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 18 "REH: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.85e-2)" "unprognostic (3.83e-5)" "unprognostic (2.53e-1)" "unprognostic (7.22e-5)" "unprognostic (1.70e-1)" "unprognostic (7.16e-5)" "unprognostic (1.65e-2)" "unprognostic (1.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.03e-2)" "unprognostic (8.76e-2)" "unprognostic (6.45e-2)" "unprognostic (7.18e-8)" "unprognostic (1.76e-1)" "unprognostic (3.07e-1)" "unprognostic (1.95e-1)" "unprognostic (3.79e-2)" 0.1 0.1 0.4 0.6 0.3 1.6 0.1 0.2 0.6 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.4 0.4 0.1 0.1 0.5 1.7 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.3 2.1 0.2 17.1 0.5 1.6 0.1 0.0 0.6 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 1.1 0.3 0.6 1.0 0.2 0.8 0.5 0.7 1.0 1.1 0.0 0.6 0.1 1.4 0.5 0.3 0.4 0.3 0.2 0.6 0.4 0.4 0.6 0.4 0.1 1.0 0.3 0.5 0.8 0.0 0.0 0.0 0.3 2.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 8.4 0.1 0.0 0.0 292.2 0.3 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.3 1.0 0.0 0.4 0.0 0.0 3.5 0.6 61.0 1.2 2.2 0.0 13.1 3.0 0.0 15.5 0.0 0.3 0.1 0.0 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 5.9 1.0 0.0 0.1 0.0 4.1 0.0 0.0 0.4 CYS1 ENSG00000205795 "Cystin 1" Q717R9 2 10056780-10080944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 106.5;pancreas: 33.9" "Group enriched" "Detected in many" 4 "Cholangiocytes: 32.9;Collecting duct cells: 51.5;Distal tubular cells: 70.5;Muller glia cells: 48.0;Proximal tubular cells: 54.1" "Cancer enhanced" "Detected in many" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "RPTEC TERT1: 111.5" "Low region specificity" "Detected in all" NA NA "unprognostic (8.48e-2)" "unprognostic (8.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.00e-2)" "unprognostic (2.80e-1)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (1.94e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-2)" "unprognostic (7.03e-2)" "prognostic favorable (1.27e-5)" "unprognostic (2.19e-3)" "unprognostic (1.47e-1)" "unprognostic (8.93e-2)" "unprognostic (1.20e-2)" 3.0 1.6 5.8 1.2 5.4 0.0 2.0 5.0 7.9 8.4 13.3 8.8 2.5 7.9 3.6 4.0 6.3 9.2 5.9 5.3 5.2 106.5 1.1 6.1 1.1 6.5 5.4 5.2 12.5 33.9 1.8 7.2 0.1 4.8 4.9 1.8 2.2 3.0 7.2 1.0 1.2 3.4 6.0 6.1 2.9 3.9 1.0 5.0 0.5 5.6 2.1 2.1 3.5 6.7 5.5 0.0 0.3 0.0 0.0 0.5 2.6 0.1 0.4 1.6 0.2 0.1 0.2 0.0 0.0 0.4 4.4 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 111.5 0.0 0.0 0.5 0.4 0.3 0.0 1.3 2.0 0.2 0.0 6.0 3.2 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.4 5.0 7.9 5.3 5.2 6.5 5.4 5.2 4.8 6.1 5.0 5.5 0.9 6.4 1.1 1.0 1.0 0.5 0.1 0.6 0.0 10.3 0.5 5.5 7.3 32.9 0.0 51.5 0.0 0.0 0.2 0.0 70.5 7.0 0.1 0.3 0.9 0.6 0.0 0.0 2.9 1.1 0.6 8.8 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.3 0.0 3.4 1.0 0.0 2.8 0.0 48.0 0.0 3.0 0.6 0.4 0.0 4.5 0.1 0.3 0.0 54.1 0.0 1.9 0.0 0.5 3.9 0.0 1.4 0.0 0.1 0.0 0.3 0.1 0.0 0.1 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662294-4665258 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 82.2;Late spermatids: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "HDLM-2: 99.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 3.5 6.6 6.7 6.2 4.5 1.5 7.3 7.8 4.6 5.0 8.1 9.4 10.6 4.0 12.8 7.5 3.3 4.6 2.8 5.1 4.3 5.5 19.0 3.4 8.3 4.3 4.8 4.4 4.1 17.3 7.7 4.8 7.1 4.7 16.5 10.0 5.1 7.8 4.9 1.9 8.2 11.5 3.4 4.7 6.0 11.4 5.9 4.3 6.2 7.1 1.5 8.5 5.3 5.1 4.7 8.2 8.3 8.8 10.9 6.9 7.7 8.8 5.5 7.1 4.4 5.0 2.2 5.3 7.9 2.2 5.5 10.9 10.0 6.2 7.8 4.6 99.2 5.9 15.7 8.7 11.3 6.3 5.7 11.4 8.5 6.2 3.4 7.5 5.8 6.6 8.8 2.7 8.1 5.6 8.8 5.4 15.0 8.1 8.2 2.9 5.3 0.0 6.1 7.6 9.3 22.0 11.1 6.5 5.8 3.5 10.8 8.2 12.7 7.8 3.9 3.3 5.3 3.6 1.7 6.4 2.0 6.1 4.1 3.7 6.8 4.1 3.5 3.1 3.7 3.6 2.6 5.6 4.8 4.2 3.3 9.6 6.9 1.8 4.2 4.4 3.2 8.6 4.1 6.7 4.5 7.8 4.6 5.1 4.3 4.3 4.8 4.4 4.7 4.7 4.3 4.7 2.8 6.4 2.7 0.0 2.6 0.0 2.5 0.0 2.8 7.5 4.2 2.7 0.0 5.7 1.3 1.8 2.1 18.6 2.9 9.7 1.9 11.0 82.2 2.1 3.4 3.0 10.9 2.1 0.0 13.9 2.9 2.3 7.1 5.3 0.0 4.1 4.2 15.3 6.5 3.3 0.0 7.3 0.0 4.7 0.0 46.3 2.8 1.7 0.0 0.0 3.0 4.6 3.1 0.0 0.0 10.8 6.5 4.9 1.5 7.5 13.4 2.8 0.0 4.9 0.0 1.7 1.8 0.5 1.1 4.6 0.0 10.4 3.4 3.5 5.1 3.1 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;lymphoid tissue: 5.9" "Group enriched" "Detected in some" 6 "dendritic cells: 111.5;Oligodendrocyte precursor cells: 32.6;T-cells: 49.9" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 24.6;NK-cell: 84.5" "Group enriched" "Detected in many" 103 "NK-cells: 84.5;T-cells: 24.6" "Cell line enhanced" "Detected in some" "GAMG: 19.1;HEL: 5.8;HeLa: 17.5;HSkMC: 4.1" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.4 0.1 4.5 0.4 4.8 2.2 0.8 4.2 7.5 0.3 3.5 1.3 0.7 0.9 0.0 0.5 0.5 1.1 0.1 4.4 4.7 0.1 0.8 1.0 1.1 5.0 4.8 4.3 1.0 0.2 0.0 0.1 0.4 5.1 0.3 0.9 0.3 0.3 0.2 0.0 0.1 1.1 0.0 4.7 5.9 2.3 0.4 4.6 0.3 0.3 0.0 1.3 0.4 0.3 6.0 0.0 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 19.1 0.0 0.0 2.2 0.0 0.0 0.0 5.8 17.5 0.3 0.0 0.6 0.0 4.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.1 1.2 0.1 0.4 0.0 0.0 0.0 0.0 0.6 2.8 0.1 0.1 0.0 0.0 0.0 24.6 0.0 0.6 0.0 0.0 11.0 0.0 0.0 0.1 9.2 0.5 84.5 0.1 0.0 0.0 4.6 4.5 4.8 4.2 7.5 4.4 4.7 5.0 4.8 4.3 5.1 4.7 4.6 6.0 0.5 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 0.3 1.2 0.0 0.6 0.0 0.0 0.0 111.5 0.2 0.0 0.2 0.0 0.1 0.1 0.1 9.6 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 9.2 32.6 0.2 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 49.9 1.7 0.3 0.2 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412315-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0" "Group enriched" "Detected in some" 4 "dendritic cells: 19.2;Oligodendrocyte precursor cells: 36.2;T-cells: 15.9" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 6 "NK-cell: 63.1" "Lineage enriched" "Detected in many" 6 "NK-cells: 63.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.4;GAMG: 2.8;HEL: 1.3;HeLa: 7.0;HSkMC: 1.2;SuSa: 1.3;U-698: 1.9" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.2 0.1 1.2 0.3 1.5 1.9 0.1 0.7 2.1 0.1 0.2 0.5 0.8 0.5 0.1 0.2 0.2 0.6 0.0 1.2 1.5 0.0 0.5 0.6 1.8 1.7 1.5 1.1 0.1 0.1 0.0 0.0 0.1 1.3 0.1 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.1 1.1 4.0 0.6 0.2 1.4 0.4 0.1 0.0 0.8 0.1 0.1 2.1 0.0 0.0 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.0 0.0 1.3 7.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.0 0.0 7.0 0.0 0.0 0.1 8.7 0.6 63.1 0.0 0.0 0.0 3.6 1.2 1.5 0.7 2.1 1.2 1.5 1.7 1.5 1.1 1.3 1.1 1.4 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 0.1 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 1.0 36.2 2.3 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.1 C16orf96 ENSG00000205832 "Chromosome 16 open reading frame 96" A6NNT2 16 4556490-4600714 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 10.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 15.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "REH: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.94e-3)" "unprognostic (1.55e-1)" "unprognostic (3.57e-4)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (5.21e-3)" "unprognostic (1.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (1.36e-2)" "unprognostic (1.06e-5)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.22e-1)" "unprognostic (9.23e-2)" "unprognostic (4.24e-4)" "unprognostic (2.66e-1)" 0.0 0.1 0.4 0.0 0.6 0.1 0.0 0.5 0.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.1 0.3 0.1 0.0 0.7 0.5 0.2 0.1 0.4 0.0 0.2 0.0 0.6 0.1 0.0 0.4 0.1 0.1 0.1 0.3 0.1 0.0 0.5 0.1 0.0 10.6 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.5 0.5 0.3 0.5 0.7 0.5 0.2 0.6 0.5 0.5 0.6 0.1 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 3.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.5 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GMNC GEMC1 ENSG00000205835 "Geminin coiled-coil domain containing" A6NCL1 3 190852737-190892429 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 8.1;liver: 4.2" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Endometrial ciliated cells: 5.9;Hepatocytes: 6.1;Proximal tubular cells: 11.5;Respiratory ciliated cells: 4.4" "Cancer enriched" "Detected in some" 5 "ovarian cancer: 4.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 45 "SCLC-21H: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA043663 Uncertain NA NA "HPA043663: AB_10959313" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (5.45e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.22e-3)" "unprognostic (2.73e-2)" "unprognostic (2.55e-3)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.4 0.2 0.2 2.3 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.3 2.2 1.9 4.2 0.0 0.0 0.5 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.4 0.2 0.3 2.2 0.5 0.9 0.1 0.5 1.0 0.7 2.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 14.6 5.9 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.5 4.4 0.2 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TTC23L FLJ25439 ENSG00000205838 "Tetratricopeptide repeat domain 23 like" Q6PF05 5 34838833-34899456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 24.9" "Group enriched" "Detected in some" 12 "Early spermatids: 373.9;Late spermatids: 218.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037807 Enhanced NA NA "HPA037807: AB_10672466" "unprognostic (7.87e-2)" "unprognostic (6.80e-3)" "unprognostic (1.36e-1)" "unprognostic (1.78e-3)" "unprognostic (8.92e-3)" "unprognostic (9.89e-3)" "unprognostic (3.48e-2)" "unprognostic (9.93e-4)" "unprognostic (1.36e-1)" "unprognostic (2.20e-2)" "unprognostic (2.30e-3)" "unprognostic (1.30e-1)" "unprognostic (3.06e-3)" "unprognostic (4.16e-1)" "unprognostic (9.90e-2)" "unprognostic (2.53e-3)" "unprognostic (4.69e-4)" 0.0 0.9 2.3 0.1 1.4 0.0 0.7 1.1 1.0 0.4 2.8 0.0 0.0 0.4 0.7 0.0 3.7 0.2 0.1 0.6 2.2 0.3 0.1 0.3 0.2 1.8 1.9 0.2 0.1 0.7 0.8 0.9 0.1 1.6 0.2 0.0 1.2 0.4 0.6 0.0 0.7 0.1 0.1 2.4 0.0 0.2 24.9 1.3 0.2 0.5 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.4 1.1 1.0 0.6 2.2 1.8 1.9 0.2 1.6 2.4 1.3 2.0 0.0 0.0 1.1 14.7 0.0 0.0 0.2 0.5 0.0 0.0 5.4 0.5 0.4 0.0 2.7 0.0 10.4 0.2 0.1 0.0 0.0 0.1 373.9 8.1 0.3 0.4 0.0 0.0 13.1 0.0 0.1 0.4 0.0 0.3 1.3 0.1 0.0 0.0 0.1 0.0 11.9 0.0 0.0 0.0 0.0 218.7 3.1 0.0 0.0 1.9 0.0 0.7 0.0 4.5 15.3 0.0 0.0 3.0 0.0 0.0 0.0 0.1 23.3 0.5 0.0 0.1 0.1 11.0 2.0 0.0 0.0 0.4 0.0 0.3 0.1 0.1 CLEC6A "CLECSF10, dectin-2" ENSG00000205846 "C-type lectin domain containing 6A" Q6EIG7 12 8455962-8478330 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 1.0;lymphoid tissue: 1.1" "Cell type enhanced" "Detected in single" "monocytes: 1.5" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 2.2" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;monocytes: 5.4" "Cell line enriched" "Detected in single" 4 "NTERA-2: 3.4" "Not detected" "Not detected" NA NA "unprognostic (1.44e-1)" "unprognostic (9.07e-3)" "unprognostic (5.32e-3)" "unprognostic (1.27e-2)" "unprognostic (2.54e-1)" "unprognostic (4.27e-4)" "unprognostic (6.06e-2)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (7.30e-4)" "unprognostic (8.89e-2)" "unprognostic (3.29e-1)" "unprognostic (2.43e-1)" "unprognostic (2.60e-2)" 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C22orf42 ENSG00000205856 "Chromosome 22 open reading frame 42" Q6IC83 22 32149006-32159322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "brain: 9.1;testis: 10.6" "Group enriched" "Detected in some" 8 "Early spermatids: 95.7;Late spermatids: 31.3" "Group enriched" "Detected in some" 5 "pancreatic cancer: 0.8;prostate cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 2.4;hypothalamus: 6.5;midbrain: 2.5;pons: 2.9;thalamus: 9.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019531 Enhanced NA NA "HPA019531: AB_1853016" "unprognostic (5.67e-2)" "unprognostic (6.13e-3)" "unprognostic (8.21e-3)" "unprognostic (7.06e-2)" "unprognostic (4.54e-2)" 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.7 2.5 0.0 0.0 0.4 0.0 0.9 0.0 2.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 10.6 9.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.9 0.0 0.3 0.0 6.5 0.7 2.5 0.0 2.9 0.1 9.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.7 0.2 0.0 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NANOGNB ENSG00000205857 "NANOG neighbor homeobox" Q7Z5D8 12 7765216-7774121 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Cancer enriched" "Detected in single" 18 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060371 Uncertain NA NA "HPA060371: AB_2684266" "unprognostic (2.76e-1)" 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 LRRC72 "CFAP279, FAP279" ENSG00000205858 "Leucine rich repeat containing 72" A6NJI9 7 16526825-16581568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 2.6" "Group enriched" "Detected in some" 83 "Early spermatids: 114.1;Late spermatids: 36.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA020554 Uncertain NA NA "HPA020554: AB_1859508" "unprognostic (1.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 36.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QTNF9B CTRP9B ENSG00000205863 "C1q and TNF related 9B" B2RNN3 13 23891099-23897502 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1;skin 1: 18.0;testis: 8.9" "Cell type enhanced" "Detected in some" "Adipocytes: 4.3;Early spermatids: 2.3;Endothelial cells: 1.4;Late spermatids: 2.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Region enriched" "Detected in many" 4 "hippocampal formation: 8.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.8;OE19: 3.6" HPA056632 Uncertain "Secreted - unknown location" NA NA "HPA056632: AB_2683197" "unprognostic (3.43e-1)" "unprognostic (3.42e-1)" "unprognostic (2.18e-2)" "unprognostic (9.51e-2)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-3)" "unprognostic (1.52e-2)" "unprognostic (7.26e-2)" "unprognostic (3.01e-3)" "unprognostic (7.04e-2)" "unprognostic (5.56e-3)" "unprognostic (3.89e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" 1.2 0.7 1.2 0.6 1.2 0.2 0.4 0.5 1.3 0.3 0.5 0.4 0.5 0.7 0.0 1.7 0.3 0.8 3.5 8.1 1.8 0.2 0.1 0.4 0.2 0.5 0.9 0.6 0.4 0.6 0.1 1.1 0.6 0.5 4.3 0.1 0.7 1.6 0.2 4.1 18.0 0.2 0.7 0.5 1.3 0.8 8.9 1.4 0.0 0.5 2.0 0.0 0.6 0.1 1.0 0.7 1.7 0.6 0.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 1.0 0.1 0.0 0.0 1.3 1.7 0.0 0.0 0.0 1.0 1.4 0.3 0.9 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.8 0.0 4.8 0.4 0.9 0.0 1.1 0.2 0.0 1.1 3.6 1.6 0.6 0.8 1.3 0.0 0.0 2.0 0.0 1.0 0.0 1.7 0.4 0.5 0.2 0.1 1.6 0.4 0.0 1.0 1.4 0.2 0.7 1.9 0.6 0.3 0.0 0.2 0.4 0.3 0.3 0.1 0.2 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.4 0.4 0.7 0.0 0.1 1.2 1.2 0.5 1.3 8.1 1.8 0.5 0.9 0.6 0.5 0.5 1.4 1.0 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.0 0.3 0.0 0.0 0.4 0.0 0.0 KRTAP5-6 KRTAP5.6 ENSG00000205864 "Keratin associated protein 5-6" Q6L8G9 11 1697195-1697755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "liver: 3.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 21 "liver cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "prognostic favorable (6.04e-5)" "unprognostic (3.70e-1)" "unprognostic (2.93e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-2 "KRTAP5-8, KRTAP5.2" ENSG00000205867 "Keratin associated protein 5-2" Q701N4 11 1597177-1598294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.3;pancreas: 1.9;skin 1: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;SCLC-21H: 2.8;SH-SY5Y: 1.2" NA NA "unprognostic (6.31e-2)" 0.0 0.3 0.3 0.1 0.3 0.0 0.0 2.3 1.2 0.0 0.0 0.2 0.5 0.1 0.3 0.0 0.1 0.6 0.1 0.6 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.2 0.0 1.9 0.0 0.4 0.0 0.4 0.1 0.0 0.6 0.6 0.0 0.1 5.8 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.3 1.2 0.6 0.0 0.2 0.1 0.2 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.1 KRTAP5-1 "KRN1L, KRTAP5.1" ENSG00000205869 "Keratin associated protein 5-1" Q6L8H4 11 1584342-1585283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" NA NA "unprognostic (2.68e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.04e-1)" "unprognostic (8.08e-2)" "unprognostic (3.36e-3)" "unprognostic (2.41e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.71e-2)" "unprognostic (9.66e-2)" "unprognostic (2.75e-2)" "unprognostic (6.32e-3)" "unprognostic (3.88e-2)" "unprognostic (1.25e-1)" "unprognostic (2.71e-2)" "unprognostic (3.10e-1)" 0.2 0.1 0.4 0.0 0.1 0.0 0.5 2.1 0.6 0.5 0.0 1.2 0.0 0.6 0.0 0.1 0.9 0.0 1.9 0.6 0.0 1.3 0.4 1.3 0.0 0.3 0.0 0.0 0.1 2.3 0.0 4.7 0.0 0.2 0.7 0.0 0.4 1.9 0.0 0.6 1.9 0.8 0.0 0.0 0.6 0.8 0.4 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.1 0.6 0.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 DEFB134 ENSG00000205882 "Defensin beta 134" Q4QY38 8 11993174-11996312 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "epididymis: 13.1" "Group enriched" "Detected in some" 21 "Early spermatids: 48.3;Late spermatids: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "unprognostic (3.80e-2)" "unprognostic (2.20e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 0.0 13.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.8 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB135 ENSG00000205883 "Defensin beta 135" Q30KP9 8 11982321-11984590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 47 "epididymis: 35.1" "Group enriched" "Detected in some" 9 "Early spermatids: 2.8;Late spermatids: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.2" "Region enhanced" "Detected in single" "white matter: 1.5" "Secreted in male reproductive system" NA NA 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.6 0.7 0.0 0.4 0.0 0.0 0.0 35.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.6 0.7 0.4 0.3 0.4 0.2 0.3 0.4 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB136 DEFB137 ENSG00000205884 "Defensin beta 136" Q30KP8 8 11973937-11974599 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.2" "Cell type enhanced" "Detected in single" "Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA068255 Enhanced "Secreted in male reproductive system" NA NA "HPA068255: AB_2732780" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BHLHA9 BHLHF42 ENSG00000205899 "Basic helix-loop-helix family member a9" Q7RTU4 17 1270444-1271815 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "brain: 1.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (9.27e-2)" "unprognostic (2.63e-1)" "unprognostic (2.99e-1)" "unprognostic (7.74e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.6 0.5 0.2 1.0 0.3 0.1 1.4 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF316 "ENST00000305834, MZF-3" ENSG00000205903 "Zinc finger protein 316" A6NFI3 7 6637318-6658279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.74e-1)" "unprognostic (2.82e-3)" "unprognostic (9.69e-3)" "unprognostic (4.56e-2)" "unprognostic (7.06e-2)" "unprognostic (3.41e-1)" "unprognostic (7.22e-2)" "unprognostic (2.49e-2)" "unprognostic (2.30e-2)" "unprognostic (4.21e-3)" "prognostic favorable (6.03e-5)" "unprognostic (1.38e-2)" "unprognostic (8.60e-2)" "unprognostic (3.69e-2)" "unprognostic (2.26e-1)" "unprognostic (6.08e-2)" "unprognostic (1.43e-3)" 16.2 15.3 13.4 18.2 12.1 20.9 13.5 10.2 14.1 18.7 11.0 17.1 13.1 18.7 17.2 15.5 17.8 9.0 11.7 12.8 10.4 13.5 16.7 15.9 16.4 14.7 11.5 11.8 16.6 17.4 21.1 18.0 11.0 13.5 17.6 8.4 8.9 13.8 8.9 26.3 19.2 17.9 12.8 10.8 28.5 15.7 12.9 11.9 13.3 23.6 6.7 12.2 17.2 14.9 12.6 26.6 23.0 28.5 27.3 15.0 7.7 17.2 20.5 9.8 9.0 9.3 21.6 18.6 35.3 13.7 15.0 35.5 26.6 14.0 13.9 8.6 10.8 15.7 24.3 39.6 12.3 16.2 30.6 26.7 11.0 14.4 14.0 16.8 18.1 8.0 16.0 46.0 17.1 10.3 44.2 11.6 38.7 16.0 18.1 17.0 21.0 21.9 15.3 9.1 59.5 32.9 53.7 15.0 55.0 16.7 24.1 31.8 33.2 15.2 17.8 35.2 25.5 28.1 37.3 37.7 27.5 14.0 25.0 36.4 0.7 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.5 0.2 0.6 0.2 0.1 13.4 12.1 10.2 14.1 12.8 10.4 14.7 11.5 11.8 13.5 10.8 11.9 12.6 9.6 6.4 9.3 15.7 8.6 0.0 3.1 0.0 12.5 13.3 12.8 11.8 9.0 10.0 3.7 14.7 10.4 3.4 10.1 13.2 3.9 4.6 1.0 10.3 9.2 8.4 16.7 4.8 9.8 6.0 2.0 6.5 15.8 11.4 1.3 12.0 9.3 13.6 7.3 18.5 9.8 9.9 0.0 10.3 0.0 0.9 6.5 13.1 0.0 7.5 9.7 5.0 9.2 7.5 9.2 6.1 6.6 7.2 10.8 7.6 5.7 3.8 1.5 7.5 0.0 11.5 8.4 4.3 3.2 15.7 0.0 2.2 7.6 12.5 9.4 5.3 DAZ4 ENSG00000205916 "Deleted in azoospermia 4" Q86SG3 Y 24833843-24907040 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "stomach 1: 23.9;testis: 11.9" "Cell type enriched" "Detected in single" 40 "Gastric mucus-secreting cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 124 "U-266/70: 153.6;U-266/84: 153.1" HPA047113 Approved NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.9 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 153.6 153.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ONECUT3 ENSG00000205922 "One cut homeobox 3" O60422 19 1753506-1780988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 2.2;stomach 1: 4.4" "Group enriched" "Detected in some" 28 "Cardiomyocytes: 89.7;Horizontal cells: 312.9" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HaCaT: 8.1;OE19: 10.9;PC-3: 18.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059936 Supported Nucleoplasm NA NA Nucleoplasm "HPA059936: AB_2684172" "unprognostic (9.43e-2)" "unprognostic (1.36e-1)" "unprognostic (6.28e-2)" "unprognostic (1.36e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-2)" "unprognostic (2.21e-1)" "unprognostic (3.61e-3)" "unprognostic (2.02e-1)" "unprognostic (1.84e-1)" "unprognostic (3.87e-2)" "unprognostic (3.64e-1)" "unprognostic (3.08e-10)" "unprognostic (1.18e-1)" "unprognostic (9.86e-2)" "unprognostic (4.62e-1)" "unprognostic (1.21e-2)" 0.0 0.0 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 4.4 0.9 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 10.9 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.2 1.1 0.7 0.4 0.1 0.5 0.2 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 1.0 0.2 0.5 89.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.9 0.2 0.4 2.9 0.0 0.0 0.1 0.2 0.0 1.3 7.1 0.8 0.0 0.0 0.0 0.1 0.1 312.9 0.1 1.3 0.0 0.0 0.8 1.5 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 6.4 0.0 0.4 0.0 0.4 0.2 0.0 0.0 2.6 0.0 0.4 2.1 3.2 2.9 0.0 0.3 0.0 0.2 0.0 0.2 0.5 CEMP1 CP-23 ENSG00000205923 "Cementum protein 1" Q6PRD7 16 2530035-2531417 "Metabolic proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Early spermatids: 2.9;granulocytes: 1.3;Late spermatids: 8.3;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 7 "basophil: 1.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HEK 293: 6.6;REH: 4.2;T-47d: 3.5;U-937: 3.6" "HPA057658, HPA075926" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057658: AB_2683492, HPA075926: " 7.3 14.5 0.8 1.0 1.0 0.2 6.8 0.1 0.8 7.1 0.6 8.1 0.2 5.8 0.0 7.2 4.3 1.5 5.0 0.8 0.3 19.1 11.3 6.3 3.5 0.9 0.6 0.6 5.8 5.4 0.3 7.0 0.1 0.7 8.3 0.0 0.6 7.4 0.4 3.4 6.9 11.0 0.0 0.4 16.6 6.5 4.2 0.8 0.1 8.1 0.0 0.0 7.0 6.1 0.5 0.0 0.0 0.7 4.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.2 6.6 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.6 1.0 0.0 0.0 0.9 0.0 1.5 0.5 1.2 4.2 0.2 0.0 0.0 1.5 2.2 1.2 0.6 3.1 1.0 0.2 3.5 0.6 0.2 1.1 0.5 1.2 0.9 0.0 1.4 1.5 0.8 3.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1.0 0.1 0.8 0.8 0.3 0.9 0.6 0.6 0.7 0.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025935-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 153 "brain: 91.3;choroid plexus: 26.6" "Group enriched" "Detected in some" 22 "Oligodendrocyte precursor cells: 124.1;Oligodendrocytes: 39.9" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "eosinophil: 19.0" "Lineage enriched" "Detected in single" 190 "granulocytes: 19.0" "Cell line enhanced" "Detected in some" "HMC-1: 56.2;NB-4: 41.8;THP-1: 35.9;WM-115: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 0.0 0.0 48.6 0.0 58.8 0.1 0.0 55.7 54.2 0.0 26.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 49.9 56.1 0.0 0.0 0.0 0.0 60.7 58.7 45.2 0.0 0.0 0.0 0.1 0.0 65.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 51.5 0.0 0.1 0.0 55.6 0.0 0.0 0.2 0.0 0.0 0.0 91.3 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.5 0.0 0.0 0.0 1.1 8.2 0.0 0.0 0.0 1.7 56.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 41.8 3.6 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 35.9 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 1.4 0.0 11.7 2.8 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.6 58.8 55.7 54.2 49.9 56.1 60.7 58.7 45.2 65.8 51.5 55.6 91.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 124.1 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 C21orf62 "B37, C21orf120, PRED81" ENSG00000205929 "Chromosome 21 open reading frame 62" Q9NYP8 21 32790673-32813743 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "choroid plexus: 16.6;epididymis: 8.5;ovary: 14.3" "Group enriched" "Detected in many" 4 "Cholangiocytes: 44.3;Distal tubular cells: 23.5;Skeletal myocytes: 26.2" "Cancer enriched" "Detected in some" 6 "glioma: 11.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 3.8;RPTEC TERT1: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016899 Enhanced "Secreted - unknown location" NA NA "HPA016899: AB_1845704" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (1.23e-1)" "unprognostic (4.37e-3)" "unprognostic (9.56e-2)" "unprognostic (3.05e-3)" "unprognostic (2.95e-2)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" 0.7 0.3 3.8 0.4 2.0 0.6 0.1 2.2 1.9 0.0 16.6 0.1 0.1 0.0 8.5 0.2 0.7 0.4 0.2 2.4 6.2 7.0 0.2 0.1 0.2 3.2 4.6 1.2 14.3 4.2 0.0 3.4 0.0 3.0 3.6 0.0 1.0 0.1 0.2 0.1 0.2 0.4 0.2 2.2 0.2 0.3 0.3 4.2 0.0 0.1 0.1 1.1 0.0 0.1 6.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.7 0.2 0.0 0.1 0.3 0.0 3.8 2.0 2.2 1.9 2.4 6.2 3.2 4.6 1.2 3.0 2.2 4.2 6.0 0.0 0.0 0.0 2.9 0.5 0.9 0.8 0.4 0.0 5.9 0.0 0.0 0.2 44.3 0.3 5.5 6.2 1.2 1.3 0.1 23.5 0.2 1.5 0.0 0.0 0.8 3.0 0.0 0.8 0.0 0.4 3.6 0.0 0.0 0.0 0.2 2.5 0.2 0.3 0.0 1.4 0.0 0.0 1.3 1.9 0.3 4.1 0.4 3.6 0.0 1.0 5.8 4.1 4.0 4.7 0.0 0.0 1.9 0.0 0.5 0.1 2.6 0.2 7.1 0.0 26.2 1.7 1.0 1.0 0.0 1.0 0.3 1.1 0.2 0.2 0.4 RNPS1 ENSG00000205937 "RNA binding protein with serine rich domain 1" Q15287 16 2253116-2268397 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044014 Approved Supported Nucleoplasm NA NA 13000 Nucleoplasm "HPA044014: AB_10966286" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (3.46e-1)" "unprognostic (1.49e-3)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.96e-1)" "unprognostic (2.76e-1)" "unprognostic (1.15e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (7.13e-3)" "unprognostic (2.38e-1)" "unprognostic (4.64e-2)" "unprognostic (2.27e-1)" 82.7 79.4 87.5 55.6 96.9 146.1 84.2 82.8 113.6 88.3 61.1 99.4 51.8 99.6 51.5 98.8 85.3 40.3 94.4 96.5 90.4 75.5 64.4 74.2 77.1 95.8 87.2 95.4 93.4 72.4 52.9 102.2 54.0 98.0 95.8 44.3 47.8 70.5 55.4 231.6 96.3 84.7 52.8 72.1 95.7 77.4 89.1 89.9 70.4 74.8 106.2 71.9 94.9 84.3 94.4 119.6 154.5 167.7 163.9 89.0 78.6 194.2 125.2 88.4 170.6 147.0 306.1 142.8 251.1 124.0 103.2 108.6 160.0 217.3 152.5 128.9 175.2 283.2 172.8 133.9 198.3 150.2 185.5 159.0 99.3 168.3 149.1 207.1 80.8 134.8 144.6 302.1 195.3 143.3 259.7 296.2 363.6 340.1 135.2 128.4 441.4 196.6 322.3 122.5 66.6 354.8 218.3 172.3 157.6 166.4 77.1 152.7 187.7 102.2 155.4 155.2 143.0 182.1 199.7 282.5 582.9 63.3 168.0 185.6 48.1 144.0 123.2 169.5 170.5 167.7 177.9 162.2 172.9 153.8 205.5 153.3 162.0 43.4 182.9 187.8 131.6 196.1 290.2 87.5 96.9 82.8 113.6 96.5 90.4 95.8 87.2 95.4 98.0 72.1 89.9 94.4 90.6 44.8 62.7 29.7 148.2 206.6 208.7 148.9 119.5 119.7 99.5 95.9 36.3 65.8 85.5 51.5 139.7 182.3 138.5 90.8 70.5 115.5 16.3 76.5 88.9 102.1 122.0 130.4 72.1 93.2 237.4 90.7 79.0 108.4 103.4 114.9 77.1 37.5 104.7 97.6 61.1 100.6 124.1 71.3 117.0 21.4 94.1 80.1 97.8 23.4 123.9 98.0 180.2 31.7 37.3 121.7 76.5 68.8 117.2 209.5 81.1 64.3 50.2 132.8 85.5 103.9 102.3 132.9 267.4 117.6 212.4 162.0 131.7 101.7 125.7 203.5 DAZ2 "MGC126442, pDP1678" ENSG00000205944 "Deleted in azoospermia 2" Q13117 Y 23219434-23291356 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "stomach 1: 14.4;testis: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-MEL-30: 1.8" HPA047113 Approved NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 14.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24399003-24419283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 18.2;Squamous epithelial cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HEL: 14.7;HUVEC TERT2: 35.6;RT4: 29.8;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 7.9 3.7 4.0 3.1 3.6 0.4 6.4 15.2 4.6 16.4 5.2 7.6 4.1 11.6 28.3 11.7 17.1 8.7 7.0 2.9 7.3 4.2 4.5 8.2 1.9 4.7 4.9 3.1 35.4 3.9 5.8 5.8 12.9 7.4 7.5 5.6 1.8 7.5 15.0 3.8 12.6 5.4 10.6 3.3 4.4 6.1 5.2 6.4 4.5 7.8 4.3 2.9 9.6 14.2 7.4 0.2 0.1 4.6 0.0 6.3 13.0 0.3 2.2 2.3 1.5 1.6 3.3 14.4 0.4 0.6 8.6 0.2 0.0 7.5 0.2 1.5 0.0 0.8 14.7 2.0 0.3 4.7 0.0 0.0 13.3 0.6 1.0 0.0 2.6 35.6 0.1 2.4 0.0 0.2 0.6 0.0 0.8 2.7 1.0 0.0 1.9 0.0 0.0 0.0 29.8 0.6 10.0 0.0 1.3 0.2 11.2 2.5 2.1 17.4 0.1 8.2 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.0 3.6 15.2 4.6 2.9 7.3 4.7 4.9 3.1 7.4 3.3 6.4 7.4 15.2 3.2 1.7 4.9 0.1 4.6 3.9 9.5 15.4 0.5 1.8 3.6 3.1 8.6 15.6 9.2 0.0 1.1 1.6 2.7 0.0 4.1 0.8 1.4 10.8 15.0 5.4 3.6 1.0 3.0 1.0 10.1 10.7 1.7 0.0 12.0 18.2 2.7 10.7 0.0 3.9 9.0 4.1 9.0 1.4 0.2 2.5 1.4 3.6 3.7 0.7 5.4 0.0 0.5 0.1 4.8 5.1 0.4 1.2 1.2 1.0 0.3 10.8 0.2 0.0 1.2 7.3 0.3 1.2 18.0 3.8 1.1 0.3 1.5 8.8 4.5 DNAJC19 "Pam18, Tim14, TIMM14" ENSG00000205981 "DnaJ heat shock protein family (Hsp40) member C19" Q96DA6 3 180983709-180989774 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone Cardiomyopathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 471.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037782 Approved NA NA "HPA037782: AB_10672611" "unprognostic (4.52e-2)" "unprognostic (3.55e-3)" "unprognostic (3.08e-2)" "unprognostic (2.45e-3)" "unprognostic (1.41e-1)" "unprognostic (5.54e-2)" "unprognostic (1.39e-1)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "prognostic favorable (8.53e-5)" "unprognostic (6.19e-2)" "unprognostic (1.76e-2)" "unprognostic (2.14e-2)" "unprognostic (1.75e-1)" "unprognostic (4.66e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-3)" 21.6 44.4 27.6 11.2 28.3 10.9 26.7 28.7 40.1 19.5 29.4 24.7 21.6 19.1 33.3 23.1 21.4 11.9 59.7 28.3 29.4 50.6 49.3 14.8 16.5 28.4 28.3 28.0 26.8 28.2 35.0 31.2 14.3 27.8 22.7 17.8 27.4 28.3 18.4 66.4 14.1 18.3 11.9 27.9 18.6 26.4 11.7 28.2 20.9 25.8 78.5 13.5 23.7 18.6 29.6 53.9 14.0 38.8 29.6 45.6 27.0 35.4 30.2 18.2 29.1 25.5 49.0 26.2 23.0 63.9 25.5 70.9 26.8 37.8 36.5 35.9 36.5 49.1 27.0 24.5 48.3 48.9 64.9 27.5 25.9 29.8 24.4 43.0 37.9 34.0 55.2 42.8 35.8 23.0 44.2 48.5 54.6 51.2 75.9 44.8 31.4 26.9 69.6 43.3 24.8 38.7 20.6 30.8 75.8 82.3 44.0 85.2 45.2 16.8 18.5 27.1 26.3 54.4 47.7 60.7 80.1 19.0 49.9 22.9 33.6 20.4 31.5 33.3 22.3 39.8 34.7 38.5 34.7 28.6 29.8 39.8 40.6 4.4 26.8 27.3 36.4 35.0 30.8 27.6 28.3 28.7 40.1 28.3 29.4 28.4 28.3 28.0 27.8 27.9 28.2 29.6 68.3 38.5 52.5 11.1 66.3 56.6 68.6 105.4 56.9 31.7 138.6 183.0 151.7 120.1 70.1 77.3 14.6 116.6 67.4 57.9 471.6 83.9 9.1 57.4 50.4 61.4 45.2 48.8 18.7 109.3 111.2 71.7 30.1 42.7 110.7 79.7 68.6 167.0 68.0 48.8 20.5 90.7 91.6 35.5 59.8 13.2 85.1 42.8 74.7 9.4 58.6 91.4 74.2 13.0 21.4 79.9 66.1 72.6 47.7 91.5 101.0 216.8 58.7 67.6 85.5 80.3 108.8 82.1 56.3 73.9 60.1 68.7 68.4 121.4 86.7 69.2 IFITM5 "BRIL, DSPA1, fragilis4, Hrmp1" ENSG00000206013 "Interferon induced transmembrane protein 5" A6NNB3 11 298200-299526 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Mineral balance" "Developmental protein" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 4.3;pancreas: 7.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 7 "cerebral cortex: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039258 Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA039258: AB_10673608" "unprognostic (9.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (7.46e-2)" "unprognostic (4.20e-2)" "unprognostic (4.42e-2)" "unprognostic (8.31e-2)" "unprognostic (7.99e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (4.90e-2)" 0.1 0.0 0.0 0.1 0.0 0.7 0.2 0.0 4.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.1 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM21 C18orf62 ENSG00000206026 "Small integral membrane protein 21" Q3B7S5 18 75409476-75427703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 2.8" "Group enriched" "Detected in some" 67 "Early spermatids: 73.8;Late spermatids: 48.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.1" HPA041686 Enhanced NA NA "HPA041686: AB_10961179" "unprognostic (7.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C18orf63 DKFZP781G0119 ENSG00000206043 "Chromosome 18 open reading frame 63" Q68DL7 18 74315839-74359189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 9.9" "Cell type enriched" "Detected in some" 10 "Spermatocytes: 83.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042233 Approved Mitochondria NA NA Mitochondria "HPA042233: AB_10960843" "unprognostic (1.40e-1)" "unprognostic (1.43e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.7 7.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 DEFA1 "DEF1, DEFA2, HNP-1, MRS" ENSG00000206047 "Defensin alpha 1" P59665 8 6977649-6980080 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "bone marrow: 18189.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "NB-4: 2.1" "CAB032548, HPA052517" Enhanced "Secreted to blood" NA NA "CAB032548: AB_2277258, HPA052517: AB_2681860" 25.4 4.4 0.6 0.6 0.7 18189.6 16.9 0.6 3.0 2.7 0.7 3.7 0.0 11.4 0.0 3.3 2.2 1.4 49.1 0.4 0.5 14.6 92.3 565.5 3.6 0.6 1.1 0.4 4.1 5.5 0.1 20.8 11.5 0.6 2.8 0.0 0.3 14.6 0.0 17.0 40.6 2.4 0.0 0.7 1818.1 6.5 3.1 0.9 37.4 16.0 0.0 0.8 3.5 5.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.6 3.0 0.4 0.5 0.6 1.1 0.4 0.6 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DOK6 "DOK5L, HsT3226, MGC20785" ENSG00000206052 "Docking protein 6" Q6PKX4 18 69400888-69849087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.9;parathyroid gland: 12.6;retina: 22.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 230.4;Excitatory neurons: 236.8;Inhibitory neurons: 259.1;Oligodendrocyte precursor cells: 178.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.5;Hep G2: 11.1;RPMI-8226: 10.5;SCLC-21H: 4.7;SH-SY5Y: 10.5;SuSa: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041099, HPA063534" Approved Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "HPA041099: AB_2677299, HPA063534: AB_2685032" "unprognostic (5.83e-2)" "unprognostic (1.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (2.77e-2)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (1.90e-2)" "unprognostic (8.62e-2)" "unprognostic (5.99e-2)" "unprognostic (1.04e-2)" "unprognostic (4.60e-3)" "unprognostic (2.13e-4)" "unprognostic (2.30e-3)" "unprognostic (2.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.09e-3)" 1.1 0.7 9.5 0.7 11.4 0.1 0.5 1.1 14.9 1.9 0.0 0.6 0.3 1.5 0.5 0.8 0.7 3.3 6.2 19.7 10.0 5.0 2.4 2.4 0.5 11.1 11.3 9.9 2.2 0.2 12.6 0.7 5.9 10.7 1.3 0.5 22.5 0.8 2.2 0.1 0.5 0.5 2.6 1.6 0.9 0.7 1.5 6.5 0.1 2.2 0.6 0.5 3.1 1.1 19.9 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.0 11.1 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.5 0.0 0.0 4.7 10.5 0.0 0.0 0.0 7.6 0.0 0.0 0.0 4.0 0.6 0.0 1.5 0.3 0.0 0.0 3.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 11.4 1.1 14.9 19.7 10.0 11.1 11.3 9.9 10.7 1.6 6.5 19.9 0.5 0.0 0.0 9.8 0.0 0.3 0.1 0.0 0.0 230.4 0.1 0.0 9.1 0.0 1.3 0.0 14.6 0.0 1.2 0.0 1.9 0.0 45.3 0.4 13.3 1.5 0.0 0.0 236.8 0.0 0.0 6.7 0.0 0.3 0.0 17.2 0.0 0.9 0.0 10.1 259.1 0.0 0.0 0.3 0.8 30.6 1.5 2.1 0.0 8.4 0.1 6.9 2.1 178.4 6.4 0.0 0.0 6.8 0.7 0.1 0.0 9.6 0.0 14.6 0.0 0.4 5.5 0.9 1.1 0.1 0.6 0.0 1.2 4.9 0.0 0.1 JPT2 "C16orf34, FLJ13092, HN1L, KIAA1426, L11" ENSG00000206053 "Jupiter microtubule associated homolog 2" Q9H910 16 1678256-1702280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 99.3;Ductal cells: 90.1;Endometrial ciliated cells: 107.3;Extravillous trophoblasts: 205.9;Glandular and luminal cells: 77.5;Pancreatic endocrine cells: 78.9;Syncytiotrophoblasts: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041888, HPA041908" Approved Approved "Plasma membrane,Cytosol" NA NA 76000 "Plasma membrane, Cytosol" "HPA041888: AB_10793937, HPA041908: AB_10794160" "unprognostic (1.49e-2)" "unprognostic (1.76e-1)" "unprognostic (1.30e-3)" "prognostic favorable (7.85e-4)" "unprognostic (3.60e-1)" "unprognostic (2.37e-2)" "prognostic unfavorable (9.14e-4)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (1.50e-2)" "unprognostic (1.12e-3)" "unprognostic (4.27e-2)" "unprognostic (1.01e-2)" "unprognostic (9.22e-3)" "unprognostic (1.65e-1)" "unprognostic (4.14e-2)" "unprognostic (2.78e-2)" 21.4 17.1 17.6 18.7 21.4 11.4 36.8 33.8 19.4 39.9 15.7 33.0 22.1 21.3 18.1 48.1 63.9 13.7 18.2 13.9 19.1 28.1 41.5 20.1 20.0 53.8 29.4 11.9 20.0 29.9 21.1 15.2 48.5 43.8 48.3 30.8 4.7 26.9 18.4 17.7 31.6 24.4 19.7 39.1 12.9 28.5 18.3 26.2 35.9 28.0 14.2 31.6 31.4 26.1 54.4 148.1 147.5 168.4 93.9 23.9 39.3 151.9 143.6 44.8 117.7 99.8 194.5 188.3 94.6 107.8 71.1 116.4 141.9 223.5 194.2 135.7 77.2 135.2 78.4 80.2 111.4 36.7 93.5 44.8 28.1 121.6 116.4 149.6 64.9 75.7 85.4 187.5 37.0 68.6 169.5 117.1 46.6 185.3 164.4 112.0 212.7 159.3 136.2 186.2 82.5 156.1 85.6 214.9 205.3 66.5 161.1 250.3 59.6 87.9 113.9 201.1 54.8 141.1 31.5 136.3 198.8 35.8 71.5 170.5 2.1 3.7 4.1 5.2 3.3 7.2 4.8 5.8 4.2 2.8 7.6 6.3 5.4 0.3 6.8 1.7 6.6 5.8 4.4 17.6 21.4 33.8 19.4 13.9 19.1 53.8 29.4 11.9 43.8 39.1 26.2 54.4 11.9 25.6 10.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 33.3 23.4 0.0 0.0 12.4 9.2 0.0 99.3 4.5 0.0 43.0 90.1 0.0 107.3 19.2 8.5 0.0 0.0 0.0 25.6 205.9 7.4 0.0 77.5 2.5 23.4 0.0 0.0 41.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 28.4 0.0 0.0 0.0 0.0 78.9 0.0 0.0 1.2 0.0 0.0 26.0 27.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 168.7 3.6 18.9 0.0 0.0 TMEM211 bA9F11.1 ENSG00000206069 "Transmembrane protein 211" Q6ICI0 22 24934954-24946695 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 2.6;salivary gland: 5.8;stomach 1: 3.2" "Cell type enriched" "Detected in some" 19 "Ionocytes: 36.7" "Group enriched" "Detected in some" 5 "colorectal cancer: 4.8;endometrial cancer: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066784 Uncertain NA NA "HPA066784: AB_2685722" "unprognostic (7.89e-3)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" "unprognostic (1.09e-2)" "unprognostic (5.97e-3)" "unprognostic (5.88e-2)" "unprognostic (1.31e-3)" "unprognostic (3.26e-2)" "unprognostic (2.06e-1)" "unprognostic (6.42e-2)" "unprognostic (2.65e-2)" "unprognostic (8.61e-3)" "unprognostic (3.59e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.1 0.3 0.3 0.0 0.5 0.4 0.2 2.6 0.0 0.3 0.0 0.6 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 5.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 1.3 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SERPINB11 EPIPIN ENSG00000206072 "Serpin family B member 11" Q96P15 18 63647579-63726432 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 27.6;prostate: 32.8" "Cell type enhanced" "Detected in some" "Club cells: 6.8;Prostatic glandular cells: 3.3;Respiratory ciliated cells: 4.4;Squamous epithelial cells: 13.7;Urothelial cells: 21.9" "Cancer enriched" "Detected in some" 5 "prostate cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" NA NA "unprognostic (5.04e-3)" "unprognostic (4.76e-2)" "unprognostic (4.05e-2)" "unprognostic (3.44e-1)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.8 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 9.1 2.9 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.2 0.0 0.0 21.9 SERPINB4 "LEUPIN, PI11, SCCA-2, SCCA1, SCCA2" ENSG00000206073 "Serpin family B member 4" P48594 18 63637259-63644256 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 94.1;vagina: 152.1" "Cell type enriched" "Detected in some" 4 "Basal respiratory cells: 3577.0" "Group enriched" "Detected in many" 5 "cervical cancer: 104.1;head and neck cancer: 29.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;HSkMC: 1.1;SiHa: 1.7;U-2197: 6.1" "HPA048341, HPA049988, HPA055992" Supported NA NA 10000000 "HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (8.81e-3)" "unprognostic (9.43e-2)" "unprognostic (8.96e-3)" "unprognostic (4.38e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (2.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 37.8 0.0 0.0 0.0 0.6 0.0 94.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.3 0.0 0.0 23.5 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 4.5 21.2 152.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 3577.0 0.0 0.0 0.0 0.0 0.0 0.0 825.8 0.0 0.0 0.0 0.0 0.0 0.0 23.9 1.4 0.1 0.1 0.2 0.0 0.0 0.0 21.7 0.2 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 97.6 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 32.4 0.0 0.3 53.0 0.0 0.0 0.0 10.7 0.1 0.0 14.8 0.0 0.8 0.0 0.0 0.0 60.5 SERPINB5 "maspin, PI5" ENSG00000206075 "Serpin family B member 5" P36952 18 63476958-63505085 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 218.6;skin 1: 241.6;urinary bladder: 91.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 964.1;Basal prostatic cells: 358.7;Basal respiratory cells: 272.9;Squamous epithelial cells: 535.4;Suprabasal keratinocytes: 1215.3;Urothelial cells: 564.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 124.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1279.3;HBEC3-KT: 425.6;hTCEpi: 875.0;hTERT-HME1: 217.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB009570, HPA019025, HPA019132, HPA020136" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 770000 Vesicles "CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (9.24e-2)" "unprognostic (1.04e-3)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.36e-1)" "unprognostic (3.47e-3)" "prognostic unfavorable (5.71e-6)" "unprognostic (1.28e-1)" "unprognostic (1.84e-6)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (3.14e-1)" "unprognostic (8.38e-2)" 0.4 0.0 0.0 4.4 0.0 0.2 37.5 0.1 0.1 18.9 0.1 4.9 16.8 0.1 0.1 218.6 1.4 2.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 10.0 4.6 0.0 37.9 1.7 1.4 241.6 22.2 0.2 0.0 0.0 9.7 2.9 0.0 14.0 0.1 0.0 40.2 91.8 79.3 0.1 80.8 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 73.4 0.1 3.8 0.0 0.1 1279.3 0.0 425.6 0.0 0.0 0.0 0.0 95.8 0.2 0.0 0.0 0.6 0.1 875.0 0.0 217.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 179.9 93.4 0.1 0.0 0.2 0.0 95.1 1.4 0.0 60.2 0.3 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.2 0.9 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 964.1 358.7 272.9 224.3 0.0 5.1 27.3 0.2 0.0 90.0 3.7 0.0 0.3 0.1 14.2 0.0 0.1 9.0 6.2 0.1 5.4 3.5 0.0 0.3 0.0 0.2 5.8 12.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.3 34.6 0.0 57.6 18.6 0.6 1.8 62.2 0.0 0.0 0.0 0.0 0.0 0.1 16.3 51.7 0.0 2.5 85.4 13.5 0.1 85.4 0.0 0.0 0.0 7.1 6.6 2.2 535.4 1215.3 0.1 4.0 0.1 30.6 564.9 ZDHHC11B ENSG00000206077 "Zinc finger DHHC-type containing 11B" P0C7U3 5 710355-784729 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "brain: 33.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 23.0;Excitatory neurons: 47.2;Inhibitory neurons: 38.3;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 70.1;Respiratory ciliated cells: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.1;SCLC-21H: 2.4;THP-1: 3.4" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.81e-1)" "unprognostic (8.38e-3)" "unprognostic (3.79e-2)" "unprognostic (5.11e-3)" "unprognostic (7.18e-2)" "unprognostic (4.02e-3)" "unprognostic (1.19e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.45e-4)" "unprognostic (6.94e-2)" "unprognostic (1.43e-2)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (2.31e-1)" 0.6 1.2 17.3 0.2 21.8 0.0 0.9 10.1 25.4 0.4 0.0 1.7 2.8 0.4 0.1 1.5 2.0 0.3 3.6 19.5 14.4 0.7 1.2 2.4 0.0 19.4 15.0 20.2 0.6 1.8 0.4 4.5 0.2 24.0 0.6 2.3 4.3 1.7 0.5 3.6 2.2 2.4 0.4 7.3 1.2 2.3 0.7 19.8 0.0 1.1 1.6 0.4 1.1 0.7 33.3 0.0 0.8 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 2.1 0.1 0.0 0.3 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.4 0.4 0.0 0.0 0.7 0.3 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.8 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 21.8 10.1 25.4 19.5 14.4 19.4 15.0 20.2 24.0 7.3 19.8 33.3 0.2 19.2 23.0 17.0 0.0 2.7 1.0 0.1 2.2 7.0 1.1 0.9 8.9 1.5 5.7 3.7 0.0 0.0 0.4 2.0 0.0 0.8 2.5 11.9 0.7 2.8 3.0 0.0 47.2 0.8 0.1 4.7 4.1 3.6 1.3 0.0 0.7 2.3 1.7 10.1 38.3 6.7 0.0 0.6 1.1 0.4 0.9 0.8 0.0 1.9 0.0 0.6 0.0 26.7 70.1 0.1 1.4 0.0 1.7 0.3 7.7 0.5 21.8 0.3 6.6 1.4 2.4 5.0 2.5 2.3 3.1 0.0 1.5 0.5 2.4 2.6 KRTAP19-8 ENSG00000206102 "Keratin associated protein 19-8" Q3LI54 21 31038159-31038476 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Early spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.94e-1)" 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-3 "KAP19D, KAP20.3, KRTAP19P4" ENSG00000206104 "Keratin associated protein 20-3" Q3LI60 21 30642864-30643136 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053598 Uncertain NA NA "HPA053598: AB_2682204" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-4 KAP20.4 ENSG00000206105 "Keratin associated protein 20-4" Q3LI62 21 30620627-30620850 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 2.0" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-2 OS: 5.1" NA NA "unprognostic (1.31e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP22-2 KAP22.2 ENSG00000206106 "Keratin associated protein 22-2" Q3LI68 21 30590105-30590397 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP27-1 ENSG00000206107 "Keratin associated protein 27-1" Q3LI81 21 30337013-30337694 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021522, HPA048826" Approved NA NA "HPA021522: AB_1852643, HPA048826: AB_2680534" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP99 ENSG00000206113 "Cilia and flagella associated protein 99" 4 2418974-2462942 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.0;choroid plexus: 4.7;fallopian tube: 4.0;retina: 1.5;testis: 5.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Early spermatids: 11.6;Endometrial ciliated cells: 13.6;Late spermatids: 11.2;Rod photoreceptor cells: 5.5;Spermatocytes: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA071642 Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA071642: " "unprognostic (7.54e-3)" "unprognostic (6.46e-3)" "unprognostic (1.12e-1)" "unprognostic (2.31e-3)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.89e-1)" "unprognostic (8.14e-2)" "unprognostic (7.93e-5)" "unprognostic (1.15e-1)" "unprognostic (5.97e-3)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (6.94e-2)" "unprognostic (3.49e-1)" 0.0 0.8 2.5 0.0 0.9 0.0 0.0 1.0 0.7 0.1 4.7 0.0 0.0 0.2 0.1 0.0 4.0 0.0 0.0 0.8 2.0 0.2 0.1 0.6 0.0 2.2 3.0 0.0 0.0 0.3 0.0 0.8 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 5.3 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 1.0 0.7 0.8 2.0 2.2 3.0 0.0 1.8 2.5 1.5 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.0 1.8 3.7 4.2 0.0 0.0 0.0 0.0 0.2 11.6 13.6 0.2 0.1 0.0 0.0 1.2 0.6 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 1.5 2.9 5.5 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 GOLGA8O ENSG00000206127 "Golgin A8 family member O" A6NCC3 15 32441914-32455634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 20.2;epididymis: 33.3;testis: 11.6;thyroid gland: 27.7" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial ciliated cells: 1.3;granulocytes: 1.3;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "gdT-cell: 1.0;NK-cell: 2.4" "Group enriched" "Detected in many" 8 "NK-cells: 2.4;T-cells: 1.0" "Group enriched" "Detected in many" 8 "HEL: 70.0;THP-1: 38.6;U-937: 133.7" NA NA "unprognostic (2.68e-2)" "unprognostic (4.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (3.71e-1)" "unprognostic (3.13e-3)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (8.25e-2)" "unprognostic (6.04e-2)" "unprognostic (3.06e-2)" 4.6 1.2 3.2 2.8 3.8 20.2 3.8 3.5 4.0 2.1 4.4 1.5 1.8 3.4 33.3 1.3 2.9 3.1 3.3 3.5 3.6 1.7 3.0 2.8 2.4 4.6 3.8 3.0 4.2 3.4 3.5 1.9 1.4 4.6 2.3 1.9 3.6 3.0 1.6 4.5 4.1 1.5 2.2 3.4 3.7 2.0 11.6 3.6 1.3 27.7 2.0 1.4 1.5 1.2 5.0 0.3 0.5 1.0 0.0 2.6 3.8 0.1 1.7 1.0 0.4 0.8 0.0 0.2 0.4 0.5 0.3 1.0 0.1 0.7 0.1 0.4 0.1 0.6 70.0 0.0 0.0 1.1 1.5 2.6 0.9 1.0 0.5 0.3 4.4 0.8 1.3 0.2 0.0 1.0 0.8 0.0 10.2 0.3 0.0 0.3 0.2 2.1 0.0 1.6 0.3 0.0 1.0 0.4 0.1 0.0 0.5 0.6 38.6 3.8 0.8 0.3 0.1 0.6 1.7 2.5 0.6 0.4 133.7 0.8 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 2.4 0.0 0.2 0.0 0.1 3.2 3.8 3.5 4.0 3.5 3.6 4.6 3.8 3.0 4.6 3.4 3.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TMEM191C ENSG00000206140 "Transmembrane protein 191C" A6NGB0 22 21466423-21471269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 36 "testis: 51.1" "Group enriched" "Detected in many" 19 "Early spermatids: 841.3;Late spermatids: 1024.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "CACO-2: 1.0" NA NA "unprognostic (2.55e-1)" "unprognostic (2.18e-2)" "unprognostic (7.12e-3)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (1.86e-1)" "unprognostic (1.77e-2)" "unprognostic (5.97e-2)" "unprognostic (1.25e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-3)" "unprognostic (2.09e-1)" "unprognostic (2.41e-1)" "unprognostic (1.78e-1)" "unprognostic (7.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.12e-3)" 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.4 0.0 0.3 0.0 0.1 0.0 1.4 0.3 0.0 0.2 0.0 0.1 0.7 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.7 0.4 0.0 0.0 0.8 0.3 51.1 0.0 0.0 0.8 0.0 0.0 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.7 0.0 0.1 2.4 0.6 0.2 0.2 0.6 0.2 0.9 1.4 0.3 0.4 0.4 3.4 0.2 0.2 0.6 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.0 2.3 0.7 9.3 5.0 1.6 5.6 5.2 3.3 4.4 6.7 0.7 4.3 2.4 5.5 2.1 48.2 8.3 21.5 0.0 2.8 841.3 5.3 0.5 1.9 10.2 0.8 2.6 0.2 22.5 2.3 9.7 2.0 7.0 0.8 1.1 4.2 10.1 13.5 2.4 8.7 4.1 8.4 8.0 1024.5 5.3 6.5 3.6 0.0 6.3 1.0 11.3 0.0 0.5 4.3 17.2 4.1 3.3 1.5 28.0 8.0 4.9 2.4 0.0 1.3 2.8 10.0 8.7 9.2 6.8 19.0 8.7 2.1 7.3 1.0 RNASE13 RAL1 ENSG00000206150 "Ribonuclease A family member 13 (inactive)" Q5GAN3 14 21032818-21034807 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "epididymis: 309.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.54e-1)" "unprognostic (2.52e-1)" "unprognostic (2.86e-1)" "unprognostic (8.40e-2)" "unprognostic (1.93e-1)" "unprognostic (7.15e-2)" "unprognostic (1.63e-3)" "unprognostic (5.20e-4)" "unprognostic (1.47e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 309.6 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBA1 HBA-T3 ENSG00000206172 "Hemoglobin subunit alpha 1" P69905 16 176680-177522 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 24541.9" "Cell type enriched" "Detected in many" 51 "Erythroid cells: 224916.4" "Group enriched" "Detected in many" 4 "endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 142.6;plasmacytoid DC: 101.1" "Group enriched" "Detected in all" 5 "dendritic cells: 101.1;granulocytes: 142.6" "Group enriched" "Detected in some" 36 "HEL: 3355.8;K-562: 2416.8" "CAB032534, HPA043780" Enhanced NA NA 14000000000 "CAB032534: AB_2294993, HPA043780: AB_2678667" "unprognostic (1.16e-1)" "unprognostic (1.45e-2)" "unprognostic (8.87e-2)" "unprognostic (9.78e-3)" "unprognostic (3.02e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-1)" "unprognostic (6.21e-3)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-2)" "unprognostic (3.59e-2)" "unprognostic (3.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.67e-2)" "unprognostic (9.56e-2)" 563.6 184.5 89.5 82.7 213.9 24541.9 319.3 152.8 802.0 157.9 2244.8 128.0 10.7 41.8 2.4 246.9 353.9 60.6 1410.3 51.0 108.5 1386.9 1109.3 2221.0 5.0 164.5 327.4 35.4 161.1 101.4 5.2 469.4 2009.5 282.8 171.6 11.6 3.1 139.4 44.1 235.9 193.3 85.8 7.1 198.0 5572.2 137.1 105.6 283.2 20.9 614.3 1133.1 3.6 168.6 354.2 403.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 58.1 0.0 5.7 2.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.2 3355.8 0.0 37.1 0.0 1.3 0.0 0.3 0.0 0.0 0.7 0.0 0.0 1.7 2416.8 0.0 0.0 14.7 0.5 0.3 0.4 1.0 0.0 0.1 1.4 79.1 0.0 1.0 7.4 5.3 2.8 0.0 0.0 0.0 1.1 0.0 8.3 0.0 0.0 0.9 0.0 0.0 0.4 0.8 0.0 0.2 0.0 8.5 7.4 48.2 26.3 0.2 0.7 7.5 3.1 8.7 10.0 4.5 8.3 25.7 142.6 13.4 0.8 101.1 0.3 2806.3 89.5 213.9 152.8 802.0 51.0 108.5 164.5 327.4 35.4 282.8 198.0 283.2 403.4 72.7 0.0 0.0 0.0 56.8 10.6 0.1 0.0 0.0 0.4 11.3 12.3 1.8 55.8 0.1 0.0 0.0 0.0 93.2 3.2 7.9 0.0 6.0 0.5 0.5 20.4 1.2 224916.4 0.0 0.0 0.0 57.9 0.0 0.4 0.0 0.1 151.0 78.8 0.0 0.0 0.0 5.7 0.0 436.7 64.1 22.4 0.0 234.0 4338.2 0.0 12.7 1.3 1166.9 0.0 0.0 0.1 2.8 0.4 0.5 0.2 0.2 11.1 0.0 16.5 0.0 8.7 58.7 1.5 7.6 0.0 13.2 0.0 155.7 0.0 3.2 0.0 HBM "HBAP2, HBK" ENSG00000206177 "Hemoglobin subunit mu" Q6B0K9 16 153892-166764 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "bone marrow: 463.6" "Cell type enriched" "Detected in some" 504 "Erythroid cells: 8988.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 980000 "unprognostic (1.30e-1)" "unprognostic (7.59e-2)" 0.7 0.1 0.1 0.0 0.4 463.6 0.3 0.0 1.3 0.1 1.5 0.1 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.0 1.8 3.1 3.9 0.0 0.0 0.3 0.2 0.2 0.1 0.0 1.2 6.4 0.3 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 17.6 0.1 0.2 0.0 0.2 0.7 0.9 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 6.9 0.1 0.4 0.0 1.3 0.2 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8988.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 3.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.6 0.0 3.3 17.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 2.1 0.0 0.1 0.0 1.9 0.0 0.0 0.0 ELOA2 "HsT832, TCEB3B, TCEB3L" ENSG00000206181 "Elongin A2" Q8IYF1 18 47032572-47035621 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 40 "brain: 4.4;choroid plexus: 3.3;testis: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " "unprognostic (2.38e-1)" "unprognostic (4.47e-1)" "unprognostic (2.54e-4)" "unprognostic (2.39e-1)" "unprognostic (8.75e-2)" "unprognostic (5.34e-2)" "unprognostic (3.64e-1)" "unprognostic (5.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-2)" "unprognostic (3.97e-2)" 0.0 0.0 2.6 0.0 1.9 0.0 0.0 1.2 1.4 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 2.1 1.6 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.9 1.2 1.4 1.3 0.8 2.1 1.6 0.3 2.4 1.4 2.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP10A "ATP10C, ATPVA, ATPVC, KIAA0566" ENSG00000206190 "ATPase phospholipid transporting 10A (putative)" O60312 15 25677271-25865184 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enriched" "Detected in many" 6 "Microglial cells: 216.4" "Cancer enhanced" "Detected in all" "melanoma: 7.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 23.0;fHDF/TERT166: 22.9;HMC-1: 19.4;SK-MEL-30: 21.9;U-2197: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041496, HPA042509" Uncertain NA NA "HPA041496: AB_2677513, HPA042509: AB_2678032" "unprognostic (3.70e-1)" "unprognostic (2.83e-2)" "unprognostic (2.30e-4)" "unprognostic (1.18e-1)" "unprognostic (9.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.67e-1)" "unprognostic (4.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.60e-5)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" "unprognostic (4.89e-2)" "unprognostic (9.42e-2)" 5.2 8.8 14.9 2.7 8.1 2.5 5.3 5.8 9.0 2.1 1.6 2.9 0.8 1.5 0.1 1.9 2.3 3.7 1.8 5.7 5.2 5.7 0.6 7.1 1.9 11.5 9.5 3.1 1.1 1.4 3.5 2.1 1.8 10.3 2.2 0.8 0.1 8.0 0.7 0.6 2.3 3.0 2.9 5.1 1.5 3.2 4.3 12.9 1.1 2.5 0.7 1.1 2.5 1.4 8.1 0.0 5.7 1.3 0.0 2.2 2.8 0.0 23.0 9.3 6.1 9.9 0.0 0.0 0.0 1.6 22.9 0.0 0.0 9.3 1.2 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 19.4 0.9 0.0 0.6 0.0 2.5 0.0 1.2 0.0 0.0 3.3 0.0 1.2 0.0 1.5 0.0 1.5 4.4 4.6 2.8 9.9 0.0 0.0 0.1 0.0 0.0 21.9 0.0 7.4 1.2 0.0 8.9 0.2 12.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.3 0.5 0.1 0.0 0.7 0.6 0.0 1.2 0.0 1.0 0.1 0.3 14.9 8.1 5.8 9.0 5.7 5.2 11.5 9.5 3.1 10.3 5.1 12.9 8.1 0.3 32.1 8.6 2.0 0.8 1.0 0.0 2.7 0.6 0.2 2.6 1.8 1.7 1.5 5.3 0.0 0.0 0.0 11.1 0.1 0.0 0.5 23.2 2.8 2.8 4.2 0.0 0.0 4.5 0.0 0.1 5.0 3.1 7.9 15.2 0.0 0.4 0.1 2.5 0.0 2.1 0.2 0.0 2.5 5.2 21.8 4.1 4.5 17.8 216.4 2.3 0.0 14.4 1.5 2.7 0.8 0.0 17.7 1.7 0.7 0.0 0.1 4.2 0.1 0.0 4.7 9.1 0.4 1.2 0.0 0.4 0.0 8.6 0.1 0.0 0.0 ANKUB1 C3orf16 ENSG00000206199 "Ankyrin repeat and ubiquitin domain containing 1" A6NFN9 3 149761100-149968385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 2.6;choroid plexus: 5.7;fallopian tube: 6.0" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 124.3;Respiratory ciliated cells: 118.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.5" "Cell line enhanced" "Detected in single" "OE19: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053749 Uncertain NA NA "HPA053749: AB_2682248" "unprognostic (1.71e-2)" "unprognostic (1.89e-4)" "unprognostic (1.01e-1)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-1)" "unprognostic (1.61e-2)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (2.18e-9)" "unprognostic (3.06e-1)" "unprognostic (2.96e-1)" "unprognostic (3.17e-1)" "unprognostic (7.07e-4)" 0.0 0.0 1.2 0.1 0.7 0.3 0.0 1.1 0.6 0.6 5.7 0.0 0.1 0.2 0.0 0.0 6.0 0.0 0.0 0.5 0.7 0.0 0.0 1.1 0.0 2.3 2.6 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.2 0.1 0.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.2 0.7 1.1 0.6 0.5 0.7 2.3 2.6 0.1 2.4 2.2 1.2 1.3 0.0 0.0 1.7 0.3 0.0 0.5 0.8 7.3 0.0 0.0 0.0 0.0 0.2 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 124.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 10.2 1.6 0.3 5.4 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 118.9 0.0 0.0 0.2 1.4 4.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.7 TSSK2 "FLJ38613, SPOGA2, STK22B" ENSG00000206203 "Testis specific serine kinase 2" Q96PF2 22 19131308-19132622 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 231 "testis: 136.9" "Group enriched" "Detected in some" 94 "Early spermatids: 1657.2;Late spermatids: 3184.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 136.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.7 0.4 0.0 0.1 0.1 0.6 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1657.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3184.4 18.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 25.7 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139003962-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXL2NB "C3orf72, FLJ43329" ENSG00000206262 "FOXL2 neighbor" Q6ZUU3 3 138947217-138953990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 50.5;parathyroid gland: 33.0" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 2.0;Granulosa cells: 3.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.4;fHDF/TERT166: 9.2;HEL: 8.7;hTCEpi: 4.4;SiHa: 6.6" "HPA061017, HPA071790" Enhanced "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA061017: AB_2684415, HPA071790: AB_2686447" "unprognostic (3.32e-1)" "unprognostic (1.13e-1)" "unprognostic (3.86e-2)" "unprognostic (4.07e-2)" "unprognostic (4.40e-5)" "unprognostic (3.30e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-10)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (2.77e-1)" "unprognostic (1.22e-2)" 0.1 1.8 1.3 0.3 1.2 0.8 0.2 2.0 1.7 16.2 0.6 0.2 0.2 18.1 2.0 0.4 15.0 0.2 0.1 1.1 0.8 0.1 0.1 0.1 0.7 1.1 1.0 1.1 50.5 0.9 33.0 8.5 0.4 1.5 0.2 0.2 0.6 0.2 1.1 0.3 0.8 0.2 4.3 0.3 0.4 0.2 0.8 1.1 0.1 0.2 0.1 0.5 0.0 3.5 1.3 1.8 1.1 0.5 4.4 0.2 0.1 2.0 0.1 0.0 0.2 0.0 0.2 0.4 0.2 0.9 9.2 0.1 0.5 0.2 0.0 0.2 0.1 0.2 8.7 3.0 0.2 0.0 0.2 0.3 0.1 4.4 0.1 0.1 0.4 0.0 0.2 3.4 0.3 2.5 0.3 0.1 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.4 1.2 0.2 0.1 6.6 0.2 0.1 0.7 0.2 2.6 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.3 1.2 2.0 1.7 1.1 0.8 1.1 1.0 1.1 1.5 0.3 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 COL6A6 ENSG00000206384 "Collagen type VI alpha 6 chain" A6NMZ7 3 130560334-130678155 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "parathyroid gland: 98.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.6;Fibroblasts: 20.6;Inhibitory neurons: 5.3;Oligodendrocytes: 4.6;Skeletal myocytes: 3.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SuSa: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "spinal cord: 10.0" HPA045239 Uncertain "Secreted to extracellular matrix" NA NA 700000 "HPA045239: AB_2679268" "unprognostic (4.86e-3)" "unprognostic (2.16e-2)" "unprognostic (9.91e-2)" "unprognostic (2.08e-4)" "unprognostic (2.79e-1)" "unprognostic (1.11e-5)" "unprognostic (3.74e-3)" "unprognostic (5.59e-2)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (8.90e-2)" "unprognostic (2.70e-1)" "unprognostic (2.96e-4)" "unprognostic (5.82e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (1.07e-1)" 1.8 0.0 0.0 0.0 0.2 0.2 2.5 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.3 0.9 0.3 0.1 2.9 0.0 0.0 0.0 0.8 7.4 0.0 0.1 0.0 0.0 0.2 0.0 98.7 3.6 0.7 0.1 0.0 0.0 0.3 1.5 0.0 0.1 0.4 0.0 0.5 0.0 1.2 0.1 0.4 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 1.1 0.0 1.1 1.3 0.0 0.9 0.0 0.0 0.0 1.1 0.2 0.4 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 2.9 0.1 0.0 0.0 4.6 0.0 0.0 20.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.0 0.0 0.0 1.5 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 3.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.3 0.8 0.0 0.4 0.0 0.9 0.1 0.2 0.0 0.0 0.0 RAB12 ENSG00000206418 "RAB12, member RAS oncogene family" Q6IQ22 18 8609437-8639382 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 96.4;Inhibitory neurons: 46.3;Microglial cells: 45.9;Oligodendrocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040727 Approved Approved Vesicles NA NA Vesicles "HPA040727: AB_10794858" "unprognostic (7.92e-2)" "unprognostic (4.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (1.25e-2)" "unprognostic (2.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (2.02e-1)" "unprognostic (1.63e-1)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (9.11e-2)" 37.1 26.4 29.8 18.0 32.2 13.7 28.2 34.7 34.0 27.0 25.6 28.4 11.9 30.0 19.8 29.1 26.9 18.7 86.3 32.1 32.6 31.7 36.8 30.6 21.1 30.0 30.5 30.5 31.3 13.5 21.9 21.5 30.3 30.0 22.9 17.1 22.8 18.1 29.9 195.7 31.7 20.4 34.6 31.0 28.2 19.4 12.2 33.1 15.3 20.0 107.5 21.0 29.3 25.5 31.2 33.1 19.4 22.1 23.2 64.3 54.2 12.2 44.0 60.2 49.1 57.4 26.3 29.7 11.3 41.7 53.1 36.8 20.6 25.7 47.1 59.3 4.5 20.8 9.7 20.7 27.7 59.5 12.8 9.8 53.9 65.2 36.3 45.9 50.6 60.2 10.0 15.0 15.8 48.2 35.9 14.8 12.9 14.3 113.8 18.0 10.2 53.6 10.9 48.5 43.8 36.5 25.8 33.6 45.1 57.6 31.0 13.2 19.5 50.6 56.6 33.0 57.2 67.7 10.6 6.6 9.8 42.4 11.8 37.0 4.5 0.9 1.0 0.8 1.5 1.1 1.3 0.9 0.9 0.7 1.1 1.1 1.1 1.6 1.5 2.4 1.7 1.0 0.5 29.8 32.2 34.7 34.0 32.1 32.6 30.0 30.5 30.5 30.0 31.0 33.1 31.2 34.1 12.8 19.3 31.6 3.8 6.5 1.7 1.9 2.8 15.1 11.6 12.2 96.4 1.5 8.3 3.7 6.2 1.8 7.1 1.6 3.9 2.3 0.0 8.1 14.1 16.1 5.4 3.2 41.6 1.3 1.4 14.5 4.6 7.6 6.3 9.4 16.4 16.0 1.7 11.8 46.3 2.5 2.0 16.6 12.3 0.4 3.4 9.3 3.6 45.9 4.5 14.1 2.1 23.6 43.3 3.2 1.7 4.5 2.4 6.3 2.2 5.9 7.0 7.7 0.0 13.2 13.6 1.0 1.5 4.5 8.4 1.1 4.5 12.3 3.1 4.5 LRRC30 ENSG00000206422 "Leucine rich repeat containing 30" A6NM36 18 7231125-7232047 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "skeletal muscle: 16.4;tongue: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041039 Uncertain NA NA "HPA041039: AB_2677270" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM200C TTMA ENSG00000206432 "Transmembrane protein 200C" A6NKL6 18 5882072-5895955 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.0;brain: 6.9;salivary gland: 5.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.3;Cone photoreceptor cells: 6.2;Inhibitory neurons: 8.0;Oligodendrocyte precursor cells: 17.6" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.1;NTERA-2: 4.7;PC-3: 22.0;U-2 OS: 10.9;U-251 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047253, HPA050490" Uncertain Approved Microtubules NA NA Microtubules "HPA047253: AB_2680001, HPA050490: AB_2681144" "unprognostic (6.57e-4)" "unprognostic (3.09e-1)" "unprognostic (1.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (3.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.12e-2)" "unprognostic (2.29e-2)" "unprognostic (6.31e-2)" "unprognostic (3.82e-4)" "unprognostic (2.48e-10)" "unprognostic (2.94e-2)" "unprognostic (6.38e-2)" "unprognostic (7.22e-2)" "unprognostic (2.38e-2)" 0.1 4.0 1.8 0.3 2.4 0.0 0.6 0.4 2.4 0.5 0.0 0.4 0.1 0.6 1.1 0.2 0.5 0.4 1.3 1.0 2.3 1.5 1.1 0.1 0.4 2.4 6.9 2.2 0.7 0.0 0.1 2.3 0.0 3.4 0.7 0.0 0.8 5.5 0.2 0.0 0.2 0.6 0.1 1.6 0.6 0.4 0.9 2.1 0.1 0.1 0.0 0.3 0.4 0.1 1.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 22.0 1.3 0.0 0.0 0.0 0.0 1.1 3.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.9 0.0 3.9 0.0 0.0 0.0 1.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 0.4 2.4 1.0 2.3 2.4 6.9 2.2 3.4 1.6 2.1 1.0 0.1 0.0 1.1 0.3 0.0 0.1 0.0 0.0 0.0 9.3 0.5 2.0 2.4 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.1 2.0 3.4 0.1 0.7 0.0 0.0 1.6 0.0 0.1 2.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.0 0.4 1.1 1.2 0.2 0.0 1.0 0.0 0.8 0.0 17.6 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.2 1.3 0.0 0.0 1.4 0.3 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.1 OR10C1 "hs6M1-17, OR10C1P, OR10C2" ENSG00000206474 "Olfactory receptor family 10 subfamily C member 1" Q96KK4 6 29439306-29440977 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049336 Uncertain NA NA "HPA049336: AB_2680718" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLA-A ENSG00000206503 "Major histocompatibility complex, class I, A" P04439 6 29941260-29945884 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 3747.8;Proximal enterocytes: 5267.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "white matter: 198.2" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6" CAB078470 Supported "Golgi apparatus,Plasma membrane" NA NA 170000000 "Plasma membrane" "Golgi apparatus" "CAB078470: AB_10985125" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (1.34e-2)" "prognostic favorable (9.59e-4)" "unprognostic (3.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "unprognostic (7.28e-2)" "unprognostic (3.42e-2)" "prognostic favorable (6.47e-4)" "unprognostic (2.96e-1)" "unprognostic (3.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.54e-2)" 621.8 720.1 49.9 35.1 21.3 138.9 571.5 20.1 36.3 496.8 24.6 560.6 280.9 480.1 182.6 369.7 393.7 242.1 453.0 20.1 26.3 683.8 395.2 1016.0 132.9 43.1 20.8 18.4 341.6 201.7 18.7 409.6 52.5 48.3 374.1 95.6 10.0 367.1 1.2 248.5 650.4 967.0 14.7 21.1 1424.5 445.9 133.7 34.4 140.3 536.3 14.6 179.8 415.9 470.8 198.2 1363.9 35.0 0.0 0.0 205.9 193.7 1.4 1.4 2.5 2.1 2.3 0.2 0.1 4.0 0.6 360.3 179.1 31.2 0.2 366.7 0.5 3.1 13.5 237.5 9.5 7.4 11.2 0.5 14.4 2.0 0.0 2.5 1.1 0.6 0.2 177.8 0.4 1.4 0.5 0.0 1.1 24.3 2.9 0.2 4.1 27.5 2.5 372.1 246.7 276.5 0.6 12.4 29.3 0.2 11.8 82.8 1.6 30.4 5.8 18.7 0.8 5.8 4.0 344.6 92.6 77.7 0.4 199.9 0.2 321.6 119.0 182.7 164.7 95.5 134.8 96.9 125.4 146.3 18.6 64.3 86.5 119.2 248.7 133.1 109.6 54.6 222.2 191.9 49.9 21.3 20.1 36.3 20.1 26.3 43.1 20.8 18.4 48.3 21.1 34.4 198.2 1622.4 371.8 478.6 22.9 1316.2 856.4 886.2 1417.5 228.8 30.8 289.6 188.5 147.4 936.5 952.5 503.9 6.2 18.3 1879.4 2631.8 88.0 3747.8 52.2 239.4 374.0 1717.8 955.2 499.4 3.6 1310.0 18.5 743.5 853.7 556.2 603.0 253.3 1266.2 276.4 1840.9 37.0 19.3 1755.3 1265.4 1575.0 1124.0 95.6 704.6 1419.1 635.0 67.5 3258.0 170.4 3201.9 49.3 16.1 1802.9 2452.4 484.1 1110.7 1026.6 5267.3 294.9 609.6 24.4 558.8 397.3 579.2 197.4 23.8 216.5 947.7 31.7 2234.9 1021.3 1225.4 1262.8 HACD2 PTPLB ENSG00000206527 "3-hydroxyacyl-CoA dehydratase 2" Q6Y1H2 3 123490820-123585053 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 249.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019282 Approved NA NA "CAB019282: " "unprognostic (3.04e-2)" "unprognostic (2.51e-1)" "unprognostic (6.11e-2)" "unprognostic (2.65e-3)" "unprognostic (5.36e-2)" "unprognostic (6.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.59e-5)" "unprognostic (6.90e-2)" "unprognostic (7.03e-3)" "unprognostic (1.48e-1)" "unprognostic (3.85e-2)" "unprognostic (1.94e-2)" "unprognostic (2.59e-2)" 68.9 11.3 17.7 16.7 23.7 8.8 23.0 20.8 20.7 14.7 10.4 27.0 30.2 16.7 17.9 19.1 13.2 16.8 10.8 17.6 22.4 24.3 48.8 19.5 21.4 20.0 20.8 16.2 12.6 17.6 21.5 7.7 15.6 21.2 29.7 27.9 13.9 16.5 13.1 5.3 32.8 26.1 16.9 18.6 12.4 21.4 19.2 18.0 15.1 19.5 8.5 28.8 14.9 17.2 35.1 76.9 42.7 28.8 21.1 88.3 19.5 106.5 53.7 22.2 54.6 39.4 87.9 66.1 44.1 37.8 51.7 63.3 162.8 52.3 67.4 57.3 28.3 17.5 30.8 37.3 68.9 28.7 41.2 29.4 27.2 169.7 26.5 73.6 85.2 29.0 30.0 6.3 42.7 33.4 59.8 19.7 12.3 37.2 92.7 37.4 29.6 31.6 46.9 66.5 48.6 50.5 15.8 249.9 52.7 34.6 41.5 54.9 21.1 22.7 56.8 42.2 57.5 53.1 25.2 34.7 35.9 25.5 28.5 31.1 0.7 1.6 1.1 1.5 1.2 2.2 1.5 1.9 1.9 2.8 2.0 1.8 1.7 0.5 1.3 1.0 1.6 2.5 1.2 17.7 23.7 20.8 20.7 17.6 22.4 20.0 20.8 16.2 21.2 18.6 18.0 35.1 19.8 6.4 43.1 8.8 17.5 0.0 28.7 0.0 23.9 9.5 27.8 21.5 13.5 22.8 15.5 46.0 6.2 21.5 18.9 29.4 7.9 15.4 19.8 22.3 14.9 17.0 15.8 15.4 34.3 18.7 16.5 17.3 25.0 35.7 3.8 17.1 16.8 47.5 22.9 1.7 29.7 16.4 0.0 24.2 0.0 10.4 11.5 25.1 0.0 12.2 19.6 14.5 19.6 25.1 32.6 19.6 16.6 17.7 15.0 40.6 33.8 17.8 2.9 13.9 6.6 14.8 11.3 10.5 24.8 35.1 0.0 6.7 14.2 11.8 19.9 33.2 CFAP44 "FLJ11142, WDR52" ENSG00000206530 "Cilia and flagella associated protein 44" Q96MT7 3 113286930-113441610 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 57.4;Endometrial ciliated cells: 40.0;Late spermatids: 61.2;Respiratory ciliated cells: 104.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.7" HPA067258 Uncertain NA NA "HPA067258: AB_2685814" "unprognostic (2.83e-1)" "unprognostic (7.07e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.35e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-4)" "unprognostic (6.73e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-1)" "unprognostic (1.62e-2)" "unprognostic (2.18e-3)" "unprognostic (2.13e-6)" "unprognostic (8.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.77e-2)" "prognostic favorable (7.09e-6)" 1.5 1.2 4.5 0.9 1.4 0.8 2.6 1.4 1.2 3.5 10.0 2.7 0.7 2.7 2.6 1.6 6.9 1.0 1.6 1.5 3.7 1.5 2.1 2.5 1.3 4.9 4.4 0.7 3.3 3.8 1.9 6.3 0.7 2.6 4.2 2.3 8.8 5.0 1.1 1.4 2.3 2.9 0.7 6.2 2.0 3.0 6.1 1.4 1.5 3.3 0.4 1.0 2.4 2.6 2.2 1.1 0.7 1.6 1.4 0.9 1.5 1.5 0.5 0.3 0.3 0.7 0.1 0.6 1.4 0.1 0.2 0.3 1.5 0.9 0.5 0.6 0.3 1.0 0.8 3.4 0.3 0.0 1.5 0.9 0.4 1.4 0.3 0.3 2.0 0.2 1.3 0.2 0.7 0.3 0.7 0.8 1.3 0.5 1.9 1.8 0.8 0.2 0.0 0.8 1.8 1.5 1.4 0.7 0.1 0.8 0.8 1.0 1.1 1.1 0.5 0.8 0.4 0.5 0.9 0.6 0.1 0.7 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.4 1.4 1.2 1.5 3.7 4.9 4.4 0.7 2.6 6.2 1.4 2.2 3.8 9.6 13.7 27.4 2.9 0.0 2.1 0.0 5.7 7.5 6.7 5.2 5.1 2.8 18.6 3.7 20.9 0.9 1.1 3.2 0.0 2.6 57.4 40.0 6.3 4.2 0.0 1.3 34.8 3.0 1.0 5.2 12.2 9.5 11.4 4.3 1.8 3.7 0.5 8.4 14.0 4.7 0.0 0.6 0.0 61.2 6.2 1.8 0.0 20.6 0.9 4.0 3.1 21.1 21.9 2.1 1.9 6.8 2.5 2.2 2.2 1.1 104.9 19.0 0.0 9.7 2.5 23.6 4.9 1.8 0.0 0.8 2.9 6.2 2.7 2.2 CD200R1L "CD200R2, CD200RLa" ENSG00000206531 "CD200 receptor 1 like" Q6Q8B3 3 112815709-112846856 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 2.8" "Group enriched" "Detected in some" 34 "Early spermatids: 23.9;Late spermatids: 45.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 379 "basophil: 85.0" "Lineage enriched" "Detected in single" 455 "granulocytes: 85.0" "Cell line enhanced" "Detected in single" "A-431: 1.0" NA NA "unprognostic (3.80e-1)" "unprognostic (1.88e-1)" "unprognostic (2.37e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-2)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 85.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 45.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401532-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 46.5;testis: 29.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 50.1;Early spermatids: 147.6;Horizontal cells: 257.4;Spermatocytes: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 4 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "PC-3: 18.7;U-266/84: 17.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 6.8;cerebral cortex: 8.7;hippocampal formation: 7.3;olfactory bulb: 5.0" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 2.2 1.9 4.7 0.8 5.7 0.1 1.9 5.4 6.1 2.5 3.2 2.0 0.7 3.2 6.8 1.3 3.0 2.1 8.6 5.1 6.3 4.3 7.8 3.1 0.9 5.2 5.7 4.7 3.9 3.3 1.7 6.2 2.7 6.0 1.9 1.5 46.5 2.0 2.3 2.9 0.6 1.2 2.8 4.6 1.3 1.5 29.2 4.7 1.3 3.6 2.1 1.1 3.1 1.7 6.0 3.2 1.7 9.9 0.9 4.1 2.9 0.7 2.0 6.3 2.7 2.8 0.9 0.9 2.4 0.9 1.9 2.8 2.1 1.8 3.2 2.9 2.6 2.1 7.1 0.5 4.0 1.8 5.4 0.8 3.5 0.8 1.2 5.0 2.5 0.3 1.0 2.7 11.6 2.1 2.7 6.2 4.3 7.6 2.1 18.7 4.6 5.4 6.1 1.9 0.4 9.5 4.9 1.6 2.7 4.5 2.3 0.6 0.6 0.7 1.0 10.4 1.0 2.2 14.9 17.3 9.5 3.3 3.3 2.1 0.0 0.0 0.0 0.4 0.0 0.9 0.3 0.3 0.2 0.2 0.1 0.4 0.4 0.0 0.1 0.0 0.0 1.4 0.1 4.7 5.7 5.4 6.1 5.1 6.3 5.2 5.7 4.7 6.0 4.6 4.7 6.0 0.9 0.0 0.5 4.2 1.8 1.0 1.3 0.7 2.2 42.2 2.2 1.9 10.5 0.0 1.5 1.8 50.1 1.5 0.3 0.6 7.9 0.8 147.6 0.9 2.3 1.2 2.4 6.1 6.9 1.0 1.9 3.2 3.1 0.7 0.0 1.2 0.0 1.7 0.6 257.4 11.3 1.6 0.0 0.3 0.3 34.2 3.4 0.3 21.4 0.0 0.7 17.1 1.0 7.5 3.7 0.6 0.5 1.2 7.5 0.8 1.1 6.0 3.3 44.3 0.0 1.9 4.6 91.8 3.3 0.6 0.6 0.4 0.7 0.7 0.8 0.5 OR5K3 ENSG00000206536 "Olfactory receptor family 5 subfamily K member 3" A6NET4 3 98390666-98391631 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991149 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.5" "Cell type enhanced" "Detected in many" "Early spermatids: 138.1;Extravillous trophoblasts: 178.1;Late spermatids: 71.8;Leydig cells: 132.3;Peritubular cells: 149.3;Skeletal myocytes: 65.9;Syncytiotrophoblasts: 80.7" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9;urothelial cancer: 6.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "U-2197: 518.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 21.2 1.5 5.8 3.3 1.6 0.4 7.5 0.5 1.6 5.5 7.1 5.3 1.1 8.1 1.4 3.0 5.5 9.6 3.5 2.0 5.3 1.5 0.6 16.1 2.3 0.9 2.1 0.3 14.4 4.0 1.2 0.3 40.5 1.0 11.1 2.3 1.1 1.6 4.2 1.7 3.6 2.2 9.1 0.7 2.0 2.6 3.5 3.1 0.5 3.1 1.5 0.8 9.4 4.1 0.7 8.1 13.1 69.5 0.2 90.5 112.2 1.1 48.6 34.0 40.8 50.8 15.2 3.1 0.0 0.1 76.9 4.6 6.9 4.8 4.6 55.9 28.4 0.1 3.6 4.8 0.3 41.3 0.5 0.2 86.6 7.6 60.1 26.9 21.8 6.1 0.1 0.0 0.1 51.5 0.1 0.5 0.4 1.4 0.1 0.3 0.1 91.7 0.4 0.0 8.3 0.2 0.1 20.8 0.7 0.1 2.4 0.2 0.3 2.8 90.3 13.4 518.3 1.6 0.2 0.2 0.0 16.8 0.0 3.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 5.8 1.6 0.5 1.6 2.0 5.3 0.9 2.1 0.3 1.0 0.7 3.1 0.7 2.5 3.2 2.2 0.0 0.0 8.0 11.1 2.1 4.0 0.0 0.9 4.6 1.2 1.5 3.3 11.0 0.0 35.6 0.1 0.0 0.0 13.4 138.1 1.3 31.0 1.7 0.0 0.0 0.4 2.6 178.1 33.4 1.1 1.2 0.0 0.1 2.5 0.0 7.5 0.0 2.0 0.0 2.0 0.0 10.3 71.8 132.3 0.7 3.6 6.5 0.0 17.1 0.0 0.0 1.4 13.2 0.0 149.3 0.0 17.7 0.0 0.1 3.2 0.3 13.1 65.9 21.8 1.1 1.4 1.8 5.3 80.7 0.5 23.1 0.0 4.5 AC109583.1 ENSG00000206549 "Novel protein identical to PRSS50" 3 46712115-46812574 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.6;skeletal muscle: 4.9;thyroid gland: 6.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040768 Supported NA NA "HPA040768: AB_2677126" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.32e-1)" "unprognostic (7.45e-2)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (8.91e-4)" "unprognostic (1.08e-1)" "unprognostic (1.46e-3)" "unprognostic (2.68e-2)" "unprognostic (1.79e-2)" "unprognostic (9.36e-2)" "unprognostic (3.66e-3)" 0.1 0.3 0.3 0.0 0.2 0.0 0.7 0.9 0.2 1.5 0.4 0.4 0.1 0.7 3.0 0.1 1.1 0.0 0.9 0.1 0.9 1.6 0.8 0.3 0.0 0.3 0.4 0.1 0.7 1.5 1.8 4.6 0.0 0.4 1.5 0.0 0.1 0.8 0.7 4.9 0.1 0.2 0.1 0.3 0.1 0.3 1.8 0.3 0.0 6.0 0.2 0.0 0.6 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.2 0.1 0.9 0.3 0.4 0.1 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM71 "LIN-41, LIN41" ENSG00000206557 "Tripartite motif containing 71" Q2Q1W2 3 32817997-32897824 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "RNA-mediated gene silencing, Ubl conjugation pathway" "Developmental protein, RNA-binding, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 4.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7" "Cancer enriched" "Detected in some" 28 "testis cancer: 28.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038141, HPA038142" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "HPA038141: AB_2675857, HPA038142: AB_10697240" "unprognostic (2.93e-2)" "unprognostic (4.29e-3)" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (2.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.25e-1)" "unprognostic (3.16e-2)" "unprognostic (3.04e-1)" "unprognostic (1.11e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-6)" "unprognostic (3.92e-2)" "unprognostic (9.27e-2)" "unprognostic (8.17e-2)" "unprognostic (4.65e-2)" 0.0 0.0 1.0 0.0 0.9 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.5 0.9 0.0 0.7 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 31.4 0.0 0.0 0.0 94.5 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 1.6 0.0 63.8 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.0 0.0 0.6 6.9 84.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 76.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.8 0.9 0.5 0.3 0.1 0.7 0.2 0.0 0.6 0.2 0.0 9.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 2.7 0.0 1.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 3.1 0.0 15.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 4.5 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 3.6 0.7 0.5 0.0 0.0 0.1 0.3 13.7 0.0 0.0 4.0 0.1 0.0 0.0 0.0 ZCWPW2 ZCW2 ENSG00000206559 "Zinc finger CW-type and PWWP domain containing 2" Q504Y3 3 28348721-28538122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.0" "Cell type enhanced" "Detected in many" "Astrocytes: 35.6;Early spermatids: 95.0;Excitatory neurons: 33.7;Inhibitory neurons: 34.9;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 31.7;Spermatocytes: 68.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035035, HPA039839" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035035: AB_10602256, HPA039839: AB_2676708" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (4.59e-3)" "unprognostic (6.53e-2)" "unprognostic (6.09e-4)" "unprognostic (3.21e-1)" "unprognostic (2.70e-2)" "unprognostic (1.73e-3)" "unprognostic (1.12e-1)" "unprognostic (1.10e-4)" "unprognostic (1.06e-2)" "unprognostic (7.88e-2)" "unprognostic (1.40e-2)" "unprognostic (2.38e-2)" 1.5 1.8 2.0 0.9 1.8 0.8 1.8 1.8 2.1 1.4 0.3 1.1 1.2 2.1 2.2 1.4 1.0 2.0 2.8 1.9 1.2 1.7 1.2 1.3 1.2 1.2 1.2 1.5 2.5 1.9 1.5 1.3 1.2 1.4 2.2 1.1 1.6 2.3 1.1 6.2 1.9 1.0 1.0 0.7 1.1 1.8 10.0 1.2 0.6 2.6 4.5 1.0 0.8 0.8 2.3 0.3 0.2 0.8 0.3 1.2 2.8 1.2 1.1 0.8 0.3 0.3 0.2 0.9 0.7 0.5 0.6 0.8 0.4 0.2 0.2 0.3 0.4 0.4 0.3 1.1 0.3 0.6 0.5 0.6 1.2 0.5 0.3 0.5 1.3 0.5 1.5 0.3 1.0 1.5 0.3 0.2 0.6 0.3 0.1 1.1 0.3 0.3 0.6 1.2 0.1 0.3 0.9 0.2 0.4 0.7 0.8 0.4 2.6 1.0 0.8 0.4 0.7 0.6 0.3 0.2 0.3 2.8 0.5 1.0 1.0 0.7 1.1 0.3 0.7 0.2 0.1 0.3 0.2 0.3 0.2 0.5 0.7 1.0 0.2 0.2 0.4 0.3 0.2 2.0 1.8 1.8 2.1 1.9 1.2 1.2 1.2 1.5 1.4 0.7 1.2 2.3 1.6 0.0 2.0 35.6 0.4 0.6 2.7 3.7 1.2 3.0 1.6 2.7 13.6 0.0 4.3 0.0 0.0 2.4 0.1 0.4 5.9 0.5 95.0 1.2 1.2 1.0 1.2 0.0 33.7 0.9 1.4 4.3 0.0 0.6 2.5 0.8 1.4 0.5 1.3 3.3 34.9 1.9 8.2 0.6 0.7 17.7 4.7 1.3 0.0 13.1 0.7 3.7 1.0 32.2 31.7 0.6 0.3 4.9 0.3 1.1 0.6 2.6 1.7 2.0 0.0 4.4 4.5 68.7 5.8 1.1 1.6 1.2 0.6 1.3 0.7 1.3 ANKRD28 "CFAP79, FAP79, KIAA0379, PITK, PP6-ARS-A, PPP1R65" ENSG00000206560 "Ankyrin repeat domain 28" O15084 3 15667236-15859771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Melanocytes: 282.8;Oligodendrocyte precursor cells: 364.4;Oligodendrocytes: 284.4;Plasma cells: 733.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 27 "basophil: 17.0" "Lineage enriched" "Detected in single" 27 "granulocytes: 17.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.72e-2)" "unprognostic (8.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-2)" "unprognostic (9.73e-2)" "unprognostic (4.29e-3)" "unprognostic (1.38e-1)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.39e-3)" "unprognostic (7.71e-2)" "prognostic favorable (2.85e-4)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.06e-1)" 10.9 7.1 9.6 5.8 10.2 11.7 13.6 13.6 11.7 10.7 8.3 10.1 9.7 9.0 28.0 7.8 7.7 10.0 4.8 9.5 10.2 10.4 13.6 9.0 5.8 10.8 10.1 8.7 11.4 13.9 15.8 5.6 6.4 10.1 6.8 9.8 14.1 8.3 7.9 24.1 10.7 7.9 6.3 9.3 7.1 10.8 12.0 9.2 10.4 13.6 20.3 8.9 9.2 10.2 12.1 16.3 10.7 11.6 7.9 38.4 31.7 37.7 20.6 28.9 26.0 29.8 6.5 16.3 31.6 7.0 20.8 20.4 6.5 9.6 17.0 26.4 6.9 13.5 15.0 14.5 10.7 62.7 23.4 10.0 46.4 11.7 24.6 25.6 32.4 27.5 17.4 11.5 41.4 67.6 11.0 19.7 15.1 23.8 10.8 8.8 17.1 21.8 26.9 24.9 16.2 5.9 10.5 15.3 15.4 63.9 10.4 9.2 18.3 21.8 32.9 20.2 25.1 20.3 25.2 31.2 18.8 24.6 16.8 25.5 17.0 0.0 0.0 0.3 0.0 0.4 0.2 0.6 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.0 0.3 0.2 0.2 9.6 10.2 13.6 11.7 9.5 10.2 10.8 10.1 8.7 10.1 9.3 9.2 12.1 39.2 32.1 51.2 63.6 69.9 42.6 20.8 17.0 17.6 27.9 37.7 16.0 18.9 18.6 39.9 7.3 139.7 8.9 71.6 19.5 9.8 14.4 95.5 25.5 55.0 61.4 19.8 37.6 175.4 20.7 9.3 73.4 36.7 42.0 196.7 17.3 21.0 45.1 41.0 52.2 144.5 18.1 22.4 59.7 181.3 92.2 34.8 87.5 282.8 47.8 16.7 43.2 19.6 364.4 284.4 14.8 14.8 10.9 733.4 35.1 12.7 11.3 45.2 41.3 0.0 45.6 29.3 24.4 10.5 25.3 33.5 3.4 195.5 10.2 20.5 21.5 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.1" "Cell type enhanced" "Detected in many" "Astrocytes: 17.3;Excitatory neurons: 45.1;Inhibitory neurons: 46.3;Late spermatids: 16.6;NK-cells: 15.5;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "MAIT T-cell: 60.9" "Lineage enriched" "Detected in many" 34 "T-cells: 60.9" "Group enriched" "Detected in some" 6 "BEWO: 11.5;HDLM-2: 3.8;U-937: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.4 2.3 3.9 0.7 3.3 0.8 2.2 4.2 4.6 4.2 9.9 3.1 1.0 3.4 1.6 0.9 8.9 1.1 18.1 4.0 2.4 2.9 3.5 2.6 3.9 3.9 2.2 3.1 3.7 1.7 3.6 5.7 0.3 2.7 4.7 0.5 0.6 1.5 0.8 10.9 1.5 2.6 0.7 3.1 7.3 2.4 5.0 1.9 2.6 2.7 5.2 3.0 2.2 2.4 3.7 0.1 0.0 0.7 0.0 0.0 0.3 11.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 3.8 0.4 0.2 0.5 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.1 0.2 0.3 0.5 0.0 0.3 0.2 0.2 0.1 0.3 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.0 0.2 1.0 0.0 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.2 0.2 0.1 0.8 0.4 0.0 0.0 5.2 0.1 0.0 0.6 0.0 9.9 0.0 60.9 0.0 5.3 7.4 0.0 0.0 0.5 0.6 0.0 1.8 0.0 0.4 0.3 3.5 3.9 3.3 4.2 4.6 4.0 2.4 3.9 2.2 3.1 2.7 3.1 1.9 3.7 0.6 0.0 0.6 17.3 0.5 0.3 0.2 0.1 0.0 0.3 0.4 0.6 0.7 0.0 1.4 0.0 0.0 0.3 7.7 0.0 0.0 0.1 4.1 6.5 1.4 0.4 1.2 0.4 45.1 0.0 0.2 0.6 1.1 0.8 0.0 3.3 1.8 0.8 0.2 6.7 46.3 0.2 2.0 0.6 0.0 16.6 1.8 0.4 0.0 7.5 0.4 0.3 15.5 18.1 18.3 0.2 0.1 4.5 2.0 0.2 0.0 0.2 4.3 0.7 0.0 0.5 0.7 1.5 0.5 0.0 0.1 2.3 4.1 1.4 0.3 0.1 METTL6 MGC24132 ENSG00000206562 "Methyltransferase like 6" Q8TCB7 3 15381275-15440566 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 223.0;Late spermatids: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035166 Uncertain Approved Vesicles No No Vesicles "HPA035166: AB_10602709" "unprognostic (2.73e-1)" "unprognostic (3.53e-1)" "unprognostic (2.60e-1)" "unprognostic (1.29e-2)" "unprognostic (6.60e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.66e-6)" "unprognostic (3.98e-1)" "unprognostic (1.82e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" 7.9 7.1 13.1 7.6 14.1 5.4 9.8 14.3 16.0 9.1 7.9 6.1 6.2 9.0 8.9 8.2 9.6 6.3 7.9 14.2 14.1 7.0 6.4 6.7 9.3 11.5 12.2 13.6 12.3 6.5 9.3 8.3 9.3 11.7 8.5 7.2 13.3 5.8 9.2 7.1 8.1 5.9 10.4 11.4 7.5 7.1 18.1 13.8 10.3 9.6 7.8 10.1 7.7 6.6 17.1 13.5 21.4 23.4 20.2 21.0 23.7 59.3 24.0 24.5 28.4 29.9 12.9 17.2 22.3 16.1 22.7 24.2 11.0 23.3 20.8 30.0 15.9 25.6 21.4 20.6 19.9 39.7 20.5 18.5 21.3 25.6 34.1 17.1 22.9 26.6 22.8 22.5 22.4 28.6 28.0 22.7 17.0 23.7 14.2 25.6 17.4 29.0 22.0 17.1 18.6 10.1 18.7 20.9 19.1 19.8 16.9 27.9 17.6 18.1 22.0 14.1 22.3 22.0 24.1 43.9 26.7 23.6 19.5 21.1 7.2 8.1 12.2 9.7 10.7 9.6 7.6 9.1 9.7 9.2 9.6 9.1 10.0 4.7 11.8 10.5 12.4 9.1 6.9 13.1 14.1 14.3 16.0 14.2 14.1 11.5 12.2 13.6 11.7 11.4 13.8 17.1 5.6 3.2 5.5 20.5 6.8 4.0 8.0 13.9 10.2 17.4 5.9 6.5 5.5 1.5 7.8 9.2 6.2 9.2 5.0 1.3 5.9 10.2 223.0 5.9 10.7 7.7 1.8 6.3 37.4 13.5 21.5 8.2 4.1 5.4 5.1 14.2 5.3 2.3 9.0 20.2 38.2 2.3 4.1 4.4 4.2 121.3 9.0 6.8 5.4 9.4 8.0 11.9 13.4 17.1 22.0 9.2 2.7 9.1 10.3 5.5 4.6 4.9 9.3 15.9 6.6 8.7 8.6 31.3 17.6 6.3 2.8 11.6 8.2 11.4 3.7 5.3 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102028-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 7.3" "Group enriched" "Detected in some" 19 "Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "REH: 2.6;RPTEC TERT1: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles NA NA Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 0.1 0.2 5.4 0.5 6.9 0.0 0.0 1.1 3.5 0.3 0.0 1.2 0.2 0.1 0.2 0.5 0.1 0.2 0.4 7.0 4.1 0.1 0.0 0.0 0.4 0.1 2.3 7.3 0.0 0.2 0.0 0.7 0.0 0.7 0.3 0.4 0.6 0.3 0.5 0.0 0.2 0.4 0.1 0.0 0.1 0.3 0.1 4.9 0.5 0.0 0.0 0.4 0.3 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 9.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 6.9 1.1 3.5 7.0 4.1 0.1 2.3 7.3 0.7 0.0 4.9 3.5 0.5 9.6 18.7 7.8 0.1 0.4 0.6 0.0 0.6 12.5 0.1 0.3 2.1 0.0 9.3 3.7 35.5 0.1 0.4 0.1 0.0 0.1 0.9 0.6 0.2 2.4 0.0 0.0 306.3 0.9 0.1 2.3 0.0 1.1 0.0 0.2 1.1 0.4 0.1 0.0 1019.5 0.0 0.0 0.0 1.0 0.0 0.0 1.4 8.8 30.0 1.8 0.6 0.0 721.3 9.4 0.4 0.0 0.0 0.4 0.6 0.0 0.1 5.2 1.6 0.0 2.6 0.4 1.1 0.1 0.2 0.9 0.1 0.5 0.1 0.0 0.7 GPX3 ENSG00000211445 "Glutathione peroxidase 3" P22352 5 151020438-151028992 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 11782.1" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 20125.9" "Cancer enhanced" "Detected in all" "renal cancer: 605.6;thyroid cancer: 856.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "neutrophil: 20.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.7" "Cell line enriched" "Detected in many" 12 "ASC diff: 7677.4" "Region enhanced" "Detected in all" "hypothalamus: 239.5" "Low region specificity" "Detected in all" CAB069456 Approved "Secreted to blood" NA NA 5090000000 6200000000 "CAB069456: AB_1616682" "unprognostic (4.03e-1)" "unprognostic (7.35e-2)" "unprognostic (5.05e-3)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.13e-2)" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (5.75e-3)" "unprognostic (2.70e-3)" "unprognostic (8.17e-3)" "unprognostic (1.14e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (2.14e-1)" "unprognostic (5.11e-2)" "unprognostic (1.26e-1)" 4266.6 447.5 63.5 76.1 66.1 8.0 3215.4 61.2 74.4 820.7 500.4 713.7 89.1 419.5 91.5 573.2 1047.5 137.6 1882.5 67.6 307.8 11782.1 994.4 2493.3 134.4 333.5 98.9 53.6 522.2 259.1 113.4 799.9 597.1 107.0 562.2 94.3 4241.6 485.3 141.3 854.8 569.4 726.7 61.6 68.9 560.1 646.5 81.0 120.1 27.0 3657.3 463.0 45.3 1206.7 899.3 74.9 2.2 10.0 8.5 2.7 7677.4 6.7 9.2 3.5 0.8 7.9 2.4 177.5 3.9 1.1 214.1 5.6 3.2 2.8 39.6 433.2 6.0 6.1 2.5 1.9 4.3 195.0 294.7 0.5 4.3 649.1 41.2 0.2 1.0 10.6 11.3 1.2 1.2 0.3 11.0 31.4 0.5 1.2 13.8 0.8 0.2 1.0 5.2 1.7 74.1 4.3 11.3 11.4 1.2 31.6 1.9 33.6 43.5 2.1 2.5 2.3 19.6 3.7 1.0 2.7 15.6 2.5 7.0 3.0 0.6 0.0 4.3 0.1 0.0 1.6 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 20.7 0.0 0.2 0.0 0.0 1.6 63.5 66.1 61.2 74.4 67.6 307.8 333.5 98.9 53.6 107.0 68.9 120.1 74.9 353.6 9.6 33.7 1.0 106.8 18.5 86.9 94.8 1.2 26.3 31.7 5.5 639.8 18.6 58.3 649.2 43.8 713.8 2.2 2.3 1772.6 5.5 2.9 48.1 71.1 144.6 45.6 24.0 4.0 48.2 1191.3 514.0 50.0 627.9 11.4 274.9 735.3 228.4 151.5 16.8 0.4 5.9 91.6 47.9 86.7 17.5 446.7 160.2 23.2 3.7 0.7 5019.8 0.0 0.0 0.3 9.9 13.8 41.0 2.2 141.8 0.5 20125.9 39.1 86.8 683.7 131.6 264.6 7.1 10.3 13.9 21.6 1767.7 68.3 1.0 1.3 34.3 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197526-80387757 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 165.3;thyroid gland: 359.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 150.7;Endometrial stromal cells: 158.3;Extravillous trophoblasts: 523.3;Muller glia cells: 246.4" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 80.8;fHDF/TERT166: 41.8;HeLa: 95.4;HHSteC: 44.2;SiHa: 168.1;SK-BR-3: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.5 3.0 19.4 0.6 15.0 0.1 15.5 16.6 26.0 165.3 8.7 1.4 1.3 40.6 0.5 59.4 0.7 5.1 12.0 19.0 27.8 5.0 0.1 1.6 0.8 15.4 17.0 15.0 0.2 1.8 6.6 31.8 14.6 17.6 9.1 1.7 7.5 33.6 30.7 6.5 7.1 1.5 4.5 6.8 0.6 5.4 4.7 14.2 1.2 359.0 71.3 33.4 6.0 25.2 17.6 0.2 9.5 0.0 0.0 0.5 1.4 0.3 80.8 16.6 6.2 0.9 0.0 0.3 0.2 0.2 41.8 0.3 1.7 2.9 0.0 6.1 0.0 0.2 0.0 95.4 0.0 44.2 0.0 0.2 5.1 0.0 1.2 0.0 3.9 1.4 0.0 0.0 0.8 0.5 1.9 0.1 0.1 1.7 0.0 0.5 0.8 3.9 0.1 0.0 0.8 0.0 0.2 168.1 35.3 0.3 7.1 0.1 0.0 0.8 0.3 7.0 17.4 20.1 2.8 0.0 0.0 7.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 15.0 16.6 26.0 19.0 27.8 15.4 17.0 15.0 17.6 6.8 14.2 17.6 0.1 0.0 0.5 52.9 0.3 2.9 0.1 0.0 2.2 3.3 150.7 34.4 1.9 0.0 0.0 0.0 0.0 4.8 0.5 0.2 0.0 0.0 29.5 14.2 158.3 2.3 0.0 0.0 1.0 0.0 523.3 24.6 0.0 15.6 0.0 0.1 0.7 0.2 9.2 1.7 1.0 0.5 0.0 1.3 5.7 12.5 3.4 1.3 5.4 4.7 0.0 246.4 0.0 8.5 1.4 1.0 0.0 4.1 0.3 0.3 0.0 0.0 0.0 7.8 0.0 69.1 6.5 9.7 0.7 8.9 3.0 28.2 1.7 0.9 0.1 0.1 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 86.3 168.6 30.2 31.8 32.5 39.7 96.5 27.9 70.6 86.9 29.4 80.1 32.0 74.3 12.0 136.1 73.4 20.8 111.2 30.7 33.1 126.5 172.6 86.6 42.8 29.6 29.8 32.4 97.2 111.8 9.3 105.4 26.5 29.7 111.6 13.2 5.4 100.3 16.3 118.0 76.5 88.7 15.2 29.5 131.2 92.1 67.3 33.9 14.6 104.0 6.2 28.1 87.8 87.0 29.8 116.5 84.5 79.8 47.6 7.6 29.1 18.8 43.1 30.3 36.4 19.8 26.7 56.2 51.0 120.7 15.4 31.0 50.9 26.6 47.1 8.3 75.7 85.3 67.8 59.0 66.4 63.7 105.1 140.0 38.4 43.3 39.0 19.4 39.9 50.4 68.9 70.2 44.0 23.7 112.6 103.5 181.1 155.6 32.8 89.6 122.5 75.6 106.7 23.6 62.2 46.0 105.1 39.1 35.2 133.6 18.3 102.2 79.7 64.1 41.1 101.2 90.3 64.2 269.8 226.2 41.3 95.3 89.0 106.1 295.2 385.8 204.5 160.2 417.6 151.4 346.4 209.6 171.4 396.4 349.2 282.1 208.8 29.7 187.7 394.2 488.1 175.3 469.5 30.2 32.5 27.9 70.6 30.7 33.1 29.6 29.8 32.4 29.7 29.5 33.9 29.8 182.7 166.7 151.8 0.0 61.0 0.0 0.0 0.0 0.0 0.0 273.3 267.0 0.0 0.0 74.3 150.8 0.0 288.7 77.7 0.0 444.1 256.7 0.0 175.5 95.2 90.2 0.0 0.0 0.0 315.1 280.8 68.4 0.0 104.1 133.7 148.5 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.1 0.0 0.0 102.4 0.0 0.0 0.0 0.0 288.7 0.0 0.0 14.8 0.0 0.0 588.6 142.8 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 147.2 49.0 190.5 0.0 0.0 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "kidney: 146.2;liver: 186.8;thyroid gland: 262.5" "Group enriched" "Detected in some" 5 "Hepatocytes: 61.5;Proximal tubular cells: 115.7" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "Hep G2: 33.9;SK-BR-3: 79.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.2 0.2 0.1 0.2 0.2 0.7 0.2 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.2 4.7 1.0 0.6 0.1 0.1 146.2 186.8 0.4 0.8 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.7 0.2 0.0 262.5 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 1.0 0.3 0.0 33.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 79.0 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.1 0.1 0.3 0.1 0.0 0.4 0.1 0.2 0.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.9 0.1 15.2 11.5 0.4 0.0 0.0 0.5 0.1 0.0 11.7 0.0 3.6 0.3 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 61.5 0.5 0.0 0.5 0.0 0.0 2.2 0.0 5.3 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 115.7 10.2 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 2.3 0.3 0.1 0.0 0.0 STK38L "KIAA0965, NDR2" ENSG00000211455 "Serine/threonine kinase 38 like" Q9Y2H1 12 27243968-27325959 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 49.9;granulocytes: 80.7;monocytes: 33.0" "Cell line enhanced" "Detected in all" "HDLM-2: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038623, HPA051324" Approved Approved Cytosol NA NA Cytosol "HPA038623: AB_10967059, HPA051324: AB_2681442" "unprognostic (2.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.94e-2)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (4.68e-2)" "unprognostic (5.56e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (1.16e-1)" "unprognostic (3.41e-2)" "unprognostic (1.09e-1)" "unprognostic (1.95e-1)" "unprognostic (5.05e-2)" "unprognostic (1.05e-2)" 24.1 11.7 7.9 21.8 8.7 17.3 14.1 7.9 11.3 17.3 11.2 24.8 13.0 27.3 7.6 23.0 15.2 25.9 45.3 7.5 16.2 13.0 12.6 12.5 12.5 10.4 8.4 6.3 7.0 12.4 27.1 7.3 15.8 9.5 20.4 21.4 6.6 13.9 15.2 8.9 10.0 14.4 33.6 9.2 12.1 18.8 11.3 9.8 17.9 9.3 16.6 14.9 24.8 15.6 10.1 12.0 15.7 40.1 17.7 18.6 12.4 30.8 7.7 11.5 4.8 6.5 19.8 8.5 29.3 17.7 6.4 13.6 21.9 19.0 13.4 7.2 157.8 17.3 18.7 17.5 10.0 15.5 43.7 19.7 14.7 13.3 17.6 21.7 29.3 38.1 36.8 21.2 21.1 9.7 8.3 28.5 46.3 49.6 31.2 25.4 10.6 47.8 22.4 6.8 22.0 6.7 22.3 33.1 19.9 13.3 38.6 9.8 14.0 16.4 15.5 13.9 23.7 20.3 7.7 8.1 29.1 8.0 19.9 6.7 16.3 33.0 60.8 10.0 28.4 7.0 11.6 7.7 9.8 49.9 9.3 9.4 7.6 80.7 11.6 22.4 21.2 10.8 14.7 7.9 8.7 7.9 11.3 7.5 16.2 10.4 8.4 6.3 9.5 9.2 9.8 10.1 24.4 19.2 16.2 32.7 20.8 35.4 36.3 88.2 22.2 12.7 16.2 14.7 76.0 10.0 33.7 9.2 2.1 11.0 21.7 33.6 9.8 49.8 23.1 12.5 15.3 26.2 19.2 15.4 57.2 40.1 9.1 19.7 15.3 14.9 17.7 10.9 24.3 14.5 28.8 10.1 37.5 33.8 18.3 36.4 73.7 5.9 6.5 45.7 21.4 37.5 46.2 8.1 14.4 42.3 16.0 70.5 26.3 12.0 22.8 24.8 9.2 16.2 11.9 7.9 19.7 8.6 41.1 12.1 13.4 20.5 32.0 27.8 15.7 9.7 23.0 42.0 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745409 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 82000 "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: AB_2686216" "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favorable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 23.8 26.6 12.5 26.4 13.7 21.3 22.2 16.8 16.2 22.3 13.6 24.2 23.5 20.8 23.6 20.4 17.1 19.4 16.5 13.3 17.6 38.5 28.4 29.2 27.0 14.5 14.7 11.7 16.4 22.0 36.1 11.0 25.2 14.5 24.5 23.8 20.5 23.1 20.8 8.8 18.5 21.8 21.4 14.5 26.5 25.2 14.3 16.0 32.8 43.9 11.5 25.2 23.1 10.9 17.2 31.0 23.0 38.0 22.0 58.8 39.2 29.6 50.1 43.0 36.9 33.1 30.5 21.8 47.8 24.3 39.8 49.8 22.7 50.4 27.0 48.9 34.3 26.8 50.8 38.2 25.7 37.6 78.0 61.5 26.5 41.1 39.9 29.6 29.9 25.6 43.2 57.9 45.7 60.6 14.0 59.5 41.4 40.1 29.6 40.1 17.2 20.0 48.4 41.2 42.7 15.0 36.1 35.5 36.3 44.7 38.0 31.0 64.1 33.7 36.2 21.1 37.0 44.5 25.3 71.7 32.5 45.1 106.8 36.2 10.3 17.1 27.5 24.6 14.2 27.5 11.0 17.8 26.0 27.2 11.9 17.6 23.5 14.1 65.2 13.0 11.1 16.7 27.6 12.5 13.7 16.8 16.2 13.3 17.6 14.5 14.7 11.7 14.5 14.5 16.0 17.2 18.4 28.9 37.3 22.5 22.2 19.6 9.1 14.6 22.2 22.8 15.2 12.3 16.6 14.3 15.7 7.3 31.3 22.9 55.4 16.4 19.6 11.1 1.6 15.9 31.9 17.6 12.0 23.4 44.7 10.0 11.2 19.5 17.3 18.5 17.1 17.2 17.2 15.4 24.5 33.7 42.7 9.4 18.3 23.0 18.7 2.9 16.8 22.6 17.8 30.9 25.5 15.8 46.4 40.7 43.6 12.9 20.7 23.0 33.2 14.6 18.5 22.3 14.1 20.7 6.6 15.8 16.6 12.3 12.0 15.7 17.3 18.3 44.5 19.5 13.6 11.6 TSN "BCLF-1, REHF-1, TRSLN" ENSG00000211460 Translin Q15631 2 121737103-121767853 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059561 Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA 280000 "Nucleoplasm, Endoplasmic reticulum" "HPA059561: AB_2684063" "unprognostic (3.15e-2)" "unprognostic (1.83e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (7.05e-4)" "unprognostic (7.13e-3)" "unprognostic (3.12e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (2.32e-2)" "unprognostic (7.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.10e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (6.48e-2)" "unprognostic (1.04e-2)" "unprognostic (3.42e-2)" "unprognostic (3.18e-1)" 16.3 17.1 23.1 13.6 24.3 48.3 25.7 25.0 28.6 17.6 21.0 23.5 17.0 15.9 18.1 16.7 14.3 13.3 19.7 22.9 25.2 24.6 23.1 14.5 19.2 23.8 24.7 22.1 16.9 18.5 21.8 13.2 10.9 24.6 14.7 19.0 16.8 15.0 17.4 31.9 19.5 14.7 14.3 23.8 14.8 15.1 26.5 25.0 24.3 17.4 31.3 18.4 15.7 12.9 26.0 56.2 24.8 38.4 34.1 35.0 27.8 21.1 45.6 43.2 50.3 48.4 71.1 32.3 81.7 51.9 45.4 30.1 27.0 55.0 46.6 69.8 43.2 44.3 48.0 33.0 68.3 40.0 69.3 32.5 24.2 51.3 56.3 38.7 23.0 43.2 40.0 72.9 39.4 47.4 30.5 38.2 77.5 46.6 32.8 47.2 67.6 43.1 59.3 63.7 36.0 48.9 30.6 31.4 46.6 61.2 29.2 29.3 54.1 30.8 36.2 56.4 22.9 45.1 33.8 97.0 85.4 40.3 46.8 45.6 27.6 29.8 28.6 22.5 27.9 26.9 27.4 23.4 19.8 27.4 21.0 26.5 22.9 9.3 26.9 24.3 20.1 25.6 28.8 23.1 24.3 25.0 28.6 22.9 25.2 23.8 24.7 22.1 24.6 23.8 25.0 26.0 34.7 32.1 24.4 15.0 37.5 39.1 34.4 49.1 23.3 32.1 38.2 27.6 34.7 42.9 36.9 42.3 22.9 34.9 34.3 22.3 43.0 64.4 80.0 24.9 29.7 42.7 19.9 34.7 19.8 60.0 33.3 32.5 15.8 23.9 40.0 36.0 58.5 44.4 35.2 16.8 19.8 27.7 57.0 35.6 34.9 19.8 36.4 29.8 67.6 15.0 45.4 88.7 44.3 29.1 33.5 45.4 22.2 31.2 25.4 34.7 24.4 58.7 33.0 29.5 26.3 39.9 81.8 152.8 96.6 36.7 43.9 28.5 36.8 38.5 37.9 28.8 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782751 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.6" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 102.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles NA NA Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favorable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favorable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 27.5 37.7 97.9 7.0 127.3 12.4 27.9 115.3 101.9 26.8 61.1 22.3 7.5 20.4 16.3 29.1 28.7 15.6 25.5 94.5 98.3 44.3 15.3 22.5 7.0 123.9 129.6 81.5 53.6 19.6 29.6 17.8 17.9 128.2 20.6 10.7 11.3 20.3 22.9 30.2 21.8 14.4 16.7 105.1 26.0 22.3 10.0 118.1 8.0 53.1 21.7 8.3 27.8 22.8 137.6 11.9 36.3 5.7 42.8 36.4 15.5 12.3 8.3 18.3 7.8 8.0 11.7 31.0 7.2 102.7 23.3 15.5 45.4 7.3 9.6 6.0 59.1 6.8 49.4 30.4 16.1 20.8 13.3 27.9 9.2 19.3 11.2 13.6 40.6 22.1 20.0 13.1 28.3 5.1 24.7 6.5 13.7 3.9 21.9 17.1 6.0 1.6 39.0 31.5 31.3 7.3 3.3 11.0 13.8 7.8 10.2 46.0 12.2 12.3 10.9 14.3 21.1 6.0 21.6 14.3 2.2 14.2 62.8 6.7 0.1 17.9 12.4 5.2 13.5 4.7 10.4 6.4 5.5 12.9 9.9 7.7 6.4 36.7 2.0 7.7 2.6 5.5 6.3 97.9 127.3 115.3 101.9 94.5 98.3 123.9 129.6 81.5 128.2 105.1 118.1 137.6 35.2 9.6 13.5 35.3 6.2 6.6 9.7 6.4 22.2 11.1 15.5 15.2 16.4 20.0 5.5 51.5 2.1 9.5 2.3 9.0 23.5 10.4 8.5 10.9 6.2 22.3 8.4 53.0 9.1 9.8 2.3 15.6 4.6 18.0 1.3 16.4 16.8 11.8 24.1 15.2 8.3 13.5 6.1 18.0 9.9 12.5 32.6 14.1 5.4 8.4 28.4 26.8 2.1 11.1 100.3 6.6 5.2 23.0 10.1 12.9 9.2 34.9 2.3 11.2 6.6 11.9 11.6 4.1 10.5 20.9 11.9 3.6 3.3 18.0 7.5 11.6 IGKC HCAK1 ENSG00000211592 "Immunoglobulin kappa constant" 2 88857161-88857683 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "intestine: 35531.9;lymphoid tissue: 63598.9" "Group enriched" "Detected in many" 12 "B-cells: 72318.1;Plasma cells: 96515.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 21 "memory B-cell: 39143.0;naive B-cell: 35081.5" "Lineage enriched" "Detected in all" 23 "B-cells: 39143.0" "Group enriched" "Detected in many" 6 "Daudi: 9909.1;U-266/70: 10337.6;U-266/84: 3927.9;U-698: 12154.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB015377 Uncertain "Immunoglobulin genes" NA NA "CAB015377: AB_2251264" "prognostic favorable (6.59e-4)" "unprognostic (1.04e-2)" "unprognostic (3.54e-2)" "unprognostic (1.06e-2)" "unprognostic (8.82e-3)" "prognostic favorable (1.18e-4)" "unprognostic (1.24e-1)" "unprognostic (1.79e-1)" "unprognostic (3.19e-2)" "unprognostic (2.81e-3)" "unprognostic (2.82e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (2.17e-9)" "unprognostic (1.85e-1)" "unprognostic (2.47e-1)" "unprognostic (9.26e-2)" "unprognostic (1.59e-1)" 1034.9 2402.5 13.0 20693.4 17.6 6371.2 11399.9 11.2 33.9 3680.4 32.9 35531.9 24737.8 885.9 478.3 5760.2 1147.7 6051.2 816.6 11.9 42.1 1162.1 1593.8 5876.7 21538.2 26.5 44.5 11.0 2233.9 466.9 73.2 102.6 22.4 16.1 851.2 30908.9 4.0 19786.9 2143.6 33.2 252.8 17203.6 1271.3 42.1 27119.7 22946.1 1092.7 17.6 8654.4 2169.1 8.2 63598.9 25033.2 710.9 27.4 17.1 0.0 0.0 0.0 0.0 0.0 103.7 0.0 0.0 0.1 0.0 0.0 0.0 9909.1 15.3 0.0 1.0 22.2 0.0 0.0 0.0 510.2 0.0 30.9 0.0 0.0 0.0 67.8 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.8 0.4 0.0 0.0 18.3 83.2 28.8 0.0 0.0 16.7 56.4 1509.5 0.6 0.0 79.6 146.1 19.6 1.5 6.0 0.5 0.5 17.2 66.7 0.0 56.9 24.3 44.0 10337.6 3927.9 12154.4 0.0 28.9 0.0 47.5 55.6 31.6 24.6 11.2 21.7 39143.0 28.3 18.3 46.6 35081.5 15.2 16.8 65.2 24.1 29.1 1735.4 23.7 8567.0 13.0 17.6 11.2 33.9 11.9 42.1 26.5 44.5 11.0 16.1 42.1 17.6 27.4 58.6 336.5 1863.8 0.0 72318.1 0.0 189.2 0.0 2.2 0.0 8.8 7.0 5.7 163.0 88.5 0.0 0.0 48.0 452.1 39.8 3.9 0.0 2.8 0.7 0.3 72.8 77.8 1658.9 0.0 0.2 37.3 186.5 64.7 0.4 849.0 15.5 340.2 334.8 8.9 0.0 0.0 35.1 0.0 496.3 0.0 11.0 0.0 64.4 0.0 0.0 26.4 0.0 59.8 0.0 0.0 0.0 25.9 0.4 96515.7 193.2 0.3 45.2 12.4 0.0 0.0 3.7 38.4 0.3 0.2 5.9 0.0 49.4 6505.3 0.1 50.2 1.9 IGKJ5 ENSG00000211593 "Immunoglobulin kappa joining 5" 2 88860568-88860605 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 1232.4;lymphoid tissue: 1378.5;stomach 1: 1076.4" "Cell type enriched" "Detected in single" 13 "B-cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 24 "memory B-cell: 9254.1;naive B-cell: 8737.5" "Lineage enriched" "Detected in all" 25 "B-cells: 9254.1" "Cell line enriched" "Detected in some" 24 "U-698: 3392.4" NA NA "unprognostic (4.92e-2)" "unprognostic (2.57e-2)" "unprognostic (3.68e-2)" "unprognostic (9.30e-3)" "prognostic favorable (1.83e-4)" "unprognostic (1.12e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (5.49e-6)" "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (2.02e-1)" 25.5 42.6 0.6 1378.5 0.8 165.9 238.9 0.7 4.5 74.4 1.1 1205.8 1232.4 13.6 5.8 131.9 8.9 79.2 26.3 0.9 6.7 18.1 31.0 159.0 534.1 2.0 3.4 0.1 63.9 29.5 6.6 0.0 4.1 1.0 23.0 1182.7 0.0 649.6 17.3 0.0 5.9 1087.7 41.0 4.6 678.6 1076.4 12.5 0.8 62.1 4.4 0.0 1224.0 440.4 0.0 1.9 17.7 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 142.3 0.0 0.0 0.0 0.0 0.0 7.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 58.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.3 3.5 11.4 3.2 1.9 3392.4 0.0 8.1 0.0 3.3 10.1 10.2 3.8 1.3 2.2 9254.1 18.4 3.5 7.4 8737.5 9.5 3.4 9.4 7.6 3.4 373.6 8.8 1167.3 0.6 0.8 0.7 4.5 0.9 6.7 2.0 3.4 0.1 1.0 4.6 0.8 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ4 ENSG00000211594 "Immunoglobulin kappa joining 4" 2 88860886-88860922 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 3312.8;lymphoid tissue: 2932.9;stomach 1: 2316.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 42 "memory B-cell: 36413.7;naive B-cell: 27723.7" "Lineage enriched" "Detected in all" 48 "B-cells: 36413.7" "Cell line enhanced" "Detected in some" "BEWO: 16.9;Daudi: 23.5;HDLM-2: 58.4;RPMI-8226: 43.3;SH-SY5Y: 27.6;U-698: 25.7" NA NA 80.8 271.3 0.9 2932.9 1.2 411.0 418.8 0.6 4.2 110.9 0.9 1861.8 3312.8 29.8 63.1 437.0 33.6 139.4 35.1 0.9 1.5 48.7 105.5 485.6 940.4 2.8 3.0 1.0 118.5 29.6 1.8 0.0 1.3 1.5 56.9 1867.2 0.3 1152.8 55.3 3.9 17.4 2202.3 78.8 2.8 1257.1 2316.3 40.0 1.6 114.5 11.5 0.0 2684.3 651.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 9.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 2.0 10.4 0.0 0.0 0.0 0.0 9.1 43.3 0.0 0.0 6.7 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.3 8.5 3.3 0.0 25.7 0.0 0.0 0.0 114.4 64.9 20.3 24.9 9.5 16.8 36413.7 15.8 15.2 32.5 27723.7 22.7 16.1 60.0 21.5 25.4 759.9 22.8 3519.3 0.9 1.2 0.6 4.2 0.9 1.5 2.8 3.0 1.0 1.5 2.8 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ3 ENSG00000211595 "Immunoglobulin kappa joining 3" 2 88861221-88861258 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 1019.9;lymphoid tissue: 1005.6;stomach 1: 716.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 10 "spinal cord: 17.8" "Group enriched" "Detected in all" 26 "memory B-cell: 8663.4;naive B-cell: 7153.9" "Lineage enriched" "Detected in all" 28 "B-cells: 8663.4" "Group enriched" "Detected in some" 6 "HDLM-2: 105.2;RPMI-8226: 89.2;U-698: 41.2" NA NA 15.2 19.8 0.7 895.1 0.5 116.0 112.3 0.3 1.7 19.4 0.3 592.9 1019.9 7.6 0.0 69.4 7.9 45.2 9.4 0.8 0.6 14.5 41.4 102.9 494.2 1.2 1.0 0.1 31.4 0.0 0.0 0.0 1.9 1.1 18.4 551.7 0.6 365.7 12.7 8.8 2.5 732.4 20.1 17.8 553.4 716.6 9.8 0.6 54.4 5.2 4.0 1005.6 238.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 105.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 89.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 41.2 0.0 0.0 0.0 17.0 8.6 57.9 1.9 1.1 9.2 8663.4 3.0 3.3 5.9 7153.9 5.7 5.1 61.8 7.1 15.2 309.9 7.8 660.0 0.7 0.5 0.3 1.7 0.8 0.6 1.2 1.0 0.1 1.1 17.8 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKJ2 J2 ENSG00000211596 "Immunoglobulin kappa joining 2" 2 88861525-88861563 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 2694.9;lymphoid tissue: 2245.4;salivary gland: 1198.5;stomach 1: 1734.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 50 "memory B-cell: 22200.6;naive B-cell: 20663.6" "Lineage enriched" "Detected in all" 52 "B-cells: 22200.6" "Group enriched" "Detected in many" 7 "HDLM-2: 213.9;RPMI-8226: 179.1" NA NA 68.5 155.5 0.6 1880.2 1.2 299.0 316.1 0.4 3.9 160.1 2.0 1779.2 2694.9 37.8 0.0 311.1 14.5 115.1 19.8 0.9 6.5 27.2 62.3 238.8 699.2 3.7 2.2 0.6 72.3 73.2 2.0 0.0 1.1 1.3 46.4 1377.1 0.0 1198.5 20.4 2.9 5.3 1990.9 28.5 1.5 1106.8 1734.9 45.2 0.9 74.2 5.2 0.0 2245.4 498.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 3.5 0.0 0.0 0.0 213.9 0.0 9.7 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 8.0 3.6 0.0 0.0 7.4 2.5 179.1 0.0 0.0 3.2 17.5 4.8 0.0 0.0 0.0 0.0 29.6 10.7 0.0 3.4 3.7 7.6 5.3 0.0 29.0 0.0 1.8 0.0 19.7 33.6 12.8 10.3 7.7 12.8 22200.6 15.0 8.1 23.3 20663.6 9.5 9.6 42.6 10.8 18.6 430.3 17.4 2451.2 0.6 1.2 0.4 3.9 0.9 6.5 3.7 2.2 0.6 1.3 1.5 0.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGKJ1 J1 ENSG00000211597 "Immunoglobulin kappa joining 1" A0A0A0MT89 2 88861886-88861923 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 3110.4;lymphoid tissue: 3332.8;salivary gland: 1213.8;stomach 1: 2841.6;urinary bladder: 1115.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 418 "memory B-cell: 38345.4;naive B-cell: 32121.1;plasmacytoid DC: 14778.6" "Group enriched" "Detected in all" 390 "B-cells: 38345.4;dendritic cells: 14778.6" "Cell line enriched" "Detected in many" 4 "U-266/70: 21925.7" "Immunoglobulin genes" NA NA 71.2 229.3 1.4 3332.8 1.1 428.3 366.8 1.2 9.3 72.3 4.7 1979.4 3110.4 42.0 0.0 280.6 18.3 158.9 31.3 2.3 3.1 32.0 92.7 385.9 846.2 3.0 2.7 0.8 128.8 50.7 2.0 0.0 6.4 2.5 50.9 1760.0 0.2 1213.8 16.6 6.9 8.9 2250.2 61.8 2.7 1529.5 2841.6 31.5 1.7 116.4 6.3 0.0 2793.6 1115.9 0.0 3.4 22.9 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 7.4 0.0 9.9 2.5 0.0 0.0 14.6 0.0 0.0 0.0 851.1 0.0 10.1 0.0 0.0 0.0 34.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 10.3 12.1 11.8 0.0 0.0 23.1 0.0 4365.8 0.0 0.0 10.3 18.7 0.0 0.0 4.9 0.0 0.0 31.0 0.0 0.0 9.7 2.4 34.6 21925.7 5461.9 93.7 0.0 6.3 0.0 48.3 44.8 22.7 19.1 17.9 25.4 38345.4 27.2 13.8 57.2 32121.1 20.1 20.9 68.0 38.9 26.9 14778.6 29.9 3897.0 1.4 1.1 1.2 9.3 2.3 3.1 3.0 2.7 0.8 2.5 2.7 1.7 3.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV4-1 "B3, IGKV41" ENSG00000211598 "Immunoglobulin kappa variable 4-1" P06312 2 88885397-88886153 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1823.0;lymphoid tissue: 3195.0" "Cell type enriched" "Detected in some" 219 "Plasma cells: 46306.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 588 "memory B-cell: 3036.3;naive B-cell: 3070.9" "Lineage enriched" "Detected in all" 591 "B-cells: 3070.9" "Cell line enhanced" "Detected in some" "Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5" "Immunoglobulin genes" NA NA 8500000000 "prognostic favorable (6.41e-5)" "unprognostic (9.19e-2)" "unprognostic (4.29e-3)" "unprognostic (5.42e-3)" "unprognostic (2.08e-2)" "prognostic favorable (8.25e-4)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (3.32e-1)" "unprognostic (3.71e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" "unprognostic (1.19e-1)" 56.4 299.2 0.5 1064.0 1.0 345.3 671.9 0.5 3.4 146.4 2.5 1823.0 1785.8 47.3 19.6 197.5 41.6 189.9 52.3 0.6 7.8 34.8 76.7 305.1 823.4 1.8 7.3 0.4 87.3 28.6 2.5 2.9 1.0 3.1 44.3 1330.7 0.1 708.3 90.4 1.0 8.7 1031.5 67.0 3.5 980.1 1135.9 126.7 0.7 408.8 51.4 0.1 3195.0 764.7 19.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.6 3.6 0.3 0.0 0.0 1.4 2.2 10.4 0.0 0.0 4.0 6.9 2.3 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.8 1.1 1.0 7.5 0.2 0.8 0.0 1.2 0.0 3.9 3.2 5.1 1.6 0.9 1.7 3036.3 1.9 1.1 2.8 3070.9 2.1 1.3 2.4 1.6 2.4 2.3 1.7 344.9 0.5 1.0 0.5 3.4 0.6 7.8 1.8 7.3 0.4 3.1 3.5 0.7 1.5 0.0 0.0 0.0 0.0 210.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.0 0.0 0.0 0.0 17.0 40.2 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46306.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 15.7 0.0 0.1 0.0 IGKV5-2 "B2, IGKV52" ENSG00000211599 "Immunoglobulin kappa variable 5-2" P06315 2 88897232-88897784 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.2;lymphoid tissue: 83.8" "Cell type enriched" "Detected in some" 193 "Plasma cells: 1664.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "memory B-cell: 21.4;naive B-cell: 17.2" "Lineage enriched" "Detected in many" 21 "B-cells: 21.4" "Group enriched" "Detected in some" 19 "Daudi: 4.2;HDLM-2: 1.8;RPMI-8226: 2.3" "Low region specificity" "Detected in all" "Immunoglobulin genes" NA NA 4700000 "unprognostic (1.77e-3)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (2.49e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.37e-1)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (8.62e-6)" "unprognostic (2.60e-1)" "unprognostic (2.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.85e-2)" 0.5 0.0 0.0 10.4 0.0 6.5 19.8 0.0 0.0 5.3 0.0 23.5 36.2 0.8 0.0 4.1 0.9 0.9 0.1 0.0 0.0 0.9 1.0 6.3 17.5 0.0 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.0 0.6 11.2 0.0 15.0 1.9 0.0 0.5 14.4 0.2 0.0 23.7 15.4 0.0 0.0 3.0 1.0 0.0 83.8 4.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1664.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGKV6-21 "A26, IGKV621" ENSG00000211611 "Immunoglobulin kappa variable 6-21 (non-functional)" A0A0C4DH24 2 89159751-89160366 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 98.2;lymphoid tissue: 142.1" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1715.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 194 "memory B-cell: 28.8;naive B-cell: 9.8" "Lineage enriched" "Detected in single" 289 "B-cells: 28.8" "Cell line enriched" "Detected in some" 6 "U-266/70: 10.5" "Immunoglobulin genes" NA NA 250000000 "prognostic favorable (1.82e-4)" "unprognostic (1.80e-2)" "unprognostic (4.99e-3)" "unprognostic (2.32e-2)" "unprognostic (1.51e-3)" "unprognostic (1.93e-1)" "unprognostic (6.32e-2)" "unprognostic (4.74e-2)" "unprognostic (8.91e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" 1.1 0.4 0.0 42.0 0.1 12.1 37.7 0.0 0.1 2.2 0.0 98.2 39.2 1.8 0.6 8.5 2.0 5.9 0.5 0.0 0.7 2.7 2.6 12.0 65.0 0.2 0.3 0.0 2.2 0.9 0.0 0.1 0.0 0.0 1.5 80.0 0.0 43.9 9.1 0.0 0.4 38.8 5.0 0.1 64.3 36.6 0.9 0.0 10.3 3.6 0.0 142.1 37.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.1 0.0 0.7 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1715.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGKV2D-26 ENSG00000211623 "Immunoglobulin kappa variable 2D-26" A0A0A0MRZ7 2 89985922-89986702 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.6;lymphoid tissue: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 245 "memory B-cell: 21.8;naive B-cell: 27.1" "Lineage enriched" "Detected in single" 272 "B-cells: 27.1" "Cell line enriched" "Detected in single" 10 "U-698: 1.0" "Immunoglobulin genes" NA NA 1000000000 "unprognostic (1.11e-1)" "unprognostic (6.09e-2)" 0.0 0.4 0.0 1.5 0.1 0.5 1.0 0.0 0.2 0.1 0.0 4.6 3.6 0.0 0.0 0.6 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.0 0.0 0.0 2.8 0.0 0.0 2.3 1.3 0.0 0.0 0.5 0.0 0.0 6.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV3D-20 ENSG00000211625 "Immunoglobulin kappa variable 3D-20" A0A0C4DH25 2 90038848-90039479 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 133.1;lymphoid tissue: 277.7" "Cell type enriched" "Detected in some" 38 "Plasma cells: 289.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 1042 "memory B-cell: 197.3;naive B-cell: 99.0" "Lineage enriched" "Detected in single" 1388 "B-cells: 197.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 19.5" HPA047702 Approved "Immunoglobulin genes" NA NA 11000000000 "HPA047702: " "prognostic favorable (6.82e-4)" "unprognostic (4.70e-3)" "unprognostic (3.16e-2)" "unprognostic (8.10e-3)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (3.37e-1)" "unprognostic (1.68e-1)" "unprognostic (5.15e-2)" "unprognostic (2.53e-2)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.56e-6)" "unprognostic (7.10e-2)" "unprognostic (2.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" 4.1 6.3 0.0 81.9 0.0 16.2 32.7 0.0 0.4 12.3 0.0 133.1 56.4 2.7 0.0 15.4 4.2 16.4 6.5 0.0 0.6 2.9 6.5 20.8 74.1 0.1 0.1 0.0 7.2 3.3 0.0 0.3 0.1 0.1 3.7 89.0 0.0 64.6 3.4 0.1 2.6 78.3 6.1 0.3 89.1 83.2 1.2 0.0 16.3 5.2 0.0 277.7 38.4 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.5 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 197.3 0.0 0.1 0.1 99.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.1 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 289.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 IGKV6D-41 ENSG00000211626 "Immunoglobulin kappa variable 6D-41 (non-functional)" A0A0C4DH26 2 90069662-90070238 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 4.7;intestine: 3.4;lymphoid tissue: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "lung cancer: 0.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "memory B-cell: 3.0;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 49 "B-cells: 4.9" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 32000000 "unprognostic (3.64e-2)" "unprognostic (4.43e-1)" 0.0 1.4 0.0 1.4 0.0 0.0 0.1 0.0 0.0 4.7 0.0 3.4 1.0 0.0 0.0 0.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.1 0.2 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV3D-11 ENSG00000211632 "Immunoglobulin kappa variable 3D-11" A0A0A0MRZ8 2 90172802-90173414 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.9;lymphoid tissue: 59.0;stomach 1: 28.0" "Cell type enriched" "Detected in some" 34 "Plasma cells: 196.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 468 "memory B-cell: 152.5;naive B-cell: 146.1" "Lineage enriched" "Detected in single" 478 "B-cells: 152.5" "Cell line enhanced" "Detected in single" "U-266/70: 2.1" HPA047702 Approved "Immunoglobulin genes" NA NA 6700000000 "HPA047702: " "prognostic favorable (6.40e-5)" "unprognostic (7.90e-3)" "unprognostic (1.91e-2)" "unprognostic (2.24e-3)" "prognostic favorable (5.58e-5)" "unprognostic (2.65e-2)" "unprognostic (2.13e-1)" "unprognostic (2.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.49e-1)" "unprognostic (3.61e-1)" "prognostic unfavorable (2.20e-6)" "unprognostic (1.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "unprognostic (1.24e-2)" 1.2 0.7 0.2 36.3 0.2 8.9 6.4 0.0 0.1 1.8 0.0 38.9 32.5 0.8 0.0 2.4 2.1 2.7 0.5 0.0 0.3 2.1 1.4 12.5 13.1 0.1 0.2 0.0 1.5 0.5 0.0 0.1 0.0 0.1 0.7 26.9 0.0 18.9 0.3 0.0 0.0 23.8 0.7 0.2 30.2 28.0 0.2 0.1 4.3 2.3 0.0 59.0 17.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 152.5 0.0 0.0 0.1 146.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 30.2 0.2 0.2 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 IGKV1D-42 ENSG00000211633 "Immunoglobulin kappa variable 1D-42 (non-functional)" A0A075B6H8 2 90190193-90190681 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.2;lymphoid tissue: 25.5" "Cell type enriched" "Detected in single" 93 "Plasma cells: 9.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "memory B-cell: 5.6;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 57 "B-cells: 5.6" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 2.6" HPA048721 Approved "Immunoglobulin genes" NA NA 41000000 "HPA048721: " "unprognostic (8.08e-6)" "unprognostic (4.83e-2)" "unprognostic (2.22e-2)" "unprognostic (2.51e-3)" "unprognostic (1.84e-1)" "unprognostic (2.10e-2)" "unprognostic (1.66e-5)" "unprognostic (1.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (1.39e-1)" 0.1 0.0 0.0 7.6 0.0 6.7 10.9 0.0 0.0 0.8 0.0 18.9 7.6 0.2 0.3 1.4 0.2 1.7 0.1 0.0 0.0 0.0 0.3 2.9 2.6 0.1 0.0 0.0 4.1 1.1 0.0 0.0 0.0 0.0 0.1 48.2 0.0 8.6 0.0 0.0 0.1 7.9 0.0 0.0 4.3 14.1 0.0 0.0 0.6 0.3 0.0 25.5 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV4-69 ENSG00000211637 "Immunoglobulin lambda variable 4-69" A0A075B6H9 22 22030934-22031472 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 434.2;lymphoid tissue: 465.1;salivary gland: 117.7;stomach 1: 288.1;urinary bladder: 205.7" "Cell type enriched" "Detected in some" 140 "Plasma cells: 4593.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "medulla oblongata: 1.2" "Group enriched" "Detected in some" 302 "memory B-cell: 331.7;naive B-cell: 224.0" "Lineage enriched" "Detected in single" 361 "B-cells: 331.7" "Cell line enhanced" "Detected in some" "Daudi: 1.0;NB-4: 1.0;REH: 1.3;RPMI-8226: 5.4;SH-SY5Y: 1.3" "Immunoglobulin genes" NA NA 320000000 "prognostic favorable (1.02e-4)" "unprognostic (1.32e-2)" "unprognostic (2.19e-3)" "unprognostic (1.34e-3)" "unprognostic (2.67e-2)" "prognostic favorable (4.04e-5)" "unprognostic (2.59e-3)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (5.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.89e-5)" "unprognostic (9.74e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-1)" "unprognostic (6.08e-2)" 15.7 9.8 0.1 174.0 0.4 43.6 64.7 0.1 0.3 28.1 0.1 328.9 434.2 5.7 0.2 52.7 5.5 44.5 15.3 0.0 0.1 6.1 14.6 72.8 454.3 1.2 0.0 0.0 10.7 8.5 0.3 1.1 0.1 0.2 6.4 211.5 0.0 117.7 6.4 0.2 0.5 221.4 3.4 0.0 308.4 288.1 1.4 0.2 82.9 9.9 0.1 465.1 205.7 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.3 0.0 5.4 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.6 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.1 331.7 0.2 0.1 0.2 224.0 0.0 0.1 0.9 0.1 0.1 0.1 0.2 32.3 0.1 0.4 0.1 0.3 0.0 0.1 1.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 11.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4593.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 IGLV8-61 ENSG00000211638 "Immunoglobulin lambda variable 8-61" A0A075B6I0 22 22098700-22099212 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 813.1;lymphoid tissue: 992.0" "Cell type enriched" "Detected in some" 4 "B-cells: 25.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Group enriched" "Detected in some" 630 "memory B-cell: 257.8;naive B-cell: 529.3" "Lineage enriched" "Detected in single" 848 "B-cells: 529.3" "Cell line enhanced" "Detected in some" "Daudi: 2.2;RPMI-8226: 3.6;SH-SY5Y: 1.8;U-266/70: 6.6" "Low region specificity" "Detected in all" "Immunoglobulin genes" NA NA 620000000 "unprognostic (1.07e-3)" "unprognostic (2.73e-2)" "prognostic favorable (3.84e-4)" "unprognostic (1.07e-2)" "unprognostic (5.24e-2)" "unprognostic (1.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.75e-3)" "unprognostic (2.05e-1)" "unprognostic (2.11e-1)" "unprognostic (3.32e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-1)" 9.5 5.0 0.4 126.7 0.4 64.5 79.0 0.3 3.5 43.9 1.1 203.0 813.1 22.9 0.8 10.7 5.6 46.9 11.8 0.3 0.4 5.4 13.8 82.9 259.5 0.4 1.3 0.3 9.3 13.5 1.3 0.8 0.0 0.8 10.6 192.7 0.0 109.6 1.0 0.2 4.0 162.9 13.1 0.3 277.9 180.8 3.3 0.4 16.6 11.6 0.0 992.0 250.1 3.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.0 0.2 3.6 0.0 0.0 1.0 1.8 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.3 6.6 1.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.2 0.1 257.8 0.3 0.0 0.4 529.3 0.0 0.0 0.2 0.1 0.4 0.1 0.2 32.7 0.4 0.4 0.3 3.5 0.3 0.4 0.4 1.3 0.3 0.8 0.3 0.4 1.4 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGLV4-60 ENSG00000211639 "Immunoglobulin lambda variable 4-60" A0A075B6I1 22 22162199-22162681 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 194.8;lymphoid tissue: 117.3;urinary bladder: 186.6" "Cell type enriched" "Detected in some" 152 "Plasma cells: 1125.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 78 "memory B-cell: 79.4;naive B-cell: 48.9" "Lineage enriched" "Detected in single" 96 "B-cells: 79.4" "Group enriched" "Detected in some" 4 "Daudi: 7.8;HEL: 13.3;U-698: 3.9" "Immunoglobulin genes" NA NA 120000000 "prognostic favorable (2.57e-4)" "unprognostic (5.46e-3)" "unprognostic (9.43e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.89e-4)" "unprognostic (3.06e-2)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.81e-1)" "unprognostic (1.29e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.19e-1)" "unprognostic (2.60e-1)" 1.8 1.9 0.0 33.2 0.0 18.2 37.0 0.0 0.2 3.3 0.1 71.4 194.8 1.5 0.0 12.4 1.9 3.4 11.5 0.0 0.0 1.5 3.9 43.9 117.3 0.0 0.0 0.0 4.7 1.1 0.4 0.2 0.2 0.1 1.1 74.1 0.0 38.2 0.8 0.1 0.1 87.5 2.1 0.0 81.0 38.1 1.7 0.0 18.5 1.7 0.0 112.9 186.6 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 0.1 0.0 0.0 48.9 0.0 0.0 0.8 0.0 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1125.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGLV6-57 ENSG00000211640 "Immunoglobulin lambda variable 6-57" P01721 22 22195799-22196276 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1829.2;urinary bladder: 681.3" "Cell type enriched" "Detected in some" 72 "Plasma cells: 10791.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory B-cell: 353.9;naive B-cell: 292.4" "Lineage enriched" "Detected in many" 13 "B-cells: 353.9" "Cell line enhanced" "Detected in some" "Daudi: 148.0;RPMI-8226: 40.6;U-266/70: 21.6;U-698: 47.3" "Immunoglobulin genes" NA NA 1900000000 "prognostic favorable (1.92e-6)" "unprognostic (5.73e-2)" "unprognostic (2.59e-2)" "unprognostic (2.11e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.36e-5)" "unprognostic (1.87e-2)" "unprognostic (2.56e-1)" "unprognostic (6.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.30e-6)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (1.11e-1)" 15.7 9.1 0.1 222.9 0.2 193.4 217.7 0.0 0.8 83.0 0.4 489.6 354.4 19.3 4.5 173.0 38.5 76.5 39.5 0.1 0.1 10.5 27.0 97.9 239.4 0.6 0.2 0.1 20.5 7.7 17.9 1.1 0.4 0.5 17.3 321.7 0.0 251.8 12.8 0.3 3.2 175.7 11.7 0.1 278.8 441.5 16.1 0.1 141.0 15.4 0.0 1829.2 681.3 8.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 148.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.2 1.0 40.6 0.0 0.0 2.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.2 0.4 21.6 15.2 47.3 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.0 2.3 353.9 0.1 0.1 0.2 292.4 0.1 0.1 27.9 0.1 0.1 1.2 0.2 27.6 0.1 0.2 0.0 0.8 0.1 0.1 0.6 0.2 0.1 0.5 0.1 0.1 0.3 0.0 0.0 0.6 0.0 148.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 1.8 26.7 0.0 0.0 0.0 4.4 67.8 0.0 0.0 0.0 3.6 2.8 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10791.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 6.2 0.0 0.5 0.0 IGLV11-55 ENSG00000211641 "Immunoglobulin lambda variable 11-55 (non-functional)" A0A075B6I3 22 22201663-22202161 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Cell type enhanced" "Detected in some" "Late spermatids: 3.5;Plasma cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 8.6;U-698: 2.7" "Immunoglobulin genes" NA NA "unprognostic (1.22e-1)" "unprognostic (6.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV10-54 ENSG00000211642 "Immunoglobulin lambda variable 10-54" A0A075B6I4 22 22038643-22215270 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 7 "breast: 123.2;intestine: 327.8;lymphoid tissue: 332.4;salivary gland: 255.9;stomach 1: 196.3" "Cell type enriched" "Detected in some" 17 "Plasma cells: 358.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 32 "memory B-cell: 60.0;naive B-cell: 35.2" "Lineage enriched" "Detected in many" 41 "B-cells: 60.0" "Cell line enhanced" "Detected in single" "TIME: 2.3" "Immunoglobulin genes" NA NA 54000000 "prognostic favorable (9.35e-5)" "unprognostic (2.65e-2)" "unprognostic (9.06e-2)" "unprognostic (8.71e-3)" "unprognostic (1.29e-1)" "prognostic favorable (8.30e-5)" "unprognostic (1.40e-1)" "unprognostic (1.83e-1)" "unprognostic (5.62e-1)" "unprognostic (1.18e-1)" "unprognostic (3.22e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (3.33e-1)" "unprognostic (5.57e-2)" "unprognostic (5.17e-2)" "unprognostic (3.86e-1)" 3.7 1.9 0.1 97.3 0.6 34.1 123.2 0.1 2.2 2.0 0.7 327.8 297.4 1.5 0.0 22.7 24.6 22.1 12.1 0.1 0.1 2.1 7.0 22.5 65.2 1.5 0.7 0.1 2.6 11.7 0.0 0.4 0.4 0.4 6.5 156.5 0.0 255.9 2.3 0.1 1.0 140.1 12.8 0.2 156.5 196.3 0.4 0.3 23.1 2.5 0.0 332.4 22.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 60.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.1 0.6 0.1 2.2 0.1 0.1 1.5 0.7 0.1 0.4 0.2 0.3 0.8 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 358.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGLV5-52 ENSG00000211643 "Immunoglobulin lambda variable 5-52" A0A0A0MRZ9 22 22318727-22319226 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "B-cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 11.7;naive B-cell: 10.3" "Lineage enriched" "Detected in many" 6 "B-cells: 11.7" "Low cell line specificity" "Detected in all" "Immunoglobulin genes" NA NA 1200000 "unprognostic (7.26e-2)" "unprognostic (7.05e-2)" "unprognostic (1.86e-2)" "unprognostic (4.66e-1)" "unprognostic (1.29e-1)" "unprognostic (7.61e-5)" "unprognostic (1.22e-1)" "unprognostic (1.89e-1)" "unprognostic (8.45e-2)" "unprognostic (1.51e-1)" "unprognostic (3.93e-2)" "unprognostic (2.25e-3)" "unprognostic (7.75e-2)" "unprognostic (3.51e-2)" "unprognostic (1.57e-1)" "unprognostic (5.46e-2)" 11.6 10.5 11.0 18.2 11.6 14.7 24.0 15.6 14.2 16.6 12.4 26.9 20.3 28.6 44.6 22.7 22.9 22.7 16.8 12.3 11.9 11.6 9.6 15.0 44.4 10.4 11.7 11.0 21.8 8.1 14.0 8.6 11.3 11.4 16.0 23.7 22.7 18.1 15.1 10.2 38.0 15.5 22.5 8.5 22.0 29.5 13.1 11.3 17.9 21.6 15.7 53.9 31.4 6.3 14.2 12.1 7.7 18.8 29.2 22.3 25.1 14.4 7.7 19.0 17.3 22.0 15.6 5.0 38.4 8.5 22.5 10.1 16.9 36.0 25.6 24.0 9.4 27.3 13.4 21.4 14.8 8.7 20.8 22.9 24.0 24.0 19.5 34.5 14.2 35.2 13.9 40.7 3.3 32.3 14.5 7.0 13.9 10.5 22.5 5.7 9.4 9.4 6.4 22.6 16.1 21.2 13.2 9.9 10.6 10.9 15.7 21.0 4.8 21.0 40.9 25.7 4.2 9.0 6.7 21.9 18.2 14.0 15.4 12.2 0.0 1.3 1.9 1.1 0.7 1.3 11.7 1.2 1.3 1.5 10.3 0.8 0.8 0.7 0.7 0.8 1.4 0.6 3.1 11.0 11.6 15.6 14.2 12.3 11.9 10.4 11.7 11.0 11.4 8.5 11.3 14.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 IGLV1-51 ENSG00000211644 "Immunoglobulin lambda variable 1-51" P01701 22 22322472-22322969 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 1331.3;lymphoid tissue: 3052.4;urinary bladder: 1598.3" "Cell type enriched" "Detected in some" 312 "Plasma cells: 34336.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 275.9;naive B-cell: 178.3" "Lineage enriched" "Detected in many" 10 "B-cells: 275.9" "Cell line enhanced" "Detected in many" "HEK 293: 17.9" "Immunoglobulin genes" NA NA 1700000000 "prognostic favorable (1.85e-4)" "unprognostic (1.71e-2)" "unprognostic (3.12e-3)" "unprognostic (1.76e-3)" "unprognostic (1.61e-1)" "prognostic favorable (1.95e-5)" "unprognostic (3.55e-3)" "unprognostic (3.78e-2)" "unprognostic (1.84e-1)" "unprognostic (1.61e-2)" "unprognostic (1.41e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (1.21e-1)" "unprognostic (5.70e-2)" "unprognostic (1.89e-1)" "unprognostic (1.07e-1)" 43.9 321.8 1.2 489.3 1.8 276.7 632.9 4.5 6.9 73.8 1.6 1331.3 1149.4 38.4 17.0 290.0 53.2 240.2 70.7 1.4 1.3 32.0 53.8 180.7 345.7 3.7 1.9 1.1 186.6 39.3 5.8 4.1 1.6 5.7 34.7 938.6 3.2 701.6 50.0 1.9 13.2 708.0 50.3 1.9 942.0 965.3 11.8 1.8 276.5 63.5 1.7 3052.4 1598.3 17.9 2.5 1.3 0.6 1.6 3.8 3.5 1.7 5.9 1.4 3.2 3.1 2.0 2.3 1.0 8.8 1.6 0.8 1.1 3.1 1.9 3.8 2.2 1.4 17.9 3.9 4.5 2.4 0.7 3.4 1.7 5.2 1.0 2.7 0.3 0.4 3.1 0.9 3.9 0.9 3.0 1.6 2.6 3.8 3.0 2.8 4.1 2.3 2.7 8.8 3.6 1.4 8.3 4.9 2.0 1.4 1.8 0.9 2.7 0.3 4.3 4.4 9.2 1.0 1.2 2.0 2.0 2.0 0.4 2.8 0.8 0.1 0.5 0.0 0.2 0.2 26.3 275.9 0.2 0.3 0.1 178.3 0.7 0.5 0.4 0.1 0.3 0.2 0.2 26.4 1.2 1.8 4.5 6.9 1.4 1.3 3.7 1.9 1.1 5.7 1.9 1.8 2.5 0.0 0.0 0.5 0.0 109.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 4.8 35.7 0.1 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34336.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 19.3 0.0 0.0 9.4 0.0 0.0 0.0 IGLV1-50 ENSG00000211645 "Immunoglobulin lambda variable 1-50 (non-functional)" A0A075B6I6 22 22327300-22327814 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.5;lymphoid tissue: 14.8;stomach 1: 20.6" "Cell type enriched" "Detected in single" 2575 "Plasma cells: 1545.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 21 "memory B-cell: 11.0;naive B-cell: 2.9" "Lineage enriched" "Detected in single" 33 "B-cells: 11.0" "Cell line enhanced" "Detected in single" "HEK 293: 1.1" "Immunoglobulin genes" NA NA "unprognostic (1.75e-4)" "unprognostic (8.01e-2)" "unprognostic (1.28e-3)" "unprognostic (6.91e-2)" "unprognostic (2.10e-1)" "prognostic favorable (7.08e-4)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (2.02e-1)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (7.38e-2)" "unprognostic (1.58e-4)" "unprognostic (4.89e-3)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" 0.5 0.6 0.3 6.1 0.3 3.4 6.8 1.6 2.2 0.5 0.0 5.4 16.5 0.6 1.2 2.4 0.5 0.8 0.0 0.7 0.1 0.2 0.2 4.5 1.9 0.7 0.1 0.0 0.9 0.1 0.1 0.1 0.0 1.9 0.3 4.5 0.7 4.7 0.3 0.4 0.0 9.5 0.2 0.0 4.0 20.6 0.4 0.2 0.6 0.2 0.0 14.8 9.4 0.1 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.3 0.5 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.0 0.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.3 1.6 2.2 0.7 0.1 0.7 0.1 0.0 1.9 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1545.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV5-48 ENSG00000211647 "Immunoglobulin lambda variable 5-48 (non-functional)" A0A075B6I7 22 22352940-22353433 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.3;lymphoid tissue: 5.5;urinary bladder: 2.7" "Cell type enriched" "Detected in some" 8 "Plasma cells: 19.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 61 "memory B-cell: 5.4;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 68 "B-cells: 6.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA "unprognostic (3.76e-3)" "unprognostic (1.91e-2)" "unprognostic (9.43e-2)" "unprognostic (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-2)" "unprognostic (2.97e-1)" 0.0 0.0 0.0 0.9 0.0 1.4 0.9 0.0 0.6 0.4 0.0 3.3 3.3 0.0 0.0 0.3 0.1 0.3 0.1 0.0 0.0 0.1 0.1 0.3 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.5 0.0 0.0 0.0 1.3 0.2 0.0 5.5 0.7 0.0 0.0 2.6 0.1 0.0 5.3 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV1-47 ENSG00000211648 "Immunoglobulin lambda variable 1-47" P01700 22 22357739-22358260 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 713.3;lymphoid tissue: 1819.2;stomach 1: 631.2" "Cell type enriched" "Detected in some" 114 "Plasma cells: 10777.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 638 "memory B-cell: 1518.1;naive B-cell: 819.6" "Lineage enriched" "Detected in many" 828 "B-cells: 1518.1" "Cell line enhanced" "Detected in some" "HL-60: 2.1;RH-30: 2.1;RPMI-8226: 4.2;SCLC-21H: 2.7;SH-SY5Y: 2.4;U-698: 7.1" "Immunoglobulin genes" NA NA 3000000000 "unprognostic (5.19e-3)" "unprognostic (2.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.66e-4)" "unprognostic (4.44e-2)" "unprognostic (1.09e-1)" "unprognostic (5.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.12e-8)" "unprognostic (5.00e-3)" "unprognostic (1.62e-1)" "unprognostic (7.08e-2)" "unprognostic (1.15e-2)" 36.3 218.1 0.6 326.1 1.8 163.8 202.5 0.5 2.3 82.8 0.7 713.3 711.1 24.0 3.0 165.1 21.5 113.8 27.4 0.3 0.3 23.4 32.1 127.8 695.1 2.9 0.4 0.2 43.9 9.0 4.9 2.1 0.5 1.0 22.7 536.4 0.2 531.4 70.8 0.7 4.7 335.6 35.0 0.5 820.3 631.2 9.9 0.7 262.5 34.4 0.0 1819.2 370.1 10.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.7 2.1 4.2 0.0 0.0 2.7 2.4 0.5 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.0 0.1 0.6 0.0 7.1 0.0 0.9 0.0 0.7 1.2 0.5 0.7 0.1 0.5 1518.1 0.7 0.6 1.0 819.6 0.3 0.6 0.6 0.5 0.5 1.8 0.6 159.6 0.6 1.8 0.5 2.3 0.3 0.3 2.9 0.4 0.2 1.0 0.5 0.7 2.4 0.0 0.0 0.0 0.0 94.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 1.7 29.0 0.0 0.0 0.0 0.7 1.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10777.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 IGLV7-46 ENSG00000211649 "Immunoglobulin lambda variable 7-46" A0A075B6I9 22 22369614-22370087 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 404.4;lymphoid tissue: 463.0;stomach 1: 252.8;urinary bladder: 447.4" "Cell type enriched" "Detected in some" 180 "Plasma cells: 6758.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 377 "memory B-cell: 183.6;naive B-cell: 82.3" "Lineage enriched" "Detected in single" 521 "B-cells: 183.6" "Cell line enhanced" "Detected in some" "Daudi: 8.0;RPMI-8226: 2.8;U-698: 6.6" HPA003182 Approved "Immunoglobulin genes" NA NA 270000000 "HPA003182: " "prognostic favorable (3.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (3.94e-3)" "unprognostic (4.25e-3)" "unprognostic (4.68e-3)" "unprognostic (1.74e-1)" "unprognostic (2.77e-2)" "unprognostic (7.47e-3)" "unprognostic (2.17e-1)" "unprognostic (4.02e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" "unprognostic (2.99e-1)" "unprognostic (2.02e-1)" 15.3 3.8 0.1 60.3 0.2 44.6 173.5 0.1 0.9 3.8 0.1 404.4 163.9 4.4 0.0 44.1 3.1 56.5 5.2 0.1 1.1 5.5 7.8 45.3 82.9 0.4 0.1 0.0 9.1 6.3 0.1 0.8 0.1 0.3 2.5 301.6 0.0 108.2 5.3 0.5 0.8 134.2 12.2 0.1 250.1 252.8 0.7 0.2 57.8 8.7 0.0 463.0 447.4 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.3 0.0 6.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 183.6 0.1 0.0 0.1 82.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 15.2 0.1 0.2 0.1 0.9 0.1 1.1 0.4 0.1 0.0 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 12.8 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6758.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 IGLV5-45 ENSG00000211650 "Immunoglobulin lambda variable 5-45" A0A087WSX0 22 22375986-22376505 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 40.9;intestine: 42.5;lymphoid tissue: 98.3;salivary gland: 49.4" "Cell type enriched" "Detected in some" 116 "Plasma cells: 6697.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "memory B-cell: 1.2;naive B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 160000000 "prognostic favorable (4.62e-4)" "unprognostic (6.18e-2)" "unprognostic (2.26e-2)" "unprognostic (1.48e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.58e-3)" "unprognostic (2.77e-1)" "unprognostic (8.89e-2)" "unprognostic (1.06e-1)" "unprognostic (5.16e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (5.95e-6)" "unprognostic (6.14e-2)" "unprognostic (2.28e-1)" "unprognostic (1.20e-1)" "unprognostic (8.36e-2)" 1.9 0.3 0.0 0.0 0.0 0.4 5.6 0.0 0.5 2.3 0.0 25.4 0.0 0.7 0.0 40.9 2.0 0.0 0.2 0.0 0.0 2.6 3.1 9.7 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.2 0.0 0.1 1.1 0.2 0.0 49.4 0.0 0.1 0.4 42.5 0.0 0.0 98.3 14.2 0.4 0.1 0.0 4.1 0.0 1.4 14.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.8 57.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6697.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 IGLV1-44 ENSG00000211651 "Immunoglobulin lambda variable 1-44" P01699 22 22380766-22381347 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 595.1;lymphoid tissue: 1935.1;stomach 1: 539.1" "Cell type enriched" "Detected in some" 108 "Plasma cells: 12023.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 840 "memory B-cell: 968.8;naive B-cell: 850.4" "Lineage enriched" "Detected in many" 894 "B-cells: 968.8" "Cell line enhanced" "Detected in some" "Daudi: 21.3;RPMI-8226: 5.5;SCLC-21H: 4.1;U-698: 15.2" "Immunoglobulin genes" NA NA 4000000000 "unprognostic (1.88e-3)" "unprognostic (1.51e-2)" "unprognostic (2.40e-2)" "unprognostic (7.23e-3)" "unprognostic (4.81e-3)" "prognostic favorable (4.71e-5)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-1)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.55e-8)" "unprognostic (1.85e-1)" "unprognostic (1.98e-1)" "unprognostic (6.48e-2)" "unprognostic (5.49e-2)" 16.9 2.0 0.0 300.0 0.5 134.7 111.4 0.0 2.0 10.8 0.0 382.3 595.1 12.0 0.0 80.8 19.7 79.4 17.6 0.0 0.0 18.5 17.3 123.3 524.0 1.6 0.7 0.0 15.4 3.6 0.0 2.6 0.0 0.3 13.9 265.6 0.0 275.3 9.5 0.7 1.6 238.5 21.6 0.0 613.6 539.1 11.7 0.4 119.0 35.4 0.0 1935.1 242.6 16.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 968.8 0.0 0.0 0.7 850.4 0.0 0.0 0.0 0.0 0.1 1.0 0.1 100.0 0.0 0.5 0.0 2.0 0.0 0.0 1.6 0.7 0.0 0.3 0.0 0.4 1.9 0.0 0.0 0.6 0.0 111.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 3.5 48.4 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12023.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.3 0.0 IGLV7-43 ENSG00000211652 "Immunoglobulin lambda variable 7-43" P04211 22 22395018-22395489 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 163.5;lymphoid tissue: 240.7;stomach 1: 116.9" "Cell type enriched" "Detected in some" 57 "Plasma cells: 1304.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 325 "memory B-cell: 132.0;naive B-cell: 54.2" "Lineage enriched" "Detected in single" 461 "B-cells: 132.0" "Cell line enhanced" "Detected in some" "Daudi: 1.9;RPMI-8226: 1.4;U-698: 1.5" HPA003182 Approved "Immunoglobulin genes" NA NA 130000000 "HPA003182: " "prognostic favorable (6.49e-6)" "unprognostic (7.85e-3)" "prognostic favorable (7.00e-4)" "unprognostic (5.57e-2)" "unprognostic (3.62e-2)" "prognostic favorable (3.08e-5)" "unprognostic (7.63e-3)" "unprognostic (8.20e-2)" "unprognostic (2.42e-1)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (6.29e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (2.29e-1)" 8.1 0.8 0.0 31.5 0.1 16.0 46.2 0.0 0.5 4.9 0.0 163.5 134.0 3.6 0.5 8.0 3.3 22.3 3.5 0.0 0.1 3.1 4.2 13.1 59.5 0.0 0.0 0.0 4.2 2.2 0.0 1.0 0.2 0.0 2.3 130.6 0.0 73.1 4.7 0.1 0.3 57.5 17.9 0.0 170.0 116.9 0.5 0.0 31.6 6.4 0.7 240.7 31.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 132.0 0.0 0.0 0.0 54.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.2 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1304.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.2 0.0 IGLV1-40 ENSG00000211653 "Immunoglobulin lambda variable 1-40" P01703 22 22409766-22410282 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1302.2;stomach 1: 1299.3" "Cell type enriched" "Detected in some" 358 "Plasma cells: 43406.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.1" "Group enriched" "Detected in some" 496 "memory B-cell: 666.4;naive B-cell: 576.7" "Lineage enriched" "Detected in many" 532 "B-cells: 666.4" "Cell line enhanced" "Detected in some" "Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3" "Immunoglobulin genes" NA NA 2300000000 "unprognostic (1.64e-3)" "unprognostic (4.68e-3)" "unprognostic (3.88e-2)" "unprognostic (3.37e-3)" "unprognostic (9.60e-3)" "prognostic favorable (5.74e-6)" "unprognostic (2.39e-2)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (5.51e-2)" "unprognostic (1.06e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.44e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (4.57e-2)" 25.3 13.1 0.8 205.4 0.4 115.4 139.9 0.1 3.1 68.7 1.0 559.0 556.6 15.0 0.6 126.5 21.7 238.2 15.3 0.3 0.2 28.4 28.5 116.4 284.7 0.5 0.9 0.2 57.1 10.1 1.1 3.4 0.6 0.5 46.5 339.8 4.3 417.2 19.9 1.2 2.3 289.6 14.5 0.2 1038.0 1299.3 7.3 0.3 180.9 61.8 0.0 1302.2 468.7 19.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 1.0 1.1 0.0 0.0 0.2 0.8 2.2 0.0 0.0 1.3 3.4 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.7 0.7 1.1 1.1 0.8 0.0 0.3 0.0 0.4 0.7 0.2 0.3 0.1 0.6 666.4 0.3 0.3 0.6 576.7 0.1 0.2 1.2 0.3 0.3 0.6 0.4 53.7 0.8 0.4 0.1 3.1 0.3 0.2 0.5 0.9 0.2 0.5 0.2 0.3 1.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.2 8.0 0.0 0.0 0.0 28.6 64.2 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 43406.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 7.4 0.0 0.1 0.0 IGLV5-37 ENSG00000211654 "Immunoglobulin lambda variable 5-37" A0A075B6J1 22 22427540-22428035 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 24.9;intestine: 10.6;lymphoid tissue: 41.8;salivary gland: 11.6;stomach 1: 16.7" "Group enriched" "Detected in some" 4 "B-cells: 2.5;Late spermatids: 1.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 54 "memory B-cell: 6.1;naive B-cell: 7.0" "Lineage enriched" "Detected in single" 58 "B-cells: 7.0" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 14000000 "prognostic favorable (4.69e-4)" "unprognostic (2.44e-2)" "unprognostic (5.68e-3)" "unprognostic (4.26e-1)" "prognostic favorable (4.71e-4)" "unprognostic (4.97e-2)" "unprognostic (3.56e-2)" "unprognostic (3.15e-1)" "unprognostic (5.34e-6)" "unprognostic (1.66e-1)" "unprognostic (4.32e-1)" "unprognostic (1.25e-1)" 0.7 0.0 0.0 9.6 0.0 1.0 3.2 0.0 0.0 1.8 0.0 10.6 10.2 0.2 0.0 4.2 0.9 24.9 0.5 0.0 0.0 0.9 0.7 3.7 4.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 8.1 0.1 11.6 0.0 0.0 0.0 8.9 0.2 0.0 22.8 16.7 1.2 0.0 8.5 0.6 0.0 41.8 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV1-36 ENSG00000211655 "Immunoglobulin lambda variable 1-36" A0A0B4J1U3 22 22431958-22432465 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 271.0;stomach 1: 123.5;urinary bladder: 87.2" "Cell type enriched" "Detected in some" 13 "Plasma cells: 59.2" "Cancer enhanced" "Detected in many" "lung cancer: 33.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 625 "memory B-cell: 60.9;naive B-cell: 85.8" "Lineage enriched" "Detected in single" 731 "B-cells: 85.8" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 980000000 "prognostic favorable (1.55e-4)" "unprognostic (5.15e-2)" "unprognostic (2.04e-2)" "prognostic favorable (2.60e-4)" "unprognostic (1.11e-3)" "unprognostic (1.15e-2)" "unprognostic (1.50e-1)" "unprognostic (6.51e-2)" "unprognostic (2.12e-1)" "unprognostic (4.53e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (2.99e-2)" "unprognostic (5.76e-2)" "unprognostic (1.54e-1)" "unprognostic (1.07e-1)" 1.0 0.3 0.0 19.8 0.0 14.6 23.9 0.0 0.4 6.1 0.0 28.5 21.8 0.7 0.6 10.6 9.2 7.3 3.0 0.0 0.0 3.2 3.4 8.8 16.7 0.0 0.1 0.0 1.7 1.1 0.0 0.1 0.0 0.1 1.6 45.2 0.0 37.6 3.1 0.0 0.6 12.4 0.8 0.0 109.0 123.5 0.3 0.0 30.7 2.8 0.0 271.0 87.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGLV2-33 ENSG00000211656 "Immunoglobulin lambda variable 2-33 (non-functional)" A0A075B6J2 22 22588155-22588688 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.3;lymphoid tissue: 2.7;salivary gland: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 1.9" "Lineage enriched" "Detected in single" 30 "B-cells: 2.9" "Group enriched" "Detected in some" 9 "RPMI-8226: 1.5;U-266/70: 5.1;U-266/84: 3.4" "Immunoglobulin genes" NA NA "unprognostic (1.29e-2)" "unprognostic (1.79e-3)" "unprognostic (2.13e-1)" "unprognostic (4.30e-1)" "unprognostic (2.64e-3)" "unprognostic (2.47e-2)" "unprognostic (2.06e-1)" "unprognostic (6.68e-2)" 0.0 0.1 0.0 1.5 0.0 1.3 0.4 0.0 0.0 0.0 0.0 2.3 4.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.6 0.0 0.0 0.0 2.4 0.2 0.0 1.5 1.5 0.0 0.0 0.1 0.0 0.0 2.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV3-32 ENSG00000211657 "Immunoglobulin lambda variable 3-32 (non-functional)" A0A0A0MS00 22 22594528-22595056 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immunoglobulin genes" NA NA "unprognostic (4.68e-2)" "unprognostic (1.31e-1)" "unprognostic (7.93e-2)" 0.0 0.0 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV3-27 ENSG00000211658 "Immunoglobulin lambda variable 3-27" P01718 22 22668288-22668806 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 405.0" "Cell type enriched" "Detected in some" 135 "Plasma cells: 1406.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 719 "memory B-cell: 194.0;naive B-cell: 367.8" "Lineage enriched" "Detected in single" 941 "B-cells: 367.8" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 720000000 "unprognostic (3.45e-2)" "unprognostic (1.87e-3)" "unprognostic (5.44e-2)" "unprognostic (4.30e-3)" "prognostic favorable (3.60e-7)" "unprognostic (8.55e-2)" "unprognostic (2.16e-1)" "unprognostic (5.91e-2)" "unprognostic (9.56e-2)" "unprognostic (4.55e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (4.95e-9)" "unprognostic (1.82e-2)" "unprognostic (2.09e-1)" "unprognostic (1.90e-1)" "unprognostic (2.07e-1)" 8.9 1.8 0.2 16.5 0.1 29.7 30.0 0.0 0.6 23.9 0.1 57.3 19.4 2.2 0.0 10.4 5.2 10.6 3.2 0.0 0.0 3.6 3.8 29.5 64.8 0.3 0.0 0.0 3.0 0.3 0.2 0.4 0.0 0.1 2.4 27.1 0.0 40.9 0.8 0.0 0.5 24.6 0.7 0.0 104.8 60.4 24.4 0.0 48.1 2.8 0.0 405.0 27.7 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 194.0 0.2 0.0 0.3 367.8 0.0 0.0 0.2 0.0 0.1 0.1 0.1 11.8 0.2 0.1 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1406.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGLV3-25 ENSG00000211659 "Immunoglobulin lambda variable 3-25" P01717 22 22686726-22687271 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 2460.5;stomach 1: 1024.7" "Cell type enriched" "Detected in some" 41 "Plasma cells: 17441.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Group enriched" "Detected in some" 45 "memory B-cell: 545.0;naive B-cell: 794.2" "Lineage enriched" "Detected in many" 53 "B-cells: 794.2" "Cell line enhanced" "Detected in some" "HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1" HPA003285 Approved "Immunoglobulin genes" NA NA 3200000000 "HPA003285: AB_1079122" "prognostic favorable (5.55e-4)" "unprognostic (8.28e-2)" "unprognostic (4.28e-3)" "unprognostic (2.89e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.43e-4)" "unprognostic (1.92e-2)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "unprognostic (1.98e-2)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.78e-7)" "unprognostic (1.25e-1)" "unprognostic (4.78e-1)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" 57.4 164.8 0.3 296.0 0.6 245.4 435.3 0.3 3.4 153.2 1.3 855.4 342.0 21.0 2.1 162.9 50.2 178.7 30.1 0.7 0.4 16.8 46.0 877.3 1033.5 1.7 0.3 0.3 22.0 14.6 1.7 1.7 0.5 0.8 19.1 471.7 0.0 537.1 117.6 0.7 2.4 230.8 34.4 0.3 547.8 1024.7 60.3 0.6 157.3 23.3 0.0 2460.5 786.6 21.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.7 0.4 1.7 0.0 0.0 1.6 1.5 2.7 0.0 0.0 4.6 5.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 0.1 0.8 1.8 0.2 0.7 0.0 1.3 0.0 0.8 0.4 0.3 0.7 0.1 0.2 545.0 0.4 0.1 0.5 794.2 0.2 0.1 14.9 0.3 0.6 0.3 0.3 76.5 0.3 0.6 0.3 3.4 0.7 0.4 1.7 0.3 0.3 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 84.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 1.9 40.8 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17441.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 417.4 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 IGLV2-23 ENSG00000211660 "Immunoglobulin lambda variable 2-23" P01705 22 22697789-22698407 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 697.4;lymphoid tissue: 1611.5;stomach 1: 678.8" "Cell type enriched" "Detected in some" 132 "Plasma cells: 12487.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 369 "memory B-cell: 2072.7;naive B-cell: 2596.0" "Lineage enriched" "Detected in all" 410 "B-cells: 2596.0" "Cell line enriched" "Detected in some" 10 "Karpas-707: 85411.7" "Immunoglobulin genes" NA NA 540000000 "prognostic favorable (3.43e-5)" "unprognostic (7.99e-2)" "unprognostic (3.89e-2)" "unprognostic (2.35e-3)" "unprognostic (2.73e-2)" "unprognostic (1.30e-2)" "unprognostic (9.33e-2)" "unprognostic (2.13e-1)" "unprognostic (1.19e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.50e-7)" "unprognostic (8.20e-2)" "unprognostic (7.79e-2)" "unprognostic (1.20e-1)" "unprognostic (7.42e-2)" 13.0 39.3 0.7 309.6 0.5 104.5 186.6 0.2 1.5 45.6 0.7 640.1 697.4 16.3 1.3 79.3 25.7 67.5 20.1 0.2 0.2 18.3 26.4 162.2 628.5 0.9 0.3 0.1 16.5 8.3 0.6 1.7 0.6 0.5 10.9 461.3 0.0 360.0 38.4 0.5 2.1 521.7 16.3 0.3 534.8 678.8 6.0 0.5 280.3 39.5 0.4 1611.5 276.8 12.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 65.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 82.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 85411.7 0.0 0.0 2.2 4.2 0.5 0.0 0.0 0.7 1.9 8843.9 0.0 0.0 2.1 4.5 0.0 4.7 0.0 0.0 1.9 0.0 1.0 0.0 1.1 3.4 0.7 213.9 81.1 0.5 92.6 0.2 35.5 1.8 3.1 1.0 1.6 0.9 1.3 2072.7 1.6 0.8 2.6 2596.0 0.6 0.9 6.3 1.6 1.7 0.9 1.3 231.7 0.7 0.5 0.2 1.5 0.2 0.2 0.9 0.3 0.1 0.5 0.3 0.5 0.5 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.7 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12487.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.5 0.0 0.2 0.0 IGLV3-22 ENSG00000211661 "Immunoglobulin lambda variable 3-22" A0A075B6J6 22 22704265-22704822 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 2.6;lymphoid tissue: 9.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 72 "memory B-cell: 6.6;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 78 "B-cells: 7.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 1100000000 "unprognostic (2.00e-1)" "unprognostic (9.93e-3)" "unprognostic (3.73e-1)" 0.0 0.7 0.0 1.0 0.0 1.5 2.6 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.3 0.0 0.0 1.5 0.0 0.0 1.4 0.8 0.3 0.0 9.5 0.0 0.0 5.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV3-21 ENSG00000211662 "Immunoglobulin lambda variable 3-21" P80748 22 22711689-22713203 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1827.4;urinary bladder: 781.1" "Cell type enriched" "Detected in some" 59 "Plasma cells: 5013.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 4.3" "Group enriched" "Detected in some" 339 "memory B-cell: 432.0;naive B-cell: 224.7" "Lineage enriched" "Detected in single" 445 "B-cells: 432.0" "Cell line enriched" "Detected in some" 103 "REH: 282.7" "Immunoglobulin genes" NA NA 4700000000 "unprognostic (1.75e-3)" "unprognostic (6.04e-3)" "unprognostic (4.21e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-3)" "prognostic favorable (3.26e-7)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.53e-1)" "unprognostic (5.30e-2)" "unprognostic (3.86e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (9.54e-8)" "unprognostic (7.83e-2)" "unprognostic (1.88e-1)" "unprognostic (2.67e-1)" "unprognostic (7.52e-2)" 17.8 64.0 0.3 325.0 0.3 250.3 122.0 0.1 4.3 111.0 1.8 360.8 353.6 13.0 0.5 63.7 10.3 121.6 10.9 0.1 0.2 21.1 36.7 109.6 274.9 0.7 0.4 0.1 36.0 5.7 0.7 1.4 0.4 0.3 16.9 233.0 0.0 263.1 20.4 0.5 2.4 152.0 9.1 0.2 424.3 509.1 14.5 0.3 173.2 20.1 0.0 1827.4 781.1 17.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 282.7 1.8 2.0 0.0 0.0 1.6 1.8 0.1 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.5 0.5 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.1 432.0 0.1 0.1 0.3 224.7 0.1 0.1 0.9 0.1 0.1 0.2 0.1 36.6 0.3 0.3 0.1 4.3 0.1 0.2 0.7 0.4 0.1 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.0 84.4 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 20.4 0.0 0.0 0.0 3.3 2.5 0.1 0.0 0.0 0.0 0.0 1.3 0.0 4.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5013.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.0 1.8 0.0 0.2 0.0 IGLV3-19 ENSG00000211663 "Immunoglobulin lambda variable 3-19" P01714 22 22720623-22721145 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1036.4;lymphoid tissue: 1996.1;stomach 1: 1252.0" "Cell type enriched" "Detected in some" 61 "Plasma cells: 3121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 355 "memory B-cell: 618.3;naive B-cell: 503.7" "Lineage enriched" "Detected in many" 391 "B-cells: 618.3" "Cell line enhanced" "Detected in some" "RPMI-8226: 6.2;SCLC-21H: 9.4;SH-SY5Y: 10.7;U-251 MG: 4.2" "Immunoglobulin genes" NA NA 1200000000 "prognostic favorable (5.92e-5)" "unprognostic (1.52e-2)" "unprognostic (1.60e-3)" "prognostic favorable (6.11e-5)" "unprognostic (1.14e-1)" "unprognostic (1.24e-3)" "unprognostic (9.58e-3)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.00e-1)" "unprognostic (3.13e-1)" "unprognostic (3.03e-1)" "prognostic unfavorable (9.37e-10)" "unprognostic (2.10e-1)" "unprognostic (2.31e-1)" "unprognostic (2.44e-1)" "unprognostic (8.52e-2)" 49.5 20.3 0.1 406.0 0.4 186.9 316.6 0.1 2.4 69.8 0.3 1036.4 720.1 19.2 265.7 155.4 66.3 184.1 37.2 0.1 0.1 25.6 58.0 194.0 468.6 1.7 0.5 0.1 45.3 11.6 1.3 2.7 0.4 0.4 17.3 920.8 0.0 307.7 63.0 0.9 4.8 388.4 35.2 0.2 719.9 1252.0 6.1 0.2 439.0 55.8 0.0 1996.1 648.2 13.7 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 2.7 0.3 0.0 0.0 0.1 0.9 6.2 0.0 0.0 9.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 4.2 0.8 0.5 0.7 0.0 0.5 0.0 0.4 0.4 1.0 0.5 0.3 0.7 618.3 0.2 0.3 0.5 503.7 0.4 0.3 1.5 0.3 0.4 0.6 0.4 36.2 0.1 0.4 0.1 2.4 0.1 0.1 1.7 0.5 0.1 0.4 0.2 0.2 1.6 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.4 15.8 0.0 1.3 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3121.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 IGLV2-18 ENSG00000211664 "Immunoglobulin lambda variable 2-18" A0A075B6J9 22 22734607-22735089 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 274.0;lymphoid tissue: 226.2" "Cell type enriched" "Detected in some" 210 "Plasma cells: 2488.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 44 "memory B-cell: 321.2;naive B-cell: 126.9" "Lineage enriched" "Detected in many" 64 "B-cells: 321.2" "Group enriched" "Detected in some" 7 "RPMI-8226: 13.4;U-266/70: 22.3;U-266/84: 7.2" "Immunoglobulin genes" NA NA 570000000 "prognostic favorable (6.06e-5)" "unprognostic (2.81e-2)" "unprognostic (7.47e-3)" "unprognostic (1.13e-2)" "prognostic favorable (7.75e-4)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (7.58e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (1.95e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-2)" 3.4 0.3 0.0 73.7 0.0 23.9 67.8 0.0 0.3 6.8 0.1 274.0 264.4 4.3 0.0 40.0 10.9 36.6 6.3 0.0 0.0 2.0 2.9 12.8 37.9 0.1 0.0 0.0 4.1 1.1 2.1 0.2 0.1 0.3 1.7 139.8 0.0 64.9 5.0 0.1 0.3 151.4 6.5 0.0 96.6 73.1 0.5 0.1 22.3 2.9 0.0 226.2 18.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 13.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 22.3 7.2 0.1 0.1 0.1 0.0 0.2 1.8 0.0 1.6 0.0 0.8 321.2 0.3 1.3 0.1 126.9 0.7 0.6 0.5 5.0 0.1 0.2 0.1 69.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2488.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGLV3-16 ENSG00000211665 "Immunoglobulin lambda variable 3-16" A0A075B6K0 22 22747383-22747921 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 81.0;urinary bladder: 43.2" "Group enriched" "Detected in some" 49 "B-cells: 6.2;Plasma cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 393 "memory B-cell: 107.2;naive B-cell: 121.2" "Lineage enriched" "Detected in single" 417 "B-cells: 121.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 350000000 "prognostic favorable (5.01e-5)" "unprognostic (2.40e-3)" "unprognostic (4.30e-3)" "unprognostic (4.05e-1)" "prognostic favorable (2.99e-5)" "unprognostic (3.88e-1)" "unprognostic (1.12e-1)" "unprognostic (9.83e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (9.08e-7)" "unprognostic (4.31e-2)" "unprognostic (3.41e-1)" "unprognostic (7.02e-2)" "unprognostic (1.60e-1)" 0.7 0.0 0.0 7.0 0.0 6.3 4.9 0.0 0.0 0.7 0.0 10.8 10.0 0.2 0.0 2.5 1.9 1.2 0.6 0.0 0.0 0.3 1.3 4.8 13.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.6 10.9 0.0 10.9 0.0 0.0 0.1 5.3 0.6 0.0 12.9 13.2 0.3 0.0 3.6 0.2 0.0 81.0 43.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 107.2 0.0 0.1 0.1 121.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV2-14 ENSG00000211666 "Immunoglobulin lambda variable 2-14" P01704 22 22758700-22759218 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2647.3;lymphoid tissue: 5420.7;stomach 1: 2553.5" "Cell type enriched" "Detected in some" 179 "Plasma cells: 58316.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 50 "memory B-cell: 3655.3;naive B-cell: 2657.4" "Lineage enriched" "Detected in all" 58 "B-cells: 3655.3" "Cell line enriched" "Detected in many" 5 "RPMI-8226: 22672.4" "Immunoglobulin genes" NA NA 2200000000 "prognostic favorable (3.23e-4)" "unprognostic (9.05e-3)" "unprognostic (1.18e-2)" "unprognostic (7.20e-3)" "unprognostic (2.00e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.69e-1)" "unprognostic (1.97e-1)" "unprognostic (7.99e-2)" "unprognostic (1.83e-2)" "unprognostic (9.11e-2)" "unprognostic (4.97e-1)" "prognostic unfavorable (5.74e-7)" "unprognostic (1.15e-1)" "unprognostic (1.33e-1)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" 84.6 194.0 0.8 761.9 1.2 361.0 757.3 0.5 6.4 120.7 4.2 2647.3 2493.0 48.2 20.9 247.4 49.4 446.2 45.6 0.6 0.8 53.8 103.0 402.9 3348.5 2.2 2.8 0.5 76.0 52.5 4.5 5.7 1.2 1.5 71.6 1084.4 0.1 804.6 120.6 2.7 21.5 1273.3 62.5 0.7 1593.2 2553.5 14.0 1.6 591.5 117.5 0.5 5420.7 1174.6 35.3 2.5 0.2 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4453.2 0.0 0.0 8.7 8.0 1.7 0.0 0.0 4.9 3.7 22672.4 0.0 0.0 11.8 11.1 0.4 17.3 0.0 0.0 7.1 0.0 5.1 0.0 4.1 5.7 1.1 20.4 37.7 1.4 12.1 1.7 5.0 3.9 5.3 1.7 47.1 1.0 28.8 3655.3 9.6 53.9 3.3 2657.4 1.4 12.7 11.6 62.5 2.4 2.2 2.1 451.3 0.8 1.2 0.5 6.4 0.6 0.8 2.2 2.8 0.5 1.5 0.7 1.6 2.5 0.0 0.0 0.0 0.0 324.1 0.0 0.0 0.0 1.2 0.0 0.3 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 14.7 0.0 0.0 0.0 9.9 121.8 0.0 0.0 0.0 1.4 1.7 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 58316.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 36.6 0.0 0.8 0.0 IGLV3-12 ENSG00000211667 "Immunoglobulin lambda variable 3-12" A0A075B6K2 22 22771824-22772582 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 4.2;memory B-cell: 9.2;memory CD8 T-cell: 4.0;naive B-cell: 6.7;NK-cell: 5.6" "Group enriched" "Detected in many" 64 "B-cells: 9.2;NK-cells: 5.6;T-cells: 4.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 850000000 "unprognostic (1.92e-3)" "unprognostic (4.30e-2)" "unprognostic (1.68e-3)" "unprognostic (2.03e-2)" "prognostic favorable (8.39e-6)" "unprognostic (8.44e-2)" "unprognostic (4.62e-2)" "unprognostic (5.01e-2)" "unprognostic (2.88e-2)" "unprognostic (3.15e-4)" "unprognostic (3.62e-2)" "unprognostic (4.71e-1)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" 0.9 1.2 0.0 4.0 0.0 2.7 1.9 0.0 0.3 0.3 0.1 7.4 5.5 0.6 0.0 1.0 0.6 3.3 0.0 0.0 0.0 0.1 0.5 2.7 15.4 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 3.9 0.0 5.1 1.7 0.0 0.2 2.7 0.1 0.0 4.6 8.3 0.9 0.0 3.9 0.2 0.0 30.4 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.1 9.2 1.0 4.0 0.0 6.7 0.0 0.2 0.0 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV2-11 ENSG00000211668 "Immunoglobulin lambda variable 2-11" P01706 22 22792491-22793007 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1556.6;lymphoid tissue: 2951.9" "Cell type enriched" "Detected in some" 85 "Plasma cells: 7693.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 37 "memory B-cell: 1402.5;naive B-cell: 850.1" "Lineage enriched" "Detected in many" 46 "B-cells: 1402.5" "Cell line enhanced" "Detected in some" "Karpas-707: 75.0;U-266/70: 20.9;U-266/84: 15.3" "Immunoglobulin genes" NA NA 980000000 "unprognostic (9.76e-3)" "unprognostic (6.86e-2)" "unprognostic (3.46e-3)" "unprognostic (7.67e-3)" "unprognostic (2.82e-3)" "prognostic favorable (4.74e-5)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (9.19e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.38e-7)" "unprognostic (3.93e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (2.27e-1)" 33.9 7.4 0.6 347.9 0.7 158.7 452.2 0.2 2.2 28.0 0.8 1469.8 1556.6 18.6 0.5 213.9 30.3 193.0 45.0 0.2 0.6 22.0 41.5 181.4 685.9 1.5 0.5 0.2 30.7 22.6 0.6 2.2 0.5 1.0 17.1 876.1 0.0 428.8 36.3 1.7 3.0 719.8 21.5 0.3 642.8 883.9 76.0 0.6 289.1 62.7 0.0 2951.9 666.7 14.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 75.0 0.0 0.0 0.9 4.6 1.1 0.0 0.0 0.8 2.8 8.3 0.0 0.0 2.9 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.1 0.3 1.6 20.9 15.3 0.0 0.3 1.1 0.0 1.2 1.0 0.7 11.5 0.2 1.4 1402.5 1.5 5.9 0.9 850.1 1.0 4.6 30.2 11.1 0.8 0.9 0.8 149.8 0.6 0.7 0.2 2.2 0.2 0.6 1.5 0.5 0.2 1.0 0.3 0.6 2.2 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 15.8 0.0 0.0 0.0 1.4 11.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7693.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 IGLV3-10 ENSG00000211669 "Immunoglobulin lambda variable 3-10" A0A075B6K4 22 22811747-22812281 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 319.9;lymphoid tissue: 713.6;stomach 1: 291.3" "Cell type enriched" "Detected in some" 52 "Plasma cells: 1090.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Group enriched" "Detected in some" 786 "memory B-cell: 548.7;naive B-cell: 315.0" "Lineage enriched" "Detected in single" 998 "B-cells: 548.7" "Cell line enhanced" "Detected in some" "Daudi: 4.9;HL-60: 1.0;RH-30: 1.6" HPA003285 Approved "Immunoglobulin genes" NA NA 2000000000 "HPA003285: AB_1079122" "unprognostic (6.00e-2)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.73e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.27e-4)" "unprognostic (7.40e-3)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (9.55e-2)" "unprognostic (2.79e-1)" "unprognostic (3.55e-1)" "prognostic unfavorable (6.95e-8)" "unprognostic (9.23e-2)" "unprognostic (1.48e-1)" "unprognostic (1.77e-1)" "unprognostic (6.04e-2)" 33.6 114.0 0.5 145.3 0.3 66.1 112.2 0.2 3.4 41.7 1.1 311.0 177.9 7.7 4.6 56.7 8.0 43.9 20.7 0.2 0.2 11.9 21.0 48.4 232.5 1.8 0.2 0.1 14.7 10.9 0.9 0.8 0.4 0.7 11.0 319.9 0.0 140.8 10.9 0.2 8.1 95.6 5.8 0.1 218.8 291.3 98.2 0.2 26.2 8.7 0.0 713.6 141.5 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.2 0.0 0.2 548.7 0.1 0.2 0.2 315.0 0.0 0.2 0.3 0.1 0.1 0.3 0.1 43.2 0.5 0.3 0.2 3.4 0.2 0.2 1.8 0.2 0.1 0.7 0.1 0.2 0.2 0.0 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 7.1 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1090.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.2 0.0 IGLV3-9 ENSG00000211670 "Immunoglobulin lambda variable 3-9" A0A075B6K5 22 22819010-22819756 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 316.5;stomach 1: 118.3" "Cell type enriched" "Detected in some" 9 "Plasma cells: 13.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.8" "Group enriched" "Detected in many" 51 "memory B-cell: 64.7;naive B-cell: 168.7" "Lineage enriched" "Detected in many" 74 "B-cells: 168.7" "Cell line enriched" "Detected in some" 5 "U-266/70: 41.3" HPA003285 Approved "Immunoglobulin genes" NA NA 1500000000 "HPA003285: AB_1079122" "prognostic favorable (2.59e-4)" "unprognostic (6.52e-3)" "unprognostic (1.95e-1)" "unprognostic (5.40e-2)" "prognostic favorable (9.80e-5)" "unprognostic (1.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.68e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.47e-2)" "unprognostic (4.58e-2)" "unprognostic (4.55e-2)" "unprognostic (3.22e-1)" 1.8 23.8 0.1 85.4 0.0 28.1 15.0 0.0 1.8 7.4 0.1 87.9 59.2 2.1 0.0 21.0 1.8 18.7 7.6 0.0 0.0 3.1 6.2 17.2 141.0 0.7 0.0 0.0 3.9 2.4 0.2 0.1 0.0 0.1 1.4 64.6 0.0 46.6 3.1 0.1 1.5 60.8 5.2 0.0 65.1 118.3 1.6 0.1 35.4 3.8 0.0 316.5 73.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.3 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.9 0.3 0.0 41.3 5.8 0.7 0.0 3.9 0.0 0.0 0.1 0.0 1.2 0.0 2.2 64.7 1.3 1.4 0.0 168.7 0.4 1.8 0.1 0.5 0.1 0.0 0.1 6.5 0.1 0.0 0.0 1.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 IGLV4-3 ENSG00000211672 "Immunoglobulin lambda variable 4-3" A0A075B6K6 22 22871507-22872035 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 15.9;stomach 1: 29.2" "Cell type enriched" "Detected in some" 23 "Plasma cells: 50.3" "Cancer enhanced" "Detected in many" "lung cancer: 4.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 98 "memory B-cell: 11.7;naive B-cell: 7.8" "Lineage enriched" "Detected in single" 118 "B-cells: 11.7" "Cell line enriched" "Detected in single" 5 "Daudi: 1.3" "Immunoglobulin genes" NA NA 1600000 "unprognostic (7.22e-2)" "unprognostic (5.51e-3)" "unprognostic (2.71e-1)" "unprognostic (4.37e-4)" "unprognostic (1.87e-1)" "unprognostic (2.74e-1)" "unprognostic (1.49e-1)" "unprognostic (1.36e-1)" 0.2 0.0 0.0 2.2 0.2 1.5 1.6 0.0 0.2 0.2 0.0 5.2 4.5 0.3 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.1 0.1 1.0 10.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 3.3 0.0 2.8 0.0 0.0 0.0 3.1 0.0 0.0 5.3 29.2 0.2 0.0 1.5 0.4 0.0 15.9 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLV3-1 ENSG00000211673 "Immunoglobulin lambda variable 3-1" P01715 22 22880706-22881396 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1246.6;lymphoid tissue: 3353.5;stomach 1: 1473.5" "Cell type enriched" "Detected in some" 321 "Plasma cells: 56277.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 725 "memory B-cell: 779.5;naive B-cell: 1038.5" "Lineage enriched" "Detected in many" 828 "B-cells: 1038.5" "Cell line enhanced" "Detected in some" "Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9" HPA003285 Approved "Immunoglobulin genes" NA NA 4300000000 "HPA003285: AB_1079122" "prognostic favorable (9.70e-5)" "unprognostic (9.06e-2)" "unprognostic (5.39e-3)" "unprognostic (2.37e-2)" "unprognostic (8.13e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (1.92e-2)" "unprognostic (1.63e-2)" "unprognostic (2.86e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (9.06e-9)" "unprognostic (2.70e-2)" "unprognostic (4.35e-1)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" 44.9 71.6 0.4 489.8 0.5 335.4 320.3 0.3 2.1 193.6 0.9 1246.6 649.2 39.6 0.0 219.6 19.3 313.3 28.3 0.2 0.5 25.8 70.7 177.8 1126.4 1.5 0.4 0.2 34.4 7.6 2.8 2.0 0.7 0.5 22.1 690.9 0.2 632.9 19.8 1.2 4.1 485.8 37.6 0.4 659.5 1473.5 56.4 1.0 338.6 36.2 0.0 3353.5 685.5 30.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.0 0.0 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.2 2.4 0.8 0.0 0.0 0.5 3.0 4.5 0.0 0.0 9.1 9.9 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 1.7 1.8 1.2 2.8 0.0 0.3 0.0 0.7 1.1 0.5 0.3 0.4 0.4 779.5 0.6 0.2 1.2 1038.5 0.2 0.3 0.6 0.4 0.8 0.5 0.5 52.3 0.4 0.5 0.3 2.1 0.2 0.5 1.5 0.4 0.2 0.5 0.4 1.0 0.9 0.0 3.2 0.0 0.0 111.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 10.7 174.8 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56277.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 11.7 0.0 0.2 0.0 IGLJ1 ENSG00000211674 "Immunoglobulin lambda joining 1" A0A0A0MT76 22 22893692-22893818 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "intestine: 96.0;lymphoid tissue: 50.4;salivary gland: 32.8;stomach 1: 41.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 19.6;naive B-cell: 11.0" "Lineage enriched" "Detected in single" 31 "B-cells: 19.6" "Group enriched" "Detected in some" 6 "Daudi: 274.6;U-266/70: 310.0;U-698: 88.7" "Immunoglobulin genes" NA NA "unprognostic (4.18e-4)" "unprognostic (4.80e-3)" "unprognostic (6.97e-2)" "unprognostic (4.68e-1)" 2.3 0.6 0.1 43.7 0.2 9.9 1.8 0.2 0.6 0.0 0.4 17.3 96.0 0.8 0.0 2.0 0.4 5.1 0.2 0.1 0.1 0.2 0.1 2.8 50.4 0.4 0.3 0.3 0.6 0.0 0.0 0.0 0.2 0.4 0.6 13.6 0.0 32.8 0.0 0.0 0.0 43.8 2.6 0.3 31.8 41.2 1.3 0.2 5.2 0.0 0.0 34.8 4.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 274.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 310.0 37.0 88.7 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 19.6 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.2 0.2 0.6 0.1 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLC1 IGLC ENSG00000211675 "Immunoglobulin lambda constant 1" 22 22895375-22895834 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 3293.9;lymphoid tissue: 5633.9;stomach 1: 2356.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 37.3;granulocytes: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 743 "memory B-cell: 5729.2;naive B-cell: 5821.4" "Lineage enriched" "Detected in all" 749 "B-cells: 5821.4" "Cell line enriched" "Detected in many" 5 "U-266/70: 600.3" "Immunoglobulin genes" NA NA 75.9 164.6 2.4 1220.2 2.9 647.5 912.1 1.8 6.5 192.5 5.4 3066.8 3293.9 63.7 2.1 539.8 114.2 646.0 105.3 1.9 2.0 145.6 115.6 474.8 2392.9 4.4 2.4 1.8 136.7 70.4 8.0 13.3 1.9 2.9 72.1 2153.0 0.7 2065.8 125.2 5.0 29.1 1401.6 78.7 2.0 3358.8 2356.4 23.9 2.8 881.2 226.4 0.0 5633.9 1966.3 79.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.0 0.0 1.0 0.0 1.9 0.2 0.0 0.0 6.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 9.1 0.0 0.0 1.1 10.2 2.0 0.0 0.0 2.3 8.9 33.4 0.0 0.0 6.3 11.1 1.4 0.0 0.0 0.0 0.0 0.3 2.5 0.0 1.3 4.3 2.6 600.3 119.9 36.5 0.0 3.5 0.0 4.2 7.7 2.0 3.7 1.7 2.9 5729.2 3.8 2.5 6.0 5821.4 0.9 2.2 7.6 2.8 4.8 5.2 3.4 897.2 2.4 2.9 1.8 6.5 1.9 2.0 4.4 2.4 1.8 2.9 2.0 2.8 4.3 0.0 6.4 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 IGLJ2 ENSG00000211676 "Immunoglobulin lambda joining 2" 22 22899481-22899655 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 263.2;lymphoid tissue: 191.4;stomach 1: 214.6" "Cell type enriched" "Detected in single" 5 "Plasma cells: 1.7" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.9;endometrial cancer: 21.6" "Region enhanced" "Detected in single" "pons: 1.3" "Group enriched" "Detected in many" 12 "memory B-cell: 876.1;naive B-cell: 864.5" "Lineage enriched" "Detected in many" 12 "B-cells: 876.1" "Cell line enhanced" "Detected in some" "Daudi: 10.8;HMC-1: 34.1;RH-30: 89.7;U-698: 19.8" NA NA "unprognostic (6.99e-3)" "unprognostic (5.36e-2)" "unprognostic (5.54e-2)" "unprognostic (1.13e-2)" "unprognostic (5.94e-7)" "unprognostic (1.51e-2)" "unprognostic (3.63e-2)" "unprognostic (3.66e-2)" "unprognostic (5.17e-2)" "unprognostic (2.92e-1)" 8.5 55.5 0.2 174.6 0.0 25.6 11.3 0.1 0.8 6.1 0.2 135.8 263.2 3.0 4.2 13.6 1.0 12.6 2.9 0.1 0.0 2.1 6.9 21.7 95.3 0.3 0.1 0.0 4.8 6.0 0.1 0.0 0.0 1.3 4.0 31.4 0.0 76.3 4.3 0.0 0.2 207.7 1.9 0.0 129.5 214.6 2.4 0.1 15.7 0.3 0.0 191.4 61.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.7 89.7 1.3 0.0 0.0 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 0.0 0.6 19.8 0.0 0.5 0.0 1.4 1.9 0.6 0.4 0.2 0.7 876.1 0.3 0.3 0.9 864.5 0.2 0.4 9.3 0.7 0.8 71.8 0.5 136.5 0.2 0.0 0.1 0.8 0.1 0.0 0.3 0.1 0.0 1.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLC2 IGLC ENSG00000211677 "Immunoglobulin lambda constant 2" P0DOY2 22 22900976-22901437 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 9822.7;lymphoid tissue: 20157.0;stomach 1: 10946.8" "Group enriched" "Detected in many" 40 "B-cells: 24632.2;Plasma cells: 18795.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 36 "memory B-cell: 11361.1;naive B-cell: 10650.3" "Lineage enriched" "Detected in all" 37 "B-cells: 11361.1" "Group enriched" "Detected in many" 190 "RPMI-8226: 62032.1;U-266/70: 102644.1;U-266/84: 83511.6" "Immunoglobulin genes" NA NA "prognostic favorable (5.76e-5)" "unprognostic (2.29e-2)" "unprognostic (4.54e-3)" "unprognostic (1.46e-2)" "unprognostic (4.02e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.96e-2)" "unprognostic (7.52e-2)" "unprognostic (7.15e-2)" "unprognostic (7.69e-3)" "unprognostic (2.83e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (4.47e-9)" "unprognostic (2.00e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" 390.2 790.2 8.3 3907.5 9.3 2765.7 2206.0 5.0 16.0 822.5 14.1 8295.4 9822.7 196.2 208.8 1705.3 233.5 2111.3 320.8 5.1 5.7 296.5 385.4 1455.6 5588.2 12.4 9.0 5.1 545.1 113.7 17.0 31.2 7.5 8.6 266.3 5102.7 0.7 5988.4 388.6 8.7 74.8 5334.9 309.0 6.2 7146.8 10946.8 258.1 7.4 2090.6 495.8 0.6 20157.0 6539.4 178.2 12.1 120.6 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 221.4 12.0 0.0 0.0 61.9 0.0 0.0 0.0 30.5 0.0 7.7 0.0 0.0 0.0 19.2 343.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 64.7 0.0 0.0 70.1 27.7 52.3 0.0 0.0 45.3 436.2 62032.1 0.0 0.0 46.7 45.7 5.6 43.0 17.3 0.0 17.7 57.2 11.7 0.0 38.9 23.4 78.2 102644.1 83511.6 298.8 0.7 21.9 0.7 9.9 18.6 5.6 5.8 3.0 5.7 11361.1 5.8 4.5 10.9 10650.3 3.5 4.7 118.0 5.8 8.7 303.3 6.5 2385.6 8.3 9.3 5.0 16.0 5.1 5.7 12.4 9.0 5.1 8.6 6.2 7.4 12.1 4.1 32.1 121.0 0.0 24632.2 0.0 0.3 0.0 1.2 0.0 16.1 3.0 3.9 44.3 8.1 0.0 0.0 0.3 8.0 28.0 0.0 0.0 0.0 0.0 0.1 86.3 62.5 222.4 0.0 0.0 0.3 42.5 14.8 0.0 65.6 0.0 222.8 539.9 2.1 0.0 0.0 21.5 0.0 134.5 0.0 0.0 0.0 8.5 0.0 0.0 11.4 0.0 15.5 0.0 0.0 0.0 20.6 0.0 18795.5 0.0 0.0 1.4 1.5 0.0 0.0 0.2 10.2 0.0 0.0 2.8 0.0 0.1 538.6 0.0 23.7 0.0 IGLJ3 ENSG00000211678 "Immunoglobulin lambda joining 3" 22 22904850-22905025 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "intestine: 557.2;lymphoid tissue: 229.5;salivary gland: 150.5;stomach 1: 466.5;urinary bladder: 149.1" "Group enriched" "Detected in some" 44 "B-cells: 4.5;Plasma cells: 4.3" "Group enriched" "Detected in some" 13 "colorectal cancer: 5.1;endometrial cancer: 10.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Group enriched" "Detected in many" 24 "memory B-cell: 1223.9;naive B-cell: 1139.6" "Lineage enriched" "Detected in many" 25 "B-cells: 1223.9" "Group enriched" "Detected in some" 7 "Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5" NA NA "unprognostic (1.19e-1)" "unprognostic (2.06e-3)" "unprognostic (2.05e-1)" "unprognostic (1.37e-1)" "unprognostic (5.00e-1)" 5.7 29.7 0.4 214.4 0.2 37.8 32.8 0.1 1.5 9.8 0.3 131.4 557.2 3.2 0.0 40.3 4.0 33.0 3.1 0.1 0.1 3.0 9.9 42.1 133.2 0.4 0.2 0.0 31.4 1.9 0.0 0.0 0.1 0.1 9.7 72.1 0.0 150.5 1.6 0.0 1.5 207.6 6.2 0.0 209.4 466.5 6.1 0.2 23.5 0.8 0.0 229.5 149.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 69.6 2.5 6.7 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.0 42.8 22.5 4.3 0.0 0.0 0.0 0.8 1.6 0.7 0.9 0.3 4.3 1223.9 0.8 0.5 1.3 1139.6 0.4 0.5 8.5 0.6 1.2 49.2 0.8 193.9 0.4 0.2 0.1 1.5 0.1 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLC3 IGLC ENSG00000211679 "Immunoglobulin lambda constant 3 (Kern-Oz+ marker)" P0DOY3 22 22906342-22906803 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 4155.1;lymphoid tissue: 8243.2;stomach 1: 4166.4;urinary bladder: 3759.6" "Group enriched" "Detected in many" 35 "B-cells: 12202.8;Plasma cells: 5357.3;T-cells: 3582.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 34 "memory B-cell: 7254.6;naive B-cell: 6119.2" "Lineage enriched" "Detected in all" 37 "B-cells: 7254.6" "Cell line enriched" "Detected in many" 15 "RPMI-8226: 10741.3" "CAB000050, CAB016533" Supported "Immunoglobulin genes" NA NA "CAB000050: , CAB016533: AB_629719" "prognostic favorable (2.32e-4)" "unprognostic (1.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.54e-2)" "unprognostic (8.41e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.45e-2)" "unprognostic (4.59e-2)" "unprognostic (8.77e-2)" "prognostic favorable (4.58e-4)" "unprognostic (9.71e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.04e-9)" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (5.97e-2)" 157.7 556.1 2.7 2399.4 4.8 848.4 1403.3 1.5 9.1 222.3 6.9 4155.1 4083.2 116.3 33.5 512.9 88.8 714.3 64.2 1.9 2.1 176.8 173.1 1090.4 2769.8 7.2 5.1 1.4 250.0 48.1 7.0 19.2 3.2 3.1 135.2 2288.7 0.3 2284.7 178.7 5.9 20.9 2392.9 114.9 2.7 4295.4 4166.4 55.8 3.5 431.1 233.9 0.9 8243.2 3759.6 112.4 6.0 0.6 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 60.1 0.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 18.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 338.0 0.0 0.0 10.8 15.0 2.8 0.0 0.0 700.2 9.3 10741.3 0.0 0.0 16.6 25.1 4.4 20.8 0.0 0.0 4.9 0.8 11.1 0.0 6.3 7.2 5.0 88.0 103.4 36.1 1.2 5.3 0.5 6.4 9.1 3.9 6.0 2.0 27.3 7254.6 5.1 3.6 6.9 6119.2 2.6 3.3 60.7 4.3 4.6 195.3 4.7 1415.5 2.7 4.8 1.5 9.1 1.9 2.1 7.2 5.1 1.4 3.1 2.7 3.5 6.0 2.0 22.4 97.3 0.0 12202.8 0.0 0.7 0.0 0.0 0.0 5.4 0.5 15.3 8.6 3.7 0.0 0.0 0.2 8.8 5.0 0.0 0.0 0.0 0.0 0.1 7.4 12.2 54.8 0.0 0.0 0.0 22.1 5.6 0.1 47.9 0.0 195.9 127.7 0.2 0.0 0.0 3.5 0.0 23.1 0.0 0.0 0.0 5.6 0.0 0.0 2.0 0.0 2.1 0.0 0.0 0.0 3.1 0.0 5357.3 0.2 0.0 1.1 2.2 0.0 0.0 0.0 4.2 0.0 0.0 0.8 0.0 0.1 3582.0 0.0 6.3 0.9 IGLJ4 ENSG00000211680 "Immunoglobulin lambda joining 4 (non-functional)" 22 22910574-22910606 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 24 "brain: 1.3;intestine: 1.9;lymphoid tissue: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "Daudi: 37.7;U-698: 13.3" NA NA 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 1.8 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.6 0.2 0.0 0.5 0.2 0.0 1.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ5 ENSG00000211681 "Immunoglobulin lambda joining 5 (non-functional)" 22 22914237-22914308 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 1.6;lymphoid tissue: 3.8;stomach 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 117 "memory B-cell: 15.2;naive B-cell: 14.1;plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 105 "B-cells: 15.2;dendritic cells: 5.7" "Group enriched" "Detected in some" 7 "Daudi: 32.4;U-698: 12.7" NA NA 0.0 0.0 0.1 2.4 0.2 0.0 1.6 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.2 0.0 0.1 0.0 0.0 3.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ6 ENSG00000211682 "Immunoglobulin lambda joining 6" 22 22918132-22918201 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "intestine: 6.7;lymphoid tissue: 8.0;urinary bladder: 5.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "colorectal cancer: 1.2;endometrial cancer: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 48 "memory B-cell: 31.6;naive B-cell: 38.3" "Lineage enriched" "Detected in single" 52 "B-cells: 38.3" "Group enriched" "Detected in some" 8 "Daudi: 14.5;U-698: 4.3" NA NA 0.0 0.0 0.0 7.3 0.2 0.0 0.4 0.0 0.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.0 0.0 8.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 5.4 1.0 0.0 0.1 0.0 0.0 0.0 2.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.2 0.0 0.3 0.1 0.3 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLJ7 ENSG00000211684 "Immunoglobulin lambda joining 7" 22 22921390-22921435 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 12.5;lymphoid tissue: 19.2;stomach 1: 17.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.0;endometrial cancer: 1.5" "Region enhanced" "Detected in single" "cerebral cortex: 2.5" "Group enriched" "Detected in some" 222 "memory B-cell: 314.0;naive B-cell: 370.8" "Lineage enriched" "Detected in many" 240 "B-cells: 370.8" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.0" NA NA 0.7 4.2 0.1 14.6 0.2 1.1 0.0 0.3 2.5 0.0 0.0 6.2 12.5 0.0 0.0 2.1 0.0 3.3 0.0 0.2 0.9 0.0 0.0 2.0 3.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.9 0.0 6.0 0.0 0.0 0.0 5.4 0.0 0.0 3.9 17.7 1.9 0.1 0.3 0.0 0.0 19.2 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.6 314.0 0.0 0.0 0.0 370.8 0.0 0.0 0.0 0.0 1.5 0.2 0.0 27.6 0.1 0.2 0.3 2.5 0.2 0.9 0.7 0.4 0.0 0.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLC7 ENSG00000211685 "Immunoglobulin lambda constant 7" 22 22922594-22923034 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 88.9;lymphoid tissue: 108.6;salivary gland: 70.8;stomach 1: 114.1" "Cell type enriched" "Detected in some" 10 "B-cells: 109.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 341 "memory B-cell: 128.8;naive B-cell: 133.0" "Lineage enriched" "Detected in single" 346 "B-cells: 133.0" "Cell line enriched" "Detected in some" 913 "Karpas-707: 122629.0" "Immunoglobulin genes" NA NA "unprognostic (1.20e-3)" "unprognostic (5.94e-2)" "unprognostic (3.91e-1)" "unprognostic (2.16e-2)" "prognostic favorable (2.03e-4)" "unprognostic (2.11e-1)" "unprognostic (9.60e-3)" "unprognostic (2.47e-2)" "unprognostic (1.88e-1)" "unprognostic (2.74e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (1.61e-6)" "unprognostic (2.86e-1)" "unprognostic (2.14e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-2)" 5.7 4.7 0.0 28.2 0.1 20.1 15.7 0.0 0.4 5.1 0.1 54.6 88.9 4.5 0.5 8.4 4.3 10.8 1.4 0.0 0.4 2.3 3.5 8.4 41.2 0.3 0.0 0.0 2.5 1.7 0.1 0.2 0.0 0.2 4.5 23.3 0.0 70.8 0.6 0.1 0.2 23.3 0.9 0.0 108.6 114.1 0.8 0.1 20.2 5.8 0.0 105.0 19.2 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122629.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 134.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.7 3.0 0.6 111.2 0.0 47.3 0.3 0.1 0.0 0.0 0.1 0.0 128.8 0.0 0.0 0.1 133.0 0.0 0.2 0.1 0.0 0.1 0.3 0.1 25.5 0.0 0.1 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.4 3.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 TRGJ2 "J2, TCRGJ2" ENSG00000211687 "T cell receptor gamma joining 2" 7 38253380-38253429 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 17.3;lymphoid tissue: 13.1;prostate: 58.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 293.4;MAIT T-cell: 274.9;memory CD8 T-cell: 299.2;naive CD8 T-cell: 194.4" "Lineage enriched" "Detected in many" 14 "T-cells: 299.2" "Group enriched" "Detected in some" 6 "HL-60: 11.7;MCF7: 15.9;SK-BR-3: 14.8;U-937: 13.5" NA NA 0.0 0.0 3.1 3.2 1.2 17.3 2.4 0.5 5.9 0.0 0.6 1.1 4.8 0.2 1.9 0.0 1.2 0.7 0.3 0.6 2.1 1.0 0.5 1.2 5.1 2.8 2.8 0.2 0.6 3.0 0.0 0.0 0.0 2.0 58.4 2.5 0.0 0.7 0.0 0.0 0.0 5.0 0.7 1.6 13.1 0.7 1.1 3.6 2.0 0.1 0.0 1.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 15.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.1 0.3 0.3 293.4 0.6 274.9 0.2 55.8 299.2 0.3 0.2 15.0 194.4 2.2 21.7 0.7 0.6 1.1 52.8 3.1 1.2 0.5 5.9 0.6 2.1 2.8 2.8 0.2 2.0 1.6 3.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRGJP2 "JP2, TCRGJP2" ENSG00000211688 "T cell receptor gamma joining P2" 7 38256337-38256396 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "bone marrow: 65.0;brain: 50.4;lung: 28.9;lymphoid tissue: 30.7;prostate: 32.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 14 "prostate cancer: 17.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 367.0" "Group enriched" "Detected in many" 85 "NK-cells: 186.9;T-cells: 367.0" "Group enriched" "Detected in some" 8 "HL-60: 61.6;NB-4: 66.3;SK-BR-3: 18.3;THP-1: 36.2;U-937: 72.4" NA NA "unprognostic (2.09e-1)" "unprognostic (5.05e-2)" 1.3 0.0 10.9 4.9 27.1 65.0 5.5 10.3 50.4 1.4 4.3 2.8 4.3 1.5 0.0 1.3 1.6 1.3 0.0 10.6 14.7 0.0 4.5 28.9 12.5 36.7 22.1 6.2 0.0 0.0 0.0 0.0 0.5 23.2 32.7 2.6 0.7 0.0 0.0 0.0 2.0 8.2 2.7 11.6 30.7 6.2 3.5 17.7 20.8 2.2 0.0 13.6 1.9 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 61.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 66.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 18.3 4.6 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.4 0.0 0.3 1.4 1.8 367.0 0.2 94.8 0.2 33.3 142.4 0.4 0.3 3.1 81.3 3.2 186.9 0.5 0.4 1.8 42.1 10.9 27.1 10.3 50.4 10.6 14.7 36.7 22.1 6.2 23.2 11.6 17.7 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRGC1 "C1, TCRGC1" ENSG00000211689 "T cell receptor gamma constant 1" 7 38257879-38265678 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "bone marrow: 32.0;prostate: 77.3" "Group enriched" "Detected in some" 5 "dendritic cells: 95.8;NK-cells: 230.7;Prostatic glandular cells: 61.9;T-cells: 65.6" "Cancer enriched" "Detected in some" 141 "prostate cancer: 107.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "gdT-cell: 384.7" "Lineage enriched" "Detected in many" 4 "T-cells: 384.7" "Cell line enhanced" "Detected in some" "HL-60: 21.0;MCF7: 89.8;SK-BR-3: 49.6;U-937: 45.5" NA NA "unprognostic (2.37e-2)" "unprognostic (2.38e-4)" "unprognostic (3.43e-3)" "unprognostic (6.04e-4)" "unprognostic (1.04e-2)" "unprognostic (3.77e-3)" "unprognostic (1.33e-3)" "unprognostic (3.80e-2)" "unprognostic (3.55e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (2.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.98e-1)" "unprognostic (8.36e-2)" "unprognostic (2.56e-2)" 0.4 0.2 1.4 1.1 1.5 32.0 2.1 1.3 2.2 0.1 1.0 0.5 1.1 0.2 0.5 0.1 0.3 1.0 0.2 1.3 1.5 0.8 0.8 1.9 2.0 1.7 2.0 1.0 0.1 0.0 0.0 0.2 0.5 1.8 77.3 0.6 0.0 0.4 0.2 0.1 0.1 1.4 0.2 1.4 6.1 0.6 0.4 1.8 7.1 0.3 0.0 1.3 0.6 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 21.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 89.8 0.2 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 49.6 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 45.5 0.0 3.8 0.3 0.5 384.7 0.4 56.7 0.2 6.8 33.5 0.3 0.0 2.3 21.7 1.8 87.5 0.3 0.5 0.1 43.7 1.4 1.5 1.3 2.2 1.3 1.5 1.7 2.0 1.0 1.8 1.4 1.8 1.4 0.5 0.0 1.1 0.0 2.1 0.0 1.3 0.0 0.0 0.0 1.8 0.6 0.2 0.0 0.6 0.0 0.0 0.0 95.8 0.1 0.0 0.0 2.3 0.0 0.1 0.5 1.2 2.7 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.9 0.0 2.1 0.0 0.0 19.5 0.0 230.7 0.0 0.0 0.0 0.0 0.0 14.3 61.9 0.0 0.3 0.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 65.6 0.0 0.3 1.2 TRGJ1 "J1, TCRGJ1" ENSG00000211690 "T cell receptor gamma joining 1" A0A075B6S0 7 38269491-38269540 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.3;lymphoid tissue: 13.1;prostate: 58.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 293.4;MAIT T-cell: 274.9;memory CD8 T-cell: 299.2;naive CD8 T-cell: 194.4" "Lineage enriched" "Detected in many" 14 "T-cells: 299.2" "Group enriched" "Detected in some" 6 "HL-60: 11.7;MCF7: 15.9;SK-BR-3: 14.8;U-937: 13.5" NA NA 0.0 0.0 3.1 3.2 1.2 17.3 2.4 0.5 5.9 0.0 0.6 1.1 4.8 0.2 1.9 0.0 1.2 0.7 0.3 0.6 2.1 1.0 0.5 1.2 5.1 2.8 2.8 0.2 0.6 3.0 0.0 0.0 0.0 2.0 58.4 2.5 0.0 0.7 0.0 0.0 0.0 5.0 0.7 1.6 13.1 0.7 1.1 3.6 2.0 0.1 0.0 1.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 15.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.1 0.3 0.3 293.4 0.6 274.9 0.2 55.8 299.2 0.3 0.2 15.0 194.4 2.2 21.7 0.7 0.6 1.1 52.8 3.1 1.2 0.5 5.9 0.6 2.1 2.8 2.8 0.2 2.0 1.6 3.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRGJP "JP, TCRGJP" ENSG00000211691 "T cell receptor gamma joining P" 7 38273587-38273647 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "bone marrow: 43.5;prostate: 96.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 46 "gdT-cell: 2370.0" "Lineage enriched" "Detected in many" 46 "T-cells: 2370.0" "Group enriched" "Detected in some" 10 "MCF7: 26.9;SK-BR-3: 60.9" NA NA 0.0 0.0 1.4 5.2 0.9 43.5 0.7 0.2 1.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 1.1 1.2 0.7 1.1 1.2 0.0 0.0 0.4 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.4 1.2 96.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.8 2.8 2.5 1.1 0.6 0.0 0.0 0.6 1.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.7 0.5 2370.0 3.2 49.6 0.8 2.0 26.9 0.8 0.3 0.4 18.5 10.2 51.9 0.9 2.0 0.6 210.4 1.4 0.9 0.2 1.6 0.7 1.1 1.1 0.6 0.0 1.2 0.6 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRGJP1 "JP1, TCRGJP1" ENSG00000211692 "T cell receptor gamma joining P1" 7 38276259-38276318 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "bone marrow: 273.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "NK-cell: 1153.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 1153.0" "Group enriched" "Detected in some" 5 "HL-60: 282.5;U-937: 715.8" NA NA 3.1 0.0 7.2 7.3 8.7 273.8 4.3 7.4 24.2 4.2 4.9 1.1 5.4 0.3 0.0 0.7 2.2 1.3 0.6 7.2 8.2 0.7 1.8 10.3 8.8 12.7 8.2 6.0 0.0 0.0 0.0 0.0 4.0 10.6 1.8 4.4 0.0 0.0 0.0 3.9 0.0 2.0 1.3 6.8 28.2 1.1 0.7 8.5 13.8 0.0 0.0 4.5 1.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 282.5 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 715.8 0.0 13.4 0.4 4.4 241.1 0.9 169.1 0.2 16.2 80.9 0.0 0.7 9.3 44.1 4.2 1153.0 0.1 2.8 0.0 58.9 7.2 8.7 7.4 24.2 7.2 8.2 12.7 8.2 6.0 10.6 6.8 8.5 8.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRGV11 "TCRGV11, V4P" ENSG00000211693 "T cell receptor gamma variable 11 (non-functional)" 7 38291616-38292078 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 30 "T-cells: 2.9" "Cell line enriched" "Detected in single" 10 "NB-4: 1.0" NA NA "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TRGV10 "TCRGV10, V3P" ENSG00000211694 "T cell receptor gamma variable 10 (non-functional)" 7 38299811-38300322 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 14.1" "Cell type enhanced" "Detected in some" "dendritic cells: 7.5;Plasma cells: 7.1;T-cells: 29.9" "Cancer enriched" "Detected in many" 8 "prostate cancer: 7.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 196.5" "Lineage enriched" "Detected in many" 8 "T-cells: 196.5" "Group enriched" "Detected in some" 24 "NB-4: 79.7;U-937: 20.5" NA NA "unprognostic (1.59e-2)" "unprognostic (4.53e-3)" "unprognostic (5.13e-2)" "unprognostic (2.94e-3)" "unprognostic (1.54e-2)" "unprognostic (1.22e-4)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.50e-2)" "unprognostic (2.53e-2)" "unprognostic (1.94e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-4)" "unprognostic (2.68e-1)" "unprognostic (9.00e-2)" "unprognostic (5.10e-2)" "unprognostic (2.07e-2)" 1.1 0.6 0.1 2.7 0.2 14.2 1.8 0.1 0.5 1.2 0.9 2.0 2.2 0.8 0.7 1.1 1.3 3.3 0.4 0.1 0.1 0.6 1.8 4.1 11.0 0.4 0.2 0.0 0.3 0.2 0.1 0.2 0.4 0.3 6.1 2.7 0.0 1.1 0.7 0.2 0.6 4.1 0.6 0.3 14.1 2.6 0.3 0.3 12.6 1.1 0.0 5.0 3.8 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 79.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.5 0.0 0.7 0.4 1.0 196.5 0.1 156.1 0.5 47.2 137.6 0.2 0.1 11.3 159.7 2.9 26.0 0.3 0.8 0.1 33.3 0.1 0.2 0.1 0.5 0.1 0.1 0.4 0.2 0.0 0.3 0.3 0.3 0.3 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.9 0.0 0.0 0.0 TRGV9 "TCRGV9, V2" ENSG00000211695 "T cell receptor gamma variable 9" Q99603 7 38317017-38318861 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 1.9;prostate: 5.5" "Group enriched" "Detected in some" 4 "dendritic cells: 14.6;NK-cells: 22.6;T-cells: 37.7" "Cancer enriched" "Detected in single" 126 "prostate cancer: 13.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 13 "gdT-cell: 426.5" "Lineage enriched" "Detected in many" 13 "T-cells: 426.5" "Group enriched" "Detected in some" 6 "MCF7: 7.7;NB-4: 2.4;U-937: 8.6" "Not detected" "Not detected" NA NA "unprognostic (1.07e-1)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (3.98e-3)" "unprognostic (4.43e-2)" "unprognostic (4.13e-2)" "unprognostic (1.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (2.41e-1)" "unprognostic (6.60e-4)" "unprognostic (1.29e-1)" "unprognostic (4.95e-1)" 0.4 0.0 0.4 0.5 0.7 1.1 0.1 0.3 0.7 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.7 0.0 0.2 0.4 0.5 0.7 0.9 0.3 0.0 0.1 0.0 0.0 1.9 0.7 5.5 0.2 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.4 1.6 0.3 0.1 0.5 1.5 0.0 0.0 0.4 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.7 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.3 0.1 426.5 0.6 29.0 0.1 1.6 19.7 0.4 0.0 0.7 8.4 1.4 33.2 0.1 0.5 0.1 38.8 0.4 0.7 0.3 0.7 0.4 0.7 0.7 0.9 0.3 0.7 0.4 0.5 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.0 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 TRGV8 "TCRGV8, V1S8" ENSG00000211696 "T cell receptor gamma variable 8" A0A0C4DH27 7 38330343-38330935 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.9;prostate: 4.9" "Cell type enriched" "Detected in some" 4 "T-cells: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 34.4;MAIT T-cell: 40.6;memory CD8 T-cell: 31.1;naive CD8 T-cell: 17.2" "Lineage enriched" "Detected in many" 7 "T-cells: 40.6" "Cell line enriched" "Detected in some" 4 "JURKAT: 44.9" NA NA 0.4 0.3 0.3 1.5 0.1 0.7 0.3 0.0 0.3 0.4 0.2 0.8 0.8 0.7 0.6 0.7 0.9 1.2 0.3 0.5 0.2 0.2 1.4 2.3 3.5 0.8 0.7 0.0 0.3 0.3 0.1 0.0 1.4 1.0 4.9 1.2 0.0 0.3 0.4 0.1 0.0 2.0 0.9 0.2 6.9 0.8 0.4 0.4 4.6 0.2 0.0 2.0 1.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 2.4 0.1 0.5 0.0 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 2.1 3.1 0.0 1.4 0.0 0.0 0.0 3.6 0.5 0.0 0.0 1.2 0.0 0.0 0.0 44.9 1.0 2.5 0.0 0.7 0.0 1.7 0.0 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.7 10.6 0.0 0.0 0.7 0.0 34.4 0.1 40.6 0.0 3.7 31.1 0.9 0.0 0.2 17.2 0.2 5.5 0.1 0.2 0.1 4.5 0.3 0.1 0.0 0.3 0.5 0.2 0.8 0.7 0.0 1.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 TRGV5 "TCRGV5, V1S5" ENSG00000211697 "T cell receptor gamma variable 5" A0A0B4J1U4 7 38349355-38350022 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.0" "Cell type enhanced" "Detected in some" "dendritic cells: 2.4;Hepatic stellate cells: 1.8;Hofbauer cells: 2.9;Kupffer cells: 7.2;Plasma cells: 2.5;T-cells: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 6.9;JURKAT: 11.1;Karpas-707: 15.2;NB-4: 4.7;U-266/84: 4.9;U-87 MG: 6.8;U-937: 6.9" NA NA "unprognostic (3.17e-2)" "unprognostic (1.21e-2)" "unprognostic (6.61e-2)" "unprognostic (2.62e-4)" "unprognostic (5.91e-3)" "unprognostic (1.66e-2)" "unprognostic (3.18e-2)" "unprognostic (3.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.88e-1)" "unprognostic (2.39e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-6)" "unprognostic (1.62e-1)" "unprognostic (2.35e-1)" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" 0.4 0.4 0.0 0.9 0.1 2.4 0.4 0.0 0.2 0.5 0.2 1.2 0.0 0.2 0.1 0.3 0.2 1.9 0.3 0.0 0.1 0.4 1.2 1.2 3.7 0.3 0.2 0.0 0.2 0.0 0.0 0.1 0.6 0.3 0.8 1.0 0.0 0.6 0.1 0.2 0.3 1.0 0.6 0.1 3.6 0.8 0.2 0.2 6.0 0.3 0.3 4.7 1.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.3 0.4 1.4 0.0 0.0 0.0 0.0 6.9 0.8 1.9 0.0 0.0 0.0 2.1 1.3 0.2 0.0 0.0 0.0 0.0 0.5 11.1 0.2 15.2 0.1 0.3 0.0 4.7 0.0 0.0 0.0 0.4 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.0 0.4 0.1 0.1 0.0 0.0 4.9 0.4 6.8 6.9 0.0 0.0 5.1 0.6 24.5 1.7 20.1 0.7 2.9 22.4 5.6 0.7 1.4 9.5 0.3 8.2 0.2 6.9 3.7 5.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.2 0.0 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 1.8 0.0 2.9 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 6.0 0.0 0.0 0.0 TRGV4 "TCRGV4, V1S4" ENSG00000211698 "T cell receptor gamma variable 4" A0A0C4DH28 7 38353715-38354517 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.2" "Cell type enhanced" "Detected in some" "dendritic cells: 2.7;Plasma cells: 2.1;T-cells: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 97.8" "Lineage enriched" "Detected in many" 15 "T-cells: 97.8" "Cell line enriched" "Detected in some" 4 "Karpas-707: 72.0" NA NA "unprognostic (7.44e-3)" "unprognostic (7.26e-3)" "unprognostic (5.77e-2)" "unprognostic (1.90e-2)" "unprognostic (3.58e-1)" "unprognostic (6.75e-3)" "unprognostic (9.66e-2)" "unprognostic (8.83e-3)" "unprognostic (1.21e-1)" "unprognostic (2.63e-2)" "unprognostic (1.42e-2)" "unprognostic (1.58e-1)" "unprognostic (2.59e-3)" "unprognostic (2.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.47e-2)" "unprognostic (3.71e-3)" 0.4 0.4 0.2 0.4 0.3 3.0 0.4 0.3 0.5 0.3 0.8 1.6 0.4 0.4 0.2 0.4 0.5 2.3 0.2 0.2 0.3 0.4 1.4 1.7 11.2 0.6 0.4 0.0 0.1 0.1 0.1 0.2 0.4 0.4 2.0 1.4 0.0 0.9 0.3 0.1 0.5 3.5 0.3 0.5 9.1 1.6 0.7 0.7 7.1 0.4 0.0 4.9 0.8 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 13.9 0.1 8.3 0.0 0.0 0.0 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.1 8.3 4.6 72.0 0.1 0.2 0.0 16.8 0.4 0.0 0.1 0.6 0.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.2 0.0 0.0 0.0 2.7 1.9 0.0 1.1 14.5 0.0 0.2 1.5 0.1 97.8 0.3 30.1 1.0 4.4 26.8 1.7 0.6 2.0 23.8 0.6 6.5 0.1 5.8 1.4 7.2 0.2 0.3 0.3 0.5 0.2 0.3 0.6 0.4 0.0 0.4 0.5 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 TRGV3 "TCRGV3, V1S3" ENSG00000211699 "T cell receptor gamma variable 3" P03979 7 38358512-38359162 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 12.5" "Cell type enhanced" "Detected in some" "dendritic cells: 1.8;Plasma cells: 2.6;T-cells: 5.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "gdT-cell: 59.0" "Lineage enriched" "Detected in many" 5 "T-cells: 59.0" "Cell line enhanced" "Detected in some" "HDLM-2: 7.0;JURKAT: 12.1;Karpas-707: 28.9;U-266/84: 5.9" NA NA "unprognostic (2.87e-2)" "unprognostic (1.63e-3)" "unprognostic (4.58e-2)" "unprognostic (6.48e-3)" "unprognostic (4.66e-2)" "unprognostic (1.57e-3)" "unprognostic (2.28e-1)" "unprognostic (1.72e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-2)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (5.26e-3)" "unprognostic (2.28e-1)" "unprognostic (3.46e-2)" "unprognostic (3.71e-2)" "unprognostic (3.42e-2)" 0.6 0.3 0.1 1.3 0.3 2.8 0.5 0.2 0.3 0.7 0.3 1.8 1.0 0.6 0.0 0.5 0.6 4.0 0.3 0.1 0.3 0.4 0.7 1.4 12.5 0.6 0.5 0.0 0.1 0.2 0.3 0.2 1.0 0.4 1.3 1.9 0.0 1.1 0.4 0.1 0.3 3.1 0.7 0.4 7.6 1.3 0.5 0.4 9.4 0.4 0.0 9.0 2.1 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 3.8 12.1 0.7 28.9 0.0 0.2 0.0 1.4 0.2 0.0 0.0 1.5 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 3.1 0.8 0.0 0.0 0.0 0.1 3.0 5.9 0.4 0.1 1.6 0.0 0.1 1.6 0.0 59.0 0.7 50.1 3.4 11.0 34.0 5.7 1.8 9.4 27.6 0.1 11.4 2.2 11.1 6.3 8.0 0.1 0.3 0.2 0.3 0.1 0.3 0.6 0.5 0.0 0.4 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 TRGV1 "TCRGV1, V1S1P" ENSG00000211701 "T cell receptor gamma variable 1 (non-functional)" 7 38367586-38368169 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.0;HL-60: 1.6;JURKAT: 1.4;Karpas-707: 2.1;U-937: 2.6" NA NA 0.1 0.0 0.2 0.6 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 1.5 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 0.5 1.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.7 2.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.3 0.1 2.6 0.0 0.0 0.6 0.0 1.8 0.1 1.8 0.1 0.8 1.2 0.2 0.0 0.2 0.8 0.0 1.7 0.0 0.6 0.0 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TRBV6-1 "TCRBV13S3, TCRBV6S1, TRBV61" ENSG00000211706 "T cell receptor beta variable 6-1" A0A0K0K1D8 7 142328297-142328786 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 48 "lymphoid tissue: 90.0" "Cell type enriched" "Detected in single" 10 "T-cells: 5.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 118.0;T-reg: 74.1" "Lineage enriched" "Detected in single" 126 "T-cells: 118.0" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 1.5" NA NA "unprognostic (1.12e-2)" "unprognostic (3.42e-4)" "unprognostic (3.40e-3)" "unprognostic (1.20e-2)" "unprognostic (1.22e-1)" "unprognostic (4.75e-5)" "unprognostic (1.08e-3)" "unprognostic (2.00e-1)" "unprognostic (2.18e-2)" "unprognostic (1.86e-5)" "unprognostic (1.28e-1)" "unprognostic (1.10e-1)" "unprognostic (1.85e-4)" "unprognostic (2.41e-1)" "unprognostic (2.48e-2)" "unprognostic (3.51e-2)" "unprognostic (3.56e-2)" 0.2 0.1 0.0 4.9 0.0 1.0 0.4 0.0 0.0 0.4 0.0 0.9 0.7 0.1 0.1 0.2 0.2 1.7 0.2 0.0 0.0 0.1 0.3 0.8 8.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.4 0.0 0.0 0.3 1.8 0.2 0.0 2.2 1.0 0.0 0.0 90.0 0.4 0.1 10.3 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 118.0 0.0 37.7 33.2 0.1 0.1 39.0 18.5 0.9 0.0 0.1 0.1 74.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 TRBV7-1 "TCRBV6S7P, TCRBV7S1, TRBV71" ENSG00000211707 "T cell receptor beta variable 7-1 (non-functional)" 7 142332182-142332701 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 8.2" "Group enriched" "Detected in some" 280 "Early spermatids: 75.2;Late spermatids: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 2.0;naive CD4 T-cell: 1.8;T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 1.8" NA NA "unprognostic (1.38e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.6 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV4-1 "BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41" ENSG00000211710 "T cell receptor beta variable 4-1" A0A577 7 142313184-142313666 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "lymphoid tissue: 116.0" "Cell type enriched" "Detected in some" 7 "T-cells: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 176.7" "Lineage enriched" "Detected in many" 89 "T-cells: 176.7" "Cell line enriched" "Detected in single" 8 "U-266/84: 1.5" NA NA "unprognostic (1.58e-4)" "unprognostic (3.14e-3)" "unprognostic (1.49e-2)" "unprognostic (5.74e-4)" "unprognostic (1.88e-1)" "unprognostic (6.43e-3)" "unprognostic (5.89e-2)" "unprognostic (2.96e-2)" "unprognostic (6.43e-3)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (6.71e-5)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.67e-2)" "unprognostic (8.99e-2)" 0.5 0.0 0.0 7.2 0.1 2.6 0.7 0.0 0.2 0.8 0.0 0.9 0.1 0.2 0.7 1.1 0.9 0.9 0.0 0.0 0.0 0.4 0.4 0.7 15.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.5 0.8 0.0 0.2 0.0 0.1 0.2 4.3 0.4 0.1 4.1 2.3 0.1 0.0 116.0 0.3 0.0 10.1 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.0 0.2 0.1 2.5 0.1 40.2 0.1 69.8 167.3 0.0 0.2 152.1 152.7 1.9 0.8 0.4 0.8 176.7 43.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 TRBV6-4 "TCRBV13S5, TCRBV6S4, TRBV64" ENSG00000211713 "T cell receptor beta variable 6-4" A0A1B0GX49 7 142380806-142381261 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.2" "Cell type enriched" "Detected in single" 6 "T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 13 "MAIT T-cell: 231.6" "Lineage enriched" "Detected in single" 1381 "T-cells: 231.6" "Not detected" "Not detected" NA NA "unprognostic (2.60e-3)" "unprognostic (4.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.79e-1)" "unprognostic (2.98e-1)" "unprognostic (1.54e-1)" "unprognostic (9.07e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 231.6 0.0 2.4 17.3 0.0 0.0 4.1 3.0 0.0 0.0 0.0 0.0 4.4 2.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 TRBV7-3 "TCRBV6S1A1N1, TCRBV7S3, TRBV73" ENSG00000211714 "T cell receptor beta variable 7-3" 7 142384329-142384841 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.0;testis: 2.7" "Group enriched" "Detected in some" 9 "Early spermatids: 32.5;Late spermatids: 39.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 31.9" "Lineage enriched" "Detected in single" 48 "T-cells: 31.9" "Cell line enhanced" "Detected in some" "ASC diff: 1.4;HBF TERT88: 2.3;HL-60: 1.6;RPTEC TERT1: 7.4;U-937: 3.8" NA NA "unprognostic (3.78e-3)" "unprognostic (5.75e-4)" "unprognostic (1.76e-2)" "unprognostic (2.64e-3)" "unprognostic (3.07e-1)" "unprognostic (1.28e-4)" "unprognostic (4.17e-3)" "unprognostic (2.34e-2)" "unprognostic (2.06e-1)" "unprognostic (4.49e-3)" "unprognostic (8.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.57e-3)" "unprognostic (1.67e-1)" "unprognostic (1.21e-1)" "unprognostic (3.72e-1)" "unprognostic (3.10e-1)" 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.0 0.0 1.9 0.2 2.7 0.0 7.0 0.2 0.0 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.6 0.0 1.9 0.1 3.6 0.0 31.9 7.8 0.5 0.6 7.3 9.9 0.0 0.0 0.0 0.4 16.4 5.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 3.7 0.1 0.0 0.0 TRBV5-3 "TCRBV5S3, TCRBV5S5P, TRBV53" ENSG00000211715 "T cell receptor beta variable 5-3 (non-functional)" 7 142389202-142389668 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 27 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 27 "T-cells: 2.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV9 "TCRBV1S1A1N1, TCRBV9S1" ENSG00000211716 "T cell receptor beta variable 9" A0A0B4J1U6 7 142391891-142392412 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.2;testis: 2.6" "Group enriched" "Detected in some" 11 "Early spermatids: 5.8;Late spermatids: 4.8;T-cells: 7.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 20.0;memory CD8 T-cell: 21.7;naive CD4 T-cell: 14.8;naive CD8 T-cell: 13.2;T-reg: 27.2" "Lineage enriched" "Detected in single" 31 "T-cells: 27.2" "Group enriched" "Detected in some" 16 "HL-60: 3.4;LHCN-M2: 6.0;U-937: 13.3" NA NA "unprognostic (7.28e-3)" "unprognostic (1.34e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-3)" "unprognostic (3.00e-1)" "unprognostic (1.58e-4)" "unprognostic (8.88e-3)" "unprognostic (6.53e-2)" "unprognostic (1.20e-2)" "unprognostic (1.69e-3)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.60e-10)" "unprognostic (1.04e-1)" "unprognostic (7.94e-2)" "unprognostic (7.64e-3)" "unprognostic (1.46e-3)" 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.3 0.0 0.4 0.2 0.4 0.0 0.6 0.3 0.0 0.4 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.1 2.1 0.0 0.0 3.0 0.6 2.6 0.0 9.2 0.4 0.4 3.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 13.3 0.0 0.1 0.8 0.0 0.2 0.2 2.5 0.0 20.0 21.7 0.5 0.0 14.8 13.2 0.1 0.0 0.0 0.4 27.2 5.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 TRBV10-1 "TCRBV10S1, TCRBV12S2, TCRBV12S2A1T, TRBV101" ENSG00000211717 "T cell receptor beta variable 10-1" A0A0K0K1A3 7 142399860-142400377 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "lymphoid tissue: 4.5" "Cell type enriched" "Detected in single" 4 "T-cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "MAIT T-cell: 3.2;memory CD4 T-cell: 4.7;memory CD8 T-cell: 3.0;naive CD4 T-cell: 6.2;naive CD8 T-cell: 2.6;T-reg: 9.5" "Lineage enriched" "Detected in single" 18 "T-cells: 9.5" "Not detected" "Not detected" NA NA "unprognostic (1.41e-2)" "unprognostic (3.88e-1)" "unprognostic (2.85e-3)" 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 4.7 3.0 0.0 0.0 6.2 2.6 0.5 0.0 0.0 0.0 9.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 TRBV11-1 "TCRBV11S1, TCRBV21S1, TRBV111" ENSG00000211720 "T cell receptor beta variable 11-1" A0A0K0K1C0 7 142407672-142408136 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 28 "lymphoid tissue: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 20.1;memory CD8 T-cell: 30.4;naive CD4 T-cell: 15.6;naive CD8 T-cell: 11.8;T-reg: 25.6" "Lineage enriched" "Detected in single" 99 "T-cells: 30.4" "Not detected" "Not detected" NA NA "unprognostic (4.15e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-2)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (5.18e-2)" "unprognostic (8.48e-2)" 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.5 3.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.9 0.3 0.0 0.0 14.5 0.1 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 20.1 30.4 0.0 0.0 15.6 11.8 0.3 0.0 0.0 0.0 25.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRBV6-5 "TCRBV13S1, TCRBV6S5, TRBV65" ENSG00000211721 "T cell receptor beta variable 6-5" A0A0K0K1A5 7 142450947-142451448 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 83.0" "Cell type enriched" "Detected in single" 121 "T-cells: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD8 T-cell: 133.8;T-reg: 137.9" "Lineage enriched" "Detected in many" 54 "T-cells: 137.9" "Cell line enriched" "Detected in some" 8 "HL-60: 61.1" NA NA "unprognostic (6.42e-3)" "unprognostic (7.43e-4)" "unprognostic (1.11e-2)" "unprognostic (2.20e-3)" "unprognostic (1.38e-1)" "unprognostic (8.63e-5)" "unprognostic (1.55e-2)" "unprognostic (1.51e-3)" "unprognostic (8.72e-3)" "unprognostic (2.11e-3)" "unprognostic (7.03e-2)" "unprognostic (4.82e-1)" "prognostic unfavorable (5.40e-5)" "unprognostic (3.12e-2)" "unprognostic (4.17e-2)" "unprognostic (7.43e-3)" "unprognostic (3.06e-2)" 0.2 0.2 0.0 4.2 0.0 2.3 0.5 0.0 0.1 0.4 0.0 0.9 1.1 0.2 0.0 0.2 0.3 1.6 0.1 0.0 0.0 0.1 0.3 2.5 16.2 0.0 0.0 0.0 0.3 7.4 0.0 0.0 0.1 0.0 0.3 1.2 0.2 0.4 0.1 0.0 0.3 2.0 0.3 0.0 3.4 1.7 0.1 0.0 83.0 0.4 0.8 12.1 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 61.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.5 0.2 0.2 1.0 0.1 32.8 0.3 78.7 76.2 0.1 0.4 92.0 133.8 2.5 0.2 0.4 0.4 137.9 59.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.1 TRBV6-6 "TCRBV13S6A2T, TCRBV6S6, TRBV66" ENSG00000211724 "T cell receptor beta variable 6-6" A0A0A6YYG2 7 142469537-142470013 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 14.8" "Cell type enriched" "Detected in single" 37 "T-cells: 3.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 81.4" "Lineage enriched" "Detected in single" 98 "T-cells: 81.4" "Cell line enriched" "Detected in some" 10 "HL-60: 10.4" NA NA "unprognostic (1.69e-4)" "unprognostic (3.82e-4)" "unprognostic (3.66e-2)" "unprognostic (2.55e-2)" "unprognostic (8.55e-2)" "unprognostic (9.93e-5)" "unprognostic (4.36e-1)" "unprognostic (1.94e-2)" "unprognostic (1.09e-2)" "unprognostic (3.42e-2)" "unprognostic (5.90e-2)" "unprognostic (2.27e-1)" "unprognostic (1.78e-3)" "unprognostic (2.40e-1)" "unprognostic (2.22e-2)" "unprognostic (4.18e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.0 2.8 0.0 0.8 0.5 0.0 0.1 0.1 0.0 0.8 0.9 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.8 0.1 1.6 0.0 0.0 0.1 1.2 0.1 0.0 2.9 0.8 0.0 0.0 14.8 0.2 0.0 10.7 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.5 0.3 14.7 0.0 34.6 47.9 0.0 0.1 48.9 21.3 0.8 0.1 0.2 0.2 81.4 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRBV5-5 "TCRBV5S3A2T, TCRBV5S5, TRBV55" ENSG00000211725 "T cell receptor beta variable 5-5" A0A597 7 142482548-142483019 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "lymphoid tissue: 18.7" "Cell type enriched" "Detected in single" 23 "T-cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 25 "memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.0;naive CD4 T-cell: 38.6;naive CD8 T-cell: 29.0;T-reg: 41.9" "Lineage enriched" "Detected in many" 30 "T-cells: 41.9" "Not detected" "Not detected" NA NA "unprognostic (4.96e-5)" "unprognostic (4.74e-3)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "unprognostic (2.19e-1)" "unprognostic (1.98e-4)" "unprognostic (2.84e-3)" "unprognostic (9.58e-2)" "unprognostic (7.35e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (4.27e-4)" "unprognostic (7.42e-2)" "unprognostic (8.32e-3)" "unprognostic (9.06e-2)" 0.1 0.0 0.2 1.8 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.1 2.3 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.5 0.0 0.7 18.7 0.1 0.0 4.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.6 0.0 0.8 0.0 36.7 28.0 0.1 0.1 38.6 29.0 0.8 0.0 0.1 0.0 41.9 11.3 0.2 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TRBV7-6 "TCRBV6S3A1N1T, TCRBV7S6, TRBV76" ENSG00000211727 "T cell receptor beta variable 7-6" A0A1B0GX31 7 142492132-142492673 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 35.6" "Group enriched" "Detected in some" 15 "Gastric mucus-secreting cells: 5.1;T-cells: 7.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 22 "memory CD4 T-cell: 54.7;memory CD8 T-cell: 42.7;naive CD4 T-cell: 62.0;naive CD8 T-cell: 37.2;T-reg: 86.1" "Lineage enriched" "Detected in many" 52 "T-cells: 86.1" "Not detected" "Not detected" NA NA "unprognostic (4.74e-2)" "unprognostic (1.21e-2)" "unprognostic (1.37e-2)" "unprognostic (4.25e-5)" "unprognostic (4.86e-3)" "unprognostic (4.06e-5)" "unprognostic (7.74e-2)" "unprognostic (3.83e-5)" "unprognostic (6.50e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (9.86e-5)" "unprognostic (1.83e-1)" "unprognostic (7.27e-2)" "unprognostic (5.90e-2)" "unprognostic (6.22e-3)" 0.1 0.0 0.4 3.7 0.2 1.4 0.2 0.3 0.4 0.1 0.1 0.6 0.0 0.1 5.3 1.7 0.1 1.5 0.0 0.4 0.2 0.0 0.4 0.8 7.0 0.5 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.6 0.0 0.4 0.3 0.0 0.4 1.1 0.0 0.4 3.7 1.1 0.6 0.9 35.6 0.2 0.0 7.6 2.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 2.5 0.1 54.7 42.7 0.1 0.3 62.0 37.2 1.6 0.1 0.1 0.1 86.1 17.1 0.4 0.2 0.3 0.4 0.4 0.2 0.5 0.3 0.1 0.4 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 TRBV5-6 "TCRBV5S2, TCRBV5S6, TRBV56" ENSG00000211728 "T cell receptor beta variable 5-6" A0A599 7 142500028-142500534 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 34.1" "Group enriched" "Detected in some" 21 "Early spermatids: 13.5;Late spermatids: 14.6;T-cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 40.2;memory CD8 T-cell: 22.9;naive CD4 T-cell: 35.9;naive CD8 T-cell: 45.2;T-reg: 66.0" "Lineage enriched" "Detected in many" 56 "T-cells: 66.0" "Not detected" "Not detected" NA NA "unprognostic (6.27e-3)" "unprognostic (8.46e-3)" "unprognostic (1.20e-1)" "unprognostic (7.21e-2)" "unprognostic (5.25e-1)" "unprognostic (3.45e-4)" "unprognostic (5.72e-2)" "unprognostic (6.24e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-3)" "unprognostic (2.64e-2)" "unprognostic (2.39e-1)" "unprognostic (2.26e-7)" "unprognostic (7.62e-2)" "unprognostic (3.14e-2)" "unprognostic (2.41e-1)" "unprognostic (1.34e-1)" 0.2 0.0 0.0 2.2 0.1 0.7 0.3 0.0 0.1 0.5 0.0 0.6 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.1 0.8 7.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.2 1.1 0.1 0.0 1.9 0.4 1.7 0.1 34.1 0.1 0.1 5.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.0 3.0 0.1 40.2 22.9 0.1 0.1 35.9 45.2 1.1 0.0 0.1 0.2 66.0 17.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 TRBV5-7 "TCRBV5S7, TCRBV5S7P, TRBV57" ENSG00000211731 "T cell receptor beta variable 5-7 (non-functional)" 7 142520090-142520556 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.1;T-reg: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" NA NA "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV5-1 "TCRBV5S1, TCRBV5S1A1T, TRBV51" ENSG00000211734 "T cell receptor beta variable 5-1" A0A578 7 142320677-142321544 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "lymphoid tissue: 44.4" "Cell type enriched" "Detected in some" 11 "T-cells: 13.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 211.6;T-reg: 295.5" "Lineage enriched" "Detected in many" 111 "T-cells: 295.5" "Not detected" "Not detected" NA NA "unprognostic (2.26e-4)" "unprognostic (1.36e-3)" "unprognostic (2.59e-2)" "unprognostic (1.49e-3)" "unprognostic (6.65e-2)" "unprognostic (7.02e-5)" "unprognostic (2.55e-2)" "unprognostic (3.66e-2)" "unprognostic (4.29e-3)" "unprognostic (5.85e-4)" "unprognostic (3.55e-2)" "unprognostic (4.36e-1)" "unprognostic (5.96e-7)" "unprognostic (2.63e-1)" "unprognostic (2.52e-2)" "unprognostic (4.06e-2)" "unprognostic (2.97e-2)" 0.2 0.0 0.0 4.9 0.0 1.1 0.2 0.0 0.1 0.4 0.0 0.7 1.0 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.2 0.7 10.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.2 0.0 0.0 0.3 1.9 0.1 0.0 2.6 1.6 0.2 0.0 44.4 0.2 0.0 9.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 2.6 0.2 11.0 0.4 166.1 65.4 0.4 0.4 211.6 128.7 2.6 0.5 0.5 0.3 295.5 82.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 TRBV4-2 "TCRBV4S2, TCRBV7S3A2T, TRBV42" ENSG00000211745 "T cell receptor beta variable 4-2" A0A539 7 142345421-142345985 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 21.2" "Cell type enriched" "Detected in some" 8 "T-cells: 23.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 100.2" "Lineage enriched" "Detected in single" 293 "T-cells: 100.2" "Not detected" "Not detected" NA NA "unprognostic (2.89e-3)" "unprognostic (4.65e-4)" "unprognostic (1.28e-3)" "unprognostic (1.06e-2)" "unprognostic (4.60e-2)" "unprognostic (7.05e-4)" "unprognostic (2.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.19e-3)" "unprognostic (1.32e-2)" "unprognostic (6.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.82e-4)" "unprognostic (5.50e-2)" "unprognostic (5.99e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-2)" 0.2 0.0 0.0 1.4 0.0 0.6 0.1 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.2 0.5 5.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.6 0.1 0.0 2.3 0.3 0.5 0.0 21.2 0.3 0.0 4.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 100.2 0.0 25.6 27.8 0.1 0.0 23.9 14.4 0.1 0.0 0.2 0.3 44.8 8.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 23.9 0.0 0.0 0.0 TRBV19 "TCRBV17S1A1T, TCRBV19S1" ENSG00000211746 "T cell receptor beta variable 19" A0A075B6N1 7 142618849-142619532 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 53.9" "Cell type enriched" "Detected in some" 5 "T-cells: 11.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 50.8;memory CD8 T-cell: 40.2;naive CD4 T-cell: 71.1;naive CD8 T-cell: 53.5;T-reg: 88.5" "Lineage enriched" "Detected in single" 191 "T-cells: 88.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.62e-3)" "unprognostic (8.91e-4)" "unprognostic (1.14e-2)" "unprognostic (5.81e-3)" "unprognostic (2.38e-2)" "unprognostic (2.29e-4)" "unprognostic (3.96e-3)" "unprognostic (3.62e-3)" "unprognostic (4.51e-3)" "unprognostic (1.14e-2)" "unprognostic (2.07e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (9.78e-2)" "unprognostic (4.14e-2)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" 0.4 0.1 0.0 5.7 0.0 0.7 0.7 0.1 0.2 0.8 0.0 1.2 0.6 0.5 0.0 0.4 0.3 3.8 0.0 0.0 0.0 0.2 0.7 1.1 28.7 0.0 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.1 0.4 2.2 0.0 0.3 0.3 0.1 0.4 3.0 0.2 0.0 3.8 3.0 0.1 0.0 53.9 0.5 0.2 2.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.4 0.1 13.5 0.4 50.8 40.2 0.1 0.0 71.1 53.5 0.4 0.1 0.2 0.0 88.5 15.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 TRBV20-1 "TCRBV20S1, TCRBV2S1, TRBV201" ENSG00000211747 "T cell receptor beta variable 20-1" A0A075B6N2 7 142626649-142627399 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "lymphoid tissue: 162.9" "Cell type enriched" "Detected in some" 15 "T-cells: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 351.7" "Lineage enriched" "Detected in many" 115 "T-cells: 351.7" "Group enriched" "Detected in some" 8 "Karpas-707: 2.4;MOLT-4: 5.0;REH: 2.5;RH-30: 3.0" "Not detected" "Not detected" NA NA "unprognostic (1.25e-3)" "prognostic favorable (4.40e-5)" "unprognostic (1.39e-2)" "prognostic favorable (8.49e-4)" "unprognostic (8.83e-2)" "unprognostic (2.69e-3)" "unprognostic (4.34e-2)" "unprognostic (8.75e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.30e-2)" "unprognostic (8.86e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (3.41e-2)" 1.7 0.2 0.1 13.8 0.0 5.1 0.6 0.1 0.2 0.6 0.0 2.4 0.5 0.3 0.0 0.7 0.7 3.3 0.1 0.1 0.1 0.5 0.6 2.7 53.7 0.2 0.2 0.1 0.5 0.2 0.0 0.8 0.0 0.3 0.9 3.1 0.0 0.5 0.2 0.1 1.9 6.0 0.9 0.1 7.3 3.7 0.3 0.2 162.9 1.0 0.0 6.0 2.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.0 0.0 0.0 2.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.6 0.2 4.6 0.3 231.9 1.1 192.7 76.4 0.6 0.6 144.0 58.9 2.3 0.3 0.8 0.4 351.7 50.2 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 0.2 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 TRBV23-1 "TCRBV19S1P, TCRBV23S1, TRBV231" ENSG00000211749 "T cell receptor beta variable 23-1 (non-functional)" 7 142645961-142646467 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Lineage enriched" "Detected in single" 9 "T-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.02e-5)" "unprognostic (7.32e-4)" "unprognostic (1.71e-4)" "unprognostic (1.34e-3)" "unprognostic (6.71e-3)" "unprognostic (1.28e-3)" "unprognostic (4.64e-2)" "unprognostic (1.17e-6)" "unprognostic (1.14e-1)" "unprognostic (5.86e-3)" "unprognostic (1.37e-1)" 0.2 0.0 0.0 3.4 0.1 2.2 0.1 0.1 0.1 0.1 0.0 0.4 0.3 0.1 0.6 0.1 0.2 1.0 0.3 0.0 0.0 0.2 0.2 0.7 9.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.4 0.0 0.2 0.0 2.0 0.2 0.0 2.3 0.2 0.0 0.0 11.8 0.3 0.1 5.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.9 0.5 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TRBV24-1 "TCRBV15S1, TCRBV24S1, TRBV241" ENSG00000211750 "T cell receptor beta variable 24-1" A0A075B6N3 7 142656701-142657213 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.7;lymphoid tissue: 6.8" "Cell type enriched" "Detected in single" 23 "T-cells: 2.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "basal ganglia: 2.7" "Immune cell enhanced" "Detected in many" "naive CD8 T-cell: 26.6" "Lineage enriched" "Detected in single" 129 "T-cells: 26.6" "Not detected" "Not detected" NA NA "unprognostic (1.42e-2)" "unprognostic (1.64e-5)" "unprognostic (1.59e-1)" "unprognostic (9.71e-3)" "unprognostic (3.82e-1)" "unprognostic (9.30e-2)" "unprognostic (3.08e-2)" "unprognostic (1.81e-1)" "unprognostic (6.73e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.43e-7)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.76e-3)" "unprognostic (4.39e-2)" 0.1 0.0 0.1 0.0 2.7 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.1 0.5 2.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.1 0.0 1.0 0.0 0.9 0.2 0.0 1.3 1.6 0.4 0.6 6.8 0.1 0.0 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 9.0 0.0 5.7 0.0 15.4 15.5 0.0 0.0 11.4 26.6 0.2 0.0 0.0 0.0 23.2 4.6 0.1 2.7 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TRBC1 "BV05S1J2.2, TCRBC1" ENSG00000211751 "T cell receptor beta constant 1" 7 142791694-142793368 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 28 "lymphoid tissue: 1534.7" "Group enriched" "Detected in many" 10 "dendritic cells: 338.0;NK-cells: 580.9;T-cells: 399.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "T-reg: 3232.4" "Lineage enriched" "Detected in all" 9 "T-cells: 3232.4" "Cell line enriched" "Detected in some" 5 "JURKAT: 1467.5" NA NA "unprognostic (1.08e-4)" "unprognostic (7.96e-4)" "unprognostic (6.02e-2)" "unprognostic (1.26e-4)" "unprognostic (1.81e-2)" "unprognostic (5.42e-5)" "unprognostic (1.76e-2)" "unprognostic (6.94e-3)" "unprognostic (2.36e-3)" "unprognostic (1.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.56e-1)" "unprognostic (3.18e-6)" "unprognostic (3.98e-1)" "unprognostic (8.83e-3)" "unprognostic (1.02e-1)" "unprognostic (4.19e-3)" 6.4 5.2 1.1 141.3 1.4 53.9 9.5 1.1 2.1 7.8 2.1 18.7 27.0 6.5 5.8 12.1 7.0 26.9 5.0 1.0 1.2 5.4 11.5 31.7 324.9 1.9 1.7 0.9 6.4 2.8 0.9 2.0 2.3 1.7 9.1 19.6 0.0 19.2 4.6 1.0 10.0 50.1 4.2 1.8 93.3 27.4 2.7 2.2 1534.7 8.5 2.1 228.9 33.5 6.2 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1467.5 2.0 0.0 0.0 0.0 0.0 1.7 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 296.5 2.0 0.0 1.9 0.0 45.6 7.2 4.7 869.6 3.5 693.8 17.1 1893.1 1259.3 5.8 15.7 1989.8 1450.7 37.3 359.8 8.3 9.7 3232.4 1917.5 1.1 1.4 1.1 2.1 1.0 1.2 1.9 1.7 0.9 1.7 1.8 2.2 2.3 7.3 19.2 40.8 0.0 11.7 0.0 0.3 0.0 0.0 0.0 5.9 5.5 0.0 0.0 3.1 1.8 0.0 0.2 338.0 0.0 0.0 0.5 0.6 1.1 0.7 1.5 0.0 10.7 0.0 0.0 0.1 3.2 4.6 0.8 20.2 0.0 5.3 1.5 0.3 0.0 0.0 0.1 0.0 8.4 0.0 1.9 17.4 13.9 0.0 0.0 17.3 0.0 580.9 0.0 0.0 0.0 0.1 8.2 23.6 0.3 0.0 2.4 0.7 0.0 0.0 1.1 3.5 0.0 0.1 0.5 0.0 0.1 399.0 0.1 0.1 0.4 TRBV27 "TCRBV14S1, TCRBV27S1" ENSG00000211752 "T cell receptor beta variable 27" A0A0K0K1C4 7 142715346-142715861 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 82.3" "Cell type enriched" "Detected in some" 4 "T-cells: 6.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 61.1;memory CD8 T-cell: 112.2;naive CD4 T-cell: 48.2;naive CD8 T-cell: 75.8;T-reg: 94.7" "Lineage enriched" "Detected in single" 137 "T-cells: 112.2" "Group enriched" "Detected in some" 4 "HAP1: 2.9;JURKAT: 3.3;U-937: 3.6" "Not detected" "Not detected" NA NA "unprognostic (3.08e-2)" "unprognostic (2.10e-2)" "unprognostic (5.66e-2)" "unprognostic (5.85e-4)" "unprognostic (8.84e-2)" "unprognostic (7.89e-2)" "unprognostic (1.91e-2)" "unprognostic (1.28e-4)" "unprognostic (1.49e-1)" "unprognostic (4.36e-2)" "unprognostic (1.91e-7)" "unprognostic (4.03e-1)" "unprognostic (3.91e-2)" "unprognostic (8.10e-2)" "unprognostic (6.43e-2)" 0.4 0.5 0.0 3.5 0.5 1.9 0.8 0.0 0.3 0.7 0.0 1.2 1.0 0.9 0.1 0.8 0.2 1.8 0.2 0.0 0.0 0.4 0.5 1.7 19.9 0.0 0.3 0.0 0.5 0.2 0.0 0.1 0.1 0.1 0.5 1.7 0.0 1.7 0.0 0.3 0.2 2.8 0.2 0.0 4.8 1.9 5.8 0.1 82.3 0.6 0.9 10.7 1.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.4 0.1 0.6 3.3 0.0 10.4 0.1 61.1 112.2 0.1 0.1 48.2 75.8 0.8 0.1 0.2 0.1 94.7 27.3 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 TRBV28 "TCRBV28S1, TCRBV3S1" ENSG00000211753 "T cell receptor beta variable 28" A0A5B6 7 142720660-142721160 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "lymphoid tissue: 201.2" "Cell type enriched" "Detected in some" 12 "T-cells: 33.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 154.5" "Lineage enriched" "Detected in many" 79 "T-cells: 154.5" "Cell line enriched" "Detected in single" 30 "JURKAT: 23.7" "Not detected" "Not detected" NA NA "unprognostic (1.34e-3)" "prognostic favorable (1.52e-4)" "unprognostic (1.94e-3)" "prognostic favorable (2.48e-5)" "unprognostic (5.54e-2)" "prognostic favorable (3.62e-4)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.35e-5)" "unprognostic (2.47e-3)" "unprognostic (3.33e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.48e-8)" "unprognostic (1.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-3)" 0.5 0.9 0.0 9.3 0.1 3.0 2.1 0.2 0.2 1.2 0.0 2.6 3.4 0.6 0.3 1.3 0.3 2.9 0.5 0.0 0.0 0.5 1.9 3.5 24.9 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.7 1.7 0.0 1.3 0.3 0.2 0.1 4.0 0.3 0.0 9.6 2.1 0.4 0.0 201.2 0.5 0.6 34.0 5.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 3.8 0.0 26.1 0.5 94.5 80.1 0.1 0.2 98.1 53.3 1.9 1.6 0.1 0.4 154.5 34.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.6 0.0 TRBJ2-1 "TCRBJ2S1, TRBJ21" ENSG00000211764 "T cell receptor beta joining 2-1" A0A0A0MTA7 7 142796365-142796414 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "bone marrow: 27.0;lymphoid tissue: 71.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "thalamus: 6.8" "Immune cell enhanced" "Detected in all" "T-reg: 1684.5" "Lineage enriched" "Detected in all" 8 "T-cells: 1684.5" "Cell line enriched" "Detected in some" 16 "MOLT-4: 2783.5" NA NA "unprognostic (1.57e-2)" "prognostic favorable (8.15e-4)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (2.30e-5)" "unprognostic (8.63e-2)" "unprognostic (6.12e-2)" "unprognostic (3.74e-1)" "unprognostic (9.28e-2)" "unprognostic (1.07e-2)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.31e-1)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (7.65e-3)" 0.7 4.3 0.8 27.2 1.5 27.0 0.4 0.0 1.5 1.0 0.0 2.2 7.9 0.5 0.0 0.0 1.5 2.2 0.7 0.3 0.0 1.0 0.6 4.6 42.1 0.3 2.3 0.0 1.6 0.0 0.0 0.0 0.7 0.2 2.9 3.0 0.9 1.2 0.0 3.1 0.0 8.5 0.7 0.1 30.0 7.6 1.3 6.8 71.9 0.8 0.0 36.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 1.9 0.0 0.9 175.1 160.3 0.0 0.0 0.0 0.0 2783.5 2.6 1.7 0.0 0.0 0.0 0.0 1.4 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.7 0.0 0.0 3.2 0.0 57.2 0.0 0.0 0.0 10.9 3.2 2.6 255.6 2.4 535.8 97.1 906.2 1179.2 2.8 69.8 916.2 888.4 11.3 209.4 4.6 8.4 1684.5 527.9 0.8 1.5 0.0 1.5 0.3 0.0 0.3 2.3 0.0 0.2 0.1 6.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TRBJ2-2 "TCRBJ2S2, TRBJ22" ENSG00000211765 "T cell receptor beta joining 2-2" 7 142796560-142796610 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 19.6;lymphoid tissue: 33.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "MAIT T-cell: 518.4;memory CD4 T-cell: 335.7;memory CD8 T-cell: 331.8;naive CD4 T-cell: 388.7;naive CD8 T-cell: 324.2;T-reg: 721.0" "Lineage enriched" "Detected in all" 12 "T-cells: 721.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 21.0;JURKAT: 42.2;MOLT-4: 90.4;RT4: 13.6;U-698: 16.3" NA NA "unprognostic (1.16e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (2.98e-4)" "unprognostic (3.51e-1)" "unprognostic (8.42e-2)" "unprognostic (6.98e-4)" 0.3 1.3 0.2 17.3 0.3 19.6 0.4 0.0 1.2 0.0 0.1 0.7 1.5 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.1 0.4 2.9 26.6 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.1 1.3 0.0 0.0 0.0 6.8 0.0 0.2 12.5 3.9 0.6 0.9 33.4 0.0 0.0 15.5 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 42.2 0.0 0.0 0.0 0.0 90.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 2.1 0.8 1.1 57.6 0.6 518.4 31.6 335.7 331.8 0.7 31.2 388.7 324.2 9.8 58.7 1.6 1.2 721.0 191.0 0.2 0.3 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TRBJ2-2P TRBJ22P ENSG00000211766 "T cell receptor beta joining 2-2P (non-functional)" 7 142796697-142796742 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 17.1;intestine: 12.5;lymphoid tissue: 35.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 7.8" "Group enriched" "Detected in all" 29 "gdT-cell: 1436.3;MAIT T-cell: 469.6;memory B-cell: 1304.3;memory CD4 T-cell: 569.8;memory CD8 T-cell: 547.5;naive B-cell: 1399.3;naive CD4 T-cell: 517.1;naive CD8 T-cell: 581.9;NK-cell: 989.3;T-reg: 1284.2" "Group enriched" "Detected in all" 40 "B-cells: 1399.3;NK-cells: 989.3;T-cells: 1436.3" "Cell line enhanced" "Detected in some" "JURKAT: 54.2;MOLT-4: 81.4;RT4: 22.7;U-698: 96.4" NA NA "unprognostic (2.22e-3)" "unprognostic (3.31e-2)" "unprognostic (1.22e-1)" "prognostic favorable (7.39e-4)" "unprognostic (4.33e-5)" "unprognostic (2.15e-2)" "unprognostic (1.31e-1)" "unprognostic (5.97e-2)" "unprognostic (7.58e-2)" "unprognostic (2.21e-2)" "unprognostic (1.22e-2)" "unprognostic (5.87e-2)" "unprognostic (1.94e-2)" 2.0 0.0 1.1 25.0 2.0 17.1 2.1 0.2 2.0 0.0 0.3 2.3 12.5 0.5 0.0 0.0 0.5 1.3 0.9 0.4 0.3 0.4 0.2 2.7 35.0 0.4 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.9 1.6 0.4 0.3 0.0 0.0 5.1 2.3 10.0 1.2 0.1 29.4 10.0 1.8 7.8 24.2 0.4 0.0 16.3 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 13.1 54.2 0.0 0.0 0.0 0.0 81.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 96.4 0.0 0.0 0.0 31.8 5.4 3.8 1436.3 2.4 469.6 1304.3 569.8 547.5 6.3 1399.3 517.1 581.9 28.0 989.3 9.5 15.7 1284.2 721.1 1.1 2.0 0.2 2.0 0.4 0.3 0.4 2.4 0.0 0.9 0.1 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ2-3 "TCRBJ2S3, TRBJ23" ENSG00000211767 "T cell receptor beta joining 2-3" A0A0B4J200 7 142796847-142796895 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 87.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "thalamus: 17.9" "Group enriched" "Detected in all" 12 "gdT-cell: 1486.3;MAIT T-cell: 905.3;memory B-cell: 1210.1;memory CD4 T-cell: 1124.0;memory CD8 T-cell: 1154.0;naive B-cell: 1430.2;naive CD4 T-cell: 1106.3;naive CD8 T-cell: 1031.1;NK-cell: 933.5;T-reg: 2317.4" "Group enriched" "Detected in all" 15 "B-cells: 1430.2;NK-cells: 933.5;T-cells: 2317.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 31.8;JURKAT: 65.6;MOLT-4: 72.9;RT4: 39.1;U-698: 218.9" NA NA "unprognostic (4.65e-3)" "unprognostic (7.01e-3)" "unprognostic (7.69e-2)" "prognostic favorable (1.47e-5)" "unprognostic (1.76e-5)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.84e-3)" "unprognostic (1.25e-1)" "unprognostic (3.05e-2)" "unprognostic (1.65e-1)" "unprognostic (1.81e-3)" "unprognostic (1.20e-1)" "unprognostic (1.74e-2)" "unprognostic (3.35e-1)" "unprognostic (1.64e-3)" 2.9 2.2 3.7 87.2 5.2 17.8 4.7 0.6 6.9 1.9 1.3 5.4 19.4 3.5 0.0 0.8 0.5 2.9 0.4 1.7 0.9 1.1 5.4 12.3 83.5 0.8 8.9 1.7 5.0 0.0 0.0 0.0 0.9 2.7 2.7 7.2 1.7 5.0 0.0 4.5 1.1 22.4 1.6 1.7 79.4 20.7 2.3 17.9 61.4 0.4 2.7 52.2 2.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 21.5 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 31.8 65.6 0.0 0.0 0.0 0.0 72.9 0.0 5.0 0.0 7.5 0.0 0.0 0.0 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.3 218.9 0.0 0.0 0.0 106.3 7.7 5.8 1486.3 3.1 905.3 1210.1 1124.0 1154.0 9.3 1430.2 1106.3 1031.1 43.1 933.5 10.8 18.1 2317.4 1057.6 3.7 5.2 0.6 6.9 1.7 0.9 0.8 8.9 1.7 2.7 1.7 17.9 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TRBJ2-4 "TCRBJ2S4, TRBJ24" ENSG00000211768 "T cell receptor beta joining 2-4" 7 142796998-142797047 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 9.1;lymphoid tissue: 19.1;stomach 1: 5.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "JURKAT: 22.7;MOLT-4: 36.5;RT4: 15.4;U-698: 58.0" NA NA "unprognostic (3.96e-2)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" 1.6 0.7 0.2 10.3 0.6 9.1 0.0 0.0 1.7 0.0 0.1 0.6 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.5 0.2 1.4 0.8 10.7 0.3 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.4 0.6 0.5 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.1 19.1 5.8 0.5 2.1 15.6 0.0 0.0 6.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 22.7 0.0 0.0 0.0 0.0 36.5 0.0 2.8 0.0 0.0 0.0 0.0 1.4 0.0 15.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 58.0 0.0 0.0 0.0 5.8 0.8 0.5 241.8 0.4 155.1 163.9 228.4 195.1 0.9 196.0 236.2 215.0 9.6 109.2 1.9 3.2 485.0 131.3 0.2 0.6 0.0 1.7 0.5 0.5 0.3 0.3 0.1 0.4 0.1 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ2-5 "TCRBJ2S5, TRBJ25" ENSG00000211769 "T cell receptor beta joining 2-5" 7 142797119-142797166 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "bone marrow: 2.8;intestine: 4.5;lymphoid tissue: 11.0;stomach 1: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 1102.2" "Lineage enriched" "Detected in all" 14 "T-cells: 1102.2" "Cell line enriched" "Detected in some" 7 "MOLT-4: 152.3" NA NA 0.0 0.0 0.2 9.1 0.7 2.8 0.0 0.1 0.8 0.0 0.0 0.9 4.5 0.0 0.0 0.4 0.0 0.6 0.0 0.6 0.1 0.0 0.5 1.1 9.7 0.5 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 11.0 7.6 0.4 1.0 9.7 0.0 0.0 6.2 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 152.3 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 2.4 0.0 0.8 1.0 0.0 21.7 0.0 0.0 0.0 2.4 1.3 3.0 103.7 0.9 271.0 47.0 586.4 389.5 1.8 81.6 664.4 355.4 12.4 36.3 2.9 3.4 1102.2 282.2 0.2 0.7 0.1 0.8 0.6 0.1 0.5 0.2 0.8 0.3 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRBJ2-6 "TCRBJ2S6, TRBJ26" ENSG00000211770 "T cell receptor beta joining 2-6" 7 142797239-142797291 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 10.4;lymphoid tissue: 24.8;stomach 1: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "MOLT-4: 187.7" NA NA 1.5 0.0 0.2 22.1 1.0 5.4 0.4 0.4 2.1 0.0 0.0 1.7 10.1 1.7 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.3 0.1 2.3 23.5 0.4 0.4 0.1 0.5 0.0 0.0 0.0 0.2 0.7 0.2 1.0 0.0 2.6 0.0 7.9 0.0 10.4 0.0 0.0 24.8 12.0 1.0 2.8 10.3 0.0 0.0 4.8 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 187.7 0.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 45.3 0.0 0.0 0.0 14.1 0.4 0.4 89.6 1.0 213.1 42.4 128.7 162.9 1.3 71.1 157.2 84.7 3.5 42.9 2.1 1.5 198.3 62.8 0.2 1.0 0.4 2.1 0.4 0.5 0.4 0.4 0.1 0.7 0.0 2.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ2-7 "TCRBJ2S7, TRBJ27" ENSG00000211771 "T cell receptor beta joining 2-7" A0A0A0MT78 7 142797456-142797502 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 45.7;lymphoid tissue: 156.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 7 "MAIT T-cell: 1275.2;memory CD4 T-cell: 2387.1;memory CD8 T-cell: 2649.6;naive CD4 T-cell: 2393.9;naive CD8 T-cell: 2831.0;T-reg: 4224.6" "Lineage enriched" "Detected in all" 18 "T-cells: 4224.6" "Cell line enhanced" "Detected in some" "JURKAT: 43.8;MOLT-4: 212.6;U-698: 55.5" NA NA "unprognostic (9.07e-3)" "unprognostic (9.26e-3)" "unprognostic (4.37e-2)" "prognostic favorable (4.79e-4)" "unprognostic (1.14e-3)" "unprognostic (2.57e-3)" "unprognostic (6.68e-3)" "unprognostic (9.60e-2)" "unprognostic (2.17e-2)" "unprognostic (6.18e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (7.27e-2)" "unprognostic (3.43e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" 3.5 4.6 1.0 97.8 2.7 45.7 2.5 1.5 3.2 0.0 2.0 7.5 18.2 5.3 0.0 0.8 0.5 9.6 0.8 0.7 3.0 0.4 0.0 4.4 109.6 1.2 2.1 0.4 2.8 5.1 0.0 0.0 1.1 2.1 2.3 6.2 0.3 3.6 0.9 0.0 0.0 36.3 0.0 0.7 54.5 25.4 2.0 7.6 156.4 0.0 0.0 48.1 4.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 8.3 43.8 0.0 0.0 0.0 3.7 212.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 42.7 6.9 10.3 360.2 6.3 1275.2 233.4 2387.1 2649.6 6.9 233.7 2393.9 2831.0 64.7 122.4 13.1 9.8 4224.6 1638.0 1.0 2.7 1.5 3.2 0.7 3.0 1.2 2.1 0.4 2.1 0.7 7.6 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TRBC2 TCRBC2 ENSG00000211772 "T cell receptor beta constant 2" 7 142801041-142802748 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 116.8;lymphoid tissue: 191.8" "Group enriched" "Detected in many" 4 "B-cells: 164.7;dendritic cells: 358.8;NK-cells: 264.7;T-cells: 498.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 76.0" "Lineage enriched" "Detected in many" 7 "T-cells: 76.0" "Cell line enriched" "Detected in some" 45 "MOLT-4: 277.9" NA NA "prognostic favorable (8.04e-5)" "prognostic favorable (1.80e-4)" "unprognostic (4.19e-3)" "prognostic favorable (3.42e-8)" "unprognostic (5.53e-2)" "prognostic favorable (6.58e-5)" "unprognostic (3.21e-2)" "unprognostic (1.30e-2)" "prognostic favorable (2.81e-4)" "unprognostic (7.53e-3)" "unprognostic (5.96e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (2.09e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (4.09e-3)" 13.5 3.1 0.3 3.9 0.3 1.5 8.7 0.2 1.2 10.3 0.2 13.8 1.7 8.8 0.0 14.7 15.8 2.2 4.7 0.4 0.1 9.6 12.8 32.6 8.6 0.4 0.3 0.2 18.4 3.6 0.1 4.0 0.0 0.3 14.4 2.8 0.0 8.0 0.2 3.4 5.4 116.8 0.5 0.2 191.8 17.1 8.8 0.4 110.2 16.5 1.2 10.9 14.1 12.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 3.5 0.0 0.0 0.0 0.0 277.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 14.4 0.0 35.0 8.1 47.6 47.3 0.3 7.7 46.6 40.3 2.0 10.5 0.1 0.0 76.0 42.4 0.3 0.3 0.2 1.2 0.4 0.1 0.4 0.3 0.2 0.3 0.2 0.4 0.3 8.3 9.6 52.4 0.0 164.7 0.0 0.3 0.0 1.8 0.1 6.2 9.7 4.8 5.7 3.7 1.8 0.0 0.4 358.8 1.4 0.0 2.9 1.0 1.1 0.8 4.0 0.0 16.6 0.0 1.3 0.1 10.8 8.6 0.9 20.2 0.0 15.0 1.6 0.4 0.0 0.0 0.8 0.0 9.0 0.0 4.2 63.6 18.9 0.0 0.0 19.0 15.6 264.7 0.0 0.0 20.1 0.1 70.3 30.6 0.4 0.1 2.2 2.9 0.4 65.7 4.2 12.4 0.1 0.8 1.3 0.0 0.3 498.0 1.4 0.9 0.2 TRAV2 ENSG00000211776 "T cell receptor alpha variable 2" A0A0B4J234 14 21712321-21712843 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "lymphoid tissue: 56.8" "Cell type enriched" "Detected in single" 5 "T-cells: 2.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 40.9" "Lineage enriched" "Detected in single" 124 "T-cells: 40.9" "Cell line enriched" "Detected in single" 21 "Daudi: 2.1" NA NA "unprognostic (1.38e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (1.93e-2)" "unprognostic (1.86e-3)" "unprognostic (3.64e-2)" "unprognostic (4.45e-2)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (5.84e-2)" "unprognostic (9.93e-5)" "unprognostic (1.92e-1)" "unprognostic (4.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" 0.3 0.2 0.0 8.3 0.0 2.5 0.3 0.0 0.5 0.2 0.0 2.0 0.8 0.0 0.0 0.9 0.3 0.9 0.3 0.0 0.0 0.2 0.3 1.6 20.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.2 0.0 0.0 0.1 1.7 0.1 0.0 3.4 2.7 0.2 0.1 56.8 0.2 0.0 13.3 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 31.3 0.0 31.5 9.9 0.0 0.0 24.5 9.6 0.1 0.0 0.0 0.3 40.9 5.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 TRAV3 ENSG00000211777 "T cell receptor alpha variable 3" A0A0B4J244 14 21723713-21724321 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 10.2" "Cell type enriched" "Detected in some" 4 "T-cells: 6.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 48.8;memory CD8 T-cell: 33.6;naive CD4 T-cell: 51.2;naive CD8 T-cell: 47.8;T-reg: 112.7" "Lineage enriched" "Detected in single" 144 "T-cells: 112.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.32e-3)" "unprognostic (4.61e-4)" "unprognostic (2.50e-1)" "unprognostic (6.25e-3)" "unprognostic (7.75e-2)" "unprognostic (8.35e-4)" "unprognostic (8.65e-3)" "unprognostic (4.31e-3)" "unprognostic (2.88e-3)" "unprognostic (4.24e-3)" "unprognostic (5.27e-2)" "unprognostic (3.35e-1)" "unprognostic (1.91e-4)" "unprognostic (1.67e-1)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" 0.2 0.2 0.0 2.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.1 0.2 0.6 0.6 0.0 0.0 0.1 0.2 0.8 7.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.2 0.0 0.0 0.3 1.4 0.0 0.0 2.0 1.0 0.3 0.3 10.2 0.1 0.1 5.8 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 14.3 0.0 48.8 33.6 0.1 0.1 51.2 47.8 0.7 0.1 0.0 0.0 112.7 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 TRAV4 "TCRAV20S1, TCRAV4S1" ENSG00000211778 "T cell receptor alpha variable 4" A0A0B4J268 14 21736152-21736982 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 38.2" "Cell type enriched" "Detected in some" 8 "T-cells: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 70 "MAIT T-cell: 66.1;memory CD4 T-cell: 81.9;memory CD8 T-cell: 124.0;naive CD4 T-cell: 77.1;naive CD8 T-cell: 81.0;T-reg: 167.9" "Lineage enriched" "Detected in many" 118 "T-cells: 167.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.13e-2)" "unprognostic (4.08e-3)" "unprognostic (1.02e-1)" "unprognostic (2.39e-4)" "unprognostic (5.20e-3)" "unprognostic (1.18e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (7.19e-3)" "unprognostic (2.48e-3)" "unprognostic (8.68e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-4)" "unprognostic (1.65e-1)" "unprognostic (3.23e-1)" "unprognostic (2.89e-1)" "unprognostic (6.49e-2)" 0.3 0.3 0.0 7.7 0.1 1.3 1.1 0.0 0.4 1.1 0.0 1.8 1.7 0.3 0.0 1.1 0.6 2.8 0.5 0.0 0.0 0.2 0.6 2.4 17.5 0.3 0.4 0.0 0.2 0.5 0.1 0.0 0.1 0.2 1.2 2.1 0.0 0.8 0.1 0.0 0.4 3.3 0.4 0.1 5.4 2.5 0.3 0.2 38.2 0.3 0.0 14.3 2.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.6 0.1 66.1 0.1 81.9 124.0 0.1 0.1 77.1 81.0 1.4 0.4 0.5 0.4 167.9 25.2 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 TRAV5 ENSG00000211779 "T cell receptor alpha variable 5" A0A0B4J249 14 21749178-21749705 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 13.0" "Cell type enriched" "Detected in some" 5 "T-cells: 7.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 52 "MAIT T-cell: 24.7;memory CD4 T-cell: 49.5;memory CD8 T-cell: 77.3;naive CD4 T-cell: 39.9;naive CD8 T-cell: 74.0;T-reg: 81.4" "Lineage enriched" "Detected in many" 73 "T-cells: 81.4" "Not detected" "Not detected" NA NA "unprognostic (1.04e-3)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.26e-5)" "unprognostic (3.58e-1)" "unprognostic (8.15e-2)" "unprognostic (5.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-1)" "unprognostic (3.11e-2)" "unprognostic (8.38e-6)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (1.78e-1)" "unprognostic (1.70e-2)" 0.1 0.4 0.0 3.6 0.1 0.5 0.7 0.0 0.3 0.3 0.4 1.0 0.5 0.7 0.0 0.3 0.1 2.7 0.2 0.1 0.0 0.2 0.8 1.1 13.0 0.3 0.2 0.0 0.3 0.6 0.0 0.0 0.0 0.1 2.2 1.6 0.0 2.6 0.3 0.0 0.0 2.7 0.8 0.0 4.6 1.8 0.1 0.2 11.6 0.8 0.8 7.7 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.0 0.5 24.7 0.2 49.5 77.3 0.1 0.1 39.9 74.0 1.1 0.0 0.2 0.3 81.4 17.9 0.0 0.1 0.0 0.3 0.1 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 TRAV6 TCRAV5S1 ENSG00000211780 "T cell receptor alpha variable 6" A0A075B6T7 14 21768489-21769080 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 11.3" "Group enriched" "Detected in some" 7 "Gastric mucus-secreting cells: 1.1;T-cells: 3.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 70 "MAIT T-cell: 17.1;memory CD4 T-cell: 33.7;memory CD8 T-cell: 19.0;naive CD4 T-cell: 26.3;naive CD8 T-cell: 16.2;T-reg: 59.6" "Lineage enriched" "Detected in single" 146 "T-cells: 59.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.78e-1)" "unprognostic (3.49e-4)" "unprognostic (3.25e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (8.90e-3)" "unprognostic (2.05e-1)" "unprognostic (1.81e-1)" "unprognostic (2.87e-5)" "unprognostic (1.32e-1)" "unprognostic (2.95e-2)" "unprognostic (3.59e-1)" "unprognostic (1.24e-2)" 0.1 0.0 0.0 2.5 0.0 0.6 0.5 0.0 0.0 0.1 0.0 1.1 0.3 0.1 0.6 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.8 5.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 0.2 0.2 0.0 0.0 2.4 0.0 0.0 2.7 0.8 0.1 0.3 11.3 0.1 0.0 4.4 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 17.1 0.2 33.7 19.0 0.0 0.1 26.3 16.2 0.4 0.0 0.0 0.0 59.6 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 TRAV7 ENSG00000211781 "T cell receptor alpha variable 7" A0A075B6U4 14 21782993-21783503 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV8-1 ENSG00000211782 "T cell receptor alpha variable 8-1" A0A0A6YYK1 14 21797287-21797886 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 11.9" "Cell type enriched" "Detected in single" 9 "T-cells: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 43 "MAIT T-cell: 14.2;memory CD4 T-cell: 39.5;memory CD8 T-cell: 20.6;naive CD4 T-cell: 37.6;naive CD8 T-cell: 16.3;T-reg: 54.4" "Lineage enriched" "Detected in single" 77 "T-cells: 54.4" "Not detected" "Not detected" NA NA "unprognostic (8.53e-3)" "unprognostic (1.98e-2)" "unprognostic (5.44e-2)" "unprognostic (1.34e-2)" "unprognostic (4.86e-4)" "unprognostic (2.84e-3)" "unprognostic (8.19e-3)" "unprognostic (1.90e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (2.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.86e-1)" "unprognostic (5.72e-2)" 0.1 0.0 0.0 3.7 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.7 0.6 0.2 0.2 0.7 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.8 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.1 0.2 0.7 0.0 0.0 1.7 0.5 0.2 0.0 11.9 0.0 0.0 4.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 14.2 0.0 39.5 20.6 0.1 0.1 37.6 16.3 0.7 0.0 0.0 0.1 54.4 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 TRAV9-1 ENSG00000211783 "T cell receptor alpha variable 9-1" A0A075B6T8 14 21811502-21811977 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV10 "TCRAV10S1, TCRAV24S1" ENSG00000211784 "T cell receptor alpha variable 10" A0A0B4J240 14 21825472-21826075 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 16.3" "Cell type enriched" "Detected in single" 6 "T-cells: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 64 "MAIT T-cell: 24.7;memory CD4 T-cell: 38.3;memory CD8 T-cell: 43.3;naive CD4 T-cell: 42.5;naive CD8 T-cell: 25.0;T-reg: 59.4" "Lineage enriched" "Detected in single" 156 "T-cells: 59.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.58e-3)" "unprognostic (1.27e-3)" "unprognostic (1.74e-2)" "unprognostic (5.74e-4)" "unprognostic (3.80e-4)" "unprognostic (2.97e-3)" "unprognostic (1.91e-1)" "unprognostic (5.63e-2)" "unprognostic (7.70e-2)" "unprognostic (2.78e-1)" "unprognostic (4.67e-5)" "unprognostic (2.49e-1)" "unprognostic (1.91e-2)" "unprognostic (1.66e-1)" 0.2 0.2 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.9 5.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.8 0.7 0.0 0.0 16.3 0.1 0.0 5.3 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 24.7 0.1 38.3 43.3 0.0 0.1 42.5 25.0 0.3 0.0 0.2 0.3 59.4 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 TRAV12-1 ENSG00000211785 "T cell receptor alpha variable 12-1" A0A0B4J245 14 21841240-21841774 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 21.3" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 4.1;Plasma cells: 1.4;T-cells: 6.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 72 "MAIT T-cell: 128.5;memory CD4 T-cell: 205.2;memory CD8 T-cell: 199.7;naive CD4 T-cell: 138.6;naive CD8 T-cell: 251.7;T-reg: 193.9" "Lineage enriched" "Detected in many" 97 "T-cells: 251.7" "Not detected" "Not detected" NA NA "unprognostic (4.83e-3)" "unprognostic (9.56e-5)" "unprognostic (2.18e-2)" "unprognostic (3.33e-3)" "unprognostic (8.05e-2)" "unprognostic (2.99e-4)" "unprognostic (3.16e-4)" "unprognostic (3.23e-2)" "unprognostic (1.77e-3)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" "unprognostic (3.97e-4)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.92e-2)" 0.5 0.1 0.0 6.5 0.0 1.2 1.3 0.0 0.2 0.6 0.0 1.3 2.9 0.4 0.8 0.7 0.4 2.6 0.1 0.0 0.0 0.1 0.5 1.3 13.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 2.6 0.0 0.2 0.0 0.4 0.0 2.3 1.2 0.0 5.0 1.9 0.1 0.1 21.3 0.2 0.2 14.4 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.9 1.9 0.4 128.5 0.2 205.2 199.7 0.3 0.6 138.6 251.7 2.6 0.3 1.0 0.2 193.9 100.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 TRAV8-2 ENSG00000211786 "T cell receptor alpha variable 8-2" A0A0B4J237 14 21846537-21847221 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 24.3" "Cell type enriched" "Detected in some" 9 "T-cells: 10.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 99 "MAIT T-cell: 59.1;memory CD4 T-cell: 143.4;memory CD8 T-cell: 81.1;naive CD4 T-cell: 143.2;naive CD8 T-cell: 80.1;T-reg: 190.6" "Lineage enriched" "Detected in many" 184 "T-cells: 190.6" "Cell line enriched" "Detected in single" 6 "JURKAT: 1.9" NA NA "unprognostic (5.88e-3)" "unprognostic (9.98e-4)" "unprognostic (2.31e-2)" "unprognostic (2.23e-2)" "unprognostic (9.88e-5)" "unprognostic (1.94e-3)" "unprognostic (7.22e-3)" "unprognostic (9.30e-3)" "unprognostic (2.82e-3)" "unprognostic (1.39e-1)" "unprognostic (1.69e-1)" "unprognostic (7.57e-5)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.02e-1)" 0.2 0.1 0.0 3.2 0.0 2.0 0.2 0.0 0.0 0.2 0.0 0.7 1.1 0.2 1.6 0.5 0.2 1.4 0.1 0.0 0.0 2.7 0.2 1.2 14.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.4 0.0 0.0 0.4 1.3 0.1 0.0 4.2 1.3 0.3 0.0 24.3 0.3 0.0 6.0 1.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.0 1.1 0.1 59.1 0.2 143.4 81.1 0.3 0.3 143.2 80.1 0.7 0.2 0.2 0.1 190.6 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 0.0 0.0 TRAV8-3 ENSG00000211787 "T cell receptor alpha variable 8-3" A0A0A6YYJ7 14 21852558-21853006 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.7" "Cell type enriched" "Detected in single" 7 "T-cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 138.2;T-reg: 153.1" "Lineage enriched" "Detected in many" 47 "T-cells: 153.1" "Cell line enriched" "Detected in single" 6 "JURKAT: 2.9" "Low region specificity" "Detected in single" NA NA "unprognostic (7.74e-4)" "unprognostic (5.25e-5)" "unprognostic (8.88e-4)" "unprognostic (1.12e-2)" "unprognostic (2.69e-1)" "unprognostic (9.64e-5)" "unprognostic (8.20e-2)" "unprognostic (1.25e-2)" "unprognostic (1.38e-2)" "unprognostic (6.44e-2)" "unprognostic (2.13e-2)" "unprognostic (1.46e-1)" "unprognostic (2.66e-5)" "unprognostic (2.99e-1)" "unprognostic (4.17e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" 0.6 0.0 0.4 6.6 0.7 3.9 2.9 0.2 1.6 2.3 0.3 3.0 2.4 0.8 17.0 1.6 9.0 5.7 0.4 0.6 0.3 0.7 1.2 3.8 40.5 0.2 0.3 0.4 0.5 0.0 0.1 0.0 0.6 0.4 1.9 4.7 0.0 2.0 0.7 0.3 0.8 2.8 1.0 0.3 9.1 2.7 3.1 0.3 71.7 0.9 1.1 30.5 6.9 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.4 1.2 0.1 29.7 0.1 106.6 48.4 0.3 0.6 138.2 77.0 3.2 0.2 0.3 0.9 153.1 34.6 0.4 0.7 0.2 1.6 0.6 0.3 0.2 0.3 0.4 0.4 0.3 0.3 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRAV13-1 ENSG00000211788 "T cell receptor alpha variable 13-1" A0A0B4J241 14 21868839-21869365 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 63.1" "Cell type enriched" "Detected in single" 26 "T-cells: 15.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 329.3" "Lineage enriched" "Detected in many" 28 "T-cells: 329.3" "Cell line enriched" "Detected in single" 20 "JURKAT: 1.9" NA NA "unprognostic (1.10e-3)" "unprognostic (9.80e-3)" "unprognostic (1.60e-2)" "unprognostic (3.04e-3)" "unprognostic (5.71e-2)" "unprognostic (3.30e-5)" "unprognostic (7.68e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.16e-5)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.20e-2)" "unprognostic (5.59e-2)" 1.2 0.3 0.0 13.8 0.1 2.2 1.1 0.0 0.2 0.2 0.1 3.8 3.7 0.7 0.3 0.8 0.9 3.7 0.5 0.0 0.1 0.4 1.0 4.4 29.4 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 1.1 3.1 0.0 1.2 0.4 0.2 0.2 7.6 0.4 0.0 8.5 3.8 0.2 0.0 63.1 0.6 0.7 30.2 5.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.7 0.4 1.4 0.4 62.6 0.4 203.8 179.6 0.5 0.6 232.3 292.5 6.2 0.5 0.5 0.9 329.3 80.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.6 0.0 0.0 0.0 TRAV12-2 ENSG00000211789 "T cell receptor alpha variable 12-2" A0A075B6T6 14 21887857-21888502 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.6" "Cell type enriched" "Detected in some" 6 "T-cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 17 "memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3" "Lineage enriched" "Detected in many" 77 "T-cells: 143.3" "Not detected" "Not detected" NA NA "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.74e-2)" "unprognostic (4.98e-3)" "unprognostic (4.75e-2)" "unprognostic (2.41e-4)" "unprognostic (2.22e-2)" "unprognostic (7.44e-2)" "unprognostic (5.23e-4)" "unprognostic (1.73e-3)" "unprognostic (1.74e-1)" "unprognostic (1.43e-1)" "unprognostic (1.03e-3)" "unprognostic (3.69e-1)" "unprognostic (3.34e-3)" "unprognostic (9.87e-2)" "unprognostic (3.01e-2)" 0.8 0.9 0.0 7.6 0.0 0.9 1.0 0.0 0.1 1.1 0.0 1.6 4.1 0.8 0.5 0.8 1.2 2.5 0.3 0.0 0.0 0.3 0.6 2.5 15.8 0.1 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.1 0.8 2.1 0.0 1.7 0.1 0.2 0.5 2.9 0.5 0.0 5.9 2.3 0.0 0.1 22.6 0.6 0.0 13.7 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.5 1.2 0.0 5.7 0.1 101.9 87.7 0.2 0.1 90.3 65.2 1.8 0.1 0.2 0.1 143.3 27.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 TRAV8-4 ENSG00000211790 "T cell receptor alpha variable 8-4" P01737 14 21894433-21895030 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 21.0" "Cell type enriched" "Detected in single" 15 "T-cells: 4.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 184.9;memory CD8 T-cell: 101.6;naive CD4 T-cell: 154.6;naive CD8 T-cell: 74.5;T-reg: 235.1" "Lineage enriched" "Detected in many" 49 "T-cells: 235.1" "Cell line enriched" "Detected in single" 1440 "JURKAT: 405.7" NA NA "unprognostic (3.41e-4)" "unprognostic (1.74e-3)" "unprognostic (2.29e-2)" "unprognostic (1.14e-4)" "unprognostic (3.47e-4)" "unprognostic (5.06e-2)" "unprognostic (1.42e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-3)" "unprognostic (1.42e-1)" "unprognostic (3.80e-2)" "unprognostic (2.60e-1)" "unprognostic (5.58e-2)" 0.3 0.0 0.0 6.5 0.0 0.6 0.5 0.0 0.1 0.3 0.3 1.0 0.8 0.0 0.2 0.1 0.2 0.8 0.2 0.0 0.0 0.1 0.3 0.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 0.1 0.1 0.6 1.7 0.3 0.0 2.9 1.5 0.2 0.0 21.0 0.2 0.1 7.7 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 405.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.4 0.2 24.1 1.9 184.9 101.6 0.1 0.2 154.6 74.5 4.7 0.3 0.3 0.3 235.1 45.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 TRAV13-2 ENSG00000211791 "T cell receptor alpha variable 13-2" A0A0B4J235 14 21918188-21918756 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "lymphoid tissue: 52.2" "Group enriched" "Detected in some" 4 "NK-cells: 4.1;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 38 "MAIT T-cell: 32.9;memory CD4 T-cell: 94.0;memory CD8 T-cell: 57.3;naive CD4 T-cell: 101.8;naive CD8 T-cell: 114.1;T-reg: 114.8" "Lineage enriched" "Detected in many" 53 "T-cells: 114.8" "Cell line enriched" "Detected in some" 4 "JURKAT: 6.1" NA NA "unprognostic (6.15e-3)" "unprognostic (1.47e-2)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" "unprognostic (5.58e-1)" "unprognostic (4.38e-4)" "unprognostic (1.08e-1)" "unprognostic (6.47e-2)" "unprognostic (2.85e-2)" "unprognostic (4.16e-2)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (3.66e-4)" "unprognostic (1.52e-1)" "unprognostic (9.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.77e-2)" 0.3 0.0 0.0 6.6 0.0 1.4 0.9 0.0 0.2 0.4 0.0 1.4 2.1 0.2 1.2 0.7 0.3 1.4 0.2 0.0 0.1 0.2 0.4 1.6 14.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.5 0.1 0.1 0.5 1.6 0.6 0.1 4.6 1.9 0.2 0.2 52.2 0.2 0.0 10.1 1.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.1 2.2 0.2 32.9 0.4 94.0 57.3 0.1 0.2 101.8 114.1 2.1 0.6 0.2 0.3 114.8 40.6 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.0 0.0 TRAV14DV4 "hADV14S1, TCRAV6S1-hDV104S1, TRAV14/DV4" ENSG00000211792 "T cell receptor alpha variable 14/delta variable 4" A0A0A6YYC5 14 21924063-21924651 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 25.9" "Cell type enriched" "Detected in single" 12 "T-cells: 6.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 38.2;memory CD8 T-cell: 78.1;naive CD4 T-cell: 30.7;naive CD8 T-cell: 122.3;T-reg: 42.6" "Lineage enriched" "Detected in single" 176 "T-cells: 122.3" "Cell line enhanced" "Detected in single" "JURKAT: 1.6" NA NA "unprognostic (6.82e-3)" "unprognostic (1.00e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-3)" "unprognostic (3.00e-5)" "unprognostic (2.52e-1)" "unprognostic (7.61e-4)" "unprognostic (3.77e-1)" "unprognostic (2.82e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (2.62e-5)" "unprognostic (3.01e-1)" "unprognostic (4.17e-2)" "unprognostic (2.90e-1)" "unprognostic (1.60e-2)" 0.6 0.1 0.0 4.2 0.1 1.5 0.6 0.0 0.1 0.5 0.0 0.8 2.0 0.3 0.0 0.6 0.7 1.6 0.2 0.0 0.0 0.2 1.1 2.5 12.8 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.2 0.1 0.0 0.2 1.7 0.1 0.0 3.5 1.4 0.0 0.1 25.9 0.2 0.0 8.1 1.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.2 9.9 0.1 38.2 78.1 0.0 0.2 30.7 122.3 0.3 0.4 0.3 0.0 42.6 21.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 TRAV9-2 ENSG00000211793 "T cell receptor alpha variable 9-2" A0A087WT02 14 21941128-21941657 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 28.1" "Cell type enriched" "Detected in single" 6 "T-cells: 5.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8" "Lineage enriched" "Detected in many" 78 "T-cells: 350.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.02e-3)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (1.14e-5)" "unprognostic (1.37e-2)" "unprognostic (2.23e-2)" "unprognostic (5.98e-4)" "unprognostic (9.53e-3)" "unprognostic (1.92e-1)" "unprognostic (2.51e-1)" "unprognostic (9.00e-4)" "unprognostic (2.49e-1)" "unprognostic (4.28e-2)" "unprognostic (3.38e-1)" "unprognostic (2.56e-2)" 0.2 0.0 0.0 5.7 0.0 0.1 0.4 0.0 0.2 0.7 0.0 1.9 0.8 0.2 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.2 1.1 1.8 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.5 0.0 0.1 0.4 0.2 0.2 2.1 0.5 0.0 5.0 3.1 0.1 0.0 28.1 0.2 0.2 16.4 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.8 0.0 14.3 0.6 178.3 43.4 0.2 0.3 172.2 42.5 4.4 0.3 0.2 1.1 350.8 40.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 TRAV12-3 "TCRAV12S3, TCRAV2S2, TRAV123" ENSG00000211794 "T cell receptor alpha variable 12-3" A0A0B4J271 14 21965451-21966061 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 60.9" "Group enriched" "Detected in some" 4 "Erythroid cells: 1.7;T-cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 186.5;T-reg: 256.6" "Lineage enriched" "Detected in many" 23 "T-cells: 256.6" "Cell line enriched" "Detected in single" 43 "JURKAT: 4.5" NA NA "unprognostic (1.62e-4)" "unprognostic (7.68e-4)" "unprognostic (5.17e-2)" "unprognostic (1.33e-3)" "unprognostic (2.32e-1)" "unprognostic (1.80e-3)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (7.55e-4)" "unprognostic (9.00e-3)" "unprognostic (1.03e-1)" "unprognostic (1.20e-1)" "unprognostic (4.52e-5)" "unprognostic (3.75e-1)" "unprognostic (4.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.68e-2)" 0.5 0.1 0.0 9.4 0.0 1.5 1.1 0.0 0.1 1.7 0.0 2.1 2.2 0.6 0.9 0.4 0.6 6.2 0.5 0.0 0.1 0.3 0.4 2.9 18.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 3.2 0.0 0.3 0.2 0.1 0.4 2.7 0.5 0.0 4.6 1.9 0.1 0.0 60.9 0.2 0.0 17.6 3.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.5 0.2 0.4 0.2 12.7 0.4 186.5 57.4 0.4 1.8 119.7 153.3 4.6 0.9 0.7 0.5 256.6 48.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TRAV8-6 ENSG00000211795 "T cell receptor alpha variable 8-6" A0A0B4J262 14 21978459-21979120 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 25.0" "Group enriched" "Detected in some" 19 "Spermatocytes: 1.2;Spermatogonia: 1.5;T-cells: 3.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 89.3;memory CD8 T-cell: 64.2;naive CD4 T-cell: 92.6;naive CD8 T-cell: 38.7;T-reg: 125.0" "Lineage enriched" "Detected in many" 45 "T-cells: 125.0" "Cell line enriched" "Detected in single" 97 "JURKAT: 9.6" NA NA "unprognostic (1.42e-2)" "unprognostic (9.23e-4)" "unprognostic (5.47e-3)" "unprognostic (1.27e-3)" "unprognostic (7.80e-2)" "unprognostic (7.74e-5)" "unprognostic (2.88e-3)" "unprognostic (5.41e-3)" "unprognostic (2.59e-3)" "unprognostic (2.24e-2)" "unprognostic (9.25e-2)" "unprognostic (2.92e-1)" "unprognostic (9.78e-5)" "unprognostic (4.65e-1)" "unprognostic (2.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.61e-3)" 0.1 0.0 0.0 3.0 0.0 0.8 0.8 0.0 0.0 0.4 0.0 0.9 0.7 0.3 0.7 0.3 0.3 2.0 0.2 0.0 0.1 0.3 0.3 1.5 10.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.1 0.1 0.2 1.3 0.4 0.1 2.9 1.5 0.4 0.0 25.0 0.1 0.1 8.3 1.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.1 17.9 0.2 89.3 64.2 0.1 0.1 92.6 38.7 2.8 0.1 0.1 0.2 125.0 24.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 TRAV16 "TCRAV16S1, TCRAV9S1" ENSG00000211796 "T cell receptor alpha variable 16" A0A0A6YYK6 14 21990496-21990938 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" "Erythroid cells: 1.3;Gastric mucus-secreting cells: 3.1;T-cells: 5.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 48.0;T-reg: 58.0" "Lineage enriched" "Detected in single" 164 "T-cells: 58.0" "Cell line enriched" "Detected in single" 184 "JURKAT: 18.3" "Not detected" "Not detected" NA NA "unprognostic (2.93e-2)" "unprognostic (1.06e-4)" "unprognostic (6.22e-3)" "unprognostic (3.67e-3)" "unprognostic (1.01e-4)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (2.79e-2)" "unprognostic (6.94e-4)" "unprognostic (5.25e-2)" "unprognostic (2.33e-1)" "unprognostic (5.27e-5)" "unprognostic (1.55e-1)" "unprognostic (3.91e-2)" "unprognostic (4.01e-1)" "unprognostic (2.07e-3)" 0.2 0.0 0.0 5.8 0.0 0.8 0.9 0.0 0.3 0.5 0.0 1.5 1.9 0.2 1.3 0.5 0.2 2.6 0.1 0.0 0.2 0.6 0.2 1.8 16.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 1.7 0.0 0.6 0.1 0.0 0.6 1.6 0.0 0.0 2.9 1.8 0.1 0.1 40.1 0.3 0.0 10.2 3.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 11.9 0.0 45.6 18.2 0.0 0.1 48.0 22.4 0.3 0.0 0.0 0.0 58.0 10.3 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 TRAV17 "TCRAV17S1, TCRAV3S1" ENSG00000211797 "T cell receptor alpha variable 17" A0A0B4J275 14 21997539-21998168 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 28.1" "Cell type enriched" "Detected in some" 5 "T-cells: 6.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 81.4;memory CD8 T-cell: 63.7;naive CD4 T-cell: 61.8;naive CD8 T-cell: 53.2;T-reg: 116.3" "Lineage enriched" "Detected in single" 226 "T-cells: 116.3" "Cell line enriched" "Detected in single" 221 "JURKAT: 22.0" "Not detected" "Not detected" NA NA "unprognostic (8.22e-4)" "unprognostic (4.50e-3)" "unprognostic (1.37e-3)" "unprognostic (2.06e-2)" "unprognostic (2.72e-6)" "unprognostic (6.44e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-2)" "unprognostic (1.67e-3)" "unprognostic (8.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.58e-5)" "unprognostic (1.73e-1)" "unprognostic (8.43e-3)" "unprognostic (8.53e-2)" "unprognostic (2.21e-1)" 0.1 0.0 0.0 6.0 0.0 0.5 0.2 0.0 0.2 0.5 0.0 1.2 1.8 0.3 0.8 0.7 0.6 1.4 0.1 0.0 0.1 0.2 0.4 1.4 13.3 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 1.6 0.0 0.1 0.0 0.0 0.1 1.5 0.3 0.1 3.3 2.3 0.1 0.1 28.1 0.3 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.7 0.0 3.9 0.2 81.4 63.7 0.0 0.2 61.8 53.2 0.5 0.1 0.1 0.3 116.3 22.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TRAV18 TCRAV18S1 ENSG00000211798 "T cell receptor alpha variable 18" A0A075B6X5 14 22003106-22003673 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "lymphoid tissue: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 12.4;naive CD8 T-cell: 7.9;T-reg: 5.1" "Lineage enriched" "Detected in single" 124 "T-cells: 12.4" "Cell line enriched" "Detected in some" 7 "JURKAT: 36.2" "Not detected" "Not detected" NA NA "unprognostic (1.30e-2)" "unprognostic (6.59e-3)" "unprognostic (2.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.92e-1)" "unprognostic (2.67e-1)" "unprognostic (9.94e-2)" "unprognostic (1.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.92e-1)" "unprognostic (5.61e-4)" 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 1.0 0.8 0.4 0.0 9.9 0.2 0.5 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 5.6 6.3 0.0 0.0 12.4 7.9 0.0 0.0 0.0 0.0 5.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TRAV19 "TCRAV12S1, TCRAV19S1" ENSG00000211799 "T cell receptor alpha variable 19" A0A0A6YYK7 14 22007512-22008181 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 37.2" "Cell type enhanced" "Detected in single" "T-cells: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "memory CD4 T-cell: 17.8;memory CD8 T-cell: 45.6;naive CD4 T-cell: 23.2;naive CD8 T-cell: 24.5;T-reg: 23.9" "Lineage enriched" "Detected in single" 173 "T-cells: 45.6" "Cell line enriched" "Detected in some" 19 "JURKAT: 26.2" "Not detected" "Not detected" NA NA "unprognostic (5.04e-3)" "unprognostic (2.11e-2)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (1.52e-1)" "unprognostic (2.95e-4)" "unprognostic (2.15e-3)" "unprognostic (1.50e-1)" "unprognostic (4.92e-2)" "unprognostic (2.99e-3)" "unprognostic (1.15e-1)" "unprognostic (3.41e-1)" "unprognostic (3.79e-2)" "unprognostic (1.22e-1)" "unprognostic (7.40e-2)" "unprognostic (1.18e-1)" "unprognostic (4.33e-3)" 0.4 0.5 0.0 6.2 0.0 1.2 0.9 0.0 0.2 0.7 0.0 1.4 2.8 0.5 0.4 1.0 0.3 2.4 0.7 0.0 0.1 0.5 0.6 3.2 18.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.5 3.1 0.0 1.2 0.4 0.0 0.3 2.4 0.7 0.0 6.5 3.7 0.8 0.1 37.2 0.4 0.3 12.8 3.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 2.6 0.0 17.8 45.6 0.0 0.0 23.2 24.5 0.2 0.0 0.0 0.0 23.9 8.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 TRAV20 ENSG00000211800 "T cell receptor alpha variable 20" A0A0B4J274 14 22040594-22041153 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 14.7" "Cell type enriched" "Detected in single" 6 "T-cells: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 124.2;memory CD8 T-cell: 94.6;naive CD4 T-cell: 124.6;naive CD8 T-cell: 98.0;T-reg: 152.3" "Lineage enriched" "Detected in many" 60 "T-cells: 152.3" "Not detected" "Not detected" NA NA "unprognostic (1.70e-2)" "unprognostic (3.31e-3)" "unprognostic (6.84e-2)" "unprognostic (2.90e-3)" "unprognostic (1.14e-2)" "unprognostic (1.93e-3)" "unprognostic (2.21e-2)" "unprognostic (4.70e-2)" "unprognostic (8.88e-2)" "unprognostic (7.00e-2)" "unprognostic (3.95e-2)" "unprognostic (1.16e-4)" "unprognostic (1.80e-1)" "unprognostic (3.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.11e-2)" 0.0 0.1 0.0 3.3 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.7 0.5 0.2 0.0 0.2 0.1 1.7 0.1 0.0 0.0 0.1 0.6 1.4 9.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.7 0.2 0.1 0.0 0.8 0.5 0.0 2.4 0.8 0.0 0.0 14.7 0.3 0.0 7.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.5 0.1 15.6 1.6 124.2 94.6 0.0 0.1 124.6 98.0 2.5 0.2 0.4 0.4 152.3 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 TRAV21 ENSG00000211801 "T cell receptor alpha variable 21" A0A0B4J279 14 22052514-22053056 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 63.7" "Group enriched" "Detected in some" 12 "Gastric mucus-secreting cells: 6.1;T-cells: 23.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 220.5;memory CD8 T-cell: 233.5;naive CD4 T-cell: 198.6;naive CD8 T-cell: 204.8;T-reg: 391.9" "Lineage enriched" "Detected in many" 76 "T-cells: 391.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.53e-4)" "unprognostic (1.03e-2)" "unprognostic (3.94e-3)" "unprognostic (3.69e-4)" "unprognostic (1.74e-1)" "unprognostic (1.22e-3)" "unprognostic (4.86e-3)" "unprognostic (2.47e-2)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" "unprognostic (4.20e-2)" "unprognostic (9.80e-2)" "unprognostic (4.53e-3)" "unprognostic (3.13e-1)" "unprognostic (2.96e-2)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" 0.4 0.1 0.0 5.9 0.0 0.8 1.4 0.0 0.1 1.1 0.1 1.9 2.0 0.1 1.7 0.9 0.7 1.7 0.1 0.0 0.2 0.7 0.5 2.7 14.3 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.7 2.7 0.0 1.0 0.1 0.4 0.3 2.7 0.7 0.1 5.5 2.5 0.1 0.1 63.7 3.8 0.0 17.2 2.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.9 1.7 0.2 17.4 0.5 220.5 233.5 0.9 0.8 198.6 204.8 5.1 0.4 0.7 0.6 391.9 73.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.0 0.0 0.0 0.0 TRAV22 "TCRAV13S1, TCRAV22S1" ENSG00000211802 "T cell receptor alpha variable 22" A0A0B4J277 14 22070557-22071208 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "lymphoid tissue: 23.0" "Group enriched" "Detected in some" 4 "NK-cells: 1.0;T-cells: 3.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 59.6" "Lineage enriched" "Detected in many" 6 "T-cells: 59.6" "Cell line enriched" "Detected in single" 5 "U-266/70: 2.7" "Not detected" "Not detected" NA NA "unprognostic (1.18e-2)" "unprognostic (6.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.82e-3)" "unprognostic (3.00e-5)" "unprognostic (4.27e-1)" "unprognostic (3.45e-2)" "unprognostic (2.51e-2)" "unprognostic (1.40e-2)" "unprognostic (4.79e-2)" "unprognostic (2.93e-2)" "unprognostic (2.63e-5)" "unprognostic (6.15e-2)" "unprognostic (1.12e-2)" "unprognostic (7.56e-3)" "unprognostic (3.15e-2)" 0.1 0.0 0.0 1.9 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.6 0.7 0.5 0.0 0.6 0.4 0.6 0.6 0.0 0.0 0.4 0.2 1.0 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 1.1 0.0 0.2 0.1 0.1 0.1 0.8 0.1 0.0 2.3 0.6 0.1 0.0 23.0 0.2 0.4 4.5 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 6.0 0.0 2.9 0.0 35.2 18.3 0.0 0.1 31.3 18.7 0.1 3.8 0.1 10.3 59.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRAV23DV6 "TCRAV17S1, TRAV23/DV6" ENSG00000211803 "T cell receptor alpha variable 23/delta variable 6" A0A075B6W5 14 22086407-22086961 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 26.5" "Cell type enriched" "Detected in single" 20 "T-cells: 4.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 79.3;naive CD4 T-cell: 85.6;T-reg: 65.6" "Lineage enriched" "Detected in many" 56 "T-cells: 85.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.79e-3)" "unprognostic (2.91e-2)" "unprognostic (2.01e-1)" "unprognostic (2.69e-1)" "unprognostic (2.66e-2)" "unprognostic (2.20e-2)" "unprognostic (1.19e-3)" "unprognostic (3.91e-2)" "unprognostic (1.04e-2)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (4.56e-3)" "unprognostic (1.34e-1)" "unprognostic (4.47e-2)" "unprognostic (7.44e-2)" "unprognostic (1.33e-1)" 0.5 0.1 0.0 6.4 0.0 1.1 0.5 0.0 0.0 0.5 0.0 1.2 2.1 0.2 0.0 1.0 0.5 1.3 0.3 0.0 0.0 0.0 0.5 1.8 10.4 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.5 0.1 0.1 0.1 1.0 0.6 0.0 3.3 2.2 0.0 0.0 26.5 0.6 0.0 10.9 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 2.0 0.0 3.2 0.0 79.3 19.6 0.0 0.1 85.6 21.4 1.5 0.1 0.0 0.0 65.6 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 TRDV1 hDV101S1 ENSG00000211804 "T cell receptor delta variable 1" A0A1B0GX56 14 22096032-22096619 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 76.0" "Group enriched" "Detected in some" 8 "Plasma cells: 2.1;T-cells: 7.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 21 "gdT-cell: 1071.6" "Lineage enriched" "Detected in many" 198 "T-cells: 1071.6" "Not detected" "Not detected" NA NA "unprognostic (1.59e-4)" "unprognostic (2.31e-3)" "unprognostic (1.49e-1)" "unprognostic (3.09e-3)" "unprognostic (3.18e-3)" "unprognostic (1.51e-2)" "unprognostic (4.21e-5)" "unprognostic (6.57e-2)" "unprognostic (1.83e-4)" "unprognostic (3.39e-1)" "unprognostic (2.21e-1)" "unprognostic (3.20e-3)" "unprognostic (1.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.01e-2)" "unprognostic (4.69e-2)" 0.3 0.2 0.0 2.1 0.0 1.0 0.3 0.0 0.0 0.5 0.0 4.7 0.5 0.2 0.0 0.1 0.3 2.6 0.0 0.0 0.3 0.0 0.8 3.5 10.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.2 2.6 0.0 0.3 0.6 0.3 0.1 0.7 0.1 0.0 20.1 1.8 1.3 0.0 76.0 1.1 0.0 5.7 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.4 1071.6 0.6 3.3 1.4 26.0 27.4 0.0 0.3 23.8 51.7 5.4 0.1 1.1 1.2 43.5 55.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 TRAV24 ENSG00000211805 "T cell receptor alpha variable 24" A0A0B4J272 14 22105343-22105846 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 21.6" "Cell type enriched" "Detected in single" 11 "T-cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 24 "memory CD4 T-cell: 24.4;memory CD8 T-cell: 47.5;naive CD4 T-cell: 22.4;naive CD8 T-cell: 66.5;T-reg: 40.9" "Lineage enriched" "Detected in single" 244 "T-cells: 66.5" "Not detected" "Not detected" NA NA "unprognostic (1.96e-3)" "unprognostic (2.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.79e-4)" "unprognostic (5.42e-2)" "unprognostic (1.04e-1)" "unprognostic (7.79e-3)" "unprognostic (3.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.47e-5)" "unprognostic (3.62e-2)" "unprognostic (3.91e-2)" "unprognostic (1.44e-2)" 0.2 0.0 0.1 3.8 0.2 0.4 0.2 0.0 0.2 0.2 0.0 0.6 1.0 0.2 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 1.0 1.4 7.4 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.1 0.0 0.6 0.0 0.0 0.0 1.2 0.7 0.0 2.3 1.7 0.0 0.6 21.6 0.1 0.5 4.6 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.7 0.1 24.4 47.5 0.0 0.0 22.4 66.5 0.2 0.0 0.1 0.2 40.9 10.0 0.1 0.2 0.0 0.2 0.0 0.1 0.2 0.5 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 TRAV25 "TCRAV25S1, TCRAV32S1" ENSG00000211806 "T cell receptor alpha variable 25" A0A0B4J276 14 22112347-22113031 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 15.4" "Cell type enriched" "Detected in single" 6 "T-cells: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 63 "memory CD4 T-cell: 33.5;memory CD8 T-cell: 20.9;naive CD4 T-cell: 32.6;naive CD8 T-cell: 22.5;T-reg: 49.4" "Lineage enriched" "Detected in single" 404 "T-cells: 49.4" "Not detected" "Not detected" NA NA "unprognostic (9.50e-3)" "unprognostic (1.49e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-5)" "unprognostic (6.65e-3)" "unprognostic (7.53e-3)" "unprognostic (7.30e-3)" "unprognostic (1.69e-1)" "unprognostic (2.04e-1)" "unprognostic (3.52e-3)" "unprognostic (9.55e-2)" "unprognostic (4.17e-2)" "unprognostic (1.17e-1)" "unprognostic (3.74e-1)" 0.1 0.0 0.0 2.7 0.1 0.3 0.5 0.0 0.2 0.1 0.0 0.8 0.8 0.3 0.6 0.2 0.2 0.5 0.0 0.0 0.0 0.2 0.1 1.5 8.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.2 0.1 0.7 0.3 0.0 2.3 1.7 0.0 0.1 15.4 0.1 0.0 7.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 33.5 20.9 0.0 0.0 32.6 22.5 0.1 0.0 0.0 0.0 49.4 7.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 TRAV26-1 ENSG00000211807 "T cell receptor alpha variable 26-1" A0A087WT03 14 22123318-22124285 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 14.1" "Cell type enriched" "Detected in single" 5 "T-cells: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 37.4;naive CD4 T-cell: 39.7;T-reg: 55.8" "Lineage enriched" "Detected in single" 69 "T-cells: 55.8" "Not detected" "Not detected" NA NA "unprognostic (1.36e-3)" "unprognostic (1.33e-5)" "unprognostic (1.21e-2)" "unprognostic (3.60e-2)" "unprognostic (1.50e-3)" "unprognostic (1.08e-2)" "unprognostic (4.89e-2)" "unprognostic (1.99e-1)" "unprognostic (4.67e-4)" "unprognostic (3.93e-3)" "unprognostic (3.28e-1)" "unprognostic (4.01e-5)" "unprognostic (1.63e-1)" "unprognostic (1.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-2)" 0.0 0.1 0.0 3.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.8 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 0.1 0.2 1.0 8.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 2.6 1.6 0.0 0.0 14.1 0.1 0.0 6.2 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 1.2 0.0 37.4 9.6 0.0 0.0 39.7 12.5 0.4 0.0 0.1 0.0 55.8 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 TRAV8-7 ENSG00000211808 "T cell receptor alpha variable 8-7 (pseudogene)" 14 22132553-22133034 "Predicted intracellular proteins, T-cell receptor genes" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAV27 ENSG00000211809 "T cell receptor alpha variable 27" A0A087WT01 14 22147995-22148633 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 20.0" "Cell type enriched" "Detected in some" 4 "T-cells: 4.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 51.6;memory CD8 T-cell: 58.9;naive CD4 T-cell: 60.4;naive CD8 T-cell: 59.1;T-reg: 81.9" "Lineage enriched" "Detected in many" 63 "T-cells: 81.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.86e-3)" "unprognostic (1.66e-2)" "unprognostic (4.15e-2)" "unprognostic (2.78e-4)" "unprognostic (1.61e-1)" "unprognostic (2.21e-3)" "unprognostic (3.13e-1)" "unprognostic (8.30e-2)" "unprognostic (1.12e-2)" "unprognostic (2.07e-2)" "unprognostic (6.61e-2)" "unprognostic (2.14e-1)" "unprognostic (1.75e-4)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.68e-1)" "unprognostic (3.12e-3)" 0.1 0.0 0.0 2.3 0.0 0.4 0.2 0.0 0.2 0.6 0.0 0.6 0.3 0.2 0.0 0.4 0.3 0.2 0.1 0.0 0.0 0.1 0.1 0.7 5.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.2 0.2 0.7 0.0 0.0 1.7 0.9 0.0 0.1 20.0 0.1 0.0 5.7 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.5 0.0 3.2 0.2 51.6 58.9 0.0 0.0 60.4 59.1 1.0 1.3 0.1 0.3 81.9 19.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 TRAV29DV5 TRAV29/DV5 ENSG00000211810 "T cell receptor alpha variable 29/delta variable 5" P04437 14 22163238-22163870 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 26.8" "Cell type enriched" "Detected in some" 5 "T-cells: 13.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 20 "memory CD4 T-cell: 99.2;memory CD8 T-cell: 126.3;naive CD4 T-cell: 105.5;naive CD8 T-cell: 66.4;T-reg: 123.9" "Lineage enriched" "Detected in single" 129 "T-cells: 126.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.25e-4)" "unprognostic (3.20e-3)" "unprognostic (4.50e-2)" "unprognostic (8.49e-4)" "unprognostic (3.24e-3)" "unprognostic (9.16e-2)" "unprognostic (2.73e-1)" "unprognostic (4.17e-3)" "unprognostic (4.47e-2)" "unprognostic (3.81e-1)" "unprognostic (1.03e-1)" "unprognostic (5.11e-4)" "unprognostic (7.53e-2)" "unprognostic (4.69e-2)" "unprognostic (9.86e-2)" "unprognostic (7.28e-2)" 0.1 0.0 0.0 4.7 0.0 0.8 0.3 0.0 0.1 0.2 0.0 1.3 1.7 0.1 0.4 0.8 0.5 0.9 0.3 0.0 0.0 0.2 0.5 1.3 11.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.3 0.2 0.0 0.0 1.8 0.2 0.0 4.8 2.0 0.1 0.1 26.8 0.1 0.0 11.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 5.1 0.2 2.5 0.1 99.2 126.3 0.1 0.2 105.5 66.4 0.9 0.2 0.2 0.2 123.9 35.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 TRAV26-2 "TCRAV26S2, TCRAV4S1, TRAV262" ENSG00000211812 "T cell receptor alpha variable 26-2" A0A0B4J265 14 22202583-22203368 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 30 "lymphoid tissue: 41.9" "Cell type enriched" "Detected in single" 11 "T-cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 35 "memory CD4 T-cell: 52.8;memory CD8 T-cell: 80.5;naive CD4 T-cell: 50.9;naive CD8 T-cell: 36.8;T-reg: 66.3" "Lineage enriched" "Detected in single" 121 "T-cells: 80.5" "Cell line enriched" "Detected in single" 122 "HDLM-2: 12.2" "Not detected" "Not detected" NA NA "unprognostic (7.57e-5)" "unprognostic (1.82e-1)" "unprognostic (2.19e-1)" "unprognostic (6.76e-4)" "unprognostic (8.84e-5)" "unprognostic (4.51e-2)" "unprognostic (2.10e-2)" "unprognostic (8.91e-3)" "unprognostic (9.24e-2)" "unprognostic (2.61e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-3)" "unprognostic (3.41e-1)" "unprognostic (5.19e-2)" 0.1 0.0 0.0 4.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 1.1 0.6 0.0 0.0 0.5 0.2 1.0 0.0 0.1 0.0 0.1 0.9 1.3 10.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.3 0.1 0.0 0.0 0.9 0.3 0.0 1.9 1.0 0.1 0.2 41.9 0.1 0.6 7.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.6 0.1 0.9 0.0 52.8 80.5 0.0 0.1 50.9 36.8 0.6 0.0 0.1 0.0 66.3 18.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 TRAV34 "TCRAV26S1, TCRAV34S1" ENSG00000211813 "T cell receptor alpha variable 34" A0A0B4J273 14 22207522-22208129 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "lymphoid tissue: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 71 "memory CD4 T-cell: 9.9;memory CD8 T-cell: 4.5;naive CD4 T-cell: 14.0;naive CD8 T-cell: 5.0;T-reg: 16.9" "Lineage enriched" "Detected in single" 169 "T-cells: 16.9" "Cell line enriched" "Detected in single" 111 "HDLM-2: 59.2" "Not detected" "Not detected" NA NA "unprognostic (3.61e-2)" "unprognostic (2.36e-4)" "unprognostic (1.24e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-1)" "unprognostic (3.68e-2)" 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 2.9 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.5 0.0 0.3 13.4 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.9 4.5 0.0 0.0 14.0 5.0 0.0 0.0 0.0 0.0 16.9 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRAV36DV7 TRAV36/DV7 ENSG00000211815 "T cell receptor alpha variable 36/delta variable 7" A0A075B6V5 14 22226746-22227254 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "lymphoid tissue: 27.7" "Cell type enriched" "Detected in single" 4 "T-cells: 2.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 29.2;memory CD8 T-cell: 21.9;naive CD4 T-cell: 37.6;naive CD8 T-cell: 23.0;T-reg: 50.1" "Lineage enriched" "Detected in many" 13 "T-cells: 50.1" "Group enriched" "Detected in some" 11 "Daudi: 1.4;HL-60: 3.3" "Not detected" "Not detected" NA NA "unprognostic (3.67e-3)" "unprognostic (1.25e-2)" "unprognostic (1.81e-2)" "unprognostic (2.74e-2)" "unprognostic (7.69e-2)" "unprognostic (2.39e-6)" "unprognostic (8.10e-2)" "unprognostic (9.54e-2)" "unprognostic (3.13e-1)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (4.62e-5)" "unprognostic (1.52e-1)" "unprognostic (2.91e-2)" "unprognostic (1.11e-1)" "unprognostic (4.17e-4)" 0.2 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.3 0.2 1.0 0.4 0.0 0.0 0.0 0.1 1.5 10.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 1.7 0.6 0.1 0.1 27.7 0.1 0.0 5.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 1.6 0.0 0.0 1.4 29.2 21.9 0.0 0.1 37.6 23.0 0.3 0.0 0.0 0.0 50.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 TRAV38-1 "TCRAV14S2, TCRAV38S1, TRAV381" ENSG00000211816 "T cell receptor alpha variable 38-1" A0A0B4J264 14 22271968-22272563 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 14.1" "Group enriched" "Detected in some" 13 "Gastric mucus-secreting cells: 1.1;T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 31 "memory CD4 T-cell: 41.2;memory CD8 T-cell: 21.9;naive CD4 T-cell: 46.4;naive CD8 T-cell: 29.2;T-reg: 71.5" "Lineage enriched" "Detected in single" 218 "T-cells: 71.5" "Cell line enriched" "Detected in single" 15 "HDLM-2: 6.1" NA NA "unprognostic (5.06e-3)" "unprognostic (1.04e-2)" "unprognostic (1.03e-1)" "unprognostic (2.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (5.75e-1)" "unprognostic (1.25e-2)" "unprognostic (2.46e-1)" "unprognostic (2.76e-2)" "unprognostic (2.26e-1)" 0.2 0.0 0.0 3.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 14.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 0.0 0.2 0.1 0.7 0.0 0.0 2.1 1.1 0.1 0.1 13.8 0.0 0.0 7.5 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.1 41.2 21.9 0.0 0.0 46.4 29.2 0.3 0.0 0.2 0.2 71.5 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 TRAV38-2DV8 "hADV38S2, TCRAV14S1, TRAV38-2/DV8, TRAV382DV8" ENSG00000211817 "T cell receptor alpha variable 38-2/delta variable 8" A0JD32 14 22281105-22281748 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "lymphoid tissue: 34.6" "Group enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 3.1;T-cells: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 182.9;memory CD8 T-cell: 113.3;naive CD4 T-cell: 152.6;naive CD8 T-cell: 96.6;T-reg: 227.6" "Lineage enriched" "Detected in many" 9 "T-cells: 227.6" "Cell line enriched" "Detected in single" 16 "HDLM-2: 1.6" NA NA 0.4 0.4 0.2 4.2 0.3 0.8 0.6 0.1 0.3 0.8 0.2 1.1 1.5 0.5 0.0 0.4 0.5 1.5 0.0 0.3 0.2 0.5 0.8 1.3 12.5 0.2 1.3 0.1 0.1 0.0 0.1 0.0 0.3 0.2 1.3 1.9 0.0 0.4 0.3 0.0 0.2 1.2 0.1 0.2 3.0 1.4 0.2 0.4 34.6 0.2 0.6 8.1 3.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.1 33.2 0.1 0.2 0.3 182.9 113.3 0.2 0.3 152.6 96.6 2.4 0.2 0.4 24.5 227.6 57.7 0.2 0.3 0.1 0.3 0.3 0.2 0.2 1.3 0.1 0.2 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 TRAV39 "TCRAV27S1, TCRAV39S1" ENSG00000211818 "T cell receptor alpha variable 39" A0A0B4J263 14 22304054-22304553 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 65.8" "Cell type enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 33.2;memory CD8 T-cell: 27.1;naive CD4 T-cell: 35.8;naive CD8 T-cell: 23.6;T-reg: 36.7" "Lineage enriched" "Detected in many" 7 "T-cells: 36.7" "Cell line enhanced" "Detected in single" "MCF7: 1.1" "Not detected" "Not detected" NA NA "unprognostic (9.69e-3)" "unprognostic (4.53e-3)" "unprognostic (8.90e-2)" "unprognostic (6.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (5.71e-2)" "unprognostic (8.03e-3)" "unprognostic (3.17e-1)" "unprognostic (8.97e-2)" "unprognostic (8.96e-2)" "unprognostic (2.29e-1)" "unprognostic (6.55e-8)" "unprognostic (7.91e-2)" "unprognostic (5.25e-2)" "unprognostic (4.51e-2)" "unprognostic (3.56e-1)" 0.6 0.3 0.2 2.8 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.5 1.0 0.7 0.0 0.1 0.2 0.5 0.7 0.4 0.1 1.8 0.0 4.0 7.8 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.8 1.3 0.0 0.1 0.6 0.0 0.2 0.4 0.3 0.2 1.9 0.7 1.3 0.2 65.8 0.0 0.6 6.0 1.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 33.2 27.1 0.0 0.0 35.8 23.6 0.0 0.0 0.0 5.3 36.7 8.6 0.2 0.2 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 TRAV40 "TCRAV31S1, TCRAV40S1" ENSG00000211819 "T cell receptor alpha variable 40" A0A0B4J280 14 22314490-22314919 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 24 "lymphoid tissue: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 5.4;memory CD8 T-cell: 3.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 4.4;T-reg: 6.4" "Lineage enriched" "Detected in single" 64 "T-cells: 6.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 9.4 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.4 3.2 0.0 0.0 4.8 4.4 0.0 0.0 0.0 0.0 6.4 1.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRAV41 "TCRAV19S1, TCRAV41S1" ENSG00000211820 "T cell receptor alpha variable 41" A0A0B4J266 14 22320188-22320691 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 39 "lymphoid tissue: 108.8" "Cell type enriched" "Detected in single" 7 "T-cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 77.1;naive CD4 T-cell: 74.1;T-reg: 71.1" "Lineage enriched" "Detected in many" 46 "T-cells: 77.1" "Cell line enriched" "Detected in some" 60 "HDLM-2: 136.5" NA NA "unprognostic (1.25e-3)" "unprognostic (1.98e-2)" "unprognostic (1.17e-1)" "unprognostic (2.30e-1)" "unprognostic (1.94e-1)" "unprognostic (8.89e-3)" "unprognostic (1.56e-1)" "unprognostic (6.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.99e-2)" "unprognostic (6.89e-3)" "unprognostic (3.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" 0.1 0.0 0.8 5.7 1.0 0.5 0.4 0.7 1.8 0.1 0.6 1.0 1.0 0.5 0.0 0.7 0.1 1.3 0.0 0.9 1.0 0.0 0.3 2.7 16.2 1.2 1.1 0.7 0.0 0.0 0.1 0.0 0.0 0.8 0.4 1.6 0.0 0.0 0.1 0.3 0.1 0.8 0.7 0.7 4.1 1.2 0.1 0.8 108.8 0.2 0.0 12.7 1.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.3 0.8 0.3 0.0 77.1 19.1 0.0 0.0 74.1 31.0 1.6 0.1 0.1 0.0 71.1 18.1 0.8 1.0 0.7 1.8 0.9 1.0 1.2 1.1 0.7 0.8 0.7 0.8 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 TRDV2 "hDV102S1, MGC117421" ENSG00000211821 "T cell receptor delta variable 2" A0JD36 14 22422371-22423042 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.2;lymphoid tissue: 3.4" "Cell type enriched" "Detected in some" 7 "T-cells: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 218 "gdT-cell: 3222.2" "Lineage enriched" "Detected in all" 575 "T-cells: 3222.2" "Cell line enriched" "Detected in single" 25 "REH: 7.3" NA NA 0.1 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.1 0.0 0.0 3.4 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 3222.2 4.4 1.6 2.1 1.9 14.7 5.6 0.4 1.7 4.2 5.1 1.3 0.8 2.3 5.9 384.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 TRDJ1 ENSG00000211825 "T cell receptor delta joining 1" A0A075B706 14 22450089-22450139 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.5;lymphoid tissue: 79.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 77 "gdT-cell: 13481.1;NK-cell: 5148.7" "Group enriched" "Detected in all" 101 "NK-cells: 5148.7;T-cells: 13481.1" "Cell line enriched" "Detected in some" 15 "NB-4: 522.3" NA NA 21.3 0.0 1.6 10.7 1.4 54.5 3.7 0.5 2.6 3.7 0.4 6.4 10.0 22.6 0.0 2.3 4.6 4.5 4.6 3.4 1.1 1.0 15.9 25.1 19.0 1.4 0.9 0.4 2.2 0.0 2.5 0.0 3.2 0.9 2.4 13.3 0.0 2.8 0.0 0.0 0.0 5.8 1.3 0.3 56.6 2.0 3.4 0.9 79.2 2.0 7.7 21.4 3.1 0.0 2.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 522.3 3.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 2.6 13.6 6.1 13481.1 20.3 9.7 15.9 27.1 86.2 20.6 4.7 30.5 120.9 92.1 5148.7 11.2 16.9 62.4 2899.6 1.6 1.4 0.5 2.6 3.4 1.1 1.4 0.9 0.4 0.9 0.3 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ4 ENSG00000211826 "T cell receptor delta joining 4" 14 22455249-22455296 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 5.9;lymphoid tissue: 13.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "ovarian cancer: 2.9" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Group enriched" "Detected in many" 45 "gdT-cell: 123.0;NK-cell: 281.9" "Group enriched" "Detected in many" 362 "NK-cells: 281.9;T-cells: 123.0" "Cell line enriched" "Detected in some" 16 "NB-4: 38.7" NA NA 1.0 0.0 0.1 0.0 0.3 0.9 1.7 0.6 2.3 0.0 2.1 1.4 5.9 2.4 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.0 0.0 1.2 1.1 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.1 0.3 13.3 1.3 0.1 0.8 4.5 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 123.0 0.0 0.3 0.2 1.9 0.6 0.3 0.0 1.5 4.5 0.0 281.9 0.5 0.0 3.0 13.1 0.1 0.3 0.6 2.3 0.5 0.4 0.3 0.3 0.2 0.6 0.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ2 ENSG00000211827 "T cell receptor delta joining 2" 14 22456689-22456742 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 89 "gdT-cell: 953.4;NK-cell: 2991.2" "Group enriched" "Detected in all" 279 "NK-cells: 2991.2;T-cells: 953.4" "Cell line enriched" "Detected in some" 17 "NB-4: 104.6" NA NA 3.0 0.0 0.3 3.7 0.2 4.8 0.8 0.1 0.9 0.0 0.0 3.3 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.8 0.6 1.2 0.0 7.7 6.4 0.7 0.2 0.3 1.7 0.0 0.0 0.0 1.8 0.4 0.0 2.9 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 26.5 1.5 0.8 0.6 37.4 0.0 0.0 2.9 0.5 0.0 1.7 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 6.3 0.4 0.0 953.4 2.0 3.3 0.8 22.0 14.7 3.9 1.7 17.6 14.4 7.0 2991.2 2.2 1.4 19.2 206.2 0.3 0.2 0.1 0.9 0.8 0.6 0.7 0.2 0.3 0.4 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDJ3 ENSG00000211828 "T cell receptor delta joining 3" 14 22459098-22459156 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "lymphoid tissue: 100.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 4 "gdT-cell: 2218.4" "Lineage enriched" "Detected in all" 4 "T-cells: 2218.4" "Cell line enriched" "Detected in some" 49 "NB-4: 148.4" NA NA 1.5 0.0 0.6 4.8 0.2 3.3 0.0 0.4 1.2 0.0 0.2 1.6 5.2 2.0 0.0 0.0 0.0 0.5 0.0 1.5 0.2 0.0 0.0 1.6 4.1 1.1 0.5 0.2 0.0 0.0 0.0 0.0 2.6 0.7 0.0 2.7 0.0 1.6 0.0 4.0 0.0 1.9 0.0 0.0 22.2 0.0 0.1 0.6 100.3 0.0 0.0 3.8 0.0 0.0 1.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 2218.4 1.1 1.1 1.0 4.4 15.1 5.5 0.3 8.2 8.0 6.7 525.7 0.8 2.8 12.9 120.0 0.6 0.2 0.4 1.2 1.5 0.2 1.1 0.5 0.2 0.7 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDC ENSG00000211829 "T cell receptor delta constant" 14 22462932-22465787 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 408.1" "Cell type enriched" "Detected in some" 4 "NK-cells: 746.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 19.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 87 "gdT-cell: 5873.4;NK-cell: 2243.9" "Group enriched" "Detected in all" 150 "NK-cells: 2243.9;T-cells: 5873.4" "Cell line enriched" "Detected in some" 38 "NB-4: 356.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-3)" "unprognostic (8.15e-3)" "unprognostic (7.03e-2)" "prognostic favorable (8.25e-4)" "unprognostic (2.53e-1)" "unprognostic (2.42e-3)" "unprognostic (2.19e-1)" "prognostic favorable (6.13e-4)" "unprognostic (2.76e-2)" "unprognostic (2.19e-2)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.67e-5)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (1.22e-2)" "unprognostic (1.99e-2)" 9.5 0.4 1.1 7.9 1.1 26.4 3.8 1.5 1.5 2.9 0.8 9.0 4.0 7.7 2.1 2.1 4.1 8.0 2.7 2.1 1.0 1.1 11.1 11.7 22.9 1.0 1.2 0.9 1.9 0.2 0.5 0.7 2.8 0.9 1.0 7.5 0.0 4.7 1.2 1.6 1.4 5.6 2.2 0.8 54.6 2.1 2.7 1.0 408.1 1.8 1.4 18.4 4.6 0.9 1.4 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 356.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 3.1 0.9 1.4 0.0 0.0 0.1 3.2 4.8 2.3 5873.4 7.9 3.8 5.7 16.7 31.7 9.2 1.9 16.2 46.6 27.0 2243.9 5.5 7.1 27.5 1292.0 1.1 1.1 1.5 1.5 2.1 1.0 1.0 1.2 0.9 0.9 0.8 1.0 1.4 1.1 3.2 5.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 165.7 0.3 0.0 0.5 0.0 0.9 0.8 0.7 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 4.2 0.5 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.9 0.0 0.0 5.7 0.0 746.6 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 123.5 0.0 0.0 0.0 TRAJ61 ENSG00000211831 "T cell receptor alpha joining 61 (non-functional)" 14 22475316-22475375 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 49 "brain: 3.0;lymphoid tissue: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 3.0" "Group enriched" "Detected in many" 8 "gdT-cell: 4.1;memory CD4 T-cell: 4.8;memory CD8 T-cell: 4.8;naive CD4 T-cell: 7.9;naive CD8 T-cell: 4.1;NK-cell: 4.3;T-reg: 7.6" "Group enriched" "Detected in many" 9 "NK-cells: 4.3;T-cells: 7.9" "Cell line enriched" "Detected in single" 23 "U-266/84: 2.3" NA NA 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 4.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.2 0.0 4.8 4.8 0.0 0.0 7.9 4.1 0.0 4.3 0.0 0.0 7.6 0.7 0.0 0.3 3.0 0.6 0.4 0.5 0.6 0.5 0.0 0.9 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ59 ENSG00000211832 "T cell receptor alpha joining 59 (non-functional)" 14 22476553-22476606 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.1;gallbladder: 1.6;lymphoid tissue: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.1" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.9;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Cell line enriched" "Detected in single" 13 "U-698: 1.3" NA NA 0.0 0.0 0.2 1.9 0.7 0.0 0.0 3.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.4 0.5 0.0 0.0 0.0 1.9 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.4 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.0 1.7 0.0 0.0 2.0 5.2 0.8 0.1 0.0 0.0 0.9 0.2 0.2 0.7 3.1 0.4 0.4 0.5 1.1 0.6 0.0 0.9 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ58 ENSG00000211833 "T cell receptor alpha joining 58 (non-functional)" 14 22477707-22477769 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.9;lymphoid tissue: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.9" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 58.2;memory CD8 T-cell: 40.9;naive CD4 T-cell: 63.7;naive CD8 T-cell: 20.7;T-reg: 57.3" "Lineage enriched" "Detected in many" 42 "T-cells: 63.7" "Group enriched" "Detected in some" 21 "Daudi: 2.4;U-266/84: 2.5;U-698: 1.3" NA NA 0.0 0.0 0.3 7.8 0.4 0.0 0.0 3.9 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.2 0.9 0.3 0.0 0.6 6.9 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 2.1 1.2 0.0 0.5 7.6 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 58.2 40.9 0.0 0.4 63.7 20.7 1.5 1.4 0.0 0.3 57.3 16.8 0.3 0.4 3.9 0.4 0.2 0.9 0.7 0.5 0.1 1.1 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ57 ENSG00000211834 "T cell receptor alpha joining 57" 14 22478872-22478934 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.3;intestine: 5.5;lymphoid tissue: 10.6;salivary gland: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.3" "Group enriched" "Detected in many" 26 "memory CD4 T-cell: 80.9;memory CD8 T-cell: 74.8;naive CD4 T-cell: 92.2;naive CD8 T-cell: 44.9;T-reg: 155.8" "Lineage enriched" "Detected in many" 46 "T-cells: 155.8" "Group enriched" "Detected in some" 46 "HAP1: 3.1;U-266/84: 2.4;U-698: 8.2" NA NA 0.0 0.0 0.3 10.6 0.4 1.1 0.0 3.3 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.0 0.0 1.5 3.6 0.8 0.8 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.7 0.6 7.5 0.0 0.0 0.0 5.5 0.0 0.3 4.0 1.1 0.0 0.5 3.4 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 8.2 0.0 0.0 0.0 0.4 0.1 0.0 1.4 0.2 0.3 3.4 80.9 74.8 0.0 0.0 92.2 44.9 1.7 0.3 0.1 0.0 155.8 23.3 0.3 0.4 3.3 0.8 0.3 0.2 0.8 0.8 0.2 1.0 0.3 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ56 ENSG00000211835 "T cell receptor alpha joining 56" 14 22479521-22479582 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.7;intestine: 3.3;lymphoid tissue: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.7" "Group enriched" "Detected in many" 40 "memory CD4 T-cell: 49.8;memory CD8 T-cell: 52.1;naive CD4 T-cell: 47.3;naive CD8 T-cell: 20.4;T-reg: 49.2" "Lineage enriched" "Detected in single" 59 "T-cells: 52.1" "Cell line enhanced" "Detected in some" "NB-4: 3.1;U-266/84: 2.5" NA NA 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.7 1.3 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.5 5.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.4 0.0 0.0 0.0 0.7 3.3 0.0 0.6 4.0 1.2 0.4 1.0 1.1 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.1 1.0 0.0 49.8 52.1 0.0 0.0 47.3 20.4 0.0 0.1 0.2 0.0 49.2 13.5 0.4 0.3 3.7 1.3 0.5 0.6 0.8 0.4 0.2 1.0 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ54 ENSG00000211836 "T cell receptor alpha joining 54" 14 22482287-22482346 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.9;brain: 2.7;intestine: 4.2;lymphoid tissue: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 162.6;memory CD8 T-cell: 115.0;naive CD4 T-cell: 186.3;naive CD8 T-cell: 82.2;T-reg: 172.9" "Lineage enriched" "Detected in many" 7 "T-cells: 186.3" "Cell line enhanced" "Detected in some" "NB-4: 3.0;U-266/84: 13.2;U-698: 4.7" NA NA 0.0 0.0 0.1 2.3 0.4 2.9 0.0 2.7 1.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.4 8.8 0.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.1 1.8 0.0 0.0 0.0 4.2 0.0 0.4 3.6 0.0 0.0 0.5 1.8 0.0 0.0 1.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 4.7 0.0 0.0 0.0 0.3 0.3 0.0 28.1 0.0 1.5 1.6 162.6 115.0 0.1 0.1 186.3 82.2 5.0 26.8 0.5 0.1 172.9 42.4 0.1 0.4 2.7 1.1 0.1 0.5 0.7 0.4 0.4 0.8 0.4 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRAJ53 ENSG00000211837 "T cell receptor alpha joining 53" 14 22483004-22483069 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 17 "memory CD4 T-cell: 78.9;memory CD8 T-cell: 38.5;naive CD4 T-cell: 94.2;naive CD8 T-cell: 38.9;T-reg: 146.9" "Lineage enriched" "Detected in many" 48 "T-cells: 146.9" "Group enriched" "Detected in some" 5 "Karpas-707: 4.6;U-698: 7.1" NA NA 0.5 0.0 0.3 2.7 0.4 2.3 0.0 1.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.6 0.8 0.3 0.0 0.0 11.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.3 5.4 2.7 0.0 0.5 0.7 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 7.1 0.0 0.0 0.0 0.2 0.3 0.0 4.7 0.0 0.3 3.0 78.9 38.5 0.8 1.9 94.2 38.9 0.8 1.6 0.4 0.0 146.9 18.3 0.3 0.4 1.0 0.4 0.6 0.8 0.4 0.4 0.0 0.8 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ52 ENSG00000211838 "T cell receptor alpha joining 52" 14 22486228-22486296 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.1;stomach 1: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 128.1;T-reg: 167.0" "Lineage enriched" "Detected in many" 157 "T-cells: 167.0" "Cell line enriched" "Detected in single" 14 "U-698: 1.4" NA NA 0.0 0.0 0.4 9.1 0.3 2.4 0.0 1.7 1.0 0.0 0.3 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 0.0 1.3 1.6 4.3 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 5.0 0.1 0.9 3.6 0.0 0.0 4.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.3 27.5 0.1 3.0 0.6 95.4 59.7 0.0 0.2 128.1 63.8 0.5 1.0 0.2 0.4 167.0 33.5 0.4 0.3 1.7 1.0 0.2 0.5 0.4 0.8 0.2 0.6 0.3 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ50 ENSG00000211839 "T cell receptor alpha joining 50" 14 22488593-22488652 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.7;lymphoid tissue: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 72.4" "Lineage enriched" "Detected in many" 22 "T-cells: 72.4" "Group enriched" "Detected in some" 12 "U-266/84: 1.1;U-698: 1.2" NA NA 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 3.3 0.0 0.0 2.7 0.0 0.4 0.0 32.6 12.3 0.0 0.1 31.2 24.3 1.0 0.1 0.0 0.0 72.4 12.9 0.1 0.9 1.7 0.7 0.3 0.3 0.7 0.7 0.1 0.6 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ49 ENSG00000211840 "T cell receptor alpha joining 49" 14 22489488-22489543 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 38 "retina: 410.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "gdT-cell: 257.1;memory CD4 T-cell: 196.1;memory CD8 T-cell: 121.1;naive CD4 T-cell: 200.3;naive CD8 T-cell: 146.4;NK-cell: 104.2;T-reg: 361.0" "Group enriched" "Detected in all" 10 "NK-cells: 104.2;T-cells: 361.0" "Cell line enhanced" "Detected in some" "RH-30: 3.2;SH-SY5Y: 5.0;U-266/84: 15.4;U-698: 3.7" NA NA 0.0 0.0 0.4 10.6 0.8 2.8 0.0 1.4 1.3 0.0 1.2 4.5 4.7 0.0 0.0 0.0 0.0 0.0 5.0 0.4 1.6 0.0 0.8 0.8 3.6 2.2 3.8 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.9 410.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 8.2 7.7 0.4 1.0 3.8 0.0 0.0 3.0 0.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 3.7 0.0 0.0 0.0 0.7 2.5 0.2 257.1 0.2 1.1 23.2 196.1 121.1 0.3 2.0 200.3 146.4 3.3 104.2 1.8 1.8 361.0 73.9 0.4 0.8 1.4 1.3 0.4 1.6 2.2 3.8 0.4 1.9 0.2 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ48 ENSG00000211841 "T cell receptor alpha joining 48" 14 22490491-22490553 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.8;retina: 28.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 37.7;memory CD4 T-cell: 80.7;memory CD8 T-cell: 71.3;naive CD4 T-cell: 100.1;naive CD8 T-cell: 78.2;T-reg: 149.4" "Group enriched" "Detected in many" 14 "B-cells: 37.7;T-cells: 149.4" "Group enriched" "Detected in some" 9 "HDLM-2: 22.6;U-266/84: 18.4;U-698: 16.2" NA NA 0.0 0.0 0.5 7.8 0.6 3.4 0.0 2.6 0.8 1.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.6 0.0 0.0 0.0 6.7 2.4 1.5 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.6 28.1 0.0 0.0 0.0 0.0 4.7 0.0 0.3 2.2 2.3 0.2 1.4 3.4 0.0 0.0 6.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 16.2 0.0 2.0 0.0 0.2 1.6 0.2 10.8 0.1 0.6 37.7 80.7 71.3 0.0 19.6 100.1 78.2 2.5 6.5 0.4 0.2 149.4 27.4 0.5 0.6 2.6 0.8 1.1 1.6 2.4 1.5 0.8 1.2 0.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ47 ENSG00000211842 "T cell receptor alpha joining 47" 14 22492851-22492907 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.3;retina: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "gdT-cell: 40.2;memory CD4 T-cell: 106.3;memory CD8 T-cell: 87.1;naive CD4 T-cell: 76.4;naive CD8 T-cell: 50.5;T-reg: 133.1" "Lineage enriched" "Detected in many" 21 "T-cells: 133.1" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;U-266/84: 37.9;U-698: 12.8" NA NA 1.3 0.0 0.7 6.3 0.5 2.7 0.0 2.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 1.6 0.0 0.0 2.3 4.0 1.0 1.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.9 13.7 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.7 1.0 0.0 1.1 3.7 0.0 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 12.8 0.0 0.0 0.0 0.5 0.6 0.0 40.2 0.5 3.2 6.1 106.3 87.1 0.1 0.1 76.4 50.5 2.9 1.2 0.0 0.7 133.1 37.0 0.7 0.5 2.0 0.8 0.5 1.6 1.0 1.0 0.0 1.0 0.6 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ46 ENSG00000211843 "T cell receptor alpha joining 46" 14 22493403-22493465 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "gdT-cell: 86.3" "Lineage enriched" "Detected in many" 9 "T-cells: 86.3" "Group enriched" "Detected in some" 59 "U-266/84: 8.5;U-698: 3.3" NA NA 0.9 0.0 0.7 0.0 1.2 0.0 0.0 2.4 0.7 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 1.7 1.2 1.6 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.8 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.0 0.9 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 3.3 0.0 0.0 0.0 0.4 0.0 0.1 86.3 0.0 0.3 1.2 24.3 10.9 0.0 9.4 22.6 13.6 0.9 2.2 0.2 0.0 18.9 9.5 0.7 1.2 2.4 0.7 0.4 0.8 1.2 1.6 0.1 1.4 0.4 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ45 ENSG00000211844 "T cell receptor alpha joining 45" 14 22493925-22493990 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.7;retina: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 318.6;memory CD4 T-cell: 130.7;memory CD8 T-cell: 151.2;naive CD4 T-cell: 134.8;naive CD8 T-cell: 138.6;T-reg: 206.9" "Lineage enriched" "Detected in many" 7 "T-cells: 318.6" "Cell line enriched" "Detected in some" 7 "HDLM-2: 479.4" NA NA 0.0 0.0 1.4 8.2 0.9 0.8 0.0 2.3 0.6 0.0 1.1 0.2 4.4 0.5 0.0 0.0 2.0 0.5 0.0 0.4 0.5 0.0 0.7 0.6 13.7 2.3 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.3 21.6 2.0 0.0 0.0 0.0 0.0 0.0 0.8 11.3 5.6 0.0 1.1 3.5 0.4 0.0 4.0 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 479.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.5 5.4 0.0 3.1 0.0 1.2 0.2 0.1 318.6 0.8 2.7 2.1 130.7 151.2 0.2 0.8 134.8 138.6 3.6 44.0 0.4 1.3 206.9 66.0 1.4 0.9 2.3 0.6 0.4 0.5 2.3 1.2 0.2 1.5 0.8 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ44 ENSG00000211845 "T cell receptor alpha joining 44" 14 22494821-22494883 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "lymphoid tissue: 26.4;retina: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "gdT-cell: 215.7;memory CD4 T-cell: 214.5;memory CD8 T-cell: 64.3;naive CD4 T-cell: 161.2;naive CD8 T-cell: 80.8;T-reg: 192.8" "Lineage enriched" "Detected in many" 25 "T-cells: 215.7" "Group enriched" "Detected in some" 8 "HDLM-2: 77.1;U-266/84: 35.5" NA NA 0.9 0.0 0.8 26.4 0.6 1.7 0.7 1.7 1.0 0.0 0.3 1.1 0.0 0.0 0.0 0.6 0.0 0.5 2.7 0.6 0.8 0.3 0.0 1.9 16.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 20.8 0.0 0.0 3.8 0.0 2.1 0.0 0.3 5.6 2.2 0.1 0.7 2.6 0.0 0.0 8.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 7.5 0.0 0.0 0.0 0.3 1.1 0.3 215.7 0.3 3.9 0.8 214.5 64.3 0.7 1.0 161.2 80.8 2.0 8.6 0.5 0.6 192.8 49.0 0.8 0.6 1.7 1.0 0.6 0.8 1.0 1.1 0.1 0.8 0.3 0.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ43 ENSG00000211846 "T cell receptor alpha joining 43" 14 22495913-22495966 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.7;retina: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 162.3;memory CD4 T-cell: 178.6;memory CD8 T-cell: 245.5;naive CD4 T-cell: 195.9;naive CD8 T-cell: 234.5;T-reg: 263.9" "Lineage enriched" "Detected in all" 30 "T-cells: 263.9" "Not detected" "Not detected" NA NA 1.1 0.0 1.0 5.7 0.6 2.8 0.0 1.9 1.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 0.0 0.3 3.0 2.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 13.9 0.0 0.0 0.0 0.0 1.7 0.0 2.0 2.4 0.0 0.0 1.3 3.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 1.0 0.6 162.3 0.3 22.4 2.0 178.6 245.5 0.7 1.6 195.9 234.5 8.8 2.1 0.7 1.5 263.9 73.8 1.0 0.6 1.9 1.3 0.7 0.6 2.1 0.9 0.2 1.2 2.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ42 ENSG00000211847 "T cell receptor alpha joining 42" A0A075B6Y9 14 22496887-22496952 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 13.0;retina: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 151.8;memory CD8 T-cell: 100.2;naive CD4 T-cell: 129.7;naive CD8 T-cell: 91.1;T-reg: 203.6" "Lineage enriched" "Detected in many" 73 "T-cells: 203.6" "Cell line enriched" "Detected in some" 7 "HDLM-2: 101.1" NA NA 0.0 0.0 0.8 13.0 0.9 4.0 0.5 1.3 2.1 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.0 1.2 11.3 3.5 0.8 0.4 0.0 0.0 0.0 0.0 0.4 1.1 1.1 1.5 23.0 0.0 0.0 0.0 3.0 1.8 0.0 1.0 3.7 2.2 0.1 1.4 4.4 0.6 0.0 5.2 0.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 101.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 13.7 3.2 0.0 0.0 0.0 1.1 0.3 0.6 31.9 0.0 4.3 2.4 151.8 100.2 0.0 0.3 129.7 91.1 2.7 1.8 1.5 0.5 203.6 39.5 0.8 0.9 1.3 2.1 0.7 1.4 3.5 0.8 0.4 1.1 1.0 1.4 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ41 ENSG00000211848 "T cell receptor alpha joining 41" 14 22497657-22497718 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.2;retina: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 95.0;memory CD8 T-cell: 77.7;naive CD4 T-cell: 96.3;naive CD8 T-cell: 304.6;T-reg: 90.4" "Lineage enriched" "Detected in many" 139 "T-cells: 304.6" "Cell line enriched" "Detected in single" 32 "NB-4: 3.1" NA NA 0.0 0.0 1.2 2.4 0.5 1.0 0.0 1.0 1.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.4 0.0 0.0 2.3 2.0 0.7 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.6 11.7 0.0 0.0 0.0 0.7 2.5 0.0 0.3 1.1 1.1 0.0 0.6 3.2 0.0 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 24.0 0.4 5.1 0.1 95.0 77.7 0.0 0.6 96.3 304.6 2.1 1.6 1.4 0.4 90.4 96.7 1.2 0.5 1.0 1.0 0.3 0.4 0.7 1.3 0.2 1.9 0.3 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ40 ENSG00000211849 "T cell receptor alpha joining 40" 14 22499689-22499749 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 5.3;retina: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 131.7;memory CD8 T-cell: 93.0;naive CD4 T-cell: 137.3;naive CD8 T-cell: 86.2;T-reg: 244.3" "Lineage enriched" "Detected in many" 25 "T-cells: 244.3" "Not detected" "Not detected" NA NA 0.9 0.0 1.6 2.4 0.9 1.0 0.0 2.6 1.7 0.0 0.8 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.0 0.0 1.2 2.3 1.7 1.2 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.7 1.2 0.0 1.5 5.3 0.0 0.0 3.9 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.5 23.0 0.1 11.2 1.1 131.7 93.0 0.1 0.2 137.3 86.2 9.8 0.6 0.7 0.0 244.3 38.9 1.6 0.9 2.6 1.7 1.1 1.7 1.7 1.2 0.1 1.6 1.3 1.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ39 ENSG00000211850 "T cell receptor alpha joining 39" 14 22501601-22501663 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;lymphoid tissue: 18.9;retina: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 204.6;T-reg: 158.0" "Lineage enriched" "Detected in many" 58 "T-cells: 204.6" "Cell line enriched" "Detected in some" 4 "U-266/84: 18.2" NA NA "unprognostic (1.88e-2)" 7.3 3.9 0.9 13.9 5.1 0.0 3.0 2.8 2.2 0.0 1.0 2.7 11.0 0.0 22.9 0.0 0.0 0.0 15.3 0.7 1.1 1.7 0.0 0.3 18.9 2.6 2.4 0.3 0.0 0.0 0.0 0.0 0.0 2.0 1.1 1.7 26.7 0.0 0.0 9.9 2.9 4.2 0.0 2.0 7.0 5.9 0.0 2.2 7.1 0.0 0.0 8.1 1.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 34.4 0.2 19.0 0.3 204.6 78.0 1.5 0.3 126.9 80.2 3.5 0.5 0.5 0.0 158.0 51.1 0.9 5.1 2.8 2.2 0.7 1.1 2.6 2.4 0.3 2.0 2.0 2.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRAJ38 ENSG00000211851 "T cell receptor alpha joining 38" 14 22502231-22502292 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 11.6;lymphoid tissue: 9.8;retina: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 124.3" "Lineage enriched" "Detected in many" 25 "T-cells: 124.3" "Group enriched" "Detected in some" 68 "HDLM-2: 9.0;JURKAT: 6.5;U-266/84: 4.8" NA NA 0.0 1.9 1.0 5.5 4.5 0.9 2.2 2.6 0.9 0.0 1.7 0.8 0.0 0.0 11.6 0.0 0.7 0.0 1.1 1.4 1.3 0.9 0.0 2.8 5.7 2.2 2.1 0.3 0.0 0.0 0.0 0.0 0.0 2.0 2.5 0.0 22.9 0.0 0.0 0.0 0.7 1.6 0.0 2.1 7.2 1.2 0.0 1.6 5.8 0.0 0.0 9.8 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 56.5 0.6 22.0 0.0 88.2 74.8 1.0 0.1 124.3 59.9 5.0 0.2 0.2 0.4 115.7 19.1 1.0 4.5 2.6 0.9 1.4 1.3 2.2 2.1 0.3 2.0 2.1 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ35 ENSG00000211854 "T cell receptor alpha joining 35 (non-functional)" 14 22506644-22506702 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 6.8;retina: 14.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 17 "gdT-cell: 39.7;MAIT T-cell: 28.6;memory CD4 T-cell: 56.7;memory CD8 T-cell: 41.6;naive CD4 T-cell: 71.1;naive CD8 T-cell: 47.3;T-reg: 73.5" "Lineage enriched" "Detected in many" 24 "T-cells: 73.5" "Group enriched" "Detected in some" 7 "AF22: 9.5;U-266/84: 35.6" NA NA "unprognostic (1.05e-1)" 0.0 0.0 0.5 0.0 0.6 0.0 0.0 1.4 0.7 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 1.2 2.4 0.0 0.4 3.3 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 14.3 1.6 0.0 0.0 0.0 0.0 1.3 0.6 0.0 1.3 0.0 0.7 6.8 0.0 0.0 3.1 0.1 0.0 2.2 1.9 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 3.1 0.0 0.0 0.0 0.3 0.4 0.1 39.7 0.0 28.6 0.4 56.7 41.6 0.4 0.3 71.1 47.3 3.0 0.0 0.6 0.1 73.5 19.7 0.5 0.6 1.4 0.7 0.5 1.2 1.0 0.7 0.0 0.7 0.6 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ34 ENSG00000211855 "T cell receptor alpha joining 34" 14 22507666-22507723 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 4.9;lymphoid tissue: 8.2;retina: 17.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 134.5;memory CD8 T-cell: 94.4;naive CD4 T-cell: 118.9;naive CD8 T-cell: 93.3;T-reg: 203.0" "Lineage enriched" "Detected in many" 181 "T-cells: 203.0" "Group enriched" "Detected in some" 41 "HDLM-2: 4.0;NTERA-2: 3.0;THP-1: 3.7;U-266/84: 5.3" NA NA "unprognostic (3.40e-1)" 0.7 0.0 2.2 0.0 2.3 2.8 0.0 1.6 1.6 0.0 4.5 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 1.2 8.2 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 3.6 17.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.0 0.0 1.4 5.2 0.0 0.0 5.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.3 1.1 0.7 7.4 0.2 26.1 0.8 134.5 94.4 0.6 0.1 118.9 93.3 0.6 0.8 0.3 0.0 203.0 35.6 2.2 2.3 1.6 1.6 1.0 1.8 1.7 0.9 0.0 1.6 1.1 1.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ33 ENSG00000211856 "T cell receptor alpha joining 33" 14 22508602-22508658 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 8.8;lymphoid tissue: 15.6;retina: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "MAIT T-cell: 2136.5" "Lineage enriched" "Detected in all" 464 "T-cells: 2136.5" "Group enriched" "Detected in some" 8 "MOLT-4: 64.5;U-698: 52.8" NA NA 0.0 0.0 1.2 15.6 2.9 3.2 0.8 1.8 0.9 0.0 2.1 0.9 8.8 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.7 1.5 0.3 1.3 4.2 1.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 19.0 0.0 0.0 0.0 0.8 6.5 0.0 1.0 3.1 0.0 0.6 1.8 6.4 0.0 0.0 10.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 52.8 0.0 0.0 0.0 3.0 1.5 1.0 14.7 0.5 2136.5 4.6 104.9 398.8 0.3 1.3 131.6 120.2 2.5 3.4 1.1 1.2 158.4 50.3 1.2 2.9 1.8 0.9 0.3 0.7 1.4 1.6 0.0 1.1 1.0 1.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ32 ENSG00000211857 "T cell receptor alpha joining 32" 14 22509341-22509406 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 15.7;retina: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "MAIT T-cell: 353.6;memory CD4 T-cell: 152.5;memory CD8 T-cell: 130.4;naive CD4 T-cell: 177.0;naive CD8 T-cell: 133.0;T-reg: 187.8" "Lineage enriched" "Detected in many" 67 "T-cells: 353.6" "Cell line enhanced" "Detected in some" "AF22: 104.2;HDLM-2: 17.5;U-266/84: 44.5;U-698: 61.7" NA NA 0.0 2.4 1.1 7.5 2.1 1.6 0.0 2.1 2.4 0.0 1.4 0.4 5.1 0.5 0.0 0.5 0.6 1.7 0.0 0.3 2.4 1.2 0.0 2.8 15.7 2.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 12.8 0.0 0.0 0.0 0.0 2.5 0.0 1.3 3.0 4.9 0.0 1.0 7.6 0.0 0.0 11.5 0.0 0.0 1.5 0.0 0.0 104.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 61.7 0.0 0.0 0.0 0.7 0.5 0.2 35.0 0.1 353.6 5.3 152.5 130.4 0.1 0.4 177.0 133.0 5.1 1.0 0.8 0.4 187.8 35.9 1.1 2.1 2.1 2.4 0.3 2.4 2.3 2.1 0.0 1.5 1.3 1.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ31 ENSG00000211858 "T cell receptor alpha joining 31" A0A075B700 14 22510968-22511024 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.3;lymphoid tissue: 15.8;retina: 17.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "stomach cancer: 2.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 147.2;memory CD8 T-cell: 73.7;naive CD4 T-cell: 121.4;naive CD8 T-cell: 84.3;T-reg: 170.1" "Lineage enriched" "Detected in many" 103 "T-cells: 170.1" "Group enriched" "Detected in some" 11 "JURKAT: 1.1;U-266/84: 1.0" NA NA "unprognostic (6.41e-2)" 0.0 0.0 0.7 6.3 2.5 1.8 2.2 3.4 7.3 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 1.1 15.8 2.0 1.5 0.0 0.0 0.0 0.0 0.0 0.6 1.7 1.2 3.7 17.5 0.0 0.0 0.0 0.0 1.8 1.4 1.2 4.8 0.0 0.0 1.3 7.2 0.0 0.0 7.8 1.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.6 24.7 0.0 147.2 73.7 0.9 0.0 121.4 84.3 1.6 0.4 0.6 0.0 170.1 35.6 0.7 2.5 3.4 7.3 0.4 1.7 2.0 1.5 0.0 1.7 1.2 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ30 ENSG00000211859 "T cell receptor alpha joining 30" 14 22512852-22512908 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.6;retina: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "memory CD4 T-cell: 79.6;memory CD8 T-cell: 129.8;naive CD4 T-cell: 121.6;naive CD8 T-cell: 114.9;T-reg: 136.0" "Lineage enriched" "Detected in many" 73 "T-cells: 136.0" "Cell line enriched" "Detected in single" 12 "U-698: 1.2" NA NA 0.0 0.0 1.1 8.6 1.6 2.1 0.0 3.0 1.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.2 0.0 0.0 6.9 1.7 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.0 11.2 0.0 0.0 0.0 0.8 2.1 0.0 0.9 2.5 0.0 3.4 1.6 4.9 0.0 0.0 0.6 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.8 16.5 0.7 79.6 129.8 0.1 0.1 121.6 114.9 1.8 0.2 0.0 0.2 136.0 31.6 1.1 1.6 3.0 1.1 0.5 0.9 1.7 0.9 0.2 1.5 0.9 1.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ29 ENSG00000211860 "T cell receptor alpha joining 29" 14 22513939-22513998 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.9;retina: 11.7;stomach 1: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 106.7;memory CD8 T-cell: 130.3;naive CD4 T-cell: 99.3;naive CD8 T-cell: 78.7;T-reg: 187.1" "Lineage enriched" "Detected in many" 61 "T-cells: 187.1" "Cell line enriched" "Detected in single" 23 "U-266/84: 2.3" NA NA 0.0 0.0 1.0 2.5 2.6 1.2 0.0 3.5 1.4 0.0 0.9 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 1.9 1.8 1.6 1.3 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 3.8 3.4 1.3 3.9 0.7 0.0 3.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.9 0.0 19.0 2.4 106.7 130.3 0.2 0.1 99.3 78.7 3.0 0.2 0.0 0.7 187.1 38.9 1.0 2.6 3.5 1.4 0.7 0.9 1.6 1.3 0.4 1.4 0.7 1.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ28 ENSG00000211861 "T cell receptor alpha joining 28" 14 22515623-22515688 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.1;retina: 14.8;stomach 1: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 138.5" "Lineage enriched" "Detected in many" 20 "T-cells: 138.5" "Cell line enriched" "Detected in single" 35 "U-266/84: 3.5" NA NA 0.0 0.0 0.3 10.3 1.3 3.4 0.5 1.2 1.0 0.0 1.9 0.4 4.4 0.0 0.0 0.0 0.0 1.2 0.0 0.8 1.1 0.0 0.0 1.8 11.1 2.3 0.9 0.3 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 14.8 2.1 0.0 0.0 0.0 1.6 0.0 0.9 2.8 6.5 0.0 1.2 2.7 0.0 0.0 2.6 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.3 0.0 7.4 0.1 28.5 0.0 84.7 72.8 0.0 0.1 76.0 80.2 0.5 6.9 0.2 0.7 138.5 32.4 0.3 1.3 1.2 1.0 0.8 1.1 2.3 0.9 0.3 1.6 0.9 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ27 ENSG00000211862 "T cell receptor alpha joining 27" 14 22516273-22516331 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.3;retina: 14.9;testis: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "MAIT T-cell: 213.3;memory CD4 T-cell: 141.9;memory CD8 T-cell: 105.6;naive CD4 T-cell: 107.7;naive CD8 T-cell: 87.8;T-reg: 157.3" "Lineage enriched" "Detected in many" 50 "T-cells: 213.3" "Cell line enhanced" "Detected in some" "NB-4: 3.0;REH: 14.4;U-266/84: 5.8;U-698: 5.5" NA NA 0.0 0.0 0.8 12.3 2.6 3.3 0.0 4.6 2.1 3.2 1.7 0.9 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.8 1.1 1.0 0.0 1.9 11.7 2.6 1.3 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.7 1.8 14.9 0.0 0.9 6.2 0.0 8.5 2.6 2.4 1.8 3.2 17.4 1.1 5.8 0.0 0.0 6.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 0.0 0.0 0.0 0.0 0.6 0.7 14.1 0.1 213.3 0.3 141.9 105.6 0.0 0.2 107.7 87.8 3.2 4.2 1.1 0.9 157.3 35.4 0.8 2.6 4.6 2.1 0.8 1.1 2.6 1.3 0.2 2.6 2.4 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ26 ENSG00000211863 "T cell receptor alpha joining 26" 14 22518446-22518505 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.9;cervix: 4.4;lymphoid tissue: 3.7;retina: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 80.4;memory CD8 T-cell: 77.1;naive CD4 T-cell: 88.1;naive CD8 T-cell: 94.8;T-reg: 151.7" "Lineage enriched" "Detected in many" 90 "T-cells: 151.7" "Cell line enriched" "Detected in single" 44 "HDLM-2: 4.3" NA NA 0.0 0.0 0.6 2.5 3.2 0.0 0.0 2.2 1.2 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 1.3 1.1 0.0 1.3 3.7 2.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.8 10.8 0.0 0.0 0.0 0.0 1.8 0.0 2.5 1.8 1.1 0.2 1.7 3.2 0.0 0.0 3.0 0.7 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 3.0 0.1 22.7 0.0 80.4 77.1 0.0 0.4 88.1 94.8 0.6 0.3 0.2 0.1 151.7 21.1 0.6 3.2 2.2 1.2 0.7 1.3 2.2 2.2 0.1 2.0 2.5 1.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ25 ENSG00000211864 "T cell receptor alpha joining 25 (non-functional)" 14 22518812-22518871 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.2;retina: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "MAIT T-cell: 4.6;memory CD4 T-cell: 5.0;memory CD8 T-cell: 5.5;naive CD4 T-cell: 6.1;naive CD8 T-cell: 2.0;T-reg: 7.6" "Lineage enriched" "Detected in single" 16 "T-cells: 7.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.6 0.0 1.7 1.0 0.0 0.8 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.8 0.3 0.0 0.3 0.4 0.7 0.8 0.0 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 1.2 4.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 4.6 0.0 5.0 5.5 0.0 0.0 6.1 2.0 0.0 0.0 0.0 0.0 7.6 1.4 0.6 1.7 0.8 0.7 0.3 0.8 0.7 0.8 0.0 1.0 0.8 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ24 ENSG00000211865 "T cell receptor alpha joining 24" 14 22519969-22520031 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.0;lymphoid tissue: 5.3;retina: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 139 "MAIT T-cell: 28.5;memory CD4 T-cell: 51.9;memory CD8 T-cell: 64.8;naive CD4 T-cell: 49.3;naive CD8 T-cell: 60.4;T-reg: 95.6" "Lineage enriched" "Detected in single" 288 "T-cells: 95.6" "Cell line enhanced" "Detected in some" "Daudi: 2.4;MOLT-4: 8.1;U-698: 1.6" NA NA 0.0 0.0 1.0 2.5 2.8 1.1 2.1 1.0 9.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 4.9 0.0 1.3 0.5 5.3 2.1 1.3 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.8 8.5 0.0 0.0 0.0 0.0 0.0 1.3 1.3 1.7 0.0 0.5 1.3 4.7 0.0 0.0 0.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.0 28.5 0.1 51.9 64.8 0.1 0.2 49.3 60.4 0.1 0.0 0.1 0.3 95.6 15.9 1.0 2.8 1.0 9.0 0.9 4.9 2.1 1.3 0.2 4.5 1.3 1.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ23 ENSG00000211866 "T cell receptor alpha joining 23" 14 22520416-22520478 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.8;retina: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 181.7" "Lineage enriched" "Detected in many" 65 "T-cells: 181.7" "Group enriched" "Detected in some" 4 "NB-4: 7.0;U-266/84: 3.6" NA NA "unprognostic (2.03e-1)" 0.0 1.9 1.2 7.8 3.2 0.0 0.6 1.7 1.9 0.0 1.2 1.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.3 0.0 0.0 5.1 2.8 1.3 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.8 13.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 5.5 0.0 0.4 2.3 6.9 0.0 0.0 3.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.0 0.0 2.8 0.3 0.0 4.2 0.4 32.6 0.1 105.8 96.9 0.0 0.3 110.9 98.5 1.9 0.5 0.1 0.1 181.7 35.0 1.2 3.2 1.7 1.9 0.8 2.3 2.8 1.3 0.4 2.3 1.2 2.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ22 ENSG00000211867 "T cell receptor alpha joining 22" 14 22522040-22522102 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 5.0;epididymis: 3.8;lymphoid tissue: 11.1;retina: 13.0;stomach 1: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 149.8;T-reg: 192.2" "Lineage enriched" "Detected in many" 87 "T-cells: 192.2" "Group enriched" "Detected in some" 35 "MOLT-4: 4.3;U-698: 2.6" NA NA 0.0 0.0 3.4 11.1 5.0 0.0 0.0 2.2 2.2 0.0 1.2 0.2 0.0 0.0 3.8 0.6 0.0 0.0 0.0 1.0 2.5 0.3 0.0 0.9 10.6 2.7 1.7 1.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.8 13.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 7.0 0.0 2.5 5.9 0.2 0.0 2.9 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.4 0.3 4.0 0.0 32.7 0.0 149.8 43.9 0.6 0.6 139.6 89.4 2.1 1.0 0.5 0.4 192.2 39.2 3.4 5.0 2.2 2.2 1.0 2.5 2.7 1.7 1.1 2.9 1.7 2.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ21 ENSG00000211868 "T cell receptor alpha joining 21" 14 22523600-22523654 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.0;intestine: 7.0;lymphoid tissue: 10.8;retina: 12.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 108.7" "Lineage enriched" "Detected in many" 71 "T-cells: 108.7" "Group enriched" "Detected in some" 23 "U-266/84: 2.2;U-698: 2.3" NA NA 1.4 0.0 3.2 0.0 5.1 1.9 0.0 2.0 1.0 0.0 8.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.2 2.2 0.3 7.7 2.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 12.2 0.0 0.0 0.0 0.0 7.0 1.4 1.6 10.8 0.9 0.0 0.8 3.9 0.0 0.0 1.5 1.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 24.8 0.2 65.7 49.4 0.0 0.2 67.7 41.8 1.5 0.7 0.0 0.0 108.7 15.0 3.2 5.1 2.0 1.0 0.7 0.4 2.3 1.8 0.2 1.5 1.6 0.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ20 ENSG00000211869 "T cell receptor alpha joining 20" 14 22524325-22524381 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 8.3;lymphoid tissue: 17.1;retina: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 25 "MAIT T-cell: 190.9;memory CD4 T-cell: 124.6;memory CD8 T-cell: 193.7;naive CD4 T-cell: 138.5;naive CD8 T-cell: 140.1;T-reg: 225.0" "Lineage enriched" "Detected in single" 280 "T-cells: 225.0" "Not detected" "Not detected" NA NA 0.0 0.0 2.4 17.1 3.7 0.0 0.0 1.9 1.8 0.0 1.5 1.0 0.0 0.0 8.3 0.0 0.0 1.4 0.0 0.8 1.1 0.0 0.9 0.0 6.1 2.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.0 11.4 0.0 0.0 0.0 0.9 4.3 0.0 0.7 5.5 2.1 0.0 1.6 6.3 0.0 0.0 3.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 6.7 0.5 190.9 0.5 124.6 193.7 0.3 0.3 138.5 140.1 0.8 0.3 0.5 0.3 225.0 50.8 2.4 3.7 1.9 1.8 0.8 1.1 2.0 0.6 0.6 2.1 0.7 1.6 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ19 ENSG00000211870 "T cell receptor alpha joining 19 (non-functional)" 14 22525263-22525322 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.5;retina: 20.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.7;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 22 "U-266/84: 2.3;U-698: 2.0" NA NA "unprognostic (2.39e-2)" 0.0 2.2 4.7 2.4 3.4 2.0 1.3 2.8 1.7 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.3 0.0 1.0 7.5 1.7 0.9 1.0 0.0 0.0 0.0 0.0 1.0 2.3 0.4 0.8 20.9 0.0 0.0 0.0 3.4 0.0 1.3 0.8 1.9 3.3 0.6 1.3 7.1 0.4 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 1.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 4.7 3.4 2.8 1.7 0.7 1.2 1.7 0.9 1.0 2.3 0.8 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ18 ENSG00000211871 "T cell receptor alpha joining 18" 14 22525650-22525715 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 28.2;retina: 16.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 66.1;memory CD8 T-cell: 37.7;naive CD4 T-cell: 96.4;naive CD8 T-cell: 82.7;T-reg: 105.0" "Lineage enriched" "Detected in many" 6 "T-cells: 105.0" "Group enriched" "Detected in some" 5 "HDLM-2: 13.1;U-266/84: 9.2" NA NA "unprognostic (1.82e-1)" 0.0 0.0 3.9 18.1 3.0 2.6 0.5 0.9 1.1 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.8 0.2 0.6 0.7 0.9 10.8 1.5 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.4 1.5 16.0 2.0 0.0 0.0 1.5 4.1 0.0 0.4 6.0 3.7 1.0 0.5 9.9 0.0 0.0 28.2 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 2.4 0.0 0.0 0.0 0.0 0.2 1.0 9.1 0.1 14.4 17.3 66.1 37.7 0.0 1.8 96.4 82.7 1.4 0.4 0.0 0.0 105.0 36.3 3.9 3.0 0.9 1.1 0.8 0.2 1.5 1.2 0.3 0.9 0.4 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ17 ENSG00000211872 "T cell receptor alpha joining 17" 14 22526844-22526906 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.3;retina: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 148.3" "Lineage enriched" "Detected in many" 31 "T-cells: 148.3" "Cell line enhanced" "Detected in some" "MOLT-4: 3.8;NB-4: 7.0;U-266/84: 2.4;U-698: 1.3" NA NA 0.0 0.0 1.6 5.0 2.7 2.5 1.2 1.3 1.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 1.2 0.0 0.0 0.3 3.2 1.7 1.2 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.9 2.5 16.1 3.5 0.0 0.0 0.7 2.1 1.2 1.5 6.1 1.1 0.5 2.4 7.3 0.0 0.0 3.6 0.4 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 26.5 0.0 97.2 71.2 0.7 0.3 86.6 57.5 4.7 0.0 0.5 0.0 148.3 29.9 1.6 2.7 1.3 1.1 0.6 1.2 1.7 1.2 0.4 1.7 1.5 2.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ16 ENSG00000211873 "T cell receptor alpha joining 16" 14 22528527-22528586 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 5.8;lymphoid tissue: 8.4;retina: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "MAIT T-cell: 39.0;memory CD4 T-cell: 55.6;memory CD8 T-cell: 52.5;naive CD4 T-cell: 44.3;naive CD8 T-cell: 37.4;T-reg: 60.2" "Lineage enriched" "Detected in many" 41 "T-cells: 60.2" "Cell line enriched" "Detected in some" 7 "HDLM-2: 8.7" NA NA 0.0 0.0 2.1 2.5 3.4 2.3 0.0 1.4 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.6 0.9 2.3 4.5 2.1 0.9 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.8 17.6 0.0 0.0 0.0 0.0 5.8 0.0 1.3 2.8 1.1 0.6 0.9 8.4 0.0 2.1 5.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 39.0 0.4 55.6 52.5 0.3 0.1 44.3 37.4 1.4 0.1 0.3 0.0 60.2 18.2 2.1 3.4 1.4 1.3 0.7 0.7 2.1 0.9 0.5 1.1 1.3 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ14 ENSG00000211875 "T cell receptor alpha joining 14" 14 22530327-22530378 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 8.6;retina: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "MAIT T-cell: 5.3;memory CD4 T-cell: 7.6;memory CD8 T-cell: 10.1;naive CD4 T-cell: 6.1;naive CD8 T-cell: 3.9;T-reg: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Not detected" "Not detected" NA NA 0.0 0.0 2.1 0.0 2.8 1.0 0.0 1.4 1.6 0.0 0.6 0.7 3.3 0.0 0.0 0.0 0.0 2.0 0.0 0.8 1.7 0.0 0.0 0.0 1.0 2.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.2 0.0 0.0 2.3 8.6 0.0 0.0 2.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 7.6 10.1 0.0 0.0 6.1 3.9 0.0 0.0 0.0 0.0 13.7 0.0 2.1 2.8 1.4 1.6 0.8 1.7 2.0 1.2 0.2 1.4 0.6 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ13 ENSG00000211876 "T cell receptor alpha joining 13" 14 22531076-22531138 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 15.6;retina: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 82.8;memory CD8 T-cell: 58.8;naive CD4 T-cell: 85.6;naive CD8 T-cell: 48.0;T-reg: 126.3" "Lineage enriched" "Detected in many" 88 "T-cells: 126.3" "Group enriched" "Detected in some" 6 "MOLT-4: 8.1;U-698: 7.1" NA NA 0.9 2.4 1.2 5.5 3.1 3.6 1.2 1.7 1.6 0.0 2.6 0.1 0.0 0.5 0.0 0.0 0.6 1.9 0.0 0.8 0.9 0.6 0.0 0.4 15.6 1.3 1.2 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.4 1.7 28.2 0.0 0.0 0.0 0.0 4.2 0.0 0.7 6.2 4.6 0.0 1.0 5.5 0.6 0.0 5.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.1 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 13.1 0.8 82.8 58.8 0.0 0.0 85.6 48.0 1.4 0.3 0.0 1.1 126.3 27.1 1.2 3.1 1.7 1.6 0.8 0.9 1.3 1.2 0.7 2.0 0.7 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ12 ENSG00000211877 "T cell receptor alpha joining 12" 14 22531939-22531998 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 30.7;retina: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 319.7" "Group enriched" "Detected in all" 110 "B-cells: 196.9;T-cells: 319.7" "Group enriched" "Detected in some" 13 "Daudi: 12.1;MOLT-4: 7.9;U-698: 30.7" NA NA 0.0 1.7 2.7 30.7 2.6 0.9 0.0 2.4 4.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 1.3 0.5 0.0 3.4 15.7 1.9 1.3 0.2 0.0 0.0 0.0 0.0 1.0 1.4 0.4 1.7 31.4 1.8 0.0 0.0 0.0 2.0 1.3 1.7 11.3 3.3 0.5 2.0 15.1 0.0 0.0 25.3 0.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.7 0.0 0.0 0.0 1.9 0.4 2.3 26.0 0.5 319.7 160.3 104.9 135.2 0.4 196.9 98.6 79.1 0.0 1.1 1.1 1.1 265.9 53.8 2.7 2.6 2.4 4.0 1.1 1.3 1.9 1.3 0.2 1.4 1.7 2.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ11 ENSG00000211878 "T cell receptor alpha joining 11" 14 22532502-22532561 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 9.8;retina: 28.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 139.0" "Lineage enriched" "Detected in single" 152 "T-cells: 139.0" "Group enriched" "Detected in some" 31 "MOLT-4: 3.9;RT4: 1.8;U-266/84: 3.5" NA NA 0.0 0.0 1.4 9.8 3.1 3.9 0.0 1.2 1.8 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 1.4 0.6 1.2 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 28.3 0.0 0.0 0.0 0.0 1.8 0.0 0.4 2.5 2.4 1.4 1.2 8.6 0.0 0.0 6.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.1 29.1 0.9 80.4 55.1 0.1 0.5 62.5 37.0 0.5 0.0 0.3 0.1 139.0 27.5 1.4 3.1 1.2 1.8 1.2 1.0 1.3 0.7 0.0 0.6 0.4 1.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ10 ENSG00000211879 "T cell receptor alpha joining 10" 14 22533497-22533560 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 22.2;retina: 32.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 156.3;memory CD8 T-cell: 239.5;naive CD4 T-cell: 141.1;naive CD8 T-cell: 425.6;T-reg: 229.4" "Lineage enriched" "Detected in many" 23 "T-cells: 425.6" "Group enriched" "Detected in some" 4 "HDLM-2: 9.0;MOLT-4: 28.5" NA NA "unprognostic (7.94e-2)" 0.6 2.4 1.0 16.1 2.1 1.7 0.0 0.3 1.6 2.5 0.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.7 0.0 0.0 2.1 22.2 1.4 0.6 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.4 0.8 32.1 2.0 0.0 0.0 0.6 6.8 0.0 0.4 13.9 4.6 3.0 0.8 9.6 0.0 0.0 13.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.6 0.0 0.0 0.0 18.2 0.4 0.3 6.8 0.2 48.5 11.3 156.3 239.5 1.1 13.4 141.1 425.6 0.7 1.2 0.8 0.4 229.4 77.6 1.0 2.1 0.3 1.6 0.6 0.7 1.4 0.6 0.4 1.1 0.4 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ9 ENSG00000211880 "T cell receptor alpha joining 9" 14 22535554-22535614 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 22.4;retina: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 137.3;memory CD8 T-cell: 150.2;naive CD4 T-cell: 118.6;naive CD8 T-cell: 188.1;T-reg: 297.5" "Lineage enriched" "Detected in many" 59 "T-cells: 297.5" "Cell line enriched" "Detected in some" 6 "MOLT-4: 7.5" NA NA 0.0 0.0 2.0 22.4 3.0 1.8 0.5 0.7 5.5 0.0 0.8 2.1 4.4 0.0 0.0 0.0 0.2 0.5 0.0 0.6 0.4 0.0 0.3 2.7 12.9 1.1 1.1 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.8 7.0 30.7 0.0 0.0 3.9 0.0 6.4 0.0 0.9 10.6 3.5 0.1 0.7 12.6 1.4 0.0 11.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.6 0.1 2.2 2.7 0.5 32.7 0.7 137.3 150.2 0.0 3.3 118.6 188.1 5.0 0.9 0.0 0.1 297.5 51.5 2.0 3.0 0.7 5.5 0.6 0.4 1.1 1.1 0.0 1.0 0.9 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ7 ENSG00000211882 "T cell receptor alpha joining 7" 14 22537622-22537680 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 15.3;retina: 42.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 48 "MAIT T-cell: 26.9;memory CD4 T-cell: 44.2;memory CD8 T-cell: 28.6;naive CD4 T-cell: 54.8;naive CD8 T-cell: 31.2;T-reg: 87.6" "Lineage enriched" "Detected in single" 92 "T-cells: 87.6" "Group enriched" "Detected in some" 71 "MOLT-4: 10.7;U-266/84: 3.3" NA NA 0.0 0.0 2.6 9.4 5.8 3.9 0.0 1.3 1.3 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.9 0.6 2.6 2.7 7.0 2.5 1.3 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.9 2.7 42.6 0.0 2.6 0.0 0.0 1.5 0.0 1.7 2.2 2.4 0.1 2.6 15.3 0.0 0.0 4.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 26.9 0.0 44.2 28.6 0.1 0.0 54.8 31.2 0.3 0.0 0.0 0.9 87.6 14.8 2.6 5.8 1.3 1.3 0.7 2.9 2.5 1.3 0.8 3.4 1.7 2.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ6 ENSG00000211883 "T cell receptor alpha joining 6" 14 22539073-22539134 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 15.4;retina: 57.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 28 "MAIT T-cell: 137.1;memory CD4 T-cell: 135.0;memory CD8 T-cell: 142.8;naive CD4 T-cell: 138.2;naive CD8 T-cell: 76.2;T-reg: 264.4" "Lineage enriched" "Detected in many" 192 "T-cells: 264.4" "Cell line enhanced" "Detected in some" "HL-60: 3.3;MOLT-4: 8.6;NB-4: 13.3" NA NA "unprognostic (8.83e-2)" 0.0 0.0 2.4 12.4 2.6 2.1 0.0 1.1 1.0 0.0 0.9 1.4 0.0 0.9 0.0 0.0 0.7 1.9 1.7 0.4 1.4 0.0 0.0 3.8 15.4 1.4 1.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.4 2.5 57.1 0.0 0.0 0.0 5.0 3.8 0.0 2.1 14.9 6.9 0.5 1.3 12.4 0.0 0.0 5.9 2.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 5.3 0.1 137.1 0.1 135.0 142.8 0.5 0.2 138.2 76.2 1.3 0.4 0.2 0.5 264.4 54.6 2.4 2.6 1.1 1.0 0.4 1.4 1.4 1.1 0.1 1.2 2.1 1.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ5 ENSG00000211884 "T cell receptor alpha joining 5" 14 22540247-22540306 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 9.7;lymphoid tissue: 12.6;retina: 44.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 62 "MAIT T-cell: 63.0;memory CD4 T-cell: 156.5;memory CD8 T-cell: 124.4;naive CD4 T-cell: 110.4;naive CD8 T-cell: 113.2;T-reg: 244.8" "Lineage enriched" "Detected in many" 113 "T-cells: 244.8" "Group enriched" "Detected in some" 27 "JURKAT: 1.3;MOLT-4: 3.6;NB-4: 3.0" NA NA "unprognostic (3.52e-1)" 0.6 0.0 1.4 7.3 1.5 2.2 0.6 1.4 1.8 0.0 0.1 0.6 9.7 0.0 0.0 0.0 0.0 1.8 0.0 0.8 0.5 0.0 0.0 2.5 10.9 1.9 1.7 0.2 1.0 0.0 0.0 0.0 0.0 1.4 0.5 4.4 44.4 0.0 0.0 3.9 0.0 3.1 0.0 0.7 9.9 0.0 0.9 0.9 12.6 0.0 0.0 11.4 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.9 63.0 0.5 156.5 124.4 0.1 0.3 110.4 113.2 2.1 0.5 0.0 0.4 244.8 56.9 1.4 1.5 1.4 1.8 0.8 0.5 1.9 1.7 0.2 1.4 0.7 0.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ4 ENSG00000211885 "T cell receptor alpha joining 4" 14 22542199-22542261 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 18.1;retina: 56.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 36 "MAIT T-cell: 78.6;memory CD4 T-cell: 222.6;memory CD8 T-cell: 164.4;naive CD4 T-cell: 175.6;naive CD8 T-cell: 107.2;T-reg: 273.2" "Lineage enriched" "Detected in many" 91 "T-cells: 273.2" "Group enriched" "Detected in some" 70 "MOLT-4: 7.7;NB-4: 6.2" NA NA "unprognostic (7.36e-2)" 0.0 0.0 2.3 7.8 2.9 5.0 3.5 1.2 1.7 0.0 0.9 1.8 5.5 0.0 0.0 0.0 0.7 3.6 0.0 0.7 0.5 1.3 1.0 6.0 15.1 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.3 5.9 56.5 2.0 0.0 0.0 2.2 1.6 0.0 1.1 11.4 3.5 0.1 1.2 18.1 0.2 0.0 10.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 4.7 0.7 78.6 0.2 222.6 164.4 0.3 0.9 175.6 107.2 2.9 0.3 0.2 0.4 273.2 46.2 2.3 2.9 1.2 1.7 0.7 0.5 1.2 1.6 0.0 1.4 1.1 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ3 ENSG00000211886 "T cell receptor alpha joining 3" A0A075B6Y3 14 22543179-22543240 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "retina: 90.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "MAIT T-cell: 139.0;memory CD4 T-cell: 200.3;memory CD8 T-cell: 172.4;naive CD4 T-cell: 186.6;naive CD8 T-cell: 293.9;T-reg: 198.9" "Lineage enriched" "Detected in many" 146 "T-cells: 293.9" "Cell line enriched" "Detected in some" 14 "JURKAT: 181.0" NA NA "unprognostic (1.21e-1)" "unprognostic (3.50e-1)" 0.9 0.0 1.7 13.2 3.3 3.8 0.0 1.3 1.5 2.7 0.2 2.4 0.0 0.0 3.8 0.0 0.0 2.1 0.0 0.9 0.8 1.3 0.0 6.1 18.6 1.8 1.4 0.2 0.0 0.0 0.0 0.0 0.4 2.0 0.0 4.3 90.0 1.9 0.0 0.0 1.4 14.7 0.0 1.2 9.2 4.9 0.7 0.9 17.3 0.0 0.0 17.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 181.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.6 11.2 0.2 139.0 0.8 200.3 172.4 0.2 0.8 186.6 293.9 2.0 0.3 0.8 1.0 198.9 56.6 1.7 3.3 1.3 1.5 0.9 0.8 1.8 1.4 0.2 2.0 1.2 0.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ2 ENSG00000211887 "T cell receptor alpha joining 2 (non-functional)" 14 22544071-22544136 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 73.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.7" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.7;memory CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 27 "T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "JURKAT: 73.0" NA NA "unprognostic (1.43e-1)" 0.0 0.0 0.4 7.5 0.9 2.2 0.0 0.6 1.4 2.4 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 4.9 10.0 1.6 0.4 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.7 4.6 73.7 0.0 0.0 0.0 0.0 8.1 0.0 0.9 15.6 6.7 0.1 0.6 13.0 0.0 0.0 2.7 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.7 2.6 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.9 0.6 1.4 0.3 0.2 1.6 0.4 0.1 0.6 0.9 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ1 ENSG00000211888 "T cell receptor alpha joining 1 (non-functional)" 14 22545037-22545098 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 28.3;retina: 94.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Cell line enriched" "Detected in some" 6 "JURKAT: 28.3" NA NA "unprognostic (1.02e-1)" 2.5 0.0 2.5 7.9 3.2 6.6 3.2 1.2 2.3 2.6 0.7 1.5 0.0 0.0 11.6 0.7 0.0 0.6 0.0 0.9 0.2 0.6 0.8 3.8 17.4 1.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.3 94.9 1.9 0.0 0.0 0.7 0.0 1.2 0.6 12.7 3.6 0.1 0.9 28.3 0.0 0.0 14.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 3.8 3.1 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.4 0.0 2.7 3.6 0.0 0.0 2.3 0.8 0.0 0.0 0.0 0.0 0.8 0.1 2.5 3.2 1.2 2.3 0.9 0.2 1.5 0.9 0.1 1.0 0.6 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHA2 ENSG00000211890 "Immunoglobulin heavy constant alpha 2 (A2m marker)" P01877 14 105583731-105588395 "Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 2874.2;salivary gland: 3758.9" "Group enriched" "Detected in many" 22 "B-cells: 3713.4;Plasma cells: 10918.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 876 "memory B-cell: 279.6;naive B-cell: 123.8" "Lineage enriched" "Detected in single" 1214 "B-cells: 279.6" "Group enriched" "Detected in some" 42 "U-266/70: 181.9;U-266/84: 63.9" "Not detected" "Not detected" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 67000000000 "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (1.98e-9)" "unprognostic (3.20e-2)" "unprognostic (2.23e-2)" "unprognostic (1.53e-2)" "unprognostic (1.93e-2)" "prognostic favorable (8.40e-5)" "unprognostic (4.56e-2)" "unprognostic (2.59e-1)" "unprognostic (3.17e-1)" "unprognostic (3.69e-2)" "unprognostic (1.20e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (7.50e-6)" "unprognostic (2.12e-1)" "unprognostic (3.28e-2)" "unprognostic (9.70e-2)" "unprognostic (4.47e-1)" 14.9 3.8 0.0 14.3 0.0 12.6 332.5 0.0 0.0 33.7 0.0 2874.2 15.4 9.0 0.0 221.4 35.3 0.9 4.0 0.0 0.0 49.0 35.4 135.4 6.9 0.0 0.0 0.0 5.3 30.5 0.0 5.0 0.3 0.0 38.0 8.9 0.0 3758.9 0.1 2.1 11.8 2280.0 1.1 0.0 706.5 675.6 1.1 0.0 22.6 60.3 0.0 13.2 94.1 67.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.9 181.9 63.9 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 279.6 0.0 0.1 0.1 123.8 0.0 0.1 0.2 0.0 0.1 0.1 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.2 12.4 0.0 3713.4 0.0 2.4 0.0 2.8 0.0 1.4 0.3 1.2 5.7 0.6 0.0 0.0 0.1 3.2 3.7 0.0 0.0 0.0 0.0 0.0 15.6 8.5 56.2 0.0 0.0 0.0 8.0 10.7 0.0 15.2 0.0 78.9 6.0 0.3 0.0 0.0 2.9 0.0 10.8 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 10918.5 0.3 0.0 0.1 0.0 0.0 0.0 0.1 23.6 0.0 0.0 12.3 0.0 0.4 325.4 0.0 4.8 0.2 IGHE ENSG00000211891 "Immunoglobulin heavy constant epsilon" P01854 14 105597691-105601728 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.9;lymphoid tissue: 4.6;thyroid gland: 2.7" "Cell type enriched" "Detected in some" 50 "Plasma cells: 462.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "U-266/70: 3818.2" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 77000000 "unprognostic (3.18e-2)" "unprognostic (1.28e-2)" "unprognostic (1.54e-3)" "unprognostic (4.99e-1)" "unprognostic (4.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.04e-2)" "unprognostic (3.88e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-2)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 4.6 1.5 0.0 0.0 0.2 2.7 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.6 3818.2 371.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 462.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 IGHG4 ENSG00000211892 "Immunoglobulin heavy constant gamma 4 (G4m marker)" P01861 14 105620506-105626066 "FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 2502.0" "Group enriched" "Detected in some" 10 "B-cells: 964.5;Plasma cells: 2099.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 8 "cerebral cortex: 8.6" "Group enriched" "Detected in some" 457 "memory B-cell: 122.7;naive B-cell: 73.7" "Lineage enriched" "Detected in single" 571 "B-cells: 122.7" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 339.7" HPA001245 Approved "Immunoglobulin genes" NA NA 170000000000 "HPA001245: AB_1079121" "unprognostic (7.29e-3)" "unprognostic (5.20e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.16e-4)" "unprognostic (4.58e-1)" "unprognostic (1.92e-2)" "unprognostic (3.49e-1)" "unprognostic (8.63e-2)" "unprognostic (4.74e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (9.09e-8)" "unprognostic (2.84e-2)" "unprognostic (4.23e-1)" "unprognostic (9.24e-2)" "unprognostic (7.72e-2)" 38.2 2.1 0.4 2502.0 0.5 42.6 5.8 0.4 8.6 32.3 0.4 25.6 86.2 10.9 0.2 405.0 28.8 102.2 19.3 0.3 1.1 44.4 44.1 49.9 137.6 0.5 0.8 0.3 3.9 4.3 0.5 1.9 0.2 1.0 31.4 44.8 0.1 16.5 4.1 0.8 3.0 187.7 1.8 1.0 838.3 57.9 2.2 0.4 50.3 109.2 0.0 879.9 593.7 29.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 43.2 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.3 0.6 339.7 0.0 0.0 3.5 3.7 0.3 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.3 1.5 0.6 0.1 57.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 122.7 0.0 0.0 0.1 73.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.6 0.4 0.5 0.4 8.6 0.3 1.1 0.5 0.8 0.3 1.0 1.0 0.4 0.4 1.3 6.4 118.8 0.0 964.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 7.0 8.6 3.7 0.0 0.0 0.0 0.3 11.5 0.0 0.0 0.2 0.0 0.4 2.5 27.8 26.7 0.0 0.0 0.0 4.3 0.0 0.0 50.4 0.0 16.4 36.7 0.0 0.0 0.0 10.5 0.0 51.9 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 0.0 2099.3 0.2 0.0 10.6 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 152.3 0.0 12.8 0.1 IGHG2 ENSG00000211893 "Immunoglobulin heavy constant gamma 2 (G2m marker)" P01859 14 105639559-105644790 "FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 4354.0" "Group enriched" "Detected in some" 8 "B-cells: 2050.1;Plasma cells: 2918.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 447 "memory B-cell: 339.0;naive B-cell: 119.3" "Lineage enriched" "Detected in single" 661 "B-cells: 339.0" "Group enriched" "Detected in some" 4 "RH-30: 9.6;RPMI-8226: 25.1" HPA001245 Approved "Immunoglobulin genes" NA NA 250000000000 "HPA001245: AB_1079121" "prognostic favorable (3.53e-4)" "unprognostic (6.88e-3)" "unprognostic (2.40e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "prognostic favorable (3.30e-6)" "unprognostic (1.06e-1)" "unprognostic (6.67e-2)" "unprognostic (1.74e-1)" "unprognostic (7.59e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (4.30e-8)" "unprognostic (4.72e-2)" "unprognostic (3.32e-2)" "unprognostic (1.05e-1)" "unprognostic (7.40e-2)" 69.2 11.1 1.4 171.6 1.0 35.1 56.5 0.2 4.1 45.1 1.4 119.2 7.6 56.3 0.8 90.9 51.9 20.9 12.1 0.3 0.3 155.9 99.0 172.5 65.9 0.5 1.0 0.3 16.4 8.1 0.1 8.2 0.0 1.4 64.7 9.5 0.0 202.9 1.3 3.6 7.6 333.4 1.0 1.5 4354.0 87.9 2.3 0.3 16.9 135.5 0.0 227.8 101.3 105.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 25.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 339.0 0.5 0.0 0.3 119.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.5 1.4 1.0 0.2 4.1 0.3 0.3 0.5 1.0 0.3 1.4 1.5 0.3 1.8 0.2 54.5 305.3 0.0 2050.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 2.8 13.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.2 4.1 0.0 32.5 0.0 0.0 0.0 3.1 0.0 0.0 126.1 0.0 8.2 5.1 0.1 0.0 0.0 0.9 0.0 12.4 0.0 0.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2918.6 0.7 0.0 3.5 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 305.5 0.0 0.7 0.0 IGHA1 ENSG00000211895 "Immunoglobulin heavy constant alpha 1" P01876 14 105703995-105708665 "Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 7478.6;lymphoid tissue: 6449.1;salivary gland: 8977.9;stomach 1: 6724.8" "Group enriched" "Detected in many" 10 "B-cells: 17763.5;Plasma cells: 34095.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 203 "memory B-cell: 2571.8;naive B-cell: 1114.6" "Lineage enriched" "Detected in many" 284 "B-cells: 2571.8" "Cell line enhanced" "Detected in many" "HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0" "HPA001217, HPA006013" Approved "Immunoglobulin genes" NA NA 130000000000 "HPA001217: AB_1079120, HPA006013: AB_1079119" "prognostic favorable (8.87e-5)" "unprognostic (5.36e-3)" "unprognostic (2.10e-2)" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "prognostic favorable (3.81e-5)" "unprognostic (1.17e-1)" "unprognostic (3.86e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.83e-7)" "unprognostic (8.10e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" 110.3 42.1 1.4 1131.7 1.9 926.2 961.7 0.7 5.0 165.1 4.1 3390.3 7478.6 80.6 3.6 647.1 205.3 669.1 74.4 0.6 0.8 273.3 330.4 1316.7 1432.8 3.7 2.1 0.8 41.0 116.1 3.5 38.6 6.7 1.3 204.2 1350.7 0.0 8977.9 69.7 10.9 38.0 3820.3 70.2 1.2 6449.1 6724.8 23.4 1.8 132.2 451.0 0.4 1965.4 1630.6 305.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.8 0.0 0.0 3.6 0.0 0.0 0.0 17.4 0.0 3.7 0.0 0.0 0.0 5.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 4.1 14.4 5.5 0.0 0.0 3.8 4.3 34.7 0.0 0.0 9.7 22.3 2.6 0.0 0.0 0.0 0.0 1.6 5.1 0.0 3.9 4.2 3.2 78.2 24.0 2.2 0.0 2.4 0.0 3.8 3.0 0.6 1.3 0.3 1.0 2571.8 0.7 1.1 1.5 1114.6 0.4 1.0 9.0 0.9 0.9 1.7 1.0 508.3 1.4 1.9 0.7 5.0 0.6 0.8 3.7 2.1 0.8 1.3 1.2 1.8 1.8 11.8 131.4 783.5 0.0 17763.5 0.0 26.0 0.0 1.2 0.0 22.4 4.6 4.7 22.8 46.4 0.0 0.0 0.7 55.5 20.8 0.0 0.0 0.0 0.1 0.1 26.5 28.4 167.0 0.0 0.0 0.5 56.5 99.4 0.1 584.8 0.0 353.8 225.1 1.6 0.0 0.0 13.6 0.0 57.8 0.0 0.0 0.0 34.6 0.0 0.0 6.7 0.0 11.3 0.0 0.0 0.0 12.8 0.0 34095.8 33.2 0.0 1.4 16.0 0.0 0.0 2.0 13.6 0.0 0.0 0.8 0.0 6.0 2514.2 0.0 27.9 1.2 IGHG1 ENSG00000211896 "Immunoglobulin heavy constant gamma 1 (G1m marker)" P01857 14 105736343-105743071 "Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11543.2;urinary bladder: 4032.9" "Group enriched" "Detected in many" 16 "B-cells: 3900.5;Plasma cells: 9883.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 6.0;hypothalamus: 13.7;medulla oblongata: 4.2;midbrain: 16.0;spinal cord: 12.9" "Immune cell enriched" "Detected in some" 6 "memory B-cell: 766.8" "Lineage enriched" "Detected in many" 123 "B-cells: 766.8" "Group enriched" "Detected in many" 9 "Karpas-707: 157.8;U-698: 392.7" "HPA001245, CAB008642" Supported "Immunoglobulin genes" NA NA 230000000000 "CAB008642: AB_1617595, HPA001245: AB_1079121" "unprognostic (6.47e-3)" "unprognostic (4.39e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.90e-2)" "unprognostic (3.25e-1)" "unprognostic (7.52e-2)" "unprognostic (5.36e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.49e-9)" "unprognostic (3.12e-1)" "unprognostic (3.52e-1)" "unprognostic (8.96e-2)" "unprognostic (7.61e-2)" 274.8 703.4 1.0 1676.8 2.1 687.7 204.9 1.0 6.0 409.6 4.1 190.9 104.6 212.3 18.5 337.6 667.4 315.8 144.3 0.9 13.7 483.3 359.0 970.9 3309.4 4.2 16.0 0.6 410.6 38.8 8.0 36.1 2.3 2.3 211.6 85.9 0.3 394.9 253.3 13.2 28.7 1017.1 27.8 12.9 11543.2 614.2 174.2 2.1 1790.1 1288.6 0.1 5875.0 4032.9 269.4 2.2 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.7 0.0 0.0 2.3 0.0 0.0 0.0 8.4 0.0 5.3 0.0 0.0 0.0 22.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 157.8 0.0 0.0 1.7 2.1 2.6 0.0 0.0 2.9 15.1 3.7 0.0 0.0 18.2 17.0 3.1 0.0 0.0 0.0 0.0 0.2 10.8 0.0 3.2 3.3 4.5 4.9 0.3 392.7 0.1 3.7 0.0 0.2 0.3 0.1 0.3 0.0 0.2 766.8 0.6 0.3 0.4 134.9 0.0 0.1 6.2 0.1 0.1 0.1 0.2 96.2 1.0 2.1 1.0 6.0 0.9 13.7 4.2 16.0 0.6 2.3 12.9 2.1 2.2 2.9 73.7 378.5 0.0 3900.5 0.0 8.1 0.0 0.0 0.0 0.5 0.0 2.8 22.8 9.3 0.0 0.0 0.0 0.4 7.0 0.0 0.0 0.5 0.0 0.1 8.5 13.9 83.4 0.0 0.0 0.0 13.6 8.2 0.0 209.4 0.0 46.1 52.9 0.1 0.0 0.0 5.0 0.0 62.8 0.0 0.9 0.0 9.7 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 5.4 0.0 9883.3 9.1 0.0 10.9 1.5 0.1 0.0 0.0 1.5 1.9 1.0 0.0 0.0 0.0 415.6 0.0 13.6 0.1 IGHG3 ENSG00000211897 "Immunoglobulin heavy constant gamma 3 (G3m marker)" 14 105764503-105771405 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 1299.4" "Group enriched" "Detected in many" 7 "B-cells: 2548.4;Plasma cells: 4543.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "medulla oblongata: 3.2" "Group enriched" "Detected in some" 415 "memory B-cell: 211.0;naive B-cell: 64.4" "Lineage enriched" "Detected in single" 636 "B-cells: 211.0" "Group enriched" "Detected in some" 5 "HDLM-2: 23.8;Karpas-707: 18.7;U-698: 49.1" "Immunoglobulin genes" NA NA "unprognostic (8.49e-3)" "unprognostic (3.93e-3)" "unprognostic (1.57e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.00e-5)" "unprognostic (1.92e-2)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "unprognostic (1.99e-2)" "unprognostic (8.36e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.46e-11)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (9.80e-2)" "unprognostic (6.79e-2)" 33.9 17.8 0.1 91.7 1.0 65.9 24.0 0.1 1.1 37.2 1.0 19.4 11.7 23.0 0.3 32.4 105.3 8.5 5.3 0.2 0.1 71.3 42.7 196.6 349.2 3.2 0.4 0.2 13.5 6.4 0.1 6.8 0.1 0.6 41.7 8.9 0.0 70.4 12.8 1.9 2.0 101.7 1.6 1.2 1299.4 66.0 32.0 0.2 27.4 88.3 0.0 936.7 88.1 29.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 6.0 3.9 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 49.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 211.0 0.0 0.0 0.0 64.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.7 0.1 1.0 0.1 1.1 0.2 0.1 3.2 0.4 0.2 0.6 1.2 0.2 0.9 1.9 57.7 363.7 0.0 2548.4 0.0 9.7 0.0 0.0 0.0 0.5 0.1 1.9 18.6 11.2 0.0 0.0 0.0 2.0 7.0 0.0 0.0 6.5 0.1 0.2 5.3 13.2 24.5 0.0 0.0 0.0 9.1 2.6 0.0 195.5 0.0 22.9 64.2 0.1 0.0 0.0 7.4 0.0 62.8 0.0 16.4 0.0 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 4543.8 13.3 0.0 0.5 2.2 0.0 0.0 0.0 0.7 4.7 0.7 0.0 0.0 0.0 467.3 0.0 13.5 0.1 IGHD "FLJ00382, FLJ46727, MGC29633" ENSG00000211898 "Immunoglobulin heavy constant delta" P01880 14 105836765-105845678 "Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 333.6" "Group enriched" "Detected in some" 47 "B-cells: 261.8;Plasma cells: 588.1;T-cells: 474.2" "Cancer enhanced" "Detected in many" "lung cancer: 58.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 63 "memory B-cell: 279.1;naive B-cell: 815.9" "Lineage enriched" "Detected in many" 93 "B-cells: 815.9" "Group enriched" "Detected in some" 7 "Daudi: 82.3;U-698: 95.8" CAB012703 Approved "Immunoglobulin genes" NA NA 14000000000 "CAB012703: AB_10554307" "prognostic favorable (1.49e-6)" "unprognostic (1.84e-2)" "unprognostic (3.99e-2)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (2.08e-3)" "unprognostic (4.63e-2)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" "unprognostic (6.16e-2)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-3)" "unprognostic (5.76e-2)" "unprognostic (2.64e-1)" "unprognostic (3.82e-3)" "unprognostic (4.30e-2)" 2.8 0.4 0.0 35.7 0.0 39.5 9.4 0.0 0.3 0.9 0.0 2.2 3.4 5.0 0.2 2.8 0.7 19.2 5.8 0.0 0.1 2.1 3.5 34.4 112.5 0.2 0.0 0.0 0.3 0.4 0.2 0.0 0.3 0.0 6.4 2.0 0.0 67.6 1.2 0.4 1.5 17.7 0.9 0.0 148.0 43.7 0.3 0.0 8.4 1.3 0.0 333.6 20.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 82.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 12.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 2.7 0.5 0.3 0.4 0.3 0.2 279.1 0.3 0.8 0.7 815.9 1.0 0.3 3.3 0.3 0.5 8.7 0.4 39.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 261.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.3 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 9.2 0.0 0.0 0.0 0.0 0.0 588.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 474.2 0.0 0.0 0.0 IGHM ENSG00000211899 "Immunoglobulin heavy constant mu" P01871 14 105851705-105856218 "Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 1325.8;lymphoid tissue: 4145.2" "Group enriched" "Detected in many" 14 "B-cells: 3757.1;Plasma cells: 9906.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 16 "memory B-cell: 4278.4;naive B-cell: 6731.2" "Lineage enriched" "Detected in all" 19 "B-cells: 6731.2" "Group enriched" "Detected in many" 9 "Daudi: 4983.6;U-698: 4905.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB008643 Uncertain "Immunoglobulin genes" NA NA 110000000000 "CAB008643: AB_1617732" "unprognostic (2.91e-3)" "prognostic favorable (6.49e-4)" "unprognostic (9.30e-3)" "unprognostic (9.90e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.70e-6)" "unprognostic (9.61e-3)" "unprognostic (1.01e-1)" "unprognostic (1.52e-2)" "unprognostic (3.23e-3)" "unprognostic (2.46e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (3.01e-1)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (6.28e-3)" 45.6 9.0 0.4 377.1 1.3 398.7 57.1 0.2 1.4 44.9 2.0 437.5 1215.8 11.2 10.3 67.5 38.8 143.1 50.9 0.2 0.4 47.4 85.4 182.2 3219.4 1.9 0.5 0.2 9.8 44.9 0.6 8.8 3.7 0.7 15.2 203.3 0.0 328.1 6.2 2.7 1.7 1325.8 8.0 1.0 4145.2 533.4 71.5 0.9 118.4 37.3 0.7 501.3 129.1 10.6 2.7 4.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 4983.6 2.9 0.0 0.0 0.8 0.0 0.0 0.0 21.6 0.0 3.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 1.7 28.7 1.2 0.0 0.0 580.2 2.2 6.9 0.0 0.0 4.0 5.8 3.0 0.5 1.2 0.0 0.2 3.8 6.5 0.0 13.8 1.2 2.5 1.5 1.5 4905.9 0.0 2.4 0.0 10.8 5.4 5.6 3.1 1.2 2.3 4278.4 5.5 6.8 5.4 6731.2 4.5 3.8 25.4 11.4 4.5 346.1 11.4 815.2 0.4 1.3 0.2 1.4 0.2 0.4 1.9 0.5 0.2 0.7 1.0 0.9 2.7 1.0 38.5 254.5 0.0 3757.1 0.0 0.2 0.0 1.2 0.0 2.2 0.8 0.3 31.5 14.2 0.0 0.0 0.0 63.8 1.8 0.0 0.0 0.0 0.0 0.1 4.2 6.7 474.1 0.0 0.0 0.0 10.8 27.5 0.0 152.6 0.0 56.7 147.9 0.1 0.0 0.0 2.2 0.0 158.1 0.0 0.0 0.0 12.4 0.0 0.0 5.2 0.0 11.3 0.0 0.0 0.0 1.2 0.0 9906.5 0.3 0.0 2.2 1.5 0.0 0.0 0.4 16.8 0.0 0.0 0.2 0.0 0.0 415.0 0.3 4.1 0.1 IGHJ6 ENSG00000211900 "Immunoglobulin heavy joining 6" 14 105863198-105863258 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "cervix: 143.6;intestine: 38.9;lung: 47.4;testis: 152.5;urinary bladder: 114.3" "Cell type enriched" "Detected in single" 56 "Plasma cells: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory B-cell: 316.2;naive B-cell: 112.7" "Lineage enriched" "Detected in many" 21 "B-cells: 316.2" "Cell line enhanced" "Detected in some" "U-266/84: 1.3;U-937: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.1 0.9 143.6 0.0 2.6 38.9 1.0 0.0 0.0 2.2 0.5 0.9 0.3 0.0 3.1 2.5 47.4 0.4 0.4 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 3.7 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.6 0.7 152.5 0.3 0.0 0.7 0.0 10.8 114.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.0 3.5 3.5 0.8 0.3 0.0 0.2 316.2 0.5 0.6 0.5 112.7 0.6 0.3 14.8 0.2 1.0 0.0 0.1 89.2 0.0 0.0 0.1 0.9 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ2 ENSG00000211904 "Immunoglobulin heavy joining 2" 14 105865199-105865250 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "cervix: 49.1;intestine: 128.5;lymphoid tissue: 176.3" "Cell type enriched" "Detected in single" 6 "Plasma cells: 3.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "hypothalamus: 4.7" "Group enriched" "Detected in some" 18 "MAIT T-cell: 49.0;naive B-cell: 12.6" "Group enriched" "Detected in many" 45 "B-cells: 12.6;T-cells: 49.0" "Group enriched" "Detected in some" 25 "Daudi: 3.8;K-562: 1.1" NA NA "unprognostic (1.03e-3)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (1.27e-2)" "prognostic favorable (1.05e-4)" "unprognostic (7.40e-2)" "unprognostic (6.38e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.33e-6)" "unprognostic (4.31e-2)" "unprognostic (1.68e-1)" "unprognostic (5.48e-2)" "unprognostic (4.60e-1)" 2.0 0.0 0.1 0.0 0.4 13.4 20.8 0.0 1.7 49.1 0.1 88.1 0.0 5.5 18.1 18.2 2.1 0.8 0.1 0.2 4.7 1.2 12.1 0.0 7.7 2.6 2.0 0.0 7.8 19.1 0.6 0.0 0.0 0.4 15.1 128.5 0.0 0.0 7.1 0.0 0.0 0.0 5.9 0.2 19.0 18.4 0.1 0.4 19.7 5.2 0.0 176.3 6.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 49.0 1.3 0.4 1.6 0.4 12.6 0.0 0.2 0.2 0.0 0.6 0.0 0.0 17.1 0.1 0.4 0.0 1.7 0.2 4.7 2.6 2.0 0.0 0.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ1 ENSG00000211905 "Immunoglobulin heavy joining 1" A0A0C4DH62 14 105865407-105865458 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "intestine: 358.1;lymphoid tissue: 417.5;salivary gland: 121.2;stomach 1: 308.2" "Cell type enriched" "Detected in single" 18 "Plasma cells: 1.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 1.9" "Group enriched" "Detected in some" 72 "memory B-cell: 276.3;naive B-cell: 180.8;plasmacytoid DC: 99.0" "Group enriched" "Detected in many" 73 "B-cells: 276.3;dendritic cells: 99.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.7;U-698: 1.8" "Immunoglobulin genes" NA NA "unprognostic (5.28e-3)" "unprognostic (2.05e-2)" "unprognostic (6.81e-2)" "unprognostic (9.53e-2)" "prognostic favorable (3.55e-4)" "unprognostic (2.51e-1)" "unprognostic (2.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.90e-2)" 8.7 5.3 0.1 198.7 0.4 35.9 73.6 0.0 1.9 18.8 0.2 262.6 358.1 3.4 0.0 15.8 5.2 12.7 1.4 0.1 0.0 2.3 6.2 28.7 47.2 1.0 0.0 0.0 8.3 3.1 0.4 0.0 0.7 0.4 4.4 184.4 0.0 121.2 0.5 0.0 0.0 172.6 12.1 0.3 101.1 308.2 1.0 0.2 14.8 2.9 0.0 417.5 61.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.2 276.3 0.6 2.5 0.2 180.8 0.3 0.3 0.0 0.1 0.1 99.0 0.2 29.1 0.1 0.4 0.0 1.9 0.1 0.0 1.0 0.0 0.0 0.4 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-26 IGHD126 ENSG00000211907 "Immunoglobulin heavy diversity 1-26" 14 105881034-105881053 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-24 IGHD524 ENSG00000211909 "Immunoglobulin heavy diversity 5-24 (non-functional)" 14 105883903-105883922 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-22 IGHD322 ENSG00000211911 "Immunoglobulin heavy diversity 3-22" 14 105886031-105886061 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 48.9" "Lineage enriched" "Detected in many" 7 "B-cells: 48.9" "Cell line enriched" "Detected in single" 13 "SH-SY5Y: 1.3" NA NA "unprognostic (4.12e-1)" "unprognostic (1.53e-1)" 0.0 0.0 0.1 0.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.2 3.1 0.0 0.0 0.7 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 48.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-21 IGHD221 ENSG00000211912 "Immunoglobulin heavy diversity 2-21" 14 105888551-105888578 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-19 IGHD619 ENSG00000211914 "Immunoglobulin heavy diversity 6-19" 14 105891699-105891719 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-18 IGHD518 ENSG00000211915 "Immunoglobulin heavy diversity 5-18" 14 105893542-105893561 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-16 IGHD316 ENSG00000211917 "Immunoglobulin heavy diversity 3-16" 14 105895634-105895670 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.0;intestine: 2.6;lymphoid tissue: 4.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Immune cell enriched" "Detected in some" 7 "naive B-cell: 27.0" "Lineage enriched" "Detected in many" 12 "B-cells: 27.0" "Group enriched" "Detected in some" 16 "HEL: 2.4;HMC-1: 1.3;NB-4: 1.0" NA NA 0.0 0.0 0.0 1.7 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 27.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-15 "D2, IGHD215" ENSG00000211918 "Immunoglobulin heavy diversity 2-15" 14 105897957-105897987 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 2.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "naive B-cell: 39.9" "Lineage enriched" "Detected in single" 400 "B-cells: 39.9" "Cell line enriched" "Detected in single" 28 "HEL: 2.7" NA NA 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-13 "DN1, IGHD613" ENSG00000211920 "Immunoglobulin heavy diversity 6-13" 14 105901142-105901162 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-12 "DK1, IGHD512" ENSG00000211921 "Immunoglobulin heavy diversity 5-12" 14 105902649-105902671 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "stomach cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-10 "DXP'1, IGHD310" ENSG00000211923 "Immunoglobulin heavy diversity 3-10" 14 105904497-105904527 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;intestine: 3.7;lymphoid tissue: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "cervical cancer: 5.2" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "naive B-cell: 5.4" "Lineage enriched" "Detected in single" 55 "B-cells: 5.4" "Cell line enriched" "Detected in single" 12 "NB-4: 1.1" NA NA 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-9 "DXP1, IGHD39" ENSG00000211924 "Immunoglobulin heavy diversity 3-9" 14 105904681-105904711 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 12.0;stomach 1: 4.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 214 "memory B-cell: 8.9;naive B-cell: 33.8" "Lineage enriched" "Detected in single" 339 "B-cells: 33.8" "Cell line enriched" "Detected in some" 5 "HEL: 5.5" NA NA "unprognostic (1.74e-1)" "unprognostic (1.50e-1)" "unprognostic (9.31e-2)" 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 2.1 1.6 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.9 0.4 0.0 0.0 2.0 0.0 0.1 2.8 4.8 0.0 0.0 2.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-8 "DLR1, IGHD28" ENSG00000211925 "Immunoglobulin heavy diversity 2-8" 14 105907211-105907241 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.7;lymphoid tissue: 1.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "naive B-cell: 3.2" "Lineage enriched" "Detected in single" 33 "B-cells: 3.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5-5 "DK4, IGHD55" ENSG00000211928 "Immunoglobulin heavy diversity 5-5" 14 105912257-105912276 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3-3 "DXP4, IGHD33" ENSG00000211930 "Immunoglobulin heavy diversity 3-3" 14 105914359-105914389 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;lymphoid tissue: 2.6;salivary gland: 3.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "naive B-cell: 62.6" "Lineage enriched" "Detected in single" 626 "B-cells: 62.6" "Group enriched" "Detected in some" 48 "NB-4: 6.9;SH-SY5Y: 2.6" NA NA "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.13e-1)" "unprognostic (1.75e-1)" 0.0 0.0 0.1 0.9 0.1 4.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.0 0.0 0.0 1.9 1.6 0.1 0.0 0.1 0.0 0.0 0.9 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2-2 IGHD22 ENSG00000211931 "Immunoglobulin heavy diversity 2-2" 14 105916826-105916856 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "bone marrow: 2.9;intestine: 2.6;lymphoid tissue: 2.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 3.0" "Lineage enriched" "Detected in single" 31 "B-cells: 3.0" "Cell line enriched" "Detected in single" 23 "NB-4: 2.3" NA NA "unprognostic (3.23e-3)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.9 0.0 2.9 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV6-1 ENSG00000211933 "Immunoglobulin heavy variable 6-1" A0A0B4J1U7 14 105939756-105940253 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 445.6;lymphoid tissue: 160.3" "Cell type enriched" "Detected in some" 175 "Plasma cells: 2295.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Immune cell enriched" "Detected in some" 6 "naive B-cell: 19.7" "Lineage enriched" "Detected in single" 53 "B-cells: 19.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 930000000 "prognostic favorable (1.35e-4)" "unprognostic (9.66e-2)" "unprognostic (4.55e-3)" "unprognostic (1.26e-1)" "prognostic favorable (1.85e-5)" "unprognostic (1.84e-1)" "unprognostic (2.13e-2)" "unprognostic (1.89e-3)" "unprognostic (1.41e-1)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.48e-6)" "unprognostic (3.69e-2)" "unprognostic (6.93e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" 9.0 2.1 0.3 0.0 0.1 0.0 7.6 0.0 0.4 3.1 0.2 445.6 0.0 1.2 0.0 18.0 4.3 1.5 1.5 0.0 1.1 3.2 6.2 13.7 0.0 0.3 0.1 0.0 0.9 11.6 0.0 0.3 0.0 0.1 1.6 0.0 0.0 57.2 8.7 0.1 2.0 41.3 11.3 0.2 160.3 19.6 0.3 0.1 0.0 6.8 0.0 0.0 3.7 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.1 19.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 1.1 0.3 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2295.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 IGHV1-2 V35 ENSG00000211934 "Immunoglobulin heavy variable 1-2" P23083 14 105986582-105987083 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 467.1;lymphoid tissue: 1167.1" "Cell type enriched" "Detected in some" 38 "Plasma cells: 609.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 52 "memory B-cell: 285.2;naive B-cell: 347.4" "Lineage enriched" "Detected in many" 57 "B-cells: 347.4" "Cell line enriched" "Detected in some" 8 "U-266/70: 14302.7" "Immunoglobulin genes" NA NA 4000000000 "unprognostic (1.63e-3)" "unprognostic (1.09e-3)" "unprognostic (1.88e-1)" "unprognostic (9.46e-2)" "unprognostic (5.78e-2)" "prognostic favorable (1.67e-5)" "unprognostic (9.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (2.37e-1)" "unprognostic (1.99e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.17e-2)" "unprognostic (8.59e-2)" "unprognostic (3.19e-1)" "unprognostic (1.17e-2)" 16.8 43.5 0.2 367.6 0.2 76.7 84.9 0.0 0.9 41.9 0.4 467.1 225.7 13.3 1.3 34.8 59.0 54.9 26.4 0.0 0.0 13.5 19.0 61.3 408.3 0.5 0.3 0.0 36.8 3.0 0.6 1.3 0.6 0.2 23.5 286.4 0.0 224.2 53.0 0.4 4.5 122.9 7.6 0.0 396.3 218.1 35.2 0.0 72.8 34.0 0.0 1167.1 257.7 9.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 2.6 0.0 0.0 2.3 0.4 2.8 0.0 0.0 3.1 0.6 0.5 0.0 0.0 1.3 1.8 0.1 0.0 0.6 0.0 0.0 0.2 0.3 0.0 1.5 0.0 1.3 14302.7 1755.5 0.5 0.0 0.4 0.0 0.3 0.6 0.1 0.3 0.0 0.2 285.2 1.6 0.7 0.2 347.4 1.5 0.6 6.1 0.2 0.3 0.5 1.1 34.0 0.2 0.2 0.0 0.9 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 1.3 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 609.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 IGHV1-3 VI-3B ENSG00000211935 "Immunoglobulin heavy variable 1-3" A0A0C4DH29 14 106005095-106005574 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 225.4;lymphoid tissue: 634.5" "Cell type enriched" "Detected in some" 335 "Plasma cells: 13473.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "memory B-cell: 52.8;naive B-cell: 27.8" "Lineage enriched" "Detected in many" 9 "B-cells: 52.8" "Cell line enriched" "Detected in some" 11 "Karpas-707: 148.5" "Immunoglobulin genes" NA NA 2600000000 "unprognostic (1.39e-2)" "unprognostic (3.81e-3)" "unprognostic (2.96e-2)" "unprognostic (4.93e-2)" "unprognostic (7.41e-3)" "unprognostic (2.42e-1)" "unprognostic (7.85e-2)" "unprognostic (5.60e-2)" "unprognostic (3.07e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.67e-7)" "unprognostic (7.02e-2)" "unprognostic (4.31e-1)" "unprognostic (1.75e-1)" "unprognostic (3.26e-1)" 10.7 59.9 0.0 209.7 0.0 36.7 47.1 0.0 0.5 42.0 0.2 195.2 220.5 4.8 15.5 45.9 6.6 86.2 1.8 0.0 0.0 7.6 8.9 41.3 173.2 0.2 0.0 0.0 8.4 7.1 0.3 0.6 0.1 0.1 6.1 225.4 0.0 121.6 23.7 0.6 0.9 142.1 11.4 0.1 248.6 190.8 0.4 0.2 58.3 24.4 0.0 634.5 92.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 14.1 1.0 148.5 0.0 0.0 0.8 1.1 0.1 0.0 0.0 0.0 0.7 0.7 0.0 0.0 10.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 2.8 1.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 52.8 0.6 0.2 0.0 27.8 1.6 0.5 0.0 0.0 0.0 5.8 1.7 6.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13473.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 IGHV2-5 ENSG00000211937 "Immunoglobulin heavy variable 2-5" P01817 14 106037902-106038365 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 470.2;lymphoid tissue: 1438.6;stomach 1: 714.4" "Cell type enriched" "Detected in some" 333 "Plasma cells: 9414.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "memory B-cell: 66.7;naive B-cell: 67.3" "Lineage enriched" "Detected in many" 22 "B-cells: 67.3" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.8" "Immunoglobulin genes" NA NA 700000000 "unprognostic (1.38e-2)" "unprognostic (4.10e-3)" "unprognostic (2.51e-2)" "unprognostic (6.62e-3)" "prognostic favorable (1.41e-4)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "unprognostic (3.63e-1)" "unprognostic (1.47e-1)" "unprognostic (8.45e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.74e-2)" "unprognostic (1.69e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" 17.0 5.0 0.0 184.7 0.2 113.9 107.1 0.0 0.4 45.4 0.3 470.2 269.0 7.6 2.5 28.1 10.8 65.6 5.8 0.0 0.1 20.3 16.5 84.7 189.6 0.6 0.1 0.0 13.9 9.4 1.0 1.1 0.3 0.6 9.4 299.1 0.0 203.1 8.9 0.4 1.6 178.5 17.6 0.3 353.8 714.4 2.3 0.1 122.6 27.9 0.0 1438.6 251.7 12.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.6 0.4 0.0 0.1 1.2 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.4 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 66.7 0.0 0.0 0.1 67.3 0.1 0.1 3.0 0.0 0.0 0.0 0.0 10.5 0.0 0.2 0.0 0.4 0.0 0.1 0.6 0.1 0.0 0.6 0.3 0.1 0.4 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 27.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9414.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 IGHV3-7 ENSG00000211938 "Immunoglobulin heavy variable 3-7" P01780 14 106062151-106062683 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 465.8;lymphoid tissue: 979.9" "Cell type enriched" "Detected in some" 255 "Plasma cells: 20463.1" "Cancer enhanced" "Detected in many" "stomach cancer: 18.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 147 "memory B-cell: 134.0;naive B-cell: 107.0" "Lineage enriched" "Detected in single" 163 "B-cells: 134.0" "Cell line enhanced" "Detected in some" "Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9" "Immunoglobulin genes" NA NA 39000000000 "unprognostic (1.29e-2)" "unprognostic (5.57e-3)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-6)" "unprognostic (1.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (5.46e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (5.18e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (7.70e-2)" 48.2 10.2 0.8 50.5 0.8 71.8 204.9 0.6 3.3 88.1 0.8 465.8 155.4 38.1 8.3 17.9 13.6 37.3 2.1 0.3 0.3 17.4 20.5 56.9 103.4 2.0 1.9 0.3 24.9 4.8 2.9 1.9 0.3 3.5 9.2 306.6 0.0 267.6 23.2 1.3 9.7 207.7 3.6 3.7 615.3 232.6 13.3 0.4 0.0 21.3 0.1 979.9 43.3 15.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.4 2.6 5.8 0.0 0.0 2.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.7 0.0 1.2 1.6 0.0 0.1 0.0 0.6 0.0 0.4 0.8 0.2 0.1 0.0 0.2 134.0 0.2 0.2 0.3 107.0 0.1 0.1 0.1 0.1 0.2 0.6 0.2 12.6 0.8 0.8 0.6 3.3 0.3 0.3 2.0 1.9 0.3 3.5 3.7 0.4 1.4 0.0 0.0 0.0 0.0 80.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 0.0 5.3 0.0 0.0 0.0 4.4 31.1 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20463.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 7.4 0.0 0.5 0.0 IGHV3-11 ENSG00000211941 "Immunoglobulin heavy variable 3-11" P01762 14 106116635-106117204 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 222.2;lymphoid tissue: 618.3;stomach 1: 208.5" "Cell type enriched" "Detected in some" 142 "Plasma cells: 1655.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 445 "memory B-cell: 43.1;naive B-cell: 45.7" "Lineage enriched" "Detected in single" 458 "B-cells: 45.7" "Cell line enhanced" "Detected in some" "Daudi: 1.1;SH-SY5Y: 1.2" "Immunoglobulin genes" NA NA 18000000000 "unprognostic (2.07e-3)" "unprognostic (4.84e-2)" "unprognostic (5.81e-3)" "unprognostic (1.07e-2)" "unprognostic (1.04e-2)" "prognostic favorable (3.42e-5)" "unprognostic (4.12e-1)" "unprognostic (6.50e-2)" "unprognostic (2.37e-1)" "unprognostic (3.44e-2)" "unprognostic (3.51e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.86e-1)" "unprognostic (1.30e-1)" 8.4 26.2 0.0 176.6 0.1 38.3 66.7 0.0 0.5 35.0 0.2 222.2 195.1 6.9 12.4 38.9 6.7 44.1 8.7 0.0 0.0 6.7 10.6 29.4 124.7 0.7 0.1 0.0 7.9 2.0 0.2 0.8 0.0 0.1 4.1 169.5 0.0 120.7 3.8 0.3 0.7 117.8 11.3 0.1 220.9 208.5 1.3 0.5 45.3 17.1 0.0 618.3 110.4 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.1 0.0 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1655.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-13 ENSG00000211942 "Immunoglobulin heavy variable 3-13" P01766 14 106129540-106130072 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 68.1;lymphoid tissue: 138.4;urinary bladder: 91.3" "Group enriched" "Detected in some" 6 "B-cells: 6.7;Plasma cells: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 193 "memory B-cell: 18.8;naive B-cell: 19.6" "Lineage enriched" "Detected in single" 197 "B-cells: 19.6" "Cell line enhanced" "Detected in some" "MOLT-4: 1.8;U-266/70: 1.0" "Immunoglobulin genes" NA NA 33000000000 "prognostic favorable (3.24e-4)" "unprognostic (7.42e-2)" "unprognostic (1.96e-2)" "unprognostic (5.03e-2)" "prognostic favorable (6.67e-6)" "unprognostic (5.44e-2)" "unprognostic (1.23e-2)" "unprognostic (1.53e-1)" "unprognostic (5.31e-2)" "unprognostic (8.27e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (7.21e-5)" "unprognostic (6.79e-2)" "unprognostic (3.21e-1)" "unprognostic (4.45e-1)" "unprognostic (7.87e-2)" 1.1 37.0 0.0 24.3 0.0 7.0 17.4 0.0 0.2 1.9 0.0 68.1 49.9 1.5 0.0 15.5 4.4 9.8 1.8 0.0 0.0 1.0 1.5 7.3 39.8 0.0 0.1 0.0 1.6 0.7 0.0 0.1 0.0 0.0 1.1 36.4 0.0 31.2 1.5 0.0 0.0 23.0 5.7 0.1 57.0 43.3 0.9 0.0 9.4 2.8 0.0 138.4 91.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 IGHV3-15 ENSG00000211943 "Immunoglobulin heavy variable 3-15" A0A0B4J1V0 14 106153624-106154163 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 185.1;lymphoid tissue: 383.3;salivary gland: 179.2;stomach 1: 113.8;urinary bladder: 174.0" "Cell type enriched" "Detected in some" 112 "Plasma cells: 6281.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "white matter: 2.3" "Group enriched" "Detected in some" 9 "MAIT T-cell: 21.6;memory B-cell: 24.4" "Group enriched" "Detected in many" 9 "B-cells: 24.4;T-cells: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7" "Immunoglobulin genes" NA NA 20000000000 "prognostic favorable (8.85e-5)" "unprognostic (2.07e-1)" "unprognostic (1.94e-2)" "unprognostic (1.41e-2)" "unprognostic (1.62e-2)" "prognostic favorable (3.34e-5)" "unprognostic (5.20e-2)" "unprognostic (2.44e-1)" "unprognostic (9.67e-2)" "unprognostic (3.24e-2)" "unprognostic (2.53e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (6.85e-2)" "unprognostic (6.92e-2)" "unprognostic (7.12e-2)" "unprognostic (3.63e-1)" 7.1 37.2 0.1 25.0 0.6 1.8 23.4 0.0 1.2 13.1 0.2 185.1 4.5 5.0 0.9 11.8 16.5 29.9 1.1 0.1 0.1 8.9 10.7 40.4 0.0 1.5 0.2 0.0 5.9 19.2 0.4 1.3 0.4 0.4 9.6 14.7 0.0 179.2 23.2 0.8 4.3 108.1 0.3 0.0 383.3 113.8 0.5 0.1 0.0 15.0 0.0 10.5 174.0 9.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 2.4 0.7 0.0 0.0 0.0 1.9 4.1 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.1 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.1 0.1 0.0 21.6 24.4 0.1 0.2 0.2 0.0 0.2 0.1 2.5 0.0 0.0 0.2 0.1 1.8 0.1 0.6 0.0 1.2 0.1 0.1 1.5 0.2 0.0 0.4 0.0 0.1 2.3 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.1 8.2 0.0 0.0 0.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6281.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 IGHV3-16 ENSG00000211944 "Immunoglobulin heavy variable 3-16 (non-functional)" A0A0C4DH30 14 106165205-106165730 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 3200000000 "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-18 ENSG00000211945 "Immunoglobulin heavy variable 1-18" A0A0C4DH31 14 106184901-106185394 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 490.6;salivary gland: 236.2" "Cell type enriched" "Detected in some" 259 "Plasma cells: 13773.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 21 "memory B-cell: 73.2" "Lineage enriched" "Detected in many" 21 "B-cells: 73.2" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6" "Immunoglobulin genes" NA NA 4700000000 "prognostic favorable (3.47e-4)" "unprognostic (2.53e-2)" "unprognostic (8.73e-3)" "unprognostic (2.56e-2)" "unprognostic (9.67e-3)" "prognostic favorable (8.27e-4)" "unprognostic (5.47e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-1)" "unprognostic (3.50e-2)" "unprognostic (3.60e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.84e-7)" "unprognostic (3.22e-1)" "unprognostic (2.62e-1)" "unprognostic (2.87e-1)" "unprognostic (2.44e-2)" 11.5 3.5 0.1 0.0 0.2 0.0 23.1 0.0 0.4 33.0 0.0 128.5 0.0 9.0 4.5 164.0 24.5 7.7 1.6 0.0 0.0 15.9 14.4 58.8 0.0 0.4 0.0 0.0 8.6 3.2 2.0 1.3 0.2 0.1 10.9 0.0 0.0 236.2 0.0 0.4 0.9 104.1 2.6 0.1 490.6 84.7 0.5 0.1 0.0 34.1 0.2 0.0 157.6 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.6 0.5 0.8 0.0 0.0 1.1 1.2 2.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.4 1.0 0.5 0.0 0.3 0.0 1.4 0.0 3.4 0.0 0.1 0.0 0.0 0.1 73.2 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 53.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13773.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 3.2 0.0 0.1 0.0 IGHV3-20 ENSG00000211946 "Immunoglobulin heavy variable 3-20" A0A0C4DH32 14 106210936-106211453 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.1;lymphoid tissue: 218.5;stomach 1: 123.6;urinary bladder: 82.6" "Cell type enriched" "Detected in some" 24 "Plasma cells: 142.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 242 "memory B-cell: 28.5;naive B-cell: 19.8" "Lineage enriched" "Detected in single" 286 "B-cells: 28.5" "Cell line enhanced" "Detected in single" "Daudi: 1.2" "Immunoglobulin genes" NA NA 2200000000 "prognostic favorable (2.56e-5)" "unprognostic (2.30e-1)" "unprognostic (9.51e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.93e-4)" "unprognostic (1.35e-2)" "unprognostic (2.37e-1)" "unprognostic (2.45e-1)" "unprognostic (2.62e-1)" "unprognostic (2.42e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.09e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" 1.9 2.2 0.0 36.6 0.2 22.8 23.9 0.0 0.1 17.5 0.2 65.4 100.1 1.8 0.0 10.2 2.3 20.9 3.1 0.0 0.0 1.5 4.7 10.6 58.4 0.1 0.0 0.0 2.8 0.4 0.1 0.2 0.0 0.0 1.3 63.1 0.0 43.5 1.4 0.0 0.3 38.0 2.0 0.0 60.1 123.6 1.2 0.0 16.8 2.8 0.0 218.5 82.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 IGHV3-21 ENSG00000211947 "Immunoglobulin heavy variable 3-21" A0A0B4J1V1 14 106235064-106235594 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 401.3;salivary gland: 215.0" "Cell type enriched" "Detected in some" 86 "Plasma cells: 3885.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.1;NB-4: 2.1;NTERA-2: 1.2;RH-30: 2.3;TIME: 1.9" "Immunoglobulin genes" NA NA 37000000000 "prognostic favorable (1.30e-4)" "unprognostic (1.21e-2)" "unprognostic (7.19e-3)" "unprognostic (1.51e-2)" "unprognostic (9.16e-3)" "prognostic favorable (9.34e-4)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (3.03e-2)" "unprognostic (2.48e-1)" "unprognostic (4.05e-1)" "prognostic unfavorable (9.31e-8)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.77e-1)" 10.5 2.7 0.3 0.0 0.2 0.0 25.0 0.2 1.2 13.6 0.2 120.6 0.0 7.1 0.9 17.5 31.2 0.0 1.4 0.3 0.2 15.0 10.8 55.7 0.0 0.4 0.2 0.2 2.9 16.3 2.4 1.3 0.6 0.4 7.3 0.0 0.0 215.0 0.3 0.4 4.3 112.2 0.8 0.3 401.3 83.6 0.4 0.3 0.0 25.8 0.0 0.0 28.0 10.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.2 0.2 1.2 0.3 0.2 0.4 0.2 0.2 0.4 0.3 0.3 1.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.0 21.4 0.0 0.0 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3885.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 IGHV3-23 ENSG00000211949 "Immunoglobulin heavy variable 3-23" P01764 14 106268606-106269140 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1699.2;lymphoid tissue: 3014.7" "Cell type enriched" "Detected in some" 139 "Plasma cells: 15979.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 406 "memory B-cell: 548.5;naive B-cell: 336.7" "Lineage enriched" "Detected in many" 503 "B-cells: 548.5" "Cell line enhanced" "Detected in some" "BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8" "Immunoglobulin genes" NA NA 42000000000 "unprognostic (1.17e-3)" "unprognostic (5.43e-2)" "unprognostic (9.68e-3)" "unprognostic (3.31e-3)" "unprognostic (1.34e-2)" "prognostic favorable (3.85e-4)" "unprognostic (3.26e-1)" "unprognostic (4.79e-1)" "unprognostic (7.26e-2)" "unprognostic (6.52e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.79e-7)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-1)" "unprognostic (6.42e-2)" 67.1 191.1 0.5 920.7 0.6 187.2 346.7 0.2 2.0 80.8 1.5 1699.2 1655.6 37.3 9.9 345.7 30.4 233.3 46.7 0.2 0.3 26.8 56.9 250.9 866.7 1.1 0.6 0.2 43.0 31.3 1.5 2.7 0.9 0.6 35.6 1097.7 0.1 704.2 54.0 0.9 15.1 894.2 40.4 0.8 809.1 1068.3 35.3 0.4 199.3 52.7 0.1 3014.7 1001.7 27.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 4.1 0.7 0.0 0.0 0.6 3.0 9.0 0.0 0.0 2.7 5.8 0.8 0.1 0.0 0.0 0.0 0.0 1.8 0.0 1.3 1.3 1.1 1.5 0.0 0.3 0.0 0.9 0.0 0.4 0.4 0.1 0.2 0.0 0.1 548.5 0.2 0.3 0.3 336.7 0.1 0.2 1.0 0.2 0.2 0.2 0.8 62.4 0.5 0.6 0.2 2.0 0.2 0.3 1.1 0.6 0.2 0.6 0.8 0.4 1.3 0.1 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 12.0 0.0 0.0 0.0 1.6 19.4 0.0 1.3 0.0 1.8 2.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15979.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.1 0.0 IGHV1-24 ENSG00000211950 "Immunoglobulin heavy variable 1-24" A0A0C4DH33 14 106276548-106277043 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 188.3;salivary gland: 76.9" "Cell type enriched" "Detected in some" 4 "Plasma cells: 231.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "medulla oblongata: 1.2" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.8" "Lineage enriched" "Detected in single" 9 "B-cells: 2.8" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4" "Immunoglobulin genes" NA NA 3100000000 "prognostic favorable (9.01e-4)" "unprognostic (2.67e-2)" "unprognostic (1.66e-2)" "unprognostic (1.93e-3)" "prognostic favorable (3.61e-4)" "unprognostic (1.28e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.59e-1)" "unprognostic (4.10e-1)" "prognostic unfavorable (2.07e-7)" "unprognostic (5.43e-2)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "unprognostic (4.78e-2)" 4.4 1.4 0.0 34.1 0.0 0.0 8.6 0.0 0.2 56.8 0.2 17.8 0.0 5.7 0.0 46.7 6.6 4.7 1.0 0.0 0.1 7.0 6.5 17.8 0.0 1.2 0.2 0.0 19.7 1.4 0.1 0.4 0.3 0.0 3.1 14.1 0.0 76.9 0.0 0.1 0.8 24.2 2.1 0.0 188.3 37.3 14.3 0.0 0.4 14.6 0.0 18.6 63.9 6.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.1 0.0 0.0 2.8 0.1 0.2 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.2 0.0 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 231.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 IGHV2-26 ENSG00000211951 "Immunoglobulin heavy variable 2-26" A0A0B4J1V2 14 106301396-106301862 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 130.0;lymphoid tissue: 99.3;urinary bladder: 228.9" "Group enriched" "Detected in some" 39 "B-cells: 8.3;Plasma cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "hypothalamus: 9.9" "Immune cell enriched" "Detected in some" 14 "memory B-cell: 13.9" "Lineage enriched" "Detected in single" 140 "B-cells: 13.9" "Cell line enhanced" "Detected in some" "HL-60: 1.3;RH-30: 1.4" "Immunoglobulin genes" NA NA 190000000 "unprognostic (9.39e-3)" "unprognostic (4.50e-2)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" "prognostic favorable (6.05e-4)" "unprognostic (4.59e-2)" "unprognostic (1.18e-1)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" "unprognostic (4.99e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (6.68e-2)" "unprognostic (2.61e-1)" "unprognostic (2.24e-1)" "unprognostic (8.09e-2)" 6.3 7.8 0.0 59.6 0.0 21.8 14.2 0.0 1.8 13.6 0.1 35.4 62.1 4.3 0.0 31.7 3.9 130.0 5.6 0.0 9.9 2.2 6.0 20.9 3.6 0.2 0.5 0.0 0.5 1.6 0.0 0.3 0.0 0.2 6.3 87.4 0.0 44.6 0.9 0.1 0.3 55.5 4.4 0.2 99.3 65.7 0.0 0.8 0.0 6.9 0.0 21.9 228.9 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 9.9 0.2 0.5 0.0 0.2 0.2 0.8 0.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV4-28 ENSG00000211952 "Immunoglobulin heavy variable 4-28" A0A0C4DH34 14 106324254-106324760 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 45.3;lymphoid tissue: 88.1;salivary gland: 40.2;stomach 1: 31.0;urinary bladder: 123.7" "Cell type enriched" "Detected in some" 230 "Plasma cells: 346.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "spinal cord: 1.3" "Group enriched" "Detected in some" 206 "memory B-cell: 28.7;naive B-cell: 12.5" "Lineage enriched" "Detected in single" 288 "B-cells: 28.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 "unprognostic (3.14e-3)" "unprognostic (1.32e-2)" "unprognostic (8.05e-2)" "unprognostic (6.64e-3)" "prognostic favorable (2.63e-4)" "unprognostic (1.58e-2)" "unprognostic (7.52e-2)" "unprognostic (1.03e-1)" "unprognostic (5.74e-2)" "unprognostic (4.76e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.45e-1)" "unprognostic (1.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-1)" 1.2 11.4 0.0 41.3 0.0 6.0 13.1 0.0 0.2 3.3 0.0 45.3 45.3 1.0 0.0 12.6 1.9 7.7 1.2 0.0 0.7 1.8 2.4 9.0 10.1 0.0 0.1 0.0 3.6 0.4 0.0 0.2 0.0 0.0 0.8 44.5 0.0 40.2 1.8 0.0 0.5 30.5 2.0 1.3 42.7 31.0 0.5 0.0 5.9 4.4 0.0 88.1 123.7 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHV3-33 ENSG00000211955 "Immunoglobulin heavy variable 3-33" P01772 14 106359793-106360324 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1076.9;lymphoid tissue: 2391.5;stomach 1: 1794.9" "Cell type enriched" "Detected in some" 26 "Plasma cells: 556.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 101 "memory B-cell: 378.9;naive B-cell: 364.1" "Lineage enriched" "Detected in many" 103 "B-cells: 378.9" "Cell line enhanced" "Detected in some" "HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1" "Immunoglobulin genes" NA NA 7500000000 "unprognostic (1.04e-3)" "unprognostic (2.38e-2)" "unprognostic (8.95e-3)" "prognostic favorable (6.36e-4)" "unprognostic (6.84e-2)" "prognostic favorable (7.19e-5)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (7.31e-2)" "unprognostic (3.82e-2)" "unprognostic (1.70e-1)" "unprognostic (5.18e-1)" "prognostic unfavorable (4.10e-6)" "unprognostic (6.23e-2)" "unprognostic (1.69e-1)" "unprognostic (3.26e-1)" "unprognostic (5.92e-2)" 21.9 68.0 1.1 518.6 0.7 118.7 292.5 0.2 3.0 54.1 2.1 1076.9 890.1 16.4 14.7 128.7 19.0 143.2 33.1 0.3 0.2 15.2 42.1 212.0 801.9 1.3 0.9 0.2 110.9 29.6 2.0 1.8 0.8 0.6 23.4 782.9 0.0 625.3 39.9 0.5 3.6 346.7 37.7 0.4 479.9 1794.9 29.6 0.7 299.5 42.6 0.1 2391.5 383.1 18.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 5.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 0.8 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.8 2.9 7.7 0.0 0.0 1.4 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.7 8.1 0.0 0.2 0.0 0.8 0.0 0.2 0.6 0.1 1.1 0.0 1.9 378.9 3.6 0.9 0.3 364.1 1.4 0.6 1.0 0.2 0.1 0.2 0.5 44.6 1.1 0.7 0.2 3.0 0.3 0.2 1.3 0.9 0.2 0.6 0.4 0.7 1.0 0.0 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.0 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 556.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 IGHV4-34 ENSG00000211956 "Immunoglobulin heavy variable 4-34" P06331 14 106373663-106374145 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 285.6;urinary bladder: 281.2" "Cell type enriched" "Detected in some" 197 "Plasma cells: 15696.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 602 "U-698: 5353.4" "Immunoglobulin genes" NA NA 4300000000 "unprognostic (5.34e-3)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (5.34e-3)" "unprognostic (6.12e-2)" "prognostic favorable (2.77e-4)" "unprognostic (8.06e-2)" "unprognostic (3.89e-1)" "unprognostic (1.23e-1)" "unprognostic (4.27e-2)" "unprognostic (2.68e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.61e-1)" "unprognostic (1.01e-1)" "unprognostic (1.75e-1)" "unprognostic (7.51e-2)" 4.6 3.0 0.2 0.0 0.3 0.0 9.9 0.2 1.6 7.7 0.3 48.4 0.0 5.6 0.9 7.3 22.7 0.0 1.5 0.3 0.8 7.1 7.0 33.7 0.0 0.7 0.2 0.1 22.2 1.3 0.4 0.9 0.3 0.4 3.8 2.2 0.0 82.8 0.0 0.3 2.8 54.6 0.3 0.2 285.6 48.4 0.3 0.3 0.0 19.4 0.0 0.0 281.2 4.0 1.5 3.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 2.6 3.2 0.0 0.0 1.4 0.0 4.1 0.0 0.3 0.0 0.6 3.7 0.0 0.1 8.8 0.4 1.8 0.0 0.8 5353.4 0.0 3.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.5 0.0 0.8 0.2 0.3 0.2 1.6 0.3 0.8 0.7 0.2 0.1 0.4 0.2 0.3 1.5 0.0 0.0 0.0 0.0 79.4 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15696.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 IGHV3-35 ENSG00000211957 "Immunoglobulin heavy variable 3-35 (non-functional)" A0A0C4DH35 14 106389392-106389858 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 14.2;lymphoid tissue: 13.0;salivary gland: 7.6;stomach 1: 16.9;urinary bladder: 20.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "memory B-cell: 3.7" "Lineage enriched" "Detected in single" 35 "B-cells: 3.7" "Cell line enriched" "Detected in single" 6 "MOLT-4: 1.3" "Immunoglobulin genes" NA NA 19000000000 "unprognostic (1.39e-3)" "unprognostic (9.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.60e-2)" "prognostic favorable (2.53e-4)" "unprognostic (1.06e-1)" "unprognostic (4.74e-1)" "unprognostic (3.44e-1)" "unprognostic (2.37e-1)" "unprognostic (3.21e-1)" "unprognostic (4.29e-6)" "unprognostic (4.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" 0.1 0.1 0.0 13.0 0.0 3.4 1.2 0.0 0.0 2.8 0.0 10.4 14.2 0.4 0.0 0.5 1.1 1.1 0.5 0.0 0.0 0.1 0.7 2.4 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 11.3 0.0 7.6 0.5 0.0 0.2 6.1 0.6 0.0 5.3 16.9 0.0 0.0 0.0 0.0 0.0 2.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-38 ENSG00000211958 "Immunoglobulin heavy variable 3-38 (non-functional)" A0A0C4DH36 14 106410493-106411021 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.0;lymphoid tissue: 10.5;stomach 1: 5.9;urinary bladder: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory B-cell: 3.4;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 34 "B-cells: 3.4" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2900000000 "unprognostic (1.03e-5)" "unprognostic (5.11e-2)" "unprognostic (3.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.31e-3)" "unprognostic (8.40e-2)" "unprognostic (3.54e-2)" "unprognostic (2.05e-1)" "unprognostic (1.98e-1)" "unprognostic (1.75e-8)" "unprognostic (6.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "unprognostic (2.52e-1)" 0.3 0.1 0.0 6.0 0.0 1.6 3.3 0.0 0.0 1.4 0.0 7.7 10.0 0.1 0.0 0.9 0.2 0.9 0.2 0.0 0.0 0.1 0.4 1.8 2.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.0 0.2 7.0 0.0 4.2 0.0 0.0 0.2 5.8 0.0 0.0 4.4 5.9 0.7 0.0 0.0 0.0 0.0 10.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-39 ENSG00000211959 "Immunoglobulin heavy variable 4-39" P01824 14 106421711-106422218 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 478.7;salivary gland: 249.1;urinary bladder: 546.5" "Cell type enriched" "Detected in some" 432 "Plasma cells: 48104.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.6;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0" "Immunoglobulin genes" NA NA 5000000000 "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.95e-3)" "unprognostic (1.46e-2)" "unprognostic (5.65e-2)" "unprognostic (2.38e-3)" "unprognostic (4.48e-2)" "unprognostic (2.63e-1)" "unprognostic (1.77e-1)" "unprognostic (2.23e-2)" "unprognostic (2.35e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (2.04e-2)" "unprognostic (2.77e-1)" "unprognostic (7.68e-2)" "unprognostic (8.33e-2)" 9.6 6.6 0.5 381.7 0.3 14.6 33.5 0.1 0.8 24.2 1.2 142.9 4.4 12.6 2.6 19.2 17.9 0.0 6.2 0.2 0.1 13.8 13.9 55.4 0.0 0.5 0.8 0.1 17.8 3.7 1.2 1.4 0.0 0.6 7.2 5.1 0.0 249.1 9.6 0.5 12.2 144.8 2.0 0.1 478.7 109.0 1.3 0.2 2.8 37.6 0.0 5.4 546.5 13.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 1.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.2 0.2 0.0 2.1 0.0 2.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.2 1.6 0.1 0.1 0.1 1.7 0.5 0.1 1.1 0.1 0.1 0.2 0.1 0.0 0.5 0.3 0.1 0.8 0.2 0.1 0.5 0.8 0.1 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 111.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48104.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.3 0.0 IGHV1-45 ENSG00000211961 "Immunoglobulin heavy variable 1-45" A0A0A0MS14 14 106506996-106507491 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 19.1;lymphoid tissue: 30.5;stomach 1: 17.6" "Cell type enriched" "Detected in single" 20 "Plasma cells: 2.0" "Cancer enriched" "Detected in many" 7 "lung cancer: 15.4" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.2;U-266/84: 1.3" "Immunoglobulin genes" NA NA 380000000 "prognostic favorable (5.57e-4)" "unprognostic (5.07e-3)" "unprognostic (2.12e-3)" "unprognostic (1.46e-1)" "unprognostic (7.64e-3)" "unprognostic (2.90e-1)" "unprognostic (3.50e-2)" "unprognostic (3.16e-1)" "unprognostic (1.48e-1)" "unprognostic (1.05e-1)" "unprognostic (4.05e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-2)" "unprognostic (2.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.16e-1)" 0.2 0.1 0.0 3.7 0.0 1.8 19.1 0.0 0.0 0.3 0.0 4.6 1.1 0.5 0.0 6.5 0.2 0.6 0.1 0.0 0.0 0.2 0.2 3.6 7.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 6.2 0.0 11.6 0.0 0.0 0.1 2.3 0.7 0.0 6.9 17.6 0.1 0.0 3.0 0.3 0.0 30.5 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.1 0.6 0.3 0.0 1.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-46 ENSG00000211962 "Immunoglobulin heavy variable 1-46" P01743 14 106511117-106511856 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 45.5;lymphoid tissue: 126.7;salivary gland: 67.9" "Cell type enriched" "Detected in some" 201 "Plasma cells: 8432.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2" "Immunoglobulin genes" NA NA 2900000000 "prognostic favorable (6.28e-4)" "unprognostic (2.49e-2)" "prognostic favorable (7.34e-4)" "unprognostic (1.10e-2)" "unprognostic (3.53e-2)" "unprognostic (1.80e-3)" "unprognostic (1.87e-1)" "unprognostic (6.76e-2)" "unprognostic (8.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-1)" "prognostic unfavorable (1.56e-6)" "unprognostic (6.19e-2)" "unprognostic (2.52e-1)" "unprognostic (2.27e-1)" "unprognostic (5.13e-1)" 2.9 1.3 0.0 0.0 0.0 0.0 7.2 0.0 0.2 6.3 0.1 38.7 0.0 2.5 1.0 5.0 3.5 0.7 4.7 0.0 0.0 3.2 4.2 15.4 0.0 0.1 0.0 0.0 3.0 5.4 0.1 0.4 0.4 0.1 1.9 45.5 0.0 67.9 0.0 0.1 0.7 34.5 0.0 0.0 126.7 25.3 0.2 0.0 0.0 10.6 0.2 0.0 5.2 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 1.2 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.1 1.1 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 1.9 41.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8432.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 IGHV3-48 ENSG00000211964 "Immunoglobulin heavy variable 3-48" P01763 14 106537810-106538344 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 521.1;lymphoid tissue: 866.0;stomach 1: 408.5" "Cell type enriched" "Detected in some" 100 "Plasma cells: 5878.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Group enriched" "Detected in some" 527 "memory B-cell: 187.1;naive B-cell: 97.5" "Lineage enriched" "Detected in single" 693 "B-cells: 187.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.6" "Immunoglobulin genes" NA NA 49000000000 "unprognostic (9.19e-3)" "unprognostic (1.87e-2)" "unprognostic (5.12e-2)" "unprognostic (9.07e-3)" "unprognostic (1.77e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.23e-1)" "unprognostic (9.59e-2)" "unprognostic (2.65e-1)" "unprognostic (4.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (4.88e-8)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" 6.9 23.1 0.0 234.8 0.1 81.9 56.9 0.0 1.3 26.1 0.5 438.3 521.1 8.2 0.1 33.7 12.2 39.0 6.9 0.0 0.0 10.6 18.7 32.6 126.3 0.4 0.1 0.0 12.3 8.9 0.9 0.9 0.1 1.3 6.9 255.6 0.0 166.1 16.2 0.6 1.6 135.5 17.8 0.2 273.3 408.5 28.1 0.1 36.6 16.1 0.0 866.0 250.8 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 187.1 0.0 0.0 0.1 97.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 22.0 0.0 0.1 0.0 1.3 0.0 0.0 0.4 0.1 0.0 1.3 0.2 0.1 0.2 0.0 0.0 0.0 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.7 17.9 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5878.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 IGHV3-49 ENSG00000211965 "Immunoglobulin heavy variable 3-49" A0A0A0MS15 14 106556936-106557477 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 212.7;lymphoid tissue: 376.7;stomach 1: 183.9" "Cell type enriched" "Detected in some" 46 "Plasma cells: 717.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "medulla oblongata: 1.0" "Group enriched" "Detected in some" 187 "memory B-cell: 59.4;naive B-cell: 42.2" "Lineage enriched" "Detected in single" 219 "B-cells: 59.4" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Immunoglobulin genes" NA NA 1600000000 "prognostic favorable (7.16e-4)" "unprognostic (7.91e-3)" "unprognostic (2.50e-2)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.34e-6)" "unprognostic (4.47e-2)" "unprognostic (4.30e-2)" "unprognostic (7.00e-3)" "unprognostic (9.17e-2)" "unprognostic (2.18e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.00e-1)" 21.0 7.2 0.1 113.3 0.3 46.1 42.9 0.0 0.5 11.6 0.2 212.7 186.0 4.7 3.9 20.2 5.1 11.0 9.4 0.0 0.1 4.9 12.9 43.6 109.5 1.0 0.1 0.0 26.8 1.8 0.2 0.4 0.0 0.3 3.0 140.6 0.0 89.2 12.2 0.2 0.3 88.9 11.6 0.1 184.7 183.9 1.8 0.1 21.6 9.8 0.0 376.7 100.9 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 42.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.8 0.1 0.3 0.0 0.5 0.0 0.1 1.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 717.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 IGHV5-51 ENSG00000211966 "Immunoglobulin heavy variable 5-51" A0A0C4DH38 14 106578744-106579236 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 551.4;salivary gland: 226.3;urinary bladder: 356.7" "Cell type enriched" "Detected in some" 87 "Plasma cells: 5993.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3" HPA006014 Approved "Immunoglobulin genes" NA NA 2700000000 "HPA006014: " "unprognostic (2.03e-3)" "unprognostic (1.00e-1)" "unprognostic (3.21e-2)" "unprognostic (7.65e-3)" "unprognostic (1.80e-2)" "prognostic favorable (5.47e-4)" "unprognostic (2.40e-2)" "unprognostic (1.15e-1)" "unprognostic (3.92e-2)" "unprognostic (6.47e-2)" "unprognostic (2.49e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.70e-1)" "unprognostic (1.17e-1)" 10.6 4.9 0.3 0.0 0.5 0.0 26.2 0.1 1.4 14.6 0.7 142.0 0.0 8.7 6.4 19.2 15.4 27.3 1.5 0.1 0.3 15.1 15.1 56.7 0.0 0.6 0.0 0.0 8.9 17.2 1.0 2.3 0.6 0.6 11.3 0.0 0.0 226.3 0.0 0.7 3.2 146.0 1.7 0.2 551.4 100.7 4.8 0.2 0.0 25.8 0.0 0.0 356.7 14.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 1.3 1.2 0.8 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.5 0.1 1.4 0.1 0.3 0.6 0.0 0.0 0.6 0.2 0.2 1.4 0.0 0.0 0.0 0.0 68.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.8 44.9 0.0 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5993.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 IGHV3-53 ENSG00000211967 "Immunoglobulin heavy variable 3-53" P01767 14 106592676-106593347 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 82.2;lymphoid tissue: 130.6;stomach 1: 43.7" "Cell type enriched" "Detected in some" 22 "Plasma cells: 176.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 99 "memory B-cell: 54.7;naive B-cell: 52.7" "Lineage enriched" "Detected in single" 101 "B-cells: 54.7" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 4300000000 "unprognostic (1.41e-3)" "unprognostic (1.12e-1)" "unprognostic (2.46e-3)" "prognostic favorable (5.66e-4)" "prognostic favorable (3.95e-4)" "unprognostic (3.91e-2)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (6.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.04e-5)" "unprognostic (1.79e-1)" "unprognostic (8.26e-2)" "unprognostic (2.64e-1)" "unprognostic (3.72e-1)" 2.9 0.8 0.0 37.5 0.0 8.0 15.7 0.0 0.1 4.7 0.0 67.2 82.2 1.0 0.3 4.2 2.0 6.7 1.4 0.0 0.0 1.8 2.8 7.8 38.9 0.0 0.0 0.0 3.3 1.3 0.1 0.1 0.0 0.0 1.1 74.7 0.0 32.5 2.0 0.0 0.2 34.1 2.3 0.0 67.4 43.7 1.6 0.0 8.2 4.6 0.0 130.6 10.3 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 54.7 0.0 0.0 0.0 52.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 176.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHV1-58 ENSG00000211968 "Immunoglobulin heavy variable 1-58" A0A0C4DH39 14 106622357-106622855 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 51.5;urinary bladder: 206.2" "Group enriched" "Detected in some" 17 "B-cells: 2.4;Plasma cells: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "memory B-cell: 8.7;naive B-cell: 12.7" "Lineage enriched" "Detected in single" 58 "B-cells: 12.7" "Cell line enhanced" "Detected in single" "MOLT-4: 1.5" "Immunoglobulin genes" NA NA 120000000 "unprognostic (9.63e-3)" "unprognostic (6.78e-2)" "unprognostic (5.64e-2)" "unprognostic (4.04e-2)" "prognostic favorable (7.25e-4)" "unprognostic (4.56e-2)" "unprognostic (1.21e-1)" "unprognostic (4.62e-1)" "unprognostic (1.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (3.24e-2)" "unprognostic (5.28e-2)" "unprognostic (6.79e-2)" "unprognostic (1.36e-1)" 8.1 3.4 0.0 13.9 0.0 6.0 3.8 0.0 0.0 0.8 0.0 19.7 15.8 0.4 0.0 8.3 1.1 4.8 1.0 0.0 0.0 0.6 1.4 5.4 42.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 28.1 0.0 23.7 1.9 0.0 0.2 9.9 0.1 0.0 26.5 13.2 0.5 0.0 10.4 1.1 0.0 51.5 206.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-61 ENSG00000211970 "Immunoglobulin heavy variable 4-61" A0A0C4DH41 14 106639119-106639657 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 208.7;lymphoid tissue: 388.4;stomach 1: 144.3" "Cell type enriched" "Detected in some" 98 "Plasma cells: 2432.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 43 "memory B-cell: 39.0;naive B-cell: 25.5" "Lineage enriched" "Detected in single" 52 "B-cells: 39.0" "Cell line enriched" "Detected in single" 11 "MOLT-4: 8.7" "Immunoglobulin genes" NA NA 4400000000 "unprognostic (2.11e-3)" "unprognostic (6.59e-2)" "unprognostic (4.92e-2)" "unprognostic (1.12e-2)" "prognostic favorable (3.71e-6)" "unprognostic (6.96e-2)" "unprognostic (5.98e-2)" "unprognostic (1.26e-1)" "unprognostic (1.72e-2)" "unprognostic (9.95e-2)" "unprognostic (9.02e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (3.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.24e-1)" "unprognostic (2.32e-2)" 6.4 44.9 0.1 98.4 0.2 31.1 56.6 0.0 1.4 10.1 0.1 208.7 187.4 5.8 0.0 15.7 5.1 22.6 3.1 0.0 0.3 5.4 10.6 28.5 54.8 0.2 1.1 0.0 10.5 1.4 0.2 0.7 0.1 0.2 4.1 122.9 0.0 105.2 7.1 0.2 0.6 87.2 8.1 0.3 182.8 144.3 1.0 0.2 30.3 23.2 0.0 388.4 44.3 5.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 8.7 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 39.0 0.0 0.1 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.6 0.1 0.2 0.0 1.4 0.0 0.3 0.2 1.1 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2432.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 IGHV3-66 ENSG00000211972 "Immunoglobulin heavy variable 3-66" A0A0C4DH42 14 106675017-106675544 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 47.7;intestine: 60.1;urinary bladder: 104.9" "Cell type enriched" "Detected in some" 107 "Plasma cells: 958.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 137 "memory B-cell: 39.7" "Lineage enriched" "Detected in single" 137 "B-cells: 39.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;U-2 OS: 2.3" "Immunoglobulin genes" NA NA 7200000000 "prognostic favorable (2.43e-6)" "unprognostic (2.48e-2)" "unprognostic (5.05e-3)" "unprognostic (1.31e-3)" "unprognostic (2.20e-3)" "unprognostic (8.65e-2)" "unprognostic (1.59e-1)" "unprognostic (4.83e-2)" "unprognostic (1.87e-2)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.89e-6)" "unprognostic (3.87e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" "unprognostic (1.19e-1)" 3.9 0.9 0.0 0.0 0.0 11.2 3.9 0.0 0.4 15.5 0.2 60.1 0.0 1.4 1.2 27.3 3.3 47.7 0.2 0.0 0.0 1.3 3.6 13.2 41.5 0.1 0.0 0.0 5.7 0.4 0.0 0.1 0.0 0.0 3.9 32.6 0.0 16.3 5.7 0.0 1.5 10.2 1.3 0.0 32.0 6.4 0.6 0.0 0.0 2.5 0.0 40.0 104.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 39.7 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 958.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 IGHV1-69 IGHV1-E ENSG00000211973 "Immunoglobulin heavy variable 1-69" P01742 14 106714684-106715181 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 140.3;lymphoid tissue: 171.6;urinary bladder: 164.1" "Cell type enriched" "Detected in some" 85 "Plasma cells: 231.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "medulla oblongata: 2.5;pons: 2.4" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.5;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.4;HMC-1: 1.0;MOLT-4: 6.2;SCLC-21H: 1.1;U-698: 1.9" "Immunoglobulin genes" NA NA 2700000000 "unprognostic (3.51e-3)" "unprognostic (7.03e-2)" "prognostic favorable (9.56e-5)" "prognostic favorable (8.32e-4)" "unprognostic (1.06e-2)" "unprognostic (1.69e-1)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (1.28e-1)" "unprognostic (2.95e-1)" "unprognostic (8.20e-2)" "unprognostic (6.82e-2)" 4.0 1.4 0.0 0.0 0.2 0.1 6.6 0.0 0.5 21.5 0.3 32.6 0.0 7.0 0.0 7.0 5.7 78.2 0.5 0.0 0.2 6.8 4.9 18.1 0.0 2.5 0.0 0.0 2.0 0.8 1.8 0.5 0.0 2.4 4.7 140.3 0.0 56.4 13.2 0.1 0.3 31.9 6.8 0.0 171.6 31.2 0.1 0.3 0.0 25.4 0.0 0.0 164.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 1.3 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.2 2.5 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 231.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 IGHV2-70D ENSG00000211974 "Immunoglobulin heavy variable 2-70D" A0A0C4DH43 14 106723574-106724093 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.1;lymphoid tissue: 91.7;stomach 1: 47.4" "Cell type enriched" "Detected in single" 10 "B-cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "memory B-cell: 9.7;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 97 "B-cells: 9.7" "Cell line enriched" "Detected in single" 7 "MOLT-4: 1.7" "Immunoglobulin genes" NA NA 110000000 "unprognostic (5.57e-2)" "unprognostic (9.48e-3)" "prognostic favorable (3.34e-4)" "unprognostic (4.34e-2)" "unprognostic (8.37e-3)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (6.70e-2)" "unprognostic (3.83e-1)" "unprognostic (3.66e-2)" "unprognostic (8.11e-2)" 1.7 0.7 0.0 16.7 0.0 4.2 7.1 0.0 0.1 5.6 0.1 37.1 14.3 1.9 0.0 5.3 4.5 21.1 1.7 0.0 0.1 2.4 2.3 6.3 4.7 0.0 0.0 0.0 0.8 0.3 0.1 0.1 0.0 0.0 0.7 33.5 0.0 30.5 0.1 0.0 0.1 21.9 0.6 0.0 41.7 47.4 0.0 0.0 4.6 2.6 0.0 91.7 3.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-73 ENSG00000211976 "Immunoglobulin heavy variable 3-73" A0A0B4J1V6 14 106802694-106803233 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 143.1;lymphoid tissue: 83.6;urinary bladder: 82.4" "Cell type enhanced" "Detected in some" "B-cells: 6.1;Cholangiocytes: 1.5;Erythroid cells: 5.3;Plasma cells: 3.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 86 "memory B-cell: 69.9;naive B-cell: 42.9" "Lineage enriched" "Detected in single" 107 "B-cells: 69.9" "Cell line enhanced" "Detected in some" "Daudi: 1.4;HEL: 1.1;HL-60: 1.1;K-562: 1.7" "Immunoglobulin genes" NA NA 3200000000 "prognostic favorable (7.89e-4)" "unprognostic (3.61e-2)" "unprognostic (1.55e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.25e-7)" "unprognostic (4.23e-2)" "unprognostic (4.32e-2)" "unprognostic (5.40e-1)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.37e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.45e-1)" "unprognostic (2.52e-1)" "unprognostic (5.25e-2)" "unprognostic (4.37e-2)" 4.5 13.4 0.0 9.5 0.0 15.9 10.6 0.0 0.5 4.7 0.2 77.6 143.1 5.2 0.0 4.1 4.0 19.3 10.5 0.0 0.0 2.9 9.9 12.4 0.0 0.2 0.3 0.0 1.5 5.9 0.0 0.5 0.1 0.2 4.3 58.6 0.0 30.8 4.0 0.4 0.2 23.8 0.4 0.0 83.6 47.9 0.4 0.1 0.0 4.1 0.0 0.2 82.4 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 69.9 0.1 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 IGHV7-81 ENSG00000211979 "Immunoglobulin heavy variable 7-81 (non-functional)" A0A0B4J1V7 14 106874583-106875071 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.8;lymphoid tissue: 18.5;stomach 1: 12.5" "Group enriched" "Detected in some" 12 "B-cells: 1.5;Plasma cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory B-cell: 5.5;naive B-cell: 3.9" "Lineage enriched" "Detected in single" 14 "B-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 1.1;Daudi: 6.1;OE19: 1.2;U-698: 2.0" "Immunoglobulin genes" NA NA 270000000 "unprognostic (5.71e-4)" "unprognostic (3.87e-1)" "unprognostic (1.06e-1)" "unprognostic (6.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.24e-1)" "unprognostic (2.07e-1)" "unprognostic (1.14e-2)" "unprognostic (6.16e-5)" "unprognostic (1.69e-3)" "unprognostic (1.78e-2)" "unprognostic (1.08e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-1)" "unprognostic (3.63e-2)" 0.1 0.1 0.0 8.5 0.0 4.6 3.6 0.0 0.0 0.3 0.0 7.7 6.5 0.4 0.0 0.6 0.3 7.9 0.2 0.0 0.0 0.3 0.2 1.8 4.3 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 2.3 12.8 0.0 5.0 0.1 0.0 0.2 6.3 0.4 0.0 2.3 12.5 0.1 0.0 1.4 0.0 0.0 18.5 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.3 0.1 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSSK1B "FKSG81, SPOGA4, STK22D, TSSK1" ENSG00000212122 "Testis specific serine kinase 1B" Q9BXA7 5 113432553-113434989 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 224 "testis: 54.0" "Group enriched" "Detected in some" 108 "Early spermatids: 490.9;Late spermatids: 1056.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027827 Enhanced NA NA "HPA027827: AB_10603138" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 490.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1056.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784746 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 50.5" "Group enriched" "Detected in many" 6 "Early spermatids: 194.8;Late spermatids: 87.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 17.3" "Not detected" "Not detected" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.7 2.7 1.3 1.6 1.6 1.9 3.0 1.2 2.8 3.0 0.5 3.0 2.5 2.2 0.6 4.9 5.5 0.6 2.2 1.4 0.9 7.2 11.9 2.3 1.4 2.0 1.8 1.0 3.4 6.4 0.5 3.8 0.9 2.0 7.1 0.4 0.8 5.1 0.4 1.4 5.9 5.9 0.3 0.9 6.5 4.0 50.5 1.5 0.9 6.1 0.1 0.5 2.4 3.0 1.9 2.1 3.5 1.5 7.3 0.0 0.2 7.2 1.5 0.6 1.1 1.7 3.6 2.0 3.3 4.0 0.3 0.8 2.6 1.1 1.5 0.2 5.1 11.3 1.5 1.8 1.3 0.6 3.4 17.3 0.8 1.2 1.6 0.5 0.1 0.3 3.9 8.4 0.0 0.9 7.9 4.1 4.3 8.9 0.3 3.6 4.0 1.4 5.2 0.3 2.4 1.9 3.6 0.3 2.6 4.4 0.3 3.0 2.8 1.1 2.6 7.2 9.5 1.8 10.0 8.6 6.4 0.2 7.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 1.2 2.8 1.4 0.9 2.0 1.8 1.0 2.0 0.9 1.5 1.9 0.7 3.2 0.5 1.6 0.8 0.3 0.5 1.3 0.0 5.9 1.8 2.2 0.3 1.5 2.5 3.7 0.0 2.2 1.8 2.3 0.0 1.0 194.8 1.5 1.1 0.9 2.4 0.0 1.6 0.7 1.0 0.9 1.5 2.0 0.0 2.9 1.1 2.6 1.1 5.0 2.1 2.5 0.0 1.3 0.2 87.6 2.1 0.6 0.0 2.8 0.0 2.4 1.0 1.5 2.0 0.8 1.8 0.4 0.1 1.2 4.3 1.5 1.2 6.3 6.6 0.8 0.5 20.4 7.4 1.2 1.1 1.8 0.5 1.6 3.3 0.5 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.3 0.2 0.0 0.3 0.0 0.3 0.3 0.4 0.7 0.2 0.4 0.0 0.6 0.0 0.2 0.4 0.0 0.3 0.3 0.2 0.2 0.2 0.4 0.0 0.5 0.5 0.1 1.4 0.4 0.0 1.1 0.0 0.6 0.4 0.0 0.2 0.2 0.0 0.5 0.2 0.3 0.0 0.2 0.3 0.3 0.6 0.2 0.1 0.4 0.0 0.0 0.4 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.4 0.3 0.2 0.5 0.5 0.1 0.6 0.2 0.2 0.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 TAS2R50 T2R51 ENSG00000212126 "Taste 2 receptor member 50" P59544 12 10985913-10986912 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.55e-2)" "unprognostic (4.25e-1)" "unprognostic (1.14e-1)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (2.94e-1)" "unprognostic (2.24e-1)" "unprognostic (1.73e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.3 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TAS2R14 "T2R14, TRB1" ENSG00000212127 "Taste 2 receptor member 14" Q9NYV8 12 10937408-11171573 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 7.1;Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.2" NA NA "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (4.26e-2)" "unprognostic (1.41e-1)" "unprognostic (6.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (1.93e-2)" "unprognostic (1.22e-4)" "unprognostic (2.45e-2)" "unprognostic (1.07e-1)" "unprognostic (9.29e-3)" "unprognostic (4.71e-3)" 1.2 2.1 1.0 0.4 0.7 0.7 1.3 0.6 1.3 2.4 0.7 1.9 0.5 2.2 2.4 1.1 2.1 0.3 1.2 1.0 0.6 1.4 1.7 1.5 0.4 1.2 0.9 0.6 3.3 1.7 0.4 3.0 0.4 1.0 2.0 0.5 1.9 1.7 0.4 1.0 1.0 2.0 0.5 0.6 2.0 1.5 0.9 0.7 0.1 2.5 0.2 0.5 1.7 1.8 0.6 0.3 0.2 0.6 0.1 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.6 0.4 1.0 0.1 0.2 0.3 0.4 0.0 0.3 0.2 0.5 0.5 0.2 0.6 0.3 0.0 0.3 0.1 0.4 0.2 0.8 0.1 0.5 0.4 0.3 0.5 0.0 0.4 0.1 0.2 2.2 0.6 0.1 0.3 0.3 0.3 0.3 0.5 0.6 0.1 0.6 0.5 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.3 0.2 0.5 0.1 0.1 0.4 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.6 1.3 1.0 0.6 1.2 0.9 0.6 1.0 0.6 0.7 0.6 1.4 3.2 1.5 0.0 1.7 0.6 0.7 1.0 0.6 7.1 1.3 1.8 0.5 1.5 0.5 0.0 10.4 2.1 1.3 0.3 3.9 0.6 0.1 1.7 2.6 0.9 3.5 0.8 0.0 0.4 0.6 1.5 0.0 1.0 0.0 4.8 2.2 1.4 1.3 1.7 0.0 0.9 0.0 1.0 0.3 0.0 2.1 1.6 0.0 0.0 1.3 1.4 1.0 0.0 0.0 0.7 0.2 2.6 0.8 1.0 0.4 0.7 0.8 7.7 0.0 2.2 1.8 0.9 0.5 0.4 0.1 0.5 1.2 4.4 1.0 0.4 TAS2R13 "T2R13, TRB3" ENSG00000212128 "Taste 2 receptor member 13" Q9NYV9 12 10907926-10909562 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.78e-1)" "unprognostic (3.66e-2)" "unprognostic (1.77e-1)" "unprognostic (5.48e-2)" "unprognostic (1.52e-3)" "unprognostic (6.66e-3)" "unprognostic (4.50e-2)" "unprognostic (8.80e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.1 0.1 0.3 0.2 0.1 0.4 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 KRTAP16-1 KAP16.1 ENSG00000212657 "Keratin associated protein 16-1" A8MUX0 17 41307700-41309253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "skin 1: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070954 Enhanced NA NA "HPA070954: AB_2686327" "unprognostic (3.65e-5)" "unprognostic (4.61e-2)" 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRTAP29-1 KAP29.2 ENSG00000212658 "Keratin associated like protein 29-1" A8MX34 17 41301826-41302851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 22 "HDLM-2: 2.2" "Not detected" "Not detected" NA NA "unprognostic (1.15e-2)" "unprognostic (2.18e-3)" "unprognostic (9.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-6 "KAP9.6, KRTAP9L2" ENSG00000212659 "Keratin associated protein 9-6" A8MVA2 17 41265339-41266641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CTAGE1 "CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2" ENSG00000212710 "Cutaneous T cell lymphoma-associated antigen 1" "Q96RT6, Q9HC47" 18 22413599-22417915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 104 "testis: 10.4" "Group enriched" "Detected in some" 4 "Early spermatids: 117.4;Spermatocytes: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922, CAB016204" Uncertain NA NA "CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.41e-1)" "unprognostic (5.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.52e-1)" "unprognostic (1.70e-2)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.4 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.3 16.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.4 0.2 0.2 0.1 0.0 0.0 0.5 0.5 36.1 0.8 0.0 0.3 0.1 0.1 0.1 0.0 0.6 KRTAP4-11 "KAP4.11, KAP4.14, KRTAP4-14" ENSG00000212721 "Keratin associated protein 4-11" Q9BYQ6 17 41117181-41118373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "skin 1: 6.0" "Cell type enhanced" "Detected in single" "B-cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-9 KAP4.9 ENSG00000212722 "Keratin associated protein 4-9" Q9BYQ8 17 41105332-41106488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 302 "skin 1: 30.1" "Cell type enhanced" "Detected in single" "Glandular and luminal cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 KRTAP2-3 KAP2.3 ENSG00000212724 "Keratin associated protein 2-3" P0C7H8 17 41059240-41060114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 61 "skin 1: 11.8" "Cell type enhanced" "Detected in some" "Ductal cells: 104.8;Endometrial ciliated cells: 22.0;Glandular and luminal cells: 35.5;Pancreatic endocrine cells: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 36.8;fHDF/TERT166: 22.2;HBF TERT88: 31.9;LHCN-M2: 41.0;U-2 OS: 15.9" HPA059203 Supported NA NA "HPA059203: AB_2683947" "unprognostic (2.22e-1)" "unprognostic (2.58e-2)" "unprognostic (3.79e-3)" "unprognostic (3.25e-3)" "unprognostic (2.78e-2)" "unprognostic (6.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.41e-4)" "unprognostic (7.83e-6)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.1 0.0 36.8 1.2 9.0 7.6 0.4 0.3 0.0 0.0 22.2 2.2 0.1 0.0 0.6 31.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.6 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 5.4 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 15.9 1.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 1.5 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 104.8 0.0 22.0 1.6 0.4 0.0 0.0 0.0 0.6 0.4 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 KRTAP2-1 KAP2.1A ENSG00000212725 "Keratin associated protein 2-1" Q9BYU5 17 41046541-41047316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 390 "skin 1: 42.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 RTL8B "CXX1c, FAM127C, MAR8B, SIRH4" ENSG00000212747 "Retrotransposon Gag like 8B" Q17RB0 X 135020513-135022542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 103.8;Distal tubular cells: 29.4;Extravillous trophoblasts: 31.2;Syncytiotrophoblasts: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 52.9;U-2197: 67.7" NA NA "prognostic unfavorable (2.41e-5)" "unprognostic (1.13e-2)" "unprognostic (8.78e-3)" "unprognostic (1.08e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (3.32e-3)" "unprognostic (4.34e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-3)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.72e-4)" "unprognostic (2.56e-1)" "unprognostic (2.02e-1)" "unprognostic (1.80e-2)" 15.5 22.4 6.8 4.3 7.9 0.2 14.5 7.1 8.0 17.8 4.6 14.4 2.4 21.6 6.3 20.0 15.7 6.8 16.7 6.1 7.5 12.5 2.6 12.5 2.2 8.0 7.1 6.2 14.8 6.6 8.2 13.5 9.3 9.3 15.4 3.3 15.1 13.8 12.4 8.7 14.3 7.6 12.2 7.6 7.7 11.8 5.2 7.4 1.5 10.7 7.6 3.0 18.9 17.4 7.6 0.0 6.0 19.6 16.0 14.4 9.3 0.1 21.8 30.1 17.2 18.3 10.7 0.8 0.0 52.9 32.0 5.3 0.9 3.8 2.8 12.8 0.1 10.7 2.7 19.1 0.0 23.6 0.0 0.0 40.7 2.4 13.1 0.0 0.6 12.5 0.0 0.0 0.0 29.4 26.2 0.0 1.6 5.6 0.0 25.1 0.0 22.4 0.1 20.1 4.9 13.3 31.9 16.9 10.6 9.0 5.2 8.9 11.6 16.9 0.1 9.3 67.7 0.6 0.0 0.0 0.1 26.0 0.0 10.9 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.9 0.0 0.5 0.3 0.2 0.0 1.6 0.6 0.0 0.8 6.8 7.9 7.1 8.0 6.1 7.5 8.0 7.1 6.2 9.3 7.6 7.4 7.6 14.4 12.8 7.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 13.5 14.0 0.0 0.0 3.7 11.0 0.0 103.8 0.4 0.0 29.4 12.6 0.0 8.2 16.1 9.7 0.0 0.0 0.0 9.6 31.2 6.9 0.0 14.3 0.0 4.8 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 17.0 0.7 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 30.9 0.4 8.9 0.0 0.0 OR2A42 ENSG00000212807 "Olfactory receptor family 2 subfamily A member 42" Q8NGT9 7 144228244-144239605 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "choroid plexus: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.41e-1)" "unprognostic (3.14e-1)" 0.1 0.1 0.4 0.0 0.4 0.4 0.2 0.2 0.6 0.2 1.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.6 0.2 0.0 0.2 0.3 0.3 0.3 0.0 0.3 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.1 0.0 0.1 0.4 0.2 0.0 0.2 0.3 0.1 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.6 0.2 0.6 0.3 0.3 0.0 0.4 0.2 0.4 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.7" "Cell type enhanced" "Detected in many" "Distal tubular cells: 25.4;Horizontal cells: 16.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 78.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 23.5;MCF7: 55.7;REH: 44.9;RPMI-8226: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 5.8 23.3 19.3 0.8 17.0 0.6 6.9 2.7 78.7 8.0 0.0 8.4 1.6 4.9 0.6 32.7 8.2 0.9 35.1 28.4 5.3 15.6 22.8 5.1 0.8 15.9 4.1 16.1 5.1 9.1 5.6 19.9 0.5 19.0 14.4 0.4 2.6 13.2 4.1 15.5 15.1 5.1 0.6 0.0 5.2 10.1 5.8 13.3 0.4 14.5 3.7 0.9 7.9 13.5 27.7 1.5 2.8 1.9 3.3 1.3 0.3 5.8 0.8 1.1 1.4 1.2 8.3 5.2 0.7 4.1 0.9 0.3 4.4 4.6 0.2 0.3 2.1 1.7 5.9 10.1 23.5 4.2 1.2 2.0 1.0 1.5 1.3 0.6 5.1 1.4 8.4 8.3 0.4 0.5 55.7 3.0 2.8 2.4 5.5 6.1 44.9 0.4 25.1 1.4 0.2 5.4 19.0 0.6 1.7 1.2 1.0 19.5 4.3 0.6 0.9 1.2 2.0 0.1 0.7 0.8 0.3 2.6 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.3 17.0 2.7 78.7 28.4 5.3 15.9 4.1 16.1 19.0 0.0 13.3 27.7 1.9 6.4 2.2 2.9 1.2 0.4 1.0 2.0 0.6 9.3 7.7 5.8 9.3 4.3 1.7 7.3 12.5 0.3 0.4 5.5 25.4 5.3 0.6 4.4 1.2 1.4 7.8 0.4 13.1 2.2 0.2 1.4 1.5 5.9 0.0 13.0 1.4 9.1 1.3 16.8 13.4 4.4 0.0 0.6 0.8 1.1 1.2 1.8 1.8 5.6 1.6 8.7 0.0 1.5 2.9 3.6 5.1 3.4 0.3 1.9 4.4 9.4 3.9 5.6 0.0 2.5 1.8 1.5 2.4 2.7 1.8 0.3 0.5 2.7 3.8 1.6 KRTAP3-3 KAP3.3 ENSG00000212899 "Keratin associated protein 3-3" Q9BYR6 17 40993430-40994164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 218 "skin 1: 77.6" "Cell type enriched" "Detected in single" 4 "Enteroendocrine cells: 1.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042992 Supported NA NA "HPA042992: AB_2678258" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP3-2 KAP3.2 ENSG00000212900 "Keratin associated protein 3-2" Q9BYR7 17 40999193-40999906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 64.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.2;Squamous epithelial cells: 4.8;Suprabasal keratinocytes: 1.1;Urothelial cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042992 Approved NA NA "HPA042992: AB_2678258" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 64.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.1 0.0 0.0 0.0 0.0 2.6 KRTAP3-1 KAP3.1 ENSG00000212901 "Keratin associated protein 3-1" Q9BYR8 17 41008521-41019324 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 285 "skin 1: 140.6" "Cell type enriched" "Detected in some" 4 "Basal prostatic cells: 581.4" "Cancer enhanced" "Detected in some" "stomach cancer: 2.8;urothelial cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;BJ: 4.9;CACO-2: 12.7;HaCaT: 2.4;T-47d: 2.0" "Not detected" "Not detected" NA NA "unprognostic (4.24e-1)" "unprognostic (3.00e-2)" "unprognostic (7.37e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 140.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 581.4 0.0 4.0 0.0 0.9 0.0 0.0 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.3 1.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.3 0.0 1.4 11.2 0.0 0.0 71.8 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 134041.0" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 30444.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 50775.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075648 Approved Centrosome,Mitochondria NA NA Mitochondria Centrosome "HPA075648: AB_2686760" "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favorable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 20284.3 30118.1 82919.4 4159.7 82861.5 3141.7 15057.0 80554.6 134041.0 6937.8 87207.2 18576.1 9108.0 7744.1 6029.0 10908.0 7818.9 4404.5 101941.2 81380.5 78950.0 46194.6 75538.8 8535.5 2809.8 92169.1 80564.4 73967.3 6785.7 16172.4 20594.0 9306.1 5889.2 88098.2 16578.2 14178.9 15885.7 13020.1 12836.1 59551.4 12235.3 17158.2 7041.9 75680.3 7344.0 28422.9 9635.9 85447.3 4476.2 11363.4 103996.2 4893.3 15242.1 7500.1 91212.5 4598.0 4121.5 7308.1 7468.2 25088.0 5217.1 3223.3 9523.0 2384.3 1468.4 2651.9 6894.3 4080.7 11229.9 3809.7 6497.0 2387.4 8496.5 1155.8 10210.3 2895.1 4454.2 4711.8 8095.9 50775.4 13024.1 3671.8 8429.4 6965.0 9229.0 10159.4 2792.9 9675.2 10923.1 2983.6 5697.7 4556.7 7771.2 5412.1 8124.5 3199.8 10639.4 1846.3 4811.8 4953.4 1842.5 3155.8 5025.1 7636.0 9464.9 2208.4 2971.3 4666.2 7283.7 3197.8 15599.0 5199.9 10420.1 9592.2 3792.1 4708.5 5630.1 3738.0 6985.1 3552.9 6053.5 2725.1 11018.8 1816.1 16170.2 4327.0 8286.8 2536.0 2849.6 3435.6 4233.2 2723.9 2939.9 2282.7 4618.7 3206.8 4006.1 2010.3 2906.4 2817.9 2884.1 2096.4 2551.4 82919.4 82861.5 80554.6 134041.0 81380.5 78950.0 92169.1 80564.4 73967.3 88098.2 75680.3 85447.3 91212.5 503.6 224.4 217.6 0.0 2303.6 228.5 254.2 170.4 5991.6 0.0 764.0 886.3 30444.3 1464.1 438.4 323.7 0.0 0.0 449.8 1428.3 90.1 152.9 52.8 870.1 618.8 942.3 256.6 3302.0 0.0 342.2 0.0 1129.2 5335.9 1186.3 479.3 1394.0 1520.3 4413.7 0.0 0.0 0.0 727.8 99.7 1977.9 193.5 286.1 417.2 1043.8 256.1 0.0 312.9 0.0 133.9 0.0 0.0 284.5 867.0 230.9 4395.8 129.7 1228.2 589.4 582.7 0.0 348.4 711.2 1052.8 247.0 207.4 5256.4 242.2 0.0 1387.0 308.6 573.4 207.9 MAP10 "KIAA1383, MTR120" ENSG00000212916 "Microtubule associated protein 10" Q9P2G4 1 232804892-232808407 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.3;Cone photoreceptor cells: 22.9;Spermatocytes: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 6.8;NB-4: 6.7;REH: 5.5;THP-1: 10.1;U-937: 6.9" "Low region specificity" "Detected in all" HPA052496 Approved NA NA "HPA052496: AB_2681852" "unprognostic (2.70e-1)" "unprognostic (6.18e-2)" "unprognostic (4.41e-2)" "unprognostic (6.05e-2)" "unprognostic (4.41e-1)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (4.60e-1)" "unprognostic (6.84e-2)" "unprognostic (1.04e-1)" "unprognostic (6.26e-3)" "unprognostic (2.03e-2)" "unprognostic (1.73e-3)" "unprognostic (3.97e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-1)" "unprognostic (7.98e-2)" 1.1 1.0 0.3 1.2 0.6 0.7 1.8 0.1 0.8 1.6 0.0 1.0 1.5 1.1 2.6 0.5 1.3 1.3 2.7 0.5 0.4 1.1 2.5 1.2 2.7 0.7 0.3 0.3 2.2 1.8 0.7 0.8 1.1 0.6 1.0 0.8 3.6 1.5 0.9 2.6 0.4 1.7 1.3 0.1 1.5 1.5 3.1 0.1 3.8 2.2 1.5 2.0 0.9 0.5 0.4 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.3 0.0 4.0 0.0 2.0 1.6 0.0 0.0 0.0 0.9 0.6 1.5 0.0 0.2 0.2 0.0 1.7 2.6 0.0 2.4 0.2 0.2 0.0 0.3 3.1 0.0 1.0 0.0 1.4 1.9 6.8 6.7 0.0 1.7 0.0 5.5 0.0 1.9 1.4 1.6 3.3 2.7 0.0 0.3 0.0 0.9 0.6 10.1 0.7 0.0 1.7 0.2 1.2 1.9 0.0 0.0 1.5 6.9 0.1 5.1 1.9 1.7 0.5 1.4 0.6 0.6 0.8 0.2 2.5 1.3 1.2 0.9 0.0 1.2 3.2 2.9 1.4 0.7 0.3 0.6 0.1 0.8 0.5 0.4 0.7 0.3 0.3 0.6 0.1 0.1 0.4 4.4 0.0 1.1 0.7 1.6 0.4 0.3 1.0 1.2 12.3 1.0 1.0 4.9 5.7 2.1 0.0 22.9 0.7 1.9 0.7 0.0 2.9 3.1 1.0 2.2 2.6 0.0 0.4 4.2 3.0 0.5 1.8 1.5 0.5 1.3 3.4 0.4 1.3 1.5 0.0 3.5 2.3 6.1 1.2 0.8 2.2 0.6 1.1 0.0 1.0 5.6 3.2 2.1 2.5 3.2 1.7 0.3 0.7 0.7 0.2 1.9 0.2 1.5 8.5 0.0 2.4 1.2 11.2 6.1 0.8 0.3 0.3 1.3 4.4 2.0 0.4 KRTAP12-4 KRTAP12.4 ENSG00000212933 "Keratin associated protein 12-4" P60329 21 44654213-44654659 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-3 "KAP10.3, KAP18.3, KRTAP18-3" ENSG00000212935 "Keratin associated protein 10-3" P60369 21 44557790-44558795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 93 "skin 1: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP6-3 KAP6.3 ENSG00000212938 "Keratin associated protein 6-3" Q3LI67 21 30592440-30593075 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU5F1B "OTF3C, OTF3P1, POU5F1P1" ENSG00000212993 "POU class 5 homeobox 1B" Q06416 8 127322183-127420066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 2.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Distal enterocytes: 3.2;Endometrial ciliated cells: 5.5;Glandular and luminal cells: 10.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;EFO-21: 1.5;hTERT-HME1: 3.7;NTERA-2: 1.9" HPA058267 Supported Nucleoplasm NA NA Nucleoplasm "HPA058267: AB_2683659" "unprognostic (1.74e-2)" "unprognostic (2.27e-2)" "unprognostic (2.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.65e-1)" "unprognostic (5.85e-2)" "unprognostic (9.31e-4)" "unprognostic (2.21e-3)" "unprognostic (1.13e-1)" "unprognostic (3.25e-1)" "unprognostic (6.56e-2)" "unprognostic (5.11e-2)" "unprognostic (5.60e-10)" "unprognostic (1.21e-1)" "unprognostic (7.05e-3)" "unprognostic (1.37e-1)" "unprognostic (7.33e-3)" 0.1 0.1 0.3 0.1 0.2 0.2 0.7 0.6 0.3 0.3 2.5 0.4 0.1 0.5 0.6 0.2 0.5 0.2 0.0 0.5 0.3 0.4 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.4 0.1 0.2 0.3 0.6 0.5 0.2 1.8 0.3 0.1 0.6 0.1 0.1 0.0 0.2 0.3 0.2 0.2 0.3 0.5 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 1.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.6 0.3 0.5 0.3 0.2 0.3 0.2 0.3 0.0 0.2 0.3 1.0 0.0 0.5 0.0 0.2 0.3 0.3 0.3 0.0 0.0 1.0 0.9 0.7 0.0 0.4 0.0 4.2 0.0 0.1 3.2 1.9 1.5 0.3 5.5 0.9 1.4 0.0 0.0 0.0 1.8 0.0 0.4 0.0 10.6 0.0 0.0 0.4 0.1 0.0 1.7 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 2.3 0.0 0.1 0.2 2.7 0.4 0.9 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.6 0.0 0.4 0.0 1.3 0.4 ZNF580 ENSG00000213015 "Zinc finger protein 580" Q9UK33 19 55635016-55643470 "Predicted intracellular proteins, Transcription factors" "Chemotaxis, Inflammatory response, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 279.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054058 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA054058: AB_2682360" "unprognostic (1.36e-2)" "unprognostic (5.13e-3)" "unprognostic (2.47e-3)" "unprognostic (3.80e-2)" "unprognostic (1.72e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (3.54e-2)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "prognostic favorable (2.36e-5)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.79e-6)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-1)" "unprognostic (3.46e-3)" 31.3 46.5 52.8 18.3 49.7 13.0 34.2 46.9 62.5 47.4 43.7 46.4 13.3 59.5 24.2 26.1 48.4 5.5 35.5 51.7 47.6 45.7 17.9 33.7 17.6 54.2 50.1 47.2 57.1 44.1 26.7 69.1 8.6 49.7 60.5 9.9 12.5 36.1 20.8 19.4 30.6 39.9 18.3 43.1 45.0 42.4 17.8 48.3 14.6 66.1 5.5 14.4 49.6 34.1 45.7 17.6 31.2 27.0 17.6 29.2 16.4 11.3 24.5 25.6 33.3 39.9 5.5 15.6 13.1 6.6 31.2 7.3 15.1 18.2 19.3 25.1 43.4 279.2 23.6 32.7 14.6 38.6 11.1 53.7 35.4 20.5 15.9 29.6 43.8 23.1 29.9 26.1 32.1 27.8 5.1 50.5 15.9 14.4 10.9 43.0 51.1 10.4 53.1 38.0 19.2 30.2 39.3 15.2 15.0 22.4 14.6 13.3 11.4 30.5 18.0 29.4 13.3 13.2 72.3 22.8 29.7 9.9 17.0 17.9 4.6 3.4 11.5 1.1 5.1 1.2 8.4 2.6 2.5 3.7 12.3 3.1 2.7 5.9 3.1 9.9 4.0 2.2 1.7 52.8 49.7 46.9 62.5 51.7 47.6 54.2 50.1 47.2 49.7 43.1 48.3 45.7 41.4 9.6 9.7 18.3 39.7 18.6 44.0 32.6 57.5 33.4 51.0 61.2 10.0 37.1 16.3 57.0 4.2 25.3 36.5 25.1 76.3 47.0 3.5 16.1 46.2 36.6 67.4 21.0 9.9 56.0 20.2 36.6 31.6 16.1 19.1 42.8 48.2 11.9 25.9 20.2 10.8 27.2 18.3 31.4 31.1 8.7 59.4 29.2 39.2 11.2 39.1 44.2 28.8 11.6 13.5 45.7 30.9 70.7 49.7 37.6 49.2 78.2 7.6 22.8 39.5 28.5 48.6 11.3 12.9 49.2 16.9 19.0 22.7 70.5 29.8 35.8 ZNF611 MGC5384 ENSG00000213020 "Zinc finger protein 611" Q8N823 19 52702813-52735073 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (9.92e-3)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-2)" "unprognostic (4.02e-4)" "unprognostic (2.93e-1)" "unprognostic (2.70e-3)" "unprognostic (1.40e-2)" "unprognostic (4.06e-3)" "unprognostic (1.34e-1)" "prognostic favorable (3.33e-4)" "unprognostic (6.43e-2)" "unprognostic (3.28e-1)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" 3.1 1.5 1.9 2.8 3.0 3.5 3.7 3.3 2.4 2.6 2.1 2.7 2.4 3.4 3.5 1.6 7.0 3.0 3.0 1.8 2.7 4.0 1.8 3.0 3.5 2.5 1.9 1.5 4.4 4.3 2.9 2.3 4.4 2.6 3.6 3.1 4.3 2.1 4.4 1.6 1.7 1.9 3.2 2.3 3.6 2.7 3.2 2.3 4.4 4.0 1.9 3.9 2.5 2.2 4.7 3.5 3.5 4.2 5.9 4.2 4.3 6.2 4.4 5.0 4.3 5.2 4.7 2.7 5.2 2.6 3.5 4.6 2.0 6.1 3.0 5.4 0.4 4.0 7.2 6.3 2.0 2.7 0.0 5.5 3.9 1.5 3.6 5.9 2.8 4.7 4.8 3.6 0.1 4.3 2.3 5.6 2.4 3.4 2.7 4.2 5.7 5.7 2.2 5.6 12.2 3.4 3.8 6.1 3.0 1.1 10.1 3.8 3.8 5.6 2.7 3.8 2.8 3.9 1.3 7.3 8.4 0.0 0.8 4.7 6.8 2.6 8.8 5.4 2.6 6.2 4.4 4.3 4.8 2.8 3.8 4.3 3.4 9.3 3.5 4.0 2.3 3.4 2.8 1.9 3.0 3.3 2.4 1.8 2.7 2.5 1.9 1.5 2.6 2.3 2.3 4.7 6.3 12.8 5.9 10.4 10.1 3.8 6.8 3.8 3.4 9.0 3.8 3.8 5.0 8.6 9.3 23.9 14.6 10.7 12.0 4.9 7.9 5.1 9.8 17.4 7.6 6.2 7.8 13.7 17.0 2.7 9.3 5.6 5.6 32.8 17.1 14.8 4.2 2.4 4.8 6.7 23.5 3.9 6.1 5.7 2.9 1.3 4.1 5.6 0.0 18.7 7.5 3.4 19.6 15.1 24.3 4.9 2.5 2.6 7.4 11.7 4.6 7.8 6.2 7.0 13.1 6.8 5.8 3.6 6.9 3.7 6.1 9.3 12.1 6.0 3.0 11.8 KLK9 KLK-L3 ENSG00000213022 "Kallikrein related peptidase 9" Q9UKQ9 19 51002508-51009634 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 11.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.0" CAB025049 Enhanced "Secreted in other tissues" NA NA "CAB025049: " "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYT3 ENSG00000213023 "Synaptotagmin 3" Q9BQG1 19 50621307-50639881 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 27.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Excitatory neurons: 10.4;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 6.0" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.8;HMC-1: 5.3;JURKAT: 3.1;NTERA-2: 5.5;SH-SY5Y: 6.1;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (1.90e-1)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (4.36e-3)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-4)" "unprognostic (1.12e-1)" "unprognostic (3.49e-4)" "unprognostic (1.82e-4)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" 0.0 0.5 7.0 0.1 9.9 0.0 0.2 6.3 27.5 0.2 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 12.8 6.7 0.6 0.0 0.2 0.1 11.6 5.8 10.5 0.0 0.6 1.3 3.8 0.7 12.5 0.7 0.0 2.3 0.3 0.4 0.0 0.1 0.2 0.1 2.3 0.0 0.2 1.3 12.2 0.0 0.4 0.0 0.0 0.1 0.2 19.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.3 0.0 0.3 0.0 0.0 0.1 7.8 0.0 0.0 0.0 0.3 0.0 5.3 0.2 0.0 0.0 0.0 0.0 0.1 3.1 0.9 0.0 0.0 2.3 0.0 0.0 5.5 0.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 6.1 0.3 0.0 0.1 0.1 0.1 1.8 0.0 0.0 3.8 0.0 0.0 0.6 0.1 0.0 0.2 2.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 9.9 6.3 27.5 12.8 6.7 11.6 5.8 10.5 12.5 2.3 12.2 19.3 0.0 0.0 3.0 1.6 0.0 0.0 0.1 0.0 0.0 1.7 0.1 0.1 0.6 0.0 0.0 1.8 4.2 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 15.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.1 0.0 6.0 1.9 0.0 0.0 0.7 0.0 0.2 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.7 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 119.2;Late spermatids: 315.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" NA Yes 31000 "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.5 29.6 13.0 37.6 12.5 27.3 19.1 17.4 16.0 22.1 12.6 22.4 23.9 27.8 11.1 25.2 25.0 18.6 19.8 13.2 14.4 18.6 32.0 19.6 38.6 14.1 12.8 12.3 30.0 21.1 18.1 23.0 22.6 15.4 20.0 21.3 11.2 22.0 17.7 33.9 23.6 24.5 28.0 14.4 30.1 19.6 50.8 13.9 42.3 16.5 24.7 38.0 24.8 20.3 16.6 126.7 115.5 88.8 74.0 26.0 30.0 79.7 92.8 65.8 99.3 98.8 79.8 71.9 141.2 51.7 60.8 65.9 73.6 108.3 62.1 96.1 211.6 112.0 109.8 59.4 72.6 30.9 108.8 106.8 28.6 44.8 62.0 54.8 44.1 71.5 82.7 138.6 135.5 69.2 59.7 196.7 83.6 82.0 117.4 102.8 170.3 99.9 120.3 46.9 93.7 96.2 68.8 88.2 103.8 46.3 63.8 78.8 51.5 53.0 150.2 85.3 49.1 155.4 96.3 295.9 132.5 62.2 90.1 113.9 12.3 33.4 6.7 17.7 34.7 24.1 15.1 17.6 19.6 33.1 14.9 11.9 15.4 5.2 22.0 20.1 29.0 17.2 22.1 13.0 12.5 17.4 16.0 13.2 14.4 14.1 12.8 12.3 15.4 14.4 13.9 16.6 16.8 25.6 22.4 0.0 28.4 34.2 16.5 16.0 21.1 11.4 23.7 26.0 15.4 21.5 18.3 9.2 6.2 37.0 24.4 24.9 9.8 23.7 113.5 19.2 23.9 27.7 21.6 39.1 0.0 16.3 48.4 19.5 20.4 25.6 23.4 30.4 30.4 13.3 49.5 63.9 0.0 27.0 16.2 36.1 119.2 315.1 24.8 41.5 21.4 0.0 77.1 19.1 22.6 0.0 0.0 22.9 22.8 23.0 23.3 24.1 20.6 16.1 19.2 16.3 19.7 18.0 16.0 71.0 39.3 20.0 32.0 21.8 24.4 17.2 33.4 16.6 CGB8 ENSG00000213030 "Chorionic gonadotropin subunit beta 8" P0DN86 19 49047638-49049106 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 19.0" "Cell type enriched" "Detected in some" 6 "Syncytiotrophoblasts: 44.3" "Cancer enriched" "Detected in some" 4 "testis cancer: 5.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 157.9;U-251 MG: 57.2" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.35e-2)" "unprognostic (1.72e-1)" "unprognostic (7.44e-3)" "unprognostic (4.70e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 1.2 0.0 0.0 0.0 0.0 157.9 0.0 0.0 0.6 0.0 0.0 5.3 0.0 0.1 1.0 4.0 1.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 10.1 0.2 0.6 0.0 2.8 7.1 0.7 57.2 0.1 0.2 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 101.3;Inhibitory neurons: 138.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA042586: AB_2678064" "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 2.0 2.7 2.7 3.8 7.9 5.7 5.8 4.2 3.1 3.2 1.6 6.1 5.8 2.1 4.1 4.4 2.0 3.5 5.8 2.5 4.7 5.6 5.0 4.3 6.5 3.6 5.1 1.2 4.1 5.8 5.9 2.5 1.6 3.8 3.8 5.7 5.9 4.5 3.2 4.0 1.9 6.9 2.0 1.6 4.4 4.9 2.2 3.6 6.7 6.0 6.0 6.5 4.0 2.8 3.4 7.2 1.8 2.0 3.4 0.9 5.0 3.0 5.4 3.7 3.3 2.0 1.9 4.5 13.0 2.7 8.3 1.9 3.6 3.2 3.9 2.9 10.0 3.4 4.7 3.7 0.9 2.7 15.5 5.6 1.7 5.2 1.3 3.6 10.0 1.4 7.4 3.6 19.6 3.3 1.3 8.3 7.9 0.7 1.8 1.7 5.1 1.7 10.3 7.9 6.6 3.4 5.3 8.3 5.5 1.5 3.1 2.3 13.4 4.0 0.4 3.1 0.2 3.2 9.8 0.0 6.4 3.4 6.2 6.2 2.3 0.1 1.1 0.9 0.3 0.4 1.2 0.6 1.4 0.7 0.3 0.3 0.6 0.4 2.7 0.3 0.9 1.8 0.3 2.7 7.9 4.2 3.1 2.5 4.7 3.6 5.1 1.2 3.8 1.6 3.6 3.4 9.1 41.7 16.2 46.4 24.1 8.4 23.6 9.2 12.0 18.3 28.9 11.9 28.3 15.7 17.3 14.7 25.0 10.4 22.1 65.5 17.6 9.7 26.8 7.9 5.7 6.5 14.4 8.0 101.3 23.1 9.7 10.9 20.9 17.1 64.7 12.8 9.3 15.3 18.9 5.0 138.5 27.4 4.1 18.9 82.4 26.8 23.9 30.0 16.0 42.2 15.8 8.6 28.8 75.4 5.8 22.5 54.5 13.2 50.7 21.9 59.9 16.4 9.6 14.0 0.0 13.9 6.3 8.1 13.9 22.9 12.1 7.4 42.5 5.7 27.9 53.5 SFT2D2 "dJ747L4.C1.2, UNQ512" ENSG00000213064 "SFT2 domain containing 2" O95562 1 168225938-168253021 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 142.6;Late spermatids: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 53.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042207 Approved NA NA "HPA042207: AB_10794789" "unprognostic (4.34e-1)" "unprognostic (8.62e-2)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (8.62e-3)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.37e-1)" "unprognostic (1.91e-1)" "unprognostic (8.54e-2)" "unprognostic (4.00e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (2.15e-3)" "unprognostic (9.22e-2)" "unprognostic (1.22e-3)" "unprognostic (1.71e-1)" 6.9 6.3 11.5 6.8 11.7 32.6 10.4 7.2 9.0 9.0 9.5 8.0 5.0 17.9 7.2 13.3 8.3 6.2 4.9 11.8 16.6 8.4 9.8 8.8 10.7 14.5 9.9 7.5 14.7 6.2 6.9 12.5 5.1 12.3 6.5 8.2 3.0 11.7 4.7 3.9 15.5 9.0 10.1 9.2 11.1 6.9 18.6 10.7 8.4 6.6 3.5 11.4 5.5 8.7 15.5 15.6 19.4 7.7 14.2 22.0 12.4 15.8 10.7 7.9 8.3 9.3 20.7 15.6 13.9 16.1 15.8 7.5 51.3 13.2 11.9 11.1 19.4 4.9 10.3 26.3 15.0 11.8 17.3 15.7 14.5 8.9 11.0 9.8 6.4 11.6 18.9 9.8 17.8 9.5 6.5 15.0 12.8 9.2 23.1 4.4 16.4 10.6 10.8 12.3 18.4 4.9 9.4 13.4 16.8 14.6 12.5 13.4 15.4 12.8 10.8 8.2 11.6 14.3 6.8 13.5 20.6 8.6 12.1 11.6 20.6 12.1 4.4 8.9 22.0 5.2 7.3 5.2 5.8 16.9 6.9 4.8 5.5 5.7 7.1 27.5 53.2 6.4 8.1 11.5 11.7 7.2 9.0 11.8 16.6 14.5 9.9 7.5 12.3 9.2 10.7 15.5 22.3 44.8 33.1 3.3 43.4 28.0 16.2 30.0 23.3 0.7 39.7 37.3 5.1 25.8 39.1 38.6 4.2 9.5 142.6 63.9 1.9 23.6 65.7 64.2 45.6 32.9 31.8 31.6 1.2 20.5 26.4 44.9 32.1 86.1 49.4 35.7 33.5 54.3 45.5 3.3 0.3 24.8 18.3 99.4 77.3 142.5 24.2 60.5 42.7 13.1 58.5 11.3 40.2 3.0 9.4 37.0 21.4 33.8 23.0 33.0 36.8 37.3 46.6 6.5 26.3 25.7 22.2 30.6 10.1 44.8 48.3 9.9 38.2 23.4 28.6 23.0 CEP43 "FGFR1OP, FOP" ENSG00000213066 "Centrosomal protein 43" O95684 6 166999317-167094789 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.3;Cytotrophoblasts: 14.2;Extravillous trophoblasts: 16.2;Hofbauer cells: 10.3;Syncytiotrophoblasts: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071876 Approved Supported Centrosome NA NA Centrosome "HPA071876: AB_2686467" "unprognostic (9.14e-2)" "unprognostic (2.24e-1)" "unprognostic (3.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (9.59e-2)" "unprognostic (1.00e-1)" "unprognostic (6.95e-2)" "unprognostic (8.83e-2)" "unprognostic (1.08e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 6.5 15.0 10.5 12.7 8.8 16.8 14.5 8.9 10.2 13.6 9.0 12.5 16.0 15.0 17.1 9.1 27.2 11.3 9.0 8.5 8.3 17.5 36.6 7.4 15.0 9.7 9.4 8.5 13.1 11.4 10.6 14.2 8.5 9.1 9.5 17.1 25.7 8.9 9.2 8.5 11.7 15.9 10.5 8.5 11.2 11.4 59.0 8.1 15.9 15.6 10.5 17.8 9.3 9.4 9.6 26.1 14.3 35.3 24.2 20.3 15.1 42.7 33.0 21.9 26.4 25.3 53.1 21.6 31.0 18.3 20.2 70.3 24.0 31.4 23.3 49.3 19.5 27.0 21.4 26.7 58.2 10.8 38.4 21.6 8.4 16.8 54.2 25.2 16.4 18.5 34.5 70.9 25.8 34.2 24.0 31.1 55.8 30.2 50.0 10.9 35.3 23.9 25.7 27.8 13.8 26.2 26.2 26.9 28.6 11.7 24.6 23.5 46.7 12.2 26.1 43.7 31.6 42.1 21.8 32.3 31.4 29.4 35.4 32.7 0.4 6.5 23.5 5.1 6.1 7.6 12.1 5.8 4.8 10.7 8.4 3.4 5.5 38.8 6.3 6.7 16.4 11.7 4.9 10.5 8.8 8.9 10.2 8.5 8.3 9.7 9.4 8.5 9.1 8.5 8.1 9.6 3.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 14.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 16.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 6.3 1.3 0.0 0.0 0.0 SCAF8 "KIAA1116, RBM16" ENSG00000213079 "SR-related CTD associated factor 8" Q9UPN6 6 154733378-154834244 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035601, HPA035602" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035601: AB_2674698, HPA035602: AB_10673220" "unprognostic (4.60e-3)" "unprognostic (3.67e-2)" "unprognostic (7.90e-3)" "unprognostic (2.50e-2)" "unprognostic (6.18e-2)" "unprognostic (1.13e-1)" "unprognostic (1.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.61e-4)" "unprognostic (3.65e-1)" "unprognostic (2.08e-1)" "unprognostic (9.08e-2)" "unprognostic (2.66e-1)" "unprognostic (1.52e-1)" "unprognostic (2.42e-1)" "unprognostic (1.11e-1)" 17.3 11.9 8.2 15.7 10.0 37.5 19.1 18.5 9.9 18.3 3.4 15.1 12.8 22.3 16.5 13.4 17.6 13.7 14.9 7.5 7.9 16.8 15.5 16.4 22.7 8.0 8.7 6.1 27.2 15.1 21.4 10.3 19.0 8.7 17.0 17.8 23.4 15.8 15.7 18.9 18.4 14.4 20.5 6.8 19.3 15.3 23.7 8.6 27.0 21.5 19.3 21.0 15.4 14.8 10.9 16.2 15.3 44.6 27.1 29.3 29.8 27.2 25.7 35.8 33.1 33.4 24.2 16.0 49.7 20.4 29.6 29.4 21.1 39.5 33.8 44.2 21.7 19.7 44.6 16.0 29.8 33.8 41.7 28.8 32.3 35.0 29.0 45.0 25.7 28.6 21.6 52.6 29.4 30.8 29.1 44.6 28.2 31.0 24.4 11.3 42.3 24.4 27.1 28.1 29.0 27.4 32.3 26.7 34.7 19.9 32.1 22.8 47.8 26.3 18.8 23.0 24.6 26.2 27.2 21.7 54.0 23.4 25.6 30.0 0.6 1.5 1.8 2.8 2.0 2.8 2.4 3.0 2.9 1.7 2.6 3.0 2.7 1.9 3.1 3.8 1.6 4.0 1.4 8.2 10.0 18.5 9.9 7.5 7.9 8.0 8.7 6.1 8.7 6.8 8.6 10.9 23.1 25.6 18.1 89.8 22.6 12.6 12.2 11.9 17.6 19.5 14.6 12.4 33.9 7.2 11.7 12.9 25.0 11.1 23.2 15.8 1.9 11.3 3.6 18.8 25.4 16.6 13.1 18.7 105.4 11.8 8.8 17.5 23.0 25.0 34.2 29.3 18.5 11.6 13.3 13.5 114.2 14.1 6.1 20.8 9.7 5.4 16.4 16.6 10.6 119.9 13.5 16.1 8.2 121.2 145.8 13.6 11.8 12.4 13.7 13.7 11.7 6.5 15.8 21.4 26.3 24.5 16.3 21.4 21.2 14.8 10.7 10.7 19.2 19.5 16.1 15.4 CFAP45 "CCDC19, NESG1" ENSG00000213085 "Cilia and flagella associated protein 45" Q9UL16 1 159872364-159900165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 45.2;testis: 28.6" "Cell type enhanced" "Detected in many" "Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7" "Cancer enriched" "Detected in many" 4 "endometrial cancer: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "eosinophil: 3.0;neutrophil: 2.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "BEWO: 9.0;HEL: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042204, HPA043618" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042204: AB_10966555, HPA043618: AB_10959305" "unprognostic (1.88e-1)" "unprognostic (4.15e-2)" "unprognostic (3.95e-1)" "unprognostic (5.18e-3)" "unprognostic (4.78e-3)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (2.57e-1)" "unprognostic (1.76e-1)" "unprognostic (5.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-12)" "unprognostic (2.95e-1)" "unprognostic (1.87e-1)" "unprognostic (3.83e-3)" "unprognostic (1.65e-1)" 0.5 0.1 8.2 0.4 1.7 0.8 0.6 2.6 1.1 1.7 11.2 0.2 0.2 1.5 0.0 0.4 45.2 0.2 0.6 1.2 7.0 0.4 0.1 5.0 0.2 6.4 6.5 0.1 0.3 0.2 0.1 0.4 0.4 4.6 0.4 0.1 0.0 0.3 0.4 0.2 0.5 0.3 0.4 8.8 0.7 0.6 28.6 2.8 0.3 0.7 0.1 0.3 0.5 0.3 4.4 2.1 0.4 0.0 0.0 0.1 0.2 9.0 1.1 1.3 1.9 0.8 1.5 2.7 0.8 0.4 0.3 1.0 1.3 0.2 0.3 1.1 0.3 0.2 12.2 0.5 0.0 0.4 1.1 0.4 0.8 0.6 2.1 0.7 2.8 1.4 0.2 1.3 0.4 0.3 3.0 0.2 0.9 0.5 1.7 1.0 0.0 0.9 0.4 0.1 0.5 0.8 0.1 1.0 3.2 0.3 2.6 3.1 0.2 1.8 0.8 2.4 1.6 2.0 0.8 0.0 0.2 4.3 0.3 0.7 0.0 0.1 3.0 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.0 0.2 2.4 0.0 0.0 0.1 0.0 0.1 8.2 1.7 2.6 1.1 1.2 7.0 6.4 6.5 0.1 4.6 8.8 2.8 4.4 2.0 0.0 4.8 0.0 0.4 0.0 0.9 0.0 0.6 0.1 1.4 0.9 5.5 0.0 29.7 5.5 0.0 1.6 0.6 0.0 0.0 1.9 256.4 98.2 1.3 3.2 0.0 0.0 0.1 2.2 7.4 1.2 0.0 3.2 3.8 0.1 1.4 0.0 0.4 0.0 0.1 0.1 0.0 0.6 0.0 57.4 2.1 4.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 1.6 0.0 1.5 3.2 1.3 0.1 0.4 166.9 0.0 0.0 0.7 0.9 43.7 3.1 1.2 0.0 0.8 1.2 0.6 0.1 1.1 ACKR1 "CCBP1, CD234, DARC, Dfy, FY, GPD" ENSG00000213088 "Atypical chemokine receptor 1 (Duffy blood group)" Q16570 1 159203307-159206500 "Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins" "Blood group antigen, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 272.7;breast: 280.6" "Group enriched" "Detected in many" 5 "Adipocytes: 383.6;Endothelial cells: 523.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 44.4;HSkMC: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016421, HPA017672" Enhanced NA NA "HPA016421: AB_1849219, HPA017672: AB_1849221" "unprognostic (8.74e-3)" "prognostic favorable (2.52e-5)" "unprognostic (9.73e-2)" "unprognostic (1.91e-1)" "unprognostic (2.34e-3)" "unprognostic (3.84e-3)" "prognostic favorable (1.48e-4)" "unprognostic (7.80e-2)" "unprognostic (2.22e-1)" "unprognostic (3.46e-2)" "unprognostic (1.65e-3)" "unprognostic (1.81e-1)" "unprognostic (3.82e-3)" "unprognostic (5.17e-3)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.30e-2)" 272.7 13.5 15.8 42.4 18.5 14.6 280.6 32.7 25.3 132.4 19.5 62.7 15.5 126.1 21.6 64.1 122.2 59.7 39.2 16.4 17.5 16.4 1.8 148.1 49.7 19.6 18.2 17.2 21.6 15.9 9.8 11.7 10.5 24.0 73.5 19.6 23.9 61.8 24.7 52.2 84.0 61.4 108.6 21.6 82.8 57.5 8.7 15.7 33.5 48.1 30.5 41.1 113.3 114.1 19.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 44.4 0.0 0.0 5.5 0.0 0.0 30.7 0.0 0.0 3.9 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 18.5 32.7 25.3 16.4 17.5 19.6 18.2 17.2 24.0 21.6 15.7 19.8 383.6 6.4 10.8 1.6 1.0 0.0 1.7 0.0 2.8 78.4 3.6 3.7 15.1 0.0 1.8 0.0 2.1 0.4 0.8 0.0 0.0 0.0 2.2 0.4 1.0 523.8 0.0 81.3 3.6 9.8 0.2 18.9 0.0 0.4 5.1 0.0 7.5 0.0 1.1 6.7 3.2 0.0 0.0 0.8 0.0 3.7 1.2 2.2 0.0 1.0 0.0 5.9 0.0 0.5 0.3 0.0 0.0 0.4 0.1 2.2 0.0 0.1 0.7 3.7 0.0 3.9 4.5 0.2 0.5 4.0 0.0 0.1 1.1 0.1 0.0 2.3 ZNF254 "BMZF-5, HD-ZNF1, ZNF539, ZNF91L" ENSG00000213096 "Zinc finger protein 254" O75437 19 24033405-24129968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 113.9;Excitatory neurons: 78.6;Inhibitory neurons: 85.1;Oligodendrocyte precursor cells: 128.7;Oligodendrocytes: 107.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.39e-2)" "unprognostic (2.51e-1)" "unprognostic (1.91e-1)" "unprognostic (1.31e-1)" "unprognostic (4.04e-2)" "unprognostic (6.92e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.60e-4)" "unprognostic (4.11e-3)" "unprognostic (2.23e-2)" "unprognostic (2.99e-3)" "unprognostic (1.96e-2)" "unprognostic (5.98e-3)" "unprognostic (4.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.12e-1)" "prognostic favorable (9.96e-4)" 4.0 5.0 4.8 3.8 5.1 7.7 7.6 9.4 6.3 9.2 3.0 6.0 4.3 7.6 8.6 5.3 6.0 5.4 4.9 4.3 5.5 7.8 8.9 6.0 6.9 4.8 5.5 3.5 11.0 4.3 10.9 6.0 5.6 5.3 7.8 7.4 5.5 5.2 7.0 2.3 3.7 3.9 5.0 3.9 5.0 6.5 4.5 5.5 11.9 17.1 5.7 6.3 6.3 6.1 6.6 4.1 5.4 24.3 12.2 5.0 5.5 4.2 5.3 9.5 7.5 12.3 5.7 7.8 6.1 10.4 4.7 4.4 2.3 15.6 5.0 11.3 35.1 24.2 11.6 6.5 3.3 4.5 5.6 2.4 6.3 5.3 8.7 7.0 11.3 9.9 13.7 15.9 0.0 8.9 6.9 12.3 10.2 18.4 1.5 9.7 17.4 12.8 14.3 10.3 11.9 14.4 14.0 0.0 0.4 7.3 21.0 5.9 9.1 6.9 3.5 1.0 7.4 8.1 0.2 6.8 16.0 0.0 6.6 3.4 7.5 1.3 4.3 1.9 1.4 2.0 3.4 2.5 2.1 2.2 3.2 2.8 2.5 3.1 3.2 3.1 2.7 3.3 1.2 4.8 5.1 9.4 6.3 4.3 5.5 4.8 5.5 3.5 5.3 3.9 5.5 6.6 13.3 38.5 18.5 113.9 10.8 3.4 8.7 5.9 5.2 22.1 10.1 9.1 18.7 20.0 10.6 12.9 14.6 6.7 11.0 8.6 15.6 11.8 49.5 11.2 19.7 9.3 16.8 3.8 78.6 7.4 11.1 13.3 10.2 13.2 7.0 27.3 8.9 10.5 5.7 37.0 85.1 6.0 12.2 8.1 5.2 16.8 11.8 6.8 7.2 65.6 5.1 15.7 5.2 128.7 107.5 9.5 4.4 16.6 4.1 7.7 1.8 8.8 8.5 14.3 13.1 11.3 13.4 5.8 9.6 5.2 5.3 8.8 8.7 13.4 7.0 9.4 DYNLT2B "MGC33212, TCTEX1D2" ENSG00000213123 "Dynein light chain Tctex-type 2B" Q8WW35 3 196291219-196318299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 6.2;Cytotrophoblasts: 29.4;Extravillous trophoblasts: 9.9;Hofbauer cells: 16.8;Syncytiotrophoblasts: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 21.9;dendritic cells: 16.2;T-cells: 25.1" "Cell line enhanced" "Detected in many" "T-47d: 101.7" HPA049555 Approved Cytosol NA NA Cytosol "HPA049555: AB_2680816" "unprognostic (1.16e-1)" "prognostic favorable (7.83e-4)" "unprognostic (5.34e-2)" "unprognostic (1.59e-2)" "unprognostic (1.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (4.61e-1)" "unprognostic (9.98e-3)" "unprognostic (3.99e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (6.23e-4)" "unprognostic (3.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" 5.0 7.9 15.8 4.5 15.8 5.1 6.6 15.5 18.8 8.5 14.6 7.2 3.4 7.1 8.0 13.1 36.5 5.2 5.9 14.9 17.5 12.3 2.3 7.1 8.8 15.5 14.6 14.6 7.3 5.2 8.0 13.9 3.1 16.4 7.0 4.3 15.2 5.3 4.0 3.0 8.2 4.0 3.7 15.8 4.4 5.0 31.1 15.2 14.8 10.2 1.5 6.1 6.7 9.5 14.9 33.1 23.9 45.3 28.0 11.1 22.3 5.4 13.8 9.3 16.8 18.8 7.9 45.0 21.0 23.0 12.1 7.0 33.7 17.8 14.5 16.3 18.4 13.3 8.6 22.3 3.4 12.7 6.4 0.9 12.1 38.2 14.7 17.1 30.5 10.2 44.0 13.3 10.8 32.6 79.0 28.9 29.4 29.6 36.6 41.5 37.3 7.7 8.7 38.9 13.4 50.9 39.7 29.2 17.2 28.0 18.7 101.7 18.3 19.2 15.0 5.8 6.1 18.0 16.9 38.0 48.8 45.0 11.4 25.8 0.0 3.1 1.4 11.7 1.2 7.1 21.9 13.9 9.0 8.8 13.7 9.1 9.4 1.8 4.6 0.8 16.2 25.1 6.3 15.8 15.8 15.5 18.8 14.9 17.5 15.5 14.6 14.6 16.4 15.8 15.2 14.9 5.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 29.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 9.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.6" "Cell type enhanced" "Detected in many" "Astrocytes: 5.2;Excitatory neurons: 5.4;Inhibitory neurons: 6.0;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.2 2.0 6.7 1.0 7.2 2.9 1.6 8.4 10.6 1.5 7.1 1.6 1.1 1.6 1.5 1.2 1.5 0.8 1.7 6.9 7.3 2.3 2.1 1.5 2.2 6.9 7.1 6.7 1.2 2.2 0.7 1.4 0.9 7.6 1.5 2.0 8.1 1.2 1.5 1.1 1.2 1.9 1.3 6.8 2.8 1.5 2.1 7.2 4.9 1.2 0.6 1.7 1.7 1.6 7.7 0.3 0.7 1.5 1.1 1.5 1.7 0.0 0.2 0.4 0.5 1.0 0.2 0.6 1.5 1.3 1.2 0.6 1.0 0.8 1.1 1.6 1.0 1.8 1.7 0.2 1.1 0.6 1.1 1.3 1.9 1.2 0.3 0.8 1.7 1.5 1.6 0.4 0.8 1.2 0.4 0.8 0.5 0.0 0.5 0.3 1.7 0.2 0.8 0.5 1.0 0.5 0.6 0.2 0.7 0.3 1.0 0.9 0.9 2.2 0.4 0.3 0.5 1.0 1.7 1.1 1.8 0.7 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.7 7.2 8.4 10.6 6.9 7.3 6.9 7.1 6.7 7.6 6.8 7.2 7.7 1.2 0.0 1.7 5.2 0.7 0.3 0.3 0.7 0.6 1.1 0.9 1.5 3.0 1.5 0.9 0.0 2.1 0.2 0.6 0.5 0.0 0.6 0.2 0.3 0.6 1.0 0.0 3.2 5.4 0.2 0.2 0.9 2.6 0.5 1.3 0.9 2.5 1.3 0.4 1.7 6.0 0.8 2.0 0.3 1.2 1.3 0.3 1.1 0.0 5.6 0.1 0.5 1.0 6.0 7.6 0.2 0.4 0.7 0.1 0.3 0.8 0.2 0.5 3.2 0.0 0.8 0.8 2.4 0.9 0.4 0.1 0.3 0.8 0.9 1.2 0.2 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" NA NA 29000 "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 263.2 21.8 20.7 61.7 16.4 29.6 182.4 18.9 36.7 148.6 24.5 120.9 122.8 108.9 208.4 119.7 119.2 28.4 218.2 15.6 23.8 98.4 17.9 256.8 84.6 22.5 22.6 14.0 50.2 18.4 21.4 41.8 28.6 20.9 50.0 55.9 0.2 136.8 88.7 45.1 291.8 315.0 42.7 22.7 95.3 95.1 14.4 18.0 80.4 183.6 50.6 136.8 114.7 99.7 17.5 0.0 699.8 4.8 0.6 12.1 8.3 66.8 1.3 0.4 9.0 0.1 21.0 415.5 228.0 2.4 191.0 2.6 464.1 0.1 0.0 0.0 329.5 0.0 17.7 294.7 116.3 1.8 0.1 0.2 3.8 0.0 23.1 0.0 0.9 0.5 64.6 0.5 0.9 0.0 3.7 8.1 1.6 7.4 1305.8 36.4 181.3 0.0 45.5 0.0 0.0 18.5 1.3 2.6 1.2 0.0 0.5 586.0 106.4 1.5 0.4 0.4 5.5 0.0 0.3 0.2 17.9 0.0 0.0 0.6 121.8 218.6 313.1 209.2 214.4 135.1 697.0 442.0 222.1 442.9 384.2 85.4 100.2 13.9 323.5 283.9 291.3 694.8 465.6 20.7 16.4 18.9 36.7 15.6 23.8 22.5 22.6 14.0 20.9 22.7 18.0 17.5 50.2 980.8 256.2 0.3 350.7 186.5 1.2 79.5 67.2 0.0 88.1 18.3 1.0 2.8 501.3 51.5 0.0 2.1 287.8 360.4 1.9 20.5 3.6 1761.1 124.5 86.4 76.5 27.3 0.0 3.1 4.3 313.3 210.0 491.9 521.5 0.1 24.7 1.3 52.2 0.0 0.0 243.1 30.5 168.0 577.3 26.2 25.1 523.7 370.0 1.9 461.4 0.2 83.4 0.0 0.1 34.2 659.2 9.4 584.3 0.7 2548.8 2.5 1702.1 0.0 223.5 8.2 448.0 1.0 11.4 29.4 251.6 1.5 524.7 0.1 190.7 3.0 KLHL23 "FLJ37812, MGC22679, MGC2610" ENSG00000213160 "Kelch like family member 23" Q8NBE8 2 169694488-169776989 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 132.5;Cone photoreceptor cells: 89.6;Sertoli cells: 170.9;Smooth muscle cells: 102.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047593 Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA047593: " "unprognostic (4.77e-2)" "unprognostic (2.65e-2)" "unprognostic (7.48e-2)" "unprognostic (4.12e-3)" "unprognostic (1.66e-2)" "unprognostic (2.13e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.19e-2)" "unprognostic (3.64e-3)" "unprognostic (1.05e-2)" "unprognostic (4.09e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.43e-5)" "unprognostic (2.61e-1)" "unprognostic (1.45e-1)" "unprognostic (2.70e-1)" "unprognostic (4.87e-3)" 7.0 2.1 7.9 6.2 10.0 1.7 6.3 13.8 10.0 9.7 0.4 15.7 11.2 25.9 4.0 12.1 9.0 6.7 8.1 9.7 8.2 6.7 5.9 6.0 3.1 4.6 6.1 7.6 18.0 7.2 6.5 3.3 12.9 6.5 13.8 14.0 13.7 8.1 12.6 12.1 1.6 11.9 25.2 2.9 2.8 5.2 11.0 6.9 11.2 8.2 16.5 3.0 8.8 3.9 7.6 17.0 8.6 64.5 18.3 3.6 1.3 43.7 8.0 6.1 14.4 15.8 18.0 14.4 10.6 6.7 0.8 20.9 2.6 67.7 5.8 21.9 37.7 33.2 31.3 16.9 29.9 5.4 44.2 4.7 2.5 4.7 6.0 10.2 9.3 11.2 38.3 43.5 1.4 4.8 8.2 65.0 17.9 52.7 9.0 6.7 20.7 55.1 1.1 13.1 49.9 83.4 57.1 12.7 1.2 7.8 20.3 10.6 14.2 4.2 5.8 18.6 5.7 13.6 4.9 4.9 47.3 4.5 13.0 9.0 0.0 0.0 0.0 0.7 0.0 0.9 0.3 0.6 0.5 0.1 0.3 1.0 1.0 0.0 3.4 0.0 0.9 0.8 0.3 7.9 10.0 13.8 10.0 9.7 8.2 4.6 6.1 7.6 6.5 2.9 6.9 7.6 13.7 3.2 8.7 0.0 1.1 1.5 6.9 2.8 7.4 132.5 15.0 17.1 52.9 14.3 6.7 0.0 89.6 5.6 3.8 14.6 3.9 15.6 4.6 2.4 12.8 12.6 31.8 9.7 0.0 30.5 9.6 11.2 4.1 5.5 0.0 27.5 7.5 11.8 0.9 40.4 0.0 21.2 28.5 0.8 1.9 3.7 2.5 1.3 0.0 0.0 0.2 14.6 5.2 0.0 0.0 16.1 13.6 8.6 0.4 17.2 9.7 16.9 4.9 34.8 170.9 11.4 102.6 3.4 20.9 4.7 1.0 1.2 5.5 13.8 20.9 4.1 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151805419 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 21.5;tongue: 5.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Melanocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4" "Region enriched" "Detected in many" 7 "spinal cord: 19.7" HPA060781 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA060781: AB_2684361" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.0 0.6 0.1 0.2 0.0 0.1 4.1 0.8 0.0 0.0 0.1 0.1 0.0 0.8 0.1 0.7 0.1 0.4 0.3 0.4 0.3 1.1 0.2 0.2 2.7 1.1 0.1 0.0 0.4 0.5 1.4 0.0 3.5 0.7 0.1 0.1 0.6 0.2 21.5 0.5 0.2 0.0 1.6 0.1 0.4 0.6 1.7 1.2 0.6 5.6 0.2 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 4.1 0.8 0.3 0.4 2.7 1.1 0.1 3.5 1.6 1.7 2.2 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 FAM24B "AC073585.2, MGC45962" ENSG00000213185 "Family with sequence similarity 24 member B" Q8N5W8 10 122849078-122879641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 14.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 50.9;Early spermatids: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "hTERT-HME1: 135.5;LHCN-M2: 181.8;TIME: 58.3" HPA052490 Supported "Intracellular and membrane" NA NA "HPA052490: AB_2681851" "unprognostic (4.03e-2)" "unprognostic (4.27e-2)" "unprognostic (3.13e-3)" "unprognostic (8.40e-5)" "unprognostic (2.55e-2)" "unprognostic (3.31e-2)" "unprognostic (6.42e-7)" "unprognostic (2.99e-1)" "unprognostic (7.06e-3)" "unprognostic (3.00e-1)" "unprognostic (5.89e-2)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" "unprognostic (2.58e-1)" "unprognostic (9.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.81e-3)" 2.0 1.3 4.9 2.6 5.1 2.6 3.0 4.8 6.5 2.6 3.8 2.8 2.3 2.4 3.0 2.4 2.2 2.1 1.4 5.2 5.7 14.8 1.0 2.4 6.0 5.3 5.0 4.9 2.9 7.8 1.1 11.0 0.4 5.2 3.0 4.0 6.0 1.9 1.5 0.9 4.2 3.6 1.6 4.8 3.8 3.2 9.3 5.3 5.0 2.5 0.2 4.7 2.7 2.3 5.8 8.1 12.8 3.1 0.1 1.9 3.7 4.0 11.8 11.1 4.8 4.4 14.2 16.6 3.0 3.6 6.5 1.4 5.2 0.0 7.1 13.1 14.0 5.3 23.8 18.4 7.6 10.4 0.0 13.8 4.3 0.9 10.4 135.5 0.9 12.6 15.5 9.5 6.0 181.8 7.3 13.9 13.9 5.0 8.1 13.3 0.0 18.5 2.8 8.6 7.2 8.6 3.7 5.5 2.9 15.0 7.7 4.7 14.1 58.3 1.4 6.7 5.0 1.2 6.5 7.1 18.0 9.7 23.3 0.0 2.2 1.5 1.0 1.7 1.5 0.6 4.2 3.4 2.4 2.1 2.3 3.5 2.1 1.0 2.1 1.5 8.1 3.6 1.2 4.9 5.1 4.8 6.5 5.2 5.7 5.3 5.0 4.9 5.2 4.8 5.3 5.8 2.5 0.0 0.5 0.0 7.1 6.6 1.6 4.2 14.2 3.6 3.7 5.8 0.2 2.8 1.2 9.2 0.0 0.1 7.7 1.6 50.9 4.3 28.2 0.5 0.7 1.9 4.8 6.5 0.0 7.3 0.2 3.8 2.0 0.6 8.9 0.5 1.8 0.8 1.2 1.7 0.0 3.5 12.2 4.1 2.9 4.1 3.7 3.3 1.8 0.0 3.5 2.9 8.2 0.0 0.0 8.7 2.7 4.1 2.7 2.0 2.3 1.8 1.2 4.3 0.0 1.7 2.3 12.9 4.6 5.5 5.4 0.0 6.7 0.2 3.5 1.2 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.0" "Cell type enriched" "Detected in many" 12 "Oligodendrocytes: 391.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" NA Yes "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favorable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 0.6 0.8 7.7 5.1 32.7 17.8 2.1 14.1 24.3 1.2 0.0 2.7 2.8 3.1 0.9 4.9 2.1 2.7 0.7 9.2 14.7 1.2 1.0 2.0 12.2 20.0 21.7 4.4 1.3 1.5 1.8 1.2 2.0 21.9 2.0 2.7 1.4 1.7 1.0 1.3 5.5 2.9 2.9 7.0 5.1 2.6 8.7 19.4 13.7 2.0 0.1 12.2 3.1 2.3 68.0 20.4 15.8 19.8 1.3 7.8 10.6 26.0 31.5 27.3 38.5 36.9 1.9 34.8 54.5 22.9 23.7 12.1 34.1 0.0 12.9 50.7 49.1 19.2 2.0 5.4 2.4 10.9 24.3 3.2 9.0 3.8 18.7 13.4 23.6 27.1 8.0 25.8 22.6 36.7 21.9 15.0 1.9 52.5 13.2 26.1 20.7 17.2 24.6 13.8 6.6 13.0 2.8 9.0 26.3 0.7 26.5 31.2 22.4 20.9 2.8 8.9 4.5 3.1 37.0 14.5 13.4 3.4 31.0 3.1 29.1 2.8 5.4 10.9 3.1 12.7 10.4 17.9 15.0 4.5 9.3 12.0 14.5 2.2 12.4 1.5 6.7 22.0 3.7 7.7 32.7 14.1 24.3 9.2 14.7 20.0 21.7 4.4 21.9 7.0 19.4 68.0 0.6 0.0 6.5 0.3 7.8 4.8 4.7 2.1 3.4 0.4 2.8 1.8 2.5 2.8 1.4 1.8 6.2 7.2 6.1 1.2 0.0 2.0 31.2 1.9 2.1 2.5 10.8 29.5 0.4 2.0 11.7 2.1 5.1 2.9 1.3 10.1 2.2 0.1 2.9 0.0 0.5 2.9 2.0 2.2 2.3 12.5 0.3 1.8 3.6 0.0 2.1 0.5 3.1 0.0 391.8 1.9 2.8 0.7 6.4 3.3 1.2 2.3 2.1 1.7 0.0 2.4 2.7 14.0 15.1 5.6 4.4 2.5 10.9 2.7 4.8 3.6 MLLT11 AF1Q ENSG00000213190 "MLLT11 transcription factor 7 cofactor" Q13015 1 151060397-151069544 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6" "Cancer enriched" "Detected in all" 4 "glioma: 29.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA000540: AB_2666024" "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 5.4 19.2 59.5 4.8 76.7 2.1 2.5 55.8 112.0 4.4 24.3 6.1 1.6 10.8 1.3 4.1 6.2 6.1 38.5 74.4 86.5 2.8 2.0 3.8 2.2 75.0 69.6 77.2 8.3 3.2 16.3 10.5 1.0 83.9 4.3 3.7 35.9 3.8 1.5 11.4 2.4 4.9 13.9 44.6 4.7 5.1 2.8 75.8 20.8 3.8 10.9 2.1 4.0 4.0 137.7 6.3 31.0 216.7 34.4 3.5 5.8 1.4 11.6 15.2 13.2 24.0 3.0 12.6 10.0 164.9 10.6 35.9 4.5 54.3 13.0 7.6 65.8 14.5 28.9 17.7 0.9 6.9 0.8 1.0 9.9 1.6 73.5 2.9 42.2 100.1 43.3 30.8 2.3 43.6 1.4 106.4 19.0 95.7 0.6 4.4 99.8 28.1 0.6 25.5 1.7 132.8 238.6 0.8 1.3 6.9 142.5 5.3 2.7 65.9 27.0 29.0 9.2 24.7 2.4 3.2 207.1 70.0 0.6 51.7 1.1 0.3 1.4 5.9 0.6 2.7 2.5 3.9 6.2 0.7 1.9 5.3 9.1 1.6 4.0 0.9 1.4 4.1 3.2 59.5 76.7 55.8 112.0 74.4 86.5 75.0 69.6 77.2 83.9 44.6 75.8 137.7 1.4 0.0 1.1 11.8 4.2 3.6 5.0 14.6 4.6 54.1 2.5 4.8 10.2 1.5 2.2 3.7 8.4 2.9 15.3 0.1 17.6 3.9 76.9 0.8 11.3 5.2 10.7 6.3 57.9 1.2 2.5 17.5 2.0 0.9 4.5 4.3 4.2 0.4 6.0 37.0 40.6 0.1 16.2 6.6 14.5 215.6 2.1 12.3 5.4 10.3 33.3 20.6 19.6 16.1 14.4 3.0 0.2 3.8 4.8 1.3 0.2 2.4 0.6 26.3 0.0 3.4 30.0 8.6 12.3 2.8 3.4 7.4 9.9 3.0 0.2 4.3 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.1" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 12.5;Early spermatids: 15.6;Granulosa cells: 14.8;Late spermatids: 61.0;Spermatocytes: 10.3" "Group enriched" "Detected in many" 4 "glioma: 3.1;testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 16.7;U-266/84: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049155: AB_2680657, HPA054805: AB_2732588" "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.4 2.1 8.2 0.3 8.9 0.6 2.7 11.9 10.9 11.6 6.6 6.0 1.1 7.7 1.5 2.0 7.2 0.7 8.4 8.2 8.5 4.7 4.1 3.2 0.8 9.6 8.7 7.3 6.4 2.1 0.5 18.3 0.6 10.1 5.4 0.6 8.7 1.6 0.4 6.0 2.8 4.2 0.8 7.2 2.9 3.8 20.1 8.7 0.6 4.1 0.9 0.7 3.1 4.3 11.8 1.5 4.0 1.7 2.7 3.7 0.0 7.4 0.4 0.2 0.3 0.5 0.8 1.9 0.9 0.4 0.2 1.8 2.4 1.0 0.0 0.7 8.9 4.5 1.7 3.4 0.0 0.0 0.1 3.9 0.9 0.7 0.2 0.0 2.9 0.1 1.1 4.2 6.8 0.5 6.3 0.3 0.4 1.8 0.1 3.3 3.1 1.7 0.5 0.3 1.4 2.3 8.2 0.6 0.5 4.3 4.9 1.8 0.4 0.1 1.4 2.1 4.3 1.1 16.7 10.2 0.1 2.3 5.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 8.9 11.9 10.9 8.2 8.5 9.6 8.7 7.3 10.1 7.2 8.7 11.8 0.4 0.0 0.5 2.9 0.5 0.6 0.0 0.2 0.0 9.7 0.6 0.6 2.1 0.0 0.2 0.0 12.5 0.2 0.3 0.6 0.0 0.2 15.6 0.9 1.1 0.3 0.0 0.0 3.4 0.4 0.2 0.3 0.5 0.8 8.9 14.8 0.0 0.9 0.6 6.7 4.2 0.1 0.0 0.6 0.9 61.0 1.5 0.4 0.0 0.0 0.6 1.6 0.0 1.5 5.1 0.4 0.0 1.9 0.1 0.3 0.2 0.2 0.6 4.9 0.0 0.7 0.4 10.3 5.6 0.0 0.9 0.7 0.3 0.2 0.2 0.2 GIMAP1 "HIMAP1, IAN2, IMAP1, IMAP38" ENSG00000213203 "GTPase, IMAP family member 1" Q8WWP7 7 150716606-150724284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.9" "Cell type enhanced" "Detected in many" "Adipocytes: 189.8;Endothelial cells: 109.9;Hepatic stellate cells: 117.8;Kupffer cells: 109.1;monocytes: 74.9;NK-cells: 185.3;T-cells: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 14.7;MOLT-4: 9.2;TIME: 3.9" "Low region specificity" "Detected in many" "HPA044887, HPA053441" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044887: AB_10960351, HPA053441: AB_2682152" "unprognostic (1.60e-2)" "unprognostic (6.58e-3)" "unprognostic (8.21e-3)" "unprognostic (2.54e-3)" "unprognostic (1.10e-1)" "unprognostic (2.33e-3)" "prognostic favorable (1.09e-4)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (3.44e-1)" "unprognostic (4.60e-3)" "unprognostic (7.89e-2)" "unprognostic (1.77e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-1)" 9.0 2.5 2.9 11.1 2.7 1.0 8.0 2.7 3.5 3.5 3.4 3.2 3.5 4.7 1.2 2.1 4.4 3.2 6.8 2.5 3.0 3.5 2.4 9.0 19.7 3.2 2.8 2.1 1.5 1.4 1.5 1.1 7.1 3.2 2.4 2.2 0.1 2.5 2.0 5.4 2.3 6.9 3.8 3.0 24.9 3.3 0.8 3.9 6.7 5.3 7.1 8.5 3.6 3.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 14.7 1.9 0.0 0.0 0.0 0.0 9.2 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 32.2 0.1 43.8 29.6 51.1 0.3 47.5 54.2 13.5 0.6 68.2 56.2 2.7 42.6 30.6 0.8 34.0 35.0 2.9 2.7 2.7 3.5 2.5 3.0 3.2 2.8 2.1 3.2 3.0 3.9 3.4 189.8 3.2 1.5 0.0 5.1 5.5 0.6 0.0 1.2 0.6 1.9 3.6 5.9 2.8 0.6 0.0 0.0 0.3 51.5 0.1 0.0 0.3 0.3 0.4 0.6 109.9 0.0 10.5 0.0 0.4 0.3 3.7 1.5 0.2 8.2 0.2 117.8 2.0 37.9 0.0 0.0 0.0 0.0 109.1 7.6 1.3 1.5 48.0 8.8 0.0 74.9 0.3 185.3 0.0 0.0 0.1 0.1 0.0 7.6 0.7 0.2 0.5 0.0 1.0 0.0 2.5 3.5 0.3 0.5 0.7 3.1 0.4 97.3 1.0 0.0 0.7 CCDC183 "bA216L13.7, KIAA1984, MGC15438" ENSG00000213213 "Coiled-coil domain containing 183" Q5T5S1 9 136796338-136807741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 22.2" "Group enriched" "Detected in many" 9 "Early spermatids: 251.7;Late spermatids: 146.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "OE19: 2.8" HPA043812 Uncertain NA NA "HPA043812: AB_10961860" "unprognostic (2.91e-1)" "unprognostic (8.34e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.27e-2)" "unprognostic (2.37e-1)" "unprognostic (6.89e-5)" "unprognostic (3.45e-2)" "unprognostic (2.26e-2)" "unprognostic (6.49e-2)" "unprognostic (8.16e-3)" "unprognostic (4.32e-2)" "unprognostic (6.98e-2)" "unprognostic (1.86e-2)" "unprognostic (1.30e-1)" "unprognostic (6.20e-2)" "unprognostic (5.15e-2)" 0.2 0.5 2.3 0.2 2.3 0.3 0.7 3.1 2.7 0.4 1.4 1.0 0.3 0.4 0.7 0.1 0.8 0.5 0.7 2.2 2.6 0.3 0.2 0.4 0.4 2.8 2.7 2.0 0.7 1.0 1.2 0.7 0.8 2.6 1.9 1.1 1.6 0.5 0.5 0.4 0.3 0.3 0.4 2.1 0.4 0.7 22.2 2.4 1.4 0.6 0.1 0.4 0.3 0.0 2.6 0.0 0.0 0.6 0.3 0.5 0.3 0.4 0.6 0.2 0.0 0.0 0.3 0.3 0.0 0.1 0.3 0.0 0.5 0.2 0.0 0.0 0.5 0.4 0.0 0.8 0.8 1.0 0.2 0.5 1.1 0.5 0.0 0.3 1.2 0.0 0.6 0.2 0.2 0.0 0.3 0.2 0.0 0.0 2.8 0.0 0.1 0.4 0.9 0.7 0.0 0.6 0.4 0.2 0.2 0.1 1.1 0.7 0.2 0.3 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 2.3 2.3 3.1 2.7 2.2 2.6 2.8 2.7 2.0 2.6 2.1 2.4 2.6 2.0 0.0 3.1 2.3 0.7 0.3 0.8 0.8 0.6 4.3 2.4 2.8 0.5 2.8 1.7 1.8 0.0 2.3 16.4 5.0 1.9 1.8 251.7 1.6 0.9 0.9 7.8 0.0 3.0 0.7 1.1 1.3 1.1 1.9 0.0 2.3 0.7 0.6 0.5 5.0 3.0 7.2 4.1 0.8 1.0 146.6 2.8 0.7 3.6 1.9 0.8 3.1 0.0 3.0 3.2 0.8 21.9 3.8 2.0 2.6 3.8 0.6 2.7 4.4 6.6 1.1 1.3 3.7 0.8 0.7 0.1 7.0 1.3 1.3 5.0 0.8 ARHGEF35 "ARHGEF5L, CTAGE4, FLJ43692" ENSG00000213214 "Rho guanine nucleotide exchange factor 35" A5YM69 7 144186083-144195833 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 107.0;Urothelial cells: 91.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 39.9;HBEC3-KT: 21.8;hTCEpi: 33.7;OE19: 32.2;RPTEC TERT1: 46.4;WM-115: 23.5" "HPA044188, HPA045619, HPA045699" Supported NA NA "HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423" "unprognostic (1.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-2)" "unprognostic (4.41e-1)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.03e-1)" "unprognostic (2.91e-2)" "unprognostic (3.31e-3)" "unprognostic (3.89e-1)" "unprognostic (1.17e-1)" "prognostic favorable (4.57e-4)" "unprognostic (2.88e-1)" "unprognostic (3.63e-2)" "unprognostic (5.56e-2)" "unprognostic (8.97e-2)" 2.1 0.9 0.6 2.1 0.6 1.1 14.7 0.4 0.5 5.5 2.5 11.1 12.3 2.3 3.9 16.6 5.8 5.0 1.3 0.3 1.8 7.1 5.4 3.5 1.4 0.6 0.6 0.2 1.6 7.6 7.2 3.4 3.9 0.6 5.6 14.5 1.0 10.5 4.2 0.2 17.9 8.6 1.1 0.5 1.6 10.6 0.6 0.6 1.3 20.6 0.7 3.4 5.8 7.1 0.9 39.9 0.8 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.2 13.0 13.6 0.0 0.0 1.6 3.3 11.0 0.0 21.8 0.4 0.1 0.0 0.0 2.7 0.0 3.6 0.0 0.0 3.4 33.7 0.2 8.1 2.9 0.1 0.0 0.0 0.0 1.4 6.9 0.0 0.0 4.4 32.2 3.7 0.1 0.0 0.0 46.4 9.8 0.0 0.0 8.0 14.8 3.5 2.3 18.1 0.8 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.6 0.4 0.5 0.3 1.8 0.6 0.6 0.2 0.6 0.5 0.6 0.9 3.3 9.6 11.5 0.0 2.5 46.5 107.0 27.0 18.2 0.8 29.9 32.5 1.0 35.8 32.6 62.5 16.7 49.0 1.5 46.4 17.6 44.4 4.3 46.1 5.9 2.0 19.2 0.0 0.0 29.7 72.2 3.9 18.8 49.9 0.0 2.9 1.1 19.4 5.3 0.0 0.0 24.8 12.2 1.3 3.2 1.4 4.7 1.4 16.0 0.0 0.0 3.9 0.0 0.0 0.0 43.8 46.1 3.0 3.1 27.4 56.6 28.8 17.1 5.6 0.0 1.0 4.3 0.8 2.1 21.5 47.0 59.9 2.5 1.7 23.6 91.8 OR2F1 "OLF3, OR14-60, OR2F3, OR2F3P, OR2F4, OR2F5, OR7-139, OR7-140" ENSG00000213215 "Olfactory receptor family 2 subfamily F member 1" Q13607 7 143954844-143997312 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CSH2 "CS-2, CSB, hCS-B" ENSG00000213218 "Chorionic somatomammotropin hormone 2" P0DML3 17 63872012-63873766 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 218 "placenta: 3319.6" "Cell type enriched" "Detected in some" 12 "Syncytiotrophoblasts: 275.5" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "BEWO: 9.3;SuSa: 13.1" HPA043715 Supported "Secreted to blood" NA NA "HPA043715: AB_2678632" "unprognostic (1.68e-1)" "unprognostic (1.85e-1)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.0 3319.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 15.2 0.0 8.6 5.2 0.2 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 275.5 0.0 0.0 0.0 0.0 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363744 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 9.1;Suprabasal keratinocytes: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 13.4;MCF7: 13.2;REH: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA062738: AB_2684857" "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 16.4 12.3 1.9 0.9 2.1 0.9 16.5 2.4 3.4 16.1 1.1 14.6 1.2 16.7 0.4 10.1 14.2 0.5 29.5 1.8 1.7 17.3 14.5 12.8 1.0 2.0 2.0 1.8 12.2 28.1 0.9 11.5 0.4 2.2 12.7 0.1 0.3 10.2 0.5 23.2 13.6 11.4 0.3 1.8 15.7 13.6 12.1 2.0 0.8 12.6 3.8 0.4 17.5 12.3 2.4 1.7 2.8 0.9 3.3 0.5 0.9 1.8 1.8 1.3 2.3 1.0 3.5 1.9 4.1 9.7 1.8 1.7 3.4 0.6 1.7 0.2 13.4 3.1 1.1 1.3 1.0 1.9 2.2 1.4 1.4 1.7 1.8 1.1 0.6 1.2 2.0 1.7 2.9 1.5 13.2 4.5 2.7 5.2 2.7 7.6 13.4 1.6 5.1 2.9 1.6 4.1 4.7 2.8 1.9 2.9 0.5 2.6 1.4 2.8 4.0 3.5 2.8 4.6 2.7 3.3 3.5 2.6 0.9 3.7 0.7 0.0 0.0 0.4 0.2 0.7 1.3 0.6 0.7 0.1 0.5 0.6 0.6 0.1 0.1 0.1 0.3 0.8 0.0 1.9 2.1 2.4 3.4 1.8 1.7 2.0 2.0 1.8 2.2 1.8 2.0 2.4 5.4 0.0 0.0 3.3 6.0 8.4 1.1 0.0 9.1 0.6 4.7 3.9 0.8 0.0 0.7 5.5 0.0 1.0 4.3 1.2 1.9 0.5 0.1 3.0 6.9 3.4 0.0 1.7 2.0 1.1 0.9 3.7 3.6 2.6 0.0 1.0 1.4 1.1 1.0 0.0 2.1 1.2 0.0 0.3 7.5 0.2 1.2 3.0 1.8 1.9 0.6 0.3 2.1 2.5 3.5 0.6 0.3 1.2 7.1 0.6 0.8 3.0 0.1 0.4 0.0 2.5 3.7 1.5 4.8 5.7 9.1 1.1 6.9 1.1 0.9 0.9 TCL1B TML1 ENSG00000213231 "TCL1 family AKT coactivator B" O95988 14 95686426-95692628 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.6" "Cell type enriched" "Detected in some" 8 "Syncytiotrophoblasts: 72.7" "Cancer enriched" "Detected in single" 72 "testis cancer: 8.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 24 "naive B-cell: 11.7;plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 24 "B-cells: 11.7;dendritic cells: 6.2" "Cell line enriched" "Detected in some" 7 "U-698: 511.8" "Not detected" "Not detected" HPA053163 Uncertain Approved Cytosol NA NA Cytosol "HPA053163: AB_2682064" "unprognostic (1.55e-1)" 0.1 0.0 0.2 0.5 0.6 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 2.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 2.6 0.3 0.2 0.0 0.0 2.5 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 73.5 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.0 2.5 0.6 0.4 0.0 0.0 1.3 0.0 0.2 0.2 0.4 511.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.3 0.3 0.0 6.2 0.0 0.3 0.2 0.6 0.1 0.2 0.1 0.4 0.5 0.3 0.0 0.5 0.2 0.3 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 9.0 0.0 0.0 72.7 0.0 0.1 0.0 0.1 SUPT4H1 "Spt4, SPT4H, Supt4a, SUPT4H" ENSG00000213246 "SPT4 homolog, DSIF elongation factor subunit" P63272 17 58345175-58353093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059748 Approved Nucleoplasm NA NA Nucleoplasm "HPA059748: " "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (7.69e-5)" "unprognostic (6.71e-2)" "unprognostic (7.05e-2)" "unprognostic (2.37e-3)" "unprognostic (1.57e-2)" "unprognostic (9.52e-2)" "unprognostic (1.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (2.54e-1)" 56.2 73.0 48.2 55.9 48.1 143.1 56.5 50.8 58.4 57.5 45.6 60.3 39.5 60.9 44.9 63.1 55.4 49.4 50.5 47.9 48.1 64.8 68.9 53.7 106.1 46.8 46.3 45.9 55.6 41.5 66.7 39.1 44.1 46.9 52.3 50.4 35.5 50.5 43.7 66.9 61.4 57.8 43.0 47.4 72.4 58.1 39.9 47.4 68.4 47.2 68.1 55.3 55.7 53.9 49.2 80.1 150.3 76.3 53.5 79.4 67.1 99.0 84.7 85.0 116.2 111.9 55.2 75.0 122.5 145.5 124.8 90.3 47.0 99.8 101.8 142.8 174.6 120.8 146.0 79.4 185.4 73.8 194.5 109.5 93.8 91.6 85.5 82.8 118.6 95.4 111.5 137.3 123.9 94.3 118.7 188.6 150.8 65.7 104.0 123.4 180.8 104.1 95.5 96.6 85.6 66.7 120.4 45.1 39.1 88.5 98.2 106.0 137.1 75.4 101.9 85.8 52.4 106.9 160.7 331.7 145.3 85.1 61.7 69.2 239.7 191.2 244.7 86.7 214.3 85.0 92.6 81.0 91.9 164.4 71.6 64.8 78.5 361.7 75.2 218.4 93.6 109.8 243.1 48.2 48.1 50.8 58.4 47.9 48.1 46.8 46.3 45.9 46.9 47.4 47.4 49.2 70.6 12.8 9.1 3.9 82.6 71.5 63.0 130.2 61.5 27.7 79.0 99.7 40.3 77.2 57.3 60.7 0.0 140.3 111.0 69.1 195.6 129.1 38.5 44.7 57.2 76.5 68.6 142.3 5.5 98.5 166.3 62.7 20.9 53.4 87.1 92.6 101.4 116.0 183.2 13.5 5.4 62.1 105.8 152.6 233.8 40.8 94.8 140.8 110.3 4.7 217.5 117.6 144.1 5.5 8.2 119.3 84.0 94.4 63.3 71.3 118.4 252.0 35.7 24.7 39.5 63.0 81.5 98.8 49.8 60.4 83.7 150.2 83.5 96.6 62.0 85.1 TSGA13 ENSG00000213265 "Testis specific 13" Q96PP4 7 130668643-130687432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 110 "testis: 14.1" "Group enriched" "Detected in some" 18 "Early spermatids: 86.4;Late spermatids: 224.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA022968 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA022968: AB_2671013" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.2 3.9 0.0 0.3 1.7 0.1 0.0 0.0 1.2 0.3 0.1 0.1 0.0 1.9 0.0 8.4 0.1 0.3 0.0 0.0 0.0 86.4 0.3 0.3 1.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.4 0.0 0.4 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.9 2.2 224.1 0.6 0.8 0.0 0.0 0.1 0.6 1.0 0.5 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 6.0 1.5 0.0 0.0 0.3 1.6 0.6 0.0 0.4 0.7 0.6 0.1 0.0 0.0 NRAS N-ras ENSG00000213281 "NRAS proto-oncogene, GTPase" P01111 1 114704469-114716771 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010157, HPA049830, CAB079912" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903" "unprognostic (4.75e-2)" "unprognostic (2.81e-1)" "unprognostic (1.09e-3)" "unprognostic (2.11e-2)" "unprognostic (8.59e-3)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-7)" "unprognostic (7.76e-3)" "unprognostic (1.57e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (6.60e-3)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.33e-2)" 19.2 9.1 11.4 25.9 12.0 59.0 18.2 12.4 12.4 12.6 10.0 28.1 21.7 12.5 7.8 20.9 10.3 17.3 8.4 11.1 12.7 21.1 25.1 18.7 30.7 13.5 13.0 10.7 9.7 11.5 9.1 4.3 28.6 13.3 11.5 26.8 6.6 11.0 7.2 7.8 19.9 22.7 14.2 13.2 18.7 22.0 9.7 12.4 39.4 16.2 7.8 29.9 22.4 8.6 14.6 93.7 24.9 65.2 24.9 26.4 56.3 46.5 43.5 48.4 79.5 89.0 50.4 33.9 70.4 56.3 58.9 55.4 26.0 88.2 70.6 113.4 96.5 34.2 47.8 34.5 60.2 52.3 120.0 71.0 51.1 56.1 91.5 66.2 25.0 102.8 54.6 77.3 78.5 71.0 248.9 83.5 46.4 111.0 30.2 17.9 62.9 116.0 44.1 70.6 49.5 39.4 59.0 44.7 36.4 107.1 75.4 31.9 96.2 79.2 43.3 82.2 81.5 90.3 137.7 101.6 81.6 86.4 64.6 159.0 38.7 12.8 12.6 11.7 19.2 10.5 12.8 9.3 11.6 12.6 10.5 9.9 12.9 3.4 15.5 17.6 9.6 13.4 13.1 11.4 12.0 12.4 12.4 11.1 12.7 13.5 13.0 10.7 13.3 13.2 12.4 14.6 22.7 16.0 16.5 8.1 25.9 30.7 31.2 23.1 15.4 5.2 18.5 13.6 5.6 18.6 19.3 22.0 8.4 22.4 27.7 49.2 13.7 34.1 3.9 22.9 24.7 29.2 24.6 31.6 5.8 31.5 50.4 16.1 29.0 38.0 31.1 22.2 33.2 29.7 49.2 5.0 5.2 28.1 30.5 44.9 30.7 5.9 8.1 30.4 23.2 9.4 41.6 7.8 22.6 5.0 8.1 51.4 32.9 6.4 39.6 30.6 28.1 39.4 23.1 3.3 6.6 12.8 15.3 7.3 15.4 24.6 36.2 31.2 21.9 13.8 28.8 40.2 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "granulocytes: 327.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 20.2;eosinophil: 63.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 63.1" "Cell line enriched" "Detected in some" 11 "HMC-1: 102.0" "Low region specificity" "Detected in many" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 7.1 6.9 0.8 0.5 0.9 2.3 5.6 1.4 1.5 4.0 1.8 3.2 0.7 5.7 0.0 3.1 11.9 0.3 9.3 0.8 1.5 7.1 1.9 7.8 0.2 1.8 1.4 0.2 5.8 2.0 0.2 3.6 0.4 2.0 4.8 0.2 0.0 4.3 0.8 1.0 2.9 3.3 0.4 2.7 6.1 3.0 1.5 1.7 0.0 5.9 0.0 0.1 4.8 4.1 3.8 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.9 8.9 0.2 0.4 0.3 0.6 102.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.2 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 1.0 0.1 20.2 0.5 63.1 0.8 0.6 3.0 0.3 2.1 1.5 8.6 0.2 0.4 1.0 0.3 4.7 0.0 0.4 0.2 0.6 0.8 0.9 1.4 1.5 0.8 1.5 1.8 1.4 0.2 2.0 2.7 1.7 3.8 32.3 0.0 3.2 2.9 2.3 9.9 9.6 11.2 14.8 0.4 26.4 38.6 0.0 14.3 6.2 14.7 0.0 10.4 5.0 0.6 1.9 5.9 0.3 4.0 1.5 49.5 3.0 2.1 0.8 2.4 1.9 8.3 3.1 5.6 327.4 0.5 72.1 0.9 41.5 0.0 0.7 1.7 0.0 20.8 46.3 0.9 16.4 53.9 1.8 28.1 2.0 0.1 2.1 1.0 1.5 1.9 0.5 47.4 10.0 3.7 2.2 54.8 5.8 0.5 0.0 0.8 1.6 0.1 0.7 5.2 7.0 3.0 10.0 1.5 3.1 10.0 ANKRD39 MGC41816 ENSG00000213337 "Ankyrin repeat domain 39" Q53RE8 2 96836611-96858016 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 263.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042678 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042678: AB_10794532" "unprognostic (6.26e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (9.53e-2)" "unprognostic (2.28e-2)" "unprognostic (2.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.68e-1)" "unprognostic (9.25e-2)" "unprognostic (3.12e-3)" "prognostic favorable (6.12e-5)" "unprognostic (6.15e-2)" "prognostic unfavorable (6.78e-9)" "unprognostic (3.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.03e-2)" "prognostic favorable (5.21e-4)" 6.9 14.3 11.3 7.3 12.3 10.6 7.3 15.1 18.9 6.9 8.2 9.6 8.4 10.3 2.9 7.6 10.3 6.0 13.7 12.2 12.4 7.9 14.9 6.2 11.1 12.3 12.3 13.0 6.6 8.4 12.4 16.1 5.5 12.5 8.3 4.0 5.3 7.4 6.9 8.0 8.5 7.5 6.2 11.3 9.8 8.4 4.1 11.9 7.5 5.9 4.6 6.5 8.5 6.9 14.0 24.0 15.7 8.8 19.2 2.9 5.7 21.1 18.1 8.4 22.5 17.3 38.8 9.9 15.2 26.4 13.2 17.7 10.3 11.2 17.3 5.0 17.6 34.1 11.0 14.4 53.5 14.8 24.9 25.6 11.0 10.2 20.5 7.9 8.4 16.3 31.1 23.5 263.1 8.4 37.9 23.3 19.5 11.1 8.1 35.8 17.8 6.2 85.3 11.8 12.3 20.3 13.3 13.1 30.6 23.7 8.0 9.3 13.5 8.2 14.0 13.8 16.0 32.5 13.4 16.2 25.3 14.0 28.5 14.9 20.1 16.0 13.4 44.4 20.8 37.7 41.6 43.6 39.3 16.6 33.2 24.0 29.2 8.3 37.6 23.5 70.4 71.0 21.1 11.3 12.3 15.1 18.9 12.2 12.4 12.3 12.3 13.0 12.5 11.3 11.9 14.0 14.0 6.4 8.9 2.6 16.9 9.4 17.2 25.7 9.1 25.2 14.9 23.2 19.5 18.6 17.6 9.2 4.2 44.9 28.1 15.1 25.4 28.8 6.1 18.1 18.7 12.9 18.6 13.5 4.6 32.0 38.6 14.9 11.7 11.8 12.7 12.7 10.8 32.0 31.6 33.7 5.3 19.9 18.3 11.1 10.4 2.9 12.5 13.8 28.4 1.0 9.3 15.9 37.0 4.5 5.9 41.3 11.3 14.7 26.2 12.5 23.4 29.4 35.0 29.8 26.3 24.9 18.8 13.6 14.3 18.9 17.8 21.6 24.4 33.5 16.9 15.7 QTRT1 TGT ENSG00000213339 "Queuine tRNA-ribosyltransferase catalytic subunit 1" Q9BXR0 19 10701430-10713437 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 260.9;Paneth cells: 224.5;Proximal enterocytes: 261.8;Undifferentiated cells: 280.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042695, HPA048651, HPA049440" Approved Approved Mitochondria NA NA Mitochondria "HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767" "unprognostic (6.19e-2)" "prognostic favorable (7.63e-5)" "unprognostic (2.90e-2)" "unprognostic (3.05e-1)" "unprognostic (4.90e-2)" "prognostic favorable (4.90e-4)" "unprognostic (2.52e-1)" "unprognostic (8.76e-3)" "unprognostic (3.88e-1)" "unprognostic (4.81e-3)" "prognostic favorable (2.13e-4)" "unprognostic (1.14e-2)" "prognostic unfavorable (1.13e-6)" "unprognostic (2.04e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" 16.9 27.3 9.5 11.9 9.9 13.5 18.3 8.5 16.1 18.2 7.5 19.6 10.4 22.9 2.7 20.6 21.1 7.3 20.7 10.3 9.3 18.3 30.4 12.7 12.3 9.6 9.1 10.5 24.6 52.3 9.6 17.8 7.8 9.7 17.0 5.0 6.2 22.5 9.2 20.7 17.8 15.4 6.1 7.7 15.0 20.8 6.4 9.2 7.1 20.9 10.3 5.1 17.8 16.6 11.2 41.5 32.3 14.6 44.1 15.3 18.2 19.7 20.8 18.3 23.8 22.9 25.6 15.0 47.1 50.1 11.5 14.4 26.6 13.8 24.9 7.7 28.1 20.8 30.4 13.3 55.7 26.6 46.4 25.7 27.8 20.3 15.3 22.1 10.5 24.2 25.5 35.0 50.2 11.8 64.2 39.7 56.5 40.3 25.3 53.5 41.2 19.9 72.2 18.8 26.1 48.4 21.6 33.0 33.4 27.8 6.2 21.5 19.0 19.5 35.0 20.3 58.2 49.7 56.7 48.3 23.3 19.3 55.0 44.4 1.9 16.6 0.4 29.6 31.4 37.4 42.0 31.7 26.4 34.0 40.8 33.3 27.5 1.3 43.9 16.6 39.8 37.9 21.3 9.5 9.9 8.5 16.1 10.3 9.3 9.6 9.1 10.5 9.7 7.7 9.2 11.2 23.2 0.0 4.5 47.3 36.6 63.7 63.5 59.0 65.4 36.7 42.6 48.6 7.3 30.0 24.5 57.0 50.1 47.8 27.3 157.0 64.6 25.8 1.6 19.8 28.8 24.7 192.5 30.3 32.8 27.6 39.7 33.5 23.9 18.8 16.5 43.7 18.2 33.9 28.8 90.9 31.4 260.9 42.7 15.8 30.9 2.6 50.7 12.8 49.8 8.4 10.5 22.0 7.2 21.6 30.0 13.9 224.5 37.6 53.2 43.6 261.8 80.3 22.6 57.9 19.7 40.7 31.1 12.9 24.6 36.9 41.9 28.0 27.0 67.4 280.7 37.2 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Component of inhibitor of nuclear factor kappa B kinase complex" O15111 10 100188300-100229596 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favorable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 13.6 10.4 7.6 11.9 8.2 19.7 10.9 7.7 8.4 8.5 8.8 12.0 12.9 8.9 9.2 9.8 7.6 9.1 6.9 7.2 9.5 21.2 17.2 10.3 12.8 8.1 8.2 6.8 5.6 11.6 14.1 6.5 10.6 8.4 9.6 13.5 8.1 8.9 9.1 14.3 7.0 10.9 11.9 8.4 10.0 11.3 8.4 9.1 14.4 11.2 11.8 12.7 13.7 6.5 9.5 27.7 22.9 23.0 34.4 21.6 19.3 17.6 34.3 33.5 31.3 38.0 25.9 15.9 37.2 19.7 23.5 21.8 26.7 38.7 18.2 34.9 39.8 33.5 24.7 18.0 28.7 18.4 46.2 34.8 15.5 19.1 36.2 35.0 21.8 22.7 30.1 28.5 29.9 34.6 16.7 36.9 28.4 15.0 21.8 16.5 23.7 25.5 17.0 19.9 17.6 13.7 20.3 18.6 14.2 30.9 18.0 28.5 27.8 23.9 19.6 21.9 21.5 39.7 34.9 33.7 35.7 21.3 36.9 15.8 1.0 1.2 2.1 0.9 1.9 1.5 1.6 1.1 1.6 1.4 1.0 1.3 1.5 2.8 1.8 1.3 0.8 1.2 0.5 7.6 8.2 7.7 8.4 7.2 9.5 8.1 8.2 6.8 8.4 8.4 9.1 9.5 11.4 12.8 11.5 17.9 10.8 19.8 7.1 5.1 8.0 6.3 7.3 4.8 9.2 7.2 5.9 5.5 2.1 6.5 14.1 12.2 11.7 7.1 7.6 8.9 8.6 8.4 6.0 12.0 22.7 11.8 7.8 6.5 7.7 12.7 8.2 6.2 7.1 14.4 10.6 13.5 21.3 8.0 8.2 16.9 12.7 8.0 6.2 11.7 7.2 19.7 15.6 4.5 9.2 20.6 27.7 10.4 6.0 6.0 18.5 9.6 9.5 20.0 6.4 5.0 19.7 7.8 12.0 16.4 12.9 13.2 19.0 13.8 11.1 10.1 6.6 10.6 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.7;Granulosa cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.7" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 16.7;monocytes: 10.9" "Cell line enhanced" "Detected in many" "HDLM-2: 176.0" "Group enriched" "Detected in many" 5 "amygdala: 1.8;basal ganglia: 2.0;cerebral cortex: 1.1;hippocampal formation: 1.0;white matter: 2.4" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 5.5 5.2 1.5 6.5 1.7 39.6 6.2 1.3 4.6 6.8 1.7 9.0 7.2 5.7 1.4 13.3 8.0 1.0 4.2 1.3 1.4 6.3 14.4 8.4 7.8 2.3 2.0 1.2 5.6 12.2 0.4 8.5 1.9 3.3 10.0 0.8 0.4 6.7 1.8 4.1 10.9 10.9 1.2 1.2 19.2 8.2 6.8 1.7 10.6 7.2 0.4 2.4 6.9 7.9 3.2 24.2 16.8 9.9 27.3 0.6 1.3 16.8 31.2 10.0 13.6 13.0 11.9 24.6 12.9 12.6 4.2 7.8 12.1 1.1 3.6 0.7 176.0 22.1 7.7 25.5 16.3 1.4 7.5 21.3 1.1 1.8 0.9 0.6 1.2 12.7 55.1 4.6 39.0 2.8 31.2 64.9 19.7 3.7 7.8 28.2 31.5 30.9 18.7 3.1 3.7 24.3 20.3 19.9 19.9 11.1 1.6 31.3 18.4 9.5 16.5 41.6 13.1 17.0 51.1 18.6 14.8 12.9 24.3 9.7 4.1 3.1 9.9 0.7 9.1 0.0 1.8 0.2 0.1 2.1 4.1 0.1 0.4 16.7 1.0 10.9 1.3 0.9 1.7 1.5 1.7 1.3 4.6 1.3 1.4 2.3 2.0 1.2 3.3 1.2 1.7 3.2 1.9 3.2 3.6 5.2 4.9 5.6 2.5 4.9 0.6 2.6 7.0 5.1 2.2 2.8 4.6 5.5 0.0 16.7 4.8 8.9 0.0 1.3 15.5 3.8 3.7 4.1 1.8 45.7 3.4 3.9 6.6 6.0 8.6 3.4 9.5 24.5 4.6 4.3 10.3 3.3 3.0 10.9 4.1 6.0 5.0 2.2 1.8 6.5 3.6 1.9 5.2 1.7 2.1 2.0 3.6 2.3 3.4 1.5 18.5 3.9 4.4 0.8 6.6 2.3 0.0 2.1 4.4 1.0 6.2 10.2 5.7 13.1 5.6 1.9 12.5 3.4 GSTM2 GST4 ENSG00000213366 "Glutathione S-transferase mu 2" P28161 1 109668022-109709551 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 116.0;HSkMC: 115.6" "Low region specificity" "Detected in all" "CAB040547, HPA055972, HPA055973" Approved Supported Vesicles,Cytosol NA NA 1200000 Cytosol Vesicles "CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (2.51e-3)" "unprognostic (1.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.57e-2)" "unprognostic (2.20e-1)" "unprognostic (5.04e-2)" "unprognostic (7.31e-2)" "prognostic favorable (9.70e-5)" "unprognostic (1.51e-2)" "unprognostic (7.43e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-1)" "unprognostic (1.48e-3)" "unprognostic (1.07e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (2.14e-1)" 68.3 85.1 83.5 12.0 96.1 10.8 81.9 79.1 105.4 152.0 97.6 92.0 26.5 71.1 44.1 62.1 103.6 22.2 93.5 84.5 93.0 75.9 35.9 45.6 14.4 85.1 86.4 79.7 243.0 54.9 54.0 114.6 9.4 85.0 160.4 17.9 25.3 55.6 81.4 220.2 75.1 66.1 34.5 82.2 53.0 89.0 42.3 88.5 16.0 98.7 109.4 12.7 109.2 145.7 83.1 0.0 3.5 37.8 38.9 44.0 116.0 7.2 24.5 42.6 22.1 28.0 6.7 0.0 0.7 25.5 61.1 18.0 0.2 3.1 0.2 28.6 1.5 0.8 14.0 0.4 9.3 29.6 1.1 25.2 115.6 1.0 32.7 0.0 58.5 16.1 11.6 4.2 0.7 48.5 0.3 19.5 24.6 6.7 0.7 32.4 23.8 0.1 0.2 6.6 0.5 8.1 18.7 0.0 1.0 13.0 21.7 38.6 7.0 0.2 24.3 1.2 35.3 1.9 11.9 19.0 1.3 36.7 0.5 0.3 1.8 3.8 29.6 3.1 6.3 3.1 8.8 8.8 3.4 23.0 6.2 34.4 15.1 2.2 18.0 4.1 29.8 9.4 10.8 83.5 96.1 79.1 105.4 84.5 93.0 85.1 86.4 79.7 85.0 82.2 88.5 83.1 2.0 0.0 4.8 16.0 4.5 4.8 2.4 0.9 20.5 1.5 4.5 4.3 61.0 2.8 11.5 3.7 0.0 0.5 6.1 0.4 0.0 0.2 1.9 2.8 10.3 5.8 0.0 10.9 1.5 0.0 0.2 19.2 14.8 2.7 2.5 4.4 1.8 0.8 1.5 3.3 2.6 1.3 2.0 0.8 2.3 10.4 15.5 3.4 5.4 11.2 0.7 7.2 8.2 12.5 0.7 0.1 0.0 10.5 28.4 0.8 0.4 1.2 9.9 0.3 6.6 5.6 13.6 0.3 0.8 27.0 2.8 0.5 5.1 4.0 0.7 1.6 COG8 "DOR1, FLJ22315" ENSG00000213380 "Component of oligomeric golgi complex 8" Q96MW5 16 69320140-69339583 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041406, HPA049429" Approved Supported "Golgi apparatus" No No "Golgi apparatus" "HPA041406: AB_2677459, HPA049429: AB_2680763" "unprognostic (4.02e-2)" "unprognostic (6.46e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-2)" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (4.35e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-1)" "prognostic favorable (3.12e-5)" "unprognostic (3.10e-1)" "prognostic favorable (2.47e-7)" "unprognostic (4.73e-2)" "unprognostic (2.58e-1)" "unprognostic (7.83e-2)" "unprognostic (1.35e-2)" 10.0 14.6 18.8 8.6 22.1 6.6 11.2 22.4 24.6 9.6 21.4 10.6 10.6 10.9 14.2 10.0 14.1 7.8 11.3 18.6 19.2 13.5 15.1 10.3 11.4 21.3 20.0 17.8 13.9 14.3 20.1 12.1 8.0 20.2 10.4 10.0 7.8 13.9 10.7 18.2 16.4 10.1 10.6 19.7 11.0 11.3 20.5 19.7 12.3 13.2 16.0 11.4 9.5 7.7 27.5 13.2 28.5 18.2 26.7 30.1 21.0 19.4 16.9 18.6 23.0 18.7 26.2 19.8 23.7 18.1 23.0 12.4 24.9 29.5 24.3 19.8 11.9 26.4 17.0 19.9 35.0 21.3 21.1 14.8 25.2 23.5 25.2 14.7 22.2 22.6 20.4 35.4 5.7 16.7 38.3 19.4 31.3 32.2 17.8 20.5 35.6 12.6 33.3 23.6 11.1 26.0 31.1 37.5 15.0 17.5 18.4 35.4 17.8 20.5 16.8 14.4 15.8 14.1 31.3 27.1 36.8 17.3 18.8 19.2 41.4 19.6 20.6 17.8 19.0 19.6 13.3 19.2 18.2 18.6 19.0 17.4 16.7 15.6 22.2 17.6 10.7 19.6 16.8 18.8 22.1 22.4 24.6 18.6 19.2 21.3 20.0 17.8 20.2 19.7 19.7 27.5 3.2 9.6 9.7 1.3 9.4 4.2 10.4 5.8 5.2 18.9 7.3 6.7 0.0 24.3 10.6 11.0 18.8 15.0 5.0 12.6 1.9 7.6 17.4 6.1 6.4 7.2 12.7 5.5 1.9 8.0 9.1 7.4 7.1 4.6 7.0 9.0 15.7 28.5 9.5 11.8 2.0 11.7 20.3 7.9 3.3 4.8 12.8 3.1 5.4 1.0 8.4 12.1 10.3 2.0 2.6 5.4 9.5 15.8 9.0 9.6 19.3 15.3 10.2 19.9 13.1 15.5 6.2 9.9 13.6 7.2 4.1 9.2 8.3 5.4 16.7 7.2 ARHGAP19 "FLJ00194, MGC14258" ENSG00000213390 "Rho GTPase activating protein 19" Q14CB8 10 97222173-97292673 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" "Spermatocytes: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA035777, HPA043231" Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA035777: AB_2674777, HPA043231: AB_10796791" "unprognostic (5.88e-2)" "unprognostic (2.39e-2)" "unprognostic (2.47e-2)" "unprognostic (1.91e-2)" "unprognostic (1.68e-1)" "unprognostic (8.79e-3)" "unprognostic (1.60e-3)" "unprognostic (2.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (6.76e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.23e-2)" "unprognostic (4.29e-2)" 3.3 2.2 2.1 7.1 3.7 18.9 7.7 3.0 2.1 3.8 1.1 4.3 3.7 5.6 2.6 4.1 4.7 3.4 3.3 1.6 3.6 4.0 2.4 4.7 13.4 4.3 3.5 0.8 9.3 1.6 5.5 0.5 5.3 4.2 3.7 4.5 3.2 3.2 3.0 1.8 3.6 5.3 4.6 3.5 8.0 3.6 18.6 3.0 21.5 3.2 4.3 13.3 3.0 2.0 6.0 18.5 6.0 31.9 56.0 2.1 8.3 9.8 9.0 9.1 13.9 9.9 11.2 16.1 40.9 7.4 6.2 8.3 12.3 27.1 11.2 17.8 20.4 14.7 27.0 7.8 7.8 2.1 42.1 27.8 4.2 3.9 9.8 22.3 4.7 19.6 57.3 27.1 21.0 12.1 8.9 39.3 9.1 16.9 12.2 5.5 45.5 27.1 11.4 4.2 7.8 2.5 14.5 6.7 3.1 14.5 11.9 19.4 22.2 9.1 5.7 6.8 8.9 23.6 18.6 20.7 54.3 7.0 48.7 6.4 21.5 7.2 11.1 5.0 6.8 4.7 5.5 4.9 4.7 5.4 5.3 5.6 5.0 15.8 4.4 6.1 3.0 6.3 5.5 2.1 3.7 3.0 2.1 1.6 3.6 4.3 3.5 0.8 4.2 3.5 3.0 6.0 5.8 3.2 3.2 0.0 4.1 0.9 1.4 2.8 3.4 2.8 3.6 8.8 1.9 2.8 1.6 0.0 0.0 2.0 3.6 2.2 0.0 1.3 9.1 2.4 2.6 5.4 0.0 6.7 0.0 1.6 3.5 3.9 1.5 3.6 5.1 5.6 11.7 2.6 3.5 6.7 0.0 1.9 2.0 9.3 1.9 6.3 3.4 6.1 1.8 0.0 5.4 1.7 5.2 0.0 0.0 1.4 2.9 4.1 5.8 2.6 2.6 0.7 4.8 1.3 0.0 3.1 2.2 13.7 10.4 5.3 2.4 1.0 3.5 3.4 3.5 1.6 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 45.4;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane, Centrosome" "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favorable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 18.9 13.1 29.8 9.3 31.1 11.1 16.3 26.8 54.4 41.3 25.5 14.5 7.2 18.0 15.2 11.5 21.5 13.3 22.0 32.6 27.0 25.3 13.7 19.7 14.5 28.8 27.5 30.0 16.2 8.3 5.0 12.0 12.4 29.6 22.7 5.8 3.0 12.6 18.0 12.1 45.1 13.4 11.6 26.9 28.7 11.6 12.7 27.8 10.5 19.4 9.2 9.6 17.5 21.8 32.5 28.2 44.9 24.1 51.2 8.9 14.1 37.2 17.8 12.1 30.1 51.4 36.2 17.3 25.5 59.2 18.5 43.1 32.0 39.6 29.4 15.6 23.6 59.6 19.3 33.5 26.9 9.3 26.9 35.5 21.1 7.4 29.5 16.4 13.1 22.4 32.5 21.7 17.6 15.7 68.9 41.7 60.5 15.7 67.5 65.8 36.5 30.2 47.0 10.2 17.3 25.1 20.5 10.3 27.4 9.6 8.9 10.8 20.8 10.7 27.1 42.9 50.8 36.1 24.0 33.7 97.6 11.7 68.9 34.6 14.8 53.2 22.7 32.6 66.7 34.5 44.0 36.1 33.6 46.7 36.5 35.2 32.2 6.7 39.1 62.0 26.0 33.8 34.3 29.8 31.1 26.8 54.4 32.6 27.0 28.8 27.5 30.0 29.6 26.9 27.8 32.5 9.4 6.4 8.1 45.4 5.3 7.1 1.6 3.6 1.2 2.1 2.7 3.0 2.5 4.3 2.6 0.0 4.2 12.6 6.0 9.3 5.9 10.4 0.1 1.0 1.8 5.6 2.4 6.6 11.9 8.0 24.6 6.3 3.6 0.7 19.7 1.6 15.4 4.2 12.2 3.3 4.9 13.8 4.1 10.0 6.8 0.5 5.9 5.0 3.6 4.7 13.4 2.0 12.3 31.7 3.5 7.4 7.7 7.5 2.5 3.3 6.9 14.9 3.5 1.9 6.6 1.9 6.5 2.2 6.7 1.3 4.7 9.3 4.9 1.7 14.9 1.5 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Hydrolase, Transferase" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 285.3" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 219.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 76.5;Hep G2: 62.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 29.2" HPA044767 Approved Nucleoplasm "Secreted to blood" NA NA 6470000000 6400000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favorable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 27.7 20.9 24.3 8.4 23.7 4.2 27.5 51.6 37.8 40.1 30.8 24.7 5.0 28.9 9.2 13.5 26.3 11.6 35.3 23.5 26.8 24.9 285.3 36.4 7.6 38.3 27.1 20.8 28.8 17.9 8.1 17.6 17.9 31.8 40.4 4.8 2.8 17.1 18.8 13.3 32.3 18.0 12.4 26.8 23.5 16.6 11.4 26.8 9.5 43.5 9.0 4.4 27.7 27.5 27.9 5.7 9.0 13.0 14.8 11.1 15.6 76.5 21.9 9.3 14.5 10.2 29.5 6.8 3.1 4.0 31.9 5.3 19.4 3.1 30.0 8.9 1.5 7.9 3.9 22.8 62.9 15.2 0.7 10.3 27.1 27.9 30.0 10.4 19.5 10.8 8.7 8.7 1.2 10.5 9.1 3.7 9.5 8.6 1.1 5.0 4.0 14.1 3.3 4.1 9.6 0.5 6.7 33.1 1.6 3.9 26.5 18.6 6.0 20.6 18.5 28.8 20.7 8.1 17.7 5.2 8.3 8.9 2.5 16.5 0.9 0.4 1.9 0.3 0.0 0.4 0.4 0.2 0.3 0.1 0.6 0.4 0.1 1.0 0.4 0.1 0.3 0.0 0.0 24.3 23.7 51.6 37.8 23.5 26.8 38.3 27.1 20.8 31.8 26.8 26.8 27.9 16.5 9.6 4.8 27.4 1.1 9.4 4.1 4.6 6.8 0.4 1.9 5.5 7.9 5.7 3.3 3.7 2.1 7.7 1.3 0.1 0.0 1.7 0.2 2.1 6.0 8.0 1.2 14.3 0.1 1.0 3.4 7.3 1.1 1.6 1.3 5.4 10.8 219.5 2.4 0.0 0.1 0.0 4.1 6.6 3.8 1.3 8.7 2.4 7.2 6.5 3.0 7.7 1.0 4.5 1.4 2.1 0.0 8.6 1.9 4.3 0.0 0.4 4.4 0.6 13.1 7.6 10.4 0.9 1.4 0.9 2.6 12.2 1.6 4.1 0.1 1.7 MAGEA12 "CT1.12, MAGE12" ENSG00000213401 "MAGE family member A12" P43365 X 152733757-152737669 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.8" "Group enriched" "Detected in some" 16 "Spermatocytes: 9.4;Spermatogonia: 20.2" "Cancer enhanced" "Detected in many" "melanoma: 10.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 143.0;HMC-1: 57.8;K-562: 89.5;OE19: 112.7;SH-SY5Y: 48.2;U-2 OS: 87.2;U-266/70: 69.2" NA NA "unprognostic (3.47e-2)" "unprognostic (4.54e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.82e-1)" "unprognostic (3.25e-1)" "unprognostic (1.60e-3)" "unprognostic (8.57e-4)" "unprognostic (4.61e-2)" "unprognostic (1.78e-1)" "unprognostic (4.06e-2)" 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.0 5.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 143.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 112.7 41.6 0.1 0.0 1.1 0.0 0.1 3.3 48.2 0.0 24.3 13.3 0.0 0.7 0.2 0.4 0.1 87.2 12.7 6.5 69.2 0.1 0.1 0.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.5 0.5 0.5 0.4 0.5 0.4 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.4 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTPRCAP "CD45-AP, LPAP" ENSG00000213402 "Protein tyrosine phosphatase receptor type C associated protein" Q14761 11 67435510-67437682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 80.3;lymphoid tissue: 175.5" "Group enriched" "Detected in some" 6 "B-cells: 203.3;Plasma cells: 283.5;T-cells: 233.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 351.1;HDLM-2: 242.3;HL-60: 140.6;MOLT-4: 206.8;NB-4: 996.9;U-698: 248.9" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Low region specificity" "Detected in many" HPA043734 Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA043734: AB_10962214" 6.0 3.0 2.4 73.7 2.4 27.2 5.4 2.2 4.9 6.4 3.7 9.4 14.2 4.6 0.0 7.9 8.0 3.0 3.4 2.0 2.6 9.9 9.0 14.6 127.6 3.2 2.7 1.7 5.1 3.8 0.3 4.3 0.6 2.7 10.7 2.4 0.0 10.3 0.6 2.2 3.9 80.3 0.9 3.0 175.5 24.9 1.5 3.6 110.2 13.1 0.3 51.7 7.6 7.0 3.5 0.4 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.2 351.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 242.3 0.5 0.2 0.9 0.0 0.0 140.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 95.5 1.1 33.3 0.1 3.7 206.8 996.9 0.0 0.0 0.3 65.8 0.2 0.6 0.0 1.1 0.2 0.4 0.2 0.0 1.1 0.0 0.6 0.3 1.4 0.0 1.5 0.0 0.3 0.3 0.3 248.9 0.0 0.3 0.1 23.6 6.7 75.0 1559.9 5.6 1322.2 1334.4 955.3 1380.5 12.7 1714.2 688.5 1083.9 33.4 826.7 8.0 848.7 1374.2 1237.9 2.4 2.4 2.2 4.9 2.0 2.6 3.2 2.7 1.7 2.7 3.0 3.6 3.5 0.0 0.0 0.0 7.2 203.3 12.7 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 15.1 0.2 0.0 0.0 4.4 17.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.3 20.6 0.0 0.0 5.0 39.2 7.5 0.5 0.0 1.0 0.5 3.1 0.0 0.0 0.0 283.5 0.0 0.0 0.1 1.4 0.0 0.0 0.0 3.5 0.0 0.0 1.6 9.7 0.0 233.3 0.0 0.0 0.0 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.8;lymphoid tissue: 38.5" "Cell type enhanced" "Detected in some" "B-cells: 3.4;granulocytes: 2.5;Horizontal cells: 3.3;NK-cells: 4.1;Plasma cells: 1.9;T-cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "gdT-cell: 233.3;MAIT T-cell: 277.1;memory B-cell: 139.3;memory CD4 T-cell: 153.0;memory CD8 T-cell: 231.4;naive B-cell: 124.3;naive CD4 T-cell: 169.5;naive CD8 T-cell: 167.1;NK-cell: 263.0;T-reg: 136.0" "Group enriched" "Detected in all" 39 "B-cells: 139.3;NK-cells: 263.0;T-cells: 277.1" "Group enriched" "Detected in some" 28 "Daudi: 96.5;JURKAT: 55.9;MOLT-4: 107.2;U-698: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.3 0.9 6.4 2.9 1.7 0.3 3.3 2.3 0.3 0.0 0.6 0.8 0.4 0.0 0.5 0.4 0.8 0.2 0.7 0.8 0.5 1.3 1.2 19.0 4.7 2.0 0.1 0.8 0.7 0.0 0.2 0.1 2.8 0.4 0.1 0.7 1.1 0.0 2.5 0.3 10.8 0.0 0.3 24.4 1.9 0.9 2.6 38.5 0.7 0.0 4.6 1.0 0.5 7.1 0.3 2.0 1.0 0.3 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.1 0.2 96.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 55.9 0.2 0.4 0.0 0.2 107.2 0.0 0.3 0.1 0.2 0.4 0.1 1.2 0.0 0.2 2.1 0.5 0.0 0.1 0.0 0.7 0.1 0.2 0.2 0.1 0.8 0.1 0.0 0.2 0.1 32.0 0.0 0.1 0.0 0.9 0.7 0.3 233.3 1.1 277.1 139.3 153.0 231.4 0.7 124.3 169.5 167.1 5.7 263.0 1.0 1.1 136.0 104.4 0.9 2.9 3.3 2.3 0.7 0.8 4.7 2.0 0.1 2.8 0.3 2.6 7.1 0.0 0.0 0.6 0.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.2 2.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 KRTAP4-12 KAP4.12 ENSG00000213416 "Keratin associated protein 4-12" Q9BQ66 17 41123091-41124182 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 170 "skin 1: 17.0" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.3;Urothelial cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 KRTAP2-4 KAP2.4 ENSG00000213417 "Keratin associated protein 2-4" Q9BYR9 17 41065116-41065879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 262 "skin 1: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPC2 "cerebroglycan, DKFZp547M109, FLJ38962" ENSG00000213420 "Glypican 2" Q8N158 7 100169606-100177381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.2;skin 1: 4.9;testis: 12.0" "Cell type enhanced" "Detected in many" "Early spermatids: 37.7;Enteroendocrine cells: 10.7;Spermatocytes: 13.6" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.8;AN3-CA: 15.8;BEWO: 14.2;SH-SY5Y: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025423 Uncertain "Intracellular and membrane" NA NA "CAB025423: " "unprognostic (4.33e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-4)" "unprognostic (3.42e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-3)" "unprognostic (6.67e-2)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-4)" "unprognostic (7.25e-4)" "unprognostic (1.67e-4)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.94e-4)" 0.5 0.3 1.2 1.0 1.1 1.1 0.7 1.2 1.4 1.3 0.8 0.7 0.3 1.8 0.1 0.5 0.9 0.2 0.4 1.2 1.1 0.3 0.1 0.4 1.2 1.4 1.1 1.1 1.6 0.2 0.7 0.8 0.1 1.4 0.7 0.4 0.5 0.8 0.2 0.4 4.9 0.9 0.4 1.3 1.1 0.3 12.0 1.2 5.2 0.2 0.0 0.5 0.6 1.0 1.7 0.1 0.2 39.8 15.8 0.0 0.0 14.2 1.3 0.0 0.2 0.3 0.0 0.5 3.5 0.9 0.4 2.3 1.4 1.4 0.5 0.0 0.0 1.2 0.3 0.6 0.1 0.7 0.8 6.1 1.3 0.8 0.9 0.0 0.7 2.0 9.2 1.6 0.0 1.0 0.6 9.7 1.2 7.0 0.7 2.3 10.7 2.9 0.1 0.2 0.7 10.5 43.5 0.8 1.0 1.6 5.6 0.7 0.8 1.5 0.4 6.2 0.9 0.3 1.4 0.5 4.9 0.4 2.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 1.2 1.4 1.2 1.1 1.4 1.1 1.1 1.4 1.3 1.2 1.7 0.6 0.0 0.0 1.0 2.2 1.8 1.0 0.6 1.8 0.2 1.1 1.7 2.3 0.0 0.1 1.8 4.2 0.4 0.2 0.4 0.0 1.4 37.7 0.9 2.1 0.8 10.7 2.1 0.2 1.0 0.8 1.6 2.6 0.8 0.0 7.9 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.6 0.4 6.4 0.9 1.0 0.0 1.0 0.6 1.2 2.1 8.0 1.1 1.3 0.4 1.2 0.1 0.8 0.0 0.1 0.4 2.3 0.0 1.8 2.8 13.6 5.7 0.3 3.8 0.4 0.9 1.6 1.1 0.7 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;retina: 8.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 53.9;Excitatory neurons: 25.9;Horizontal cells: 28.6;Inhibitory neurons: 24.4;Muller glia cells: 46.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 9.7" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195" "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 1.1 2.7 4.4 0.1 6.5 0.0 0.3 7.3 9.6 0.4 0.8 0.5 0.4 0.5 5.0 0.3 0.3 3.3 0.2 5.6 5.8 0.5 2.8 0.2 0.1 4.6 4.9 5.2 0.1 0.5 0.7 1.8 0.0 5.7 1.1 0.5 8.1 0.2 1.4 0.0 0.1 0.9 0.5 2.8 1.8 0.3 0.3 6.2 0.4 0.7 0.1 0.1 0.4 0.4 8.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 6.5 7.3 9.6 5.6 5.8 4.6 4.9 5.2 5.7 2.8 6.2 8.5 1.5 0.0 0.5 1.3 0.0 0.1 0.8 0.0 1.8 53.9 1.0 0.6 0.5 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.4 0.0 0.1 4.3 0.0 0.0 25.9 0.2 0.2 2.5 0.0 0.0 2.5 0.0 2.2 3.5 0.0 28.6 24.4 0.2 0.0 0.3 0.3 0.6 6.5 0.0 0.0 2.8 0.0 46.7 0.0 1.5 2.1 0.1 0.0 0.7 0.0 0.1 1.2 2.7 0.0 8.9 0.0 0.0 0.2 0.2 1.2 0.9 0.0 0.1 0.1 0.0 0.1 0.1 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638101-65650918 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 96.4" "Cell type enhanced" "Detected in many" "dendritic cells: 82.5;NK-cells: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 19.1 17.3 12.8 49.1 12.4 54.3 16.3 12.3 14.3 20.3 11.2 21.2 12.6 21.0 3.4 14.4 19.7 16.2 20.5 12.8 18.3 17.1 15.2 37.3 61.2 18.3 13.2 7.6 13.2 8.5 3.5 7.6 19.6 15.8 17.2 6.0 0.9 14.2 10.1 10.1 8.0 38.1 12.1 15.4 96.4 16.0 4.7 20.2 21.5 15.0 6.5 32.8 19.0 15.4 18.1 1.6 13.3 9.1 20.1 5.4 11.1 21.7 14.9 12.7 11.7 11.3 3.9 14.5 21.3 33.2 7.6 0.4 7.8 3.4 5.1 3.9 22.7 8.1 52.6 20.7 7.4 9.6 21.5 21.5 11.4 2.3 16.2 2.1 11.5 34.4 21.8 30.3 9.2 5.8 5.8 8.6 36.1 6.4 5.4 12.3 38.8 5.1 19.3 4.4 0.8 3.4 20.9 7.5 12.6 31.7 8.5 9.6 32.5 49.2 14.2 28.7 15.2 3.0 14.1 12.2 48.4 19.5 33.0 42.0 3.2 3.3 9.3 5.8 3.9 4.1 4.1 2.8 3.7 2.3 4.7 2.0 3.1 11.1 4.7 4.8 2.1 3.0 3.0 12.8 12.4 12.3 14.3 12.8 18.3 18.3 13.2 7.6 15.8 15.4 20.2 18.1 22.5 6.4 5.2 7.5 59.0 6.8 24.7 23.2 17.6 2.1 24.8 26.5 7.2 21.5 19.2 23.9 0.0 10.1 82.5 16.5 37.2 19.8 3.0 8.3 6.8 26.8 21.0 31.6 0.1 14.5 19.6 12.2 11.2 14.9 7.0 37.1 42.8 22.0 38.4 5.0 0.2 12.8 30.5 44.4 11.4 9.8 8.1 40.2 10.6 14.0 23.7 7.6 88.6 0.5 4.0 27.2 12.7 13.2 29.6 29.0 39.0 20.7 6.0 1.8 13.1 7.4 20.9 0.8 13.8 14.4 11.1 13.5 50.4 30.9 14.3 31.9 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990356-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 27.7" "HPA017209, HPA046508" Enhanced Approved Vesicles NA NA Vesicles "HPA017209: AB_2732419, HPA046508: AB_2732525" "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 23.0 33.3 5.5 8.6 5.0 9.4 15.2 4.4 6.4 8.2 5.7 4.9 3.5 10.1 32.8 15.3 8.1 16.6 5.5 5.0 9.2 4.8 3.2 9.8 5.8 5.6 5.9 4.5 7.4 5.4 15.4 8.2 13.5 6.0 7.4 5.8 13.7 12.2 7.5 3.6 10.2 4.5 7.6 5.9 7.0 6.4 8.8 5.4 6.7 7.7 1.9 7.5 6.3 11.6 6.3 3.3 1.0 17.4 27.7 11.3 4.7 12.4 5.7 6.3 2.0 4.6 1.2 20.5 5.5 5.3 2.2 4.0 3.9 2.6 1.5 3.2 4.1 1.5 2.8 1.6 11.5 1.0 6.7 3.7 5.1 1.6 1.8 0.6 10.4 11.6 6.0 12.7 10.3 8.1 8.1 4.9 5.0 5.1 10.8 1.2 11.4 0.7 3.7 3.5 6.8 3.6 16.8 6.2 1.9 0.7 18.9 4.7 16.4 9.2 6.7 1.0 5.1 2.8 3.2 7.8 1.6 5.7 20.8 4.1 0.0 1.0 2.4 0.6 1.8 0.5 0.4 0.1 0.4 0.8 0.5 0.3 0.4 7.0 1.1 0.5 0.4 1.2 0.6 5.5 5.0 4.4 6.4 5.0 9.2 5.6 5.9 4.5 6.0 5.9 5.4 6.3 7.1 3.2 13.1 17.9 32.5 4.2 15.6 17.0 7.4 24.8 13.7 10.4 2.1 24.3 25.5 16.5 29.2 16.5 21.6 4.4 9.8 14.4 7.3 6.2 8.6 10.9 13.8 19.4 12.2 17.9 12.7 8.3 12.8 5.9 8.2 20.4 13.6 3.6 9.7 18.5 13.0 9.1 16.2 21.8 16.5 4.8 11.5 19.8 10.6 14.0 16.7 11.3 36.0 24.1 14.0 17.6 7.8 9.8 10.0 12.5 15.4 4.9 14.0 21.4 6.6 7.6 8.7 12.2 11.8 8.6 5.7 40.2 20.5 10.7 6.7 31.1 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366499-70417090 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 140.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria NA NA Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favorable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 10.3 10.2 11.6 7.4 10.8 1.3 10.0 10.2 9.6 8.2 13.0 13.8 19.8 9.1 8.0 8.3 7.3 8.5 15.1 9.2 10.2 21.9 20.4 9.6 6.6 11.7 10.7 8.2 7.3 7.5 25.1 6.6 9.3 10.8 13.0 15.2 16.5 9.6 12.0 29.0 5.7 16.1 10.8 11.4 9.1 15.7 3.9 11.3 5.1 11.3 29.6 6.5 8.7 6.2 11.8 14.0 9.1 15.3 10.3 11.7 13.4 10.6 10.8 11.1 7.4 8.3 8.7 12.8 0.0 10.0 12.7 7.5 11.6 15.7 11.6 17.5 1.9 8.0 5.2 13.9 11.4 10.3 0.0 1.7 10.5 9.2 9.4 5.3 13.1 16.6 5.8 3.1 2.7 13.4 10.2 7.2 2.1 11.1 13.9 10.9 9.0 22.4 3.9 16.0 20.7 11.1 19.4 14.6 12.0 8.8 9.9 22.7 3.6 18.5 17.7 12.1 6.9 8.7 3.7 15.0 0.0 15.6 1.8 14.9 0.3 3.0 0.1 2.3 3.1 2.7 2.5 2.8 2.7 3.0 2.0 3.8 3.1 0.3 2.3 2.1 1.9 2.3 1.1 11.6 10.8 10.2 9.6 9.2 10.2 11.7 10.7 8.2 10.8 11.4 11.3 11.8 36.6 38.5 46.6 0.0 17.8 6.0 28.7 49.4 9.1 44.9 25.9 15.4 89.4 48.6 43.3 75.4 81.3 38.3 13.1 50.1 140.8 49.0 36.9 56.0 26.5 38.4 19.8 5.7 0.0 39.2 31.5 21.7 21.9 85.7 9.5 33.5 37.1 50.4 24.7 30.3 0.0 41.2 44.7 23.6 9.1 9.8 30.4 16.9 14.2 0.0 28.8 37.1 28.8 0.0 0.0 35.7 43.5 41.3 4.2 25.8 87.3 77.0 31.5 88.0 26.3 37.6 27.8 68.9 12.9 12.5 4.8 10.9 17.4 25.0 62.6 30.3 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014160-65022184 "FDA approved drug targets, Predicted intracellular proteins" "Cell cycle" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 125.2 94.4 148.6 40.9 176.5 51.7 113.0 158.4 201.8 103.0 120.4 107.5 53.2 122.2 28.4 67.8 95.4 48.5 163.9 145.7 155.4 139.0 22.6 91.1 38.0 156.9 154.8 140.4 96.5 75.9 65.8 69.0 56.6 154.9 85.4 33.2 43.9 68.4 67.2 215.9 94.1 74.0 61.5 164.6 63.9 85.9 117.0 158.2 33.8 86.4 159.5 29.2 113.1 94.3 172.7 162.0 257.0 76.5 115.8 207.4 156.5 70.5 82.5 181.7 111.2 109.1 72.8 110.0 62.1 144.5 112.7 168.1 101.4 82.9 140.0 53.1 65.5 130.6 61.9 109.2 111.9 157.8 77.9 54.9 123.7 114.6 92.6 204.4 160.5 150.4 74.0 152.8 110.1 76.4 194.1 63.1 174.5 120.3 77.7 208.6 33.4 81.6 152.9 120.9 70.6 143.3 79.3 66.4 67.6 225.8 74.4 72.3 94.3 109.2 205.9 68.6 164.7 82.1 37.9 57.6 38.5 97.2 112.5 171.3 46.5 78.2 72.5 120.4 80.2 130.9 163.1 110.0 116.9 101.7 149.0 123.5 137.2 10.2 83.3 48.2 140.1 79.0 136.9 148.6 176.5 158.4 201.8 145.7 155.4 156.9 154.8 140.4 154.9 164.6 158.2 172.7 179.1 22.4 43.6 0.0 42.7 81.4 94.4 118.4 63.7 70.2 66.8 83.9 103.2 51.5 66.4 82.8 29.2 179.7 40.0 110.0 268.0 142.0 430.8 42.2 59.0 148.0 83.3 69.4 0.0 76.0 193.5 107.0 29.6 50.7 95.7 71.5 137.4 19.7 98.3 69.0 0.0 68.4 83.4 49.7 73.5 1125.1 71.7 49.5 177.9 0.0 100.6 208.4 55.6 0.0 0.0 68.3 115.7 71.1 16.5 79.9 162.4 505.5 47.0 48.9 65.7 74.2 109.7 126.5 79.4 56.3 82.8 107.3 40.0 65.7 98.0 75.9 TTLL13P "FLJ46079, MGC33417, TTLL13" ENSG00000213471 "Tubulin tyrosine ligase like 13, pseudogene" A6NNM8 15 90249530-90265482 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "testis: 9.0" "Cell type enhanced" "Detected in single" "Inhibitory neurons: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041305 Enhanced NA NA "HPA041305: AB_2732492" "unprognostic (6.23e-3)" "unprognostic (2.19e-2)" "unprognostic (6.49e-4)" "unprognostic (6.09e-4)" "unprognostic (2.46e-1)" "unprognostic (1.43e-1)" "unprognostic (8.58e-2)" "unprognostic (5.17e-3)" "unprognostic (3.61e-3)" "unprognostic (9.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.79e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-2)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.88e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GBP7 "FLJ38822, GBP4L" ENSG00000213512 "Guanylate binding protein 7" Q8N8V2 1 89131742-89176009 "Predicted intracellular proteins" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 156 "liver: 101.0" "Cell type enhanced" "Detected in some" "Endothelial cells: 4.7;Hepatic stellate cells: 5.7;Hepatocytes: 16.3;Theca cells: 4.1" "Cancer enriched" "Detected in single" 58 "liver cancer: 10.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051245 Uncertain NA NA "HPA051245: AB_2681404" "unprognostic (4.22e-5)" "unprognostic (7.32e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.63e-1)" "unprognostic (3.66e-3)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (2.80e-1)" "unprognostic (8.79e-2)" "unprognostic (1.57e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.57e-1)" "unprognostic (6.35e-2)" 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 101.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 1.3 0.8 0.0 0.8 0.2 0.0 0.0 0.1 0.1 0.6 1.5 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.1 4.7 0.0 0.0 0.6 0.0 0.1 0.6 0.0 0.2 0.0 0.3 5.7 16.3 0.9 0.0 0.8 0.0 0.0 0.8 0.0 0.1 0.6 0.7 0.0 1.9 0.5 3.0 3.1 0.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.3 0.6 0.0 0.4 0.0 0.0 0.0 1.1 4.1 0.0 0.7 RBMXL1 KAT3 ENSG00000213516 "RBMX like 1" Q96E39 1 88979456-88992960 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA057707: AB_2683508" "prognostic favorable (7.60e-4)" "unprognostic (2.22e-1)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-1)" "unprognostic (5.84e-2)" "unprognostic (1.17e-3)" "unprognostic (2.89e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (2.55e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" "unprognostic (2.35e-1)" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" 7.8 5.1 10.8 6.6 11.6 15.8 7.8 10.5 10.1 9.1 8.0 5.4 5.5 9.8 5.7 10.3 8.7 6.5 7.7 9.5 15.5 6.2 9.8 7.4 8.3 11.3 11.3 8.5 12.4 8.4 8.3 3.4 7.4 11.2 9.3 5.2 10.6 6.5 6.7 5.0 5.5 5.2 8.7 11.9 7.6 6.0 8.7 12.4 8.7 7.8 5.9 8.1 8.2 5.7 13.2 15.3 4.5 12.0 14.7 13.8 14.6 22.2 6.3 12.5 12.2 14.2 7.0 10.1 13.2 11.7 7.2 26.6 8.7 21.3 15.5 14.2 11.9 10.7 15.2 14.4 9.6 9.2 12.1 7.9 8.4 9.1 11.1 9.8 5.7 7.3 9.3 20.3 8.1 7.0 5.6 12.7 6.6 22.3 9.1 9.5 11.8 27.8 6.6 8.9 18.4 8.4 14.7 7.4 14.1 16.3 16.3 11.5 13.2 6.2 7.6 15.5 9.9 10.6 13.6 13.3 13.5 5.6 7.2 7.4 2.3 4.8 4.4 4.6 6.2 5.9 4.7 6.2 4.7 6.1 5.9 6.9 4.3 8.8 4.4 7.8 3.2 5.4 6.8 10.8 11.6 10.5 10.1 9.5 15.5 11.3 11.3 8.5 11.2 11.9 12.4 13.2 12.6 35.3 36.9 0.0 14.7 30.7 55.2 18.5 22.2 20.2 18.9 16.0 21.3 18.6 24.9 12.9 14.6 30.2 11.9 11.7 3.9 9.5 1.4 12.7 12.5 17.5 28.8 8.2 0.0 8.7 29.4 16.4 15.3 21.3 34.8 16.9 15.7 32.9 11.8 25.2 0.0 10.7 10.2 22.4 15.5 2.3 17.1 13.8 21.4 0.0 20.2 28.5 12.3 0.0 0.0 10.8 4.6 15.1 10.0 24.6 9.1 5.9 21.6 18.0 6.6 20.4 19.7 12.1 18.6 28.1 24.3 34.1 18.5 14.6 12.0 34.6 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA044598: AB_2679013, HPA050153: AB_2681033" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favorable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 11.8 34.3 9.2 7.8 9.4 9.6 9.8 15.6 12.7 9.7 9.3 11.6 5.1 8.3 6.1 9.4 9.5 5.6 11.3 9.8 9.5 12.4 26.0 15.1 6.3 8.6 9.3 8.8 15.0 7.6 4.7 22.3 5.9 10.5 12.6 4.8 7.3 15.0 6.3 14.6 9.3 12.0 5.4 8.9 17.8 14.2 22.7 9.2 5.6 13.0 2.6 5.2 9.5 8.9 9.8 9.7 22.7 11.8 12.3 5.6 7.6 16.4 16.1 9.1 10.3 10.8 41.8 5.9 8.2 11.7 6.2 5.5 6.4 2.1 12.0 4.1 12.7 13.9 7.2 25.0 16.1 12.0 13.1 9.4 14.7 6.1 5.5 2.8 9.1 4.7 13.8 7.4 12.1 6.9 29.5 10.7 20.4 3.6 5.2 18.0 11.7 10.0 7.9 5.4 11.3 8.3 9.8 9.4 8.5 11.6 4.1 10.5 14.7 7.5 9.7 5.1 8.5 13.2 15.1 10.9 8.6 12.0 16.8 6.5 16.1 26.0 20.3 10.7 23.8 9.9 15.8 10.2 10.4 25.2 14.0 8.2 9.4 43.0 13.6 23.6 15.2 19.5 26.8 9.2 9.4 15.6 12.7 9.8 9.5 8.6 9.3 8.8 10.5 8.9 9.2 9.8 43.3 6.4 49.4 13.4 46.7 52.4 68.5 126.1 38.7 23.6 57.8 48.9 71.7 57.2 86.4 33.1 8.4 103.7 56.9 87.8 113.5 102.7 104.6 59.5 33.4 39.8 38.4 35.1 15.5 148.2 117.9 48.6 64.7 43.1 68.4 21.8 42.1 69.7 93.1 15.2 17.2 71.6 107.8 61.2 71.5 150.0 25.1 82.0 67.6 7.5 90.4 59.5 42.2 9.0 11.5 186.0 78.7 29.7 113.7 82.9 83.7 131.0 84.1 23.7 26.3 26.7 76.1 77.2 30.7 62.3 45.9 179.0 47.4 66.8 49.2 142.6 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897548 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 9.1 9.8 7.6 8.1 7.4 23.4 7.9 6.3 7.2 10.1 3.9 8.0 5.9 10.7 5.7 6.7 12.9 7.0 6.2 6.3 5.8 7.1 30.8 12.2 9.6 8.0 7.4 5.8 8.8 11.8 6.1 6.1 5.4 7.0 7.6 4.9 4.6 10.8 8.0 17.7 8.1 8.1 9.5 6.2 11.2 8.7 7.0 6.4 10.4 8.9 5.2 8.3 11.0 7.8 7.5 9.6 8.2 12.6 22.1 27.9 17.7 24.8 13.3 15.5 18.5 17.0 10.2 10.0 9.2 2.6 16.1 17.8 8.7 15.1 13.7 12.8 20.3 10.6 15.3 10.3 15.9 18.4 23.0 11.3 13.8 18.6 20.7 9.3 11.7 15.4 15.2 5.2 9.3 15.8 7.9 12.7 12.9 11.3 8.0 15.8 6.7 8.5 6.4 8.8 12.5 2.7 9.1 14.1 9.5 12.9 6.9 8.2 20.3 15.5 14.8 8.4 19.7 16.5 16.8 11.9 9.0 13.0 23.2 11.5 0.0 1.6 0.9 1.0 3.1 0.9 0.9 1.6 1.2 2.0 0.7 0.8 0.6 0.1 0.4 2.9 1.1 2.4 0.8 7.6 7.4 6.3 7.2 6.3 5.8 8.0 7.4 5.8 7.0 6.2 6.4 7.5 2.4 0.0 2.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.6 7.3 0.0 1.8 1.8 0.0 1.9 2.4 0.0 24.2 1.7 0.5 0.0 0.0 0.0 2.9 6.9 0.8 0.0 1.6 0.0 1.4 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 15.4 9.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.9 1.2 4.6 0.0 0.0 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73247255 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 92.6" "Cell type enhanced" "Detected in all" "Erythroid cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" NA NA 39000 Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 8.4 10.7 18.1 17.8 18.7 92.6 15.6 20.4 21.7 11.1 16.6 16.1 14.7 12.9 12.5 17.0 9.7 6.9 8.3 18.1 18.1 10.1 13.5 9.7 28.4 17.6 17.8 18.0 15.4 8.8 10.3 10.7 17.8 18.9 11.5 18.2 25.3 11.4 11.3 11.6 17.9 14.0 11.9 17.2 14.9 12.3 12.5 18.0 36.1 8.5 13.2 32.6 11.6 12.0 19.3 135.0 77.3 93.8 68.4 16.1 19.3 45.7 101.5 59.4 101.1 106.1 130.8 89.4 86.9 33.5 43.6 43.7 83.1 92.9 67.5 118.1 98.5 63.8 188.3 79.4 93.4 14.8 173.1 71.0 14.8 33.2 107.1 93.4 36.4 66.2 112.1 168.3 103.0 81.4 118.4 155.0 124.7 36.3 64.4 215.1 114.2 85.1 47.6 52.9 61.5 44.3 73.4 73.5 114.5 52.9 43.7 62.1 76.8 48.0 65.2 118.3 71.3 168.0 45.0 70.6 141.8 64.8 162.9 45.9 23.9 3.7 29.1 25.5 10.7 29.2 32.8 31.3 28.2 6.5 28.3 30.3 26.9 4.5 24.8 10.9 20.3 36.8 18.0 18.1 18.7 20.4 21.7 18.1 18.1 17.6 17.8 18.0 18.9 17.2 18.0 19.3 17.3 9.6 12.3 11.1 39.5 47.7 34.1 31.9 33.0 26.1 21.5 24.8 2.7 17.2 24.8 9.2 8.4 107.8 44.6 18.3 21.5 31.5 80.4 15.9 14.0 20.6 12.0 173.8 11.8 31.4 111.4 17.6 12.2 19.0 42.3 26.0 13.9 9.8 61.9 15.2 12.8 25.6 54.9 10.9 19.6 43.3 14.0 17.4 32.0 6.5 23.0 29.5 32.0 7.5 6.5 44.1 16.7 20.3 49.7 27.6 18.2 16.3 21.9 43.2 26.3 17.7 28.3 28.7 65.4 38.2 43.5 58.0 45.2 19.7 38.0 37.5 C8orf82 MGC70857 ENSG00000213563 "Chromosome 8 open reading frame 82" Q6P1X6 8 144525733-144529132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 138.9;Proximal tubular cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034331 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034331: AB_1565393" "unprognostic (3.56e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (8.60e-2)" "unprognostic (6.31e-3)" "unprognostic (1.95e-1)" "unprognostic (4.57e-2)" "unprognostic (3.82e-1)" "unprognostic (1.22e-1)" "unprognostic (3.61e-1)" "unprognostic (4.09e-2)" "prognostic favorable (1.70e-5)" "unprognostic (5.72e-3)" "unprognostic (3.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-3)" 10.4 14.7 8.6 4.5 7.7 2.8 11.5 9.9 10.6 14.4 3.2 12.8 11.2 11.9 2.6 16.9 12.0 3.9 14.7 7.3 6.6 16.2 35.9 8.6 3.8 8.6 7.5 6.7 15.2 13.3 6.7 12.2 3.4 8.5 26.5 3.8 4.7 11.7 5.6 12.1 9.0 11.8 2.8 6.4 10.0 12.4 7.4 8.0 4.6 12.7 3.6 2.4 15.1 11.9 9.9 6.8 16.8 9.8 7.9 4.0 3.4 8.2 7.2 3.9 3.9 3.9 8.3 11.2 11.9 11.4 4.5 3.3 8.1 2.2 2.5 1.4 9.0 25.7 23.0 10.4 15.6 4.2 3.5 10.8 5.1 5.5 2.5 2.5 6.4 2.7 6.6 19.1 5.9 2.9 35.7 8.9 14.2 5.3 10.1 46.6 9.9 3.3 5.8 6.1 10.1 33.3 27.3 11.0 7.8 7.1 3.3 14.3 7.1 14.6 7.5 28.7 8.4 5.3 4.2 2.8 9.8 9.9 4.3 7.3 0.1 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 8.6 7.7 9.9 10.6 7.3 6.6 8.6 7.5 6.7 8.5 6.4 8.0 9.9 12.2 3.2 6.9 0.3 12.9 15.9 49.6 1.9 23.3 30.4 39.6 38.6 17.9 18.6 1.9 16.5 14.6 33.4 13.0 46.3 138.9 5.8 16.8 10.3 22.1 12.3 34.2 14.9 0.1 7.7 35.1 18.5 19.4 26.0 5.7 16.3 9.7 69.8 18.6 28.6 0.1 31.9 2.0 16.1 16.1 21.4 24.2 15.2 33.8 0.0 7.5 28.0 13.4 0.0 0.1 6.7 22.1 20.3 16.3 55.6 35.4 99.1 0.4 35.8 32.9 21.1 23.0 24.4 18.8 36.9 20.9 25.2 13.1 34.5 34.6 43.3 CPLX3 CPX-III ENSG00000213578 "Complexin 3" Q8WVH0 15 74826627-74831802 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lymphoid tissue: 111.2;prostate: 123.4;retina: 99.4" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 496.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 2.0;SK-BR-3: 1.1;U-266/84: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB079003 Supported NA NA "CAB079003: " 0.1 7.2 10.4 0.2 9.6 0.1 0.2 16.5 10.3 0.2 4.2 0.3 0.1 0.0 0.1 0.8 0.1 0.0 25.5 18.1 7.1 0.0 0.1 0.1 0.2 8.1 12.9 8.9 0.1 0.1 0.1 5.4 0.0 12.6 123.4 0.1 99.4 18.1 0.0 0.0 0.3 0.3 0.0 6.2 111.2 15.0 6.4 20.5 0.1 0.0 0.0 0.2 0.1 0.3 10.5 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.1 0.5 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 9.6 16.5 10.3 18.1 7.1 8.1 12.9 8.9 12.6 6.2 20.5 10.5 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 496.1 0.1 0.0 0.0 0.0 0.0 0.0 77.2 0.0 0.1 0.5 0.0 0.0 3.9 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.2 6.9 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 19.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 56.0 0.0 0.0 0.0 8.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 VDAC1 "MGC111064, PORIN" ENSG00000213585 "Voltage dependent anion channel 1" P21796 5 133971871-134004975 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1055.6;tongue: 819.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005885, HPA030780, CAB072343" Supported NA NA 1300000 "CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608" "prognostic unfavorable (5.30e-4)" "unprognostic (7.63e-3)" "unprognostic (3.07e-3)" "unprognostic (2.01e-1)" "unprognostic (5.11e-3)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (8.49e-4)" "prognostic unfavorable (2.87e-5)" "unprognostic (1.81e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (2.64e-1)" "unprognostic (3.19e-2)" "unprognostic (8.98e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" 90.8 130.9 108.3 97.1 120.5 54.4 107.3 119.4 135.3 60.9 143.3 155.6 268.1 54.9 198.6 173.7 62.0 91.1 407.3 118.0 127.2 202.8 207.9 80.0 90.3 118.3 112.3 114.7 61.3 100.6 183.3 63.9 105.4 120.5 83.2 168.0 318.7 134.0 73.2 1055.6 113.5 180.6 91.5 114.2 60.7 165.1 37.8 122.7 91.8 69.1 819.2 130.4 109.4 91.7 150.1 364.5 315.8 282.8 295.3 277.5 385.0 398.0 398.1 292.2 386.5 395.2 650.0 282.9 497.4 291.5 418.0 515.1 278.2 403.4 701.2 480.7 296.1 331.7 287.3 308.9 526.0 282.2 266.5 272.9 353.3 368.5 301.1 333.0 385.3 381.2 248.0 260.1 197.8 511.8 404.5 326.3 264.1 198.5 555.2 264.3 296.5 282.6 474.3 608.6 450.0 315.0 177.7 253.7 305.2 416.0 385.9 147.0 257.6 311.6 361.4 241.6 335.9 530.2 262.9 278.3 309.4 537.1 351.9 420.7 24.9 83.2 30.3 54.5 118.4 60.0 58.3 55.6 57.3 140.7 40.5 38.8 43.8 6.9 87.7 105.1 41.1 74.5 72.9 108.3 120.5 119.4 135.3 118.0 127.2 118.3 112.3 114.7 120.5 114.2 122.7 150.1 89.9 105.8 63.1 21.2 101.9 204.8 246.6 250.8 128.7 463.6 163.7 98.3 276.0 198.8 133.2 126.9 81.3 372.4 94.9 333.1 729.8 303.4 68.7 140.8 161.1 120.7 104.1 96.7 41.5 302.6 471.4 136.9 225.8 184.6 121.8 163.9 57.1 203.9 332.7 519.9 40.6 202.7 189.2 130.6 243.5 50.3 95.7 165.7 249.1 31.9 315.8 277.0 60.8 24.1 23.8 300.7 227.7 112.1 162.0 353.6 415.8 585.3 121.2 257.2 85.5 132.8 171.4 10.9 32.7 275.5 232.9 325.6 111.0 229.1 326.7 265.1 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457544 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 2.4 4.0 0.7 1.5 0.8 1.8 2.3 0.7 1.5 2.1 6.8 2.2 2.4 2.7 1.7 3.8 2.5 0.7 2.4 1.7 1.5 2.8 3.2 2.4 1.9 0.8 0.4 0.2 3.0 3.0 0.7 10.1 0.5 0.7 2.4 1.4 1.9 2.9 0.1 1.8 3.8 2.8 0.8 0.0 3.6 2.7 7.5 0.3 0.2 2.2 1.0 3.3 2.6 2.2 0.3 1.0 0.3 11.6 2.9 2.1 0.1 11.3 0.6 0.2 0.2 0.1 3.0 0.8 2.7 1.8 0.3 16.5 1.2 4.8 2.4 1.3 3.1 2.0 9.0 2.3 0.0 0.0 2.3 14.2 0.5 0.9 3.3 2.6 0.6 0.1 1.5 3.2 1.8 2.6 1.6 0.6 0.9 4.3 0.5 0.7 5.6 3.0 2.7 2.2 2.3 1.8 1.1 3.3 0.3 1.1 1.1 1.6 0.4 1.9 0.9 1.3 1.3 1.2 0.7 3.5 12.0 0.9 2.9 0.3 5.2 1.1 0.4 2.8 0.8 1.2 0.4 1.2 2.6 1.5 0.8 2.5 1.9 0.8 1.3 1.7 0.3 2.2 0.6 0.7 0.8 0.7 1.5 1.7 1.5 0.8 0.4 0.2 0.7 0.0 0.3 0.3 0.1 0.0 0.0 1.3 2.1 4.5 0.0 1.9 1.8 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.5 0.0 1.5 0.3 0.4 0.1 0.6 1.8 1.3 1.2 1.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.7 6.1 0.0 1.2 1.1 0.0 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.6 1.0 0.1 0.0 0.6 0.0 0.2 0.1 4.3 0.0 0.0 0.0 0.7 0.1 0.1 0.8 3.7 0.0 0.7 0.1 1.0 0.0 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712593-57740973 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Lissencephaly, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: AB_2685116" "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favorable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (3.37e-4)" 51.4 75.7 80.9 37.7 84.8 27.2 51.0 90.2 102.8 43.7 99.2 70.7 56.9 39.7 58.7 63.3 43.1 33.5 66.6 78.5 86.1 70.4 84.1 45.4 31.7 85.5 85.4 74.6 41.3 58.2 85.6 43.4 44.4 86.7 50.5 81.6 65.3 50.0 54.3 45.1 43.2 58.8 43.5 83.7 45.3 61.4 30.9 87.7 35.2 57.6 41.7 48.0 48.7 44.1 93.8 122.7 141.4 78.5 143.4 144.8 77.2 86.6 144.2 111.8 140.0 117.9 135.3 205.6 115.1 156.6 116.3 207.1 220.0 203.5 115.4 146.3 83.3 88.9 110.2 105.7 136.8 119.3 156.6 145.5 94.8 166.5 154.8 243.2 76.3 80.6 95.3 194.4 130.9 157.7 62.7 93.0 177.1 153.8 227.7 191.5 124.7 97.9 242.5 174.4 136.4 90.3 129.3 110.2 255.7 168.3 76.7 228.5 102.2 66.7 130.5 84.8 176.1 152.1 127.9 269.5 115.3 146.6 109.3 198.3 37.8 41.5 40.0 34.6 72.4 44.0 36.8 34.4 40.9 40.6 34.9 43.1 43.8 11.2 37.8 86.0 49.7 32.0 45.0 80.9 84.8 90.2 102.8 78.5 86.1 85.5 85.4 74.6 86.7 83.7 87.7 93.8 37.9 38.5 34.0 0.0 32.0 32.1 44.9 108.2 19.9 43.4 35.8 28.1 42.6 30.0 60.8 49.7 31.3 108.0 29.9 39.5 43.0 72.4 2.0 19.6 27.4 36.8 28.8 37.6 0.0 43.5 85.6 38.6 23.0 20.7 43.1 29.9 31.8 48.7 62.0 30.3 0.0 49.6 81.4 30.8 21.4 3.6 48.7 31.9 48.0 0.0 37.8 91.1 19.6 0.0 0.0 54.5 32.0 43.6 32.5 49.0 51.4 41.1 37.4 66.7 39.5 36.3 34.5 60.7 62.2 33.6 32.7 99.6 26.6 46.6 75.2 43.6 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340924-72376420 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 234.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 50.2 56.7 18.0 37.9 20.2 111.0 59.1 20.1 23.9 74.4 27.7 55.7 50.2 43.0 166.1 25.0 48.2 77.4 54.8 19.0 26.9 91.0 80.1 84.9 54.7 22.2 19.8 18.0 39.7 30.9 54.5 26.5 102.8 22.1 45.7 67.7 32.4 45.4 53.8 22.3 22.0 41.6 60.0 21.2 55.2 45.5 36.0 23.7 38.4 77.2 33.4 42.8 72.3 19.8 28.3 39.8 66.4 27.8 53.8 223.6 253.1 39.7 54.8 274.1 115.3 182.8 34.6 282.7 32.9 50.9 110.0 59.9 77.1 74.5 34.6 72.5 26.5 30.0 41.4 60.4 60.9 172.9 99.9 113.1 216.7 101.3 50.4 89.3 210.3 107.4 48.4 65.1 197.6 156.0 33.9 21.7 50.0 16.0 128.9 0.3 22.3 60.6 75.3 129.1 61.6 23.8 26.4 136.5 126.6 307.3 56.1 23.4 123.9 54.1 171.9 70.7 160.1 59.3 104.7 151.8 33.4 62.1 130.4 85.3 24.2 84.6 60.1 43.8 35.7 38.7 41.1 28.8 38.9 98.0 38.0 22.5 33.2 8.1 51.3 13.3 37.3 28.2 63.0 18.0 20.2 20.1 23.9 19.0 26.9 22.2 19.8 18.0 22.1 21.2 23.7 28.3 68.9 64.1 62.4 19.9 46.3 22.2 33.3 94.3 19.4 42.4 28.6 30.4 26.9 30.0 68.0 66.2 106.3 150.2 54.2 36.6 60.7 88.3 20.6 27.2 30.2 50.8 47.2 19.1 22.7 38.0 68.0 78.7 42.8 40.6 29.9 49.9 43.5 42.9 234.3 26.9 24.7 46.3 81.4 92.8 75.0 13.7 74.3 118.1 94.3 24.4 60.3 38.4 82.4 20.6 26.7 39.1 74.6 44.8 37.7 33.0 68.5 66.7 37.5 56.9 46.0 24.5 31.7 24.3 32.3 13.5 15.6 157.6 36.7 45.2 50.6 27.5 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 294.7" "Cell type enhanced" "Detected in all" "Distal tubular cells: 405.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA 14000 Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 52.7 92.1 46.2 16.7 48.8 44.5 51.2 53.8 50.4 42.9 54.0 85.9 54.3 50.1 26.5 79.3 43.0 18.3 164.0 46.8 49.2 94.0 97.0 40.8 25.7 47.7 47.4 43.9 37.6 57.1 54.1 68.0 17.7 48.1 44.3 53.2 23.7 61.4 27.7 294.7 65.8 70.0 26.8 47.5 55.9 82.1 48.5 52.6 34.1 50.2 195.9 33.5 51.8 52.4 47.4 37.7 68.7 59.8 62.9 48.8 52.3 48.2 35.0 60.3 84.6 80.4 103.6 65.1 81.8 34.8 49.7 63.0 64.9 81.7 61.8 69.4 44.2 137.2 49.5 90.6 106.5 49.7 121.5 62.1 50.1 46.6 32.0 52.2 37.5 55.3 69.2 73.7 57.1 57.7 118.6 87.0 164.9 83.6 109.6 97.7 100.7 81.8 68.7 76.4 60.2 63.9 47.1 43.4 76.9 83.5 35.2 84.4 118.2 37.0 49.3 56.4 57.0 80.4 61.2 93.5 91.8 50.1 94.9 51.3 38.3 69.3 48.9 43.2 79.8 46.4 60.6 45.2 47.5 83.3 59.2 42.4 46.0 18.4 45.6 66.7 89.3 61.3 90.3 46.2 48.8 53.8 50.4 46.8 49.2 47.7 47.4 43.9 48.1 47.5 52.6 47.4 54.7 54.5 42.6 23.5 54.6 65.6 67.4 217.5 62.6 45.6 60.2 72.5 176.9 81.5 108.5 69.9 41.7 122.0 70.8 183.1 405.0 113.0 132.3 56.8 58.6 60.0 84.7 73.8 12.7 111.3 116.5 60.8 81.1 40.5 57.7 67.1 58.5 126.3 195.9 60.6 14.5 162.8 173.0 66.9 59.3 63.2 67.4 62.8 119.2 7.5 83.9 117.9 58.7 12.5 13.1 91.7 109.3 69.2 69.8 53.0 257.8 297.0 109.7 59.5 105.2 55.5 154.8 85.5 74.7 115.3 75.9 89.1 55.5 128.3 210.7 85.3 LEPROT "FLJ90360, OB-RGRP, OBRGRP, VPS55" ENSG00000213625 "Leptin receptor overlapping transcript" O15243 1 65420587-65436007 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 240.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069444 Approved Centrosome NA NA Centrosome "HPA069444: AB_2686137" "unprognostic (3.64e-2)" "unprognostic (2.24e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "unprognostic (6.13e-3)" "unprognostic (1.52e-1)" "unprognostic (2.21e-1)" "unprognostic (4.88e-2)" "unprognostic (6.85e-2)" "unprognostic (6.43e-3)" "unprognostic (2.25e-2)" "unprognostic (4.56e-3)" "unprognostic (2.25e-3)" "unprognostic (8.22e-2)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" 71.1 54.0 22.9 35.2 26.3 66.7 49.3 24.6 23.8 50.7 39.5 44.4 34.2 57.6 33.6 41.7 38.1 50.2 43.2 21.1 32.2 77.3 53.5 57.3 26.9 29.7 25.0 18.2 64.1 40.4 55.5 17.1 70.4 27.5 38.4 42.1 15.0 30.6 42.5 27.6 42.1 35.4 51.0 26.6 44.8 42.7 20.3 27.3 17.5 49.5 33.3 22.8 43.5 28.7 27.8 74.0 25.6 25.6 11.5 153.4 109.8 92.4 112.9 95.3 54.7 56.5 22.0 35.9 17.4 67.8 77.1 88.1 41.7 13.0 41.9 68.3 99.8 13.5 80.2 41.7 30.5 43.0 17.8 36.7 167.3 68.8 49.2 40.1 82.8 72.9 12.0 39.6 28.7 100.9 11.3 5.8 13.7 37.9 18.8 22.7 4.1 54.3 17.2 240.9 54.7 21.9 35.1 64.1 37.1 48.5 93.8 41.5 20.1 125.8 66.7 67.9 58.1 37.0 47.7 65.2 9.5 58.7 32.4 46.1 90.8 60.7 53.7 17.8 50.6 18.9 10.8 13.8 13.7 39.4 7.3 15.6 12.5 50.4 21.0 76.0 28.0 13.7 47.7 22.9 26.3 24.6 23.8 21.1 32.2 29.7 25.0 18.2 27.5 26.6 27.3 27.8 283.5 166.7 66.6 0.0 26.3 57.6 90.3 189.5 47.3 20.8 79.5 101.0 57.3 98.7 130.4 178.4 22.9 214.1 46.2 71.4 82.2 142.0 6.6 84.3 124.7 181.6 55.8 148.5 0.0 144.3 100.4 170.4 37.2 142.8 62.6 95.4 215.6 82.1 104.7 38.7 0.0 58.8 130.2 126.5 68.5 10.9 198.8 128.6 72.9 0.0 112.3 82.4 43.3 0.0 0.0 163.4 58.0 149.0 25.3 81.2 54.1 186.5 101.0 28.0 190.7 132.3 159.3 15.9 20.6 49.8 66.9 367.8 37.6 209.6 47.2 84.4 LBH ENSG00000213626 "LBH regulator of WNT signaling pathway" Q53QV2 2 30231534-30323730 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 210.6;Pancreatic endocrine cells: 298.9;Smooth muscle cells: 435.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 112.4;MAIT T-cell: 110.2;memory B-cell: 92.0;memory CD4 T-cell: 83.8;memory CD8 T-cell: 86.1;naive B-cell: 123.0;naive CD4 T-cell: 140.2;naive CD8 T-cell: 124.6;T-reg: 89.2" "Group enriched" "Detected in all" 7 "B-cells: 123.0;T-cells: 140.2" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 302.4;hTERT-RPE1: 150.6;U-2 OS: 95.1" "Low region specificity" "Detected in all" HPA034669 Approved Approved Vesicles NA NA Vesicles "HPA034669: AB_10600820" "unprognostic (2.13e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-1)" "unprognostic (4.77e-3)" "unprognostic (1.23e-3)" "unprognostic (1.57e-1)" "unprognostic (2.69e-1)" "unprognostic (3.65e-3)" "unprognostic (1.93e-1)" "unprognostic (3.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.60e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.25e-2)" "unprognostic (7.91e-3)" "unprognostic (1.67e-1)" 31.5 10.4 10.0 57.9 8.6 28.8 32.3 13.8 22.3 40.0 17.9 26.3 14.6 83.7 27.2 17.2 42.1 45.3 83.2 15.4 28.3 37.9 15.1 131.9 118.8 22.3 16.1 6.5 63.8 14.6 85.5 16.9 54.9 18.3 27.5 18.2 71.4 64.5 26.6 14.5 26.5 41.6 48.7 10.9 84.2 23.0 9.9 14.8 126.9 69.5 20.6 101.7 35.9 22.9 13.2 0.1 11.4 14.0 2.5 3.6 2.2 1.1 14.5 19.1 3.8 0.6 59.4 15.2 28.6 33.3 302.4 3.8 19.5 81.1 0.8 0.6 41.3 3.4 4.6 12.2 0.2 10.9 0.4 4.0 13.0 1.1 5.0 0.3 150.6 0.7 19.0 14.6 0.2 14.2 0.2 32.3 0.4 84.6 2.6 0.6 33.1 75.4 9.7 2.6 5.0 3.9 10.0 23.7 2.3 1.0 49.7 0.1 1.2 18.9 26.8 95.1 52.0 1.8 53.8 3.3 2.7 11.9 1.8 8.4 0.7 0.7 1.1 112.4 1.2 110.2 92.0 83.8 86.1 0.8 123.0 140.2 124.6 4.0 18.9 3.2 12.1 89.2 110.4 10.0 8.6 13.8 22.3 15.4 28.3 22.3 16.1 6.5 18.3 10.9 14.8 13.2 46.9 109.0 20.0 0.7 167.3 12.4 64.5 51.7 16.5 41.2 13.0 125.0 65.1 12.8 40.8 25.8 210.6 18.3 152.2 6.0 13.7 85.4 39.4 110.5 18.0 81.8 23.8 85.9 2.2 56.9 10.8 54.7 23.4 45.2 15.8 2.3 23.6 1.2 33.2 8.4 16.4 9.3 30.5 10.0 23.1 144.5 10.5 14.3 23.2 14.0 6.7 13.1 163.7 9.5 0.7 298.9 8.7 26.7 26.3 95.3 0.7 21.7 67.8 45.4 177.5 36.3 435.6 0.7 6.6 9.1 10.7 9.3 205.3 8.8 6.3 56.8 ADAT3 TAD3 ENSG00000213638 "Adenosine deaminase tRNA specific 3" 19 1905399-1913447 "Human disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 9.1;Gastric mucus-secreting cells: 8.2;Squamous epithelial cells: 13.7;Suprabasal keratinocytes: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 13.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA058899 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA058899: AB_2683847" "unprognostic (1.79e-1)" "unprognostic (7.99e-2)" "unprognostic (1.57e-1)" "unprognostic (3.61e-3)" "unprognostic (4.43e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.48e-4)" "unprognostic (2.18e-1)" "unprognostic (1.63e-1)" "unprognostic (1.38e-1)" "unprognostic (4.78e-3)" "unprognostic (5.27e-2)" "unprognostic (2.21e-2)" "prognostic favorable (6.98e-4)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "unprognostic (9.55e-3)" 2.6 4.7 2.0 0.8 2.4 0.7 3.2 2.6 1.8 4.0 0.8 5.5 7.6 3.5 0.2 10.7 3.7 0.2 2.7 0.8 1.1 7.2 5.5 3.7 0.5 5.0 2.9 0.5 3.2 6.4 0.1 3.3 0.2 3.8 6.5 0.7 0.0 8.2 0.4 1.9 13.5 6.7 0.1 3.3 6.2 4.8 2.9 2.3 0.1 4.6 0.2 0.3 2.9 5.3 5.9 4.9 1.2 0.7 1.0 0.4 0.0 5.9 1.7 0.3 0.6 0.9 1.9 1.5 2.8 0.7 0.2 0.3 3.1 0.2 0.2 0.0 6.9 12.5 0.7 3.7 2.5 0.2 1.3 8.8 0.0 0.2 0.8 0.0 0.1 0.6 0.8 8.1 1.5 0.4 1.0 2.3 4.2 6.5 0.2 8.4 7.6 1.1 4.8 0.7 1.2 2.6 6.4 2.1 5.0 2.5 0.3 3.9 1.0 1.6 0.6 2.8 2.4 3.7 2.7 2.6 2.5 0.5 1.3 1.6 0.2 1.2 0.0 1.3 0.7 1.4 0.9 2.0 2.3 1.7 2.5 1.4 2.3 0.3 4.1 1.1 13.2 2.6 0.8 2.0 2.4 2.6 1.8 0.8 1.1 5.0 2.9 0.5 3.8 3.3 2.3 5.9 1.1 0.0 1.5 0.0 2.9 6.1 1.0 1.0 9.1 0.0 4.0 1.8 0.6 1.5 0.5 0.0 0.0 1.8 5.5 4.1 1.9 1.5 0.1 6.3 1.2 1.4 1.2 0.4 0.0 0.7 2.4 1.6 8.2 3.1 0.0 0.5 2.2 0.8 1.8 0.0 0.0 1.1 0.0 1.4 3.1 0.6 0.0 2.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 4.3 0.7 6.4 0.3 4.2 4.0 2.3 0.0 0.0 0.8 1.2 0.8 3.1 13.7 11.1 4.5 3.6 0.8 1.7 1.2 PPP1CB "MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 985.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3800000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022558: , CAB069426: , HPA065425: AB_2685489" "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 91.7 75.9 64.9 75.3 79.5 120.2 111.6 64.6 75.5 149.9 82.1 110.3 85.6 139.5 104.9 248.0 114.4 104.0 186.9 60.0 87.7 85.2 71.1 74.0 60.9 80.3 70.1 58.0 93.5 76.9 127.9 46.2 75.5 78.6 150.4 93.8 71.4 115.6 124.6 389.7 74.3 76.6 161.1 81.1 66.3 82.5 48.0 67.8 71.9 79.5 265.1 91.8 119.1 105.0 94.9 186.0 114.6 391.1 121.7 130.8 121.0 227.0 97.7 110.6 92.2 91.0 102.6 106.9 147.5 119.2 101.5 102.7 111.4 112.6 129.9 109.8 235.9 58.2 111.3 130.1 111.5 284.3 127.8 50.5 93.5 181.3 100.1 207.8 97.4 113.8 77.0 103.6 140.4 123.3 93.2 136.9 110.3 128.3 141.8 89.8 132.2 344.9 112.7 304.3 220.6 106.7 131.3 151.4 166.2 136.2 111.4 80.4 70.6 137.6 122.6 134.6 89.3 119.0 100.4 171.0 299.8 130.1 135.0 93.5 72.4 59.4 84.9 39.8 96.7 50.8 38.6 59.3 46.8 65.4 31.6 51.8 58.8 103.6 61.4 115.2 49.8 74.3 52.8 64.9 79.5 64.6 75.5 60.0 87.7 80.3 70.1 58.0 78.6 81.1 67.8 94.9 172.2 93.0 80.6 59.4 147.8 492.1 176.7 101.5 64.9 62.4 208.0 117.0 352.1 112.9 124.1 310.8 27.1 129.6 210.4 324.5 244.6 297.0 514.0 330.2 245.7 129.3 283.0 200.2 68.5 210.5 202.1 147.8 78.5 258.9 146.6 91.2 137.8 108.7 114.7 163.2 71.8 144.2 111.9 182.6 985.1 406.2 196.7 238.1 336.2 59.0 137.9 116.6 55.6 64.3 68.4 236.8 181.3 302.0 100.9 364.9 106.6 227.4 213.3 65.2 631.1 225.8 264.8 55.2 66.6 135.6 458.0 392.9 237.7 65.8 154.4 498.9 SULT1A4 ENSG00000213648 "Sulfotransferase family 1A member 4" P0DMN0 16 29459913-29464966 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.0;Club cells: 3.7;Distal enterocytes: 1.6;Proximal enterocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 23.1;myeloid DC: 17.2" "Group enriched" "Detected in many" 12 "dendritic cells: 17.2;monocytes: 23.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 69.2;Hep G2: 156.6;SK-BR-3: 32.4" "HPA049500, HPA051051" Supported NA NA "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" 30.4 4.8 1.8 7.4 2.0 3.2 25.2 1.8 4.3 8.4 1.4 29.4 29.3 7.7 0.7 5.7 11.8 3.5 16.5 2.0 1.5 7.1 7.0 21.2 1.6 2.9 1.7 1.0 3.7 4.0 2.0 3.8 2.5 2.6 4.5 7.6 0.7 14.7 3.5 6.3 8.7 62.3 1.9 1.4 35.1 15.6 2.3 1.8 1.2 10.5 0.6 2.6 12.9 9.2 2.7 0.6 0.6 6.7 1.3 0.5 1.2 1.5 3.6 0.2 1.0 0.5 2.5 69.2 0.2 22.2 1.2 2.9 13.3 1.4 0.9 0.6 1.5 2.7 0.9 3.0 156.6 1.6 0.0 5.6 0.4 0.0 1.4 0.6 4.0 4.0 0.5 2.9 4.1 0.4 3.0 1.1 19.3 3.2 2.8 1.1 4.2 0.6 1.5 3.9 4.0 0.8 0.8 0.0 32.4 0.1 0.6 0.6 0.3 1.0 3.0 0.5 0.5 1.2 7.5 9.6 3.2 2.3 2.3 0.3 1.6 7.0 0.0 0.8 23.1 0.1 0.7 0.1 0.1 17.2 0.0 0.4 0.0 0.4 0.1 5.3 0.1 0.1 5.1 1.8 2.0 1.8 4.3 2.0 1.5 2.9 1.7 1.0 2.6 1.4 1.8 2.7 0.2 6.4 2.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 3.5 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.0 GPSM3 "AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1" ENSG00000213654 "G protein signaling modulator 3" Q9Y4H4 6 32190766-32195523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 162.2;lymphoid tissue: 231.1" "Cell type enhanced" "Detected in many" "B-cells: 261.0;dendritic cells: 238.9;Hofbauer cells: 278.3;Kupffer cells: 397.2;Langerhans cells: 209.3;Macrophages: 268.2;monocytes: 375.1;NK-cells: 352.2;T-cells: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 226.9;NB-4: 115.8;THP-1: 107.1;U-937: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 73000 "unprognostic (2.93e-2)" "unprognostic (2.51e-2)" "unprognostic (2.02e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (3.66e-1)" "unprognostic (6.61e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (6.92e-9)" "unprognostic (2.01e-2)" "unprognostic (1.69e-2)" "unprognostic (5.47e-2)" "unprognostic (5.87e-2)" 23.9 11.9 9.2 97.7 11.9 162.2 15.7 9.3 14.2 8.1 11.0 14.0 14.5 6.9 9.2 9.5 14.1 25.0 13.4 8.9 12.6 15.1 14.6 63.5 141.1 13.0 10.6 7.3 5.3 6.2 1.9 7.7 22.3 12.5 13.9 16.0 0.3 11.8 5.6 3.8 9.1 68.2 10.1 11.6 231.1 17.6 5.6 12.7 83.8 11.7 5.6 101.7 33.1 9.2 16.2 1.0 0.0 1.6 0.6 0.1 0.2 1.5 1.3 17.0 5.6 8.8 0.2 5.2 41.1 7.8 6.7 0.5 0.9 0.1 7.2 3.1 53.8 0.1 59.5 0.0 1.2 9.6 0.0 226.9 2.0 0.0 1.9 5.9 1.2 25.8 25.7 11.4 47.9 1.6 0.0 23.6 115.8 0.0 0.0 0.5 24.5 0.0 38.4 1.4 0.0 0.6 0.1 0.0 0.6 8.7 2.1 1.1 107.1 22.6 3.0 3.1 0.0 1.5 1.1 0.9 25.9 0.9 76.3 15.5 44.1 55.8 194.3 35.5 73.3 35.7 52.8 45.5 44.7 57.9 41.9 38.5 42.7 244.9 27.1 71.5 24.3 34.7 53.2 9.2 11.9 9.3 14.2 8.9 12.6 13.0 10.6 7.3 12.5 11.6 12.7 16.2 12.8 0.0 2.2 1.0 261.0 11.2 12.9 11.5 4.0 0.2 7.7 9.1 0.5 2.8 7.3 3.7 0.0 3.4 238.9 2.2 0.0 7.9 6.5 1.1 1.0 19.5 1.2 46.3 0.1 5.2 5.1 7.1 8.6 0.9 57.8 0.5 28.2 4.4 278.3 0.0 0.3 6.5 30.5 397.2 209.3 12.1 1.2 268.2 44.4 4.7 375.1 0.5 352.2 0.0 0.3 20.5 34.2 0.0 76.4 5.8 0.5 2.4 5.5 0.5 6.6 1.3 9.4 0.8 3.9 1.4 8.5 6.3 256.1 7.8 3.7 24.6 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990784 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 119.1" "Group enriched" "Detected in many" 6 "dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 19 "basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8" "Group enriched" "Detected in all" 142 "granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8" "Cell line enhanced" "Detected in many" "HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5" "Not detected" "Not detected" "CAB002223, HPA011157, CAB012978, CAB079960" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 140000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 7.7 4.4 8.5 24.1 8.7 17.6 6.7 8.3 12.0 15.4 7.8 24.7 9.3 19.5 5.3 8.2 11.7 9.6 3.5 8.5 7.7 14.9 10.5 14.2 66.4 8.8 7.8 8.0 7.8 5.7 2.0 14.4 3.9 8.6 21.8 5.3 3.5 7.8 9.6 4.2 10.8 22.9 5.8 7.3 32.2 13.5 4.2 8.8 119.1 17.8 1.6 29.2 25.0 13.4 8.7 1.0 2.3 1.5 2.5 3.7 2.4 4.9 5.5 1.4 1.7 2.2 2.3 3.0 0.7 7.2 2.2 0.6 2.9 2.6 1.3 0.8 1.6 3.3 189.8 5.4 3.3 1.0 5.9 765.9 2.1 3.8 1.7 0.7 2.8 0.9 62.7 2.6 21.7 0.8 5.6 279.5 38.3 3.4 0.4 2.7 3.2 0.8 24.9 1.9 1.6 5.3 1.0 0.9 1.8 2.7 1.4 2.7 31.7 3.6 3.6 18.0 3.9 1.3 7.6 7.0 3.1 45.5 2.7 2.9 307.7 1.4 0.7 303.4 1.5 212.5 1.7 295.1 307.2 1.1 1.7 276.0 266.9 14.6 114.6 1.3 1.9 410.8 196.5 8.5 8.7 8.3 12.0 8.5 7.7 8.8 7.8 8.0 8.6 7.3 8.8 8.7 5.2 0.0 13.1 4.6 6.2 7.1 2.1 1.1 2.8 11.0 3.7 4.3 1.7 7.2 3.1 9.2 6.2 2.6 80.7 1.2 1.9 1.7 0.3 1.5 2.3 4.7 0.0 16.6 4.7 0.5 0.9 3.0 7.7 2.7 78.9 4.9 8.6 2.9 14.3 6.7 5.5 1.5 0.0 7.3 9.4 0.1 1.5 55.9 10.6 5.6 9.2 3.0 152.4 3.0 3.5 1.0 0.7 0.7 17.0 2.2 1.3 1.3 1.3 9.6 0.0 3.0 3.8 1.7 2.1 1.9 5.3 2.7 151.7 1.7 1.4 1.3 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 122.8" "Cell type enhanced" "Detected in many" "Peritubular cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" NA NA 110000 "Plasma membrane" "CAB019267: , HPA050005: AB_2680988" "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 18.8 17.8 21.0 6.4 28.4 5.9 17.1 16.2 46.4 14.9 2.7 12.9 10.1 13.0 11.5 11.2 16.4 12.5 30.0 26.0 21.8 19.1 14.5 16.6 8.5 24.0 18.8 27.3 31.4 11.9 122.8 20.3 11.2 26.5 17.6 9.9 11.4 14.2 16.0 12.7 19.3 12.6 11.8 12.2 11.6 11.7 16.5 20.8 6.4 13.7 10.1 7.0 12.7 14.7 28.4 20.9 18.0 18.0 18.6 24.0 14.5 25.0 20.5 22.8 22.2 28.2 26.6 12.4 15.3 10.9 12.2 25.4 13.8 23.2 27.1 12.7 17.3 28.3 27.4 73.2 21.5 20.9 18.8 29.6 14.0 23.3 30.9 19.3 25.2 12.8 19.1 9.5 19.8 18.1 15.3 17.1 15.8 21.0 20.6 31.5 8.6 8.3 25.8 12.3 21.2 18.7 15.1 21.4 19.9 17.4 16.3 17.7 22.7 7.2 19.0 21.3 22.8 27.5 17.7 14.1 17.0 21.7 24.6 29.8 0.6 2.9 0.1 2.1 3.4 1.5 2.9 2.4 2.4 3.6 1.4 3.5 2.4 0.2 3.4 1.8 5.2 2.9 2.9 21.0 28.4 16.2 46.4 26.0 21.8 24.0 18.8 27.3 26.5 12.2 20.8 28.4 15.9 0.0 6.9 7.2 2.9 2.5 3.7 8.1 1.8 9.2 3.8 5.5 17.0 5.7 4.0 1.8 12.5 9.6 4.5 10.8 5.9 7.0 2.4 4.7 5.5 8.1 8.4 4.8 11.8 4.6 10.5 5.4 6.6 5.8 5.7 7.6 23.6 6.4 8.6 11.8 10.9 6.0 6.1 6.5 6.1 2.5 18.3 6.4 1.8 1.9 4.5 3.5 0.0 2.5 8.3 7.5 6.2 47.4 3.9 2.3 13.8 7.6 3.9 6.3 13.1 4.0 6.4 5.6 18.4 2.8 1.7 8.2 3.3 8.6 8.7 2.3 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli NA NA 46000000 Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 34.9 41.1 7.7 7.5 8.4 29.6 40.6 7.0 10.0 50.2 4.3 42.5 12.0 46.4 16.8 57.1 46.0 11.6 31.3 8.3 7.7 37.0 35.4 36.0 14.3 8.2 8.3 7.2 57.6 43.8 14.3 43.3 8.9 10.3 44.1 14.1 8.1 45.3 6.4 22.5 53.3 47.3 8.9 7.4 60.5 45.7 29.5 10.3 16.9 51.5 5.0 17.1 44.7 47.4 9.4 2.5 6.3 18.1 29.7 17.8 18.9 11.5 9.8 13.3 13.7 20.8 25.2 20.9 30.4 26.8 60.1 14.5 17.0 23.5 37.2 8.1 18.3 34.5 11.2 36.1 24.7 28.9 2.9 40.0 17.2 16.1 5.4 31.4 25.5 44.0 47.9 38.0 32.9 39.9 18.3 25.5 17.4 5.1 20.8 5.4 7.5 7.6 20.7 17.5 6.3 1.8 6.4 35.2 13.9 40.5 5.0 39.5 12.5 17.1 3.6 13.0 13.7 15.6 33.8 20.4 17.0 15.5 18.5 21.9 4.2 1.1 0.7 1.9 1.7 1.5 1.6 1.0 0.9 2.3 1.1 0.6 1.4 0.9 2.5 1.5 1.4 1.7 2.2 7.7 8.4 7.0 10.0 8.3 7.7 8.2 8.3 7.2 10.3 7.4 10.3 9.4 39.1 12.8 15.2 31.6 72.7 24.9 37.6 83.0 33.6 89.3 31.8 26.0 2.0 50.1 53.1 55.2 95.9 88.4 64.9 52.9 5.9 48.1 3.3 22.0 24.5 40.3 53.5 39.8 29.5 42.8 50.2 29.8 39.8 27.8 16.5 148.5 43.5 18.5 52.8 43.7 29.9 53.9 79.3 55.4 40.5 8.9 70.8 42.0 32.0 28.1 65.4 35.0 124.6 21.6 24.1 37.2 58.6 51.9 40.3 30.6 64.3 14.6 43.5 98.0 59.2 30.5 29.8 64.3 58.6 36.1 25.3 89.2 58.6 49.5 55.7 39.8 TREX1 "AGS1, DRN3" ENSG00000213689 "Three prime repair exonuclease 1" Q9NSU2 3 48465811-48467645 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Exonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease variant, Neurodegeneration, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 53.6;Club cells: 24.5;Ionocytes: 40.7;Langerhans cells: 22.6;Melanocytes: 24.9;Respiratory ciliated cells: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035437, HPA046721" Supported Supported Cytosol NA NA Cytosol "HPA035437: AB_10672092, HPA046721: AB_2732531" 10.0 14.4 32.9 16.6 33.2 29.0 12.4 33.1 42.4 13.9 38.3 12.5 11.2 7.8 11.5 19.4 15.7 14.0 10.8 32.9 33.8 12.2 12.9 13.9 26.9 33.2 34.0 31.6 7.4 13.3 11.4 20.7 8.4 33.4 16.7 10.0 1.9 36.8 15.5 9.8 26.6 12.1 7.1 32.5 25.2 13.8 4.0 33.2 18.3 8.4 14.0 18.3 13.2 10.5 37.3 19.2 18.1 13.3 10.3 18.1 17.5 0.0 6.7 29.5 46.9 67.5 0.3 21.8 23.8 11.7 24.4 44.8 21.4 0.9 27.2 6.7 19.9 1.6 13.5 58.1 0.5 20.1 12.8 9.3 16.2 2.5 25.9 9.8 9.8 20.4 16.9 0.0 32.6 20.7 0.4 17.3 8.6 0.1 11.0 11.2 14.4 4.9 43.2 13.4 3.8 0.1 8.1 21.8 29.6 15.4 0.9 0.8 20.3 22.2 8.5 9.2 21.8 14.2 26.4 16.9 10.4 21.5 25.4 7.5 7.7 142.3 11.0 32.6 119.2 18.7 86.8 43.0 31.4 125.9 87.5 40.3 33.8 82.2 30.9 94.6 99.1 43.3 78.6 32.9 33.2 33.1 42.4 32.9 33.8 33.2 34.0 31.6 33.4 32.5 33.2 37.3 0.0 0.0 0.5 6.8 2.1 9.1 0.0 53.6 0.6 0.0 0.0 0.0 6.3 0.0 24.5 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 1.7 2.3 0.0 0.0 4.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.8 40.7 0.0 22.6 0.0 0.0 2.0 24.9 5.6 0.0 0.0 0.0 1.0 5.9 0.0 1.1 0.0 3.9 0.0 0.0 0.0 29.9 0.0 0.0 0.0 4.2 0.0 0.0 2.7 13.9 0.0 2.6 0.0 1.5 0.0 S1PR3 "EDG-3, EDG3" ENSG00000213694 "Sphingosine-1-phosphate receptor 3" "Q99500, Q6ZRZ4" 9 88990863-89005155 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 55.5;Sertoli cells: 65.7;Smooth muscle cells: 35.0;Theca cells: 65.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "classical monocyte: 7.0" "Lineage enriched" "Detected in single" 18 "monocytes: 7.0" "Cell line enhanced" "Detected in many" "AF22: 116.0;ASC diff: 157.9;ASC TERT1: 158.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "prognostic favorable (5.91e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.91e-3)" "unprognostic (2.02e-1)" "unprognostic (4.41e-2)" "unprognostic (2.77e-2)" "unprognostic (5.22e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.91e-6)" "unprognostic (4.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.93e-2)" "unprognostic (1.37e-1)" 18.5 25.2 6.3 10.7 6.4 3.3 11.4 8.4 7.5 31.2 12.0 11.8 4.5 17.4 6.3 17.8 26.3 14.3 17.2 6.5 19.3 20.2 6.1 9.0 11.5 16.7 10.9 4.9 5.2 11.8 1.7 17.1 15.2 10.3 20.3 3.5 4.2 3.9 12.0 4.4 3.1 10.8 36.3 8.9 13.4 12.6 2.2 11.0 4.8 4.8 8.3 9.5 20.6 21.1 14.0 0.5 17.7 116.0 6.0 157.9 158.7 0.1 24.8 61.4 17.0 17.0 0.2 0.0 0.0 0.3 37.2 16.6 0.2 0.3 18.0 11.5 0.0 1.2 0.0 23.3 0.1 13.7 8.1 0.1 28.6 1.0 22.2 4.0 13.2 29.9 17.0 2.1 0.1 4.7 17.1 14.3 8.7 11.2 0.8 6.2 1.5 0.0 0.1 0.3 7.1 1.5 8.1 23.4 5.7 0.0 22.8 2.7 7.4 60.3 25.4 10.3 27.8 4.1 0.0 0.1 0.0 36.8 7.1 9.1 0.3 7.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 2.1 6.3 6.4 8.4 7.5 6.5 19.3 16.7 10.9 4.9 10.3 8.9 11.0 14.0 3.0 0.0 1.7 3.6 0.0 10.1 9.5 1.8 2.8 1.0 9.9 3.7 9.2 1.5 1.7 1.8 2.1 17.9 0.1 0.0 0.0 0.3 0.0 2.1 55.5 10.6 0.0 0.0 0.5 0.5 1.3 21.5 0.5 2.4 0.0 3.8 1.8 1.6 2.4 3.3 1.7 0.0 0.0 1.8 4.0 0.5 3.7 4.4 0.0 7.5 6.9 7.1 0.0 0.0 0.2 0.9 0.0 6.8 0.2 7.0 0.0 1.4 2.9 1.6 65.7 16.1 35.0 0.0 1.2 1.5 3.3 5.5 2.2 65.8 0.0 6.4 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 129.9;Karpas-707: 117.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.11e-4)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 17.8 20.9 8.6 7.3 9.2 4.6 16.3 9.1 9.7 13.5 6.8 9.6 8.0 12.0 7.4 22.2 10.8 7.4 12.5 8.5 10.2 19.5 17.9 12.1 6.6 12.5 11.5 6.4 8.6 10.4 21.5 10.9 9.5 11.1 11.5 5.7 5.9 14.6 8.2 12.9 21.4 10.1 10.2 9.2 10.9 11.4 5.1 10.6 5.7 16.2 10.0 7.7 12.2 13.1 11.0 24.6 43.6 12.3 32.6 41.7 19.4 20.4 14.9 20.3 16.8 15.2 27.9 44.5 6.6 23.4 18.7 42.0 29.4 18.1 26.9 11.8 11.5 10.1 7.6 16.4 23.3 129.9 7.8 36.4 29.8 26.9 18.9 62.7 7.6 19.9 9.6 14.2 117.3 16.9 40.5 10.0 7.0 7.6 17.2 10.9 8.9 35.9 10.9 44.1 20.3 9.6 12.7 22.8 37.4 25.4 10.1 14.1 8.2 19.2 21.8 24.0 30.7 15.2 23.9 32.6 12.9 23.6 13.4 21.0 12.1 18.1 8.0 11.9 25.6 7.0 4.8 8.2 10.8 11.4 3.6 5.3 7.9 11.7 13.6 30.9 7.8 5.9 9.5 8.6 9.2 9.1 9.7 8.5 10.2 12.5 11.5 6.4 11.1 9.2 10.6 11.0 39.0 12.8 10.5 11.8 5.9 17.0 13.2 10.2 7.4 17.2 17.5 10.2 13.5 28.6 11.1 33.1 6.2 24.1 12.0 21.5 7.9 34.2 1.7 13.4 29.7 20.8 9.1 0.8 6.9 38.7 22.3 25.2 12.2 22.8 1.3 11.9 31.8 25.4 51.2 15.2 7.9 11.2 8.2 61.0 16.8 1.5 18.3 28.8 28.4 4.7 19.8 19.2 11.3 9.0 10.8 48.2 14.3 12.0 5.5 18.3 21.5 57.2 9.0 11.1 26.3 17.8 20.2 3.7 7.1 14.9 25.7 38.0 10.6 16.8 11.2 11.7 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 115.3" "Cell type enriched" "Detected in some" 7 "Early spermatids: 1680.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 2.0;U-266/84: 2.2" HPA042144 Enhanced NA NA "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.7 0.2 0.6 0.6 0.6 11.9 0.8 0.6 0.9 0.5 0.7 0.5 0.2 0.4 0.0 0.5 0.6 0.3 0.4 0.6 0.6 0.5 0.8 1.0 1.3 0.6 0.6 0.5 0.2 0.7 0.3 0.9 0.1 0.6 0.7 0.4 0.2 0.7 0.3 0.9 1.1 0.9 0.2 0.6 2.6 0.6 115.3 0.6 0.6 0.4 0.4 0.9 0.5 0.5 0.7 0.0 1.0 0.2 0.0 0.0 0.1 0.1 0.4 0.7 0.9 0.3 0.7 0.0 0.1 0.7 0.4 0.2 0.6 0.5 0.3 0.8 0.2 0.4 0.4 0.0 0.2 0.1 1.1 1.6 0.6 0.9 0.1 0.5 0.0 0.0 0.7 0.0 0.9 0.0 1.1 0.4 1.0 0.2 0.0 0.5 0.3 0.2 0.0 0.6 0.3 0.6 0.1 0.3 1.4 0.2 0.2 0.6 0.2 0.0 0.1 0.2 0.6 0.0 2.0 2.2 0.3 0.1 0.4 0.1 0.0 0.3 1.0 0.6 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.6 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.6 0.7 0.3 0.0 1.9 0.0 0.1 0.1 0.5 0.4 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.5 0.3 0.0 0.9 1680.6 0.2 0.1 0.9 1.2 0.0 0.6 1.6 0.5 0.1 0.0 0.3 1.3 0.1 0.4 0.2 0.6 0.0 0.4 0.2 0.0 1.6 0.7 238.2 11.5 1.0 0.0 0.0 0.9 0.0 2.1 0.0 0.9 0.8 0.1 8.2 0.0 0.3 0.4 1.0 1.1 0.0 0.0 0.1 0.4 12.8 7.1 0.0 0.0 0.0 0.4 0.1 0.1 0.6 CLIC1 "CLCNL1, G6, NCC27, p64CLCP" ENSG00000213719 "Chloride intracellular channel 1" O00299 6 31730581-31739763 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020825, CAB040557" Enhanced Supported Cytosol NA NA 22000000 Cytosol "CAB020825: , CAB040557: " "unprognostic (7.26e-2)" "unprognostic (9.32e-2)" "unprognostic (2.78e-3)" "unprognostic (7.29e-2)" "unprognostic (6.93e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (8.90e-7)" "unprognostic (2.58e-2)" "unprognostic (8.51e-2)" "unprognostic (8.71e-3)" "unprognostic (1.19e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (8.11e-5)" "unprognostic (4.51e-2)" "unprognostic (2.89e-1)" "unprognostic (1.35e-2)" "unprognostic (7.31e-2)" 294.5 157.7 6.6 43.7 6.9 64.6 258.9 7.1 11.1 209.8 9.4 241.4 37.3 199.5 21.1 399.1 192.2 44.1 181.9 6.4 11.7 311.9 103.5 333.3 44.5 9.2 7.3 5.7 151.1 149.3 20.2 112.4 45.9 8.7 218.8 64.7 2.6 253.3 22.5 47.7 324.6 233.6 33.0 8.6 335.2 249.8 41.4 8.5 35.5 182.3 11.2 58.5 259.9 248.8 8.4 119.5 54.1 87.0 45.6 56.6 118.6 43.3 52.8 105.4 92.6 77.9 125.2 87.2 48.7 73.6 186.0 116.9 70.2 65.8 154.9 124.4 38.9 34.4 93.0 43.4 109.3 73.0 164.3 125.9 74.3 80.5 157.0 148.4 101.7 157.9 44.6 109.4 149.5 181.0 79.2 77.2 213.2 7.7 128.9 78.4 13.5 47.5 115.3 210.2 73.0 16.5 19.5 43.1 49.1 71.5 60.4 33.7 228.3 105.0 128.6 91.2 39.0 166.8 48.3 98.3 66.0 62.4 122.0 136.6 244.3 179.4 239.3 165.6 194.3 135.8 186.1 98.0 155.5 143.8 150.3 30.5 92.3 341.1 176.3 174.3 80.5 149.2 414.2 6.6 6.9 7.1 11.1 6.4 11.7 9.2 7.3 5.7 8.7 8.6 8.5 8.4 514.8 70.5 67.0 0.7 382.5 960.8 589.1 869.7 331.2 0.4 274.3 300.5 18.6 296.0 457.7 237.3 0.0 545.5 472.2 730.7 602.6 1096.2 31.8 271.1 212.7 490.1 381.4 208.6 0.0 1008.9 912.5 296.6 370.5 301.3 554.1 431.2 300.9 54.2 1047.6 0.0 0.0 665.6 516.8 533.7 1529.8 17.3 233.9 685.7 524.7 13.1 426.4 86.8 706.5 0.5 0.0 1470.4 997.1 188.1 420.2 851.1 707.7 572.1 473.6 6.9 203.8 136.1 554.0 28.7 16.2 464.1 928.0 572.7 522.2 283.3 675.0 1005.9 DDAH2 G6A ENSG00000213722 "Dimethylarginine dimethylaminohydrolase 2" O95865 6 31727038-31730617 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012389, HPA012509" Uncertain Supported Mitochondria NA NA 1500000 Mitochondria "HPA012389: , HPA012509: AB_1847533" "unprognostic (2.29e-2)" "unprognostic (1.38e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-1)" "unprognostic (7.67e-2)" "unprognostic (1.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.62e-1)" "unprognostic (8.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (9.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.24e-2)" "unprognostic (2.72e-2)" 88.6 17.3 21.5 12.1 19.2 10.9 81.9 19.9 45.0 127.2 21.0 66.3 4.4 95.2 8.8 39.3 81.2 44.4 57.2 18.8 32.4 59.3 32.4 62.8 20.8 25.2 20.6 16.5 68.2 16.7 17.7 26.2 18.5 22.2 65.8 7.7 5.9 58.6 27.3 13.5 64.6 39.2 12.0 26.7 49.8 35.7 13.6 22.8 9.6 65.7 4.6 7.8 61.6 91.7 26.8 2.0 20.1 0.7 28.5 17.0 26.6 3.8 0.0 10.6 10.9 7.3 40.4 6.7 0.4 24.4 26.5 0.9 2.4 0.5 9.7 1.9 0.0 14.2 1.9 7.8 22.4 18.2 0.3 1.5 18.8 1.2 12.2 0.9 3.7 33.3 14.1 0.4 11.1 4.8 63.0 1.5 27.5 4.1 4.3 12.2 0.2 0.9 10.5 21.6 0.5 1.5 5.7 0.0 4.7 27.4 2.9 37.7 7.8 0.1 16.9 24.7 11.2 0.0 4.1 12.8 3.3 11.3 5.9 4.3 141.3 15.4 135.0 14.8 37.4 5.8 49.7 4.0 5.3 26.8 39.6 2.7 3.4 27.8 29.2 44.9 93.9 4.1 11.4 21.5 19.2 19.9 45.0 18.8 32.4 25.2 20.6 16.5 22.2 26.7 22.8 26.8 102.3 28.9 14.7 10.4 76.8 66.9 88.7 49.6 56.3 4.5 132.8 96.0 39.5 62.9 36.9 82.8 29.2 15.5 84.4 386.3 178.1 148.2 83.1 62.6 94.2 101.2 150.0 20.4 0.3 32.3 37.3 154.1 33.1 75.0 113.3 121.7 94.9 31.9 223.2 0.0 0.3 71.5 109.9 139.7 301.2 23.6 180.5 95.7 103.2 14.0 64.2 120.9 40.2 4.5 2.7 85.1 299.5 153.1 24.5 95.2 61.5 165.8 50.5 25.7 105.2 122.7 153.0 4.1 12.5 35.8 59.2 18.1 41.1 21.3 104.6 67.0 RPS29 "S29, uS14" ENSG00000213741 "Ribosomal protein S29" P62273 14 49570984-49599164 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA004107 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA004107: AB_1079848" "prognostic favorable (2.66e-4)" "unprognostic (1.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (4.40e-3)" "unprognostic (4.13e-2)" "unprognostic (9.95e-2)" "unprognostic (4.21e-2)" "unprognostic (2.98e-2)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (1.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.18e-2)" "unprognostic (1.66e-1)" "unprognostic (7.48e-3)" "unprognostic (7.71e-2)" 2839.4 2365.7 1721.2 1563.3 1740.4 3313.9 3235.4 1707.4 2622.9 2982.8 1707.9 2696.3 1420.5 1902.0 918.5 3321.0 2664.1 404.7 2097.1 1688.9 1733.8 2337.6 2719.6 2219.5 2384.9 1740.6 1728.0 1684.5 4796.2 4424.9 1058.3 1495.2 894.4 1749.3 2265.9 1133.3 591.2 2646.4 805.3 3655.3 4611.1 3300.1 600.0 1817.4 4121.6 2666.8 1044.8 1744.2 3111.6 1922.7 1785.7 2097.1 2456.6 2801.2 1789.9 3057.7 1984.5 2021.5 1823.8 2271.9 3830.2 2675.3 2042.2 1722.2 1821.1 1483.1 2020.7 2733.7 2772.5 2264.9 1729.0 895.7 2605.0 2373.0 2922.0 2014.3 1811.3 4267.9 2191.4 1630.4 3564.5 2776.6 5612.2 1803.4 4011.6 4623.6 1204.7 3464.6 3181.7 2623.2 4723.4 2489.2 3498.4 1791.5 4047.4 3845.0 3454.4 2484.9 5075.2 5572.2 3178.5 2521.0 3196.6 2248.6 2696.4 1527.3 1753.1 1455.4 2636.2 5088.5 1938.5 3444.4 4786.4 2459.7 1381.7 3726.2 1295.6 1836.9 4014.0 4872.1 3856.3 973.0 2256.8 1363.0 3144.8 4379.9 1967.1 6689.0 3436.4 8449.9 11659.9 12162.6 8749.3 5025.2 10334.9 13471.6 11360.1 968.3 5389.4 3185.1 6778.8 7617.0 26592.8 1721.2 1740.4 1707.4 2622.9 1688.9 1733.8 1740.6 1728.0 1684.5 1749.3 1817.4 1744.2 1789.9 1348.6 1131.4 2051.0 7.8 5426.0 3418.6 1043.1 2689.6 672.1 235.2 4463.4 3147.6 609.1 2805.3 2104.4 1074.1 129.3 3390.8 4425.2 2370.0 2424.1 2731.6 1371.1 1272.1 2960.5 1727.4 2673.2 2790.5 10.7 7061.8 4966.0 1443.2 650.3 1997.1 3019.4 2592.2 4092.8 7356.4 3048.0 107.7 12.0 6874.6 769.0 5623.6 5164.4 3280.3 3747.1 2396.2 2002.8 10.3 4580.9 1122.2 5206.1 10.1 17.9 5207.4 5628.6 1617.8 1584.1 1084.2 4951.5 3523.5 985.2 355.1 1091.3 1292.9 1159.9 1090.2 994.1 1255.0 4894.6 3673.2 4742.9 954.8 6917.3 1177.5 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214748 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "breast: 241.8" "Group enriched" "Detected in some" 4 "Breast glandular cells: 13.7;Cholangiocytes: 7.2" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 42 "basophil: 4.7;eosinophil: 3.5" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.7" "Not detected" "Not detected" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.0 0.1 0.0 0.1 241.8 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.9 0.0 0.5 11.5 0.0 0.0 0.0 3.6 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.5 0.0 7.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 ATP6V1G2 "ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10" ENSG00000213760 "ATPase H+ transporting V1 subunit G2" O95670 6 31544444-31548427 "Metabolic proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 92.7;choroid plexus: 30.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 83.7;Cone photoreceptor cells: 14.6;Enteroendocrine cells: 14.3;Horizontal cells: 30.3;Muller glia cells: 25.1;Rod photoreceptor cells: 14.1" "Cancer enriched" "Detected in many" 11 "glioma: 15.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;HSkMC: 3.2;Karpas-707: 6.7;RPMI-8226: 4.9;SCLC-21H: 9.5" "CAB004616, HPA068667" Enhanced NA NA "CAB004616: AB_667829, HPA068667: " "unprognostic (9.95e-2)" "unprognostic (8.75e-2)" "unprognostic (9.21e-3)" "unprognostic (2.11e-4)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.41e-5)" "unprognostic (1.36e-1)" "unprognostic (7.22e-3)" "unprognostic (3.94e-2)" "unprognostic (1.77e-1)" "unprognostic (3.86e-2)" "unprognostic (1.02e-1)" 0.9 2.4 54.9 0.7 69.2 0.1 1.0 85.1 92.7 1.7 30.1 3.8 0.3 1.6 0.2 0.7 1.6 1.0 2.6 66.3 54.9 2.7 0.8 1.3 0.5 57.4 55.7 64.1 3.0 0.8 0.0 9.3 0.0 64.7 2.0 0.3 13.8 0.8 0.0 1.8 0.7 2.9 0.4 51.8 2.8 1.8 1.9 61.2 0.0 3.0 0.0 0.5 1.2 2.1 90.3 0.0 0.5 2.6 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.5 0.0 0.0 0.0 3.2 0.3 0.1 0.0 0.8 0.0 0.0 0.5 3.2 0.5 0.7 0.1 1.4 0.0 0.9 0.7 6.7 0.2 0.0 0.7 1.4 0.0 0.0 0.0 0.2 0.0 4.9 0.0 0.0 9.5 2.3 0.0 0.2 0.0 0.0 0.8 1.4 0.8 0.5 0.1 0.0 0.0 0.3 0.4 0.3 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 54.9 69.2 85.1 92.7 66.3 54.9 57.4 55.7 64.1 64.7 51.8 61.2 90.3 0.9 0.0 0.5 0.0 1.2 0.4 0.3 0.4 0.0 83.7 0.7 0.8 2.3 0.0 0.1 1.8 14.6 0.2 0.1 0.3 9.8 0.3 0.0 0.1 2.6 1.2 14.3 0.4 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.2 0.0 0.2 0.6 30.3 0.0 0.5 2.0 0.0 1.1 0.2 0.9 0.4 1.8 0.0 0.1 25.1 1.0 0.0 0.0 0.1 0.0 2.2 0.5 0.1 0.7 7.8 0.0 14.1 0.0 1.7 3.2 0.1 2.0 0.4 0.1 0.1 1.5 0.4 0.1 0.1 ZNF134 pHZ-15 ENSG00000213762 "Zinc finger protein 134" P52741 19 57614233-57624724 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA009064 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA009064: AB_1080668" "unprognostic (3.60e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.88e-1)" "unprognostic (4.29e-2)" "unprognostic (9.62e-2)" "prognostic unfavorable (5.21e-4)" "unprognostic (6.34e-2)" "unprognostic (1.35e-1)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (3.39e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.61e-4)" "unprognostic (1.56e-2)" "unprognostic (3.40e-1)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" 4.6 5.5 5.4 4.8 5.7 12.7 7.6 9.3 5.4 5.8 4.2 5.6 3.5 5.6 6.1 5.4 6.5 4.5 6.0 5.4 5.2 5.7 4.9 5.9 7.5 4.4 4.5 5.5 7.7 3.8 12.1 5.7 8.0 5.7 7.3 4.6 10.7 5.5 8.4 6.3 6.9 5.0 6.0 3.8 7.2 6.0 6.7 6.6 11.2 8.4 7.2 8.6 6.2 4.1 5.2 2.5 6.6 15.5 8.4 6.8 9.1 7.7 6.8 11.1 9.8 4.9 2.2 2.9 5.0 4.7 8.5 7.5 2.1 7.2 12.6 16.8 0.1 33.2 15.8 7.0 6.2 9.9 10.6 11.2 12.3 12.1 7.4 16.7 12.9 6.6 8.2 2.1 5.7 14.8 3.7 21.0 4.4 21.8 1.6 13.6 12.2 22.5 7.9 7.3 21.5 12.4 14.5 11.3 4.9 7.2 17.0 6.9 8.4 8.7 14.7 6.3 3.5 9.0 15.3 21.8 6.9 7.7 1.8 9.9 2.3 4.2 7.4 6.3 3.0 8.3 9.5 6.5 6.7 4.6 8.3 7.5 7.5 3.4 11.9 3.4 3.5 4.4 5.5 5.4 5.7 9.3 5.4 5.4 5.2 4.4 4.5 5.5 5.7 3.8 6.6 5.2 6.0 9.6 4.1 1.0 14.4 5.4 12.7 4.4 8.6 8.4 9.8 8.0 11.2 11.5 5.6 3.7 12.5 8.2 11.1 1.2 7.9 7.8 1.7 6.0 7.8 8.3 1.2 13.0 1.0 3.7 4.3 6.2 1.1 7.3 6.3 10.6 9.7 4.1 5.3 8.4 0.9 4.0 6.1 5.1 3.2 1.5 7.2 4.4 3.6 0.0 7.0 11.3 9.2 1.0 1.6 3.8 2.6 14.7 5.0 9.3 2.8 4.6 5.1 11.9 6.6 6.6 8.5 2.2 15.2 6.7 7.7 16.3 8.8 8.0 3.6 13.8 GTF2H4 "P52, TFB2, TFIIH" ENSG00000213780 "General transcription factor IIH subunit 4" Q92759 6 30908207-30914106 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 12.5;Gastric mucus-secreting cells: 9.7;granulocytes: 7.0;Plasma cells: 9.2;Squamous epithelial cells: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074336 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA074336: AB_2686679" "unprognostic (7.05e-2)" "unprognostic (1.79e-1)" "unprognostic (3.07e-1)" "unprognostic (4.79e-4)" "unprognostic (7.42e-2)" "unprognostic (1.11e-1)" "unprognostic (5.54e-2)" "unprognostic (1.58e-1)" "unprognostic (1.84e-1)" "unprognostic (2.36e-2)" "unprognostic (5.66e-4)" "unprognostic (7.74e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.22e-1)" "unprognostic (9.53e-2)" "unprognostic (6.06e-2)" "unprognostic (2.07e-2)" 12.1 11.2 4.4 6.6 5.5 4.8 11.5 5.4 6.5 12.5 4.2 11.4 1.8 12.9 2.0 14.5 10.6 2.2 8.6 4.8 5.8 14.6 21.7 10.2 5.7 4.5 4.6 4.2 12.3 11.1 6.8 13.6 3.5 4.3 10.6 4.0 1.1 8.6 3.5 13.3 9.1 10.5 1.9 4.5 12.0 12.5 12.0 5.5 8.8 13.6 3.8 3.7 11.8 11.8 7.1 20.5 15.0 15.9 16.5 16.0 11.6 17.7 3.3 5.3 5.8 9.6 14.9 9.1 12.3 8.0 21.1 11.1 16.6 10.7 21.4 10.6 18.6 2.5 10.0 11.5 13.8 10.1 0.0 17.0 18.5 20.5 9.8 0.0 10.3 6.1 9.1 35.2 11.3 11.4 25.0 22.5 16.9 18.5 10.4 6.1 28.5 0.0 11.8 20.7 11.4 9.2 4.5 0.8 11.5 8.8 9.8 16.2 13.7 6.8 15.5 21.5 16.4 28.6 11.1 13.1 9.3 8.9 16.8 7.0 1.8 1.1 0.9 0.8 1.2 0.3 1.3 1.2 1.3 2.5 0.6 1.2 2.2 0.0 1.1 0.6 1.2 2.1 0.3 4.4 5.5 5.4 6.5 4.8 5.8 4.5 4.6 4.2 4.3 4.5 5.5 7.1 0.6 0.0 0.0 4.2 4.0 0.4 0.1 0.4 12.5 0.7 1.1 0.8 0.0 1.5 0.1 0.0 2.1 0.4 0.5 0.4 1.9 0.6 0.1 1.1 1.0 1.8 0.0 4.2 4.6 0.6 0.4 1.4 9.7 1.0 7.0 0.8 0.7 1.1 0.3 0.0 3.3 0.0 0.0 1.2 1.2 0.0 0.9 1.5 1.8 1.9 0.3 0.5 0.0 3.5 2.8 0.0 1.2 0.7 9.2 0.1 0.1 0.9 0.8 0.3 0.0 0.4 1.9 1.4 0.4 13.8 1.0 0.3 3.5 0.4 0.6 0.1 DDX47 "DKFZp564O176, FLJ30012, HQ0256, RRP3" ENSG00000213782 "DEAD-box helicase 47" Q9H0S4 12 12813316-12829981 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014855 Approved Supported Nucleoli NA NA Nucleoli "HPA014855: AB_1847567" "unprognostic (3.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-2)" "unprognostic (2.38e-1)" "unprognostic (4.91e-2)" "unprognostic (5.84e-4)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-3)" "unprognostic (2.79e-1)" "unprognostic (3.49e-3)" "unprognostic (6.55e-9)" "unprognostic (1.68e-1)" "unprognostic (1.27e-1)" "unprognostic (3.24e-1)" "unprognostic (8.20e-6)" 27.1 24.4 24.6 22.9 25.2 41.6 32.5 25.8 31.0 28.0 25.8 27.0 18.4 31.1 22.5 29.3 30.1 20.1 22.7 24.1 25.7 32.4 38.1 25.1 32.9 25.4 25.0 23.6 36.0 31.0 36.9 17.7 29.1 25.5 26.7 26.6 17.0 24.7 29.2 45.0 30.2 21.9 33.7 25.7 23.6 29.6 23.3 24.6 35.9 33.6 42.1 40.1 48.1 25.7 26.6 161.7 68.3 65.6 53.7 63.1 61.7 111.8 67.8 77.0 141.0 131.0 104.1 101.0 82.4 25.9 92.2 87.4 102.6 95.2 78.0 157.7 117.2 68.1 75.5 45.3 59.7 53.5 87.0 46.5 60.0 72.4 84.0 68.8 110.7 110.4 63.9 74.3 18.2 78.3 57.7 71.0 60.1 288.7 74.4 41.4 77.7 127.2 50.0 86.5 114.2 28.6 72.5 82.3 52.1 69.2 161.4 21.4 64.9 49.9 56.5 136.5 36.8 103.4 25.2 49.1 148.1 60.2 44.9 66.8 10.5 32.9 8.4 46.6 43.8 55.5 48.0 40.9 43.2 56.8 44.9 53.0 51.5 3.8 40.6 44.4 33.3 43.4 35.8 24.6 25.2 25.8 31.0 24.1 25.7 25.4 25.0 23.6 25.5 25.7 24.6 26.6 5.1 3.2 8.2 9.1 8.4 2.2 2.7 2.4 14.2 0.6 1.4 1.0 0.1 0.0 8.5 0.0 0.0 1.7 2.3 3.2 1.9 22.6 0.1 3.0 4.1 4.3 4.8 3.4 8.2 17.8 1.9 3.2 4.6 5.7 12.0 0.9 1.1 0.9 0.9 0.0 9.4 4.2 2.0 1.0 1.6 0.4 0.6 2.5 0.0 12.2 9.7 0.9 2.1 8.0 12.6 19.0 4.2 0.4 12.3 1.9 2.8 1.1 6.3 1.6 6.6 1.6 3.4 0.7 0.7 9.0 1.8 1.4 6.2 0.6 6.5 2.8 ZNF888 ENSG00000213793 "Zinc finger protein 888" P0CJ79 19 52904417-52923481 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 34.9;Glandular and luminal cells: 41.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 72.9" NA NA "prognostic unfavorable (5.28e-4)" "unprognostic (7.35e-2)" "unprognostic (7.60e-2)" "unprognostic (6.88e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (5.00e-3)" "unprognostic (5.86e-3)" "unprognostic (7.58e-2)" "unprognostic (1.42e-1)" "unprognostic (4.31e-1)" "unprognostic (2.80e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (5.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.00e-3)" 1.8 1.9 0.9 2.3 0.9 5.0 3.2 1.7 1.1 11.2 1.5 5.3 2.9 4.6 4.9 3.0 8.3 5.2 0.9 0.8 0.8 4.5 0.8 2.9 3.5 0.8 0.7 0.7 2.7 5.6 2.3 0.9 4.8 0.9 9.1 8.2 1.0 3.8 6.8 0.4 3.5 2.6 1.6 0.8 2.9 7.6 1.0 0.8 3.4 3.0 0.9 3.5 9.6 3.8 0.9 6.3 0.1 2.0 6.5 1.9 1.1 9.2 4.8 2.9 3.8 6.5 4.6 4.2 6.1 6.4 2.8 4.0 3.7 4.8 3.9 5.9 2.8 7.5 5.3 5.8 4.9 0.9 0.0 8.8 2.2 3.7 3.7 4.5 1.8 2.3 4.0 9.9 0.3 1.0 1.7 6.3 6.7 3.1 0.3 5.2 4.1 3.9 2.9 14.4 72.9 0.9 2.9 0.0 8.4 1.2 4.6 6.3 8.6 3.2 0.8 3.8 1.5 5.4 1.6 3.2 7.2 0.2 4.0 4.4 0.4 0.8 1.0 0.6 0.5 0.8 0.5 0.6 0.8 1.0 0.7 0.7 0.6 0.4 1.3 0.8 2.0 0.9 0.6 0.9 0.9 1.7 1.1 0.8 0.8 0.8 0.7 0.7 0.9 0.8 0.8 0.9 1.6 6.4 3.6 1.0 0.7 0.0 0.2 0.2 0.0 0.0 1.7 2.2 1.1 0.0 2.5 9.2 0.0 0.1 2.0 0.1 0.0 2.9 0.0 34.9 5.2 0.7 0.0 0.0 0.8 1.6 0.1 0.8 0.5 41.0 0.0 4.4 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.6 0.0 0.0 0.0 1.6 0.0 1.0 1.0 0.0 0.0 1.0 0.7 3.3 0.0 0.0 0.7 0.0 0.0 1.6 5.2 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.3 1.0 1.7 0.0 0.1 ZNF845 ENSG00000213799 "Zinc finger protein 845" Q96IR2 19 53333749-53356906 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.85e-3)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (5.78e-2)" "unprognostic (1.07e-3)" "unprognostic (9.79e-2)" "unprognostic (3.12e-3)" "unprognostic (1.05e-1)" "unprognostic (7.52e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.98e-4)" "unprognostic (3.13e-1)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" 2.6 1.7 1.1 2.7 1.5 5.0 4.1 2.1 1.4 2.9 1.5 2.9 2.5 2.2 2.4 2.5 3.0 2.0 2.1 1.1 1.5 2.5 1.5 3.0 4.4 1.4 1.4 1.0 4.2 2.1 3.7 1.0 3.0 1.5 3.0 3.1 1.3 2.1 2.4 0.6 3.2 2.6 2.0 1.2 3.6 3.6 2.3 1.4 4.2 3.7 2.0 3.9 2.7 2.3 2.1 4.7 5.6 3.3 5.1 4.5 4.6 9.0 3.8 5.4 4.1 6.0 4.4 3.5 7.8 3.3 4.1 5.0 5.2 6.1 6.0 6.5 2.3 9.5 9.1 3.6 3.7 4.6 0.0 6.2 4.6 5.9 4.6 6.4 3.6 5.1 6.2 6.6 0.0 5.8 4.8 10.1 3.3 6.1 7.4 5.8 6.9 9.2 5.5 3.0 15.2 4.9 3.0 12.0 6.0 2.9 7.7 4.4 6.2 4.8 6.8 4.4 3.5 4.5 5.4 8.1 12.7 1.3 5.1 6.7 1.3 1.6 2.3 2.2 2.3 3.3 3.3 2.5 3.4 1.8 2.0 3.3 3.1 1.3 2.3 1.4 1.3 3.8 1.9 1.1 1.5 2.1 1.4 1.1 1.5 1.4 1.4 1.0 1.5 1.2 1.4 2.1 3.6 0.0 6.1 1.6 3.5 0.4 1.7 1.0 3.4 1.4 3.0 2.8 3.1 2.8 3.8 1.8 4.2 2.7 6.5 4.5 1.9 2.8 0.4 2.1 2.4 2.8 0.0 3.6 1.0 3.6 1.9 3.5 1.5 2.8 1.3 5.7 4.2 1.2 2.4 3.3 1.3 2.7 0.0 3.8 1.7 0.1 2.1 2.6 3.6 4.7 3.4 1.4 2.1 1.0 3.6 2.5 2.1 1.2 2.3 1.9 3.1 2.2 3.5 0.6 0.0 2.0 2.8 0.9 2.8 1.3 1.8 7.7 3.0 2.4 2.0 1.8 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.3;lymphoid tissue: 43.2" "Cell type enhanced" "Detected in some" "dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 40 "gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8" "Group enriched" "Detected in all" 50 "NK-cells: 335.8;T-cells: 287.4" "Cell line enriched" "Detected in some" 9 "U-698: 64.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" NA NA 47000 "Plasma membrane" "CAB021896: , HPA068877: AB_2686052" "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 3.9 2.1 1.9 12.7 2.1 22.3 4.2 1.9 2.9 2.3 1.4 3.9 4.8 2.5 2.4 2.3 2.8 7.4 1.8 1.9 1.9 2.0 5.5 12.2 37.3 2.2 1.9 1.8 2.4 1.1 0.5 1.1 1.4 2.1 2.6 4.5 0.4 4.5 0.9 0.8 1.1 12.3 1.9 2.0 43.2 7.3 2.6 1.9 10.0 3.6 1.5 19.1 4.5 3.3 2.4 0.3 0.0 0.7 2.8 0.2 7.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 2.6 0.0 0.0 0.2 0.2 0.0 0.7 1.4 0.0 0.3 0.0 0.4 0.2 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.8 0.3 0.1 0.1 0.0 2.0 0.2 0.3 0.1 0.1 0.8 0.0 0.0 0.0 0.0 64.2 0.2 0.0 0.3 0.4 0.5 0.2 287.4 0.6 111.5 6.2 1.7 261.2 0.6 6.1 2.3 258.8 4.8 335.8 1.3 1.9 0.7 127.9 1.9 2.1 1.9 2.9 1.9 1.9 2.2 1.9 1.8 2.1 2.0 1.9 2.4 0.0 0.0 1.3 0.0 2.4 0.0 0.1 0.2 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.5 1.8 0.0 0.5 0.0 6.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 22.2 1.0 0.0 0.0 CEACAM18 ENSG00000213822 "CEA cell adhesion molecule 18" A8MTB9 19 51478622-51490952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "intestine: 10.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.8;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "CACO-2: 4.3;OE19: 3.5;RT4: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA059487 Uncertain Approved Midbody Yes NA Midbody "HPA059487: AB_2684036" "unprognostic (1.12e-1)" "unprognostic (1.87e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580632 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 232.6" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 49.7 9.8 15.1 12.5 14.0 0.7 49.9 13.8 17.2 41.7 18.9 46.8 15.7 26.1 45.9 153.4 35.8 17.9 59.1 12.3 14.0 13.3 83.9 232.6 5.7 14.9 14.1 10.5 55.4 13.8 33.0 13.4 23.2 14.3 39.1 34.4 2.1 39.6 17.5 22.7 141.7 28.6 22.5 13.5 16.1 39.4 7.3 16.9 5.3 27.9 25.6 33.1 39.9 73.5 14.5 28.7 39.1 15.9 18.9 35.0 30.0 31.3 40.0 36.8 23.9 35.7 128.5 98.2 0.2 12.6 48.4 17.2 123.9 41.1 49.8 31.3 0.1 26.1 0.1 76.6 72.1 6.1 0.2 0.4 18.4 13.1 31.9 3.2 5.4 10.1 0.1 9.6 2.6 66.9 268.1 0.4 0.6 18.3 46.4 9.5 7.5 18.2 61.7 5.5 182.0 22.0 25.0 49.6 256.2 15.2 45.2 156.6 6.2 5.7 75.5 32.2 25.6 22.7 0.8 1.0 0.2 33.2 0.5 75.7 1.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 1.1 0.3 0.3 0.3 0.2 0.1 15.1 14.0 13.8 17.2 12.3 14.0 14.9 14.1 10.5 14.3 13.5 16.9 14.5 239.7 4163.5 368.4 13.1 3.1 356.9 137.9 172.2 111.0 2.3 105.0 94.0 53.1 100.1 255.8 42.3 0.0 74.2 3.1 119.5 0.0 3.8 8.0 78.8 30.9 183.9 104.9 0.0 0.7 67.0 17.8 152.7 46.4 51.9 36.7 68.7 161.0 235.1 10.1 0.0 0.6 207.8 81.4 19.6 136.5 9.3 190.7 17.0 87.2 41.2 33.6 5.7 0.0 22.6 0.6 32.9 158.4 276.1 1.6 86.0 21.0 0.2 142.8 2.2 52.6 256.3 129.3 5.7 12.9 319.5 1174.3 48.0 9.3 73.3 178.5 221.4 KCTD11 "C17orf36, KCASH1, REN" ENSG00000213859 "Potassium channel tetramerization domain containing 11" Q693B1 17 7351889-7354944 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Ubl conjugation pathway" "Developmental protein, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 32.2;Pancreatic endocrine cells: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.6" "Group enriched" "Detected in all" 4 "granulocytes: 9.6;monocytes: 3.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 53.6;hTCEpi: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052035 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052035: AB_2681704" "unprognostic (1.98e-1)" "unprognostic (5.67e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.55e-4)" "unprognostic (6.78e-3)" "unprognostic (1.92e-2)" "unprognostic (2.38e-2)" "unprognostic (1.59e-3)" "unprognostic (3.91e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (7.93e-2)" "unprognostic (3.62e-1)" "unprognostic (1.99e-1)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" 9.7 7.3 5.6 6.2 5.9 1.0 8.3 6.5 6.4 20.8 6.2 8.2 5.8 11.5 8.0 40.4 9.3 7.5 6.3 5.6 7.4 7.0 6.3 8.1 6.0 6.9 5.8 4.7 7.9 7.9 9.2 6.6 7.5 5.9 8.9 5.6 3.4 15.7 9.9 5.3 34.9 8.5 7.9 6.0 8.8 8.6 3.5 6.7 3.0 9.9 3.9 10.3 28.9 35.8 8.0 18.2 7.7 5.6 4.0 23.5 13.6 5.1 10.9 19.3 12.5 10.6 6.6 8.1 2.3 6.1 20.2 11.8 32.3 0.7 53.6 10.9 10.4 2.1 0.2 4.0 0.8 11.7 0.3 10.2 10.7 38.1 13.8 7.6 25.7 3.8 1.9 2.4 3.0 9.7 8.1 1.5 2.5 1.5 8.5 3.3 1.9 5.1 2.3 13.3 7.1 0.3 2.4 8.1 8.4 1.2 6.9 11.5 1.0 7.6 10.3 8.2 7.0 6.2 2.1 0.9 0.8 12.1 5.1 7.4 9.6 2.6 1.6 1.4 3.5 0.4 1.0 0.7 0.6 1.5 0.7 0.3 1.0 0.4 1.0 2.9 0.1 0.1 1.9 5.6 5.9 6.5 6.4 5.6 7.4 6.9 5.8 4.7 5.9 6.0 6.7 8.0 3.1 9.6 1.1 3.3 3.4 1.8 17.6 32.2 4.0 3.9 5.8 4.1 0.8 7.2 13.8 5.5 2.1 6.1 1.6 11.1 3.9 13.3 25.3 9.4 12.1 3.8 7.2 0.0 0.0 9.4 6.5 9.3 15.8 6.1 4.5 4.0 4.2 2.5 4.8 1.7 0.4 6.5 10.2 3.5 5.0 8.7 17.7 3.5 1.8 1.9 10.5 3.7 11.3 0.0 1.4 32.8 5.0 21.8 3.8 13.1 8.0 3.4 24.5 1.9 19.7 5.9 11.6 1.2 1.2 6.6 4.4 9.9 3.6 4.1 4.0 18.4 UBD FAT10 ENSG00000213886 "Ubiquitin D" O15205 6 29555515-29559732 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 152.5" "Group enriched" "Detected in many" 7 "Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6" "Cancer enhanced" "Detected in all" "liver cancer: 75.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "Hep G2: 63.9;RT4: 52.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043710 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA043710: AB_2756303" "unprognostic (2.99e-3)" "unprognostic (4.16e-2)" "unprognostic (6.37e-2)" "unprognostic (2.61e-2)" "unprognostic (3.93e-2)" "unprognostic (3.53e-3)" "unprognostic (1.60e-1)" "unprognostic (9.47e-2)" "unprognostic (1.44e-2)" "prognostic favorable (7.35e-4)" "unprognostic (1.28e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (4.04e-2)" "unprognostic (6.02e-2)" "unprognostic (8.40e-2)" "unprognostic (1.21e-2)" 3.2 0.4 0.3 35.9 0.4 0.0 8.7 0.3 0.7 1.4 0.4 13.4 4.2 1.9 1.2 8.3 4.8 0.9 0.6 0.3 0.7 22.9 25.7 11.0 88.2 0.4 0.3 0.3 1.2 27.5 1.7 1.4 0.0 0.3 12.0 19.2 0.0 14.7 1.3 0.4 1.8 31.3 1.2 0.3 23.1 27.3 0.8 0.3 91.0 3.0 0.1 152.5 26.1 1.7 0.3 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 63.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 52.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.9 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.7 0.3 0.7 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 3.2 3.1 0.0 0.7 0.1 0.1 2.3 16.5 0.0 1.9 1.9 0.0 21.5 13.3 0.0 0.0 0.0 0.1 6.9 1.9 534.8 0.0 0.3 0.2 7.1 3.6 0.0 0.0 273.8 0.0 2.2 13.3 0.2 0.0 0.0 0.7 0.3 0.1 0.0 0.0 5.2 6.1 0.3 0.0 0.0 0.0 1.2 0.0 0.0 151.9 0.0 0.0 0.0 0.0 510.6 8.3 0.0 0.0 0.5 49.1 1.1 9.7 0.0 0.0 0.0 3.4 0.0 0.0 2.2 0.0 0.0 0.2 0.0 11.1 0.1 PPM1N FLJ40125 ENSG00000213889 "Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)" Q8N819 19 45488777-45502510 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 215.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 123.1;Rod photoreceptor cells: 74.3" "Cancer enhanced" "Detected in many" "testis cancer: 11.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "non-classical monocyte: 142.4" "Lineage enriched" "Detected in all" 11 "monocytes: 142.4" "Cell line enhanced" "Detected in many" "OE19: 24.1;RT4: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043577 Supported Vesicles NA NA Vesicles "HPA043577: " "unprognostic (2.38e-2)" "unprognostic (1.11e-2)" "unprognostic (8.53e-2)" "unprognostic (6.59e-2)" "unprognostic (4.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-3)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-16)" "unprognostic (3.42e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (1.86e-3)" 2.0 0.8 14.0 2.0 13.2 2.6 3.3 13.0 20.0 2.0 13.1 2.6 0.6 0.7 1.3 2.6 0.9 1.4 1.3 13.8 13.3 0.8 2.7 2.6 3.1 13.2 13.0 13.1 0.6 0.5 2.2 1.2 4.7 13.8 1.2 1.3 26.0 0.9 2.0 215.3 3.1 1.6 1.2 12.6 9.3 2.9 5.3 12.8 2.4 1.1 0.2 3.5 2.4 1.7 14.7 2.6 7.1 1.2 5.1 5.9 7.8 14.7 1.9 3.0 0.6 2.3 1.7 15.8 11.1 3.2 1.8 4.1 7.6 3.0 2.2 0.9 10.9 4.5 9.0 2.7 1.9 1.4 0.8 18.1 3.2 3.6 3.1 1.9 4.0 1.0 4.4 10.3 9.6 1.0 1.9 3.1 4.6 4.0 24.1 1.4 2.0 1.5 3.0 3.4 29.9 5.8 6.8 1.0 11.1 9.2 8.8 3.8 2.7 1.5 8.2 4.7 4.3 1.4 1.7 4.5 2.3 6.1 2.3 7.2 6.7 4.4 3.2 6.4 22.5 5.5 6.3 3.9 6.2 12.8 3.6 4.3 7.9 6.5 3.1 142.4 2.4 4.5 5.7 14.0 13.2 13.0 20.0 13.8 13.3 13.2 13.0 13.1 13.8 12.6 12.8 14.7 6.4 0.0 2.7 1.0 7.5 3.4 14.7 6.2 17.6 14.1 5.9 32.5 2.3 17.2 2.5 3.7 31.3 3.2 6.0 5.5 0.0 2.9 12.5 2.0 3.9 3.5 3.0 0.8 1.1 1.8 123.1 6.5 3.1 7.4 7.0 1.0 5.3 1.3 20.1 1.7 1.4 4.2 0.0 15.5 15.7 4.9 0.9 15.2 1.8 1.0 6.1 7.3 20.6 0.0 0.3 3.1 4.7 0.7 1.7 6.7 6.9 0.6 0.8 74.3 0.0 25.6 5.5 2.9 9.1 3.4 4.1 8.5 7.5 0.3 3.1 8.4 CEACAM16 DFNA4B ENSG00000213892 "CEA cell adhesion molecule 16, tectorial membrane component" Q2WEN9 19 44699151-44710718 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "pancreas: 2.1" "Group enriched" "Detected in some" 7 "Bipolar cells: 7.7;Skeletal myocytes: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045075 Uncertain "Secreted in other tissues" NA NA "HPA045075: AB_10959617" "unprognostic (1.27e-1)" "unprognostic (3.73e-1)" "unprognostic (3.12e-1)" "unprognostic (3.32e-2)" "unprognostic (4.72e-1)" "unprognostic (1.42e-2)" "unprognostic (7.76e-2)" "unprognostic (3.59e-2)" "unprognostic (7.81e-3)" "unprognostic (3.88e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (7.94e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 20.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "intestine: 18.6;kidney: 46.0" "Group enriched" "Detected in many" 5 "Proximal enterocytes: 55.9;Proximal tubular cells: 14.4" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 4.9;U-266/70: 3.1" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Not detected" "Not detected" HPA019059 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.9 0.4 1.1 0.9 0.9 0.1 0.9 1.0 1.1 2.7 1.0 2.9 7.7 1.6 0.5 2.2 1.5 0.5 0.9 0.8 0.8 46.0 4.0 1.3 0.7 1.0 0.9 0.6 1.8 1.1 0.8 0.5 1.1 0.9 2.4 1.6 0.2 1.0 0.6 0.2 1.9 18.6 0.7 0.9 1.5 1.2 0.1 0.9 0.3 2.4 0.1 0.8 1.1 2.3 1.2 0.5 0.2 0.1 0.6 2.0 1.1 0.4 1.2 0.3 0.2 0.7 1.1 0.7 0.2 0.4 0.8 0.0 1.7 0.4 0.1 0.3 1.1 0.9 1.1 1.2 0.1 0.4 0.1 0.4 0.4 4.9 0.4 1.5 1.9 0.6 0.6 0.1 0.4 0.3 0.2 0.0 0.5 0.0 0.4 0.1 0.3 0.3 0.4 1.6 1.9 0.2 0.5 0.1 0.0 1.3 0.5 0.5 0.5 1.4 1.1 0.7 1.0 0.4 3.1 0.1 1.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 1.0 1.1 0.8 0.8 1.0 0.9 0.6 0.9 0.9 0.9 1.2 0.6 0.0 0.5 0.0 1.7 1.5 1.4 0.5 0.6 1.1 0.9 1.1 0.3 1.5 0.3 1.8 0.0 0.3 0.5 3.8 1.9 0.2 0.0 0.2 0.8 1.0 1.8 0.4 0.3 0.0 0.1 0.8 0.0 0.9 0.0 0.5 1.1 1.2 0.2 0.0 0.3 4.0 0.0 0.9 0.8 0.0 1.5 1.0 1.8 1.0 1.1 1.2 0.0 0.0 0.0 0.4 6.0 1.2 0.2 1.5 55.9 14.4 0.1 0.2 0.0 0.8 1.0 0.0 0.2 0.7 1.6 0.4 0.8 0.6 3.9 0.9 LTB4R "BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7" ENSG00000213903 "Leukotriene B4 receptor" Q15722 14 24311450-24318036 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;skin 1: 100.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 45.5;Macrophages: 28.0;Suprabasal keratinocytes: 47.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 18.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 100.3" "Group enriched" "Detected in many" 6 "granulocytes: 100.3;monocytes: 38.4" "Cell line enhanced" "Detected in many" "HaCaT: 20.3;Karpas-707: 17.4" "Low region specificity" "Detected in single" HPA003873 Approved NA NA "HPA003873: AB_1078288" "unprognostic (4.07e-2)" "unprognostic (7.67e-2)" "unprognostic (3.67e-3)" "unprognostic (2.40e-3)" "unprognostic (4.90e-2)" "unprognostic (9.00e-3)" "unprognostic (1.15e-2)" "unprognostic (8.63e-2)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "prognostic favorable (1.85e-4)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (2.88e-1)" "unprognostic (2.97e-1)" "unprognostic (6.59e-2)" "unprognostic (7.45e-2)" 12.4 12.6 1.2 5.0 1.5 16.1 11.9 1.5 1.6 20.5 1.5 5.7 4.3 6.7 5.4 103.9 10.5 2.2 5.1 1.2 1.5 10.3 18.2 15.5 5.5 1.5 1.3 1.1 8.5 7.8 0.5 10.9 2.2 1.6 16.9 1.6 4.3 23.7 2.2 5.9 100.1 12.3 1.6 1.4 41.0 6.0 7.9 1.6 4.1 10.3 0.7 9.3 6.8 51.9 1.5 2.7 5.7 2.0 1.6 1.3 1.3 8.4 1.1 0.8 1.2 1.4 4.2 3.2 4.2 1.9 1.1 2.1 20.3 1.8 3.1 1.7 11.5 6.3 4.0 8.4 2.9 0.6 5.7 5.9 0.7 5.5 2.3 3.0 1.8 2.0 6.8 3.7 17.4 0.5 5.6 2.5 10.1 1.4 0.2 4.3 9.9 1.8 7.4 0.7 4.3 4.3 1.7 5.3 2.9 3.0 3.5 4.9 6.2 1.3 4.3 4.2 4.2 1.5 9.9 2.3 7.1 0.9 14.9 2.8 17.0 38.4 40.5 3.4 4.9 2.4 0.0 2.5 2.7 11.2 0.2 1.2 0.8 100.3 2.1 1.2 1.1 0.6 13.7 1.2 1.5 1.5 1.6 1.2 1.5 1.5 1.3 1.1 1.6 1.4 1.6 1.5 10.1 0.0 0.6 3.6 2.5 24.0 10.5 18.5 12.0 3.0 6.3 5.0 1.4 5.7 4.3 0.0 6.2 0.9 14.2 2.2 0.0 2.1 0.3 4.6 1.8 5.6 0.0 1.3 1.5 6.1 0.8 2.5 3.1 4.5 1.3 1.4 7.9 4.1 15.6 0.0 1.3 2.8 8.2 45.5 3.7 1.1 3.4 28.0 3.6 2.8 25.4 1.6 18.6 1.0 1.2 4.6 5.4 1.5 6.2 2.7 5.4 0.9 6.4 10.8 6.6 2.0 1.8 1.5 1.4 22.6 47.0 0.8 13.5 1.3 3.2 2.5 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 38.0;skin 1: 43.4" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 4.6 5.9 0.3 2.1 0.6 5.5 4.8 0.5 0.5 9.3 0.4 2.4 2.6 3.0 0.8 38.0 4.1 0.9 2.0 0.3 0.5 2.8 4.0 4.7 2.0 1.1 0.4 0.2 5.0 4.8 0.2 3.9 1.0 0.8 5.0 0.5 2.1 11.8 1.2 3.1 43.4 5.1 0.5 0.4 13.6 2.7 4.2 0.5 1.7 3.9 0.1 3.2 2.7 21.8 0.6 2.4 3.9 1.6 1.7 0.3 0.5 7.1 0.8 0.4 1.2 0.7 3.1 1.3 2.9 1.4 0.5 1.6 15.0 1.1 2.5 0.8 3.7 4.4 2.0 3.7 1.5 0.4 3.4 3.7 0.5 3.1 1.7 2.0 1.0 0.5 5.3 2.6 3.3 0.5 4.4 1.8 3.5 0.9 0.1 4.7 7.4 1.5 1.7 0.3 2.8 3.1 1.5 1.5 1.8 1.3 1.7 3.4 2.5 1.5 2.3 2.8 3.6 1.3 7.1 2.1 4.7 0.5 5.5 1.8 0.0 0.5 0.3 0.6 0.3 0.3 0.0 0.5 0.5 0.5 0.0 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.3 0.6 0.5 0.5 0.3 0.5 1.1 0.4 0.2 0.8 0.4 0.5 0.6 2.3 0.0 0.0 0.0 0.7 0.3 3.4 0.1 18.2 0.4 0.6 1.3 0.0 0.0 0.0 1.8 0.0 0.2 1.2 0.5 0.0 0.2 0.0 1.9 0.2 1.6 1.8 2.1 0.0 1.4 0.1 0.5 1.5 0.4 0.0 0.2 1.1 1.0 0.7 3.3 0.0 0.4 0.0 1.9 0.0 0.0 0.3 1.8 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.4 1.2 0.0 3.0 0.4 1.1 0.3 0.7 0.5 0.0 0.3 0.2 0.9 0.2 15.7 0.1 0.3 2.3 0.3 0.8 0.8 DNASE1 DNL1 ENSG00000213918 "Deoxyribonuclease 1" P24855 16 3611728-3680143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Actin-binding, Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 34.8" "Cell type enriched" "Detected in many" 11 "Proximal enterocytes: 715.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010703 Enhanced Supported Vesicles "Secreted in other tissues" NA NA 420000 Vesicles "HPA010703: AB_10600806" "unprognostic (5.18e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (2.38e-1)" "unprognostic (1.90e-2)" "unprognostic (3.73e-2)" "unprognostic (3.82e-1)" "unprognostic (3.20e-1)" "unprognostic (9.91e-2)" "unprognostic (1.69e-3)" "unprognostic (5.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.14e-4)" 4.3 5.0 5.7 6.7 5.8 4.4 4.6 12.5 6.2 8.8 6.8 6.0 29.9 5.2 5.0 7.2 6.9 2.7 5.3 5.7 5.4 21.2 6.0 4.9 10.1 5.9 5.3 4.6 7.5 23.8 2.7 16.4 4.3 8.4 11.7 5.1 4.4 5.0 2.5 3.8 7.9 34.8 2.7 3.4 9.3 11.3 9.2 5.3 9.5 7.4 1.3 8.7 6.0 8.6 9.7 2.9 6.5 11.4 5.9 3.3 2.8 5.2 4.7 0.8 3.7 5.3 8.0 6.9 12.3 3.6 0.7 7.8 4.8 4.2 1.3 3.9 5.5 6.4 4.4 11.3 5.4 1.7 2.9 9.6 2.3 4.8 5.0 1.2 5.8 2.5 10.3 11.2 5.0 3.2 12.3 6.3 13.6 6.9 8.7 3.6 14.9 5.3 5.7 3.1 2.5 8.1 7.6 3.5 10.5 1.9 5.7 10.4 7.7 3.4 6.8 5.0 4.3 2.5 4.8 7.5 21.4 1.7 5.7 6.6 2.7 1.1 3.2 1.5 0.7 1.0 1.4 1.2 1.3 0.6 2.1 1.3 1.8 5.0 1.0 0.7 1.1 1.4 0.5 5.7 5.8 12.5 6.2 5.7 5.4 5.9 5.3 4.6 8.4 3.4 5.3 9.7 4.9 9.6 10.3 27.1 9.1 2.7 8.6 3.1 10.8 27.3 5.5 4.8 6.0 4.3 9.7 16.5 22.9 8.6 9.3 11.8 56.7 5.3 19.3 9.8 10.0 7.7 14.3 7.6 20.5 11.0 4.1 7.4 13.3 8.4 2.5 23.3 7.5 1.8 3.9 25.2 22.0 38.6 20.3 5.0 4.2 52.4 8.4 4.4 1.8 15.9 13.2 8.6 30.9 22.1 20.6 5.3 61.4 7.9 7.2 12.4 715.5 2.4 9.1 17.9 0.0 13.6 6.3 28.5 24.5 5.8 3.8 6.2 12.2 10.4 33.4 6.3 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213943-24216070 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm NA NA 29000 Nucleoplasm "HPA003064: AB_10602350, HPA070338: AB_2686256" "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 13.1 18.8 7.2 3.2 7.1 3.9 14.7 7.4 7.5 14.3 6.9 11.6 3.1 11.6 7.9 7.3 12.2 4.0 17.7 7.3 7.4 16.9 10.4 9.3 5.9 7.1 7.4 7.3 12.4 15.4 5.9 20.2 4.0 7.3 13.9 3.5 4.2 10.7 4.8 15.1 12.6 9.6 4.5 7.4 11.7 12.0 7.8 7.0 5.4 13.7 4.9 4.8 12.6 11.2 8.4 4.1 9.5 7.2 4.7 6.9 6.3 0.3 4.2 8.9 8.2 8.4 5.0 10.9 15.7 10.4 4.3 2.4 3.7 3.4 8.2 5.0 5.4 3.9 6.0 3.3 12.1 6.7 7.9 4.2 4.5 7.7 4.9 9.4 8.3 5.9 11.1 1.9 11.4 7.4 21.1 11.7 12.6 2.2 7.8 16.9 8.0 5.0 12.6 8.0 5.7 8.7 8.6 6.6 14.3 9.4 3.9 8.3 4.5 3.5 8.8 8.7 3.9 4.4 18.6 8.4 11.7 8.3 3.8 6.9 5.1 13.9 16.5 7.7 15.2 7.3 13.4 9.9 9.0 16.1 12.9 11.7 9.9 4.6 12.4 13.0 29.9 16.3 10.3 7.2 7.1 7.4 7.5 7.3 7.4 7.1 7.4 7.3 7.3 7.4 7.0 8.4 6.6 6.4 12.9 0.0 11.0 4.6 3.5 5.6 16.5 3.9 8.2 11.7 0.0 4.3 2.1 5.5 0.0 3.7 7.3 5.9 13.7 13.8 5.7 4.6 5.5 8.2 11.5 7.8 0.0 19.6 5.3 8.1 9.2 4.3 5.1 4.3 8.6 5.8 7.9 3.3 0.0 10.8 12.2 3.3 8.7 3.0 6.2 10.6 17.8 0.0 21.9 5.2 4.1 0.0 0.0 11.7 6.2 7.5 25.8 2.9 23.7 21.7 13.2 2.9 13.1 7.7 8.7 4.4 3.5 11.5 4.5 2.5 9.7 3.4 8.8 2.6 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786291 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSNK1E "CKIE, CKIepsilon, HCKIE" ENSG00000213923 "Casein kinase 1 epsilon" P49674 22 38290691-38318084 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 280.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009626, HPA026288" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009626: AB_2084517, HPA026288: AB_1847276" "unprognostic (2.32e-1)" "unprognostic (8.41e-2)" "unprognostic (5.14e-2)" "unprognostic (5.01e-3)" "unprognostic (1.95e-2)" "unprognostic (4.50e-3)" "prognostic unfavorable (8.20e-5)" "unprognostic (2.08e-3)" "unprognostic (3.69e-1)" "unprognostic (1.22e-1)" "unprognostic (9.63e-2)" "unprognostic (4.16e-3)" "prognostic unfavorable (4.67e-6)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-1)" "unprognostic (3.25e-3)" 87.0 53.2 76.3 41.6 76.0 52.0 89.1 74.4 95.8 94.0 59.5 66.2 41.8 83.4 53.0 69.6 84.0 49.1 79.4 78.3 68.4 55.7 37.7 93.0 40.6 74.3 74.2 74.8 110.4 65.4 74.6 85.8 71.7 78.8 80.9 35.9 47.7 72.2 45.3 61.1 90.6 51.3 45.7 65.1 64.2 58.5 29.7 76.8 33.6 64.9 47.6 38.2 66.3 89.2 86.6 101.5 57.4 121.6 114.7 61.5 88.3 92.1 126.9 168.6 116.7 114.3 63.9 76.7 74.2 53.0 120.7 70.7 77.9 96.1 177.9 79.2 123.0 215.2 23.9 181.2 47.4 123.7 48.3 61.9 90.2 143.8 171.7 220.3 141.0 121.1 60.6 50.9 155.0 110.8 68.4 71.1 60.9 87.2 67.3 69.1 130.8 90.1 123.4 99.0 92.4 181.6 69.3 102.9 109.3 124.7 68.0 59.5 73.0 134.3 94.0 111.3 58.7 102.1 61.2 105.2 104.5 151.0 56.9 176.3 4.8 1.6 3.6 3.0 0.8 3.8 2.1 3.4 3.0 1.8 3.1 1.9 2.5 3.8 5.7 0.5 15.9 1.6 1.2 76.3 76.0 74.4 95.8 78.3 68.4 74.3 74.2 74.8 78.8 65.1 76.8 86.6 73.4 38.5 21.7 0.0 32.3 78.6 158.8 89.1 68.9 132.6 53.7 42.4 49.8 34.3 73.9 23.9 60.5 35.2 42.3 28.4 7.9 30.8 46.0 94.3 72.5 76.4 62.8 12.6 0.0 41.8 49.2 60.8 39.8 126.5 3.8 46.6 45.0 21.3 23.1 72.3 0.0 46.0 46.8 17.6 54.1 69.1 85.4 21.8 60.5 0.0 13.3 117.9 28.8 0.0 0.0 57.5 33.1 66.2 83.5 160.5 9.0 6.5 62.8 60.7 72.3 85.7 98.0 8.0 20.0 50.3 104.7 125.5 26.0 34.9 37.6 280.8 CCL27 "ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine" ENSG00000213927 "C-C motif chemokine ligand 27" Q9Y4X3 9 34661880-34664048 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "skin 1: 488.9" "Group enriched" "Detected in some" 26 "Basal keratinocytes: 704.5;Suprabasal keratinocytes: 1004.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.9" "Not detected" "Not detected" HPA073848 Enhanced "Secreted to blood" NA NA 436000 1800000 "HPA073848: AB_2732243" 0.2 0.0 2.1 0.1 2.1 1.7 28.0 3.5 4.8 0.6 1.7 0.1 0.3 0.7 3.1 0.7 0.2 0.7 0.6 2.0 2.0 0.0 0.3 0.1 0.3 2.1 2.0 1.9 0.9 0.1 0.1 0.1 0.3 2.2 0.2 0.2 0.9 0.3 0.2 1.4 488.9 0.1 0.2 2.0 0.1 0.1 1.3 2.0 4.6 1.2 0.3 0.2 0.1 0.6 2.5 0.0 0.0 0.3 1.9 0.8 0.3 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.9 1.4 0.0 1.1 0.7 0.0 0.0 1.1 0.4 0.3 0.0 0.0 1.4 0.8 0.2 0.0 0.3 0.0 0.5 0.2 1.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 1.2 0.0 0.1 0.5 0.0 0.0 0.1 1.3 0.7 0.0 0.0 0.9 0.8 0.7 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 2.1 3.5 4.8 2.0 2.0 2.1 2.0 1.9 2.2 2.0 2.0 2.5 0.1 0.0 0.0 0.3 0.0 704.5 0.3 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 7.8 0.0 0.3 1.7 0.0 0.0 0.2 0.2 0.8 2.3 0.0 0.1 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.2 0.0 0.0 28.4 9.6 0.3 0.0 32.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.5 0.0 0.2 0.0 0.2 1.6 4.5 1.5 0.0 1004.0 1.9 0.8 0.0 0.2 0.1 IRF9 ISGF3G ENSG00000213928 "Interferon regulatory factor 9" Q00978 14 24161265-24166565 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 76.6;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;GAMG: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001862 Approved Supported Cytosol NA NA Cytosol "HPA001862: AB_1079153" "unprognostic (4.96e-3)" "unprognostic (4.91e-2)" "unprognostic (6.84e-3)" "unprognostic (8.17e-3)" "unprognostic (5.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.00e-1)" "unprognostic (1.77e-2)" "unprognostic (4.50e-1)" "unprognostic (9.10e-2)" "unprognostic (4.08e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (7.58e-8)" "unprognostic (1.56e-1)" "unprognostic (4.44e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.92e-4)" 25.3 27.4 16.8 25.3 16.8 25.7 22.7 16.2 17.5 28.6 13.8 26.6 17.7 28.0 13.2 22.0 25.2 24.5 18.8 14.1 20.8 29.3 26.1 28.4 25.5 19.2 16.6 13.0 25.2 14.2 11.7 22.3 13.0 17.3 22.3 10.0 3.7 36.7 12.8 9.0 20.6 27.1 17.7 18.6 48.9 25.5 8.4 18.6 22.9 23.0 8.9 20.6 27.2 22.7 21.9 3.9 2.4 2.5 0.9 15.9 17.6 1.6 7.3 37.5 76.6 58.9 5.2 22.5 5.0 7.7 20.3 48.5 6.0 1.6 1.5 19.3 24.3 0.0 11.6 2.1 6.1 25.3 1.1 14.2 17.2 5.3 9.1 1.9 15.1 8.3 1.0 1.7 32.6 10.0 4.5 2.0 4.8 0.4 2.8 7.4 0.8 2.5 3.0 17.2 2.6 0.4 2.6 6.6 3.5 38.9 5.1 1.1 9.7 16.1 8.1 5.7 4.8 1.7 32.4 24.9 4.7 9.4 1.8 7.3 197.2 80.5 112.3 73.4 103.1 58.1 93.3 72.4 62.0 61.7 88.7 64.0 58.4 202.8 74.8 103.9 75.1 103.0 103.4 16.8 16.8 16.2 17.5 14.1 20.8 19.2 16.6 13.0 17.3 18.6 18.6 21.9 37.9 25.6 15.1 21.2 22.8 2.3 8.6 6.1 6.2 6.6 8.0 10.3 0.2 10.0 9.7 5.5 8.4 1.5 32.0 6.1 0.0 4.9 0.2 9.0 19.4 21.0 1.8 7.4 5.0 5.5 21.9 14.8 20.9 9.4 24.6 42.0 11.0 1.7 7.0 8.4 4.9 5.3 10.2 8.2 8.0 1.0 12.8 13.4 5.4 26.2 13.4 11.2 73.2 32.2 9.5 6.2 10.9 6.8 13.2 8.4 21.8 2.6 32.3 4.3 13.1 33.7 15.1 1.3 1.7 3.7 2.7 1.6 26.1 24.9 4.9 12.4 GALT ENSG00000213930 "Galactose-1-phosphate uridylyltransferase" P07902 9 34638133-34651035 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Nucleotidyltransferase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004868, HPA005729" Enhanced Approved Cytosol NA NA 260000 Cytosol "HPA004868: AB_1079130, HPA005729: AB_1079131" "unprognostic (2.38e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-3)" "unprognostic (1.54e-1)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.13e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-2)" "prognostic favorable (3.11e-5)" "unprognostic (9.68e-2)" "prognostic favorable (6.25e-6)" "unprognostic (7.90e-2)" "unprognostic (2.74e-1)" "unprognostic (3.56e-1)" "unprognostic (7.75e-2)" 6.6 14.1 4.7 6.8 4.9 8.1 6.4 5.0 6.6 6.4 3.9 8.3 18.5 6.9 5.4 5.3 7.9 6.9 10.0 4.5 5.4 9.7 50.4 6.7 12.1 4.7 4.9 4.9 8.3 7.6 13.1 6.1 9.3 4.9 6.5 6.8 6.4 12.4 7.6 10.3 15.3 16.7 4.1 3.8 9.8 8.2 2.4 5.4 7.9 8.2 7.6 7.8 5.3 6.1 4.1 5.5 7.5 6.8 2.4 9.0 9.2 7.8 4.2 12.1 4.3 5.1 9.5 4.8 6.1 4.2 5.2 1.6 2.9 1.3 11.8 0.8 9.7 4.8 2.5 14.7 9.8 8.7 1.4 2.9 12.6 7.4 2.7 3.6 9.3 10.6 8.3 2.3 6.4 7.3 5.1 5.4 10.3 2.3 6.7 1.3 8.4 5.9 3.3 12.5 7.8 1.6 5.7 5.0 9.8 5.4 5.0 9.2 8.2 1.6 1.7 3.4 3.4 0.0 3.9 2.4 1.3 4.1 4.4 10.8 16.5 23.7 11.7 15.4 21.5 21.3 24.8 25.2 21.1 21.5 13.2 15.3 14.8 4.6 29.0 20.4 18.2 30.0 17.6 4.7 4.9 5.0 6.6 4.5 5.4 4.7 4.9 4.9 4.9 3.8 5.4 4.1 12.6 6.4 21.2 10.7 19.0 21.7 13.4 19.3 19.4 44.0 10.5 12.1 25.7 14.3 15.4 16.5 47.9 72.5 13.9 17.3 29.4 18.3 7.6 7.8 11.8 14.6 16.3 13.7 9.1 7.3 36.3 18.3 9.2 8.0 20.3 24.7 23.6 69.9 24.1 47.1 12.5 17.0 26.4 15.5 8.7 36.8 18.3 12.4 21.4 5.6 15.9 18.7 34.0 6.0 3.7 6.9 37.5 13.9 10.7 4.7 67.1 46.3 11.1 38.5 6.6 11.2 12.2 4.8 6.6 8.6 20.2 59.1 25.5 27.4 20.4 9.2 HBE1 HBE ENSG00000213931 "Hemoglobin subunit epsilon 1" P02100 11 5268345-5505652 "Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 174.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "K-562: 10059.8" "Not detected" "Not detected" HPA043234 Approved NA NA 510000000 "HPA043234: AB_2678378" "unprognostic (7.59e-2)" "unprognostic (6.70e-2)" "unprognostic (3.76e-2)" "unprognostic (4.25e-1)" "unprognostic (1.64e-1)" "unprognostic (9.03e-2)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (7.32e-2)" "unprognostic (1.02e-3)" "unprognostic (2.14e-1)" "unprognostic (5.80e-2)" "unprognostic (7.34e-2)" 0.3 0.3 0.2 0.0 0.6 0.3 0.2 0.0 1.1 0.4 0.0 0.2 0.0 0.3 0.4 0.1 0.4 0.0 0.3 0.3 0.3 0.3 1.3 0.3 0.0 0.7 0.1 0.7 0.6 0.2 0.0 0.3 0.8 0.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.2 0.2 0.0 0.4 0.2 0.6 0.3 0.2 0.3 0.0 0.0 0.2 0.3 0.6 1.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 649.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10059.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.7 0.7 0.0 0.0 31.9 0.1 0.9 19.4 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 1.1 0.3 0.3 0.7 0.1 0.7 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.9 0.0 0.3 4.3 0.0 16.0 0.5 0.0 31.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 174.7 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.3 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.0 14.8 0.1 0.0 0.9 0.1 HBG1 HBG-T2 ENSG00000213934 "Hemoglobin subunit gamma 1" P69891 11 5248269-5249857 "Human disease related genes, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "placenta: 370.7" "Cell type enriched" "Detected in single" 76 "Macrophages: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 48 "K-562: 3611.8" HPA043234 Approved NA NA "HPA043234: AB_2678378" "unprognostic (3.17e-2)" 1.0 0.5 0.3 0.0 0.3 0.3 0.5 0.4 0.5 0.6 0.3 0.3 0.2 0.4 0.0 0.4 0.3 0.0 1.7 0.3 0.3 1.3 1.3 3.1 0.0 0.6 0.4 0.3 0.4 0.4 0.0 0.6 370.7 0.4 0.4 0.0 0.0 0.2 0.0 0.9 0.3 0.3 0.0 0.3 5.6 0.4 0.2 0.4 0.9 1.1 2.3 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3611.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.3 0.3 0.4 0.5 0.3 0.3 0.6 0.4 0.3 0.4 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012923-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.7;pituitary gland: 25.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Ductal cells: 9.5;Endometrial ciliated cells: 8.6;Pancreatic endocrine cells: 8.1;Respiratory ciliated cells: 18.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.7;CAPAN-2: 7.3;MCF7: 24.2;SCLC-21H: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA076613 Supported "Vesicles,Cell Junctions" NA NA "Cell Junctions" Vesicles "HPA076613: AB_2686808" "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.2 4.1 0.2 3.9 2.7 0.2 9.7 5.3 0.2 2.2 0.4 0.7 0.0 0.0 0.1 1.2 0.2 1.1 3.4 3.3 0.5 5.3 1.2 0.0 4.7 4.2 2.8 0.0 6.4 1.4 25.4 0.1 6.3 0.3 0.0 1.9 0.6 0.0 1.2 0.2 0.5 0.0 3.6 2.3 0.5 0.3 4.4 0.3 0.4 0.1 0.0 0.2 0.1 5.3 4.7 0.2 0.0 2.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 7.3 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.0 24.2 0.0 2.0 0.1 0.3 0.2 0.0 0.0 0.2 0.2 0.1 20.8 0.0 0.6 0.9 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 3.9 9.7 5.3 3.4 3.3 4.7 4.2 2.8 6.3 3.6 4.4 5.3 0.0 0.0 0.0 0.0 0.0 0.1 2.6 1.4 0.0 1.3 1.1 0.4 0.3 15.7 2.3 0.0 0.0 0.3 0.0 0.6 0.0 9.5 0.1 8.6 0.3 0.1 1.8 0.0 0.8 1.7 0.9 0.1 0.0 2.7 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.4 2.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 3.4 8.1 1.5 0.0 0.0 1.2 0.4 0.1 18.1 0.7 0.0 0.0 0.6 0.1 0.2 0.0 0.4 1.1 0.1 0.0 0.6 1.8 ITGA1 "CD49a, VLA1" ENSG00000213949 "Integrin subunit alpha 1" P56199 5 52787916-52959209 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042555 Uncertain NA NA 6300000 "HPA042555: AB_10794281" "unprognostic (1.48e-1)" "unprognostic (1.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (1.38e-1)" "unprognostic (9.89e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (1.79e-3)" "unprognostic (1.50e-2)" "unprognostic (2.62e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.13e-3)" "unprognostic (2.06e-2)" "unprognostic (1.07e-2)" "unprognostic (1.62e-2)" 14.0 22.5 0.8 1.0 0.9 0.0 10.3 0.9 0.9 4.7 0.7 28.5 1.1 16.5 2.6 5.8 10.0 2.2 9.6 0.7 0.9 11.0 17.3 22.3 0.8 1.0 1.0 0.5 3.6 3.1 2.2 2.3 5.9 0.9 12.7 2.7 0.1 2.3 7.3 4.6 2.0 12.6 5.9 0.9 28.1 16.8 0.8 1.0 0.2 9.8 2.5 0.4 18.0 5.1 1.1 0.0 0.0 0.3 0.0 1.4 0.4 0.1 0.3 1.3 0.3 0.7 0.7 0.0 0.0 0.1 4.5 0.5 0.2 0.1 0.4 0.2 0.0 0.4 0.0 0.3 0.3 4.5 0.0 0.0 0.7 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.7 0.5 0.0 0.0 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.9 0.9 0.7 0.9 1.0 1.0 0.5 0.9 0.9 1.0 1.1 264.1 54.5 26.8 2.9 1.7 3.2 4.7 1.5 2.8 1.8 3.6 13.8 12.6 5.7 8.7 5.5 2.1 1.5 2.9 5.5 1.9 3.0 21.3 7.7 41.8 120.5 16.4 5.3 3.6 5.4 16.8 40.2 6.1 22.1 10.1 1.0 77.1 110.5 2.2 0.0 19.5 14.0 0.0 7.2 8.2 6.1 9.3 5.6 7.2 63.7 9.1 0.4 0.0 1.5 4.2 19.6 7.7 8.2 2.9 3.2 6.5 15.1 6.3 2.0 98.6 18.6 143.9 0.9 1.1 0.5 3.1 3.4 46.0 13.6 14.0 2.3 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 5.1 11.8 4.1 4.2 4.2 8.5 4.6 4.0 4.5 3.4 8.3 7.0 7.2 3.6 5.4 11.2 3.6 2.9 9.7 4.2 4.7 6.4 6.9 6.5 5.8 4.6 4.4 4.1 3.8 8.5 7.2 4.0 4.5 4.6 7.6 7.3 8.4 7.0 3.6 24.1 8.9 6.2 4.3 4.2 5.2 8.1 2.8 4.4 3.1 3.6 13.1 5.1 6.3 5.6 4.5 21.5 24.7 2.7 24.0 8.1 10.5 0.2 11.9 4.4 8.7 8.2 14.0 11.6 0.1 14.0 13.8 6.7 13.7 16.7 13.9 11.4 24.8 10.0 27.7 9.3 5.0 11.2 20.9 8.2 8.5 18.1 7.4 17.8 10.1 13.0 4.2 21.6 15.3 15.9 14.3 0.1 19.3 2.9 5.9 11.5 0.1 5.2 12.1 14.4 15.7 10.7 15.4 21.2 17.7 15.9 4.7 9.8 25.4 10.4 11.9 7.7 12.0 21.5 17.8 16.3 6.9 14.4 20.0 11.2 11.1 26.5 15.4 18.2 36.7 20.0 13.0 18.9 22.6 19.5 9.4 14.9 20.4 5.1 32.2 42.4 15.9 23.6 11.9 4.1 4.2 4.0 4.5 4.2 4.7 4.6 4.4 4.1 4.6 4.2 4.4 4.5 5.9 12.8 14.5 7.5 6.4 21.9 9.4 4.6 8.0 14.5 12.0 6.6 22.8 2.8 6.2 7.3 12.5 11.0 9.1 10.6 27.4 2.9 7.7 8.5 9.3 7.3 12.1 10.3 5.9 11.5 11.5 6.6 3.1 10.7 1.3 11.3 13.2 12.5 14.3 3.3 6.7 12.7 8.2 17.6 11.6 3.7 4.1 10.2 12.4 4.7 10.7 4.6 4.1 6.6 7.4 12.0 13.1 9.4 4.1 12.0 15.7 18.8 6.5 30.4 0.0 6.9 7.4 1.6 2.2 9.9 31.5 7.8 9.1 22.3 18.4 10.6 ZNF726 ZNF92P3 ENSG00000213967 "Zinc finger protein 726" A6NNF4 19 23914876-23945159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.2;NK-cell: 3.1" "Group enriched" "Detected in many" 4 "granulocytes: 8.2;NK-cells: 3.1" "Cell line enhanced" "Detected in many" "MOLT-4: 29.6" NA NA "unprognostic (5.40e-2)" "unprognostic (2.27e-1)" "unprognostic (4.41e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.80e-1)" "unprognostic (2.91e-2)" "unprognostic (8.26e-4)" "unprognostic (5.65e-4)" "unprognostic (2.14e-2)" "unprognostic (9.87e-3)" "unprognostic (2.90e-2)" "unprognostic (4.25e-2)" "unprognostic (1.64e-1)" "unprognostic (4.97e-2)" "unprognostic (3.20e-3)" 1.2 1.3 2.7 1.8 2.0 5.9 4.2 3.8 2.3 2.9 1.1 1.9 1.2 2.3 5.2 2.4 1.7 2.1 0.8 2.2 2.2 2.2 2.3 1.6 4.3 2.2 2.4 1.8 1.4 0.7 2.1 0.6 3.4 2.7 2.5 3.9 3.2 1.3 2.0 1.6 4.9 1.3 1.0 1.6 2.5 3.0 2.9 2.9 6.1 2.2 1.0 3.4 1.7 2.9 2.8 1.1 1.9 16.3 9.0 1.1 1.1 0.8 4.0 1.4 8.7 8.3 1.4 5.3 0.1 7.5 1.7 6.3 1.2 15.2 0.2 11.8 11.3 8.0 6.6 1.5 0.4 0.6 0.1 3.8 1.2 0.9 5.2 0.3 1.0 0.0 9.5 5.2 0.1 3.3 5.6 29.6 19.8 9.8 0.1 8.4 21.6 12.1 4.8 3.0 6.6 5.4 9.1 0.0 0.1 4.1 7.9 10.5 1.3 1.1 3.1 2.3 13.5 8.5 0.1 9.2 13.1 0.1 2.4 4.5 8.2 0.4 0.2 0.4 0.5 0.2 0.7 1.0 1.0 0.4 1.0 1.0 1.2 0.8 3.1 0.3 1.1 1.2 0.6 2.7 2.0 3.8 2.3 2.2 2.2 2.2 2.4 1.8 2.7 1.6 2.9 2.8 0.6 3.2 0.0 2.9 2.4 0.9 1.6 0.2 0.6 3.8 2.4 1.3 4.5 1.5 1.1 3.7 0.0 7.2 2.9 1.5 1.9 1.4 0.1 1.8 2.4 2.2 0.0 9.0 1.0 0.2 6.7 1.8 0.0 2.6 3.8 5.3 1.4 2.0 2.2 5.0 2.4 0.7 2.0 1.9 2.0 0.3 0.3 1.2 0.0 0.0 0.8 0.6 3.1 5.0 2.9 0.6 0.3 1.9 1.4 0.9 0.1 0.5 2.5 1.2 0.0 1.7 1.7 2.3 6.0 2.0 1.7 4.1 2.4 1.8 0.5 1.5 ZNF99 "C19orf9, MGC24986" ENSG00000213973 "Zinc finger protein 99" A8MXY4 19 22752183-22784151 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Cell type enhanced" "Detected in some" "Oligodendrocyte precursor cells: 5.0;Sertoli cells: 19.7;Spermatocytes: 19.5;Spermatogonia: 8.5" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.31e-2)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-2)" "unprognostic (2.28e-1)" "unprognostic (9.83e-2)" "unprognostic (4.22e-2)" "unprognostic (2.65e-1)" "unprognostic (1.92e-3)" "unprognostic (2.61e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (3.49e-1)" "unprognostic (4.05e-3)" "unprognostic (8.55e-2)" 0.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.1 0.2 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.4 0.4 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.9 0.4 0.4 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.9 0.0 1.1 0.1 1.1 0.4 0.0 0.0 1.2 0.0 0.3 0.7 0.0 0.0 0.0 4.0 0.7 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 5.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 19.7 0.4 0.6 19.5 8.5 0.0 0.0 0.3 0.1 0.4 0.0 0.2 TAX1BP3 TIP-1 ENSG00000213977 "Tax1 binding protein 3" O14907 17 3662895-3668679 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 395.9;Ductal cells: 351.0;Exocrine glandular cells: 385.9;Pancreatic endocrine cells: 505.8;Paneth cells: 362.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 164.3;granulocytes: 217.8;monocytes: 78.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046410, HPA063078" Approved Approved "Nucleoli fibrillar center,Vesicles,Actin filaments" NA NA 120000 "Nucleoli fibrillar center" "Vesicles, Actin filaments" "HPA046410: AB_2679656, HPA063078: AB_2684937" "unprognostic (6.15e-2)" "unprognostic (6.46e-3)" "unprognostic (3.37e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.68e-1)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.80e-2)" "unprognostic (5.45e-3)" "unprognostic (5.19e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (5.12e-2)" "unprognostic (2.10e-1)" "unprognostic (2.10e-3)" "unprognostic (1.92e-1)" 100.3 132.9 62.6 49.7 75.6 16.6 95.2 71.1 67.8 175.3 51.9 107.9 109.8 129.2 33.9 260.6 85.1 91.7 187.0 59.6 59.6 110.6 40.1 95.8 39.6 76.3 75.2 49.3 96.7 81.0 23.7 31.2 53.6 69.0 92.5 78.1 3.7 110.6 106.5 28.9 116.4 120.6 70.9 69.3 52.7 137.7 51.6 65.7 45.0 64.1 33.6 49.4 103.7 161.5 83.2 183.1 319.1 68.4 38.5 219.2 175.6 81.3 223.6 184.5 234.0 136.7 135.9 144.5 19.1 159.1 290.8 77.2 282.6 39.1 205.3 90.8 50.7 64.4 25.9 75.8 106.6 191.1 4.3 37.7 267.6 322.5 145.1 68.9 165.3 266.0 50.1 9.6 14.4 280.1 169.4 52.2 15.1 65.9 116.7 112.6 50.0 41.8 16.3 248.6 141.2 14.7 43.2 276.2 116.2 39.4 67.5 125.3 23.2 269.6 195.3 75.2 154.9 230.2 5.7 2.6 5.5 117.4 30.0 190.3 217.8 65.4 120.4 26.9 78.9 22.2 29.2 25.0 26.6 58.7 25.3 17.3 22.7 73.8 20.0 73.6 164.3 36.7 53.3 62.6 75.6 71.1 67.8 59.6 59.6 76.3 75.2 49.3 69.0 69.3 65.7 83.2 51.5 60.9 25.8 0.0 19.0 95.3 79.7 229.3 99.6 1.6 51.0 28.2 41.5 92.9 107.6 99.3 0.0 124.7 68.5 395.9 88.0 351.0 16.2 12.8 27.3 77.0 24.6 21.4 0.0 385.9 145.3 72.6 43.8 16.1 26.6 21.2 75.3 11.1 69.8 5.0 0.0 120.0 71.2 35.2 73.2 10.5 174.6 64.0 113.8 0.0 85.5 19.8 26.8 0.0 0.0 505.8 362.8 209.9 5.8 89.0 279.2 185.3 26.8 2.6 39.5 44.1 78.6 8.6 12.8 94.5 76.0 155.6 16.1 92.0 103.0 107.9 AP1G2 G2AD ENSG00000213983 "Adaptor related protein complex 1 subunit gamma 2" O75843 14 23559565-23568070 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 108.3;RT4: 151.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004106 Approved NA NA "HPA004106: AB_1078172" "unprognostic (1.94e-3)" "unprognostic (2.49e-1)" "unprognostic (2.56e-2)" "unprognostic (2.73e-2)" "unprognostic (7.34e-2)" "unprognostic (6.61e-2)" "unprognostic (6.61e-2)" "unprognostic (6.28e-3)" "unprognostic (1.16e-1)" "unprognostic (8.65e-3)" "unprognostic (8.85e-2)" "unprognostic (8.40e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.30e-2)" "unprognostic (3.22e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-3)" 11.7 18.2 32.2 23.5 36.3 30.8 20.2 34.8 40.8 21.1 30.0 25.3 28.9 11.8 14.4 35.8 19.9 18.4 5.8 34.9 31.5 26.5 15.2 19.0 39.4 31.8 30.9 33.4 23.2 36.5 25.1 67.9 13.1 33.1 34.1 23.2 9.9 30.0 16.0 2.2 45.5 37.8 10.4 29.0 46.1 35.5 7.5 31.3 30.4 27.4 1.6 43.2 26.5 26.4 32.4 29.1 30.4 0.8 3.1 4.5 7.2 45.5 3.5 8.3 10.3 13.5 28.6 64.8 53.8 15.6 2.8 0.1 53.5 16.2 45.4 7.0 30.0 9.2 20.8 14.5 67.7 16.9 31.6 108.3 20.9 66.0 7.0 24.1 11.2 6.1 37.5 9.2 22.3 4.4 70.8 26.3 28.8 6.9 59.2 11.1 38.9 0.2 16.7 41.3 151.2 8.2 11.5 15.0 68.0 5.6 17.9 40.4 7.8 5.3 2.7 20.2 2.6 0.2 16.2 9.2 21.3 1.2 21.3 3.3 40.6 25.4 43.8 29.5 35.2 28.0 30.7 31.5 31.5 42.5 28.1 25.4 24.8 10.2 38.7 37.0 22.2 42.2 35.6 32.2 36.3 34.8 40.8 34.9 31.5 31.8 30.9 33.4 33.1 29.0 31.3 32.4 9.1 19.2 21.7 6.2 31.4 13.5 18.9 33.1 29.0 31.1 23.7 21.8 0.5 17.2 38.2 12.9 2.1 22.8 23.7 38.7 5.9 30.4 1.1 9.7 4.7 9.7 32.4 9.9 21.5 29.4 24.1 7.1 64.2 15.6 31.7 22.0 6.4 2.5 15.2 72.3 15.7 29.4 42.7 15.2 21.0 1.2 9.3 15.1 10.6 6.5 27.5 8.6 12.3 4.0 4.7 26.6 53.1 6.0 14.0 11.0 33.1 9.6 24.3 6.2 0.0 1.6 5.0 5.8 3.9 16.4 9.8 24.5 30.9 13.9 34.6 23.3 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 0.3 0.2 0.1 0.6 0.3 0.6 0.5 0.8 0.2 0.8 0.1 0.5 0.2 0.9 0.6 0.4 0.8 0.3 0.2 0.1 0.6 0.3 0.1 0.7 1.2 0.2 0.2 0.0 1.5 0.9 1.8 0.3 1.3 0.3 0.6 0.7 0.0 0.3 1.4 0.2 1.1 0.6 0.6 0.1 0.5 0.8 0.6 0.3 0.8 1.9 0.0 0.8 1.0 0.7 0.3 0.0 0.0 3.7 9.5 0.0 0.0 0.0 0.9 0.3 3.3 4.0 3.2 2.3 1.3 1.7 0.6 2.5 1.1 0.0 0.5 5.7 0.0 0.9 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 7.9 17.0 0.0 0.0 0.0 3.1 0.4 2.3 3.3 0.0 3.9 0.0 1.4 0.2 10.5 1.8 0.0 0.0 1.0 0.0 7.0 3.7 0.0 1.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.1 0.6 0.2 0.2 0.0 0.3 0.1 0.3 0.3 2.2 6.4 8.4 1.0 31.7 217.1 112.5 32.7 2.8 0.6 7.8 6.6 1.9 50.1 16.7 7.3 2.1 87.5 25.1 4.8 17.6 2.3 8.2 1.9 4.9 28.8 8.5 26.7 0.5 2.0 99.1 27.6 1.5 4.5 1.3 9.3 54.3 57.1 47.8 0.0 0.7 16.9 14.2 107.1 329.2 24.2 60.9 14.9 124.5 5.6 34.6 2.2 44.3 1.5 2.9 1.2 12.3 34.6 1.8 87.8 8.4 14.0 8.6 2.5 19.7 45.2 451.1 8.6 16.7 1.9 280.3 81.5 40.1 16.0 19.0 66.4 NAXD "CARKD, FLJ10769, LP3298" ENSG00000213995 "NAD(P)HX dehydratase" Q8IW45 13 110615545-110639996 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.8;Distal tubular cells: 39.2;Extravillous trophoblasts: 26.7;Granulosa cells: 27.6;Syncytiotrophoblasts: 30.9;Theca cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010551 Approved NA NA 390000 "HPA010551: AB_1848669" "unprognostic (1.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" "prognostic favorable (3.15e-4)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (3.48e-2)" "unprognostic (2.89e-1)" "unprognostic (3.20e-1)" "unprognostic (9.01e-2)" "unprognostic (1.94e-2)" "unprognostic (4.36e-3)" "prognostic favorable (4.63e-5)" "unprognostic (2.19e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.62e-2)" 17.5 37.5 42.3 16.1 41.9 8.3 19.6 41.6 46.7 16.8 38.4 20.7 23.1 18.9 26.9 23.6 22.8 21.5 26.7 43.4 42.2 25.1 65.9 18.9 21.0 44.3 43.4 41.0 39.4 36.5 28.7 22.6 23.5 42.8 26.0 19.9 14.4 23.0 29.2 32.2 30.7 23.1 21.9 42.4 22.0 30.6 24.4 43.4 18.5 25.7 33.9 17.3 17.4 15.1 43.3 36.0 15.7 28.1 24.3 29.8 23.6 35.4 27.9 22.7 24.6 26.2 43.9 35.1 7.3 28.4 21.7 25.3 28.1 16.3 24.4 16.0 31.6 27.4 22.5 47.9 23.5 34.2 29.3 20.2 29.1 42.4 19.8 17.7 32.5 21.9 31.8 19.6 0.2 22.3 30.0 23.1 48.4 21.2 64.4 17.2 8.2 14.4 5.9 30.3 30.1 42.5 28.6 16.8 75.4 21.6 18.5 39.7 54.4 25.3 17.1 14.3 0.1 22.4 25.6 18.7 0.3 27.7 8.7 28.9 0.0 8.3 0.8 9.6 9.0 6.3 8.4 9.6 8.9 10.4 8.2 9.9 9.1 1.0 9.2 6.5 10.1 10.5 8.3 42.3 41.9 41.6 46.7 43.4 42.2 44.3 43.4 41.0 42.8 42.4 43.4 43.3 9.3 19.2 12.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 14.2 11.3 0.0 0.0 9.9 22.0 0.0 34.8 5.4 0.0 39.2 15.0 0.0 7.3 10.5 4.0 0.0 0.0 0.0 11.8 26.7 6.2 0.0 8.8 1.3 27.6 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.6 0.0 0.0 2.1 0.0 0.0 22.4 8.7 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 30.9 2.1 24.4 0.0 0.0 TM6SF2 Lpr4 ENSG00000213996 "Transmembrane 6 superfamily member 2" Q9BZW4 19 19264364-19273391 "Predicted membrane proteins, Transporters" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "intestine: 76.2;liver: 33.9" "Cell type enriched" "Detected in some" 6 "Proximal enterocytes: 231.1" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8" "Low region specificity" "Detected in single" HPA066026 Uncertain NA NA "HPA066026: AB_2685598" "unprognostic (2.41e-1)" "unprognostic (4.81e-3)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (3.29e-1)" "unprognostic (2.35e-1)" "unprognostic (1.39e-3)" "unprognostic (4.00e-2)" "unprognostic (4.15e-2)" "unprognostic (4.53e-4)" "unprognostic (9.55e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.56e-2)" "unprognostic (1.51e-1)" "unprognostic (6.15e-2)" 0.2 0.4 0.2 0.1 0.2 0.0 0.2 0.2 0.5 0.9 0.4 2.0 76.2 0.6 0.2 0.1 0.3 0.5 0.4 0.2 0.6 3.2 33.9 0.4 0.1 0.3 0.3 0.2 0.0 0.1 0.2 0.6 0.5 0.2 0.6 2.1 0.0 0.1 0.3 0.0 0.1 69.4 0.3 0.1 0.1 2.4 0.1 0.3 0.0 0.1 0.1 0.0 0.2 0.5 0.2 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.8 0.4 0.4 0.5 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.4 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.2 0.6 0.3 0.3 0.2 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.9 0.0 0.0 0.2 1.8 0.1 0.0 0.0 0.8 0.2 0.3 1.2 21.4 0.1 4.5 0.0 1.1 35.6 0.1 0.0 1.1 8.6 0.0 0.3 0.4 0.0 0.6 0.0 1.8 1.0 0.0 0.0 0.0 3.5 0.1 0.1 29.7 0.4 0.0 0.0 231.1 5.5 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.1 0.1 0.1 0.1 0.1 9.6 0.0 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145567-19192131 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 39.6" "Cell type enriched" "Detected in some" 4 "Plasma cells: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "Daudi: 223.4;U-266/70: 217.6;U-698: 299.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 3.0 1.8 4.2 14.0 4.2 2.3 2.6 3.6 6.2 4.0 3.4 2.8 1.8 2.3 0.7 2.2 3.5 1.4 2.0 3.4 3.7 2.7 3.8 2.6 39.6 4.6 3.9 2.7 3.9 1.5 0.4 2.6 1.0 4.2 4.5 1.1 1.0 2.7 1.4 1.0 2.8 5.0 1.3 3.6 8.8 2.6 3.2 3.8 1.8 3.5 0.7 31.7 2.4 3.3 5.3 2.3 0.5 1.5 2.1 1.3 2.5 2.2 1.3 0.9 1.8 2.2 0.0 3.2 223.4 1.0 0.9 0.5 2.0 0.3 0.8 0.3 1.0 5.1 1.4 0.6 1.1 2.8 1.2 2.0 1.0 1.8 1.1 1.6 1.0 0.1 4.2 0.9 3.9 0.8 3.9 1.6 1.8 0.2 0.2 12.8 4.6 0.9 5.2 0.5 0.3 0.3 1.8 2.5 0.3 1.7 0.0 0.0 2.5 0.7 1.1 4.0 6.9 1.8 217.6 24.0 299.5 2.6 3.9 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 4.2 4.2 3.6 6.2 3.4 3.7 4.6 3.9 2.7 4.2 3.6 3.8 5.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 29.3 0.0 0.0 0.0 0.0 0.0 6.6 0.0 1.4 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016949, HPA051522" Approved Approved Cytosol NA NA Cytosol "HPA016949: AB_1849465, HPA051522: " "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favorable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 9.0 7.6 7.8 10.4 12.1 14.5 8.9 10.0 9.3 9.2 9.9 10.7 8.9 11.1 18.0 12.3 8.7 9.5 8.6 7.2 11.8 9.5 13.4 20.6 10.1 11.7 10.5 6.4 13.1 8.5 11.4 7.9 8.1 12.7 8.6 12.6 9.8 14.6 8.8 13.1 10.1 9.9 9.9 10.1 12.0 8.6 12.4 10.2 10.4 12.2 10.7 10.3 8.3 9.3 18.9 9.0 4.9 10.7 11.6 12.3 17.2 7.1 19.2 19.7 19.7 16.4 6.4 6.2 4.9 10.2 18.6 14.3 18.3 12.6 19.5 13.6 12.3 6.0 11.9 12.1 12.8 10.4 11.6 10.1 11.8 11.4 8.1 13.6 11.7 13.5 12.0 12.6 13.0 15.8 1.7 7.9 12.7 6.7 4.3 5.5 14.7 12.4 17.0 14.7 8.4 8.2 11.7 10.8 9.4 7.0 5.6 3.3 27.0 13.6 21.6 5.7 17.8 12.1 13.9 20.7 9.7 10.4 20.9 12.1 16.8 11.8 10.2 4.5 13.1 6.2 19.6 7.2 8.6 15.5 23.1 8.9 5.4 6.7 5.7 10.9 12.3 7.3 6.5 7.8 12.1 10.0 9.3 7.2 11.8 11.7 10.5 6.4 12.7 10.1 10.2 18.9 6.2 19.2 47.9 35.6 14.5 10.5 17.1 7.9 12.0 5.6 5.6 6.2 8.2 4.3 8.9 1.8 10.4 5.3 4.0 9.5 5.9 5.9 18.6 7.7 11.1 5.0 4.2 5.0 18.9 3.8 5.1 8.1 9.7 11.9 10.8 8.1 5.7 12.4 6.5 3.3 28.5 5.7 10.2 11.7 5.4 4.7 7.2 10.9 14.2 36.5 14.0 9.5 7.2 31.7 86.7 5.4 15.7 6.4 7.1 9.1 7.9 7.7 9.8 8.5 13.1 9.2 7.0 20.5 15.7 18.9 5.3 2.9 6.9 6.4 8.5 20.7 TTLL3 "DKFZP434B103, HOTTL" ENSG00000214021 "Tubulin tyrosine ligase like 3" Q9Y4R7 3 9808086-9855138 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.9" "Low region specificity" "Detected in all" HPA051413 Approved NA NA "HPA051413: AB_2681476" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" "unprognostic (7.23e-3)" "unprognostic (2.08e-1)" "unprognostic (4.96e-1)" "unprognostic (4.04e-4)" "unprognostic (3.14e-2)" "unprognostic (4.39e-2)" "unprognostic (7.71e-2)" "unprognostic (6.83e-2)" "unprognostic (5.46e-3)" "unprognostic (1.08e-2)" "prognostic unfavorable (6.45e-6)" "unprognostic (1.77e-2)" "unprognostic (2.09e-1)" "unprognostic (2.82e-1)" "prognostic favorable (9.51e-6)" 29.2 23.9 25.2 12.5 25.9 31.2 27.7 23.7 30.9 53.2 29.5 27.1 11.6 29.2 16.7 16.1 37.6 25.5 22.4 23.8 29.4 25.1 10.0 25.0 23.2 28.8 26.5 22.5 63.5 17.6 11.1 37.8 12.9 27.9 40.1 13.2 8.6 20.3 30.7 11.9 41.4 23.0 20.5 27.2 29.6 19.5 41.1 26.2 13.3 27.5 12.7 15.2 31.0 40.3 29.4 2.0 5.1 10.9 2.1 19.2 36.4 63.9 6.7 6.5 3.6 4.9 8.7 7.7 11.7 5.8 12.5 3.6 3.0 6.9 1.3 2.2 13.6 19.7 14.2 17.6 8.9 6.6 12.9 24.1 23.6 9.2 6.9 2.7 20.8 6.2 17.6 14.0 28.0 8.0 7.0 2.3 20.3 1.4 1.3 2.9 6.7 4.4 5.2 5.4 14.9 5.1 4.6 3.4 1.8 5.8 5.3 4.9 8.9 20.2 9.6 12.4 9.2 3.2 17.8 8.6 16.8 8.0 18.9 3.4 5.9 2.1 6.6 2.3 5.9 1.1 2.8 1.6 1.2 2.7 2.7 1.8 1.5 8.5 2.3 3.5 3.0 2.9 0.9 25.2 25.9 23.7 30.9 23.8 29.4 28.8 26.5 22.5 27.9 27.2 26.2 29.4 11.7 12.8 9.1 0.0 5.6 5.2 5.1 6.7 9.1 11.1 6.0 6.5 3.3 1.5 8.5 9.2 25.0 5.4 12.0 11.7 0.0 4.3 29.1 16.5 14.2 10.1 12.0 1.7 0.0 6.7 5.4 14.9 27.0 10.5 8.2 13.6 9.3 1.6 5.3 6.7 0.0 11.9 2.0 14.4 5.7 17.8 22.7 9.2 10.6 0.0 7.9 9.4 11.3 0.0 0.0 7.4 8.2 12.4 4.0 6.6 3.0 2.2 28.7 13.8 13.1 11.6 8.8 15.1 6.7 4.1 4.7 5.1 7.5 9.5 8.5 7.3 REPIN1 "AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464" ENSG00000214022 "Replication initiator 1" Q9BWE0 7 150368189-150374044 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 7.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 246.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036022 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA036022: AB_10610417" "unprognostic (2.73e-1)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (7.50e-3)" "unprognostic (5.42e-2)" "unprognostic (7.00e-3)" "unprognostic (1.52e-2)" "unprognostic (6.88e-3)" "unprognostic (6.68e-2)" "unprognostic (6.59e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.40e-2)" "prognostic favorable (5.56e-4)" "prognostic favorable (1.61e-4)" "unprognostic (1.79e-1)" "unprognostic (2.02e-3)" "prognostic favorable (6.41e-4)" 28.5 77.9 46.0 25.4 40.3 44.5 35.4 41.0 45.1 28.4 46.1 60.1 42.6 37.8 32.1 37.7 41.2 14.7 58.4 35.4 36.9 49.6 87.3 31.9 36.0 49.5 43.5 31.6 37.6 68.2 35.8 70.3 12.2 49.4 49.6 28.5 23.9 42.0 24.1 135.6 31.9 56.9 15.5 39.2 56.6 53.5 18.4 45.7 41.4 45.4 66.8 25.0 42.8 25.2 40.9 59.4 71.3 66.1 81.5 15.8 11.3 40.2 28.7 35.2 27.6 23.8 55.5 37.6 65.5 70.9 20.6 48.0 43.4 36.4 11.4 13.9 72.0 54.8 38.4 40.3 70.4 52.3 68.4 60.1 14.7 34.1 15.2 3.5 26.1 39.4 39.1 93.5 39.9 23.1 76.7 95.1 77.4 69.5 39.7 69.9 51.8 76.4 246.3 29.4 103.7 96.9 123.7 43.3 107.5 75.8 27.2 52.8 54.2 42.1 21.2 17.4 23.6 58.7 115.4 46.1 59.8 37.1 59.9 53.3 0.0 1.4 2.7 0.8 0.7 1.3 2.5 1.8 1.5 2.2 2.4 2.3 1.1 1.4 1.8 0.3 7.8 0.8 0.9 46.0 40.3 41.0 45.1 35.4 36.9 49.5 43.5 31.6 49.4 39.2 45.7 40.9 21.1 35.3 18.6 17.9 26.9 9.4 18.3 11.5 14.8 57.9 39.3 33.1 46.5 45.8 15.0 14.7 41.7 28.0 49.5 53.7 62.6 37.3 7.8 53.4 14.3 24.3 68.1 14.5 13.0 50.3 12.9 16.1 23.4 35.8 24.7 56.3 26.0 69.7 32.0 80.8 15.8 68.6 32.6 14.8 23.9 9.8 22.1 21.8 16.0 9.4 88.4 101.3 40.2 17.6 16.6 34.3 37.1 19.9 26.4 31.6 47.0 32.8 36.2 55.8 6.6 28.0 20.1 10.2 3.1 17.6 17.8 25.6 16.0 33.5 109.7 19.9 MRPL23 "L23MRP, RPL23L" ENSG00000214026 "Mitochondrial ribosomal protein L23" Q16540 11 1947278-1984522 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 342.1" HPA050406 Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (2.40e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-2)" "unprognostic (8.32e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (1.82e-1)" "unprognostic (6.33e-2)" "unprognostic (7.23e-3)" "unprognostic (4.08e-2)" 67.1 124.1 16.6 16.5 17.7 42.8 66.9 17.6 26.2 61.9 17.9 65.6 27.4 54.5 14.4 126.9 58.3 11.0 122.1 17.1 17.6 97.0 141.2 68.0 27.0 17.6 17.0 16.6 91.5 119.0 23.7 93.1 8.6 18.3 72.4 19.3 7.0 91.1 14.7 160.8 121.5 67.7 13.2 17.5 82.4 95.0 27.3 17.6 17.9 72.1 40.0 24.1 60.3 71.5 19.0 69.3 74.9 39.7 49.2 15.9 44.0 67.4 20.9 28.0 31.8 23.4 4.8 79.2 72.9 43.6 44.4 44.5 70.6 64.5 88.8 15.0 75.4 342.1 28.1 24.5 98.2 41.7 65.2 40.8 34.9 34.0 22.0 6.4 37.3 23.0 38.3 24.9 34.6 46.5 71.4 57.9 55.8 64.1 58.5 71.9 77.7 27.2 92.0 28.4 25.0 86.5 81.6 25.0 56.2 45.6 22.0 1.4 78.1 30.8 43.6 32.4 11.0 44.0 58.4 47.7 68.7 68.2 56.0 0.1 2.7 18.5 16.8 8.0 14.5 6.4 36.4 11.8 9.4 23.9 34.6 25.7 8.1 1.0 8.3 10.4 10.6 20.0 5.2 16.6 17.7 17.6 26.2 17.1 17.6 17.6 17.0 16.6 18.3 17.5 17.6 19.0 33.9 12.8 6.3 17.0 79.1 186.3 69.9 154.6 19.4 7.0 105.4 111.6 69.7 95.8 88.7 38.6 0.0 125.3 43.6 298.1 123.3 126.6 10.2 57.9 29.1 37.5 136.2 117.8 9.4 232.6 224.4 43.3 54.6 40.2 96.6 54.7 57.8 178.9 178.5 5.0 9.9 258.7 99.7 163.9 214.3 18.5 23.0 78.4 200.9 3.7 133.6 30.6 63.8 7.5 12.2 171.1 273.6 36.5 76.8 61.9 175.4 245.0 98.7 11.7 39.5 33.5 69.2 24.4 39.8 47.5 258.7 90.6 50.2 67.0 256.1 82.8 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133104779-133130274 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.4;Early spermatids: 70.4;Horizontal cells: 40.4;Rod photoreceptor cells: 32.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 0.9 1.7 1.4 1.0 1.7 1.3 2.0 3.4 1.5 1.3 0.9 0.9 0.9 2.1 1.4 1.2 1.4 0.9 0.8 1.5 1.2 1.2 0.8 0.9 1.3 1.4 1.4 1.3 2.3 0.9 1.3 1.4 1.0 1.6 1.2 1.1 4.8 1.1 1.1 1.0 1.7 0.9 1.5 0.9 1.2 1.0 4.2 1.4 1.3 1.8 1.4 1.3 0.8 0.9 2.9 1.1 1.4 4.1 0.1 1.4 1.9 3.5 0.8 1.2 2.2 1.7 0.9 0.6 0.1 1.1 1.2 2.6 1.6 3.0 1.8 1.6 0.0 2.3 3.7 3.7 1.2 1.4 2.3 1.9 1.4 0.9 2.0 2.0 2.0 1.4 3.0 2.4 0.3 2.2 0.8 3.4 2.6 3.5 2.2 2.0 3.4 3.8 2.4 1.0 2.2 3.5 1.5 3.0 0.6 1.0 3.0 2.9 1.3 0.8 2.0 2.4 1.5 1.5 0.2 0.1 3.4 0.5 0.9 1.5 0.5 0.3 0.6 0.9 0.3 0.7 1.1 0.7 0.9 0.3 1.3 1.3 1.3 0.4 1.0 0.3 0.6 0.9 0.4 1.4 1.7 3.4 1.5 1.5 1.2 1.4 1.4 1.3 1.6 0.9 1.4 2.9 6.4 3.2 5.3 2.0 14.3 1.8 5.9 2.3 2.8 31.4 3.2 3.9 5.7 5.7 6.7 11.0 29.2 3.4 5.2 1.1 0.0 3.9 70.4 6.6 11.9 5.9 6.7 4.0 2.8 1.9 2.3 6.2 3.6 5.6 1.3 16.7 6.8 2.0 2.0 40.4 3.4 2.4 0.0 2.8 0.8 10.0 5.3 4.3 1.8 1.9 2.7 10.6 10.3 3.5 3.6 1.8 2.1 6.0 2.7 3.7 2.4 2.2 9.5 32.4 19.7 11.2 8.4 14.2 14.1 3.0 1.7 2.3 6.5 8.9 3.2 2.4 IFNA7 "IFN-alphaJ, IFNA-J" ENSG00000214042 "Interferon alpha 7" P01567 9 21201469-21202205 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM7 "C19orf42, MGC2747" ENSG00000214046 "Small integral membrane protein 7" Q9BQ49 19 16630751-16660442 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043127 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA043127: AB_10806378" "unprognostic (6.61e-2)" "unprognostic (1.61e-2)" "unprognostic (1.90e-1)" "unprognostic (3.71e-2)" "unprognostic (2.52e-1)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "unprognostic (1.79e-2)" "unprognostic (6.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-1)" "unprognostic (1.76e-3)" "unprognostic (8.29e-3)" "unprognostic (2.94e-1)" "unprognostic (2.29e-1)" "unprognostic (8.38e-2)" "unprognostic (7.64e-2)" 42.0 39.9 38.7 25.0 40.4 20.1 47.6 40.6 48.9 37.1 39.3 34.5 34.7 32.8 73.5 30.3 37.2 30.8 36.2 37.1 39.8 53.2 67.3 33.8 34.0 41.7 40.4 35.8 32.5 48.1 54.5 16.3 34.9 40.5 46.9 42.4 18.8 52.7 39.6 18.9 32.4 25.6 36.7 42.8 27.0 38.6 21.2 39.7 29.5 50.5 21.2 34.3 33.1 18.1 44.0 60.6 52.1 48.7 42.3 74.4 64.4 48.9 50.4 69.4 70.7 68.8 45.2 111.8 44.4 67.7 69.3 50.5 48.0 44.5 69.8 86.7 38.1 34.4 42.4 34.9 48.5 43.3 64.2 46.5 49.3 49.8 51.5 52.9 43.0 68.9 40.3 59.9 53.7 81.6 120.2 42.4 55.1 45.2 121.5 77.4 41.3 32.9 43.4 83.4 66.3 26.0 48.2 37.8 41.0 51.2 26.8 59.9 80.5 41.5 55.4 35.7 130.3 83.2 46.4 72.6 56.0 56.3 75.6 71.2 47.5 73.3 38.3 37.1 65.8 35.3 49.6 38.0 37.0 58.8 44.3 37.0 33.6 31.0 42.8 78.3 79.2 44.9 45.3 38.7 40.4 40.6 48.9 37.1 39.8 41.7 40.4 35.8 40.5 42.8 39.7 44.0 63.5 67.3 64.5 29.0 75.5 34.2 62.8 114.3 70.6 70.1 69.0 84.6 38.5 57.2 68.8 57.0 95.9 144.1 68.5 67.6 129.1 85.2 18.4 58.2 60.8 61.5 73.0 54.7 35.3 86.3 105.2 74.9 57.1 51.5 50.1 42.3 66.0 85.7 115.6 63.9 32.1 78.3 77.3 77.2 43.9 21.6 88.9 64.6 48.0 21.5 102.4 101.3 98.9 21.6 44.8 87.6 87.0 83.1 76.5 77.6 85.1 140.0 54.6 121.4 72.3 42.3 64.8 84.0 81.0 74.7 35.8 156.4 54.7 66.7 62.7 57.7 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490278 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 18.6;pituitary gland: 17.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Excitatory neurons: 44.4;Inhibitory neurons: 43.6;Rod photoreceptor cells: 48.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "plasmacytoid DC: 9.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 9.6" "Cell line enhanced" "Detected in many" "AF22: 20.3;Karpas-707: 22.4" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.5 1.8 4.0 0.9 5.6 2.2 2.6 7.1 7.0 4.2 3.9 1.6 2.0 1.1 18.6 0.7 4.5 1.4 1.1 5.0 4.9 3.2 6.0 1.5 1.4 2.4 2.5 5.3 0.7 4.7 7.2 17.4 0.6 3.2 3.5 2.0 14.4 3.4 5.1 1.1 0.3 2.9 0.7 0.3 1.2 2.2 4.2 4.2 0.6 7.1 0.9 2.9 1.2 0.7 5.8 16.5 2.9 20.3 7.5 0.5 0.0 0.3 0.2 0.5 3.0 5.5 3.1 4.6 5.8 7.2 0.1 8.1 5.1 2.3 3.5 3.0 2.6 3.6 2.7 0.3 1.7 0.0 3.5 1.9 0.2 10.8 0.7 3.2 1.5 0.0 5.6 1.1 22.4 1.0 5.7 0.5 5.0 3.9 2.2 4.5 0.2 4.5 8.2 3.9 2.4 13.1 5.4 0.4 3.3 9.5 3.5 13.8 5.9 0.6 1.6 5.8 3.2 3.0 5.2 5.0 5.2 6.8 0.7 3.5 0.3 0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.7 0.2 0.1 0.2 0.9 0.0 0.1 9.6 0.2 0.1 4.0 5.6 7.1 7.0 5.0 4.9 2.4 2.5 5.3 3.2 0.3 4.2 5.8 0.0 3.2 4.1 7.5 1.7 0.1 3.0 10.9 5.2 8.2 3.9 3.4 2.1 8.6 7.9 3.7 35.5 0.6 0.0 0.5 7.9 5.3 12.1 13.5 1.3 0.2 10.2 0.0 44.4 4.6 0.4 0.9 1.5 6.4 0.0 1.9 0.4 1.9 2.7 5.0 43.6 3.9 4.1 0.8 2.3 12.4 1.2 0.4 0.0 2.8 0.0 9.3 0.0 23.6 3.2 3.1 0.4 0.7 11.1 1.7 0.2 4.7 23.4 48.6 0.0 0.5 1.8 10.5 5.6 1.2 0.0 0.0 0.5 4.2 1.0 1.7 TSPAN4 "NAG-2, TETRASPAN, TM4SF7, TSPAN-4" ENSG00000214063 "Tetraspanin 4" O14817 11 842812-867116 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 194.2;Fibroblasts: 168.7;Hofbauer cells: 240.6;Leydig cells: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 146.4;intermediate monocyte: 143.5;myeloid DC: 101.2;NK-cell: 95.6;non-classical monocyte: 39.9" "Group enriched" "Detected in all" 10 "dendritic cells: 101.2;monocytes: 146.4;NK-cells: 95.6" "Low cell line specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 142.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.39e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (9.49e-2)" "unprognostic (2.41e-2)" "unprognostic (1.29e-2)" "unprognostic (2.61e-2)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" 128.6 37.4 14.0 29.9 12.0 12.0 102.9 15.6 18.8 88.6 38.1 53.2 13.8 84.9 9.3 26.3 86.5 54.6 57.4 13.6 20.0 60.9 37.9 102.3 46.7 14.8 13.2 11.3 92.1 32.8 17.7 24.4 62.1 13.2 53.4 10.6 2.5 34.5 34.0 25.9 53.0 43.7 27.7 13.2 85.7 37.3 17.0 15.4 13.3 80.6 23.1 12.9 67.4 72.4 12.1 30.7 238.7 40.8 73.6 61.2 121.4 27.5 153.0 182.5 118.4 81.3 49.5 37.5 2.3 60.4 221.3 68.2 11.3 14.5 145.6 22.2 20.4 17.4 32.5 75.7 71.6 201.4 10.4 38.9 211.5 26.1 42.8 129.0 116.1 78.5 12.5 13.5 184.5 115.8 64.6 7.0 13.0 52.3 39.2 172.7 24.2 29.1 55.4 138.3 2.0 48.0 28.6 75.8 83.6 162.1 17.4 118.5 7.7 116.0 134.2 53.4 27.3 52.2 10.2 1.5 4.5 138.5 11.1 121.8 0.1 146.4 0.1 7.4 143.5 4.6 6.9 3.7 7.2 101.2 5.4 6.2 11.7 3.4 95.6 39.9 7.0 3.6 65.2 14.0 12.0 15.6 18.8 13.6 20.0 14.8 13.2 11.3 13.2 13.2 15.4 12.1 194.2 105.8 68.5 6.5 5.6 47.5 22.2 78.8 13.6 9.5 19.4 38.6 9.5 74.4 24.6 31.3 4.2 39.5 8.1 1.7 7.9 82.6 2.1 5.9 43.2 117.3 0.0 12.0 0.6 16.7 31.9 168.7 5.6 10.8 37.2 62.8 97.5 28.2 240.6 13.5 2.9 2.6 4.1 109.9 71.5 7.3 172.7 70.3 147.7 11.2 19.2 43.8 8.2 2.5 0.3 61.3 0.3 95.2 9.3 15.7 0.3 34.7 5.8 6.7 59.2 23.9 67.5 4.7 31.5 6.1 32.8 16.8 10.2 44.7 1.1 6.1 CPNE1 CPN1 ENSG00000214078 "Copine 1" Q99829 20 35626031-35664956 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065876, HPA072634" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA 300000 "Nucleoplasm, Nuclear membrane" "HPA065876: , HPA072634: AB_2686541" "unprognostic (5.94e-2)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.74e-10)" "unprognostic (3.10e-1)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" 59.6 48.3 15.4 51.0 14.8 71.6 59.0 14.2 16.7 68.1 16.9 60.8 32.8 74.8 59.0 59.2 63.0 48.7 36.9 15.0 16.2 44.2 39.0 60.1 52.8 16.5 14.3 16.2 65.3 48.8 38.9 52.5 70.4 14.9 52.8 47.8 17.8 52.0 42.3 44.1 63.2 63.4 70.9 14.6 78.9 51.4 25.7 15.3 83.6 60.7 33.9 82.5 65.0 60.3 19.2 264.1 202.5 112.0 47.3 14.3 18.6 85.4 123.9 219.8 295.0 192.1 590.5 111.2 181.6 115.8 185.3 251.6 98.1 88.1 233.7 182.8 34.7 65.7 459.1 149.9 440.5 131.9 151.5 61.9 121.6 235.8 118.1 139.0 178.9 188.1 183.9 61.4 90.3 144.0 142.9 226.0 201.9 27.8 264.2 187.6 159.1 334.0 125.4 119.9 183.9 78.9 87.9 277.2 129.6 188.1 31.1 134.3 148.8 123.6 306.6 56.4 101.3 131.6 61.5 66.9 126.9 222.7 81.8 69.6 53.6 102.9 180.5 119.3 100.5 164.8 120.8 115.2 112.5 143.7 113.8 111.3 113.6 140.4 206.7 98.8 78.0 153.7 164.5 15.4 14.8 14.2 16.7 15.0 16.2 16.5 14.3 16.2 14.9 14.6 15.3 19.2 47.0 19.2 37.3 33.6 55.2 55.1 71.8 82.3 44.9 34.6 40.2 46.0 15.7 32.9 56.5 25.8 20.9 125.1 73.4 26.8 25.4 72.7 39.6 23.3 44.1 53.2 33.6 42.5 37.2 37.8 76.7 56.2 25.0 28.3 48.2 59.9 34.6 23.3 62.4 21.9 33.7 30.8 81.4 43.0 79.6 9.6 54.7 45.5 48.0 30.0 85.0 24.8 62.8 32.6 39.4 44.2 34.0 61.7 60.2 78.6 38.2 34.8 33.9 18.1 46.0 47.0 55.0 13.1 22.9 41.4 49.0 106.3 77.0 65.9 41.2 71.7 ARL16 ENSG00000214087 "ADP ribosylation factor like GTPase 16" 17 81681187-81683797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043711 Uncertain NA NA "HPA043711: AB_10964639" "unprognostic (1.73e-2)" "unprognostic (1.92e-2)" "unprognostic (3.20e-1)" "unprognostic (5.73e-3)" "unprognostic (5.73e-2)" "unprognostic (1.24e-1)" "unprognostic (6.60e-3)" "unprognostic (1.05e-1)" "unprognostic (1.26e-2)" "unprognostic (3.23e-1)" "unprognostic (1.17e-2)" "unprognostic (5.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.44e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 25.8 23.8 24.1 7.6 25.5 13.3 26.9 23.8 27.4 28.7 21.5 24.4 8.4 25.5 18.0 22.2 23.4 13.5 22.6 25.8 23.6 39.6 20.3 18.5 13.6 23.5 23.0 25.1 27.4 22.1 18.3 19.0 17.9 22.9 25.9 8.4 13.9 21.1 14.3 23.8 24.5 17.0 11.2 23.6 19.3 22.1 25.5 23.2 16.3 22.7 19.1 10.9 26.9 24.9 25.0 23.2 36.0 39.6 46.4 18.7 24.3 22.6 46.3 43.3 55.0 42.5 42.9 23.7 22.4 28.5 43.1 39.7 21.3 32.6 33.9 32.6 19.9 58.0 24.9 29.5 20.0 52.7 54.8 18.9 29.5 19.1 42.0 40.8 39.8 35.2 28.6 19.7 19.2 36.3 21.5 52.0 57.5 32.4 27.7 43.4 57.7 37.6 15.2 40.2 30.1 71.5 72.5 30.5 18.5 48.5 33.0 24.9 49.2 40.2 74.9 38.5 40.4 56.1 28.0 12.8 43.7 44.7 29.5 42.3 41.8 27.0 27.6 21.1 25.3 25.8 43.2 19.9 19.5 23.4 52.4 31.9 24.2 15.1 41.9 21.3 32.1 20.3 22.5 24.1 25.5 23.8 27.4 25.8 23.6 23.5 23.0 25.1 22.9 23.6 23.2 25.0 39.1 25.6 30.9 6.2 32.7 37.7 28.7 64.2 36.5 37.1 47.9 61.1 20.1 38.6 48.4 44.1 31.3 64.6 41.8 49.2 60.7 48.4 10.4 44.0 31.1 35.4 36.1 21.5 13.4 44.5 47.5 38.5 60.1 35.1 21.5 44.2 29.3 21.2 35.0 21.9 10.6 37.5 42.7 20.0 34.9 8.8 40.7 26.1 33.8 7.5 41.1 43.3 43.3 14.1 11.3 43.9 39.7 44.0 29.4 38.8 60.7 86.1 40.9 38.9 52.6 22.4 41.7 66.5 50.3 34.7 34.7 38.6 33.8 54.7 45.4 31.4 SMCO1 "C3orf43, DKFZp313B0440, FLJ41923" ENSG00000214097 "Single-pass membrane protein with coiled-coil domains 1" Q147U7 3 196506879-196515346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "heart muscle: 38.9;skeletal muscle: 150.6;tongue: 107.9" "Cell type enriched" "Detected in some" 34 "Cardiomyocytes: 89.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061937 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA061937: AB_2684642" "unprognostic (4.86e-2)" "unprognostic (1.62e-1)" "unprognostic (1.51e-2)" "unprognostic (6.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-2)" "unprognostic (2.95e-1)" "unprognostic (2.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.6 2.4 0.0 0.0 38.9 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.7 0.0 0.1 0.7 0.0 150.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 107.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WEE2 "FLJ16107, WEE1B" ENSG00000214102 "WEE2 oocyte meiosis inhibiting kinase" P0C1S8 7 141708353-141731271 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Meiosis "Kinase, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Distal tubular cells: 1.9;Proximal tubular cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "CACO-2: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA027418, HPA054280" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027418: AB_10603144, HPA054280: " "unprognostic (6.35e-2)" "unprognostic (1.47e-1)" "unprognostic (1.89e-1)" "unprognostic (3.18e-1)" "unprognostic (2.33e-1)" "unprognostic (4.00e-2)" "unprognostic (2.90e-1)" "unprognostic (1.97e-2)" "unprognostic (3.23e-2)" "unprognostic (3.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.76e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-2)" "unprognostic (2.66e-1)" "unprognostic (6.07e-2)" "unprognostic (2.88e-3)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.1 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.7 0.1 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB1 "CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322" ENSG00000214107 "MAGE family member B1" P43366 X 30243730-30252040 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "testis: 15.6" "Group enriched" "Detected in some" 9 "Spermatocytes: 14.2;Spermatogonia: 14.6" "Cancer enriched" "Detected in some" 9 "testis cancer: 7.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 70 "K-562: 25.1;U-266/70: 53.8;U-266/84: 40.5" "HPA001193, HPA002820" Enhanced NA NA "HPA001193: AB_1079296, HPA002820: AB_1079295" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 53.8 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYRM4 "C6orf149, CGI-203, ISD11" ENSG00000214113 "LYR motif containing 4" Q9HD34 6 5103629-5260950 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030362 Approved Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA030362: AB_10601546" "unprognostic (2.41e-2)" "unprognostic (3.72e-2)" "unprognostic (7.68e-2)" "unprognostic (8.58e-2)" "unprognostic (1.30e-1)" "unprognostic (8.73e-2)" "unprognostic (1.85e-3)" "unprognostic (4.58e-2)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-3)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (9.80e-2)" "unprognostic (5.23e-1)" 16.1 18.9 23.2 14.8 22.9 19.2 19.2 21.9 31.2 16.3 23.9 13.3 7.7 18.3 18.3 13.5 19.3 11.3 20.7 22.7 22.8 14.7 13.7 12.2 23.1 23.3 22.6 22.7 27.3 19.6 16.1 20.6 14.3 23.3 12.4 16.4 16.0 13.1 10.3 14.5 16.9 10.5 16.7 23.0 16.0 14.2 16.2 22.1 21.0 19.7 11.1 22.0 17.1 14.3 24.4 28.9 27.4 41.1 32.0 41.3 60.1 37.1 27.1 44.0 36.9 38.0 57.8 19.2 44.7 51.7 35.8 51.6 25.4 58.9 34.2 41.0 79.4 45.9 19.7 20.9 77.4 25.9 52.2 19.2 47.9 53.1 33.1 43.3 34.9 35.8 42.4 64.3 15.2 32.1 15.6 49.6 70.5 39.6 45.9 42.1 49.2 30.8 82.2 38.6 23.4 55.2 35.6 23.8 14.6 65.5 58.6 39.8 44.7 29.5 39.2 26.3 32.9 44.8 22.4 82.4 42.7 19.0 36.6 54.2 1.9 18.8 2.1 11.7 19.8 15.6 31.3 17.5 13.3 34.4 26.2 26.6 24.6 4.3 23.6 17.5 23.0 19.1 17.6 23.2 22.9 21.9 31.2 22.7 22.8 23.3 22.6 22.7 23.3 23.0 22.1 24.4 75.6 25.6 16.2 28.4 45.0 73.5 55.6 80.9 25.0 16.4 51.9 48.4 29.1 28.6 33.9 18.4 8.4 49.5 23.0 12.3 31.3 44.1 38.8 26.0 29.3 40.3 32.3 32.0 103.4 43.8 72.2 37.6 11.2 19.0 41.3 39.6 41.7 35.9 65.2 11.8 57.4 26.5 32.6 46.8 93.0 91.7 46.3 31.7 69.4 32.8 74.2 45.1 23.7 80.4 50.8 34.1 15.3 35.3 32.6 108.9 7.2 90.0 26.6 16.8 32.9 32.2 34.8 79.4 78.7 32.1 82.8 47.2 29.5 43.9 38.6 63.5 MYCBP AMY-1 ENSG00000214114 "MYC binding protein" Q99417 1 38862493-38873368 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041188, HPA078331" Supported Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (2.42e-2)" "unprognostic (6.60e-2)" "unprognostic (3.85e-3)" "unprognostic (9.46e-3)" "unprognostic (8.77e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.03e-6)" "unprognostic (7.59e-2)" "unprognostic (3.00e-3)" "unprognostic (5.03e-3)" "unprognostic (4.41e-3)" "unprognostic (2.34e-3)" "unprognostic (5.81e-3)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (2.41e-2)" 11.6 11.1 2.9 17.1 3.4 16.2 18.9 3.2 4.3 12.6 2.9 22.9 16.5 9.7 17.5 23.3 27.3 11.4 8.0 2.3 2.6 18.1 11.6 12.5 16.4 5.6 3.0 1.7 6.7 16.2 18.8 8.8 19.5 4.1 15.0 22.7 8.7 16.9 16.2 12.2 13.3 21.8 11.8 2.6 11.3 16.3 15.7 3.8 12.8 18.6 5.7 18.1 17.0 11.8 5.6 51.3 22.5 18.0 13.0 10.7 18.4 74.4 38.9 12.9 38.6 29.7 27.8 56.5 42.1 43.3 18.3 6.5 35.8 29.1 51.9 46.0 52.3 49.7 44.1 29.5 26.7 2.8 107.7 38.9 16.4 38.9 32.3 20.3 14.7 28.3 45.6 64.1 35.8 41.4 31.3 35.1 54.9 47.3 75.3 53.4 33.4 54.4 58.0 50.3 40.6 34.9 23.5 37.0 47.5 25.7 42.4 33.5 52.6 23.2 20.4 33.5 31.2 45.6 25.3 48.7 45.1 20.5 63.9 26.0 51.6 32.8 85.2 18.8 39.7 21.6 22.0 22.1 22.5 40.9 17.7 18.8 21.4 64.4 27.2 38.0 54.3 33.8 22.6 2.9 3.4 3.2 4.3 2.3 2.6 5.6 3.0 1.7 4.1 2.6 3.8 5.6 9.2 9.6 13.1 0.0 18.7 10.6 15.7 31.8 22.2 0.7 25.9 14.1 7.9 20.0 37.5 27.6 0.0 106.0 26.7 35.1 64.6 27.0 68.3 84.1 11.4 11.8 9.6 38.7 0.0 27.2 86.2 9.5 21.9 17.9 26.1 9.3 8.9 15.3 21.0 10.1 0.0 25.2 26.4 15.0 14.8 25.2 7.2 20.5 19.6 0.0 31.0 5.5 18.6 0.0 0.0 29.7 40.2 9.1 69.6 18.2 31.2 50.3 142.2 5.0 6.6 6.7 14.8 29.9 64.5 53.4 17.8 88.1 19.3 14.0 31.5 22.4 TMEM213 ENSG00000214128 "Transmembrane protein 213" A2RRL7 7 138797952-138838101 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 13 "kidney: 76.7;salivary gland: 52.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 53.3;Distal tubular cells: 144.8;Melanocytes: 26.6" "Cancer enriched" "Detected in some" 22 "renal cancer: 21.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 2.1;neutrophil: 1.1;NK-cell: 2.0" "Group enriched" "Detected in many" 5 "granulocytes: 2.1;NK-cells: 2.0" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA054059 Enhanced NA NA "HPA054059: AB_2682361" "unprognostic (2.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (6.84e-2)" "unprognostic (1.17e-2)" "unprognostic (2.10e-1)" "unprognostic (6.14e-2)" "unprognostic (6.08e-2)" "unprognostic (1.91e-2)" "prognostic favorable (5.54e-7)" "unprognostic (4.33e-1)" "unprognostic (9.99e-2)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" 0.1 0.1 0.5 0.2 0.6 1.1 4.8 0.5 0.7 2.8 0.5 0.1 1.3 0.2 0.6 0.3 0.1 0.2 0.0 0.7 0.2 76.7 0.1 1.1 0.2 0.4 0.2 0.7 0.1 0.6 0.0 0.1 0.1 0.4 0.4 0.1 0.3 52.7 1.2 0.1 5.0 0.3 0.1 0.1 0.2 0.4 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.2 0.1 0.0 0.1 2.1 0.2 0.2 0.3 0.2 0.4 0.2 0.1 0.2 0.1 0.3 0.2 0.1 1.1 2.0 0.2 0.2 0.1 0.1 0.5 0.6 0.5 0.7 0.7 0.2 0.4 0.2 0.7 0.4 0.1 0.3 0.9 0.1 3.2 9.9 0.0 0.1 0.0 0.9 3.0 0.0 0.4 14.1 7.9 0.4 0.0 4.4 53.3 0.0 0.0 0.2 0.0 144.8 0.0 0.0 0.9 0.4 0.5 0.0 0.0 0.6 0.2 0.1 0.2 0.0 1.3 1.3 0.1 0.0 0.0 0.1 1.7 0.4 0.0 2.0 0.0 0.8 0.0 0.0 0.1 26.6 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.9 3.5 1.3 0.0 0.5 0.2 0.0 0.2 0.0 0.4 0.0 0.6 0.0 0.2 0.6 PRCD RP36 ENSG00000214140 "Photoreceptor disc component" Q00LT1 17 76527586-76553578 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "retina: 48.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 134.3;Cone photoreceptor cells: 152.2;Muller glia cells: 100.4;Rod photoreceptor cells: 551.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;Hep G2: 2.1;HSkMC: 1.1;SH-SY5Y: 2.4" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-3)" "unprognostic (3.74e-1)" "unprognostic (1.31e-4)" "unprognostic (6.56e-2)" "unprognostic (4.07e-3)" "unprognostic (1.76e-1)" "unprognostic (2.07e-1)" "unprognostic (4.04e-2)" "unprognostic (2.45e-1)" "unprognostic (1.19e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (8.94e-3)" "unprognostic (1.39e-2)" 1.0 0.6 0.4 0.4 0.3 0.0 1.1 2.8 0.9 1.4 1.3 0.5 0.4 0.9 0.0 0.3 1.0 0.2 1.1 0.2 0.3 0.2 0.2 0.7 0.7 1.2 0.8 0.3 0.7 0.3 0.2 0.2 0.5 1.4 0.9 0.1 48.4 0.5 0.3 0.4 0.5 0.5 0.1 0.5 1.1 0.3 0.5 0.6 0.0 0.7 0.0 0.2 1.3 1.3 1.4 0.0 0.0 0.0 0.0 0.7 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.1 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.8 0.9 0.2 0.3 1.2 0.8 0.3 1.4 0.5 0.6 1.4 8.5 0.0 0.0 0.7 13.5 0.5 0.2 0.6 0.0 134.3 0.1 0.5 5.4 0.0 0.7 0.0 152.2 0.1 1.3 0.0 0.0 0.2 4.3 0.3 0.4 7.8 0.0 0.0 2.1 0.0 0.0 5.3 0.0 0.0 0.0 0.2 1.1 0.0 0.1 37.0 4.9 0.0 0.0 0.0 1.1 11.0 6.2 0.5 7.2 2.8 0.1 100.4 0.0 0.5 26.0 0.2 0.0 1.9 1.8 0.2 0.0 0.2 0.3 551.3 6.6 10.5 3.4 3.3 0.9 0.1 0.3 0.3 1.2 1.1 0.0 0.1 ALG3 "CDGS4, D16Ertd36e, Not56, NOT56L" ENSG00000214160 "ALG3 alpha-1,3- mannosyltransferase" Q92685 3 184242301-184249548 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045103 Enhanced NA NA "HPA045103: AB_10960547" "unprognostic (3.63e-2)" "unprognostic (2.60e-1)" "unprognostic (2.36e-2)" "unprognostic (1.80e-3)" "unprognostic (3.63e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (1.58e-5)" "prognostic unfavorable (8.67e-5)" "unprognostic (6.18e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-3)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (9.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (5.02e-2)" 20.6 32.9 9.0 15.1 9.0 15.9 19.9 10.5 11.1 17.0 12.5 21.8 17.1 17.7 12.6 30.8 15.3 11.7 18.9 8.4 9.0 18.1 58.4 18.3 13.1 10.2 9.5 8.1 12.8 37.4 23.3 14.7 19.7 10.4 20.0 18.5 6.0 27.0 13.8 30.5 24.6 20.6 16.5 9.9 20.9 23.3 25.9 10.2 12.4 18.6 14.9 14.2 22.7 20.0 10.6 77.2 67.6 18.0 59.5 70.2 39.4 59.3 40.6 46.0 54.9 47.3 102.8 50.9 67.6 108.4 50.8 112.0 90.8 64.1 90.0 34.5 49.0 76.7 60.8 49.3 84.7 64.3 99.5 52.4 47.0 74.7 64.8 90.9 29.4 30.0 46.0 60.7 132.6 36.1 95.8 48.5 83.1 55.9 153.3 85.8 49.9 27.5 269.7 63.2 25.7 44.3 36.7 37.6 147.0 67.5 21.8 140.2 54.8 24.3 57.2 36.0 51.2 88.4 72.3 137.8 71.3 51.5 129.2 52.9 0.6 60.9 14.6 35.8 61.1 40.5 31.6 38.3 36.8 71.4 30.8 33.9 33.2 2.0 48.9 51.3 65.3 44.6 41.7 9.0 9.0 10.5 11.1 8.4 9.0 10.2 9.5 8.1 10.4 9.9 10.2 10.6 14.2 6.4 18.1 4.6 24.5 25.0 28.3 61.0 26.2 10.4 24.1 20.8 11.7 21.5 43.0 20.2 10.4 79.2 21.0 24.9 7.9 62.3 95.7 9.1 17.7 18.7 14.5 24.4 5.6 63.1 100.4 22.3 25.0 13.5 12.7 16.3 12.5 51.7 69.8 8.4 5.9 33.3 50.8 24.9 15.5 211.5 12.5 25.8 21.4 7.5 21.2 13.7 16.5 7.1 6.3 44.6 22.0 15.1 63.8 47.2 39.4 31.8 16.7 13.0 19.7 9.0 34.6 29.7 34.3 39.4 27.0 65.8 17.6 23.1 45.6 29.1 SH3D21 "C1orf113, FLJ22938" ENSG00000214193 "SH3 domain containing 21" A4FU49 1 36306368-36329340 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.1;thyroid gland: 28.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 15.3;Late spermatids: 53.6;Proximal enterocytes: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.4;HaCaT: 21.1;hTERT-RPE1: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042212, HPA042456, HPA066168" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627" "prognostic favorable (2.60e-4)" "unprognostic (8.35e-3)" "unprognostic (3.86e-3)" "unprognostic (9.01e-2)" "unprognostic (2.07e-3)" "unprognostic (7.32e-3)" "unprognostic (2.04e-4)" "unprognostic (7.47e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.38e-3)" "prognostic unfavorable (1.76e-6)" "unprognostic (8.88e-2)" "unprognostic (2.25e-1)" "unprognostic (7.99e-2)" "unprognostic (8.59e-2)" 1.0 0.7 3.0 2.5 1.2 1.3 10.9 0.5 6.1 3.4 0.0 3.4 14.1 2.3 1.4 6.9 1.3 2.0 1.6 1.0 0.5 8.8 0.8 3.9 2.1 1.3 0.4 1.2 3.5 0.5 0.3 1.7 3.1 1.1 6.8 3.8 3.2 13.5 1.4 0.8 16.7 21.1 1.1 0.0 2.2 2.0 6.8 1.7 0.7 28.0 0.3 3.0 1.3 7.3 2.4 11.2 0.3 2.0 2.2 0.5 1.3 14.4 6.1 0.9 2.8 1.3 7.1 4.3 2.2 5.5 1.6 0.3 21.1 1.4 3.3 2.1 0.9 2.1 2.1 4.8 5.3 1.1 1.2 3.2 0.9 3.0 1.9 1.4 21.7 1.0 4.3 0.4 2.6 1.6 7.3 1.4 1.1 1.2 2.6 2.4 2.3 0.3 1.2 3.7 1.8 4.4 2.1 1.1 11.0 3.4 10.3 0.7 0.3 3.2 1.6 1.2 4.3 1.0 3.3 1.0 2.2 3.9 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 3.0 1.2 0.5 6.1 1.0 0.5 1.3 0.4 1.2 1.1 0.0 1.7 2.4 1.1 0.0 2.0 0.3 1.7 3.1 1.7 3.0 1.8 6.9 6.2 4.3 1.4 0.0 1.9 5.5 0.0 2.9 1.9 15.3 1.9 0.6 14.2 2.5 2.0 1.6 0.0 0.0 1.6 0.4 2.2 1.9 4.6 7.7 1.3 2.6 1.1 0.3 7.7 11.8 1.2 2.9 2.0 6.1 7.7 53.6 1.2 5.0 3.6 0.0 2.2 1.2 1.0 0.0 0.2 4.3 5.8 2.6 2.9 2.6 14.9 1.1 2.3 1.2 0.0 0.7 2.1 2.6 1.2 2.4 3.1 5.7 1.3 3.2 1.6 1.3 SMIM30 LINC00998 ENSG00000214194 "Small integral membrane protein 30" A4D0T7 7 113116718-113118560 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 126.9;Distal tubular cells: 414.8;Hofbauer cells: 243.9;Proximal tubular cells: 396.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.25e-1)" "unprognostic (1.73e-3)" "unprognostic (6.77e-2)" "unprognostic (1.04e-2)" "unprognostic (2.44e-3)" "unprognostic (3.89e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.25e-2)" "unprognostic (5.00e-3)" "unprognostic (7.07e-3)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (2.46e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-1)" 45.0 53.7 41.9 27.1 42.6 12.3 47.6 42.7 58.4 37.6 42.6 33.6 32.6 30.9 71.5 39.8 30.8 37.7 207.3 41.4 46.9 84.5 58.1 40.4 38.9 44.2 41.7 39.8 27.1 42.0 84.6 26.5 29.6 43.3 37.9 35.9 43.9 48.2 30.3 143.8 21.0 27.8 39.4 43.9 41.8 39.8 19.8 43.0 30.5 60.6 151.0 32.0 51.1 21.6 46.1 48.0 24.1 56.3 49.6 100.8 159.8 0.2 57.3 95.0 60.5 94.0 25.1 82.7 57.4 69.5 72.0 104.5 29.9 55.8 126.5 146.8 37.9 113.3 130.3 32.7 42.9 66.8 179.2 0.4 120.8 120.1 91.6 46.8 111.0 95.7 60.6 176.1 52.4 199.6 24.7 76.3 196.4 58.6 72.6 66.0 47.7 136.2 156.9 118.8 63.9 85.1 61.8 43.1 85.6 140.2 97.5 57.5 117.4 55.1 96.8 49.6 110.9 86.2 77.6 102.6 205.3 126.9 161.0 138.0 2.0 15.8 12.5 16.1 17.6 17.9 19.6 18.3 16.9 25.2 17.0 17.2 17.5 0.6 19.7 14.1 36.5 23.2 16.7 41.9 42.6 42.7 58.4 41.4 46.9 44.2 41.7 39.8 43.3 43.9 43.0 46.1 32.6 51.3 68.9 0.0 10.4 0.0 0.0 0.0 0.0 0.0 77.4 42.7 0.0 0.0 32.8 126.9 0.0 76.2 8.2 0.0 414.8 102.3 0.0 51.5 37.8 27.7 0.0 0.0 0.0 69.8 61.8 20.7 0.0 43.5 32.8 27.0 0.0 0.0 243.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 44.5 0.0 0.0 0.0 0.0 83.7 0.0 0.0 1.3 0.0 0.0 396.3 32.8 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 41.6 11.0 70.8 0.0 0.0 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 98.9" "Cell type enhanced" "Detected in many" "Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8" "Group enriched" "Detected in all" 20 "dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8" "Cell line enriched" "Detected in some" 4 "U-937: 50.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 3.7 1.0 3.5 11.3 3.7 98.9 1.2 4.1 4.5 2.1 3.7 1.8 1.7 1.1 2.8 1.0 2.3 2.9 0.9 3.2 4.3 1.1 3.2 6.2 5.3 5.0 3.9 2.8 2.0 1.8 0.4 0.8 1.8 4.9 1.4 1.3 0.7 0.9 0.9 2.7 0.6 2.3 3.4 4.3 21.8 1.6 11.2 4.0 3.2 0.5 1.5 3.0 4.6 1.6 6.3 2.4 0.1 0.2 0.4 2.2 1.2 0.2 0.4 0.1 0.4 0.9 0.2 0.4 5.9 0.5 0.0 0.2 0.2 0.3 0.3 0.3 2.7 0.6 0.3 0.0 0.0 1.6 3.9 0.6 6.0 0.7 1.0 0.3 0.1 0.1 0.6 0.3 12.2 0.2 2.2 0.2 9.3 0.5 0.4 0.4 4.5 0.0 3.1 0.0 0.2 0.3 0.1 1.2 0.0 0.9 0.1 0.2 8.7 0.0 0.1 0.0 1.1 0.1 7.3 3.7 1.7 0.0 50.9 0.0 7.8 282.3 169.4 0.6 312.5 1.6 13.0 0.8 0.8 162.2 8.5 4.9 1.5 230.1 8.0 392.8 3.6 2.3 157.7 3.5 3.7 4.1 4.5 3.2 4.3 5.0 3.9 2.8 4.9 4.3 4.0 6.3 0.3 0.0 1.8 1.6 10.6 0.8 0.4 2.1 1.2 0.1 0.6 0.5 1.1 0.0 1.7 1.8 2.1 1.0 0.7 0.3 0.0 0.1 3.7 0.9 0.3 1.1 0.0 4.8 0.9 1.3 0.9 1.6 4.1 1.0 2.5 0.3 0.4 1.1 22.3 0.0 0.9 0.6 2.0 90.1 33.4 6.1 0.9 59.2 1.8 0.0 86.7 3.1 4.1 0.0 3.1 0.1 3.5 0.7 24.7 0.3 0.2 0.7 5.1 1.1 6.6 0.5 0.6 28.5 19.2 0.3 0.9 0.7 2.1 0.1 0.6 0.6 IQCJ ENSG00000214216 "IQ motif containing J" Q1A5X6 3 158962928-159266307 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 6.3" "Group enriched" "Detected in some" 97 "Early spermatids: 27.3;Late spermatids: 50.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "Daudi: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052835 Uncertain NA NA "HPA052835: AB_2681970" "unprognostic (1.99e-2)" 0.0 0.0 6.3 0.0 4.5 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 2.9 0.0 0.0 0.0 0.0 1.3 0.3 4.5 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 4.5 0.0 4.4 5.1 2.9 1.3 0.3 4.5 1.4 0.0 1.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C17orf67 ENSG00000214226 "Chromosome 17 open reading frame 67" Q0P5P2 17 56791913-56838773 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 9.5;MOLT-4: 14.6;PC-3: 9.7" "Region enriched" "Detected in single" 5 "olfactory bulb: 3.1" "Region enhanced" "Detected in many" "spinal cord: 15.6" HPA043479 Approved "Secreted to blood" NA NA "HPA043479: AB_10964083" "unprognostic (2.78e-2)" "unprognostic (5.24e-2)" "unprognostic (1.83e-1)" "unprognostic (3.54e-3)" "unprognostic (1.69e-3)" "unprognostic (1.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.47e-1)" "unprognostic (4.63e-2)" "unprognostic (2.82e-3)" "unprognostic (9.64e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-5)" "unprognostic (2.49e-1)" "unprognostic (3.27e-1)" "unprognostic (2.20e-2)" "unprognostic (1.43e-3)" 1.3 0.4 3.6 1.3 2.1 0.5 1.0 2.3 4.2 1.9 2.2 1.2 0.7 1.8 1.4 0.8 1.5 1.7 0.9 2.9 2.8 0.8 2.3 1.6 1.6 2.7 2.1 1.9 1.8 1.7 0.5 1.3 0.8 3.0 1.7 0.5 0.8 1.0 1.2 0.6 0.5 1.6 1.2 2.3 2.7 1.0 1.8 2.8 5.5 1.3 0.9 1.0 1.5 1.7 4.8 3.2 2.0 1.3 1.4 0.6 0.9 0.6 1.8 2.3 1.5 1.7 2.6 1.1 1.7 3.1 0.8 1.7 1.6 0.9 0.5 1.5 9.5 3.4 1.6 2.4 1.6 0.8 1.2 3.1 0.3 2.4 1.0 1.0 1.1 1.5 3.3 1.6 7.9 1.0 2.5 14.6 2.2 1.2 1.0 9.7 3.1 2.5 1.8 1.1 0.8 0.7 1.6 1.8 0.4 1.0 0.5 2.0 0.9 2.2 1.6 4.0 1.1 1.3 3.2 8.7 0.9 1.1 1.4 0.6 0.0 0.1 0.3 0.2 0.2 0.3 1.5 0.6 0.8 0.1 0.8 0.6 0.8 0.2 0.2 0.3 0.3 1.5 0.3 3.6 2.1 2.3 4.2 2.9 2.8 2.7 2.1 1.9 3.0 2.3 2.8 4.8 15.3 3.2 0.0 2.9 8.4 2.3 16.3 0.5 4.6 12.4 3.9 5.6 1.8 11.5 0.1 7.3 14.6 0.1 8.4 12.1 0.0 3.3 9.0 3.3 6.3 13.5 8.9 3.6 7.2 1.4 0.8 4.8 3.1 6.8 1.3 3.1 7.9 9.0 2.9 5.0 10.6 4.6 0.0 8.1 4.7 7.4 7.8 5.0 1.8 15.9 3.8 2.7 12.3 6.6 6.2 2.2 11.9 1.2 4.3 12.4 4.1 0.4 1.0 20.1 0.0 2.4 5.1 12.9 9.5 2.2 1.7 0.3 11.0 4.3 6.3 7.2 MINDY4B "C3orf76, FAM188B2" ENSG00000214237 "MINDY family member 4B" A8MYZ0 3 150870376-150905439 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (1.91e-4)" "unprognostic (6.32e-3)" "unprognostic (6.09e-3)" "unprognostic (3.14e-1)" "unprognostic (3.96e-1)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-3)" "unprognostic (3.36e-1)" "unprognostic (8.66e-3)" "unprognostic (1.43e-1)" "unprognostic (2.22e-1)" "unprognostic (4.70e-1)" "unprognostic (2.54e-1)" "unprognostic (4.77e-1)" "unprognostic (2.16e-1)" 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.3 0.1 0.2 0.2 0.0 0.1 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FIS1 "CGI-135, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 891.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017430 Approved Supported Mitochondria NA NA 140000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favorable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 202.5 229.5 202.2 60.5 222.2 111.1 196.8 227.8 232.5 147.1 188.7 186.4 83.8 169.5 101.3 157.1 167.5 71.5 333.8 192.8 208.3 250.8 297.3 141.6 73.8 226.6 218.6 187.3 153.6 210.5 202.9 210.9 76.1 230.1 161.7 70.1 35.1 143.6 90.9 479.5 174.1 138.4 84.5 231.5 164.3 196.0 146.7 215.4 84.7 180.4 286.7 64.3 164.6 142.3 251.2 110.1 124.3 94.7 133.6 103.6 136.6 63.5 118.1 139.0 103.2 88.3 81.7 173.2 107.4 145.7 159.4 98.1 64.0 65.8 184.5 56.8 87.9 101.0 49.8 154.7 100.6 124.5 93.1 75.0 131.9 172.5 73.4 111.5 117.2 185.6 60.3 109.0 142.9 155.0 445.1 145.1 160.4 100.8 221.2 123.0 70.7 53.4 235.8 155.1 107.5 120.6 141.9 57.0 261.5 83.0 81.3 88.0 101.5 159.6 120.6 76.6 127.9 125.3 122.2 98.6 61.6 111.7 103.0 159.0 153.9 137.7 135.9 122.3 141.7 126.4 152.7 115.5 115.9 149.6 152.8 115.0 120.5 104.5 126.3 131.6 123.2 155.6 207.9 202.2 222.2 227.8 232.5 192.8 208.3 226.6 218.6 187.3 230.1 231.5 215.4 251.2 301.0 102.5 119.1 16.0 127.5 104.9 158.6 158.4 114.4 48.2 220.5 309.2 349.4 207.3 114.8 229.9 16.7 259.8 120.7 334.5 561.5 263.5 208.5 145.4 120.7 205.8 219.4 423.7 13.6 293.4 309.2 166.7 110.1 126.4 136.3 132.4 182.0 384.9 297.0 35.3 13.2 317.9 128.1 170.9 133.5 730.3 193.9 136.0 218.7 15.0 214.1 281.5 171.9 6.6 83.1 232.2 460.4 179.0 184.8 221.0 603.6 891.2 130.9 59.6 98.6 161.1 233.3 188.0 201.2 192.7 135.7 324.1 127.5 247.4 277.5 192.5 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 52 "liver: 3042.7" "Cell type enriched" "Detected in many" 24 "Hepatocytes: 4816.3" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.5;myeloid DC: 14.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Hep G2: 152.2;OE19: 116.1" "Low region specificity" "Detected in all" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 410000000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 37.0 3.1 3.6 6.1 3.3 1.0 38.1 3.6 5.0 37.4 5.4 32.9 23.4 23.6 18.1 9.9 30.7 28.8 13.6 3.4 6.1 18.6 3042.7 18.7 3.6 4.3 3.8 2.9 58.6 31.1 5.3 5.0 3.8 4.0 33.0 46.1 2.2 53.0 13.4 6.3 27.5 27.3 10.5 4.5 7.5 58.7 10.3 3.7 1.5 8.9 10.6 4.2 25.0 31.6 4.6 3.7 9.9 2.3 0.0 23.9 27.8 0.3 4.8 8.8 1.1 4.0 5.9 5.1 0.4 1.5 12.0 8.0 3.8 2.8 3.1 1.3 18.4 3.8 0.9 5.1 152.2 5.0 4.0 0.5 22.2 2.5 1.5 5.1 11.8 5.7 4.2 0.2 27.0 3.5 0.7 0.9 1.2 0.7 116.1 10.7 0.7 3.9 11.3 2.3 2.9 0.0 0.4 4.6 1.7 6.5 5.1 4.0 0.7 6.0 1.9 2.8 1.7 0.7 5.9 4.8 0.5 3.2 2.0 5.0 0.0 24.5 0.0 0.6 2.9 0.4 5.8 1.2 1.1 14.5 4.9 0.3 0.2 0.4 0.0 0.1 2.3 0.8 7.1 3.6 3.3 3.6 5.0 3.4 6.1 4.3 3.8 2.9 4.0 4.5 3.7 4.6 9.7 28.9 17.7 0.0 9.7 27.1 43.3 39.2 14.2 0.1 33.8 24.8 0.8 194.5 24.6 11.0 0.0 1.6 0.7 32.5 11.7 40.0 1.0 6.2 9.7 11.0 71.0 27.8 0.0 31.6 5.3 48.8 56.1 24.9 0.0 10.7 62.4 4816.3 15.9 0.0 0.0 171.9 12.2 95.9 18.7 2.9 71.1 13.8 23.2 0.0 4.9 10.1 0.0 0.0 0.0 21.6 33.3 24.0 11.7 43.7 91.3 61.2 76.5 0.6 13.1 29.7 17.7 1.0 1.3 9.4 52.4 9.3 5.6 0.5 51.6 39.2 SCART1 CD163c-alpha ENSG00000214279 "Scavenger receptor family member expressed on T cells 1" Q4G0T1 10 133453928-133523558 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 3.7;NB-4: 3.6;THP-1: 1.1;U-266/84: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043101 Supported NA NA "HPA043101: AB_10797026" "unprognostic (4.32e-2)" "unprognostic (2.15e-2)" "unprognostic (1.13e-2)" "unprognostic (2.40e-2)" "unprognostic (7.42e-2)" "unprognostic (8.20e-4)" "unprognostic (1.29e-3)" "unprognostic (4.28e-3)" "unprognostic (2.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.91e-1)" "unprognostic (2.24e-2)" "unprognostic (6.24e-5)" "unprognostic (8.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" 0.0 0.1 0.3 0.0 0.5 0.2 0.1 1.0 1.1 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.4 0.1 0.1 0.1 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 3.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.2 0.2 4.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.0 1.1 0.8 0.4 0.3 0.3 0.3 0.3 0.2 0.4 0.6 0.8 0.0 1.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.9 0.8 0.5 0.0 0.0 1.3 0.2 0.0 0.4 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.1 0.0 NPS ENSG00000214285 "Neuropeptide S" P0C0P6 10 127549309-127553540 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "brain: 1.0" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "head and neck cancer: 4.0" "Region enhanced" "Detected in single" "white matter: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "midbrain: 5.4;pons and medulla: 5.1" "Group enriched" "Detected in some" 6 "cerebral cortex: 4.8;white matter: 2.2" CAB020139 Uncertain "Secreted in brain" NA NA "CAB020139: AB_776718" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COLCA2 "C11orf93, CASC13" ENSG00000214290 "Colorectal cancer associated 2" A8K830 11 111298555-111308735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 25.9;Cholangiocytes: 24.3;Early spermatids: 73.2;Ionocytes: 38.7;Late spermatids: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 11.7;OE19: 41.4;RT4: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.73e-3)" "unprognostic (5.15e-2)" "unprognostic (6.97e-3)" "unprognostic (1.30e-3)" "unprognostic (1.15e-1)" "unprognostic (9.04e-2)" "unprognostic (1.13e-3)" "unprognostic (3.28e-2)" "unprognostic (6.03e-3)" "unprognostic (3.54e-2)" "unprognostic (3.34e-2)" "unprognostic (1.90e-1)" "prognostic favorable (8.97e-6)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.05e-2)" "unprognostic (2.46e-1)" 3.4 2.9 9.4 1.9 9.7 0.1 4.5 9.4 11.2 5.3 7.9 9.8 10.9 8.7 27.4 8.5 19.7 10.0 1.3 9.0 8.4 9.5 2.7 4.3 4.7 8.7 9.0 7.8 12.4 8.5 19.1 2.9 2.6 8.8 9.8 11.2 0.2 17.9 16.0 2.1 1.6 8.6 6.6 7.8 0.7 20.2 11.3 9.2 3.4 10.4 3.0 4.8 10.7 8.0 8.4 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 3.1 1.9 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 11.7 0.1 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.6 41.4 0.0 0.7 0.0 0.0 0.0 10.6 1.9 0.5 0.4 4.2 0.0 1.0 5.6 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.7 9.4 11.2 9.0 8.4 8.7 9.0 7.8 8.8 7.8 9.2 8.4 0.3 0.0 0.5 13.1 1.6 0.4 9.7 25.9 0.6 0.0 0.1 3.9 0.6 24.3 14.8 7.3 0.0 0.0 0.1 3.6 11.7 7.6 73.2 7.9 7.0 0.2 1.8 0.0 2.3 16.7 0.0 5.3 7.7 1.4 1.3 0.9 0.0 0.9 0.0 0.0 2.7 13.1 38.7 0.0 0.7 67.5 8.4 0.4 1.8 1.9 0.0 0.0 0.0 0.5 0.2 5.6 3.3 5.7 1.0 2.1 5.6 3.5 23.5 0.0 0.0 0.9 2.0 1.1 1.4 4.1 0.1 0.0 0.2 0.3 5.7 5.6 SPDYE3 ENSG00000214300 "Speedy/RINGO cell cycle regulator family member E3" A6NKU9 7 100307702-100322196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 2.5" "Cell type enriched" "Detected in many" 4 "Early spermatids: 181.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Supported NA NA "HPA051750: AB_2681590" "prognostic favorable (8.73e-4)" "unprognostic (6.27e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.06e-2)" "unprognostic (1.54e-1)" "unprognostic (5.04e-2)" "unprognostic (2.96e-2)" "unprognostic (2.90e-1)" "unprognostic (6.91e-2)" "unprognostic (3.99e-2)" "unprognostic (7.32e-2)" "unprognostic (5.25e-2)" "unprognostic (9.08e-2)" "unprognostic (5.06e-2)" "unprognostic (9.17e-2)" "unprognostic (3.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.5 8.1 0.5 1.7 0.7 1.2 0.0 5.2 0.4 0.0 2.3 1.5 1.0 0.0 10.4 0.1 1.5 0.0 0.0 0.0 181.7 1.2 1.7 0.9 0.0 0.4 13.6 0.0 0.2 0.8 0.0 0.9 0.0 1.1 0.0 0.2 0.2 0.0 11.5 0.3 4.1 0.3 0.8 44.4 2.1 0.4 0.0 3.7 0.0 0.7 0.0 11.6 8.1 0.0 0.0 1.9 0.0 0.6 0.0 0.2 1.0 3.7 0.0 1.1 0.9 3.4 1.1 0.0 1.7 0.1 0.9 0.6 0.0 0.7 MBLAC1 MGC49416 ENSG00000214309 "Metallo-beta-lactamase domain containing 1" A4D2B0 7 100126785-100128495 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071574 Uncertain NA NA "HPA071574: AB_2686419" "unprognostic (8.28e-3)" "unprognostic (4.83e-2)" "unprognostic (8.85e-2)" "unprognostic (1.41e-1)" "unprognostic (6.84e-3)" "unprognostic (2.38e-4)" "unprognostic (1.18e-1)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-1)" "prognostic favorable (1.18e-4)" "unprognostic (1.21e-1)" "prognostic favorable (7.90e-5)" "unprognostic (7.83e-2)" "unprognostic (5.30e-2)" "unprognostic (4.07e-1)" "unprognostic (5.88e-2)" 1.6 2.3 1.7 0.9 2.9 1.0 1.9 4.9 5.4 3.2 0.0 2.5 2.7 3.3 0.5 2.9 3.1 0.6 2.9 2.6 0.7 2.8 2.3 1.3 1.0 1.7 0.9 2.3 3.6 2.3 1.2 3.9 0.4 2.9 4.0 0.6 1.1 2.8 1.8 2.6 2.3 2.1 0.7 0.1 2.0 2.3 2.8 1.4 1.2 2.5 0.6 0.5 2.9 2.7 2.8 2.5 2.7 1.3 1.5 1.5 0.3 1.9 2.8 1.0 1.2 1.0 3.3 1.8 1.5 2.5 1.2 3.8 1.2 0.5 0.0 0.2 5.3 3.0 0.8 1.8 2.6 1.3 2.7 2.3 0.9 0.2 0.8 0.6 1.2 1.0 2.0 2.0 7.0 0.9 2.8 5.1 1.8 1.6 0.3 5.2 3.4 2.0 2.7 0.4 3.0 1.9 4.1 4.3 6.2 2.4 0.4 0.7 1.0 1.3 3.3 5.8 2.2 4.1 4.2 2.9 6.0 1.2 2.1 3.8 0.0 0.2 0.7 0.3 0.2 0.3 0.1 0.5 0.6 0.2 0.9 0.7 0.7 0.9 0.4 0.6 0.2 0.0 0.1 1.7 2.9 4.9 5.4 2.6 0.7 1.7 0.9 2.3 2.9 0.1 1.4 2.8 1.7 0.0 1.1 2.9 1.6 0.5 4.3 0.6 1.8 5.7 3.3 3.0 3.9 2.8 1.3 3.7 4.2 1.7 3.4 4.0 11.7 3.8 0.4 2.2 2.3 2.1 3.0 2.7 2.1 5.0 1.2 2.9 0.0 2.1 0.0 2.7 3.3 2.5 2.8 5.0 1.8 2.5 2.0 0.6 1.0 1.2 7.5 1.6 0.0 1.9 2.8 6.2 3.1 1.5 1.1 3.0 1.6 4.1 1.0 3.1 3.2 8.2 0.7 4.7 6.6 3.5 2.9 2.3 2.1 2.3 1.1 2.1 2.2 3.7 2.0 2.4 C3orf56 FLJ40141 ENSG00000214324 "Chromosome 3 open reading frame 56" Q8N813 3 127193131-127198185 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055395 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA055395: " "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXI3 ENSG00000214336 "Forkhead box I3" A8MTJ6 2 88446787-88452693 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "placenta: 5.2;retina: 2.0" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 3.3;Muller glia cells: 6.4;Syncytiotrophoblasts: 2.7" "Cancer enriched" "Detected in some" 5 "testis cancer: 10.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 43.2;SuSa: 55.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.72e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-1)" "unprognostic (6.72e-4)" "unprognostic (8.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 5.2 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 55.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.6" "Group enriched" "Detected in some" 9 "Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.3 1.0 4.0 0.6 2.8 0.0 0.1 3.3 7.6 0.3 0.0 0.3 0.1 0.8 0.0 0.8 0.3 0.7 0.2 4.0 0.9 0.2 0.1 1.0 0.2 4.6 1.9 2.4 1.2 0.6 0.0 2.0 0.4 5.4 0.4 0.2 1.2 0.4 0.1 0.1 0.3 0.6 0.1 2.0 0.4 1.3 0.7 4.8 0.0 0.7 0.1 0.0 0.4 0.3 5.4 0.3 4.2 9.3 1.5 0.0 0.8 0.4 0.9 1.1 1.2 2.9 0.3 0.4 0.6 0.3 0.2 7.3 0.0 1.0 0.0 0.7 1.1 0.1 0.8 0.0 0.1 0.0 0.4 0.2 1.5 0.0 4.4 0.0 1.0 0.0 1.5 0.4 0.2 0.7 0.7 6.5 0.0 4.3 0.0 1.0 0.6 2.2 0.0 0.2 0.0 28.9 16.9 0.0 0.0 0.2 1.1 0.0 0.4 0.2 6.8 1.5 0.5 2.2 0.3 0.1 0.1 5.4 1.5 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.0 2.8 3.3 7.6 4.0 0.9 4.6 1.9 2.4 5.4 2.0 4.8 5.4 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 57.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 44.2 32.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 NEURL1B "DKFZP761M1511, Neur2, RNF67B" ENSG00000214357 "Neuralized E3 ubiquitin protein ligase 1B" A8MQ27 5 172641263-172691540 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 82.8;Distal enterocytes: 82.5;Endothelial cells: 53.8;Leydig cells: 54.7;Paneth cells: 42.1;Proximal enterocytes: 53.4;Smooth muscle cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 43.7;T-47d: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037612 Approved Supported "Actin filaments,Cytosol" NA Yes Cytosol "Actin filaments" "HPA037612: AB_10795573" "unprognostic (3.56e-2)" "unprognostic (8.46e-2)" "unprognostic (6.72e-3)" "unprognostic (2.70e-1)" "unprognostic (1.64e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (2.95e-1)" "unprognostic (2.86e-1)" "unprognostic (1.09e-1)" "unprognostic (7.13e-3)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.00e-6)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-2)" "unprognostic (3.22e-3)" 24.7 16.1 7.6 5.2 10.7 2.0 21.3 2.5 24.9 18.0 3.9 26.5 7.0 24.9 24.3 13.6 22.2 11.8 24.1 17.8 5.8 9.6 6.0 12.8 3.7 5.3 4.4 9.1 14.8 5.3 3.2 8.3 6.2 5.2 17.7 13.9 0.3 6.7 32.4 14.1 18.2 17.8 20.6 3.8 0.7 7.8 4.3 4.9 6.0 10.4 16.1 4.0 26.0 17.5 8.1 7.2 3.7 2.0 8.9 0.6 0.3 0.1 8.0 3.5 4.1 6.0 13.7 3.2 0.0 2.1 5.2 5.0 2.1 0.7 3.6 2.8 13.2 0.5 9.8 13.3 0.1 0.6 0.0 2.9 0.0 15.1 0.9 4.1 1.2 0.6 1.4 0.0 3.0 8.9 8.0 2.3 0.2 1.3 3.1 0.3 43.7 9.4 1.4 0.1 1.6 1.6 8.9 7.6 11.9 0.3 3.5 20.0 1.5 1.3 3.1 18.1 2.2 5.1 1.2 0.4 0.0 9.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 10.7 2.5 24.9 17.8 5.8 5.3 4.4 9.1 5.2 3.8 4.9 8.1 82.8 0.0 1.9 0.3 0.6 4.8 0.7 3.0 0.6 0.6 1.5 1.3 9.3 1.5 4.8 0.0 0.0 0.3 0.4 82.5 0.0 0.7 2.6 1.9 2.5 53.8 13.9 11.4 5.2 0.7 0.2 10.3 2.0 0.6 0.0 4.9 30.4 0.3 0.3 0.0 1.0 10.2 2.0 1.9 2.6 6.6 54.7 2.2 7.2 4.7 0.7 0.7 0.0 5.0 13.0 4.5 42.1 12.4 0.1 1.9 53.4 0.8 12.8 0.3 26.3 11.6 58.8 2.5 3.4 7.7 5.4 0.1 0.7 2.5 20.0 1.2 EFCAB9 ENSG00000214360 "EF-hand calcium binding domain 9" A8MZ26 5 172194172-172203454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 10.1" "Group enriched" "Detected in some" 26 "Early spermatids: 103.5;Late spermatids: 30.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "WM-115: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (2.32e-1)" "unprognostic (6.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.7 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 30.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 HAUS3 "C4orf15, dgt3, IT1, MGC4701" ENSG00000214367 "HAUS augmin like complex subunit 3" Q68CZ6 4 2078998-2242276 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040649, HPA048190" Approved Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria" Yes No Mitochondria "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA040649: AB_2677060, HPA048190: AB_2680308" "unprognostic (4.22e-2)" "unprognostic (1.50e-1)" "unprognostic (6.30e-2)" "unprognostic (2.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.57e-3)" "unprognostic (7.63e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.79e-2)" "unprognostic (2.15e-2)" "unprognostic (2.79e-1)" "unprognostic (4.40e-2)" "prognostic favorable (4.78e-5)" 8.9 8.7 4.2 7.6 4.2 27.8 9.0 9.8 5.0 7.8 3.0 8.1 6.6 7.4 4.9 8.1 7.3 4.2 5.5 4.1 3.6 6.2 7.4 9.1 10.3 4.1 4.1 4.0 7.4 10.6 4.1 5.6 6.6 5.5 8.5 5.4 5.8 8.6 4.6 7.5 8.5 9.3 4.7 3.4 12.1 9.1 10.7 3.9 8.7 7.4 4.6 8.4 7.2 7.8 5.0 9.8 4.7 14.2 13.0 5.5 8.5 12.8 14.3 6.0 12.7 10.6 9.5 12.5 18.9 6.5 5.7 14.3 9.3 11.9 7.2 15.9 6.8 6.9 12.5 13.1 7.0 4.5 11.6 11.2 4.3 10.2 11.0 5.8 6.6 10.3 8.8 22.0 21.2 12.5 5.4 19.6 19.5 11.2 8.5 12.3 13.9 12.4 10.4 6.3 6.7 18.4 10.0 10.1 7.6 8.4 10.5 15.7 7.8 8.5 18.1 7.8 11.1 17.0 11.2 10.6 16.9 8.8 16.8 12.0 9.6 4.2 12.2 7.9 5.8 10.1 5.5 8.2 8.9 3.8 9.1 9.5 8.9 4.7 10.7 6.9 6.8 12.0 6.6 4.2 4.2 9.8 5.0 4.1 3.6 4.1 4.1 4.0 5.5 3.4 3.9 5.0 15.5 3.2 4.8 0.0 15.8 12.6 5.0 6.4 15.4 11.9 9.3 8.8 5.8 7.2 10.3 3.7 12.5 7.3 24.0 3.9 1.9 7.4 11.8 8.9 11.8 9.4 7.2 23.1 0.0 5.7 11.7 9.6 4.6 8.3 13.3 12.1 6.8 3.7 7.2 25.2 0.0 6.4 12.2 5.4 9.3 6.4 9.9 10.4 12.4 0.0 7.9 6.5 16.5 0.0 0.0 5.3 1.8 8.6 22.5 5.1 5.8 2.6 5.4 12.5 0.0 12.3 17.7 34.4 25.3 10.5 7.7 5.1 26.5 10.1 5.8 3.0 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850618 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.5;placenta: 4.4" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: AB_2732704" "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.2 0.2 1.9 0.1 2.0 0.0 0.4 1.1 3.5 1.1 0.3 1.2 0.1 0.4 1.2 0.1 0.2 0.4 0.1 1.7 3.1 0.8 0.0 0.1 0.0 2.9 2.0 1.7 0.1 0.5 0.1 0.6 4.4 3.3 0.5 1.7 0.5 0.4 0.4 0.0 0.1 0.7 0.7 1.3 0.0 1.9 0.2 2.8 0.0 0.1 0.0 0.1 0.2 0.1 4.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.5 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.4 0.0 0.0 0.1 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 1.1 3.5 1.7 3.1 2.9 2.0 1.7 3.3 1.3 2.8 4.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.9 0.5 0.5 0.3 0.0 0.1 0.0 0.0 22.3 0.1 1.1 0.0 0.4 0.0 0.3 0.2 0.1 0.0 0.0 5.2 3.0 0.7 0.3 1.5 0.7 0.0 0.1 0.0 0.0 1.5 0.0 9.2 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 1.1 2.1 0.4 0.0 0.1 0.5 1.5 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.1 5.9 0.0 0.0 1.6 0.1 LCNL1 FLJ45224 ENSG00000214402 "Lipocalin like 1" Q6ZST4 9 136981904-136986410 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.8;choroid plexus: 1.3;testis: 1.6" "Cell type enhanced" "Detected in some" "Astrocytes: 71.2;dendritic cells: 24.9;Leydig cells: 53.4;Muller glia cells: 30.2;Peritubular cells: 127.5" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.39e-1)" "unprognostic (4.60e-3)" "unprognostic (1.08e-3)" "unprognostic (5.14e-2)" "unprognostic (3.39e-1)" "unprognostic (2.03e-5)" "unprognostic (6.46e-2)" "unprognostic (6.67e-2)" "unprognostic (7.79e-2)" "unprognostic (9.51e-2)" "unprognostic (2.16e-1)" "unprognostic (9.82e-2)" "unprognostic (1.34e-9)" "unprognostic (4.31e-2)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" 0.0 0.1 1.4 0.0 1.4 0.0 0.0 1.4 2.8 0.5 1.3 0.0 0.0 0.3 0.2 0.0 0.4 0.0 0.5 1.3 1.3 0.4 0.0 0.1 0.1 1.6 1.4 1.3 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.3 0.3 0.0 1.6 1.8 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.4 1.4 2.8 1.3 1.3 1.6 1.4 1.3 2.2 1.3 1.8 1.5 0.0 0.0 0.0 71.2 0.0 0.1 0.0 0.0 0.0 8.3 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.1 24.9 0.0 0.0 0.0 2.0 0.3 3.9 1.5 0.0 0.0 2.6 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 14.2 0.0 0.0 0.0 0.0 6.0 53.4 0.1 0.0 7.5 0.0 30.2 5.2 3.5 11.9 0.0 0.0 127.5 0.3 0.0 0.0 0.0 0.0 2.0 0.0 1.8 0.2 0.4 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.1 BBIP1 "bA348N5.3, BBIP10, BBS18, NCRNA00081" ENSG00000214413 "BBSome interacting protein 1" A8MTZ0 10 110898730-110919201 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.8" "Group enriched" "Detected in all" 4 "Early spermatids: 597.4;Late spermatids: 501.6;Spermatocytes: 399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055206 Approved NA NA "HPA055206: AB_2682737" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "unprognostic (1.50e-1)" "unprognostic (6.25e-3)" "unprognostic (3.08e-2)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (6.26e-2)" "unprognostic (2.60e-2)" "unprognostic (3.00e-2)" "unprognostic (6.79e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.81e-1)" "unprognostic (3.85e-2)" 17.2 25.1 28.1 16.1 32.2 10.2 15.7 32.6 41.5 18.2 26.2 14.5 10.4 16.7 25.5 10.5 20.2 12.4 20.2 28.3 31.6 28.6 23.7 14.3 16.5 30.6 30.2 26.8 19.7 13.9 19.1 25.8 13.9 31.6 19.4 10.8 50.5 10.6 16.3 15.6 7.1 12.5 16.2 29.6 16.9 14.4 103.8 29.6 17.9 21.9 10.2 16.7 16.3 13.0 40.0 22.1 28.9 33.0 34.0 41.4 51.0 9.8 27.2 56.4 30.9 42.7 14.4 26.9 13.3 19.2 44.9 31.4 21.5 23.9 30.1 47.5 26.9 28.6 22.0 28.3 18.9 54.4 18.9 37.0 31.8 27.1 42.4 75.7 68.9 50.3 23.7 16.5 49.8 37.0 13.9 23.8 27.0 14.0 15.3 18.1 10.5 59.7 18.8 48.6 13.9 24.9 39.6 20.7 9.1 45.4 21.1 10.4 16.9 36.5 22.3 27.2 27.3 38.2 27.9 26.0 19.9 63.4 33.5 17.6 25.5 11.2 47.6 9.7 15.0 11.5 8.2 14.5 12.0 9.5 7.2 17.6 14.9 53.6 7.8 13.0 8.4 18.8 7.4 28.1 32.2 32.6 41.5 28.3 31.6 30.6 30.2 26.8 31.6 29.6 29.6 40.0 32.3 25.6 10.0 25.8 24.2 11.2 36.2 41.4 17.1 32.3 13.9 16.3 18.5 22.8 24.3 22.0 31.3 19.3 21.4 9.5 105.7 35.8 597.4 60.4 27.1 26.4 16.9 18.3 58.8 34.5 25.6 27.7 14.3 24.4 16.5 21.0 25.4 22.1 20.0 45.4 52.6 18.4 50.8 22.4 15.8 501.6 46.6 22.4 23.2 14.0 27.1 52.4 26.8 27.6 67.5 36.0 12.0 33.8 32.2 21.6 13.5 69.4 75.7 63.8 52.6 46.0 32.7 399.5 36.5 12.5 11.9 12.3 27.2 21.0 10.0 29.7 TRIM77 TRIM77P ENSG00000214414 "Tripartite motif containing 77" I1YAP6 11 89710299-89717872 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039896 Uncertain NA NA "HPA039896: AB_2676732" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNAT3 "GDCA, gustducin" ENSG00000214415 "G protein subunit alpha transducin 3" A8MTJ3 7 80458635-80512064 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "intestine: 1.8" "Cell type enhanced" "Detected in single" "Early spermatids: 2.8" "Group enriched" "Detected in some" 6 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SCLC-21H: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA071345 Enhanced NA NA "HPA071345: " "unprognostic (2.01e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 AS3MT CYT19 ENSG00000214435 "Arsenite methyltransferase" Q9HBK9 10 102869470-102901899 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "adrenal gland: 304.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Basal squamous epithelial cells: 1.2;Proximal tubular cells: 1.0" "Cancer enhanced" "Detected in single" "liver cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.8;REH: 54.6;SH-SY5Y: 27.8;T-47d: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017856 Enhanced Approved Mitochondria NA NA Mitochondria "HPA017856: AB_1847420" "unprognostic (1.11e-1)" "unprognostic (2.02e-4)" "unprognostic (2.45e-1)" "unprognostic (2.25e-1)" "unprognostic (3.39e-1)" "unprognostic (1.66e-1)" "unprognostic (7.02e-4)" "unprognostic (3.22e-1)" "unprognostic (1.42e-1)" "unprognostic (3.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.83e-1)" "unprognostic (3.83e-10)" "unprognostic (1.04e-2)" "unprognostic (4.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" 5.1 304.9 8.0 1.3 8.1 0.8 6.3 11.8 8.7 7.1 9.1 5.0 3.0 7.8 4.4 3.6 5.9 6.8 27.0 7.4 8.8 19.4 59.7 4.0 2.0 8.6 8.5 7.7 8.8 11.8 66.2 6.6 1.0 9.8 9.2 1.8 4.8 4.8 5.2 11.6 4.3 3.3 4.0 7.1 18.5 4.7 8.8 7.7 3.8 7.8 15.3 1.6 3.2 5.1 8.6 0.0 7.6 26.8 17.4 0.6 0.6 5.1 8.1 6.7 11.9 14.3 21.3 1.2 0.0 2.4 10.7 0.6 0.4 23.8 1.4 12.4 0.3 6.7 0.0 3.2 20.9 7.7 0.2 0.6 3.7 3.1 1.6 0.0 21.3 0.5 25.3 0.0 0.4 10.8 0.1 4.9 0.7 13.2 0.1 1.0 54.6 0.0 0.2 2.7 0.0 0.4 27.8 0.0 0.4 3.7 8.8 43.9 0.6 0.1 2.6 0.0 3.9 0.0 0.2 0.4 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.0 8.1 11.8 8.7 7.4 8.8 8.6 8.5 7.7 9.8 7.1 7.7 8.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 FAM187A ENSG00000214447 "Family with sequence similarity 187 member A" A6NFU0 17 44899712-44905390 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.1;testis: 16.1" "Cell type enriched" "Detected in single" 36 "Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.7;U-87 MG: 16.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" 0.5 1.9 2.6 0.4 2.2 0.5 1.2 1.7 3.0 1.5 2.7 0.7 0.1 0.8 2.3 0.4 15.1 0.8 0.3 1.8 3.2 2.8 0.3 1.1 0.5 2.1 2.5 1.7 1.3 1.3 1.7 2.2 0.1 2.2 0.6 0.7 5.4 0.5 1.0 0.2 0.4 0.3 0.5 2.3 0.2 0.4 16.1 1.9 0.4 3.4 0.1 0.4 0.6 0.3 1.7 1.2 5.6 2.3 1.5 2.5 3.2 1.3 0.5 4.9 2.5 3.3 2.4 4.8 0.2 1.4 1.6 4.6 5.4 0.7 1.9 1.3 5.9 1.4 0.8 2.8 0.7 1.3 1.1 0.7 0.7 2.5 4.5 1.0 4.8 1.2 1.0 1.4 0.2 0.6 1.3 0.1 1.3 0.9 3.0 1.1 0.9 0.1 0.4 13.7 0.7 6.9 1.3 0.5 0.1 1.0 1.1 5.8 1.1 0.5 1.0 1.4 1.3 1.1 0.1 0.2 0.5 16.0 0.8 1.1 0.0 0.8 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 2.6 2.2 1.7 3.0 1.8 3.2 2.1 2.5 1.7 2.2 2.3 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLIN5 "LSDA5, LSDP5, MLDP, OXPAT" ENSG00000214456 "Perilipin 5" Q00G26 19 4522531-4535224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 203.7;pancreas: 113.2;skeletal muscle: 150.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 47.1;Astrocytes: 53.8;Cardiomyocytes: 39.8;Hepatic stellate cells: 42.1;Hepatocytes: 140.5" "Cancer enhanced" "Detected in many" "liver cancer: 9.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in single" 20 "granulocytes: 13.9" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;BEWO: 3.2;RT4: 3.1;SH-SY5Y: 2.8;T-47d: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA077050 Supported "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA077050: " "prognostic favorable (7.68e-4)" "unprognostic (1.01e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (8.56e-4)" "unprognostic (1.24e-2)" "unprognostic (6.06e-3)" "prognostic favorable (2.81e-4)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (1.97e-4)" "unprognostic (3.18e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "prognostic favorable (2.16e-4)" 37.5 6.5 10.9 3.6 10.2 5.3 29.5 7.1 9.6 5.1 11.2 4.9 1.5 2.7 3.9 3.4 12.7 2.0 46.2 8.3 7.7 29.9 203.7 9.4 0.5 9.6 7.8 7.9 91.5 113.2 1.5 19.0 0.2 8.7 17.8 0.6 0.9 61.6 3.9 150.4 5.6 5.4 0.5 6.3 8.2 59.4 3.4 9.7 0.4 9.9 25.0 1.0 11.3 2.7 6.6 0.2 0.1 0.5 2.3 1.7 0.1 3.2 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.7 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.4 0.3 0.4 0.4 0.0 0.0 0.0 0.2 0.2 0.1 0.7 0.2 0.1 0.6 0.1 0.4 0.4 0.3 0.3 0.1 0.1 2.1 0.2 3.1 0.3 2.8 0.2 0.4 0.0 0.2 6.3 0.4 0.3 0.3 0.3 0.2 0.2 0.3 0.1 0.1 0.2 0.6 0.1 1.9 0.4 0.8 0.3 0.3 0.2 0.3 0.2 0.2 0.1 0.4 0.3 0.3 13.9 0.6 0.3 0.3 0.1 0.1 10.9 10.2 7.1 9.6 8.3 7.7 9.6 7.8 7.9 8.7 6.3 9.7 6.6 6.0 9.6 47.1 53.8 1.6 0.5 18.4 2.3 4.0 1.2 9.2 1.9 39.8 35.8 11.5 1.8 0.0 0.4 0.1 11.9 9.8 8.7 1.5 20.8 1.4 7.4 0.0 2.7 1.1 12.3 0.5 1.3 16.3 5.1 3.8 18.7 42.1 140.5 0.5 0.0 1.8 6.9 4.1 6.9 0.5 0.3 0.3 2.5 0.0 5.6 0.1 8.1 0.0 11.1 2.0 4.8 1.3 2.6 0.5 6.6 0.5 11.1 10.4 1.2 13.1 25.8 1.8 6.2 6.6 0.5 1.0 1.4 1.1 20.5 8.8 11.5 SEC14L6 ENSG00000214491 "SEC14 like lipid binding 6" B5MCN3 22 30522799-30546682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 21.3;parathyroid gland: 30.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.5;Cholangiocytes: 11.5;Collecting duct cells: 12.9;Ductal cells: 6.6;Muller glia cells: 18.6" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 12.3;RPTEC TERT1: 21.8;SiHa: 6.6" HPA067695 Approved Nucleoplasm NA NA Nucleoplasm "HPA067695: AB_2685889" "unprognostic (3.49e-2)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (4.09e-2)" "unprognostic (3.04e-2)" "unprognostic (1.12e-1)" "unprognostic (7.28e-3)" "unprognostic (3.88e-2)" "unprognostic (3.13e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.25e-2)" "unprognostic (8.69e-2)" "unprognostic (8.20e-2)" "unprognostic (2.12e-1)" "unprognostic (2.48e-2)" "unprognostic (6.02e-2)" 0.7 1.4 5.5 0.3 4.9 2.2 3.9 4.8 5.0 3.5 5.4 0.4 0.6 3.3 21.3 0.3 1.7 4.6 0.2 4.6 6.7 8.2 0.4 12.0 0.4 8.1 6.1 3.7 2.4 5.5 30.8 2.5 0.5 9.0 1.8 0.3 5.1 0.4 2.6 0.2 6.5 0.5 2.2 5.4 0.4 1.2 5.5 7.5 0.3 0.3 0.8 0.6 0.4 0.4 6.6 0.2 0.1 0.9 0.3 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.2 0.5 0.3 1.1 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 3.0 0.3 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.7 0.0 0.1 12.3 0.2 0.0 0.5 0.1 0.4 0.5 0.0 0.1 0.2 0.0 0.1 21.8 0.2 0.2 0.1 6.6 0.1 0.0 0.2 1.8 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.1 0.1 0.5 0.0 5.5 4.9 4.8 5.0 4.6 6.7 8.1 6.1 3.7 9.0 5.4 7.5 6.6 0.0 12.8 10.5 0.3 0.2 0.1 0.5 0.0 0.0 0.2 0.4 0.5 0.3 11.5 3.7 12.9 0.0 0.0 0.0 0.0 1.9 6.6 0.0 0.3 0.4 1.0 0.0 0.0 0.7 0.8 0.0 0.2 0.0 1.5 1.3 0.2 0.7 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.6 18.6 0.0 1.5 0.6 1.8 0.0 0.7 0.0 0.1 0.0 2.9 0.0 0.5 0.0 2.7 0.1 0.9 0.4 0.0 0.0 0.1 0.9 0.0 0.0 0.2 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor Kazal type 13" Q1W4C9 5 148268180-148286255 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "epididymis: 331.7" "Group enriched" "Detected in some" 6 "Leydig cells: 39.7;Peritubular cells: 26.7" "Cancer enhanced" "Detected in some" "renal cancer: 3.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "HeLa: 574.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036456 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.3 1.9 0.5 0.1 1.2 0.0 0.0 0.8 1.4 0.1 0.0 0.7 0.0 0.2 331.7 0.1 0.4 0.2 0.5 0.4 0.4 0.6 0.0 0.3 0.1 1.2 1.2 0.2 0.5 0.2 0.0 0.5 0.0 2.0 1.7 0.0 1.5 0.2 31.6 0.4 0.5 0.0 0.1 0.5 0.0 1.6 1.4 0.7 0.1 0.3 0.0 0.1 1.5 0.1 2.8 0.0 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 574.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.0 1.5 0.0 0.0 0.3 30.0 0.2 0.3 0.0 22.5 0.0 0.0 0.2 1.9 0.0 0.6 1.1 0.1 0.4 0.1 0.6 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.8 1.4 0.4 0.4 1.2 1.2 0.2 2.0 0.5 0.7 2.8 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.0 0.6 0.0 0.0 0.0 0.0 0.1 39.7 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.4 2.8 0.0 26.7 0.1 0.5 0.0 0.1 0.0 0.6 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIGD1C Gm921 ENSG00000214511 "HIG1 hypoxia inducible domain family member 1C" A8MV81 12 50953922-50970506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.2" "Cell type enhanced" "Detected in some" "Astrocytes: 6.2;Early spermatids: 8.2;Excitatory neurons: 3.3;Inhibitory neurons: 4.0;Oligodendrocyte precursor cells: 7.1;Oligodendrocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.2;Karpas-707: 1.6" "Region enriched" "Detected in single" 10 "hypothalamus: 1.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.81e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-1)" "unprognostic (4.21e-1)" "unprognostic (2.70e-1)" "unprognostic (5.49e-1)" "unprognostic (2.99e-1)" 0.4 0.3 0.7 0.0 1.1 0.0 0.1 3.2 1.3 0.1 0.5 0.2 0.0 0.2 0.0 0.1 0.5 0.5 0.0 0.5 0.6 0.2 1.2 0.6 0.8 1.1 0.7 0.3 0.4 1.0 0.5 0.1 0.0 2.7 0.1 0.3 0.2 0.4 0.2 0.3 0.6 0.3 0.3 0.6 0.3 0.5 1.7 1.2 0.4 1.0 0.2 0.3 0.3 0.0 2.3 0.0 0.0 0.1 0.5 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.1 3.2 1.3 0.5 0.6 1.1 0.7 0.3 2.7 0.6 1.2 2.3 0.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 7.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NOTO ENSG00000214513 "Notochord homeobox" A8MTQ0 2 73202574-73212513 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034660, HPA063906" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034660: AB_10601974, HPA063906: " "unprognostic (6.09e-2)" "unprognostic (9.77e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.68e-2)" 0.0 0.1 0.3 0.1 0.2 0.5 0.0 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.5 0.3 0.2 0.2 0.5 0.3 0.1 0.5 0.3 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPME1 "ABDH19, PME-1" ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171267-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 432.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 45000 Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254" "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 14.8 25.3 14.3 10.1 18.7 17.1 15.0 8.4 21.0 17.5 9.3 15.3 11.1 17.0 29.4 21.0 24.3 14.1 21.6 18.4 18.7 18.8 10.2 13.1 9.3 12.4 13.8 17.0 18.4 15.5 62.9 14.6 15.0 16.2 24.0 15.9 24.0 20.3 25.2 30.0 28.9 11.6 21.6 9.0 8.1 13.5 32.1 13.4 19.0 23.3 24.3 14.8 22.5 14.0 22.8 50.5 62.3 42.4 45.9 45.4 36.0 41.3 71.8 48.4 134.8 103.6 139.1 32.3 26.3 47.7 55.1 73.6 79.9 63.4 50.3 123.1 36.4 23.8 38.7 66.6 64.1 96.7 28.9 33.2 34.6 41.8 69.7 32.7 54.8 39.1 37.5 93.0 22.5 236.6 34.1 38.0 36.1 34.4 71.2 50.3 39.9 432.4 39.9 56.7 33.9 57.2 49.2 85.1 38.7 108.4 46.2 72.7 29.1 23.5 52.1 67.6 51.5 55.2 41.4 54.6 46.9 39.2 26.7 43.4 1.4 8.7 11.3 10.4 10.5 13.2 7.2 13.4 12.6 11.2 8.3 13.3 10.9 4.9 13.7 9.5 11.8 10.9 9.2 14.3 18.7 8.4 21.0 18.4 18.7 12.4 13.8 17.0 16.2 9.0 13.4 22.8 16.1 28.9 12.8 28.7 10.8 20.3 24.4 30.5 23.3 31.3 18.5 17.7 18.0 7.2 28.5 35.0 37.5 14.1 11.2 15.4 17.6 16.9 51.4 44.9 32.8 15.0 25.7 96.4 65.3 13.4 38.9 19.1 23.9 24.2 8.2 21.2 10.8 9.7 13.6 33.7 59.3 13.5 34.6 6.7 14.8 13.4 13.7 11.1 3.6 20.6 10.8 15.2 16.5 35.7 40.5 16.6 12.0 25.2 8.2 19.2 10.3 11.6 40.9 18.8 6.6 19.0 33.0 61.9 45.6 21.5 24.9 15.5 12.4 18.8 13.4 17.3 KRTAP2-2 KAP2.2 ENSG00000214518 "Keratin associated protein 2-2" Q9BYT5 17 41054498-41055230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 337 "skin 1: 33.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STARD10 "CGI-52, NY-CO-28, PCTP2, SDCCAG28" ENSG00000214530 "StAR related lipid transfer domain containing 10" Q9Y365 11 72754729-72794047 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 715.5" "Cell type enhanced" "Detected in all" "Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 21.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026661 Uncertain Supported Cytosol NA NA 13000 Cytosol "HPA026661: AB_1857538" "prognostic favorable (6.92e-4)" "unprognostic (2.07e-1)" "unprognostic (8.03e-2)" "unprognostic (1.74e-3)" "unprognostic (3.71e-2)" "unprognostic (1.37e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "unprognostic (4.16e-1)" "unprognostic (4.69e-2)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (4.24e-3)" "unprognostic (8.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.12e-2)" "unprognostic (1.04e-1)" 11.8 179.7 38.9 17.9 41.0 10.4 62.7 41.9 41.0 72.5 41.4 182.3 48.9 27.5 103.8 52.4 26.6 60.1 67.9 37.1 37.3 50.5 715.5 38.0 14.6 40.5 36.6 35.9 31.2 214.4 73.7 36.5 40.6 41.6 86.9 189.9 18.8 95.3 31.1 67.3 62.6 66.6 26.9 31.9 20.4 269.0 185.7 39.3 15.7 48.3 159.3 22.0 24.7 41.4 42.9 51.2 15.3 7.7 28.7 9.8 9.6 98.3 5.6 26.2 17.3 17.3 209.8 36.7 4.4 16.7 19.2 42.3 31.8 23.4 46.8 20.2 28.3 9.0 5.9 11.1 217.6 35.2 1.6 10.0 6.6 127.0 19.1 26.7 47.2 17.8 10.0 12.1 21.5 3.9 617.7 4.8 11.1 3.4 1316.9 20.1 4.5 13.3 3.4 23.5 61.4 13.0 10.1 8.6 427.4 73.3 32.8 235.5 6.3 13.6 17.0 11.4 6.0 10.1 22.2 19.8 7.5 4.3 5.6 6.5 12.9 2.6 16.0 1.6 1.1 1.2 4.2 1.5 1.7 1.2 2.4 1.6 1.6 21.7 7.5 0.6 2.6 2.1 1.1 38.9 41.0 41.9 41.0 37.1 37.3 40.5 36.6 35.9 41.6 31.9 39.3 42.9 10.6 35.3 74.1 8.1 18.1 31.5 76.3 41.0 25.0 10.5 163.3 125.3 45.3 270.2 76.4 55.2 22.9 212.8 17.1 362.8 123.3 70.7 520.2 26.5 6.8 18.5 302.2 22.9 11.6 94.3 93.1 21.1 372.1 25.3 25.4 10.1 30.0 660.0 26.4 33.7 13.9 717.9 85.5 26.0 34.4 2055.8 26.1 12.3 16.0 5.6 7.7 64.4 7.2 8.0 11.8 93.9 398.9 25.2 13.3 150.9 73.5 58.0 34.5 16.6 6.6 11.3 19.6 101.2 22.7 30.2 55.0 352.2 15.6 7.7 440.7 132.7 ZNF705E ENSG00000214534 "Zinc finger protein 705E" A8MWA4 11 71814045-71821548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.65e-2)" "unprognostic (1.34e-2)" "unprognostic (5.02e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (8.00e-5)" "unprognostic (6.79e-2)" "unprognostic (1.37e-2)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (5.94e-2)" "unprognostic (2.70e-1)" "unprognostic (5.13e-4)" "unprognostic (9.18e-3)" "unprognostic (1.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.34e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 NUTM2D FAM22D ENSG00000214562 "NUT family member 2D" Q5VT03 10 87357720-87370695 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Cone photoreceptor cells: 4.2;Gastric mucus-secreting cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 12.4;hTCEpi: 11.7" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (2.13e-1)" "unprognostic (7.95e-2)" "unprognostic (3.94e-2)" "unprognostic (2.16e-1)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.35e-4)" "unprognostic (1.87e-1)" "unprognostic (2.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.46e-1)" "unprognostic (3.57e-1)" "unprognostic (7.76e-3)" "unprognostic (1.00e-2)" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (2.32e-1)" 2.8 3.1 5.5 1.4 7.3 2.4 3.1 5.1 7.1 2.3 0.4 3.5 2.1 3.1 3.4 2.8 3.1 2.6 5.3 4.9 5.0 3.9 4.2 3.3 2.2 8.3 7.4 3.7 3.7 4.8 4.1 4.8 2.5 11.3 4.5 2.0 2.7 4.0 2.0 3.8 4.7 3.2 1.3 4.3 3.7 4.0 5.0 7.3 2.5 4.5 2.9 1.6 3.1 3.1 10.9 3.9 2.8 6.1 0.0 1.6 2.3 1.4 1.0 5.0 2.2 2.5 1.8 1.9 3.3 0.9 1.7 1.0 1.8 0.1 2.0 1.0 2.2 2.7 4.9 0.2 2.8 3.8 3.1 12.4 3.7 11.7 2.5 1.9 3.4 2.2 4.3 5.2 0.8 0.5 3.5 2.4 5.2 3.4 0.8 0.3 3.3 0.4 0.1 2.2 0.8 2.4 3.7 1.1 2.6 1.2 2.3 4.9 2.4 5.5 1.5 1.0 1.4 1.8 4.0 2.4 0.9 0.9 1.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 7.3 5.1 7.1 4.9 5.0 8.3 7.4 3.7 11.3 4.3 7.3 10.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.3 0.3 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 CPEB1 "CPEB, FLJ13203" ENSG00000214575 "Cytoplasmic polyadenylation element binding protein 1" Q9BZB8 15 82543201-82648861 "Predicted intracellular proteins" "mRNA processing, Translation regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9;testis: 32.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 14.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1" HPA040396 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040396: AB_2676960" "unprognostic (3.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-2)" "unprognostic (7.51e-3)" "unprognostic (1.97e-3)" "unprognostic (9.50e-3)" "unprognostic (8.17e-2)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" 2.8 5.0 12.8 1.3 17.9 0.2 2.5 20.3 17.9 8.8 4.4 5.3 1.2 4.2 7.9 3.6 8.4 4.0 2.9 13.9 17.2 1.2 0.2 1.6 0.5 22.4 17.8 11.9 14.4 1.3 0.8 21.9 0.3 23.7 2.3 2.4 4.5 1.5 3.8 2.4 1.7 2.5 3.4 22.5 0.6 2.5 32.7 18.1 0.4 2.3 10.6 0.5 7.8 6.2 34.9 0.1 3.6 0.3 0.4 2.6 0.2 0.1 2.8 0.3 1.8 1.4 0.2 0.1 0.0 6.3 1.1 19.5 0.1 5.1 0.0 0.4 0.0 4.2 0.1 0.1 0.1 1.8 0.1 2.3 1.4 0.0 3.5 0.0 0.2 0.0 7.6 8.9 0.2 1.3 0.2 0.6 0.1 8.2 0.1 1.0 0.0 0.2 0.1 0.0 0.1 10.5 2.4 9.2 0.5 37.9 11.2 0.1 1.1 0.1 18.9 7.5 106.0 6.0 5.3 14.3 1.4 39.1 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.5 0.0 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 17.9 20.3 17.9 13.9 17.2 22.4 17.8 11.9 23.7 22.5 18.1 34.9 0.3 0.0 0.0 19.6 0.1 0.8 0.3 0.0 0.0 11.5 0.6 0.3 1.9 0.0 0.0 0.0 10.4 0.0 0.1 0.1 0.0 0.1 12.6 0.5 1.4 0.2 0.0 0.0 70.0 0.0 0.0 5.9 0.5 0.1 1.3 0.3 0.4 0.0 0.3 11.8 44.3 0.0 0.0 0.0 0.8 20.0 4.1 0.4 5.4 10.3 0.1 5.2 0.0 10.1 196.5 0.1 0.0 2.2 0.2 0.5 0.0 0.4 2.2 4.3 6.6 1.9 1.8 34.1 62.3 0.0 0.6 0.1 0.4 0.0 0.0 0.1 EML6 FLJ42562 ENSG00000214595 "EMAP like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.4;retina: 14.0" "Cell type enhanced" "Detected in many" "Astrocytes: 145.0;Excitatory neurons: 372.7;Inhibitory neurons: 265.1;Oligodendrocyte precursor cells: 95.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 10.9;SCLC-21H: 34.0;U-698: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA062808: AB_2684872, HPA068759: AB_2686027" "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.3 3.0 2.0 4.0 1.9 0.7 0.7 1.6 3.4 0.2 0.2 0.7 0.7 0.3 1.1 0.6 0.4 0.2 0.1 2.2 1.9 1.1 0.5 0.4 7.1 1.4 1.6 1.8 0.1 0.8 1.9 3.2 1.5 1.5 0.6 0.9 14.0 0.5 0.5 1.0 0.9 2.0 0.4 0.8 2.7 0.5 1.3 1.2 0.6 2.6 0.6 10.4 0.6 0.4 3.1 0.7 2.0 0.2 1.5 1.0 0.3 2.0 0.2 0.3 0.2 0.2 0.8 0.3 10.9 0.2 0.7 0.4 0.3 1.4 0.5 0.4 1.0 0.4 0.6 0.9 5.1 0.0 0.3 0.0 0.1 0.1 0.6 1.1 0.2 0.2 6.2 0.0 2.0 0.0 1.1 2.1 0.4 0.5 0.2 2.3 0.9 0.7 0.8 0.1 1.4 34.0 4.2 0.5 0.1 0.0 0.2 0.1 0.1 0.3 0.4 2.1 0.5 0.6 7.8 2.2 35.0 1.8 3.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.9 1.6 3.4 2.2 1.9 1.4 1.6 1.8 1.5 0.8 1.2 3.1 0.9 0.0 1.1 145.0 7.3 3.7 1.9 0.6 1.8 28.0 1.1 0.8 2.0 0.0 3.5 3.7 56.3 0.4 0.4 0.5 0.0 0.2 24.6 2.9 0.6 1.3 2.4 0.0 372.7 0.4 0.6 1.0 2.0 1.2 0.0 0.8 1.4 0.6 1.3 38.7 265.1 3.6 0.0 1.0 2.3 11.2 0.6 0.6 0.0 19.7 0.0 14.3 1.0 95.5 30.2 0.1 0.1 0.7 8.4 1.6 1.1 0.7 7.0 32.7 0.0 2.2 1.5 5.1 2.6 0.6 4.4 0.1 0.8 0.9 0.4 2.3 DEFB113 DEFB-13 ENSG00000214642 "Defensin beta 113" Q30KQ7 6 49968677-49969625 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 469 "epididymis: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB133 ENSG00000214643 "Defensin beta 133" Q30KQ1 6 49946021-49950265 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 131 "epididymis: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF727 ZNF727P ENSG00000214652 "Zinc finger protein 727" A8MUV8 7 64045434-64085339 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 7.2;Excitatory neurons: 13.3;Inhibitory neurons: 7.7;Microglial cells: 9.4;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 27.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "T-47d: 7.2" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (5.87e-2)" "unprognostic (3.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.75e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "unprognostic (3.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (2.54e-1)" "unprognostic (4.04e-2)" "unprognostic (5.73e-4)" "unprognostic (8.70e-2)" "unprognostic (6.36e-2)" "unprognostic (8.61e-2)" 1.2 0.7 1.9 0.3 2.4 0.1 2.4 3.1 2.1 1.5 0.1 0.6 0.3 1.9 2.7 0.6 1.7 0.6 0.7 2.5 2.2 1.1 0.1 0.8 0.5 2.4 2.4 1.5 3.3 0.9 1.2 1.1 0.0 2.6 2.0 0.6 3.6 1.0 1.1 0.6 1.4 0.3 1.3 1.3 0.7 0.6 1.9 3.1 0.4 3.1 0.9 0.3 0.7 0.9 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.9 7.2 0.0 0.0 0.1 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.9 2.4 3.1 2.1 2.5 2.2 2.4 2.4 1.5 2.6 1.3 3.1 3.1 1.3 0.0 0.0 7.2 0.1 0.0 0.3 0.0 0.6 2.2 0.5 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.9 0.2 2.1 0.4 2.1 0.6 0.0 0.0 13.3 0.0 0.0 0.9 0.0 0.2 0.0 1.5 0.0 0.1 0.0 1.7 7.7 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 9.4 0.0 0.4 0.0 34.2 27.0 0.2 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.5 0.0 1.3 0.9 0.6 1.7 0.7 0.0 0.0 0.0 1.6 0.0 0.0 B3GNT10 ENSG00000214654 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10 (putative)" A8MXE2 9 120792403-120799918 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Distal tubular cells: 1.9;Endometrial ciliated cells: 1.5;Endometrial stromal cells: 1.3;Proximal tubular cells: 1.3;Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (4.59e-3)" "unprognostic (2.71e-2)" "unprognostic (3.04e-2)" "unprognostic (5.71e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (7.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.57e-2)" "unprognostic (1.08e-7)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" 1.2 1.2 0.8 1.9 1.1 4.8 2.2 0.9 0.7 1.3 1.1 1.8 1.6 0.8 2.0 1.2 1.9 1.2 1.1 0.6 1.2 2.7 1.2 1.2 2.7 1.2 1.1 0.1 1.7 1.4 2.2 0.8 1.2 1.0 1.9 2.2 2.4 1.3 1.5 1.0 1.2 1.5 0.9 1.0 1.9 2.3 2.5 0.9 2.2 2.8 0.4 2.9 1.2 0.5 2.7 3.0 3.7 4.0 2.6 3.4 2.6 4.9 2.8 2.9 4.7 2.8 1.2 4.5 5.7 2.4 1.4 5.5 7.8 7.1 5.7 5.4 7.0 2.2 3.3 2.7 1.9 5.7 3.9 1.4 2.8 2.9 3.5 8.2 1.0 0.9 6.5 10.2 7.7 2.9 4.3 2.9 0.9 5.8 6.4 3.6 3.0 7.6 8.8 2.6 2.9 5.7 4.4 5.2 2.5 5.5 2.5 10.1 0.8 1.4 2.3 2.0 5.0 2.8 9.1 14.8 5.4 4.9 2.2 4.8 0.3 0.5 1.2 0.9 0.5 1.0 0.8 0.9 1.1 0.6 0.8 1.3 0.7 0.4 1.1 1.0 0.4 1.2 0.7 0.8 1.1 0.9 0.7 0.6 1.2 1.2 1.1 0.1 1.0 1.0 0.9 2.7 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 3.7 0.0 0.0 0.6 0.0 1.9 0.5 0.0 1.5 1.3 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785606-73801797 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favorable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 58.6 97.8 86.2 19.9 87.3 43.2 59.8 84.3 111.4 77.5 86.8 68.9 27.5 64.4 43.8 106.4 63.0 25.2 61.4 87.0 86.1 97.4 144.8 69.5 25.3 87.2 85.7 86.0 70.4 65.0 35.6 146.1 25.0 88.1 91.9 18.0 27.8 71.5 28.6 62.7 89.2 70.6 28.4 83.6 110.7 68.6 97.2 86.5 25.3 88.3 22.6 21.8 75.1 77.7 89.9 14.0 23.3 28.4 46.9 65.6 31.2 16.3 17.5 48.1 24.3 29.1 20.7 11.3 7.9 12.3 28.6 23.6 20.6 10.1 19.9 12.2 12.6 21.3 11.2 26.1 27.7 49.2 7.7 41.4 51.4 36.2 30.2 35.0 66.0 28.5 16.4 16.0 14.9 28.3 21.2 11.7 22.8 8.4 11.2 72.8 13.9 13.5 4.7 34.9 29.6 6.8 30.9 14.5 42.1 25.9 24.5 28.5 15.8 29.6 26.7 16.0 12.2 18.1 37.6 21.6 5.1 29.5 11.3 14.1 2.4 2.2 1.9 3.0 1.5 1.7 1.8 1.3 1.3 1.8 1.2 0.6 1.9 4.9 1.1 2.5 3.8 1.8 1.0 86.2 87.3 84.3 111.4 87.0 86.1 87.2 85.7 86.0 88.1 83.6 86.5 89.9 17.2 3.2 11.5 49.6 7.2 12.4 7.4 15.1 11.4 32.8 20.2 17.7 1.4 20.0 12.8 20.2 68.8 13.4 27.2 21.7 1.9 13.7 5.5 14.0 19.0 17.1 20.4 11.4 34.0 14.8 8.4 13.2 24.5 22.2 0.0 18.8 29.6 35.0 19.0 35.3 30.2 18.3 14.2 24.2 15.7 2.2 22.1 17.1 16.0 21.5 19.2 19.6 15.5 26.7 36.5 17.5 19.5 24.0 8.2 17.7 41.3 11.7 15.4 45.3 13.1 21.1 18.3 35.8 15.9 14.9 14.2 28.7 13.9 19.3 12.1 17.9 IQCF5 ENSG00000214681 "IQ motif containing F5" A8MTL0 3 51873721-51875601 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 504 "testis: 105.2" "Group enriched" "Detected in some" 92 "Early spermatids: 926.1;Late spermatids: 2733.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" NA NA "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 926.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2733.9 12.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 18.6 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF6 ENSG00000214686 "IQ motif containing F6" A8MYZ5 3 51778561-51779241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 21.6" "Group enriched" "Detected in some" 218 "Early spermatids: 379.2;Late spermatids: 188.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 1.0;U-937: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.98e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 379.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.6 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf105 FLJ00245 ENSG00000214688 "Chromosome 10 open reading frame 105" Q8TEF2 10 71711701-71737824 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 28.4" "Group enriched" "Detected in some" 4 "Early spermatids: 8.7;Langerhans cells: 2.4;Late spermatids: 5.1;Melanocytes: 3.6" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.8;non-classical monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "BJ hTERT+: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.60e-3)" "unprognostic (6.76e-3)" "unprognostic (5.45e-1)" "unprognostic (4.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.37e-6)" "unprognostic (5.25e-2)" "unprognostic (2.10e-3)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.35e-1)" "unprognostic (7.37e-2)" "unprognostic (4.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" 0.4 0.0 18.0 0.7 12.2 0.5 0.1 17.2 6.9 0.2 3.5 0.1 0.2 0.1 0.0 0.1 0.4 0.2 0.2 9.3 23.6 0.0 0.1 0.5 1.1 28.4 27.4 5.3 0.5 0.0 0.0 0.1 0.1 18.9 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.0 17.6 2.8 0.1 1.4 24.7 0.5 0.0 0.1 0.4 0.1 0.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.1 18.0 12.2 17.2 6.9 9.3 23.6 28.4 27.4 5.3 18.9 17.6 24.7 14.4 0.4 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.4 5.1 0.0 0.7 3.6 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889875-38975454 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 23.3" "Cell type enhanced" "Detected in many" "Early spermatids: 34.8;Excitatory neurons: 15.2;Late spermatids: 26.8;Spermatocytes: 34.7;Spermatogonia: 35.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "eosinophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Group enriched" "Detected in some" 4 "BEWO: 5.6;HeLa: 2.6;SiHa: 7.2" "Region enriched" "Detected in many" 32 "cerebellum: 280.4" "Region enriched" "Detected in all" 6 "cerebellum: 23.1" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.4 2.1 5.8 0.6 5.3 0.0 0.9 23.3 5.9 1.4 3.9 0.7 0.1 1.5 2.6 0.4 1.4 0.8 0.4 5.0 4.3 0.7 0.2 0.7 0.3 4.4 5.5 4.6 3.5 0.4 0.7 3.4 0.5 8.3 0.9 0.3 4.1 0.5 0.7 0.3 0.8 0.4 0.5 3.8 0.3 0.5 5.8 6.9 0.1 1.2 0.0 0.2 0.7 0.7 6.1 0.2 0.0 0.2 0.1 0.1 0.1 5.6 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.1 2.6 0.1 0.4 0.2 0.1 0.5 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.3 0.3 0.2 7.2 0.3 0.0 0.6 0.0 0.2 0.4 0.1 0.9 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.2 3.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.8 5.3 23.3 5.9 5.0 4.3 4.4 5.5 4.6 8.3 3.8 6.9 6.1 0.4 0.0 1.5 7.8 0.1 0.0 0.1 0.0 0.6 2.5 0.3 0.6 0.8 1.5 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.1 34.8 1.8 1.2 0.4 0.0 2.7 15.2 0.0 1.9 1.2 0.0 0.2 0.0 1.4 0.0 0.2 1.0 0.0 11.4 0.4 0.0 0.0 0.0 26.8 1.2 0.2 0.0 1.9 0.1 3.6 0.0 5.5 3.4 0.0 0.0 3.4 0.0 0.1 0.0 0.4 3.9 2.9 0.0 0.3 1.5 34.7 35.6 0.1 0.1 0.5 0.0 2.0 0.1 0.2 C12orf71 LOC728858 ENSG00000214700 "Chromosome 12 open reading frame 71" A8MTZ7 12 27081057-27082578 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.4;testis: 3.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 19.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "NK-cell: 1.0" "Lineage enriched" "Detected in single" 10 "NK-cells: 1.0" "Cell line enhanced" "Detected in single" "HDLM-2: 1.4" "Not detected" "Not detected" "HPA038359, HPA058728" Uncertain Approved Cytosol NA NA Cytosol "HPA038359: , HPA058728: AB_2683800" "unprognostic (1.14e-1)" "unprognostic (9.86e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (2.36e-1)" "unprognostic (6.78e-3)" "unprognostic (9.90e-2)" "unprognostic (3.13e-1)" "unprognostic (7.12e-3)" "unprognostic (1.02e-1)" "unprognostic (6.73e-3)" "unprognostic (1.96e-1)" "unprognostic (4.15e-8)" "unprognostic (4.85e-2)" "unprognostic (9.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.1 0.1 0.3 0.1 0.3 1.4 0.1 0.0 0.3 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.1 3.3 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.3 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 IFRD2 "IFNRP, SKMc15, SM15" ENSG00000214706 "Interferon related developmental regulator 2" Q12894 3 50287732-50292918 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 139.9;Prostatic glandular cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068560 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA068560: AB_2686005" "prognostic favorable (7.22e-4)" "unprognostic (5.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.61e-3)" "unprognostic (3.88e-1)" "unprognostic (2.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.91e-2)" "unprognostic (7.78e-3)" "prognostic favorable (2.50e-4)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" 33.9 45.3 18.1 14.1 18.8 15.8 34.2 18.6 21.0 23.1 19.9 33.2 20.3 27.1 11.9 44.7 28.5 11.0 56.7 17.5 20.0 38.2 97.8 30.9 14.3 19.0 19.0 17.0 23.3 88.0 17.9 22.2 9.4 18.6 45.5 15.2 3.7 34.0 16.8 110.5 24.1 28.4 15.1 19.4 28.5 68.4 17.6 19.2 8.5 32.1 45.0 12.6 36.4 23.8 19.3 70.1 70.5 19.1 60.3 19.2 22.0 44.0 52.4 28.2 62.8 44.3 58.3 69.5 47.3 37.7 36.3 53.9 40.0 40.2 83.8 32.3 45.4 80.7 68.4 93.5 69.5 37.9 70.1 41.4 20.4 70.6 65.7 81.9 20.7 54.0 41.8 44.2 37.9 37.6 65.1 46.5 82.0 48.1 86.1 135.4 29.8 27.7 108.1 38.0 41.3 33.7 32.5 33.2 90.4 34.4 18.3 43.1 66.4 39.5 52.2 65.6 91.3 107.9 26.5 48.9 41.8 41.4 91.1 77.9 11.7 24.1 3.6 33.1 34.4 47.5 32.4 35.0 32.3 35.2 34.0 36.7 33.3 2.3 39.0 19.7 35.0 30.9 30.5 18.1 18.8 18.6 21.0 17.5 20.0 19.0 19.0 17.0 18.6 19.4 19.2 19.3 36.9 19.2 24.6 5.9 26.8 67.3 71.7 51.7 31.9 17.3 48.5 37.1 1.7 32.9 36.4 20.2 20.9 35.3 23.8 22.1 29.4 68.8 67.2 11.3 27.8 30.3 15.6 93.6 7.1 89.6 49.5 24.8 62.7 13.1 7.6 28.6 13.9 50.7 31.2 18.5 6.7 29.6 34.6 13.7 28.4 139.9 13.7 15.2 35.6 2.8 16.5 13.3 25.7 4.5 7.3 68.2 26.8 14.3 31.9 153.3 31.3 58.6 10.4 12.0 0.0 30.8 34.9 21.9 19.1 43.1 68.6 30.4 19.2 40.3 56.3 76.8 CAPN14 ENSG00000214711 "Calpain 14" A8MX76 2 31173056-31233858 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "esophagus: 145.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.2;Inhibitory neurons: 4.2;Squamous epithelial cells: 8.2;Urothelial cells: 15.5" "Cancer enhanced" "Detected in some" "cervical cancer: 2.9;head and neck cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.1;U-266/70: 3.4" "Not detected" "Not detected" NA NA "unprognostic (5.81e-3)" "unprognostic (1.20e-1)" "unprognostic (4.57e-2)" "unprognostic (1.88e-2)" "unprognostic (3.85e-2)" "unprognostic (3.30e-1)" "unprognostic (3.61e-2)" "unprognostic (4.67e-2)" "unprognostic (1.71e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" "unprognostic (1.60e-1)" "unprognostic (3.71e-4)" "unprognostic (8.42e-2)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (4.47e-4)" 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.6 0.8 0.1 0.0 1.7 0.0 0.7 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.6 0.8 0.1 0.2 0.0 0.0 3.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 1.7 4.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.5 0.5 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 8.2 0.0 1.4 0.1 0.0 0.1 15.5 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500976 "Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 91.0" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 18.1 36.1 19.0 11.9 15.9 7.3 17.0 19.8 16.2 16.3 11.1 15.5 19.0 18.1 5.4 12.3 13.1 13.1 27.2 13.4 15.5 13.9 32.8 12.3 12.6 24.2 19.5 10.1 13.2 21.6 11.4 10.5 10.0 20.4 15.5 11.6 8.2 16.9 10.6 71.4 21.8 20.6 9.4 20.1 15.6 14.9 7.8 20.6 11.4 12.2 37.8 9.4 13.2 13.0 25.3 11.6 28.3 20.2 22.4 12.6 13.3 91.0 16.1 17.5 9.3 10.7 36.4 10.0 22.8 18.1 21.5 25.5 5.4 19.5 16.7 6.9 27.0 26.0 17.0 23.4 31.3 16.5 10.6 34.1 19.7 12.8 9.8 7.3 13.8 22.1 15.2 21.9 7.3 18.2 8.2 17.7 8.5 49.9 7.4 16.6 14.0 20.0 10.8 15.6 22.2 24.0 23.6 13.7 36.2 25.6 22.6 10.0 22.3 30.7 19.9 10.5 11.0 17.7 8.7 0.1 37.4 8.1 14.8 11.5 2.2 11.8 10.3 10.6 11.7 9.3 8.4 6.1 5.9 13.3 11.2 5.7 4.9 12.5 5.5 9.8 9.7 6.4 11.7 19.0 15.9 19.8 16.2 13.4 15.5 24.2 19.5 10.1 20.4 20.1 20.6 25.3 12.9 12.8 11.7 0.0 20.7 15.2 17.6 14.1 29.6 55.5 12.9 12.4 27.8 40.0 9.2 25.8 14.6 15.9 18.7 23.3 11.7 22.8 0.4 23.0 18.2 17.5 15.5 7.6 0.0 23.4 18.0 22.6 8.2 28.5 14.7 37.1 18.5 37.3 18.0 10.1 0.0 19.4 10.2 22.2 24.9 1.3 19.9 19.5 8.8 0.0 23.0 20.5 34.0 0.0 0.0 22.7 17.3 23.0 8.8 19.7 25.5 18.1 15.8 23.5 6.6 23.7 19.2 0.7 2.6 15.8 11.2 38.0 14.4 29.5 23.2 12.9 TOMM6 "OBTP, Tom6" ENSG00000214736 "Translocase of outer mitochondrial membrane 6" Q96B49 6 41787662-41789898 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 18.7;Astrocytes: 31.0;Club cells: 10.5;Excitatory neurons: 16.5;granulocytes: 8.8;Inhibitory neurons: 15.5;Microglial cells: 10.3;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 26.3;Respiratory ciliated cells: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 2247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004801 Approved Supported Mitochondria NA NA Mitochondria "HPA004801: AB_1859553" 168.8 269.9 242.7 138.0 245.1 229.9 222.1 246.9 323.4 155.7 252.7 159.7 102.7 140.9 272.7 235.9 164.3 97.1 242.1 243.7 251.1 248.6 234.2 144.8 209.2 245.6 241.4 242.5 180.5 210.1 195.0 144.3 142.4 246.1 179.1 178.8 130.0 167.6 121.5 274.6 190.3 136.0 133.4 248.3 201.9 171.6 134.9 244.6 194.4 162.7 234.9 263.0 168.1 155.2 255.5 647.0 319.0 372.7 382.2 337.6 398.5 391.6 312.2 324.8 390.3 380.4 559.4 295.3 289.3 373.3 370.1 445.4 201.2 597.3 523.3 505.9 409.8 619.8 525.5 382.4 928.6 264.9 708.7 328.6 362.0 529.4 431.8 366.2 277.1 480.4 407.1 1335.5 350.4 481.7 766.0 519.4 1124.8 329.7 2247.1 312.6 373.3 234.1 865.3 540.1 329.3 327.6 458.7 213.0 369.5 548.5 389.7 451.6 1411.8 342.8 272.0 340.9 274.2 478.8 318.6 751.6 1314.8 155.9 586.7 362.7 119.3 439.5 259.3 291.7 448.3 283.7 419.2 294.4 291.2 454.1 380.7 329.3 324.1 55.9 230.6 475.3 474.6 303.3 674.5 242.7 245.1 246.9 323.4 243.7 251.1 245.6 241.4 242.5 246.1 248.3 244.6 255.5 0.0 3.2 18.7 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.5 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 10.3 0.0 0.0 0.0 12.1 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 HNRNPUL2 "DKFZp762N1910, HNRPUL2" ENSG00000214753 "Heterogeneous nuclear ribonucleoprotein U like 2" Q1KMD3 11 62712630-62727457 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA041632, HPA056696, HPA067699" Supported Enhanced Nucleoplasm NA NA 88000 Nucleoplasm "HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891" "unprognostic (3.06e-3)" "unprognostic (2.31e-1)" "unprognostic (7.48e-2)" "unprognostic (9.27e-3)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (1.91e-2)" "unprognostic (2.21e-1)" "unprognostic (2.83e-1)" "unprognostic (4.99e-3)" "unprognostic (2.35e-1)" "unprognostic (6.43e-2)" "unprognostic (2.50e-1)" "unprognostic (3.92e-2)" "unprognostic (2.17e-1)" "unprognostic (2.33e-2)" "unprognostic (6.45e-2)" 30.7 21.1 48.0 28.9 48.5 27.6 26.5 51.5 51.4 28.7 41.0 39.1 29.3 32.8 36.6 37.5 29.3 17.2 29.7 48.5 47.1 25.1 21.2 26.0 35.4 46.3 48.0 45.6 26.8 32.8 24.9 21.0 25.3 48.4 26.8 28.2 37.8 30.9 30.5 49.1 39.6 35.5 28.6 45.8 34.4 31.6 16.9 48.6 47.8 24.5 36.2 37.9 34.5 28.5 47.9 110.9 49.8 83.5 50.3 45.1 55.3 14.4 70.2 41.5 52.1 40.2 34.4 37.5 129.1 36.5 57.9 45.0 62.2 51.2 66.3 69.1 59.1 27.8 123.0 64.9 39.1 41.2 127.8 78.1 43.8 50.7 50.2 61.4 41.0 64.8 33.5 46.6 47.8 61.0 63.5 128.1 114.1 39.8 41.4 42.9 88.6 77.0 62.3 65.4 65.2 48.4 56.3 71.7 57.8 75.3 39.3 43.5 55.6 72.8 61.0 28.2 77.4 74.4 60.8 54.3 124.6 55.3 62.1 57.5 1.1 0.8 1.3 1.4 0.6 1.0 1.0 1.0 1.2 0.5 1.3 0.8 0.9 1.0 0.8 1.4 1.4 1.0 0.5 48.0 48.5 51.5 51.4 48.5 47.1 46.3 48.0 45.6 48.4 45.8 48.6 47.9 21.1 28.9 12.1 0.0 19.0 29.4 15.0 20.2 13.6 31.3 25.0 18.7 43.8 30.0 17.5 53.3 10.4 27.9 32.4 68.8 5.9 27.4 9.9 20.8 26.3 30.6 38.4 23.5 0.0 36.0 26.9 23.0 19.4 29.7 15.2 28.0 37.5 40.7 37.9 42.1 0.0 48.3 22.4 54.1 29.4 6.9 42.0 27.6 14.2 0.0 38.0 18.2 24.7 0.0 0.0 35.0 42.7 45.9 12.5 24.1 59.6 25.6 16.1 19.7 32.9 22.8 27.5 15.6 20.1 19.6 32.1 25.2 19.8 20.6 58.6 17.4 CSKMT "CS-KMT, METTL12, U99HG" ENSG00000214756 "Citrate synthase lysine methyltransferase" A8MUP2 11 62665309-62668496 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "Adipocytes: 40.4;Alveolar cells type 2: 41.4;Breast glandular cells: 65.9;Breast myoepithelial cells: 68.5;dendritic cells: 46.3;Endometrial stromal cells: 37.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038533 Approved NA Yes "HPA038533: AB_10697392" "prognostic favorable (8.73e-4)" "unprognostic (2.59e-1)" "unprognostic (3.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.48e-2)" "unprognostic (3.17e-1)" "unprognostic (9.43e-5)" "unprognostic (1.55e-2)" "unprognostic (7.62e-2)" "unprognostic (2.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (4.98e-3)" "unprognostic (2.72e-3)" "unprognostic (1.85e-1)" "unprognostic (1.57e-2)" "unprognostic (3.28e-1)" 0.3 0.3 0.4 0.1 0.4 0.1 0.4 0.4 0.7 0.5 0.4 0.4 0.5 0.4 0.1 0.5 0.5 0.1 0.2 0.4 0.4 0.3 0.3 0.2 0.2 0.4 0.4 0.4 0.6 0.7 0.1 0.2 0.5 0.4 0.4 0.4 0.1 0.3 0.5 0.9 0.3 0.2 0.1 0.4 0.2 0.4 0.0 0.4 0.2 0.2 0.2 0.3 0.4 0.5 0.4 0.9 0.9 0.3 0.4 2.6 1.0 0.4 0.3 0.6 0.7 0.9 0.7 0.9 1.6 0.4 1.2 0.2 1.7 1.6 0.8 1.4 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.6 0.9 2.7 0.2 1.0 0.7 0.2 0.2 0.7 0.0 1.0 0.8 0.5 0.7 1.6 0.0 0.8 0.8 0.4 0.2 0.3 0.1 0.0 0.0 0.8 1.0 0.9 0.4 2.0 0.2 0.0 0.2 0.9 2.4 0.0 0.3 0.0 0.0 0.2 0.4 0.4 0.7 1.1 0.1 0.8 1.8 1.7 2.9 2.4 1.1 1.1 1.5 2.9 2.5 0.0 0.5 1.3 1.3 1.3 1.4 0.4 0.4 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 40.4 12.8 41.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 65.9 68.5 0.0 0.0 21.1 18.4 0.0 27.7 46.3 0.0 5.9 7.4 0.0 17.5 37.7 10.1 0.0 0.0 0.0 5.6 20.0 13.2 0.0 23.0 27.8 15.3 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 8.8 0.0 0.0 9.8 6.6 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 26.5 24.4 13.5 0.0 0.0 MS4A18 ENSG00000214782 "Membrane spanning 4-domains A18" Q3C1V0 11 60729304-60744212 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 24 "breast: 7.8;intestine: 23.8" "Group enriched" "Detected in some" 8 "Early spermatids: 5.1;Late spermatids: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045121 Approved NA NA "HPA045121: AB_10969456" "unprognostic (1.02e-1)" "unprognostic (8.87e-2)" "unprognostic (2.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A4E ENSG00000214787 "Membrane spanning 4-domains A4E" Q96PG1 11 60200270-60243137 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "dendritic cells: 1.4;Erythroid cells: 1.3;Kupffer cells: 3.4;Macrophages: 5.4;Microglial cells: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 17.8" "Cell line enhanced" "Detected in many" "HMC-1: 8.1" HPA040075 Uncertain NA NA "HPA040075: AB_10793915" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (9.42e-2)" "unprognostic (5.99e-2)" "unprognostic (1.45e-2)" "unprognostic (8.97e-2)" "unprognostic (1.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (4.16e-2)" "unprognostic (9.88e-3)" "unprognostic (4.97e-2)" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (4.05e-2)" 6.0 4.1 5.5 3.5 5.4 7.8 3.7 7.8 7.1 1.1 7.3 2.8 3.3 1.8 2.8 1.6 1.5 3.0 1.3 6.1 4.4 1.8 5.5 2.9 2.9 5.4 4.2 5.1 1.6 1.5 1.3 0.0 1.8 5.6 2.0 2.7 4.6 1.7 1.2 4.4 4.3 4.5 2.9 2.6 4.8 2.8 3.0 4.8 1.1 1.2 0.8 1.9 1.5 0.0 5.6 4.2 1.7 0.9 2.2 0.7 0.4 3.2 1.7 0.2 0.2 0.3 1.2 1.8 1.3 1.7 0.1 1.2 3.4 0.3 0.2 0.3 5.0 1.1 2.3 3.5 2.0 0.6 1.3 8.1 0.5 1.5 0.5 0.7 0.9 0.2 1.8 2.4 4.2 0.2 1.6 1.9 2.6 1.8 2.0 1.3 1.6 1.7 1.8 0.5 2.1 1.3 2.2 4.9 1.8 2.4 2.0 2.4 2.4 1.1 1.7 7.8 4.8 1.6 5.6 4.7 1.9 0.9 2.8 1.5 17.8 1.4 0.2 0.4 1.6 0.3 0.5 0.3 0.2 2.5 0.7 0.3 0.4 2.7 0.9 1.4 1.4 0.2 0.3 5.5 5.4 7.8 7.1 6.1 4.4 5.4 4.2 5.1 5.6 2.6 4.8 5.6 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 5.4 0.0 1.9 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 10.9;stomach 1: 43.5" "Group enriched" "Detected in some" 9 "Early spermatids: 15.8;Gastric mucus-secreting cells: 39.3;Intestinal goblet cells: 10.4;Late spermatids: 30.5;Pancreatic endocrine cells: 10.8" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;ASC TERT1: 1.8;BJ hTERT+: 1.2;PC-3: 1.7;U-87 MG: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054117 Enhanced NA NA "HPA054117: AB_2682387" "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 5.1 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 3.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.9 0.0 0.0 0.0 0.1 0.0 4.6 0.1 0.0 0.0 43.5 2.5 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 1.0 0.0 0.0 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.4 15.8 0.3 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.4 0.0 0.0 0.0 30.5 0.9 0.0 0.0 1.9 0.0 0.0 0.0 1.0 1.0 10.8 2.2 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 CDRT15L2 ENSG00000214819 "CMT1A duplicated region transcript 15 like 2" A8MXV6 17 20579724-20580911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 15.7" "Cell type enriched" "Detected in some" 4 "Early spermatids: 120.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTCP1 "P13MTCP1, p8MTCP1, TCL1C" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155064034-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Erythroid cells: 3.2;Respiratory ciliated cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032040: AB_2674122" "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 1.0 2.1 0.9 1.9 1.1 2.9 1.8 1.7 1.4 1.3 1.0 1.6 2.0 1.7 2.7 1.2 1.4 1.3 1.5 0.9 1.0 1.7 2.5 1.2 2.5 1.2 1.1 0.8 2.4 2.6 1.0 1.7 1.0 1.3 1.7 2.0 2.5 1.6 1.4 1.2 4.2 1.8 1.4 0.9 1.9 2.1 5.3 1.0 1.9 1.9 0.7 2.6 1.4 0.9 1.3 1.2 3.9 1.9 3.1 1.2 1.0 2.1 2.4 1.2 1.5 3.7 3.5 6.0 2.2 2.4 0.5 2.4 3.9 2.6 2.8 1.9 1.5 2.5 1.0 13.6 1.9 1.1 2.4 2.5 1.9 1.3 2.5 2.4 1.8 1.4 3.8 0.9 3.9 1.1 1.7 3.2 5.1 0.9 1.5 0.6 3.4 2.0 5.1 2.0 1.7 0.9 1.4 1.7 1.0 1.7 1.3 1.8 1.1 1.5 1.8 3.0 1.7 1.9 8.6 4.1 4.4 3.4 2.9 2.6 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.1 1.7 1.4 0.9 1.0 1.2 1.1 0.8 1.3 0.9 1.0 1.3 0.5 0.0 1.5 0.0 0.5 0.3 0.3 0.7 0.6 0.0 0.6 0.5 1.4 1.5 1.4 0.0 0.0 0.2 0.8 0.6 0.0 0.8 0.0 0.7 0.3 0.5 1.8 3.2 0.0 1.2 0.4 0.6 0.0 0.6 0.0 2.2 0.4 2.0 0.4 0.0 0.0 0.0 0.0 1.0 0.3 0.6 1.2 0.8 1.8 0.0 1.0 0.0 1.0 0.0 0.0 1.0 0.2 0.4 0.9 0.3 0.3 0.3 2.4 0.0 0.0 0.6 0.4 0.6 0.2 0.4 0.9 0.3 0.7 0.8 0.5 0.1 RAD51AP2 FLJ17540 ENSG00000214842 "RAD51 associated protein 2" Q09MP3 2 17510584-17518439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 9.5" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 457.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.87e-2)" "unprognostic (3.31e-2)" "unprognostic (9.98e-2)" "unprognostic (3.12e-2)" "unprognostic (4.61e-1)" "unprognostic (3.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.84e-3)" "unprognostic (2.64e-1)" "unprognostic (1.92e-1)" "unprognostic (1.71e-1)" "unprognostic (6.26e-3)" "unprognostic (3.82e-2)" "unprognostic (1.62e-3)" "unprognostic (1.15e-1)" 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.2 0.5 1.5 0.9 1.2 0.1 0.7 2.8 0.9 0.0 0.2 0.0 2.1 0.0 0.0 6.0 0.0 0.0 12.8 0.0 0.1 0.2 0.0 0.0 8.0 0.0 0.0 0.2 2.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 4.1 0.7 0.0 0.0 0.2 5.7 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.1 0.1 0.4 0.1 1.1 0.0 0.1 0.2 0.2 26.3 0.1 0.4 457.6 51.7 0.6 0.6 0.0 0.0 0.5 1.6 0.9 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377778-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 17.0;skin 1: 5.0;vagina: 8.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.1;Basal squamous epithelial cells: 8.0;Spermatogonia: 5.8;Squamous epithelial cells: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.2;HaCaT: 1.1;HeLa: 2.4;hTCEpi: 7.1;RT4: 2.5;SiHa: 1.3;T-47d: 2.1" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.2 17.0 0.1 0.0 0.0 0.0 0.0 0.9 2.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.0 2.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.4 1.1 0.0 0.1 2.2 8.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 1.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.5 1.6 1.3 8.0 0.0 0.1 0.6 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 5.8 10.9 1.3 0.0 0.0 0.0 0.2 1.0 DCDC2C ENSG00000214866 "Doublecortin domain containing 2C" A8MYV0 2 3703575-3848008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 4.2" "Group enriched" "Detected in some" 7 "Early spermatids: 171.3;Late spermatids: 59.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA045848 Uncertain NA NA "HPA045848: AB_10961120" "unprognostic (2.63e-2)" "unprognostic (1.81e-1)" "unprognostic (3.81e-3)" "unprognostic (6.98e-2)" 0.1 0.0 0.6 0.0 0.5 0.4 0.1 1.0 0.9 0.0 0.9 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.4 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.2 4.2 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.0 0.9 0.6 0.2 0.2 0.1 0.4 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.3 0.0 0.4 2.3 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 59.9 5.6 0.1 0.0 15.9 0.0 0.0 0.0 0.0 0.2 0.3 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMTNL1 CHASM ENSG00000214872 "Smoothelin like 1" A8MU46 11 57542641-57550274 "Predicted intracellular proteins" "Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "skeletal muscle: 718.1;tongue: 194.6" "Cell type enriched" "Detected in some" 5 "Skeletal myocytes: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.6;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.35e-2)" "unprognostic (3.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.79e-3)" "unprognostic (3.09e-1)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (8.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.53e-3)" "unprognostic (4.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.04e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (4.49e-1)" "unprognostic (1.44e-2)" 0.4 0.2 0.7 0.9 0.4 2.3 0.4 0.2 0.3 0.4 0.0 0.2 0.4 0.3 0.0 8.9 0.5 0.3 0.2 0.2 1.4 0.2 0.8 0.9 0.8 2.7 0.4 0.0 0.5 0.1 0.0 0.5 0.1 0.6 1.6 0.0 0.6 6.1 0.0 718.1 0.3 0.5 0.0 0.1 1.1 0.2 0.5 0.9 0.0 0.4 194.6 0.0 0.2 0.4 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.1 0.7 0.3 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.6 1.0 0.0 0.1 0.4 0.0 0.6 0.3 0.7 0.4 0.4 0.4 0.2 0.3 0.5 0.2 0.3 0.6 0.4 1.1 0.2 0.5 0.2 0.2 0.1 0.7 0.4 0.2 0.3 0.2 1.4 2.7 0.4 0.0 0.6 0.1 0.9 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64C ENSG00000214891 "Tripartite motif containing 64C" A6NLI5 11 49053714-49059112 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045370 Uncertain NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMA6E ENSG00000214897 "PNMA family member 6E" A0A0J9YXQ4 X 153395639-153401392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 3.2;ovary: 2.4;testis: 12.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (2.99e-2)" "unprognostic (1.77e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D1 "FAM75D1, FLJ46321" ENSG00000214929 "SPATA31 subfamily D member 1" Q6ZQQ2 9 81988772-81995253 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 113 "testis: 11.2" "Cell type enriched" "Detected in some" 4 "Early spermatids: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047897 Uncertain NA NA "HPA047897: AB_2680204" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 61.3;EFO-21: 58.1;HMC-1: 217.0;SCLC-21H: 53.1;THP-1: 60.6" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 13.6 9.7 11.8 2.6 12.0 6.9 13.4 14.5 23.6 11.7 10.5 22.7 0.2 12.7 0.5 10.2 29.0 0.1 11.3 12.2 11.4 8.5 9.6 12.5 2.5 12.0 11.4 12.0 20.9 11.1 6.3 36.7 6.4 13.0 17.1 2.1 5.1 9.9 7.6 19.1 13.3 13.0 0.4 11.7 13.2 14.0 21.0 11.9 3.1 13.9 0.1 0.1 15.9 10.9 11.8 0.0 2.3 0.3 0.5 1.5 0.7 0.7 0.0 0.0 0.1 0.2 0.4 10.5 61.3 58.1 0.5 0.0 0.1 23.6 7.1 0.1 0.1 0.1 0.1 1.9 2.0 9.7 0.1 217.0 0.3 0.0 0.0 0.0 0.1 4.3 14.4 24.4 0.2 0.0 0.1 0.0 0.2 16.4 24.8 0.0 2.5 36.2 1.7 0.3 0.2 53.1 16.8 0.0 0.4 0.6 11.2 0.0 60.6 0.0 1.1 0.1 0.2 13.8 0.0 0.1 0.2 18.6 16.5 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.8 12.0 14.5 23.6 12.2 11.4 12.0 11.4 12.0 13.0 11.7 11.9 11.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 ZSWIM7 SWS1 ENSG00000214941 "Zinc finger SWIM-type containing 7" Q19AV6 17 15976560-15999717 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054681 Uncertain Uncertain Cytosol NA NA Cytosol "HPA054681: AB_2682572" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.54e-5)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (4.23e-2)" "unprognostic (1.84e-2)" "unprognostic (8.56e-2)" "unprognostic (2.45e-3)" "unprognostic (8.80e-3)" "unprognostic (1.70e-1)" 11.8 18.2 7.6 6.0 7.6 4.3 12.7 7.2 10.5 11.6 6.6 12.3 7.4 11.8 4.8 8.5 10.9 4.4 16.8 7.5 7.7 14.5 13.9 10.2 7.3 7.9 7.5 7.2 15.8 12.7 6.7 16.3 5.5 7.6 10.9 4.7 5.7 9.4 4.7 33.0 10.5 10.2 5.5 7.0 14.0 10.3 5.8 7.8 4.6 11.8 10.3 3.7 10.5 10.5 8.1 17.2 24.5 12.4 30.1 5.1 4.8 15.1 11.3 4.4 11.7 8.6 4.6 4.9 8.1 9.8 12.2 3.5 5.5 4.1 8.9 5.5 8.7 14.1 9.3 11.5 9.7 12.1 7.5 15.1 11.7 15.4 6.4 11.0 1.7 15.1 21.2 5.9 4.5 6.1 23.2 26.2 17.4 8.1 25.0 14.4 16.2 31.7 13.1 10.6 9.0 4.4 18.9 17.5 17.4 12.4 33.2 12.5 1.8 21.5 18.9 6.4 4.9 9.9 2.3 6.3 9.8 16.2 9.3 16.3 28.0 27.2 12.0 13.6 27.5 14.6 26.8 15.9 13.1 42.0 24.6 18.8 18.0 1.6 18.0 19.8 25.9 12.6 19.7 7.6 7.6 7.2 10.5 7.5 7.7 7.9 7.5 7.2 7.6 7.0 7.8 8.1 42.4 35.3 54.5 16.6 35.7 25.6 33.7 50.0 37.0 38.4 56.0 65.0 65.0 67.2 32.7 40.5 62.6 99.9 39.2 35.0 86.1 56.5 13.6 32.9 40.0 33.9 50.8 24.0 16.1 52.0 58.9 29.5 21.9 27.6 55.2 52.3 37.5 55.2 49.7 18.5 13.4 37.1 59.0 55.4 37.8 14.4 45.4 53.0 55.2 15.0 46.9 60.1 53.5 14.6 21.9 50.6 35.7 39.9 24.5 37.0 50.0 134.5 35.8 56.9 26.3 33.9 30.6 87.1 74.1 28.8 27.6 72.8 29.1 71.2 36.3 28.8 GPR33 ENSG00000214943 "G protein-coupled receptor 33" Q49SQ1 14 31482875-31488039 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.6" "Lineage enhanced" "Detected in single" "dendritic cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.20e-1)" "unprognostic (8.10e-3)" "unprognostic (6.53e-4)" "unprognostic (9.13e-2)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.1;Granulosa cells: 83.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 97.8;LHCN-M2: 92.2;TIME: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 4.7 24.1 4.9 1.1 5.1 0.0 7.5 0.5 4.3 3.8 0.9 3.4 3.2 4.1 2.5 6.4 9.9 5.3 1.5 4.8 3.1 31.8 6.5 7.4 0.4 2.1 2.1 4.8 19.2 20.9 1.2 6.0 0.5 2.3 5.0 3.7 6.1 19.3 3.6 0.9 15.0 2.5 3.5 1.2 2.8 21.9 1.6 3.1 4.0 13.8 1.0 2.9 3.7 6.7 3.2 30.1 21.0 0.1 2.6 2.6 3.6 0.0 10.8 21.5 13.5 13.3 6.3 12.8 0.1 22.5 3.7 30.4 10.0 1.4 17.4 20.2 0.2 3.1 0.6 3.3 27.2 20.9 0.0 0.0 3.3 7.0 21.0 97.8 25.2 44.4 0.6 0.0 0.0 92.2 2.8 0.0 0.0 0.2 7.9 8.5 0.0 5.5 3.7 36.4 18.0 2.0 3.9 5.3 0.8 0.6 0.0 4.6 0.1 59.8 6.6 9.2 0.5 10.3 1.1 0.0 0.2 10.1 1.4 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.9 5.1 0.5 4.3 4.8 3.1 2.1 2.1 4.8 2.3 1.2 3.1 3.2 9.1 28.9 16.4 3.9 0.2 25.7 14.1 14.1 40.5 4.9 7.5 11.0 2.0 24.3 15.5 31.3 0.0 0.3 2.1 3.7 15.6 13.0 9.6 32.7 1.7 12.8 11.4 2.7 73.1 11.3 0.3 3.1 35.7 12.6 1.3 83.2 2.2 7.3 0.3 13.5 34.5 10.7 40.7 0.3 0.9 2.6 10.2 3.3 1.8 32.8 0.6 26.8 1.0 34.7 15.2 26.3 4.6 5.7 1.2 16.0 3.9 26.7 50.4 1.6 6.6 0.5 7.0 1.0 1.3 20.4 25.6 0.1 1.2 32.3 6.7 17.3 TBC1D26 MGC51025 ENSG00000214946 "TBC1 domain family member 26" Q86UD7 17 15732247-15749192 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 17.7" "Group enriched" "Detected in some" 79 "Early spermatids: 171.9;Late spermatids: 145.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.4" HPA050460 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050460: AB_2681136" "unprognostic (3.65e-2)" "unprognostic (2.31e-1)" "unprognostic (7.90e-2)" "unprognostic (3.22e-1)" "unprognostic (1.16e-1)" "unprognostic (3.20e-1)" "unprognostic (5.15e-9)" "unprognostic (9.32e-2)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "unprognostic (6.16e-2)" 0.0 0.0 2.3 0.0 2.4 0.0 0.1 1.7 3.0 0.3 1.6 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.5 1.9 0.0 0.0 0.1 0.0 2.0 1.8 2.0 0.3 0.0 0.0 0.2 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.7 0.0 0.0 17.7 1.9 0.0 0.1 0.0 0.1 0.1 0.1 2.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.4 1.7 3.0 2.5 1.9 2.0 1.8 2.0 1.9 1.7 1.9 2.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 145.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.9" "Cell type enhanced" "Detected in many" "Early spermatids: 77.3;Late spermatids: 18.0;Microglial cells: 27.2;Oligodendrocytes: 27.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.3;SuSa: 5.2;U-266/70: 16.0;U-266/84: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.3 0.5 0.3 0.9 0.5 0.1 0.6 0.6 0.4 0.3 0.7 0.4 0.2 0.2 0.9 0.3 0.2 0.4 0.5 0.2 0.6 0.4 0.3 0.4 1.1 0.7 0.5 0.1 0.2 0.3 0.9 0.2 0.4 0.8 0.5 0.8 0.6 0.7 0.3 0.5 1.7 0.4 0.8 0.6 0.7 0.4 2.9 0.5 0.8 0.5 0.4 0.7 0.7 0.3 1.0 0.6 0.6 0.1 0.4 0.6 1.3 1.0 0.3 0.1 0.2 0.3 0.9 0.8 0.9 0.4 0.2 0.1 0.6 0.7 1.1 0.3 0.3 6.3 1.4 1.8 0.4 0.2 0.5 1.0 0.4 1.0 0.4 0.7 0.4 0.1 1.1 1.0 0.5 0.4 0.2 0.3 0.4 0.6 1.0 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 5.2 1.4 1.0 0.5 0.2 0.6 0.1 0.8 16.0 9.5 3.8 0.1 2.1 0.8 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.0 0.4 0.4 0.2 0.0 0.1 0.1 0.4 0.5 0.0 0.3 0.5 0.6 0.4 0.2 0.6 0.7 0.5 0.1 0.8 0.6 0.5 1.0 1.1 0.0 1.1 16.0 1.5 4.7 2.9 1.3 0.6 1.9 1.6 0.6 2.9 0.0 1.5 3.7 4.2 2.3 2.0 1.1 3.9 1.5 77.3 1.2 0.4 2.7 2.4 0.8 5.3 1.2 1.9 1.7 0.0 0.6 0.0 1.0 4.2 0.6 0.9 0.0 6.4 2.2 6.1 1.3 7.0 18.0 2.8 1.6 7.2 27.2 4.2 1.1 2.1 7.5 27.9 1.8 1.6 1.2 0.2 5.3 0.4 0.9 6.1 3.2 0.0 4.7 2.7 4.2 4.0 0.7 5.3 1.0 2.2 0.9 1.7 2.3 CRPPA "hCG_1745121, ISPD, Nip" ENSG00000214960 "CDP-L-ribitol pyrophosphorylase A" A4D126 7 16087525-16502504 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "choroid plexus: 22.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 8.0;Cytotrophoblasts: 3.5;Extravillous trophoblasts: 10.6;Syncytiotrophoblasts: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 29 "basophil: 13.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "HEL: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053554 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA053554: AB_2682185" "unprognostic (4.65e-3)" "unprognostic (5.92e-2)" "unprognostic (2.61e-1)" "unprognostic (9.41e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-2)" "unprognostic (2.07e-1)" "prognostic favorable (1.38e-11)" "unprognostic (4.01e-2)" "unprognostic (1.78e-4)" "unprognostic (6.26e-2)" "unprognostic (2.79e-1)" 1.1 1.2 1.4 0.8 1.7 1.6 0.9 0.8 3.3 1.3 22.0 1.0 0.6 1.0 0.5 0.5 0.9 1.1 2.6 3.9 1.0 3.0 4.2 1.0 1.4 0.9 1.0 0.5 0.7 1.5 1.1 0.7 1.0 1.1 1.0 1.2 1.2 1.2 0.8 1.5 1.2 0.6 1.2 0.3 1.0 3.5 2.2 1.6 1.2 0.8 1.3 1.4 1.1 0.5 2.0 0.4 2.2 1.0 1.6 1.0 1.3 6.8 1.5 1.4 1.5 1.3 2.2 1.9 4.3 3.2 2.7 0.9 2.5 1.2 0.0 2.9 1.5 0.9 9.6 1.4 0.7 1.5 1.9 2.4 2.2 0.8 1.6 0.4 0.9 1.2 3.0 3.2 0.2 4.2 0.7 3.0 1.2 1.8 1.1 0.5 1.1 1.9 0.2 2.1 0.8 1.5 0.9 1.4 2.1 1.7 2.5 1.6 2.0 2.0 1.9 1.5 0.4 1.7 0.4 0.0 4.8 1.5 2.3 2.2 13.8 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.4 0.3 0.2 0.4 0.4 0.1 0.3 0.1 0.0 1.4 1.7 0.8 3.3 3.9 1.0 0.9 1.0 0.5 1.1 0.3 1.6 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 10.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 NPIPA7 ENSG00000214967 "Nuclear pore complex interacting protein family member A7" E9PJI5 16 16379055-16393954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 16.2;Endothelial cells: 3.8;Fibroblasts: 4.8;granulocytes: 5.7;Respiratory ciliated cells: 2.9;Smooth muscle cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HMC-1: 91.3;THP-1: 81.3" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.17e-2)" 12.5 24.4 38.3 9.8 38.5 13.0 11.0 43.5 45.7 15.1 37.2 18.5 9.8 11.2 24.9 23.4 14.8 16.9 9.2 38.8 38.2 20.5 29.1 14.9 16.1 38.1 37.4 37.1 17.8 36.8 27.1 85.3 10.0 39.8 23.6 22.8 29.0 17.0 9.2 9.6 35.8 18.8 11.1 36.6 28.3 18.9 26.5 37.8 14.4 28.4 4.1 13.0 13.8 13.7 38.8 7.6 16.6 19.6 7.6 11.5 9.2 12.8 15.7 6.1 17.6 9.2 17.3 11.9 19.0 12.2 16.5 10.6 22.8 13.9 16.1 13.0 5.6 4.2 19.2 59.5 26.0 10.9 6.8 91.3 16.5 61.1 9.7 20.6 21.7 9.2 31.3 11.6 23.8 19.4 32.5 15.4 39.5 13.6 27.8 5.5 22.5 13.2 11.1 29.1 32.3 25.3 13.5 12.4 28.3 12.8 23.9 20.4 81.3 7.9 16.8 7.9 7.7 13.5 4.9 19.7 15.4 9.6 21.2 7.6 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 38.5 43.5 45.7 38.8 38.2 38.1 37.4 37.1 39.8 36.6 37.8 38.8 0.0 3.2 2.6 0.3 0.2 1.7 0.0 0.5 0.0 0.0 0.0 0.0 16.2 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.6 0.0 0.0 4.8 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.5 0.0 GSG1L2 ENSG00000214978 "GSG1 like 2" A8MUP6 17 9802386-9822071 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 95 "renal cancer: 4.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACSM4 ENSG00000215009 "Acyl-CoA synthetase medium chain family member 4" P0C7M7 12 7304284-7328724 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 1.4;Excitatory neurons: 1.2;Inhibitory neurons: 1.1;Spermatogonia: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;Karpas-707: 1.1;NB-4: 1.8;SH-SY5Y: 2.0;U-87 MG: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049895 Uncertain NA NA "HPA049895: AB_2680940" "unprognostic (9.50e-5)" "unprognostic (5.45e-2)" "unprognostic (4.84e-2)" "unprognostic (6.06e-4)" "unprognostic (1.77e-2)" "unprognostic (1.76e-2)" "unprognostic (2.24e-3)" "unprognostic (3.31e-3)" "unprognostic (3.85e-2)" "unprognostic (8.78e-2)" "unprognostic (3.27e-1)" "unprognostic (3.60e-1)" "unprognostic (2.45e-9)" "unprognostic (1.82e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.73e-1)" 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 2.0 0.3 0.5 0.0 0.0 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.6 0.1 0.0 0.9 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL10 "BOP, C22orf29, FLJ21125" ENSG00000215012 "Retrotransposon Gag like 10" Q7L3V2 22 19846138-19854896 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Cytotrophoblasts: 20.6;Distal tubular cells: 13.7;Extravillous trophoblasts: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 95.9" "HPA000721, HPA001419" Uncertain NA NA "HPA000721: AB_1079000, HPA001419: AB_1078999" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (3.70e-2)" "unprognostic (2.29e-2)" "unprognostic (4.72e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (8.04e-5)" "unprognostic (2.26e-2)" "unprognostic (2.36e-2)" "unprognostic (1.63e-2)" "unprognostic (1.38e-1)" "unprognostic (3.79e-2)" "unprognostic (6.67e-2)" "unprognostic (7.20e-3)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (7.55e-2)" 3.0 3.6 1.6 3.9 3.3 4.9 4.6 2.3 4.2 4.5 0.5 3.0 7.2 4.6 6.8 7.6 8.9 2.5 3.1 3.4 1.7 3.0 3.8 5.1 5.2 1.5 0.5 3.6 5.2 7.4 6.2 4.0 5.1 2.0 6.2 3.0 3.6 7.1 5.1 4.3 13.5 4.8 3.8 0.0 4.1 4.3 2.4 1.3 10.9 5.8 4.0 7.2 4.1 4.6 1.7 18.9 7.6 8.5 9.5 9.1 8.0 10.7 10.4 12.0 15.0 9.1 15.5 10.4 16.4 4.3 17.8 4.6 26.4 8.6 17.0 6.6 5.6 12.9 8.7 17.6 10.9 5.8 25.7 7.4 6.0 19.9 12.6 10.6 7.2 14.1 9.9 95.9 6.0 14.5 12.5 21.0 7.8 4.6 21.4 10.3 11.8 25.1 4.0 5.5 17.3 13.9 5.0 10.8 12.2 10.3 8.8 13.4 5.7 18.2 14.7 16.8 4.8 10.0 5.3 5.0 9.8 5.6 6.9 9.9 2.6 1.4 3.1 1.8 1.6 1.7 1.1 2.0 1.8 1.3 1.4 3.9 3.0 2.3 0.8 4.0 2.6 3.0 1.8 1.6 3.3 2.3 4.2 3.4 1.7 1.5 0.5 3.6 2.0 0.0 1.3 1.7 3.6 22.4 9.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 8.3 5.8 0.0 0.0 5.0 9.2 0.0 20.6 2.2 0.0 13.7 7.6 0.0 8.8 5.0 4.4 0.0 0.0 0.0 5.0 16.6 2.4 0.0 9.7 1.3 10.8 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.2 0.0 0.0 1.4 0.0 0.0 5.4 5.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.7 2.1 6.4 0.0 0.0 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535873 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 18.4" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9" "Region enriched" "Detected in single" 8 "olfactory bulb: 3.6" "Region enriched" "Detected in some" 31 "spinal cord: 33.5" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA043844: AB_2732508, HPA060468: AB_2684288" "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 1.1 3.2 0.9 1.7 1.4 0.3 2.9 2.3 3.0 3.2 1.2 8.9 1.2 2.3 14.2 2.1 5.0 1.5 2.6 1.7 1.1 3.1 0.7 1.2 0.2 1.0 1.5 1.1 1.2 5.9 0.2 11.3 0.5 1.1 3.9 4.2 6.8 18.4 5.2 5.9 2.1 3.4 1.7 0.1 0.4 6.5 3.8 0.8 0.2 1.2 3.3 0.1 2.9 4.5 1.8 1.5 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.4 0.0 0.0 1.1 0.4 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.2 1.4 0.1 0.2 0.0 0.7 0.9 0.3 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.5 0.7 0.1 0.5 1.3 0.0 9.8 2.8 0.0 0.2 0.6 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.9 1.4 2.3 3.0 1.7 1.1 1.0 1.5 1.1 1.1 0.1 0.8 1.8 0.4 0.0 4.1 39.5 0.0 0.3 0.1 0.2 0.0 5.3 1.6 1.5 0.9 0.0 3.3 3.7 18.8 0.3 0.1 0.8 0.0 0.1 2.0 21.1 0.5 0.1 0.0 0.0 23.4 0.2 0.0 3.1 0.0 3.9 1.3 0.5 1.8 0.0 0.1 5.0 22.6 0.5 0.0 0.3 0.3 1.1 0.9 0.1 0.0 7.5 0.0 2.2 0.0 12.5 9.1 0.4 5.4 0.7 0.0 0.1 0.2 0.5 16.3 5.4 0.0 1.8 0.2 0.9 1.0 0.1 0.1 0.3 0.1 0.2 0.3 0.1 PHB2 "Bap37, BCAP37, p22, REA" ENSG00000215021 "Prohibitin 2" Q99623 12 6965327-6970780 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014889, CAB026335, HPA039874" Supported Enhanced Mitochondria NA NA 77000 Mitochondria "CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448" "unprognostic (4.64e-3)" "unprognostic (4.32e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (3.80e-4)" "unprognostic (3.07e-3)" "unprognostic (1.67e-1)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (7.18e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.07e-1)" "unprognostic (8.17e-2)" "unprognostic (5.61e-2)" 134.8 168.0 75.4 96.0 75.2 150.6 140.1 76.1 81.9 150.4 77.5 163.1 151.2 135.1 123.7 170.1 138.2 81.0 149.5 72.5 76.1 113.1 235.3 88.8 143.1 74.4 74.7 69.8 246.5 201.2 131.9 76.9 85.6 75.7 115.0 146.8 48.6 139.3 98.7 306.4 149.7 128.5 103.1 73.8 114.5 142.9 36.4 76.0 145.8 104.3 233.2 164.1 137.0 126.5 75.4 270.5 261.1 214.1 295.8 170.6 295.0 469.2 183.6 245.6 329.7 259.8 420.5 283.0 567.8 78.8 187.4 200.6 225.0 395.9 337.5 267.2 306.9 316.1 296.4 146.3 409.2 284.1 488.8 212.4 307.2 229.2 208.0 452.5 331.8 331.4 157.0 270.1 127.1 238.5 277.2 449.0 452.9 813.3 236.8 224.7 307.4 338.3 356.7 270.0 312.8 111.7 372.9 152.2 434.9 503.8 440.1 67.6 379.3 191.8 141.5 227.4 115.2 402.2 128.1 166.3 586.7 186.7 251.0 207.6 78.5 88.3 43.8 84.2 107.2 103.8 102.8 96.2 98.1 138.5 98.1 85.0 85.1 35.4 117.8 94.8 129.0 123.6 114.2 75.4 75.2 76.1 81.9 72.5 76.1 74.4 74.7 69.8 75.7 73.8 76.0 75.4 114.1 48.1 54.8 14.7 155.0 74.4 106.8 110.1 191.8 42.9 155.1 230.8 45.1 91.5 62.1 35.0 39.6 212.9 99.8 104.6 115.4 134.1 2.8 68.2 124.8 86.0 100.6 143.7 10.0 162.3 282.2 97.7 100.4 88.0 63.5 177.2 92.1 172.5 163.0 18.5 11.4 142.7 77.3 125.0 70.4 7.2 97.3 105.0 72.9 8.4 131.0 87.3 102.0 12.5 12.9 119.8 90.3 68.8 145.9 99.4 197.3 142.4 40.1 46.8 72.3 109.1 128.7 33.3 57.0 245.3 76.3 170.1 102.9 218.5 268.5 113.4 TCP11X2 ENSG00000215029 "T-complex 11 family, X-linked 2" X 102456862-102471842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "Early spermatids: 4.6;Late spermatids: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048311 Supported NA NA "HPA048311: AB_2680351" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEURL4 KIAA1787 ENSG00000215041 "Neuralized E3 ubiquitin protein ligase 4" Q96JN8 17 7315628-7329393 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043678, HPA055314" Uncertain NA NA "HPA043678: AB_10963092, HPA055314: AB_2682782" "unprognostic (4.38e-1)" "unprognostic (1.12e-1)" "unprognostic (4.70e-2)" "unprognostic (3.25e-3)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (8.96e-3)" "prognostic favorable (2.34e-5)" "unprognostic (4.96e-2)" "unprognostic (3.72e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.47e-1)" "unprognostic (8.12e-2)" 6.7 6.7 1.6 3.3 2.8 3.0 7.9 1.0 4.0 10.5 0.4 10.9 4.0 11.5 1.8 7.1 10.4 2.4 8.7 2.6 1.6 7.9 5.7 7.0 3.9 1.9 1.6 3.0 12.9 8.8 4.6 12.4 2.3 1.8 10.1 1.8 2.5 8.5 3.3 19.0 9.3 9.9 2.4 0.1 9.4 8.7 9.8 1.5 3.9 12.5 5.2 2.3 10.1 8.7 2.2 3.3 11.5 7.3 11.7 4.4 2.8 8.7 5.0 3.2 6.0 4.9 8.0 2.7 10.2 5.1 3.0 4.9 9.4 7.8 4.7 2.6 5.5 12.3 5.1 13.2 4.7 3.0 5.0 6.9 2.7 4.8 6.2 3.5 4.7 3.8 8.5 7.3 2.1 2.6 4.2 7.5 9.3 5.1 3.9 5.6 12.9 5.8 4.1 3.7 3.4 6.8 5.7 5.2 5.2 2.0 3.7 4.4 3.5 4.8 5.5 4.2 4.6 5.6 4.3 2.9 4.3 3.5 4.6 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.8 1.0 4.0 2.6 1.6 1.9 1.6 3.0 1.8 0.1 1.5 2.2 3.4 0.0 2.2 10.4 2.4 2.5 0.8 2.3 0.6 11.4 4.9 5.3 1.6 4.3 2.3 5.5 14.6 2.3 1.9 5.4 1.9 2.5 2.0 4.3 4.1 2.9 4.2 2.1 8.4 1.4 1.8 2.1 8.2 3.8 2.5 6.4 4.6 3.4 2.6 5.0 7.0 5.0 4.1 2.5 1.8 1.6 2.8 3.5 0.0 4.7 1.9 3.1 5.2 4.5 6.4 2.4 2.1 1.9 2.0 1.6 5.1 5.8 2.5 8.7 0.0 2.7 3.7 4.2 4.5 3.4 2.8 1.9 2.5 3.2 5.7 0.6 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "brain: 26.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.8;Inhibitory neurons: 2.9;Oligodendrocyte precursor cells: 4.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "thalamus: 26.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "REH: 3.6" "Group enriched" "Detected in many" 5 "cerebellum: 22.4;thalamus: 7.2" "Low region specificity" "Detected in all" HPA045381 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.0 0.4 6.3 0.1 4.6 0.2 0.2 10.1 1.5 0.1 0.0 0.3 0.4 0.1 0.0 0.3 0.2 0.1 0.1 0.3 7.2 0.1 0.0 0.2 0.1 3.2 10.4 0.0 0.2 0.5 0.5 0.9 0.0 5.9 0.5 0.1 0.5 0.5 0.3 0.0 0.7 0.3 0.0 0.0 0.3 0.5 0.3 26.8 0.2 0.3 0.0 0.1 0.1 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.3 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 4.6 10.1 1.5 0.3 7.2 3.2 10.4 0.0 5.9 0.0 26.8 1.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.6 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.5 0.1 0.0 0.1 0.0 0.4 2.8 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.5 1.3 0.1 0.0 0.0 0.3 0.2 0.4 0.1 0.0 1.0 0.0 0.0 0.1 0.8 0.2 1.2 0.0 0.0 0.1 0.9 0.1 0.2 CXorf49B ENSG00000215113 "Chromosome X open reading frame 49B" A8MYA2 X 71763424-71767204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "A-431: 9.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBXN2B p37 ENSG00000215114 "UBX domain protein 2B" Q14CS0 8 58411359-58451501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 42.8" "Group enriched" "Detected in all" 5 "granulocytes: 42.8;monocytes: 12.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045278 Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA045278: AB_10963578" "unprognostic (1.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.15e-3)" "unprognostic (1.63e-1)" "unprognostic (2.22e-1)" "unprognostic (2.46e-1)" "unprognostic (8.71e-2)" "unprognostic (3.36e-1)" "unprognostic (5.97e-2)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-3)" "unprognostic (1.26e-1)" "unprognostic (8.22e-2)" "unprognostic (2.00e-1)" "unprognostic (1.42e-2)" 8.0 9.2 10.7 12.1 12.4 15.5 11.1 15.0 13.3 6.7 10.4 8.3 7.8 8.1 10.8 5.9 8.6 8.7 9.9 12.3 13.6 15.8 18.9 9.7 9.2 11.6 10.4 11.1 9.1 8.9 16.2 7.9 7.6 11.5 9.6 9.3 13.5 13.0 8.6 9.0 6.5 7.9 9.9 10.8 10.2 8.3 9.5 10.7 12.0 14.3 11.1 9.5 9.0 4.4 12.5 11.1 20.2 16.9 20.9 3.0 1.5 11.7 6.7 12.3 8.2 10.6 8.8 20.4 13.0 13.4 8.3 22.2 9.9 25.1 12.1 11.5 10.0 12.7 16.2 17.0 11.0 12.6 14.5 15.1 5.4 19.0 3.8 18.9 19.5 10.2 19.7 11.4 23.8 7.4 11.3 26.0 16.0 22.1 38.6 4.8 14.5 7.5 8.9 26.4 16.8 6.2 25.4 11.6 11.7 19.7 16.5 23.7 17.3 2.3 6.3 13.4 13.7 14.0 12.4 13.3 18.0 20.6 13.6 8.5 15.8 11.9 18.0 4.3 11.0 4.2 3.4 4.1 3.6 5.9 3.3 4.9 4.3 42.8 5.4 12.9 2.9 5.3 5.3 10.7 12.4 15.0 13.3 12.3 13.6 11.6 10.4 11.1 11.5 10.8 10.7 12.5 4.0 9.6 8.7 27.7 11.4 5.7 10.6 10.3 4.0 16.0 13.7 11.7 18.4 10.0 9.0 11.0 22.9 15.9 10.4 15.9 9.8 11.2 35.8 8.6 9.3 4.7 12.0 13.5 55.3 11.1 17.6 9.5 10.7 11.8 23.5 13.3 4.6 17.1 23.0 11.8 62.4 9.6 14.2 32.4 12.4 61.8 10.5 27.5 8.8 21.5 26.0 13.6 15.5 43.2 41.4 10.8 8.2 14.7 8.4 10.4 15.5 29.7 8.9 25.6 0.0 13.9 8.5 20.4 17.8 9.3 6.7 8.6 10.9 8.6 9.1 10.4 CXorf49 ENSG00000215115 "Chromosome X open reading frame 49" A8MYA2 X 71714371-71718151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 3.4" "Group enriched" "Detected in some" 10 "Alveolar cells type 1: 3.2;Fibroblasts: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "A-431: 9.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CBWD6 CBWD7 ENSG00000215126 "COBW domain containing 6" Q4V339 9 41131306-41199261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 39.4;Excitatory neurons: 24.9;Inhibitory neurons: 20.2;Langerhans cells: 30.0;Oligodendrocyte precursor cells: 18.6;Suprabasal keratinocytes: 42.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 17.3;PC-3: 26.8;TIME: 16.6" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (9.48e-2)" "unprognostic (6.02e-2)" "unprognostic (1.62e-2)" "unprognostic (1.91e-2)" "unprognostic (1.30e-2)" "unprognostic (6.28e-2)" "unprognostic (5.92e-2)" "unprognostic (3.71e-2)" "unprognostic (2.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.24e-2)" "unprognostic (1.09e-1)" "unprognostic (2.28e-4)" "unprognostic (5.65e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (9.94e-4)" 1.8 5.4 1.5 0.7 1.5 2.2 2.1 1.5 3.5 0.8 2.0 1.8 1.1 1.2 0.2 2.9 0.9 1.5 3.0 1.5 1.6 3.3 7.3 2.0 0.3 1.6 1.8 1.4 1.6 3.4 0.1 2.7 0.2 1.9 1.7 0.1 0.9 2.5 1.9 3.6 1.4 1.9 0.3 1.6 2.1 2.3 1.9 1.7 0.1 2.2 0.0 0.5 1.1 1.9 1.5 2.0 0.5 0.9 0.2 0.9 2.4 1.6 11.0 12.4 12.6 0.0 4.3 1.2 2.7 0.5 9.0 0.5 1.8 15.9 0.3 0.4 2.8 10.6 0.7 6.4 2.9 0.1 3.4 1.0 0.2 1.5 8.4 10.1 0.9 9.7 0.8 1.4 1.5 17.3 1.8 5.1 0.7 2.3 4.5 26.8 1.2 10.8 3.6 11.5 0.5 0.7 1.2 2.7 0.8 1.1 2.2 0.9 1.5 16.6 0.2 1.0 0.3 1.2 4.9 0.8 13.5 1.5 1.0 1.2 1.6 4.1 1.7 0.6 5.0 0.9 3.5 2.9 2.3 2.3 1.2 1.8 2.2 0.6 0.4 7.0 2.7 1.3 2.4 1.5 1.5 1.5 3.5 1.5 1.6 1.6 1.8 1.4 1.9 1.6 1.7 1.5 2.0 3.2 8.9 5.2 1.3 39.4 0.0 11.0 0.0 0.0 5.1 2.7 0.0 0.0 7.5 5.5 0.0 5.2 1.4 0.0 3.9 4.3 0.0 1.5 0.9 1.4 0.0 0.0 24.9 4.9 5.2 1.4 0.0 1.4 8.8 2.2 0.0 0.0 3.0 0.0 20.2 0.0 8.2 0.0 30.0 0.0 0.0 1.4 14.2 5.6 1.6 0.0 0.0 18.6 8.1 4.4 0.0 0.0 1.4 0.0 0.0 8.8 7.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 42.9 6.3 2.8 1.4 0.0 0.0 C16orf90 LOC646174 ENSG00000215131 "Chromosome 16 open reading frame 90" A8MZG2 16 3493484-3495489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "testis: 48.7" "Group enriched" "Detected in some" 9 "Early spermatids: 246.4;Late spermatids: 501.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (1.96e-2)" "unprognostic (1.03e-3)" "unprognostic (3.17e-1)" "unprognostic (2.18e-1)" "unprognostic (1.08e-1)" "unprognostic (9.33e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (6.29e-3)" "unprognostic (1.26e-1)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 48.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.4 0.0 0.2 0.1 0.1 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 246.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 501.1 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS41 TESSP1 ENSG00000215148 "Serine protease 41" Q7RTY9 16 2798470-2805304 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 105 "eosinophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Cell line enriched" "Detected in single" 10 "BEWO: 1.8" "Not detected" "Not detected" NA NA "unprognostic (1.58e-1)" "unprognostic (3.65e-1)" "unprognostic (3.04e-3)" "unprognostic (1.03e-1)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (1.98e-1)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 NLRP2B "CLRX.1, NALP2P, NLRP2P, NOD24, POP4" ENSG00000215174 "NLR family pyrin domain containing 2B" P0DMW2 X 57677067-57680260 "Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.37e-2)" "unprognostic (1.07e-1)" "unprognostic (6.67e-2)" "unprognostic (3.84e-2)" "unprognostic (1.80e-1)" "unprognostic (5.78e-3)" "unprognostic (3.49e-2)" "unprognostic (1.44e-3)" "unprognostic (1.39e-2)" "unprognostic (7.56e-4)" "unprognostic (7.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.75e-3)" "unprognostic (9.00e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC5AC MUC5 ENSG00000215182 "Mucin 5AC, oligomeric mucus/gel-forming" P98088 11 1157953-1201138 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 101 "stomach 1: 186.7" "Cell type enriched" "Detected in some" 248 "Gastric mucus-secreting cells: 10434.9" "Group enriched" "Detected in many" 4 "pancreatic cancer: 25.3;stomach cancer: 61.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "A549: 19.9;OE19: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002774, CAB009395, HPA040615" Enhanced "Secreted to digestive system" NA NA "CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042" "unprognostic (2.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.51e-2)" "unprognostic (4.56e-2)" "unprognostic (6.49e-2)" "unprognostic (2.44e-2)" "unprognostic (1.30e-3)" "unprognostic (8.46e-2)" "unprognostic (5.83e-4)" "unprognostic (1.84e-1)" "unprognostic (9.21e-3)" "unprognostic (4.07e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 186.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 13.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 17.4 0.0 0.1 5.4 0.0 0.0 0.1 0.0 2.7 0.0 42.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 2.8 10434.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 4.1 0.0 0.0 0.2 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.1 0.0 30.0 8.9 0.0 0.0 10.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.1 7.9 0.0 0.0 28.1 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.5;choroid plexus: 1.1;pituitary gland: 1.5;placenta: 1.2" "Group enriched" "Detected in some" 50 "Early spermatids: 96.3;Late spermatids: 216.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 85.7;PC-3: 108.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in other tissues" No No 30000 Vesicles Cytosol "HPA055174: AB_2682726" 0.1 0.0 0.5 0.2 0.3 0.0 0.1 0.3 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.2 1.5 0.4 0.3 0.0 0.0 0.0 1.5 1.2 0.9 0.0 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.5 0.3 0.3 0.7 0.3 0.3 1.5 0.4 0.3 0.9 0.6 0.3 0.6 1.3 0.0 1.1 0.0 1.1 0.4 1.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 1.4 96.3 0.6 0.1 3.1 0.0 0.0 0.0 2.0 0.2 0.3 0.0 0.2 0.0 0.5 2.5 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.8 216.6 0.3 0.1 1.8 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.1 0.7 0.1 1.5 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.8 0.5 0.0 0.1 0.3 0.2 0.1 0.3 1.3 GOLGA6B ENSG00000215186 "Golgin A6 family member B" A6NDN3 15 72654738-72666394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 20 "liver: 3.5;testis: 7.2" "Group enriched" "Detected in some" 4 "Astrocytes: 3.9;Early spermatids: 8.6;Excitatory neurons: 2.7;Inhibitory neurons: 2.7;Oligodendrocytes: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (5.47e-3)" "unprognostic (1.88e-2)" "unprognostic (2.07e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM166B ENSG00000215187 "Family with sequence similarity 166 member B" A8MTA8 9 35561831-35563899 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "adrenal gland: 272.2;fallopian tube: 83.8;skeletal muscle: 187.7" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 108.0;Respiratory ciliated cells: 126.4" "Group enriched" "Detected in many" 5 "endometrial cancer: 11.7;ovarian cancer: 4.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045540 Enhanced NA NA "HPA045540: AB_10962627" "unprognostic (4.18e-5)" "unprognostic (7.56e-3)" "unprognostic (1.65e-1)" "prognostic favorable (2.61e-5)" "unprognostic (5.66e-3)" "unprognostic (3.48e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (2.21e-1)" "prognostic favorable (6.20e-6)" "unprognostic (3.69e-3)" "unprognostic (9.09e-2)" "unprognostic (4.37e-3)" "unprognostic (5.82e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (3.52e-5)" 5.3 272.2 4.0 0.0 1.5 0.0 2.5 2.4 1.4 2.1 7.2 0.3 0.0 1.3 9.0 0.6 83.8 0.1 0.5 1.2 2.9 0.7 0.6 4.2 0.1 3.8 5.6 0.4 0.3 0.2 0.1 0.4 0.0 4.4 0.4 0.2 0.1 0.7 0.6 187.7 0.6 0.6 0.1 6.1 0.2 0.4 0.2 2.8 0.0 0.3 18.5 0.3 0.2 0.2 2.8 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.5 2.4 1.4 1.2 2.9 3.8 5.6 0.4 4.4 6.1 2.8 2.8 0.3 0.0 0.5 0.0 0.0 4.7 1.2 9.2 2.2 0.0 0.3 2.4 0.3 0.0 10.1 0.0 2.1 0.2 0.3 0.0 0.0 0.2 0.3 108.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.2 0.0 0.1 0.4 0.5 0.1 0.0 0.1 0.0 24.4 0.0 0.7 0.3 0.3 0.3 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 3.3 126.4 0.2 0.0 3.1 3.3 0.2 0.2 2.0 2.0 0.0 0.3 2.1 0.2 0.5 PEX26 FLJ20695 ENSG00000215193 "Peroxisomal biogenesis factor 26" Q7Z412 22 18077923-18105396 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 198.7;Proximal enterocytes: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB070429 Approved NA NA "CAB070429: AB_11154363" "unprognostic (2.25e-1)" "unprognostic (5.75e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.77e-3)" "unprognostic (5.46e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.10e-4)" "unprognostic (1.59e-2)" "unprognostic (5.34e-2)" "unprognostic (8.19e-2)" "unprognostic (1.88e-2)" "unprognostic (1.96e-1)" "prognostic favorable (1.38e-4)" "unprognostic (3.17e-3)" "unprognostic (4.53e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" 7.5 5.9 7.2 7.9 6.1 12.2 6.7 3.9 6.1 4.9 4.6 17.1 19.4 5.6 5.3 7.5 6.0 5.4 5.8 7.9 5.7 7.6 7.3 5.0 7.4 8.5 7.7 6.3 5.5 8.1 9.3 4.2 5.1 7.9 5.3 13.3 3.2 6.5 5.7 6.4 5.7 20.0 5.5 5.6 8.2 9.4 3.1 10.1 7.4 6.9 4.1 6.8 6.1 3.9 6.4 18.3 8.7 10.2 9.2 10.5 6.6 18.8 11.8 12.2 12.8 10.5 15.2 15.1 11.3 10.8 17.5 11.2 18.7 15.9 16.5 10.9 19.0 12.4 19.4 12.3 12.8 10.0 26.0 23.6 8.2 12.7 17.3 16.2 6.1 15.2 11.1 21.2 8.1 12.7 22.0 22.8 8.8 13.2 24.9 15.7 17.6 8.6 4.1 14.8 20.6 17.7 15.5 17.1 12.0 16.3 8.2 19.3 9.7 20.4 23.6 10.2 12.8 12.4 21.4 15.8 16.6 10.9 12.3 17.1 1.2 1.7 1.4 2.0 1.1 1.9 1.4 1.8 2.6 1.5 2.0 2.0 1.3 1.2 2.7 2.6 3.1 0.8 1.0 7.2 6.1 3.9 6.1 7.9 5.7 8.5 7.7 6.3 7.9 5.6 10.1 6.4 10.5 6.4 10.3 1.3 14.7 13.5 14.8 9.3 8.6 24.5 12.4 7.2 29.3 25.8 13.8 7.3 43.8 11.9 18.0 198.7 5.9 24.7 1.0 16.3 16.2 17.6 24.5 11.1 4.9 23.6 9.8 13.0 20.9 18.6 12.0 19.8 18.9 33.0 15.2 30.3 5.6 22.9 6.1 20.4 10.7 2.8 12.5 11.0 0.0 2.8 20.4 9.2 22.6 4.5 4.3 31.6 51.8 11.7 11.8 20.4 91.7 21.7 11.5 25.5 13.1 18.8 9.6 9.4 10.1 13.7 17.6 9.3 13.9 21.4 29.4 18.7 GRXCR1 "DFNB25, PPP1R88" ENSG00000215203 "Glutaredoxin and cysteine rich domain containing 1" A8MXD5 4 42892713-43030658 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "seminal vesicle: 2.6" "Group enriched" "Detected in some" 4 "Early spermatids: 3.2;Spermatocytes: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040824 Uncertain NA NA "HPA040824: AB_10794863" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C5orf49 LOC134121 ENSG00000215217 "Chromosome 5 open reading frame 49" A4QMS7 5 7830378-7851151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;fallopian tube: 76.4;testis: 37.4" "Group enriched" "Detected in many" 11 "Early spermatids: 821.2;Endometrial ciliated cells: 353.9;Late spermatids: 410.2;Respiratory ciliated cells: 502.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043759 Enhanced NA NA "HPA043759: AB_2678655" "unprognostic (1.55e-1)" "unprognostic (5.82e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (2.13e-3)" "unprognostic (4.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (7.93e-2)" "unprognostic (7.54e-3)" "unprognostic (1.85e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (2.28e-2)" "unprognostic (2.20e-2)" 0.2 0.5 19.8 0.1 15.8 0.0 0.9 14.4 16.6 2.9 23.7 0.1 0.1 1.4 1.7 0.0 76.4 0.5 0.1 14.4 30.6 3.9 3.3 6.1 0.0 20.1 20.3 12.0 1.0 2.7 6.3 10.5 0.1 19.8 3.5 0.0 1.4 0.3 1.3 0.0 0.6 0.1 0.3 20.1 0.1 0.6 37.4 15.1 0.7 0.8 0.0 0.0 0.2 0.8 17.3 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 15.8 14.4 16.6 14.4 30.6 20.1 20.3 12.0 19.8 20.1 15.1 17.3 0.1 0.0 5.4 2.3 1.0 0.0 2.6 32.0 0.0 0.4 4.7 3.0 0.4 1.5 41.4 9.2 0.0 0.2 0.0 0.0 3.9 5.6 821.2 353.9 4.3 1.2 5.4 0.0 2.8 0.9 2.9 1.7 0.0 5.8 1.3 0.2 0.4 0.8 0.1 1.7 3.5 0.2 46.8 0.0 0.4 410.2 8.7 0.8 3.6 1.0 0.0 2.3 0.0 1.5 0.2 1.6 0.0 3.8 0.0 4.1 0.0 39.9 502.4 3.6 6.6 0.8 13.4 41.1 8.4 0.0 0.6 0.3 0.9 0.1 0.0 1.5 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448859-6496723 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.6;retina: 28.6;skeletal muscle: 54.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favorable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 1.1 1.4 12.1 0.4 16.2 0.0 1.1 18.4 24.6 1.9 4.0 3.8 0.3 0.8 1.0 0.4 0.7 0.4 12.4 20.1 12.7 3.3 1.3 0.1 0.1 13.6 10.1 14.1 2.6 0.6 0.1 3.2 0.0 15.4 3.6 0.3 28.6 0.8 5.5 54.9 1.5 1.4 0.7 7.3 0.2 3.0 0.7 11.7 0.3 1.2 14.0 0.2 0.3 1.4 19.2 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 29.7 0.0 5.3 0.0 0.0 0.3 0.0 24.6 0.1 0.0 11.5 0.0 0.0 23.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.4 52.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 16.2 18.4 24.6 20.1 12.7 13.6 10.1 14.1 15.4 7.3 11.7 19.2 0.2 0.0 0.0 5.5 0.3 1.3 0.5 0.5 0.0 30.0 0.4 1.0 27.6 0.0 0.0 0.0 6.2 0.0 0.0 0.0 5.9 0.0 0.0 0.2 0.4 1.0 5.4 0.0 47.8 0.2 0.0 3.6 1.1 0.1 0.0 45.5 0.0 1.0 0.1 45.4 35.3 0.0 0.0 0.3 0.3 0.3 4.1 0.1 0.0 2.8 0.0 9.4 0.0 12.1 5.4 0.1 0.0 6.8 1.8 0.9 0.0 0.2 0.0 63.6 0.0 3.2 1.4 0.1 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 FASTKD5 FLJ13149 ENSG00000215251 "FAST kinase domains 5" Q7L8L6 20 3146519-3159865 "Predicted intracellular proteins" "mRNA processing" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043833 Approved NA NA "HPA043833: AB_10962718" "unprognostic (1.10e-1)" "unprognostic (2.52e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "unprognostic (8.49e-2)" "prognostic unfavorable (4.05e-5)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (2.96e-1)" "unprognostic (4.06e-1)" "unprognostic (6.95e-2)" "prognostic favorable (8.19e-8)" "unprognostic (6.80e-2)" "unprognostic (2.36e-1)" "unprognostic (7.84e-2)" "unprognostic (5.04e-2)" 8.0 14.1 6.1 9.1 6.5 37.3 8.0 9.4 8.3 7.3 8.3 9.1 9.7 7.1 5.4 9.7 6.6 7.5 15.9 6.3 6.7 16.5 12.7 8.3 11.7 7.0 6.6 6.3 7.1 5.6 12.8 5.4 8.4 7.3 7.1 9.1 10.4 8.9 6.6 35.0 7.4 9.0 8.9 6.3 9.3 8.0 10.2 6.9 12.8 7.4 27.2 12.7 10.3 5.7 8.5 25.7 28.7 18.4 22.9 17.8 12.0 18.1 14.7 15.3 20.0 16.9 41.3 14.5 36.0 11.1 19.0 26.6 31.9 45.3 35.6 25.0 10.0 23.2 31.4 12.7 50.5 15.4 36.1 28.9 17.0 29.7 19.2 7.6 12.0 19.2 23.5 35.2 17.6 23.6 12.1 21.2 26.2 26.7 33.2 24.6 21.4 24.5 32.6 28.0 29.1 17.5 20.4 17.4 55.1 36.6 21.5 20.1 27.7 20.4 12.8 17.5 12.0 21.3 19.4 36.0 27.0 8.5 22.6 20.3 30.2 12.4 20.5 10.1 14.7 18.1 10.9 13.3 13.5 12.1 8.5 16.5 18.2 10.2 8.4 17.7 6.1 17.8 13.1 6.1 6.5 9.4 8.3 6.3 6.7 7.0 6.6 6.3 7.3 6.3 6.9 8.5 5.8 16.0 8.9 0.0 9.0 9.4 10.7 10.0 5.7 5.7 6.1 4.6 17.7 14.3 9.7 7.3 14.6 13.4 9.2 8.4 7.9 11.2 13.8 9.5 5.3 6.1 5.4 3.6 0.0 6.5 8.9 6.1 4.1 10.0 5.7 6.8 5.7 10.7 7.0 15.2 0.0 5.8 8.2 6.3 8.4 4.0 4.7 8.1 3.6 0.0 11.4 8.9 5.2 0.0 0.0 8.7 4.4 6.0 4.9 4.7 11.5 12.9 12.4 16.6 0.0 8.3 6.9 25.3 11.6 7.7 9.2 19.7 10.0 9.0 6.7 10.9 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 230.3" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 14.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 14.5 29.1 12.9 7.2 13.0 18.6 21.0 15.8 14.5 24.7 12.8 16.0 0.9 17.0 12.1 10.1 28.2 7.0 14.7 13.0 13.2 41.3 42.2 24.0 19.8 13.2 13.3 12.9 56.1 230.3 0.7 61.0 3.0 13.6 38.1 1.5 8.0 18.3 10.7 10.2 12.6 25.4 2.0 13.0 38.8 28.9 43.5 13.0 2.9 114.8 1.3 7.5 19.9 13.5 13.1 2.6 2.8 0.3 5.3 2.8 5.4 7.3 2.3 0.7 2.5 4.0 2.8 3.5 0.0 4.7 2.5 0.3 2.1 0.9 2.4 1.9 3.6 8.4 0.4 20.4 16.2 3.9 2.3 2.5 7.8 3.3 1.5 4.5 2.7 2.6 4.0 0.9 0.2 2.3 1.2 1.2 24.5 3.2 5.0 4.6 0.1 0.0 0.4 2.2 4.9 3.8 5.8 1.3 0.4 3.2 3.9 2.2 4.8 0.0 3.7 8.8 1.1 4.0 1.8 1.7 3.9 1.2 1.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 13.0 15.8 14.5 13.0 13.2 13.2 13.3 12.9 13.6 13.0 13.0 13.1 19.0 192.3 66.5 95.0 34.8 21.9 8.8 10.9 33.0 53.6 30.9 34.3 37.4 20.0 74.7 31.3 73.0 7.6 30.6 2.8 1.9 9.2 53.8 17.3 27.1 11.0 7.2 13.0 133.4 13.0 5.4 12.7 20.4 24.5 9.5 36.4 11.0 28.7 1.5 45.4 126.1 10.1 12.2 6.6 9.9 10.8 39.4 5.0 21.4 12.2 6.4 9.3 32.0 112.1 24.2 16.8 4.9 37.6 45.1 7.6 7.1 5.8 39.9 67.8 13.1 13.5 13.8 48.9 28.4 10.0 14.8 2.9 49.8 22.0 9.4 6.6 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936125 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 7.5" "Group enriched" "Detected in some" 15 "Early spermatids: 61.1;Late spermatids: 24.3" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 7.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 7.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 24.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "retina: 1.7;stomach 1: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 4.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "AN3-CA: 439.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 439.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 54.7 0.0 0.0 8.4 0.5 0.1 0.2 0.0 0.0 0.0 0.2 0.0 20.8 0.2 1.5 0.9 0.5 1.6 0.8 0.8 2.0 0.2 0.0 1.5 0.3 1.7 0.0 0.3 1.4 0.9 4.7 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.6" "Group enriched" "Detected in all" 6 "Early spermatids: 309.7;Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favorable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favorable (1.75e-4)" "unprognostic (3.23e-1)" 6.2 5.0 4.7 4.8 5.9 1.5 6.8 5.9 5.9 6.5 3.9 6.8 7.4 5.3 8.1 9.9 7.1 5.2 7.9 4.7 5.1 9.5 6.2 6.2 4.6 6.5 5.5 3.7 10.0 7.9 8.9 3.7 5.7 6.2 6.5 6.2 6.0 7.1 9.7 9.1 7.7 5.0 7.3 4.8 5.6 7.9 34.6 5.8 9.5 7.3 15.0 8.0 11.0 5.8 6.5 7.0 7.2 13.0 12.3 19.8 8.7 14.8 7.2 9.4 6.8 8.7 3.3 14.6 15.2 6.1 7.1 16.0 23.3 17.3 18.0 8.5 8.4 6.6 5.2 6.0 14.1 25.8 7.6 4.4 13.5 17.7 5.4 11.8 15.1 13.1 17.0 15.6 6.0 11.8 16.1 5.9 5.2 5.3 21.3 4.1 9.2 9.7 6.7 12.5 28.5 4.2 5.2 6.9 19.3 7.8 19.7 12.0 8.9 14.6 4.7 2.1 5.9 3.3 25.1 11.3 5.0 2.5 5.5 7.2 2.9 5.0 7.3 3.5 4.5 2.8 2.6 3.0 2.9 4.8 2.3 3.2 3.9 0.8 2.4 3.4 2.9 4.1 2.9 4.7 5.9 5.9 5.9 4.7 5.1 6.5 5.5 3.7 6.2 4.8 5.8 6.5 3.7 6.4 7.0 4.6 5.6 2.8 18.4 19.9 9.1 5.8 7.0 5.7 6.9 12.8 14.4 23.9 6.2 6.9 4.6 6.8 13.7 11.0 309.7 4.4 4.2 5.7 3.6 5.0 1.9 10.9 6.6 5.2 13.7 6.9 3.8 8.2 5.3 6.9 8.7 10.1 2.0 9.2 8.2 6.1 5.1 78.9 6.8 5.8 3.6 6.5 15.1 6.9 5.2 3.0 6.8 9.1 5.5 7.5 6.1 16.3 8.6 19.8 12.9 3.7 6.6 4.7 4.7 15.2 5.3 10.1 5.1 9.3 4.2 3.8 7.9 29.1 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;testis: 1.6" "Cell type enhanced" "Detected in some" "Granulosa cells: 2.1;Leydig cells: 1.2;Microglial cells: 1.0;Peritubular cells: 1.2;Spermatocytes: 3.2;Spermatogonia: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5;WM-115: 1.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 1.5 0.0 1.3 0.0 0.2 1.0 2.0 0.1 0.9 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.1 1.0 1.2 0.0 0.0 0.0 0.2 1.1 1.1 0.9 0.9 0.0 0.0 0.8 0.0 1.0 0.1 0.1 0.6 0.0 0.3 0.1 0.0 0.0 0.3 1.3 0.1 0.0 1.6 1.0 0.0 0.2 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.2 2.5 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 1.0 2.0 1.0 1.2 1.1 1.1 0.9 1.0 1.3 1.0 1.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 5.2 0.0 0.1 0.0 0.0 0.6 0.0 0.1 RNF212B C14orf164 ENSG00000215277 "Ring finger protein 212B" A8MTL3 14 23185316-23273477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 27.4" "Group enriched" "Detected in some" 5 "Early spermatids: 42.9;Proximal tubular cells: 44.9;Spermatocytes: 94.6;Spermatogonia: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;Daudi: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053574 Uncertain NA NA "HPA053574: AB_2682195" "unprognostic (2.88e-1)" "unprognostic (2.17e-1)" "unprognostic (4.65e-1)" "unprognostic (8.54e-2)" "unprognostic (1.30e-1)" "unprognostic (4.79e-1)" "unprognostic (4.48e-2)" "unprognostic (2.98e-2)" "unprognostic (3.82e-1)" "unprognostic (1.83e-2)" "unprognostic (4.96e-3)" "unprognostic (4.45e-1)" "unprognostic (7.33e-5)" "unprognostic (9.60e-2)" "unprognostic (3.40e-1)" "unprognostic (7.56e-2)" "unprognostic (5.39e-3)" 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.1 27.4 0.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 5.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.7 0.0 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.2 42.9 0.2 0.2 0.1 0.0 0.0 3.5 0.2 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 2.2 0.5 0.0 0.0 0.0 9.5 0.9 3.2 0.0 0.0 1.6 0.2 0.0 0.5 1.6 0.1 0.0 0.4 0.1 0.0 1.0 44.9 0.0 0.3 0.0 0.1 0.1 94.6 24.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3 X-linked" O00571 X 41333348-41364472 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 887.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol NA NA 260000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073" "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 166.2 124.3 29.3 114.4 30.5 147.4 100.8 32.5 37.6 103.3 38.3 86.4 81.4 124.6 39.4 108.6 109.8 112.0 97.3 27.9 51.1 111.5 131.6 104.4 119.7 34.3 32.4 23.5 109.0 77.6 134.0 52.9 108.2 36.8 69.3 76.5 82.6 73.6 65.4 127.9 92.0 82.2 146.4 33.7 104.1 85.2 43.4 29.8 171.2 105.2 113.5 112.4 154.7 98.5 34.9 230.5 225.6 236.3 122.3 273.6 211.1 136.4 150.6 239.3 167.1 132.3 238.8 141.4 2.5 103.9 185.8 212.4 149.4 292.2 235.0 248.3 130.2 232.9 132.6 237.6 152.1 140.5 253.8 236.4 159.1 150.9 278.4 270.3 204.1 258.3 131.5 258.4 134.5 158.9 157.8 163.0 83.2 212.2 121.3 114.2 187.8 223.3 182.6 143.7 279.1 147.1 220.0 352.3 184.3 194.3 248.9 158.9 172.4 224.5 159.6 166.3 178.7 188.2 153.6 194.0 215.7 161.5 156.1 151.5 50.8 39.0 30.7 23.3 35.3 33.5 21.0 23.3 26.3 34.7 13.0 25.4 25.3 54.0 30.7 39.4 11.7 24.8 37.8 29.3 30.5 32.5 37.6 27.9 51.1 34.3 32.4 23.5 36.8 33.7 29.8 34.9 466.5 86.6 150.0 66.9 280.1 264.3 160.5 63.7 191.8 77.1 295.1 237.6 158.0 81.5 96.5 58.8 131.3 94.6 415.2 231.1 43.0 64.3 370.6 261.1 237.7 238.5 183.7 113.0 43.8 85.6 95.1 191.8 178.9 290.1 165.5 180.6 144.2 174.5 123.1 60.6 47.1 161.4 71.2 208.7 269.1 887.5 66.5 319.0 128.1 47.8 112.2 90.0 79.3 44.7 63.1 114.1 156.7 62.8 241.8 145.0 234.9 87.3 102.5 127.1 72.3 351.4 210.1 30.6 57.7 212.6 333.4 172.9 342.4 144.8 129.1 225.8 VPS16 ENSG00000215305 "VPS16 core subunit of CORVET and HOPS complexes" Q9H269 20 2840703-2866732 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043229, HPA048661" Approved NA NA "HPA043229: AB_2678373, HPA048661: AB_2680484" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (7.13e-3)" "unprognostic (2.22e-1)" "unprognostic (3.72e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (1.43e-4)" "unprognostic (9.30e-2)" "unprognostic (5.48e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.89e-5)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.02e-5)" "unprognostic (1.33e-1)" "unprognostic (1.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.22e-3)" 17.9 16.1 9.1 18.4 9.5 23.3 17.7 8.9 11.3 20.8 9.3 16.9 17.1 22.2 10.8 16.5 18.4 13.9 12.8 9.8 10.0 14.8 16.1 18.1 18.0 11.3 9.3 10.1 19.3 22.1 19.7 16.2 14.1 10.2 18.1 11.0 8.9 19.2 12.8 18.7 21.7 21.0 20.6 8.6 23.6 18.3 11.3 10.1 21.3 22.7 14.9 17.5 17.2 18.0 9.7 27.1 36.7 28.8 27.8 27.5 30.1 16.0 24.0 31.3 27.5 24.8 22.1 25.5 18.3 16.6 27.6 43.9 34.6 25.0 45.5 14.8 30.0 20.7 21.4 15.4 24.4 27.8 21.6 21.3 38.7 21.0 32.6 21.1 18.1 27.5 35.2 30.6 30.2 23.9 28.2 20.4 40.1 27.3 42.7 30.4 26.4 20.8 28.2 26.0 24.8 23.9 39.6 25.7 57.1 26.7 18.7 29.3 26.2 24.0 27.0 24.7 17.6 16.3 40.9 44.4 17.0 12.7 38.6 26.1 24.0 25.8 28.4 35.2 24.6 19.5 12.3 15.4 22.6 32.1 9.1 15.8 20.4 14.5 34.3 29.5 10.6 25.7 25.5 9.1 9.5 8.9 11.3 9.8 10.0 11.3 9.3 10.1 10.2 8.6 10.1 9.7 12.7 12.8 15.9 1.3 10.4 6.0 14.5 13.7 8.6 14.4 9.7 7.6 7.5 18.6 11.0 12.9 8.4 14.2 18.7 24.8 9.8 16.1 2.6 8.2 11.9 11.5 5.4 8.6 4.2 13.2 17.8 12.9 16.3 6.9 7.0 11.8 10.0 15.5 23.3 23.5 4.1 13.0 12.2 18.4 8.8 3.3 13.1 15.2 14.2 1.9 22.3 20.8 33.0 3.0 3.5 13.0 11.6 9.4 12.8 5.6 33.2 19.4 11.2 15.0 13.1 8.4 17.9 20.9 16.1 8.0 3.8 14.1 17.4 17.6 13.9 9.2 ZNF705D ENSG00000215343 "Zinc finger protein 705D" P0CH99 8 12104389-12115516 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "epididymis: 3.7" "Group enriched" "Detected in some" 40 "Early spermatids: 5.1;Late spermatids: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705B ENSG00000215356 "Zinc finger protein 705B" P0CI00 8 7926337-7952413 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "testis: 1.0" "Group enriched" "Detected in some" 6 "Early spermatids: 3.6;Late spermatids: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705G ENSG00000215372 "Zinc finger protein 705G" A8MUZ8 8 7355517-7385558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "Early spermatids: 28.8;Late spermatids: 30.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 66.7" "Cell type enhanced" "Detected in many" "Late spermatids: 87.3;Proximal enterocytes: 55.5;Rod photoreceptor cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 60.4" "Not detected" "Not detected" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 16.9 21.6 25.5 7.0 24.9 11.5 16.8 25.3 32.7 10.3 23.6 15.6 20.8 7.5 18.0 20.2 8.0 8.3 9.9 24.5 24.4 19.3 22.4 11.1 11.1 27.0 25.1 24.5 7.8 10.0 15.4 13.8 5.1 29.8 18.4 13.1 66.7 13.4 9.0 24.9 18.8 25.4 5.7 24.4 16.2 12.5 22.4 25.1 10.1 13.7 8.4 10.3 11.3 13.4 26.6 4.3 6.9 24.8 13.2 60.4 41.2 11.9 10.2 13.6 10.2 9.3 8.4 17.7 4.9 4.8 16.6 7.3 6.2 4.0 7.0 3.0 9.2 5.0 7.4 11.7 7.9 21.0 11.3 6.5 31.3 6.5 8.1 8.4 14.8 6.3 10.4 7.7 6.5 12.7 8.0 6.1 7.8 5.2 8.8 10.4 5.4 5.3 3.0 16.9 19.9 11.3 6.4 3.4 8.5 7.2 8.0 13.7 10.2 10.4 8.7 1.6 7.5 6.0 24.7 5.3 2.9 9.5 10.1 4.6 15.5 8.2 1.5 3.3 5.5 4.2 8.7 5.6 2.0 7.7 12.7 6.7 6.8 5.8 18.4 12.3 14.5 2.6 5.8 25.5 24.9 25.3 32.7 24.5 24.4 27.0 25.1 24.5 29.8 24.4 25.1 26.6 4.5 0.0 11.9 2.3 11.7 12.0 6.8 12.8 18.2 6.3 12.9 14.5 1.4 7.2 5.7 7.3 20.9 7.3 9.2 22.7 11.7 9.6 22.2 9.1 6.9 5.9 5.4 4.2 1.4 4.7 5.4 7.5 13.7 5.3 13.9 4.9 10.4 18.3 22.7 11.8 1.3 11.4 6.1 21.2 8.6 87.3 7.2 12.4 7.2 1.0 22.8 22.2 13.4 0.5 1.6 6.1 13.2 3.8 5.1 8.3 55.5 42.6 8.2 74.3 6.6 21.7 5.6 14.1 4.4 21.2 13.4 5.5 5.9 14.7 15.4 9.7 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-675802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 41 "brain: 7.2;retina: 3.9" "Cell type enriched" "Detected in some" 11 "Horizontal cells: 60.6" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 1.7;NTERA-2: 1.7;RPMI-8226: 3.4;SCLC-21H: 1.8;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA067697 Approved Nucleoplasm NA NA Nucleoplasm "HPA067697: AB_2685890" "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.8 0.0 1.0 0.0 0.0 5.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 4.8 3.2 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 1.0 5.4 7.2 1.3 0.5 4.8 3.2 0.0 3.0 0.5 5.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 60.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF407 "FLJ13839, FLJ20307, KIAA1703" ENSG00000215421 "Zinc finger protein 407" Q9C0G0 18 74597870-75065671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 96.9;Excitatory neurons: 111.0;Inhibitory neurons: 100.2;Microglial cells: 113.4;Oligodendrocyte precursor cells: 122.6;Oligodendrocytes: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028255, HPA041673" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA028255: AB_10603466, HPA041673: AB_2677610" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (2.48e-1)" "unprognostic (8.62e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-2)" "unprognostic (1.76e-2)" "unprognostic (4.31e-1)" "unprognostic (1.19e-3)" "unprognostic (4.04e-4)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "prognostic favorable (9.79e-5)" "unprognostic (8.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" 2.4 2.0 2.6 3.1 3.2 5.3 2.9 8.0 2.6 2.8 7.4 2.4 2.2 3.7 1.9 2.5 2.8 2.1 3.3 2.2 2.6 2.4 2.2 2.4 3.4 3.5 3.2 1.5 4.8 2.2 4.0 1.5 2.8 4.2 2.8 2.3 2.9 2.4 2.8 4.0 2.3 2.5 3.1 2.8 3.5 2.3 4.1 3.0 5.5 3.6 3.6 3.1 2.4 2.0 3.8 3.9 4.0 4.4 4.1 3.2 4.7 3.2 5.1 4.4 3.7 4.0 1.7 2.2 5.6 1.5 7.1 2.5 4.5 4.2 5.5 5.4 9.3 2.6 7.1 5.5 3.2 2.9 10.9 6.0 4.3 2.4 5.9 5.1 3.5 5.6 3.9 4.1 8.0 5.7 3.1 5.3 1.5 2.6 1.4 3.6 5.4 5.8 4.4 2.6 7.2 4.2 4.0 4.7 2.9 3.6 3.2 3.4 4.6 7.9 8.3 3.5 2.3 4.1 2.8 6.2 5.7 3.0 4.6 5.0 1.6 0.7 0.9 1.0 0.9 1.0 0.8 0.8 0.6 0.3 0.8 0.9 1.1 2.2 1.1 0.6 1.3 0.2 0.4 2.6 3.2 8.0 2.6 2.2 2.6 3.5 3.2 1.5 4.2 2.8 3.0 3.8 16.5 6.4 6.3 96.9 10.6 3.2 5.0 3.0 2.8 11.2 6.3 6.0 19.4 2.8 4.9 5.5 6.2 4.2 11.4 6.9 0.0 4.3 4.6 8.6 15.3 10.0 4.2 3.4 111.0 2.9 2.7 7.6 17.3 14.4 1.3 10.2 3.3 5.5 3.2 5.0 100.2 5.7 2.0 5.3 2.8 3.3 5.3 7.6 5.4 113.4 6.1 6.2 8.2 122.6 130.5 4.8 6.0 4.5 11.1 4.4 4.3 2.6 6.2 13.2 6.6 10.8 8.1 9.0 12.8 5.6 4.1 5.2 10.1 12.1 6.0 3.9 NPEPL1 "bA261P9.2, FLJ11583" ENSG00000215440 "Aminopeptidase like 1" Q8NDH3 20 58689131-58719238 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 23.9;classical monocyte: 18.5;eosinophil: 7.2;intermediate monocyte: 13.0;myeloid DC: 11.4;neutrophil: 13.7;non-classical monocyte: 18.8" "Group enriched" "Detected in all" 5 "dendritic cells: 11.4;granulocytes: 23.9;monocytes: 18.8" "Cell line enhanced" "Detected in many" "MCF7: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004986, CAB017025, HPA036356" Approved Approved Nucleoplasm,Cytosol NA NA 14000 Nucleoplasm Cytosol "CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082" "unprognostic (1.68e-1)" "unprognostic (5.87e-3)" "unprognostic (8.28e-2)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (2.86e-3)" "unprognostic (3.11e-2)" "unprognostic (4.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.62e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.87e-9)" "unprognostic (7.97e-2)" "unprognostic (1.64e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.73e-4)" 29.5 25.0 17.8 9.4 19.2 20.1 28.4 17.0 29.1 19.9 19.0 34.2 16.1 25.1 3.9 27.2 23.4 16.0 27.1 17.9 17.9 40.6 20.8 26.9 13.7 19.4 16.9 16.2 23.8 24.3 16.9 27.2 10.1 18.9 29.5 4.5 2.5 30.0 15.3 66.9 23.2 25.6 8.7 16.7 40.4 27.3 23.3 17.3 7.8 39.5 29.0 6.2 39.5 22.3 18.1 22.5 31.2 5.5 4.5 11.8 21.7 1.7 8.5 0.7 26.6 14.9 18.0 16.6 1.0 44.6 15.7 0.3 24.0 7.5 10.4 2.6 20.0 7.5 8.0 26.0 8.3 29.6 8.1 13.0 21.3 31.7 9.3 0.0 9.8 22.6 6.1 1.1 3.5 10.6 106.6 3.3 21.2 8.3 13.1 33.8 6.6 2.6 12.6 11.1 14.8 10.1 3.2 22.4 6.1 41.8 3.0 23.4 15.3 25.3 6.7 5.4 14.0 4.4 11.7 4.3 0.7 9.8 15.2 2.7 23.9 18.5 7.2 2.5 13.0 3.1 1.4 1.5 1.7 11.4 0.9 0.9 1.8 13.7 3.2 18.8 0.5 3.7 6.3 17.8 19.2 17.0 29.1 17.9 17.9 19.4 16.9 16.2 18.9 16.7 17.3 18.1 23.6 9.6 15.6 0.0 3.5 9.2 8.2 17.1 10.8 19.0 17.2 16.0 16.7 10.0 16.4 27.6 25.0 15.0 11.8 7.6 13.7 14.8 2.3 11.9 8.1 13.6 12.0 3.0 0.0 9.2 7.8 16.1 18.8 6.4 2.5 32.3 15.0 9.1 11.2 8.4 0.0 10.2 20.3 16.7 12.0 8.5 22.1 15.1 7.2 0.0 16.3 20.1 6.2 0.0 0.0 10.8 14.3 14.7 8.4 4.4 17.6 19.9 19.0 8.5 19.7 14.9 15.2 6.7 3.0 16.9 11.2 8.9 9.0 9.7 13.1 7.7 KRTAP10-4 "KAP10.4, KRTAP18-4, KRTAP18.4" ENSG00000215454 "Keratin associated protein 10-4" P60372 21 44573724-44638284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "skin 1: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-1 "KAP10.1, KAP18.1, KRTAP18-1" ENSG00000215455 "Keratin associated protein 10-1" P60331 21 44538981-44540195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "skin 1: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL17-C18orf32 ENSG00000215472 "RPL17-C18orf32 readthrough" 18 49481681-49492479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 153.8;Alveolar cells type 2: 154.3;Club cells: 96.6;granulocytes: 65.6;Respiratory ciliated cells: 117.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043724, HPA046385" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA043724: AB_2678637, HPA046385: AB_2679646" "unprognostic (1.62e-1)" "unprognostic (1.67e-2)" "unprognostic (1.70e-3)" "unprognostic (3.83e-4)" "unprognostic (1.95e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" "unprognostic (2.38e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (5.42e-2)" 42.1 78.4 122.5 36.1 123.9 49.5 50.1 129.2 160.6 36.8 124.2 44.1 51.8 32.5 70.9 26.0 31.4 39.0 64.2 118.6 130.6 96.9 85.7 42.6 35.4 128.7 125.5 114.2 34.7 52.3 85.1 9.5 35.6 128.2 49.1 42.0 105.6 55.0 34.7 30.4 22.4 48.7 26.9 130.7 36.2 56.2 30.8 124.0 33.1 53.9 38.5 27.4 38.5 5.3 139.2 29.4 25.0 57.3 47.1 55.7 42.3 42.7 34.6 36.6 27.9 32.9 7.7 33.8 21.8 74.0 33.5 30.5 29.6 26.2 29.7 31.1 67.7 20.2 28.0 15.7 28.3 56.6 46.3 59.2 50.5 65.0 22.5 42.3 61.4 35.2 48.6 19.2 60.9 79.2 16.8 41.4 26.8 20.1 28.0 13.0 26.2 21.2 59.4 115.2 34.7 64.5 120.0 22.0 36.8 76.1 41.4 50.3 45.4 33.0 37.4 25.7 23.4 36.8 106.2 60.1 24.9 42.0 26.0 42.7 92.6 30.2 71.3 23.0 41.1 33.4 28.3 27.1 26.5 27.9 20.3 23.3 31.2 85.1 22.3 48.5 38.4 30.9 49.2 122.5 123.9 129.2 160.6 118.6 130.6 128.7 125.5 114.2 128.2 130.7 124.0 139.2 0.5 153.8 154.3 0.3 0.4 0.3 0.7 0.3 0.6 0.4 0.5 0.5 0.0 0.0 96.6 0.0 0.0 0.1 0.2 0.2 0.0 0.2 2.8 0.3 0.7 17.8 0.0 0.0 0.1 0.2 0.1 18.5 0.5 0.4 65.6 0.2 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.6 0.0 4.3 0.0 20.9 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.3 117.3 0.3 0.0 0.2 0.4 1.0 0.5 1.0 0.1 0.3 9.1 0.5 0.1 0.5 SKOR2 "CORL2, Fussel-18, FUSSEL18" ENSG00000215474 "SKI family transcriptional corepressor 2" Q2VWA4 18 47206169-47251660 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.8;Spermatocytes: 2.5;Spermatogonia: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "NTERA-2: 3.9" "Region enriched" "Detected in single" 5 "cerebellum: 2.4" "Not detected" "Not detected" HPA046206 Uncertain NA NA "HPA046206: AB_2679588" "unprognostic (1.53e-1)" "unprognostic (1.93e-1)" "unprognostic (1.92e-1)" "unprognostic (6.31e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.0 0.7 0.5 1.8 0.0 0.0 0.8 1.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777242-45851753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8;fallopian tube: 3.1" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.5;ovarian cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "EFO-21: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.0 0.2 0.5 0.1 1.0 0.1 0.0 2.5 0.9 0.9 0.0 0.0 0.0 0.3 0.3 0.0 3.1 0.0 0.0 0.5 0.7 0.3 0.0 0.0 0.0 0.8 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.3 0.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 2.5 0.9 0.5 0.7 0.8 2.8 0.8 0.9 0.3 0.3 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.5 0.0 0.0 1.8 2.1 0.0 0.0 0.0 1.9 0.0 0.0 28.6 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 EFCAB8 ENSG00000215529 "EF-hand calcium binding domain 8" A8MWE9 20 32858923-32961609 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 3.4" "Cell type enhanced" "Detected in some" "Early spermatids: 3.7;Late spermatids: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034246, HPA042751" Uncertain NA NA "CAB034246: AB_1565078, HPA042751: AB_2678145" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (7.35e-2)" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-4)" "unprognostic (2.35e-2)" "unprognostic (1.50e-1)" "unprognostic (3.26e-1)" "unprognostic (9.35e-2)" "unprognostic (2.10e-4)" "unprognostic (4.48e-2)" "unprognostic (4.44e-10)" "unprognostic (1.66e-1)" "unprognostic (6.57e-2)" "unprognostic (2.31e-1)" "unprognostic (3.74e-3)" 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 3.4 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 DEFB116 DEFB-16 ENSG00000215545 "Defensin beta 116" Q30KQ4 20 31303212-31308585 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047430 Uncertain "Secreted in male reproductive system" NA NA "HPA047430: AB_10964749" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB115 DEFB-15 ENSG00000215547 "Defensin beta 115" Q30KQ5 20 31257664-31259632 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "epididymis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "U-2 OS: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053160 Uncertain "Secreted in male reproductive system" NA NA "HPA053160: AB_2682062" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAB4 ENSG00000215568 "GRB2 associated binding protein family member 4" Q2WGN9 22 16961936-17008222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.0" "Cell type enhanced" "Detected in some" "Early spermatids: 8.2;Late spermatids: 25.1;Spermatocytes: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044621 Uncertain NA NA "HPA044621: AB_10967265" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf202 ENSG00000215595 "Chromosome 20 open reading frame 202" A1L168 20 1203454-1208279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 3.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Early spermatids: 3.6;Late spermatids: 2.1;Paneth cells: 1.3;Proximal enterocytes: 1.2;Sertoli cells: 6.6;Smooth muscle cells: 1.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.0" "Group enriched" "Detected in some" 15 "cerebellum: 8.0;olfactory bulb: 2.6" "Low region specificity" "Detected in many" HPA042786 Uncertain NA NA "HPA042786: AB_10795760" "unprognostic (8.20e-2)" "unprognostic (1.66e-1)" "unprognostic (7.27e-2)" "unprognostic (2.73e-2)" "unprognostic (3.49e-3)" "unprognostic (1.92e-3)" "unprognostic (1.15e-2)" "unprognostic (7.41e-3)" "unprognostic (1.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (7.55e-2)" "unprognostic (5.82e-3)" "unprognostic (7.98e-2)" "unprognostic (5.70e-3)" "unprognostic (1.26e-1)" "unprognostic (7.24e-3)" 0.5 0.1 0.5 0.1 0.6 0.0 0.4 1.0 0.8 0.2 0.4 0.3 0.3 0.1 0.0 0.3 0.4 0.7 0.5 0.4 0.5 0.4 0.1 1.3 0.2 0.6 0.6 0.5 0.1 0.3 0.4 0.2 3.4 0.7 0.1 0.3 0.4 0.4 0.6 0.5 0.5 1.1 0.2 0.5 0.2 0.3 0.7 0.7 0.1 0.2 0.3 0.1 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.6 1.0 0.8 0.4 0.5 0.6 0.6 0.5 0.7 0.5 0.7 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 1.2 0.1 0.0 0.0 6.6 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 HMX1 "H6, NKX5-3" ENSG00000215612 "H6 family homeobox 1" Q9NP08 4 8846076-8871839 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cataract, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;retina: 2.4;testis: 1.3" "Group enriched" "Detected in some" 13 "Horizontal cells: 267.5;Muller glia cells: 247.9" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.1;EFO-21: 2.9;HEK 293: 5.5;SH-SY5Y: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.11e-2)" "unprognostic (1.63e-2)" "unprognostic (2.97e-1)" "unprognostic (6.35e-2)" "unprognostic (7.94e-2)" "unprognostic (9.36e-2)" "unprognostic (1.97e-1)" 0.0 0.0 1.8 0.0 1.2 0.0 0.0 1.8 1.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 1.6 1.7 0.8 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.2 1.8 1.3 1.1 1.1 1.6 1.7 0.8 1.5 1.2 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.1 0.6 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 267.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 247.9 0.0 6.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.2 0.1 0.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814008 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 171.0" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 74.6" "Cancer enriched" "Detected in many" 4 "liver cancer: 10.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071228 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 2.6 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.7 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 35.7 171.0 0.0 0.1 0.2 0.1 0.0 0.0 1.5 6.3 0.2 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 1.2 0.6 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.0 0.6 0.0 0.5 0.0 0.3 0.6 0.0 0.3 3.7 2.1 0.0 0.0 0.1 3.9 0.2 0.1 0.4 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 74.6 0.1 0.0 0.5 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.0 0.2 0.0 0.1 0.0 RSC1A1 RS1 ENSG00000215695 "Regulator of solute carriers 1" Q92681 1 15659869-15661722 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027813, HPA028676" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA027813: AB_10600308, HPA028676: AB_10600895" 3.0 1.5 0.0 2.6 0.1 4.2 1.9 0.2 0.9 1.2 0.7 1.4 0.5 2.0 0.3 4.2 2.0 1.9 3.0 0.1 0.2 4.6 8.3 2.3 3.0 0.3 0.3 0.0 1.9 1.1 2.9 0.5 3.2 0.4 2.0 2.0 2.4 0.2 1.4 0.2 0.6 1.4 3.7 0.2 0.8 1.4 2.4 0.2 2.0 2.4 4.9 4.2 2.2 1.0 1.4 4.1 4.7 5.7 3.8 6.9 4.8 7.5 3.4 5.6 9.2 8.5 7.8 6.5 9.2 3.2 7.6 4.6 2.8 14.9 4.8 11.2 6.0 3.8 8.5 9.1 8.4 1.6 12.6 4.2 3.8 0.0 15.8 8.7 2.2 5.9 6.1 23.6 8.3 6.8 4.1 6.7 0.0 6.2 2.4 2.7 5.6 8.0 3.8 2.2 7.5 4.6 1.9 6.3 2.9 4.9 4.8 4.0 1.1 5.8 4.7 8.5 4.2 2.5 2.6 5.2 15.6 1.9 3.4 3.4 0.0 0.4 0.1 0.1 0.9 0.4 0.3 0.1 0.6 0.9 0.0 0.2 0.1 0.0 0.4 0.0 0.2 0.7 0.5 0.0 0.1 0.2 0.9 0.1 0.2 0.3 0.3 0.0 0.4 0.2 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CELA2B "ELA2B, RP11-265F14.2" ENSG00000215704 "Chymotrypsin like elastase 2B" P08218 1 15465909-15491395 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1671 "pancreas: 20621.8" "Cell type enriched" "Detected in some" 73 "Exocrine glandular cells: 1227.6" "Cancer enriched" "Detected in single" 574 "pancreatic cancer: 69.9" "Region enhanced" "Detected in some" "cerebral cortex: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-138 MG: 3.9" "Secreted to digestive system" NA NA "unprognostic (4.36e-3)" "unprognostic (5.45e-2)" "unprognostic (6.66e-2)" "unprognostic (5.31e-3)" "unprognostic (4.47e-3)" "unprognostic (1.37e-3)" "unprognostic (4.66e-2)" "unprognostic (6.32e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-1)" "unprognostic (2.94e-1)" "unprognostic (3.85e-2)" "unprognostic (1.22e-6)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-1)" "unprognostic (7.80e-2)" 0.9 3.0 0.4 0.5 0.1 1.0 0.6 2.0 3.2 0.2 0.0 0.1 3.8 0.4 0.1 0.3 0.1 0.6 4.5 0.4 0.5 0.2 0.6 0.3 1.2 0.1 0.2 0.0 12.3 20621.8 0.0 0.1 1.2 0.7 0.3 0.0 1.7 3.4 0.0 0.3 1.0 2.4 0.0 0.6 0.3 1.2 0.7 0.5 0.0 0.8 0.0 0.0 0.1 0.1 0.6 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.5 0.8 0.4 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 3.2 0.4 0.5 0.1 0.2 0.0 0.7 0.6 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 1.4 1227.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 TMEM242 "BM033, C6orf35" ENSG00000215712 "Transmembrane protein 242" Q9NWH2 6 157289025-157323601 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025764 Approved NA NA "HPA025764: AB_1845742" "unprognostic (5.42e-3)" "unprognostic (6.02e-2)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (6.24e-2)" "unprognostic (2.21e-3)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (7.14e-2)" "unprognostic (1.18e-3)" "unprognostic (1.28e-1)" "unprognostic (6.50e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 6.7 9.3 9.4 5.1 10.5 11.1 6.5 10.2 10.7 7.1 9.1 7.0 5.9 7.7 8.0 6.1 5.9 5.1 14.2 10.2 9.9 8.3 10.3 5.5 5.5 9.1 9.3 9.9 6.5 5.5 10.8 6.3 6.1 9.7 6.6 6.2 9.6 6.9 5.4 12.2 6.1 5.8 7.9 9.0 5.3 6.6 4.7 9.8 6.0 7.4 12.0 5.9 7.2 6.9 10.9 5.1 4.0 8.3 8.8 15.4 10.0 6.2 9.7 9.1 9.7 10.7 5.3 4.9 7.7 12.5 10.6 13.3 9.0 8.7 8.7 9.9 11.1 14.3 10.9 9.1 10.8 16.0 11.3 8.3 10.2 9.3 6.9 14.1 13.4 11.8 10.3 17.1 10.1 8.7 5.2 6.6 14.9 5.6 3.2 7.8 3.8 5.4 11.1 13.9 4.5 10.9 5.7 8.7 5.8 11.8 7.6 5.9 11.9 9.9 6.7 7.6 14.5 13.0 9.7 10.5 7.3 13.7 13.0 11.2 15.0 19.5 12.4 13.9 16.8 13.4 18.5 14.0 13.9 18.6 19.5 12.1 13.8 3.0 17.1 11.6 29.8 16.7 12.1 9.4 10.5 10.2 10.7 10.2 9.9 9.1 9.3 9.9 9.7 9.0 9.8 10.9 28.8 12.8 10.0 7.5 21.6 27.5 18.8 62.2 25.6 25.1 20.3 25.4 51.8 20.0 27.1 22.0 4.2 51.2 28.0 19.6 33.2 49.1 11.7 25.8 32.8 28.0 9.6 40.0 23.0 39.1 53.2 27.5 13.3 28.6 15.8 16.9 25.4 28.5 36.5 38.7 28.3 21.8 32.6 17.3 26.7 6.8 21.1 17.7 42.7 14.0 21.7 26.9 27.8 15.1 22.0 39.6 26.9 26.7 23.7 17.9 32.0 38.2 29.7 30.5 59.2 22.8 36.0 34.7 37.1 24.4 24.3 41.6 24.8 24.6 24.6 16.8 TMEM167B "AD-020, C1orf119, FLJ90710" ENSG00000215717 "Transmembrane protein 167B" Q9NRX6 1 109090764-109096934 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.89e-2)" "unprognostic (3.28e-1)" "unprognostic (4.96e-2)" "prognostic favorable (8.86e-4)" "unprognostic (3.76e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-3)" "unprognostic (2.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.15e-2)" "unprognostic (2.25e-1)" 32.0 35.8 31.9 24.4 32.2 54.2 33.4 31.8 34.7 32.7 31.7 27.9 23.4 31.2 31.9 24.2 25.6 25.8 36.2 31.7 32.3 33.6 33.3 28.7 26.4 31.6 32.1 30.4 30.0 26.0 45.5 16.0 34.1 31.5 37.3 30.1 31.5 30.6 28.1 21.5 29.1 23.9 30.9 33.5 28.6 32.6 23.6 32.5 25.3 42.1 26.1 27.9 27.4 16.5 34.9 36.1 6.5 23.4 32.3 47.8 47.0 20.9 54.2 49.7 30.0 27.8 13.7 13.4 24.0 30.1 55.9 17.8 17.4 15.1 24.1 43.0 37.4 11.4 22.4 8.7 18.8 53.6 43.6 36.6 38.8 64.7 27.9 46.7 40.8 26.5 30.8 28.5 33.9 33.0 22.2 33.0 28.1 17.7 31.0 33.1 20.5 37.1 19.0 38.6 22.5 16.6 17.0 26.2 38.0 53.0 20.8 23.7 32.0 25.2 30.6 30.8 67.0 26.6 34.0 20.6 23.7 51.7 44.7 65.0 38.1 20.7 35.4 13.3 23.8 19.1 14.4 17.6 17.0 19.1 13.5 17.8 17.8 45.4 17.5 30.8 11.7 17.9 19.9 31.9 32.2 31.8 34.7 31.7 32.3 31.6 32.1 30.4 31.5 33.5 32.5 34.9 29.6 32.1 31.4 10.7 30.1 30.5 29.4 25.7 16.5 30.1 28.2 17.9 34.0 22.8 28.6 18.4 12.5 42.1 38.7 20.0 19.6 26.7 19.1 16.2 25.2 30.7 20.9 25.9 11.5 30.1 44.3 32.3 23.0 27.1 32.3 21.7 27.8 21.7 39.1 25.2 12.5 25.2 24.4 36.8 42.8 17.0 28.9 38.8 26.6 6.5 56.3 36.0 24.7 12.5 16.4 29.3 19.7 25.2 16.8 39.8 25.9 29.6 19.7 30.1 0.0 21.7 26.8 28.9 28.2 26.0 35.7 63.1 32.9 20.4 19.1 51.5 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145095974-145112696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.0;lymphoid tissue: 6.7" "Group enriched" "Detected in some" 4 "Early spermatids: 7.3;Erythroid cells: 9.7;Extravillous trophoblasts: 5.5;Spermatocytes: 15.4;Spermatogonia: 4.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 0.7 0.3 0.4 3.0 0.5 4.0 0.5 0.7 0.5 0.2 0.2 0.8 1.0 0.3 0.1 1.1 0.2 0.5 0.2 0.5 0.7 0.2 0.3 0.5 4.9 0.6 0.6 0.4 0.2 0.1 0.2 0.1 1.1 0.5 0.1 1.0 0.1 0.2 0.1 0.0 1.9 1.3 0.5 0.6 1.2 0.6 2.2 0.7 6.7 0.2 0.1 4.5 0.6 0.5 0.8 16.6 10.4 11.7 4.5 0.5 1.0 12.4 9.8 3.0 11.1 7.1 7.5 14.7 26.6 9.3 1.5 11.1 17.3 13.6 3.0 12.8 22.6 14.1 13.6 5.8 9.7 0.6 24.0 14.2 0.8 1.1 9.4 16.9 2.0 5.6 33.0 26.8 34.9 7.2 12.4 16.6 22.5 21.1 20.3 14.4 13.9 14.3 30.7 4.0 2.2 10.9 9.1 7.3 6.3 4.4 13.9 17.2 15.7 2.7 8.3 9.6 7.3 16.7 27.0 46.5 39.3 0.2 18.7 10.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.5 0.7 0.5 0.5 0.7 0.6 0.6 0.4 0.5 0.6 0.7 0.8 2.0 0.0 0.0 0.0 0.8 1.0 0.0 0.2 1.2 0.0 0.2 0.4 1.1 0.0 0.2 0.0 0.0 1.2 0.1 0.8 0.0 0.1 7.3 0.2 0.3 2.1 0.0 9.7 0.3 0.0 5.5 0.8 0.0 0.2 0.0 0.3 0.4 0.1 1.5 0.0 0.5 0.8 0.0 1.0 1.0 0.6 0.0 1.8 1.8 1.0 0.8 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.8 0.2 0.3 0.1 0.3 0.0 0.0 0.5 0.8 15.4 4.5 1.6 1.0 0.3 0.4 0.1 1.4 0.1 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6460786-6466175 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.3;pituitary gland: 30.1;skin 1: 25.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 34.1;Excitatory neurons: 37.5;T-cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "MAIT T-cell: 5.6;memory CD4 T-cell: 4.4;memory CD8 T-cell: 2.2;naive CD4 T-cell: 4.4;T-reg: 7.9" "Lineage enriched" "Detected in many" 7 "T-cells: 7.9" "Cell line enhanced" "Detected in many" "HDLM-2: 20.5;RPMI-8226: 25.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.4;hippocampal formation: 2.0" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favorable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 5.0 4.2 3.5 3.2 3.4 0.8 4.1 10.4 6.2 4.8 4.1 4.6 3.0 3.0 0.6 10.3 5.7 2.2 5.8 4.3 3.5 3.3 1.2 2.5 4.4 3.2 3.8 4.2 3.1 1.5 0.9 30.1 4.5 7.3 5.2 1.4 1.2 3.3 2.3 1.1 25.5 5.1 0.5 2.7 44.3 2.0 0.9 3.2 2.0 3.2 1.3 2.8 2.5 4.7 4.5 1.8 0.4 1.1 2.0 0.0 0.6 1.3 1.5 0.6 0.3 0.0 1.7 2.8 0.0 2.5 0.0 1.3 4.2 0.6 4.7 0.0 20.5 1.5 0.6 1.7 0.1 0.7 0.0 0.1 0.0 3.2 1.5 4.1 2.7 4.0 1.1 0.0 0.0 0.0 2.2 0.0 8.0 1.4 1.4 3.4 0.6 0.3 25.7 1.3 0.7 3.4 5.3 0.0 2.5 0.1 0.6 2.0 2.9 2.5 1.3 2.1 0.0 2.0 0.0 3.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.0 0.2 5.6 0.0 4.4 2.2 0.5 0.0 4.4 0.7 0.0 0.8 1.0 0.0 7.9 0.9 3.5 3.4 10.4 6.2 4.3 3.5 3.2 3.8 4.2 7.3 2.7 3.2 4.5 19.0 3.2 5.0 3.9 2.5 24.6 2.3 5.6 11.4 3.1 4.2 5.5 1.1 1.5 3.3 1.8 2.1 0.7 12.8 34.1 0.0 0.2 0.2 4.1 11.2 11.5 6.7 3.0 37.5 0.4 2.0 2.3 5.6 6.9 7.0 4.8 7.9 1.1 4.0 5.0 21.6 20.3 0.0 1.2 6.6 0.3 2.8 4.0 7.2 14.0 3.0 10.2 10.3 7.5 2.1 1.4 16.0 9.4 3.2 3.7 9.8 0.6 4.8 9.1 0.0 2.6 2.6 0.4 1.2 8.6 28.6 0.1 41.4 0.7 25.0 6.8 ZC3H11B ZC3HDC11B ENSG00000215817 "Zinc finger CCCH-type containing 11B" A0A1B0GTU1 1 219608010-219613145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 5.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.3;Cardiomyocytes: 1.5;Collecting duct cells: 1.8;monocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026439, HPA028490, HPA028526" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (1.75e-1)" "unprognostic (5.54e-2)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.92e-1)" "unprognostic (5.07e-1)" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.30e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-2)" "unprognostic (7.87e-2)" "unprognostic (9.15e-2)" "unprognostic (2.56e-2)" "unprognostic (1.87e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.3 0.4 0.2 0.1 0.0 0.2 0.2 5.1 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.3 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.3 1.5 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.6 0.8 0.3 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 TSTD1 KAT ENSG00000215845 "Thiosulfate sulfurtransferase like domain containing 1" Q8NFU3 1 161037631-161038977 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 684.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 205.3;OE19: 215.1;SK-BR-3: 284.0;T-47d: 274.9;U-266/70: 315.4;U-266/84: 243.2" "Region enriched" "Detected in some" 4 "olfactory bulb: 6.6" "Low region specificity" "Detected in all" "HPA006518, HPA006655" Approved Approved "Cytosol,Cytoplasmic bodies" NA NA 57000 "Cytosol, Cytoplasmic bodies" "HPA006518: AB_2667608, HPA006655: AB_10600919" "unprognostic (6.10e-2)" "unprognostic (4.70e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" "unprognostic (5.77e-2)" "unprognostic (1.63e-1)" "unprognostic (6.56e-2)" "unprognostic (2.51e-3)" "unprognostic (2.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "unprognostic (1.13e-1)" "unprognostic (4.64e-2)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (8.57e-3)" "unprognostic (8.88e-3)" 34.1 72.7 27.4 26.0 31.6 48.7 74.4 19.6 40.6 31.7 31.9 60.9 40.8 10.5 102.4 92.0 69.8 19.1 37.0 27.4 26.9 117.3 75.3 47.8 53.3 21.6 23.0 29.7 55.6 94.2 168.6 120.1 13.3 21.9 99.4 41.2 11.5 177.2 43.9 39.1 73.5 50.9 8.6 20.6 40.0 61.7 35.9 24.6 60.1 141.1 18.7 51.6 30.1 46.8 24.9 119.8 1.6 0.3 0.6 0.0 0.0 2.1 0.2 0.0 0.2 0.0 11.1 112.5 25.0 67.9 0.0 0.0 107.2 0.1 46.4 0.0 98.4 84.9 13.3 43.2 0.0 12.2 43.7 0.9 0.6 28.2 0.0 4.8 0.1 15.6 100.8 0.4 130.8 12.8 205.3 118.6 0.6 0.7 215.1 0.3 38.7 0.0 184.8 98.0 32.8 67.5 37.2 0.0 284.0 0.9 54.0 274.9 0.6 0.5 0.0 41.5 0.6 4.8 315.4 243.2 26.3 0.3 0.2 0.4 438.2 24.2 357.7 226.5 72.0 218.8 530.9 296.2 252.0 72.6 506.1 333.3 282.1 337.5 306.5 104.8 203.9 410.8 220.6 27.4 31.6 19.6 40.6 27.4 26.9 21.6 23.0 29.7 21.9 20.6 24.6 24.9 6.5 253.2 228.8 1.0 170.3 86.3 307.5 331.1 160.5 16.2 443.9 457.1 68.4 223.1 259.0 367.8 27.1 271.5 101.2 478.1 684.8 169.7 16.3 336.9 29.2 14.0 218.5 29.0 5.8 151.5 112.7 35.8 59.1 201.2 124.7 88.7 10.8 149.3 72.3 3.3 1.9 418.1 402.8 18.7 116.2 25.1 8.4 40.7 151.2 1.9 178.3 73.0 206.0 1.0 0.7 131.5 383.6 9.8 110.5 386.2 426.6 665.8 615.1 31.8 19.7 99.5 37.7 73.3 44.4 199.6 135.8 151.0 149.3 31.7 267.0 384.9 RPTN FLJ39117 ENSG00000215853 Repetin Q6XPR3 1 152153595-152159228 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 52.6;skin 1: 29.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 4 "head and neck cancer: 6.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030483, HPA030485" Enhanced "Secreted to extracellular matrix" NA NA "HPA030483: AB_2673495, HPA030485: AB_10601159" "unprognostic (1.37e-2)" "unprognostic (5.06e-2)" "unprognostic (2.35e-1)" "unprognostic (4.54e-2)" "unprognostic (4.00e-2)" "unprognostic (5.23e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 29.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 52.6 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 CYB5RL LOC606495 ENSG00000215883 "Cytochrome b5 reductase like" Q6IPT4 1 54169651-54200036 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042671, HPA060463" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042671: AB_2678107, HPA060463: AB_2684286" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (1.72e-2)" "unprognostic (1.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-3)" "unprognostic (1.90e-4)" "unprognostic (6.45e-3)" "unprognostic (9.75e-2)" "unprognostic (2.04e-1)" "unprognostic (5.93e-2)" "unprognostic (2.58e-1)" "unprognostic (2.35e-1)" "unprognostic (1.80e-2)" "unprognostic (5.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.86e-1)" 2.1 4.5 1.6 1.4 1.8 2.3 2.5 1.6 2.0 2.2 2.4 2.5 2.8 2.7 2.5 2.3 2.9 2.3 3.5 1.6 1.3 2.5 3.0 1.9 2.6 1.5 1.4 1.6 4.5 4.2 3.0 3.8 1.6 1.7 2.4 2.8 2.7 3.7 1.7 4.2 3.8 2.1 2.6 1.3 3.1 3.1 1.4 1.5 1.7 3.2 4.1 2.6 2.0 1.9 1.9 3.6 4.7 6.3 6.6 5.0 4.8 2.2 2.8 4.0 5.3 5.7 4.4 3.9 6.0 3.2 1.9 12.1 3.3 10.1 2.9 6.0 6.8 4.1 6.8 8.0 4.7 3.8 5.8 3.4 2.6 3.8 6.3 2.8 3.7 4.7 5.3 7.5 2.8 3.9 4.3 5.9 3.2 6.4 4.1 3.7 9.3 7.8 5.6 2.4 4.0 9.3 4.6 1.9 6.3 5.7 5.1 4.4 4.4 2.1 4.0 3.3 6.0 5.0 4.3 7.1 8.5 4.5 12.2 6.3 0.7 0.4 0.4 0.2 0.9 0.1 0.2 0.3 0.1 0.4 0.3 0.2 0.2 0.5 0.8 0.2 0.4 0.1 0.3 1.6 1.8 1.6 2.0 1.6 1.3 1.5 1.4 1.6 1.7 1.3 1.5 1.9 1.6 0.0 7.2 1.3 1.3 0.1 1.1 0.9 0.0 4.0 2.3 2.4 5.1 2.8 3.0 3.7 4.2 1.9 0.4 1.1 7.9 3.0 0.1 3.6 2.0 6.1 2.4 6.1 2.4 4.2 2.3 2.4 1.1 2.1 2.5 4.8 3.9 2.9 5.3 0.0 2.2 1.2 4.1 1.6 0.4 1.0 1.5 1.2 0.0 2.8 1.2 1.9 4.1 2.5 3.1 1.4 0.8 1.9 2.0 0.8 1.4 2.7 5.9 4.0 0.0 2.6 1.4 1.2 5.1 0.8 0.9 0.3 1.6 2.9 2.3 0.9 LACTBL1 ENSG00000215906 "Lactamase beta like 1" A8MY62 1 22953043-22965338 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "retina: 3.0" "Cell type enriched" "Detected in single" 10 "Bipolar cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066810 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA066810: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf167 "DKFZp434E1410, RP11-56N19.2" ENSG00000215910 "Chromosome 1 open reading frame 167" Q5SNV9 1 11761787-11789585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 47 "testis: 28.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Early spermatids: 18.0;Late spermatids: 18.7;Spermatocytes: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 54 "U-698: 32.0" "Not detected" "Not detected" HPA039114 Enhanced NA NA "HPA039114: AB_10673606" "unprognostic (2.93e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-3)" "unprognostic (3.96e-1)" "unprognostic (2.38e-4)" "unprognostic (2.71e-1)" "unprognostic (5.55e-3)" "unprognostic (3.92e-2)" "unprognostic (5.10e-2)" "unprognostic (4.90e-3)" "unprognostic (3.96e-2)" "unprognostic (8.38e-5)" "unprognostic (5.46e-4)" "unprognostic (1.52e-1)" "unprognostic (2.71e-1)" "unprognostic (2.38e-2)" 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.3 0.1 28.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 4.5 22.4 2.6 0.0 0.8 1.1 1.4 0.3 0.0 0.5 2.8 1.1 0.6 0.0 0.9 3.7 0.0 0.7 0.3 1.3 1.9 1.2 18.0 1.1 1.9 2.5 0.0 0.0 0.4 8.2 0.3 4.8 4.6 2.4 0.0 0.2 5.0 0.0 0.5 5.0 0.4 0.4 0.0 0.3 1.2 18.7 6.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.8 2.3 3.8 0.6 1.4 1.2 4.2 0.2 0.3 0.0 4.2 3.6 20.0 4.0 0.5 1.7 0.3 0.4 1.8 0.5 3.6 TTC34 ENSG00000215912 "Tetratricopeptide repeat domain 34" A8MYJ7 1 2635976-2801717 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.8" "Cell type enhanced" "Detected in some" "Early spermatids: 22.8;Late spermatids: 27.4;Respiratory ciliated cells: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA066832 Uncertain NA NA "HPA066832: AB_2685731" "unprognostic (1.45e-4)" "unprognostic (5.00e-2)" "unprognostic (7.09e-2)" "unprognostic (3.25e-2)" "unprognostic (3.55e-2)" "unprognostic (3.52e-2)" "unprognostic (1.70e-1)" "unprognostic (3.93e-2)" "unprognostic (1.98e-3)" "unprognostic (1.71e-1)" "unprognostic (3.69e-3)" "unprognostic (9.93e-2)" "unprognostic (1.95e-1)" "unprognostic (9.16e-3)" "unprognostic (2.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.68e-4)" 0.2 0.3 2.1 0.1 0.6 0.0 0.6 0.4 0.6 0.6 0.5 0.1 0.0 0.5 0.2 0.0 2.1 0.0 0.1 0.3 0.5 0.6 0.1 0.5 0.1 0.9 1.8 0.2 0.9 0.3 0.1 0.8 0.0 0.8 0.6 0.0 0.1 0.3 0.1 0.0 0.1 0.4 0.0 1.5 0.5 0.2 5.8 0.6 0.1 1.7 0.0 0.1 0.4 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.4 0.6 0.3 0.5 0.9 1.8 0.2 0.8 1.5 0.6 0.5 0.3 6.4 0.0 2.9 0.6 0.0 0.5 0.3 0.0 3.3 0.4 2.8 6.0 4.3 1.0 0.0 0.0 0.1 0.3 0.2 0.0 0.7 22.8 1.1 0.4 0.4 0.0 0.0 0.9 0.6 0.0 0.5 0.0 0.1 4.5 3.0 0.7 0.0 0.3 0.0 0.8 0.6 2.0 1.3 0.4 27.4 0.6 0.3 1.8 1.0 1.1 2.1 1.0 0.5 0.1 0.6 0.1 0.0 0.0 0.3 0.3 0.4 6.9 3.5 0.0 1.0 0.5 2.1 0.7 0.0 0.1 0.0 0.6 1.0 0.6 0.0 ATAD3C FLJ34599 ENSG00000215915 "ATPase family AAA domain containing 3C" Q5T2N8 1 1449689-1470163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Collecting duct cells: 20.2;Distal tubular cells: 45.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 13.1" HPA065305 Approved Mitochondria NA NA Mitochondria "HPA065305: AB_2685459" "unprognostic (9.23e-2)" "unprognostic (3.48e-2)" "unprognostic (3.20e-2)" "unprognostic (4.35e-3)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (3.79e-2)" "prognostic favorable (5.15e-4)" "unprognostic (1.23e-1)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (2.65e-1)" "unprognostic (3.80e-2)" "unprognostic (1.83e-1)" "unprognostic (5.74e-2)" "unprognostic (2.22e-1)" "unprognostic (2.12e-3)" 0.8 0.2 7.1 0.9 6.2 0.5 1.6 5.1 6.1 1.6 4.3 1.7 0.6 1.7 1.2 1.1 2.0 0.7 0.8 5.4 6.9 3.1 5.3 1.5 0.5 6.9 6.2 4.8 1.1 4.6 0.1 1.8 0.3 7.2 4.1 0.3 1.2 2.6 2.1 0.2 0.8 0.8 0.7 6.0 0.4 0.7 1.2 6.9 0.4 4.0 0.0 0.5 2.9 1.4 12.7 0.2 0.0 0.2 0.3 0.3 0.0 0.2 0.1 0.0 0.2 0.0 1.2 2.5 0.2 0.3 0.1 0.1 0.3 1.0 0.4 0.1 0.1 1.0 0.2 0.9 1.6 0.2 0.2 0.2 0.0 0.1 0.1 0.7 0.0 0.0 0.3 0.2 3.0 0.1 0.7 0.3 0.8 0.5 0.1 0.2 0.3 0.1 13.1 0.8 0.2 2.0 0.7 0.0 0.5 0.1 2.1 2.6 0.2 0.2 0.1 0.2 0.3 0.1 1.4 2.1 0.4 0.1 0.3 0.0 0.8 0.1 0.3 0.3 0.1 1.2 0.5 0.4 0.3 0.0 0.3 0.5 0.4 0.5 0.5 0.1 0.1 0.6 0.2 7.1 6.2 5.1 6.1 5.4 6.9 6.9 6.2 4.8 7.2 6.0 6.9 12.7 2.5 6.4 19.8 0.7 4.2 3.4 3.5 1.3 4.6 5.0 17.4 14.4 4.6 0.0 2.7 20.2 16.7 0.7 2.0 2.0 45.0 5.3 0.4 3.6 3.8 4.2 4.2 0.0 1.0 9.2 0.3 1.8 0.0 6.1 3.8 0.6 1.8 6.8 1.8 6.7 0.6 1.9 0.0 2.9 2.5 1.4 1.2 0.7 3.6 2.8 0.5 2.8 4.1 1.0 10.8 4.4 0.3 4.9 8.4 3.0 1.3 16.2 1.3 9.1 0.0 7.3 1.6 0.5 1.5 1.5 5.7 0.8 3.6 4.2 1.3 3.1 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30 lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 577.7;lymphoid tissue: 714.5" "Cell type enhanced" "Detected in many" "Hofbauer cells: 155.9;Kupffer cells: 205.4;Langerhans cells: 139.3;Macrophages: 426.2;monocytes: 144.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 9509.8;eosinophil: 3890.4;intermediate monocyte: 14243.6;myeloid DC: 5699.9;non-classical monocyte: 9865.9" "Group enriched" "Detected in all" 8 "dendritic cells: 5699.9;granulocytes: 3890.4;monocytes: 14243.6" "Cell line enhanced" "Detected in many" "Daudi: 655.7;RPMI-8226: 717.7;SK-BR-3: 457.4;U-266/84: 794.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 110000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 133.6 122.0 21.8 714.5 24.5 286.4 59.1 23.8 105.4 41.1 51.8 130.2 199.1 22.4 27.2 39.0 57.8 110.6 27.1 20.6 60.4 80.3 149.4 577.7 373.8 34.0 25.3 19.0 14.9 61.8 75.6 28.1 129.8 32.6 31.9 149.5 2.7 66.8 22.2 12.7 55.5 154.9 166.6 32.9 388.4 113.2 16.2 61.2 92.8 54.7 9.1 222.8 217.7 19.8 39.6 115.5 59.2 0.4 37.9 11.2 19.9 102.6 11.8 17.2 34.6 91.8 132.3 193.1 655.7 96.6 39.7 175.2 85.1 69.9 30.1 3.7 182.5 55.2 8.1 98.1 188.9 111.8 20.1 46.9 70.4 60.4 59.8 19.7 4.4 2.0 23.8 96.8 394.8 16.6 217.3 9.9 2.5 21.2 380.6 68.7 65.8 4.5 717.7 101.1 3.7 5.3 8.0 200.5 457.4 11.3 7.4 31.6 8.8 4.2 55.2 34.2 120.7 12.0 14.6 794.7 368.5 154.1 133.5 8.5 106.9 9509.8 3890.4 40.8 14243.6 38.8 952.6 28.5 31.1 5699.9 708.1 19.7 24.3 2102.8 70.2 9865.9 173.2 41.5 11082.7 21.8 24.5 23.8 105.4 20.6 60.4 34.0 25.3 19.0 32.6 32.9 61.2 39.6 6.4 9.6 38.8 0.0 54.2 3.6 2.5 2.1 2.2 0.4 8.6 13.2 1.1 4.3 18.3 12.9 0.0 5.6 4.0 8.3 1.9 1.8 0.3 2.5 1.7 8.4 0.0 4.6 0.1 1.1 14.8 8.1 6.6 4.1 13.9 0.2 3.6 1.3 155.9 0.0 0.1 14.9 2.0 205.4 139.3 0.2 0.3 426.2 5.4 1.0 144.1 0.7 5.2 0.0 0.1 1.2 3.4 0.0 47.7 4.6 5.9 5.4 8.9 0.7 0.0 2.6 1.8 0.2 0.7 3.7 3.3 12.0 9.6 1.5 9.6 1.2 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613563-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 16.0;liver: 24.7" "Cell type enhanced" "Detected in some" "Cholangiocytes: 5.7;Early spermatids: 7.9;Hepatocytes: 11.9;Late spermatids: 9.9;Proximal enterocytes: 40.8" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "CACO-2: 10.5;Hep G2: 5.4;SiHa: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA051811 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA051811: AB_2681621" "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.2 14.8 0.1 0.7 0.0 0.0 0.1 0.3 0.2 0.2 0.4 24.7 0.2 0.0 0.4 0.1 0.0 0.0 3.7 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 16.0 0.0 0.1 0.0 0.1 1.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.3 0.0 0.0 0.5 0.3 0.5 0.0 0.4 10.5 0.3 0.0 0.7 0.3 0.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 5.4 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.7 1.6 0.0 0.0 0.2 0.0 1.9 0.3 0.4 0.4 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.4 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.9 0.3 0.0 0.1 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.7 11.9 0.0 0.0 0.4 1.2 0.0 0.3 0.0 9.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 1.2 0.0 0.0 0.0 40.8 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.0 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 1.8" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.4;U-266/84: 2.1" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM240C ENSG00000216921 "Family with sequence similarity 240 member C" A0A1B0GVR7 2 241893988-241902551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 227.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.5;REH: 2.4;SCLC-21H: 1.6" HPA073342 Approved Nucleoplasm NA NA Nucleoplasm "HPA073342: " "unprognostic (9.31e-2)" "unprognostic (4.59e-2)" "unprognostic (1.61e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (3.12e-1)" "unprognostic (2.93e-2)" "unprognostic (4.75e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (5.12e-2)" "unprognostic (5.44e-2)" "unprognostic (8.45e-2)" "unprognostic (2.44e-1)" "unprognostic (3.29e-1)" 3.6 0.7 5.4 0.1 5.6 0.3 3.9 6.0 8.3 1.1 5.0 0.2 0.2 1.9 0.0 4.1 1.8 0.1 0.7 4.9 5.4 0.1 0.2 0.1 0.4 5.7 5.6 4.9 1.6 37.1 0.5 0.4 0.2 6.1 3.5 0.0 0.6 5.5 4.0 10.3 3.1 0.2 0.1 5.1 0.3 0.4 1.3 5.9 3.4 6.9 227.1 0.2 0.4 1.0 5.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.2 0.0 0.7 0.5 0.0 0.2 0.0 0.0 2.4 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.6 6.0 8.3 4.9 5.4 5.7 5.6 4.9 6.1 5.1 5.9 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "brain: 28.0;testis: 78.7" "Cell type enhanced" "Detected in many" "Early spermatids: 489.6;Late spermatids: 914.3;Oligodendrocytes: 161.0;Spermatocytes: 176.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 1.0 1.2 14.6 0.9 16.7 2.4 1.3 28.0 12.3 1.2 0.0 1.1 1.2 1.3 1.5 1.2 0.8 1.1 1.1 3.0 9.8 1.1 0.7 1.2 1.6 13.8 12.4 1.9 1.5 1.5 0.8 1.7 0.9 19.4 1.1 1.5 3.0 0.8 1.3 0.7 0.7 1.0 1.2 11.1 1.1 1.3 78.7 10.8 0.8 1.9 0.6 1.4 0.8 1.0 23.7 1.4 1.5 0.4 1.8 1.2 0.9 0.6 1.2 0.4 0.4 1.2 0.3 2.0 1.0 0.6 0.8 1.1 0.6 0.7 0.7 1.6 3.6 0.2 0.5 1.3 0.4 2.1 0.6 0.9 0.8 0.3 0.8 0.3 0.8 0.5 1.6 0.8 3.4 1.5 0.2 0.4 0.3 0.4 0.7 1.4 0.9 1.9 0.1 1.2 0.3 0.9 1.0 0.2 0.2 0.9 0.5 1.0 0.8 2.0 1.0 1.2 1.3 0.7 1.1 0.8 1.0 1.3 4.0 0.6 0.0 0.3 0.0 1.7 0.2 1.7 1.2 2.7 1.5 0.1 0.6 2.9 2.0 0.0 1.8 0.1 1.0 2.0 0.3 14.6 16.7 28.0 12.3 3.0 9.8 13.8 12.4 1.9 19.4 11.1 10.8 23.7 7.4 6.4 8.6 87.8 4.8 1.9 1.1 0.5 2.2 8.9 4.1 3.9 7.2 0.0 3.0 1.8 4.2 0.7 6.2 2.0 1.9 4.6 489.6 5.0 6.1 3.5 3.0 2.1 84.3 3.4 1.1 3.7 4.1 5.4 12.6 7.0 0.0 0.0 1.7 0.0 103.3 2.8 0.0 0.0 1.2 914.3 9.6 3.1 1.8 93.7 2.4 3.5 4.1 96.0 161.0 2.8 0.5 7.2 3.8 0.5 2.4 1.1 1.1 23.1 13.1 6.0 3.6 176.0 9.4 1.3 1.1 0.1 8.6 4.6 2.1 0.6 FNIP1 KIAA1961 ENSG00000217128 "Folliculin interacting protein 1" Q8TF40 5 131641714-131797063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 398.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 16.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068099, HPA071213" Approved NA NA "HPA068099: AB_2685952, HPA071213: AB_2686362" "unprognostic (1.91e-3)" "unprognostic (2.47e-1)" "unprognostic (6.41e-3)" "unprognostic (2.49e-1)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (6.32e-2)" "unprognostic (1.25e-1)" "unprognostic (6.00e-2)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (5.52e-2)" "unprognostic (7.05e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-1)" "unprognostic (3.13e-3)" "unprognostic (4.47e-1)" 10.2 8.4 8.3 6.7 15.5 16.0 8.9 9.2 13.2 8.7 5.3 6.5 8.2 9.3 6.9 6.1 7.2 8.1 9.0 8.8 10.8 7.5 12.2 8.4 6.3 10.4 11.4 8.5 13.0 6.8 12.9 5.6 7.7 11.3 8.3 6.5 7.2 6.5 5.3 13.3 8.1 7.1 7.5 10.8 7.1 7.5 13.9 9.9 5.7 10.5 14.4 6.2 7.4 6.8 30.1 10.8 9.2 6.7 19.1 23.1 16.2 11.7 12.1 21.4 13.9 22.5 11.9 10.7 8.5 7.9 14.6 43.0 8.8 7.9 9.9 19.7 11.9 5.7 21.3 9.7 7.4 15.6 4.1 39.7 18.7 12.8 15.4 25.9 11.6 6.7 9.9 9.3 19.1 17.3 3.5 8.5 10.8 4.0 3.2 4.3 7.2 14.2 5.5 8.3 18.1 6.8 7.4 10.7 5.8 17.6 11.1 11.1 14.6 12.2 23.4 10.7 20.5 10.7 17.9 17.8 8.4 19.3 11.3 13.3 7.2 3.0 3.9 2.0 3.4 2.2 3.5 2.1 1.9 1.8 2.7 2.2 2.6 16.6 2.7 3.1 1.8 2.2 1.3 8.3 15.5 9.2 13.2 8.8 10.8 10.4 11.4 8.5 11.3 10.8 9.9 30.1 36.1 6.4 26.9 108.7 55.2 36.7 68.3 9.0 33.6 46.3 53.7 28.8 31.2 41.5 11.9 11.0 98.0 26.1 55.3 26.2 3.9 34.5 11.6 33.7 43.9 37.8 31.3 38.3 142.3 26.4 36.5 49.7 56.1 41.9 24.6 30.7 41.7 32.1 49.3 45.4 153.1 18.6 16.2 70.6 44.0 9.1 60.9 72.3 44.4 105.9 57.9 35.6 46.4 126.7 398.7 29.6 32.7 44.4 29.6 71.2 80.1 17.8 9.3 54.6 6.6 58.3 35.7 84.8 43.9 22.9 31.1 69.2 41.7 32.9 26.5 72.3 SP9 ZNF990 ENSG00000217236 "Sp9 transcription factor" P0CG40 2 174334954-174338500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.0" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 11.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.2;fHDF/TERT166: 5.5;HEK 293: 2.2;THP-1: 11.6" "Group enriched" "Detected in many" 6 "basal ganglia: 5.8;olfactory bulb: 11.7" "Group enriched" "Detected in many" 4 "basal ganglia: 5.6;olfactory bulb: 21.6" HPA062616 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062616: AB_2684808" "unprognostic (2.04e-2)" "unprognostic (6.94e-3)" "unprognostic (1.44e-1)" "unprognostic (3.95e-1)" "unprognostic (7.55e-3)" "unprognostic (8.54e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" 0.0 0.0 2.5 0.0 3.0 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 1.3 0.3 1.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 7.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.5 0.0 0.1 0.2 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.0 0.0 2.8 0.6 0.9 1.3 0.3 1.2 0.7 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562919 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 46 "testis: 143.2" "Cell type enhanced" "Detected in many" "Early spermatids: 497.2;Late spermatids: 99.0;Spermatocytes: 508.0;Spermatogonia: 182.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.0;Karpas-707: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 1.1 1.6 0.5 1.6 0.3 1.1 1.6 3.1 0.4 1.4 0.7 0.2 0.0 1.6 0.5 1.2 1.0 0.2 1.5 1.8 2.7 1.8 0.6 0.5 1.7 1.9 1.4 0.0 0.4 0.6 1.3 0.3 1.9 0.5 0.1 1.4 0.5 0.1 0.1 0.4 0.2 0.0 1.5 0.2 0.4 143.2 1.7 0.8 1.7 0.0 0.3 0.5 0.2 1.8 0.2 0.4 0.1 0.1 0.3 0.3 0.2 0.3 0.0 0.1 0.0 0.0 5.0 0.2 1.7 0.0 1.0 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.4 0.0 2.1 0.0 0.9 1.3 1.1 0.2 0.8 0.2 0.0 1.0 0.0 4.1 0.2 1.8 0.0 0.0 0.2 2.1 0.0 0.0 0.0 2.3 0.6 1.5 0.4 1.3 0.0 1.2 0.9 0.2 1.2 1.0 0.0 0.4 0.4 0.0 0.0 1.0 0.2 0.7 0.5 0.1 0.1 0.0 0.7 0.8 0.0 0.6 0.1 0.0 0.0 0.0 1.1 0.2 0.0 0.1 4.3 0.0 0.5 0.0 0.0 0.1 1.6 1.6 1.6 3.1 1.5 1.8 1.7 1.9 1.4 1.9 1.5 1.7 1.8 0.3 0.0 0.0 0.0 0.1 0.1 0.4 3.7 2.8 0.8 5.6 5.6 0.5 2.8 2.1 1.8 0.0 5.9 0.1 0.4 3.9 1.7 497.2 2.7 0.4 0.7 0.0 0.0 0.1 0.6 3.2 0.2 0.0 2.0 0.0 0.0 0.7 3.2 1.7 0.0 0.1 0.1 4.1 1.2 0.0 99.0 10.8 0.8 0.0 0.0 2.9 1.2 0.0 0.0 0.2 0.9 0.1 7.2 0.0 0.6 0.4 7.6 4.7 0.8 46.0 0.0 0.7 508.0 182.4 0.8 0.1 3.7 0.1 0.0 0.2 0.8 CKLF "C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1" ENSG00000217555 "Chemokine like factor" Q9UBR5 16 66552563-66566251 "Predicted membrane proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 345.1;Spermatocytes: 300.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1384.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA062779 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA062779: AB_2684867" "unprognostic (1.64e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (4.97e-2)" "unprognostic (3.06e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.79e-2)" "unprognostic (8.05e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.06e-9)" "unprognostic (2.36e-1)" "unprognostic (2.65e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.07e-1)" 36.9 31.4 25.0 55.3 25.8 68.9 36.3 26.2 30.0 27.9 25.2 42.5 32.1 24.0 27.7 19.4 31.4 40.6 14.7 24.3 27.5 21.1 29.9 36.5 62.1 26.8 25.2 23.5 25.9 18.1 58.6 19.9 29.9 27.5 15.6 42.9 9.8 19.9 18.6 14.9 17.1 39.0 33.8 26.8 67.5 25.8 57.3 25.9 90.9 23.9 20.2 51.7 46.6 20.1 27.7 194.6 169.2 34.7 101.5 92.7 76.1 25.5 95.2 72.4 101.7 150.9 158.8 231.4 75.8 116.6 81.8 106.4 102.5 70.5 57.2 142.1 94.2 35.3 55.5 145.0 197.3 56.0 175.7 144.1 52.0 45.3 126.9 44.9 122.1 122.8 229.4 90.8 212.8 129.2 64.8 169.9 172.1 11.5 114.0 273.1 287.5 184.2 215.6 343.2 106.3 48.8 58.8 290.5 19.3 93.0 23.3 55.5 116.5 76.6 146.5 131.8 51.0 113.5 100.3 224.0 393.0 123.5 151.5 121.1 807.1 380.9 773.3 187.6 203.9 238.9 100.6 174.8 186.6 317.6 97.7 92.7 126.4 1384.5 187.6 199.2 161.6 236.0 401.2 25.0 25.8 26.2 30.0 24.3 27.5 26.8 25.2 23.5 27.5 26.8 25.9 27.7 65.7 19.2 49.0 0.0 68.7 27.3 24.7 84.2 12.0 8.4 80.8 94.0 1.8 87.2 50.8 57.0 0.0 54.8 109.7 57.1 17.6 141.4 67.7 34.8 21.5 52.4 33.0 63.5 0.0 130.0 117.7 38.6 21.4 17.5 345.1 17.7 67.5 38.4 247.4 1.7 0.0 73.6 61.1 138.2 238.4 31.4 49.4 244.2 40.9 0.0 157.8 28.1 188.4 0.0 0.0 224.2 51.3 30.1 94.6 10.0 95.9 83.4 79.3 9.0 32.9 24.5 38.1 300.0 77.1 30.8 23.0 17.4 192.6 23.9 79.0 25.8 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 67.2;Gastric mucus-secreting cells: 36.2;Plasma cells: 39.5;Squamous epithelial cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 184.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 24.0 44.6 14.3 6.5 15.1 14.6 24.8 13.0 29.2 21.0 13.4 22.8 15.0 20.7 7.1 26.2 22.5 3.9 60.7 14.4 14.1 26.8 67.0 22.6 7.7 13.7 13.7 14.3 20.2 39.6 7.5 27.9 6.2 13.8 20.8 4.8 4.7 19.3 8.3 110.2 20.5 19.8 5.2 12.9 22.6 27.0 34.7 13.7 5.9 18.1 17.8 6.2 26.4 20.8 14.3 20.7 41.2 13.8 41.1 5.2 15.2 44.1 34.3 9.8 23.3 15.5 39.0 28.5 49.4 43.7 10.6 22.6 28.5 12.0 16.3 5.5 56.1 87.8 44.8 26.0 20.4 23.4 33.0 34.6 17.7 27.6 17.2 13.0 12.5 13.2 44.1 68.9 24.8 13.2 57.1 40.1 92.8 41.6 16.2 71.5 54.5 18.6 61.5 10.0 12.8 61.8 49.6 32.7 31.7 52.4 8.3 25.7 54.0 13.2 26.0 41.9 184.8 49.7 34.0 46.7 71.1 15.3 30.3 34.8 0.3 25.0 3.2 17.9 16.2 17.0 26.0 16.3 16.4 17.5 23.2 20.0 20.7 14.3 18.3 18.1 33.2 21.7 18.9 14.3 15.1 13.0 29.2 14.4 14.1 13.7 13.7 14.3 13.8 12.9 13.7 14.3 2.6 3.2 4.8 0.0 12.8 4.0 1.4 6.9 67.2 0.8 9.8 7.7 0.5 10.0 5.0 0.0 0.0 2.3 3.7 1.8 7.9 4.0 3.3 14.3 11.9 4.4 0.0 18.5 0.0 3.1 2.8 7.0 36.2 10.0 1.3 12.0 3.3 14.6 1.6 1.7 0.0 2.6 2.0 4.3 1.5 2.2 5.0 6.9 1.8 0.0 4.5 0.4 0.0 0.0 0.0 4.8 2.5 3.8 39.5 1.2 5.5 7.3 5.1 0.6 6.6 2.0 5.1 9.7 13.7 81.3 5.8 1.2 8.8 1.7 3.5 1.3 CDC14C "CDC14B2, CDC14Bretro, CDC14CP, MGC26484" ENSG00000218305 "Cell division cycle 14C" A4D256 7 48919765-48927454 "Enzymes, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 2.0;testis: 7.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Oligodendrocyte precursor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064747 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA064747: AB_2732719" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" 0.1 0.0 0.3 0.2 0.3 0.4 0.1 0.8 0.5 0.0 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.1 0.1 0.1 0.3 0.3 0.3 0.1 0.2 0.0 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 7.3 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.4 0.3 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.3 0.3 0.8 0.5 0.5 0.4 0.3 0.3 0.3 0.3 0.1 0.4 0.4 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TENM3 "KIAA1455, ODZ3, Ten-M3, TEN3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;placenta: 13.3" "Cell type enriched" "Detected in many" 4 "Inhibitory neurons: 635.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047043 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047043: AB_2679914" "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 5.1 5.2 6.9 1.6 20.0 0.0 2.0 0.0 11.0 1.5 0.0 3.0 0.8 2.9 0.7 0.8 1.0 2.4 1.2 23.2 10.6 0.9 0.3 0.9 0.8 5.5 2.9 13.1 3.9 1.2 5.1 4.5 13.3 3.6 3.8 0.8 3.9 0.6 3.6 2.1 0.3 0.9 2.3 0.6 2.3 0.7 2.1 5.7 2.9 6.1 4.3 1.2 1.6 1.4 6.1 0.3 2.6 66.3 0.4 13.2 23.5 63.3 7.8 2.7 6.9 6.1 33.9 17.6 0.0 0.9 52.6 28.6 3.3 16.0 3.4 6.8 90.0 26.7 0.0 0.0 0.0 1.3 0.0 0.0 31.2 1.2 21.5 15.0 15.4 9.6 0.0 0.0 0.4 10.6 2.3 0.1 0.1 21.4 0.0 2.8 0.0 17.1 0.2 0.1 0.1 27.2 25.2 4.0 0.5 0.1 35.8 86.0 3.4 21.2 53.7 38.2 0.2 39.6 0.0 0.0 0.0 28.2 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 20.0 0.0 11.0 23.2 10.6 5.5 2.9 13.1 3.6 0.6 5.7 6.1 0.1 0.0 0.0 23.8 0.0 0.4 0.2 0.7 1.8 50.8 1.6 2.2 3.9 0.0 0.1 3.7 4.2 112.7 0.0 0.0 1.9 0.1 12.4 0.1 4.5 0.7 5.3 0.0 115.6 1.8 54.6 4.1 0.0 0.6 0.0 7.7 1.1 0.7 10.4 5.0 635.6 0.0 0.0 0.0 0.7 3.2 8.4 0.0 1.8 8.4 0.0 10.6 0.0 12.1 24.4 0.4 0.0 2.6 0.0 0.4 0.0 0.3 0.0 3.1 0.0 4.8 3.2 3.8 7.2 1.8 0.0 133.4 0.1 4.1 0.1 0.1 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053866: AB_2682283" "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavorable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 22.5 46.9 25.2 15.1 26.2 25.6 22.6 28.0 33.0 23.5 26.3 26.9 24.0 23.6 38.8 24.5 24.1 17.9 37.9 26.8 25.9 30.7 28.1 17.9 22.9 26.1 25.4 26.3 28.6 23.0 25.1 31.3 22.1 26.4 30.2 22.8 28.4 26.4 18.3 53.9 24.1 22.7 20.4 25.6 20.8 24.7 22.9 26.4 18.5 26.3 37.6 19.7 24.2 22.1 28.8 59.9 19.4 41.1 32.9 42.5 47.0 39.4 43.2 39.3 27.2 19.8 18.5 26.4 20.7 22.9 42.8 36.2 33.7 22.4 32.9 33.4 55.3 47.1 56.2 21.6 29.0 38.2 70.5 29.4 49.6 44.0 37.1 42.1 36.7 44.3 21.4 42.6 28.9 45.3 11.9 17.2 67.6 60.2 47.6 29.5 51.4 55.8 47.2 48.6 15.9 43.4 42.6 33.4 54.0 43.5 22.1 23.9 41.2 39.0 29.1 35.9 43.2 38.1 53.0 0.5 44.1 54.0 41.2 42.5 32.4 23.0 21.2 27.3 26.4 32.2 34.1 31.1 29.2 22.8 26.9 38.5 34.9 8.8 23.2 20.6 49.2 23.5 22.3 25.2 26.2 28.0 33.0 26.8 25.9 26.1 25.4 26.3 26.4 25.6 26.4 28.8 46.6 54.5 40.9 13.7 37.7 0.0 51.6 0.0 51.2 46.5 37.6 38.9 43.0 27.1 21.1 38.6 18.8 83.0 43.6 25.7 92.0 46.8 76.0 59.1 35.7 27.9 17.5 30.1 14.7 33.7 50.7 35.6 41.3 41.4 17.1 30.3 27.5 27.4 44.5 32.0 19.5 32.6 0.0 27.7 0.0 18.2 47.2 34.7 0.0 18.7 39.9 59.8 46.4 13.6 27.1 41.8 31.0 44.4 30.4 38.9 54.2 92.1 27.0 56.2 46.0 31.0 33.0 115.8 58.8 48.5 0.0 69.1 37.8 33.4 33.1 41.6 TDRD15 ENSG00000218819 "Tudor domain containing 15" B5MCY1 2 21123968-21144368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.5" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Late spermatids: 12.1;Sertoli cells: 6.6;Spermatocytes: 34.5;Spermatogonia: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.5;U-266/70: 7.5;U-266/84: 3.0" "HPA051770, HPA054675" Uncertain NA NA "HPA051770: AB_2681601, HPA054675: AB_2682569" "unprognostic (4.20e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 12.1 0.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 34.5 8.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 PAPOLB PAPT ENSG00000218823 "Poly(A) polymerase beta" Q9NRJ5 7 4857738-4862030 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 30.1" "Cell type enhanced" "Detected in some" "Early spermatids: 94.8;Late spermatids: 89.7;Smooth muscle cells: 18.5;Spermatocytes: 37.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047285 Approved Nucleoplasm NA NA Nucleoplasm "HPA047285: " "unprognostic (7.58e-2)" "unprognostic (1.25e-1)" "unprognostic (1.68e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.2 0.2 0.3 0.2 0.3 0.0 0.4 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.4 1.2 0.2 0.0 0.9 0.2 0.1 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.8 0.2 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 89.7 2.5 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.8 0.0 0.7 18.5 37.4 4.0 0.0 0.9 0.3 0.1 0.1 0.0 0.3 ZNF579 FLJ35453 ENSG00000218891 "Zinc finger protein 579" Q8NAF0 19 55576774-55580848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEK 293: 43.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062812 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA062812: AB_2684873" "unprognostic (1.76e-2)" "unprognostic (1.43e-2)" "unprognostic (4.09e-2)" "unprognostic (9.08e-2)" "unprognostic (2.87e-1)" "unprognostic (5.95e-2)" "unprognostic (4.79e-2)" "unprognostic (2.87e-2)" "unprognostic (5.39e-2)" "unprognostic (1.71e-1)" "unprognostic (5.85e-3)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (5.27e-2)" "unprognostic (3.46e-1)" "unprognostic (1.57e-1)" "unprognostic (4.08e-3)" 9.8 9.2 9.0 3.4 8.2 4.5 9.4 16.5 10.1 8.7 5.0 10.5 4.5 14.8 6.8 6.8 12.8 7.9 13.6 8.5 7.9 14.0 11.9 10.2 4.8 12.1 9.2 8.3 13.6 15.4 3.3 12.7 2.5 12.2 12.1 2.6 6.8 8.5 4.6 33.7 6.7 8.8 4.2 7.7 8.9 21.1 3.7 9.4 3.1 16.8 13.5 2.2 10.0 6.5 12.4 7.9 15.9 8.6 8.8 13.1 9.6 11.0 15.3 4.2 8.4 8.5 5.4 9.3 13.1 6.1 8.9 2.7 7.6 5.2 8.3 8.8 2.6 43.9 8.3 32.5 10.1 13.2 4.9 6.5 24.0 8.9 6.4 6.7 18.8 4.7 4.6 16.6 4.2 17.0 10.4 7.3 6.7 7.8 4.3 24.6 12.4 7.8 5.5 11.4 14.9 10.4 14.6 10.2 7.6 7.8 16.7 4.0 7.0 10.9 11.0 10.6 3.4 9.7 11.6 10.3 7.2 5.6 7.8 5.7 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 9.0 8.2 16.5 10.1 8.5 7.9 12.1 9.2 8.3 12.2 7.7 9.4 12.4 10.3 3.2 6.7 4.2 4.7 3.3 7.9 1.7 6.2 13.3 8.9 8.0 5.2 18.6 1.5 5.5 12.5 0.7 4.5 4.3 3.9 6.0 0.0 8.6 7.6 6.8 11.4 2.5 2.7 4.8 0.6 5.3 15.3 9.8 4.5 17.2 13.6 7.2 5.1 15.2 3.4 7.1 0.0 5.7 2.8 0.5 8.4 3.8 3.6 3.7 1.8 15.9 3.1 2.5 3.6 6.6 2.0 12.4 2.5 9.4 2.1 11.1 3.0 8.9 13.1 4.7 9.2 0.9 0.9 3.7 3.3 0.4 3.5 13.6 6.1 9.3 CELA3B "CBPP, ELA3B" ENSG00000219073 "Chymotrypsin like elastase 3B" P08861 1 21977022-21998642 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2086 "pancreas: 50042.6" "Cell type enriched" "Detected in some" 45 "Exocrine glandular cells: 14881.1" "Cancer enriched" "Detected in single" 1218 "pancreatic cancer: 408.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (2.89e-1)" "unprognostic (4.01e-3)" "unprognostic (6.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (6.40e-2)" 7.9 1.8 0.0 0.6 0.0 0.8 4.6 0.0 0.0 2.6 0.0 1.7 6.3 1.7 0.1 2.6 1.2 0.0 8.4 0.0 0.0 1.6 5.1 1.2 1.1 0.0 0.0 0.0 23.9 50042.6 0.0 2.2 3.5 0.0 3.1 0.1 0.0 9.6 0.0 1.6 1.6 2.7 0.0 0.0 2.3 17.4 2.5 0.0 0.0 1.2 0.0 0.0 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 10.4 78.6 0.3 0.0 0.6 0.0 0.0 0.2 14881.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 309.9 0.9 0.9 0.0 0.0 60.4 0.0 0.0 0.0 0.2 325.6 16.0 0.7 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 RNASEK MGC71993 ENSG00000219200 "Ribonuclease K" Q6P5S7 17 7012417-7014532 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 246.4;Macrophages: 174.7;Plasma cells: 253.2;Squamous epithelial cells: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044708 Uncertain NA NA "HPA044708: AB_10962051" "unprognostic (7.59e-2)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "unprognostic (5.92e-2)" "unprognostic (9.73e-3)" "unprognostic (4.82e-2)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (6.50e-3)" "prognostic favorable (1.92e-4)" "unprognostic (2.93e-3)" "unprognostic (1.72e-3)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.14e-1)" "unprognostic (2.33e-3)" 303.0 597.4 256.1 175.4 269.0 295.5 280.8 256.9 394.0 254.3 302.4 258.6 162.6 256.7 136.3 243.5 241.5 174.8 325.3 266.1 328.5 514.8 282.5 350.4 219.6 271.8 271.0 249.2 267.5 235.9 290.3 509.0 160.0 279.8 257.2 119.4 82.3 248.4 162.5 324.5 295.9 231.0 146.1 257.9 400.0 277.5 181.6 278.1 161.1 258.2 228.6 168.2 233.0 227.2 277.2 223.4 353.3 160.9 276.4 406.6 363.4 142.8 224.5 389.5 283.9 320.6 149.6 205.6 157.2 221.3 435.5 343.2 328.5 199.1 274.7 153.6 319.2 520.8 157.0 264.7 252.9 466.1 99.9 748.3 462.4 321.7 338.5 194.0 316.1 344.6 168.0 138.1 327.7 348.4 206.0 137.0 327.4 111.7 178.2 314.0 160.7 92.3 180.9 374.2 192.4 82.1 291.9 191.0 135.6 421.5 157.8 176.0 177.3 322.5 304.6 132.8 383.9 289.3 267.6 278.0 68.6 475.7 225.3 253.2 993.4 1136.6 1378.0 373.6 1031.0 369.9 593.4 413.9 381.0 848.3 542.0 329.5 321.0 2175.1 420.9 1007.1 1070.5 451.1 1052.7 256.1 269.0 256.9 394.0 266.1 328.5 271.8 271.0 249.2 279.8 257.9 278.1 277.2 21.3 57.7 65.7 0.0 109.7 20.5 9.2 16.3 246.4 16.3 21.6 14.9 0.8 8.6 47.9 5.5 41.7 5.3 31.5 21.0 3.9 21.4 5.8 45.4 32.4 37.9 13.2 62.0 0.0 5.5 3.4 58.9 110.1 38.6 54.2 14.4 20.0 16.2 14.2 11.8 0.0 15.9 8.2 62.3 47.0 6.2 9.0 174.7 21.4 0.0 42.4 7.6 28.8 0.0 0.0 12.1 10.8 6.4 253.2 12.1 20.4 6.7 58.8 31.5 26.3 11.4 35.6 3.6 1.2 250.2 21.7 11.8 98.0 15.9 15.1 13.8 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300358-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "testis: 590.9" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.1;Endometrial stromal cells: 12.7;Extravillous trophoblasts: 36.3;Syncytiotrophoblasts: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 13.9;PC-3: 7.9;T-47d: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052822 Approved Nucleoplasm NA NA Nucleoplasm "HPA052822: AB_2797245" "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.4 0.2 4.0 0.1 4.1 0.0 0.6 6.1 6.3 0.8 2.2 0.2 0.1 0.5 0.0 0.4 0.2 0.6 0.1 4.4 3.5 0.3 0.3 0.5 0.1 3.7 3.4 4.0 0.1 0.6 0.6 0.1 0.8 3.7 0.8 0.3 0.4 0.2 0.0 0.2 1.2 0.2 0.0 2.6 0.1 0.3 590.9 3.5 0.0 1.0 0.1 0.0 0.3 0.3 4.1 0.0 3.5 0.3 0.1 0.4 0.8 4.8 0.0 0.3 0.0 0.0 13.9 2.8 0.1 0.2 0.1 0.1 3.1 2.6 0.4 0.1 0.0 0.0 1.3 0.1 0.9 0.1 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 0.0 1.4 0.6 0.2 0.6 0.0 0.6 0.9 4.0 7.9 1.5 0.0 1.8 3.9 1.2 0.1 0.8 1.4 0.4 0.2 0.2 6.6 0.3 0.2 0.2 0.0 1.8 0.0 0.4 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.1 6.1 6.3 4.4 3.5 3.7 3.4 4.0 3.7 2.6 3.5 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 12.7 0.2 0.0 0.0 0.0 0.5 36.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 TAFA5 "FAM19A5, TAFA-5" ENSG00000219438 "TAFA chemokine like family member 5" Q7Z5A7 22 48489553-48850912 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Fibroblasts: 1.1" "Cancer enhanced" "Detected in all" "glioma: 13.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.3;HEK 293: 13.6;Hep G2: 32.1;NTERA-2: 12.7;U-2 OS: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025629 Approved "Secreted in brain" NA NA "CAB025629: " "unprognostic (2.86e-1)" "unprognostic (2.98e-1)" "unprognostic (3.42e-2)" "unprognostic (2.19e-1)" "unprognostic (3.57e-1)" "unprognostic (1.80e-1)" "unprognostic (2.82e-3)" "unprognostic (2.41e-2)" "unprognostic (6.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (9.31e-3)" "unprognostic (2.64e-2)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.94e-2)" 2.0 1.3 49.0 0.8 39.5 0.0 2.0 36.1 52.2 16.9 13.1 6.4 1.0 8.1 4.7 0.9 5.3 2.0 1.9 50.3 39.6 2.3 2.8 2.1 0.4 53.9 86.2 35.6 12.2 2.4 4.4 7.0 0.1 47.7 6.9 0.2 3.6 4.9 3.2 1.5 5.4 3.4 0.7 37.2 0.3 2.9 3.4 47.6 1.2 0.8 1.7 0.1 4.0 4.9 40.4 0.0 1.3 2.5 0.1 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 17.3 0.1 0.1 1.3 0.0 0.0 0.0 13.6 0.0 0.2 32.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.1 0.3 12.7 0.6 0.0 0.6 0.0 7.4 0.0 0.0 7.2 0.2 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 21.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 39.5 36.1 52.2 50.3 39.6 53.9 86.2 35.6 47.7 37.2 47.6 40.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF1 "FLJ20719, KIAA1693" ENSG00000219481 "NBPF member 1" Q3BBV0 1 16562319-16613562 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 73.8;Distal enterocytes: 66.4;Oligodendrocyte precursor cells: 68.3;Oligodendrocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (8.16e-3)" "unprognostic (6.96e-2)" "unprognostic (1.33e-2)" "unprognostic (6.09e-2)" "unprognostic (3.49e-1)" "unprognostic (4.76e-2)" "unprognostic (1.15e-5)" "unprognostic (2.16e-2)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.90e-2)" "unprognostic (2.14e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.68e-1)" 8.6 32.9 4.1 2.5 4.7 2.0 9.6 5.0 3.7 16.0 2.8 14.0 3.5 10.7 2.6 6.4 10.8 3.3 5.7 3.2 4.1 7.7 8.2 6.3 1.3 5.1 5.3 2.8 18.3 7.4 6.0 9.1 4.7 9.0 10.0 5.4 2.9 9.4 4.2 5.5 6.8 13.7 5.8 5.1 8.3 8.8 23.1 4.9 1.7 7.3 2.6 1.8 13.7 11.1 6.0 6.1 8.6 8.4 5.1 2.3 2.7 1.5 4.1 5.4 7.7 6.8 3.1 2.4 4.8 1.2 11.7 3.0 5.5 3.9 2.5 8.9 3.0 4.5 1.5 3.0 3.0 3.7 2.4 3.6 2.9 3.1 11.1 3.2 4.0 3.5 10.9 5.2 2.6 3.0 4.7 10.5 1.8 1.6 1.1 16.3 8.9 4.6 0.5 2.2 1.2 10.4 10.3 10.6 4.3 5.8 2.4 6.6 1.7 4.1 6.7 3.6 9.2 3.6 1.3 6.7 2.7 1.5 3.5 2.8 0.1 0.1 1.3 0.3 0.2 0.4 0.3 0.3 0.4 0.1 0.5 0.3 0.4 0.0 0.1 0.3 0.2 0.0 0.1 4.1 4.7 5.0 3.7 3.2 4.1 5.1 5.3 2.8 9.0 5.1 4.9 6.0 5.2 16.0 14.8 73.8 5.7 8.2 3.0 10.9 29.0 7.5 8.4 8.6 14.5 8.6 11.6 11.0 8.4 6.3 3.5 66.4 3.9 5.5 10.4 4.4 8.2 10.2 3.0 5.9 33.6 3.5 7.9 19.7 12.2 3.1 6.3 17.1 3.6 6.1 12.8 10.1 52.1 25.4 12.2 6.6 15.9 6.9 6.8 7.1 8.8 47.8 4.4 5.0 9.2 68.3 87.9 6.1 19.3 7.2 5.3 3.8 24.0 10.8 15.5 6.5 6.6 7.9 10.0 52.5 24.3 14.7 7.7 3.1 4.0 43.2 15.2 3.1 UMAD1 "RPA3-AS1, RPA3OS" ENSG00000219545 "UBAP1-MVB12-associated (UMA) domain containing 1" C9J7I0 7 7640711-7968020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.7;Inhibitory neurons: 114.3;Microglial cells: 79.6;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044806 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA044806: AB_10961141" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" "unprognostic (9.08e-3)" "unprognostic (9.24e-2)" "unprognostic (6.86e-3)" "unprognostic (4.87e-1)" "unprognostic (2.56e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "prognostic favorable (1.73e-8)" "unprognostic (6.66e-3)" "unprognostic (8.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.58e-1)" 9.3 16.6 6.3 11.3 6.5 9.5 10.4 5.6 6.3 10.1 6.8 12.9 15.5 10.4 11.5 9.0 10.3 10.8 13.8 5.1 8.5 17.3 14.4 12.1 15.8 7.0 6.8 4.6 13.7 36.4 30.0 10.3 9.3 7.2 19.0 11.7 11.6 20.8 11.8 11.4 7.0 16.8 9.9 6.1 10.4 23.2 5.9 6.9 18.6 24.8 10.6 13.5 12.4 8.5 7.4 24.7 17.9 9.0 10.5 12.7 14.9 10.3 14.9 17.2 11.5 17.4 7.6 17.9 13.4 15.4 9.4 46.3 15.7 10.4 15.0 14.3 10.1 8.1 7.3 12.4 8.9 14.2 13.6 16.3 14.2 18.6 16.6 12.7 13.5 7.1 17.2 15.1 40.0 15.4 19.9 12.4 7.4 16.2 16.5 14.8 13.6 21.3 21.3 20.9 11.1 3.6 14.8 21.0 26.7 21.6 26.5 20.8 16.3 7.8 11.7 27.2 23.3 15.2 28.6 34.2 15.5 26.4 19.2 36.8 51.8 16.0 43.5 19.3 21.5 23.9 28.8 27.2 24.2 13.8 26.0 31.8 23.8 46.1 18.5 24.1 16.3 38.7 17.9 6.3 6.5 5.6 6.3 5.1 8.5 7.0 6.8 4.6 7.2 6.1 6.9 7.4 12.1 25.6 11.9 58.8 22.8 0.0 27.7 0.0 12.0 6.5 13.8 12.3 10.9 11.5 9.9 14.7 14.6 16.7 7.7 7.6 39.2 8.4 7.1 9.7 7.6 7.1 6.1 6.7 96.7 14.5 23.6 11.4 33.1 10.6 15.2 3.8 6.4 9.5 16.8 15.2 114.3 13.3 0.0 13.2 0.0 3.7 13.4 12.9 0.0 79.6 8.9 11.4 16.5 80.9 119.3 10.4 9.0 7.9 28.4 19.3 16.8 34.2 9.5 9.8 26.3 12.0 9.6 4.8 5.0 12.6 0.0 21.2 17.0 7.6 7.7 21.2 PPP1R3G ENSG00000219607 "Protein phosphatase 1 regulatory subunit 3G" B7ZBB8 6 5085341-5089487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 5.9;liver: 6.2" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 18.5;Glandular and luminal cells: 7.2" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.3;PC-3: 3.9;THP-1: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA056393 Uncertain NA NA "HPA056393: AB_2683115" "unprognostic (1.99e-2)" "unprognostic (5.50e-3)" "unprognostic (2.10e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (6.56e-3)" "unprognostic (8.64e-3)" "unprognostic (1.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.04e-2)" "unprognostic (3.71e-1)" "unprognostic (7.60e-2)" "unprognostic (1.33e-2)" "unprognostic (5.56e-2)" "unprognostic (3.17e-3)" "unprognostic (1.27e-1)" 1.6 3.1 2.3 0.3 1.9 0.1 1.4 1.5 2.7 2.0 0.9 1.5 0.2 1.2 1.1 1.8 1.0 0.3 5.9 2.0 1.5 0.5 6.2 0.3 0.5 2.2 2.0 1.7 0.8 0.1 0.3 0.2 0.7 2.1 1.2 0.5 0.2 0.6 1.5 0.5 1.1 0.5 0.5 1.4 2.8 0.6 0.2 2.1 0.2 0.3 0.2 0.4 2.8 2.2 1.9 0.0 0.2 0.1 0.0 1.6 1.0 0.0 0.3 0.4 0.2 0.3 0.0 0.3 0.0 3.3 0.6 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 3.9 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.3 0.0 14.6 0.0 0.0 0.0 0.8 0.5 2.0 1.7 0.0 0.6 0.0 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 2.3 1.9 1.5 2.7 2.0 1.5 2.2 2.0 1.7 2.1 1.4 2.1 1.9 4.2 0.0 0.0 0.0 0.4 0.5 0.5 0.4 0.0 0.5 0.2 0.1 18.5 0.0 0.1 3.7 0.0 0.8 0.0 1.3 0.0 0.3 0.0 1.2 2.0 1.9 1.2 0.0 0.0 0.0 0.4 3.7 0.0 7.2 0.0 1.4 2.9 0.0 4.5 0.0 0.0 0.9 0.0 4.0 4.7 0.2 0.9 1.8 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.6 1.8 3.0 1.8 0.4 0.0 2.1 0.2 0.2 0.0 2.0 2.5 0.1 0.9 0.2 0.3 0.8 0.2 0.5 1.4 1.2 FAM228B ENSG00000219626 "Family with sequence similarity 228 member B" P0C875 2 24076526-24169640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 116.9;Late spermatids: 100.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052598, HPA063357" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA052598: AB_2681880, HPA063357: AB_2684994" "unprognostic (2.48e-1)" "unprognostic (1.98e-1)" "unprognostic (1.15e-2)" "unprognostic (2.66e-1)" "unprognostic (3.81e-1)" "unprognostic (5.05e-2)" "unprognostic (1.85e-2)" "unprognostic (9.14e-2)" "unprognostic (3.32e-1)" "unprognostic (1.32e-1)" "unprognostic (3.39e-5)" "unprognostic (5.62e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (5.15e-1)" "unprognostic (6.93e-2)" 19.2 15.1 47.7 3.0 51.3 7.9 17.3 57.4 64.1 20.4 38.6 16.4 1.7 12.3 19.3 6.9 18.6 9.3 22.7 44.3 49.3 13.3 4.9 11.1 5.5 49.1 47.9 42.6 21.6 8.4 15.0 30.8 6.6 49.5 21.8 4.3 9.0 7.6 12.5 13.3 7.8 10.5 7.9 50.1 12.8 11.4 33.6 48.8 6.3 14.1 9.8 5.0 17.0 14.6 59.0 2.6 1.9 3.7 13.9 9.6 12.5 0.4 6.3 5.9 2.3 1.5 0.2 1.6 3.3 3.1 4.8 4.6 0.2 0.9 0.7 2.2 5.0 6.1 4.0 0.6 0.7 18.6 2.0 1.0 11.7 6.5 1.0 9.3 15.5 5.0 3.0 0.4 4.0 3.1 4.1 0.6 9.4 1.2 0.3 5.4 3.2 1.7 1.5 6.8 2.7 1.3 10.0 2.0 0.0 11.3 5.9 3.8 9.3 5.2 4.2 0.4 0.8 2.1 6.7 2.2 3.9 9.2 7.1 2.9 9.4 5.0 10.1 5.2 3.5 2.6 7.4 3.7 4.2 6.0 4.8 5.5 5.7 4.1 4.5 3.3 9.9 3.8 3.1 47.7 51.3 57.4 64.1 44.3 49.3 49.1 47.9 42.6 49.5 50.1 48.8 59.0 19.1 51.3 35.3 49.9 10.7 6.4 9.5 8.8 5.2 24.7 11.5 18.7 24.7 10.0 34.9 14.7 8.4 9.7 17.2 1.6 31.3 5.4 116.9 13.2 11.8 17.4 9.6 6.9 52.1 5.5 4.2 20.1 2.6 5.5 25.9 22.3 20.7 3.5 10.4 37.0 52.1 3.2 10.2 12.8 21.7 100.5 42.3 13.2 10.6 39.4 14.7 39.0 21.6 41.7 78.3 3.8 1.1 38.4 4.6 4.3 2.4 12.3 41.9 27.7 52.6 24.3 21.6 39.4 11.4 2.6 7.4 3.3 13.2 17.4 3.1 5.4 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 30.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 39.5;Oligodendrocyte precursor cells: 17.1" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.3;eosinophil: 4.0;neutrophil: 1.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.0" "Group enriched" "Detected in some" 5 "HMC-1: 17.4;RPMI-8226: 4.5" "Region enhanced" "Detected in all" "basal ganglia: 59.6" "Group enriched" "Detected in many" 8 "basal ganglia: 28.8;cerebellum: 19.6;hippocampal formation: 8.4" "HPA043781, HPA059558" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043781: AB_2678668, HPA059558: AB_2684062" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.3 0.3 4.5 1.2 30.8 1.1 0.2 8.5 11.1 0.2 0.0 0.5 0.2 0.3 0.0 0.3 0.3 0.0 0.1 4.6 5.1 0.2 0.2 0.9 1.1 10.1 2.4 3.2 0.1 0.2 0.0 0.4 0.0 19.0 0.4 0.0 0.6 0.3 0.0 0.1 0.2 5.0 0.0 2.5 6.3 0.5 0.4 3.6 0.0 0.3 0.0 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 2.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 2.4 0.2 0.0 0.1 1.7 0.0 4.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 4.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 0.4 0.0 0.0 1.4 0.1 0.0 0.0 0.3 0.0 4.5 30.8 8.5 11.1 4.6 5.1 10.1 2.4 3.2 19.0 2.5 3.6 4.8 0.0 0.0 0.0 1.6 3.1 0.1 0.0 0.0 0.0 39.5 0.2 0.6 0.7 0.0 0.0 0.0 4.2 0.0 2.0 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.4 5.1 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.2 3.3 3.0 0.0 0.0 2.2 0.6 0.0 0.0 0.8 0.0 1.9 1.3 0.1 5.2 17.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.2 0.0 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger GATA like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 9.5;Hofbauer cells: 12.7;Kupffer cells: 20.0;Macrophages: 12.6;Spermatogonia: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 32.8;U-937: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA049855: AB_2680916" "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 1.6 1.5 4.7 1.0 4.9 0.5 2.3 4.5 10.8 3.6 4.1 2.4 1.0 2.5 0.4 1.9 3.3 0.8 1.5 5.2 4.3 5.3 6.5 2.3 1.8 4.5 4.0 5.2 5.2 3.4 0.5 8.4 0.9 5.2 6.8 0.2 0.5 2.5 1.0 1.2 2.1 2.6 0.2 3.5 5.0 1.9 5.1 4.1 0.4 9.3 0.4 0.7 2.6 2.7 4.7 0.5 1.2 1.7 0.6 1.1 0.5 4.3 0.9 0.3 0.8 1.8 1.2 0.4 1.9 0.9 0.3 0.8 1.8 1.2 0.4 0.3 1.6 5.5 1.8 2.0 0.7 0.7 0.0 0.5 0.9 2.5 0.8 0.5 0.7 0.2 1.4 1.8 1.3 1.1 2.0 0.2 32.8 2.7 0.4 2.0 1.8 0.8 0.8 0.7 0.8 1.4 1.6 0.4 0.3 1.6 0.4 2.5 0.6 0.6 2.5 2.9 2.4 0.3 6.2 7.9 0.9 0.4 8.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 4.9 4.5 10.8 5.2 4.3 4.5 4.0 5.2 5.2 3.5 4.1 4.7 1.1 0.0 1.8 4.6 0.5 0.9 0.6 1.2 0.0 1.6 2.0 2.4 0.8 0.0 1.2 1.8 0.0 0.5 0.8 0.9 0.0 0.6 0.8 0.9 1.3 1.1 0.0 0.4 9.5 0.0 0.4 0.6 0.0 0.9 0.0 2.7 0.7 1.2 12.7 6.7 6.9 0.7 0.0 20.0 7.9 1.3 0.9 12.6 3.6 2.8 7.8 1.7 0.0 1.5 1.6 0.3 1.5 0.7 0.1 0.9 0.4 0.4 1.5 1.5 0.0 0.5 0.8 2.2 16.3 0.3 0.9 0.1 0.6 0.8 1.6 0.0 VAMP2 "SYB2, VAMP-2" ENSG00000220205 "Vesicle associated membrane protein 2" P63027 17 8159149-8163546 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 1134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB078785 Supported NA NA "CAB078785: " "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (1.58e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (7.28e-2)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.83e-6)" "unprognostic (8.27e-2)" "prognostic favorable (9.76e-8)" "unprognostic (1.21e-2)" "unprognostic (7.00e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" 84.4 127.6 222.6 47.9 298.7 173.5 89.3 188.1 346.5 115.0 60.0 90.0 43.5 110.2 63.6 61.3 120.9 39.4 97.8 282.7 239.0 118.1 60.3 86.1 70.9 230.6 239.8 303.8 172.3 81.2 182.9 229.2 42.7 286.8 103.8 51.8 454.8 72.7 69.2 99.7 118.7 92.4 68.1 136.0 116.4 88.9 66.5 280.1 72.1 102.9 64.2 65.6 79.6 90.8 384.4 28.3 21.6 52.6 28.1 45.1 35.0 22.3 25.7 34.2 27.0 36.8 8.7 19.6 32.3 18.0 43.8 25.1 34.4 34.8 29.0 31.1 37.6 36.0 23.1 61.4 12.0 40.1 15.6 33.6 39.0 42.9 30.9 46.4 55.4 26.6 56.3 17.5 37.6 46.5 15.5 40.9 20.7 11.8 19.7 15.2 50.7 23.8 26.0 34.8 19.5 23.6 37.8 20.6 11.7 27.7 22.9 26.2 19.7 39.1 16.2 21.0 29.6 25.0 38.4 24.6 23.4 41.5 26.5 37.8 46.5 21.9 78.4 79.0 21.7 69.5 79.8 79.6 86.1 17.5 68.1 93.0 85.8 113.8 79.3 28.9 46.7 65.1 29.7 222.6 298.7 188.1 346.5 282.7 239.0 230.6 239.8 303.8 286.8 136.0 280.1 384.4 175.1 41.7 28.3 43.4 193.9 113.8 179.6 184.7 72.8 1134.0 167.6 177.0 27.4 143.0 84.2 231.8 248.1 202.5 238.1 109.8 395.2 81.0 8.4 30.3 48.2 141.1 323.0 57.9 125.0 83.4 109.6 118.6 40.2 48.1 150.5 101.0 157.8 75.7 111.8 466.1 126.9 179.1 152.5 109.6 112.6 18.5 261.9 82.8 193.9 37.5 147.8 528.0 295.5 56.8 98.5 116.6 141.3 215.5 78.3 106.2 184.1 195.9 38.5 637.9 295.9 202.0 156.4 137.3 136.1 45.9 150.7 320.0 229.1 120.9 94.1 124.1 TRIM51GP ENSG00000220948 "Tripartite motif-containing 51G, pseudogene" 11 48975324-48983826 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.1" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B1 OR7-3 ENSG00000221813 "Olfactory receptor family 6 subfamily B member 1" O95007 7 144000320-144008793 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.5" "Not detected" "Not detected" HPA053164 Uncertain NA NA "HPA053164: AB_2682065" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EBF2 "COE2, FLJ11500" ENSG00000221818 "EBF transcription factor 2" Q9HAK2 8 25841725-26045413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.0" "Cell type enhanced" "Detected in some" "Adipocytes: 11.9;Fibroblasts: 23.2;Microglial cells: 13.1;Sertoli cells: 39.5;Smooth muscle cells: 53.4" "Cancer enhanced" "Detected in many" "renal cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 22.7;ASC TERT1: 45.7;HSkMC: 46.9;hTEC/SVTERT24-B: 26.7;U-138 MG: 17.1;U-2197: 22.7;U-87 MG: 19.1" "Group enriched" "Detected in many" 4 "basal ganglia: 5.7;cerebellum: 3.1;hypothalamus: 2.0;midbrain: 4.4;pons and medulla: 2.8" "Region enriched" "Detected in many" 5 "spinal cord: 8.7" "HPA003954, HPA055101" Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003954: , HPA055101: " "unprognostic (3.70e-1)" "unprognostic (3.88e-3)" "unprognostic (2.69e-2)" "unprognostic (2.47e-3)" "unprognostic (1.03e-1)" "unprognostic (6.10e-2)" "unprognostic (5.92e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-2)" "unprognostic (6.13e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (7.41e-4)" "unprognostic (2.28e-1)" "unprognostic (3.80e-2)" "unprognostic (1.82e-2)" 18.0 0.7 0.5 0.9 0.5 0.0 8.1 0.1 0.2 0.6 0.3 1.2 0.0 0.8 1.9 0.8 4.1 2.6 9.9 0.0 1.0 0.5 0.0 0.6 0.6 1.4 3.3 0.0 1.0 0.9 2.2 0.4 0.5 2.1 0.5 0.4 0.2 1.4 0.4 4.7 1.3 0.7 1.8 1.9 0.0 0.8 1.1 0.8 1.4 6.2 9.7 0.2 1.9 1.2 1.3 0.0 0.0 0.8 0.0 22.7 45.7 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 26.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 17.1 0.2 22.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.2 0.0 1.0 1.4 3.3 0.0 2.1 1.9 0.8 1.3 11.9 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.2 0.3 5.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.1 5.6 0.0 0.0 0.5 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 3.2 5.9 0.6 0.0 13.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 39.5 2.6 53.4 1.0 0.2 0.4 0.3 0.0 0.2 0.1 0.0 0.1 C6orf226 LOC441150 ENSG00000221821 "Chromosome 6 open reading frame 226" Q5I0X4 6 42890265-42890821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045350 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA045350: AB_10964640" "prognostic favorable (1.93e-5)" "unprognostic (2.21e-3)" "unprognostic (2.91e-1)" "unprognostic (2.77e-3)" "unprognostic (1.71e-1)" "unprognostic (4.17e-2)" "unprognostic (5.40e-2)" "unprognostic (2.00e-3)" "unprognostic (8.82e-2)" "unprognostic (3.50e-3)" "prognostic favorable (5.13e-4)" "unprognostic (2.24e-2)" "prognostic favorable (3.35e-4)" "unprognostic (4.63e-1)" "unprognostic (3.97e-2)" "unprognostic (6.13e-2)" "unprognostic (5.82e-3)" 16.3 32.2 11.1 5.9 10.8 13.3 15.8 11.4 19.8 13.9 9.4 17.0 7.9 18.7 6.3 11.8 13.7 2.2 13.9 10.5 11.9 20.0 15.0 14.5 5.5 11.3 10.5 9.7 12.7 13.6 4.2 25.7 2.3 11.9 17.6 1.5 5.6 12.9 7.1 19.9 24.5 15.1 2.6 12.0 19.0 15.6 11.4 11.5 6.4 15.7 3.7 3.0 18.7 12.5 11.5 9.9 7.5 6.7 13.6 7.2 6.3 8.1 6.0 3.2 7.2 9.4 2.8 3.3 2.1 12.2 2.9 4.6 7.8 1.8 3.8 2.1 9.3 13.9 7.8 6.6 19.7 7.4 2.1 5.5 7.1 4.9 3.6 1.7 2.0 5.6 8.1 0.5 11.1 4.5 19.9 16.0 13.4 2.4 9.6 6.3 7.0 4.8 10.4 4.0 7.6 13.1 15.9 11.4 5.0 16.3 2.4 12.1 6.1 7.5 5.7 17.0 10.7 5.7 26.9 22.1 32.9 3.5 4.2 4.0 7.5 21.8 21.8 17.4 17.3 13.1 16.8 22.1 18.0 25.4 15.7 17.1 21.0 9.6 23.8 24.6 23.7 19.3 15.1 11.1 10.8 11.4 19.8 10.5 11.9 11.3 10.5 9.7 11.9 12.0 11.5 11.5 18.7 12.8 10.4 7.5 12.9 14.4 19.3 26.8 24.5 29.9 15.2 18.2 13.9 15.7 16.9 22.0 6.2 22.8 24.9 11.1 66.5 21.9 1.5 31.6 10.2 15.7 9.7 7.4 2.5 32.7 9.7 16.0 14.8 18.1 7.0 28.8 12.1 18.2 21.6 30.3 3.9 10.6 16.2 20.4 14.8 2.3 14.6 19.8 30.2 7.5 18.2 54.2 36.0 1.5 10.8 22.3 13.8 13.5 17.2 12.6 11.0 38.6 33.2 29.3 0.0 12.3 15.4 2.9 5.4 18.3 17.0 16.7 20.3 17.0 9.1 20.0 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 191.6" "Cell type enhanced" "Detected in all" "Excitatory neurons: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Supported "Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane" Cytosol "CAB005610: AB_325975, HPA047157: AB_2679960" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 54.2 38.0 54.4 32.7 87.0 74.3 27.4 56.5 137.3 26.6 11.3 27.8 25.9 31.3 26.3 30.3 23.5 28.2 20.7 115.9 62.1 21.6 58.6 27.9 40.6 41.1 37.5 83.4 25.1 20.9 17.2 18.5 36.9 51.2 26.5 28.0 191.6 25.1 30.3 89.6 33.9 24.1 35.6 29.8 34.5 25.1 20.8 46.0 43.0 24.0 31.3 40.9 33.2 28.8 77.2 61.5 51.7 69.7 48.4 47.4 54.3 70.5 86.3 75.9 98.8 86.8 75.9 55.4 85.7 28.7 61.4 69.5 41.8 74.4 64.8 120.0 59.4 52.9 284.0 38.3 71.1 93.1 111.9 92.2 55.1 57.6 76.9 78.0 55.9 67.2 72.2 67.8 96.8 73.2 53.8 96.1 99.4 81.9 52.0 44.4 69.1 90.6 139.9 61.7 66.1 91.4 64.2 50.4 72.3 65.9 45.0 33.9 51.8 69.5 84.6 76.5 64.2 75.1 53.8 62.6 124.7 61.3 115.2 54.0 1.5 0.5 1.3 0.2 0.3 0.5 0.2 0.3 0.1 0.5 0.3 0.3 0.5 2.7 0.3 0.6 0.7 0.3 0.4 54.4 87.0 56.5 137.3 115.9 62.1 41.1 37.5 83.4 51.2 29.8 46.0 77.2 37.0 9.6 12.7 81.6 40.4 74.8 11.6 7.0 72.8 22.2 21.0 13.1 17.9 10.0 7.7 16.5 52.1 11.7 34.0 20.5 11.7 7.1 20.0 19.9 23.0 34.0 15.1 52.8 151.2 8.7 17.2 24.2 18.8 29.1 19.7 11.2 15.4 19.2 24.7 11.8 93.1 15.6 4.1 40.0 105.1 7.7 9.9 54.7 35.6 105.9 21.2 27.8 18.6 72.9 77.5 12.9 10.6 8.6 39.2 17.3 12.6 20.1 5.8 92.7 13.1 14.4 29.8 2.9 6.1 64.0 70.5 12.0 39.9 14.2 13.2 21.3 PSG3 ENSG00000221826 "Pregnancy specific beta-1-glycoprotein 3" Q16557 19 42721638-42740481 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 199 "placenta: 142.8" "Cell type enriched" "Detected in some" 88 "Syncytiotrophoblasts: 1579.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.4" HPA046327 Supported "Secreted in female reproductive system" NA NA 67000000 "HPA046327: AB_2679624" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 142.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 3.9 11.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 17.9 0.9 0.0 0.8 0.0 0.1 0.0 0.0 3.8 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1579.6 0.0 0.0 0.0 0.0 FANCG "FAG, XRCC9" ENSG00000221829 "FA complementation group G" O15287 9 35073835-35079942 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 20.6;Spermatogonia: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: AB_2679292" "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 3.4 3.1 2.9 5.2 2.6 12.5 4.5 3.5 3.8 5.1 2.1 4.3 5.0 4.2 2.4 6.0 5.8 3.3 1.8 2.6 2.8 3.3 2.9 3.3 7.8 2.7 2.6 2.7 6.3 6.3 4.7 3.0 4.6 3.2 3.9 4.0 2.4 4.3 4.1 2.3 6.5 4.6 4.6 2.5 5.5 4.2 6.5 2.7 12.3 4.1 1.7 7.0 3.5 4.7 3.3 34.7 40.7 30.4 28.3 6.4 10.2 25.0 23.6 16.3 44.9 42.5 20.1 21.2 33.4 15.8 7.7 33.1 20.5 25.3 22.0 17.6 38.7 14.8 24.5 45.5 13.2 1.8 24.5 26.9 8.1 4.1 39.5 18.2 8.0 23.8 40.7 15.7 44.3 23.5 31.5 43.2 34.5 32.5 26.4 30.1 43.8 35.2 23.1 10.9 14.6 14.4 26.1 15.7 22.3 8.3 13.4 28.4 17.2 13.4 21.0 42.8 28.3 33.1 12.4 24.0 20.6 19.2 18.5 30.1 10.5 0.7 6.7 6.1 2.2 5.3 5.6 4.8 4.6 1.9 5.4 3.6 3.8 1.1 7.8 2.0 4.2 8.2 3.1 2.9 2.6 3.5 3.8 2.6 2.8 2.7 2.6 2.7 3.2 2.5 2.7 3.3 3.2 3.2 4.6 6.8 4.9 4.5 6.1 3.9 10.2 4.7 5.9 5.0 1.5 2.8 3.3 3.7 4.2 15.0 4.1 3.0 3.9 4.9 0.4 2.3 3.8 4.4 1.8 11.6 3.0 2.3 20.6 5.1 1.5 3.6 14.0 10.3 4.2 1.1 7.7 5.0 3.3 4.1 2.0 1.3 4.7 0.6 3.4 2.3 3.6 1.0 2.8 4.0 3.1 0.5 4.1 1.9 2.4 4.1 14.1 4.4 3.5 2.3 1.3 3.1 0.0 3.0 3.9 14.7 20.7 8.5 2.6 6.6 4.9 2.8 6.7 5.2 OR2A5 "OR2A26, OR2A8, OR7-138, OR7-141" ENSG00000221836 "Olfactory receptor family 2 subfamily A member 5" Q96R48 7 144048948-144058845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-9 "KAP10.9, KAP18.9, KRTAP18-9" ENSG00000221837 "Keratin associated protein 10-9" P60411 21 44627093-44628378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "skin 1: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP4M1 "MU-4, MU-ARP2, SPG50" ENSG00000221838 "Adaptor related protein complex 4 subunit mu 1" O00189 7 100101549-100110345 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 95.9;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066774 Approved NA NA "HPA066774: AB_2685718" "unprognostic (6.40e-2)" "unprognostic (3.28e-1)" "unprognostic (1.78e-1)" "unprognostic (1.14e-1)" "unprognostic (7.22e-2)" "unprognostic (2.24e-3)" "prognostic unfavorable (7.63e-5)" "unprognostic (1.58e-2)" "unprognostic (6.98e-3)" "unprognostic (1.73e-1)" "unprognostic (3.05e-2)" "unprognostic (7.18e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (6.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "unprognostic (1.46e-1)" 8.1 7.4 10.9 4.7 10.5 4.9 9.7 10.4 12.2 11.4 10.3 13.4 12.6 15.9 6.1 10.4 12.5 8.6 9.9 10.4 11.3 10.4 4.8 8.9 6.4 11.8 11.0 10.7 9.4 12.5 7.8 15.5 5.7 11.3 12.4 6.2 6.5 10.2 11.1 10.8 11.8 10.0 8.1 10.7 7.3 12.9 32.8 10.8 6.2 11.0 5.6 4.6 12.5 10.4 10.7 9.3 13.0 13.9 35.4 7.8 17.8 15.8 5.5 9.6 7.1 8.9 10.6 23.7 11.1 25.2 13.4 10.2 9.9 6.1 12.0 3.9 8.9 8.6 6.2 12.7 9.4 16.2 7.2 10.9 15.1 20.5 20.7 12.5 13.7 23.5 14.3 11.9 8.4 24.6 28.7 25.9 14.1 10.9 8.4 13.3 21.8 7.0 13.9 18.0 11.9 24.2 21.1 14.0 40.9 11.9 7.9 18.6 14.0 26.0 21.2 16.9 19.8 9.4 6.2 6.8 16.8 17.7 8.3 18.8 4.3 6.3 9.1 4.5 7.9 4.1 5.3 4.0 5.1 8.7 3.4 1.8 3.2 2.1 3.2 10.8 5.3 4.5 4.3 10.9 10.5 10.4 12.2 10.4 11.3 11.8 11.0 10.7 11.3 10.7 10.8 10.7 12.6 16.0 4.6 20.5 10.4 9.4 17.3 17.7 9.1 17.7 14.2 17.8 3.2 20.0 13.3 16.5 52.1 14.7 6.8 17.7 7.9 24.4 69.3 20.3 14.6 12.5 12.1 8.2 9.5 19.0 18.1 12.4 14.8 11.2 3.8 22.8 13.2 3.3 9.9 6.7 7.0 15.6 12.2 7.3 7.7 95.9 14.6 6.9 14.2 10.3 14.5 21.0 8.2 6.0 8.1 19.6 17.7 12.8 5.9 13.7 21.9 11.1 29.5 67.9 13.1 15.3 12.4 84.7 39.5 8.8 8.4 14.0 8.2 16.0 14.2 11.2 OR4A5 ENSG00000221840 "Olfactory receptor family 4 subfamily A member 5" Q8NH83 11 54706832-54707902 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 21.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 94.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.4;SiHa: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA052136: AB_2681742, HPA056962: AB_2683290" "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.1 0.4 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.2 0.0 0.3 0.2 0.2 0.3 0.1 0.1 0.1 1.2 0.1 0.1 0.3 0.0 0.1 0.5 0.3 0.0 0.5 0.0 0.5 0.3 0.0 1.5 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.4 21.6 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.2 0.6 0.6 0.9 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.8 0.3 0.8 0.0 0.6 0.2 0.0 0.0 0.0 0.6 0.1 1.2 0.5 0.6 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.5 0.8 0.0 0.1 0.0 0.3 0.1 0.3 0.0 0.5 0.5 0.2 0.0 0.6 2.4 0.4 1.8 0.4 0.2 0.1 0.4 0.4 1.1 0.5 0.8 0.3 0.4 0.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 94.1 0.3 0.2 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 14.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-5 KAP1.5 ENSG00000221852 "Keratin associated protein 1-5" Q9BYS1 17 41026026-41027208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "skin 1: 46.9" "Group enriched" "Detected in some" 8 "Basal prostatic cells: 4.1;Syncytiotrophoblasts: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.9;BJ: 17.1;fHDF/TERT166: 10.6;HDLM-2: 6.5;U-138 MG: 4.6;U-87 MG: 3.4" NA NA "unprognostic (1.76e-1)" "unprognostic (2.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (9.98e-2)" "unprognostic (1.80e-2)" "unprognostic (5.60e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.2 TAS2R41 T2R59 ENSG00000221855 "Taste 2 receptor member 41" P59536 7 143477873-143478796 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057063 Uncertain NA NA "HPA057063: AB_2683324" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A12 OR2A12P ENSG00000221858 "Olfactory receptor family 2 subfamily A member 12" Q8NGT7 7 144086278-144098953 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-10 "KAP10.10, KAP18.10, KRTAP18-10" ENSG00000221859 "Keratin associated protein 10-10" P60014 21 44637356-44638455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 77 "skin 1: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-2 "KAP12.2, KRTAP12.2" ENSG00000221864 "Keratin associated protein 12-2" P59991 21 44666189-44666927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "skin 1: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 13.9;brain: 30.9" "Group enriched" "Detected in many" 4 "Excitatory neurons: 235.3;Inhibitory neurons: 261.3" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Region enhanced" "Detected in many" "cerebral cortex: 30.9" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Cell line enhanced" "Detected in some" "ASC diff: 25.2;HMC-1: 17.1;hTERT-RPE1: 22.1;RH-30: 18.5;TIME: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 13.9 2.4 4.8 1.7 6.4 0.3 7.6 0.3 30.9 8.4 0.0 1.2 0.4 1.6 0.2 3.9 2.0 1.9 3.7 27.7 4.1 0.7 0.3 1.2 1.0 3.1 0.8 6.1 3.7 0.4 0.1 1.0 3.6 4.4 0.5 0.7 4.8 0.4 0.9 0.7 2.2 0.8 2.6 0.0 1.5 1.6 1.1 1.6 0.2 1.5 3.1 0.4 1.1 0.7 7.3 0.0 0.1 0.2 0.0 25.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 17.1 0.2 0.0 0.1 0.0 22.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 18.5 2.0 0.0 0.0 0.4 9.6 0.0 0.0 0.0 0.2 0.0 0.0 57.6 5.7 0.2 1.3 0.5 0.0 0.0 0.0 5.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.0 0.0 4.8 6.4 0.3 30.9 27.7 4.1 3.1 0.8 6.1 4.4 0.0 1.6 7.3 2.5 0.0 0.0 5.2 0.6 0.6 0.2 0.0 0.0 22.4 2.2 0.1 10.9 0.0 0.0 12.9 16.7 0.1 17.4 0.0 0.0 0.0 14.0 2.1 3.0 2.7 1.2 0.0 235.3 0.0 0.1 7.4 1.1 5.0 1.3 1.6 5.0 0.2 0.1 0.0 261.3 0.1 0.0 0.0 1.1 9.8 14.0 0.7 7.2 10.3 0.0 11.3 2.1 51.8 3.7 0.8 0.0 7.2 0.7 0.1 0.0 0.5 0.0 1.5 0.0 0.7 1.1 0.2 0.3 0.1 1.3 0.0 1.7 0.4 0.1 0.4 MAGEA3 "CT1.3, HIP8, HYPD, MAGE3, MGC14613" ENSG00000221867 "MAGE family member A3" P43357 X 152698767-152702347 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 8.1" "Group enriched" "Detected in some" 16 "Spermatocytes: 35.7;Spermatogonia: 54.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 264.2;K-562: 174.3;OE19: 379.3;PC-3: 155.9;SH-SY5Y: 153.4;SK-BR-3: 184.7;U-266/70: 242.7;U-266/84: 291.4" NA NA "unprognostic (1.29e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (3.58e-4)" "unprognostic (4.20e-2)" "unprognostic (2.48e-1)" "unprognostic (2.53e-3)" "unprognostic (3.95e-2)" "unprognostic (2.92e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.1 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 264.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 48.8 1.2 0.0 0.0 112.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.3 16.6 0.0 0.0 0.1 0.3 0.0 379.3 155.9 0.3 0.0 3.1 0.0 0.0 33.6 153.4 0.0 184.7 9.1 0.1 1.8 11.1 1.0 10.1 19.0 10.2 15.2 242.7 291.4 0.1 1.1 0.0 105.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.7 54.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 CEBPD "C/EBP-delta, CELF, CRP3, NF-IL6-beta" ENSG00000221869 "CCAAT enhancer binding protein delta" P49716 8 47736913-47738164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 54.9" "Group enriched" "Detected in many" 5 "granulocytes: 54.9;monocytes: 19.9" "Cell line enhanced" "Detected in many" "BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067581 Approved Nucleoplasm NA NA Nucleoplasm "HPA067581: AB_2685865" "prognostic favorable (2.28e-5)" "unprognostic (1.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.74e-2)" "unprognostic (2.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.52e-2)" "unprognostic (2.12e-1)" "unprognostic (6.81e-2)" "unprognostic (5.16e-2)" "unprognostic (5.47e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (4.62e-2)" "unprognostic (3.40e-2)" 203.2 72.6 40.2 62.7 33.3 34.6 169.5 39.2 57.8 99.4 49.9 120.0 27.0 83.5 2.8 86.1 193.7 14.8 122.6 33.3 176.8 104.7 209.5 158.9 8.8 80.9 39.2 24.3 267.5 82.6 7.6 118.3 50.4 55.1 152.4 12.2 17.0 90.0 19.6 134.1 106.2 80.3 21.8 47.6 110.6 117.3 14.4 62.8 18.7 104.3 21.8 6.7 169.6 141.1 78.4 9.5 7.4 0.3 0.1 41.5 43.2 51.9 24.1 18.7 6.8 14.4 14.8 14.8 0.1 17.3 6.6 5.8 9.9 1.7 12.9 2.1 0.1 3.9 0.5 6.0 6.3 66.8 4.1 0.0 66.7 33.7 1.6 16.0 4.3 1.4 0.4 4.1 7.3 2.5 2.9 0.1 148.7 2.8 6.2 2.5 0.1 5.1 0.5 20.6 7.8 2.8 1.0 58.7 7.7 6.3 2.6 6.4 33.5 6.2 1.5 3.9 15.6 1.5 0.1 0.1 0.1 7.9 0.1 0.3 2.3 19.9 10.6 2.1 8.4 6.2 0.1 0.3 1.2 7.4 0.6 0.0 0.0 54.9 3.7 3.2 0.2 0.3 2.8 40.2 33.3 39.2 57.8 33.3 176.8 80.9 39.2 24.3 55.1 47.6 62.8 78.4 1541.7 102.5 196.3 31.3 14.9 663.5 1435.6 98.7 2487.0 6.0 551.3 617.1 79.2 185.8 76.5 224.3 6.2 189.8 152.8 59.2 217.2 50.7 3.5 287.0 418.9 547.9 23.4 30.3 12.5 77.2 457.9 1377.3 387.3 621.0 5.1 96.4 269.5 157.7 220.3 1.7 2.5 44.3 42.7 520.1 502.0 21.5 435.5 912.6 268.6 29.0 163.5 321.9 150.4 6.0 0.5 53.2 58.4 144.8 34.9 1668.5 127.1 353.4 54.9 17.3 466.8 1386.3 1290.5 3.7 13.9 940.2 817.5 351.9 122.7 85.9 73.2 814.5 ZNF816-ZNF321P ZNF816-ZNF321 ENSG00000221874 "ZNF816-ZNF321P readthrough" 19 52928475-52962823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 9.8;Syncytiotrophoblasts: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RT4: 9.0" HPA051271 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051271: AB_2681415" "unprognostic (4.18e-2)" 0.2 0.1 0.0 0.3 0.0 0.4 0.8 0.0 0.2 0.7 0.0 0.9 0.0 0.5 0.0 0.2 0.8 0.3 0.2 0.0 0.0 0.5 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.3 0.2 0.2 0.8 0.0 1.7 1.5 0.0 0.4 0.7 0.0 0.2 0.2 0.0 0.0 0.3 1.0 0.1 0.0 0.2 0.2 0.0 0.4 0.6 0.4 0.0 0.3 0.0 0.8 0.2 0.5 0.1 0.5 0.0 0.3 0.5 0.5 0.0 0.3 0.9 0.3 0.4 0.8 0.1 0.8 0.1 0.0 0.5 1.1 0.4 0.1 1.1 0.6 0.0 0.2 0.5 0.0 0.8 0.0 0.3 0.4 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.3 0.1 0.0 0.2 9.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.4 0.6 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 0.8 0.0 3.8 0.0 3.4 0.0 1.5 2.4 0.6 4.3 0.0 0.0 0.0 9.8 1.2 4.4 3.9 3.6 1.9 7.3 1.9 1.0 0.0 3.0 0.7 3.6 5.7 1.1 6.6 7.4 4.5 1.5 1.4 0.3 3.7 0.0 0.3 3.6 0.0 1.6 0.0 1.1 0.3 1.8 0.0 1.0 2.9 0.0 4.1 1.0 0.6 3.5 2.5 0.7 1.0 2.7 1.9 1.1 0.0 0.0 0.0 1.3 1.1 1.3 1.6 2.0 0.0 11.2 1.6 1.0 3.0 5.9 PSG7 ENSG00000221878 "Pregnancy specific beta-1-glycoprotein 7" Q13046 19 42924132-42937207 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "placenta: 4.2;skin 1: 1.2" "Cell type enriched" "Detected in some" 95 "Syncytiotrophoblasts: 162.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.6;fHDF/TERT166: 1.1;HBF TERT88: 2.3;U-2197: 1.8" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.1 0.5 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 162.0 0.0 0.0 0.0 0.0 KRTAP1-3 KAP1.3 ENSG00000221880 "Keratin associated protein 1-3" Q8IUG1 17 41033884-41034874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 334 "skin 1: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OR3A2 "OLFRA04, OR17-228, OR228" ENSG00000221882 "Olfactory receptor family 3 subfamily A member 2" P47893 17 3276942-3386317 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 3.3;retina: 1.1;testis: 3.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.9;granulocytes: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 11.3;JURKAT: 11.8" "Low region specificity" "Detected in single" NA NA "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" 0.1 0.0 1.0 0.1 0.9 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.2 0.3 0.6 1.1 0.3 0.2 0.0 0.0 0.2 0.2 1.6 0.1 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 3.2 2.4 0.3 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.2 0.0 0.4 0.9 0.3 0.0 0.2 0.1 0.3 0.4 0.2 0.1 0.0 1.0 0.1 0.2 1.0 0.9 0.0 1.2 0.4 1.3 0.6 1.1 0.3 1.6 0.1 2.4 3.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ZBED8 "Buster3, C5orf54" ENSG00000221886 "Zinc finger BED-type containing 8" Q8IZ13 5 160393148-160400054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 12.6;Sertoli cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045445, HPA055817" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045445: AB_10959608, HPA055817: AB_2682933" "unprognostic (1.51e-1)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (8.40e-2)" "unprognostic (7.04e-3)" "unprognostic (7.50e-2)" "unprognostic (1.47e-5)" "unprognostic (6.52e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "prognostic favorable (3.72e-4)" "unprognostic (1.16e-1)" "unprognostic (7.44e-2)" "unprognostic (9.74e-2)" "unprognostic (9.25e-2)" "unprognostic (2.50e-1)" "unprognostic (9.96e-3)" 2.5 4.7 5.8 1.1 7.0 0.2 4.0 10.9 6.6 7.1 5.4 3.9 1.6 6.2 7.8 2.1 5.4 2.5 4.2 5.2 6.0 3.7 1.8 2.4 1.6 5.8 6.3 5.4 11.0 3.2 3.3 9.9 4.6 6.6 4.8 1.9 8.9 5.1 4.8 2.6 2.8 2.0 3.8 6.0 2.4 2.7 4.3 6.0 2.2 5.6 3.1 1.8 4.9 4.4 9.3 5.7 4.4 10.8 9.6 8.5 6.2 4.4 4.8 4.5 5.8 8.8 4.0 4.4 4.7 9.1 1.6 13.7 6.0 6.2 2.8 7.7 4.8 6.2 3.0 6.7 5.2 3.1 1.9 3.6 2.4 5.8 4.3 2.8 5.3 3.0 4.0 2.1 4.4 6.2 2.3 1.8 3.2 2.6 2.3 4.7 2.3 12.5 3.1 2.7 1.6 11.1 3.7 6.4 1.8 5.5 4.3 4.2 2.0 2.1 8.7 5.7 2.7 4.1 4.0 7.2 1.2 6.2 2.9 8.7 0.0 0.7 0.3 0.7 0.5 0.4 0.2 0.6 0.5 0.9 0.1 0.4 0.3 0.0 1.1 1.0 0.8 0.0 0.4 5.8 7.0 10.9 6.6 5.2 6.0 5.8 6.3 5.4 6.6 6.0 6.0 9.3 1.4 0.0 0.5 4.2 0.2 0.0 1.0 0.0 1.8 5.7 1.6 1.3 3.3 0.0 0.6 1.8 2.1 4.0 0.1 0.5 1.9 1.4 1.3 2.6 3.0 1.7 0.0 1.7 4.0 0.4 1.6 3.4 1.1 1.3 0.0 7.2 1.1 0.2 1.5 3.3 5.5 0.7 0.0 0.9 0.0 0.4 6.5 0.6 0.0 1.0 1.1 6.1 0.0 4.5 12.6 0.7 0.7 5.7 0.4 0.7 0.4 1.2 5.1 4.1 13.1 2.4 3.2 3.8 5.1 0.8 0.0 1.4 0.3 2.1 0.7 0.3 HMSD "ACC-6, ACC6, C18orf53" ENSG00000221887 "Histocompatibility minor serpin domain containing" "A8MTL9, P0C7T4" 18 63949301-63981774 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9" "Group enriched" "Detected in some" 4 "monocytes: 28.4;Oligodendrocytes: 11.1;Spermatogonia: 9.6" "Cancer enhanced" "Detected in single" "cervical cancer: 1.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 18 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.4;GAMG: 8.6;HDLM-2: 18.8;Karpas-707: 7.1" "Secreted to blood" NA NA "unprognostic (5.83e-3)" "unprognostic (1.40e-1)" "unprognostic (1.40e-2)" "unprognostic (5.42e-3)" "unprognostic (6.20e-2)" "unprognostic (1.16e-2)" "unprognostic (4.91e-2)" "unprognostic (3.80e-1)" "unprognostic (1.41e-2)" "unprognostic (5.19e-3)" "unprognostic (8.67e-2)" "unprognostic (1.44e-1)" "unprognostic (7.14e-6)" "unprognostic (1.22e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-3)" "unprognostic (3.55e-1)" 0.7 0.4 2.5 0.9 3.2 0.0 0.3 4.0 6.1 0.1 1.6 0.4 0.1 0.0 0.0 1.0 0.7 0.0 0.6 2.3 3.0 0.0 0.7 1.9 1.6 5.8 3.8 2.2 0.2 0.2 0.0 0.1 0.0 5.3 0.2 0.5 0.1 0.2 0.0 0.1 0.7 1.0 0.0 4.3 1.1 0.3 0.6 3.2 0.9 0.7 0.1 1.2 0.1 0.5 6.9 3.3 0.0 0.0 0.0 3.2 7.4 0.0 0.6 2.1 0.3 3.9 0.0 0.8 0.0 0.0 0.9 8.6 3.4 1.3 0.2 2.5 18.8 0.0 0.0 0.1 0.0 0.8 0.0 0.0 4.1 0.0 2.7 0.1 1.0 0.0 0.0 0.0 7.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 3.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.5 3.2 4.0 6.1 2.3 3.0 5.8 3.8 2.2 5.3 4.3 3.2 6.9 0.1 3.2 0.0 0.3 0.0 1.7 0.2 3.6 0.0 0.1 0.1 0.1 0.3 0.0 0.9 0.0 0.0 0.4 2.9 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.5 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 2.0 0.0 2.7 0.4 0.3 0.5 0.0 0.0 28.4 0.9 0.0 0.5 11.1 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 1.5 9.6 0.9 0.1 0.1 0.2 0.1 0.6 0.1 OR1C1 "HSTPCR27, TPCR27" ENSG00000221888 "Olfactory receptor family 1 subfamily C member 1" Q15619 1 247754846-247760556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.40e-1)" "unprognostic (3.58e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38844028 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 281.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 18.0;Excitatory neurons: 41.7;Inhibitory neurons: 50.4;Oligodendrocyte precursor cells: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 23.3;SCLC-21H: 30.8;SiHa: 23.6;U-87 MG: 87.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 420000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.7 5.0 91.3 1.9 79.0 0.3 2.9 0.6 152.1 8.2 0.0 7.2 1.3 11.0 3.9 3.0 8.0 2.0 15.8 281.5 22.7 1.4 1.9 1.9 1.6 11.0 17.4 100.5 8.2 5.2 7.1 6.8 0.4 34.0 8.2 1.5 5.3 4.8 7.0 0.7 1.0 3.3 7.6 0.7 2.5 5.1 1.8 91.7 0.7 2.8 2.5 1.5 7.4 4.8 54.9 1.0 6.2 0.2 1.8 12.2 1.2 0.0 4.1 0.9 7.9 2.7 6.2 1.3 0.0 7.2 1.1 23.3 0.8 1.7 0.2 2.6 0.6 2.0 0.0 0.2 9.6 1.2 0.1 0.3 3.9 0.4 7.2 0.1 11.4 0.3 0.1 7.7 0.3 0.3 9.7 0.0 0.5 7.3 3.0 2.2 1.6 0.0 15.3 2.0 17.1 30.8 2.0 23.6 0.1 0.7 1.7 9.9 2.5 0.4 14.1 8.4 0.0 0.7 2.1 0.0 0.0 87.9 18.5 7.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 91.3 79.0 0.6 152.1 281.5 22.7 11.0 17.4 100.5 34.0 0.7 91.7 54.9 4.7 0.0 0.0 9.4 0.3 1.1 2.7 0.9 0.0 6.6 3.3 1.5 18.0 4.3 3.0 3.7 2.1 0.0 2.3 0.0 0.0 7.3 1.7 1.7 3.2 4.2 1.8 0.0 41.7 3.8 0.0 1.5 0.5 3.0 0.0 1.5 5.0 0.4 0.2 0.0 50.4 0.2 6.1 0.3 0.9 0.8 1.8 0.3 1.8 1.9 0.0 4.8 6.2 19.1 10.5 2.0 0.0 2.2 0.9 3.8 0.1 0.5 2.2 3.3 0.0 2.4 2.8 0.2 1.3 0.1 1.0 0.0 1.7 0.3 0.0 3.4 POM121L12 DKFZp564N2472 ENSG00000221900 "POM121 transmembrane nucleoporin like 12" Q8N7R1 7 53035633-53036925 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "testis: 13.4" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027836 Enhanced NA NA "HPA027836: AB_10669592" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM200A "C7orf38, DKFZp727G131, FLJ36794" ENSG00000221909 "Family with sequence similarity 200 member A" Q8TCP9 7 99546300-99558536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017855 Uncertain NA NA "HPA017855: AB_1847703" "unprognostic (3.98e-3)" "unprognostic (2.36e-2)" "unprognostic (2.67e-1)" "unprognostic (6.44e-2)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "prognostic unfavorable (9.24e-4)" "unprognostic (2.38e-3)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "prognostic favorable (2.17e-7)" "unprognostic (8.38e-2)" "unprognostic (3.46e-2)" "unprognostic (7.84e-2)" "unprognostic (2.41e-2)" 3.2 7.5 5.6 4.4 5.7 1.7 6.1 7.2 6.1 6.3 5.4 3.4 3.6 5.3 6.6 4.2 5.1 3.7 5.4 5.5 6.3 6.5 3.6 3.9 6.2 5.4 5.6 5.3 10.4 4.7 7.1 6.3 5.2 5.8 7.0 3.2 8.8 6.5 5.0 5.4 5.4 3.7 3.2 5.4 4.9 4.9 9.6 5.9 7.4 6.8 6.5 5.3 4.0 3.5 6.2 8.5 5.1 11.7 13.8 10.2 9.8 7.5 7.6 8.0 6.5 8.0 4.9 7.1 5.2 7.8 5.0 10.5 6.6 9.3 7.1 10.7 7.5 8.3 5.8 6.8 6.0 8.2 6.8 6.5 6.9 12.6 6.2 12.0 8.7 6.8 8.5 12.7 4.4 12.0 6.3 12.7 13.3 10.5 2.3 8.2 6.2 9.9 5.3 6.0 5.7 8.9 17.2 4.5 7.4 13.1 13.9 5.7 7.4 5.4 9.8 11.8 14.1 6.8 5.9 5.5 6.1 7.8 5.6 15.8 6.5 2.3 3.0 4.0 1.6 5.9 3.4 4.0 5.0 2.5 5.0 7.1 6.0 1.5 2.5 1.4 2.6 5.9 2.3 5.6 5.7 7.2 6.1 5.5 6.3 5.4 5.6 5.3 5.8 5.4 5.9 6.2 5.3 9.6 5.3 15.7 10.8 1.9 3.4 3.1 9.1 13.3 4.5 5.8 7.3 4.3 5.0 7.3 0.0 7.9 3.2 2.0 7.9 5.6 83.0 6.2 8.9 5.8 0.0 1.3 12.4 3.4 5.5 5.5 4.1 5.2 0.0 10.2 3.3 1.8 4.3 13.5 14.2 2.6 4.1 3.5 1.4 14.4 9.0 4.4 1.8 10.3 5.0 11.0 7.2 8.5 25.4 3.9 5.4 6.0 8.7 3.1 2.6 5.1 5.4 10.1 0.0 5.2 4.5 19.6 9.1 5.8 3.3 8.1 6.3 9.1 3.1 1.6 OR2F2 OR7-1 ENSG00000221910 "Olfactory receptor family 2 subfamily F member 2" O95006 7 143935166-143936279 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PPP2R2A "B55A, B55alpha, PR52A, PR55A, PR55alpha" ENSG00000221914 "Protein phosphatase 2 regulatory subunit Balpha" P63151 8 26291508-26372680 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, CAB079289" Approved Approved Cytosol NA NA Cytosol "CAB079289: AB_659890, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (1.17e-1)" "unprognostic (2.68e-2)" "unprognostic (4.29e-3)" "unprognostic (5.34e-2)" "unprognostic (3.44e-2)" "unprognostic (2.11e-2)" "unprognostic (4.64e-3)" "unprognostic (3.65e-1)" "unprognostic (2.48e-1)" "unprognostic (3.87e-2)" "unprognostic (2.71e-2)" "unprognostic (8.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (2.90e-1)" "unprognostic (3.44e-2)" "unprognostic (1.16e-1)" 31.4 16.3 10.6 12.8 13.2 4.8 30.6 10.1 14.4 26.6 8.3 18.7 21.9 22.5 8.6 60.1 24.8 14.2 25.5 10.6 11.5 18.2 28.6 26.0 16.1 10.8 11.1 9.4 24.9 14.8 14.1 13.6 38.5 10.5 19.6 15.3 10.6 27.3 16.1 53.8 38.6 19.6 18.4 10.7 18.0 17.9 18.2 10.5 16.1 19.5 23.9 25.9 24.4 37.3 15.0 42.1 33.5 52.5 32.2 28.3 43.6 54.2 74.5 49.4 63.1 65.2 48.9 24.2 54.5 19.1 28.9 31.5 51.2 56.9 50.1 78.0 23.8 24.4 43.8 36.6 23.0 42.0 25.2 19.1 29.3 62.4 39.4 52.0 31.7 96.1 27.5 64.1 37.1 51.7 26.0 54.4 17.6 62.5 73.6 20.5 36.1 35.1 41.8 31.0 74.8 21.0 27.7 30.3 27.9 41.0 37.2 26.9 13.7 45.8 28.5 46.0 31.4 47.0 18.6 32.4 80.9 35.1 39.7 52.2 0.6 0.4 1.6 0.4 0.9 0.7 1.3 1.1 1.0 1.1 1.1 0.6 0.9 1.0 0.9 0.9 0.7 1.8 0.7 10.6 13.2 10.1 14.4 10.6 11.5 10.8 11.1 9.4 10.5 10.7 10.5 15.0 63.4 73.7 67.8 42.1 59.2 136.6 215.9 81.6 72.8 53.0 65.6 52.5 36.9 27.1 98.8 14.7 47.9 76.6 70.2 57.5 49.0 45.5 47.9 100.5 51.6 82.3 76.9 53.5 95.1 32.2 65.3 65.5 57.6 98.4 55.2 61.0 55.3 34.6 36.6 37.0 49.9 51.2 61.1 32.0 66.1 128.8 46.9 47.6 60.5 72.1 48.1 51.6 35.0 122.6 250.6 61.0 50.1 73.4 53.5 140.0 44.4 43.9 111.2 40.8 52.6 56.1 76.7 44.6 57.2 102.3 142.9 66.9 66.5 59.9 50.6 232.8 C19orf73 FLJ10490 ENSG00000221916 "Chromosome 19 open reading frame 73" Q9NVV2 19 49118402-49119143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.5" HPA062719 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062719: AB_2684847" "unprognostic (3.02e-1)" "unprognostic (3.75e-2)" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (2.04e-2)" "unprognostic (4.39e-3)" "unprognostic (2.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.92e-1)" "unprognostic (1.97e-3)" "prognostic favorable (1.58e-4)" "unprognostic (3.05e-1)" "unprognostic (9.00e-5)" "unprognostic (1.19e-1)" "unprognostic (6.70e-2)" "unprognostic (1.91e-1)" "unprognostic (5.13e-3)" 0.8 1.3 3.6 0.4 3.7 0.1 1.5 5.7 4.6 0.6 2.3 1.3 2.1 1.0 1.4 2.0 0.6 0.3 1.7 4.1 3.6 1.7 3.4 1.0 0.2 4.0 3.6 3.7 0.2 4.9 0.8 3.8 0.2 4.2 1.6 0.7 1.1 2.5 0.4 1.8 2.5 1.5 0.2 3.7 1.8 1.4 1.3 3.7 0.6 1.9 0.9 0.3 0.7 1.2 4.4 1.7 2.1 0.8 4.0 1.3 0.2 0.9 0.5 0.3 0.8 0.6 0.1 0.9 1.2 0.4 0.3 1.2 1.1 1.0 0.1 0.1 2.4 8.5 1.1 1.6 1.4 1.3 0.0 0.4 0.1 2.7 0.6 2.2 0.6 0.1 4.2 2.0 2.0 0.4 1.8 1.4 1.3 0.6 1.8 0.4 1.2 1.6 1.6 1.5 0.7 4.2 1.9 0.8 1.0 1.6 0.5 1.0 0.4 0.8 1.0 1.8 0.3 0.4 1.2 2.5 1.4 0.7 1.5 1.2 0.0 2.0 0.4 1.6 1.3 2.7 1.5 1.2 1.5 3.4 4.4 2.4 1.8 0.0 5.0 2.8 2.7 1.2 1.5 3.6 3.7 5.7 4.6 4.1 3.6 4.0 3.6 3.7 4.2 3.7 3.7 4.4 1.6 0.0 0.0 1.3 2.8 2.2 10.3 2.9 4.0 3.9 6.1 6.1 0.7 4.3 2.6 3.7 0.0 1.0 1.0 3.5 3.9 2.6 0.5 1.4 1.1 1.7 3.0 5.7 1.3 2.0 0.9 1.3 3.1 1.0 0.0 0.3 2.2 7.2 1.3 1.7 1.4 4.8 10.2 0.8 0.6 0.7 0.0 1.5 3.6 0.0 0.9 6.9 4.1 1.5 3.0 1.7 1.9 1.5 3.3 8.6 5.0 8.9 2.5 4.8 0.0 1.1 1.6 0.7 4.9 5.4 2.6 0.4 1.7 2.6 5.0 4.1 ZNF880 ENSG00000221923 "Zinc finger protein 880" Q6PDB4 19 52369917-52385795 "Predicted intracellular proteins, Transcription factors" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 38.9" HPA077316 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "HPA077316: AB_2686833" "unprognostic (2.66e-3)" "unprognostic (2.19e-2)" "unprognostic (2.55e-1)" "unprognostic (3.99e-2)" "unprognostic (7.72e-2)" "unprognostic (1.54e-2)" "unprognostic (7.61e-2)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (2.52e-1)" "prognostic favorable (4.33e-8)" "unprognostic (4.14e-2)" "unprognostic (4.99e-1)" "unprognostic (1.77e-1)" "unprognostic (5.60e-3)" 11.1 11.0 9.3 11.0 11.1 17.9 13.6 24.1 11.2 12.0 7.5 9.8 5.8 13.2 11.3 6.3 12.2 10.8 17.7 9.3 10.3 10.9 3.6 11.3 14.8 11.7 11.3 7.5 18.5 7.3 5.4 10.5 10.1 12.5 17.3 8.9 16.1 10.9 13.1 7.2 10.8 10.0 12.0 10.0 14.5 9.6 10.0 12.5 15.5 18.3 8.0 14.4 13.6 8.9 13.3 0.3 1.6 19.1 16.0 10.8 29.1 21.9 13.5 13.9 9.2 17.7 0.4 9.1 0.3 4.8 22.2 19.1 3.2 0.1 12.5 14.5 0.3 24.2 0.6 1.0 0.0 12.7 0.5 16.7 23.1 15.6 16.7 0.0 1.1 14.7 1.7 1.7 0.7 18.4 1.3 2.0 1.2 27.6 0.0 3.3 1.4 38.9 1.4 25.8 20.8 14.9 18.8 0.1 4.0 5.9 35.2 0.7 4.3 11.8 0.6 0.4 4.2 12.7 0.8 8.0 0.6 0.4 0.4 26.8 80.3 12.9 31.9 25.1 12.9 32.4 50.3 31.8 27.2 20.9 53.4 37.9 33.0 5.2 26.2 15.2 41.2 37.2 17.5 9.3 11.1 24.1 11.2 9.3 10.3 11.7 11.3 7.5 12.5 10.0 12.5 13.3 13.3 12.8 3.9 4.2 15.2 5.9 22.6 22.6 10.8 15.9 7.2 9.7 13.1 4.3 20.4 20.2 12.5 9.9 12.4 2.2 29.4 18.8 12.8 19.2 10.6 10.8 0.0 5.9 3.5 14.8 14.8 11.9 5.6 13.5 10.1 6.0 9.3 1.5 7.0 23.5 4.2 6.2 18.3 4.9 9.8 5.3 13.7 8.2 8.8 1.9 13.9 12.1 32.0 4.5 5.8 20.8 7.9 6.4 2.8 23.3 2.3 8.4 11.3 16.7 19.7 12.3 14.0 4.6 10.1 4.3 7.1 14.4 13.5 5.2 4.0 23.5 TRIM16 EBBP ENSG00000221926 "Tripartite motif containing 16" O95361 17 15627960-15684311 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 147.1" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 153.4;Squamous epithelial cells: 95.5;Urothelial cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "T-reg: 45.1" "Lineage enriched" "Detected in many" 12 "T-cells: 45.1" "Cell line enhanced" "Detected in all" "A549: 283.8;HaCaT: 229.0;HeLa: 203.8;OE19: 364.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023623, HPA066431" Uncertain Supported "Plasma membrane,Cytosol" NA NA 19000 Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (9.61e-2)" "unprognostic (1.31e-2)" "unprognostic (6.19e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.94e-3)" "unprognostic (3.75e-2)" "unprognostic (4.65e-1)" "unprognostic (3.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.08e-1)" "unprognostic (8.48e-2)" "unprognostic (9.21e-3)" "prognostic unfavorable (6.71e-4)" 17.6 32.9 19.8 7.9 15.4 17.5 13.5 17.4 17.6 24.5 10.6 13.8 23.0 6.2 4.9 147.1 8.8 16.4 20.3 13.8 14.8 8.6 6.0 14.6 9.7 19.5 15.6 12.2 7.4 6.1 3.6 4.5 34.8 20.1 10.3 11.3 3.6 38.3 11.8 28.4 44.7 12.6 9.0 18.2 6.1 32.0 12.8 17.1 10.2 18.9 27.4 37.6 36.0 70.8 33.7 91.5 283.8 8.6 19.4 40.4 46.1 9.6 14.8 51.9 17.9 25.0 17.2 115.6 9.8 54.7 64.7 106.9 229.0 25.6 65.7 12.0 120.0 16.4 4.5 203.8 9.5 67.1 5.4 9.6 25.7 40.9 39.3 22.3 49.6 38.8 11.4 5.7 45.8 49.2 32.2 20.2 11.7 13.1 364.2 17.0 8.7 71.8 6.9 92.4 116.0 6.4 17.7 64.7 72.2 22.1 49.7 10.9 12.6 61.0 22.5 26.3 10.9 51.3 11.1 12.9 1.0 34.6 12.6 58.3 0.4 3.8 1.0 1.2 1.1 0.8 0.5 4.9 1.5 2.6 0.6 1.3 2.6 0.6 0.9 0.5 0.4 45.1 2.3 19.8 15.4 17.4 17.6 13.8 14.8 19.5 15.6 12.2 20.1 18.2 17.1 33.7 34.9 38.5 2.6 14.0 5.3 30.8 59.0 55.6 10.2 7.2 11.8 5.7 12.5 10.0 73.5 11.0 18.8 13.6 2.8 9.9 0.0 49.1 1.1 16.5 9.9 28.7 4.2 9.0 9.6 17.3 8.4 9.6 34.7 25.7 4.5 12.4 3.6 3.2 4.0 3.3 14.0 21.7 28.5 2.9 8.6 3.9 7.2 2.9 7.2 11.2 13.0 6.6 4.1 18.6 19.2 153.4 26.9 4.5 3.7 29.5 4.3 6.2 33.5 8.4 6.6 5.8 14.0 10.3 12.1 95.5 77.6 4.7 5.9 60.9 18.4 111.9 OR6X1 ENSG00000221931 "Olfactory receptor family 6 subfamily X member 1" Q8NH79 11 123753488-123754545 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 10.7;brain: 42.4;liver: 21.1" "Group enriched" "Detected in some" 23 "Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "medulla oblongata: 42.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 287 "Hep G2: 55.5" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 10.7 0.2 6.4 0.1 15.9 0.0 8.4 1.0 10.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.5 4.4 2.6 0.2 21.1 0.1 0.1 42.4 9.4 0.7 0.1 0.2 0.0 2.4 0.0 8.4 0.8 0.0 2.2 0.4 0.0 0.2 0.3 0.7 0.0 3.2 0.1 0.5 0.5 15.5 0.0 0.2 0.0 0.0 0.2 0.5 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 15.9 1.0 10.0 4.4 2.6 42.4 9.4 0.7 8.4 3.2 15.5 16.9 0.2 0.0 0.0 94.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 3.1 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 1.9 0.0 29.1 0.0 49.3 114.6 0.0 0.0 1.2 0.0 0.1 0.0 2.2 0.0 1.9 0.0 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 OR2A25 "OR2A25P, OR2A27" ENSG00000221933 "Olfactory receptor family 2 subfamily A member 25" A4D2G3 7 144069811-144075870 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.2;Club cells: 1.8;granulocytes: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 6.4 5.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 TAS2R40 GPR60 ENSG00000221937 "Taste 2 receptor member 40" P59535 7 143222037-143223079 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "brain: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 1.4 0.6 3.6 0.0 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.9 0.0 0.0 0.1 0.0 5.6 3.2 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.8 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.4 3.6 2.1 2.3 0.5 2.9 5.6 3.2 0.1 5.9 4.2 3.5 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A14 "OR2A14P, OR2A6, OST182" ENSG00000221938 "Olfactory receptor family 2 subfamily A member 14" Q96R47 7 144123176-144131188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232543883-232550557 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies" "HPA041717: AB_2677636" "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 1.8 2.3 5.7 2.3 5.9 6.6 2.7 13.6 8.1 3.1 4.8 2.7 1.9 2.6 2.9 2.8 3.8 2.0 2.3 5.7 2.9 5.2 2.7 2.5 3.4 4.2 3.1 5.4 5.8 3.0 1.7 5.1 2.0 6.3 4.5 2.1 10.5 2.7 1.7 4.0 4.2 3.7 1.3 1.8 6.2 3.4 5.3 4.7 3.3 4.8 1.4 2.2 2.8 3.0 10.3 3.1 2.3 4.7 7.5 1.7 2.3 3.6 2.1 1.2 2.6 2.9 2.8 3.6 5.0 1.5 1.6 2.8 3.2 4.1 1.3 3.8 3.0 3.9 4.5 7.7 3.5 1.1 3.6 2.9 2.6 1.2 2.6 1.6 2.5 1.5 6.5 3.6 5.0 2.1 5.3 4.9 8.3 2.8 1.9 2.7 4.7 6.3 2.3 1.5 3.5 6.1 6.0 2.2 2.1 2.3 3.3 3.1 3.9 2.5 4.3 4.5 2.7 2.1 4.8 3.4 4.5 2.5 3.6 2.6 1.6 1.7 1.8 1.9 1.4 1.9 1.7 2.0 1.5 1.1 2.1 3.1 2.5 2.3 1.8 1.5 1.2 1.6 0.7 5.7 5.9 13.6 8.1 5.7 2.9 4.2 3.1 5.4 6.3 1.8 4.7 10.3 2.4 9.6 3.9 4.2 5.3 1.3 4.5 2.3 1.8 4.9 2.5 2.2 2.0 1.5 2.9 3.7 8.4 2.2 3.1 1.7 0.0 3.6 4.2 1.0 3.6 1.7 1.2 6.5 4.5 1.5 1.3 3.1 7.7 1.5 0.0 6.4 1.4 0.7 1.4 6.7 5.7 1.5 2.0 1.6 1.7 0.7 4.7 2.4 1.8 1.0 2.8 7.5 5.2 5.0 8.1 2.0 2.4 1.9 5.6 2.6 3.5 1.4 1.7 7.0 6.6 3.7 2.0 3.9 5.7 3.7 2.0 1.4 4.1 4.0 3.0 2.9 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154302 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 275.3" "Cell type enhanced" "Detected in many" "dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2" "Cancer enhanced" "Detected in some" "glioma: 4.2;ovarian cancer: 3.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 52.1" "Group enriched" "Detected in many" 23 "B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7" "Cell line enhanced" "Detected in some" "HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1" HPA026916 Approved NA NA "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 1.9 0.4 97.1 1.7 118.1 0.6 1.1 24.2 275.3 4.0 19.7 2.1 0.6 1.9 0.0 0.4 0.9 0.4 0.6 135.5 72.8 0.4 1.1 1.1 2.8 92.2 60.8 115.4 1.0 0.2 0.0 2.1 0.1 96.0 1.0 0.3 1.6 0.5 0.3 2.7 1.2 2.0 0.2 45.4 2.8 1.0 1.3 88.8 0.2 0.5 0.1 1.6 0.8 3.1 169.6 0.6 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.0 0.2 1.8 0.0 0.2 0.3 0.1 0.2 0.6 0.0 0.1 0.0 5.3 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.5 2.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.2 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.1 0.0 0.0 0.0 15.0 0.0 9.5 19.0 23.7 17.2 0.1 14.6 7.5 13.8 0.6 52.1 0.1 1.3 7.5 4.9 97.1 118.1 24.2 275.3 135.5 72.8 92.2 60.8 115.4 96.0 45.4 88.8 169.6 1.1 0.0 1.3 7.2 8.0 2.0 0.1 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 1.8 0.0 0.0 14.0 0.0 0.0 0.0 0.1 0.0 1.0 0.9 0.0 0.4 42.0 0.2 0.1 1.1 0.0 0.0 1.3 0.1 0.7 0.2 0.1 1.7 12.9 0.0 0.0 0.0 4.4 0.2 1.2 0.7 3.6 9.4 0.2 1.5 0.0 3.5 6.2 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 6.6 0.7 1.1 3.1 5.0 0.1 1.1 0.3 19.2 0.0 0.0 0.0 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669339-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.4;testis: 7.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 42.0;Inhibitory neurons: 17.9;Oligodendrocytes: 23.0;Spermatocytes: 82.3;Spermatogonia: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.3;hTCEpi: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044430 Enhanced Approved Mitochondria NA NA Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.2 1.2 0.5 0.4 0.5 0.5 0.4 0.2 1.5 0.2 0.0 0.9 2.7 0.2 1.3 0.5 0.1 2.2 0.2 0.4 0.5 0.5 3.4 0.6 0.5 0.7 0.6 0.2 0.2 0.3 0.1 0.6 0.4 1.1 0.6 0.5 2.5 0.5 0.0 0.2 0.9 5.4 0.3 0.0 0.5 1.8 7.8 0.4 0.5 0.5 0.3 0.5 1.0 0.2 1.5 2.3 0.1 0.5 0.2 0.0 0.5 0.3 0.9 0.4 0.3 0.9 3.3 0.2 0.3 1.5 0.0 1.1 0.1 0.0 0.5 1.1 0.4 0.3 0.2 0.2 0.2 0.0 0.7 1.2 0.6 6.4 0.1 0.0 0.2 0.0 1.6 0.1 2.3 0.1 0.3 0.4 0.3 1.3 0.1 0.4 0.3 0.6 0.1 0.1 1.7 1.4 0.2 0.4 1.0 0.3 0.1 0.3 0.1 0.2 0.3 0.6 0.4 0.3 2.0 0.5 1.5 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.4 0.2 0.4 0.2 0.0 0.2 0.6 0.4 0.1 0.2 0.0 0.0 0.8 0.0 0.5 0.5 0.2 1.5 0.4 0.5 0.7 0.6 0.2 1.1 0.0 0.4 1.5 0.1 6.4 2.2 14.4 1.1 2.7 3.5 3.9 4.6 2.2 0.7 1.0 0.4 1.5 3.3 0.0 8.4 1.0 0.3 1.4 0.0 1.6 5.3 0.5 0.3 0.6 0.0 0.0 42.0 4.6 0.6 0.8 6.1 0.6 0.0 0.3 0.0 2.3 0.3 1.7 17.9 3.4 0.0 0.3 0.4 4.9 0.9 0.2 0.0 1.9 0.0 1.5 2.1 1.5 23.0 6.0 1.3 0.4 0.8 1.7 11.7 0.5 3.2 5.3 0.0 0.1 0.2 82.3 19.7 0.5 0.9 1.0 1.0 0.1 0.4 2.3 OR4C12 ENSG00000221954 "Olfactory receptor family 4 subfamily C member 12" Q96R67 11 49981473-49982535 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 23.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 0.8 1.1 2.9 1.2 3.0 0.0 2.4 1.2 3.3 1.5 9.7 3.6 5.7 0.6 3.7 4.1 2.0 8.4 0.4 3.6 2.2 2.2 6.8 2.2 0.6 1.7 1.9 2.8 0.3 10.1 4.3 2.3 2.7 2.2 2.8 4.2 0.1 12.0 0.6 0.1 1.1 3.7 0.7 1.0 0.3 4.1 2.3 1.9 0.5 23.1 0.0 0.9 2.1 2.3 2.5 14.7 0.0 2.7 0.0 3.3 4.6 6.7 0.8 2.0 0.9 1.7 19.6 6.8 0.0 1.9 5.6 2.8 8.5 0.0 0.0 0.5 0.0 0.0 0.0 7.2 0.0 33.6 0.0 1.0 8.7 8.3 1.9 0.9 16.3 0.0 0.0 0.0 0.6 1.3 3.9 0.0 0.0 9.3 27.6 0.7 0.0 0.2 0.0 6.8 1.3 4.2 0.0 7.0 8.4 0.1 0.9 15.6 0.4 0.2 0.2 1.3 67.9 0.0 0.1 1.9 5.0 3.3 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.0 1.2 3.3 3.6 2.2 1.7 1.9 2.8 2.2 1.0 1.9 2.5 0.2 0.0 0.5 7.2 0.1 1.0 1.3 3.3 3.4 0.0 5.6 4.3 1.1 2.8 2.5 23.9 0.0 0.5 0.1 1.6 0.0 3.9 0.3 0.8 1.4 0.3 5.4 0.0 38.4 3.5 6.5 2.1 7.7 2.7 17.8 1.8 0.0 9.4 0.9 0.0 27.8 36.6 0.0 0.0 0.7 0.5 0.0 0.5 0.0 7.5 2.1 0.0 1.0 31.7 2.0 2.9 3.4 0.0 0.2 6.2 2.6 1.5 0.4 0.0 0.0 0.2 0.7 0.6 0.4 4.3 0.3 3.0 0.8 0.1 5.6 1.0 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648446-35668404 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 135.9;NK-cells: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 23.6 7.3 4.5 16.0 5.0 16.2 10.0 3.4 4.0 6.8 3.7 13.4 19.4 5.5 5.6 6.0 6.6 9.2 4.2 3.9 6.7 6.4 46.9 15.6 15.6 9.0 4.6 2.7 12.4 2.9 2.7 2.5 7.9 5.7 7.9 11.9 2.6 14.1 5.2 3.2 4.5 19.9 7.5 4.5 18.3 14.2 2.3 5.8 10.2 8.5 4.0 10.5 13.4 3.8 7.4 12.8 4.1 0.3 1.5 30.1 15.0 17.3 5.3 14.2 17.3 21.7 2.0 14.2 17.7 2.6 14.0 12.6 16.2 0.1 8.6 4.5 33.6 0.1 7.4 2.6 4.0 23.7 10.4 12.4 19.3 5.7 5.9 3.3 3.9 3.6 8.0 0.8 31.2 3.2 1.3 14.6 3.2 0.5 0.9 5.3 6.1 6.8 8.7 7.6 28.9 0.4 0.2 8.5 7.2 10.0 1.1 1.2 12.1 3.9 4.3 2.6 3.0 2.8 16.4 14.2 1.7 8.1 16.2 6.1 7.5 4.8 2.6 7.3 7.6 6.1 1.0 4.8 5.8 2.4 0.7 4.6 5.3 7.5 5.0 8.5 0.3 5.5 4.2 4.5 5.0 3.4 4.0 3.9 6.7 9.0 4.6 2.7 5.7 4.5 5.8 7.4 58.6 70.5 34.3 6.8 15.7 8.0 10.8 14.7 13.6 0.2 16.8 10.8 7.3 34.3 38.6 12.9 0.0 8.3 79.1 101.1 9.8 33.6 10.5 18.4 48.9 33.4 47.3 11.6 0.2 41.9 35.6 33.4 41.8 17.2 36.8 12.2 39.3 135.9 34.9 0.0 1.3 55.3 20.3 58.1 19.9 7.4 26.1 50.5 8.8 17.8 68.5 3.8 126.7 9.5 2.1 45.7 43.7 18.8 51.0 43.2 88.6 31.6 47.4 0.0 0.0 25.3 22.0 0.5 0.2 15.6 5.3 2.5 67.7 6.0 35.9 62.0 FADS3 "CYB5RP, LLCDL3" ENSG00000221968 "Fatty acid desaturase 3" Q9Y5Q0 11 61873519-61892051 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 164.6;Extravillous trophoblasts: 138.4;Rod photoreceptor cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 7.7;naive B-cell: 8.7" "Group enriched" "Detected in many" 4 "B-cells: 8.7;granulocytes: 5.7;T-cells: 2.1" "Cell line enhanced" "Detected in all" "ASC diff: 283.2;HHSteC: 243.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045224 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA045224: AB_10967570" "unprognostic (4.69e-3)" "unprognostic (1.31e-2)" "unprognostic (5.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.91e-2)" "prognostic unfavorable (9.54e-5)" "unprognostic (1.76e-3)" "unprognostic (3.46e-1)" "unprognostic (6.45e-2)" "unprognostic (1.49e-1)" "unprognostic (1.28e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.50e-9)" "unprognostic (1.14e-1)" "unprognostic (3.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.37e-1)" 100.2 72.9 30.3 23.6 31.6 5.2 73.2 24.3 51.1 28.6 45.5 23.7 4.9 28.1 32.0 9.6 26.9 12.2 73.5 31.4 32.0 29.6 23.9 45.8 21.7 29.5 27.3 33.5 36.0 25.6 11.5 14.2 64.5 30.1 21.5 4.7 15.1 14.4 13.2 45.6 12.1 28.3 19.6 24.2 22.5 22.8 13.5 29.6 4.3 18.2 15.0 21.1 37.1 21.6 30.8 37.3 11.4 3.6 22.5 283.2 57.0 71.5 73.1 177.9 77.0 73.7 16.2 13.3 27.5 46.5 147.1 60.0 20.1 13.7 199.4 40.8 7.9 7.6 22.7 48.9 32.8 243.6 2.1 4.5 62.5 85.2 92.4 175.4 46.8 90.1 14.3 22.2 50.8 132.6 42.7 8.3 11.3 10.7 4.1 29.4 46.4 142.8 76.8 86.0 13.0 5.7 7.2 83.4 11.2 77.9 29.9 16.4 5.0 61.2 74.5 51.1 22.0 32.6 15.5 8.0 35.0 62.4 11.2 55.2 0.0 0.7 5.7 1.6 1.2 1.4 7.7 1.4 2.1 0.6 8.7 0.1 0.5 0.3 0.6 0.8 0.0 0.4 0.6 30.3 31.6 24.3 51.1 31.4 32.0 29.5 27.3 33.5 30.1 24.2 29.6 30.8 164.6 32.1 5.2 54.5 39.0 6.8 8.2 15.6 2.8 11.2 23.3 26.2 19.5 18.6 2.0 5.5 8.4 38.9 15.2 35.7 1.9 46.4 17.4 8.2 31.2 57.7 6.7 13.0 31.6 20.6 138.4 31.3 16.8 13.1 7.0 12.4 20.3 9.8 19.7 1.7 10.0 21.0 0.0 3.9 43.0 14.0 28.6 16.5 35.6 8.4 8.0 48.5 5.2 17.1 17.6 16.4 6.7 17.7 13.1 10.7 6.3 13.9 2.9 120.3 19.7 97.3 90.2 2.0 5.5 3.5 5.5 68.0 17.6 16.1 15.8 4.3 OR2A1 ENSG00000221970 "Olfactory receptor family 2 subfamily A member 1" Q8NGT9 7 144312419-144322737 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (3.98e-1)" "unprognostic (6.53e-2)" "unprognostic (1.13e-2)" "unprognostic (9.14e-2)" "unprognostic (2.22e-1)" 0.6 0.2 0.3 0.1 0.4 0.2 0.7 0.2 0.4 0.6 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.1 0.3 0.1 0.7 0.4 0.2 0.8 0.1 0.4 0.5 0.1 1.1 0.3 0.0 0.4 0.0 0.3 0.4 0.0 0.1 0.3 0.0 0.0 0.5 0.6 0.0 0.2 0.7 0.2 0.2 0.5 0.0 2.4 0.0 0.0 0.4 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.4 0.1 0.7 0.4 0.5 0.1 0.3 0.2 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4E2 ENSG00000221977 "Olfactory receptor family 4 subfamily E member 2" Q8NGC2 14 21653835-21667642 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCNL2 "ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138" ENSG00000221978 "Cyclin L2" Q96S94 1 1385711-1399335 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053137 Supported Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA053137: AB_2682053" "unprognostic (3.08e-2)" "unprognostic (2.60e-1)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.59e-3)" "unprognostic (2.06e-1)" "unprognostic (3.91e-2)" "unprognostic (1.67e-2)" "unprognostic (1.15e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.61e-2)" "unprognostic (6.17e-2)" "unprognostic (3.71e-1)" "prognostic favorable (1.46e-7)" 65.5 80.5 16.4 29.9 16.8 33.6 74.6 23.3 21.7 97.8 26.1 71.8 36.4 89.5 31.1 67.8 87.3 26.6 56.1 16.1 19.2 65.2 101.3 62.7 32.4 17.7 15.6 15.8 105.2 91.0 31.9 74.0 34.7 18.8 76.6 23.0 23.1 78.7 32.2 50.1 66.9 76.4 26.8 15.3 62.6 71.8 31.4 15.9 31.9 92.2 18.6 28.4 77.6 83.2 25.8 30.1 24.5 72.5 29.7 39.2 63.9 37.1 63.8 33.8 32.1 31.6 27.5 57.9 30.6 35.3 42.8 27.7 68.4 26.8 40.9 24.6 14.7 68.9 38.4 142.0 43.8 47.8 19.9 42.8 81.1 29.0 31.4 48.5 94.6 34.9 41.0 37.3 32.4 37.6 32.1 25.1 78.7 23.7 21.2 48.5 48.8 17.6 39.1 56.5 37.1 45.4 63.0 40.7 60.6 37.5 42.8 48.8 30.3 60.1 70.8 32.5 29.4 25.2 64.9 12.1 53.7 35.0 50.7 18.5 5.4 6.1 8.5 7.4 4.6 5.0 7.2 7.2 7.9 7.1 9.0 8.3 7.4 5.8 6.6 7.3 6.7 4.3 2.9 16.4 16.8 23.3 21.7 16.1 19.2 17.7 15.6 15.8 18.8 15.3 15.9 25.8 66.4 35.3 107.5 76.7 46.6 45.5 36.6 48.3 50.7 31.7 50.8 56.4 37.2 40.0 58.1 29.5 47.9 43.2 48.7 43.1 21.5 30.6 22.4 49.0 82.1 56.0 50.6 26.5 44.7 26.7 33.8 49.9 78.5 55.2 43.1 81.4 37.5 45.6 24.7 60.6 41.2 41.5 52.9 22.9 34.0 14.6 51.3 31.0 32.0 48.7 27.2 35.5 47.4 31.2 52.5 40.2 40.7 32.7 46.7 31.1 33.9 18.4 58.6 39.4 59.2 56.8 59.9 45.1 30.6 40.3 44.0 63.8 46.4 73.6 34.6 39.0 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 11928.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196" "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 1137.4 962.8 824.3 800.5 825.4 2200.1 1125.0 802.2 1029.4 1190.8 827.5 941.2 535.9 946.0 974.6 1206.4 993.0 616.3 956.4 791.8 861.1 936.8 935.0 896.4 1481.7 853.3 821.4 772.7 1635.6 1678.8 851.1 763.9 726.8 846.0 924.8 797.2 237.6 1070.3 621.2 1643.3 1415.7 924.3 719.1 884.5 1249.2 997.7 761.2 855.9 1500.8 754.8 1207.3 1687.6 1004.0 1116.9 855.6 1680.6 1304.1 961.2 1612.8 2437.7 2298.9 2376.3 1260.7 1738.5 2044.2 1618.9 2381.2 1521.6 2403.4 1268.0 2092.8 803.0 1103.3 1881.9 2242.7 1918.7 650.0 2938.0 1320.1 1942.1 2733.4 1770.8 2898.3 1616.2 2684.2 3008.4 1406.4 2024.7 1778.7 2083.2 1508.8 2131.5 3231.7 1769.8 2786.9 2336.4 2584.2 2162.6 3166.1 2800.9 1899.3 958.6 2769.6 2001.7 2497.0 1246.1 1505.9 914.3 2187.0 2300.9 1424.6 970.6 3681.4 1562.7 1017.6 850.0 2172.8 2271.9 1973.0 2863.7 2412.2 1386.0 3245.8 1412.8 962.6 2155.2 1163.1 1761.2 1764.2 2401.7 3126.7 2616.4 2119.8 2320.3 3025.4 2946.4 2445.0 1168.8 1864.5 1629.2 2469.2 2250.9 4829.5 824.3 825.4 802.2 1029.4 791.8 861.1 853.3 821.4 772.7 846.0 884.5 855.9 855.6 831.5 464.8 673.1 15.0 2198.0 1898.4 2027.9 1544.8 1365.8 117.9 1444.5 1279.9 332.3 1109.5 886.1 654.7 68.8 2020.5 1806.7 1264.6 1571.0 1437.7 3146.5 772.1 1337.9 1108.6 1106.6 2241.7 10.8 2271.5 2803.3 1060.1 672.2 1194.9 805.8 1061.9 1385.3 1919.9 2574.7 104.3 12.4 1812.7 710.1 3200.4 2894.6 11928.8 1875.2 2003.3 1250.4 8.4 3379.8 599.1 2276.1 11.1 23.1 1799.4 1853.6 1034.7 1202.4 2110.3 1645.1 2688.2 510.4 219.1 696.8 1483.1 2041.1 629.9 674.5 1939.2 2239.4 2282.9 1892.0 1285.6 1783.6 2426.6 MYBPHL ENSG00000221986 "Myosin binding protein H like" A2RUH7 1 109292365-109307011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "heart muscle: 86.1" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 156.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;RH-30: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA077633 Approved Vesicles NA NA Vesicles "HPA077633: " "unprognostic (6.07e-3)" "unprognostic (1.43e-1)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.24e-2)" "unprognostic (5.53e-2)" "unprognostic (5.89e-1)" "unprognostic (5.22e-3)" "unprognostic (4.10e-1)" "unprognostic (7.05e-9)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (5.81e-2)" "unprognostic (2.64e-1)" 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.7 3.1 0.0 0.1 0.0 0.0 0.0 0.4 0.6 2.3 0.0 86.1 2.3 0.9 0.0 0.0 1.2 0.0 1.0 1.0 1.0 0.0 0.0 0.0 3.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.6 0.0 0.1 0.0 0.7 0.0 0.5 0.5 0.9 0.0 0.0 0.6 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.7 3.1 2.3 0.9 1.0 1.0 1.0 1.0 0.7 0.9 2.8 0.0 0.0 5.1 0.3 0.0 0.0 0.1 0.7 0.0 1.8 0.1 0.1 156.7 0.0 1.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 3.1 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 2.2 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.8 11.1 0.0 25.0 1.6 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.4 PPT2 ENSG00000221988 "Palmitoyl-protein thioesterase 2" Q9UMR5 6 32153441-32163678 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 33.6;Smooth muscle cells: 27.8;Syncytiotrophoblasts: 23.3" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 21.3;HEK 293: 27.9;SK-MEL-30: 29.4" HPA000414 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA000414: " "unprognostic (1.90e-2)" "unprognostic (1.09e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.03e-5)" "unprognostic (1.62e-1)" "unprognostic (6.75e-3)" "unprognostic (2.92e-3)" "unprognostic (6.41e-3)" "unprognostic (7.12e-2)" "unprognostic (2.56e-3)" "unprognostic (5.28e-3)" "unprognostic (1.12e-2)" "unprognostic (2.75e-3)" "unprognostic (5.09e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.24e-3)" 18.6 18.1 1.2 2.1 1.2 0.1 18.9 1.2 4.8 26.1 1.2 21.8 1.7 22.1 2.6 28.4 21.8 0.0 24.5 1.2 1.2 20.0 14.1 14.5 1.7 1.2 1.3 1.2 46.5 14.4 0.0 13.8 3.9 1.2 17.3 1.5 6.2 15.1 0.0 19.1 28.9 15.0 1.3 1.2 13.4 21.2 8.4 1.2 1.9 14.7 0.2 1.0 18.2 24.4 1.4 0.0 0.0 0.0 0.4 21.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.2 1.6 0.7 5.3 2.6 5.0 0.0 0.0 27.9 4.0 0.0 0.0 0.0 3.5 1.8 4.0 1.6 0.0 7.3 3.8 0.0 14.9 0.0 1.8 1.7 13.0 4.6 0.0 0.0 0.9 0.0 6.3 5.8 0.0 14.3 0.0 1.6 5.4 8.7 5.2 29.4 15.2 0.0 3.7 0.8 0.0 11.4 0.0 0.0 0.8 12.6 3.0 5.8 2.2 3.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.1 1.2 1.2 1.2 4.8 1.2 1.2 1.2 1.3 1.2 1.2 1.2 1.2 1.4 9.4 0.0 0.5 0.0 0.7 3.3 2.9 2.6 5.7 12.4 4.2 2.9 6.8 2.8 2.8 3.7 16.7 14.5 4.4 2.4 1.9 1.8 0.3 4.5 4.3 7.6 4.9 17.4 0.0 3.0 9.2 6.3 1.5 5.0 0.0 33.6 6.4 4.4 3.0 3.3 0.0 2.6 2.0 1.3 1.3 1.1 4.1 1.1 7.2 0.0 0.2 9.5 3.1 0.0 0.0 1.8 3.8 3.0 1.7 1.4 1.4 3.1 0.6 6.1 0.0 3.6 27.8 4.0 6.7 4.4 2.3 23.3 1.4 5.0 3.0 1.5 OR2A2 "OR2A17P, OR2A2P, OST008" ENSG00000221989 "Olfactory receptor family 2 subfamily A member 2" Q6IF42 7 144109514-144110564 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 5.0;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 5.3" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001053: AB_2666183, HPA068130: AB_2685961" "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 1.6 2.2 3.9 1.5 4.1 0.9 2.8 5.0 4.7 3.6 4.1 2.3 1.8 2.6 2.8 2.1 2.7 2.5 2.7 3.7 3.8 2.4 1.4 2.1 1.8 4.1 4.3 3.4 4.7 3.2 4.2 2.6 1.6 4.2 3.9 2.5 3.8 2.3 2.8 1.0 1.7 1.8 2.4 3.7 2.3 2.9 0.7 4.1 0.9 3.8 1.2 1.5 3.0 2.7 4.7 1.0 0.7 0.2 0.0 0.1 0.0 0.0 1.4 0.5 1.1 0.6 2.3 4.0 0.1 0.8 1.4 1.6 1.8 0.0 0.8 0.9 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 1.0 4.0 2.3 0.0 2.6 0.7 0.0 0.0 4.2 2.5 4.3 0.0 0.0 1.5 3.5 1.2 0.5 1.0 0.0 1.7 2.2 2.3 1.8 5.3 3.7 1.4 3.2 4.3 0.9 1.3 0.0 1.8 1.8 0.0 0.0 3.7 0.0 0.0 0.1 3.3 2.3 0.8 2.0 0.8 0.3 0.9 1.0 0.7 0.7 1.5 0.6 0.9 1.0 0.9 0.7 0.3 0.4 0.5 0.9 3.9 4.1 5.0 4.7 3.7 3.8 4.1 4.3 3.4 4.2 3.7 4.1 4.7 0.8 0.0 0.0 2.6 1.4 0.1 1.0 0.8 3.4 2.5 1.6 1.3 1.6 0.0 0.8 1.8 0.0 0.1 0.4 0.9 1.9 1.4 0.0 1.2 1.9 1.2 4.2 0.8 2.2 1.1 0.9 1.4 1.1 1.3 0.0 4.0 1.8 0.3 0.9 0.0 2.6 1.6 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.0 1.3 0.7 0.0 5.0 3.2 1.0 0.6 0.4 1.0 0.9 1.1 0.7 0.5 1.0 6.6 1.4 1.4 0.2 0.4 1.7 0.3 0.3 1.1 4.0 1.0 0.8 TIAF1 ENSG00000221995 "TGFB1-induced anti-apoptotic factor 1" O95411 17 29073521-29078857 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 37.4" NA NA "unprognostic (1.16e-1)" "unprognostic (8.34e-2)" "unprognostic (7.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.07e-3)" "unprognostic (1.35e-1)" "unprognostic (3.97e-8)" "unprognostic (1.54e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" 2.1 1.7 7.5 1.1 10.7 1.3 2.3 9.1 10.9 3.8 2.6 3.1 1.5 3.1 2.3 4.2 2.4 1.0 5.8 6.7 7.5 2.6 9.1 2.5 1.4 12.1 10.0 5.8 2.8 2.3 0.5 3.0 0.7 13.3 3.5 1.2 3.0 2.1 0.9 6.7 4.1 3.1 1.1 6.8 3.5 2.4 2.3 9.4 1.4 2.2 1.1 1.7 2.4 4.1 16.0 0.6 0.2 1.0 0.5 0.6 0.7 0.7 0.7 0.3 0.4 0.4 0.8 0.8 0.5 0.5 0.9 0.9 1.7 0.7 0.7 0.9 0.7 0.4 0.2 1.4 0.6 0.2 0.9 0.7 0.5 0.4 1.1 0.3 2.0 0.2 1.6 1.9 1.2 0.6 0.5 0.8 1.9 0.1 37.4 0.6 7.0 0.5 0.8 1.2 0.4 0.7 0.3 0.3 3.3 0.3 2.1 0.5 2.9 0.2 0.6 0.6 0.3 0.5 0.4 0.9 0.3 0.8 0.8 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.5 0.1 0.2 0.4 0.0 0.0 7.5 10.7 9.1 10.9 6.7 7.5 12.1 10.0 5.8 13.3 6.8 9.4 16.0 0.5 3.2 2.0 0.0 0.1 0.4 0.3 0.0 0.0 1.6 0.2 0.1 0.9 0.0 0.6 0.0 0.0 0.1 1.7 0.3 0.0 0.1 0.4 0.1 0.3 0.5 0.0 0.0 0.0 0.2 0.3 0.6 1.1 0.1 0.0 1.1 1.1 0.9 0.9 0.0 0.0 0.6 0.0 0.6 0.4 0.2 0.0 0.6 0.0 0.0 0.4 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.9 6.6 0.5 0.4 0.2 0.2 0.5 0.3 0.0 0.3 0.3 0.2 0.8 OR52B4 ENSG00000221996 "Olfactory receptor family 52 subfamily B member 4" Q8NGK2 11 4367263-4368386 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;HUVEC TERT2: 5.1;TIME: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 2.0 4.4 0.6 1.1 0.6 0.9 1.4 0.7 1.1 3.7 7.5 1.0 0.4 5.4 0.7 0.7 4.0 1.2 1.8 0.5 3.2 1.4 0.8 2.3 0.4 3.2 1.6 0.2 4.3 0.6 1.5 5.3 0.8 1.3 1.3 0.4 0.0 0.8 1.3 0.4 0.5 1.1 1.7 1.5 0.9 1.0 0.7 1.2 0.1 3.2 0.4 0.3 1.1 2.1 2.7 0.1 0.9 0.8 0.8 1.7 2.0 0.6 1.7 1.0 0.7 1.6 0.0 0.7 0.0 0.7 2.9 0.4 0.2 0.0 0.8 0.3 0.8 0.1 1.6 0.3 0.9 1.8 0.0 1.2 3.0 0.1 2.9 0.5 5.4 5.1 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 0.9 1.0 0.0 0.0 11.9 3.0 2.3 1.4 1.3 0.4 0.1 0.0 1.8 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.7 1.1 0.5 3.2 3.2 1.6 0.2 1.3 1.5 1.2 2.7 5.8 3.2 4.2 0.0 1.4 2.0 1.9 0.8 3.4 0.1 4.2 1.8 1.3 1.5 2.9 1.8 0.0 0.4 1.2 2.6 0.0 0.9 0.6 3.8 6.8 5.2 0.0 0.4 0.6 0.6 0.4 6.2 2.0 7.3 2.5 1.1 6.1 3.3 2.9 0.0 0.3 1.7 0.0 5.9 6.2 0.1 3.1 8.1 3.6 1.9 0.5 1.1 0.0 0.5 0.1 1.0 1.4 1.2 2.3 1.1 2.6 3.3 1.5 0.1 0.0 9.3 4.5 1.0 0.2 2.1 2.3 1.2 2.7 4.1 1.0 1.4 FAM185A MGC35361 ENSG00000222011 "Family with sequence similarity 185 member A" Q8N0U4 7 102748971-102809225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 64.0;Excitatory neurons: 132.4;Inhibitory neurons: 134.5;Microglial cells: 63.7;Oligodendrocyte precursor cells: 70.9;Oligodendrocytes: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020470, HPA029883" Uncertain Approved Cytosol NA NA Cytosol "HPA020470: AB_1853890, HPA029883: AB_10601903" "unprognostic (8.28e-2)" "unprognostic (2.28e-1)" "unprognostic (8.19e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (6.06e-2)" "unprognostic (1.63e-2)" "unprognostic (1.59e-3)" "unprognostic (3.97e-2)" "unprognostic (4.45e-2)" "unprognostic (7.11e-2)" "unprognostic (2.03e-1)" "prognostic favorable (9.36e-5)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (2.13e-3)" "unprognostic (5.25e-2)" 0.8 1.2 0.5 0.6 0.5 0.8 0.8 0.9 0.8 1.2 0.4 0.9 0.4 0.8 0.4 1.0 0.7 0.4 1.0 0.3 0.4 1.2 2.8 0.6 0.4 0.6 0.5 0.2 1.0 1.3 1.5 0.7 0.5 0.3 1.2 0.7 1.2 0.8 0.8 3.5 1.2 0.8 0.5 0.2 0.6 1.9 0.4 0.5 0.7 0.9 2.0 0.4 1.3 1.0 1.2 0.6 2.0 0.4 2.4 0.4 0.9 1.5 0.6 1.3 0.3 0.0 1.7 2.1 0.6 0.9 0.6 1.5 2.3 1.0 0.9 0.4 1.2 0.1 0.2 0.2 2.8 0.6 0.9 1.1 0.0 1.8 0.0 0.4 1.5 0.6 0.5 1.0 1.1 1.1 3.2 2.1 0.6 0.9 2.7 0.5 0.2 0.0 6.7 0.2 1.4 0.4 1.7 4.0 4.5 0.1 0.0 2.7 0.0 1.6 0.2 1.1 2.1 0.4 3.1 1.4 0.6 0.4 0.6 0.2 0.0 1.4 1.9 1.1 1.2 1.1 2.2 0.7 1.0 1.6 0.8 0.9 0.7 3.7 0.8 0.5 1.2 0.8 0.4 0.5 0.5 0.9 0.8 0.3 0.4 0.6 0.5 0.2 0.3 0.2 0.5 1.2 2.9 3.2 1.5 64.0 5.1 4.2 8.1 5.8 9.6 8.8 5.1 3.6 6.3 11.5 6.0 0.0 10.4 13.8 5.6 2.0 19.6 4.6 5.4 5.0 3.8 4.0 1.2 9.4 132.4 2.3 6.5 4.0 9.2 4.1 0.0 7.0 6.4 7.4 4.4 5.0 134.5 3.2 6.1 2.8 1.4 3.3 7.2 3.3 7.2 63.7 3.2 4.9 2.1 70.9 89.2 2.5 1.7 5.3 6.3 3.8 4.6 11.1 3.0 21.4 13.1 4.3 4.1 9.2 5.1 6.7 4.5 8.1 4.1 7.0 3.6 7.0 RAB6C WTH3 ENSG00000222014 "RAB6C, member RAS oncogene family" Q9H0N0 2 129979666-129982738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;breast: 2.5;parathyroid gland: 3.6" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 10.3;Oligodendrocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 0.7;prostate cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1" HPA059131 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (3.84e-2)" "unprognostic (5.77e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (8.62e-2)" "unprognostic (1.83e-1)" "unprognostic (1.98e-1)" "unprognostic (1.38e-2)" "unprognostic (1.50e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (6.04e-2)" "unprognostic (1.24e-1)" "unprognostic (4.78e-1)" 0.1 0.6 1.1 0.1 1.9 0.0 2.5 0.6 2.2 1.9 0.6 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.1 1.5 1.5 0.1 0.0 0.0 0.0 1.3 1.8 1.0 0.1 0.0 3.6 0.2 0.3 1.8 1.7 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.5 0.5 0.0 0.9 1.3 0.0 0.1 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.5 3.2 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.6 2.2 1.5 1.5 1.3 1.8 1.0 1.8 0.5 1.3 3.8 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.3 0.0 0.0 0.9 0.1 10.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.1 1.7 1.0 0.0 0.0 0.7 0.0 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.4 0.0 0.3 0.4 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.7 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.6 1.4 1.4 1.3 0.0 1.1 0.5 0.1 0.1 0.1 0.3 FAM243A C21orf140 ENSG00000222018 "Family with sequence similarity 243 member A" B9A014 21 34400112-34401072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;hTERT-RPE1: 1.2;T-47d: 1.0" "Not detected" "Not detected" HPA045123 Uncertain NA NA "HPA045123: AB_10961912" 1.1 0.9 0.2 0.3 0.3 0.0 1.2 0.2 1.2 1.9 0.3 1.5 0.0 1.6 0.0 0.6 1.5 0.3 1.1 0.2 0.4 1.2 1.0 1.1 0.3 0.2 0.3 0.2 2.0 1.1 0.0 1.6 0.1 0.5 1.6 0.0 1.4 1.4 0.0 1.1 0.8 1.0 0.0 0.1 1.2 3.8 5.5 0.1 0.0 2.0 0.0 0.0 1.4 1.5 0.8 0.1 0.0 0.4 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.8 0.2 1.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.1 0.7 0.0 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 1.0 0.5 0.1 0.1 0.2 0.0 0.2 0.3 0.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.2 0.2 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMB11 beta5t ENSG00000222028 "Proteasome subunit beta 11" A5LHX3 14 23042212-23044060 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "lymphoid tissue: 30.9" "Group enriched" "Detected in some" 10 "Early spermatids: 2.4;Late spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA028967, HPA056970" Enhanced NA NA "HPA028967: AB_2732444, HPA056970: AB_2683293" "unprognostic (7.96e-2)" "unprognostic (2.77e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEM "ACT, P704P, POTE14beta" ENSG00000222036 "POTE ankyrin domain family member M" A6NI47 14 18967434-19003752 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "prostate: 18.9" "Cell type enhanced" "Detected in single" "Langerhans cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.2;K-562: 4.2;U-2 OS: 7.4" NA NA "unprognostic (6.16e-2)" 0.1 0.3 0.5 0.2 0.4 0.2 0.3 0.5 0.9 0.2 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.5 0.3 0.1 0.0 0.2 0.2 0.5 0.4 0.1 0.3 0.2 0.1 0.0 0.4 0.6 18.9 0.1 1.1 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.2 4.2 0.2 0.1 0.6 0.1 0.1 0.1 0.0 0.9 0.7 0.7 0.3 0.6 0.1 0.1 3.2 0.3 0.1 0.1 0.1 0.6 0.1 0.4 0.4 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.2 0.3 1.0 1.0 0.0 0.3 0.8 0.1 0.2 0.4 0.0 0.2 0.1 0.1 4.2 1.8 0.2 0.7 0.4 0.3 0.8 0.0 0.5 0.3 0.3 0.8 0.2 0.2 0.2 1.1 0.3 1.7 0.1 0.9 2.1 0.2 0.5 0.3 7.4 0.4 0.3 0.8 1.5 0.1 0.2 0.3 0.4 0.7 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.5 0.4 0.5 0.9 0.5 0.3 0.5 0.4 0.1 0.6 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 POTEJ POTE2beta ENSG00000222038 "POTE ankyrin domain family member J" P0CG39 2 130611440-130658037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (8.11e-2)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "unprognostic (3.55e-1)" "unprognostic (3.35e-1)" "unprognostic (2.07e-2)" "unprognostic (5.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" "unprognostic (1.18e-2)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (3.30e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCDC2B ENSG00000222046 "Doublecortin domain containing 2B" A2VCK2 1 32209094-32216196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "fallopian tube: 27.9" "Group enriched" "Detected in some" 6 "Endometrial ciliated cells: 31.7;Respiratory ciliated cells: 112.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045832 Uncertain NA NA "HPA045832: AB_10962048" "unprognostic (6.45e-3)" "unprognostic (3.71e-2)" "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (1.87e-3)" "unprognostic (7.66e-3)" "unprognostic (6.35e-2)" "unprognostic (4.84e-2)" "unprognostic (3.33e-1)" "unprognostic (2.71e-3)" "unprognostic (8.73e-2)" "unprognostic (6.18e-4)" "unprognostic (8.53e-2)" "unprognostic (2.00e-1)" "unprognostic (4.76e-2)" "unprognostic (4.39e-3)" 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.4 0.8 0.0 0.0 0.3 0.0 0.0 27.9 0.3 0.0 0.1 0.3 0.0 0.0 1.7 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.5 1.0 0.1 0.0 0.0 4.4 0.0 2.8 0.2 0.4 0.0 0.0 7.9 1.8 4.2 0.1 0.0 0.1 0.0 0.0 7.4 31.7 0.5 0.3 0.0 0.0 1.3 0.0 0.0 0.5 0.5 0.5 1.3 0.1 0.0 0.0 0.0 3.3 1.1 0.1 10.2 0.0 0.0 11.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 112.0 4.6 0.0 0.2 1.9 2.5 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 IGLV9-49 ENSG00000223350 "Immunoglobulin lambda variable 9-49" A0A0B4J1Y8 22 22343187-22343732 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 126.7;lymphoid tissue: 119.0" "Cell type enriched" "Detected in some" 20 "Plasma cells: 46.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 672 "memory B-cell: 70.3;naive B-cell: 88.1" "Lineage enriched" "Detected in single" 747 "B-cells: 88.1" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 43000000 "prognostic favorable (3.04e-5)" "unprognostic (4.30e-3)" "unprognostic (1.83e-2)" "unprognostic (5.61e-2)" "prognostic favorable (2.00e-5)" "unprognostic (6.29e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.12e-8)" "unprognostic (1.66e-1)" "unprognostic (3.07e-1)" "unprognostic (3.90e-2)" "unprognostic (7.16e-2)" 2.2 126.7 0.0 14.8 0.0 9.8 6.1 0.1 0.5 3.3 0.0 33.9 36.8 2.2 0.0 6.1 3.3 1.1 1.2 0.2 0.1 1.0 4.5 44.2 119.0 0.2 0.0 0.0 3.3 1.4 0.0 0.1 0.1 0.2 0.9 15.2 0.0 30.0 1.0 0.1 0.1 28.5 0.4 0.0 66.4 46.7 2.0 0.0 14.2 3.4 0.2 98.7 39.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.1 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.1 0.5 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 285 "basophil: 28.5" "Lineage enriched" "Detected in single" 285 "granulocytes: 28.5" "Not detected" "Not detected" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L2 DUB3 ENSG00000223443 "Ubiquitin specific peptidase 17 like family member 2" Q6R6M4 8 12137168-12139077 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "brain: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" "unprognostic (2.01e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.6 0.4 1.3 0.9 1.5 0.0 1.1 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EXOSC6 "EAP4, hMtr3p, MTR3, Mtr3p, p11" ENSG00000223496 "Exosome component 6" Q5RKV6 16 70246778-70251940 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.90e-1)" "unprognostic (3.57e-2)" "unprognostic (6.98e-2)" "unprognostic (3.73e-2)" "unprognostic (7.60e-2)" "unprognostic (1.32e-2)" "unprognostic (1.23e-3)" "unprognostic (2.43e-1)" "unprognostic (1.95e-1)" "unprognostic (1.14e-2)" "unprognostic (8.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.25e-1)" "unprognostic (1.99e-1)" "unprognostic (4.30e-1)" "unprognostic (2.51e-2)" "unprognostic (7.02e-2)" 8.4 11.1 15.5 6.0 14.9 11.2 7.9 14.4 16.2 6.9 3.0 7.4 5.2 8.5 5.9 8.2 7.8 4.2 7.4 13.3 14.0 7.1 10.2 6.5 8.8 15.9 14.3 14.2 8.3 10.3 7.8 10.5 5.0 19.9 7.8 5.3 9.2 7.1 4.9 10.9 10.5 8.4 5.7 9.1 9.7 7.7 5.0 16.0 6.9 11.2 5.1 7.7 7.5 7.3 16.0 7.7 6.5 12.8 18.5 9.1 9.4 14.5 9.3 7.7 11.8 8.7 8.0 9.3 13.6 7.9 8.0 8.8 16.6 9.5 7.1 15.5 6.0 12.7 9.2 6.6 13.6 19.4 17.4 14.8 9.0 21.5 12.2 11.7 6.9 8.6 15.3 14.8 9.4 11.3 11.7 18.2 32.6 14.8 5.3 6.8 30.2 7.7 12.3 9.9 6.6 18.1 18.8 30.4 7.4 13.5 9.3 12.5 13.0 12.4 21.3 13.9 13.6 12.4 16.5 15.3 30.7 8.1 11.6 20.9 5.2 2.2 2.4 3.8 3.2 3.7 3.5 3.9 3.5 1.9 4.3 4.5 4.3 2.1 4.9 3.0 6.2 3.5 1.0 15.5 14.9 14.4 16.2 13.3 14.0 15.9 14.3 14.2 19.9 9.1 16.0 16.0 40.5 22.4 19.7 2.0 41.9 19.5 55.0 3.0 25.6 38.0 25.6 15.2 24.3 28.6 7.9 36.8 41.7 11.4 58.8 18.9 46.9 10.5 1.0 27.2 30.1 29.2 26.9 20.0 2.3 22.6 10.6 27.0 13.7 27.3 8.2 24.6 34.2 33.7 13.7 35.3 2.5 22.3 2.0 23.8 11.4 1.8 19.3 24.3 16.0 3.7 22.5 24.9 24.7 3.0 3.1 19.2 17.2 17.3 23.9 43.2 24.3 64.7 8.1 30.6 59.2 53.6 25.7 4.7 7.0 24.1 25.1 7.7 40.2 32.8 24.3 41.0 VPS52 "ARE1, SACM2L" ENSG00000223501 "VPS52 subunit of GARP complex" Q8N1B4 6 33250272-33272047 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 45.3;THP-1: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042667, HPA048128" Approved NA NA "HPA042667: AB_2678105, HPA048128: AB_2680278" "unprognostic (2.65e-2)" "unprognostic (2.13e-1)" "unprognostic (9.44e-2)" "unprognostic (1.03e-3)" "unprognostic (6.07e-3)" "unprognostic (3.13e-1)" "unprognostic (2.28e-2)" "unprognostic (4.38e-2)" "unprognostic (1.49e-3)" "unprognostic (2.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.17e-1)" "unprognostic (3.33e-2)" "unprognostic (7.63e-2)" 19.8 28.4 2.8 8.3 4.5 3.8 21.8 2.8 4.2 23.5 5.3 22.9 10.0 23.4 8.3 30.1 20.9 7.4 19.3 3.5 3.8 20.8 24.5 18.3 12.5 6.2 3.3 3.1 25.1 25.5 0.0 26.4 3.2 6.4 22.9 6.2 2.9 24.2 2.7 38.2 26.8 25.3 7.0 2.5 27.8 23.9 18.0 6.7 10.5 28.2 23.5 10.1 22.6 24.2 5.8 0.1 6.6 0.4 26.4 9.3 9.2 24.7 0.0 0.0 0.0 0.0 11.1 0.0 0.0 18.1 0.0 10.9 20.2 25.3 0.0 0.0 0.0 2.9 0.0 6.6 13.4 11.2 0.0 24.2 0.0 0.0 0.0 17.8 16.4 11.8 10.5 27.1 2.0 0.0 0.1 0.4 0.0 20.8 11.0 16.7 9.9 4.0 27.5 15.0 17.4 0.0 16.3 13.1 45.3 14.4 0.0 0.8 39.1 0.0 13.7 7.0 16.0 22.2 0.0 0.0 18.7 0.0 11.5 0.0 5.7 4.5 4.1 2.8 3.6 2.1 2.4 3.0 4.1 3.7 2.2 3.3 4.0 2.0 4.9 2.9 1.7 4.5 4.2 2.8 4.5 2.8 4.2 3.5 3.8 6.2 3.3 3.1 6.4 2.5 6.7 5.8 8.4 12.8 13.0 18.9 8.8 6.6 6.3 9.0 10.8 13.0 12.2 10.4 1.3 10.0 9.3 3.7 2.1 16.7 6.9 17.7 7.9 11.0 7.8 10.0 8.8 8.7 7.2 7.8 10.7 11.8 16.0 7.3 18.3 14.2 1.3 10.7 11.4 19.1 11.4 6.7 11.1 14.5 12.2 14.1 4.6 7.2 6.8 8.5 7.2 15.9 11.4 13.3 2.1 7.5 16.4 9.7 7.7 9.1 14.2 4.3 13.7 8.9 10.6 12.6 13.1 7.0 6.9 25.7 14.2 15.4 8.7 17.6 6.6 8.4 12.5 6.4 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.1" "Group enriched" "Detected in some" 24 "Early spermatids: 117.5;Late spermatids: 88.5;Spermatocytes: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 3.8" HPA055952 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055952: AB_2682983" "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.4 0.3 1.2 0.1 0.6 0.1 1.3 0.4 0.2 0.2 0.2 0.8 0.2 0.2 0.3 0.1 0.4 0.3 0.3 0.0 0.1 0.4 0.3 2.7 0.5 0.2 0.0 0.4 0.2 0.0 0.1 0.1 1.0 0.2 0.0 0.4 0.7 0.0 0.1 3.4 0.8 0.0 0.0 0.9 0.4 21.1 0.4 0.0 0.5 0.0 0.0 0.1 0.2 0.6 0.7 1.3 0.9 2.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 2.5 0.3 2.1 0.4 0.0 0.3 0.9 0.0 0.0 0.0 2.1 3.8 1.2 2.6 1.8 0.0 1.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 1.0 1.0 0.4 0.0 0.5 1.0 1.6 0.8 1.5 1.2 0.8 0.3 0.8 0.0 1.0 1.0 1.8 0.2 0.5 0.3 2.7 0.4 0.5 1.1 3.2 0.4 0.8 0.9 0.7 0.8 0.9 0.5 1.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 1.3 0.4 0.3 0.0 0.5 0.2 0.0 1.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.5 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF844 FLJ14959 ENSG00000223547 "Zinc finger protein 844" Q08AG5 19 12064731-12081565 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/84: 11.7" HPA046982 Approved NA NA "HPA046982: AB_10964399" "unprognostic (2.07e-1)" "unprognostic (1.50e-2)" "unprognostic (1.75e-1)" "unprognostic (8.95e-2)" "unprognostic (2.92e-3)" "unprognostic (9.68e-3)" "unprognostic (1.93e-1)" "unprognostic (1.87e-2)" "unprognostic (1.86e-2)" "unprognostic (5.86e-2)" "unprognostic (2.47e-2)" "unprognostic (6.74e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.99e-1)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (3.63e-2)" 3.1 2.0 3.3 1.8 4.7 3.9 4.7 7.7 3.6 3.9 4.5 3.6 1.9 3.9 3.8 2.9 5.0 1.5 5.4 3.3 3.4 7.1 2.9 2.6 2.1 4.3 3.9 2.8 8.6 3.3 7.4 3.2 2.5 4.4 3.7 3.0 12.0 5.2 3.5 3.4 3.5 2.6 2.8 3.3 2.8 3.0 3.7 4.3 1.6 7.8 4.6 1.9 4.2 3.5 7.1 0.0 0.1 1.3 3.4 2.5 1.5 1.3 1.8 0.3 1.6 0.9 3.4 0.6 2.0 2.2 1.7 1.4 1.0 0.0 0.3 1.2 0.1 0.1 4.2 0.3 0.8 2.2 0.2 3.0 1.9 0.2 0.9 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.1 1.6 0.8 1.8 0.0 0.1 0.2 4.5 0.5 0.9 0.1 1.4 1.0 0.0 1.5 0.6 2.4 3.6 0.1 0.1 0.6 1.5 1.9 1.9 3.8 11.7 0.2 0.1 0.2 0.3 3.2 0.5 1.2 0.4 0.8 0.2 0.6 0.2 0.2 0.2 0.6 0.4 0.4 1.9 0.7 0.4 0.2 0.1 0.3 3.3 4.7 7.7 3.6 3.3 3.4 4.3 3.9 2.8 4.4 3.3 4.3 7.1 20.0 16.0 11.5 4.2 16.0 2.4 5.6 2.2 10.8 19.2 16.2 16.3 31.5 14.3 11.1 3.7 33.3 4.1 6.8 14.0 5.9 3.9 2.8 9.9 15.5 10.2 14.4 2.1 1.7 3.3 3.4 13.4 17.3 13.5 19.6 11.6 7.5 4.2 6.4 25.2 0.6 8.4 2.0 6.2 4.0 2.8 3.7 9.7 7.2 3.7 3.3 12.5 7.2 7.1 3.6 1.4 7.6 6.8 6.4 6.9 5.9 7.4 7.7 60.6 0.0 31.5 12.6 19.2 8.7 14.0 3.3 5.2 5.8 3.1 6.9 5.4 USP17L15 ENSG00000223569 "Ubiquitin specific peptidase 17 like family member 15" C9J2P7 4 9234385-9236046 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 102 "brain: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 7.5 0.0 4.7 0.0 0.0 0.4 9.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 5.7 0.0 0.0 0.0 0.0 12.8 6.1 5.8 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 4.7 0.4 9.8 8.4 5.7 12.8 6.1 5.8 14.6 1.3 8.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CKMT1A CKMT1 ENSG00000223572 "Creatine kinase, mitochondrial 1A" P12532 15 43692886-43699222 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 84.5;intestine: 75.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 73.0;Distal enterocytes: 110.5;Intestinal goblet cells: 53.4;Paneth cells: 57.4;Proximal enterocytes: 94.5;Syncytiotrophoblasts: 94.0;Undifferentiated cells: 92.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 127.5;hTCEpi: 56.8;OE19: 144.3;SK-BR-3: 107.8;T-47d: 100.3" HPA043491 Uncertain "Intracellular and membrane" NA NA 2000000 "HPA043491: AB_2678510" "unprognostic (2.04e-2)" "unprognostic (2.53e-2)" "unprognostic (1.17e-1)" "unprognostic (4.02e-3)" "unprognostic (3.80e-1)" "unprognostic (7.44e-2)" "unprognostic (2.21e-1)" "unprognostic (3.10e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.51e-2)" "unprognostic (3.78e-9)" "unprognostic (3.52e-2)" "unprognostic (1.03e-1)" "unprognostic (7.37e-2)" "unprognostic (1.73e-3)" 1.0 3.8 19.3 7.2 26.0 0.0 7.7 33.4 50.0 5.1 15.1 75.7 71.3 0.5 0.4 84.5 2.1 9.5 0.5 23.6 29.3 6.0 0.2 0.9 0.1 27.3 25.2 27.8 0.1 3.5 12.4 8.6 9.6 29.5 4.4 70.0 32.1 31.6 1.1 0.1 38.3 63.7 3.4 15.5 0.1 23.5 0.3 28.9 0.2 2.8 0.0 14.9 8.4 26.3 47.5 0.3 2.9 0.7 0.1 1.3 0.0 31.9 0.0 0.0 0.0 0.0 6.8 22.1 0.1 1.4 0.0 2.4 127.5 22.4 39.0 0.0 0.0 17.1 0.0 2.1 0.7 0.0 0.0 6.1 0.2 56.8 0.0 10.3 0.0 0.0 5.0 5.7 0.1 0.0 34.8 0.0 0.2 10.1 144.3 8.2 0.1 0.0 6.7 6.7 4.7 47.1 20.0 0.0 107.8 8.6 2.9 100.3 0.8 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 26.0 33.4 50.0 23.6 29.3 27.3 25.2 27.8 29.5 15.5 28.9 47.5 0.1 0.0 0.0 2.3 0.3 17.7 10.5 30.3 1.8 6.7 4.2 5.2 0.5 10.0 14.9 1.8 20.9 73.0 0.1 110.5 27.4 4.2 0.0 0.7 0.0 0.3 18.0 0.0 10.6 20.2 23.5 0.4 26.0 0.8 8.9 1.5 0.0 0.0 4.5 6.7 9.0 53.4 12.2 0.0 0.7 0.2 0.0 0.0 5.4 1.0 0.0 4.8 0.0 1.5 1.6 12.9 57.4 0.0 0.0 2.7 94.5 1.0 4.1 11.6 0.0 0.0 0.9 0.0 0.1 16.1 18.5 94.0 0.4 0.0 92.7 20.1 TINCR "FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2" ENSG00000223573 "TINCR ubiquitin domain containing" 19 5558167-5578349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "skin 1: 120.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.4;Cytotrophoblasts: 61.0;Extravillous trophoblasts: 116.9;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 92.2;Syncytiotrophoblasts: 204.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 53.3;HaCaT: 35.9;MCF7: 14.9;SK-BR-3: 56.1" NA NA "unprognostic (4.75e-2)" "unprognostic (2.99e-2)" "unprognostic (7.78e-2)" "unprognostic (1.78e-3)" "unprognostic (3.69e-1)" "unprognostic (2.54e-3)" "unprognostic (3.38e-2)" "unprognostic (3.95e-1)" "unprognostic (3.07e-1)" "unprognostic (1.66e-2)" "unprognostic (8.87e-2)" "unprognostic (1.24e-1)" "unprognostic (0.00e+0)" "unprognostic (4.22e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (7.32e-2)" 0.7 1.9 6.9 0.7 6.5 2.9 3.7 4.0 6.8 2.9 1.3 2.0 0.5 0.6 1.5 21.3 0.7 0.5 0.5 4.6 3.9 1.1 0.1 2.9 0.9 4.2 7.6 7.7 0.6 0.3 0.3 3.0 18.0 4.7 4.7 2.5 2.8 4.3 0.8 0.9 120.1 0.9 0.4 1.1 0.9 0.3 1.7 9.8 0.2 0.6 0.0 5.0 1.4 13.8 4.6 2.0 1.6 0.2 0.6 0.5 1.0 53.3 0.2 0.1 0.1 0.2 0.9 6.3 0.3 0.5 0.2 0.5 35.9 0.6 0.1 0.4 0.6 1.2 0.4 1.9 0.5 0.1 0.7 0.5 0.0 11.5 0.3 0.3 0.3 0.0 2.9 0.3 0.8 0.1 14.9 0.2 0.8 1.0 1.4 2.5 1.2 0.4 1.3 0.0 3.8 0.7 0.1 3.9 56.1 5.6 5.0 6.7 0.5 0.0 0.6 0.5 1.0 0.1 1.4 0.4 1.0 0.3 0.7 1.1 3.2 0.4 0.5 0.4 0.3 0.3 0.9 0.3 0.3 0.1 0.9 0.3 0.4 2.3 0.6 0.4 1.3 0.4 0.2 6.9 6.5 4.0 6.8 4.6 3.9 4.2 7.6 7.7 4.7 1.1 9.8 4.6 2.1 12.8 1.7 0.3 0.6 46.4 5.2 2.9 21.1 4.2 6.1 3.2 1.3 4.3 2.6 1.8 0.0 61.0 1.4 3.3 11.7 0.0 0.4 1.2 1.8 2.4 1.8 0.0 0.8 0.5 116.9 1.7 0.0 2.6 0.0 0.5 2.9 0.3 6.6 0.0 1.2 3.0 4.1 1.4 4.6 0.2 0.6 1.2 7.2 0.0 0.5 3.5 1.0 0.0 0.2 0.1 7.5 0.7 0.1 5.9 0.1 0.4 1.9 2.1 0.0 3.6 1.3 1.0 3.1 53.3 92.2 204.5 1.1 0.2 0.9 10.1 CENPVL1 "CENPVP1, PRR6L1" ENSG00000223591 "Centromere protein V like 1" A0A0U1RR11 X 51710512-51712131 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 2.5;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 1.1 0.0 2.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 1.0 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.5 0.0 1.1 0.3 2.0 1.0 0.9 0.6 0.6 0.4 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EBLN1 ENSG00000223601 "Endogenous Bornavirus like nucleoprotein 1" P0CF75 10 22208814-22210021 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 2.8" "Group enriched" "Detected in some" 10 "Early spermatids: 21.3;Late spermatids: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "GAMG: 1.0" NA NA "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 57 "bone marrow: 2820.5" "Cell type enriched" "Detected in some" 318 "Erythroid cells: 22112.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5" "CAB037087, HPA043234" Supported NA NA 6600000000 "CAB037087: AB_260051, HPA043234: AB_2678378" "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 1.3 0.3 0.9 0.6 0.9 2820.5 0.7 1.3 3.1 0.1 1.8 0.5 0.0 0.1 0.0 0.3 2.8 0.1 2.0 0.9 0.8 3.1 7.5 6.2 0.5 1.0 1.2 0.9 0.3 0.2 4.6 2.2 19.7 1.1 0.2 0.4 0.1 2.2 0.3 0.5 0.7 0.2 0.0 1.0 49.5 0.3 0.1 0.8 4.3 1.0 11.6 0.2 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 74.5 0.0 0.0 0.0 0.3 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.4 25.5 0.0 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.2 0.0 1.6 0.0 105.0 0.9 0.9 1.3 3.1 0.9 0.8 1.0 1.2 0.9 1.1 1.0 0.8 1.4 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 22112.3 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 13.6 13.4 0.1 0.0 0.0 0.0 0.0 16.9 1.9 0.1 0.0 6.2 69.4 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 SUPT20HL2 FAM48B2 ENSG00000223611 "SUPT20H like 2" P0C7V6 X 24310862-24314079 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.65e-2)" "unprognostic (2.98e-1)" "unprognostic (1.05e-2)" "unprognostic (4.63e-1)" 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF735 ZNF735P ENSG00000223614 "Zinc finger protein 735" P0CB33 7 64207090-64220508 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL4A "RFPL4, RNF210" ENSG00000223638 "Ret finger protein like 4A" A6NLU0 19 55759014-55763175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.4;liver: 3.4;testis: 1.6" "Cell type enhanced" "Detected in some" "Early spermatids: 1.1;Langerhans cells: 1.4" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 9.7" "Group enriched" "Detected in many" 4 "dendritic cells: 3.1;monocytes: 9.7" "Cell line enriched" "Detected in some" 20 "U-2 OS: 68.4" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (3.74e-1)" "unprognostic (2.96e-2)" "unprognostic (9.20e-2)" 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 3.4 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 68.4 0.0 0.2 0.4 0.4 0.2 0.0 0.0 0.0 0.0 9.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 1.4 0.0 0.7 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 IGHV3-64 ENSG00000223648 "Immunoglobulin heavy variable 3-64" A0A075B6Q5 14 106657725-106658258 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 32.4;salivary gland: 21.2" "Cell type enriched" "Detected in some" 38 "Plasma cells: 88.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 19 "memory B-cell: 11.1" "Lineage enriched" "Detected in single" 111 "B-cells: 11.1" "Cell line enhanced" "Detected in single" "HL-60: 1.1" "Immunoglobulin genes" NA NA 4300000000 "prognostic favorable (6.09e-6)" "unprognostic (6.52e-2)" "unprognostic (2.11e-3)" "unprognostic (3.10e-2)" "unprognostic (1.39e-3)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (8.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.33e-1)" "unprognostic (2.52e-1)" "prognostic unfavorable (3.93e-5)" "unprognostic (1.58e-1)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.07e-2)" 0.9 0.1 0.0 2.0 0.0 8.7 7.2 0.0 0.4 0.5 0.0 11.8 7.0 0.9 0.0 1.2 1.9 4.2 1.2 0.0 0.0 0.7 2.3 4.3 0.0 0.0 0.0 0.0 3.3 3.6 0.0 0.1 0.0 0.0 0.6 1.2 0.0 21.2 0.4 0.0 0.0 11.4 1.3 0.0 32.4 6.1 0.0 0.0 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 C1GALT1C1L ENSG00000223658 "C1GALT1 specific chaperone 1 like" P0DN25 2 43675151-43676429 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 7.0;Muller glia cells: 5.1;Spermatocytes: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.1;U-2 OS: 8.2" NA NA "unprognostic (2.18e-1)" "unprognostic (3.71e-2)" "unprognostic (2.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.32e-1)" "unprognostic (5.71e-3)" "unprognostic (2.19e-3)" "unprognostic (4.91e-2)" "unprognostic (2.78e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (3.81e-3)" "unprognostic (8.88e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-2)" 1.4 1.8 0.9 0.4 1.1 0.0 2.1 1.2 1.1 1.7 0.9 1.8 0.3 4.1 6.0 0.3 1.1 0.6 2.3 0.9 1.6 1.8 0.1 0.3 0.2 1.1 1.1 0.8 1.1 1.0 2.0 0.7 0.9 1.0 1.5 0.7 3.9 1.2 2.4 0.5 0.4 0.5 3.2 1.1 0.3 0.5 5.9 0.9 0.2 1.2 0.8 0.3 1.0 0.7 1.1 0.0 0.3 0.0 0.0 2.4 1.2 0.1 0.2 0.4 0.8 1.0 0.5 3.8 0.0 3.7 0.3 3.3 0.3 0.0 0.2 2.0 0.0 2.9 1.7 1.1 0.8 0.8 0.0 0.0 1.6 0.6 2.5 0.1 1.3 2.6 0.0 2.0 0.0 0.2 4.0 0.0 3.7 0.0 0.0 0.0 0.0 1.4 0.0 3.2 0.8 0.1 13.1 0.0 0.2 2.7 0.3 0.9 2.7 0.0 3.3 8.2 0.2 0.8 0.0 2.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 1.2 1.1 0.9 1.6 1.1 1.1 0.8 1.0 1.1 0.9 1.1 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.8 1.0 0.5 1.0 0.5 2.8 0.6 0.0 0.0 0.3 0.1 0.0 0.0 1.3 2.8 1.0 7.0 0.5 0.0 0.0 0.0 0.6 0.3 2.4 0.0 0.3 0.0 1.6 0.7 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.1 0.1 0.2 1.5 3.7 0.0 1.9 2.1 18.8 2.4 0.2 0.0 0.1 0.0 2.2 0.3 0.1 SUPT20HL1 "FAM48B1, SPT20L" ENSG00000223731 "SUPT20H like 1" X 24362325-24365424 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HDLM-2: 2.4" NA NA "unprognostic (2.93e-1)" "unprognostic (1.14e-2)" "unprognostic (1.15e-2)" "unprognostic (6.98e-2)" "unprognostic (6.19e-3)" "unprognostic (1.36e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 288.3;choroid plexus: 74.8" "Cell type enriched" "Detected in some" 5 "Late spermatids: 126.6" "Group enriched" "Detected in many" 5 "glioma: 13.5;melanoma: 4.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 32.1;HEK 293: 34.7;NB-4: 39.3;NTERA-2: 25.2" HPA045724 Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 0.9 3.1 190.1 0.8 203.8 0.2 0.6 242.3 218.3 2.0 74.8 2.6 0.1 0.7 0.5 1.0 0.7 2.5 2.9 196.1 177.3 0.3 0.2 0.5 0.0 288.3 211.2 151.5 2.8 0.9 2.9 12.9 0.3 226.5 1.5 0.3 4.9 0.9 0.5 21.5 0.6 1.0 1.5 230.7 0.2 1.3 29.6 221.9 0.3 1.1 12.4 0.1 1.7 1.7 238.2 0.2 3.3 19.1 32.1 1.1 0.4 0.8 2.2 0.1 5.4 3.9 15.7 1.2 0.1 22.0 1.4 4.4 0.3 13.8 0.6 2.1 0.0 34.7 0.2 0.7 11.7 2.4 3.4 0.5 1.2 0.2 1.7 0.6 6.0 1.3 0.2 2.2 0.2 3.7 8.4 0.3 39.3 25.2 0.1 0.7 0.2 0.6 0.7 4.1 0.0 17.8 15.8 0.8 0.1 14.1 6.0 5.5 20.5 0.5 0.1 4.3 3.4 4.8 0.7 0.5 0.1 0.2 1.2 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 190.1 203.8 242.3 218.3 196.1 177.3 288.3 211.2 151.5 226.5 230.7 221.9 238.2 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 3.6 0.6 1.3 0.6 0.0 0.0 0.0 2.1 0.0 0.1 0.2 0.0 0.0 21.1 0.3 0.4 0.6 0.0 0.0 0.0 0.2 0.0 1.0 0.0 1.1 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 126.6 1.2 0.2 1.8 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.0 1.6 0.0 1.0 0.4 1.4 2.9 0.0 0.4 0.3 0.1 0.4 0.0 0.0 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075990-33089696 "Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 281.1;lymphoid tissue: 412.7" "Cell type enhanced" "Detected in many" "B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "myeloid DC: 285.5" "Group enriched" "Detected in all" 10 "B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5" "Group enriched" "Detected in some" 6 "HDLM-2: 65.9;REH: 26.5" "HPA011078, HPA058509" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA 470000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: AB_2683737" "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favorable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 127.6 102.1 1.1 42.4 1.2 5.9 113.8 3.2 2.0 61.2 2.2 60.4 12.6 50.7 2.9 44.3 56.2 17.4 50.7 1.0 1.5 84.6 38.9 281.1 67.3 2.0 1.6 0.4 26.5 32.6 1.0 51.9 0.8 2.0 70.9 2.5 1.6 57.7 6.5 25.3 72.5 177.9 4.7 2.0 412.7 54.6 12.9 1.3 11.0 70.1 1.4 42.5 49.6 57.0 3.9 0.0 0.0 0.1 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.2 0.2 0.0 0.1 0.0 0.0 0.0 65.9 1.9 1.5 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.9 0.0 0.0 26.5 0.1 0.3 0.3 0.0 0.9 0.0 0.0 0.3 0.1 0.4 0.0 0.1 1.8 0.1 0.2 0.0 0.0 7.2 0.3 4.4 1.1 0.0 0.0 0.5 59.6 4.0 14.8 137.5 1.8 226.6 5.1 22.2 285.5 227.8 2.3 11.9 1.6 8.2 60.3 77.5 22.7 107.8 1.1 1.2 3.2 2.0 1.0 1.5 2.0 1.6 0.4 2.0 2.0 1.3 3.9 354.8 67.3 330.7 1.3 1569.6 300.5 26.0 5.6 19.4 26.9 54.0 123.6 10.3 67.2 62.3 29.5 16.7 4.8 692.9 7.8 3.9 58.3 3.6 2.0 16.3 297.8 9.6 87.9 1.3 15.6 8.1 62.3 48.4 2.7 61.6 13.6 97.1 8.8 1099.4 8.4 1.6 13.0 10.2 2374.2 12627.8 10.1 27.4 2453.8 323.7 20.6 3754.7 43.3 203.9 2.5 0.2 7.4 10.0 21.1 50.9 28.2 154.7 60.2 54.4 21.9 46.0 21.4 47.5 1.3 7.8 6.4 233.3 9.0 200.7 3.9 23.0 51.7 C1QTNF5 "CTRP5, DKFZp586B0621, LORD" ENSG00000223953 "C1q and TNF related 5" Q9BXJ0 11 119338942-119340940 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Ductal cells: 4.7;Endothelial cells: 1.5;Exocrine glandular cells: 1.1;Fibroblasts: 3.6;Gastric mucus-secreting cells: 1.5;Smooth muscle cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 17.7;fHDF/TERT166: 14.7;HHSteC: 35.8;hTERT-RPE1: 28.5;HUVEC TERT2: 54.7;TIME: 50.5" "Low region specificity" "Detected in all" "CAB025607, HPA038604" Uncertain "Secreted to blood" NA NA 219000000 1500000 "CAB025607: , HPA038604: AB_2676110" 50.0 13.5 18.9 13.0 20.1 0.1 36.9 22.3 20.8 35.1 25.8 22.2 15.0 51.1 7.6 11.6 27.5 45.9 36.1 18.0 27.1 32.7 11.2 42.3 8.9 21.2 21.8 13.5 11.4 18.9 6.8 14.9 13.7 20.3 19.7 7.9 2.2 17.1 8.8 8.9 17.6 24.4 27.0 22.2 32.6 27.3 2.6 26.1 2.8 32.3 15.3 4.6 31.9 21.0 22.5 0.0 0.0 3.3 0.0 17.7 4.9 0.2 4.6 0.3 0.6 2.7 0.1 0.0 0.1 2.0 14.7 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 35.8 0.0 0.0 8.4 0.0 0.3 0.0 28.5 54.7 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.9 0.0 0.1 0.0 4.1 0.0 0.1 0.0 0.0 6.5 0.0 0.0 1.1 0.9 0.0 0.0 50.5 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 20.1 22.3 20.8 18.0 27.1 21.2 21.8 13.5 20.3 22.2 26.1 22.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.0 3.6 1.5 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TRDD1 ENSG00000223997 "T cell receptor delta diversity 1" P0DPR3 14 22438547-22438554 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV3D-15 ENSG00000224041 "Immunoglobulin kappa variable 3D-15" A0A087WSY6 2 90114838-90115402 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 127.9;lymphoid tissue: 204.7;salivary gland: 54.6;stomach 1: 88.2;urinary bladder: 58.5" "Cell type enriched" "Detected in some" 622 "Plasma cells: 3673.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 191 "memory B-cell: 181.1;naive B-cell: 155.6" "Lineage enriched" "Detected in single" 206 "B-cells: 181.1" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7" HPA047702 Approved "Immunoglobulin genes" NA NA 4800000000 "HPA047702: " "prognostic favorable (6.11e-4)" "prognostic favorable (7.46e-4)" "unprognostic (9.16e-3)" "unprognostic (1.74e-1)" "unprognostic (1.90e-3)" "unprognostic (7.20e-2)" "unprognostic (9.19e-2)" "unprognostic (4.93e-1)" "unprognostic (3.42e-2)" "unprognostic (1.41e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (1.82e-6)" "unprognostic (8.99e-2)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.04e-1)" 3.0 4.4 0.1 94.4 0.3 11.2 17.3 0.1 0.5 5.9 0.3 112.6 63.6 1.0 0.0 16.5 5.2 10.2 2.3 0.1 0.1 3.5 2.0 18.2 44.0 0.4 0.3 0.1 18.1 4.0 0.3 0.1 0.0 0.2 1.7 127.9 0.0 54.6 1.2 0.1 0.6 47.1 4.3 0.4 56.7 88.2 0.2 0.1 13.2 4.5 0.0 204.7 58.5 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 181.1 0.0 0.0 0.1 155.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 27.5 0.1 0.3 0.1 0.5 0.1 0.1 0.4 0.3 0.1 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3673.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CPTP "GLTPD1, MGC10334" ENSG00000224051 "Ceramide-1-phosphate transfer protein" Q5TA50 1 1324756-1328896 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 72.5;Late spermatids: 167.1;Proximal enterocytes: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056832 Approved Approved Cytosol NA NA Cytosol "HPA056832: AB_2683251" "unprognostic (9.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.94e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.52e-2)" "unprognostic (1.32e-2)" "unprognostic (2.79e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.27e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-2)" "unprognostic (5.27e-2)" 15.4 19.6 11.8 6.1 10.4 2.8 17.0 10.7 22.3 16.0 10.4 22.1 20.0 14.3 8.6 49.3 12.6 3.7 60.0 12.5 8.1 28.6 70.5 12.7 5.5 13.0 11.6 10.1 10.9 18.7 14.2 8.1 4.6 14.6 19.3 4.9 2.1 37.5 6.6 55.8 32.3 23.4 2.7 9.6 21.4 31.6 71.2 12.5 4.0 14.3 23.0 4.4 14.9 25.0 11.7 36.0 12.7 6.0 11.0 5.7 4.8 9.7 18.4 9.8 17.1 11.1 17.4 19.6 14.2 20.9 8.5 11.3 26.3 4.8 10.9 6.2 16.8 16.5 10.6 13.6 17.7 14.4 10.3 10.3 9.3 8.3 18.0 5.0 8.3 9.1 9.0 15.8 8.3 5.7 13.3 11.4 12.1 5.5 9.3 55.1 14.0 9.8 41.1 14.0 9.5 14.2 14.9 14.8 46.3 32.8 3.1 16.5 7.1 15.5 18.3 12.8 20.1 15.2 18.1 14.8 14.8 17.6 15.1 5.6 1.8 1.2 6.1 1.6 0.6 0.9 2.9 1.9 1.5 0.8 1.5 1.1 0.9 1.6 1.2 1.2 1.2 5.1 1.4 11.8 10.4 10.7 22.3 12.5 8.1 13.0 11.6 10.1 14.6 9.6 12.5 11.7 20.0 0.0 3.2 2.0 7.2 0.0 7.8 0.0 5.2 9.7 15.8 8.6 22.6 12.8 1.3 7.3 0.0 18.6 10.8 35.3 39.2 25.9 72.5 5.9 4.9 13.8 6.1 5.5 3.0 24.3 21.3 7.0 26.5 9.4 0.0 9.1 13.9 31.5 16.4 23.5 3.3 14.0 0.0 7.6 0.0 167.1 12.2 6.3 0.0 5.6 15.8 16.3 18.6 2.0 2.7 49.3 13.3 9.8 18.6 12.0 72.0 18.2 0.0 7.0 13.1 4.7 6.8 52.3 4.8 14.0 0.0 19.6 7.5 9.8 18.4 9.1 CT47A10 CT47.10 ENSG00000224089 "Cancer/testis antigen family 47 member A10" Q5JQC4 X 120938701-120942023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETDB LINC00633 ENSG00000224107 "Embryonic testis differentiation homolog B" P0DPP9 X 135118955-135120526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.6 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPVL3 CENPVP3 ENSG00000224109 "Centromere protein V like 3" A0A0U1RRI6 X 51617020-51618912 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.8;testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 4.3;PC-3: 14.0;U-2 OS: 9.5" NA NA "unprognostic (3.07e-2)" "unprognostic (1.48e-1)" 0.0 0.5 1.5 0.0 2.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.9 1.3 1.3 0.0 0.0 0.5 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 3.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.1 0.0 1.2 0.9 2.7 0.9 1.3 1.3 1.0 0.5 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 IGHV4-59 ENSG00000224373 "Immunoglobulin heavy variable 4-59" P01825 14 106627249-106627825 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 530.9;lymphoid tissue: 918.7;urinary bladder: 708.4" "Cell type enriched" "Detected in some" 301 "Plasma cells: 12374.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 37 "memory B-cell: 169.0;naive B-cell: 77.2" "Lineage enriched" "Detected in many" 51 "B-cells: 169.0" "Cell line enhanced" "Detected in some" "MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2" "Immunoglobulin genes" NA NA 5500000000 "prognostic favorable (1.62e-5)" "unprognostic (3.95e-2)" "unprognostic (7.25e-3)" "unprognostic (9.13e-2)" "unprognostic (1.13e-2)" "prognostic favorable (9.18e-5)" "unprognostic (2.88e-2)" "unprognostic (3.55e-1)" "unprognostic (2.16e-1)" "unprognostic (3.22e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (6.04e-2)" "unprognostic (2.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.76e-1)" 21.6 3.3 0.0 263.0 0.3 96.4 90.2 0.0 1.1 40.8 0.7 530.9 303.7 12.3 2.7 90.4 18.1 169.6 28.1 0.0 2.0 13.7 20.8 90.7 149.2 0.5 1.6 0.0 23.7 10.4 1.7 1.5 0.3 0.2 12.7 460.2 0.0 227.5 8.9 0.5 3.6 224.5 19.7 1.9 469.1 262.8 15.1 0.3 87.2 44.5 0.0 918.7 708.4 10.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 8.1 1.0 0.3 0.3 0.0 0.8 1.0 0.7 0.0 0.0 2.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.4 0.4 0.1 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 169.0 0.0 0.2 1.4 77.2 0.1 0.0 0.0 0.0 0.1 3.3 0.1 11.9 0.0 0.3 0.0 1.1 0.0 2.0 0.5 1.6 0.0 0.2 1.9 0.3 0.3 0.0 0.0 0.6 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.2 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12374.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.6 0.0 0.5 0.0 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004305 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "fallopian tube: 58.8" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;REH: 3.7;TIME: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051264 Uncertain Nucleoli NA NA Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 2.0 0.3 7.3 0.5 3.2 0.3 2.2 4.7 2.4 3.7 10.8 0.4 0.2 0.6 0.3 0.2 58.8 0.7 1.1 3.1 6.0 1.1 0.2 10.5 0.4 10.3 10.4 1.0 0.6 0.3 0.9 10.8 0.3 7.0 0.7 0.0 0.0 0.6 0.6 0.6 0.4 0.7 0.2 9.7 5.8 0.4 14.0 4.9 0.2 4.8 0.0 0.3 0.8 0.6 4.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 3.5 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 1.0 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.7 0.1 3.7 0.0 1.5 0.3 0.0 0.2 1.0 0.0 0.1 0.2 0.5 0.5 0.0 2.8 0.1 1.1 0.4 0.1 0.4 0.1 0.2 0.4 0.1 0.0 0.9 0.2 0.0 0.4 0.5 0.1 0.1 0.4 0.2 0.1 0.2 0.7 0.4 0.2 0.2 0.4 0.0 0.2 0.3 7.3 3.2 4.7 2.4 3.1 6.0 10.3 10.4 1.0 7.0 9.7 4.9 4.0 3.3 0.0 2.8 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.2 1.5 9.9 3.7 0.0 0.0 0.7 0.0 0.0 0.1 12.4 57.4 0.5 2.1 0.0 0.0 0.5 0.0 0.1 0.6 0.0 1.1 0.0 1.6 1.8 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 10.5 0.0 0.9 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.1 89.6 0.0 0.0 0.3 0.3 18.1 1.4 0.0 0.0 0.3 0.7 3.5 0.0 0.1 C4B "C4B1, C4B3, C4F, CH, CO4, CPAMD3" ENSG00000224389 "Complement C4B (Chido blood group)" P0C0L5 6 32014795-32035418 "Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Inflammatory response, Innate immunity" "Blood group antigen" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 223.3;liver: 388.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 103.9;Cardiomyocytes: 71.8;Club cells: 22.9;Fibroblasts: 53.9" "Cancer enhanced" "Detected in many" "liver cancer: 33.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 129.8" "HPA046356, HPA048287, HPA050103" Approved "Secreted to blood" NA NA 120000000000 "HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016" "unprognostic (1.29e-1)" "unprognostic (2.99e-2)" "unprognostic (5.50e-3)" "unprognostic (1.30e-1)" "unprognostic (8.09e-2)" "unprognostic (6.24e-2)" "unprognostic (6.09e-2)" "unprognostic (1.05e-1)" "unprognostic (4.81e-2)" "unprognostic (1.12e-1)" "unprognostic (6.24e-2)" "unprognostic (6.86e-2)" "unprognostic (1.04e-1)" "unprognostic (3.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.99e-3)" "unprognostic (1.11e-2)" 15.6 223.3 2.9 0.4 7.6 0.6 16.1 3.8 23.8 7.0 1.2 21.1 2.0 16.8 0.0 2.2 24.2 5.9 17.3 1.5 19.7 38.8 388.4 13.7 2.7 10.2 7.0 0.3 57.0 25.3 1.1 20.2 1.6 9.2 10.2 6.1 2.5 21.2 1.2 1.3 1.0 16.7 9.8 7.0 16.5 10.4 3.1 32.4 7.6 49.5 0.2 4.3 18.6 3.7 27.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 21.0 7.8 0.5 0.0 26.2 0.1 0.0 0.0 2.6 0.0 0.0 0.0 129.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.6 3.8 23.8 1.5 19.7 10.2 7.0 0.3 9.2 7.0 32.4 27.3 0.0 3.2 103.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 71.8 1.5 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.2 0.0 53.9 0.0 0.0 1.3 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.1 0.0 0.5 8.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ADM5 "AM5, C19orf76" ENSG00000224420 "Adrenomedullin 5 (putative)" C9JUS6 19 49688664-49690575 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 29.3;Endothelial cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 18.0" "Secreted to blood" NA NA "unprognostic (2.34e-2)" "unprognostic (2.56e-1)" "unprognostic (3.08e-3)" "unprognostic (5.62e-2)" "unprognostic (2.18e-2)" "unprognostic (2.64e-2)" "unprognostic (1.28e-1)" "unprognostic (2.39e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (1.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.21e-11)" "unprognostic (2.39e-2)" "unprognostic (9.25e-2)" "unprognostic (9.92e-3)" "prognostic favorable (6.74e-4)" 6.2 0.8 1.5 0.7 1.5 1.4 6.0 4.3 2.9 3.6 1.2 2.4 0.8 4.3 0.3 3.4 5.0 0.6 1.6 1.6 1.5 2.8 1.8 4.3 1.0 1.6 1.7 1.4 2.0 1.8 0.1 2.7 0.8 2.4 4.0 0.2 1.5 2.6 0.4 3.9 4.9 3.0 0.8 1.4 6.8 2.3 3.1 1.7 0.7 2.6 0.4 0.7 3.6 3.6 1.6 3.4 5.7 3.3 2.3 0.1 0.0 3.9 0.3 0.3 1.1 0.6 6.6 3.1 5.1 1.2 0.2 0.3 1.0 5.9 1.9 0.4 6.0 11.3 5.8 1.6 4.3 0.1 1.7 3.8 0.6 4.2 0.7 0.5 0.8 1.1 5.4 4.2 3.7 0.2 5.4 2.6 18.0 4.4 0.6 1.6 7.4 2.5 5.3 0.5 5.9 2.0 0.9 0.8 1.6 1.6 0.8 3.6 2.5 0.9 1.8 6.6 0.9 1.4 12.6 10.7 5.9 1.2 10.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 4.3 2.9 1.6 1.5 1.6 1.7 1.4 2.4 1.4 1.7 1.6 29.3 0.0 1.5 1.3 1.4 6.1 1.4 1.4 6.2 4.3 5.4 6.1 0.1 1.5 1.5 0.0 0.0 0.5 1.0 1.8 0.0 0.5 8.1 3.0 1.9 47.3 1.2 0.0 0.3 1.1 0.5 2.2 1.5 6.0 0.0 0.7 5.0 0.3 0.3 0.0 0.4 1.5 0.0 1.0 4.9 4.3 0.6 1.3 5.4 0.0 0.2 0.9 0.0 0.0 0.9 0.6 0.4 0.7 0.2 1.9 0.3 0.0 1.6 2.4 0.0 2.9 1.5 1.1 1.2 6.2 6.3 0.1 1.3 0.3 1.6 1.1 CXorf51A CXorf51 ENSG00000224440 "Chromosome X open reading frame 51A" A0A1B0GTR3 X 146814106-146814726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 124 "testis: 12.3" "Group enriched" "Detected in some" 29 "Early spermatids: 5.5;Late spermatids: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATXN1L BOAT1 ENSG00000224470 "Ataxin 1 like" P0C7T5 16 71845976-71885268 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 263.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062596, HPA062789" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062596: AB_2684802, HPA062789: AB_2684868" "unprognostic (1.51e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.67e-1)" "unprognostic (3.01e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" "unprognostic (8.13e-2)" "unprognostic (1.99e-1)" "prognostic favorable (5.33e-8)" "unprognostic (1.61e-1)" "unprognostic (1.42e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (8.42e-4)" 14.1 8.1 12.0 10.0 12.8 39.9 11.0 9.4 9.6 11.2 6.3 9.8 8.3 12.5 7.4 9.8 11.0 9.0 9.6 9.8 9.6 18.9 6.6 12.1 10.0 11.2 12.1 8.6 12.8 12.6 16.6 5.3 10.9 12.7 8.2 9.3 8.0 9.5 10.5 10.5 12.1 9.4 13.0 10.8 11.9 10.1 12.3 12.7 12.9 12.0 13.8 10.6 9.0 7.4 11.2 11.8 15.7 15.7 11.5 18.1 8.9 18.4 9.8 10.8 17.4 13.2 22.6 12.9 13.2 15.0 15.4 8.0 20.3 13.4 14.9 18.9 3.6 11.9 9.7 17.7 15.9 13.5 11.9 19.0 12.8 18.6 19.8 14.2 11.4 16.0 17.0 11.1 10.2 10.4 33.6 20.2 11.7 14.3 9.3 7.4 21.4 15.9 15.8 12.1 16.4 8.3 14.2 19.5 10.2 11.9 16.4 16.0 12.5 19.4 19.0 19.9 12.1 13.3 23.0 20.8 30.7 11.8 7.9 16.3 0.6 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.4 0.2 0.2 0.5 0.5 0.4 0.4 0.2 0.1 0.7 0.3 12.0 12.8 9.4 9.6 9.8 9.6 11.2 12.1 8.6 12.7 10.8 12.7 11.2 11.1 0.0 10.6 4.2 14.9 22.8 15.3 11.4 14.2 11.2 16.0 10.2 15.7 14.3 9.5 14.7 14.6 8.3 19.9 15.2 17.6 11.9 44.2 19.1 15.0 14.2 7.8 5.7 6.8 11.8 7.9 11.0 5.6 35.4 12.7 8.0 14.3 12.3 8.5 15.2 5.7 8.7 8.2 14.3 25.2 263.0 14.9 11.8 12.4 5.6 16.9 6.3 29.9 3.5 9.1 14.4 19.6 12.8 16.0 18.3 13.3 15.8 9.9 17.2 13.1 15.5 14.3 22.4 21.1 13.1 24.9 11.5 15.8 8.0 10.6 28.4 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11093834-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 24.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 75.1;Syncytiotrophoblasts: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 4.7 4.6 18.6 3.4 19.3 2.9 3.4 24.8 23.5 4.4 9.4 3.6 3.7 5.0 3.5 4.8 3.0 4.2 6.7 19.3 21.1 4.3 9.8 3.6 3.0 20.5 21.0 18.6 4.1 3.0 6.5 4.1 12.8 22.7 4.7 3.6 17.3 3.7 4.8 11.6 5.0 3.2 5.3 19.6 2.9 3.1 3.4 22.9 3.4 3.0 14.4 3.0 5.0 3.7 23.4 9.9 8.3 12.6 10.6 12.7 14.4 13.2 26.7 11.3 13.4 14.9 11.1 3.1 12.1 35.9 8.6 13.3 8.6 26.3 9.3 24.0 7.1 19.1 12.7 9.1 8.8 16.9 23.8 2.9 17.4 25.5 13.7 18.0 10.6 14.4 11.0 18.3 5.0 25.7 5.4 10.1 14.0 5.9 6.5 7.1 13.5 23.1 17.2 8.2 7.6 29.4 16.3 5.6 18.2 32.4 17.2 4.6 9.9 20.7 20.3 15.0 8.6 18.1 9.5 33.0 17.1 4.8 9.9 31.8 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 18.6 19.3 24.8 23.5 19.3 21.1 20.5 21.0 18.6 22.7 19.6 22.9 23.4 14.3 12.8 1.5 12.4 9.1 75.1 17.1 13.7 10.8 16.4 10.6 10.3 12.7 12.8 5.2 11.0 20.9 29.3 14.4 5.7 3.9 5.2 10.3 11.8 15.6 11.4 3.6 11.8 26.8 7.4 36.6 11.9 6.1 12.0 10.8 4.2 7.9 25.6 13.5 30.3 31.4 8.1 10.2 8.1 29.4 4.3 2.8 12.0 16.0 10.3 6.3 7.6 7.2 18.6 28.0 10.5 3.1 4.1 14.6 18.8 5.8 7.8 4.6 15.2 0.0 7.7 9.8 16.8 24.8 12.7 39.5 65.1 12.9 10.4 8.7 16.2 HNRNPA1P48 ENSG00000224578 "Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48" 16 51553436-51647132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "Ductal cells: 88.9;Enteroendocrine cells: 67.5;Exocrine glandular cells: 138.9;granulocytes: 109.6;monocytes: 57.4;Pancreatic endocrine cells: 77.9;Undifferentiated cells: 66.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001666, HPA005812" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA001666: AB_1850836, HPA005812: AB_2667441" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (3.22e-2)" "unprognostic (2.07e-3)" "unprognostic (7.23e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.48e-1)" "unprognostic (2.86e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-3)" "unprognostic (7.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-3)" "unprognostic (2.11e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 19.2 32.8 0.0 32.7 0.0 0.0 0.0 0.0 0.0 25.1 16.4 12.2 0.0 22.3 1.8 0.0 0.0 14.9 19.1 11.7 88.9 0.0 7.0 12.6 13.1 67.5 0.0 0.0 138.9 0.0 13.7 0.0 8.1 109.6 13.0 0.0 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 57.4 0.0 0.0 0.0 0.0 77.9 14.3 0.0 1.6 0.0 0.0 21.1 14.6 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 20.9 8.7 66.2 0.0 GPX5 ENSG00000224586 "Glutathione peroxidase 5" O75715 6 28525881-28534955 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "epididymis: 9.3" "Group enriched" "Detected in some" 46 "Early spermatids: 14.3;Late spermatids: 41.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (3.34e-2)" "unprognostic (3.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3-74 ENSG00000224650 "Immunoglobulin heavy variable 3-74" A0A0B4J1X5 14 106810442-106811131 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.1;lymphoid tissue: 329.7;salivary gland: 103.4" "Cell type enriched" "Detected in some" 454 "Plasma cells: 19404.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 861 "Daudi: 2948.0" "Immunoglobulin genes" NA NA 27000000000 "prognostic favorable (2.47e-4)" "unprognostic (9.70e-2)" "prognostic favorable (8.33e-4)" "unprognostic (6.96e-3)" "unprognostic (1.42e-1)" "prognostic favorable (7.79e-4)" "unprognostic (1.06e-1)" "unprognostic (7.06e-2)" "unprognostic (3.94e-1)" "unprognostic (3.07e-2)" "unprognostic (2.42e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (4.70e-6)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-1)" 11.4 1.2 0.1 0.0 0.2 0.0 12.7 0.0 1.5 9.4 0.0 58.9 0.0 2.1 1.9 88.1 2.7 1.3 0.7 0.0 0.1 4.6 6.7 22.4 0.0 0.5 0.4 0.0 2.5 1.9 0.6 0.8 0.1 0.2 6.6 0.0 0.0 103.4 0.0 0.5 3.3 74.7 0.0 0.1 329.7 27.7 0.2 0.1 0.0 7.7 0.0 0.0 46.9 5.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 2948.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 1.1 0.2 0.0 0.0 0.1 1.2 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.7 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.1 0.5 0.4 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 42.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.4 27.5 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19404.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.1 0.3 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "AN3-CA: 1145.9;K-562: 290.3" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1145.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 290.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 32.4 0.0 0.0 0.0 0.2 0.5 0.0 2.5 32.2 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 4.2;Respiratory ciliated cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;hTERT-RPE1: 6.4;NB-4: 10.6;SK-MEL-30: 15.9" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 5.1 3.6 3.4 0.8 3.5 0.7 4.7 4.4 7.7 6.4 3.0 7.3 0.2 6.8 0.8 4.4 5.8 2.5 4.4 3.7 3.4 3.2 3.8 4.7 0.4 3.7 3.5 3.3 7.7 4.0 2.5 10.8 0.5 3.7 5.9 0.9 2.0 3.2 1.0 7.4 5.6 4.2 0.4 3.4 4.1 4.7 6.5 3.5 0.1 4.7 0.3 0.4 7.2 5.4 3.7 0.0 0.6 0.1 0.3 0.0 0.1 1.4 0.5 0.0 0.4 0.4 0.0 1.9 3.3 0.2 1.2 0.7 0.1 0.1 2.1 0.2 0.1 0.0 0.3 0.7 0.4 0.2 0.1 0.5 4.4 0.7 1.2 0.1 6.4 0.1 0.6 0.1 0.2 0.2 1.2 0.0 10.6 0.8 0.0 0.0 0.1 0.0 0.0 2.9 1.0 0.4 0.4 0.0 0.2 15.9 0.6 0.2 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.1 1.7 0.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.5 4.4 7.7 3.7 3.4 3.7 3.5 3.3 3.7 3.4 3.5 3.7 0.2 3.2 0.5 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.1 4.2 0.0 0.7 0.0 0.0 0.1 0.0 1.2 0.0 0.1 1.1 0.1 0.1 0.8 1.2 0.0 0.1 0.2 0.1 1.2 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.6 0.0 0.7 0.6 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.3 1.0 0.5 0.3 0.0 0.0 0.3 0.3 0.0 0.7 0.1 NDUFAF8 C17orf89 ENSG00000224877 "NADH:ubiquinone oxidoreductase complex assembly factor 8" A1L188 17 81239305-81241310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 266.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 130.5;Breast myoepithelial cells: 162.6;Distal tubular cells: 279.7;Proximal tubular cells: 337.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057732 Uncertain Approved Mitochondria NA NA Mitochondria "HPA057732: AB_2683513" "unprognostic (4.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" "unprognostic (1.97e-1)" "unprognostic (9.32e-2)" "unprognostic (3.06e-1)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.71e-2)" "unprognostic (2.40e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.74e-2)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" 43.9 65.7 164.2 28.4 163.4 37.3 40.6 158.7 266.4 30.8 153.5 44.1 22.0 30.7 33.9 46.2 32.3 9.8 106.6 159.9 156.3 55.5 79.8 27.7 26.7 162.8 158.0 157.4 33.9 56.8 40.4 54.7 14.7 157.8 44.5 29.6 24.2 37.0 20.4 145.9 31.8 31.9 22.0 161.9 40.7 45.9 30.9 167.6 31.1 39.0 93.8 32.3 45.6 31.8 159.7 142.1 199.9 73.2 72.1 80.4 84.9 79.0 122.1 49.3 82.0 47.1 102.5 60.0 131.6 60.2 86.2 68.2 69.2 69.2 117.4 97.8 33.3 437.1 99.8 222.2 233.3 84.7 139.2 60.8 113.5 140.2 59.3 124.8 87.8 133.0 103.6 132.5 77.3 106.8 130.4 194.6 145.1 41.1 114.6 288.2 121.6 104.8 96.7 89.5 96.1 84.1 107.7 100.5 82.2 126.1 107.2 115.1 127.7 81.5 101.4 154.8 73.2 123.2 110.2 41.1 124.0 91.7 72.8 79.9 41.2 80.1 69.1 73.4 67.1 73.4 103.6 80.4 88.9 82.0 87.6 96.4 94.4 10.3 78.0 76.2 138.0 87.3 77.5 164.2 163.4 158.7 266.4 159.9 156.3 162.8 158.0 157.4 157.8 161.9 167.6 159.7 47.9 19.2 17.3 0.0 24.9 0.0 0.0 0.0 0.0 0.0 130.5 162.6 0.0 0.0 9.3 101.2 0.0 120.5 41.0 0.0 279.7 98.1 0.0 59.8 75.1 21.6 0.0 0.0 0.0 124.6 99.0 32.0 0.0 48.1 1.3 73.5 0.0 0.0 129.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 117.4 0.0 0.0 10.6 0.0 0.0 337.8 3.6 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.0 45.6 23.1 96.8 0.0 0.0 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 232 "testis: 23.2" "Group enriched" "Detected in some" 15 "Spermatocytes: 1.4;Spermatogonia: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 55 "A-431: 53.9;U-266/84: 164.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.3 1.4 0.0 0.0 0.0 164.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOC4-APOC2 ENSG00000224916 "APOC4-APOC2 readthrough (NMD candidate)" 19 44942238-44949565 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1257 "liver: 2239.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 147.1" "Cancer enriched" "Detected in some" 17 "liver cancer: 9.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "THP-1: 4.2" HPA055877 Supported NA NA "HPA055877: AB_2682953" "unprognostic (1.45e-1)" "unprognostic (4.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.42e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (4.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" "unprognostic (2.01e-4)" "unprognostic (2.28e-1)" "unprognostic (2.88e-1)" "unprognostic (5.95e-2)" "unprognostic (1.68e-2)" 0.1 0.4 0.5 0.0 0.4 0.0 0.2 0.4 0.6 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.4 0.4 0.2 2239.2 1.7 0.0 0.5 0.5 0.4 0.0 0.3 0.0 0.8 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.5 1.2 0.1 0.4 0.6 0.0 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.4 0.4 0.5 0.5 0.4 0.5 0.5 0.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.1 147.1 2.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 58.2" "Group enriched" "Detected in some" 7 "Bipolar cells: 4.8;Horizontal cells: 10.1;Inhibitory neurons: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 225.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 13.8 1.3 2.8 0.4 2.4 58.2 8.6 2.8 2.9 1.7 0.4 1.2 0.1 0.5 0.0 2.7 1.1 0.7 1.2 1.7 4.2 0.1 0.4 0.9 0.1 4.0 3.8 2.4 1.1 0.3 0.4 0.2 0.0 3.1 0.4 0.2 1.0 1.1 0.8 4.5 1.8 1.2 0.4 2.7 2.1 2.1 0.4 4.0 0.6 0.5 4.5 0.0 0.6 3.0 3.9 0.0 0.1 0.3 0.5 1.3 0.1 3.8 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.2 8.8 0.1 1.3 0.0 0.0 0.1 0.0 0.0 12.8 0.0 0.0 0.0 1.0 2.6 46.6 1.2 0.0 0.1 12.9 0.6 1.0 0.0 0.1 0.5 225.3 0.4 0.2 0.3 1.5 0.1 6.1 0.0 0.0 1.0 0.5 0.1 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.4 2.8 2.9 1.7 4.2 4.0 3.8 2.4 3.1 2.7 4.0 3.9 0.4 0.0 0.0 1.0 0.0 0.6 0.1 0.2 0.6 4.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.1 0.2 10.1 12.6 0.0 0.0 0.0 0.7 0.0 0.9 0.1 0.0 0.0 0.1 1.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.3 0.0 0.8 1.2 0.3 0.3 0.1 0.0 0.0 0.1 PPP4R3C "FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1" ENSG00000224960 "Protein phosphatase 4 regulatory subunit 3C" Q6ZMV5 X 27460207-27463341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "liver cancer: 0.6;testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 140 "U-2197: 20.4" "Not detected" "Not detected" NA NA "unprognostic (8.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM233 "DSPB2, IFITMD2" ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593774-119643075 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 67.1;tongue: 21.3" "Group enriched" "Detected in some" 5 "granulocytes: 79.1;Skeletal myocytes: 77.8" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 22.2;hTERT-RPE1: 9.0;RH-30: 11.8;U-2197: 17.9;U-87 MG: 70.3" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.7 0.6 3.3 0.1 6.7 0.0 0.4 1.1 9.1 0.4 1.6 0.2 0.2 0.3 0.2 0.3 0.2 0.5 1.1 4.1 2.3 1.2 0.6 0.9 0.2 1.8 1.4 4.2 1.0 0.2 1.4 0.8 0.2 1.8 0.6 0.2 0.2 0.5 0.3 67.1 0.1 0.3 0.4 1.4 0.2 0.3 0.2 2.9 0.9 14.5 21.3 0.2 1.0 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 1.7 0.0 22.2 0.0 9.0 0.1 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.7 1.1 9.1 4.1 2.3 1.8 1.4 4.2 1.8 1.4 2.9 4.0 12.0 3.2 1.1 0.7 0.0 0.0 0.4 0.0 0.0 2.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.9 9.5 0.3 0.1 13.3 0.0 0.0 5.4 8.5 0.0 3.6 0.0 0.4 79.1 5.5 15.4 0.1 0.1 8.4 3.7 0.0 0.0 0.6 0.0 4.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.5 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 77.8 2.2 3.1 1.0 0.2 0.1 0.1 0.9 9.2 0.0 0.2 PNMA6F PNMA6BL ENSG00000225110 "PNMA family member 6F" A0A0J9YX94 X 153317680-153321767 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "brain: 19.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.52e-2)" "unprognostic (7.19e-2)" 0.0 0.7 9.3 0.0 8.6 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 17.7 0.0 0.0 0.0 0.0 5.6 8.1 6.8 0.0 0.0 0.0 0.4 0.0 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.4 19.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 8.6 0.1 4.9 4.4 17.7 5.6 8.1 6.8 8.0 2.2 19.9 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PVALEF AATK-AS1 ENSG00000225180 "Parvalbumin like EF-hand containing" A0A1B0GWK0 17 81165507-81183166 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.35e-2)" "unprognostic (2.55e-1)" "unprognostic (4.40e-1)" "unprognostic (2.30e-1)" "unprognostic (3.26e-1)" "unprognostic (1.09e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.1 0.3 0.1 0.2 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 32.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "OE19: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: AB_2676526" "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favorable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 6.7 6.5 2.7 5.5 2.6 9.8 6.2 3.3 3.1 9.0 3.1 5.9 3.6 5.7 1.0 32.0 5.9 5.4 6.2 2.7 2.8 3.6 3.6 8.8 4.8 3.6 3.3 2.4 5.0 6.1 4.4 5.7 2.9 3.1 5.2 3.6 1.6 14.5 0.9 12.4 10.7 6.3 2.0 2.6 6.9 5.7 3.4 3.3 5.5 6.6 7.3 4.8 6.8 13.7 3.6 7.3 11.0 1.7 5.4 8.4 4.8 0.1 3.3 4.9 1.9 2.6 4.2 6.0 5.2 3.4 3.9 14.1 1.7 4.1 1.9 1.6 13.7 3.5 0.0 5.6 6.9 2.0 0.0 4.3 2.2 4.9 0.9 8.0 3.8 10.0 0.0 5.2 6.2 9.1 6.0 5.2 1.1 1.7 26.6 9.0 2.8 5.6 5.3 6.0 16.8 3.2 2.1 3.2 4.5 5.2 4.8 10.1 5.3 19.1 12.7 3.6 5.2 5.9 0.6 6.2 1.8 7.7 2.8 5.8 2.8 1.2 1.0 0.2 0.3 0.0 1.2 0.6 0.2 0.3 0.3 0.2 0.0 6.5 0.7 0.4 0.2 0.5 0.2 2.7 2.6 3.3 3.1 2.7 2.8 3.6 3.3 2.4 3.1 2.6 3.3 3.6 12.6 12.8 18.1 7.8 17.5 18.0 18.1 10.3 6.8 10.4 11.7 8.4 8.7 15.7 12.7 12.9 16.7 4.8 24.3 25.6 5.9 8.1 4.3 24.9 11.1 12.1 13.8 10.8 13.5 8.2 4.7 12.1 19.9 27.9 1.3 5.4 12.8 8.1 9.1 16.8 13.3 13.0 4.1 27.9 15.2 2.0 7.2 21.1 7.2 9.4 13.7 7.3 14.4 7.5 20.8 18.3 17.7 7.9 22.9 27.2 8.6 10.5 11.9 8.2 0.0 17.7 7.6 7.6 3.7 10.0 16.3 8.6 18.5 9.3 12.2 43.1 USP17L3 "USP17B, USP17F" ENSG00000225327 "Ubiquitin specific peptidase 17 like family member 3" A6NCW0 8 7976393-7977985 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236D ENSG00000225396 "Family with sequence similarity 236 member D" A0A1B0GTK5 X 72807425-72808210 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.5 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV6D-21 "A10, IGKV6D21" ENSG00000225523 "Immunoglobulin kappa variable 6D-21 (non-functional)" A0A0A0MT36 2 90021567-90022185 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "intestine: 67.7;lymphoid tissue: 154.1;urinary bladder: 229.5" "Cell type enriched" "Detected in some" 7 "Plasma cells: 234.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 154 "memory B-cell: 14.2;naive B-cell: 16.5" "Lineage enriched" "Detected in single" 166 "B-cells: 16.5" "Not detected" "Not detected" "Immunoglobulin genes" NA NA "prognostic favorable (1.95e-4)" "unprognostic (5.47e-3)" "unprognostic (2.85e-3)" "prognostic favorable (5.25e-5)" "unprognostic (1.51e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (7.23e-2)" "unprognostic (2.00e-1)" "unprognostic (1.24e-1)" "unprognostic (2.07e-1)" 0.5 0.4 0.0 17.4 0.2 17.3 11.9 0.0 0.1 5.4 0.0 67.7 39.2 1.6 0.0 22.3 0.8 2.7 2.2 0.1 0.0 1.6 2.5 6.3 20.0 0.4 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.1 0.8 32.1 0.0 21.2 17.4 0.0 1.2 38.1 1.1 0.0 45.7 13.5 3.4 0.0 9.2 1.4 0.0 154.1 229.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 234.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.3;intestine: 8.1" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 6.6;Proximal enterocytes: 7.5;Respiratory ciliated cells: 4.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebellum: 4.4;pons: 1.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;CAPAN-2: 13.8;HBEC3-KT: 3.4;MCF7: 3.2;RT4: 5.7;T-47d: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA065586: AB_2685514, HPA065753: AB_2685553" "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.0 0.0 0.0 0.4 0.3 0.0 1.3 4.4 0.7 1.8 0.0 4.3 8.1 0.2 9.3 4.6 1.9 2.2 2.1 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 0.2 4.1 1.1 1.6 0.4 1.2 0.9 5.0 1.3 7.0 1.9 0.4 2.5 7.7 0.0 0.0 0.0 5.1 0.1 0.0 0.2 0.6 0.0 0.9 1.0 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 13.8 0.0 0.3 0.0 0.0 0.6 0.0 3.4 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 2.0 5.7 0.2 0.0 0.0 0.8 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.4 0.7 0.1 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.5 0.0 0.7 0.0 1.8 0.7 2.9 1.3 0.7 2.8 0.6 3.7 0.0 2.7 0.0 1.9 0.0 1.7 1.5 3.0 0.5 0.2 0.0 0.0 2.3 2.2 0.6 0.0 6.6 2.8 0.0 0.2 0.0 0.0 0.2 0.0 2.6 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.8 2.1 2.2 0.0 0.2 0.4 7.5 1.1 4.4 1.0 0.0 0.1 0.1 0.2 0.1 3.4 0.0 0.3 0.0 0.1 2.1 0.9 Z82206.1 ENSG00000225528 "Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7" 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;lymphoid tissue: 4.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "K-562: 12.5" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.1 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.1 0.1 0.1 0.0 4.3 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 12.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.1 2.7 2.9 1.3 2.5 2.3 3.5 3.2 1.6 2.0 3.6 4.4 2.4 1.3 1.2 1.7 2.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 C2CD4D FAM148D ENSG00000225556 "C2 calcium dependent domain containing 4D" B7Z1M9 1 151837819-151840557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.7;skin 1: 2.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Enteroendocrine cells: 5.4;Granulosa cells: 11.5;Syncytiotrophoblasts: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HDLM-2: 19.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.17e-3)" "unprognostic (5.08e-1)" "unprognostic (3.00e-1)" "unprognostic (3.60e-2)" "unprognostic (1.62e-2)" "unprognostic (9.03e-4)" "unprognostic (2.69e-1)" "unprognostic (9.66e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.84e-3)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (2.41e-3)" "unprognostic (1.51e-1)" "unprognostic (2.62e-1)" "unprognostic (3.28e-2)" 0.1 0.3 0.6 0.2 0.6 0.0 0.3 0.3 1.4 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.2 0.2 1.3 0.2 0.5 0.2 0.3 0.3 0.8 0.6 0.0 0.0 0.8 0.0 0.6 0.0 1.5 0.6 0.0 0.0 1.4 0.2 0.2 2.1 0.2 0.0 0.4 0.2 0.7 0.3 0.7 0.0 0.2 0.0 0.0 0.1 0.2 1.7 2.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 19.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.7 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 2.0 1.3 1.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.3 1.4 1.3 0.2 0.8 0.6 0.0 1.5 0.4 0.7 1.7 0.1 0.0 0.0 0.0 0.3 0.8 1.2 0.0 0.0 0.0 3.0 2.4 0.5 1.5 0.0 0.0 0.0 1.0 0.6 0.9 9.8 0.2 0.0 1.6 0.2 0.3 5.4 0.0 1.5 0.5 0.2 0.2 1.5 1.8 0.0 11.5 0.0 0.1 0.1 0.0 0.2 2.7 2.0 0.0 0.3 0.3 0.6 0.1 3.6 0.0 0.0 2.0 1.0 0.0 2.2 0.4 2.1 0.4 1.7 1.3 0.3 0.8 0.0 0.2 0.0 0.8 0.2 0.2 0.7 0.4 1.0 10.7 2.5 0.0 2.5 1.6 ZNF469 "KIAA1858, Zfp469" ENSG00000225614 "Zinc finger protein 469" Q96JG9 16 88382959-88440757 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 7.5;Excitatory neurons: 9.4;Granulosa cells: 9.3;Inhibitory neurons: 8.3;Oligodendrocyte precursor cells: 16.6;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.3;BJ hTERT+: 4.6;HeLa: 4.7;SiHa: 4.9;THP-1: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA077792 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA077792: " "unprognostic (1.80e-1)" "unprognostic (7.79e-3)" "unprognostic (7.71e-2)" "unprognostic (7.01e-2)" "unprognostic (2.97e-1)" "unprognostic (2.30e-1)" "unprognostic (9.17e-3)" "unprognostic (7.08e-3)" "unprognostic (5.04e-2)" "unprognostic (5.02e-2)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (8.71e-7)" "unprognostic (2.24e-2)" "unprognostic (1.83e-2)" "unprognostic (2.20e-2)" "unprognostic (3.34e-2)" 0.7 0.5 3.2 0.9 1.1 0.1 0.5 0.2 2.1 1.4 0.0 0.3 0.2 1.6 0.0 0.1 0.7 1.0 0.3 3.5 0.3 0.1 0.1 0.3 0.6 2.1 1.5 0.6 2.2 0.4 0.1 0.1 0.3 1.5 0.8 0.0 0.0 0.4 0.3 0.7 0.2 0.4 0.8 0.9 0.8 0.4 0.2 1.2 0.4 0.1 0.1 0.3 0.9 0.4 0.9 0.0 4.3 0.1 0.0 0.6 0.9 0.0 2.6 4.6 0.6 0.0 0.0 0.1 0.0 0.1 3.6 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.7 0.0 2.9 0.1 0.1 1.0 0.0 1.0 0.0 0.7 2.7 0.0 0.0 0.0 0.7 0.4 0.0 0.6 0.5 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 2.1 4.9 0.0 0.0 0.0 0.9 6.4 3.3 3.6 0.9 2.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 1.1 0.2 2.1 3.5 0.3 2.1 1.5 0.6 1.5 0.9 1.2 0.9 0.3 0.0 1.8 2.0 0.8 0.3 0.6 1.1 0.0 0.5 2.1 1.1 7.5 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.2 0.6 1.1 2.3 0.0 0.0 9.4 0.0 0.1 3.9 0.0 0.1 0.0 9.3 2.9 0.0 3.1 3.3 8.3 0.0 0.0 1.4 0.6 0.2 0.0 1.9 0.0 1.9 1.6 0.6 2.1 16.6 0.8 0.7 0.0 1.5 0.2 1.1 0.0 0.2 1.1 0.1 6.6 1.3 4.8 0.1 0.7 0.0 0.1 0.1 0.5 1.7 0.0 0.3 MCRIP1 "FAM195B, GRAN2, MCRIP" ENSG00000225663 "MAPK regulated corepressor interacting protein 1" C9JLW8 17 81822361-81833302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 116.5;Exocrine glandular cells: 243.8;Extravillous trophoblasts: 154.1;Hofbauer cells: 161.7;Pancreatic endocrine cells: 137.0;Proximal tubular cells: 140.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045542 Approved Approved Cytosol NA NA Cytosol "HPA045542: AB_2679363" "unprognostic (3.11e-3)" "unprognostic (3.82e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-3)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (3.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (9.08e-3)" "prognostic favorable (2.26e-4)" "unprognostic (2.53e-2)" "unprognostic (3.65e-2)" "unprognostic (4.84e-2)" "unprognostic (1.64e-1)" "unprognostic (2.87e-1)" "unprognostic (1.86e-1)" 93.6 76.6 62.3 18.9 57.1 27.7 88.4 54.8 99.2 96.9 36.6 105.4 9.2 101.7 10.5 35.9 88.1 18.5 135.9 57.4 54.7 98.3 83.3 78.3 24.3 62.2 60.1 54.4 95.3 98.5 17.0 94.8 18.2 59.0 109.5 3.7 7.4 55.0 15.8 52.7 44.8 57.8 16.1 55.7 85.8 72.1 169.7 63.8 20.1 86.3 16.6 8.1 107.0 65.8 60.4 25.8 38.0 42.8 44.8 26.7 30.1 32.8 29.7 21.1 34.8 37.8 9.9 24.8 15.6 17.3 24.6 12.7 5.8 5.1 17.0 8.6 17.1 52.5 28.0 7.1 38.4 26.2 18.7 25.4 32.7 16.4 19.7 8.5 18.9 61.3 35.5 22.7 13.0 23.1 16.8 60.2 42.4 27.0 10.2 21.5 24.0 27.4 7.1 11.9 22.7 36.0 111.7 14.9 19.5 93.2 16.3 17.9 25.0 39.8 50.1 55.0 56.0 55.3 6.8 2.3 10.8 46.6 16.6 40.5 65.7 31.8 45.4 37.8 43.2 29.2 23.7 29.6 34.0 29.4 33.8 23.7 27.3 24.9 28.3 46.3 39.9 39.5 40.3 62.3 57.1 54.8 99.2 57.4 54.7 62.2 60.1 54.4 59.0 55.7 63.8 60.4 84.9 19.2 35.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 69.4 76.6 0.0 0.0 11.2 38.6 0.0 116.5 57.9 0.0 74.3 113.5 0.0 27.5 48.5 38.9 0.0 0.0 0.0 243.8 154.1 38.3 0.0 37.7 20.2 70.7 0.0 0.0 161.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.0 49.1 0.0 0.0 0.0 0.0 137.0 0.0 0.0 6.1 0.0 0.0 140.0 13.8 0.0 0.0 0.0 54.3 0.0 0.0 0.0 0.0 98.6 23.3 50.9 0.0 0.0 SLC26A6 DKFZp586E1422 ENSG00000225697 "Solute carrier family 26 member 6" Q9BXS9 3 48625723-48635493 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 69.7;Intestinal goblet cells: 34.0;Paneth cells: 40.9;Proximal enterocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048363 Approved NA NA "HPA048363: AB_2680371" "unprognostic (1.54e-1)" "unprognostic (4.94e-2)" "unprognostic (3.34e-1)" "unprognostic (3.15e-2)" "unprognostic (2.15e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.39e-1)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (9.66e-3)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.58e-2)" 5.6 6.8 4.9 5.2 5.2 18.3 5.6 5.1 6.3 9.2 5.7 22.5 8.3 7.4 3.6 5.3 6.6 3.7 8.1 4.8 5.3 19.3 7.7 9.6 3.9 5.6 5.5 4.8 7.4 11.5 3.7 5.6 5.5 6.0 12.5 21.8 4.1 5.9 4.2 9.6 6.2 22.6 5.6 5.4 12.6 27.0 5.7 5.7 3.8 6.3 6.1 3.3 6.6 7.9 6.3 8.5 8.9 13.2 15.0 39.9 19.8 11.2 13.7 17.7 25.8 27.4 17.6 7.6 12.0 4.6 11.6 28.7 11.2 12.1 12.5 7.2 9.3 12.0 10.8 29.6 34.3 29.4 5.2 16.5 27.4 44.0 17.7 12.4 22.1 8.0 12.4 8.6 13.2 6.2 9.8 10.4 27.0 18.5 23.0 17.9 5.2 4.8 14.5 18.8 7.9 3.3 6.2 17.7 21.3 25.2 17.9 11.2 19.2 6.9 11.6 9.2 15.0 31.7 15.7 17.8 5.6 9.7 20.5 28.4 6.8 11.1 2.3 3.0 10.8 2.7 0.9 1.8 1.9 9.0 0.2 1.0 1.5 1.5 0.6 10.1 5.1 3.4 5.0 4.9 5.2 5.1 6.3 4.8 5.3 5.6 5.5 4.8 6.0 5.4 5.7 6.3 4.3 3.2 5.9 10.7 2.1 3.2 2.6 8.0 5.7 2.1 3.8 2.7 6.6 1.5 3.8 1.8 14.6 9.3 2.4 69.7 0.0 2.9 1.2 1.3 3.2 5.1 20.4 4.0 2.0 6.3 15.0 4.0 13.3 2.7 0.0 3.1 4.2 6.3 7.0 5.0 2.1 34.0 10.2 5.3 7.4 0.9 3.7 6.3 5.4 1.9 5.8 1.6 6.2 2.5 2.5 5.8 40.9 9.4 5.8 2.0 43.6 6.2 3.7 6.9 0.0 1.3 4.5 2.9 6.9 2.4 3.4 10.5 3.8 13.5 26.8 1.0 IGHV3-72 ENSG00000225698 "Immunoglobulin heavy variable 3-72" A0A0B4J1Y9 14 106790691-106791233 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 58.7;lymphoid tissue: 122.6;urinary bladder: 102.0" "Cell type enriched" "Detected in some" 271 "Plasma cells: 3507.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "memory B-cell: 52.4" "Lineage enriched" "Detected in many" 50 "B-cells: 52.4" "Cell line enhanced" "Detected in some" "NB-4: 1.3;RH-30: 1.3;RPMI-8226: 1.2;TIME: 2.2;U-698: 5.8" "Immunoglobulin genes" NA NA 9600000000 "prognostic favorable (9.10e-6)" "unprognostic (2.18e-2)" "unprognostic (1.32e-2)" "unprognostic (2.93e-2)" "prognostic favorable (8.57e-5)" "unprognostic (9.14e-3)" "unprognostic (3.98e-2)" "unprognostic (1.86e-1)" "unprognostic (9.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "prognostic unfavorable (4.40e-4)" "unprognostic (9.29e-2)" "unprognostic (1.29e-1)" "unprognostic (8.81e-2)" "unprognostic (1.32e-1)" 4.8 2.6 0.1 18.5 0.0 15.6 7.1 0.0 0.6 5.2 0.2 56.3 28.7 3.0 2.9 17.6 3.4 0.3 0.3 0.0 0.0 1.9 5.4 8.7 2.7 0.3 0.1 0.0 2.3 3.4 0.1 0.2 0.1 0.1 1.9 48.2 0.0 46.9 0.9 0.1 0.3 58.7 5.5 0.0 122.6 29.7 0.0 0.0 2.6 2.3 0.5 12.3 102.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.0 0.1 1.3 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 52.4 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3507.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 OR6V1 GPR138 ENSG00000225781 "Olfactory receptor family 6 subfamily V member 1" Q8N148 7 143052320-143053347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "brain: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.24e-2)" 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.6 0.2 0.7 1.7 0.9 0.0 1.6 1.0 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131B ENSG00000225805 "Defensin beta 131B" A0A096LNP1 11 71878453-71884561 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "epididymis: 69.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 15.6" "Secreted in male reproductive system" NA NA "unprognostic (5.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" "unprognostic (3.57e-2)" "unprognostic (3.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (7.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-1)" "unprognostic (5.21e-2)" "unprognostic (3.39e-1)" "unprognostic (1.05e-2)" "unprognostic (3.62e-1)" 0.2 0.6 0.7 1.1 0.8 0.4 0.0 0.6 1.2 0.0 0.0 0.7 1.9 0.4 69.5 0.1 0.0 2.5 0.5 0.4 0.3 0.5 0.0 0.2 1.9 0.4 0.4 0.0 1.2 0.0 0.0 0.0 0.2 1.8 0.5 0.0 3.6 0.7 0.1 0.4 0.8 1.0 0.0 0.0 0.7 0.6 0.8 0.2 0.0 3.2 0.0 0.0 1.0 0.0 1.3 0.5 0.0 3.1 1.4 0.0 0.0 0.4 3.6 0.0 0.0 0.0 4.4 2.8 3.0 1.1 0.0 1.5 3.4 0.0 0.0 0.0 2.8 2.8 3.8 0.0 2.5 0.0 4.8 1.6 0.0 0.0 0.0 0.0 1.1 0.0 6.2 7.3 5.9 0.0 3.2 2.1 0.9 0.5 3.7 3.7 3.0 15.6 1.0 0.0 1.1 2.9 1.6 2.5 1.4 2.6 2.5 3.0 0.4 2.1 1.2 3.4 2.0 0.3 2.5 1.1 4.4 2.0 2.8 0.8 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.2 0.0 0.7 0.8 0.6 1.2 0.4 0.3 0.4 0.4 0.0 1.8 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-25 IGHD625 ENSG00000225825 "Immunoglobulin heavy diversity 6-25" 14 105881539-105881556 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.69e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM229A ENSG00000225828 "Family with sequence similarity 229 member A" H3BQW9 1 32361270-32364278 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "testis: 120.7" "Group enriched" "Detected in many" 58 "Early spermatids: 3112.7;Late spermatids: 3901.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.2;U-2 OS: 2.5;U-266/70: 3.5" "Not detected" "Not detected" NA NA "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (5.73e-3)" "unprognostic (1.16e-1)" "unprognostic (4.82e-1)" "unprognostic (4.59e-3)" "unprognostic (1.99e-3)" "unprognostic (2.02e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.73e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (2.46e-2)" "unprognostic (1.12e-1)" "unprognostic (8.03e-2)" "prognostic favorable (2.33e-4)" 3.6 6.8 1.4 0.2 1.8 2.4 4.0 4.2 5.1 5.9 0.7 3.7 0.4 5.2 0.0 2.8 6.2 0.0 3.0 1.8 1.2 8.8 10.0 4.4 0.1 2.3 1.3 0.9 9.5 3.5 0.0 4.0 0.1 1.7 6.9 0.0 0.2 4.0 0.1 1.8 5.3 5.6 0.0 1.2 8.8 4.1 120.7 1.0 0.1 6.6 0.0 0.2 4.7 4.2 2.3 0.4 0.2 0.1 0.3 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.5 8.2 0.4 0.6 0.1 0.0 0.2 0.7 0.2 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.6 0.0 0.8 0.2 2.3 1.0 0.1 0.1 2.1 0.2 1.3 0.1 0.0 0.5 2.0 0.0 0.2 1.1 0.0 0.3 0.5 0.6 0.4 2.5 0.5 1.0 3.5 1.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 1.8 4.2 5.1 1.8 1.2 2.3 1.3 0.9 1.7 1.2 1.0 2.3 3.6 3.2 3.1 4.2 2.3 2.3 1.9 2.7 0.6 5.0 8.4 7.4 4.1 4.3 2.1 9.2 0.0 0.8 2.8 6.6 21.5 2.5 3112.7 4.3 6.7 5.9 13.8 5.7 1.8 3.3 0.8 4.3 2.6 8.6 0.0 7.9 4.6 2.8 0.7 5.0 2.3 7.0 8.2 1.6 1.6 3901.3 38.5 3.6 0.0 1.9 1.8 11.4 3.1 4.0 3.2 6.0 5.8 32.7 2.5 4.8 6.2 3.0 1.6 5.8 19.7 5.3 4.0 60.2 21.2 1.3 1.4 0.3 2.0 6.4 4.8 3.4 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "P0DP91, Q03468" 10 49454168-49539538 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 53.8;hTERT-RPE1: 123.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Yes No Nucleoplasm "Nuclear bodies" "HPA071297: AB_2732177" "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 2.6 2.1 1.5 1.9 1.4 4.6 3.8 3.0 2.0 3.2 6.2 2.4 2.0 3.0 1.5 3.8 3.0 2.8 3.4 1.3 1.3 3.2 3.3 2.7 2.9 2.3 1.8 0.6 4.5 3.1 5.9 2.8 3.4 2.1 3.4 2.8 3.1 3.2 2.2 3.5 4.5 2.5 2.4 2.1 2.9 2.4 3.1 1.6 3.4 5.1 3.6 3.4 2.7 3.4 1.8 11.2 5.5 4.1 2.1 6.6 10.5 3.4 21.2 27.1 14.1 9.9 6.2 5.6 4.9 3.7 18.7 6.7 9.5 6.3 16.6 13.5 8.4 4.1 3.9 21.7 3.4 3.9 5.0 3.7 4.3 17.2 12.9 53.8 123.4 19.8 2.9 6.8 0.8 16.8 8.3 3.4 2.0 4.0 3.5 10.2 2.3 5.8 2.6 4.1 7.1 5.9 4.7 15.4 3.6 8.2 9.4 7.1 2.7 38.9 7.0 5.5 8.6 5.2 3.3 4.5 4.1 7.3 5.0 5.1 13.1 3.0 7.5 4.1 2.6 3.0 6.8 2.3 2.2 3.9 5.2 2.8 1.4 7.2 1.2 5.3 2.2 3.1 1.8 1.5 1.4 3.0 2.0 1.3 1.3 2.3 1.8 0.6 2.1 2.1 1.6 1.8 6.9 16.0 13.2 14.7 6.0 3.6 1.4 1.5 5.2 0.0 7.1 7.1 7.1 5.7 8.2 9.2 0.0 2.5 10.9 4.8 5.9 5.2 11.3 8.1 8.7 5.1 1.2 1.3 24.3 6.0 2.1 4.9 2.0 10.1 7.6 8.9 5.3 4.3 2.6 0.0 21.7 5.3 0.0 4.4 2.6 15.3 2.8 8.0 1.8 23.4 11.2 0.0 4.1 17.6 16.6 5.2 2.6 2.2 3.6 2.5 5.0 3.6 9.0 0.0 6.6 4.4 4.2 5.3 5.0 3.5 4.1 1.8 7.4 11.4 2.8 1.9 FRG2B ENSG00000225899 "FSHD region gene 2 family member B" Q96QU4 10 133623895-133626795 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 39 "Distal tubular cells: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "HDLM-2: 4.3" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615335-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 43.0 44.3 29.6 21.9 30.9 29.7 42.3 32.2 34.3 37.6 28.6 42.7 27.0 38.0 23.6 38.5 35.9 16.8 46.0 29.0 30.9 48.1 38.2 32.5 26.0 31.3 30.4 27.5 41.0 49.3 40.5 36.2 21.3 31.2 35.4 20.0 16.8 38.3 19.4 44.9 36.9 36.7 16.2 30.4 38.1 38.2 42.0 30.7 15.4 37.4 17.2 20.5 41.8 35.2 34.2 71.7 37.2 31.7 42.7 26.9 26.1 74.4 71.8 29.3 48.4 44.4 60.0 24.9 97.8 137.4 34.4 57.7 46.5 46.9 42.4 47.8 57.5 105.0 91.2 36.3 104.0 45.4 112.0 61.4 25.5 41.5 42.5 24.2 29.8 33.6 45.5 135.7 22.2 44.7 38.1 70.6 147.6 42.1 37.0 74.1 74.4 46.8 140.5 57.9 21.7 92.5 60.3 40.9 88.0 94.9 36.2 53.6 42.8 65.7 48.0 51.9 57.8 108.3 66.2 123.2 100.2 30.7 70.7 75.6 34.5 59.6 82.1 59.2 76.4 68.2 104.0 84.7 71.4 73.2 87.8 90.7 69.0 27.4 61.9 82.9 91.4 96.0 67.9 29.6 30.9 32.2 34.3 29.0 30.9 31.3 30.4 27.5 31.2 30.4 30.7 34.2 103.1 93.0 73.5 10.4 112.5 90.8 117.3 151.0 50.1 62.1 78.9 97.0 214.9 68.6 112.0 57.0 22.9 137.4 71.5 72.7 123.3 188.7 202.3 105.8 95.0 109.2 37.1 89.4 14.0 261.2 153.8 90.9 58.1 91.6 90.6 67.0 61.1 61.8 115.1 48.8 17.1 97.8 130.2 52.6 81.8 38.9 82.6 78.5 101.4 8.4 119.7 124.2 78.2 13.6 19.0 175.0 94.3 79.4 138.8 121.7 81.2 163.6 135.6 61.7 65.7 92.5 119.4 186.3 112.9 70.8 90.5 155.3 99.5 99.2 91.0 117.2 CTAGE4 "cTAGE-4, FLJ43692" ENSG00000225932 "CTAGE family member 4" Q8IX94 7 144183466-144186053 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 15.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.6;Club cells: 1.3;Early spermatids: 1.1;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.3;hTCEpi: 12.9;RPTEC TERT1: 11.6;T-47d: 8.3;WM-115: 8.0" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.76e-1)" "unprognostic (3.24e-3)" "unprognostic (2.89e-1)" "unprognostic (5.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.65e-3)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (4.69e-2)" "unprognostic (1.91e-2)" "unprognostic (9.50e-3)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (8.36e-2)" "unprognostic (2.68e-1)" 1.2 0.5 0.2 0.4 0.3 0.6 4.6 0.2 0.3 2.0 1.1 2.8 4.8 0.8 3.1 8.6 1.5 2.6 0.7 0.1 0.8 6.4 5.8 2.9 0.7 0.4 0.3 0.2 1.8 5.6 0.7 2.7 1.6 0.3 4.3 4.1 1.2 4.7 1.0 0.1 10.9 3.9 0.3 0.2 1.6 4.1 15.1 0.3 0.5 10.1 0.1 0.6 1.5 4.0 0.3 15.3 0.1 0.0 0.0 0.0 0.0 6.2 0.4 0.2 0.0 0.1 1.4 4.9 0.0 0.0 0.5 0.3 0.4 0.0 2.7 0.1 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.3 12.9 0.4 4.0 0.7 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.0 11.6 3.7 0.0 0.0 6.1 5.8 0.4 2.3 8.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.1 0.8 0.4 0.3 0.2 0.3 0.2 0.3 0.3 0.0 3.2 5.6 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.1 NTF4 "GLC1O, NT-4/5, NTF5" ENSG00000225950 "Neurotrophin 4" P34130 19 49061066-49065054 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 20.3;skeletal muscle: 17.3;skin 1: 31.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 35.6;Basal respiratory cells: 24.0;Basal squamous epithelial cells: 15.4;Breast myoepithelial cells: 24.3;Club cells: 9.5;Cytotrophoblasts: 13.6;Urothelial cells: 11.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;HaCaT: 31.1;HBEC3-KT: 11.7;hTCEpi: 50.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049376 Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA049376: AB_2680735" "unprognostic (4.15e-2)" "unprognostic (1.07e-1)" "unprognostic (9.27e-4)" "unprognostic (1.76e-4)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.73e-2)" "unprognostic (4.87e-3)" "unprognostic (3.90e-4)" "unprognostic (2.97e-1)" "unprognostic (1.40e-3)" "unprognostic (3.71e-2)" "unprognostic (2.49e-1)" "unprognostic (1.89e-2)" "unprognostic (2.46e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 2.7 0.5 0.0 0.0 0.1 3.7 10.9 2.5 0.0 0.7 0.1 0.0 0.0 0.0 3.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 1.6 3.2 0.1 20.3 0.0 0.0 8.2 7.2 17.3 31.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 4.0 1.6 2.5 1.1 6.6 9.7 0.1 3.9 0.2 0.3 2.1 0.0 0.0 9.3 0.0 0.0 0.1 0.0 3.4 13.8 0.0 3.5 0.0 0.5 31.1 0.1 11.7 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 50.4 0.0 1.6 3.1 0.0 0.1 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 8.8 0.0 0.1 0.7 0.1 0.0 4.3 8.0 0.1 0.2 1.8 3.5 0.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 3.2 0.0 0.0 0.0 7.0 35.6 24.0 15.4 0.0 3.4 24.3 0.4 0.0 9.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.3 1.7 3.1 2.7 0.3 0.1 0.0 11.9 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 6.2;Endothelial cells: 5.7;Hepatic stellate cells: 7.1;Hepatocytes: 13.5;Inhibitory neurons: 19.2;Rod photoreceptor cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 31.2;U-138 MG: 18.5;U-2 OS: 27.0;U-2197: 32.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066382 Approved "Nucleoplasm,Cell Junctions" NA NA 43000 "Nucleoplasm, Cell Junctions" "HPA066382: AB_2732744" "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 2.2 0.5 2.0 0.3 2.3 0.0 1.5 0.8 3.1 4.2 0.0 0.6 0.1 2.9 0.1 0.5 1.5 0.4 4.4 1.4 3.5 2.1 14.7 0.6 0.1 3.2 3.5 1.3 0.4 0.6 0.1 0.8 0.4 3.5 1.0 0.0 3.1 0.4 0.1 0.7 1.0 0.8 0.2 3.5 1.1 0.6 0.8 2.3 0.7 0.9 0.4 0.0 0.6 1.7 2.5 0.3 0.0 4.6 9.7 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.1 0.5 0.0 4.6 2.1 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 5.7 0.0 4.7 1.9 0.0 1.1 31.2 0.0 3.1 0.0 0.0 4.3 2.0 0.3 0.2 0.0 0.5 0.1 0.3 0.1 18.5 27.0 32.1 0.0 0.0 0.4 8.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 0.8 3.1 1.4 3.5 3.2 3.5 1.3 3.5 3.5 2.3 2.5 4.8 0.0 0.6 0.0 0.0 0.1 0.3 0.3 2.8 1.3 0.1 0.3 1.8 0.0 0.0 0.0 6.2 0.0 0.0 0.0 3.9 0.1 0.1 0.3 2.0 5.7 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 7.1 13.5 0.1 0.0 19.2 0.0 0.0 0.6 0.7 0.1 0.9 0.1 1.8 1.0 0.0 0.9 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 0.9 0.0 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 PIGBOS1 ENSG00000225973 "PIGB opposite strand 1" A0A0B4J2F0 15 55317184-55319161 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (4.19e-4)" "unprognostic (1.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (2.31e-1)" "unprognostic (3.27e-2)" "unprognostic (2.58e-3)" "unprognostic (4.62e-3)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (4.96e-1)" 14.3 13.1 7.0 11.7 7.6 17.6 15.1 7.2 7.9 12.1 8.1 12.6 10.3 13.7 9.2 9.2 13.6 8.3 11.7 6.8 7.6 14.3 15.1 11.5 14.0 8.2 7.4 6.8 12.6 12.5 8.3 13.5 11.8 8.0 11.5 8.2 6.7 12.9 6.5 13.9 8.8 13.6 7.7 7.3 16.5 15.6 11.3 7.8 10.2 16.4 6.8 8.9 13.0 10.9 9.6 15.7 15.3 12.7 9.2 16.3 18.0 16.2 14.8 15.2 12.3 8.3 8.4 9.7 19.8 18.3 10.6 19.6 13.8 4.6 8.3 7.8 25.2 7.4 33.6 14.6 15.8 14.1 23.4 26.6 16.3 14.8 8.1 9.2 16.6 14.1 17.7 39.5 17.6 11.1 12.9 12.0 44.9 7.7 16.3 7.7 16.6 12.3 36.8 10.1 10.2 9.5 15.9 9.5 15.6 48.6 15.9 15.8 52.1 14.1 19.1 22.4 11.0 23.9 17.8 48.9 16.2 17.8 49.3 19.7 49.7 41.9 58.0 24.7 33.2 23.5 31.0 29.8 27.1 33.6 30.6 40.3 29.4 44.3 33.3 46.3 42.7 41.0 26.4 7.0 7.6 7.2 7.9 6.8 7.6 8.2 7.4 6.8 8.0 7.3 7.8 9.6 20.0 28.9 21.6 0.0 24.8 0.0 12.3 0.0 14.8 14.1 15.9 22.2 8.9 14.3 9.9 18.4 6.2 33.4 34.0 15.6 39.2 24.6 19.4 21.0 23.7 22.5 30.1 23.8 0.0 39.5 35.3 21.7 13.3 15.4 7.0 21.7 25.0 34.5 38.7 18.5 0.0 18.5 0.0 27.4 0.0 5.1 29.8 21.9 0.0 0.0 45.1 21.4 50.4 0.0 0.0 31.2 22.5 19.5 19.6 21.3 34.6 48.1 19.0 19.2 32.9 16.6 16.3 23.4 15.8 14.2 0.0 23.8 19.7 22.3 15.3 12.1 CT47A6 CT47.6 ENSG00000226023 "Cancer/testis antigen family 47 member A6" Q5JQC4 X 120958165-120961487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FTCDNL1 FONG ENSG00000226124 "Formiminotransferase cyclodeaminase N-terminal like" E5RQL4 2 199760544-199851192 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 39.8;Excitatory neurons: 43.5;Oligodendrocytes: 115.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065748 Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA065748: " "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-2)" "unprognostic (9.80e-2)" "unprognostic (3.09e-1)" "unprognostic (7.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (5.37e-2)" "unprognostic (9.86e-2)" "prognostic favorable (3.31e-4)" "unprognostic (3.92e-2)" "unprognostic (4.63e-2)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.21e-2)" 2.5 4.9 4.5 0.9 8.3 2.3 2.1 6.1 5.3 0.6 1.7 1.0 1.0 0.4 1.9 1.3 1.9 0.9 3.0 4.8 5.5 4.2 10.1 1.4 2.0 7.6 6.8 4.5 1.0 2.2 1.6 0.9 0.6 6.2 1.2 1.1 1.4 2.5 0.6 8.2 1.2 0.8 1.1 6.5 4.6 0.9 1.0 5.9 0.7 5.8 8.5 0.8 0.7 0.9 7.8 0.6 1.9 0.1 0.0 1.9 1.1 1.4 0.7 0.7 1.0 0.4 0.0 3.5 2.0 0.2 0.8 5.7 0.0 0.9 5.3 1.2 2.3 0.5 1.5 0.8 1.7 0.7 5.5 6.5 0.8 0.2 0.4 0.1 0.7 0.0 4.9 2.7 0.1 0.7 6.0 1.9 2.1 1.6 0.5 4.0 0.3 0.2 0.0 0.4 0.0 2.3 0.0 3.4 3.2 3.2 1.3 4.8 7.1 0.6 2.7 0.0 1.8 1.1 4.7 2.9 1.1 5.2 2.7 1.3 0.0 4.1 1.7 0.4 5.5 1.7 3.4 1.7 0.6 5.8 2.1 1.1 1.8 0.0 1.1 5.1 8.7 0.0 1.4 4.5 8.3 6.1 5.3 4.8 5.5 7.6 6.8 4.5 6.2 6.5 5.9 7.8 0.8 0.0 0.0 39.8 3.2 2.7 2.9 0.0 13.6 3.3 6.2 5.5 5.7 4.3 1.3 3.7 4.2 1.5 3.3 0.3 1.9 0.2 2.4 8.4 0.8 1.5 0.0 5.9 43.5 0.7 1.4 1.4 4.6 3.3 0.0 5.9 2.2 6.9 7.4 1.7 23.5 1.2 0.0 8.1 4.7 1.0 0.3 8.2 7.2 17.8 2.1 1.7 0.0 24.6 115.4 0.3 0.1 0.4 1.4 2.6 1.0 10.6 0.0 6.5 0.0 2.4 3.4 0.4 2.0 6.9 2.3 0.3 1.5 10.3 1.1 1.2 TEX22 ENSG00000226174 "Testis expressed 22" C9J3V5 14 105398538-105450106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.0" "Group enriched" "Detected in some" 8 "Early spermatids: 290.6;Late spermatids: 614.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;U-266/70: 2.3;U-937: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA065576 Enhanced NA NA "HPA065576: AB_2685513" "unprognostic (3.99e-2)" "unprognostic (6.00e-2)" "unprognostic (1.30e-3)" "unprognostic (2.06e-1)" "unprognostic (3.36e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (1.52e-2)" "unprognostic (3.95e-2)" "unprognostic (1.53e-5)" "unprognostic (1.42e-4)" "unprognostic (8.13e-2)" "unprognostic (5.96e-2)" "unprognostic (2.18e-2)" "unprognostic (5.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.91e-3)" 0.1 0.0 0.8 0.2 0.8 0.4 0.3 1.2 0.7 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.7 0.5 0.3 0.1 0.1 0.5 0.9 0.7 0.4 0.6 0.3 0.2 0.1 0.1 0.7 0.5 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.0 0.9 0.7 0.2 5.0 0.8 1.0 0.3 0.0 0.2 0.1 0.2 1.2 0.2 0.3 0.3 1.4 0.4 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.2 0.8 0.1 0.0 0.0 0.2 0.2 0.0 0.0 3.2 0.2 0.1 0.5 0.0 0.1 0.2 0.8 0.2 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.9 0.0 1.0 0.1 0.1 0.1 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.3 0.0 2.3 0.3 0.3 0.1 1.7 1.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.8 1.2 0.7 0.7 0.5 0.9 0.7 0.4 0.7 0.9 0.8 1.2 0.3 0.0 0.0 6.2 1.1 0.4 0.4 0.2 0.6 0.1 1.0 0.9 0.4 0.0 0.1 0.0 0.0 0.2 0.3 0.2 1.9 0.6 290.6 1.3 0.5 0.4 0.0 0.8 3.2 0.6 0.1 0.4 0.0 0.4 4.5 2.2 0.0 0.1 1.0 0.0 4.8 0.2 0.0 1.9 0.3 614.3 4.1 1.0 1.8 1.0 1.2 0.3 0.0 6.6 5.8 0.6 0.1 2.2 0.3 0.5 0.8 0.5 0.4 0.2 6.6 0.9 0.6 54.2 3.0 0.4 0.1 0.1 0.6 0.4 0.2 0.2 OR52I2 ENSG00000226288 "Olfactory receptor family 52 subfamily I member 2" Q8NH67 11 4581743-4593340 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049343 Uncertain NA NA "HPA049343: AB_2680721" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CROCC2 ENSG00000226321 "Ciliary rootlet coiled-coil, rootletin family member 2" H7BZ55 2 240906330-240993311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 19.1;fallopian tube: 7.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 9.7;Endometrial ciliated cells: 43.6;Respiratory ciliated cells: 13.1" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.0;RPMI-8226: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048678 Enhanced NA NA "HPA048678: AB_2680491" "unprognostic (4.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.24e-2)" "unprognostic (1.68e-3)" "unprognostic (7.92e-2)" "unprognostic (1.75e-4)" "unprognostic (2.84e-3)" "unprognostic (3.10e-2)" "unprognostic (8.28e-2)" "unprognostic (3.45e-2)" "unprognostic (6.56e-3)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-2)" "unprognostic (9.90e-3)" "unprognostic (7.19e-2)" 0.0 0.0 2.4 0.1 0.8 0.0 0.0 1.4 1.1 0.7 19.1 0.0 0.2 0.1 0.0 0.0 7.1 0.0 0.0 2.2 1.4 0.0 0.2 1.6 0.6 2.1 3.7 0.0 0.1 0.0 0.0 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 2.3 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.8 1.4 1.1 2.2 1.4 2.1 3.7 0.0 2.7 1.9 1.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 DCAF8L1 WDR42B ENSG00000226372 "DDB1 and CUL4 associated factor 8 like 1" A6NGE4 X 27977992-27981449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 3.0" "Group enriched" "Detected in some" 23 "Spermatocytes: 8.0;Spermatogonia: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "Karpas-707: 18.7" HPA043787 Enhanced NA NA "HPA043787: AB_10961430" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L7 ENSG00000226430 "Ubiquitin specific peptidase 17 like family member 7" P0C7H9 8 12132417-12134099 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" "unprognostic (5.31e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM185B "FAM11B, FLJ20979" ENSG00000226479 "Transmembrane protein 185B" Q9H7F4 2 120217479-120223400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA048295: AB_2680345, HPA071744: AB_2686441" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.44e-4)" "prognostic unfavorable (4.96e-6)" "unprognostic (1.35e-2)" "unprognostic (1.55e-2)" "prognostic unfavorable (5.71e-7)" "unprognostic (3.09e-3)" "unprognostic (1.65e-1)" "unprognostic (9.01e-2)" "unprognostic (1.96e-2)" "unprognostic (8.28e-2)" "unprognostic (6.03e-3)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" 10.7 7.9 7.5 7.6 8.6 5.8 9.9 8.4 7.3 7.3 7.7 8.1 6.2 10.5 5.3 10.0 9.7 6.6 11.5 7.2 8.0 6.7 6.8 8.8 7.0 8.8 8.6 7.0 5.5 9.1 26.1 6.3 7.3 8.5 9.3 6.0 4.6 9.9 7.1 10.9 7.9 8.1 9.2 8.9 7.2 8.1 13.2 8.2 7.5 10.3 7.9 7.9 9.4 8.1 9.6 29.5 11.2 9.0 18.8 20.2 24.9 16.7 23.1 21.1 19.3 16.5 34.8 27.7 0.0 16.7 20.9 22.1 18.1 8.8 17.2 24.2 13.5 15.4 13.5 9.7 7.3 22.7 0.0 26.3 20.7 24.9 20.8 24.7 18.1 15.7 14.7 13.1 14.9 17.3 23.2 13.9 19.6 13.0 13.1 23.7 9.7 0.0 9.1 17.9 22.0 13.5 12.8 19.1 27.5 18.2 10.2 9.5 21.4 20.2 10.2 22.7 20.9 8.6 10.1 15.5 12.8 12.4 15.2 27.9 0.1 0.6 0.9 0.9 0.9 1.0 0.3 0.7 0.5 0.6 0.4 0.7 0.7 1.5 1.4 0.7 0.5 0.8 0.3 7.5 8.6 8.4 7.3 7.2 8.0 8.8 8.6 7.0 8.5 8.9 8.2 9.6 12.2 16.0 2.6 4.9 9.4 8.4 36.0 7.3 14.8 2.7 8.2 5.7 8.6 5.7 4.3 7.3 6.2 9.4 4.7 4.6 1.9 18.0 12.6 4.1 5.7 11.1 1.2 3.4 2.0 12.3 29.3 12.1 12.2 7.4 7.0 5.4 7.5 4.5 15.4 1.7 1.8 4.5 2.0 7.2 4.7 6.1 4.7 8.4 7.2 3.7 5.4 7.5 5.2 5.5 6.1 13.4 6.7 2.2 6.9 16.2 5.0 3.9 6.0 3.8 0.0 17.1 8.8 18.5 9.3 10.4 4.4 14.5 7.9 4.1 4.6 14.2 AC138647.1 ENSG00000226490 "Novel protein" 8 141514638-141518737 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "brain: 3.7;testis: 9.9" "Group enriched" "Detected in some" 5 "Early spermatids: 226.6;Late spermatids: 66.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.2 0.2 3.7 1.1 0.0 0.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 226.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A9 CT47.9 ENSG00000226600 "Cancer/testis antigen family 47 member A9" Q5JQC4 X 120943561-120946883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018141 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 3.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 TRBV2 "TCRBV22S1A2N1T, TCRBV2S1" ENSG00000226660 "T cell receptor beta variable 2" A0A1B0GX68 7 142300924-142301432 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 90.1" "Cell type enriched" "Detected in single" 80 "T-cells: 8.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "memory CD4 T-cell: 120.3;memory CD8 T-cell: 64.5;naive CD4 T-cell: 71.5;naive CD8 T-cell: 44.5;T-reg: 122.7" "Lineage enriched" "Detected in many" 21 "T-cells: 122.7" "Cell line enriched" "Detected in single" 10 "RPMI-8226: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.62e-4)" "unprognostic (4.94e-4)" "unprognostic (5.79e-2)" "unprognostic (1.29e-3)" "unprognostic (1.09e-1)" "unprognostic (4.71e-5)" "unprognostic (3.60e-2)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (1.16e-2)" "unprognostic (1.94e-2)" "unprognostic (1.77e-1)" "unprognostic (3.70e-5)" "unprognostic (3.83e-1)" "unprognostic (6.31e-2)" "unprognostic (1.89e-1)" "unprognostic (3.41e-2)" 1.1 0.3 0.0 8.4 0.0 3.9 1.2 0.0 0.1 1.1 0.0 2.6 2.5 0.3 1.1 1.7 0.2 2.4 0.1 0.0 0.0 0.4 1.0 1.6 25.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 2.1 0.0 0.3 0.5 0.0 0.3 1.7 0.8 0.0 6.8 3.5 0.3 0.0 90.1 0.5 0.3 22.3 3.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.9 0.0 5.5 0.1 120.3 64.5 0.3 0.1 71.5 44.5 1.2 0.1 0.1 5.8 122.7 29.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 CT47A12 CT47.12 ENSG00000226685 "Cancer/testis antigen family 47 member A12" Q5JQC4 X 120930250-120932301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC013470.2 ENSG00000226690 "Novel protein" 7 12469621-12542222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 6.2;fallopian tube: 4.8" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 60.6;Respiratory ciliated cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.4" "Region enhanced" "Detected in many" "midbrain: 5.0" NA NA "unprognostic (3.89e-1)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "unprognostic (1.48e-1)" "unprognostic (8.16e-2)" "unprognostic (1.53e-4)" "unprognostic (1.14e-3)" "unprognostic (3.62e-3)" "unprognostic (7.82e-3)" "unprognostic (3.61e-1)" "unprognostic (8.04e-2)" "unprognostic (8.40e-2)" "unprognostic (1.98e-1)" "unprognostic (2.88e-2)" "unprognostic (2.67e-1)" 0.1 0.1 4.1 0.0 1.4 0.1 0.0 1.6 0.7 0.0 0.7 0.1 0.0 0.3 0.1 0.0 4.8 0.0 0.0 0.8 2.6 0.0 0.0 0.4 0.0 6.2 4.0 0.2 0.0 0.2 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.1 0.7 2.2 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 4.1 1.4 1.6 0.7 0.8 2.6 6.2 4.0 0.2 4.1 3.8 2.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 7.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSBP1L1 "FLJ10967, MGC189743" ENSG00000226742 "Heat shock factor binding protein 1 like 1" C9JCN9 18 79964582-79970822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "granulocytes: 31.9;T-cells: 26.0" "Cell line enhanced" "Detected in many" "HHSteC: 162.8;SK-MEL-30: 100.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048273 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048273: AB_2680337" "unprognostic (2.08e-1)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.71e-2)" "unprognostic (3.70e-2)" "unprognostic (8.15e-3)" "unprognostic (8.86e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (2.53e-3)" "unprognostic (7.41e-2)" "unprognostic (4.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.12e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-2)" 8.5 17.5 17.4 2.9 16.9 2.9 9.7 19.2 26.6 10.0 21.6 16.1 6.8 7.7 11.2 17.5 8.8 5.8 6.6 16.5 17.8 18.4 29.9 10.7 4.3 18.9 17.7 16.0 6.6 20.6 19.9 6.7 9.9 19.3 10.3 13.2 14.9 12.9 7.7 12.6 15.5 6.6 5.7 17.7 5.3 10.2 0.8 19.7 4.4 9.0 10.7 5.0 6.3 10.7 19.9 32.2 8.6 0.3 0.5 4.6 15.4 12.7 14.3 32.2 14.8 13.0 16.5 21.7 0.0 3.6 18.8 0.2 18.3 28.5 18.9 7.0 30.6 6.7 0.0 8.8 9.6 162.8 0.0 0.0 18.0 49.6 1.7 10.8 31.5 0.3 4.8 0.0 0.0 0.7 26.8 0.1 0.0 0.0 17.6 30.1 0.3 0.0 0.0 53.7 7.6 0.5 1.8 15.2 20.9 100.2 1.4 11.9 7.6 0.0 0.1 0.0 0.4 0.1 0.0 16.7 0.0 0.2 8.9 0.6 31.9 6.8 8.6 5.8 4.4 6.9 2.2 10.1 6.2 2.8 2.5 26.0 14.0 0.4 5.2 1.6 3.3 4.9 6.2 17.4 16.9 19.2 26.6 16.5 17.8 18.9 17.7 16.0 19.3 17.7 19.7 19.9 36.4 54.5 34.5 12.1 5.0 39.8 66.0 135.5 67.2 12.0 89.8 93.6 12.4 48.6 109.2 49.7 22.9 126.6 9.6 119.8 68.4 63.8 1.3 47.2 13.2 23.0 11.5 11.4 5.7 62.1 67.1 16.0 31.6 59.4 19.0 37.2 30.0 122.5 44.7 20.2 11.0 81.3 71.2 20.5 18.0 1.3 19.9 16.0 39.2 6.5 4.0 33.2 6.2 1.0 3.1 137.3 99.6 24.5 2.3 80.2 70.6 80.6 80.3 33.0 0.0 6.3 15.9 1.3 1.3 46.8 57.8 117.4 12.2 34.5 99.6 104.4 TAS2R46 T2R54 ENSG00000226761 "Taste 2 receptor member 46" P59540 12 11061365-11062294 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (7.73e-4)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.4 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SRRM5 ENSG00000226763 "Serine/arginine repetitive matrix 5" B3KS81 19 43596617-43614498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 48.2" "Group enriched" "Detected in some" 43 "Early spermatids: 176.5;Late spermatids: 64.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA047399, HPA052924" Uncertain Approved Vesicles,Centrosome NA NA Vesicles Centrosome "HPA047399: AB_10963088, HPA052924: " "unprognostic (3.95e-3)" "unprognostic (7.56e-3)" "unprognostic (6.72e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "unprognostic (3.69e-2)" "unprognostic (2.16e-2)" "unprognostic (2.68e-5)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.00e-3)" 0.4 0.9 1.1 0.6 1.3 0.4 0.5 2.5 1.3 0.8 0.6 0.7 0.3 0.5 0.3 1.0 0.7 0.4 0.7 1.1 0.9 1.1 1.1 0.6 1.0 1.2 1.0 0.8 0.9 1.2 0.2 1.6 0.2 1.4 2.0 0.1 1.9 0.9 0.1 0.5 0.8 0.8 0.1 0.8 0.9 0.7 48.2 1.0 0.1 1.1 0.0 0.1 0.6 0.9 2.0 1.3 1.1 0.4 0.8 0.4 0.3 0.3 0.3 0.1 0.1 0.1 0.7 0.5 0.4 0.7 0.1 0.3 0.8 0.4 0.1 0.2 0.5 0.5 0.4 1.1 0.6 0.1 0.3 0.6 0.3 0.4 0.0 0.1 0.4 0.1 0.6 0.3 1.1 0.0 1.1 0.5 0.5 0.1 0.9 0.3 0.8 0.3 0.3 0.3 1.7 0.8 0.3 0.1 0.4 0.4 0.5 0.9 0.2 0.6 1.1 0.7 0.4 0.6 1.3 0.9 0.5 0.6 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 2.5 1.3 1.1 0.9 1.2 1.0 0.8 1.4 0.8 1.0 2.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 2.8 0.3 0.3 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 176.5 0.3 0.4 0.1 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.4 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 64.9 1.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.9 0.0 0.8 0.1 0.7 0.6 0.8 0.3 0.1 0.2 0.3 0.1 0.1 PGAM4 "dJ1000K24.1, PGAM-B, PGAM1, PGAM3" ENSG00000226784 "Phosphoglycerate mutase family member 4" Q8N0Y7 X 77967949-77969638 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 2.3;Basal respiratory cells: 1.6;Langerhans cells: 1.5;Melanocytes: 3.6;Suprabasal keratinocytes: 2.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.3" "HPA042528, HPA060483" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA042528: AB_2678039, HPA060483: AB_2684292" "unprognostic (3.10e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (4.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (7.52e-3)" "unprognostic (3.19e-2)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (1.10e-1)" "unprognostic (2.76e-3)" 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 1.3 0.4 0.1 0.4 0.0 0.0 0.6 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.8 1.0 0.3 0.0 0.1 0.3 0.1 0.4 0.1 0.1 0.0 0.6 0.2 0.1 0.5 0.2 0.2 0.2 0.0 0.2 0.4 0.4 1.0 0.5 0.4 0.3 1.0 0.7 0.1 0.5 1.0 1.5 0.5 1.0 0.4 0.3 0.5 0.5 0.8 0.3 0.3 0.5 0.6 0.4 1.1 0.2 0.9 1.7 0.1 0.1 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.1 0.1 0.0 0.0 0.0 C13orf42 LINC00371 ENSG00000226792 "Chromosome 13 open reading frame 42" A0A1B0GVH6 13 51082119-51200252 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1" "Cancer enriched" "Detected in single" 46 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 8.6;NTERA-2: 10.7;SuSa: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.77e-2)" "unprognostic (5.61e-2)" "unprognostic (1.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751586 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 13.0;placenta: 10.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 74.4;Extravillous trophoblasts: 102.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 46.9;hTCEpi: 32.5;RPTEC TERT1: 24.2" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 6000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.1 0.5 0.8 0.2 0.5 0.0 0.9 0.5 1.1 0.8 0.5 0.2 0.2 0.7 0.6 1.2 0.5 0.2 2.6 0.7 0.6 3.5 0.1 0.6 0.2 0.7 0.5 0.5 1.4 0.5 13.0 0.0 10.9 0.8 0.4 0.5 0.0 0.4 0.8 0.0 0.3 0.1 0.2 0.7 0.5 0.4 0.7 0.8 0.0 0.4 0.0 0.4 0.5 0.6 0.8 7.6 0.3 1.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 46.9 9.9 0.0 1.0 0.1 0.7 0.5 0.0 3.4 0.0 0.0 0.4 0.0 0.1 0.5 0.6 0.0 0.0 2.1 32.5 0.0 4.8 0.0 0.0 0.0 2.7 0.0 0.1 0.5 0.0 0.0 3.1 3.0 1.4 0.0 0.0 0.0 24.2 0.7 2.0 0.4 3.1 1.3 0.0 4.7 4.1 0.7 0.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.5 1.1 0.7 0.6 0.7 0.5 0.5 0.8 0.7 0.8 0.8 0.1 0.0 0.0 0.0 0.5 0.5 1.8 2.3 2.2 0.0 2.2 1.9 2.9 0.0 0.6 7.3 0.0 74.4 0.0 0.1 0.0 2.5 4.2 0.6 0.9 1.3 0.0 0.0 0.4 0.8 102.9 1.5 0.0 1.7 0.0 2.6 0.0 0.0 7.4 0.0 0.2 0.3 2.0 0.0 0.0 3.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.0 0.0 3.7 0.0 3.0 0.1 0.0 0.0 0.2 0.5 0.2 0.4 2.8 0.1 17.4 0.0 0.2 0.4 1.4 CT47A11 CT47.11 ENSG00000226929 "Cancer/testis antigen family 47 member A11" Q5JQC4 X 120933840-120937158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-266/70: 1.7" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1J ENSG00000226941 "RNA binding motif protein Y-linked family 1 member J" Q15415 Y 22403461-22417881 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 193 "U-266/70: 25.2;U-266/84: 13.3" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LTA "LT, TNFB, TNFSF1" ENSG00000226979 "Lymphotoxin alpha" P01374 6 31572054-31574324 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 2.0;lymphoid tissue: 5.6;testis: 4.2" "Group enriched" "Detected in some" 4 "B-cells: 13.7;T-cells: 14.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;MOLT-4: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA007729 Uncertain "Secreted to blood" NA NA 8150 "HPA007729: AB_1852906" "unprognostic (3.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.36e-3)" "unprognostic (8.99e-5)" "unprognostic (3.22e-1)" "unprognostic (5.13e-3)" "unprognostic (2.07e-1)" "unprognostic (4.71e-2)" "unprognostic (3.10e-2)" "unprognostic (3.39e-4)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (8.72e-12)" "unprognostic (2.59e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-1)" 0.2 0.0 0.1 0.6 0.1 0.8 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.4 2.4 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.0 0.2 0.0 0.2 0.1 2.0 0.0 0.1 5.6 0.1 4.2 0.1 0.0 0.2 0.0 2.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 1.1 0.0 1.1 2.3 13.7 0.1 0.1 0.0 0.6 0.6 0.5 1.3 2.5 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 1.9 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.4 0.4 0.0 0.3 0.0 1.0 0.4 0.0 1.0 2.5 2.4 0.1 0.0 0.4 0.5 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.3 1.8 0.5 0.5 0.4 0.0 14.5 0.1 0.0 0.0 C14orf132 C14orf88 ENSG00000227051 "Chromosome 14 open reading frame 132" Q9NPU4 14 96039362-96093971 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Bipolar cells: 57.8;Endometrial ciliated cells: 55.2;Horizontal cells: 63.9;Skeletal myocytes: 44.9" "Cancer enhanced" "Detected in many" "glioma: 12.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 49.9;SCLC-21H: 52.5;SH-SY5Y: 52.0;U-87 MG: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.47e-2)" "unprognostic (2.50e-2)" "unprognostic (1.27e-1)" "unprognostic (1.82e-1)" "unprognostic (4.42e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.51e-2)" "unprognostic (5.55e-3)" "unprognostic (1.47e-2)" "unprognostic (3.09e-2)" "unprognostic (1.33e-5)" "prognostic unfavorable (4.95e-4)" 5.6 14.2 61.0 3.2 62.2 0.1 7.0 66.3 71.9 20.9 25.7 18.6 2.1 26.4 14.4 7.2 22.7 5.1 4.1 75.3 53.6 5.6 4.1 18.6 0.8 54.8 55.6 55.0 5.2 3.3 0.2 39.1 0.8 51.1 9.6 4.5 13.0 3.0 19.9 3.0 13.9 14.3 22.5 54.8 6.2 15.9 1.3 57.7 3.2 2.5 6.7 1.2 8.6 12.0 59.6 0.0 6.4 30.8 9.7 22.0 22.0 0.1 10.6 23.8 13.6 8.3 0.1 0.1 0.0 2.4 23.8 9.0 0.7 3.7 0.8 11.7 0.0 1.4 0.1 1.2 0.1 2.7 0.0 0.2 12.0 1.2 12.7 1.0 0.0 0.2 3.0 0.0 0.1 6.3 49.9 0.8 0.1 15.0 0.0 0.0 28.5 5.0 0.1 11.0 22.4 52.5 52.0 8.3 1.0 1.5 8.3 28.9 1.4 0.0 10.8 6.5 18.0 0.0 0.0 0.0 0.1 46.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.2 61.0 62.2 66.3 71.9 75.3 53.6 54.8 55.6 55.0 51.1 54.8 57.7 59.6 4.8 38.5 10.6 14.7 0.4 2.7 3.7 5.9 5.2 57.8 0.7 7.1 1.9 1.5 3.9 7.3 20.9 0.3 0.2 0.0 5.9 5.8 3.0 55.2 23.8 8.6 9.0 0.0 20.3 0.2 1.0 16.6 2.0 6.8 1.3 5.4 19.2 4.0 0.3 63.9 11.2 0.1 4.1 0.6 7.1 3.0 15.8 0.5 8.8 7.5 0.1 4.0 0.0 11.1 24.7 1.2 0.1 13.5 0.1 2.1 0.0 0.0 13.6 6.1 0.0 44.9 4.4 0.3 0.6 6.8 7.7 0.3 1.0 0.6 0.1 2.3 WDR46 "BING4, C6orf11, UTP7" ENSG00000227057 "WD repeat domain 46" O15213 6 33279108-33289247 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043004, HPA055425" Uncertain Supported Nucleoli NA NA Nucleoli "HPA043004: AB_10967417, HPA055425: " "unprognostic (1.84e-1)" "unprognostic (7.54e-2)" "unprognostic (2.82e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.51e-3)" "unprognostic (2.63e-3)" "unprognostic (2.62e-1)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (9.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.97e-1)" "unprognostic (2.32e-1)" 19.2 19.2 2.6 14.2 2.8 12.7 19.0 2.4 3.8 21.1 3.1 16.4 13.6 23.8 13.8 19.2 17.5 3.2 12.9 3.1 4.0 13.5 17.3 14.8 10.7 2.6 2.7 3.1 17.5 19.3 3.0 19.9 5.5 3.1 17.0 11.3 3.0 18.8 2.8 26.3 23.1 15.7 9.7 2.9 20.6 16.8 14.9 2.5 6.3 16.5 12.8 19.0 19.8 18.0 4.0 0.9 21.1 15.3 61.2 11.4 1.6 56.2 42.3 4.9 0.2 7.0 27.8 15.5 49.4 35.5 22.5 60.2 23.4 3.9 31.0 19.3 31.6 32.2 65.6 20.3 54.0 10.4 56.6 74.2 12.5 5.2 18.4 9.5 15.6 0.0 26.6 37.5 13.8 6.8 23.3 32.1 46.8 45.1 8.5 18.3 47.1 28.1 40.3 9.3 20.7 30.9 40.3 20.4 44.4 46.9 18.3 17.2 37.8 30.9 37.9 42.8 31.6 64.3 56.5 104.3 83.5 16.4 55.9 35.3 12.1 17.3 6.2 24.9 28.7 21.4 16.1 18.2 22.4 27.9 18.9 17.0 21.7 1.2 28.1 33.9 13.7 18.6 20.1 2.6 2.8 2.4 3.8 3.1 4.0 2.6 2.7 3.1 3.1 2.9 2.5 4.0 21.0 0.0 11.7 2.9 30.4 43.7 30.8 40.7 28.5 14.4 23.8 20.2 7.2 17.2 25.7 23.9 6.2 44.0 33.9 20.4 11.7 43.5 65.0 19.0 30.9 22.9 13.8 13.7 11.1 43.0 48.7 27.7 20.4 24.3 21.6 35.1 14.6 26.4 28.9 13.5 6.5 21.5 22.4 19.0 24.1 23.3 25.7 22.0 17.8 5.6 29.0 17.9 36.0 2.5 2.8 33.1 15.6 23.0 25.0 38.0 18.2 37.8 14.7 10.1 13.1 35.7 28.3 42.3 37.2 23.6 42.6 38.2 26.1 46.8 31.9 30.0 ANHX ENSG00000227059 "Anomalous homeobox" E9PGG2 12 133218312-133235877 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 39 "testis: 5.0" "Cell type enriched" "Detected in some" 7 "Spermatogonia: 27.8" "Cancer enriched" "Detected in single" 55 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.28e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-14 "DM2, IGHD114" ENSG00000227108 "Immunoglobulin heavy diversity 1-14 (non-functional)" 14 105900638-105900654 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75678660-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 47.7" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 5.1 5.8 8.3 3.4 9.7 2.8 7.4 7.9 9.6 5.5 4.8 5.1 5.8 5.9 15.5 5.4 7.3 4.6 5.9 7.4 8.1 9.4 8.0 4.7 4.9 9.1 8.6 7.3 8.0 9.0 8.3 9.3 5.0 9.3 6.7 6.7 7.8 7.2 4.8 4.3 10.0 5.2 4.3 8.8 7.1 7.5 8.2 8.9 4.8 9.4 4.4 7.2 5.8 5.5 12.6 11.4 5.8 5.2 3.6 6.1 8.5 3.9 3.5 5.2 5.1 5.9 9.4 9.8 5.2 4.6 6.0 5.0 6.3 6.8 4.5 4.2 0.5 7.0 8.6 9.4 0.9 15.9 0.5 8.6 10.4 4.8 12.8 17.4 4.3 0.7 0.5 47.7 11.6 5.7 1.8 0.6 17.1 5.2 8.9 6.3 7.7 4.5 27.0 7.6 3.8 4.2 17.4 3.5 6.6 14.6 5.1 16.8 4.6 1.6 9.3 10.9 6.4 1.4 12.0 19.9 5.2 4.7 1.3 6.0 1.3 2.6 5.1 2.1 3.8 1.2 5.1 3.3 2.0 2.7 6.1 6.3 3.7 0.7 3.0 3.8 4.1 1.1 2.0 8.3 9.7 7.9 9.6 7.4 8.1 9.1 8.6 7.3 9.3 8.8 8.9 12.6 6.6 3.2 3.1 28.1 6.0 3.2 4.2 3.4 5.2 8.5 9.1 8.3 5.6 8.6 4.2 7.3 2.1 5.2 5.8 2.2 11.7 4.6 5.0 3.4 4.8 5.1 5.3 7.4 21.7 4.4 1.8 5.7 4.6 2.6 8.9 11.4 7.9 8.2 7.3 10.1 27.2 7.0 4.1 5.7 4.1 2.1 2.5 4.5 1.8 16.9 5.0 5.2 5.2 25.6 35.4 3.9 2.0 3.0 0.7 5.1 6.3 17.5 6.3 8.1 0.0 5.1 5.3 11.1 8.6 7.0 4.4 3.4 3.1 7.9 5.0 3.9 USP17L5 ENSG00000227140 "Ubiquitin specific peptidase 17 like family member 5" A8MUK1 4 9339403-9340995 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20D ENSG00000227151 "Proline rich 20D" P86480 13 57160632-57163653 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRGC2 "TCRGC2, TRGC2(2X), TRGC2(3X)" ENSG00000227191 "T cell receptor gamma constant 2" 7 38239580-38249572 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 30.8;lymphoid tissue: 34.9;prostate: 23.9" "Group enriched" "Detected in some" 7 "dendritic cells: 149.1;NK-cells: 90.6;T-cells: 122.0" "Cancer enriched" "Detected in many" 18 "prostate cancer: 26.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 720.5" "Lineage enriched" "Detected in many" 5 "T-cells: 720.5" "Cell line enhanced" "Detected in some" "HL-60: 11.4;JURKAT: 36.6;NB-4: 29.9;SK-BR-3: 9.8;U-937: 53.9" NA NA "unprognostic (2.79e-3)" "prognostic favorable (1.06e-5)" "unprognostic (1.62e-4)" "unprognostic (3.52e-5)" "unprognostic (3.34e-1)" "unprognostic (1.46e-3)" "unprognostic (8.79e-4)" "unprognostic (4.60e-2)" "unprognostic (1.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.12e-1)" "unprognostic (3.90e-1)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (2.92e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-3)" 2.5 1.2 8.5 5.2 10.4 30.8 1.8 8.5 14.9 1.3 7.3 3.6 4.5 1.3 3.2 1.1 2.2 3.9 0.9 8.3 9.2 1.6 3.6 9.8 17.7 11.4 10.1 7.4 0.5 0.8 0.2 1.0 0.5 10.3 23.9 4.1 0.1 1.8 0.8 0.4 0.5 8.0 1.0 9.0 30.0 3.8 2.2 9.6 34.9 2.1 0.1 7.0 3.4 2.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 3.7 1.2 29.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.9 0.0 1.1 1.3 1.4 720.5 1.2 287.4 0.6 64.8 341.6 1.0 0.3 13.5 212.9 4.9 149.7 1.0 1.2 1.3 167.5 8.5 10.4 8.5 14.9 8.3 9.2 11.4 10.1 7.4 10.3 9.0 9.6 9.4 1.2 0.0 2.4 0.0 2.4 0.0 0.2 0.0 0.0 0.0 1.0 1.3 0.7 1.5 0.6 0.0 0.0 0.0 149.1 0.3 0.0 0.2 15.5 0.2 0.1 0.8 0.0 6.6 0.0 0.0 0.0 0.4 2.6 0.2 0.0 0.2 3.9 1.0 0.0 0.0 0.0 0.5 0.0 3.5 0.0 6.7 0.0 2.8 0.0 0.0 10.6 0.0 90.6 0.0 0.0 0.0 0.0 0.4 14.2 2.8 0.0 0.5 0.0 0.0 0.0 0.2 1.3 0.8 0.2 0.3 0.0 0.3 122.0 0.0 0.2 0.3 IGHD4-23 IGHD423 ENSG00000227196 "Immunoglobulin heavy diversity 4-23 (non-functional)" 14 105884870-105884888 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002594-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "testis: 89.5" "Group enriched" "Detected in some" 160 "Early spermatids: 686.8;Late spermatids: 2015.4" "Group enriched" "Detected in some" 4 "breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (8.55e-2)" 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.5 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 81.9 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 16.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 27.4 1.9 0.7 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 686.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2015.4 6.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 0.0 0.0 6.6 0.0 0.1 8.4 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859158-87863533 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.6" "Cell type enhanced" "Detected in many" "granulocytes: 5.7;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;Karpas-707: 5.1" HPA074502 Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.0 0.7 1.0 0.6 0.7 0.5 0.6 1.4 1.3 0.7 0.7 0.9 0.5 0.5 1.0 0.4 1.4 0.4 0.5 0.8 0.8 0.9 0.9 0.4 0.8 0.5 0.7 0.7 0.4 0.2 0.5 0.5 0.6 0.7 0.4 0.8 1.0 0.3 0.5 4.6 0.4 0.4 0.5 0.2 0.9 0.6 1.1 0.6 1.0 0.7 0.5 0.8 0.3 0.3 1.5 0.8 1.0 1.1 0.7 0.5 0.3 0.8 0.7 0.9 0.5 0.7 0.6 2.6 2.0 0.3 0.2 0.5 0.9 0.7 0.8 0.4 0.5 0.3 0.7 1.5 0.6 0.6 1.4 0.5 0.6 0.8 0.7 0.8 0.9 0.3 5.0 0.4 5.1 0.5 1.8 4.1 1.6 0.4 0.6 0.5 2.6 0.1 2.6 0.4 0.8 0.4 1.0 0.9 0.6 0.1 0.7 1.6 1.2 0.3 0.5 0.3 0.9 0.3 2.9 3.3 2.9 0.9 2.9 0.6 1.6 0.3 0.6 0.2 0.5 0.4 0.4 0.3 0.3 0.3 0.5 0.4 0.3 2.5 0.6 0.8 0.5 0.2 0.2 1.0 0.7 1.4 1.3 0.8 0.8 0.5 0.7 0.7 0.7 0.2 0.6 1.5 0.6 0.0 0.0 0.3 0.5 0.1 0.3 0.2 0.6 1.7 1.0 1.3 2.7 1.5 1.3 0.0 0.0 0.7 2.0 3.0 0.0 0.2 3.9 0.8 0.9 0.6 0.0 0.8 0.4 0.2 0.4 1.1 3.6 0.4 5.7 0.3 0.7 0.4 0.3 3.3 0.5 1.8 0.0 1.3 0.0 2.0 0.0 0.6 0.0 0.0 0.3 1.6 0.0 0.0 0.1 0.3 2.5 0.0 0.2 0.3 1.8 1.9 2.3 1.0 6.6 1.1 2.9 0.3 1.2 0.6 0.4 0.5 0.7 0.3 1.3 0.2 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: AB_2682014" "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 5.4 6.6 4.1 6.2 4.1 3.2 7.1 8.0 4.8 6.2 1.9 7.4 8.9 6.1 4.7 7.1 5.9 5.5 8.6 4.2 4.6 12.8 7.0 5.2 9.2 4.1 4.0 3.3 5.5 4.0 9.0 4.3 7.8 4.1 6.7 7.9 5.9 5.3 6.4 12.1 7.4 7.1 6.4 3.5 6.9 6.5 7.8 4.2 9.2 6.7 9.1 9.1 6.2 5.2 4.7 15.3 9.5 20.0 17.8 11.2 13.6 14.9 13.6 17.2 17.0 16.1 9.8 15.2 10.5 10.7 13.3 7.8 17.7 17.3 10.2 19.8 15.5 16.6 11.6 7.7 13.2 13.8 16.5 8.9 8.4 21.0 12.3 22.4 13.4 10.6 14.0 18.8 11.1 14.9 9.2 18.0 20.0 22.4 10.5 26.8 21.1 20.7 13.9 16.1 8.4 16.0 19.7 10.6 21.6 17.1 21.2 23.8 10.9 10.0 11.5 12.4 11.8 15.9 10.4 16.2 21.9 18.9 18.8 8.8 6.1 2.5 1.4 2.3 2.2 3.2 3.0 3.0 2.8 2.7 2.9 3.7 3.5 1.3 3.9 3.5 2.9 2.8 2.3 4.1 4.1 8.0 4.8 4.2 4.6 4.1 4.0 3.3 4.1 3.5 4.2 4.7 8.2 9.6 15.3 22.2 12.2 6.1 5.2 4.3 12.0 13.9 9.5 7.4 28.6 14.3 9.2 12.9 27.1 7.7 8.9 10.4 9.8 7.3 6.1 17.7 14.8 11.1 6.6 12.8 42.5 6.5 6.2 12.0 11.2 11.8 14.5 17.0 6.8 13.6 9.7 5.0 37.9 10.0 2.0 12.0 4.3 4.6 7.5 11.6 3.6 35.6 12.4 7.3 24.7 26.7 41.4 8.1 3.7 8.2 9.9 5.3 8.7 40.3 21.5 20.7 0.0 11.3 12.0 17.1 13.3 13.8 6.0 4.7 12.0 20.0 11.2 4.4 AKR1B15 ENSG00000227471 "Aldo-keto reductase family 1 member B15" C9JRZ8 7 134549110-134579875 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "breast: 168.4" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;Fibroblasts: 2.9;Late spermatids: 3.6;Skeletal myocytes: 12.5;Syncytiotrophoblasts: 10.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 15.8;HDLM-2: 12.8;Hep G2: 11.2;SK-BR-3: 5.1;U-87 MG: 6.7" "HPA020280, HPA073633" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (9.74e-3)" "unprognostic (2.74e-2)" "unprognostic (2.08e-1)" "prognostic favorable (8.36e-4)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.04e-2)" "unprognostic (2.39e-1)" "unprognostic (2.75e-1)" "unprognostic (2.14e-3)" "unprognostic (1.24e-1)" "unprognostic (1.22e-7)" "unprognostic (6.88e-2)" "unprognostic (4.29e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.90e-5)" 0.2 0.1 0.3 0.2 1.1 0.0 168.4 0.1 0.6 0.5 0.0 0.7 14.1 0.0 0.2 3.2 0.0 5.2 0.1 0.3 0.7 0.1 2.1 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.3 0.7 0.3 1.9 0.0 7.9 0.7 4.5 0.0 0.3 0.0 12.1 0.6 0.6 0.2 0.1 19.0 0.3 0.9 2.7 1.4 0.1 15.8 0.1 0.0 0.6 0.5 0.9 0.0 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 12.8 0.0 0.1 0.2 11.2 0.0 0.2 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.2 0.2 3.1 0.4 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.6 5.1 0.0 0.1 0.0 0.3 0.0 0.1 0.7 0.3 0.0 0.2 0.2 0.2 6.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.6 0.3 0.7 0.7 0.9 0.0 0.5 0.3 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.5 0.1 0.0 0.7 0.0 0.3 10.4 0.1 0.0 0.0 0.1 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 273 "testis: 27.3" "Cell type enriched" "Detected in single" 10 "Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/84: 37.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 9.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905372-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favorable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 21.8 27.7 27.1 15.6 33.6 11.5 25.7 37.7 32.8 26.9 25.8 21.2 20.0 26.3 17.6 40.2 38.6 19.7 15.1 24.7 32.6 34.7 28.6 25.8 15.7 44.5 38.3 19.6 27.3 36.8 16.0 32.1 18.9 41.5 32.0 9.9 7.4 44.2 20.6 14.0 35.9 20.5 12.4 38.0 25.3 26.6 22.2 35.2 8.4 33.0 5.8 9.4 22.2 25.2 50.6 53.6 53.9 25.7 56.8 50.7 31.7 29.6 35.5 33.1 39.3 46.7 44.9 51.1 22.5 32.1 30.7 23.1 63.7 24.7 38.2 14.5 34.8 21.7 15.8 19.0 44.3 65.6 16.9 23.2 48.8 24.2 34.8 21.2 32.9 27.2 25.2 35.7 25.3 23.3 67.8 21.5 31.6 38.8 31.1 18.6 25.9 18.1 34.6 49.8 47.5 33.8 45.0 23.9 49.9 31.4 18.1 50.6 41.5 29.6 44.8 30.5 81.1 35.7 57.8 62.6 21.0 59.1 26.9 30.1 1.7 4.4 1.9 3.9 4.9 2.0 5.1 2.7 2.6 4.8 3.4 1.5 2.9 2.1 5.8 4.5 12.0 2.3 3.7 27.1 33.6 37.7 32.8 24.7 32.6 44.5 38.3 19.6 41.5 38.0 35.2 50.6 16.9 9.6 7.3 12.1 22.9 17.1 25.0 20.8 33.0 19.7 40.0 23.5 3.0 21.5 14.1 49.7 75.0 40.0 59.6 53.0 7.9 20.8 0.8 63.2 23.2 17.8 18.7 11.6 8.3 12.5 38.1 18.2 43.3 42.1 17.2 27.8 15.7 13.4 38.0 21.9 8.0 36.1 20.3 20.1 24.9 1.9 21.8 24.2 21.4 5.6 21.0 29.6 33.0 16.6 18.9 16.1 25.3 17.3 16.0 30.0 47.6 10.1 33.2 52.2 0.0 15.8 15.7 19.0 26.1 30.8 20.2 59.0 20.4 26.9 31.1 28.1 LTB "p33, TNFC, TNFSF3" ENSG00000227507 "Lymphotoxin beta" Q06643 6 31580525-31582522 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 67.2;lymphoid tissue: 231.1" "Cell type enhanced" "Detected in many" "B-cells: 1087.8;dendritic cells: 183.5;Ductal cells: 280.4;Pancreatic endocrine cells: 296.2;T-cells: 554.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.6;Daudi: 127.4;HDLM-2: 82.2;HMC-1: 38.1;NB-4: 62.3;REH: 58.6;U-698: 90.8" "Not detected" "Not detected" HPA048884 Approved Approved Centrosome NA NA Centrosome "HPA048884: AB_2680543" "unprognostic (1.43e-2)" "unprognostic (3.89e-2)" "unprognostic (7.29e-2)" "prognostic favorable (2.36e-6)" "unprognostic (2.91e-3)" "prognostic favorable (1.74e-4)" "unprognostic (1.45e-1)" "unprognostic (9.49e-3)" "unprognostic (1.42e-3)" "unprognostic (4.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (8.91e-2)" "unprognostic (4.92e-2)" "unprognostic (6.56e-3)" "unprognostic (1.99e-1)" 2.9 0.7 0.2 83.4 0.3 19.3 1.3 0.2 0.6 1.3 0.7 5.4 8.3 1.2 0.0 4.4 1.2 4.8 0.9 0.2 0.4 9.3 4.8 8.8 104.7 0.4 0.2 0.1 0.4 2.5 0.2 0.7 0.9 0.3 2.4 2.7 0.0 4.3 0.3 1.0 2.2 67.2 1.9 0.2 231.1 14.0 0.2 0.4 84.1 3.9 1.4 48.0 8.8 1.4 0.2 18.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 35.6 127.4 1.8 0.0 0.2 0.0 0.0 0.0 0.0 82.2 0.0 1.4 0.0 0.0 0.0 0.4 38.1 0.0 0.0 0.0 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.0 18.5 62.3 0.0 0.0 0.0 58.6 0.0 11.4 32.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.7 0.0 0.0 0.5 0.0 0.0 0.0 0.8 90.8 0.0 0.0 0.0 79.2 9.2 542.5 95.7 55.9 646.7 1027.3 924.3 419.4 14.5 1021.9 713.6 317.0 327.8 142.5 94.5 412.0 672.0 308.9 0.2 0.3 0.2 0.6 0.2 0.4 0.4 0.2 0.1 0.3 0.2 0.4 0.2 3.0 0.0 9.0 1.3 1087.8 16.3 0.5 45.7 2.2 0.7 2.9 3.7 0.5 2.8 4.7 90.1 0.0 0.9 183.5 0.9 1.9 280.4 3.5 2.2 2.0 8.4 0.0 11.2 0.9 113.1 0.3 6.3 3.1 1.5 14.0 0.1 10.8 3.5 10.1 0.0 0.9 0.4 160.7 31.0 112.1 0.2 0.6 49.8 42.7 0.0 72.3 1.8 99.9 0.0 0.3 296.2 1.6 0.0 13.6 3.0 0.0 11.6 0.9 0.2 6.6 1.3 4.3 0.4 1.2 1.2 12.4 0.3 554.0 0.3 3.6 0.3 USP17L12 ENSG00000227551 "Ubiquitin specific peptidase 17 like family member 12" C9JPN9 4 9220152-9221744 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RD3L "TDRD9-AS1, TDRD9AS1" ENSG00000227729 "Retinal degeneration 3 like" P0DJH9 14 103940426-103942561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 26 "heart muscle: 23.6;retina: 13.5" "Group enriched" "Detected in some" 9 "Bipolar cells: 78.5;Cardiomyocytes: 40.8;Cone photoreceptor cells: 29.2;Horizontal cells: 26.9;Rod photoreceptor cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 10.4" "Low region specificity" "Detected in all" HPA067971 Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA067971: AB_2685935" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.5 0.0 0.0 40.8 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4-17 IGHD417 ENSG00000227800 "Immunoglobulin heavy diversity 4-17" 14 105894508-105894523 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 7.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX46 C1orf234 ENSG00000227868 "Testis expressed 46" H3BTG2 1 23010834-23015852 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "testis: 83.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.11e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (2.13e-1)" "unprognostic (1.24e-2)" "unprognostic (6.33e-2)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (9.76e-2)" "unprognostic (8.12e-2)" "unprognostic (3.82e-3)" "unprognostic (2.29e-5)" "unprognostic (1.06e-1)" "unprognostic (1.15e-1)" "unprognostic (7.60e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.3 0.5 1.5 0.1 0.0 0.0 0.1 0.2 0.7 0.4 0.2 0.0 0.1 0.7 0.5 0.1 0.1 0.2 0.0 0.7 0.7 0.4 0.1 0.2 0.1 0.2 0.0 0.7 0.2 0.0 0.7 0.0 0.0 0.1 0.7 0.0 0.1 0.2 0.0 0.0 83.8 0.5 0.0 0.0 0.0 0.2 0.0 0.1 1.2 0.1 0.0 0.4 0.1 0.9 0.2 0.4 0.0 0.1 0.3 0.2 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.1 1.1 0.3 0.1 0.2 0.0 0.2 0.6 0.2 0.1 0.2 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.5 1.5 0.7 0.5 0.7 0.7 0.4 0.7 0.2 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MRLN "Linc-RAM, LINC00948, M1, MLN, MUSER1" ENSG00000227877 Myoregulin P0DMT0 10 59736692-59756041 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 271.5;tongue: 148.6" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 118.8;Proximal tubular cells: 25.8;Respiratory ciliated cells: 35.7;Rod photoreceptor cells: 37.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Group enriched" "Detected in some" 4 "cerebellum: 4.5;pons: 1.7" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "RH-30: 13.3" "Region enriched" "Detected in many" 11 "cerebellum: 21.6" NA NA "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (4.54e-1)" "unprognostic (3.17e-3)" "unprognostic (9.77e-2)" "unprognostic (1.09e-2)" "unprognostic (8.49e-2)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (6.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" 0.1 0.2 0.5 0.1 0.4 0.3 0.2 4.5 0.7 0.5 0.4 0.2 1.0 0.5 0.8 1.2 5.1 0.7 0.1 0.5 0.3 8.2 0.2 0.7 0.1 0.5 0.6 0.3 0.3 2.8 0.0 12.0 0.1 1.7 1.3 0.1 30.9 7.0 0.1 271.5 0.6 1.1 0.1 0.0 0.5 1.0 0.8 0.4 0.3 0.3 148.6 0.1 0.0 0.1 0.7 0.0 0.8 0.4 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.6 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.7 0.2 1.8 1.1 0.1 0.0 0.6 1.0 0.0 0.6 0.0 0.1 0.0 0.1 0.1 1.0 0.0 1.1 0.0 1.0 0.2 0.2 0.8 0.5 13.3 0.0 0.0 0.2 0.6 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.3 0.3 0.6 0.2 0.5 0.1 0.1 0.4 0.3 0.0 1.7 0.3 0.4 0.6 0.1 0.4 0.5 0.3 0.3 0.2 0.6 0.2 0.5 1.2 0.3 0.3 0.4 0.3 0.0 0.5 0.4 4.5 0.7 0.5 0.3 0.5 0.6 0.3 1.7 0.0 0.4 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.1 1.0 0.0 1.8 0.0 2.1 0.0 0.1 1.5 0.0 0.2 5.6 118.8 0.8 0.7 0.0 0.0 1.3 0.2 6.4 0.4 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.5 0.6 0.3 0.0 0.4 0.0 0.1 0.0 25.8 35.7 37.8 0.0 10.1 0.2 2.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebral cortex: 5.6;medulla oblongata: 3.1;pons: 8.0" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.0;RT4: 14.0;U-2 OS: 13.6" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 1.5 1.9 0.2 3.8 0.8 2.3 2.5 0.4 5.6 2.0 0.0 2.0 3.2 1.8 2.3 3.1 1.7 2.7 1.7 0.5 0.0 2.8 2.6 2.6 3.1 3.1 0.3 0.0 2.3 3.0 3.4 2.4 1.2 8.0 2.4 1.8 4.1 2.4 1.1 4.7 3.8 4.5 0.6 0.0 4.7 2.5 1.4 0.3 1.2 3.1 1.1 4.3 1.9 2.6 0.8 2.7 2.2 1.6 1.9 3.5 5.0 3.1 3.0 0.7 1.7 1.8 1.8 5.4 2.8 0.5 2.0 1.0 2.5 1.1 0.8 4.8 2.0 3.1 1.5 4.0 1.1 1.7 6.5 2.8 0.9 0.5 1.3 2.6 0.8 0.7 1.7 2.9 6.9 1.3 1.0 20.0 2.0 1.2 0.9 0.6 2.5 0.5 2.5 1.1 14.0 1.5 1.8 2.5 1.4 1.2 2.4 0.8 1.0 1.1 3.9 13.6 0.6 2.3 3.1 2.4 2.4 1.8 2.8 1.4 11.0 2.8 2.2 3.9 1.6 2.6 4.1 4.0 2.9 1.3 5.2 4.3 3.3 2.2 2.2 2.5 4.3 2.6 1.0 0.2 0.8 0.4 5.6 0.5 0.0 3.1 0.3 0.0 8.0 0.0 0.3 0.8 2.0 6.4 2.6 8.1 4.6 1.7 4.0 1.6 0.6 6.9 2.1 1.5 0.0 5.7 1.1 9.2 10.4 6.9 8.8 2.2 5.9 4.4 0.1 1.2 2.4 3.8 3.6 5.7 15.9 0.8 4.2 2.5 4.6 1.3 1.3 5.6 6.4 2.2 3.6 5.0 12.9 2.7 4.1 5.9 1.5 0.4 9.0 3.6 0.0 6.5 7.5 2.4 15.5 9.5 10.0 1.6 1.2 3.4 2.9 2.3 8.5 4.0 2.5 11.9 0.0 5.4 3.1 8.2 11.9 0.5 1.3 7.8 4.8 5.4 2.0 3.4 BOD1L2 "BOD1P, FAM44C, MGC33608" ENSG00000228075 "Biorientation of chromosomes in cell division 1 like 2" Q8IYS8 18 57147087-57150410 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 929 "testis: 278.6" "Group enriched" "Detected in some" 5 "Early spermatids: 1765.1;Late spermatids: 4911.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036293 Uncertain NA NA "HPA036293: AB_10673127" "unprognostic (2.35e-3)" "unprognostic (3.72e-1)" "unprognostic (2.47e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 278.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1765.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4911.3 45.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.1 0.0 0.0 0.0 0.0 13.1 0.0 0.0 585.3 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA14 "IFN-alphaH, LEIF2H" ENSG00000228083 "Interferon alpha 14" P01570 9 21239002-21240005 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD6-6 "D(N4), IGHD66" ENSG00000228131 "Immunoglobulin heavy diversity 6-6" 14 105910410-105910427 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M3 "OR2M3P, OR2M6, OST003" ENSG00000228198 "Olfactory receptor family 2 subfamily M member 3" Q8NG83 1 248197265-248212925 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7" "Cell type enriched" "Detected in single" 13 "Club cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" NA NA 0.6 0.6 2.1 0.7 2.0 2.6 0.6 4.7 5.7 0.3 0.6 1.0 0.8 0.6 1.3 0.6 0.4 0.7 0.5 1.7 0.7 1.2 1.2 0.5 0.9 1.7 1.4 0.5 0.8 0.8 0.2 0.0 0.6 2.2 0.6 1.1 3.8 1.2 0.3 1.0 1.7 0.7 0.2 0.4 0.9 0.8 1.2 0.8 0.4 0.9 0.2 0.3 0.3 0.0 5.3 1.3 0.7 1.1 1.1 0.4 0.4 1.0 0.9 0.1 0.1 0.2 2.8 1.6 1.5 1.0 0.2 1.5 1.1 0.4 0.3 0.3 1.4 0.9 0.7 2.7 0.9 0.1 1.0 0.9 0.3 0.4 0.2 0.3 0.7 0.2 1.0 1.7 2.9 0.2 1.0 0.8 1.1 1.7 1.0 0.6 0.9 1.2 1.4 0.4 0.9 1.1 0.9 1.3 0.6 0.7 1.3 1.2 0.8 1.4 1.3 1.6 1.3 0.9 1.8 1.1 1.1 1.0 0.9 1.1 1.0 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.7 0.2 0.3 0.3 0.2 0.1 2.1 2.0 4.7 5.7 1.7 0.7 1.7 1.4 0.5 2.2 0.4 0.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MT-ATP8 "A6L, ATP8, MTATP8" ENSG00000228253 "Mitochondrially encoded ATP synthase membrane subunit 8" P03928 MT 8366-8572 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 254447.9" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 29301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 10572.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 10572.1" "Cell line enhanced" "Detected in all" "HeLa: 50977.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.54e-1)" "unprognostic (4.12e-2)" "unprognostic (3.95e-2)" "unprognostic (2.56e-1)" "unprognostic (3.07e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.56e-5)" "unprognostic (5.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.52e-3)" "unprognostic (8.26e-2)" "unprognostic (1.30e-2)" "unprognostic (1.10e-1)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (2.62e-1)" "unprognostic (1.63e-2)" 53012.1 73645.3 90600.2 6396.5 88959.1 4624.3 40301.3 84683.9 135906.4 14884.5 105942.0 46699.8 21094.4 18977.5 2127.4 28593.3 17393.7 3597.6 254447.9 84346.3 77576.9 120819.3 156462.7 20504.9 3699.0 109730.5 83733.5 73633.9 16809.2 41389.0 34682.7 26230.8 5141.8 112044.6 39707.2 6830.0 18664.9 30912.9 4395.9 193712.5 32365.0 47507.3 2697.9 74560.9 20481.5 64344.9 22441.4 90221.8 4597.6 27373.9 94318.9 2419.3 29700.0 19955.8 93381.6 9856.9 3525.9 11216.6 2135.1 11962.8 1899.3 5504.5 19957.4 1175.7 896.0 1537.1 4090.3 6356.6 24786.3 4872.4 4328.0 3394.0 16426.4 706.7 6608.9 1397.3 11058.2 4500.9 18761.8 50977.1 9430.6 2174.3 11096.3 15424.0 4128.5 3403.9 1971.6 1680.6 12377.4 1285.7 9692.8 10174.9 7582.9 2738.5 5189.9 6492.1 16113.6 2467.4 5471.7 2512.1 5306.1 5447.4 5282.8 6499.8 9510.1 3516.6 6319.5 7567.6 6909.7 7767.4 17681.0 6781.8 22941.8 18909.8 4285.7 9562.3 9574.5 9412.0 5112.9 9201.9 14522.4 4225.0 18954.8 2666.9 10572.1 1775.5 2174.2 955.4 1388.5 1410.8 1767.9 1079.8 1154.3 992.0 1612.2 1301.2 1614.6 968.7 1526.5 1514.0 1189.7 924.2 673.4 90600.2 88959.1 84683.9 135906.4 84346.3 77576.9 109730.5 83733.5 73633.9 112044.6 74560.9 90221.8 93381.6 76.9 189.1 178.7 0.0 1182.0 11.6 7.0 9.5 3775.0 0.0 104.1 150.4 29301.8 225.9 340.8 12.9 0.0 0.0 78.7 124.2 3.9 13.4 7.3 182.9 170.7 625.6 29.2 733.7 0.0 30.7 0.0 771.2 3726.9 282.0 295.9 161.6 219.2 729.6 0.0 0.0 0.0 59.9 0.0 344.8 8.0 42.1 40.7 539.8 12.4 0.0 23.5 0.0 21.6 0.0 0.0 20.3 98.8 25.2 1785.2 4.5 63.6 21.3 363.2 0.0 39.5 113.1 718.6 23.9 30.7 2607.0 9.1 0.0 731.3 62.3 52.8 6.7 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333251 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 327 "liver: 8946.0" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 10792.5" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 40 "neutrophil: 12.0" "Lineage enriched" "Detected in single" 40 "granulocytes: 12.0" "Cell line enriched" "Detected in some" 232 "Hep G2: 831.1" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 422000000 41000000000 Vesicles "Golgi apparatus" "HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 3.1 4.1 0.9 3.2 0.3 27.3 3.0 0.1 0.2 1.3 0.2 0.3 0.2 2.1 0.1 0.4 0.4 0.6 0.7 0.1 0.2 1.8 8946.0 5.8 1.1 0.2 0.3 0.0 0.3 2.2 0.0 0.2 0.2 0.1 23.8 0.1 3.6 0.3 0.0 0.4 0.4 0.4 0.1 0.7 7.4 22.1 1.4 0.1 0.5 0.3 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 831.1 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.1 1.1 0.4 2.5 0.0 0.3 1.9 0.1 0.0 0.3 0.1 0.0 2.6 2.0 0.2 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.6 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.1 0.0 0.0 0.1 0.9 0.3 0.1 0.2 0.1 0.2 0.2 0.3 0.0 0.1 0.7 0.1 0.2 0.0 0.0 10.5 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 263.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.6 1.1 0.1 7.0 0.0 141.7 0.0 6.0 0.0 0.0 15.8 1.3 0.0 0.0 162.8 10792.5 0.0 0.0 0.0 0.0 0.0 236.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.2 FAM174C "C19orf24, FLJ20640" ENSG00000228300 "Family with sequence similarity 174 member C" Q9BVV8 19 1275530-1279244 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 89.9;Extravillous trophoblasts: 148.9;Hofbauer cells: 121.6;Syncytiotrophoblasts: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 40.7 74.0 28.4 27.8 27.3 25.0 39.2 28.0 46.2 34.1 28.8 35.1 27.8 36.9 11.6 52.7 29.7 20.2 29.7 26.1 26.7 52.2 122.9 32.0 32.0 28.8 26.9 24.1 28.0 56.5 12.2 42.7 16.6 30.0 49.6 7.2 2.1 41.1 16.6 22.0 47.0 36.7 9.5 27.2 54.5 43.3 45.0 27.7 17.9 45.1 4.9 10.5 40.4 33.7 28.5 97.3 90.3 8.6 72.6 13.8 32.7 34.0 48.0 24.8 48.2 42.4 102.8 52.2 29.5 64.3 16.5 32.0 51.5 15.3 48.8 5.6 103.2 87.0 31.2 79.1 61.1 57.6 67.1 65.3 39.2 61.1 36.3 16.0 14.0 35.2 85.3 61.1 153.8 19.6 96.0 78.9 94.4 43.7 45.4 96.4 58.2 17.4 172.4 26.9 50.5 60.4 39.6 31.0 69.2 109.0 5.9 50.5 105.1 24.2 86.6 27.9 106.6 111.2 102.4 146.1 36.6 93.5 80.2 79.2 46.6 94.6 35.3 107.8 104.2 106.6 153.2 114.9 114.2 97.9 136.8 106.2 109.0 16.4 78.5 93.5 165.3 121.5 81.4 28.4 27.3 28.0 46.2 26.1 26.7 28.8 26.9 24.1 30.0 27.2 27.7 28.5 16.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 89.9 17.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 148.9 7.3 0.0 0.0 0.0 0.0 0.0 0.0 121.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 96.2 3.0 0.0 0.0 0.0 IGKV3D-7 ENSG00000228325 "Immunoglobulin kappa variable 3D-7" A0A0C4DH55 2 90234812-90235370 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.6;lymphoid tissue: 5.6;stomach 1: 4.5;urinary bladder: 5.5" "Cell type enriched" "Detected in single" 415 "Plasma cells: 207.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "memory B-cell: 2.8;naive B-cell: 4.3" "Lineage enriched" "Detected in single" 44 "B-cells: 4.3" "Cell line enriched" "Detected in some" 12 "RPMI-8226: 48.7" HPA047702 Approved "Immunoglobulin genes" NA NA 3700000000 "HPA047702: " "unprognostic (2.74e-1)" "unprognostic (8.62e-3)" "unprognostic (6.59e-2)" "unprognostic (2.14e-1)" "unprognostic (3.05e-1)" "unprognostic (4.02e-1)" 0.1 0.0 0.0 5.6 0.2 1.3 0.1 0.0 0.1 0.2 0.0 4.1 4.6 0.0 0.0 1.9 0.1 1.6 0.0 0.1 0.2 0.0 0.2 0.5 1.4 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 2.1 0.1 0.0 0.0 4.5 0.0 0.0 3.8 4.5 0.0 0.1 0.3 0.6 0.0 4.4 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 207.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OST4 ENSG00000228474 "Oligosaccharyltransferase complex subunit 4, non-catalytic" P0C6T2 2 27070472-27071654 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-2)" "unprognostic (4.42e-2)" "unprognostic (2.24e-1)" "unprognostic (3.63e-1)" "unprognostic (5.95e-2)" "unprognostic (1.95e-3)" "prognostic unfavorable (5.11e-4)" "unprognostic (2.66e-1)" "unprognostic (1.18e-1)" "unprognostic (2.88e-2)" "unprognostic (7.89e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (7.35e-5)" "unprognostic (1.33e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-1)" "unprognostic (9.88e-2)" 304.7 327.0 336.7 279.2 343.1 449.8 291.6 345.7 444.4 368.3 353.4 370.0 257.6 216.6 462.9 270.9 260.9 300.4 546.5 331.6 370.7 314.2 396.1 222.7 373.5 354.1 342.3 328.2 332.2 297.9 380.5 170.4 234.1 351.5 270.7 330.7 147.6 415.4 323.7 400.7 207.2 300.6 328.6 351.0 262.9 271.6 139.1 352.7 447.3 279.5 538.9 355.0 485.5 233.7 385.4 526.7 444.8 492.1 336.3 1362.9 1154.9 327.7 635.8 749.7 386.9 559.9 450.5 435.2 248.4 427.1 1044.1 572.4 244.1 321.3 701.9 305.9 486.4 491.5 527.4 300.4 1082.4 769.3 386.5 465.7 1235.3 591.0 509.8 468.3 952.9 916.5 490.1 337.2 509.8 882.5 641.8 472.7 710.4 293.7 1029.8 695.8 274.1 543.6 617.9 906.6 577.2 289.7 660.5 337.8 541.2 469.8 622.6 294.5 449.5 683.7 541.5 461.0 409.5 449.6 835.8 720.7 893.5 551.9 427.2 466.0 3182.5 1405.3 2129.1 1337.7 1230.8 1558.0 1748.5 1752.0 1469.2 1341.1 1473.3 1607.2 1551.1 1133.7 1049.8 1221.4 2614.4 1818.9 4735.8 336.7 343.1 345.7 444.4 331.6 370.7 354.1 342.3 328.2 351.5 351.0 352.7 385.4 370.4 176.3 301.9 13.7 522.3 411.2 417.7 1106.0 233.9 58.1 754.0 1020.4 369.3 377.4 595.2 663.9 20.9 527.6 555.4 597.3 1195.4 611.5 211.3 296.4 453.3 395.7 435.1 465.9 4.7 661.7 841.8 394.3 215.6 561.8 460.2 316.1 616.8 808.5 843.3 33.7 6.1 993.1 573.7 569.5 600.1 142.5 504.2 577.1 597.7 6.5 1041.6 309.1 632.4 9.5 13.5 668.3 725.3 429.1 749.7 509.8 1012.6 1348.1 310.0 81.8 295.9 230.7 492.5 242.3 392.6 424.9 589.0 577.1 532.4 299.2 669.3 620.6 C2orf92 LINC01125 ENSG00000228486 "Chromosome 2 open reading frame 92" A0A1B0GVN3 2 97664217-97703064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 11.8" "Cell type enhanced" "Detected in some" "Adipocytes: 2.5;Alveolar cells type 2: 7.5;Breast glandular cells: 3.3;Breast myoepithelial cells: 2.7;Club cells: 2.5;Endometrial ciliated cells: 3.7;Endometrial stromal cells: 2.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HDLM-2: 2.0" "Not detected" "Not detected" NA NA "unprognostic (5.53e-2)" "unprognostic (8.76e-2)" "unprognostic (1.65e-2)" "unprognostic (2.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.09e-3)" "unprognostic (9.29e-2)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.98e-3)" "unprognostic (2.76e-2)" "unprognostic (7.45e-7)" "unprognostic (5.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.11e-1)" "unprognostic (5.23e-5)" 1.3 1.3 2.7 0.3 2.8 0.4 1.8 2.9 4.5 1.6 2.7 1.1 0.4 1.0 1.8 0.8 1.2 0.2 1.6 2.7 2.8 1.5 2.6 1.6 0.2 2.8 2.8 2.6 0.9 2.1 0.3 1.5 0.3 2.8 2.0 0.4 0.7 1.9 0.6 1.5 2.1 1.3 0.2 2.8 3.0 1.1 11.8 2.8 0.4 3.6 0.0 0.5 0.8 1.3 3.1 0.1 0.0 1.6 0.3 0.7 0.6 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.8 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.4 0.6 0.1 0.5 0.7 0.2 1.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.8 2.9 4.5 2.7 2.8 2.8 2.8 2.6 2.8 2.8 2.8 3.1 2.5 0.0 7.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.3 2.7 0.0 0.0 2.5 0.0 0.0 0.7 1.6 0.0 0.0 0.6 0.0 3.7 2.7 0.5 0.0 0.0 0.0 1.6 0.6 0.6 0.0 2.3 1.3 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.9 1.6 0.0 0.0 CT47A7 CT47.7 ENSG00000228517 "Cancer/testis antigen family 47 member A7" Q5JQC4 X 120953282-120956600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VN1R4 V1RL4 ENSG00000228567 "Vomeronasal 1 receptor 4" Q7Z5H5 19 53266676-53267723 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027018 Uncertain NA NA "HPA027018: AB_10603142" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUTM2E FAM22E ENSG00000228570 "NUT family member 2E" B1AL46 10 79841358-79850878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.2;Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.0;NB-4: 1.6;U-266/84: 1.2" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (2.82e-1)" "unprognostic (3.95e-1)" "unprognostic (1.90e-1)" "unprognostic (1.00e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-1)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (2.33e-1)" "unprognostic (1.03e-1)" "unprognostic (2.58e-1)" "unprognostic (3.66e-1)" "unprognostic (4.35e-1)" "unprognostic (4.09e-1)" 0.1 0.1 0.6 0.0 0.6 0.1 0.1 1.1 0.7 0.2 0.1 0.1 0.2 0.2 0.6 0.1 0.2 0.1 0.2 0.6 0.4 0.1 0.2 0.2 0.3 0.7 0.5 0.4 0.2 0.3 0.0 0.5 0.1 0.9 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.4 0.3 0.1 0.7 0.6 0.5 0.3 0.3 0.0 0.1 0.1 2.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 2.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.6 1.6 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.7 1.2 0.1 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.1 0.7 0.6 0.4 0.7 0.5 0.4 0.9 0.4 0.6 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 FNDC10 C1orf233 ENSG00000228594 "Fibronectin type III domain containing 10" F2Z333 1 1598012-1600135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.6;brain: 24.1" "Group enriched" "Detected in some" 6 "Granulosa cells: 57.0;Theca cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 27.8" "Low region specificity" "Detected in all" NA NA "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (8.35e-2)" "unprognostic (7.32e-3)" "unprognostic (4.33e-2)" "unprognostic (3.33e-1)" "unprognostic (3.12e-1)" "unprognostic (2.72e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (1.50e-1)" "unprognostic (6.00e-2)" "unprognostic (5.76e-2)" 1.0 25.6 9.0 1.6 9.1 2.7 1.4 8.9 24.1 1.4 3.5 1.3 2.2 1.1 0.0 9.6 0.8 2.2 2.1 10.5 16.3 3.7 0.5 2.4 1.1 18.2 12.9 9.2 1.9 0.9 7.5 11.0 1.0 16.8 0.9 0.5 0.6 2.2 0.4 0.3 9.9 1.6 0.6 5.7 3.1 2.9 8.3 11.2 0.3 5.3 0.3 0.8 1.2 3.7 14.6 0.0 4.1 3.9 12.1 7.9 1.8 5.5 9.6 1.9 15.1 0.8 3.7 17.2 0.0 11.2 4.7 0.1 2.5 0.9 2.1 1.3 0.0 3.5 0.2 4.1 9.1 1.8 3.0 27.8 2.6 9.5 0.7 0.1 1.8 1.0 11.0 8.0 0.0 1.8 18.7 2.3 9.1 16.6 5.8 5.9 0.0 0.0 9.7 5.4 0.9 17.9 14.8 10.2 15.1 10.6 2.5 0.0 9.3 1.6 0.0 2.9 6.5 0.0 2.9 0.3 0.2 0.0 6.2 4.3 0.0 0.7 1.6 0.1 0.5 0.1 0.0 0.3 0.3 0.7 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.3 0.2 9.0 9.1 8.9 24.1 10.5 16.3 18.2 12.9 9.2 16.8 5.7 11.2 14.6 0.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.9 8.5 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 3.9 1.3 0.0 2.4 3.0 0.5 0.0 0.0 0.0 0.9 2.5 2.4 0.0 4.7 0.0 57.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 46.3 0.0 0.0 CLDN25 ENSG00000228607 "Claudin 25" C9JDP6 11 113779747-113780500 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053555 Uncertain NA NA "HPA053555: AB_2682186" "unprognostic (1.02e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395104 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 81.8" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 7 "HDLM-2: 104.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053354, HPA060103" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053354: , HPA060103: AB_2684205" "unprognostic (4.14e-2)" "prognostic favorable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 1.4 4.9 4.1 0.9 3.2 0.4 1.5 4.6 2.6 1.3 1.9 1.3 1.2 1.7 0.4 1.0 2.1 0.4 16.8 2.9 5.3 1.7 0.6 0.9 1.0 5.3 6.2 1.7 0.6 0.4 2.4 3.0 0.6 4.9 3.3 0.1 0.3 2.4 1.3 81.8 0.6 1.6 0.5 6.3 1.6 1.2 0.8 4.8 0.7 1.0 18.5 0.6 1.6 1.0 3.6 1.5 0.6 0.3 0.3 0.1 0.3 0.5 1.2 0.3 1.3 1.1 4.3 2.6 5.7 1.1 3.9 0.1 0.7 0.5 0.1 0.3 104.7 1.4 1.4 2.7 0.5 3.0 0.0 3.2 0.9 0.7 2.8 0.6 0.7 0.1 3.7 0.5 5.7 4.1 1.2 4.9 2.6 1.4 0.6 2.7 15.4 0.4 12.5 0.2 0.1 1.3 0.7 6.0 4.5 0.2 1.3 2.1 3.0 0.4 0.1 0.4 0.2 0.4 1.0 1.8 9.2 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 3.2 4.6 2.6 2.9 5.3 5.3 6.2 1.7 4.9 6.3 4.8 3.6 2.4 0.0 0.0 0.0 0.7 0.0 0.3 0.0 1.2 0.0 0.4 0.1 29.7 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.2 2.4 1.5 2.5 0.0 0.4 0.0 0.0 0.3 1.2 1.1 0.9 0.0 0.7 2.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.3 0.1 1.2 3.0 0.3 0.0 2.4 0.0 0.2 6.6 5.6 2.9 0.4 0.8 0.3 0.0 2.6 0.4 2.4 0.6 0.3 ARL17B ARL17 ENSG00000228696 "ADP ribosylation factor like GTPase 17B" Q8IVW1 17 46274784-46361797 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 63.3;Excitatory neurons: 107.1;Inhibitory neurons: 96.0;Microglial cells: 62.8;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 54.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 18.4;U-266/84: 21.2" HPA046814 Uncertain NA NA "HPA046814: AB_2679821" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (8.11e-2)" "unprognostic (1.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.56e-2)" "unprognostic (5.29e-2)" "unprognostic (1.99e-1)" "unprognostic (7.25e-2)" "unprognostic (6.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (7.57e-2)" "unprognostic (1.57e-1)" "unprognostic (8.36e-2)" "unprognostic (2.78e-2)" "unprognostic (8.83e-2)" 3.9 5.6 3.2 4.1 4.4 5.7 5.3 10.3 6.3 5.7 1.7 4.9 0.6 5.8 2.9 5.1 4.5 0.9 4.1 3.4 3.0 3.1 4.3 3.5 4.8 5.0 2.1 2.8 5.9 3.9 4.4 4.5 1.8 5.2 4.8 3.6 9.3 3.9 2.8 7.4 5.4 3.5 4.8 1.4 3.4 4.0 4.5 4.2 4.3 5.3 5.9 4.0 5.1 4.7 11.5 2.3 0.6 6.4 2.5 2.2 1.4 0.9 2.1 1.0 0.9 2.3 10.2 3.1 14.3 1.6 0.7 13.4 0.9 2.2 0.2 1.6 7.2 16.7 1.9 18.4 10.9 2.9 3.1 1.5 0.8 6.4 1.4 0.7 1.9 3.4 5.4 1.0 3.1 6.3 1.0 2.8 2.8 3.5 0.6 1.0 8.2 11.6 5.4 0.2 5.0 2.5 1.4 2.3 1.5 0.3 2.6 2.0 9.6 6.5 8.9 10.1 1.5 1.4 10.2 21.2 1.3 2.2 7.6 3.3 17.3 4.7 1.5 4.3 2.3 3.6 4.5 5.3 4.8 3.5 8.9 7.1 6.9 2.9 6.8 2.5 7.7 3.2 2.7 3.2 4.4 10.3 6.3 3.4 3.0 5.0 2.1 2.8 5.2 1.4 4.2 11.5 4.6 6.4 2.2 63.3 4.6 5.0 2.2 3.7 0.6 7.8 3.9 3.9 4.8 1.5 4.9 3.7 10.4 2.9 4.5 1.3 3.9 1.8 4.3 3.9 6.4 3.5 3.5 0.8 107.1 2.9 1.6 4.4 0.5 3.5 3.8 8.9 2.5 0.6 1.6 8.4 96.0 1.0 4.1 2.2 4.0 3.6 5.0 2.7 3.6 62.8 3.8 4.5 4.1 56.3 54.2 1.6 0.5 6.0 1.5 2.8 1.2 1.7 4.1 12.6 19.7 4.3 4.7 9.5 4.4 0.6 4.0 0.8 4.0 4.4 1.9 11.2 DHFR ENSG00000228716 "Dihydrofolate reductase" P00374 5 80626226-80654983 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methotrexate resistance, One-carbon metabolism" "Oxidoreductase, RNA-binding" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 145.8;Spermatocytes: 132.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037129, HPA051465" Uncertain Approved Mitochondria NA Yes Mitochondria "CAB037129: AB_439683, HPA051465: AB_2681494" "unprognostic (1.44e-2)" "unprognostic (1.03e-2)" "unprognostic (2.24e-3)" "unprognostic (2.91e-3)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (2.83e-2)" "unprognostic (2.35e-2)" "unprognostic (2.02e-2)" "unprognostic (4.19e-3)" "unprognostic (1.83e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (1.82e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" 25.4 5.4 18.4 20.9 18.2 54.8 12.1 18.0 19.9 8.0 14.8 21.6 24.7 8.7 7.1 14.3 7.5 8.5 7.2 15.8 18.9 21.5 60.6 7.6 41.8 19.1 18.7 14.3 6.7 3.3 9.2 6.4 14.5 19.7 9.0 25.5 10.4 6.9 9.6 19.8 9.9 25.3 12.1 19.9 10.4 12.3 18.7 18.0 61.2 8.3 26.0 39.8 10.4 5.7 19.9 98.1 66.6 164.8 122.7 30.7 32.0 60.6 76.5 58.1 130.2 149.0 63.8 114.6 196.9 32.5 44.6 106.0 67.0 214.4 98.6 208.5 88.2 132.1 94.8 104.5 59.5 6.6 111.7 40.3 22.3 9.9 116.9 13.0 22.2 63.9 142.0 108.3 146.7 133.5 98.2 276.5 44.9 83.6 48.3 38.5 176.7 323.3 194.1 75.1 61.5 134.3 93.7 107.9 49.9 54.6 83.5 98.5 108.6 38.5 41.0 62.0 116.0 148.3 68.2 146.6 210.3 91.5 222.1 107.7 0.2 0.3 0.2 0.5 0.6 0.2 0.5 0.6 0.8 0.5 0.5 0.5 0.6 0.8 0.5 0.5 0.8 0.9 0.6 18.4 18.2 18.0 19.9 15.8 18.9 19.1 18.7 14.3 19.7 19.9 18.0 19.9 4.1 6.4 11.7 4.9 21.4 6.9 6.5 6.0 4.0 3.5 8.9 8.9 13.0 4.3 6.1 14.7 2.1 35.2 7.4 19.3 9.8 7.4 7.4 10.8 7.7 7.7 4.9 145.8 7.3 3.7 47.3 12.0 11.7 8.0 2.5 22.0 10.0 48.3 44.7 3.3 7.2 19.1 4.1 18.9 4.4 6.4 14.0 12.8 0.0 4.7 7.1 14.5 13.4 3.5 6.0 4.7 10.3 16.1 60.9 2.9 26.6 40.0 6.9 3.2 13.1 9.0 12.5 132.2 49.8 21.2 5.5 13.3 11.8 12.3 38.1 12.1 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762996-31764851 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 21.7" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;U-2 OS: 1.1;U-937: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071699 Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA071699: AB_2686433" "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 2.2 1.1 0.4 0.0 0.3 0.2 2.5 0.4 0.9 2.3 0.4 3.3 0.0 2.6 0.1 2.6 4.0 0.0 1.2 0.4 0.3 7.4 3.1 2.0 0.6 0.4 0.3 0.3 3.8 2.1 0.0 6.1 0.1 0.3 6.1 0.3 1.2 2.3 0.1 1.0 21.7 3.9 0.1 0.4 4.9 2.6 3.6 0.4 0.2 2.3 0.0 0.1 2.5 2.3 0.4 0.4 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.3 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.7 0.4 0.2 0.2 0.2 0.5 0.0 0.1 0.7 1.4 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.3 0.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.7 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.9 0.4 0.3 0.4 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;pituitary gland: 1.9;testis: 3.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Spermatogonia: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/84: 195.1" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.6 1.3 0.2 0.0 0.0 0.0 1.9 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.1 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 6.4 0.0 0.1 2.0 195.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.3 1.0 0.4 1.2 0.6 1.3 0.2 1.8 0.3 1.5 2.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L30 ENSG00000228856 "Ubiquitin specific peptidase 17 like family member 30" Q0WX57 4 9363129-9364721 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY3 CT78 ENSG00000228927 "Testis specific protein Y-linked 3" P0CV98 Y 9398421-9401223 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 3.0" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "U-266/70: 148.5;U-266/84: 145.3" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 148.5 145.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDD3 ENSG00000228985 "T cell receptor delta diversity 3" 14 22449113-22449125 "Predicted intracellular proteins, T-cell receptor genes" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL41 L41 ENSG00000229117 "Ribosomal protein L41" P62945 12 56116590-56117967 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 35670.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053169 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053169: AB_2682067" "unprognostic (7.99e-2)" "unprognostic (1.07e-1)" "unprognostic (2.11e-1)" "unprognostic (3.53e-2)" "unprognostic (8.94e-2)" "unprognostic (1.43e-1)" "unprognostic (4.61e-3)" "unprognostic (1.50e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.79e-1)" "unprognostic (8.79e-2)" "unprognostic (1.80e-1)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" 3853.1 4329.2 3403.7 3130.1 3404.8 7004.2 7627.8 3299.5 4901.1 4497.5 3522.1 4681.3 3193.0 3244.0 5233.7 5239.8 4491.3 2417.0 3073.3 3323.0 3621.3 3359.1 4392.3 3137.7 5552.4 3497.5 3374.7 3250.9 8773.3 8575.2 4196.4 3156.3 2411.9 3455.9 4148.2 4450.7 1741.0 5163.7 3013.8 6191.2 6011.2 3551.0 2895.0 3484.7 3916.9 4332.8 971.5 3461.2 5368.2 3553.3 4769.7 6509.6 4716.7 4362.0 3573.3 6313.5 7806.3 7002.4 4830.9 7462.6 11563.8 4509.5 5592.4 7268.0 6990.8 5609.0 7636.8 7281.1 11851.0 7075.7 7144.1 2202.9 5093.1 8802.0 9018.4 6003.8 4866.6 8636.4 5198.6 5743.2 7893.5 8420.9 9422.8 4324.7 12971.4 11986.3 6362.7 13815.8 13392.7 8210.7 6311.2 5234.4 11000.9 6880.6 11434.7 8612.8 13968.6 8415.8 7977.4 7366.9 6352.2 6645.3 9568.4 9027.5 8830.5 4162.2 7204.8 5240.2 7801.5 11830.4 4744.8 9323.1 11208.4 5182.2 2985.4 5510.3 3766.0 5664.5 4989.5 9471.9 9750.5 4626.0 7490.8 3249.4 5072.5 5556.2 2971.9 6805.5 4758.3 9483.2 13388.0 10983.9 8845.1 6687.5 11498.7 11453.0 10037.6 2088.9 6839.0 4546.0 8108.0 9032.3 22344.5 3403.7 3404.8 3299.5 4901.1 3323.0 3621.3 3497.5 3374.7 3250.9 3455.9 3484.7 3461.2 3573.3 5593.1 2484.0 4469.3 30.3 8258.1 20641.6 3999.9 15748.5 2099.5 489.3 25242.7 35670.2 584.2 6852.9 7643.1 3948.6 218.9 5477.3 8310.1 4631.3 10318.6 6428.1 822.2 3402.2 5615.0 4720.6 5139.1 3676.0 34.1 17900.6 8796.9 4448.1 803.8 4299.0 3546.3 5173.9 6544.8 10920.0 5896.5 213.7 31.0 11437.4 4752.5 9497.7 16486.3 3378.1 6739.8 4472.1 11120.4 34.7 11045.4 2983.4 7243.1 20.1 42.9 11407.4 10209.4 2920.3 2410.0 4695.0 12534.2 12547.9 4754.9 804.3 2143.1 4895.2 5070.6 550.0 666.0 3054.1 25829.7 5993.0 7150.4 4176.6 12114.5 4014.3 PGA4 ENSG00000229183 "Pepsinogen A4" P0DJD7 11 61222349-61231694 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1759 "stomach 1: 67237.8" "Cell type enriched" "Detected in some" 8 "Exocrine glandular cells: 109.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4" "Lineage enriched" "Detected in single" 26 "monocytes: 10.9" "Group enriched" "Detected in some" 6 "BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7" HPA046875 Supported "Secreted to digestive system" NA NA "HPA046875: AB_2679851" "unprognostic (2.22e-1)" 7.8 8.4 0.0 2.1 0.0 0.0 9.0 0.0 0.2 5.5 0.0 28.4 2.5 4.6 0.0 9.1 19.2 0.3 5.0 0.1 0.0 30.6 11.8 38.2 0.0 0.0 0.0 0.0 4.1 19.0 0.0 3.6 3.8 0.1 16.4 0.4 0.3 4.6 0.7 2.5 3.8 2.9 0.8 0.1 5.2 67237.8 4.4 0.0 0.1 3.1 0.0 0.2 5.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.0 3.4 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 109.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL4AL1 RNF210B ENSG00000229292 "Ret finger protein like 4A like 1" F8VTS6 19 55769118-55773420 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.3;monocytes: 3.5" "Cell line enriched" "Detected in some" 19 "U-2 OS: 40.2" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (8.87e-2)" 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 192 "liver: 43326.9" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 58657.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 47 "neutrophil: 193.9" "Lineage enriched" "Detected in many" 47 "granulocytes: 193.9" "Cell line enriched" "Detected in some" 12 "Hep G2: 1182.7" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 945000000000 61000000000 Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 8.8 10.3 0.7 12.8 0.2 225.2 6.7 0.1 0.4 2.1 0.2 1.4 0.1 2.7 0.3 2.0 1.9 1.0 3.3 0.2 0.1 5.0 43326.9 24.6 0.7 0.3 0.2 0.0 1.6 8.2 0.0 1.4 1.3 0.2 58.1 0.0 1.1 1.4 0.0 2.0 1.6 2.3 0.3 0.5 51.7 19.4 2.8 0.1 1.2 2.8 0.3 0.1 1.6 2.2 0.2 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 3.4 0.6 1182.7 0.1 5.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.2 1.0 0.1 0.0 0.7 7.1 0.0 0.0 0.4 0.0 0.0 5.7 5.5 0.0 0.0 0.4 102.0 1.2 0.0 0.5 0.0 0.0 1.2 0.6 3.5 0.0 4.3 0.1 0.0 4.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.9 0.0 1.0 0.0 0.0 1.8 0.7 0.2 0.1 0.4 0.2 0.1 0.3 0.2 0.0 0.2 0.5 0.1 0.2 0.0 3.2 18.1 0.0 81.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1166.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 1.3 0.2 34.4 0.0 890.4 0.0 4.9 0.3 0.2 0.0 2.5 0.0 0.0 930.9 58657.7 0.1 0.0 0.0 0.0 0.0 1260.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.3 SPINK8 ENSG00000229453 "Serine peptidase inhibitor Kazal type 8 (putative)" P0C7L1 3 48306842-48328341 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "bone marrow: 11.6;breast: 44.6" "Group enriched" "Detected in some" 5 "Breast glandular cells: 22.1;Breast myoepithelial cells: 9.9" "Group enriched" "Detected in some" 10 "breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "eosinophil: 1.3;neutrophil: 1.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.7" "Cell line enriched" "Detected in some" 60 "SK-BR-3: 73.2" "Region enriched" "Detected in many" 9 "hippocampal formation: 73.7" "Low region specificity" "Detected in all" HPA053151 Uncertain "Secreted to blood" NA NA "HPA053151: AB_2682059" "prognostic unfavorable (8.47e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" 0.0 0.0 2.0 0.0 2.0 11.6 44.6 2.4 4.6 0.0 0.3 0.0 0.1 0.0 2.5 2.9 0.2 0.0 0.0 2.9 1.7 0.0 0.0 0.1 0.0 2.8 1.7 1.9 0.0 0.4 0.0 0.2 0.2 2.5 0.5 0.0 0.3 2.1 0.3 0.0 0.1 0.0 0.0 1.3 0.6 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 73.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 2.0 2.0 2.4 4.6 2.9 1.7 2.8 1.7 1.9 2.5 1.3 1.9 2.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 22.1 9.9 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.1 0.0 1.2 0.0 0.0 2.7 1.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 PATL2 Pat1a ENSG00000229474 "PAT1 homolog 2" C9JE40 15 44665732-44711316 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.8;lymphoid tissue: 17.3" "Cell type enhanced" "Detected in many" "B-cells: 29.2;dendritic cells: 19.1;NK-cells: 51.5;Plasma cells: 15.7;T-cells: 29.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8" "Lineage enriched" "Detected in many" 6 "T-cells: 21.6" "Cell line enriched" "Detected in some" 28 "U-266/70: 124.9" "Not detected" "Not detected" NA NA "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (3.30e-3)" "unprognostic (5.55e-2)" "unprognostic (7.28e-2)" "unprognostic (1.11e-2)" "unprognostic (3.00e-3)" "unprognostic (7.82e-2)" "unprognostic (3.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.44e-2)" "unprognostic (9.48e-2)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (9.69e-4)" 0.9 1.1 0.7 7.8 1.0 7.8 1.3 0.8 1.0 0.3 1.6 2.1 2.4 1.1 1.7 0.6 1.4 2.3 0.7 0.7 1.3 0.6 1.7 4.0 17.3 1.4 0.8 0.4 1.0 0.6 0.4 0.2 1.1 1.1 0.8 2.5 0.1 2.5 0.6 0.3 2.8 3.2 0.8 0.9 14.0 3.2 0.5 1.1 3.6 0.7 0.0 10.9 2.1 0.2 1.5 0.2 0.0 0.0 0.1 0.0 1.1 2.8 0.1 0.4 0.9 0.9 0.6 1.2 0.9 0.1 0.3 1.8 1.3 0.1 0.2 0.5 2.1 0.0 1.2 0.0 0.1 0.5 0.5 0.7 1.2 0.1 0.5 0.3 0.2 0.0 1.4 0.2 4.5 0.3 0.3 0.1 1.4 0.4 0.1 0.1 1.8 0.0 0.5 0.1 0.4 0.1 0.0 0.0 1.3 0.1 0.2 0.1 0.9 0.6 0.3 0.0 0.8 0.0 124.9 4.3 0.4 1.2 3.1 0.4 1.5 0.3 2.6 21.6 0.7 3.2 3.3 6.0 17.7 0.7 3.5 3.6 12.8 1.6 2.7 0.5 0.6 0.9 3.7 0.7 1.0 0.8 1.0 0.7 1.3 1.4 0.8 0.4 1.1 0.9 1.1 1.5 1.4 3.2 1.7 1.6 29.2 0.9 0.6 0.5 0.6 0.0 0.6 0.6 11.7 0.0 0.4 0.0 0.0 0.2 19.1 2.0 0.0 0.4 0.3 2.4 1.0 1.8 0.0 3.0 0.3 0.6 0.5 1.9 8.2 0.8 0.0 1.2 1.4 1.0 2.0 0.0 0.4 1.4 0.0 4.8 2.3 0.0 0.3 5.6 0.0 3.7 5.2 0.0 51.5 0.5 1.3 0.4 0.3 0.0 15.7 0.6 2.2 0.4 8.5 0.0 0.0 1.0 2.6 0.1 0.4 1.4 0.9 0.3 29.8 1.8 0.9 1.3 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445243-124450035 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Basal squamous epithelial cells: 2.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.7;hTCEpi: 5.4;NTERA-2: 10.8;SCLC-21H: 4.7;SuSa: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA029367 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 5.7 0.5 0.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.1 0.0 0.1 12.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 TSPY8 ENSG00000229549 "Testis specific protein Y-linked 8" P0CW00 Y 9357797-9360599 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 1.3" "Group enriched" "Detected in some" 17 "Spermatocytes: 2.0;Spermatogonia: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 266 "U-266/84: 291.5" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 1.0 291.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF25 ENSG00000229571 "PRAME family member 25" A6NGN4 1 13068677-13077884 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L26 ENSG00000229579 "Ubiquitin specific peptidase 17 like family member 26" Q0WX57 4 9334658-9336250 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAC2 "C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253" ENSG00000229637 "PRAC2 small nuclear protein" D3DTV9 17 48723185-48724758 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "intestine: 9.8;prostate: 13.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 36.2;Distal enterocytes: 17.5;Early spermatids: 32.9;Enteroendocrine cells: 31.9;Intestinal goblet cells: 15.5;Late spermatids: 60.5;Prostatic glandular cells: 20.2;Undifferentiated cells: 22.7;Urothelial cells: 30.1" "Cancer enriched" "Detected in many" 8 "prostate cancer: 26.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 49.3;REH: 20.0" "Intracellular and membrane" NA NA "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.26e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (9.98e-2)" "unprognostic (3.27e-2)" "unprognostic (9.77e-2)" "unprognostic (8.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 13.4 9.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.5 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 49.3 20.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 2.8 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 32.9 0.0 0.0 0.1 31.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.5 0.0 0.0 0.3 60.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.4 0.0 20.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 22.7 30.1 PRR20C ENSG00000229665 "Proline rich 20C" P86479 13 57140918-57157082 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AL1RP ENSG00000229674 "H2A.L variant histone R, pseudogene" X 37994252-37994918 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.0;testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.4 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.5 0.7 0.5 0.3 0.2 0.4 0.8 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF492 "KIAA1473, ZNF115" ENSG00000229676 "Zinc finger protein 492" Q9P255 19 22634324-22667671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6;testis: 1.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 6.9;Granulosa cells: 5.4;Spermatocytes: 8.1;Spermatogonia: 9.1" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.6;HAP1: 3.3;NB-4: 4.3;NTERA-2: 4.1;U-2197: 3.9" NA NA "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.14e-1)" "unprognostic (1.24e-3)" "unprognostic (7.94e-2)" "unprognostic (2.42e-2)" "unprognostic (1.47e-2)" "unprognostic (6.75e-2)" "unprognostic (1.08e-3)" "unprognostic (5.63e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.91e-2)" "unprognostic (2.65e-1)" "unprognostic (8.93e-2)" "unprognostic (6.04e-2)" 0.3 0.0 0.3 0.1 0.2 2.6 0.7 0.8 0.6 0.3 0.2 0.2 0.0 0.2 0.1 0.2 0.3 0.1 0.1 0.3 0.1 0.3 0.0 0.1 0.3 0.2 0.2 0.2 0.5 0.2 0.3 0.0 0.2 0.5 0.1 0.3 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.0 0.2 0.1 1.9 0.1 0.7 0.3 0.1 0.3 0.1 0.1 0.4 0.0 0.0 1.4 0.1 0.0 0.0 5.6 0.9 0.0 0.4 0.5 0.0 0.0 0.0 2.0 0.7 2.4 0.0 3.3 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 2.2 0.9 0.1 0.0 0.5 0.0 4.3 4.1 0.0 0.1 0.0 0.0 0.6 0.5 1.0 0.0 2.3 0.0 0.0 0.3 0.9 1.7 1.5 0.0 0.0 2.1 3.9 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.8 0.6 0.3 0.1 0.2 0.2 0.2 0.5 0.0 0.1 0.4 0.9 0.0 3.8 1.3 1.0 0.5 1.2 0.0 1.8 1.8 1.0 1.1 1.0 0.0 0.6 0.0 0.0 1.0 0.4 0.2 0.0 0.5 0.7 0.5 1.2 1.3 0.0 6.9 0.3 0.2 2.4 1.1 0.0 0.6 1.3 5.4 1.1 0.1 0.1 3.3 0.2 0.2 0.0 0.3 1.1 0.4 0.9 0.5 0.0 1.9 0.1 1.0 0.0 3.0 0.6 0.2 0.2 0.4 0.0 0.9 0.0 0.0 1.5 2.4 0.0 0.6 1.2 8.1 9.1 0.6 0.6 0.5 0.5 0.8 0.3 0.7 TRBV10-2 "TCRBV10S2, TCRBV12S3, TRBV102" ENSG00000229769 "T cell receptor beta variable 10-2" A0A0K0K1G8 7 142424965-142425465 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 2.7" "Cell type enriched" "Detected in single" 20 "T-cells: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 11.8;memory CD8 T-cell: 33.8;naive CD4 T-cell: 10.3;naive CD8 T-cell: 9.1;T-reg: 24.5" "Lineage enriched" "Detected in single" 338 "T-cells: 33.8" "Not detected" "Not detected" NA NA "unprognostic (1.30e-3)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (5.26e-2)" "unprognostic (2.24e-5)" "unprognostic (2.97e-2)" "unprognostic (5.84e-2)" "unprognostic (2.77e-1)" "unprognostic (5.65e-1)" "unprognostic (2.55e-3)" "unprognostic (5.27e-2)" "unprognostic (3.55e-3)" "unprognostic (3.51e-1)" 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.7 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 2.7 0.4 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.4 0.0 11.8 33.8 0.0 0.0 10.3 9.1 0.0 0.0 0.0 0.0 24.5 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569672-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 180.3;Late spermatids: 576.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favorable (5.90e-4)" "prognostic favorable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favorable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favorable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favorable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 8.8 8.5 16.4 9.9 16.8 11.6 5.2 19.3 19.2 6.7 15.5 9.8 14.8 7.9 5.6 5.7 10.5 4.3 7.1 15.8 15.4 8.3 8.3 7.6 9.6 16.7 16.2 16.8 9.2 12.4 9.8 8.4 3.4 18.0 7.6 6.4 5.6 10.2 7.0 25.9 9.1 11.7 5.9 15.6 12.1 10.2 13.7 16.9 8.3 5.2 9.8 5.4 6.7 5.8 19.2 10.4 9.5 7.3 8.1 13.3 5.2 3.1 6.7 8.2 5.0 4.0 2.5 15.1 6.2 12.8 6.9 6.0 8.6 2.2 3.6 4.7 16.7 6.4 3.8 3.7 2.7 6.3 4.3 17.9 8.7 8.2 5.3 6.0 7.7 4.7 7.7 3.9 12.0 5.3 13.5 14.9 9.9 3.3 8.6 4.9 13.3 3.8 9.2 8.2 3.2 12.1 13.2 2.4 14.1 15.3 2.0 15.6 7.8 5.4 5.5 4.0 5.2 4.7 20.5 13.2 5.7 12.2 4.3 9.7 12.0 4.6 11.0 6.2 4.2 5.4 6.5 6.6 6.8 4.2 7.6 5.7 5.0 5.3 20.4 6.5 7.4 11.2 3.3 16.4 16.8 19.3 19.2 15.8 15.4 16.7 16.2 16.8 18.0 15.6 16.9 19.2 16.3 6.4 3.1 5.9 22.8 6.4 10.5 12.6 16.5 19.8 20.3 22.7 11.2 22.8 10.2 16.5 18.8 7.5 26.0 38.6 49.0 24.8 180.3 25.4 9.5 14.0 20.4 11.2 5.1 31.2 9.6 15.6 17.9 9.0 5.1 12.1 20.7 22.6 24.4 21.9 5.1 27.7 12.2 33.1 12.0 576.6 19.9 17.4 17.8 1.9 28.3 31.2 30.9 9.0 10.3 21.8 37.2 19.9 16.7 10.1 59.2 54.1 38.4 27.4 6.6 17.2 20.2 34.5 8.5 11.2 7.1 4.7 23.2 15.1 23.6 8.5 PET100 C19orf79 ENSG00000229833 "PET100 cytochrome c oxidase chaperone" P0DJ07 19 7629793-7631956 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067288 Approved Mitochondria NA NA Mitochondria "HPA067288: AB_2732762" "unprognostic (7.02e-2)" "prognostic favorable (6.81e-4)" "unprognostic (1.57e-1)" "unprognostic (9.87e-3)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (1.70e-1)" "prognostic favorable (7.97e-4)" "unprognostic (4.89e-1)" "unprognostic (2.88e-3)" "unprognostic (2.49e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (2.66e-2)" "prognostic favorable (2.44e-4)" 35.3 46.0 79.0 38.7 78.1 85.9 39.2 78.2 126.7 28.0 81.7 39.9 38.5 25.3 46.5 40.6 23.6 6.7 61.7 78.2 77.8 42.4 66.1 28.7 26.8 77.8 77.4 78.0 23.2 33.4 76.6 41.8 23.2 78.5 30.1 28.4 65.3 43.7 23.0 80.0 31.2 33.3 17.2 75.6 36.8 46.2 31.3 79.5 76.6 35.0 65.7 32.2 27.5 29.8 80.1 72.2 63.5 112.2 67.9 54.9 39.3 40.7 60.0 34.6 40.9 39.7 60.6 47.3 48.3 102.8 46.3 49.8 61.9 52.3 55.4 34.1 110.5 108.0 69.1 136.8 96.5 27.4 118.8 62.2 44.4 35.4 27.6 28.6 64.5 59.2 113.5 50.5 179.4 43.2 80.7 128.1 182.0 73.0 83.2 141.0 77.0 64.4 113.6 85.8 86.8 63.3 74.3 79.4 71.5 68.3 69.6 51.9 153.2 63.6 31.8 39.1 64.4 90.1 157.5 134.0 86.0 58.1 89.3 38.7 806.4 481.1 576.6 241.3 408.1 227.5 338.5 276.8 256.6 309.2 332.5 256.1 268.1 468.2 227.4 370.5 538.5 390.0 501.2 79.0 78.1 78.2 126.7 78.2 77.8 77.8 77.4 78.0 78.5 75.6 79.5 80.1 109.5 150.6 189.0 6.2 137.2 50.2 39.8 194.1 87.6 52.7 136.8 109.6 54.1 197.3 150.6 259.3 22.9 126.7 159.3 275.4 215.2 215.7 51.1 156.7 101.9 93.3 191.5 238.4 4.5 318.3 128.9 82.6 144.3 160.7 106.9 69.0 171.0 542.3 171.7 18.5 4.5 255.4 158.7 236.4 103.8 47.3 101.5 161.2 113.8 10.3 228.8 123.0 130.7 4.5 8.4 351.4 302.4 83.1 198.9 57.0 341.9 295.9 160.2 96.5 85.5 52.0 80.4 126.5 84.0 127.0 59.1 178.8 131.0 30.1 213.1 53.0 PGA3 ENSG00000229859 "Pepsinogen A3" P0DJD8 11 61203307-61213098 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 924 "stomach 1: 89793.9" "Cell type enriched" "Detected in some" 526 "Gastric mucus-secreting cells: 3263.5" "Cancer enriched" "Detected in single" 498 "stomach cancer: 24.8" "Region enhanced" "Detected in some" "hippocampal formation: 3.2" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 2.8;THP-1: 1.1" "CAB026358, HPA046875" Enhanced "Secreted to digestive system" NA NA "CAB026358: , HPA046875: AB_2679851" "unprognostic (6.39e-2)" "unprognostic (1.11e-1)" 41.6 10.1 0.6 0.2 0.3 0.2 18.4 0.8 1.0 8.5 0.0 78.0 1.3 3.8 0.0 97.1 4.5 0.1 7.7 3.2 0.1 5.2 16.3 6.3 0.0 0.1 0.0 0.6 5.4 13.1 0.0 13.6 0.5 0.1 5.5 0.1 0.9 6.8 0.8 4.4 5.6 5.7 0.4 0.0 6.4 89793.9 7.4 0.0 0.1 5.0 0.6 0.1 6.2 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.7 1.3 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.6 0.4 0.2 0.3 0.0 0.0 1.3 0.6 0.3 0.8 1.0 3.2 0.1 0.1 0.0 0.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 6.2 0.0 0.3 3263.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.1 0.0 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.1 GK3P "GKP3, GKTB" ENSG00000229894 "Glycerol kinase 3 pseudogene" Q14409 4 165277812-165279679 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Distal tubular cells: 1.9;Excitatory neurons: 1.3;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060687 Uncertain NA NA "HPA060687: AB_2684343" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.17e-2)" "unprognostic (2.11e-2)" "unprognostic (3.94e-1)" "unprognostic (1.61e-1)" "unprognostic (2.04e-1)" "unprognostic (6.19e-2)" "unprognostic (6.99e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (4.56e-1)" "unprognostic (3.34e-4)" 0.0 0.0 0.1 0.0 0.8 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 0.0 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 1.2 1.8 2.4 0.3 0.0 0.3 0.4 0.0 0.2 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A26 FAM90A26P ENSG00000229924 "Family with sequence similarity 90 member A26" D6RGX4 4 9170409-9176730 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (1.80e-2)" "unprognostic (3.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (4.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRPS1L1 "PRPS3, PRPSL" ENSG00000229937 "Phosphoribosyl pyrophosphate synthetase 1 like 1" P21108 7 18026770-18027846 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 318 "testis: 31.8" "Group enriched" "Detected in some" 7 "Early spermatids: 71.0;Spermatocytes: 129.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051269 Uncertain Vesicles NA NA Vesicles "HPA051269: " "unprognostic (2.39e-2)" "unprognostic (3.18e-2)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 6.6 0.0 1.1 129.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF3 ENSG00000229972 "IQ motif containing F3" P0C7M6 3 51826883-51830856 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 114 "testis: 106.6" "Group enriched" "Detected in some" 179 "Early spermatids: 1689.1;Late spermatids: 6153.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.83e-1)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 106.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.9 0.4 0.3 0.3 0.3 0.3 0.4 0.1 0.3 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1689.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6153.2 21.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 20.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB2 ENSG00000230031 "POTE ankyrin domain family member B2" H3BUK9 15 20835372-20866314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX53 ENSG00000230054 "Testis expressed 53" A0A1B0GU33 9 114656304-114662374 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 68.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.8" "Not detected" "Not detected" NA NA "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.79e-2)" "unprognostic (2.94e-1)" "unprognostic (2.85e-2)" "unprognostic (1.90e-2)" "unprognostic (6.83e-2)" "unprognostic (4.19e-2)" "unprognostic (8.18e-4)" "unprognostic (8.64e-6)" "unprognostic (9.94e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 68.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.8 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD66 ENSG00000230062 "Ankyrin repeat domain 66" B4E2M5 6 46746917-46759506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 40.5" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 104.2;Respiratory ciliated cells: 184.4" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (2.52e-1)" "unprognostic (2.44e-2)" "unprognostic (2.03e-2)" "unprognostic (9.36e-2)" "unprognostic (4.30e-3)" "unprognostic (2.19e-1)" 0.0 0.0 2.4 0.0 1.0 0.0 0.0 1.5 0.5 0.8 0.7 0.0 0.0 0.8 0.0 0.0 40.5 0.0 0.0 0.5 2.1 0.0 0.0 3.2 0.0 4.2 3.1 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.0 1.5 0.5 0.5 2.1 4.2 3.1 0.2 3.2 3.9 1.7 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.1 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 184.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 TRBV5-4 "TCRBV5S4, TCRBV5S6A3N2T, TRBV54" ENSG00000230099 "T cell receptor beta variable 5-4" A0A0C4DH59 7 142462916-142463581 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 22.3;pancreas: 11.7" "Group enriched" "Detected in some" 9 "Plasma cells: 6.1;T-cells: 6.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 115.7" "Lineage enriched" "Detected in many" 115 "T-cells: 115.7" "Cell line enriched" "Detected in some" 5 "MOLT-4: 11.1" NA NA "unprognostic (6.48e-3)" "unprognostic (6.75e-4)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-1)" "unprognostic (1.76e-3)" "unprognostic (5.82e-2)" "unprognostic (2.79e-2)" "unprognostic (1.59e-2)" "unprognostic (4.88e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.60e-4)" "unprognostic (2.77e-1)" "unprognostic (4.95e-2)" "unprognostic (4.78e-3)" "unprognostic (1.64e-2)" 0.1 0.1 0.0 2.5 0.2 1.2 0.1 0.0 0.1 0.2 0.0 0.7 0.8 0.0 0.1 0.3 0.1 0.5 0.3 0.1 0.0 0.1 0.2 0.4 8.3 0.1 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.2 0.2 1.0 0.7 0.5 0.0 0.2 0.3 1.1 0.0 0.0 2.2 1.0 0.2 0.1 22.3 0.2 0.0 8.1 2.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.3 0.0 0.0 0.5 0.0 0.2 0.2 0.0 1.3 0.1 2.1 0.0 49.7 26.7 0.0 0.1 62.8 36.4 1.0 0.1 0.1 0.1 115.7 18.6 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 18.0 19.2 12.0 15.1 11.7 26.1 18.6 15.4 13.9 20.5 11.7 18.2 15.4 21.6 15.3 15.2 17.8 17.8 22.5 11.2 11.6 17.8 15.6 15.4 19.2 11.6 10.8 10.3 24.9 19.7 25.2 14.5 28.5 12.6 16.5 13.7 7.3 17.5 17.5 24.2 20.4 13.9 18.7 10.4 18.0 15.6 33.3 11.4 20.7 20.2 20.8 18.2 19.7 17.5 14.0 69.4 56.4 47.6 33.2 33.9 57.4 91.1 31.3 69.7 57.6 52.0 80.1 52.8 60.0 62.2 35.3 27.5 47.0 36.2 62.7 38.3 44.5 56.8 48.3 51.9 48.2 82.2 85.5 41.2 51.1 89.5 35.9 59.0 52.4 66.2 49.9 74.5 48.9 48.4 70.7 68.1 84.1 47.8 53.2 20.3 67.3 38.0 119.4 51.4 40.8 68.0 86.0 44.4 74.6 44.9 48.6 75.6 65.4 50.4 40.8 45.3 49.5 71.0 88.1 55.7 137.4 43.4 50.7 47.7 3.1 13.1 4.4 13.6 20.0 15.4 18.1 11.6 11.8 22.0 11.6 13.9 16.3 0.9 27.3 16.3 17.7 11.7 12.2 12.0 11.7 15.4 13.9 11.2 11.6 11.6 10.8 10.3 12.6 10.4 11.4 14.0 31.5 32.1 33.0 60.4 32.7 21.3 29.9 38.7 42.7 64.2 23.6 33.3 42.3 21.5 35.4 16.5 39.6 165.0 38.7 3.8 41.1 43.7 106.9 22.2 38.0 31.9 19.4 25.0 124.9 41.6 41.7 35.6 19.9 23.3 20.2 52.2 23.9 13.4 44.6 52.2 118.1 15.7 34.6 17.8 18.6 59.2 51.3 25.0 37.4 60.9 30.0 37.8 26.8 98.0 109.3 36.2 12.9 50.8 48.4 27.2 19.6 51.2 27.4 6.6 59.2 38.4 53.4 143.6 64.6 40.5 22.4 84.4 29.4 63.2 19.2 24.8 OR4F3 ENSG00000230178 "Olfactory receptor family 4 subfamily F member 3" Q6IEY1 5 181367268-181368262 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P8 ENSG00000230268 "SSU72 pseudogene 8" 7 124476371-124476955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H6 ENSG00000230301 "Olfactory receptor family 5 subfamily H member 6" Q8NGV6 3 98263252-98265356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Early spermatids: 1.3;Late spermatids: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A8 CT47.8 ENSG00000230347 "Cancer/testis antigen family 47 member A8" Q5JQC4 X 120948422-120951744 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE21 SPDYE21P ENSG00000230358 "Speedy/RINGO cell cycle regulator family member E21" 7 67278714-67286664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 4 "basophil: 4.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.2" "Not detected" "Not detected" HPA051750 Approved NA NA "HPA051750: AB_2681590" "unprognostic (5.31e-4)" "unprognostic (7.24e-3)" "unprognostic (4.63e-3)" "unprognostic (4.46e-1)" "unprognostic (1.02e-3)" "unprognostic (1.81e-1)" "unprognostic (1.73e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (2.59e-1)" "unprognostic (5.08e-2)" "unprognostic (7.88e-2)" "unprognostic (1.87e-3)" "unprognostic (1.70e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-3)" "unprognostic (8.51e-2)" 0.0 0.1 1.1 0.1 0.5 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.3 0.7 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.3 0.1 0.0 0.0 0.7 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.2 0.4 0.0 0.1 0.4 4.2 0.2 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.1 0.6 0.4 0.5 0.9 0.1 0.6 1.0 0.1 0.2 1.1 0.5 0.6 0.8 0.4 0.3 0.6 0.3 0.7 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L25 ENSG00000230430 "Ubiquitin specific peptidase 17 like family member 25" Q0WX57 4 9329911-9331503 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 31.5;choroid plexus: 8.7" "Cell type enhanced" "Detected in many" "Early spermatids: 34.4;Excitatory neurons: 13.8;Muller glia cells: 22.3;Spermatocytes: 41.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 27.5" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 0.4 0.2 14.4 0.0 15.1 0.1 0.1 31.5 30.4 0.2 8.7 0.0 0.0 0.1 0.1 1.9 0.2 0.4 0.0 15.1 12.6 0.0 0.0 0.1 0.1 18.9 13.4 13.5 0.0 0.0 0.0 0.4 0.2 20.6 1.2 0.0 1.9 0.1 0.0 0.7 2.2 0.0 0.0 10.2 0.3 0.0 3.9 11.8 0.0 0.2 0.1 0.1 0.7 0.9 17.4 10.0 8.8 0.6 0.1 0.2 1.5 0.9 2.1 2.1 2.7 2.9 2.1 0.2 0.2 0.4 0.3 2.9 2.2 5.9 2.1 3.6 0.1 5.2 10.2 13.1 1.5 0.0 3.5 0.6 0.8 3.6 3.7 9.3 0.7 5.0 0.0 5.5 0.5 3.0 1.7 0.0 27.5 9.1 0.2 4.8 0.0 13.0 2.0 1.6 2.4 0.3 8.5 4.2 0.3 0.4 5.5 7.5 13.4 4.6 1.5 5.8 4.4 3.9 1.5 0.8 0.0 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 15.1 31.5 30.4 15.1 12.6 18.9 13.4 13.5 20.6 10.2 11.8 17.4 0.0 0.0 0.0 0.7 0.0 2.0 5.4 2.9 1.2 8.5 0.5 0.9 3.1 4.3 2.8 1.8 0.0 0.0 0.0 0.6 0.0 0.8 34.4 12.1 0.2 0.3 0.0 0.0 13.8 0.5 0.4 0.1 0.0 4.0 0.0 12.1 0.4 0.1 0.2 0.0 9.0 2.0 4.1 0.0 0.3 3.7 0.6 0.2 0.0 1.9 0.0 22.3 0.0 4.0 0.8 0.4 1.7 0.7 0.0 2.5 0.3 0.1 9.8 5.5 0.0 0.5 0.5 41.4 2.1 6.2 3.3 0.0 0.2 0.0 1.3 3.9 MBD3L2 ENSG00000230522 "Methyl-CpG binding domain protein 3 like 2" Q8NHZ7 19 7049321-7051735 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L1 USP17L1P ENSG00000230549 "Ubiquitin specific peptidase 17 like family member 1" Q7RTZ2 8 7332387-7333979 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.2 0.1 0.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC192 LINC01183 ENSG00000230561 "Coiled-coil domain containing 192" P0DO97 5 127703389-127941634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 13.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;Ductal cells: 1.0;Exocrine glandular cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;U-266/70: 1.2" "Low region specificity" "Detected in many" NA NA "unprognostic (2.64e-1)" "unprognostic (4.24e-2)" "unprognostic (9.22e-2)" "unprognostic (1.09e-2)" "unprognostic (2.44e-2)" "unprognostic (3.01e-2)" "unprognostic (4.07e-5)" "unprognostic (2.46e-2)" "unprognostic (9.34e-2)" "unprognostic (8.18e-2)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "unprognostic (1.52e-6)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" 0.7 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.2 0.0 0.4 0.1 0.1 0.1 0.0 2.9 0.3 0.2 0.0 0.0 0.1 0.2 13.0 0.0 0.0 0.2 0.7 0.0 0.3 0.5 0.1 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 CT47A4 CT47.4 ENSG00000230594 "Cancer/testis antigen family 47 member A4" Q5JQC4 X 120967886-120971208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX48 ENSG00000230601 "Testis expressed 48" A0A1B0GUV7 9 114666434-114682192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.70e-1)" "unprognostic (6.41e-2)" "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.70e-1)" "unprognostic (5.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 1.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 5.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011005.1 ENSG00000230626 "Novel protein similar to mitogen-activated protein kinase kinase 2 MAP2K2" 7 129126518-129130793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051993 Uncertain Approved Cytosol NA NA Cytosol "HPA051993: AB_2681685" "unprognostic (2.03e-1)" "unprognostic (7.97e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-3)" "unprognostic (1.58e-1)" "unprognostic (2.67e-3)" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (3.11e-2)" "unprognostic (3.61e-1)" "unprognostic (2.60e-2)" "unprognostic (3.01e-1)" "unprognostic (1.06e-1)" "unprognostic (4.36e-5)" "unprognostic (3.43e-2)" 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.0 0.5 0.2 0.0 0.6 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.4 0.4 0.4 0.0 0.0 0.3 0.4 3.1 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRB4 ENSG00000230657 "Proline rich protein BstNI subfamily 4" 12 11307077-11310436 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 206 "salivary gland: 3691.4" "Cell type enhanced" "Detected in single" "Early spermatids: 1.9" "Group enriched" "Detected in some" 10 "lung cancer: 2.0;melanoma: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA "unprognostic (1.05e-1)" "unprognostic (8.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3691.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SETSIP SETP18 ENSG00000230667 "SET like protein" P0DME0 1 92074533-92075441 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 1.4;Cardiomyocytes: 3.5;Early spermatids: 1.7;granulocytes: 3.8;NK-cells: 3.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063683 Approved Supported "Nucleoplasm,Lipid droplets" NA NA Nucleoplasm "Lipid droplets" "HPA063683: AB_2685088" "unprognostic (2.31e-2)" "unprognostic (3.79e-3)" "unprognostic (7.59e-2)" "unprognostic (5.74e-2)" "unprognostic (5.60e-2)" "unprognostic (7.74e-2)" "unprognostic (1.88e-8)" "unprognostic (3.43e-1)" "unprognostic (1.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.35e-4)" "unprognostic (1.63e-2)" "unprognostic (2.58e-1)" "unprognostic (3.10e-2)" "unprognostic (4.93e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.6 0.0 0.0 0.6 0.0 0.1 0.0 0.0 1.7 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.8 0.5 0.0 0.1 3.8 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.0 3.1 0.5 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.1 0.7 0.0 0.0 0.5 0.4 0.0 0.0 0.9 AL589987.1 ENSG00000230707 "Novel protein (LOC389895)" X 140091415-140092911 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.4;brain: 3.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "endometrial cancer: 2.0;glioma: 1.0;ovarian cancer: 0.9;testis cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;HAP1: 2.1;NTERA-2: 1.7;U-251 MG: 2.2" HPA041568 Uncertain NA NA "HPA041568: AB_10796677" "unprognostic (1.27e-1)" "unprognostic (3.32e-2)" "unprognostic (2.17e-1)" "unprognostic (4.08e-2)" "unprognostic (5.26e-1)" "unprognostic (1.28e-2)" 0.1 6.4 2.5 0.1 3.0 0.0 0.0 2.4 3.8 0.9 1.2 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 2.8 2.6 0.0 0.0 0.0 0.0 2.4 2.2 2.7 0.3 0.0 0.1 0.0 2.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 0.0 1.4 2.3 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.0 2.4 3.8 2.8 2.6 2.4 2.2 2.7 2.4 2.3 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD63 ENSG00000230778 "Ankyrin repeat domain 63" C9JTQ0 15 40281444-40282586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 101 "brain: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 20.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.9;THP-1: 1.4" "Region enhanced" "Detected in many" "basal ganglia: 56.7" HPA066743 Approved Mitochondria NA NA Mitochondria "HPA066743: " "unprognostic (9.36e-2)" "unprognostic (7.45e-2)" "unprognostic (8.32e-2)" "unprognostic (4.42e-1)" 0.0 0.0 2.5 0.0 20.2 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 6.1 0.1 0.0 0.0 0.0 5.9 0.6 5.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.9 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 20.2 0.0 8.8 1.2 6.1 5.9 0.6 5.6 5.1 0.0 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YY2 ZNF631 ENSG00000230797 "YY2 transcription factor" O15391 X 21855987-21858740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 5.8" "Group enriched" "Detected in many" 6 "Spermatocytes: 23.6;Spermatogonia: 57.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001119, HPA030335" Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001119: AB_1858930, HPA030335: AB_2673434" "unprognostic (1.90e-2)" "unprognostic (3.34e-2)" "unprognostic (2.75e-2)" "unprognostic (8.39e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-2)" "unprognostic (4.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (2.21e-2)" "unprognostic (2.03e-1)" "unprognostic (8.78e-4)" "unprognostic (4.04e-1)" "unprognostic (9.38e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" 1.2 1.2 0.5 1.1 0.6 0.5 1.0 1.4 0.8 1.1 0.5 0.8 0.4 1.7 1.3 0.9 1.0 0.9 0.7 0.5 0.6 0.7 1.7 0.9 0.7 0.8 0.6 0.4 1.8 0.9 0.7 1.3 1.5 0.9 1.2 0.7 0.7 0.9 1.0 0.8 1.2 0.7 1.3 0.5 0.8 0.6 5.8 0.6 0.9 0.9 0.6 0.6 0.8 0.9 0.8 3.2 2.9 1.9 6.2 2.3 1.0 0.2 3.4 2.0 3.8 4.4 2.3 5.1 3.6 1.9 4.5 5.0 1.7 4.2 4.6 6.7 2.6 4.1 1.0 7.5 1.9 4.1 3.9 1.9 1.9 3.4 2.9 4.7 3.0 2.4 1.3 3.8 4.2 6.9 2.2 2.1 4.0 3.6 1.6 3.7 2.0 3.2 5.5 2.1 1.3 1.1 2.7 2.0 1.7 5.7 5.0 3.0 1.3 2.7 7.0 1.4 12.4 4.0 2.8 3.5 2.2 4.6 1.9 5.7 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.5 0.6 1.4 0.8 0.5 0.6 0.8 0.6 0.4 0.9 0.5 0.6 0.8 1.8 0.0 2.6 0.0 0.7 0.9 0.9 1.5 0.6 2.7 1.6 1.3 1.0 1.5 0.7 1.8 4.2 2.9 0.4 0.4 0.0 0.9 0.4 1.0 2.1 2.6 1.2 0.4 0.0 0.7 1.4 1.9 0.0 1.0 1.3 4.4 1.4 2.9 2.3 6.7 0.0 0.9 0.0 1.6 0.6 1.4 6.2 1.0 0.0 0.0 3.4 1.5 2.1 0.0 0.0 1.4 0.5 3.8 1.1 1.5 0.7 0.9 0.8 3.3 0.0 2.7 1.4 23.6 57.5 0.7 1.4 2.1 0.8 3.7 0.8 1.1 STMND1 FLJ23152 ENSG00000230873 "Stathmin domain containing 1" H3BQB6 6 17102050-17131378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 18.0;gallbladder: 5.3;testis: 5.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 93.8;Respiratory ciliated cells: 72.8;Spermatocytes: 18.7;Spermatogonia: 23.8" "Group enriched" "Detected in some" 6 "breast cancer: 4.1;endometrial cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 2.4;SCLC-21H: 6.0;T-47d: 7.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA067970 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA067970: AB_2685934" "unprognostic (7.70e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-2)" "unprognostic (2.09e-3)" "unprognostic (6.88e-2)" "unprognostic (6.64e-2)" "unprognostic (4.29e-2)" "unprognostic (4.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.72e-2)" "unprognostic (5.29e-4)" "unprognostic (7.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" 0.0 0.0 0.6 0.1 0.3 0.0 3.1 0.3 0.4 0.4 1.8 0.9 0.1 0.5 0.3 0.0 18.0 5.3 0.0 0.4 0.5 0.0 0.1 2.4 0.0 0.5 0.6 0.3 0.0 3.5 0.0 0.5 0.1 0.3 0.0 0.9 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 5.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.5 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.2 0.0 0.0 0.6 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.3 0.3 0.5 0.3 0.6 0.0 0.0 1.3 0.0 0.0 0.0 1.7 2.9 0.0 0.1 5.0 1.4 0.7 2.8 8.3 0.0 0.0 0.0 0.0 1.2 0.0 0.6 1.3 93.8 0.9 0.5 1.8 0.0 0.5 0.2 0.0 0.4 0.0 2.3 0.0 0.7 0.0 0.3 0.0 0.0 0.2 0.7 2.0 0.0 0.4 2.8 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.6 0.3 0.4 0.0 0.7 0.0 0.0 72.8 0.0 6.6 1.3 2.7 18.7 23.8 0.0 0.9 0.0 0.3 0.0 1.8 0.6 HSBP1 ENSG00000230989 "Heat shock factor binding protein 1" O75506 16 83807978-83819737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 12000 "unprognostic (3.27e-2)" "unprognostic (9.23e-2)" "unprognostic (2.22e-1)" "prognostic favorable (5.73e-4)" "unprognostic (1.85e-2)" "unprognostic (3.74e-3)" "unprognostic (1.03e-2)" "unprognostic (3.07e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.96e-4)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (2.84e-3)" "unprognostic (4.39e-2)" "unprognostic (9.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.70e-2)" 18.3 34.7 31.3 20.7 31.3 12.7 18.9 32.9 39.7 19.4 33.2 21.1 25.1 16.1 12.3 40.7 19.5 8.5 37.1 30.1 36.0 26.8 19.3 18.4 10.4 33.6 32.0 29.4 21.7 19.0 32.7 22.0 18.9 33.5 16.7 15.3 22.1 29.9 10.9 41.1 12.0 22.4 13.1 34.7 17.3 22.0 33.2 34.0 19.7 25.3 32.3 15.0 21.3 21.2 35.7 69.1 91.8 124.6 57.5 50.5 44.7 57.9 97.5 47.4 67.6 31.6 77.4 65.7 46.7 96.9 80.3 65.8 66.2 88.3 64.3 60.3 16.8 101.5 35.8 70.9 105.8 41.6 54.3 58.2 44.7 47.1 72.0 39.7 58.1 43.4 35.1 87.8 13.7 52.0 173.4 44.2 65.1 103.8 76.9 67.5 59.7 94.3 22.6 104.4 62.4 85.6 79.7 166.5 34.5 46.9 63.6 119.1 62.9 75.8 86.1 69.8 55.0 70.4 44.6 52.6 186.3 67.5 63.6 96.1 60.9 118.0 158.5 23.4 159.9 25.8 69.1 28.5 26.7 96.2 48.6 26.0 25.0 157.1 31.4 158.1 71.9 43.7 132.7 31.3 31.3 32.9 39.7 30.1 36.0 33.6 32.0 29.4 33.5 34.7 34.0 35.7 159.3 157.0 124.8 21.5 79.9 194.6 236.1 694.7 157.1 89.1 239.1 250.3 712.8 140.2 465.6 252.0 20.9 391.1 76.7 233.9 659.3 410.6 364.4 484.6 161.7 183.1 238.9 78.0 16.0 335.7 482.0 231.5 116.2 202.1 68.5 214.2 141.7 161.2 427.1 109.4 23.8 274.7 547.3 223.2 177.0 241.1 219.6 260.9 304.1 15.0 242.4 236.9 76.2 17.6 33.7 440.2 291.0 143.0 90.8 318.7 259.7 562.7 858.5 90.3 118.3 154.1 220.4 685.0 243.5 279.3 207.7 285.4 58.9 282.5 234.4 376.1 USP17L28 ENSG00000231051 "Ubiquitin specific peptidase 17 like family member 28" Q0WX57 4 9348893-9350485 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP21-3 ENSG00000231068 "Keratin associated protein 21-3" Q3LHN1 21 30718525-30718777 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046554 Uncertain NA NA "HPA046554: AB_2679695" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H1 "HSHTPCRX14, HTPCRX14" ENSG00000231192 "Olfactory receptor family 5 subfamily H member 1" A6NKK0 3 98130721-98138548 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "BEWO: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLSCR5 ENSG00000231213 "Phospholipid scramblase family member 5" A0PG75 3 146576555-146605346 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "Inhibitory neurons: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "SuSa: 1.6" "Region enhanced" "Detected in single" "midbrain: 1.0" "Low region specificity" "Detected in some" HPA047249 Uncertain NA NA "HPA047249: AB_2679997" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.3 0.3 0.5 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP97D1 C17orf105 ENSG00000231256 "CFAP97 domain containing 1" B2RV13 17 43780435-43787620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053028 Approved NA NA "HPA053028: AB_2682020" "unprognostic (7.80e-2)" "unprognostic (5.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.64e-2)" "unprognostic (1.87e-1)" "unprognostic (1.36e-1)" "unprognostic (1.98e-1)" "unprognostic (2.77e-1)" "unprognostic (4.80e-2)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.73e-1)" "unprognostic (6.24e-2)" "unprognostic (2.28e-3)" "unprognostic (1.41e-1)" 0.0 0.0 0.2 0.1 0.2 0.5 0.1 1.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.1 0.4 0.1 0.1 0.3 0.1 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.1 13.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.2 0.2 1.0 0.4 0.3 0.1 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 27.9;tongue: 15.2" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.0;CACO-2: 1.8;CAPAN-2: 2.9;K-562: 1.2;NTERA-2: 1.3;RH-30: 2.2" "Not detected" "Not detected" HPA078322 Approved Mitochondria NA NA Mitochondria "HPA078322: AB_2732379" "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.5 0.0 0.1 0.1 0.0 0.0 1.0 0.3 0.1 0.2 0.2 0.1 0.4 0.2 0.0 2.0 0.2 0.3 27.9 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.0 6.6 0.2 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.5 15.2 0.0 0.3 0.1 0.2 0.0 5.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.8 2.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.3 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1OR2-108 "IGKV1/OR2-108, IGKV1OR2108, IGO1" ENSG00000231292 "Immunoglobulin kappa variable 1/OR2-108 (non-functional)" 2 113406396-113406872 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.6;lymphoid tissue: 57.2" "Cell type enriched" "Detected in single" 652 "Plasma cells: 65.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 55 "memory B-cell: 13.5;naive B-cell: 12.2" "Lineage enriched" "Detected in single" 58 "B-cells: 13.5" "Cell line enhanced" "Detected in some" "Daudi: 6.6;HBEC3-KT: 7.2;hTEC/SVTERT24-B: 4.1;REH: 4.1" "Not detected" "Not detected" HPA048721 Approved NA NA "HPA048721: " "prognostic favorable (1.53e-6)" "unprognostic (2.73e-2)" "unprognostic (1.55e-2)" "unprognostic (3.37e-1)" "unprognostic (3.64e-3)" "unprognostic (3.57e-2)" "unprognostic (3.20e-1)" "unprognostic (5.21e-2)" "unprognostic (1.17e-1)" "unprognostic (4.63e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (9.96e-6)" "unprognostic (6.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.95e-1)" 0.5 1.4 0.1 23.5 0.3 11.3 16.9 0.0 0.2 4.8 4.5 38.6 22.0 0.3 0.0 6.9 0.4 5.6 0.2 0.9 0.3 0.1 1.5 6.9 14.1 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.9 22.3 0.1 15.4 0.5 0.1 4.8 14.1 0.8 0.0 12.8 17.0 0.0 0.0 3.8 1.3 0.0 57.2 21.9 0.1 0.1 2.1 0.7 0.3 0.0 0.0 0.0 0.4 0.0 2.2 0.3 1.5 3.0 1.2 6.6 0.0 0.9 1.1 0.3 0.0 7.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.1 2.4 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.6 0.4 0.0 1.6 4.1 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.6 0.0 1.3 0.2 0.2 0.1 1.2 0.1 0.4 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.1 0.3 0.0 0.2 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLA-DPA1 HLA-DP1A ENSG00000231389 "Major histocompatibility complex, class II, DP alpha 1" P20036 6 33064569-33080775 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 322.7;lymphoid tissue: 362.5" "Cell type enhanced" "Detected in many" "B-cells: 1387.3;Kupffer cells: 1794.6;Langerhans cells: 8122.8;Macrophages: 2736.9;monocytes: 2940.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 81.8;intermediate monocyte: 187.4;memory B-cell: 150.4;myeloid DC: 296.0;naive B-cell: 136.5;non-classical monocyte: 124.1;plasmacytoid DC: 82.6" "Group enriched" "Detected in all" 7 "B-cells: 150.4;dendritic cells: 296.0;monocytes: 187.4" "Cell line enhanced" "Detected in many" "Daudi: 37.2;HDLM-2: 115.9;REH: 30.3;U-698: 26.1" HPA017967 Enhanced Supported Vesicles NA NA 240000 Vesicles "HPA017967: AB_1853929" "unprognostic (8.93e-3)" "unprognostic (3.15e-2)" "unprognostic (3.64e-2)" "unprognostic (9.40e-3)" "unprognostic (9.07e-2)" "unprognostic (2.80e-2)" "unprognostic (5.69e-2)" "unprognostic (1.82e-2)" "unprognostic (7.28e-2)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.17e-1)" "unprognostic (4.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.06e-1)" 157.2 108.9 2.5 33.7 3.1 12.9 139.5 3.1 3.4 67.6 3.5 62.0 20.4 55.8 8.4 43.5 63.6 13.1 59.9 2.3 5.6 94.7 37.1 322.7 51.7 4.3 3.2 1.8 25.1 28.8 5.9 58.5 3.4 4.7 64.5 16.3 2.0 60.0 16.3 29.7 64.5 175.9 14.7 4.4 362.5 52.6 13.5 3.7 30.5 77.2 7.4 52.0 59.1 60.5 5.3 0.1 0.0 0.0 0.0 0.8 1.3 1.1 0.4 0.4 0.5 0.0 0.0 4.9 37.2 5.0 0.9 7.1 0.0 0.0 0.0 0.1 115.9 2.5 6.2 0.0 0.0 0.1 0.0 11.6 1.7 0.0 2.2 0.0 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 30.3 0.0 4.9 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 1.3 2.6 7.8 0.1 0.1 0.0 5.6 0.9 26.1 12.2 0.2 4.4 2.2 81.8 6.6 21.6 187.4 5.7 150.4 9.6 23.9 296.0 136.5 3.4 15.7 3.0 20.9 124.1 82.6 29.2 136.0 2.5 3.1 3.1 3.4 2.3 5.6 4.3 3.2 1.8 4.7 4.4 3.7 5.3 621.8 83.3 404.3 0.3 1387.3 206.7 7.2 12.4 9.1 2.8 41.2 110.4 12.1 64.3 107.3 23.9 0.0 4.2 574.9 10.6 9.8 36.4 2.8 1.2 4.1 337.8 10.2 80.3 0.5 18.8 9.3 53.7 48.4 2.8 64.6 14.3 62.2 7.5 1153.8 5.0 0.9 18.2 12.2 1794.6 8122.8 11.7 18.0 2736.9 302.4 32.8 2940.3 5.1 94.7 0.0 0.1 4.7 5.4 27.4 100.2 10.6 114.0 42.7 129.2 5.0 52.6 14.7 29.8 1.3 4.8 6.0 175.2 6.8 157.8 11.5 28.6 34.4 USP17L10 ENSG00000231396 "Ubiquitin specific peptidase 17 like family member 10" C9JJH3 4 9210657-9212249 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-31 ENSG00000231475 "Immunoglobulin heavy variable 4-31" A0A087WSY4 14 106349283-106349792 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 471.6;urinary bladder: 192.5" "Cell type enriched" "Detected in some" 183 "Plasma cells: 1651.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hypothalamus: 4.8;midbrain: 4.5;spinal cord: 1.5" "Group enriched" "Detected in some" 48 "memory B-cell: 43.6;naive B-cell: 19.4" "Lineage enriched" "Detected in single" 66 "B-cells: 43.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.4;SH-SY5Y: 1.0" "Immunoglobulin genes" NA NA 710000000 "unprognostic (1.53e-3)" "unprognostic (9.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (5.74e-4)" "prognostic favorable (4.64e-5)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (5.05e-2)" "unprognostic (1.72e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (2.00e-1)" "unprognostic (1.48e-1)" "unprognostic (3.63e-1)" "unprognostic (1.09e-1)" 2.6 1.8 0.0 48.5 0.0 5.4 38.0 0.1 0.7 15.5 0.0 104.8 72.7 6.6 1.5 32.5 5.4 106.1 11.8 0.0 4.8 3.8 6.4 19.3 104.8 0.2 4.5 0.0 58.5 4.8 0.2 0.5 0.0 0.2 11.5 25.1 0.0 53.7 8.4 0.1 1.3 91.1 3.1 1.5 139.7 88.6 1.3 0.2 76.8 15.9 0.0 471.6 192.5 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.1 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.1 0.7 0.0 4.8 0.2 4.5 0.0 0.2 1.5 0.2 0.1 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1651.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RPS18 "D6S218E, HKE3, KE-3, KE3, S18" ENSG00000231500 "Ribosomal protein S18" P62269 6 33272075-33276511 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 26385.3;Suprabasal keratinocytes: 31942.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050159, HPA055007" Approved Supported Cytosol NA NA 120000 Cytosol "HPA050159: AB_2681035, HPA055007: AB_2682668" "prognostic favorable (9.81e-4)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (7.74e-2)" "unprognostic (4.00e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (4.63e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.15e-10)" "unprognostic (7.00e-2)" "unprognostic (4.00e-2)" "unprognostic (2.85e-1)" "unprognostic (9.19e-2)" 3251.1 2372.5 1859.3 2116.9 1860.3 6123.1 6170.9 1819.1 2364.7 3776.0 1822.2 3089.7 2042.9 2408.8 2903.0 4607.3 3096.3 1622.7 1791.8 1797.1 1903.7 2067.5 2266.7 2052.0 4882.5 1880.7 1853.6 1775.2 6552.1 5600.8 1305.4 1423.2 1972.4 1873.2 2804.2 3005.9 703.1 3072.1 1428.5 2885.4 6562.2 2586.4 1907.8 1951.8 3112.1 2655.8 796.0 1903.0 3125.7 2103.2 2159.1 4523.0 3039.4 3716.4 1916.3 4603.2 2645.2 3377.1 8930.5 5769.4 11474.6 5486.7 4471.1 6678.3 5939.4 4461.0 6787.2 2617.5 15106.6 4694.9 4890.5 2759.3 3293.1 5472.9 7251.7 4665.1 4722.4 8590.2 5617.0 2868.6 9108.9 11226.3 9771.0 2849.3 12386.6 14318.8 4498.5 13349.4 5436.5 5770.2 4373.8 7686.7 4590.7 5362.0 7880.9 4994.9 10924.1 4652.3 5367.0 3798.3 5853.7 5446.7 10293.5 5524.1 6007.1 3902.3 5714.2 1754.6 8884.0 14781.0 2429.4 6105.7 16713.0 4642.3 2714.4 3129.5 2894.4 5978.6 5376.3 12310.7 11828.5 1512.3 10665.4 3350.2 578.7 1878.9 236.8 2362.1 1653.6 4023.7 5634.6 4545.5 3382.7 3273.4 4515.8 4968.4 4374.8 184.7 3177.0 1265.3 2962.7 3727.6 9405.4 1859.3 1860.3 1819.1 2364.7 1797.1 1903.7 1880.7 1853.6 1775.2 1873.2 1951.8 1903.0 1916.3 4065.5 1480.8 2569.4 9.4 8276.1 20537.2 16151.5 18150.8 5757.2 343.9 19342.8 26385.3 596.5 4185.0 6755.1 1841.0 231.4 8761.7 5535.7 2348.6 5106.4 4750.1 1164.5 1985.2 7580.0 5826.2 3089.9 3782.1 7.5 12662.2 14558.3 4617.6 2073.4 3457.9 3051.1 5393.6 6329.9 4513.1 6281.1 159.9 8.1 7793.0 4418.8 6115.9 12428.1 3197.4 9895.8 4296.2 8448.8 13.1 6356.1 1521.4 4753.9 5.0 11.5 8283.0 5985.7 4056.9 3499.7 14221.0 5563.4 5974.5 1936.4 683.4 2005.0 7010.5 6802.2 773.3 1827.1 8678.7 31942.8 8778.2 6742.0 7987.5 9896.2 16152.8 USP17L29 ENSG00000231637 "Ubiquitin specific peptidase 17 like family member 29" Q0WX57 4 9353638-9355230 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPAN19 ENSG00000231738 "Tetraspanin 19" P0C672 12 85014311-85036277 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 4.4;testis: 4.5" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 382.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.5;SK-BR-3: 1.7;U-266/70: 1.6" "Low region specificity" "Detected in many" HPA057066 Uncertain NA NA "HPA057066: AB_2683325" "unprognostic (1.94e-1)" "unprognostic (9.81e-4)" "unprognostic (8.57e-2)" "unprognostic (8.37e-2)" "unprognostic (2.33e-1)" "unprognostic (6.57e-2)" "unprognostic (2.26e-3)" "unprognostic (9.52e-2)" "unprognostic (5.09e-3)" "unprognostic (2.22e-1)" "unprognostic (3.78e-2)" 0.1 0.3 1.2 0.3 0.9 1.1 0.0 2.3 1.4 0.2 1.3 0.2 0.4 0.3 0.9 0.1 0.9 0.3 0.0 0.7 0.7 0.4 0.0 2.7 0.3 1.3 0.7 1.0 0.2 0.8 0.1 2.0 0.1 1.2 0.5 0.1 4.4 0.0 0.0 0.9 1.3 0.2 0.0 0.5 0.3 0.1 4.5 0.9 0.0 1.8 0.5 0.2 0.1 0.0 1.6 0.3 0.0 0.6 0.2 0.3 0.5 0.8 0.4 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.5 0.0 0.3 0.3 0.9 0.6 0.7 0.4 0.4 0.4 0.2 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 1.1 0.0 1.7 0.4 0.2 0.4 0.0 0.5 1.0 0.3 0.5 0.3 1.6 0.0 0.2 1.3 0.0 0.5 0.3 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.2 0.2 1.4 0.2 0.1 0.2 0.0 0.0 1.2 0.9 2.3 1.4 0.7 0.7 1.3 0.7 1.0 1.2 0.5 0.9 1.6 0.1 3.2 2.0 0.7 0.0 0.1 0.0 18.2 0.0 3.5 0.1 0.1 1.1 0.0 30.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 72.7 0.6 0.0 0.5 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 14.2 0.0 0.3 6.9 0.0 0.1 0.0 1.0 0.0 5.1 0.0 0.0 3.1 0.0 0.0 0.4 0.1 0.6 0.0 0.1 382.1 9.1 6.6 0.4 5.2 7.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RPS27AP5 ENSG00000231767 "Ribosomal protein S27a pseudogene 5" 1 192716132-192716653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Cancer enhanced" "Detected in all" "ovarian cancer: 16.3" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 4.6;SK-MEL-30: 4.2;THP-1: 4.7" "HPA041344, HPA049132, HPA054087" Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (2.56e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-2)" "unprognostic (8.64e-2)" "unprognostic (3.78e-1)" "unprognostic (5.09e-2)" "unprognostic (7.80e-3)" "prognostic favorable (5.72e-4)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (3.07e-2)" "unprognostic (6.43e-2)" "unprognostic (5.80e-2)" "unprognostic (7.99e-2)" "unprognostic (2.58e-2)" "unprognostic (2.10e-2)" "unprognostic (3.62e-2)" 0.2 0.3 0.2 0.8 0.2 0.7 0.5 0.1 0.6 0.2 0.1 0.2 0.8 0.5 0.0 0.2 0.2 0.1 0.2 0.2 0.3 0.3 0.1 0.1 1.1 0.2 0.2 0.1 0.7 0.0 0.0 0.2 0.2 0.2 0.0 0.3 1.0 0.1 1.1 0.1 0.5 0.0 0.2 0.5 0.3 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.2 1.0 0.4 0.2 0.6 0.3 0.0 2.5 0.1 0.5 0.0 0.3 0.0 0.7 0.2 2.5 0.0 0.2 1.0 0.1 0.3 0.0 0.9 0.5 0.4 0.4 1.9 0.2 0.7 1.3 0.3 0.4 0.2 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.5 0.9 4.6 1.1 0.1 0.2 1.0 0.3 0.6 0.3 1.3 0.8 1.6 0.2 1.5 4.2 0.1 1.0 4.7 0.5 0.6 1.2 0.8 2.4 1.5 1.1 0.9 0.8 0.7 0.1 1.2 0.9 0.5 2.0 1.3 2.8 4.2 3.5 2.2 1.8 3.8 4.4 4.5 0.3 3.0 1.0 1.6 2.5 5.6 0.2 0.2 0.1 0.6 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AKAIN1 C18orf42 ENSG00000231824 "A-kinase anchor inhibitor 1" P0CW23 18 5142911-5197503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.3;brain: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049365 Uncertain NA NA "HPA049365: AB_2680729" "unprognostic (4.86e-1)" "unprognostic (1.49e-3)" "unprognostic (7.05e-2)" 0.0 10.3 2.1 0.0 1.0 0.0 0.0 21.7 14.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.0 0.2 1.1 0.0 0.0 3.0 3.5 0.1 0.1 0.7 0.7 2.4 0.0 6.8 0.0 0.1 4.4 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.8 6.3 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 1.0 21.7 14.2 10.2 1.0 3.0 3.5 0.1 6.8 1.1 6.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP21A2 "CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B" ENSG00000231852 "Cytochrome P450 family 21 subfamily A member 2" P08686 6 32038327-32041644 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Steroidogenesis "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 46 "adrenal gland: 2058.4" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 15.9" "Cancer enhanced" "Detected in some" "liver cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048979, HPA053371" Enhanced NA NA "HPA048979: AB_2680584, HPA053371: AB_2682131" "unprognostic (1.03e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-4)" "unprognostic (2.58e-1)" "unprognostic (2.97e-1)" "unprognostic (2.93e-2)" "unprognostic (2.76e-2)" "unprognostic (8.75e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (6.67e-7)" "unprognostic (7.39e-2)" "unprognostic (5.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.82e-1)" 1.4 2058.4 0.0 0.0 0.0 0.0 1.5 0.0 0.6 1.6 0.0 1.9 0.0 1.5 0.6 0.6 2.5 0.0 2.2 0.0 0.0 6.9 45.1 0.8 0.0 0.0 0.0 0.0 4.4 0.9 0.0 1.9 0.0 0.0 1.9 0.0 0.0 4.0 0.0 0.3 0.6 1.2 0.0 0.0 5.6 0.8 0.8 0.0 0.0 2.4 0.0 0.0 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 2.4 0.5 0.3 1.5 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.8 0.9 1.8 0.0 0.1 0.0 0.0 1.6 0.0 0.2 1.3 0.4 0.0 15.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.6 0.1 1.8 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 2.0 1.2 0.6 0.0 0.3 0.6 0.6 0.4 0.0 0.0 0.0 0.3 1.0 0.0 0.0 OR5K2 ENSG00000231861 "Olfactory receptor family 5 subfamily K member 2" Q8NHB8 3 98497604-98498663 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (8.45e-3)" "unprognostic (1.69e-3)" "unprognostic (6.47e-3)" "unprognostic (7.17e-2)" "unprognostic (1.45e-1)" "unprognostic (3.61e-2)" "unprognostic (1.19e-2)" "unprognostic (6.57e-2)" "unprognostic (3.77e-2)" "unprognostic (5.93e-2)" 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.1 0.3 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.8 0.2 0.5 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRH1 Pa ENSG00000231887 "Proline rich protein HaeIII subfamily 1" 12 10824960-11171608 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 204 "salivary gland: 12178.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2472.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;OE19: 1.3" NA NA "unprognostic (1.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.83e-3)" "unprognostic (3.61e-1)" "unprognostic (1.66e-1)" "unprognostic (3.70e-1)" "unprognostic (6.81e-2)" "unprognostic (6.85e-2)" "unprognostic (7.35e-3)" "unprognostic (2.14e-1)" "unprognostic (5.00e-3)" "unprognostic (1.16e-1)" "unprognostic (1.61e-2)" "unprognostic (1.50e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-2)" "unprognostic (2.68e-1)" 0.9 1.8 0.6 0.1 0.6 0.9 1.2 0.3 1.0 1.5 0.1 0.9 0.0 1.3 0.0 11.3 0.9 0.0 1.6 0.9 0.3 1.5 2.2 1.4 0.0 1.3 1.0 0.3 1.8 6.2 0.3 4.4 1.2 1.2 1.5 0.0 0.2 12178.5 0.1 0.4 0.8 1.0 0.0 0.5 1.3 0.9 59.6 0.5 0.4 1.6 0.0 0.0 0.9 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.2 1.8 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.6 0.6 0.3 1.0 0.9 0.3 1.3 1.0 0.3 1.2 0.5 0.5 1.3 16.7 9.6 2.0 0.0 7.0 0.0 0.5 0.0 0.6 1.9 13.8 11.4 0.9 0.0 4.3 23.9 4.2 1.0 15.2 1.2 1.9 11.4 586.1 5.9 12.7 5.4 1.8 2.7 0.0 6.9 0.4 7.0 0.5 4.9 0.0 45.8 4.6 0.7 0.9 3.3 0.0 0.4 0.0 1.0 0.0 2472.1 7.8 6.7 0.0 0.0 10.7 2.6 1.0 0.0 0.0 15.3 0.3 6.4 3.2 0.6 0.6 3.9 0.7 1.3 0.0 0.8 8.7 7.9 4.6 0.2 0.0 0.8 8.8 46.8 1.2 0.3 PSG1 "CD66f, PBG1, PSBG1, PSGGA" ENSG00000231924 "Pregnancy specific beta-1-glycoprotein 1" P11464 19 42866464-42879822 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 193 "placenta: 262.1" "Cell type enriched" "Detected in some" 98 "Syncytiotrophoblasts: 207.0" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "U-2197: 412.3" HPA046327 Supported "Secreted in female reproductive system" NA NA 75000000 "HPA046327: AB_2679624" "unprognostic (2.02e-1)" "unprognostic (3.54e-1)" "unprognostic (2.44e-7)" "unprognostic (2.28e-2)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 262.1 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.1 18.1 6.0 1.5 2.3 0.0 0.4 0.0 0.0 21.1 4.3 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 2.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 21.9 0.2 0.0 0.7 0.0 0.0 412.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.3 0.7 0.4 0.0 0.2 0.0 0.2 0.7 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 207.0 0.0 0.0 0.0 0.0 TAPBP TAPA ENSG00000231925 "TAP binding protein" O15533 6 33299694-33314387 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5" "Low region specificity" "Detected in all" HPA007066 Approved NA NA 20000 "HPA007066: AB_1857769" "prognostic favorable (2.76e-4)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.98e-2)" "unprognostic (1.59e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "prognostic favorable (6.29e-4)" "unprognostic (1.67e-2)" "unprognostic (2.37e-1)" "unprognostic (3.63e-1)" "unprognostic (1.61e-2)" "unprognostic (3.82e-1)" "unprognostic (1.19e-2)" "unprognostic (1.21e-1)" "unprognostic (6.54e-3)" 45.2 73.7 0.1 28.8 7.9 25.2 43.4 0.1 9.9 39.7 0.0 59.2 52.8 38.5 13.4 57.8 44.1 10.6 58.4 0.4 0.0 67.5 108.3 82.8 21.4 11.5 4.7 0.0 33.6 48.6 15.0 39.1 18.8 17.2 64.8 19.8 4.2 62.4 17.3 27.0 52.1 82.6 23.3 9.4 130.0 52.6 16.3 2.0 24.6 59.6 6.5 37.0 45.4 43.8 0.9 3.3 1.2 6.3 26.1 20.3 25.6 92.9 18.5 88.1 42.5 57.1 0.1 168.7 48.1 38.1 41.3 92.2 2.9 0.3 30.3 15.8 125.5 4.1 19.1 9.9 24.8 0.2 20.4 63.0 51.7 20.6 0.8 8.2 37.8 0.4 16.0 1.5 140.8 14.7 19.6 51.9 44.1 0.5 0.0 6.3 2.8 0.4 1.3 35.5 1.2 8.6 0.6 0.6 2.4 23.7 3.7 1.4 0.9 45.5 89.4 18.6 1.3 2.0 140.5 117.4 46.2 58.6 38.8 58.8 159.7 87.9 172.1 137.3 121.6 117.0 97.1 99.7 114.3 90.0 86.0 76.2 109.9 151.3 159.6 139.0 102.9 85.9 150.5 0.1 7.9 0.1 9.9 0.4 0.0 11.5 4.7 0.0 17.2 9.4 2.0 0.9 116.8 125.0 102.1 22.5 186.6 77.0 93.3 148.2 66.6 34.7 82.0 64.1 73.9 84.4 105.8 71.7 33.3 46.9 223.7 259.6 13.7 256.4 1.9 64.0 52.4 99.1 84.6 58.0 25.9 282.9 85.9 63.9 105.5 78.4 91.9 65.9 75.0 143.7 119.7 20.2 15.0 174.6 83.4 124.3 128.0 9.2 33.2 131.9 119.2 30.9 229.3 34.7 195.7 23.6 8.7 215.5 172.4 32.0 194.9 130.4 283.2 33.1 113.3 30.4 32.9 39.3 57.6 1.2 0.6 53.6 56.3 49.1 163.7 66.4 162.3 141.0 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" Q6NXS1 5 156850295-156852528 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 121 "testis: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "U-266/84: 1.2" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 MAGEB6B MAGEB6P1 ENSG00000232030 "MAGE family member B6B" X 26160601-26161824 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.8" "Group enriched" "Detected in many" 4 "Early spermatids: 27.2;Spermatocytes: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.1 0.5 0.6 0.1 0.7 0.1 0.9 1.7 0.8 0.9 0.1 0.4 0.2 0.6 3.1 0.2 1.2 0.2 0.3 0.6 0.6 0.8 1.2 0.5 0.1 0.3 0.4 0.5 1.7 0.8 0.9 0.7 0.6 0.6 1.4 0.5 1.5 0.7 1.9 0.0 0.2 0.2 0.3 0.1 0.0 0.3 8.8 0.4 0.4 1.7 0.0 0.2 0.2 0.3 0.7 1.1 1.2 1.2 0.0 0.0 0.0 1.3 0.2 0.0 0.2 0.7 0.0 0.7 0.0 4.7 0.1 2.4 0.6 0.0 1.3 0.2 0.0 3.0 0.2 0.8 1.1 0.7 0.0 0.0 0.6 4.4 0.1 2.1 0.7 0.0 0.0 8.3 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.6 0.4 0.5 0.0 1.3 1.3 1.2 2.8 0.0 1.2 0.0 1.6 0.0 0.3 0.0 0.0 1.3 0.0 0.8 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.7 0.8 0.6 0.6 0.3 0.4 0.5 0.6 0.1 0.4 0.7 0.0 0.0 3.2 0.3 0.2 0.0 0.9 0.0 2.2 1.6 1.5 0.8 1.9 2.8 0.6 0.0 2.1 2.8 0.0 1.0 1.9 1.7 27.2 1.1 0.3 0.3 1.2 0.0 5.2 1.3 1.5 0.3 0.0 1.1 0.0 1.7 0.0 1.9 0.4 0.0 5.7 1.4 0.0 0.0 0.0 5.4 2.5 0.1 0.0 0.0 0.1 1.1 0.0 1.0 0.2 0.4 0.8 0.0 0.0 0.9 0.5 0.6 0.7 1.5 0.0 0.2 0.2 24.9 3.5 1.3 0.0 1.0 0.0 0.2 1.2 0.6 TMEM253 "C14orf176, C14orf95, NCRNA00220" ENSG00000232070 "Transmembrane protein 253" P0C7T8 14 21098811-21103724 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "intestine: 98.2" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 201.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA052329, HPA065092" Enhanced NA NA "HPA052329: AB_2681791, HPA065092: AB_2685420" "unprognostic (7.48e-3)" "unprognostic (1.33e-2)" "unprognostic (7.19e-2)" "unprognostic (3.84e-2)" "unprognostic (1.41e-2)" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.93e-2)" "unprognostic (3.59e-1)" "unprognostic (1.80e-1)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" 0.6 2.4 0.9 0.8 0.8 0.1 0.6 0.9 1.6 0.6 0.8 15.2 98.2 0.4 1.6 1.5 0.5 0.9 0.4 0.8 1.0 0.8 1.1 0.5 0.1 0.8 0.9 0.7 0.5 1.3 0.4 0.6 0.4 0.9 0.7 12.9 0.2 6.9 1.3 0.1 1.2 89.5 0.8 0.8 0.5 0.7 0.4 0.9 0.4 5.8 0.0 0.3 0.5 1.0 1.1 0.1 0.4 0.7 0.9 0.7 0.0 1.7 0.4 0.7 0.1 0.4 0.9 0.5 1.5 0.2 0.0 0.0 1.7 0.3 1.4 0.0 0.9 0.1 0.7 1.4 1.0 0.0 0.0 0.0 0.2 1.0 0.2 0.9 0.6 0.1 0.5 0.5 0.0 0.3 0.0 0.0 0.1 0.6 1.6 0.0 0.3 0.2 0.8 0.7 0.6 0.3 0.6 0.5 0.3 0.8 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.9 1.6 0.8 1.0 0.8 0.9 0.7 0.9 0.8 0.9 1.1 0.0 0.0 0.0 2.0 0.5 0.8 1.0 1.3 2.2 0.9 0.7 1.3 0.2 1.5 0.3 0.0 0.0 1.1 0.1 45.3 0.0 0.3 0.1 0.0 0.2 0.4 3.6 0.0 0.1 0.0 0.2 0.2 2.0 0.2 0.0 0.6 0.0 0.2 0.2 0.0 0.2 11.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.1 8.8 0.0 0.1 0.2 201.8 0.7 0.1 0.5 0.0 0.4 0.4 0.0 0.3 1.6 0.6 1.0 0.1 0.2 23.4 0.8 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 235.1 279.1 499.1 222.7 507.2 438.3 244.3 501.9 593.5 221.7 499.1 255.7 194.6 180.9 347.6 313.0 183.3 119.0 336.0 499.9 507.8 320.0 275.5 209.8 281.6 510.7 501.9 488.6 261.8 232.2 312.5 304.3 147.8 506.8 241.6 231.5 298.0 217.7 144.0 516.4 200.9 222.3 133.9 512.0 275.1 237.4 217.7 505.9 391.9 234.3 290.0 300.1 215.3 241.4 512.3 565.0 398.8 634.2 456.6 514.0 497.1 435.6 454.1 355.7 425.1 419.3 326.3 395.9 365.2 315.3 397.8 553.6 215.5 559.8 512.5 471.6 452.6 475.5 689.4 910.3 845.8 399.0 792.2 443.0 459.7 538.2 402.6 388.8 414.2 546.0 641.1 376.6 379.0 615.3 581.2 929.4 1071.2 847.1 607.0 637.3 262.2 397.0 620.4 746.0 748.7 207.8 526.1 511.0 369.3 736.1 583.6 356.7 1156.3 412.1 358.0 650.8 560.5 902.6 626.1 1001.6 902.8 459.1 754.2 379.9 1923.2 1058.7 2195.0 1127.1 1022.5 1237.6 1412.6 1486.0 1377.1 1150.8 1172.2 1464.7 1408.1 2036.5 943.8 1028.9 1521.6 1652.1 2663.7 499.1 507.2 501.9 593.5 499.9 507.8 510.7 501.9 488.6 506.8 512.0 505.9 512.3 518.8 240.4 370.4 20.9 615.0 716.3 534.0 1308.9 618.6 219.6 866.8 1111.2 633.4 513.3 616.2 901.2 106.3 785.4 797.4 948.2 1717.8 566.9 653.6 524.8 511.4 474.5 635.3 609.1 25.8 1032.9 830.9 443.7 356.3 646.1 454.4 376.5 574.7 1098.6 854.5 119.5 25.4 985.5 695.8 652.4 790.5 1123.9 646.8 544.3 777.3 18.7 850.3 522.8 1080.3 10.1 28.3 872.9 980.3 464.6 593.9 584.6 1211.0 1438.8 466.4 321.9 355.0 393.6 448.4 547.4 689.4 805.5 898.4 440.1 757.1 351.9 937.2 572.2 TEX50 ENSG00000232113 "Testis expressed 50" A0A1B0GTY4 1 173635338-173637130 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 21.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.1 0.2 0.4 0.5 0.3 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCTS1 MCT-1 ENSG00000232119 "MCTS1 re-initiation and release factor" Q9ULC4 X 120594010-120621159 "Predicted intracellular proteins" "Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation" "Initiation factor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001045 Supported "Plasma membrane,Cytosol" NA NA 160000 Cytosol "Plasma membrane" "HPA001045: " "prognostic unfavorable (1.38e-4)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (9.37e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (3.27e-5)" "unprognostic (2.94e-3)" "unprognostic (9.59e-2)" "unprognostic (8.28e-2)" "unprognostic (4.89e-2)" "unprognostic (7.42e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (1.95e-1)" "unprognostic (7.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 27.3 31.3 5.5 4.0 6.0 3.9 26.6 5.9 7.1 22.4 4.7 23.4 4.6 19.9 6.4 39.2 19.5 3.1 31.7 6.3 6.1 29.7 41.1 20.9 5.6 5.6 5.4 5.8 17.2 39.9 4.9 34.5 3.9 5.8 20.6 5.3 5.6 27.0 3.7 28.7 23.4 24.1 3.1 5.2 29.2 30.7 12.0 5.6 6.8 21.7 6.5 6.8 22.8 24.6 6.1 13.9 8.2 8.2 9.9 16.2 19.2 9.9 13.8 11.9 15.2 17.0 6.6 15.8 18.6 14.3 18.3 23.6 9.6 18.0 17.7 23.4 9.7 8.5 6.3 11.3 6.4 15.6 13.6 10.3 14.1 14.2 14.9 14.2 12.6 19.5 11.0 14.5 10.8 21.9 13.5 11.3 17.5 10.3 27.9 15.7 10.5 7.6 19.2 17.7 6.4 11.0 10.0 8.5 15.2 9.0 10.1 9.1 10.6 16.5 13.3 6.4 14.3 20.7 7.5 12.5 22.2 14.3 18.8 12.9 3.4 5.0 3.5 3.5 5.9 5.6 6.1 4.6 4.4 6.5 4.9 4.2 4.3 2.3 4.9 5.9 8.4 6.1 4.1 5.5 6.0 5.9 7.1 6.3 6.1 5.6 5.4 5.8 5.8 5.2 5.6 6.1 53.5 19.2 22.9 13.1 65.4 32.2 65.5 108.4 27.9 14.5 49.3 46.9 80.8 42.9 63.5 46.0 8.4 97.0 52.0 71.3 129.1 87.4 54.4 53.1 55.6 49.9 55.7 22.5 28.2 88.5 182.0 48.5 50.0 43.9 52.0 50.4 51.4 84.4 132.6 15.2 25.5 111.0 71.2 81.7 43.2 88.7 42.0 60.4 62.2 10.3 67.6 27.0 39.1 15.1 25.3 92.7 83.7 27.8 92.0 52.6 118.2 153.5 57.4 21.0 39.5 25.3 66.1 17.7 15.0 50.4 34.5 112.9 46.5 90.0 82.2 75.3 DYTN ENSG00000232125 Dystrotelin A2CJ06 2 206651621-206721570 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Erythroid cells: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.23e-3)" "unprognostic (8.52e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTRNR2L4 ENSG00000232196 "MT-RNR2 like 4" P0CJ71 16 3370979-3372668 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 296.3" "Cell type enriched" "Detected in some" 14 "Cardiomyocytes: 154.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 168.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 168.2" "Cell line enhanced" "Detected in many" "AN3-CA: 48.8;HaCaT: 51.3;HeLa: 88.0" "Secreted to blood" NA NA "unprognostic (8.53e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-1)" "unprognostic (1.05e-1)" "unprognostic (3.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (6.81e-3)" "unprognostic (1.65e-1)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (9.27e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" 18.1 53.2 17.3 10.9 17.3 9.5 2.5 18.4 39.3 1.1 17.3 14.8 20.9 4.7 2.2 10.9 2.4 3.4 66.6 19.6 17.2 32.1 17.2 5.8 3.9 19.5 17.1 17.2 4.9 14.0 1.7 0.3 6.4 18.8 7.4 9.1 7.4 17.2 2.9 296.3 9.7 21.9 3.4 17.3 9.2 19.3 12.3 17.3 0.2 1.8 3.2 3.3 1.4 0.1 18.7 13.8 8.8 2.6 48.8 1.1 1.6 15.0 7.3 0.4 0.9 0.7 4.2 28.7 10.2 14.5 0.4 0.3 51.3 0.1 0.5 0.4 7.8 5.0 9.0 88.0 36.6 0.2 3.0 23.5 1.0 0.7 0.2 0.5 1.1 0.1 1.1 6.9 13.6 1.5 3.0 6.4 23.8 4.0 0.5 1.7 11.6 6.9 9.2 2.1 10.2 5.7 13.0 4.6 11.6 19.1 0.8 16.1 22.7 6.6 15.4 13.5 18.0 5.3 7.1 2.5 9.7 10.6 22.8 3.7 62.3 25.6 72.1 4.9 12.9 5.5 14.3 6.2 6.4 11.1 16.5 6.9 8.7 168.2 8.6 13.4 13.4 7.7 23.3 17.3 17.3 18.4 39.3 19.6 17.2 19.5 17.1 17.2 18.8 17.3 17.3 18.7 0.2 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 0.2 0.1 154.2 2.8 0.0 1.8 0.0 0.1 0.1 0.0 3.9 0.0 0.0 0.1 0.2 3.1 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.8 0.0 10.4 0.0 0.0 0.0 2.5 3.3 1.0 0.3 0.0 0.3 0.1 0.4 0.1 0.0 1.4 IGHV3-43 ENSG00000232216 "Immunoglobulin heavy variable 3-43" A0A0B4J1X8 14 106470264-106470800 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 213.9;stomach 1: 315.0;urinary bladder: 154.3" "Cell type enriched" "Detected in some" 28 "Plasma cells: 557.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 321 "memory B-cell: 29.4;naive B-cell: 39.0" "Lineage enriched" "Detected in single" 366 "B-cells: 39.0" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SH-SY5Y: 2.3" "Immunoglobulin genes" NA NA 4000000000 "prognostic favorable (2.31e-4)" "unprognostic (2.22e-2)" "prognostic favorable (1.46e-4)" "unprognostic (4.87e-3)" "prognostic favorable (8.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.34e-1)" "unprognostic (4.63e-1)" "unprognostic (7.27e-3)" "unprognostic (4.50e-2)" "unprognostic (8.73e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (1.75e-2)" 9.4 2.3 0.0 23.9 0.3 11.6 44.2 0.0 0.3 46.4 0.0 102.7 103.4 2.0 0.0 10.3 3.6 10.8 0.3 0.0 0.0 2.6 9.9 10.9 4.3 0.9 0.1 0.0 4.2 2.2 1.0 0.3 0.1 0.1 2.7 66.7 0.0 58.6 5.5 0.1 1.1 48.8 4.4 0.0 84.4 315.0 0.2 0.1 0.0 3.8 0.0 213.9 154.3 4.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.3 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 557.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 ASCL5 bHLHa47 ENSG00000232237 "Achaete-scute family bHLH transcription factor 5" Q7RTU5 1 201113953-201127184 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 2.2" "Cell type enhanced" "Detected in single" "Oligodendrocyte precursor cells: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.8;cerebral cortex: 2.1;hippocampal formation: 1.6" "Not detected" "Not detected" NA NA "unprognostic (9.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (6.32e-2)" "unprognostic (9.43e-2)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.37e-1)" "unprognostic (4.84e-2)" "unprognostic (9.50e-2)" "unprognostic (7.48e-2)" "unprognostic (9.82e-2)" "unprognostic (2.25e-7)" "unprognostic (2.95e-1)" "unprognostic (1.38e-1)" "unprognostic (4.70e-2)" "unprognostic (1.48e-2)" 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.0 0.1 0.1 0.3 0.2 0.6 0.3 2.2 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.5 0.9 0.5 0.3 0.2 0.6 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 TMEM114 ENSG00000232258 "Transmembrane protein 114" B3SHH9 16 8537605-8590193 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "seminal vesicle: 19.8" "Cell type enhanced" "Detected in single" "Microglial cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 6.6" NA NA "unprognostic (3.72e-5)" "unprognostic (2.26e-1)" "unprognostic (3.98e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.6 0.0 2.1 1.1 0.9 0.0 1.2 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP25-1 KAP25.1 ENSG00000232263 "Keratin associated protein 25-1" Q3LHN0 21 30289145-30289514 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031438 Uncertain Approved "Nuclear membrane,Plasma membrane,Cytosol" NA NA "Nuclear membrane" "Plasma membrane, Cytosol" "HPA031438: AB_10610000" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L24 ENSG00000232264 "Ubiquitin specific peptidase 17 like family member 24" Q0WX57 4 9325165-9326757 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52I1 ENSG00000232268 "Olfactory receptor family 52 subfamily I member 1" Q8NGK6 11 4593614-4596574 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 2.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Club cells: 8.6;granulocytes: 8.8;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.95e-1)" 0.1 0.1 1.9 0.2 2.0 0.6 0.2 2.8 2.9 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 1.7 1.3 0.1 0.1 0.1 0.2 1.8 1.1 2.0 0.1 0.1 0.1 0.0 0.1 2.3 0.2 0.1 0.5 0.1 0.0 0.1 0.6 0.2 0.1 0.5 0.3 0.2 0.3 1.4 0.0 0.1 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.4 0.1 0.1 0.2 0.4 0.3 0.3 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.3 0.1 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 2.0 2.8 2.9 1.7 1.3 1.8 1.1 2.0 2.3 0.5 1.4 2.4 0.2 9.6 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.3 1.8 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 8.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 OR5K1 "HSHTPCRX10, HTPCRX10" ENSG00000232382 "Olfactory receptor family 5 subfamily K member 1" Q8NHB7 3 98463201-98472924 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 252.6;Breast myoepithelial cells: 317.5;Distal tubular cells: 389.4;Proximal tubular cells: 588.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA068733: AB_2686024" "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favorable (7.84e-5)" 76.1 105.2 98.0 44.0 101.5 84.1 108.1 107.7 124.1 73.0 108.9 82.9 63.8 67.7 136.0 71.6 79.5 68.5 120.5 98.3 102.8 96.7 118.7 54.1 73.2 100.5 99.4 96.0 114.1 104.3 100.2 91.4 51.8 101.9 71.9 70.5 63.7 91.8 62.5 245.5 66.6 66.3 57.0 100.7 58.3 99.4 37.9 100.4 89.5 86.0 215.4 74.2 80.5 64.2 108.2 99.3 129.1 94.3 98.0 85.9 116.0 110.8 72.3 86.5 83.4 95.2 80.9 113.0 99.4 81.1 79.7 149.1 106.8 90.4 120.2 95.9 42.5 112.9 131.7 59.4 270.2 162.4 86.6 96.5 100.0 159.4 94.6 152.2 144.7 128.1 120.8 98.5 89.3 105.4 125.0 104.0 240.4 53.8 188.5 153.6 67.4 110.0 136.8 192.0 100.4 92.8 98.1 77.2 145.6 297.5 82.9 106.8 126.0 65.8 58.1 60.8 71.7 76.6 85.0 229.8 113.7 52.2 56.2 44.4 142.4 133.5 108.6 96.5 116.6 102.8 155.6 131.7 112.3 164.5 145.7 145.0 139.2 241.3 99.5 112.8 157.7 150.0 130.5 98.0 101.5 107.7 124.1 98.3 102.8 100.5 99.4 96.0 101.9 100.7 100.4 108.2 83.8 128.2 83.8 0.0 44.4 0.0 0.0 0.0 0.0 0.0 252.6 317.5 0.0 0.0 35.9 171.0 0.0 205.5 62.6 0.0 389.4 146.2 0.0 185.2 95.5 36.4 0.0 0.0 0.0 214.3 137.9 57.8 0.0 118.7 35.3 100.5 0.0 0.0 188.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 66.2 0.0 0.0 0.0 0.0 187.7 0.0 0.0 12.1 0.0 0.0 588.2 87.5 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 208.0 37.2 108.8 0.0 0.0 USP17L13 ENSG00000232399 "Ubiquitin specific peptidase 17 like family member 13" C9JLJ4 4 9224896-9226488 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF6 ENSG00000232423 "PRAME family member 6" Q5VXH4 1 12938472-12947580 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AJM1 "ajm-1, C9orf172" ENSG00000232434 "Apical junction component 1 homolog" C9J069 9 136844415-136848801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1;pituitary gland: 20.0" "Cell type enhanced" "Detected in some" "Collecting duct cells: 5.5;dendritic cells: 5.2;Granulosa cells: 4.9;Theca cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021200 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "HPA021200: AB_10601695" "unprognostic (3.30e-3)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (9.54e-2)" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-2)" "unprognostic (8.00e-2)" "unprognostic (6.29e-2)" "unprognostic (4.33e-1)" "unprognostic (2.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (2.71e-3)" "unprognostic (2.94e-1)" "unprognostic (6.07e-3)" "unprognostic (7.27e-2)" 2.2 3.1 13.6 1.1 10.6 1.2 1.7 23.1 16.8 3.6 0.0 14.1 2.1 4.7 0.2 3.3 4.1 0.4 5.3 17.5 3.7 3.6 4.9 2.2 0.5 13.4 3.0 12.3 1.5 7.5 0.8 20.0 0.6 18.1 7.7 0.8 0.8 2.3 1.3 3.1 2.3 5.7 0.6 1.6 5.0 5.9 6.5 7.4 0.3 3.2 0.5 0.3 9.4 3.6 5.4 3.0 2.3 0.3 0.9 0.4 0.3 3.7 2.3 0.4 0.3 0.1 0.8 1.5 1.8 1.9 0.6 0.7 3.2 0.3 0.9 0.0 4.6 1.7 0.4 5.2 0.7 1.2 1.1 3.2 0.7 1.1 0.3 0.2 1.8 0.2 0.8 2.8 1.1 0.5 3.3 0.3 3.6 0.9 2.4 3.0 2.2 0.7 5.9 0.7 0.5 5.6 2.0 1.5 5.8 3.3 0.4 4.6 2.2 2.4 3.8 2.6 1.3 1.4 5.0 3.7 0.6 6.6 3.6 0.9 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.5 1.1 0.0 0.2 13.6 10.6 23.1 16.8 17.5 3.7 13.4 3.0 12.3 18.1 1.6 7.4 5.4 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 1.4 0.0 0.0 0.0 5.5 0.0 0.6 5.2 0.0 0.0 1.8 0.0 0.8 1.1 0.2 0.0 0.0 0.0 0.5 0.9 0.4 0.0 1.8 1.3 4.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 1.0 2.3 0.0 0.0 IGHD4-11 "DA1, IGHD411" ENSG00000232543 "Immunoglobulin heavy diversity 4-11 (non-functional)" 14 105903616-105903631 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KANTR "LINC01155, Spasm" ENSG00000232593 "KDM5C adjacent transcript" X 53094145-53170914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 15.9;Astrocytes: 13.4;Excitatory neurons: 20.5;Inhibitory neurons: 24.9;Oligodendrocytes: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.3" NA NA "unprognostic (2.89e-1)" "unprognostic (1.66e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (5.52e-2)" "unprognostic (2.18e-2)" "unprognostic (7.30e-2)" "unprognostic (4.79e-2)" "unprognostic (2.30e-3)" "unprognostic (2.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.46e-2)" "unprognostic (3.47e-6)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-3)" "unprognostic (1.81e-3)" 0.0 0.1 2.1 0.0 2.3 0.7 0.1 2.9 2.8 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 2.1 2.6 0.0 0.0 0.1 0.0 2.0 2.0 2.1 0.3 0.0 0.0 0.4 0.1 2.2 0.1 0.0 0.4 0.1 0.0 0.1 0.3 0.1 0.0 1.1 0.1 0.0 0.2 2.9 0.0 0.1 0.0 0.0 0.1 0.1 2.4 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.1 0.5 0.2 0.1 0.2 1.3 0.2 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.6 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.3 0.5 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 2.3 2.9 2.8 2.1 2.6 2.0 2.0 2.1 2.2 1.1 2.9 2.4 6.9 0.0 15.9 13.4 4.3 0.0 0.2 0.0 5.2 1.2 6.6 6.1 0.7 0.0 3.7 5.5 10.4 0.2 7.1 0.0 0.0 2.6 0.0 2.7 8.3 2.6 0.0 1.7 20.5 2.3 0.3 3.3 0.5 3.6 1.3 7.7 0.4 0.2 0.2 1.7 24.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 8.4 0.6 0.2 0.0 12.5 16.8 1.1 0.0 0.0 5.0 0.3 0.2 2.4 2.2 3.3 0.0 0.9 3.2 0.0 0.1 1.5 0.0 0.3 3.8 4.2 0.0 0.3 HLA-DQB2 HLA-DXB ENSG00000232629 "Major histocompatibility complex, class II, DQ beta 2" P05538 6 32756098-32763532 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 14.8;skin 1: 46.8" "Cell type enriched" "Detected in some" 33 "Langerhans cells: 1010.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073187 Enhanced NA NA "HPA073187: " "prognostic favorable (5.55e-4)" "unprognostic (3.75e-3)" "unprognostic (2.16e-1)" "unprognostic (2.50e-2)" "unprognostic (2.10e-1)" "unprognostic (6.60e-2)" "unprognostic (8.15e-2)" "unprognostic (3.73e-3)" "unprognostic (6.48e-2)" "unprognostic (1.25e-1)" "unprognostic (3.74e-1)" "unprognostic (1.94e-1)" "unprognostic (6.66e-2)" "unprognostic (1.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.92e-2)" 3.9 1.9 0.0 0.0 0.0 0.1 3.8 0.0 0.0 2.3 0.1 1.4 0.3 0.9 0.1 7.3 1.5 0.5 1.2 0.0 0.1 2.3 0.6 14.8 0.7 0.1 0.0 0.0 0.4 0.6 0.0 1.9 0.0 0.0 1.5 1.0 0.0 2.5 0.0 0.8 46.8 6.6 0.0 0.0 12.9 1.3 0.6 0.0 0.2 2.4 0.0 0.4 1.4 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 1.3 0.0 0.0 1.1 0.8 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 3.2 13.0 0.0 5.9 28.4 0.0 0.1 0.0 0.0 0.4 1.7 0.4 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.1 0.0 0.0 2.4 0.0 0.1 0.0 0.0 6.2 1010.0 0.5 0.9 30.5 26.6 1.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.2 0.6 0.1 27.6 0.1 2.7 0.0 0.0 0.4 GOLGA8N ENSG00000232653 "Golgin A8 family member N" F8WBI6 15 32593456-32607310 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 92.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "gdT-cell: 1.1;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "NK-cells: 2.3;T-cells: 1.1" "Group enriched" "Detected in some" 4 "HEL: 61.6;THP-1: 38.1;U-937: 33.2" NA NA "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.55e-3)" "unprognostic (5.11e-3)" "unprognostic (1.78e-2)" "unprognostic (5.67e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (2.59e-3)" "unprognostic (1.93e-1)" "unprognostic (8.26e-2)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 10.5 6.7 1.9 1.9 2.7 6.4 9.8 1.9 3.4 12.8 3.2 8.9 1.2 10.3 5.0 6.0 12.7 0.7 10.9 1.6 2.0 8.0 12.1 8.6 1.9 3.3 3.1 1.0 19.5 31.6 3.1 23.1 0.5 3.4 8.8 0.5 2.4 8.0 2.4 6.8 7.0 8.6 1.3 1.6 9.7 8.3 16.3 2.2 0.9 34.5 1.9 1.2 10.1 10.3 3.0 0.0 0.0 0.1 0.5 2.2 3.0 0.1 1.0 0.5 0.2 0.3 0.0 0.8 0.8 0.3 0.7 0.2 0.0 0.4 0.1 0.4 0.1 0.5 61.6 0.0 0.0 0.6 1.0 0.1 0.9 1.2 0.0 0.8 3.1 0.0 0.0 0.2 0.0 0.3 1.0 0.0 10.9 0.1 0.1 0.0 0.1 1.5 0.0 0.1 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.0 38.1 1.5 1.2 0.2 0.0 0.0 3.1 3.2 0.5 0.3 33.2 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 2.3 0.0 0.2 0.0 0.1 1.9 2.7 1.9 3.4 1.6 2.0 3.3 3.1 1.0 3.4 1.6 2.2 3.0 7.4 19.2 18.6 6.2 1.6 0.0 0.4 0.0 0.0 1.8 0.9 1.4 10.9 1.5 6.2 1.8 0.0 0.2 8.3 1.3 0.0 0.4 92.7 15.9 3.7 3.6 3.5 4.2 2.9 2.0 0.0 4.9 3.6 6.5 6.3 3.3 2.2 5.3 0.6 13.5 3.3 1.1 0.0 1.3 0.0 10.1 5.6 6.2 0.0 1.9 3.2 1.8 15.5 4.5 5.4 0.6 0.8 2.2 2.5 0.3 1.4 0.8 6.6 1.9 0.0 3.4 5.6 11.5 0.9 2.0 0.0 0.1 5.4 1.4 1.3 0.2 TNF "DIF, TNF-alpha, TNFA, TNFSF2" ENSG00000232810 "Tumor necrosis factor" P01375 6 31575565-31578336 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.8;lymphoid tissue: 6.5" "Cell type enhanced" "Detected in many" "B-cells: 90.7;dendritic cells: 60.8;Langerhans cells: 72.7;Macrophages: 108.3;T-cells: 100.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 68.0" "Group enriched" "Detected in all" 5 "granulocytes: 20.8;monocytes: 68.0;T-cells: 36.6" "Group enriched" "Detected in some" 8 "HDLM-2: 103.7;NB-4: 214.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB078469 Supported "Secreted to blood" NA NA 10100 "CAB078469: AB_908070" "unprognostic (1.93e-1)" "unprognostic (1.07e-2)" "unprognostic (3.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-2)" "unprognostic (1.67e-1)" "unprognostic (3.46e-1)" "unprognostic (1.19e-2)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-2)" "unprognostic (1.82e-1)" "unprognostic (9.85e-3)" "unprognostic (1.09e-1)" "unprognostic (2.04e-1)" 0.7 0.5 0.0 3.3 0.0 12.8 0.5 0.0 0.1 0.0 0.1 0.7 0.0 1.5 0.0 0.7 0.3 0.6 1.6 0.0 0.0 1.1 0.6 3.6 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 1.3 2.4 0.2 0.0 6.5 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.8 0.0 0.0 0.0 0.0 103.7 0.0 19.4 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 214.4 0.0 0.0 0.0 9.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 10.1 0.0 23.2 39.5 36.6 7.2 17.2 13.9 7.6 7.0 5.0 5.2 20.8 2.0 68.0 4.3 13.6 14.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 3.0 0.0 90.7 8.4 1.2 12.1 4.6 0.2 17.4 20.4 2.0 2.8 4.0 0.0 2.1 0.9 60.8 0.5 0.0 7.4 0.1 15.5 5.9 10.7 0.0 0.0 0.0 3.3 1.7 2.0 1.5 30.5 12.6 0.0 1.8 0.1 36.5 0.0 0.0 0.4 10.2 14.1 72.7 0.0 0.3 108.3 5.4 1.9 3.4 0.1 2.1 0.0 0.1 14.3 0.0 0.0 10.4 1.7 0.0 0.1 3.0 0.2 0.0 0.6 4.0 0.0 0.0 1.3 4.1 1.1 100.0 0.0 0.4 0.3 PET117 CSRP2BP ENSG00000232838 "PET117 cytochrome c oxidase chaperone" Q6UWS5 20 18137863-18143169 "Disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA047716 Approved "Intracellular and membrane" NA NA "HPA047716: AB_2680128" "unprognostic (1.34e-2)" "unprognostic (2.83e-1)" "unprognostic (3.94e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.76e-6)" "unprognostic (7.74e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-2)" "unprognostic (4.90e-1)" "unprognostic (2.78e-1)" "prognostic favorable (4.15e-4)" "unprognostic (3.73e-1)" "unprognostic (4.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 8.4 16.9 14.3 5.6 14.7 8.1 8.6 14.5 16.8 8.3 15.1 12.0 15.7 10.0 10.4 8.1 8.6 5.1 10.9 14.4 14.7 14.2 12.6 8.1 6.1 14.5 14.3 14.2 10.1 11.5 9.8 11.9 7.4 14.5 9.4 9.5 9.7 10.5 6.6 23.1 10.1 11.0 5.9 14.6 8.7 16.6 7.3 14.7 4.5 9.0 9.7 5.4 9.6 7.6 15.4 33.0 28.7 10.4 10.6 14.9 11.3 29.8 16.8 16.5 19.6 18.2 26.5 26.7 19.5 27.0 16.1 34.9 17.6 19.0 31.5 20.5 4.4 20.9 21.9 19.2 63.8 24.6 29.2 23.2 17.8 17.1 19.3 20.1 15.7 15.7 23.3 18.6 17.1 14.3 26.8 17.1 33.5 15.4 35.2 31.8 15.3 33.4 35.0 21.2 19.4 18.9 18.6 23.1 43.0 46.9 27.1 26.2 21.3 15.0 17.7 13.7 19.0 29.4 24.4 41.8 31.5 8.8 9.5 16.3 3.4 24.9 11.4 18.3 23.3 20.7 26.2 22.7 23.0 22.0 23.2 31.6 24.2 1.5 21.0 29.7 41.0 20.4 15.8 14.3 14.7 14.5 16.8 14.4 14.7 14.5 14.3 14.2 14.5 14.6 14.7 15.4 10.3 19.2 10.6 0.3 11.4 3.8 16.7 17.2 8.0 16.9 13.5 14.6 13.7 35.8 16.3 16.5 4.2 29.8 12.4 15.4 33.2 21.8 1.0 12.3 8.8 9.1 15.7 16.8 2.6 26.7 34.5 10.1 24.5 11.9 8.8 6.9 8.9 25.8 14.9 23.5 2.5 18.4 16.2 13.9 4.0 3.2 16.1 7.7 7.2 1.9 15.1 19.7 16.5 3.5 1.4 34.0 12.3 6.8 9.4 26.8 44.0 53.1 9.4 13.7 6.6 9.6 10.8 16.3 31.3 13.4 6.3 13.0 11.9 9.7 23.6 14.5 LYRM9 "C17orf108, HSD24" ENSG00000232859 "LYR motif containing 9" A8MSI8 17 27878314-27894752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 78.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023051 Uncertain NA NA "HPA023051: AB_10602333" "unprognostic (1.31e-1)" "unprognostic (6.20e-3)" "unprognostic (2.38e-1)" "unprognostic (6.16e-3)" "unprognostic (2.05e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-3)" "unprognostic (1.18e-3)" "unprognostic (1.03e-1)" "unprognostic (2.01e-2)" "prognostic favorable (9.46e-4)" "unprognostic (1.75e-1)" "prognostic favorable (5.41e-4)" "unprognostic (4.24e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (7.93e-3)" 16.0 44.3 30.0 5.5 32.0 6.4 18.3 17.4 33.1 16.3 20.0 13.1 7.9 17.6 33.2 6.3 19.1 10.6 16.7 32.9 30.3 26.0 15.7 10.3 12.3 26.7 23.9 32.5 27.1 23.0 24.7 28.1 4.7 24.6 16.6 6.1 7.4 14.4 19.1 20.9 15.1 11.3 9.4 19.8 15.7 13.8 18.3 31.2 7.3 34.7 11.0 8.5 12.3 11.2 25.7 1.1 1.3 4.8 5.1 9.5 9.7 6.9 2.2 3.7 1.1 0.6 10.5 2.0 0.6 7.4 2.4 0.7 0.3 0.5 2.4 0.6 7.3 3.4 3.2 0.2 0.6 14.1 0.2 1.6 14.3 4.8 0.5 4.4 4.2 2.5 11.4 1.0 1.2 5.4 6.1 2.2 0.4 2.5 4.6 0.1 2.1 0.2 0.0 8.2 2.3 3.4 3.0 5.8 8.6 11.1 2.6 23.1 1.5 2.8 2.0 1.3 5.9 1.1 3.1 0.6 0.1 2.2 0.8 2.3 5.1 3.0 2.3 5.9 5.6 6.0 7.6 8.1 6.1 3.9 11.2 14.8 10.1 8.0 4.3 7.5 2.5 9.5 6.0 30.0 32.0 17.4 33.1 32.9 30.3 26.7 23.9 32.5 24.6 19.8 31.2 25.7 15.4 9.6 9.7 10.7 13.7 6.5 7.4 11.4 5.7 17.8 19.0 23.5 13.3 20.0 5.4 53.3 14.6 18.7 5.3 1.4 78.2 13.6 3.9 10.5 5.4 12.2 9.0 6.1 19.5 23.4 6.7 14.7 6.1 5.6 11.4 14.9 13.2 14.1 10.0 16.8 18.8 6.1 12.2 8.0 12.3 2.2 18.6 7.0 39.2 2.8 15.4 31.5 16.5 9.5 14.5 8.4 3.1 23.3 2.0 5.2 11.9 40.9 16.3 14.5 26.3 11.4 11.8 35.4 39.5 3.4 6.5 4.5 13.2 25.5 8.9 5.3 TRBV29-1 "TCRBV29S1, TCRBV4S1A1T, TRBV291" ENSG00000232869 "T cell receptor beta variable 29-1" A0A5B7 7 142740206-142740894 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 99.4" "Cell type enriched" "Detected in single" 11 "T-cells: 4.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 44 "MAIT T-cell: 45.1;memory CD4 T-cell: 128.6;memory CD8 T-cell: 83.2;naive CD4 T-cell: 137.8;naive CD8 T-cell: 110.8;T-reg: 178.2" "Lineage enriched" "Detected in many" 69 "T-cells: 178.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "prognostic favorable (1.23e-4)" "unprognostic (9.31e-4)" "unprognostic (1.29e-1)" "unprognostic (8.13e-3)" "unprognostic (3.28e-2)" "unprognostic (3.47e-4)" "unprognostic (6.84e-3)" "unprognostic (1.71e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-2)" "unprognostic (1.94e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.45e-1)" "unprognostic (2.46e-2)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" 0.6 0.3 0.0 6.6 0.0 4.4 1.2 0.3 0.2 1.5 0.1 2.0 2.7 0.6 0.0 1.0 0.3 2.6 0.1 0.1 0.0 0.4 1.2 1.5 21.9 0.1 0.0 0.0 0.6 21.4 0.0 0.1 0.0 0.1 0.7 2.1 0.0 0.7 0.6 0.1 0.4 3.9 1.3 0.0 5.5 2.4 0.1 0.0 99.4 0.7 0.5 23.6 2.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.7 0.1 45.1 2.0 128.6 83.2 0.1 1.8 137.8 110.8 2.5 0.2 0.3 0.7 178.2 51.1 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 DEFB130A "DEFB-30, DEFB130, DEFB30" ENSG00000232948 "Defensin beta 130A" P0DP74 8 12310962-12318316 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "epididymis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA9 ENSG00000233024 "Nuclear pore complex interacting protein family, member A9" 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" HPA053611 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 67.0 63.4 166.1 26.9 161.2 29.6 67.1 219.2 285.4 78.4 132.6 100.7 26.0 75.3 58.9 64.0 78.7 30.9 74.6 168.7 148.2 64.6 64.6 67.7 32.6 165.9 153.1 146.3 136.2 75.8 45.0 226.1 23.0 167.1 90.1 40.6 73.1 56.3 43.5 116.2 70.7 69.8 48.1 131.4 75.3 65.2 85.5 149.3 31.0 82.1 29.3 27.5 70.8 66.9 160.6 23.6 15.1 82.7 67.9 69.4 64.4 19.3 88.5 32.1 42.6 63.0 15.2 13.6 32.6 33.2 78.4 25.2 41.7 26.0 24.0 51.9 27.8 24.8 87.0 85.7 75.4 70.3 41.7 190.6 66.6 105.3 53.5 71.4 89.2 21.1 39.3 20.4 62.7 43.1 35.8 68.2 89.3 34.8 23.2 19.0 97.1 20.6 32.5 42.4 43.9 23.4 36.2 55.5 34.5 49.3 31.6 31.9 48.4 40.4 56.9 24.9 48.4 27.5 46.9 40.3 49.2 25.5 56.2 30.1 0.0 0.1 0.1 0.5 0.0 0.2 1.4 0.4 0.3 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 166.1 161.2 219.2 285.4 168.7 148.2 165.9 153.1 146.3 167.1 131.4 149.3 160.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHGR1 ENSG00000233041 "Proline, histidine and glycine rich 1" C9JFL3 15 40351033-40356434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 2339.3" "Cell type enhanced" "Detected in some" "Distal enterocytes: 19911.4;Intestinal goblet cells: 8220.0;Paneth cells: 9497.7;Proximal enterocytes: 51149.4" "Group enriched" "Detected in many" 16 "colorectal cancer: 248.3;stomach cancer: 94.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "OE19: 833.5" HPA068787 Enhanced Approved Vesicles NA NA Vesicles "HPA068787: AB_2686035" "prognostic favorable (2.05e-4)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (1.18e-1)" "unprognostic (2.80e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" 3.7 0.4 0.1 89.7 0.1 0.2 11.2 0.4 0.1 0.5 0.0 1489.2 888.9 1.2 0.0 2.0 3.6 0.3 0.3 0.1 0.2 1.9 1.0 0.2 1.2 0.1 0.1 0.0 0.5 1.9 0.0 0.5 0.0 0.2 2.5 374.1 0.0 0.3 3.1 0.4 2.5 2339.3 17.5 0.1 0.4 178.6 0.3 0.1 0.0 0.4 0.0 0.0 5.6 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.0 0.1 833.5 0.3 0.1 0.0 10.8 0.0 1.5 61.5 7.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 46.0 0.0 0.2 0.3 0.0 0.0 40.2 38.0 0.0 117.2 0.0 0.0 0.0 0.0 0.1 19911.4 0.0 2.5 0.1 0.0 0.0 0.2 1938.2 0.0 0.0 0.2 0.0 0.5 884.8 0.1 213.9 0.0 0.0 0.6 0.0 0.0 0.0 8220.0 20.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 9497.7 0.0 2.1 1.1 51149.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 32.6 0.0 4881.6 1.0 DEFB130B ENSG00000233050 "Defensin beta 130B" P0DP73 8 12064389-12071747 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "epididymis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERVH48-1 "C21orf105, NDUFV3-AS1, SUPYN" ENSG00000233056 "Endogenous retrovirus group 48 member 1" M5A8F1 21 42916803-42925646 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "placenta: 153.5" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 130.7;Extravillous trophoblasts: 258.3;Syncytiotrophoblasts: 88.8" "Cancer enriched" "Detected in some" 18 "testis cancer: 74.5" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 6 "neutrophil: 7.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.7" "Cell line enriched" "Detected in some" 7 "BEWO: 296.4" "Secreted in female reproductive system" NA NA 57000 "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (5.28e-2)" "unprognostic (5.92e-2)" "unprognostic (5.66e-2)" "unprognostic (9.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.90e-1)" "unprognostic (1.92e-2)" "unprognostic (3.48e-1)" "unprognostic (1.52e-2)" "unprognostic (7.74e-2)" "unprognostic (3.12e-3)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" 0.1 0.4 0.7 0.2 0.9 0.7 0.1 2.4 1.7 0.0 0.6 0.1 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.7 0.1 0.1 0.1 0.4 0.4 0.7 0.2 0.9 0.2 0.7 0.0 153.5 2.5 0.7 0.0 1.5 0.4 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.3 1.4 0.8 1.3 0.4 0.0 0.0 0.0 1.2 0.0 0.3 0.7 0.1 0.0 0.0 296.4 0.1 0.0 0.0 0.0 11.9 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 2.8 1.4 0.4 0.1 1.2 0.2 0.0 0.0 0.2 0.0 0.1 11.1 1.0 0.7 0.6 0.0 0.2 8.2 5.0 0.9 0.0 0.3 6.4 0.3 0.1 0.0 0.2 0.4 0.3 0.1 0.0 0.0 44.6 0.3 0.2 0.3 0.2 0.6 0.4 0.1 0.9 2.9 0.5 0.4 3.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.7 0.9 2.4 1.7 0.7 0.1 0.7 0.2 0.9 2.5 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 130.7 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 258.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 19.2 3.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 88.8 0.0 0.0 0.0 0.0 RAB6D "RAB6CL, WTH3DI" ENSG00000233087 "RAB6D, member RAS oncogene family" Q53S08 2 131361111-131364142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "parathyroid gland: 7.5" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Cancer enhanced" "Detected in some" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 2.2" HPA059131 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (4.19e-2)" "unprognostic (8.54e-2)" "unprognostic (1.16e-1)" "unprognostic (3.03e-2)" "unprognostic (4.08e-1)" "unprognostic (4.79e-2)" "unprognostic (4.41e-2)" "unprognostic (1.01e-1)" "unprognostic (1.87e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-1)" "unprognostic (2.55e-2)" "unprognostic (2.61e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.12e-1)" 0.0 0.2 0.4 0.1 0.6 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.4 0.3 0.4 0.1 0.0 7.5 0.0 0.0 0.6 1.4 0.8 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.9 0.7 0.7 0.4 0.3 0.4 0.6 0.2 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L11 ENSG00000233136 "Ubiquitin specific peptidase 17 like family member 11" C9JVI0 4 9215405-9216997 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "brain: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 2.9 0.0 1.8 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 0.0 0.0 2.4 0.9 1.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 0.1 2.4 1.5 2.7 2.4 0.9 1.0 3.9 0.1 1.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227502-137229640 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 3.4;pituitary gland: 5.9" "Cell type enhanced" "Detected in single" "Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA079078 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA079078: " "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.2 0.2 0.7 0.0 0.3 0.2 0.3 0.2 0.4 0.4 0.0 0.2 0.3 0.2 0.0 3.4 1.5 0.3 0.3 0.1 1.1 2.1 0.0 0.8 0.1 0.5 0.8 0.0 0.1 0.8 0.0 5.9 0.0 0.5 1.0 0.0 0.2 1.4 0.0 0.1 0.6 0.5 0.0 0.7 0.2 0.6 1.2 0.4 0.0 0.9 0.0 0.1 0.4 0.9 0.3 0.6 1.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 5.5 0.1 0.2 0.0 0.3 2.7 0.0 0.1 0.0 1.8 0.2 0.0 4.3 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.4 0.0 9.8 0.1 0.0 0.4 0.7 1.3 0.6 0.2 0.1 0.1 0.6 0.0 1.1 0.5 2.0 0.0 0.7 1.9 0.2 0.2 0.2 0.1 1.1 0.0 0.6 0.2 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.4 0.1 1.1 0.5 0.8 0.0 0.5 0.7 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.9 2.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 22.4" "Cell type enriched" "Detected in some" 4 "Early spermatids: 152.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 1.4 1.0 4.0 1.4 3.0 2.6 1.0 5.3 8.1 0.5 0.0 1.4 1.0 1.3 2.1 0.2 0.7 0.3 0.4 4.1 0.9 0.6 1.3 0.8 1.5 2.7 0.8 0.9 1.6 1.7 0.4 0.3 0.7 3.7 1.0 1.4 4.6 0.8 1.1 5.0 3.2 1.3 0.7 0.0 1.3 2.4 22.4 2.1 1.1 0.6 1.0 0.6 0.5 0.1 3.3 0.6 4.1 3.0 2.0 1.3 1.3 6.3 1.5 0.1 0.3 0.5 1.5 1.8 3.2 0.9 1.0 0.3 2.0 0.9 0.6 0.2 1.1 1.5 1.2 4.5 3.1 0.6 2.8 6.3 1.4 3.1 1.0 0.9 1.6 0.1 1.9 1.0 2.2 0.7 5.4 0.7 2.9 1.9 0.2 0.2 2.6 1.8 1.6 0.2 1.5 1.6 0.8 1.3 0.5 0.6 2.8 2.2 1.2 2.2 1.1 2.8 1.5 1.0 4.4 2.2 3.1 0.4 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.0 5.3 8.1 4.1 0.9 2.7 0.8 0.9 3.7 0.0 2.1 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.0 152.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 GPX1 ENSG00000233276 "Glutathione peroxidase 1" P07203 3 49357176-49358353 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 3273.8;Kupffer cells: 3971.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 1534.3;granulocytes: 1010.7;monocytes: 1337.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011582, HPA044758" Approved Supported Cytosol NA NA 3100000 Cytosol "CAB011582: AB_2112120, HPA044758: AB_2679076" "unprognostic (1.50e-2)" "unprognostic (4.34e-3)" "unprognostic (1.25e-1)" "prognostic favorable (7.78e-4)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (6.73e-3)" "unprognostic (5.03e-2)" "unprognostic (3.40e-2)" "unprognostic (2.48e-1)" "unprognostic (5.46e-2)" "unprognostic (1.53e-1)" "unprognostic (7.64e-3)" "unprognostic (9.14e-3)" "unprognostic (3.16e-2)" "unprognostic (5.72e-3)" "unprognostic (7.64e-3)" 324.3 201.6 155.9 153.3 158.2 248.8 152.7 168.1 301.2 91.5 212.7 86.9 123.3 82.9 17.9 135.4 87.3 91.9 90.7 148.1 206.2 152.5 283.9 169.7 175.8 185.1 184.0 139.0 62.5 75.0 35.5 86.4 122.2 189.3 107.9 43.1 8.3 114.1 54.4 158.6 68.7 114.6 71.1 203.7 197.4 93.7 31.7 193.6 76.0 82.8 62.3 87.4 117.8 95.7 202.6 322.8 189.2 72.6 95.4 113.5 205.9 225.9 217.7 114.7 151.5 80.1 157.8 229.7 0.6 301.6 139.8 181.7 93.2 98.8 660.3 31.6 200.2 271.6 224.8 190.2 397.4 575.6 161.0 594.4 455.9 267.6 292.4 221.5 190.0 341.5 78.6 0.5 179.3 125.9 0.8 51.2 407.0 441.3 147.4 510.5 190.8 93.8 120.3 258.2 385.6 87.7 178.5 249.5 1.5 287.3 75.7 1.5 559.5 546.5 209.7 236.0 385.8 453.6 1.1 127.9 116.3 390.5 436.3 507.8 1010.7 1337.0 707.6 69.8 483.7 100.9 314.2 127.7 83.7 1093.1 276.8 118.4 116.2 136.4 107.4 275.8 1534.3 233.3 1401.2 155.9 158.2 168.1 301.2 148.1 206.2 185.1 184.0 139.0 189.3 203.7 193.6 202.6 0.0 109.0 323.5 6.2 148.1 249.7 432.8 985.0 92.2 32.1 0.0 0.0 0.0 220.2 616.7 0.0 10.4 499.9 491.5 229.5 0.0 0.0 300.7 0.0 0.0 227.8 251.3 364.1 12.8 0.0 830.3 131.0 73.4 0.0 480.6 0.0 585.7 888.1 3273.8 1.7 17.9 285.0 386.6 3971.6 965.7 1102.9 134.5 1305.5 273.9 41.2 828.6 63.4 138.0 8.0 7.6 0.0 179.0 67.0 82.4 481.0 349.9 0.0 490.0 14.6 210.4 150.6 151.8 12.7 169.4 112.1 154.1 278.8 112.2 0.0 367.3 517.0 TRGV2 "TCRGV2, VIS2" ENSG00000233306 "T cell receptor gamma variable 2" A0A075B6R0 7 38362864-38363518 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 6.6" "Cell type enriched" "Detected in some" 5 "T-cells: 19.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD8 T-cell: 147.8" "Lineage enriched" "Detected in many" 22 "T-cells: 147.8" "Cell line enriched" "Detected in some" 4 "Karpas-707: 17.4" NA NA "unprognostic (1.51e-3)" "unprognostic (8.88e-5)" "unprognostic (1.77e-1)" "unprognostic (1.01e-2)" "unprognostic (1.72e-1)" "unprognostic (4.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.13e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (7.48e-2)" "unprognostic (3.02e-1)" "unprognostic (4.21e-5)" "unprognostic (1.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-3)" 0.2 0.6 0.1 1.6 0.2 0.9 0.1 0.0 0.2 0.2 0.4 0.8 0.8 0.3 0.1 0.2 0.3 1.0 0.2 0.0 0.1 0.1 0.4 0.9 5.0 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 1.3 0.6 0.1 0.9 0.1 0.1 0.2 1.4 0.4 0.2 6.6 0.7 0.3 0.3 4.8 0.3 0.0 0.7 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 2.4 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.0 17.4 0.0 0.0 0.5 0.8 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 1.7 0.1 0.0 3.8 0.0 0.2 0.4 0.0 59.4 0.2 58.4 0.1 29.7 147.8 1.4 0.2 7.0 54.9 0.9 6.8 0.1 1.5 0.6 22.0 0.1 0.2 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 OR5H15 ENSG00000233412 "Olfactory receptor family 5 subfamily H member 15" A6NDH6 3 98166696-98169774 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTBD18 ENSG00000233436 "BTB domain containing 18" B2RXH4 11 57743514-57751781 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 3.0;testis: 2.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.7;Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 1.6;Spermatocytes: 5.5;Spermatogonia: 3.9" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049325 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Vesicles "HPA049325: AB_2680713" "unprognostic (6.68e-2)" "unprognostic (3.13e-2)" "unprognostic (3.43e-1)" "unprognostic (4.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.47e-2)" "unprognostic (8.69e-3)" "unprognostic (4.84e-3)" "unprognostic (1.77e-1)" "unprognostic (2.96e-1)" "unprognostic (7.17e-3)" "unprognostic (5.95e-3)" "unprognostic (1.42e-2)" "unprognostic (2.34e-2)" "unprognostic (3.15e-1)" "unprognostic (3.34e-1)" "unprognostic (2.88e-1)" 0.0 0.0 0.2 0.0 0.4 0.4 0.0 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.4 3.0 1.0 0.3 0.0 0.3 0.1 0.1 1.4 0.1 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.4 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 5.5 3.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 TMEM238 ENSG00000233493 "Transmembrane protein 238" C9JI98 19 55379244-55384292 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 16.0;stomach 1: 16.7" "Group enriched" "Detected in many" 4 "Breast glandular cells: 102.2;Breast myoepithelial cells: 233.7;Endometrial ciliated cells: 80.6;Glandular and luminal cells: 104.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 52.1;stomach cancer: 48.5" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 30.6;CAPAN-2: 18.3;HaCaT: 27.3;RPMI-8226: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.90e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-2)" "unprognostic (4.69e-2)" "unprognostic (1.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (7.35e-2)" "unprognostic (7.21e-2)" "unprognostic (2.25e-2)" "unprognostic (5.49e-2)" "unprognostic (5.33e-2)" "prognostic favorable (8.84e-6)" "unprognostic (1.78e-3)" "unprognostic (5.55e-2)" "unprognostic (7.91e-3)" "unprognostic (1.17e-3)" 1.1 1.0 0.6 2.5 0.5 1.1 2.4 2.4 1.0 1.3 2.5 16.0 14.0 0.5 0.2 8.9 1.5 0.1 0.3 0.6 0.5 4.8 9.0 3.2 0.8 1.0 0.9 0.5 0.4 13.5 1.1 3.1 0.1 1.2 4.4 2.0 0.1 9.3 0.4 1.0 6.8 14.5 0.1 0.5 1.6 16.7 0.3 0.6 0.3 6.3 0.0 0.6 1.9 3.3 0.7 30.6 2.1 0.1 1.7 0.0 0.0 1.7 1.3 0.1 0.0 0.0 1.3 18.3 13.8 5.5 0.1 0.0 27.3 0.5 0.7 0.1 4.0 0.8 0.4 2.6 0.0 0.1 2.9 0.5 0.0 3.7 0.1 0.6 0.2 0.0 2.5 1.8 11.3 0.0 6.8 3.7 1.6 0.8 7.6 9.5 6.8 0.2 19.0 1.2 9.6 9.1 2.9 1.2 14.2 2.1 0.1 10.8 1.7 0.0 0.3 2.4 0.1 0.3 7.5 5.1 3.5 0.1 1.6 0.2 0.0 0.0 0.1 0.4 0.0 1.0 0.6 1.0 0.7 0.0 0.4 0.7 0.6 0.0 0.2 0.0 0.2 1.3 0.1 0.6 0.5 2.4 1.0 0.6 0.5 1.0 0.9 0.5 1.2 0.5 0.6 0.7 13.0 0.0 2.4 0.0 20.2 8.5 3.7 0.5 1.2 0.3 102.2 233.7 1.1 27.1 0.5 7.3 0.0 0.0 21.4 29.1 1.9 1.9 0.0 80.6 8.2 2.4 13.8 0.4 0.4 4.3 0.1 2.0 4.1 104.2 0.0 4.5 1.4 13.6 0.3 3.3 0.4 22.8 0.0 2.8 4.9 0.0 0.0 4.3 1.8 0.0 0.7 8.6 2.1 0.0 0.4 3.9 12.9 0.0 16.5 2.3 12.3 1.8 0.5 1.5 0.0 6.3 2.6 0.0 0.0 3.1 26.0 0.0 19.9 2.7 20.3 3.8 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910534 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 83.3" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 95.4;Fibroblasts: 58.9;Leydig cells: 48.1;Peritubular cells: 39.1;Theca cells: 23.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "hypothalamus: 3.5" "Immune cell enriched" "Detected in single" 24 "eosinophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 80.0;ASC TERT1: 50.5;BJ: 69.3;BJ hTERT+: 212.4;fHDF/TERT166: 97.4;U-2197: 81.3" "Low region specificity" "Detected in single" HPA062870 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA062870: AB_2684888" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 56.3 4.1 0.4 1.4 0.4 0.4 43.6 0.3 0.6 83.3 1.0 17.9 0.3 31.6 0.7 10.2 30.7 1.7 7.8 0.4 3.5 1.8 0.7 9.3 0.3 0.4 0.7 0.5 40.3 1.8 0.1 8.4 3.1 0.4 25.9 1.1 0.0 8.0 3.8 1.8 33.4 9.0 2.9 0.5 2.3 10.4 1.9 0.4 0.1 8.3 1.0 0.4 21.4 54.6 0.5 0.1 4.5 0.4 0.0 80.0 50.5 0.1 69.3 212.4 31.0 46.4 0.0 0.0 0.0 2.1 97.4 2.5 0.5 0.7 5.4 22.5 0.0 7.3 0.0 4.0 0.2 13.7 0.0 1.6 11.8 2.9 15.0 12.5 3.7 4.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.7 0.0 0.9 11.8 1.2 2.2 81.3 0.8 0.0 0.0 0.0 0.3 2.1 4.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.6 0.4 3.5 0.4 0.7 0.5 0.4 0.5 0.4 0.5 2.5 0.0 2.6 0.0 0.1 2.0 16.0 0.0 7.4 0.0 0.5 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 3.6 95.4 1.3 0.0 0.0 4.4 0.0 1.9 58.9 0.0 2.1 1.3 0.5 2.9 0.1 2.2 0.0 0.2 0.0 0.0 0.0 3.6 1.2 48.1 0.8 1.8 12.2 0.4 0.0 8.2 0.5 0.1 0.1 0.0 39.1 0.0 20.5 0.0 0.0 0.0 0.0 0.0 1.1 9.6 0.5 3.3 0.2 1.7 1.6 1.6 23.2 0.0 3.7 IGHD4-4 "DA4, IGHD44" ENSG00000233655 "Immunoglobulin heavy diversity 4-4" 14 105913222-105913237 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822470-10838087 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 22.2" "Cell type enhanced" "Detected in single" "Astrocytes: 2.6" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.0 2.5 8.0 1.2 7.5 0.0 0.0 12.7 5.6 0.0 1.6 3.3 1.0 0.0 0.0 0.1 0.2 0.1 0.0 5.6 9.9 0.0 0.0 0.0 0.0 18.9 14.7 2.7 0.0 0.0 0.0 0.0 0.0 13.8 0.1 2.6 0.2 0.0 0.0 0.0 0.2 1.9 0.8 12.0 0.0 1.5 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 7.5 12.7 5.6 5.6 9.9 18.9 14.7 2.7 13.8 12.0 22.2 12.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-10 IGHV3/OR16-10 ENSG00000233732 "Immunoglobulin heavy variable 3/OR16-10 (non-functional)" 16 32995048-32995505 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 4.9;intestine: 6.3;lymphoid tissue: 8.4;salivary gland: 7.0;stomach 1: 5.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Not detected" "Not detected" NA NA "unprognostic (1.40e-3)" "unprognostic (4.22e-2)" "unprognostic (3.45e-2)" "unprognostic (3.41e-4)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (2.30e-1)" 0.0 0.2 0.1 1.0 0.0 1.1 0.7 0.2 0.2 0.0 0.0 4.1 6.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 7.0 0.0 0.0 0.0 2.1 1.2 0.0 1.4 5.6 3.5 0.0 0.9 0.2 0.0 8.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092835.1 ENSG00000233757 "Novel C2H2 type zinc finger protein" 2 95207535-95259774 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.4" "Cell type enhanced" "Detected in some" "Adipocytes: 1.1;Endometrial stromal cells: 1.9;Granulosa cells: 2.2;Theca cells: 1.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.89e-2)" "unprognostic (3.55e-1)" "unprognostic (9.21e-2)" "unprognostic (9.21e-3)" "unprognostic (1.74e-2)" "unprognostic (2.44e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (1.73e-1)" "unprognostic (7.72e-2)" "unprognostic (6.65e-3)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (2.96e-1)" "unprognostic (7.92e-2)" "unprognostic (4.47e-2)" 0.7 0.4 0.6 0.7 1.0 0.2 0.7 1.1 1.9 0.9 0.0 0.5 0.4 1.3 0.2 0.5 0.7 0.6 0.7 0.8 0.2 0.7 0.2 0.6 0.5 0.4 0.6 0.6 0.9 1.1 1.4 0.3 0.8 1.1 0.5 0.4 1.6 0.9 0.9 0.5 0.3 0.3 0.8 0.0 1.0 0.5 2.1 0.9 1.8 1.5 0.3 0.7 0.5 0.4 3.4 2.0 0.6 3.7 4.1 1.0 2.0 2.3 0.8 0.8 1.9 2.0 0.5 0.5 1.6 0.4 0.8 1.5 1.6 3.1 1.1 2.6 0.0 0.4 0.3 1.6 0.0 0.5 0.0 2.8 0.6 1.1 1.5 3.5 1.5 1.0 4.3 0.0 0.0 1.4 0.0 5.2 0.4 4.5 0.5 0.0 4.6 0.4 0.0 0.6 0.8 5.3 2.4 0.5 1.1 0.0 3.8 1.0 0.8 1.1 0.7 2.5 0.6 0.0 0.0 0.6 0.1 0.0 0.0 2.1 0.0 0.1 0.2 0.7 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.6 1.0 1.1 1.9 0.8 0.2 0.4 0.6 0.6 1.1 0.0 0.9 3.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.0 0.0 0.6 0.0 0.5 1.9 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 186 "basophil: 18.6" "Lineage enriched" "Detected in single" 186 "granulocytes: 18.6" "Not detected" "Not detected" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY4 ENSG00000233803 "Testis specific protein Y-linked 4" P0CV99 Y 9337464-9340284 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 138 "testis: 33.0" "Cell type enriched" "Detected in single" 11 "Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 591 "U-266/70: 1954.4;U-266/84: 2232.7" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.4 1954.4 2232.7 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA13 ENSG00000233816 "Interferon alpha 13" P01562 9 21367424-21368962 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.3" "Cell type enriched" "Detected in single" 17 "Granulosa cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.1 1.0 0.5 0.3 0.8 0.6 0.4 0.9 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2BC15 "H2B/d, H2BFD, HIST1H2BN" ENSG00000233822 "H2B clustered histone 15" Q99877 6 27837760-27855709 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.9;Cytotrophoblasts: 11.7;dendritic cells: 4.8;Extravillous trophoblasts: 5.3;Hofbauer cells: 11.3;Plasma cells: 4.4;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 5.5;SCLC-21H: 6.4;U-266/84: 7.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 0.2 1.5 0.3 0.5 0.5 1.0 0.6 1.9 0.6 0.6 0.5 0.3 0.4 0.6 0.8 0.3 0.7 0.3 1.5 0.5 0.2 0.4 0.9 0.5 0.6 0.2 0.3 0.4 1.0 1.4 0.6 1.0 0.3 0.4 0.8 0.3 1.8 0.5 0.1 0.9 0.3 0.5 0.2 0.5 0.6 0.4 1.5 0.2 0.6 1.2 0.1 0.2 0.3 0.4 1.8 0.7 0.1 1.1 0.8 0.9 0.2 0.6 0.5 0.3 0.2 0.2 0.2 0.6 0.5 1.8 0.2 0.5 1.1 1.0 0.3 0.2 0.9 2.1 0.6 2.4 0.6 1.0 0.7 1.8 0.9 0.2 0.1 0.4 0.8 0.1 1.0 5.5 3.8 0.6 0.5 1.6 1.9 0.6 0.5 0.5 0.9 0.7 4.1 0.3 0.2 6.4 1.0 2.2 1.0 0.8 0.5 1.7 0.6 1.2 1.3 1.4 0.7 0.3 3.4 7.1 1.5 0.5 0.4 0.5 0.5 1.4 1.0 1.9 1.2 1.1 4.8 1.3 1.3 2.9 3.3 0.9 0.8 8.8 0.8 0.8 4.0 1.8 0.7 0.3 0.5 1.9 0.6 0.5 0.2 0.2 0.3 0.4 0.4 0.5 0.2 1.8 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 11.7 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.1 1.2 0.0 0.0 0.0 POTEB "A26B1, CT104.5, POTE-15, POTE15" ENSG00000233917 "POTE ankyrin domain family member B" A0A0A6YYL3 15 21846329-21877735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPS28 "eS28, S28" ENSG00000233927 "Ribosomal protein S28" P62857 19 8321158-8323340 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 19765.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047132 Approved Approved Cytosol NA NA 730000 Cytosol "HPA047132: AB_10962147" "unprognostic (3.47e-2)" "unprognostic (7.47e-3)" "unprognostic (1.49e-1)" "prognostic favorable (2.47e-4)" "unprognostic (3.09e-2)" "unprognostic (2.84e-3)" "unprognostic (2.16e-1)" "unprognostic (6.34e-2)" "unprognostic (1.56e-1)" "unprognostic (3.61e-2)" "unprognostic (2.80e-2)" "unprognostic (2.19e-2)" "unprognostic (3.22e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-2)" "unprognostic (8.82e-2)" "unprognostic (1.81e-2)" 210.8 204.6 106.7 114.7 106.2 289.1 228.8 103.7 191.4 212.0 106.1 174.2 129.0 148.5 53.0 331.0 173.7 95.7 194.9 99.2 105.5 185.3 249.5 172.5 222.1 107.4 105.3 97.2 315.6 436.0 72.7 164.0 88.9 106.9 212.9 48.2 20.5 229.8 61.1 255.0 342.8 198.7 42.9 111.5 275.6 221.2 56.1 110.5 118.4 178.9 81.5 98.9 178.2 242.0 106.9 245.9 97.7 86.6 197.5 122.3 183.2 136.6 156.9 141.7 177.6 144.5 133.2 104.7 364.4 189.3 91.7 75.9 183.0 114.9 269.0 25.6 223.2 772.6 176.4 110.4 134.5 219.6 204.6 188.5 294.9 303.7 129.7 116.4 110.9 165.2 279.0 251.6 402.9 80.2 152.5 314.8 725.0 260.8 141.4 587.2 222.7 92.9 390.9 118.6 115.5 165.7 162.3 112.7 206.7 289.3 27.6 157.0 340.9 210.4 147.0 125.1 288.1 266.5 468.3 265.8 248.1 155.7 389.3 101.2 21.3 61.7 13.2 54.5 39.3 76.6 105.0 88.5 64.5 55.9 90.7 98.9 70.0 8.8 44.6 36.3 98.0 61.0 166.2 106.7 106.2 103.7 191.4 99.2 105.5 107.4 105.3 97.2 106.9 111.5 110.5 106.9 4308.7 1458.3 2798.6 9.8 6575.7 7900.9 4267.0 4952.1 5103.9 484.0 11594.7 19765.7 382.7 3044.0 2801.5 1340.8 296.1 3851.9 4608.0 2028.0 3335.8 3189.3 262.2 1687.9 4074.7 3610.1 2654.0 3550.8 7.4 7271.1 4542.0 2535.5 2746.2 2586.9 1954.3 4062.9 5016.7 5562.8 4537.9 267.5 9.3 5334.5 1287.8 5745.6 5979.8 559.6 3915.0 3716.8 3523.6 21.5 5150.0 1694.4 3560.3 6.6 14.5 5090.4 4152.6 1644.9 4225.1 3830.4 4316.3 5555.1 1153.6 729.0 1084.7 3477.1 2508.7 367.9 953.1 7848.6 10873.6 4244.9 5017.4 2121.3 5894.5 4043.4 CTXN2 ENSG00000233932 "Cortexin 2" P0C2S0 15 48178122-48203758 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9;choroid plexus: 1.7;pituitary gland: 1.1;retina: 1.2" "Group enriched" "Detected in some" 4 "Early spermatids: 43.4;Late spermatids: 34.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053168 Uncertain NA NA "HPA053168: AB_2682066" "unprognostic (1.90e-1)" "unprognostic (3.85e-3)" "unprognostic (7.43e-2)" "unprognostic (2.18e-4)" "unprognostic (6.81e-3)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" "unprognostic (4.61e-2)" 0.0 0.1 2.6 0.0 2.5 0.0 0.0 2.4 3.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 3.2 0.0 0.0 0.0 0.0 2.9 2.9 2.4 0.0 0.1 0.0 1.1 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 2.5 2.4 3.9 2.4 3.2 2.9 2.9 2.4 3.1 2.3 3.0 3.4 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 43.4 0.4 0.0 0.0 4.9 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 34.0 0.9 0.0 0.0 1.9 0.0 2.0 0.0 5.5 0.8 0.1 2.7 0.0 0.0 0.0 0.1 0.6 0.2 1.1 0.0 0.0 0.0 8.2 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 UQCRHL ENSG00000233954 "Ubiquinol-cytochrome c reductase hinge protein like" A0A096LP55 1 15807169-15809348 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 13.9" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 444.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA042574 Approved NA NA "HPA042574: AB_10960998" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (3.70e-2)" "unprognostic (3.19e-2)" "unprognostic (7.10e-2)" "unprognostic (4.01e-3)" "unprognostic (4.83e-1)" "unprognostic (6.76e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-1)" "unprognostic (9.67e-3)" "unprognostic (9.76e-3)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (9.70e-3)" "unprognostic (1.02e-1)" 3.0 2.2 1.6 0.3 1.4 1.2 2.8 2.7 1.8 3.0 0.9 4.0 0.3 2.3 0.7 4.7 2.7 0.3 13.9 1.5 1.0 4.7 3.4 2.4 0.3 1.6 1.4 1.3 3.9 3.0 0.1 2.7 0.1 1.8 2.6 0.2 2.9 3.4 0.1 10.5 3.0 3.3 0.2 0.9 2.8 3.5 1.7 1.3 0.3 2.4 0.2 0.2 3.0 3.3 2.4 0.2 0.1 0.8 0.8 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.2 0.6 0.3 0.2 0.1 0.2 0.3 0.1 0.1 0.1 0.6 0.1 0.3 0.6 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.3 0.0 0.4 0.2 0.5 0.0 0.5 0.1 0.4 0.4 0.1 0.3 0.3 0.2 0.2 0.0 0.4 0.5 0.4 0.2 0.5 0.2 0.2 0.2 0.7 0.1 0.5 0.3 0.3 0.2 0.5 0.2 0.3 0.2 0.5 0.2 1.8 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.4 0.3 0.3 1.6 0.4 0.2 0.4 0.2 0.2 1.6 1.4 2.7 1.8 1.5 1.0 1.6 1.4 1.3 1.8 0.9 1.3 2.4 1.4 0.0 1.1 6.2 12.3 0.0 39.0 0.0 1.8 3.8 3.1 6.2 444.8 24.3 0.6 9.2 6.2 21.4 4.1 6.1 23.5 1.1 3.0 4.0 6.7 10.7 7.3 6.6 5.3 0.7 21.5 13.9 1.5 4.6 2.5 9.7 17.9 23.1 20.6 1.7 5.4 12.6 0.0 48.3 0.0 3.6 11.1 11.9 0.0 0.0 12.9 3.0 16.5 1.0 2.9 0.6 6.1 12.4 7.8 31.9 11.5 10.3 0.0 6.9 6.6 33.2 12.7 6.2 12.5 5.5 0.0 23.5 5.4 3.9 15.4 31.1 IGKV3OR2-268 "IGKV268, IGKV3/OR2-268, IGKV3/OR2-268A, IGKV3OR2-268A" ENSG00000233999 "Immunoglobulin kappa variable 3/OR2-268 (non-functional)" 2 87338511-87339035 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 101.3;lymphoid tissue: 86.4" "Cell type enriched" "Detected in some" 302 "Plasma cells: 2604.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "memory B-cell: 220.0;naive B-cell: 78.9" "Lineage enriched" "Detected in many" 7 "B-cells: 220.0" "Group enriched" "Detected in some" 71 "U-266/70: 183.9;U-266/84: 593.2" HPA047702 Approved NA NA "HPA047702: " "prognostic favorable (8.06e-4)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.26e-1)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (8.68e-2)" "unprognostic (2.61e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (2.80e-2)" "unprognostic (3.83e-1)" "unprognostic (1.58e-1)" "unprognostic (4.41e-1)" 0.3 1.3 0.2 46.2 0.3 11.9 28.8 0.1 0.8 3.4 0.1 101.3 34.2 0.9 0.0 1.3 0.7 24.9 1.4 0.3 0.4 0.6 2.6 7.6 24.0 0.2 1.2 0.2 3.3 1.2 0.0 0.0 0.1 0.2 1.6 60.1 0.0 29.6 1.7 0.0 0.6 28.0 4.1 0.0 19.4 34.3 0.4 0.2 10.4 1.2 0.0 86.4 24.6 0.9 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.5 0.2 183.9 593.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 220.0 2.8 0.1 0.1 78.9 0.0 0.1 0.1 0.1 0.0 0.2 30.0 32.7 0.2 0.3 0.1 0.8 0.3 0.4 0.2 1.2 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2604.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 PAGE2 "CT16.4, GAGEC2, MGC62094, PAGE-2" ENSG00000234068 "PAGE family member 2" Q7Z2X7 X 55089018-55092842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 28.1" "Group enriched" "Detected in some" 5 "Spermatocytes: 107.5;Spermatogonia: 234.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "U-266/70: 1058.4;U-266/84: 1493.9" HPA052619 Supported NA NA "HPA052619: AB_2681887" "unprognostic (3.49e-2)" "unprognostic (7.73e-2)" 0.2 0.2 0.3 0.0 0.3 0.2 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.1 28.1 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.3 0.3 0.0 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.3 0.0 0.0 255.7 0.9 1.9 1058.4 1493.9 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.8 0.3 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.3 9.7 0.0 0.0 0.2 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.8 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 107.5 234.6 0.0 0.0 4.0 0.0 0.0 0.0 0.0 TRIM26 "RNF95, ZNF173" ENSG00000234127 "Tripartite motif containing 26" Q12899 6 30184455-30213427 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044975, HPA050456" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044975: AB_2679162, HPA050456: AB_2681133" "unprognostic (1.93e-1)" "unprognostic (5.41e-2)" "unprognostic (8.53e-2)" "unprognostic (1.96e-3)" "unprognostic (1.52e-1)" "unprognostic (5.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.40e-2)" "unprognostic (2.85e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (1.37e-2)" "unprognostic (1.63e-3)" "unprognostic (5.21e-2)" "unprognostic (8.82e-2)" "prognostic favorable (3.25e-5)" 15.5 16.6 7.5 6.9 4.5 4.6 16.5 4.6 7.3 15.3 4.1 17.3 5.6 17.0 2.9 29.1 16.6 4.9 12.0 5.3 3.8 18.1 26.4 16.9 6.6 5.7 4.4 2.3 12.6 15.6 4.2 14.2 3.0 8.2 18.4 2.3 4.2 21.1 3.3 14.6 20.7 20.0 1.1 5.2 18.1 17.7 11.5 4.4 3.9 17.7 1.3 6.7 18.0 17.6 11.6 15.7 8.3 0.0 23.8 8.1 4.6 7.8 9.7 5.4 11.4 11.6 0.0 0.9 38.2 13.0 12.4 17.0 17.6 0.0 16.8 3.5 0.0 13.0 6.1 2.5 16.7 7.1 13.3 5.4 4.6 5.7 11.9 7.1 0.0 7.6 18.4 2.8 0.0 0.0 0.0 19.1 17.8 0.0 0.0 6.7 16.9 15.1 5.3 9.8 14.5 0.5 11.0 18.5 0.9 5.2 5.0 8.0 2.3 16.5 8.7 5.8 0.0 0.2 15.1 31.2 18.1 0.0 21.3 15.0 0.5 1.5 0.1 1.8 1.9 1.2 1.0 1.2 1.5 1.2 1.4 0.7 1.0 0.5 0.7 1.6 0.5 1.6 1.3 7.5 4.5 4.6 7.3 5.3 3.8 5.7 4.4 2.3 8.2 5.2 4.4 11.6 13.5 28.9 21.7 18.3 23.8 30.1 22.4 13.1 34.7 20.1 22.0 18.0 13.5 18.6 15.7 12.9 16.7 18.6 31.1 21.8 11.7 16.1 0.5 25.7 15.1 16.2 22.3 1.7 16.5 15.9 14.4 12.7 17.9 34.7 5.1 12.2 9.3 52.9 13.8 13.5 25.1 15.4 6.1 17.3 25.7 1.6 7.5 21.0 17.8 18.7 24.0 12.1 21.6 18.1 26.9 13.6 15.7 12.0 26.3 20.2 17.1 15.8 24.4 19.7 6.6 10.7 12.1 5.0 13.4 42.0 34.0 17.6 28.7 9.4 17.2 22.3 C16orf82 TNT ENSG00000234186 "Chromosome 16 open reading frame 82" 16 27066927-27069166 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 700 "testis: 278.5" "Cell type enriched" "Detected in some" 4 "Late spermatids: 4722.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.18e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 278.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1003.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4722.1 23.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 35.5 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030921-124033067 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.8;intestine: 8.5;testis: 5.4" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 3.7;Oligodendrocytes: 11.4;Proximal enterocytes: 10.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 130.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.0 1.0 7.5 0.0 10.9 0.0 0.0 9.7 8.6 0.1 2.8 0.1 8.5 0.1 0.4 0.0 0.6 0.0 0.2 7.7 9.6 0.0 0.0 0.0 0.0 10.3 12.8 6.6 0.2 0.0 0.8 0.9 0.1 11.6 0.2 0.1 0.1 0.4 0.0 0.0 0.0 3.9 0.1 8.1 0.1 1.9 5.4 10.4 0.0 0.0 0.0 0.0 0.3 0.0 11.9 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 130.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 10.9 9.7 8.6 7.7 9.6 10.3 12.8 6.6 11.6 8.1 10.4 11.9 0.0 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.2 0.0 2.0 11.4 0.0 2.5 0.0 0.0 0.1 10.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.2 0.7 0.2 PRR20E ENSG00000234278 "Proline rich 20E" P86478 13 57167197-57170218 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF879 DKFZp686E2433 ENSG00000234284 "Zinc finger protein 879" B4DU55 5 179023804-179035064 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 12.5;Spermatocytes: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 9.9;BEWO: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068608 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA068608: AB_2686010" "unprognostic (3.20e-2)" "unprognostic (5.24e-3)" "unprognostic (7.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (5.83e-2)" "unprognostic (8.80e-3)" "unprognostic (3.19e-3)" "unprognostic (6.04e-2)" "unprognostic (5.69e-4)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (2.10e-1)" "unprognostic (3.79e-1)" "unprognostic (4.72e-2)" "unprognostic (5.17e-3)" 2.3 1.6 2.6 2.1 3.7 0.8 2.7 4.0 3.4 2.1 2.8 1.9 1.2 2.7 2.2 2.0 2.4 1.6 2.8 2.7 2.8 2.3 1.4 2.0 3.1 3.6 3.3 2.5 3.9 1.7 2.5 2.6 2.8 3.6 2.7 1.2 7.2 2.2 3.2 2.2 3.5 1.9 2.3 3.0 3.2 1.7 6.2 2.9 3.5 3.8 3.2 3.5 1.9 1.8 4.7 0.0 3.6 3.2 9.9 3.0 2.3 10.5 1.8 2.6 4.2 5.2 3.3 1.8 2.7 2.5 1.7 4.9 1.5 0.0 2.0 3.4 0.0 0.3 0.0 2.3 0.6 4.8 0.0 4.9 2.3 1.9 2.3 1.2 1.9 1.5 2.6 0.5 0.0 3.5 1.8 3.1 1.0 3.5 1.3 0.9 2.8 1.1 0.3 3.1 2.9 1.3 3.3 3.4 0.5 4.6 4.8 4.8 3.0 1.5 1.9 3.5 2.2 0.4 0.0 0.0 4.1 0.0 0.0 2.6 14.0 3.8 3.9 4.9 3.4 4.9 4.1 4.3 4.0 3.5 4.0 6.6 5.1 0.1 5.4 3.3 2.4 6.0 3.0 2.6 3.7 4.0 3.4 2.7 2.8 3.6 3.3 2.5 3.6 3.0 2.9 4.7 1.8 6.4 1.1 2.9 3.1 0.5 1.7 1.3 0.0 8.7 1.2 0.6 2.2 5.7 1.1 5.5 12.5 3.6 5.6 0.7 5.9 1.7 6.0 0.6 1.2 2.5 1.2 0.4 1.7 0.8 2.0 2.5 2.0 0.8 2.5 4.0 1.8 0.9 2.2 10.1 1.8 0.3 2.0 1.6 1.9 3.4 1.5 1.2 0.0 1.0 1.4 3.1 8.2 2.5 2.4 0.8 0.1 2.2 1.0 1.7 1.4 1.6 1.5 5.6 6.6 4.6 2.4 13.3 9.8 0.6 1.1 4.2 2.2 2.2 0.7 1.1 H2BS1 H2BFS ENSG00000234289 "H2B.S histone 1" P57053 21 43565182-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;K-562: 1.0;U-2 OS: 1.6" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 0.7 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.7 0.1 0.7 0.0 0.9 0.0 1.3 0.7 0.0 0.5 0.1 0.1 0.2 2.0 1.0 0.1 0.1 0.1 0.0 0.6 1.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.7 0.0 0.1 0.6 0.8 0.0 0.0 1.6 0.6 1.1 0.1 0.0 0.7 0.0 0.0 0.4 0.9 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148416-20151055 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 40.5" "Group enriched" "Detected in some" 89 "Early spermatids: 313.0;Late spermatids: 988.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 4.0;SCLC-21H: 5.5;SH-SY5Y: 7.2;TIME: 3.1;U-2 OS: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049901 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA049901: AB_2680943" "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.3 0.6 0.5 0.5 0.5 0.5 1.3 0.3 0.6 0.7 0.0 0.5 0.8 0.8 0.0 0.3 1.0 0.3 0.5 1.1 1.0 0.5 0.2 1.0 0.6 0.2 0.1 0.2 0.4 0.5 0.0 9.7 0.6 1.5 0.5 0.0 0.2 0.4 0.0 0.6 1.1 0.6 0.2 0.0 1.5 0.5 40.5 0.5 0.0 0.6 0.0 0.0 0.7 0.6 0.3 0.0 0.0 4.0 0.2 0.0 0.5 0.0 1.1 0.5 0.9 0.7 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.2 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.2 2.6 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 5.5 7.2 0.4 0.0 0.4 0.1 0.0 0.1 3.1 1.6 3.0 2.0 0.2 0.5 0.1 0.2 2.7 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.5 0.3 0.6 1.1 1.0 0.2 0.1 0.2 1.5 0.0 0.5 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.0 7.3 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 988.5 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 4.1 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RBMY1A1 "RBM1, RBM2, YRRM1, YRRM2" ENSG00000234414 "RNA binding motif protein Y-linked family 1 member A1" P0DJD3 Y 21511372-21549326 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 97 "testis: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "U-266/84: 15.1" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KBTBD13 "hCG_1645727, NEM6" ENSG00000234438 "Kelch repeat and BTB domain containing 13" C9JR72 15 65076746-65079948 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062737 Uncertain NA NA "HPA062737: AB_2684856" "unprognostic (1.18e-1)" "unprognostic (7.88e-2)" "unprognostic (6.07e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.5 0.1 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF736 ENSG00000234444 "Zinc finger protein 736" B4DX44 7 64307459-64356634 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 48.9;Inhibitory neurons: 45.8;Late spermatids: 70.1;Oligodendrocyte precursor cells: 42.7;Rod photoreceptor cells: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (2.41e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (4.14e-1)" "unprognostic (1.24e-1)" "unprognostic (1.20e-3)" "unprognostic (4.89e-2)" "unprognostic (2.51e-2)" "unprognostic (2.11e-2)" "unprognostic (2.01e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.26e-1)" "unprognostic (9.63e-2)" "unprognostic (5.28e-2)" "unprognostic (2.22e-3)" "prognostic favorable (8.65e-4)" 2.6 2.0 1.8 2.8 2.5 7.7 3.7 1.9 3.0 3.5 0.5 2.3 1.2 3.0 2.6 2.1 3.3 1.8 2.0 1.9 1.0 3.1 1.4 3.1 4.2 1.3 1.2 1.3 5.0 3.0 1.7 2.9 1.7 1.5 2.7 1.8 12.5 3.1 1.4 1.6 4.8 3.6 1.7 0.7 3.9 2.5 7.6 1.4 4.1 4.0 2.7 4.2 2.5 3.0 3.3 0.5 0.2 4.6 15.9 1.5 2.4 4.6 2.3 0.1 3.5 5.3 1.2 2.5 12.7 3.7 2.1 4.0 1.9 3.4 0.8 5.6 0.3 3.3 5.4 1.5 0.2 1.7 2.4 7.1 2.1 1.0 3.7 0.0 1.5 0.4 7.1 6.5 2.9 4.1 3.1 8.3 12.7 8.5 0.1 1.1 6.8 7.8 6.0 4.1 7.3 5.1 7.2 6.0 4.1 1.5 8.4 9.6 9.1 0.3 5.2 3.6 1.3 3.2 3.1 5.0 15.2 0.1 2.6 0.1 0.4 0.5 1.1 0.4 0.6 0.3 1.8 0.6 0.4 0.7 1.4 0.6 0.5 0.2 0.1 0.6 1.2 0.4 0.3 1.8 2.5 1.9 3.0 1.9 1.0 1.3 1.2 1.3 1.5 0.7 1.4 3.3 7.0 6.4 5.4 28.7 27.1 3.8 2.4 3.5 10.2 12.8 8.6 5.3 3.6 8.6 5.6 5.5 12.5 3.6 8.0 2.2 5.9 4.0 48.9 8.6 7.1 5.9 1.2 18.3 40.7 2.2 3.0 5.2 4.6 13.3 0.0 15.2 6.1 2.7 3.7 8.4 45.8 5.6 6.1 8.1 7.1 70.1 2.5 8.9 3.6 19.7 4.4 7.4 1.0 42.7 41.2 2.1 2.5 3.0 5.4 2.6 1.4 3.9 4.5 43.6 0.0 4.2 5.6 8.2 7.5 9.9 4.0 2.7 9.1 9.6 3.8 2.1 PINLYP ENSG00000234465 "Phospholipase A2 inhibitor and LY6/PLAUR domain containing" A6NC86 19 43575801-43583964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 23.5;Proximal tubular cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 21.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 73.1;HMC-1: 46.6;JURKAT: 37.1;REH: 29.8;THP-1: 36.6" "Not detected" "Not detected" HPA061218 Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA061218: AB_2684453" "unprognostic (6.72e-2)" "unprognostic (6.21e-2)" "unprognostic (4.72e-1)" "unprognostic (3.13e-2)" "unprognostic (2.46e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" "unprognostic (5.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.85e-2)" "unprognostic (1.14e-1)" "unprognostic (4.36e-3)" "unprognostic (1.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (3.60e-2)" 8.9 3.6 16.0 3.3 16.3 2.8 8.6 17.9 22.3 17.0 15.5 10.3 1.4 14.8 9.5 10.6 17.2 9.4 7.1 15.8 17.1 18.8 2.1 7.8 5.0 17.0 16.5 15.4 19.8 2.4 0.7 15.0 2.8 16.1 13.6 3.1 2.7 5.8 10.5 1.7 6.9 6.5 11.2 16.2 8.5 7.4 5.5 16.5 10.7 11.9 3.3 5.2 10.4 13.1 15.7 0.7 0.3 1.9 0.3 3.4 4.5 0.4 0.8 1.2 1.6 4.3 0.0 0.1 0.0 0.2 19.0 1.8 4.0 0.0 0.2 1.5 0.1 0.2 73.1 0.8 0.1 10.3 0.0 46.6 10.2 0.4 10.3 0.2 4.3 2.7 37.1 0.9 1.0 0.7 0.4 8.9 1.1 1.8 0.1 0.7 29.8 0.2 0.0 0.8 0.4 0.3 0.0 0.0 0.4 0.1 0.3 0.1 36.6 1.2 4.7 0.9 0.1 3.1 0.0 0.0 4.4 16.0 0.0 0.4 10.4 1.5 0.7 3.0 1.2 3.6 1.7 0.9 2.5 2.3 4.7 0.3 3.6 0.5 1.4 0.2 21.0 2.0 1.7 16.0 16.3 17.9 22.3 15.8 17.1 17.0 16.5 15.4 16.1 16.2 16.5 15.7 1.8 12.8 3.2 2.3 1.1 3.6 10.0 5.6 8.6 6.1 2.4 5.6 2.8 8.6 5.7 9.2 6.2 0.4 1.8 0.1 23.5 1.3 6.4 2.1 9.9 4.3 0.0 4.4 0.5 0.4 0.4 9.1 2.0 2.0 0.0 7.6 5.7 0.0 5.1 6.7 1.1 0.8 2.0 1.0 3.9 7.3 11.5 2.7 5.4 1.9 3.3 5.6 0.0 5.0 0.5 0.4 0.1 9.8 1.7 5.2 0.7 19.0 15.0 3.3 0.0 2.1 5.9 2.3 1.2 6.7 3.1 0.1 1.2 13.6 1.7 6.6 CLDN34 ENSG00000234469 "Claudin 34" H7C241 X 9967358-9968352 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 6.2;Early spermatids: 13.5;Late spermatids: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.54e-2)" "unprognostic (6.73e-5)" "unprognostic (1.25e-1)" "unprognostic (2.80e-1)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "unprognostic (6.82e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-3)" "unprognostic (5.39e-1)" "unprognostic (8.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.89e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.2 13.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 C5orf58 ENSG00000234511 "Chromosome 5 open reading frame 58" C9J3I9 5 170232447-170252575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 35 "testis: 218.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 12 "U-266/84: 85.6" "Not detected" "Not detected" NA NA "unprognostic (9.24e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (5.55e-2)" "unprognostic (2.92e-1)" "unprognostic (1.35e-1)" "unprognostic (5.33e-6)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (8.48e-2)" "unprognostic (1.85e-1)" "unprognostic (2.78e-1)" "unprognostic (3.29e-10)" "unprognostic (4.83e-3)" "unprognostic (5.45e-2)" "unprognostic (3.94e-2)" "unprognostic (8.27e-2)" 2.6 0.8 0.3 2.7 0.4 6.3 2.5 0.3 2.0 1.2 0.8 0.7 0.6 0.5 0.0 0.4 0.7 1.1 0.8 0.2 0.4 0.5 1.0 5.0 2.2 0.7 0.5 0.0 0.4 0.3 0.0 0.6 1.2 1.2 1.0 0.0 0.0 1.9 0.0 0.5 0.8 1.4 0.0 0.9 3.6 0.6 218.3 0.7 0.0 0.9 0.0 0.1 0.9 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.9 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 6.9 0.8 0.0 0.0 0.0 0.0 0.0 2.6 85.6 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.6 0.3 0.4 0.0 0.4 0.6 0.0 0.0 0.3 0.9 1.0 0.6 0.3 0.0 0.0 0.0 0.3 0.4 0.3 2.0 0.2 0.4 0.7 0.5 0.0 1.2 0.9 0.7 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560758-92590393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 13.8 13.8 22.6 12.8 24.5 35.8 16.4 26.7 43.5 15.6 21.4 13.1 13.5 14.4 22.6 13.7 13.3 9.9 11.1 22.5 22.0 12.6 16.7 11.2 16.8 23.1 22.9 21.5 16.8 16.0 11.9 12.6 10.6 24.5 13.8 12.1 9.6 13.4 11.2 16.3 14.5 13.3 10.9 22.5 14.1 13.2 8.3 22.8 17.4 14.1 15.2 14.8 13.8 14.4 27.9 24.5 12.1 34.5 55.4 20.8 22.8 20.0 29.1 29.9 26.4 32.5 21.1 27.6 43.5 26.5 19.0 22.7 19.9 28.5 17.5 40.0 22.4 37.5 35.2 20.6 43.9 20.5 36.8 27.6 14.6 17.8 20.4 24.5 21.0 16.1 31.6 46.0 50.4 29.9 30.8 58.8 59.2 50.0 22.6 16.8 42.9 36.9 34.0 26.7 27.5 35.1 31.7 26.3 29.3 32.1 32.9 27.7 26.6 19.8 28.7 46.6 37.4 30.5 12.1 14.4 76.3 18.8 48.5 39.6 15.9 13.8 14.0 12.7 15.0 18.5 30.3 16.4 17.2 13.7 23.4 19.5 17.3 5.8 15.2 11.4 31.2 21.0 7.7 22.6 24.5 26.7 43.5 22.5 22.0 23.1 22.9 21.5 24.5 22.5 22.8 27.9 157.6 57.7 64.3 23.8 146.2 114.3 196.1 130.7 84.2 83.7 120.3 113.2 27.8 184.5 87.9 88.3 75.0 61.7 258.3 126.9 99.7 93.3 47.8 174.1 167.5 89.3 137.3 119.5 28.0 87.0 62.0 99.6 59.1 294.0 87.0 76.3 109.9 120.9 72.4 55.5 27.1 118.7 95.6 121.2 155.1 19.2 102.6 116.5 76.5 27.2 112.5 104.8 121.5 27.6 57.8 89.2 122.3 88.8 139.3 126.1 84.2 98.1 55.1 73.8 52.6 207.3 107.0 100.9 115.7 75.4 104.8 70.6 151.7 78.5 113.3 137.9 OR10G8 ENSG00000234560 "Olfactory receptor family 10 subfamily G member 8" Q8NGN5 11 124026798-124030634 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCIDAS "IDAS, MCI, MCIN" ENSG00000234602 "Multiciliate differentiation and DNA synthesis associated cell cycle protein" D6RGH6 5 55219564-55227315 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" Activator "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "parathyroid gland: 2.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 4.9;HeLa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049981, HPA058073" Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA049981: , HPA058073: AB_2683596" "unprognostic (3.11e-2)" "unprognostic (7.50e-4)" "unprognostic (2.48e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (2.41e-3)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (3.17e-2)" "unprognostic (4.67e-1)" "unprognostic (2.90e-3)" "unprognostic (4.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "unprognostic (2.70e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 2.9 0.4 0.0 0.6 0.0 0.0 4.9 0.0 0.0 0.4 0.7 4.0 4.4 0.0 0.4 0.0 1.2 0.7 2.9 0.2 0.0 0.2 4.0 0.0 6.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 1.9 1.4 0.0 0.0 1.6 0.0 0.1 0.2 0.7 2.2 0.8 1.5 0.0 1.7 2.6 1.3 0.0 2.1 0.5 2.2 0.0 4.0 0.4 0.0 0.0 3.4 0.2 0.1 3.3 4.2 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.7 0.0 0.9 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" O75564 8 142657460-142681968 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 3.7 4.5 6.3 4.2 6.3 2.1 4.1 8.0 7.7 6.7 4.1 5.5 3.1 6.8 3.4 5.0 5.5 2.5 5.0 6.2 5.1 6.4 4.0 3.9 5.4 6.5 5.7 6.0 8.6 5.4 4.6 6.5 3.1 6.6 6.2 2.9 3.8 4.8 4.0 7.6 6.1 5.3 3.7 4.5 7.3 5.7 6.7 6.4 5.1 6.9 4.8 5.9 5.7 4.8 7.1 6.5 6.9 8.0 6.4 7.6 10.8 4.8 10.4 4.2 11.9 6.8 6.3 13.1 11.0 4.1 8.2 8.2 8.7 7.0 6.2 6.0 8.5 12.0 11.2 25.3 7.2 3.1 8.6 7.5 7.2 5.4 7.6 4.3 6.0 6.8 13.1 12.0 4.8 10.1 11.1 10.1 4.8 6.8 4.6 9.6 13.1 5.0 6.2 4.1 11.1 14.5 9.6 18.1 7.3 4.3 5.0 7.3 5.2 8.1 9.1 19.5 9.1 5.5 6.3 7.6 6.3 6.9 10.7 9.0 1.0 0.7 0.9 0.9 0.5 0.5 0.4 1.0 0.9 0.7 1.2 1.3 1.0 0.8 0.6 0.2 0.6 0.6 0.4 6.3 6.3 8.0 7.7 6.2 5.1 6.5 5.7 6.0 6.6 4.5 6.4 7.1 3.5 6.4 1.1 8.5 4.8 0.0 2.5 0.0 2.2 14.7 4.5 3.3 11.5 4.3 0.6 7.3 20.9 4.4 8.6 3.2 3.9 2.8 1.9 1.4 4.9 6.5 9.1 12.0 11.3 2.5 2.7 3.7 6.6 2.1 1.3 15.5 8.2 2.6 3.0 10.1 11.0 3.1 0.0 6.6 0.0 2.2 11.5 3.4 0.0 8.4 4.5 4.4 12.3 9.5 9.5 5.6 1.4 11.7 4.3 3.7 2.7 2.7 0.7 10.0 0.0 5.8 4.8 9.1 19.4 3.2 0.0 2.2 2.5 6.8 4.2 4.5 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family member B2" A6NJ64 16 11927259-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.2" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;granulocytes: 2.5;Granulosa cells: 3.1;Proximal tubular cells: 4.4;Respiratory ciliated cells: 2.2;Theca cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 15.5;U-266/70: 26.9" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 2.2 2.0 4.7 0.4 5.0 0.9 2.1 5.0 6.3 2.5 4.3 1.9 1.6 2.3 4.1 1.1 2.5 1.3 1.4 4.7 4.4 3.3 1.6 1.6 1.3 4.9 4.3 4.4 3.1 2.1 2.9 2.7 1.1 4.7 2.1 1.4 4.1 1.7 1.8 1.5 3.5 2.0 2.2 3.9 1.9 1.7 15.2 4.7 7.8 3.0 0.4 0.7 1.8 2.0 6.3 0.1 1.6 2.0 1.1 4.6 7.4 3.0 2.2 3.9 1.0 0.6 1.2 1.8 1.0 0.7 2.1 0.3 0.4 1.3 1.7 2.0 1.2 1.7 0.5 2.1 1.8 7.4 1.1 0.4 0.3 3.5 2.3 4.9 0.3 0.3 0.2 0.2 5.5 0.7 2.3 0.3 0.8 0.6 1.4 1.6 2.2 0.1 15.5 0.7 1.0 2.9 0.0 5.0 0.3 0.0 2.0 0.3 3.6 0.5 0.3 0.3 0.4 0.2 26.9 8.8 1.2 3.1 0.4 1.2 0.0 1.0 0.2 0.3 0.0 0.0 0.8 0.5 0.4 0.8 0.4 0.9 0.2 0.2 1.5 0.1 0.7 0.0 0.4 4.7 5.0 5.0 6.3 4.7 4.4 4.9 4.3 4.4 4.7 3.9 4.7 6.3 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 1.8 0.0 0.7 0.5 0.0 5.9 0.5 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.7 0.2 0.6 0.0 0.5 2.5 3.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 4.4 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.4 2.6 0.0 0.0 HLA-B AS ENSG00000234745 "Major histocompatibility complex, class I, B" P01889 6 31353872-31357188 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 2513.8" "Cell type enhanced" "Detected in all" "monocytes: 5683.6;NK-cells: 7881.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 638.3;EFO-21: 547.1;U-266/70: 1285.6;U-698: 377.2" CAB015418 Enhanced NA NA 190000000 "CAB015418: AB_831547" "unprognostic (2.87e-2)" "unprognostic (1.49e-1)" "unprognostic (4.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.81e-1)" "unprognostic (5.16e-3)" "unprognostic (8.51e-2)" "prognostic favorable (2.90e-4)" "unprognostic (2.69e-3)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (7.83e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-2)" 941.8 586.4 6.7 433.2 10.8 53.9 857.3 6.7 14.5 554.0 9.9 663.8 4.7 571.9 224.0 437.9 492.9 465.3 497.1 6.3 10.4 727.8 493.0 1660.6 1071.3 20.4 9.9 5.0 299.4 270.9 24.4 290.6 107.5 23.0 443.0 240.9 8.1 489.9 3.8 239.8 905.5 1306.4 76.0 8.0 2513.8 544.5 133.6 8.2 4.4 598.1 3.8 418.2 480.3 587.0 17.3 638.3 0.0 0.0 0.1 13.5 98.9 3.8 0.5 1.2 0.5 1.1 0.0 1.9 22.7 547.1 111.0 203.2 231.9 116.4 112.4 0.0 2.3 29.9 8.3 0.8 0.0 79.8 0.2 2.4 200.2 0.5 0.0 13.9 183.3 0.4 39.8 1.3 30.2 0.0 0.3 1.5 161.4 0.6 0.0 0.1 19.7 3.4 4.7 163.5 0.6 0.9 3.7 5.5 1.4 1.4 0.2 32.6 6.2 134.7 21.4 4.8 4.9 2.3 1285.6 291.0 377.2 1.1 6.5 0.6 141.1 196.5 232.6 233.0 163.6 215.7 162.4 194.8 198.8 150.8 113.0 150.9 212.0 420.5 179.3 123.6 127.3 213.1 400.2 6.7 10.8 6.7 14.5 6.3 10.4 20.4 9.9 5.0 23.0 8.0 8.2 17.3 2836.3 913.5 1007.9 14.0 2936.9 1165.9 761.2 1139.6 396.1 27.7 533.2 550.2 168.5 1382.6 948.3 388.1 6.2 31.4 3876.2 3264.3 68.4 4206.8 63.9 311.6 349.2 2480.7 836.0 550.3 1.4 1771.3 182.3 777.7 1044.4 773.2 620.5 212.5 2189.2 701.5 2602.0 60.6 3.4 2121.8 1129.1 4229.7 2158.6 65.7 644.9 2674.7 891.2 126.5 5683.6 209.2 7881.6 25.1 3.9 2085.3 2327.5 306.9 2983.6 993.4 4541.4 183.9 829.4 27.3 1314.8 356.3 729.7 652.9 91.6 360.3 1004.3 50.9 3661.2 1219.5 1527.4 1161.2 C11orf94 ENSG00000234776 "Chromosome 11 open reading frame 94" C9JXX5 11 45906513-45907272 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 148 "testis: 55.1" "Group enriched" "Detected in some" 82 "Early spermatids: 390.0;Late spermatids: 189.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.55e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-1)" "unprognostic (7.28e-2)" "unprognostic (5.99e-2)" "unprognostic (6.21e-3)" "unprognostic (1.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.11e-2)" "unprognostic (3.33e-2)" "unprognostic (4.24e-2)" "unprognostic (9.05e-4)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (3.28e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 390.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 189.9 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.5 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 IQCM ENSG00000234828 "IQ motif containing M" A0A1B0GVH7 4 149351709-149896233 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (3.22e-1)" "unprognostic (1.17e-3)" "unprognostic (2.18e-1)" "unprognostic (2.85e-2)" "unprognostic (1.91e-1)" "unprognostic (8.47e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA17 "IFN-alphaI, LEIF2C1" ENSG00000234829 "Interferon alpha 17" P01571 9 21227243-21228222 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOC2 ENSG00000234906 "Apolipoprotein C2" P02655 19 44946035-44949565 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Disease variant, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 79 "liver: 9720.4" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 1170.2" "Cancer enriched" "Detected in some" 17 "liver cancer: 49.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 30 "NK-cell: 3.2" "Lineage enriched" "Detected in single" 30 "NK-cells: 3.2" "Group enriched" "Detected in many" 4 "Hep G2: 713.0;THP-1: 1354.4" HPA055877 Supported "Secreted to blood" NA NA 43000000000 49000000000 "HPA055877: AB_2682953" "unprognostic (4.28e-2)" "unprognostic (7.73e-3)" "unprognostic (1.33e-1)" "unprognostic (3.66e-2)" "unprognostic (8.91e-2)" "unprognostic (1.90e-1)" "unprognostic (2.07e-1)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (1.96e-2)" "unprognostic (2.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.14e-8)" "unprognostic (1.32e-1)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (9.80e-3)" 1.0 5.5 70.1 1.7 63.9 1.1 5.4 64.5 117.2 4.5 53.6 4.4 41.8 1.2 4.9 2.4 4.3 3.8 0.8 59.1 83.1 16.5 9720.4 35.2 16.0 74.7 67.7 54.9 0.4 2.2 6.7 3.0 2.9 77.9 1.4 4.4 2.8 2.4 2.2 1.9 4.3 66.2 0.7 77.5 3.9 2.7 1.1 70.5 3.2 0.9 0.7 9.9 2.2 0.8 122.4 2.9 0.6 0.3 0.4 0.5 0.6 1.3 0.1 0.0 0.0 0.1 2.0 2.8 0.7 0.3 0.0 0.0 2.6 0.0 0.1 0.0 0.7 0.1 123.0 2.7 713.0 0.2 15.4 237.5 0.2 0.3 0.0 0.0 0.3 0.0 0.1 1.7 2.9 0.1 0.8 0.9 126.3 0.5 3.2 0.4 0.8 5.2 1.1 0.0 1.5 0.1 0.1 1.9 0.2 7.7 0.0 0.7 1354.4 0.0 0.3 0.6 0.8 0.8 2.3 0.9 2.2 0.2 3.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 70.1 63.9 64.5 117.2 59.1 83.1 74.7 67.7 54.9 77.9 77.5 70.5 122.4 0.1 0.0 2.3 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.1 11.5 0.0 3.7 0.0 0.1 0.1 0.0 3.9 0.0 0.0 0.0 0.1 0.3 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 13.6 1170.2 33.8 0.0 0.0 0.4 0.0 15.5 1.2 0.0 0.0 24.0 7.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 10.0 0.7 0.0 0.1 17.7 32.3 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.4 0.3 1.8 0.0 1.3 0.0 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 12 "adrenal gland: 14.0;brain: 45.7" "Cell type enriched" "Detected in some" 18 "Horizontal cells: 477.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 7 "cerebellum: 45.7;pons: 20.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HEK 293: 19.3" "Group enriched" "Detected in many" 4 "cerebellum: 7.8;olfactory bulb: 15.7;white matter: 4.0" "Low region specificity" "Detected in all" HPA059173 Uncertain NA NA "HPA059173: AB_2683938" "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favorable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.0 14.0 1.7 0.5 0.5 0.1 0.0 45.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 1.2 0.5 0.9 0.4 0.0 0.1 1.2 0.9 4.0 0.3 0.0 0.0 0.1 1.7 0.0 20.2 0.1 0.0 0.3 0.8 0.0 0.3 0.3 1.6 0.0 2.4 2.5 0.2 0.2 4.9 0.0 0.1 0.1 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 45.7 3.2 0.5 0.9 0.9 4.0 0.3 20.2 2.4 4.9 0.8 0.1 0.0 0.0 0.3 10.8 0.0 0.0 0.0 0.0 11.5 22.7 0.0 3.7 0.0 0.0 0.0 4.2 0.0 0.5 0.0 1.9 0.0 1.1 5.2 0.5 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.0 0.0 0.0 477.8 25.9 0.0 0.0 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 1.0 1.6 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.0 4.5 0.0 0.0 0.1 1.9 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 AL158151.3 ENSG00000235007 "Novel protein" 9 129139413-129260575 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in single" "Endometrial stromal cells: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SuSa: 1.8" NA NA "unprognostic (8.74e-2)" "unprognostic (7.80e-2)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.33e-1)" 0.2 0.3 0.6 0.4 0.8 0.3 0.2 0.3 0.8 0.2 0.1 0.2 0.3 0.4 0.2 0.1 0.3 0.5 0.1 0.7 0.4 0.1 0.1 0.2 0.4 0.8 0.5 0.6 0.4 0.0 0.0 0.2 1.0 0.2 0.2 0.3 0.2 0.2 0.3 0.5 0.2 0.3 0.4 0.8 0.1 0.4 0.7 1.0 0.1 0.2 0.2 0.2 1.1 0.0 0.1 0.2 0.3 0.2 0.1 0.4 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.1 0.6 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.4 0.3 0.1 0.3 0.0 0.0 0.5 0.4 0.2 0.6 0.2 0.4 0.3 0.2 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.3 0.2 1.8 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.7 0.6 0.2 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.4 0.9 2.2 0.9 0.4 0.1 0.3 0.2 0.5 0.6 0.8 0.3 0.8 0.7 0.4 0.8 0.5 0.6 1.0 0.4 0.7 1.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 2.1;testis: 7.0" "Cell type enhanced" "Detected in many" "Collecting duct cells: 20.2;Early spermatids: 30.7;Muller glia cells: 65.4;Rod photoreceptor cells: 29.3;Spermatocytes: 17.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HMC-1: 1.5;JURKAT: 1.2;K-562: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome NA NA "Vesicles, Aggresome" "HPA060238: AB_2684228" "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.5 0.0 0.4 0.1 0.0 2.1 1.3 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.6 0.4 0.6 0.0 0.0 0.3 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.5 4.3 0.4 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.0 0.8 0.0 0.0 0.2 0.7 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.1 1.3 0.7 0.5 0.6 0.4 0.6 0.8 0.2 0.4 0.7 0.2 0.0 0.0 0.3 0.5 2.2 1.7 0.0 12.0 14.9 4.0 4.3 1.3 1.5 0.0 20.2 8.4 0.1 3.0 0.1 13.7 7.9 30.7 2.3 1.4 1.5 0.0 0.8 1.5 1.3 0.3 0.9 0.0 5.4 0.0 1.4 1.8 0.0 0.9 11.8 2.1 0.0 0.0 0.3 0.8 6.4 0.6 0.9 5.4 1.0 2.6 65.4 0.0 1.5 3.5 4.4 0.0 0.7 0.1 6.0 0.0 0.2 0.0 29.3 0.0 1.1 1.8 17.1 5.0 0.9 4.3 0.0 0.8 2.7 0.0 0.4 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.0;Glandular and luminal cells: 88.4;Respiratory ciliated cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "myeloid DC: 3.5;plasmacytoid DC: 7.8" "Lineage enriched" "Detected in single" 23 "dendritic cells: 7.8" "Group enriched" "Detected in some" 8 "Hep G2: 35.9;RT4: 34.5;SCLC-21H: 46.3" "Not detected" "Not detected" HPA065720 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA065720: AB_2685545" "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 5.9 1.0 25.1 3.2 29.9 0.2 10.4 26.7 27.0 8.1 19.5 10.6 2.3 7.7 5.9 15.7 37.0 2.9 3.7 23.4 26.3 6.0 1.5 11.3 9.2 32.4 29.8 21.5 8.6 15.3 1.5 2.3 7.0 32.4 20.1 1.7 2.6 16.2 22.1 3.2 5.7 6.4 4.1 26.2 1.7 10.0 7.4 26.4 7.9 4.4 3.3 7.3 21.3 9.4 36.0 1.0 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.5 0.9 0.0 4.5 0.3 4.3 0.0 0.5 0.4 0.0 0.0 35.9 0.8 0.1 0.0 0.4 5.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.2 0.1 0.0 0.3 4.6 0.0 0.0 34.5 46.3 0.5 0.2 0.0 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.3 0.0 0.3 0.0 0.0 0.0 7.8 0.0 0.2 25.1 29.9 26.7 27.0 23.4 26.3 32.4 29.8 21.5 32.4 26.2 26.4 36.0 11.8 22.4 29.0 5.5 0.1 2.2 12.9 14.1 13.1 8.5 5.9 32.5 0.7 14.3 20.1 1.8 0.0 26.0 0.0 0.0 9.8 19.0 0.0 65.0 20.5 11.7 1.8 2.7 4.4 30.7 0.8 13.3 3.1 88.4 8.8 2.9 1.4 0.8 2.2 8.4 2.0 0.0 14.2 1.0 3.3 0.9 20.8 1.5 3.6 1.0 1.2 16.6 0.0 3.5 20.5 11.0 0.1 29.0 0.1 6.3 0.0 0.5 51.8 3.1 0.0 25.7 3.6 0.3 0.3 10.7 3.1 16.8 1.1 0.7 0.0 10.8 BRD3OS "bA374P20.3, FLJ35348, LINC00094, NCRNA00094" ENSG00000235106 "BRD3 opposite strand" A0A1B0GUI7 9 134025481-134034666 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Collecting duct cells: 16.5;Distal tubular cells: 19.6;Endometrial ciliated cells: 18.3;Endometrial stromal cells: 11.9;Proximal tubular cells: 15.5;Respiratory ciliated cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (7.26e-2)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-1)" "unprognostic (3.02e-1)" "unprognostic (3.87e-2)" "unprognostic (1.62e-1)" "unprognostic (1.83e-1)" "unprognostic (2.66e-1)" "unprognostic (1.83e-1)" "unprognostic (7.12e-3)" "unprognostic (1.97e-1)" "prognostic favorable (4.24e-5)" "unprognostic (1.95e-1)" "unprognostic (5.25e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.31e-4)" 8.0 14.0 29.4 5.4 30.5 2.0 7.8 24.6 32.3 11.2 24.3 9.3 3.0 12.1 11.6 6.1 22.7 9.7 7.8 31.0 28.0 10.8 5.5 7.0 7.9 27.0 29.6 30.1 16.4 8.8 18.1 28.2 5.0 26.5 11.1 3.7 30.6 7.3 12.9 2.8 4.6 6.6 8.7 25.3 7.0 7.7 11.7 29.6 7.7 14.6 4.5 7.9 9.8 7.2 26.9 11.4 17.6 14.6 26.0 21.1 28.5 6.4 12.9 18.0 21.8 11.2 13.1 9.6 6.7 9.4 26.5 25.8 16.3 15.4 16.8 11.9 10.2 7.9 4.8 26.2 5.3 13.3 10.4 9.3 18.2 24.5 22.5 9.5 37.5 14.6 20.0 5.7 10.0 16.6 16.2 20.5 5.0 19.8 14.9 15.6 8.9 13.5 13.3 21.5 5.1 35.3 17.6 18.3 9.1 6.6 8.5 28.7 9.8 15.5 22.0 16.7 26.7 15.4 3.9 7.9 3.3 26.1 10.0 10.5 1.4 3.6 0.1 12.3 3.7 11.0 12.7 13.0 11.9 3.5 14.4 13.1 10.6 2.6 10.6 9.3 4.7 5.5 6.6 29.4 30.5 24.6 32.3 31.0 28.0 27.0 29.6 30.1 26.5 25.3 29.6 26.9 3.3 12.8 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 6.1 7.1 0.0 0.0 5.0 16.5 0.0 2.2 2.7 0.0 19.6 10.5 0.0 18.3 11.9 1.5 0.0 0.0 0.0 7.8 7.1 4.5 0.0 4.6 0.0 4.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.7 0.0 0.0 15.5 21.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.4 1.5 10.0 0.0 0.0 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell type enhanced" "Detected in many" "Early spermatids: 138.5;Late spermatids: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "basophil: 17.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 17.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;EFO-21: 40.1;TIME: 31.0;U-2 OS: 47.6" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favorable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.3 3.4 23.2 2.6 13.9 4.7 13.2 24.4 19.9 8.2 5.3 7.9 4.2 19.4 9.6 11.4 7.9 18.9 7.9 14.3 8.4 6.2 5.6 10.8 2.5 22.2 11.6 10.9 19.9 7.3 4.5 6.2 3.0 24.0 8.4 6.1 8.3 6.5 9.4 9.7 13.5 4.4 12.7 18.9 2.7 17.1 21.0 16.7 4.7 13.6 8.1 4.2 5.8 6.3 43.6 2.0 2.7 4.1 19.1 0.7 0.9 6.0 0.9 1.2 0.9 0.8 2.5 29.5 0.5 40.1 1.4 5.9 6.2 2.1 1.8 0.6 3.6 1.7 6.5 16.0 4.5 1.7 14.0 8.3 0.7 16.2 1.1 1.7 1.9 28.0 5.4 7.7 4.9 4.3 2.9 2.4 3.4 1.3 1.4 12.1 6.2 3.7 3.7 2.8 2.5 13.6 3.7 26.3 16.6 3.9 3.0 8.4 4.7 31.0 6.1 47.6 1.2 2.2 2.1 3.3 0.5 0.7 6.7 1.4 17.6 0.3 0.6 1.3 0.2 1.2 1.2 1.1 1.0 0.3 1.0 0.8 1.2 0.2 1.3 0.3 1.8 0.2 0.3 23.2 13.9 24.4 19.9 14.3 8.4 22.2 11.6 10.9 24.0 18.9 16.7 43.6 7.0 28.9 3.3 15.7 0.5 0.8 2.4 7.5 14.8 8.9 3.3 2.8 7.6 2.8 11.6 3.7 0.0 1.9 1.8 4.9 7.9 2.9 138.5 6.6 1.5 7.4 6.0 0.8 27.9 8.1 0.9 4.1 10.2 5.8 2.5 2.2 1.8 4.8 0.7 1.7 11.7 2.5 16.2 0.8 1.2 65.0 3.7 0.7 1.8 4.7 0.7 7.2 1.0 4.0 18.5 4.8 2.6 5.3 2.0 1.4 1.2 8.1 3.9 5.9 6.6 2.7 3.4 11.2 4.5 6.8 2.3 0.8 1.1 2.3 3.3 1.5 FAM237A ENSG00000235118 "Family with sequence similarity 237 member A" A0A1B0GTK4 2 206642487-206649365 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Low region specificity" "Detected in single" NA NA "unprognostic (3.02e-1)" 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.3 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.8 0.0 0.0 0.0 0.0 0.4 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 0.8 0.6 0.8 0.4 0.4 0.6 0.5 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C12orf75 "AGD3, OCC-1, OCC1" ENSG00000235162 "Chromosome 12 open reading frame 75" Q8TAD7 12 105235290-105396097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 110.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 841.2;Ductal cells: 626.3;Endometrial ciliated cells: 579.1;Extravillous trophoblasts: 1228.2;Proximal tubular cells: 762.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 661.2" "Group enriched" "Detected in all" 6 "dendritic cells: 661.2;T-cells: 169.9" "Cell line enhanced" "Detected in all" "BJ: 877.8;BJ hTERT+: 517.0;fHDF/TERT166: 432.7;RPTEC TERT1: 425.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065311 Uncertain Approved Vesicles NA NA Vesicles "HPA065311: AB_2685463" "unprognostic (5.96e-2)" "unprognostic (3.85e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (6.73e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.61e-2)" "unprognostic (1.01e-1)" "unprognostic (2.60e-2)" "unprognostic (1.33e-1)" "unprognostic (7.00e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "unprognostic (4.47e-3)" 10.1 7.4 5.4 8.9 5.1 11.4 11.7 10.1 7.0 31.6 4.8 25.2 9.3 18.7 6.1 8.8 21.1 38.5 2.5 4.4 7.6 57.5 2.0 7.5 14.8 5.6 5.8 4.4 6.7 34.1 20.2 3.5 9.4 5.6 41.5 22.2 2.8 4.3 110.3 32.3 9.0 8.9 6.8 7.9 6.4 50.4 26.8 7.7 10.9 2.9 11.9 19.2 5.1 27.2 5.9 43.6 66.6 16.5 14.9 61.2 117.3 30.3 877.8 517.0 194.2 109.4 133.2 3.6 12.2 348.9 432.7 31.7 70.4 36.6 50.3 212.9 241.1 65.0 38.8 17.7 26.5 7.7 29.8 37.7 49.6 12.0 66.4 73.8 113.0 26.1 69.9 1.9 58.8 192.4 14.4 115.3 262.5 39.6 15.8 153.3 21.6 44.3 11.2 425.3 4.3 73.5 18.4 36.9 7.7 16.2 45.2 22.6 7.1 44.2 201.7 77.2 77.0 118.1 34.9 57.6 58.8 44.5 9.7 55.3 39.0 0.7 1.2 165.5 0.5 80.4 19.7 69.2 169.9 23.3 16.2 19.8 102.4 3.5 69.4 1.6 661.2 144.1 88.3 5.4 5.1 10.1 7.0 4.4 7.6 5.6 5.8 4.4 5.6 7.9 7.7 5.9 12.8 3.2 2.8 1.6 61.2 100.2 65.9 21.9 38.7 4.5 32.2 26.9 1.1 271.7 20.9 187.6 4.2 35.3 519.5 469.8 841.2 626.3 152.3 579.1 32.6 14.8 333.2 15.8 2.7 222.3 1228.2 53.0 160.5 293.1 2.5 9.7 13.2 1.8 31.9 63.9 2.9 63.6 85.5 5.3 97.3 324.1 15.5 48.2 60.5 40.3 29.1 6.4 299.7 0.5 0.4 420.0 175.5 4.9 160.3 87.0 102.1 762.3 129.7 4.9 6.6 8.6 127.8 102.9 118.6 37.1 61.2 40.6 143.0 0.7 63.9 37.3 SMIM1 Vel ENSG00000235169 "Small integral membrane protein 1 (Vel blood group)" B2RUZ4 1 3772749-3775982 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.4;testis: 42.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 84.1;Erythroid cells: 404.4;Granulosa cells: 81.5;Proximal tubular cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 11 "eosinophil: 48.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 48.5" "Group enriched" "Detected in many" 4 "HEL: 68.0;Hep G2: 32.5;K-562: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA069088 Enhanced NA NA 340000 "HPA069088: AB_2686080" "unprognostic (9.50e-3)" "unprognostic (7.19e-4)" "unprognostic (5.40e-2)" "unprognostic (2.10e-2)" "unprognostic (2.50e-3)" "unprognostic (3.25e-1)" "unprognostic (2.63e-3)" "unprognostic (2.13e-2)" "unprognostic (2.31e-2)" "unprognostic (9.85e-2)" "unprognostic (2.90e-1)" "unprognostic (1.87e-1)" "unprognostic (2.25e-2)" "unprognostic (7.10e-2)" "unprognostic (2.91e-2)" "unprognostic (5.56e-2)" "unprognostic (1.32e-2)" 2.0 2.8 2.7 0.4 2.3 32.4 3.3 3.6 3.0 5.5 5.1 2.4 0.7 2.8 1.1 1.4 3.4 1.3 26.5 1.3 3.0 16.8 13.2 3.8 1.0 7.0 5.0 0.6 8.8 9.5 4.4 16.2 2.2 8.8 7.0 0.1 0.4 17.4 5.6 1.1 2.1 2.1 0.2 5.4 4.0 6.7 42.6 3.3 0.4 9.4 0.2 0.5 3.4 3.7 5.6 0.3 1.4 1.4 3.0 0.0 0.0 5.0 0.9 1.2 0.0 0.0 3.5 3.9 0.1 6.3 0.0 0.2 1.3 0.4 1.5 0.0 6.1 3.6 68.0 0.0 32.5 2.4 0.0 1.2 2.1 0.8 0.3 0.5 2.9 0.0 0.3 33.9 1.2 0.0 7.8 0.0 2.1 0.3 3.4 6.0 0.0 0.0 9.9 3.8 1.0 1.6 6.3 0.2 6.8 4.8 0.5 7.0 3.7 0.4 0.0 0.8 0.0 0.0 2.8 0.8 0.2 0.0 0.0 0.2 4.4 2.0 48.5 1.1 1.0 0.4 2.5 1.6 0.6 0.6 3.7 4.0 1.9 3.2 0.2 0.4 0.6 1.2 2.2 2.7 2.3 3.6 3.0 1.3 3.0 7.0 5.0 0.6 8.8 5.4 3.3 5.6 1.1 6.4 20.1 0.7 5.9 1.7 13.1 4.4 10.2 0.4 31.1 35.9 57.0 8.6 8.1 16.5 0.0 23.4 1.4 1.6 84.1 17.2 10.8 3.7 1.2 3.9 5.4 404.4 0.1 14.5 18.8 10.1 6.6 3.5 1.3 81.5 3.9 50.2 10.4 1.7 0.1 3.9 8.2 8.9 1.0 27.8 9.9 8.5 42.7 0.0 4.3 47.0 2.1 0.0 1.6 13.7 1.7 9.8 11.1 10.2 1.9 247.9 2.2 1.5 0.0 3.6 4.3 8.7 20.4 1.7 1.1 6.7 4.6 3.0 4.3 9.1 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137774-144140851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 26.4;PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: AB_2678013" "unprognostic (2.13e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 2.4 3.2 1.8 1.0 1.3 0.6 1.5 1.4 1.8 1.8 1.0 2.0 0.6 2.3 0.1 3.1 1.7 0.5 1.7 1.7 1.0 1.9 3.2 1.4 0.7 2.2 1.3 1.6 1.7 3.1 0.8 1.4 0.4 1.7 1.9 0.5 0.1 1.8 0.8 2.7 2.1 1.6 0.7 1.3 2.2 2.9 2.4 1.5 0.6 2.0 1.2 0.6 2.6 1.9 1.4 8.3 2.7 1.9 3.5 2.7 1.7 4.9 13.8 1.1 2.9 1.9 3.6 2.1 23.9 18.7 2.6 1.1 8.6 3.8 1.9 0.9 11.7 14.5 9.1 2.4 1.8 2.6 5.1 5.9 1.2 5.9 3.2 2.0 1.0 1.3 4.9 26.4 0.9 1.8 6.9 17.5 4.7 5.4 3.1 46.6 21.8 1.6 3.7 1.7 1.9 4.1 4.4 6.4 3.4 5.1 0.6 2.9 1.8 4.9 1.7 14.2 5.1 16.5 13.9 9.7 6.1 1.7 8.5 2.8 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.4 0.7 0.2 0.8 0.4 0.3 0.0 0.6 0.2 0.1 0.1 0.1 1.8 1.3 1.4 1.8 1.7 1.0 2.2 1.3 1.6 1.7 1.3 1.5 1.4 5.2 0.0 2.4 2.6 5.8 0.0 2.6 0.0 5.2 4.2 6.7 5.7 2.2 2.8 0.6 5.5 0.0 11.1 7.2 1.3 11.7 3.5 11.2 2.8 7.0 3.1 4.9 5.9 1.2 1.8 13.4 4.3 7.1 4.0 0.0 7.9 1.4 9.9 12.2 6.7 1.2 4.0 0.0 4.8 0.0 22.1 7.5 5.6 0.0 1.0 3.5 8.3 14.4 0.0 1.0 2.9 5.6 3.4 4.9 3.2 5.4 10.2 1.5 3.7 6.6 2.6 3.8 15.1 14.8 6.9 0.0 3.1 5.9 11.0 6.5 1.6 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295652-23302859 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 47.5" "Cell type enhanced" "Detected in all" "Early spermatids: 111.9;Late spermatids: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 41.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 5.6 8.1 16.8 5.8 19.5 4.0 6.4 19.4 23.9 9.9 11.2 7.4 6.3 6.5 10.1 6.0 9.6 3.4 6.0 16.8 16.6 11.6 11.3 5.8 9.6 20.5 18.5 17.1 12.6 10.7 5.8 19.4 2.8 21.1 12.2 5.9 47.5 8.6 6.2 15.0 11.0 13.4 3.5 15.6 15.3 9.1 14.8 18.4 8.3 15.0 5.4 8.2 7.9 8.5 25.1 1.1 3.0 3.6 2.5 6.9 2.9 1.7 1.2 2.2 2.0 1.7 1.7 5.8 11.2 0.8 1.6 2.2 7.6 2.1 1.2 2.5 4.0 2.1 2.0 6.9 4.0 1.8 2.3 4.4 2.5 4.5 1.2 6.1 3.3 0.9 6.0 1.9 9.8 1.7 2.6 2.1 3.6 0.9 3.6 2.8 3.4 2.5 7.2 1.1 2.5 4.5 1.2 1.8 1.6 1.2 1.8 1.9 0.8 1.7 2.4 1.3 4.1 0.9 41.1 4.6 5.1 1.9 4.0 1.5 0.2 0.4 0.2 0.5 1.4 0.6 1.0 0.1 0.2 0.3 0.6 0.5 0.3 0.4 0.2 1.8 0.3 0.4 0.3 16.8 19.5 19.4 23.9 16.8 16.6 20.5 18.5 17.1 21.1 15.6 18.4 25.1 5.8 3.2 4.8 30.0 25.4 5.6 9.0 5.3 11.4 59.4 7.8 11.6 8.8 7.2 5.0 20.2 37.5 8.2 12.8 8.0 5.9 2.1 111.9 3.7 6.6 7.2 8.4 7.2 25.0 3.3 2.0 6.1 20.4 4.3 3.8 9.4 7.5 7.2 7.4 32.0 33.0 7.7 4.1 9.5 9.6 62.9 27.4 9.2 10.6 15.9 8.1 20.4 26.8 16.1 56.1 2.4 11.6 25.9 11.9 6.7 19.5 9.5 4.8 38.1 13.1 3.5 5.4 36.5 13.9 8.4 9.1 5.2 15.7 7.2 9.6 8.6 KDM4E "JMJD2E, KDM4DL, KDM5E" ENSG00000235268 "Lysine demethylase 4E" B2RXH2 11 95025258-95027596 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051740, HPA054225" Uncertain NA NA "HPA051740: AB_2681586, HPA054225: AB_2682421" "unprognostic (1.32e-1)" "unprognostic (6.31e-2)" "unprognostic (4.74e-2)" "unprognostic (3.69e-1)" "unprognostic (9.27e-2)" "unprognostic (5.54e-2)" "unprognostic (8.10e-4)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAMACL "C6orf119, dJ427A4.2, FAM103A2P, RAMMETL" ENSG00000235272 "RNA guanine-7 methyltransferase activating subunit like (pseudogene)" 6 166585604-166587594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 3.5;ASC TERT1: 2.8;HEK 293: 5.9;HeLa: 2.2;HHSteC: 4.9;TIME: 1.8" "HPA041923, HPA041948" Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (3.49e-2)" "unprognostic (1.17e-3)" "unprognostic (1.33e-2)" "unprognostic (8.15e-2)" "unprognostic (8.71e-2)" "unprognostic (5.31e-3)" "unprognostic (2.04e-1)" "unprognostic (4.69e-2)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (4.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.62e-3)" "unprognostic (2.33e-2)" 0.0 0.4 1.3 0.0 1.0 0.7 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 1.5 0.7 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.7 0.3 0.0 0.0 1.4 0.7 0.4 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 3.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 2.2 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.3 3.9 1.7 2.1 1.9 2.9 2.0 1.9 2.6 2.8 1.9 1.7 4.4 2.2 1.1 1.7 2.6 2.1 1.3 1.0 0.2 0.8 0.7 1.2 1.5 0.7 0.5 1.5 0.7 1.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.1;Cone photoreceptor cells: 8.4;Ionocytes: 2.0;Rod photoreceptor cells: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.0 3.1 0.0 0.0 1.9 0.0 0.7 0.0 8.4 0.3 1.3 0.5 0.0 0.5 0.1 0.1 0.0 0.3 1.8 0.0 0.6 0.2 0.5 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.5 2.0 0.0 1.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.2 4.4 0.0 0.0 0.4 0.1 0.3 0.0 0.3 0.4 0.1 0.0 0.7 0.0 SPAAR "LINC00961, SPAR" ENSG00000235387 "Small regulatory polypeptide of amino acid response" A0A1B0GVQ0 9 35909490-35937153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 10.8;breast: 10.9" "Cell type enriched" "Detected in some" 7 "Adipocytes: 42.3" "Cancer enhanced" "Detected in many" "renal cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "HUVEC TERT2: 34.0;TIME: 40.1" "Not detected" "Not detected" NA NA "unprognostic (3.17e-1)" "unprognostic (2.19e-2)" "unprognostic (1.91e-2)" "unprognostic (7.00e-3)" "unprognostic (4.23e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.00e-1)" "unprognostic (3.40e-3)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (7.72e-2)" "unprognostic (7.12e-3)" "unprognostic (1.67e-2)" "unprognostic (3.04e-1)" "unprognostic (1.27e-1)" "unprognostic (3.22e-1)" 10.8 1.2 3.2 0.6 2.6 0.0 10.9 2.4 3.3 0.7 1.4 1.1 0.3 1.2 0.1 0.5 1.2 0.7 6.4 2.5 2.3 3.1 0.8 3.2 0.5 3.2 2.8 1.8 0.7 0.5 0.5 0.7 4.7 3.0 1.0 0.4 1.4 0.7 0.5 3.1 0.8 0.9 0.6 2.4 0.7 0.9 7.5 2.9 0.2 1.9 1.8 0.0 1.5 0.8 2.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.4 0.1 0.2 0.0 0.0 34.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 40.1 0.0 0.8 2.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.6 2.4 3.3 2.5 2.3 3.2 2.8 1.8 3.0 2.4 2.9 2.9 42.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 SMIM27 "C9orf133, TOPORS-AS1" ENSG00000235453 "Small integral membrane protein 27" A0A1B0GUW7 9 32551144-32568621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 48.6;Distal tubular cells: 119.3;Proximal tubular cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 680.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 680.4" "Low cell line specificity" "Detected in all" NA NA "prognostic favorable (4.18e-5)" "prognostic favorable (6.11e-4)" "unprognostic (1.47e-1)" "unprognostic (5.30e-2)" "unprognostic (4.88e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-1)" "unprognostic (4.74e-3)" "unprognostic (8.58e-2)" "prognostic favorable (8.39e-4)" "prognostic favorable (7.33e-5)" "unprognostic (1.30e-1)" "prognostic favorable (3.46e-4)" "unprognostic (7.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.38e-2)" "unprognostic (2.14e-3)" 9.8 19.1 21.2 9.4 22.5 17.6 10.4 24.5 28.2 8.7 20.1 10.5 9.7 8.5 13.9 8.6 8.5 3.1 17.0 21.2 22.1 18.7 9.1 9.8 12.3 22.0 21.4 21.3 8.6 20.0 13.1 24.2 4.8 22.5 10.3 4.0 19.0 12.0 6.0 28.8 10.9 10.8 4.0 22.1 16.7 12.9 42.0 21.8 17.2 11.8 13.8 8.8 9.5 8.2 24.2 13.8 7.2 13.7 12.4 5.9 17.8 7.5 6.4 10.2 5.3 10.8 1.9 3.5 10.3 10.0 10.2 9.7 5.3 9.4 6.2 7.7 20.0 21.1 50.5 22.5 17.5 13.5 13.0 8.2 13.1 9.6 5.2 12.2 15.1 12.3 33.6 7.4 25.6 9.7 10.3 22.6 52.5 17.0 13.9 14.5 11.1 6.1 18.8 12.8 7.1 10.2 12.4 16.5 6.3 8.8 16.5 5.0 11.0 6.3 3.6 9.5 4.9 6.9 28.5 23.8 38.0 22.7 7.6 3.0 116.8 47.3 332.4 79.5 51.3 107.8 122.1 114.0 93.7 41.8 129.3 135.6 117.4 680.4 93.3 54.9 56.9 129.0 62.9 21.2 22.5 24.5 28.2 21.2 22.1 22.0 21.4 21.3 22.5 22.1 21.8 24.2 22.2 28.9 30.1 0.0 13.4 0.0 0.0 0.0 0.0 0.0 38.6 48.6 0.0 0.0 9.3 29.5 0.0 26.4 27.3 0.0 119.3 20.4 0.0 43.9 18.1 8.1 0.0 0.0 0.0 32.2 12.6 6.4 0.0 29.2 25.2 15.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.2 0.0 0.0 0.0 0.0 22.9 0.0 0.0 5.3 0.0 0.0 112.9 29.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 20.0 16.7 11.2 0.0 0.0 NFAM1 CNAIP ENSG00000235568 "NFAT activating protein with ITAM motif 1" Q8NET5 22 42380407-42432403 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.2;lymphoid tissue: 20.1" "Cell type enhanced" "Detected in some" "granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 90.4" "Group enriched" "Detected in many" 4 "granulocytes: 90.4;monocytes: 48.2" "Cell line enriched" "Detected in some" 4 "THP-1: 37.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031812 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA031812: AB_10603121" "unprognostic (9.77e-3)" "unprognostic (2.77e-3)" "unprognostic (8.21e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.83e-2)" "unprognostic (8.76e-3)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "unprognostic (9.12e-3)" "unprognostic (9.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.00e-1)" "unprognostic (8.12e-3)" "unprognostic (1.75e-1)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" 6.4 1.9 1.6 12.5 1.8 31.2 1.1 1.7 2.5 1.8 2.5 1.5 1.4 0.6 0.6 1.3 2.0 2.4 1.1 1.9 3.0 1.2 2.3 7.6 5.5 3.1 2.1 1.0 0.3 0.9 0.3 0.6 2.9 2.7 0.9 1.2 0.1 0.8 1.5 0.4 1.4 2.3 2.9 2.1 20.1 1.2 0.7 2.5 2.1 0.7 1.5 2.2 3.2 0.7 3.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 8.8 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 5.8 0.0 0.0 0.1 0.0 0.4 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.3 48.2 2.8 0.1 32.5 0.2 0.0 0.1 0.0 16.5 0.1 0.0 0.0 90.4 0.0 31.1 0.3 0.0 25.4 1.6 1.8 1.7 2.5 1.9 3.0 3.1 2.1 1.0 2.7 2.1 2.5 3.7 0.4 0.0 3.7 0.0 0.5 0.9 0.7 0.9 0.6 0.2 0.4 0.0 0.6 1.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 2.8 0.4 0.2 0.5 1.2 0.0 0.7 0.2 0.1 0.5 0.0 0.3 11.4 0.0 0.7 0.6 17.0 0.0 0.6 0.0 0.0 53.9 8.2 5.6 0.3 27.2 0.0 8.4 44.6 0.0 0.0 2.0 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.5 0.5 0.8 0.7 0.0 1.0 0.3 1.3 0.4 0.0 0.5 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406442 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF148 MGC35222 ENSG00000235631 "Ring finger protein 148" Q8N7C7 7 122701668-122702922 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 49.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 405.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 9.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.8;MCF7: 1.1" "Not detected" "Not detected" HPA045587 Approved Cytosol NA NA Cytosol "HPA045587: AB_10963695" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (3.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.85e-1)" "unprognostic (3.23e-2)" "unprognostic (1.04e-2)" "unprognostic (9.81e-2)" "unprognostic (8.48e-2)" "unprognostic (2.14e-2)" "unprognostic (2.18e-1)" "unprognostic (2.37e-1)" "unprognostic (3.33e-2)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-2)" "unprognostic (1.09e-1)" 0.2 0.2 0.0 0.0 0.2 0.0 0.2 9.7 1.6 0.2 0.4 0.1 0.0 0.6 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.3 0.3 0.4 0.0 0.1 0.5 0.0 0.1 0.3 0.0 0.2 0.0 3.6 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 49.6 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.8 0.0 1.1 0.0 0.0 0.3 0.6 0.3 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.7 1.6 0.3 0.1 0.1 0.5 0.0 3.6 0.0 0.2 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 405.2 0.5 0.5 0.5 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.8 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 62.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.9 0.0 0.1 0.0 0.2 0.0 0.0 6.6 0.2 0.1 3.9 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 CXorf51B ENSG00000235699 "Chromosome X open reading frame 51B" P0DPH9 X 146809771-146810411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1383 "testis: 151.2" "Group enriched" "Detected in some" 54 "Early spermatids: 17.3;Late spermatids: 48.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD34C ENSG00000235711 "Ankyrin repeat domain 34C" P0C6C1 15 79293285-79298235 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "brain: 4.9" "Group enriched" "Detected in some" 4 "Excitatory neurons: 3.0;Inhibitory neurons: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "SCLC-21H: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045329 Approved Mitochondria NA NA Mitochondria "HPA045329: AB_2679291" "unprognostic (3.20e-1)" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.42e-3)" "unprognostic (5.31e-2)" "unprognostic (2.48e-1)" 0.1 0.1 1.4 0.0 0.5 0.0 0.0 2.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 2.7 0.0 0.0 0.1 0.0 2.0 3.8 0.4 0.0 0.2 0.0 0.7 0.0 2.7 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 2.1 1.9 0.7 2.7 2.0 3.8 0.4 2.7 0.1 4.9 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MFRP "C1QTNF5, FLJ30570, NNO2, rd6" ENSG00000235718 "Membrane frizzled-related protein" Q9BY79 11 119338942-119346705 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Microphthalmia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "choroid plexus: 285.0" "Cell type enhanced" "Detected in single" "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "hippocampal formation: 26.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 11.8;pons and medulla: 10.3;thalamus: 8.4" "Region enhanced" "Detected in all" "medulla oblongata: 17.6" NA NA 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.6 4.6 0.0 285.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.2 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 3.6 4.6 26.4 0.2 0.6 4.4 0.0 0.9 0.2 3.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIAA0040 ENSG00000235750 KIAA0040 Q15053 1 175156986-175192999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 101.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 105.8;Skeletal myocytes: 107.0;Syncytiotrophoblasts: 377.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 91.3;RPMI-8226: 65.5;U-698: 115.6" "HPA016895, HPA068812" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016895: AB_2669476, HPA068812: AB_2686041" "unprognostic (5.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (1.01e-2)" "unprognostic (8.54e-3)" "unprognostic (2.91e-1)" "unprognostic (2.87e-2)" "unprognostic (3.83e-1)" "unprognostic (1.21e-1)" "unprognostic (2.66e-2)" "unprognostic (1.63e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-1)" "unprognostic (2.28e-2)" "unprognostic (3.05e-1)" 45.2 9.0 5.3 23.4 4.8 13.2 25.0 5.2 6.6 16.1 7.2 11.3 12.0 11.8 5.5 9.7 18.9 21.8 18.5 4.2 9.2 18.5 22.9 40.1 30.7 9.2 5.9 4.0 6.2 25.9 12.4 7.8 101.4 7.3 11.8 12.4 1.0 23.7 6.1 17.4 7.3 14.8 11.0 5.8 27.1 15.1 2.8 6.4 21.6 10.9 16.1 32.3 17.2 10.6 8.6 8.8 0.3 0.4 0.0 0.0 0.0 0.0 3.9 10.5 0.1 0.0 4.5 12.5 91.3 20.9 0.0 0.5 35.9 6.3 42.2 0.0 31.2 5.1 9.8 19.0 0.6 1.0 0.7 1.2 0.0 11.4 0.0 15.6 0.0 13.9 13.0 8.2 14.9 0.0 2.1 11.7 0.1 2.9 7.5 7.7 9.8 4.5 65.5 13.3 21.8 0.5 3.3 6.5 34.9 0.8 21.5 22.3 2.0 5.6 0.0 4.0 0.1 0.8 36.4 47.4 115.6 1.6 0.0 9.6 32.3 12.4 2.0 11.0 6.5 9.8 29.3 11.8 9.1 10.7 28.1 12.2 10.7 51.2 6.3 2.5 2.4 18.7 11.8 5.3 4.8 5.2 6.6 4.2 9.2 9.2 5.9 4.0 7.3 5.8 6.4 8.6 57.2 38.5 5.5 0.7 59.4 26.6 105.8 22.4 29.0 0.0 41.3 39.4 4.0 10.0 11.4 12.9 0.0 71.8 14.1 22.6 13.7 13.6 0.5 41.1 18.9 29.7 4.2 10.3 0.1 23.6 7.9 45.7 20.9 41.7 11.4 8.9 16.4 7.4 11.4 0.0 0.2 7.4 10.2 10.4 18.9 1.6 16.8 13.5 7.2 1.0 18.7 4.9 18.6 0.0 0.1 23.6 26.4 10.5 36.9 55.7 8.1 5.1 12.5 0.1 26.3 107.0 89.3 0.4 3.6 10.3 11.1 377.1 31.8 1.2 18.4 43.5 USP17L27 ENSG00000235780 "Ubiquitin specific peptidase 17 like family member 27" Q0WX57 4 9344148-9345740 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 B3GALT4 "beta3Gal-T4, GalT4" ENSG00000235863 "Beta-1,3-galactosyltransferase 4" O96024 6 33277123-33284832 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.1" "Cell type enhanced" "Detected in many" "Late spermatids: 71.8;Spermatocytes: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;MOLT-4: 1.1;SCLC-21H: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043001 Approved NA NA "HPA043001: AB_2678265" "unprognostic (3.71e-2)" "unprognostic (1.33e-2)" "unprognostic (6.02e-2)" "unprognostic (1.00e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-2)" "unprognostic (6.00e-2)" "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.98e-2)" "unprognostic (1.96e-1)" "unprognostic (1.17e-3)" "unprognostic (6.83e-2)" "unprognostic (1.94e-1)" "unprognostic (1.22e-2)" "unprognostic (3.75e-2)" 8.2 8.8 0.3 0.0 0.8 0.0 8.0 1.6 0.8 7.6 0.2 10.9 0.0 8.1 0.0 19.7 6.5 0.0 7.9 0.2 0.6 7.0 1.5 7.7 0.0 1.0 1.3 0.2 3.5 3.5 0.0 5.7 0.0 1.9 9.0 0.0 0.0 12.5 0.0 2.5 14.9 10.9 0.0 1.1 12.9 9.6 28.1 0.8 0.0 7.4 0.0 0.0 9.8 11.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.7 4.6 2.4 1.8 1.8 1.8 3.1 2.5 8.8 1.8 2.4 2.8 5.0 5.7 4.7 4.5 2.0 0.3 0.8 1.6 0.8 0.2 0.6 1.0 1.3 0.2 1.9 1.1 0.8 2.3 12.6 12.8 4.8 1.3 12.0 3.2 6.3 18.9 4.0 14.5 7.6 4.2 3.8 15.7 18.9 14.7 4.2 18.4 20.2 38.2 5.9 17.7 36.8 12.1 3.1 11.1 12.6 5.2 1.0 18.4 12.9 8.2 13.3 11.0 10.2 5.0 15.0 0.4 20.3 11.8 1.4 15.8 16.2 22.3 8.6 71.8 7.8 15.2 8.8 4.7 27.2 9.8 54.6 1.5 2.1 20.0 32.6 6.0 6.2 9.1 35.5 6.1 26.0 15.0 6.6 3.3 5.9 81.2 2.7 13.2 4.8 32.0 14.2 5.1 11.2 17.0 LCE6A C1orf44 ENSG00000235942 "Late cornified envelope 6A" A0A183 1 152842856-152843983 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 248.6" "Cell type enriched" "Detected in single" 8 "Suprabasal keratinocytes: 2.6" "Cancer enriched" "Detected in some" 5 "melanoma: 5.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046376 Enhanced NA NA "HPA046376: AB_10965998" "unprognostic (4.25e-2)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 248.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072454-153075019 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 27.0;Distal tubular cells: 11.7;Horizontal cells: 23.5;Muller glia cells: 21.1;Proximal tubular cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 16 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "HHSteC: 7.5;HMC-1: 6.7;SK-MEL-30: 6.9;U-2 OS: 14.7;U-698: 8.5" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045007: AB_2679181, HPA052115: AB_2681734" "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favorable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.7 1.8 14.1 0.2 16.7 0.4 1.1 8.7 26.9 3.1 3.5 1.4 0.6 2.5 6.0 0.4 3.0 1.0 2.1 15.4 17.2 8.1 10.3 0.6 0.4 16.2 14.1 17.5 5.2 0.9 2.2 12.0 0.2 18.2 0.5 0.2 3.5 1.0 0.7 0.5 1.0 0.9 0.7 8.0 0.9 1.2 1.7 15.2 0.3 3.1 0.7 0.3 0.4 0.7 20.2 0.0 5.3 0.1 1.5 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.8 0.4 0.9 0.0 2.8 0.0 0.0 0.0 0.6 0.0 0.3 0.2 7.5 3.3 6.7 1.1 0.0 0.1 0.0 0.2 0.2 5.6 1.4 0.0 0.1 0.4 1.1 0.0 3.3 5.9 0.0 0.0 0.0 0.0 0.3 0.0 3.2 1.9 0.4 0.0 6.9 0.3 0.0 4.2 0.0 0.0 14.7 0.0 0.0 5.7 4.6 8.5 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.1 16.7 8.7 26.9 15.4 17.2 16.2 14.1 17.5 18.2 8.0 15.2 20.2 0.2 0.0 0.0 4.6 0.5 0.0 0.3 0.0 0.0 27.0 0.3 0.5 2.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 1.5 0.0 0.4 3.4 0.4 0.0 0.0 8.1 0.2 0.0 2.4 0.0 0.8 0.0 6.5 0.7 2.9 4.0 23.5 9.6 0.0 0.0 0.8 0.4 0.7 2.8 0.8 0.0 1.9 0.0 21.1 0.0 4.5 1.4 0.3 0.0 3.0 0.7 0.1 0.0 27.0 0.0 8.7 0.0 0.8 1.9 1.0 2.8 0.0 0.0 0.0 0.7 0.9 0.0 0.1 PATE3 "HEL-127, PATE-DJ" ENSG00000236027 "Prostate and testis expressed 3" B3GLJ2 11 125788127-125791600 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "epididymis: 159.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 159.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H14 ENSG00000236032 "Olfactory receptor family 5 subfamily H member 14" A6NHG9 3 98147479-98156614 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "B-cells: 1.0;Collecting duct cells: 1.8;Early spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.5 0.3 0.3 0.2 0.3 0.3 0.3 0.0 0.2 0.6 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ZBTB22 "BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A" ENSG00000236104 "Zinc finger and BTB domain containing 22" O15209 6 33314406-33317942 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043848 Approved Nucleoplasm No No Nucleoplasm "HPA043848: AB_10961146" "unprognostic (1.32e-1)" "unprognostic (2.87e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.82e-1)" "unprognostic (1.31e-1)" "unprognostic (1.55e-2)" "unprognostic (2.06e-1)" "unprognostic (6.88e-2)" "unprognostic (4.98e-2)" "unprognostic (1.81e-1)" "unprognostic (6.54e-3)" "unprognostic (1.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.66e-2)" "unprognostic (9.32e-3)" 9.9 15.2 1.0 2.6 1.0 2.1 11.4 1.0 2.8 15.3 0.6 10.0 4.7 15.7 8.6 13.4 12.8 1.7 10.4 1.1 1.2 12.0 10.2 12.1 1.1 2.0 0.9 0.7 15.0 12.3 11.7 10.6 2.3 1.3 12.2 4.3 5.8 12.1 3.8 8.7 18.4 11.7 3.0 1.6 13.8 11.9 6.1 1.2 5.3 15.2 4.0 3.9 12.1 13.4 3.9 0.3 0.3 8.5 4.4 8.3 3.3 3.5 7.5 7.3 7.1 4.6 0.1 1.9 1.9 5.6 12.5 9.1 0.6 0.3 4.6 5.2 11.7 2.8 7.5 4.4 4.1 0.0 0.0 2.8 10.8 10.0 0.3 2.6 9.8 0.7 6.3 2.9 7.8 2.6 4.7 4.6 6.7 0.0 0.4 2.2 0.5 0.1 4.2 6.3 0.4 9.7 0.6 0.7 0.4 4.3 5.0 0.7 0.4 10.7 3.9 4.5 0.2 0.2 4.3 4.5 1.9 5.6 1.1 4.3 0.8 0.2 0.8 0.3 0.3 0.1 0.5 0.4 0.2 0.2 0.3 0.7 0.1 0.3 0.1 0.2 0.4 0.1 0.2 1.0 1.0 1.0 2.8 1.1 1.2 2.0 0.9 0.7 1.3 1.6 1.2 3.9 9.4 0.0 5.0 2.6 7.3 6.4 16.3 6.0 8.6 20.1 9.9 7.6 4.3 4.3 4.9 7.3 8.4 6.3 3.3 9.8 23.5 11.0 1.6 8.3 5.2 7.7 7.7 4.0 2.8 7.1 4.6 6.7 5.6 6.9 3.8 6.5 7.9 2.0 5.3 20.2 2.8 8.7 12.2 4.4 4.0 1.8 9.3 5.3 1.8 3.7 12.1 18.2 8.2 3.5 2.6 6.5 8.6 6.4 4.0 10.9 7.6 8.3 6.0 21.2 13.1 10.0 7.6 2.2 2.0 8.1 7.4 10.1 4.9 8.0 5.8 11.8 USP17L4 ENSG00000236125 "Ubiquitin specific peptidase 17 like family member 4" A6NCW7 8 7337115-7338707 "Enzymes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A3 CT47.3 ENSG00000236126 "Cancer/testis antigen family 47 member A3" Q5JQC4 X 120972746-120976068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-1 IGHD11 ENSG00000236170 "Immunoglobulin heavy diversity 1-1" P0DOY5 14 105919502-105919518 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC2L FLJ32986 ENSG00000236279 "C-type lectin domain family 2 member L" P0C7M8 7 139523685-139544985 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 38.4;parathyroid gland: 14.4" "Group enriched" "Detected in some" 8 "Excitatory neurons: 51.7;Inhibitory neurons: 49.5;Theca cells: 72.8" "Cancer enhanced" "Detected in many" "testis cancer: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "OE19: 12.0;U-266/84: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045050 Enhanced NA NA "HPA045050: AB_10965839" "unprognostic (1.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.20e-4)" "unprognostic (1.24e-2)" "unprognostic (1.33e-2)" "unprognostic (6.17e-2)" "unprognostic (2.29e-6)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (6.73e-2)" "unprognostic (2.68e-1)" "unprognostic (8.31e-2)" "unprognostic (7.94e-4)" "unprognostic (3.57e-3)" "unprognostic (4.03e-2)" "unprognostic (8.42e-3)" "unprognostic (3.02e-2)" 0.3 0.1 15.3 0.2 13.6 0.4 0.1 29.8 34.2 0.8 4.7 0.3 0.1 1.5 0.0 0.6 0.1 0.8 0.2 18.0 16.6 0.0 0.0 0.1 0.1 32.5 16.5 13.2 0.2 0.1 14.4 0.5 0.0 37.4 0.0 0.1 10.4 0.1 0.0 3.1 0.2 0.3 0.8 12.0 0.2 0.1 0.6 34.6 8.1 0.2 6.6 0.1 0.1 0.1 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.5 0.0 1.2 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.3 13.6 29.8 34.2 18.0 16.6 32.5 16.5 13.2 37.4 12.0 34.6 38.4 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 51.7 0.0 2.8 1.7 0.0 0.1 0.0 2.7 0.0 0.0 0.2 5.0 49.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.8 0.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.8 1.9 0.0 0.0 0.4 0.0 72.8 0.0 0.1 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 25.4 22.2 17.8 36.9 21.7 34.4 33.1 35.1 20.2 38.8 21.1 31.3 25.8 46.0 36.0 26.6 38.8 26.0 32.8 16.5 17.2 27.7 15.9 31.8 57.5 19.3 18.9 16.4 45.4 29.1 35.3 30.7 28.1 21.6 36.6 30.2 51.2 29.9 22.2 33.6 51.8 36.8 29.1 19.9 43.3 28.8 21.4 18.3 50.2 40.4 29.3 45.8 31.0 31.9 32.3 46.8 36.7 63.1 41.2 33.8 52.0 32.7 37.4 38.2 24.8 24.5 27.0 99.6 50.7 27.5 28.0 34.5 56.8 39.8 39.3 33.1 49.8 35.5 13.4 89.3 15.6 27.5 42.3 17.1 36.0 55.3 18.8 41.0 44.3 31.0 25.3 35.0 56.0 36.0 23.6 41.9 46.2 34.1 33.3 47.8 62.8 34.3 27.4 29.2 64.6 30.9 54.4 38.4 49.1 30.6 35.3 46.8 23.1 31.1 53.2 38.4 35.9 26.6 27.9 36.8 39.8 46.0 29.5 41.2 1.1 8.7 8.0 11.0 9.6 14.3 20.6 13.1 14.1 12.2 21.2 17.0 17.2 7.3 17.8 11.6 15.8 12.3 8.5 17.8 21.7 35.1 20.2 16.5 17.2 19.3 18.9 16.4 21.6 19.9 18.3 32.3 17.1 57.7 33.0 32.0 44.6 34.7 46.1 25.0 34.7 32.8 15.9 11.8 38.8 20.0 39.4 22.0 29.2 17.1 13.6 12.3 23.5 22.2 6.9 13.9 29.4 22.7 27.6 8.8 18.1 16.2 8.5 27.3 15.3 14.0 8.8 25.8 20.7 6.2 12.1 28.6 22.3 15.6 26.4 15.7 19.8 7.9 27.4 19.3 16.0 16.9 18.1 21.6 14.4 25.6 40.9 18.3 13.1 27.4 26.6 25.3 12.5 14.5 42.7 35.8 19.7 41.2 25.2 43.4 22.2 25.9 35.7 12.4 22.6 18.7 16.7 28.5 SLFN14 ENSG00000236320 "Schlafen family member 14" P0C7P3 17 35543985-35560819 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "bone marrow: 4.0" "Group enriched" "Detected in some" 41 "Erythroid cells: 16.8;Macrophages: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA022994, HPA023065" Uncertain NA NA "HPA022994: AB_10670035, HPA023065: AB_2671055" "unprognostic (4.27e-3)" "unprognostic (4.72e-4)" "unprognostic (1.21e-1)" "unprognostic (6.43e-2)" "unprognostic (1.07e-3)" "unprognostic (6.50e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-1)" "unprognostic (5.33e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-1)" "unprognostic (7.59e-8)" "unprognostic (1.21e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-1)" "unprognostic (1.13e-3)" 0.0 0.0 0.1 0.3 0.1 4.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 18.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PPIAL4G ENSG00000236334 "Peptidylprolyl isomerase A like 4G" P0DN37 1 148482548-148483302 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.8;Langerhans cells: 7.4;NK-cells: 9.2;Suprabasal keratinocytes: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.9;TIME: 1.9" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (2.17e-3)" "unprognostic (3.63e-1)" "unprognostic (4.83e-1)" "unprognostic (2.26e-1)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (3.95e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" 0.1 0.5 0.4 0.5 0.4 1.0 0.1 1.4 0.7 0.0 0.1 0.2 0.7 0.1 0.4 0.0 0.0 0.0 0.1 0.5 0.3 0.3 0.1 0.3 0.7 0.2 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.6 0.3 0.1 1.1 0.4 0.0 0.9 0.7 0.7 0.0 0.1 0.4 0.4 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 0.9 0.1 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.4 1.1 0.0 0.3 0.0 0.9 0.4 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.8 1.4 0.2 0.6 0.9 0.0 1.9 0.2 1.1 1.2 0.3 1.1 0.8 0.9 0.0 0.5 0.4 0.2 0.2 0.5 1.2 0.4 0.7 1.2 0.8 0.7 0.4 0.8 0.6 0.7 0.0 2.2 1.7 0.3 1.1 0.6 0.4 0.4 1.4 0.7 0.5 0.3 0.2 0.2 0.3 0.6 0.1 0.3 0.6 0.1 0.0 0.6 0.0 1.0 6.8 0.4 0.8 0.0 1.8 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.1 1.4 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.3 0.1 0.4 0.5 0.2 1.7 0.0 0.0 0.0 1.2 7.4 0.3 0.0 0.2 1.8 0.0 0.4 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 1.1 0.0 0.5 2.6 0.0 0.1 0.0 12.5 0.1 3.2 0.1 0.0 0.2 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, O76087, P0CL82" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 180.3" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 1630.3;K-562: 1415.3" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 10.8 180.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.9 0.0 0.0 1630.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1415.3 30.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 360.9 0.0 5.1 56.9 7.5 0.3 1.0 0.6 72.0 0.0 0.2 0.0 171.2 1.3 11.5 4.6 4.8 12.1 3.4 8.4 12.6 8.7 0.0 7.8 9.7 8.6 1.4 14.7 10.5 12.4 20.2 11.5 0.6 0.4 0.2 0.4 0.4 0.0 0.5 0.0 0.1 0.3 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A1 CT47.1 ENSG00000236371 "Cancer/testis antigen family 47 member A1" Q5JQC4 X 120982476-120985788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-266/70: 2.2" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC200 "LINC00854, TMEM106A-AS1" ENSG00000236383 "Coiled-coil domain containing 200" A0A1B0GVQ3 17 43216941-43305397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 45.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Immune cell enhanced" "Detected in many" "basophil: 8.8;NK-cell: 7.3" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;NK-cells: 7.3" "Cell line enhanced" "Detected in many" "HeLa: 7.6;Hep G2: 6.8;HMC-1: 4.6" "Not detected" "Not detected" NA NA "unprognostic (3.14e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-3)" "unprognostic (4.29e-2)" "unprognostic (3.95e-2)" "unprognostic (7.19e-4)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (2.10e-1)" "unprognostic (2.88e-4)" "unprognostic (2.11e-1)" "unprognostic (3.88e-2)" "unprognostic (5.95e-2)" "unprognostic (3.08e-2)" 0.8 0.7 0.7 2.2 1.5 2.3 0.6 9.3 1.1 1.0 0.0 0.6 0.6 0.7 0.6 0.9 0.8 0.9 0.7 0.3 1.2 3.7 0.7 1.2 2.5 1.4 1.6 0.1 1.2 0.6 0.0 0.6 0.8 2.8 0.9 0.1 4.6 0.9 0.0 1.7 2.4 1.0 0.2 0.1 2.8 1.0 45.5 2.1 0.1 1.7 0.0 0.5 0.7 0.6 3.1 0.8 3.2 0.6 0.9 0.1 0.1 1.4 1.0 0.0 0.2 0.0 2.9 0.8 1.7 0.8 0.5 0.4 0.9 0.0 0.0 0.0 1.0 2.4 1.1 7.6 6.8 0.5 0.9 4.6 0.0 0.3 0.0 0.0 0.4 0.0 1.5 0.3 1.0 0.0 2.8 1.5 4.0 0.2 1.2 0.4 2.5 0.8 0.2 0.0 0.2 2.0 0.1 0.6 0.9 0.5 0.5 0.4 1.7 2.6 1.1 0.7 1.0 0.5 1.2 0.4 0.4 0.6 2.0 1.1 8.8 1.0 1.1 0.6 0.8 0.3 0.9 0.4 0.4 0.3 1.7 0.4 0.4 3.1 7.3 0.3 1.7 0.4 0.4 0.7 1.5 9.3 1.1 0.3 1.2 1.4 1.6 0.1 2.8 0.1 2.1 3.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G4 "AMAC1L1, SLC35G4P" ENSG00000236396 "Solute carrier family 35 member G4" P0C7Q5 18 11609596-11610612 "Predicted membrane proteins, Transporters" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R39 ENSG00000236398 "Taste 2 receptor member 39" P59534 7 143183419-143184435 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 86 "brain: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060680 Uncertain NA NA "HPA060680: AB_2684341" 0.0 0.0 1.5 0.0 3.3 0.0 0.0 1.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 5.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.3 1.8 1.9 0.5 2.5 5.4 3.2 0.0 5.5 3.5 3.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPY10 ENSG00000236424 "Testis specific protein Y-linked 10" P0CW01 Y 9527880-9530682 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 1.7" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 10.3" "Cancer enriched" "Detected in single" 13 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/84: 63.8" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (5.36e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 63.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" A0A1B0GUS4 13 30422488-30429758 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 46.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.6 0.2 0.2 0.2 0.1 0.3 0.4 0.4 0.4 0.4 0.0 0.3 0.2 0.8 0.2 0.3 0.5 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.4 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.7 0.2 0.4 0.0 0.2 0.2 46.9 0.0 0.3 0.2 0.0 0.2 0.3 0.3 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.2 0.0 0.4 0.2 0.3 0.2 0.7 0.2 0.6 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.4 0.3 0.3 0.4 0.7 0.2 0.1 0.4 0.4 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CT47B1 CT47.13 ENSG00000236446 "Cancer/testis antigen family 47 member B1" P0C2W7 X 120872603-120875929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 6.9" "Group enriched" "Detected in some" 42 "Spermatocytes: 112.2;Spermatogonia: 76.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 76.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL354761.1 ENSG00000236543 "Lipocalin 1-like" 9 135604345-135619893 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 30 "skin 1: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "BEWO: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD7-27 "DHQ52, IGHD727" ENSG00000236597 "Immunoglobulin heavy diversity 7-27" 14 105865551-105865561 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "endometrial cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615610-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.2;Granulosa cells: 15.1;Muller glia cells: 13.2;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 20.1;SH-SY5Y: 29.5;U-2 OS: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli NA NA Nucleoli "HPA067690: AB_2685888" "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 3.7 2.8 26.3 2.3 23.2 0.7 4.6 21.6 24.7 8.7 12.5 9.4 1.2 11.4 4.4 4.3 9.3 4.5 10.6 23.8 23.8 3.5 0.5 3.7 3.0 28.7 26.8 21.2 12.1 7.1 5.6 6.6 2.8 28.8 7.9 1.7 5.2 5.4 8.7 27.4 2.8 4.4 6.7 25.6 3.5 5.0 2.7 24.8 3.3 8.0 20.4 2.0 10.2 4.9 23.3 0.0 1.6 4.7 20.1 0.2 0.0 0.2 0.4 0.0 2.1 0.4 3.6 0.8 0.0 7.8 0.0 0.7 0.0 7.2 0.2 2.0 0.0 2.6 0.6 0.0 3.8 2.8 0.0 0.1 0.7 0.6 0.2 0.1 2.0 0.0 1.6 3.2 0.1 1.3 0.1 0.5 2.7 7.5 0.0 0.0 2.3 7.8 0.1 1.5 7.6 6.3 29.5 0.0 0.3 1.2 3.9 1.1 4.3 0.0 1.5 19.5 0.0 1.9 0.4 0.1 0.1 0.0 0.0 7.8 0.0 0.0 0.8 0.2 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 26.3 23.2 21.6 24.7 23.8 23.8 28.7 26.8 21.2 28.8 25.6 24.8 23.3 4.3 0.0 0.0 2.0 1.0 0.5 1.5 0.2 1.2 13.2 3.2 4.4 10.4 0.0 0.6 7.3 6.2 0.0 2.0 0.1 0.0 0.6 1.6 7.5 4.3 3.2 1.8 0.4 1.5 0.7 0.0 4.4 0.5 2.3 0.0 15.1 2.5 0.0 0.1 5.0 2.7 0.0 0.0 0.0 0.9 2.4 5.3 0.2 3.6 1.9 0.1 13.2 1.0 2.0 2.8 0.4 0.1 8.6 1.3 3.3 0.0 0.2 2.3 10.4 13.1 6.4 5.4 0.5 0.5 0.4 0.3 0.3 1.8 6.9 0.1 0.7 IFNA4 "IFN-alpha4a, MGC142200" ENSG00000236637 "Interferon alpha 4" P05014 9 21186694-21187671 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 7.9;pancreas: 6.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 7.9 0.0 0.0 2.5 0.0 2.7 1.9 0.3 5.6 0.1 0.6 3.2 0.0 0.0 0.0 2.5 0.1 3.7 0.0 0.0 0.0 0.0 0.0 6.5 0.0 2.0 0.0 0.0 5.8 4.2 0.0 4.9 0.4 0.3 0.5 2.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 48.5 0.0 0.2 0.0 1.1 1.1 0.0 0.0 17.9 6.1 1.8 4.3 12.6 12.9 0.0 0.2 0.2 9.8 9.8 6.8 1.9 12.6 0.5 0.3 8.4 0.0 0.3 5.8 0.1 0.3 9.2 7.8 0.0 0.0 0.0 0.1 0.1 0.0 0.3 14.8 10.2 0.0 0.2 0.4 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.1 2.4 6.4 0.0 0.1 9.4 4.8 0.5 31.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.4 0.8 GAGE12B ENSG00000236737 "G antigen 12B" X 49529869-49529985 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "testis: 142.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "JURKAT: 1.0;PC-3: 2.8;U-2197: 1.5" NA NA 0.3 0.6 1.0 0.0 1.0 0.0 0.2 0.8 5.2 2.4 0.4 0.2 1.2 2.7 0.0 0.4 0.0 0.0 0.1 0.8 1.3 0.3 0.0 0.5 0.0 1.1 0.9 0.8 0.9 0.1 0.0 1.6 0.0 1.8 0.6 0.0 0.6 0.4 0.0 0.5 0.5 1.0 0.0 0.7 1.3 0.3 142.7 0.8 0.0 0.5 0.0 0.0 2.6 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.6 0.1 1.0 1.0 0.8 5.2 0.8 1.3 1.1 0.9 0.8 1.8 0.7 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE9 ENSG00000236761 "CTAGE family member 9" A4FU28 6 131708441-131711017 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.4" "Group enriched" "Detected in some" 5 "Early spermatids: 8.6;Spermatocytes: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (3.92e-2)" "unprognostic (6.84e-2)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (9.89e-3)" "unprognostic (2.36e-1)" "unprognostic (5.55e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-2)" "unprognostic (5.74e-4)" "unprognostic (3.15e-2)" "unprognostic (9.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 AL391650.1 ENSG00000236782 "Novel protein" 1 26169516-26171831 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "retina: 29.2" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.6;NTERA-2: 2.2" NA NA "unprognostic (4.80e-2)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.24e-3)" "unprognostic (9.79e-2)" "unprognostic (4.84e-2)" "unprognostic (4.87e-3)" "unprognostic (6.44e-4)" "unprognostic (4.45e-1)" "unprognostic (9.33e-2)" "unprognostic (1.93e-2)" "unprognostic (2.29e-1)" "unprognostic (1.17e-1)" "unprognostic (3.23e-1)" "unprognostic (7.73e-2)" "unprognostic (1.57e-2)" "unprognostic (2.26e-1)" 0.1 0.3 0.3 0.2 0.7 0.3 0.1 2.1 0.7 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.2 0.3 0.4 0.2 0.1 0.1 0.1 0.3 0.6 0.5 0.2 1.0 0.6 0.0 0.2 0.1 0.8 0.2 0.0 29.2 0.1 0.0 2.1 0.2 0.2 0.0 0.1 0.1 0.2 0.5 0.3 0.0 0.4 0.3 0.0 0.1 0.0 1.6 0.7 0.3 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.5 2.6 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.7 1.6 0.5 0.2 0.5 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 1.9 0.4 0.0 0.5 0.5 0.4 2.2 0.2 0.7 0.5 0.7 0.1 0.0 0.6 1.6 0.6 0.1 0.5 0.9 0.7 0.4 0.0 0.1 0.1 1.7 0.7 0.3 0.5 0.3 1.1 0.0 0.9 0.7 0.0 0.4 0.0 0.5 0.5 0.4 0.7 0.7 0.5 0.6 0.9 0.7 0.5 0.0 0.3 0.5 0.8 0.8 0.5 0.3 0.7 2.1 0.7 0.4 0.2 0.6 0.5 0.2 0.8 0.1 0.3 1.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 C3orf84 ENSG00000236980 "Chromosome 3 open reading frame 84" H3BNL1 3 49177634-49191858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 7.3" "Group enriched" "Detected in some" 109 "Early spermatids: 112.3;Late spermatids: 84.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 84.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G9 OR10G10P ENSG00000236981 "Olfactory receptor family 10 subfamily G member 9" Q8NGN4 11 124023013-124023948 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1-20 IGHD120 ENSG00000237020 "Immunoglobulin heavy diversity 1-20" 14 105891191-105891207 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L8 ENSG00000237038 "Ubiquitin specific peptidase 17 like family member 8" P0C7I0 8 7971661-7973253 "Enzymes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR9 "TA3, TAR3, TRAR3" ENSG00000237110 "Trace amine associated receptor 9" Q96RI9 6 132538290-132539336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4orf51 ENSG00000237136 "Chromosome 4 open reading frame 51" C9J302 4 145680146-145771032 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 5.8" "Cell type enriched" "Detected in some" 9 "Early spermatids: 82.7" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (4.37e-1)" "unprognostic (1.32e-1)" "unprognostic (2.19e-3)" "unprognostic (8.13e-2)" "unprognostic (2.16e-1)" "unprognostic (3.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (6.07e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 82.7 0.9 0.0 0.1 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 9.1 1.5 0.0 0.0 1.9 0.0 0.0 0.0 2.5 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 B3GNT9 MGC4655 ENSG00000237172 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9" Q6UX72 16 67148104-67150998 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052743, HPA062734" Approved Approved "Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoli fibrillar center" "HPA052743: AB_2681934, HPA062734: AB_2684854" "unprognostic (2.56e-2)" "unprognostic (2.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.07e-1)" "unprognostic (6.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.28e-2)" "unprognostic (3.01e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (4.96e-3)" "unprognostic (7.56e-3)" 6.1 8.4 6.6 4.2 7.2 0.2 5.8 7.9 6.7 14.4 8.1 6.8 3.3 13.5 7.4 5.2 13.8 6.8 10.9 6.6 12.1 7.4 2.5 9.1 3.0 8.5 8.2 4.6 15.2 3.5 22.0 20.7 8.0 8.2 11.9 3.3 1.4 9.0 14.9 1.9 5.8 5.7 7.8 9.1 5.7 6.2 6.0 6.8 1.6 18.8 2.1 2.5 11.8 9.0 10.6 4.9 8.8 0.7 0.9 27.7 28.6 1.0 22.5 36.2 14.4 18.5 4.0 0.8 0.6 1.5 34.9 6.0 11.1 0.3 1.0 7.8 7.6 3.2 0.7 9.7 3.5 22.3 0.6 0.5 23.7 8.3 14.0 0.4 35.8 2.0 0.5 1.0 2.7 22.6 2.6 2.6 1.2 5.4 3.8 7.7 7.4 12.9 4.4 2.3 6.0 5.0 11.2 50.9 0.2 0.8 4.3 1.3 3.9 4.6 25.6 1.1 25.9 10.2 3.2 2.4 0.8 31.9 1.3 12.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 6.6 7.2 7.9 6.7 6.6 12.1 8.5 8.2 4.6 8.2 9.1 6.8 10.6 1.2 6.4 5.0 1.0 1.2 3.2 2.8 2.4 9.6 1.6 3.2 2.3 2.6 5.7 2.4 3.7 0.0 0.3 0.1 0.4 0.0 1.3 5.3 2.5 7.6 2.0 2.4 0.0 0.4 1.7 0.5 12.9 2.6 2.2 0.0 3.0 6.4 0.1 1.8 0.0 1.3 0.9 2.0 0.6 3.3 6.9 11.5 0.4 1.8 0.0 0.1 0.9 0.0 1.0 2.3 0.9 0.1 13.5 4.7 2.4 0.1 0.9 4.2 0.3 6.6 3.2 6.6 4.4 2.8 2.7 4.1 0.8 1.5 2.9 0.8 1.3 CDKN2AIPNL "C2AIL, MGC13017" ENSG00000237190 "CDKN2A interacting protein N-terminal like" Q96HQ2 5 134402065-134411881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043966 Approved NA NA "HPA043966: AB_2678750" "unprognostic (7.58e-2)" "unprognostic (1.24e-1)" "unprognostic (7.33e-3)" "unprognostic (4.54e-3)" "unprognostic (2.56e-1)" "unprognostic (7.38e-2)" "unprognostic (1.03e-3)" "unprognostic (1.08e-1)" "unprognostic (4.76e-1)" "unprognostic (3.55e-2)" "unprognostic (1.35e-3)" "unprognostic (1.00e-1)" "unprognostic (5.84e-3)" "unprognostic (1.30e-1)" "unprognostic (1.62e-1)" "unprognostic (1.59e-1)" "unprognostic (8.79e-2)" 14.9 23.9 26.4 11.1 28.2 17.1 14.3 26.8 31.7 11.4 21.0 16.2 19.4 12.4 15.7 12.9 11.8 9.5 32.4 27.9 28.8 21.1 17.4 10.9 16.7 29.7 26.4 28.5 12.8 33.3 19.9 19.4 11.5 30.7 14.0 14.0 24.5 18.5 10.5 82.5 15.0 17.6 10.0 25.8 14.7 19.4 19.8 28.8 19.2 21.2 43.3 15.9 15.8 11.9 32.1 71.2 42.1 44.1 95.4 22.5 30.5 46.1 37.8 21.5 47.2 52.1 73.1 41.8 47.1 50.3 25.5 68.0 23.0 59.2 93.0 50.8 67.4 89.5 44.1 45.0 43.8 37.8 30.8 25.8 24.5 44.6 59.4 46.3 37.9 49.7 75.3 42.4 54.3 35.4 41.2 50.6 58.2 77.6 37.3 53.1 43.0 46.5 58.3 44.2 23.9 58.7 64.5 50.8 14.1 69.1 49.3 63.1 55.2 33.4 55.8 37.0 44.7 53.7 38.8 69.2 50.2 65.2 53.7 58.7 10.5 16.7 12.4 17.8 18.2 22.7 30.1 22.9 17.7 20.2 28.1 21.7 21.6 4.6 17.8 20.9 24.2 25.3 15.2 26.4 28.2 26.8 31.7 27.9 28.8 29.7 26.4 28.5 30.7 25.8 28.8 32.1 21.3 3.2 15.6 3.3 23.7 13.5 16.6 33.6 13.6 21.9 23.9 20.2 50.7 18.6 14.1 9.2 14.6 37.8 17.4 15.3 58.7 28.6 22.0 17.3 16.4 22.7 31.0 34.5 8.8 36.3 40.4 17.2 8.6 12.3 15.2 34.7 22.1 12.6 24.6 15.2 9.1 21.2 36.7 19.4 15.4 46.1 22.1 14.2 23.2 3.7 31.3 30.1 15.5 3.5 7.0 26.0 17.4 19.9 22.6 11.9 30.0 45.4 10.7 26.8 19.7 15.6 22.4 35.1 32.3 18.6 15.3 20.2 17.6 23.5 22.9 14.4 IGHD1-7 "DM1, IGHD17" ENSG00000237197 "Immunoglobulin heavy diversity 1-7" 14 105909907-105909923 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRDD2 ENSG00000237235 "T cell receptor delta diversity 2" 14 22439007-22439015 "Predicted intracellular proteins, T-cell receptor genes" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L5 ENSG00000237247 "Methyl-CpG binding domain protein 3 like 5" A6NJ08 19 7030578-7033011 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV30 "TCRBV20S1A1N2, TCRBV30S1" ENSG00000237254 "T cell receptor beta variable 30" A0A0K0K1B3 7 142812586-142813399 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" "Fibroblasts: 1.9;Gastric mucus-secreting cells: 1.1;T-cells: 6.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 162.3" "Lineage enriched" "Detected in many" 49 "T-cells: 162.3" "Cell line enriched" "Detected in some" 6 "MOLT-4: 41.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.72e-3)" "unprognostic (2.36e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (3.56e-4)" "unprognostic (7.71e-2)" "unprognostic (4.19e-2)" "unprognostic (2.60e-3)" "unprognostic (2.32e-3)" "unprognostic (4.96e-2)" "unprognostic (4.95e-2)" "unprognostic (4.37e-4)" "unprognostic (3.50e-1)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.88e-4)" 0.2 0.0 0.1 1.1 0.3 2.2 0.1 0.0 0.2 0.4 0.0 0.6 2.1 0.0 0.1 0.9 0.1 1.7 0.0 0.1 0.0 0.0 0.3 1.3 10.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 2.5 0.2 0.0 1.1 1.2 0.1 0.0 2.6 0.9 0.0 0.1 25.6 0.1 0.0 13.5 1.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 41.3 0.0 0.0 6.7 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 2.1 0.1 30.7 3.3 74.2 42.3 0.2 0.9 89.9 49.6 0.2 0.1 0.0 0.5 162.3 21.6 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.1 CKMT1B "CKMT, CKMT1, UMTCK" ENSG00000237289 "Creatine kinase, mitochondrial 1B" P12532 15 43593054-43604901 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;esophagus: 74.9;intestine: 81.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 122.4;Distal enterocytes: 146.4;Intestinal goblet cells: 78.3;Paneth cells: 69.9;Proximal enterocytes: 124.6;Syncytiotrophoblasts: 137.9;Undifferentiated cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 139.8;hTCEpi: 69.2;OE19: 156.0;SK-BR-3: 183.1;T-47d: 100.7" HPA043491 Uncertain "Intracellular and membrane" NA NA 2000000 "HPA043491: AB_2678510" "unprognostic (3.47e-2)" "unprognostic (9.73e-3)" "unprognostic (3.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.29e-1)" "unprognostic (1.96e-1)" "unprognostic (5.19e-2)" "unprognostic (2.84e-1)" "unprognostic (3.64e-1)" "unprognostic (5.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (2.26e-8)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.43e-2)" "unprognostic (4.36e-2)" 1.0 1.9 20.8 6.4 25.0 0.0 6.1 37.8 59.0 4.1 13.5 81.5 64.0 0.3 0.4 74.9 1.9 9.0 0.4 25.9 28.7 5.2 0.1 0.7 0.1 30.6 26.1 24.1 0.1 3.1 12.0 9.6 12.9 30.5 3.1 66.7 23.6 28.7 0.8 0.1 24.9 49.8 4.0 13.4 0.0 29.8 0.2 28.7 0.1 6.3 0.0 13.4 8.5 22.2 39.6 0.3 0.9 0.8 0.0 0.2 0.0 35.3 0.0 0.0 0.1 0.1 7.8 23.8 0.0 1.0 0.0 7.2 139.8 28.4 55.8 0.1 0.8 16.0 0.0 3.0 3.8 0.0 0.1 8.6 0.0 69.2 0.0 6.9 0.0 0.0 5.9 9.1 0.0 0.0 38.2 0.1 0.2 12.0 156.0 14.9 0.0 0.0 0.8 3.0 3.7 55.4 19.5 0.9 183.1 10.9 2.3 100.7 0.0 0.0 0.1 1.8 0.2 2.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 25.0 37.8 59.0 25.9 28.7 30.6 26.1 24.1 30.5 13.4 28.7 39.6 0.1 0.0 0.5 2.6 0.1 25.1 10.4 40.5 3.4 7.5 3.8 4.1 0.4 5.7 12.7 5.5 18.8 122.4 0.4 146.4 21.5 4.0 0.0 0.9 0.0 0.5 21.0 0.0 37.6 28.0 26.1 0.5 33.1 0.5 0.0 1.1 0.0 0.0 9.4 6.7 36.5 78.3 10.2 0.0 0.7 0.0 0.0 0.1 3.6 2.8 0.0 2.2 0.0 5.0 2.4 18.6 69.9 0.0 0.1 2.0 124.6 0.9 6.0 12.2 0.0 0.0 0.7 0.0 0.0 17.5 24.7 137.9 0.6 0.0 123.7 19.9 RNF223 ENSG00000237330 "Ring finger protein 223" E7ERA6 1 1070967-1074306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 26.4;vagina: 13.1" "Cell type enhanced" "Detected in many" "Breast glandular cells: 29.1;Endometrial ciliated cells: 30.9;Extravillous trophoblasts: 19.3;Gastric mucus-secreting cells: 38.2;Glandular and luminal cells: 32.1;Urothelial cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.4;CAPAN-2: 11.1;HaCaT: 7.0;MCF7: 24.4;OE19: 7.0;SK-BR-3: 16.0;T-47d: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.08e-5)" "unprognostic (3.50e-1)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (3.91e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-3)" "unprognostic (1.50e-1)" "unprognostic (1.16e-1)" "unprognostic (4.58e-1)" "unprognostic (9.52e-3)" 0.0 0.0 0.3 0.0 0.4 0.2 0.4 1.0 0.5 5.1 0.0 0.7 0.1 0.3 0.0 26.4 0.0 0.0 0.0 0.2 0.3 0.7 0.0 0.4 0.0 0.7 0.3 0.3 0.0 0.1 0.0 0.0 0.6 1.0 0.4 0.3 0.2 4.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.9 0.1 0.4 0.0 0.0 0.0 0.9 3.4 13.1 0.7 15.4 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.5 11.1 0.0 0.1 0.0 0.1 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.4 0.0 0.1 0.0 7.0 0.3 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.2 16.0 0.3 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.5 0.2 0.3 0.7 0.3 0.3 1.0 0.0 0.4 0.7 0.1 9.6 0.0 0.0 0.1 0.5 8.8 1.3 0.0 0.0 29.1 10.8 0.6 0.0 2.3 1.8 0.0 0.8 0.4 15.6 0.0 7.3 0.0 30.9 3.0 0.5 0.0 0.0 0.0 3.1 19.3 0.3 38.2 32.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.7 2.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.1 0.0 0.0 7.0 0.9 0.1 3.8 0.0 0.0 0.2 0.5 0.0 0.0 11.7 1.4 5.1 0.3 0.0 5.2 32.8 PATE4 "FLJ41047, PATE-B" ENSG00000237353 "Prostate and testis expressed 4" P0C8F1 11 125833316-125840072 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "seminal vesicle: 107.8" "Group enriched" "Detected in some" 70 "Early spermatids: 22.9;Late spermatids: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045632 Approved "Secreted in male reproductive system" NA NA "HPA045632: AB_10960489" "unprognostic (4.90e-1)" "unprognostic (2.93e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" 0.1 0.2 0.5 0.1 0.8 0.5 0.1 2.0 1.5 0.1 0.0 0.0 0.1 0.1 15.1 0.1 0.1 0.2 0.1 0.7 0.2 0.4 0.1 0.1 0.2 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.9 3.0 0.1 0.7 0.1 107.8 0.2 0.4 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.0 0.4 0.0 0.0 0.1 0.0 1.3 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.3 0.5 0.2 0.3 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.8 2.0 1.5 0.7 0.2 0.2 0.0 0.7 0.9 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL445989.1 ENSG00000237378 "Keratin-associated protein 21-1-like" 13 63746741-63751080 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A47 ENSG00000237388 "Olfactory receptor family 4 subfamily A member 47" Q6IF82 11 48488717-48489780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059763 Uncertain NA NA "HPA059763: AB_2684122" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS56 ENSG00000237412 "Serine protease 56" P0CW18 2 232520388-232525716 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 3.1;retina: 5.3;skeletal muscle: 9.8" "Group enriched" "Detected in some" 10 "Early spermatids: 29.0;Muller glia cells: 45.8" "Group enriched" "Detected in many" 4 "cervical cancer: 1.2;colorectal cancer: 2.5;endometrial cancer: 1.4;melanoma: 2.1;urothelial cancer: 4.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "Daudi: 1.0" "Group enriched" "Detected in some" 10 "basal ganglia: 1.8;olfactory bulb: 4.2" "Region enhanced" "Detected in many" "olfactory bulb: 14.9" NA NA "unprognostic (3.26e-1)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.73e-3)" "unprognostic (2.28e-1)" "unprognostic (7.15e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" 0.0 0.0 1.0 0.0 0.8 0.0 0.0 1.6 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 2.8 1.2 0.2 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 5.3 0.0 0.0 9.8 0.0 0.0 0.0 1.0 0.0 0.0 0.8 1.2 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 1.6 3.1 0.1 2.4 2.8 1.2 0.2 3.1 1.0 1.2 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 45.8 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 3.6 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF737 ZNF102 ENSG00000237440 "Zinc finger protein 737" O75373 19 20535825-20565809 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 27.0;Inhibitory neurons: 25.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 26.4;RT4: 27.3" NA NA "unprognostic (3.86e-2)" "unprognostic (1.61e-1)" "unprognostic (8.63e-2)" "unprognostic (3.42e-1)" "unprognostic (3.14e-2)" "unprognostic (1.23e-3)" "unprognostic (1.61e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-2)" "unprognostic (1.51e-2)" "unprognostic (2.62e-2)" "unprognostic (1.06e-1)" "unprognostic (1.33e-3)" "unprognostic (8.49e-2)" "unprognostic (8.28e-2)" "unprognostic (3.43e-2)" "unprognostic (1.47e-3)" 5.1 11.0 4.2 6.7 13.3 4.4 14.2 10.2 7.4 11.1 0.0 6.7 4.2 8.2 11.5 4.2 10.2 6.5 4.6 6.8 4.8 9.9 1.5 7.2 17.7 3.5 3.6 5.5 30.1 13.1 12.9 4.8 5.2 4.8 11.0 8.8 9.8 4.8 12.0 1.7 12.8 5.6 5.9 1.1 11.6 10.0 4.2 4.8 20.5 38.3 2.3 14.9 11.7 3.7 11.4 0.1 0.9 4.7 11.5 6.6 10.9 4.7 4.2 2.8 5.6 6.9 2.1 4.0 7.3 7.1 4.5 3.8 2.1 0.6 0.7 6.9 0.5 2.9 0.3 0.9 3.1 2.6 0.5 0.3 5.4 2.3 2.3 0.6 4.4 3.7 7.6 0.5 0.9 5.2 1.7 26.4 4.2 6.0 0.0 0.3 14.2 7.1 1.5 7.2 27.3 10.0 8.4 0.2 1.2 1.5 11.7 5.2 3.0 1.6 0.3 0.2 4.8 3.1 1.8 9.8 7.4 0.2 0.1 2.0 3.9 0.3 4.5 4.5 0.7 3.9 7.9 5.8 6.7 0.8 9.0 6.4 5.0 5.4 2.2 0.7 2.1 5.2 1.7 4.2 13.3 10.2 7.4 6.8 4.8 3.5 3.6 5.5 4.8 1.1 4.8 11.4 4.5 0.0 2.0 15.7 10.2 0.3 0.6 0.1 2.8 7.1 3.1 2.9 1.8 0.0 3.3 1.8 0.0 1.3 4.8 0.2 9.8 2.2 2.2 5.6 4.5 2.5 0.0 5.7 27.0 1.7 0.7 4.3 3.1 4.7 1.3 11.4 2.2 0.2 0.3 16.8 25.3 1.1 0.0 0.6 0.6 1.7 4.1 1.0 0.0 14.0 0.9 3.9 5.2 32.2 34.4 1.2 2.6 1.9 3.7 0.7 0.7 1.6 0.9 2.5 0.0 3.1 3.4 6.3 8.9 2.1 0.3 1.4 5.7 9.7 0.7 0.6 RGL2 "HKE1.5, KE1.5, RAB2L" ENSG00000237441 "Ral guanine nucleotide dissociation stimulator like 2" O15211 6 33291654-33298942 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047039, HPA053444" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047039: AB_2732538, HPA053444: AB_2682153" "unprognostic (4.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-2)" "unprognostic (2.74e-3)" "unprognostic (2.64e-1)" "unprognostic (1.04e-2)" "unprognostic (3.30e-2)" "unprognostic (2.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.62e-2)" 10.4 8.7 3.0 0.6 2.2 2.3 9.2 3.0 1.8 12.2 7.9 8.6 2.2 11.1 0.0 5.5 12.6 2.0 7.9 2.1 8.2 8.4 2.5 11.5 0.8 6.7 2.9 0.4 13.1 6.9 2.7 20.8 5.6 2.9 9.6 0.6 0.1 7.5 3.1 18.7 5.7 8.1 4.1 2.5 24.4 10.0 5.4 3.7 1.0 16.1 8.6 0.2 9.3 7.4 2.8 15.7 2.8 0.2 1.0 2.1 7.2 0.0 1.5 6.0 2.4 1.5 0.2 2.5 2.7 14.0 2.8 5.4 0.3 0.6 5.8 1.4 0.9 0.6 6.5 0.0 2.8 12.9 1.8 5.3 5.4 6.0 5.0 3.6 2.6 19.0 0.0 4.0 0.1 2.4 0.0 1.9 7.9 1.6 1.0 9.7 4.4 0.4 4.1 4.8 3.5 2.9 11.8 0.1 0.0 20.4 0.0 0.0 4.9 22.6 5.1 5.1 3.0 14.8 2.8 1.9 1.6 3.4 4.1 10.4 4.3 4.2 8.8 2.0 3.1 1.7 1.6 1.3 1.5 3.3 2.1 0.7 1.1 9.6 2.4 1.1 0.4 1.3 2.8 3.0 2.2 3.0 1.8 2.1 8.2 6.7 2.9 0.4 2.9 2.5 3.7 2.8 75.5 16.0 41.5 52.2 20.6 28.4 36.5 30.3 37.0 30.4 58.8 40.4 28.7 20.0 38.6 22.0 22.9 30.4 18.4 8.4 13.7 21.2 5.1 19.9 13.6 60.8 28.6 7.8 13.0 14.5 39.0 20.1 16.3 21.1 11.4 21.4 75.7 10.7 32.3 32.0 18.2 10.8 22.4 27.0 23.4 17.4 16.8 23.0 17.8 30.9 13.4 22.5 19.6 17.6 11.1 22.4 25.5 14.7 7.8 30.5 5.6 11.7 39.9 30.9 26.3 20.4 26.9 26.2 18.9 20.0 24.3 102.2 16.5 28.3 10.0 39.2 MEIOSIN "BHMG1, HMGDC" ENSG00000237452 "Meiosis initiator" C9JSJ3 19 45733439-45764541 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 7.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 1.5;K-562: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA049521 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049521: AB_2680803" "unprognostic (4.15e-2)" "unprognostic (2.97e-2)" "unprognostic (2.64e-1)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-3)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (1.15e-2)" "unprognostic (1.08e-1)" "unprognostic (6.53e-12)" "unprognostic (2.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.87e-1)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf143 LINC00959 ENSG00000237489 "Chromosome 10 open reading frame 143" A0A1B0GUT2 10 130020025-130110830 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 6.7;Breast glandular cells: 8.2;Breast myoepithelial cells: 9.7;Collecting duct cells: 11.0;Distal tubular cells: 13.7;Proximal tubular cells: 12.8;Theca cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 9.6;MCF7: 8.8;NB-4: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.58e-2)" "unprognostic (3.36e-2)" "unprognostic (5.61e-2)" "unprognostic (1.24e-2)" "unprognostic (8.12e-2)" "unprognostic (6.64e-3)" "unprognostic (8.68e-3)" "unprognostic (2.48e-3)" "unprognostic (1.59e-1)" "unprognostic (8.61e-2)" "unprognostic (7.26e-4)" "unprognostic (1.34e-1)" "unprognostic (2.36e-7)" "unprognostic (2.06e-1)" "unprognostic (3.29e-1)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" 3.6 4.2 3.6 3.3 3.8 2.4 5.0 3.8 4.6 4.5 3.8 5.8 5.3 5.5 5.8 3.5 4.7 3.8 2.4 3.3 4.0 5.2 4.8 2.9 5.3 4.0 3.7 3.2 3.9 4.3 3.9 4.5 1.1 3.9 5.8 3.4 1.6 3.8 6.6 9.6 4.0 4.6 3.9 3.9 5.4 4.2 3.9 3.7 5.6 5.9 5.1 4.7 6.1 4.4 3.7 1.1 1.5 1.7 3.5 9.6 3.6 0.2 2.1 3.0 0.9 1.3 0.0 0.9 7.3 0.4 2.0 1.1 1.5 0.6 0.1 0.3 2.0 1.1 1.3 0.1 0.9 3.8 3.5 1.4 3.5 1.9 0.4 2.2 1.1 0.5 5.9 0.2 1.6 3.3 8.8 1.5 13.5 3.5 1.6 1.4 1.3 0.2 0.3 3.2 0.6 0.8 1.0 1.3 0.4 0.9 1.3 0.2 1.1 0.4 1.3 0.2 3.7 0.3 2.1 4.3 1.1 2.5 0.6 0.0 0.0 6.5 4.0 16.7 10.6 17.8 20.7 18.1 19.3 11.4 17.6 17.9 23.6 1.2 22.0 9.7 7.3 23.6 9.1 3.6 3.8 3.8 4.6 3.3 4.0 4.0 3.7 3.2 3.9 3.9 3.7 3.7 3.1 0.0 6.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 8.2 9.7 0.0 0.0 2.5 11.0 0.0 0.7 5.0 0.0 13.7 4.2 0.0 3.9 3.2 1.1 0.0 0.0 0.0 3.1 0.1 1.4 0.0 2.2 1.3 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 12.8 5.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 3.1 7.8 0.0 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901598-13240416 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.1" "Group enriched" "Detected in many" 17 "Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 48.5;LHCN-M2: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 0.5 2.8 14.0 0.8 14.4 1.3 0.6 0.2 13.0 0.3 0.0 2.3 0.8 0.4 1.1 0.5 0.2 0.4 0.6 10.8 8.7 1.9 0.6 0.2 0.4 7.9 6.1 15.1 0.4 0.6 0.1 0.9 0.4 8.9 4.2 1.0 3.8 0.9 0.7 1.6 0.9 0.9 0.6 0.7 0.4 0.5 0.7 11.5 0.1 2.2 0.0 0.3 0.2 0.2 10.9 0.8 0.4 0.6 0.5 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.3 0.5 0.5 48.5 0.1 0.7 0.6 0.1 0.2 0.1 0.6 0.2 0.6 0.9 0.3 0.1 0.6 0.6 1.5 0.1 0.1 3.3 0.4 0.1 0.6 0.4 1.0 40.5 5.5 0.4 0.7 10.2 0.7 0.5 0.6 0.4 0.3 10.9 1.5 10.1 0.5 0.4 1.4 0.4 4.4 0.9 0.4 0.4 0.6 5.8 0.6 0.4 0.9 1.0 0.5 0.4 0.3 1.0 0.8 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 14.0 14.4 0.2 13.0 10.8 8.7 7.9 6.1 15.1 8.9 0.7 11.5 10.9 0.0 25.6 20.1 5.2 0.1 0.1 0.5 0.2 0.0 0.8 1.7 0.8 1.3 1.5 7.0 1.8 0.0 0.1 0.0 0.3 1.9 1.4 4.8 0.1 0.5 1.1 0.0 0.0 265.0 0.0 0.0 2.0 0.0 0.3 11.4 0.0 0.0 0.0 0.0 0.0 427.9 0.3 0.0 0.0 0.4 3.4 0.3 1.0 0.0 5.6 0.0 0.5 0.0 636.3 4.9 0.1 2.3 0.0 0.0 1.8 0.0 1.3 11.8 0.3 0.0 6.6 0.2 0.5 2.0 0.0 0.1 0.1 1.3 0.0 0.8 0.6 OR7E24 "HSHT2, OR19-8, OR7E24P, OR7E24Q" ENSG00000237521 "Olfactory receptor family 7 subfamily E member 24" Q6IFN5 19 9247344-9252625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.8" "Group enriched" "Detected in some" 20 "Early spermatids: 15.9;Late spermatids: 5.0" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX51 ENSG00000237524 "Testis expressed 51" A0A1B0GUA7 2 126898864-126902097 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 182 "testis: 60.4" "Cell type enriched" "Detected in single" 11 "Proximal tubular cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HLA-DQA2 HLA-DXA ENSG00000237541 "Major histocompatibility complex, class II, DQ alpha 2" P01906 6 32741391-32747198 "Human disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 21.0;lymphoid tissue: 27.3" "Cell type enriched" "Detected in many" 4 "Langerhans cells: 1196.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.06e-3)" "unprognostic (2.46e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "unprognostic (2.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.64e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-2)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-2)" 8.4 4.6 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.3 0.0 3.0 0.0 2.1 0.0 3.1 2.8 0.1 2.1 0.0 0.0 5.7 1.7 21.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 2.5 0.0 0.0 2.5 0.0 0.0 3.4 0.0 1.4 8.0 11.7 0.0 0.0 27.3 2.9 0.6 0.0 0.3 3.7 0.0 0.3 3.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 3.2 3.6 0.0 179.2 23.5 0.3 1.8 1.2 0.0 2.5 1.3 0.5 0.0 7.5 3.7 0.0 0.2 144.1 0.1 0.0 0.2 0.7 0.1 0.2 20.6 2.4 0.4 0.0 0.0 0.8 1.6 0.0 0.3 0.0 0.8 2.2 0.3 110.0 0.0 0.0 0.0 0.0 78.9 1196.5 2.0 1.2 243.1 24.9 0.0 125.3 0.0 8.2 0.0 0.0 0.2 0.0 0.0 9.5 0.0 0.0 11.2 12.4 0.0 6.6 0.7 1.2 0.1 0.3 0.1 23.3 0.4 13.8 0.0 0.0 0.7 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391823-33409896 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 40.1;lymphoid tissue: 48.0" "Cell type enhanced" "Detected in many" "Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055997, HPA062674" Enhanced Approved Centrosome NA Yes Centrosome "HPA055997: AB_2683001, HPA062674: AB_2684829" "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 1.1 1.1 0.3 10.7 0.2 40.1 2.2 0.3 1.2 1.6 0.4 8.0 8.9 1.8 0.2 11.8 0.8 1.5 0.5 0.7 0.5 0.7 1.1 2.4 24.8 0.4 0.5 0.2 2.1 0.7 0.3 0.6 5.6 0.3 0.9 8.3 0.4 2.1 0.2 0.2 9.9 8.2 4.1 0.3 5.3 4.7 12.4 0.5 48.0 0.7 0.4 25.1 2.8 3.9 1.8 133.5 47.9 120.6 124.2 5.2 8.1 64.0 82.5 48.4 122.6 104.6 80.6 53.3 120.2 38.3 41.5 102.0 88.1 87.1 60.7 79.7 114.3 60.3 93.9 71.6 73.5 0.5 96.0 75.7 2.5 4.7 73.2 38.8 13.8 64.2 87.5 76.0 112.3 81.0 86.2 125.7 103.2 47.5 67.6 48.4 129.7 110.7 61.4 38.4 42.8 100.1 57.2 54.3 91.9 44.1 51.3 78.7 105.4 32.2 74.6 104.6 56.2 128.9 58.2 132.4 126.1 18.8 94.8 101.0 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.2 0.2 0.0 0.0 0.0 1.0 0.3 0.0 1.6 0.5 0.3 0.2 0.3 1.2 0.7 0.5 0.4 0.5 0.2 0.3 0.3 0.5 1.8 0.4 0.0 2.5 1.0 4.1 5.6 1.5 4.6 2.2 0.4 2.8 2.2 0.5 0.0 1.9 0.0 0.0 18.7 3.7 8.8 0.0 0.7 32.0 2.7 1.9 2.4 0.0 62.3 0.3 0.0 39.6 4.2 4.1 6.1 1.3 15.0 1.8 0.3 14.3 0.0 0.3 8.0 2.0 2.4 9.8 12.0 0.3 4.7 3.6 1.0 3.1 0.3 0.0 1.0 0.6 0.3 2.1 0.7 12.0 0.9 2.1 0.7 0.8 0.5 0.0 2.5 7.5 13.9 9.6 14.4 3.7 6.7 5.7 0.6 12.1 3.1 C2orf74 LOC339804 ENSG00000237651 "Chromosome 2 open reading frame 74" A8MZ97 2 61145068-61164828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 191.7;Early spermatids: 573.5;Proximal tubular cells: 142.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA026826 Approved Approved Centrosome NA NA Centrosome "HPA026826: AB_10671091" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (4.54e-2)" "unprognostic (8.10e-2)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-3)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (6.65e-2)" "unprognostic (3.52e-1)" "unprognostic (6.22e-2)" 25.9 28.4 75.7 12.9 74.8 4.2 27.8 72.6 92.9 22.9 67.8 22.7 5.5 18.7 43.2 13.6 20.0 13.2 43.4 73.3 75.6 38.9 36.1 17.5 20.9 74.7 75.0 71.3 26.9 19.9 23.9 38.7 17.0 75.7 20.9 8.8 33.0 16.2 17.3 25.2 8.3 13.8 15.2 72.7 22.5 20.1 56.4 75.4 16.4 24.2 18.0 15.9 23.5 13.2 81.3 15.1 25.7 26.2 0.0 55.0 55.6 23.6 38.7 44.4 36.4 30.0 0.2 25.1 18.8 52.7 31.8 24.0 19.9 0.0 31.6 62.0 24.1 16.0 0.0 26.1 30.2 22.0 23.5 20.4 57.5 51.1 27.2 55.1 26.0 20.5 0.4 0.0 13.9 56.1 27.6 0.1 43.4 25.1 11.4 16.2 34.1 32.5 31.9 50.2 11.8 54.0 20.7 4.9 5.0 34.2 23.0 20.0 22.0 10.8 30.4 13.3 18.4 48.0 58.0 28.6 71.4 40.3 16.5 27.5 16.2 7.7 27.6 16.8 16.5 20.9 31.5 18.1 17.2 16.8 20.9 29.6 23.8 1.8 30.1 16.1 14.0 26.3 10.7 75.7 74.8 72.6 92.9 73.3 75.6 74.7 75.0 71.3 75.7 72.7 75.4 81.3 16.5 12.8 14.5 4.9 14.0 0.0 16.5 1.0 8.6 9.6 15.5 28.6 3.8 21.5 2.8 22.0 8.4 25.7 11.2 0.0 191.7 23.8 573.5 15.8 10.5 16.4 0.0 7.4 5.1 31.0 24.2 11.3 4.6 6.0 14.5 23.1 34.6 24.3 21.8 11.8 4.7 0.2 0.0 28.9 0.2 103.0 37.0 15.2 1.8 2.8 23.9 33.0 29.9 1.5 7.1 24.3 0.0 45.1 11.7 8.7 0.2 142.3 11.8 20.1 19.7 13.1 11.0 21.1 27.7 2.2 0.0 6.4 11.6 40.8 0.2 8.8 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 273 "testis: 27.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/84: 37.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 9.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRGM "IFI1, IRGM1, LRG-47, LRG47" ENSG00000237693 "Immunity related GTPase M" A1A4Y4 5 150846523-150900736 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Cell type enhanced" "Detected in some" "dendritic cells: 1.4;granulocytes: 4.5;T-cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "basophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HL-60: 1.4;JURKAT: 1.8;NB-4: 2.4;THP-1: 1.2;U-937: 3.1" NA NA "unprognostic (8.73e-2)" "unprognostic (2.28e-2)" "unprognostic (2.96e-2)" "unprognostic (2.29e-1)" "unprognostic (4.71e-2)" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-3)" "unprognostic (1.43e-1)" "unprognostic (9.36e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-3)" "unprognostic (1.12e-10)" "unprognostic (5.93e-2)" "unprognostic (8.28e-2)" "unprognostic (2.53e-1)" "unprognostic (1.11e-1)" 0.0 0.1 0.3 0.3 0.4 0.5 0.1 1.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.1 0.0 0.1 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.7 0.1 0.1 0.4 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.3 0.2 0.7 0.3 0.2 0.2 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.3 0.1 0.0 1.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.0 0.2 0.4 2.4 1.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 1.2 0.0 0.1 0.4 0.2 0.1 0.2 0.2 0.2 0.2 3.1 0.0 2.1 0.1 0.1 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 0.1 0.1 0.1 0.2 0.3 0.4 1.1 0.5 0.5 0.1 0.4 0.2 0.2 0.7 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.6 0.0 0.1 0.1 2.3 0.1 0.0 0.1 PRAMEF33 PRAMEF33P ENSG00000237700 "PRAME family member 33" A0A0G2JMD5 1 13303539-13308907 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "liver: 1.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.42e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV3-1 "TCRBV3S1, TCRBV9S1A1T, TRBV31" ENSG00000237702 "T cell receptor beta variable 3-1" A0A576 7 142308542-142309048 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 51.6" "Group enriched" "Detected in some" 22 "Plasma cells: 10.1;T-cells: 12.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 52.4;memory CD8 T-cell: 45.9;naive CD4 T-cell: 71.6;naive CD8 T-cell: 117.4;T-reg: 99.6" "Lineage enriched" "Detected in many" 32 "T-cells: 117.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.98e-5)" "unprognostic (2.38e-3)" "unprognostic (5.19e-3)" "unprognostic (2.46e-2)" "unprognostic (1.19e-2)" "unprognostic (6.19e-4)" "unprognostic (1.46e-2)" "unprognostic (5.42e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.56e-1)" "unprognostic (2.20e-1)" "unprognostic (2.01e-4)" "unprognostic (1.75e-1)" "unprognostic (1.13e-3)" "unprognostic (1.53e-2)" "unprognostic (1.26e-2)" 0.3 0.0 0.0 5.3 0.0 1.9 0.4 0.0 0.1 0.3 0.0 0.9 0.5 0.3 0.1 0.3 0.3 1.2 0.2 0.0 0.0 0.1 0.2 0.8 10.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 1.0 0.0 0.8 0.2 0.0 0.2 2.2 0.2 0.0 2.8 1.0 0.0 0.0 51.6 0.3 0.1 10.5 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.1 0.3 1.8 0.1 16.6 0.2 52.4 45.9 0.1 0.1 71.6 117.4 2.0 0.4 0.1 0.4 99.6 29.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 AMY1A AMY1 ENSG00000237763 "Amylase alpha 1A" P04745 1 103655290-103664554 "Metabolic proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 290 "salivary gland: 22262.5" "Cell type enriched" "Detected in some" 6 "Respiratory ciliated cells: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004310, HPA045394, HPA045399, HPA046980" Enhanced "Secreted to digestive system" NA NA 70000000 "CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 76.7 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.9 6.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 22262.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.5 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.2 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 FAM200B C4orf53 ENSG00000237765 "Family with sequence similarity 200 member B" P0CF97 4 15681662-15690447 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 406.9;Late spermatids: 306.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 15.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017855 Uncertain NA NA "HPA017855: AB_1847703" "unprognostic (7.38e-2)" "unprognostic (5.05e-3)" "unprognostic (8.91e-2)" "unprognostic (1.95e-2)" "unprognostic (5.56e-2)" "unprognostic (8.00e-3)" "unprognostic (3.82e-1)" "prognostic favorable (9.89e-4)" "unprognostic (3.86e-2)" "unprognostic (2.23e-3)" "prognostic favorable (4.39e-4)" "unprognostic (3.46e-1)" "prognostic favorable (3.87e-4)" "unprognostic (6.44e-2)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "prognostic favorable (3.35e-5)" 6.4 6.9 13.8 5.1 15.1 3.8 7.3 15.1 16.5 6.9 11.1 5.1 6.7 6.5 9.4 4.8 6.3 5.1 5.2 14.1 14.4 10.4 8.9 4.2 5.5 13.6 13.9 13.4 8.6 5.6 5.8 6.6 6.5 13.5 6.1 5.7 9.0 4.7 6.0 5.6 4.9 5.8 3.8 14.2 5.5 4.4 4.8 15.7 9.7 9.0 6.6 3.9 4.1 5.0 16.3 6.3 9.2 14.6 8.0 10.2 13.5 5.2 7.7 4.3 10.0 9.0 6.8 4.3 7.4 3.9 8.4 13.1 4.4 14.5 7.4 15.6 3.7 8.0 5.7 12.3 10.7 8.1 5.4 2.4 7.9 8.4 9.7 6.1 16.9 5.7 4.7 7.6 4.4 22.1 3.6 5.6 5.9 19.4 3.6 7.3 5.0 22.5 1.1 9.2 4.9 20.0 11.0 5.6 1.6 13.6 12.8 3.3 6.6 8.1 10.3 8.1 8.4 10.5 2.1 4.6 3.5 6.4 7.2 23.5 3.7 6.7 6.8 1.4 3.0 1.9 0.8 1.7 1.3 3.3 1.3 2.9 2.3 15.1 1.1 2.4 1.1 2.1 3.7 13.8 15.1 15.1 16.5 14.1 14.4 13.6 13.9 13.4 13.5 14.2 15.7 16.3 35.2 28.9 47.5 16.0 21.7 53.8 61.8 80.0 76.8 53.4 72.8 96.1 94.9 78.6 52.4 77.3 12.5 72.4 34.8 54.3 406.9 50.1 224.1 64.6 46.1 42.9 66.0 27.1 23.4 58.7 60.2 59.0 17.9 62.9 13.3 64.5 44.3 91.9 68.2 53.8 23.5 68.5 97.6 77.3 48.6 306.0 93.8 60.4 62.2 5.6 84.7 133.3 59.8 10.6 39.4 51.9 79.3 70.0 8.5 45.4 105.2 233.8 55.1 21.1 46.0 48.1 56.7 113.4 38.0 45.4 51.1 34.6 38.8 71.2 66.7 64.7 CT47A5 CT47.5 ENSG00000237957 "Cancer/testis antigen family 47 member A5" Q5JQC4 X 120963026-120966348 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2I1P "HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P" ENSG00000237988 "Olfactory receptor family 2 subfamily I member 1 pseudogene" 6 29550407-29557721 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Ductal cells: 1.0;granulocytes: 1.3;monocytes: 1.0" "Cancer enhanced" "Detected in all" "liver cancer: 71.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.45e-3)" "unprognostic (1.69e-2)" "unprognostic (6.00e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.60e-2)" "unprognostic (1.07e-3)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (5.34e-3)" "prognostic favorable (5.58e-4)" "unprognostic (1.32e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (4.00e-6)" "unprognostic (8.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 TSPY9P TSPY9 ENSG00000238074 "Testis specific protein Y-linked 9, pseudogene" Y 9487313-9489893 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 625 "U-266/70: 678.1;U-266/84: 699.0" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 678.1 699.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.1;testis: 6.6" "Cell type enhanced" "Detected in many" "Astrocytes: 34.0;Early spermatids: 46.8;Excitatory neurons: 55.9;Inhibitory neurons: 55.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 47.7;Oligodendrocytes: 46.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "white matter: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.3;THP-1: 1.2" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.4 0.1 0.0 0.2 0.4 0.5 0.5 0.1 1.3 0.2 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.2 0.7 0.0 0.0 0.2 0.2 0.4 0.7 0.0 0.8 0.3 0.3 0.4 0.2 0.3 0.6 0.6 0.4 0.2 0.0 0.1 0.2 6.6 0.5 0.4 0.3 0.2 0.2 0.4 0.3 4.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.4 1.2 0.2 0.7 0.6 0.0 0.2 0.4 0.3 0.1 0.0 0.3 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.3 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.5 4.1 2.5 22.4 14.6 34.0 3.8 1.5 4.2 1.0 2.2 7.1 2.6 2.2 2.5 1.5 5.1 0.0 12.5 1.1 8.5 2.3 0.0 2.6 46.8 8.3 5.6 3.0 1.8 0.8 55.9 0.9 0.9 3.2 1.5 5.5 11.4 5.4 1.4 0.8 1.4 13.5 55.5 2.5 0.0 1.2 1.8 11.5 3.4 3.5 0.0 34.7 1.8 2.4 3.1 47.7 46.4 1.0 2.7 1.9 3.0 2.5 1.2 0.4 11.3 8.8 13.1 4.1 2.7 7.9 3.0 1.4 2.3 0.7 6.1 1.7 1.6 2.9 MPC1L SLC54A3 ENSG00000238205 "Mitochondrial pyruvate carrier 1 like" P0DKB6 X 40623566-40624136 "Metabolic proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 18.5" "Cell type enriched" "Detected in single" 5 "Endometrial ciliated cells: 1.2" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.47e-4)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETDA ENSG00000238210 "Embryonic testis differentiation homolog A" Q3ZM63 X 135252061-135253583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.34e-1)" 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 17.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM250 "bA83N9.1, C9orf69" ENSG00000238227 "Transmembrane protein 250" H0YL14 9 136114581-136118875 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 17.1;Extravillous trophoblasts: 21.3;Pancreatic endocrine cells: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066070 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066070: AB_2685608" "unprognostic (2.79e-2)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "prognostic favorable (1.09e-4)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (4.34e-2)" "unprognostic (1.27e-3)" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.31e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-2)" "unprognostic (9.33e-3)" "unprognostic (1.09e-2)" "unprognostic (2.41e-2)" "unprognostic (1.64e-1)" 15.0 14.1 17.8 11.7 17.1 4.4 13.6 13.7 20.4 12.5 9.2 19.9 16.8 14.4 7.4 29.3 12.3 7.0 15.2 18.8 11.2 15.3 21.9 13.2 11.5 15.5 13.4 16.9 13.3 13.3 8.3 12.0 10.5 17.4 14.8 8.1 3.0 14.1 8.6 28.8 20.6 17.3 7.8 12.3 16.9 15.7 13.1 15.7 8.7 11.0 10.5 9.0 19.7 15.1 15.2 24.9 46.2 17.7 26.5 24.7 22.4 54.9 29.2 20.7 17.3 12.3 26.4 35.5 18.3 33.3 31.5 27.6 62.2 12.6 20.6 5.4 78.8 24.1 15.4 48.3 18.7 34.2 28.2 19.2 20.2 38.8 18.8 19.6 22.3 27.9 18.0 35.1 18.9 15.3 57.3 34.6 22.7 39.2 43.4 49.6 14.0 24.5 30.5 19.0 17.9 30.4 23.1 31.5 21.6 26.4 10.4 19.7 42.1 31.6 30.2 13.3 39.8 32.9 11.0 11.3 10.9 30.4 19.9 29.0 4.3 2.9 1.8 6.2 4.2 4.5 1.8 4.7 5.2 3.0 1.3 2.2 4.1 3.4 3.5 4.2 1.9 2.6 2.1 17.8 17.1 13.7 20.4 18.8 11.2 15.5 13.4 16.9 17.4 12.3 15.7 15.2 11.9 6.4 7.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 12.9 11.9 0.0 0.0 1.3 14.7 0.0 17.1 15.2 0.0 3.9 13.1 0.0 9.8 12.6 6.0 0.0 0.0 0.0 10.6 21.3 5.1 0.0 7.0 2.5 14.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.8 0.0 0.0 1.3 0.0 0.0 13.2 1.5 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 7.8 5.5 11.5 0.0 0.0 OR2W3 "OR2W3P, OR2W8P, OST718" ENSG00000238243 "Olfactory receptor family 2 subfamily W member 3" Q7Z3T1 1 247895587-247896531 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "bone marrow: 13.1;brain: 4.7;thyroid gland: 6.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;K-562: 4.1;PC-3: 13.2;U-2 OS: 8.4;U-937: 6.3;WM-115: 9.4" "Not detected" "Not detected" HPA045594 Uncertain NA NA "HPA045594: AB_10960280" "unprognostic (9.44e-2)" "unprognostic (3.03e-1)" "unprognostic (3.29e-2)" "unprognostic (1.57e-5)" "unprognostic (1.98e-1)" "unprognostic (5.11e-2)" "unprognostic (2.79e-6)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.71e-3)" "unprognostic (9.05e-3)" "unprognostic (9.34e-3)" "unprognostic (5.66e-2)" "unprognostic (1.48e-1)" 0.3 0.6 0.9 0.4 1.2 13.1 0.2 0.0 1.3 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.8 0.1 0.1 1.4 4.0 0.1 0.1 0.5 0.1 2.8 2.6 1.6 0.0 0.3 0.0 0.2 1.4 3.3 0.5 0.6 0.3 0.1 0.2 0.0 0.4 0.2 0.5 0.5 1.0 0.2 1.2 4.7 0.1 6.3 0.9 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 3.9 0.0 0.0 0.0 0.3 13.5 0.0 0.0 0.0 1.7 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.3 4.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 13.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 8.4 0.0 0.0 1.4 0.0 0.0 0.0 6.3 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 1.2 0.0 1.3 1.4 4.0 2.8 2.6 1.6 3.3 0.5 4.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE2B CT16.5 ENSG00000238269 "PAGE family member 2B" Q5JRK9 X 55075030-55078909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 57.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 240.8;Spermatogonia: 322.4" "Cancer enhanced" "Detected in many" "liver cancer: 6.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "U-266/70: 1390.8;U-266/84: 2279.6" HPA052619 Supported NA NA "HPA052619: AB_2681887" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.40e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (3.52e-1)" "unprognostic (3.22e-1)" "unprognostic (3.81e-2)" "unprognostic (2.05e-8)" "unprognostic (1.41e-1)" "unprognostic (8.84e-2)" 0.1 0.0 0.3 0.0 0.3 4.1 0.3 0.3 0.7 0.2 0.3 0.1 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.4 0.4 0.2 0.4 0.2 0.2 0.4 0.4 0.3 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.7 0.4 0.1 0.4 0.7 0.1 57.0 0.4 0.2 0.1 0.7 0.4 0.2 0.2 0.4 3.8 0.0 0.0 0.8 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.9 0.0 0.2 0.0 1.3 0.4 2.9 0.5 0.2 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.3 0.1 0.5 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.9 0.0 0.0 216.2 0.2 2.6 1390.8 2279.6 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.7 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 36.1 0.0 0.0 0.3 0.0 26.5 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.3 13.0 4.4 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.8 4.1 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 19.7 0.0 0.0 240.8 322.4 0.0 0.0 0.3 0.1 0.4 0.0 0.0 TXNDC5 "EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15" ENSG00000239264 "Thioredoxin domain containing 5" Q8NBS9 6 7881517-7910788 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 42 "Plasma cells: 677.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 13.0;naive B-cell: 6.9;plasmacytoid DC: 26.7" "Group enriched" "Detected in many" 21 "B-cells: 13.0;dendritic cells: 26.7" "Cell line enhanced" "Detected in all" "RPMI-8226: 2833.2;U-266/84: 6053.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034677, HPA034678" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 6900000 "Endoplasmic reticulum" "HPA034677: AB_2674275, HPA034678: AB_2674276" "unprognostic (3.15e-1)" "unprognostic (1.09e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.95e-2)" "unprognostic (1.20e-2)" "unprognostic (6.07e-2)" "unprognostic (5.81e-2)" "unprognostic (3.56e-2)" "unprognostic (1.54e-1)" "unprognostic (1.18e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.05e-1)" "unprognostic (7.98e-2)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" 98.3 75.5 20.9 174.6 22.2 62.4 165.0 21.2 22.7 133.3 49.4 268.7 265.9 81.3 86.5 78.9 64.5 99.5 59.0 19.2 25.3 63.6 134.4 91.7 195.8 23.7 23.0 18.7 97.2 155.9 69.1 42.9 135.2 22.3 73.8 215.7 4.5 221.3 94.5 25.3 31.9 195.6 123.0 24.2 252.6 290.2 28.6 26.3 54.6 70.2 29.5 266.0 192.6 57.4 24.6 166.1 159.0 111.5 365.9 911.2 388.1 175.9 361.5 349.7 246.2 265.2 238.8 119.0 176.1 620.7 557.2 273.6 127.3 195.5 178.6 280.3 148.8 166.6 267.6 128.3 435.9 268.5 307.2 255.0 266.7 256.8 236.6 259.2 542.1 1334.0 109.7 170.5 1216.5 171.7 147.7 75.2 185.7 142.8 260.5 340.6 128.0 160.4 2833.2 201.1 149.6 168.7 90.5 462.4 280.2 209.4 514.9 143.5 133.9 369.7 280.5 194.2 243.0 386.5 1408.7 6053.9 305.0 144.7 191.7 392.2 0.0 0.4 0.0 0.9 0.7 0.7 13.0 0.2 0.7 1.0 6.9 0.2 0.4 0.0 0.0 0.1 26.7 0.9 0.5 20.9 22.2 21.2 22.7 19.2 25.3 23.7 23.0 18.7 22.3 24.2 26.3 24.6 1.3 0.0 4.8 0.0 14.6 0.9 0.2 0.4 3.4 0.0 1.8 1.3 0.2 0.0 2.0 0.0 0.0 0.9 5.6 1.2 0.0 9.0 0.1 1.1 6.9 3.2 4.9 11.2 0.0 10.7 1.9 4.1 6.1 2.3 1.3 0.6 3.9 4.9 1.5 0.0 0.0 15.9 0.0 0.8 0.7 0.0 0.0 1.3 3.6 0.0 1.8 0.1 0.0 0.0 0.0 9.5 1.5 0.4 677.7 0.4 3.2 0.5 1.7 0.5 6.6 0.5 4.2 0.1 0.1 3.9 0.1 1.2 2.0 0.2 5.8 0.2 CASTOR1 GATSL3 ENSG00000239282 "Cytosolic arginine sensor for mTORC1 subunit 1" Q8WTX7 22 30285117-30289622 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 48.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 71.8;Extravillous trophoblasts: 55.4;monocytes: 45.5;Syncytiotrophoblasts: 36.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073183 Approved NA NA "HPA073183: " "unprognostic (1.48e-2)" "unprognostic (1.48e-2)" "unprognostic (1.92e-3)" "unprognostic (7.40e-3)" "unprognostic (2.75e-2)" "unprognostic (2.45e-2)" "unprognostic (8.60e-2)" "unprognostic (3.33e-2)" "unprognostic (1.65e-1)" "unprognostic (3.95e-1)" "unprognostic (3.95e-2)" "unprognostic (3.32e-2)" "unprognostic (3.37e-5)" "unprognostic (9.28e-2)" "unprognostic (8.70e-2)" "unprognostic (3.17e-2)" "unprognostic (4.26e-2)" 12.3 6.5 9.5 3.3 9.3 1.5 13.4 8.1 15.9 17.9 8.2 6.4 0.6 9.1 2.5 48.4 11.1 4.3 8.4 8.9 10.3 12.2 7.6 11.0 7.3 9.4 9.9 7.9 14.0 5.6 14.6 8.7 11.1 9.6 13.6 0.6 1.2 12.1 12.1 2.8 12.1 6.0 3.3 7.9 9.4 7.8 17.3 9.3 4.8 13.2 3.1 3.4 10.4 35.5 8.1 1.5 5.9 1.8 6.2 6.6 7.3 12.6 0.5 1.5 0.9 1.0 2.1 1.4 0.5 1.9 3.5 9.4 2.9 1.8 2.4 0.1 0.9 1.4 0.4 1.1 1.7 13.5 0.5 4.5 12.9 5.4 3.0 0.5 9.4 6.1 10.8 1.3 5.2 3.5 7.6 3.4 4.0 1.0 6.2 2.8 5.0 3.2 5.0 3.5 2.0 0.4 4.2 1.8 3.8 1.4 5.5 5.8 0.7 4.8 3.6 3.8 2.3 0.4 0.4 0.4 0.3 1.7 2.2 1.3 12.2 7.6 19.5 9.8 5.1 5.9 15.6 12.9 10.4 7.6 16.3 21.4 16.0 3.0 29.2 2.6 8.2 14.8 7.5 9.5 9.3 8.1 15.9 8.9 10.3 9.4 9.9 7.9 9.6 7.9 9.3 8.1 13.6 0.0 2.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.0 5.7 0.0 0.0 1.8 7.3 0.0 71.8 2.6 0.0 9.8 6.0 0.0 1.5 1.3 2.4 0.0 0.0 0.0 2.4 55.4 3.1 0.0 4.0 2.5 2.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 45.5 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 11.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 36.4 1.5 2.6 0.0 0.0 RNF103 "hkf-1, KF1, ZFP103" ENSG00000239305 "Ring finger protein 103" O00237 2 86603398-86623866 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 7.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057922 Approved NA NA "HPA057922: AB_2683555" "unprognostic (4.41e-1)" "unprognostic (1.56e-1)" "unprognostic (6.04e-2)" "unprognostic (3.26e-1)" "unprognostic (3.20e-2)" "unprognostic (1.79e-1)" "unprognostic (7.42e-2)" "unprognostic (8.37e-2)" "unprognostic (4.06e-1)" "unprognostic (1.13e-2)" "unprognostic (6.21e-2)" "unprognostic (1.44e-1)" "unprognostic (3.54e-3)" "unprognostic (1.50e-1)" "unprognostic (1.77e-1)" "unprognostic (3.67e-2)" "prognostic favorable (6.77e-5)" 14.3 15.5 28.8 9.0 32.6 13.7 21.1 39.7 30.4 16.0 25.3 22.0 18.9 23.8 45.8 14.2 17.1 19.5 38.0 28.6 30.1 15.4 54.9 11.4 8.2 30.6 31.4 28.1 16.1 24.9 25.4 15.7 15.7 30.4 23.5 16.6 10.4 18.9 17.9 21.6 14.1 23.2 21.1 31.2 10.5 22.8 15.6 30.4 8.2 10.3 19.3 10.0 14.5 14.1 34.2 9.6 12.9 6.4 9.9 28.6 18.3 10.3 13.6 20.6 6.8 9.2 7.5 16.1 15.9 15.9 20.4 24.8 11.5 8.7 10.7 10.2 13.4 11.7 9.1 5.4 16.7 27.1 3.0 13.0 26.9 21.8 10.1 12.6 24.3 20.7 7.4 3.3 9.3 19.0 11.9 7.0 8.0 2.9 19.0 9.0 4.3 27.5 9.4 25.1 14.9 10.2 10.4 16.0 35.2 14.0 8.0 13.5 7.4 23.6 13.2 6.3 13.4 8.2 32.3 11.5 10.7 10.5 5.1 6.5 4.5 0.5 7.2 0.7 0.7 1.0 0.9 1.1 1.6 1.1 1.0 1.2 0.9 1.0 2.3 0.4 0.8 2.5 0.6 28.8 32.6 39.7 30.4 28.6 30.1 30.6 31.4 28.1 30.4 31.2 30.4 34.2 22.6 9.6 14.5 0.0 16.6 48.3 35.5 13.9 33.6 15.8 45.9 31.1 40.0 31.5 22.1 20.2 4.2 13.6 15.7 72.4 1.9 17.6 16.8 20.4 17.9 22.4 31.8 16.4 0.0 28.4 7.8 27.6 44.4 30.0 18.4 19.9 22.9 68.9 9.6 18.5 0.0 45.9 12.2 14.1 29.5 9.3 25.4 19.8 10.6 0.0 8.0 17.2 2.1 0.0 0.0 33.9 41.5 23.0 41.1 45.0 56.1 12.9 33.6 9.5 6.6 40.3 25.7 27.5 12.6 32.6 44.2 40.9 19.5 9.0 24.3 48.6 RBM14 "COAA, DKFZp779J0927, SIP, SYTIP1" ENSG00000239306 "RNA binding motif protein 14" Q96PK6 11 66616626-66629934 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006628 Supported Supported "Nuclear speckles" NA NA 31000 "Nuclear speckles" "HPA006628: AB_1078546" "unprognostic (6.96e-2)" "unprognostic (4.79e-2)" "unprognostic (4.34e-3)" "unprognostic (4.45e-2)" "unprognostic (2.15e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.08e-2)" "prognostic favorable (1.04e-4)" "unprognostic (9.38e-3)" "unprognostic (8.59e-3)" "unprognostic (1.29e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-1)" "unprognostic (1.94e-1)" 25.5 32.2 40.2 25.2 39.7 32.9 24.3 49.7 48.4 36.2 44.8 29.1 15.8 31.0 19.3 34.2 37.9 10.8 31.1 41.9 39.2 35.5 40.8 27.5 28.5 38.8 41.9 40.0 45.5 34.4 17.6 34.8 19.7 45.9 36.7 18.3 36.1 25.5 14.7 29.9 28.4 29.4 15.8 38.0 40.7 30.4 44.3 43.7 25.9 28.7 11.7 29.4 30.6 28.9 48.3 83.0 77.9 55.9 43.2 25.3 16.8 97.0 45.0 16.4 40.8 24.0 79.2 60.6 130.9 49.2 21.9 45.0 69.0 63.4 36.5 43.3 63.9 68.7 81.7 67.1 71.2 14.1 71.5 70.0 11.8 13.3 41.9 23.3 24.1 31.0 38.2 98.6 83.9 40.2 70.3 122.4 79.4 107.2 69.0 85.7 125.3 65.4 67.3 34.2 71.5 67.0 61.9 78.0 55.9 33.9 45.9 77.3 63.5 50.5 49.4 97.9 40.5 72.6 49.8 75.2 109.0 41.8 68.9 120.1 19.7 24.3 27.3 27.9 26.1 27.2 21.3 24.1 26.8 33.6 21.8 24.3 28.2 9.0 21.7 27.2 21.3 23.1 34.0 40.2 39.7 49.7 48.4 41.9 39.2 38.8 41.9 40.0 45.9 38.0 43.7 48.3 12.6 9.6 17.0 0.0 27.4 38.1 45.7 20.7 15.4 24.8 19.1 16.3 16.3 18.6 17.2 14.7 29.2 56.3 32.7 17.7 17.6 26.5 37.3 18.1 16.5 21.3 21.6 23.1 0.0 18.4 54.4 20.1 9.7 17.5 19.7 20.4 22.5 24.5 29.0 11.8 0.0 20.9 24.4 16.0 30.2 27.0 17.1 20.1 12.4 0.0 25.4 18.1 34.0 0.0 0.0 19.3 21.7 16.1 20.7 26.9 19.0 12.2 23.2 49.4 6.6 15.1 21.5 53.9 40.1 20.9 31.1 69.2 29.0 13.7 25.2 32.6 ALKBH6 MGC15677 ENSG00000239382 "AlkB homolog 6" Q3KRA9 19 36009120-36014239 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073835, HPA074340" Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA073835: AB_2686637, HPA074340: AB_2686680" "unprognostic (1.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (5.86e-5)" "unprognostic (6.21e-2)" "unprognostic (4.53e-2)" "unprognostic (3.95e-1)" "unprognostic (3.56e-2)" "unprognostic (8.78e-4)" "unprognostic (1.77e-2)" "unprognostic (2.31e-5)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (3.82e-1)" "unprognostic (1.05e-3)" 5.4 8.4 9.4 3.1 8.2 3.4 5.3 9.6 12.5 6.3 6.2 8.6 2.9 7.6 2.3 7.7 6.8 2.2 6.6 9.2 9.8 7.3 11.6 5.6 4.3 14.5 10.5 8.4 5.6 4.4 4.8 10.0 2.7 14.9 7.6 2.0 2.7 6.2 4.0 6.4 6.2 7.3 3.7 8.2 7.9 7.9 4.5 13.7 4.1 6.7 3.9 3.8 8.0 6.0 16.0 12.5 13.1 4.9 7.2 7.4 4.5 8.2 12.1 8.0 13.9 14.0 5.4 6.4 10.8 18.8 6.7 7.2 4.9 5.1 14.0 7.2 17.2 9.4 6.2 5.1 5.9 8.4 5.4 18.3 6.8 9.9 11.5 3.9 4.8 9.5 16.2 9.9 8.0 7.5 13.1 13.1 7.0 3.8 12.8 8.3 8.4 6.7 7.9 10.3 5.5 5.9 6.0 8.2 9.8 10.8 6.8 7.8 12.1 4.1 7.2 10.5 16.6 12.0 14.9 9.6 7.8 15.5 6.1 7.8 58.5 18.2 47.8 26.2 26.0 20.4 32.9 23.8 25.4 16.0 24.6 20.2 19.3 16.0 28.8 20.7 22.7 34.4 16.0 9.4 8.2 9.6 12.5 9.2 9.8 14.5 10.5 8.4 14.9 8.2 13.7 16.0 6.1 3.2 1.7 6.8 16.5 6.8 11.1 4.5 9.1 5.6 8.0 6.5 2.0 10.0 3.3 18.4 0.0 17.7 13.1 9.5 5.9 10.4 7.6 6.8 5.0 5.9 13.1 14.5 8.1 9.2 15.8 8.1 14.3 6.3 0.0 7.1 7.9 12.7 11.0 10.1 7.2 11.9 2.0 5.3 7.7 5.4 11.1 9.1 8.8 3.7 15.2 5.5 23.7 2.0 6.5 13.3 13.6 4.5 12.1 7.1 7.8 11.8 2.3 3.3 6.6 4.1 10.1 3.6 2.4 8.7 5.1 19.0 15.5 6.4 9.5 9.5 ASB14 DKFZp313L0121 ENSG00000239388 "Ankyrin repeat and SOCS box containing 14" A6NK59 3 57268342-57292685 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "skeletal muscle: 28.4;tongue: 18.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 8.2;Excitatory neurons: 4.8;Inhibitory neurons: 4.3;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-3)" "unprognostic (1.85e-1)" "unprognostic (3.64e-1)" "unprognostic (7.14e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.37e-3)" "unprognostic (1.81e-4)" "unprognostic (1.11e-1)" "unprognostic (1.37e-1)" "unprognostic (1.24e-2)" "unprognostic (1.45e-2)" "unprognostic (6.69e-2)" "unprognostic (6.87e-2)" "unprognostic (9.68e-2)" "unprognostic (5.93e-2)" "unprognostic (5.71e-3)" 0.6 0.3 0.5 0.5 0.2 2.0 0.6 1.4 0.3 0.5 0.3 0.4 0.3 0.3 0.0 0.4 0.5 0.2 3.9 0.1 0.2 0.3 0.3 0.6 0.7 0.3 0.2 0.0 0.5 1.6 0.0 0.4 0.1 0.4 0.3 0.0 1.6 0.7 0.0 28.4 0.8 0.5 0.0 0.5 0.6 0.5 0.3 0.3 0.0 0.4 18.1 0.0 0.4 0.6 0.5 0.2 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.7 0.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.2 0.4 1.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.6 0.0 0.1 0.7 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.0 0.6 0.2 0.7 0.1 0.3 0.1 0.4 0.3 0.1 0.3 0.1 0.2 0.7 0.6 0.4 0.6 0.4 0.7 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 1.4 0.3 0.1 0.2 0.3 0.2 0.0 0.4 0.5 0.3 0.5 0.1 3.2 0.5 2.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.2 0.2 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 PCDHA13 "CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13" ENSG00000239389 "Protocadherin alpha 13" Q9Y5I0 5 140882124-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.1;parathyroid gland: 3.5;retina: 1.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 2.8;Horizontal cells: 1.7;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 3.7;WM-115: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.07e-1)" "unprognostic (5.25e-2)" "unprognostic (5.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.48e-2)" "unprognostic (2.64e-3)" "unprognostic (5.53e-2)" "unprognostic (1.36e-1)" 0.2 0.1 0.7 0.1 0.8 0.0 0.1 4.1 1.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.8 0.0 0.6 3.5 0.4 0.0 1.2 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 4.1 1.2 0.5 0.3 0.2 0.5 0.8 1.2 0.3 0.2 0.9 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118470.1 ENSG00000239395 "Novel protein" 1 247711813-247723764 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 34 "GAMG: 3.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526258 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 42 "skeletal muscle: 5086.1;tongue: 3504.5" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 108.1;Skeletal myocytes: 251.8" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 1.2 0.5 1.8 0.2 1.4 0.0 2.0 3.2 1.9 1.0 1.3 1.1 0.1 0.8 1.5 75.7 1.2 6.8 101.2 1.3 1.6 0.6 0.9 2.8 0.3 1.1 2.7 1.2 1.1 1.1 0.5 5.8 0.1 1.5 50.4 0.3 16.2 52.6 0.7 5086.1 3.0 0.8 0.6 1.1 0.8 1.3 2.6 3.0 1.7 2.3 3504.5 0.3 5.9 0.9 1.7 0.0 0.1 0.0 0.6 0.4 2.7 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.2 0.2 0.0 21.6 0.5 0.3 0.0 0.2 0.1 0.2 0.1 0.0 35.4 0.1 0.1 0.2 0.0 0.0 0.2 0.0 55.9 0.0 0.2 0.1 0.7 0.1 0.1 0.0 1.5 0.1 0.0 0.1 0.0 0.4 0.2 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.4 3.2 1.9 1.3 1.6 1.1 2.7 1.2 1.5 1.1 3.0 1.7 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.1 0.0 2.4 0.2 0.1 108.1 0.0 2.0 0.0 8.4 0.0 0.0 0.1 0.0 0.5 5.8 1.3 0.2 1.0 1.2 0.0 4.1 0.5 0.0 6.4 0.0 0.1 0.0 0.2 0.4 0.2 0.2 0.0 4.6 0.1 0.0 0.3 0.0 2.9 0.9 0.8 0.0 3.7 0.0 0.7 0.0 1.5 2.3 0.7 0.1 1.2 0.0 0.3 0.0 0.3 4.1 5.8 0.0 251.8 1.8 4.1 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.1 IGKV2D-30 ENSG00000239571 "Immunoglobulin kappa variable 2D-30" A0A075B6S6 2 89936859-89937679 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.5;lymphoid tissue: 33.8;stomach 1: 22.4" "Cell type enriched" "Detected in some" 222 "Plasma cells: 1314.8" "Cancer enhanced" "Detected in some" "stomach cancer: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 379 "memory B-cell: 124.9;naive B-cell: 164.0" "Lineage enriched" "Detected in single" 430 "B-cells: 164.0" "Cell line enriched" "Detected in some" 6 "U-698: 51.7" "Immunoglobulin genes" NA NA "unprognostic (1.17e-3)" "unprognostic (6.82e-2)" "unprognostic (1.58e-1)" "unprognostic (2.98e-4)" "unprognostic (5.74e-3)" "unprognostic (3.19e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.55e-1)" 0.3 0.4 0.0 6.4 0.0 4.3 6.0 0.0 0.1 0.8 0.0 15.5 11.9 0.4 0.0 1.0 0.4 0.8 0.8 0.1 0.0 1.3 0.7 2.9 6.8 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.5 11.3 0.0 13.1 4.6 0.0 1.3 8.6 2.0 0.0 29.6 22.4 0.1 0.0 1.6 0.8 0.0 33.8 5.6 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 124.9 0.0 0.1 0.1 164.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 19.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1314.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 OR1J4 "HSHTPCRX01, HTPCRX01" ENSG00000239590 "Olfactory receptor family 1 subfamily J member 4" Q8NGS1 9 122519141-122520082 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.82e-1)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155308 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047366: , HPA052691: AB_2681918" "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.7 0.3 0.0 0.0 0.1 0.2 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 14.9 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.4 0.5 0.7 0.3 0.4 0.3 0.2 0.5 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20G ENSG00000239620 "Proline rich 20G" P0DPQ3 3 127283783-127288046 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 41 "testis: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "testis cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.60e-3)" "unprognostic (2.41e-3)" "unprognostic (1.45e-1)" "unprognostic (5.78e-2)" "unprognostic (4.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEIKIN ENSG00000239642 "Meiotic kinetochore factor" A0A087WXM9 5 131806990-131945698 "Metabolic proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;choroid plexus: 1.7;testis: 7.5" "Cell type enhanced" "Detected in some" "Astrocytes: 179.6;Excitatory neurons: 46.6;Inhibitory neurons: 54.4;Microglial cells: 27.2;Oligodendrocyte precursor cells: 35.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (3.21e-1)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-1)" "unprognostic (4.64e-6)" "unprognostic (2.38e-1)" "unprognostic (3.81e-1)" 0.0 0.0 2.0 0.1 2.0 0.0 0.0 2.3 3.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.9 0.0 0.1 0.1 0.0 2.0 1.9 2.0 0.0 0.0 0.1 0.0 0.3 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 1.8 0.2 0.0 7.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.0 2.0 2.3 3.0 2.1 1.9 2.0 1.9 2.0 2.0 1.8 2.0 2.2 0.0 0.0 0.0 179.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 54.4 0.0 0.0 0.0 0.0 0.5 0.0 1.9 0.0 27.2 2.2 0.0 0.0 35.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NME1 "NDPKA, NM23, NM23-H1" ENSG00000239672 "NME/NM23 nucleoside diphosphate kinase 1" P15531 17 51153559-51162428 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008467, CAB040571, HPA041113" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 21000000 Cytosol "Nucleoplasm, Plasma membrane" "CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.24e-1)" "unprognostic (2.01e-1)" "unprognostic (3.48e-3)" "unprognostic (5.96e-2)" "unprognostic (9.71e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (2.60e-5)" "unprognostic (4.54e-2)" "unprognostic (3.35e-1)" "unprognostic (2.33e-3)" "unprognostic (2.90e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.07e-9)" "unprognostic (9.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.83e-1)" "unprognostic (9.46e-2)" 55.3 85.1 79.2 75.3 85.1 77.6 63.8 81.9 103.1 36.6 80.5 60.7 39.1 50.1 47.2 91.8 49.0 21.0 37.7 90.9 89.8 51.5 83.9 41.6 74.5 85.1 83.7 83.8 33.9 68.4 53.3 47.8 39.5 85.8 39.1 78.4 220.3 51.1 30.7 35.8 56.1 33.4 66.9 80.3 48.9 42.2 25.5 82.6 61.7 41.7 21.1 96.6 72.9 49.3 97.3 483.6 833.1 285.9 444.8 118.6 183.7 479.7 355.3 227.3 652.2 489.7 656.9 288.1 754.2 372.4 304.1 272.4 252.1 542.5 553.3 553.4 398.4 729.3 504.9 605.8 975.9 237.1 575.8 243.8 177.8 341.7 493.1 458.6 120.6 404.6 247.8 739.0 270.0 392.8 720.4 715.2 647.1 390.7 957.5 739.3 446.9 587.6 751.3 511.5 320.2 418.6 461.1 188.1 521.0 385.3 246.2 554.0 419.6 279.5 476.9 452.2 307.0 774.4 374.0 840.9 956.3 286.2 480.4 385.8 1.1 55.0 2.1 47.2 77.1 69.3 96.4 50.3 53.8 134.0 67.6 54.3 60.4 1.7 69.6 48.6 84.8 49.1 68.4 79.2 85.1 81.9 103.1 90.9 89.8 85.1 83.7 83.8 85.8 80.3 82.6 97.3 53.1 32.1 30.5 0.0 71.3 132.4 97.5 198.8 88.8 283.3 98.8 118.1 34.2 65.8 92.3 71.7 285.7 180.0 25.4 54.2 150.6 211.3 34.2 40.2 107.2 85.1 89.7 81.8 0.0 201.5 269.7 85.0 64.2 37.2 45.7 113.5 27.8 123.3 207.1 40.4 0.0 107.4 101.7 25.7 88.9 93.7 61.2 48.9 129.9 0.0 47.2 105.6 27.8 0.0 0.0 194.0 50.5 58.6 113.8 170.6 12.2 195.2 42.0 323.7 13.1 83.0 182.9 22.7 98.8 139.4 133.1 88.5 38.0 215.5 157.7 98.2 TNFSF12 "APO3L, DR3LG, TWEAK" ENSG00000239697 "TNF superfamily member 12" O43508 17 7549058-7557890 "Predicted secreted proteins" "Angiogenesis, Apoptosis, Differentiation" "Cytokine, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.7;BJ hTERT+: 18.4;HDLM-2: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035984, HPA052967" Uncertain Approved Vesicles "Secreted to blood" NA NA 853000 130000 Vesicles "HPA035984: , HPA052967: AB_2682000" "unprognostic (2.96e-3)" "unprognostic (2.96e-1)" "unprognostic (4.71e-2)" "prognostic favorable (5.70e-5)" "unprognostic (5.31e-2)" "unprognostic (7.91e-2)" "unprognostic (6.45e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (6.09e-2)" "unprognostic (6.20e-2)" "unprognostic (8.62e-2)" "unprognostic (3.29e-2)" "unprognostic (4.11e-2)" "unprognostic (3.15e-2)" "unprognostic (8.74e-2)" "unprognostic (2.38e-1)" 42.0 28.7 49.7 9.9 48.7 3.1 36.9 42.8 67.0 37.7 43.2 51.1 9.8 38.5 7.1 14.0 38.1 15.8 39.4 47.9 44.0 32.8 16.6 38.1 15.9 50.8 46.8 45.5 43.0 23.4 11.2 18.1 11.3 47.6 39.7 5.8 3.0 26.3 27.4 17.1 15.3 27.0 13.4 44.9 38.7 39.1 5.6 50.0 4.9 23.1 9.4 5.6 47.5 30.4 46.8 0.0 0.5 0.7 0.0 14.9 17.7 4.0 6.9 18.4 7.7 5.7 0.1 2.5 0.0 5.8 16.3 0.8 1.4 1.4 0.6 1.6 20.3 2.0 0.9 0.4 2.3 12.8 0.0 0.0 15.0 2.6 2.8 0.3 3.0 12.1 0.0 0.0 0.0 7.0 0.0 0.0 0.5 0.6 0.1 7.5 0.1 0.0 0.1 11.6 0.0 0.0 7.9 2.5 0.0 12.6 0.1 1.4 0.6 16.1 15.1 1.1 0.1 8.8 0.0 0.0 0.0 2.4 0.0 10.5 2.6 3.5 11.6 5.1 5.9 6.0 2.9 4.3 3.1 2.2 1.8 4.1 4.2 2.0 2.8 1.5 2.5 4.0 1.1 49.7 48.7 42.8 67.0 47.9 44.0 50.8 46.8 45.5 47.6 44.9 50.0 46.8 115.9 9.6 12.2 0.0 20.4 6.1 11.1 1.5 6.8 6.7 21.7 41.7 4.3 17.2 3.4 16.5 0.0 1.6 38.3 2.5 7.9 15.2 0.4 4.1 15.2 33.9 1.2 3.2 0.0 12.1 0.8 42.7 4.6 8.5 34.3 6.8 48.5 3.4 44.3 20.2 0.0 3.4 0.0 59.7 26.8 1.2 50.7 62.1 19.6 0.0 28.6 46.6 40.2 0.0 0.0 8.1 1.7 50.4 3.6 6.7 0.4 39.6 0.6 2.6 59.2 34.4 56.7 0.2 1.1 2.1 7.5 0.8 38.7 9.4 4.1 6.0 CDRT4 FLJ36674 ENSG00000239704 "CMT1A duplicated region transcript 4" Q8N9R6 17 15436015-15503608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 36 "Early spermatids: 65.8;Late spermatids: 202.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 10.1;NB-4: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA021590 Uncertain Approved Mitochondria NA NA Mitochondria "HPA021590: AB_1848906" "unprognostic (5.46e-6)" "unprognostic (9.47e-2)" "unprognostic (7.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.51e-2)" "unprognostic (7.74e-3)" "unprognostic (9.29e-2)" "unprognostic (2.12e-2)" "unprognostic (3.93e-2)" "unprognostic (1.39e-1)" "unprognostic (2.10e-5)" "unprognostic (2.00e-3)" "unprognostic (1.74e-6)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (4.18e-1)" "unprognostic (9.27e-2)" 5.8 18.8 13.2 1.7 13.3 6.2 9.4 14.3 12.2 18.1 12.1 8.8 1.0 8.8 24.0 10.9 20.9 3.2 5.4 12.5 12.5 12.3 10.1 8.9 5.1 12.2 11.5 12.2 20.6 19.9 1.6 48.4 2.5 12.8 20.3 4.7 12.0 16.1 3.8 1.8 21.9 12.0 2.3 8.5 16.0 11.5 15.5 12.9 3.3 23.7 0.8 2.9 9.1 12.9 12.9 2.5 2.2 2.8 1.0 2.4 1.7 2.9 0.9 2.5 1.1 1.0 1.4 0.7 0.0 1.2 1.4 0.2 0.8 3.0 2.4 1.7 0.5 0.4 0.4 2.0 10.1 0.7 0.9 3.9 1.9 3.6 1.6 4.0 4.3 2.6 1.0 0.5 1.6 2.1 0.4 1.0 8.0 0.9 0.4 0.8 0.4 0.0 0.0 2.9 2.0 0.4 1.3 0.8 0.4 0.8 6.2 1.1 2.0 2.4 0.3 1.1 1.0 1.0 2.2 0.9 0.1 0.0 0.0 0.3 0.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 13.2 13.3 14.3 12.2 12.5 12.5 12.2 11.5 12.2 12.8 8.5 12.9 12.9 0.4 0.0 1.1 0.0 0.3 0.1 0.2 0.2 0.0 1.4 0.6 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.6 0.0 0.8 65.8 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 2.5 1.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 202.7 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.4 0.4 0.0 3.7 1.5 0.0 0.3 0.2 1.0 0.7 0.0 0.0 0.1 0.2 0.5 1.0 0.3 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077067-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" "dendritic cells: 145.4;monocytes: 69.1;NK-cells: 251.3;Plasma cells: 69.5;T-cells: 120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.0;Daudi: 38.3;HDLM-2: 31.8;Karpas-707: 44.2" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 5.5 8.2 2.9 21.9 3.1 16.1 8.7 3.2 4.6 7.7 2.9 7.7 5.6 10.4 10.5 6.1 21.3 11.2 4.3 2.7 4.1 3.7 5.7 14.6 46.3 3.6 3.3 2.3 22.9 1.7 4.8 3.6 5.1 3.7 7.8 9.5 1.4 8.5 22.6 1.2 1.6 9.7 9.7 3.5 28.4 10.1 20.3 3.6 26.2 5.9 2.7 35.4 15.8 6.5 4.6 4.5 0.1 0.0 0.0 5.0 9.7 0.3 1.0 16.8 19.9 30.0 1.6 22.6 38.3 0.5 7.3 11.6 0.1 0.2 1.3 6.0 31.8 0.1 23.1 0.0 0.2 21.8 7.1 10.1 14.3 0.5 10.9 2.4 0.0 2.4 1.2 1.9 44.2 3.1 0.0 7.6 7.7 0.6 0.0 1.7 15.3 0.0 25.8 0.0 19.6 0.0 0.0 0.5 0.0 2.0 1.7 0.0 13.2 0.0 2.8 0.2 0.0 0.0 0.0 3.5 0.5 3.2 6.9 5.0 30.7 42.3 28.7 363.8 98.1 207.6 84.9 108.8 281.7 52.4 66.1 34.3 160.2 34.8 232.2 123.0 28.1 92.3 297.8 2.9 3.1 3.2 4.6 2.7 4.1 3.6 3.3 2.3 3.7 3.5 3.6 4.6 8.4 3.2 8.9 1.0 55.7 1.8 15.5 27.0 4.6 0.4 3.0 6.6 3.7 7.2 14.4 0.0 2.1 3.9 145.4 0.6 5.9 11.7 47.2 5.7 6.4 8.9 6.0 8.6 0.1 2.3 1.1 10.0 2.0 3.9 12.6 62.5 11.4 0.9 30.6 0.0 0.1 1.9 10.2 20.4 9.8 13.7 19.0 21.3 7.2 3.7 69.1 8.1 251.3 0.5 0.0 2.2 1.8 9.1 69.5 16.0 0.1 2.1 12.1 1.2 19.7 4.7 10.1 1.3 1.6 2.0 1.3 1.0 120.5 20.3 1.5 18.0 TLR9 CD289 ENSG00000239732 "Toll like receptor 9" Q9NR96 3 52221080-52225645 "CD markers, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;lymphoid tissue: 6.1" "Group enriched" "Detected in some" 5 "B-cells: 3.3;Microglial cells: 1.0;Paneth cells: 1.1;Plasma cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 7 "plasmacytoid DC: 166.9" "Lineage enriched" "Detected in many" 7 "dendritic cells: 166.9" "Group enriched" "Detected in some" 8 "Daudi: 53.5;RPMI-8226: 52.4;U-698: 27.6" NA NA "unprognostic (6.03e-2)" "unprognostic (5.08e-2)" "unprognostic (3.58e-3)" "unprognostic (6.69e-7)" "unprognostic (1.16e-1)" "unprognostic (1.89e-2)" "unprognostic (2.69e-1)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (1.89e-1)" "unprognostic (4.40e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-3)" "unprognostic (2.44e-2)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (7.91e-3)" 0.5 0.2 1.3 2.6 1.0 1.3 0.4 2.1 5.7 1.2 0.8 0.7 0.4 0.7 0.0 0.3 0.9 0.6 0.3 1.2 0.9 0.3 0.3 0.6 6.1 1.4 1.0 0.8 1.5 0.1 0.0 0.3 0.2 1.6 0.7 0.1 0.0 0.7 0.2 1.2 0.3 1.3 0.1 1.5 3.0 0.5 0.4 1.2 1.5 0.6 0.4 4.1 0.7 0.8 2.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 5.4 1.1 0.0 0.0 0.0 1.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.1 0.0 0.0 3.6 1.7 27.6 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.2 2.7 23.5 0.9 0.6 0.3 12.8 0.2 0.2 0.5 0.0 0.0 166.9 2.5 1.8 1.3 1.0 2.1 5.7 1.2 0.9 1.4 1.0 0.8 1.6 1.5 1.2 2.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 WBP1 WBP-1 ENSG00000239779 "WW domain binding protein 1" Q96G27 2 74458400-74460891 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 29.0;Gastric mucus-secreting cells: 33.1;Plasma cells: 57.2;Squamous epithelial cells: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057067 Approved Approved Cytosol No No Cytosol "HPA057067: AB_2683326" "unprognostic (5.94e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (6.05e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" "unprognostic (5.80e-2)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "prognostic favorable (6.83e-4)" "unprognostic (1.17e-2)" "unprognostic (1.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (6.36e-4)" 35.0 71.3 126.3 19.8 126.3 32.2 38.0 123.6 173.2 47.7 115.9 41.9 29.4 39.5 45.2 36.0 56.6 36.9 49.0 121.6 121.9 71.3 81.0 34.0 32.5 129.7 124.7 116.9 56.1 62.8 74.3 61.3 25.1 122.8 70.5 17.9 24.7 56.9 37.7 31.7 32.6 33.5 20.0 121.8 42.8 58.5 32.1 126.1 45.1 67.5 54.3 20.8 46.1 37.8 126.0 20.6 91.3 56.2 66.7 69.9 54.0 45.7 20.6 40.3 22.4 17.5 47.3 41.9 19.4 39.3 48.9 33.2 28.3 24.8 55.8 19.0 74.3 49.1 27.4 41.4 68.9 47.6 10.3 27.4 76.2 58.9 30.4 42.2 93.8 44.7 51.6 11.5 72.0 54.8 133.8 40.1 25.5 43.3 53.6 46.3 36.4 63.5 33.6 55.9 83.1 35.0 81.3 28.2 49.9 62.5 49.4 65.5 26.9 26.5 53.0 41.9 20.0 23.5 106.7 38.8 22.2 56.2 27.0 48.5 24.1 28.5 19.2 26.5 23.5 22.5 28.4 23.0 25.5 30.2 27.8 31.3 28.0 18.6 34.6 20.1 47.0 39.2 27.1 126.3 126.3 123.6 173.2 121.6 121.9 129.7 124.7 116.9 122.8 121.8 126.1 126.0 1.5 3.2 4.2 0.0 14.3 0.9 0.6 2.0 29.0 1.6 3.2 2.2 0.5 0.0 4.2 1.8 2.1 1.4 1.7 3.3 1.9 5.5 2.4 3.1 2.4 3.6 1.8 9.7 0.0 3.9 1.4 7.2 33.1 1.8 1.3 1.1 0.4 0.8 1.7 0.0 0.0 4.7 2.0 2.4 1.0 1.8 2.1 7.1 0.0 0.0 6.0 1.7 2.1 0.0 0.0 5.2 3.1 1.2 57.2 1.2 5.6 3.3 13.1 1.7 0.0 0.5 5.8 0.6 0.2 28.1 1.3 1.8 10.4 0.9 3.7 0.3 MRPS17 "HSPC011, MRP-S17, RPMS17" ENSG00000239789 "Mitochondrial ribosomal protein S17" Q9Y2R5 7 55951877-55956500 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 195.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047159 Approved NA NA "HPA047159: AB_2679961" "unprognostic (3.38e-1)" "unprognostic (2.71e-2)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (2.16e-2)" "unprognostic (1.94e-2)" "unprognostic (7.07e-3)" "unprognostic (1.80e-1)" "unprognostic (3.92e-1)" "unprognostic (2.86e-2)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-3)" "unprognostic (7.17e-2)" "unprognostic (2.36e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-1)" 9.1 13.7 15.5 7.9 16.0 10.3 11.3 15.7 18.5 7.2 12.7 12.5 8.9 10.0 9.3 13.6 10.2 5.1 17.4 16.7 15.5 11.6 22.3 7.0 9.1 15.2 15.1 16.7 9.6 13.7 9.8 8.4 6.6 15.8 10.4 9.9 5.7 9.1 10.6 33.2 8.0 9.2 9.4 14.2 10.2 11.7 12.0 16.0 9.2 8.2 32.9 9.4 11.1 7.9 16.6 195.1 25.3 17.4 36.6 17.3 16.9 22.0 20.6 20.3 25.0 28.4 31.0 26.0 49.3 29.6 16.9 57.9 43.3 38.6 39.3 30.1 20.7 30.0 14.7 35.8 32.2 24.9 37.4 14.5 19.4 31.6 25.0 41.2 18.3 26.5 27.8 57.9 19.2 22.6 21.8 29.9 51.4 37.4 47.7 43.2 23.9 16.8 38.9 40.4 23.4 25.7 22.6 23.4 76.1 28.5 29.6 49.9 29.3 17.9 8.3 40.8 60.2 47.8 16.7 34.2 83.2 8.4 18.9 38.2 3.6 8.7 2.7 10.5 10.7 12.7 17.1 14.4 15.2 13.3 14.2 16.1 14.3 2.3 12.5 11.0 13.2 15.5 7.9 15.5 16.0 15.7 18.5 16.7 15.5 15.2 15.1 16.7 15.8 14.2 16.0 16.6 9.6 22.4 11.7 2.6 12.3 0.0 21.3 0.0 26.7 6.7 14.3 14.4 0.0 22.8 14.2 5.5 0.0 30.4 8.7 8.2 29.4 48.1 22.6 18.5 9.5 11.3 4.9 30.9 3.5 54.5 26.2 9.9 23.0 10.0 5.1 10.3 18.9 33.7 19.2 18.5 3.9 15.5 0.0 11.6 0.0 5.5 9.3 9.1 0.0 1.0 20.6 10.6 21.6 3.0 4.6 46.0 14.8 10.9 21.3 19.9 24.2 28.9 13.8 7.0 6.6 10.0 11.2 29.2 12.0 31.2 0.0 21.3 10.7 10.8 21.8 11.9 PRAMEF11 ENSG00000239810 "PRAME family member 11" O60813 1 12824605-12831410 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-8 ENSG00000239819 "Immunoglobulin kappa variable 1D-8" A0A087WSZ0 2 90220727-90221384 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 14.3;salivary gland: 5.7" "Cell type enriched" "Detected in some" 29 "Plasma cells: 338.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 323 "memory B-cell: 32.7;naive B-cell: 31.8" "Lineage enriched" "Detected in single" 328 "B-cells: 32.7" "Cell line enriched" "Detected in some" 26 "RPMI-8226: 38.3" HPA048721 Approved "Immunoglobulin genes" NA NA 1900000000 "HPA048721: " "prognostic favorable (2.93e-4)" "unprognostic (1.03e-3)" "unprognostic (2.23e-2)" "unprognostic (2.76e-3)" "prognostic favorable (8.80e-5)" "unprognostic (6.07e-2)" "unprognostic (9.76e-3)" "unprognostic (2.67e-1)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.35e-1)" "unprognostic (9.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" 0.3 0.0 0.0 5.4 0.0 0.7 1.2 0.0 0.0 0.5 0.0 2.4 1.6 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.3 1.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 2.6 0.0 5.7 0.0 0.0 0.0 2.9 0.0 0.0 8.3 1.9 0.0 0.0 1.2 0.6 0.0 14.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 338.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DEFA3 "DEF3, HNP-3" ENSG00000239839 "Defensin alpha 3" P59666 8 7015869-7018297 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "bone marrow: 37966.0" "Cell type enhanced" "Detected in some" "B-cells: 17.9;Erythroid cells: 10.1;Hepatocytes: 17.0;Macrophages: 5.7;Plasma cells: 4.0;T-cells: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in many" 19 "neutrophil: 854.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 854.3" "Cell line enriched" "Detected in single" 8 "NB-4: 1.5" HPA052517 Supported "Secreted to blood" NA NA "HPA052517: AB_2681860" "unprognostic (8.21e-2)" 7.5 1.2 0.6 1.1 0.4 37966.0 5.0 0.4 1.1 1.1 0.9 1.1 0.0 5.6 0.0 1.0 0.7 0.2 13.9 0.3 0.3 4.2 26.3 181.8 5.3 0.5 1.3 0.2 1.3 1.6 0.0 7.7 18.9 0.6 0.8 0.0 0.2 24.3 0.0 5.0 42.5 0.7 0.0 0.6 594.1 1.8 0.6 0.7 149.3 4.5 1.1 1.3 1.1 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 24.4 3.6 44.3 1.2 1.6 2.3 1.0 0.8 1.0 1.1 6.9 0.3 854.3 0.4 2.6 1.4 0.3 6033.6 0.6 0.4 0.4 1.1 0.3 0.3 0.5 1.3 0.2 0.6 0.6 0.7 0.5 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.8 17.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 IGKV1-6 ENSG00000239855 "Immunoglobulin kappa variable 1-6" A0A0C4DH72 2 88966262-88966767 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 157.0;lymphoid tissue: 611.3" "Cell type enriched" "Detected in some" 33 "Plasma cells: 877.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.5" "Group enriched" "Detected in some" 801 "memory B-cell: 123.6;naive B-cell: 85.7" "Lineage enriched" "Detected in single" 946 "B-cells: 123.6" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 12000000000 "HPA048721: " "prognostic favorable (3.44e-5)" "unprognostic (5.25e-3)" "unprognostic (3.78e-2)" "unprognostic (8.68e-3)" "unprognostic (3.23e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.86e-3)" "unprognostic (3.86e-2)" "unprognostic (3.00e-2)" "unprognostic (5.80e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (5.23e-3)" "unprognostic (3.02e-1)" "unprognostic (2.54e-1)" "unprognostic (2.54e-1)" 4.5 1.7 0.1 84.9 0.0 37.4 50.8 0.0 1.5 16.7 0.1 157.0 111.5 4.1 4.1 23.7 5.1 18.3 5.4 0.0 0.2 7.7 6.3 20.2 82.9 0.1 0.1 0.0 4.1 1.8 0.0 1.1 0.0 0.0 4.3 147.2 0.0 95.8 2.3 0.2 0.5 59.6 5.2 0.2 211.2 131.6 0.7 0.1 23.0 16.6 0.0 611.3 146.1 8.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 123.6 0.0 0.0 0.1 85.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.1 0.1 0.0 0.0 1.5 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 877.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Guided entry of tail-anchored proteins factor 4" Q7L5D6 7 876554-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nucleoli, Mitotic chromosome" "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 24.3 98.8 28.7 12.6 30.5 31.9 27.1 27.0 37.3 27.5 17.2 33.3 21.0 25.8 21.3 44.1 32.4 11.5 32.3 26.6 27.8 69.2 99.2 25.7 15.9 33.6 31.5 27.3 34.6 46.4 13.8 71.2 20.7 33.7 38.1 8.9 16.5 29.0 12.4 56.8 46.7 33.9 7.8 28.3 37.8 41.9 79.6 29.5 14.5 34.6 22.1 10.5 31.6 29.2 43.6 78.8 38.1 25.8 38.4 13.2 9.1 81.7 21.2 14.9 26.5 26.6 103.4 95.1 28.5 21.7 12.4 73.7 48.7 29.3 23.3 11.5 11.6 50.9 15.8 31.5 59.5 29.1 27.1 28.1 13.8 27.6 23.4 15.1 19.9 21.1 32.5 103.6 25.7 15.2 59.7 20.8 65.2 93.3 46.1 56.0 43.0 4.5 30.8 23.8 45.4 46.7 50.5 19.5 71.2 32.2 31.5 54.2 47.8 21.4 19.6 43.6 45.7 29.5 38.5 25.9 37.5 20.1 46.2 50.3 22.3 28.5 32.4 23.9 27.6 23.3 24.3 26.4 24.1 29.4 24.5 25.2 27.0 21.9 27.7 35.3 33.3 26.9 24.8 28.7 30.5 27.0 37.3 26.6 27.8 33.6 31.5 27.3 33.7 28.3 29.5 43.6 0.3 0.0 3.1 14.7 10.6 1.0 0.3 0.2 14.8 0.8 1.1 0.9 0.6 0.0 2.2 0.0 4.2 1.1 0.7 2.3 0.0 0.9 4.0 2.0 1.1 1.5 0.0 9.2 9.1 0.7 0.7 3.8 36.7 2.8 1.3 1.2 0.0 0.4 0.6 8.4 9.1 2.8 0.0 0.6 0.8 2.7 0.0 6.1 0.0 4.7 0.5 0.2 0.0 10.1 15.8 0.8 1.0 0.0 37.2 0.4 3.6 1.1 2.1 1.4 0.0 0.8 1.8 0.6 1.1 23.5 1.0 1.6 9.9 0.8 1.7 0.8 IGKV1-37 "IGKV137, O14" ENSG00000239862 "Immunoglobulin kappa variable 1-37 (non-functional)" A0A075B6S9 2 89297264-89297785 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.2;lymphoid tissue: 17.4;urinary bladder: 5.6" "Cell type enriched" "Detected in some" 24 "Plasma cells: 73.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 247 "memory B-cell: 21.2;naive B-cell: 28.2" "Lineage enriched" "Detected in single" 283 "B-cells: 28.2" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA "HPA048721: " "unprognostic (3.47e-1)" "unprognostic (1.17e-1)" 0.1 0.2 0.0 2.9 0.0 0.8 2.4 0.0 0.0 0.5 0.0 4.5 3.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.4 1.2 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 2.6 0.6 0.0 0.0 2.0 0.2 0.0 3.7 1.5 0.0 0.0 0.9 0.1 0.0 17.4 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-2 KAP9.2 ENSG00000239886 "Keratin associated protein 9-2" Q9BYQ4 17 41226648-41227652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 140 "skin 1: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf226 FLJ13137 ENSG00000239887 "Chromosome 1 open reading frame 226" A1L170 1 162378841-162386812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 29.2;Early spermatids: 22.7;Hepatocytes: 30.0;Late spermatids: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 14.0;HEL: 18.4;OE19: 16.0" "Low region specificity" "Detected in all" "HPA052251, HPA074060" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052251: AB_2681775, HPA074060: " "prognostic favorable (2.60e-4)" "unprognostic (1.30e-1)" "unprognostic (2.69e-2)" "unprognostic (1.59e-2)" "unprognostic (6.71e-3)" "unprognostic (9.80e-2)" "unprognostic (8.55e-2)" "unprognostic (1.65e-1)" "unprognostic (2.05e-1)" "unprognostic (4.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-3)" "prognostic favorable (4.44e-5)" "unprognostic (9.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.13e-4)" 1.9 9.7 3.6 1.1 4.0 2.0 8.2 4.8 3.0 3.8 4.8 8.8 5.6 2.5 2.4 4.2 3.2 3.4 2.8 3.8 4.4 8.4 22.1 2.5 0.4 7.4 5.5 3.0 1.2 3.7 4.1 9.9 2.4 5.0 4.9 9.8 7.0 8.6 7.8 0.6 4.9 8.0 2.5 6.1 0.6 8.7 4.1 4.2 0.4 0.8 0.6 1.5 2.5 2.2 7.9 14.0 0.9 13.1 8.9 0.4 0.0 0.2 0.9 1.4 0.8 0.5 2.0 7.2 0.0 9.5 0.3 4.7 10.3 3.7 0.9 0.7 0.1 4.4 18.4 0.8 10.2 0.3 0.0 0.0 1.4 1.1 0.0 0.5 3.9 3.2 2.3 1.7 0.1 0.2 5.6 0.5 0.0 6.3 16.0 7.5 0.3 2.2 0.0 12.1 7.0 5.9 3.7 4.6 1.6 3.1 5.3 5.7 0.9 3.1 0.1 1.4 0.1 4.0 6.3 0.0 0.0 2.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.0 4.8 3.0 3.8 4.4 7.4 5.5 3.0 5.0 6.1 4.2 7.9 2.5 3.2 2.6 0.3 0.1 0.8 1.7 1.1 0.6 0.8 10.3 14.9 3.4 4.3 2.4 14.7 29.2 0.1 0.1 11.6 0.0 0.9 22.7 2.6 1.1 2.2 2.4 0.0 2.8 2.3 0.1 0.7 0.0 4.2 0.0 3.4 4.2 30.0 0.1 6.7 1.8 11.6 4.1 1.0 0.7 38.4 2.1 0.1 0.0 3.7 0.0 5.0 0.0 6.6 3.7 1.7 3.6 1.9 0.0 2.6 7.7 0.2 2.7 0.4 0.0 0.2 0.6 1.1 0.9 0.6 1.4 0.1 0.3 0.5 7.1 2.5 ADSL ENSG00000239900 "Adenylosuccinate lyase" P30566 22 40346461-40390463 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Lyase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "skeletal muscle: 348.4;tongue: 244.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000525, CAB019285" Enhanced Enhanced Cytosol NA NA 440000 Cytosol "CAB019285: , HPA000525: AB_1078106" "unprognostic (2.80e-1)" "unprognostic (2.12e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.64e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "prognostic unfavorable (5.81e-8)" "unprognostic (1.35e-1)" "unprognostic (1.25e-1)" "unprognostic (3.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (8.43e-2)" "unprognostic (2.70e-1)" "unprognostic (4.06e-1)" "unprognostic (1.44e-2)" 28.8 34.1 11.2 31.3 11.8 40.9 33.5 13.1 13.4 30.3 12.7 33.9 22.9 35.2 22.1 30.1 33.8 20.8 46.1 12.0 11.4 34.0 32.4 22.9 47.3 11.1 11.4 11.9 33.8 45.6 29.5 22.2 30.5 11.5 24.0 35.7 10.3 25.9 22.5 348.4 21.7 29.0 41.5 10.8 33.7 28.2 29.4 11.1 50.9 29.8 244.4 48.9 36.4 25.4 11.8 98.0 110.2 88.3 124.9 62.6 89.5 106.5 82.0 85.2 187.3 138.1 189.0 51.9 279.0 73.2 102.3 84.9 67.3 203.5 137.4 187.7 75.3 197.5 126.5 98.4 166.5 134.6 423.0 96.3 97.7 76.5 161.5 169.8 91.3 138.9 127.3 153.1 114.3 136.4 105.0 130.2 131.2 152.5 121.3 119.3 195.1 203.6 198.2 118.9 67.8 58.8 54.4 106.2 54.1 170.7 78.5 76.8 134.7 91.2 93.3 173.7 85.3 168.8 109.0 212.6 218.2 80.9 149.5 97.7 29.0 47.2 19.9 35.5 55.2 49.5 34.6 76.1 48.5 68.1 33.5 58.3 45.0 4.1 48.2 49.7 34.4 81.7 62.3 11.2 11.8 13.1 13.4 12.0 11.4 11.1 11.4 11.9 11.5 10.8 11.1 11.8 10.0 12.8 10.8 9.4 28.3 18.1 18.8 48.6 23.9 16.1 14.8 15.0 30.0 30.0 20.8 3.7 37.5 85.3 15.5 13.0 7.9 61.3 44.0 5.6 9.2 21.6 13.8 54.6 11.4 43.7 78.9 21.2 21.4 5.6 36.8 8.8 28.9 25.6 60.3 6.7 10.7 24.1 24.4 44.8 26.7 25.2 24.8 22.7 12.4 1.0 41.9 45.1 19.6 9.5 9.8 33.7 15.6 14.3 52.4 21.3 21.4 19.7 12.3 18.1 26.3 38.5 20.8 61.2 82.8 35.7 15.2 33.1 32.2 8.7 37.7 14.1 IGKV3-20 ENSG00000239951 "Immunoglobulin kappa variable 3-20" P01619 2 89142574-89143160 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 3110.0;lymphoid tissue: 5290.0" "Cell type enriched" "Detected in some" 138 "Plasma cells: 52154.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 329 "memory B-cell: 1602.7;naive B-cell: 1222.4" "Lineage enriched" "Detected in many" 373 "B-cells: 1602.7" "Group enriched" "Detected in many" 215 "U-266/70: 3769.9;U-266/84: 1732.3" HPA047702 Approved "Immunoglobulin genes" NA NA 20000000000 "HPA047702: " "prognostic favorable (1.86e-4)" "unprognostic (4.16e-2)" "unprognostic (1.64e-2)" "unprognostic (1.97e-2)" "unprognostic (1.13e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-1)" "unprognostic (1.37e-1)" "unprognostic (3.93e-3)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (7.35e-2)" "unprognostic (5.08e-1)" "unprognostic (6.64e-2)" "unprognostic (2.70e-2)" 81.9 56.9 0.9 1808.2 1.2 383.7 743.7 0.6 4.2 329.7 2.7 3110.0 1729.8 59.6 7.8 304.8 106.1 643.2 56.1 0.6 11.7 104.6 114.5 458.1 2840.2 2.2 5.9 0.5 154.8 33.1 5.9 9.7 1.8 1.8 56.6 2757.4 0.2 1282.2 226.7 3.3 13.5 1367.1 83.5 10.0 2720.7 1425.6 24.9 1.4 677.6 226.2 1.8 5290.0 1657.9 70.6 1.4 2.5 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.5 0.0 2.1 0.0 0.0 0.0 6.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 2.0 5.9 2.8 0.0 0.0 3.0 6.0 10.4 0.0 0.0 7.7 12.8 1.4 0.0 0.1 0.0 0.0 0.8 4.4 0.0 2.0 1.5 4.3 3769.9 1732.3 1.8 0.0 2.3 0.0 4.0 1.2 0.7 0.7 0.4 0.8 1602.7 0.8 0.6 3.5 1222.4 0.4 0.7 4.2 0.8 1.0 0.9 0.8 196.9 0.9 1.2 0.6 4.2 0.6 11.7 2.2 5.9 0.5 1.8 10.0 1.4 1.4 0.1 3.2 1.3 0.0 376.9 0.0 0.0 0.0 5.2 0.0 0.1 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 9.4 0.0 0.0 0.0 55.3 124.4 0.0 1.3 0.0 3.6 5.0 0.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 52154.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 26.7 0.0 0.2 0.0 LILRA4 "CD85g, ILT7" ENSG00000239961 "Leukocyte immunoglobulin like receptor A4" P59901 19 54333185-54339162 "CD markers, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 11.0" "Cell type enriched" "Detected in some" 26 "dendritic cells: 336.0" "Cancer enhanced" "Detected in many" "glioma: 2.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 21 "plasmacytoid DC: 176.1" "Lineage enriched" "Detected in many" 21 "dendritic cells: 176.1" "Not detected" "Not detected" HPA049418 Approved NA NA 12000000 "HPA049418: AB_2680756" "unprognostic (5.11e-2)" "unprognostic (1.21e-4)" "unprognostic (2.65e-2)" "unprognostic (5.94e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-3)" "unprognostic (7.62e-2)" "unprognostic (1.36e-3)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (9.30e-2)" "unprognostic (8.28e-7)" "unprognostic (2.12e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-1)" "unprognostic (5.86e-2)" 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.7 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.5 11.0 0.0 0.1 0.4 0.0 0.0 0.0 2.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 1.1 3.9 0.0 0.0 0.0 0.4 0.0 176.1 0.0 1.1 0.2 0.3 0.3 0.3 0.2 0.3 0.7 0.5 0.1 0.6 0.5 0.4 0.7 0.0 0.0 0.6 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 336.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.0 1.6 0.0 0.0 5.9 0.0 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.1 IGKV1D-33 ENSG00000239975 "Immunoglobulin kappa variable 1D-33" P01593 2 89913982-89916052 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 63.5;salivary gland: 73.9" "Cell type enriched" "Detected in some" 410 "Plasma cells: 5131.4" "Cancer enhanced" "Detected in many" "stomach cancer: 5.0" "Region enriched" "Detected in single" 11 "midbrain: 6.9" "Group enriched" "Detected in some" 116 "memory B-cell: 6.3;naive B-cell: 16.8" "Lineage enriched" "Detected in single" 169 "B-cells: 16.8" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 4900000000 "HPA048721: " "unprognostic (5.10e-3)" "unprognostic (2.03e-1)" "unprognostic (2.11e-2)" "unprognostic (2.03e-4)" "unprognostic (7.90e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-2)" 1.8 0.5 0.0 3.9 0.1 2.3 8.4 0.0 0.1 2.3 0.1 18.6 1.4 1.4 0.0 4.7 2.8 2.7 0.2 0.1 0.6 3.9 2.2 18.0 6.8 0.1 6.9 0.0 0.4 0.5 0.0 0.1 0.0 0.0 1.6 2.1 0.0 73.9 8.6 0.0 0.3 19.3 0.0 0.4 63.5 21.4 0.1 0.0 4.8 3.3 0.2 9.1 16.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.1 0.6 0.1 6.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5131.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 LILRA2 "CD85h, ILT1, LIR-7, LIR7" ENSG00000239998 "Leukocyte immunoglobulin like receptor A2" Q8N149 19 54572920-54590287 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.6;lymphoid tissue: 57.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 22.0;Kupffer cells: 79.9;Macrophages: 39.1;monocytes: 48.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 31.6" "Group enriched" "Detected in many" 6 "granulocytes: 31.6;monocytes: 11.6" "Cell line enhanced" "Detected in some" "NB-4: 1.7;REH: 2.0;THP-1: 4.0;U-937: 9.1" "Secreted to blood" NA NA 140000000 "unprognostic (2.04e-1)" "unprognostic (7.72e-2)" "unprognostic (6.94e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (2.65e-2)" "unprognostic (8.45e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-1)" "unprognostic (3.53e-5)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (5.43e-2)" "unprognostic (5.58e-2)" "unprognostic (3.30e-4)" "unprognostic (4.21e-2)" "unprognostic (6.59e-2)" 4.4 3.2 1.1 2.9 1.3 15.6 1.8 1.2 1.5 0.7 1.1 1.4 0.2 1.0 0.2 0.9 4.0 0.4 1.9 1.2 1.3 1.3 3.4 10.3 0.2 1.8 1.3 0.9 0.8 1.4 0.1 0.8 0.2 2.0 1.4 0.2 0.2 1.7 0.1 0.5 0.6 1.7 0.4 2.0 57.9 1.6 0.8 1.7 0.2 0.8 0.3 0.3 2.2 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.1 0.0 5.3 7.6 3.0 0.1 11.6 0.1 0.1 0.1 0.1 3.3 0.3 0.1 0.1 31.6 0.4 11.3 0.7 0.1 6.1 1.1 1.3 1.2 1.5 1.2 1.3 1.8 1.3 0.9 2.0 2.0 1.7 2.0 0.2 3.2 3.0 0.0 0.3 0.3 1.6 0.0 0.0 0.9 0.4 0.1 0.5 1.5 1.8 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.8 0.0 0.2 0.2 0.6 0.0 0.1 6.3 0.1 0.4 0.4 22.0 0.0 0.0 0.0 0.0 79.9 5.9 0.6 0.0 39.1 0.0 8.4 48.7 0.0 2.1 0.0 0.1 0.0 0.0 0.0 1.1 1.0 0.0 0.1 1.5 0.6 0.0 2.1 0.3 0.3 0.3 0.0 0.1 0.4 1.4 0.0 0.0 0.6 TEX35 "C1orf49, DKFZP564J047, TSC24" ENSG00000240021 "Testis expressed 35" Q5T0J7 1 178513109-178548602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 118.9" "Group enriched" "Detected in some" 137 "Early spermatids: 1312.2;Late spermatids: 2214.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039190 Approved NA NA "HPA039190: AB_10794425" "unprognostic (2.20e-1)" "unprognostic (1.77e-2)" "unprognostic (1.26e-1)" "unprognostic (1.89e-2)" "unprognostic (8.92e-3)" "unprognostic (1.08e-2)" "unprognostic (7.04e-2)" "unprognostic (9.60e-2)" "unprognostic (1.21e-1)" "unprognostic (2.51e-3)" "unprognostic (2.01e-2)" "unprognostic (1.92e-1)" "unprognostic (5.23e-1)" "unprognostic (5.41e-2)" 0.3 0.2 1.9 0.3 3.0 2.2 0.6 9.4 3.1 0.2 0.0 0.3 1.6 0.5 1.4 0.4 0.2 0.3 0.6 2.0 1.2 0.2 0.2 0.4 0.6 1.3 0.9 2.2 0.7 0.4 0.4 0.0 0.5 4.5 0.5 0.6 2.0 0.3 0.2 0.3 2.2 0.4 0.3 0.0 0.8 1.6 118.9 1.4 0.3 0.5 0.3 0.4 0.3 0.1 4.9 0.2 0.1 0.1 0.5 0.3 0.9 2.8 0.1 0.2 0.2 0.1 0.0 0.3 0.4 0.2 0.3 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.1 0.2 0.1 0.0 0.2 0.7 0.3 0.1 0.3 0.2 0.4 0.1 0.2 0.3 0.5 0.9 0.0 0.1 0.3 0.0 0.2 0.4 0.4 0.2 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.7 0.4 0.3 0.5 0.1 0.7 0.6 0.2 0.3 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.9 3.0 9.4 3.1 2.0 1.2 1.3 0.9 2.2 4.5 0.0 1.4 4.9 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1312.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2214.6 8.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 11.5 7.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 AMY2B AMY2 ENSG00000240038 "Amylase alpha 2B" P19961 1 103553815-103579534 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 122 "pancreas: 31512.9" "Cell type enhanced" "Detected in many" "Astrocytes: 56.2;Excitatory neurons: 61.2;Exocrine glandular cells: 148.0;Inhibitory neurons: 48.4;Oligodendrocytes: 41.8" "Cancer enriched" "Detected in many" 15 "pancreatic cancer: 25.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.8;EFO-21: 10.3" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 77000000 "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (8.69e-4)" "unprognostic (3.71e-3)" "unprognostic (6.41e-2)" "unprognostic (9.75e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-4)" "unprognostic (1.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (2.49e-2)" "unprognostic (7.41e-3)" "unprognostic (1.55e-2)" "unprognostic (5.74e-2)" "unprognostic (4.22e-1)" "unprognostic (3.12e-4)" 32.9 25.0 32.5 11.3 38.3 13.5 35.2 43.6 37.3 38.0 23.6 28.5 16.7 22.9 20.4 13.2 50.8 14.2 40.3 31.5 32.4 59.5 39.3 30.5 20.1 32.8 32.7 30.7 40.3 31512.9 15.0 37.1 7.0 34.2 35.6 12.0 70.4 258.5 14.8 64.2 43.0 32.0 9.9 29.0 35.0 18.3 5.2 32.3 12.7 64.0 25.4 14.0 29.6 26.0 33.1 0.0 0.5 1.1 0.0 5.6 9.8 1.1 0.8 0.8 0.6 1.5 0.0 0.2 1.0 10.3 0.3 0.0 1.2 0.1 1.3 1.4 1.3 1.6 1.9 4.5 0.8 0.8 2.5 2.6 6.7 6.7 0.8 1.2 1.8 0.2 3.0 0.0 3.2 0.9 0.0 1.9 0.5 0.1 0.1 1.4 0.5 0.0 4.7 5.7 2.0 2.8 0.6 2.4 1.1 0.8 1.8 0.1 1.4 0.8 0.3 0.9 0.5 0.7 3.5 0.1 0.3 1.9 1.8 0.2 0.0 5.0 1.0 0.4 2.5 0.3 1.0 0.1 0.2 1.6 0.9 0.6 0.2 1.2 0.1 2.2 0.5 0.2 1.2 32.5 38.3 43.6 37.3 31.5 32.4 32.8 32.7 30.7 34.2 29.0 32.3 33.1 2.8 12.8 20.1 56.2 3.2 4.7 4.2 1.4 0.6 11.7 2.9 2.7 7.2 2.8 11.2 1.8 33.3 0.4 2.4 3.6 0.0 1.3 7.3 1.1 0.6 2.7 4.9 1.3 61.2 148.0 0.4 3.2 2.0 0.7 3.8 0.5 2.2 6.5 1.6 10.1 48.4 2.5 0.0 9.4 3.5 2.7 2.5 3.4 5.4 11.2 4.0 3.1 2.1 22.1 41.8 1.3 2.7 1.9 1.4 1.5 4.3 0.8 14.6 15.4 0.0 1.0 2.5 1.5 0.9 0.4 3.0 0.3 1.7 0.4 2.2 1.6 IGHJ4 ENSG00000240041 "Immunoglobulin heavy joining 4" 14 105864215-105864260 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 421.2;lymphoid tissue: 1582.1;urinary bladder: 556.5" "Cell type enriched" "Detected in single" 148 "Plasma cells: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 187 "memory B-cell: 6029.7;naive B-cell: 2618.0" "Lineage enriched" "Detected in all" 261 "B-cells: 6029.7" "Cell line enriched" "Detected in some" 87 "U-698: 3990.3" NA NA 0.0 0.0 7.1 0.0 3.5 0.0 242.7 0.9 10.9 0.0 2.8 381.0 0.0 0.0 0.0 201.9 7.4 4.1 12.5 1.1 32.2 0.0 39.4 0.0 0.0 6.8 38.0 0.8 0.0 0.0 13.7 0.0 2.5 21.5 7.1 421.2 0.0 0.0 0.0 0.0 20.8 0.0 0.0 2.0 45.8 7.3 3.7 2.0 32.6 3.9 0.0 1582.1 556.5 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 14.0 17.5 0.0 0.0 0.0 0.0 6.8 3.6 0.0 0.0 0.0 0.0 0.0 8.9 0.0 45.8 0.0 0.0 6.2 0.0 3990.3 0.0 12.2 0.0 13.9 3.6 5.4 5.0 1.3 3.0 6029.7 13.2 4.0 23.1 2618.0 1.5 6.0 20.1 3.3 6.0 0.0 6.6 1048.2 7.1 3.5 0.9 10.9 1.1 32.2 6.8 38.0 0.8 21.5 2.0 2.0 5.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRIT1 DWORF ENSG00000240045 "Small transmembrane regulator of ion transport 1" P0DN84 3 155290227-155293683 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "skeletal muscle: 1725.4;tongue: 704.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1;prostate cancer: 1.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" NA NA "unprognostic (6.77e-4)" "unprognostic (1.60e-2)" "unprognostic (6.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.82e-3)" "unprognostic (1.33e-2)" 0.4 0.1 3.3 0.2 12.2 0.2 0.5 3.8 3.5 0.0 2.7 0.2 6.3 0.2 0.5 14.2 0.1 0.5 5.6 3.1 2.3 5.9 0.3 0.2 0.3 3.2 4.4 3.2 0.1 0.3 0.1 0.1 0.1 3.5 12.2 0.2 0.3 8.8 0.1 1725.4 1.3 3.6 0.0 2.5 0.2 0.2 0.2 4.7 0.0 0.4 704.6 0.1 0.0 0.1 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 12.2 3.8 3.5 3.1 2.3 3.2 4.4 3.2 3.5 2.5 4.7 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6G5B "C6orf19, G5b" ENSG00000240053 "Lymphocyte antigen 6 family member G5B" Q8NDX9 6 31670167-31673776 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA048307 Approved "Secreted to blood" NA NA "HPA048307: AB_2680348" "unprognostic (2.69e-2)" "unprognostic (1.52e-1)" "unprognostic (8.53e-2)" "unprognostic (1.44e-2)" "unprognostic (5.80e-2)" "unprognostic (9.85e-3)" "unprognostic (5.04e-3)" "unprognostic (8.34e-3)" "unprognostic (5.45e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-4)" "unprognostic (7.27e-3)" "unprognostic (1.98e-5)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (3.00e-2)" "unprognostic (3.98e-4)" 25.1 13.6 2.5 9.6 2.9 30.1 26.1 6.6 7.2 25.7 2.5 24.6 6.9 25.2 11.2 15.9 25.3 6.4 13.8 2.9 3.9 15.6 15.1 28.1 12.2 3.1 3.0 2.3 33.5 14.7 2.8 21.0 8.3 4.8 22.3 11.5 11.4 20.4 7.5 15.5 44.0 28.1 9.5 2.2 30.8 19.3 13.1 3.3 7.8 24.9 3.3 13.2 21.3 20.6 3.4 5.4 5.8 11.4 15.5 2.6 5.5 14.5 10.4 3.3 7.3 7.2 7.1 6.8 12.9 2.8 13.0 4.7 8.6 2.7 13.7 11.6 5.2 18.0 12.4 8.1 5.7 2.2 15.6 9.9 11.8 7.9 10.7 5.0 10.3 3.9 9.7 7.7 7.8 5.0 4.9 8.4 12.0 6.4 1.5 2.6 11.8 3.5 5.7 3.4 14.7 8.0 12.9 4.7 1.8 3.6 13.9 4.7 10.3 7.6 14.2 7.5 6.6 2.6 13.6 10.1 11.5 5.1 14.6 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 6.6 7.2 2.9 3.9 3.1 3.0 2.3 4.8 2.2 3.3 3.4 0.3 3.2 0.0 0.0 1.4 1.0 1.2 0.7 0.0 1.1 0.7 0.3 0.1 1.5 0.2 0.0 0.0 0.4 0.8 0.6 0.0 0.1 0.0 0.4 0.8 0.5 1.2 0.0 0.5 0.2 0.4 0.9 1.1 1.1 0.0 1.2 0.4 0.4 0.5 0.0 0.6 0.9 0.0 0.0 2.2 0.0 0.6 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.6 1.1 1.8 0.0 0.1 2.3 0.0 1.5 0.8 0.1 0.3 0.4 1.3 0.5 1.4 0.4 1.0 0.8 PSMB9 "beta1i, LMP2, PSMB6i, RING12" ENSG00000240065 "Proteasome 20S subunit beta 9" P28065 6 32844136-32859851 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 162.2" "Cell type enhanced" "Detected in many" "monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015180, HPA042818, HPA053280" Enhanced Supported Cytosol NA NA 340000 Cytosol "CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098" "unprognostic (1.09e-2)" "unprognostic (1.68e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-3)" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (5.68e-2)" "unprognostic (6.67e-2)" "unprognostic (1.56e-2)" "unprognostic (6.50e-3)" "unprognostic (1.87e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.96e-3)" "unprognostic (5.99e-2)" 47.1 31.3 4.3 18.6 4.9 7.0 41.7 4.0 5.5 27.2 2.7 31.1 10.3 27.0 2.3 25.9 26.2 4.8 27.0 4.2 5.9 36.5 37.7 60.7 26.4 6.6 4.5 3.4 18.3 12.2 1.5 14.1 3.4 5.7 26.7 8.8 1.3 20.5 5.0 12.0 26.2 78.7 5.8 4.9 162.2 26.8 5.0 5.2 15.2 28.9 3.9 22.3 23.8 31.1 6.9 5.5 0.3 0.0 0.2 3.4 8.5 3.0 0.7 11.5 17.3 27.7 0.0 3.1 40.8 1.3 2.9 14.3 10.0 0.2 5.8 2.6 9.3 0.1 17.6 0.7 0.8 17.3 1.8 2.2 2.1 0.3 7.0 1.0 3.3 2.7 10.1 1.4 12.8 1.9 1.0 16.1 8.0 0.0 0.0 0.8 19.0 1.2 7.4 2.1 2.5 0.0 0.0 1.0 2.1 10.7 0.0 4.4 10.3 0.0 2.5 1.6 14.7 1.2 11.3 23.9 9.3 7.5 6.8 4.0 92.7 30.3 75.6 56.1 55.8 45.9 59.7 45.1 55.9 26.6 45.3 41.0 49.6 96.3 61.5 60.9 20.5 61.0 46.2 4.3 4.9 4.0 5.5 4.2 5.9 6.6 4.5 3.4 5.7 4.9 5.2 6.9 258.6 41.7 51.1 1.3 197.2 72.5 37.4 155.6 30.1 2.4 25.3 47.0 7.3 50.1 64.8 25.8 0.0 1.5 216.2 88.0 19.6 116.6 1.3 28.9 47.5 146.5 33.5 29.9 0.0 115.6 6.6 45.1 34.1 42.6 77.3 20.0 119.6 26.6 117.2 0.0 0.1 148.0 99.7 126.8 155.7 2.1 29.2 145.2 35.6 8.4 323.0 22.7 495.4 0.5 8.3 67.8 150.3 15.8 136.1 40.4 318.5 40.5 133.7 1.7 32.9 23.1 50.8 1.5 7.4 21.0 58.7 1.4 241.8 45.3 110.6 39.1 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512977 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 310.5" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 8.0;Bipolar cells: 8.4;Endometrial stromal cells: 5.5;Fibroblasts: 10.2;Horizontal cells: 11.8;Skeletal myocytes: 6.6" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 24 "plasmacytoid DC: 15.3" "Lineage enriched" "Detected in single" 24 "dendritic cells: 15.3" "Cell line enhanced" "Detected in many" "ASC diff: 200.7;HSkMC: 186.2;U-138 MG: 244.1;WM-115: 382.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" NA NA 1200000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832" "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (6.00e-4)" 62.3 64.8 224.3 15.5 211.8 0.2 60.4 203.1 310.5 106.3 146.8 50.9 7.5 82.0 61.4 55.0 63.2 30.5 78.3 214.6 218.5 35.8 29.7 102.8 9.6 238.4 216.3 186.1 65.6 35.0 37.1 79.6 37.4 241.1 66.6 20.6 36.6 46.7 41.1 27.9 64.4 32.3 39.8 197.4 22.4 39.0 22.2 237.6 15.9 46.1 26.5 14.9 61.1 80.7 201.4 12.8 7.7 48.1 14.0 200.7 178.3 0.6 58.6 162.6 30.9 32.5 0.0 12.7 43.5 39.7 108.0 111.7 46.2 6.1 20.7 28.2 0.2 20.0 0.1 1.2 1.2 62.6 0.5 1.5 186.2 31.6 46.9 37.2 104.2 19.7 0.0 0.2 1.6 79.2 24.8 1.0 5.4 2.3 0.8 0.1 30.0 97.1 0.4 17.9 13.7 16.6 69.8 17.3 0.6 115.9 16.8 40.0 66.9 22.1 244.1 12.2 46.7 72.2 0.1 0.6 0.7 60.3 0.1 382.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.3 0.0 0.1 224.3 211.8 203.1 310.5 214.6 218.5 238.4 216.3 186.1 241.1 197.4 237.6 201.4 2.5 0.0 0.0 0.0 0.3 0.3 0.5 0.3 8.0 8.4 0.2 1.1 0.8 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.2 1.4 0.3 5.5 1.9 0.0 0.0 0.0 0.2 0.2 10.2 0.0 0.5 0.0 0.2 1.1 0.0 0.3 11.8 0.0 0.2 0.0 0.3 0.3 0.7 1.2 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.6 0.0 0.1 0.0 1.0 0.0 6.6 1.7 1.6 0.0 3.9 0.1 0.7 0.1 3.5 0.0 0.5 SMKR1 ENSG00000240204 "Small lysine rich protein 1" H3BMG3 7 129502531-129512918 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "testis: 124.5" "Group enriched" "Detected in many" 50 "Early spermatids: 1894.5;Late spermatids: 6100.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 19.7;SCLC-21H: 32.8" "Low region specificity" "Detected in all" HPA078358 Approved Nucleoli NA NA Nucleoli "HPA078358: AB_2686883" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (9.24e-2)" "unprognostic (4.05e-2)" "unprognostic (2.00e-1)" "unprognostic (6.30e-2)" "unprognostic (1.72e-6)" "unprognostic (1.67e-2)" "unprognostic (1.11e-2)" "unprognostic (6.40e-2)" "unprognostic (3.67e-2)" 0.2 1.1 5.0 0.4 5.9 0.1 1.9 4.3 5.9 0.5 4.1 0.1 0.4 0.3 1.4 0.4 6.6 0.2 0.0 5.4 5.3 0.7 0.1 0.4 0.9 4.5 4.7 5.3 0.2 2.3 6.4 6.1 0.2 5.0 0.4 0.2 0.7 0.2 0.3 0.1 0.4 0.4 0.1 4.4 0.5 0.4 124.5 5.8 0.3 0.7 0.1 0.8 0.2 0.2 5.3 13.4 13.0 0.4 11.1 0.0 0.0 0.1 0.0 0.4 1.1 1.1 0.1 3.4 0.0 1.1 0.7 7.2 1.6 2.3 0.1 1.6 12.6 1.3 0.0 2.5 0.0 2.3 0.2 8.2 0.1 5.5 3.3 2.3 1.4 0.4 7.9 0.7 0.3 0.6 19.7 2.5 1.2 1.5 3.4 11.2 1.3 0.0 2.9 4.7 0.0 32.8 9.0 9.6 1.1 0.8 2.1 3.0 1.7 0.1 0.0 0.3 7.3 2.8 3.2 4.5 0.2 4.5 0.5 0.9 0.0 0.0 0.0 1.3 0.0 0.6 1.0 0.2 0.7 0.0 0.8 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.1 5.0 5.9 4.3 5.9 5.4 5.3 4.5 4.7 5.3 5.0 4.4 5.8 5.3 0.1 3.2 0.0 1.0 6.4 0.1 2.2 1.1 2.2 1.4 8.9 10.9 0.3 0.0 1.4 5.5 0.0 0.0 7.7 0.1 9.8 2.3 1894.5 21.1 0.3 1.9 9.0 0.4 2.9 6.2 0.3 1.0 1.5 0.9 0.0 2.1 0.7 0.0 0.1 0.0 2.3 0.0 4.1 0.3 0.4 6100.1 37.6 2.3 1.8 0.0 0.8 1.1 40.2 0.5 0.3 3.0 0.0 27.4 2.4 5.3 0.0 1.9 12.6 0.6 0.0 1.1 0.7 78.8 29.7 1.4 0.3 0.1 5.3 0.1 0.2 1.2 UGT1A5 UGT1E ENSG00000240224 "UDP glucuronosyltransferase family 1 member A5" P35504 2 233712992-233773299 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 2.4;intestine: 7.5;liver: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.18e-3)" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX19 MGC104475 ENSG00000240230 "Cytochrome c oxidase assembly factor COX19" Q49B96 7 898778-975549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021226 Approved Supported Cytosol NA NA Cytosol "HPA021226: AB_1847176" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (1.05e-2)" "unprognostic (3.76e-2)" "unprognostic (5.22e-2)" "unprognostic (1.05e-1)" "unprognostic (2.13e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-1)" "unprognostic (5.60e-2)" "unprognostic (4.79e-2)" "unprognostic (3.36e-2)" "unprognostic (2.37e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-1)" "unprognostic (2.74e-1)" "unprognostic (9.14e-3)" 4.4 12.4 4.6 3.2 4.7 6.8 4.4 6.0 4.8 5.1 2.4 6.3 5.3 4.8 2.3 5.8 6.8 2.0 4.6 4.2 3.8 6.2 5.9 5.0 4.5 4.8 4.3 4.2 5.5 7.6 6.5 6.0 2.8 5.6 6.2 3.5 2.9 6.0 2.8 7.6 7.8 7.4 2.4 4.0 7.6 6.0 4.0 4.2 3.8 5.6 4.9 3.5 5.1 4.8 7.0 13.9 3.7 4.1 5.2 3.1 4.4 7.8 6.1 4.4 5.2 4.3 9.6 7.6 6.8 2.0 3.7 8.2 9.1 4.3 4.2 4.1 2.1 7.2 3.0 4.5 7.1 9.8 7.3 6.8 5.1 9.7 4.0 9.2 5.8 3.3 6.9 9.0 5.7 3.4 9.0 3.1 8.6 10.6 16.3 8.6 7.4 0.9 3.3 4.6 6.0 5.4 5.4 3.5 14.4 12.0 6.7 7.2 17.1 4.2 5.2 7.6 6.0 9.5 7.1 5.2 6.6 4.6 10.4 8.7 9.4 5.2 8.3 5.8 5.1 5.9 6.6 6.1 5.2 4.5 6.1 7.5 7.2 5.0 5.4 5.5 7.9 5.9 4.4 4.6 4.7 6.0 4.8 4.2 3.8 4.8 4.3 4.2 5.6 4.0 4.2 7.0 25.4 12.8 21.4 6.2 35.4 24.6 35.9 37.7 19.4 19.3 21.7 19.2 14.2 31.5 24.1 31.3 12.5 27.8 49.7 29.9 15.6 34.9 7.4 58.4 23.8 23.5 44.9 17.2 13.1 34.0 41.8 19.0 17.3 49.3 34.9 28.1 25.0 31.0 26.1 15.2 13.3 32.6 36.7 24.9 28.5 2.7 19.6 29.4 21.4 13.1 46.6 33.3 64.9 6.6 22.7 49.6 31.7 14.3 20.8 36.8 37.7 25.8 36.2 27.0 6.6 18.7 23.2 19.2 32.7 21.4 25.7 41.9 39.5 30.9 32.2 45.3 DEFA1B ENSG00000240247 "Defensin alpha 1B" P59665 8 6996766-6999195 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 878.7" "Cell type enriched" "Detected in single" 37 "T-cells: 3.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052517 Supported "Secreted to blood" NA NA "HPA052517: AB_2681860" 1.9 0.3 0.1 0.8 0.1 878.7 1.1 0.1 2.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.9 0.2 0.1 0.9 9.2 52.6 0.0 0.2 0.6 0.1 0.3 0.1 0.0 1.4 7.3 0.4 0.1 0.0 0.1 9.5 0.0 0.8 0.2 0.2 0.0 0.1 151.6 0.6 0.1 0.3 28.0 1.2 5.8 1.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.2 0.1 0.2 0.6 0.1 0.4 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 ACAD11 FLJ12592 ENSG00000240303 "Acyl-CoA dehydrogenase family member 11" Q709F0 3 132558138-132660082 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 65.0;liver: 104.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Erythroid cells: 5.7;Plasma cells: 7.6;Syncytiotrophoblasts: 9.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048317 Enhanced NA NA "HPA048317: AB_2680354" "unprognostic (5.04e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (3.31e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-4)" "unprognostic (1.20e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (5.90e-2)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (1.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.71e-2)" "unprognostic (2.93e-1)" 16.4 7.7 8.9 2.8 10.1 7.9 6.1 8.5 13.4 8.1 20.1 6.3 17.2 8.1 6.8 4.0 8.6 4.0 15.6 8.0 9.8 65.0 104.5 5.8 3.3 9.7 8.8 7.8 10.0 8.2 8.9 9.8 9.9 9.9 6.7 3.4 11.8 5.7 6.0 4.3 5.8 15.9 6.4 8.9 4.4 4.8 8.3 8.9 4.6 6.5 2.0 3.2 5.5 6.5 10.7 5.8 5.2 10.5 13.6 23.2 17.9 10.5 13.6 21.0 8.0 10.5 19.3 2.1 3.9 7.6 7.7 9.0 4.3 8.0 11.9 12.7 6.7 5.6 4.3 5.5 18.1 23.0 4.7 4.1 12.2 8.9 11.0 27.2 18.6 7.9 5.0 2.3 8.2 11.2 7.8 3.0 3.2 6.2 2.8 5.2 3.3 8.4 6.4 18.0 3.8 4.1 6.7 10.5 5.0 28.5 10.9 10.5 3.4 6.5 6.3 3.9 3.6 4.8 6.7 2.3 4.0 8.4 1.6 5.2 0.0 0.2 0.0 0.6 0.4 0.5 0.6 0.6 0.3 0.2 0.6 1.4 0.7 0.0 0.9 0.3 0.9 0.3 0.2 8.9 10.1 8.5 13.4 8.0 9.8 9.7 8.8 7.8 9.9 8.9 8.9 10.7 1.4 6.4 3.2 0.0 2.1 0.1 0.2 0.7 2.8 0.9 0.6 0.4 0.0 0.0 0.8 0.0 0.0 4.2 0.8 0.4 0.0 0.8 0.6 1.5 2.0 1.0 4.8 5.7 0.0 1.1 0.9 1.6 0.0 0.8 1.3 1.5 0.4 3.9 0.7 0.0 0.0 0.5 0.0 0.8 0.2 0.2 0.6 0.8 0.0 0.0 2.3 0.6 4.1 0.0 0.0 0.4 0.2 0.7 7.6 0.2 4.4 1.6 1.0 2.9 0.0 0.9 1.1 0.1 0.3 0.9 0.3 9.7 2.2 1.1 0.7 0.1 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Approved Nucleoplasm,Nucleoli NA NA 120000 Nucleoplasm Nucleoli "HPA040765: AB_2677125, HPA062187: AB_2684706" "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favorable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 13.1 16.6 17.1 19.9 16.9 35.4 25.6 19.0 22.5 15.8 16.3 19.2 14.8 20.4 28.6 18.7 22.7 13.2 18.3 16.6 18.5 18.5 22.0 15.1 32.5 17.6 17.7 16.6 35.7 12.2 14.2 15.0 17.8 18.9 15.2 19.7 26.0 17.2 18.4 18.2 18.1 18.3 12.6 17.8 17.7 19.2 21.3 17.3 30.4 21.0 11.2 32.7 16.4 12.6 20.0 19.9 18.3 53.0 23.5 42.5 90.8 17.5 32.0 35.3 37.1 37.2 13.0 37.5 19.5 32.0 35.4 41.9 24.6 19.3 38.1 33.2 41.4 43.8 84.0 48.3 90.6 21.3 79.7 39.8 32.7 37.7 30.3 47.1 62.0 25.3 38.4 67.4 46.3 46.3 32.4 61.7 67.2 32.9 19.8 28.9 23.3 30.5 29.1 49.6 30.4 22.2 21.1 31.3 29.9 51.7 62.3 24.6 36.9 34.2 51.4 28.8 31.2 26.2 45.5 51.0 94.2 39.6 36.2 33.7 36.2 17.5 19.7 17.5 16.4 25.5 35.2 20.9 17.7 30.9 26.7 25.3 27.6 4.5 31.8 23.1 25.6 30.3 14.6 17.1 16.9 19.0 22.5 16.6 18.5 17.6 17.7 16.6 18.9 17.8 17.3 20.0 12.5 0.0 11.5 16.0 33.6 31.7 43.1 71.5 37.5 12.0 23.7 28.2 18.5 15.7 30.4 16.5 10.4 50.3 24.8 9.7 56.7 26.0 44.1 16.1 21.4 16.2 9.5 25.5 19.3 16.1 51.6 22.1 16.3 13.4 26.0 17.2 13.6 19.4 47.0 3.3 18.1 25.3 48.8 32.1 59.1 9.5 36.7 26.8 28.4 9.4 30.2 23.1 37.0 15.1 19.7 18.2 18.1 28.2 24.5 15.9 25.4 59.7 28.7 11.9 19.7 18.2 39.6 45.7 22.6 34.5 46.3 30.8 31.1 8.9 29.4 35.6 IGKV1-17 "A30, IGKV117" ENSG00000240382 "Immunoglobulin kappa variable 1-17" P01599 2 89117342-89117844 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 378.6;lymphoid tissue: 458.2" "Cell type enriched" "Detected in some" 113 "Plasma cells: 4510.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 425 "memory B-cell: 105.7;naive B-cell: 82.2" "Lineage enriched" "Detected in single" 478 "B-cells: 105.7" "Cell line enhanced" "Detected in some" "Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4" HPA048721 Approved "Immunoglobulin genes" NA NA 8400000000 "HPA048721: " "unprognostic (7.72e-3)" "unprognostic (1.60e-1)" "unprognostic (7.37e-3)" "unprognostic (1.78e-2)" "unprognostic (5.08e-3)" "prognostic favorable (4.11e-4)" "unprognostic (8.04e-2)" "unprognostic (1.00e-1)" "unprognostic (9.59e-2)" "unprognostic (1.76e-2)" "unprognostic (5.06e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (3.44e-7)" "unprognostic (3.12e-3)" "unprognostic (8.83e-2)" "unprognostic (3.80e-1)" "unprognostic (7.28e-2)" 11.5 26.8 0.1 185.4 0.2 27.9 87.9 0.0 0.7 9.0 0.4 362.0 297.5 6.6 4.2 55.2 12.5 56.2 11.0 0.0 0.1 10.1 14.3 36.8 96.4 0.5 0.3 0.0 12.5 3.3 1.1 1.0 0.1 0.2 5.5 378.6 0.0 135.4 31.3 1.3 0.8 154.0 4.7 0.1 308.5 161.1 2.5 0.2 46.0 26.0 0.0 458.2 184.3 6.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.8 2.0 0.0 0.0 0.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 105.7 0.0 0.0 0.1 82.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 12.6 0.1 0.2 0.0 0.7 0.0 0.1 0.5 0.3 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4510.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 LCE1F LEP6 ENSG00000240386 "Late cornified envelope 1F" Q5T754 1 152776372-152776728 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skin 1: 211.4" "Cell type enriched" "Detected in some" 10 "Suprabasal keratinocytes: 18.3" "Group enriched" "Detected in some" 13 "head and neck cancer: 5.5;melanoma: 14.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+: 6.5;hTERT-HME1: 3.0" NA NA "unprognostic (2.21e-1)" "unprognostic (8.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 211.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 KIR3DL2 "CD158K, cl-5, nkat4, nkat4a, nkat4b" ENSG00000240403 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2" P43630 19 54850443-54867207 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.9" "Group enriched" "Detected in some" 8 "dendritic cells: 37.7;NK-cells: 14.4;T-cells: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.99e-2)" "unprognostic (1.83e-1)" "unprognostic (3.64e-1)" "unprognostic (4.56e-4)" "unprognostic (1.40e-1)" "unprognostic (2.99e-2)" "unprognostic (8.39e-3)" "unprognostic (5.96e-2)" "unprognostic (2.73e-1)" "unprognostic (2.12e-1)" "unprognostic (4.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.65e-3)" "unprognostic (3.62e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 KRTAP13-3 KAP13.3 ENSG00000240432 "Keratin associated protein 13-3" Q3SY46 21 30425265-30425968 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXO3B FKHRL1P1 ENSG00000240445 "Forkhead box O3B" A0A2Z4LIS9 17 18667629-18682314 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.49e-5)" "unprognostic (5.05e-2)" "unprognostic (1.42e-2)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (9.48e-2)" "unprognostic (3.14e-2)" "unprognostic (1.41e-1)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" 1.0 1.1 0.9 1.4 1.6 1.0 1.5 2.6 1.3 1.3 0.3 1.0 0.9 3.5 0.3 1.3 1.7 1.3 1.7 0.7 1.4 1.0 0.4 0.9 2.0 1.8 1.5 0.4 5.9 0.9 1.6 1.4 1.3 1.3 0.8 1.8 1.0 1.2 1.3 1.6 0.3 1.7 1.0 1.2 1.0 1.5 1.6 2.5 1.0 1.7 1.7 1.0 3.3 7.0 10.5 13.2 8.9 2.5 6.0 6.0 3.9 3.4 6.9 6.2 9.5 1.3 10.0 0.9 5.7 6.2 7.0 11.6 4.3 5.1 0.5 10.2 6.6 6.0 2.1 3.8 0.0 2.6 4.7 2.7 10.9 7.2 5.1 4.0 10.4 7.4 0.8 6.9 3.7 12.9 2.2 6.5 2.3 1.0 6.5 20.8 1.0 1.0 2.1 5.1 10.9 13.9 1.7 3.9 18.4 3.4 1.5 2.9 3.2 8.8 8.4 10.3 3.7 6.7 0.2 2.4 1.9 8.7 0.0 0.0 0.2 0.6 0.0 0.6 0.5 0.6 1.2 0.1 0.5 0.9 0.7 0.0 0.4 0.1 0.0 0.9 0.3 0.9 1.6 2.6 1.3 0.7 1.4 1.8 1.5 0.4 1.3 1.0 1.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNFRSF13B "CD267, IGAD2, TACI" ENSG00000240505 "TNF receptor superfamily member 13B" O14836 17 16929816-16972118 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 19.1;lymphoid tissue: 33.3;skeletal muscle: 63.5" "Group enriched" "Detected in some" 4 "B-cells: 117.3;Plasma cells: 143.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 41 "memory B-cell: 130.9;naive B-cell: 51.8" "Lineage enriched" "Detected in many" 59 "B-cells: 130.9" "Group enriched" "Detected in some" 9 "Karpas-707: 167.2;RPMI-8226: 106.7;U-266/70: 72.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030453 Uncertain NA NA "HPA030453: AB_10601700" "unprognostic (3.94e-5)" "unprognostic (1.11e-3)" "unprognostic (4.88e-2)" "unprognostic (4.30e-3)" "unprognostic (1.23e-4)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-2)" "unprognostic (1.61e-4)" "unprognostic (2.22e-1)" "unprognostic (9.78e-2)" "unprognostic (1.59e-5)" "unprognostic (1.20e-1)" "unprognostic (4.49e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" 0.4 0.1 0.3 9.0 0.4 1.2 0.7 0.0 0.6 0.2 0.0 3.5 4.2 0.1 0.0 1.4 0.4 0.5 5.4 0.1 0.1 0.3 0.3 0.8 17.4 0.4 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.4 2.5 0.3 2.1 0.3 63.5 0.0 19.1 0.1 0.2 33.3 5.3 0.1 0.2 2.0 0.5 0.0 21.8 2.6 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 167.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.2 106.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.6 0.0 13.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 130.9 0.0 0.0 0.0 51.8 0.0 0.1 0.5 0.0 0.0 0.0 2.2 2.7 0.3 0.4 0.0 0.6 0.1 0.1 0.4 0.9 0.1 0.6 0.2 0.2 0.9 0.0 0.0 0.0 0.0 117.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.1 0.0 0.0 0.4 1.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.5 32.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 143.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.6 0.0 6.2 0.0 0.0 0.0 KRTAP9-1 "KAP9.1, KRTAP9L3" ENSG00000240542 "Keratin associated protein 9-1" A8MXZ3 17 41189887-41190639 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 46 "HDLM-2: 4.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 L1TD1 "ECAT11, FLJ10884" ENSG00000240563 "LINE1 type transposase domain containing 1" Q5T7N2 1 62194849-62212328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 5.6;intestine: 5.4;lymphoid tissue: 4.8;placenta: 11.7;testis: 5.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 110.2;Extravillous trophoblasts: 26.2;Intestinal goblet cells: 37.5;Spermatogonia: 53.1;Syncytiotrophoblasts: 28.2" "Cancer enriched" "Detected in some" 14 "testis cancer: 120.2" "Region enhanced" "Detected in some" "cerebellum: 5.6" "Immune cell enriched" "Detected in single" 13 "non-classical monocyte: 5.0" "Lineage enriched" "Detected in single" 21 "monocytes: 5.0" "Group enriched" "Detected in some" 22 "NTERA-2: 255.7;SuSa: 191.2" "Not detected" "Not detected" "HPA028501, HPA030064" Enhanced Vesicles NA NA Vesicles "HPA028501: AB_10599287, HPA030064: AB_10600538" "unprognostic (2.03e-2)" "unprognostic (7.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.51e-1)" "unprognostic (2.29e-1)" "unprognostic (2.46e-1)" "unprognostic (4.03e-1)" "unprognostic (1.09e-1)" "unprognostic (9.23e-2)" "unprognostic (4.04e-2)" "unprognostic (4.61e-2)" "unprognostic (1.52e-5)" "unprognostic (3.49e-2)" "unprognostic (2.43e-1)" "unprognostic (5.75e-2)" "unprognostic (1.95e-1)" 0.2 0.3 0.3 4.8 0.6 0.0 0.2 5.6 1.5 0.3 0.0 5.4 0.1 0.1 0.3 0.0 0.1 0.3 0.0 0.6 0.1 0.1 0.0 1.5 0.2 0.4 0.2 0.4 0.2 0.0 0.0 0.1 11.7 1.6 0.1 1.2 0.0 0.4 0.1 0.0 0.1 0.3 0.4 0.0 0.9 0.1 5.8 0.1 0.2 0.5 0.0 0.1 0.1 0.2 0.7 0.0 0.0 0.2 0.1 0.0 0.0 10.1 0.1 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 191.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.3 0.6 5.6 1.5 0.6 0.1 0.4 0.2 0.4 1.6 0.0 0.1 0.7 0.5 6.4 13.0 0.0 1.8 0.4 0.7 0.1 0.0 2.5 1.0 2.2 0.3 0.0 7.5 0.0 6.2 110.2 2.1 3.6 0.0 0.0 0.5 0.8 0.5 2.3 10.7 0.0 0.6 0.4 26.2 3.6 0.0 1.7 1.3 2.2 0.0 0.1 7.6 3.3 0.4 37.5 0.0 1.4 1.2 1.0 1.8 4.3 0.0 0.0 0.5 0.4 1.0 0.0 0.1 0.3 1.6 18.4 1.1 0.6 0.1 0.1 6.0 3.7 0.0 1.1 2.7 0.7 53.1 0.0 0.1 28.2 1.9 2.3 9.2 0.3 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911853-30925517 "Blood group antigen proteins, Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 727.9;Alveolar cells type 2: 231.8;Cholangiocytes: 358.9;Endothelial cells: 606.7;Hepatic stellate cells: 325.6;Proximal tubular cells: 319.7" "Cancer enhanced" "Detected in all" "glioma: 336.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 34.7;HeLa: 12.5;SH-SY5Y: 14.7;U-2 OS: 14.9;WM-115: 76.4" "Group enriched" "Detected in some" 6 "medulla oblongata: 5.5;spinal cord: 22.0" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" NA NA 49000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favorable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favorable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 333.9 30.8 93.8 29.6 137.3 51.1 252.4 107.3 68.0 134.6 254.0 79.8 51.4 162.1 42.0 144.8 167.2 163.7 208.7 128.1 139.2 527.7 13.0 417.4 45.9 493.1 194.6 39.8 28.3 259.8 48.6 15.3 37.2 188.9 84.5 33.0 0.8 115.0 85.1 200.9 102.9 91.6 143.6 325.6 12.7 81.1 7.9 164.2 39.3 114.2 392.1 34.5 139.6 144.4 433.1 0.1 0.5 0.3 0.6 0.3 1.3 0.7 2.4 0.5 0.0 0.0 0.2 0.8 0.1 34.7 1.9 0.1 0.4 0.0 0.0 0.0 0.3 0.3 0.5 12.5 0.0 0.3 0.3 0.1 4.9 0.1 0.3 0.0 0.1 5.1 0.1 2.3 0.1 0.0 0.0 0.0 0.9 0.7 1.0 0.0 0.0 8.9 0.3 0.9 0.0 0.3 14.7 1.9 1.2 0.0 4.6 0.3 0.1 0.0 0.0 14.9 1.1 0.5 0.8 0.6 0.6 0.0 0.1 76.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.8 137.3 107.3 68.0 128.1 139.2 493.1 194.6 39.8 188.9 325.6 164.2 433.1 727.9 179.5 231.8 75.7 3.6 91.5 1.2 0.3 5.2 0.7 11.5 29.0 78.0 358.9 3.9 31.3 8.4 3.4 3.7 3.7 29.4 53.3 2.3 2.5 1.2 606.7 7.3 86.9 3.5 2.5 4.8 67.6 0.0 0.9 1.3 0.5 325.6 2.0 3.7 0.0 1.0 28.6 0.0 5.1 107.7 2.1 1.2 6.0 88.9 0.0 1.6 0.4 0.0 0.5 0.2 2.4 14.5 3.4 3.7 1.2 90.6 319.7 6.2 0.4 13.1 23.1 42.3 0.3 1.5 2.6 78.7 7.3 8.1 4.7 67.8 1.0 C1QTNF9 "AQL1, C1QTNF9A, CTRP9, MGC48915" ENSG00000240654 "C1q and TNF related 9" P0C862 13 24307166-24322535 "Predicted secreted proteins, Transporters" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 8.5" "Group enriched" "Detected in some" 10 "Adipocytes: 34.9;Endothelial cells: 12.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "hippocampal formation: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056632 Uncertain "Secreted to blood" NA NA 210000000 "HPA056632: AB_2683197" "unprognostic (1.18e-2)" "unprognostic (3.22e-2)" "unprognostic (2.44e-2)" "unprognostic (3.14e-3)" "unprognostic (9.22e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-2)" "unprognostic (3.63e-2)" "unprognostic (1.03e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-2)" "unprognostic (4.16e-2)" "unprognostic (3.29e-4)" "unprognostic (1.38e-2)" "unprognostic (1.41e-1)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" 2.4 0.2 0.3 0.1 0.3 0.2 1.5 0.4 0.4 0.3 0.0 1.2 0.6 0.3 0.4 0.4 0.3 0.8 2.6 2.0 0.3 0.2 0.5 0.2 0.2 0.2 0.1 0.1 0.1 0.6 0.1 0.1 1.3 0.2 0.6 0.3 0.4 0.4 0.1 8.5 2.2 0.6 0.6 0.0 0.4 0.6 0.9 0.2 0.2 0.2 3.3 0.1 0.8 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.4 2.0 0.3 0.2 0.1 0.1 0.2 0.0 0.2 0.3 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.3 2.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.5 0.1 12.9 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.9 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.1 IGKV1-8 "IGKV18, L9" ENSG00000240671 "Immunoglobulin kappa variable 1-8" A0A0C4DH67 2 88992409-88992931 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 30.0;lymphoid tissue: 55.5;salivary gland: 21.3;stomach 1: 18.8;urinary bladder: 42.1" "Cell type enriched" "Detected in some" 40 "Plasma cells: 622.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 311 "memory B-cell: 131.0;naive B-cell: 136.4" "Lineage enriched" "Detected in single" 317 "B-cells: 136.4" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 6100000000 "HPA048721: " "prognostic favorable (1.64e-4)" "unprognostic (1.56e-2)" "unprognostic (8.07e-2)" "unprognostic (6.41e-3)" "prognostic favorable (5.13e-4)" "unprognostic (6.87e-2)" "unprognostic (2.91e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-2)" "unprognostic (1.75e-1)" "unprognostic (7.79e-2)" "prognostic unfavorable (4.14e-7)" "unprognostic (6.94e-2)" "unprognostic (1.34e-1)" "unprognostic (4.22e-2)" "unprognostic (2.98e-1)" 1.1 2.5 0.0 13.7 0.0 7.2 6.8 0.0 0.1 2.0 0.0 30.0 12.1 1.3 0.0 2.9 1.5 5.5 0.8 0.0 0.0 3.2 2.1 4.8 13.8 0.0 0.0 0.0 0.5 0.9 0.0 0.1 0.0 0.0 1.4 19.5 0.0 21.3 0.7 0.0 0.0 14.0 0.6 0.0 51.7 18.8 0.3 0.0 7.1 3.4 0.0 55.5 42.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 131.0 0.0 0.4 0.1 136.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 12.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 622.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 ISY1 "fSAP33, KIAA1160" ENSG00000240682 "ISY1 splicing factor homolog" Q9ULR0 3 129127415-129161063 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006312, HPA016995" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (2.20e-2)" "prognostic favorable (2.46e-5)" "unprognostic (1.46e-2)" "unprognostic (1.84e-3)" "unprognostic (2.19e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.25e-4)" "unprognostic (4.08e-1)" "unprognostic (5.94e-2)" "unprognostic (7.38e-2)" "unprognostic (1.71e-1)" "unprognostic (7.34e-2)" "unprognostic (2.23e-3)" "unprognostic (2.49e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" 18.2 13.8 9.5 19.2 9.1 52.0 17.1 9.7 9.7 19.0 8.1 19.3 15.6 19.6 15.2 22.4 15.6 17.5 21.6 9.0 8.6 13.0 10.9 14.3 32.3 9.2 8.6 8.5 19.9 15.9 11.3 8.8 22.3 9.2 13.4 17.0 10.5 15.1 12.4 35.2 20.3 16.4 20.5 8.4 18.4 15.0 12.5 9.3 23.0 15.0 21.5 30.3 18.4 19.6 10.2 53.7 20.5 29.6 41.6 35.1 36.4 34.5 39.3 35.0 46.1 44.2 40.6 39.3 67.3 41.3 32.6 40.0 44.8 56.3 31.8 64.9 65.0 26.5 78.0 35.2 32.8 32.7 121.2 53.4 22.9 21.7 40.6 62.3 28.7 37.7 43.2 57.1 33.5 25.2 54.2 73.8 67.1 32.3 55.9 31.3 64.9 67.3 47.5 17.3 33.5 46.8 35.3 72.7 15.7 41.9 16.0 30.3 99.1 45.2 33.5 33.4 49.8 41.6 40.1 26.1 131.9 30.8 69.4 39.0 79.8 57.6 94.2 54.8 56.4 61.4 56.1 55.8 58.7 62.8 50.7 61.0 55.0 90.7 84.8 51.2 54.5 73.5 56.5 9.5 9.1 9.7 9.7 9.0 8.6 9.2 8.6 8.5 9.2 8.4 9.3 10.2 26.5 25.6 23.4 0.0 27.4 27.4 16.5 21.3 20.5 19.7 17.0 15.6 19.7 21.5 21.8 9.2 22.9 44.1 38.5 15.8 23.5 26.7 2.8 11.9 23.0 25.3 9.0 29.0 0.0 28.0 41.2 21.8 12.8 21.0 45.6 25.8 26.0 12.3 34.8 20.2 0.0 16.7 16.2 21.1 25.6 1.8 16.1 23.9 10.6 0.0 43.7 20.7 46.4 0.0 0.0 24.4 15.3 16.1 24.1 17.4 18.8 23.2 14.8 19.0 19.7 18.8 20.9 57.4 42.6 20.0 35.8 45.8 32.9 18.7 20.5 16.9 PNMA2 "MA2, RGAG2" ENSG00000240694 "PNMA family member 2" Q9UL42 8 26504701-26514092 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 80.3;retina: 24.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 71.2;Horizontal cells: 30.3;Inhibitory neurons: 92.0;Muller glia cells: 26.9" "Cancer enhanced" "Detected in many" "glioma: 28.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 63.0;hTERT-RPE1: 78.4;JURKAT: 43.3;SH-SY5Y: 44.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001936 Enhanced NA NA "HPA001936: AB_1079647" "unprognostic (1.25e-2)" "unprognostic (1.27e-2)" "unprognostic (6.39e-2)" "unprognostic (1.43e-6)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" "unprognostic (8.76e-2)" "prognostic favorable (1.81e-4)" "unprognostic (4.66e-2)" "unprognostic (1.34e-2)" "unprognostic (1.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (5.12e-2)" "unprognostic (4.58e-5)" "unprognostic (9.00e-3)" 2.0 10.9 48.8 1.2 65.5 0.4 1.9 6.7 80.3 3.5 0.0 1.3 0.8 0.9 1.0 0.5 2.5 3.9 3.3 56.9 71.6 3.1 0.9 6.9 0.4 36.1 37.7 59.0 0.8 3.9 2.8 15.5 0.5 48.1 0.8 1.0 24.7 0.3 0.9 0.5 0.6 1.1 1.9 17.7 0.5 2.9 1.7 58.1 0.2 2.7 0.2 0.3 2.2 0.9 70.0 0.0 11.7 63.0 0.6 12.2 2.6 0.1 3.2 17.2 7.8 2.6 0.5 8.4 0.0 2.3 1.2 19.3 0.2 39.5 0.0 6.0 0.0 7.0 0.0 8.7 0.1 0.9 0.0 0.4 4.2 0.0 33.4 0.2 78.4 37.7 43.3 0.0 0.1 4.9 0.3 19.3 0.1 34.7 0.7 0.1 0.1 12.8 0.0 18.7 4.3 30.7 44.9 0.0 0.1 2.1 4.5 0.2 1.2 18.6 0.8 12.7 16.1 2.6 5.9 4.6 0.1 36.1 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 48.8 65.5 6.7 80.3 56.9 71.6 36.1 37.7 59.0 48.1 17.7 58.1 70.0 0.4 3.2 13.0 20.5 0.6 0.0 0.1 0.2 0.0 6.5 0.9 1.1 0.5 0.0 3.7 0.0 2.1 0.0 0.0 0.1 0.0 0.3 5.4 1.0 4.5 1.0 10.8 0.0 71.2 0.0 0.1 3.6 0.0 1.5 1.3 0.0 0.4 0.1 0.1 30.3 92.0 0.5 0.0 1.6 0.8 1.5 11.1 0.1 1.8 12.2 0.0 26.9 0.0 19.1 11.5 2.7 0.0 12.0 0.0 0.0 0.0 5.4 2.9 6.2 0.0 0.2 4.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.2 0.2 LRRD1 IMAGE:4798971 ENSG00000240720 "Leucine rich repeats and death domain containing 1" A4D1F6 7 92141643-92179531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 16.7" "Group enriched" "Detected in some" 90 "Early spermatids: 258.1;Late spermatids: 869.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055670, HPA079440" Enhanced Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA055670: , HPA079440: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (3.72e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.27e-2)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" "unprognostic (1.77e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.13e-3)" 0.0 0.0 0.4 0.0 0.5 0.3 0.1 1.7 0.8 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.6 0.4 0.5 0.1 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.5 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.0 16.7 0.6 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.0 0.4 0.5 1.7 0.8 0.5 0.7 0.6 0.4 0.5 0.8 0.2 0.6 1.1 0.1 0.0 0.6 1.6 0.0 0.3 0.5 0.0 0.0 0.6 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.0 0.0 258.1 0.1 0.6 0.3 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.3 1.3 0.4 0.0 0.0 0.1 1.7 2.8 0.0 0.0 0.0 0.7 869.3 4.7 0.5 0.0 1.0 0.0 0.3 0.0 1.5 1.4 0.0 0.0 3.0 0.0 0.4 0.1 0.1 1.5 0.9 0.0 1.2 0.3 6.2 2.6 0.0 0.3 0.0 0.5 0.3 0.1 0.3 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 24 "testis: 199.4" "Cell type enhanced" "Detected in many" "Early spermatids: 250.9;Late spermatids: 111.3;Spermatocytes: 883.9;Spermatogonia: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.2;CAPAN-2: 50.0;EFO-21: 22.6;GAMG: 35.2;hTEC/SVTERT24-B: 33.7;hTERT-HME1: 23.0;U-2197: 67.7" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 2.9 4.8 2.9 0.2 2.9 0.6 4.0 3.1 3.9 4.8 2.8 3.8 1.7 5.3 8.1 4.4 3.9 1.2 3.0 3.0 3.0 3.6 0.6 1.6 0.9 3.0 2.9 2.9 7.0 3.9 0.8 4.1 1.3 3.0 3.7 2.0 2.0 2.4 5.4 1.6 5.2 1.8 4.7 2.9 1.2 2.8 199.4 3.0 1.5 5.2 1.1 1.6 3.8 3.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 8.7 22.2 0.2 0.0 0.1 50.0 0.0 22.6 1.8 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 9.7 0.0 33.7 23.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 17.0 0.0 67.7 0.0 7.4 2.6 0.0 3.8 0.0 1.4 0.0 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 4.0 0.7 1.0 0.3 0.0 2.9 2.9 3.1 3.9 3.0 3.0 3.0 2.9 2.9 3.0 2.9 3.0 3.1 2.2 0.0 2.6 1.6 0.1 0.0 2.6 0.0 0.6 8.8 4.2 11.3 5.6 2.8 1.8 5.5 2.1 12.0 0.2 0.4 19.6 4.2 250.9 4.4 7.7 1.6 0.0 0.0 0.8 12.0 10.1 6.1 0.0 2.5 0.0 3.8 1.4 1.0 2.2 1.7 1.4 1.4 0.0 0.0 0.0 111.3 20.2 1.0 0.0 1.0 0.0 18.3 1.0 1.5 1.0 6.8 3.2 13.5 0.0 1.8 1.2 3.1 0.7 8.8 13.1 5.2 6.9 883.9 176.0 0.6 0.0 9.0 0.2 14.3 2.8 1.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489081-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 26.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Region enhanced" "Detected in many" "hippocampal formation: 26.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 4.6;SuSa: 7.4;U-138 MG: 14.4;U-251 MG: 6.5;U-87 MG: 8.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076140" Supported Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 0.3 0.5 5.6 0.1 9.8 0.0 0.3 0.0 12.6 0.8 0.0 0.9 0.0 1.2 0.2 0.3 0.8 0.2 3.7 26.7 5.5 0.2 0.1 0.7 0.0 0.1 0.0 9.9 0.7 0.4 0.0 1.2 0.1 2.0 0.5 0.0 1.2 0.4 0.5 1.2 0.5 0.2 0.8 0.0 0.1 0.3 0.6 0.6 0.1 0.2 0.2 0.0 0.5 0.6 2.0 0.0 0.0 0.3 0.3 0.3 1.5 0.1 0.8 0.5 0.4 0.5 0.0 0.0 0.4 1.4 2.2 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 4.6 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 7.4 0.1 0.2 0.1 14.4 0.2 0.2 6.5 0.0 0.0 0.0 8.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 9.8 0.0 12.6 26.7 5.5 0.1 0.0 9.9 2.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGEF25 "GEFT, p63RhoGEF" ENSG00000240771 "Rho guanine nucleotide exchange factor 25" Q86VW2 12 57610180-57617245 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 20.8;Leydig cells: 24.8;Peritubular cells: 45.9;Sertoli cells: 26.3;Smooth muscle cells: 38.9" "Cancer enhanced" "Detected in all" "glioma: 23.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 59.1;RH-30: 129.7;SH-SY5Y: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052016 Approved NA NA "HPA052016: AB_2681695" "unprognostic (8.43e-2)" "unprognostic (4.24e-3)" "unprognostic (2.13e-3)" "unprognostic (6.95e-3)" "unprognostic (8.12e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (9.18e-2)" "unprognostic (2.45e-2)" "unprognostic (2.39e-2)" "unprognostic (4.63e-3)" "unprognostic (2.51e-1)" "prognostic unfavorable (4.20e-7)" "unprognostic (1.41e-2)" "unprognostic (2.03e-1)" "unprognostic (6.82e-3)" "unprognostic (3.22e-3)" 32.5 12.2 34.8 10.8 42.4 0.1 29.3 43.3 77.7 64.5 18.1 107.7 10.4 93.6 44.7 29.9 86.2 23.8 24.3 70.8 32.2 14.0 5.1 21.9 6.3 26.6 26.2 40.5 58.7 8.6 9.5 26.6 9.5 31.0 61.1 19.7 13.3 14.0 81.2 11.5 11.4 34.7 69.4 20.8 20.3 45.4 10.7 26.6 2.1 14.2 13.9 4.9 85.0 51.9 44.5 0.8 8.9 41.6 26.1 0.1 0.0 3.3 12.7 37.4 16.5 20.2 5.2 8.1 3.5 10.7 23.4 7.7 0.4 16.2 0.7 13.9 11.7 13.9 7.4 6.1 11.4 11.6 0.2 19.2 11.5 3.5 7.5 1.1 59.1 6.5 2.0 15.5 16.0 12.2 3.0 2.7 0.3 26.5 0.4 0.4 0.0 129.7 0.7 0.7 0.7 24.1 58.7 2.4 1.2 4.8 14.8 4.3 8.9 0.0 14.8 14.0 9.7 4.7 33.5 5.4 0.1 12.4 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 42.4 43.3 77.7 70.8 32.2 26.6 26.2 40.5 31.0 20.8 26.6 44.5 5.6 0.0 0.0 8.5 0.0 2.0 1.8 0.2 4.6 17.7 1.8 8.6 11.6 0.0 0.6 0.0 2.1 0.2 0.6 0.0 0.0 0.5 0.2 1.1 20.8 4.4 0.0 0.0 15.3 1.4 0.5 12.6 0.5 0.6 0.0 2.6 6.8 0.0 0.5 8.4 8.5 0.0 0.0 0.0 1.7 1.5 24.8 0.2 0.0 8.4 0.0 5.4 2.1 3.0 1.6 0.3 0.0 45.9 0.3 0.8 0.0 0.4 0.0 2.8 26.3 6.3 38.9 1.4 1.4 0.9 1.1 0.3 0.5 9.6 0.0 0.4 PEDS1 "CarF, Kua, TMEM189" ENSG00000240849 "Plasmanylethanolamine desaturase 1" A5PLL7 20 50118254-50153734 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 86.8;Extravillous trophoblasts: 167.6;Hofbauer cells: 38.6;Syncytiotrophoblasts: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059549 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA059549: AB_2684059" "unprognostic (3.11e-2)" "unprognostic (7.04e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (2.03e-3)" "unprognostic (7.00e-2)" "unprognostic (2.19e-2)" "unprognostic (1.35e-1)" "unprognostic (8.63e-2)" "unprognostic (5.79e-2)" "prognostic unfavorable (5.79e-11)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (9.46e-2)" "unprognostic (4.42e-2)" 12.4 14.1 23.3 7.4 26.4 5.7 10.5 27.4 24.3 10.3 18.6 16.4 8.7 13.9 10.8 26.2 9.1 7.3 18.7 22.4 23.3 9.4 18.0 13.8 6.0 28.1 27.2 20.5 5.6 9.4 12.9 5.9 17.7 27.5 11.7 7.2 2.3 12.5 13.6 17.0 22.2 9.9 22.0 24.9 10.1 15.3 6.3 25.7 7.8 7.8 16.5 7.4 15.5 15.2 31.6 19.6 17.7 20.7 16.3 30.7 23.0 34.6 13.6 12.6 27.8 15.6 48.6 30.5 7.2 21.2 12.8 39.7 52.8 10.4 27.4 10.0 3.8 8.0 9.3 24.5 41.6 17.3 15.1 24.2 19.7 62.7 15.6 16.4 13.4 33.6 12.2 9.8 10.2 9.5 17.3 12.0 38.1 10.1 50.1 18.3 9.7 15.9 7.8 53.7 28.4 10.8 7.1 15.4 52.2 32.4 20.3 8.3 21.2 26.8 23.1 12.1 15.1 13.5 7.5 13.6 2.9 19.9 11.1 19.1 4.9 5.3 6.2 3.1 10.2 2.6 1.8 3.5 2.6 5.6 1.5 2.9 3.4 2.0 4.0 14.0 3.6 5.6 3.8 23.3 26.4 27.4 24.3 22.4 23.3 28.1 27.2 20.5 27.5 24.9 25.7 31.6 8.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 86.8 6.3 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 167.6 6.3 0.0 0.0 0.0 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 50.1 1.2 0.0 0.0 0.0 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560679 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056686, HPA078577" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056686: AB_2683209, HPA078577: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 14.0 14.6 11.9 8.4 12.1 5.5 12.7 12.2 12.5 9.8 15.9 13.8 11.7 14.3 12.3 9.9 12.0 9.5 27.2 11.8 11.9 14.1 18.7 11.9 12.6 12.1 11.8 12.0 10.0 14.2 18.9 11.4 13.1 12.7 13.4 10.5 8.4 10.8 11.1 28.4 9.6 11.5 12.1 12.2 11.5 14.8 11.5 12.4 12.6 11.2 27.3 9.5 15.6 10.3 12.8 28.6 8.9 7.3 6.0 21.8 22.9 24.7 16.8 17.7 15.2 15.0 6.9 14.6 28.2 9.7 10.3 19.7 15.3 10.8 19.9 17.6 15.6 28.8 10.8 10.6 21.4 18.6 13.7 14.1 17.5 19.9 14.8 22.9 21.2 14.2 11.2 19.9 9.2 25.2 9.2 11.8 23.7 19.9 21.9 24.1 16.5 20.1 12.1 29.9 18.4 11.2 19.3 9.3 20.4 25.8 15.4 10.1 7.2 14.4 21.5 13.1 16.6 20.6 26.0 23.1 20.8 15.1 9.0 17.1 1.4 1.4 6.5 3.3 1.7 5.5 7.3 3.9 4.9 1.9 11.6 5.5 4.5 0.5 3.1 1.7 6.1 5.1 1.3 11.9 12.1 12.2 12.5 11.8 11.9 12.1 11.8 12.0 12.7 12.2 12.4 12.8 21.7 16.0 12.8 0.0 36.1 24.5 31.0 27.9 31.3 23.5 20.1 24.5 55.6 32.9 20.9 16.5 6.2 44.6 34.8 20.6 31.3 37.8 27.4 27.4 19.7 19.4 13.2 18.7 0.0 35.3 50.3 38.5 20.4 19.7 12.7 16.4 20.3 30.0 24.2 15.2 0.0 27.1 20.3 17.2 14.6 13.6 66.8 15.4 23.2 0.0 23.2 31.3 29.9 0.0 0.0 27.0 36.3 44.8 15.6 45.1 23.3 38.1 18.8 22.4 32.9 28.5 29.6 79.5 30.6 18.9 18.6 45.7 27.1 30.9 29.2 27.3 IGKV1-16 "IGKV116, L1" ENSG00000240864 "Immunoglobulin kappa variable 1-16" P04430 2 89099859-89100361 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 282.4;lymphoid tissue: 602.8;urinary bladder: 262.5" "Cell type enriched" "Detected in some" 559 "Plasma cells: 18463.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 523 "memory B-cell: 164.7;naive B-cell: 112.8" "Lineage enriched" "Detected in single" 621 "B-cells: 164.7" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" HPA048721 Approved "Immunoglobulin genes" NA NA 10000000000 "HPA048721: " "prognostic favorable (2.63e-4)" "unprognostic (7.81e-2)" "unprognostic (1.43e-3)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.69e-2)" "unprognostic (1.87e-1)" "unprognostic (8.35e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (2.84e-1)" "unprognostic (1.17e-1)" "unprognostic (3.84e-2)" "unprognostic (5.82e-2)" 10.6 4.8 0.1 160.6 0.1 40.4 76.6 0.0 0.8 76.7 0.5 282.4 201.2 6.3 0.5 34.6 6.7 99.9 11.5 0.0 0.2 9.2 15.1 40.9 156.3 0.1 0.1 0.0 17.9 2.0 0.1 3.6 0.1 0.1 5.7 237.9 0.0 127.9 31.1 0.8 0.5 144.8 11.9 0.1 317.9 160.3 2.0 0.1 46.1 18.5 0.0 602.8 262.5 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 164.7 0.0 0.0 0.1 112.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 16.9 0.1 0.1 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 21.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18463.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 KRTAP4-7 KAP4.7 ENSG00000240871 "Keratin associated protein 4-7" Q9BYR0 17 41084150-41085141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 358 "skin 1: 35.7" "Cell type enhanced" "Detected in single" "Endometrial ciliated cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.7;retina: 14.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 160.4;Hepatocytes: 168.6;Proximal tubular cells: 196.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 7.1" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 0.2 0.3 2.5 1.6 3.2 4.7 0.2 0.8 7.7 0.2 0.0 1.2 2.8 0.3 0.2 0.5 0.2 0.8 0.3 4.3 1.5 0.6 1.0 0.6 2.9 4.1 4.5 2.5 0.2 0.6 0.1 1.4 1.0 4.6 0.3 1.5 14.9 0.9 0.2 0.2 0.6 2.7 0.3 1.4 1.6 0.9 1.0 4.7 2.8 1.3 0.1 2.2 0.5 0.3 6.1 2.3 2.1 2.0 0.9 0.0 0.1 0.6 4.0 1.9 3.7 3.2 1.4 1.1 1.7 2.0 0.2 1.2 5.6 0.8 3.7 7.1 0.5 1.0 0.4 4.1 1.3 0.3 0.5 2.0 0.0 0.7 1.2 2.2 3.4 2.0 2.1 0.0 4.0 0.4 0.2 1.2 0.4 0.7 1.5 5.1 1.1 2.8 1.6 1.7 2.3 0.4 3.4 0.8 0.5 0.8 2.2 0.3 0.1 2.0 0.8 5.0 0.4 0.8 4.8 0.7 0.3 0.4 0.3 0.2 0.3 0.0 0.0 1.8 0.0 1.8 0.3 0.9 1.8 0.1 0.4 0.4 0.9 0.1 1.1 0.0 3.8 0.9 0.3 2.5 3.2 0.8 7.7 4.3 1.5 4.1 4.5 2.5 4.6 1.4 4.7 6.1 0.4 19.2 2.2 3.3 2.3 0.1 9.9 17.1 7.4 0.8 2.9 1.8 3.7 22.8 3.5 60.7 4.2 0.0 8.4 1.6 160.4 44.2 11.9 0.9 0.2 0.7 25.1 0.0 11.7 50.1 0.0 0.4 7.1 1.5 0.0 5.4 0.4 168.6 0.0 6.7 6.0 7.8 2.0 1.6 0.0 12.0 0.3 1.8 0.0 3.7 0.0 0.0 2.1 7.5 0.9 50.1 0.2 0.4 3.9 7.9 1.0 196.6 1.0 3.5 0.0 0.0 1.7 0.5 0.5 2.2 0.1 0.0 5.3 0.5 1.5 14.1 MIF "GIF, GLIF" ENSG00000240972 "Macrophage migration inhibitory factor" P14174 22 23894383-23895227 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Isomerase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 2032.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 4974.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003868, CAB005284" Approved Enhanced Nucleoplasm,Cytosol "Secreted to blood" No No 13800000 5000000 Cytosol Nucleoplasm "CAB005284: AB_648587, HPA003868: AB_1079290" "unprognostic (1.68e-1)" "unprognostic (7.79e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.36e-2)" "unprognostic (9.48e-2)" "unprognostic (1.22e-3)" "unprognostic (2.17e-2)" "unprognostic (1.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-2)" "unprognostic (2.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" 194.9 471.8 135.1 120.6 153.2 147.2 225.2 159.7 453.8 220.7 146.1 195.6 99.8 207.0 50.2 518.4 221.3 21.1 264.7 196.6 201.9 532.5 488.6 210.0 62.0 178.5 165.5 159.3 225.6 257.8 128.9 370.9 101.2 165.6 321.5 35.6 24.0 235.5 134.1 100.1 296.4 173.1 43.8 198.6 206.2 232.7 114.4 171.3 65.6 276.3 19.7 46.5 258.0 319.3 298.6 1698.3 605.3 122.2 499.0 58.9 111.3 590.7 581.2 154.7 298.9 382.1 526.4 364.4 761.3 499.8 83.1 115.2 788.1 155.0 546.8 51.5 642.2 4974.4 286.2 534.6 1126.5 225.3 1077.2 758.6 230.9 354.9 173.8 103.5 248.8 241.3 589.4 466.9 540.1 122.2 1476.0 827.0 2345.5 532.8 488.6 2365.8 1040.4 127.9 2398.8 294.7 179.6 1080.9 1290.4 380.3 531.9 1374.7 37.6 671.2 442.6 424.7 232.5 1227.9 127.3 9.9 1647.2 732.5 1020.9 967.5 484.6 477.9 484.2 543.5 443.5 872.4 579.5 1250.8 1527.9 1221.7 983.3 796.9 1378.9 1040.4 928.4 166.8 1158.9 383.3 977.1 1258.3 1803.3 135.1 153.2 159.7 453.8 196.6 201.9 178.5 165.5 159.3 165.6 198.6 171.3 298.6 161.2 157.0 199.4 21.5 433.4 672.2 295.5 1134.8 1027.2 28.3 856.0 778.2 0.3 479.0 489.1 693.4 2.1 462.7 171.3 317.9 1649.4 859.0 190.5 733.7 485.3 248.5 348.9 455.7 17.1 377.7 885.0 336.2 606.5 844.3 180.3 192.2 261.6 885.2 278.8 21.9 24.1 432.5 697.8 207.7 505.2 153.9 336.1 232.6 773.7 19.7 217.0 59.5 155.5 17.6 52.8 649.9 360.4 302.8 1337.1 269.8 476.8 2032.7 404.6 33.2 138.1 338.1 349.7 21.3 124.2 1511.3 758.8 686.0 386.3 227.6 473.0 256.1 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase 6" Q8TEA1 10 18545561-18659285 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 61.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 6.3 12.3 14.4 7.5 14.4 12.5 9.4 16.1 16.1 8.7 13.6 6.2 8.6 9.7 12.3 5.7 8.8 6.1 8.1 14.1 13.7 8.7 61.6 6.6 11.4 14.3 14.9 13.5 12.8 12.1 7.9 17.3 6.6 14.8 10.6 8.5 13.0 8.5 5.6 4.5 9.2 8.8 6.2 14.3 9.9 8.6 17.6 14.0 11.9 12.1 4.9 11.0 9.2 7.7 17.9 7.5 6.3 16.6 12.3 8.1 11.1 7.2 10.3 2.5 8.4 11.3 12.0 11.2 17.0 4.3 4.0 5.9 11.0 17.1 10.8 10.8 16.6 13.9 17.8 8.8 14.5 8.3 8.1 11.6 8.6 10.3 8.0 5.5 8.3 3.9 20.0 25.1 16.1 8.2 4.2 18.6 9.3 8.5 14.8 4.8 13.1 8.6 17.4 6.3 9.1 8.9 11.0 8.7 9.0 7.3 11.3 5.8 6.4 6.7 7.0 8.1 12.8 7.6 9.9 11.0 18.8 5.0 14.5 4.3 1.5 3.5 2.8 4.4 4.7 7.0 8.0 6.3 5.6 2.9 6.1 7.8 6.7 1.6 5.3 8.2 4.0 10.5 2.5 14.4 14.4 16.1 16.1 14.1 13.7 14.3 14.9 13.5 14.8 14.3 14.0 17.9 75.4 9.6 15.1 57.8 34.9 28.7 17.1 11.0 30.1 33.2 32.4 34.7 8.1 18.6 13.6 9.2 22.9 10.1 39.6 19.5 5.9 10.0 19.7 23.6 38.9 37.5 14.5 20.8 43.5 12.7 8.0 19.2 40.2 49.0 17.7 32.0 26.7 86.6 7.4 25.2 45.0 24.5 18.3 24.2 52.4 12.7 25.7 28.5 12.4 23.4 15.3 15.3 17.5 43.7 57.6 11.1 20.0 17.0 31.0 10.1 40.2 10.9 14.5 28.9 13.1 20.1 19.1 49.5 21.8 21.3 26.7 6.7 31.0 26.7 18.7 14.2 HLA-DOB ENSG00000241106 "Major histocompatibility complex, class II, DO beta" P13765 6 32812763-32820466 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 19.7;lymphoid tissue: 41.3" "Cell type enhanced" "Detected in many" "B-cells: 84.4;Langerhans cells: 35.6;monocytes: 44.7;Plasma cells: 35.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 213.8;naive B-cell: 258.1" "Lineage enriched" "Detected in many" 20 "B-cells: 258.1" "Cell line enhanced" "Detected in some" "Daudi: 38.1;U-698: 14.9;U-937: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013846 Enhanced NA NA "HPA013846: AB_1853928" "prognostic favorable (4.29e-4)" "unprognostic (3.84e-2)" "unprognostic (7.12e-3)" "unprognostic (6.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "unprognostic (4.48e-2)" "unprognostic (4.26e-3)" "unprognostic (6.95e-2)" "prognostic favorable (4.17e-5)" "unprognostic (2.37e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (1.37e-1)" "unprognostic (1.64e-1)" "unprognostic (7.18e-2)" "unprognostic (2.46e-1)" 1.0 0.6 0.1 0.9 0.2 3.3 1.5 0.2 0.5 0.9 0.0 2.6 1.9 0.8 0.0 2.0 0.7 1.2 0.5 0.2 0.3 1.4 0.9 2.9 21.8 0.3 0.3 0.1 0.6 0.3 0.0 2.7 0.0 0.2 1.1 1.9 1.1 4.2 0.8 0.2 1.6 19.7 0.4 0.2 41.3 2.0 1.3 0.2 8.4 1.9 1.3 28.4 3.7 1.3 0.2 0.2 0.0 0.0 0.1 0.4 1.3 0.1 0.1 0.0 0.0 0.8 0.4 2.2 38.1 0.3 0.5 0.0 0.5 2.6 2.3 0.0 1.0 0.6 0.1 1.1 0.0 0.0 0.1 0.3 0.6 0.7 0.0 1.0 0.0 0.0 0.4 2.0 1.4 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.7 0.2 2.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.3 0.9 0.5 14.9 0.0 7.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 213.8 0.3 0.1 13.2 258.1 0.0 0.2 0.5 0.2 0.3 0.6 0.8 6.8 0.1 0.2 0.2 0.5 0.2 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.2 1.7 0.0 4.8 5.9 84.4 1.0 0.3 2.2 1.2 0.9 1.2 0.9 0.0 0.0 1.0 0.0 0.0 0.0 4.7 0.1 0.0 0.9 1.3 4.3 2.4 0.9 0.0 2.7 1.0 0.2 0.4 0.3 0.0 14.8 1.3 0.2 0.0 0.0 0.6 0.0 1.8 0.1 0.0 1.0 35.6 0.9 0.0 4.6 14.2 1.9 44.7 0.7 2.1 2.0 1.3 0.4 0.0 0.0 35.0 0.3 0.4 0.3 0.4 0.6 6.6 0.4 1.2 0.1 0.3 0.7 1.6 0.0 2.3 0.1 0.3 0.4 UGT1A9 "HLUGP4, LUGP4, UGT1AI" ENSG00000241119 "UDP glucuronosyltransferase family 1 member A9" O60656 2 233671898-233773300 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 650 "kidney: 462.8;liver: 197.1" "Group enriched" "Detected in some" 11 "Hepatocytes: 7.5;Proximal tubular cells: 6.6" "Group enriched" "Detected in some" 157 "liver cancer: 16.1;renal cancer: 16.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "A549: 1.4;RT4: 1.2" NA NA "unprognostic (2.46e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (5.04e-5)" "unprognostic (4.26e-2)" "unprognostic (1.60e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 462.8 197.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-5 "KAP10.5, KAP18.5, KRTAP18-5" ENSG00000241123 "Keratin associated protein 10-5" P60370 21 44579455-44580604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 82 "skin 1: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YAE1 "C7orf36, CIAB2, GK003, YAE1D1" ENSG00000241127 "YAE1 maturation factor of ABCE1" Q9NRH1 7 39566385-39610320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 17.2;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 12.0;Fibroblasts: 6.2;Hofbauer cells: 10.0;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019226, HPA031249" Uncertain Approved Cytosol NA NA Cytosol "HPA019226: AB_1845759, HPA031249: AB_2673807" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (8.73e-3)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (4.30e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (3.04e-3)" "unprognostic (1.17e-2)" "unprognostic (1.45e-2)" "unprognostic (2.39e-2)" "unprognostic (1.67e-2)" "unprognostic (6.54e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-3)" 11.3 14.0 15.2 9.8 16.3 2.4 17.6 18.0 20.4 14.7 15.6 19.1 14.6 17.2 22.1 15.3 15.6 11.1 16.5 15.6 15.8 15.4 12.1 11.2 10.1 15.2 15.2 15.0 21.2 11.2 21.3 14.5 11.0 15.5 13.6 20.1 18.5 13.5 12.4 14.0 11.1 19.5 16.1 15.2 9.4 14.2 20.0 14.8 11.1 15.0 16.7 9.2 12.5 11.7 17.1 29.3 18.5 35.5 40.2 28.5 28.5 21.3 43.8 33.6 35.4 39.7 14.9 17.1 15.1 19.9 33.4 62.4 27.9 35.2 26.3 33.1 15.4 28.7 13.7 20.9 28.7 26.6 14.6 10.5 26.9 21.0 39.3 42.4 21.1 29.6 13.7 46.8 6.9 29.7 18.5 11.8 29.2 81.0 34.6 21.8 16.5 24.9 17.4 33.0 24.4 48.1 52.3 32.7 46.6 44.1 38.9 41.3 27.6 21.3 17.7 34.3 23.8 35.5 22.1 50.3 34.9 22.1 34.6 56.2 21.6 6.4 8.6 9.9 6.8 11.0 16.1 12.8 15.2 7.1 16.2 22.7 16.6 0.7 10.7 5.1 10.6 15.5 7.9 15.2 16.3 18.0 20.4 15.6 15.8 15.2 15.2 15.0 15.5 15.2 14.8 17.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 15.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 12.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 OR14A2 "OR5AX1, OR5AX1P" ENSG00000241128 "Olfactory receptor family 14 subfamily A member 2" Q96R54 1 247722957-247724043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 2.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "GAMG: 5.0" HPA052685 Uncertain NA NA "HPA052685: AB_2681914" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF722P ZNF722 ENSG00000241149 "Zinc finger protein 722, pseudogene" 7 63998874-64016130 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 21 "testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 19 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.95e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TDGF1 "CR, CR-1, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582457 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.6;lymphoid tissue: 21.1" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 121.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 27.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3" "Group enriched" "Detected in many" 5 "cerebellum: 11.2;pons and medulla: 8.7" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.3 3.4 2.2 0.5 1.8 0.4 0.3 1.9 3.1 0.7 1.3 2.6 0.7 1.1 2.1 0.1 0.1 0.7 0.4 2.1 1.7 8.6 1.3 0.4 0.4 2.3 1.7 1.4 7.8 0.4 0.1 0.1 0.2 2.4 0.4 4.6 0.4 1.0 0.3 1.5 0.3 0.5 1.2 1.6 21.1 2.7 0.6 3.3 15.2 0.8 1.5 0.1 0.2 0.1 1.9 0.1 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.0 25.7 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 110.6 4.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 66.3 0.1 0.1 1.8 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.0 0.0 2.2 1.8 1.9 3.1 2.1 1.7 2.3 1.7 1.4 2.4 1.6 3.3 1.9 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.9 121.3 0.2 5.0 0.3 0.1 8.2 2.4 0.0 0.0 0.0 0.0 0.3 8.2 0.2 0.0 14.3 0.4 1.4 0.1 0.0 0.0 5.5 0.0 0.0 0.0 1.0 0.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.1 17.7 6.1 0.0 C3orf85 FLJ22763 ENSG00000241224 "Chromosome 3 open reading frame 85" A0A1B0GTC6 3 109118252-109151401 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 71.1;kidney: 14.1;liver: 20.0" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 169.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 2900000 "unprognostic (9.10e-2)" "unprognostic (9.48e-3)" "unprognostic (3.80e-4)" "unprognostic (1.15e-1)" "unprognostic (6.70e-2)" 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.4 0.3 0.0 0.0 5.4 71.1 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.1 14.1 20.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.1 0.0 0.0 0.0 0.0 65.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.3 0.1 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 KRTAP5-8 "KRTAP5-2, KRTAP5.8, UHSKerB" ENSG00000241233 "Keratin associated protein 5-8" O75690 11 71538025-71539209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.8;skin 1: 5.0" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Cancer enhanced" "Detected in single" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.72e-2)" "unprognostic (8.49e-2)" "unprognostic (9.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-2)" "unprognostic (1.99e-1)" "unprognostic (6.92e-2)" "unprognostic (2.89e-2)" "unprognostic (2.42e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (2.21e-3)" 0.1 0.1 0.4 0.0 0.4 0.0 0.1 0.3 0.8 0.0 0.2 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.4 0.3 5.8 0.2 0.1 0.0 0.5 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.1 5.0 0.1 0.0 0.3 0.1 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.8 0.4 0.3 0.5 0.3 0.3 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 KRTAP4-16 "KAP4A, KRTAP4-16P, KRTAP4P1" ENSG00000241241 "Keratin associated protein 4-16" 17 41101502-41102209 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.8 0.3 0.2 0.6 0.3 0.2 0.5 0.2 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-16 ENSG00000241244 "Immunoglobulin kappa variable 1D-16" P01601 2 90100236-90100738 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 79.8;intestine: 92.9;lymphoid tissue: 166.8" "Cell type enriched" "Detected in some" 249 "Plasma cells: 1994.1" "Cancer enhanced" "Detected in many" "lung cancer: 17.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 327 "memory B-cell: 57.6;naive B-cell: 120.1" "Lineage enriched" "Detected in single" 442 "B-cells: 120.1" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 9000000000 "HPA048721: " "prognostic favorable (2.41e-4)" "unprognostic (4.41e-3)" "unprognostic (3.96e-3)" "unprognostic (5.39e-2)" "unprognostic (1.35e-3)" "unprognostic (8.61e-2)" "unprognostic (2.92e-1)" "unprognostic (1.27e-1)" "unprognostic (1.54e-2)" "unprognostic (6.61e-3)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (4.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.66e-2)" "unprognostic (2.84e-1)" 2.4 0.4 0.0 30.5 0.0 15.1 19.1 0.0 0.4 11.1 0.1 92.9 39.3 1.6 0.0 14.0 2.5 79.8 1.3 0.0 0.0 1.6 3.9 10.1 27.8 0.0 0.5 0.0 2.5 1.0 0.6 0.1 0.0 0.1 3.6 50.7 0.0 30.6 0.9 0.0 0.1 34.7 1.0 0.1 57.1 26.9 0.4 0.0 10.0 2.8 0.0 166.8 23.8 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 57.6 0.0 0.0 0.1 120.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1994.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 CRCP "C17, CGRP-RCP, POLR3I, RCP, RCP9" ENSG00000241258 "CGRP receptor component" O75575 7 66114604-66154568 "Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006883, HPA007216" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA006883: , HPA007216: AB_1856160" "unprognostic (2.36e-2)" "unprognostic (4.43e-1)" "unprognostic (2.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.38e-2)" "unprognostic (6.26e-2)" "unprognostic (2.67e-3)" "unprognostic (8.17e-2)" "unprognostic (1.77e-3)" "unprognostic (2.59e-3)" "unprognostic (8.49e-2)" "unprognostic (9.35e-2)" "unprognostic (1.39e-3)" "unprognostic (3.87e-2)" "unprognostic (4.81e-1)" "unprognostic (3.50e-1)" "unprognostic (2.06e-1)" 13.6 15.4 10.9 13.9 11.5 37.8 17.8 12.5 14.2 14.8 11.5 18.5 17.0 14.8 11.4 20.2 17.5 13.2 17.7 11.4 13.1 16.7 26.7 14.7 16.5 11.8 12.5 10.8 17.0 20.7 21.3 11.2 13.8 13.1 17.4 19.7 14.4 16.3 15.9 14.9 16.3 14.8 18.3 11.7 17.5 18.1 8.4 13.5 15.3 20.2 13.7 16.8 16.7 14.5 14.7 44.0 26.9 19.5 26.4 27.0 33.7 19.0 29.9 31.9 43.7 33.7 43.5 34.6 40.6 35.7 29.0 37.0 32.4 26.7 35.9 46.1 26.0 27.3 23.1 19.1 20.9 19.4 47.6 32.6 27.0 30.9 38.3 71.6 27.8 23.7 23.1 49.3 28.8 30.0 35.0 36.7 37.7 39.8 58.7 33.6 38.4 30.1 37.8 27.8 40.5 46.1 60.3 34.3 95.2 29.2 22.8 73.6 24.0 27.6 63.4 33.6 36.5 56.3 35.4 70.0 54.3 35.9 36.8 51.6 25.9 12.0 20.4 17.6 11.1 17.1 14.4 15.4 14.9 9.1 13.4 14.5 17.3 20.9 10.9 17.0 12.0 16.0 12.0 10.9 11.5 12.5 14.2 11.4 13.1 11.8 12.5 10.8 13.1 11.7 13.5 14.7 24.8 28.9 32.5 12.1 30.4 13.4 22.2 13.9 24.5 29.9 19.7 19.2 25.7 12.8 23.0 16.5 22.9 12.6 47.8 15.5 35.2 21.3 4.4 27.7 30.3 18.1 16.1 12.2 19.5 24.8 11.8 20.5 27.5 29.4 34.1 22.8 9.7 25.2 12.1 30.3 20.5 15.4 8.2 13.6 9.2 4.3 18.6 17.7 16.0 12.2 20.6 23.0 22.6 12.5 17.2 29.8 10.2 22.2 26.5 26.2 10.5 17.6 32.8 25.8 6.6 27.2 18.5 24.5 16.7 20.9 14.8 11.5 27.3 28.6 14.7 32.1 IGKV2-24 ENSG00000241294 "Immunoglobulin kappa variable 2-24" A0A0C4DH68 2 89176328-89177160 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 275.3;lymphoid tissue: 478.7;urinary bladder: 942.3" "Cell type enriched" "Detected in some" 252 "Plasma cells: 5620.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in some" "hypothalamus: 3.9" "Immune cell enriched" "Detected in some" 4 "memory B-cell: 48.1" "Lineage enriched" "Detected in single" 482 "B-cells: 48.1" "Cell line enhanced" "Detected in single" "NB-4: 1.3" "Immunoglobulin genes" NA NA 840000000 "prognostic favorable (5.74e-6)" "unprognostic (4.92e-3)" "unprognostic (1.04e-2)" "unprognostic (2.38e-2)" "unprognostic (3.79e-3)" "prognostic favorable (1.59e-4)" "unprognostic (5.02e-2)" "unprognostic (1.65e-1)" "unprognostic (2.71e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.82e-5)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" 13.8 14.7 0.1 66.4 0.2 27.6 92.7 0.1 0.7 11.6 0.4 275.3 253.1 3.2 1.1 82.7 6.6 24.4 14.8 0.2 3.9 7.7 8.7 30.2 132.8 0.5 2.6 0.1 6.4 5.7 0.2 0.9 0.2 0.2 5.4 182.4 0.0 221.3 3.4 0.3 3.3 99.3 8.0 1.2 478.7 107.8 1.2 0.4 24.0 11.2 0.0 237.6 942.3 14.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.2 0.1 0.7 0.2 3.9 0.5 2.6 0.1 0.2 1.2 0.4 0.4 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5620.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619704 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 8.6;testis: 12.7" "Group enriched" "Detected in some" 4 "Early spermatids: 22.9;Late spermatids: 11.8;Spermatocytes: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 35.7;HeLa: 14.3;OE19: 9.3" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.3 2.4 1.0 1.0 1.0 0.4 1.0 1.2 1.0 1.3 0.5 0.5 2.3 0.2 0.9 8.6 0.7 0.6 1.0 0.8 0.9 0.5 1.4 1.3 0.8 1.1 1.0 0.7 0.2 0.3 0.1 0.5 1.4 1.0 0.6 0.7 0.4 2.6 0.3 2.6 3.5 1.2 0.2 0.8 0.4 2.2 12.7 1.5 0.3 2.1 0.8 2.3 1.8 4.3 1.3 3.0 8.4 0.3 2.8 0.4 0.8 0.2 0.7 2.0 0.3 1.0 7.7 19.6 0.3 0.5 1.8 2.1 35.7 0.6 0.4 0.4 3.2 0.3 0.2 14.3 0.4 0.3 0.1 0.3 0.6 1.2 0.9 0.6 0.1 0.2 0.5 0.0 1.5 1.1 0.2 0.6 0.5 0.3 9.3 1.1 0.1 0.6 0.0 2.4 5.1 0.2 0.1 2.7 2.5 0.2 0.9 0.2 0.2 1.8 0.6 1.8 0.2 0.5 1.0 4.0 0.1 2.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.0 1.2 1.0 0.8 0.9 1.1 1.0 0.7 1.0 0.8 1.5 1.3 0.9 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 22.9 0.5 0.1 0.3 0.0 0.0 2.5 0.2 0.0 0.2 3.6 0.8 0.0 0.2 0.4 0.2 0.1 0.0 2.3 0.2 0.0 0.0 0.0 11.8 0.6 0.2 0.0 1.0 0.0 0.1 0.0 1.5 2.2 1.8 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.2 0.0 0.1 0.0 8.6 0.5 0.6 0.0 0.0 0.0 2.5 0.0 0.3 RPL36A "L36A, RPL44" ENSG00000241343 "Ribosomal protein L36a" P83881 X 101390824-101396155 "Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 3019.1;Undifferentiated cells: 3021.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 2852.7" "Low region specificity" "Detected in all" "HPA063979, HPA077586" Uncertain Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA063979: AB_2685164, HPA077586: AB_2686846" "unprognostic (3.38e-2)" "unprognostic (2.11e-2)" "unprognostic (7.04e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (4.19e-3)" "unprognostic (4.15e-3)" "unprognostic (1.28e-1)" "unprognostic (2.86e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (8.81e-11)" "unprognostic (1.87e-2)" "unprognostic (4.50e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" 1643.0 1010.2 407.0 181.2 405.8 506.2 1794.4 403.0 613.6 1839.2 407.6 1347.3 165.4 1302.3 280.9 1838.3 1555.5 95.5 882.0 401.0 409.3 1113.7 836.3 1075.6 307.1 414.8 405.3 398.9 3583.3 2601.5 161.6 805.9 232.3 409.6 1358.5 293.2 95.4 1314.9 221.7 1558.7 2380.8 1381.0 211.6 413.7 1587.9 1329.8 268.4 404.5 434.3 989.6 226.1 506.2 1442.7 1765.8 422.2 508.3 1045.1 465.5 237.5 640.1 1232.0 273.6 198.9 532.7 642.1 1017.6 1196.0 360.1 571.6 367.5 318.1 399.5 350.5 727.8 641.2 651.0 309.1 1445.2 205.8 1919.5 1159.3 803.0 413.1 364.3 985.5 1395.8 436.6 895.6 931.0 576.9 563.1 486.8 660.7 546.2 2852.7 288.5 1285.4 583.8 1637.7 1118.7 367.7 384.8 863.5 633.5 811.3 314.8 508.8 116.8 506.3 608.3 459.4 238.4 806.3 187.0 206.4 369.8 477.2 350.9 330.0 475.0 470.0 223.6 749.5 240.3 130.7 562.7 109.4 608.3 591.8 1102.4 1242.0 1212.6 866.9 814.7 957.9 1322.5 1179.8 51.0 760.6 615.8 919.8 678.7 1804.2 407.0 405.8 403.0 613.6 401.0 409.3 414.8 405.3 398.9 409.6 413.7 404.5 422.2 309.5 439.1 987.0 0.0 1100.1 917.4 432.3 574.6 595.8 28.9 1600.3 970.8 16.1 885.0 946.8 174.7 14.6 762.3 615.9 641.2 434.3 1235.1 9.4 124.9 331.6 566.0 1100.8 1215.5 0.0 3019.1 1125.2 523.5 315.0 164.3 1272.4 137.9 1387.8 738.4 609.1 15.2 0.0 2744.0 183.1 2089.7 1144.3 49.3 1055.9 565.6 524.7 0.0 1620.0 187.9 710.6 0.0 0.0 2338.4 1805.5 418.6 559.4 350.6 1349.6 611.7 329.9 41.2 236.7 512.1 467.7 28.7 99.3 758.7 1122.1 751.4 875.8 153.1 3021.8 351.4 IGKV3-11 ENSG00000241351 "Immunoglobulin kappa variable 3-11" P04433 2 89027171-89027731 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1386.5;lymphoid tissue: 2836.4;urinary bladder: 1837.9" "Cell type enriched" "Detected in some" 129 "Plasma cells: 27475.3" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "hypothalamus: 6.1;spinal cord: 19.9" "Group enriched" "Detected in many" 292 "memory B-cell: 1729.8;naive B-cell: 1401.2" "Lineage enriched" "Detected in many" 323 "B-cells: 1729.8" "Cell line enhanced" "Detected in some" "BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6" HPA047702 Approved "Immunoglobulin genes" NA NA 18000000000 "HPA047702: " "unprognostic (3.97e-3)" "unprognostic (1.17e-2)" "unprognostic (3.51e-2)" "unprognostic (1.91e-2)" "unprognostic (2.70e-2)" "prognostic favorable (1.36e-5)" "unprognostic (2.02e-1)" "unprognostic (3.20e-1)" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.70e-1)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.26e-8)" "unprognostic (5.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" 42.3 61.1 0.4 740.1 0.4 190.8 389.1 0.3 2.1 137.4 0.5 1386.5 707.9 32.4 11.6 144.8 34.3 255.9 19.0 0.2 6.1 43.5 55.7 229.6 580.5 0.5 1.6 0.2 121.9 13.8 1.9 3.3 0.9 0.8 30.4 1101.3 0.1 500.0 61.5 1.2 14.3 540.5 60.0 19.9 1108.8 795.9 22.4 0.3 264.3 89.6 0.9 2836.4 1837.9 33.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.4 1.8 1.5 0.0 0.0 3.7 4.6 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.7 0.7 0.6 1.8 0.3 0.1 0.0 1.4 0.0 1.9 1.3 1.2 2.0 0.2 0.7 1729.8 0.8 0.6 1.6 1401.2 0.8 0.8 5.3 0.9 1.1 1.2 1.3 186.7 0.4 0.4 0.3 2.1 0.2 6.1 0.5 1.6 0.2 0.8 19.9 0.3 1.0 0.0 0.0 0.5 0.0 211.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 82.6 0.0 0.0 0.0 2.5 1.9 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.7 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27475.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 62.0 0.0 0.3 0.0 PDXP "CIN, dJ37E16.5, FLJ32703" ENSG00000241360 "Pyridoxal phosphatase" Q96GD0 22 37658723-37666932 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 210.8;choroid plexus: 91.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 19.4;Inhibitory neurons: 25.0;Microglial cells: 7.5;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 5.8;Plasma cells: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "plasmacytoid DC: 11.6" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000531 Approved NA NA 94000 "HPA000531: AB_2666018" "unprognostic (6.29e-2)" "unprognostic (7.89e-3)" "unprognostic (1.00e-1)" "unprognostic (2.89e-1)" "unprognostic (2.15e-2)" "unprognostic (3.25e-2)" "unprognostic (2.81e-1)" "unprognostic (4.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (1.57e-3)" "unprognostic (2.76e-2)" "unprognostic (1.77e-1)" "unprognostic (3.03e-3)" "unprognostic (2.04e-1)" "unprognostic (4.66e-2)" "unprognostic (2.38e-1)" 5.6 23.9 150.1 0.8 166.0 5.9 5.3 114.7 210.8 6.3 91.9 17.6 26.8 8.6 5.6 3.8 8.0 3.9 23.4 165.6 144.0 16.0 75.1 5.7 7.6 126.3 142.3 172.4 8.6 13.6 9.6 40.0 1.1 140.7 7.4 11.7 29.9 12.1 6.0 16.0 3.2 32.5 7.2 110.1 14.4 12.0 27.2 135.9 13.6 5.9 14.2 9.6 7.8 3.8 156.4 8.6 19.6 39.4 34.4 12.0 3.7 5.3 18.9 9.7 34.0 26.7 9.9 1.2 54.0 18.8 9.8 28.5 4.4 52.8 0.6 28.5 16.9 105.2 11.0 26.6 41.2 8.3 39.2 47.0 1.8 4.7 17.6 23.7 14.0 15.6 61.1 33.3 31.1 29.9 12.3 74.3 61.3 20.6 15.2 46.4 58.5 28.5 39.7 14.6 1.1 89.5 57.8 17.8 15.4 36.1 17.2 5.0 31.8 9.8 28.7 36.6 30.2 37.6 33.0 44.1 57.4 27.2 14.3 38.5 0.0 0.3 0.5 0.9 0.5 0.1 1.3 0.4 0.5 0.6 1.2 0.3 0.1 0.3 0.9 0.4 11.6 0.5 0.2 150.1 166.0 114.7 210.8 165.6 144.0 126.3 142.3 172.4 140.7 110.1 135.9 156.4 0.1 0.0 0.6 3.3 2.8 0.0 0.0 0.0 2.8 1.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.4 0.1 0.0 2.1 19.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 25.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 7.5 0.1 0.2 0.0 8.0 5.8 0.1 0.1 0.0 9.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.9 0.2 0.4 0.1 RPP21 "C6orf135, Em:AB014085.3, FLJ22638" ENSG00000241370 "Ribonuclease P/MRP subunit p21" Q9H633 6 30345131-30346884 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 97.3;Squamous epithelial cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 49.2;HHSteC: 46.3;JURKAT: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.73e-1)" "unprognostic (1.09e-3)" "unprognostic (2.83e-1)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (6.46e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (2.86e-1)" "unprognostic (1.65e-2)" "unprognostic (2.65e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.54e-2)" "unprognostic (1.01e-2)" "unprognostic (4.13e-2)" "prognostic favorable (6.78e-5)" 34.4 39.9 3.0 0.7 2.6 2.7 36.7 2.9 12.9 46.3 2.2 63.3 0.8 60.7 4.2 63.2 42.0 2.7 36.0 2.5 4.5 35.6 38.0 27.2 2.3 3.6 5.1 1.9 42.3 62.6 0.1 35.6 2.5 3.4 42.4 0.0 0.4 36.5 6.8 57.0 45.5 39.1 11.9 3.3 32.0 52.5 34.8 2.9 4.2 31.5 11.1 1.4 57.2 48.6 4.4 34.0 0.0 0.0 14.8 21.8 1.6 18.7 11.7 6.8 26.3 17.6 0.9 0.0 20.4 31.0 7.1 32.1 2.1 0.0 24.4 7.9 26.0 49.2 5.7 0.0 1.0 46.3 0.0 0.0 0.7 5.3 4.1 1.5 5.8 0.1 59.8 5.4 14.4 8.1 2.4 0.0 4.7 16.9 0.0 0.0 4.9 0.0 7.3 12.2 26.9 29.1 11.0 0.0 11.6 34.3 4.6 0.1 0.6 0.8 0.0 0.0 36.0 0.0 12.7 31.1 11.7 0.0 5.3 0.0 60.4 45.4 41.8 25.9 51.8 30.4 86.6 41.2 29.6 35.3 85.2 51.9 33.1 14.4 25.4 53.8 15.9 70.1 41.9 3.0 2.6 2.9 12.9 2.5 4.5 3.6 5.1 1.9 3.4 3.3 2.9 4.4 10.6 6.4 18.4 0.0 53.3 35.7 11.4 23.5 97.3 3.2 30.3 27.6 1.2 17.2 28.9 25.8 0.0 12.9 16.7 27.1 7.9 37.0 4.5 17.1 15.1 16.2 42.6 28.8 0.0 60.1 19.3 18.5 68.8 15.8 13.3 5.8 13.6 16.5 10.4 1.7 0.0 29.9 26.4 11.0 20.0 2.1 13.7 17.0 24.9 0.0 14.4 3.0 12.3 0.0 0.0 41.8 42.6 10.5 44.1 8.7 42.7 22.2 13.0 3.3 6.6 9.2 18.5 19.1 25.4 122.9 40.5 11.4 42.3 3.3 33.7 10.2 CD302 "BIMLEC, CLEC13A, DCL-1, KIAA0022" ENSG00000241399 "CD302 molecule" Q8IX05 2 159768628-159798255 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 195.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 352.2;Kupffer cells: 382.4;Macrophages: 194.3;monocytes: 166.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 215 "dendritic cells: 24.4;granulocytes: 32.2;monocytes: 33.0" "Cell line enriched" "Detected in many" 5 "ASC diff: 246.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 110000 "unprognostic (2.52e-1)" "unprognostic (5.44e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (6.88e-2)" "unprognostic (1.68e-2)" "unprognostic (9.12e-3)" "unprognostic (5.29e-3)" "unprognostic (2.37e-2)" "unprognostic (4.38e-2)" "unprognostic (2.14e-1)" "unprognostic (4.67e-3)" "unprognostic (1.75e-2)" "unprognostic (6.61e-2)" "unprognostic (7.45e-2)" "unprognostic (3.61e-3)" 49.8 25.7 6.6 15.6 7.5 30.9 31.3 7.2 9.3 34.9 11.3 17.0 24.3 22.0 14.3 11.8 15.2 31.0 13.4 6.2 9.6 17.0 195.4 50.5 11.8 8.5 7.2 5.4 42.3 17.8 10.9 3.3 19.6 8.5 21.5 20.9 2.1 12.1 20.5 3.0 5.6 28.4 22.7 7.8 31.6 15.8 9.1 7.2 9.8 31.4 17.4 9.9 24.9 13.4 8.7 0.1 1.4 1.2 0.0 246.9 51.5 0.0 5.3 25.9 7.4 10.9 1.6 2.2 0.4 2.0 13.5 7.8 0.0 5.5 3.0 10.1 1.6 8.6 7.0 1.3 3.6 12.3 18.6 6.0 41.2 1.4 8.0 0.0 6.0 18.9 0.0 0.6 5.8 9.5 0.6 0.0 13.1 2.4 0.0 6.7 0.0 1.8 0.2 1.6 0.2 2.7 2.9 1.8 5.9 5.7 3.8 4.8 18.3 4.1 13.7 0.0 0.2 4.1 0.5 0.0 0.0 9.9 1.5 3.1 13.5 33.0 32.2 0.0 24.1 0.0 0.1 0.0 0.0 24.4 0.1 0.0 0.0 29.2 0.1 26.1 6.8 0.0 12.5 6.6 7.5 7.2 9.3 6.2 9.6 8.5 7.2 5.4 8.5 7.8 7.2 8.7 28.0 44.8 111.9 0.0 5.0 6.6 15.9 2.4 16.5 3.3 20.2 15.2 3.9 31.5 26.5 3.7 0.0 2.5 19.3 3.7 0.0 4.0 31.7 3.0 38.7 25.3 9.6 21.0 0.0 3.5 10.5 80.5 20.4 3.0 30.9 26.7 65.7 352.2 42.7 3.3 0.0 25.2 0.0 382.4 97.3 16.4 122.7 194.3 19.6 0.0 166.6 2.1 2.1 0.0 0.0 2.3 12.2 93.6 3.5 13.9 19.6 4.1 17.1 2.4 65.7 24.8 30.7 27.9 11.6 3.6 4.4 2.7 6.5 8.6 22.7 10.4 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164595-32168281 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Granulosa cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.2;SK-MEL-30: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" NA NA Vesicles "Nuclear speckles" "HPA061173: AB_2684443" "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 13.2 7.3 3.1 0.5 2.8 1.1 13.7 3.0 5.7 22.6 6.0 16.3 0.6 10.1 0.8 12.4 16.5 3.1 12.4 3.1 3.2 12.5 7.4 9.5 0.3 3.1 3.2 2.5 31.4 5.1 0.4 8.3 3.0 2.9 17.0 0.5 0.0 8.0 1.5 3.8 12.9 8.9 0.3 3.2 8.0 10.3 4.4 3.2 0.6 8.7 2.5 0.2 13.6 17.4 3.1 0.2 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.5 0.0 0.3 3.2 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.2 0.7 0.5 0.0 0.0 0.6 1.0 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 3.4 0.0 1.0 0.7 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 3.0 5.7 3.1 3.2 3.1 3.2 2.5 2.9 3.2 3.2 3.1 1.2 6.4 4.1 0.0 0.3 1.5 0.6 0.3 4.6 1.5 0.5 0.3 0.1 0.0 1.6 1.8 2.1 0.8 0.6 0.2 0.0 0.4 0.1 1.0 1.9 1.7 0.0 1.7 0.0 0.2 0.4 1.5 4.6 1.3 0.0 10.4 3.3 0.3 0.2 0.0 0.0 1.1 0.0 0.6 1.6 0.2 3.7 0.7 0.0 0.0 0.0 0.9 3.1 0.0 0.0 0.3 0.2 1.2 2.1 0.7 0.4 0.1 1.6 1.5 0.0 2.0 1.5 0.5 0.4 4.0 2.3 0.8 0.9 1.5 1.3 0.5 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466186 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 60000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 326.4 427.0 658.3 271.1 671.5 407.8 314.0 673.4 875.5 225.0 675.6 475.3 446.7 189.9 301.7 530.9 193.4 145.1 1039.0 668.5 672.7 561.9 565.8 243.9 295.5 669.5 656.4 655.1 180.6 273.9 514.1 334.7 237.6 672.6 318.2 371.4 323.5 320.4 207.9 1349.8 269.2 387.8 193.7 651.2 284.0 357.6 313.0 669.5 443.4 243.3 1451.8 303.7 306.0 306.0 673.2 1251.5 1130.6 905.3 1400.5 752.1 739.2 561.1 799.3 705.9 947.2 994.6 1226.2 1091.7 1161.7 822.7 548.5 1513.9 735.7 1064.0 981.3 1021.4 831.0 1333.6 800.1 1584.6 1555.4 530.7 1324.4 824.4 835.6 944.9 766.6 858.9 760.5 919.8 1009.4 1681.6 1213.0 1057.4 3128.1 1984.5 2396.1 1228.2 2594.9 1410.9 874.9 741.6 1985.9 1936.7 1376.1 845.3 925.9 1073.7 2519.4 773.1 1365.1 644.9 1687.5 703.0 706.0 1142.1 1197.3 1181.5 685.7 1795.6 2432.4 829.7 1325.8 1131.8 1020.3 904.1 1069.1 440.2 912.7 425.6 597.7 508.3 494.8 1122.9 512.2 445.1 468.3 428.0 555.2 731.2 890.5 754.9 1505.3 658.3 671.5 673.4 875.5 668.5 672.7 669.5 656.4 655.1 672.6 651.2 669.5 673.2 147.7 22.4 44.9 0.0 57.9 0.0 0.0 0.0 0.0 0.0 252.4 289.6 0.0 0.0 36.5 386.2 0.0 777.4 125.6 0.0 1430.2 460.9 0.0 302.6 225.3 82.0 0.0 0.0 0.0 578.8 636.3 110.5 0.0 278.3 64.3 188.1 0.0 0.0 787.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.2 0.0 0.0 339.1 0.0 0.0 0.0 0.0 589.5 0.0 0.0 18.6 0.0 0.0 1616.3 51.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 436.3 64.0 206.4 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 15.1" "Cell type enriched" "Detected in single" 4 "Spermatogonia: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045683, HPA071685" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP8 "BPGAP1, FLJ20185" ENSG00000241484 "Rho GTPase activating protein 8" P85298 22 44752558-44862788 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 24.1;salivary gland: 23.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 20.5;Cytotrophoblasts: 26.9;Ductal cells: 25.6;Pancreatic endocrine cells: 30.5;Urothelial cells: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 26.9;BEWO: 47.5;CACO-2: 30.9;HEK 293: 43.6;MCF7: 44.9;SK-BR-3: 40.1" "Not detected" "Not detected" HPA069694 Approved NA No "HPA069694: AB_2686173" "unprognostic (4.14e-1)" "unprognostic (1.21e-2)" "unprognostic (6.88e-2)" "unprognostic (8.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-2)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-1)" "unprognostic (8.78e-3)" "unprognostic (9.58e-2)" "unprognostic (7.65e-6)" "unprognostic (8.59e-2)" "unprognostic (3.29e-1)" "unprognostic (2.32e-2)" "unprognostic (2.22e-2)" 0.8 0.4 0.2 1.2 0.2 0.6 9.5 1.1 1.0 2.4 3.4 8.3 1.7 1.7 11.5 7.6 6.9 4.3 0.1 0.4 0.2 24.1 1.1 4.4 0.7 0.2 0.2 0.1 0.3 10.4 5.6 6.5 7.5 0.4 13.7 7.2 0.3 23.4 8.4 0.1 1.9 3.6 0.3 0.1 9.0 6.5 3.3 0.4 0.5 17.7 0.0 1.1 2.0 2.9 0.4 26.9 0.4 0.4 0.2 0.0 0.4 47.5 0.2 3.1 0.0 0.2 30.9 13.5 0.2 1.6 0.0 0.4 19.1 8.5 21.9 0.2 0.1 43.6 0.0 0.9 0.4 0.1 0.1 0.4 0.2 9.3 0.2 0.4 0.6 0.1 0.5 0.9 0.7 0.1 44.9 0.1 0.2 6.7 19.3 0.0 0.0 0.1 0.4 11.6 17.9 2.7 0.1 0.0 40.1 0.9 9.9 17.5 0.3 0.4 0.0 1.5 0.1 0.2 3.9 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.2 1.1 1.0 0.4 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.4 0.1 3.2 12.5 0.0 0.5 0.6 20.5 5.9 3.4 0.4 8.9 2.4 0.8 4.3 9.1 18.4 4.2 26.9 0.7 8.6 0.0 25.6 2.3 4.1 1.0 1.1 7.2 0.0 0.0 10.8 2.1 1.3 7.1 12.3 0.0 0.5 0.4 0.0 3.3 0.0 0.0 11.7 12.2 1.0 0.4 3.2 0.3 0.6 0.0 0.0 0.1 0.7 5.2 0.0 0.0 30.5 12.1 0.4 0.6 20.0 1.2 2.0 4.1 0.7 0.0 1.7 0.7 0.1 3.9 6.0 0.3 7.0 1.0 6.9 17.0 20.8 AC244197.3 ENSG00000241489 "Novel protein" X 149477104-149540926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;granulocytes: 5.1;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.57e-2)" "unprognostic (2.77e-2)" "unprognostic (5.48e-2)" "unprognostic (4.27e-2)" "unprognostic (4.81e-2)" "unprognostic (9.16e-3)" "unprognostic (4.51e-3)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.01e-3)" "unprognostic (4.33e-2)" "unprognostic (1.37e-5)" "unprognostic (1.84e-1)" "unprognostic (2.58e-1)" "unprognostic (3.90e-2)" "unprognostic (3.27e-4)" 9.0 12.8 31.7 7.6 19.2 8.8 10.1 0.1 33.3 11.7 9.6 9.0 9.7 23.8 62.0 9.5 26.7 11.0 17.9 35.7 3.4 10.3 5.1 16.2 9.2 10.9 4.0 18.6 24.8 15.0 11.5 45.7 8.4 11.5 18.1 15.1 20.7 17.3 19.6 6.9 20.3 10.3 12.8 0.3 12.7 11.5 8.2 7.1 8.0 15.5 5.8 9.9 11.1 10.8 17.8 5.9 20.1 12.4 4.4 6.3 5.8 2.1 3.8 3.9 3.1 8.9 2.8 9.8 10.2 9.4 8.5 7.8 17.3 1.7 6.4 2.8 11.8 5.9 1.8 15.2 1.5 2.4 2.6 14.3 10.5 5.4 7.7 5.7 18.5 3.5 4.7 1.6 12.6 4.1 15.4 2.3 1.9 1.0 8.4 6.0 2.4 3.1 6.9 8.9 6.2 6.4 6.5 2.7 4.8 1.2 6.4 4.2 2.0 8.9 6.0 7.4 5.5 4.1 11.0 4.6 3.9 8.9 4.7 2.7 0.3 3.1 15.7 5.7 2.9 3.0 1.6 1.8 2.7 1.9 0.9 0.9 0.8 11.5 3.1 5.1 2.0 5.6 5.4 31.7 19.2 0.1 33.3 35.7 3.4 10.9 4.0 18.6 11.5 0.3 7.1 17.8 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ARPC4 "ARC20, p20-Arc" ENSG00000241553 "Actin related protein 2/3 complex subunit 4" P59998 3 9792495-9807101 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 468.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 5900000 "unprognostic (2.54e-1)" "unprognostic (4.69e-2)" "unprognostic (8.93e-2)" "unprognostic (2.97e-2)" "unprognostic (2.49e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.79e-1)" "unprognostic (6.43e-2)" "unprognostic (2.05e-1)" "unprognostic (3.57e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (5.20e-2)" "unprognostic (4.83e-2)" "unprognostic (7.89e-2)" "prognostic favorable (2.34e-4)" 101.7 98.6 139.2 136.5 138.7 149.8 84.9 131.6 147.5 80.8 128.3 127.3 99.5 94.0 67.3 140.1 83.3 69.4 68.8 151.2 144.7 101.5 82.3 92.5 172.9 137.6 140.1 138.8 70.5 58.9 77.6 54.7 78.2 139.1 70.5 118.9 18.4 70.3 71.6 92.5 99.8 98.8 114.0 141.0 144.4 84.2 38.3 144.7 133.9 70.3 61.8 206.8 122.9 85.6 142.1 151.7 168.9 150.2 95.5 189.9 157.8 402.2 225.1 238.2 204.5 177.6 106.8 199.3 106.2 126.6 326.5 201.1 95.8 102.9 182.7 183.6 202.2 67.2 315.6 156.0 120.7 209.9 291.8 410.6 173.7 166.9 245.6 149.4 171.5 239.0 59.1 165.5 92.2 327.0 302.3 244.2 261.1 278.5 201.9 200.2 209.9 105.9 160.8 248.6 198.0 62.9 209.9 137.1 155.9 161.5 128.3 189.5 450.6 243.8 188.8 87.8 194.2 329.4 60.8 197.1 293.0 272.7 224.2 286.4 300.2 377.6 431.4 279.8 469.0 230.7 210.3 232.4 230.4 314.4 194.9 161.7 218.0 639.5 218.0 457.8 432.2 274.6 480.6 139.2 138.7 131.6 147.5 151.2 144.7 137.6 140.1 138.8 139.1 141.0 144.7 142.1 91.1 16.0 42.0 0.0 104.0 68.2 79.5 37.7 17.6 12.9 56.2 38.4 24.3 44.3 32.2 58.8 8.4 117.4 228.5 213.3 72.4 136.0 9.8 42.8 70.9 79.5 112.9 56.8 0.0 126.1 240.3 59.7 44.9 62.1 104.1 69.4 81.4 54.7 340.3 23.5 0.0 151.8 30.5 237.1 155.8 7.4 49.4 210.3 78.2 0.0 468.8 40.7 300.7 0.0 0.0 171.2 182.6 66.2 31.7 75.3 118.8 136.2 29.1 13.3 39.5 43.8 82.4 12.9 32.0 33.9 65.8 169.1 132.1 103.1 154.4 87.9 CORT MGC32686 ENSG00000241563 Cortistatin O00230 1 10450031-10451998 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 10.2" "Cell type enhanced" "Detected in some" "Adipocytes: 2.3;Early spermatids: 4.9;Late spermatids: 5.1;Spermatocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted in brain" NA NA "unprognostic (1.25e-2)" "unprognostic (1.79e-2)" "unprognostic (1.65e-1)" "unprognostic (3.70e-3)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.94e-3)" "unprognostic (7.08e-7)" "unprognostic (2.01e-1)" "unprognostic (9.01e-4)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.14e-4)" 0.5 0.5 3.8 0.1 10.2 0.3 0.4 1.9 6.3 0.7 1.2 0.7 0.8 0.4 0.3 0.4 0.5 0.3 0.3 4.0 4.0 1.4 1.0 0.4 0.1 1.8 1.4 4.1 0.6 0.5 0.2 1.8 0.9 3.3 0.9 0.2 1.0 0.4 0.1 0.3 0.4 0.8 0.1 1.1 0.4 0.6 1.9 3.0 0.2 0.8 0.1 0.0 0.4 0.4 3.1 0.7 1.7 0.5 0.7 0.2 0.0 0.4 0.6 0.1 0.1 0.1 1.4 0.2 0.6 0.4 0.0 0.2 0.5 0.0 0.0 0.0 1.2 1.3 0.8 1.5 1.5 0.0 0.9 0.4 0.1 0.2 0.2 0.1 0.2 0.0 0.6 0.6 0.4 0.0 1.5 0.2 1.5 0.1 0.0 2.2 0.5 0.9 0.2 0.1 0.5 0.6 0.4 0.3 0.5 0.5 0.3 0.3 0.0 0.6 0.0 1.0 0.9 0.2 0.3 1.5 0.5 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 10.2 1.9 6.3 4.0 4.0 1.8 1.4 4.1 3.3 1.1 3.0 3.1 2.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 4.9 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 1.8 0.4 0.3 0.3 0.0 0.0 0.0 0.1 0.2 IGKV2D-24 ENSG00000241566 "Immunoglobulin kappa variable 2D-24 (non-functional)" A0A075B6R9 2 90004797-90005629 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.8;lymphoid tissue: 25.8;urinary bladder: 15.4" "Cell type enriched" "Detected in single" 207 "Plasma cells: 165.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "hippocampal formation: 1.6" "Group enriched" "Detected in some" 48 "memory B-cell: 6.7;naive B-cell: 2.7" "Lineage enriched" "Detected in single" 68 "B-cells: 6.7" "Cell line enriched" "Detected in single" 8 "U-937: 1.0" "Immunoglobulin genes" NA NA "prognostic favorable (1.21e-4)" "unprognostic (1.78e-1)" "prognostic favorable (8.07e-4)" "unprognostic (2.09e-2)" "prognostic favorable (2.11e-4)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (4.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.74e-5)" "unprognostic (7.60e-2)" "unprognostic (1.57e-2)" "unprognostic (3.85e-1)" "unprognostic (3.47e-1)" 0.7 0.8 0.1 4.3 0.0 2.7 6.2 0.0 0.6 0.3 0.0 16.9 19.8 0.1 0.0 1.5 0.4 3.5 0.1 1.6 0.2 0.6 0.5 1.8 6.1 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 7.3 0.0 9.7 0.5 0.0 0.3 7.0 0.1 0.1 25.2 5.2 0.1 0.1 1.7 0.4 0.0 25.8 15.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.2 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-4 KAP9.4 ENSG00000241595 "Keratin associated protein 9-4" Q9BYQ2 17 41249687-41250653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 250 "skin 1: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 KRTAP5-4 KRTAP5.4 ENSG00000241598 "Keratin associated protein 5-4" 11 1620958-1622138 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "skin 1: 2.9" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.52e-2)" "unprognostic (4.04e-4)" "unprognostic (1.80e-1)" "unprognostic (7.83e-2)" "unprognostic (2.00e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A1 "GNT1, UGT1, UGT1A" ENSG00000241635 "UDP glucuronosyltransferase family 1 member A1" P22309 2 233760270-233773300 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "intestine: 203.0;liver: 325.1" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 105.0" "Cancer enriched" "Detected in some" 19 "liver cancer: 16.4" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "HaCaT: 14.0;OE19: 64.5;RT4: 34.7" "Not detected" "Not detected" NA NA "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (3.60e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-3)" "unprognostic (6.31e-3)" "unprognostic (1.94e-5)" "unprognostic (2.78e-3)" "unprognostic (2.99e-4)" 0.1 0.1 0.5 0.2 0.5 0.5 0.2 1.5 0.7 0.1 0.1 3.0 203.0 0.2 0.4 3.5 0.1 1.0 0.2 0.5 0.4 4.1 325.1 0.2 0.3 0.3 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.8 0.2 2.5 0.9 0.5 0.3 0.1 1.8 79.8 0.1 0.0 0.2 2.4 0.6 0.3 0.1 0.2 0.1 0.3 10.1 0.9 0.6 0.3 1.1 0.2 0.2 0.1 0.1 0.6 0.0 0.0 0.0 0.1 5.4 0.3 0.2 2.5 0.1 0.1 14.0 0.0 0.2 0.0 0.2 0.1 0.1 0.6 1.6 0.0 0.5 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.8 0.1 0.3 0.5 64.5 6.5 0.1 0.1 0.6 0.0 34.7 0.2 0.4 2.6 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.3 0.0 0.2 0.2 0.1 0.7 0.4 0.2 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 1.4 0.3 0.1 0.1 0.1 0.0 0.5 0.5 1.5 0.7 0.5 0.4 0.3 0.1 0.3 0.8 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.7 1.8 0.0 0.0 0.0 1.8 0.0 0.1 2.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.4 0.0 2.4 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.1 6.9 14.6 2.2 1.5 0.0 0.0 0.4 0.1 0.2 0.1 1.5 0.0 0.0 0.1 0.0 0.7 7.3 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 207.6" "Group enriched" "Detected in many" 7 "Endothelial cells: 150.4;Hepatic stellate cells: 268.4;Leydig cells: 285.2;Peritubular cells: 455.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 16.7;HHSteC: 6.7" HPA061343 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA061343: AB_2684483" "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favorable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 36.1 51.7 3.1 2.7 5.8 0.7 10.3 8.2 13.4 6.0 11.5 8.6 2.9 16.1 25.7 15.2 44.2 8.3 55.4 6.6 13.3 19.7 23.5 207.6 7.7 9.8 6.5 2.2 17.8 11.4 5.8 7.8 33.9 5.0 29.9 4.7 0.5 9.2 48.4 14.5 4.0 8.5 26.0 2.2 13.1 12.8 15.9 4.0 1.7 21.5 13.4 4.0 11.2 7.3 17.2 0.0 0.1 0.0 0.1 1.5 2.1 0.3 0.2 2.1 0.0 0.0 16.7 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 6.7 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.2 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.1 0.6 0.0 0.6 0.1 0.0 1.0 0.0 0.6 0.2 0.0 0.7 0.3 0.0 0.2 0.1 0.3 1.6 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.5 0.1 0.3 0.1 0.2 3.1 5.8 8.2 13.4 6.6 13.3 9.8 6.5 2.2 5.0 2.2 4.0 17.2 39.4 0.0 3.6 0.0 1.0 2.2 0.1 0.0 1.2 0.0 0.4 0.6 10.0 7.2 2.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 2.3 0.1 0.8 150.4 1.2 8.0 0.0 0.0 0.4 38.2 0.0 0.0 0.0 0.9 268.4 5.1 0.8 0.0 0.0 0.2 0.0 16.6 4.4 16.0 285.2 0.7 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 455.5 1.5 0.2 0.0 0.1 0.7 0.0 32.9 5.0 19.6 1.3 1.3 0.4 2.3 1.8 1.3 0.2 0.0 0.4 ARPC1A "Arc40, SOP2Hs, SOP2L" ENSG00000241685 "Actin related protein 2/3 complex subunit 1A" Q92747 7 99325898-99366262 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 442.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA004334 Approved Approved "Cell Junctions,Cytosol" NA NA 760000 "Cell Junctions" Cytosol "HPA004334: AB_1078215" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (6.22e-3)" "unprognostic (1.93e-2)" "unprognostic (8.38e-3)" "unprognostic (1.95e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (2.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.89e-2)" "unprognostic (7.88e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (7.07e-2)" "unprognostic (1.83e-1)" 71.0 83.6 60.3 40.1 61.3 40.8 63.7 57.4 69.1 68.6 69.4 81.4 93.6 60.6 81.6 125.6 76.1 53.8 122.8 74.1 64.9 66.1 78.0 62.7 42.3 63.1 64.9 61.3 82.3 64.3 65.9 62.6 54.7 65.9 57.4 79.0 33.3 67.1 56.1 48.4 85.2 85.6 57.7 58.9 53.2 100.0 42.7 66.7 39.5 79.5 47.5 45.3 62.1 75.5 70.0 265.3 144.3 155.1 73.6 144.2 242.4 133.5 185.5 216.1 185.5 184.4 164.4 301.7 92.3 270.5 226.7 273.8 110.6 208.0 270.8 221.5 46.7 186.4 49.7 99.9 137.1 156.1 59.2 63.7 227.6 149.1 237.8 252.0 220.0 310.8 75.9 125.9 105.6 289.8 398.6 99.4 78.5 150.5 295.3 326.1 58.1 107.8 113.9 142.0 162.7 161.7 138.3 180.9 260.2 255.9 264.2 130.2 88.4 239.3 239.0 211.0 424.7 302.1 39.6 80.0 130.7 206.6 130.1 320.2 111.7 49.9 88.8 24.2 80.8 19.3 30.8 23.1 31.5 43.0 28.8 30.0 22.6 63.7 30.7 86.1 31.9 33.5 26.9 60.3 61.3 57.4 69.1 74.1 64.9 63.1 64.9 61.3 65.9 58.9 66.7 70.0 124.3 51.3 55.5 20.9 45.2 41.4 139.5 249.1 54.7 38.0 107.2 131.6 46.7 95.8 130.1 58.8 18.8 189.6 27.3 196.2 135.0 213.6 32.1 55.0 43.7 96.4 74.2 68.8 31.6 276.9 345.8 70.6 140.2 57.4 13.3 141.4 135.0 75.8 84.6 33.7 28.0 209.4 132.2 77.5 26.1 24.6 66.8 56.0 80.0 26.2 68.6 79.8 42.2 19.1 28.4 442.5 191.6 67.4 52.4 151.5 295.7 155.5 102.2 40.1 184.1 59.1 188.4 171.6 130.0 88.9 47.9 129.7 29.8 87.7 166.3 280.7 AL035460.1 ENSG00000241690 "Novel protein" 20 2814968-2818066 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 35 "testis: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 4.9;U-2197: 1.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEFF1 "C9orf2, CT120.1, H7365" ENSG00000241697 "Transmembrane protein with EGF like and two follistatin like domains 1" Q8IYR6 9 100473149-100577636 "Predicted membrane proteins, Transporters" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 28.7" "Cell type enhanced" "Detected in single" "Endometrial stromal cells: 1.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;BEWO: 14.8;NTERA-2: 29.8;REH: 20.4;SCLC-21H: 25.4;SH-SY5Y: 16.9" "Low region specificity" "Detected in all" HPA051501 Uncertain NA NA "HPA051501: AB_2681509" "unprognostic (1.96e-1)" "unprognostic (2.30e-1)" "unprognostic (9.69e-3)" "unprognostic (2.32e-2)" "unprognostic (9.02e-2)" "unprognostic (3.59e-2)" "unprognostic (2.87e-2)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (1.05e-1)" "unprognostic (5.04e-6)" "unprognostic (1.30e-4)" "unprognostic (1.52e-1)" "unprognostic (3.97e-2)" "unprognostic (3.44e-3)" 0.0 0.0 6.7 0.0 14.5 0.1 0.0 9.1 9.0 0.3 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.2 0.0 8.6 12.3 0.0 0.0 0.0 0.1 13.4 11.9 4.8 0.3 0.0 0.0 0.2 0.3 15.5 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 10.6 0.1 0.1 4.0 12.4 0.2 0.8 0.1 0.0 0.0 0.1 28.7 0.0 0.0 12.0 0.6 0.1 0.4 14.8 0.9 0.2 0.6 0.8 0.8 0.1 0.0 2.7 0.4 0.2 0.0 4.6 0.0 0.7 0.0 6.7 0.0 0.3 0.7 0.6 0.0 0.0 0.4 0.0 0.7 0.2 0.5 1.9 5.3 0.2 0.0 0.9 0.1 7.7 0.0 29.8 0.0 0.4 20.4 10.3 0.0 0.5 0.0 25.4 16.9 0.1 0.0 0.4 6.8 0.0 0.1 2.7 2.3 3.9 0.1 0.9 4.6 3.5 4.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.5 9.1 9.0 8.6 12.3 13.4 11.9 4.8 15.5 10.6 12.4 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 IGKV1-9 "IGKV19, L8" ENSG00000241755 "Immunoglobulin kappa variable 1-9" A0A0C4DH69 2 89009982-89010515 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 432.1;lymphoid tissue: 676.7;stomach 1: 286.2" "Cell type enriched" "Detected in some" 116 "Plasma cells: 7178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 705 "memory B-cell: 300.5;naive B-cell: 296.8" "Lineage enriched" "Detected in single" 709 "B-cells: 300.5" "Cell line enhanced" "Detected in some" "HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2" HPA048721 Approved "Immunoglobulin genes" NA NA 4500000000 "HPA048721: " "prognostic favorable (2.10e-7)" "unprognostic (1.30e-2)" "unprognostic (1.95e-2)" "unprognostic (2.55e-3)" "unprognostic (4.70e-2)" "prognostic favorable (4.91e-4)" "unprognostic (3.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.09e-2)" "unprognostic (6.80e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.04e-8)" "unprognostic (4.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (3.40e-1)" 12.7 12.7 0.2 186.1 0.2 54.1 204.8 0.0 1.3 11.6 0.4 432.1 269.4 8.3 0.8 53.3 79.1 30.3 14.0 0.3 1.1 15.1 18.1 40.4 203.4 0.3 0.6 0.0 20.9 2.5 0.5 1.3 0.1 0.2 12.9 351.9 0.0 223.3 13.5 0.5 1.0 184.4 13.4 0.3 315.6 286.2 35.4 0.1 85.8 34.4 0.0 676.7 189.3 8.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.9 2.9 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.1 300.5 0.1 0.0 0.3 296.8 0.0 0.1 0.3 0.2 0.2 0.1 0.3 34.5 0.2 0.2 0.0 1.3 0.3 1.1 0.3 0.6 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.0 0.0 61.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7178.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 SPRR2A ENSG00000241794 "Small proline rich protein 2A" P35326 1 153056120-153057512 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 5304.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 37.6;Club cells: 23.0;Ductal cells: 20.6;Exocrine glandular cells: 57.1;Squamous epithelial cells: 82.3" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 743.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.4;hTCEpi: 7.8;hTERT-HME1: 10.3;Karpas-707: 12.6" NA NA "unprognostic (3.15e-1)" "unprognostic (2.48e-1)" "unprognostic (3.11e-3)" "unprognostic (1.64e-2)" "unprognostic (6.80e-3)" "unprognostic (3.51e-1)" "unprognostic (3.36e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.37e-5)" 1.1 0.9 0.0 0.0 0.0 0.1 0.9 0.0 0.1 546.8 0.0 0.6 0.0 0.8 0.0 5304.1 0.8 7.9 1.7 0.0 0.0 1.4 1.8 0.6 0.0 0.0 0.0 0.0 1.6 2.2 0.0 1.2 0.0 0.0 0.6 0.0 0.0 1144.1 0.0 1.7 27.1 0.8 0.6 0.0 0.9 2.9 0.8 0.0 0.8 0.6 0.0 770.5 1.0 1236.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.0 10.3 0.0 0.0 0.0 0.8 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.3 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.5 0.1 37.6 0.6 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 57.1 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.6 0.0 0.0 82.3 11.8 0.0 0.0 0.4 0.0 2.1 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915814 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 1615.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 610.3;Distal tubular cells: 1794.2;Extravillous trophoblasts: 623.2;Hofbauer cells: 627.0;Proximal tubular cells: 1236.8;Syncytiotrophoblasts: 542.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Approved Mitochondria NA NA 150000 Mitochondria "CAB016209: AB_631361, HPA041394: AB_2677450" "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 214.9 182.7 292.3 149.2 296.6 313.2 283.3 312.3 421.1 206.5 324.3 355.3 360.4 170.8 253.3 291.0 218.6 159.3 1124.9 294.9 319.6 462.3 405.1 150.2 245.2 304.6 297.4 286.8 275.5 198.3 436.6 108.8 193.8 303.4 159.4 395.6 221.3 238.4 203.9 1073.8 189.9 296.2 219.3 299.0 144.7 307.0 151.6 299.0 284.2 226.4 1615.9 295.4 244.6 162.9 298.8 398.4 187.3 491.1 486.6 340.0 435.1 554.6 218.5 394.4 371.4 361.9 553.5 372.7 531.5 187.2 345.1 355.2 217.5 549.0 764.7 440.6 400.0 544.0 790.3 260.4 513.5 389.7 603.7 260.9 445.8 467.9 358.4 581.9 407.0 522.8 421.2 656.3 665.9 488.5 402.5 461.6 593.0 561.3 992.2 540.1 471.6 490.1 1007.5 1032.8 337.0 404.4 232.1 380.2 559.7 525.7 425.6 562.9 660.5 291.0 236.8 280.6 423.0 252.6 429.1 524.2 559.7 438.2 1046.2 349.3 329.7 561.5 407.8 335.9 596.2 400.9 575.4 439.5 404.8 753.0 487.3 540.9 459.4 136.2 412.6 539.8 445.4 585.3 1077.9 292.3 296.6 312.3 421.1 294.9 319.6 304.6 297.4 286.8 303.4 299.0 299.0 298.8 195.8 243.6 191.1 0.0 82.1 0.0 0.0 0.0 0.0 0.0 282.6 476.1 0.0 0.0 121.3 222.5 0.0 610.3 81.3 0.0 1794.2 394.5 0.0 133.0 140.9 87.3 0.0 0.0 0.0 420.2 623.2 109.7 0.0 114.8 114.8 198.9 0.0 0.0 627.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 131.2 0.0 0.0 218.1 0.0 0.0 0.0 0.0 331.9 0.0 0.0 17.8 0.0 0.0 1236.8 102.0 0.0 0.0 0.0 119.0 0.0 0.0 0.0 0.0 542.1 67.4 208.9 0.0 0.0 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868002 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 104.0" "Cell type enhanced" "Detected in many" "Hofbauer cells: 63.2;Kupffer cells: 52.3;Macrophages: 46.5;Muller glia cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 27.1;granulocytes: 77.3;monocytes: 73.0" "Cell line enhanced" "Detected in many" "ASC diff: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 35.5 32.0 21.3 30.8 22.8 52.5 22.9 23.2 25.2 17.1 16.0 20.6 10.1 20.0 5.8 14.0 22.6 26.3 16.6 19.1 25.6 14.3 11.9 42.5 34.6 29.6 22.9 17.9 15.1 8.3 7.4 10.4 25.6 25.9 17.6 7.8 14.5 10.0 14.1 5.8 9.8 17.9 23.1 25.0 104.0 16.5 8.3 25.0 16.1 30.2 8.3 21.2 26.0 16.9 26.9 6.5 4.2 7.9 7.8 68.0 38.8 18.4 18.5 27.4 19.2 19.6 5.1 4.0 17.1 9.5 37.7 19.5 2.2 9.0 7.4 11.2 26.6 2.7 17.2 1.9 6.0 52.2 19.4 24.7 28.3 6.5 24.0 7.8 16.6 27.0 3.5 5.2 59.5 25.9 1.9 4.1 20.9 15.0 3.2 3.7 14.9 19.0 12.2 3.1 4.4 0.6 6.7 7.7 2.6 25.4 12.9 2.7 26.1 35.3 14.8 13.4 14.1 7.8 22.0 37.1 5.8 16.0 24.8 8.8 22.2 43.2 25.6 13.2 52.3 11.9 9.8 7.4 12.2 27.1 6.8 3.1 6.5 77.3 7.0 73.0 3.1 10.7 36.0 21.3 22.8 23.2 25.2 19.1 25.6 29.6 22.9 17.9 25.9 25.0 25.0 26.9 24.9 0.0 5.6 17.3 9.1 5.6 2.3 2.3 0.6 0.6 6.4 8.3 3.6 2.8 2.4 9.2 0.0 4.2 15.9 0.5 3.9 2.4 5.0 1.4 5.9 26.1 0.0 2.1 0.2 1.5 5.9 8.6 0.5 2.3 18.4 2.5 34.2 2.1 63.2 0.0 0.2 0.3 4.1 52.3 24.3 2.9 18.3 46.5 14.2 8.4 18.9 56.8 16.5 2.5 2.7 2.0 0.0 25.6 2.7 3.5 0.0 2.2 2.1 3.8 13.1 10.2 5.9 0.9 2.3 1.9 4.4 6.0 10.5 4.6 0.4 3.4 C8orf58 FLJ34715 ENSG00000241852 "Chromosome 8 open reading frame 58" Q8NAV2 8 22599599-22604150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 28.1;Extravillous trophoblasts: 30.4;Sertoli cells: 26.3;Syncytiotrophoblasts: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024667, HPA028286" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA024667: AB_1845783, HPA028286: AB_1845784" "unprognostic (8.88e-3)" "unprognostic (4.58e-2)" "unprognostic (1.99e-1)" "unprognostic (1.69e-2)" "unprognostic (6.72e-2)" "unprognostic (9.68e-2)" "unprognostic (2.60e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (8.70e-2)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.67e-1)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" 11.0 7.2 8.5 4.4 7.5 4.5 10.9 12.5 10.0 10.3 7.8 7.2 3.5 9.3 4.9 9.9 9.0 7.2 8.9 7.7 8.3 13.2 8.0 10.7 5.5 9.0 8.0 7.2 9.4 6.2 5.0 5.5 16.7 9.1 8.4 3.2 6.0 7.2 5.6 9.1 13.4 7.3 4.8 7.8 25.9 6.4 16.6 8.0 3.5 8.2 4.8 3.5 8.6 10.0 8.9 7.7 11.4 30.8 18.2 8.3 9.5 8.4 16.9 14.2 20.9 15.0 2.2 6.4 1.5 8.0 18.7 14.2 7.5 5.6 15.9 13.4 2.3 2.6 4.5 12.0 1.2 14.5 1.6 6.7 13.7 13.5 12.4 7.8 18.7 12.2 5.9 2.8 2.2 16.8 5.5 3.4 8.4 18.8 6.3 7.5 5.6 7.7 1.8 12.8 7.0 3.2 10.0 8.3 5.9 20.0 31.8 5.6 3.6 17.0 22.7 18.1 15.9 15.7 2.7 1.8 1.5 11.7 3.3 18.6 0.0 0.2 1.2 0.1 0.5 0.1 0.4 0.1 0.3 0.1 0.4 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.1 8.5 7.5 12.5 10.0 7.7 8.3 9.0 8.0 7.2 9.1 7.8 8.0 8.9 9.8 3.2 2.0 3.9 5.0 10.3 3.8 7.0 2.8 2.9 4.2 5.0 2.4 0.0 4.9 0.0 0.0 28.1 3.6 3.4 0.0 11.5 1.2 1.4 6.4 12.1 4.2 0.8 1.0 6.7 30.4 6.1 2.0 3.2 1.3 5.4 15.7 0.8 9.5 1.7 1.1 1.7 6.1 3.1 5.4 2.3 8.7 2.9 3.6 1.9 7.9 6.5 1.0 1.0 0.3 12.5 3.3 6.4 2.8 5.1 3.9 2.3 2.4 4.8 26.3 3.1 6.7 1.8 2.9 4.1 9.7 55.8 3.8 4.6 2.2 2.8 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Cataract, Deafness, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 80.7" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.27e-5)" 34.4 13.8 6.1 12.4 5.7 18.9 16.1 13.8 8.6 7.3 6.4 8.4 8.8 10.2 4.9 7.4 10.9 7.1 6.3 5.5 6.3 13.8 6.4 14.8 8.5 6.4 5.9 6.9 7.6 9.3 5.1 12.7 20.1 8.6 9.1 2.1 3.5 7.6 5.3 5.4 7.9 7.9 3.3 3.3 18.2 8.3 20.5 7.7 3.9 11.6 3.2 4.3 7.3 7.1 5.8 21.7 19.7 5.8 5.8 17.3 6.6 13.2 17.4 13.6 11.9 12.9 28.6 6.6 12.9 18.0 8.8 15.8 24.0 7.9 15.5 1.9 14.4 16.9 13.5 12.8 23.7 35.9 28.7 34.2 12.4 8.5 21.2 9.1 4.9 10.6 9.0 40.3 7.6 6.9 80.7 12.5 12.4 5.7 14.2 8.1 17.4 6.5 13.0 7.6 18.9 14.2 8.4 10.1 31.8 11.0 4.7 26.5 15.5 21.0 14.9 17.7 9.6 16.3 8.9 13.3 16.2 14.2 19.0 12.1 24.1 21.7 16.1 10.6 15.8 10.3 11.9 7.7 9.0 18.3 11.9 10.3 8.6 47.0 10.4 8.7 8.9 8.2 13.8 6.1 5.7 13.8 8.6 5.5 6.3 6.4 5.9 6.9 8.6 3.3 7.7 5.8 11.1 16.0 15.6 17.3 12.4 25.6 34.7 31.5 38.7 26.0 18.6 12.6 55.5 12.8 31.1 42.3 20.9 223.5 12.9 12.0 11.7 33.2 60.0 36.2 17.9 19.6 20.9 32.4 40.3 16.8 25.9 13.6 17.3 87.3 18.3 13.2 8.9 7.5 36.4 18.5 35.5 12.9 22.4 36.4 12.7 81.9 9.6 19.8 3.6 9.4 27.1 11.8 24.7 16.1 19.9 15.9 8.4 7.2 11.4 52.1 12.3 13.9 10.9 25.8 19.7 4.9 11.1 25.0 17.9 27.7 21.3 245.0 11.8 8.3 14.2 43.5 HOGA1 "C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2" ENSG00000241935 "4-hydroxy-2-oxoglutarate aldolase 1" Q86XE5 10 97584323-97612802 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 52.3;liver: 55.3" "Cell type enhanced" "Detected in some" "Cholangiocytes: 35.8;Distal tubular cells: 29.4;Hepatocytes: 43.3;Late spermatids: 18.4;Proximal tubular cells: 98.0" "Group enriched" "Detected in many" 5 "liver cancer: 4.5;renal cancer: 9.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;EFO-21: 9.7;Hep G2: 26.1;RPTEC TERT1: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039466 Approved NA NA 16000 "HPA039466: AB_2676522" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (7.50e-2)" "unprognostic (2.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.29e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-3)" "unprognostic (4.72e-1)" "unprognostic (2.37e-1)" "unprognostic (1.28e-1)" "unprognostic (6.80e-2)" "prognostic favorable (9.08e-4)" "unprognostic (2.20e-1)" "unprognostic (1.80e-1)" "unprognostic (2.94e-3)" "unprognostic (7.20e-4)" 4.2 8.4 5.4 0.2 7.0 0.4 1.9 9.3 5.1 0.7 9.9 0.2 0.3 1.1 3.8 1.0 2.0 2.5 14.9 4.4 6.3 52.3 55.3 1.4 0.3 9.6 9.1 3.4 0.2 15.5 5.8 3.7 0.1 8.7 1.1 0.1 0.8 1.7 2.1 3.4 1.4 0.3 0.5 7.3 0.4 0.2 0.9 7.9 0.3 1.8 12.2 0.2 0.4 0.9 10.3 0.3 3.7 0.1 7.8 1.5 0.3 0.1 0.1 0.2 0.0 0.0 3.0 0.2 0.3 9.7 0.2 0.5 2.6 0.0 0.2 0.1 0.1 4.0 0.1 1.4 26.1 1.1 0.2 0.1 0.3 0.7 0.1 0.1 1.9 0.4 0.1 0.0 0.4 0.6 1.6 0.1 0.1 0.2 0.2 0.0 0.1 0.6 0.4 31.5 0.6 0.6 1.0 0.1 1.3 0.5 0.2 2.8 0.0 0.2 0.8 0.2 0.3 0.2 0.5 0.9 0.1 2.0 0.1 0.1 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.1 0.4 0.2 0.2 1.0 0.2 0.2 0.3 0.2 0.1 5.4 7.0 9.3 5.1 4.4 6.3 9.6 9.1 3.4 8.7 7.3 7.9 10.3 0.0 0.0 0.0 7.2 1.5 0.1 0.7 0.5 1.8 0.4 0.1 0.4 6.0 35.8 0.2 9.2 0.0 0.1 0.0 0.1 29.4 5.9 3.8 1.8 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.2 0.0 0.5 0.0 0.1 0.4 43.3 0.1 1.7 1.2 0.0 0.0 1.3 0.0 18.4 0.0 0.8 1.8 1.0 0.0 2.0 0.0 1.5 12.3 0.5 0.1 0.0 0.0 0.1 0.0 98.0 3.2 0.3 0.0 4.5 0.9 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.2 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2 small subunit processome component" Q15269 21 44107373-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6" HPA024573 Uncertain Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 3.7 3.3 3.2 3.3 5.6 0.9 3.3 3.7 6.0 4.2 2.5 3.3 1.5 3.3 2.7 3.5 5.8 0.5 3.4 3.5 3.5 2.6 3.1 3.2 3.0 4.9 4.7 3.4 2.9 4.1 1.9 2.2 2.6 5.7 3.0 0.3 1.2 3.4 1.4 5.1 5.0 3.7 0.5 3.5 4.6 4.7 3.1 4.8 5.6 2.9 7.3 6.9 4.1 3.3 16.3 4.7 0.5 1.5 3.6 10.4 11.4 28.5 39.2 16.9 44.3 29.5 82.9 1.4 84.3 1.4 0.0 4.5 4.2 1.5 26.4 24.7 24.4 59.5 10.8 15.6 19.2 6.2 6.8 2.9 0.7 0.0 27.1 0.0 10.1 1.7 39.2 32.5 33.8 17.1 1.1 0.2 2.1 1.5 4.1 3.3 4.8 0.2 44.1 0.0 1.2 26.8 5.4 2.2 3.0 24.2 14.6 0.9 3.2 20.9 19.6 3.1 42.4 4.3 47.6 66.6 3.7 1.8 10.6 28.4 0.5 2.2 2.5 4.7 2.7 5.8 5.1 4.0 5.1 1.8 3.4 3.7 4.6 1.1 2.7 3.7 2.2 3.3 3.0 3.2 5.6 3.7 6.0 3.5 3.5 4.9 4.7 3.4 5.7 3.5 4.8 16.3 0.4 0.0 2.0 0.3 3.2 10.7 0.1 9.6 3.4 0.7 1.1 0.3 4.5 0.0 5.4 0.0 0.0 0.1 2.3 4.6 1.9 0.0 0.1 0.2 0.2 2.0 2.4 4.8 0.0 0.0 2.0 1.8 1.1 0.4 0.0 0.3 2.2 0.3 1.9 0.0 0.0 3.8 6.1 5.4 4.9 0.0 1.2 0.4 1.8 0.0 0.6 0.5 3.1 0.0 0.0 0.0 2.4 0.0 1.5 1.2 1.8 0.3 4.6 0.3 0.0 1.4 3.7 1.4 1.7 0.8 8.5 0.7 2.6 0.5 4.6 0.3 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 209.1;Inhibitory neurons: 127.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: AB_2686753" "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favorable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favorable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 17.7 21.7 25.8 19.4 58.4 24.3 17.0 2.0 75.0 20.5 6.6 22.7 16.0 24.4 10.0 14.4 19.7 13.6 21.4 54.2 29.2 21.3 25.4 19.3 20.7 15.6 8.4 54.1 21.6 18.9 34.8 25.4 18.1 23.2 19.7 15.1 27.9 16.6 17.0 23.8 14.6 23.1 22.1 0.0 21.1 26.2 25.9 11.0 34.6 18.2 16.0 18.1 22.4 17.1 44.2 24.5 20.2 17.4 26.3 48.7 29.1 24.9 21.6 32.6 31.3 30.4 15.9 10.2 45.6 12.6 43.9 30.7 21.1 33.4 20.9 19.0 38.9 50.9 47.1 27.1 18.3 24.3 47.0 36.1 26.2 12.9 26.7 14.7 20.4 25.8 13.8 130.2 37.6 24.6 33.8 41.6 16.0 13.8 43.4 20.6 41.1 38.1 8.5 17.3 38.3 42.6 31.0 28.4 32.6 22.6 24.3 27.6 21.3 26.2 56.4 29.1 21.1 18.5 28.6 31.3 35.8 37.4 33.2 24.1 2.1 3.7 5.3 3.2 3.8 3.1 3.4 3.6 3.9 2.5 3.4 3.6 5.0 5.1 7.0 3.3 8.5 4.3 2.2 25.8 58.4 2.0 75.0 54.2 29.2 15.6 8.4 54.1 23.2 0.0 11.0 44.2 13.0 12.8 30.4 65.6 14.7 10.1 6.5 7.6 9.6 35.8 17.2 14.4 30.2 20.0 10.5 7.3 47.9 17.8 21.5 19.7 1.9 9.7 36.5 10.3 17.9 15.5 19.2 12.4 209.1 6.3 19.6 15.6 38.7 15.8 12.0 13.8 11.4 19.7 20.1 37.0 127.4 16.7 10.2 21.0 12.6 25.3 19.9 20.2 10.6 39.4 10.9 23.1 16.5 50.3 88.4 8.9 9.7 24.0 15.5 10.1 23.8 10.3 9.6 25.4 26.3 14.5 19.3 35.3 29.6 14.1 9.8 20.0 15.3 26.1 14.3 8.9 KIR3DL3 "CD158Z, KIR3DL7, KIR44, KIRC1" ENSG00000242019 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3" 19 54724479-54736536 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "dendritic cells: 1.6;NK-cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.14e-2)" "unprognostic (2.79e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 HYPK "C15orf63, FLJ20431, HSPC136" ENSG00000242028 "Huntingtin interacting protein K" Q9NX55 15 43796142-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055252 Uncertain Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "HPA055252: AB_2682759" "unprognostic (2.89e-2)" "unprognostic (5.82e-2)" "unprognostic (2.14e-2)" "unprognostic (7.58e-3)" "unprognostic (1.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.55e-1)" "unprognostic (1.48e-1)" "unprognostic (4.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.36e-3)" "unprognostic (2.39e-3)" "unprognostic (6.52e-7)" "unprognostic (2.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.61e-1)" "unprognostic (2.78e-4)" 9.0 9.9 14.2 5.9 14.3 5.0 6.6 16.5 22.2 5.1 14.2 4.9 3.8 4.3 5.1 4.2 6.1 2.9 8.6 14.1 13.9 6.6 14.3 7.7 6.6 15.1 15.0 13.4 6.3 9.5 6.2 5.7 3.6 15.6 6.9 3.9 8.7 5.5 4.4 19.4 6.1 5.2 4.9 13.7 5.6 5.8 8.0 14.8 6.2 5.3 14.9 7.8 8.4 4.3 18.2 13.5 36.8 17.3 19.5 11.6 11.5 6.5 21.8 13.1 18.9 12.6 23.7 7.4 19.8 25.9 16.7 17.8 23.1 30.3 24.9 14.3 17.3 37.3 26.4 64.6 34.0 17.8 30.4 16.3 10.1 24.2 21.3 18.1 9.3 14.7 20.9 40.5 16.9 17.2 33.5 19.2 33.9 19.5 48.6 40.9 15.4 12.6 22.4 17.7 26.5 33.9 24.7 20.7 31.1 13.3 10.6 23.7 19.5 13.3 22.6 11.8 24.2 55.8 20.5 40.6 46.2 15.1 33.1 26.8 16.8 25.7 22.1 25.0 37.7 26.4 30.0 26.8 26.7 23.5 31.4 29.9 27.9 9.4 26.7 47.7 39.8 27.5 23.5 14.2 14.3 16.5 22.2 14.1 13.9 15.1 15.0 13.4 15.6 13.7 14.8 18.2 11.3 6.4 14.5 0.0 11.1 30.0 15.0 8.1 13.6 11.2 14.4 11.9 0.7 8.6 12.1 7.3 54.2 6.6 8.2 6.4 9.8 6.5 2.4 7.2 9.6 10.7 10.7 9.5 0.0 8.4 4.4 12.5 26.0 7.7 8.8 4.5 6.4 6.5 3.9 13.5 0.0 11.6 8.2 4.4 26.2 1.1 5.0 9.1 23.2 0.0 4.7 4.9 6.2 0.0 0.0 6.8 4.7 2.2 11.3 14.8 7.2 10.4 15.4 28.5 0.0 23.2 11.8 3.9 4.7 19.4 37.4 4.9 10.4 9.1 9.4 11.1 IGKV1-33 "IGKV133, O18" ENSG00000242076 "Immunoglobulin kappa variable 1-33" P01594 2 89266494-89268506 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Bence-Jones protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1742.2;stomach 1: 633.2;urinary bladder: 629.1" "Cell type enriched" "Detected in some" 131 "Plasma cells: 2044.1" "Cancer enhanced" "Detected in many" "stomach cancer: 5.5" "Group enriched" "Detected in many" 11 "hypothalamus: 9.0;midbrain: 14.7;spinal cord: 11.3" "Group enriched" "Detected in some" 378 "memory B-cell: 369.6;naive B-cell: 441.5" "Lineage enriched" "Detected in many" 411 "B-cells: 441.5" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5" HPA048721 Approved "Immunoglobulin genes" NA NA "HPA048721: " "unprognostic (1.76e-2)" "unprognostic (6.79e-2)" "unprognostic (1.52e-2)" "prognostic favorable (4.58e-5)" "unprognostic (5.06e-2)" "unprognostic (8.55e-3)" "unprognostic (2.31e-1)" "unprognostic (1.63e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-1)" 51.0 22.1 0.2 268.7 0.5 140.8 323.7 0.8 1.0 130.9 0.4 476.0 298.9 20.9 2.8 107.2 33.7 189.0 23.4 0.3 9.0 36.3 38.2 131.5 533.9 0.5 14.7 0.1 37.4 8.4 1.9 2.7 0.4 0.7 18.9 516.7 0.2 480.4 129.0 0.7 2.1 177.4 14.6 11.3 827.4 633.2 13.7 0.2 385.5 54.4 0.2 1742.2 629.1 26.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.1 1.9 2.7 0.0 0.0 9.1 8.8 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.4 3.5 0.7 0.0 0.2 0.0 0.6 0.0 0.4 0.3 0.4 0.1 0.0 0.1 369.6 0.2 0.1 0.3 441.5 0.2 0.1 1.0 0.2 0.3 0.3 0.2 39.5 0.2 0.5 0.8 1.0 0.3 9.0 0.5 14.7 0.1 0.7 11.3 0.2 1.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2044.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986165-34008104 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 135.5;liver: 182.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5" "Group enriched" "Detected in all" 4 "liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 175.4;U-266/84: 98.0" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 70000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 8.7 15.1 5.9 5.0 5.3 3.1 6.4 4.7 6.1 6.6 4.5 40.4 18.1 4.7 9.7 15.8 6.2 20.7 10.2 5.1 6.6 135.5 182.0 9.3 3.6 5.9 5.9 5.8 7.8 13.9 13.1 5.7 7.8 6.0 39.6 43.3 12.1 61.2 12.6 19.4 4.7 16.0 7.1 5.1 5.4 35.1 4.4 6.7 4.8 8.3 15.1 5.7 8.9 8.6 7.0 12.7 20.2 11.1 14.3 7.7 11.9 19.1 16.6 12.2 7.6 5.7 66.1 15.1 4.1 8.7 23.6 28.6 5.8 2.8 12.0 7.7 12.7 10.9 9.8 13.7 19.0 5.4 6.0 3.0 18.1 6.0 9.7 3.6 10.7 8.5 8.3 3.8 14.7 22.4 9.6 5.0 7.6 10.0 9.4 32.9 6.0 18.6 6.5 33.2 62.4 6.1 8.7 27.6 19.3 16.9 9.1 14.9 5.9 15.6 24.6 5.4 6.2 13.6 175.4 98.0 7.4 7.0 12.1 18.8 0.3 6.0 9.3 8.3 8.0 7.0 7.1 7.2 6.4 8.9 5.2 6.6 4.8 10.0 8.7 14.2 4.6 7.9 6.0 5.9 5.3 4.7 6.1 5.1 6.6 5.9 5.9 5.8 6.0 5.1 6.7 7.0 0.8 3.2 4.1 0.0 2.2 0.4 0.4 0.9 1.8 4.3 1.4 0.9 1.1 8.6 3.7 1.8 0.0 1.0 2.2 19.7 5.9 0.8 8.9 2.3 1.2 3.0 4.2 2.1 0.0 3.8 1.0 2.9 4.1 1.5 0.0 1.2 1.1 21.6 1.1 5.0 0.0 5.1 4.1 0.9 0.2 21.6 0.6 1.2 0.0 0.0 1.5 9.3 3.1 0.0 0.0 2.6 4.5 2.2 1.6 0.6 4.7 38.5 3.1 0.9 0.0 1.7 3.7 0.7 0.7 3.4 0.6 0.3 1.5 1.2 4.4 0.4 MTFP1 "HSPC242, MTP18" ENSG00000242114 "Mitochondrial fission process 1" Q9UDX5 22 30425623-30429054 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 69.7;Exocrine glandular cells: 52.2;Plasma cells: 43.5;Undifferentiated cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077396 Approved Mitochondria NA NA Mitochondria "HPA077396: AB_2686837" "unprognostic (2.19e-2)" "unprognostic (1.18e-1)" "unprognostic (3.12e-1)" "unprognostic (6.20e-2)" "unprognostic (4.86e-2)" "unprognostic (1.72e-3)" "unprognostic (1.52e-3)" "unprognostic (8.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.65e-1)" "unprognostic (6.37e-3)" "unprognostic (1.54e-1)" "unprognostic (1.49e-1)" "unprognostic (6.40e-2)" "unprognostic (3.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.66e-2)" 11.6 15.7 8.6 10.2 8.7 14.4 11.7 11.2 9.9 8.4 14.9 14.8 17.0 3.8 15.3 20.0 3.4 8.2 25.4 9.0 10.0 36.4 32.2 12.0 16.7 9.6 9.6 7.9 5.1 19.2 22.0 8.2 11.5 9.4 13.6 13.0 23.6 10.1 4.9 26.4 7.6 13.5 4.8 8.7 21.0 19.9 4.1 10.9 7.9 8.6 19.5 14.9 13.8 7.6 9.7 91.9 69.5 23.8 37.1 5.1 4.1 27.2 8.6 8.2 51.3 78.5 33.6 52.4 99.5 25.3 6.0 41.3 46.5 74.0 77.6 34.7 56.2 96.5 26.7 38.6 64.9 14.8 66.7 52.7 7.6 25.7 31.4 47.4 15.7 43.5 45.1 51.2 35.5 16.3 109.5 63.3 71.8 41.5 82.9 73.2 85.6 23.1 87.3 61.0 24.8 40.6 44.5 19.9 90.6 35.6 16.9 28.8 31.4 18.4 55.9 72.4 27.6 26.3 17.8 15.5 86.1 22.4 75.9 23.7 0.2 14.3 0.1 49.2 17.1 65.5 34.0 39.6 42.3 20.3 23.7 41.7 48.2 1.8 14.0 11.6 10.5 36.0 25.6 8.6 8.7 11.2 9.9 9.0 10.0 9.6 9.6 7.9 9.4 8.7 10.9 9.7 5.3 6.4 3.0 3.9 21.7 5.6 1.8 12.0 6.2 0.0 10.1 3.7 4.4 7.2 6.7 3.7 0.0 13.4 14.8 33.2 15.6 69.7 0.1 1.9 1.4 5.8 8.4 9.2 0.8 52.2 30.4 2.5 20.9 2.6 9.5 0.4 5.0 11.1 17.6 0.0 2.7 28.1 2.0 10.3 9.6 0.2 0.6 6.4 3.6 1.0 36.6 0.0 10.3 0.5 0.3 40.3 13.8 0.4 43.5 3.5 28.3 11.8 1.9 0.0 0.0 1.5 5.1 0.6 2.1 16.5 5.5 16.8 29.6 0.7 45.3 2.2 MDFIC2 ENSG00000242120 "MyoD family inhibitor domain containing 2" A0A1B0GVS7 3 70194479-70312638 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 4.2" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 280450-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 251.4;pancreas: 113.6" "Cell type enhanced" "Detected in some" "Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA078260: AB_2732375" "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 4.5 2.8 102.1 1.1 123.2 0.2 1.3 103.8 251.4 0.4 38.6 4.9 16.9 0.1 0.9 0.5 0.5 0.1 9.8 111.8 103.1 0.3 0.2 0.5 0.0 100.6 95.4 132.8 0.3 113.6 0.6 10.2 2.2 107.1 0.9 0.4 4.0 0.4 0.3 1.9 0.2 7.0 0.6 70.5 0.1 27.0 3.6 97.5 0.0 0.3 1.4 0.4 0.4 1.1 124.2 0.0 0.8 0.2 2.9 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.4 0.1 0.0 0.9 0.1 0.0 0.1 7.6 0.0 0.0 0.0 26.6 0.0 0.4 0.2 0.7 0.0 0.1 0.2 0.0 0.0 0.0 1.3 0.3 0.0 1.8 0.1 0.0 34.9 0.0 0.0 3.1 1.6 0.0 0.0 0.0 0.3 0.0 0.0 10.9 13.9 0.2 0.1 0.0 0.4 2.6 0.0 0.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.1 123.2 103.8 251.4 111.8 103.1 100.6 95.4 132.8 107.1 70.5 97.5 124.2 0.1 0.0 0.0 12.1 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.3 1.4 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 0.2 0.4 0.0 0.4 0.1 1.2 2.7 27.8 11.7 0.2 2.5 6.1 0.0 0.0 0.2 1.4 0.0 0.4 0.0 32.1 3.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 8.4 0.0 2.2 0.0 6.6 10.9 3.9 3.9 0.0 0.0 0.1 64.0 0.1 0.0 3.7 0.0 0.0 0.4 0.2 3.9 0.0 0.0 0.4 0.0 0.0 7.0 0.1 TCP10L PRED77 ENSG00000242220 "T-complex 10 like" Q8TDR4 21 32497967-32587373 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 205.2" "Cell type enhanced" "Detected in many" "Early spermatids: 1153.7;Late spermatids: 1940.5;Spermatocytes: 455.0" "Cancer enhanced" "Detected in single" "liver cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.2;hTERT-RPE1: 2.0;SCLC-21H: 1.4;THP-1: 1.8" HPA044709 Approved NA NA "HPA044709: AB_10961410" "unprognostic (2.31e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-3)" "unprognostic (5.05e-2)" "unprognostic (1.03e-1)" "unprognostic (1.63e-1)" "unprognostic (1.33e-3)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (8.41e-5)" "unprognostic (4.98e-2)" "unprognostic (5.94e-2)" "unprognostic (5.67e-2)" "unprognostic (1.64e-3)" 0.6 0.8 2.2 0.0 1.8 1.4 0.8 3.7 4.2 1.6 0.9 0.9 0.3 0.9 1.9 0.5 1.8 0.4 2.0 1.7 1.4 1.5 18.7 0.6 0.2 1.5 1.1 1.5 1.4 0.6 0.2 1.4 0.4 1.8 1.6 0.4 1.9 0.7 0.5 0.7 0.9 0.5 0.0 0.9 0.8 0.6 205.2 1.1 0.4 1.0 0.3 0.4 0.7 1.0 2.3 0.0 0.2 0.3 0.1 0.4 0.2 0.2 0.1 0.4 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.4 2.2 0.2 0.2 0.2 0.2 0.1 0.4 0.0 2.0 0.0 0.1 0.1 0.1 0.3 0.6 0.3 0.8 0.1 0.1 0.0 0.1 0.2 0.3 0.4 0.1 1.4 0.0 0.0 0.0 0.4 0.5 0.3 1.8 0.6 0.4 0.1 0.1 0.0 0.5 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 2.2 1.8 3.7 4.2 1.7 1.4 1.5 1.1 1.5 1.8 0.9 1.1 2.3 1.1 0.0 0.5 2.0 0.3 1.1 0.5 1.2 0.0 1.1 0.8 0.9 2.5 1.5 0.9 0.0 0.0 0.2 0.0 0.2 0.0 0.6 1153.7 1.9 0.4 0.9 0.0 0.0 2.9 0.2 0.2 0.8 0.0 0.5 4.5 0.7 0.7 23.0 0.3 0.0 1.7 0.8 2.0 0.8 0.3 1940.5 16.8 1.2 0.0 0.0 0.0 3.8 0.0 0.5 1.6 0.2 0.1 10.1 0.0 0.7 0.0 1.5 1.6 1.1 26.3 0.4 0.6 455.0 9.2 0.0 1.4 0.3 0.1 0.1 0.4 0.2 PSG2 "CEA, PSBG2, PSG1, PSGGB" ENSG00000242221 "Pregnancy specific beta-1-glycoprotein 2" P11465 19 43064209-43083045 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 223 "placenta: 240.7" "Cell type enriched" "Detected in some" 30 "Syncytiotrophoblasts: 802.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 10.8;fHDF/TERT166: 23.9;HBF TERT88: 34.8;SuSa: 9.4;U-2197: 45.7" "Secreted in female reproductive system" NA NA 41000000 "unprognostic (1.02e-2)" 0.0 0.0 0.2 0.0 0.1 0.8 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 240.7 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.9 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 1.8 1.0 4.7 0.0 0.0 0.0 0.0 23.9 1.3 0.5 0.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.1 45.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.6 0.3 0.0 0.2 0.0 0.1 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 802.3 0.0 0.0 0.0 0.8 ARFGAP3 ARFGAP1 ENSG00000242247 "ADP ribosylation factor GTPase activating protein 3" Q9NP61 22 42796502-42858106 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000638 Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA000638: AB_1078188" "unprognostic (3.29e-2)" "unprognostic (6.08e-2)" "unprognostic (3.22e-1)" "prognostic favorable (8.97e-6)" "unprognostic (5.83e-2)" "unprognostic (8.85e-3)" "unprognostic (5.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.31e-1)" "unprognostic (9.06e-3)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (2.52e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.65e-4)" "unprognostic (1.73e-1)" 30.4 89.7 16.9 34.4 17.8 48.3 31.2 20.0 20.5 56.6 24.4 27.2 36.8 32.5 53.7 22.3 23.1 36.9 23.8 18.3 30.0 37.5 49.6 32.6 28.3 21.5 19.9 16.4 20.8 86.5 38.3 38.4 35.1 20.5 65.3 30.9 35.8 69.1 40.6 31.6 20.0 51.6 31.1 19.8 26.2 43.6 50.0 19.8 26.1 61.9 22.0 32.9 45.7 23.6 21.4 59.6 19.3 41.1 24.7 57.2 94.1 17.3 111.8 76.4 50.5 60.9 23.5 32.8 30.1 24.5 102.9 41.8 14.4 18.7 33.0 54.7 18.5 25.4 35.7 27.6 37.4 79.6 31.9 53.2 42.0 57.6 42.6 75.9 71.9 52.4 27.4 16.1 132.0 89.6 15.7 49.4 17.5 6.7 32.7 23.2 31.1 92.3 38.3 80.7 27.5 14.6 9.0 54.3 21.5 46.0 30.6 22.7 24.4 67.0 58.7 42.5 52.1 30.7 94.7 48.2 33.1 41.9 34.0 46.7 86.2 33.2 36.8 45.1 44.4 58.8 27.1 29.7 39.8 32.5 26.1 19.2 27.2 50.8 49.4 50.9 53.1 28.8 30.1 16.9 17.8 20.0 20.5 18.3 30.0 21.5 19.9 16.4 20.5 19.8 19.8 21.4 40.8 38.5 54.8 27.4 41.7 26.6 86.9 43.0 19.9 42.8 43.1 29.5 26.5 37.1 62.1 57.0 18.8 18.8 67.3 36.4 66.5 65.9 19.1 60.5 89.9 42.4 49.1 17.5 26.1 64.3 23.7 58.1 30.1 96.3 65.9 28.4 30.4 37.3 28.7 33.7 28.8 53.0 46.8 21.7 89.3 15.0 48.1 68.2 69.4 35.6 33.7 40.5 38.1 43.7 40.0 83.0 15.6 45.5 110.0 121.5 70.9 62.9 65.5 33.7 39.5 80.0 65.5 178.7 67.6 14.6 26.7 59.9 49.6 39.0 22.7 86.7 BGLAP OCN ENSG00000242252 "Bone gamma-carboxyglutamate protein" P02818 1 156242184-156243317 "FDA approved drug targets, Predicted secreted proteins" Biomineralization "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 20.0;choroid plexus: 8.4;intestine: 6.4" "Cell type enhanced" "Detected in some" "Ionocytes: 4.1;Melanocytes: 3.6;Plasma cells: 2.8;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "NK-cell: 1.8;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 17 "dendritic cells: 1.6;NK-cells: 1.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.3;U-87 MG: 5.4" "Region enriched" "Detected in single" 9 "olfactory bulb: 7.8" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 15500000 2200000 "unprognostic (2.50e-2)" "unprognostic (4.49e-2)" "unprognostic (3.82e-4)" "unprognostic (1.13e-1)" "unprognostic (1.57e-1)" "unprognostic (8.44e-5)" "unprognostic (2.63e-2)" "unprognostic (6.54e-2)" "unprognostic (5.64e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-3)" "unprognostic (4.70e-2)" "unprognostic (9.67e-6)" "unprognostic (3.02e-2)" "unprognostic (1.72e-1)" "unprognostic (4.34e-2)" "unprognostic (8.64e-3)" 0.6 0.5 10.5 0.6 11.2 0.9 0.6 11.0 20.0 1.6 8.4 6.4 0.6 1.4 1.1 0.7 1.4 0.6 0.6 10.1 10.4 1.1 1.6 0.6 0.4 12.4 11.7 9.3 1.9 0.8 0.2 1.2 0.4 11.4 2.0 1.8 0.2 1.7 0.7 0.5 1.7 2.3 1.8 11.8 1.9 0.9 0.4 10.7 0.3 1.4 0.0 0.2 0.8 1.0 12.5 0.1 1.5 0.7 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.5 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.5 0.1 0.2 0.4 0.0 0.0 0.7 0.6 0.1 0.3 0.7 0.1 0.4 1.8 0.0 0.2 0.6 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.4 0.7 1.1 1.4 5.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.6 0.0 0.0 10.5 11.2 11.0 20.0 10.1 10.4 12.4 11.7 9.3 11.4 11.8 10.7 12.5 0.6 0.0 0.0 0.0 0.6 1.5 1.0 1.0 0.6 0.2 1.1 0.9 0.0 0.0 1.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.2 0.3 1.0 0.5 0.5 0.0 1.1 1.1 0.2 0.2 0.0 0.0 0.9 4.1 0.0 0.8 0.2 1.5 0.5 3.6 0.0 0.4 0.4 1.0 0.0 0.0 0.0 1.1 0.4 2.8 0.7 0.3 2.0 0.3 0.6 6.6 0.5 0.3 0.4 0.8 0.6 1.3 0.4 0.6 0.8 0.8 0.7 C22orf39 MGC74441 ENSG00000242259 "Chromosome 22 open reading frame 39" Q6P5X5 22 19351368-19447711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073701 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA073701: AB_2686627" "unprognostic (4.97e-2)" "unprognostic (2.67e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.16e-4)" "unprognostic (1.27e-2)" "unprognostic (6.53e-2)" "unprognostic (5.07e-2)" "unprognostic (1.95e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (1.45e-3)" "unprognostic (5.34e-3)" "prognostic favorable (1.44e-4)" "unprognostic (6.51e-2)" "unprognostic (2.92e-1)" "unprognostic (1.32e-2)" "unprognostic (5.32e-2)" 23.6 23.1 38.5 8.9 37.6 13.8 22.2 37.3 50.0 21.5 36.2 31.3 10.5 22.4 11.3 15.5 22.5 7.8 40.7 37.6 36.1 22.7 18.2 18.0 12.9 38.8 37.9 36.7 20.0 26.5 22.8 24.5 10.5 39.7 26.4 11.9 24.1 16.5 13.7 119.5 19.0 19.9 11.4 37.9 21.2 23.7 16.9 38.4 16.3 28.1 45.2 12.5 27.1 17.9 38.3 20.7 7.1 16.3 11.5 17.5 15.4 12.1 5.9 5.7 13.7 15.8 11.3 4.8 15.8 6.8 6.4 8.2 17.3 16.3 10.9 14.7 17.3 66.7 20.1 19.2 26.5 17.1 30.8 19.5 12.9 17.6 7.3 19.9 14.7 14.0 33.6 60.6 21.5 9.0 10.1 24.0 27.3 7.2 42.4 18.2 25.8 23.9 11.5 18.4 12.1 24.8 12.4 11.8 8.3 23.9 14.9 11.4 18.4 13.4 9.9 18.6 7.0 9.1 29.4 12.6 22.8 11.6 14.7 9.4 36.4 29.6 72.0 23.0 33.8 21.9 27.8 25.7 19.7 26.1 27.9 25.9 21.4 43.0 31.1 30.3 38.8 35.3 26.7 38.5 37.6 37.3 50.0 37.6 36.1 38.8 37.9 36.7 39.7 37.9 38.4 38.3 41.6 22.4 40.4 10.1 39.5 24.3 28.4 58.8 23.3 28.7 42.8 44.3 94.1 27.1 50.8 36.8 16.7 54.6 50.8 44.3 107.6 40.4 21.5 36.0 20.8 29.7 45.1 41.2 13.9 77.9 47.9 31.2 35.7 26.4 26.6 25.9 36.0 35.3 65.4 18.5 17.3 44.4 52.9 38.0 33.5 12.7 35.1 32.8 39.2 5.6 59.6 52.3 60.8 10.1 14.5 58.7 42.0 33.8 37.6 34.6 69.0 67.2 46.1 20.4 46.0 31.9 36.9 54.8 57.6 37.8 32.5 50.3 34.9 33.1 55.9 31.2 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 173.7;brain: 263.2;placenta: 470.9" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6" "Region enhanced" "Detected in all" "hypothalamus: 110.7" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372" "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 3.2 173.7 116.0 2.6 113.9 0.9 24.8 44.0 45.5 7.6 0.0 4.0 0.8 5.7 1.9 2.3 10.1 3.2 1.6 38.8 236.1 7.4 2.4 15.5 5.1 57.7 118.0 41.5 65.7 11.5 2.1 89.0 470.9 102.0 2.7 2.0 23.2 9.2 2.6 2.2 0.6 1.6 3.9 18.6 2.0 2.9 41.5 263.2 13.4 11.5 3.3 3.2 3.7 1.6 97.4 22.8 111.6 773.3 329.0 16.0 28.5 45.0 60.7 35.3 42.8 57.3 187.6 37.0 2.5 2.2 70.2 87.5 6.9 1015.3 43.1 58.9 2.9 107.0 0.1 121.8 805.0 12.0 129.6 0.2 63.9 13.9 105.7 73.0 37.1 25.8 0.0 0.5 243.7 84.5 5.8 0.5 0.1 355.4 19.1 70.5 48.5 247.6 67.4 194.3 83.2 488.6 28.2 0.4 16.9 59.9 192.8 105.8 0.3 0.0 33.7 2.0 4.2 46.9 65.2 46.4 97.1 76.3 0.1 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 116.0 113.9 44.0 45.5 38.8 236.1 57.7 118.0 41.5 102.0 18.6 263.2 97.4 4.0 153.8 82.4 11.4 37.1 0.8 9.1 2.5 0.6 87.5 49.4 74.3 42.8 5.7 69.8 16.5 8.4 2015.8 3.3 0.9 64.6 18.1 4.5 9.7 3.0 8.4 60.4 0.0 15.8 5.3 205.1 45.3 2.0 15.4 2.5 24.2 4.2 4.7 175.8 37.0 21.9 0.6 8.2 0.0 0.6 18.9 9.0 1.7 14.2 4.7 0.0 109.0 0.0 10.1 12.8 5.2 0.0 4.1 1.5 9.6 0.0 22.0 8.9 29.7 6.6 173.1 23.0 52.9 51.5 2.5 0.9 2856.1 2.6 68.9 0.7 0.6 CT47A2 CT47.2 ENSG00000242362 "Cancer/testis antigen family 47 member A2" Q5JQC4 X 120977606-120980928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A8 UGT1H ENSG00000242366 "UDP glucuronosyltransferase family 1 member A8" Q9HAW9 2 233617645-233773310 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.1;liver: 20.2;urinary bladder: 30.3" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 4.5;Club cells: 1.0;Ionocytes: 2.0;Paneth cells: 2.5;Proximal enterocytes: 1.3;Squamous epithelial cells: 1.1" "Cancer enriched" "Detected in some" 5 "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 64 "RT4: 121.4" NA NA "unprognostic (1.27e-2)" "unprognostic (1.35e-1)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (4.78e-1)" "unprognostic (9.71e-12)" "unprognostic (9.26e-2)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 2.8 0.0 0.0 1.9 0.0 6.6 0.0 0.0 0.0 1.8 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.9 0.0 0.5 0.0 0.0 0.1 4.4 1.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 30.3 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 121.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.4 0.2 IGKV1-39 ENSG00000242371 "Immunoglobulin kappa variable 1-39" P01597 2 89319625-89320146 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 75.0;lymphoid tissue: 256.9;salivary gland: 152.5;stomach 1: 83.9" "Cell type enriched" "Detected in some" 151 "Plasma cells: 16225.1" "Cancer enhanced" "Detected in many" "stomach cancer: 13.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 388 "memory B-cell: 1069.8;naive B-cell: 935.1" "Lineage enriched" "Detected in many" 415 "B-cells: 1069.8" "Cell line enriched" "Detected in some" 21 "Daudi: 194.2" HPA048721 Approved "Immunoglobulin genes" NA NA 8000000000 "HPA048721: " "prognostic favorable (1.76e-4)" "unprognostic (5.10e-3)" "unprognostic (4.71e-2)" "prognostic favorable (1.70e-5)" "unprognostic (2.38e-1)" "unprognostic (7.33e-2)" "unprognostic (1.78e-1)" "unprognostic (6.62e-6)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (4.27e-1)" "unprognostic (2.25e-1)" 6.0 9.2 0.0 55.2 0.0 14.3 17.8 0.0 0.1 13.9 0.0 62.9 71.1 5.7 0.0 11.7 12.6 14.4 1.6 0.2 0.0 10.7 6.8 27.4 36.8 0.1 0.0 0.0 1.8 3.2 0.0 0.5 0.0 0.1 4.3 13.5 0.0 152.5 1.0 0.2 0.8 75.0 1.2 0.0 256.9 83.9 0.3 0.0 6.0 31.3 0.0 42.8 17.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 1.8 0.0 9.0 0.0 0.0 0.0 0.9 1.0 0.7 0.3 0.3 0.3 1069.8 0.5 0.4 1.1 935.1 0.3 0.6 2.5 0.4 0.6 1.3 0.8 136.4 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 10.7 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16225.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 4.9 0.0 0.3 0.0 EIF6 "b(2)gcn, EIF3A, ITGB4BP, p27BBP" ENSG00000242372 "Eukaryotic translation initiation factor 6" P56537 20 35278907-35284985 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 700.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040873 Enhanced Supported Nucleoplasm NA NA 260000 Nucleoplasm "HPA040873: AB_2677182" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.06e-1)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.25e-5)" "unprognostic (9.94e-3)" "unprognostic (4.97e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.51e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (9.18e-2)" "unprognostic (8.15e-2)" 66.9 100.2 54.6 62.3 55.7 76.5 88.2 57.1 65.4 77.0 61.4 121.4 143.9 81.0 81.4 244.5 99.9 65.3 51.1 55.8 59.2 129.6 173.8 64.5 76.1 58.0 57.0 55.7 68.0 74.3 93.8 56.9 68.7 59.0 77.4 124.0 21.8 89.5 85.0 52.6 167.1 120.3 93.7 57.6 69.4 84.0 72.4 56.4 79.7 65.4 57.4 121.4 147.9 126.6 60.2 338.1 447.4 115.3 137.1 136.9 161.9 148.6 205.5 250.8 431.5 322.3 864.0 306.2 232.1 251.2 258.2 326.7 261.8 234.6 671.8 299.9 60.0 154.8 397.5 188.7 752.0 262.6 225.1 177.1 162.8 430.3 331.3 680.3 185.8 298.1 131.4 253.1 116.6 459.7 325.8 128.2 285.5 151.2 367.4 375.3 173.1 203.9 207.1 590.5 243.6 194.2 178.3 163.4 675.6 266.5 93.3 314.7 177.0 248.2 478.8 211.7 244.0 326.3 135.0 149.4 221.8 243.2 216.7 274.6 420.1 267.8 230.4 166.0 278.1 182.5 261.7 165.1 183.9 318.5 263.4 132.7 158.1 89.6 247.4 316.1 291.0 196.8 353.2 54.6 55.7 57.1 65.4 55.8 59.2 58.0 57.0 55.7 59.0 57.6 56.4 60.2 80.8 64.1 54.2 4.9 75.7 281.3 270.0 333.6 95.6 32.6 81.9 102.4 27.8 114.4 201.0 165.5 10.4 237.5 82.5 363.7 197.6 375.8 68.9 92.3 60.1 90.3 105.7 50.9 5.7 378.8 217.7 78.5 73.9 90.2 99.0 62.2 60.7 216.0 176.6 25.2 5.0 150.7 193.3 78.6 169.8 94.5 81.7 89.9 106.7 1.9 226.8 68.3 81.4 2.0 6.2 700.9 468.3 67.0 53.9 213.1 373.0 527.0 116.8 32.2 65.7 70.7 170.7 130.5 77.8 197.3 346.5 256.0 70.0 120.4 215.0 468.0 RBMY1E ENSG00000242389 "RNA binding motif protein Y-linked family 1 member E" A6NEQ0 Y 21903618-21918067 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 2.6" "Group enriched" "Detected in some" 6 "Spermatocytes: 1.7;Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-266/84: 2.3" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 35.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.1;Horizontal cells: 3.3" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 9.1;SCLC-21H: 7.3;SH-SY5Y: 14.2;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.2 1.1 17.8 0.1 11.9 0.0 0.2 19.6 11.0 0.3 0.0 0.4 0.0 0.4 0.2 0.2 0.3 0.2 1.6 12.5 35.6 0.1 0.1 0.4 0.1 16.1 18.5 13.4 0.4 0.3 0.0 1.1 0.1 10.3 0.2 0.1 6.7 0.3 0.1 0.7 0.5 0.2 0.2 22.0 0.1 0.2 0.9 17.1 0.0 0.1 0.3 0.2 0.2 0.3 32.1 0.0 0.0 0.9 0.2 0.2 0.7 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.8 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 1.3 0.0 0.0 9.1 0.5 0.0 0.0 0.1 7.3 14.2 0.1 0.0 0.1 10.0 0.1 0.3 0.1 0.8 0.1 0.2 0.6 0.2 0.0 0.2 0.6 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 11.9 19.6 11.0 12.5 35.6 16.1 18.5 13.4 10.3 22.0 17.1 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GTF2A1L ALF ENSG00000242441 "General transcription factor IIA subunit 1 like" Q9UNN4 2 48617798-48733148 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 60.5" "Cell type enhanced" "Detected in some" "Early spermatids: 9.2;Late spermatids: 2.3;Spermatocytes: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.6;hTERT-RPE1: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.59e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-1)" "unprognostic (4.77e-1)" "unprognostic (5.02e-2)" 1.8 0.5 1.2 0.0 0.7 0.0 1.2 1.5 0.7 2.5 0.7 5.9 0.4 4.2 0.5 0.7 3.0 1.1 0.7 0.4 0.6 1.1 0.2 1.2 0.2 3.8 1.2 0.2 2.1 0.2 0.0 0.5 0.2 2.4 2.1 0.1 0.1 0.2 0.2 0.6 0.4 1.7 0.6 2.0 1.3 2.6 60.5 1.5 0.1 0.5 0.1 0.0 4.3 1.6 3.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 1.5 0.7 0.4 0.6 3.8 1.2 0.2 2.4 2.0 1.5 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 IGHJ5 ENSG00000242472 "Immunoglobulin heavy joining 5" 14 105863814-105863862 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 74.0;intestine: 73.0" "Cell type enriched" "Detected in single" 397 "Plasma cells: 39.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "hypothalamus: 28.0" "Immune cell enriched" "Detected in many" 263 "memory B-cell: 1081.0" "Lineage enriched" "Detected in many" 263 "B-cells: 1081.0" "Group enriched" "Detected in some" 11 "HL-60: 10.5;REH: 14.0;RH-30: 18.0" NA NA 33.8 0.0 1.2 0.0 3.0 0.0 74.0 1.2 6.7 0.0 2.1 73.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 1.5 28.0 4.6 29.7 17.2 0.0 3.7 4.0 0.6 0.0 4.8 0.0 0.0 0.0 2.5 33.0 0.2 0.2 0.0 0.0 0.0 7.9 0.0 0.0 1.4 0.0 0.0 0.4 1.9 0.0 4.9 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.6 2.1 1.2 0.7 1081.0 0.4 0.6 4.1 0.0 2.6 0.9 2.3 0.7 0.6 0.0 1.1 316.0 1.2 3.0 1.2 6.7 1.5 28.0 3.7 4.0 0.6 2.5 1.4 1.9 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPL20 FLJ10024 ENSG00000242485 "Mitochondrial ribosomal protein L20" Q9BYC9 1 1401909-1407293 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047074 Supported Supported Mitochondria NA NA Mitochondria "HPA047074: AB_10964064" "unprognostic (4.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-2)" "unprognostic (5.79e-2)" "unprognostic (3.71e-1)" "unprognostic (2.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (2.80e-2)" "unprognostic (2.33e-1)" "unprognostic (4.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (1.64e-1)" 107.2 121.2 149.4 82.5 152.9 72.7 110.9 151.9 180.9 82.8 149.1 116.6 84.4 90.5 136.2 118.2 91.0 69.1 170.4 148.7 169.5 126.5 154.0 87.5 101.2 151.8 152.5 132.6 84.9 137.7 101.5 118.2 69.2 149.5 111.8 87.7 60.1 133.1 91.2 279.8 97.1 92.0 76.1 156.5 101.0 117.7 61.0 161.9 72.5 103.2 162.3 103.4 108.5 88.4 160.2 216.1 204.2 149.7 152.8 113.4 122.7 110.6 188.3 143.8 240.7 171.1 244.9 255.4 228.5 256.8 162.9 111.4 133.8 247.6 203.8 185.9 199.0 350.3 247.0 369.0 244.8 156.5 367.3 152.7 143.9 76.8 184.8 196.4 138.4 181.1 213.8 254.6 131.8 204.8 216.3 285.2 279.2 155.8 249.6 409.1 186.0 138.3 291.3 189.9 142.8 265.4 218.5 179.2 369.9 288.7 124.7 158.8 268.0 155.2 144.9 170.0 219.6 236.2 200.6 313.5 450.5 224.2 296.4 103.7 124.6 191.2 146.5 164.8 190.1 183.7 189.3 181.9 163.3 198.2 177.2 204.1 199.0 89.2 163.1 150.8 289.2 175.0 219.6 149.4 152.9 151.9 180.9 148.7 169.5 151.8 152.5 132.6 149.5 156.5 161.9 160.2 97.5 67.3 115.5 19.9 120.3 130.3 134.8 206.8 99.0 77.8 153.0 171.4 255.2 145.8 166.0 161.8 35.5 234.5 129.2 138.6 530.2 232.6 39.3 153.1 121.8 118.4 138.2 152.7 13.7 325.9 265.0 113.6 87.7 126.3 106.2 92.7 131.0 384.0 220.6 50.5 13.8 185.5 177.0 139.7 111.0 30.7 107.8 117.9 138.7 11.2 200.8 279.3 183.4 9.5 20.8 261.8 167.4 110.9 163.3 254.8 194.1 543.9 146.9 107.7 65.7 121.8 135.7 131.7 202.7 179.9 157.7 226.2 109.2 121.9 216.1 170.2 ARPIN "C15orf38, MGC61550" ENSG00000242498 "Actin related protein 2/3 complex inhibitor" Q7Z6K5 15 89895006-89912952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 109.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 5.3;intermediate monocyte: 2.9;myeloid DC: 4.5" "Group enriched" "Detected in many" 6 "dendritic cells: 4.5;monocytes: 5.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040513, HPA047173, HPA052278" Uncertain NA NA "HPA040513: AB_2677015, HPA047173: AB_2679969, HPA052278: AB_2681783" "unprognostic (2.63e-1)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.01e-2)" "unprognostic (2.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (7.46e-2)" "unprognostic (2.67e-3)" "unprognostic (1.75e-2)" "unprognostic (1.57e-1)" "prognostic favorable (4.19e-4)" "unprognostic (8.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.23e-1)" "unprognostic (6.62e-3)" 10.7 4.8 9.1 7.1 9.7 0.9 8.5 11.0 9.0 11.2 5.3 15.1 14.6 12.0 14.0 10.4 11.6 8.2 8.2 8.1 9.3 7.5 5.2 12.0 4.6 10.9 9.2 7.1 14.9 40.3 13.0 5.0 8.7 9.8 12.7 16.8 9.5 9.0 11.4 9.6 12.3 17.1 11.6 9.2 7.8 8.0 6.1 9.8 3.4 8.8 8.2 5.5 9.6 10.8 9.6 13.9 18.5 18.6 12.3 10.9 14.9 3.5 12.8 9.5 8.5 9.6 2.6 18.8 0.1 6.3 11.6 3.4 6.4 0.1 12.6 7.6 0.1 4.6 0.1 22.1 3.5 7.2 0.1 1.2 9.7 12.2 10.2 2.1 6.5 14.9 0.1 0.1 0.6 11.1 2.8 0.0 0.3 7.5 11.6 2.1 0.0 0.5 0.1 4.5 13.2 0.6 6.1 28.1 11.4 14.5 9.9 22.4 3.8 10.3 15.8 17.6 20.3 6.4 0.3 0.1 0.2 13.1 0.1 5.9 0.5 5.3 0.1 0.1 2.9 0.3 0.1 0.1 0.0 4.5 0.2 0.1 0.1 0.7 0.2 0.4 0.3 0.0 1.3 9.1 9.7 11.0 9.0 8.1 9.3 10.9 9.2 7.1 9.8 9.2 9.8 9.6 14.8 25.6 21.0 0.0 1.0 0.0 16.2 0.0 11.4 9.5 11.1 10.3 10.2 22.8 8.1 16.5 12.5 16.1 0.3 19.0 3.9 10.0 33.3 13.0 11.8 13.2 12.2 1.7 0.0 15.8 17.5 13.6 9.2 10.9 6.3 15.7 13.2 13.4 24.4 5.0 0.0 18.3 0.0 26.6 0.0 109.0 15.2 18.5 0.0 0.0 23.0 14.0 0.0 0.0 0.0 12.8 23.8 17.0 0.2 12.5 50.6 19.2 5.1 15.4 13.1 18.3 11.9 20.2 5.7 18.2 0.0 6.7 0.8 6.4 20.6 12.1 UGT1A10 UGT1J ENSG00000242515 "UDP glucuronosyltransferase family 1 member A10" Q9HAW8 2 233636454-233773305 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 22.2;intestine: 80.2;stomach 1: 33.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 1.8;Gastric mucus-secreting cells: 3.6;Intestinal goblet cells: 1.0;Paneth cells: 1.4;Proximal enterocytes: 3.9;Squamous epithelial cells: 4.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 143 "RT4: 523.3" "Intracellular and membrane" NA NA "unprognostic (9.33e-2)" "unprognostic (7.64e-2)" "unprognostic (2.45e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.49e-10)" "unprognostic (2.90e-1)" "unprognostic (1.50e-1)" "unprognostic (3.59e-3)" 0.1 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 50.0 80.2 0.1 0.0 14.8 0.0 22.2 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 36.8 0.0 0.9 0.0 0.0 0.9 53.5 2.0 0.0 0.0 33.0 1.5 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 523.3 0.0 0.1 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 0.3 IGKV2D-28 ENSG00000242534 "Immunoglobulin kappa variable 2D-28" P01615 2 89959979-89960754 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 223.6;lymphoid tissue: 466.4;salivary gland: 261.9" "Cell type enriched" "Detected in some" 98 "Plasma cells: 4332.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 224 "memory B-cell: 3054.0;naive B-cell: 2203.9" "Lineage enriched" "Detected in all" 260 "B-cells: 3054.0" "Cell line enhanced" "Detected in some" "HDLM-2: 5.0;RPMI-8226: 2.0;SCLC-21H: 1.9;SH-SY5Y: 4.3;U-698: 4.4" "Immunoglobulin genes" NA NA 3500000000 "unprognostic (3.88e-3)" "unprognostic (2.68e-2)" "unprognostic (2.51e-3)" "unprognostic (1.22e-1)" "unprognostic (1.13e-1)" "unprognostic (4.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.66e-1)" 7.9 4.8 0.1 163.5 0.3 23.5 35.5 0.1 1.5 7.2 0.4 205.7 223.6 8.4 1.2 114.5 14.1 26.3 4.9 0.4 2.0 11.5 13.4 41.0 168.0 0.7 0.4 0.2 2.9 1.9 0.1 0.9 0.4 0.5 11.2 66.5 0.0 261.9 19.4 0.3 0.9 144.5 8.8 0.2 466.4 188.0 5.7 0.3 41.3 38.1 0.3 193.6 159.2 8.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 1.1 0.0 0.0 0.0 5.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.1 0.0 0.0 0.7 0.0 2.0 0.0 0.0 1.9 4.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.6 1.3 0.0 4.4 0.0 1.1 0.0 11.7 7.8 1.2 1.2 0.5 1.3 3054.0 1.3 0.9 2.0 2203.9 0.2 0.9 2.2 1.0 1.5 1.4 1.3 248.7 0.1 0.3 0.1 1.5 0.4 2.0 0.7 0.4 0.2 0.5 0.2 0.3 0.4 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4332.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 31.5 0.0 0.1 0.0 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "bone marrow: 75.4" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.3;eosinophil: 1.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-937: 104.1" "Not detected" "Not detected" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol NA NA 59000 Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: AB_2684072" "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 0.2 0.1 0.3 0.1 0.2 75.4 0.0 0.4 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 1.2 0.1 0.1 0.1 0.7 0.1 0.0 0.2 0.9 0.0 0.0 0.6 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.7 0.1 1.5 0.1 0.0 0.0 0.1 0.1 104.1 0.1 0.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.3 0.3 0.2 0.4 0.4 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.0 4.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.2 HLA-DMB "D6S221E, RING7" ENSG00000242574 "Major histocompatibility complex, class II, DM beta" P28068 6 32934629-32941028 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 79.4;lymphoid tissue: 102.3" "Group enriched" "Detected in many" 4 "B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9" "Low region specificity" "Detected in all" "HPA012298, HPA077524" Supported Supported Vesicles NA NA Vesicles "HPA012298: AB_1853927, HPA077524: " "unprognostic (5.34e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.89e-5)" "unprognostic (3.07e-1)" "unprognostic (7.64e-3)" "unprognostic (4.00e-1)" "unprognostic (3.46e-3)" "unprognostic (6.99e-2)" "unprognostic (8.76e-2)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (6.82e-3)" "unprognostic (2.03e-1)" "unprognostic (4.14e-2)" "unprognostic (8.35e-2)" "unprognostic (5.60e-2)" 32.9 36.2 0.4 13.3 0.5 7.0 25.9 0.6 0.9 16.2 0.4 15.6 0.0 14.8 7.5 9.4 14.7 0.1 10.3 0.3 2.9 32.8 7.9 60.4 17.8 0.6 1.3 0.3 9.5 9.2 0.0 9.3 0.8 1.4 13.3 15.0 0.5 14.8 0.0 5.3 14.0 79.4 0.0 1.7 102.3 17.7 2.2 0.5 10.0 46.3 0.0 19.0 14.5 10.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 27.6 12.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 7.8 0.4 31.9 0.0 0.1 0.0 0.5 73.2 16.7 1.2 73.8 2.6 94.0 1.0 2.9 85.0 128.8 0.7 2.4 4.7 16.2 28.1 85.3 6.7 71.4 0.4 0.5 0.6 0.9 0.3 2.9 0.6 1.3 0.3 1.4 1.7 0.5 0.6 36.8 9.6 57.0 0.7 228.5 12.0 1.0 5.4 2.2 0.2 2.5 4.7 2.6 5.7 12.7 16.5 0.0 1.7 129.4 3.3 11.7 28.8 0.5 7.5 5.4 37.2 4.2 10.3 0.8 4.4 1.6 3.8 3.1 38.5 15.2 22.7 5.7 0.5 274.8 0.0 0.6 8.5 2.0 201.9 472.8 1.5 3.4 272.4 16.0 27.2 187.1 0.5 21.6 1.0 0.1 2.5 17.8 1.9 3.8 1.3 284.8 7.4 16.8 1.1 6.6 1.6 3.1 0.6 0.7 1.1 10.9 2.7 17.6 0.9 10.3 8.7 IGKV1D-43 ENSG00000242580 "Immunoglobulin kappa variable 1D-43" A0A0B4J1Z2 2 90209873-90210529 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.9;lymphoid tissue: 4.9;stomach 1: 3.7" "Cell type enriched" "Detected in some" 86 "Plasma cells: 695.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 152 "memory B-cell: 13.3;naive B-cell: 17.0" "Lineage enriched" "Detected in single" 171 "B-cells: 17.0" "Cell line enriched" "Detected in single" 310 "RPMI-8226: 79.1" HPA048721 Approved "Immunoglobulin genes" NA NA 380000000 "HPA048721: " "prognostic favorable (3.32e-5)" "unprognostic (6.71e-2)" "unprognostic (4.01e-2)" "unprognostic (1.27e-2)" "unprognostic (4.57e-3)" "unprognostic (1.37e-3)" "unprognostic (3.15e-1)" "unprognostic (2.67e-2)" "unprognostic (3.82e-5)" "unprognostic (3.96e-2)" "unprognostic (2.20e-1)" "unprognostic (6.26e-2)" "unprognostic (1.06e-1)" 0.2 0.0 0.0 2.8 0.0 1.3 1.4 0.0 0.0 0.0 0.0 2.7 1.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 2.0 0.2 0.0 0.0 2.9 0.0 0.0 1.8 3.7 0.0 0.0 0.5 0.1 0.0 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 695.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DECR2 "PDCR, SDR17C1" ENSG00000242612 "2,4-dienoyl-CoA reductase 2" Q9NUI1 16 401858-412487 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 166.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 129.2;Proximal enterocytes: 81.3;Proximal tubular cells: 159.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047631 Approved Peroxisomes,Microtubules NA NA Peroxisomes Microtubules "HPA047631: " "unprognostic (2.74e-2)" "unprognostic (3.84e-1)" "unprognostic (1.83e-1)" "unprognostic (4.44e-3)" "unprognostic (1.77e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (3.02e-2)" "unprognostic (3.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-1)" "unprognostic (2.21e-1)" "unprognostic (1.94e-1)" "unprognostic (4.22e-3)" 13.1 35.1 4.4 1.6 4.6 5.8 11.9 4.5 8.2 9.3 4.2 16.3 20.8 10.1 2.0 12.1 9.3 2.1 12.1 4.8 5.3 35.4 166.4 6.9 1.2 4.6 4.5 4.6 8.7 21.4 1.7 8.4 2.4 4.5 12.0 2.8 0.5 9.6 7.1 32.6 10.3 17.6 1.5 4.6 6.8 14.0 11.5 5.0 1.9 6.3 7.2 1.0 10.8 8.2 5.1 2.4 22.5 3.4 14.7 4.1 6.3 7.7 7.0 5.7 6.0 6.7 16.2 16.2 6.1 12.2 7.5 3.7 3.5 2.1 6.4 1.3 12.4 5.7 2.3 10.3 37.6 17.7 4.9 11.1 9.1 4.8 4.2 5.5 6.1 6.9 9.5 4.3 7.9 5.5 27.7 3.2 10.2 8.0 9.0 7.5 5.8 1.3 12.2 6.9 6.3 4.3 8.5 11.3 15.9 8.8 1.3 21.9 10.1 10.8 5.1 5.8 7.5 5.6 6.7 7.1 2.6 7.0 10.2 16.1 0.0 3.8 0.1 2.7 5.1 1.5 1.8 1.1 1.5 5.1 1.7 2.6 1.5 0.2 2.9 2.5 7.8 0.9 2.6 4.4 4.6 4.5 8.2 4.8 5.3 4.6 4.5 4.6 4.5 4.6 5.0 5.1 9.6 12.8 16.2 5.2 4.3 3.8 7.3 5.6 10.2 2.0 14.9 15.6 8.3 20.0 7.4 20.2 0.0 34.3 5.7 53.8 39.2 37.3 2.6 7.1 8.1 9.4 12.5 29.5 2.3 38.9 7.1 9.9 38.7 9.6 12.7 15.8 7.5 129.2 12.9 3.3 2.7 30.6 6.1 7.3 5.7 6.3 6.5 6.0 5.4 0.0 10.0 7.0 5.2 3.0 2.8 25.3 37.2 6.8 3.8 6.4 81.3 159.1 7.7 3.0 0.0 7.7 8.3 3.8 6.3 12.6 6.0 12.6 3.5 25.8 38.8 5.1 GNG10 ENSG00000242616 "G protein subunit gamma 10" P50151 9 111661605-111670226 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 75.7;Gastric mucus-secreting cells: 40.8;Macrophages: 49.7;Squamous epithelial cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 513.9" "Lineage enriched" "Detected in all" 9 "granulocytes: 513.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.25e-1)" "unprognostic (1.15e-1)" "unprognostic (2.21e-2)" "unprognostic (3.99e-2)" "unprognostic (4.68e-2)" "prognostic unfavorable (3.21e-5)" "unprognostic (3.62e-1)" "unprognostic (7.60e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (6.14e-2)" "unprognostic (8.91e-2)" "unprognostic (5.78e-2)" "unprognostic (8.83e-2)" "unprognostic (1.50e-1)" "unprognostic (3.27e-2)" "unprognostic (1.42e-1)" 99.5 94.0 59.5 94.4 60.5 87.3 50.8 58.0 80.8 58.6 61.0 47.5 37.6 49.3 50.3 41.8 43.2 59.5 69.7 60.6 65.9 53.4 72.8 64.0 79.2 63.1 62.8 58.9 34.3 40.0 99.5 45.7 84.2 61.2 81.1 46.6 11.4 54.3 42.4 36.5 23.3 44.6 69.5 60.7 49.3 41.8 26.8 65.4 37.5 58.1 59.4 42.6 124.0 27.0 63.9 126.1 60.3 54.7 81.8 186.1 138.5 86.6 128.4 159.0 119.2 110.0 92.0 90.4 7.5 54.0 165.0 182.2 91.6 94.4 124.4 148.0 42.4 92.8 16.7 64.3 69.7 121.3 51.6 44.2 120.8 94.8 104.2 149.8 133.7 146.1 55.3 54.9 32.3 204.3 81.6 35.6 45.2 90.2 189.8 134.3 26.3 246.9 6.8 230.4 79.5 81.4 69.2 126.7 61.0 127.6 82.1 138.0 81.5 101.2 111.5 92.2 234.2 138.7 21.5 43.1 15.8 161.2 124.3 74.2 27.6 57.9 83.8 13.0 54.8 20.4 10.8 16.8 16.2 49.4 14.7 17.8 13.7 513.9 12.6 47.0 31.9 32.6 35.7 59.5 60.5 58.0 80.8 60.6 65.9 63.1 62.8 58.9 61.2 60.7 65.4 63.9 3.8 12.8 15.3 0.0 10.9 1.8 1.5 3.7 75.7 0.7 3.8 2.4 0.2 4.3 7.7 1.8 0.0 4.5 0.7 6.2 0.0 22.1 0.1 2.2 7.2 13.1 13.8 28.4 0.0 20.8 5.5 16.4 40.8 2.3 10.1 0.9 5.0 2.9 7.2 0.0 0.0 9.0 2.0 9.9 2.8 0.2 1.8 49.7 0.0 0.0 8.5 1.1 1.0 0.0 0.0 21.9 20.2 2.2 25.8 1.4 14.2 3.9 8.1 0.6 0.0 2.4 12.1 0.1 0.1 51.0 1.1 1.5 11.1 1.3 10.4 1.5 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622665-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.0;brain: 6.3" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 7.9" "Low region specificity" "Detected in all" HPA019654 Approved Approved Vesicles NA NA 69200 Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 0.8 0.5 1.8 0.6 3.0 7.0 0.7 3.6 2.2 0.2 1.5 0.6 0.9 0.2 0.9 0.6 4.8 0.5 1.6 1.5 3.1 0.6 0.8 0.6 0.5 6.1 3.8 1.3 0.2 0.5 0.5 0.4 0.4 3.6 0.3 0.8 0.8 1.1 0.3 3.2 0.7 0.7 0.4 4.7 0.4 0.4 0.6 2.3 0.7 0.6 1.8 0.4 0.4 0.3 6.3 1.3 0.5 2.1 2.2 0.6 0.2 1.1 0.9 1.4 1.0 0.7 1.9 1.8 2.8 0.7 1.4 1.1 2.4 2.3 2.5 2.0 1.9 1.3 1.4 3.1 1.0 0.3 2.2 2.5 0.6 0.8 3.2 1.0 0.4 1.0 1.9 2.2 0.6 1.3 0.5 2.1 2.1 1.3 1.0 1.0 1.3 1.4 2.0 1.2 1.6 0.9 2.6 1.4 1.5 3.7 1.5 1.8 1.6 0.7 1.5 1.1 7.9 2.6 1.4 3.3 2.3 4.0 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.0 3.6 2.2 1.5 3.1 6.1 3.8 1.3 3.6 4.7 2.3 6.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 CCDC169 "C13orf38, LOC728591, RP11-251J8.1" ENSG00000242715 "Coiled-coil domain containing 169" A6NNP5 13 36222008-36297840 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 59.6" "Group enriched" "Detected in many" 11 "Early spermatids: 830.4;Late spermatids: 2135.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 15.0;U-937: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.12e-3)" "unprognostic (1.05e-1)" "unprognostic (7.09e-2)" "unprognostic (2.38e-1)" "unprognostic (3.51e-2)" "unprognostic (7.26e-4)" "unprognostic (6.91e-2)" "unprognostic (3.31e-2)" "unprognostic (5.78e-3)" "unprognostic (2.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (8.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.14e-2)" 0.6 0.4 1.3 0.4 1.2 2.9 0.7 2.4 2.8 0.4 0.0 0.6 0.5 1.2 2.5 0.7 0.4 0.5 0.6 1.1 0.4 0.6 0.3 0.2 0.4 0.6 0.5 0.7 0.4 0.4 1.9 0.1 0.5 1.3 1.3 0.5 2.7 0.2 1.3 0.5 0.6 0.4 1.5 0.1 0.4 0.7 59.6 0.2 0.2 0.4 0.6 0.1 1.0 0.1 3.3 0.2 0.4 0.8 0.4 1.5 2.7 4.7 0.8 1.2 0.7 0.5 0.2 0.3 0.6 0.5 0.3 2.6 0.5 5.5 0.3 1.5 0.7 0.5 4.9 1.2 0.3 3.5 15.0 0.5 1.9 1.3 0.5 1.1 1.2 3.3 0.4 4.3 1.5 2.7 0.2 0.5 6.0 0.4 0.1 0.3 0.4 1.4 0.3 0.7 1.9 0.7 2.2 0.3 0.7 0.2 4.9 0.5 6.5 1.1 0.9 1.9 0.6 1.5 0.7 0.6 0.2 0.6 9.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 1.2 2.4 2.8 1.1 0.4 0.6 0.5 0.7 1.3 0.1 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 0.3 2.3 1.4 0.8 0.0 1.0 1.8 4.2 2.8 0.0 0.0 0.0 0.1 830.4 0.8 1.2 1.0 1.2 3.8 0.0 0.0 4.0 0.4 0.0 1.4 0.0 4.1 0.0 0.0 0.5 3.3 0.0 0.1 2.0 0.0 0.0 2135.2 13.1 1.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 7.2 0.0 1.2 0.0 5.2 0.2 0.2 13.1 0.5 0.3 124.0 14.9 0.3 0.1 5.6 0.3 3.9 0.2 0.7 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 7.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favorable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favorable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 1.3 1.3 1.2 0.4 1.0 0.2 1.2 3.2 1.2 2.2 1.6 1.8 0.4 2.6 2.0 0.5 2.3 1.1 0.8 0.7 1.1 1.4 0.8 1.4 0.3 0.2 0.3 0.8 2.8 0.6 1.1 7.2 1.0 1.4 1.5 0.4 0.7 0.8 1.3 0.3 0.4 1.1 1.2 0.0 0.8 1.9 1.4 1.1 0.1 3.8 0.4 0.1 1.7 1.5 0.8 0.0 0.1 3.7 4.2 0.9 1.1 0.2 1.4 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.3 0.6 0.0 0.8 0.1 0.7 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 7.0 0.2 0.0 0.0 1.5 0.1 0.0 0.4 0.5 0.4 0.9 0.0 0.1 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 3.2 1.2 0.7 1.1 0.2 0.3 0.8 1.4 0.0 1.1 0.8 2.9 3.2 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 5.0 0.0 0.0 1.8 0.0 0.0 0.1 2.7 0.0 1.9 0.1 0.0 3.8 8.9 0.6 0.0 0.0 0.0 0.0 0.4 2.0 0.0 2.3 2.5 0.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 1.1 7.0 0.0 0.0 IGKV1D-17 ENSG00000242766 "Immunoglobulin kappa variable 1D-17" A0A075B6S4 2 90082635-90083291 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.8;lymphoid tissue: 12.6;salivary gland: 5.8" "Cell type enriched" "Detected in some" 13 "Plasma cells: 36.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 60 "memory B-cell: 7.7;naive B-cell: 4.1" "Lineage enriched" "Detected in single" 78 "B-cells: 7.7" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 1000000000 "HPA048721: " "prognostic favorable (1.47e-4)" "unprognostic (4.23e-2)" "unprognostic (2.43e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.68e-4)" "unprognostic (1.19e-1)" "unprognostic (6.18e-2)" "unprognostic (2.27e-1)" "unprognostic (8.86e-2)" "unprognostic (1.74e-5)" "unprognostic (1.38e-1)" "unprognostic (1.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.04e-3)" 0.6 0.1 0.1 5.1 0.2 0.9 0.8 0.0 0.3 0.3 0.6 3.7 1.5 0.2 0.0 0.5 0.8 0.6 0.0 0.1 0.1 0.3 0.4 1.5 0.8 0.5 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 2.2 0.0 5.8 0.3 0.0 0.4 4.8 0.4 0.1 12.6 2.0 0.0 0.1 0.3 0.5 0.0 4.6 1.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP5Z1 "KIAA0415, SPG48, zeta" ENSG00000242802 "Adaptor related protein complex 5 subunit zeta 1" O43299 7 4775615-4794397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035693 Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA035693: AB_10960687" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (3.01e-3)" "unprognostic (4.24e-2)" "unprognostic (2.43e-3)" "unprognostic (5.19e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.26e-2)" "unprognostic (5.32e-3)" "unprognostic (8.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.95e-2)" "unprognostic (2.22e-1)" 13.3 18.7 6.0 0.7 5.8 1.6 11.9 6.1 10.1 12.1 4.3 13.1 1.1 13.5 1.0 11.1 11.1 0.8 7.7 5.7 4.6 9.2 9.2 13.0 1.8 7.0 5.5 5.5 11.8 10.0 0.8 9.9 1.2 6.4 11.8 0.4 0.6 12.5 0.7 8.6 20.2 15.7 0.4 4.7 23.1 12.1 8.6 5.5 0.9 11.3 0.2 0.6 13.5 11.0 5.9 2.8 4.2 0.7 2.4 1.0 0.9 4.3 1.3 1.9 2.0 1.7 5.2 3.5 1.6 1.8 0.9 5.1 5.4 0.7 0.5 0.6 1.8 3.5 2.4 4.5 4.6 3.0 2.5 5.1 2.2 1.6 1.8 1.3 0.7 0.5 2.2 3.4 1.1 1.2 7.7 0.3 15.0 5.9 0.3 4.3 2.9 2.6 4.8 1.0 4.4 1.7 3.0 1.8 8.7 6.4 0.5 6.4 8.9 3.8 2.3 4.4 6.5 1.7 8.5 7.4 2.3 1.7 5.6 3.6 1.9 2.3 2.9 2.4 2.8 1.4 1.9 1.8 2.4 1.2 1.8 2.5 2.2 2.2 2.4 2.5 2.4 1.8 1.3 6.0 5.8 6.1 10.1 5.7 4.6 7.0 5.5 5.5 6.4 4.7 5.5 5.9 12.4 9.6 15.0 7.5 18.2 6.9 2.9 8.8 8.0 10.5 5.7 5.8 4.3 15.7 6.6 11.0 4.2 11.5 20.3 20.1 0.0 14.1 2.2 9.9 10.1 11.6 12.0 5.0 12.4 13.6 7.7 9.9 21.4 16.4 17.1 14.3 12.5 8.1 28.7 18.5 10.7 15.1 10.2 12.3 10.7 1.5 13.4 16.3 14.2 13.1 23.4 8.2 21.6 10.6 12.6 20.6 15.9 10.9 19.8 4.9 14.7 6.8 8.3 9.4 0.0 5.8 9.5 8.1 10.8 7.6 11.1 16.6 15.6 12.6 14.1 3.8 ZNF709 FLJ38281 ENSG00000242852 "Zinc finger protein 709" Q8N972 19 12461184-12513854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 15.4" "Cell type enhanced" "Detected in some" "Early spermatids: 39.8;Excitatory neurons: 14.5;Inhibitory neurons: 14.8;Late spermatids: 35.7;Oligodendrocyte precursor cells: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA045573, HPA053153" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045573: AB_2679370, HPA053153: AB_2682060" "unprognostic (2.27e-1)" "unprognostic (7.40e-4)" "unprognostic (3.53e-2)" "unprognostic (3.01e-2)" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (4.19e-3)" "unprognostic (2.58e-4)" "unprognostic (6.76e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-3)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" "unprognostic (1.71e-1)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (8.53e-5)" 1.1 0.9 2.3 0.8 2.1 0.5 1.6 2.8 2.5 1.5 1.4 0.8 0.0 1.4 1.6 0.6 2.1 0.6 1.0 2.2 2.3 1.6 0.4 0.9 0.8 3.2 2.2 1.8 2.7 1.2 2.3 1.6 1.0 1.5 1.8 0.5 3.1 1.1 1.3 0.9 0.8 0.8 1.1 2.0 1.3 0.8 15.4 2.2 2.1 2.9 1.0 1.2 0.9 1.2 2.0 1.1 0.0 3.6 4.4 0.6 1.0 0.6 1.1 1.3 1.2 1.3 1.0 0.1 1.1 0.7 1.2 0.3 0.8 2.0 0.8 1.4 0.3 0.5 1.0 0.7 0.7 1.4 0.2 1.6 0.5 0.3 0.7 0.0 1.7 0.8 1.4 0.6 0.1 1.5 2.1 2.6 1.3 1.3 0.4 1.1 1.3 3.5 3.5 1.2 1.8 1.6 2.3 0.0 0.1 0.5 1.6 0.8 0.6 0.0 1.8 0.4 0.8 0.8 2.0 3.0 1.6 0.0 0.0 0.9 2.7 0.1 0.0 0.9 0.0 1.4 0.9 1.5 0.9 0.4 0.9 2.0 1.4 0.0 2.5 0.6 0.6 0.9 0.4 2.3 2.1 2.8 2.5 2.2 2.3 3.2 2.2 1.8 1.5 2.0 2.2 2.0 0.7 0.0 0.5 8.5 1.3 0.4 0.2 0.3 0.0 0.8 0.8 0.4 0.5 0.0 0.8 1.8 0.0 0.4 0.5 0.4 0.0 0.4 39.8 1.5 0.6 0.6 0.0 0.8 14.5 0.4 0.3 0.4 0.5 0.5 0.0 2.3 1.4 0.4 0.5 0.0 14.8 0.5 0.0 1.3 0.4 35.7 0.9 0.5 0.0 7.5 0.1 1.5 0.0 17.6 8.2 0.3 0.1 0.7 0.6 0.4 0.1 1.2 1.0 2.3 6.6 0.6 1.0 6.8 3.3 0.6 0.6 0.3 0.5 0.4 0.3 0.2 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 8.6;pituitary gland: 4.4;retina: 3.6;testis: 5.1" "Cell type enhanced" "Detected in some" "Astrocytes: 10.1;Excitatory neurons: 55.7;Inhibitory neurons: 35.4;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048083 Enhanced NA NA "HPA048083: AB_2732545" "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.1 0.6 3.0 0.0 3.8 0.0 0.3 8.6 8.0 0.2 0.5 0.2 0.1 0.1 1.0 0.2 0.5 0.0 0.1 3.9 2.7 0.5 0.6 0.1 0.0 3.8 2.7 3.6 0.6 0.2 0.0 4.4 0.0 5.4 1.0 0.0 3.6 0.7 0.0 0.4 0.7 0.4 0.0 1.4 0.3 0.3 5.1 3.1 0.6 1.0 0.0 0.0 0.1 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.8 8.6 8.0 3.9 2.7 3.8 2.7 3.6 5.4 1.4 3.1 5.0 0.2 0.0 0.0 10.1 0.0 0.6 0.1 0.2 0.0 2.6 0.6 0.9 0.3 0.0 0.2 0.0 6.2 0.3 0.0 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.0 0.0 55.7 0.2 0.1 0.1 0.0 0.3 0.0 2.0 0.4 0.3 0.1 3.3 35.4 0.2 0.0 0.3 0.2 0.5 0.0 0.1 1.8 6.5 0.0 2.3 0.0 13.0 15.4 0.2 1.3 0.4 0.1 0.2 0.7 0.1 0.3 8.7 0.0 0.2 0.1 4.5 0.9 0.0 0.4 0.7 0.2 0.0 0.1 0.0 RBMY1B ENSG00000242875 "RNA binding motif protein Y-linked family 1 member B" A6NDE4 Y 21511338-21549094 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHJ3 ENSG00000242887 "Immunoglobulin heavy joining 3" 14 105864587-105864635 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 36.8;intestine: 58.4;pancreas: 62.2" "Cell type enriched" "Detected in single" 48 "Plasma cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 9.0;naive B-cell: 29.1" "Group enriched" "Detected in many" 7 "B-cells: 29.1;granulocytes: 9.0" "Cell line enhanced" "Detected in some" "Daudi: 1.5;RPMI-8226: 6.1;TIME: 8.0;U-251 MG: 2.6" NA NA "prognostic favorable (8.67e-4)" "unprognostic (8.67e-3)" "unprognostic (1.12e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.86e-5)" "unprognostic (3.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (4.22e-2)" "unprognostic (2.03e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (3.24e-4)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (9.62e-2)" "unprognostic (1.30e-1)" 16.3 3.0 0.7 0.0 0.9 0.0 0.0 0.2 2.2 1.9 0.5 0.0 0.0 0.0 0.0 36.8 0.7 9.1 0.0 0.5 0.7 1.0 10.3 17.5 0.0 1.6 3.3 0.0 11.4 62.2 0.0 0.0 0.0 1.5 7.6 58.4 0.1 0.0 4.3 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.3 0.8 0.0 2.4 0.0 0.0 5.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.4 0.2 0.0 0.9 0.0 0.7 1.1 2.6 29.1 1.5 1.2 0.0 0.4 0.7 0.0 1.2 0.0 0.7 0.9 0.2 2.2 0.5 0.7 1.6 3.3 0.0 1.5 0.3 0.8 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ERVW-1 "envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW" ENSG00000242950 "Endogenous retrovirus group W member 1, envelope" Q9UQF0 7 92468380-92477986 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 55.0" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 272.2;Syncytiotrophoblasts: 853.9" "Cancer enriched" "Detected in single" 143 "testis cancer: 31.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "BEWO: 85.2;SuSa: 26.2" "Not detected" "Not detected" NA NA 54000 "unprognostic (2.85e-1)" "unprognostic (1.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (1.48e-4)" "unprognostic (4.80e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-2)" "unprognostic (8.02e-2)" 0.5 0.7 1.0 0.8 1.3 0.8 0.7 2.1 1.7 0.2 0.6 0.4 0.5 0.5 3.5 0.1 0.2 0.3 0.2 0.9 0.8 0.3 0.3 0.6 0.7 1.6 0.9 0.2 0.5 0.7 0.3 0.0 55.0 1.7 0.5 0.5 6.9 1.0 0.2 0.7 1.0 0.6 0.4 0.4 0.9 1.2 6.1 1.1 0.4 0.7 0.0 0.4 0.2 0.0 4.3 0.2 0.4 0.7 0.5 0.0 0.6 85.2 0.2 0.0 0.0 0.0 0.4 0.4 0.2 0.5 0.0 1.2 0.6 0.3 0.2 0.1 0.2 0.4 0.4 1.4 0.3 0.1 0.4 0.6 0.2 0.2 0.1 0.0 0.3 0.0 0.6 0.7 1.3 0.1 0.5 0.4 0.7 0.3 0.1 0.2 0.5 0.2 0.1 0.2 0.4 0.3 0.6 0.1 1.2 0.0 26.2 0.3 0.5 0.2 0.1 1.5 0.4 0.2 1.5 0.7 0.2 0.1 0.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 1.3 2.1 1.7 0.9 0.8 1.6 0.9 0.2 1.7 0.4 1.1 4.3 0.7 3.2 3.1 0.0 0.1 0.8 0.8 0.2 0.0 2.1 0.1 0.1 0.2 0.0 1.4 0.0 0.0 272.2 0.0 0.1 0.0 0.0 47.9 0.4 0.2 1.4 0.0 0.0 0.1 0.0 86.2 2.4 0.0 0.2 2.5 0.1 0.0 0.0 27.4 0.0 0.1 0.0 0.0 1.9 0.7 10.4 1.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 3.4 0.1 0.4 0.0 0.1 5.3 1.8 0.0 2.6 0.4 1.0 0.3 0.0 2.0 853.9 0.3 0.1 0.1 1.0 EIF4EBP3 4E-BP3 ENSG00000243056 "Eukaryotic translation initiation factor 4E binding protein 3" O60516 5 140547662-140549576 "Metabolic proteins, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 59.2;Exocrine glandular cells: 29.0;Gastric mucus-secreting cells: 26.5;Proximal enterocytes: 43.3;Squamous epithelial cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 25.1;JURKAT: 42.3;Karpas-707: 28.9" "Low region specificity" "Detected in some" HPA045537 Uncertain NA NA "HPA045537: AB_10965796" "unprognostic (7.29e-2)" "unprognostic (4.20e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-1)" "unprognostic (6.64e-2)" "unprognostic (4.84e-3)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (2.57e-1)" "unprognostic (8.36e-2)" "unprognostic (4.87e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.82e-2)" "unprognostic (3.75e-1)" 41.6 66.6 23.2 6.5 23.9 12.6 46.0 24.8 29.8 26.8 24.8 34.3 12.8 22.0 6.9 37.1 37.3 17.2 41.7 22.7 30.9 41.3 55.8 26.2 12.2 24.9 23.5 21.2 30.2 49.4 2.9 17.1 7.0 24.9 41.7 17.6 2.7 54.6 15.6 122.8 48.8 40.3 8.6 25.2 31.4 59.6 32.3 23.5 12.7 35.9 56.2 9.3 30.3 29.0 26.0 0.4 1.7 1.5 2.3 18.4 19.2 3.4 1.6 0.4 0.9 1.6 3.4 1.4 0.9 8.7 3.6 1.3 1.3 0.7 1.8 1.1 3.1 5.6 0.2 3.8 6.3 25.1 10.3 4.9 23.6 2.3 1.5 1.2 4.5 2.8 42.3 0.6 28.9 1.1 0.0 7.9 18.6 2.2 5.3 6.3 8.3 1.2 0.3 2.9 3.6 9.1 1.3 2.8 23.1 7.6 2.0 3.1 11.9 2.2 7.8 1.5 5.0 1.2 2.6 2.3 0.9 5.4 20.0 2.1 9.4 43.6 1.4 11.3 51.2 14.1 41.3 20.5 10.3 37.7 37.1 41.7 34.1 22.3 24.1 38.6 117.5 17.6 24.3 23.2 23.9 24.8 29.8 22.7 30.9 24.9 23.5 21.2 24.9 25.2 23.5 26.0 0.8 0.0 13.7 0.0 8.0 0.3 0.6 0.7 59.2 0.0 6.5 3.2 0.2 7.2 4.6 0.0 0.0 0.8 1.5 13.0 3.9 8.6 1.1 4.9 0.9 2.8 8.5 11.8 0.0 29.0 0.9 8.0 26.5 1.5 12.0 0.1 2.2 7.2 2.4 0.0 0.0 15.1 0.0 5.7 0.2 1.1 1.8 9.0 0.0 0.0 7.1 0.0 1.0 0.0 0.0 14.2 19.4 0.0 0.9 0.8 43.3 7.9 7.8 0.0 0.0 0.6 1.2 2.6 0.6 42.3 0.6 1.0 3.4 0.2 18.8 0.4 IGKV3-7 ENSG00000243063 "Immunoglobulin kappa variable 3-7 (non-functional)" A0A075B6H7 2 88978468-88979081 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.8;lymphoid tissue: 22.4;salivary gland: 16.1;stomach 1: 10.3" "Group enriched" "Detected in some" 37 "B-cells: 1.5;Plasma cells: 5.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 61 "memory B-cell: 27.8;naive B-cell: 24.3" "Lineage enriched" "Detected in single" 65 "B-cells: 27.8" "Not detected" "Not detected" HPA047702 Approved "Immunoglobulin genes" NA NA 850000000 "HPA047702: " "prognostic favorable (1.17e-4)" "unprognostic (3.07e-3)" "unprognostic (3.96e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-3)" "unprognostic (1.19e-1)" "unprognostic (5.91e-2)" "unprognostic (2.73e-1)" "unprognostic (4.24e-2)" "unprognostic (2.15e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" 0.3 0.4 0.0 15.1 0.0 4.2 4.0 0.0 0.0 2.1 0.0 18.8 15.3 0.3 0.1 1.5 0.1 1.3 0.0 0.0 0.0 0.2 0.5 1.8 2.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 13.8 0.0 16.1 0.1 0.0 0.0 11.2 0.7 0.0 5.0 10.3 0.0 0.0 1.4 0.1 0.0 22.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 24.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF4 RP5-845O24.6 ENSG00000243073 "PRAME family member 4" O60810 1 12879212-12886201 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSG11 "MGC22484, PSG13, PSG14" ENSG00000243130 "Pregnancy specific beta-1-glycoprotein 11" Q9UQ72 19 43007656-43026474 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "placenta: 53.4" "Cell type enriched" "Detected in some" 57 "Syncytiotrophoblasts: 161.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-2197: 16.4" "HPA042240, HPA046327" Enhanced "Secreted in female reproductive system" NA NA 40000000 "HPA042240: AB_10797384, HPA046327: AB_2679624" "unprognostic (2.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.9 0.0 0.1 0.0 0.0 UGT1A3 UGT1C ENSG00000243135 "UDP glucuronosyltransferase family 1 member A3" P35503 2 233729108-233773299 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 74.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "liver cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HaCaT: 11.4" NA NA "unprognostic (5.15e-2)" "unprognostic (9.93e-2)" "unprognostic (2.97e-1)" "unprognostic (4.59e-2)" "unprognostic (1.04e-4)" "unprognostic (8.22e-2)" "unprognostic (2.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 74.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSG4 ENSG00000243137 "Pregnancy specific beta-1-glycoprotein 4" Q00888 19 43192702-43207299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "parathyroid gland: 55.9;placenta: 144.8" "Cell type enriched" "Detected in some" 38 "Syncytiotrophoblasts: 553.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "fHDF/TERT166: 552.6;U-2197: 147.3" HPA046327 Supported "Secreted in female reproductive system" NA NA 58000000 "HPA046327: AB_2679624" "unprognostic (4.29e-2)" "unprognostic (5.18e-2)" "unprognostic (9.49e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (7.75e-2)" "unprognostic (8.82e-3)" "unprognostic (1.03e-3)" "unprognostic (1.68e-2)" "unprognostic (2.85e-1)" "unprognostic (2.57e-1)" 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.8 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 55.9 0.1 144.8 0.4 0.2 0.0 0.0 1.2 0.2 0.0 3.3 0.0 1.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 1.8 0.1 0.7 0.3 0.0 2.7 0.0 1.9 552.6 4.6 0.0 0.2 0.4 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 8.2 53.6 3.6 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.4 0.0 0.0 0.0 7.1 0.9 14.5 0.0 0.0 4.4 2.1 5.5 147.3 0.1 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.3 0.0 1.5 0.4 0.5 0.3 0.0 0.3 0.0 0.0 4.7 0.0 0.0 0.0 14.3 0.1 0.1 0.2 0.1 0.0 0.0 1.0 0.0 11.9 0.4 0.0 2.7 0.0 0.1 0.0 0.0 2.0 0.0 1.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.3 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 553.7 0.0 0.0 0.0 0.3 MRPL33 "C2orf1, RPL33L" ENSG00000243147 "Mitochondrial ribosomal protein L33" O75394 2 27771717-27988087 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1318.9;Distal tubular cells: 710.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066872 Approved NA NA "HPA066872: AB_2685739" "unprognostic (5.13e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-2)" "unprognostic (7.92e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.68e-4)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.78e-2)" "unprognostic (9.67e-2)" "unprognostic (2.48e-1)" "unprognostic (1.70e-3)" "unprognostic (1.54e-1)" "unprognostic (8.20e-2)" 139.7 648.2 143.9 67.3 146.2 99.1 132.6 146.6 217.0 126.8 149.4 191.7 77.5 147.0 152.5 94.8 142.0 82.6 483.2 142.8 148.7 229.2 136.7 132.8 80.5 146.5 143.4 140.5 133.6 121.0 162.4 190.7 74.8 144.3 152.4 98.9 137.0 115.7 121.8 723.2 78.0 115.8 122.3 145.6 123.9 168.0 109.5 145.7 111.5 113.7 655.8 82.5 164.0 111.0 150.0 378.2 168.6 302.0 124.0 186.5 209.7 141.3 233.7 294.8 230.7 300.9 151.0 288.2 108.1 286.5 246.9 347.4 112.8 171.6 186.1 328.9 169.6 325.9 211.0 161.8 272.2 282.7 213.4 120.5 270.6 162.2 209.1 364.8 370.9 297.2 163.5 167.6 178.4 307.1 126.0 147.6 231.8 170.4 384.0 241.9 73.8 341.1 152.1 711.5 150.6 172.8 248.4 161.7 205.2 268.1 277.6 92.0 216.5 253.1 145.8 314.7 143.3 375.0 205.5 347.2 325.7 200.8 346.6 137.1 502.5 203.4 211.2 126.7 160.5 136.8 128.3 143.8 135.6 284.0 112.3 121.5 147.2 154.2 125.9 160.6 183.3 175.0 125.4 143.9 146.2 146.6 217.0 142.8 148.7 146.5 143.4 140.5 144.3 145.6 145.7 150.0 213.3 179.5 144.5 10.4 104.3 56.0 107.2 283.5 66.0 48.6 171.2 190.4 1318.9 165.8 205.6 321.8 25.0 138.1 103.8 132.3 710.2 202.8 97.0 249.6 143.3 207.1 153.2 66.3 16.3 349.6 131.4 131.1 81.1 229.1 190.4 91.7 165.0 259.2 150.2 42.1 17.2 186.8 207.5 161.3 120.2 53.2 170.6 119.3 154.7 6.5 200.7 134.4 141.1 12.1 16.8 239.3 151.3 197.8 84.7 134.7 134.9 386.1 191.5 64.9 164.3 134.3 184.0 214.9 152.4 71.4 57.1 104.0 113.0 101.8 173.9 129.9 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024561 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 88.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 11.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.1" "Cell line enhanced" "Detected in all" "WM-115: 131.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" Yes No "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 16.1 12.1 19.0 15.1 17.1 17.5 11.3 88.0 30.3 15.6 2.5 23.0 11.1 31.3 17.2 19.8 38.9 13.6 35.9 15.1 6.1 11.0 19.0 8.4 23.1 19.6 8.9 8.3 26.7 14.1 38.8 7.2 16.8 33.7 16.5 20.8 14.2 11.0 20.0 48.7 19.0 14.6 37.6 2.5 17.9 10.7 24.6 10.2 6.0 14.8 21.0 20.5 16.0 12.1 47.0 34.0 39.6 20.2 33.7 15.6 19.2 25.6 32.6 33.1 43.6 34.5 36.1 4.8 35.1 15.5 39.3 51.2 38.7 30.1 31.9 43.0 35.6 25.2 35.9 44.6 11.9 9.6 17.1 20.2 14.4 25.9 46.9 43.7 25.2 24.9 9.7 47.6 22.8 16.9 26.6 16.9 10.7 13.0 27.3 26.4 23.2 30.3 1.9 32.1 24.8 53.5 21.1 40.6 26.0 65.2 31.5 10.8 7.0 43.9 46.0 28.4 29.7 63.6 16.4 30.2 50.8 40.0 7.7 131.6 11.1 0.0 0.1 0.3 0.0 0.6 2.5 0.3 0.3 0.0 2.6 0.2 0.1 0.1 0.9 0.0 0.2 0.7 0.2 19.0 17.1 88.0 30.3 15.1 6.1 19.6 8.9 8.3 33.7 2.5 10.2 47.0 19.6 3.2 10.2 57.1 32.1 11.2 15.2 17.9 13.1 20.9 13.7 15.5 16.5 12.8 13.2 12.9 52.1 14.1 6.2 43.5 0.0 23.9 10.5 36.4 10.2 16.4 10.2 19.3 176.5 9.8 40.3 10.5 13.3 38.8 19.0 9.7 8.9 37.3 3.1 1.7 164.6 20.8 8.2 3.2 9.6 13.9 4.1 4.2 8.8 23.4 6.0 38.2 5.2 71.9 216.0 24.6 23.6 6.4 12.5 14.4 19.8 5.5 27.8 12.2 0.0 11.0 12.1 19.8 13.8 11.2 11.8 11.2 9.1 24.2 21.5 10.1 PPAN-P2RY11 ENSG00000243207 "PPAN-P2RY11 readthrough" 19 10106223-10114780 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 16.6" HPA014232 Uncertain NA NA "HPA014232: AB_1854883" "unprognostic (4.81e-1)" "unprognostic (5.85e-2)" "unprognostic (3.18e-1)" "unprognostic (3.11e-2)" "unprognostic (3.54e-1)" "unprognostic (1.61e-1)" "unprognostic (4.85e-2)" "unprognostic (2.01e-1)" "unprognostic (5.27e-3)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (2.23e-1)" "unprognostic (9.20e-2)" "unprognostic (5.85e-3)" "unprognostic (2.34e-1)" 1.0 0.4 1.5 1.0 1.7 2.1 0.9 1.2 2.4 1.1 0.3 1.0 1.0 0.6 0.6 0.4 1.4 0.4 0.3 1.7 1.7 0.3 0.4 0.6 1.2 2.2 1.5 1.8 1.1 1.7 0.7 0.5 0.6 1.8 0.7 0.5 0.6 1.1 0.9 0.9 2.1 1.2 0.5 1.3 2.1 1.1 0.9 1.8 0.7 0.7 0.6 0.9 0.9 0.5 1.9 2.9 2.4 0.9 3.0 1.7 1.9 7.8 2.2 1.0 1.1 1.6 2.9 1.2 7.6 3.2 0.7 0.6 3.9 1.7 2.8 0.4 4.5 16.6 7.1 4.4 1.9 2.3 4.1 8.1 3.0 3.6 1.2 3.0 1.4 0.8 2.9 4.4 4.9 0.8 6.7 4.2 13.4 5.9 2.8 7.9 7.1 2.8 3.6 1.7 2.8 4.2 7.5 0.7 1.4 7.1 0.1 1.4 5.1 1.8 2.8 2.0 5.8 2.4 13.1 9.0 3.6 2.7 8.8 3.2 0.0 0.6 0.2 1.7 0.9 1.8 2.6 0.7 2.6 0.5 1.8 0.5 1.0 0.0 1.7 0.4 0.2 0.7 0.8 1.5 1.7 1.2 2.4 1.7 1.7 2.2 1.5 1.8 1.8 1.3 1.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966470-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 43.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.3;Hepatic stellate cells: 2.2;Respiratory ciliated cells: 1.6;Rod photoreceptor cells: 1.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076190 Approved Nucleoplasm,Mitochondria NA NA 1100000 Nucleoplasm Mitochondria "HPA076190: AB_2686785" "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 0.6 1.1 2.5 0.5 5.0 0.0 0.1 4.0 7.2 0.9 0.0 0.3 0.1 0.6 0.1 0.0 0.2 2.7 0.7 4.4 2.9 0.4 0.7 2.3 2.1 1.1 5.7 5.9 0.1 0.4 43.3 1.6 1.8 3.9 0.3 0.3 9.8 0.6 0.1 0.0 0.1 0.2 1.0 0.0 1.7 0.5 1.6 4.7 0.0 1.2 0.0 0.6 0.2 0.0 4.9 0.0 13.1 1.2 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 3.7 0.0 2.5 0.1 1.3 6.9 0.0 0.0 0.2 0.0 13.7 0.0 0.8 0.0 0.0 0.2 8.8 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.5 0.0 2.3 0.0 0.0 0.0 1.7 0.1 2.7 10.6 0.0 0.0 0.1 1.2 2.6 0.4 0.0 1.1 1.2 0.0 0.6 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 5.0 4.0 7.2 4.4 2.9 1.1 5.7 5.9 3.9 0.0 4.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.4 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 IGKV2-30 ENSG00000243238 "Immunoglobulin kappa variable 2-30" P06310 2 89244781-89245596 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 637.0;lymphoid tissue: 675.5;stomach 1: 326.0" "Cell type enriched" "Detected in some" 365 "Plasma cells: 25365.6" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 316 "memory B-cell: 561.0;naive B-cell: 325.4" "Lineage enriched" "Detected in many" 400 "B-cells: 561.0" "Cell line enriched" "Detected in some" 388 "U-698: 8426.0" "Immunoglobulin genes" NA NA 6800000000 "prognostic favorable (6.84e-5)" "unprognostic (1.26e-2)" "unprognostic (2.88e-2)" "unprognostic (1.41e-1)" "prognostic favorable (6.78e-5)" "unprognostic (6.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.45e-2)" "unprognostic (9.82e-3)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (4.53e-6)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.53e-1)" "unprognostic (3.50e-1)" 15.2 9.5 0.1 162.2 0.3 76.6 239.4 0.1 1.3 14.1 0.6 637.0 397.9 5.7 0.8 38.2 11.6 35.4 18.0 0.1 0.3 15.0 29.9 67.9 178.1 1.3 0.4 0.1 15.9 7.8 0.1 2.4 0.2 0.2 7.9 327.5 0.0 222.3 23.5 0.6 1.2 262.3 19.3 0.4 675.5 326.0 21.4 0.2 41.3 19.0 0.0 605.4 209.4 21.6 1.5 5.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 13.1 4.6 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.3 0.0 0.0 0.1 2.7 1.9 0.0 0.4 0.0 0.9 3.8 0.0 2.6 0.0 0.0 5.6 0.0 0.0 21.7 0.1 2.6 0.3 1.7 8426.0 0.0 2.7 0.0 0.5 0.4 0.2 0.2 0.0 0.2 561.0 0.1 0.2 0.4 325.4 0.0 0.2 1.4 0.2 0.3 0.7 0.3 53.3 0.1 0.3 0.1 1.3 0.1 0.3 1.3 0.4 0.1 0.2 0.4 0.2 1.5 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 30.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25365.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.3 0.0 STON1 "SBLF, stoned-b1" ENSG00000243244 "Stonin 1" Q9Y6Q2 2 48529383-48598513 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 42.0;Muller glia cells: 33.4;Sertoli cells: 26.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 1.9;neutrophil: 1.0" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 23.7;ASC TERT1: 28.6;HSkMC: 36.1;hTERT-RPE1: 17.0;SuSa: 19.6" "Low region specificity" "Detected in all" HPA005715 Uncertain NA NA "HPA005715: AB_1080113" "unprognostic (1.61e-1)" "unprognostic (4.44e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-4)" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (8.99e-3)" "unprognostic (1.09e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.69e-4)" "unprognostic (1.06e-2)" "unprognostic (2.50e-1)" "unprognostic (8.68e-2)" "unprognostic (2.49e-3)" 20.2 5.2 2.7 5.7 6.3 0.5 11.0 11.1 3.6 10.5 9.2 24.8 3.6 27.7 4.6 16.1 17.3 15.8 5.2 1.8 18.9 9.4 2.2 11.0 2.8 33.2 13.3 1.1 24.7 2.0 2.1 2.9 18.5 23.2 21.9 8.5 18.3 2.5 19.5 2.2 3.7 8.0 25.4 24.9 7.4 13.1 1.1 6.2 2.5 4.7 6.4 1.4 22.4 10.6 30.7 0.1 0.0 8.6 0.1 23.7 28.6 4.9 1.0 9.2 0.9 2.1 0.1 0.0 0.0 0.3 12.0 4.6 9.0 8.3 0.3 1.7 0.1 2.3 1.4 0.6 0.0 13.5 0.0 0.4 36.1 1.7 2.5 1.0 17.0 16.4 0.8 0.2 0.2 5.7 0.5 0.7 0.3 8.0 0.0 0.1 1.3 1.7 0.0 0.9 6.6 0.3 1.9 0.7 1.5 4.0 19.6 0.7 0.3 8.8 3.0 2.3 0.0 0.7 0.5 0.1 0.0 1.6 0.1 1.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.7 6.3 11.1 3.6 1.8 18.9 33.2 13.3 1.1 23.2 24.9 6.2 30.7 16.4 0.0 0.5 0.0 1.1 2.4 15.4 1.1 16.5 3.8 0.8 1.8 2.3 0.0 0.8 5.5 2.1 15.1 0.5 0.6 3.9 0.8 0.4 1.9 42.0 7.7 2.4 0.0 0.0 0.4 1.0 9.9 0.5 2.6 0.0 3.9 11.4 0.2 2.7 13.5 0.0 0.3 0.0 1.3 2.8 0.9 12.2 1.6 0.0 0.0 1.2 33.4 1.0 0.0 0.0 0.4 0.3 10.1 0.2 13.8 0.4 2.0 0.6 2.3 26.3 1.9 15.1 0.3 1.7 1.9 2.4 12.6 1.5 2.6 0.9 14.3 IGKV2D-29 ENSG00000243264 "Immunoglobulin kappa variable 2D-29" A0A075B6S2 2 89947512-89948279 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 254.7;lymphoid tissue: 468.7" "Cell type enriched" "Detected in some" 8 "Plasma cells: 184.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 253 "memory B-cell: 360.5;naive B-cell: 489.4" "Lineage enriched" "Detected in many" 292 "B-cells: 489.4" "Cell line enhanced" "Detected in some" "Daudi: 8.5;HDLM-2: 1.2;TIME: 2.1;U-698: 2.2" "Immunoglobulin genes" NA NA 1500000000 "prognostic favorable (3.31e-4)" "unprognostic (2.43e-2)" "unprognostic (1.34e-3)" "unprognostic (1.76e-2)" "prognostic favorable (8.34e-4)" "unprognostic (4.43e-3)" "unprognostic (1.54e-1)" "unprognostic (2.34e-1)" "unprognostic (2.47e-2)" "unprognostic (5.09e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (9.46e-2)" "unprognostic (2.20e-1)" "unprognostic (2.61e-1)" "unprognostic (7.80e-2)" 6.9 1.1 0.1 74.4 0.2 29.7 49.9 0.3 1.3 12.7 0.9 254.7 97.9 3.9 0.0 9.6 6.6 14.4 3.8 0.2 0.2 3.4 8.5 41.8 140.6 0.4 0.6 0.1 9.9 2.8 0.2 0.3 0.0 0.2 3.6 111.9 0.0 107.8 10.4 0.4 3.0 68.4 2.9 0.5 171.6 127.1 1.0 0.2 38.3 7.9 0.0 468.7 35.4 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.2 0.1 0.0 2.2 0.0 0.1 0.0 0.3 0.4 0.2 0.1 0.0 0.2 360.5 0.2 0.1 0.6 489.4 0.0 0.1 1.6 0.2 0.4 0.2 0.2 42.2 0.1 0.2 0.3 1.3 0.2 0.2 0.4 0.6 0.1 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071161-49074002 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 164.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340" "unprognostic (1.50e-1)" "prognostic favorable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavorable (1.66e-6)" "prognostic favorable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favorable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavorable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 26.3 39.0 66.7 15.7 66.8 8.3 23.4 67.5 83.2 41.3 61.9 26.5 6.2 52.0 164.8 11.8 36.3 14.9 27.2 66.3 69.8 25.9 11.6 30.0 12.9 69.0 70.2 64.8 38.0 10.6 29.5 75.1 11.5 71.0 26.7 11.2 21.7 14.0 36.1 12.2 14.2 18.0 44.0 64.5 21.9 22.0 28.5 72.0 21.7 27.9 9.1 15.1 33.4 26.2 69.4 17.0 35.0 40.0 51.5 140.4 84.7 5.0 59.1 61.9 39.7 43.2 2.0 5.3 1.7 14.0 129.3 32.6 15.5 1.6 32.3 43.6 31.3 45.4 13.4 43.0 1.8 143.2 8.8 25.0 108.3 27.0 75.0 54.0 80.9 61.6 41.3 2.1 4.6 69.5 31.4 56.6 10.6 22.5 8.3 2.3 30.8 21.9 3.8 60.0 5.0 26.6 66.3 49.5 25.5 35.2 35.1 25.0 6.2 37.8 30.1 39.6 65.6 17.5 71.7 19.8 13.4 72.7 15.3 48.1 47.0 13.0 18.5 38.6 15.0 43.2 32.0 41.6 33.9 14.9 30.2 36.7 40.1 34.1 39.0 11.2 5.9 68.4 26.0 66.7 66.8 67.5 83.2 66.3 69.8 69.0 70.2 64.8 71.0 64.5 72.0 69.4 21.5 12.8 10.0 7.5 8.7 7.6 14.9 34.8 11.4 23.1 8.0 10.7 5.8 11.5 16.3 11.0 12.5 3.3 13.2 2.2 11.7 16.7 3.4 6.8 31.6 30.9 10.2 5.2 5.8 5.7 13.4 29.9 4.1 9.2 15.9 13.4 33.5 3.6 6.1 16.8 7.0 4.7 40.7 5.7 11.3 6.0 38.2 6.6 14.2 5.6 5.6 29.2 16.5 3.5 9.9 4.1 0.8 41.3 10.5 10.1 1.5 18.5 17.7 8.6 19.7 13.2 33.4 14.7 4.5 5.0 7.4 9.7 17.5 36.3 1.5 9.3 VSIG8 ENSG00000243284 "V-set and immunoglobulin domain containing 8" P0DPA2 1 159854316-159862657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.6;skin 1: 20.9" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 11.2;Collecting duct cells: 5.5;Gastric mucus-secreting cells: 5.1;Suprabasal keratinocytes: 4.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 4.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA023219 Uncertain NA NA 650000 "HPA023219: AB_1845635" "unprognostic (8.66e-3)" "unprognostic (2.17e-1)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (4.50e-3)" "unprognostic (1.15e-2)" "unprognostic (9.26e-2)" "unprognostic (6.28e-2)" "unprognostic (1.68e-2)" "unprognostic (2.79e-1)" "unprognostic (2.93e-3)" "unprognostic (9.32e-2)" "unprognostic (7.94e-7)" "unprognostic (1.72e-2)" "unprognostic (4.25e-1)" "unprognostic (1.81e-3)" "unprognostic (1.99e-1)" 0.3 0.1 2.1 0.1 0.5 0.0 0.1 2.2 0.2 1.8 1.5 0.1 0.1 0.1 0.0 4.0 1.3 0.1 0.2 0.2 0.2 5.3 0.0 0.5 0.1 1.4 0.7 0.0 0.8 0.1 0.0 0.2 0.1 1.7 0.1 0.0 0.0 5.6 0.0 0.1 20.9 0.1 0.0 1.5 0.2 0.1 0.4 0.6 0.4 0.2 0.0 6.6 0.1 3.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.5 2.2 0.2 0.2 0.2 1.4 0.7 0.0 1.7 1.5 0.6 0.8 0.5 0.0 0.0 0.0 0.1 11.2 0.7 0.2 1.2 2.6 0.5 0.4 0.2 1.5 0.3 5.5 0.0 0.2 0.6 0.6 0.0 0.1 0.6 1.7 0.8 0.5 3.6 0.0 0.0 0.0 0.2 0.9 5.1 0.9 0.0 2.3 0.4 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.9 0.2 0.6 0.4 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.1 0.0 1.4 0.8 2.1 0.1 2.2 0.4 0.0 0.9 0.6 0.5 0.0 1.8 4.5 0.1 1.1 1.1 1.1 0.8 IGKV1-12 "IGKV112, L19" ENSG00000243290 "Immunoglobulin kappa variable 1-12" A0A0C4DH73 2 89040224-89040745 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 399.6;lymphoid tissue: 795.5" "Cell type enriched" "Detected in some" 92 "Plasma cells: 12442.9" "Cancer enhanced" "Detected in many" "stomach cancer: 17.2" "Region enhanced" "Detected in some" "midbrain: 3.1" "Group enriched" "Detected in some" 820 "memory B-cell: 259.8;naive B-cell: 164.2" "Lineage enriched" "Detected in single" 1005 "B-cells: 259.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9" HPA048721 Approved "Immunoglobulin genes" NA NA 13000000000 "HPA048721: " "prognostic favorable (6.09e-4)" "prognostic favorable (1.59e-4)" "unprognostic (7.33e-2)" "unprognostic (3.74e-2)" "prognostic favorable (3.85e-5)" "unprognostic (5.89e-2)" "unprognostic (5.74e-1)" "unprognostic (7.13e-2)" "unprognostic (6.15e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (6.59e-8)" "unprognostic (1.18e-1)" "unprognostic (1.84e-1)" "unprognostic (2.68e-1)" "unprognostic (1.71e-1)" 10.3 146.2 0.1 203.6 0.2 73.7 118.0 0.0 0.3 51.2 0.2 399.6 242.8 7.3 0.0 57.6 16.3 70.2 10.0 0.1 1.1 13.6 18.0 65.9 240.6 0.7 3.1 0.0 18.3 7.3 0.2 1.4 0.0 1.0 7.3 281.3 0.0 220.8 5.4 0.4 2.8 233.1 11.3 0.9 363.3 257.1 6.8 0.1 70.2 33.0 0.0 795.5 245.3 9.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 259.8 0.0 0.1 0.1 164.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 24.3 0.1 0.2 0.0 0.3 0.1 1.1 0.7 3.1 0.0 1.0 0.9 0.1 1.4 0.0 0.0 0.0 0.0 134.3 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 20.4 0.0 0.0 0.0 1.8 1.6 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12442.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.3 5.0 0.0 0.0 0.0 STMP1 "C7orf73, Mm47, PL-5283" ENSG00000243317 "Short transmembrane mitochondrial protein 1" E0CX11 7 135662496-135693418 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 249.0;Distal tubular cells: 197.6;Extravillous trophoblasts: 261.3;Hofbauer cells: 185.2;Proximal tubular cells: 209.5;Syncytiotrophoblasts: 275.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 431.7;eosinophil: 127.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 431.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065565 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA065565: AB_2685512" "unprognostic (3.94e-2)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (3.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.81e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-1)" "unprognostic (4.43e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (7.21e-3)" "unprognostic (4.90e-2)" "unprognostic (9.99e-2)" "unprognostic (9.62e-3)" "unprognostic (6.81e-2)" 15.8 28.7 17.1 17.9 19.1 41.7 23.1 17.7 20.7 17.8 19.4 20.0 18.3 16.2 25.9 47.1 16.0 16.7 25.6 16.9 18.8 25.2 32.2 15.3 21.4 19.4 18.2 15.6 13.0 15.3 18.7 19.1 20.0 19.5 20.4 22.7 19.3 21.1 15.1 48.9 21.1 19.4 16.6 18.7 14.8 20.6 24.1 18.1 29.0 32.5 33.1 26.4 20.2 27.6 19.6 41.5 19.4 44.9 42.4 52.6 73.2 27.3 44.8 43.5 36.3 37.8 12.0 45.2 38.3 39.3 68.7 35.6 17.0 43.9 57.0 48.9 48.2 36.1 59.4 20.4 28.8 51.7 61.3 36.8 46.0 63.6 43.6 40.4 54.9 30.5 48.5 65.3 33.0 80.9 54.0 87.6 69.5 88.6 57.4 48.5 43.6 48.0 63.0 102.2 21.5 56.6 54.7 60.8 41.3 43.9 43.1 16.9 66.0 51.1 35.3 29.0 63.5 63.2 38.1 58.5 72.9 109.1 63.1 65.9 431.7 57.3 127.7 23.8 61.2 22.8 24.9 22.5 24.3 61.0 21.0 21.0 24.1 44.6 38.9 68.1 34.5 33.1 50.9 17.1 19.1 17.7 20.7 16.9 18.8 19.4 18.2 15.6 19.5 18.7 18.1 19.6 67.4 41.7 47.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 128.9 145.3 0.0 0.0 27.9 97.5 0.0 249.0 57.2 0.0 197.6 164.3 0.0 102.2 97.3 39.4 0.0 0.0 0.0 97.4 261.3 43.9 0.0 90.8 56.8 80.1 0.0 0.0 185.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.7 0.0 0.0 146.8 0.0 0.0 0.0 0.0 131.8 0.0 0.0 6.4 0.0 0.0 209.5 34.2 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 275.4 29.8 65.8 0.0 0.0 KCTD7 "CLN14, EPM3, FLJ32069" ENSG00000243335 "Potassium channel tetramerization domain containing 7" Q96MP8 7 66628881-66649067 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 66.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Oligodendrocytes: 42.7;Rod photoreceptor cells: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.53e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (8.07e-4)" "unprognostic (1.30e-3)" "unprognostic (3.74e-2)" "unprognostic (1.34e-2)" "unprognostic (4.49e-5)" "unprognostic (1.26e-2)" "unprognostic (2.64e-1)" "unprognostic (2.97e-2)" "prognostic favorable (3.26e-4)" "unprognostic (1.45e-1)" "unprognostic (7.76e-2)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.58e-2)" "unprognostic (3.19e-2)" 8.6 11.7 18.8 8.8 22.2 5.6 7.9 22.9 21.0 15.6 13.5 14.4 5.1 14.1 13.8 4.8 13.1 7.2 10.2 18.7 21.7 8.8 5.9 8.0 12.5 25.6 22.5 18.8 21.0 5.3 10.1 13.9 7.8 24.3 11.0 7.0 66.3 6.7 10.2 5.9 6.3 12.8 8.6 22.0 11.0 10.9 17.6 22.7 8.1 10.1 6.7 12.2 16.7 10.5 32.9 4.5 6.3 17.5 12.8 8.2 10.5 1.2 6.6 7.0 10.2 9.6 9.0 5.3 14.4 1.7 8.3 25.0 2.4 14.4 2.3 10.4 13.0 6.4 1.6 16.0 7.8 4.4 3.9 11.6 6.6 7.3 8.4 5.0 14.4 5.3 6.9 13.8 12.5 8.5 1.6 3.8 5.7 11.1 1.6 6.8 4.7 7.2 5.8 6.9 1.6 8.8 16.2 5.5 3.5 15.4 16.8 5.6 4.5 6.8 13.1 9.5 4.5 5.8 5.4 4.0 11.2 17.2 5.2 10.2 2.5 1.2 6.9 3.3 0.9 3.6 2.1 2.8 2.7 1.2 3.4 1.8 2.7 0.9 2.6 1.3 1.1 3.1 1.4 18.8 22.2 22.9 21.0 18.7 21.7 25.6 22.5 18.8 24.3 22.0 22.7 32.9 5.4 3.2 9.0 20.2 10.5 1.1 1.7 2.8 8.0 17.1 3.8 3.0 12.0 0.0 2.9 0.0 37.5 5.2 9.3 1.8 1.9 1.2 9.0 4.6 10.2 4.8 8.4 3.4 14.9 1.2 2.2 6.3 4.1 3.3 5.1 12.5 6.8 2.0 5.9 18.5 16.5 2.7 0.0 3.8 1.6 18.2 6.5 6.6 1.8 27.2 4.2 20.3 12.3 7.5 42.7 1.2 5.2 12.4 7.1 1.5 4.0 1.7 3.0 53.1 6.6 5.8 7.2 13.0 9.9 1.7 1.1 2.7 10.7 5.4 2.2 0.6 EFNA4 "EPLG4, LERK4" ENSG00000243364 "Ephrin A4" P52798 1 155063737-155069553 "Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 29.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 86.1;Theca cells: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" CAB021350 Uncertain "Secreted to blood" NA NA "CAB021350: " "unprognostic (4.65e-2)" "unprognostic (8.07e-2)" "unprognostic (3.43e-2)" "unprognostic (7.04e-2)" "unprognostic (7.91e-2)" "unprognostic (4.81e-1)" "prognostic unfavorable (1.00e-5)" "unprognostic (1.37e-2)" "unprognostic (3.89e-2)" "unprognostic (6.17e-2)" "unprognostic (2.87e-2)" "unprognostic (7.97e-3)" "prognostic unfavorable (3.14e-4)" "prognostic favorable (3.60e-5)" "unprognostic (3.35e-2)" "unprognostic (1.97e-1)" "unprognostic (6.29e-2)" 3.5 12.1 2.8 4.6 2.8 1.3 9.5 2.9 3.4 9.2 3.8 11.9 10.6 6.5 12.5 18.8 5.0 5.2 3.5 2.9 3.9 5.4 8.4 4.5 5.1 3.2 2.9 2.4 10.0 5.7 7.9 2.5 4.6 3.0 9.2 12.2 0.9 13.2 4.4 1.3 29.8 10.7 4.4 3.0 6.6 5.9 2.4 3.3 3.8 6.3 1.8 7.4 4.8 14.4 3.1 11.4 8.5 20.4 30.4 11.8 7.5 17.0 5.1 9.6 9.7 9.0 12.5 18.5 14.6 28.2 5.1 7.7 26.2 12.3 7.6 3.9 6.9 3.7 1.4 7.7 17.8 4.3 3.3 22.0 4.5 23.2 4.9 5.7 8.4 19.7 11.9 6.2 9.5 5.5 25.2 7.5 8.3 37.6 43.3 17.5 26.0 8.1 14.3 15.2 9.6 4.9 22.3 10.1 37.1 4.5 14.7 24.3 10.2 10.2 5.8 17.0 11.7 7.8 9.7 11.0 14.6 5.5 7.8 5.9 0.1 10.1 7.3 7.7 9.2 8.0 22.9 8.5 8.8 8.3 17.3 11.8 8.1 10.9 3.9 13.7 25.2 8.9 6.6 2.8 2.8 2.9 3.4 2.9 3.9 3.2 2.9 2.4 3.0 3.0 3.3 3.1 2.5 0.0 6.3 2.0 9.0 25.1 8.6 21.2 19.4 0.2 20.7 15.6 1.3 8.6 12.1 16.5 0.0 9.2 12.3 23.9 1.9 32.4 0.1 4.9 4.5 6.8 3.0 2.1 0.2 14.0 86.1 8.4 3.6 6.6 1.3 15.6 5.7 3.6 12.8 0.0 0.2 18.7 8.2 6.3 6.8 0.4 7.8 5.3 17.8 1.0 5.9 5.6 4.1 0.0 0.8 21.5 37.0 5.7 2.2 21.2 38.3 4.4 6.5 0.2 0.0 1.7 6.0 0.5 4.1 15.4 32.7 9.9 7.2 73.3 28.3 10.8 TICAM2 "TICAM-2, TIRP, TRAM" ENSG00000243414 "Toll like receptor adaptor molecule 2" Q86XR7 5 115578496-115602479 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Basal squamous epithelial cells: 1.8;Endometrial stromal cells: 2.6;Macrophages: 2.0;monocytes: 1.7;Plasma cells: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 29.0;U-138 MG: 16.0;U-2197: 19.1" NA NA "unprognostic (1.78e-1)" "unprognostic (4.27e-4)" "unprognostic (6.46e-2)" "unprognostic (1.04e-1)" "unprognostic (7.37e-2)" "unprognostic (2.08e-3)" "unprognostic (1.58e-1)" "unprognostic (6.56e-3)" "unprognostic (1.63e-1)" "unprognostic (1.44e-2)" "unprognostic (1.62e-1)" "unprognostic (3.27e-1)" "unprognostic (2.94e-4)" "unprognostic (9.82e-2)" "unprognostic (1.31e-2)" "unprognostic (1.00e-3)" "unprognostic (1.83e-1)" 3.0 3.3 2.4 3.5 2.3 0.8 2.3 2.1 4.2 3.3 3.0 2.5 0.8 2.6 3.2 1.4 2.3 1.7 2.3 2.6 2.3 1.9 2.9 2.8 3.7 2.6 2.4 1.8 2.6 3.3 0.6 2.1 1.4 2.5 2.4 1.3 0.6 2.9 1.9 7.0 1.2 2.2 2.1 2.6 4.3 2.6 0.6 2.7 0.7 2.0 2.0 2.0 2.6 2.6 3.1 4.5 0.2 0.1 0.3 2.5 11.2 0.1 11.6 6.3 5.5 4.2 0.0 1.3 0.0 0.8 9.9 1.2 0.3 0.6 1.4 6.3 29.0 0.7 0.6 2.2 0.0 1.1 0.3 0.2 4.5 0.6 4.9 0.2 2.6 1.2 0.0 0.7 1.1 9.4 0.0 0.1 1.0 0.0 0.5 1.9 1.0 0.2 0.5 3.8 0.1 0.1 0.4 0.7 0.0 0.3 0.4 0.0 1.3 5.3 16.0 0.9 19.1 10.2 0.4 0.3 0.0 10.8 0.6 2.4 0.0 7.4 2.2 0.1 8.3 0.0 2.7 0.1 0.3 6.3 1.6 0.6 0.1 2.1 0.5 6.4 3.7 0.1 2.4 2.4 2.3 2.1 4.2 2.6 2.3 2.6 2.4 1.8 2.5 2.6 2.7 3.1 0.5 3.2 0.5 0.0 1.1 0.0 0.0 0.0 1.8 0.6 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.6 0.2 0.0 0.4 0.0 0.2 0.1 1.2 0.5 0.2 1.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.3 2.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.9 0.0 0.3 0.3 0.0 0.0 0.1 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.7;pituitary gland: 75.1;testis: 56.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 412.4;Paneth cells: 484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 158.3;NB-4: 117.3;PC-3: 343.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Approved Cytosol "Secreted to blood" NA NA 190000 Cytosol "HPA052447: AB_2681837" "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 10.1 18.4 48.0 4.6 53.4 2.7 9.6 65.3 67.1 4.2 46.0 13.3 2.7 5.6 0.2 4.3 7.8 0.4 6.7 42.3 51.4 14.6 4.0 8.0 1.3 74.9 54.2 31.6 6.7 19.0 2.4 75.1 2.1 62.1 7.1 0.9 0.2 9.3 1.4 1.2 3.1 16.4 0.6 70.4 18.6 12.0 56.5 57.0 0.3 9.4 0.0 0.6 6.8 3.0 95.7 33.4 27.1 5.3 24.9 2.4 3.9 35.3 31.2 6.0 5.6 5.3 18.6 19.6 4.4 29.2 1.2 10.4 9.2 0.6 3.5 1.7 20.1 158.3 10.5 15.8 10.7 5.2 21.7 70.3 3.0 5.9 1.2 0.0 1.8 5.9 17.9 35.1 0.1 3.9 20.6 24.6 117.3 15.8 1.8 343.1 56.1 8.3 11.2 5.0 12.3 42.7 60.0 15.3 0.7 47.7 0.5 8.3 10.3 26.5 14.7 31.9 11.0 35.3 23.8 22.4 0.4 14.6 13.2 20.8 88.5 451.6 431.5 123.6 325.6 127.5 187.7 157.2 138.3 270.0 167.9 89.1 92.9 349.2 29.6 290.7 301.1 199.8 192.8 48.0 53.4 65.3 67.1 42.3 51.4 74.9 54.2 31.6 62.1 70.4 57.0 95.7 13.3 0.0 1.9 8.8 58.1 21.9 6.6 13.2 7.4 12.0 147.0 139.8 10.6 20.0 14.2 200.5 0.0 8.0 52.8 412.4 70.5 320.8 97.1 326.7 92.6 42.1 235.1 30.7 5.6 222.7 116.5 47.7 35.7 107.3 107.5 209.0 123.1 11.9 235.5 18.5 8.2 154.2 44.7 272.1 113.3 350.5 19.3 158.9 327.3 7.5 205.2 78.8 20.6 6.0 41.1 198.2 484.2 28.2 84.1 10.9 223.7 7.9 28.8 15.0 13.1 1.7 53.2 99.7 193.2 5.7 10.1 13.1 73.9 50.9 117.1 11.1 IGKV1-5 ENSG00000243466 "Immunoglobulin kappa variable 1-5" P01602 2 88947301-88947957 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 784.5;lymphoid tissue: 1471.3;urinary bladder: 953.4" "Cell type enriched" "Detected in some" 240 "Plasma cells: 39194.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 364 "memory B-cell: 859.0;naive B-cell: 860.5" "Lineage enriched" "Detected in many" 364 "B-cells: 860.5" "Cell line enhanced" "Detected in some" "Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5" HPA048721 Approved "Immunoglobulin genes" NA NA 8400000000 "HPA048721: " "prognostic favorable (1.19e-4)" "unprognostic (1.26e-2)" "unprognostic (3.12e-3)" "unprognostic (5.00e-3)" "unprognostic (1.59e-2)" "prognostic favorable (3.47e-4)" "unprognostic (7.60e-2)" "unprognostic (2.84e-1)" "unprognostic (1.68e-1)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (3.58e-1)" "prognostic unfavorable (4.36e-8)" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.27e-2)" "unprognostic (3.17e-2)" 27.0 82.8 0.2 645.8 0.6 116.4 236.2 0.2 1.9 116.8 0.6 784.5 533.5 17.3 2.1 147.5 87.7 125.9 18.8 0.1 1.4 35.6 32.3 126.4 390.4 1.0 1.8 0.2 61.3 10.9 0.5 3.0 0.4 0.3 16.9 752.3 0.0 395.4 35.1 0.9 3.3 433.3 24.6 1.3 922.7 460.4 11.6 0.4 156.7 58.9 0.0 1471.3 953.4 28.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 1.6 0.5 0.0 0.0 0.3 1.0 5.0 0.0 0.0 2.9 4.5 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.4 0.7 0.4 0.6 0.1 0.4 0.0 0.6 0.0 0.7 1.2 1.3 0.5 0.2 0.4 859.0 2.3 0.3 1.0 860.5 0.2 0.3 1.4 0.4 0.6 0.7 0.6 113.5 0.2 0.6 0.2 1.9 0.1 1.4 1.0 1.8 0.2 0.3 1.3 0.4 1.1 0.0 0.0 0.6 0.0 163.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 7.0 89.7 0.0 0.0 0.0 0.7 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39194.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 11.8 0.0 0.2 0.0 NAA80 "FUS2, NAT6" ENSG00000243477 "N-alpha-acetyltransferase 80, NatH catalytic subunit" Q93015 3 50296402-50299416 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 66.0" "Cell type enhanced" "Detected in many" "Adipocytes: 6.5;Exocrine glandular cells: 8.8;monocytes: 9.3;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 7.5;Theca cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 56.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 56.3" "Cell line enhanced" "Detected in all" "HMC-1: 60.5" "Low region specificity" "Detected in all" HPA039576 Approved NA NA "HPA039576: AB_10794750" "prognostic favorable (3.62e-4)" "unprognostic (1.02e-2)" "unprognostic (6.04e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-1)" "unprognostic (7.78e-2)" "unprognostic (7.49e-2)" "unprognostic (4.62e-2)" "unprognostic (1.89e-1)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (4.38e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.88e-1)" "unprognostic (1.01e-1)" "unprognostic (9.16e-2)" "unprognostic (2.55e-1)" 12.4 12.3 9.0 7.7 9.7 32.7 14.0 11.5 14.9 15.6 3.9 11.9 6.4 13.5 7.0 15.5 15.5 6.4 16.1 9.5 7.5 15.0 14.8 15.6 10.3 11.7 8.0 8.7 17.7 15.2 9.1 14.4 5.8 12.8 19.3 7.8 3.8 13.9 10.7 18.1 20.7 13.5 6.8 5.6 16.6 17.8 66.0 8.2 8.3 14.6 7.2 9.8 13.2 16.0 10.6 8.0 6.2 9.0 9.5 10.7 12.3 6.0 7.4 14.6 11.5 9.9 5.4 15.0 24.6 5.5 12.9 9.4 9.9 5.3 24.2 4.7 15.6 9.0 49.2 37.7 12.3 9.4 8.3 60.5 14.8 16.8 19.3 13.3 17.0 14.1 13.2 4.4 22.7 10.5 8.3 9.9 37.7 5.0 3.6 19.9 6.4 3.2 29.9 19.4 3.9 6.3 8.9 8.4 17.5 3.5 5.5 7.6 23.4 11.7 9.2 9.2 11.4 7.3 15.4 8.9 6.1 15.9 15.5 8.8 13.7 3.1 56.3 7.1 4.2 10.3 10.4 9.7 8.6 5.2 7.5 7.6 6.4 0.9 9.8 2.7 2.6 9.4 5.5 9.0 9.7 11.5 14.9 9.5 7.5 11.7 8.0 8.7 12.8 5.6 8.2 10.6 6.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.8 4.1 0.0 0.0 0.0 3.7 0.0 5.4 4.5 0.0 3.9 4.8 0.0 3.1 3.4 2.1 0.0 0.0 0.0 8.8 5.1 2.1 0.0 3.2 0.0 3.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.4 0.0 0.0 7.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.1 2.1 6.4 0.0 0.0 AMY2A AMY2 ENSG00000243480 "Amylase alpha 2A" P04746 1 103616811-103625780 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1982 "pancreas: 149956.9" "Cell type enriched" "Detected in some" 114 "Exocrine glandular cells: 1016.0" "Cancer enriched" "Detected in single" 2010 "pancreatic cancer: 200.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045394, HPA045399, CAB045960, HPA046980" Enhanced "Secreted to digestive system" NA NA "CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (3.27e-1)" "unprognostic (1.78e-3)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.13e-2)" 5.3 1.3 1.3 2.9 1.5 0.3 3.9 0.8 1.4 1.9 0.8 1.4 22.7 2.9 0.1 2.3 0.8 0.0 26.9 1.3 1.2 1.5 4.7 1.0 5.5 1.0 1.0 1.3 75.6 149956.9 0.1 1.5 8.4 1.1 2.1 0.0 0.6 30.3 0.0 1.5 1.4 10.8 0.0 0.8 1.8 2.2 1.2 1.1 0.0 1.1 0.0 0.0 0.5 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 0.8 1.4 1.3 1.2 1.0 1.0 1.3 1.1 0.8 1.1 1.4 0.1 0.0 0.0 2.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 0.0 0.0 0.2 0.0 0.0 1.3 1016.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 KRTAP10-11 "KAP10.11, KAP18.11, KRTAP18-11, KRTAP18.11" ENSG00000243489 "Keratin associated protein 10-11" P60412 21 44646414-44647650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "skin 1: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNFRSF6B "DcR3, M68, TR6" ENSG00000243509 "TNF receptor superfamily member 6b" O95407 20 63696652-63698684 "Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 16 "plasmacytoid DC: 21.6" "Lineage enriched" "Detected in many" 16 "dendritic cells: 21.6" "Group enriched" "Detected in some" 4 "HBEC3-KT: 28.3;RPTEC TERT1: 110.7;TIME: 69.0" HPA047154 Approved "Secreted to blood" NA NA 406000 "HPA047154: AB_2679959" 27.4 5.1 12.6 14.4 10.8 0.2 24.9 8.7 18.3 7.7 5.8 11.7 0.0 8.0 0.0 11.8 9.7 0.5 6.9 8.7 11.0 16.7 5.5 51.7 1.2 13.4 13.4 6.7 7.3 8.4 0.0 15.6 0.0 17.5 10.7 0.1 0.0 10.3 0.0 7.2 13.3 16.3 1.0 11.9 39.6 9.8 6.8 17.3 0.0 12.4 0.0 3.4 16.1 9.7 16.6 0.0 0.5 0.0 0.0 0.0 0.2 1.5 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.5 0.0 0.0 9.4 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.8 0.0 0.0 0.0 110.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 69.0 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 1.3 21.6 0.1 0.1 12.6 10.8 8.7 18.3 8.7 11.0 13.4 13.4 6.7 17.5 11.9 17.3 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFDC6 "C20orf171, dJ461P17.11, WAP6" ENSG00000243543 "WAP four-disulfide core domain 6" Q9BQY6 20 45534196-45539482 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 253.1" "Cell type enriched" "Detected in some" 4 "Respiratory ciliated cells: 34.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.9;testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-87 MG: 2.6" "Secreted in male reproductive system" NA NA "unprognostic (3.68e-3)" "unprognostic (2.21e-3)" "unprognostic (1.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.91e-2)" 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.0 0.0 0.0 0.2 253.1 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510525-76516522 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 55.2;esophagus: 65.3;lung: 50.4;urinary bladder: 42.6" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 121.8" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1" "Not detected" "Not detected" HPA010506 Approved NA NA "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 55.2 0.7 0.1 0.1 0.4 0.1 1.5 0.0 0.3 4.6 0.8 1.0 0.0 0.7 0.2 65.3 10.1 0.1 5.8 0.0 0.2 0.6 1.0 50.4 0.1 0.1 0.2 0.0 7.0 1.3 0.0 1.8 0.0 0.1 2.7 0.0 0.2 8.3 0.0 0.5 4.1 1.0 0.0 0.0 2.1 2.9 4.3 0.6 0.0 1.4 0.0 1.9 42.6 12.2 0.1 1.1 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 48.2 0.0 0.4 0.0 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 2.9 0.1 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.3 3.9 0.0 0.1 27.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.6 0.1 0.3 121.8 3.3 0.0 0.3 1.7 0.4 18.3 4.6 0.4 0.2 0.0 0.3 20.0 20.4 3.7 4.2 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.9 1.1 0.5 1.3 0.1 0.7 0.1 0.1 1.7 0.0 0.0 6.1 0.3 2.5 0.0 12.2 0.3 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.1 0.0 11.1 0.2 0.0 0.0 1.1 0.0 0.1 2.1 2.8 0.1 0.4 0.0 0.2 14.2 SMIM34A ENSG00000243627 "Small integral membrane protein 34A" A8MWV9 21 34418715-34423951 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 1.2;kidney: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.2 0.1 0.5 2.4 0.2 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.5 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL10RB "CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2" ENSG00000243646 "Interleukin 10 receptor subunit beta" Q08334 21 33266367-33310187 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 198.4;Extravillous trophoblasts: 164.9;Syncytiotrophoblasts: 315.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020670, HPA047550" Approved Approved Cytosol NA NA 1600000 Cytosol "CAB020670: , HPA047550: AB_2680086" "unprognostic (8.43e-2)" "unprognostic (6.50e-2)" "unprognostic (5.88e-2)" "unprognostic (1.77e-1)" "unprognostic (1.48e-2)" "unprognostic (7.78e-2)" "unprognostic (1.97e-3)" "unprognostic (1.26e-1)" "unprognostic (5.69e-3)" "unprognostic (1.31e-1)" "unprognostic (1.19e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.62e-9)" "unprognostic (3.09e-1)" "unprognostic (2.76e-1)" "unprognostic (1.29e-2)" "unprognostic (1.05e-1)" 23.2 14.6 8.4 30.6 8.6 20.0 18.2 8.3 11.3 20.4 9.1 41.0 36.8 14.9 10.0 27.9 24.1 24.1 13.3 8.3 10.2 14.9 27.8 26.1 27.8 9.2 8.3 8.3 20.6 25.6 10.8 11.4 63.0 9.2 18.8 38.3 4.8 23.9 12.4 12.5 19.3 46.1 20.0 9.0 43.5 34.2 5.1 9.4 30.8 14.2 9.9 26.2 29.6 19.5 9.4 28.8 21.6 4.9 19.1 82.7 61.3 30.0 22.9 62.3 23.5 33.6 20.6 36.1 10.9 25.0 37.8 48.3 34.5 13.2 14.8 17.3 28.5 15.5 30.8 15.1 15.2 58.3 29.5 54.6 62.5 26.8 41.2 23.5 36.8 34.6 25.6 20.6 79.7 32.5 29.1 22.6 27.4 4.2 59.1 11.4 18.5 14.4 33.9 22.6 16.6 7.5 8.0 45.4 35.3 37.5 9.7 21.3 104.5 31.0 24.1 22.7 40.0 12.4 49.9 48.3 6.8 40.5 44.5 19.4 103.8 115.0 98.9 32.0 134.9 35.2 51.6 39.3 38.1 67.9 54.1 36.8 36.3 219.4 56.9 141.6 73.6 77.6 87.5 8.4 8.6 8.3 11.3 8.3 10.2 9.2 8.3 8.3 9.2 9.0 9.4 9.4 3.1 35.3 20.5 11.8 26.5 14.5 38.0 54.0 19.4 5.8 3.3 2.8 12.3 32.9 32.3 3.7 14.6 198.4 33.6 102.1 0.0 20.1 1.1 2.3 3.5 23.5 10.2 17.7 14.5 30.1 164.9 24.2 29.6 2.4 35.5 2.1 31.8 23.2 116.6 8.4 12.7 64.4 30.5 111.3 25.3 1.6 31.7 54.3 14.2 23.4 80.6 6.7 49.4 14.6 18.5 23.4 86.8 23.7 39.9 44.3 103.1 1.1 15.8 6.4 19.7 16.9 9.1 2.9 5.0 21.7 14.6 315.6 21.0 0.2 41.4 67.6 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 34 "liver: 2634.7" "Cell type enhanced" "Detected in many" "Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1" "Low region specificity" "Detected in all" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" NA NA 879000000 120000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favorable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 77.5 18.2 3.4 33.1 3.3 0.1 28.8 3.2 10.0 11.7 3.8 19.2 28.4 8.3 14.4 24.3 54.1 0.8 25.6 3.4 3.2 58.4 2634.7 39.5 4.2 4.1 3.3 3.1 9.9 52.3 0.2 17.8 5.0 3.5 60.8 14.7 1.4 43.6 0.0 3.1 7.6 73.7 48.8 3.1 13.0 54.9 2.1 3.5 1.9 15.7 0.7 6.8 17.9 9.3 3.4 0.5 1.9 0.1 0.0 15.0 23.0 0.1 0.0 0.2 1.1 0.0 0.1 8.6 0.1 25.1 14.1 0.6 6.0 0.0 1.8 1.2 1.0 0.3 0.7 0.4 0.5 0.0 1.0 0.4 19.1 0.4 0.6 0.5 1.3 0.2 0.1 0.3 0.7 0.1 0.2 0.1 0.3 0.4 0.0 0.4 0.3 0.3 1.3 1.7 0.5 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 3.4 1.2 0.4 0.4 0.7 2.1 1.0 10.1 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 3.3 3.2 10.0 3.4 3.2 4.1 3.3 3.1 3.5 3.1 3.5 3.4 1.0 0.0 16.9 0.0 2.6 0.8 0.9 64.8 11.4 0.3 4.9 0.9 0.4 44.3 127.3 5.5 0.0 0.1 0.0 3.7 3.9 873.6 0.0 1.9 0.4 3.9 2.4 16.0 0.2 197.3 0.2 34.6 20.9 1.2 0.0 0.0 11.7 284.0 1.0 0.0 0.2 8.5 18.3 19.7 1.0 0.0 2.8 1.1 0.0 5.6 18.1 0.4 0.0 0.0 0.0 318.0 10.6 0.0 0.1 8.6 139.7 17.1 75.4 0.7 0.0 1.0 12.6 0.1 0.1 3.9 1.8 1.6 1.6 0.0 12.4 4.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" 10 43436841-43483181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.4" "Cell type enhanced" "Detected in many" "Early spermatids: 191.2;Endometrial ciliated cells: 65.7;Late spermatids: 289.9;Respiratory ciliated cells: 73.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 2.7 2.1 7.9 2.0 2.7 4.4 2.8 3.4 6.4 3.1 3.6 2.3 2.4 3.8 2.1 2.1 6.1 3.7 2.1 2.4 3.8 2.3 2.2 3.0 2.4 7.0 4.3 1.3 4.3 1.6 3.6 2.4 1.9 5.2 2.3 1.9 9.0 1.5 2.7 1.2 2.1 2.5 3.0 7.4 2.4 2.3 28.4 3.0 3.7 3.3 1.6 2.3 3.3 2.2 3.8 1.7 1.6 2.0 2.1 2.4 4.8 0.6 2.7 4.7 2.5 2.7 2.6 4.7 4.3 0.4 3.4 2.4 2.7 0.6 1.0 2.4 0.5 0.9 1.4 0.4 1.5 3.1 1.4 1.7 5.0 2.3 4.2 3.0 5.2 0.9 0.9 0.7 0.6 1.9 3.0 2.9 1.1 0.4 0.8 0.9 1.5 0.7 1.8 5.7 1.9 1.7 1.3 2.4 1.3 1.1 1.2 2.2 1.6 1.5 2.4 1.5 1.4 0.7 0.3 1.1 4.7 5.6 2.0 0.9 1.8 3.0 4.5 3.3 2.2 2.6 1.9 2.4 2.9 3.9 2.5 1.9 2.3 10.4 2.9 1.2 2.9 1.6 2.1 7.9 2.7 3.4 6.4 2.4 3.8 7.0 4.3 1.3 5.2 7.4 3.0 3.8 4.0 22.4 4.8 11.8 6.2 1.8 6.3 6.6 3.4 5.4 6.6 7.7 3.3 7.2 8.3 5.5 8.4 1.4 9.8 6.1 11.7 4.5 191.2 65.7 6.5 5.3 7.8 1.3 19.4 2.1 4.0 5.4 5.6 6.3 0.0 3.4 3.3 2.7 3.3 6.7 21.1 4.4 10.2 5.6 3.1 289.9 4.7 6.3 1.8 0.0 7.3 12.6 2.1 6.0 7.1 2.1 3.9 6.8 3.6 3.2 13.0 12.7 73.5 18.7 0.0 6.3 5.1 16.7 7.5 1.9 2.8 1.6 5.6 3.8 3.5 6.1 WDR92 "FLJ31741, Monad" ENSG00000243667 "WD repeat domain 92" Q96MX6 2 68122936-68157549 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 47.9;Respiratory ciliated cells: 40.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035335, HPA035336" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035335: AB_10959456, HPA035336: AB_10964348" "unprognostic (3.55e-2)" "unprognostic (3.42e-3)" "unprognostic (6.80e-2)" "unprognostic (1.69e-2)" "unprognostic (1.31e-1)" "unprognostic (3.20e-2)" "unprognostic (3.76e-3)" "unprognostic (2.51e-2)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.61e-1)" "unprognostic (3.56e-3)" "unprognostic (9.86e-2)" "unprognostic (7.23e-2)" "unprognostic (4.07e-1)" "unprognostic (3.15e-2)" 6.0 7.0 6.9 6.6 6.4 3.7 8.7 7.7 5.6 5.5 8.9 6.1 6.3 7.5 16.1 7.1 11.2 5.4 9.1 5.2 5.2 5.5 5.2 5.8 9.8 5.7 6.0 5.0 7.0 4.3 7.3 4.7 5.7 5.0 8.2 8.1 7.0 6.4 6.9 11.6 10.6 5.3 7.6 6.2 8.2 6.0 8.1 5.0 8.2 8.4 9.2 9.0 5.1 5.2 5.6 15.3 9.4 12.0 12.6 14.5 14.7 10.3 11.6 10.1 12.1 12.8 7.0 12.5 16.5 3.7 10.3 16.5 15.0 13.0 8.8 15.6 11.2 13.8 16.9 13.1 8.0 7.0 18.5 5.2 9.4 11.5 10.0 8.6 12.9 11.7 15.2 11.3 11.1 14.3 7.3 13.2 18.6 12.2 12.8 12.9 15.9 15.3 14.1 12.5 8.6 12.4 10.6 8.6 15.5 9.6 11.8 11.9 12.1 13.6 18.4 7.4 11.6 10.1 7.6 11.6 11.6 17.3 17.6 9.3 0.7 2.3 1.7 3.2 2.5 4.2 5.3 3.4 3.8 2.7 4.9 4.0 5.0 1.0 6.3 1.8 5.1 4.0 2.1 6.9 6.4 7.7 5.6 5.2 5.2 5.7 6.0 5.0 5.0 6.2 5.0 5.6 7.8 3.2 10.9 5.9 5.2 3.4 4.7 6.5 2.2 28.7 5.6 5.6 3.1 1.5 11.1 5.5 47.9 13.6 12.2 1.3 1.9 6.7 5.8 26.3 6.8 7.4 0.0 7.0 17.9 6.5 9.2 5.7 1.5 4.3 13.3 9.7 8.2 6.3 7.3 11.8 16.4 3.3 4.1 3.5 1.2 2.8 7.8 3.5 1.8 8.4 7.2 12.0 6.2 14.1 11.6 6.2 2.9 9.4 2.0 3.3 3.7 6.7 40.2 21.9 6.6 9.0 5.9 26.0 15.2 1.8 4.1 5.1 3.6 9.4 6.0 2.1 NME2 "NDPKB, NM23-H2" ENSG00000243678 "NME/NM23 nucleoside diphosphate kinase 2" P22392 17 51165435-51171744 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 918.0;Gastric mucus-secreting cells: 438.3;Plasma cells: 778.5;Squamous epithelial cells: 1490.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB036213, CAB036214, CAB036215, HPA041113" Approved Supported "Plasma membrane,Midbody ring,Cytosol" Yes NA Cytosol "Plasma membrane, Midbody ring" "CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305" "unprognostic (7.21e-3)" "prognostic unfavorable (4.74e-4)" "unprognostic (4.85e-2)" "unprognostic (1.15e-2)" "unprognostic (8.86e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.62e-3)" "unprognostic (5.68e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (2.82e-1)" "unprognostic (9.09e-2)" "unprognostic (8.87e-2)" "unprognostic (3.19e-2)" 483.1 431.8 312.9 261.9 318.6 332.2 493.3 330.1 383.0 426.3 416.2 402.7 338.2 386.6 238.1 615.5 353.7 188.7 400.2 315.3 348.9 461.7 431.9 342.5 291.3 330.0 322.0 298.2 504.3 637.3 203.6 236.8 206.4 323.5 370.8 333.5 63.9 435.9 249.8 550.2 524.2 310.1 288.6 332.6 338.7 406.8 78.4 338.6 191.8 307.9 356.8 291.5 467.5 468.1 337.6 1638.6 2233.9 466.1 913.7 969.3 1399.2 1449.2 1091.7 954.0 1404.8 1053.5 1789.7 792.3 1314.3 1662.9 913.0 706.6 956.2 947.3 1273.3 1035.7 1604.8 3283.2 1120.3 1345.8 2513.4 1116.1 1736.0 760.5 1324.1 1420.0 901.9 1466.4 914.6 860.9 856.5 1541.7 773.7 956.1 2741.9 931.3 2144.8 831.4 2974.6 3364.2 875.9 1731.8 2157.2 1417.9 1800.2 1160.6 641.9 674.1 1472.7 1583.0 806.1 1201.7 1268.5 1013.5 1462.8 1158.2 1135.2 1774.8 1520.9 2176.6 1558.1 815.1 919.1 819.2 66.8 243.4 14.0 166.7 325.5 235.6 338.9 211.9 183.3 439.5 259.2 153.5 170.0 13.8 251.6 282.5 478.1 211.2 298.2 312.9 318.6 330.1 383.0 315.3 348.9 330.0 322.0 298.2 323.5 332.6 338.6 337.6 9.7 28.9 67.2 0.0 146.8 14.5 8.3 10.8 918.0 0.9 41.6 35.9 0.0 22.8 85.7 5.5 0.0 10.0 10.1 7.1 37.2 47.4 0.6 16.4 34.3 60.9 14.6 298.2 0.0 34.5 27.8 99.0 438.3 21.3 42.9 6.8 22.9 37.6 16.4 0.0 0.0 19.3 8.2 34.8 17.4 2.1 25.7 136.7 10.6 0.0 55.5 0.4 2.1 0.0 0.0 40.7 15.6 12.8 778.5 7.6 11.7 33.8 63.6 0.8 6.6 10.2 43.3 0.6 5.6 1490.1 14.9 8.8 87.0 6.8 25.0 11.0 PLA2G4B "cPLA2-beta, HsT16992" ENSG00000243708 "Phospholipase A2 group IVB" P0C869 15 41837775-41848147 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.1;Club cells: 1.3;Rod photoreceptor cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 7.8" NA NA "unprognostic (6.16e-2)" "unprognostic (6.48e-3)" "unprognostic (5.06e-3)" "unprognostic (1.27e-4)" "unprognostic (1.06e-1)" "unprognostic (2.56e-3)" "unprognostic (1.53e-1)" "unprognostic (2.27e-2)" "unprognostic (3.60e-2)" "unprognostic (1.90e-2)" "unprognostic (1.23e-2)" "unprognostic (5.14e-3)" "unprognostic (3.26e-5)" "unprognostic (4.36e-1)" "unprognostic (5.91e-2)" "unprognostic (1.22e-1)" "unprognostic (2.97e-2)" 8.4 7.7 6.2 0.5 6.2 3.8 10.7 6.2 10.2 21.4 6.2 8.8 1.6 8.4 1.9 36.9 14.1 1.8 9.8 6.2 6.2 15.5 16.8 11.5 3.4 6.2 6.2 6.2 20.2 19.5 0.3 16.4 0.5 6.2 25.0 0.8 0.4 16.8 2.4 5.4 45.0 12.6 0.6 6.2 17.0 12.6 9.7 6.3 1.4 23.1 0.1 5.8 12.4 30.5 6.2 1.1 0.8 0.0 0.0 0.2 0.1 2.9 0.3 0.8 1.0 0.2 0.4 0.5 0.2 0.1 0.6 0.1 3.6 1.0 0.9 0.2 0.1 1.7 0.9 1.3 2.5 1.5 0.2 1.4 0.6 3.6 0.3 1.0 0.2 0.4 1.6 1.2 0.1 0.2 1.6 1.1 3.1 0.8 4.0 0.9 0.0 0.9 0.5 0.8 7.8 0.4 0.7 0.0 1.4 0.8 0.6 4.2 1.4 0.0 0.0 0.8 1.0 0.1 2.5 0.1 0.7 0.2 3.8 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.1 0.2 0.1 1.5 0.2 0.2 0.0 1.1 0.0 0.1 0.4 0.0 6.2 6.2 6.2 10.2 6.2 6.2 6.2 6.2 6.2 6.2 6.2 6.3 6.2 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 LEFTY1 "LEFTB, LEFTYB" ENSG00000243709 "Left-right determination factor 1" O75610 1 225886282-225911382 "Metabolic proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "intestine: 58.9;pancreas: 97.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 201.5;Glandular and luminal cells: 175.0;Intestinal goblet cells: 86.1;Paneth cells: 228.9;Undifferentiated cells: 301.0" "Group enriched" "Detected in many" 4 "colorectal cancer: 44.8;endometrial cancer: 36.2;pancreatic cancer: 13.8;testis cancer: 15.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 51 "basophil: 17.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 17.0" "Cell line enriched" "Detected in some" 6 "NTERA-2: 50.2" "HPA047883, HPA056210" Approved "Secreted in other tissues" NA NA "HPA047883: AB_2680200, HPA056210: AB_2683067" "unprognostic (2.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.26e-2)" "unprognostic (1.18e-2)" "unprognostic (1.83e-2)" "unprognostic (3.50e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" "unprognostic (2.19e-1)" "unprognostic (1.28e-1)" "unprognostic (7.76e-2)" "unprognostic (6.13e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (2.78e-2)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (2.61e-2)" 0.3 0.2 2.0 7.9 2.1 0.0 0.4 1.7 2.7 1.4 1.3 58.9 0.2 0.5 7.0 0.1 0.6 0.0 0.3 2.1 1.8 1.7 0.9 0.4 0.0 1.7 1.6 2.1 4.1 97.7 0.0 1.0 0.2 1.8 0.9 32.7 0.8 1.5 3.3 0.4 0.2 2.9 0.9 1.8 0.3 1.4 0.8 1.7 0.0 0.1 0.1 0.1 1.5 0.2 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 0.3 0.0 0.0 0.0 4.5 0.1 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 5.4 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 2.0 2.1 1.7 2.7 2.1 1.8 1.7 1.6 2.1 1.8 1.8 1.7 1.9 0.2 0.0 0.0 0.7 1.0 0.4 1.6 0.0 0.0 1.8 0.2 0.3 0.1 14.3 0.0 0.0 0.0 0.0 0.0 51.7 1.9 20.1 1.8 201.5 9.9 0.3 31.5 0.0 2.3 29.6 0.1 1.6 0.0 175.0 0.0 1.6 0.0 0.2 0.0 0.0 2.3 86.1 0.0 0.0 0.0 3.9 1.5 2.1 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.5 228.9 1.9 0.0 0.8 0.7 6.0 0.0 1.4 0.0 0.0 0.6 2.5 4.2 0.0 0.0 0.0 1.0 1.3 301.0 1.3 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172330-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 8.9;fallopian tube: 23.6;testis: 15.9" "Group enriched" "Detected in some" 7 "Early spermatids: 38.6;Endometrial ciliated cells: 62.4;Late spermatids: 26.7;Respiratory ciliated cells: 85.2;Spermatocytes: 25.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;HDLM-2: 1.8;TIME: 1.5" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol NA NA Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.3 0.1 2.5 0.0 1.3 0.0 0.3 1.4 1.0 0.9 8.9 0.0 0.0 0.6 2.8 0.1 23.6 0.2 0.1 1.3 3.8 1.0 2.8 2.5 0.0 3.4 2.9 0.3 0.2 0.6 0.1 2.0 0.2 2.4 0.4 0.1 1.5 0.1 0.2 0.1 0.6 0.0 0.1 3.1 0.0 0.1 15.9 1.2 0.2 1.0 0.0 0.1 0.2 0.1 1.3 0.9 0.3 0.2 0.1 0.0 0.0 0.2 0.3 0.7 0.5 0.5 0.3 0.3 0.0 0.3 1.0 0.3 2.8 0.2 0.3 1.1 1.8 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.5 0.5 0.1 0.7 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.2 0.2 0.3 0.1 0.3 0.0 0.3 0.3 0.6 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 2.5 1.3 1.4 1.0 1.3 3.8 3.4 2.9 0.3 2.4 3.1 1.2 1.3 0.2 6.4 0.5 1.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.3 0.5 0.0 5.6 0.0 6.2 0.9 0.0 0.2 0.0 0.2 38.6 62.4 0.6 0.3 0.0 0.0 3.5 0.2 0.1 0.6 0.0 1.2 0.0 0.1 1.1 0.5 0.1 1.7 1.2 0.0 0.0 0.0 0.0 26.7 0.9 0.2 0.0 0.0 2.1 0.6 0.0 0.0 1.1 0.3 0.0 0.7 0.0 0.1 0.7 1.9 85.2 1.2 0.0 0.0 0.1 25.4 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 57.1;Club cells: 50.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 56.8 36.8 51.2 67.4 24.0 137.7 58.5 51.3 104.0 61.3 4.0 60.7 36.8 42.2 126.0 41.5 55.4 27.9 49.8 23.9 15.2 49.1 38.7 77.7 83.3 34.2 14.7 1.3 57.6 49.8 14.8 50.8 29.5 88.1 59.4 47.7 116.7 57.2 23.0 79.2 213.7 91.7 25.5 1.5 85.3 51.3 41.3 29.8 43.5 76.1 17.9 61.6 46.3 59.3 24.0 31.3 25.7 16.3 23.3 27.8 24.9 35.4 18.9 6.3 11.5 13.9 35.4 53.3 43.9 34.7 17.4 11.3 24.5 41.2 21.3 19.0 53.8 17.2 16.1 85.6 66.1 27.5 83.5 29.1 30.1 20.9 23.0 41.1 20.6 18.3 45.0 43.5 52.8 10.3 57.6 26.6 101.3 46.4 4.9 11.7 44.7 12.1 51.1 18.2 18.9 21.0 14.9 23.3 36.6 19.7 32.9 19.9 30.8 71.4 39.4 17.4 31.2 30.6 35.7 18.9 54.4 15.7 63.6 14.3 6.2 2.7 2.1 3.9 1.2 1.6 6.8 3.8 2.6 1.4 7.7 4.0 3.5 6.0 2.8 2.5 5.2 2.0 1.3 51.2 24.0 51.3 104.0 23.9 15.2 34.2 14.7 1.3 88.1 1.5 29.8 24.0 30.0 28.9 57.1 1.0 20.3 14.4 11.2 3.0 17.1 16.5 10.5 7.1 34.8 4.3 50.6 5.5 10.4 5.1 22.8 3.3 0.0 3.8 7.1 19.3 20.5 23.6 1.2 17.2 0.3 1.4 2.8 20.4 22.4 32.7 10.1 21.0 8.2 2.0 4.4 6.7 0.2 3.8 0.0 8.1 16.7 2.8 10.2 25.5 5.4 1.0 14.2 5.5 12.3 0.5 0.3 5.0 4.0 6.4 21.7 13.0 4.3 1.6 31.6 23.8 0.0 32.7 22.7 3.6 2.3 14.0 11.5 5.9 29.7 9.3 3.3 10.3 TTC4 "CNS1, FLJ41930, MGC5097" ENSG00000243725 "Tetratricopeptide repeat domain 4" O95801 1 54715861-54742657 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041608, HPA042459" Approved Enhanced "Intermediate filaments,Cytoplasmic bodies" NA NA "Intermediate filaments" "Cytoplasmic bodies" "HPA041608: AB_10794485, HPA042459: AB_10797496" "unprognostic (4.89e-2)" "unprognostic (1.81e-1)" "unprognostic (2.05e-2)" "unprognostic (8.62e-4)" "unprognostic (8.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.21e-5)" "unprognostic (1.39e-4)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (2.42e-3)" "unprognostic (7.12e-2)" "unprognostic (2.85e-1)" "unprognostic (7.79e-2)" "unprognostic (5.86e-2)" "unprognostic (1.76e-3)" 8.9 8.9 22.8 5.4 23.3 2.0 10.5 23.8 24.9 10.5 21.9 9.5 5.7 8.5 8.1 10.7 9.2 3.9 14.6 23.0 23.4 11.0 10.2 5.6 7.3 23.4 23.6 22.7 12.7 11.8 11.8 12.9 7.7 23.8 8.9 6.4 9.0 9.2 8.4 34.0 10.1 8.0 7.7 24.1 6.6 10.9 8.6 23.4 12.9 8.0 22.4 9.0 11.1 10.2 25.4 24.3 18.2 20.1 10.9 29.2 16.6 17.9 32.6 16.0 39.8 26.6 20.5 6.9 40.1 17.4 22.4 42.2 13.1 43.7 31.1 41.6 38.2 31.7 38.4 7.7 11.9 27.4 32.4 10.6 16.1 30.4 58.2 34.9 17.8 17.3 31.3 45.5 6.3 22.7 11.3 30.0 18.3 41.0 29.1 30.9 27.1 43.0 22.5 19.9 6.5 13.5 9.7 28.4 13.8 27.2 33.0 13.2 16.5 17.4 19.5 21.2 20.5 44.9 16.1 29.9 34.0 25.9 36.5 20.8 7.3 12.3 10.3 13.9 14.0 14.8 12.6 11.1 13.3 13.5 12.6 15.9 14.3 0.2 18.9 15.1 11.2 11.8 13.0 22.8 23.3 23.8 24.9 23.0 23.4 23.4 23.6 22.7 23.8 24.1 23.4 25.4 3.7 9.6 2.6 0.0 6.2 1.1 3.4 2.1 7.4 4.5 3.1 3.3 3.2 1.5 5.2 0.0 0.0 3.9 2.4 1.5 0.0 3.5 0.5 4.7 8.8 3.4 1.2 3.0 0.0 4.2 2.4 5.4 3.6 4.5 7.0 3.0 3.9 2.4 1.4 5.0 0.0 1.3 0.0 0.6 1.5 0.7 4.1 2.7 1.8 0.0 5.9 2.3 6.2 0.0 0.0 3.9 1.7 2.6 6.1 3.0 2.0 6.4 2.6 3.8 0.0 3.8 3.5 9.2 8.2 5.7 1.6 1.4 4.6 1.9 2.5 1.8 OR5V1 hs6M1-21 ENSG00000243729 "Olfactory receptor family 5 subfamily V member 1" Q9UGF6 6 29353749-29431967 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "Early spermatids: 17.3;Late spermatids: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "olfactory bulb: 1.3" "Not detected" "Not detected" HPA046707 Uncertain NA NA "HPA046707: AB_2679763" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.1 0.1 0.6 0.3 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 22.4;Alveolar cells type 2: 13.4;Club cells: 6.2;granulocytes: 8.8;Respiratory ciliated cells: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 115.3;CAPAN-2: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051024: AB_2681316" "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 45.5 36.3 11.9 25.4 11.8 13.7 40.5 12.0 18.6 41.7 16.6 27.4 16.8 36.5 39.4 15.6 41.6 41.4 28.6 11.5 13.9 35.0 40.4 44.6 40.3 13.1 12.2 11.2 32.8 29.8 30.0 22.0 63.9 13.0 30.7 26.8 2.2 26.0 35.1 8.6 13.3 27.8 30.3 12.9 32.7 24.7 22.8 13.0 30.0 45.1 20.5 31.2 36.6 33.6 13.9 25.8 19.5 4.2 7.3 115.3 67.1 9.3 27.7 46.2 19.1 25.8 19.4 113.1 12.6 42.1 28.4 30.3 27.2 8.1 23.4 15.0 49.2 12.9 27.2 9.0 23.1 63.2 18.0 27.5 67.7 21.3 17.4 36.6 39.1 38.3 26.8 17.5 36.2 34.2 16.2 13.3 18.6 20.2 0.0 13.6 17.7 37.3 4.0 53.6 24.9 11.1 3.5 42.4 0.6 39.5 21.3 10.3 27.9 39.4 25.6 24.0 22.7 15.8 20.9 12.7 8.9 25.7 29.4 22.2 161.3 101.2 112.4 188.7 118.6 202.9 108.9 205.0 208.3 71.3 89.9 177.7 179.9 31.4 165.4 100.4 159.5 232.4 182.9 11.9 11.8 12.0 18.6 11.5 13.9 13.1 12.2 11.2 13.0 12.9 13.0 13.9 0.6 22.4 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 6.2 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.0 0.3 0.7 2.1 0.0 0.0 0.0 0.2 0.2 2.0 0.0 0.3 8.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 15.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 KIR2DL3 "CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58" ENSG00000243772 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3" P43628 19 54738513-54753052 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.5" "Group enriched" "Detected in some" 15 "dendritic cells: 30.8;NK-cells: 22.6;T-cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (7.37e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.92e-1)" "unprognostic (7.76e-3)" "unprognostic (1.55e-2)" "unprognostic (1.99e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-4)" "unprognostic (1.19e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (1.59e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 JMJD7 ENSG00000243789 "Jumonji domain containing 7" P0C870 15 41828092-41837581 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 2.0;Squamous epithelial cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 31.2;RT4: 43.5" "Low region specificity" "Detected in all" HPA005726 Approved Approved Cytosol NA NA Cytosol "HPA005726: AB_1852017" "unprognostic (2.92e-1)" "unprognostic (7.99e-2)" "unprognostic (1.47e-2)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.78e-2)" "unprognostic (2.11e-2)" "unprognostic (1.77e-1)" "unprognostic (2.42e-1)" "unprognostic (8.74e-3)" "unprognostic (3.13e-1)" "unprognostic (7.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" 6.6 8.5 6.0 4.2 5.5 8.3 9.1 17.7 9.6 10.9 6.7 7.0 4.8 6.6 3.1 35.7 8.6 6.6 11.3 5.6 5.3 8.5 10.4 10.9 7.4 6.0 6.1 5.4 11.7 16.0 9.1 9.9 3.1 10.1 14.6 3.0 1.9 22.1 6.8 7.8 30.7 8.1 2.9 4.8 8.0 11.6 6.7 5.6 5.7 15.8 6.7 6.7 11.5 21.1 6.9 7.9 7.5 9.3 2.6 2.5 1.7 5.8 3.1 6.6 5.1 4.1 10.5 5.9 1.0 6.4 2.0 5.3 19.6 4.3 15.6 1.6 7.7 4.6 10.5 10.4 6.5 4.1 5.1 11.0 1.1 13.6 3.4 7.2 4.7 5.8 9.9 7.0 6.2 3.7 10.8 6.6 4.9 4.0 31.2 4.8 2.9 6.3 7.6 11.5 43.5 9.9 3.5 2.6 13.5 4.3 2.7 26.2 5.4 5.4 3.7 8.3 8.0 6.1 10.2 3.7 3.2 4.9 12.4 5.7 6.1 14.8 10.8 14.1 15.8 14.8 7.2 15.7 18.6 10.6 11.1 19.7 15.6 3.9 13.0 15.8 6.7 16.7 12.6 6.0 5.5 17.7 9.6 5.6 5.3 6.0 6.1 5.4 10.1 4.8 5.6 6.9 0.1 3.2 5.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.8 0.0 0.2 0.0 0.2 2.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 3.4 0.1 0.0 0.6 0.0 0.0 0.0 APOBEC3D "APOBEC3DE, APOBEC3E, ARP6" ENSG00000243811 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3D" Q96AK3 22 39021113-39033277 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.4" "Cell type enhanced" "Detected in many" "B-cells: 6.7;NK-cells: 9.2;Plasma cells: 6.4;T-cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 11.8;Karpas-707: 46.7" HPA055116 Approved NA NA "HPA055116: AB_2682701" "prognostic favorable (2.51e-5)" "prognostic favorable (1.31e-4)" "unprognostic (2.69e-2)" "prognostic favorable (4.47e-4)" "unprognostic (2.62e-2)" "unprognostic (3.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (2.45e-2)" "unprognostic (4.50e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (3.76e-7)" "unprognostic (4.76e-2)" "unprognostic (6.00e-2)" "unprognostic (1.06e-2)" "prognostic favorable (3.01e-4)" 1.7 2.2 1.1 8.7 1.2 2.6 1.8 1.4 1.3 3.5 1.5 3.5 3.9 3.4 3.0 1.7 5.2 4.2 1.2 1.0 1.1 1.7 1.2 3.4 15.4 1.5 1.1 0.9 4.2 0.5 1.2 0.9 2.2 1.2 2.6 4.3 0.3 2.8 2.3 0.9 1.4 5.3 2.5 1.3 12.1 5.3 2.5 1.5 7.7 1.9 1.2 13.9 4.6 2.7 1.5 0.5 0.0 0.3 2.1 3.1 5.5 1.9 0.3 3.3 3.9 4.4 0.9 5.3 6.1 0.9 4.4 2.5 0.6 0.3 0.0 1.4 11.1 1.2 10.7 0.1 0.0 8.3 1.5 11.8 3.6 0.5 6.3 0.0 0.0 2.9 9.0 2.7 46.7 0.2 0.0 5.2 3.4 0.8 0.0 0.5 4.3 0.3 0.1 0.0 0.0 0.1 0.3 0.2 0.1 1.7 1.4 0.1 0.5 1.1 0.1 1.2 0.6 0.0 3.2 3.9 0.8 1.6 3.3 1.5 4.8 1.3 3.5 8.0 3.5 5.2 6.7 5.8 7.3 0.8 6.8 2.7 3.6 1.7 4.9 6.5 5.4 5.8 3.4 1.1 1.2 1.4 1.3 1.0 1.1 1.5 1.1 0.9 1.2 1.3 1.5 1.5 0.9 3.2 0.5 0.0 6.7 1.0 1.5 0.9 0.0 0.2 0.3 0.6 0.4 5.7 1.1 1.8 0.0 1.3 3.8 3.0 0.0 0.2 0.5 1.0 0.8 1.9 1.8 1.7 0.0 0.2 0.7 1.8 2.6 0.6 0.0 1.1 2.5 0.2 2.5 0.0 0.0 3.6 0.0 3.4 1.0 0.0 3.1 1.1 3.6 2.8 1.2 0.3 9.2 0.5 0.0 0.2 0.1 1.9 6.4 1.4 1.3 0.3 2.7 0.5 0.0 0.9 1.4 0.2 0.4 0.2 0.9 0.5 8.7 0.8 2.1 2.6 OR2A7 HSDJ0798C17 ENSG00000243896 "Olfactory receptor family 2 subfamily A member 7" Q96R45 7 144257663-144264792 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 6 "basophil: 12.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 12.3" "Cell line enhanced" "Detected in some" "A-431: 12.7;hTCEpi: 6.2;RT4: 5.0;SK-BR-3: 5.3" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.57e-1)" "unprognostic (1.40e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (4.13e-2)" "unprognostic (5.75e-2)" "unprognostic (7.28e-2)" "unprognostic (3.33e-1)" "unprognostic (9.08e-2)" "unprognostic (3.58e-3)" "unprognostic (5.52e-2)" "unprognostic (5.13e-2)" "unprognostic (3.06e-1)" "unprognostic (3.22e-1)" 1.8 0.7 0.7 1.2 0.8 3.1 5.9 0.5 0.7 3.4 2.5 5.8 10.6 1.7 3.8 5.3 3.4 3.1 1.0 0.1 1.6 3.9 3.2 3.1 1.4 0.8 0.9 0.1 3.4 6.1 3.1 2.0 1.7 0.8 4.8 5.5 1.8 5.4 1.4 0.2 11.3 7.6 1.1 0.5 1.8 6.5 0.9 0.6 0.9 10.1 0.3 1.4 2.3 4.4 0.8 12.7 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.1 0.0 0.0 0.6 3.4 0.0 0.0 0.0 0.0 2.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 6.2 0.4 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 3.2 5.0 0.0 0.0 3.1 5.3 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 12.3 0.1 0.0 0.7 0.0 0.2 0.6 1.0 0.5 0.0 2.0 0.6 0.5 0.0 1.5 0.0 0.0 0.7 0.0 0.7 0.8 0.5 0.7 0.1 1.6 0.8 0.9 0.1 0.8 0.5 0.6 0.8 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUBA4B "FLJ13940, TUBA4" ENSG00000243910 "Tubulin alpha 4b" Q9H853 2 219253243-219272197 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 40.4" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 148.9;Respiratory ciliated cells: 83.1" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 8.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.20e-5)" "unprognostic (1.47e-4)" "unprognostic (1.85e-1)" "unprognostic (3.70e-3)" "unprognostic (9.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.18e-3)" "unprognostic (7.32e-2)" "unprognostic (9.50e-2)" "unprognostic (6.56e-2)" "unprognostic (2.50e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-3)" "unprognostic (3.78e-2)" "unprognostic (9.57e-2)" "unprognostic (3.91e-2)" "unprognostic (4.08e-1)" 0.0 0.0 2.5 0.0 0.6 0.0 0.0 0.8 0.2 0.8 3.9 0.0 0.1 0.5 0.7 0.0 40.4 0.0 0.0 0.4 0.8 1.4 0.2 3.5 0.1 1.6 2.6 0.0 0.1 0.0 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 3.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.3 0.3 0.0 0.2 0.3 0.3 0.6 0.1 0.1 0.0 0.3 1.4 2.5 0.6 0.8 0.2 0.4 0.8 1.6 2.6 0.0 1.7 3.0 0.7 1.5 0.0 0.0 3.2 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.3 1.8 0.0 0.0 0.0 0.0 1.9 0.0 1.8 148.9 0.9 0.1 1.8 0.0 0.3 0.2 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 27.9 83.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 MRPS6 "C21orf101, MRP-S6, RPMS6" ENSG00000243927 "Mitochondrial ribosomal protein S6" P82932 21 34073224-34143034 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 747.4;Prostatic glandular cells: 568.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007861, HPA008163, HPA049676" Supported Supported Mitochondria NA NA Mitochondria "HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846" "unprognostic (2.71e-2)" "unprognostic (4.85e-2)" "unprognostic (5.16e-3)" "unprognostic (4.01e-2)" "unprognostic (9.84e-3)" "unprognostic (3.72e-2)" "unprognostic (7.58e-3)" "unprognostic (1.80e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.87e-2)" "unprognostic (2.52e-1)" "unprognostic (1.02e-3)" "unprognostic (9.37e-2)" "unprognostic (5.13e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.06e-5)" 57.1 73.1 54.1 34.1 56.0 15.7 46.5 53.6 93.0 39.3 78.9 69.3 22.9 37.4 51.2 31.5 38.2 25.0 49.9 55.2 67.0 126.0 51.0 38.2 47.1 58.0 53.5 53.3 42.0 22.4 24.4 39.8 52.2 55.6 33.4 36.8 25.8 26.4 42.0 96.9 53.8 39.4 37.0 61.0 28.9 51.8 45.2 58.5 38.7 98.3 77.5 50.2 51.1 34.0 59.3 70.8 56.6 211.0 77.2 74.1 72.9 71.4 79.5 185.4 68.7 70.0 181.8 134.9 105.6 51.7 104.0 92.8 28.7 124.6 106.0 73.4 193.5 65.4 89.6 34.3 47.8 35.4 45.2 31.7 35.0 107.8 127.2 116.5 104.2 47.4 45.2 116.5 28.0 140.7 66.0 73.4 104.1 136.9 135.4 122.1 99.6 37.4 101.5 307.4 60.4 187.5 50.0 84.5 46.2 103.6 112.6 87.3 58.7 24.3 62.8 36.6 115.4 46.3 132.5 125.8 96.3 204.2 118.4 62.8 67.0 53.8 60.4 90.3 53.7 66.6 74.9 67.0 81.4 56.1 48.4 83.8 87.3 46.8 115.7 57.5 101.4 74.0 79.6 54.1 56.0 53.6 93.0 55.2 67.0 58.0 53.5 53.3 55.6 61.0 58.5 59.3 45.1 22.4 40.9 32.3 83.9 266.8 229.8 226.6 126.9 40.5 78.9 125.9 59.8 28.6 75.8 252.0 10.4 195.2 103.0 56.3 747.4 41.1 83.1 85.2 88.6 58.0 91.5 45.4 25.7 36.7 237.0 111.7 32.6 58.6 137.7 184.5 25.7 95.7 126.5 8.4 57.9 211.0 75.3 36.4 207.6 73.1 28.0 104.8 101.4 32.8 164.0 37.9 108.1 45.2 6.2 52.8 138.5 102.7 102.0 568.4 61.0 159.2 66.0 26.5 118.3 26.9 104.8 90.4 136.5 71.0 331.0 182.4 124.2 49.8 99.9 335.6 ZNF512 KIAA1805 ENSG00000243943 "Zinc finger protein 512" Q96ME7 2 27582969-27623217 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031430 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031430: AB_10603844" "prognostic favorable (9.79e-4)" "unprognostic (4.19e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (7.75e-3)" "prognostic favorable (5.08e-9)" "unprognostic (6.08e-2)" "unprognostic (2.33e-1)" "prognostic favorable (5.19e-4)" "unprognostic (1.10e-2)" "unprognostic (8.09e-3)" "unprognostic (4.44e-2)" "unprognostic (1.85e-1)" "unprognostic (5.66e-2)" "unprognostic (5.60e-3)" 10.4 13.2 8.9 10.8 9.3 6.2 16.7 9.3 12.7 18.8 8.4 14.3 7.9 25.2 15.0 8.4 21.6 11.0 13.2 9.1 11.7 12.5 7.1 13.9 17.0 8.9 9.9 7.9 34.6 7.8 20.3 13.7 13.1 9.0 18.2 12.1 26.6 11.2 19.4 7.5 7.2 13.0 17.0 8.4 17.2 11.1 13.4 10.7 27.3 20.7 10.6 17.7 16.5 13.1 11.1 26.2 22.8 46.2 20.6 22.4 25.2 0.0 12.7 17.9 23.6 27.7 17.7 16.2 22.8 14.0 14.6 19.6 8.7 41.3 12.0 25.0 21.2 33.0 47.9 18.4 27.0 17.3 31.4 20.8 23.2 12.9 18.4 5.3 18.9 37.9 39.3 42.0 16.2 35.0 3.3 3.3 24.0 32.1 17.2 0.0 52.2 65.0 19.8 16.8 7.2 45.0 44.8 12.0 7.6 36.0 21.9 9.3 17.8 31.5 8.3 20.0 8.6 16.8 16.2 12.1 38.9 12.5 38.4 17.3 24.5 5.5 9.8 10.2 6.7 14.1 12.4 12.9 15.0 8.2 11.1 17.1 14.6 1.7 22.1 5.5 5.9 9.8 10.8 8.9 9.3 9.3 12.7 9.1 11.7 8.9 9.9 7.9 9.0 8.4 10.7 11.1 8.9 9.6 14.2 16.6 10.0 3.8 10.4 4.3 6.8 22.8 8.1 7.6 15.6 7.2 7.8 18.4 16.7 1.6 9.7 2.2 9.8 6.8 11.9 5.2 12.7 11.5 9.0 14.7 22.5 1.9 1.1 11.6 8.2 5.2 6.3 25.5 11.7 4.4 5.3 18.5 28.9 6.3 6.1 7.2 7.1 5.7 14.9 6.2 1.8 23.4 8.9 17.0 9.2 25.1 27.2 4.6 3.3 17.3 9.0 5.8 2.3 4.2 8.9 15.7 19.7 14.6 13.4 8.3 9.0 6.6 3.0 1.2 10.3 13.6 5.0 6.9 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791371-52803860 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 924.0;kidney: 951.8;liver: 2632.1" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2" "Cancer enriched" "Detected in many" 4 "liver cancer: 555.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 263.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.5 924.0 0.0 2.5 0.0 0.0 4.3 0.0 0.2 2.0 0.0 7.3 678.0 0.4 7.0 5.3 86.8 120.6 0.2 0.0 0.0 951.8 2632.1 12.3 0.5 0.0 0.0 0.0 79.6 149.9 0.0 0.2 0.5 0.0 18.9 8.2 0.0 21.7 0.6 0.1 0.9 680.2 0.3 0.1 0.2 136.8 339.7 0.2 0.1 0.1 0.0 11.6 2.2 5.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 19.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.1 263.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.4 2.1 0.0 0.2 1.5 2.1 0.3 0.0 0.0 1.1 0.0 0.2 0.5 0.5 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 6.4 7.7 0.0 13.5 0.0 5.0 35.7 0.0 0.0 7.0 1.5 0.0 453.2 159.9 73.5 0.0 0.1 0.1 5.8 536.1 71.3 11.8 0.4 0.1 3.1 3.0 45.5 0.0 1652.6 0.2 7.3 116.7 0.5 2.5 3177.1 26.4 1013.9 0.1 0.0 0.0 165.6 42.7 31.5 0.0 43.0 65.6 25.3 0.0 0.0 13.3 0.0 1.0 0.0 0.1 629.1 187.4 4.5 0.2 27.6 4294.8 3190.6 533.5 0.0 0.0 0.0 98.6 36.8 3.4 6.8 0.0 0.5 10.4 4578.2 295.3 58.7 RTL9 "KIAA1318, Mar9, Mart9, RGAG1, SIRH10" ENSG00000243978 "Retrotransposon Gag like 9" Q8NET4 X 110358816-110456334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;testis: 10.4" "Cell type enriched" "Detected in single" 6 "Theca cells: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 2.0;U-2197: 1.5;U-87 MG: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA001242 Enhanced NA NA "HPA001242: AB_1079804" "unprognostic (6.03e-2)" "unprognostic (5.59e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-4)" "unprognostic (8.17e-2)" "unprognostic (3.04e-1)" "unprognostic (9.65e-3)" "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (1.45e-2)" "unprognostic (8.05e-3)" "unprognostic (1.03e-1)" "unprognostic (7.61e-3)" "unprognostic (6.98e-4)" "unprognostic (2.02e-1)" "unprognostic (3.37e-1)" "unprognostic (1.10e-2)" 0.1 0.1 0.4 0.0 0.8 0.0 0.0 0.5 0.8 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.2 0.0 0.0 0.7 2.6 0.4 0.8 0.0 0.0 0.2 0.7 2.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 10.4 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.7 0.1 0.0 0.0 0.3 0.8 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 2.0 0.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 1.5 0.5 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.5 0.8 0.2 1.5 0.7 2.6 0.4 2.2 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 ACY1 ENSG00000243989 "Aminoacylase 1" Q03154 3 51983340-51989197 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "intestine: 183.2;kidney: 454.1;liver: 277.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 128.0" "CAB003695, HPA036174, HPA036175" Enhanced NA NA 23000000 "CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989" "unprognostic (4.28e-2)" "unprognostic (1.89e-1)" "unprognostic (2.10e-1)" "unprognostic (2.48e-3)" "unprognostic (3.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.08e-2)" "unprognostic (2.36e-2)" "unprognostic (2.70e-2)" "prognostic favorable (2.93e-4)" "unprognostic (3.57e-1)" "unprognostic (3.75e-1)" "unprognostic (7.88e-2)" "prognostic favorable (6.77e-4)" 19.3 24.2 5.3 7.4 5.2 8.9 20.9 6.0 7.4 14.0 9.8 30.8 183.2 4.4 22.0 10.8 13.2 10.8 14.7 4.8 5.9 454.1 277.1 9.3 7.3 6.1 5.5 4.4 4.9 8.7 28.5 4.8 9.8 6.1 14.5 30.8 1.9 16.6 11.2 20.4 7.6 139.3 7.0 6.5 8.2 23.8 3.3 6.0 5.2 21.2 34.9 9.3 12.6 7.1 6.3 15.9 26.2 13.2 34.1 28.9 39.4 40.5 12.6 28.2 29.4 14.9 41.2 67.9 7.2 12.2 22.0 13.2 20.0 14.7 81.2 11.5 21.8 10.7 25.3 13.9 128.0 49.7 19.8 21.0 48.0 67.2 25.4 69.1 25.8 11.5 14.6 47.1 23.9 29.9 35.2 0.6 38.9 23.4 92.1 39.3 8.0 14.1 63.5 74.5 50.8 16.9 18.2 12.6 62.6 29.5 7.5 42.3 27.9 7.1 22.0 21.9 24.8 18.8 61.7 16.9 12.1 28.1 42.9 29.0 9.1 15.7 0.4 10.7 15.1 5.7 7.4 2.6 4.5 21.2 6.1 4.1 4.7 0.0 20.4 6.4 2.8 3.8 9.7 5.3 5.2 6.0 7.4 4.8 5.9 6.1 5.5 4.4 6.1 6.5 6.0 6.3 0.5 3.2 3.2 0.0 4.9 0.6 1.0 1.9 17.1 0.2 2.7 1.3 0.2 1.5 2.5 5.5 0.0 3.9 0.3 31.6 9.8 16.6 0.2 0.2 0.9 0.9 2.4 15.8 0.0 8.3 4.5 4.3 32.6 0.6 7.0 0.2 1.1 13.1 1.9 0.0 0.0 11.2 4.1 1.9 0.3 0.8 0.6 4.2 0.0 0.0 9.3 0.8 1.0 0.0 0.0 16.4 23.3 0.0 14.9 0.6 144.8 92.0 1.7 1.1 0.0 0.6 2.0 0.1 0.2 18.5 0.4 4.1 2.6 1.0 14.5 0.4 NFS1 "IscS, NifS" ENSG00000244005 "NFS1 cysteine desulfurase" Q9Y697 20 35668052-35699355 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034314, HPA051801, HPA054755" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594" "unprognostic (1.72e-1)" "unprognostic (2.96e-1)" "unprognostic (1.27e-2)" "unprognostic (5.88e-3)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-1)" "unprognostic (9.00e-2)" "unprognostic (1.73e-1)" "unprognostic (6.52e-3)" "unprognostic (3.93e-2)" "prognostic favorable (4.72e-6)" "unprognostic (2.33e-2)" "unprognostic (1.97e-1)" "unprognostic (1.64e-2)" "unprognostic (5.54e-2)" 12.1 28.9 16.8 7.8 18.1 4.5 10.7 18.2 20.5 11.7 17.1 13.2 12.5 9.1 10.4 11.1 12.6 8.6 22.8 16.6 18.6 42.6 38.1 6.9 8.7 17.4 17.0 16.4 13.2 12.0 26.1 12.4 8.7 18.9 10.0 14.3 17.3 13.6 12.7 25.6 10.7 11.1 11.1 14.9 7.7 12.2 19.2 18.3 9.4 10.7 36.8 12.2 9.7 9.2 18.4 29.6 36.0 12.3 13.0 32.7 29.9 24.9 21.9 23.1 32.2 20.9 65.4 16.3 25.1 42.1 20.6 33.3 36.3 42.6 44.5 29.3 11.3 20.0 53.7 37.6 51.4 27.1 22.9 9.9 24.2 41.6 25.5 27.9 24.1 24.6 29.0 38.9 16.3 23.1 45.3 25.8 24.0 14.3 67.1 53.3 10.1 39.9 42.2 33.0 19.6 15.4 14.1 54.9 52.3 36.9 28.6 46.9 20.1 18.2 36.4 17.4 21.6 21.9 23.5 34.3 22.6 30.9 24.2 18.5 3.0 6.8 6.5 5.8 6.7 7.7 8.4 6.7 8.9 9.4 5.6 7.8 7.2 2.7 10.6 5.2 4.5 9.6 5.5 16.8 18.1 18.2 20.5 16.6 18.6 17.4 17.0 16.4 18.9 14.9 18.3 18.4 9.7 6.4 15.0 9.4 8.0 6.1 8.1 16.7 6.2 14.9 11.7 10.3 20.6 21.5 10.4 18.4 10.4 35.2 5.4 12.3 33.2 15.9 6.0 7.2 8.5 6.9 6.7 13.9 9.0 11.2 22.5 10.7 11.2 8.8 7.0 8.7 6.8 26.8 16.1 15.2 9.9 7.0 16.2 8.9 4.8 4.4 5.6 7.0 10.6 6.5 12.3 15.2 5.2 4.5 12.6 10.9 11.0 10.5 5.8 5.6 17.3 56.6 7.6 13.5 13.1 8.6 9.1 50.7 19.7 9.1 5.7 21.1 7.4 25.4 14.8 7.9 MT1HL1 MT1P2 ENSG00000244020 "Metallothionein 1H like 1" P0DM35 1 237004103-237004441 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "heart muscle: 5.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 7.9;Hepatocytes: 14.7;Paneth cells: 8.8;Proximal tubular cells: 48.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.79e-2)" "unprognostic (2.78e-1)" "unprognostic (2.65e-1)" "unprognostic (3.77e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.9 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.5 0.0 0.0 0.4 14.7 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 1.4 4.1 48.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.9 0.0 KRTAP19-3 KAP19.3 ENSG00000244025 "Keratin associated protein 19-3" Q7Z4W3 21 30491462-30492013 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 82 "skeletal muscle: 6.8;skin 1: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDOST "GATD6, KIAA0115, OST, OST48, WBP1" ENSG00000244038 "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit" P39656 1 20651767-20661544 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009746, HPA046841, HPA052867" Supported Supported "Endoplasmic reticulum" NA NA 120000 "Endoplasmic reticulum" "CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977" "unprognostic (8.57e-3)" "unprognostic (1.35e-2)" "unprognostic (1.57e-2)" "prognostic favorable (5.99e-4)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (2.70e-2)" "unprognostic (3.59e-2)" "unprognostic (3.72e-1)" "prognostic unfavorable (9.05e-7)" "unprognostic (1.07e-1)" "unprognostic (2.98e-1)" "unprognostic (1.69e-2)" "unprognostic (1.07e-1)" 91.8 133.8 43.6 109.5 45.2 193.1 113.0 44.1 46.7 131.8 60.3 162.9 120.5 116.7 226.4 114.1 138.6 99.1 123.1 44.9 56.9 100.4 138.3 105.3 105.4 46.3 44.6 43.5 140.7 262.0 113.6 120.0 184.8 44.9 100.7 167.3 42.5 153.0 131.6 80.6 86.7 109.3 123.8 46.0 114.0 140.2 84.0 49.7 84.7 187.3 67.0 122.6 120.4 93.6 48.5 366.0 206.7 178.8 533.9 347.4 359.8 376.6 286.1 545.9 435.5 445.3 278.9 678.8 275.8 501.8 447.0 238.7 292.7 250.4 334.3 321.3 257.0 256.3 235.7 138.5 375.0 513.2 377.5 618.8 371.6 370.2 365.2 439.5 522.8 504.1 180.5 116.3 445.0 266.5 251.1 179.6 308.2 196.5 529.8 214.2 164.5 238.6 492.2 358.7 150.4 133.0 238.3 294.0 299.1 413.5 257.1 237.8 566.8 260.2 249.7 279.6 435.1 274.6 586.1 677.5 195.6 409.4 489.4 342.0 272.0 268.3 257.3 255.6 284.2 270.3 230.4 218.1 239.9 389.7 207.8 203.1 209.6 63.8 266.1 251.4 320.1 256.0 490.6 43.6 45.2 44.1 46.7 44.9 56.9 46.3 44.6 43.5 44.9 46.0 49.7 48.5 62.0 35.3 72.3 7.5 93.6 50.2 95.8 200.6 47.3 18.3 70.0 62.5 22.1 77.2 120.0 35.0 29.2 350.7 92.9 52.5 39.2 162.5 29.9 44.7 71.9 65.2 71.8 49.6 10.9 148.3 270.0 102.8 74.5 71.6 79.1 113.2 55.3 74.4 140.8 16.8 9.4 152.6 79.3 66.8 78.8 13.9 74.6 74.5 85.4 6.5 96.4 54.1 87.6 15.6 10.7 93.5 89.7 60.9 320.5 68.9 69.1 54.3 78.9 24.6 46.0 42.5 103.3 136.0 171.3 55.1 53.6 349.7 78.5 122.9 133.7 84.3 TMEM199 "C17orf32, MGC45714, VMA12, VPH2" ENSG00000244045 "Transmembrane protein 199" Q8N511 17 28357642-28363683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027051 Uncertain NA NA "HPA027051: AB_10600915" "unprognostic (3.01e-1)" "unprognostic (3.45e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (9.98e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.78e-1)" "unprognostic (6.38e-3)" "unprognostic (1.09e-1)" "unprognostic (9.25e-2)" "unprognostic (2.75e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-3)" "unprognostic (5.95e-2)" 8.1 12.0 9.6 10.4 10.6 13.5 8.7 10.4 13.1 9.0 9.9 8.6 7.5 9.6 9.7 10.7 8.1 6.2 8.8 9.8 10.5 12.0 14.5 8.5 12.8 10.4 10.3 9.9 8.1 9.0 15.6 11.8 9.6 10.8 9.9 8.0 14.0 9.6 6.8 7.2 11.5 9.1 6.2 9.8 13.3 8.9 7.8 10.8 12.9 10.9 7.5 11.3 8.9 8.9 12.3 12.2 20.4 19.6 16.7 7.9 6.8 16.5 14.8 9.5 20.6 18.5 48.9 9.6 17.6 14.8 11.0 26.4 20.6 21.8 13.9 18.0 32.8 19.6 13.0 17.7 23.6 15.9 18.7 22.0 9.7 12.6 19.6 13.0 12.2 10.2 16.1 21.6 21.8 15.4 24.1 21.3 25.6 16.2 21.0 13.9 17.2 24.4 16.3 15.5 20.2 24.8 26.0 17.8 45.6 27.1 20.1 28.7 16.9 14.0 17.4 13.5 15.0 25.3 29.3 38.9 16.2 21.6 11.4 22.2 28.5 24.2 20.0 15.1 25.2 16.6 17.1 13.1 13.4 20.0 16.0 16.4 14.5 18.9 15.6 23.0 14.0 14.9 19.1 9.6 10.6 10.4 13.1 9.8 10.5 10.4 10.3 9.9 10.8 9.8 10.8 12.3 12.4 32.1 8.6 8.8 21.0 5.7 10.5 34.3 15.4 13.8 14.3 14.4 5.6 12.8 23.5 9.2 8.4 40.2 15.5 21.1 43.0 40.2 3.7 12.0 11.4 14.6 15.6 12.2 11.0 31.4 38.1 10.6 7.7 10.9 7.6 11.9 17.5 26.8 51.3 11.8 10.5 15.7 32.6 22.9 9.5 4.5 11.5 22.4 21.4 6.5 45.0 19.1 25.7 7.5 13.7 35.4 19.4 6.4 15.1 13.1 20.3 54.0 15.1 14.0 13.1 8.6 14.2 26.5 35.4 14.0 8.8 48.4 15.2 14.7 13.0 11.4 LCE3C "LEP15, SPRL3A" ENSG00000244057 "Late cornified envelope 3C" Q5T5A8 1 152600662-152601086 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 25.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "head and neck cancer: 3.8;melanoma: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-HME1: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSTA2 GST2 ENSG00000244067 "Glutathione S-transferase alpha 2" P09210 6 52750087-52763475 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 702.5;liver: 2075.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5" "Group enriched" "Detected in many" 16 "liver cancer: 124.6;renal cancer: 48.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 25.9;Hep G2: 20.0" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (6.43e-3)" "unprognostic (2.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.34e-2)" "unprognostic (1.91e-1)" "unprognostic (6.54e-2)" 0.4 4.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 150.9 0.0 0.7 0.1 2.5 110.4 0.0 0.0 0.0 702.5 2075.0 4.8 0.1 0.0 0.0 0.0 0.2 301.8 0.0 0.0 0.1 0.0 3.8 0.1 0.0 0.5 0.0 0.0 0.0 116.5 0.0 0.0 0.0 11.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 25.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.0 20.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.6 0.0 0.0 0.3 0.6 0.5 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.7 0.0 0.2 1.5 0.0 0.0 0.1 0.1 0.0 201.6 31.1 16.5 0.0 0.0 0.0 0.1 213.2 8.1 6.9 0.0 0.0 0.6 0.0 0.0 0.0 239.6 0.2 0.5 7.7 0.0 0.0 37.2 0.7 124.2 0.1 0.0 0.0 13.7 2.0 2.2 0.0 14.6 1.2 5.1 0.0 0.0 5.2 0.0 0.0 0.0 0.1 334.7 18.8 0.4 0.0 3.9 367.0 1186.6 435.5 0.0 0.0 0.0 1.5 1.9 0.7 0.0 0.0 0.0 2.6 10.4 30.1 1.3 SPRR2F ENSG00000244094 "Small proline rich protein 2F" Q96RM1 1 153112121-153113516 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 266.8;lymphoid tissue: 70.8;ovary: 113.4" "Cell type enriched" "Detected in some" 29 "Granulosa cells: 681.7" "Group enriched" "Detected in many" 5 "cervical cancer: 16.0;head and neck cancer: 53.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "K-562: 2.7" NA NA "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-2)" "unprognostic (2.41e-2)" "unprognostic (4.37e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.96e-1)" "unprognostic (1.78e-3)" 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 266.8 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 113.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.1 0.0 0.1 70.8 0.1 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 18.8 0.0 0.0 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 23.0 0.0 0.7 0.0 0.0 0.0 0.2 4.5 0.0 0.3 DNAJC25-GNG10 ENSG00000244115 "DNAJC25-GNG10 readthrough" 9 111631386-111670229 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.8;Club cells: 7.4;granulocytes: 6.3;Respiratory ciliated cells: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 8 "neutrophil: 73.1" "Lineage enriched" "Detected in all" 10 "granulocytes: 73.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" NA NA 12.0 11.5 9.7 9.7 10.3 11.8 9.8 9.5 11.2 8.6 11.4 8.8 4.9 8.7 5.8 5.4 9.3 4.6 9.9 10.5 12.0 8.0 8.8 10.9 6.5 11.4 10.2 9.0 6.9 5.2 12.3 11.8 10.4 10.5 9.2 4.7 2.5 7.1 5.8 6.9 3.1 6.2 7.4 10.6 10.9 7.7 3.5 10.9 4.9 7.1 8.1 4.4 14.2 7.5 11.3 13.4 7.5 6.7 12.3 22.6 22.3 10.7 17.0 16.6 12.1 10.0 10.6 11.8 1.1 7.2 17.5 23.9 12.5 11.7 17.6 20.7 3.2 8.8 2.5 9.1 8.3 15.1 6.5 6.4 15.6 15.3 9.8 27.9 16.9 16.4 7.2 6.0 5.7 20.1 8.1 4.7 4.7 9.1 24.5 14.8 4.2 32.6 1.1 22.6 8.8 8.8 7.2 14.2 5.4 16.1 11.4 14.0 7.6 13.8 12.9 10.3 27.0 15.5 5.6 5.0 2.3 19.0 14.6 8.5 3.9 6.9 9.4 1.5 6.3 2.8 1.3 2.1 1.9 5.3 1.6 2.3 1.4 73.1 1.8 5.6 3.6 4.3 4.2 9.7 10.3 9.5 11.2 10.5 12.0 11.4 10.2 9.0 10.5 10.6 10.9 11.3 0.9 12.8 10.8 0.0 0.7 0.0 0.4 0.0 0.6 0.0 0.4 0.3 0.0 0.0 7.4 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.1 0.3 1.2 1.5 2.4 0.4 0.6 0.2 0.3 1.2 0.5 0.3 6.3 0.2 0.0 0.2 0.5 0.0 0.6 0.1 0.0 0.3 0.0 0.1 0.0 3.5 0.0 0.0 1.1 0.8 0.0 0.0 0.2 0.5 1.2 0.0 0.3 0.2 0.3 0.2 8.0 0.1 0.0 0.6 0.8 0.0 0.0 1.3 0.0 0.1 0.8 0.5 0.2 0.4 IGKV2-28 ENSG00000244116 "Immunoglobulin kappa variable 2-28" A0A075B6P5 2 89221698-89222461 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1054.5;lymphoid tissue: 1749.9" "Cell type enriched" "Detected in some" 92 "Plasma cells: 1868.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 13 "naive B-cell: 11.1" "Lineage enriched" "Detected in single" 13 "B-cells: 11.1" "Cell line enhanced" "Detected in some" "BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7" "Immunoglobulin genes" NA NA "unprognostic (1.03e-2)" "unprognostic (1.73e-2)" "unprognostic (1.34e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.12e-2)" "unprognostic (6.32e-3)" "unprognostic (3.14e-1)" "unprognostic (3.71e-2)" "unprognostic (5.21e-2)" "unprognostic (2.64e-2)" 24.2 40.6 0.2 406.2 0.2 181.8 429.6 0.1 1.1 57.0 0.8 1054.5 763.5 38.6 5.0 668.8 29.3 132.0 22.4 0.1 0.9 45.5 40.5 159.0 589.5 0.4 0.7 0.0 88.7 19.7 3.8 3.3 0.5 0.3 21.2 716.4 0.1 739.1 95.9 1.8 7.2 429.2 24.1 0.7 1217.4 534.7 163.0 0.5 169.1 85.5 0.0 1749.9 498.3 31.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 1.1 4.5 0.0 0.4 2.1 1.7 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 11.1 0.2 0.1 0.8 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.1 1.1 0.1 0.9 0.4 0.7 0.0 0.3 0.7 0.5 0.8 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1868.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 UGT1A7 UGT1G ENSG00000244122 "UDP glucuronosyltransferase family 1 member A7" Q9HAW7 2 233681938-233773299 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "esophagus: 84.4" "Cell type enriched" "Detected in some" 4 "Squamous epithelial cells: 40.7" "Group enriched" "Detected in some" 10 "cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "SiHa: 112.2" NA NA "unprognostic (6.27e-2)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.09e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-7)" "unprognostic (2.14e-1)" "unprognostic (4.57e-2)" 0.1 1.3 0.3 0.0 0.1 0.0 0.4 0.6 0.9 0.6 0.3 0.1 0.2 0.0 0.0 84.4 0.0 0.0 0.0 0.3 0.1 0.6 4.3 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.2 5.7 0.0 0.0 3.4 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 5.3 0.4 7.1 0.9 0.0 1.8 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 112.2 7.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.9 0.3 0.1 0.4 0.3 0.3 0.5 0.2 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.4 2.3 1.3 4.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.7 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 40.7 1.7 0.0 0.0 0.0 0.5 8.5 P2RY11 P2Y11 ENSG00000244165 "Purinergic receptor P2Y11" Q96G91 19 10111693-10115372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hofbauer cells: 37.8;NK-cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.9" "Group enriched" "Detected in many" 5 "NK-cells: 13.9;T-cells: 18.9" "Cell line enhanced" "Detected in many" "HEK 293: 29.7;NB-4: 33.7" "Low region specificity" "Detected in many" HPA014232 Approved NA NA "HPA014232: AB_1854883" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (2.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (2.34e-1)" "unprognostic (5.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-1)" "unprognostic (2.04e-3)" "unprognostic (2.22e-2)" "unprognostic (4.32e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.77e-4)" 7.0 4.5 7.0 3.8 7.7 5.7 7.0 6.7 12.5 8.1 3.2 9.1 4.1 6.3 0.7 8.3 10.6 1.1 5.3 6.9 6.2 7.6 10.2 7.4 6.9 7.1 6.2 6.1 9.2 7.7 0.6 9.6 1.1 7.7 11.8 0.8 1.7 7.4 1.2 9.0 16.9 11.0 0.7 5.7 15.1 7.3 11.0 6.7 1.4 11.4 0.3 2.0 9.9 8.4 10.7 5.2 4.8 1.7 6.5 2.5 2.0 10.6 1.9 1.0 1.1 2.1 5.7 3.0 9.8 2.6 0.5 0.8 8.2 1.7 5.0 0.2 4.3 29.7 7.7 8.4 3.3 3.7 3.5 14.8 3.7 4.1 1.6 2.7 2.0 0.7 6.2 3.5 13.8 1.1 7.5 6.8 33.7 11.7 4.9 3.9 10.5 3.3 5.6 2.1 6.5 7.3 12.1 1.2 4.1 14.7 0.7 3.6 14.2 2.0 7.1 2.8 11.6 3.8 25.6 20.0 3.1 4.8 20.8 6.3 3.5 1.7 0.1 7.3 2.0 18.9 1.2 1.0 6.9 0.8 0.6 0.7 5.5 0.5 13.9 1.2 0.2 1.5 4.9 7.0 7.7 6.7 12.5 6.9 6.2 7.1 6.2 6.1 7.7 5.7 6.7 10.7 2.3 6.4 3.7 0.0 3.3 4.8 2.6 2.6 0.6 7.6 3.8 3.2 1.7 5.7 2.6 1.8 2.1 1.8 7.3 4.4 1.9 1.2 0.3 3.8 3.6 2.8 3.6 3.2 0.0 1.1 1.4 1.9 4.6 5.0 3.8 4.2 2.2 3.6 37.8 6.7 0.0 5.2 4.1 2.4 3.3 0.4 3.4 8.7 1.8 0.0 0.8 1.9 22.6 0.0 0.0 1.5 1.6 1.2 2.9 4.1 1.2 1.5 3.5 6.0 0.0 6.8 2.7 1.8 3.6 1.3 4.0 1.4 9.3 5.1 5.6 1.7 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791344-136793317 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 580.8;Distal tubular cells: 626.1;Intestinal goblet cells: 547.5;Paneth cells: 682.0;Proximal enterocytes: 633.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 228.2;T-47d: 221.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: AB_2681061" "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 28.2 44.5 36.0 23.5 37.3 40.5 49.2 41.8 43.0 36.8 36.5 121.6 48.8 25.5 64.1 110.5 48.6 28.1 70.0 34.9 39.1 117.6 135.8 39.7 21.3 39.1 38.1 35.2 33.7 74.7 83.7 62.7 42.3 42.4 133.5 113.3 12.3 62.1 28.8 38.4 62.8 61.1 22.6 38.2 39.0 76.8 33.4 40.1 30.1 66.8 36.1 26.7 39.5 49.9 42.1 55.0 35.9 34.9 21.1 42.2 34.1 69.9 30.8 47.4 35.9 29.0 47.9 47.5 53.4 44.1 32.5 32.0 78.2 14.0 87.8 11.6 38.7 27.5 30.4 18.0 52.3 60.8 31.1 35.5 33.1 146.4 26.7 79.0 42.3 54.6 67.4 28.9 26.7 48.2 102.0 42.0 21.2 16.7 228.2 43.8 34.6 37.6 156.1 82.1 28.4 55.3 25.7 32.9 125.7 35.1 27.1 221.4 28.9 38.5 24.6 19.9 46.3 19.5 17.0 29.7 28.2 39.9 44.2 37.2 19.5 29.5 20.4 23.1 44.2 20.6 18.2 15.1 16.0 24.1 23.0 20.6 19.5 7.3 29.9 37.4 90.6 16.4 29.1 36.0 37.3 41.8 43.0 34.9 39.1 39.1 38.1 35.2 42.4 38.2 40.1 42.1 62.0 57.7 79.0 6.5 39.6 40.7 99.3 120.5 55.2 13.8 128.7 152.9 42.3 124.4 100.9 117.7 8.4 182.4 64.0 580.8 626.1 179.2 48.4 80.1 50.4 48.5 206.9 53.6 8.2 78.5 141.7 59.1 76.5 148.2 41.8 67.5 56.0 171.7 148.5 5.0 6.4 547.5 109.9 61.6 29.8 134.9 37.6 53.7 85.4 2.8 85.7 61.1 78.2 2.5 11.7 90.1 682.0 29.7 34.8 193.7 633.0 459.2 60.9 30.0 46.0 32.4 46.9 57.2 53.5 156.7 62.8 274.3 42.7 65.1 460.1 125.9 TMEM225B ENSG00000244219 "Transmembrane protein 225B" P0DP42 7 99598267-99611045 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 34 "testis: 138.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.0;Breast glandular cells: 3.0;Breast myoepithelial cells: 3.0;Exocrine glandular cells: 2.5;Granulosa cells: 2.9;Proximal tubular cells: 2.0;Theca cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.9;U-266/70: 6.6" "Low region specificity" "Detected in many" NA NA "unprognostic (1.91e-3)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.95e-1)" "unprognostic (6.27e-3)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.25e-1)" "unprognostic (7.08e-2)" "unprognostic (1.62e-1)" "unprognostic (4.00e-1)" "unprognostic (6.86e-2)" "unprognostic (1.17e-1)" "unprognostic (2.50e-1)" 2.7 2.0 2.7 0.2 2.9 0.3 3.1 2.6 4.0 2.1 2.3 1.1 0.3 1.9 3.6 1.4 2.4 1.0 0.7 2.6 2.8 2.9 0.7 1.4 0.6 3.0 2.7 2.6 1.5 1.4 2.5 2.9 1.3 3.0 2.2 0.5 0.7 1.7 1.4 0.8 3.5 1.2 0.8 3.1 1.2 1.2 138.1 2.9 1.8 2.5 0.0 1.1 1.5 2.0 3.2 1.1 1.5 0.8 0.2 3.8 1.0 0.0 0.5 2.6 1.4 1.6 0.1 0.9 1.2 0.0 0.0 0.5 0.1 0.4 0.0 2.9 3.8 0.6 0.2 0.0 0.3 1.2 0.9 0.8 0.3 0.5 0.1 2.3 5.1 0.0 1.9 0.6 11.9 0.6 0.0 2.0 4.6 0.1 0.0 0.0 0.7 1.1 1.7 0.4 0.1 0.5 1.1 0.3 0.0 0.4 0.6 0.0 0.6 0.0 0.5 1.7 3.7 0.2 6.6 1.6 2.3 0.6 1.4 1.1 0.0 0.0 1.3 0.6 0.1 1.1 1.0 0.8 0.4 0.5 2.2 0.8 1.4 0.3 1.3 0.2 1.4 0.6 0.6 2.7 2.9 2.6 4.0 2.6 2.8 3.0 2.7 2.6 3.0 3.1 2.9 3.2 0.5 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.0 0.0 0.6 0.0 0.0 1.2 0.8 0.0 0.0 1.1 0.0 0.5 0.8 0.1 0.0 0.0 0.0 2.5 0.4 1.0 0.0 0.5 1.3 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 5.4 0.0 0.0 GMCL2 "GCL, GMCL1L, GMCL1P1" ENSG00000244234 "Germ cell-less 2, spermatogenesis associated" Q8NEA9 5 178184505-178187371 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 80 "testis: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039579 Uncertain NA NA "HPA039579: AB_10805480" "unprognostic (3.25e-1)" "unprognostic (3.69e-1)" "unprognostic (2.58e-4)" "unprognostic (2.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFITM10 DSPA3 ENSG00000244242 "Interferon induced transmembrane protein 10" A6NMD0 11 1732406-1750595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.6;bone marrow: 1.6;brain: 3.8;choroid plexus: 2.3;retina: 1.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 46.0;Bipolar cells: 30.5;granulocytes: 28.5;Hepatic stellate cells: 40.0;Oligodendrocyte precursor cells: 39.7;Respiratory ciliated cells: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.9;hTERT-RPE1: 4.7;MCF7: 4.4;SH-SY5Y: 11.2;SK-MEL-30: 4.0;U-87 MG: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.22e-6)" "unprognostic (6.49e-3)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (3.66e-1)" "unprognostic (4.09e-1)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-1)" "unprognostic (2.44e-2)" "unprognostic (3.76e-2)" 0.1 2.6 2.8 0.1 2.5 1.6 0.0 3.6 2.9 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.7 2.6 0.1 0.3 0.2 0.0 2.8 2.6 2.5 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 1.5 0.3 0.5 0.2 0.4 0.1 0.0 2.6 0.1 0.0 0.3 2.7 0.0 0.0 0.0 0.1 0.3 0.1 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 11.2 0.0 0.0 4.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.6 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.5 3.6 2.9 2.7 2.6 2.8 2.6 2.5 3.8 2.6 2.7 3.1 0.3 3.2 0.6 1.0 1.3 2.2 9.3 46.0 14.2 30.5 0.8 1.7 1.9 1.5 16.4 0.0 0.0 1.8 0.4 8.1 1.9 3.9 0.4 1.2 0.5 1.0 0.0 0.0 10.5 2.6 0.6 5.4 1.1 2.7 28.5 0.0 40.0 1.6 20.6 1.7 11.4 0.9 18.3 5.0 1.1 0.6 0.9 9.3 0.0 1.9 2.6 2.1 3.1 39.7 1.0 2.3 4.2 1.5 1.3 1.3 3.3 0.1 49.4 2.3 0.0 2.4 4.0 0.5 1.3 3.2 0.9 2.6 2.5 0.1 1.9 12.7 AL645922.1 ENSG00000244255 "Novel complement component 2 (C2) and complement factor B (CFB) protein" 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "liver: 2.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;Club cells: 3.1;Fibroblasts: 1.2;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" NA NA "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 1435.5;choroid plexus: 613.5" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 15 "dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 65.0 29.9 782.9 33.9 1010.3 7.2 59.9 939.7 961.9 68.6 613.5 143.7 55.0 107.5 42.1 59.2 103.6 33.4 342.3 772.6 865.8 39.0 10.4 63.6 21.5 956.4 953.4 698.9 39.4 40.2 65.9 41.7 43.3 984.2 70.8 92.0 35.2 48.1 90.2 319.3 65.8 79.1 101.8 906.0 30.6 82.9 14.5 917.0 23.4 37.5 250.4 27.5 119.7 70.3 1435.5 78.0 13.6 10.8 76.3 6.8 3.0 15.0 44.7 48.4 36.7 24.8 37.2 103.4 1.1 7.7 44.4 13.9 112.1 74.7 4.0 22.4 0.6 43.9 64.5 57.0 34.3 43.1 3.5 94.0 1.2 12.6 13.9 12.8 63.5 25.3 64.8 4.7 1.5 2.9 99.0 5.6 4.9 14.0 50.8 80.0 0.3 1.0 0.7 105.3 1.4 24.8 12.7 15.6 8.4 99.3 7.6 104.0 19.9 41.1 1.5 72.5 48.8 49.5 1.1 1.6 0.3 5.3 0.6 10.9 0.0 10.4 0.0 9.1 12.5 3.3 0.2 8.0 6.8 7.6 0.3 7.4 6.9 0.5 0.8 7.2 18.7 7.4 4.5 782.9 1010.3 939.7 961.9 772.6 865.8 956.4 953.4 698.9 984.2 906.0 917.0 1435.5 0.3 3.2 0.5 0.0 3.3 0.0 0.2 0.1 18.8 0.0 0.6 0.3 1.0 0.0 2.5 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.3 0.4 0.2 2.7 0.0 2.1 0.0 0.0 0.0 7.3 20.4 0.4 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 10.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.5 0.0 3.9 0.4 0.9 0.0 5.3 0.0 0.0 0.6 23.6 0.1 0.0 32.7 0.6 0.0 5.3 0.1 0.4 0.3 LY6G6D "C6orf23, G6D, Ly6-D, MEGT1, NG25" ENSG00000244355 "Lymphocyte antigen 6 family member G6D" O95868 6 31715356-31717804 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 15.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 22 "colorectal cancer: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.7" "Region enhanced" "Detected in many" "cerebellum: 6.1" HPA054412 Uncertain "Intracellular and membrane" NA NA "HPA054412: AB_2682480" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (2.13e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 2.5 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.1 0.0 0.0 1.4 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 KRTAP19-7 KAP19.7 ENSG00000244362 "Keratin associated protein 19-7" Q3SYF9 21 30560875-30561314 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1D ENSG00000244395 "RNA binding motif protein Y-linked family 1 member D" P0C7P1 Y 21880076-21894526 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETV5 ERM ENSG00000244405 "ETS variant transcription factor 5" P41161 3 186046314-186110318 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.0;Oligodendrocyte precursor cells: 169.9;Syncytiotrophoblasts: 88.8" "Cancer enhanced" "Detected in all" "melanoma: 50.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 178.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009590, HPA063065, HPA073889" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: " "unprognostic (3.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.54e-2)" "unprognostic (3.30e-1)" "unprognostic (9.00e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (7.85e-9)" "unprognostic (3.52e-3)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (4.18e-2)" "unprognostic (1.48e-1)" "unprognostic (1.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.57e-1)" "unprognostic (3.58e-2)" "unprognostic (3.84e-3)" 6.2 39.7 16.2 7.0 23.2 1.4 15.2 18.0 22.9 5.0 9.8 3.4 6.2 8.2 7.4 4.2 5.1 5.7 11.6 18.6 20.3 9.0 7.9 29.9 5.3 20.8 16.9 17.2 2.2 17.6 42.5 25.6 17.3 19.9 7.4 3.3 16.0 6.6 5.9 12.0 5.8 3.0 7.5 17.3 11.0 14.9 9.4 15.5 4.8 22.0 7.1 4.3 4.4 4.1 21.7 42.4 28.6 36.1 79.2 21.9 22.7 2.6 35.7 39.7 27.7 29.6 31.7 25.4 1.1 46.4 34.7 41.3 7.1 0.8 27.2 40.7 9.3 1.0 12.4 1.0 36.4 36.3 31.2 22.1 19.9 4.4 44.3 53.7 32.9 41.0 4.4 11.6 14.6 47.5 19.8 4.1 47.7 54.2 12.1 32.4 86.6 36.0 28.7 23.0 9.9 1.6 45.8 8.7 0.4 178.3 14.4 0.1 17.3 40.0 15.0 24.3 38.2 70.5 11.1 49.9 0.3 45.8 24.6 91.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.1 16.2 23.2 18.0 22.9 18.6 20.3 20.8 16.9 17.2 19.9 17.3 15.5 21.7 5.7 3.2 68.5 26.1 5.6 15.7 10.6 8.2 45.5 17.8 9.4 30.4 5.7 17.2 2.4 0.0 12.5 57.6 3.1 0.6 3.9 9.4 24.6 2.0 4.3 9.2 10.7 1.7 94.0 9.4 18.8 12.5 15.8 4.7 8.2 0.8 10.4 9.0 56.4 5.0 43.7 2.8 0.0 64.4 19.4 49.0 9.0 27.1 16.0 45.9 2.1 60.4 1.0 169.9 47.5 12.5 1.1 15.4 4.9 3.6 1.5 22.9 1.3 18.8 0.0 25.4 13.6 16.9 14.4 8.7 5.3 88.8 1.9 3.1 1.5 2.7 KRTAP5-7 "KRTAP5-3, KRTAP5.7" ENSG00000244411 "Keratin associated protein 5-7" Q6L8G8 11 71527267-71528669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.4;testis: 1.9" "Group enriched" "Detected in some" 4 "Early spermatids: 1.6;Late spermatids: 3.5;Spermatocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "RT4: 1.7" NA NA "unprognostic (3.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (3.40e-2)" "unprognostic (7.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.83e-1)" "unprognostic (2.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.35e-1)" "unprognostic (5.68e-3)" 0.0 0.0 0.6 0.0 0.7 0.0 0.1 0.3 1.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.5 0.0 0.0 0.9 0.7 0.6 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.1 3.4 0.0 0.0 0.5 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.3 1.0 0.5 0.6 0.9 0.7 0.6 0.9 0.5 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.3 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CFHR1 "CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2" ENSG00000244414 "Complement factor H related 1" Q03591 1 196819731-196832189 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 276 "liver: 2098.7" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 320.0" "Cancer enriched" "Detected in single" 798 "liver cancer: 182.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;HeLa: 1.2;HL-60: 2.0;U-266/70: 2.4" "Not detected" "Not detected" "HPA038915, HPA038922, HPA040726" Supported Approved Vesicles "Secreted to blood" NA NA 13000000000 Vesicles "HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101" "unprognostic (2.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.88e-2)" "prognostic favorable (8.71e-6)" "unprognostic (3.02e-1)" "unprognostic (3.70e-1)" "unprognostic (2.50e-1)" "unprognostic (8.48e-2)" "unprognostic (7.21e-4)" "unprognostic (7.01e-4)" "unprognostic (1.13e-1)" "unprognostic (6.41e-2)" 1.5 0.6 0.0 1.8 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.9 7.6 2098.7 0.1 6.7 0.1 0.8 0.1 0.3 0.3 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.2 0.1 0.8 0.2 0.1 6.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.9 0.3 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.1 0.1 0.0 2.4 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.9 0.1 0.8 0.1 0.2 0.1 0.2 0.1 0.5 3.2 0.0 0.0 2.2 0.4 0.1 0.0 0.0 1.2 0.0 0.1 1.8 11.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.7 0.0 0.0 0.0 9.9 0.0 0.0 0.0 6.0 15.0 320.0 5.6 0.0 0.4 0.0 0.0 16.9 0.4 0.2 1.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 41.0 2.1 0.3 1.5 0.0 0.0 0.3 1.4 5.6 0.1 0.1 IGKV3-15 ENSG00000244437 "Immunoglobulin kappa variable 3-15" P01624 2 89085177-89085787 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 793.4;lymphoid tissue: 2012.9;urinary bladder: 791.3" "Cell type enriched" "Detected in some" 85 "Plasma cells: 22923.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 561 "memory B-cell: 2243.8;naive B-cell: 1651.4" "Lineage enriched" "Detected in all" 646 "B-cells: 2243.8" "Cell line enhanced" "Detected in some" "Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5" HPA047702 Approved "Immunoglobulin genes" NA NA 7200000000 "HPA047702: " "prognostic favorable (1.57e-4)" "unprognostic (1.29e-2)" "unprognostic (7.02e-3)" "unprognostic (3.89e-3)" "unprognostic (9.06e-3)" "unprognostic (2.06e-3)" "unprognostic (5.36e-2)" "unprognostic (3.55e-1)" "unprognostic (1.45e-1)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.15e-7)" "unprognostic (2.00e-1)" "unprognostic (2.54e-1)" "unprognostic (2.07e-1)" "unprognostic (1.17e-1)" 24.9 115.6 0.1 609.5 0.2 132.2 176.0 0.1 1.5 143.0 0.6 793.4 435.3 19.6 35.0 121.0 30.3 145.7 14.9 0.1 1.8 34.6 37.0 186.5 505.1 0.5 2.2 0.1 55.9 9.4 2.5 3.0 0.5 0.2 18.5 655.6 0.0 402.6 115.3 1.1 1.8 338.6 29.8 1.4 1028.9 635.5 65.4 0.2 252.5 78.3 0.0 2012.9 791.3 28.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 1.9 0.6 0.0 0.0 0.0 1.2 2.2 0.0 0.0 1.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.4 0.7 0.5 0.0 0.0 0.0 1.0 0.0 1.8 3.4 0.8 1.0 0.4 0.8 2243.8 1.0 1.1 1.8 1651.4 1.0 1.1 1.9 1.0 1.3 1.7 1.5 193.1 0.1 0.2 0.1 1.5 0.1 1.8 0.5 2.2 0.1 0.2 1.4 0.2 1.0 0.0 0.0 0.0 0.0 269.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.6 73.4 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22923.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.5 0.0 0.0 0.2 0.0 0.0 28.2 0.0 0.0 0.0 RBM12 "HRIHFB2091, KIAA0765, SWAN" ENSG00000244462 "RNA binding motif protein 12" Q9NTZ6 20 35648925-35664956 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043258, HPA043621" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043258: AB_2678395, HPA043621: AB_2678584" "unprognostic (8.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-3)" "unprognostic (7.57e-2)" "unprognostic (1.04e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (7.96e-2)" "unprognostic (8.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.47e-2)" "unprognostic (3.34e-2)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (4.44e-1)" "unprognostic (3.92e-1)" "unprognostic (6.87e-2)" 24.8 20.3 2.6 29.0 2.8 30.4 22.8 19.5 8.1 18.3 6.1 24.8 20.5 28.8 12.5 23.6 26.8 23.9 18.6 3.1 6.7 17.9 18.6 23.1 40.2 4.6 3.5 1.7 39.4 20.1 25.4 14.0 30.4 8.2 23.6 24.3 27.7 19.4 19.5 19.3 17.6 20.4 28.7 0.7 27.3 22.4 23.2 3.5 51.0 23.2 17.3 45.2 36.7 17.1 8.2 87.9 57.6 121.3 74.5 29.1 57.0 74.5 47.7 56.1 65.5 64.0 80.4 60.3 157.5 51.8 96.0 68.3 60.7 144.8 121.9 83.3 74.8 52.2 132.0 56.6 54.2 50.0 145.1 67.9 82.0 61.7 75.2 49.7 41.8 73.9 84.0 128.1 73.9 58.0 64.3 172.8 40.8 88.4 56.7 59.2 104.2 149.0 77.0 47.0 142.2 63.9 82.9 85.1 66.0 64.3 99.2 85.1 52.4 104.9 54.8 81.0 54.3 71.7 79.7 93.4 165.3 48.3 55.3 72.9 6.7 10.5 8.9 11.7 11.6 13.6 12.2 10.4 13.7 12.7 11.5 10.7 9.8 7.5 9.9 9.8 8.1 10.1 11.5 2.6 2.8 19.5 8.1 3.1 6.7 4.6 3.5 1.7 8.2 0.7 3.5 8.2 22.6 25.6 24.1 0.0 28.7 29.6 23.8 17.4 19.4 15.8 19.4 19.3 22.5 17.2 19.2 3.7 27.1 21.5 35.8 17.1 1.9 14.9 4.8 20.7 24.0 18.7 24.6 25.2 0.0 17.8 18.5 22.6 11.2 24.9 26.6 31.5 20.0 14.0 18.5 8.4 0.0 20.4 20.3 24.6 20.6 4.8 14.6 25.7 16.0 0.0 23.7 13.5 21.6 0.0 0.0 21.0 14.6 16.6 22.9 18.5 15.0 9.8 25.3 14.4 6.6 28.0 22.6 15.1 17.4 21.8 29.5 17.5 29.7 18.7 19.8 27.8 UGT1A4 "HUG-BR2, UGT1D" ENSG00000244474 "UDP glucuronosyltransferase family 1 member A4" P22310 2 233718736-233773300 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "liver: 394.9" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 15.1" "Cancer enriched" "Detected in single" 487 "liver cancer: 24.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.89e-3)" "unprognostic (6.77e-5)" "unprognostic (2.59e-1)" "unprognostic (3.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 394.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERVFRD-1 "envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2" ENSG00000244476 "Endogenous retrovirus group FRD member 1, envelope" P60508 6 11102489-11111725 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 37.3" "Cell type enriched" "Detected in some" 56 "Syncytiotrophoblasts: 575.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 38.8" HPA011812 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments" "Nucleoplasm, Cytosol" "HPA011812: AB_1857702" "unprognostic (1.99e-1)" "unprognostic (3.29e-4)" "unprognostic (4.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (2.19e-3)" "unprognostic (3.35e-1)" "unprognostic (6.44e-2)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-2)" "unprognostic (2.78e-3)" "unprognostic (5.80e-4)" "unprognostic (3.40e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" 0.3 0.4 0.6 0.1 0.5 0.2 0.4 1.8 0.5 0.4 0.0 0.3 0.5 0.3 1.0 0.3 0.2 0.4 0.1 0.6 0.3 0.4 0.2 0.6 0.0 0.6 0.4 0.4 0.0 0.0 7.5 0.0 37.3 0.9 0.3 0.2 0.2 0.2 0.3 0.0 0.5 0.5 0.2 0.1 0.0 0.3 0.1 0.5 0.5 0.0 0.4 0.0 0.5 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.5 1.8 0.5 0.6 0.3 0.6 0.4 0.4 0.9 0.1 0.5 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 10.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 575.5 0.4 0.5 0.0 0.0 LILRA6 "CD85b, ILT8, LILRB6" ENSG00000244482 "Leukocyte immunoglobulin like receptor A6" Q6PI73 19 54236592-54242791 "Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lung: 9.1;lymphoid tissue: 17.0" "Group enriched" "Detected in some" 4 "Hofbauer cells: 13.8;Kupffer cells: 31.7;Macrophages: 30.6;monocytes: 19.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 3.4;intermediate monocyte: 3.9;neutrophil: 8.2" "Group enriched" "Detected in many" 26 "granulocytes: 8.2;monocytes: 3.9" "Not detected" "Not detected" HPA026985 Approved "Plasma membrane,Cytosol" NA NA 21000000 "Plasma membrane" Cytosol "HPA026985: " "unprognostic (1.00e-1)" "unprognostic (8.38e-2)" "unprognostic (5.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.95e-2)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (2.51e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-1)" "unprognostic (9.11e-2)" "unprognostic (1.51e-1)" "unprognostic (7.47e-5)" "unprognostic (7.76e-2)" "unprognostic (4.01e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-2)" 2.9 1.1 0.0 1.3 0.0 1.6 1.1 0.0 0.2 0.4 0.1 0.9 0.1 0.5 0.0 0.3 2.2 0.2 1.1 0.0 0.0 0.7 1.3 9.1 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.9 0.0 0.4 0.2 0.8 1.4 0.0 17.0 0.8 0.2 0.1 0.0 0.5 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 5.3 0.0 0.0 0.2 0.4 0.0 0.1 3.8 0.0 0.7 0.9 13.8 0.0 0.0 0.0 0.0 31.7 5.2 0.0 0.0 30.6 0.0 1.0 19.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424584-20437826 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 44.8;Fibroblasts: 21.2;Leydig cells: 13.4;Peritubular cells: 17.7;Sertoli cells: 13.1;Smooth muscle cells: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 25.5;SH-SY5Y: 28.5;SK-MEL-30: 31.7;U-138 MG: 38.7;U-2 OS: 40.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 580000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (4.28e-4)" 14.5 5.5 1.8 2.0 2.1 0.4 10.8 0.2 3.3 19.2 3.6 8.6 1.4 22.6 0.5 3.7 15.7 3.6 9.3 1.7 2.6 10.6 3.6 23.4 1.3 4.8 2.0 1.3 20.4 4.0 0.4 5.5 3.8 1.7 15.6 0.3 0.1 4.6 4.6 3.1 8.8 6.1 2.2 1.5 9.5 7.8 2.7 3.1 0.2 11.9 0.4 0.2 13.4 13.4 1.9 0.7 0.4 5.8 10.1 3.4 4.8 2.3 25.5 10.8 6.2 3.3 0.1 0.1 0.4 14.6 12.7 0.4 0.2 3.4 0.1 0.7 0.9 21.6 2.1 0.5 4.9 21.3 0.0 1.1 8.2 0.1 3.0 1.5 3.0 3.0 0.1 0.2 0.2 2.2 1.1 0.0 0.5 7.8 0.0 3.3 0.6 16.1 0.0 0.1 0.1 2.5 28.5 0.1 0.0 31.7 1.1 0.9 0.1 3.7 38.7 40.7 1.0 5.9 1.2 0.5 0.4 0.1 0.5 19.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 2.1 0.2 3.3 1.7 2.6 4.8 2.0 1.3 1.7 1.5 3.1 1.9 3.6 0.0 0.0 1.6 0.1 2.8 1.6 0.7 0.0 2.9 0.3 0.9 44.8 0.0 0.3 0.0 2.1 0.4 0.3 0.1 0.0 0.0 0.3 2.6 8.9 10.5 0.0 0.0 1.9 0.0 1.6 21.2 1.5 1.0 0.0 0.6 3.9 0.7 0.7 0.0 5.2 0.2 0.0 0.8 2.4 0.5 13.4 0.4 3.6 6.5 0.0 0.3 1.0 3.0 1.1 0.0 0.1 17.7 0.2 7.1 0.0 0.2 4.2 0.8 13.1 1.4 19.5 1.1 0.7 0.3 2.7 0.4 1.2 2.1 0.2 0.6 APOBEC3C "APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI" ENSG00000244509 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3C" Q9NRW3 22 39014257-39020352 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB033048, HPA071523" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB033048: AB_2057401, HPA071523: AB_2686409" "unprognostic (1.79e-3)" "prognostic favorable (1.08e-5)" "unprognostic (4.32e-3)" "unprognostic (3.20e-3)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (5.18e-2)" "unprognostic (2.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-3)" "unprognostic (7.40e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (8.91e-10)" "unprognostic (5.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-1)" "unprognostic (3.52e-3)" 12.1 36.5 3.0 31.4 3.3 31.7 12.4 3.2 4.0 23.3 4.0 20.0 14.2 22.8 52.2 22.9 56.5 18.6 24.2 2.8 6.0 6.0 7.1 20.8 58.2 5.0 3.4 2.3 38.5 5.1 10.6 3.9 11.7 4.7 26.1 33.5 3.5 22.3 36.5 2.7 19.9 17.5 31.0 4.2 36.9 18.3 29.6 3.8 25.5 15.3 11.4 68.3 27.9 17.5 6.4 39.4 38.1 6.3 73.9 40.2 82.6 32.4 28.3 54.9 41.0 54.5 36.8 43.7 115.5 18.6 56.1 26.2 39.4 6.5 120.2 39.5 44.3 32.0 111.8 1.6 30.6 43.5 73.4 107.1 90.5 68.1 54.0 13.3 20.4 23.0 0.9 69.9 142.3 83.0 0.4 29.6 39.8 9.8 0.5 82.8 51.1 16.9 96.6 27.2 51.4 1.9 4.9 40.9 0.2 21.7 15.9 0.2 26.8 11.9 21.8 37.1 11.9 12.4 38.6 42.7 9.5 66.9 47.1 58.8 86.6 104.4 277.0 309.1 220.6 212.6 241.6 164.7 276.9 106.9 249.1 54.0 196.9 14.1 196.9 247.8 86.9 168.9 173.6 3.0 3.3 3.2 4.0 2.8 6.0 5.0 3.4 2.3 4.7 4.2 3.8 6.4 3.3 3.2 16.2 0.0 68.8 25.2 45.4 44.1 24.5 0.2 16.4 8.9 23.0 28.6 18.4 7.3 0.0 4.3 60.2 56.6 0.0 31.6 3.2 11.0 16.4 9.6 26.4 57.2 0.0 1.3 1.4 26.5 5.6 15.6 57.0 78.6 30.0 1.2 61.9 0.0 0.0 17.8 28.5 49.0 37.3 9.3 57.8 34.2 44.4 0.0 65.1 24.4 117.4 0.5 0.0 11.5 16.6 38.0 55.4 18.9 3.2 1.3 13.6 0.8 26.3 11.9 20.1 1.5 1.5 9.7 16.3 1.9 67.7 53.5 18.8 41.9 KRTAP4-2 KAP4.2 ENSG00000244537 "Keratin associated protein 4-2" Q9BYR5 17 41177446-41178221 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 142 "skin 1: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1-27 "A20, IGKV127" ENSG00000244575 "Immunoglobulin kappa variable 1-27" A0A075B6S5 2 89213423-89213928 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 270.6;lymphoid tissue: 350.0;salivary gland: 179.1" "Cell type enriched" "Detected in some" 126 "Plasma cells: 4951.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 6 "midbrain: 5.0" "Group enriched" "Detected in some" 683 "memory B-cell: 152.7;naive B-cell: 185.3" "Lineage enriched" "Detected in single" 748 "B-cells: 185.3" "Cell line enhanced" "Detected in single" "BEWO: 1.8" "Not detected" "Not detected" HPA048721 Approved "Immunoglobulin genes" NA NA 8300000000 "HPA048721: " "prognostic favorable (2.56e-5)" "unprognostic (6.50e-3)" "unprognostic (2.65e-2)" "unprognostic (1.68e-3)" "unprognostic (1.72e-2)" "prognostic favorable (8.14e-4)" "unprognostic (9.60e-2)" "unprognostic (1.31e-1)" "unprognostic (2.41e-1)" "unprognostic (6.99e-3)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (8.84e-5)" "unprognostic (3.23e-2)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.67e-2)" 8.9 9.3 0.1 134.7 0.1 28.8 70.7 0.0 0.3 16.9 0.2 270.6 185.0 6.2 7.8 30.7 6.9 37.8 10.8 0.1 0.8 11.6 9.8 55.7 125.7 0.6 5.0 0.0 8.8 4.9 0.2 1.0 0.0 0.1 6.5 214.3 0.0 179.1 8.9 0.6 0.6 201.9 5.2 0.2 279.1 92.7 1.0 0.1 47.3 19.5 0.0 350.0 88.5 6.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 152.7 0.1 0.1 0.1 185.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 15.8 0.1 0.1 0.0 0.3 0.1 0.8 0.6 5.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 12.2 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4951.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 RAD21L1 "dJ545L17.2, RAD21L" ENSG00000244588 "RAD21 cohesin complex component like 1" Q9H4I0 20 1226056-1296421 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 32 "testis: 11.6" "Group enriched" "Detected in some" 14 "Early spermatids: 110.9;Late spermatids: 109.4;Spermatocytes: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;TIME: 1.5" "Low region specificity" "Detected in some" HPA053282 Approved NA NA "HPA053282: AB_2682099" "unprognostic (2.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.62e-4)" "unprognostic (2.04e-1)" "unprognostic (8.87e-4)" "unprognostic (1.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 1.5 0.8 0.3 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 110.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 109.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.4 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42705756-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.9;choroid plexus: 1.9;fallopian tube: 2.9;retina: 4.4;testis: 6.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 28.0;Distal tubular cells: 17.6;Early spermatids: 18.1;Endometrial ciliated cells: 23.3;Late spermatids: 18.4;Respiratory ciliated cells: 53.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047429 Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA047429: AB_2680043" "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.1 0.1 1.4 0.0 1.7 0.0 0.1 1.3 1.2 0.4 1.9 0.3 0.0 0.2 0.3 0.1 2.9 0.0 0.3 0.9 1.4 0.4 0.8 0.8 0.0 1.6 1.3 0.6 0.0 0.3 0.0 0.7 0.0 1.4 0.3 0.1 4.4 0.1 0.0 0.3 0.0 0.2 0.0 1.4 0.1 0.3 6.0 1.3 0.0 0.6 0.0 0.0 0.2 0.2 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.7 1.3 1.2 0.9 1.4 1.6 1.3 0.6 1.4 1.4 1.3 2.9 0.3 0.0 0.6 7.2 0.4 1.0 0.4 2.8 0.6 28.0 0.8 0.5 1.2 1.5 5.6 3.7 4.2 0.1 0.3 0.9 17.6 0.9 18.1 23.3 2.1 0.6 0.0 0.0 6.0 0.2 0.5 0.8 0.0 1.1 1.3 0.2 0.4 0.4 2.6 0.0 4.0 0.4 0.0 1.6 2.8 18.4 1.5 1.4 1.8 3.7 2.7 1.8 1.0 2.0 4.6 0.2 2.4 0.7 0.0 1.0 0.0 4.6 53.4 5.4 0.0 0.0 1.7 13.3 3.7 0.1 1.1 0.0 0.5 1.0 0.1 0.7 ASPRV1 "FLJ25084, SASPase, Taps" ENSG00000244617 "Aspartic peptidase retroviral like 1" Q53RT3 2 69960089-69962265 "Human disease related genes, Plasma proteins, Predicted membrane proteins" "Aspartyl protease, Hydrolase, Protease" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "skin 1: 363.5" "Cell type enhanced" "Detected in some" "NK-cells: 3.1;Oligodendrocytes: 4.2;Spermatogonia: 3.3;Suprabasal keratinocytes: 10.7" "Group enriched" "Detected in many" 8 "head and neck cancer: 23.1;melanoma: 35.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 8.7" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.7" "Cell line enhanced" "Detected in some" "NB-4: 2.9;REH: 4.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA034809, HPA034810" Enhanced Approved Cytosol NA NA 150000 Cytosol "HPA034809: AB_2674343, HPA034810: AB_10601456" "unprognostic (4.75e-4)" "unprognostic (1.90e-3)" "unprognostic (2.34e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (1.17e-2)" "unprognostic (1.93e-3)" "unprognostic (1.51e-1)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (4.19e-3)" "unprognostic (1.27e-1)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.84e-2)" "unprognostic (2.43e-2)" 2.3 2.1 6.2 0.9 7.2 0.9 17.3 6.1 6.5 3.1 3.3 1.4 1.6 2.5 2.6 0.9 2.4 1.1 1.8 5.4 5.6 2.2 1.9 1.7 1.0 7.2 6.7 5.1 4.8 0.7 0.2 4.0 0.9 7.4 2.2 0.6 1.5 1.3 1.3 4.4 363.5 1.7 1.2 6.2 3.9 1.2 3.6 6.2 2.1 1.3 2.1 1.0 1.5 4.6 9.4 0.0 0.3 0.9 1.9 1.2 0.4 0.2 0.2 0.4 0.2 0.1 0.6 0.0 0.7 0.1 0.2 0.2 0.2 0.8 0.1 0.2 1.3 2.5 1.5 0.2 0.6 0.4 1.3 1.0 0.5 0.4 0.2 0.4 0.3 0.2 1.6 0.5 1.9 0.2 0.3 1.1 2.9 1.0 0.2 0.2 4.9 0.5 0.3 0.0 0.0 1.0 0.2 0.1 0.7 0.8 0.2 0.0 0.5 0.1 0.0 0.9 0.0 0.2 2.0 1.3 1.4 0.1 0.9 1.0 0.0 0.1 1.5 0.5 0.1 0.5 0.0 0.2 0.4 0.0 0.1 0.1 0.4 8.7 0.3 0.0 0.8 0.7 0.4 6.2 7.2 6.1 6.5 5.4 5.6 7.2 6.7 5.1 7.4 6.2 6.2 9.4 1.1 0.0 0.0 1.3 0.0 0.4 0.1 0.2 0.0 1.1 0.5 0.9 2.6 0.0 0.1 1.8 0.0 0.3 0.1 0.5 0.0 0.1 0.1 0.4 0.5 0.8 0.0 0.0 1.0 0.2 0.0 0.7 0.0 0.4 0.0 1.1 1.4 0.1 0.2 0.0 1.5 0.9 0.0 0.3 0.6 0.5 0.9 0.3 0.0 1.0 0.2 1.2 3.1 1.5 4.2 0.3 0.0 0.7 0.1 0.2 1.1 0.9 0.2 1.6 0.0 0.7 1.1 1.4 3.3 0.0 10.7 0.4 0.2 0.5 0.2 0.1 OR2AE1 OR2AE2 ENSG00000244623 "Olfactory receptor family 2 subfamily AE member 1" Q8NHA4 7 99875987-99877057 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042957 Uncertain NA NA "HPA042957: AB_10794539" "unprognostic (6.75e-2)" "unprognostic (6.22e-2)" "unprognostic (5.21e-2)" "unprognostic (1.58e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KRTAP20-1 KAP20.1 ENSG00000244624 "Keratin associated protein 20-1" Q3LI63 21 30616425-30616699 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2V1 "CROC-1, CROC1, UBE2V, UEV-1, UEV1A" ENSG00000244687 "Ubiquitin conjugating enzyme E2 V1" Q13404 20 50081124-50115959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 74.0;Erythroid cells: 80.1;Plasma cells: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052535, HPA053186" Enhanced Nucleoplasm NA NA 1100000 Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (1.01e-3)" "unprognostic (2.16e-1)" "unprognostic (2.00e-2)" "unprognostic (2.81e-3)" "unprognostic (4.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.32e-2)" "unprognostic (2.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (2.58e-2)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" 61.8 58.2 52.0 57.4 57.1 51.8 51.7 44.9 72.8 47.0 47.8 63.7 58.9 45.8 53.6 72.5 47.0 48.4 65.8 55.7 49.8 59.3 78.8 59.9 69.0 44.8 45.5 51.9 44.6 65.2 61.6 37.6 66.9 49.1 53.9 61.8 47.6 56.1 55.5 88.7 63.9 52.3 74.1 40.9 55.9 57.2 41.3 48.8 61.4 50.3 71.5 89.9 68.4 54.1 55.0 155.0 94.1 174.3 104.8 141.6 238.7 97.3 172.6 168.0 356.3 169.9 466.6 112.8 148.8 155.9 223.8 155.1 134.5 129.5 235.4 307.1 105.0 81.2 146.0 66.2 212.2 125.9 178.3 113.2 192.4 140.4 176.1 115.1 199.6 243.5 120.4 185.2 88.4 200.9 102.7 162.9 143.8 121.9 204.5 164.7 89.0 196.8 136.4 248.7 109.9 101.8 123.2 174.4 301.0 136.7 173.2 115.0 161.2 215.1 196.5 182.3 165.7 140.8 85.7 118.5 119.0 213.9 92.2 139.4 120.7 162.3 146.5 219.9 161.5 221.9 149.2 178.9 210.7 165.3 134.1 180.3 197.2 55.8 233.6 147.9 130.4 189.5 351.7 52.0 57.1 44.9 72.8 55.7 49.8 44.8 45.5 51.9 49.1 40.9 48.8 55.0 18.9 51.3 30.9 0.0 39.1 5.9 5.0 18.4 74.0 4.6 10.6 7.9 9.2 7.2 36.3 11.0 6.2 6.4 24.6 10.7 23.5 11.5 19.1 36.3 32.0 18.4 10.2 80.1 0.0 11.3 5.7 21.2 38.2 36.1 36.6 4.8 16.8 14.5 7.0 0.0 0.0 5.2 8.2 17.8 5.9 19.8 7.8 29.6 8.8 0.0 18.4 3.0 12.3 0.0 0.0 16.1 15.4 4.9 79.4 2.8 7.7 27.2 47.8 5.4 6.6 6.9 14.8 12.9 6.7 67.8 8.5 7.1 41.1 5.4 4.9 5.1 CTAGE8 ENSG00000244693 "CTAGE family member 8" P0CG41 7 144266701-144269288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 10.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.6;Club cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.8;CAPAN-2: 3.7;HaCaT: 4.5;OE19: 7.1;RT4: 4.5" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (4.80e-2)" "unprognostic (2.54e-1)" "unprognostic (1.93e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.92e-3)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (1.33e-2)" "unprognostic (8.73e-2)" "unprognostic (6.23e-3)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" 0.8 0.3 0.4 0.6 0.3 0.6 2.1 0.2 0.2 1.4 1.6 1.8 2.3 0.7 0.4 5.3 1.0 1.0 0.5 0.1 0.3 4.1 3.6 1.9 0.3 0.3 0.3 0.0 1.4 3.4 2.0 1.8 0.6 0.3 3.1 1.1 0.6 3.3 0.6 0.1 7.1 3.0 0.2 0.2 1.1 2.9 10.9 0.3 0.2 7.1 0.2 0.6 1.0 2.5 0.3 9.8 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 2.2 3.7 0.0 0.0 0.0 0.0 4.5 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.4 1.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.5 7.1 0.0 0.0 0.0 0.0 1.0 4.5 0.0 0.0 2.2 2.2 1.8 0.6 1.5 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.2 0.1 0.3 0.3 0.3 0.0 0.3 0.2 0.3 0.3 0.0 6.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47856673-48111197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 479.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 0.4 0.1 0.3 0.0 0.6 0.0 0.3 0.0 1.4 0.6 0.1 0.2 0.1 0.4 0.6 0.3 0.5 0.2 0.4 0.8 0.4 0.4 0.3 0.5 0.0 0.2 0.9 0.2 0.2 0.2 0.0 0.9 0.3 0.2 0.5 0.1 0.8 0.5 1.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.9 0.1 0.0 0.3 0.3 0.6 0.0 0.0 9.4 0.0 1.3 3.9 12.4 1.2 2.8 0.0 0.4 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.2 21.8 0.5 0.0 0.0 6.2 5.4 0.0 0.1 4.4 1.8 2.5 0.0 0.0 9.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.5 0.1 0.0 0.0 20.1 0.0 0.0 9.9 2.3 1.9 0.0 0.2 0.0 0.0 0.0 3.3 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 1.4 0.8 0.4 0.2 0.9 0.2 0.2 0.1 0.2 0.6 0.5 0.0 1.1 6.5 0.0 0.1 0.0 1.0 0.0 1.0 0.4 0.3 0.2 0.0 1.3 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 90.6 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 479.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 89.9 0.0 0.6 0.0 2.5 2.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 1.1 0.9 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 C4A "C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG" ENSG00000244731 "Complement C4A (Rodgers blood group)" P0C0L4 6 31982057-32002681 "Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Inflammatory response, Innate immunity" "Blood group antigen" "Disease variant, FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 116.8;liver: 339.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 46.4;Cardiomyocytes: 8.3;Club cells: 13.6;Fibroblasts: 19.1" "Cancer enhanced" "Detected in many" "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 58.5;HSkMC: 72.8;U-266/70: 17.1;U-266/84: 33.9" "CAB009811, CAB032603, HPA046356, HPA048287, HPA050103" Supported "Secreted to blood" NA NA 342000000 120000000000 "CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016" "unprognostic (2.13e-1)" "unprognostic (3.02e-2)" "unprognostic (3.74e-2)" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (3.09e-2)" "unprognostic (2.48e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (3.20e-2)" "unprognostic (5.20e-2)" "unprognostic (3.97e-2)" "unprognostic (8.63e-2)" 15.4 116.8 3.2 10.7 1.2 0.4 15.8 0.5 2.5 9.2 0.4 23.6 7.6 17.1 11.9 2.6 30.2 2.3 18.7 0.7 1.8 41.9 339.6 15.1 4.6 6.5 1.8 1.0 58.0 23.2 0.6 20.8 0.5 6.6 11.2 3.8 5.6 14.3 0.0 1.7 1.6 17.1 0.0 0.7 15.4 11.8 4.2 1.8 4.2 44.9 0.0 2.9 23.3 4.1 1.7 0.0 0.3 0.0 0.0 1.0 5.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.7 0.2 0.1 0.1 0.4 0.0 58.5 0.5 0.0 0.3 1.0 0.0 0.0 0.0 72.8 0.0 0.0 0.0 0.5 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.2 17.1 33.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.2 0.5 2.5 0.7 1.8 6.5 1.8 1.0 6.6 0.7 1.8 1.7 0.0 9.6 46.4 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 8.3 2.8 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.5 4.4 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 134386.5" "Cell type enriched" "Detected in many" 24 "Erythroid cells: 672352.3" "Group enriched" "Detected in all" 4 "cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "neutrophil: 658.1;plasmacytoid DC: 379.7" "Group enriched" "Detected in all" 11 "dendritic cells: 379.7;granulocytes: 658.1" "Cell line enhanced" "Detected in some" "HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2" "CAB009526, HPA043234" Enhanced NA NA 10000000000 "CAB009526: AB_2143058, HPA043234: AB_2678378" "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 1042.1 486.0 418.9 219.2 731.0 134386.5 644.6 502.4 2433.0 349.2 2881.9 255.8 29.1 79.5 46.0 510.2 836.8 799.5 2206.8 384.6 499.0 2306.6 1922.8 4075.1 27.0 534.9 824.6 366.6 291.5 159.9 50.9 814.5 6397.9 921.5 314.8 150.2 31.3 552.9 293.3 584.6 126.3 171.3 66.9 587.8 9299.9 271.4 172.0 936.9 198.6 1161.7 13016.8 40.6 323.4 638.9 1021.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.4 0.3 0.0 0.0 5.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.1 4.2 0.0 0.0 0.0 0.0 99.5 25.3 73.7 37.8 1.3 4.0 21.5 6.8 1.1 35.2 13.8 13.7 39.9 658.1 47.9 5.0 379.7 1.4 22388.9 418.9 731.0 502.4 2433.0 384.6 499.0 534.9 824.6 366.6 921.5 587.8 936.9 1021.6 441.7 3.2 8.4 0.0 280.5 157.0 2.3 5.1 0.0 4.0 54.7 72.0 3.4 217.3 4.5 7.3 4.2 2.2 369.9 5.2 50.9 0.0 0.0 6.8 6.6 151.7 3.6 672352.3 0.0 0.0 11.3 276.1 0.0 5.1 0.0 4.6 443.4 420.5 7.3 3.3 0.0 7.2 6.1 1452.1 702.6 0.0 0.0 1091.0 27383.1 0.0 72.7 9.7 38.1 0.0 0.0 0.1 3.5 0.0 1.9 0.0 0.1 272.4 84.9 117.8 0.0 126.0 396.8 0.0 0.0 0.0 252.5 2.2 769.8 0.3 3.0 0.1 CRYBB2 "CCA2, CRYB2, CRYB2A" ENSG00000244752 "Crystallin beta B2" P43320 22 25212564-25231870 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 10.6;Breast myoepithelial cells: 12.8;Distal tubular cells: 27.4;Melanocytes: 12.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 2.1" "Region enhanced" "Detected in some" "hippocampal formation: 1.7" "Low region specificity" "Detected in many" HPA043749 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043749: AB_2678652" "unprognostic (1.28e-1)" "unprognostic (2.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.95e-1)" "unprognostic (5.06e-2)" "unprognostic (7.04e-2)" "unprognostic (8.57e-3)" "unprognostic (9.51e-3)" "unprognostic (8.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-3)" 0.2 0.4 2.4 0.0 2.4 0.0 0.3 1.8 4.6 0.3 1.8 0.3 0.2 0.1 0.3 0.4 0.1 0.1 0.2 2.5 2.1 0.4 0.3 0.3 0.0 2.0 2.0 2.4 0.1 0.2 0.0 1.4 0.0 2.1 0.6 0.3 0.4 0.3 0.1 0.5 0.4 0.3 0.2 1.9 0.1 0.2 1.7 2.4 0.0 1.0 0.0 0.0 0.2 0.4 2.6 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.9 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 2.4 2.4 1.8 4.6 2.5 2.1 2.0 2.0 2.4 2.1 1.9 2.4 2.6 0.9 0.0 0.0 2.0 1.0 5.4 0.6 6.7 0.6 0.3 10.6 12.8 1.4 1.5 1.5 1.8 0.0 0.1 0.9 1.7 27.4 0.1 3.0 1.7 1.2 2.9 0.0 8.0 2.4 0.2 0.1 3.4 0.0 2.5 0.0 3.1 4.6 3.2 0.2 0.0 0.4 0.3 0.0 1.2 3.1 9.6 2.5 0.8 12.4 1.9 0.0 0.4 0.0 0.5 0.3 0.5 0.1 8.2 0.0 0.4 0.0 9.7 0.6 0.1 0.0 6.2 2.1 2.6 3.3 0.4 3.8 0.1 1.3 7.6 0.2 0.6 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981" "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 29.3 28.7 29.8 20.1 33.1 26.6 41.3 40.3 36.6 28.9 26.8 25.5 18.0 39.5 38.2 23.5 27.5 29.2 43.1 27.4 29.5 31.1 37.2 35.2 28.6 29.2 29.8 25.0 47.9 18.3 33.9 23.1 23.6 31.6 36.4 28.4 38.3 24.2 30.5 65.9 29.4 25.1 31.9 29.2 32.0 26.3 20.2 29.3 33.3 36.9 61.3 25.2 31.8 19.9 38.2 18.1 13.7 35.0 25.4 31.6 39.1 29.7 34.0 31.8 28.3 25.7 24.1 44.7 19.4 18.2 37.4 44.7 30.2 36.1 32.6 37.7 46.7 17.9 35.6 30.9 29.4 50.1 46.0 20.3 42.4 42.4 26.1 31.2 47.7 43.9 34.4 28.6 18.2 39.8 24.1 36.1 44.5 31.4 79.2 15.6 29.7 32.0 21.5 36.2 24.9 12.8 32.1 22.2 25.0 48.4 39.9 27.6 64.7 33.5 15.4 17.1 17.1 16.4 17.3 19.6 16.4 21.2 30.5 25.7 35.4 13.7 29.3 17.1 16.4 23.7 18.1 20.3 18.0 13.0 16.1 23.4 20.1 20.3 21.2 23.0 16.6 20.1 12.2 29.8 33.1 40.3 36.6 27.4 29.5 29.2 29.8 25.0 31.6 29.2 29.3 38.2 269.4 173.1 174.2 321.3 275.3 137.9 319.5 236.5 166.8 222.0 167.1 144.8 186.6 138.7 180.1 217.0 248.1 182.4 311.3 208.5 92.0 132.9 132.3 164.3 180.6 199.5 175.8 118.9 354.5 74.7 81.8 189.0 175.8 139.2 212.8 256.3 198.5 134.6 119.1 249.0 386.1 173.0 217.7 161.6 129.6 140.2 370.0 175.9 124.5 244.5 308.4 108.4 382.1 367.4 586.4 116.7 282.3 301.7 187.9 253.3 338.7 92.3 175.1 335.8 315.5 234.5 197.3 187.6 89.8 89.3 137.7 191.5 292.6 180.5 122.4 275.1 ZNF585B "FLJ14928, SZFP41, Zfp27" ENSG00000245680 "Zinc finger protein 585B" Q52M93 19 37181579-37218153 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075556 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA075556: AB_2686757" "unprognostic (9.53e-3)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.30e-2)" "unprognostic (9.52e-2)" "unprognostic (2.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.13e-1)" "unprognostic (3.11e-2)" "unprognostic (5.01e-2)" "unprognostic (3.56e-2)" "unprognostic (2.58e-1)" "unprognostic (3.26e-2)" "unprognostic (4.59e-2)" "unprognostic (2.79e-1)" "unprognostic (6.41e-2)" "unprognostic (4.18e-3)" 3.1 4.2 5.0 2.2 4.6 1.2 4.3 5.3 5.7 5.0 4.6 4.2 2.9 5.8 6.2 2.9 4.5 3.4 3.7 4.4 5.3 4.2 3.3 2.9 3.9 4.5 4.8 4.4 6.7 3.1 7.5 6.4 4.0 4.9 4.4 3.7 8.4 3.2 5.7 2.7 3.1 4.0 4.4 3.8 5.2 4.2 4.2 4.9 4.5 6.7 4.1 4.5 4.5 3.7 5.0 2.0 3.4 3.0 6.8 5.7 8.9 1.8 3.2 4.8 5.5 8.2 2.2 2.6 0.1 6.1 4.1 3.7 0.4 0.0 3.2 6.5 4.3 1.9 2.9 4.6 1.3 5.3 0.0 5.9 7.0 2.5 5.8 2.1 4.1 2.2 0.4 0.0 0.1 3.2 1.4 5.6 2.0 3.9 1.0 1.2 0.0 2.0 0.0 1.7 8.7 5.3 3.7 0.0 0.1 1.4 4.3 2.6 3.2 1.8 0.4 1.1 4.5 3.6 4.4 7.6 6.3 0.2 0.1 5.8 1.9 0.5 1.4 1.5 1.1 1.7 1.3 1.4 1.3 0.7 1.3 1.7 2.1 1.0 1.0 1.9 0.5 1.2 0.9 5.0 4.6 5.3 5.7 4.4 5.3 4.5 4.8 4.4 4.9 3.8 4.9 5.0 3.7 6.4 5.6 16.3 5.4 1.7 1.6 2.6 3.4 7.0 5.2 3.9 5.8 4.3 8.3 12.9 2.1 3.0 3.0 3.6 1.9 3.2 16.7 3.6 4.2 5.5 0.0 4.6 17.5 1.9 2.5 3.9 4.6 3.9 7.0 4.7 4.2 2.5 3.4 3.3 19.5 2.6 8.2 3.8 0.9 7.3 4.1 3.3 1.8 13.1 1.0 3.2 2.1 20.6 28.4 2.5 2.0 6.8 1.3 2.0 2.8 3.4 7.0 4.1 0.0 4.2 3.8 5.3 4.9 7.0 1.6 3.1 4.6 4.3 2.0 2.2 CEBPA "C/EBP-alpha, CEBP" ENSG00000245848 "CCAAT enhancer binding protein alpha" P49715 19 33299934-33302534 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 99.5;liver: 196.3;skin 1: 110.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3" "Cancer enhanced" "Detected in all" "liver cancer: 70.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7" "Group enriched" "Detected in many" 15 "dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7" "Cell line enhanced" "Detected in many" "BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052734, HPA065037, HPA067937" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927" "unprognostic (1.80e-1)" "unprognostic (7.62e-3)" "unprognostic (2.09e-3)" "unprognostic (2.21e-2)" "unprognostic (3.38e-1)" "unprognostic (3.99e-2)" "unprognostic (1.94e-1)" "unprognostic (2.43e-3)" "unprognostic (5.95e-2)" "unprognostic (3.96e-2)" "unprognostic (3.09e-1)" "unprognostic (9.45e-2)" "unprognostic (8.02e-3)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (2.72e-2)" 99.5 2.9 18.2 5.7 17.8 22.8 68.3 19.3 27.1 7.4 11.2 21.2 21.4 2.9 0.8 21.0 4.4 3.0 2.8 15.4 18.9 3.6 196.3 25.7 9.2 21.9 20.6 12.4 1.3 9.8 27.0 2.6 16.1 26.4 8.9 11.6 0.6 9.9 3.4 19.3 110.1 20.9 2.5 31.2 7.8 12.6 1.0 19.6 4.2 6.6 4.5 6.3 8.7 14.9 25.1 2.5 5.1 0.1 7.1 55.8 0.0 196.9 0.1 1.5 0.1 0.0 24.8 0.1 0.0 3.0 0.0 1.1 9.4 5.8 0.6 0.0 35.8 7.2 0.1 0.1 110.9 0.9 36.6 42.1 2.2 25.4 0.0 0.2 0.0 0.0 2.8 2.4 0.0 0.0 12.7 0.2 114.1 5.0 61.8 2.7 0.0 0.4 1.1 0.2 17.7 0.4 1.7 0.7 0.5 0.8 6.2 13.7 407.7 0.1 0.1 0.8 0.1 0.9 0.4 0.0 0.2 0.0 130.9 0.0 16.0 7.1 0.0 0.8 12.3 0.7 0.0 0.1 0.5 5.1 0.1 0.2 0.4 2.5 0.0 15.7 0.2 0.0 2.1 18.2 17.8 19.3 27.1 15.4 18.9 21.9 20.6 12.4 26.4 31.2 19.6 25.1 5.4 16.0 37.8 0.0 2.8 37.3 20.8 3.3 22.2 0.7 6.2 12.2 0.4 57.2 5.1 0.0 0.0 40.3 14.4 91.6 3.9 0.5 0.0 0.8 0.8 4.9 4.2 5.7 1.9 5.8 44.3 9.5 12.8 1.3 1.3 0.0 2.2 106.5 87.0 0.0 0.3 24.8 4.1 35.0 27.4 0.2 3.1 42.9 5.4 17.8 28.2 8.4 6.2 1.0 0.4 1.9 30.6 1.5 2.0 15.1 42.5 4.9 5.1 0.5 0.0 4.1 3.1 0.2 0.7 29.7 171.8 212.3 5.0 0.3 51.5 12.2 H2AJ "FLJ10903, H2AFJ, MGC921" ENSG00000246705 "H2A.J histone" Q9BTM1 12 14774383-14778002 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 569.4" "Cell type enhanced" "Detected in some" "Adipocytes: 58.1;Cytotrophoblasts: 130.2;dendritic cells: 56.4;Extravillous trophoblasts: 124.3;Fibroblasts: 59.5;Hofbauer cells: 241.2;Syncytiotrophoblasts: 160.3" "Cancer enhanced" "Detected in all" "prostate cancer: 151.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 256.2;MCF7: 338.4;RT4: 239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.38e-2)" "unprognostic (8.49e-2)" "unprognostic (9.15e-2)" "unprognostic (7.06e-2)" "unprognostic (2.43e-3)" "unprognostic (4.70e-2)" "unprognostic (3.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (3.32e-3)" "unprognostic (3.43e-2)" "unprognostic (8.66e-3)" "unprognostic (5.22e-3)" "unprognostic (3.87e-3)" 229.6 187.5 25.0 34.1 28.9 60.9 225.5 28.7 41.2 114.6 34.1 112.1 55.9 106.5 21.1 157.0 107.6 36.4 106.5 22.9 30.6 116.3 83.4 130.7 29.8 32.3 27.4 21.4 64.2 183.8 21.2 34.5 58.2 30.4 278.1 29.6 5.3 168.2 35.3 92.1 189.8 85.9 25.3 30.4 95.6 112.0 569.4 28.7 34.5 85.7 25.0 18.3 123.8 125.9 34.1 107.9 256.2 10.0 0.0 112.2 73.8 163.2 78.9 43.4 31.3 30.4 50.9 172.4 0.1 48.7 38.6 0.2 100.7 6.2 60.1 8.5 5.7 4.6 4.3 92.6 43.8 160.5 0.1 39.0 97.0 64.5 43.3 40.0 12.7 63.0 0.0 0.1 0.1 15.9 338.4 0.7 28.7 16.0 77.8 58.0 42.4 0.0 21.0 51.0 239.0 3.0 1.0 99.8 122.3 0.4 34.6 187.0 32.6 63.1 0.3 29.6 46.2 15.6 25.0 39.4 0.4 8.6 0.3 25.4 84.0 127.6 29.3 51.3 76.4 46.3 16.8 49.6 38.0 117.2 21.7 34.9 38.2 46.6 61.2 69.4 58.2 78.1 72.1 25.0 28.9 28.7 41.2 22.9 30.6 32.3 27.4 21.4 30.4 30.4 28.7 34.1 58.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 130.2 56.4 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 124.3 59.5 0.0 0.0 0.0 0.0 0.0 0.0 241.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 160.3 6.5 0.0 0.0 0.0 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092760-65115200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 13.6;retina: 26.6" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 241.8;Rod photoreceptor cells: 167.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.5;U-266/70: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 15.8" HPA065334 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA065334: AB_2685472" "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.1 1.1 7.3 0.3 8.5 0.4 1.3 13.0 13.6 2.9 4.0 1.3 0.2 2.0 0.3 1.1 2.6 0.2 1.0 7.0 7.0 1.2 2.1 1.0 0.4 11.7 9.5 7.7 3.4 1.0 0.1 2.1 0.2 10.6 2.0 0.1 26.6 0.8 0.5 2.2 1.3 1.3 0.4 5.9 1.6 0.8 1.8 8.4 0.5 2.2 0.3 0.2 1.6 1.7 10.8 0.0 0.0 0.2 0.7 0.2 0.0 0.6 0.4 0.0 0.2 0.2 0.4 0.1 0.3 0.5 0.0 0.1 0.5 0.4 0.0 0.0 0.6 0.3 0.0 0.4 0.1 0.2 0.3 0.3 0.2 0.3 0.1 0.1 0.5 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.5 0.1 0.4 0.0 0.1 0.3 0.2 0.2 0.0 2.5 0.3 0.1 0.3 0.0 0.2 0.1 0.2 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.3 8.5 13.0 13.6 7.0 7.0 11.7 9.5 7.7 10.6 5.9 8.4 10.8 2.1 0.0 1.1 6.2 1.0 0.6 1.7 1.2 2.2 35.3 2.5 1.9 5.0 0.0 1.5 3.7 241.8 0.8 2.4 0.3 1.9 0.5 0.6 1.7 1.9 2.3 1.2 0.4 18.4 0.9 0.3 1.4 1.1 1.7 0.0 3.3 1.8 2.0 0.3 3.3 18.3 1.2 2.0 0.6 0.8 1.3 3.4 1.0 1.8 3.7 0.0 21.8 0.0 5.5 19.9 1.0 1.1 3.4 1.4 1.3 3.1 9.9 0.3 167.3 6.6 1.8 2.2 2.0 3.4 0.8 0.9 0.7 1.9 1.5 0.8 0.6 PGAM5 "BXLBv68, MGC5352" ENSG00000247077 "PGAM family member 5, mitochondrial serine/threonine protein phosphatase" Q96HS1 12 132710819-132722734 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Necrosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036978, HPA036979, CAB068215" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559" "unprognostic (9.57e-2)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (3.11e-2)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.13e-6)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (5.67e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (6.42e-3)" "unprognostic (1.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (5.53e-2)" 10.5 17.8 11.5 17.1 13.2 16.5 9.7 13.3 17.9 8.9 9.7 16.3 15.4 11.0 6.7 24.1 12.5 8.8 20.2 19.4 11.3 12.4 29.1 9.4 21.4 9.7 10.3 13.5 7.3 26.1 10.8 9.9 10.8 12.6 9.5 11.4 6.0 15.7 11.6 33.4 17.2 13.3 11.4 8.8 12.9 13.4 16.7 11.4 14.9 11.7 19.1 16.3 15.7 11.9 11.4 72.2 134.3 28.2 79.5 19.4 15.6 66.1 37.4 22.0 59.1 33.0 168.6 40.2 92.3 67.2 31.2 30.4 61.2 132.9 67.5 24.1 47.3 106.7 110.7 61.6 89.2 44.0 105.8 61.8 19.4 48.8 69.0 73.6 19.3 43.6 73.4 143.3 36.9 23.5 128.5 144.5 105.7 108.0 61.8 94.4 109.4 31.2 73.3 38.4 97.4 102.8 58.0 62.2 86.1 38.9 22.2 108.9 57.5 38.2 29.9 65.5 60.6 89.9 77.2 124.8 133.5 38.8 85.3 51.1 4.9 1.1 0.3 1.1 1.2 1.8 1.7 1.3 1.3 1.0 1.7 1.3 1.7 0.9 1.6 1.7 3.3 1.1 0.8 11.5 13.2 13.3 17.9 19.4 11.3 9.7 10.3 13.5 12.6 8.8 11.4 11.4 6.6 3.2 6.1 3.9 8.9 11.5 16.7 2.6 2.2 9.5 7.8 5.5 15.1 15.7 1.5 5.5 14.6 7.6 11.9 11.7 5.9 5.8 14.5 6.3 6.3 7.0 13.1 5.0 5.1 7.9 14.4 4.9 4.1 9.3 0.0 7.1 5.7 22.4 7.3 6.7 3.9 8.9 2.0 6.9 5.8 20.6 5.9 4.7 3.6 1.9 5.3 4.4 3.1 2.0 2.3 7.5 6.9 6.8 9.7 19.5 5.2 11.5 4.5 12.9 6.6 8.0 6.4 15.1 10.1 10.8 17.3 6.2 7.4 9.2 15.7 16.1 ZCCHC3 "C20orf99, dJ1103G7.7" ENSG00000247315 "Zinc finger CCHC-type containing 3" Q9NUD5 20 297570-300321 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042972 Approved Vesicles NA NA Vesicles "HPA042972: AB_10959663" "unprognostic (5.98e-3)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.01e-3)" "unprognostic (2.13e-1)" "unprognostic (3.04e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (1.29e-4)" "unprognostic (4.30e-1)" "unprognostic (3.34e-3)" "unprognostic (6.33e-2)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (1.74e-2)" 10.0 11.5 14.9 11.8 14.1 17.9 8.5 15.8 17.0 10.9 14.9 9.0 9.9 11.3 12.6 6.9 13.1 8.3 9.9 13.6 17.9 9.4 10.1 8.7 17.8 14.8 15.2 13.3 18.3 10.9 11.8 11.0 20.2 14.6 9.3 7.6 8.6 8.9 10.8 9.8 6.2 11.4 8.1 13.2 15.5 10.4 9.6 16.3 23.3 9.0 12.7 15.9 9.9 6.4 15.0 24.0 18.4 56.7 28.4 18.3 18.6 33.6 14.7 16.2 16.2 16.7 28.4 14.0 21.8 9.6 9.5 16.7 32.6 29.2 16.5 15.3 11.8 26.8 44.1 9.3 90.0 21.2 50.9 11.7 18.2 19.2 9.9 11.7 16.8 26.2 24.4 55.7 21.5 12.7 10.6 38.8 62.1 50.7 23.3 19.6 56.5 27.1 27.7 14.4 15.2 23.5 34.7 17.5 34.9 46.8 24.2 16.0 93.8 11.4 16.6 16.3 6.8 17.8 39.1 53.9 42.3 6.0 32.4 16.3 2.5 1.2 2.2 1.6 0.7 1.5 1.7 1.4 1.3 0.9 2.1 1.6 1.6 0.4 1.1 0.5 2.1 1.4 0.8 14.9 14.1 15.8 17.0 13.6 17.9 14.8 15.2 13.3 14.6 13.2 16.3 15.0 17.3 0.0 9.1 8.8 12.6 15.8 22.7 3.5 11.4 26.9 16.1 12.8 7.6 17.2 4.9 9.2 8.4 22.4 22.3 13.0 3.9 5.9 0.7 22.6 28.0 16.4 21.0 17.9 6.8 5.4 13.4 14.5 8.2 14.9 0.0 16.1 19.2 10.2 11.0 37.0 8.0 16.2 4.1 9.8 9.7 2.1 17.4 11.5 12.4 8.4 11.0 19.6 8.2 7.1 12.3 5.2 10.3 10.5 8.9 16.3 12.2 6.8 8.9 22.1 6.6 14.2 12.3 5.8 7.6 7.2 5.7 20.7 11.1 21.2 13.3 16.0 SPTY2D1OS SPTY2D1-AS1 ENSG00000247595 "SPTY2D1 opposite strand" A0A0U1RRN3 11 18588781-18610255 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 34 "testis: 491.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 7.5;Distal tubular cells: 23.5;Endometrial stromal cells: 6.9;Granulosa cells: 18.4;Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 4.4;HeLa: 7.6;Hep G2: 4.5" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "unprognostic (1.07e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" "unprognostic (5.14e-2)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (4.44e-7)" "unprognostic (1.75e-1)" "unprognostic (1.39e-2)" "unprognostic (7.83e-2)" "unprognostic (5.36e-2)" "unprognostic (6.50e-3)" "unprognostic (5.41e-4)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.48e-2)" 0.9 1.8 2.1 1.4 2.2 0.9 2.7 3.6 3.2 1.7 3.6 1.5 0.2 2.0 3.8 1.3 1.6 1.2 1.5 1.6 2.8 1.2 0.7 0.8 0.7 2.5 3.0 2.1 2.5 1.1 0.9 1.7 1.2 2.5 2.0 2.3 3.5 1.7 1.4 1.5 14.2 1.0 1.3 1.6 1.3 0.9 491.3 2.3 0.4 1.7 0.3 0.8 0.9 1.3 3.0 0.5 4.4 1.7 2.3 1.5 2.3 2.1 0.3 0.5 0.9 1.0 3.4 1.2 0.8 0.2 0.4 0.9 0.9 0.0 0.0 0.0 1.3 1.6 0.5 7.6 4.5 0.2 0.6 1.3 0.9 0.3 0.2 1.0 1.1 0.9 0.0 1.2 0.3 0.3 1.6 0.1 1.6 1.2 1.1 2.7 0.1 0.5 0.3 1.8 1.8 0.4 0.2 1.6 0.1 0.0 0.6 0.9 0.0 0.9 1.6 1.3 0.8 0.1 0.0 0.2 0.0 0.6 0.9 1.1 0.2 0.3 0.6 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.1 0.1 0.3 0.2 2.1 2.2 3.6 3.2 1.6 2.8 2.5 3.0 2.1 2.5 1.6 2.3 3.0 2.8 3.2 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 6.0 0.0 0.0 1.3 5.5 0.0 1.0 1.5 0.0 23.5 3.2 0.0 4.9 6.9 1.1 0.0 0.0 0.0 5.0 1.1 1.8 0.0 3.9 0.0 18.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 14.3 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.8 2.1 0.0 0.0 TWF2 "A6r, A6RP, PTK9L" ENSG00000247596 "Twinfilin actin binding protein 2" Q6IBS0 3 52228612-52246788 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 184.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 205.0;monocytes: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053874 Uncertain Uncertain "Plasma membrane" NA NA 5900000 "Plasma membrane" "HPA053874: AB_2682287" "unprognostic (4.24e-2)" "unprognostic (8.61e-2)" "unprognostic (2.18e-1)" "unprognostic (2.62e-2)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (5.46e-3)" "unprognostic (2.76e-1)" "unprognostic (6.56e-2)" "unprognostic (1.97e-1)" "unprognostic (2.58e-2)" "unprognostic (5.07e-2)" "unprognostic (4.31e-3)" "unprognostic (4.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.07e-2)" 44.6 32.3 10.5 28.4 12.7 28.5 39.3 9.2 26.8 34.8 9.2 32.1 22.0 35.7 0.6 44.8 28.1 17.4 69.3 13.6 11.4 31.1 29.5 35.2 33.6 11.9 10.4 11.8 29.7 17.4 6.8 18.4 16.0 11.0 29.3 4.9 0.9 37.0 18.9 184.9 31.2 33.9 14.3 12.4 55.3 24.7 14.3 10.7 21.5 24.0 4.4 15.2 36.5 36.7 12.5 24.9 59.8 10.7 28.6 29.1 47.5 35.7 56.0 55.9 49.1 43.4 32.3 51.6 89.9 36.5 27.1 39.2 37.5 11.9 60.0 4.2 52.4 34.0 89.6 38.0 78.9 49.1 54.3 139.6 46.4 28.8 50.4 12.8 21.9 82.9 50.1 21.0 36.0 20.7 21.7 65.0 117.1 30.4 15.2 171.9 27.0 22.0 92.0 22.3 38.4 13.6 59.7 19.7 74.7 109.2 4.2 19.3 40.5 105.9 55.1 68.4 50.4 47.4 37.4 35.9 45.6 125.9 143.8 73.7 97.5 167.8 143.4 107.7 169.1 95.0 109.1 112.4 114.6 159.7 83.1 86.5 108.9 242.0 93.7 181.6 150.6 141.9 149.6 10.5 12.7 9.2 26.8 13.6 11.4 11.9 10.4 11.8 11.0 12.4 10.7 12.5 44.3 6.4 7.8 2.0 50.7 17.2 29.5 59.2 12.5 14.0 29.9 28.2 28.8 27.1 23.7 12.9 0.0 42.4 77.0 64.4 37.2 86.8 3.1 34.2 27.5 35.9 22.1 17.7 7.5 100.8 84.3 34.0 18.8 86.3 40.6 28.4 31.1 13.3 205.0 6.7 4.2 20.2 30.5 108.8 56.7 2.7 35.1 111.8 33.8 3.7 202.4 14.9 97.9 3.5 3.5 103.2 55.7 33.8 25.2 20.3 65.5 25.4 12.2 5.1 52.6 16.1 38.6 1.7 25.1 27.2 15.3 22.6 64.4 53.7 23.9 31.3 MARS2 "mtMetRS, SPAX3" ENSG00000247626 "Methionyl-tRNA synthetase 2, mitochondrial" Q96GW9 2 197705369-197708395 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 17.1;Suprabasal keratinocytes: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035589, HPA035590" Uncertain NA NA "HPA035589: AB_10601870, HPA035590: AB_2674693" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.12e-4)" "unprognostic (2.99e-2)" "unprognostic (2.35e-2)" "unprognostic (1.53e-1)" "unprognostic (7.61e-2)" "unprognostic (1.04e-1)" "unprognostic (9.54e-2)" "unprognostic (1.86e-3)" "prognostic favorable (6.14e-5)" "unprognostic (1.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.47e-2)" "unprognostic (8.74e-2)" 3.0 4.8 1.8 4.7 3.0 3.7 4.2 2.8 3.1 1.8 1.2 5.4 4.7 1.9 1.4 5.0 2.3 2.2 4.1 2.0 2.6 4.0 5.8 2.0 6.6 2.7 2.8 2.0 1.6 5.3 4.2 1.0 2.6 3.1 2.0 5.0 1.7 3.1 1.7 4.8 3.1 3.7 2.6 2.5 4.5 3.3 1.9 2.6 3.2 3.1 6.1 6.7 4.3 2.2 4.1 6.9 8.2 7.7 13.0 7.2 3.5 14.5 5.2 4.1 9.8 7.3 21.1 6.3 43.4 7.6 3.0 5.2 12.8 27.2 11.2 10.3 11.8 15.9 26.7 9.7 18.7 6.8 39.7 12.3 3.7 14.0 6.6 11.3 2.6 6.5 12.6 31.7 15.1 5.6 11.7 20.3 18.7 13.3 16.1 20.6 20.7 8.1 30.7 11.8 12.2 13.6 6.5 6.5 17.5 11.9 10.0 7.5 13.8 5.2 8.0 6.3 6.1 15.4 10.0 8.0 35.7 6.0 23.8 7.5 0.0 2.5 0.7 4.3 4.0 5.0 2.7 3.5 3.9 4.0 3.0 5.6 6.3 0.1 8.6 1.9 2.8 6.6 3.6 1.8 3.0 2.8 3.1 2.0 2.6 2.7 2.8 2.0 3.1 2.5 2.6 4.1 0.7 0.0 1.1 0.7 5.3 17.1 6.2 2.6 9.1 1.7 3.3 1.4 1.9 0.0 1.8 3.7 0.0 1.8 2.1 3.7 5.9 2.1 2.8 0.6 1.7 2.2 0.0 7.2 1.7 1.8 1.3 1.6 3.1 0.9 4.5 1.5 1.1 7.7 2.6 0.0 1.7 1.6 0.0 2.2 4.2 0.8 1.5 0.8 5.4 2.8 1.7 1.6 0.0 1.5 2.0 1.2 2.4 0.4 2.1 3.1 1.1 4.4 1.3 2.3 0.0 2.5 3.1 3.5 2.7 7.3 18.9 0.8 3.9 4.1 5.4 4.8 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 52.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.7;Muller glia cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 7.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favorable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favorable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 1.4 3.2 2.9 0.9 2.6 0.5 1.7 2.8 2.8 1.9 3.8 0.8 0.4 3.2 52.2 0.7 5.5 0.8 2.1 2.1 3.6 3.7 1.2 1.5 1.1 2.1 2.8 2.0 6.5 1.1 5.7 1.4 2.4 2.2 2.4 0.8 3.1 0.8 2.5 0.4 1.1 0.7 2.0 2.4 1.9 0.8 2.3 3.3 2.5 5.3 1.1 1.2 0.9 0.7 2.8 0.0 0.6 3.9 1.1 1.9 1.0 0.0 0.6 0.3 0.7 0.9 1.2 0.5 0.0 4.6 0.8 0.8 0.2 1.0 0.4 1.2 1.3 0.0 1.0 0.2 0.0 0.8 2.5 0.2 3.9 0.0 0.4 0.0 0.3 0.2 3.0 3.1 3.0 0.6 2.6 2.4 1.3 4.8 0.0 0.2 3.4 0.7 1.5 0.9 0.1 0.0 0.7 1.1 0.1 3.7 7.0 0.9 1.3 0.2 1.5 2.1 0.4 0.1 4.7 2.0 0.9 1.0 1.4 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.8 2.8 2.1 3.6 2.1 2.8 2.0 2.2 2.4 3.3 2.8 5.1 3.2 5.5 3.3 2.6 0.9 2.2 0.9 2.2 23.7 3.8 7.4 6.9 1.5 2.0 3.7 6.2 4.3 1.2 0.2 9.8 1.5 0.3 9.0 9.2 6.0 3.6 5.0 2.7 0.0 2.2 8.1 0.0 2.1 1.3 7.9 6.4 0.7 7.6 6.7 5.0 0.5 0.0 5.6 2.5 1.0 4.1 4.7 5.4 1.9 0.3 32.9 3.1 3.5 3.7 0.2 0.3 8.2 1.0 1.0 0.0 13.1 11.2 16.4 0.0 7.1 5.0 11.4 12.5 1.0 0.4 2.7 3.1 13.0 0.4 0.5 BCKDHA "MSU, OVD1A" ENSG00000248098 "Branched chain keto acid dehydrogenase E1 subunit alpha" P12694 19 41397808-41425002 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 26.2;Gastric mucus-secreting cells: 23.4;Plasma cells: 25.0;Squamous epithelial cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036640 Supported NA NA 7700 "HPA036640: AB_10671964" "unprognostic (4.50e-2)" "unprognostic (6.85e-2)" "unprognostic (1.14e-1)" "unprognostic (8.58e-3)" "unprognostic (1.26e-2)" "prognostic favorable (9.37e-4)" "unprognostic (2.41e-2)" "unprognostic (8.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.53e-1)" "prognostic favorable (5.33e-10)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.27e-5)" "unprognostic (9.66e-2)" 34.1 79.0 29.9 19.4 32.6 32.7 25.4 34.1 39.6 21.6 32.7 20.2 20.1 18.0 14.2 65.6 29.0 15.6 84.5 30.1 32.9 44.1 110.9 22.6 24.7 32.5 32.0 28.8 25.7 46.5 56.8 24.2 19.2 33.3 24.0 15.2 21.9 41.2 23.4 111.1 31.8 18.8 12.8 30.6 24.6 53.0 27.3 33.3 27.2 42.0 123.1 21.4 21.9 32.2 36.8 42.7 75.1 14.2 44.1 22.2 12.8 17.1 11.9 25.3 24.4 29.9 18.2 36.0 34.6 23.7 15.1 11.0 17.1 15.0 25.9 12.1 36.0 41.0 27.1 35.2 21.3 51.5 25.5 17.7 27.6 37.6 16.9 38.2 36.0 45.0 50.9 25.9 68.9 17.6 41.5 28.0 20.0 12.8 61.1 21.1 27.1 22.8 89.6 29.8 19.8 32.5 38.6 39.6 84.7 34.1 12.1 45.4 81.0 29.3 22.2 23.0 12.0 22.0 131.9 55.1 34.1 81.8 56.6 24.6 61.4 149.4 59.7 49.5 123.9 56.7 46.0 47.0 49.1 154.6 49.5 43.2 44.9 46.4 82.4 95.5 62.6 63.9 125.6 29.9 32.6 34.1 39.6 30.1 32.9 32.5 32.0 28.8 33.3 30.6 33.3 36.8 0.6 0.0 13.1 4.9 10.0 0.3 0.1 2.6 26.2 0.2 1.5 0.4 0.1 1.5 5.3 5.5 0.0 1.9 0.9 3.8 3.9 14.7 0.7 0.5 0.6 2.4 6.1 15.5 5.8 11.8 1.7 3.7 23.4 0.7 5.1 0.4 2.5 2.4 2.7 0.0 6.2 7.6 8.2 2.2 0.8 0.9 0.6 6.6 3.6 3.7 12.4 0.4 5.2 4.0 5.7 8.4 3.8 0.4 25.0 0.2 6.7 2.3 1.2 1.2 0.0 0.2 3.6 1.8 0.9 27.2 0.9 2.1 6.3 0.3 7.3 0.1 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 413.0" "Cell type enriched" "Detected in some" 19 "Theca cells: 24080.8" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7" HPA028615 Enhanced "Secreted to blood" NA NA 566000 "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.4 1.7 1.1 4.8 1.4 1.8 0.5 2.1 1.5 0.1 1.6 0.4 1.5 0.3 0.8 0.6 0.8 0.4 0.2 1.3 1.2 0.4 0.4 0.9 2.9 1.3 1.2 1.0 29.8 0.2 0.0 0.2 0.3 1.6 0.6 0.0 0.1 0.6 0.0 0.2 0.3 1.7 0.0 1.2 5.3 0.8 413.0 1.3 0.5 0.3 0.4 1.3 0.4 0.3 1.3 0.2 0.6 0.1 0.5 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.1 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.5 0.0 0.2 0.0 0.0 1.2 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 1.0 0.2 1.1 0.0 1.1 2.6 0.9 0.0 0.1 0.1 0.3 5.2 4.7 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.4 2.1 0.1 0.1 1.3 0.0 0.4 0.2 0.0 0.7 0.4 0.7 0.0 0.9 0.9 0.1 1.1 0.7 1.0 2.2 0.5 0.1 0.1 0.8 0.5 1.1 1.4 2.1 1.5 1.3 1.2 1.3 1.2 1.0 1.6 1.2 1.3 1.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.1 6.8 0.0 0.1 3.4 0.0 0.0 0.3 0.0 0.4 42.3 0.0 0.0 0.0 0.9 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 257.1 1240.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 2.9 5.7 0.0 0.0 0.5 0.8 24080.8 0.0 0.0 MARCOL ENSG00000248109 "MARCO like" A0A1B0GUY1 5 148221650-148243580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.0;urinary bladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HeLa: 808.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 808.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 85.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADH1C ADH3 ENSG00000248144 "Alcohol dehydrogenase 1C (class I), gamma polypeptide" P00326 4 99336497-99352746 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "intestine: 603.5;liver: 2078.8;stomach 1: 575.8" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5" "Cancer enriched" "Detected in many" 7 "liver cancer: 238.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1" "HPA047814, HPA060902" Supported Supported "Plasma membrane,Cytosol" NA NA 31000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (3.98e-2)" "unprognostic (9.88e-3)" "unprognostic (7.04e-2)" "unprognostic (1.90e-1)" "unprognostic (5.14e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.55e-4)" "prognostic favorable (2.99e-4)" "unprognostic (8.25e-2)" "unprognostic (8.89e-3)" "unprognostic (7.95e-2)" "unprognostic (2.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (9.37e-2)" 17.2 0.8 0.1 30.1 0.1 0.0 19.3 0.1 0.1 4.7 0.1 332.7 603.5 5.2 7.3 5.1 5.8 52.1 4.9 0.1 0.0 19.7 2078.8 2.9 0.6 0.1 0.1 0.1 4.0 16.8 0.1 1.6 0.1 0.1 9.5 193.6 0.0 19.4 6.3 24.1 0.7 192.2 16.4 0.1 0.7 575.8 0.8 0.0 0.5 3.0 31.3 0.5 5.9 3.6 0.1 0.0 2.1 0.0 0.0 1.4 3.6 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.2 1.1 0.3 11.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.8 0.2 0.0 0.1 0.1 0.8 2.1 0.8 0.0 0.3 1.1 0.5 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.3 0.1 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.1 3.2 7.3 0.7 1.3 0.0 4.0 0.0 25.0 0.0 0.1 0.3 1.0 64.3 24.8 29.5 0.0 0.0 0.1 108.4 0.0 159.5 2.3 1.3 0.8 1.2 21.6 29.5 0.3 699.4 0.0 21.1 611.2 1.3 0.0 0.0 13.2 440.6 0.0 0.0 0.2 86.3 0.0 13.2 0.0 1.0 10.5 0.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 66.3 120.8 0.0 0.6 3.1 59.4 1.4 43.7 0.0 0.0 1.3 2.0 0.0 0.7 10.6 0.0 0.0 1.8 1.6 420.5 3.6 TRIM39-RPP21 ENSG00000248167 "TRIM39-RPP21 readthrough" 6 30328907-30346854 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Club cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051120 Uncertain Approved Cytosol NA NA Cytosol "HPA051120: AB_2681348" "unprognostic (1.20e-1)" "unprognostic (7.35e-2)" "unprognostic (2.56e-1)" "unprognostic (1.60e-1)" "unprognostic (4.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.56e-1)" "unprognostic (5.84e-4)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (6.89e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AC037459.1 ENSG00000248235 "Novel protein" 8 22589274-22602084 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.9;U-2 OS: 1.9;U-2197: 3.7;U-87 MG: 2.0" HPA024667 Uncertain NA NA "HPA024667: AB_1845783" "unprognostic (3.72e-2)" "unprognostic (5.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.01e-1)" "unprognostic (7.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.96e-1)" "unprognostic (2.29e-2)" "unprognostic (9.64e-2)" "unprognostic (1.67e-1)" "unprognostic (4.64e-3)" "unprognostic (2.29e-1)" "unprognostic (2.55e-4)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.28e-1)" "unprognostic (8.23e-3)" 0.7 0.4 0.3 0.8 0.2 0.0 0.2 0.7 0.8 0.6 0.2 0.4 0.4 0.5 0.0 0.3 0.2 0.3 0.2 0.1 0.2 0.4 0.2 0.7 0.7 0.7 0.3 0.1 0.4 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.0 0.8 0.0 1.4 0.7 1.7 0.3 0.2 2.7 0.5 0.0 0.3 0.2 0.2 0.1 0.0 0.3 0.5 0.5 0.1 0.7 0.3 1.6 0.0 1.5 0.2 1.0 1.3 0.5 1.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.2 0.3 0.0 0.5 0.0 0.3 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.7 0.9 1.5 0.1 0.6 0.3 0.0 0.9 1.9 3.7 0.1 0.0 0.0 0.1 2.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.7 0.8 0.1 0.2 0.7 0.3 0.1 0.6 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APELA "ELA, Ende, tdl" ENSG00000248329 "Apelin receptor early endogenous ligand" P0DMC3 4 164877178-164898965 "Predicted secreted proteins" "Angiogenesis, Differentiation, Gastrulation" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.2;prostate: 4.2" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 28.2;Proximal tubular cells: 28.5;Syncytiotrophoblasts: 40.9" "Cancer enhanced" "Detected in some" "prostate cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 41.7;SuSa: 25.1" "Secreted in other tissues" NA NA "unprognostic (2.97e-2)" "unprognostic (6.97e-2)" "unprognostic (9.83e-4)" "unprognostic (8.92e-3)" "unprognostic (1.43e-3)" "unprognostic (4.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.71e-1)" "unprognostic (3.38e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-1)" "unprognostic (8.35e-2)" "unprognostic (1.95e-4)" 0.0 0.0 0.0 0.2 0.0 0.2 1.5 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 2.2 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 4.2 0.0 0.2 0.1 0.0 0.1 1.1 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 3.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.7 4.3 0.3 0.0 0.0 1.8 0.0 28.2 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 28.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 40.9 0.1 0.1 0.0 0.3 CDK11B "CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58" ENSG00000248333 "Cyclin dependent kinase 11B" P21127 1 1635225-1659012 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 174.6;Spermatogonia: 176.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025061, HPA073626" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA025061: AB_1846407, HPA073626: AB_2686619" "unprognostic (7.52e-3)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (1.48e-1)" "unprognostic (2.18e-1)" "unprognostic (1.14e-2)" "unprognostic (6.04e-2)" "unprognostic (8.45e-2)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (6.52e-3)" 30.7 29.3 21.3 17.8 19.6 43.4 30.2 17.8 21.1 32.2 16.1 44.2 25.9 36.2 5.9 30.6 31.8 10.0 34.4 18.1 17.5 27.1 32.4 41.4 19.7 21.0 19.5 15.8 33.7 35.3 9.0 30.8 10.7 25.5 31.9 9.5 9.0 28.7 12.8 86.6 39.2 45.0 10.5 19.9 48.1 34.8 50.2 20.7 13.3 31.1 17.9 10.7 38.3 31.0 20.3 47.2 36.4 21.9 17.4 17.8 12.0 30.6 43.7 18.8 24.0 20.8 41.3 43.7 40.8 43.9 18.7 16.9 35.4 18.6 22.0 18.4 36.3 40.4 43.9 68.9 36.1 24.1 50.4 44.3 16.1 15.8 26.2 19.9 14.1 24.5 42.3 51.9 26.9 14.4 31.0 47.9 42.5 38.9 13.8 43.7 46.9 43.4 33.5 12.7 16.6 28.3 36.4 40.3 36.7 42.3 15.0 25.2 33.4 37.4 29.8 33.0 22.7 43.0 60.5 58.7 85.6 37.4 55.9 23.2 7.2 3.3 5.3 6.1 2.8 2.7 3.3 3.8 3.6 2.8 3.7 4.1 3.1 13.8 4.4 3.2 5.1 3.2 1.6 21.3 19.6 17.8 21.1 18.1 17.5 21.0 19.5 15.8 25.5 19.9 20.7 20.3 35.2 19.2 43.1 13.7 42.9 14.4 19.5 10.2 25.6 32.0 22.2 18.3 42.9 30.0 31.7 27.6 20.9 27.7 44.7 86.6 9.8 33.3 39.7 28.1 34.2 32.3 28.8 25.0 14.1 35.2 31.5 25.1 48.9 36.3 55.6 24.1 25.7 38.6 20.5 15.2 12.3 73.8 10.2 30.1 14.5 25.6 28.9 33.9 5.4 15.0 36.3 20.5 76.2 10.1 18.2 37.4 93.3 26.7 54.7 19.6 95.4 19.2 29.4 42.4 52.6 25.9 31.0 174.6 176.5 27.5 17.3 44.6 48.9 16.5 56.9 15.9 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926299-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 30.0" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.7;EFO-21: 2.5;hTCEpi: 5.9;PC-3: 4.2;SCLC-21H: 2.9" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.4 0.4 0.4 0.5 0.7 0.0 0.1 4.4 1.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 1.0 0.0 0.5 0.6 0.2 0.1 0.7 1.2 1.8 0.9 0.6 0.0 1.2 30.0 0.7 0.0 2.2 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.7 1.0 0.0 0.9 0.0 0.6 0.1 0.0 1.2 0.0 5.7 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.7 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 4.2 0.0 0.0 0.0 0.1 0.3 2.9 1.7 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 4.4 1.0 0.5 0.6 1.8 0.9 0.6 2.2 0.1 1.0 1.2 0.1 6.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.2 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TARM1 ENSG00000248385 "T cell-interacting, activating receptor on myeloid cells 1" B6A8C7 19 54069895-54081365 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "bone marrow: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051022, HPA054401" Uncertain NA NA "HPA051022: AB_2681315, HPA054401: AB_2682476" "unprognostic (1.56e-1)" 0.0 0.1 0.3 0.0 0.3 7.0 0.0 0.6 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.2 0.3 0.3 0.6 0.4 0.3 0.2 0.4 0.3 0.3 0.5 0.3 0.3 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PRR5-ARHGAP8 ENSG00000248405 "PRR5-ARHGAP8 readthrough" 22 44702233-44862706 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 4.9;Collecting duct cells: 5.5;Pancreatic endocrine cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 2.1;HEK 293: 2.7;MCF7: 2.1;U-266/70: 6.8" NA NA "unprognostic (1.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "unprognostic (5.52e-2)" "unprognostic (3.65e-2)" "unprognostic (6.61e-3)" "unprognostic (3.29e-2)" "unprognostic (1.77e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-2)" "unprognostic (2.53e-2)" "unprognostic (6.47e-3)" "unprognostic (9.28e-8)" "unprognostic (8.64e-2)" "unprognostic (9.91e-2)" "unprognostic (2.41e-2)" "unprognostic (3.45e-1)" 0.4 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.3 0.2 0.1 0.7 0.5 0.1 0.1 0.6 0.6 0.5 0.0 0.1 0.1 1.4 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.5 0.2 0.1 0.8 0.3 0.0 0.7 0.8 0.0 0.5 0.4 0.0 0.0 1.0 0.4 0.1 0.0 0.0 1.4 0.0 0.2 0.3 0.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.3 0.0 0.0 2.1 0.3 0.0 0.1 0.0 0.0 0.7 0.5 1.4 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.6 0.1 0.7 0.2 0.0 0.0 0.9 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.2 1.5 4.9 0.0 0.4 1.0 0.2 0.0 0.0 0.6 0.3 0.1 0.0 0.8 5.5 0.0 0.7 0.1 0.6 1.9 1.9 0.0 0.6 0.1 0.0 1.2 0.0 0.9 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.9 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.2 0.5 0.9 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741600 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;testis: 1.9" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8;Rod photoreceptor cells: 14.4;Spermatocytes: 22.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 1.4" "Not detected" "Not detected" HPA077615 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.0 0.0 0.6 0.1 0.9 0.4 0.2 1.9 1.0 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.1 0.0 0.2 0.8 0.6 0.4 0.1 0.0 0.0 0.0 0.1 0.9 0.1 0.1 1.0 0.1 0.1 0.1 0.4 0.2 0.0 0.4 0.1 0.2 1.9 1.0 0.1 0.2 0.0 0.1 0.0 0.0 1.8 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.1 1.4 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.6 0.9 1.9 1.0 0.5 0.5 0.8 0.6 0.4 0.9 0.4 1.0 1.8 2.3 3.2 2.2 0.0 4.3 2.2 2.6 1.8 0.0 10.7 2.8 1.5 0.4 1.5 1.0 1.8 6.2 1.0 4.7 1.3 0.0 1.6 2.7 3.0 3.2 2.5 3.0 3.2 0.0 0.9 0.9 2.1 1.1 3.3 8.2 5.8 2.5 0.9 1.1 16.8 0.0 0.3 0.0 2.4 6.2 7.6 4.7 2.4 1.8 0.0 3.3 2.9 11.3 0.0 0.0 2.1 1.2 1.5 1.8 2.1 1.8 0.5 2.1 14.4 0.0 3.4 1.8 22.3 2.3 0.7 2.7 0.5 4.8 4.6 1.2 2.3 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258745-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.5;pituitary gland: 85.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 35.8;Bipolar cells: 82.8;Inhibitory neurons: 34.0;Sertoli cells: 19.7;Squamous epithelial cells: 23.5;Urothelial cells: 39.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 21.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "RT4: 13.8;T-47d: 8.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "olfactory bulb: 206.6" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA052833: AB_2681968" "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favorable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 2.8 0.4 16.4 0.8 70.5 0.1 1.8 21.8 29.5 3.6 2.3 4.9 1.7 1.8 2.6 18.9 2.1 2.0 0.8 9.1 21.5 0.5 4.0 4.6 0.2 37.6 24.2 14.7 2.2 0.5 0.4 85.0 0.3 42.8 11.1 2.6 39.6 1.9 16.5 0.5 4.6 2.8 6.6 22.1 0.4 2.0 1.8 20.3 2.0 0.7 1.6 2.6 35.9 17.2 65.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 13.8 1.9 0.0 0.0 0.2 0.0 0.2 8.9 0.3 0.2 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 16.4 70.5 21.8 29.5 9.1 21.5 37.6 24.2 14.7 42.8 22.1 20.3 65.9 0.0 3.2 6.4 2.0 0.0 0.0 35.8 8.3 12.5 82.8 3.2 1.0 0.2 0.0 7.6 0.0 6.2 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 3.1 1.3 1.9 0.2 4.6 0.3 1.3 0.0 0.0 0.9 0.1 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 3.5 0.0 5.0 1.4 0.2 0.0 1.9 0.0 2.5 0.0 0.6 0.9 5.9 19.7 0.0 10.0 1.3 1.5 23.5 0.3 1.8 0.0 0.0 0.0 39.9 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 124.3;Rod photoreceptor cells: 115.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 79.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles NA NA 420000 Vesicles "HPA038153: AB_2675868, HPA056913: AB_2683275" "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favorable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 20.5 49.0 59.2 8.3 62.2 13.6 18.5 70.1 78.6 23.8 60.9 15.8 10.7 15.2 28.5 8.4 24.4 12.2 33.5 60.5 62.4 35.6 26.3 14.4 11.5 57.2 58.3 61.8 27.3 26.8 27.3 50.0 9.0 58.0 19.1 7.0 43.8 23.4 14.6 35.1 7.6 13.0 7.6 54.9 14.7 17.8 13.3 63.7 11.6 33.0 39.4 8.4 19.6 16.9 63.3 6.9 12.9 8.2 24.7 79.8 39.9 4.5 9.0 14.8 10.6 14.3 14.8 27.0 7.8 6.0 22.4 12.1 6.2 9.0 10.0 3.4 25.1 10.0 22.7 37.4 50.0 22.4 31.4 29.0 37.9 6.6 9.0 4.6 23.7 13.8 14.6 9.3 25.4 16.8 7.8 14.5 31.8 4.7 32.4 30.4 10.3 4.2 73.9 20.7 10.6 16.8 26.1 22.5 4.7 13.5 1.7 7.1 33.7 8.2 9.6 10.4 23.4 10.7 37.0 37.4 6.6 18.1 49.6 14.1 6.9 20.3 15.2 94.0 12.7 96.5 49.0 80.9 83.5 36.2 41.5 73.7 79.0 2.1 45.5 8.6 46.0 88.4 54.9 59.2 62.2 70.1 78.6 60.5 62.4 57.2 58.3 61.8 58.0 54.9 63.7 63.3 15.9 6.4 21.7 0.0 20.2 9.7 25.1 29.0 4.0 90.8 21.0 22.9 24.3 20.0 20.8 33.1 25.0 10.3 29.6 7.1 33.2 15.5 4.7 23.5 18.0 14.1 40.2 2.5 0.0 12.4 15.3 36.9 4.6 14.9 15.2 12.8 17.2 16.2 29.3 58.9 0.0 14.0 24.4 14.2 18.5 24.9 88.0 14.6 12.4 0.0 7.4 59.9 41.2 0.0 0.0 17.1 5.6 33.1 16.3 17.0 13.8 124.3 29.5 115.2 19.7 24.7 16.8 18.2 57.8 1.8 5.5 4.9 28.9 20.6 15.3 19.5 STIMATE-MUSTN1 TMEM110-MUSTN1 ENSG00000248592 "STIMATE-MUSTN1 readthrough" 3 52833121-52897562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 15.0;skeletal muscle: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;Karpas-707: 5.8;PC-3: 6.5" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (5.95e-2)" "unprognostic (7.28e-2)" "unprognostic (5.35e-2)" "unprognostic (3.11e-4)" "unprognostic (4.73e-2)" "unprognostic (2.66e-2)" "unprognostic (1.59e-2)" "unprognostic (2.51e-2)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.01e-6)" "unprognostic (5.49e-2)" "unprognostic (7.31e-2)" "unprognostic (4.55e-2)" "unprognostic (5.09e-5)" 3.5 1.7 0.7 0.5 1.0 1.4 2.6 1.1 1.4 2.7 1.4 1.2 0.0 2.1 0.3 2.2 1.2 0.1 3.2 0.6 1.0 3.1 15.0 2.3 0.1 1.3 0.9 0.7 1.6 3.2 0.0 1.4 0.0 2.2 1.4 0.1 0.1 1.6 0.0 10.0 1.7 1.7 0.1 0.7 2.4 2.0 1.4 1.0 0.2 2.1 0.6 0.1 2.5 2.7 3.1 1.8 0.5 0.0 4.0 0.3 0.0 1.1 4.1 0.6 0.1 0.1 0.0 0.5 1.8 0.8 0.0 1.3 1.7 1.0 0.7 0.0 8.8 4.4 2.1 0.0 0.0 0.1 2.8 2.7 0.0 0.2 0.1 0.7 0.0 0.1 2.4 1.6 5.8 0.0 0.6 1.9 0.9 1.4 0.1 6.5 0.8 0.0 1.3 0.0 0.0 0.4 0.7 0.9 0.5 1.9 0.2 0.3 0.9 1.1 0.4 2.2 0.8 2.3 5.0 4.2 0.8 0.9 2.9 1.3 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 1.0 1.1 1.4 0.6 1.0 1.3 0.9 0.7 2.2 0.7 1.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 10.0" HPA047849 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047849: AB_2680180" "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 0.5 0.8 2.1 0.4 1.5 3.0 0.6 2.4 2.6 0.6 1.8 1.2 0.1 0.8 0.8 1.0 0.7 0.7 2.7 2.2 1.9 0.9 3.0 0.7 0.6 2.2 1.5 2.2 0.6 1.1 0.3 1.0 0.4 1.9 1.1 0.4 0.7 0.9 0.5 1.1 0.6 1.0 0.5 0.6 1.2 1.0 0.5 1.4 0.8 1.0 0.4 0.4 1.1 0.7 3.6 1.6 0.9 0.7 1.3 1.0 0.1 0.8 0.9 0.5 1.6 0.3 2.6 0.5 0.9 1.3 0.7 1.2 2.5 1.8 0.6 0.6 0.8 0.7 2.7 1.8 2.0 0.5 1.7 1.5 0.4 0.5 0.8 0.2 0.6 0.0 1.4 3.8 1.4 1.0 3.2 2.5 10.0 1.7 1.9 4.4 2.8 3.4 1.5 0.7 1.8 2.2 1.0 0.7 2.3 5.9 0.5 1.4 1.2 0.7 2.1 1.5 1.7 1.1 1.1 1.0 1.7 1.8 1.2 1.8 4.8 4.3 5.9 4.6 4.8 2.7 5.9 2.9 3.1 4.3 5.9 1.9 2.5 2.8 3.5 5.0 8.4 2.1 3.6 2.1 1.5 2.4 2.6 2.2 1.9 2.2 1.5 2.2 1.9 0.6 1.4 3.6 0.5 0.0 1.1 5.5 1.1 0.0 0.5 0.1 1.2 1.1 0.4 0.4 0.0 1.5 5.0 0.0 4.2 0.5 2.0 0.3 0.0 0.5 1.7 1.4 0.9 0.6 0.0 0.4 8.7 0.2 0.4 0.8 1.1 1.1 0.0 0.7 0.0 0.5 0.2 0.0 8.7 0.5 0.0 0.3 0.3 0.9 0.0 1.2 0.0 5.6 0.0 0.1 0.0 4.0 10.3 0.4 0.1 0.0 1.0 0.5 0.0 0.4 3.6 0.8 0.0 0.8 0.4 1.0 0.9 1.0 0.1 1.1 1.0 0.5 0.2 0.8 LY75-CD302 ENSG00000248672 "LY75-CD302 readthrough" 2 159771851-159904710 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.4;intestine: 1.8;lymphoid tissue: 2.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.1;Club cells: 1.3;granulocytes: 1.3;Microglial cells: 1.0;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;HDLM-2: 7.4;Karpas-707: 27.6;RT4: 11.7;TIME: 7.3" HPA049108 Uncertain NA NA "HPA049108: AB_2680635" "unprognostic (2.53e-1)" "unprognostic (1.55e-1)" "unprognostic (2.33e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (1.68e-4)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (3.32e-1)" "unprognostic (4.47e-2)" "unprognostic (1.88e-1)" 0.1 0.0 0.0 2.4 0.0 2.4 0.7 0.2 0.1 0.3 0.1 1.2 1.8 0.2 0.0 0.0 0.4 0.4 0.2 0.0 0.1 0.2 0.1 1.2 0.7 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 1.2 0.2 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.6 0.3 0.1 0.2 1.9 0.6 0.0 0.4 0.3 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 7.0 3.5 1.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 7.4 0.0 4.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.4 0.0 0.0 3.3 0.0 0.0 27.6 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.1 0.0 11.7 0.0 0.0 3.2 0.7 0.0 0.1 0.0 1.2 7.3 0.0 0.0 0.0 0.0 2.4 0.5 0.8 0.0 1.7 0.0 2.5 2.9 3.4 1.1 3.1 1.6 0.9 1.0 1.3 7.3 1.0 1.1 0.9 5.5 0.6 1.4 1.6 1.3 2.4 0.0 0.0 0.2 0.1 0.0 0.1 0.4 0.1 0.0 0.3 0.2 0.2 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.2" "Group enriched" "Detected in many" 7 "Endometrial ciliated cells: 92.3;Respiratory ciliated cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 4.0;neutrophil: 15.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;EFO-21: 4.2;HEL: 5.0;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.1 0.7 2.1 0.5 1.1 2.5 0.7 2.2 1.5 0.9 2.3 0.6 0.3 0.8 0.2 1.0 11.2 1.1 0.3 1.0 1.2 1.3 0.4 1.5 0.3 1.4 1.0 1.3 0.2 0.3 2.8 3.4 0.9 1.6 0.4 0.5 1.5 0.5 1.1 0.4 0.7 0.6 0.5 1.6 0.5 1.1 1.8 1.4 0.3 0.8 0.0 0.2 0.4 0.5 1.7 0.6 0.9 0.9 1.0 0.2 0.1 2.8 0.6 1.1 0.4 0.5 1.9 4.8 0.2 4.2 0.2 1.3 0.5 0.3 1.1 0.1 1.1 0.6 5.0 0.4 0.3 0.7 0.6 0.3 0.5 0.7 1.2 0.3 1.4 1.2 0.6 0.7 0.9 0.1 3.4 0.3 0.7 0.3 1.2 1.0 0.7 0.1 0.3 0.4 0.8 1.0 0.2 1.3 0.8 0.7 0.3 8.8 1.4 1.2 0.7 0.5 0.3 0.4 0.4 0.5 0.2 0.3 0.2 0.3 0.5 2.3 4.0 0.3 1.6 0.1 0.3 0.2 0.4 1.7 0.3 0.5 0.4 15.8 0.2 1.6 1.7 0.4 0.8 2.1 1.1 2.2 1.5 1.0 1.2 1.4 1.0 1.3 1.6 1.6 1.4 1.7 4.4 0.0 6.1 0.0 0.6 2.8 1.7 14.9 1.8 0.4 2.3 2.2 0.4 1.5 19.8 7.3 0.0 4.3 0.7 5.3 0.0 1.1 3.5 92.3 1.9 3.3 1.8 0.0 0.5 2.0 3.5 2.1 4.6 2.3 0.0 1.5 3.3 1.8 3.6 0.0 0.4 4.2 12.2 4.6 5.5 7.0 0.3 2.7 3.6 1.0 4.5 0.8 1.0 0.0 0.6 1.1 11.3 2.6 3.0 1.0 3.3 4.8 186.9 2.0 6.6 0.7 9.9 5.9 4.0 1.6 2.3 3.3 0.6 0.5 2.9 2.7 C4orf54 "FOPV, LOC285556" ENSG00000248713 "Chromosome 4 open reading frame 54" D6RIA3 4 99636529-99654648 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 73.4" "Cell type enriched" "Detected in single" 17 "Endometrial ciliated cells: 14.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 1.6;SK-BR-3: 1.1" "Low region specificity" "Detected in single" HPA079091 Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA079091: " "unprognostic (3.91e-2)" "unprognostic (3.76e-1)" "unprognostic (4.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.76e-2)" "unprognostic (4.00e-3)" "unprognostic (2.31e-3)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (2.20e-1)" "unprognostic (2.42e-3)" "unprognostic (1.89e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 5.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.0 73.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 14.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ACTN3 ENSG00000248746 "Actinin alpha 3" Q08043 11 66546395-66563334 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 72 "skeletal muscle: 1686.9" "Group enriched" "Detected in some" 6 "Early spermatids: 6.3;Late spermatids: 16.2;Skeletal myocytes: 15.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HDLM-2: 13.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA006035 Uncertain Uncertain "Actin filaments" NA NA 11000000 "Actin filaments" "HPA006035: AB_1078095" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (6.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.35e-4)" "unprognostic (1.40e-3)" "unprognostic (5.37e-3)" "unprognostic (5.09e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "unprognostic (6.71e-9)" "unprognostic (2.06e-1)" "unprognostic (6.98e-2)" "unprognostic (5.16e-2)" "unprognostic (2.48e-1)" 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.2 0.2 0.0 0.2 0.0 0.1 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.3 0.1 1686.9 0.1 0.1 0.0 0.0 0.1 0.1 4.0 0.0 0.0 0.3 23.5 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.3 0.0 0.0 0.2 1.8 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.2 1.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC004997.1 ENSG00000248751 "Novel protein" 22 30285238-30299482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.3;Karpas-707: 1.0;LHCN-M2: 1.0" HPA073183 Uncertain NA NA "HPA073183: " "unprognostic (2.09e-1)" "unprognostic (1.68e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-2)" "unprognostic (3.83e-2)" "unprognostic (7.25e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (1.18e-2)" "unprognostic (2.46e-1)" "unprognostic (9.84e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-5)" "unprognostic (7.90e-2)" "unprognostic (7.28e-2)" "unprognostic (4.96e-3)" "unprognostic (1.02e-2)" 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.0 0.3 0.2 0.1 0.3 0.2 0.1 0.0 0.3 0.1 0.2 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.2 0.0 0.1 0.3 0.0 0.3 0.4 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.7 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 1.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.3 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.4 0.5 0.4 0.1 0.2 0.0 0.0 0.3 0.2 0.2 0.2 0.1 0.6 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXL3 ENSG00000248767 "Forkhead box L3" A0A1W2PRP0 7 290170-294422 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM31 LINC01207 ENSG00000248771 "Small integral membrane protein 31" A0A1B0GVY4 4 164754064-164803795 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 7.9;intestine: 24.8;prostate: 11.1" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 93.3;Pancreatic endocrine cells: 139.7" "Cancer enhanced" "Detected in many" "prostate cancer: 8.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted - unknown location" NA NA "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.87e-4)" "unprognostic (2.95e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-2)" "unprognostic (4.82e-1)" "unprognostic (9.47e-2)" "unprognostic (5.63e-3)" 0.1 0.1 0.4 1.5 0.3 1.0 1.0 0.5 0.6 5.1 0.3 15.6 22.2 0.3 1.0 0.1 0.1 7.9 0.1 0.3 0.2 0.1 0.1 0.4 0.3 0.4 0.2 0.4 0.1 0.5 0.1 0.0 0.1 0.5 11.1 15.7 0.2 1.2 0.1 0.2 0.2 24.8 0.7 0.1 0.1 0.6 0.1 0.3 0.0 0.1 0.0 0.1 1.7 0.0 0.9 0.1 0.8 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.3 0.1 0.4 0.0 0.1 0.0 0.3 1.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.0 0.4 0.3 0.5 0.6 0.3 0.2 0.4 0.2 0.4 0.5 0.1 0.3 0.9 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 0.0 0.0 9.3 3.7 0.0 0.1 0.0 0.0 0.0 3.8 0.0 2.5 2.2 0.3 0.0 0.0 0.0 93.3 0.0 0.2 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.8 10.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 TNFSF12-TNFSF13 TWE-PRIL ENSG00000248871 "TNFSF12-TNFSF13 readthrough" 17 7549099-7561601 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.2;choroid plexus: 5.8" "Group enriched" "Detected in some" 17 "Alveolar cells type 2: 3.7;Club cells: 3.7;granulocytes: 3.8;Macrophages: 4.5;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.7;fHDF/TERT166: 1.3;HUVEC TERT2: 1.1;U-138 MG: 1.7;U-251 MG: 1.7" "Low region specificity" "Detected in all" "HPA004863, HPA035984, HPA052967" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000" "unprognostic (1.59e-1)" "unprognostic (1.48e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (3.04e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (8.96e-3)" "unprognostic (1.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.23e-2)" 3.6 1.3 5.0 0.7 5.5 0.7 1.8 4.8 9.2 0.5 5.8 1.1 0.2 0.4 0.0 0.3 0.4 0.1 1.9 4.8 5.6 2.3 0.7 4.7 1.0 5.4 5.4 4.8 0.4 0.5 0.2 0.4 0.2 5.2 0.7 0.0 0.1 0.6 0.2 0.7 0.7 0.8 0.3 5.0 3.1 0.7 0.1 5.1 0.2 0.4 0.0 0.5 1.1 0.3 5.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.5 1.7 0.6 0.9 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.2 0.4 2.4 7.2 0.2 4.5 0.3 0.7 0.5 0.3 1.8 1.5 0.3 0.1 0.3 0.2 0.2 0.9 1.0 1.4 5.0 5.5 4.8 9.2 4.8 5.6 5.4 5.4 4.8 5.2 5.0 5.1 5.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765544-33194714 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 30.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 117.0;Cone photoreceptor cells: 221.0;Excitatory neurons: 439.4;Inhibitory neurons: 340.0" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Region enriched" "Detected in many" 4 "cerebral cortex: 14.3" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 21.4;RH-30: 26.9;SK-MEL-30: 28.7;T-47d: 24.8;U-138 MG: 17.2;U-2197: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 1.8 0.8 0.0 2.4 0.0 1.2 3.0 0.0 14.3 5.4 0.0 5.7 1.4 1.0 0.7 2.0 3.1 2.4 0.7 3.5 0.6 2.8 0.5 3.4 1.0 1.8 0.0 0.0 0.2 1.3 1.5 3.8 3.7 1.2 1.9 4.4 30.3 4.2 1.2 0.7 4.2 1.8 2.2 0.0 1.0 8.0 10.3 1.2 3.8 2.6 0.5 0.6 1.3 3.7 0.0 3.8 4.0 0.8 0.4 0.1 0.4 4.9 5.4 4.1 1.5 4.0 0.6 5.0 0.6 1.8 6.1 3.4 3.7 0.1 3.7 3.9 0.0 0.2 3.1 0.8 0.4 0.2 0.0 0.2 1.5 0.2 7.9 0.1 3.1 0.0 0.1 0.0 21.4 8.8 3.9 0.1 0.0 1.1 7.0 0.3 0.6 26.9 4.9 1.8 1.5 0.3 0.9 0.0 3.3 28.7 0.9 24.8 0.0 4.9 17.2 2.7 17.9 1.6 0.0 0.0 0.9 7.3 0.2 10.1 1.3 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 14.3 3.5 0.6 1.8 0.0 0.0 1.2 0.0 1.2 0.0 0.4 41.7 46.9 10.1 1.6 3.7 3.2 2.0 3.4 117.0 7.7 5.1 3.1 14.3 17.3 0.0 221.0 12.0 5.4 13.3 11.7 5.7 16.5 17.4 2.4 2.7 9.0 0.4 439.4 1.8 5.9 2.6 97.9 7.0 24.0 1.8 0.0 0.4 10.9 47.1 340.0 16.8 16.2 28.0 3.9 12.8 0.9 29.6 33.8 64.6 5.8 6.9 0.0 8.0 61.9 11.4 11.4 0.7 2.2 4.5 4.0 1.6 29.4 102.4 0.0 13.0 1.0 18.4 16.0 7.3 3.4 18.3 5.0 0.1 9.9 5.7 ATP5MF-PTCD1 ATP5J2-PTCD1 ENSG00000248919 "ATP5MF-PTCD1 readthrough" 7 99419749-99466197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020106, HPA047679" Uncertain Approved Mitochondria NA NA Mitochondria "HPA020106: AB_2176551, HPA047679: AB_2680119" "unprognostic (1.15e-3)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (2.83e-1)" "unprognostic (3.29e-2)" "unprognostic (3.51e-1)" "unprognostic (1.18e-3)" "unprognostic (2.84e-2)" "unprognostic (6.44e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (2.00e-2)" "unprognostic (7.50e-2)" 2.9 2.8 1.1 2.8 1.1 0.0 2.3 1.2 1.8 3.0 1.0 3.1 2.7 3.0 1.6 4.7 3.3 2.0 3.7 1.1 1.0 1.7 2.8 1.8 2.6 1.3 1.2 0.9 2.6 2.6 3.6 1.7 2.5 1.2 3.8 2.1 0.5 2.6 3.5 9.0 2.4 2.3 2.5 0.9 2.3 2.8 3.5 1.3 2.3 2.3 5.5 2.5 4.2 3.4 1.1 7.7 8.2 6.8 19.1 8.1 4.8 14.6 5.1 6.2 12.8 11.6 31.5 12.3 10.0 12.6 4.9 11.9 7.3 11.6 10.6 5.4 11.2 10.9 5.8 5.0 6.5 8.5 8.0 5.7 8.2 9.4 11.5 9.3 4.7 5.3 11.5 19.5 14.9 8.3 15.7 18.5 10.2 11.9 13.2 10.5 9.9 6.3 26.6 6.7 2.4 8.7 8.8 11.0 18.0 11.0 4.5 9.2 12.5 3.3 8.9 7.8 18.7 13.8 11.7 10.8 16.0 6.5 8.9 16.3 1.3 4.0 1.2 3.3 5.4 3.4 2.1 2.7 2.8 5.6 2.4 2.8 3.6 0.3 4.5 3.2 2.7 2.2 5.0 1.1 1.1 1.2 1.8 1.1 1.0 1.3 1.2 0.9 1.2 0.9 1.3 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 USP17L19 ENSG00000248920 "Ubiquitin specific peptidase 17 like family member 19" D6RCP7 4 9253378-9254970 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L22 ENSG00000248933 "Ubiquitin specific peptidase 17 like family member 22" D6RA61 4 9267619-9269211 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 21 "brain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 2.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 1.6 1.0 1.0 2.0 0.7 0.8 2.0 0.1 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645941.2 ENSG00000248993 "Novel protein" 6 32937364-32953122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012298 Uncertain NA NA "HPA012298: AB_1853927" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (4.98e-1)" "unprognostic (5.56e-4)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.93e-1)" "unprognostic (3.25e-2)" "unprognostic (3.78e-1)" "unprognostic (1.60e-1)" "unprognostic (8.18e-2)" "unprognostic (4.73e-2)" 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L17 ENSG00000249104 "Ubiquitin specific peptidase 17 like family member 17" D6RBQ6 4 9243879-9245471 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAUS5 "dgt5, KIAA0841" ENSG00000249115 "HAUS augmin like complex subunit 5" O94927 19 35612735-35625355 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 55.4;Spermatogonia: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067250 Approved NA NA "HPA067250: AB_2685812" "unprognostic (9.24e-3)" "prognostic favorable (7.68e-4)" "unprognostic (4.18e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-3)" "prognostic unfavorable (2.77e-6)" "unprognostic (2.64e-2)" "unprognostic (3.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (4.15e-8)" "unprognostic (2.09e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-1)" "unprognostic (1.22e-1)" 4.0 5.1 6.5 4.0 6.7 5.7 4.8 7.6 10.8 7.5 6.4 3.6 1.6 5.2 2.3 6.5 6.2 1.7 3.6 6.5 6.5 4.9 5.2 3.8 6.0 6.7 6.6 6.5 10.4 6.2 1.8 5.0 1.9 7.2 4.7 2.2 4.1 4.5 1.2 7.6 5.2 5.3 2.6 6.4 7.7 4.2 11.0 6.5 4.1 4.8 1.2 5.0 4.2 5.5 7.3 6.7 5.1 14.0 5.2 1.9 2.9 1.6 7.0 2.1 4.4 6.0 3.4 5.1 14.1 6.1 2.5 2.8 4.1 9.1 4.2 9.8 10.3 7.8 16.2 7.7 3.2 1.9 12.5 3.4 2.9 2.4 3.2 5.0 4.1 3.9 14.2 9.0 12.1 5.3 6.0 16.9 5.2 3.7 8.1 5.9 12.3 12.6 6.5 3.6 4.2 4.3 3.4 6.6 5.7 4.2 8.7 7.3 10.3 3.7 3.2 9.1 5.0 5.4 6.5 5.3 13.5 4.8 10.5 4.1 0.8 0.8 0.2 3.1 1.8 3.0 3.4 2.9 2.2 1.9 2.3 3.0 2.5 0.4 4.2 1.0 1.5 2.3 1.1 6.5 6.7 7.6 10.8 6.5 6.5 6.7 6.6 6.5 7.2 6.4 6.5 7.3 5.8 0.0 5.6 8.5 10.3 6.0 5.7 5.0 9.6 5.4 6.2 6.6 4.1 7.2 2.8 14.7 8.4 10.9 6.5 3.5 3.9 4.2 15.1 6.2 5.9 5.8 2.4 10.1 3.3 3.5 10.8 6.2 6.1 4.5 7.0 12.2 5.7 3.9 4.7 3.3 6.3 2.9 2.0 0.6 7.0 7.9 5.3 3.9 5.4 1.9 2.5 3.7 6.2 5.0 9.5 4.2 2.1 6.8 11.2 2.2 0.6 1.3 13.1 4.3 0.0 5.1 5.8 55.4 30.3 7.2 5.7 7.3 7.8 4.3 4.8 3.7 EPPIN-WFDC6 SPINLW1-WFDC6 ENSG00000249139 "EPPIN-WFDC6 readthrough" O95925 20 45534196-45547662 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 78 "epididymis: 64.1;testis: 54.0" "Cell type enriched" "Detected in single" 6 "Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067335 Supported "Secreted in male reproductive system" NA NA "HPA067335: " "unprognostic (1.46e-3)" "unprognostic (6.38e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL159163.1 ENSG00000249141 "Novel protein" 6 166858094-166956124 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 3.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.3;Hofbauer cells: 4.6;Pancreatic endocrine cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 4.7;OE19: 6.2;U-937: 2.6" NA NA "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (7.52e-2)" "unprognostic (7.60e-2)" "unprognostic (1.51e-2)" "unprognostic (4.47e-2)" "unprognostic (7.13e-3)" "unprognostic (1.87e-1)" "unprognostic (2.27e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.90e-3)" "unprognostic (1.76e-10)" "unprognostic (2.10e-1)" "unprognostic (1.24e-3)" "unprognostic (1.52e-1)" "unprognostic (9.28e-3)" 0.5 0.7 1.4 0.4 1.6 0.6 0.3 0.5 1.1 0.8 0.2 2.6 1.0 0.2 2.1 0.5 0.0 1.0 0.0 1.3 2.1 0.2 0.4 0.4 1.0 1.0 0.8 1.0 0.0 3.6 0.1 0.4 0.4 0.8 0.2 2.1 0.4 1.6 0.1 0.4 0.3 0.4 0.6 0.9 1.0 1.4 0.2 1.1 0.1 0.2 0.0 1.7 0.4 0.2 0.8 0.3 0.0 0.7 0.4 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.6 1.1 0.2 0.0 0.6 0.6 0.5 1.1 0.4 1.2 0.0 0.6 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.0 4.7 0.1 6.2 0.0 0.0 0.0 1.2 1.5 0.2 0.2 0.5 0.0 2.5 0.0 0.5 0.2 1.0 0.0 0.0 0.6 2.4 0.0 0.9 1.9 0.0 0.7 2.6 0.0 1.7 3.5 0.2 0.5 5.0 0.8 0.9 1.8 0.6 5.5 1.8 1.1 0.2 1.6 0.2 7.9 5.5 2.1 1.7 1.4 1.6 0.5 1.1 1.3 2.1 1.0 0.8 1.0 0.8 0.9 1.1 0.8 0.1 0.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 TAF11L12 ENSG00000249156 "TATA-box binding protein associated factor 11 like 12" 5 17610496-17611583 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.4" NA NA "unprognostic (2.61e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012347 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1;parathyroid gland: 2.7;retina: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;AN3-CA: 10.7;EFO-21: 7.6;MCF7: 4.4;T-47d: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" NA NA "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: AB_2686827" "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.3 1.1 0.1 1.4 0.0 0.2 4.1 2.2 0.8 0.0 0.1 0.0 0.5 0.2 0.0 0.2 0.8 0.0 1.0 0.4 0.7 0.1 0.4 0.1 0.1 0.4 1.1 0.0 1.8 2.7 1.0 0.0 1.1 0.1 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.8 0.0 2.1 4.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.6 0.0 0.8 0.0 0.1 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.3 0.0 1.0 0.0 0.1 0.0 4.4 0.0 0.0 3.5 0.8 2.8 0.0 0.0 0.0 0.4 1.6 0.2 1.9 0.0 1.9 0.4 1.9 6.5 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 4.1 2.2 1.0 0.4 0.1 0.4 1.1 1.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000311.1 ENSG00000249209 "Novel protein similar to ATP synthase delta (OSCP) subunit domain" 21 33584687-33931607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in all" 6 "T-cells: 12.8" "Cell line enhanced" "Detected in many" "U-2 OS: 5.7" HPA039558 Uncertain NA NA "HPA039558: AB_2676570" "unprognostic (4.72e-1)" 0.4 0.3 0.7 0.6 0.8 0.1 0.2 0.5 1.0 0.1 0.5 0.4 0.3 0.3 0.4 0.5 0.3 0.3 0.9 0.8 0.6 0.3 0.4 0.4 1.1 0.9 0.7 0.7 0.3 0.0 0.2 0.0 0.9 0.8 0.4 0.5 0.1 0.7 0.0 0.9 0.3 0.4 0.0 0.4 0.2 0.5 0.9 0.6 0.4 0.3 1.0 0.1 0.1 0.0 0.9 2.6 0.2 0.6 0.2 0.3 0.0 1.0 0.3 0.5 0.3 0.2 3.7 1.4 0.3 2.2 0.1 0.5 1.5 1.2 1.5 0.0 1.7 3.3 1.2 0.7 0.4 0.5 1.1 0.7 0.4 0.0 0.5 0.5 0.1 0.1 2.4 1.8 3.2 0.6 0.7 1.7 0.5 3.3 5.0 2.9 2.2 0.5 1.3 0.1 1.2 2.5 0.1 2.8 1.3 0.4 2.8 1.7 1.6 0.3 0.3 5.7 0.9 0.2 1.5 1.7 0.8 1.8 0.9 0.0 1.7 1.4 1.2 5.8 1.0 7.8 2.0 8.2 8.6 1.6 2.2 7.2 7.2 0.8 1.0 1.1 1.7 12.8 3.9 0.7 0.8 0.5 1.0 0.8 0.6 0.9 0.7 0.7 0.8 0.4 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.4;brain: 2.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 11.6;Distal tubular cells: 5.9;Extravillous trophoblasts: 7.7;Hofbauer cells: 11.2;Syncytiotrophoblasts: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044629 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044629: AB_2679028" "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.1 0.0 0.8 0.0 0.7 1.4 0.0 2.3 1.3 0.0 0.7 0.0 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.6 0.7 0.1 0.0 0.1 0.3 0.9 0.5 0.8 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.3 0.0 0.1 0.9 0.1 0.0 0.5 0.1 0.2 0.1 1.0 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.9 0.1 0.2 0.2 0.1 0.3 0.8 0.7 2.3 1.3 0.6 0.7 0.9 0.5 0.8 1.0 0.5 1.0 1.7 1.1 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 1.8 0.0 11.6 0.7 0.0 5.9 0.6 0.0 0.8 0.8 0.9 0.0 0.0 0.0 1.1 7.7 1.0 0.0 1.3 2.5 1.2 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 2.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.6 0.8 1.2 0.0 0.0 AC069368.1 ENSG00000249240 "Novel protein" 15 64841883-64930920 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 30.4" NA NA "unprognostic (2.49e-1)" "unprognostic (1.95e-2)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (3.28e-1)" "unprognostic (3.68e-2)" "unprognostic (4.45e-2)" "unprognostic (7.51e-2)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (4.25e-1)" "unprognostic (2.83e-1)" "unprognostic (1.97e-1)" 1.3 2.8 0.9 4.3 1.0 0.0 0.1 1.0 3.5 0.2 1.1 1.6 2.8 1.3 0.0 0.5 0.2 0.6 0.1 0.5 1.6 0.7 0.9 0.8 1.4 1.7 0.8 0.1 0.4 0.1 0.1 0.0 0.8 2.2 0.4 0.6 0.9 0.5 0.0 0.6 0.0 0.8 0.9 0.7 6.3 2.2 0.4 1.0 0.3 0.5 0.0 0.1 0.7 0.1 1.6 2.9 0.0 0.6 0.9 0.7 3.3 1.0 11.4 5.0 0.6 1.8 0.9 0.0 10.0 4.2 2.8 0.5 0.2 0.0 0.0 1.7 11.4 0.0 9.0 2.9 0.0 1.4 12.1 5.5 1.1 0.5 0.7 0.0 1.3 0.0 0.9 2.5 11.0 0.0 0.2 1.5 0.1 1.5 0.0 0.0 1.8 9.3 3.4 0.0 2.2 0.0 2.7 2.7 0.0 1.5 0.1 0.4 1.2 11.9 3.3 2.8 3.4 2.7 5.6 30.4 3.0 4.3 6.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 1.0 1.0 3.5 0.5 1.6 1.7 0.8 0.1 2.2 0.7 1.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 136.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3" "Cancer enhanced" "Detected in all" "breast cancer: 23.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 12.4 43.4 12.8 4.7 15.5 1.9 22.2 10.4 17.0 15.2 7.1 7.1 7.4 5.0 136.1 3.7 7.4 6.5 12.8 15.4 12.8 17.4 14.0 6.3 14.8 13.2 13.5 15.1 31.8 3.5 5.4 8.4 9.9 12.9 12.7 4.3 4.6 17.1 7.7 6.9 4.3 7.0 7.0 12.0 14.5 5.1 3.3 11.8 9.2 11.5 9.8 12.9 5.0 5.2 13.4 0.1 1.0 8.8 10.9 0.1 0.1 0.4 1.9 4.7 1.3 1.2 0.0 0.6 0.3 0.9 0.3 3.6 0.2 5.0 0.0 1.4 0.4 2.3 0.7 1.2 0.1 0.0 0.0 1.0 4.5 0.6 0.0 0.0 0.8 2.7 5.3 0.0 0.0 0.2 32.2 0.6 0.8 3.9 0.0 0.5 1.0 0.2 1.2 0.2 4.8 20.1 3.5 0.5 0.4 2.8 4.1 0.5 0.2 0.8 0.5 0.3 0.1 1.1 0.1 0.5 0.4 0.6 0.1 2.2 2.6 0.3 0.5 0.2 0.2 0.1 1.0 0.3 0.2 0.1 1.1 0.2 0.2 1.4 0.5 0.3 0.6 0.1 0.1 12.8 15.5 10.4 17.0 15.4 12.8 13.2 13.5 15.1 12.9 12.0 11.8 13.4 30.7 0.0 1.1 36.6 0.2 2.4 3.5 1.9 0.6 1.1 19.3 13.6 10.1 5.7 6.1 14.7 2.1 88.6 1.4 0.2 0.0 7.2 5.5 2.6 11.2 24.8 1.2 3.0 35.6 2.5 1.3 13.1 0.5 10.5 6.3 104.7 25.4 20.4 5.7 1.7 24.2 1.1 0.0 1.0 3.6 2.9 14.3 1.8 1.8 7.5 7.8 14.8 0.0 17.6 13.1 1.4 0.2 9.8 1.2 4.9 0.4 2.6 7.1 2.2 0.0 3.9 7.8 1.1 4.1 1.6 1.1 117.3 0.6 1.8 4.3 0.9 AC068533.4 ENSG00000249319 "Novel protein" 7 66087761-66152277 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 10.6" NA NA "unprognostic (7.24e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" "unprognostic (2.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.74e-1)" "unprognostic (2.32e-1)" "unprognostic (2.50e-3)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" 0.6 0.4 1.0 0.9 1.2 1.8 1.7 1.1 3.4 2.0 0.8 2.8 2.1 1.0 1.0 0.9 1.1 0.8 0.4 1.1 1.5 1.6 4.7 1.2 0.5 1.3 1.2 1.0 0.9 0.5 1.8 0.5 0.5 1.4 1.4 1.8 2.7 0.6 1.4 0.4 0.5 1.0 1.2 0.8 0.7 1.6 0.4 1.2 0.9 1.1 1.3 1.0 0.6 0.4 1.2 1.6 0.0 1.6 1.2 3.9 6.0 0.5 2.1 2.7 0.6 1.0 1.0 2.4 2.1 2.4 6.7 4.1 2.2 0.3 1.4 3.0 0.4 1.8 0.7 0.9 0.0 2.2 1.0 2.3 3.4 3.1 3.7 6.0 5.6 1.1 0.5 1.7 0.9 0.3 0.9 1.5 1.2 0.0 7.9 1.9 0.8 1.1 2.2 2.7 1.1 2.2 2.9 1.6 10.6 0.5 4.0 3.4 0.6 3.8 0.8 0.6 1.9 1.7 1.4 2.0 0.6 7.4 3.0 0.3 2.0 0.8 0.4 1.0 0.5 1.2 1.9 0.4 1.0 0.3 1.0 1.1 1.4 1.6 1.7 1.3 0.4 0.9 0.3 1.0 1.2 1.1 3.4 1.1 1.5 1.3 1.2 1.0 1.4 0.8 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAIP "BIRC1, NLRB1" ENSG00000249437 "NLR family apoptosis inhibitory protein" Q13075 5 70968166-71025339 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 31.8" "Cell type enhanced" "Detected in many" "Kupffer cells: 138.4;Macrophages: 97.4;Microglial cells: 113.4;Oligodendrocytes: 177.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 8.4;myeloid DC: 5.3" "Group enriched" "Detected in many" 16 "dendritic cells: 5.3;granulocytes: 4.4;monocytes: 8.4" "Cell line enhanced" "Detected in some" "MOLT-4: 3.9;SiHa: 2.1;T-47d: 2.3" HPA042438 Approved NA NA "HPA042438: AB_10796578" "unprognostic (9.03e-2)" "unprognostic (6.03e-2)" "unprognostic (1.31e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (1.12e-3)" "unprognostic (1.12e-1)" "unprognostic (2.23e-2)" "unprognostic (4.36e-2)" "unprognostic (1.86e-1)" "unprognostic (2.54e-2)" "unprognostic (5.13e-1)" "unprognostic (1.69e-3)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (9.96e-2)" 4.6 2.7 1.0 2.7 1.0 1.6 3.4 1.9 1.7 2.8 1.0 2.8 0.3 2.1 0.8 1.5 4.6 1.1 2.8 1.2 1.3 2.8 3.4 6.9 2.5 1.0 0.8 1.2 2.9 3.3 0.2 1.5 0.6 1.3 2.2 0.5 2.1 1.8 0.5 1.0 2.0 4.7 0.8 0.7 31.8 2.9 4.1 1.3 0.4 3.6 0.0 0.2 3.0 2.7 1.2 0.0 0.0 0.6 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.4 0.5 0.7 0.1 0.8 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.4 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.2 0.1 0.4 0.0 2.1 0.0 0.1 0.4 2.3 0.0 0.0 0.6 0.2 0.1 0.0 0.5 0.0 0.3 0.1 0.1 0.4 0.2 8.4 0.0 0.2 2.0 0.1 0.0 0.0 0.1 5.3 0.2 0.2 0.1 4.4 0.3 0.4 0.3 0.1 2.5 1.0 1.0 1.9 1.7 1.2 1.3 1.0 0.8 1.2 1.3 0.7 1.3 1.2 8.5 19.2 9.7 60.7 9.4 3.6 2.4 2.2 2.8 16.2 10.2 4.6 3.2 11.5 8.2 5.5 22.9 3.7 7.3 4.1 0.0 1.9 44.0 10.0 15.1 11.1 10.7 18.3 50.2 2.3 2.4 8.2 14.3 10.9 5.1 15.8 9.3 7.3 69.3 16.8 46.4 5.6 2.0 138.4 16.4 11.6 10.8 97.4 1.8 113.4 44.2 6.7 4.1 67.8 177.5 1.6 2.5 7.2 9.8 2.3 1.6 1.3 6.9 38.4 6.6 12.8 5.5 13.7 4.4 3.6 3.8 2.9 8.5 6.0 4.0 1.5 ZNF324B FLJ45850 ENSG00000249471 "Zinc finger protein 324B" Q6AW86 19 58451611-58457833 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Inhibitory neurons: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "NK-cell: 4.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 4.0" "Cell line enhanced" "Detected in all" "HEK 293: 38.7" HPA023400 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023400: AB_1859195" "unprognostic (2.75e-1)" "unprognostic (2.36e-2)" "unprognostic (2.27e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-1)" "unprognostic (5.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.47e-3)" "unprognostic (2.65e-1)" "unprognostic (3.21e-1)" "prognostic favorable (2.83e-4)" "unprognostic (5.58e-2)" "unprognostic (2.43e-1)" "unprognostic (9.50e-2)" "unprognostic (1.40e-1)" "unprognostic (1.56e-3)" "unprognostic (2.94e-2)" 2.4 2.2 0.8 2.8 1.3 1.7 2.7 2.6 2.4 3.2 0.4 2.3 1.8 2.9 1.4 3.0 3.1 2.1 1.7 1.5 0.5 2.1 2.5 2.3 2.3 0.9 0.4 1.1 3.0 3.7 2.7 3.1 1.5 0.9 2.7 1.8 1.9 2.7 2.4 3.1 3.8 2.3 2.2 0.0 3.4 2.7 3.0 0.4 2.6 2.8 1.7 2.0 3.0 2.6 0.8 5.9 9.6 5.2 8.6 3.6 3.1 3.8 5.2 3.8 4.2 3.0 3.4 2.5 8.0 3.2 3.1 4.3 4.8 6.9 4.8 3.2 8.1 38.7 6.9 8.5 1.3 3.7 11.3 9.8 3.1 4.8 4.7 4.0 2.7 3.0 7.0 10.1 4.7 4.3 3.9 8.4 2.7 2.8 6.9 5.4 7.9 6.8 4.8 2.7 11.4 12.2 7.0 4.9 7.9 1.3 3.5 2.9 3.2 3.5 9.9 2.5 5.3 8.5 10.2 9.9 5.7 3.9 4.8 3.9 0.0 0.6 0.0 0.6 0.3 0.4 0.2 0.3 0.4 0.3 0.5 0.6 0.4 0.7 4.0 0.2 0.3 0.2 0.5 0.8 1.3 2.6 2.4 1.5 0.5 0.9 0.4 1.1 0.9 0.0 0.4 0.8 1.8 0.0 0.5 9.1 2.9 0.8 1.0 0.6 1.8 3.1 1.6 1.3 0.9 1.5 2.2 1.8 22.9 0.9 2.4 2.2 0.0 1.8 1.0 1.9 3.1 1.5 0.0 2.1 9.5 1.6 0.9 1.5 1.5 1.2 0.0 1.8 1.4 1.3 0.9 5.0 10.6 1.0 0.0 2.2 0.4 1.8 3.1 1.2 0.0 0.0 2.0 2.0 3.1 7.5 9.5 1.4 0.6 2.6 1.5 1.0 1.2 1.2 2.7 6.6 6.6 2.3 1.6 6.6 4.8 1.2 1.0 0.7 2.0 4.2 1.3 1.0 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342650-44380179 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 5.9;fallopian tube: 7.7;testis: 22.3" "Group enriched" "Detected in some" 13 "Early spermatids: 30.9;Late spermatids: 12.1;Respiratory ciliated cells: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SK-MEL-30: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030897, HPA049722" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030897: AB_2673647, HPA049722: AB_2680861" "unprognostic (2.30e-3)" 0.0 0.1 2.8 0.0 0.7 0.2 0.0 0.6 0.8 0.2 0.6 0.0 0.0 0.2 5.9 0.0 7.7 0.0 0.1 0.7 0.7 0.0 0.0 0.6 0.1 1.2 1.6 0.5 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.1 22.3 0.7 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.4 0.1 0.0 0.1 7.9 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 2.8 0.7 0.6 0.8 0.7 0.7 1.2 1.6 0.5 1.0 1.5 0.7 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN2 ENSG00000249581 "Clarin 2" A0PK11 4 17515165-17527104 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042407 Uncertain NA NA "HPA042407: AB_10806237" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004832.3 ENSG00000249590 "Novel SEC14-like 2 (S. cerevisiae) (SEC14L2) and mitochondrial protein 18 kDa (MTP18) protein" 22 30409255-30428990 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 6.9" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 8.4;HUVEC TERT2: 2.2" NA NA 0.1 0.2 0.6 0.8 0.7 0.1 0.1 0.7 1.7 0.1 2.0 0.4 0.4 0.1 1.0 0.2 0.1 0.2 0.2 0.5 0.9 1.5 2.0 0.3 0.0 0.9 0.8 0.5 0.1 0.2 0.0 0.0 0.0 0.9 0.5 1.4 6.9 0.1 0.0 0.0 0.4 0.3 0.0 0.8 0.1 0.5 0.4 0.8 0.0 0.2 0.2 0.9 0.0 0.1 1.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.2 1.2 2.2 0.0 0.0 0.2 1.2 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.7 0.7 1.7 0.5 0.9 0.9 0.8 0.5 0.9 0.8 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000295.1 ENSG00000249624 "Novel protein" 21 33229901-33297160 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;Club cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 5.9" "Group enriched" "Detected in many" 6 "granulocytes: 5.9;monocytes: 2.8" "Cell line enhanced" "Detected in some" "HEL: 3.9;hTERT-RPE1: 3.3;MOLT-4: 4.0;RH-30: 3.9" NA NA "unprognostic (2.39e-1)" "unprognostic (8.87e-2)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.62e-1)" "unprognostic (3.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.12e-1)" "unprognostic (5.46e-2)" "unprognostic (2.92e-2)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (2.33e-2)" 0.5 0.1 0.0 0.2 0.1 1.2 0.1 0.0 0.2 0.3 0.0 0.3 0.0 0.2 0.0 0.3 0.3 0.5 0.1 0.0 0.0 0.6 1.1 0.7 0.3 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.7 0.0 0.2 0.2 0.6 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.4 0.2 0.0 0.3 0.1 0.0 0.6 1.2 0.0 0.1 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.4 0.0 0.9 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.6 0.0 0.4 0.0 3.9 0.0 0.0 0.0 1.9 2.6 2.3 0.1 0.0 1.9 3.3 0.6 1.5 0.4 1.0 0.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 3.9 1.1 0.2 0.0 1.7 0.0 2.5 0.0 0.0 0.8 0.0 0.0 1.9 0.0 0.3 0.0 0.0 1.5 2.6 0.2 0.6 0.0 0.0 0.0 0.8 3.0 0.1 1.8 0.5 0.1 0.5 0.4 0.5 0.0 0.4 0.3 5.9 0.7 2.8 0.4 0.6 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 LINC02218 ENSG00000249662 "Long intergenic non-protein coding RNA 2218" 5 17444010-17486829 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 86 "neutrophil: 8.6" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.6" "Cell line enriched" "Detected in single" 9 "U-937: 2.0" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THEGL ENSG00000249693 "Theg spermatid protein like" P0DJG4 4 56530606-56603507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.5" "Group enriched" "Detected in some" 6 "Early spermatids: 27.3;Late spermatids: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA066627, HPA068093" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA066627: , HPA068093: AB_2685951" "unprognostic (4.33e-2)" "unprognostic (2.88e-3)" "unprognostic (7.97e-2)" "unprognostic (1.19e-1)" "unprognostic (3.69e-2)" "unprognostic (3.26e-1)" "unprognostic (1.90e-2)" "unprognostic (6.55e-2)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" "unprognostic (4.70e-2)" "unprognostic (4.49e-2)" "unprognostic (1.73e-1)" "unprognostic (8.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.2 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.5 0.0 0.1 0.1 0.0 0.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.3 0.0 0.0 0.1 0.0 1.3 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 20.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 ZNF564 MGC26914 ENSG00000249709 "Zinc finger protein 564" Q8TBZ8 19 12525373-12551542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 13.1;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043998 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA043998: AB_10969446" "unprognostic (3.85e-2)" "unprognostic (1.40e-3)" "unprognostic (4.61e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.26e-3)" "unprognostic (4.25e-1)" "unprognostic (2.53e-2)" "unprognostic (1.76e-3)" "unprognostic (8.69e-2)" "unprognostic (3.94e-2)" "unprognostic (5.24e-3)" "unprognostic (1.26e-5)" "unprognostic (5.77e-3)" "unprognostic (3.07e-1)" "unprognostic (4.51e-3)" "unprognostic (1.83e-2)" 4.0 3.5 4.8 3.7 5.7 4.4 7.5 11.7 6.0 5.5 2.7 7.5 6.4 6.8 6.2 3.1 6.6 3.4 5.2 5.0 5.4 7.7 5.7 4.3 6.9 5.2 5.1 4.4 6.1 3.7 7.6 3.2 5.1 6.3 6.3 7.4 7.2 4.9 6.1 6.3 5.4 7.1 4.4 4.1 6.9 6.8 3.0 4.9 7.6 8.0 8.0 7.5 5.3 4.3 9.4 4.3 1.2 4.9 6.2 7.4 5.5 6.0 4.3 6.0 5.3 7.0 3.2 2.7 5.3 5.8 3.9 3.2 4.9 2.5 4.1 5.6 4.3 4.1 3.7 3.9 6.7 5.4 6.6 6.8 5.5 10.3 2.5 6.3 5.5 4.5 5.5 7.8 2.2 6.6 5.7 5.4 3.9 5.0 4.8 5.5 3.2 5.4 4.4 5.9 6.9 3.4 3.0 5.2 2.9 6.2 7.2 4.5 11.4 4.6 8.0 2.5 5.0 3.3 7.6 9.2 4.2 2.4 4.4 3.4 15.2 7.3 18.6 11.9 10.1 11.0 14.7 10.2 10.9 9.4 11.1 11.5 10.6 13.7 11.3 13.1 7.3 9.3 7.1 4.8 5.7 11.7 6.0 5.0 5.4 5.2 5.1 4.4 6.3 4.1 4.9 9.4 1.8 0.0 1.5 6.5 6.9 0.0 0.9 0.8 2.8 2.1 1.0 1.1 0.5 5.7 1.5 0.0 4.2 1.3 3.6 1.5 3.9 1.2 0.1 2.0 1.7 1.8 0.0 4.0 8.4 0.7 0.9 1.5 7.7 1.6 0.0 4.9 2.5 1.1 1.1 0.0 8.6 1.0 0.0 1.6 0.4 0.3 0.6 1.4 1.8 13.1 2.0 2.4 5.2 11.1 8.8 1.6 1.0 0.7 5.9 1.7 2.0 0.8 6.3 4.4 0.0 2.2 1.3 1.2 2.3 1.1 0.0 1.2 4.0 1.4 0.9 1.5 FER1L5 DKFZp434I0121 ENSG00000249715 "Fer-1 like family member 5" A0AVI2 2 96642737-96704887 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 1.4;testis: 4.2" "Cell type enhanced" "Detected in some" "Astrocytes: 4.9;Early spermatids: 22.7;Excitatory neurons: 5.5;Late spermatids: 6.9;Spermatocytes: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-3)" "unprognostic (5.81e-3)" "unprognostic (2.06e-1)" "unprognostic (1.12e-4)" "unprognostic (4.49e-4)" "unprognostic (1.39e-2)" "unprognostic (6.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-2)" "unprognostic (2.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.16e-3)" 0.0 0.0 0.5 0.0 0.8 0.0 0.3 0.5 0.4 0.0 1.4 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.5 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.5 0.4 0.4 0.3 0.5 0.4 0.3 0.2 0.0 0.2 0.4 0.1 3.2 1.1 4.9 0.5 0.0 1.1 0.0 0.0 0.3 0.7 0.3 1.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.9 0.5 22.7 0.1 0.5 0.2 0.0 0.0 5.5 0.6 0.0 0.3 0.0 0.1 1.3 0.1 1.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 6.9 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.1 0.0 0.4 0.1 0.6 0.0 0.1 1.5 0.1 0.0 0.4 0.2 4.3 1.4 0.0 0.0 0.3 0.2 1.3 0.0 0.4 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448560-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Adipocytes: 235.8;Endothelial cells: 214.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 122 "EFO-21: 172.1;HUVEC TERT2: 443.7;TIME: 330.9" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: AB_2732701" "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 62.2 12.8 5.2 11.3 5.0 0.2 60.3 5.1 8.6 26.8 6.0 19.2 4.7 29.6 7.5 16.0 33.8 12.2 46.1 4.7 5.3 25.9 6.0 60.7 11.7 5.6 5.0 4.0 10.5 6.8 4.8 7.2 33.8 5.4 19.8 8.1 0.8 16.2 7.4 15.3 16.4 20.9 24.6 5.5 23.6 15.3 3.3 6.8 3.5 41.2 17.3 7.3 35.8 26.3 7.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 172.1 0.3 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 443.7 0.1 0.0 0.0 1.4 0.0 0.0 0.9 2.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 330.9 0.4 0.4 0.0 1.7 0.0 0.0 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.0 5.1 8.6 4.7 5.3 5.6 5.0 4.0 5.4 5.5 6.8 7.4 235.8 0.0 3.9 0.0 1.0 14.9 0.4 0.0 0.0 0.0 1.9 2.5 0.0 0.0 0.6 0.0 0.0 0.2 1.0 0.0 0.0 0.6 0.0 0.4 0.5 214.9 0.0 0.0 0.1 1.2 0.1 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 18.3 0.0 0.0 1.7 10.6 5.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.5 0.0 0.0 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 13.9 0.3 1.3 0.9 0.0 1.6 AC092647.5 ENSG00000249773 "Novel zinc finger protein 713 (ZNF713) and mitochondrial ribosomal protein S17 (MRPS17) protein" 7 55887277-55955239 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 2.8" "Cell type enhanced" "Detected in some" "granulocytes: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA047159 Uncertain NA NA "HPA047159: AB_2679961" "unprognostic (1.54e-1)" "unprognostic (5.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.21e-2)" "unprognostic (2.29e-1)" "unprognostic (7.02e-2)" "unprognostic (3.98e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-3)" "unprognostic (3.99e-4)" "unprognostic (1.87e-1)" "unprognostic (4.67e-3)" "unprognostic (7.51e-2)" "unprognostic (1.01e-1)" "unprognostic (1.62e-2)" "unprognostic (7.06e-2)" 0.3 0.2 1.0 0.2 1.0 0.7 0.8 0.9 1.0 0.5 0.3 0.3 0.3 0.8 0.2 0.3 0.8 0.2 0.4 0.8 1.1 0.5 0.2 0.4 0.0 1.2 1.0 0.6 0.4 0.5 0.5 0.9 0.3 1.2 0.4 0.2 0.8 0.3 0.4 0.3 0.3 0.4 0.4 1.0 0.2 0.6 2.8 1.3 0.8 0.5 0.3 0.3 0.3 0.3 1.5 5.2 0.2 3.4 3.7 0.4 0.1 1.2 0.8 0.1 0.5 0.3 0.1 1.9 2.3 1.6 0.2 2.5 0.7 1.7 1.1 0.3 1.4 1.7 0.8 2.0 0.5 0.5 1.7 0.9 0.3 0.8 0.3 1.0 0.8 0.8 1.4 1.4 0.7 0.4 0.5 2.1 0.7 3.0 1.0 1.0 2.0 0.8 0.4 1.8 0.4 2.7 3.2 3.3 0.9 0.2 1.5 3.1 1.1 0.7 0.1 4.7 0.3 1.8 1.2 1.4 1.9 0.8 0.9 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 1.0 0.9 1.0 0.8 1.1 1.2 1.0 0.6 1.2 1.0 1.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 USP17L21 ENSG00000249811 "Ubiquitin specific peptidase 17 like family member 21" D6R901 4 9262872-9264464 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HS3ST5 3-OST-5 ENSG00000249853 "Heparan sulfate-glucosamine 3-sulfotransferase 5" Q8IZT8 6 114055586-114343045 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;skeletal muscle: 3.2" "Cell type enhanced" "Detected in some" "Astrocytes: 102.5;Excitatory neurons: 154.8;Inhibitory neurons: 130.9;Oligodendrocytes: 606.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 4.6;RT4: 6.8;SCLC-21H: 14.2;U-266/70: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021823, HPA064677" Approved NA NA "HPA021823: AB_1851100, HPA064677: AB_2685318" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-2)" "unprognostic (1.04e-2)" "unprognostic (1.72e-2)" "unprognostic (3.00e-2)" "unprognostic (7.98e-4)" "unprognostic (5.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.53e-2)" 0.0 0.3 4.2 0.1 8.9 0.2 0.0 3.4 4.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 4.7 0.1 0.0 0.1 0.0 7.1 5.8 2.3 0.0 0.2 0.0 0.0 0.0 7.3 0.0 0.1 1.1 0.0 1.3 3.2 0.2 0.1 0.1 5.0 0.0 0.2 0.1 6.3 0.0 0.0 1.4 0.0 2.3 0.0 6.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 1.9 4.6 0.0 0.8 0.0 0.0 6.8 14.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.1 4.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 8.9 3.4 4.6 2.8 4.7 7.1 5.8 2.3 7.3 5.0 6.3 6.0 0.0 0.0 0.0 102.5 0.0 1.3 0.0 0.0 0.0 3.8 0.0 0.0 0.6 0.0 0.0 11.0 18.8 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.1 0.0 0.0 154.8 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 130.9 0.4 0.0 0.0 0.0 0.8 3.7 0.0 0.0 9.4 0.0 0.0 0.0 11.6 606.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 7.9 0.1 1.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.5 MTRNR2L5 ENSG00000249860 "MT-RNR2 like 5" P0CJ72 10 55599042-55600728 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 1.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" 0.0 0.1 1.2 0.1 0.9 0.3 0.0 0.4 1.2 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 1.2 1.6 0.1 0.1 0.0 0.2 1.1 1.0 1.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.7 0.2 0.1 0.0 0.4 0.2 0.1 0.0 1.6 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 1.2 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 1.2 0.2 0.1 0.1 0.0 0.1 1.2 0.9 0.4 1.2 1.2 1.6 1.1 1.0 1.0 0.9 0.4 1.6 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 LGALS16 ENSG00000249861 "Galectin 16" A8MUM7 19 39655913-39660647 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "placenta: 5.6" "Cell type enriched" "Detected in some" 66 "Syncytiotrophoblasts: 1019.7" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 81 "BEWO: 4.2;SuSa: 11.8" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1019.7 0.0 0.0 0.0 0.0 RNF103-CHMP3 RNF103-VPS24 ENSG00000249884 "RNF103-CHMP3 readthrough" 2 86505668-86721122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;brain: 3.7;heart muscle: 4.2" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Excitatory neurons: 17.6;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.4" "HPA015673, HPA073383" Uncertain NA NA "HPA015673: AB_1858761, HPA073383: AB_2732224" "unprognostic (3.77e-2)" "unprognostic (5.47e-2)" "unprognostic (8.91e-4)" "unprognostic (9.64e-3)" "unprognostic (1.39e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-4)" "unprognostic (3.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.56e-2)" "unprognostic (5.83e-3)" "unprognostic (7.12e-2)" "unprognostic (8.90e-3)" "unprognostic (4.68e-2)" "unprognostic (6.56e-2)" "unprognostic (6.45e-2)" "unprognostic (6.94e-3)" 0.4 0.3 1.3 0.9 1.4 4.4 1.1 3.4 3.7 0.4 0.0 0.5 0.7 0.4 0.0 0.7 0.6 0.4 4.2 1.7 0.5 0.2 0.4 0.2 0.3 2.1 0.9 0.4 0.3 0.1 0.3 0.2 0.6 1.4 0.4 0.3 0.4 0.1 0.4 2.2 0.3 0.3 0.4 0.6 0.3 0.9 1.2 0.9 0.6 0.2 0.5 0.5 0.1 0.2 1.8 1.5 0.4 0.9 1.0 1.0 0.0 1.6 1.2 0.6 0.7 1.0 1.3 2.0 2.3 0.8 0.7 11.4 0.6 0.3 0.3 0.2 1.6 0.6 0.8 0.0 1.0 0.2 1.0 1.3 0.8 0.2 0.4 1.1 1.1 0.1 2.5 0.9 1.2 1.3 0.3 2.0 1.0 0.0 0.6 0.2 4.7 2.1 0.1 0.1 1.2 1.7 1.5 1.7 1.8 0.7 0.2 0.2 1.2 0.5 0.6 3.9 0.8 0.9 1.8 0.4 2.1 0.8 1.4 0.2 0.0 0.3 0.2 0.1 0.4 0.5 1.3 0.3 0.4 0.4 1.7 0.1 0.1 2.0 0.7 0.0 1.8 0.2 0.2 1.3 1.4 3.4 3.7 1.7 0.5 2.1 0.9 0.4 1.4 0.6 0.9 1.8 0.0 0.0 1.1 5.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.3 17.6 0.4 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.5 0.0 0.0 1.0 10.1 4.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 PDCD6 "ALG-2, PEF1B" ENSG00000249915 "Programmed cell death 6" O75340 5 271621-314974 "Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047221 Supported Nucleoplasm,Cytosol No No 1800000 Cytosol Nucleoplasm "HPA047221: " "unprognostic (1.32e-1)" "unprognostic (5.01e-2)" "unprognostic (2.10e-2)" "unprognostic (4.41e-3)" "unprognostic (4.94e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.47e-5)" "unprognostic (1.56e-1)" "unprognostic (1.27e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (7.97e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-1)" "prognostic favorable (2.19e-4)" 63.2 109.2 95.0 49.1 95.1 42.5 75.6 100.6 103.4 69.2 92.7 83.8 72.3 63.9 99.1 135.9 65.4 48.8 51.2 95.3 102.6 81.5 85.7 53.6 60.4 97.5 95.9 93.8 62.2 66.1 78.0 77.0 61.9 95.4 64.8 86.2 29.8 74.5 54.9 42.6 71.0 72.4 53.3 98.9 77.6 69.6 50.7 96.7 81.9 73.4 27.5 75.2 73.4 87.6 105.1 151.8 208.6 88.4 133.5 156.1 141.9 185.6 115.5 151.9 144.2 134.6 147.3 186.4 119.6 283.2 155.4 187.2 112.9 137.3 288.2 116.0 409.9 170.9 105.9 508.7 194.0 193.3 155.7 129.5 128.1 175.0 117.4 208.9 148.3 137.9 81.2 136.8 90.3 130.7 237.7 125.7 270.1 95.6 183.8 295.1 102.0 83.8 171.5 344.7 192.6 86.3 117.5 297.2 309.4 224.7 91.9 215.1 210.7 108.5 94.0 76.9 82.8 100.0 121.4 163.4 141.8 138.9 198.9 128.9 172.8 209.7 284.4 158.2 206.0 199.7 251.9 196.4 179.6 229.3 224.6 217.8 175.5 231.0 260.7 206.6 183.2 236.7 356.2 95.0 95.1 100.6 103.4 95.3 102.6 97.5 95.9 93.8 95.4 98.9 96.7 105.1 134.6 64.1 57.4 9.4 99.5 82.1 129.6 250.6 85.4 47.9 140.1 182.1 50.4 78.6 146.7 103.0 37.5 239.1 104.4 146.4 252.4 172.0 55.4 130.9 91.6 110.7 79.7 83.9 10.7 129.1 321.6 104.3 68.8 99.9 82.5 101.3 69.9 77.7 140.4 63.9 11.3 187.5 219.7 84.1 75.5 55.5 117.4 90.0 124.5 10.3 175.3 136.8 137.0 5.5 11.0 164.0 136.7 116.6 57.7 170.7 175.6 205.1 181.9 42.0 85.5 85.3 109.5 100.8 137.8 123.8 92.5 356.7 92.6 173.3 192.3 176.6 GOLGA8K ENSG00000249931 "Golgin A8 family member K" D6RF30 15 32392782-32403292 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 6.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.0;JURKAT: 1.0;THP-1: 1.7;U-937: 2.4" NA NA "unprognostic (2.47e-1)" "unprognostic (3.27e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-2)" "unprognostic (6.62e-2)" "unprognostic (7.35e-2)" "unprognostic (2.86e-1)" "unprognostic (5.75e-2)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (4.81e-2)" "unprognostic (1.18e-2)" "unprognostic (9.81e-2)" 0.6 0.2 0.1 0.1 0.6 0.6 0.4 0.2 0.6 0.4 0.1 0.4 0.0 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.4 0.2 0.1 0.5 0.0 0.6 0.2 0.0 0.4 0.9 0.1 0.5 0.0 0.6 0.3 0.0 0.2 0.3 0.1 0.1 0.3 0.4 0.1 0.1 0.3 0.2 6.6 0.1 0.0 1.3 0.0 0.2 0.5 0.4 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.3 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.6 0.1 0.4 0.6 0.2 0.0 0.6 0.1 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TERB1 "CCDC79, FLJ35894" ENSG00000249961 "Telomere repeat binding bouquet formation protein 1" Q8NA31 16 66754640-66801620 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA079436 Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA079436: " "unprognostic (2.15e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (3.91e-2)" "unprognostic (9.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (7.57e-5)" "unprognostic (6.49e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-2)" "unprognostic (6.81e-6)" "unprognostic (1.66e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-1)" "unprognostic (6.14e-3)" 0.1 0.3 0.7 0.2 0.5 1.5 0.0 1.2 0.9 0.0 1.2 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.2 0.3 1.1 0.5 0.7 0.1 0.0 0.0 0.0 0.1 0.9 0.1 0.1 0.4 0.3 0.0 0.1 0.7 0.1 0.0 0.2 0.2 0.0 12.7 0.6 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.2 0.6 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.1 0.7 0.4 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.2 0.1 0.5 0.0 0.6 0.3 0.3 0.1 0.2 0.1 0.4 0.0 0.2 0.0 0.4 0.2 0.5 0.2 0.3 0.2 0.6 0.3 0.3 0.1 1.9 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.0 0.4 0.1 0.2 0.8 0.4 0.1 1.1 0.1 0.3 0.7 0.5 1.2 0.9 0.4 0.4 1.1 0.5 0.7 0.9 0.2 0.6 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AL355315.1 ENSG00000249967 "Novel protein" 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "tongue: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;EFO-21: 1.3;GAMG: 1.0;HBEC3-KT: 1.1;hTERT-RPE1: 1.9" HPA076857 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA076857: AB_2686817" 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 1.3 0.2 1.0 0.7 0.0 1.1 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158" Q8WZ71 3 45224466-45226287 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;endometrium 1: 70.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 24.5;Breast myoepithelial cells: 24.5;Endometrial stromal cells: 61.0;Muller glia cells: 87.4" "Cancer enhanced" "Detected in many" "glioma: 38.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 336.1;GAMG: 111.9;U-138 MG: 138.9;U-87 MG: 455.3" "Region enhanced" "Detected in all" "basal ganglia: 95.5" "Low region specificity" "Detected in all" HPA074974 Approved NA NA "HPA074974: AB_2732274" "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favorable (6.43e-5)" "prognostic unfavorable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 1.9 9.3 23.8 3.8 31.5 1.9 1.6 8.1 21.9 7.8 7.6 6.5 0.8 70.1 2.3 18.4 3.9 6.4 0.5 21.9 20.8 2.8 0.7 1.6 0.5 18.1 20.9 21.5 1.4 1.9 0.2 12.3 0.8 18.2 13.4 1.9 1.6 1.5 22.9 2.0 2.1 1.9 17.2 13.8 0.4 1.9 2.5 20.7 0.2 0.7 0.7 1.1 8.8 2.8 16.5 12.9 2.1 4.4 0.8 7.7 18.3 3.7 31.6 336.1 17.0 27.5 0.7 0.8 0.1 1.6 10.5 111.9 17.2 5.1 1.4 50.2 0.8 2.0 0.0 6.1 0.1 10.7 2.5 6.1 24.6 0.6 33.7 2.7 39.2 1.8 0.0 80.3 0.9 30.4 0.5 0.0 22.3 37.8 0.3 46.5 0.0 1.0 4.9 6.7 11.9 6.1 1.4 12.2 0.4 2.1 3.4 0.3 4.3 5.1 138.9 10.4 88.4 110.2 0.0 0.1 0.0 455.3 12.6 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.8 31.5 8.1 21.9 21.9 20.8 18.1 20.9 21.5 18.2 13.8 20.7 16.5 1.6 0.0 0.5 1.6 0.4 24.5 6.1 2.1 2.8 4.4 13.1 24.5 1.0 1.5 0.8 9.2 0.0 0.1 0.5 0.6 0.0 2.9 0.2 10.8 61.0 1.3 7.7 0.0 8.7 0.4 0.1 9.3 0.5 4.2 0.0 0.7 2.5 2.7 5.1 1.7 5.7 0.6 2.0 0.8 16.4 0.7 8.4 6.4 0.0 1.9 1.4 87.4 0.0 6.0 1.2 1.0 0.5 0.0 0.0 1.7 0.0 0.2 0.4 2.9 0.0 4.9 8.3 0.3 0.5 1.0 10.5 0.3 0.6 16.7 0.7 4.2 ARPIN-AP3S2 C15orf38-AP3S2 ENSG00000250021 "ARPIN-AP3S2 readthrough" 15 89834308-89912882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040513, HPA047173, HPA049270, HPA052278" Uncertain Approved Vesicles NA NA Vesicles "HPA040513: AB_2677015, HPA047173: AB_2679969, HPA049270: AB_2680696, HPA052278: AB_2681783" "unprognostic (1.27e-1)" "unprognostic (8.88e-2)" "unprognostic (4.94e-2)" "unprognostic (1.04e-1)" "unprognostic (3.25e-2)" "unprognostic (3.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.84e-1)" "unprognostic (2.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (8.35e-2)" "unprognostic (2.29e-1)" "unprognostic (4.49e-2)" 11.9 12.9 12.5 8.0 13.9 6.0 11.6 14.2 12.4 9.0 10.5 14.7 10.5 9.1 11.5 12.9 9.2 8.2 18.0 11.3 13.1 12.8 23.5 10.3 5.9 14.8 13.8 11.6 10.7 20.5 11.0 10.2 9.3 14.5 11.1 15.2 11.0 10.4 8.7 22.2 10.4 9.7 9.5 13.2 9.6 9.4 12.1 14.5 9.1 11.3 15.3 8.1 11.1 10.1 14.9 11.7 25.0 19.5 26.1 27.7 12.5 13.9 20.3 22.8 25.5 25.5 8.1 26.8 6.2 20.8 17.1 21.6 14.2 15.9 17.8 17.2 12.6 14.7 8.6 11.2 18.4 16.1 4.2 6.6 15.2 14.7 15.1 15.2 13.8 23.0 7.5 8.3 14.4 19.8 16.6 6.4 7.0 20.2 29.7 6.0 5.0 7.7 4.1 24.4 13.3 6.1 9.9 36.3 35.2 27.9 25.1 23.3 8.9 11.8 22.6 16.8 31.4 13.0 4.6 13.0 6.6 19.1 5.6 17.0 13.1 26.7 11.8 6.8 23.1 9.1 7.2 8.4 7.5 20.0 6.8 6.2 6.2 18.7 10.9 16.8 8.4 9.3 16.9 12.5 13.9 14.2 12.4 11.3 13.1 14.8 13.8 11.6 14.5 13.2 14.5 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-37 "IGKV1D37, O4" ENSG00000250036 "Immunoglobulin kappa variable 1D-37 (non-functional)" P0DSN7 2 89884740-89885216 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 12.8;stomach 1: 15.2;urinary bladder: 20.3" "Cell type enriched" "Detected in single" 11 "Plasma cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 209 "memory B-cell: 13.6;naive B-cell: 29.1" "Lineage enriched" "Detected in single" 284 "B-cells: 29.1" "Cell line enriched" "Detected in single" 5 "HDLM-2: 2.5" HPA048721 Approved "Immunoglobulin genes" NA NA 6700000000 "HPA048721: " "unprognostic (2.68e-1)" 0.1 0.0 0.0 4.2 0.0 3.3 2.5 0.0 0.0 0.8 0.0 8.7 12.8 0.1 0.4 2.1 0.2 0.5 0.3 0.4 0.0 0.1 0.4 0.8 4.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.1 0.0 0.7 1.0 0.0 7.2 0.0 0.2 0.0 6.1 0.2 0.0 6.6 15.2 0.2 0.0 1.2 0.1 0.0 2.5 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 YJEFN3 "FLJ44968, hYjeF_N3-19p13.11" ENSG00000250067 "YjeF N-terminal domain containing 3" A6XGL0 19 19528861-19537581 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 41.5;testis: 24.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 605.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 10.3;HEK 293: 12.1" HPA060789 Enhanced Approved Mitochondria NA NA Mitochondria "HPA060789: AB_2684366" "unprognostic (2.59e-2)" "unprognostic (2.50e-1)" "unprognostic (5.99e-6)" "unprognostic (1.65e-1)" "unprognostic (3.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.37e-4)" "unprognostic (2.38e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.25e-4)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.17e-2)" "unprognostic (8.26e-2)" "unprognostic (2.48e-1)" "unprognostic (9.49e-3)" 0.3 0.4 19.3 0.4 40.0 0.0 0.3 0.2 39.2 0.4 0.4 0.6 0.1 0.3 2.7 0.3 0.8 0.1 1.3 41.5 14.9 2.2 0.9 0.4 0.4 10.8 7.1 29.1 0.7 0.6 0.1 4.4 0.3 10.2 1.9 0.4 0.5 0.2 0.3 0.5 1.3 0.5 0.2 0.3 0.9 0.6 24.5 5.4 0.2 1.0 0.1 0.3 0.6 0.4 12.6 0.2 0.8 1.7 0.7 0.2 0.4 10.3 0.6 0.1 0.4 0.6 0.8 0.6 0.5 1.4 0.1 0.1 1.1 0.2 0.2 0.0 0.1 12.1 0.0 1.8 0.0 0.1 0.2 0.5 0.1 0.5 0.2 0.4 0.1 0.0 0.7 0.8 0.6 0.0 0.9 0.0 0.1 3.3 0.0 2.5 1.9 0.4 0.3 0.0 0.1 0.2 2.8 0.2 0.0 0.3 0.5 1.2 1.4 0.7 0.3 0.8 3.2 0.8 2.7 2.2 0.6 0.2 1.6 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 19.3 40.0 0.2 39.2 41.5 14.9 10.8 7.1 29.1 10.2 0.3 5.4 12.6 2.7 9.6 0.5 11.8 2.3 2.0 2.2 1.8 0.6 19.7 3.2 3.2 1.9 1.5 4.4 0.0 10.4 1.6 2.3 6.2 1.9 1.8 136.4 2.6 4.0 2.5 5.4 4.4 22.4 0.6 1.1 2.4 5.6 5.5 1.3 4.0 1.4 1.8 1.1 10.1 29.0 6.7 0.0 0.6 2.0 605.2 3.7 2.0 1.8 5.6 1.4 5.1 3.1 3.5 6.3 0.7 2.6 1.9 0.7 2.4 4.4 0.5 2.3 17.2 6.6 7.5 3.8 16.1 13.2 0.7 4.1 1.8 2.8 0.9 6.0 1.2 PCDHA10 "CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10" ENSG00000250120 "Protocadherin alpha 10" Q9Y5I2 5 140855883-141012347 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.3;pancreas: 4.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.3;Cone photoreceptor cells: 8.4;Horizontal cells: 8.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 16.2" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (4.24e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (4.70e-2)" "unprognostic (4.19e-1)" "unprognostic (2.36e-1)" "unprognostic (6.46e-2)" "unprognostic (8.24e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-2)" "unprognostic (2.65e-1)" "unprognostic (6.14e-3)" "unprognostic (1.93e-2)" "unprognostic (3.57e-3)" "unprognostic (5.21e-2)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" 0.8 0.5 1.4 0.3 1.8 0.1 0.7 6.3 2.4 0.9 0.0 0.2 0.3 1.8 2.0 0.0 1.0 1.2 0.1 1.6 1.2 1.5 0.0 0.8 0.2 2.1 1.3 1.3 1.1 4.2 0.7 1.5 0.0 2.1 0.4 0.1 2.4 0.5 0.2 0.1 0.1 0.7 1.6 1.5 0.1 0.3 1.4 1.2 0.0 2.1 0.1 0.0 0.2 0.1 2.9 0.0 0.2 0.5 3.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 16.2 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.3 1.2 0.8 0.0 0.1 0.0 2.4 0.3 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 1.8 6.3 2.4 1.6 1.2 2.1 1.3 1.3 2.1 1.5 1.2 2.9 0.9 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 7.3 1.2 1.4 0.6 1.5 0.1 0.0 8.4 0.0 0.0 0.2 0.0 0.2 3.2 0.6 2.7 0.6 1.8 0.0 0.0 0.9 0.0 0.6 0.0 0.5 0.0 0.3 0.4 0.0 0.0 8.4 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 3.2 0.0 2.5 2.3 2.2 0.3 0.0 0.0 0.0 0.2 0.3 0.1 0.3 ARPC4-TTLL3 ENSG00000250151 "ARPC4-TTLL3 readthrough" 3 9793082-9835401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.4;B-cells: 1.8;Basal squamous epithelial cells: 1.8;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.0;Macrophages: 1.5;Plasma cells: 1.7;T-cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (9.59e-3)" "unprognostic (7.61e-2)" "unprognostic (6.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.55e-3)" "unprognostic (2.86e-2)" "unprognostic (1.95e-2)" "unprognostic (2.78e-1)" "unprognostic (4.13e-2)" "unprognostic (3.31e-1)" "unprognostic (6.67e-2)" "unprognostic (1.82e-1)" "unprognostic (3.42e-4)" "unprognostic (5.49e-2)" "unprognostic (4.06e-1)" "unprognostic (2.58e-1)" "unprognostic (2.37e-4)" 1.9 1.6 1.2 2.9 1.2 6.7 1.6 1.3 3.2 2.0 1.3 1.5 2.3 1.2 0.6 2.1 1.5 1.3 1.4 1.3 1.3 1.5 1.0 1.9 2.2 1.6 1.3 1.1 1.6 0.8 1.1 1.6 1.2 1.3 1.3 0.9 0.6 1.3 0.7 1.6 2.0 2.0 1.5 1.4 3.2 1.3 1.6 1.6 2.4 1.3 0.5 2.1 1.6 1.6 1.5 2.9 0.4 3.0 1.2 3.1 4.6 8.0 3.1 3.3 2.1 2.3 1.4 1.0 3.8 1.4 9.6 4.2 1.5 3.1 2.5 2.6 6.8 1.5 6.1 1.5 0.9 4.3 6.1 9.4 5.6 3.5 5.5 2.4 2.8 3.1 5.8 4.7 4.1 3.1 0.0 3.8 4.9 3.3 1.7 2.1 5.6 2.5 0.1 4.0 3.1 1.6 2.6 2.1 4.3 3.1 1.7 0.8 13.4 4.0 1.8 2.1 3.7 4.5 4.6 6.7 9.6 3.9 5.7 3.9 0.8 2.9 3.0 2.7 2.8 1.7 1.3 1.8 1.4 3.0 1.3 1.4 1.5 3.2 1.3 3.3 2.7 1.4 3.8 1.2 1.2 1.3 3.2 1.3 1.3 1.6 1.3 1.1 1.3 1.4 1.6 1.5 0.1 0.0 2.4 0.0 1.8 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.0 3.0 0.2 0.0 0.1 1.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 1.5 0.0 0.0 0.1 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960398-37961128 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.7;Early spermatids: 5.2;Langerhans cells: 12.9;Smooth muscle cells: 3.7;Spermatocytes: 4.3;Suprabasal keratinocytes: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 0.2 0.0 0.8 0.2 1.0 1.1 0.1 0.8 0.9 0.3 0.5 1.0 0.0 0.5 0.3 0.1 0.5 0.2 0.9 1.2 0.4 0.3 0.3 0.4 0.2 0.5 0.4 0.5 0.2 0.2 0.1 0.2 0.1 0.6 0.3 0.1 0.0 0.1 0.2 0.7 0.1 0.4 0.3 0.3 0.9 0.3 0.0 0.3 0.1 0.2 0.6 0.2 0.6 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 1.0 0.8 0.9 1.2 0.4 0.5 0.4 0.5 0.6 0.3 0.3 1.3 0.3 0.0 0.0 0.0 0.8 4.7 0.7 0.7 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.0 0.6 1.5 0.0 0.0 0.0 5.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.6 12.9 0.5 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.6 3.7 4.3 0.2 0.0 2.8 0.0 0.6 0.0 0.2 0.4 AL669918.1 ENSG00000250264 "Novel protein, TAP2-HLA-DOB readthrough" 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 19.9;HDLM-2: 11.5;HEL: 9.8;U-698: 10.0" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 1.7 1.0 0.6 11.9 0.4 1.4 1.0 0.7 0.5 1.0 0.2 1.2 2.0 1.4 0.0 1.4 1.1 0.7 0.6 0.5 0.9 0.6 0.5 1.9 5.9 0.7 0.5 0.2 0.6 0.4 0.4 1.5 0.2 0.7 0.7 1.0 0.0 2.8 0.0 0.4 1.0 5.1 0.4 0.6 7.1 4.5 0.6 0.9 0.7 1.1 0.0 1.3 1.1 1.2 1.2 2.4 2.9 0.0 0.8 1.6 1.8 0.6 0.7 0.3 0.0 0.7 0.0 3.3 19.9 1.7 0.4 0.2 6.2 2.1 2.8 0.7 11.5 0.4 9.8 2.8 0.3 0.5 0.0 1.3 0.0 0.9 0.6 0.2 0.0 0.0 2.1 3.8 2.4 0.1 0.7 1.6 1.1 0.3 0.0 3.8 4.0 0.6 6.3 0.1 0.0 0.3 0.4 2.2 6.1 1.6 0.0 4.6 1.0 0.0 1.4 2.0 0.5 1.0 1.8 4.7 10.0 1.0 4.2 0.4 0.7 1.8 3.7 1.5 1.7 1.9 4.5 1.6 2.2 3.4 4.5 1.2 2.6 4.1 1.3 3.0 3.1 2.5 3.3 0.6 0.4 0.7 0.5 0.5 0.9 0.7 0.5 0.2 0.7 0.6 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GIMD1 ENSG00000250298 "GIMAP family P-loop NTPase domain containing 1" P0DJR0 4 106357392-106368778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 115.5;choroid plexus: 300.0" "Cell type enhanced" "Detected in some" "Club cells: 9.9;Collecting duct cells: 14.7;Distal tubular cells: 11.7;Endometrial ciliated cells: 35.1;Glandular and luminal cells: 18.7;Respiratory ciliated cells: 14.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Region enhanced" "Detected in all" "cerebellum: 115.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.0;BJ: 8.7;fHDF/TERT166: 11.9;RPTEC TERT1: 4.0;SCLC-21H: 4.3;U-266/84: 4.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 31.1" HPA024673 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favorable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 1.3 0.4 7.4 0.6 7.2 0.3 2.3 115.5 8.3 1.6 300.0 1.1 0.7 1.0 0.9 0.9 2.0 1.6 5.4 26.4 6.3 3.5 2.3 1.8 0.4 4.4 15.7 3.2 0.3 2.3 1.6 1.4 0.4 35.5 1.2 1.2 24.7 2.6 1.0 3.2 3.3 1.2 0.4 4.4 1.5 1.1 1.2 12.4 0.2 34.0 1.6 0.3 0.9 0.8 5.4 0.1 0.0 6.0 0.0 0.0 0.0 1.4 8.7 2.0 1.2 0.6 0.0 0.1 0.1 0.4 11.9 1.1 0.2 0.1 0.2 1.2 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.6 0.2 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.1 0.7 0.1 0.0 1.0 0.0 0.1 4.0 0.1 4.3 0.1 0.0 0.0 0.1 1.9 0.1 0.0 0.0 0.1 0.8 0.8 0.1 0.2 4.4 0.0 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 7.4 7.2 115.5 8.3 26.4 6.3 4.4 15.7 3.2 35.5 4.4 12.4 5.4 6.2 6.4 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 6.7 0.0 0.0 9.9 14.7 0.0 1.0 0.2 0.0 11.7 2.3 0.0 35.1 6.4 2.1 0.0 0.0 0.0 1.1 0.2 1.8 0.0 18.7 1.3 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.3 14.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 ZNF718 FLJ90036 ENSG00000250312 "Zinc finger protein 718" Q3SXZ3 4 124501-202303 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 37.5;Excitatory neurons: 40.1;Inhibitory neurons: 58.2;Microglial cells: 47.8;Oligodendrocyte precursor cells: 62.8;Oligodendrocytes: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 19.3" NA Yes "unprognostic (1.96e-1)" "unprognostic (1.38e-1)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (3.62e-2)" "unprognostic (6.59e-3)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.60e-1)" "unprognostic (8.97e-2)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.67e-6)" "unprognostic (1.39e-1)" "unprognostic (6.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" 1.8 3.0 1.9 2.2 1.9 3.0 2.7 3.5 2.5 3.3 0.8 2.5 1.7 2.3 2.2 1.8 2.9 2.0 1.9 1.4 2.3 2.5 1.4 2.0 3.9 2.1 2.6 1.2 3.6 2.6 2.7 2.0 2.9 2.1 3.0 2.2 2.7 2.2 2.2 1.0 3.0 1.9 1.9 1.8 2.9 1.9 2.1 2.8 4.6 4.8 1.8 3.4 2.0 2.4 3.8 0.0 0.9 5.4 0.0 3.3 6.2 1.3 6.9 0.9 4.3 3.3 5.9 7.7 8.5 4.0 2.5 7.6 2.0 4.4 3.2 5.8 0.0 1.6 0.0 1.5 0.0 4.1 0.1 0.1 3.2 2.8 4.3 0.6 3.9 2.9 2.4 4.1 0.1 7.6 4.4 0.8 5.3 6.6 0.0 2.4 19.3 2.1 4.7 3.5 2.1 7.3 1.7 3.5 1.2 4.2 4.3 12.5 1.6 2.1 3.2 4.0 4.1 5.1 0.0 0.0 13.3 0.0 0.0 4.0 2.6 1.3 5.7 2.2 1.8 2.1 2.0 1.9 1.4 2.4 2.2 2.2 2.1 1.6 5.4 1.1 2.4 1.6 1.2 1.9 1.9 3.5 2.5 1.4 2.3 2.1 2.6 1.2 2.1 1.8 2.8 3.8 4.0 3.2 3.6 37.5 6.5 2.0 2.2 1.4 4.6 8.4 3.5 3.0 2.4 0.0 5.1 0.0 2.1 1.9 7.6 1.2 0.0 3.1 0.3 1.0 3.7 3.4 1.2 9.7 40.1 1.4 1.4 3.6 4.1 1.6 5.7 6.6 6.1 0.9 1.4 8.4 58.2 0.7 0.0 1.6 1.9 0.7 3.7 2.9 3.6 47.8 1.7 2.6 15.5 62.8 85.0 1.6 0.1 4.5 4.6 0.9 0.5 1.4 2.6 5.1 0.0 4.4 3.8 2.4 4.1 3.0 0.9 1.4 5.5 4.0 0.8 1.4 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 27.9 37.0 34.3 16.8 34.6 13.3 27.4 35.8 50.6 21.8 37.2 31.0 40.2 24.1 72.8 15.8 24.0 24.1 43.0 33.6 36.0 45.0 38.5 19.9 30.6 35.5 33.6 32.6 34.2 43.8 28.5 17.7 14.2 34.4 24.1 25.7 30.1 35.4 17.7 96.8 13.2 35.4 18.0 35.1 23.8 38.9 20.7 34.7 17.5 31.7 61.9 25.0 29.1 19.3 37.0 29.9 24.5 32.3 31.3 34.9 75.4 43.0 28.4 34.3 24.0 30.4 21.9 51.6 48.8 48.1 31.7 49.6 8.5 37.9 36.3 33.4 27.9 30.1 28.3 16.4 42.0 59.1 34.0 18.0 53.9 71.6 30.6 46.1 46.7 18.7 32.5 45.9 15.5 29.6 19.1 37.0 57.5 61.0 39.6 36.1 30.1 42.0 31.7 53.5 21.6 41.3 38.4 18.3 12.7 66.0 35.2 26.3 47.5 31.4 25.8 30.5 29.3 36.8 30.2 26.9 52.6 39.2 35.6 33.4 30.6 31.5 15.9 26.2 37.7 34.5 47.3 37.5 33.2 36.9 47.9 50.4 41.1 16.3 35.6 29.4 38.3 42.9 31.7 34.3 34.6 35.8 50.6 33.6 36.0 35.5 33.6 32.6 34.4 35.1 34.7 37.0 21.5 9.6 41.6 9.4 48.0 21.9 30.4 89.4 26.7 7.7 49.8 63.1 61.8 61.5 59.0 36.8 8.4 63.7 22.5 50.9 131.0 70.0 11.5 34.7 30.6 23.1 19.3 9.2 3.8 62.5 59.7 40.0 31.6 34.6 10.8 37.1 21.8 66.5 69.7 1.7 4.6 64.0 59.0 62.9 32.1 23.1 37.6 44.5 44.4 4.7 42.9 95.3 38.1 9.5 7.9 46.2 44.6 48.2 38.4 38.9 130.1 166.5 47.0 22.2 72.3 26.8 35.8 44.5 36.4 27.3 19.5 43.8 29.8 71.2 65.4 30.8 AF241726.1 ENSG00000250349 "Novel proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1) and tetraspanin 7 (TSPAN7) protein" X 37349330-38687674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.8;skeletal muscle: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;JURKAT: 1.4;RPTEC TERT1: 2.1" HPA003140 Uncertain NA NA "HPA003140: AB_1078454" 0.6 0.2 0.4 0.0 1.0 0.0 0.0 1.7 0.8 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.8 0.2 0.1 0.1 0.0 1.6 1.0 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.1 0.1 0.0 4.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.0 0.1 0.1 0.7 0.0 0.1 0.0 2.8 1.1 0.2 0.2 0.1 0.4 0.2 0.0 0.2 0.6 0.1 0.3 1.4 0.2 0.0 0.9 0.2 0.1 0.1 1.2 0.7 0.1 0.3 0.8 0.6 0.1 0.0 0.5 0.0 0.0 0.7 0.4 0.2 0.2 0.1 0.4 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.0 2.1 0.0 0.2 0.0 0.4 0.2 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.7 0.8 0.4 0.8 1.6 1.0 0.2 1.5 1.5 1.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GYPB "CD235b, GPB, MNS, SS" ENSG00000250361 "Glycophorin B (MNS blood group)" P06028 4 143996104-144019380 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "bone marrow: 63.7" "Cell type enriched" "Detected in some" 450 "Erythroid cells: 1351.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 159.0" "Intracellular and membrane" NA NA 0.1 0.0 0.1 0.0 0.6 63.7 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.3 0.5 0.5 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.2 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.4 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.6 0.0 1.0 0.5 0.2 0.1 0.0 0.7 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.1 0.1 0.0 1351.4 3.0 0.0 1.2 0.2 0.0 0.0 0.0 2.1 0.0 0.9 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 TUNAR "HI-LNC78, LINC00617, TUNA" ENSG00000250366 "TCL1 upstream neural differentiation-associated RNA" 14 95876392-95925663 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 34.4;fallopian tube: 8.6;retina: 8.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.1;Endometrial ciliated cells: 11.5;Endometrial stromal cells: 8.9;Excitatory neurons: 4.6;Glandular and luminal cells: 16.8;Spermatogonia: 3.5" "Cancer enhanced" "Detected in many" "testis cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 16.3;HAP1: 7.0;NTERA-2: 11.8;SCLC-21H: 16.1;SuSa: 4.6" NA NA "unprognostic (1.28e-3)" "unprognostic (3.94e-1)" "unprognostic (4.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.55e-4)" "unprognostic (5.33e-2)" "unprognostic (2.92e-2)" "unprognostic (1.18e-1)" 0.0 0.1 7.3 0.1 34.4 0.3 0.4 6.3 11.3 0.3 0.1 0.0 0.1 6.6 0.1 0.0 8.6 0.1 0.0 10.5 9.9 0.2 0.0 0.0 0.3 28.4 13.9 7.3 0.1 2.7 0.0 1.3 0.0 32.4 0.0 0.0 8.6 0.0 3.6 0.0 0.1 0.0 0.0 6.2 0.1 0.5 1.3 27.1 0.1 1.1 0.0 0.2 0.0 0.0 33.9 0.0 0.1 16.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 7.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 11.8 0.0 0.1 0.7 0.0 0.0 0.4 0.1 16.1 1.3 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 34.4 6.3 11.3 10.5 9.9 28.4 13.9 7.3 32.4 6.2 27.1 33.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.0 2.8 11.5 8.9 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRIM75P TRIM75 ENSG00000250374 "Tripartite motif containing 75, pseudogene" A6NK02 4 165053864-165060554 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 8 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "BEWO: 1.7" NA NA "unprognostic (8.51e-2)" "unprognostic (2.81e-2)" "unprognostic (1.94e-3)" "unprognostic (3.29e-2)" "unprognostic (3.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 39.7;seminal vesicle: 20.0;testis: 31.1" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.0" "Not detected" "Not detected" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 1.6 39.7 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 20.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.0 1.9 25.2 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.6 0.0 11.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 11.5 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.4 1.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 AC004691.2 ENSG00000250424 "Novel protein, MINDY4 and AQP1 readthrough" 7 30852273-30923812 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019206, HPA030130" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019206: AB_1844965, HPA030130: AB_10601565" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" "unprognostic (2.72e-4)" "unprognostic (5.13e-2)" "unprognostic (3.44e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-2)" "unprognostic (3.76e-1)" "unprognostic (2.49e-1)" "unprognostic (3.71e-2)" 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.0 0.4 0.4 0.4 0.4 0.2 0.6 0.9 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHCHD10 "C22orf16, MIX17A, N27C7-4" ENSG00000250479 "Coiled-coil-helix-coiled-coil-helix domain containing 10" Q8WYQ3 22 23765834-23767972 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1332.6;skeletal muscle: 1231.0" "Cell type enhanced" "Detected in all" "Distal enterocytes: 1264.7;Distal tubular cells: 2498.5;Hepatocytes: 1879.9;Proximal enterocytes: 1501.3;Proximal tubular cells: 1437.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003440 Enhanced Supported Mitochondria NA NA Mitochondria "HPA003440: AB_1078348" "unprognostic (3.88e-2)" "unprognostic (2.36e-3)" "unprognostic (8.90e-2)" "unprognostic (9.80e-2)" "unprognostic (7.68e-2)" "unprognostic (5.97e-3)" "unprognostic (1.59e-1)" "unprognostic (1.85e-1)" "unprognostic (2.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" "prognostic favorable (2.15e-7)" "unprognostic (5.19e-3)" "unprognostic (2.06e-1)" "unprognostic (5.68e-3)" "unprognostic (2.62e-3)" 166.0 137.6 171.0 30.6 164.2 12.6 145.7 166.2 250.8 75.1 220.6 220.7 93.4 35.8 32.7 148.5 43.5 11.0 1332.6 162.9 169.0 384.6 796.2 57.4 28.8 164.9 163.2 143.6 29.2 119.0 221.9 113.1 12.0 172.2 107.3 77.0 63.7 149.5 51.0 1231.0 72.4 160.3 18.1 149.9 101.1 161.5 28.0 183.9 14.2 226.5 666.5 34.8 111.1 89.9 165.0 33.1 66.4 19.7 85.9 42.1 27.7 41.9 11.9 22.8 23.5 28.4 124.1 35.1 113.5 30.7 41.2 12.9 99.8 109.2 34.1 20.5 35.9 140.6 22.5 48.8 117.1 73.8 63.6 108.2 53.3 91.9 35.6 9.3 4.9 29.0 17.2 47.7 48.0 20.6 121.8 21.8 48.2 16.9 194.9 183.5 90.0 4.0 209.0 112.7 55.3 41.3 23.8 13.9 145.7 149.7 36.6 54.9 47.0 15.3 1.0 1.1 18.3 0.2 28.8 11.1 62.5 20.5 54.9 11.2 0.2 4.1 11.2 3.0 9.1 1.9 11.7 3.2 4.0 1.8 10.6 4.9 3.5 0.0 0.8 8.2 7.3 4.3 1.2 171.0 164.2 166.2 250.8 162.9 169.0 164.9 163.2 143.6 172.2 149.9 183.9 165.0 88.7 12.8 10.5 36.2 294.8 48.2 415.4 28.2 144.5 136.2 156.9 238.2 503.8 268.8 20.5 419.3 114.7 42.5 104.7 1264.7 2498.5 88.1 27.0 76.6 229.8 47.4 310.5 74.3 38.5 54.5 255.7 67.8 300.7 94.3 84.0 171.9 78.1 1879.9 647.5 99.3 37.6 860.9 26.4 262.1 127.5 18.0 48.7 243.1 373.5 15.9 107.8 188.5 25.7 17.1 17.4 45.9 890.1 29.3 297.3 192.4 1501.3 1437.4 10.0 287.8 124.9 254.0 200.4 32.3 43.4 459.3 43.9 105.2 123.0 216.0 952.4 470.1 CDK3 ENSG00000250506 "Cyclin dependent kinase 3" Q00526 17 76000906-76005999 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 5.3;Breast myoepithelial cells: 5.0;Glandular and luminal cells: 5.2;Granulosa cells: 6.3;Ionocytes: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA007420 Uncertain Approved Cytosol NA NA Cytosol "HPA007420: AB_1078490" "unprognostic (6.77e-2)" "unprognostic (1.26e-1)" "unprognostic (3.69e-2)" "unprognostic (1.87e-3)" "unprognostic (6.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.61e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-3)" "unprognostic (1.34e-1)" "unprognostic (9.80e-5)" "unprognostic (1.19e-2)" "unprognostic (6.75e-7)" "unprognostic (4.25e-2)" "unprognostic (1.63e-2)" "unprognostic (4.68e-1)" "unprognostic (4.47e-4)" 12.0 11.1 11.6 7.7 11.7 10.7 12.3 11.6 13.9 15.6 12.2 11.8 10.5 11.6 10.8 11.1 13.8 10.4 8.3 11.3 12.4 17.4 35.0 14.3 10.6 12.0 11.8 11.1 16.0 15.2 4.8 19.9 8.9 12.1 25.9 10.2 7.0 13.7 8.4 3.6 24.9 14.8 7.7 11.8 22.1 12.3 15.7 11.7 5.8 19.7 3.4 10.6 10.9 13.4 13.7 5.5 7.5 13.5 6.5 7.3 9.0 26.1 4.6 4.6 8.0 7.4 7.0 11.0 6.5 4.5 5.7 4.6 11.6 10.2 4.1 5.6 3.3 14.1 12.7 17.8 7.3 6.7 5.9 14.9 8.7 10.8 7.3 5.1 13.0 6.9 4.1 5.6 4.5 4.3 12.1 6.3 21.8 6.3 3.8 8.4 10.4 5.2 7.2 6.9 15.8 8.4 22.0 3.8 12.0 3.2 14.2 17.4 10.9 5.5 16.4 9.6 5.4 6.7 9.9 7.2 6.2 5.4 5.5 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 11.6 11.7 11.6 13.9 11.3 12.4 12.0 11.8 11.1 12.1 11.8 11.7 13.7 4.3 0.0 0.0 0.0 0.5 2.7 0.0 4.0 0.0 0.0 5.3 5.0 0.3 0.0 2.2 0.0 0.0 0.0 3.1 0.0 1.9 2.0 0.0 2.9 3.9 1.4 0.0 0.0 0.0 2.3 0.0 1.3 0.0 5.2 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 4.4 0.0 0.0 1.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 1.2 2.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.7 0.0 1.0 2.8 0.0 0.0 GPR162 "A-2, GRCA" ENSG00000250510 "G protein-coupled receptor 162" Q16538 12 6821624-6829972 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 181.7;choroid plexus: 101.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 86.3;Excitatory neurons: 36.8;Horizontal cells: 40.4;Inhibitory neurons: 32.9;Muller glia cells: 55.9;Respiratory ciliated cells: 56.2" "Cancer enriched" "Detected in many" 6 "glioma: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 6.9;intermediate monocyte: 4.3;neutrophil: 17.4" "Group enriched" "Detected in many" 6 "granulocytes: 17.4;monocytes: 6.9" "Cell line enhanced" "Detected in many" "AF22: 17.7;AN3-CA: 21.1;hTERT-RPE1: 18.1;NTERA-2: 19.8;SH-SY5Y: 13.5;U-2 OS: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055135 Enhanced Approved "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA055135: AB_2682710" "unprognostic (4.76e-2)" "unprognostic (8.00e-2)" "unprognostic (8.24e-3)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (2.38e-1)" "unprognostic (4.78e-2)" "unprognostic (2.25e-2)" "unprognostic (5.83e-3)" "unprognostic (1.18e-1)" "prognostic favorable (4.29e-5)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.37e-6)" "unprognostic (3.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.64e-2)" 3.8 6.9 108.4 4.5 119.6 1.3 2.8 109.4 181.7 4.9 101.3 12.5 3.1 7.7 2.5 2.3 18.4 6.0 11.0 137.5 105.4 4.8 6.3 17.8 1.5 98.2 97.8 119.8 5.8 2.5 10.6 32.0 4.4 107.1 5.9 2.8 20.8 1.4 1.7 1.5 1.4 8.1 6.0 90.4 6.7 5.0 1.5 101.4 1.5 2.9 1.1 0.7 7.3 2.8 114.7 0.0 3.9 17.7 21.1 1.9 1.3 0.1 1.3 4.6 3.9 2.3 0.4 0.0 0.0 0.1 2.6 0.1 0.1 2.8 0.0 1.9 0.0 1.3 2.1 0.2 0.0 3.0 0.4 0.0 3.2 0.0 6.0 0.3 18.1 10.9 1.6 1.0 0.1 1.5 0.0 0.5 1.5 19.8 0.0 0.1 0.0 2.2 3.9 1.3 0.0 1.5 13.5 0.0 0.0 0.6 12.0 0.1 5.3 7.4 2.7 16.1 1.4 2.5 0.0 1.3 0.1 2.9 3.8 0.3 0.0 6.9 0.0 0.0 4.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 17.4 0.0 1.5 1.7 0.0 1.9 108.4 119.6 109.4 181.7 137.5 105.4 98.2 97.8 119.8 107.1 90.4 101.4 114.7 0.5 0.0 0.0 11.8 0.3 0.8 0.2 2.3 0.0 86.3 3.6 1.3 3.8 1.5 2.6 1.8 4.2 0.1 0.0 0.0 1.9 0.0 0.1 9.3 5.6 3.5 0.0 0.4 36.8 0.0 0.1 2.9 0.0 0.3 0.0 0.6 6.1 1.5 2.6 40.4 32.9 0.0 2.0 3.7 3.4 0.6 7.5 5.2 0.0 6.5 4.2 55.9 0.0 23.1 3.7 0.1 0.0 14.7 0.1 0.5 0.0 1.9 56.2 9.0 0.0 0.5 8.1 0.0 0.2 0.2 0.1 0.3 0.2 1.3 0.1 0.1 ATP6V1E2 "ATP6E1, ATP6EL2, ATP6V1EL2, MGC9341, VMA4" ENSG00000250565 "ATPase H+ transporting V1 subunit E2" Q96A05 2 46490750-46542577 "Metabolic proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 28.6" "Group enriched" "Detected in many" 10 "Early spermatids: 350.9;Late spermatids: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 19.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075092 Enhanced NA NA "HPA075092: " "unprognostic (1.62e-1)" "unprognostic (9.65e-3)" "unprognostic (4.31e-2)" "unprognostic (4.39e-3)" "unprognostic (1.02e-1)" "unprognostic (1.52e-2)" "unprognostic (4.52e-3)" "unprognostic (8.56e-2)" "unprognostic (2.98e-1)" "unprognostic (5.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.58e-1)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (9.32e-2)" 1.8 2.3 4.2 1.4 4.2 0.9 2.1 3.7 4.4 1.5 3.2 1.4 0.5 1.5 6.5 1.3 1.4 0.7 1.4 3.9 3.7 1.5 2.0 1.2 1.7 4.1 3.9 3.6 1.7 2.8 1.7 2.8 1.1 4.4 3.0 0.7 2.4 2.4 1.6 3.5 2.7 1.4 0.8 3.9 2.0 1.6 28.6 3.9 1.3 1.4 1.4 1.6 1.8 1.6 4.1 8.6 5.5 1.8 4.2 1.7 3.1 0.9 2.9 1.1 1.3 0.6 1.7 1.4 5.1 5.2 2.8 4.2 2.0 4.2 2.1 2.8 7.8 3.3 1.2 1.0 1.2 1.9 2.2 2.4 2.6 19.2 1.8 4.0 1.5 1.3 5.4 3.6 8.8 0.9 5.6 1.5 6.6 3.5 4.4 4.6 3.7 4.4 6.4 2.6 1.9 4.8 10.3 1.9 2.0 4.3 3.0 1.3 1.0 1.3 1.4 5.1 2.5 2.1 4.3 3.7 5.3 2.0 6.6 2.3 0.0 0.8 0.2 0.8 0.4 1.1 0.8 1.5 1.6 0.7 1.0 1.1 1.6 0.5 0.3 0.5 1.7 1.0 0.5 4.2 4.2 3.7 4.4 3.9 3.7 4.1 3.9 3.6 4.4 3.9 3.9 4.1 4.7 3.2 0.5 5.5 12.9 5.7 11.3 1.7 8.6 11.8 14.8 18.5 6.7 5.7 2.4 3.7 12.5 2.9 4.0 2.5 9.8 3.3 350.9 3.8 7.8 3.1 3.5 2.5 7.2 3.3 2.2 9.8 5.1 3.9 0.0 5.0 5.0 2.7 2.2 18.5 6.8 2.1 0.0 7.7 5.1 196.3 9.9 5.9 5.4 1.0 7.0 16.5 6.2 4.5 7.4 3.3 0.1 6.8 7.0 5.5 0.3 7.1 3.9 25.8 6.6 6.8 7.4 7.7 10.4 5.0 8.1 0.8 7.8 2.7 3.1 3.8 GLI4 "HKR4, ZNF928" ENSG00000250571 "GLI family zinc finger 4" P10075 8 143267433-143276931 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023131 Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA023131: AB_2671080" "unprognostic (4.98e-2)" "unprognostic (2.69e-1)" "unprognostic (5.64e-3)" "unprognostic (1.65e-1)" "unprognostic (9.07e-2)" "unprognostic (2.71e-2)" "unprognostic (1.00e-2)" "unprognostic (4.57e-2)" "unprognostic (2.22e-1)" "unprognostic (2.65e-1)" "unprognostic (7.45e-3)" "unprognostic (5.03e-1)" "unprognostic (6.88e-3)" "unprognostic (4.61e-2)" "unprognostic (1.23e-1)" "unprognostic (3.21e-2)" "unprognostic (3.71e-3)" 11.2 6.6 7.3 4.8 6.0 5.8 10.8 5.9 15.6 12.1 1.6 10.6 6.5 10.4 2.1 12.9 10.3 2.8 11.9 8.0 4.5 13.7 12.1 7.0 5.7 6.4 5.7 5.7 13.5 12.7 4.6 9.4 2.1 6.8 13.6 3.7 2.6 9.3 3.9 9.3 12.8 10.5 1.8 3.1 11.7 11.6 10.5 5.4 5.6 10.2 2.0 4.8 11.3 11.2 5.9 6.7 13.5 6.2 9.9 9.9 4.1 7.0 3.9 2.3 2.9 3.5 3.9 19.1 8.7 7.2 6.5 4.2 8.7 3.4 4.3 1.9 15.3 10.3 13.4 7.1 4.6 7.1 4.2 4.3 12.9 2.3 4.0 8.5 6.7 6.4 13.2 7.2 14.1 8.0 18.5 19.7 3.5 5.8 12.8 19.0 11.9 2.9 8.8 7.0 15.0 6.0 7.0 11.7 5.0 8.2 5.7 22.1 1.9 3.6 4.3 12.1 6.2 4.1 18.6 9.7 7.0 7.0 8.0 7.3 0.0 0.3 0.0 0.3 0.3 0.6 0.4 0.4 0.2 0.1 0.3 0.6 0.2 0.3 1.1 0.0 1.1 0.6 0.2 7.3 6.0 5.9 15.6 8.0 4.5 6.4 5.7 5.7 6.8 3.1 5.4 5.9 9.5 0.0 0.0 13.1 11.2 7.4 12.7 1.3 13.6 14.6 10.9 12.2 2.0 12.8 1.1 12.9 20.9 5.0 20.6 15.4 25.4 2.6 6.3 8.2 10.6 6.8 11.5 5.9 7.2 4.0 4.5 9.5 11.7 7.3 4.5 15.8 8.9 7.7 7.2 6.7 8.4 7.6 2.0 10.1 5.7 4.3 16.1 9.9 8.8 12.2 6.9 11.9 13.4 4.5 15.5 3.6 17.9 16.6 8.8 9.4 16.4 20.1 2.3 11.9 6.6 11.2 10.6 13.4 14.7 15.8 10.7 2.9 11.9 14.6 13.7 9.9 LY6G6F-LY6G6D "G6F-LY6G6D, MEGT-1, MEGT1" ENSG00000250641 "LY6G6F-LY6G6D readthrough" 6 31706904-31717918 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "skin 1: 3.4;testis: 2.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 9.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA008053 Uncertain NA NA "HPA008053: AB_1840160" "unprognostic (5.02e-2)" "unprognostic (1.31e-1)" "unprognostic (3.47e-1)" "unprognostic (5.90e-2)" "unprognostic (1.07e-2)" "unprognostic (2.66e-1)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068580.4 ENSG00000250644 "Novel protein" 11 1734821-1763954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 204.5;liver: 54.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;granulocytes: 1.3;Macrophages: 1.7;Respiratory ciliated cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 241.6;hTERT-RPE1: 212.9;U-87 MG: 63.6" HPA003001 Uncertain NA NA "HPA003001: AB_1078404" "unprognostic (5.71e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-6)" "unprognostic (1.77e-2)" "unprognostic (5.21e-2)" "unprognostic (6.20e-2)" "unprognostic (4.05e-3)" "unprognostic (1.45e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.45e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-3)" "unprognostic (8.30e-4)" "unprognostic (7.35e-2)" "unprognostic (5.79e-5)" "unprognostic (7.47e-2)" 7.5 204.5 11.2 2.2 14.0 13.5 7.7 15.0 21.4 3.9 3.1 3.7 2.8 4.0 6.8 7.0 3.3 10.0 3.6 11.4 10.1 20.3 54.5 11.6 1.9 15.6 11.2 10.5 2.5 3.2 0.8 2.5 7.1 18.7 7.7 2.2 2.2 14.3 15.3 20.8 14.7 6.6 1.3 15.5 30.4 4.6 8.6 13.7 1.1 1.6 3.2 2.9 16.0 11.2 20.1 1.2 9.0 0.5 1.8 4.2 2.3 2.5 3.2 4.2 0.9 1.1 2.2 241.6 0.5 4.1 13.4 8.3 18.5 0.4 0.3 0.3 1.1 4.6 1.7 1.3 0.9 4.2 2.5 5.0 9.6 2.7 1.1 1.7 212.9 0.6 0.9 0.3 4.0 22.9 23.1 0.0 3.2 1.1 10.9 1.6 0.5 3.6 2.1 10.0 11.3 0.9 49.2 1.6 18.8 32.6 0.6 41.4 1.1 5.9 12.2 1.8 2.8 4.3 10.9 25.8 0.5 63.6 2.2 10.2 1.3 5.9 1.7 1.5 2.5 1.1 0.3 0.7 1.0 1.6 0.1 1.1 1.6 5.8 7.0 3.4 3.0 0.9 5.0 11.2 14.0 15.0 21.4 11.4 10.1 15.6 11.2 10.5 18.7 15.5 13.7 20.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 REELD1 ENSG00000250673 "Reeler domain containing 1" A0A1B0GV85 4 146214515-146230878 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 88 "HDLM-2: 9.6" "Low region specificity" "Detected in single" NA NA "unprognostic (6.26e-3)" "unprognostic (1.40e-1)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (3.77e-2)" "unprognostic (7.75e-2)" "unprognostic (7.88e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.40e-1)" "unprognostic (3.55e-6)" "unprognostic (2.19e-2)" "unprognostic (3.14e-1)" "unprognostic (3.90e-1)" "unprognostic (3.13e-2)" 0.6 0.2 0.2 0.2 0.3 0.1 0.7 0.3 0.5 0.3 0.2 0.1 0.0 0.2 0.3 0.1 0.5 0.0 0.3 0.3 0.3 0.5 0.6 0.4 0.0 0.3 0.3 0.3 0.2 0.4 0.0 0.1 0.0 0.5 0.6 0.0 0.4 0.3 0.0 0.4 0.5 0.6 0.0 0.3 1.3 0.2 0.5 0.3 0.0 0.2 0.0 0.2 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 CCDC169-SOHLH2 C13orf38-SOHLH2 ENSG00000250709 "CCDC169-SOHLH2 readthrough" 13 36168794-36297842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 10.3" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Inhibitory neurons: 1.2;Late spermatids: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;HL-60: 2.6;NB-4: 1.5;U-937: 2.0" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (5.56e-2)" "unprognostic (3.93e-1)" "unprognostic (3.60e-2)" "unprognostic (4.66e-1)" "unprognostic (2.17e-1)" "unprognostic (1.84e-2)" "unprognostic (6.12e-2)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 10.3 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.4 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P3R3URF ENSG00000250719 "PIK3R3 upstream reading frame" A0A087WWA1 1 46175486-46176488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "testis: 142.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "intestine: 2105.2;liver: 6319.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7" "Cancer enriched" "Detected in all" 4 "liver cancer: 116.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "Hep G2: 567.4;HSkMC: 451.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 1800000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 725.6 428.3 175.3 181.6 329.4 40.4 623.7 382.8 292.5 463.9 184.2 650.1 625.6 339.0 463.7 242.9 379.9 676.3 239.3 168.0 247.7 861.5 6319.6 516.6 557.0 518.9 332.0 147.7 707.5 230.9 248.0 109.2 981.2 448.7 216.1 721.0 59.7 172.3 377.6 157.8 173.2 2105.2 235.2 356.2 957.0 259.4 88.6 298.2 172.0 148.4 267.9 178.9 418.2 214.9 549.3 0.7 1.7 7.7 1.0 43.6 12.2 7.3 4.1 10.9 0.0 0.0 12.5 65.3 2.0 36.3 1.5 1.4 1.7 0.2 0.1 0.0 2.4 52.7 3.1 0.2 567.4 25.9 3.2 0.4 451.1 0.7 0.0 0.1 1.9 0.1 1.5 6.4 12.9 23.5 1.3 1.1 6.4 30.6 17.0 0.9 1.3 2.0 100.8 12.5 8.0 2.2 2.7 2.7 16.7 1.6 54.6 125.4 0.7 0.7 3.2 1.7 5.2 1.0 8.4 1.5 2.0 1.7 5.9 1.5 0.1 0.1 0.5 0.5 0.1 0.6 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.5 0.6 0.2 0.9 0.3 0.3 175.3 329.4 382.8 292.5 168.0 247.7 518.9 332.0 147.7 448.7 356.2 298.2 549.3 312.7 448.7 529.3 0.0 15.2 0.0 0.0 0.0 0.0 0.0 312.0 271.1 0.0 0.0 102.1 125.0 0.0 223.4 9.4 0.0 197.6 73.4 0.0 83.8 231.0 75.8 0.0 0.0 0.0 52.8 17.5 358.7 0.0 116.1 26.5 458.1 0.0 0.0 858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 373.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 4.9 0.0 0.0 1044.7 52.5 0.0 0.0 0.0 133.1 0.0 0.0 0.0 0.0 112.9 10.0 361.8 0.0 0.0 NT5C1B-RDH14 ENSG00000250741 "NT5C1B-RDH14 readthrough" 2 18555545-18589564 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 126 "testis: 16.7" "Group enriched" "Detected in some" 97 "Early spermatids: 52.3;Late spermatids: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056683 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA056683: AB_2683207" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L20 ENSG00000250745 "Ubiquitin specific peptidase 17 like family member 20" D6RJB6 4 9258124-9259716 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 1.7 0.6 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.1 1.3 0.6 1.7 0.6 0.7 1.0 0.5 0.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L14 ENSG00000250782 "TATA-box binding protein associated factor 11 like 14" 5 17634460-17635053 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-2 OS: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "kidney: 140.3;liver: 175.0" "Group enriched" "Detected in some" 13 "Hepatocytes: 157.6;Proximal tubular cells: 559.9" "Cancer enriched" "Detected in some" 5 "liver cancer: 28.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "Hep G2: 33.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA051287 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051287: AB_2681420" "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.3 175.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.9 1.5 0.0 12.9 0.0 0.0 0.0 0.0 27.4 0.0 2.8 0.3 0.0 0.3 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 157.6 0.1 0.0 0.1 0.0 0.0 4.7 0.0 0.9 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 559.9 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 AC010255.2 ENSG00000250803 "Zinc finger protein 474-like" 5 122129622-122183949 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 56 "testis: 101.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 7.5" NA NA "unprognostic (8.24e-2)" "unprognostic (3.81e-3)" "unprognostic (3.43e-2)" "unprognostic (1.42e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-1)" "unprognostic (4.18e-1)" "unprognostic (5.54e-2)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.2 0.6 0.3 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 101.9 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.3 0.5 0.0 0.4 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EXOC1L ENSG00000250821 "Exocyst complex component 1 like" A0A1B0GW35 4 55819790-55837489 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "Theca cells: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 20 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 20 "NK-cells: 1.9" "Cell line enhanced" "Detected in single" "HEK 293: 1.5" "Region enriched" "Detected in single" 4 "pons and medulla: 2.8" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 USP17L18 ENSG00000250844 "Ubiquitin specific peptidase 17 like family member 18" D6R9N7 4 9248630-9250222 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L23 ENSG00000250913 "Ubiquitin specific peptidase 17 like family member 23" D6RBM5 4 9272364-9272914 "Enzymes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC083800.1 ENSG00000251012 "Novel chromosome 3 open reading frame 30 (C3orf30) and uroplakin 1B (UPK1B)" 3 119147375-119187807 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV2D-40 ENSG00000251039 "Immunoglobulin kappa variable 2D-40" P01614 2 89851791-89852497 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 124.3" "Cell type enriched" "Detected in some" 489 "Plasma cells: 1517.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 30.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 494 "memory B-cell: 134.9;naive B-cell: 96.8" "Lineage enriched" "Detected in single" 575 "B-cells: 134.9" "Cell line enhanced" "Detected in single" "Daudi: 3.7" "Immunoglobulin genes" NA NA 1900000000 "prognostic favorable (5.01e-4)" "unprognostic (1.16e-2)" "unprognostic (8.37e-2)" "unprognostic (6.04e-2)" "prognostic favorable (9.78e-7)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (2.32e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (3.59e-2)" "unprognostic (3.02e-1)" "unprognostic (2.91e-1)" "unprognostic (1.25e-1)" 1.7 1.5 0.0 21.2 0.0 14.9 13.6 0.0 0.1 10.1 0.0 16.8 7.0 3.1 0.0 35.9 14.5 7.8 2.0 0.0 0.0 1.0 2.9 19.7 66.3 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.6 22.0 0.0 32.6 21.9 0.0 0.0 31.4 1.6 0.0 45.2 38.9 0.4 0.0 26.6 5.7 0.0 124.3 34.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 134.9 0.0 0.0 0.0 96.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1517.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC002456.2 ENSG00000251154 "Uncharacterized LOC102723899" 7 90469639-90513397 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 67 "testis: 9.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.4;Basal respiratory cells: 3.0;Cholangiocytes: 2.8;Hepatocytes: 3.3;Melanocytes: 1.8;Spermatogonia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.4 3.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.1 0.6 0.8 1.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.5 1.3 0.8 2.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 AL672142.1 ENSG00000251184 "Novel protein" 9 128941478-128957021 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 2.5;skeletal muscle: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;BJ: 1.9;HL-60: 1.7;RH-30: 1.9;U-138 MG: 1.4;U-698: 1.4" "Not detected" "Not detected" NA NA 0.0 0.1 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.3 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.1 0.9 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 2.5 0.0 0.0 1.5 0.0 0.0 0.1 0.6 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.0 0.2 0.4 1.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.4 0.0 0.0 0.6 0.3 0.7 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.1 0.0 0.4 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.7 0.5 0.5 0.6 0.9 0.6 0.2 0.8 0.6 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF674 "MRX92, ZNF673B" ENSG00000251192 "Zinc finger protein 674" Q2M3X9 X 46497727-46545457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 13.5;Inhibitory neurons: 11.4;Oligodendrocytes: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA031026, HPA065295" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031026: AB_10602690, HPA065295: AB_2685456" "unprognostic (6.11e-4)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.30e-2)" "unprognostic (1.54e-2)" "unprognostic (3.39e-2)" "unprognostic (6.41e-5)" "unprognostic (2.74e-4)" "unprognostic (5.68e-2)" "unprognostic (2.43e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (3.25e-4)" "unprognostic (8.45e-4)" 1.0 1.2 1.9 1.1 2.0 1.0 1.4 2.9 2.1 1.3 1.2 1.1 1.1 1.6 1.6 0.9 1.0 1.2 1.3 1.9 2.0 1.4 2.2 1.0 1.5 1.7 1.6 1.7 1.8 2.0 1.4 1.3 1.2 2.1 2.0 1.3 3.9 1.1 1.4 1.4 1.3 1.1 1.7 1.5 1.5 1.0 0.9 1.5 1.5 1.8 1.1 1.2 1.1 1.2 2.6 1.7 2.2 2.1 2.7 1.9 1.9 2.1 1.8 2.5 2.3 2.4 1.4 1.4 1.9 1.1 3.1 4.1 1.6 2.9 2.2 2.6 1.6 1.8 0.8 2.5 1.2 2.5 2.1 3.3 1.8 3.4 1.7 5.6 2.4 1.7 3.2 1.0 2.8 2.1 1.1 2.1 0.9 3.4 0.5 2.1 1.0 3.6 2.2 1.5 0.7 0.8 1.8 2.7 0.9 5.7 5.9 2.3 1.5 1.6 2.9 3.3 1.8 1.7 3.3 3.2 0.8 1.2 1.0 3.0 0.9 0.6 0.9 0.5 1.1 0.5 0.7 0.7 0.4 0.6 0.3 0.5 0.6 1.7 0.5 0.2 0.7 0.6 0.6 1.9 2.0 2.9 2.1 1.9 2.0 1.7 1.6 1.7 2.1 1.5 1.5 2.6 2.7 9.6 1.8 5.2 1.3 1.9 3.1 0.5 1.2 6.6 1.1 1.3 4.4 0.0 2.9 1.8 0.0 0.8 2.3 1.5 0.0 0.9 0.0 1.5 2.2 3.4 0.0 0.8 9.3 0.5 0.7 2.0 3.1 1.9 2.5 1.9 3.6 2.1 1.0 13.5 11.4 1.0 0.0 1.9 2.2 0.5 0.3 1.4 0.0 5.6 2.0 2.5 2.1 9.5 12.3 1.3 1.4 1.9 2.3 2.6 1.1 0.9 2.7 5.8 0.0 3.2 1.5 1.3 4.2 1.1 1.7 0.4 1.9 1.2 0.9 2.2 TMED7-TICAM2 ENSG00000251201 "TMED7-TICAM2 readthrough" 5 115578642-115626161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 2.9;Excitatory neurons: 4.8;Inhibitory neurons: 5.1;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 13.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008960 Uncertain NA NA "HPA008960: AB_1080280" "unprognostic (7.37e-6)" "unprognostic (5.18e-4)" "unprognostic (2.84e-2)" "unprognostic (8.53e-2)" "unprognostic (5.16e-2)" "unprognostic (5.79e-3)" "unprognostic (1.47e-3)" "unprognostic (6.56e-5)" "unprognostic (1.03e-1)" "unprognostic (8.25e-2)" "unprognostic (3.91e-3)" "unprognostic (1.20e-1)" "unprognostic (8.61e-5)" "unprognostic (1.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.32e-2)" "unprognostic (6.42e-2)" 1.9 2.6 1.1 2.9 1.3 1.0 1.6 1.4 2.6 3.2 0.8 2.0 1.8 1.7 1.8 1.2 1.6 1.7 0.8 1.0 1.5 2.1 2.5 2.0 1.8 1.7 1.2 0.7 1.3 1.5 1.7 0.4 4.2 1.6 2.0 2.0 2.8 1.3 3.1 0.4 0.4 2.0 2.7 1.5 2.6 2.4 0.9 1.4 1.9 2.0 1.0 2.7 2.7 0.4 2.5 4.1 2.9 2.7 10.9 16.2 30.7 10.2 19.0 14.9 11.2 19.9 2.5 9.6 1.1 8.4 21.4 7.7 8.1 1.8 11.4 22.1 9.4 2.1 0.7 1.5 0.3 12.1 2.2 5.5 15.1 9.9 12.5 12.8 19.6 7.0 1.6 1.4 3.3 13.7 4.6 1.7 0.5 0.4 9.6 4.4 1.4 4.6 1.3 9.2 2.2 2.1 3.1 8.8 0.9 15.6 11.1 1.5 3.1 11.8 10.4 11.3 9.8 16.8 5.7 4.5 1.2 11.1 3.1 8.2 1.8 3.4 1.3 0.5 3.9 1.1 0.4 0.4 0.6 3.4 0.3 0.4 0.4 1.1 0.6 3.1 0.5 0.8 1.3 1.1 1.3 1.4 2.6 1.0 1.5 1.7 1.2 0.7 1.6 1.5 1.4 2.5 0.0 3.2 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 4.7 1.1 0.0 0.0 5.5 13.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 AL691442.1 ENSG00000251246 "Novel ephrin-A4 (EFNA4) and ephrin-A3 (EFNA3) protein" 1 155063748-155086807 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 3.4;U-266/70: 2.7;U-266/84: 1.9" NA NA "unprognostic (9.62e-2)" 0.2 0.2 0.2 0.3 0.6 0.0 0.1 0.2 0.9 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.4 0.1 0.4 0.4 0.0 0.1 0.6 0.2 0.1 0.0 0.3 0.1 0.4 0.3 0.3 0.1 0.0 0.2 0.2 0.3 0.2 0.3 0.0 0.0 0.1 0.0 0.1 1.0 0.3 0.3 0.2 0.8 0.5 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.5 0.7 1.0 0.2 0.0 1.1 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.3 0.1 0.4 1.1 0.1 0.1 0.6 0.0 0.9 0.5 0.5 0.2 0.5 0.1 0.4 0.8 0.4 0.2 1.0 0.7 1.0 0.2 3.4 0.0 0.0 1.2 1.3 0.0 0.8 0.0 0.4 1.0 0.3 0.2 0.1 0.0 0.0 0.0 2.7 1.9 0.3 0.2 0.1 0.0 0.0 0.2 0.5 0.3 0.2 0.3 0.4 0.2 0.1 0.5 0.5 0.4 0.1 0.0 0.3 0.1 0.6 0.6 0.0 0.2 0.6 0.2 0.9 0.6 0.3 0.3 0.2 0.4 0.6 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF345 HZF10 ENSG00000251247 "Zinc finger protein 345" Q14585 19 36850361-36913029 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 18 "Early spermatids: 304.8;Late spermatids: 382.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025816 Uncertain NA NA "HPA025816: AB_10602354" "unprognostic (1.55e-3)" "unprognostic (9.11e-3)" "unprognostic (2.19e-1)" "unprognostic (5.17e-4)" "unprognostic (6.14e-2)" "unprognostic (2.53e-3)" "unprognostic (1.54e-2)" "unprognostic (5.78e-5)" "unprognostic (1.70e-2)" "unprognostic (2.07e-2)" "unprognostic (6.87e-3)" "unprognostic (1.27e-3)" "unprognostic (3.33e-3)" "unprognostic (1.22e-1)" "unprognostic (1.70e-1)" "unprognostic (9.32e-2)" "unprognostic (3.87e-5)" 4.4 4.7 2.4 5.2 1.6 5.1 6.5 7.2 4.0 5.7 0.0 4.6 5.3 6.4 6.3 3.9 4.5 4.5 3.2 2.4 2.7 3.6 3.6 4.7 7.3 0.9 1.1 0.6 7.2 3.3 5.8 4.2 5.0 2.5 5.2 4.8 6.9 5.2 4.3 2.7 8.2 5.2 4.1 0.5 6.2 4.6 14.9 1.4 6.5 5.6 2.5 5.6 4.6 5.4 3.4 0.3 0.8 9.0 5.1 2.3 2.7 3.1 1.6 2.2 1.4 3.7 0.5 2.4 2.1 4.3 1.3 3.2 2.1 2.1 2.0 2.2 6.2 5.2 3.9 2.1 2.3 1.8 3.3 3.9 5.9 2.6 2.5 0.0 3.8 2.7 6.9 0.9 1.0 2.6 1.6 6.3 4.6 3.4 0.1 1.8 4.8 6.4 3.5 1.1 6.9 6.2 5.9 5.1 0.5 1.5 3.8 2.7 3.2 2.2 3.6 4.6 2.7 1.5 5.9 4.0 4.3 0.2 0.2 5.0 13.0 1.4 5.1 3.6 1.3 3.7 2.1 4.3 3.3 1.3 3.1 6.1 4.8 1.7 3.1 1.4 1.6 4.3 2.5 2.4 1.6 7.2 4.0 2.4 2.7 0.9 1.1 0.6 2.5 0.5 1.4 3.4 4.7 9.6 3.9 10.1 5.3 3.6 3.7 3.3 1.8 5.3 5.0 4.7 3.2 1.5 4.6 1.8 0.0 5.0 6.9 1.0 7.9 2.7 304.8 3.8 3.5 4.8 2.4 2.1 7.7 1.0 2.5 3.7 1.1 3.7 3.8 7.8 5.3 2.6 3.4 0.0 8.6 3.0 2.0 1.3 4.0 382.5 6.2 3.4 5.4 5.6 2.2 4.7 11.3 14.1 18.2 1.8 1.0 10.5 3.0 2.2 3.1 3.5 8.6 6.8 6.6 6.6 5.4 18.3 10.8 2.1 3.8 4.7 5.7 4.6 1.8 6.9 RFPL4B RNF211 ENSG00000251258 "Ret finger protein like 4B" Q6ZWI9 6 112347330-112351294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 1.7" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 15.7" "Group enriched" "Detected in some" 7 "liver cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.9;RPTEC TERT1: 2.3;U-266/70: 1.0;U-266/84: 8.0" "HPA059324, HPA066464" Uncertain NA NA "HPA059324: , HPA066464: " "unprognostic (4.26e-1)" "unprognostic (1.45e-1)" "unprognostic (6.66e-2)" "unprognostic (3.78e-1)" "unprognostic (2.80e-3)" "unprognostic (3.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 ALG1L2 ENSG00000251287 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;retina: 2.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 6.0;Erythroid cells: 6.1;Granulosa cells: 16.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favorable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.5 0.6 0.1 0.0 1.0 0.0 0.3 0.5 1.2 0.0 2.6 0.7 1.7 0.0 6.0 0.0 0.0 1.7 1.4 1.7 0.4 0.0 0.6 1.8 4.2 0.3 0.9 0.8 1.9 0.2 0.4 0.7 3.0 0.9 0.0 6.1 0.8 0.0 0.3 1.7 1.5 0.9 0.0 16.7 0.7 0.4 0.2 5.0 0.6 1.4 0.0 0.0 0.0 0.0 3.7 0.9 0.0 0.0 0.3 3.2 0.0 0.5 0.8 0.0 0.0 2.6 1.1 3.3 1.2 1.1 0.7 3.0 0.0 3.3 2.2 1.3 0.2 0.5 0.0 0.0 1.5 1.5 1.5 1.7 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6;lymphoid tissue: 50.9" "Cell type enhanced" "Detected in many" "Adipocytes: 195.3;Endothelial cells: 65.0;Hepatic stellate cells: 70.3;Microglial cells: 44.0;Oligodendrocytes: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 33.3;TIME: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 33.7 4.0 38.2 4.9 16.4 1.1 33.8 60.6 54.0 12.9 0.0 7.0 3.4 13.5 2.0 5.3 12.5 5.8 21.9 40.0 15.7 11.9 4.5 20.4 4.2 11.6 17.7 17.8 4.4 4.0 3.5 5.3 13.8 36.9 8.4 1.2 0.8 8.3 4.2 23.5 7.2 6.4 5.2 0.0 50.9 5.7 2.2 43.0 1.7 14.9 9.0 1.4 10.8 10.2 19.4 6.6 2.6 6.2 4.8 0.5 1.6 3.2 1.3 0.0 0.4 0.5 1.6 2.4 0.0 4.0 1.0 3.1 1.2 0.9 2.3 0.0 0.0 10.4 8.0 1.8 7.1 1.9 1.8 0.4 2.2 1.8 0.1 0.3 0.1 33.3 1.9 0.2 0.2 0.5 2.6 1.4 0.5 3.2 0.6 2.2 7.5 0.0 1.7 0.4 1.3 2.3 3.0 2.7 0.0 3.1 0.7 0.3 0.7 37.6 0.4 9.3 2.0 0.7 0.3 0.4 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 16.4 60.6 54.0 40.0 15.7 11.6 17.7 17.8 36.9 0.0 43.0 19.4 195.3 0.0 1.1 4.6 0.5 0.3 0.1 0.5 4.0 1.2 1.3 2.4 27.6 0.0 0.8 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.9 3.9 2.4 65.0 2.4 0.0 28.3 0.0 0.0 3.3 0.0 1.5 0.0 0.3 70.3 6.5 0.4 0.0 21.7 0.0 2.0 3.1 0.0 0.4 0.0 0.3 0.0 44.0 0.0 1.4 0.0 25.1 31.3 0.1 0.0 0.4 0.0 0.2 0.0 0.9 0.9 0.0 0.0 1.0 3.8 0.2 0.8 1.0 0.3 0.0 0.6 0.7 0.1 0.3 MSANTD3-TMEFF1 C9orf30-TMEFF1 ENSG00000251349 "MSANTD3-TMEFF1 readthrough" 9 100442271-100577636 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 42.3;choroid plexus: 23.5" "Cell type enhanced" "Detected in some" "Astrocytes: 2.0;Excitatory neurons: 12.0;Inhibitory neurons: 9.6;Microglial cells: 1.9;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 99.0;NTERA-2: 48.9;SCLC-21H: 51.9;SuSa: 70.3" "Low region specificity" "Detected in all" NA NA "unprognostic (8.53e-3)" "unprognostic (1.95e-3)" "unprognostic (5.92e-2)" "unprognostic (5.32e-2)" "unprognostic (8.87e-2)" "unprognostic (3.00e-1)" "unprognostic (3.39e-4)" "unprognostic (6.34e-2)" "unprognostic (2.19e-1)" "unprognostic (8.88e-3)" "unprognostic (1.46e-1)" "unprognostic (9.55e-3)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" 1.5 1.4 33.0 2.3 38.5 0.5 1.3 29.3 42.3 3.5 23.5 2.3 0.5 5.3 1.9 1.4 1.5 2.2 1.7 29.9 33.3 1.2 0.6 1.4 0.6 32.4 35.1 25.8 2.3 0.5 1.0 0.9 2.3 32.5 2.1 1.4 4.3 0.6 3.2 1.6 0.5 1.1 4.5 29.5 0.5 1.3 5.5 34.4 2.2 5.8 3.1 1.0 2.2 1.4 37.7 2.8 4.7 99.0 8.3 12.0 6.7 15.7 11.0 7.7 8.0 8.5 0.6 3.2 2.1 5.2 10.0 22.7 1.8 31.4 3.3 18.4 8.0 5.6 0.7 3.2 1.5 6.1 2.1 1.8 2.9 2.7 7.8 9.3 18.1 20.4 19.0 2.1 1.2 16.3 2.0 12.7 1.9 48.9 8.8 4.4 15.1 41.7 0.3 8.0 1.1 51.9 24.0 3.5 2.3 5.5 70.3 1.1 6.4 7.2 8.3 8.5 10.0 10.1 4.4 11.1 9.2 13.0 1.2 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 38.5 29.3 42.3 29.9 33.3 32.4 35.1 25.8 32.5 29.5 34.4 37.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000350.4 ENSG00000251357 "Novel protein" 22 23862188-23895223 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 78.1;Club cells: 43.0;Fibroblasts: 25.6;granulocytes: 54.2;Melanocytes: 33.8;Respiratory ciliated cells: 44.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.1;SK-MEL-30: 1.6;THP-1: 1.5" HPA042960 Uncertain NA NA "HPA042960: AB_2678241" 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.2 0.1 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.5 0.4 0.6 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 1.1 1.0 0.0 0.5 1.6 0.1 0.1 1.5 0.0 0.0 0.5 0.4 0.0 0.8 0.0 0.4 0.3 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.5 78.1 0.0 0.2 16.4 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 54.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.2 0.0 15.5 0.0 0.0 3.3 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 44.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 14.5 0.0 9.0 0.0 0.5 0.0 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003251 Uncertain Approved Vesicles,Microtubules NA NA Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 2.9 3.8 2.0 5.2 2.1 5.3 6.0 5.6 2.7 5.6 2.7 2.8 2.2 4.6 4.0 3.1 4.6 3.1 5.6 2.0 1.8 2.9 3.0 3.4 6.8 1.7 1.8 1.7 9.2 2.4 7.9 2.5 6.5 2.8 6.0 2.9 7.4 4.2 4.5 2.2 4.0 3.6 3.3 1.1 7.8 3.5 2.8 1.9 7.5 4.9 3.3 5.5 3.7 1.3 3.1 4.3 3.0 8.4 8.0 2.8 6.9 0.0 5.7 4.8 5.0 2.1 3.7 3.9 1.2 3.9 4.2 4.0 3.6 4.4 5.0 6.3 0.1 23.2 11.5 10.9 4.9 4.1 10.1 4.3 5.8 3.0 3.9 11.2 6.9 4.2 10.6 1.8 0.1 5.4 1.0 15.5 4.4 9.2 1.3 5.8 12.3 8.7 12.1 2.7 7.6 7.8 11.0 7.2 4.8 3.5 5.9 5.5 6.6 4.8 6.9 4.2 2.6 5.6 24.0 24.0 10.0 2.8 5.8 6.1 0.4 1.4 2.0 3.6 1.9 4.5 1.8 4.5 2.5 2.0 2.6 5.8 3.4 0.4 5.2 0.6 0.7 4.5 2.3 2.0 2.1 5.6 2.7 2.0 1.8 1.7 1.8 1.7 2.8 1.1 1.9 3.1 4.5 0.0 1.1 4.2 8.9 5.1 3.9 2.6 5.7 4.5 4.7 3.6 7.2 2.8 3.4 0.0 6.2 4.2 4.9 0.5 1.9 2.8 1.0 3.4 4.7 5.8 3.6 5.0 4.8 1.2 4.4 3.9 0.5 2.9 5.1 8.3 5.0 3.2 2.3 11.8 5.3 2.8 4.1 1.9 2.2 0.6 4.7 1.4 3.6 2.8 2.5 3.0 12.3 4.0 3.7 2.2 0.8 0.7 3.4 6.7 1.2 0.9 6.5 5.1 0.0 3.3 4.4 3.2 5.0 4.4 6.8 5.2 6.2 4.4 2.7 4.3 DCANP1 "C5orf20, DCNP1" ENSG00000251380 "Dendritic cell associated nuclear protein" Q8TF63 5 135444214-135447348 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "Microglial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "THP-1: 1.8" HPA048308 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA048308: AB_2680349" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD1 "FKHL8, FREAC4" ENSG00000251493 "Forkhead box D1" Q16676 5 73444827-73448777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2;choroid plexus: 3.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.6;Microglial cells: 9.4;Muller glia cells: 20.9;Proximal enterocytes: 6.9;Spermatocytes: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 55.1;hTERT-RPE1: 63.9;U-138 MG: 74.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "spinal cord: 9.6" NA NA "unprognostic (7.06e-4)" "unprognostic (1.02e-3)" "unprognostic (3.00e-5)" "unprognostic (1.48e-4)" "unprognostic (1.09e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.26e-1)" "unprognostic (7.92e-2)" "unprognostic (2.06e-2)" "unprognostic (6.18e-2)" "unprognostic (2.61e-10)" "unprognostic (3.64e-2)" "unprognostic (2.75e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (9.65e-4)" 0.6 1.9 1.9 0.1 2.8 0.0 0.6 1.8 2.5 0.7 3.7 0.1 0.0 0.1 0.2 1.8 0.6 0.4 0.0 1.6 4.2 2.1 0.0 0.3 0.4 2.1 1.9 1.4 0.1 0.0 0.1 2.0 1.3 2.2 0.2 0.0 0.4 0.7 0.0 0.4 1.2 1.3 0.0 1.5 0.2 0.2 3.3 2.9 0.0 0.3 2.0 0.5 0.4 0.8 2.1 36.5 2.4 0.2 12.9 6.4 6.3 1.3 28.1 13.2 32.5 28.6 0.1 43.1 0.0 1.0 25.5 22.0 12.6 4.2 16.8 34.6 10.5 19.8 0.4 0.4 0.1 2.5 1.8 0.2 7.0 11.1 55.1 17.0 63.9 0.0 5.8 0.4 0.0 34.3 8.3 0.0 0.1 8.1 0.0 5.9 8.8 6.2 1.0 12.4 2.7 5.0 1.3 9.2 0.4 1.5 3.6 1.0 48.5 0.1 74.5 44.9 23.4 0.3 0.0 0.0 0.0 41.1 2.4 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 1.8 2.5 1.6 4.2 2.1 1.9 1.4 2.2 1.5 2.9 2.1 1.1 0.0 0.0 0.3 0.4 0.8 0.0 0.8 0.0 9.6 0.2 0.6 1.6 0.0 0.4 0.0 0.0 0.0 2.9 0.1 0.0 0.0 2.9 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.7 0.0 1.8 2.0 0.0 1.3 1.3 0.3 0.4 0.0 9.4 0.0 20.9 0.0 0.0 0.1 0.1 1.2 1.9 2.2 0.1 6.9 0.3 0.3 2.9 0.0 0.1 2.5 5.0 2.6 0.1 0.4 0.0 1.1 0.0 1.0 0.0 CENPS-CORT APITD1-CORT ENSG00000251503 "CENPS-CORT readthrough" 1 10430102-10452153 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 36.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Proximal tubular cells: 3.5;Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 33.0" NA NA "unprognostic (2.73e-1)" "unprognostic (8.54e-4)" "unprognostic (7.66e-2)" "unprognostic (1.08e-1)" "unprognostic (7.28e-2)" "unprognostic (4.61e-2)" "unprognostic (9.73e-3)" "unprognostic (6.21e-2)" "unprognostic (1.67e-2)" "unprognostic (4.97e-3)" "unprognostic (9.53e-2)" "unprognostic (1.96e-1)" "unprognostic (9.32e-4)" "unprognostic (2.31e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (5.06e-2)" 0.4 0.9 2.6 0.6 3.0 8.5 0.9 2.3 5.6 0.4 1.7 0.9 1.6 0.6 0.9 1.4 0.8 0.7 0.3 2.4 3.0 2.4 1.3 0.7 1.1 2.1 2.3 2.1 0.5 1.2 1.4 2.5 0.3 2.2 0.8 0.1 2.5 0.9 0.1 0.3 0.5 0.7 0.1 1.6 0.7 1.2 36.4 2.5 2.1 1.6 0.9 0.9 0.3 0.7 2.8 13.4 18.5 10.1 1.2 1.4 1.3 1.9 13.5 3.0 17.5 7.8 8.2 5.0 12.5 6.5 2.5 4.3 8.3 6.4 4.7 1.5 11.6 7.6 23.3 3.9 14.6 0.3 31.6 12.7 0.0 2.8 14.3 1.4 3.6 2.0 5.2 6.2 8.3 0.6 5.6 11.2 8.0 4.6 2.8 6.1 11.5 10.6 12.8 3.2 2.2 4.7 6.4 15.7 6.7 3.4 2.8 5.0 6.6 4.7 9.8 20.8 6.3 12.1 1.4 5.7 19.6 8.2 33.0 8.7 0.0 0.6 0.6 0.5 0.9 0.8 4.3 0.9 1.6 0.8 4.8 1.0 0.6 1.1 2.4 0.6 1.9 2.6 1.3 2.6 3.0 2.3 5.6 2.4 3.0 2.1 2.3 2.1 2.2 1.6 2.5 2.8 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.6 0.0 0.0 0.8 0.7 0.0 0.0 0.7 0.0 0.9 0.4 0.3 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.4 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 3.5 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 AC005324.2 ENSG00000251537 "Novel tripartite motif-containing 16 (TRIM16) and CMT1A duplicated region transcript 1 (CDRT1) protein" 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;CAPAN-2: 1.1;HaCaT: 2.1;HeLa: 1.1" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-39 ENSG00000251546 "Immunoglobulin kappa variable 1D-39" P04432 2 89862482-89862981 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2950.1;lymphoid tissue: 6546.1;stomach 1: 2280.3" "Cell type enriched" "Detected in some" 298 "Plasma cells: 7890.2" "Cancer enhanced" "Detected in many" "stomach cancer: 12.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 226 "memory B-cell: 470.5;naive B-cell: 733.0" "Lineage enriched" "Detected in many" 275 "B-cells: 733.0" "Group enriched" "Detected in some" 36 "Daudi: 731.4;U-698: 516.7" HPA048721 Approved "Immunoglobulin genes" NA NA "HPA048721: " "prognostic favorable (1.88e-4)" "unprognostic (4.70e-2)" "unprognostic (2.14e-3)" "prognostic favorable (5.99e-5)" "unprognostic (3.84e-1)" "unprognostic (4.34e-2)" "unprognostic (1.28e-1)" "unprognostic (9.06e-2)" "unprognostic (2.96e-2)" "unprognostic (3.92e-1)" "unprognostic (1.84e-1)" 148.7 182.8 0.7 1625.0 1.4 470.4 1000.3 0.7 4.6 372.1 2.9 2950.1 2073.9 80.8 52.9 616.8 133.3 635.6 88.2 0.5 5.8 81.0 173.3 691.4 1985.4 2.5 7.4 0.5 216.7 26.8 3.5 5.5 1.3 3.1 81.6 2282.9 0.4 1240.9 149.9 2.3 33.4 1266.3 89.5 4.0 1725.6 2280.3 27.8 1.6 777.6 211.1 0.0 6546.1 1831.8 47.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 731.4 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.0 0.0 5.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 2.3 6.6 2.4 0.0 0.0 1.0 2.9 10.3 0.0 0.0 11.1 17.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.8 2.5 0.0 0.1 516.7 0.0 1.6 0.0 0.5 0.4 0.8 0.6 0.2 0.4 470.5 0.3 0.3 0.4 733.0 0.5 0.2 2.6 0.8 0.4 0.4 0.3 47.6 0.7 1.4 0.7 4.6 0.5 5.8 2.5 7.4 0.5 3.1 4.0 1.6 2.4 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7890.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 14.0 0.0 0.0 0.0 AC093899.2 ENSG00000251569 "Novel protein" 2 169479480-169525922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "retina: 18.6;testis: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6;HSkMC: 3.0;LHCN-M2: 5.4;SK-MEL-30: 2.5" HPA046125 Uncertain NA NA "HPA046125: AB_2679549" 0.6 0.1 0.5 0.1 0.6 0.0 1.6 0.6 1.3 0.7 0.5 0.3 0.1 1.4 1.3 0.3 1.8 1.9 1.4 0.5 0.6 1.0 0.1 0.9 0.3 0.6 0.6 0.5 1.2 0.5 1.0 0.5 0.4 0.6 1.7 0.7 18.6 0.4 1.3 2.7 0.2 0.1 1.1 0.5 0.6 0.4 8.8 0.5 0.6 1.8 2.5 0.6 0.8 0.1 0.5 0.0 0.0 1.0 0.1 0.8 4.6 0.0 1.0 0.6 0.9 0.5 0.0 0.0 0.0 0.2 1.1 1.2 0.0 0.7 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.1 0.5 0.0 3.0 0.5 1.2 0.4 1.1 1.5 0.9 0.3 0.0 5.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.7 0.1 0.3 0.0 2.5 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 1.3 0.5 0.6 0.6 0.6 0.5 0.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRB1 "PM, PMF, PMS, PRB1L, PRB1M" ENSG00000251655 "Proline rich protein BstNI subfamily 1" 12 11351823-11395566 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 2524 "salivary gland: 16449.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 6.5 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16449.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 28.9;Alveolar cells type 2: 5.1;Bipolar cells: 11.4;Cone photoreceptor cells: 6.2;Horizontal cells: 5.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.1;hTCEpi: 3.4;PC-3: 5.1;RT4: 5.2;SH-SY5Y: 2.1" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 0.1 0.3 0.5 0.0 0.5 0.0 0.2 4.0 1.2 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.7 0.0 0.4 0.5 0.7 0.1 1.5 0.0 0.4 0.4 0.5 0.0 0.7 0.0 0.8 0.0 1.1 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 7.1 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.6 1.7 5.1 0.0 0.0 0.0 0.1 5.2 0.2 2.1 0.0 0.6 0.0 0.3 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 4.0 1.2 0.4 0.5 0.4 0.4 0.5 1.1 0.2 0.1 0.7 0.2 28.9 5.1 0.0 0.0 0.0 0.0 0.8 0.0 11.4 0.8 1.3 0.4 4.3 1.9 1.8 6.2 0.0 0.0 0.1 0.0 0.7 1.3 0.8 0.3 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.8 0.0 0.1 1.4 0.1 0.0 5.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 0.0 0.2 1.3 3.6 0.0 0.2 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTX4 C16orf38 ENSG00000251692 "Pentraxin 4" Q96A99 16 1485886-1488981 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HL-60: 21.2;NB-4: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 1.0" "Low region specificity" "Detected in all" HPA073694 Supported "Secreted - unknown location" NA NA "HPA073694: AB_2732237" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.54e-2)" "unprognostic (1.55e-2)" "unprognostic (1.12e-1)" "unprognostic (1.84e-4)" "unprognostic (3.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.10e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (3.54e-1)" "unprognostic (1.52e-4)" "unprognostic (2.23e-3)" "unprognostic (4.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.03e-1)" 0.0 0.2 0.5 0.0 0.2 0.7 0.0 0.7 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 15.7 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.2 0.7 0.3 0.2 0.7 1.0 1.2 0.0 1.8 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OC90 PLA2L ENSG00000253117 "Otoconin 90" Q02509 8 132024216-132059382 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.92e-1)" "unprognostic (2.93e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RGS21 ENSG00000253148 "Regulator of G protein signaling 21" Q2M5E4 1 192316992-192367285 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "Early spermatids: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA052843 Uncertain NA NA "HPA052843: AB_2681971" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430507-141512975 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Cell type enhanced" "Detected in some" "Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0" "Group enriched" "Detected in many" 5 "glioma: 1.7;melanoma: 5.8" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 21000 "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 2.6 4.3 5.2 0.8 4.7 0.0 1.5 5.7 4.1 2.0 1.1 1.1 0.2 2.6 0.4 1.0 1.9 4.0 3.7 5.2 16.3 0.8 0.7 3.2 0.4 9.5 4.3 2.7 1.9 1.1 0.3 1.4 2.2 7.5 1.0 0.3 1.4 0.9 1.5 1.3 1.7 0.8 1.7 5.7 1.2 1.0 0.3 5.3 0.9 1.6 1.1 0.4 1.2 2.0 5.3 0.0 0.0 0.1 1.9 0.8 1.4 0.1 9.3 15.4 0.0 0.0 0.0 0.0 0.5 0.0 23.3 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 0.0 16.5 0.0 4.5 0.0 0.0 5.4 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 2.6 7.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.2 4.7 5.7 4.1 5.2 16.3 9.5 4.3 2.7 7.5 5.7 5.3 5.3 2.2 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.8 0.2 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 2.2 0.0 0.0 0.0 0.2 0.0 3.2 1.1 0.1 0.0 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.7 0.0 2.0 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 TRBV6-7 "TCRBV13S8P, TCRBV6S7, TRBV67" ENSG00000253188 "T cell receptor beta variable 6-7 (non-functional)" 7 142487863-142488295 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.4;lymphoid tissue: 1.3;pancreas: 1.7;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 6 "T-cells: 1.9" "Not detected" "Not detected" NA NA "unprognostic (1.38e-1)" 0.0 0.0 0.7 0.0 0.4 0.2 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.3 0.7 0.4 0.2 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.3 1.4 1.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.7 0.0 0.0 1.9 0.3 0.3 0.0 0.0 0.0 0.7 0.1 0.7 0.4 0.4 0.7 1.0 0.5 0.7 0.4 0.2 0.8 0.4 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8orf88 ENSG00000253250 "Chromosome 8 open reading frame 88" P0DMB2 8 90958471-90985238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 92.4" "Cell type enhanced" "Detected in many" "Early spermatids: 612.7;Late spermatids: 138.4;Spermatocytes: 329.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 63.4" "Low region specificity" "Detected in all" HPA078486 Enhanced NA NA "HPA078486: " "unprognostic (2.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.51e-2)" "unprognostic (2.95e-4)" "unprognostic (4.07e-2)" "unprognostic (1.19e-1)" "unprognostic (8.44e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.18e-2)" "unprognostic (6.04e-2)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (6.23e-6)" 7.9 3.9 2.2 4.2 2.9 11.1 6.7 2.5 3.0 10.5 4.8 24.1 2.1 21.6 13.2 8.7 12.0 7.2 37.2 2.2 5.7 4.6 1.0 4.8 1.7 3.3 3.0 1.9 13.4 1.3 0.4 4.1 3.5 2.9 14.0 5.8 1.6 2.5 23.7 1.4 6.9 6.6 31.1 3.1 3.0 13.4 92.4 2.8 13.2 11.0 1.8 1.4 19.2 7.9 4.5 0.1 2.4 13.4 1.2 15.4 13.4 0.2 14.6 22.8 19.8 29.7 0.1 3.8 0.3 1.3 14.9 20.6 0.1 0.2 1.1 36.7 0.0 38.6 41.7 11.5 0.0 63.4 0.0 1.3 14.1 0.3 22.3 37.0 28.9 2.1 13.6 25.0 23.9 30.3 0.0 39.7 14.9 3.3 0.0 0.7 0.0 26.1 0.1 16.3 0.1 11.4 19.8 0.6 0.0 19.6 15.1 0.0 1.9 8.5 22.8 38.0 0.3 15.5 33.3 33.4 21.2 22.6 0.0 10.5 0.0 0.0 0.0 0.9 0.0 1.2 1.1 0.8 1.0 0.2 0.9 0.7 1.4 0.0 3.8 0.0 3.2 0.6 0.4 2.2 2.9 2.5 3.0 2.2 5.7 3.3 3.0 1.9 2.9 3.1 2.8 4.5 6.4 0.0 1.1 1.3 2.9 18.9 9.3 1.0 19.4 0.0 0.5 8.6 12.4 2.8 0.1 3.7 0.0 0.2 0.8 0.0 5.9 1.1 612.7 0.3 9.0 4.7 0.0 55.6 3.1 0.0 0.9 13.7 0.0 0.2 2.5 4.9 5.0 0.0 0.6 0.0 6.4 0.0 0.0 0.8 3.8 138.4 19.0 1.7 10.6 1.9 0.6 0.9 0.0 2.0 4.0 3.6 0.0 21.8 3.0 6.6 0.0 1.4 0.1 0.2 19.7 8.2 21.1 329.5 30.7 6.9 26.6 0.0 2.8 2.0 0.0 1.2 SHLD3 "AC008560.1, CTC-534A2.2, FLJ26957, RINN1" ENSG00000253251 "Shieldin complex subunit 3" Q6ZNX1 5 65625027-65630928 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 17.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 2.3 2.7 2.9 2.8 3.0 17.7 4.3 3.3 3.5 1.8 2.3 2.8 2.9 2.3 3.1 1.5 1.9 2.5 1.7 2.8 2.8 2.9 2.6 2.5 4.9 3.1 2.7 2.9 1.5 3.5 2.1 2.5 2.5 2.8 4.4 3.0 3.7 2.1 2.5 1.8 2.9 2.8 1.7 2.6 2.5 2.4 3.2 2.9 3.9 2.4 1.9 3.6 2.5 1.3 3.7 2.6 3.6 5.0 10.8 2.9 3.5 6.3 3.8 3.5 5.8 7.0 5.9 8.0 4.9 4.2 4.6 6.5 3.1 5.1 4.7 8.5 6.7 6.5 4.3 10.3 8.3 2.5 5.0 7.5 2.1 6.8 6.0 6.1 1.6 3.7 7.7 6.4 11.5 4.7 6.9 6.7 7.7 4.0 1.5 2.2 4.4 4.9 7.9 4.9 6.0 6.7 5.5 3.2 3.3 11.0 3.4 3.8 4.6 3.0 5.0 6.8 4.1 6.6 7.2 14.3 10.7 3.7 6.1 4.7 15.9 3.0 6.4 3.8 2.9 4.0 3.9 4.5 4.0 2.8 3.1 6.1 5.6 3.3 4.9 3.1 3.2 6.2 2.1 2.9 3.0 3.3 3.5 2.8 2.8 3.1 2.7 2.9 2.8 2.6 2.9 3.7 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 3.6 0.0 0.0 0.0 0.0 0.0 4.0 5.9 0.0 3.9 3.1 0.0 1.9 1.8 0.8 0.0 0.0 0.0 2.9 3.8 0.9 0.0 2.1 0.0 2.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.1 1.8 2.1 0.0 0.0 CCDC71L "C7orf74, FLJ36031" ENSG00000253276 "Coiled-coil domain containing 71 like" Q8N9Z2 7 106654360-106661158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 78.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "hypothalamus: 36.3" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067925 Approved Approved "Golgi apparatus,Actin filaments,Cytosol" NA NA "Golgi apparatus, Actin filaments" Cytosol "HPA067925: AB_2685925" "unprognostic (1.51e-1)" "prognostic unfavorable (9.08e-4)" "unprognostic (7.26e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-2)" "unprognostic (1.95e-3)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (2.38e-3)" "unprognostic (6.03e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.53e-6)" "unprognostic (3.34e-2)" "unprognostic (3.72e-1)" "unprognostic (2.26e-1)" "unprognostic (6.35e-2)" 33.6 9.9 3.5 19.7 2.8 15.9 18.8 2.2 3.0 11.3 3.9 14.7 6.6 17.0 2.8 6.9 36.5 10.9 7.2 3.0 36.3 9.7 47.1 22.3 9.7 8.4 2.8 3.0 10.2 9.4 5.3 6.4 3.7 3.1 11.3 5.5 1.0 12.7 6.7 5.4 5.9 15.9 7.2 3.9 18.8 16.4 7.0 4.4 14.6 10.3 2.5 8.1 40.4 9.4 3.6 24.8 5.1 7.4 8.9 16.3 15.4 0.0 37.0 47.5 14.2 15.4 0.7 15.3 16.5 12.6 63.3 27.1 2.8 3.6 10.7 11.7 38.7 8.5 2.1 0.9 0.0 25.5 8.4 19.4 13.2 6.4 6.5 3.7 24.1 50.0 9.2 56.0 39.9 17.1 7.1 11.5 13.3 16.0 2.0 17.0 15.4 2.1 3.3 7.3 1.4 3.2 22.1 23.9 8.6 55.9 15.4 3.9 10.1 22.0 31.4 2.9 3.7 14.6 38.4 3.8 13.5 24.3 10.8 35.3 4.9 0.6 1.8 1.1 0.4 0.8 1.3 0.8 0.8 0.4 0.9 0.4 0.6 4.1 0.6 0.7 1.4 1.7 0.5 3.5 2.8 2.2 3.0 3.0 36.3 8.4 2.8 3.0 3.1 3.9 4.4 3.6 44.0 3.2 11.6 1.0 9.4 8.2 50.5 2.1 6.8 4.3 39.9 33.0 6.2 18.6 1.6 5.5 2.1 3.0 26.2 12.9 11.7 7.4 1.2 18.7 78.7 21.4 6.6 11.6 1.8 10.7 7.4 47.8 3.6 20.2 12.0 3.3 45.7 34.4 8.1 6.7 2.8 7.3 4.1 10.0 13.9 2.1 21.8 22.5 12.4 1.9 6.5 5.0 10.3 2.5 1.8 13.9 10.1 17.7 4.3 11.0 10.1 4.7 6.8 4.8 0.0 24.5 30.1 7.1 4.9 4.0 5.1 3.3 13.7 3.4 9.5 18.3 TRBV7-7 "TCRBV6S6A2T, TCRBV7S7, TRBV77" ENSG00000253291 "T cell receptor beta variable 7-7" A0A0K0K1E9 7 142511626-142512127 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "lymphoid tissue: 8.3" "Cell type enriched" "Detected in single" 11 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 7.8;memory CD8 T-cell: 2.5;naive CD4 T-cell: 7.6;naive CD8 T-cell: 3.3;T-reg: 10.1" "Lineage enriched" "Detected in single" 101 "T-cells: 10.1" "Not detected" "Not detected" NA NA "unprognostic (2.82e-4)" "unprognostic (2.74e-1)" "unprognostic (1.93e-3)" "unprognostic (2.30e-2)" "unprognostic (1.89e-3)" "unprognostic (2.87e-1)" "unprognostic (1.04e-2)" "unprognostic (1.74e-2)" 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.1 0.0 8.3 0.0 0.0 1.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 7.8 2.5 0.0 0.0 7.6 3.3 0.0 0.0 0.0 0.0 10.1 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 HOXA10 "HOX1, HOX1H" ENSG00000253293 "Homeobox A10" P31260 7 27170592-27180261 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 77.4;skeletal muscle: 77.1" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 10.7;NK-cell: 13.1" "Group enriched" "Detected in many" 5 "granulocytes: 10.7;NK-cells: 13.1" "Cell line enhanced" "Detected in many" "HEK 293: 179.0;THP-1: 96.7;U-937: 100.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 190 "spinal cord: 18.9" "CAB019384, HPA071918" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB019384: , HPA071918: " "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.73e-3)" "unprognostic (2.61e-2)" "unprognostic (1.41e-2)" "unprognostic (8.05e-2)" "unprognostic (2.71e-2)" "unprognostic (3.83e-3)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (8.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-2)" 12.8 6.8 0.0 6.2 0.0 4.3 6.8 0.0 0.0 38.8 0.0 29.0 0.1 77.4 9.2 0.2 8.3 0.1 0.1 0.0 0.0 12.9 0.1 0.1 2.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 13.5 0.0 26.5 13.3 0.0 0.0 15.5 77.1 5.7 8.0 45.3 0.1 0.2 0.1 0.3 0.0 5.2 0.1 0.0 0.2 20.6 17.3 0.1 20.6 4.3 0.0 59.9 29.3 28.0 0.2 40.1 27.2 18.0 16.8 6.1 17.8 0.0 10.9 31.6 0.0 22.6 15.5 0.0 13.2 9.5 179.0 21.6 15.0 0.5 0.8 9.6 31.4 17.8 0.9 1.5 0.0 0.0 27.5 6.3 0.9 0.0 13.3 0.0 0.0 63.1 0.0 16.6 18.8 1.9 4.0 0.1 34.7 9.6 46.7 0.1 13.8 0.0 0.1 6.4 0.1 96.7 0.0 0.0 16.1 21.1 0.2 0.4 0.1 0.0 0.0 100.4 0.5 10.7 0.1 0.3 2.2 0.0 0.0 0.1 0.0 0.2 1.2 0.3 0.0 0.0 0.0 13.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.5 0.0 0.0 0.0 0.2 3.7 10.0 0.0 0.6 0.0 4.4 4.6 1.6 0.0 0.0 7.3 0.0 0.5 4.5 28.8 19.6 0.0 0.0 3.1 174.0 5.4 68.1 15.5 0.0 0.0 0.4 13.3 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 25.0 0.0 2.5 4.7 0.0 0.0 2.0 5.4 0.0 0.5 0.0 7.2 0.0 0.0 0.0 32.1 0.4 1.3 18.1 18.8 27.1 0.0 0.0 0.0 13.3 15.7 2.3 4.6 0.5 4.1 0.5 3.1 0.0 25.5 10.1 TMEM200B TTMB ENSG00000253304 "Transmembrane protein 200B" Q69YZ2 1 29119429-29123903 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 61.1" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 8.8;Fibroblasts: 6.1;Leydig cells: 12.8;Melanocytes: 8.8;Peritubular cells: 15.1;Sertoli cells: 6.6;Smooth muscle cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 28.2;BJ hTERT+ SV40 Large T+: 26.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.5;fHDF/TERT166: 29.0;HBF TERT88: 25.3" "Low region specificity" "Detected in all" HPA055254 Uncertain NA NA "HPA055254: AB_2682760" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" "unprognostic (8.25e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-3)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (1.52e-2)" "unprognostic (6.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.24e-2)" "unprognostic (1.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-3)" 14.6 4.4 1.9 4.0 5.4 0.0 11.9 7.0 2.9 46.4 5.8 23.0 2.3 61.1 7.8 5.6 21.7 7.4 6.4 1.9 4.0 9.3 8.5 10.6 1.2 3.0 2.1 2.2 33.6 2.5 26.3 3.6 6.6 4.6 24.8 4.2 0.3 4.2 40.0 2.2 5.4 9.3 35.4 2.0 6.5 6.5 13.4 2.5 1.0 5.0 2.6 1.3 21.1 24.5 2.1 21.0 0.0 3.4 0.0 28.2 23.4 1.1 14.4 22.6 26.7 29.5 1.1 2.3 0.0 3.5 29.0 9.8 0.4 2.3 0.0 25.3 0.1 0.9 0.1 5.7 1.8 19.6 0.0 0.1 12.5 2.7 20.1 3.9 1.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.3 1.9 0.0 5.8 0.0 0.0 0.0 0.3 0.1 0.0 1.7 20.7 0.0 0.1 9.5 0.0 0.0 0.0 9.4 0.4 19.9 0.4 0.0 0.0 0.0 11.6 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.4 7.0 2.9 1.9 4.0 3.0 2.1 2.2 4.6 2.0 2.5 2.1 2.0 3.2 0.6 0.7 0.2 1.9 0.4 0.2 2.8 0.8 0.6 1.8 1.0 1.5 0.7 0.0 2.1 0.1 0.2 0.1 0.0 0.0 0.1 1.0 8.8 1.3 0.0 0.0 0.3 0.0 0.5 6.1 0.0 0.6 0.0 0.0 1.1 1.2 0.1 0.0 0.1 0.0 0.0 0.0 1.2 2.4 12.8 0.1 8.8 1.9 0.1 0.1 0.0 0.0 0.1 0.0 0.1 15.1 0.0 0.3 0.0 5.9 0.4 1.9 6.6 1.1 9.5 0.3 0.6 0.2 0.6 0.5 0.4 0.0 0.0 0.3 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.9;Cone photoreceptor cells: 6.2;Horizontal cells: 10.1;Skeletal myocytes: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.0;EFO-21: 5.4;HSkMC: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 3.1 3.1 3.0 0.9 3.4 0.4 2.2 5.0 2.4 2.9 2.8 1.9 0.5 3.3 2.0 1.2 2.9 1.8 2.4 2.6 6.8 1.1 1.3 2.0 0.7 3.4 3.4 1.9 6.1 1.2 2.8 1.8 3.1 3.1 1.4 0.7 2.8 2.2 2.4 2.9 2.0 1.0 2.0 3.2 1.5 1.1 0.6 4.7 0.7 2.6 1.5 0.6 1.8 2.3 4.0 0.0 0.1 16.0 0.1 0.5 0.6 0.8 1.4 0.0 0.4 0.9 0.2 0.2 1.4 5.4 0.9 0.2 0.3 0.0 0.3 1.0 0.0 0.3 0.0 0.2 0.1 1.3 0.1 0.1 3.6 1.8 0.8 0.1 0.1 0.5 0.3 0.1 0.2 0.1 0.3 0.1 1.1 0.6 0.0 0.0 0.2 0.0 0.1 2.5 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.2 0.3 2.6 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 3.0 3.4 5.0 2.4 2.6 6.8 3.4 3.4 1.9 3.1 3.2 4.7 4.0 3.6 3.2 0.5 0.0 1.0 0.0 1.5 0.0 0.0 6.9 0.6 0.4 3.9 0.0 1.3 0.0 6.2 0.2 0.6 0.4 0.0 0.7 0.0 0.6 3.8 2.6 0.0 0.0 0.0 1.2 0.1 3.3 1.1 0.5 0.0 0.4 1.4 0.7 0.3 10.1 0.0 0.4 0.0 0.0 0.0 0.2 1.8 0.2 0.0 0.0 0.1 2.7 0.0 0.0 0.0 2.0 0.1 1.2 1.5 0.8 0.1 0.3 0.7 2.5 0.0 5.2 3.2 0.2 0.5 0.3 0.1 0.1 0.7 0.8 0.4 0.8 SERPINE3 ENSG00000253309 "Serpin family E member 3" A8MV23 13 51335773-51364735 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.6;pancreas: 1.3;retina: 1.8" "Cell type enhanced" "Detected in some" "Astrocytes: 1.6;Early spermatids: 2.6;Excitatory neurons: 2.3;Inhibitory neurons: 1.9;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.5;Spermatocytes: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 1.3" "HPA051904, HPA055804" Uncertain "Secreted in other tissues" NA NA "HPA051904: AB_2681659, HPA055804: AB_2682928" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (9.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (8.54e-3)" "unprognostic (2.67e-3)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (3.94e-6)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" 0.3 0.1 0.1 0.2 0.3 0.0 0.1 1.6 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.5 0.1 0.1 0.2 0.0 0.3 1.5 0.5 0.2 0.1 1.3 0.0 0.1 0.0 1.1 0.1 0.0 1.8 0.1 0.0 0.0 0.9 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.6 0.8 0.2 0.5 0.0 0.3 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.6 0.9 0.5 0.1 1.5 0.5 0.2 1.1 0.0 0.3 0.6 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.6 0.2 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 2.9 0.0 0.9 0.0 0.0 0.5 0.7 0.0 0.0 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281877-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.9;Paneth cells: 100.8;Proximal enterocytes: 128.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 14 "basophil: 2.2" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "A-431: 12.1;BEWO: 13.0;CACO-2: 12.6;CAPAN-2: 39.8;OE19: 33.1;SK-BR-3: 13.8;T-47d: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013788 Uncertain Uncertain "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.2 0.1 0.3 2.9 0.3 0.2 14.6 0.7 0.5 8.3 0.4 32.7 44.3 1.3 13.1 17.1 6.1 10.0 0.1 0.3 0.2 22.0 6.2 9.0 0.1 0.3 0.3 0.4 0.1 23.0 10.4 8.5 1.6 0.5 8.2 30.5 0.5 19.7 3.9 0.0 15.8 39.1 1.3 0.2 0.1 29.4 0.3 0.3 1.0 17.1 0.0 2.4 3.2 8.1 0.8 12.1 0.0 0.0 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 12.6 39.8 0.0 0.3 0.0 0.0 9.0 0.0 5.6 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.0 0.0 0.2 0.1 33.1 0.0 0.1 0.1 0.4 1.0 7.8 4.6 0.3 0.1 13.8 0.0 2.1 15.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.7 0.5 0.3 0.2 0.3 0.3 0.4 0.5 0.2 0.3 0.8 0.1 22.4 16.1 0.3 0.6 1.1 6.2 11.5 2.8 0.0 22.4 12.8 0.0 28.6 13.8 22.0 0.0 12.9 0.0 125.9 29.4 21.3 0.1 8.5 1.4 0.2 33.6 0.0 0.0 33.7 3.9 0.2 25.5 14.2 0.0 0.0 0.0 1.2 0.7 0.0 0.0 42.4 8.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.3 100.8 0.0 0.0 6.6 128.1 39.6 7.3 0.0 0.0 0.0 0.7 0.3 0.0 8.9 2.6 4.7 0.3 0.0 37.0 8.8 TUG1 "FLJ20618, LINC00080, NCRNA00080" ENSG00000253352 "Taurine up-regulated 1" 22 30969245-30979395 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.83e-1)" "unprognostic (7.04e-2)" "unprognostic (1.87e-1)" "unprognostic (9.18e-2)" "unprognostic (8.34e-3)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.68e-1)" "unprognostic (2.89e-2)" "unprognostic (9.60e-3)" "unprognostic (3.98e-2)" "unprognostic (7.55e-2)" "unprognostic (1.50e-3)" "unprognostic (2.49e-1)" "unprognostic (1.93e-1)" "unprognostic (6.53e-2)" "prognostic favorable (8.27e-4)" 7.0 6.6 7.0 8.0 6.9 5.2 8.2 7.0 6.9 11.0 8.1 7.9 8.1 12.5 8.2 6.4 8.4 7.8 5.7 6.6 7.9 8.1 5.2 7.5 7.3 8.5 7.3 6.7 11.5 5.6 11.2 13.0 7.1 12.0 8.0 11.9 8.4 9.6 3.2 7.3 8.3 9.4 7.3 9.9 8.3 9.6 7.5 11.9 11.0 4.2 7.1 6.6 8.4 18.9 6.9 22.5 17.3 12.1 15.5 14.1 21.8 10.9 14.2 16.2 12.6 9.2 23.5 14.4 16.6 15.4 17.7 17.7 9.2 18.9 18.2 12.1 17.5 15.4 8.9 10.3 18.4 8.8 15.5 15.4 13.0 13.1 15.1 14.4 13.7 18.9 12.6 13.3 13.0 10.2 13.7 7.8 15.2 11.0 21.9 14.7 9.1 9.3 21.1 28.6 27.1 17.1 9.6 14.4 18.0 19.7 12.2 22.1 18.6 18.5 11.4 11.4 15.8 21.2 12.2 8.3 11.8 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 6.9 7.0 6.9 6.6 7.9 8.5 7.3 6.7 7.1 7.3 7.5 8.4 0.0 0.0 0.0 91.7 16.8 34.2 36.2 30.2 35.9 56.6 0.0 0.0 0.0 40.0 19.2 0.0 56.3 38.7 6.7 44.2 0.0 0.0 57.8 0.0 0.0 26.3 64.8 25.4 32.8 0.0 26.1 21.7 34.7 0.0 8.9 0.0 60.0 23.3 23.1 53.8 41.2 59.1 24.4 36.8 22.4 44.7 56.8 25.8 16.0 60.0 29.4 46.6 21.6 38.7 67.5 0.0 29.3 62.4 16.8 45.2 33.1 0.0 21.9 52.1 26.3 55.2 16.3 42.6 18.0 51.2 44.0 36.9 12.7 0.0 47.2 44.9 TRNP1 "C1orf225, TRNP" ENSG00000253368 "TMF1 regulated nuclear protein 1" Q6NT89 1 26993692-27000886 "Predicted intracellular proteins" "Cell cycle, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 86.0;retina: 85.0;stomach 1: 125.7" "Group enriched" "Detected in many" 6 "Bipolar cells: 448.0;Gastric mucus-secreting cells: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 208.3;BJ hTERT+: 206.4;EFO-21: 171.4;RPTEC TERT1: 174.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.41e-1)" "unprognostic (7.15e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-3)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.53e-1)" "unprognostic (8.39e-3)" "unprognostic (1.64e-1)" "unprognostic (1.90e-1)" "unprognostic (9.71e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.55e-2)" 10.2 5.0 21.3 1.9 22.4 0.0 9.4 21.6 43.3 14.9 5.7 12.4 4.5 17.8 4.1 86.0 16.9 17.7 24.8 24.2 23.3 21.7 4.5 9.7 0.9 30.5 21.1 24.0 4.4 21.5 21.8 13.7 7.6 33.1 10.2 2.5 85.0 7.9 10.3 2.4 9.4 6.7 10.5 12.1 5.4 125.7 2.1 36.4 2.1 4.2 1.1 9.8 20.2 18.2 36.5 30.8 88.0 21.1 13.6 162.3 208.3 0.2 153.1 206.4 13.7 6.5 12.1 14.5 0.0 171.4 143.5 5.6 31.0 11.5 62.0 17.0 0.5 8.9 0.1 2.1 63.0 117.3 0.1 0.4 120.3 128.8 7.2 131.0 13.4 13.6 1.0 2.3 0.1 33.7 4.6 0.3 2.3 27.9 136.7 143.7 8.6 0.4 2.4 174.2 9.1 35.5 2.6 29.5 6.3 73.5 13.1 3.0 0.8 71.9 4.6 34.7 73.6 6.7 0.4 0.5 0.6 4.8 0.8 8.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 21.3 22.4 21.6 43.3 24.2 23.3 30.5 21.1 24.0 33.1 12.1 36.4 36.5 3.4 19.2 0.6 1.3 0.8 7.4 13.9 1.2 4.6 448.0 6.4 28.4 27.9 32.9 2.4 9.2 8.4 0.2 1.5 0.4 31.3 7.0 0.8 22.2 8.1 2.7 12.0 0.0 7.9 30.9 0.1 3.0 116.7 17.3 0.0 0.4 1.4 1.1 0.2 8.4 11.6 3.5 0.0 3.7 1.1 0.9 9.6 1.7 3.6 1.9 1.3 43.2 0.0 3.0 1.4 25.3 0.1 3.0 0.2 6.6 0.3 0.3 5.6 35.7 26.3 0.8 19.7 1.6 0.8 22.5 8.8 0.0 0.9 0.0 0.3 10.8 TRBV7-4 "TCRBV6S8A2T, TCRBV7S4, TRBV74" ENSG00000253409 "T cell receptor beta variable 7-4" A0A1B0GX95 7 142455174-142455635 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 17 "lymphoid tissue: 25.8;pancreas: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enriched" "Detected in some" 7 "HL-60: 90.9" NA NA "unprognostic (8.71e-5)" "unprognostic (4.23e-3)" "unprognostic (7.05e-5)" "unprognostic (8.94e-4)" "unprognostic (2.75e-1)" "unprognostic (3.50e-3)" "unprognostic (4.40e-1)" "unprognostic (1.95e-3)" "unprognostic (4.97e-3)" "unprognostic (3.73e-2)" "unprognostic (9.93e-3)" 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 25.8 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 90.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 1.0 0.6 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 2.9 0.5 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638580-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.5;pituitary gland: 5.4;retina: 3.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.0 0.9 2.2 0.0 2.3 0.9 0.0 4.5 3.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 3.4 1.0 0.0 0.0 0.0 2.7 3.4 2.2 0.0 0.4 0.0 5.4 0.0 3.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.2 0.6 0.6 1.1 0.4 1.1 0.9 0.7 0.6 0.3 0.9 0.9 1.3 0.7 0.0 0.8 1.4 1.0 0.1 2.2 2.3 4.5 3.2 2.5 3.4 2.7 3.4 2.2 3.2 2.0 2.8 3.6 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.2 0.1 1.8 0.0 2.9 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 5.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.9 0.0 5.5 1.1 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 15.8;ASC TERT1: 6.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 1.0 0.6 1.4 0.3 1.6 0.1 1.2 5.1 1.1 2.3 0.1 0.9 0.1 2.0 0.6 0.8 1.4 1.1 1.9 1.2 2.7 0.3 0.2 1.1 0.2 2.2 1.8 0.7 2.0 0.6 0.6 0.9 0.6 2.0 1.4 0.3 1.2 0.8 0.9 0.6 0.7 0.4 1.1 1.4 0.2 0.5 0.3 1.2 0.3 0.5 0.7 0.1 1.0 1.3 2.2 0.0 0.4 0.2 0.1 15.8 6.2 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.3 0.8 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 1.5 0.2 0.0 0.0 0.4 0.5 0.0 0.1 0.5 0.6 0.3 0.5 0.6 0.1 0.0 0.3 0.8 0.6 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.2 1.4 0.0 0.9 0.5 0.1 0.9 0.6 0.1 0.9 0.1 0.3 0.1 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 1.4 1.6 5.1 1.1 1.2 2.7 2.2 1.8 0.7 2.0 1.4 1.2 2.2 1.8 0.0 1.1 0.0 0.2 0.1 0.8 0.1 0.6 11.5 0.3 0.4 2.6 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.4 9.2 1.9 0.0 0.0 0.0 0.2 0.0 4.0 0.0 0.2 1.3 0.6 1.4 0.3 0.1 10.1 0.0 0.0 0.0 0.3 0.0 0.0 3.7 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.5 0.0 0.1 0.1 1.3 6.6 5.7 1.7 0.0 0.3 0.3 0.0 0.0 0.6 0.9 0.0 0.4 NACA2 "MGC71999, NACAL" ENSG00000253506 "Nascent polypeptide associated complex subunit alpha 2" Q9H009 17 61590421-61591219 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 64.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 143.4;Early spermatids: 418.0;Late spermatids: 155.3;Spermatocytes: 233.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.2;SK-MEL-30: 2.0" "HPA073152, HPA073648" Approved Cytosol NA NA Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (9.59e-2)" "unprognostic (5.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.45e-1)" "unprognostic (8.14e-3)" "unprognostic (4.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.18e-2)" "unprognostic (7.80e-2)" "unprognostic (2.08e-1)" "unprognostic (1.80e-2)" "unprognostic (6.88e-2)" "unprognostic (7.53e-3)" "unprognostic (5.45e-3)" "unprognostic (3.09e-3)" 1.0 0.9 0.0 0.5 0.0 0.2 1.1 0.0 0.0 0.9 0.0 0.8 0.1 0.7 0.0 1.1 0.7 0.0 0.9 0.0 0.0 0.7 0.8 0.7 0.4 0.0 0.0 0.0 1.9 1.1 0.0 0.7 0.1 0.0 1.0 0.1 0.0 0.8 0.0 1.0 1.3 0.7 0.1 0.0 0.7 0.8 64.6 0.0 0.0 0.8 0.0 0.2 0.8 1.1 0.0 0.3 0.0 0.3 0.3 0.1 0.2 0.9 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.3 0.3 0.1 0.1 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 1.0 0.0 0.1 0.4 3.2 0.7 0.0 0.1 0.4 0.2 1.1 0.1 0.0 0.3 0.7 0.2 0.4 2.0 0.0 0.8 1.1 0.0 0.1 0.4 0.6 0.3 0.3 0.3 0.3 0.4 0.2 0.2 0.1 0.3 0.1 0.2 0.7 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.0 0.3 0.7 0.4 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.0 11.2 69.3 60.6 15.0 0.0 0.7 2.2 3.2 143.4 35.8 5.2 1.8 0.0 17.5 11.7 2.9 86.1 0.3 418.0 0.5 1.1 17.6 3.6 2.7 3.4 0.8 24.1 18.5 0.0 0.6 0.0 0.7 26.4 15.1 14.5 0.0 4.0 9.1 10.2 50.7 66.3 155.3 33.8 8.2 46.2 1.0 23.7 1.5 23.7 1.5 3.5 0.6 11.1 11.3 0.0 48.1 8.1 62.1 2.9 0.9 13.1 63.8 107.3 233.8 11.4 0.0 79.3 24.1 16.3 1.1 11.8 42.9 TRBV6-8 "TCRBV13S7P, TCRBV6S8, TRBV68" ENSG00000253534 "T cell receptor beta variable 6-8" A0A0A6YYG3 7 142507382-142507810 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Early spermatids: 1.1;Late spermatids: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" NA NA "unprognostic (2.52e-1)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.3;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.2;Skeletal myocytes: 2.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.3;BJ hTERT+: 20.8;hTERT-RPE1: 10.9;SH-SY5Y: 18.6;T-47d: 8.1" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 0.5 0.4 1.1 0.2 1.1 0.0 0.6 5.9 1.0 1.0 0.0 0.9 0.1 1.3 1.1 0.5 1.0 0.4 1.3 1.1 2.3 0.6 0.4 0.7 0.1 1.6 1.4 0.6 1.5 0.8 2.3 0.8 1.3 1.7 1.0 0.3 1.7 0.8 0.8 0.7 1.0 0.4 0.8 1.1 0.4 0.3 0.5 1.2 0.2 1.9 0.5 0.1 0.9 0.7 2.2 0.0 1.6 2.3 0.0 6.6 11.3 0.0 3.3 20.8 4.2 6.1 0.0 0.0 0.5 5.2 0.7 0.2 0.2 0.0 0.1 3.4 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.0 5.0 0.1 0.0 0.7 10.9 1.7 0.0 0.0 0.1 0.1 0.1 0.6 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 18.6 0.0 0.1 0.1 3.7 8.1 0.0 6.7 0.1 0.1 3.1 0.1 0.1 1.9 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 5.9 1.0 1.1 2.3 1.6 1.4 0.6 1.7 1.1 1.2 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.3 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.0 2.8 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.3 PYDC2 POP2 ENSG00000253548 "Pyrin domain containing 2" Q56P42 3 191461163-191461456 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "brain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "A549: 1.1" "Not detected" "Not detected" HPA055895 Uncertain NA NA "HPA055895: AB_2682962" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.6 0.6 0.1 0.0 1.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693631-81695058 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.9;liver: 11.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 4.1;Enteroendocrine cells: 3.6;Gastric mucus-secreting cells: 6.1;Hepatocytes: 2.8;Proximal enterocytes: 7.2;Respiratory ciliated cells: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 3.6" "Not detected" "Not detected" HPA025966 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.1 0.2 0.8 0.3 1.0 0.0 0.2 2.0 1.5 0.3 0.0 2.9 3.2 0.3 0.7 0.3 0.3 1.7 0.2 1.0 0.9 1.9 11.4 0.2 0.0 0.8 0.8 0.9 0.3 1.0 0.2 1.0 0.0 1.2 0.6 3.7 0.5 0.3 0.2 0.2 0.4 3.9 0.2 0.5 0.3 3.5 0.1 0.9 0.1 0.5 0.3 0.2 0.3 0.2 1.0 0.2 0.2 0.2 0.3 0.2 0.5 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.4 0.5 0.0 0.0 0.2 0.3 0.1 0.2 0.2 0.8 0.6 1.3 0.5 0.1 0.0 0.1 0.1 0.6 0.2 0.8 0.6 0.1 0.2 0.5 0.3 0.3 0.2 0.2 0.4 0.0 3.6 0.2 0.0 0.1 0.2 0.2 1.4 0.5 0.3 0.1 0.2 0.1 0.1 0.5 0.1 0.3 0.3 0.5 0.4 0.5 0.3 0.9 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 2.0 1.5 1.0 0.9 0.8 0.8 0.9 1.2 0.5 0.9 1.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.6 0.0 0.5 0.0 0.0 0.0 0.0 4.1 1.9 0.4 0.0 0.4 0.3 0.2 3.6 0.0 0.9 1.1 0.1 0.1 6.1 0.3 0.0 0.3 0.7 2.8 0.0 0.0 0.8 1.5 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.5 1.9 0.0 0.0 0.4 7.2 1.7 4.1 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 2.4 0.5 EIF5AL1 "bA342M3.3, EIF5AP1" ENSG00000253626 "Eukaryotic translation initiation factor 5A like 1" Q6IS14 10 79512533-79516440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 10.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 79.2;Intestinal goblet cells: 96.7;Spermatocytes: 76.5;Undifferentiated cells: 121.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-251 MG: 2.2" HPA074052 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA074052: " "unprognostic (2.16e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.55e-1)" "unprognostic (4.14e-3)" "unprognostic (1.50e-1)" "unprognostic (3.48e-2)" "unprognostic (4.25e-2)" "unprognostic (2.50e-3)" "unprognostic (2.04e-2)" "unprognostic (3.57e-1)" "unprognostic (1.01e-1)" "unprognostic (8.79e-3)" "unprognostic (1.56e-1)" "unprognostic (8.63e-2)" "unprognostic (1.87e-1)" "unprognostic (6.68e-2)" "unprognostic (1.81e-1)" 0.6 0.8 0.1 0.2 0.1 0.2 0.6 0.4 0.3 0.3 0.0 0.5 0.2 0.5 0.2 1.4 0.4 0.0 0.8 0.1 0.0 0.5 1.3 0.6 0.3 0.0 0.0 0.1 0.3 0.7 0.2 0.4 0.0 0.2 0.5 0.2 0.8 0.5 0.0 1.5 1.0 0.5 0.0 0.0 0.5 0.5 10.6 0.0 0.0 0.5 0.0 0.3 0.5 0.7 0.1 0.4 0.8 0.3 1.7 0.0 0.2 0.3 0.3 0.1 0.3 0.2 0.6 0.3 0.9 0.3 0.0 0.2 0.5 0.1 0.0 0.2 0.2 0.7 0.2 1.0 0.4 0.1 0.3 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.6 1.0 0.9 1.2 0.1 0.1 0.3 0.7 0.6 0.5 0.8 0.2 0.5 0.5 0.4 0.6 0.1 0.8 0.7 0.2 0.4 1.0 1.1 2.2 0.4 0.5 0.8 0.7 0.2 0.6 1.1 0.8 0.6 1.2 2.0 1.4 1.3 1.2 1.3 1.6 1.3 0.9 1.3 0.7 1.7 1.3 2.5 1.0 0.8 0.1 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.8 16.0 30.0 1.3 10.4 33.8 3.0 7.8 0.0 0.6 5.1 2.4 43.1 2.8 16.1 0.0 0.0 20.8 2.4 79.2 11.7 64.5 14.7 2.9 4.4 12.9 60.0 10.7 0.6 47.8 35.1 15.5 0.0 3.2 48.2 0.9 4.2 5.1 17.5 1.7 0.6 96.7 8.2 8.7 27.9 8.7 5.0 7.2 19.6 0.0 41.9 1.2 13.4 0.0 1.0 65.6 61.2 3.0 0.5 10.3 66.5 11.1 6.1 0.5 0.0 6.9 25.9 76.5 4.3 0.0 34.5 27.6 8.9 3.3 121.3 5.0 PRSS51 ENSG00000253649 "Serine protease 51" A0A1B0GVH4 8 10482878-10547585 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "brain: 22.7" "Group enriched" "Detected in some" 10 "Early spermatids: 3.2;Late spermatids: 3.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 7 "cerebellum: 22.7;pons: 8.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in brain" NA NA "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (3.10e-1)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.72e-1)" "unprognostic (7.48e-2)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (1.02e-1)" "unprognostic (6.33e-3)" "unprognostic (2.71e-3)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" 0.0 0.1 0.2 0.1 0.8 0.2 1.1 22.7 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.6 0.1 0.0 0.0 1.1 0.7 0.0 0.2 0.0 0.2 0.0 8.7 0.1 0.0 0.7 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 22.7 2.2 0.6 0.0 0.0 1.1 0.7 8.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG11 "CDG1P, KIAA0266" ENSG00000253710 "ALG11 alpha-1,2-mannosyltransferase" Q2TAA5 13 52012391-52079232 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047214 Approved NA NA "HPA047214: AB_10961640" "unprognostic (9.21e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (3.04e-2)" "unprognostic (9.15e-3)" "unprognostic (1.69e-1)" "unprognostic (2.28e-1)" "unprognostic (8.97e-3)" "unprognostic (8.89e-3)" "unprognostic (7.47e-2)" "unprognostic (2.30e-4)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.03e-2)" "unprognostic (9.71e-3)" 10.2 9.6 7.7 8.4 8.6 4.2 12.2 9.7 10.1 12.2 1.7 11.1 10.2 11.1 9.4 7.6 10.8 8.9 10.5 8.1 5.2 14.8 19.4 9.2 8.1 5.7 4.3 8.3 11.7 8.7 17.3 2.5 12.8 6.1 12.2 11.9 9.1 10.9 11.0 6.6 7.3 9.8 11.5 2.0 10.1 11.7 6.2 4.5 9.6 16.9 8.9 8.7 8.8 2.5 9.8 6.7 10.5 17.8 15.2 18.6 13.3 14.2 17.7 16.3 12.9 10.3 8.5 14.5 16.2 4.2 18.4 15.8 15.3 18.2 12.0 17.0 16.7 12.9 31.0 8.8 11.4 14.1 28.3 31.0 12.9 17.8 10.1 18.4 14.1 11.5 18.5 17.8 10.4 19.4 5.7 14.7 9.7 19.2 28.8 7.5 15.2 11.9 8.9 16.7 10.8 6.9 15.2 11.9 17.1 11.9 15.0 11.9 20.8 17.8 10.4 11.5 13.6 11.8 9.1 13.5 17.7 6.4 11.7 18.0 13.2 5.4 7.2 7.7 4.5 7.6 5.1 7.0 6.6 6.9 7.1 8.9 8.9 2.2 7.3 12.0 9.8 7.2 4.9 7.7 8.6 9.7 10.1 8.1 5.2 5.7 4.3 8.3 6.1 2.0 4.5 9.8 5.3 19.2 8.2 5.5 7.1 2.4 3.2 7.8 8.0 6.8 4.2 3.2 7.5 5.7 9.3 3.7 6.2 3.4 6.2 2.1 1.9 2.9 0.9 5.1 7.3 5.2 3.0 12.6 9.3 2.2 3.9 8.2 9.7 5.4 3.8 6.5 6.1 4.0 2.5 5.0 8.1 2.7 6.1 2.2 3.1 0.5 3.4 3.5 1.8 5.6 2.6 2.8 11.3 13.0 8.9 2.7 1.7 1.2 14.0 2.6 3.5 1.7 13.5 7.5 0.0 4.2 6.4 4.8 3.5 7.8 2.4 4.8 7.2 3.7 2.1 4.0 ATXN7L3B lnc-SCA7 ENSG00000253719 "Ataxin 7 like 3B" Q96GX2 12 74537835-74545430 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056612 Approved Nucleoplasm NA NA Nucleoplasm "HPA056612: AB_2683190" "unprognostic (3.43e-3)" "unprognostic (1.07e-1)" "unprognostic (4.76e-2)" "unprognostic (3.20e-2)" "unprognostic (3.68e-1)" "unprognostic (9.26e-2)" "unprognostic (1.81e-3)" "unprognostic (7.12e-2)" "unprognostic (9.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.49e-1)" "prognostic favorable (2.25e-6)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 13.9 18.7 28.8 15.3 29.1 20.2 22.4 27.2 31.0 18.4 24.7 17.4 20.5 21.3 25.2 14.1 33.5 14.4 18.1 28.7 30.8 23.8 20.7 16.7 21.2 26.2 28.6 27.9 32.6 23.1 26.1 16.0 23.0 29.9 22.5 19.3 46.7 23.5 21.3 21.1 18.0 19.1 18.1 26.4 19.3 38.6 8.9 29.6 30.8 24.8 21.1 23.0 14.3 12.1 31.4 21.5 16.6 54.3 34.6 33.6 31.4 23.2 20.1 20.0 23.3 18.1 19.3 11.6 31.0 15.6 20.0 15.6 21.1 28.4 19.4 19.2 28.8 22.3 41.5 17.3 29.4 32.0 41.6 8.4 36.4 44.3 17.9 29.2 40.6 27.3 35.5 52.1 15.2 19.3 31.0 46.2 29.5 31.0 29.4 15.8 35.7 29.4 28.1 21.5 34.8 85.1 53.7 22.7 26.6 32.6 35.0 62.8 26.9 23.6 22.3 19.5 13.4 12.7 18.0 18.0 39.9 9.6 15.0 22.8 17.3 9.5 12.7 5.1 8.9 6.2 4.2 7.7 5.7 8.9 4.8 13.1 7.4 2.7 8.4 12.1 4.9 6.1 9.1 28.8 29.1 27.2 31.0 28.7 30.8 26.2 28.6 27.9 29.9 26.4 29.6 31.4 40.1 73.7 46.3 10.1 33.4 18.4 42.1 25.2 56.9 87.9 40.6 44.7 53.0 41.5 48.3 38.6 33.3 58.7 54.8 33.1 31.3 39.6 0.7 76.1 67.5 39.9 36.2 36.2 17.2 32.8 34.0 41.7 98.4 37.5 46.2 35.8 27.8 27.5 22.9 52.2 18.2 38.7 10.2 23.9 10.7 2.0 37.6 25.9 21.4 13.1 32.9 104.5 62.8 9.5 17.9 61.8 23.4 37.6 27.6 47.3 23.3 39.8 113.5 80.8 19.7 58.8 81.5 11.6 15.8 37.0 22.9 45.0 37.5 46.7 35.8 37.9 PRKDC "DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7" ENSG00000253729 "Protein kinase, DNA-activated, catalytic subunit" P78527 8 47773111-47960178 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005167, HPA035174" Supported Enhanced Nucleoplasm NA NA 250000 Nucleoplasm "CAB005167: AB_2172845, HPA035174: AB_2674504" "unprognostic (3.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.95e-2)" "unprognostic (1.34e-1)" "unprognostic (7.70e-3)" "unprognostic (5.74e-2)" "unprognostic (1.12e-2)" "unprognostic (1.60e-2)" "unprognostic (7.76e-3)" "unprognostic (7.77e-2)" "unprognostic (2.84e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (6.76e-3)" "unprognostic (2.15e-2)" 17.1 16.9 9.1 14.2 10.8 19.4 16.3 9.7 12.0 17.3 10.6 16.1 7.0 20.3 8.0 24.2 18.4 7.5 16.8 10.0 11.3 11.5 14.1 15.0 18.0 10.4 10.0 8.8 19.9 18.1 14.1 16.4 11.0 9.5 13.7 11.7 24.0 16.1 9.3 26.6 19.8 17.3 12.2 9.7 18.9 16.7 18.4 9.6 28.0 13.5 15.1 17.2 18.9 17.6 14.3 123.5 103.4 98.4 93.9 59.9 63.0 41.6 51.2 49.9 70.3 68.9 68.0 39.6 117.1 43.1 63.3 52.3 68.5 131.3 70.2 109.3 26.3 81.8 230.2 92.1 83.7 25.8 88.6 46.0 45.9 22.5 111.3 115.3 27.1 73.4 79.5 156.6 48.0 78.8 57.7 125.8 72.3 108.6 85.6 31.2 60.8 77.3 41.2 35.5 104.4 49.2 62.5 158.1 50.6 51.1 60.2 72.6 60.1 86.2 91.5 78.0 73.0 104.2 41.3 56.7 162.8 51.7 97.9 75.6 11.4 8.1 4.1 8.7 6.8 11.0 13.1 10.8 9.2 6.5 16.7 11.2 10.3 7.7 12.8 13.7 15.3 8.3 2.9 9.1 10.8 9.7 12.0 10.0 11.3 10.4 10.0 8.8 9.5 9.7 9.6 14.3 73.4 38.5 36.1 56.8 67.9 38.4 48.3 59.7 77.4 103.4 63.1 64.0 82.1 22.8 44.1 42.3 125.1 61.1 81.9 17.5 17.6 41.9 29.0 66.0 166.5 59.7 25.8 147.6 85.5 36.0 60.6 73.2 55.0 72.6 45.6 105.1 32.5 41.2 35.9 104.3 77.1 31.2 38.7 45.5 20.1 15.5 56.8 54.6 19.6 61.8 63.6 73.1 57.7 82.0 76.0 34.9 16.6 69.6 69.3 57.1 13.2 23.5 50.1 111.6 52.6 91.2 69.3 100.7 106.3 85.3 40.6 33.0 71.0 143.2 55.2 36.4 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373891-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 10.6;Cardiomyocytes: 5.0;Endometrial stromal cells: 4.6;Hepatic stellate cells: 3.6;Skeletal myocytes: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 9.6;T-47d: 5.6;WM-115: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 1.4 1.1 1.9 0.7 2.0 0.1 1.3 7.2 1.6 2.5 0.2 1.6 0.2 3.2 1.4 0.8 2.0 1.1 2.3 1.9 2.1 0.8 0.5 1.5 0.4 1.9 1.8 1.6 3.6 1.2 1.1 1.8 2.3 2.5 1.2 0.4 2.1 1.5 1.6 0.9 1.5 0.8 2.0 0.7 0.9 0.7 0.8 1.5 0.5 1.2 1.0 0.4 1.6 1.5 2.1 0.0 0.3 2.7 0.4 1.3 4.7 0.1 2.1 0.7 1.1 1.1 0.0 0.1 2.0 2.6 3.3 1.0 0.4 0.1 0.4 0.7 0.0 0.2 0.0 0.3 0.2 0.7 0.1 0.1 4.9 0.3 0.2 0.1 1.0 1.6 0.1 0.2 1.1 0.3 0.4 0.7 1.7 0.3 0.0 0.1 1.4 0.4 0.0 0.3 0.1 9.6 0.7 0.1 0.3 0.6 0.6 5.6 0.1 4.8 0.7 0.3 0.7 0.7 0.4 1.7 0.4 0.8 0.7 12.2 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.9 2.0 7.2 1.6 1.9 2.1 1.9 1.8 1.6 2.5 0.7 1.5 2.1 2.8 0.0 2.2 0.0 0.4 0.0 0.8 0.0 0.0 10.6 0.3 1.0 5.0 1.5 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.5 0.4 4.6 1.8 0.0 0.4 0.0 1.5 0.1 2.2 0.0 0.4 0.0 0.6 3.6 0.7 0.1 1.7 0.0 0.2 0.0 0.3 0.0 0.3 1.2 0.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.1 2.2 1.6 0.4 0.0 0.3 0.7 0.9 0.0 5.2 1.9 0.3 0.3 0.5 0.0 0.3 0.2 0.5 0.2 0.2 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 3.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.1 0.1 0.7 0.1 0.7 0.4 0.1 3.9 0.9 0.2 0.3 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.9 0.6 0.1 0.1 0.1 0.1 1.1 0.7 0.5 0.3 0.1 0.0 0.2 0.2 1.3 0.1 0.1 0.5 0.1 0.0 0.3 0.3 0.1 0.1 0.4 0.1 0.1 0.1 0.8 0.1 0.4 0.1 0.1 0.1 0.1 1.9 0.0 0.0 0.3 0.1 0.2 0.6 0.1 0.6 0.4 0.4 0.1 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.6 0.2 0.4 0.6 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.7 0.7 3.9 0.9 0.9 0.6 1.1 0.7 0.5 1.3 0.4 0.8 1.9 1.2 0.0 0.6 0.0 0.1 0.0 0.9 0.0 0.0 11.4 0.3 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.1 2.1 1.2 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.2 0.0 0.3 0.4 0.7 0.1 3.3 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.2 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.1 0.1 1.5 0.0 0.7 0.0 0.2 0.0 1.7 0.0 5.2 0.9 0.7 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.5 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;JURKAT: 2.2;MOLT-4: 1.3;NB-4: 5.7;RPTEC TERT1: 2.1;THP-1: 2.9" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 5.4 5.3 3.9 0.0 3.7 0.0 5.2 3.7 4.2 5.7 4.0 6.1 0.3 7.2 0.0 4.4 5.9 0.0 6.1 3.5 3.5 4.8 7.8 4.8 0.6 3.5 3.8 3.3 5.6 6.9 1.2 5.5 0.0 3.6 5.4 0.0 2.2 6.7 0.0 6.7 3.6 5.6 0.2 3.4 5.1 6.0 3.3 3.7 1.8 6.1 2.4 0.0 5.5 5.2 3.8 0.0 0.0 1.2 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 1.3 5.7 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.7 3.7 4.2 3.5 3.5 3.5 3.8 3.3 3.6 3.4 3.7 3.8 9.9 6.4 17.5 8.5 8.2 5.9 5.6 10.8 9.6 13.9 13.7 7.9 23.8 12.8 15.8 16.5 4.2 10.1 5.1 21.2 0.0 7.3 0.4 9.1 13.9 13.9 18.6 19.9 8.9 7.6 9.6 13.9 5.1 12.4 11.4 14.4 14.6 33.6 9.3 25.2 9.0 14.7 8.2 13.5 3.9 0.8 10.5 8.1 8.8 5.6 8.2 14.1 10.3 6.6 10.7 7.7 11.3 14.3 8.4 12.7 9.9 6.4 14.8 11.6 6.6 20.2 12.6 7.2 13.3 14.0 8.4 7.0 7.2 9.4 14.1 6.7 ETV3L FLJ16478 ENSG00000253831 "ETS variant transcription factor 3 like" Q6ZN32 1 157092043-157112412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 9.2" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.3;Breast myoepithelial cells: 2.0;Langerhans cells: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "midbrain: 9.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HDLM-2: 36.2" "Not detected" "Not detected" NA NA "unprognostic (7.39e-4)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (1.79e-5)" "unprognostic (2.25e-1)" "unprognostic (5.91e-2)" "unprognostic (1.57e-2)" "unprognostic (3.09e-4)" "unprognostic (1.88e-1)" "unprognostic (5.37e-2)" "unprognostic (3.37e-1)" 0.0 0.0 0.2 0.3 0.3 0.0 0.8 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.1 9.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.2 1.4 0.1 9.2 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.7;Cone photoreceptor cells: 16.7;Horizontal cells: 23.5;Skeletal myocytes: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 14.6;HSkMC: 16.1;T-47d: 19.7;U-2197: 11.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 1.6 1.7 3.5 0.4 3.0 0.1 1.1 4.0 2.5 1.3 0.9 1.0 0.8 1.3 0.7 1.8 1.3 1.5 1.0 2.8 7.1 0.5 1.5 1.4 0.4 3.3 3.0 1.8 1.3 0.6 2.1 0.8 3.6 3.2 1.4 0.9 2.6 1.8 1.8 1.1 2.0 1.0 1.1 4.0 0.9 2.1 0.5 4.4 0.4 2.1 0.3 0.5 0.8 1.4 4.0 0.0 0.0 14.6 7.5 6.3 2.7 6.9 2.6 0.1 3.6 5.6 0.3 0.9 0.8 9.6 3.7 0.2 0.4 3.5 2.4 2.8 0.9 0.1 0.0 0.3 0.0 2.5 1.5 0.3 16.1 0.4 2.4 1.0 0.4 1.4 0.3 0.0 0.1 9.0 0.1 0.1 0.4 1.4 0.0 0.1 0.2 1.2 0.0 2.4 0.1 2.0 0.7 0.4 0.1 0.4 3.5 19.7 1.9 3.3 6.7 0.4 11.6 0.1 0.2 1.2 0.1 3.4 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 3.0 4.0 2.5 2.8 7.1 3.3 3.0 1.8 3.2 4.0 4.4 4.0 5.8 0.0 2.0 0.0 0.9 0.1 2.3 0.6 1.2 27.7 2.2 2.2 3.4 1.5 1.6 1.8 16.7 2.1 1.3 0.7 0.0 1.0 0.0 1.3 7.7 4.8 1.2 0.4 0.0 1.4 1.3 4.8 1.5 2.0 1.3 1.0 4.6 1.7 1.0 23.5 0.0 1.6 0.0 0.0 0.0 0.2 3.4 0.7 1.8 0.0 0.0 5.7 0.0 0.0 0.0 3.1 0.4 2.2 0.5 2.8 0.4 0.5 0.0 6.7 6.6 14.9 3.7 0.4 0.7 1.2 0.4 0.4 0.5 3.0 1.3 1.5 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512975 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 0.8 0.7 1.5 0.7 1.8 0.0 0.6 5.1 1.5 0.8 0.8 0.8 0.2 0.8 0.3 0.7 0.9 0.5 1.5 2.1 4.6 0.4 0.4 0.6 0.4 2.0 1.3 0.5 1.1 0.5 0.3 0.6 2.2 2.0 0.5 0.3 3.1 0.7 0.7 1.1 1.7 0.4 0.8 2.4 0.3 0.4 0.8 2.1 0.3 0.8 0.6 0.3 0.6 0.8 3.1 0.0 0.0 0.7 2.4 24.3 25.9 0.9 5.5 10.6 4.2 6.6 0.1 0.2 0.6 9.1 5.6 47.4 3.7 0.1 0.6 6.6 0.2 2.4 0.1 0.1 0.0 4.0 0.4 0.0 19.0 0.3 7.4 0.1 69.8 6.5 1.2 0.0 0.1 0.1 0.0 0.0 0.3 2.9 0.0 0.1 17.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 21.3 9.9 0.5 3.2 7.9 0.8 0.1 0.6 0.1 0.0 0.4 0.0 0.1 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 1.8 5.1 1.5 2.1 4.6 2.0 1.3 0.5 2.0 2.4 2.1 3.1 0.5 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.7 0.1 0.5 0.8 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.1 0.0 0.2 1.1 0.0 0.4 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.6 0.3 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.1 0.1 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.2;Cardiomyocytes: 1.4;Endometrial stromal cells: 1.0;Fibroblasts: 1.2" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 13.5;ASC TERT1: 9.8;LHCN-M2: 8.2;REH: 7.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350" "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 1.6 1.0 2.6 0.6 3.7 0.1 1.1 6.5 3.1 2.2 0.1 0.9 0.2 3.0 0.9 0.9 1.7 2.0 1.7 3.4 4.3 0.7 0.7 1.7 0.3 3.7 3.1 1.8 2.8 0.8 1.2 1.0 1.2 3.3 1.3 0.8 1.6 0.8 1.2 0.8 0.8 0.5 1.5 3.6 0.6 0.6 0.5 2.6 0.4 0.7 0.9 0.3 0.9 1.2 5.9 0.1 0.3 2.0 0.2 13.5 9.8 0.1 2.1 2.9 0.6 3.2 0.0 0.3 3.7 1.0 1.7 7.1 0.5 0.4 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.5 0.2 0.2 2.5 0.5 0.2 0.1 4.7 1.7 0.1 0.2 1.2 8.2 0.5 2.9 0.7 0.1 0.9 0.9 7.8 2.6 0.2 0.2 0.3 1.5 1.6 0.2 0.4 0.4 1.5 3.0 0.2 5.9 2.9 0.6 4.4 3.9 0.2 2.2 0.6 3.1 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 6.5 3.1 3.4 4.3 3.7 3.1 1.8 3.3 3.6 2.6 5.9 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.6 2.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.1;Horizontal cells: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 43.3;SuSa: 15.5;TIME: 22.7" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 1.3 1.1 1.8 0.4 1.7 0.0 0.9 4.5 1.4 1.4 1.7 0.9 0.2 1.6 1.6 0.7 1.3 0.5 1.5 1.8 2.9 1.4 1.6 1.1 0.1 2.1 1.7 0.9 2.4 1.0 1.9 1.2 3.0 2.1 1.2 0.4 1.4 1.6 1.4 1.1 1.7 0.5 1.0 1.5 0.4 0.5 0.5 2.2 0.7 1.7 0.8 0.2 1.0 1.1 1.7 0.0 1.1 11.1 0.1 6.9 8.5 1.3 10.8 43.3 4.4 3.0 0.0 0.0 0.4 8.3 0.3 0.2 3.3 0.0 0.0 4.6 0.0 0.0 0.0 0.2 2.4 2.8 0.0 0.0 8.4 0.1 4.1 0.0 0.1 6.7 0.0 0.4 0.1 0.0 0.0 1.1 0.2 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 15.5 5.6 4.2 22.7 6.0 1.8 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 1.7 4.5 1.4 1.8 2.9 2.1 1.7 0.9 2.1 1.5 2.2 1.7 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.6 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701937-8704096 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 15.8" "Group enriched" "Detected in many" 4 "Distal enterocytes: 418.8;Paneth cells: 449.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "myeloid DC: 1.3;plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 7.7;Daudi: 6.4;RT4: 6.7;SK-BR-3: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061306 Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA Vesicles "Plasma membrane, Cell Junctions" "HPA061306: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favorable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 5.8 1.1 0.3 2.3 0.3 0.1 5.8 0.2 0.3 2.3 1.9 9.4 4.1 1.0 1.9 3.3 1.4 1.2 0.7 0.3 0.6 4.2 10.5 4.7 0.4 0.4 0.3 0.2 1.6 4.1 2.1 0.9 1.5 0.4 1.4 6.9 0.1 6.8 1.3 0.5 13.0 10.2 0.3 0.4 1.8 15.8 0.5 0.4 0.1 5.0 0.3 0.3 5.0 2.7 0.7 0.1 2.6 0.0 0.1 0.7 0.1 7.7 1.9 1.5 2.0 3.1 1.5 4.2 6.4 0.0 0.1 0.7 2.5 0.0 0.0 0.2 1.3 0.0 0.0 0.7 0.1 3.5 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.3 0.0 0.2 1.9 0.3 1.3 0.0 0.0 0.0 0.9 6.7 0.3 0.9 2.6 6.8 0.1 0.7 0.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.3 0.2 0.3 0.3 0.6 0.4 0.3 0.2 0.4 0.4 0.4 0.7 13.0 9.6 3.1 0.3 1.1 0.1 6.6 4.2 2.2 0.1 6.8 3.4 0.7 30.0 6.9 1.8 0.0 19.1 2.8 418.8 7.9 26.9 0.0 6.0 2.5 3.4 7.7 0.0 0.0 10.7 14.9 3.3 59.7 6.7 4.5 0.8 8.2 10.6 16.8 0.0 0.0 49.9 26.4 2.4 1.4 0.0 0.3 4.6 3.6 1.9 1.4 1.1 0.0 0.0 0.0 28.1 449.9 0.4 0.1 3.3 99.1 4.7 10.3 1.1 6.6 1.5 3.2 0.0 0.0 3.9 0.6 9.4 1.3 0.3 55.2 12.2 ZNF260 "ozrf1, Zfp260" ENSG00000254004 "Zinc finger protein 260" Q3ZCT1 19 36510687-36528271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028806 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028806: AB_10795285" "unprognostic (1.34e-1)" "unprognostic (6.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.11e-3)" "unprognostic (3.55e-2)" "unprognostic (1.29e-3)" "unprognostic (7.83e-3)" "unprognostic (3.91e-1)" "unprognostic (1.13e-2)" "unprognostic (8.36e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-2)" "prognostic favorable (1.44e-4)" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (7.89e-3)" 4.5 5.1 5.1 4.2 5.9 1.7 8.0 5.7 5.8 6.7 4.7 4.0 4.2 7.3 5.3 5.2 5.4 5.5 5.1 4.9 5.7 7.5 5.8 4.9 6.3 5.4 6.0 4.2 8.5 4.0 11.8 3.2 6.8 5.5 6.6 4.6 9.0 4.8 4.7 2.4 6.9 4.2 5.3 5.8 5.9 5.6 3.1 6.1 7.7 9.8 4.2 6.8 6.2 3.5 7.3 11.2 11.2 25.1 19.1 7.7 11.5 10.9 9.6 10.1 8.6 11.0 5.1 6.2 7.3 15.2 7.8 6.6 4.1 12.8 5.9 13.2 9.7 5.6 10.8 8.6 5.8 10.7 5.5 8.7 10.6 9.8 8.9 13.7 12.5 11.7 10.7 8.7 7.9 17.4 6.1 20.6 3.6 15.9 7.0 4.8 13.5 15.5 5.5 9.8 19.6 18.1 19.9 21.3 11.4 8.0 15.3 9.5 10.5 10.2 15.0 15.5 8.9 8.7 10.0 20.4 16.7 0.4 5.9 20.7 4.6 1.3 1.4 1.7 1.2 1.8 2.4 2.3 1.4 1.5 2.9 3.1 2.4 0.6 1.9 1.9 1.0 2.2 1.4 5.1 5.9 5.7 5.8 4.9 5.7 5.4 6.0 4.2 5.5 5.8 6.1 7.3 10.9 9.6 6.2 9.4 14.1 10.3 8.2 7.2 18.2 7.9 12.3 9.8 8.9 1.5 11.1 0.0 8.4 6.4 8.9 2.7 5.9 8.2 18.0 9.3 12.7 9.7 12.0 10.7 13.2 4.4 7.0 9.3 7.7 9.2 8.2 15.9 10.8 4.0 4.6 21.9 13.4 5.1 12.2 5.7 3.3 4.1 5.9 5.4 1.8 9.4 6.0 7.9 5.2 24.1 27.7 6.6 3.5 8.2 3.7 7.1 3.4 8.3 6.3 7.9 6.6 6.4 9.1 8.0 3.8 16.2 13.1 4.1 10.4 9.2 4.6 11.9 LYN JTK8 ENSG00000254087 "LYN proto-oncogene, Src family tyrosine kinase" P07948 8 55879835-56014169 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 74.5;lymphoid tissue: 86.1" "Cell type enhanced" "Detected in many" "B-cells: 237.5;Kupffer cells: 183.7;Macrophages: 226.0;monocytes: 182.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 64.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 198.4;HMC-1: 193.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001231, CAB004492" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA 770000 "Golgi apparatus, Plasma membrane" Vesicles "CAB004492: AB_627897, HPA001231: AB_1079286" "unprognostic (7.87e-2)" "unprognostic (4.89e-2)" "unprognostic (9.04e-2)" "unprognostic (3.74e-1)" "unprognostic (8.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.70e-2)" "unprognostic (1.11e-1)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (3.68e-2)" "unprognostic (7.15e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.13e-1)" "unprognostic (2.72e-3)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" 17.4 7.3 3.5 79.9 4.3 74.5 9.3 7.3 8.1 11.1 8.9 14.3 36.6 6.3 4.9 8.6 10.1 23.7 5.4 4.2 10.3 6.0 15.0 28.5 49.6 9.5 5.0 3.2 3.6 9.6 6.3 4.8 23.7 7.6 5.7 13.4 9.0 17.1 9.8 1.6 3.6 31.8 14.4 7.8 86.1 13.4 3.1 7.5 10.5 10.7 4.4 53.5 30.0 5.8 11.3 47.2 24.6 6.9 0.7 0.5 0.0 43.6 34.6 54.7 21.0 15.7 18.0 15.5 41.2 15.0 12.1 15.3 19.3 22.2 23.8 14.6 70.0 19.8 198.4 6.9 5.5 4.0 20.6 193.4 0.8 7.8 0.6 13.6 13.1 27.2 0.0 98.3 90.2 3.0 3.3 0.1 21.5 38.6 72.9 2.1 3.3 9.6 5.0 9.8 24.9 4.5 74.8 17.3 0.1 7.5 44.9 3.4 41.4 33.1 0.0 10.0 0.1 15.0 26.4 13.2 102.4 1.5 38.8 1.7 4.5 12.2 22.7 1.6 28.3 1.3 15.9 0.3 0.6 10.3 16.1 0.2 0.7 64.4 4.3 49.1 16.2 0.0 5.0 3.5 4.3 7.3 8.1 4.2 10.3 9.5 5.0 3.2 7.6 7.8 7.5 11.3 21.0 35.3 37.5 27.7 237.5 5.4 23.8 32.4 4.6 6.3 10.3 7.0 2.2 18.6 44.5 9.2 2.1 2.9 130.0 14.5 0.0 21.8 0.9 14.6 26.2 28.1 6.0 40.4 1.1 53.0 65.2 13.6 18.8 15.9 72.8 0.5 22.9 13.2 126.6 0.0 2.5 14.1 14.2 183.7 96.1 2.4 3.4 226.0 5.4 92.8 182.6 54.3 94.7 13.0 1.7 40.7 13.3 1.2 58.9 62.9 26.0 2.1 40.9 2.6 19.7 3.7 6.4 1.2 2.1 4.9 5.8 38.7 25.0 62.5 17.1 82.4 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1" ENSG00000254093 "PIN2 (TERF1) interacting telomerase inhibitor 1" Q96BK5 8 10764961-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 20.0;Extravillous trophoblasts: 13.0;Hofbauer cells: 16.1;Syncytiotrophoblasts: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 9.9 7.8 6.6 8.9 7.7 9.1 10.0 8.4 8.6 9.7 5.7 9.0 6.2 9.4 4.5 12.2 8.9 4.0 8.1 7.1 6.8 8.7 11.8 8.1 11.6 6.9 6.7 6.1 9.9 9.1 6.1 6.4 7.3 6.9 8.2 6.2 12.2 7.4 4.2 13.6 14.2 7.7 8.5 6.6 9.3 8.2 9.8 7.2 13.1 8.3 9.4 11.2 10.3 10.6 7.5 14.5 18.9 20.1 19.2 16.6 13.5 23.1 21.5 9.7 23.2 15.6 20.0 12.4 38.5 7.4 11.7 28.3 28.6 51.4 39.9 29.8 15.7 15.3 16.2 13.3 22.0 18.8 17.4 9.7 11.3 24.9 18.3 34.0 8.2 32.7 25.8 52.3 23.1 22.9 17.1 57.7 21.8 46.3 62.6 21.0 46.5 24.5 35.2 17.5 17.5 16.6 17.3 14.5 17.0 48.3 24.3 18.1 21.7 20.0 13.9 30.3 18.0 28.1 10.3 29.0 71.2 14.4 32.6 32.1 1.9 8.4 6.1 14.6 10.7 18.9 12.9 12.8 15.6 11.1 10.8 17.1 13.5 0.5 12.5 9.9 8.6 16.1 10.4 6.6 7.7 8.4 8.6 7.1 6.8 6.9 6.7 6.1 6.9 6.6 7.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 13.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 48.2 0.0 0.0 0.0 0.0 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 7.9;Fibroblasts: 3.4;Horizontal cells: 3.3;Skeletal myocytes: 5.9" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "AN3-CA: 86.7;HSkMC: 26.7;hTERT-RPE1: 72.4" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 5.3 4.7 4.2 1.8 4.3 0.1 4.2 10.9 3.5 4.7 4.7 3.9 0.9 5.8 2.2 3.0 4.4 4.5 4.3 4.7 11.0 2.4 1.5 5.9 1.2 6.1 5.9 2.0 8.2 1.7 4.4 2.2 5.6 5.0 3.8 1.7 5.8 3.8 5.6 3.0 3.3 2.1 5.1 7.7 2.7 2.4 1.9 6.8 1.5 4.0 4.1 0.9 3.3 3.8 7.7 0.0 0.0 2.9 86.7 1.9 0.3 0.9 5.7 0.7 2.1 4.3 0.1 5.3 0.7 4.6 11.7 0.8 1.4 0.2 1.0 2.0 0.1 0.6 0.0 0.2 0.0 6.4 0.5 0.1 26.7 0.7 1.7 0.9 72.4 4.6 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.0 0.6 10.1 1.9 0.0 0.2 0.0 9.3 12.8 0.2 0.0 0.0 1.0 1.0 0.9 11.5 10.3 0.2 0.9 0.1 0.1 0.2 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 4.3 10.9 3.5 4.7 11.0 6.1 5.9 2.0 5.0 7.7 6.8 7.7 2.2 3.2 1.3 0.0 0.3 0.4 0.8 0.0 0.0 7.9 0.3 0.5 1.4 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.0 0.2 0.1 0.4 2.1 2.2 0.0 0.0 0.0 0.5 0.1 3.4 0.0 0.3 1.3 0.5 0.4 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 0.0 1.9 0.1 0.4 0.0 0.3 0.0 0.7 0.0 5.9 2.2 0.0 0.1 0.5 0.4 0.0 0.0 1.2 0.1 0.2 CD8B2 CD8BP ENSG00000254126 "CD8b2 molecule" A6NJW9 2 106487364-106544297 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.5;lymphoid tissue: 7.4" "Cell type enhanced" "Detected in some" "Proximal tubular cells: 2.9;T-cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory CD8 T-cell: 18.8;naive CD8 T-cell: 30.7" "Lineage enriched" "Detected in many" 14 "T-cells: 30.7" "Cell line enriched" "Detected in some" 8 "RPMI-8226: 390.6" NA NA "unprognostic (9.34e-3)" "unprognostic (7.84e-2)" "unprognostic (2.32e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-1)" "unprognostic (5.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.27e-1)" "unprognostic (1.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.90e-2)" "unprognostic (9.67e-3)" 0.0 0.0 2.2 0.5 1.8 0.0 0.1 1.8 2.7 0.4 1.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 1.6 1.6 2.0 0.0 0.0 2.0 2.9 2.3 1.4 0.0 0.0 0.3 0.0 3.5 0.8 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.0 0.1 0.8 0.1 2.4 7.4 0.0 0.0 5.7 0.7 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 51.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 390.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 12.0 42.7 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.6 0.0 2.8 0.0 0.0 18.8 0.0 0.0 0.1 30.7 0.1 0.2 0.0 0.0 0.0 11.8 2.2 1.8 1.8 2.7 1.6 1.6 2.9 2.3 1.4 3.5 2.0 2.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 IGHV8-51-1 "IGHV(III)-51-1, IGHVIII-51-1" ENSG00000254167 "Immunoglobulin heavy variable IGHV8-51-1 (non-functional)" 14 106583501-106583807 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "MOLT-4: 10.8" "Immunoglobulin genes" NA NA "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Early spermatids: 17.5;Intestinal goblet cells: 9.4;Undifferentiated cells: 9.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.6 1.7 6.1 2.9 5.8 4.7 2.5 6.7 8.5 2.9 6.2 2.5 2.0 2.1 3.2 2.2 3.1 1.8 2.3 5.9 5.1 3.3 4.2 2.5 6.1 6.5 4.6 4.4 3.3 2.0 0.9 2.7 1.2 7.3 2.8 1.7 5.8 2.2 0.6 4.5 6.8 3.7 0.9 3.2 4.4 2.8 4.9 6.1 2.1 3.2 0.9 1.1 2.4 2.6 9.1 1.5 1.2 2.2 3.2 1.6 1.2 2.9 1.4 0.6 1.2 0.5 1.7 2.9 9.0 2.1 0.7 0.5 2.6 1.8 2.1 1.2 2.2 2.4 2.1 4.4 2.8 0.8 2.6 4.9 0.7 1.6 1.3 1.8 2.5 0.6 2.4 2.7 2.6 1.1 3.5 2.2 8.3 3.8 0.9 2.7 3.3 0.9 3.0 1.3 1.1 2.9 1.4 0.4 2.0 1.1 6.8 1.1 3.3 3.0 3.0 1.3 2.1 1.9 2.5 1.7 7.3 1.7 3.3 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.5 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 6.1 5.8 6.7 8.5 5.9 5.1 6.5 4.6 4.4 7.3 3.2 6.1 9.1 1.4 9.6 5.6 3.6 4.2 0.0 0.1 0.3 0.6 0.2 1.5 0.9 2.5 1.5 2.6 0.0 0.0 0.3 3.7 8.8 0.0 1.2 17.5 0.6 0.5 2.6 7.2 1.3 4.6 0.8 0.2 1.8 3.6 0.6 5.1 0.4 0.4 0.2 0.3 5.0 5.4 9.4 0.0 0.0 0.0 5.9 0.3 1.6 0.0 1.0 1.5 0.1 5.2 2.5 4.2 1.9 5.9 0.7 2.7 0.1 3.7 0.3 2.3 0.3 0.0 0.5 1.0 0.8 0.1 0.5 0.0 0.4 4.4 0.3 9.8 0.0 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Cell type enhanced" "Detected in some" "Early spermatids: 5.7;Late spermatids: 7.6;Melanocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;ASC TERT1: 6.6;hTERT-RPE1: 7.1;T-47d: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 0.6 0.8 2.1 0.1 1.4 0.0 0.5 2.3 2.2 0.6 0.0 0.2 0.0 1.2 0.4 0.3 0.4 0.5 0.5 3.0 3.1 0.4 0.1 0.6 0.0 2.1 2.8 1.3 1.4 0.8 2.3 1.0 0.2 2.4 0.6 0.1 1.6 0.3 0.9 0.2 0.2 0.1 0.9 2.3 0.1 0.1 0.4 2.2 0.1 0.6 0.3 0.0 0.3 0.3 4.0 0.1 1.9 1.6 0.0 12.9 6.6 0.1 1.2 3.2 0.5 0.7 0.2 0.5 0.5 4.2 0.5 3.1 0.6 0.3 0.2 0.4 0.0 0.8 0.0 0.2 1.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 7.1 0.1 0.0 0.2 0.2 3.0 1.7 0.4 0.3 0.2 0.0 0.0 0.0 2.4 0.1 0.0 0.0 1.0 0.7 0.0 0.8 0.1 1.2 8.6 0.0 1.0 0.2 1.3 1.1 0.0 0.0 2.4 0.3 2.5 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.4 2.3 2.2 3.0 3.1 2.1 2.8 1.3 2.4 2.3 2.2 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.4;Cardiomyocytes: 1.6;Endometrial stromal cells: 1.9;Fibroblasts: 1.3;Horizontal cells: 3.3;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 7.1;BJ: 2.3;EFO-21: 5.7" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 1.2 1.2 2.9 0.2 1.8 0.0 0.9 2.5 2.8 1.4 0.2 0.5 0.0 1.4 0.9 0.2 1.2 0.9 3.8 2.7 1.9 0.5 0.6 0.9 0.0 3.7 3.0 1.5 2.5 1.0 0.6 1.2 1.7 2.4 0.7 0.2 1.8 0.7 0.8 0.8 0.5 0.2 0.9 2.8 0.3 0.4 1.5 2.7 0.2 0.8 0.9 0.1 0.8 0.9 2.6 0.0 0.0 7.1 0.0 0.0 0.9 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 2.5 2.8 2.7 1.9 3.7 3.0 1.5 2.4 2.8 2.7 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.9 0.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.9 0.1 0.5 0.0 0.0 0.1 0.0 0.4 0.0 0.0 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522388-144527033 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 13.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 103.2;Cone photoreceptor cells: 73.0;Horizontal cells: 30.3;Late spermatids: 69.0;Rod photoreceptor cells: 86.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;SCLC-21H: 2.7;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles NA NA Vesicles "HPA028171: AB_2672504, HPA052250: AB_2681774" "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 1.9 3.6 5.1 0.1 5.5 0.3 2.4 2.9 7.9 4.7 0.4 2.7 0.3 4.5 0.2 3.9 5.5 0.1 1.9 4.6 7.3 3.7 3.3 2.7 0.2 9.3 7.2 6.5 6.1 3.0 1.2 13.4 0.2 5.2 11.6 0.1 1.5 1.5 0.6 1.2 1.8 2.6 0.2 3.3 2.1 2.4 3.1 4.7 0.3 3.4 0.1 0.1 3.0 3.2 4.9 0.2 0.5 0.4 0.9 0.4 0.3 1.1 0.3 0.4 0.4 0.3 0.1 1.0 0.5 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 1.3 0.3 0.6 0.2 0.3 0.0 0.6 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.6 0.1 0.0 2.6 0.7 1.0 0.1 0.1 0.5 1.1 0.0 0.4 0.1 0.3 2.7 7.4 0.2 0.1 0.2 0.0 2.3 0.8 0.0 0.1 0.7 0.3 0.1 0.5 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 2.9 7.9 4.6 7.3 9.3 7.2 6.5 5.2 3.3 4.7 4.9 0.7 0.0 2.3 8.5 1.0 0.9 0.5 0.0 0.0 103.2 2.3 2.8 0.0 1.5 0.7 1.8 73.0 0.6 0.5 2.1 3.9 0.2 23.7 1.5 1.5 1.1 10.7 0.8 3.8 0.2 0.4 1.4 3.1 1.6 0.0 4.8 0.7 3.1 0.5 30.3 6.5 2.7 0.0 0.8 1.7 69.0 2.8 0.8 5.4 1.0 0.2 18.6 1.0 4.5 2.2 0.3 1.9 3.0 1.2 1.8 1.9 3.6 0.1 86.2 0.0 2.9 1.9 11.2 3.5 1.7 0.4 0.4 0.6 8.4 1.9 0.9 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 28.6;lymphoid tissue: 40.6" "Cell type enhanced" "Detected in some" "Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3" "Group enriched" "Detected in many" 7 "dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1" "Group enriched" "Detected in some" 11 "HMC-1: 98.7;U-937: 24.7" "HPA014377, HPA014428" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA 24000000 Vesicles "Plasma membrane" "HPA014377: AB_2189277, HPA014428: " "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 3.4 2.4 1.0 25.4 1.3 28.6 1.0 1.2 2.5 1.8 1.1 1.8 0.7 0.9 0.3 1.2 2.4 2.7 1.3 0.9 3.5 0.7 3.6 7.3 13.4 3.0 1.6 0.2 0.4 1.1 0.4 0.5 2.5 4.5 0.9 1.6 0.1 1.1 0.9 0.4 0.3 6.2 2.5 1.9 40.6 1.6 2.4 2.5 1.9 0.6 0.0 14.3 4.2 0.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 1.6 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 16.6 109.1 1.8 0.3 125.1 0.1 19.3 0.2 0.3 65.4 18.2 0.1 0.1 200.1 0.7 93.3 12.0 0.2 40.3 1.0 1.3 1.2 2.5 0.9 3.5 3.0 1.6 0.2 4.5 1.9 2.5 7.1 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.0 41.5 6.0 0.8 0.3 13.5 0.0 1.0 24.1 0.0 2.1 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 PBOV1 "UC28, UROC28" ENSG00000254440 "Prostate and breast cancer overexpressed 1" Q9GZY1 6 138215986-138218491 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "brain: 3.2" "Cell type enhanced" "Detected in single" "Bipolar cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063021, HPA069649" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA063021: AB_2684923, HPA069649: " "unprognostic (3.32e-3)" "unprognostic (8.23e-2)" "unprognostic (9.35e-2)" "unprognostic (1.22e-1)" "unprognostic (4.77e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-4)" 0.0 0.0 0.8 0.0 1.2 0.2 0.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.1 0.0 0.0 0.0 0.9 0.5 0.9 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.8 1.2 2.6 1.0 1.2 0.7 0.9 0.5 0.9 1.1 0.6 0.9 3.2 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 OR4D10 "OR4D10P, OST711" ENSG00000254466 "Olfactory receptor family 4 subfamily D member 10" Q8NGI6 11 59473315-59479361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002495.1 ENSG00000254469 "XRCC1 N-terminal domain containing 1-like" Q6ZNB5 11 71865504-71928665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051121, HPA051124" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes NA Nucleoli "Mitotic chromosome" "HPA051121: AB_2681349, HPA051124: " "unprognostic (1.66e-1)" "unprognostic (1.19e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "unprognostic (2.39e-1)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (9.79e-4)" "unprognostic (5.91e-3)" "unprognostic (5.04e-3)" "unprognostic (7.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (3.60e-1)" "unprognostic (3.12e-3)" 1.8 2.2 2.4 2.2 3.4 4.7 3.2 4.3 3.0 2.6 3.0 2.2 2.6 3.8 5.3 2.7 2.4 2.1 2.1 2.1 1.6 2.9 2.2 1.8 4.2 3.0 2.3 2.2 4.6 3.1 2.9 2.5 2.0 2.8 3.2 3.5 7.4 2.2 2.8 1.6 4.2 2.6 2.4 0.9 2.9 2.4 3.3 2.5 3.2 3.3 1.5 3.4 2.3 2.2 5.3 2.6 6.2 4.7 4.5 1.8 1.6 3.1 2.9 2.3 3.1 3.0 6.5 6.4 5.8 2.6 2.0 3.9 8.4 4.9 3.3 3.2 8.4 4.5 9.4 7.7 4.2 1.1 4.2 3.1 2.2 1.6 5.2 3.6 2.6 4.9 8.0 6.3 7.6 3.0 4.9 4.8 3.5 4.9 9.6 4.5 3.6 16.3 4.0 3.5 3.1 6.9 6.6 4.6 4.1 9.2 3.3 5.1 2.3 4.6 2.5 4.1 4.9 1.9 5.5 8.4 7.0 4.0 4.6 3.7 2.7 1.9 1.7 2.9 3.0 1.7 2.5 5.1 3.8 2.2 3.3 4.8 4.1 2.0 1.2 1.9 4.8 4.9 1.9 2.4 3.4 4.3 3.0 2.1 1.6 3.0 2.3 2.2 2.8 0.9 2.5 5.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 subunit beta 1" Q2VPB7 11 65773898-65780976 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 44.4" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 25.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 7.5 4.9 3.2 7.0 2.5 44.4 6.7 5.6 3.5 4.9 1.0 5.9 5.8 7.1 2.0 10.2 5.3 3.1 4.9 3.5 1.4 5.7 5.9 8.8 4.8 3.6 1.4 3.4 3.0 10.3 6.4 3.6 3.8 2.8 5.0 3.0 2.5 7.0 4.6 9.6 8.7 6.8 3.2 1.2 10.1 6.1 2.5 2.1 4.8 4.9 3.4 4.3 6.7 5.2 2.4 12.8 9.8 2.8 14.3 8.6 4.1 16.4 5.3 6.2 6.1 4.7 7.7 6.0 7.8 9.4 6.3 12.4 15.8 8.7 4.3 2.9 12.1 10.1 7.0 12.0 3.8 5.8 9.9 13.3 7.0 10.1 4.0 2.9 6.0 5.2 13.6 15.6 9.7 3.6 9.2 5.5 10.5 4.6 4.4 10.1 17.3 0.5 16.8 5.9 15.8 2.7 5.4 4.1 2.6 26.0 3.7 4.4 14.1 7.6 10.2 8.6 13.6 6.0 10.0 11.2 8.1 7.5 8.5 10.5 1.1 1.7 0.6 0.5 1.0 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 25.0 0.4 1.3 0.3 0.2 0.8 3.2 2.5 5.6 3.5 3.5 1.4 3.6 1.4 3.4 2.8 1.2 2.1 2.4 2.0 0.0 8.8 6.2 3.9 2.4 12.3 4.3 7.4 5.0 4.2 2.0 1.6 2.8 3.7 7.3 14.6 7.6 5.9 12.8 1.9 8.9 1.4 6.3 2.9 3.0 3.0 0.0 3.6 13.6 18.2 2.9 6.6 10.7 2.5 5.3 1.4 7.1 14.0 11.8 3.2 3.8 6.1 12.4 2.1 0.7 0.6 11.6 7.2 3.7 17.8 3.0 6.2 1.0 2.2 9.4 6.9 3.8 3.6 5.6 10.1 8.8 2.9 8.0 0.0 3.7 3.0 0.6 4.7 6.0 2.3 34.9 4.3 2.0 4.5 10.0 CHMP4A "C14orf123, HSPC134, VPS32A" ENSG00000254505 "Charged multivesicular body protein 4A" Q9BY43 14 24209615-24213830 "Metabolic proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068473 Approved NA NA 1400000 "HPA068473: AB_2685994" "unprognostic (4.33e-3)" "unprognostic (3.76e-2)" "unprognostic (4.29e-2)" "unprognostic (5.45e-2)" "unprognostic (4.29e-1)" "unprognostic (1.25e-1)" "unprognostic (1.74e-4)" "unprognostic (2.02e-3)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (3.91e-8)" "unprognostic (3.30e-1)" "unprognostic (3.42e-1)" "unprognostic (7.37e-2)" "unprognostic (6.90e-2)" 59.3 39.9 79.8 49.7 80.7 38.8 51.9 78.5 110.2 39.4 73.9 59.8 39.8 33.9 79.7 51.0 45.6 36.2 47.3 75.5 79.8 52.9 53.9 36.4 73.2 80.9 79.9 73.5 31.1 42.8 73.5 23.1 34.2 81.1 51.5 65.1 15.7 31.8 61.2 20.3 52.0 43.9 52.1 81.3 51.9 46.2 16.6 81.2 71.1 43.8 27.6 85.6 48.2 32.3 84.6 48.7 100.5 43.8 49.1 75.4 67.9 59.7 52.9 62.6 53.0 60.7 46.6 114.9 79.0 48.5 80.6 49.8 56.4 47.5 84.7 58.8 142.6 25.6 64.7 91.6 207.4 131.8 101.1 69.9 69.1 121.6 43.9 168.4 60.8 72.3 84.6 68.2 119.7 107.1 136.1 98.0 93.5 29.0 123.3 83.0 71.9 37.5 86.7 99.3 128.4 28.4 34.3 112.7 101.8 73.8 49.8 65.7 90.2 49.4 33.0 40.0 42.7 47.2 117.1 133.2 86.4 31.2 71.7 71.3 144.3 152.2 103.4 123.4 195.6 132.9 182.8 131.8 138.5 179.9 169.3 101.6 109.9 42.6 138.4 193.6 190.0 185.2 171.6 79.8 80.7 78.5 110.2 75.5 79.8 80.9 79.9 73.5 81.1 81.3 81.2 84.6 74.2 16.0 33.3 13.4 78.6 52.6 76.0 154.8 18.8 31.8 66.7 65.7 2.1 92.9 86.3 62.5 64.6 93.4 111.4 50.0 97.8 116.0 11.0 49.1 52.5 58.8 39.2 53.7 14.3 82.3 84.0 39.3 25.5 53.2 76.5 41.1 67.5 73.1 162.5 25.2 12.6 69.9 99.7 94.8 90.3 19.1 66.8 80.1 69.4 11.2 202.6 64.7 178.2 12.1 15.5 76.0 66.7 48.5 44.8 76.1 144.9 159.3 72.2 24.2 98.6 40.6 58.1 20.4 18.3 32.3 78.8 120.7 102.8 43.8 79.7 70.4 SIGLEC12 "S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG" ENSG00000254521 "Sialic acid binding Ig like lectin 12" Q96PQ1 19 51491227-51501800 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 6.1;lymphoid tissue: 15.0" "Group enriched" "Detected in some" 8 "granulocytes: 2.5;Hofbauer cells: 2.2;Kupffer cells: 3.8;Macrophages: 4.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HMC-1: 146.9;U-937: 81.3" NA NA "unprognostic (1.46e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-2)" "unprognostic (9.13e-2)" "unprognostic (9.58e-4)" "unprognostic (1.38e-1)" "unprognostic (3.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (3.73e-1)" "unprognostic (1.29e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-5)" "unprognostic (2.45e-1)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-1)" 1.9 0.6 0.0 4.7 0.0 1.4 0.1 0.0 0.0 0.1 0.1 0.5 6.1 0.1 0.0 0.2 0.1 1.3 0.1 0.0 0.0 0.1 0.7 2.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 1.9 0.0 0.2 0.0 0.0 0.0 5.0 2.6 0.0 15.0 0.3 0.0 0.0 0.8 0.0 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 146.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 81.3 0.0 0.0 0.4 0.8 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PABPC4L ENSG00000254535 "Poly(A) binding protein cytoplasmic 4 like" P0CB38 4 134196333-134201789 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 10.4" "Cell type enhanced" "Detected in some" "Adipocytes: 5.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 5.7;Fibroblasts: 5.5;Glandular and luminal cells: 12.2;Leydig cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 11.4;HeLa: 15.8;REH: 8.1;RH-30: 8.5;U-2 OS: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.00e-1)" "unprognostic (3.53e-2)" "unprognostic (1.96e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (2.55e-3)" "unprognostic (1.58e-1)" "unprognostic (3.63e-1)" "unprognostic (9.05e-3)" "unprognostic (2.97e-1)" "unprognostic (9.52e-2)" "unprognostic (6.44e-2)" "prognostic favorable (1.11e-5)" "unprognostic (4.41e-3)" "unprognostic (1.82e-1)" "unprognostic (1.22e-1)" "unprognostic (4.14e-3)" 1.5 0.4 0.7 0.5 0.6 0.0 0.8 0.5 0.9 2.4 0.6 0.3 0.3 3.8 1.4 0.7 2.1 1.2 1.7 0.7 0.5 1.0 0.1 0.5 0.2 0.5 0.5 0.3 2.2 0.3 5.4 0.3 10.4 0.5 2.9 0.3 0.0 2.1 4.2 0.2 0.3 0.3 2.5 0.5 0.1 0.3 0.5 1.2 0.9 2.0 0.9 0.5 0.7 0.9 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 3.4 2.3 1.6 1.9 0.0 0.0 0.0 3.5 0.0 0.0 0.3 11.4 0.1 2.3 0.0 2.6 4.5 15.8 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.6 0.0 2.3 0.0 1.3 0.0 0.1 0.0 0.0 0.0 1.4 8.1 8.5 0.0 0.5 0.0 3.4 0.9 0.0 0.7 0.2 2.9 0.0 1.5 0.2 2.9 8.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.5 0.9 0.7 0.5 0.5 0.5 0.3 0.5 0.5 1.2 0.7 5.3 3.2 1.1 0.0 0.0 0.3 0.4 0.0 1.2 0.0 0.2 0.9 1.5 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 7.4 5.7 4.3 0.0 0.0 0.0 0.0 0.4 5.5 0.0 12.2 0.0 3.8 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 2.3 5.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.7 1.4 3.1 1.3 0.8 0.1 0.8 0.3 4.5 0.0 0.1 OMP ENSG00000254550 "Olfactory marker protein" P47874 11 77102840-77103331 "Predicted intracellular proteins" "Olfaction, Sensory transduction" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;OE19: 1.4" "Region enriched" "Detected in some" 62 "olfactory bulb: 96.7" "Low region specificity" "Detected in some" NA NA "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (8.53e-2)" "unprognostic (3.54e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.52e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-2)" "unprognostic (4.23e-1)" "unprognostic (5.33e-3)" "unprognostic (3.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (8.17e-2)" 0.0 0.4 0.4 0.2 0.2 1.2 0.0 0.8 0.5 0.1 0.0 1.5 2.7 0.0 0.0 0.4 0.1 1.2 0.1 0.3 0.5 0.2 1.4 0.0 0.1 1.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.2 1.9 0.0 0.1 0.1 0.1 0.0 2.5 0.2 0.2 0.1 1.0 0.3 0.6 0.0 0.2 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.8 0.1 1.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.8 0.5 0.3 0.5 1.0 0.3 0.1 1.1 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEL2 "NDNL1, nM15" ENSG00000254585 "MAGE family member L2" Q9UJ55 15 23643549-23647867 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" Repressor "Autism spectrum disorder, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 16.6;pituitary gland: 8.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.7;Granulosa cells: 5.0;Horizontal cells: 3.3;Inhibitory neurons: 5.8;Leydig cells: 2.8;Muller glia cells: 2.2;Spermatocytes: 2.7" "Cancer enriched" "Detected in some" 4 "testis cancer: 4.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;JURKAT: 1.2;NTERA-2: 1.9;SuSa: 2.2" "Region enhanced" "Detected in many" "hypothalamus: 17.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.18e-1)" "unprognostic (2.63e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-3)" "unprognostic (1.65e-2)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "unprognostic (5.38e-3)" "unprognostic (3.51e-3)" "unprognostic (8.61e-2)" "unprognostic (1.31e-2)" "unprognostic (9.55e-2)" "unprognostic (2.96e-9)" "unprognostic (1.66e-4)" "unprognostic (3.30e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-2)" 0.4 0.2 5.6 0.1 3.5 0.0 0.3 0.3 3.6 2.0 0.0 0.2 0.0 1.5 0.2 0.0 0.5 0.2 0.0 1.0 16.6 0.1 0.0 0.0 0.0 3.0 3.7 1.5 2.1 0.8 0.0 8.8 1.3 3.9 0.2 0.0 0.8 0.1 0.4 0.0 0.1 0.1 0.6 1.3 0.3 0.1 1.5 7.5 0.0 0.7 0.1 0.0 0.1 0.9 5.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 3.5 0.3 3.6 1.0 16.6 3.0 3.7 1.5 3.9 1.3 7.5 5.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.9 0.0 0.0 0.0 5.0 1.1 0.0 0.0 3.3 5.8 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.0 1.9 0.0 2.2 0.0 2.0 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.7 2.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 CSNK2A3 CSNK2A1P ENSG00000254598 "Casein kinase 2 alpha 3" Q8NEV1 11 11351942-11353250 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.4;Cholangiocytes: 4.3;Smooth muscle cells: 6.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;SK-BR-3: 1.3" "HPA059206, HPA061698" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (3.10e-2)" "unprognostic (3.39e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.82e-2)" "unprognostic (1.60e-1)" "unprognostic (6.25e-4)" "unprognostic (4.36e-2)" "unprognostic (5.42e-2)" "unprognostic (1.88e-1)" "unprognostic (5.46e-3)" "unprognostic (1.07e-1)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.38e-2)" 0.5 0.5 0.9 0.2 0.3 0.0 0.5 0.6 0.9 0.4 0.0 0.5 0.3 0.6 0.0 0.7 0.4 0.0 0.8 1.1 0.0 0.4 0.3 0.6 0.0 0.1 0.0 0.3 0.5 0.5 0.0 0.3 0.2 0.2 0.3 0.0 0.1 0.6 0.0 1.8 0.7 0.4 0.2 0.0 0.2 0.5 0.9 0.1 0.0 0.5 0.0 0.0 0.4 0.5 0.2 2.1 0.4 0.1 0.6 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.3 0.2 0.3 0.2 0.2 0.5 0.3 0.6 0.1 0.9 0.4 0.1 0.3 0.2 0.3 0.1 0.5 0.6 1.3 0.3 0.0 0.4 0.1 0.3 0.3 0.4 0.1 0.2 0.2 0.3 0.3 0.9 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.6 0.9 1.1 0.0 0.1 0.0 0.3 0.2 0.0 0.1 0.2 1.2 3.2 0.5 0.0 0.5 1.8 1.0 0.7 0.0 1.2 0.6 0.9 12.4 4.3 1.0 3.7 0.0 0.7 0.5 0.4 0.0 0.7 2.5 0.1 0.3 2.0 1.2 0.0 0.0 0.8 0.5 0.9 0.0 0.4 1.3 0.6 1.8 0.3 0.3 3.3 0.0 0.3 0.0 1.6 0.8 1.9 0.6 0.2 0.0 0.0 0.6 0.9 1.0 0.0 0.0 0.5 1.2 0.0 0.1 1.2 0.6 0.7 0.9 0.5 0.0 2.3 6.9 0.9 0.9 0.0 1.0 1.0 0.6 1.1 0.6 0.6 ARMS2 "ARMD8, LOC387715" ENSG00000254636 "Age-related maculopathy susceptibility 2" P0C7Q2 10 122454653-122457352 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.4;testis: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 16.9;Late spermatids: 59.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067225 Enhanced NA NA "HPA067225: AB_2685806" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (2.61e-2)" "unprognostic (2.84e-2)" "unprognostic (3.49e-2)" "unprognostic (1.98e-2)" "unprognostic (3.47e-3)" "unprognostic (3.60e-2)" "unprognostic (5.29e-5)" "unprognostic (2.53e-2)" "unprognostic (9.46e-3)" "unprognostic (2.68e-2)" "unprognostic (5.25e-2)" 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.3 1.4 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.6 0.5 0.3 0.1 0.2 0.0 0.0 0.4 0.3 0.3 0.7 0.0 0.0 0.4 1.3 0.5 0.1 0.0 0.5 0.8 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 1.4 0.5 0.3 0.4 0.3 0.3 0.5 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 16.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 59.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 8.6 0.0 0.0 0.0 0.0 INS "IDDM1, IDDM2" ENSG00000254647 Insulin P01308 11 2159779-2161221 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism" Hormone "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 135 "pancreas: 13093.3" "Cell type enriched" "Detected in some" 21 "Pancreatic endocrine cells: 1475.2" "Cancer enriched" "Detected in single" 7165 "pancreatic cancer: 1751.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 13 "midbrain: 1.3" "CAB000048, HPA004932, CAB012098, CAB053843" Enhanced "Secreted to blood" NA NA 437000 "CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816" "unprognostic (7.61e-2)" 19.4 4.0 0.1 0.2 0.1 50.3 0.6 0.0 0.0 0.4 0.0 12.9 1.5 1.4 0.0 1.9 0.3 3.7 5.6 0.1 0.1 41.0 1.4 1.7 5.4 0.2 0.5 0.0 2.7 13093.3 0.0 0.3 1.4 0.4 0.5 0.0 0.0 3.1 0.0 0.3 97.2 0.7 0.0 0.0 1.4 42.5 0.3 0.2 0.0 1.3 0.0 0.0 5.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 268.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 376.2 0.0 31.8 0.0 15.9 132.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.5 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 67.2 0.0 0.0 0.0 0.0 1475.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100879753-100903722 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 1.7;brain: 5.4;placenta: 2.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 572.5" "Low region specificity" "Detected in many" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 1.7 2.0 0.0 1.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 5.4 0.0 0.0 0.0 0.0 3.5 4.3 1.1 0.7 0.1 0.0 0.2 2.9 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 2.2 18.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 572.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 1.2 1.6 1.3 5.4 3.5 4.3 1.1 5.1 0.3 4.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FPGT GFPP ENSG00000254685 "Fucose-1-phosphate guanylyltransferase" O14772 1 74198212-74234086 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072331 Uncertain Vesicles NA NA Vesicles "HPA072331: " "unprognostic (1.53e-1)" "unprognostic (1.94e-1)" "unprognostic (8.18e-3)" "unprognostic (4.32e-2)" "unprognostic (5.14e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.86e-1)" "unprognostic (5.14e-2)" "unprognostic (2.58e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-1)" "unprognostic (3.59e-3)" "unprognostic (1.44e-1)" "unprognostic (7.88e-2)" "unprognostic (3.53e-2)" "unprognostic (1.91e-1)" 10.6 10.6 4.4 10.0 5.8 4.2 13.0 5.5 5.3 8.9 6.1 12.1 11.8 8.8 10.7 10.8 9.3 13.3 8.8 4.3 6.6 15.5 14.2 9.0 9.0 5.6 5.8 3.9 13.4 10.5 13.6 5.3 10.9 6.0 10.0 11.2 6.9 10.7 8.5 5.0 12.1 12.5 8.9 5.5 10.2 12.7 8.2 5.2 8.6 19.7 5.7 9.8 8.4 6.0 8.7 12.4 10.1 7.5 11.0 17.0 15.8 11.2 16.0 10.6 10.8 12.7 5.7 9.1 7.6 19.2 9.5 12.2 10.3 13.6 14.6 17.1 15.4 5.8 17.3 11.1 9.7 14.1 13.2 12.7 13.1 18.6 10.8 5.1 7.4 11.3 10.5 18.2 8.8 17.1 3.3 7.4 2.7 8.2 15.9 9.1 7.8 17.5 10.8 9.5 8.9 7.8 7.8 11.8 17.1 18.6 2.4 20.6 14.9 10.3 4.7 8.8 25.8 12.2 9.6 7.3 10.2 19.0 12.8 16.2 19.5 20.1 21.7 5.5 20.5 6.5 5.0 5.5 5.2 12.6 6.1 6.2 5.6 6.1 5.8 18.4 1.2 7.6 10.7 4.4 5.8 5.5 5.3 4.3 6.6 5.6 5.8 3.9 6.0 5.5 5.2 8.7 7.1 6.4 3.2 0.0 3.0 6.8 4.9 13.3 4.6 7.1 7.6 5.6 10.2 14.3 9.3 11.0 2.1 12.7 2.5 7.8 19.6 5.3 8.9 6.0 4.8 4.9 6.0 9.5 0.0 7.1 11.0 7.0 4.1 4.2 5.1 4.9 6.4 9.8 15.1 3.3 0.0 7.3 6.1 9.4 4.6 7.3 10.2 10.3 5.4 0.0 9.0 10.6 8.2 0.0 0.0 6.5 8.9 5.7 1.2 2.5 11.0 15.3 12.7 5.5 26.3 5.8 7.2 9.7 10.4 5.7 6.5 6.2 5.2 4.9 7.3 3.0 AL136295.1 ENSG00000254692 "Novel protein" 14 24189157-24213473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;granulocytes: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 8.1" HPA059249 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.45e-2)" 1.8 3.1 0.6 2.1 0.6 2.0 0.8 0.7 1.5 0.7 0.4 1.1 2.5 1.0 0.2 0.8 1.2 0.4 1.7 0.5 0.6 1.7 0.8 1.1 1.4 0.7 0.5 0.4 0.9 1.4 0.5 0.5 0.8 0.6 0.9 0.9 1.3 0.8 0.6 1.9 1.2 2.2 0.6 0.4 0.8 1.3 1.0 0.7 1.6 0.8 0.0 0.4 0.8 0.7 0.8 1.5 1.4 2.4 0.9 2.2 1.3 1.9 1.4 2.0 1.0 2.2 1.0 5.1 1.5 0.2 1.8 2.9 1.5 1.5 0.8 3.2 2.4 0.0 0.9 0.8 1.2 0.4 4.3 2.5 0.5 0.8 1.2 0.0 3.5 0.7 1.3 0.1 4.3 1.7 1.2 1.1 0.0 2.1 0.7 0.0 1.7 1.9 0.0 1.9 1.1 0.2 1.0 8.1 2.7 3.4 2.8 2.0 3.4 4.4 0.2 1.0 1.3 2.1 3.4 2.6 3.6 0.5 0.9 0.8 0.0 0.1 0.5 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.1 0.6 0.6 0.7 1.5 0.5 0.6 0.7 0.5 0.4 0.6 0.4 0.7 0.8 0.0 6.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL512785.2 ENSG00000254706 "Novel protein" 1 162365407-162383531 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.6;HEL: 12.0" "Low region specificity" "Detected in all" "HPA052251, HPA074060" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052251: AB_2681775, HPA074060: " "unprognostic (1.41e-2)" "unprognostic (2.12e-1)" "unprognostic (4.50e-1)" "unprognostic (9.12e-3)" "unprognostic (6.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.57e-1)" "unprognostic (3.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.96e-1)" "unprognostic (7.61e-3)" "unprognostic (6.07e-2)" "unprognostic (1.19e-2)" "unprognostic (6.10e-2)" 1.1 0.6 0.9 0.3 1.0 1.2 1.8 2.4 0.7 1.9 3.1 2.1 2.1 0.9 0.0 1.0 1.2 2.4 0.6 0.5 2.3 1.2 2.7 1.1 0.2 4.0 1.6 0.1 0.3 3.2 1.0 0.4 0.7 2.2 1.1 0.5 0.0 5.1 4.0 0.2 1.0 1.5 0.7 2.7 0.1 2.1 1.5 1.6 0.2 0.1 0.2 0.1 0.7 0.3 4.5 7.6 0.0 4.0 4.4 0.2 0.0 0.0 0.8 0.5 0.4 0.0 1.7 2.6 0.0 5.8 0.0 1.5 3.0 0.4 0.5 0.0 0.1 3.9 12.0 0.0 2.8 0.1 0.2 0.0 0.8 0.2 0.0 0.5 0.7 1.5 0.9 1.2 0.2 0.2 2.7 0.4 0.0 3.5 2.1 3.0 0.3 0.1 0.0 1.4 2.7 1.7 1.9 2.6 0.4 1.9 0.5 4.3 0.0 2.1 0.1 1.0 0.1 1.8 5.8 0.0 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 2.4 0.7 0.5 2.3 4.0 1.6 0.1 2.2 2.7 1.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGLL5 ENSG00000254709 "Immunoglobulin lambda like polypeptide 5" B9A064 22 22887780-22896111 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 412.1;lymphoid tissue: 679.7;stomach 1: 310.9" "Cell type enriched" "Detected in some" 55 "Melanocytes: 93931.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 226 "memory B-cell: 515.9;naive B-cell: 615.5" "Lineage enriched" "Detected in many" 246 "B-cells: 615.5" "Group enriched" "Detected in some" 7 "Daudi: 637.2;U-266/70: 386.4;U-698: 441.1" "Secreted to blood" NA NA 53000000000 "prognostic favorable (6.10e-4)" "unprognostic (7.64e-3)" "unprognostic (4.33e-2)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.76e-2)" "unprognostic (2.18e-1)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.94e-8)" "unprognostic (1.85e-1)" "unprognostic (4.63e-1)" "unprognostic (8.52e-2)" "unprognostic (6.50e-2)" 10.7 25.3 0.4 166.3 0.3 95.2 140.6 0.2 1.2 33.1 0.6 409.4 412.1 7.9 0.0 50.8 14.8 67.9 11.3 0.3 0.3 16.7 16.1 66.3 311.1 0.5 0.4 0.2 18.8 11.1 1.5 1.5 0.2 0.3 8.4 251.7 0.1 281.9 22.4 0.5 2.7 183.1 8.8 0.4 462.5 310.9 4.3 0.3 124.8 26.5 0.2 679.7 225.5 10.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 637.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 3.6 0.9 0.0 0.0 0.6 1.0 0.4 0.0 0.1 0.0 0.0 0.9 1.4 0.0 1.9 0.1 0.2 386.4 68.5 441.1 0.0 0.3 0.0 0.4 0.7 0.2 0.3 0.1 0.2 515.9 0.2 0.2 0.8 615.5 0.1 0.2 1.0 0.2 0.4 2.5 0.3 68.1 0.4 0.3 0.2 1.2 0.3 0.3 0.5 0.4 0.2 0.3 0.4 0.3 0.5 0.0 3.2 30.9 0.0 222.5 108.6 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 12.7 1.2 5.7 0.0 0.0 0.0 7.7 3.1 0.0 11.4 0.1 1.1 4.2 0.0 0.0 0.0 0.1 0.0 0.8 113.1 3.8 0.0 0.9 93931.2 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1680.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 93.5 0.0 49.3 0.0 2.4 0.0 MEX3A "RKHD4, RNF162" ENSG00000254726 "Mex-3 RNA binding family member A" A1L020 1 156072013-156082465 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 3.3;ovary: 4.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 16.5;Breast glandular cells: 20.8;Breast myoepithelial cells: 20.2;Granulosa cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 60.4;NTERA-2: 55.7;SCLC-21H: 57.4;SH-SY5Y: 105.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062703 Supported Cytosol NA NA Cytosol "HPA062703: AB_2684840" "unprognostic (8.63e-2)" "unprognostic (2.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.55e-3)" "unprognostic (6.18e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.23e-8)" "unprognostic (4.25e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (1.08e-3)" "unprognostic (4.73e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" "unprognostic (4.96e-2)" 0.2 0.2 1.0 0.5 0.7 0.4 1.2 1.1 0.8 1.8 0.2 0.4 0.4 3.3 0.3 0.7 0.8 0.5 0.1 0.8 0.7 0.7 1.1 0.4 0.2 1.1 0.8 0.6 4.5 0.4 0.3 0.2 0.3 0.9 0.8 0.5 1.0 1.1 0.3 0.0 0.4 0.3 0.8 1.0 0.2 0.3 0.5 1.1 0.9 0.4 0.0 0.3 0.8 0.8 1.0 1.1 1.9 60.4 15.2 0.7 0.9 7.3 1.5 0.3 2.5 2.2 3.7 0.9 2.0 7.3 0.7 1.5 1.3 26.5 1.2 2.9 3.2 7.4 1.5 3.2 6.3 1.2 0.9 1.3 1.8 2.0 1.2 1.0 6.2 11.7 14.2 14.9 0.2 3.5 4.2 7.4 1.2 55.7 2.6 8.1 23.6 4.9 0.4 2.1 2.9 57.4 105.2 1.8 6.9 3.7 25.2 12.0 4.7 4.2 3.8 9.4 1.1 3.7 1.4 1.0 3.4 0.4 1.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 1.1 0.8 0.8 0.7 1.1 0.8 0.6 0.9 1.0 1.1 1.0 3.6 0.0 0.5 0.0 0.8 4.0 2.4 3.7 16.5 1.7 20.8 20.2 1.0 0.0 1.7 0.0 10.4 0.8 1.4 0.6 1.9 11.8 0.2 4.3 13.3 7.6 6.0 3.8 0.2 1.5 2.2 4.1 1.1 7.7 0.0 26.8 8.6 6.7 2.2 3.3 0.6 1.8 10.2 1.0 1.5 0.4 5.0 1.2 5.4 0.0 0.0 1.4 0.0 5.5 0.7 3.5 0.2 1.2 0.4 8.3 0.0 11.9 4.3 3.1 0.0 3.4 12.5 0.3 4.3 6.0 3.4 0.3 1.2 4.3 2.5 1.9 OR10G4 ENSG00000254737 "Olfactory receptor family 10 subfamily G member 4" Q8NGN3 11 124012997-124018732 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.4 0.4 0.2 0.2 0.1 0.4 0.3 0.0 0.1 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 EEF1G EF1G ENSG00000254772 "Eukaryotic translation elongation factor 1 gamma" P26641 11 62559596-62574086 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040688, HPA055316" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 2500000 Cytosol "Golgi apparatus" "HPA040688: AB_10961632, HPA055316: AB_2732593" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (2.44e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-1)" "unprognostic (9.22e-4)" "unprognostic (1.14e-1)" "unprognostic (5.14e-2)" "unprognostic (5.07e-3)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (8.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (6.04e-2)" 1168.8 890.8 622.6 959.8 627.5 1913.4 1909.9 623.2 727.9 1483.4 667.3 1240.6 1104.8 1088.8 1088.7 1648.0 1569.4 756.5 1072.2 596.1 677.3 1166.3 892.5 825.2 1545.3 657.3 631.9 575.8 2627.9 2210.2 842.4 713.6 787.0 649.9 1229.5 1284.5 419.6 1601.7 883.8 4856.1 2175.7 1107.7 1000.1 677.7 1081.6 1099.2 445.3 648.8 1293.5 1059.6 3057.4 1967.8 1184.7 1452.7 656.7 1773.6 1824.3 1859.1 2656.2 2742.6 3529.1 1866.2 1505.0 2692.9 1830.1 1392.3 2045.9 2161.9 5161.2 2365.4 2392.2 1048.0 2018.3 2229.8 2200.1 1663.3 1693.2 2071.2 1348.7 2061.8 2120.7 2974.2 2810.2 1523.6 4060.8 3913.9 1812.1 4419.8 3014.9 2562.7 1777.2 2755.8 2451.2 2190.6 3611.0 3035.5 4895.3 2304.9 1546.3 1575.0 2545.1 2390.9 4978.7 2454.9 2276.4 1608.2 2002.3 901.7 3010.3 4214.5 1179.1 3496.3 3012.0 1759.8 1057.1 1476.4 2070.0 1338.6 1680.0 1783.1 2609.2 1210.8 2005.2 1517.1 883.9 2365.5 589.6 2182.3 2151.6 4333.1 5399.6 4153.2 2825.0 3623.0 5080.7 6117.7 4188.5 320.6 3285.2 1837.0 2869.7 3307.5 11090.3 622.6 627.5 623.2 727.9 596.1 677.3 657.3 631.9 575.8 649.9 677.7 648.8 656.7 2.8 150.6 366.9 14.4 403.6 7.9 2.5 8.8 1021.0 0.5 21.9 10.3 0.0 14.3 300.8 1.8 2.1 17.7 9.6 63.7 3.9 124.8 4.3 2.2 7.2 70.2 148.5 405.0 8.4 188.5 26.8 149.5 252.8 3.5 375.6 1.8 11.0 4.9 12.5 0.0 13.8 152.0 4.1 8.8 4.9 18.8 3.1 134.7 1.8 24.4 126.4 0.8 16.5 6.0 13.0 114.9 121.0 2.2 770.5 3.0 132.1 12.1 152.0 0.5 0.0 1.6 43.9 1.4 0.8 1166.7 6.1 21.1 235.3 1.1 223.8 2.3 CKLF-CMTM1 ENSG00000254788 "CKLF-CMTM1 readthrough" 16 66552587-66579135 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 5.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Early spermatids: 3.9;granulocytes: 20.2;Late spermatids: 8.9;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 17.4" HPA017136 Approved NA NA "HPA017136: AB_1846992" "unprognostic (9.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (2.19e-2)" "unprognostic (9.65e-2)" "unprognostic (5.90e-3)" "unprognostic (3.16e-2)" "unprognostic (1.73e-1)" "unprognostic (9.69e-2)" "unprognostic (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (2.98e-2)" "unprognostic (7.51e-2)" "unprognostic (4.45e-2)" "unprognostic (2.12e-1)" "unprognostic (1.44e-1)" 0.8 0.9 1.4 2.9 1.4 0.8 0.7 1.4 1.6 1.1 0.7 1.1 0.8 1.8 1.1 0.9 1.4 1.5 1.0 1.4 1.7 1.1 0.5 1.4 1.6 1.5 1.1 1.1 2.0 1.4 1.1 1.0 1.3 1.7 0.8 0.6 0.9 0.7 0.8 0.2 0.7 1.7 1.0 1.3 2.0 1.2 5.8 1.5 3.3 1.1 0.3 1.0 0.8 0.9 2.6 4.7 5.9 2.3 5.6 2.6 5.1 0.8 5.4 2.9 4.6 7.0 2.1 4.9 1.8 2.9 0.6 1.4 3.5 2.8 0.3 3.0 5.3 1.5 0.4 1.9 0.2 1.9 4.0 3.0 0.2 0.3 2.7 0.6 8.3 2.7 6.3 2.1 5.0 3.6 1.4 9.1 5.0 1.4 0.6 2.4 17.4 8.2 5.9 4.1 1.3 3.5 4.9 9.4 0.6 1.7 0.2 2.2 2.1 1.9 6.3 11.3 4.5 2.0 3.0 6.6 7.1 4.1 4.0 10.5 9.8 4.1 11.8 2.8 1.7 3.0 0.4 1.1 1.8 3.6 0.7 0.5 1.4 12.9 2.0 2.1 1.4 4.0 3.0 1.4 1.4 1.4 1.6 1.4 1.7 1.5 1.1 1.1 1.7 1.3 1.5 2.6 0.0 3.2 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.2 3.9 0.0 0.1 0.1 0.0 0.4 0.0 0.2 0.1 0.2 0.0 0.0 20.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.7 8.9 0.3 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887344-2903575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 14.4;kidney: 10.8;liver: 15.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "classical monocyte: 7.0" "Group enriched" "Detected in many" 8 "dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0" "Cell line enhanced" "Detected in some" "A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8" HPA068288 Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 3.2 0.6 0.5 2.2 0.5 0.2 0.7 0.4 1.7 0.6 0.5 14.4 13.6 0.8 0.4 1.2 0.4 1.7 0.3 0.6 0.9 10.8 15.0 0.6 0.4 0.8 0.7 0.4 0.4 0.3 0.0 0.3 2.4 1.0 0.8 10.3 0.4 1.9 0.1 0.1 1.1 9.8 0.7 0.8 0.7 1.6 0.5 0.6 0.1 0.3 0.0 0.1 0.7 0.9 1.1 1.2 9.4 0.3 0.5 0.0 0.0 0.9 0.5 0.4 0.0 0.2 2.2 9.4 0.0 0.8 0.0 0.6 0.5 0.0 0.3 0.0 0.4 0.1 0.0 0.8 5.8 0.7 0.0 0.1 0.1 0.3 0.0 0.6 0.4 0.3 0.5 0.0 0.9 0.0 18.8 0.0 0.4 0.2 8.4 0.3 0.3 0.0 1.0 0.8 0.0 0.1 0.3 0.9 0.4 35.8 0.2 0.0 0.9 1.9 0.0 0.7 0.3 0.2 0.0 0.0 0.2 0.2 2.6 14.8 4.0 7.0 1.2 0.2 3.9 0.1 0.0 0.1 0.2 3.9 0.0 0.0 0.1 1.6 0.4 2.9 0.0 0.6 2.4 0.5 0.5 0.4 1.7 0.6 0.9 0.8 0.7 0.4 1.0 0.8 0.6 1.1 0.6 0.0 0.5 0.0 1.3 0.5 1.1 6.3 1.2 0.0 1.2 0.9 0.4 1.5 2.7 7.3 0.0 19.5 0.4 163.3 9.8 1.7 0.1 0.1 0.3 0.7 9.1 3.2 0.4 0.8 9.8 1.4 2.6 0.5 1.3 0.0 2.9 22.7 17.7 0.0 0.1 26.2 6.1 6.3 5.5 0.2 0.3 6.4 3.6 0.0 4.6 0.0 0.0 0.0 0.1 2.4 124.4 0.0 0.0 1.0 75.7 104.0 1.0 0.0 0.0 0.0 0.6 0.1 0.4 2.1 1.1 80.7 0.9 0.8 48.5 2.5 OR5M10 ENSG00000254834 "Olfactory receptor family 5 subfamily M member 10" Q6IEU7 11 56576736-56577787 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.8;Astrocytes: 2.9;granulocytes: 10.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.8;NB-4: 2.4" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" 4.7 2.9 0.8 0.3 0.7 0.3 4.7 1.0 2.9 5.3 0.6 7.2 0.2 4.5 0.8 4.0 3.6 0.2 3.9 0.9 0.7 3.0 2.8 4.1 0.3 1.0 0.8 0.8 6.8 4.4 0.3 9.7 0.3 1.1 5.1 0.8 1.5 3.1 0.3 7.1 5.4 4.0 0.2 0.8 3.6 4.3 14.7 0.7 0.5 4.1 0.3 0.2 5.5 4.8 1.1 0.2 0.2 0.1 0.0 0.2 0.1 6.8 0.5 0.3 0.0 0.1 0.2 0.9 0.0 0.6 0.5 0.1 0.8 0.2 0.0 0.0 0.5 0.4 0.4 0.6 0.1 0.2 0.1 1.6 0.0 0.9 0.9 0.6 0.0 0.1 0.8 0.5 0.4 0.1 1.4 0.8 2.4 0.4 0.0 0.2 0.7 0.4 0.1 0.3 0.3 0.6 0.3 0.2 0.4 1.1 0.9 0.0 0.6 0.5 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.8 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 1.0 2.9 0.9 0.7 1.0 0.8 0.8 1.1 0.8 0.7 1.1 0.8 3.2 4.8 2.9 0.1 2.3 0.0 0.2 0.0 0.0 0.8 0.5 1.1 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.9 0.0 0.0 2.2 0.8 0.0 1.1 0.0 0.1 10.1 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.0 MPV17L2 "FKSG24, MGC12972" ENSG00000254858 "MPV17 mitochondrial inner membrane protein like 2" Q567V2 19 18193218-18196948 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043111 Uncertain NA NA "HPA043111: AB_10794176" "unprognostic (3.71e-1)" "unprognostic (2.75e-3)" "unprognostic (5.52e-2)" "unprognostic (1.28e-1)" "unprognostic (6.74e-2)" "unprognostic (8.23e-2)" "unprognostic (4.41e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (9.93e-3)" "unprognostic (5.21e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.30e-4)" "unprognostic (1.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (5.20e-2)" 9.1 22.5 9.4 6.4 9.6 4.0 9.8 9.4 12.6 7.1 9.4 13.8 5.3 9.0 9.0 9.3 9.2 4.7 16.6 9.2 9.3 13.1 22.3 9.3 7.1 10.1 10.1 9.0 8.9 12.7 10.2 11.9 4.8 10.1 10.8 5.1 4.4 9.6 10.0 15.5 9.0 9.7 7.4 9.7 10.5 13.9 6.9 10.1 5.7 10.1 16.6 7.1 10.9 7.0 10.7 13.7 15.3 15.7 23.1 11.1 7.0 31.3 17.7 16.6 31.9 28.7 17.3 12.5 17.3 34.3 10.9 23.3 15.9 29.4 22.1 15.3 12.7 36.2 13.5 11.0 22.9 17.8 17.4 19.7 10.0 18.2 18.4 21.5 5.9 14.4 26.2 28.4 17.1 16.3 48.2 26.3 19.6 19.3 31.2 59.3 22.6 13.8 24.0 20.8 9.2 17.8 13.2 15.6 21.7 14.3 10.9 9.4 16.0 13.3 18.3 9.5 56.8 20.5 13.3 26.6 26.0 12.6 29.0 19.6 13.4 19.4 18.2 16.1 27.1 19.3 25.8 12.7 12.6 25.3 16.2 10.2 12.9 5.5 18.3 19.0 24.2 18.0 11.9 9.4 9.6 9.4 12.6 9.2 9.3 10.1 10.1 9.0 10.1 9.7 10.1 10.7 9.5 6.4 3.9 2.9 14.1 10.6 5.8 10.3 15.4 8.1 14.2 11.8 8.2 7.2 7.8 11.0 2.1 22.0 9.4 5.8 23.5 17.9 1.4 3.2 7.4 11.5 6.6 2.5 1.2 26.0 29.4 7.0 5.1 6.1 1.3 6.4 5.7 7.8 18.5 6.7 1.1 9.5 12.2 6.3 24.5 0.2 3.4 13.0 12.4 3.7 32.3 7.8 8.2 3.0 3.3 22.5 6.2 5.3 14.9 10.1 6.2 8.2 2.1 9.8 0.0 3.0 9.7 9.1 8.4 5.4 11.1 22.8 6.6 12.8 9.8 3.9 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favorable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 12.8 12.5 25.1 12.0 25.6 16.1 8.5 25.4 35.0 6.1 23.1 9.8 11.1 6.6 6.5 11.8 10.9 7.6 17.6 25.0 26.8 13.5 10.8 10.6 12.6 25.6 26.1 25.3 5.4 11.1 16.1 20.4 7.7 26.6 10.0 8.8 5.6 10.0 8.0 14.4 8.8 8.2 8.9 24.0 10.1 9.9 8.7 26.3 12.3 12.7 18.2 8.7 10.9 6.3 27.4 21.9 15.4 13.5 14.4 17.8 8.7 22.5 22.4 16.3 25.9 25.7 17.9 26.1 12.9 36.6 22.1 19.1 12.9 12.9 28.5 9.9 12.6 18.9 11.1 23.0 18.0 14.8 17.4 17.8 13.6 15.0 23.2 9.2 11.0 29.7 19.0 26.1 21.1 28.5 38.6 25.7 14.5 9.8 23.3 18.7 10.3 9.9 18.7 27.3 17.1 26.2 14.5 22.4 17.0 15.9 10.0 20.8 17.3 17.0 14.1 14.9 32.5 34.3 15.7 15.3 15.3 16.8 14.0 27.8 45.3 32.4 57.2 14.5 44.9 12.5 27.0 15.4 14.6 22.2 19.6 12.9 13.2 79.9 14.9 45.9 30.1 19.7 20.0 25.1 25.6 25.4 35.0 25.0 26.8 25.6 26.1 25.3 26.6 24.0 26.3 27.4 16.6 12.8 21.6 0.0 13.6 0.0 15.4 0.0 5.2 17.0 19.6 18.5 0.0 25.8 7.4 14.7 10.4 31.8 22.5 11.6 43.0 38.0 5.0 25.4 12.1 12.3 10.9 10.8 0.0 32.7 34.9 11.1 13.3 15.7 10.1 11.6 12.1 16.6 41.0 18.5 0.0 9.3 0.0 23.4 0.0 5.2 7.8 24.0 0.0 0.0 37.1 13.2 15.5 0.0 0.0 42.4 9.5 6.8 15.3 14.7 25.6 40.8 13.1 18.3 0.0 11.6 15.0 33.8 23.9 7.4 0.0 39.5 14.0 18.6 9.5 17.2 AP000781.2 ENSG00000254979 "Novel protein" 11 57387365-57424059 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;liver: 7.3;placenta: 7.1" "Cell type enriched" "Detected in single" 10 "granulocytes: 6.3" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "basophil: 3.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.5" "Cell line enriched" "Detected in some" 7 "HMC-1: 186.9" HPA038515 Supported NA NA "HPA038515: AB_10675800" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.55e-4)" "unprognostic (2.16e-1)" "unprognostic (4.01e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.08e-2)" "unprognostic (1.33e-2)" "unprognostic (1.79e-1)" "unprognostic (1.51e-10)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (5.59e-2)" "unprognostic (3.10e-1)" 4.2 0.2 0.0 0.6 0.0 13.4 2.6 0.0 0.3 0.5 0.0 0.5 0.7 0.4 0.0 1.1 0.2 1.1 0.6 0.0 0.0 0.3 7.3 1.0 1.0 0.1 0.0 0.0 0.3 2.9 0.0 0.2 7.1 0.1 0.3 0.4 0.0 1.4 0.0 1.0 5.0 0.5 0.3 0.0 0.5 0.3 0.1 0.0 0.4 1.2 0.1 0.9 1.0 0.7 0.0 0.7 0.0 0.1 0.0 0.0 0.9 0.8 0.0 0.3 0.2 0.6 0.0 0.2 0.8 0.0 0.1 0.0 1.3 0.0 0.0 0.6 0.0 0.0 4.2 0.0 0.0 0.8 28.6 186.9 1.7 0.0 0.6 0.0 0.0 0.4 0.7 0.4 1.6 0.0 0.0 1.1 9.1 0.3 0.0 0.0 4.0 0.0 8.7 0.2 0.0 1.0 0.3 0.2 0.4 2.9 0.0 0.0 0.9 0.1 0.2 0.5 3.3 0.0 0.3 0.0 1.0 0.9 1.1 1.3 3.5 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DPP3 ENSG00000254986 "Dipeptidyl peptidase 3" Q9NY33 11 66480013-66509657 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035780, HPA035781" Approved Supported Cytosol NA NA 3200000 Cytosol "HPA035780: AB_2674778, HPA035781: AB_10669529" "unprognostic (5.74e-2)" "unprognostic (1.16e-3)" "unprognostic (2.62e-3)" "unprognostic (4.77e-2)" "unprognostic (1.99e-1)" "unprognostic (5.44e-3)" "unprognostic (1.67e-3)" "unprognostic (1.25e-3)" "unprognostic (1.73e-2)" "unprognostic (9.87e-2)" "unprognostic (1.02e-2)" "unprognostic (3.87e-1)" "unprognostic (5.85e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.81e-2)" "unprognostic (3.43e-1)" "unprognostic (5.66e-2)" 11.6 17.6 8.5 21.6 8.9 20.9 11.3 10.1 10.5 11.1 5.2 30.4 25.1 11.8 7.9 23.7 9.9 14.6 9.9 8.4 8.8 17.0 18.8 14.5 22.0 10.0 8.7 7.6 6.8 17.4 12.0 8.7 14.4 11.7 14.6 26.6 16.1 18.9 13.0 26.7 13.7 20.7 16.3 8.9 15.5 19.4 9.8 9.9 18.8 11.8 7.4 23.5 17.4 13.6 11.4 84.1 71.6 32.5 36.3 26.4 28.3 50.4 46.5 61.8 61.4 40.7 90.8 68.4 48.7 154.0 52.9 52.2 73.6 52.1 57.0 39.4 92.5 23.8 63.1 32.1 54.2 40.7 77.6 101.1 40.5 54.5 46.2 22.8 26.5 47.8 50.1 45.1 28.2 56.7 95.3 91.0 78.7 55.5 82.0 43.2 63.1 32.7 79.6 52.6 71.7 61.1 52.2 39.7 45.6 62.5 30.3 70.8 44.7 50.1 36.5 39.4 40.7 46.2 23.3 46.6 56.6 48.5 36.5 45.9 20.7 18.8 21.3 21.4 40.0 13.3 11.5 15.8 17.7 32.3 11.1 9.4 13.9 3.2 30.8 27.9 22.5 29.6 17.7 8.5 8.9 10.1 10.5 8.4 8.8 10.0 8.7 7.6 11.7 8.9 9.9 11.4 5.8 16.0 13.2 6.8 11.6 6.0 17.4 34.8 8.6 11.4 7.1 3.8 3.0 10.0 27.0 23.9 10.4 46.9 11.5 41.6 13.7 45.6 24.6 8.7 6.2 10.5 18.6 3.4 3.4 61.3 34.2 7.4 29.0 11.5 1.3 9.9 3.6 14.7 37.4 6.7 4.0 19.5 63.1 7.9 9.0 7.0 2.1 10.8 16.0 3.7 31.3 21.6 18.6 4.5 5.6 40.8 25.2 5.3 15.7 11.0 26.4 28.7 17.3 72.9 13.1 4.4 16.2 8.8 20.7 14.4 6.0 36.0 13.1 20.1 29.5 19.5 ANKHD1-EIF4EBP3 MASK-BP3 ENSG00000254996 "ANKHD1-EIF4EBP3 readthrough" 5 140401908-140549569 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 27.3;Club cells: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA008718 Approved NA NA "HPA008718: AB_1078162" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (6.17e-3)" "unprognostic (4.10e-3)" "unprognostic (4.84e-2)" "unprognostic (8.79e-2)" "unprognostic (2.82e-3)" "unprognostic (4.69e-2)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (1.69e-3)" "unprognostic (4.53e-1)" "unprognostic (8.92e-3)" "unprognostic (2.92e-2)" "unprognostic (3.27e-1)" "unprognostic (4.33e-3)" "unprognostic (2.60e-2)" 9.3 14.8 3.8 6.6 3.9 5.7 10.6 4.1 4.5 8.4 7.1 11.5 7.4 8.2 19.8 15.1 8.0 6.5 7.7 3.2 4.6 9.0 9.7 11.2 9.2 4.7 3.8 2.7 9.0 16.6 21.3 10.2 7.0 4.1 12.2 12.0 12.0 12.3 9.4 10.6 14.6 11.8 7.3 3.4 15.8 11.8 11.5 4.4 14.5 10.2 8.2 13.5 10.1 10.6 4.7 8.8 12.0 21.1 17.9 27.5 15.4 14.0 5.9 11.8 12.9 16.3 19.9 13.8 16.8 5.3 11.0 24.7 10.8 17.5 16.2 16.3 14.6 7.9 9.0 16.7 18.0 15.7 10.6 11.3 10.8 27.9 16.8 17.0 13.7 17.9 5.6 5.9 5.0 12.5 7.2 13.4 5.4 8.7 8.7 6.1 12.7 10.1 12.6 19.6 16.2 8.3 6.8 15.7 13.7 5.2 11.9 17.8 8.5 9.6 10.9 6.1 7.2 10.7 12.1 7.1 9.7 7.6 8.2 13.5 1.1 0.7 0.9 1.0 1.0 0.7 1.3 1.2 1.2 1.4 1.1 1.0 1.4 1.6 0.7 0.9 1.2 0.4 1.0 3.8 3.9 4.1 4.5 3.2 4.6 4.7 3.8 2.7 4.1 3.4 4.4 4.7 1.3 6.4 27.3 3.6 0.9 0.9 0.4 0.3 1.8 0.8 1.2 0.6 1.1 2.8 14.6 1.8 0.0 0.4 2.0 0.5 0.0 0.6 0.3 1.0 1.1 1.6 1.2 1.3 6.1 0.2 0.1 3.2 4.1 1.5 1.3 0.9 0.7 1.8 0.4 0.0 5.8 0.3 0.0 0.6 0.4 0.0 0.0 2.6 1.8 2.8 1.2 0.4 1.0 5.0 4.1 0.7 0.2 0.0 2.0 0.9 0.7 0.2 7.1 0.9 0.0 2.0 1.1 0.5 0.2 4.4 2.4 0.8 1.6 0.9 0.6 0.8 KRTAP5-9 "KRN1, KRTAP5-1, KRTAP5.9" ENSG00000254997 "Keratin associated protein 5-9" P26371 11 71548420-71549608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.2" "Group enriched" "Detected in some" 7 "Early spermatids: 2.3;Late spermatids: 5.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "RT4: 8.6" NA NA "unprognostic (1.72e-3)" "unprognostic (2.20e-1)" "unprognostic (2.22e-2)" "unprognostic (2.16e-1)" "unprognostic (4.13e-1)" "unprognostic (6.53e-2)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (7.76e-2)" "unprognostic (7.23e-2)" "unprognostic (2.56e-1)" "unprognostic (3.29e-1)" "unprognostic (2.05e-2)" "unprognostic (2.01e-1)" "unprognostic (4.82e-4)" "prognostic favorable (9.25e-4)" 0.3 0.3 0.7 0.0 0.7 0.2 0.3 0.4 1.2 0.2 0.3 0.4 0.1 0.2 1.7 0.5 0.4 0.3 0.1 0.7 0.5 0.5 0.8 0.4 0.1 0.6 0.6 0.4 0.1 0.2 0.2 0.8 0.1 0.5 0.6 0.2 0.3 0.3 0.4 0.4 0.8 0.5 0.0 0.4 0.6 0.2 3.2 0.5 0.0 0.3 0.0 0.1 1.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.4 1.2 0.7 0.5 0.6 0.6 0.4 0.5 0.4 0.5 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1 subunit of SCAR/WAVE actin nucleating complex" Q8WUW1 3 10115675-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2544.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" NA NA 170000 "Nuclear speckles" "Cell Junctions" "HPA060391: AB_2684272" "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 166.7 121.9 169.8 110.9 170.7 164.9 162.9 165.7 202.8 150.3 168.8 163.6 102.1 152.1 173.1 177.1 154.0 119.1 151.2 172.4 173.0 178.3 155.7 136.4 158.6 167.0 166.4 168.9 153.8 117.6 155.8 112.4 110.2 165.9 139.2 134.5 62.6 138.9 131.5 187.4 153.9 124.4 156.7 170.3 132.2 152.1 143.2 171.6 153.1 135.2 168.8 181.7 175.6 148.9 169.0 179.1 210.4 218.0 114.1 358.2 389.0 516.5 259.0 258.1 238.9 235.6 145.5 203.9 205.1 120.5 301.0 208.2 91.0 159.7 263.9 260.5 227.3 220.8 282.7 233.5 219.9 203.4 272.1 204.2 256.8 250.4 267.9 193.0 312.2 339.2 168.9 187.3 231.9 366.4 393.0 177.1 216.7 252.1 251.9 263.6 168.8 224.5 224.2 315.9 292.5 84.6 146.8 208.6 179.3 217.2 216.0 291.8 233.8 307.9 237.9 182.2 281.4 234.8 131.9 385.1 460.6 343.9 368.5 200.4 303.2 334.5 357.1 238.7 337.0 213.8 304.7 228.6 226.9 380.0 307.9 205.9 223.5 337.5 228.7 345.8 404.8 287.9 469.9 169.8 170.7 165.7 202.8 172.4 173.0 167.0 166.4 168.9 165.9 170.3 171.6 169.0 224.7 64.1 79.3 16.6 198.4 263.8 307.2 560.2 137.7 41.6 332.8 352.2 125.5 233.1 291.4 204.1 20.9 254.2 220.3 149.0 493.1 375.7 1034.0 145.6 152.2 273.7 298.7 191.2 33.5 361.6 282.9 223.2 119.3 127.3 173.3 152.3 272.4 255.0 442.7 47.1 20.7 211.3 307.2 373.9 380.3 2544.4 247.3 295.5 354.0 28.1 556.8 208.4 375.9 13.6 21.7 479.4 202.9 253.9 130.2 338.3 274.7 887.5 204.6 38.7 236.7 158.7 254.6 212.0 160.1 264.4 315.4 213.2 185.9 267.4 235.4 418.7 UBTFL1 C11orf27 ENSG00000255009 "Upstream binding transcription factor like 1" P0CB47 11 90085950-90087131 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M1 OST050 ENSG00000255012 "Olfactory receptor family 5 subfamily M member 1" Q8NGP8 11 56609236-56614874 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAA2-SAA4 ENSG00000255071 "SAA2-SAA4 readthrough" 11 18231423-18248635 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "liver: 128.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 20.7" "Cancer enriched" "Detected in many" 13 "liver cancer: 39.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.6;EFO-21: 1.5;GAMG: 1.1;HaCaT: 1.0" HPA060139 Uncertain NA NA "HPA060139: AB_2684210" "prognostic favorable (4.56e-4)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-3)" "unprognostic (9.41e-3)" "unprognostic (1.96e-2)" "unprognostic (1.96e-1)" "unprognostic (8.27e-3)" "unprognostic (3.17e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (2.92e-8)" "unprognostic (1.92e-1)" "unprognostic (2.72e-1)" 23.9 1.5 0.0 1.5 0.0 0.0 5.2 0.0 0.3 15.4 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.6 0.0 0.0 0.4 0.2 128.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 18.9 0.2 5.3 0.3 0.2 0.1 0.0 0.1 0.2 0.2 0.1 0.6 0.0 0.0 0.6 0.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 1.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGY MGC14156 ENSG00000255072 "Phosphatidylinositol glycan anchor biosynthesis class Y" Q3MUY2 4 88520998-88523776 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059018 Uncertain NA NA "HPA059018: AB_2683884" 36.1 39.9 37.1 23.3 38.6 44.9 48.7 40.6 43.8 32.4 35.7 31.0 31.0 34.3 46.0 28.7 34.1 22.7 32.7 36.0 39.4 41.6 52.4 26.5 28.0 40.0 37.7 34.7 34.6 41.6 42.2 3.4 28.7 38.7 32.6 31.5 23.1 43.5 34.3 49.1 27.4 28.6 36.5 41.1 26.3 24.8 22.6 39.1 27.6 32.3 42.7 29.6 28.9 3.7 41.7 60.1 19.8 39.1 46.4 76.7 78.3 26.2 43.2 60.6 53.1 44.6 15.5 46.3 0.2 47.3 61.7 36.4 25.2 35.6 54.4 66.6 73.4 61.8 66.2 24.8 59.9 58.0 110.7 40.9 54.4 80.8 34.5 69.5 50.4 88.5 20.4 75.9 64.9 77.8 45.5 68.5 67.6 32.7 70.5 37.5 68.0 36.3 69.8 44.4 33.4 46.7 45.7 54.9 49.4 119.9 38.4 23.0 54.8 60.6 56.1 51.9 55.3 40.6 45.6 40.1 7.5 49.3 55.7 63.1 82.4 92.1 79.0 90.4 94.9 102.2 98.9 103.2 98.3 111.0 80.5 105.4 101.6 18.1 108.9 95.3 68.3 116.8 186.1 37.1 38.6 40.6 43.8 36.0 39.4 40.0 37.7 34.7 38.7 41.1 39.1 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851413-11854444 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 364.4" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 514.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Approved Nucleoplasm,Midbody Yes No Midbody Nucleoplasm "HPA061997: AB_2684653, HPA062896: AB_2684898" "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favorable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 43.7 36.0 26.0 36.5 25.5 61.8 29.3 21.1 27.2 25.8 30.7 39.4 39.1 28.6 26.5 39.4 25.0 39.7 34.9 27.4 28.2 33.4 31.3 30.0 30.2 23.5 23.1 24.4 29.9 25.0 40.2 29.5 28.0 23.0 28.0 37.8 17.8 29.7 35.3 364.4 39.9 49.2 23.9 22.2 30.4 30.8 14.1 24.6 46.5 52.7 53.7 25.0 50.0 24.0 24.7 30.0 28.8 36.5 31.1 46.9 32.7 52.9 31.4 52.6 21.0 27.9 37.5 29.4 18.5 45.9 34.2 35.0 25.0 16.8 43.7 18.5 17.2 20.8 13.5 43.6 31.1 34.6 51.7 22.3 47.7 92.5 23.5 53.9 46.8 30.7 41.6 23.1 23.4 33.3 37.3 36.1 39.6 15.3 94.9 14.3 18.4 18.8 32.1 56.5 40.5 35.5 35.5 53.1 24.7 50.5 33.9 20.2 47.2 45.2 46.7 24.5 37.3 34.0 27.8 34.3 23.5 43.3 23.8 22.7 32.5 38.8 66.7 15.4 35.7 14.3 14.7 14.3 18.5 30.2 14.7 17.6 16.4 77.9 18.3 36.6 26.7 21.5 29.2 26.0 25.5 21.1 27.2 27.4 28.2 23.5 23.1 24.4 23.0 22.2 24.6 24.7 71.2 67.3 47.0 0.0 152.9 419.6 141.8 291.8 216.9 30.5 71.3 59.4 21.7 52.9 157.7 132.4 8.4 135.9 171.0 281.4 60.7 123.0 80.4 146.6 110.2 69.9 143.8 40.4 0.0 80.3 144.4 99.3 70.8 298.3 149.9 38.4 52.8 44.1 118.0 28.6 0.0 104.6 111.9 139.9 440.8 42.6 37.9 354.5 158.3 0.0 102.1 32.2 78.2 0.0 0.0 134.0 393.7 37.2 21.8 93.9 179.2 139.1 84.8 16.8 78.9 61.2 94.5 16.0 21.1 177.1 514.7 253.2 135.5 43.9 96.8 252.2 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 61.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8" "Cancer enhanced" "Detected in many" "testis cancer: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9" "Not detected" "Not detected" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059367: AB_2683992" "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 2.8 3.1 1.9 3.6 1.9 5.3 2.4 2.2 2.4 3.0 2.8 2.5 0.8 2.8 2.7 1.8 3.1 2.7 1.9 2.1 10.6 1.8 1.4 3.0 6.2 7.0 2.6 1.8 4.1 2.5 1.2 3.7 1.7 2.3 3.3 0.9 6.7 1.4 5.6 0.6 2.4 2.7 2.3 2.6 3.0 2.2 61.8 2.4 3.8 1.5 1.0 3.9 2.4 2.1 3.8 0.3 9.1 0.3 0.9 2.0 2.0 1.7 8.5 6.9 4.0 6.8 0.2 0.5 0.1 0.0 1.9 1.8 0.2 0.3 0.7 5.9 0.5 0.1 1.7 8.9 1.4 2.9 0.1 0.5 2.7 0.0 2.5 0.5 0.4 0.6 0.4 0.1 0.5 2.5 0.1 3.1 1.3 0.4 0.1 1.8 0.2 0.0 0.1 2.2 0.3 0.1 0.0 5.6 0.4 0.2 0.2 0.0 0.0 1.3 0.1 0.3 2.0 0.4 0.4 0.2 0.1 0.2 0.0 0.9 0.0 0.3 0.5 4.4 1.4 4.6 2.3 5.6 5.4 0.2 2.3 7.9 5.0 0.7 6.2 0.9 0.5 7.3 2.2 1.9 1.9 2.2 2.4 2.1 10.6 7.0 2.6 1.8 2.3 2.6 2.4 3.8 4.7 0.0 6.0 0.0 5.9 13.4 78.5 5.9 1.8 4.9 2.4 3.9 1.4 2.8 2.7 1.8 27.1 2.4 11.1 2.4 0.0 3.5 72.8 13.8 9.6 14.0 0.0 6.6 0.0 1.3 1.6 12.7 5.1 21.1 1.3 6.1 5.3 3.0 1.9 11.8 0.0 1.2 4.1 4.7 26.8 23.5 8.7 6.8 1.8 0.0 4.0 7.5 6.2 0.0 0.0 4.9 4.5 4.5 4.3 47.6 1.2 1.7 7.5 18.6 6.6 7.6 8.4 306.8 44.3 1.4 7.7 2.5 11.1 15.6 1.0 46.9 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" A0A0U1RQE8 11 59086307-59094786 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "breast: 7.4;lymphoid tissue: 2.8" "Cell type enriched" "Detected in single" 57 "Proximal tubular cells: 5.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.8 0.0 0.0 7.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.9 0.0 1.8 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58320193 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.5" "Cell type enhanced" "Detected in some" "Club cells: 1.3;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.8 7.3 4.1 6.6 5.0 7.3 8.8 7.4 5.5 6.9 4.7 9.0 12.2 8.5 5.9 8.7 7.9 6.9 12.6 4.6 5.5 11.2 15.3 5.7 6.9 3.7 4.4 4.3 12.2 7.4 12.1 5.7 6.8 4.8 7.2 9.2 9.2 7.5 8.7 44.5 7.9 8.8 7.7 4.3 7.3 7.1 7.5 4.6 6.7 10.5 38.1 8.0 7.0 5.0 5.5 10.4 7.1 10.9 8.7 11.6 11.2 15.1 13.8 10.2 17.0 14.4 15.9 7.7 19.9 4.0 10.1 12.8 8.7 18.5 12.6 16.8 11.0 13.1 13.7 16.1 13.9 11.3 16.7 11.4 15.1 15.1 17.3 11.4 11.0 14.6 14.3 12.2 19.9 11.1 6.4 11.2 8.9 17.2 10.2 17.3 7.2 7.2 14.7 12.5 13.8 7.0 10.5 8.4 9.4 17.2 12.1 10.9 15.9 8.1 14.5 10.8 14.3 17.2 15.4 27.6 15.7 12.7 11.9 9.8 17.9 19.2 29.2 19.7 23.7 21.5 28.1 20.0 25.2 20.2 27.6 27.5 21.3 13.6 24.9 20.4 24.5 15.6 15.7 4.1 5.0 7.4 5.5 4.6 5.5 3.7 4.4 4.3 4.8 4.3 4.6 5.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC166 ENSG00000255181 "Coiled-coil domain containing 166" P0CW27 8 143706694-143708109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 4.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 27.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA025058 Uncertain NA NA "HPA025058: AB_2671717" "unprognostic (2.65e-1)" "unprognostic (3.64e-1)" "unprognostic (6.18e-2)" "unprognostic (4.97e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NANOGP8 ENSG00000255192 "Nanog homeobox retrogene P8" Q6NSW7 15 35083410-35085295 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 415 "testis cancer: 20.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 69 "NTERA-2: 33.2;SuSa: 11.6" HPA072117 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA072117: " "unprognostic (1.58e-1)" "unprognostic (9.05e-3)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" 0.1 0.1 0.4 0.0 3.2 0.2 0.1 2.0 1.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.9 0.1 0.1 0.1 0.0 0.7 0.3 0.7 0.2 0.2 0.0 0.2 0.0 1.3 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.7 0.7 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 3.2 2.0 1.4 0.2 0.9 0.7 0.3 0.7 1.3 0.1 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M11 OR11-199 ENSG00000255223 "Olfactory receptor family 5 subfamily M member 11" Q96RB7 11 56542262-56543281 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Late spermatids: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 4.5;salivary gland: 4.5" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 97.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MOLT-4: 6.5;RPTEC TERT1: 7.3" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA068838: AB_2686047, HPA075209: AB_2732285" 0.2 0.2 0.2 0.0 0.3 0.0 0.2 0.4 0.5 0.4 0.1 0.6 0.1 1.0 0.9 0.1 0.6 0.9 0.5 0.3 0.3 4.5 0.2 0.4 0.0 0.3 0.2 0.2 1.3 1.9 0.0 0.3 0.2 0.2 0.3 0.0 0.0 4.5 0.1 0.2 0.1 0.4 0.3 0.2 0.9 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.4 0.2 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.0 0.0 0.2 0.0 7.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.5 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 11.0 0.0 0.0 0.0 0.0 97.8 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.3 2.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 15.8 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 PRR23D1 ENSG00000255251 "Proline rich 23 domain containing 1" E9PI22 8 7539628-7542450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "epididymis: 47.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM35 TMPRSS4-AS1 ENSG00000255274 "Small integral membrane protein 35" A0A1B0GVV1 11 118003634-118088299 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.2;kidney: 1.1" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Karpas-707: 10.9;RPMI-8226: 7.2" "Group enriched" "Detected in some" 5 "basal ganglia: 1.2;olfactory bulb: 3.5" "Region enriched" "Detected in some" 6 "basal ganglia: 7.9" NA NA "unprognostic (8.83e-2)" "unprognostic (3.42e-2)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-4)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" 0.0 0.1 0.2 0.5 0.3 1.2 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 1.1 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 7.2 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.3 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 1.6 0.1 0.2 0.3 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G5 "OR8G5P, OR8G6" ENSG00000255298 "Olfactory receptor family 8 subfamily G member 5" 11 124256376-124266218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "testis: 2.5" "Group enriched" "Detected in some" 11 "Early spermatids: 18.3;Late spermatids: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 1.8;PC-3: 1.0;T-47d: 1.7" NA NA "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 29.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EID1 "C15orf3, CRI1, EID-1" ENSG00000255302 "EP300 interacting inhibitor of differentiation 1" Q9Y6B2 15 48878134-48880173 "Predicted intracellular proteins" "Cell cycle, Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051122, HPA051123" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA051122: AB_2681350, HPA051123: AB_2681351" "unprognostic (1.38e-1)" "unprognostic (6.69e-2)" "unprognostic (1.64e-1)" "unprognostic (3.18e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.41e-1)" "unprognostic (6.75e-3)" "unprognostic (2.46e-1)" "unprognostic (3.62e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.09e-1)" 129.8 208.2 109.6 96.3 116.1 61.5 113.1 109.8 152.0 151.1 117.5 118.6 82.4 162.5 133.2 97.4 136.1 122.0 282.6 115.3 122.1 149.3 126.1 100.3 112.9 114.3 108.5 105.6 188.3 102.9 146.0 131.1 94.1 116.8 157.4 72.0 159.8 99.2 148.7 281.5 58.0 79.6 143.0 110.7 116.3 85.0 68.6 114.7 118.2 139.8 229.7 84.6 114.0 82.1 134.7 131.5 109.1 260.9 231.6 239.9 316.9 16.4 337.6 304.5 220.3 294.3 95.0 58.0 174.9 305.3 207.0 155.5 115.4 130.2 130.8 247.9 484.1 127.1 300.6 235.8 4.1 186.0 183.0 132.2 278.1 115.1 146.1 91.9 221.4 262.8 151.2 182.3 162.6 258.5 188.7 134.6 174.1 0.5 98.9 97.4 185.1 302.6 290.6 287.4 142.3 233.8 234.6 210.2 80.2 401.2 212.7 145.0 240.6 262.9 322.4 177.7 305.6 299.3 208.4 616.7 125.1 264.6 410.0 230.0 345.0 311.5 275.5 221.3 285.3 209.2 168.3 249.4 231.8 358.1 183.2 179.6 165.3 40.4 230.0 297.5 354.9 332.4 440.1 109.6 116.1 109.8 152.0 115.3 122.1 114.3 108.5 105.6 116.8 110.7 114.7 134.7 327.4 387.8 207.7 31.3 127.5 175.5 139.9 459.5 138.9 345.3 188.5 286.4 480.8 183.0 329.9 261.1 120.9 351.6 168.0 46.0 606.5 386.5 17.5 116.0 324.4 356.8 233.7 219.2 38.0 268.0 151.2 443.4 88.2 116.7 188.0 173.8 339.8 166.2 211.3 238.9 43.5 114.0 301.1 208.1 262.0 49.2 702.4 189.7 487.4 30.9 302.2 844.1 213.1 28.6 80.9 191.0 102.1 651.4 134.3 81.4 91.9 446.5 240.2 329.9 322.1 350.7 379.1 98.6 75.0 125.9 145.6 109.6 180.7 463.2 101.5 96.9 OR52B2 ENSG00000255307 "Olfactory receptor family 52 subfamily B member 2" Q96RD2 11 6169330-6170408 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.53e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOX5 "NOX5A, NOX5B" ENSG00000255346 "NADPH oxidase 5" Q96PH1 15 68930525-69062762 "Predicted membrane proteins, Transporters" "Angiogenesis, Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 8.8;testis: 2.2" "Cell type enhanced" "Detected in some" "Early spermatids: 17.6;Excitatory neurons: 6.4;Inhibitory neurons: 5.4;Late spermatids: 11.2;Theca cells: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.33e-1)" "unprognostic (1.63e-2)" "unprognostic (6.11e-2)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (4.91e-3)" "unprognostic (6.80e-2)" "unprognostic (5.50e-3)" "unprognostic (3.48e-2)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (8.21e-2)" "unprognostic (4.58e-3)" "unprognostic (2.71e-3)" "unprognostic (4.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.0 0.5 0.9 0.2 0.3 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.3 0.2 0.2 0.7 0.0 0.5 0.0 0.2 0.0 0.1 0.2 0.8 0.0 8.8 0.2 2.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.5 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 1.7 0.4 0.3 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 17.6 0.4 0.3 0.6 0.0 0.0 6.4 0.0 0.1 0.7 0.0 0.1 0.0 0.6 0.0 0.0 0.5 0.0 5.4 0.0 0.0 0.0 0.0 11.2 0.6 0.1 0.0 1.9 0.0 0.4 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.3 0.1 5.0 2.3 0.0 0.0 1.8 0.0 31.0 0.0 0.1 CCDC179 ENSG00000255359 "Coiled-coil domain containing 179" H3BU77 11 22846922-22860474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "testis: 23.7" "Group enriched" "Detected in some" 161 "Early spermatids: 1079.5;Late spermatids: 2024.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1079.5 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2024.9 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R43 T2R52 ENSG00000255374 "Taste 2 receptor member 43" P59537 12 11091287-11092313 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.69e-3)" "unprognostic (1.48e-1)" "unprognostic (2.19e-1)" "unprognostic (1.48e-2)" "unprognostic (2.67e-1)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (3.49e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.2 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.2 0.2 0.5 0.5 0.0 0.7 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 PRR23D2 ENSG00000255378 "Proline rich 23 domain containing 2" P0DMB1 8 7778591-7781413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "epididymis: 47.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP4B ENSG00000255393 "Oocyte secreted protein family member 4B" A0A2R8Y4Y8 11 59978020-60031077 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HCAR3 "GPR109B, HCA3, HM74" ENSG00000255398 "Hydroxycarboxylic acid receptor 3" P49019 12 122714756-122716811 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;esophagus: 16.9;lymphoid tissue: 19.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 94.4;Basal prostatic cells: 81.1;Basal respiratory cells: 57.3;Basal squamous epithelial cells: 159.4;Langerhans cells: 57.4;Squamous epithelial cells: 66.9;Suprabasal keratinocytes: 106.3;Urothelial cells: 66.1" "Group enriched" "Detected in some" 4 "cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9" "Region enriched" "Detected in some" 4 "cerebral cortex: 4.2" "Group enriched" "Detected in many" 6 "basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4" "Group enriched" "Detected in many" 50 "granulocytes: 177.2;monocytes: 84.4" "Cell line enriched" "Detected in some" 4 "RT4: 37.1" HPA028660 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (2.32e-1)" "unprognostic (5.82e-2)" "unprognostic (8.23e-2)" "unprognostic (2.27e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" "unprognostic (1.64e-3)" "unprognostic (1.60e-1)" "unprognostic (6.29e-2)" "unprognostic (9.87e-2)" "unprognostic (1.50e-2)" "unprognostic (2.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-1)" "unprognostic (9.28e-2)" 5.7 0.1 0.0 9.2 0.0 27.6 2.3 0.0 4.2 1.4 0.3 0.5 0.2 0.0 0.5 16.9 0.8 0.7 0.5 0.1 0.0 0.9 1.8 8.3 0.4 0.1 0.1 0.0 0.1 0.0 3.4 0.2 1.9 1.0 1.5 0.1 0.1 3.5 2.7 0.1 15.0 0.2 0.2 0.0 19.8 0.4 0.1 0.1 4.0 0.4 1.1 7.8 7.2 4.4 0.2 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 9.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 37.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 58.6 2.2 0.8 0.0 16.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 177.2 0.0 84.4 0.0 0.0 2.9 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.1 0.2 0.1 3.2 6.7 0.0 0.7 94.4 81.1 57.3 159.4 0.2 0.7 0.3 0.0 0.0 24.6 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 21.5 1.4 0.0 0.1 3.8 0.0 0.0 0.1 6.0 0.0 0.0 0.0 12.2 10.6 57.4 0.2 0.0 20.1 8.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 14.7 0.0 0.1 2.2 0.2 0.0 0.0 1.4 0.1 0.0 66.9 106.3 13.8 1.0 0.0 0.0 66.1 PCDHA3 PCDH-ALPHA3 ENSG00000255408 "Protocadherin alpha 3" Q9Y5H8 5 140801028-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;T-47d: 9.2;U-2197: 1.4;WM-115: 2.4" "Low region specificity" "Detected in all" NA NA "unprognostic (5.21e-2)" "unprognostic (2.77e-2)" "unprognostic (7.20e-3)" "unprognostic (2.69e-1)" "unprognostic (1.62e-1)" "unprognostic (7.83e-2)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (7.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.09e-3)" "unprognostic (1.72e-2)" "unprognostic (7.25e-3)" "unprognostic (8.41e-2)" "unprognostic (5.66e-3)" "unprognostic (2.67e-2)" 0.4 0.8 0.5 0.1 0.8 0.0 0.6 2.7 0.7 0.7 0.0 0.4 0.2 1.3 0.2 0.1 0.5 0.5 0.2 0.4 0.6 0.6 0.0 0.8 0.2 1.1 0.9 0.4 1.1 1.2 0.1 1.5 0.0 0.8 0.4 0.1 0.9 0.2 0.3 0.1 0.1 0.3 0.4 1.0 0.2 0.2 1.1 0.5 0.0 0.5 0.0 0.0 0.2 0.3 1.6 0.0 1.8 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.2 0.7 0.2 9.2 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 2.7 0.7 0.4 0.6 1.1 0.9 0.4 0.8 1.0 0.5 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.2 1.2 0.4 2.3 1.5 15.5 2.3 0.9 1.1 2.3 1.8 1.8 1.3 2.6 2.4 1.6 2.6 1.3 1.7 0.5 1.4 0.9 1.7 2.8 2.0 1.5 1.1 0.5 3.7 2.3 0.7 1.2 2.0 1.6 1.5 2.4 2.7 2.7 0.8 1.5 2.0 2.2 1.5 0.9 2.4 2.0 1.1 1.1 1.6 2.1 0.3 1.7 1.8 2.5 4.4 0.6 0.4 2.6 2.3 0.6 1.4 1.9 1.0 0.2 0.6 0.5 1.3 2.1 1.7 0.4 1.4 0.6 0.9 1.0 1.1 1.3 0.6 0.6 1.1 3.0 1.1 0.3 2.2 2.4 1.4 0.8 1.3 1.3 1.2 0.9 1.4 0.8 2.5 0.7 1.4 1.0 3.0 1.6 0.5 0.7 2.7 0.6 1.0 0.7 2.8 0.6 1.2 0.6 1.1 0.3 1.8 1.7 0.8 1.7 0.7 1.4 2.0 1.6 2.5 1.3 1.3 0.7 2.3 1.3 0.1 0.7 3.3 1.6 0.2 1.3 0.7 1.4 1.4 0.2 1.2 1.2 1.7 1.5 0.5 0.3 1.0 1.9 0.1 0.4 1.5 0.9 1.1 0.5 1.4 1.5 1.1 0.5 1.6 0.9 1.1 4.4 4.3 0.0 2.2 0.0 5.8 5.7 12.6 6.7 1.8 5.3 3.2 3.0 1.1 12.8 6.2 3.7 8.4 9.7 5.9 6.8 0.0 3.2 1.8 4.0 4.4 4.6 4.2 6.1 0.0 1.6 6.2 3.9 4.1 7.4 1.3 9.2 10.8 5.1 2.8 3.3 0.0 4.0 4.1 5.1 11.5 0.8 8.4 5.4 1.8 0.0 5.2 2.0 5.2 0.0 0.0 3.9 4.1 3.8 5.2 9.3 6.2 0.5 6.3 6.0 6.6 8.0 4.8 3.5 5.0 1.1 6.3 14.6 6.8 6.7 5.1 13.2 AP001458.2 ENSG00000255432 "Novel protein" 11 62649694-62665178 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.9 0.9 0.3 0.6 0.2 0.5 0.4 0.6 0.4 0.4 0.5 0.7 0.3 0.5 0.1 0.6 0.3 0.3 0.8 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.3 0.1 0.2 0.1 0.8 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC135050.2 ENSG00000255439 "Novel protein, VKORC1 and PRSS53 readthrough" 16 31083439-31094956 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "thalamus: 1.6" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 5.2;NB-4: 6.8;RPMI-8226: 8.7;U-266/70: 5.7" HPA042720 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.68e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "unprognostic (3.57e-1)" "unprognostic (2.79e-2)" "unprognostic (4.48e-3)" "unprognostic (8.49e-2)" "unprognostic (2.84e-8)" "unprognostic (4.96e-6)" "unprognostic (1.39e-1)" "unprognostic (4.81e-1)" "unprognostic (2.29e-4)" 0.4 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.7 0.1 0.3 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.2 0.2 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.0 0.3 0.6 0.0 1.6 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.9 0.4 0.0 0.4 1.0 1.2 0.3 5.2 0.3 0.0 0.2 0.2 0.3 3.4 1.8 0.1 0.0 0.2 0.0 0.1 0.0 1.3 2.7 0.8 0.3 0.2 0.0 0.5 1.1 0.3 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.7 0.1 0.4 0.8 6.8 0.1 0.0 1.5 3.4 0.3 8.7 0.0 0.3 2.1 2.6 1.2 0.4 1.0 0.0 0.0 0.2 1.3 0.5 0.0 1.6 0.5 5.7 0.7 0.6 1.2 0.9 0.2 0.6 0.7 2.5 2.0 0.8 2.7 2.1 2.1 2.8 0.9 1.6 1.3 1.9 0.9 0.9 1.8 1.6 2.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CARD18 "ICEBERG, pseudo-ICE, UNQ5804" ENSG00000255501 "Caspase recruitment domain family member 18" P57730 11 105137714-105531697 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 33.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 3.2;Basal respiratory cells: 1.9;Early spermatids: 8.7;Late spermatids: 8.2;Suprabasal keratinocytes: 2.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;hTCEpi: 2.5;K-562: 2.9;OE19: 2.3;U-2 OS: 4.8" HPA038582 Approved NA NA "HPA038582: AB_10960549" "unprognostic (3.90e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (3.42e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 7.5 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.7 0.4 0.0 0.1 33.4 0.1 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 2.8 0.2 0.1 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 3.2 0.0 1.9 0.0 0.0 0.0 0.6 0.4 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 8.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.2 2.3 1.1 0.0 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 14.0" "Group enriched" "Detected in some" 14 "Early spermatids: 19.9;Late spermatids: 35.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "hTCEpi: 20.6" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.8 0.6 0.5 0.2 0.5 0.2 1.1 0.6 0.8 1.6 0.2 1.5 0.9 0.9 0.2 1.0 0.9 0.0 0.7 0.6 0.5 0.9 1.8 1.2 0.1 0.6 0.4 0.5 1.7 1.7 0.0 1.8 0.0 0.6 1.7 0.1 0.6 2.1 0.0 0.7 1.3 1.8 0.0 0.4 1.1 1.4 14.0 0.4 0.0 1.5 0.0 0.1 1.0 1.2 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.5 0.2 20.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.8 0.6 0.5 0.6 0.4 0.5 0.6 0.4 0.4 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 35.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEDD8-MDP1 ENSG00000255526 "NEDD8-MDP1 readthrough" 14 24213955-24232352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 1.3;testis: 1.3" "Group enriched" "Detected in some" 11 "Alveolar cells type 2: 3.1;granulocytes: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.5;MCF7: 1.5;MOLT-4: 2.3" "HPA003064, HPA060254" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003064: AB_10602350, HPA060254: AB_2732644" "unprognostic (2.72e-3)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (6.44e-2)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (6.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (1.99e-2)" "unprognostic (1.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-2)" 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 1.3 0.3 0.4 0.1 0.0 0.1 0.2 1.3 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.3 0.2 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.5 0.1 0.5 0.3 0.4 0.2 0.6 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.2 0.2 0.0 0.6 0.1 0.0 0.1 1.5 2.3 0.2 0.1 0.8 0.0 0.1 0.0 0.8 0.1 0.0 0.3 0.1 0.0 0.3 0.5 0.1 0.2 0.4 0.0 0.0 0.7 0.0 0.4 1.3 0.9 0.9 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 POLR2M "GCOM1, Gdown, Gdown1, GRINL1A" ENSG00000255529 "RNA polymerase II subunit M" "P0CAP2, Q6EEV4" 15 57706695-57782762 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068141 Approved Nucleoplasm NA NA Nucleoplasm "HPA068141: AB_2685962" "unprognostic (3.07e-1)" "unprognostic (1.08e-1)" "unprognostic (2.63e-1)" "unprognostic (3.73e-1)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (9.80e-2)" "unprognostic (7.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.25e-2)" "unprognostic (2.81e-1)" "unprognostic (3.56e-2)" "unprognostic (6.61e-2)" "unprognostic (1.39e-1)" "unprognostic (3.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.07e-1)" 19.6 20.2 26.2 10.7 30.8 17.1 18.6 28.9 26.3 22.0 18.5 15.6 12.4 35.0 19.7 15.4 19.7 16.3 29.4 23.2 31.1 20.3 15.5 14.4 19.3 33.5 33.2 16.6 31.5 16.3 25.8 9.1 18.3 34.0 26.3 15.2 12.8 16.2 24.3 36.4 15.4 13.3 27.3 36.1 21.5 15.2 10.5 32.4 21.6 24.3 39.2 17.4 15.3 13.4 39.6 18.4 21.8 20.9 52.2 38.6 38.4 15.8 29.4 49.0 33.3 30.4 19.5 14.8 27.7 25.9 22.3 25.2 33.1 26.2 24.3 44.5 24.3 27.9 37.9 21.5 15.6 42.1 33.4 31.0 36.3 38.3 19.0 54.2 37.5 26.1 29.5 34.6 20.7 28.5 8.8 38.2 22.7 31.9 27.7 19.0 37.8 49.1 22.0 25.2 19.5 14.6 26.6 21.2 25.1 35.9 29.2 28.4 49.0 24.7 47.0 47.2 68.4 30.7 26.5 27.1 36.1 28.4 52.4 32.2 26.6 14.7 12.1 17.4 13.3 16.2 16.1 15.1 16.4 13.9 17.1 19.6 14.6 1.5 24.4 11.6 12.4 19.0 15.6 26.2 30.8 28.9 26.3 23.2 31.1 33.5 33.2 16.6 34.0 36.1 32.4 39.6 19.5 22.4 11.5 0.0 25.7 16.8 20.2 12.4 26.7 14.9 16.9 12.6 27.7 10.0 14.5 25.8 4.2 12.8 25.3 11.8 25.4 13.3 48.5 13.9 22.7 23.2 23.4 24.0 0.0 15.3 19.1 24.3 16.8 32.4 12.6 11.0 25.0 15.4 18.2 11.8 0.0 16.6 18.3 27.4 15.8 14.6 22.1 17.9 24.9 0.0 18.9 24.9 29.9 0.0 0.0 19.5 15.8 28.2 13.3 30.3 13.6 17.2 13.3 9.8 19.7 17.2 20.8 21.2 24.2 22.7 14.3 12.0 22.9 16.9 20.0 23.7 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.4;skin 1: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 114 "HEL: 23.7" HPA056234 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056234: AB_2732601" "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.1 0.0 0.1 0.0 0.2 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.1;Late spermatids: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 1.2 1.9 1.1 1.9 1.2 2.0 2.2 0.9 1.2 1.8 0.9 1.4 1.6 1.4 2.4 1.1 1.5 1.0 0.9 1.2 1.2 1.3 1.6 1.7 3.1 1.1 1.1 1.1 1.5 1.5 1.6 0.9 1.3 1.1 1.2 1.7 0.7 0.8 0.9 0.7 2.7 1.5 1.1 1.1 2.4 1.0 3.2 1.3 1.7 1.3 0.8 3.2 1.6 0.8 1.3 1.4 1.9 2.1 5.3 2.0 1.8 1.2 1.1 1.2 1.2 1.2 2.4 3.1 5.5 2.7 1.0 1.5 4.3 2.6 2.5 2.7 6.9 1.1 6.1 1.1 1.8 1.2 6.4 5.3 1.5 1.5 1.7 2.2 1.0 2.2 6.5 4.4 6.4 2.3 1.8 6.0 6.2 1.4 6.0 2.7 3.6 1.6 6.5 2.8 2.5 1.0 1.6 1.5 3.2 1.4 1.2 4.5 3.9 1.7 2.5 2.7 3.0 2.6 3.6 5.5 14.1 1.6 9.1 3.7 0.3 2.3 1.5 5.0 3.7 6.5 4.6 4.4 4.4 3.8 3.8 6.5 7.5 0.7 4.8 3.0 3.6 2.5 3.7 1.1 1.2 0.9 1.2 1.2 1.2 1.1 1.1 1.1 1.1 1.1 1.3 1.3 2.2 6.4 0.6 0.7 3.1 0.8 1.3 4.2 1.2 3.0 1.6 1.4 1.6 0.0 3.0 0.0 0.0 3.4 1.3 1.2 5.9 2.5 37.1 1.5 1.2 1.8 2.4 0.8 1.0 3.3 1.9 1.3 1.1 0.9 1.3 2.2 2.2 1.8 4.0 1.7 1.3 1.4 4.1 1.3 1.2 14.2 3.1 2.0 0.0 1.9 2.2 3.2 4.1 1.0 1.2 2.1 0.5 0.4 1.6 1.9 0.9 2.3 1.6 2.5 6.6 1.1 1.2 7.5 9.1 1.0 1.3 2.2 2.6 3.8 1.6 0.8 TRAV1-1 "TCRAV1S1, TCRAV7S1, TRAV11" ENSG00000255569 "T cell receptor alpha variable 1-1" A0A0B4J248 14 21621838-21622567 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 18.1" "Cell type enriched" "Detected in single" 10 "T-cells: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 18 "MAIT T-cell: 26.0;memory CD4 T-cell: 11.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 17.7;naive CD8 T-cell: 25.7;T-reg: 30.6" "Lineage enriched" "Detected in many" 23 "T-cells: 30.6" "Cell line enriched" "Detected in single" 160 "MOLT-4: 30.7" NA NA "unprognostic (1.56e-1)" "unprognostic (6.87e-2)" "unprognostic (5.07e-1)" "unprognostic (6.72e-4)" "unprognostic (2.62e-3)" "unprognostic (6.08e-3)" "unprognostic (2.29e-1)" "unprognostic (6.56e-2)" "unprognostic (4.69e-2)" "unprognostic (2.96e-1)" "unprognostic (9.40e-5)" "unprognostic (3.51e-2)" "unprognostic (3.14e-1)" "unprognostic (1.40e-1)" 0.2 0.0 0.0 2.7 0.0 0.7 0.1 0.0 0.1 0.6 0.0 0.6 0.7 0.2 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 1.9 1.4 0.1 0.0 18.1 0.1 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 26.0 0.0 11.8 27.1 0.2 0.0 17.7 25.7 0.0 0.0 0.0 0.0 30.6 6.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 OR10G2 ENSG00000255582 "Olfactory receptor family 10 subfamily G member 2" Q8NGC3 14 21633836-21634940 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.80e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB44 "dJ431A14.3, RASD3, RASL13" ENSG00000255587 "RAB44, member RAS oncogene family" Q7Z6P3 6 36697826-36733184 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "bone marrow: 59.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.4;granulocytes: 14.5;monocytes: 2.3;Squamous epithelial cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "basophil: 10.6;eosinophil: 7.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.6" "Cell line enhanced" "Detected in some" "HEL: 21.9;HL-60: 30.9;HMC-1: 88.9;NB-4: 76.7;THP-1: 30.1;U-937: 60.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA079390 Approved Vesicles NA NA Vesicles "HPA079390: " "unprognostic (8.86e-2)" "unprognostic (5.58e-3)" "unprognostic (5.09e-2)" "unprognostic (4.66e-2)" "unprognostic (1.37e-1)" "unprognostic (1.28e-3)" "unprognostic (9.56e-2)" "unprognostic (6.35e-4)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" "unprognostic (2.57e-1)" "unprognostic (3.02e-2)" "unprognostic (3.13e-3)" "unprognostic (3.03e-2)" "unprognostic (9.67e-3)" "unprognostic (5.79e-2)" 0.3 0.0 0.0 0.6 0.1 59.4 0.4 0.0 0.1 0.4 0.0 0.4 0.6 0.3 0.2 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.1 0.1 0.5 0.9 0.4 0.0 0.5 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 30.9 88.9 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 76.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 10.6 0.8 7.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.2 4.4 0.7 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.0 1.3 0.3 0.2 0.0 0.3 0.0 0.5 14.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.3 0.0 1.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.3 0.0 0.0 2.2 0.0 0.0 0.4 0.1 0.0 0.1 AC005833.1 ENSG00000255639 "Novel protein" 12 4649101-4774184 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.3;tongue: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA012638, HPA042268, HPA073212" Supported Approved Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA012638: AB_2294503, HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (9.01e-2)" "unprognostic (1.36e-2)" "unprognostic (5.11e-2)" "unprognostic (2.54e-1)" "unprognostic (3.41e-1)" "unprognostic (1.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.31e-1)" "unprognostic (6.29e-3)" "unprognostic (2.94e-2)" "unprognostic (3.24e-1)" "unprognostic (4.16e-1)" 2.1 1.3 1.3 3.9 1.4 2.0 2.6 1.4 1.6 1.9 1.1 14.7 14.3 1.2 1.0 2.2 1.7 1.3 7.1 1.3 1.3 6.8 6.4 1.4 1.8 1.4 1.4 1.2 1.1 0.5 7.1 1.9 1.4 1.8 23.3 0.7 2.5 2.4 2.2 1.1 14.6 3.3 1.4 1.3 2.6 3.4 1.4 2.9 1.6 18.5 3.5 2.8 1.5 4.4 7.0 5.1 3.4 3.4 3.5 11.8 3.7 5.2 10.4 8.6 13.6 7.6 8.8 1.0 5.7 6.5 6.0 9.3 6.4 11.9 8.9 5.0 10.0 7.4 8.9 7.1 9.6 3.0 5.0 6.0 5.6 10.2 4.0 10.6 5.9 7.0 19.9 7.8 5.0 3.6 3.3 16.5 10.2 2.2 6.5 9.6 6.0 8.6 8.2 2.7 2.3 5.3 9.5 4.6 11.7 1.8 3.0 5.1 4.7 9.5 2.5 8.3 1.3 4.6 10.6 3.5 4.5 4.5 3.6 7.4 2.6 5.2 7.4 5.9 6.0 4.9 5.7 9.6 3.9 4.1 4.0 0.3 5.6 6.9 8.7 6.7 14.7 1.3 1.4 1.4 1.6 1.3 1.3 1.4 1.4 1.2 1.4 1.4 1.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068775.1 ENSG00000255641 "Novel protein" 12 10412312-10436001 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.2;choroid plexus: 2.8;lymphoid tissue: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "NK-cell: 134.8" "Lineage enriched" "Detected in many" 6 "NK-cells: 134.8" "Cell line enhanced" "Detected in some" "GAMG: 3.1;HeLa: 8.6;HSkMC: 1.5;SuSa: 3.4" HPA062570 Uncertain NA NA "HPA062570: AB_2684795" "unprognostic (6.09e-2)" 0.3 0.1 3.8 0.3 3.8 1.7 0.2 3.4 5.2 0.1 2.8 0.6 0.3 0.4 0.0 0.1 0.2 0.1 0.2 3.8 3.7 0.1 0.4 1.0 0.8 4.0 3.7 3.5 0.1 0.1 0.0 0.0 0.1 4.1 0.2 0.4 0.1 0.4 0.0 0.0 0.0 0.8 0.1 3.5 5.1 0.4 0.2 3.9 0.6 0.2 0.1 0.4 0.2 0.2 4.2 0.0 0.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 8.6 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.0 17.2 0.0 0.1 0.0 0.0 15.0 0.0 0.0 0.1 20.8 0.8 134.8 0.0 0.1 0.0 8.4 3.8 3.8 3.4 5.2 3.8 3.7 4.0 3.7 3.5 4.1 3.5 3.9 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 TRIL KIAA0644 ENSG00000255690 "TLR4 interactor with leucine rich repeats" Q7L0X0 7 28953358-28958330 "Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 62.3" "Cell type enriched" "Detected in many" 4 "Astrocytes: 72.1" "Cancer enhanced" "Detected in many" "glioma: 20.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 22.2;SH-SY5Y: 40.0;SK-BR-3: 35.7;T-47d: 15.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (3.29e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-2)" "unprognostic (8.77e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (4.27e-3)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.07e-2)" 3.6 2.3 40.0 0.6 51.6 0.0 4.2 62.3 32.2 2.6 8.0 1.9 2.1 3.6 1.7 2.4 2.3 1.0 3.5 33.9 39.8 5.3 0.6 2.6 0.4 61.7 62.3 20.7 1.6 0.6 0.8 1.6 1.1 52.1 1.9 1.9 1.0 8.2 1.5 3.2 1.6 2.4 3.4 46.7 2.7 2.4 0.5 59.4 0.4 3.0 0.8 0.3 2.3 3.5 40.7 0.0 0.0 22.2 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.8 40.0 0.1 35.7 0.0 3.2 15.8 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 51.6 62.3 32.2 33.9 39.8 61.7 62.3 20.7 52.1 46.7 59.4 40.7 7.0 12.8 5.3 72.1 0.0 0.0 0.2 0.0 4.0 0.4 7.4 11.0 2.7 0.0 0.6 1.8 0.0 0.2 0.0 0.1 3.9 0.1 0.0 0.4 0.2 4.3 0.0 0.0 0.7 0.0 1.9 15.9 0.0 1.1 0.0 0.2 2.5 0.4 0.1 6.7 0.6 0.4 0.0 0.0 0.0 0.2 1.2 0.5 0.0 5.6 0.0 17.1 0.0 13.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.8 13.1 15.2 4.9 0.5 0.7 2.2 0.0 0.1 0.1 2.0 0.8 0.1 OR4D2 ENSG00000255713 "Olfactory receptor family 4 subfamily D member 2" P58180 17 58166982-58171411 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011462.1 ENSG00000255730 "Novel protein" 19 41350853-41425001 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA036640 Approved NA NA "HPA036640: AB_10671964" "unprognostic (9.81e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (2.65e-1)" "unprognostic (3.39e-2)" "unprognostic (1.45e-1)" "unprognostic (3.73e-2)" "unprognostic (2.18e-8)" "unprognostic (8.91e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (2.97e-2)" 7.8 14.1 0.0 0.0 0.1 0.8 8.1 0.0 0.5 8.5 0.0 7.5 0.0 6.6 0.1 17.1 7.9 0.1 16.1 0.0 0.2 12.6 20.3 8.4 0.0 0.0 0.0 0.0 8.3 13.3 0.0 9.0 0.0 0.0 8.6 0.0 0.0 9.4 0.0 11.9 14.6 6.5 0.0 0.0 10.1 7.9 12.7 0.1 0.0 10.1 0.0 0.1 8.7 11.9 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.1 0.2 0.8 0.0 0.0 0.3 0.2 0.8 0.0 0.2 0.1 2.4 0.1 0.3 0.2 0.2 0.8 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 OR6J1 "OR6J1P, OR6J2" ENSG00000255804 "Olfactory receptor family 6 subfamily J member 1" Q8NGC5 14 22630929-22644352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.3" "Cell type enhanced" "Detected in single" "granulocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.6 0.2 0.5 0.6 0.1 1.3 0.7 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.6 0.8 0.1 0.0 0.1 0.1 0.6 0.4 0.4 0.1 0.2 0.0 0.0 0.1 0.7 0.1 0.0 0.8 0.2 0.0 0.3 0.3 0.1 0.0 0.2 0.2 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.1 0.1 0.1 0.6 0.5 1.3 0.7 0.6 0.8 0.6 0.4 0.4 0.7 0.2 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTRNR2L8 ENSG00000255823 "MT-RNR2 like 8" P0CJ75 11 10507894-10509186 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15956.5;choroid plexus: 6507.5;skeletal muscle: 7622.1" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 32407.2" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 3689.6;eosinophil: 2784.3;neutrophil: 9219.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 9219.1" "Cell line enhanced" "Detected in all" "HeLa: 3532.5;Hep G2: 1873.3" "Secreted to blood" NA NA "unprognostic (6.19e-2)" "unprognostic (1.43e-1)" "unprognostic (6.66e-2)" "unprognostic (3.26e-2)" "unprognostic (3.71e-2)" "unprognostic (3.52e-2)" "unprognostic (2.81e-2)" "unprognostic (3.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (4.59e-2)" "unprognostic (4.59e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-2)" 1009.0 1793.9 6511.6 333.8 6511.8 484.6 252.0 6510.4 15956.5 106.7 6507.5 914.8 618.2 225.0 266.1 648.5 202.7 303.4 3901.3 6888.0 6511.1 1796.8 1291.3 191.9 200.2 7062.6 6512.3 6503.2 241.3 618.4 514.2 1.3 238.5 6699.1 345.4 748.5 872.2 749.3 274.4 7622.1 626.6 729.9 288.4 6567.0 378.9 687.7 604.5 6511.8 97.7 150.8 1913.9 269.2 203.4 0.6 6538.8 527.3 715.6 334.3 1521.1 294.0 151.4 438.7 562.6 61.4 61.1 75.9 427.1 742.2 698.2 544.0 91.4 54.0 1407.6 10.0 103.2 66.3 307.0 613.3 685.6 3532.5 1873.3 109.4 143.3 625.4 277.5 137.1 58.0 141.0 578.3 54.0 412.8 543.6 353.2 180.7 260.8 202.2 910.4 124.0 222.2 194.5 333.0 287.7 352.4 328.7 447.0 186.5 418.8 248.4 399.0 703.2 282.9 418.6 836.4 416.2 433.8 414.5 508.2 189.6 213.6 116.4 414.1 313.4 1053.0 125.3 3689.6 1275.5 2784.3 319.4 577.0 409.2 944.6 407.8 353.4 445.8 957.8 509.9 480.1 9219.1 466.8 613.2 688.5 439.4 1155.3 6511.6 6511.8 6510.4 15956.5 6888.0 6511.1 7062.6 6512.3 6503.2 6699.1 6567.0 6511.8 6538.8 649.6 830.1 866.0 0.0 131.5 471.7 1069.8 27.1 1.2 0.0 599.2 1010.1 32407.2 124.4 492.7 57.0 0.0 6.9 118.0 2.1 72.4 0.0 23.1 785.5 473.5 1034.0 0.0 139.8 0.0 0.0 6.9 1450.7 3.1 916.4 543.7 140.3 119.2 384.5 12.8 0.0 0.0 0.5 4.1 129.6 1091.1 52.7 65.6 420.6 723.9 0.0 14.5 0.0 8.2 0.0 0.3 0.1 0.3 44.8 92.0 618.5 0.3 770.4 481.4 0.0 65.7 2750.1 1533.4 30.9 38.2 0.8 488.9 11.2 370.6 42.0 0.5 1232.9 TIFAB ENSG00000255833 "TIFA inhibitor" Q6ZNK6 5 135444226-135452351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.7" "Cell type enhanced" "Detected in some" "dendritic cells: 8.0;Early spermatids: 4.2;Hofbauer cells: 4.0;Langerhans cells: 17.6;Late spermatids: 9.2;monocytes: 4.6" "Cancer enriched" "Detected in single" 4 "testis cancer: 0.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "myeloid DC: 4.5;plasmacytoid DC: 13.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 13.9" "Cell line enriched" "Detected in some" 5 "THP-1: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049372 Uncertain NA NA "HPA049372: AB_2680733" "unprognostic (1.33e-2)" "unprognostic (1.09e-2)" "unprognostic (1.63e-2)" "unprognostic (1.71e-2)" "unprognostic (1.35e-1)" "unprognostic (1.98e-5)" "unprognostic (3.87e-1)" "unprognostic (3.25e-3)" "unprognostic (5.29e-2)" "unprognostic (1.09e-2)" "unprognostic (6.08e-2)" "unprognostic (1.96e-1)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (9.01e-2)" 0.1 0.0 0.0 3.7 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.9 1.0 0.1 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.5 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.9 1.1 0.2 0.1 2.7 0.7 0.3 0.0 1.9 0.0 0.0 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 17.6 9.2 0.0 2.2 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL117348.2 ENSG00000255835 "Novel protein" 1 225886696-225924278 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.52e-4)" "unprognostic (3.37e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R20 "T2R20, T2R56, TAS2R49" ENSG00000255837 "Taste 2 receptor member 20" P59543 12 10996495-10997875 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (1.12e-3)" "unprognostic (2.16e-4)" "unprognostic (2.92e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.98e-2)" "unprognostic (5.14e-4)" "unprognostic (6.23e-3)" "unprognostic (1.27e-9)" "unprognostic (2.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-2)" "unprognostic (6.44e-3)" 1.2 1.0 0.3 0.1 0.5 0.1 1.3 0.5 0.7 1.9 0.5 1.1 0.0 1.4 0.0 0.7 1.3 0.0 1.0 0.5 0.5 0.7 1.2 1.4 0.2 0.6 0.8 0.3 2.4 1.1 0.0 1.6 0.1 0.7 1.3 0.1 0.9 1.0 0.1 1.4 1.1 1.4 0.1 0.3 1.6 0.9 0.7 0.5 0.2 1.5 0.0 0.0 1.0 1.6 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 0.7 0.5 0.5 0.6 0.8 0.3 0.7 0.3 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 KDM4F JMJD2F ENSG00000255855 "Lysine demethylase 4F" 11 95049422-95051338 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP2A6 "CPA6, CYP2A, CYP2A3" ENSG00000255974 "Cytochrome P450 family 2 subfamily A member 6" P11509 19 40843541-40850447 "Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 171 "liver: 1625.1" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 322.3" "Cancer enriched" "Detected in some" 12 "liver cancer: 281.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.1" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (1.21e-1)" "unprognostic (4.10e-1)" "unprognostic (5.05e-2)" "unprognostic (2.64e-2)" "prognostic favorable (5.38e-5)" "unprognostic (4.98e-3)" "unprognostic (4.86e-2)" "unprognostic (6.23e-2)" "unprognostic (5.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.25e-2)" "unprognostic (8.83e-3)" "unprognostic (2.46e-1)" "unprognostic (3.07e-2)" "unprognostic (2.55e-1)" 0.6 0.2 0.0 0.0 0.0 0.0 9.4 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 1625.1 0.3 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.2 5.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 8.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 11.4 322.3 0.0 0.0 0.1 0.0 0.0 14.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.5 CTSO CTSO1 ENSG00000256043 "Cathepsin O" P43234 4 155921580-155953912 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.1;HSkMC: 44.6;Karpas-707: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002041 Approved "Intracellular and membrane" NA NA 25000 "HPA002041: AB_1078408" "unprognostic (3.96e-3)" "unprognostic (1.62e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (9.10e-3)" "unprognostic (2.55e-1)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (6.62e-2)" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.55e-2)" "unprognostic (4.87e-3)" "unprognostic (4.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" 19.0 31.8 9.2 18.0 9.3 5.0 32.2 7.6 10.7 37.0 8.8 17.6 33.1 37.5 36.4 16.8 37.3 41.1 20.4 9.1 8.0 34.8 99.6 37.2 24.7 9.2 7.9 8.9 28.2 20.1 24.7 9.6 41.5 9.1 30.1 23.4 5.2 22.3 32.5 6.8 10.0 34.3 31.0 7.4 40.1 15.6 9.5 8.4 14.2 34.8 18.0 18.1 28.2 15.5 9.3 0.8 0.6 4.1 3.7 17.3 37.1 0.2 1.6 18.3 3.3 5.7 0.4 14.4 0.2 1.2 6.8 1.2 0.1 0.2 0.1 2.6 1.6 0.1 0.4 0.5 0.2 18.1 1.4 0.2 44.6 3.5 2.2 1.8 25.6 3.5 0.7 0.3 85.8 11.7 0.7 1.1 0.4 0.7 0.6 0.7 4.8 0.5 1.0 16.8 7.5 0.5 4.3 2.4 9.3 2.3 2.0 4.2 2.6 3.0 13.3 0.7 0.4 2.3 8.3 0.2 0.2 24.4 0.3 18.6 5.3 0.9 0.6 1.2 0.7 3.0 1.2 1.4 0.8 0.4 1.5 1.6 2.0 0.7 3.0 0.9 1.0 3.3 1.4 9.2 9.3 7.6 10.7 9.1 8.0 9.2 7.9 8.9 9.1 7.4 8.4 9.3 29.3 38.5 20.8 15.0 19.9 10.5 13.1 11.3 12.0 10.4 20.1 13.0 5.0 44.3 14.3 25.8 2.1 20.5 19.6 15.6 13.7 24.6 0.4 20.9 34.6 28.2 6.7 8.6 1.7 20.7 7.7 51.5 8.6 27.3 8.8 25.0 43.2 58.1 16.3 5.0 1.7 7.9 8.2 29.2 23.7 1.5 30.4 21.4 30.2 7.5 26.5 17.0 22.6 36.7 5.4 12.7 6.3 25.2 7.0 17.5 21.1 10.7 14.5 1.9 19.7 34.0 24.6 0.3 2.1 5.9 9.1 10.5 14.5 14.3 6.6 9.5 MTRNR2L10 ENSG00000256045 "MT-RNR2 like 10" P0CJ77 X 55181392-55182442 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "brain: 1176.5" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 9177.9" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Region enriched" "Detected in all" 43 "cerebral cortex: 1176.5" "Group enriched" "Detected in all" 5 "basophil: 171.3;eosinophil: 137.1;neutrophil: 395.3" "Lineage enriched" "Detected in all" 8 "granulocytes: 395.3" "Cell line enhanced" "Detected in many" "A549: 178.6;HeLa: 834.8;Hep G2: 578.6" "Secreted to blood" NA NA "unprognostic (4.42e-1)" "unprognostic (3.04e-2)" "unprognostic (1.15e-1)" "unprognostic (5.10e-4)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-2)" "unprognostic (8.42e-2)" "unprognostic (1.58e-2)" "unprognostic (9.01e-2)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (6.28e-2)" "unprognostic (2.97e-2)" "unprognostic (4.99e-2)" "unprognostic (3.97e-4)" 38.6 32.5 14.4 5.8 14.5 8.3 3.8 14.4 1176.5 0.7 14.4 39.3 11.4 12.1 38.8 23.3 17.1 10.7 162.7 27.1 14.4 123.1 80.2 3.4 2.6 24.8 14.4 14.3 15.0 24.0 5.2 0.0 6.7 16.9 8.4 66.7 2.5 28.0 3.5 129.1 12.8 10.6 24.8 15.9 8.5 10.8 22.7 14.5 1.0 5.7 15.1 21.4 4.4 0.0 14.8 10.5 178.6 2.4 49.1 4.5 2.2 12.8 16.1 0.8 0.9 0.5 12.1 25.7 24.2 3.4 1.1 2.1 36.6 0.1 1.2 0.5 7.0 36.4 12.3 834.8 578.6 1.1 4.1 6.5 6.2 2.7 0.3 2.0 42.0 0.7 18.4 21.8 13.7 1.9 67.9 3.8 28.8 1.1 0.9 14.0 9.2 9.9 11.3 4.0 111.5 2.5 10.2 4.7 4.3 18.1 23.2 14.4 21.1 25.7 18.0 3.8 6.2 1.6 4.4 3.1 2.0 11.2 5.3 4.0 171.3 50.3 137.1 9.5 25.1 11.4 38.2 14.8 12.7 21.7 36.5 19.1 22.3 395.3 22.8 24.5 26.2 16.2 63.8 14.4 14.5 14.4 1176.5 27.1 14.4 24.8 14.4 14.3 16.9 15.9 14.5 14.8 3.8 0.0 0.0 0.0 4.9 8.2 411.9 1.0 0.0 0.0 15.8 6.6 9177.9 2.8 0.6 42.3 0.0 0.3 1.3 0.0 84.1 0.0 0.3 11.5 6.5 296.2 0.0 0.0 0.0 0.0 0.3 289.5 0.0 16.0 0.0 4.0 1.8 6.2 0.6 0.0 0.0 0.0 2.0 5.5 23.2 1.1 0.6 75.9 16.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 222.0 0.0 611.6 0.6 0.0 0.0 995.2 385.1 0.6 0.9 0.0 9.1 0.3 70.1 4.3 0.0 449.2 COA8 "APOP-1, APOPT1, C14orf153, MGC2562" ENSG00000256053 "Cytochrome c oxidase assembly factor 8" Q96IL0 14 103562960-103607523 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Apoptosis "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.3" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 62.6;Cytotrophoblasts: 75.7;Extravillous trophoblasts: 54.9;Hofbauer cells: 85.8;Syncytiotrophoblasts: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (4.06e-1)" "unprognostic (1.93e-1)" "unprognostic (6.74e-3)" "prognostic unfavorable (6.34e-5)" "unprognostic (1.83e-1)" "unprognostic (7.59e-2)" "prognostic favorable (4.78e-4)" "unprognostic (2.24e-1)" "unprognostic (2.26e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-2)" "unprognostic (2.98e-2)" "unprognostic (3.14e-1)" "unprognostic (3.99e-1)" 20.5 13.5 21.4 12.6 21.3 12.2 20.0 22.3 25.7 17.7 21.8 23.5 19.5 15.9 18.6 20.5 13.9 15.6 32.3 21.6 21.4 22.9 18.7 14.7 17.1 22.0 21.5 21.0 15.0 24.4 14.9 11.4 16.4 21.8 15.6 19.3 9.6 25.0 15.6 123.3 21.3 16.5 16.6 21.1 12.1 20.3 56.7 21.2 11.4 25.9 77.7 17.0 20.6 15.3 24.1 27.5 19.2 17.1 36.5 39.6 45.2 32.2 29.3 31.7 34.7 41.5 23.3 43.9 24.2 29.6 38.7 33.0 37.9 14.6 33.2 46.4 36.8 19.5 9.9 19.3 18.5 47.8 22.0 21.6 33.9 56.4 22.9 53.6 39.3 38.3 26.8 22.2 34.8 37.9 37.8 21.2 28.8 24.9 66.4 71.9 18.3 19.0 22.8 49.1 26.5 34.1 18.1 21.3 26.8 60.0 23.9 41.1 25.6 28.2 30.6 19.9 46.0 40.7 15.3 31.7 30.3 41.9 22.2 33.0 45.6 25.9 34.3 23.4 24.9 21.8 29.5 22.5 24.0 20.8 30.2 20.8 23.2 15.2 31.4 23.3 20.0 30.4 23.7 21.4 21.3 22.3 25.7 21.6 21.4 22.0 21.5 21.0 21.8 21.1 21.2 24.1 15.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.6 0.0 0.0 0.0 0.0 75.7 8.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 54.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 69.4 1.4 0.0 0.0 0.0 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363551-57365405 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: AB_2684982" "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 15.0 20.7 9.4 6.9 9.8 10.7 14.4 11.7 11.6 8.0 10.4 11.0 5.1 10.7 11.1 12.6 9.9 9.9 19.1 9.3 10.3 12.6 11.1 10.5 12.4 9.5 9.4 9.3 12.9 7.3 10.9 15.0 10.9 9.7 10.2 5.7 8.6 11.0 6.8 30.5 11.4 8.6 9.3 9.4 13.4 9.6 23.4 9.9 15.3 12.3 17.2 10.8 12.5 8.6 9.9 16.9 11.9 18.0 12.0 16.2 18.9 16.2 11.5 25.9 16.6 48.6 6.4 12.5 13.0 15.3 14.9 28.3 6.1 8.4 18.5 17.8 5.9 60.8 13.0 18.7 14.6 16.7 14.3 20.9 18.9 23.1 12.6 9.4 19.1 12.5 14.5 4.1 0.1 19.5 5.0 22.1 13.0 6.0 1.2 25.3 10.7 17.0 20.2 18.8 26.7 18.8 15.4 10.9 12.5 11.1 15.9 18.7 18.1 13.9 15.8 13.7 7.7 18.6 20.5 27.8 25.4 22.7 9.1 16.0 68.4 23.5 30.8 12.0 22.2 24.6 45.1 25.3 20.2 26.5 48.5 24.4 19.5 27.7 44.1 20.9 37.9 24.6 22.4 9.4 9.8 11.7 11.6 9.3 10.3 9.5 9.4 9.3 9.7 9.4 9.9 9.9 38.9 9.6 13.1 0.0 13.2 0.0 0.0 0.0 0.0 0.0 21.7 28.2 26.1 0.0 9.9 18.4 0.0 38.1 16.3 0.0 25.4 32.9 0.0 29.3 13.4 15.4 0.0 0.0 0.0 22.1 18.3 10.3 0.0 25.7 21.5 18.2 0.0 0.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 11.9 0.0 0.0 0.0 0.0 28.7 0.0 0.0 4.4 0.0 0.0 17.0 13.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 91.9 11.7 32.7 0.0 0.0 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 171.5;Proximal tubular cells: 34.4;Respiratory ciliated cells: 102.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051048 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051048: AB_2681325" "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.0 2.0 5.5 1.1 4.8 1.2 3.3 3.7 6.8 2.9 7.3 0.9 0.6 3.8 10.7 1.2 11.2 2.3 1.0 4.9 5.0 5.0 0.5 4.4 1.1 4.9 5.0 4.5 2.6 2.1 8.6 3.6 0.7 3.8 2.0 0.9 27.7 1.5 2.0 0.8 1.8 0.8 2.0 3.7 1.3 1.0 11.4 5.4 0.7 8.7 0.5 0.9 1.4 0.7 4.1 7.0 4.8 4.9 10.4 2.0 3.5 1.5 1.0 2.6 3.2 3.6 1.0 2.9 0.6 4.4 2.1 5.2 2.1 1.9 2.7 3.7 2.4 2.5 2.6 3.2 1.7 1.8 5.4 4.2 2.2 5.7 7.6 2.9 5.1 7.2 2.2 0.8 0.3 4.8 2.9 1.3 4.7 2.9 11.0 3.7 1.1 2.3 0.9 17.6 2.3 4.9 10.7 4.3 1.3 6.5 4.2 6.2 1.4 2.5 5.0 2.5 4.4 5.2 2.1 5.4 1.7 8.3 1.3 1.5 0.1 0.7 0.5 0.3 0.5 0.3 1.4 0.5 0.5 0.6 1.3 0.7 0.5 1.4 0.4 0.5 1.9 0.7 0.3 5.5 4.8 3.7 6.8 4.9 5.0 4.9 5.0 4.5 3.8 3.7 5.4 4.1 4.1 12.8 15.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 7.9 9.8 0.0 0.0 15.5 12.9 0.0 2.0 0.4 0.0 5.9 13.6 0.0 171.5 9.0 2.8 0.0 0.0 0.0 5.1 1.5 3.4 0.0 13.3 2.5 9.7 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.0 0.0 34.4 102.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.7 7.2 0.0 0.0 ZNF432 KIAA0798 ENSG00000256087 "Zinc finger protein 432" O94892 19 52031378-52095738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 26.9;Rod photoreceptor cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA052082, HPA060274, HPA065606" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518" "unprognostic (1.62e-1)" "unprognostic (2.34e-1)" "unprognostic (1.92e-1)" "unprognostic (7.04e-3)" "unprognostic (1.08e-2)" "unprognostic (2.41e-3)" "unprognostic (3.19e-2)" "unprognostic (2.56e-1)" "unprognostic (6.92e-2)" "unprognostic (1.83e-1)" "unprognostic (3.14e-2)" "unprognostic (5.49e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.90e-1)" "prognostic favorable (4.11e-5)" 5.5 13.5 3.7 3.7 3.7 8.1 6.5 5.6 3.7 6.4 7.8 5.1 5.2 7.1 8.8 6.6 6.1 3.6 5.8 3.2 3.8 4.8 4.1 5.6 4.3 4.2 3.4 2.7 6.9 18.1 5.6 12.5 4.4 3.8 11.9 4.3 24.8 7.2 4.6 4.2 7.8 5.2 4.4 2.9 4.4 6.4 7.3 3.9 4.0 6.7 4.4 4.1 5.0 6.5 4.7 4.6 3.7 8.2 13.0 5.6 7.2 2.8 5.2 3.9 3.7 5.9 3.2 2.7 3.1 1.6 5.6 4.0 3.4 4.8 4.5 6.4 3.2 11.8 9.5 9.2 6.0 2.6 0.0 8.5 7.3 3.6 5.4 7.9 7.1 4.9 3.7 2.6 14.0 6.8 2.6 9.3 5.2 3.0 2.4 6.3 4.9 9.5 5.4 5.5 22.2 4.8 5.0 8.1 4.4 2.6 5.8 3.9 3.7 7.0 3.1 4.7 3.7 5.5 7.2 10.7 7.5 7.2 0.8 6.1 0.9 1.1 1.3 1.4 1.3 1.0 1.9 0.8 0.8 0.9 1.2 1.5 1.1 1.0 0.6 0.6 0.6 1.2 0.8 3.7 3.7 5.6 3.7 3.2 3.8 4.2 3.4 2.7 3.8 2.9 3.9 4.7 6.2 16.0 10.0 8.1 8.0 2.0 3.3 3.4 3.4 9.8 3.8 3.2 6.0 2.8 11.6 9.2 16.7 2.7 6.4 3.7 3.9 3.5 14.7 11.9 6.4 5.7 10.2 2.5 9.4 1.6 5.8 5.8 6.6 9.0 12.6 7.8 3.9 1.3 2.3 26.9 6.7 4.9 4.1 4.1 1.3 12.4 3.7 3.2 3.6 9.4 3.8 7.7 10.3 9.0 6.9 2.1 5.2 4.5 4.0 3.6 2.0 2.7 11.6 30.7 6.6 7.1 6.4 10.0 8.4 2.2 2.3 4.9 6.5 4.2 3.1 3.3 AP000721.1 ENSG00000256100 "Novel transcript" 11 63974620-63988346 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.2;Club cells: 3.7;Respiratory ciliated cells: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055942 Uncertain NA NA "HPA055942: AB_2682979" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (5.96e-2)" "unprognostic (3.95e-1)" "unprognostic (2.67e-1)" "unprognostic (7.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMLR1 ENSG00000256162 "Small leucine rich protein 1" H3BR10 6 130827406-130837135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 57.1" "Group enriched" "Detected in some" 11 "Hepatocytes: 243.3;Proximal enterocytes: 144.8" "Cancer enriched" "Detected in some" 20 "liver cancer: 16.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "Hep G2: 81.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066060 Uncertain NA NA "HPA066060: AB_2685607" "unprognostic (1.73e-1)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.32e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (6.43e-3)" "unprognostic (2.68e-3)" "unprognostic (3.29e-1)" 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 57.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 81.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 10.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.7 1.4 243.3 0.1 0.0 0.0 3.1 0.0 5.2 0.0 0.2 0.0 0.1 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 144.8 17.5 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 2.0 1.5 0.0 TAS2R30 "T2R30, TAS2R47" ENSG00000256188 "Taste 2 receptor member 30" P59541 12 11132958-11134644 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Endothelial cells: 2.3;Granulosa cells: 2.0;Horizontal cells: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.19e-3)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (3.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (7.01e-6)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.14e-1)" 0.0 0.0 0.5 0.0 0.9 0.1 0.1 2.9 1.1 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.8 0.9 0.2 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 2.9 1.1 0.6 0.9 0.8 0.9 0.2 1.2 0.5 0.7 1.7 0.8 0.0 1.1 0.0 0.9 0.1 0.1 0.2 0.0 1.2 0.3 0.3 0.3 0.0 0.7 0.0 8.4 0.1 0.9 0.3 0.0 0.1 0.0 0.4 1.0 2.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 2.0 0.0 0.4 0.1 3.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.0 0.3 0.1 1.5 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.0 0.4 0.7 0.2 0.1 MTRNR2L3 ENSG00000256222 "MT-RNR2 like 3" P0CJ70 20 57358447-57359498 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.3;skeletal muscle: 1.0" "Cell type enriched" "Detected in some" 49 "Cardiomyocytes: 3203.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebral cortex: 3.3" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enhanced" "Detected in single" "HeLa: 1.1" "Secreted - unknown location" NA NA "unprognostic (1.55e-4)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (8.34e-2)" "unprognostic (2.64e-1)" "unprognostic (1.80e-2)" "unprognostic (9.44e-6)" "unprognostic (2.56e-1)" "unprognostic (6.68e-2)" "unprognostic (5.35e-3)" "unprognostic (1.52e-3)" "unprognostic (7.52e-2)" "unprognostic (5.36e-2)" "unprognostic (4.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (2.94e-3)" 0.0 0.1 0.2 0.0 0.3 0.2 0.0 0.5 3.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 1.1 0.0 0.1 0.0 0.1 0.1 0.2 0.3 0.5 3.3 0.4 0.3 0.2 0.3 0.2 0.4 0.2 0.3 0.5 0.7 0.0 0.0 0.0 1.0 3.2 32.3 0.3 0.0 0.0 2.4 1.3 3203.4 1.5 0.1 0.0 0.0 0.4 0.2 0.0 1.9 0.0 0.1 0.3 0.3 58.4 0.0 2.7 0.0 0.0 0.4 64.9 0.0 0.7 0.0 0.2 2.2 2.6 0.7 0.0 0.0 0.0 0.0 3.9 12.0 0.5 1.5 1.8 7.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 17.7 0.0 10.6 0.1 0.0 0.0 9.2 60.8 0.3 0.7 0.0 3.1 0.5 1.2 0.1 0.0 18.1 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 45.5;Excitatory neurons: 46.0;Inhibitory neurons: 48.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 6.2 14.4 5.5 3.7 6.0 8.7 12.4 8.5 7.8 13.3 6.6 9.4 3.7 15.2 23.7 6.1 12.2 10.4 7.2 5.8 7.9 9.0 10.7 7.7 6.0 5.5 6.9 5.2 22.6 13.3 17.5 45.7 5.2 5.3 15.2 6.3 13.2 8.0 12.8 4.9 8.9 7.1 8.7 5.5 6.1 10.6 15.5 7.6 7.8 21.3 6.4 5.8 10.8 8.9 7.4 3.8 2.2 10.8 0.0 11.5 4.8 6.5 4.4 3.9 5.3 3.6 3.9 2.4 0.0 6.0 4.4 2.9 1.7 6.8 3.6 3.9 0.0 6.6 8.0 10.5 4.4 3.5 5.0 2.6 5.0 3.3 5.7 6.3 7.9 4.4 6.3 6.0 0.0 6.3 1.2 12.0 10.6 11.1 2.1 4.4 9.9 6.8 5.4 4.2 7.9 10.7 7.0 8.7 1.4 3.7 4.9 6.6 5.0 4.3 3.9 3.6 3.7 3.7 0.2 0.0 12.8 1.2 1.7 3.7 0.9 0.5 1.4 2.9 0.6 3.2 3.1 3.4 4.1 1.4 3.0 6.5 3.3 0.5 6.3 0.4 3.4 0.9 1.8 5.5 6.0 8.5 7.8 5.8 7.9 5.5 6.9 5.2 5.3 5.5 7.6 7.4 6.8 0.0 9.0 39.2 39.6 3.8 5.3 3.9 45.5 15.9 9.9 9.4 7.7 4.3 7.1 0.0 31.3 4.5 9.1 1.8 1.9 2.3 24.6 11.9 7.6 5.0 12.6 5.0 46.0 1.4 2.0 15.5 21.4 11.7 10.8 5.0 1.4 4.9 2.5 5.0 48.4 3.9 6.1 3.8 4.6 6.3 2.8 9.0 3.6 21.5 1.5 9.1 2.1 54.3 45.4 1.0 2.1 6.8 16.3 2.6 2.2 2.5 2.7 16.2 0.0 6.3 14.3 20.4 15.4 21.4 3.8 3.8 21.9 6.0 3.3 1.6 ZNF486 "KRBO2, MGC2396" ENSG00000256229 "Zinc finger protein 486" Q96H40 19 20167214-20200488 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 34.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 13.6;Theca cells: 14.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.5" "Cell line enhanced" "Detected in many" "EFO-21: 19.9;HBF TERT88: 21.5;SuSa: 19.8" NA NA "unprognostic (9.94e-3)" "unprognostic (1.29e-1)" "unprognostic (6.89e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-3)" "unprognostic (4.14e-2)" "unprognostic (4.83e-2)" "unprognostic (2.42e-2)" "unprognostic (1.51e-2)" "unprognostic (3.25e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (4.65e-2)" "unprognostic (2.43e-2)" 2.5 2.4 1.6 4.1 2.3 2.9 8.5 3.4 2.1 8.4 1.5 2.6 1.3 6.3 3.8 3.0 5.8 5.0 3.3 1.5 1.8 6.4 1.1 3.5 7.2 2.4 2.2 1.2 7.9 3.0 6.5 0.8 8.0 2.4 3.5 3.0 1.8 2.0 4.6 0.8 5.1 1.5 3.2 1.4 5.0 3.5 2.1 2.0 5.7 34.3 3.1 6.8 12.3 1.8 3.4 0.1 0.1 5.9 0.4 4.3 4.6 0.5 8.1 6.4 15.3 14.5 0.7 3.6 7.2 19.9 6.9 10.8 3.4 0.0 0.7 21.5 0.1 2.4 0.1 0.1 2.1 5.4 0.0 0.1 8.5 2.2 9.0 0.9 5.3 1.0 0.2 3.3 0.1 3.6 0.2 1.5 6.6 10.5 0.0 2.3 4.9 8.1 3.0 18.0 5.7 3.3 9.7 0.0 9.7 1.4 19.8 4.3 0.0 2.2 1.5 0.6 10.5 6.4 0.8 9.4 6.6 0.2 0.1 2.9 2.5 0.7 0.7 0.8 1.2 1.0 1.6 1.1 1.1 0.8 2.1 1.5 2.2 9.5 1.0 1.0 0.9 1.5 0.6 1.6 2.3 3.4 2.1 1.5 1.8 2.4 2.2 1.2 2.4 1.4 2.0 3.4 4.7 6.4 6.7 1.3 4.9 0.1 1.9 0.2 0.0 1.1 4.8 4.7 2.3 0.0 4.0 3.7 0.0 4.5 2.0 1.1 3.9 8.4 0.5 13.0 6.4 4.3 1.2 4.4 1.2 7.1 13.6 4.0 3.1 12.5 5.1 5.7 1.4 0.0 2.2 0.0 1.6 1.8 0.0 1.3 2.0 0.5 4.4 1.5 0.0 2.8 1.4 2.1 4.1 2.0 3.8 2.7 0.9 2.6 1.9 1.1 0.1 1.0 10.5 0.4 6.6 4.4 2.5 2.6 2.7 1.4 1.1 1.5 3.1 14.1 1.6 2.7 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150778757-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 162.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 85.5;Basal squamous epithelial cells: 80.8;granulocytes: 90.0;Macrophages: 79.3;Sertoli cells: 138.1;Smooth muscle cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 409.9;ASC TERT1: 200.1;LHCN-M2: 193.8;U-87 MG: 291.5" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles NA NA Vesicles "HPA075345: AB_2686744" "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 162.5 36.6 22.3 25.7 21.2 90.3 72.1 21.4 26.6 20.0 38.3 24.8 13.5 16.3 22.8 16.9 30.5 25.9 35.8 21.1 23.7 28.3 12.3 31.2 11.8 23.5 22.5 18.6 26.1 34.0 27.1 15.2 46.4 25.1 27.8 19.3 20.6 14.1 24.3 15.1 11.3 23.2 28.5 21.3 25.5 21.8 4.1 23.3 17.8 21.2 15.6 8.8 29.3 18.9 23.9 13.8 4.5 7.3 60.8 409.9 200.1 15.9 52.3 114.6 19.2 77.2 21.5 35.3 0.0 3.1 55.1 12.7 10.7 12.5 11.8 28.6 0.2 3.8 20.0 2.8 9.9 72.4 19.7 130.0 167.9 23.6 54.2 25.1 122.3 6.4 46.6 5.5 0.4 193.8 10.5 28.5 27.0 3.8 10.7 12.5 15.2 1.2 0.0 20.6 10.2 1.8 4.7 7.8 1.1 16.1 8.1 25.4 120.6 10.1 84.2 15.2 65.9 27.5 0.0 0.4 0.2 291.5 75.0 10.8 68.7 41.0 72.4 20.8 17.2 12.7 1.3 14.5 14.4 19.4 0.2 14.1 12.1 42.7 13.0 16.2 57.3 2.3 38.0 22.3 21.2 21.4 26.6 21.1 23.7 23.5 22.5 18.6 25.1 21.3 23.3 23.9 53.7 6.4 8.6 2.6 3.2 0.0 85.5 0.0 80.8 0.8 12.0 16.6 9.9 7.2 2.5 7.3 0.0 8.5 22.8 4.0 13.7 6.4 0.8 1.3 11.1 25.4 4.8 8.4 1.0 31.3 5.0 53.5 2.6 1.1 90.0 1.7 13.2 1.0 45.2 0.0 2.0 36.8 0.0 34.2 0.0 0.6 14.0 79.3 0.0 16.9 30.2 62.1 11.3 5.5 0.1 18.2 1.1 36.9 3.5 15.9 3.9 8.8 0.0 1.9 138.1 72.3 77.2 0.1 0.5 20.1 0.0 8.1 28.8 3.0 7.4 40.1 HMBS "PBGD, PORC, UPS" ENSG00000256269 "Hydroxymethylbilane synthase" P08397 11 119084866-119093549 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 172.2" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 935.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006114, HPA050659" Supported Approved "Lipid droplets" NA NA 21000000 "Lipid droplets" "HPA006114: AB_1079067, HPA050659: AB_2681206" "unprognostic (6.24e-2)" "unprognostic (9.10e-3)" "unprognostic (1.42e-2)" "unprognostic (4.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (2.29e-3)" "unprognostic (2.81e-1)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (2.90e-3)" "unprognostic (3.91e-3)" "unprognostic (9.53e-2)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" 9.4 16.0 9.3 9.4 10.1 172.2 9.5 11.2 10.5 7.7 9.6 13.8 12.6 10.2 12.0 14.6 7.7 4.1 15.6 8.9 9.7 12.3 23.0 8.9 9.3 10.6 10.1 8.3 3.9 16.3 9.3 8.5 10.7 10.3 8.7 15.0 6.0 10.0 8.7 30.7 10.0 10.2 10.6 10.7 15.3 11.8 5.7 10.6 7.7 9.0 24.1 11.9 9.7 8.1 12.7 40.0 59.9 27.7 47.5 21.6 27.2 41.7 31.1 34.8 45.0 38.2 74.4 60.2 59.4 68.3 40.1 42.0 53.7 41.6 60.1 28.2 42.0 42.4 97.2 22.5 55.0 40.8 37.6 31.2 29.8 38.0 71.5 53.1 18.7 21.5 55.9 154.6 25.7 35.9 158.4 36.3 72.6 32.1 72.8 36.5 41.9 27.8 59.5 45.3 36.2 31.1 41.4 24.6 38.4 29.3 19.3 64.7 52.3 20.0 33.0 25.5 32.9 36.0 14.2 16.7 36.6 22.7 47.4 40.0 48.5 38.5 4.4 13.6 35.2 17.8 21.4 12.5 15.1 52.8 24.4 19.7 14.7 1.3 11.5 22.2 35.1 14.2 26.6 9.3 10.1 11.2 10.5 8.9 9.7 10.6 10.1 8.3 10.3 10.7 10.6 12.7 5.2 9.6 9.0 4.2 12.1 7.9 11.0 26.7 13.6 5.6 14.5 16.8 13.7 18.6 12.8 11.0 27.1 57.8 12.1 12.4 19.6 25.6 1.7 5.8 10.4 6.2 13.2 935.9 3.8 31.2 61.1 9.0 5.6 5.8 2.5 6.3 4.6 23.7 29.1 10.1 5.7 19.1 14.2 13.0 10.4 3.0 5.9 9.5 14.2 1.9 15.3 7.5 8.2 4.5 8.6 23.3 13.0 8.6 25.0 14.5 9.2 24.5 13.6 25.9 0.0 8.6 11.7 1.7 32.0 18.8 8.1 23.3 6.1 16.7 31.0 10.5 ZNF225 ENSG00000256294 "Zinc finger protein 225" Q9UK10 19 44112181-44134822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.1" HPA073778 Approved Nucleoplasm NA NA Nucleoplasm "HPA073778: AB_2686634" "unprognostic (1.52e-1)" "unprognostic (8.99e-2)" "unprognostic (1.36e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-2)" "unprognostic (9.03e-2)" "unprognostic (7.54e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (7.18e-3)" "unprognostic (5.67e-2)" "unprognostic (7.54e-2)" "unprognostic (1.84e-1)" "unprognostic (6.60e-2)" "unprognostic (5.90e-2)" "unprognostic (3.17e-4)" 2.2 3.2 4.5 2.7 5.5 2.4 8.1 5.5 5.3 4.1 4.2 2.5 2.5 3.5 2.5 2.1 3.2 2.9 3.2 4.2 4.4 3.0 2.8 2.8 3.7 4.8 5.0 4.0 5.3 2.0 4.5 2.5 3.3 5.0 3.4 2.5 7.0 3.1 3.5 2.6 3.2 2.2 2.5 4.4 4.1 3.0 12.9 5.0 5.3 4.1 2.4 3.9 2.6 2.0 7.1 2.6 4.2 5.4 6.3 7.9 7.0 1.2 4.2 6.4 4.9 6.3 2.6 1.6 1.1 3.2 4.6 2.8 2.2 5.0 3.1 4.3 2.6 4.8 7.7 5.4 2.4 4.6 4.7 6.8 6.6 3.7 4.4 7.1 8.3 4.8 3.4 2.3 1.3 4.2 0.8 3.4 3.3 4.8 1.9 4.3 2.8 7.4 2.5 4.8 5.2 3.2 5.6 7.6 18.1 2.3 5.5 2.0 8.0 4.9 4.5 4.7 2.2 2.8 5.9 3.8 0.8 2.1 2.8 4.1 11.6 3.2 5.2 3.4 4.6 3.3 3.3 2.5 2.6 4.4 5.3 4.7 3.5 0.7 4.4 1.9 2.0 3.8 2.4 4.5 5.5 5.5 5.3 4.2 4.4 4.8 5.0 4.0 5.0 4.4 5.0 7.1 1.5 0.0 1.7 3.9 2.7 0.3 0.7 0.5 1.2 4.3 1.3 1.0 1.6 1.5 1.5 1.8 0.0 2.3 6.0 1.0 3.9 1.3 9.7 0.7 1.9 2.0 1.2 4.4 3.4 1.3 1.1 2.1 2.6 0.7 0.0 3.8 2.9 1.8 1.5 6.7 3.4 1.0 0.0 3.5 1.1 2.0 2.8 1.3 0.0 0.0 1.3 3.0 3.1 2.5 5.8 1.3 1.9 1.9 1.4 0.4 1.5 1.2 1.7 4.3 0.0 2.3 1.6 4.1 2.2 0.5 0.4 0.3 2.1 3.4 0.9 0.5 AP002748.5 ENSG00000256349 "Novel protein" 11 66509079-66533613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;choroid plexus: 1.8;retina: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 9.7;THP-1: 2.8" HPA058283 Uncertain Approved Midbody Yes NA Midbody "HPA058283: AB_2683667" 0.0 0.1 2.0 0.0 1.9 0.0 0.2 1.9 2.7 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 2.1 0.4 0.2 0.2 0.2 2.3 2.1 1.8 0.0 0.9 0.2 0.0 0.2 2.2 0.1 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.2 2.2 0.1 0.1 0.0 2.3 0.1 0.1 0.0 0.0 0.1 0.0 2.3 0.6 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.0 0.1 1.1 0.1 0.0 1.3 0.1 0.4 0.0 0.6 0.3 0.6 9.7 0.8 0.0 0.8 0.0 0.0 0.7 1.4 0.2 0.1 0.2 0.5 0.4 0.2 0.9 2.8 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 1.9 1.9 2.7 2.0 2.1 2.3 2.1 1.8 2.2 2.2 2.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIAL4D ENSG00000256374 "Peptidylprolyl isomerase A like 4D" F5H284 1 145241630-145242124 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Langerhans cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (9.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.05e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.4 0.8 0.1 0.6 1.9 0.6 2.4 1.2 0.8 1.7 1.6 1.1 1.5 0.0 1.2 1.3 1.7 2.2 3.3 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 ASIC5 "ACCN5, HINAC, INAC" ENSG00000256394 "Acid sensing ion channel subunit family member 5" Q9NY37 4 155829729-155866277 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "intestine: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014903, HPA029444" Approved NA NA "HPA014903: AB_1844498, HPA029444: AB_10611671" "unprognostic (8.52e-5)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R31 "T2R31, T2R53, TAS2R44" ENSG00000256436 "Taste 2 receptor member 31" P59538 12 11030387-11031407 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Endothelial cells: 2.2;Granulosa cells: 1.7;Theca cells: 1.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.23e-2)" "unprognostic (3.80e-1)" "unprognostic (2.85e-2)" "unprognostic (4.70e-3)" "unprognostic (2.16e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-1)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (1.60e-2)" "unprognostic (2.72e-2)" "unprognostic (4.32e-2)" "unprognostic (7.54e-4)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (6.53e-3)" "unprognostic (1.83e-1)" 0.3 0.3 0.2 0.0 0.3 0.0 0.4 0.4 0.6 0.5 0.3 0.3 0.0 0.6 0.2 0.1 0.5 0.0 0.3 0.3 0.5 0.2 0.1 0.3 0.0 0.6 0.6 0.2 0.9 0.4 0.0 0.6 0.0 0.7 0.3 0.0 0.1 0.2 0.0 0.2 0.3 0.3 0.0 0.2 0.2 0.2 0.7 0.3 0.2 0.3 0.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.4 0.6 0.3 0.5 0.6 0.6 0.2 0.7 0.2 0.3 0.7 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.7 0.2 0.1 0.0 0.0 0.1 0.0 4.2 0.1 0.2 0.0 0.0 0.1 0.0 0.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.7 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.8 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.1 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673576 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 12.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 11.4;Early spermatids: 42.6;Horizontal cells: 20.2;Spermatogonia: 40.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059723 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA059723: " 0.4 0.2 2.3 0.0 2.3 0.2 0.4 2.4 3.3 0.5 2.0 0.4 0.1 0.3 0.2 0.4 0.6 0.0 0.4 2.2 2.2 0.5 1.0 0.6 0.1 2.3 2.4 2.2 0.4 0.8 0.4 1.3 0.1 2.4 0.9 0.4 0.0 0.4 0.2 0.7 0.6 0.6 0.2 2.2 1.0 0.3 12.3 2.5 0.7 0.6 0.1 0.6 0.3 0.4 2.4 0.1 0.2 0.3 0.2 0.3 0.1 0.7 0.0 0.3 1.1 1.0 0.3 0.2 0.3 0.1 0.2 0.1 0.3 0.7 0.3 0.4 0.2 0.7 0.1 0.7 0.1 0.4 0.2 0.4 0.2 1.1 0.9 0.5 0.1 0.4 0.3 0.2 0.0 0.4 0.1 0.0 1.1 0.2 0.0 0.7 0.9 0.1 0.1 0.5 0.1 0.5 0.4 0.0 0.0 0.3 0.2 0.1 0.2 0.0 0.3 0.6 0.2 0.0 1.6 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.3 2.4 3.3 2.2 2.2 2.3 2.4 2.2 2.4 2.2 2.5 2.4 0.4 3.2 1.1 3.9 1.3 0.5 0.9 0.8 0.0 11.4 1.1 1.0 0.0 1.5 0.7 3.7 4.2 0.3 0.7 0.5 0.0 0.2 42.6 1.2 1.4 0.9 1.2 2.7 3.6 0.4 0.6 0.7 0.5 1.6 0.0 1.7 1.1 1.9 0.6 20.2 3.5 0.9 0.0 1.3 1.5 7.2 0.6 1.0 0.0 1.0 0.2 2.5 1.0 2.5 3.6 0.4 0.1 0.4 0.6 2.0 0.4 0.1 0.5 6.6 0.0 1.7 0.8 6.2 40.0 1.0 1.0 0.3 1.9 0.4 0.9 1.6 SALL3 ZNF796 ENSG00000256463 "Spalt like transcription factor 3" Q9BXA9 18 78980275-79002677 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.6;prostate: 6.0;vagina: 8.0" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Bipolar cells: 14.7;Cone photoreceptor cells: 47.9;Horizontal cells: 25.2;Oligodendrocyte precursor cells: 21.1" "Cancer enriched" "Detected in some" 6 "glioma: 6.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.7;HEK 293: 2.7;NTERA-2: 9.5;SuSa: 1.6" "Region enriched" "Detected in many" 4 "olfactory bulb: 12.5" "Low region specificity" "Detected in many" HPA016656 Uncertain NA NA "HPA016656: AB_1856546" "unprognostic (3.96e-2)" "unprognostic (3.41e-3)" "unprognostic (8.16e-2)" "unprognostic (1.87e-2)" "unprognostic (2.37e-1)" "unprognostic (4.23e-1)" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-1)" "unprognostic (5.86e-3)" 0.0 0.0 5.9 0.0 5.9 0.0 0.0 5.8 5.8 0.4 2.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 4.9 7.5 3.2 0.0 0.0 0.0 8.6 6.0 4.4 0.0 0.0 0.0 1.2 0.0 6.5 6.0 0.0 1.8 0.7 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 1.3 6.5 0.0 0.0 0.0 0.0 0.4 8.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 5.9 5.8 5.8 4.9 7.5 8.6 6.0 4.4 6.5 8.6 6.5 7.3 0.2 0.0 0.0 25.5 0.0 0.0 7.4 0.0 0.0 14.7 0.0 0.1 1.8 0.0 0.0 1.8 47.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 25.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 4.8 0.0 0.0 0.0 0.0 8.4 0.0 0.1 0.0 1.8 6.6 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 AL139300.1 ENSG00000256500 "Novel protein" 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.0;tongue: 16.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;granulocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA044617, HPA052450" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 4.4 2.6 0.8 2.9 1.1 0.9 1.3 1.0 5.2 1.2 0.2 1.1 0.0 0.8 0.2 1.6 0.9 0.1 11.0 1.4 1.3 0.5 0.5 1.0 1.6 1.0 1.7 0.9 1.1 2.6 7.6 3.8 0.1 1.6 1.4 0.0 3.5 1.6 1.1 32.0 0.4 0.7 3.1 1.3 0.4 0.7 9.4 1.0 3.0 0.1 16.6 1.7 3.4 0.5 1.3 8.1 15.9 18.5 0.6 8.2 7.8 5.6 25.7 19.7 29.3 17.0 9.5 12.1 22.0 17.2 19.2 19.3 5.5 12.4 13.3 17.4 6.7 0.0 8.7 6.1 8.7 9.7 10.8 3.4 8.6 0.6 13.5 11.0 14.5 15.2 13.7 11.6 3.4 21.4 15.4 18.9 1.2 12.1 19.5 13.9 7.7 12.1 11.4 13.6 9.0 22.1 12.2 14.6 5.7 12.1 6.2 13.0 6.6 8.4 11.3 9.2 16.9 10.4 6.4 8.6 25.6 19.6 3.4 9.8 0.2 0.8 1.1 0.5 1.3 0.7 0.3 0.7 0.9 0.4 1.3 1.0 0.4 0.7 0.6 1.6 1.5 1.4 0.3 0.8 1.1 1.0 5.2 1.4 1.3 1.0 1.7 0.9 1.6 1.3 1.0 1.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AP003419.1 ENSG00000256514 "Novel protein" 11 67351572-67373584 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;Club cells: 1.8;granulocytes: 3.8;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 160.8" HPA078008 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA078008: " "unprognostic (1.64e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" 24.1 26.8 44.4 46.0 46.8 39.3 26.9 47.5 57.5 29.1 45.5 68.7 47.3 14.9 38.8 46.5 25.6 50.3 44.8 43.5 51.5 31.8 92.6 37.0 84.1 48.1 46.0 42.9 23.8 68.7 20.2 14.7 28.9 47.0 37.0 72.6 8.3 42.3 32.4 37.8 30.8 44.3 34.4 48.7 38.8 46.3 20.7 48.2 58.5 26.2 75.7 124.1 47.4 11.4 50.6 14.4 14.9 8.1 12.1 81.4 124.2 3.4 18.9 82.0 26.0 26.9 0.0 160.8 15.4 49.2 122.4 48.9 19.3 8.1 102.3 15.5 10.1 0.2 17.3 2.3 0.0 122.6 5.4 40.2 122.2 96.3 64.0 111.7 115.7 80.3 31.0 7.1 41.8 94.7 3.9 13.5 15.4 3.3 138.1 1.0 15.7 22.0 18.9 80.9 2.5 1.4 6.1 13.9 17.6 53.9 34.4 50.4 19.4 45.8 42.5 7.0 42.8 8.6 16.5 2.4 25.6 99.3 12.2 25.8 43.2 39.6 74.0 45.8 48.6 43.7 87.9 60.8 60.3 39.1 96.3 61.9 51.7 34.6 24.3 90.4 72.9 84.0 62.0 44.4 46.8 47.5 57.5 43.5 51.5 48.1 46.0 42.9 47.0 48.7 48.2 50.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497054 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017030, HPA023202, HPA078396" Approved Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "CAB017030: , HPA023202: AB_1855523, HPA078396: " "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavorable (6.59e-4)" "prognostic unfavorable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 4.5 5.8 2.9 4.4 3.2 3.6 4.5 4.1 4.5 6.6 3.3 4.6 3.6 4.7 2.0 4.0 5.7 2.4 4.8 3.0 3.3 5.0 5.3 3.9 5.4 3.3 3.1 2.7 8.0 4.7 2.4 4.0 3.0 3.3 5.1 1.9 2.6 4.0 2.9 6.8 4.2 5.6 2.1 3.2 7.5 4.0 12.9 3.1 6.3 5.9 4.2 4.1 4.8 5.3 4.0 8.1 10.4 6.7 7.6 7.2 4.7 8.4 4.6 4.6 7.0 5.9 10.1 6.2 15.7 5.4 2.8 6.5 5.3 9.3 3.9 8.8 4.6 11.0 9.9 12.2 10.5 7.0 14.2 10.6 4.5 4.7 5.3 7.2 8.4 4.7 7.6 18.3 4.7 6.5 10.0 15.3 15.4 7.3 8.6 11.2 13.3 23.8 14.2 6.4 2.4 9.3 10.0 4.4 7.1 8.0 8.7 7.4 12.0 6.1 7.0 9.9 5.8 12.3 8.4 7.2 11.3 5.9 13.4 4.8 7.2 5.2 6.0 6.5 3.2 6.6 10.7 7.5 6.2 9.7 11.9 9.7 9.7 0.9 5.8 8.4 4.4 8.1 4.0 2.9 3.2 4.1 4.5 3.0 3.3 3.3 3.1 2.7 3.3 3.2 3.1 4.0 24.6 12.8 21.2 7.8 19.6 8.2 13.7 7.8 16.5 5.0 30.1 37.5 18.4 12.8 13.3 3.7 0.0 13.0 22.7 31.7 0.0 5.4 14.7 16.5 26.7 16.0 10.9 20.4 9.1 3.8 14.4 19.2 14.8 29.2 13.3 9.9 14.6 4.7 9.2 6.7 7.4 13.9 6.1 6.9 7.1 7.3 6.5 17.7 7.2 11.2 8.0 4.5 18.6 13.0 14.1 2.9 21.8 3.0 6.3 9.8 8.9 5.2 7.1 9.2 6.6 92.0 18.4 49.7 9.2 10.8 8.7 4.0 16.2 15.2 19.8 5.2 SMIM10L1 ENSG00000256537 "Small integral membrane protein 10 like 1" P0DMW3 12 11171194-11176016 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.27e-1)" "unprognostic (5.11e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-1)" "unprognostic (2.97e-3)" "unprognostic (3.14e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.71e-4)" "unprognostic (2.80e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (8.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.70e-4)" 5.9 16.2 13.9 4.8 13.2 5.8 5.0 12.4 14.4 4.3 12.5 8.4 5.2 6.8 8.0 4.2 4.6 3.5 12.9 13.6 13.2 7.5 10.7 4.7 4.7 13.6 13.6 11.8 3.8 4.8 5.6 8.8 4.8 14.3 6.6 4.5 7.4 11.6 6.3 21.9 2.6 6.0 5.5 14.3 6.2 6.5 3.2 13.7 6.3 6.1 10.3 4.0 7.0 3.9 13.7 10.5 6.3 16.6 7.3 13.2 9.6 14.5 15.4 9.2 9.9 7.7 13.3 9.2 8.7 6.7 8.7 12.6 6.8 9.9 7.7 12.6 30.3 11.7 15.9 9.2 12.9 9.1 22.4 5.1 8.5 6.7 10.1 10.1 11.8 8.1 14.5 11.6 7.7 11.4 10.1 15.7 18.6 26.9 5.7 8.1 13.0 19.8 9.3 12.5 11.9 8.8 9.7 12.5 7.6 23.0 27.0 4.1 15.1 9.9 17.7 25.1 7.7 15.5 6.6 14.5 21.3 12.9 13.0 16.3 22.1 9.7 11.4 8.9 8.3 9.6 6.1 9.3 9.4 7.9 7.4 10.3 8.5 1.2 12.8 7.9 9.6 10.4 9.0 13.9 13.2 12.4 14.4 13.6 13.2 13.6 13.6 11.8 14.3 14.3 13.7 13.7 33.8 16.0 27.4 0.0 25.6 0.0 15.3 0.0 23.3 26.7 33.6 38.2 88.4 35.8 18.0 7.3 25.0 56.7 47.3 9.3 52.8 48.7 5.2 33.1 26.0 36.1 12.2 40.0 0.0 50.7 23.9 28.0 17.3 21.0 16.4 24.9 29.3 34.9 43.8 26.9 0.0 18.5 0.0 25.8 0.0 9.9 26.4 26.8 0.0 0.0 38.5 29.5 56.7 0.0 0.0 52.7 13.3 32.4 41.8 23.4 38.0 68.1 16.8 34.4 32.9 22.9 33.6 11.5 22.0 19.8 0.0 17.9 30.7 46.8 17.3 11.1 TRAV1-2 ENSG00000256553 "T cell receptor alpha variable 1-2" A0A0B4J238 14 21642889-21643578 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 19.5" "Cell type enriched" "Detected in single" 6 "T-cells: 4.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 7 "MAIT T-cell: 2027.8" "Lineage enriched" "Detected in many" 507 "T-cells: 2027.8" "Not detected" "Not detected" NA NA "unprognostic (1.19e-3)" "unprognostic (1.29e-3)" "unprognostic (1.59e-2)" "unprognostic (1.84e-3)" "unprognostic (5.87e-3)" "unprognostic (1.55e-3)" "unprognostic (3.56e-2)" "unprognostic (8.90e-2)" "unprognostic (6.50e-4)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.13e-2)" "unprognostic (2.15e-1)" "unprognostic (1.43e-1)" "unprognostic (8.99e-2)" "unprognostic (8.30e-2)" 0.3 0.7 0.0 4.5 0.0 1.3 0.4 0.0 0.4 0.6 0.0 1.2 1.6 0.3 0.3 0.5 0.8 3.1 0.1 0.0 0.1 0.2 1.1 2.0 7.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 1.2 0.0 0.3 0.0 0.0 0.4 1.3 0.3 0.1 4.6 1.5 0.1 0.0 19.5 0.5 0.0 7.3 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.7 1.0 0.6 2027.8 0.4 44.9 311.2 0.8 0.2 40.9 70.0 3.9 0.3 1.3 1.7 79.5 40.4 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 OR13A1 ENSG00000256574 "Olfactory receptor family 13 subfamily A member 1" Q8NGR1 10 45302298-45315608 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "Daudi: 10.4;U-698: 9.3" "Not detected" "Not detected" HPA057237 Uncertain NA NA "HPA057237: AB_2683378" "unprognostic (7.88e-2)" "unprognostic (1.90e-1)" "unprognostic (5.52e-2)" "unprognostic (2.33e-5)" "unprognostic (6.43e-3)" "unprognostic (6.04e-2)" "unprognostic (8.65e-2)" "unprognostic (3.59e-1)" "unprognostic (2.45e-1)" "unprognostic (2.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.67e-15)" "unprognostic (6.54e-2)" "unprognostic (2.87e-1)" "unprognostic (8.55e-2)" "unprognostic (4.09e-3)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.1 0.2 0.1 0.7 0.0 0.0 0.3 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 TRDV3 hDV103S1 ENSG00000256590 "T cell receptor delta variable 3" A0JD37 14 22469041-22469698 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "epididymis: 12.7;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in some" "Fibroblasts: 1.8;NK-cells: 1.0;T-cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 10 "gdT-cell: 63.4" "Lineage enriched" "Detected in single" 303 "T-cells: 63.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.31e-2)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" 0.4 0.0 0.3 0.1 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.5 0.0 0.0 12.7 0.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 0.1 1.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 2.1 0.1 0.0 0.3 9.3 0.0 0.0 1.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.2 0.7 0.7 0.0 0.1 1.0 6.1 0.0 0.1 0.0 0.0 2.7 1.8 0.3 0.4 0.3 0.4 0.5 0.4 0.4 0.4 0.2 0.3 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 AP003108.2 ENSG00000256591 "Novel transcript" 11 61429220-61485822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 1.4;Endometrial stromal cells: 1.5;Glandular and luminal cells: 1.4;Granulosa cells: 3.4;Respiratory ciliated cells: 1.5;Theca cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 28.0" "Low region specificity" "Detected in all" HPA039732 Approved NA NA "HPA039732: AB_10962868" "unprognostic (1.23e-1)" "unprognostic (8.61e-2)" "unprognostic (9.60e-2)" "unprognostic (4.91e-2)" "unprognostic (5.69e-2)" "unprognostic (5.98e-2)" "unprognostic (4.41e-2)" "unprognostic (6.40e-2)" "unprognostic (3.53e-2)" "unprognostic (5.83e-2)" "unprognostic (4.98e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-7)" "unprognostic (5.74e-2)" "unprognostic (9.69e-2)" "unprognostic (1.40e-1)" "unprognostic (4.66e-3)" 5.1 4.8 2.9 4.1 3.2 8.8 4.1 3.1 3.7 5.9 2.8 2.7 2.2 3.6 3.2 3.4 3.3 4.9 7.0 3.2 3.3 3.6 2.4 3.9 4.6 3.4 3.1 2.9 2.1 2.0 2.4 1.3 3.2 3.4 3.3 3.3 1.0 2.6 2.7 1.8 1.6 2.6 4.2 3.2 4.4 3.4 2.9 3.3 7.7 5.2 6.0 4.8 5.5 1.9 3.2 6.8 3.3 3.8 6.1 9.7 8.1 2.0 8.9 7.6 6.6 6.2 2.6 4.5 7.1 14.5 8.3 5.5 3.0 4.5 6.3 3.9 6.3 5.3 5.4 0.9 0.9 11.4 4.2 2.0 15.6 3.8 9.8 7.8 4.2 16.7 9.2 5.8 6.0 10.9 5.3 14.1 4.0 8.5 5.8 4.5 8.4 5.8 8.6 4.4 5.4 3.0 3.8 3.7 3.5 12.6 2.5 4.9 4.8 28.0 8.4 4.7 4.5 5.0 2.2 9.5 4.8 7.2 5.5 6.3 5.9 8.0 8.4 11.6 7.3 14.6 5.9 11.5 11.8 6.3 6.8 13.2 12.3 11.2 7.4 6.8 6.8 12.9 10.2 2.9 3.2 3.1 3.7 3.2 3.3 3.4 3.1 2.9 3.4 3.2 3.3 3.2 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.6 3.7 0.0 0.3 1.4 0.0 0.0 0.2 0.0 0.7 1.5 0.6 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.4 1.3 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 1.5 0.0 0.0 MTRNR2L1 ENSG00000256618 "MT-RNR2 like 1" P0CJ68 17 22523415-22524663 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 18493.0;choroid plexus: 7037.0" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 16283.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4804.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 4804.8" "Cell line enhanced" "Detected in all" "HeLa: 3045.1;Hep G2: 1708.1" "Secreted to blood" NA NA "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.41e-3)" "unprognostic (2.99e-2)" "unprognostic (9.82e-3)" "prognostic favorable (8.99e-4)" "unprognostic (2.14e-1)" "unprognostic (2.59e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-2)" "unprognostic (1.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (5.21e-3)" 719.4 1005.9 7037.8 175.1 7037.6 276.7 265.0 7037.0 18493.0 112.7 7037.0 631.7 361.3 132.1 206.6 377.1 140.6 198.4 2333.2 7321.5 7036.9 1199.8 949.4 144.2 126.6 7378.2 7037.3 7036.7 140.0 407.7 621.5 0.0 186.0 7144.3 235.2 541.5 638.8 444.9 283.6 3673.5 421.6 405.2 205.8 7054.4 218.4 449.4 373.0 7038.7 120.9 101.4 3357.2 194.7 178.7 0.0 7055.1 268.9 621.7 231.5 771.3 365.2 150.1 292.9 243.5 59.4 57.5 66.0 386.2 417.6 362.9 260.2 130.7 40.4 685.1 18.1 90.8 71.0 214.7 441.0 331.6 3045.1 1708.1 118.5 77.8 376.1 338.0 191.1 63.1 152.7 407.1 62.9 232.2 276.6 211.5 172.8 222.1 121.7 528.1 65.0 208.0 138.3 196.3 145.4 186.7 321.5 380.3 121.8 215.0 119.2 217.6 376.5 222.6 205.9 551.4 118.8 302.6 251.1 364.1 156.7 196.5 68.6 174.1 169.9 483.3 67.0 2097.9 721.0 1313.4 204.5 325.1 248.2 597.3 255.0 225.8 245.8 585.3 331.9 301.3 4804.8 301.1 339.6 428.7 248.4 677.0 7037.8 7037.6 7037.0 18493.0 7321.5 7036.9 7378.2 7037.3 7036.7 7144.3 7054.4 7038.7 7055.1 16.2 131.4 117.3 0.0 16.2 84.4 1432.1 2.8 0.0 0.0 54.3 88.4 16283.9 5.7 145.5 77.3 0.0 0.8 3.0 4.0 111.6 0.6 6.6 23.4 4.5 460.8 1.8 0.0 0.0 0.7 0.7 591.3 0.0 56.4 166.5 128.9 4.2 11.9 0.8 0.0 0.0 6.5 0.0 7.2 56.2 17.8 15.5 71.6 62.2 0.0 1.3 0.0 0.0 0.0 0.1 0.3 2.7 4.1 0.5 261.1 1.0 1169.4 101.8 0.0 0.0 346.1 450.7 10.2 18.2 0.0 171.3 1.0 79.5 34.6 2.2 749.7 AC010132.3 ENSG00000256646 "Novel PSMA2 and C7orf25 readthrough" 7 42909273-42932214 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.3;Club cells: 1.8;granulocytes: 2.5;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA008188 Uncertain NA NA "HPA008188: AB_1855819" "unprognostic (1.73e-1)" "unprognostic (3.83e-4)" "unprognostic (3.10e-1)" "unprognostic (6.63e-3)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (3.20e-2)" "unprognostic (4.69e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.38e-3)" "unprognostic (3.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.1 4.5 0.9 2.1 0.6 1.1 0.7 0.9 0.9 0.9 1.0 1.1 0.6 0.6 0.3 0.9 1.0 0.9 1.2 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CLEC12B ENSG00000256660 "C-type lectin domain family 12 member B" Q2HXU8 12 10010627-10018796 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 5.2;skin 1: 4.3;testis: 13.2" "Cell type enriched" "Detected in some" 5 "Melanocytes: 80.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "GAMG: 2.8;U-937: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.08e-2)" "unprognostic (4.81e-2)" "unprognostic (3.60e-1)" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (3.36e-3)" "unprognostic (4.14e-4)" "unprognostic (7.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-5)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" "unprognostic (5.48e-1)" "unprognostic (8.95e-4)" 0.4 0.0 0.0 0.5 0.1 5.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.8 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 4.3 0.1 0.1 0.0 1.6 0.1 13.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.8 9.5 0.3 2.2 80.0 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.0 LIMS4 LIMS3L ENSG00000256671 "LIM zinc finger domain containing 4" P0CW20 2 110446640-110473075 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 1.5;Glandular and luminal cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.0;hTEC/SVTERT24-B: 1.8;HUVEC TERT2: 1.0;U-138 MG: 1.9" HPA058455 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.12e-1)" 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 ZNF350 "ZBRK1, ZFQR" ENSG00000256683 "Zinc finger protein 350" Q9GZX5 19 51964340-51986856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001521 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA001521: AB_1080705" "unprognostic (7.26e-3)" "unprognostic (4.02e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.03e-2)" "unprognostic (4.17e-2)" "unprognostic (7.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.08e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.25e-3)" "unprognostic (6.64e-3)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (8.30e-2)" "prognostic favorable (2.54e-4)" 5.9 4.5 5.9 5.5 7.2 26.5 13.9 8.8 6.8 5.5 4.3 6.6 5.5 6.4 8.3 4.7 5.8 5.2 5.0 6.4 6.3 7.1 5.4 6.3 9.7 6.0 5.7 5.8 8.4 4.5 9.3 4.9 9.3 6.2 27.7 9.2 9.8 6.5 6.4 4.5 7.5 6.1 5.8 5.8 9.1 7.3 6.4 6.3 9.1 9.9 5.9 9.2 6.3 5.2 7.3 0.8 4.4 5.6 6.8 7.5 6.7 1.1 4.6 6.5 4.8 9.5 0.0 3.5 2.1 3.6 5.5 8.8 5.8 4.9 6.5 6.6 0.0 10.5 8.6 7.5 3.9 6.3 2.2 10.1 9.5 9.9 6.4 6.6 9.4 5.5 3.5 2.3 0.1 5.8 2.8 8.5 10.2 3.7 0.5 6.8 4.0 8.0 6.9 7.6 11.9 4.7 6.3 0.0 6.0 5.0 7.9 9.8 7.7 5.9 5.2 3.7 3.1 4.7 1.6 2.8 2.7 1.0 0.1 5.6 65.3 11.2 26.9 16.2 12.7 16.4 16.8 15.3 15.6 13.6 17.2 17.7 14.2 30.8 21.5 16.2 8.8 13.4 8.1 5.9 7.2 8.8 6.8 6.4 6.3 6.0 5.7 5.8 6.2 5.8 6.3 7.3 9.1 0.0 7.3 4.6 13.1 5.9 11.0 11.1 5.7 9.9 6.0 5.3 6.6 2.8 10.7 9.2 12.5 12.2 12.9 5.1 7.9 6.7 13.0 4.5 4.7 8.0 7.3 2.5 4.2 5.3 9.9 7.1 3.6 6.7 12.0 9.7 6.4 3.1 7.8 6.7 4.1 5.9 16.2 9.5 12.0 3.4 11.1 10.8 12.4 6.5 11.6 7.9 23.7 4.0 9.1 6.0 5.7 6.0 7.5 14.5 7.6 3.9 7.8 13.1 0.0 7.2 8.4 10.2 5.7 3.5 7.0 23.1 15.1 6.8 3.8 13.4 PGA5 ENSG00000256713 "Pepsinogen A5" P0DJD9 11 61241175-61251444 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 3701 "stomach 1: 40192.3" "Cell type enriched" "Detected in some" 77 "Exocrine glandular cells: 4383.1" "Cancer enriched" "Detected in some" 12 "stomach cancer: 15.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 44 "monocytes: 4.3" "Cell line enriched" "Detected in some" 19 "BJ hTERT+: 28.8" HPA046875 Supported "Secreted to digestive system" NA NA "HPA046875: AB_2679851" "unprognostic (1.36e-3)" "unprognostic (2.98e-2)" "unprognostic (5.83e-3)" "unprognostic (2.11e-1)" "unprognostic (4.22e-1)" "unprognostic (4.36e-2)" "unprognostic (2.16e-2)" "unprognostic (1.05e-1)" "unprognostic (7.10e-2)" 10.8 4.4 0.4 1.1 0.3 0.0 4.5 0.1 0.4 2.9 0.0 4.0 0.6 1.9 0.0 7.0 5.1 0.1 2.9 0.8 0.2 2.4 7.1 5.5 0.0 0.1 0.1 0.6 2.6 8.3 0.0 3.8 0.5 0.1 1.8 0.1 1.5 2.5 0.5 1.9 2.2 2.1 0.9 0.0 4.0 40192.3 2.3 0.0 0.2 3.1 0.2 0.1 2.4 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.4 0.3 0.1 0.4 0.8 0.2 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4383.1 0.0 0.1 56.6 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 5.1 0.0 1.6 0.9 1.3 0.0 0.0 1.0 25.1 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 STH MAPTIT ENSG00000256762 Saitohin Q8IWL8 17 45999250-45999694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 4.8" "Group enriched" "Detected in some" 6 "Bipolar cells: 3.0;Cone photoreceptor cells: 2.1;Horizontal cells: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" 0.0 0.0 1.1 0.0 2.0 0.0 0.3 2.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 1.6 0.6 0.3 0.0 0.0 0.0 0.1 0.3 1.6 0.0 0.0 0.5 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.0 2.7 1.3 1.2 0.1 1.6 0.6 0.3 1.6 0.0 1.2 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF253 "BMZF-1, FLJ90391, ZNF411" ENSG00000256771 "Zinc finger protein 253" O75346 19 19865882-19894674 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 25.6;Oligodendrocytes: 33.7;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.03e-2)" "unprognostic (3.54e-1)" "unprognostic (7.10e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.39e-5)" "unprognostic (4.75e-2)" "unprognostic (4.77e-2)" "unprognostic (2.80e-2)" "unprognostic (5.26e-3)" "prognostic favorable (2.19e-4)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "prognostic favorable (9.69e-5)" "unprognostic (4.88e-2)" "unprognostic (3.68e-1)" "unprognostic (1.84e-3)" "unprognostic (4.54e-3)" 3.2 4.5 0.9 4.2 2.6 2.5 8.4 7.1 4.5 6.3 0.3 4.8 4.4 5.0 4.6 2.5 6.2 3.3 4.8 1.2 1.9 7.1 4.3 3.9 8.8 1.7 2.5 0.1 13.1 4.5 8.5 3.6 4.4 3.3 6.0 5.3 20.0 5.6 5.4 7.5 3.4 4.3 2.5 0.4 6.3 5.5 3.9 2.2 9.1 14.7 10.6 8.6 4.4 3.0 4.8 0.0 0.1 17.5 14.0 2.4 2.4 7.4 2.4 1.1 4.8 5.5 2.2 4.2 12.2 8.8 2.3 4.2 2.2 0.0 0.6 6.9 1.4 4.1 0.9 1.1 3.6 2.9 0.1 0.3 3.6 3.2 3.2 0.4 6.7 0.2 0.3 7.8 6.2 7.0 5.5 20.6 4.2 18.5 0.0 2.3 19.7 10.1 10.1 6.4 9.6 10.0 10.3 10.2 2.3 2.9 13.5 6.3 14.8 0.2 6.1 0.2 4.4 3.2 9.0 8.1 19.7 0.3 0.4 3.1 13.5 1.5 4.1 5.7 2.1 7.6 9.1 7.9 7.9 3.4 9.8 15.4 10.3 1.4 7.5 1.9 4.5 6.0 4.7 0.9 2.6 7.1 4.5 1.2 1.9 1.7 2.5 0.1 3.3 0.4 2.2 4.8 3.7 9.6 3.6 7.8 9.4 0.4 1.9 1.1 1.8 12.2 3.7 4.3 5.9 4.3 4.1 5.5 6.2 5.6 6.8 2.6 17.6 6.1 12.2 4.3 5.6 5.3 7.7 4.2 16.3 2.9 3.3 4.6 1.5 5.2 2.5 9.0 3.9 2.5 2.9 13.5 22.3 2.1 0.0 2.5 1.8 1.0 5.0 2.6 1.8 8.4 1.4 12.6 11.3 25.6 33.7 2.3 2.7 4.5 6.4 1.7 1.9 6.4 6.8 26.7 0.0 4.0 4.8 7.2 7.1 1.0 0.4 4.9 7.3 9.4 3.7 1.5 KLRF2 NKp65 ENSG00000256797 "Killer cell lectin like receptor F2" D3W0D1 12 9881489-9895833 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "skin 1: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "NK-cell: 3.1;plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 32 "dendritic cells: 3.2;NK-cells: 3.1" "Cell line enriched" "Detected in single" 47 "U-937: 31.5" NA NA "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (5.57e-2)" "unprognostic (3.40e-5)" "unprognostic (9.03e-2)" "unprognostic (3.16e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" A8MU93 17 6651762-6693202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 32.9;Late spermatids: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 10.0;SH-SY5Y: 9.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: AB_2679825" "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.9 1.6 4.0 1.7 4.8 0.5 1.5 3.6 5.1 2.0 2.3 1.4 3.0 1.6 2.3 4.3 2.1 1.1 0.6 3.7 4.5 2.3 3.6 1.2 3.2 3.9 4.0 3.9 1.3 4.5 3.5 9.6 0.8 3.7 2.5 1.5 5.3 2.9 1.1 0.6 7.3 3.0 0.8 3.2 3.0 2.4 5.5 4.2 1.7 3.3 0.8 1.2 1.9 2.3 4.2 1.1 2.1 4.6 1.5 0.7 1.3 2.2 0.6 3.4 1.4 2.7 3.2 1.5 1.3 2.3 1.1 3.6 4.1 0.9 2.2 2.0 5.6 6.3 1.2 2.4 10.0 1.6 0.2 3.2 1.8 2.1 0.7 1.5 4.1 0.8 6.7 1.6 1.2 1.8 2.4 1.4 2.1 0.6 1.9 1.4 2.6 0.8 2.0 2.9 1.0 4.8 9.4 2.9 0.3 3.4 1.4 2.5 0.3 1.3 1.3 2.6 0.8 1.1 1.7 1.2 0.8 1.1 0.4 3.1 3.9 0.9 4.0 1.2 1.3 1.6 2.3 2.2 1.4 1.6 2.5 2.5 1.4 0.8 1.4 1.3 0.5 1.5 0.9 4.0 4.8 3.6 5.1 3.7 4.5 3.9 4.0 3.9 3.7 3.2 4.2 4.2 1.7 0.0 1.7 0.0 3.2 2.8 5.4 4.8 8.0 3.8 4.9 5.0 0.4 0.0 4.9 0.0 2.1 1.7 0.6 3.8 1.9 4.1 32.9 3.0 3.0 1.8 7.7 1.3 1.4 3.2 1.8 1.6 4.1 2.9 8.9 4.7 0.0 0.0 1.2 1.7 1.4 7.1 10.2 0.0 1.3 48.7 0.9 0.7 1.8 1.0 1.2 5.1 1.0 1.5 2.2 3.3 2.6 1.9 0.9 4.5 9.0 2.1 2.4 5.8 6.6 1.9 3.0 16.4 4.6 7.0 3.0 1.5 1.7 3.8 3.9 5.1 CAPNS2 "MGC12536, MGC14804" ENSG00000256812 "Calpain small subunit 2" Q96L46 16 55566684-55567687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 86.4;skin 1: 96.0;vagina: 33.8" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 87.8;Basal squamous epithelial cells: 117.3;Squamous epithelial cells: 108.6;Suprabasal keratinocytes: 149.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.3;urothelial cancer: 21.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "eosinophil: 3.8;intermediate monocyte: 1.0" "Group enriched" "Detected in many" 9 "granulocytes: 3.8;monocytes: 1.0" "Cell line enriched" "Detected in some" 10 "hTCEpi: 223.0" "Not detected" "Not detected" "HPA059749, HPA076768" Enhanced Approved Cytosol NA NA Cytosol "HPA059749: AB_2732639, HPA076768: AB_2732322" "unprognostic (3.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.77e-3)" "unprognostic (4.14e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (7.21e-2)" "unprognostic (3.38e-2)" "unprognostic (3.62e-1)" "unprognostic (2.42e-2)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" 0.3 0.0 0.3 0.1 0.6 0.7 6.7 0.8 0.5 6.9 0.7 0.0 0.0 0.1 0.2 86.4 0.8 0.0 0.1 0.4 0.5 0.0 0.1 0.2 0.0 1.1 0.7 0.1 0.1 0.1 0.0 0.1 0.3 1.6 4.3 0.0 0.1 16.9 0.1 0.7 96.0 0.1 0.0 1.2 0.1 0.1 0.1 0.8 0.2 0.3 0.0 18.7 18.3 33.8 1.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 23.0 0.0 1.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.7 0.8 0.0 223.0 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 1.1 0.1 7.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 1.2 0.0 0.1 3.8 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.8 0.5 0.4 0.5 1.1 0.7 0.1 1.6 1.2 0.8 1.3 0.6 0.0 0.5 0.0 0.0 87.8 10.0 13.7 117.3 0.0 0.2 0.3 0.0 0.0 11.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.8 7.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.5 0.7 0.0 0.0 108.6 149.3 2.3 0.2 0.1 0.0 15.4 AC026786.1 ENSG00000256825 "Novel protein" 12 133130984-133202369 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC5A8 AIT ENSG00000256870 "Solute carrier family 5 member 8" Q8N695 12 101155493-101210238 "Metabolic proteins, Predicted membrane proteins, Transporters" "Apoptosis, Ion transport, Sodium transport, Symport, Transport" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix: 20.4;kidney: 5.6;thyroid gland: 15.7" "Cell type enhanced" "Detected in some" "Club cells: 9.1;Early spermatids: 7.9;Enteroendocrine cells: 31.5;Excitatory neurons: 14.6;Horizontal cells: 10.1;Inhibitory neurons: 17.3;Proximal tubular cells: 21.4" "Group enriched" "Detected in many" 4 "breast cancer: 2.7;renal cancer: 7.6;thyroid cancer: 5.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "SK-BR-3: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic favorable (9.04e-6)" "unprognostic (1.84e-1)" "unprognostic (1.17e-2)" "unprognostic (1.27e-3)" "unprognostic (1.24e-1)" "unprognostic (5.20e-1)" "unprognostic (1.16e-2)" "prognostic favorable (1.97e-4)" "unprognostic (6.16e-2)" "unprognostic (2.30e-2)" "unprognostic (2.87e-2)" 0.0 2.5 0.4 0.0 0.4 0.0 0.0 0.2 1.1 20.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 5.6 0.0 0.9 0.0 0.8 0.2 0.3 1.1 0.0 0.0 0.1 0.0 0.5 0.8 0.0 0.1 0.9 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.2 1.0 0.2 15.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 1.1 0.4 0.4 0.8 0.2 0.3 0.5 0.3 1.0 0.7 0.0 0.0 5.3 1.3 0.0 0.0 0.0 4.6 0.0 3.9 0.1 0.1 0.6 0.0 9.1 1.8 0.0 0.0 0.0 0.3 1.9 0.0 7.9 0.0 0.1 0.0 31.5 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 17.3 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.2 21.4 2.1 0.1 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.9 MTRNR2L7 ENSG00000256892 "MT-RNR2 like 7" P0CJ74 10 37601440-37602974 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 1.7" "Cell type enriched" "Detected in some" 26 "Cardiomyocytes: 188.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (2.28e-1)" "unprognostic (5.87e-2)" 0.0 0.1 0.4 0.0 0.4 0.1 0.0 0.4 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.1 0.0 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 1.7 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 188.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 LIMS3 ENSG00000256977 "LIM zinc finger domain containing 3" P0CW19 2 109898428-109924868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 6.6;fallopian tube: 6.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.6;Distal tubular cells: 1.9;Exocrine glandular cells: 1.2;NK-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.1;HMC-1: 41.3" HPA058455 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.23e-2)" 1.2 1.7 0.3 2.6 0.3 0.4 0.7 0.3 0.5 1.3 0.5 0.5 0.7 6.6 1.7 1.6 6.4 1.3 1.8 0.3 0.5 2.8 0.2 0.5 0.6 0.5 0.4 0.2 2.3 0.9 0.5 0.6 1.6 0.4 0.5 1.2 0.4 1.0 1.0 5.7 0.2 0.8 1.5 0.5 0.5 0.7 1.2 0.4 1.0 0.6 2.0 0.4 1.7 0.3 0.9 0.1 0.1 1.8 2.1 0.7 0.6 0.0 2.2 0.0 0.4 0.9 2.2 0.0 0.0 6.5 0.4 4.2 1.2 0.0 2.6 1.8 3.5 0.0 14.1 0.6 1.3 1.9 2.5 41.3 3.0 1.5 1.6 1.9 0.0 3.5 0.0 3.0 2.3 4.6 0.1 0.0 0.3 2.2 1.4 0.8 2.6 4.4 1.5 1.2 2.2 0.6 5.0 5.7 0.0 1.2 0.1 0.0 0.7 10.4 8.8 8.1 4.6 0.4 0.0 0.0 2.8 1.2 0.0 2.6 5.6 3.2 12.3 0.7 5.4 1.4 0.6 4.7 1.5 2.4 0.2 0.8 0.3 0.6 1.2 5.7 0.2 6.1 8.5 0.3 0.3 0.3 0.5 0.3 0.5 0.5 0.4 0.2 0.4 0.5 0.4 0.9 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.1 0.6 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 KHDC1L RP11-257K9.7 ENSG00000256980 "KH domain containing 1 like" Q5JSQ8 6 73223544-73225770 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;testis: 5.6" "Group enriched" "Detected in some" 10 "Early spermatids: 31.8;Late spermatids: 96.9" "Cancer enriched" "Detected in some" 9 "testis cancer: 33.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 51.5" NA NA "unprognostic (1.18e-1)" "unprognostic (6.11e-5)" "unprognostic (3.06e-2)" "unprognostic (1.93e-1)" "unprognostic (3.07e-2)" "unprognostic (9.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.99e-2)" "unprognostic (1.48e-1)" "unprognostic (4.01e-2)" "unprognostic (1.31e-2)" "unprognostic (4.13e-1)" "unprognostic (6.63e-2)" "unprognostic (3.17e-3)" 0.0 0.0 1.4 0.0 2.0 0.2 0.0 1.6 1.7 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.1 1.2 0.0 0.0 0.6 0.0 1.2 1.1 1.1 0.2 0.1 0.1 1.5 0.5 1.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 5.6 1.2 0.4 0.1 0.0 0.4 0.1 0.1 1.3 10.7 0.2 0.0 0.4 0.0 0.0 51.5 0.2 0.3 0.3 0.2 0.4 0.2 0.4 0.4 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.2 0.2 0.5 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.0 1.6 1.7 1.1 1.2 1.2 1.1 1.1 1.2 1.1 1.2 1.3 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 31.8 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 96.9 0.3 0.2 0.0 0.0 0.6 0.1 0.0 1.0 0.2 0.3 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 5.9 0.0 0.0 0.1 0.0 0.2 0.1 0.1 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 4 "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HP ENSG00000257017 Haptoglobin P00738 16 72054505-72061055 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Immunity" "Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 194 "liver: 61616.4" "Cell type enriched" "Detected in many" 43 "Hepatocytes: 59512.7" "Cancer enriched" "Detected in many" 81 "liver cancer: 1297.4" "Group enriched" "Detected in all" 4 "hypothalamus: 29.8;medulla oblongata: 29.9" "Group enriched" "Detected in many" 5 "classical monocyte: 49.3;eosinophil: 80.2" "Group enriched" "Detected in many" 7 "granulocytes: 80.2;monocytes: 49.3" "Group enriched" "Detected in some" 5 "Hep G2: 232.2;HSkMC: 121.4" "CAB003787, HPA047750, HPA066795" Enhanced Approved Vesicles "Secreted to blood" NA NA 998000000000 100000000000 Vesicles "CAB003787: , HPA047750: AB_2680146, HPA066795: " "unprognostic (6.38e-3)" "unprognostic (7.73e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (2.34e-3)" "unprognostic (2.07e-1)" "unprognostic (7.79e-3)" "unprognostic (1.37e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.94e-13)" "unprognostic (4.34e-4)" "unprognostic (1.80e-1)" "unprognostic (6.61e-2)" "unprognostic (2.49e-2)" 318.1 11.5 2.1 27.1 2.4 233.7 34.5 2.0 2.9 72.5 3.9 3.6 1.5 3.5 3.0 5.4 75.2 1.3 86.5 2.1 29.8 19.2 61616.4 92.1 1.8 29.9 2.5 2.0 10.0 7.7 0.2 50.3 2.5 3.9 7.4 0.6 0.7 6.2 0.2 5.0 3.2 4.5 4.5 2.9 72.5 6.2 2.1 7.3 2.7 6.4 0.4 3.1 3.8 3.4 6.7 0.0 0.0 0.0 0.0 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 8.5 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 11.2 0.2 232.2 0.3 33.3 6.2 121.4 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 2.0 0.4 2.6 0.0 0.0 1.1 23.6 0.0 0.0 0.1 0.0 0.0 16.2 0.0 0.0 0.0 0.0 6.8 5.1 0.0 0.8 0.0 0.0 3.9 0.0 14.1 0.0 12.7 0.0 6.2 49.3 80.2 0.0 2.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 14.2 0.0 2.1 0.0 0.0 15.2 2.1 2.4 2.0 2.9 2.1 29.8 29.9 2.5 2.0 3.9 2.9 7.3 6.7 0.4 19.2 228.7 1.6 96.1 0.1 0.7 1.9 0.0 0.4 0.4 0.3 66.6 1085.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 56.7 0.0 1128.3 0.0 10.4 0.1 45.5 0.0 1.3 3.8 0.4 1038.7 59512.7 2.3 0.0 0.0 0.2 4.1 1381.4 0.0 0.5 10.2 7.8 1.8 0.0 0.3 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 1.5 7.5 0.2 0.0 2.6 1.8 0.0 0.0 0.1 0.3 0.1 90.3 0.0 0.3 0.1 SLCO1B3-SLCO1B7 "LST-3TM12, OATP1B3-1B7" ENSG00000257046 "SLCO1B3-SLCO1B7 readthrough" 12 20815674-21090245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "breast: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.7;A549: 1.1;CAPAN-2: 1.7;HeLa: 2.9" HPA050892 Uncertain NA NA "HPA050892: AB_2681265" "unprognostic (2.74e-1)" "unprognostic (1.39e-3)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf97 LINC01171 ENSG00000257057 "Chromosome 11 open reading frame 97" A0A1B0GVM6 11 94512461-94532123 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 19.3;testis: 18.4" "Group enriched" "Detected in some" 5 "Early spermatids: 239.3;Endometrial ciliated cells: 258.2;Respiratory ciliated cells: 109.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (4.18e-1)" "unprognostic (4.70e-1)" "unprognostic (9.64e-3)" "unprognostic (9.44e-3)" "unprognostic (3.86e-3)" 0.0 0.0 2.6 0.0 2.7 0.3 0.0 0.6 1.7 0.7 3.3 0.0 0.0 0.5 0.1 0.0 19.3 0.1 0.0 1.6 1.2 0.9 1.4 2.5 0.0 2.1 2.1 1.4 0.0 0.5 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 18.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 0.6 1.7 1.6 1.2 2.1 2.1 1.4 1.4 2.3 1.7 1.4 0.0 3.2 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 11.2 0.0 0.0 0.3 0.0 0.1 0.0 0.4 239.3 258.2 1.4 0.6 0.0 0.0 3.4 0.2 0.0 0.5 0.0 3.2 0.0 0.0 0.0 4.5 0.1 0.0 2.0 0.0 0.0 0.0 0.0 34.4 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 18.1 109.3 0.0 0.0 0.0 0.0 37.9 9.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 DENND11 "KIAA1147, LCHN" ENSG00000257093 "DENN domain containing 11" A4D1U4 7 141656728-141702166 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.2;B-cells: 3.8;Cardiomyocytes: 4.3;dendritic cells: 8.5;Hofbauer cells: 7.6;Plasma cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HDLM-2: 5.5;HEK 293: 5.3;U-266/70: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029467, HPA061437" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA029467: AB_10602915, HPA061437: AB_2684517" "unprognostic (1.27e-1)" "unprognostic (5.68e-2)" "unprognostic (7.05e-2)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "prognostic favorable (6.24e-4)" "unprognostic (6.49e-2)" "unprognostic (3.63e-2)" "unprognostic (3.02e-2)" "unprognostic (4.27e-1)" "unprognostic (7.62e-2)" "unprognostic (3.75e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-3)" "unprognostic (1.78e-1)" 8.4 6.0 5.6 1.0 7.7 0.9 9.6 5.0 9.4 7.9 3.3 10.0 3.6 7.0 0.6 12.6 8.2 0.5 6.7 10.4 4.8 8.9 14.8 13.4 1.6 8.8 7.5 6.5 7.5 17.5 1.0 11.9 0.3 8.5 9.0 1.5 2.8 20.8 0.7 5.8 8.3 14.5 0.7 6.4 14.3 17.9 1.4 5.2 0.6 12.5 0.5 1.3 8.6 11.4 10.2 1.9 1.5 0.9 1.2 0.5 0.2 0.3 0.4 0.3 0.3 0.3 1.9 1.3 0.1 3.1 0.3 0.8 0.6 1.0 0.8 0.7 5.5 5.3 0.9 0.8 0.3 0.1 1.7 0.3 0.2 0.7 0.2 0.3 0.8 1.3 1.0 0.0 0.3 0.2 0.7 1.5 1.2 1.5 2.1 1.0 3.6 0.2 1.7 0.6 1.0 1.4 2.7 1.2 2.1 0.2 0.5 0.8 0.2 4.3 0.2 1.0 0.4 2.2 7.5 1.8 2.4 0.6 2.3 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 7.7 5.0 9.4 10.4 4.8 8.8 7.5 6.5 8.5 6.4 5.2 10.2 9.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 LSM14A "C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A" ENSG00000257103 "LSM14A mRNA processing body assembly factor" Q8ND56 19 34172504-34229288 "Predicted intracellular proteins" "Translation regulation" "Developmental protein, Repressor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017961 Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 18000 "Cytoplasmic bodies" Cytosol "HPA017961: AB_1845610" "unprognostic (2.38e-1)" "unprognostic (3.30e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-2)" "unprognostic (2.45e-3)" "unprognostic (1.88e-1)" "unprognostic (9.62e-3)" "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (4.98e-2)" "unprognostic (4.17e-2)" "unprognostic (2.52e-2)" "unprognostic (5.55e-2)" "unprognostic (1.56e-1)" 42.7 38.8 31.0 27.7 31.1 72.7 42.3 32.8 36.1 45.8 33.8 44.1 25.0 48.2 32.0 41.6 41.0 22.9 36.7 30.4 33.4 38.0 37.9 38.0 46.9 30.7 31.7 29.8 52.1 33.1 34.1 30.6 37.8 30.8 36.8 29.5 53.3 36.7 32.6 74.8 46.8 38.6 33.2 32.3 37.0 33.0 33.4 30.9 51.1 46.3 44.1 41.1 44.6 42.2 33.6 66.0 46.1 62.9 49.7 33.4 42.9 20.4 24.7 39.5 43.9 42.9 50.2 27.7 107.9 28.9 46.7 14.7 17.6 57.0 42.7 70.8 71.5 10.4 102.2 30.0 50.5 58.7 82.1 34.6 39.4 63.0 33.3 47.8 56.1 63.3 36.3 56.6 44.8 45.6 32.0 64.8 62.2 59.9 61.0 7.5 42.7 44.1 40.7 58.4 32.9 52.8 40.8 56.7 85.2 61.5 56.2 54.8 102.0 38.7 66.3 25.6 25.5 53.1 43.3 59.0 78.6 42.0 57.5 40.4 16.5 9.3 18.9 11.4 12.1 15.2 11.9 13.4 12.8 10.9 8.0 14.3 12.7 8.1 17.8 14.6 5.2 13.4 11.1 31.0 31.1 32.8 36.1 30.4 33.4 30.7 31.7 29.8 30.8 32.3 30.9 33.6 64.3 25.6 42.8 81.9 118.7 123.9 70.2 64.6 86.0 92.3 68.1 50.0 70.6 61.5 58.4 58.8 20.9 161.2 108.2 39.0 68.4 77.7 65.6 54.3 64.2 75.5 57.2 100.4 68.0 54.1 176.6 70.1 37.8 57.0 62.1 64.6 63.9 50.6 67.0 62.2 70.1 52.7 73.2 63.7 96.7 75.5 126.2 73.5 67.6 85.3 137.2 104.3 232.8 92.0 113.4 59.6 40.2 127.2 80.2 110.0 49.9 88.0 47.6 78.8 78.9 64.2 78.8 194.9 151.6 75.4 131.6 137.4 101.5 69.2 51.4 71.7 NHLRC4 ENSG00000257108 "NHL repeat containing 4" P0CG21 16 567005-569495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 23.9;Endometrial ciliated cells: 23.3;Erythroid cells: 11.8;Leydig cells: 8.1;Respiratory ciliated cells: 18.1;Theca cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 3.3;HMC-1: 9.6;REH: 2.6;RPMI-8226: 4.3" "Low region specificity" "Detected in single" HPA077301 Approved Mitochondria NA NA Mitochondria "HPA077301: " "unprognostic (7.95e-2)" "unprognostic (5.87e-2)" "unprognostic (4.28e-3)" "unprognostic (2.53e-2)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" "unprognostic (2.28e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-3)" "unprognostic (1.19e-2)" "unprognostic (1.16e-2)" "unprognostic (5.16e-3)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.60e-1)" 0.7 5.5 1.3 0.7 0.8 2.9 1.2 1.0 0.5 1.3 1.7 0.8 1.0 1.1 2.2 0.3 11.8 0.9 0.7 0.5 1.7 6.8 0.2 2.1 1.9 2.3 2.7 0.2 3.0 0.2 3.2 1.1 0.6 1.7 1.4 0.2 0.0 2.2 2.5 0.5 0.3 1.5 0.4 2.7 3.8 0.6 2.7 1.0 2.4 0.4 0.2 0.6 0.7 0.6 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.1 3.3 0.0 0.8 0.7 0.2 9.6 1.9 0.0 0.1 0.2 0.0 0.2 0.6 1.0 1.1 0.0 0.0 0.3 2.5 0.2 0.0 0.0 2.6 0.0 4.3 0.2 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.4 0.5 0.5 0.0 0.0 0.0 0.0 1.5 1.4 0.7 0.0 0.1 0.2 0.0 0.2 2.3 0.1 0.0 0.2 0.4 0.5 0.2 0.2 0.2 0.5 0.3 0.0 0.3 0.1 1.7 0.5 0.3 1.3 0.8 1.0 0.5 0.5 1.7 2.3 2.7 0.2 1.7 2.7 1.0 0.6 1.6 0.0 0.0 0.3 1.2 0.0 0.5 0.8 0.6 0.1 1.9 1.4 0.2 0.0 2.2 23.9 0.0 0.2 1.8 0.1 0.0 0.0 0.0 23.3 1.1 1.0 0.0 11.8 0.1 0.2 0.0 2.3 0.0 1.0 0.0 0.4 1.1 0.0 1.7 0.0 0.5 0.2 2.0 0.6 0.9 0.4 8.1 0.5 0.0 1.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 4.5 0.9 0.3 0.3 0.1 18.1 0.1 6.6 0.1 2.0 0.1 0.1 0.0 0.1 0.0 0.7 12.7 0.2 0.3 OR11H12 ENSG00000257115 "Olfactory receptor family 11 subfamily H member 12" B2RN74 14 18601045-18602129 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R38 "PTC, T2R61" ENSG00000257138 "Taste 2 receptor member 38" P59533 7 141972631-141973773 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043862, HPA054366" Uncertain NA NA "HPA043862: AB_2678703, HPA054366: AB_2682464" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.58e-1)" "unprognostic (1.25e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-2)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004080.3 ENSG00000257184 "HOXA10-HOXA9 readthrough" 7 27163535-27180013 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ: 1.3" "Region enriched" "Detected in single" 165 "spinal cord: 16.4" NA NA "unprognostic (4.27e-1)" "unprognostic (4.63e-1)" "unprognostic (4.49e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 1.3 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GATC "15E1.2, FLJ37000" ENSG00000257218 "Glutamyl-tRNA amidotransferase subunit C" O43716 12 120446444-120463749 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.10e-1)" "unprognostic (3.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.04e-2)" "unprognostic (2.22e-1)" "unprognostic (8.46e-2)" "prognostic unfavorable (4.21e-5)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (1.02e-1)" "unprognostic (1.64e-1)" "unprognostic (1.02e-1)" "unprognostic (4.10e-3)" "unprognostic (1.32e-1)" "unprognostic (1.70e-1)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" 10.1 10.4 12.7 8.4 13.4 7.5 12.1 15.5 15.1 11.2 10.7 10.3 11.8 8.4 11.0 8.8 7.8 7.4 6.6 12.4 13.1 15.4 16.5 8.6 10.3 13.6 13.9 12.2 10.0 38.1 13.2 8.0 9.3 13.6 8.7 10.8 12.9 10.5 8.0 8.6 9.5 10.3 7.8 14.1 9.3 9.6 4.7 13.3 12.1 11.7 8.0 11.9 10.1 8.3 16.1 12.7 40.7 19.4 22.6 23.4 23.1 13.8 16.1 15.0 17.5 12.9 37.9 9.3 25.2 17.6 14.7 15.5 20.4 30.7 17.6 17.1 19.4 28.7 24.1 25.3 25.4 25.8 23.4 13.6 21.7 18.8 13.7 24.4 24.0 24.8 23.4 33.3 12.9 17.9 20.0 26.3 25.8 12.3 19.0 25.7 17.6 22.5 33.9 20.7 21.5 35.7 17.3 28.8 15.1 21.0 15.3 26.8 12.9 21.9 14.6 13.5 19.8 12.6 18.4 32.6 32.5 19.8 14.5 23.5 7.0 5.3 4.0 6.1 3.6 5.9 6.2 4.7 3.6 3.9 5.9 4.3 5.0 3.7 4.7 5.5 6.2 5.4 5.4 12.7 13.4 15.5 15.1 12.4 13.1 13.6 13.9 12.2 13.6 14.1 13.3 16.1 14.8 3.2 19.1 11.4 13.0 9.4 20.6 4.4 16.5 17.6 13.4 12.4 6.2 18.6 13.8 18.4 16.7 13.3 16.4 18.3 11.7 17.8 3.2 14.6 19.5 17.2 27.0 10.1 14.0 24.4 12.3 12.5 11.2 18.2 24.1 17.6 18.5 22.8 11.3 18.5 12.8 15.5 6.1 14.9 4.2 1.9 14.6 14.6 3.6 4.7 18.5 12.0 11.3 13.6 13.6 29.4 14.1 20.3 13.9 25.8 19.8 22.4 7.5 14.1 6.6 20.0 12.0 11.7 8.0 15.3 9.9 14.9 12.6 11.7 19.3 22.0 ZBED6 ENSG00000257315 "Zinc finger BED-type containing 6" P86452 1 203795714-203854999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Urothelial cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068807 Supported "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA068807: AB_2686040" "unprognostic (1.79e-1)" "unprognostic (4.96e-3)" "unprognostic (4.81e-2)" "unprognostic (2.73e-1)" "unprognostic (6.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" "unprognostic (1.24e-2)" "unprognostic (2.28e-3)" "unprognostic (7.54e-3)" "unprognostic (1.56e-1)" "unprognostic (4.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.15e-3)" "unprognostic (1.47e-2)" 5.1 4.4 3.4 3.6 6.8 3.1 3.7 6.4 5.9 6.4 8.5 3.3 6.1 5.9 3.3 4.0 4.1 4.4 2.8 2.4 6.0 4.5 5.7 3.7 4.0 5.1 5.2 1.4 7.0 7.0 3.9 3.2 6.0 5.7 3.2 3.8 5.6 4.7 4.2 4.4 4.9 3.6 3.8 3.8 5.0 4.9 2.5 4.9 5.4 5.1 6.2 4.3 3.4 3.7 11.9 4.4 7.2 10.2 5.0 7.6 16.8 4.1 6.2 15.2 4.4 4.9 1.7 4.4 3.0 1.3 10.3 2.6 7.0 3.3 5.2 7.1 8.3 2.7 6.2 7.7 1.4 3.8 4.7 4.4 9.2 2.4 5.8 6.3 9.7 12.2 3.8 7.6 8.7 6.5 3.0 3.2 3.4 2.4 2.1 2.7 2.5 9.1 3.3 2.5 7.3 2.1 10.2 7.4 6.6 2.8 8.7 10.7 5.0 21.4 6.7 6.3 3.2 4.4 4.9 2.0 0.9 7.7 2.4 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.4 6.8 6.4 5.9 2.4 6.0 5.1 5.2 1.4 5.7 3.8 4.9 11.9 1.5 9.6 6.3 0.0 8.9 15.9 35.3 11.3 6.8 15.0 0.4 0.5 2.5 8.6 15.2 0.0 31.3 14.5 5.4 15.7 0.0 0.1 1.0 2.2 3.0 14.5 18.5 12.0 0.0 0.0 13.9 16.0 11.2 2.3 33.0 1.1 10.0 4.6 6.0 11.8 0.0 14.0 8.2 9.3 19.6 1.0 19.9 8.9 14.2 0.0 5.8 14.7 15.5 0.0 0.0 0.1 14.5 15.1 3.8 43.0 35.1 0.1 11.0 21.1 26.3 37.3 15.2 6.5 8.2 5.6 17.0 34.9 12.0 1.5 14.2 56.9 MGAM MGA ENSG00000257335 Maltase-glucoamylase O43451 7 141907813-142106747 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 25.8;intestine: 88.3" "Group enriched" "Detected in some" 5 "Late spermatids: 156.4;Proximal enterocytes: 521.4" "Cancer enriched" "Detected in some" 7 "renal cancer: 4.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Immune cell enriched" "Detected in some" 7 "neutrophil: 13.5" "Lineage enriched" "Detected in single" 102 "granulocytes: 13.5" "Cell line enhanced" "Detected in some" "A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0" "Region enriched" "Detected in single" 12 "olfactory bulb: 2.0" "Low region specificity" "Detected in many" HPA002270 Enhanced NA NA 310000 "HPA002270: AB_1079366" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (6.95e-3)" "unprognostic (2.80e-1)" "unprognostic (7.81e-2)" "unprognostic (7.32e-3)" "unprognostic (3.83e-2)" "unprognostic (4.97e-1)" "unprognostic (2.17e-2)" "unprognostic (6.86e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.16e-5)" "unprognostic (1.82e-1)" "unprognostic (2.82e-1)" "unprognostic (1.34e-3)" "unprognostic (3.03e-1)" 2.6 0.1 0.2 2.6 0.2 18.3 0.2 0.2 1.9 0.4 0.7 0.4 59.5 0.1 25.8 0.3 1.2 0.4 0.3 0.1 0.5 18.9 0.5 3.3 0.1 0.5 0.3 0.0 0.1 0.2 0.0 0.1 0.3 0.5 0.1 0.2 0.0 0.1 7.2 0.1 0.1 88.3 0.4 0.4 12.7 1.8 1.3 0.5 0.4 0.1 1.1 0.0 0.6 0.1 0.3 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 4.3 1.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 1.9 0.1 0.5 0.5 0.3 0.0 0.5 0.4 0.5 0.3 0.0 0.0 2.5 3.3 0.1 0.0 0.0 0.6 0.0 0.2 0.5 0.1 1.4 0.0 3.2 12.9 0.0 0.0 2.8 1.8 1.9 0.1 59.7 0.1 0.2 0.3 1.2 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.7 17.8 0.0 0.0 2.5 156.4 0.6 1.1 0.0 0.0 0.7 0.6 5.2 1.5 0.6 0.2 16.3 0.4 0.0 0.1 521.4 24.4 6.7 0.0 0.0 0.5 0.1 1.8 1.2 0.0 0.0 0.0 0.4 0.0 7.3 0.3 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986895-65062652 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 70.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome NA NA Centrosome "HPA062743: AB_2684861" "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 8.8 8.8 18.4 5.1 27.9 2.9 7.8 39.3 21.6 7.8 13.9 6.6 6.0 6.7 8.5 13.4 9.6 5.9 13.1 15.9 21.7 8.3 5.9 6.8 5.7 53.5 34.5 14.0 7.4 5.7 13.1 7.1 8.8 41.1 9.1 7.7 6.2 9.3 9.3 18.2 11.9 5.2 11.7 47.4 4.7 5.6 9.6 29.7 6.6 5.8 19.9 8.4 7.7 9.0 70.0 37.1 31.9 20.4 12.5 13.9 11.9 14.6 20.2 14.7 22.4 23.0 15.9 14.6 6.0 12.0 21.1 13.2 24.1 47.5 15.1 18.3 9.0 15.9 23.2 8.0 28.1 9.0 8.3 32.2 9.7 14.3 9.4 5.7 22.4 19.1 10.9 13.7 8.4 13.1 30.9 13.3 22.6 8.4 23.1 29.9 12.2 17.6 7.6 16.2 15.7 12.0 13.5 11.9 24.4 30.2 15.9 22.7 14.0 15.2 16.2 34.7 8.4 14.2 5.7 5.6 6.6 18.3 10.3 39.4 21.9 12.8 11.5 3.8 9.9 9.6 2.5 6.2 5.1 7.4 1.7 4.7 3.7 3.4 4.0 5.1 5.8 6.2 7.4 18.4 27.9 39.3 21.6 15.9 21.7 53.5 34.5 14.0 41.1 47.4 29.7 70.0 3.9 12.8 2.2 0.0 1.6 2.4 3.5 4.3 2.8 4.6 6.2 6.6 8.3 2.8 5.6 3.7 2.1 15.9 2.4 4.3 0.0 6.6 9.2 3.9 3.0 4.5 7.7 7.8 0.0 4.8 15.3 4.9 4.1 4.8 0.0 12.7 5.0 8.0 8.1 5.0 0.0 5.9 6.1 8.1 2.5 6.0 5.6 15.7 5.4 0.0 7.5 7.6 2.1 0.0 0.0 4.2 1.9 8.6 2.1 4.7 4.0 6.0 4.0 4.1 19.7 5.1 5.5 2.7 4.7 6.7 3.7 8.2 2.5 7.3 5.3 3.3 AC023055.1 ENSG00000257390 "Novel protein" 12 55757275-55827546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 9.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 6.3;granulocytes: 2.5;Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.0" "HPA017653, HPA030902, HPA030903" Uncertain Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (8.84e-4)" "unprognostic (2.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.55e-3)" "unprognostic (1.86e-1)" "unprognostic (6.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.05e-2)" "unprognostic (2.16e-2)" "unprognostic (1.16e-5)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-3)" 0.2 0.1 0.0 0.1 0.2 0.5 0.1 0.2 0.2 0.0 0.3 0.1 0.2 0.0 0.3 0.2 0.1 0.4 0.2 0.1 0.3 0.1 0.2 0.1 0.4 0.3 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.2 0.3 0.9 0.1 0.1 0.2 0.2 0.5 0.0 0.0 0.1 0.2 9.0 0.2 0.0 0.0 0.0 0.2 0.3 0.1 0.4 0.1 0.0 1.2 1.7 1.1 0.0 1.3 0.8 0.6 0.1 0.5 0.5 0.4 1.3 0.2 0.7 0.4 0.7 1.0 1.2 0.5 0.0 1.2 0.9 0.3 0.5 0.5 1.4 1.0 0.2 0.0 0.5 0.2 0.0 0.1 0.7 0.6 0.0 0.2 0.0 0.7 1.0 1.9 1.4 0.0 1.1 1.4 0.8 0.7 0.6 1.6 0.5 0.5 2.1 3.0 0.5 0.4 0.4 0.0 0.0 0.1 0.2 0.3 0.0 1.1 0.9 0.3 0.2 0.2 1.2 0.4 1.4 1.1 0.8 0.7 1.9 1.3 0.7 1.1 1.3 0.9 1.3 0.2 1.8 2.0 0.6 1.8 1.4 0.0 0.2 0.2 0.2 0.1 0.3 0.3 0.2 0.0 0.5 0.0 0.2 0.4 0.1 6.4 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 2.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 AC034102.2 ENSG00000257411 "Novel protein" 12 56101331-56109289 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 56.9;HBF TERT88: 124.0;HUVEC TERT2: 57.4;LHCN-M2: 70.9;U-266/84: 58.8;U-698: 94.5" NA NA 6.9 0.0 0.0 0.0 0.0 0.0 12.6 0.0 1.8 14.1 0.4 17.6 0.8 3.3 0.0 17.2 9.8 5.6 0.1 0.2 0.1 7.1 7.7 4.3 0.9 0.0 0.6 0.0 2.1 0.1 12.6 0.1 2.6 0.3 1.0 13.3 5.7 0.5 13.6 0.2 0.1 0.0 13.6 0.0 0.1 0.0 6.6 0.2 18.5 4.4 4.1 19.8 10.1 0.0 0.3 0.0 0.0 8.9 0.0 6.0 27.4 0.0 1.8 29.7 56.9 54.5 0.0 0.0 0.8 4.9 8.8 4.4 0.0 33.6 18.1 124.0 0.0 0.0 0.0 0.0 14.8 4.5 0.0 0.0 19.0 19.2 7.9 18.4 27.5 57.4 20.3 0.0 0.0 70.9 0.0 0.0 0.0 4.4 32.4 0.0 0.0 0.0 0.0 47.2 23.6 0.0 0.0 2.4 0.0 0.5 41.1 0.4 3.7 0.0 6.7 8.7 3.9 1.3 0.0 58.8 94.5 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 0.6 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.0;Cytotrophoblasts: 1.2;Spermatogonia: 1.2;Syncytiotrophoblasts: 1.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052735: AB_2681932" "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 0.2 0.3 0.1 0.2 0.1 1.3 0.2 0.6 0.4 0.3 0.2 0.3 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.3 0.5 0.2 0.4 0.2 0.2 0.2 0.0 0.5 0.5 0.1 0.2 0.7 0.3 0.3 0.2 0.4 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.3 0.3 1.0 0.5 0.2 0.3 0.1 0.1 0.3 0.2 0.5 1.5 0.0 0.8 3.2 0.0 0.0 2.0 0.5 0.2 0.6 0.8 1.3 0.2 0.7 0.7 0.2 0.9 0.4 0.3 0.5 0.5 0.0 0.5 0.9 0.0 1.7 0.0 0.6 1.6 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 1.6 0.9 1.8 0.0 0.2 1.2 1.6 0.0 1.1 1.2 0.8 0.1 0.0 0.0 0.1 1.7 1.7 2.1 0.0 0.9 0.7 0.7 0.9 0.6 2.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.1 0.3 0.2 0.2 0.0 0.3 0.2 0.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.0 0.8 0.0 0.0 0.0 0.0 1.2 0.3 0.1 0.0 0.3 0.1 0.2 0.2 0.4 0.0 0.0 0.2 0.2 0.9 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.4 1.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 RPL36A-HNRNPH2 ENSG00000257529 "RPL36A-HNRNPH2 readthrough" X 101391011-101412297 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 39.9;Club cells: 29.1;Fibroblasts: 8.8;granulocytes: 27.8;Respiratory ciliated cells: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: AB_2686846" "unprognostic (3.69e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.65e-3)" "unprognostic (1.63e-1)" "unprognostic (2.96e-1)" "unprognostic (1.79e-1)" "unprognostic (5.34e-2)" "unprognostic (2.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (1.49e-3)" "unprognostic (2.04e-4)" "unprognostic (1.56e-1)" "unprognostic (4.81e-2)" "unprognostic (3.94e-1)" 156.9 115.8 153.9 149.0 157.9 477.8 375.0 151.8 213.0 171.0 156.5 179.8 121.4 133.1 92.1 83.1 125.1 57.4 69.6 151.2 160.3 104.0 138.0 84.9 208.6 157.7 154.8 150.6 434.6 200.4 117.1 0.3 118.0 158.0 112.6 134.9 39.0 164.6 97.1 196.0 116.8 143.2 90.5 165.6 150.4 139.5 33.2 156.7 351.7 83.4 189.9 225.6 210.3 0.5 167.1 479.9 63.6 351.8 196.0 556.6 603.8 207.1 411.5 307.5 363.4 528.3 37.6 249.6 1272.3 379.1 379.3 282.1 312.4 692.9 639.6 308.0 494.4 334.8 589.7 99.9 58.4 726.0 839.5 372.7 837.9 498.0 458.3 744.0 628.2 359.2 413.5 590.6 507.6 266.5 119.0 364.7 535.8 425.9 1038.7 262.3 388.8 984.7 647.3 412.1 29.5 230.9 445.6 512.1 373.3 416.7 288.6 171.7 707.0 594.4 115.8 314.9 330.7 357.0 374.5 651.9 710.4 186.8 1188.4 141.9 97.1 324.6 105.0 284.3 334.8 348.1 373.2 363.3 332.4 450.1 354.6 364.2 357.9 57.5 277.5 292.2 306.2 274.4 605.1 153.9 157.9 151.8 213.0 151.2 160.3 157.7 154.8 150.6 158.0 165.6 156.7 167.1 0.0 12.8 39.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.5 0.0 0.0 8.8 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 ZNF625 ENSG00000257591 "Zinc finger protein 625" Q96I27 19 12142090-12156734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 8.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 9.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA074014 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA074014: AB_2686652" "unprognostic (7.88e-3)" "unprognostic (6.74e-2)" "unprognostic (9.56e-2)" "unprognostic (8.75e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-3)" "unprognostic (4.72e-2)" "unprognostic (3.31e-2)" "unprognostic (6.23e-2)" "unprognostic (2.73e-1)" "unprognostic (5.49e-2)" "unprognostic (3.70e-2)" "unprognostic (8.29e-2)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.62e-1)" 1.2 2.2 2.4 0.8 2.3 1.2 2.4 5.1 6.3 2.2 1.9 1.8 0.8 2.2 3.0 1.4 2.0 0.9 1.6 2.3 2.9 2.5 1.0 1.4 1.2 2.4 2.7 2.1 2.1 1.8 1.4 3.5 1.7 3.3 2.8 0.8 8.9 1.8 1.5 0.5 2.2 1.4 1.7 2.3 2.4 1.4 1.6 3.0 0.9 2.8 0.8 1.1 2.1 1.6 3.4 0.7 0.0 5.5 8.7 2.2 1.5 0.9 2.2 2.8 3.2 3.6 0.1 0.1 0.0 4.1 1.6 2.3 0.4 0.0 2.9 2.9 0.0 1.6 2.7 0.0 2.6 0.9 0.1 3.5 1.1 1.2 3.1 1.1 2.3 2.7 0.2 0.0 0.0 4.9 1.9 0.0 1.2 6.6 0.0 1.8 0.2 4.5 0.0 2.7 7.5 3.5 2.4 0.0 0.1 2.0 6.4 3.6 0.2 1.6 7.3 3.5 5.9 3.1 6.1 5.1 0.0 2.0 0.0 2.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.4 0.1 2.4 2.3 5.1 6.3 2.3 2.9 2.4 2.7 2.1 3.3 2.3 3.0 3.4 2.1 3.2 1.5 0.0 0.5 0.4 0.5 1.0 1.2 5.0 2.0 2.2 0.1 2.8 0.4 1.8 10.4 4.1 0.5 0.5 3.9 3.4 0.1 1.9 3.5 2.5 1.2 0.0 0.0 3.1 3.9 1.3 0.0 1.5 0.0 4.9 6.4 0.8 1.5 5.0 0.0 0.6 2.0 4.1 2.0 1.3 0.6 0.5 0.0 0.0 1.7 5.1 7.2 0.0 0.0 3.6 1.9 1.5 1.6 0.7 0.3 2.7 2.5 9.5 0.0 1.8 1.7 2.9 6.6 0.3 0.9 1.2 0.4 2.0 1.0 0.3 GALNT4 GalNAc-T4 ENSG00000257594 "Polypeptide N-acetylgalactosaminyltransferase 4" Q8N4A0 12 89519412-89524796 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 31.9" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 11.2;Glandular and luminal cells: 3.4;Paneth cells: 3.4;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.2" HPA076116 Approved "Golgi apparatus" NA NA 520000 "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (2.96e-2)" "unprognostic (7.65e-3)" "unprognostic (8.76e-2)" "unprognostic (3.94e-5)" "unprognostic (3.50e-1)" "unprognostic (4.87e-2)" "unprognostic (2.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.24e-1)" "unprognostic (5.81e-6)" "unprognostic (2.34e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-2)" "unprognostic (2.52e-1)" 3.1 2.2 1.5 6.1 1.8 7.8 4.0 1.6 1.7 16.3 1.5 18.8 17.4 13.7 2.7 3.4 12.0 11.9 1.9 1.6 2.0 5.7 4.8 3.8 3.5 1.9 1.7 1.2 2.9 5.1 1.9 1.2 3.0 2.0 3.8 17.5 3.9 16.3 2.2 0.3 1.9 18.6 3.1 1.9 5.9 31.9 0.8 1.6 1.2 3.2 1.7 3.5 5.0 1.5 2.0 3.2 9.4 3.3 18.2 6.3 9.1 2.3 7.6 3.6 3.1 3.3 3.5 5.8 0.0 1.9 5.7 1.3 4.8 0.9 4.9 5.2 8.4 2.1 3.9 1.6 3.2 3.3 3.8 8.3 4.1 2.2 6.3 2.7 7.1 9.9 0.7 2.5 1.7 4.8 2.6 0.3 7.2 2.2 7.1 22.2 1.0 0.6 1.6 9.2 9.6 0.2 1.7 1.0 5.0 7.0 3.1 10.0 3.7 9.1 6.2 2.2 3.9 2.7 1.7 2.9 1.6 3.2 2.0 3.8 3.9 3.3 1.6 2.0 4.9 3.5 1.3 1.1 1.5 2.2 1.9 1.5 1.3 3.2 4.9 5.3 0.8 1.3 2.0 1.5 1.8 1.6 1.7 1.6 2.0 1.9 1.7 1.2 2.0 1.9 1.6 2.0 0.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.0 0.6 0.1 0.0 1.3 0.0 0.2 0.0 0.7 11.2 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.4 0.0 2.9 0.9 0.0 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.1 INAFM1 PRR24 ENSG00000257704 "InaF motif containing 1" C9JVW0 19 47274885-47275723 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 100.3;Smooth muscle cells: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 58.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064015 Uncertain NA NA "HPA064015: AB_2685177" "unprognostic (3.88e-2)" "unprognostic (8.88e-3)" "prognostic unfavorable (3.20e-5)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (2.32e-1)" "unprognostic (3.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (9.99e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (3.52e-2)" "unprognostic (2.02e-1)" "unprognostic (4.03e-1)" "unprognostic (4.36e-3)" 24.2 65.9 25.3 9.1 20.2 9.1 23.0 21.1 30.5 38.8 24.6 27.4 6.5 32.5 4.8 14.8 31.6 9.9 23.9 24.8 28.5 19.0 18.2 26.3 5.6 29.4 28.2 20.6 34.2 27.9 4.6 21.2 6.7 27.0 32.7 3.4 16.2 15.3 9.1 17.2 25.2 16.0 9.4 21.6 18.7 23.2 13.0 26.8 5.0 21.8 4.9 3.3 31.5 27.1 28.9 11.1 10.1 8.8 14.4 2.6 7.7 5.2 12.6 4.2 5.7 7.4 4.9 4.9 5.8 3.9 7.8 4.5 8.0 2.2 5.0 1.4 11.6 13.6 9.3 6.3 7.7 13.1 6.7 13.6 10.9 8.9 5.4 4.8 4.2 2.3 6.4 15.1 12.4 2.3 22.5 5.1 43.1 2.6 11.2 10.1 9.0 3.5 4.8 4.5 6.5 6.6 8.4 13.8 4.3 6.2 2.3 6.1 6.5 5.4 6.5 9.6 3.7 6.7 5.9 5.0 5.5 13.4 4.7 5.8 11.0 15.4 36.3 3.1 11.0 2.5 11.3 3.6 4.3 13.6 8.6 6.6 4.7 58.6 2.9 14.4 16.0 5.0 7.1 25.3 20.2 21.1 30.5 24.8 28.5 29.4 28.2 20.6 27.0 21.6 26.8 28.9 23.8 9.6 7.0 7.5 6.3 0.0 43.5 0.0 15.9 16.5 20.7 20.8 9.4 8.6 3.7 11.0 10.4 20.1 3.1 12.6 19.6 11.4 13.5 16.4 100.3 18.3 7.3 18.9 5.0 12.4 15.3 30.5 11.7 16.5 1.3 10.2 11.4 14.8 10.0 3.3 11.6 13.0 0.0 15.9 0.0 22.9 61.8 12.3 0.0 4.7 8.0 5.9 8.2 3.5 2.7 9.6 17.7 25.9 9.0 31.3 28.4 15.4 0.7 48.6 46.0 12.9 73.4 10.3 13.0 10.6 0.0 27.6 6.5 16.2 13.2 49.0 CNPY2 "HP10390, TMEM4, ZSIG9" ENSG00000257727 "Canopy FGF signaling regulator 2" Q9Y2B0 12 56309842-56316119 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 475.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038465, HPA038466" Supported Supported Cytosol "Intracellular and membrane" NA NA 220000 Cytosol "HPA038465: AB_10967609, HPA038466: AB_10672646" "unprognostic (3.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.49e-1)" "unprognostic (2.46e-2)" "unprognostic (4.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.17e-3)" "unprognostic (1.46e-1)" "unprognostic (7.68e-2)" "unprognostic (2.04e-3)" "prognostic favorable (8.37e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (5.06e-2)" 31.5 53.0 30.1 26.0 32.5 24.9 42.2 31.6 30.3 43.6 38.1 36.9 31.2 35.9 75.0 34.4 38.5 25.6 26.4 29.5 32.6 37.8 76.3 30.7 22.2 32.9 30.8 28.8 43.1 59.4 47.7 67.3 41.1 30.5 35.6 38.8 18.9 53.5 36.7 21.3 22.3 34.9 25.2 32.2 35.4 42.4 20.1 31.6 27.2 45.1 18.7 26.8 33.2 31.3 33.9 50.6 75.5 76.0 62.8 186.0 64.0 120.7 51.0 117.4 108.7 76.5 116.0 87.9 51.2 95.0 132.4 53.2 72.4 92.3 62.8 68.7 51.3 57.5 49.9 106.1 121.8 83.6 94.9 60.4 76.5 80.5 89.9 106.6 165.5 91.1 59.0 73.8 113.5 81.3 76.2 58.2 105.3 72.6 107.5 109.5 65.1 58.3 84.9 90.1 47.6 67.9 41.7 85.1 86.8 93.6 92.7 78.0 176.8 41.2 42.7 33.6 52.2 74.7 58.4 88.2 41.5 90.2 88.2 70.9 56.8 66.5 36.8 65.8 56.9 77.8 73.2 70.7 71.7 69.5 66.2 70.4 67.0 9.8 70.9 34.6 71.3 68.4 76.4 30.1 32.5 31.6 30.3 29.5 32.6 32.9 30.8 28.8 30.5 32.2 31.6 33.9 76.2 48.1 93.7 17.3 79.2 54.8 75.2 129.9 17.1 80.5 178.6 191.6 9.8 140.2 95.2 101.2 64.6 248.3 74.0 80.2 52.8 191.8 40.2 54.7 59.9 72.6 141.9 34.3 31.8 168.7 475.0 77.5 31.1 53.1 91.3 60.7 98.9 185.8 147.4 58.9 32.4 187.2 103.7 59.2 55.8 17.7 103.8 47.8 122.7 13.1 99.7 88.6 125.7 40.2 45.6 162.4 114.1 100.1 68.2 107.4 176.6 145.5 74.1 92.2 26.3 59.1 82.8 72.4 44.0 20.0 53.8 236.4 60.5 78.2 177.8 71.0 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 11.9;pancreas: 4.1;salivary gland: 5.9" "Group enriched" "Detected in some" 4 "Early spermatids: 27.4;Late spermatids: 18.2" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 1.6;RH-30: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.0 0.0 0.0 0.4 0.0 0.2 1.1 0.0 0.3 0.0 0.3 1.3 11.9 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.9 0.0 0.0 0.0 9.7 0.0 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 AC002996.1 ENSG00000257767 "Novel protein" 12 111753890-111791418 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 64.8;brain: 40.6;skeletal muscle: 38.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 88.5;myeloid DC: 88.0" "Group enriched" "Detected in many" 5 "dendritic cells: 88.0;monocytes: 88.5" "Cell line enhanced" "Detected in many" "BEWO: 9.1;EFO-21: 17.4;SK-BR-3: 8.7" NA NA "unprognostic (4.89e-1)" "unprognostic (1.20e-1)" 64.8 16.6 23.1 2.9 21.6 0.3 6.5 25.1 19.5 3.1 6.1 11.8 9.7 7.5 0.0 5.9 7.2 0.1 12.5 15.2 22.7 7.8 24.2 10.0 0.7 31.9 30.5 8.0 5.4 1.4 0.0 2.4 0.9 29.1 1.8 0.2 1.6 5.8 1.6 38.1 4.6 6.5 0.0 29.4 1.9 17.8 1.3 40.6 0.1 3.6 0.0 0.2 7.6 4.3 38.8 3.5 0.0 0.0 0.9 0.0 1.4 9.1 1.0 4.2 1.6 0.8 0.0 2.0 0.0 17.4 1.9 1.5 3.2 0.0 0.7 0.1 0.5 0.4 0.0 2.6 0.0 0.0 0.4 0.0 0.0 1.9 1.9 0.0 0.0 4.5 0.0 1.6 0.2 0.7 0.0 0.0 0.7 5.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.6 4.7 0.0 8.7 0.1 0.1 6.3 3.4 0.0 0.0 2.0 0.3 0.0 1.3 2.1 5.4 2.5 0.1 0.0 2.1 88.5 18.7 0.3 38.6 0.7 3.2 0.0 0.2 88.0 1.1 0.2 0.1 3.7 1.0 13.0 23.7 0.4 53.5 23.1 21.6 25.1 19.5 15.2 22.7 31.9 30.5 8.0 29.1 29.4 40.6 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC025165.3 ENSG00000257921 "Novel protein" 12 57772660-57797554 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "glioma: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;RH-30: 1.6" NA NA "unprognostic (1.28e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.88e-1)" "unprognostic (1.38e-4)" "unprognostic (3.74e-2)" "unprognostic (6.78e-4)" "unprognostic (2.19e-2)" "unprognostic (2.05e-1)" "unprognostic (8.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" "unprognostic (3.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.74e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CUX1 "CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6" ENSG00000257923 "Cut like homeobox 1" "P39880, Q13948" 7 101815904-102283958 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Transport" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 35.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003277, HPA003317" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA003277: AB_10601804, HPA003317: AB_2666891" "unprognostic (5.86e-2)" "unprognostic (5.39e-3)" "unprognostic (9.62e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (5.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (2.89e-3)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "prognostic favorable (5.72e-7)" "unprognostic (1.12e-1)" "unprognostic (8.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.97e-1)" 30.8 18.1 23.2 25.0 31.9 33.7 18.1 52.2 39.8 35.4 27.1 36.3 34.0 61.4 17.1 32.9 35.6 32.0 83.6 21.4 25.6 40.4 23.4 33.4 19.6 30.7 27.3 21.7 47.3 63.9 46.3 24.8 23.3 31.3 31.0 25.5 19.3 36.4 23.4 45.9 24.2 37.6 41.2 27.3 17.0 35.6 9.7 27.5 35.0 49.9 39.1 20.8 32.6 25.0 31.2 41.8 44.0 30.3 37.7 24.1 49.3 18.4 41.1 43.0 17.0 10.9 26.2 26.2 53.6 64.2 40.8 31.3 33.4 19.4 32.9 10.1 25.9 21.8 18.8 32.8 22.2 63.7 24.7 9.9 34.6 65.9 13.1 29.5 48.7 22.3 34.0 44.5 44.2 16.3 85.9 80.8 30.1 12.3 64.0 45.4 52.6 25.1 64.4 27.6 46.5 27.7 82.6 35.8 88.4 35.4 25.1 17.4 29.0 33.5 71.2 47.8 54.4 23.7 28.8 14.5 114.7 65.8 22.3 50.8 3.3 13.9 2.3 3.1 13.4 3.0 2.9 2.3 3.1 10.8 2.4 2.2 3.1 7.0 4.5 35.0 18.2 2.2 8.4 23.2 31.9 52.2 39.8 21.4 25.6 30.7 27.3 21.7 31.3 27.3 27.5 31.2 33.7 99.3 60.5 78.4 35.3 26.3 30.9 30.9 33.6 67.2 23.9 17.1 110.5 31.5 40.3 40.5 68.8 54.6 59.6 69.2 9.8 34.4 9.5 50.6 165.2 42.1 42.5 50.0 129.0 24.0 55.5 51.8 62.2 85.0 12.0 97.8 37.5 36.1 32.8 53.8 116.2 48.7 38.7 70.2 42.5 9.4 41.3 75.4 17.8 139.6 65.2 47.7 32.0 96.0 117.5 34.1 50.2 60.9 46.0 55.5 42.9 64.5 37.9 57.3 26.3 105.2 56.6 13.5 14.4 39.9 43.3 88.0 25.7 34.7 46.0 43.8 TEN1 "C17orf106, FLJ39785" ENSG00000257949 "TEN1 subunit of CST complex" Q86WV5 17 75979240-76000586 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 55.1;Exocrine glandular cells: 88.9;Pancreatic endocrine cells: 89.1;Proximal tubular cells: 89.0;Suprabasal keratinocytes: 52.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA065069 Supported Nucleoplasm NA NA Nucleoplasm "HPA065069: AB_2685418" "unprognostic (1.61e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-2)" "unprognostic (1.07e-1)" "unprognostic (3.02e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-3)" "unprognostic (2.95e-1)" "unprognostic (2.85e-2)" "unprognostic (9.03e-2)" "unprognostic (8.61e-3)" "unprognostic (3.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" "unprognostic (2.85e-4)" 21.1 27.9 9.5 14.9 9.9 32.5 22.1 9.8 12.7 17.6 11.2 16.0 22.9 16.9 11.9 43.8 15.3 16.1 16.7 9.4 10.8 27.5 49.9 20.9 18.9 10.8 10.6 9.2 16.2 33.1 12.9 22.5 11.6 10.7 28.4 9.6 3.4 28.0 10.3 12.2 45.4 25.9 7.9 10.5 23.5 27.2 13.4 10.1 6.8 20.3 7.9 13.0 16.4 25.2 10.9 19.2 15.1 12.1 16.6 16.5 21.6 32.7 12.3 18.4 21.5 21.9 18.6 32.3 25.0 20.4 15.0 22.4 18.1 7.7 18.6 6.3 13.8 24.8 28.7 21.3 21.0 19.8 18.6 45.7 19.4 25.8 11.8 12.3 18.0 29.0 14.6 12.4 24.2 12.8 31.8 23.9 40.3 11.8 19.4 25.6 21.7 12.0 22.7 27.5 33.5 23.8 40.1 9.6 83.5 16.3 9.3 43.4 28.8 15.9 41.7 24.0 17.8 28.3 25.3 10.1 14.2 22.4 13.2 13.3 81.8 53.7 33.4 40.0 52.5 33.3 60.8 31.6 34.0 48.5 49.2 23.7 28.4 32.7 45.3 29.2 52.8 37.9 36.3 9.5 9.9 9.8 12.7 9.4 10.8 10.8 10.6 9.2 10.7 10.5 10.1 10.9 14.0 0.0 4.2 0.0 13.0 39.0 0.0 55.1 5.2 0.0 39.2 32.8 0.0 0.0 23.4 5.5 0.0 0.0 21.7 0.1 39.2 39.5 0.0 12.4 13.0 10.2 0.0 0.8 0.0 88.9 0.1 8.8 2.6 19.0 2.5 16.9 0.0 0.0 0.1 0.0 0.0 0.2 34.6 0.0 39.9 0.0 0.0 19.7 30.2 0.0 37.2 0.0 0.0 0.0 0.0 89.1 0.0 0.0 7.9 0.0 0.0 89.0 8.7 0.0 0.0 0.1 12.9 0.0 0.0 6.1 52.7 0.0 9.4 24.4 0.0 0.1 TEX49 LINC00935 ENSG00000257987 "Testis expressed 49" A0A1B0GTD5 12 48727435-48765790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 21.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "stomach cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066635 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA066635: " "unprognostic (2.63e-2)" "unprognostic (6.32e-3)" "unprognostic (8.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A4 ENSG00000258083 "Olfactory receptor family 9 subfamily A member 4" Q8NGU2 7 141916399-141920625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 29.7;Excitatory neurons: 4.2;Inhibitory neurons: 5.9;Microglial cells: 3.7;Oligodendrocyte precursor cells: 14.6;Oligodendrocytes: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-937: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.77e-1)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 14.6 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576606 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 40.5;Langerhans cells: 33.4;Paneth cells: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.2" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 1.8 2.3 0.2 0.7 0.4 3.9 1.5 1.9 0.6 0.7 0.7 0.9 1.3 1.4 1.2 1.8 1.0 1.6 2.2 0.3 0.8 1.3 1.1 1.2 1.1 0.5 0.5 0.1 1.4 0.8 0.1 0.9 0.7 0.8 0.8 1.5 0.9 1.2 0.0 4.3 1.6 1.4 1.5 0.5 0.8 0.8 1.1 0.4 0.7 0.9 0.5 1.5 0.8 0.9 0.6 1.4 0.7 1.5 1.8 0.4 0.5 1.6 2.8 0.2 0.0 0.1 2.7 2.0 1.1 1.8 0.2 3.4 1.0 0.4 0.3 0.5 1.0 1.9 0.6 2.7 4.9 0.9 0.9 1.0 0.1 0.4 0.9 0.7 3.9 1.9 1.2 3.3 3.0 0.3 2.7 1.0 1.9 0.8 1.2 2.6 1.4 0.2 3.6 0.2 1.5 1.5 2.3 1.9 0.6 7.2 2.8 1.0 0.4 0.7 2.6 0.9 2.2 1.4 2.2 3.3 3.6 3.9 1.4 1.3 38.6 11.6 34.2 7.8 11.8 7.2 9.0 8.8 7.9 9.4 7.7 6.1 7.0 43.5 9.8 14.2 9.6 15.9 13.6 0.2 0.4 1.9 0.6 0.3 0.8 0.5 0.5 0.1 0.8 0.5 0.4 0.6 1.9 0.0 1.7 10.7 4.0 24.2 17.3 6.1 0.0 1.5 1.1 2.5 40.5 1.5 4.6 0.0 0.0 2.5 2.8 22.7 7.9 0.2 12.3 2.8 2.2 8.0 1.8 24.0 4.4 0.0 2.4 8.3 0.0 5.9 7.0 0.9 2.5 2.0 4.5 13.5 8.6 7.5 12.2 7.2 33.4 14.2 4.7 5.5 10.6 1.0 2.4 0.5 7.2 4.0 1.7 0.4 63.1 3.8 0.1 12.5 2.5 8.1 3.1 1.1 0.0 9.0 8.0 20.8 11.5 0.0 21.5 11.4 8.2 0.8 5.9 21.8 PRSS58 TRYX3 ENSG00000258223 "Serine protease 58" Q8IYP2 7 142252143-142258058 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 180 "testis: 26.0" "Group enriched" "Detected in some" 129 "Early spermatids: 640.5;Late spermatids: 243.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 640.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 243.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 41.7" "Group enriched" "Detected in some" 6 "Hofbauer cells: 18.0;Langerhans cells: 67.5;Macrophages: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 8 "classical monocyte: 9.1" "Lineage enriched" "Detected in many" 8 "monocytes: 9.1" "Group enriched" "Detected in some" 23 "HL-60: 40.9;U-937: 157.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054137: AB_2732582" "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.1 1.8 1.1 7.4 1.0 41.7 0.6 1.5 2.2 0.6 2.0 0.2 0.1 0.3 0.0 1.2 0.5 1.8 0.5 0.9 3.0 0.5 1.8 4.0 0.1 2.2 2.5 0.4 0.3 1.3 1.2 0.5 0.9 1.8 0.4 0.3 1.0 1.2 0.5 0.0 2.6 0.0 1.3 2.2 1.1 0.2 0.5 3.8 0.6 0.7 0.0 0.2 2.3 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.3 0.0 0.0 9.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 1.8 1.1 1.0 1.5 2.2 0.9 3.0 2.2 2.5 0.4 1.8 2.2 3.8 1.7 0.1 0.0 4.8 0.7 0.6 1.9 0.0 0.0 0.0 0.2 0.1 0.1 0.3 1.5 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.5 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.0 2.5 0.0 0.0 0.0 18.0 0.0 0.2 0.0 0.0 4.7 67.5 0.7 0.0 58.1 1.8 7.5 6.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.9 0.4 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.3 0.4 0.0 0.0 0.0 CHURC1 "C14orf52, FLJ33064, My015" ENSG00000258289 "Churchill domain containing 1" Q8WUH1 14 64914361-64944591 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040072 Approved Approved Cytosol NA NA Cytosol "HPA040072: AB_10963788" "unprognostic (2.94e-1)" "unprognostic (2.42e-1)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.80e-1)" "unprognostic (2.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.64e-2)" "unprognostic (4.64e-1)" "unprognostic (6.78e-3)" "unprognostic (2.12e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-2)" "unprognostic (6.67e-2)" "unprognostic (3.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" 48.2 42.4 33.3 39.4 37.7 44.2 37.7 37.8 41.5 41.6 32.1 39.6 31.2 40.3 32.9 34.6 34.5 32.8 57.7 32.9 41.0 35.0 52.9 29.6 44.1 40.8 36.6 32.4 44.3 30.5 46.5 25.4 34.8 40.5 32.7 36.8 36.0 26.7 38.0 83.6 30.3 34.2 46.2 39.2 42.6 34.0 25.6 37.1 61.7 33.2 53.4 43.7 38.6 30.7 43.7 119.6 61.8 58.8 43.7 70.1 75.6 68.9 85.3 74.3 47.4 53.9 34.1 75.1 69.9 57.7 73.7 75.2 84.9 51.7 69.2 51.8 79.7 25.3 67.9 47.7 79.3 66.1 37.7 64.9 89.9 50.5 43.0 81.4 79.7 51.6 107.2 30.6 60.5 58.1 97.6 72.7 61.6 31.4 140.9 101.1 63.4 63.2 42.6 64.5 83.8 30.0 36.7 57.6 59.8 81.0 53.7 101.8 78.4 64.8 41.3 87.8 45.0 56.0 49.5 46.8 162.0 43.0 44.6 51.8 201.6 131.9 145.4 111.5 137.6 128.2 161.8 167.5 134.1 107.4 135.9 166.3 139.8 292.8 122.4 138.3 154.7 238.5 143.5 33.3 37.7 37.8 41.5 32.9 41.0 40.8 36.6 32.4 40.5 39.2 37.1 43.7 154.6 102.5 89.0 0.0 128.2 58.5 73.8 176.8 130.3 73.8 85.0 98.7 53.4 94.4 98.2 99.3 43.8 90.4 97.9 89.3 131.0 160.7 82.0 130.8 87.3 109.9 89.8 91.5 0.0 222.7 89.7 100.9 75.4 80.8 95.6 69.6 127.5 190.4 89.3 53.8 0.0 100.3 107.8 172.6 69.6 27.1 104.1 130.5 83.6 0.0 214.3 155.2 132.8 0.0 0.0 216.8 118.9 121.5 79.7 70.5 124.6 211.0 145.1 87.2 131.5 100.6 135.7 131.1 81.1 158.3 65.9 89.8 137.0 205.8 121.1 72.2 AC009779.3 ENSG00000258311 "Novel protein" 12 55716036-55724703 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;Club cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 11.4" NA NA "unprognostic (3.10e-3)" "unprognostic (9.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-2)" "unprognostic (7.25e-2)" "unprognostic (4.89e-3)" "unprognostic (2.23e-2)" "unprognostic (1.34e-2)" "unprognostic (2.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-3)" "unprognostic (3.73e-1)" "unprognostic (7.46e-2)" "unprognostic (4.05e-3)" "unprognostic (2.56e-1)" 13.1 2.6 3.7 2.9 4.3 4.7 9.4 4.0 3.8 3.0 3.1 7.5 4.2 3.2 3.1 3.0 4.4 1.9 12.9 3.4 3.5 3.7 12.4 2.8 3.0 4.1 4.0 3.1 4.7 2.2 0.9 3.4 1.0 4.2 4.5 4.2 10.2 3.1 1.4 14.6 4.1 7.0 4.8 3.6 6.3 4.0 3.6 3.7 1.4 3.9 6.2 2.5 4.1 3.0 5.4 1.1 0.8 3.3 1.2 4.4 6.7 1.9 2.0 0.9 1.5 1.1 1.6 5.8 4.9 1.1 1.5 1.2 2.4 1.8 0.3 1.1 4.6 3.7 1.9 3.0 1.8 0.4 2.3 2.1 2.8 1.0 5.9 0.2 8.8 0.4 4.6 2.9 3.8 3.9 1.1 1.1 1.3 3.7 0.9 0.6 1.7 2.5 0.8 0.0 1.1 3.1 4.1 1.3 0.4 2.4 1.9 2.1 3.4 2.1 3.9 3.7 2.0 0.7 3.0 4.0 3.4 11.4 1.3 2.1 2.7 0.6 1.3 0.5 0.5 0.4 0.6 0.2 0.2 0.5 1.0 0.2 0.3 1.7 0.4 2.0 0.6 0.0 0.6 3.7 4.3 4.0 3.8 3.4 3.5 4.1 4.0 3.1 4.2 3.6 3.7 5.4 0.1 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 C17orf49 "BAP18, HEPIS, MGC49942" ENSG00000258315 "Chromosome 17 open reading frame 49" Q8IXM2 17 7014495-7017525 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 62.0;Smooth muscle cells: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA022961, HPA024457" Supported Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (1.48e-2)" "unprognostic (1.67e-3)" "unprognostic (9.09e-2)" "unprognostic (5.15e-2)" "unprognostic (4.54e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (7.62e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-2)" "unprognostic (2.25e-2)" "unprognostic (1.49e-2)" "unprognostic (1.06e-9)" "unprognostic (5.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.41e-2)" "unprognostic (4.62e-2)" 55.0 43.0 54.4 62.0 53.9 123.2 56.0 55.2 60.9 38.9 49.9 38.1 35.2 36.3 53.6 53.3 49.7 38.6 47.2 53.0 54.7 46.3 47.5 55.8 98.3 54.6 53.1 51.7 35.9 51.2 38.0 40.4 37.2 53.8 35.6 42.7 39.5 42.6 27.1 70.2 62.0 37.3 34.3 53.6 73.6 35.8 28.4 56.8 98.5 53.3 55.6 106.3 54.4 39.8 55.6 68.2 88.3 136.8 106.6 95.4 134.5 47.0 36.1 58.7 70.8 57.5 43.6 54.5 64.6 97.1 86.8 23.0 55.1 34.5 69.8 53.7 227.6 91.6 58.4 27.9 85.3 71.6 37.7 74.8 85.4 92.4 52.9 106.0 50.7 112.0 51.6 21.9 179.3 87.5 77.7 62.3 125.1 45.9 77.1 51.2 38.3 40.0 95.1 80.9 44.6 37.2 105.3 63.4 32.3 67.5 49.1 41.0 47.9 61.7 40.8 50.3 69.7 93.5 63.8 39.5 22.5 63.6 55.6 59.9 259.3 159.7 157.7 190.8 225.8 122.3 238.7 195.9 193.8 251.3 221.0 128.9 143.0 148.1 391.4 177.4 346.7 215.3 193.1 54.4 53.9 55.2 60.9 53.0 54.7 54.6 53.1 51.7 53.8 53.6 56.8 55.6 9.6 3.2 10.3 0.0 18.2 10.5 5.9 8.2 13.1 1.2 8.9 11.2 1.1 2.8 7.2 1.8 0.0 10.9 18.1 8.2 17.6 17.7 0.2 2.3 4.1 12.3 30.6 8.6 0.0 23.1 16.5 6.0 2.6 4.2 18.9 3.1 9.3 2.1 11.1 0.0 0.0 12.5 14.2 7.8 32.3 1.4 4.1 12.0 24.9 0.0 62.0 2.1 16.5 0.0 0.0 24.2 14.3 1.5 14.1 6.6 8.8 6.0 4.1 3.5 6.6 6.1 41.9 5.4 18.5 11.9 11.8 10.4 17.6 3.3 14.0 6.2 RTEL1 "bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL" ENSG00000258366 "Regulator of telomere elongation helicase 1" Q9NZ71 20 63657810-63696253 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020622, HPA067329, HPA078328" Approved "Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles, Nuclear bodies" "HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380" "unprognostic (3.63e-2)" "unprognostic (8.08e-3)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.27e-1)" "unprognostic (9.30e-3)" "unprognostic (2.59e-1)" "unprognostic (3.64e-2)" "unprognostic (3.30e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (9.50e-2)" "unprognostic (8.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" "unprognostic (8.84e-2)" 4.8 7.1 1.1 6.2 1.6 8.2 5.3 5.0 4.9 6.8 0.4 7.5 4.9 10.1 3.0 4.6 6.2 3.1 3.9 1.2 0.6 4.1 4.8 6.0 4.3 2.9 0.7 0.9 6.5 8.6 2.9 12.3 4.3 3.2 6.7 2.2 2.5 6.4 4.5 5.5 4.3 5.9 3.2 0.1 6.1 6.6 7.7 0.8 4.8 7.9 2.3 2.4 6.5 6.1 2.2 8.3 11.7 7.9 15.5 1.6 1.7 14.5 16.8 4.5 26.0 6.6 22.2 7.0 11.0 8.6 5.2 9.8 15.3 5.5 11.1 6.1 5.5 11.0 13.8 21.2 21.5 5.7 13.4 24.1 2.2 6.0 6.4 7.9 4.9 9.0 19.6 17.4 10.4 5.8 8.7 21.3 17.5 7.8 7.1 22.3 17.2 7.4 11.6 4.1 9.7 15.7 9.3 9.3 27.5 2.2 3.6 7.2 15.2 12.1 29.4 9.5 10.1 13.2 9.4 4.2 7.1 7.1 9.5 10.4 0.0 1.0 0.0 0.9 1.1 0.5 0.3 0.5 0.6 1.3 0.5 0.9 0.4 0.0 0.1 1.0 1.1 0.5 0.8 1.1 1.6 5.0 4.9 1.2 0.6 2.9 0.7 0.9 3.2 0.1 0.8 2.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.6 0.0 3.8 0.0 0.0 0.0 0.4 3.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 1.1 0.1 0.0 0.7 0.0 0.0 0.0 ZNF578 FLJ31384 ENSG00000258405 "Zinc finger protein 578" Q96N58 19 52453553-52516882 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.4" "Cell type enhanced" "Detected in many" "Horizontal cells: 6.7;NK-cells: 8.2;Oligodendrocyte precursor cells: 10.1;Rod photoreceptor cells: 8.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 5.5;U-266/84: 9.4" NA NA "unprognostic (6.57e-3)" "unprognostic (1.43e-2)" "unprognostic (1.56e-2)" "unprognostic (3.77e-2)" "unprognostic (1.60e-3)" "unprognostic (2.96e-3)" "unprognostic (5.42e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-2)" "unprognostic (8.14e-2)" "unprognostic (9.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.81e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-1)" "unprognostic (3.96e-2)" "unprognostic (2.42e-1)" 0.7 0.7 2.4 0.7 3.2 0.8 0.8 4.7 2.8 0.9 1.6 0.5 0.4 1.2 1.8 0.4 1.3 0.6 1.2 2.1 2.4 0.9 0.3 0.7 0.8 2.6 2.2 1.8 1.7 0.7 1.0 0.3 1.3 3.1 1.4 0.7 3.1 0.7 1.2 0.9 1.2 0.4 0.9 1.8 1.3 0.6 6.4 2.5 1.1 1.7 0.6 0.7 0.5 0.2 3.7 0.5 0.3 2.1 2.7 1.2 0.7 1.2 1.3 0.7 0.5 0.9 0.9 0.7 0.9 0.5 2.0 2.5 0.7 1.1 0.6 0.6 0.2 1.5 0.8 1.6 0.5 1.1 0.2 2.7 1.9 0.3 0.9 0.8 1.0 0.9 0.8 0.6 0.6 2.6 0.8 0.9 1.2 4.1 0.6 0.7 0.8 0.8 0.3 1.8 2.7 0.6 1.5 0.6 0.6 0.2 5.5 2.0 0.6 1.3 0.6 0.7 0.8 0.7 0.5 9.4 0.8 0.1 0.2 1.7 1.4 0.3 0.4 0.9 0.3 0.7 0.5 0.6 0.5 0.1 0.8 0.7 0.8 0.5 1.1 0.3 0.5 0.3 0.3 2.4 3.2 4.7 2.8 2.1 2.4 2.6 2.2 1.8 3.1 1.8 2.5 3.7 3.9 0.0 0.0 4.9 1.3 0.9 1.7 0.2 0.0 4.4 0.5 0.5 4.1 0.0 0.2 0.0 4.2 0.7 4.0 0.0 0.0 0.2 5.9 0.9 1.4 1.6 0.0 0.8 3.9 0.2 0.8 1.4 0.0 2.1 1.3 3.9 0.7 0.0 0.2 6.7 5.8 0.1 0.0 0.3 0.6 6.1 0.6 0.4 0.0 0.0 0.4 1.8 8.2 10.1 6.2 0.0 0.0 0.0 0.4 1.0 0.2 0.8 0.1 8.2 0.0 0.7 1.8 0.2 2.3 0.1 0.4 0.8 1.8 2.6 0.1 1.7 AC100868.1 ENSG00000258417 "Novel protein" 8 132024238-132085655 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.82e-1)" "unprognostic (1.78e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDF ENSG00000258429 "Peptide deformylase, mitochondrial" Q9HBH1 16 69326913-69330588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063409 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA063409: AB_2685007" "unprognostic (4.28e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.35e-4)" "unprognostic (5.84e-2)" "unprognostic (4.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-1)" "prognostic favorable (6.11e-4)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (5.98e-2)" "unprognostic (1.22e-2)" 5.4 8.8 1.1 1.0 1.2 1.4 5.6 2.0 1.9 4.3 1.3 4.7 2.1 5.9 0.4 10.3 4.8 0.5 4.7 2.4 0.8 18.9 28.0 4.4 1.1 1.5 1.0 1.7 3.2 8.8 1.7 4.4 0.6 1.6 5.1 0.9 0.3 7.3 0.6 12.5 7.7 5.3 0.4 1.1 5.1 5.6 4.9 1.5 0.6 6.0 0.8 0.7 4.8 4.9 1.7 6.3 4.8 1.3 4.1 1.1 0.8 7.7 6.0 1.0 2.9 2.4 8.6 5.7 13.1 6.2 1.6 2.2 11.5 1.8 2.1 1.3 3.5 23.3 6.6 5.3 12.6 1.8 10.8 5.7 1.7 4.3 2.5 1.2 0.8 1.5 7.2 16.1 2.4 1.9 7.6 9.2 8.3 6.4 2.6 7.1 20.8 2.1 11.0 2.2 5.4 9.3 7.1 10.8 2.9 5.2 0.3 11.0 3.3 4.6 3.9 6.4 5.8 6.8 12.1 9.4 15.2 3.1 6.9 5.9 1.4 0.7 1.0 0.4 0.3 0.9 1.2 1.0 1.2 0.6 4.1 1.5 0.7 0.0 0.4 0.4 1.3 0.9 0.3 1.1 1.2 2.0 1.9 2.4 0.8 1.5 1.0 1.7 1.6 1.1 1.5 1.7 0.2 3.2 0.0 0.0 3.0 0.0 0.1 0.0 8.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.5 0.3 0.6 0.0 4.6 0.0 0.2 0.3 1.2 8.6 0.5 0.0 0.2 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 14.7 0.1 0.4 1.1 0.0 0.0 0.0 0.1 0.8 0.2 0.1 17.7 0.4 0.3 1.4 0.1 0.0 0.1 RNASE12 RAI1 ENSG00000258436 "Ribonuclease A family member 12 (inactive)" Q5GAN4 14 20590193-20590823 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 300 "epididymis: 870.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044175, HPA059465" Enhanced "Secreted in male reproductive system" NA NA "HPA044175: AB_10960390, HPA059465: AB_2732638" 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 870.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H2 "C14orf15, OR11H2P, OR11H8P" ENSG00000258453 "Olfactory receptor family 11 subfamily H member 2" Q8NH07 14 19712904-19714332 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL139011.2 ENSG00000258465 "Novel protein" 1 160216800-160285130 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Group enriched" "Detected in some" 10 "Alveolar cells type 2: 2.6;Club cells: 1.8;granulocytes: 5.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Immune cell enriched" "Detected in single" 9 "basophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044837 Uncertain NA NA "HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 0.1 0.0 0.1 0.0 0.2 0.0 0.0 1.0 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 AC005726.1 ENSG00000258472 "Novel protein" 17 28455752-28614185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.2;Club cells: 5.6;granulocytes: 6.3;Proximal tubular cells: 20.4;Respiratory ciliated cells: 5.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 9.6 13.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 2.4 0.0 0.0 5.6 3.7 0.0 1.7 0.5 0.0 1.9 1.2 0.0 1.7 2.4 1.4 0.0 0.0 0.0 2.0 0.8 1.6 0.0 3.2 6.3 2.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 20.4 5.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.3 1.1 1.2 0.0 0.0 SPESP1 SP-ESP ENSG00000258484 "Sperm equatorial segment protein 1" Q6UW49 15 68818221-68946811 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 73.8" "Group enriched" "Detected in many" 4 "Early spermatids: 400.4;Spermatocytes: 455.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045936, HPA051040" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted in male reproductive system" NA NA 52000 "Nucleoplasm, Vesicles" Cytosol "HPA045936: AB_2679504, HPA051040: AB_2681322" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (9.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (5.96e-2)" "unprognostic (2.79e-1)" "unprognostic (2.40e-1)" "unprognostic (8.99e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (9.67e-2)" 2.2 3.4 1.1 0.9 1.1 0.4 2.2 1.1 1.5 1.1 0.9 1.4 1.2 1.5 6.4 2.6 1.9 3.6 2.8 1.0 1.2 1.8 1.2 1.1 0.8 1.3 1.2 0.8 3.4 1.9 4.8 1.2 13.0 1.2 3.5 1.1 2.9 1.9 2.9 1.6 1.0 0.9 1.2 1.3 1.3 1.6 73.8 1.1 1.0 1.9 2.0 0.7 2.4 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 17.8 18.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.7 5.0 0.0 0.0 0.0 0.0 6.3 0.0 13.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 2.9 0.0 0.0 3.3 15.9 0.0 0.0 1.4 0.0 26.8 0.2 19.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 31.6 1.1 1.3 0.4 0.2 1.1 0.5 0.5 0.4 0.3 0.8 0.3 0.3 0.5 0.5 0.2 0.8 0.4 0.4 0.5 1.1 1.1 1.1 1.5 1.0 1.2 1.3 1.2 0.8 1.2 1.3 1.1 1.5 5.1 0.0 0.0 0.0 0.2 1.9 3.0 23.7 1.8 1.0 2.7 4.1 4.1 1.5 4.0 7.3 4.2 92.3 0.3 0.2 1.9 2.1 400.4 3.9 3.4 3.6 1.8 0.8 0.0 2.7 7.2 5.5 0.0 2.0 0.0 1.7 2.2 1.8 7.8 0.0 0.0 0.9 6.1 2.1 3.3 90.3 21.1 1.2 5.4 0.0 1.0 5.3 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.3 0.0 3.9 6.3 5.6 46.0 3.4 4.2 455.0 88.7 1.1 2.3 62.1 0.5 11.1 0.2 1.5 AP001781.2 ENSG00000258529 "Novel protein" 11 111786286-111879425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;HeLa: 3.0" HPA038575 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038575: AB_10672718" 0.6 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.6 0.0 0.0 0.7 0.7 0.4 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.2 0.7 0.0 0.2 0.1 0.3 0.3 1.1 0.1 0.4 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.0 0.7 0.1 0.8 0.0 0.1 0.0 2.8 0.0 0.1 0.5 0.0 0.8 1.0 0.0 0.0 0.6 0.2 0.0 1.7 3.0 0.2 0.0 0.0 0.3 1.0 1.0 0.7 1.5 0.4 0.0 1.0 0.1 1.0 0.0 0.0 0.6 1.3 0.2 0.0 0.0 0.0 0.0 1.1 0.4 0.9 0.0 0.0 0.7 0.0 0.1 0.0 0.6 0.6 0.0 1.2 0.3 0.5 0.1 0.8 0.7 2.1 0.3 1.5 0.2 0.3 0.5 0.5 1.2 0.6 0.8 0.5 0.7 0.7 0.6 0.6 1.3 0.6 0.0 0.7 0.5 0.7 0.2 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "A549: 4.8" HPA077996 Uncertain Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BCL2L2-PABPN1 ENSG00000258643 "BCL2L2-PABPN1 readthrough" Q92843 14 23306833-23326175 "Cancer-related genes, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 10.1;Excitatory neurons: 10.9;Inhibitory neurons: 14.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 13.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000637, HPA048740" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553, HPA048740: " "unprognostic (1.32e-2)" "unprognostic (8.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-3)" "unprognostic (9.82e-3)" "unprognostic (2.85e-2)" "unprognostic (1.05e-6)" "unprognostic (4.39e-2)" "unprognostic (1.67e-1)" "unprognostic (1.84e-3)" "unprognostic (7.61e-2)" "unprognostic (3.47e-2)" "unprognostic (1.72e-7)" "unprognostic (3.13e-2)" "unprognostic (8.77e-2)" "unprognostic (3.46e-3)" "unprognostic (4.95e-2)" 7.6 4.2 7.7 4.3 9.6 10.8 9.7 7.8 20.7 11.0 2.7 12.4 10.5 8.4 2.0 11.7 10.9 11.0 7.3 9.0 8.5 3.3 4.3 7.3 4.3 9.5 8.6 12.5 4.7 12.5 8.0 7.1 10.9 13.9 12.2 6.4 5.7 25.1 22.3 4.9 11.0 8.9 7.8 11.3 6.1 10.4 12.6 11.4 1.2 8.8 0.9 4.2 13.5 7.5 17.2 11.4 18.0 15.2 31.3 15.3 29.3 14.0 13.4 27.3 39.8 44.2 10.1 38.0 3.5 4.0 21.2 22.5 24.2 16.9 21.4 17.9 8.5 21.6 4.7 11.2 26.0 14.5 10.0 29.7 37.4 29.7 17.6 6.1 27.3 14.7 0.2 8.2 8.2 19.3 18.1 0.4 7.5 17.3 10.3 18.2 7.9 4.0 5.9 10.3 10.1 16.0 10.0 9.8 22.6 15.2 10.8 8.7 8.2 15.4 18.7 8.4 17.1 12.8 4.9 6.6 1.1 25.2 10.5 19.4 0.8 2.5 0.1 0.1 1.2 0.0 0.5 0.0 0.0 0.8 1.0 0.1 0.0 0.5 1.6 1.4 0.4 0.0 0.6 7.7 9.6 7.8 20.7 9.0 8.5 9.5 8.6 12.5 13.9 11.3 11.4 17.2 0.0 3.2 3.9 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 10.9 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.8 0.0 0.0 0.0 16.6 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 SYNJ2BP-COX16 ENSG00000258644 "SYNJ2BP-COX16 readthrough" 14 70326064-70417074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.4" "Cell type enhanced" "Detected in some" "Erythroid cells: 4.8;Excitatory neurons: 3.1;Inhibitory neurons: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 10.1;U-2 OS: 10.6" "Low region specificity" "Detected in all" "HPA000866, HPA062659" Approved Supported Approved Mitochondria NA NA Mitochondria "HPA000866: AB_2276678, HPA062659: AB_2684823" "unprognostic (9.44e-2)" "unprognostic (2.42e-1)" "unprognostic (4.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (8.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-2)" "unprognostic (3.00e-1)" "unprognostic (2.21e-2)" "unprognostic (6.41e-2)" "unprognostic (6.73e-4)" "unprognostic (6.68e-2)" "unprognostic (6.93e-2)" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" 2.5 2.8 0.9 1.4 1.0 0.4 2.2 1.1 2.5 2.3 1.0 2.5 1.1 2.7 0.8 1.8 1.8 0.8 4.0 0.9 1.1 2.4 2.3 2.1 1.7 1.1 1.0 0.9 2.8 0.7 1.3 1.7 1.0 1.1 1.9 0.7 0.7 1.2 0.5 3.2 1.2 1.4 1.5 1.0 2.0 2.1 11.4 1.0 2.4 1.7 2.4 1.1 2.5 1.8 0.9 5.9 1.6 3.4 1.2 0.0 0.2 2.3 6.2 0.5 2.7 2.4 0.6 7.4 0.0 4.6 0.0 4.9 4.7 0.0 1.1 2.0 0.7 2.0 0.0 1.0 2.5 2.6 0.0 1.2 0.0 1.4 2.3 0.0 4.2 1.9 4.7 0.0 0.5 1.6 0.4 3.6 1.1 1.6 10.1 1.8 4.7 0.7 2.9 1.4 2.3 2.9 4.7 1.1 2.2 3.5 4.2 2.2 2.9 0.0 2.9 10.6 0.0 3.2 0.3 2.6 0.0 5.3 0.0 4.0 1.6 8.9 0.1 11.1 11.2 11.5 14.4 12.1 11.0 12.0 13.6 11.4 10.8 0.0 15.1 5.7 9.2 12.8 7.9 0.9 1.0 1.1 2.5 0.9 1.1 1.1 1.0 0.9 1.1 1.0 1.0 0.9 0.6 0.0 0.5 1.0 1.1 0.0 0.1 0.0 1.2 0.3 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.3 1.4 0.0 1.9 0.4 1.6 2.0 0.7 1.8 0.0 4.8 3.1 0.8 0.4 1.1 1.1 2.6 0.0 0.3 0.7 0.7 0.2 0.0 2.7 0.0 0.0 0.8 0.0 0.9 0.6 1.0 0.0 0.0 0.1 0.3 2.1 0.5 0.6 0.3 0.1 0.4 2.4 0.0 0.2 0.6 0.0 0.3 0.0 0.2 0.9 1.0 0.2 1.5 0.0 0.3 0.6 0.2 0.4 0.0 TRIM34 RNF21 ENSG00000258659 "Tripartite motif containing 34" Q9BYJ4 11 5619764-5644398 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "B-cells: 6.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 4.6;Macrophages: 1.8;Squamous epithelial cells: 4.3;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 22.9;SK-BR-3: 24.6" "Low region specificity" "Detected in all" HPA077996 Approved Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" "unprognostic (8.66e-3)" "unprognostic (9.94e-2)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.71e-1)" "unprognostic (5.88e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.74e-1)" "unprognostic (9.16e-3)" "unprognostic (8.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.40e-1)" "unprognostic (6.76e-2)" 5.2 8.7 1.4 9.2 1.5 2.1 6.3 1.3 1.8 5.0 1.8 7.0 7.5 5.3 6.8 4.6 5.6 6.3 2.9 1.3 2.4 4.6 5.2 8.5 12.2 1.8 1.6 1.0 8.2 3.1 3.2 2.3 9.7 1.7 4.9 7.4 0.5 7.5 4.8 1.0 6.1 7.6 6.4 1.9 13.7 6.9 2.6 1.5 6.3 4.5 2.2 12.3 6.2 5.0 2.3 3.3 1.7 0.7 0.1 7.3 11.3 22.9 5.0 14.5 12.7 12.3 1.5 11.6 11.8 2.2 6.8 9.5 5.3 0.4 10.8 6.4 15.7 0.5 6.3 0.5 0.7 3.3 7.0 4.3 11.9 9.1 6.4 2.1 9.9 16.6 10.3 0.3 0.8 6.1 1.4 6.3 3.9 0.0 4.7 1.0 9.3 0.4 0.7 7.7 9.1 0.0 0.0 0.1 24.6 3.7 2.1 4.3 3.3 13.4 3.3 0.5 1.3 1.8 1.2 1.5 4.5 9.4 0.9 1.6 11.7 18.7 4.7 6.6 20.5 7.3 15.0 6.3 8.3 20.2 16.0 7.7 6.8 19.0 8.0 18.1 10.1 12.2 10.5 1.4 1.5 1.3 1.8 1.3 2.4 1.8 1.6 1.0 1.7 1.9 1.5 2.3 0.2 0.0 0.5 0.0 6.2 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.2 1.0 0.0 1.3 0.0 0.0 0.5 1.3 4.6 0.1 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 0.4 2.1 0.2 0.3 0.1 AC011448.1 ENSG00000258674 "Novel protein" 19 19516227-19536076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 16.0;Alveolar cells type 2: 19.9;Club cells: 9.3;granulocytes: 8.8;Respiratory ciliated cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 17.7" "Low region specificity" "Detected in many" NA NA "unprognostic (8.39e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-3)" "unprognostic (5.40e-3)" "unprognostic (1.61e-1)" "unprognostic (2.85e-2)" "unprognostic (1.77e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.41e-2)" "unprognostic (6.73e-5)" "unprognostic (7.15e-2)" "unprognostic (5.78e-2)" "unprognostic (1.62e-2)" "unprognostic (3.46e-1)" "unprognostic (5.89e-2)" "unprognostic (2.89e-2)" 1.9 1.5 6.1 1.1 8.7 1.5 1.8 3.1 7.4 2.2 1.2 3.4 0.9 2.1 2.1 2.0 2.9 0.3 5.0 9.3 3.3 2.9 2.6 1.8 0.9 6.7 2.8 5.9 2.5 2.6 0.7 2.5 0.7 4.9 3.4 0.6 0.6 1.7 0.6 4.4 1.9 2.6 0.5 2.3 2.6 2.4 5.4 3.8 0.8 2.6 1.6 0.4 2.8 2.1 4.7 2.3 2.1 2.6 1.8 1.7 1.9 17.7 1.3 1.9 1.5 1.7 3.0 4.1 2.9 6.1 1.1 1.1 3.4 1.2 1.2 0.4 2.2 10.3 1.2 2.3 0.9 1.7 1.3 2.7 1.4 1.3 1.8 0.4 0.6 1.0 2.4 3.4 2.3 0.9 4.0 1.4 5.0 10.0 1.8 5.6 5.5 1.3 1.8 1.8 2.2 1.9 3.2 1.9 0.7 1.9 0.9 2.9 4.4 1.0 2.9 3.0 6.7 2.9 6.6 3.6 2.4 1.5 5.4 1.6 4.2 4.0 3.3 2.6 4.5 2.2 4.5 3.3 2.8 3.8 4.0 2.8 2.8 1.3 2.4 3.8 3.1 4.9 7.6 6.1 8.7 3.1 7.4 9.3 3.3 6.7 2.8 5.9 4.9 2.3 3.8 4.7 0.0 16.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 AL355102.2 ENSG00000258691 "Novel protein" 14 96204844-96263929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.0;HaCaT: 2.8;hTCEpi: 1.9" NA NA "unprognostic (6.82e-2)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (6.16e-3)" "unprognostic (7.02e-2)" "unprognostic (5.97e-2)" "unprognostic (4.71e-2)" "unprognostic (2.46e-1)" "unprognostic (3.57e-3)" "unprognostic (9.07e-2)" 0.6 0.0 0.1 0.1 0.2 0.0 0.3 0.5 0.5 1.0 0.0 0.9 0.2 0.2 0.0 2.4 0.4 0.6 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.5 0.1 0.2 0.6 0.6 0.6 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.4 1.6 1.6 0.5 0.2 1.0 0.0 0.0 0.0 1.7 0.0 1.3 5.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.5 2.8 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.6 1.9 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.5 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.5 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf141 dJ860F19.4 ENSG00000258713 "Chromosome 20 open reading frame 141" Q9NUB4 20 2814987-2815833 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "testis: 131.3" "Group enriched" "Detected in some" 181 "Early spermatids: 1196.9;Late spermatids: 4648.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 21.6" "Not detected" "Not detected" NA NA "unprognostic (4.52e-1)" "unprognostic (1.40e-2)" "unprognostic (1.35e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-2)" 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 131.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1196.9 0.1 1.3 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4648.3 12.8 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.0 0.0 16.1 9.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1" ENSG00000258724 "PIN2 (TERF1) interacting telomerase inhibitor 1" 8 10725399-10839847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "vagina: 5.6" "Cell type enhanced" "Detected in many" "Early spermatids: 37.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.9" HPA009065 Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (2.57e-1)" "unprognostic (6.34e-2)" 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.4 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 3.2 6.7 12.4 10.4 26.6 20.7 12.0 14.2 5.6 0.0 0.0 0.0 8.6 8.2 3.7 12.5 0.0 4.0 6.9 11.7 0.0 37.0 0.0 0.0 7.3 8.4 6.9 25.0 0.0 0.0 5.3 7.7 0.0 14.0 0.0 12.5 7.0 0.0 3.3 22.4 5.0 8.2 5.4 10.3 32.7 9.3 3.9 7.2 13.1 3.3 9.0 7.2 17.6 15.3 0.0 5.3 6.4 14.0 20.2 6.5 13.3 7.0 22.1 0.0 12.5 5.5 21.5 22.7 12.0 28.6 0.0 8.3 0.0 9.6 8.9 AL162231.3 ENSG00000258728 "Novel protein (GALT-IL11RA readthrough)" 9 34646645-34657113 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C13 ENSG00000258817 "Olfactory receptor family 4 subfamily C member 13" Q8NGP0 11 49952391-49953419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE4 RAB1 ENSG00000258818 "Ribonuclease A family member 4" P34096 14 20684560-20701216 "Plasma proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 482.7" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 67.3;Gastric mucus-secreting cells: 47.4;Hepatocytes: 55.8;Intestinal goblet cells: 110.0" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 92.6;ASC TERT1: 107.2;Hep G2: 136.9;HSkMC: 63.1;OE19: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 61000000 "unprognostic (1.07e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-2)" "unprognostic (3.18e-4)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "prognostic favorable (9.62e-5)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (6.88e-2)" "unprognostic (3.71e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (1.57e-1)" "unprognostic (9.16e-2)" "unprognostic (4.27e-2)" 98.3 7.9 6.1 8.9 5.6 1.2 97.4 5.7 8.4 94.5 8.8 57.0 22.2 59.7 37.3 20.2 78.0 56.1 32.9 5.4 11.0 40.6 482.7 40.7 12.3 6.9 6.1 4.8 112.7 41.3 14.8 12.6 5.7 6.5 77.4 65.8 4.8 75.4 46.2 14.3 46.2 42.2 26.1 6.8 11.9 85.4 10.6 5.3 5.9 26.7 31.8 10.7 65.9 76.5 7.8 2.7 12.1 2.6 0.1 92.6 107.2 0.5 10.5 23.8 1.4 4.5 3.4 4.1 0.1 2.9 24.6 6.2 2.5 1.4 2.6 1.7 17.2 1.8 0.3 2.9 136.9 10.2 1.3 0.6 63.1 5.8 1.6 10.3 34.6 12.6 4.2 0.1 12.2 6.9 1.5 1.0 0.2 0.5 92.3 10.3 0.6 2.1 3.6 2.9 2.4 0.1 0.5 5.0 2.3 2.6 4.2 3.4 0.2 13.3 3.0 1.7 4.1 0.3 2.6 3.5 0.4 4.7 1.3 2.7 0.2 24.1 0.1 0.8 1.2 1.0 5.3 1.5 0.6 13.8 4.9 0.3 0.6 0.6 0.6 0.1 3.3 3.3 8.4 6.1 5.6 5.7 8.4 5.4 11.0 6.9 6.1 4.8 6.5 6.8 5.3 7.8 1.8 38.5 19.1 2.0 3.4 2.8 1.7 2.5 11.4 0.0 9.9 2.5 0.2 28.6 4.7 3.7 0.0 0.2 0.3 30.4 0.0 34.4 0.2 0.1 0.8 4.0 67.3 8.4 0.1 22.2 0.4 39.2 47.4 0.8 1.3 0.3 5.0 55.8 1.6 0.0 0.2 110.0 2.0 6.2 4.0 0.3 12.5 3.6 3.6 1.9 2.7 1.3 1.0 0.0 0.9 12.8 33.2 4.1 5.9 1.7 41.7 10.2 11.6 0.3 0.0 2.6 8.1 0.2 0.1 10.2 4.1 0.4 0.8 0.1 39.6 1.5 MC1R MSH-R ENSG00000258839 "Melanocortin 1 receptor" Q01726 16 89912119-89920973 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 28.1;testis: 29.2" "Cell type enhanced" "Detected in many" "granulocytes: 17.2;Melanocytes: 17.8;Spermatocytes: 10.6" "Cancer enriched" "Detected in many" 5 "melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 23.0;SK-MEL-30: 47.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.90e-2)" "unprognostic (9.05e-2)" "unprognostic (5.39e-7)" "unprognostic (5.00e-2)" "unprognostic (1.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.00e-2)" "unprognostic (1.73e-1)" "unprognostic (1.55e-2)" "unprognostic (8.26e-2)" "prognostic favorable (7.88e-4)" "unprognostic (1.02e-2)" "unprognostic (5.20e-3)" "unprognostic (4.25e-2)" "unprognostic (5.17e-2)" "unprognostic (2.58e-2)" "unprognostic (1.16e-2)" 3.5 4.5 6.9 2.1 7.2 1.0 3.3 9.7 8.3 6.3 4.5 5.3 1.9 5.1 2.7 2.6 8.8 3.0 4.4 7.1 7.1 8.4 2.6 4.2 1.9 7.7 6.2 6.1 7.9 3.5 0.6 28.1 3.2 8.3 10.0 0.9 3.1 5.2 1.8 1.2 7.3 5.3 2.1 5.8 4.5 3.8 29.2 6.6 1.0 15.9 0.2 1.0 6.2 4.7 7.4 3.3 14.6 2.4 3.8 2.4 4.5 3.3 4.4 3.9 3.2 2.0 3.9 3.6 2.8 6.2 4.7 1.6 7.4 1.5 1.1 1.2 1.6 4.2 0.6 5.8 11.0 0.6 0.8 3.3 6.5 2.0 4.3 1.3 2.8 2.8 0.9 3.1 3.5 2.2 23.0 0.1 20.9 3.0 3.6 2.8 1.7 3.1 2.6 2.7 1.8 4.8 2.5 4.9 1.8 47.6 1.5 20.3 3.3 1.9 4.6 9.8 2.2 1.6 14.0 8.5 1.3 5.9 10.1 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 7.2 9.7 8.3 7.1 7.1 7.7 6.2 6.1 8.3 5.8 6.6 7.4 1.0 3.2 1.7 2.3 1.0 2.3 0.8 1.2 0.0 7.1 2.4 1.3 0.9 1.5 1.6 1.8 8.4 1.3 1.6 2.0 0.0 0.9 1.0 2.2 2.8 1.5 4.2 0.4 2.2 1.8 2.3 2.0 5.1 2.8 17.2 0.7 2.9 2.2 0.8 6.7 2.3 2.3 2.0 0.6 1.0 1.0 0.6 1.1 17.8 1.0 0.2 2.0 2.1 2.0 1.0 1.2 1.5 0.4 0.8 1.5 2.1 0.3 1.9 2.6 0.0 1.6 1.7 10.6 2.8 1.2 2.4 4.5 1.2 0.6 1.9 0.9 DUXA ENSG00000258873 "Double homeobox A" A6NLW8 19 57154021-57167485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059358 Uncertain NA NA "HPA059358: AB_2683989" "unprognostic (2.34e-1)" 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.6 0.2 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007040.2 ENSG00000258881 "Novel protein" 2 70939318-70995336 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;retina: 1.4" "Cell type enriched" "Detected in single" 4 "Cytotrophoblasts: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.1;JURKAT: 2.4;U-2 OS: 2.1" NA NA "unprognostic (1.86e-1)" "unprognostic (2.94e-1)" "unprognostic (7.99e-4)" "unprognostic (1.36e-1)" "unprognostic (9.49e-2)" "unprognostic (1.78e-3)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (2.93e-1)" "unprognostic (2.53e-9)" "unprognostic (6.54e-2)" "unprognostic (7.86e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" 0.1 0.0 0.7 0.1 0.6 0.2 0.1 1.3 1.1 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.7 0.4 0.1 0.0 0.0 0.1 0.7 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.3 0.0 0.2 0.5 0.0 0.0 0.2 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.1 0.1 0.6 0.1 0.1 0.4 0.0 0.0 0.2 0.2 0.1 0.1 1.6 0.1 0.2 3.1 0.2 0.4 0.0 0.3 1.3 1.0 1.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.6 2.4 0.1 0.4 0.2 0.3 0.1 0.1 0.1 0.2 0.1 1.3 0.4 0.0 0.3 0.1 0.1 0.1 0.2 0.2 0.5 0.0 0.3 0.0 0.4 1.2 2.1 0.3 1.0 0.1 0.0 0.0 1.3 0.5 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.6 1.3 1.1 0.7 0.4 0.7 0.5 0.6 0.9 0.2 0.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506865-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052426, HPA052428, HPA061371" Approved Uncertain "Centriolar satellite,Cytosol" NA No Cytosol "Centriolar satellite" "HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 8.5 6.5 12.0 11.8 10.8 42.9 17.7 20.0 12.3 12.9 14.0 11.8 13.6 23.6 16.0 9.5 16.8 13.1 8.5 9.2 11.2 10.5 11.4 11.4 20.3 10.1 12.2 7.3 25.8 14.5 10.5 6.3 9.6 11.0 14.8 14.7 40.8 9.7 11.8 9.6 23.3 11.9 12.6 11.1 14.1 14.1 19.2 8.9 19.1 21.5 6.9 16.6 9.8 8.0 16.8 18.5 10.7 26.3 22.8 8.6 15.4 23.7 9.6 10.9 12.8 16.9 14.4 11.3 28.7 6.1 13.3 13.2 25.3 21.2 15.9 24.9 7.3 15.6 27.2 28.2 30.8 21.1 28.9 15.3 18.9 19.8 14.2 30.7 18.5 10.9 29.1 31.5 21.5 12.5 21.4 40.3 23.4 14.8 20.9 14.2 31.6 46.1 21.0 16.5 28.4 14.9 28.0 11.8 22.0 30.2 39.1 20.2 25.0 12.7 27.6 23.9 11.5 13.1 23.6 18.5 31.4 11.6 21.5 19.0 0.6 2.7 2.1 2.9 2.9 7.1 3.5 3.6 4.3 3.0 3.7 5.9 4.0 0.9 2.0 2.8 2.9 3.2 1.8 12.0 10.8 20.0 12.3 9.2 11.2 10.1 12.2 7.3 11.0 11.1 8.9 16.8 14.9 41.7 26.3 44.7 29.4 16.2 25.6 14.3 40.5 29.9 17.9 20.2 17.6 14.3 29.4 3.7 45.9 9.4 25.1 18.1 7.9 18.6 58.0 45.9 28.9 13.8 7.7 26.5 47.5 11.8 10.8 23.5 18.8 44.8 29.7 31.9 13.2 8.9 8.5 18.5 56.2 13.8 8.2 10.3 12.8 18.5 20.8 16.6 12.4 23.4 15.2 21.3 15.5 42.7 46.7 14.1 10.4 21.4 21.1 15.4 20.2 6.8 53.1 84.8 13.1 41.3 21.6 38.8 27.5 28.4 20.3 6.6 23.7 23.8 19.7 21.9 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 266.6" "Cell type enhanced" "Detected in some" "Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.5" "Cell line enhanced" "Detected in many" "A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA 89000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.8 25.1 92.6 12.2 90.8 3.5 2.2 99.7 128.7 2.8 0.2 15.5 3.7 9.8 0.2 3.7 2.3 8.8 5.4 76.8 166.1 6.5 0.9 4.1 7.2 173.8 152.4 98.0 3.9 3.3 0.4 55.5 1.8 211.5 3.0 2.6 25.0 10.6 0.4 0.6 5.0 8.1 12.8 70.2 1.3 7.3 38.3 196.3 1.0 2.5 0.3 5.2 7.3 5.3 266.6 30.1 421.3 152.6 173.9 17.9 170.8 6.8 181.0 31.0 105.8 48.2 57.2 53.5 89.6 93.6 136.8 74.3 112.1 148.9 26.7 26.3 22.7 15.5 0.7 32.5 383.7 6.0 0.0 67.6 98.4 7.9 161.9 14.0 136.8 88.4 5.9 9.2 2.5 122.3 288.6 1.2 31.5 274.3 11.2 237.3 0.1 54.1 9.5 131.8 8.1 424.9 433.8 251.2 4.4 137.1 27.5 15.0 1.9 110.9 142.8 156.9 197.3 185.3 1.4 19.6 35.2 150.2 11.5 260.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 92.6 90.8 99.7 128.7 76.8 166.1 173.8 152.4 98.0 211.5 70.2 196.3 266.6 0.4 0.0 0.0 20.2 0.0 0.0 0.0 0.0 3.4 1.8 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 28.7 8.2 0.5 2.6 3.8 4.9 0.0 37.9 21.4 0.7 6.1 27.0 0.7 0.0 0.0 0.0 0.0 0.2 5.0 45.1 0.1 0.0 0.0 0.0 16.8 0.3 0.2 0.0 9.4 0.0 0.3 0.0 16.1 9.2 49.2 0.0 0.4 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.1 0.2 0.4 3.0 0.0 1.0 0.1 0.0 0.2 0.0 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 28.7;pituitary gland: 88.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 58.1;Horizontal cells: 65.6" "Group enriched" "Detected in some" 4 "glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 0.2 11.5 15.1 0.4 17.8 0.0 0.1 10.2 28.7 0.0 3.2 3.1 0.2 0.1 0.4 0.1 0.3 0.1 0.7 16.4 20.6 0.5 0.5 0.1 0.0 25.6 22.8 17.5 0.1 4.0 0.1 88.8 0.8 25.7 0.8 0.2 6.3 0.1 0.1 0.1 0.0 1.5 0.3 9.5 0.0 1.3 5.2 19.0 0.0 0.1 0.0 0.0 0.1 0.8 26.7 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 37.3 11.6 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 17.8 10.2 28.7 16.4 20.6 25.6 22.8 17.5 25.7 9.5 19.0 26.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 1.2 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 65.6 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 1.5 0.0 7.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.7 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AL355916.3 ENSG00000258989 "Novel protein" 14 61529128-61657964 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 12.8;Alveolar cells type 2: 12.9;Club cells: 5.0;granulocytes: 6.3;Respiratory ciliated cells: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 15.8;LHCN-M2: 17.9;U-2 OS: 28.1" NA NA 2.0 1.4 8.5 1.6 11.3 7.8 1.2 25.5 26.3 1.4 5.5 1.0 3.2 1.8 7.7 0.8 1.5 1.3 0.7 10.2 6.4 1.7 1.5 1.4 1.6 9.2 12.0 5.6 1.7 1.4 1.1 0.0 2.0 14.2 1.7 1.1 9.7 2.6 1.5 3.4 2.4 1.6 0.8 2.1 2.2 1.8 3.3 7.2 1.7 1.1 1.4 1.3 0.6 0.0 26.5 2.8 0.0 1.5 1.7 0.6 0.5 3.1 2.1 0.3 0.8 0.6 0.1 1.7 1.5 15.8 0.6 9.2 1.8 0.3 0.4 0.6 1.7 1.6 1.7 3.5 3.0 0.8 2.0 1.4 1.5 0.3 1.7 1.6 3.9 0.2 1.8 1.1 2.3 17.9 1.8 3.0 3.2 3.1 1.1 1.7 1.8 4.9 2.0 0.8 3.3 7.7 3.4 9.7 6.1 1.7 2.4 5.1 3.4 2.8 2.0 28.1 13.2 2.6 3.5 2.7 1.2 5.3 1.1 2.4 0.8 0.4 1.6 1.6 0.2 0.7 0.3 1.1 1.4 0.2 0.4 1.4 1.8 1.5 1.3 0.2 0.4 1.4 0.5 8.5 11.3 25.5 26.3 10.2 6.4 9.2 12.0 5.6 14.2 2.1 7.2 26.5 0.0 12.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 TSPY1 "CT78, TSPY" ENSG00000258992 "Testis specific protein Y-linked 1" Q01534 Y 9466955-9469749 "Disease related genes, Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 75 "testis: 7.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 366 "U-266/70: 248.7;U-266/84: 249.2" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 248.7 249.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TVP23C-CDRT4 FAM18B2-CDRT4 ENSG00000259024 "TVP23C-CDRT4 readthrough" 17 15436021-15563561 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "Astrocytes: 16.0;Excitatory neurons: 18.0;Inhibitory neurons: 23.9;Microglial cells: 21.5;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 29.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 35.1" HPA065603 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA065603: AB_2685517" "unprognostic (3.95e-3)" "unprognostic (1.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.59e-1)" "unprognostic (8.67e-3)" "unprognostic (9.05e-2)" "unprognostic (4.71e-2)" "unprognostic (9.40e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (2.07e-1)" "unprognostic (2.08e-1)" 3.1 6.0 1.4 1.6 1.3 1.4 2.3 1.5 2.4 5.4 2.5 2.4 3.5 3.4 6.0 3.2 5.9 2.2 2.1 1.0 2.4 3.2 1.3 1.8 1.8 1.9 1.9 1.0 5.7 4.9 5.3 5.1 3.1 2.3 3.6 2.5 8.4 5.2 4.4 1.4 2.0 4.0 2.1 1.9 1.9 3.1 0.1 1.5 2.3 5.9 1.2 2.9 2.1 2.4 2.3 6.3 4.8 3.8 7.0 3.5 4.3 9.1 3.9 15.8 7.0 8.2 5.2 1.1 0.0 8.2 8.5 2.6 5.5 4.3 3.5 6.7 7.4 3.8 2.3 3.6 9.5 8.3 3.0 6.4 3.0 1.6 4.1 16.8 18.4 6.6 3.9 3.4 3.0 2.2 2.6 4.4 6.6 2.9 4.6 3.3 0.7 0.0 0.0 3.8 4.0 2.3 5.6 4.0 0.8 2.1 35.1 3.1 1.8 2.8 0.3 2.7 1.9 2.7 6.4 3.6 0.0 0.7 0.0 1.0 5.3 0.4 5.1 2.8 0.2 3.1 1.2 2.3 2.6 1.1 0.7 1.4 1.7 0.1 3.3 0.2 1.3 2.3 1.1 1.4 1.3 1.5 2.4 1.0 2.4 1.9 1.9 1.0 2.3 1.9 1.5 2.3 0.3 0.0 2.0 16.0 0.1 0.0 0.1 0.0 1.2 0.4 0.2 0.3 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.1 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 18.0 0.0 0.4 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.5 0.0 0.0 0.0 29.1 29.5 0.0 0.0 0.0 0.9 0.3 0.0 0.1 2.2 0.2 0.0 0.0 0.1 1.0 0.5 0.4 0.0 0.3 0.5 0.2 0.0 0.3 FPGT-TNNI3K ENSG00000259030 "FPGT-TNNI3K readthrough" 1 74198235-74544393 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 8.8" "Cell type enhanced" "Detected in many" "Astrocytes: 13.1;Cardiomyocytes: 10.2;Cone photoreceptor cells: 10.4;Excitatory neurons: 10.3;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.3;CAPAN-2: 2.2;SiHa: 3.1" HPA072331 Approved Vesicles NA NA Vesicles "HPA072331: " "unprognostic (6.29e-2)" "unprognostic (4.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.24e-1)" "unprognostic (3.44e-3)" "unprognostic (8.37e-2)" "unprognostic (1.70e-2)" "unprognostic (6.63e-2)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (8.37e-2)" "unprognostic (6.76e-3)" "unprognostic (3.20e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (7.87e-3)" 2.5 1.2 0.7 0.5 1.3 0.4 1.5 2.9 1.9 1.1 0.0 1.5 0.3 1.4 0.8 1.4 1.4 0.8 8.8 0.9 0.9 1.6 0.4 1.4 0.6 1.4 1.5 0.8 1.3 0.5 1.0 1.4 0.5 1.7 1.2 0.7 3.4 0.9 1.3 3.5 2.1 0.8 1.5 1.1 1.5 1.0 0.8 0.9 0.2 1.1 1.8 0.7 1.3 1.1 2.3 0.0 0.5 0.3 0.7 0.4 2.3 0.0 1.0 0.5 0.1 0.1 0.5 2.2 0.0 1.5 0.1 0.0 0.0 0.1 1.5 0.2 0.0 0.0 0.8 0.0 0.0 0.3 0.2 0.1 0.9 0.9 0.0 0.1 0.3 0.1 0.1 0.0 0.8 0.5 0.0 0.0 0.1 0.0 0.8 0.4 1.1 1.8 0.0 0.2 0.0 0.5 1.5 3.1 0.1 0.1 0.0 0.0 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.9 0.4 0.5 0.4 1.3 1.6 1.4 0.4 1.9 1.2 0.9 1.4 0.8 0.9 0.9 1.8 0.9 1.8 0.4 0.5 0.8 1.6 1.6 0.7 1.3 2.9 1.9 0.9 0.9 1.4 1.5 0.8 1.7 1.1 0.9 2.3 0.5 3.2 1.1 13.1 0.9 0.1 0.5 0.2 0.0 4.9 0.6 0.9 10.2 1.5 0.7 0.0 10.4 0.2 0.2 0.5 0.0 0.2 1.4 0.6 0.3 0.9 3.0 0.0 10.3 1.0 0.2 1.3 0.0 0.2 2.5 1.6 1.8 0.5 0.2 5.0 11.2 0.2 0.0 0.9 0.3 0.6 2.8 0.7 1.8 7.5 0.1 1.1 0.0 17.1 26.7 1.3 1.6 0.7 0.3 0.3 0.0 1.4 1.6 2.7 0.0 1.5 1.1 2.1 1.7 0.1 0.1 0.0 0.4 0.8 0.5 0.2 AL163195.3 ENSG00000259060 "Novel protein" 14 20582892-20609795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "epididymis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 AL110118.1 ENSG00000259066 "Novel protein" 14 93184973-93218586 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.50e-2)" "unprognostic (9.26e-2)" "unprognostic (2.37e-1)" "unprognostic (4.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.62e-1)" "unprognostic (2.69e-2)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (3.26e-2)" "unprognostic (3.51e-2)" "unprognostic (5.61e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (1.18e-3)" "unprognostic (6.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POC1B-GALNT4 ENSG00000259075 "POC1B-GALNT4 readthrough" 12 89519408-89526262 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "B-cells: 2.5;Basal squamous epithelial cells: 3.4;Club cells: 3.1;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.6;Glandular and luminal cells: 2.5;Respiratory ciliated cells: 2.9;Squamous epithelial cells: 1.8;T-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 10.2" HPA076116 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (4.91e-2)" "unprognostic (5.00e-2)" "unprognostic (1.26e-1)" "unprognostic (2.77e-6)" "unprognostic (7.99e-2)" "unprognostic (1.55e-2)" "unprognostic (2.26e-1)" "unprognostic (2.64e-1)" "unprognostic (7.67e-2)" "unprognostic (2.44e-1)" "unprognostic (7.72e-3)" "unprognostic (1.95e-1)" "unprognostic (1.61e-4)" "unprognostic (7.65e-3)" "unprognostic (1.05e-1)" "unprognostic (2.15e-2)" "unprognostic (5.16e-2)" 0.9 0.3 0.2 1.6 0.5 2.8 0.4 0.7 0.5 0.5 0.0 0.8 1.7 1.1 0.0 0.5 1.1 1.3 0.4 0.4 0.3 0.5 0.4 0.5 0.9 0.4 0.3 0.0 0.8 0.4 0.5 0.4 0.5 0.5 0.5 1.0 1.3 1.4 0.1 0.8 0.5 0.9 0.4 0.3 0.7 2.0 0.9 0.3 0.4 0.7 0.2 0.5 0.6 0.5 0.6 1.1 1.0 2.2 10.2 0.3 0.2 0.6 0.4 0.9 1.4 1.0 0.9 0.8 0.9 0.2 1.1 0.9 0.8 2.1 0.7 1.5 2.2 1.3 1.6 1.3 1.8 0.0 1.3 1.8 0.0 0.6 1.5 0.8 1.4 1.2 1.6 1.1 0.6 0.4 0.6 1.3 1.5 0.7 2.1 3.9 1.5 1.4 2.6 0.8 1.5 0.9 1.1 1.2 1.0 0.5 0.7 2.0 1.5 1.4 1.5 0.8 0.7 1.2 0.9 1.7 1.2 1.1 1.1 1.4 1.1 0.8 0.8 0.9 0.9 1.5 0.3 0.6 0.7 0.6 0.7 0.7 0.8 1.7 0.8 1.1 0.4 0.7 0.6 0.2 0.5 0.7 0.5 0.4 0.3 0.4 0.3 0.0 0.5 0.3 0.3 0.6 0.3 0.0 0.6 0.0 2.5 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.1 0.0 3.0 0.0 0.0 0.0 0.3 2.6 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 1.8 0.1 0.2 0.1 TRAV30 ENSG00000259092 "T cell receptor alpha variable 30" A0A087WSZ9 14 22168429-22168988 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 13.8" "Cell type enriched" "Detected in single" 11 "T-cells: 2.2" "Cancer enriched" "Detected in many" 6 "renal cancer: 11.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 19 "memory CD4 T-cell: 23.4;memory CD8 T-cell: 21.4;naive CD4 T-cell: 35.5;naive CD8 T-cell: 22.8;T-reg: 42.3" "Lineage enriched" "Detected in many" 28 "T-cells: 42.3" "Group enriched" "Detected in some" 14 "HDLM-2: 13.7;HHSteC: 11.4" NA NA "unprognostic (1.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.34e-2)" "unprognostic (2.37e-2)" "unprognostic (3.75e-3)" "unprognostic (3.51e-1)" "unprognostic (2.35e-2)" "unprognostic (3.56e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-1)" "unprognostic (1.57e-1)" "unprognostic (4.17e-2)" "unprognostic (3.85e-3)" "unprognostic (8.04e-3)" 0.1 0.0 0.0 1.5 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.8 1.4 0.8 0.0 0.2 1.7 0.4 0.0 0.1 0.0 2.2 2.0 0.9 6.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.0 1.6 0.5 0.0 0.0 13.8 0.0 0.3 3.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 1.1 0.0 0.8 0.0 23.4 21.4 0.2 0.0 35.5 22.8 1.4 0.0 0.0 0.2 42.3 11.6 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.0;Club cells: 1.3;Excitatory neurons: 4.0;Inhibitory neurons: 3.2;Melanocytes: 1.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.4;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 58.3;EFO-21: 47.1" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" 6.9 6.5 4.4 3.4 5.5 10.7 6.1 6.0 9.5 3.5 3.2 5.1 12.4 1.9 0.9 4.1 7.2 3.6 10.6 5.6 4.9 2.8 5.7 3.6 7.8 5.0 4.5 4.3 1.7 2.7 4.8 0.3 2.9 4.4 5.2 2.7 1.3 11.7 11.9 11.0 4.9 8.2 3.7 5.0 2.5 7.3 2.3 4.4 10.5 10.2 17.2 3.8 3.6 0.4 5.7 4.6 12.6 4.2 1.2 4.2 2.7 6.4 12.8 13.1 14.8 10.8 58.3 6.1 6.6 47.1 6.8 11.1 5.8 4.5 11.5 1.9 17.2 18.1 3.5 3.9 42.1 26.7 3.0 15.7 3.4 4.8 11.3 3.0 8.6 11.0 28.9 9.0 3.8 10.7 19.9 18.8 13.3 5.9 36.1 27.0 9.8 5.6 23.9 7.1 8.3 4.9 8.0 12.0 2.6 6.3 1.8 7.0 8.5 5.1 3.7 19.4 17.4 5.0 7.5 16.7 14.4 2.5 7.9 5.8 113.1 104.9 108.0 98.8 82.2 84.2 119.8 98.4 93.8 131.3 103.5 89.8 84.1 31.4 69.4 93.3 213.4 135.7 194.6 4.4 5.5 6.0 9.5 5.6 4.9 5.0 4.5 4.3 4.4 5.0 4.4 5.7 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.8 1.0 0.0 0.0 0.0 2.5 2.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.0 SMIM6 "C17orf110, ELN" ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647975 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.3;kidney: 21.7;stomach 1: 33.4;testis: 26.3" "Cell type enhanced" "Detected in many" "Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 42 "plasmacytoid DC: 34.2" "Lineage enriched" "Detected in single" 42 "dendritic cells: 34.2" "Cell line enhanced" "Detected in some" "A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2" HPA065721 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA065721: AB_2685546" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favorable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favorable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favorable (1.64e-4)" 0.1 0.1 4.1 0.8 6.0 1.1 0.1 5.3 5.0 2.4 2.9 6.5 9.6 1.1 2.8 0.1 24.3 9.7 0.0 4.0 4.6 21.7 6.6 2.5 0.4 5.5 6.0 3.3 0.1 5.7 2.1 0.0 0.3 6.2 0.2 6.6 0.1 0.1 1.4 0.1 0.3 5.9 0.1 4.8 0.2 33.4 26.3 5.0 0.1 0.1 0.0 0.3 1.8 0.1 8.7 0.7 11.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 3.3 0.0 8.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 6.7 0.4 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.2 4.2 1.9 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 34.2 0.0 0.3 4.1 6.0 5.3 5.0 4.0 4.6 5.5 6.0 3.3 6.2 4.8 5.0 8.7 0.1 3.2 3.1 0.0 0.9 0.1 3.4 2.3 0.0 0.0 0.2 0.1 0.1 35.8 5.4 35.0 0.0 0.5 9.5 56.2 137.0 35.9 565.7 233.1 2.9 0.8 197.1 0.0 0.0 16.6 3.7 0.3 70.3 22.1 0.0 0.0 0.4 7.0 0.6 0.0 0.0 51.5 8.2 0.0 0.3 1243.9 6.5 1.4 0.0 0.0 1.6 0.0 0.0 0.0 4.5 55.8 129.5 1.9 0.5 2.6 32.7 24.5 38.4 0.0 6.6 0.2 0.4 5.2 2.6 0.0 0.0 4.1 0.9 0.0 4.4 9.6 AL132780.3 ENSG00000259132 "Novel protein" 14 22946270-22982258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "Alveolar cells type 1: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 38.9;MCF7: 23.7" HPA029803 Approved NA NA "HPA029803: AB_10601428" 3.0 4.9 10.1 2.8 9.9 4.7 2.6 9.7 14.0 3.8 9.5 5.7 4.0 2.6 6.8 4.2 4.8 4.2 6.9 10.2 9.9 6.8 7.0 4.0 6.4 10.7 9.9 9.8 7.0 12.9 2.3 3.1 2.8 10.4 4.7 4.0 2.0 3.8 2.1 5.9 6.2 4.2 1.8 10.0 10.2 5.4 3.5 10.4 4.7 3.4 1.5 2.6 3.6 3.0 10.9 4.0 13.0 4.4 0.8 7.1 7.1 6.1 0.0 5.6 3.7 4.1 2.9 0.0 0.0 1.9 9.4 1.3 0.6 2.9 3.9 2.1 0.0 1.6 0.0 7.7 38.9 4.1 4.2 0.1 4.3 8.1 3.5 8.3 8.5 6.9 12.7 0.0 5.6 3.4 23.7 6.2 16.8 2.2 6.4 5.1 5.7 3.9 4.4 14.1 10.8 4.4 1.9 0.0 2.8 1.4 4.7 4.6 7.9 0.1 5.4 2.6 0.6 4.4 4.7 9.4 7.1 0.4 1.7 3.1 0.3 2.8 1.2 1.7 2.5 0.6 1.6 1.0 1.0 2.8 2.3 1.8 1.0 5.8 0.5 1.6 1.4 2.4 1.5 10.1 9.9 9.7 14.0 10.2 9.9 10.7 9.9 9.8 10.4 10.0 10.4 10.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL163636.1 ENSG00000259171 "Novel protein, ANG-RNASE4 readthrough" 14 20684587-20700576 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 116.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "liver cancer: 0.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 9.9;memory B-cell: 3.6;myeloid DC: 5.8" "Group enriched" "Detected in many" 12 "B-cells: 3.6;dendritic cells: 5.8;monocytes: 9.9" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;ASC TERT1: 38.5;Hep G2: 26.0;HSkMC: 16.9;OE19: 75.0" NA NA "unprognostic (1.88e-1)" "unprognostic (3.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-3)" "unprognostic (1.93e-1)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "unprognostic (8.66e-2)" "unprognostic (6.61e-2)" "unprognostic (6.87e-3)" "unprognostic (8.58e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-2)" "unprognostic (5.11e-2)" 45.6 5.8 0.7 6.9 0.6 0.1 35.0 0.6 1.6 29.6 1.3 29.8 26.8 25.3 10.7 11.9 27.6 48.5 11.2 0.6 2.0 15.8 116.0 24.0 5.5 1.0 0.7 0.4 70.3 19.6 3.4 3.2 2.6 1.3 41.8 35.4 0.3 35.4 16.7 6.8 17.4 31.9 18.0 1.2 3.7 58.9 7.2 0.6 1.5 8.3 14.7 5.1 24.9 25.9 1.4 2.6 0.8 2.0 0.0 17.2 38.5 0.0 2.4 6.4 0.0 1.7 0.0 2.7 0.0 0.0 10.2 2.7 0.8 0.6 0.2 0.0 6.4 0.4 0.4 0.0 26.0 1.3 0.0 0.0 16.9 1.4 0.0 0.9 12.1 0.5 1.8 0.0 11.6 2.9 0.0 0.2 0.5 0.0 75.0 0.3 0.3 1.4 2.1 0.1 0.9 0.0 0.2 4.0 1.6 2.0 0.0 1.9 0.2 1.8 3.3 0.6 2.0 0.4 2.2 1.6 0.0 3.2 0.4 3.8 0.0 9.9 0.0 0.0 0.5 0.3 3.6 0.4 0.2 5.8 1.2 0.2 0.0 0.1 0.0 0.0 1.0 0.5 2.4 0.7 0.6 0.6 1.6 0.6 2.0 1.0 0.7 0.4 1.3 1.2 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253827-47313743 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 51.9" "Cell type enhanced" "Detected in some" "Early spermatids: 3.9;Late spermatids: 8.8;Macrophages: 15.8;Proximal tubular cells: 4.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Region enhanced" "Detected in many" "hypothalamus: 7.2" "Group enriched" "Detected in some" 19 "basophil: 5.4;neutrophil: 2.5" "Lineage enriched" "Detected in single" 26 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "EFO-21: 167.8;HEL: 163.4;RPTEC TERT1: 109.8;U-87 MG: 78.3;WM-115: 255.9" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 38000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 7.4 0.6 0.3 9.6 0.8 6.2 5.4 0.7 1.3 3.4 1.6 13.9 3.5 13.3 2.6 4.3 7.6 3.5 4.8 0.3 7.2 13.2 3.4 5.7 0.9 2.2 1.1 0.2 1.6 0.8 1.2 1.2 4.5 1.6 4.9 7.1 0.9 2.6 16.3 1.5 2.4 5.8 23.2 1.0 2.9 3.8 2.5 1.0 0.3 51.9 2.5 1.2 9.7 2.6 0.9 0.1 1.5 0.7 0.1 8.6 3.8 0.1 4.7 23.1 9.6 8.6 0.3 0.1 0.6 167.8 1.2 13.4 0.0 0.1 0.0 12.6 3.4 0.0 163.4 0.5 0.0 7.8 0.0 0.2 3.4 0.0 54.6 1.4 6.7 43.6 2.5 0.5 0.3 2.1 0.0 1.0 0.1 0.1 0.0 0.8 0.0 4.2 0.0 109.8 0.2 0.0 0.5 5.6 0.0 33.2 8.8 0.1 0.2 47.1 2.1 2.4 1.3 11.7 0.2 0.1 1.1 78.3 0.0 255.9 5.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.5 0.1 0.1 0.1 0.0 6.8 0.3 0.8 0.7 1.3 0.3 7.2 2.2 1.1 0.2 1.6 1.0 1.0 0.9 1.3 0.0 0.0 0.0 0.5 0.1 0.2 0.9 0.0 0.0 0.1 0.3 0.8 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 3.9 0.8 0.9 3.1 0.0 0.0 0.4 0.4 0.0 2.1 0.0 0.9 0.0 0.6 1.8 0.7 0.8 0.0 0.6 0.0 0.0 0.3 0.7 8.8 0.3 15.8 0.0 1.0 0.4 0.0 0.0 0.0 0.4 1.5 0.0 1.2 0.0 0.3 0.0 4.6 0.2 0.0 6.6 0.3 2.1 0.0 2.0 0.1 0.4 1.2 0.3 0.4 0.0 0.2 SLC35G6 "AMAC1L3, TMEM21B" ENSG00000259224 "Solute carrier family 35 member G6" P0C7Q6 17 7481332-7483496 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 5.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.81e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (1.65e-3)" "unprognostic (3.29e-1)" "unprognostic (9.19e-3)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (5.21e-2)" "unprognostic (3.79e-2)" "unprognostic (2.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 IGHV4OR15-8 "IGHV4/OR15-8, IGHV4OR158, VSIG6" ENSG00000259261 "Immunoglobulin heavy variable 4/OR15-8 (non-functional)" 15 22184967-22185402 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;lymphoid tissue: 1.4;urinary bladder: 2.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "stomach cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.68e-3)" "unprognostic (9.63e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV2OR16-5 IGHV2/OR16-5 ENSG00000259303 "Immunoglobulin heavy variable 2/OR16-5 (non-functional)" 16 32847713-32848156 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "epididymis: 4.8;intestine: 1.8;lymphoid tissue: 3.2;salivary gland: 1.4;stomach 1: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 2.6;HMC-1: 1.6" NA NA "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 1.7 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.5 0.0 1.4 0.0 0.0 0.1 1.8 0.0 0.0 0.3 5.3 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.0" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 2.5 2.4 1.6 1.1 1.8 8.6 2.5 2.2 1.8 2.3 1.4 1.8 2.0 1.8 1.8 2.8 2.1 1.1 2.5 1.4 1.9 2.0 2.6 3.0 2.4 1.8 1.5 1.2 2.3 1.6 1.1 3.6 1.7 1.9 2.5 2.4 2.9 2.5 1.3 4.1 2.5 1.9 1.6 1.5 3.0 1.8 1.4 1.9 2.2 2.1 1.9 2.7 1.9 2.3 2.3 3.4 4.3 3.1 2.2 1.9 2.1 2.0 1.5 1.5 3.6 2.7 3.5 2.6 2.0 1.3 2.5 2.1 2.2 3.5 1.9 5.4 3.5 7.3 5.9 3.1 4.2 1.9 1.2 3.1 2.8 2.8 2.9 1.8 1.5 4.2 5.9 4.9 2.8 3.2 10.6 5.0 3.9 0.8 6.8 4.7 3.9 2.0 2.8 2.5 3.4 4.8 3.4 3.0 26.0 1.6 1.7 3.9 1.1 0.3 1.5 3.0 2.5 3.4 3.9 5.2 4.3 2.1 3.2 1.1 1.7 2.9 4.8 2.0 4.1 1.9 2.7 2.6 1.8 2.5 2.9 2.1 1.8 1.0 2.7 2.9 2.3 4.9 2.0 1.6 1.8 2.2 1.8 1.4 1.9 1.8 1.5 1.2 1.9 1.5 1.9 2.3 2.5 0.0 1.1 4.6 2.0 3.1 5.3 2.5 0.0 0.4 2.2 2.0 1.1 1.5 2.7 3.7 0.0 1.9 5.2 0.9 1.9 1.8 1.4 1.0 1.0 1.7 3.0 0.0 2.0 1.8 2.6 1.8 0.0 0.8 0.0 1.7 2.2 0.8 2.7 10.1 2.8 2.2 4.1 1.3 2.1 1.4 0.9 2.0 1.8 0.0 2.4 0.9 3.1 4.5 4.9 2.2 0.5 1.2 0.7 2.9 1.6 1.3 4.3 1.4 0.0 1.6 1.4 2.7 2.5 0.4 1.4 1.0 1.3 0.8 1.4 7.0 INAFM2 "LINC00984, OGU1" ENSG00000259330 "InaF motif containing 2" P0DMQ5 15 40323692-40326715 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 18.0;Early spermatids: 25.3;Hofbauer cells: 19.5;Spermatocytes: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;granulocytes: 2.6;monocytes: 1.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.59e-2)" "unprognostic (9.05e-2)" "unprognostic (8.01e-3)" "unprognostic (2.43e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (1.88e-7)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" 11.4 8.5 17.4 10.0 19.3 12.8 7.7 16.9 18.1 8.2 16.5 37.8 6.8 12.3 5.8 8.1 21.5 11.1 24.9 17.7 28.9 6.2 6.7 11.6 5.9 21.1 18.6 17.0 10.0 11.6 12.3 10.5 17.8 18.8 10.9 13.5 12.7 9.5 22.7 13.7 6.1 13.1 17.5 19.3 10.8 28.4 10.3 18.0 5.2 27.1 15.2 6.2 14.5 7.9 22.0 18.7 1.8 16.8 10.7 14.2 6.9 38.6 23.0 11.5 18.0 14.8 6.9 3.7 1.6 19.8 12.6 10.6 41.7 26.3 27.1 25.1 5.5 8.8 50.4 6.9 3.9 18.3 27.0 34.3 18.2 9.8 6.7 18.8 26.5 18.7 12.9 27.6 39.6 25.4 2.7 7.9 21.5 12.3 14.5 14.1 3.9 20.2 44.8 13.2 21.3 35.9 14.2 8.2 9.7 8.3 28.6 9.4 33.1 24.5 24.8 18.4 12.6 16.8 10.2 2.7 4.8 18.4 43.5 24.1 0.6 1.0 2.6 0.1 1.1 0.1 0.3 0.1 0.0 0.5 0.0 0.0 0.1 0.7 0.1 1.0 1.1 0.2 0.6 17.4 19.3 16.9 18.1 17.7 28.9 21.1 18.6 17.0 18.8 19.3 18.0 22.0 6.4 0.0 3.7 3.9 2.3 0.0 1.2 0.0 0.0 7.8 6.8 5.5 18.0 4.3 0.6 3.7 4.2 3.3 3.1 4.3 0.0 2.3 25.3 2.2 3.8 6.0 2.4 1.7 3.4 2.6 0.6 2.4 3.6 2.3 1.3 1.8 12.1 2.7 19.5 8.4 4.5 1.4 0.0 14.1 0.0 4.6 1.2 13.8 0.0 6.5 8.0 6.7 4.1 4.0 1.4 2.3 1.9 4.9 0.4 3.2 1.4 0.8 1.5 4.8 0.0 2.4 9.8 32.4 4.4 1.1 0.0 1.4 1.7 4.9 1.5 2.4 ST20-MTHFS ENSG00000259332 "ST20-MTHFS readthrough" 15 79845150-79923754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 97.4" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.8;Collecting duct cells: 1.8;Erythroid cells: 4.2;Gastric mucus-secreting cells: 5.1;Squamous epithelial cells: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 492.2" "Group enriched" "Detected in all" 4 "granulocytes: 492.2;monocytes: 133.6" "Low cell line specificity" "Detected in all" HPA008067 Uncertain NA NA "HPA008067: AB_1078882" "unprognostic (9.84e-2)" "unprognostic (1.74e-2)" "unprognostic (2.06e-2)" "unprognostic (4.41e-2)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "unprognostic (3.75e-3)" "unprognostic (6.63e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-4)" "unprognostic (2.38e-1)" "unprognostic (5.26e-2)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (2.04e-1)" 10.0 10.3 6.5 15.3 6.7 10.2 7.9 7.5 10.5 8.6 8.8 9.6 11.0 6.8 10.1 3.9 7.4 7.8 6.6 7.1 7.6 39.0 97.4 11.1 11.9 7.4 8.0 6.2 6.1 15.1 24.2 2.4 9.7 7.6 15.6 8.8 12.3 12.9 8.6 10.6 3.8 14.7 7.6 7.0 7.7 12.1 7.7 8.1 10.3 11.2 10.2 12.9 7.3 1.5 7.8 16.2 33.1 6.6 6.5 24.0 14.2 19.1 13.9 22.1 27.4 24.6 15.7 35.9 20.1 29.6 13.1 25.6 29.7 44.2 13.6 17.3 24.8 14.6 20.5 20.4 24.3 25.2 10.5 3.7 21.1 32.2 8.1 27.0 19.5 7.9 26.7 37.6 19.7 13.0 20.9 13.7 26.2 16.3 56.3 13.5 20.4 12.4 22.0 32.5 14.8 16.2 9.8 33.3 22.6 40.8 24.3 26.6 21.0 11.4 11.7 19.9 1.2 10.9 10.8 37.0 21.9 6.4 45.4 9.7 76.4 82.3 223.6 38.9 87.1 48.2 53.1 51.3 42.9 50.8 53.7 58.9 51.0 492.2 77.5 133.6 35.5 60.6 75.7 6.5 6.7 7.5 10.5 7.1 7.6 7.4 8.0 6.2 7.6 7.0 8.1 7.8 0.0 0.0 0.5 0.0 1.6 0.1 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 1.4 1.8 0.0 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.2 0.1 0.0 0.2 0.8 5.1 0.2 0.0 0.1 0.0 1.5 0.3 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 1.3 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.4 0.3 1.4 1.6 0.0 0.3 0.0 AL136295.3 ENSG00000259371 "Novel protein" 14 24120956-24131829 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.38e-1)" "unprognostic (4.35e-3)" "unprognostic (4.81e-2)" "unprognostic (1.87e-2)" "unprognostic (6.61e-5)" "unprognostic (5.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (1.53e-2)" "unprognostic (4.52e-4)" "unprognostic (2.37e-1)" "unprognostic (9.36e-2)" "unprognostic (2.23e-1)" 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.0 0.3 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GH1 "GH, GH-N, GHN, hGH-N" ENSG00000259384 "Growth hormone 1" P01241 17 63917200-63918839 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 869 "pituitary gland: 59830.2" "Cell type enhanced" "Detected in single" "Adipocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043715 Supported "Secreted to blood" NA NA 2690000 6400000 "HPA043715: AB_2678632" "unprognostic (1.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-1)" "unprognostic (9.45e-4)" "unprognostic (2.48e-1)" "unprognostic (2.09e-4)" "unprognostic (2.03e-2)" "unprognostic (6.57e-2)" "unprognostic (2.33e-1)" 9.3 68.8 0.1 0.0 0.1 0.1 2.1 0.1 0.6 1.5 0.2 3.0 0.5 4.1 0.0 9.6 2.8 0.0 5.6 0.1 0.7 3.9 18.5 3.5 0.0 0.1 0.1 0.1 6.2 7.7 0.0 59830.2 0.8 0.1 5.5 0.0 0.0 4.8 0.0 3.6 21.7 3.9 0.0 0.1 7.8 11.9 7.3 0.1 0.3 5.4 0.1 0.0 1.5 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 TGIF2-RAB5IF TGIF2-C20orf24 ENSG00000259399 "TGIF2-RAB5IF readthrough" 20 36574553-36612384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.38e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (5.58e-2)" "unprognostic (2.62e-2)" "unprognostic (1.94e-1)" "unprognostic (7.39e-2)" "unprognostic (2.22e-2)" "unprognostic (6.57e-3)" "unprognostic (3.97e-2)" "unprognostic (2.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" 0.7 1.0 0.7 4.6 0.8 3.8 1.6 1.0 3.5 2.1 1.7 0.7 1.2 1.9 1.6 0.2 3.1 1.1 0.3 0.7 0.8 1.3 1.7 0.8 1.4 1.2 0.9 0.6 2.0 0.3 1.8 0.2 1.8 1.3 0.6 0.8 1.9 2.4 1.1 0.1 0.3 1.0 2.9 1.2 1.8 0.8 2.6 0.8 2.8 0.7 0.0 3.6 1.8 0.4 1.4 4.0 1.5 25.5 11.1 2.6 0.6 1.5 1.0 4.0 6.8 5.1 9.5 6.0 2.0 2.0 3.6 2.0 2.0 18.9 0.0 8.8 6.5 2.8 5.0 3.7 9.7 1.2 6.0 1.1 1.1 2.5 2.8 5.5 9.3 5.0 11.4 1.6 9.8 1.5 7.9 15.0 3.3 4.4 2.3 0.6 11.8 2.0 6.2 1.0 3.3 2.7 8.2 1.3 6.9 3.1 2.8 7.5 13.0 1.5 1.1 0.7 0.3 2.6 3.0 1.5 8.4 0.2 6.9 4.5 0.0 0.5 0.0 0.7 0.6 0.7 1.2 0.1 0.0 1.0 1.4 0.9 1.0 0.9 0.6 0.1 0.9 0.1 0.3 0.7 0.8 1.0 3.5 0.7 0.8 1.2 0.9 0.6 1.3 1.2 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTXND1 LINC01314 ENSG00000259417 "Cortexin domain containing 1" A0A1B0GTU2 15 80195481-80252213 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.5;liver: 9.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 6.3;Proximal tubular cells: 14.0" "Group enriched" "Detected in many" 7 "glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 1.6;WM-115: 4.7" "Region enriched" "Detected in all" 4 "hippocampal formation: 35.0" NA NA "unprognostic (4.15e-5)" "unprognostic (8.42e-2)" "unprognostic (6.08e-2)" "unprognostic (1.86e-3)" "unprognostic (5.59e-2)" "unprognostic (3.48e-1)" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (2.41e-1)" "unprognostic (7.04e-2)" "unprognostic (3.90e-4)" "unprognostic (2.43e-1)" "unprognostic (1.72e-2)" "unprognostic (1.92e-3)" "unprognostic (1.06e-1)" "unprognostic (5.14e-3)" "unprognostic (1.34e-1)" 0.2 3.7 11.1 0.2 7.5 0.0 0.2 5.3 14.4 0.3 2.8 0.7 0.4 0.1 5.4 0.1 0.3 0.1 2.7 31.5 12.5 2.2 9.4 1.6 0.2 7.2 9.4 6.5 0.4 0.5 0.0 1.4 0.0 8.7 0.3 0.3 1.4 0.1 0.1 0.5 0.8 0.5 0.0 5.1 1.4 2.6 0.4 12.2 0.0 0.4 0.1 0.2 0.5 0.3 6.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 7.5 5.3 14.4 31.5 12.5 7.2 9.4 6.5 8.7 5.1 12.2 6.7 0.0 0.0 6.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 1.9 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8;Spermatocytes: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 13.7 17.7 28.6 10.5 37.7 8.2 11.1 28.0 31.3 9.5 28.4 10.4 14.3 12.2 15.2 8.6 15.0 9.7 14.9 30.3 27.7 14.0 11.4 9.6 10.7 31.6 27.5 32.1 12.7 11.5 19.9 11.2 6.8 27.9 16.2 10.7 13.3 17.4 14.1 23.8 7.0 9.9 11.9 26.6 10.8 10.8 20.3 28.6 11.1 11.6 20.9 10.3 10.3 7.3 29.5 3.9 24.1 11.4 12.4 26.3 14.6 6.3 11.2 9.7 10.7 10.5 4.9 15.9 7.2 9.5 13.1 12.1 11.8 12.1 13.8 7.8 15.9 13.7 10.2 16.9 13.3 13.0 9.1 8.7 20.6 10.2 16.4 12.0 22.9 13.0 11.6 7.7 15.9 15.7 11.6 14.6 3.7 4.1 20.9 20.1 9.9 7.9 13.4 18.9 7.6 22.1 10.6 10.8 22.0 6.6 6.6 14.9 4.4 10.9 7.0 7.4 14.5 6.5 18.9 12.2 4.4 7.3 4.2 10.9 13.7 16.0 8.7 9.8 12.0 9.8 10.2 7.2 7.6 14.7 15.3 11.7 10.2 1.7 8.3 16.1 18.7 6.4 10.9 28.6 37.7 28.0 31.3 30.3 27.7 31.6 27.5 32.1 27.9 26.6 28.6 29.5 8.1 6.4 7.5 16.6 14.5 0.0 7.8 0.0 6.8 27.4 12.0 10.7 0.1 8.6 3.7 7.3 8.4 11.0 9.2 7.2 54.8 14.5 21.9 6.7 9.2 6.2 6.1 3.4 11.8 12.4 5.1 9.9 9.2 6.7 23.5 7.7 7.1 10.8 18.4 8.4 23.1 7.5 0.0 7.9 0.0 23.0 11.5 9.8 0.0 4.7 9.9 33.4 14.4 15.1 37.0 8.2 9.6 7.5 11.3 9.3 15.2 38.9 2.9 11.6 13.1 13.2 7.7 57.5 8.3 9.5 0.0 6.7 9.3 14.2 7.7 5.9 IGHV3OR15-7 IGHV3/OR15-7 ENSG00000259490 "Immunoglobulin heavy variable 3/OR15-7 (pseudogene)" 15 19987656-19988117 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.0;stomach 1: 1.9" "Cell type enriched" "Detected in single" 104 "Plasma cells: 10.4" "Cancer enhanced" "Detected in many" "lung cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.08e-2)" "unprognostic (8.21e-2)" "unprognostic (1.08e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.43e-5)" "unprognostic (4.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-4)" "unprognostic (7.46e-2)" "unprognostic (1.35e-1)" "unprognostic (3.50e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459477-88467390 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Proximal tubular cells: 133.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050166, HPA076046" Approved Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039, HPA076046: " "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 23.0 51.9 20.1 13.0 21.1 11.4 22.9 22.7 25.6 14.7 20.8 24.1 20.2 17.3 18.3 26.6 17.3 13.1 76.1 20.2 22.8 35.0 71.5 12.8 21.1 22.5 21.3 19.8 17.3 16.3 24.8 16.4 19.8 22.4 15.0 23.9 17.0 17.3 15.3 73.9 17.2 19.8 18.5 21.3 19.3 25.0 28.3 21.9 19.1 17.4 85.4 20.5 20.9 16.3 23.2 27.8 87.2 27.2 29.8 38.0 28.6 51.5 38.6 35.5 56.9 50.4 108.6 59.3 64.9 38.6 34.9 51.0 65.9 107.4 47.4 44.8 26.3 86.4 53.6 61.5 114.3 24.6 54.2 40.4 32.7 56.6 42.8 28.7 29.0 50.2 63.2 60.7 26.6 42.7 59.6 44.2 68.4 43.5 50.5 52.9 51.9 37.9 49.2 44.5 88.2 42.1 26.5 36.6 57.7 81.8 44.6 64.8 65.7 31.3 44.0 41.9 23.3 56.4 24.2 55.7 53.0 48.5 58.1 34.2 27.1 45.5 33.7 60.0 60.5 69.6 78.8 63.3 58.7 58.7 69.5 69.5 61.6 7.9 62.9 45.0 50.5 68.0 61.5 20.1 21.1 22.7 25.6 20.2 22.8 22.5 21.3 19.8 22.4 21.3 21.9 23.2 18.9 0.0 10.3 5.2 21.0 13.8 22.4 59.8 9.6 21.2 17.3 21.3 70.4 37.1 32.3 36.8 27.1 94.3 10.7 20.4 119.3 35.0 67.1 20.0 16.6 18.4 28.3 17.7 4.2 38.0 42.1 19.2 19.9 19.5 22.2 25.8 17.2 105.0 35.6 15.2 5.9 20.6 44.7 13.4 5.5 16.3 14.3 10.8 7.2 3.7 42.1 25.1 20.6 4.5 6.1 31.7 18.4 18.8 17.3 21.9 32.1 133.6 26.2 28.4 26.3 19.5 25.5 55.3 27.4 27.1 23.3 80.7 18.5 66.9 36.1 29.4 BLID BRCC2 ENSG00000259571 "BH3-like motif containing, cell death inducer" Q8IZY5 11 122115340-122116215 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "brain: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;hTEC/SVTERT24-B: 1.0;hTERT-RPE1: 1.0;LHCN-M2: 1.4;U-87 MG: 1.7" NA NA 0.0 0.0 1.3 0.0 2.9 0.0 0.0 1.5 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.7 0.0 0.0 0.0 0.0 3.6 2.4 0.3 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.3 0.2 0.3 0.0 0.9 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.9 1.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.4 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.9 1.5 1.6 0.9 8.7 3.6 2.4 0.3 2.6 1.9 2.2 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 IGHV3OR16-17 IGHV3/OR16-17 ENSG00000259680 "Immunoglobulin heavy variable 3/OR16-17 (non-functional)" 16 33844784-33845229 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 11.6;lymphoid tissue: 24.6;stomach 1: 11.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "memory B-cell: 1.5;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Not detected" "Not detected" NA NA "unprognostic (1.57e-3)" "unprognostic (1.35e-2)" "unprognostic (5.32e-2)" "prognostic favorable (6.96e-5)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-3)" "unprognostic (7.52e-2)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.58e-1)" 0.2 0.1 0.0 9.4 0.0 4.3 3.4 0.0 0.0 4.0 0.0 11.6 9.7 0.1 0.0 4.1 0.1 0.5 1.0 0.0 0.0 0.0 0.4 1.0 1.3 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 6.5 0.0 4.3 0.0 0.0 0.0 5.6 0.4 0.0 4.1 11.9 0.0 0.0 0.5 0.0 0.0 24.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093525.1 ENSG00000259784 "Novel protein" 16 2513965-2527955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;brain: 1.5;intestine: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;REH: 1.4;THP-1: 1.4;U-266/70: 2.0" NA NA 0.3 0.1 0.3 0.0 0.3 1.9 0.0 0.6 1.5 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.2 0.2 0.6 0.4 0.2 0.0 0.2 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.2 0.1 1.1 0.3 0.1 0.2 0.5 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.7 0.0 0.4 0.0 0.3 0.0 0.2 0.5 0.0 1.5 0.0 0.0 1.1 0.0 0.4 0.0 0.3 0.0 0.5 0.4 0.0 1.0 0.0 0.0 0.3 0.3 0.2 0.4 0.0 0.5 0.0 0.4 0.2 0.0 0.3 1.4 0.4 0.5 0.0 0.0 0.4 0.1 0.0 0.7 0.1 0.1 0.4 1.4 0.0 0.4 0.1 0.2 0.4 2.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.3 0.6 1.5 0.3 0.5 0.6 0.4 0.2 1.4 0.1 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A31 ENSG00000259803 "Solute carrier family 22 member 31" A6NKX4 16 89195761-89201651 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 23.3;lung: 41.0;pancreas: 33.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 130.7;Late spermatids: 33.6" "Cancer enhanced" "Detected in many" "lung cancer: 26.2;thyroid cancer: 20.4" "Group enriched" "Detected in some" 10 "cerebellum: 23.3;pons: 11.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 33.7;Hep G2: 28.7;NB-4: 14.7;RPMI-8226: 17.7;THP-1: 9.3" NA NA "unprognostic (2.71e-3)" "unprognostic (2.53e-1)" "unprognostic (5.02e-3)" "unprognostic (6.82e-2)" "unprognostic (8.20e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-1)" "unprognostic (8.98e-2)" "unprognostic (1.09e-1)" "unprognostic (8.26e-4)" "unprognostic (2.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.72e-3)" "unprognostic (1.89e-1)" 0.1 0.8 0.0 0.2 0.3 0.9 0.1 23.3 0.8 0.6 0.0 0.3 0.4 0.2 0.0 0.1 0.9 0.0 0.2 0.0 0.2 0.5 1.2 41.0 0.1 0.4 1.7 0.0 3.1 33.2 0.1 0.5 0.0 11.0 0.6 0.0 0.0 0.4 0.1 0.0 1.2 0.6 0.0 0.2 3.6 3.3 5.2 0.3 0.0 0.4 0.0 0.0 0.2 0.5 0.4 0.0 0.1 0.0 1.6 0.0 0.0 33.7 0.1 0.0 0.0 0.0 1.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 28.7 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.5 0.0 14.7 0.8 0.3 3.4 0.0 3.7 17.7 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.1 0.3 9.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 23.3 0.8 0.0 0.2 0.4 1.7 0.0 11.0 0.2 0.3 0.4 0.0 6.4 130.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 19.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.1 1.1 0.0 8.2 0.0 0.4 0.3 0.7 0.0 0.4 0.0 0.0 0.3 0.0 33.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.9 3.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 LYPD8 ENSG00000259823 "LY6/PLAUR domain containing 8" Q6UX82 1 248739415-248755759 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 217.9" "Group enriched" "Detected in some" 5 "Distal enterocytes: 710.5;Paneth cells: 1098.0" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 15.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA "unprognostic (6.69e-3)" "unprognostic (3.53e-2)" "unprognostic (1.08e-5)" "unprognostic (1.42e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-4)" "unprognostic (8.62e-2)" "unprognostic (7.28e-2)" "unprognostic (3.22e-1)" "unprognostic (9.73e-2)" "unprognostic (1.87e-1)" "unprognostic (1.19e-4)" "unprognostic (2.57e-1)" "unprognostic (2.89e-1)" "unprognostic (1.07e-1)" 0.1 0.0 1.1 11.5 1.4 0.5 0.6 0.0 2.0 0.0 0.0 217.9 0.7 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.2 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 128.1 0.0 0.0 0.4 0.0 0.0 26.6 3.5 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 1.1 1.4 0.0 2.0 1.0 0.4 0.4 0.0 1.3 0.7 0.0 0.1 1.1 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 710.5 1.9 0.0 4.7 0.0 0.0 0.0 31.5 0.0 15.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 166.9 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 1098.0 0.0 0.0 0.1 38.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.3 0.3 0.0 16.6 0.0 AL845331.1 ENSG00000259916 "Putative aquaporin-7-like protein 3" 2 94588522-94604573 "Metabolic proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "adipose tissue: 7.5;breast: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "ASC diff: 1.9" NA NA "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (8.07e-3)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (9.15e-3)" "unprognostic (6.22e-2)" "unprognostic (4.66e-2)" 7.5 0.1 0.0 0.0 0.5 0.0 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBM15B "HUMAGCGB, OTT3" ENSG00000259956 "RNA binding motif protein 15B" Q8NDT2 3 51391285-51397908 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036645, HPA058136" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036645: AB_10671965, HPA058136: AB_2683618" "unprognostic (2.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (5.28e-2)" "unprognostic (3.13e-3)" "unprognostic (1.70e-1)" "unprognostic (5.25e-2)" "unprognostic (3.11e-1)" "unprognostic (3.39e-1)" "unprognostic (3.01e-2)" "prognostic favorable (1.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (3.84e-1)" 13.2 10.4 10.0 10.7 9.6 11.2 12.4 8.9 10.6 11.8 7.5 14.0 10.5 17.1 10.7 17.1 12.1 9.4 9.7 9.9 9.1 8.8 9.9 11.6 11.3 9.9 9.9 9.5 14.7 17.9 13.9 10.8 8.1 9.8 10.9 12.0 8.3 12.4 11.1 6.2 16.6 13.1 12.3 9.3 11.5 14.7 11.5 9.4 19.9 10.8 7.1 12.3 13.1 10.6 9.5 19.2 16.7 38.2 40.1 33.7 26.2 23.3 17.4 32.2 27.2 22.3 20.8 13.6 27.5 14.1 31.5 30.0 17.3 22.0 31.3 13.1 22.2 17.3 23.9 26.2 17.9 19.7 31.4 13.0 28.6 38.2 25.0 29.5 29.6 28.5 44.3 18.1 18.2 23.6 20.4 54.8 19.8 30.5 17.6 25.9 19.4 16.8 23.5 24.5 45.5 24.7 35.5 22.4 29.5 20.6 25.2 23.4 36.7 26.0 27.7 24.1 23.6 33.3 26.6 25.9 30.3 22.6 24.8 30.2 0.0 1.9 0.7 1.8 2.7 1.9 1.0 2.2 1.9 2.1 2.4 2.2 1.3 0.4 1.7 2.7 2.3 1.1 1.6 10.0 9.6 8.9 10.6 9.9 9.1 9.9 9.9 9.5 9.8 9.3 9.4 9.5 16.7 3.2 5.4 4.2 15.2 25.4 38.9 12.6 16.5 18.2 24.9 20.2 17.3 20.0 12.5 14.7 10.4 15.2 19.8 19.9 11.7 19.4 22.4 17.6 17.2 19.1 12.6 19.0 4.4 23.2 20.7 16.7 21.4 19.6 5.1 31.0 17.9 20.5 18.4 15.2 5.1 21.0 12.2 33.1 20.9 10.6 15.8 15.1 7.2 2.8 16.3 14.2 22.6 3.5 5.0 28.2 13.4 15.1 16.4 32.8 15.2 16.5 11.2 15.5 26.3 26.0 21.1 14.9 7.9 28.0 28.1 19.7 16.3 21.0 24.4 36.7 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7914830-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "pituitary gland: 106.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 7.3;Late spermatids: 8.6;Plasma cells: 9.2;Proximal tubular cells: 8.9;Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;REH: 4.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA074356 Enhanced Approved Vesicles NA NA Vesicles "HPA074356: AB_2686681" "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.0 0.3 0.3 0.1 0.2 0.3 0.0 1.2 1.0 1.0 0.0 0.3 2.1 1.3 0.1 0.0 1.0 0.1 0.7 0.3 0.1 0.8 1.4 0.1 0.1 0.6 0.0 0.4 0.0 0.1 0.0 106.9 0.0 0.3 0.5 0.0 0.2 0.1 0.1 0.1 0.2 1.5 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.5 0.0 0.2 0.2 0.4 0.1 0.0 2.4 0.7 0.0 0.0 0.0 0.4 0.1 0.2 0.8 0.0 0.0 0.8 0.1 0.0 0.0 1.5 0.5 0.2 0.6 0.3 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.4 0.7 0.0 0.7 0.5 0.2 0.2 0.1 1.5 4.3 0.0 1.1 0.0 0.1 0.4 0.8 0.1 0.0 0.3 0.0 0.4 0.6 0.1 0.9 1.4 1.4 0.3 0.6 0.6 0.4 0.1 0.3 0.4 0.6 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.2 1.0 0.3 0.1 0.6 0.0 0.4 0.3 0.0 0.1 0.5 0.3 0.0 0.0 2.0 2.4 1.5 2.9 0.3 0.0 1.6 1.6 2.3 1.8 0.0 0.6 0.0 0.0 0.1 1.8 0.1 3.9 0.3 0.5 1.4 3.7 0.2 0.0 0.0 7.3 0.2 0.8 0.8 0.0 0.5 0.0 0.2 1.4 2.9 0.3 0.0 3.3 0.2 0.0 0.3 0.4 8.6 1.2 0.6 5.4 1.9 0.1 3.4 0.0 0.5 1.8 0.3 0.0 1.2 9.2 4.3 0.5 8.9 0.3 2.4 13.1 0.2 3.5 0.4 1.9 0.0 1.4 0.4 4.4 0.1 0.2 0.4 AC107871.1 ENSG00000260007 "Novel protein" 15 68184032-68229718 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.6;Club cells: 1.8;Endometrial stromal cells: 1.5;Exocrine glandular cells: 1.4;granulocytes: 1.3;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;HAP1: 1.6;HEK 293: 2.9" NA NA "unprognostic (1.22e-1)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (9.23e-3)" "unprognostic (2.82e-1)" "unprognostic (4.30e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 1.6 0.9 0.8 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.6 0.4 0.7 0.0 2.9 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.1 0.5 0.9 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 1.5 0.3 0.0 0.0 0.0 1.4 0.0 0.7 0.0 1.2 1.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607232-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "epididymis: 136.3" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 7 "medulla oblongata: 5.4;spinal cord: 11.3;white matter: 9.7" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3" "Region enriched" "Detected in single" 58 "pons and medulla: 5.7" "Region enriched" "Detected in some" 7 "spinal cord: 22.2" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 11.6 11.1 0.0 4.0 0.9 0.2 12.5 0.0 0.3 22.0 0.1 17.0 1.1 5.3 136.3 0.4 8.8 0.7 0.3 0.0 0.1 24.1 0.4 2.2 2.7 5.4 0.0 0.0 0.5 0.8 5.6 0.1 5.8 1.2 2.5 16.0 0.0 0.2 17.0 1.7 3.2 18.3 6.8 11.3 3.0 6.0 1.9 0.9 0.2 0.4 0.2 0.9 7.7 5.5 9.7 48.1 20.6 0.0 0.5 14.2 21.1 0.0 0.0 0.0 0.2 0.8 31.9 0.9 0.9 81.9 19.9 23.9 6.9 0.1 0.0 0.0 22.3 15.1 7.4 15.4 0.0 11.7 0.0 14.8 13.8 6.3 14.2 0.0 3.5 43.8 14.7 8.0 0.3 46.0 12.5 1.0 0.4 0.0 74.7 0.1 0.0 39.2 5.5 66.5 15.8 0.0 0.1 16.0 0.0 84.3 1.1 3.8 4.7 38.1 0.0 24.8 20.5 36.9 2.6 6.3 0.1 0.4 0.0 58.6 0.0 0.0 0.0 1.5 0.0 0.8 0.7 0.2 0.8 0.0 1.4 0.0 0.5 0.0 1.0 0.0 0.7 2.1 0.2 0.0 0.9 0.0 0.3 0.0 0.1 5.4 0.0 0.0 1.2 11.3 0.9 9.7 55.4 0.0 0.0 0.0 2.0 5.5 0.9 0.0 0.6 0.0 0.9 1.0 0.3 0.0 0.0 86.5 0.0 6.8 1.6 131.3 148.7 0.1 0.3 82.9 6.3 20.3 36.5 1.3 0.0 1.3 19.3 6.4 0.0 73.1 5.1 0.0 1.4 0.2 11.5 0.0 0.0 77.6 0.0 10.6 5.4 0.2 0.6 2.8 24.9 0.0 1.7 0.0 2.1 0.0 0.0 0.3 67.8 0.0 5.1 0.6 140.3 31.6 0.0 0.0 0.0 3.5 8.9 1.7 20.9 0.2 2.0 1.8 2.6 0.1 63.1 3.5 SPDYE6 ENSG00000260097 "Speedy/RINGO cell cycle regulator family member E6" P0CI01 7 102345746-102356444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 5.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.0;Inhibitory neurons: 1.1;Microglial cells: 1.9;Oligodendrocyte precursor cells: 1.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "pons: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 5.3" HPA051750 Approved NA NA "HPA051750: AB_2681590" "unprognostic (5.47e-2)" "unprognostic (3.61e-1)" "unprognostic (1.66e-1)" "unprognostic (4.89e-3)" "unprognostic (3.45e-1)" "unprognostic (1.23e-2)" "unprognostic (5.84e-3)" "unprognostic (9.81e-2)" "unprognostic (1.36e-2)" "unprognostic (4.09e-2)" "unprognostic (8.22e-3)" "unprognostic (3.49e-2)" "unprognostic (7.81e-6)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" 0.7 0.8 0.2 1.3 0.2 1.0 0.7 0.7 0.5 0.6 0.2 1.0 0.7 0.9 0.0 1.2 0.7 0.1 1.1 0.3 0.0 1.3 1.0 1.1 1.4 0.6 1.0 0.0 0.9 1.7 0.0 1.2 0.2 2.6 1.2 0.0 0.7 1.2 0.0 2.4 1.2 1.7 0.0 0.0 1.9 1.1 5.0 0.3 0.0 1.4 0.0 0.0 0.9 1.0 0.8 1.2 0.1 0.7 0.7 0.0 0.0 1.5 1.7 0.0 0.0 0.0 0.4 1.2 1.7 0.7 0.0 0.1 1.0 0.0 0.0 0.0 0.6 1.1 1.1 2.9 0.2 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 5.3 0.0 1.2 0.7 1.3 0.7 0.2 0.1 1.4 0.2 1.7 0.0 1.4 0.8 0.5 1.8 0.9 0.5 1.1 0.4 0.8 0.5 2.0 1.1 0.9 1.0 1.2 0.9 1.2 0.4 1.3 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.7 0.5 0.3 0.0 0.6 1.0 0.0 2.6 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC090527.2 ENSG00000260170 "Novel protein" 15 45587351-45676314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;THP-1: 1.1" HPA041589 Approved NA NA "HPA041589: AB_2677565" "unprognostic (5.93e-2)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" 0.1 0.0 0.2 0.0 0.2 0.4 0.1 0.0 0.2 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.3 0.2 2.2 1.7 0.9 0.8 0.8 1.0 0.7 0.7 0.3 0.0 1.3 1.6 0.4 6.2 0.0 0.9 0.5 1.2 0.4 0.2 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.0 1.0 0.2 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC187 MGC50722 ENSG00000260220 "Coiled-coil domain containing 187" A0A096LP49 9 136249973-136306901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 11.1;pituitary gland: 7.2;testis: 29.9" "Cell type enriched" "Detected in some" 4 "Late spermatids: 446.1" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "RPMI-8226: 10.4;SCLC-21H: 3.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 3.2" NA NA "unprognostic (1.11e-1)" "unprognostic (9.60e-3)" "unprognostic (1.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (4.31e-2)" "unprognostic (6.18e-2)" "unprognostic (1.72e-1)" "unprognostic (2.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (5.54e-2)" "unprognostic (8.93e-4)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.1 2.8 0.0 11.1 0.0 0.0 0.0 0.5 0.2 0.0 2.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 29.9 0.3 0.0 4.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 10.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 107.8 49.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 446.1 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.0 0.1 22.6 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 FRRS1L "C9orf4, CG-6" ENSG00000260230 "Ferric chelate reductase 1 like" Q9P0K9 9 109130293-109167249 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;ovary: 11.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 59.1;Excitatory neurons: 91.6;Horizontal cells: 97.6;Inhibitory neurons: 81.3;Oligodendrocyte precursor cells: 27.6" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071086 Enhanced NA NA "HPA071086: AB_2686342" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (2.21e-1)" "unprognostic (9.01e-2)" "unprognostic (3.10e-1)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (9.94e-2)" "unprognostic (1.51e-1)" "unprognostic (9.21e-4)" "unprognostic (7.35e-3)" "unprognostic (7.02e-2)" "unprognostic (5.78e-3)" "unprognostic (5.89e-2)" "unprognostic (2.85e-1)" "unprognostic (5.38e-3)" 0.1 7.9 12.0 0.3 18.1 0.3 0.3 10.8 16.0 1.3 0.0 0.6 0.4 1.5 2.8 1.9 1.4 1.0 1.1 16.6 14.5 0.1 0.1 0.2 0.2 6.3 8.1 17.1 11.1 0.6 3.1 7.3 0.0 5.0 3.2 0.3 7.9 0.2 1.7 0.1 0.2 0.5 1.5 3.3 0.2 0.8 0.8 12.6 0.0 0.2 0.1 0.1 0.1 0.2 11.6 0.0 0.2 1.6 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.0 12.0 18.1 10.8 16.0 16.6 14.5 6.3 8.1 17.1 5.0 3.3 12.6 11.6 0.1 3.2 0.6 1.3 0.1 0.4 1.5 0.0 0.6 59.1 0.7 0.4 5.0 0.0 0.6 0.0 2.1 0.4 1.5 1.6 0.0 0.0 7.9 3.2 1.6 0.8 1.2 0.0 91.6 0.0 0.2 4.3 0.0 1.8 1.3 16.3 0.4 0.1 0.1 97.6 81.3 0.8 0.0 0.6 1.2 4.6 13.1 0.5 1.8 4.7 0.2 16.6 0.0 27.6 5.9 0.1 0.4 17.0 0.0 1.1 4.1 0.1 0.0 7.0 0.0 1.6 1.5 0.3 1.2 0.0 0.6 0.3 0.3 10.8 1.3 0.8 PMF1-BGLAP ENSG00000260238 "PMF1-BGLAP readthrough" 1 156212982-156243332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Proximal tubular cells: 2.5;Sertoli cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (8.15e-2)" "unprognostic (1.80e-1)" "unprognostic (8.56e-4)" "unprognostic (1.65e-2)" "unprognostic (4.01e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.66e-2)" "unprognostic (1.28e-1)" "unprognostic (8.52e-3)" "unprognostic (1.85e-4)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.31e-3)" "unprognostic (2.36e-1)" 5.4 9.1 6.8 2.3 7.1 4.6 5.0 7.5 11.6 10.8 7.0 7.7 2.8 6.7 5.1 5.3 7.3 3.6 14.5 6.8 6.9 8.5 7.7 4.9 3.4 6.8 6.7 6.5 10.1 5.8 3.9 10.4 4.8 7.3 11.1 1.6 5.0 7.8 4.1 13.4 3.8 4.6 3.0 6.6 6.6 6.6 3.5 7.3 3.0 8.7 10.1 2.5 6.9 7.3 8.4 8.9 8.4 11.6 7.8 3.0 7.4 5.2 7.8 5.0 7.5 6.0 6.6 7.9 7.7 12.8 7.0 3.1 6.0 10.8 10.1 3.5 13.4 18.4 5.3 8.5 12.5 14.5 5.3 9.3 9.7 9.3 7.0 6.2 6.9 7.3 7.0 5.4 12.4 5.0 11.1 4.7 11.3 23.7 5.9 16.1 8.7 4.5 11.4 4.8 4.2 7.9 10.3 5.2 2.0 13.6 10.0 11.8 20.9 7.9 3.7 3.8 4.6 7.0 7.4 9.4 11.5 4.7 6.9 7.5 2.3 5.7 3.1 2.8 3.9 2.9 2.7 4.6 4.3 4.2 7.7 6.2 3.6 6.4 3.0 4.3 4.4 5.6 5.7 6.8 7.1 7.5 11.6 6.8 6.9 6.8 6.7 6.5 7.3 6.6 7.3 8.4 0.6 0.0 1.5 0.3 1.3 0.0 0.5 0.1 1.8 0.0 0.5 0.4 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 3.9 0.4 0.0 0.4 1.1 0.3 0.0 1.3 0.2 0.0 0.2 1.1 0.5 0.4 0.0 0.6 0.7 0.5 0.4 0.0 0.3 0.3 0.0 0.6 0.0 0.1 1.5 0.8 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.1 0.1 0.4 2.4 0.1 0.4 2.5 1.5 0.0 6.6 0.3 0.6 0.3 0.5 2.2 0.0 1.0 1.3 0.2 0.6 0.3 AC093525.2 ENSG00000260272 "Novel protein" 16 2496032-2520218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 3.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.1;Club cells: 17.3;granulocytes: 17.7;Macrophages: 7.7;Respiratory ciliated cells: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;RPMI-8226: 1.1;SCLC-21H: 1.0;SH-SY5Y: 1.3" HPA044712 Uncertain NA NA "HPA044712: AB_10795619" "unprognostic (4.12e-1)" "unprognostic (9.64e-2)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (3.34e-2)" "unprognostic (2.34e-1)" "unprognostic (1.37e-1)" "unprognostic (9.77e-3)" "unprognostic (9.13e-2)" "unprognostic (9.83e-2)" "unprognostic (5.98e-3)" 0.3 0.2 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.0 0.0 3.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.3 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.1 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.7 0.1 0.3 0.0 0.0 0.3 0.1 0.0 1.1 0.1 0.0 1.0 1.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.4 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 ARMH2 C6orf229 ENSG00000260286 "Armadillo like helical domain containing 2" H3BNL8 6 24797335-24798917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 13.5" "Cell type enriched" "Detected in single" 9 "Endometrial ciliated cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 13.5 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.1 0.3 0.1 0.7 0.5 0.3 0.5 0.2 0.7 0.5 0.3 2.5 0.2 0.1 0.2 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SiHa: 1.3" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.4 0.8 0.1 0.0 0.1 0.0 0.5 0.1 0.9 0.7 0.1 0.5 0.1 1.0 0.0 1.2 1.5 0.0 0.4 0.1 0.1 0.8 1.2 0.6 0.0 0.1 0.1 0.1 0.9 0.6 0.0 0.9 0.0 0.1 1.4 0.0 0.0 0.6 0.0 0.5 1.0 0.6 0.0 0.1 1.5 0.4 26.3 0.1 0.0 0.4 0.0 0.0 1.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRC1 "bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1" ENSG00000260314 "Mannose receptor C-type 1" P22897 10 17809348-17911164 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 123.4" "Group enriched" "Detected in many" 4 "Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 16 "myeloid DC: 4.8" "Lineage enriched" "Detected in single" 16 "dendritic cells: 4.8" "Group enriched" "Detected in some" 19 "MOLT-4: 19.3;TIME: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004114, HPA045134, CAB068203" Enhanced NA NA 170000000 "CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.03e-2)" "unprognostic (2.58e-1)" "unprognostic (5.62e-2)" "unprognostic (4.30e-1)" "unprognostic (6.36e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (6.05e-2)" "unprognostic (5.61e-2)" "unprognostic (4.12e-1)" "unprognostic (2.94e-2)" "unprognostic (4.97e-2)" "unprognostic (3.05e-2)" "unprognostic (1.74e-2)" "unprognostic (7.02e-2)" 54.9 29.0 1.2 24.2 1.2 0.7 16.5 0.3 6.4 17.4 11.4 16.3 10.0 7.3 1.7 13.3 12.0 27.9 10.3 1.4 3.4 7.6 41.3 123.4 15.3 1.4 0.8 0.5 6.3 8.1 4.6 1.5 54.7 0.9 2.2 18.7 0.1 5.0 8.1 1.8 2.7 17.6 30.6 0.6 51.1 9.8 7.6 2.2 8.0 5.5 8.8 3.1 29.3 2.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.3 0.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.2 1.2 0.3 6.4 1.4 3.4 1.4 0.8 0.5 0.9 0.6 2.2 1.3 4.0 32.1 43.5 1.3 3.5 0.4 0.0 0.0 0.0 0.0 128.9 1.7 3.6 11.5 7.4 0.0 0.0 0.9 1.0 1.4 0.0 0.1 27.3 0.0 0.1 39.0 0.0 3.2 0.8 0.4 1.4 2.5 0.0 0.1 13.9 0.1 397.7 13.1 176.1 0.0 1.3 0.9 0.0 361.4 46.8 19.4 1.5 316.5 0.0 60.9 0.5 0.0 0.0 0.5 0.5 0.1 1.5 0.0 1.0 0.0 2.2 0.1 5.8 0.0 32.9 3.0 2.2 0.4 2.3 1.2 0.4 2.1 4.7 1.7 0.8 0.1 HSPB9 CT51 ENSG00000260325 "Heat shock protein family B (small) member 9" Q9BQS6 17 42122804-42123352 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 18.0" "Group enriched" "Detected in some" 5 "Early spermatids: 375.3;Late spermatids: 1017.0" "Cancer enhanced" "Detected in single" "liver cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HEK 293: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA053091 Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA053091: " "unprognostic (2.36e-1)" "unprognostic (2.63e-1)" "unprognostic (8.35e-2)" "unprognostic (1.99e-2)" "unprognostic (5.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.30e-2)" "unprognostic (3.42e-6)" "unprognostic (2.31e-1)" "unprognostic (5.13e-2)" "unprognostic (3.82e-1)" "unprognostic (8.62e-2)" "unprognostic (3.36e-3)" "unprognostic (3.68e-4)" "unprognostic (4.78e-2)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" 0.4 0.2 1.2 0.4 1.2 0.6 0.2 1.4 1.7 0.2 0.8 0.3 0.3 0.2 0.0 0.1 0.8 0.6 0.2 1.1 1.1 0.6 3.6 0.3 0.4 1.2 1.0 0.9 1.3 4.8 0.2 0.5 0.2 1.1 0.5 0.0 0.0 2.9 0.5 1.5 0.4 0.4 0.1 1.1 0.5 0.4 18.0 1.2 0.0 0.2 1.0 0.0 0.2 0.2 1.5 0.2 0.2 0.3 0.9 0.0 0.0 3.3 0.0 0.0 0.0 0.3 1.0 0.1 0.3 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.3 3.0 0.5 1.2 0.4 0.0 0.3 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.4 0.2 0.0 0.4 0.3 1.1 0.1 0.3 0.0 0.1 0.2 1.0 0.0 0.7 1.4 0.3 0.0 1.5 0.2 0.1 0.2 0.1 0.4 0.7 0.0 0.6 0.2 0.6 0.3 0.6 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.0 1.2 1.2 1.4 1.7 1.1 1.1 1.2 1.0 0.9 1.1 1.1 1.2 1.5 0.7 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.6 0.6 0.6 0.5 0.6 2.8 0.0 0.0 2.1 3.2 0.2 0.4 19.6 0.0 375.3 0.5 0.3 0.6 0.0 0.0 0.1 1.1 0.8 0.7 0.0 0.3 0.0 0.5 1.8 15.3 0.2 3.3 0.1 0.7 0.0 0.8 0.4 1017.0 7.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.3 6.8 0.0 0.4 0.6 0.9 0.1 0.4 0.0 0.8 0.3 127.3 4.5 0.1 0.3 0.3 0.2 0.6 0.3 0.2 AC138811.2 ENSG00000260342 "Novel protein" 16 18788063-18801519 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 14.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 5.6;Club cells: 2.5;Endothelial cells: 2.0;granulocytes: 2.5;Macrophages: 1.8;Respiratory ciliated cells: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 52.4;HDLM-2: 69.2" HPA045307 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (1.03e-2)" "unprognostic (8.89e-3)" "unprognostic (1.22e-1)" "unprognostic (3.59e-3)" "unprognostic (2.28e-1)" "unprognostic (6.32e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (1.46e-1)" "unprognostic (1.40e-2)" "unprognostic (3.27e-1)" "unprognostic (3.18e-4)" "unprognostic (2.92e-1)" "unprognostic (3.89e-2)" "unprognostic (2.65e-2)" "unprognostic (3.95e-2)" 0.7 0.8 1.3 1.4 3.5 0.9 0.6 0.6 4.8 0.5 1.0 3.7 0.0 0.4 0.4 0.9 0.3 0.4 0.5 2.3 1.7 1.0 1.0 0.4 0.6 4.7 1.3 3.3 0.3 2.3 2.7 0.2 0.4 5.1 0.2 0.7 1.0 0.4 0.7 3.9 0.3 1.1 1.2 1.5 1.1 1.4 14.9 1.8 1.6 0.3 0.5 0.7 0.5 0.3 2.2 17.7 2.6 4.1 19.8 1.6 0.6 0.6 24.8 1.7 2.8 3.6 15.8 11.4 5.3 52.4 6.5 6.4 21.3 9.8 4.1 8.1 69.2 3.1 5.8 8.5 4.7 0.0 27.9 10.9 1.6 0.9 9.3 0.0 2.5 1.7 3.3 11.5 16.2 3.0 0.0 7.9 0.7 1.3 1.7 0.6 32.8 7.4 2.0 2.0 12.9 10.5 1.1 29.5 5.2 2.2 2.3 3.4 0.7 20.9 8.9 14.7 9.4 22.3 4.3 34.2 11.9 12.2 3.9 20.3 116.7 76.9 48.7 128.7 56.2 98.7 89.9 99.2 122.2 76.2 94.1 84.6 92.2 61.5 120.7 76.0 162.2 159.6 188.5 1.3 3.5 0.6 4.8 2.3 1.7 4.7 1.3 3.3 5.1 1.5 1.8 2.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 AC026464.3 ENSG00000260371 "Novel protein" 16 69335091-69356306 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.7 1.0 0.2 0.5 0.6 0.4 0.2 0.1 0.9 0.2 0.8 1.6 0.4 0.8 0.0 1.0 0.3 0.0 0.0 0.7 0.5 0.5 0.7 0.4 0.5 0.6 0.8 0.8 1.2 2.6 1.8 0.1 0.1 0.9 0.3 0.0 0.5 0.0 0.9 2.3 0.1 0.9 0.0 0.1 0.9 0.7 1.1 0.7 2.6 0.0 2.2 0.7 1.5 0.1 1.0 1.2 7.9 2.0 3.7 0.3 6.0 0.0 0.5 4.0 4.3 4.7 2.1 3.3 0.9 1.7 0.6 2.2 2.7 2.6 2.7 1.8 0.0 1.5 0.1 4.5 5.6 2.3 1.1 1.8 0.0 0.0 1.3 3.1 1.8 1.3 0.8 0.6 3.2 6.5 1.7 4.9 0.0 3.8 3.1 0.0 3.8 1.0 0.9 3.8 0.7 2.0 0.9 0.0 2.4 0.0 2.7 2.8 6.4 0.0 2.6 0.9 0.7 3.2 3.3 4.0 5.8 3.4 1.2 2.9 0.1 0.5 0.4 0.8 0.3 0.0 0.9 0.6 0.7 0.4 1.3 0.9 0.5 0.6 2.0 1.1 0.1 0.6 0.4 0.2 0.6 0.1 0.9 0.7 0.5 0.6 0.8 0.8 0.9 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCX "bHLHa41, bHLHa48, SCXA, SCXB" ENSG00000260428 "Scleraxis bHLH transcription factor" Q7RTU7 8 144266453-144268481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 19.7;thyroid gland: 38.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.2;Horizontal cells: 16.8" "Group enriched" "Detected in all" 6 "endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;HaCaT: 5.3" "Region enhanced" "Detected in many" "cerebellum: 10.7" "Low region specificity" "Detected in some" HPA043183 Uncertain NA NA "HPA043183: AB_2678357" "unprognostic (5.32e-2)" "unprognostic (1.06e-2)" "unprognostic (7.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-2)" "unprognostic (6.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (7.89e-3)" 1.2 3.4 2.9 0.9 2.1 0.6 1.4 7.7 6.9 6.7 2.5 7.0 0.9 2.9 0.5 3.4 3.9 0.1 8.2 2.5 2.5 6.0 2.1 3.5 0.4 5.3 2.4 2.3 2.6 3.8 0.8 19.7 0.2 5.3 4.5 0.2 0.1 2.7 0.1 14.0 3.1 5.0 0.2 0.7 4.6 5.9 5.2 2.4 0.7 38.4 1.2 0.1 2.7 3.3 3.8 2.0 0.4 0.1 0.5 0.0 0.0 4.8 0.1 0.0 0.1 0.0 0.1 1.4 1.3 1.4 0.2 0.2 5.3 0.0 0.0 0.0 0.9 0.8 0.3 1.9 0.2 0.2 0.1 2.2 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.2 0.6 0.1 3.0 0.5 1.1 1.1 0.4 2.3 1.6 0.2 0.8 0.1 2.0 0.2 0.9 0.5 1.8 2.2 0.1 2.3 0.9 0.3 0.4 3.5 1.6 0.3 1.8 0.6 0.3 0.8 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.1 7.7 6.9 2.5 2.5 5.3 2.4 2.3 5.3 0.7 2.4 3.8 3.4 0.0 2.7 8.5 2.5 0.0 1.2 0.0 0.6 14.2 6.7 8.3 6.2 1.5 1.3 3.7 0.0 1.5 7.5 2.2 1.9 0.6 0.2 5.7 1.4 1.2 2.4 0.0 5.9 1.4 0.6 1.2 8.2 7.1 0.0 3.2 0.4 0.4 0.4 16.8 8.5 2.3 0.0 0.6 0.0 0.9 0.3 0.9 0.0 1.0 0.0 8.2 1.0 2.5 0.3 1.5 2.1 0.7 0.7 2.7 1.5 0.2 0.0 1.5 0.0 4.2 6.4 2.5 9.0 0.6 0.0 1.1 3.1 0.3 1.8 1.0 C16orf95 ENSG00000260456 "Chromosome 16 open reading frame 95" Q9H693 16 87083562-87317420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 102.2" "Group enriched" "Detected in many" 4 "Early spermatids: 94.6;Late spermatids: 96.2;Spermatocytes: 127.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA040850, HPA067924" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA040850: AB_10794882, HPA067924: AB_2685924" "unprognostic (3.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-2)" "unprognostic (4.30e-2)" "unprognostic (3.92e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.45e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-1)" "unprognostic (6.71e-2)" "unprognostic (1.79e-1)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.61e-2)" "unprognostic (1.23e-1)" 2.5 3.8 1.9 1.2 1.8 3.3 2.2 2.2 3.3 1.1 1.4 1.5 1.4 1.2 0.4 1.5 1.2 0.9 2.6 2.0 1.9 2.6 7.0 1.3 1.3 1.9 2.1 1.8 1.5 3.2 1.3 2.2 0.5 2.1 1.2 0.8 0.6 1.5 0.6 4.3 1.2 1.5 0.4 1.8 1.6 2.2 102.2 2.2 1.7 1.2 3.1 0.8 1.4 1.2 1.8 3.4 9.2 3.2 3.9 3.7 2.1 5.4 3.1 1.3 3.0 2.3 4.4 5.4 8.3 8.6 0.6 3.3 2.7 3.0 2.1 1.4 4.2 5.4 7.9 3.5 6.5 3.2 0.9 1.5 3.7 0.7 3.5 1.1 1.5 2.9 6.1 7.2 4.2 3.6 8.7 3.0 7.4 3.0 2.1 5.5 6.7 1.4 4.8 1.9 1.4 4.0 3.3 7.6 0.4 2.5 1.1 4.5 4.2 3.3 5.5 2.3 3.3 3.0 12.5 10.9 16.2 7.4 8.0 3.8 0.0 2.5 0.6 2.6 2.7 1.8 1.7 2.1 2.3 2.4 1.4 1.7 2.9 0.4 0.7 3.4 3.3 2.9 1.8 1.9 1.8 2.2 3.3 2.0 1.9 1.9 2.1 1.8 2.1 1.8 2.2 1.8 1.9 0.0 1.5 1.0 1.9 1.7 0.5 0.6 6.2 2.5 2.0 2.9 2.4 1.5 0.3 0.0 2.1 2.6 0.4 6.0 1.9 2.8 94.6 0.5 0.4 1.3 0.0 6.9 1.5 3.4 3.4 1.3 4.1 0.4 0.0 0.7 2.2 5.9 2.9 1.7 1.5 3.4 0.0 1.6 1.8 96.2 3.4 0.9 0.0 1.9 2.7 3.7 2.1 1.0 1.8 4.0 2.4 5.3 6.4 0.6 6.4 3.4 1.0 2.2 26.3 0.4 1.8 127.9 8.0 3.0 0.6 1.1 1.1 0.6 5.3 0.4 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium inwardly rectifying channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 7.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8;head and neck cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012184.2 ENSG00000260537 "Novel protein, DDX19B and DDX19A readthrough" 16 70299194-70372582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 34.2;U-698: 35.1" "HPA046380, HPA066668" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046380: AB_2679645, HPA066668: " 3.4 1.8 0.0 4.3 0.0 4.5 1.3 0.0 0.2 0.5 0.0 3.1 4.0 0.5 0.0 4.0 0.5 2.8 4.7 0.0 0.0 2.3 1.9 1.2 4.0 0.0 0.0 0.0 0.2 6.4 1.6 0.0 1.3 0.0 0.9 2.6 0.8 2.2 0.2 6.1 3.0 2.8 1.0 0.0 1.1 3.0 0.0 0.0 1.3 3.1 2.1 5.9 4.4 0.7 0.0 2.2 7.6 5.5 14.4 0.0 6.4 12.7 6.6 7.9 11.8 12.6 14.0 19.2 13.1 8.7 6.4 1.4 7.2 0.0 5.0 6.6 3.9 9.6 8.7 4.5 0.9 7.3 12.2 6.2 4.3 1.1 11.5 0.0 2.3 7.7 3.3 5.3 3.5 4.8 4.8 0.1 0.0 6.7 0.6 1.8 34.2 2.7 22.9 3.6 9.2 7.3 8.1 18.1 3.2 3.2 0.9 5.4 3.0 7.8 8.1 7.6 3.2 4.8 11.0 8.0 35.1 1.0 9.0 13.8 22.4 16.1 11.6 15.5 19.8 12.8 10.4 13.3 15.3 18.2 11.5 11.3 11.3 2.2 15.9 14.8 3.8 22.1 14.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "Early spermatids: 4.9;Late spermatids: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5" "Low region specificity" "Detected in some" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.4 0.0 4.7 6.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.9 0.6 0.0 0.1 0.0 0.2 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092718.2 ENSG00000260643 "Novel protein" 16 81053587-81096296 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 13.4" HPA041368 Approved Approved Vesicles NA NA Vesicles "HPA041368: AB_10804001" "unprognostic (3.87e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (8.06e-2)" "unprognostic (1.08e-1)" "unprognostic (3.95e-2)" "unprognostic (8.11e-2)" "unprognostic (2.85e-1)" "unprognostic (2.42e-1)" "unprognostic (3.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.69e-2)" "unprognostic (2.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.56e-3)" "unprognostic (3.03e-1)" 3.8 2.9 13.3 1.1 14.5 0.5 3.5 13.1 15.6 3.0 12.6 2.3 0.3 2.5 5.1 1.7 4.8 1.3 4.0 13.8 13.5 6.5 9.7 2.6 0.9 14.1 14.2 12.6 3.2 2.9 3.2 8.2 2.8 14.5 4.6 0.8 5.7 2.6 1.7 6.4 1.2 1.4 1.6 12.1 1.3 2.2 6.3 14.1 1.3 14.3 3.0 0.6 3.7 2.7 14.6 4.1 3.1 4.8 3.4 11.1 3.9 5.0 2.1 0.9 1.8 0.3 0.3 4.7 0.6 4.1 0.9 4.1 3.3 3.0 1.3 2.7 1.4 5.3 0.7 1.5 3.1 3.9 3.0 2.6 4.7 5.9 2.8 2.6 5.3 1.9 5.9 3.6 0.3 2.5 4.5 4.1 13.4 2.3 3.2 1.7 11.7 1.0 1.9 7.3 1.6 3.8 3.7 2.4 1.0 4.1 5.1 1.1 4.7 2.1 0.8 1.7 2.2 1.7 2.6 3.3 5.4 2.4 2.1 2.0 0.9 0.4 0.3 1.2 0.3 1.3 1.6 0.8 0.4 1.1 1.5 1.2 0.7 0.3 1.7 0.4 1.8 0.2 1.0 13.3 14.5 13.1 15.6 13.8 13.5 14.1 14.2 12.6 14.5 12.1 14.1 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD20A1 "ANKRD20A, DKFZp434A171" ENSG00000260691 "Ankyrin repeat domain 20 family member A1" Q5TYW2 9 67832765-67920552 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.9;testis: 4.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.8;Excitatory neurons: 14.8;Inhibitory neurons: 9.0;Oligodendrocyte precursor cells: 12.5;Spermatocytes: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 8.7;U-266/70: 8.7;U-266/84: 5.6" "HPA043239, HPA046346, HPA046695, HPA047112, HPA047167, HPA047766, HPA049923, HPA051288, HPA051753" Uncertain Uncertain "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA043239: , HPA046346: AB_2679631, HPA046695: , HPA047112: , HPA047167: , HPA047766: , HPA049923: AB_2680954, HPA051288: AB_2681421, HPA051753: AB_2681592" "unprognostic (4.92e-1)" "unprognostic (4.31e-3)" "unprognostic (3.97e-1)" "unprognostic (2.30e-2)" "unprognostic (5.94e-2)" "unprognostic (2.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-2)" "unprognostic (7.17e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" 0.3 0.2 1.2 0.1 2.4 0.5 0.4 0.1 3.9 0.3 0.0 0.4 0.1 0.2 0.3 0.8 0.4 0.2 0.6 2.6 0.8 0.3 0.2 0.5 0.1 1.1 0.2 0.5 0.2 1.0 0.2 0.7 0.0 1.5 0.4 0.7 0.8 0.4 0.2 0.1 0.4 0.3 0.2 0.1 0.7 0.1 4.5 0.7 0.3 0.5 0.0 0.0 0.1 0.4 3.8 0.2 0.2 1.3 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.3 0.5 0.9 0.3 0.0 0.0 0.2 1.5 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.2 0.3 1.4 0.3 8.7 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.3 0.4 0.8 8.7 5.6 0.0 0.3 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 2.4 0.1 3.9 2.6 0.8 1.1 0.2 0.5 1.5 0.1 0.7 3.8 0.0 3.2 2.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.3 1.2 0.2 0.0 0.8 0.0 0.0 14.8 1.8 0.0 0.3 1.5 0.1 1.3 0.5 0.0 0.0 0.0 0.0 9.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.0 0.0 12.5 0.3 0.5 2.5 0.0 0.0 0.0 1.8 0.0 2.2 0.0 0.0 0.0 0.2 10.3 1.9 0.7 0.0 0.0 0.4 0.0 1.3 0.1 TLE7 ENSG00000260734 "TLE family member 7" A0A1W2PR48 16 71429980-71442054 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 26 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERTM2 LINC00890 ENSG00000260802 "Serine rich and transmembrane domain containing 2" A0A1B0GWG4 X 111511662-111522399 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "endometrium 1: 27.6;epididymis: 42.3;seminal vesicle: 76.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;granulocytes: 1.3" "Cancer enhanced" "Detected in some" "prostate cancer: 2.9;renal cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 16.9" "Region enhanced" "Detected in some" "basal ganglia: 2.8" "Low region specificity" "Detected in many" NA NA "unprognostic (9.56e-2)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (2.42e-1)" "unprognostic (2.65e-1)" "unprognostic (3.79e-2)" "unprognostic (5.74e-2)" "unprognostic (1.93e-2)" "unprognostic (4.03e-2)" "unprognostic (3.51e-1)" "unprognostic (8.77e-3)" "unprognostic (3.86e-3)" "unprognostic (1.94e-1)" "unprognostic (2.26e-1)" "unprognostic (9.57e-3)" 0.0 0.1 0.1 0.8 0.0 0.0 0.3 0.0 0.1 9.0 0.0 1.3 0.1 27.6 42.3 0.0 4.2 0.2 0.0 0.0 0.5 0.2 5.4 0.2 0.1 0.3 0.2 0.0 0.8 0.0 0.0 1.0 0.3 0.3 9.9 0.1 0.3 0.0 76.5 0.0 0.0 0.4 4.8 0.1 0.4 2.1 0.0 0.5 0.0 0.0 0.0 0.3 0.7 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.3 0.2 0.0 0.3 0.1 0.5 0.2 0.1 3.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 AC245033.1 ENSG00000260836 "Novel protein" 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 32.1;Alveolar cells type 2: 45.1;Club cells: 8.6;granulocytes: 12.6;Respiratory ciliated cells: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-2197: 12.6" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: AB_2682686" "unprognostic (2.91e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.4 0.4 12.6 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.6 0.3 0.0 0.3 0.2 0.1 0.5 0.3 0.3 0.8 0.0 32.1 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 AL049634.2 ENSG00000260861 "Novel protein, SIRPB1-SIRPD readthrough" 20 1540144-1620009 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.7;lymphoid tissue: 2.6;testis: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 78.3;neutrophil: 127.7" "Group enriched" "Detected in many" 7 "granulocytes: 127.7;monocytes: 43.6" "Cell line enhanced" "Detected in some" "HL-60: 3.5;HMC-1: 6.7;NB-4: 2.6;THP-1: 4.0;U-937: 2.1" NA NA 0.4 0.8 0.1 2.6 0.1 2.7 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.7 0.8 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.6 0.6 0.2 0.8 0.1 3.4 0.4 0.2 0.0 0.0 0.4 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.7 0.0 0.1 0.2 0.0 1.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.0 1.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 2.1 0.1 0.6 35.3 78.3 0.6 27.5 0.3 0.1 0.0 0.4 12.9 0.0 0.1 0.1 127.7 0.2 43.6 10.4 0.2 26.0 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XKR7 "C20orf159, dJ310O13.4" ENSG00000260903 "XK related 7" Q5GH72 20 31968151-32003387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 8.9;pituitary gland: 4.3;retina: 4.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.1;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.1;Early spermatids: 2.1;Excitatory neurons: 4.5;Horizontal cells: 1.7;Inhibitory neurons: 4.8;Late spermatids: 2.1;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 8.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 20.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.3" HPA040854 Uncertain NA NA "HPA040854: AB_10795481" "unprognostic (2.74e-2)" "unprognostic (5.60e-3)" "unprognostic (8.03e-2)" "unprognostic (3.74e-7)" "unprognostic (4.29e-2)" "unprognostic (9.34e-2)" "unprognostic (1.45e-1)" "unprognostic (2.69e-2)" "unprognostic (4.47e-2)" "unprognostic (2.68e-3)" "unprognostic (2.12e-1)" "unprognostic (1.26e-3)" "unprognostic (3.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-5)" "unprognostic (1.99e-1)" 0.0 0.2 1.0 0.0 3.0 0.0 0.0 8.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 1.0 0.9 2.3 0.0 0.3 0.0 4.3 0.0 2.3 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 20.9 4.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.0 8.9 1.9 1.3 0.8 1.0 0.9 2.3 2.3 0.0 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.8 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AC026464.4 ENSG00000260914 "Novel protein" 16 69299682-69322700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 158.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA060092 Approved Midbody Yes NA Midbody "HPA060092: AB_2684203" "unprognostic (2.95e-1)" "unprognostic (4.21e-1)" "unprognostic (7.34e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-1)" "unprognostic (3.50e-1)" "unprognostic (4.08e-2)" "unprognostic (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (5.11e-2)" 44.5 30.7 23.6 29.4 26.9 28.9 32.0 25.1 37.4 27.4 14.9 33.0 30.8 32.9 12.4 42.1 29.7 22.2 43.6 27.1 27.9 30.6 20.9 29.1 28.3 27.9 25.7 25.0 34.0 47.6 48.0 16.2 29.7 29.2 28.0 26.6 35.7 36.4 26.8 158.1 33.8 35.4 32.0 24.0 30.1 32.0 18.9 26.2 26.5 30.5 98.0 30.3 32.5 28.6 30.1 64.9 56.5 65.5 62.3 48.9 51.3 36.9 80.1 53.7 83.6 54.6 72.3 35.1 61.6 81.7 64.5 42.9 49.7 62.2 54.6 52.9 38.2 30.0 48.9 30.1 37.3 61.5 62.3 49.8 43.7 73.8 69.2 75.7 47.9 70.0 52.4 63.2 29.6 68.7 84.5 62.1 30.8 53.1 42.7 27.0 94.3 37.4 82.1 38.7 41.2 67.7 38.1 107.8 35.6 47.7 39.9 50.7 43.0 74.0 77.7 55.5 67.8 61.3 101.4 78.6 147.0 78.7 23.3 94.8 16.1 25.4 36.1 31.0 20.7 28.4 23.0 27.4 36.9 26.8 20.2 27.7 27.4 17.1 22.5 28.3 18.5 28.5 33.7 23.6 26.9 25.1 37.4 27.1 27.9 27.9 25.7 25.0 29.2 24.0 26.2 30.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 279.2;neutrophil: 296.6" "Group enriched" "Detected in all" 7 "granulocytes: 296.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: AB_2668242, HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavorable (5.07e-4)" "prognostic unfavorable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 39.2 38.2 25.0 23.9 29.0 64.4 34.4 24.8 29.3 61.6 37.2 33.6 24.5 27.0 36.4 20.3 22.2 54.3 56.8 24.6 25.0 52.0 67.5 39.7 22.4 19.4 17.5 25.2 23.1 85.6 73.9 32.6 27.7 21.5 41.3 33.5 48.6 77.8 42.7 53.4 13.6 25.9 33.8 14.4 28.9 47.9 29.9 25.0 12.3 85.1 35.6 24.4 30.2 9.8 24.3 13.9 47.7 10.9 24.4 173.6 59.3 15.5 30.0 56.4 17.2 26.1 14.4 23.5 20.8 99.5 97.5 33.6 18.7 9.5 25.1 14.4 55.5 14.2 28.1 58.4 12.8 223.9 39.6 84.2 49.5 59.8 35.6 34.4 143.3 65.2 0.8 47.7 337.4 55.1 17.9 0.2 19.3 6.5 54.4 11.8 6.2 17.4 84.8 36.1 10.1 14.0 21.5 35.3 19.5 151.4 35.0 31.0 85.1 65.7 50.8 11.1 38.9 20.4 65.2 259.6 13.0 95.6 77.2 41.0 220.8 59.4 279.2 26.8 50.7 22.5 18.1 16.6 20.7 27.6 13.4 13.9 20.0 296.6 25.7 84.2 4.7 23.0 32.9 25.0 29.0 24.8 29.3 24.6 25.0 19.4 17.5 25.2 21.5 14.4 25.0 24.3 92.3 115.4 118.1 0.0 44.6 15.4 30.3 99.2 13.6 68.7 40.2 40.1 14.4 50.1 136.5 88.3 93.8 29.3 42.9 43.7 5.9 60.9 136.2 49.6 41.0 60.1 16.7 25.2 0.0 145.3 23.2 78.6 33.1 62.3 39.1 30.0 76.1 96.1 51.0 85.8 0.0 28.8 114.0 55.9 25.2 216.1 56.5 71.7 48.0 0.0 89.8 72.6 38.1 0.0 0.0 67.6 45.1 116.6 180.8 42.6 29.5 36.7 123.8 128.0 52.6 80.2 48.1 43.3 41.1 11.8 16.6 24.6 41.8 70.0 16.2 21.8 SULT1A3 "STM, TL-PST" ENSG00000261052 "Sulfotransferase family 1A member 3" P0DMM9 16 30199228-30204310 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 239.4" "Cell type enriched" "Detected in many" 4 "Proximal enterocytes: 129.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "classical monocyte: 61.3;intermediate monocyte: 53.2;myeloid DC: 33.7;non-classical monocyte: 25.0" "Group enriched" "Detected in all" 11 "dendritic cells: 33.7;monocytes: 61.3" "Cell line enhanced" "Detected in all" "CAPAN-2: 166.9;Hep G2: 303.6;Karpas-707: 239.4" "HPA049500, HPA051051" Supported NA NA 160000 "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (2.61e-1)" "unprognostic (1.72e-3)" "unprognostic (1.98e-3)" "unprognostic (4.98e-2)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (7.27e-2)" "unprognostic (2.09e-2)" "unprognostic (2.99e-2)" "unprognostic (2.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.18e-8)" "unprognostic (2.34e-2)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (9.48e-5)" 15.9 13.8 56.4 22.1 56.8 37.1 15.9 59.6 73.5 15.5 57.7 57.9 239.4 17.0 18.1 14.5 18.1 15.0 10.4 56.9 57.5 25.8 34.8 26.8 30.5 57.1 57.1 57.3 10.9 16.0 17.7 24.0 22.6 61.1 20.2 46.9 23.4 26.0 17.9 11.2 25.9 147.8 24.7 54.7 32.1 22.4 9.7 57.7 16.5 20.4 19.1 29.6 13.6 10.6 63.1 32.6 48.8 30.6 21.3 28.4 19.8 46.0 15.8 16.9 16.7 18.9 21.1 166.9 16.9 150.0 16.0 10.9 45.5 38.8 14.0 16.7 19.9 30.6 93.2 61.2 303.6 11.1 14.2 34.9 21.9 20.9 25.4 5.9 34.2 30.6 21.9 19.0 239.4 12.0 55.4 9.6 62.3 19.1 76.2 20.9 38.6 14.8 32.2 29.4 22.0 15.3 24.7 4.8 43.0 7.8 11.4 23.8 22.1 38.3 34.0 17.4 29.4 11.7 28.8 78.1 8.7 17.4 31.7 20.5 1.9 61.3 0.3 4.3 53.2 0.9 3.4 1.1 1.5 33.7 1.7 0.8 0.7 1.6 1.4 25.0 0.5 0.9 20.4 56.4 56.8 59.6 73.5 56.9 57.5 57.1 57.1 57.3 61.1 54.7 57.7 63.1 3.3 12.8 12.0 0.0 4.2 2.0 2.2 1.2 0.6 5.3 2.4 1.3 1.8 4.3 7.6 0.0 8.4 5.3 2.8 13.9 0.0 3.3 1.3 0.9 0.9 5.8 1.2 6.1 0.0 4.0 2.3 4.4 2.6 1.3 1.3 1.7 3.9 2.8 1.5 1.7 0.0 13.4 2.0 5.0 3.7 0.5 0.9 2.6 1.8 0.0 4.9 2.6 4.1 0.0 0.0 6.3 25.3 1.9 1.4 4.3 129.1 0.5 2.3 6.7 0.0 1.7 1.7 0.8 0.3 0.9 2.7 3.0 3.8 1.2 26.8 2.1 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074064-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 10.9;parathyroid gland: 12.0;tongue: 12.3" "Group enriched" "Detected in many" 5 "Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.3 1.4 3.2 0.6 5.1 0.0 0.6 0.3 7.5 0.3 0.0 0.6 0.0 0.8 0.4 0.7 0.3 0.3 10.9 6.2 5.0 1.3 0.0 0.3 1.4 1.7 5.7 5.0 0.1 1.0 12.0 4.3 0.0 3.6 2.3 0.3 5.6 1.3 0.6 4.6 0.2 0.4 1.1 0.0 0.7 0.3 0.5 5.3 1.4 8.5 12.3 3.1 0.5 0.2 2.2 0.0 0.1 0.0 0.0 0.5 0.2 1.5 0.1 2.3 0.7 0.8 0.0 0.0 1.9 2.0 0.1 0.5 0.0 6.0 0.0 1.9 5.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 5.1 0.0 0.0 0.4 0.9 2.6 8.2 2.4 6.4 3.9 0.1 0.2 0.9 1.2 0.8 0.0 0.0 0.1 0.9 2.7 0.0 0.0 0.0 0.0 0.4 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.1 0.3 7.5 6.2 5.0 1.7 5.7 5.0 3.6 0.0 5.3 2.2 1.3 0.0 0.0 175.0 0.0 0.5 0.7 0.9 0.6 25.5 1.4 0.5 48.7 0.0 1.3 1.8 2.1 0.0 0.0 0.0 1.9 0.1 1.3 0.2 0.1 1.2 0.0 0.0 584.8 0.4 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 30.3 566.2 0.0 2.0 0.0 0.0 1.6 0.0 0.1 1.8 24.4 0.0 4.2 0.0 306.1 81.3 0.8 0.0 0.7 0.0 2.2 0.0 3.4 0.2 1.8 0.0 3.9 0.8 1.4 0.7 2.9 0.1 0.3 0.3 0.2 0.1 2.0 AC140504.1 ENSG00000261130 "MPV17 mitochondrial inner membrane protein like" 16 15395754-15515348 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPPK1 EPIPL1 ENSG00000261150 "Epiplakin 1" P58107 8 143857324-143878467 "Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 15.4" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 137.1;Suprabasal keratinocytes: 274.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.3;EFO-21: 13.3;HaCaT: 13.8;HeLa: 26.8;MCF7: 20.2;SK-BR-3: 9.3" "Not detected" "Not detected" "HPA066808, HPA067357, HPA069333" Approved Enhanced "Intermediate filaments" NA NA 1200000 "Intermediate filaments" "HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (5.52e-5)" "unprognostic (2.85e-2)" "unprognostic (5.86e-3)" "unprognostic (4.90e-2)" "unprognostic (8.73e-2)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.35e-1)" "unprognostic (1.97e-3)" "unprognostic (5.94e-3)" "unprognostic (4.35e-1)" "unprognostic (3.68e-3)" "unprognostic (5.08e-3)" 0.1 0.0 1.1 0.3 0.8 0.1 1.0 4.5 0.5 0.3 1.0 2.9 2.2 2.4 0.3 1.7 2.0 0.2 0.0 0.9 0.9 1.1 0.3 0.9 0.1 2.6 1.9 0.3 0.0 0.7 0.2 0.2 0.2 1.6 1.4 0.6 0.0 2.3 1.4 0.2 15.4 2.7 0.9 1.7 1.2 2.1 1.8 1.2 0.1 0.2 0.0 0.2 1.9 0.9 0.4 7.9 0.1 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 7.4 0.5 0.0 13.3 0.0 0.0 13.8 1.4 0.1 0.0 0.0 3.4 0.0 26.8 4.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 20.2 0.0 0.0 1.4 1.8 0.0 0.0 0.1 0.0 0.0 4.9 2.3 0.0 2.2 9.3 0.0 1.2 7.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 4.5 0.5 0.9 0.9 2.6 1.9 0.3 1.6 1.7 1.2 0.4 0.7 19.2 9.2 1.0 1.1 137.1 20.3 8.2 8.0 0.6 32.7 25.0 27.9 11.5 4.4 14.7 0.0 2.5 0.0 48.1 0.0 11.3 0.5 12.6 0.5 3.2 6.0 0.0 0.3 14.7 0.3 2.4 12.2 10.1 0.0 0.6 0.7 4.4 0.3 0.0 0.0 14.5 12.2 0.0 8.2 0.3 0.0 0.4 16.0 0.0 0.0 0.6 0.0 0.0 0.1 31.9 21.7 0.0 0.2 8.6 28.2 7.0 24.2 0.2 0.0 0.0 5.2 1.5 1.0 10.6 274.3 6.2 1.2 0.1 28.4 31.5 CLEC19A ENSG00000261210 "C-type lectin domain containing 19A" Q6UXS0 16 19285731-19322145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "brain: 3.0" "Group enriched" "Detected in some" 4 "Microglial cells: 6.5;Respiratory ciliated cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (3.19e-1)" "unprognostic (3.72e-1)" "unprognostic (1.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" 0.0 0.0 2.7 0.0 1.7 0.0 0.0 1.3 1.9 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 0.1 0.0 0.6 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.7 1.3 1.9 2.3 0.2 0.6 1.2 3.0 0.5 0.0 0.6 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605647-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 35.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA068079: AB_2685947" "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 8.2 7.9 4.6 3.0 4.3 4.3 8.5 5.2 6.5 10.0 0.1 11.3 3.7 12.5 0.9 7.5 10.2 0.7 15.0 4.7 1.7 8.4 8.1 8.6 2.4 5.1 3.6 3.2 11.1 10.0 3.7 10.5 1.6 5.5 11.6 1.0 1.6 8.6 2.1 35.2 11.2 9.5 1.3 1.7 13.1 9.4 4.1 3.3 3.1 10.7 6.3 1.3 10.8 8.1 3.6 7.4 5.9 2.5 4.1 2.7 2.1 6.9 5.2 2.9 2.8 2.7 1.9 4.7 8.5 5.8 3.8 1.4 6.1 1.6 3.2 1.1 8.5 19.4 4.9 3.8 2.6 4.3 5.7 9.3 3.1 4.9 3.4 2.0 2.5 1.9 5.2 9.6 5.7 1.8 3.5 8.9 6.1 5.7 4.3 10.3 13.8 4.0 5.4 3.3 5.0 6.0 9.7 7.2 4.3 4.6 1.3 3.4 8.8 5.6 4.2 10.1 3.9 6.6 11.9 11.0 4.4 5.2 4.3 6.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 4.3 5.2 6.5 4.7 1.7 5.1 3.6 3.2 5.5 1.7 3.3 3.6 7.2 0.0 0.0 3.9 6.3 4.1 1.3 3.1 8.0 5.3 5.4 3.7 20.5 4.3 1.3 14.7 0.0 2.6 3.4 8.3 5.9 3.7 2.3 3.0 3.5 5.4 6.0 3.0 3.2 4.5 3.2 5.2 8.6 3.6 0.0 6.9 7.1 6.7 4.7 10.1 3.0 5.6 4.1 5.3 5.8 5.2 5.3 5.1 5.4 1.0 4.0 4.5 3.1 4.0 2.7 6.1 1.8 10.1 4.5 1.4 5.8 4.0 1.6 3.3 6.6 4.3 6.4 1.3 1.2 4.5 4.3 2.6 5.7 5.6 6.1 1.1 BOP1 KIAA0124 ENSG00000261236 "BOP1 ribosomal biogenesis factor" Q14137 8 144262045-144291438 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 223.5" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA047869: AB_2680193, HPA066764: AB_2685716" "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 17.0 18.0 6.2 8.9 6.3 9.8 16.5 7.1 11.0 15.4 2.9 16.5 5.6 18.4 1.0 26.2 13.4 2.9 20.7 6.9 5.3 12.1 21.7 13.4 8.0 6.4 5.7 7.0 11.2 32.2 5.6 17.0 3.7 6.6 15.4 1.9 1.1 13.3 3.1 77.2 21.0 15.0 3.1 3.9 20.5 15.6 20.3 5.5 5.4 17.1 8.2 3.6 19.4 16.6 5.7 45.0 87.4 11.8 50.6 6.4 7.7 41.4 30.5 6.5 30.3 19.1 66.3 25.4 54.1 50.1 11.6 11.5 34.9 21.2 36.2 6.9 47.8 82.5 68.4 54.4 49.7 15.1 30.8 35.6 15.5 17.0 25.2 22.1 5.7 18.8 48.3 70.1 18.1 11.9 112.8 82.4 37.6 28.3 45.1 223.5 61.4 17.6 82.2 12.5 30.1 64.7 25.8 32.5 41.9 20.3 5.5 30.6 27.7 36.6 27.8 83.3 37.1 88.5 16.5 11.7 45.6 20.3 48.6 36.7 0.0 2.2 1.3 1.9 2.3 2.1 2.5 2.2 2.5 3.0 1.8 2.0 1.8 0.1 1.8 2.0 2.0 2.0 1.2 6.2 6.3 7.1 11.0 6.9 5.3 6.4 5.7 7.0 6.6 3.9 5.5 5.7 12.8 9.6 5.1 3.9 16.7 0.5 18.7 0.0 13.1 9.8 12.7 13.8 7.2 10.0 3.7 11.0 0.0 25.2 20.9 18.7 5.9 25.8 11.2 7.5 10.7 12.0 26.9 22.1 4.4 21.7 45.3 13.2 17.3 8.3 10.2 13.5 4.6 14.8 21.5 15.2 3.5 11.5 0.0 11.1 0.0 24.3 10.5 12.8 0.0 1.0 16.2 16.7 18.6 5.0 2.8 26.4 11.3 9.8 25.4 39.5 11.3 17.2 1.5 4.6 13.1 12.9 15.1 13.9 53.4 25.7 0.1 17.8 11.8 29.6 31.8 14.3 GOLGA8T ENSG00000261247 "Golgin A8 family member T" H3BQL2 15 30135149-30145567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 7.0" "Cell type enriched" "Detected in single" 6 "Early spermatids: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (5.20e-2)" "unprognostic (5.37e-2)" "unprognostic (2.10e-2)" 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.2 0.0 0.4 0.0 0.2 0.4 0.0 0.6 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.2 7.0 0.0 0.0 1.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC22 PBMUCL1 ENSG00000261272 "Mucin 22" E2RYF6 6 31010474-31035402 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "esophagus: 18.0" "Cell type enriched" "Detected in single" 6 "Microglial cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.46e-1)" "unprognostic (1.91e-1)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.65e-1)" "unprognostic (1.35e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FIGNL2 ENSG00000261308 "Fidgetin like 2" A6NMB9 12 51817899-51848718 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.2;parathyroid gland: 2.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 17.4;BEWO: 11.4;NTERA-2: 7.0;SuSa: 12.7" "Not detected" "Not detected" NA NA "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.26e-2)" "unprognostic (7.36e-4)" "unprognostic (1.99e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.71e-2)" "unprognostic (4.75e-2)" "unprognostic (6.40e-2)" "unprognostic (9.78e-6)" "unprognostic (7.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.15e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.48e-2)" 0.5 0.0 0.6 0.2 0.8 0.0 0.2 1.1 1.0 0.2 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.8 0.6 2.2 0.5 0.3 0.3 0.9 0.6 1.0 0.0 0.1 2.2 0.4 0.8 0.7 0.2 0.1 0.4 0.7 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.4 0.5 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.6 0.0 0.1 17.4 0.0 0.2 0.1 11.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 1.7 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.0 7.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 2.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.1 1.0 0.8 0.6 0.9 0.6 1.0 0.7 0.2 0.7 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 AC010325.1 ENSG00000261341 "Uncharacterized LOC105372440" 19 50776141-50793142 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "testis: 217.8" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.3;Exocrine glandular cells: 2.0;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;HEK 293: 6.5;hTERT-HME1: 4.0;NTERA-2: 3.9" NA NA "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (2.63e-2)" "unprognostic (2.47e-1)" "unprognostic (9.62e-3)" "unprognostic (9.41e-2)" "unprognostic (1.11e-2)" "unprognostic (5.95e-3)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.52e-1)" "unprognostic (5.32e-7)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.37e-3)" "unprognostic (3.00e-1)" 0.1 0.4 0.4 0.1 0.3 0.6 0.2 1.5 1.4 0.0 0.0 0.1 0.0 0.6 2.6 0.2 0.2 0.1 0.0 0.6 0.0 0.0 0.1 0.1 0.4 0.4 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.5 0.3 0.2 0.3 0.1 0.1 9.0 0.1 0.0 0.0 0.5 0.2 217.8 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.2 0.5 0.0 4.9 1.5 0.0 0.0 0.9 1.3 0.0 2.7 2.0 0.0 0.1 0.1 0.3 0.4 0.4 1.0 0.2 0.0 0.1 0.8 6.5 0.3 0.0 0.5 0.0 0.4 0.5 0.0 0.0 0.9 4.0 0.0 1.3 0.6 1.5 3.0 0.3 0.6 0.5 0.1 3.9 0.0 0.4 0.3 2.5 0.6 0.2 1.0 0.5 0.4 0.3 0.0 0.0 0.3 0.3 0.2 0.0 0.0 1.4 2.2 0.1 0.3 2.2 0.7 1.0 0.7 1.5 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.3 0.6 0.8 0.4 0.2 0.1 0.1 0.3 0.1 0.8 0.6 0.3 0.4 0.3 1.5 1.4 0.6 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 2.0 0.3 0.6 0.0 0.3 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 PECAM1 CD31 ENSG00000261371 "Platelet and endothelial cell adhesion molecule 1" P16284 17 64319415-64413776 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 458.9" "Cell type enhanced" "Detected in many" "Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 702.3" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HUVEC TERT2: 773.0;TIME: 537.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004690, HPA004871" Enhanced Approved "Nucleoli,Plasma membrane" NA NA 110000000 "Plasma membrane" Nucleoli "HPA004690: AB_1078462, HPA004871: " "unprognostic (2.79e-1)" "unprognostic (2.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (4.42e-3)" "unprognostic (2.84e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.25e-2)" "unprognostic (4.53e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (8.98e-5)" "unprognostic (9.72e-3)" "unprognostic (9.57e-2)" "unprognostic (1.56e-1)" "unprognostic (4.16e-2)" 171.4 21.6 21.4 79.7 20.6 35.8 129.6 21.7 29.2 55.4 36.7 38.3 30.0 51.5 9.2 54.8 45.5 89.4 71.0 17.5 21.7 43.6 22.6 206.7 68.6 24.3 22.5 15.0 10.8 21.5 30.2 9.7 458.9 22.6 23.7 38.1 4.0 33.7 24.7 36.0 32.7 39.8 84.3 24.0 95.7 31.1 5.0 28.9 63.0 70.4 97.8 60.9 84.8 36.0 27.3 0.1 0.3 1.3 0.1 1.1 1.5 0.4 0.2 0.3 0.0 0.1 4.7 0.1 4.2 121.1 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 95.0 1.8 2.2 3.7 0.5 0.3 0.3 0.0 0.8 0.2 1.6 773.0 34.1 2.3 57.8 0.1 0.4 33.3 8.1 0.1 0.0 9.1 1.4 15.3 3.8 0.0 0.1 0.4 0.3 1.8 0.0 0.1 0.2 0.0 48.5 537.8 0.8 0.5 0.9 0.2 3.4 6.3 6.8 1.6 6.7 0.1 54.8 263.9 219.2 19.8 419.6 18.9 26.7 2.2 46.6 154.0 32.7 36.3 68.6 392.0 40.3 702.3 88.6 2.1 224.2 21.4 20.6 21.7 29.2 17.5 21.7 24.3 22.5 15.0 22.6 24.0 28.9 27.3 672.9 16.0 37.9 0.7 24.4 0.0 0.5 0.0 4.0 0.0 4.8 4.6 23.3 1.5 3.1 9.2 0.0 0.5 50.1 0.0 0.0 0.8 0.9 1.1 1.1 468.2 0.0 17.9 1.2 0.2 4.0 22.0 0.0 1.6 8.8 0.0 275.3 3.0 45.8 0.0 1.2 0.0 0.0 110.4 0.0 1.1 2.5 143.9 0.0 47.8 93.8 0.3 26.8 0.5 1.3 0.1 0.0 1.9 109.1 1.3 0.0 0.5 7.3 1.2 0.0 6.9 15.8 0.1 0.5 1.6 0.0 0.8 21.2 4.3 0.1 1.0 TUBB8 bA631M21.2 ENSG00000261456 "Tubulin beta 8 class VIII" Q3ZCM7 10 46888-74163 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.75e-2)" "unprognostic (6.02e-2)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-1)" "unprognostic (1.80e-1)" "unprognostic (7.74e-2)" "unprognostic (8.33e-3)" "unprognostic (1.50e-1)" "unprognostic (4.15e-3)" "unprognostic (7.17e-2)" "unprognostic (3.30e-2)" "unprognostic (1.33e-3)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.19e-2)" "unprognostic (6.86e-3)" 0.1 0.1 0.4 0.1 0.3 0.0 0.2 0.2 0.6 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.3 0.3 0.0 0.1 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.1 2.4 0.3 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.4 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 13.0 15.9 0.0 0.0 0.0 0.0 0.4 0.0 0.6 TP53TG3B ENSG00000261509 "TP53 target 3B" Q9ULZ0 16 33360274-33363478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "epididymis: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM249 C8orfK29 ENSG00000261587 "Transmembrane protein 249" Q2WGJ8 8 144352219-144354914 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 27.9" "Group enriched" "Detected in some" 9 "Early spermatids: 32.4;Late spermatids: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA078901 Approved NA NA "HPA078901: " "unprognostic (2.23e-1)" "unprognostic (8.91e-3)" "unprognostic (1.72e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.03e-4)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (3.21e-1)" "unprognostic (1.13e-7)" "unprognostic (6.56e-3)" "unprognostic (1.62e-2)" "unprognostic (8.44e-3)" "unprognostic (3.46e-2)" 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 27.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.2 0.0 0.0 0.2 0.3 0.4 0.0 0.1 0.4 0.0 0.2 0.3 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 32.4 0.1 0.2 0.1 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 3.3 1.6 0.3 0.0 0.0 0.0 30.4 0.6 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.4 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.1 1.1 0.7 0.0 0.0 0.0 0.1 0.0 0.4 0.0 TPBGL ENSG00000261594 "Trophoblast glycoprotein like" P0DKB5 11 75240774-75243704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.9;testis: 4.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 16.9;Melanocytes: 3.6;Muller glia cells: 10.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Region enhanced" "Detected in many" "medulla oblongata: 9.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;HMC-1: 1.8;SCLC-21H: 1.8" "Low region specificity" "Detected in many" NA NA "unprognostic (1.55e-2)" "unprognostic (4.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.70e-3)" "unprognostic (1.93e-2)" "unprognostic (5.52e-2)" "unprognostic (1.50e-1)" "unprognostic (2.27e-2)" "unprognostic (1.02e-1)" "unprognostic (3.73e-2)" "unprognostic (3.12e-2)" "unprognostic (3.47e-2)" "unprognostic (1.49e-14)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" 0.3 1.7 2.1 0.4 3.0 0.0 0.2 0.0 3.4 0.3 0.0 0.2 0.1 0.9 0.0 0.1 0.3 0.3 0.1 1.2 0.9 0.2 0.1 0.2 0.2 9.9 0.6 2.4 0.2 0.1 0.0 0.3 0.0 1.5 0.1 0.1 1.4 0.1 0.1 0.0 0.1 0.2 0.6 0.3 0.2 0.1 4.5 1.4 0.1 0.1 0.0 0.2 0.2 0.2 0.9 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.0 0.0 3.4 1.2 0.9 9.9 0.6 2.4 1.5 0.3 1.4 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.8 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 GAN "GAN1, GIG, KLHL16" ENSG00000261609 Gigaxonin Q9H2C0 16 81314944-81390809 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 25.1" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011825, HPA049473" Approved Supported Microtubules NA NA Microtubules "CAB011825: AB_732515, HPA049473: AB_2680782" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (8.23e-2)" "unprognostic (2.51e-2)" "unprognostic (8.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.42e-4)" "unprognostic (1.90e-1)" "unprognostic (3.86e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-3)" "unprognostic (5.91e-3)" "unprognostic (3.12e-3)" "unprognostic (5.93e-2)" "unprognostic (9.98e-2)" "unprognostic (1.46e-2)" "unprognostic (5.86e-2)" 1.2 0.9 6.9 0.7 5.5 0.7 2.4 7.5 5.2 1.9 1.1 2.2 0.8 1.4 1.1 5.5 1.3 0.6 1.4 7.1 8.3 0.8 1.1 1.7 0.7 9.2 8.3 4.1 1.4 1.2 0.8 1.4 0.8 6.3 2.0 1.2 3.2 2.3 0.7 1.5 25.1 1.4 0.9 8.5 0.9 1.8 1.0 8.5 0.9 1.1 1.4 1.3 1.5 4.4 9.6 1.6 2.0 1.5 2.1 1.9 1.0 10.4 1.2 0.7 0.8 0.3 5.1 1.8 2.5 1.4 1.6 0.4 3.1 2.7 1.3 1.8 0.6 1.4 2.2 1.8 4.1 2.0 2.1 2.4 1.1 3.8 1.3 3.5 1.1 1.7 2.1 2.8 1.1 1.1 9.1 1.9 2.9 4.0 2.2 0.6 3.7 1.4 1.0 1.6 5.0 1.5 1.0 4.3 4.2 1.4 3.6 2.9 2.0 2.5 2.3 2.1 0.8 1.9 2.2 2.7 5.8 1.2 2.4 1.7 0.7 0.4 0.2 0.8 0.4 0.7 0.4 0.8 0.6 0.2 0.5 0.7 0.9 0.3 0.9 0.3 0.9 0.6 0.2 6.9 5.5 7.5 5.2 7.1 8.3 9.2 8.3 4.1 6.3 8.5 8.5 9.6 12.2 12.8 8.2 69.5 9.9 91.3 66.8 15.0 34.1 28.4 15.4 18.5 12.5 7.2 29.5 5.5 89.6 19.3 17.4 27.5 0.0 9.4 2.3 11.6 19.3 14.7 5.4 12.6 21.2 6.7 15.4 14.1 17.3 14.0 1.3 7.2 12.1 6.7 5.6 23.5 29.5 15.1 10.2 6.8 30.9 4.6 9.6 8.6 37.4 14.0 7.5 14.0 9.2 22.1 18.3 18.6 16.8 12.8 11.0 75.0 14.8 3.8 30.1 43.8 6.6 20.2 17.6 11.9 16.4 67.1 130.4 21.3 16.1 5.3 15.6 188.7 GOLGA6L7 GOLGA6L7P ENSG00000261649 "Golgin A6 family like 7" A0A1B0GV03 15 28841833-28848675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;U-266/70: 1.3;U-266/84: 1.3" NA NA "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (3.65e-5)" "unprognostic (3.84e-1)" "unprognostic (6.81e-2)" "unprognostic (1.66e-2)" "unprognostic (5.10e-2)" "unprognostic (5.62e-11)" "unprognostic (2.53e-1)" "unprognostic (3.14e-1)" "unprognostic (2.59e-1)" 0.0 0.2 0.6 0.0 0.5 0.1 0.0 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 28.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.3 1.4 0.4 0.2 1.3 0.8 0.3 1.6 0.3 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408495-55418798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 168.5;Endometrial ciliated cells: 79.4;Respiratory ciliated cells: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "hTCEpi: 13.2;SK-MEL-30: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 1.3 2.1 3.6 0.5 3.3 0.6 3.2 3.2 3.4 4.3 5.0 3.5 1.8 1.9 6.0 0.8 7.9 3.1 4.5 3.1 3.5 5.3 1.3 2.3 1.1 3.9 3.6 2.8 1.3 8.6 4.6 8.9 0.5 3.5 3.3 3.6 7.5 9.1 2.7 6.9 1.4 1.6 2.1 3.6 1.2 6.3 9.1 3.4 1.5 4.0 2.8 1.1 1.6 1.1 3.8 0.9 1.3 2.7 1.7 4.0 5.8 0.4 1.5 2.2 1.2 2.5 0.0 1.5 1.2 4.0 5.1 3.2 1.2 0.0 2.5 0.4 2.5 1.8 1.2 9.3 0.4 7.6 2.8 1.5 1.9 13.2 3.8 1.0 6.9 2.4 0.0 2.3 4.0 5.8 2.1 0.1 7.6 0.7 4.8 3.0 0.5 0.0 10.5 7.0 0.0 7.7 4.3 1.9 3.2 13.0 1.1 6.4 2.7 1.8 2.1 0.9 2.0 0.7 1.8 4.8 1.0 5.9 6.7 1.1 4.7 0.4 1.7 0.2 0.7 0.0 0.9 0.0 0.3 0.3 0.8 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 3.6 3.3 3.2 3.4 3.1 3.5 3.9 3.6 2.8 3.5 3.6 3.4 3.8 3.3 3.2 1.1 4.6 3.3 1.3 3.7 13.1 2.2 1.7 8.6 10.8 7.8 5.7 8.0 5.5 0.0 1.1 0.5 6.7 17.6 8.8 168.5 79.4 4.1 3.9 3.6 0.4 4.0 11.0 1.5 3.6 5.1 7.2 4.5 1.9 4.6 1.7 2.9 3.3 2.7 18.8 14.2 1.9 1.9 17.0 4.4 1.0 3.6 1.0 0.8 5.1 0.0 1.0 0.9 6.6 16.8 5.7 2.6 4.8 1.9 22.5 47.5 8.2 6.6 3.2 3.4 23.9 3.6 0.8 1.7 0.0 1.0 4.2 4.8 2.1 LY6L ENSG00000261667 "Lymphocyte antigen 6 family member L" H3BQJ8 8 143080457-143083001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;kidney: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "prostate cancer: 2.8" "Region enhanced" "Detected in single" "midbrain: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (5.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCRT1 "DKFZp547F072, ZNF898" ENSG00000261678 "Scratch family transcriptional repressor 1" Q9BWW7 8 144330565-144336482 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 60.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.5" "Region enhanced" "Detected in many" "cerebral cortex: 60.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045265 Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA045265: AB_10959521" "unprognostic (7.70e-2)" "unprognostic (7.97e-2)" "unprognostic (6.96e-3)" "unprognostic (6.88e-4)" "unprognostic (2.43e-2)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (1.97e-1)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.83e-4)" "unprognostic (5.02e-2)" "unprognostic (7.05e-2)" "unprognostic (2.78e-1)" "unprognostic (2.35e-1)" "unprognostic (2.66e-3)" "unprognostic (1.04e-1)" 0.0 0.5 4.2 0.0 5.7 0.0 0.0 11.2 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 15.4 0.0 0.0 0.0 0.0 20.6 9.0 0.0 0.0 0.3 0.0 3.4 0.0 19.3 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 24.4 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 5.7 11.2 60.7 4.4 15.4 20.6 9.0 0.0 19.3 0.0 24.4 21.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.1 1.6 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 55.6 0.0 0.0 0.3 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 14.2 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 HPR ENSG00000261701 "Haptoglobin-related protein" P00739 16 72063148-72077246 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 818.5" "Group enriched" "Detected in some" 14 "Hepatocytes: 503.0;Smooth muscle cells: 128.8" "Cancer enriched" "Detected in some" 53 "liver cancer: 185.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 50.6" HPA047750 Supported Approved Vesicles "Secreted to blood" NA NA 49000000000 55000000000 Vesicles "HPA047750: AB_2680146" "unprognostic (2.43e-1)" "unprognostic (4.69e-2)" "unprognostic (5.97e-3)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.66e-1)" "unprognostic (8.21e-2)" "unprognostic (2.30e-1)" "unprognostic (3.44e-6)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" 3.6 0.5 16.0 0.2 17.1 0.1 2.0 16.1 16.5 1.1 13.4 1.1 0.6 0.3 0.4 0.3 1.3 0.7 80.7 15.9 15.9 3.9 818.5 1.5 0.7 16.7 16.8 15.0 2.0 0.6 0.0 0.3 0.0 16.0 1.6 0.1 0.8 0.3 0.3 1.7 0.6 1.1 0.1 14.5 0.3 1.7 1.9 17.0 0.2 1.1 0.2 0.1 0.4 1.9 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 2.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.0 0.1 0.0 0.6 0.6 0.0 16.0 17.1 16.1 16.5 15.9 15.9 16.7 16.8 15.0 16.0 14.5 17.0 15.3 0.0 0.0 7.5 2.3 0.4 0.1 0.0 0.9 0.0 0.1 0.0 0.0 22.4 12.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.8 0.0 5.3 0.2 0.2 0.0 2.6 0.0 0.0 0.0 1.1 10.8 503.0 0.0 0.0 0.2 0.0 2.0 12.8 0.0 2.8 9.9 0.0 0.0 0.0 0.0 4.9 0.0 0.0 1.2 0.0 0.0 5.3 0.0 0.0 0.0 13.0 0.2 0.1 0.0 6.1 128.8 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.2 0.0 AC009163.5 ENSG00000261717 "Novel TMEM170A-CFDP1 readthrough protein" 16 75412684-75464706 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.8;skeletal muscle: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "white matter: 4.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 9.3;REH: 9.0;U-698: 28.4" "Low region specificity" "Detected in all" HPA041316 Uncertain NA NA "HPA041316: AB_10794371" "unprognostic (1.57e-1)" 0.6 0.1 0.5 0.0 0.7 0.6 0.0 0.6 0.8 0.1 0.1 1.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.2 0.0 0.2 0.4 0.2 0.7 1.2 0.1 0.1 0.0 0.1 0.0 0.0 4.8 3.0 0.3 1.0 0.0 0.0 0.0 5.9 5.0 0.8 0.0 0.1 1.5 1.3 1.2 9.3 0.0 0.0 1.0 0.0 1.2 0.0 3.8 2.1 0.8 0.7 2.1 0.0 3.0 2.4 0.3 0.3 0.0 0.3 0.0 0.0 0.9 1.9 0.0 0.0 3.6 1.0 1.0 1.2 0.0 1.6 9.0 1.4 3.2 0.0 1.8 1.1 0.9 1.5 0.0 0.7 0.4 0.7 0.4 0.7 0.0 6.4 0.5 1.5 2.6 6.0 28.4 0.8 0.3 0.6 8.5 17.5 32.0 10.4 22.2 15.1 18.1 9.5 11.9 18.6 18.6 10.7 9.8 18.0 10.5 17.0 15.9 11.6 13.3 0.5 0.7 0.6 0.8 0.5 0.1 1.3 0.5 0.0 1.1 0.2 1.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8S ENSG00000261739 "Golgin A8 family member S" H3BPF8 15 23354748-23367231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "testis: 1.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Early spermatids: 18.3;Horizontal cells: 6.7;Spermatocytes: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.64e-2)" "unprognostic (7.02e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.80e-2)" "unprognostic (1.75e-2)" "unprognostic (9.39e-3)" "unprognostic (8.10e-2)" "unprognostic (3.01e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.3 0.6 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 6.7 0.7 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 9.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BOLA2-SMG1P6 ENSG00000261740 "BOLA2-SMG1P6 readthrough" 16 29443230-29454651 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 21.8;Exocrine glandular cells: 27.3;granulocytes: 18.9;Pancreatic endocrine cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (4.45e-2)" "unprognostic (3.08e-3)" "unprognostic (7.50e-2)" "unprognostic (9.88e-2)" "unprognostic (2.64e-1)" "unprognostic (8.79e-3)" "unprognostic (2.30e-1)" "unprognostic (3.82e-3)" "unprognostic (9.90e-2)" "unprognostic (5.75e-2)" "unprognostic (1.07e-2)" "unprognostic (9.64e-2)" 9.3 11.8 7.0 9.0 7.1 20.1 9.0 7.6 8.7 7.0 7.2 12.6 9.0 5.2 1.6 14.0 7.2 4.9 15.4 7.3 7.8 13.0 10.2 7.1 14.2 7.2 7.1 6.7 5.2 10.9 14.6 6.8 6.1 7.5 6.1 12.9 4.1 10.0 3.0 14.5 8.9 10.3 6.7 7.5 11.6 10.1 9.0 7.7 10.0 5.8 11.1 9.9 8.7 8.9 7.6 17.5 38.1 44.9 18.9 14.7 16.5 25.7 41.3 29.8 31.7 28.5 8.9 37.6 25.8 58.1 25.5 33.5 32.4 12.1 31.6 45.8 28.3 36.4 17.2 21.2 57.9 34.8 44.6 27.4 22.5 26.4 35.3 39.4 17.9 28.0 102.9 51.6 28.5 34.0 57.9 33.5 73.7 78.3 64.0 52.3 35.6 27.8 68.3 37.4 13.4 30.0 57.3 11.1 51.0 57.5 0.5 29.9 68.2 17.8 16.0 16.3 22.2 27.6 34.7 45.6 61.4 31.9 33.7 40.0 1.8 13.9 8.3 13.1 20.7 13.3 14.9 12.1 10.0 21.4 10.8 9.2 13.5 1.8 8.2 28.0 23.8 22.4 11.8 7.0 7.1 7.6 8.7 7.3 7.8 7.2 7.1 6.7 7.5 7.5 7.7 7.6 1.9 9.6 9.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.0 2.2 0.0 0.0 8.6 0.0 0.0 3.4 2.7 0.0 3.9 21.8 0.0 1.7 1.8 4.8 0.0 0.0 0.0 27.3 3.0 2.4 0.0 1.9 18.9 0.7 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.4 0.0 0.0 5.5 5.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.2 3.7 0.4 0.0 0.0 TCF24 bHLHa25 ENSG00000261787 "Transcription factor 24" Q7RTU0 8 66946501-66962591 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 1.1;testis: 1.5" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 5.1;Spermatocytes: 4.7;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.2;HEK 293: 5.5;HMC-1: 4.7;K-562: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.07e-1)" "unprognostic (9.14e-3)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.30e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (2.25e-1)" "unprognostic (9.38e-3)" "unprognostic (9.36e-2)" "unprognostic (1.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.7 0.3 0.6 1.1 0.0 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.2 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.5 0.2 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.2 0.3 0.6 0.6 0.7 0.1 0.6 0.9 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL929554.1 ENSG00000261793 "Novel transcript, TMEM210 and LRRC26 readthrough" 9 137168854-137171984 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "salivary gland: 47.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Immune cell enriched" "Detected in single" 31 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 31 "dendritic cells: 3.0" "Group enriched" "Detected in some" 5 "REH: 10.3;RPMI-8226: 16.6;SK-BR-3: 11.1;T-47d: 6.4" NA NA 0.0 0.2 0.2 0.4 0.3 0.1 0.4 1.9 0.7 0.6 0.0 1.0 2.3 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.0 0.0 0.8 11.0 0.1 0.0 47.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.2 0.1 0.2 0.0 10.3 0.0 16.6 0.0 1.3 0.4 0.1 0.0 11.1 0.0 0.0 6.4 0.5 0.0 0.0 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.3 1.9 0.7 0.4 0.2 0.1 0.1 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8H GOLGA6L11 ENSG00000261794 "Golgin A8 family member H" P0CJ92 15 30604126-30614561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.4" "Cell type enhanced" "Detected in some" "Astrocytes: 6.8;Early spermatids: 20.3;Inhibitory neurons: 3.1;Microglial cells: 4.7;Spermatocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.4;HMC-1: 2.9;RH-30: 4.1;SH-SY5Y: 2.3;TIME: 2.2;U-937: 2.3" NA NA "unprognostic (4.32e-3)" "unprognostic (7.13e-2)" "unprognostic (4.86e-2)" "unprognostic (2.92e-1)" "unprognostic (2.71e-1)" "unprognostic (7.33e-2)" "unprognostic (6.91e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (6.44e-3)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-2)" "unprognostic (1.10e-1)" "unprognostic (6.08e-2)" "unprognostic (1.14e-1)" 1.1 0.3 0.2 0.4 0.3 2.7 0.5 0.0 0.3 0.8 0.2 0.4 0.2 0.7 0.5 0.3 1.2 0.5 1.1 0.2 0.1 0.2 0.1 0.8 0.5 0.6 0.4 0.0 0.5 1.5 0.9 0.4 0.2 0.5 0.3 0.3 0.7 0.4 0.3 0.4 0.3 0.4 0.7 0.2 0.5 0.3 6.4 0.1 0.1 1.9 0.3 0.2 0.6 0.4 0.8 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.3 0.1 0.6 0.0 1.5 0.0 1.2 0.0 0.0 0.1 1.0 2.4 0.1 0.0 0.0 0.6 2.9 0.1 0.1 0.1 0.1 1.8 0.6 1.4 0.3 0.1 0.3 0.3 0.0 0.2 0.2 0.1 0.3 0.0 4.1 0.0 0.3 0.2 0.3 2.3 0.1 0.0 0.0 0.2 0.2 1.7 2.2 0.0 0.8 0.0 0.3 0.4 0.0 1.0 0.0 2.3 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.1 0.6 0.4 0.0 0.5 0.2 0.1 0.8 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 2.5 0.1 0.1 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.3 0.3 0.0 4.7 1.7 0.0 0.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ISY1-RAB43 ENSG00000261796 "ISY1-RAB43 readthrough" 3 129087575-129161036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA006312, HPA016995" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (1.09e-1)" "unprognostic (5.42e-2)" "unprognostic (1.52e-1)" "unprognostic (9.05e-3)" "unprognostic (2.81e-1)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (1.87e-1)" 7.7 7.3 2.2 10.2 2.5 7.2 7.6 2.2 5.8 7.2 2.7 7.7 3.9 8.2 4.5 5.3 7.0 4.3 5.2 2.2 2.5 7.1 9.7 9.5 8.1 2.4 2.5 1.7 9.5 7.3 8.9 5.6 6.5 3.0 7.6 7.4 2.7 6.7 8.4 3.9 5.1 6.8 7.7 1.9 9.3 6.9 5.2 2.3 16.9 7.7 3.7 9.1 7.7 4.7 3.3 26.1 5.7 12.9 11.9 15.8 9.3 5.6 12.2 28.5 19.4 23.6 3.0 13.1 0.9 17.7 22.0 22.2 9.8 5.1 20.4 11.9 9.9 1.0 2.4 2.5 10.2 27.1 10.8 12.9 21.5 10.7 12.1 7.7 19.2 25.4 23.7 4.2 9.9 16.9 10.8 16.3 7.7 9.1 27.7 6.7 13.7 5.6 9.1 20.8 9.9 0.9 5.8 5.8 13.1 18.9 10.7 6.5 10.3 21.0 9.4 7.9 13.5 5.6 14.3 7.0 4.4 10.7 1.1 13.3 0.1 0.5 0.1 0.6 0.2 0.6 0.0 0.6 0.8 0.2 0.1 0.8 0.7 0.6 0.6 0.4 0.2 0.4 0.6 2.2 2.5 2.2 5.8 2.2 2.5 2.4 2.5 1.7 3.0 1.9 2.3 3.3 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC138894.1 ENSG00000261832 "Novel protein" 16 28456371-28492098 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.3;Distal tubular cells: 1.9;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053611 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.93e-3)" "unprognostic (8.88e-3)" "unprognostic (4.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.59e-1)" "unprognostic (9.85e-2)" "unprognostic (3.82e-4)" "unprognostic (3.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (6.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (3.74e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.2 0.6 0.3 6.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.6 0.0 0.0 0.9 0.1 0.0 1.9 0.4 0.0 0.6 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 1.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 MIA CD-RAP ENSG00000261857 "MIA SH3 domain containing" Q16674 19 40771648-40777490 "Cancer-related genes, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 58.4;pituitary gland: 76.8;salivary gland: 43.7;stomach 1: 66.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 51.4;Breast myoepithelial cells: 171.7;Melanocytes: 103.2;monocytes: 30.0;Pancreatic endocrine cells: 66.8;Respiratory ciliated cells: 53.9" "Cancer enriched" "Detected in many" 5 "melanoma: 58.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.7" "Group enriched" "Detected in some" 29 "AN3-CA: 90.1;CAPAN-2: 80.6;SK-MEL-30: 271.9;WM-115: 247.7" HPA042369 Approved "Secreted to blood" NA NA 8270000 64000 "HPA042369: AB_10794420" "prognostic favorable (2.08e-4)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (9.02e-3)" "unprognostic (2.27e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-3)" "unprognostic (3.67e-2)" "unprognostic (1.61e-1)" "unprognostic (9.37e-2)" "unprognostic (1.17e-1)" "unprognostic (3.19e-1)" "unprognostic (3.29e-8)" "unprognostic (5.88e-2)" "unprognostic (2.44e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" 2.4 3.0 6.0 7.0 6.4 2.9 58.4 5.9 6.4 8.3 5.6 12.9 2.0 1.3 2.0 6.7 3.7 2.9 3.7 4.6 7.5 2.4 2.7 1.9 2.1 5.7 5.1 4.0 7.0 1.4 0.0 76.8 2.1 6.7 6.4 4.3 0.4 43.7 3.3 0.7 9.5 6.0 7.7 5.5 7.0 66.4 1.7 5.7 2.4 2.9 1.7 1.7 4.0 5.3 8.1 0.3 0.9 1.5 90.1 1.3 1.2 1.0 0.0 0.0 0.0 0.5 0.5 80.6 0.2 0.0 0.0 0.3 0.2 0.4 4.9 0.1 2.9 0.9 0.0 1.0 0.1 0.4 0.2 0.4 0.7 4.2 0.0 1.5 1.4 0.0 1.4 0.0 0.9 0.0 0.0 0.1 0.0 0.2 5.9 0.3 0.1 0.2 0.0 2.5 0.0 0.2 0.1 0.1 0.0 271.9 3.4 0.5 1.2 0.0 0.2 3.4 0.1 1.0 0.0 0.2 0.9 0.1 0.4 247.7 0.6 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 6.0 6.4 5.9 6.4 4.6 7.5 5.7 5.1 4.0 6.7 5.5 5.7 8.1 1.0 0.0 0.5 0.0 0.3 5.2 0.1 11.2 0.6 0.0 51.4 171.7 0.6 0.0 4.9 0.0 0.0 0.8 0.5 1.7 0.0 0.5 0.0 0.9 0.0 1.4 0.0 0.0 0.0 3.2 0.1 1.1 14.3 0.2 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.1 4.1 0.0 0.7 0.3 0.6 0.2 103.2 0.0 30.0 0.0 0.0 0.0 0.0 66.8 5.1 0.0 0.1 0.8 0.4 0.0 53.9 0.0 0.0 0.2 1.3 0.1 0.6 6.1 1.3 0.7 0.3 0.8 4.1 0.5 SMIM36 ENSG00000261873 "Small integral membrane protein 36" A0A1B0GVT2 17 55448433-55511444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 6.7" "Cell type enhanced" "Detected in single" "Club cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.07e-1)" 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.5;Cardiomyocytes: 1.3;Endometrial stromal cells: 1.5;Horizontal cells: 3.3;Skeletal myocytes: 2.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HSkMC: 4.0;hTERT-RPE1: 16.9;TIME: 4.6;U-87 MG: 5.1" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 1.8 1.6 3.3 0.7 3.5 0.1 1.3 6.6 3.0 2.0 0.6 1.0 0.5 2.5 1.1 1.5 1.9 2.1 1.0 3.9 3.1 0.8 0.4 1.5 0.5 3.7 2.8 3.3 2.9 0.8 1.1 0.9 1.0 3.5 1.6 0.7 4.4 1.2 2.2 0.8 1.7 0.6 1.9 3.3 1.1 0.8 0.4 3.4 0.6 1.4 1.2 0.7 1.2 1.4 6.0 0.0 0.1 0.6 1.6 0.1 0.2 0.2 0.7 0.0 0.6 0.6 0.2 0.4 1.3 3.6 2.0 0.3 0.1 0.1 0.2 0.7 0.0 0.3 0.0 0.1 0.0 1.1 0.0 0.2 4.0 0.1 0.4 0.3 16.9 1.0 0.0 0.1 0.2 0.3 0.3 0.1 0.5 0.2 0.0 0.0 0.1 0.4 0.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.4 0.9 0.4 4.6 0.3 0.3 0.1 2.5 0.2 0.0 0.0 5.1 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.5 6.6 3.0 3.9 3.1 3.7 2.8 3.3 3.5 3.3 3.4 6.0 0.6 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.6 4.5 0.2 0.3 1.3 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.4 0.2 0.1 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 2.3 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 GFY Goofy ENSG00000261949 "Golgi associated olfactory signaling regulator" I3L273 19 49423749-49428987 "Predicted membrane proteins" "Olfaction, Sensory transduction" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.1;testis: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 1.8;SCLC-21H: 4.0;T-47d: 1.1;U-266/84: 2.7" "Region enriched" "Detected in single" 13 "olfactory bulb: 1.4" "Region enriched" "Detected in some" 6 "cerebellum: 6.6" NA NA "unprognostic (8.04e-2)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (8.99e-2)" "unprognostic (8.85e-2)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (9.62e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.5 0.2 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC00514 ENSG00000262152 "Long intergenic non-protein coding RNA 514" 16 2988256-3002016 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 2.8;lymphoid tissue: 2.6;skin 1: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HaCaT: 3.8;hTCEpi: 2.6;MCF7: 2.0;OE19: 3.1;SCLC-21H: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (2.02e-2)" "unprognostic (2.23e-3)" "unprognostic (2.72e-1)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (3.44e-1)" "unprognostic (4.86e-2)" "unprognostic (3.87e-2)" "unprognostic (2.16e-2)" "unprognostic (6.27e-3)" "unprognostic (2.65e-2)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "unprognostic (4.10e-2)" "unprognostic (1.65e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.7 0.3 0.1 0.1 0.4 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.2 0.1 0.1 2.6 0.0 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 1.8 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.0 0.0 0.1 0.0 3.1 0.0 0.0 0.5 0.0 0.0 0.0 2.5 0.0 0.2 1.1 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.6 0.2 0.0 0.2 0.2 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 AC233723.1 ENSG00000262165 "Novel protein" 17 4801159-4807013 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 15.9;choroid plexus: 7.5" "Cell type enhanced" "Detected in some" "Breast glandular cells: 5.5;Breast myoepithelial cells: 7.4;Cytotrophoblasts: 3.5;Endometrial ciliated cells: 3.4;Hofbauer cells: 3.7;monocytes: 7.8;Proximal tubular cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;SCLC-21H: 10.2" "Region enhanced" "Detected in single" "basal ganglia: 2.9" NA NA "unprognostic (3.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.23e-2)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (5.14e-3)" "unprognostic (9.42e-2)" "unprognostic (3.09e-2)" "unprognostic (1.16e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 0.6 0.7 8.8 0.0 9.4 0.0 0.7 8.9 15.9 1.2 7.5 0.4 0.0 0.5 0.4 0.8 1.0 0.0 0.8 8.8 9.1 0.7 0.8 0.5 0.1 10.7 8.9 8.1 2.5 2.0 0.9 1.1 0.1 8.9 0.8 0.0 1.4 0.5 0.5 1.0 1.5 0.2 0.5 9.0 0.4 0.4 0.5 9.0 0.0 0.4 0.2 0.4 0.5 0.9 9.4 0.3 0.6 0.0 3.3 0.5 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.8 0.0 0.0 0.5 1.0 0.9 0.4 0.3 0.7 0.5 0.0 0.9 0.3 0.5 0.0 0.6 0.5 1.0 0.9 0.0 0.1 0.0 1.1 0.0 10.2 0.6 0.0 0.0 0.2 0.9 0.0 0.0 1.4 0.1 0.3 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.3 0.3 0.2 0.0 0.1 0.3 0.3 0.5 0.2 0.0 0.3 0.0 0.0 0.1 8.8 9.4 8.9 15.9 8.8 9.1 10.7 8.9 8.1 8.9 9.0 9.0 9.4 1.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 7.4 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 1.9 0.7 0.0 3.4 2.0 0.4 0.0 0.0 0.0 0.2 1.4 0.6 0.0 1.9 0.0 2.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 7.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.1 1.2 0.0 0.0 MYMX MINION ENSG00000262179 "Myomixer, myoblast fusion factor" A0A1B0GTQ4 6 44216926-44218234 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "adipose tissue: 7.6;breast: 6.9;pancreas: 5.6;stomach 1: 2.3" "Group enriched" "Detected in some" 4 "Adipocytes: 5.5;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 1.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 106 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 106 "dendritic cells: 10.6" "Cell line enriched" "Detected in some" 31 "RH-30: 134.6" "Not detected" "Not detected" HPA051451 Supported Approved Vesicles,Mitochondria,Cytosol NA NA Vesicles "Mitochondria, Cytosol" "HPA051451: " "unprognostic (1.24e-1)" "unprognostic (8.55e-2)" "unprognostic (6.86e-2)" "unprognostic (6.51e-3)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-2)" "unprognostic (2.10e-3)" "unprognostic (4.32e-1)" "unprognostic (1.77e-1)" "unprognostic (8.71e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-4)" "unprognostic (1.63e-2)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.67e-1)" 7.6 0.1 0.0 0.2 0.0 0.0 6.9 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.5 0.8 0.0 0.0 0.7 0.1 0.4 0.6 0.1 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.4 0.9 0.5 0.1 0.0 0.8 2.3 0.4 0.0 0.8 0.4 0.2 0.4 0.5 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 134.6 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 1.7 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 2.2 1.6 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370242-141512975 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 0.7 0.3 0.9 0.2 0.8 0.0 0.5 3.8 0.7 0.7 0.0 0.6 0.0 1.0 0.6 0.3 0.7 0.4 1.0 0.9 2.2 0.3 0.2 0.5 0.2 1.4 1.1 0.2 1.2 0.7 1.1 0.7 0.4 1.3 0.4 0.3 0.8 0.9 0.4 0.5 0.6 0.3 0.7 0.7 0.4 0.4 0.4 0.6 0.3 0.6 0.5 0.2 0.6 0.6 1.5 0.0 0.6 0.4 0.3 10.4 8.4 0.2 1.2 2.0 0.7 0.8 0.0 0.0 1.8 0.3 3.5 0.6 0.5 0.0 0.2 0.5 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 2.1 0.4 0.2 0.1 0.2 1.0 0.0 0.2 0.8 0.2 0.4 0.6 0.9 0.1 0.0 0.1 1.5 0.6 0.0 0.2 0.1 2.4 0.5 0.0 0.0 0.2 0.3 0.6 0.0 5.5 0.5 0.1 0.5 0.6 0.2 1.8 0.2 0.4 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 3.8 0.7 0.9 2.2 1.4 1.1 0.2 1.3 0.7 0.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CORO7 FLJ22021 ENSG00000262246 "Coronin 7" P57737 16 4354542-4425705 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 75.3;RPMI-8226: 142.8" "HPA041657, HPA053586" Uncertain NA NA 50000 "HPA041657: AB_10796351, HPA053586: AB_2682201" "unprognostic (4.75e-3)" "prognostic favorable (8.68e-4)" "unprognostic (2.18e-1)" "prognostic favorable (4.25e-4)" "unprognostic (3.80e-2)" "unprognostic (1.05e-1)" "unprognostic (7.54e-4)" "unprognostic (3.32e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-3)" "unprognostic (1.20e-2)" "unprognostic (6.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.04e-1)" "unprognostic (9.55e-2)" "unprognostic (4.06e-3)" 15.0 15.9 8.4 17.0 14.7 70.1 13.6 10.3 14.7 12.7 3.7 19.2 15.4 13.9 1.8 11.0 16.9 9.1 11.0 10.8 10.4 15.5 8.9 27.7 24.4 14.9 11.6 6.5 8.2 10.9 4.6 13.6 9.8 14.8 17.2 4.7 1.4 13.5 5.7 6.5 11.5 31.3 5.6 9.2 57.0 15.4 27.6 12.5 11.0 14.6 1.7 8.0 14.7 11.7 22.5 8.8 12.0 8.0 8.7 1.6 1.1 13.3 5.0 4.4 7.5 6.8 6.8 20.3 18.0 5.0 5.2 5.9 12.2 6.1 9.1 2.5 6.1 29.9 6.1 15.0 6.2 7.0 20.6 48.3 6.3 2.3 4.5 1.9 2.3 13.6 15.0 18.7 75.3 3.8 30.8 15.2 58.1 10.0 6.5 3.1 47.2 24.9 142.8 4.7 13.3 14.9 5.5 6.4 5.7 14.6 3.3 4.8 32.9 16.9 6.5 10.3 16.7 6.7 35.9 20.3 48.7 4.9 29.2 6.6 17.1 16.8 30.8 14.5 23.5 16.4 8.6 13.1 16.8 14.0 3.6 6.5 9.7 17.3 9.1 20.3 7.3 15.5 15.9 8.4 14.7 10.3 14.7 10.8 10.4 14.9 11.6 6.5 14.8 9.2 12.5 22.5 10.3 3.2 10.8 0.0 21.2 9.4 6.4 4.8 2.2 13.6 6.4 3.8 2.7 7.2 6.2 5.5 43.8 11.3 41.2 16.6 3.9 12.1 6.6 9.5 4.0 11.9 7.8 2.1 0.0 16.3 12.3 6.3 8.6 8.0 12.0 3.8 21.0 2.4 37.9 28.6 0.0 9.5 28.5 42.8 19.3 5.8 5.0 31.4 17.8 0.0 26.6 7.4 33.0 0.0 0.0 17.3 16.4 3.4 32.1 7.3 16.0 3.0 14.6 19.1 6.6 11.6 5.9 11.5 7.9 4.4 11.9 9.2 34.4 6.0 13.9 8.2 MMP12 HME ENSG00000262406 "Matrix metallopeptidase 12" P39900 11 102862736-102874982 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.9;lymphoid tissue: 40.7;urinary bladder: 16.1" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 303.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "BJ: 3.3;fHDF/TERT166: 11.4;hTEC/SVTERT24-B: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.69e-2)" "unprognostic (7.31e-2)" "unprognostic (1.52e-2)" "unprognostic (1.52e-3)" "unprognostic (5.45e-2)" "unprognostic (3.05e-6)" "unprognostic (1.08e-2)" "unprognostic (4.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.92e-2)" 0.4 0.0 0.0 40.7 0.1 0.0 0.4 0.0 0.0 0.1 0.0 13.6 6.9 0.6 0.0 0.4 0.0 2.6 0.0 0.0 0.2 0.8 0.1 0.6 7.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 7.4 0.1 1.3 15.9 0.0 2.4 0.0 0.0 0.5 7.9 2.2 0.1 3.7 3.5 0.0 0.1 3.9 0.0 0.0 19.6 16.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 11.4 0.1 0.4 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 18.6 303.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 2.2 SPDYE9 SPDYE9P ENSG00000262461 "Speedy/RINGO cell cycle regulator family member E9" 7 73076165-73086038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Uncertain NA NA "HPA051750: AB_2681590" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.5 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCER2 ENSG00000262484 "Coiled-coil glutamate rich protein 2" I3L3R5 19 38908980-38912158 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 4.9" "Cell type enriched" "Detected in some" 8 "Melanocytes: 617.2" "Group enriched" "Detected in many" 5 "glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;THP-1: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069716 Uncertain "Secreted - unknown location" NA NA 8800 "HPA069716: AB_2686183" "unprognostic (6.58e-2)" "unprognostic (2.24e-2)" "unprognostic (5.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (2.76e-3)" "unprognostic (3.88e-2)" "unprognostic (2.16e-1)" "unprognostic (5.97e-2)" "unprognostic (1.45e-1)" "unprognostic (4.08e-3)" "unprognostic (3.82e-2)" "unprognostic (1.01e-9)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.32e-4)" 0.5 0.6 2.2 0.2 2.3 0.7 0.8 2.2 3.4 0.9 1.8 0.8 0.3 0.7 0.3 1.2 1.1 0.1 0.6 2.2 2.1 1.3 3.0 0.5 0.3 2.8 2.2 2.1 0.8 0.5 0.2 2.5 0.1 2.4 1.4 0.1 1.0 0.9 0.2 2.3 3.9 0.9 0.1 2.0 1.1 0.6 4.9 2.2 0.4 1.2 0.0 0.1 0.9 0.8 2.3 0.1 1.4 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.6 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.9 0.2 0.9 0.0 0.9 0.2 0.4 0.3 0.0 0.2 0.7 0.1 0.2 0.1 0.6 0.4 0.2 0.1 0.1 0.0 0.1 1.0 1.4 0.0 0.0 0.7 0.0 0.0 0.6 0.5 0.2 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 2.2 3.4 2.2 2.1 2.8 2.2 2.1 2.4 2.0 2.2 2.3 0.1 3.2 0.0 3.9 0.1 76.9 0.1 0.1 0.0 2.5 0.4 0.5 0.4 1.5 0.1 1.8 4.2 0.4 0.4 0.3 0.0 0.0 1.4 0.3 0.2 0.6 1.2 0.4 2.3 0.0 0.1 0.8 0.0 0.5 0.0 0.3 0.0 0.6 0.2 0.0 3.3 0.2 0.0 0.3 7.2 4.9 0.3 0.2 617.2 0.0 0.0 1.3 0.0 3.5 2.2 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.4 3.8 0.0 0.4 0.7 1.1 2.1 0.0 3.0 0.3 0.4 0.2 0.6 0.1 SMIM28 ENSG00000262543 "Small integral membrane protein 28" A0A1B0GU29 6 138377905-138383486 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.50e-2)" "unprognostic (5.48e-2)" 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355021-141512975 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Skeletal myocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.4;BJ: 4.3;HSkMC: 4.3;HUVEC TERT2: 4.3;U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 1.7 1.3 1.6 0.5 1.8 0.0 0.9 3.6 1.8 1.3 0.1 0.7 0.2 1.6 0.8 0.4 0.9 0.9 1.5 2.6 2.1 0.4 0.3 1.0 0.1 2.2 1.9 1.0 1.7 2.1 2.3 1.0 0.8 1.6 1.1 0.3 1.5 0.8 1.1 0.7 0.5 0.3 1.5 1.8 0.3 0.5 0.7 2.0 0.2 0.7 1.0 0.1 0.7 0.8 2.7 0.0 0.1 0.8 0.4 3.3 7.4 0.0 4.3 3.4 0.2 0.8 0.0 0.1 0.7 1.4 3.7 1.3 0.0 0.1 0.1 0.4 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.3 4.3 0.1 0.0 0.0 2.6 4.3 0.0 0.1 0.2 1.8 0.6 0.2 0.2 0.1 0.0 0.2 0.3 1.2 0.1 0.2 0.0 0.6 1.3 0.2 0.2 0.9 0.3 1.6 0.0 2.8 1.8 0.5 2.4 0.3 0.1 0.2 0.1 6.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.8 3.6 1.8 2.6 2.1 2.2 1.9 1.0 1.6 1.8 2.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 OR1D5 OR17-31 ENSG00000262628 "Olfactory receptor family 1 subfamily D member 5" P58170 17 3062669-3063607 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962723-14268133 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 102.3" "Cell type enhanced" "Detected in many" "Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9" "Cancer enriched" "Detected in all" 5 "ovarian cancer: 199.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 3.3" "Lineage enriched" "Detected in single" 33 "T-cells: 3.3" "Group enriched" "Detected in some" 36 "EFO-21: 213.7;RPTEC TERT1: 604.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 28000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 54.7 17.1 25.6 18.8 27.7 0.1 19.7 26.7 22.5 44.2 7.7 32.1 31.9 36.8 15.3 17.5 63.6 102.3 19.6 25.3 34.8 11.7 2.0 49.6 1.6 26.1 32.6 17.0 24.1 4.6 0.8 10.1 41.6 25.6 17.0 47.0 64.4 7.0 8.8 0.8 7.7 28.6 47.3 15.4 8.4 29.1 2.5 30.0 1.8 5.3 1.6 1.2 52.0 12.6 21.4 0.1 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 9.8 0.2 0.2 213.7 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.9 0.0 0.1 0.1 0.0 0.0 0.1 11.4 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.7 0.0 0.1 1.7 0.0 0.1 604.1 0.1 0.1 0.2 0.0 0.0 0.0 4.1 0.0 0.1 2.6 0.2 0.7 0.5 0.3 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.6 27.7 26.7 22.5 25.3 34.8 26.1 32.6 17.0 25.6 15.4 30.0 21.4 0.2 0.0 2.3 399.9 13.5 0.0 17.3 0.0 1.2 13.5 2.0 5.5 1.9 5.7 0.0 0.0 2.1 3.4 4.8 38.9 3.9 4.3 1.5 36.1 78.9 2.5 16.7 0.0 17.0 2.0 4.2 41.2 0.5 61.5 2.5 1.8 2.5 0.2 1.9 1.7 16.8 24.0 0.0 0.3 0.0 1.3 4.4 1.0 0.0 11.2 0.5 141.9 20.6 62.4 1.6 6.8 20.6 30.1 0.9 9.0 18.4 2.1 0.7 26.8 6.6 5.8 7.0 0.4 0.8 0.6 0.0 4.9 7.8 1.1 40.9 9.4 AC139530.2 ENSG00000262660 "Novel protein" 17 81703371-81720539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.4;skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;Karpas-707: 6.8;MOLT-4: 18.0;SK-BR-3: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022853, HPA023043, HPA023048" Approved Supported Mitochondria NA NA Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950" "unprognostic (2.36e-3)" "unprognostic (1.17e-1)" "unprognostic (2.87e-1)" "unprognostic (3.83e-1)" 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 1.3 0.6 1.6 5.5 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.3 0.5 0.9 0.3 0.0 1.6 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.5 0.6 0.2 0.1 0.0 6.8 0.0 0.8 18.0 0.8 1.0 0.7 0.0 3.9 0.6 1.4 0.0 0.0 3.3 1.5 0.0 6.6 1.8 0.4 3.2 1.5 0.0 0.5 1.1 1.1 1.8 0.6 0.0 0.7 1.4 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVCA2 ENSG00000262664 "OVCA2 serine hydrolase domain containing" Q8WZ82 17 2042022-2043425 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "B-cells: 10.3;Basal squamous epithelial cells: 19.9;Erythroid cells: 11.3;Gastric mucus-secreting cells: 21.9;Macrophages: 8.4;Plasma cells: 31.0;Squamous epithelial cells: 32.2;T-cells: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059002 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059002: AB_2683875" 24.0 39.7 37.4 21.0 37.3 32.5 23.8 37.7 42.3 15.5 37.8 24.1 26.3 18.3 22.5 36.7 17.8 22.5 28.1 37.5 37.8 36.6 42.4 21.2 31.2 37.4 37.3 36.3 16.8 38.1 23.6 33.3 18.1 37.8 24.9 21.7 18.4 27.0 16.5 33.2 31.1 26.7 16.7 37.7 30.3 31.6 29.9 38.5 22.7 21.8 26.8 24.9 30.4 21.3 38.0 57.7 64.6 24.1 49.5 30.2 40.5 39.3 39.2 49.1 51.1 44.7 70.1 39.6 19.3 41.4 63.9 32.7 44.5 36.2 62.8 35.7 28.5 74.1 28.9 34.4 31.2 79.1 20.6 54.5 54.9 59.0 48.8 34.6 27.1 68.9 28.7 21.8 60.3 62.4 47.1 32.7 33.5 20.3 48.7 38.5 27.6 22.3 26.9 62.7 39.6 17.2 55.9 26.9 44.0 57.1 23.9 55.3 37.3 53.3 66.2 20.8 49.2 75.4 36.6 39.9 13.0 58.5 44.9 56.7 21.7 84.6 35.7 71.5 77.5 72.3 75.6 69.5 75.9 75.8 66.0 49.3 47.3 23.9 89.9 59.7 87.8 124.7 87.7 37.4 37.3 37.7 42.3 37.5 37.8 37.4 37.3 36.3 37.8 37.7 38.5 38.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.0 11.3 0.0 0.0 0.0 3.8 21.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 32.2 0.0 0.0 10.4 0.1 0.0 0.0 MRPL12 "MRPL7, MRPL7/L12, RPML12" ENSG00000262814 "Mitochondrial ribosomal protein L12" P52815 17 81703367-81707517 "Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 303.2;Undifferentiated cells: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022853, HPA023043" Supported Supported Mitochondria NA NA 49000 Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (6.59e-2)" "unprognostic (1.66e-2)" "unprognostic (9.52e-2)" "unprognostic (5.97e-2)" "unprognostic (5.97e-3)" "prognostic unfavorable (2.35e-4)" "unprognostic (1.78e-1)" "unprognostic (6.47e-3)" "unprognostic (8.17e-2)" "unprognostic (3.07e-1)" "unprognostic (8.77e-3)" "unprognostic (3.41e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (9.26e-2)" 46.8 74.3 36.5 28.7 35.7 31.3 44.4 43.4 52.3 31.6 42.9 66.3 47.7 39.4 11.1 97.6 35.4 11.0 174.2 36.6 38.2 87.5 186.4 35.2 25.7 38.0 39.9 33.6 27.0 61.1 46.3 39.4 19.7 37.4 45.3 37.6 7.4 48.5 21.7 171.1 47.5 51.8 20.8 34.9 54.2 58.4 32.5 43.6 20.3 34.3 149.4 27.9 45.8 46.9 38.5 153.6 256.8 67.5 78.2 50.2 55.0 124.3 117.0 71.3 173.2 128.3 216.5 71.6 236.5 69.2 77.5 116.7 127.1 87.6 150.7 87.6 55.9 438.3 181.1 140.2 246.5 74.0 200.5 90.9 63.4 108.5 119.4 132.4 55.4 146.1 115.6 179.4 75.6 87.1 194.2 171.6 295.9 106.0 165.9 330.6 160.7 109.5 176.4 129.8 126.1 171.4 220.7 86.1 366.1 199.8 69.1 186.2 180.5 76.7 131.0 155.8 103.4 241.2 146.2 54.3 137.0 89.3 143.0 100.6 17.7 63.1 9.0 37.9 84.8 52.6 66.2 37.8 42.6 93.7 62.1 39.2 36.0 6.9 43.5 49.8 77.0 35.8 48.9 36.5 35.7 43.4 52.3 36.6 38.2 38.0 39.9 33.6 37.4 34.9 43.6 38.5 43.0 19.2 12.8 4.9 42.2 53.3 83.7 101.7 8.6 17.1 67.2 85.0 88.7 84.4 47.6 46.0 4.2 172.4 29.1 303.2 219.2 113.0 38.9 40.6 39.8 47.8 104.0 40.4 4.5 118.5 187.2 38.9 28.5 33.6 30.5 75.7 39.7 223.4 167.0 23.5 6.0 257.7 44.7 62.2 34.5 127.2 39.4 36.8 58.7 1.9 59.7 29.7 45.3 3.0 4.6 126.5 126.9 32.7 24.4 137.1 196.2 258.5 35.0 17.3 32.9 30.8 65.1 46.5 56.9 30.1 60.5 112.5 25.2 126.0 364.0 109.8 C19orf84 ENSG00000262874 "Chromosome 19 open reading frame 84" I3L1E1 19 51388289-51390591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 22.2" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 31.9" "Group enriched" "Detected in some" 5 "ovarian cancer: 1.3;testis cancer: 3.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA068082 Uncertain Approved Vesicles NA NA Vesicles "HPA068082: AB_2685949" "unprognostic (5.94e-2)" "unprognostic (7.72e-2)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.13e-3)" "unprognostic (9.28e-4)" "unprognostic (1.31e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (3.84e-1)" "unprognostic (2.61e-7)" "unprognostic (8.30e-3)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (3.99e-3)" 0.0 0.0 0.4 0.2 0.4 0.7 0.0 0.4 0.7 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.1 0.3 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 22.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.4 0.7 0.5 0.4 0.5 0.4 0.2 0.4 0.4 0.4 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.3 0.3 0.0 0.0 0.2 0.0 3.1 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 31.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 CCNQ "CycM, FAM58A" ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587925-153600045 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA050137: AB_2681029, HPA059843: AB_2684140" "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 11.6 12.9 17.1 8.3 18.6 7.4 11.8 16.9 25.1 11.6 13.3 15.0 9.0 13.0 12.8 13.3 11.1 4.0 27.8 18.5 18.8 13.6 13.3 10.7 12.6 21.1 19.8 18.2 10.6 15.1 10.4 23.8 9.2 21.2 13.7 8.1 6.4 13.0 8.9 34.6 11.9 13.7 6.2 17.4 17.4 13.4 6.3 18.3 9.1 11.2 13.7 12.3 14.2 11.8 22.8 43.7 31.2 12.1 43.5 20.9 11.2 18.7 25.0 21.8 23.5 23.6 33.3 14.3 34.9 44.6 25.1 35.3 26.7 38.4 22.6 22.2 20.3 39.2 7.8 19.4 23.5 19.0 28.2 18.9 14.1 20.1 15.7 16.1 10.0 19.0 16.1 10.6 15.6 19.1 50.5 19.7 38.0 15.1 44.4 52.4 22.6 20.0 17.8 17.0 17.6 16.0 21.1 12.0 19.3 34.4 11.9 7.3 25.0 14.6 20.5 29.3 46.7 38.5 21.8 23.1 43.4 18.5 45.4 15.7 0.0 1.6 4.9 2.7 1.4 1.0 6.1 2.3 1.9 1.3 4.1 2.5 1.7 0.9 0.7 0.8 1.2 3.4 1.1 17.1 18.6 16.9 25.1 18.5 18.8 21.1 19.8 18.2 21.2 17.4 18.3 22.8 21.0 3.2 13.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 24.1 31.0 0.0 0.0 3.1 7.3 0.0 40.7 20.4 0.0 72.4 23.3 0.0 11.9 17.3 7.8 0.0 0.0 0.0 37.1 98.6 8.4 0.0 8.7 2.5 16.3 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 22.7 0.0 0.0 0.0 0.0 34.0 0.0 0.0 5.9 0.0 0.0 41.6 2.2 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 120.9 10.0 18.4 0.0 0.0 GTF2I "BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6" ENSG00000263001 "General transcription factor IIi" P78347 7 74650231-74760692 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004595, HPA026638" Supported Enhanced Nucleoplasm NA NA 55000 Nucleoplasm "CAB004595: AB_628345, HPA026638: AB_1857959" "unprognostic (3.47e-1)" "unprognostic (2.26e-2)" "unprognostic (3.63e-1)" "unprognostic (1.61e-1)" "unprognostic (3.21e-1)" "unprognostic (1.11e-1)" "unprognostic (7.08e-2)" "unprognostic (2.53e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-1)" "unprognostic (8.80e-3)" "unprognostic (1.28e-1)" "prognostic favorable (6.35e-6)" "unprognostic (7.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.19e-1)" "unprognostic (5.88e-2)" 61.8 76.0 31.5 48.6 36.6 32.9 52.7 37.0 36.0 58.0 56.1 37.6 53.3 58.1 41.7 55.4 67.5 47.4 51.7 30.8 35.4 71.6 58.1 52.8 57.2 32.3 33.4 28.3 65.0 50.2 106.8 43.3 56.6 30.8 64.8 40.3 83.5 70.0 54.7 85.0 63.4 48.4 62.0 28.6 48.0 68.2 25.6 31.3 71.3 119.1 57.3 69.3 49.8 39.1 46.0 136.4 110.4 222.6 219.9 120.6 106.7 46.3 83.7 76.9 90.5 89.6 76.9 161.6 165.4 33.7 104.1 121.6 116.3 221.1 101.3 116.2 126.4 115.9 85.6 128.0 107.7 72.3 159.5 126.9 98.8 84.7 68.8 70.0 132.6 123.3 55.2 165.3 80.0 110.9 126.8 133.7 147.5 243.6 286.9 67.1 146.0 77.5 133.1 118.7 232.2 185.5 236.3 153.0 226.5 78.7 185.8 116.4 105.2 111.7 123.6 66.8 62.8 108.8 90.2 83.3 256.2 70.9 95.8 126.6 20.4 10.0 17.4 11.3 7.3 16.6 22.1 14.6 16.7 14.6 24.1 17.8 17.4 4.1 21.3 6.6 23.0 8.7 9.7 31.5 36.6 37.0 36.0 30.8 35.4 32.3 33.4 28.3 30.8 28.6 31.3 46.0 118.5 80.1 60.6 55.8 80.3 60.2 83.3 136.3 125.7 276.4 140.7 113.7 30.3 210.1 106.3 119.5 283.5 112.6 101.5 46.0 56.7 155.4 37.1 368.7 201.3 98.2 112.5 91.7 68.6 83.0 64.4 78.8 117.8 321.8 13.3 246.1 115.3 101.0 80.3 250.7 74.1 71.0 73.2 106.7 53.7 39.8 152.8 76.0 55.2 46.9 122.3 200.9 101.0 102.5 98.1 132.5 70.6 193.0 81.4 117.6 150.6 110.2 233.3 184.3 85.5 96.8 87.8 34.1 51.9 145.8 91.9 72.2 60.5 172.7 63.9 124.3 ZNF234 "HZF4, ZNF269" ENSG00000263002 "Zinc finger protein 234" Q14588 19 44141554-44160313 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA001664 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001664: AB_1080694" "unprognostic (9.03e-2)" "unprognostic (8.56e-2)" "unprognostic (5.31e-2)" "unprognostic (4.97e-2)" "unprognostic (2.53e-2)" "unprognostic (2.96e-1)" "unprognostic (7.77e-3)" "unprognostic (2.22e-1)" "unprognostic (5.07e-2)" "unprognostic (3.43e-1)" "unprognostic (3.77e-2)" "unprognostic (2.57e-2)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (1.70e-1)" "unprognostic (7.31e-2)" "prognostic favorable (4.34e-5)" 3.5 4.9 2.1 4.0 2.8 0.7 4.8 3.5 3.0 3.7 3.0 3.5 3.7 3.8 2.7 3.1 3.2 3.4 4.2 2.1 2.6 3.3 3.1 3.3 4.8 2.4 2.6 1.8 5.3 2.9 4.7 3.5 4.7 3.0 4.1 3.7 5.3 3.6 3.5 3.4 4.4 4.0 4.3 2.1 5.7 4.0 2.1 2.4 4.8 4.3 3.0 5.2 3.3 3.3 4.5 5.1 3.5 8.4 8.0 9.8 9.9 3.8 6.5 4.7 5.0 8.3 4.4 3.1 0.1 4.3 5.9 4.7 3.8 6.4 4.1 6.0 0.0 7.7 10.1 8.1 5.8 4.6 0.0 6.8 5.7 9.1 5.4 6.2 6.9 5.7 0.0 0.6 0.1 7.6 1.6 6.8 2.4 5.6 3.3 3.3 0.0 9.6 1.6 3.1 9.7 4.7 7.8 4.7 3.8 3.4 8.6 4.3 4.1 5.8 9.3 7.6 1.7 6.0 5.2 4.7 0.1 1.0 0.0 7.6 1.4 2.0 3.1 3.6 2.6 3.0 2.2 2.1 2.5 2.4 3.4 3.9 3.8 0.7 4.4 1.8 1.6 1.2 1.7 2.1 2.8 3.5 3.0 2.1 2.6 2.4 2.6 1.8 3.0 2.1 2.4 4.5 5.0 0.0 2.0 6.2 4.7 3.1 2.4 3.1 2.8 4.8 2.8 2.8 8.3 0.0 4.7 1.8 2.1 5.8 4.2 2.2 5.9 4.1 11.0 3.2 4.7 4.5 3.6 9.1 5.6 2.0 2.5 6.6 3.6 2.5 3.8 7.5 6.8 0.9 2.8 5.0 4.1 2.8 2.0 2.7 2.8 6.3 6.8 2.3 1.8 8.4 3.4 2.9 10.3 7.5 14.2 2.3 5.0 5.7 0.9 2.4 3.3 2.2 2.1 5.7 6.6 4.7 4.3 4.0 4.8 2.7 2.8 3.1 4.8 7.9 2.2 2.2 AL662899.2 ENSG00000263020 "Novel protein" 6 31666102-31673546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Club cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005944, HPA048307" Uncertain NA NA "HPA005944: AB_1847290, HPA048307: AB_2680348" "unprognostic (7.19e-2)" "unprognostic (4.75e-1)" "unprognostic (2.65e-1)" "unprognostic (7.07e-3)" "unprognostic (1.09e-2)" "unprognostic (6.32e-2)" "unprognostic (1.37e-3)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (3.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" 7.7 7.0 0.0 0.0 0.0 10.4 7.6 0.1 0.1 8.0 0.0 7.3 0.0 6.3 0.1 8.1 8.8 0.1 6.3 0.0 0.1 7.5 8.2 7.5 0.1 0.0 0.0 0.0 9.4 7.1 0.0 6.3 0.0 0.0 8.8 0.1 0.2 6.3 0.0 5.7 13.6 10.8 0.0 0.0 15.2 7.7 7.4 0.0 0.0 7.3 0.3 0.0 6.7 6.5 0.0 0.4 0.3 0.7 0.6 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.5 0.7 0.6 0.3 0.5 0.9 0.5 0.1 1.5 1.7 0.4 1.2 1.2 0.3 0.2 0.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.6 0.2 0.4 1.1 1.2 0.1 0.5 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.5 1.4 0.4 0.3 0.1 0.0 0.3 0.3 0.1 0.7 1.6 0.0 0.0 0.0 0.3 1.4 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYZAP "GCOM1, Gup, Gup1, MYOZAP" ENSG00000263155 "Myocardial zonula adherens protein" P0CAP1 15 57591904-57685364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "heart muscle: 594.4" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 481.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.4;naive CD4 T-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1" HPA039827 Approved NA NA "HPA039827: AB_10673364" "unprognostic (1.30e-2)" "unprognostic (1.25e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (9.26e-3)" "unprognostic (1.49e-1)" "unprognostic (6.10e-3)" "unprognostic (5.19e-2)" "unprognostic (8.92e-2)" "unprognostic (2.30e-2)" "unprognostic (1.26e-1)" "unprognostic (9.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-1)" "unprognostic (3.86e-2)" "unprognostic (1.77e-2)" 65.8 55.1 2.3 2.6 2.0 4.1 22.5 6.0 2.4 11.3 1.5 13.8 17.0 29.7 1.8 41.7 4.7 4.8 594.4 1.7 2.9 5.2 2.4 32.0 6.0 6.0 3.4 1.4 5.1 35.4 0.6 1.8 57.0 8.0 20.0 11.9 1.3 18.4 38.5 11.8 8.3 15.6 17.3 1.5 12.5 23.6 2.5 3.0 1.4 3.8 15.6 8.6 84.7 27.1 3.0 6.0 1.7 0.0 10.5 2.3 0.1 3.2 0.9 8.6 1.4 1.7 7.3 4.1 0.1 0.7 0.0 8.9 2.6 0.0 4.4 1.7 0.0 0.2 137.3 1.7 0.1 0.4 0.0 0.1 0.0 3.1 0.3 24.0 0.1 28.3 0.2 1.9 0.0 0.7 2.3 0.0 0.1 0.1 47.5 2.4 0.0 11.4 0.3 0.0 25.1 0.0 4.1 0.6 5.9 0.0 1.2 7.9 0.1 33.1 0.1 2.6 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.0 0.0 3.4 2.0 0.0 0.5 0.0 0.8 0.0 0.2 2.4 2.3 2.0 6.0 2.4 1.7 2.9 6.0 3.4 1.4 8.0 1.5 3.0 3.0 22.9 9.6 0.6 0.0 0.3 0.0 10.2 0.0 0.0 0.3 3.0 1.0 481.4 5.7 0.6 25.8 0.0 4.4 0.0 26.9 7.9 32.5 0.1 1.1 3.0 15.1 1.8 1.3 0.0 18.9 2.4 9.8 7.1 3.5 0.0 65.1 4.6 0.2 1.4 0.0 0.0 7.9 0.0 7.9 0.0 0.7 4.7 8.7 0.0 0.0 3.4 0.6 0.0 0.0 0.0 21.5 24.9 17.0 0.0 11.0 18.1 0.3 0.7 0.2 0.0 0.2 8.1 0.0 1.6 0.0 0.0 1.2 0.2 13.2 6.6 22.4 DPEP2NB ENSG00000263201 "DPEP2 neighbor" A0A0U1RQF7 16 68013436-68015911 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 4.0" "Cell type enriched" "Detected in some" 54 "Syncytiotrophoblasts: 65.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.91e-1)" "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.7 0.0 0.0 0.0 0.0 PPIAL4A "COAS2, PPIAL4, PPIAL4B" ENSG00000263353 "Peptidylprolyl isomerase A like 4A" Q9Y536 1 120889746-120890405 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;NB-4: 1.8;SK-BR-3: 1.9" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (3.49e-3)" "unprognostic (2.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-1)" "unprognostic (1.77e-1)" "unprognostic (2.09e-1)" "unprognostic (1.42e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.83e-2)" "unprognostic (1.74e-1)" 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.4 0.8 1.8 1.0 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.4 0.1 0.1 1.9 0.2 0.0 1.3 1.1 0.3 1.2 0.4 1.2 0.7 0.5 0.4 1.0 1.1 0.7 1.3 0.0 0.4 0.2 0.4 0.4 0.4 0.8 0.6 0.7 0.9 0.6 0.4 0.7 0.0 0.7 0.3 0.9 0.7 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM238L LINC00675 ENSG00000263429 "Transmembrane protein 238 like" 17 10794913-10804099 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "intestine: 37.9;stomach 1: 45.6;urinary bladder: 22.0" "Group enriched" "Detected in some" 5 "Collecting duct cells: 16.5;Theca cells: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "OE19: 6.4;RT4: 4.1" "Not detected" "Not detected" NA NA "unprognostic (7.23e-3)" "unprognostic (1.55e-1)" "unprognostic (3.49e-2)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (2.59e-2)" "unprognostic (2.99e-2)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "unprognostic (9.30e-3)" "unprognostic (6.09e-2)" "unprognostic (1.74e-1)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "unprognostic (7.56e-2)" "unprognostic (1.19e-2)" 0.1 0.1 0.5 1.8 0.5 0.0 1.7 0.4 0.6 0.7 0.1 37.4 18.4 0.1 0.7 5.5 0.4 2.7 0.0 0.4 0.5 2.2 0.8 0.0 0.0 0.5 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.6 37.9 0.0 0.6 3.5 0.0 1.2 16.8 1.3 0.4 0.0 45.6 0.3 1.2 0.0 0.0 0.0 0.4 22.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.6 0.4 0.5 0.5 0.5 0.3 0.7 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 PPIAL4C ENSG00000263464 "Peptidylprolyl isomerase A like 4C" A0A0B4J2A2 1 149583865-149584464 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.5;lymphoid tissue: 2.2" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 18.8;THP-1: 22.5" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (3.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (7.93e-2)" "unprognostic (5.98e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.25e-1)" 0.3 1.9 0.5 2.2 0.5 0.2 0.4 0.7 0.9 0.4 0.4 0.8 3.5 0.9 0.0 0.1 0.1 0.1 0.0 0.5 0.5 0.7 0.3 1.0 2.1 0.5 0.5 0.4 0.2 0.0 0.2 0.2 0.9 0.5 0.4 0.2 0.0 0.0 0.1 0.5 0.3 1.8 0.1 0.4 1.7 0.8 0.0 0.5 0.0 0.1 0.0 0.8 0.1 0.1 0.5 4.1 0.0 0.5 3.2 0.2 0.5 2.8 0.5 0.2 1.2 0.9 0.0 6.4 1.9 2.4 0.0 3.1 4.5 0.0 0.3 0.8 4.8 0.0 0.4 0.0 0.0 0.1 1.1 1.7 0.2 1.0 0.8 0.4 0.0 0.0 0.2 0.9 6.1 0.9 0.7 7.4 18.8 7.6 0.8 0.1 7.2 0.1 12.2 0.0 0.0 5.0 6.8 0.8 13.1 7.9 0.0 6.1 22.5 0.0 4.4 6.1 3.2 10.5 4.4 6.9 11.9 5.0 5.8 9.8 1.6 3.8 1.6 4.1 5.2 4.8 7.0 4.6 4.5 8.0 6.2 3.8 5.0 0.3 3.3 3.6 8.3 6.1 12.0 0.5 0.5 0.7 0.9 0.5 0.5 0.5 0.5 0.4 0.5 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRSF8 "SFRS2B, SRP46" ENSG00000263465 "Serine and arginine rich splicing factor 8" Q9BRL6 11 95066919-95071225 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049905 Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (1.55e-2)" "unprognostic (1.05e-1)" "prognostic favorable (9.99e-7)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (5.39e-2)" "unprognostic (2.75e-3)" 13.7 13.7 17.0 12.2 16.9 14.8 16.9 17.6 17.5 14.7 17.2 15.3 15.8 17.4 16.1 14.6 15.5 12.1 13.5 16.7 17.2 19.5 15.3 13.7 17.5 16.0 16.3 16.4 20.9 22.1 18.0 15.8 14.4 16.5 19.1 15.7 10.5 20.1 17.0 13.3 14.7 17.5 14.8 17.3 20.2 16.0 5.3 17.8 12.4 23.4 14.3 14.8 13.3 13.7 18.8 7.6 7.7 19.1 0.0 24.9 15.5 21.7 11.1 12.2 5.1 5.5 18.4 24.2 40.3 32.2 16.9 9.4 16.3 16.2 24.1 5.9 24.4 17.8 33.8 9.0 16.6 18.3 34.3 17.7 20.3 25.1 5.4 25.3 15.0 16.2 18.1 25.9 21.5 10.1 10.3 17.9 30.4 10.2 19.8 21.7 22.1 5.8 32.1 20.1 24.8 24.2 24.7 13.8 24.1 16.7 12.0 9.6 18.7 15.3 9.9 13.3 13.5 11.6 11.6 19.1 21.4 5.1 22.5 22.1 10.1 2.1 0.7 5.4 1.2 7.9 9.2 9.4 8.1 4.0 7.1 12.0 9.1 0.6 6.2 1.1 3.7 10.9 4.1 17.0 16.9 17.6 17.5 16.7 17.2 16.0 16.3 16.4 16.5 17.3 17.8 18.8 32.5 44.8 29.3 8.8 82.8 0.0 51.4 0.0 57.5 49.3 54.4 60.3 21.4 58.6 11.8 33.1 33.3 39.2 56.5 41.1 150.6 36.7 1.8 22.1 27.6 45.8 56.9 122.9 18.3 45.7 52.7 31.4 40.2 33.8 10.2 43.2 52.5 57.8 26.1 18.5 16.6 82.6 0.0 24.2 0.0 6.0 41.0 41.9 0.0 18.7 40.2 45.7 97.9 13.6 29.6 28.9 40.8 60.9 46.8 46.4 53.4 110.1 9.5 50.9 32.9 34.6 31.0 7.2 6.4 63.5 0.0 51.2 58.4 52.1 67.5 38.0 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.9;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" "Erythroid cells: 7.8;Extravillous trophoblasts: 4.5;Sertoli cells: 6.6;Spermatocytes: 9.4;Spermatogonia: 3.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 64.9" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.4 0.2 0.1 1.5 0.1 2.9 0.3 0.3 0.2 0.2 0.1 0.4 0.6 0.2 0.0 1.3 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.3 4.6 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.5 0.1 0.1 0.6 0.0 0.2 0.0 0.0 1.2 0.4 0.3 0.1 1.2 0.3 1.6 0.1 5.5 0.1 0.1 4.6 0.4 0.4 0.2 18.7 10.6 12.5 5.7 0.6 1.7 12.1 8.9 2.8 12.0 9.0 1.6 21.7 44.4 11.6 1.0 11.0 17.4 17.2 5.5 13.0 15.3 10.0 19.1 9.4 3.3 0.4 39.5 16.6 0.3 0.1 9.1 24.3 2.5 5.1 34.7 34.0 20.5 0.8 1.4 23.2 30.4 10.2 20.8 6.6 29.7 9.0 31.5 2.1 2.3 6.3 11.5 8.7 5.0 4.9 13.0 12.5 33.4 3.7 9.4 15.4 12.5 20.3 41.9 64.9 26.0 5.1 24.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.8 0.0 0.0 0.0 0.5 0.1 0.1 0.3 0.6 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 2.3 0.3 0.2 1.3 0.0 7.8 0.2 0.2 4.5 0.3 0.0 0.1 0.0 0.5 1.8 0.1 1.7 0.0 0.3 0.6 0.0 2.2 1.4 0.5 0.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 6.6 0.3 0.7 9.4 3.5 1.3 0.3 0.3 0.7 0.3 0.5 0.0 IKBKE "IKK-i, IKKE, KIAA0151" ENSG00000263528 "Inhibitor of nuclear factor kappa B kinase subunit epsilon" Q14164 1 206470476-206496889 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 47.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015788, CAB025983" Approved Supported Cytosol NA NA Cytosol "CAB025983: , HPA015788: AB_1851566" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.76e-2)" "unprognostic (7.78e-3)" "unprognostic (7.37e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.34e-7)" "unprognostic (1.48e-2)" "unprognostic (5.77e-2)" "unprognostic (2.84e-3)" "unprognostic (2.84e-2)" 2.4 3.7 2.6 16.8 4.5 8.8 3.2 2.2 2.8 4.1 2.1 7.9 7.5 1.7 3.9 14.7 2.8 5.1 1.2 2.6 4.5 3.4 1.6 4.2 24.5 3.7 3.3 2.0 1.2 3.5 1.1 1.9 2.6 3.5 3.6 7.8 0.1 6.9 2.1 0.5 15.1 8.1 2.5 3.1 14.3 7.3 0.7 4.0 16.6 4.5 0.3 20.6 8.5 6.8 3.4 17.8 13.9 3.7 0.4 6.7 9.2 3.9 7.1 22.3 9.4 10.4 11.5 26.9 35.3 18.6 14.5 11.5 23.0 0.1 18.1 2.2 5.5 3.5 4.7 8.8 7.6 8.4 29.5 14.8 12.2 3.2 7.7 1.7 10.9 14.2 9.4 2.3 10.0 10.5 3.6 19.2 47.7 5.2 4.3 10.9 9.7 4.3 27.7 10.7 29.4 0.0 0.0 2.9 22.9 4.2 4.5 13.8 20.3 26.5 9.0 5.5 6.9 8.5 3.5 1.8 23.3 17.1 24.2 3.7 12.2 32.8 0.6 21.2 23.3 14.8 26.4 32.4 30.1 9.5 14.0 25.7 27.3 2.2 23.9 13.4 3.2 52.8 28.6 2.6 4.5 2.2 2.8 2.6 4.5 3.7 3.3 2.0 3.5 3.1 4.0 3.4 0.4 0.0 4.5 0.7 13.7 1.9 3.6 37.8 1.8 0.0 4.3 3.7 0.9 4.3 16.3 0.0 0.0 4.2 7.9 11.7 0.0 12.1 3.3 1.5 0.9 0.7 3.6 4.4 1.5 12.6 5.2 3.4 17.3 2.4 5.1 3.7 2.2 0.8 13.8 0.0 1.5 6.4 8.2 12.9 0.7 7.0 0.9 16.0 7.2 1.9 9.0 0.0 14.4 1.0 0.2 15.9 21.5 0.7 6.4 3.2 10.7 3.5 14.5 0.0 0.0 0.7 3.1 0.3 0.9 11.1 4.8 1.5 15.8 3.9 10.2 11.6 AC129492.3 ENSG00000263620 "Novel protein" 17 8150816-8162975 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 79.7;skeletal muscle: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 37.0;HEK 293: 27.0;REH: 20.1" NA NA 13.8 2.1 20.4 0.3 40.1 1.7 0.6 1.2 79.7 0.9 0.0 7.8 2.3 2.1 0.0 0.3 1.2 0.2 13.7 36.6 36.7 3.6 2.2 3.3 0.2 26.0 15.2 58.2 0.0 4.4 1.0 0.0 0.6 16.3 3.6 0.3 0.1 2.3 6.2 32.4 4.2 4.5 0.5 0.0 10.2 9.7 1.0 22.2 0.0 0.1 0.0 0.5 0.7 0.2 38.2 6.5 0.2 0.7 0.0 0.7 0.0 9.9 8.8 0.0 0.8 0.0 0.0 0.0 6.1 9.2 0.0 5.9 7.9 0.3 1.3 0.0 37.0 27.0 1.8 0.0 0.0 3.2 0.5 12.1 0.0 0.0 0.6 0.0 0.6 1.3 6.7 5.2 0.0 0.0 2.4 1.9 3.0 1.5 0.0 13.9 20.1 0.9 8.1 0.3 0.0 4.2 6.7 2.6 0.0 3.5 0.0 3.0 2.8 13.9 0.0 7.5 1.6 7.4 14.5 10.8 6.8 0.0 1.8 4.6 81.8 38.1 152.8 138.4 47.1 125.0 129.5 141.1 159.3 34.8 113.0 166.2 144.9 199.4 127.2 57.1 94.1 114.5 63.3 20.4 40.1 1.2 79.7 36.6 36.7 26.0 15.2 58.2 16.3 0.0 22.2 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46048180 "Cancer-related genes, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "prostate: 9466.5" "Cell type enriched" "Detected in many" 4 "Prostatic glandular cells: 10715.4" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 25.6;NB-4: 21.6;RPMI-8226: 11.3;SH-SY5Y: 6.1;SK-BR-3: 5.9;U-2197: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" NA NA 6000000 "CAB026357: , HPA051257: AB_2681410" "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.19e-4)" 5.1 4.6 0.0 3.0 0.0 0.1 20.7 0.0 0.0 3.2 0.0 1.6 10.4 0.3 45.5 12.4 4.7 3.0 0.5 0.0 0.0 1.8 1.8 30.2 0.2 0.0 0.0 0.0 0.3 2.3 0.2 0.5 0.6 0.0 9466.5 0.1 0.0 32.1 0.6 0.4 36.5 2.3 0.0 0.0 0.7 557.1 10.2 0.0 1.1 0.8 0.0 10.1 7.2 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 21.6 0.2 0.0 0.0 0.0 0.0 11.3 0.0 1.6 1.0 6.1 0.0 5.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.3 0.0 195.9 586.4 0.0 0.0 6.4 1.3 0.0 4.3 2203.2 0.0 0.0 2.1 0.1 0.3 0.0 0.1 48.9 0.6 0.0 10.7 0.0 0.0 0.1 0.2 0.4 9.5 404.2 0.2 1.3 0.0 0.0 1.2 0.2 0.0 0.0 0.8 419.1 0.0 0.0 78.8 0.3 30.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 29.6 0.0 0.8 10715.4 0.3 0.0 570.6 0.0 0.0 0.0 271.0 0.5 1.4 0.0 0.4 1.5 14.3 0.0 0.1 192.4 LINC02210-CRHR1 ENSG00000263715 "LINC02210-CRHR1 readthrough" 17 45620344-45835826 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.9" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.1;Collecting duct cells: 3.7;Distal tubular cells: 1.9;Endometrial ciliated cells: 1.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 1.9 0.4 0.3 0.2 0.2 0.4 0.2 0.1 0.3 0.5 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 3.7 0.0 0.1 0.3 0.0 1.9 0.2 0.0 1.9 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 GDF2 "BMP-9, BMP9" ENSG00000263761 "Growth differentiation factor 2" Q9UK05 10 47322454-47327588 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Angiogenesis "Cytokine, Growth factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "liver: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB023357 Uncertain "Secreted to blood" NA NA 2210000 740000 "CAB023357: AB_2111086" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC00672 ENSG00000263874 "Long intergenic non-protein coding RNA 672" 17 38925168-38929384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 18.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 42.7;granulocytes: 35.0;Horizontal cells: 30.3;NK-cells: 37.0" "Cancer enhanced" "Detected in many" "glioma: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.3" NA NA "unprognostic (3.28e-1)" "unprognostic (9.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.15e-2)" "unprognostic (8.81e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.68e-6)" "unprognostic (7.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.44e-2)" "unprognostic (2.59e-4)" 0.9 1.9 11.9 1.0 10.1 3.2 0.9 7.8 11.0 1.0 5.4 1.3 0.9 2.0 2.3 0.8 2.2 1.5 1.0 10.8 10.2 0.6 0.6 1.5 1.3 9.7 9.9 10.4 2.0 1.0 0.1 1.9 0.9 10.5 1.3 1.4 3.8 0.8 2.3 0.7 1.8 2.5 1.8 7.5 2.3 1.7 0.5 11.4 0.8 0.5 0.3 0.8 1.2 1.1 18.0 0.4 0.5 1.1 0.7 0.5 0.7 0.2 0.4 0.3 0.1 0.3 0.2 2.1 0.3 0.4 0.6 0.0 1.1 0.0 0.2 0.3 0.2 0.3 0.4 0.6 0.0 0.2 0.8 1.4 0.8 0.4 0.3 0.1 0.8 0.1 0.6 0.1 0.3 0.2 0.4 0.4 0.8 6.3 0.3 0.0 1.8 0.1 0.5 0.6 0.5 0.1 2.4 0.6 0.7 0.4 0.5 0.8 0.7 1.2 0.2 0.4 0.4 0.2 0.6 0.9 0.4 0.5 0.6 0.2 0.4 0.2 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.6 0.9 0.3 0.1 0.2 0.1 0.1 11.9 10.1 7.8 11.0 10.8 10.2 9.7 9.9 10.4 10.5 7.5 11.4 18.0 7.5 12.8 3.4 0.3 3.9 1.1 1.9 1.5 0.0 42.7 6.6 10.3 2.7 2.8 2.4 0.0 2.1 0.3 15.7 2.7 0.0 2.0 0.6 3.5 4.2 4.8 1.8 2.7 14.4 1.4 0.8 6.7 7.7 9.8 35.0 1.8 4.6 0.7 1.5 30.3 13.3 3.8 6.1 3.1 3.4 0.4 3.7 3.5 3.6 3.7 7.4 9.3 37.0 8.0 6.1 3.3 4.8 4.1 3.3 2.7 3.9 0.3 4.4 8.0 0.0 9.5 7.0 0.1 0.4 0.9 0.6 0.3 9.3 1.7 4.1 1.9 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favorable (3.20e-5)" 8.5 7.6 4.3 5.7 5.2 7.7 9.6 4.5 5.4 11.2 4.8 8.5 4.3 9.6 17.2 6.6 10.4 3.8 5.4 4.3 4.8 7.3 18.2 7.0 7.5 6.4 4.9 3.7 11.7 12.2 7.8 7.8 4.7 5.9 9.9 5.7 7.3 8.8 7.1 3.3 12.1 10.6 6.6 5.6 12.7 12.1 6.6 5.2 6.1 9.9 1.5 7.8 9.1 8.6 7.5 5.4 4.4 8.6 8.3 5.8 4.7 5.8 4.7 4.5 3.9 4.2 3.4 5.4 9.3 3.7 5.8 3.7 7.1 5.4 1.8 4.8 5.1 5.8 4.2 15.6 3.8 4.1 5.9 14.4 4.1 5.0 5.1 9.8 6.0 3.0 7.9 6.8 0.4 4.0 11.0 6.9 11.0 7.5 12.6 5.6 9.1 4.8 3.6 4.0 10.8 3.4 8.9 7.8 5.3 8.0 11.2 7.7 10.1 7.3 5.0 4.3 7.8 6.1 5.3 4.7 6.3 4.9 3.7 2.9 3.7 0.9 3.0 1.8 0.6 1.3 1.6 1.6 1.1 0.9 2.2 1.6 1.3 0.1 0.5 1.9 1.9 0.6 0.6 4.3 5.2 4.5 5.4 4.3 4.8 6.4 4.9 3.7 5.9 5.6 5.2 7.5 6.0 12.8 12.0 19.9 11.9 1.1 2.3 0.3 9.6 4.5 7.8 6.2 6.9 5.7 5.2 3.7 10.4 4.9 9.1 5.5 0.0 3.4 9.7 4.3 4.5 6.9 3.5 8.8 28.1 3.3 4.2 7.0 11.2 7.5 13.9 6.6 7.5 19.1 3.3 5.0 16.8 8.0 0.0 9.6 3.4 1.4 5.3 6.6 7.2 24.4 15.9 3.8 6.2 30.7 29.9 4.1 16.0 2.6 6.9 1.5 4.9 2.7 3.8 6.8 6.6 4.4 5.5 6.9 3.9 8.6 1.4 2.9 8.1 3.3 8.4 1.1 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206053173-206102449 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.6" "Group enriched" "Detected in some" 14 "Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3" "Group enriched" "Detected in many" 5 "endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 152 "basophil: 1312.1" "Lineage enriched" "Detected in single" 1544 "granulocytes: 1312.1" "Cell line enriched" "Detected in some" 5 "HMC-1: 1562.9" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 3.2 0.4 0.0 3.0 0.0 1.4 4.7 0.0 0.0 24.6 0.0 7.6 3.3 12.9 16.4 7.8 5.4 16.4 0.9 0.0 0.0 14.2 1.0 10.8 4.2 0.0 0.1 0.0 0.2 1.4 0.3 0.4 0.6 0.0 2.9 7.5 0.0 2.8 20.2 1.0 4.1 6.7 7.4 0.0 3.0 6.5 1.0 0.2 3.1 2.0 2.6 4.6 7.8 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 143.8 0.0 0.9 0.0 75.2 1562.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 5.9 330.8 0.0 0.0 0.0 0.1 0.2 0.7 20.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.6 0.9 1.1 0.8 1312.1 0.0 8.6 0.0 0.1 0.1 0.5 0.2 0.0 0.6 0.2 0.1 0.2 0.5 0.0 0.2 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 13.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 20.2 0.0 2.3 0.7 0.0 1.9 3.6 0.0 202.9 17.6 1.3 0.0 0.0 0.0 0.2 0.2 0.4 0.0 337.5 334.3 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 AKR1C8P AKR1CL1 ENSG00000264006 "Aldo-keto reductase family 1 member C8, pseudogene" Q5T2L2 10 5154140-5185187 "Predicted intracellular proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "choroid plexus: 2.7;epididymis: 3.4;liver: 8.1" "Cell type enhanced" "Detected in single" "Microglial cells: 1.0" "Cancer enriched" "Detected in single" 9 "liver cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 41 "HDLM-2: 19.5" NA NA "unprognostic (3.47e-1)" "unprognostic (2.14e-1)" "unprognostic (4.76e-1)" "unprognostic (4.20e-2)" "unprognostic (3.69e-1)" "unprognostic (3.07e-1)" "unprognostic (1.10e-1)" "unprognostic (1.92e-2)" "unprognostic (2.66e-2)" "unprognostic (6.28e-3)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 19.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 196.8;skin 1: 328.0;vagina: 101.3" "Cell type enriched" "Detected in many" 4 "Squamous epithelial cells: 118.7" "Cancer enhanced" "Detected in many" "cervical cancer: 5.2;head and neck cancer: 5.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 374.5;HBEC3-KT: 485.0;hTCEpi: 140.1;SiHa: 116.6" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 18.3 0.2 0.0 0.0 0.0 1.2 22.1 0.0 0.1 22.8 0.0 0.2 0.0 0.1 0.0 196.8 6.2 0.1 1.6 0.0 0.0 0.0 1.1 16.7 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 24.3 0.0 6.8 0.0 0.0 41.1 4.6 1.1 328.0 0.1 0.0 0.0 0.1 0.3 0.8 0.0 4.3 0.1 0.0 35.4 37.7 101.3 0.0 70.1 18.2 0.0 0.0 0.0 0.0 24.8 0.9 0.1 0.0 0.0 1.9 12.6 0.0 0.6 0.3 0.5 374.5 0.0 485.0 0.0 28.9 0.0 0.0 33.3 0.0 9.3 0.0 0.7 0.0 140.1 0.2 58.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 70.2 0.2 0.7 0.0 0.0 0.8 0.0 0.0 76.0 0.1 0.0 116.6 12.0 0.0 7.2 0.0 0.7 0.0 0.1 12.2 0.1 0.3 0.0 0.1 0.0 2.8 0.1 0.2 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 1.1 0.0 0.0 0.0 3.0 0.2 11.4 1.6 2.3 2.4 3.7 18.6 19.9 0.0 0.0 14.8 0.0 3.0 0.0 0.7 0.4 1.0 0.0 0.9 0.0 0.0 0.0 0.2 11.4 12.8 5.6 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.7 1.4 0.0 1.2 2.5 5.2 0.0 10.9 0.2 13.1 0.0 1.5 0.3 2.4 118.7 1.1 6.3 0.6 0.0 0.2 5.9 NOTCH2NLA "N2N, NOTCH2NL" ENSG00000264343 "Notch 2 N-terminal like A" Q7Z3S9 1 146146203-146229026 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "B-cells: 1.6;dendritic cells: 2.8;Extravillous trophoblasts: 2.0;Fibroblasts: 1.2;Hofbauer cells: 2.1;Macrophages: 2.2;Plasma cells: 3.0;Smooth muscle cells: 1.4;Syncytiotrophoblasts: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB004669 Uncertain "Secreted to blood" NA NA "CAB004669: AB_426149" "unprognostic (1.54e-1)" "unprognostic (8.28e-3)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (4.28e-4)" "unprognostic (1.26e-2)" "unprognostic (1.81e-1)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.91e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-2)" 12.5 6.0 6.9 6.9 4.6 5.3 13.5 3.1 10.0 17.4 17.1 7.7 5.1 9.0 13.8 22.1 9.9 7.0 8.5 8.6 23.0 8.5 15.6 13.2 6.0 7.3 4.8 2.0 11.7 11.0 8.9 3.7 9.7 6.7 14.7 6.5 8.7 15.0 7.9 9.2 29.2 7.2 8.6 4.1 11.5 7.5 34.2 5.7 5.4 10.7 3.8 6.8 9.2 21.2 7.8 22.8 7.8 12.2 4.4 11.4 31.4 4.8 12.3 20.7 14.1 16.0 4.3 10.5 5.0 5.1 9.7 7.6 10.1 6.9 15.7 22.1 13.5 5.8 17.1 15.8 2.0 12.9 7.6 6.1 28.5 4.9 15.5 33.2 17.4 10.2 7.4 5.4 26.6 20.1 15.9 4.2 5.2 3.6 1.7 14.9 4.1 11.9 16.2 7.4 12.0 1.9 1.2 21.0 12.2 4.9 7.9 20.5 7.7 42.2 9.5 8.2 19.9 16.1 51.0 14.2 12.5 15.6 6.1 8.4 16.8 13.4 27.9 4.3 13.4 4.1 14.3 4.0 4.0 10.5 11.4 5.8 4.2 19.5 4.5 18.1 17.3 4.2 3.0 6.9 4.6 3.1 10.0 8.6 23.0 7.3 4.8 2.0 6.7 4.1 5.7 7.8 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083419-58095542 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 455.4;Late spermatids: 892.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 24.7 42.2 89.5 17.9 83.8 17.9 17.0 81.1 74.6 18.0 48.5 24.2 25.2 19.8 22.6 20.5 19.6 13.5 50.8 68.1 84.2 42.5 35.5 18.0 15.6 87.4 91.6 62.4 20.6 18.0 47.5 28.9 30.6 102.3 30.6 20.2 41.5 31.1 26.5 114.8 19.3 24.5 19.1 86.2 18.1 21.5 26.4 89.1 22.7 33.3 59.3 18.6 20.8 17.7 88.1 54.1 36.0 72.3 33.1 44.0 24.0 114.6 53.2 21.1 25.2 19.7 80.4 25.4 48.0 58.8 33.1 30.1 28.4 33.8 42.2 43.2 47.8 24.5 52.1 21.9 47.7 34.8 56.2 31.1 24.3 28.2 29.4 23.2 26.4 17.1 39.8 52.7 28.4 24.7 81.5 64.1 23.2 49.9 35.3 36.5 58.3 42.5 19.9 22.0 57.9 49.3 39.4 47.7 19.0 42.0 37.2 56.2 26.1 31.0 49.3 62.2 33.2 39.8 52.6 68.5 57.0 25.5 44.2 35.2 1.0 0.2 0.5 0.6 0.1 0.7 0.4 0.5 0.6 0.1 0.4 0.5 0.8 0.4 0.4 0.9 0.2 0.4 0.2 89.5 83.8 81.1 74.6 68.1 84.2 87.4 91.6 62.4 102.3 86.2 89.1 88.1 33.9 12.8 43.8 1.0 28.1 49.1 40.7 13.7 45.5 63.7 55.7 39.8 186.2 44.3 23.8 60.7 39.6 102.1 59.7 56.7 31.3 37.6 455.4 51.5 57.3 32.5 67.2 40.6 1.2 31.2 73.4 30.6 20.9 55.2 22.8 19.1 23.9 104.7 43.0 70.7 2.0 55.7 26.4 28.4 37.4 892.8 29.5 32.8 65.8 1.9 31.9 74.7 19.6 0.5 2.8 38.0 38.6 26.7 19.4 35.3 50.0 78.2 18.4 41.1 26.3 40.1 86.1 46.5 44.8 45.1 46.0 60.1 46.9 29.0 49.7 36.5 MYH4 "MYH2B, MyHC-2B, MyHC-IIb" ENSG00000264424 "Myosin heavy chain 4" Q9Y623 17 10443290-10469559 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "skeletal muscle: 10.7" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 3.3" "Cancer enriched" "Detected in single" 115 "liver cancer: 9.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 25 "OE19: 9.0" HPA001349 Supported Uncertain "Focal adhesion sites" NA NA 86000000 "Focal adhesion sites" "HPA001349: AB_1079437" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (4.94e-2)" "unprognostic (1.69e-2)" "unprognostic (4.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.21e-3)" "unprognostic (3.52e-4)" "unprognostic (9.97e-2)" 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 OTUD7B "CEZANNE, ZA20D1" ENSG00000264522 "OTU deubiquitinase 7B" Q6GQQ9 1 149937812-150010726 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 106.3;Oligodendrocytes: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027045, HPA076357" Supported Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA027045: AB_1854847, HPA076357: " "unprognostic (2.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.90e-1)" "prognostic favorable (7.47e-4)" "unprognostic (1.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.23e-3)" "unprognostic (1.46e-2)" "prognostic favorable (5.09e-5)" "unprognostic (4.90e-2)" "unprognostic (7.72e-2)" "unprognostic (8.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.67e-2)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (1.58e-2)" 11.8 7.8 23.7 3.8 36.8 1.1 7.9 28.7 19.0 10.0 7.9 7.1 6.2 10.6 3.9 7.8 9.4 4.9 7.2 15.0 22.3 5.7 10.7 7.4 1.9 43.8 38.2 9.4 11.0 6.1 11.0 3.4 7.1 40.5 6.7 7.2 10.2 7.8 7.5 18.8 5.8 6.3 10.9 32.4 3.6 6.8 12.8 30.3 2.2 6.8 16.4 3.3 6.4 5.2 44.7 17.2 13.5 9.3 15.6 12.0 11.1 8.8 11.8 17.3 14.0 9.6 10.0 13.6 0.2 7.5 21.7 6.3 13.4 13.2 13.1 14.6 16.5 6.7 6.6 18.9 6.8 12.8 7.6 6.9 12.4 9.9 23.7 20.6 10.9 11.5 2.0 18.4 18.1 10.1 17.5 1.3 2.1 11.9 12.8 13.1 1.8 12.9 4.4 5.4 23.2 6.0 11.4 20.8 15.2 18.5 12.1 12.6 4.0 13.9 14.4 13.2 9.8 14.0 19.1 20.0 2.0 12.8 2.2 24.1 2.0 0.0 0.4 0.7 0.0 0.5 0.1 0.3 0.4 0.0 0.1 0.2 0.3 0.3 0.4 0.0 0.1 0.1 0.0 23.7 36.8 28.7 19.0 15.0 22.3 43.8 38.2 9.4 40.5 32.4 30.3 44.7 10.2 35.3 11.7 56.8 3.0 15.9 22.7 8.7 13.1 28.0 18.3 9.3 22.2 12.8 15.3 11.0 106.3 23.5 5.1 41.1 7.9 14.5 63.4 21.8 17.8 16.7 17.4 14.9 20.6 11.1 11.6 14.8 21.4 40.2 0.0 22.0 20.3 33.0 3.1 23.5 24.6 15.8 8.2 0.8 5.9 79.4 14.6 2.4 37.4 22.5 4.3 23.6 15.5 33.2 176.8 20.6 21.3 23.0 4.7 20.2 17.1 11.5 17.4 66.9 0.0 19.8 17.9 11.1 7.2 11.8 16.6 21.2 7.5 11.1 11.1 34.0 AC138696.1 ENSG00000264668 "Novel protein" 8 143247110-143276403 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.7;MOLT-4: 1.2" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Plasma membrane" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: AB_2683082" "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 0.3 0.3 0.2 0.0 0.2 0.0 0.3 0.1 0.5 0.2 0.0 0.3 0.1 0.6 0.0 0.1 0.7 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.5 0.6 0.1 0.2 0.0 0.2 0.3 0.0 0.1 0.2 0.2 0.4 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.5 0.0 0.0 0.3 1.7 0.1 0.1 0.5 1.1 0.6 0.2 0.0 0.7 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 1.0 0.4 0.0 0.3 0.2 0.3 0.4 0.0 0.0 0.0 0.0 1.2 0.0 1.1 0.1 0.3 0.6 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 1.1 0.0 0.8 0.2 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY4R2 CH17-360D5.1 ENSG00000264717 "Neuropeptide Y receptor Y4-2" P0DQD5 10 47918739-47923524 "Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "A549: 10.2" HPA027863 Uncertain NA NA "HPA027863: AB_10602819" "unprognostic (1.74e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-1)" "unprognostic (7.78e-2)" "unprognostic (6.72e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA5 CX40 ENSG00000265107 "Gap junction protein alpha 5" P36382 1 147756199-147773362 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.2" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 135.3;Extravillous trophoblasts: 345.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 133.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB013080, HPA071370" Enhanced NA NA "CAB013080: AB_2533263, HPA071370: " "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-2)" "unprognostic (2.94e-2)" "unprognostic (3.88e-2)" "unprognostic (8.95e-2)" "unprognostic (1.23e-3)" "unprognostic (5.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (7.57e-2)" "unprognostic (1.97e-2)" "unprognostic (2.44e-1)" "unprognostic (4.41e-2)" "unprognostic (3.43e-2)" "unprognostic (8.93e-2)" 18.7 2.2 2.6 6.1 3.0 0.0 10.6 2.5 6.0 4.9 7.4 4.6 3.4 10.9 2.3 4.8 8.3 6.3 37.0 2.5 2.3 17.2 1.2 26.6 1.7 3.8 3.0 2.1 4.0 2.7 3.4 0.5 86.2 2.7 4.0 4.1 0.2 1.6 9.5 2.2 1.3 6.0 8.3 2.8 3.9 3.0 2.9 2.8 0.6 5.4 8.9 2.3 7.4 3.9 2.8 1.8 0.0 0.3 0.0 0.0 0.0 5.7 4.4 2.2 2.2 0.5 0.1 0.2 0.0 1.4 0.7 0.0 0.3 0.0 9.3 3.5 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 13.1 0.0 0.1 0.1 0.2 133.8 0.0 12.2 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.0 2.5 6.0 2.5 2.3 3.8 3.0 2.1 2.7 2.8 2.8 2.8 14.3 3.2 4.2 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.2 1.5 17.7 0.0 0.0 3.7 0.0 135.3 0.1 0.0 0.0 0.0 7.6 0.1 0.3 14.7 0.0 0.0 0.0 0.0 345.3 3.7 0.0 0.1 0.0 19.9 37.9 0.0 15.8 0.0 0.0 0.0 0.0 0.6 0.0 9.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 39.5 0.5 11.1 4.3 0.4 0.2 0.3 31.1 0.5 0.1 0.0 0.1 AC134669.1 ENSG00000265118 "Novel protein" 17 31305213-31318831 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.9;lymphoid tissue: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 220.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.6;HMC-1: 3.4;MOLT-4: 7.1;RPMI-8226: 5.5" HPA045033 Uncertain NA NA "HPA045033: AB_2679191" "unprognostic (5.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (5.88e-2)" "unprognostic (2.94e-2)" "unprognostic (2.40e-2)" "unprognostic (4.63e-2)" "unprognostic (3.23e-1)" "unprognostic (5.45e-5)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" 1.2 0.2 0.6 3.7 1.6 2.0 0.4 1.4 1.6 0.2 1.0 0.5 0.8 0.2 0.0 0.5 0.5 1.1 0.2 0.8 2.4 0.0 0.3 1.3 2.3 2.9 1.5 0.4 0.2 0.2 0.2 0.1 1.2 2.5 0.1 0.7 0.2 0.3 0.4 0.5 0.4 0.7 0.8 2.2 1.9 1.5 0.6 1.7 8.5 0.1 0.2 3.2 0.6 0.1 4.9 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.3 0.6 0.4 0.9 0.0 0.0 0.7 0.0 0.3 1.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 1.3 3.4 0.8 0.0 0.0 1.5 0.4 0.0 1.4 0.0 3.1 1.3 0.0 7.1 0.6 0.0 0.0 0.0 2.0 0.4 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 1.2 1.6 0.6 0.1 0.8 0.8 3.1 0.0 2.4 0.2 1.1 0.7 8.5 94.4 8.5 31.0 41.4 28.2 35.0 35.2 32.3 54.9 22.5 35.3 31.9 220.3 19.0 43.9 18.7 48.6 96.4 0.6 1.6 1.4 1.6 0.8 2.4 2.9 1.5 0.4 2.5 2.2 1.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 ANXA8 ANX8 ENSG00000265190 "Annexin A8" P13928 10 47460162-47484158 "Predicted intracellular proteins" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 219.4;skin 1: 268.4;vagina: 111.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Astrocytes: 38.8;Club cells: 40.7;Excitatory neurons: 47.8;Fibroblasts: 34.5;Inhibitory neurons: 41.0;Microglial cells: 35.6;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 48.1;Squamous epithelial cells: 63.6" "Group enriched" "Detected in many" 4 "cervical cancer: 14.3;head and neck cancer: 16.1;lung cancer: 4.3;urothelial cancer: 11.1" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 394.3;HBEC3-KT: 622.3;hTCEpi: 357.6;hTERT-HME1: 134.2;RT4: 159.6" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (8.32e-4)" "unprognostic (2.52e-1)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (5.94e-2)" "unprognostic (2.88e-2)" "unprognostic (2.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.19e-1)" "unprognostic (7.55e-15)" "unprognostic (1.04e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" 33.4 0.7 0.4 0.1 0.3 0.7 11.8 0.8 1.0 24.8 0.4 0.4 0.0 0.1 1.0 219.4 3.8 0.4 2.5 0.5 0.1 0.0 1.8 13.2 0.0 0.8 0.5 0.2 1.3 0.3 0.0 0.3 31.2 0.6 12.5 0.1 0.0 47.7 9.9 0.4 268.4 0.2 0.0 0.5 0.2 0.4 0.8 0.9 4.8 0.2 0.2 47.0 67.0 111.6 0.8 123.4 16.2 0.0 0.0 0.0 0.0 33.7 2.3 0.3 0.0 0.0 8.7 35.0 0.0 2.5 1.0 1.8 394.3 0.0 622.3 0.0 27.9 0.0 0.0 39.6 0.0 26.2 0.0 1.3 0.2 357.6 0.2 134.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 37.2 0.1 4.0 0.0 0.0 0.5 0.0 0.0 159.6 0.0 0.0 56.4 16.4 0.3 8.7 0.1 3.5 0.0 0.0 39.5 0.7 2.4 0.2 0.1 0.2 4.4 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.3 0.8 1.0 0.5 0.1 0.8 0.5 0.2 0.6 0.5 0.9 0.8 0.1 99.3 7.3 38.8 0.0 1.1 10.3 1.6 2.8 0.0 4.9 3.4 2.6 7.2 40.7 3.7 0.0 14.7 0.1 1.0 0.0 3.1 0.6 2.1 0.0 0.5 0.0 0.0 47.8 0.4 6.7 34.5 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 41.0 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 35.6 0.1 0.0 0.0 50.8 48.1 17.3 0.0 0.0 0.0 8.5 1.5 0.0 14.2 0.0 0.0 0.0 0.6 0.2 1.4 63.6 2.0 6.2 0.3 0.1 0.2 17.2 RBP3 "D10S64, D10S65, D10S66, RP66" ENSG00000265203 "Retinol binding protein 3" P10745 10 47348363-47357881 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" Transport "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "retina: 547.0" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 2070.4;Rod photoreceptor cells: 1610.0" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "midbrain: 5.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.3" "Low region specificity" "Detected in many" "HPA041301, HPA044239" Enhanced "Secreted in other tissues" NA NA "HPA041301: AB_2677398, HPA044239: AB_2678868" "unprognostic (3.48e-2)" "unprognostic (4.78e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.40e-1)" "unprognostic (1.58e-2)" "unprognostic (5.09e-2)" "unprognostic (5.14e-3)" "unprognostic (7.44e-2)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 547.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 1.2 0.9 0.5 5.9 0.0 0.8 0.1 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.7 0.0 0.0 0.5 0.0 0.0 0.0 2070.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1610.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RBM8A "BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP" ENSG00000265241 "RNA binding motif protein 8A" Q9Y5S9 1 145917714-145927678 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 735.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018403 Supported Supported "Nuclear speckles" NA NA 100000 "Nuclear speckles" "HPA018403: AB_1858908" "unprognostic (3.81e-1)" "unprognostic (3.99e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-2)" "unprognostic (1.12e-1)" "unprognostic (3.16e-1)" "unprognostic (4.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (8.79e-3)" "unprognostic (7.27e-3)" "prognostic unfavorable (1.55e-4)" "unprognostic (3.30e-3)" "unprognostic (2.18e-1)" "unprognostic (3.77e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-3)" 81.9 75.5 37.5 106.4 39.9 216.6 83.0 39.0 43.3 67.7 36.0 71.2 70.7 68.2 49.8 164.9 62.8 58.5 72.8 37.0 40.4 72.7 78.2 73.5 127.5 40.1 39.3 34.7 72.6 60.5 79.1 66.3 86.0 41.4 67.0 57.0 45.4 79.9 48.7 216.6 91.2 69.8 58.2 43.2 82.3 68.1 71.8 40.2 121.8 69.4 100.9 124.7 113.8 81.1 44.1 377.0 300.7 268.8 215.7 94.6 92.2 330.0 224.3 150.7 315.0 230.1 400.0 277.4 342.0 344.9 155.3 166.5 252.5 289.3 245.3 257.0 305.6 275.7 264.2 229.2 299.8 133.6 446.6 222.6 102.2 180.8 283.0 300.3 137.4 238.1 291.9 405.2 314.7 246.2 1033.8 452.3 352.2 463.7 323.9 518.4 394.4 234.6 341.2 203.2 355.6 274.6 335.7 334.5 169.7 316.5 231.0 318.0 534.3 247.3 252.3 324.0 250.9 626.0 352.2 603.4 502.6 226.4 264.9 223.2 464.6 316.5 513.6 337.2 363.9 322.1 444.3 317.6 346.4 318.0 389.6 296.1 328.3 363.7 389.8 361.3 498.4 386.3 582.7 37.5 39.9 39.0 43.3 37.0 40.4 40.1 39.3 34.7 41.4 43.2 40.2 44.1 289.1 70.5 132.4 8.1 251.0 332.9 396.7 475.4 244.2 66.3 168.5 184.7 78.0 98.7 262.8 88.3 54.2 376.2 276.0 125.3 187.9 224.1 243.7 148.0 134.3 206.0 158.9 149.2 10.8 223.2 506.3 174.1 80.5 152.8 244.0 136.8 120.3 124.4 204.3 35.3 9.1 127.6 313.3 100.3 265.2 54.4 102.2 170.7 208.1 9.4 197.7 120.3 165.8 6.0 16.1 245.4 159.8 85.4 174.9 259.6 119.5 204.1 195.1 86.3 98.6 213.7 208.1 212.0 168.9 208.1 318.0 735.5 282.1 139.7 141.7 393.0 AC099850.2 ENSG00000265303 "Novel protein" 17 59197566-59215226 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NB-4: 11.0;SK-MEL-30: 2.4;THP-1: 5.9" NA NA 1.1 3.1 6.6 0.0 6.7 0.7 1.2 6.8 9.5 1.3 6.6 1.4 0.0 1.2 0.0 2.5 1.1 0.0 2.6 6.7 6.6 2.1 6.0 1.0 0.5 6.7 6.6 6.5 1.4 3.3 0.0 2.5 0.1 6.7 1.6 0.2 0.4 1.2 0.1 1.2 2.0 1.8 0.0 6.6 3.8 2.5 2.9 6.7 0.3 1.1 0.2 0.6 1.2 1.2 6.8 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.3 0.0 0.6 0.0 1.5 0.7 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.3 0.3 1.1 0.0 0.0 0.7 0.0 0.6 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.3 0.0 2.4 0.3 0.3 5.9 0.0 0.0 0.7 0.2 0.1 0.2 0.4 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 0.2 0.1 0.0 6.6 6.7 6.8 9.5 6.7 6.6 6.7 6.6 6.5 6.7 6.6 6.7 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972489-46003742 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 148.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031408 Approved Supported Mitochondria NA NA Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favorable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 39.3 50.5 49.6 35.8 50.7 66.9 38.7 52.1 63.4 28.4 55.7 40.5 57.0 27.1 62.5 43.4 28.3 32.0 85.7 50.7 53.1 60.1 74.8 26.8 36.7 52.3 53.1 48.4 20.7 32.5 50.9 35.3 35.5 53.4 34.9 40.3 43.2 32.7 37.2 129.7 35.9 38.0 38.0 50.5 25.8 33.1 81.3 51.4 40.4 43.7 135.7 45.8 53.5 27.3 55.3 162.6 167.5 108.7 110.3 88.5 82.4 106.1 130.6 156.1 155.6 164.0 212.8 125.4 144.1 105.7 138.6 111.3 136.1 168.0 139.9 153.3 108.0 165.6 92.1 120.8 231.7 142.2 173.1 98.7 99.4 122.3 133.4 188.0 64.7 146.1 123.0 166.0 78.8 138.7 162.7 155.5 239.0 131.7 119.0 51.8 118.6 105.0 105.5 177.6 111.8 127.3 117.0 72.8 159.4 132.8 83.8 168.7 102.1 108.1 74.8 130.6 96.8 188.9 83.6 148.9 203.2 139.3 246.7 63.9 54.8 98.1 54.3 73.1 131.1 75.7 82.1 70.0 79.1 111.2 79.8 62.5 69.5 22.8 79.1 118.6 92.2 85.8 129.5 49.6 50.7 52.1 63.4 50.7 53.1 52.3 53.1 48.4 53.4 50.5 51.4 55.3 13.3 9.6 22.2 10.7 19.4 21.9 18.1 32.7 15.9 14.3 16.0 11.9 97.5 30.0 24.4 12.9 8.4 42.1 17.0 16.1 45.0 40.4 101.5 26.6 20.8 18.3 10.2 43.3 19.1 30.1 47.7 24.8 20.9 23.8 27.8 14.2 13.2 27.3 34.5 0.0 18.6 16.5 36.7 16.0 15.8 35.0 17.7 18.9 23.2 12.2 29.3 23.0 20.6 14.6 19.6 36.7 14.7 11.7 36.0 20.3 22.3 61.0 26.9 10.4 6.6 13.1 26.0 148.7 48.4 38.7 21.6 35.6 16.6 17.0 25.6 22.4 RNF115 "CL469780, ZNF364" ENSG00000265491 "Ring finger protein 115" Q9Y4L5 1 145738868-145824095 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019130 Approved Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA019130: AB_1859220" "unprognostic (3.44e-2)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (2.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.64e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" "unprognostic (3.23e-1)" "unprognostic (4.77e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" 7.6 5.1 8.1 4.7 7.5 7.5 7.6 15.5 9.1 7.1 6.6 7.5 3.5 12.3 4.2 5.7 8.0 4.7 25.1 7.9 7.2 5.6 5.1 6.0 5.1 6.8 8.0 7.6 5.5 5.4 6.9 5.3 3.6 9.0 7.3 3.7 14.0 6.0 5.2 32.4 5.8 5.5 11.2 6.0 5.1 5.9 3.9 7.8 5.0 6.1 25.5 4.7 8.0 5.6 7.9 11.0 4.5 5.4 3.9 9.6 12.5 4.2 8.1 15.1 5.9 7.1 4.9 3.8 7.7 9.0 11.7 5.7 7.5 6.0 5.5 6.3 7.7 3.9 6.1 5.9 4.6 6.1 9.7 13.7 7.3 4.8 6.0 7.1 6.7 7.7 5.9 6.1 12.2 10.8 8.3 7.1 6.0 6.8 7.0 9.4 6.7 5.4 6.4 11.6 3.6 5.3 7.4 6.6 8.0 6.3 6.6 8.9 9.1 9.4 8.4 6.6 5.1 8.7 10.2 10.3 8.0 4.2 6.4 5.4 6.4 1.0 1.6 1.4 0.8 1.2 1.5 1.0 1.4 0.8 1.2 1.0 1.4 0.7 1.6 0.8 1.1 1.0 0.7 8.1 7.5 15.5 9.1 7.9 7.2 6.8 8.0 7.6 9.0 6.0 7.8 7.9 168.4 16.0 29.2 61.7 43.5 20.6 32.6 24.4 23.9 101.3 35.9 29.1 152.5 38.6 27.0 18.4 114.7 26.8 155.6 13.2 33.2 44.8 68.5 52.9 45.4 72.3 27.1 60.6 91.2 80.3 28.7 60.8 28.1 55.8 31.7 39.1 71.7 33.1 37.2 82.4 77.6 23.5 28.5 41.5 36.2 25.3 39.4 38.9 39.2 84.3 71.0 64.4 90.6 81.4 83.9 52.4 18.8 80.9 90.5 76.0 22.5 46.6 29.6 111.1 59.2 60.2 53.5 76.5 63.7 23.7 18.0 19.8 75.7 65.2 23.6 40.2 CFAP298-TCP10L "C21orf77, FLJ10932, LINC00846" ENSG00000265590 "CFAP298-TCP10L readthrough" 21 32402511-32612865 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019055, HPA028849" Approved NA NA "HPA019055: AB_1845701, HPA028849: AB_10602111" "unprognostic (3.42e-2)" "unprognostic (2.31e-1)" "unprognostic (6.98e-2)" "unprognostic (6.14e-3)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.42e-1)" "unprognostic (8.92e-2)" "unprognostic (2.81e-1)" "unprognostic (7.06e-2)" "unprognostic (3.36e-2)" "unprognostic (3.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.10e-1)" "unprognostic (3.70e-2)" "unprognostic (5.33e-2)" "unprognostic (1.11e-1)" 6.1 7.0 2.6 6.7 2.4 5.1 9.7 2.6 3.5 10.1 3.1 8.9 6.1 9.8 19.6 10.5 28.7 8.5 11.1 2.4 2.6 14.3 11.7 7.5 9.7 2.4 2.4 2.2 8.2 7.8 14.0 1.1 7.6 2.4 10.5 12.0 10.7 9.5 9.2 9.5 7.5 5.7 11.0 2.3 4.3 5.8 26.6 2.5 5.7 16.3 5.1 12.7 9.9 0.8 2.6 22.9 14.3 17.6 23.2 15.8 14.4 22.8 13.9 18.9 24.0 18.1 21.9 18.0 20.9 11.9 18.9 16.7 8.5 29.0 27.3 28.6 9.8 10.6 30.5 14.7 35.4 20.3 41.6 20.3 7.7 33.0 38.5 28.4 21.1 26.7 24.4 45.2 12.8 21.2 36.7 29.3 17.8 24.0 41.3 10.6 19.0 21.6 31.3 43.5 14.6 28.7 19.7 19.2 23.8 33.1 21.0 24.6 20.3 9.8 7.2 8.0 16.4 20.2 4.5 36.9 40.1 15.0 50.9 15.6 3.1 2.2 2.4 7.6 1.8 11.3 3.3 5.2 5.5 4.5 2.1 3.3 5.0 0.4 6.1 3.6 3.8 3.6 1.4 2.6 2.4 2.6 3.5 2.4 2.6 2.4 2.4 2.2 2.4 2.3 2.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL17 "L17, rpL23" ENSG00000265681 "Ribosomal protein L17" P18621 18 49488453-49492523 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 2876.9;Squamous epithelial cells: 3332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043724, HPA046385" Supported Supported "Endoplasmic reticulum,Cytosol" NA NA 160000 "Endoplasmic reticulum, Cytosol" "HPA043724: AB_2678637, HPA046385: AB_2679646" "unprognostic (1.11e-1)" "unprognostic (8.77e-2)" "unprognostic (1.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (3.34e-3)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.69e-1)" "unprognostic (3.29e-3)" "unprognostic (2.11e-1)" "unprognostic (4.35e-3)" "unprognostic (2.72e-2)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (6.54e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-3)" 1904.5 1998.9 944.4 1006.9 958.2 2581.1 2725.2 981.5 1430.5 2398.1 996.0 1913.1 888.1 1761.7 1306.5 2279.7 2058.0 827.4 1411.0 925.0 995.1 1627.1 1482.3 1423.0 2026.0 959.9 952.1 914.3 4509.6 4217.0 869.6 1506.7 895.6 968.7 1844.8 1100.1 617.6 1803.5 908.2 1362.2 2245.7 1633.3 920.0 992.3 1865.2 2054.8 579.3 975.8 1652.0 1620.4 875.8 1686.4 1989.5 2105.5 977.4 2205.3 1360.2 1937.9 2315.0 3146.0 6392.2 1829.3 2400.4 2783.7 2229.8 1677.4 1860.7 1039.7 3785.8 1572.2 2399.7 1250.1 2569.5 2690.1 4329.7 2377.4 1547.4 2773.8 1999.8 1500.4 2560.9 2718.4 6578.1 1526.2 6150.1 4787.7 2333.9 5487.0 5189.2 3100.5 2538.6 1995.5 2685.2 2794.0 1781.7 2386.9 4203.2 1993.4 1327.9 1110.7 2333.6 2538.1 4932.3 3037.1 2571.4 1462.8 1741.2 882.6 1827.5 3949.5 2366.9 1726.9 4230.9 2473.3 1633.3 1389.1 815.2 2570.9 2341.0 2404.3 3520.5 1564.3 3936.3 1593.2 312.8 840.7 151.3 1081.4 743.0 2106.6 1907.9 1763.3 1442.8 1305.7 1574.1 1936.2 1697.1 104.4 1431.9 618.7 1427.3 1509.5 2477.8 944.4 958.2 981.5 1430.5 925.0 995.1 959.9 952.1 914.3 968.7 992.3 975.8 977.4 104.8 663.4 916.1 0.0 1445.5 701.8 237.9 319.7 2876.9 15.3 704.3 451.7 0.7 348.9 969.4 103.0 10.4 396.5 311.7 386.7 497.0 864.7 195.8 102.2 169.2 426.4 819.2 1193.5 0.0 1630.2 582.5 558.6 1132.5 98.5 998.9 58.9 414.1 217.3 272.3 10.1 0.0 1233.6 81.4 561.1 588.8 452.1 527.2 616.8 291.7 0.0 973.9 42.7 515.9 0.0 0.0 1268.6 909.2 272.3 1659.1 177.3 768.9 648.6 561.5 23.8 249.8 401.7 297.5 100.8 100.5 3332.8 922.5 414.8 1066.7 61.1 1437.8 216.6 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384293 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 35.8;intestine: 22.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 7.0;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 20.1;Proximal enterocytes: 21.5;Syncytiotrophoblasts: 36.1" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 46.9;HDLM-2: 70.1;RT4: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: AB_2674887" "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.2 0.1 12.6 0.1 21.7 0.0 0.8 24.0 18.5 0.2 5.2 0.6 22.6 0.1 1.6 1.0 0.1 0.2 0.1 19.9 19.1 1.0 0.0 0.2 0.0 31.0 28.2 10.9 0.3 0.0 0.0 0.8 3.4 29.3 0.3 0.6 2.6 0.4 0.1 0.0 1.7 11.3 0.1 26.1 0.0 0.3 0.8 23.6 0.3 0.1 0.1 0.6 0.5 0.5 35.8 4.9 13.7 2.3 0.7 0.0 0.0 0.2 0.5 0.6 0.8 0.8 5.3 12.7 0.3 0.8 0.0 5.3 46.9 1.2 5.2 0.7 70.1 1.4 0.2 1.5 0.4 0.0 0.1 0.7 0.0 12.2 0.5 1.3 0.2 0.0 2.7 0.0 0.0 0.0 0.2 0.5 0.2 3.5 10.3 1.3 0.0 5.8 0.0 0.3 38.2 11.1 2.0 3.3 0.5 0.0 5.1 1.1 0.1 0.0 0.0 3.5 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 21.7 24.0 18.5 19.9 19.1 31.0 28.2 10.9 29.3 26.1 23.6 35.8 0.2 0.0 0.0 1.0 0.0 0.6 0.9 0.4 0.0 1.8 0.2 0.4 0.6 0.0 0.2 0.0 0.0 7.0 0.0 0.8 5.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 1.9 0.2 0.5 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 10.1 20.1 0.6 0.0 0.0 0.0 1.1 21.5 0.2 0.0 0.5 0.0 0.2 0.6 0.1 1.5 0.0 0.1 36.1 0.0 0.1 1.5 0.4 SEC22B "ERS-24, SEC22L1" ENSG00000265808 "SEC22 homolog B, vesicle trafficking protein" O75396 1 120150898-120176520 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079017 Approved NA NA 91000 "CAB079017: " "unprognostic (2.21e-1)" "unprognostic (2.29e-2)" "unprognostic (5.02e-2)" "unprognostic (8.52e-2)" "unprognostic (1.13e-1)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "prognostic favorable (4.58e-4)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.34e-4)" "unprognostic (5.80e-2)" "unprognostic (2.48e-1)" "unprognostic (1.52e-2)" "unprognostic (2.15e-1)" 24.5 23.8 15.6 20.0 15.5 15.8 21.0 17.6 16.2 23.1 17.3 18.3 21.1 20.5 34.9 13.8 17.2 18.4 16.9 15.0 19.1 20.0 34.0 20.5 21.3 16.1 16.5 14.3 18.2 25.7 24.3 29.6 25.3 16.3 23.2 22.6 58.8 29.0 18.3 20.1 14.6 22.2 19.0 16.5 17.5 21.7 10.5 17.0 18.3 21.9 13.3 20.2 19.2 15.3 18.5 31.2 10.1 19.2 29.9 108.4 76.2 25.4 72.1 59.2 49.6 91.3 16.7 13.3 19.8 34.4 45.7 30.2 12.7 18.3 19.4 67.7 25.1 17.0 22.2 57.4 29.1 62.1 30.5 26.2 74.6 24.5 64.1 34.4 86.6 31.1 25.5 14.8 41.1 67.9 60.6 28.6 16.3 27.9 21.8 26.7 26.5 44.8 22.0 38.2 23.6 19.7 21.2 25.7 36.8 39.9 27.7 19.4 34.6 42.9 67.8 32.3 119.2 47.6 28.1 20.5 30.1 104.7 26.8 76.7 21.1 16.7 15.5 12.9 15.8 17.4 12.9 14.3 13.3 10.5 10.8 14.3 16.2 26.7 15.6 14.8 16.9 12.5 12.4 15.6 15.5 17.6 16.2 15.0 19.1 16.1 16.5 14.3 16.3 16.5 17.0 18.5 39.9 28.9 39.8 7.8 38.5 0.0 27.1 0.0 15.4 32.7 56.5 23.6 17.7 38.6 14.9 42.3 33.3 66.5 42.9 37.5 111.6 40.3 5.4 31.9 52.4 34.8 42.5 52.6 11.5 39.2 68.2 56.9 35.2 45.4 51.4 32.1 37.9 77.2 48.0 11.8 10.5 73.9 0.0 60.7 0.0 7.3 50.4 53.1 0.0 9.4 45.2 71.4 54.6 16.6 16.4 36.7 26.4 48.2 73.0 46.5 57.2 82.7 10.2 142.1 52.6 44.2 36.6 24.4 16.1 23.3 0.0 109.3 35.2 43.0 41.3 47.2 FSBP ENSG00000265817 "Fibrinogen silencer binding protein" O95073 8 94378377-94436952 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 12.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Endometrial ciliated cells: 15.3;Glandular and luminal cells: 6.2;Rod photoreceptor cells: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025059, HPA026509" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA025059: AB_2671718, HPA026509: AB_10602307" 0.7 1.0 1.4 0.6 1.6 1.4 1.4 1.8 1.8 1.7 3.2 0.6 0.6 1.5 2.6 1.1 1.6 0.9 1.4 1.0 1.3 1.0 1.3 0.7 0.9 1.9 2.4 0.9 2.7 1.0 1.1 1.6 1.0 1.7 1.9 0.7 12.1 1.1 2.1 1.3 1.5 0.7 0.8 1.4 0.8 1.4 1.8 2.0 1.2 1.1 0.6 0.8 1.5 1.1 1.2 3.7 1.7 7.6 3.8 1.1 1.3 1.3 1.4 1.4 1.5 1.3 1.9 1.9 2.6 4.1 1.1 1.2 0.9 4.7 2.4 2.6 2.6 1.8 2.9 1.4 1.6 3.3 1.9 0.8 2.4 0.5 2.1 6.4 2.5 2.4 9.0 4.5 4.4 1.4 2.4 6.6 2.3 4.9 1.4 1.1 1.4 4.4 2.5 4.0 5.1 2.5 3.0 0.9 0.3 4.6 5.9 2.5 0.7 2.1 3.0 1.3 1.6 1.5 1.3 1.9 1.3 1.8 2.8 3.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.4 1.6 1.8 1.8 1.0 1.3 1.9 2.4 0.9 1.7 1.4 2.0 1.2 0.6 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 1.1 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 15.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.0 6.2 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.5 0.9 0.0 0.0 TXNIP "ARRDC6, EST01027, HHCPA78, THIF, VDUP1" ENSG00000265972 "Thioredoxin interacting protein" Q9H3M7 1 145992435-145996579 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 2550.5;NK-cells: 2028.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 951.8;HSkMC: 1276.5;hTCEpi: 664.0;hTERT-RPE1: 781.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031085, HPA053694" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA031085: AB_10601706, HPA053694: AB_2682232" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.92e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (2.51e-1)" "unprognostic (9.23e-2)" "unprognostic (1.20e-1)" "unprognostic (3.65e-2)" "unprognostic (1.19e-1)" "unprognostic (8.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (8.19e-2)" "unprognostic (2.22e-3)" 1556.6 470.7 132.3 571.7 158.0 408.3 1408.6 140.5 159.9 796.1 183.8 883.5 225.3 819.5 384.6 432.6 736.5 398.6 617.6 119.2 182.3 537.5 205.7 849.2 807.4 179.8 142.5 104.3 386.3 585.4 639.4 193.7 599.0 175.1 355.4 492.1 14.7 571.6 559.7 1458.0 1063.7 817.5 664.6 172.0 954.6 719.3 107.4 144.0 377.1 561.2 2326.6 1077.9 747.1 644.1 218.9 56.5 0.2 13.0 0.9 291.6 951.8 29.7 66.0 131.3 58.5 79.7 35.3 74.6 15.8 379.6 18.1 9.7 15.0 13.0 124.8 154.8 74.2 7.1 45.7 20.2 32.6 13.8 189.7 91.7 1276.5 664.0 119.0 206.7 781.9 23.2 61.8 184.8 121.2 30.2 76.5 31.9 180.2 36.3 112.5 48.5 28.5 107.8 498.3 151.6 122.8 61.7 99.9 283.1 80.5 239.0 26.2 29.1 266.6 56.5 160.1 10.0 304.2 108.7 169.3 170.7 13.8 39.3 86.6 86.3 1059.6 571.2 1219.2 792.2 551.3 729.8 519.3 668.8 710.4 334.4 542.4 650.2 708.5 1246.6 637.1 496.3 154.8 674.5 1684.4 132.3 158.0 140.5 159.9 119.2 182.3 179.8 142.5 104.3 175.1 172.0 144.0 218.9 2550.5 227.6 328.5 26.4 1360.4 70.7 236.9 129.8 413.8 6.5 167.4 111.2 526.0 185.8 184.4 272.2 29.2 5.0 1004.6 578.0 450.0 79.7 8.3 179.8 594.5 740.2 164.2 270.8 0.2 53.8 4.1 666.5 160.5 464.2 377.4 53.6 349.8 114.8 231.9 6.7 0.5 320.9 136.3 845.1 184.9 35.5 654.5 730.8 108.5 36.5 892.0 3.6 2028.9 45.2 55.8 225.7 459.4 447.2 639.6 370.7 79.0 169.3 155.8 3.7 1196.5 452.4 398.7 7.6 63.7 160.1 72.2 10.9 1142.8 303.9 186.9 516.2 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.9" "Cell type enriched" "Detected in many" 4 "Microglial cells: 497.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 23.5 20.0 30.1 16.0 36.8 22.5 18.1 107.9 39.0 16.0 26.1 10.9 5.8 13.9 13.6 13.0 14.7 11.8 12.0 34.9 38.0 15.3 8.0 21.0 15.4 47.3 38.0 26.5 18.4 8.0 25.5 10.5 20.2 55.4 9.0 6.0 10.0 10.1 9.0 6.8 46.0 10.7 15.4 43.9 24.9 8.8 10.8 47.2 14.0 10.0 18.1 13.8 12.0 16.7 51.9 45.6 30.0 99.7 25.6 46.4 41.6 39.0 38.5 28.7 32.9 35.9 20.7 34.0 17.6 21.6 42.9 43.8 36.1 30.0 25.4 32.7 22.2 24.4 36.5 56.4 31.2 19.3 25.4 39.4 37.6 21.6 42.2 29.3 35.7 57.9 22.6 30.6 55.4 21.2 31.6 20.3 22.4 32.2 8.1 34.1 45.3 40.8 42.6 14.1 8.2 33.2 15.2 32.7 23.9 47.5 37.4 29.7 44.4 57.9 32.1 38.4 39.9 35.8 36.8 35.7 16.5 38.4 34.6 80.0 1.0 12.2 0.7 3.2 11.8 1.3 2.6 2.6 3.3 8.3 5.3 1.0 2.2 17.7 2.1 14.0 16.2 4.0 3.7 30.1 36.8 107.9 39.0 34.9 38.0 47.3 38.0 26.5 55.4 43.9 47.2 51.9 45.5 9.6 12.1 9.4 18.0 23.8 6.1 7.5 8.6 39.5 3.6 4.4 4.6 11.5 7.9 11.0 4.2 4.1 17.1 0.3 0.0 7.2 57.7 16.4 18.4 37.2 1.2 13.2 72.2 2.1 18.3 18.6 10.2 9.7 8.2 12.0 28.9 2.9 19.0 1.7 105.0 3.3 0.0 46.2 62.5 51.0 7.8 54.1 16.0 497.5 25.4 6.6 5.2 54.3 58.5 4.8 1.3 2.6 16.0 4.2 1.4 0.8 14.5 5.8 0.0 18.5 17.9 19.0 11.6 12.1 36.4 4.2 11.9 9.7 1.8 5.8 BAHCC1 "BAHD2, KIAA1447" ENSG00000266074 "BAH domain and coiled-coil containing 1" Q9P281 17 81395457-81466332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 47.3;Cone photoreceptor cells: 22.9;Horizontal cells: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 25.5;MOLT-4: 31.7;NB-4: 108.4;REH: 33.0" "Low region specificity" "Detected in all" "HPA023386, HPA076910" Approved Approved Nucleoli NA NA Nucleoli "HPA023386: AB_1859537, HPA076910: AB_2732325" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-2)" "unprognostic (5.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.05e-2)" "prognostic favorable (7.38e-4)" "unprognostic (1.43e-1)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.78e-2)" 5.2 5.5 3.5 1.8 4.2 5.0 5.1 7.1 5.0 5.1 0.0 4.7 3.4 6.6 1.0 2.9 6.8 3.1 3.9 2.6 1.8 4.5 3.2 4.4 0.8 3.8 3.2 2.2 7.7 5.2 2.1 5.2 1.0 5.5 5.6 0.9 2.1 3.7 1.9 3.8 3.5 4.3 1.5 0.7 3.8 5.8 4.0 4.2 4.0 8.4 0.9 0.4 6.0 4.0 7.2 4.1 6.9 4.9 16.3 1.7 2.6 2.3 3.0 2.6 1.6 0.9 1.3 1.8 0.1 4.3 3.4 2.3 4.1 2.4 1.9 0.3 0.0 7.5 5.6 1.8 2.1 1.5 25.5 5.2 4.4 0.7 1.4 1.4 2.5 1.8 6.2 4.0 0.0 0.7 2.4 31.7 108.4 0.3 2.5 4.6 33.0 3.4 0.0 2.0 0.3 22.5 3.5 3.8 0.0 13.3 0.5 0.8 20.3 2.2 8.8 1.2 4.8 1.5 0.0 0.0 0.0 0.0 11.6 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 4.2 7.1 5.0 2.6 1.8 3.8 3.2 2.2 5.5 0.7 4.2 7.2 6.7 6.4 13.1 11.4 0.0 0.0 1.5 0.0 3.4 47.3 4.8 4.3 10.0 8.6 3.7 3.7 22.9 0.1 4.4 2.4 1.9 3.3 0.7 1.4 2.0 6.7 8.4 1.7 15.5 4.0 0.2 7.5 4.1 1.7 0.0 7.3 6.1 3.7 0.6 33.7 18.9 4.7 0.0 2.8 0.0 0.4 7.5 2.8 0.0 2.8 2.5 8.6 0.0 12.5 15.1 2.0 1.7 5.7 0.0 1.8 4.6 1.2 2.2 17.8 0.0 7.6 9.8 1.8 10.0 3.1 0.0 0.0 0.2 4.9 5.4 0.9 RASSF5 "Maxp1, NORE1, RAPL" ENSG00000266094 "Ras association domain family member 5" Q8WWW0 1 206507531-206589448 "Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 110.3;lymphoid tissue: 83.9" "Cell type enhanced" "Detected in many" "dendritic cells: 119.3;granulocytes: 140.0;Langerhans cells: 147.7;Macrophages: 78.0;NK-cells: 118.4;T-cells: 97.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 90.9;Karpas-707: 192.6;MOLT-4: 84.1;RPMI-8226: 218.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070480 Approved NA NA "HPA070480: AB_2686271" "unprognostic (1.92e-3)" "prognostic favorable (1.46e-4)" "unprognostic (1.37e-2)" "unprognostic (4.44e-3)" "unprognostic (1.93e-1)" "unprognostic (5.17e-3)" "unprognostic (4.19e-2)" "unprognostic (3.95e-2)" "unprognostic (2.79e-1)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (3.29e-1)" "unprognostic (5.58e-2)" "unprognostic (4.28e-2)" "unprognostic (6.28e-3)" 6.8 15.3 3.4 48.6 3.3 110.3 4.9 1.6 4.2 6.9 1.7 9.0 9.2 3.9 1.9 42.0 10.3 18.4 8.0 3.8 4.7 4.3 14.1 26.7 63.9 4.0 4.6 2.7 3.6 10.9 8.4 10.4 5.4 4.5 8.1 9.4 1.0 30.5 7.2 14.9 27.5 17.8 6.8 2.8 56.7 17.5 1.5 7.3 83.9 5.8 3.7 60.5 30.5 20.9 4.9 9.3 4.2 0.1 1.6 3.2 1.8 0.0 0.6 4.9 1.7 2.3 0.4 19.5 32.4 2.5 2.1 0.3 13.5 3.5 2.2 1.5 22.4 12.7 35.2 1.0 0.2 1.2 59.1 90.9 2.2 8.9 2.0 2.4 3.2 0.3 76.0 14.4 192.6 0.9 1.1 84.1 37.8 1.8 0.1 3.6 39.4 4.6 218.8 0.1 14.7 4.7 0.3 15.6 1.7 0.6 0.1 3.7 37.5 0.1 0.4 6.4 8.0 2.1 67.7 52.8 30.2 3.0 34.1 1.0 211.8 40.3 268.7 112.3 53.7 99.7 28.4 82.6 117.0 43.9 26.6 112.1 105.8 157.2 131.2 84.0 34.2 78.2 154.7 3.4 3.3 1.6 4.2 3.8 4.7 4.0 4.6 2.7 4.5 2.8 7.3 4.9 2.1 38.5 27.9 1.6 64.0 32.8 16.6 8.6 27.9 1.8 7.4 4.4 7.7 15.7 11.3 0.0 0.0 0.2 119.3 1.0 3.9 8.1 0.3 0.5 0.5 4.4 2.4 16.4 19.4 8.9 0.1 11.6 9.2 0.6 140.0 0.1 5.7 6.2 12.1 8.4 16.8 1.0 10.2 49.0 147.7 0.1 7.5 78.0 14.2 6.5 54.2 0.1 118.4 2.0 0.7 8.3 2.6 9.1 41.1 13.7 0.0 0.8 9.6 0.2 0.0 2.1 6.8 0.1 0.6 48.6 27.3 0.1 97.7 0.2 2.1 49.6 STRADA "LYK5, NY-BR-96, Stlk, STRAD" ENSG00000266173 "STE20 related adaptor alpha" Q7RTN6 17 63682336-63741986 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 48.0;Excitatory neurons: 49.1;Inhibitory neurons: 47.5;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031637 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA031637: AB_10601718" "unprognostic (1.59e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-3)" "unprognostic (5.52e-2)" "unprognostic (8.91e-2)" "unprognostic (7.56e-5)" "unprognostic (6.79e-4)" "unprognostic (3.68e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "prognostic favorable (5.34e-5)" "unprognostic (7.29e-2)" "prognostic unfavorable (6.08e-7)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "prognostic favorable (6.43e-4)" 19.9 28.5 32.7 12.8 34.1 18.5 19.7 33.0 36.0 23.6 30.9 20.6 8.9 20.6 18.3 21.3 23.2 13.5 22.7 33.6 34.1 24.1 23.1 19.1 20.4 35.6 33.3 33.2 24.9 17.9 19.2 26.6 13.5 34.0 22.7 11.7 14.0 15.7 14.4 14.8 20.7 19.6 17.3 32.1 32.2 20.6 49.4 33.2 20.3 20.2 10.2 20.5 22.7 20.2 33.9 12.7 37.5 31.9 32.3 30.8 22.8 12.4 23.8 21.6 33.6 29.8 9.9 14.4 19.5 14.4 20.3 16.7 10.5 21.4 23.1 33.0 21.5 20.7 38.4 25.9 23.7 21.8 36.7 26.5 23.9 19.4 38.2 22.1 22.3 37.6 30.0 24.9 20.0 32.2 23.6 43.4 25.0 16.0 10.7 21.2 27.9 50.8 23.8 30.2 24.9 36.0 39.4 16.3 26.3 26.1 32.9 19.7 26.4 30.5 31.7 22.5 25.8 20.0 19.9 22.9 24.3 23.4 21.8 25.7 19.2 9.5 8.8 9.6 6.9 8.8 10.3 8.7 10.7 15.8 7.5 8.5 7.6 10.8 16.8 10.7 13.3 7.3 8.0 32.7 34.1 33.0 36.0 33.6 34.1 35.6 33.3 33.2 34.0 32.1 33.2 33.9 6.4 9.6 7.3 48.0 12.5 0.0 0.1 0.5 6.2 2.1 3.6 3.4 0.5 0.0 2.9 9.2 0.0 2.1 9.3 1.2 0.0 7.0 1.1 8.6 9.4 3.7 0.0 3.4 49.1 2.8 0.9 4.7 6.1 7.2 2.5 12.7 0.7 0.1 1.5 1.7 47.5 2.2 2.0 1.3 1.4 2.2 0.6 6.7 0.0 27.2 17.9 1.2 5.2 33.2 71.4 4.8 2.0 1.5 10.2 0.4 1.9 2.0 2.5 3.7 0.0 2.0 4.1 3.1 1.2 4.7 0.4 2.5 9.1 9.3 2.0 0.2 AC005697.1 ENSG00000266202 "Novel protein" 17 27798806-27893365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023051 Uncertain NA NA "HPA023051: AB_10602333" "unprognostic (1.92e-2)" 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.8 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KLF14 BTEB5 ENSG00000266265 "Kruppel like factor 14" Q8TD94 7 130730697-130734207 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.1;testis: 1.0" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 1.8;Early spermatids: 4.1;Late spermatids: 4.1" "Cancer enriched" "Detected in single" 6 "melanoma: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.0;RH-30: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA044729 Uncertain NA NA "HPA044729: AB_10960356" "unprognostic (4.49e-2)" "unprognostic (2.62e-1)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (9.90e-3)" "unprognostic (7.98e-2)" "unprognostic (5.30e-3)" "unprognostic (7.14e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (7.03e-3)" "unprognostic (3.63e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" 0.6 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.4 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.4 0.0 0.0 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 1.3;NK-cells: 1.3;T-cells: 2.5" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 17.3 14.0 7.9 10.2 7.8 2.3 18.8 11.4 8.5 21.1 7.4 18.3 4.0 17.6 20.4 13.8 20.2 7.7 13.2 7.6 7.9 16.6 36.8 24.3 16.9 7.2 7.2 7.3 21.4 21.5 9.0 17.2 9.9 8.7 18.2 7.9 18.8 14.5 7.4 5.6 14.6 19.5 12.1 6.5 29.1 14.3 7.0 8.0 2.4 26.0 2.9 12.4 15.5 17.3 7.0 13.7 9.3 15.8 29.8 18.2 28.6 19.5 24.6 24.2 15.0 15.2 7.9 14.8 7.0 6.6 18.5 16.9 10.5 17.5 8.0 23.0 23.4 9.6 0.4 23.6 9.6 14.0 0.4 6.5 23.8 13.5 17.7 36.4 20.7 21.1 2.7 3.1 20.5 36.0 29.7 0.3 6.0 6.5 5.0 19.8 6.4 9.2 11.1 16.2 12.4 1.4 35.7 10.5 15.7 17.5 20.1 16.2 5.9 22.6 23.7 15.3 21.0 23.5 18.2 21.0 11.8 0.3 0.7 11.4 0.0 0.2 0.0 0.5 0.0 0.8 1.3 1.5 1.1 0.1 0.9 1.8 0.7 0.1 1.3 0.2 0.0 2.5 0.8 7.9 7.8 11.4 8.5 7.6 7.9 7.2 7.2 7.3 8.7 6.5 8.0 7.0 5.9 44.8 20.8 5.9 14.8 2.0 1.5 0.7 22.8 2.7 5.1 3.2 10.3 4.3 12.8 1.8 6.2 1.7 4.9 1.6 0.0 6.4 5.3 2.6 9.6 9.7 6.1 1.7 16.9 4.4 3.2 12.2 11.2 3.8 15.2 5.3 6.1 8.9 1.6 3.3 10.4 3.0 0.0 7.5 1.4 1.4 8.7 8.1 1.8 14.0 6.2 3.1 1.0 7.1 3.4 6.6 23.6 10.5 10.3 1.5 1.4 1.0 5.0 7.1 0.0 3.5 8.7 3.7 1.9 17.6 1.3 0.3 8.4 3.8 5.2 0.4 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030623 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 476.2;Macrophages: 316.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 251.9;granulocytes: 839.6;monocytes: 363.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 118.2 68.4 47.8 92.3 53.3 191.1 97.9 58.3 51.3 85.9 56.5 111.3 252.0 70.8 75.2 111.3 63.1 88.6 158.2 43.0 57.2 161.2 376.0 109.2 103.4 55.2 55.0 41.1 66.1 65.2 98.7 25.4 132.4 55.7 133.4 116.8 34.0 79.9 79.5 165.0 71.7 157.2 99.1 56.9 149.4 91.2 44.0 53.7 125.6 87.8 195.3 151.5 105.6 47.2 63.0 142.7 58.5 68.0 70.4 176.9 159.4 170.3 128.3 204.8 122.1 119.6 91.0 102.3 161.2 149.2 211.2 69.1 141.8 72.6 142.3 137.1 114.4 74.1 108.4 74.3 263.5 124.0 279.9 229.7 156.1 139.2 104.2 175.7 131.6 185.5 79.5 119.7 93.5 171.9 64.0 136.1 104.3 41.4 110.2 34.8 79.5 99.3 96.7 148.9 119.4 68.2 46.1 128.9 146.2 131.5 133.5 105.7 135.3 171.6 75.8 89.9 81.3 87.5 69.3 79.1 156.9 94.6 231.2 41.2 692.1 363.6 611.8 78.9 223.6 86.2 57.6 73.3 74.9 251.9 53.8 78.2 66.4 839.6 119.0 275.3 77.4 92.8 559.4 47.8 53.3 58.3 51.3 43.0 57.2 55.2 55.0 41.1 55.7 56.9 53.7 63.0 44.5 51.3 95.2 13.4 44.6 49.5 39.3 126.2 50.7 14.3 49.6 38.5 161.3 45.8 96.2 44.1 29.2 104.7 58.2 108.8 80.3 45.3 105.4 45.1 37.7 52.9 26.9 476.2 17.4 51.8 107.2 45.3 42.3 56.9 195.2 28.2 55.3 166.7 181.4 20.2 20.5 45.4 59.0 254.5 74.2 72.4 37.3 316.1 51.6 16.9 158.4 38.2 44.3 18.6 22.9 47.8 63.9 47.4 37.6 62.0 162.5 128.8 59.7 13.0 13.1 36.7 46.7 24.5 16.5 71.9 56.7 158.2 41.3 60.7 71.3 52.0 MRPS21 ENSG00000266472 "Mitochondrial ribosomal protein S21" P82921 1 150293861-150308979 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 863.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078289 Supported Mitochondria NA NA Mitochondria "HPA078289: AB_2686881" "unprognostic (3.48e-2)" "unprognostic (1.94e-2)" "unprognostic (5.46e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (1.15e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (9.71e-2)" "unprognostic (7.59e-2)" "unprognostic (2.12e-2)" "unprognostic (4.02e-2)" "unprognostic (3.97e-2)" "unprognostic (1.46e-1)" 45.0 77.3 95.2 36.0 98.1 39.3 52.2 97.2 122.4 48.9 99.9 47.7 38.7 47.1 54.2 54.9 46.7 27.8 70.4 96.7 98.7 65.2 60.4 39.5 43.1 97.0 96.5 96.6 57.1 51.6 65.9 70.7 32.8 98.9 52.0 29.2 42.7 44.0 39.5 56.0 44.0 45.5 39.1 93.3 53.7 52.6 52.6 98.1 49.4 53.5 67.1 47.0 48.3 46.2 105.6 112.7 88.4 112.9 57.5 108.3 108.2 93.9 80.5 69.1 77.0 74.5 18.0 101.6 111.9 54.2 89.3 22.8 102.9 96.8 86.4 67.8 77.7 125.9 64.3 133.4 137.0 84.7 98.4 53.8 119.2 87.0 93.4 105.8 47.0 100.3 96.8 106.7 144.3 107.1 255.8 84.3 89.1 196.0 216.3 159.3 75.9 59.0 195.8 93.7 79.9 83.7 182.1 68.4 131.9 136.4 126.3 73.4 143.0 71.7 28.1 56.7 81.6 90.9 120.4 136.4 112.7 39.5 53.1 58.3 41.1 78.4 50.7 70.1 79.7 86.6 116.8 92.7 82.5 89.1 102.1 103.8 89.6 17.8 71.5 73.6 136.2 97.2 104.9 95.2 98.1 97.2 122.4 96.7 98.7 97.0 96.5 96.6 98.9 93.3 98.1 105.6 124.7 112.2 115.8 24.8 152.7 120.3 199.9 466.6 191.8 72.6 189.3 246.4 295.6 201.6 227.8 263.0 33.3 283.8 110.4 114.4 526.3 226.2 863.2 217.2 216.0 150.2 138.5 151.7 31.8 311.4 245.5 172.3 152.4 155.7 132.9 157.8 189.2 366.9 288.2 48.8 34.7 141.6 266.5 196.2 162.3 605.4 230.2 143.7 181.5 18.7 234.1 140.3 118.4 23.1 27.1 300.8 133.1 233.2 156.5 197.6 230.1 703.7 291.7 59.5 98.6 115.4 211.1 276.4 112.1 262.6 147.2 235.2 144.4 183.8 168.5 200.9 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300197-47313577 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.8;retina: 18.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 20.9;Cone photoreceptor cells: 16.7;Fibroblasts: 25.7;Rod photoreceptor cells: 34.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.5;MOLT-4: 3.0;SH-SY5Y: 5.5" "Region enriched" "Detected in all" 8 "cerebellum: 42.5" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 7.6 3.3 5.4 0.3 5.1 0.0 9.8 4.8 4.3 2.2 1.0 2.1 0.0 4.2 0.3 2.4 1.6 2.2 2.7 5.7 2.8 0.1 0.1 19.8 0.8 2.8 5.5 3.0 0.3 13.4 0.0 0.7 0.0 2.1 2.2 0.3 18.5 8.9 0.2 2.2 2.4 0.6 0.4 2.6 0.1 1.8 7.2 5.8 0.4 9.8 10.5 1.0 1.3 1.7 3.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.1 4.8 4.3 5.7 2.8 2.8 5.5 3.0 2.1 2.6 5.8 3.4 2.4 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.0 20.9 0.1 0.0 0.8 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.2 25.7 0.0 0.0 1.3 0.0 0.0 0.0 0.1 1.7 0.0 0.2 0.0 0.0 2.6 0.7 0.9 0.2 1.8 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.6 1.6 0.4 1.3 0.0 0.9 0.0 0.4 0.0 0.0 0.0 MYO15B MYO15BP ENSG00000266714 "Myosin XVB" Q96JP2 17 75588058-75626849 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 180.9" "Group enriched" "Detected in many" 4 "Distal enterocytes: 275.4;Paneth cells: 294.2;Proximal enterocytes: 127.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 46.4;HEL: 17.7;HMC-1: 24.9;THP-1: 37.7" "Not detected" "Not detected" "HPA022857, HPA023105" Approved Cytosol No No Cytosol "HPA022857: AB_1848813, HPA023105: AB_1859526" "prognostic favorable (9.34e-4)" "unprognostic (7.55e-2)" "unprognostic (6.99e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (5.59e-4)" "unprognostic (7.29e-3)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-3)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.90e-5)" 36.3 17.4 30.7 17.4 35.0 57.5 38.4 31.6 45.4 74.9 28.6 44.4 180.9 46.5 7.5 18.8 66.1 26.1 42.0 28.6 34.0 76.0 30.1 55.5 19.3 36.7 33.8 25.7 87.8 20.7 4.7 29.1 15.2 37.6 56.9 21.7 9.9 23.8 14.2 13.3 15.5 150.2 9.9 34.9 109.1 25.9 21.0 33.8 17.8 66.3 8.1 7.3 29.3 44.4 41.5 0.6 46.4 0.3 1.2 0.3 0.1 0.7 0.0 0.0 0.0 0.0 5.8 13.6 0.1 1.5 0.0 0.6 0.5 0.0 0.0 0.0 0.6 2.8 17.7 9.5 11.6 1.3 0.0 24.9 0.8 0.8 0.0 0.1 0.8 0.3 7.3 1.2 5.1 0.0 5.0 0.4 7.8 0.7 12.3 11.2 12.7 0.3 2.1 0.3 1.0 1.3 3.2 0.3 0.5 1.5 1.4 3.5 37.7 0.1 0.3 1.2 0.2 0.0 1.7 0.2 0.2 0.7 8.9 0.6 1.3 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.0 0.4 0.2 0.0 0.1 30.7 35.0 31.6 45.4 28.6 34.0 36.7 33.8 25.7 37.6 34.9 33.8 41.5 13.7 0.0 3.3 44.7 8.4 2.4 2.4 2.0 8.0 4.5 4.0 2.7 7.5 11.5 2.4 9.2 16.7 0.1 11.9 275.4 1.9 1.6 0.7 11.6 8.9 14.6 31.7 9.2 1.1 1.5 0.1 7.1 52.0 8.1 14.0 13.6 21.0 2.1 5.5 1.7 1.4 40.3 12.2 10.0 12.6 2.7 5.6 17.5 3.6 42.2 6.9 4.9 12.3 32.6 46.6 8.8 294.2 4.9 1.4 1.9 127.5 14.4 8.0 13.5 6.6 7.1 8.4 3.3 6.8 2.2 3.0 0.1 6.2 4.7 20.1 1.8 IGBP1P2 ENSG00000266826 "Immunoglobulin (CD79A) binding protein 1 pseudogene 2" 17 58660424-58692018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000634, HPA001004" Uncertain Approved Cytosol NA NA Cytosol "HPA000634: AB_1079102, HPA001004: AB_1079104" "unprognostic (3.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.37e-1)" "unprognostic (8.67e-2)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092073.1 ENSG00000266953 "Novel protein, readthrough between GPI and PDCD2" 19 34396315-34409364 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 1.0;brain: 1.2;retina: 2.6;skeletal muscle: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.7;HaCaT: 1.6" NA NA "unprognostic (1.18e-1)" "unprognostic (2.34e-2)" "unprognostic (3.43e-1)" "unprognostic (6.48e-3)" "unprognostic (3.25e-2)" "unprognostic (2.61e-1)" "unprognostic (6.67e-2)" 0.1 0.2 0.6 0.0 0.9 1.0 0.1 1.0 1.2 0.2 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.6 0.1 0.1 0.0 0.1 0.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 2.6 0.0 0.1 2.6 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.4 0.2 0.0 0.1 0.1 0.2 0.1 0.6 1.7 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.3 0.5 0.0 0.0 1.6 0.0 0.3 0.1 0.3 0.0 0.4 0.2 0.3 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.0 0.3 0.5 0.8 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.8 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.9 1.0 1.2 0.5 0.6 0.5 0.1 0.6 0.7 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138824-35143109 "Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1394.5;tongue: 846.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 8.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 11.0" "Group enriched" "Detected in many" 4 "B-cells: 11.0;T-cells: 6.9" "Cell line enhanced" "Detected in some" "ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 129.0 26.4 429.7 9.7 441.5 2.2 126.2 441.8 642.5 267.9 518.6 129.7 14.4 174.7 62.7 71.4 189.0 56.8 562.9 419.3 426.4 28.6 563.2 86.6 6.7 494.7 426.3 396.9 145.9 19.3 3.8 40.1 29.6 438.2 117.0 25.8 36.3 37.5 74.1 1394.5 46.8 67.8 105.3 429.0 20.9 73.2 12.2 474.4 8.2 38.4 846.2 6.8 80.7 196.6 432.9 1.1 0.0 0.0 0.2 46.7 13.5 1.3 5.7 0.1 0.0 0.0 0.0 0.3 3.8 1.5 0.0 0.1 1.0 1.1 0.7 0.0 3.4 1.3 0.7 0.0 1.9 5.2 0.3 0.4 19.3 0.0 0.1 0.5 0.5 0.2 0.1 1.0 3.7 0.1 0.0 0.1 0.8 0.2 2.8 0.6 0.0 0.2 1.1 0.0 0.0 0.3 0.2 0.7 0.2 1.8 0.3 0.2 6.1 0.5 0.1 0.5 0.4 0.0 0.1 0.0 0.4 0.9 0.6 7.7 1.6 0.3 0.0 1.3 0.7 0.8 11.0 3.6 1.5 0.3 6.9 0.7 0.9 0.5 2.1 0.8 0.6 6.9 0.6 429.7 441.5 441.8 642.5 419.3 426.4 494.7 426.3 396.9 438.2 429.0 474.4 432.9 46.1 0.0 0.0 44.4 15.8 29.4 3.7 2.7 8.0 1.8 4.4 18.0 0.3 11.5 0.8 25.8 4.2 1.2 9.5 42.2 0.0 0.1 1.9 2.2 47.4 13.3 0.0 8.4 3.7 4.9 1.6 225.1 2.0 1.2 0.0 0.1 36.0 651.7 4.4 0.0 0.4 0.8 2.0 14.4 49.0 12.0 430.3 5.3 53.4 2.8 1.0 343.4 1.0 1.5 0.5 1.1 5.3 128.2 2.5 3.3 0.4 0.2 12.6 8.6 118.3 188.7 205.7 10.7 21.7 3.0 27.3 2.9 18.8 0.1 0.7 2.5 AARSD1 MGC2744 ENSG00000266967 "Alanyl-tRNA synthetase domain containing 1" Q9BTE6 17 42950526-42964498 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.2;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Supported Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (2.85e-3)" "unprognostic (9.78e-2)" "unprognostic (1.67e-1)" "unprognostic (8.53e-2)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (7.41e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.67e-6)" "unprognostic (2.20e-1)" "unprognostic (2.51e-1)" "unprognostic (3.73e-2)" "unprognostic (4.69e-3)" 18.2 19.8 19.2 13.8 21.3 16.6 20.5 18.9 21.9 19.7 18.5 18.5 12.9 20.9 21.3 18.8 20.5 13.6 34.8 20.2 21.0 20.3 24.6 13.9 17.6 20.1 19.4 19.5 26.2 25.8 24.9 20.7 14.7 20.6 18.3 17.5 13.6 20.6 18.6 69.6 15.8 13.8 23.4 18.6 14.3 20.7 72.9 19.5 19.4 21.5 61.1 20.9 19.7 17.7 21.2 38.7 52.4 39.6 39.8 47.0 44.8 30.5 41.2 34.5 46.9 31.1 45.8 32.0 104.3 2.0 43.2 28.7 32.1 55.2 62.2 53.7 35.1 43.7 41.4 57.6 25.3 61.6 81.6 22.2 40.8 33.1 32.6 81.5 32.2 38.3 46.4 76.3 21.3 45.0 22.0 81.8 58.3 27.6 53.5 26.3 53.3 80.8 107.0 46.7 35.8 51.1 32.0 20.0 20.5 54.0 43.0 54.8 68.4 37.3 48.4 43.4 24.9 58.6 33.6 46.3 64.7 31.7 50.1 52.7 4.1 19.0 1.5 20.5 27.3 27.1 27.2 21.4 24.4 29.9 31.2 26.9 26.3 0.6 25.4 24.5 33.3 22.6 17.8 19.2 21.3 18.9 21.9 20.2 21.0 20.1 19.4 19.5 20.6 18.6 19.5 21.2 6.3 12.8 8.2 0.0 22.6 8.3 11.7 10.6 26.2 22.1 8.4 8.0 0.7 4.3 13.2 14.7 33.3 8.7 6.9 11.9 3.9 7.2 68.2 7.5 7.0 7.1 12.0 14.7 0.0 6.1 8.7 12.4 12.8 5.3 5.1 11.1 7.5 4.2 5.0 15.2 0.0 6.7 22.4 4.1 6.4 26.9 13.1 6.8 3.6 0.0 6.1 5.5 17.5 0.0 0.0 4.3 4.5 10.9 21.7 9.6 4.5 4.9 9.6 16.2 0.0 7.2 15.0 44.5 21.4 17.4 4.5 2.7 17.7 13.7 10.0 6.7 AC006538.2 ENSG00000267001 "Novel protein" 19 2717769-2740048 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA058526 Uncertain NA NA "HPA058526: AB_2683743" 5.1 0.0 0.4 0.7 0.3 1.3 1.0 0.2 1.4 1.1 0.2 2.8 2.7 0.7 0.0 0.2 1.3 0.3 0.2 0.3 0.7 1.2 1.8 1.6 0.7 0.4 0.3 0.2 0.0 0.0 2.6 0.0 0.3 0.3 1.4 0.6 0.1 2.2 2.3 6.6 1.2 0.7 2.5 0.6 1.2 1.8 2.8 0.3 0.9 0.1 3.0 0.3 0.9 0.0 0.6 9.8 13.0 2.3 0.0 10.4 11.1 7.1 7.1 5.2 6.2 11.4 12.7 0.7 7.7 8.6 6.0 4.8 3.6 0.0 3.1 0.0 0.0 9.3 24.6 9.1 17.4 22.0 6.4 3.4 6.0 7.2 11.5 0.4 1.8 2.7 8.5 23.5 4.1 1.7 11.7 3.2 3.4 2.1 1.3 16.2 3.9 2.2 7.9 0.0 5.9 3.6 6.1 10.1 1.8 9.5 0.0 3.2 17.8 1.9 1.6 2.8 11.2 8.2 11.6 16.4 5.0 1.0 26.0 1.7 7.1 8.8 12.5 8.0 8.0 7.9 7.7 7.4 7.6 12.5 6.9 5.5 6.7 3.1 6.5 8.5 15.0 4.5 7.4 0.4 0.3 0.2 1.4 0.3 0.7 0.4 0.3 0.2 0.3 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF850 ZNF850P ENSG00000267041 "Zinc finger protein 850" A8MQ14 19 36714383-36772825 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.2" "Cell type enhanced" "Detected in many" "Early spermatids: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.2;NTERA-2: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029299 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029299: AB_2672987" "unprognostic (1.35e-2)" "unprognostic (5.54e-2)" "unprognostic (3.85e-2)" "unprognostic (1.38e-3)" "unprognostic (7.78e-2)" "unprognostic (6.63e-2)" "unprognostic (1.65e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-2)" "unprognostic (1.25e-1)" "unprognostic (3.00e-2)" "unprognostic (5.56e-2)" "unprognostic (4.11e-3)" "unprognostic (1.77e-1)" "unprognostic (7.49e-2)" "unprognostic (4.49e-2)" "unprognostic (7.37e-3)" 0.7 0.6 0.7 1.0 0.6 5.2 0.9 2.4 1.0 0.7 0.7 0.7 0.6 0.7 0.3 1.0 0.7 0.8 1.6 1.5 0.9 0.5 1.0 0.7 1.5 0.9 0.8 0.7 1.2 0.6 1.0 0.5 3.1 1.0 0.9 1.0 1.0 0.7 0.7 0.4 1.2 0.6 0.8 0.2 1.1 0.8 2.6 0.7 0.7 0.7 0.5 0.8 0.5 0.5 1.5 0.3 1.7 3.7 6.0 0.8 0.2 7.0 2.2 1.3 1.5 1.8 1.3 0.4 1.2 5.1 0.4 7.6 1.1 2.6 0.5 2.7 0.8 2.3 15.2 0.3 1.2 1.0 1.8 8.6 1.0 0.1 2.3 0.0 0.5 1.3 1.8 4.4 0.8 3.6 0.8 2.7 1.7 11.9 0.6 1.0 1.7 7.8 1.1 0.7 7.5 2.4 3.8 3.5 0.2 0.5 5.0 1.5 3.3 2.9 3.6 5.9 2.1 3.7 1.4 2.7 3.2 0.0 0.9 5.6 1.8 1.2 0.9 1.3 1.3 1.7 2.7 1.6 1.1 1.1 1.7 1.8 2.0 1.9 1.3 1.5 1.2 1.2 2.2 0.7 0.6 2.4 1.0 1.5 0.9 0.9 0.8 0.7 1.0 0.2 0.7 1.5 2.4 0.0 0.0 0.7 1.7 2.2 1.3 0.5 1.8 1.1 1.9 1.5 5.1 1.5 0.2 3.7 0.0 4.4 1.3 0.3 0.0 1.0 8.0 1.6 1.5 2.9 0.0 5.7 1.3 0.7 5.4 3.0 0.5 2.4 0.0 3.6 7.1 2.1 1.3 5.0 1.0 3.5 2.0 2.2 2.1 3.3 1.2 0.8 3.6 1.9 0.5 1.2 2.1 3.0 3.7 0.6 0.4 0.4 0.7 0.8 0.1 0.7 0.2 0.5 0.0 2.5 1.6 5.9 5.7 1.1 3.4 2.9 1.1 1.7 0.8 0.9 PTGES3L ENSG00000267060 "Prostaglandin E synthase 3 like" 17 42968088-42980433 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "heart muscle: 38.2;skeletal muscle: 125.5;tongue: 96.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 45.6;Cone photoreceptor cells: 8.4;Early spermatids: 13.1;Spermatocytes: 8.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 4.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.1" "Cell line enhanced" "Detected in many" "THP-1: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (9.77e-2)" "unprognostic (6.61e-2)" "unprognostic (7.45e-2)" "unprognostic (4.66e-2)" "unprognostic (2.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (6.23e-2)" "unprognostic (2.80e-4)" "unprognostic (9.24e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (6.25e-2)" "unprognostic (4.08e-2)" 0.9 0.6 1.9 1.4 2.8 3.0 1.1 2.0 2.8 1.2 1.7 9.6 1.4 8.2 1.5 3.4 2.5 1.6 38.2 1.9 1.5 0.5 0.3 0.7 1.1 1.8 1.5 2.5 0.6 0.5 0.4 1.3 0.5 2.1 2.9 2.8 1.7 2.4 3.5 125.5 1.0 2.5 7.3 1.1 0.7 3.4 2.2 1.7 0.6 0.9 96.0 0.9 5.7 1.2 2.4 0.8 0.6 1.9 2.8 0.1 0.3 1.6 1.2 0.5 1.0 0.6 1.7 0.7 0.7 0.5 0.5 1.0 1.6 1.4 1.5 1.9 0.5 0.7 4.3 3.1 3.1 0.1 0.8 7.1 0.5 1.1 2.2 1.8 0.7 0.3 3.1 1.8 1.4 2.1 0.7 2.8 2.1 1.8 2.2 0.6 1.4 6.3 0.7 1.7 1.5 1.5 4.9 1.3 3.4 2.0 2.2 1.9 16.7 0.4 2.0 1.8 0.6 1.2 3.0 2.1 0.8 0.3 1.0 0.7 0.9 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.5 0.3 0.1 4.1 0.1 0.4 1.9 2.8 2.0 2.8 1.9 1.5 1.8 1.5 2.5 2.1 1.1 1.7 2.4 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.8 1.5 1.3 45.6 0.0 0.1 0.0 8.4 0.1 2.9 1.4 0.0 1.4 13.1 1.2 0.4 1.0 1.8 0.0 0.0 0.2 0.6 2.4 0.0 1.1 0.0 0.8 0.7 0.1 1.1 0.0 0.0 0.9 0.0 0.6 0.7 4.5 0.6 2.1 0.0 0.0 1.7 0.8 1.0 0.0 0.0 0.7 2.8 0.4 0.0 0.7 1.1 0.5 0.9 2.6 0.0 2.7 2.5 8.2 3.4 0.0 0.0 0.1 0.2 4.8 1.1 0.3 AC007998.2 ENSG00000267140 "Novel protein" 18 35443871-35497940 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.8" "Cell type enhanced" "Detected in single" "Endothelial cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 63 "HUVEC TERT2: 257.0" NA NA "unprognostic (6.67e-3)" "unprognostic (5.32e-2)" "unprognostic (2.01e-1)" "unprognostic (3.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (7.77e-2)" "unprognostic (4.11e-2)" "unprognostic (1.04e-1)" "unprognostic (2.61e-1)" 1.9 0.2 0.1 1.8 0.1 0.5 3.3 0.1 0.2 2.6 0.2 0.9 0.5 0.8 0.2 0.9 3.3 1.7 0.6 0.1 0.2 0.6 0.1 1.5 4.8 0.2 0.1 0.1 0.3 0.5 0.1 0.0 0.5 0.2 0.1 0.8 0.0 0.1 0.7 0.9 0.2 0.6 1.7 0.1 0.8 0.5 0.2 0.2 0.4 1.8 1.5 1.4 1.6 0.1 0.1 0.6 0.4 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.8 0.6 1.1 0.0 0.6 0.7 0.2 0.0 1.3 0.9 0.0 0.2 0.2 1.2 4.1 0.3 2.4 0.5 0.6 1.6 0.0 0.5 0.2 0.3 0.7 257.0 0.0 0.1 0.1 0.0 0.3 0.1 1.1 0.1 0.0 0.0 0.1 0.2 1.6 0.2 0.5 1.1 0.2 0.3 0.7 0.0 0.9 0.0 0.0 0.7 0.6 0.1 0.0 0.8 0.5 0.4 2.0 0.3 1.1 0.2 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 AC011499.1 ENSG00000267157 "Novel protein" 19 5784005-5785619 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 2.5;U-266/84: 3.6" NA NA "unprognostic (2.00e-2)" "unprognostic (2.61e-2)" "unprognostic (2.86e-1)" "unprognostic (1.40e-3)" "unprognostic (9.31e-2)" "unprognostic (1.21e-1)" "unprognostic (3.85e-2)" "unprognostic (2.08e-2)" "unprognostic (1.01e-1)" "unprognostic (4.63e-1)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (4.75e-5)" "unprognostic (2.28e-3)" "unprognostic (3.82e-1)" "unprognostic (2.26e-1)" "unprognostic (3.70e-2)" 0.1 0.1 0.1 0.5 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.2 0.4 0.2 0.4 0.4 0.2 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.2 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.4 0.2 0.1 0.1 0.2 0.0 0.3 0.3 0.3 0.0 0.0 0.2 0.2 0.7 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.7 0.5 1.4 0.0 0.0 0.6 0.4 0.0 0.2 0.6 1.3 0.5 0.7 0.7 0.0 0.1 0.0 0.0 1.1 0.0 1.6 0.5 0.3 0.2 0.2 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.1 1.1 1.3 0.0 1.7 0.1 0.0 0.4 0.2 0.0 0.1 0.9 0.5 0.0 0.3 0.3 1.2 0.0 0.8 0.4 0.8 0.7 1.5 2.5 0.9 1.2 3.6 1.8 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.2 0.2 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005837.2 ENSG00000267168 "Novel protein" 17 76732978-76738522 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.2 0.2 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.3 0.6 0.3 0.1 0.1 0.1 0.2 0.8 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC245748.1 ENSG00000267173 "Novel protein" 19 44329695-44401608 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008770.2 ENSG00000267179 "Novel protein" 19 11925075-11979290 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" HPA047845 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047845: AB_2680178" "unprognostic (2.46e-3)" "unprognostic (9.75e-5)" "unprognostic (1.14e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (2.38e-3)" "unprognostic (1.26e-1)" "unprognostic (1.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.97e-2)" "unprognostic (4.82e-3)" "unprognostic (2.69e-2)" "unprognostic (5.04e-3)" "unprognostic (2.24e-2)" "unprognostic (9.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" 0.1 0.2 0.1 0.3 0.2 0.0 0.4 0.1 0.3 0.2 0.2 0.2 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.3 0.3 0.2 0.1 0.4 0.3 0.3 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.9 0.3 0.4 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.7 0.2 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.1 0.5 0.5 0.1 0.5 0.0 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.4 0.2 0.7 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 LCN6 ENSG00000267206 "Lipocalin 6" P62502 9 136744017-136748525 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 83 "epididymis: 1595.5" "Group enriched" "Detected in some" 4 "Adipocytes: 20.2;Endothelial cells: 80.6" "Cancer enriched" "Detected in some" 10 "thyroid cancer: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 3.3;REH: 10.7" "Secreted in male reproductive system" NA NA "unprognostic (4.05e-2)" "unprognostic (1.01e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (3.23e-1)" "unprognostic (1.26e-1)" "unprognostic (3.83e-4)" "unprognostic (3.41e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-2)" "unprognostic (2.89e-3)" "unprognostic (1.78e-1)" "unprognostic (5.55e-2)" "unprognostic (2.96e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-2)" "unprognostic (1.45e-1)" 9.9 0.3 2.0 1.4 1.6 4.4 9.9 1.5 2.8 9.8 1.9 4.7 0.4 19.2 1595.5 3.3 12.8 2.0 17.9 1.5 1.6 0.4 0.3 3.4 0.9 1.7 1.8 1.3 5.7 3.2 0.9 0.5 0.0 1.9 7.6 0.8 0.0 4.6 4.3 2.8 2.2 7.7 5.3 1.5 3.2 7.3 3.9 2.6 0.4 5.2 6.6 0.4 8.4 6.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 1.5 2.8 1.5 1.6 1.7 1.8 1.3 1.9 1.5 2.6 1.7 20.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 80.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 5.6 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 0.1 6.6 0.1 1.6 0.4 0.5 0.0 0.0 0.0 5.3 0.0 0.0 1.5 C17orf113 ENSG00000267221 "Chromosome 17 open reading frame 113" A0A1B0GUU1 17 42038232-42050601 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.4;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.0;Exocrine glandular cells: 1.4;Granulosa cells: 2.4;Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (2.06e-2)" "unprognostic (3.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.47e-1)" "unprognostic (1.64e-1)" "unprognostic (1.53e-1)" "unprognostic (2.24e-3)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" "unprognostic (8.86e-4)" "unprognostic (2.73e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.24e-7)" "unprognostic (7.06e-2)" "unprognostic (2.22e-1)" "unprognostic (1.85e-3)" "unprognostic (1.28e-1)" 0.7 0.4 1.8 0.4 1.7 0.7 1.4 3.4 1.9 1.7 0.6 1.0 0.6 1.0 0.7 0.6 1.6 0.3 1.1 1.6 1.5 1.9 0.5 0.8 0.4 1.7 1.7 1.8 2.3 3.2 1.1 2.2 0.3 2.2 1.7 0.6 2.3 1.7 0.6 1.2 0.9 1.2 0.3 1.2 0.8 1.2 2.9 1.6 0.6 2.0 0.6 0.2 1.3 1.2 2.5 0.4 0.9 0.7 0.0 0.1 0.2 0.5 0.0 0.1 0.3 0.2 0.7 1.5 0.0 0.6 0.0 0.0 1.1 0.5 0.2 0.1 0.6 1.3 0.6 0.3 0.3 0.3 0.8 0.7 0.1 1.4 0.0 0.8 0.4 0.2 1.0 0.2 0.1 0.0 0.9 2.0 0.5 0.3 1.4 0.4 1.1 0.0 2.1 0.2 1.0 1.4 0.9 0.6 1.6 0.2 0.4 2.0 0.5 0.0 0.1 0.9 0.1 0.0 1.2 0.3 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 1.7 3.4 1.9 1.6 1.5 1.7 1.7 1.8 2.2 1.2 1.6 2.5 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 AC099811.2 ENSG00000267261 "Novel protein" 17 42119674-42154916 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 32 "Alveolar cells type 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 2.9;REH: 2.1;SK-BR-3: 2.3;U-87 MG: 2.0" "Low region specificity" "Detected in all" NA NA 0.1 0.0 0.3 0.5 0.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.3 0.0 0.9 1.1 0.0 0.3 0.0 0.9 0.5 0.6 0.5 0.7 0.0 0.0 0.0 0.9 0.2 0.6 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 2.9 0.0 0.5 1.1 0.0 2.1 0.5 0.0 0.0 0.6 0.2 0.9 0.0 2.3 0.1 0.5 0.0 0.0 0.0 0.4 0.5 0.0 0.7 1.1 0.3 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.1 0.1 0.3 0.2 0.4 0.4 0.6 0.3 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATF7-NPFF ENSG00000267281 "ATF7-NPFF readthrough" 12 53506688-53625979 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.4" HPA003384 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (1.14e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (8.37e-4)" "unprognostic (6.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.08e-5)" "unprognostic (1.91e-2)" "unprognostic (2.26e-7)" "unprognostic (9.21e-2)" "unprognostic (2.50e-1)" "unprognostic (3.72e-1)" "unprognostic (9.77e-3)" 0.1 0.0 0.2 0.0 0.4 0.3 0.0 1.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.5 0.2 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.5 0.2 0.2 0.0 0.9 0.2 1.4 0.0 0.1 0.5 0.7 0.0 0.0 0.4 0.5 0.1 0.1 0.2 0.5 0.1 0.0 0.0 0.4 0.1 0.3 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.5 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.7 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.8 0.5 0.1 0.6 0.7 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.7 0.0 0.0 0.4 0.1 0.1 0.2 0.4 1.1 0.5 0.0 0.2 0.3 0.2 0.0 0.5 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 AC005702.1 ENSG00000267318 "Novel protein" 17 59940908-59973101 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.3;tongue: 23.2" "Group enriched" "Detected in some" 8 "Alveolar cells type 2: 1.7;Club cells: 1.8;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 22.5" NA NA 8.1 3.5 1.5 0.7 1.6 0.9 4.3 2.3 2.7 0.8 1.3 2.3 1.7 0.2 7.8 0.9 1.3 1.4 7.1 1.5 1.8 4.8 10.6 1.3 1.1 2.1 1.9 1.4 0.6 0.5 2.1 0.2 0.6 2.4 1.3 2.3 1.9 1.2 0.3 25.3 2.3 1.4 0.7 1.7 0.9 1.2 6.3 1.7 0.7 0.5 23.2 0.9 1.3 0.1 1.9 0.7 1.2 0.5 2.0 1.3 0.2 2.3 0.7 0.3 1.0 1.3 0.3 7.4 0.7 4.1 0.8 1.4 0.1 1.4 1.3 1.2 5.2 1.1 3.4 0.5 0.9 1.8 0.8 6.8 1.8 0.6 1.6 1.4 0.1 0.0 0.6 0.9 2.8 0.7 8.2 0.5 0.4 0.0 4.6 0.9 1.1 2.2 0.8 0.2 0.3 0.1 0.5 1.5 1.3 2.8 0.5 4.5 3.2 0.0 1.6 2.1 1.1 1.3 6.1 22.5 4.7 1.0 2.5 0.9 0.0 0.5 2.0 1.0 1.3 2.7 1.5 1.7 1.5 0.7 0.4 1.2 1.9 0.1 2.4 4.2 0.9 4.4 0.8 1.5 1.6 2.3 2.7 1.5 1.8 2.1 1.9 1.4 2.4 1.7 1.7 1.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC008687.1 ENSG00000267335 "Novel protein" 19 49022953-49036895 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.6;HMC-1: 4.4;U-138 MG: 1.6;U-251 MG: 6.0" HPA038925 Uncertain Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038925: AB_2676272" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 17.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.6 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.6 0.0 0.2 0.0 0.0 1.6 1.3 0.3 6.0 0.3 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AC012309.1 ENSG00000267360 "Novel protein" 19 37093019-37210512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (7.33e-2)" "unprognostic (1.96e-1)" "unprognostic (2.68e-1)" "unprognostic (2.08e-1)" "unprognostic (3.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.09e-4)" "unprognostic (5.94e-2)" "unprognostic (1.68e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-1)" 0.2 0.0 0.2 0.0 0.5 0.0 0.0 1.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.3 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.5 1.4 0.5 0.4 0.1 0.5 0.6 0.3 0.6 0.1 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPK3BL1 "UPK3BL, UPLP" ENSG00000267368 "Uroplakin 3B like 1" B0FP48 7 102637025-102642791 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 275.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.7;Club cells: 3.1;granulocytes: 7.6;Respiratory ciliated cells: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 113.0" HPA011403 Supported NA NA "HPA011403: AB_2668503" "unprognostic (4.63e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (6.19e-3)" "unprognostic (3.35e-1)" "unprognostic (2.88e-1)" "unprognostic (9.39e-3)" "unprognostic (4.00e-1)" "unprognostic (8.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.93e-2)" 37.3 37.2 24.9 9.3 24.3 23.6 38.6 24.2 33.4 65.9 28.6 45.4 10.0 44.7 4.5 275.0 50.7 2.9 44.6 24.8 27.5 68.8 59.9 48.7 21.7 37.4 44.7 23.1 46.2 53.9 7.0 56.7 4.9 63.7 74.7 4.0 5.7 95.4 56.0 35.0 51.7 63.0 2.5 23.1 99.6 47.0 22.4 23.8 18.4 81.8 12.7 94.4 99.6 174.2 46.1 17.9 13.5 8.6 3.6 3.6 0.5 11.8 0.0 1.9 1.8 4.7 2.0 9.3 2.6 2.9 2.2 2.8 113.0 2.6 12.8 1.6 15.9 19.8 2.6 7.5 4.3 1.0 4.6 4.3 7.1 16.0 0.0 3.0 15.1 16.1 0.2 6.9 8.9 5.7 40.3 7.3 37.8 3.8 15.4 4.2 7.1 4.8 14.7 16.4 13.9 5.9 13.3 23.4 5.9 6.4 7.0 1.7 6.8 5.3 32.2 14.1 11.6 6.8 9.8 4.8 1.6 6.9 10.5 5.4 15.8 3.9 6.7 6.1 3.6 3.1 3.5 3.4 3.4 5.4 3.0 4.4 3.5 5.0 6.2 1.4 4.9 6.0 4.1 24.9 24.3 24.2 33.4 24.8 27.5 37.4 44.7 23.1 63.7 23.1 23.8 46.1 0.6 9.6 13.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.1 0.0 0.0 0.2 0.7 0.0 0.0 2.2 0.0 0.1 0.4 1.3 0.0 0.0 0.0 0.7 0.1 0.6 0.0 0.2 7.6 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.0 1.8 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.2 0.3 0.0 0.0 APOC4 ENSG00000267467 "Apolipoprotein C4" P55056 19 44942237-44945496 "Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 228 "liver: 634.1" "Cell type enriched" "Detected in single" 37 "Hepatocytes: 3.8" "Cancer enriched" "Detected in single" 15 "liver cancer: 0.7" "Region enriched" "Detected in single" 4 "white matter: 2.7" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.4;TIME: 1.2" "Not detected" "Not detected" HPA062671 Approved "Secreted to blood" NA NA 1000000000 980000000 "HPA062671: AB_2684828" "unprognostic (1.82e-3)" 0.2 0.3 0.3 0.0 0.6 0.5 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.4 0.7 0.0 0.2 0.3 0.2 0.1 0.1 0.0 634.1 0.2 0.1 0.3 0.2 0.0 0.3 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.1 1.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 0.1 0.5 0.3 2.4 0.0 0.3 0.0 1.2 0.1 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.4 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.0 0.1 0.1 0.4 0.0 0.0 0.3 0.6 0.2 0.6 0.1 0.1 0.3 0.2 0.0 0.3 0.3 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF285 ZNF285A ENSG00000267508 "Zinc finger protein 285" Q96NJ3 19 44382298-44401608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 5.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.0" "HPA046100, HPA049212" Uncertain NA NA "HPA046100: AB_2679538, HPA049212: AB_2680677" "unprognostic (3.23e-2)" "unprognostic (1.90e-3)" "unprognostic (6.42e-2)" "unprognostic (9.86e-2)" "unprognostic (1.76e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.20e-2)" "unprognostic (2.91e-3)" "unprognostic (3.60e-2)" "unprognostic (6.41e-2)" "unprognostic (2.07e-2)" "unprognostic (2.42e-6)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.46e-1)" "unprognostic (1.55e-3)" 0.9 2.1 4.7 0.9 4.7 0.2 2.5 5.6 5.5 1.5 3.3 1.6 0.9 1.9 1.6 1.0 2.9 1.1 2.2 4.4 4.4 1.6 0.7 0.7 1.3 4.3 4.6 4.5 6.4 1.1 2.5 2.0 1.1 4.5 2.0 1.1 5.6 0.9 2.0 1.8 0.8 0.9 1.9 4.0 1.7 1.5 2.9 4.6 1.8 2.8 2.3 1.4 2.0 1.2 5.4 0.1 3.1 3.0 0.0 2.3 2.4 0.1 1.1 1.1 1.5 2.0 0.5 1.9 0.0 1.6 0.7 2.0 1.0 0.0 2.1 2.6 0.0 2.0 4.4 1.2 0.9 3.3 0.6 0.0 1.9 0.0 0.6 6.0 4.4 2.7 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.8 0.8 1.5 0.0 0.0 1.9 1.6 2.5 1.3 2.2 0.1 0.5 0.0 2.9 3.7 1.5 2.6 1.6 1.3 0.8 0.1 1.9 4.2 0.0 1.5 0.0 1.9 1.8 0.1 0.0 0.1 0.2 0.1 1.6 0.3 0.2 0.5 4.0 2.2 2.3 0.0 1.2 0.4 0.4 0.6 0.6 4.7 4.7 5.6 5.5 4.4 4.4 4.3 4.6 4.5 4.5 4.0 4.6 5.4 0.7 0.0 0.0 2.9 0.9 0.3 0.5 0.5 0.0 2.4 0.8 0.8 3.7 0.0 0.9 1.8 4.2 0.5 0.2 0.3 0.0 0.9 1.5 1.0 0.6 0.8 1.2 1.7 5.8 0.6 0.5 0.4 0.0 0.7 0.0 3.9 1.8 0.2 0.4 1.7 3.6 0.6 2.0 0.0 0.6 0.2 0.3 0.4 0.0 0.0 0.1 1.1 3.1 4.5 5.9 0.2 0.2 1.2 0.0 0.9 0.8 0.6 0.6 0.9 0.0 1.1 0.5 3.9 3.0 0.0 0.1 0.0 0.4 1.4 1.1 0.4 S1PR2 "AGR16, DFNB68, EDG5, Gpcr13, H218" ENSG00000267534 "Sphingosine-1-phosphate receptor 2" O95136 19 10221433-10231331 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 45.0" "Group enriched" "Detected in many" 8 "granulocytes: 45.0;T-cells: 12.4" "Cell line enhanced" "Detected in many" "BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014255, HPA014307" Approved Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear speckles" "HPA014255: , HPA014307: AB_1847989" "unprognostic (5.38e-3)" "unprognostic (1.83e-3)" "unprognostic (1.20e-1)" "unprognostic (1.26e-2)" "unprognostic (3.31e-2)" "unprognostic (1.05e-3)" "unprognostic (8.50e-2)" "unprognostic (8.71e-2)" "unprognostic (2.84e-1)" "unprognostic (1.70e-1)" "unprognostic (7.40e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.91e-2)" "unprognostic (4.56e-2)" "unprognostic (3.11e-1)" "unprognostic (8.09e-2)" 6.9 2.5 1.7 6.5 1.7 1.2 5.5 1.6 1.6 10.5 1.7 4.4 1.8 8.4 2.8 3.3 8.5 6.2 6.5 1.5 2.0 2.1 5.7 13.8 11.0 2.3 1.7 1.5 5.7 2.9 2.6 3.0 18.6 2.2 7.0 2.4 1.2 4.1 2.3 0.8 5.1 4.8 4.2 1.8 1.9 4.4 13.3 1.8 1.4 3.4 1.3 11.0 8.4 7.0 2.6 3.0 0.4 3.4 6.9 18.2 22.2 29.4 4.4 8.9 1.9 4.1 1.9 1.7 54.1 5.1 8.2 2.3 1.7 1.2 2.1 1.3 5.5 2.7 1.2 1.2 1.3 6.1 1.4 1.1 12.2 1.1 3.8 1.3 5.3 0.2 2.6 1.3 11.1 1.3 2.5 0.6 2.5 3.4 0.9 1.7 3.8 1.4 2.0 1.6 2.5 2.4 4.7 2.5 1.5 3.8 2.6 1.2 1.3 0.4 6.9 2.2 15.9 1.3 38.9 19.6 57.3 2.6 2.7 38.6 45.0 2.8 0.6 7.2 2.4 8.9 0.3 9.2 7.0 2.6 0.5 3.7 3.8 0.7 3.6 1.0 0.4 12.4 2.0 1.7 1.7 1.6 1.6 1.5 2.0 2.3 1.7 1.5 2.2 1.8 1.8 2.6 2.0 0.0 1.1 0.3 2.0 0.0 4.6 0.0 1.2 0.6 8.3 4.6 0.6 2.8 0.6 1.8 2.1 92.9 5.4 0.0 0.0 3.6 92.3 8.6 21.5 2.0 2.4 0.0 0.3 3.3 18.1 17.7 0.0 18.1 0.0 2.0 3.9 7.6 13.2 0.0 0.9 0.5 0.0 3.1 0.0 184.9 22.1 7.2 0.0 0.0 4.0 7.1 3.1 6.6 0.5 2.7 0.3 13.2 2.6 4.9 0.0 0.9 0.0 0.5 13.1 2.0 4.6 1.5 1.2 2.0 0.0 68.4 4.2 1.1 0.2 4.1 AC093155.3 ENSG00000267561 "Novel protein" 1 86993009-87169204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 19.5" "Cell type enriched" "Detected in single" 6 "granulocytes: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.4;HEL: 14.7;HMC-1: 17.9;THP-1: 12.7" "HPA043069, HPA043603" Approved Uncertain Mitochondria NA NA Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432" "unprognostic (4.41e-1)" "unprognostic (3.13e-2)" "unprognostic (2.05e-1)" "unprognostic (1.85e-2)" "unprognostic (3.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.51e-2)" "unprognostic (5.19e-3)" "unprognostic (3.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" 19.5 1.8 2.5 3.1 3.6 0.3 7.1 1.9 5.0 4.5 2.2 3.7 2.4 2.6 2.2 3.2 1.5 4.9 8.4 2.9 2.8 1.9 1.7 5.6 2.2 2.1 2.1 2.9 6.9 1.1 0.8 0.0 6.0 2.1 0.8 3.4 0.3 2.9 2.4 1.3 0.4 3.1 4.6 2.2 2.7 1.2 3.9 2.0 1.2 1.9 3.7 1.0 4.7 0.0 2.7 0.0 0.1 0.9 2.2 2.5 9.4 0.3 0.0 0.1 0.0 0.4 0.7 0.9 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.4 0.1 0.5 14.7 0.4 0.1 0.1 0.3 17.9 1.6 0.3 0.2 0.0 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.2 0.2 0.4 1.2 0.0 0.2 0.3 0.0 0.4 0.4 0.2 0.4 0.3 0.0 0.5 0.9 0.2 12.7 0.0 0.3 0.7 0.1 1.5 1.0 4.0 0.0 0.7 0.1 0.4 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.5 3.6 1.9 5.0 2.9 2.8 2.1 2.1 2.9 2.1 2.2 2.0 2.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 AC004223.3 ENSG00000267618 "RAD51L3-RFFL readthrough" 17 35011349-35121493 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "adipose tissue: 1.3;testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 7 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;TIME: 2.5" NA NA 1.3 0.0 0.2 0.4 0.2 0.6 0.1 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.7 0.3 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.2 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.3 0.2 4.3 0.3 0.2 0.3 0.2 0.2 0.0 0.0 0.3 0.3 1.9 0.0 0.7 0.0 0.3 1.1 0.0 0.0 0.9 0.8 0.0 0.6 0.1 1.0 0.0 0.2 0.1 0.0 0.0 0.1 2.1 0.5 0.4 0.9 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.4 0.0 0.4 0.0 1.2 0.0 0.4 0.1 0.0 0.1 0.0 1.4 0.2 0.0 1.1 0.7 0.1 0.0 1.6 1.4 2.5 0.0 0.5 0.5 0.6 0.4 1.9 0.2 0.7 0.8 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.4 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CGB1 ENSG00000267631 "Chorionic gonadotropin subunit beta 1" A6NKQ9 19 49035569-49036895 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "pancreas: 2.8;pituitary gland: 4.3" "Cell type enriched" "Detected in single" 77 "Syncytiotrophoblasts: 69.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 17.7" "HPA038925, HPA038934" Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 69.9 0.0 0.0 0.0 0.0 FDX2 "FDX1L, MGC19604" ENSG00000267673 "Ferredoxin 2" Q6P4F2 19 10310045-10316015 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Ductal cells: 38.5;Exocrine glandular cells: 30.3;Hofbauer cells: 37.0;monocytes: 31.6;Pancreatic endocrine cells: 30.2;Proximal tubular cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 266.8" HPA043986 Approved NA NA "HPA043986: AB_10960282" "unprognostic (1.48e-2)" "unprognostic (3.76e-2)" "unprognostic (7.61e-3)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-3)" "unprognostic (9.70e-3)" "unprognostic (2.29e-1)" "unprognostic (1.42e-3)" "unprognostic (4.92e-2)" "unprognostic (3.73e-2)" "unprognostic (3.93e-2)" "unprognostic (3.14e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" 15.0 27.4 55.1 9.2 58.4 5.0 15.3 52.8 80.4 15.1 52.8 17.8 7.8 16.5 13.3 14.5 13.7 9.9 22.0 58.9 57.7 32.2 28.4 14.3 11.3 53.9 57.2 58.6 15.4 20.2 30.2 29.0 9.4 56.9 20.3 6.9 4.5 14.2 16.1 24.9 12.6 11.6 13.4 50.3 15.3 17.5 12.2 56.2 8.8 24.6 22.3 7.9 19.7 14.0 61.4 34.9 28.4 19.4 33.4 40.2 31.7 20.2 32.2 51.0 53.6 44.5 41.4 24.5 26.2 59.2 45.9 37.7 26.5 32.3 61.1 20.7 28.6 46.0 38.3 30.0 30.5 58.4 18.7 12.3 28.9 42.6 45.2 44.4 25.9 32.9 30.0 47.2 20.4 61.2 56.2 35.1 266.8 33.8 32.7 52.2 26.3 16.0 39.0 62.1 36.4 42.5 25.7 40.0 46.7 36.6 13.1 39.3 13.7 23.2 73.9 18.6 76.7 48.2 44.9 73.2 42.1 68.6 41.2 39.3 0.0 9.1 0.0 10.8 19.6 14.7 19.7 10.9 14.0 20.9 14.1 13.6 15.6 1.7 24.4 19.0 15.4 15.5 7.7 55.1 58.4 52.8 80.4 58.9 57.7 53.9 57.2 58.6 56.9 50.3 56.2 61.4 11.3 9.6 10.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 18.9 18.7 0.0 0.0 4.3 11.0 0.0 14.1 3.5 0.0 29.4 38.5 0.0 5.7 5.1 4.9 0.0 0.0 0.0 30.3 19.5 5.7 0.0 4.3 2.5 5.5 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.6 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.9 0.0 0.0 69.9 5.8 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 7.9 2.1 5.7 0.0 0.0 ZNF224 "BMZF-2, KOX22, ZNF255, ZNF27" ENSG00000267680 "Zinc finger protein 224" Q9NZL3 19 44094339-44109886 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054045 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA054045: AB_2682354" "unprognostic (1.01e-3)" "unprognostic (4.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.40e-3)" "unprognostic (8.47e-2)" "unprognostic (4.25e-4)" "unprognostic (9.61e-2)" "unprognostic (6.35e-3)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.81e-3)" "unprognostic (2.64e-2)" "prognostic unfavorable (5.32e-4)" "unprognostic (1.68e-1)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.53e-7)" 14.2 15.6 13.8 17.8 14.8 9.7 17.1 16.8 14.0 15.9 16.3 14.5 18.3 18.0 23.3 9.5 16.2 13.9 11.5 13.1 14.1 14.2 15.9 16.5 22.6 14.6 14.1 12.9 20.8 14.8 14.2 19.7 14.9 14.4 17.3 21.4 18.0 15.7 15.8 7.6 24.8 22.3 13.5 13.5 27.4 16.2 6.5 14.1 18.5 20.0 5.9 22.8 12.8 13.1 17.6 8.5 13.9 14.7 12.1 14.4 15.0 12.0 10.5 15.6 7.1 16.2 7.0 6.6 10.2 11.3 13.9 5.4 9.5 8.1 9.0 9.4 10.5 16.4 19.7 26.5 7.3 7.6 14.3 22.0 18.6 16.0 8.8 13.1 22.6 13.1 10.1 6.1 12.0 12.0 2.2 12.6 17.2 6.4 4.7 9.5 7.4 15.9 6.3 10.8 26.9 7.5 17.1 14.4 6.2 5.0 14.4 6.1 18.5 13.8 15.7 10.1 7.1 7.4 16.2 16.3 5.8 8.4 11.0 7.4 49.6 9.1 22.0 18.4 6.3 20.3 16.9 15.5 18.7 9.7 17.8 19.5 15.1 6.9 16.7 13.7 8.7 19.5 10.4 13.8 14.8 16.8 14.0 13.1 14.1 14.6 14.1 12.9 14.4 13.5 14.1 17.6 16.0 22.4 14.6 16.3 26.2 5.6 7.3 14.7 10.8 26.8 9.1 5.7 4.7 18.6 11.3 25.8 18.8 13.1 30.4 14.5 1.9 8.1 14.5 7.9 9.9 12.2 9.6 12.0 26.2 5.3 8.1 12.4 8.6 8.2 21.0 20.5 16.1 7.6 7.3 26.9 23.4 11.2 20.3 13.9 8.9 4.4 16.1 10.4 5.4 14.0 19.8 11.8 47.4 14.1 29.0 8.6 13.3 13.9 12.1 10.4 29.8 3.3 7.4 22.1 13.1 10.9 9.3 5.4 4.1 6.8 6.8 8.2 27.3 19.9 11.0 9.3 EDDM13 ENSG00000267710 "Epididymal protein 13" A0A1B0GTR0 19 56272748-56310454 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 77 "epididymis: 99.6" "Cell type enhanced" "Detected in some" "Adipocytes: 1.5;Alveolar cells type 2: 1.3;Breast myoepithelial cells: 2.2;dendritic cells: 1.1;Endothelial cells: 2.2;granulocytes: 1.3;Respiratory ciliated cells: 1.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "unprognostic (1.08e-4)" "unprognostic (1.19e-2)" "unprognostic (2.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (3.22e-3)" "unprognostic (1.33e-1)" "unprognostic (5.23e-3)" "unprognostic (2.93e-2)" "unprognostic (9.16e-2)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" "unprognostic (3.84e-2)" "unprognostic (4.20e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 99.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.5 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.1 1.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.7 0.6 2.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 AC024592.3 ENSG00000267740 "Novel protein" 19 5866171-5903787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.1;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.12e-2)" "unprognostic (2.24e-1)" "unprognostic (3.38e-1)" 1.0 1.9 0.7 0.2 0.7 1.0 1.0 0.7 1.6 0.9 0.9 1.4 0.8 1.0 0.2 2.2 0.6 0.6 2.6 0.8 0.9 1.3 2.4 1.0 0.3 0.9 0.9 0.6 1.2 1.0 0.2 1.1 0.3 0.9 1.1 0.0 0.3 1.1 0.2 2.4 1.2 1.1 0.6 0.8 1.1 1.2 0.7 0.9 0.6 0.8 1.2 0.4 1.2 1.5 1.0 3.5 4.6 1.4 3.9 2.7 0.5 1.2 2.3 3.2 4.3 3.0 1.7 2.9 2.9 2.2 1.8 2.0 2.4 0.9 2.7 0.8 1.2 1.4 0.7 1.8 3.9 1.8 1.3 1.5 1.1 4.5 3.3 1.5 1.3 1.4 4.1 1.2 3.7 0.6 2.9 4.8 1.0 2.2 1.5 2.2 4.5 1.4 3.7 2.0 1.1 2.3 3.2 1.7 2.3 2.5 0.6 1.4 4.3 2.8 0.8 2.1 5.3 4.6 3.4 4.1 1.6 2.7 4.6 1.9 4.4 4.8 2.3 3.2 4.3 2.8 4.2 3.4 3.1 5.0 4.0 3.8 3.1 2.7 3.6 3.9 6.2 4.4 8.1 0.7 0.7 0.7 1.6 0.8 0.9 0.9 0.9 0.6 0.9 0.8 0.9 1.0 0.1 3.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 AC011479.1 ENSG00000267748 "Novel protein" 19 38289151-38304910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "salivary gland: 11.7" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 28.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 1.6;REH: 1.7;SK-BR-3: 3.5;U-266/84: 2.7" NA NA "unprognostic (1.48e-2)" "unprognostic (7.63e-2)" "unprognostic (8.91e-3)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-1)" "unprognostic (4.78e-2)" "unprognostic (1.12e-1)" "unprognostic (7.66e-2)" "unprognostic (2.00e-1)" "unprognostic (3.94e-2)" "unprognostic (4.41e-2)" "unprognostic (2.40e-1)" "unprognostic (3.56e-1)" 0.1 0.5 0.4 0.0 0.3 0.3 1.0 0.3 0.6 0.8 0.4 1.1 1.7 0.4 1.2 1.7 0.3 0.2 0.1 0.3 0.5 2.1 0.2 1.1 0.4 0.4 0.3 0.3 2.2 5.2 0.2 1.8 1.1 0.4 1.9 0.6 0.0 11.7 0.8 0.2 2.0 1.1 0.0 0.3 0.5 2.1 0.8 0.3 0.3 2.3 0.0 0.1 0.5 1.2 0.4 2.1 1.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.3 0.3 0.9 0.3 1.7 0.0 0.0 0.4 0.8 0.0 0.0 0.3 3.5 0.0 0.2 0.5 1.4 0.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 0.3 19.8 4.5 22.8 0.2 2.6 0.3 4.9 2.0 0.7 17.9 7.1 4.0 3.6 2.4 0.5 2.6 22.5 0.6 8.8 0.4 0.3 0.3 0.6 0.3 0.5 0.4 0.3 0.3 0.4 0.3 0.3 0.4 0.0 28.9 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 4.3 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.5 2.5 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SMIM22 CASIMO1 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 192.7;pancreas: 155.6;salivary gland: 148.4;stomach 1: 203.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2005.0;Intestinal goblet cells: 1223.5;Paneth cells: 1462.9;Proximal enterocytes: 1685.8;Respiratory ciliated cells: 686.7;Undifferentiated cells: 775.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CAPAN-2: 261.7;OE19: 247.3;RT4: 89.8;SCLC-21H: 70.7;SK-BR-3: 201.2" "Low region specificity" "Detected in many" HPA077331 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 1.2 0.3 0.2 14.7 1.2 3.5 48.7 3.7 1.8 45.8 0.0 192.7 130.8 9.0 50.8 10.4 78.0 33.6 0.4 0.6 0.2 25.2 1.4 24.3 0.6 3.1 1.0 0.1 0.5 155.6 0.1 49.2 2.0 2.6 43.0 123.8 1.5 148.4 36.7 0.2 10.4 129.5 6.4 0.6 0.3 203.3 34.0 1.7 0.2 1.2 0.0 2.7 46.5 6.5 2.7 0.2 0.0 0.1 0.6 0.0 0.0 1.9 0.3 0.1 0.1 0.1 0.6 261.7 0.3 7.3 0.0 0.3 1.3 0.1 0.0 0.1 0.4 1.9 0.1 5.8 0.9 0.1 0.7 0.3 0.2 1.4 0.0 0.0 0.2 0.1 0.4 0.0 0.6 0.0 1.9 0.1 0.6 0.8 247.3 0.0 0.8 0.3 23.6 1.5 89.8 70.7 0.8 0.5 201.2 0.0 0.5 15.2 0.0 0.0 0.6 0.8 1.1 0.1 0.2 0.6 0.9 0.0 0.7 0.6 1.2 0.3 0.4 0.3 0.1 0.1 0.1 0.3 0.1 0.0 0.4 0.3 0.1 0.9 0.3 0.1 0.4 0.1 0.1 0.2 1.2 3.7 1.8 0.6 0.2 3.1 1.0 0.1 2.6 0.6 1.7 2.7 1.4 48.1 117.7 0.0 5.8 2.2 22.7 92.7 0.0 4.2 363.3 267.5 0.5 183.0 154.9 250.1 0.0 3.9 3.0 2005.0 25.4 259.8 40.1 430.4 26.5 4.4 470.3 0.0 0.5 381.9 0.4 4.7 438.8 258.3 18.4 0.1 0.4 0.2 0.4 1.7 0.3 1223.5 152.5 0.0 0.8 107.3 0.6 4.2 23.2 0.0 5.3 0.6 0.0 0.0 1.3 539.9 1462.9 1.2 1.0 29.5 1685.8 99.4 686.7 4.2 0.0 0.0 15.9 38.6 0.6 2.3 2.3 3.7 6.6 0.2 775.6 148.6 LIN37 "F25965, lin-37, ZK418.4" ENSG00000267796 "Lin-37 DREAM MuvB core complex component" Q96GY3 19 35748361-35754519 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043253, HPA047809" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA043253: AB_2678391, HPA047809: AB_2680162" "unprognostic (7.10e-2)" "unprognostic (1.32e-1)" "unprognostic (7.07e-2)" "unprognostic (2.45e-3)" "unprognostic (7.77e-3)" "unprognostic (5.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.67e-4)" "unprognostic (9.88e-3)" "prognostic unfavorable (1.62e-6)" "unprognostic (2.53e-2)" "unprognostic (8.89e-2)" "unprognostic (4.35e-1)" "unprognostic (5.14e-2)" 10.2 10.0 20.2 6.8 21.0 9.8 9.2 21.4 27.1 12.0 18.1 9.5 9.3 11.3 7.8 7.1 10.9 7.0 12.7 20.4 20.8 7.4 7.7 7.5 9.7 20.4 20.5 20.8 16.0 8.5 9.3 11.1 11.8 20.4 8.9 5.0 8.7 8.0 8.4 15.9 10.5 8.0 8.3 19.6 8.7 8.0 9.0 21.6 9.8 7.9 12.8 7.6 9.6 9.0 21.3 13.7 29.7 11.4 15.5 18.4 14.4 12.0 14.4 15.7 22.8 24.6 9.8 6.3 7.8 16.3 17.1 15.3 6.9 8.2 12.1 8.8 26.5 11.6 10.0 14.6 15.0 42.2 8.0 22.6 13.4 22.1 20.4 34.9 15.0 16.9 20.8 10.4 15.1 16.5 27.6 13.3 11.0 3.2 22.4 12.9 5.9 7.5 8.4 15.1 6.4 9.8 11.2 13.5 26.7 12.5 9.1 11.1 17.0 16.4 17.2 10.1 16.8 18.3 22.3 19.0 7.3 18.3 12.0 12.9 16.8 7.9 26.4 18.3 8.6 17.2 19.6 19.8 21.4 9.0 18.8 20.6 18.7 32.0 18.4 8.1 18.8 22.2 13.7 20.2 21.0 21.4 27.1 20.4 20.8 20.4 20.5 20.8 20.4 19.6 21.6 21.3 2.0 0.0 1.1 2.9 5.0 3.8 0.7 2.5 8.0 1.5 2.2 1.4 0.1 1.5 0.8 3.7 2.1 4.2 1.9 2.8 3.9 1.5 5.5 1.0 1.0 2.0 1.2 4.8 5.9 1.2 3.4 3.3 5.6 0.7 4.5 1.0 1.1 1.0 1.9 1.7 5.6 0.7 2.0 3.1 4.4 5.8 4.1 3.2 5.4 0.0 2.6 1.0 3.1 3.5 4.3 2.8 2.8 3.4 7.3 0.7 9.8 3.2 1.3 2.4 6.6 1.5 3.0 9.2 2.3 6.4 5.4 11.5 5.6 1.0 1.3 0.3 NDUFA7 B14.5a ENSG00000267855 "NADH:ubiquinone oxidoreductase subunit A7" O95182 19 8308768-8321375 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 247.6;tongue: 246.9" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 167.5;Proximal enterocytes: 183.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA059251, HPA071866" Enhanced Supported Mitochondria NA NA Mitochondria "HPA059251: AB_2683960, HPA071866: AB_2686465" "unprognostic (6.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (3.85e-1)" "unprognostic (2.18e-1)" "unprognostic (5.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (3.40e-1)" "unprognostic (1.13e-3)" "unprognostic (1.81e-2)" "unprognostic (1.43e-1)" "unprognostic (1.09e-2)" "unprognostic (5.53e-2)" "unprognostic (1.29e-2)" "unprognostic (2.59e-2)" "unprognostic (9.35e-3)" 34.0 88.2 73.8 20.0 75.4 34.5 33.4 76.9 96.8 21.3 80.4 47.0 24.4 27.9 54.0 58.1 42.7 25.4 134.2 74.0 77.6 88.2 84.1 31.3 29.8 75.4 73.6 73.3 25.3 37.4 104.6 87.0 23.6 74.2 41.5 33.8 32.5 43.8 20.9 247.6 30.8 34.3 23.0 74.4 42.3 55.2 18.9 76.6 41.2 41.6 246.9 32.4 35.8 28.4 75.6 78.9 62.8 64.7 43.3 42.6 32.3 44.2 16.5 18.0 56.0 44.1 57.7 59.7 36.1 25.1 42.6 35.0 65.1 29.0 97.4 33.8 88.3 173.6 26.6 90.1 157.7 63.9 45.8 45.1 43.3 61.7 25.2 39.1 57.1 72.3 141.2 57.0 217.7 80.6 89.4 93.5 236.1 65.1 119.9 187.7 52.2 13.7 99.0 117.6 40.8 65.9 50.5 19.0 90.6 58.5 40.1 33.0 74.8 26.4 42.5 34.0 61.6 60.1 79.2 58.0 49.9 67.8 80.2 77.3 61.9 104.5 80.2 62.1 124.6 65.4 83.3 66.7 58.2 130.5 81.6 66.0 61.6 30.5 81.8 117.6 186.1 95.3 82.6 73.8 75.4 76.9 96.8 74.0 77.6 75.4 73.6 73.3 74.2 74.4 76.6 75.6 19.5 44.8 68.4 10.1 28.4 0.0 10.3 0.0 21.1 14.9 51.6 38.1 0.0 44.3 20.4 53.3 6.2 62.0 32.6 57.6 99.7 147.3 38.9 36.1 10.5 19.8 87.4 44.2 9.5 157.2 45.4 15.0 28.1 19.4 21.5 8.4 27.5 64.0 52.8 8.4 13.3 101.6 0.0 42.7 0.0 17.7 13.4 30.4 0.0 10.3 122.5 27.9 45.3 9.5 13.2 167.5 110.2 13.2 61.6 14.7 183.8 97.6 70.7 17.1 6.6 7.3 19.6 24.8 27.5 53.3 0.0 46.9 20.9 11.7 107.6 12.1 AC243967.1 ENSG00000267881 "Novel protein, readthrough between CEACAM5-CEACAM6" 19 41708657-41756737 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "intestine: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.3" NA NA "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (9.59e-3)" 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC177 "C14orf162, PLPL" ENSG00000267909 "Coiled-coil domain containing 177" Q9NQR7 14 69569799-69574871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 5.5;retina: 4.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 14.7;Cone photoreceptor cells: 10.4;Horizontal cells: 5.0;Rod photoreceptor cells: 9.0" "Cancer enhanced" "Detected in single" "cervical cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 5.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.21e-1)" "unprognostic (2.33e-2)" "unprognostic (6.94e-3)" "unprognostic (1.34e-2)" "unprognostic (2.64e-3)" "unprognostic (1.77e-3)" "unprognostic (6.34e-4)" "unprognostic (2.58e-2)" "unprognostic (1.19e-1)" "unprognostic (1.99e-2)" "unprognostic (3.16e-1)" "unprognostic (7.84e-5)" "unprognostic (2.15e-4)" "unprognostic (3.81e-1)" "unprognostic (1.45e-1)" 0.0 0.1 0.6 0.0 0.7 0.0 0.1 5.5 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.4 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 5.5 2.6 1.9 0.4 0.0 0.1 1.1 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.1 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 AC008878.1 ENSG00000267952 "Novel transcript" 19 7507052-7519622 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.0;skeletal muscle: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.0;ASC diff: 12.2;fHDF/TERT166: 13.7;hTERT-RPE1: 15.6;SuSa: 11.7" NA NA "unprognostic (4.56e-1)" "unprognostic (8.56e-2)" 0.6 0.9 2.9 0.4 3.3 0.8 1.8 2.8 13.0 2.7 2.9 0.9 0.0 0.9 0.0 0.3 2.0 0.0 0.4 3.1 3.2 2.7 0.6 0.8 0.1 3.1 3.3 3.0 0.6 0.1 0.0 0.2 0.2 3.2 0.3 0.7 5.1 0.3 0.0 12.3 0.3 0.6 0.0 2.9 1.1 0.4 0.4 3.4 1.0 0.8 1.1 0.0 0.5 0.3 3.2 0.0 0.0 11.0 1.2 12.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.6 0.0 1.1 2.6 7.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.3 15.6 4.5 0.0 0.0 0.0 3.0 0.7 0.2 0.0 0.2 3.1 0.0 2.7 3.9 2.0 4.0 0.0 0.0 3.2 1.2 1.1 0.0 11.7 0.6 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.3 2.8 13.0 3.1 3.2 3.1 3.3 3.0 3.2 2.9 3.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "testis: 10.1" "Group enriched" "Detected in some" 4 "Spermatocytes: 39.6;Spermatogonia: 16.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.0 0.1 82.4 0.0 0.2 0.0 6.3 0.0 131.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 55.1 73.7 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 39.6 16.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 2.2;Karpas-707: 5.4;U-266/70: 4.5;U-266/84: 3.3" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.4 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERFL erfl1 ENSG00000268041 "ETS repressor factor like" A0A1W2PQ73 19 41907705-41928516 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.8;lymphoid tissue: 3.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HMC-1: 4.5;U-2 OS: 2.7;U-266/70: 2.4;U-698: 3.8;U-937: 2.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" NA NA "unprognostic (1.97e-1)" "unprognostic (1.84e-3)" "unprognostic (3.88e-4)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "unprognostic (6.71e-2)" "unprognostic (1.12e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-2)" "unprognostic (3.42e-1)" "unprognostic (1.57e-1)" "unprognostic (1.21e-14)" "unprognostic (5.11e-1)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (9.98e-3)" 0.3 0.0 0.7 1.3 1.3 0.8 0.3 0.7 0.6 0.7 0.0 0.6 0.2 0.5 0.0 0.2 0.8 0.6 0.2 0.3 0.8 0.2 0.1 0.6 3.0 1.4 0.5 0.3 0.8 0.3 0.6 0.2 0.0 1.5 0.5 0.2 0.4 0.2 0.0 0.1 0.3 2.8 0.0 0.5 2.9 0.5 1.4 0.9 0.5 0.3 0.0 1.2 0.4 0.4 1.2 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.5 6.3 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 4.5 0.0 0.2 0.2 0.1 0.2 0.0 0.9 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.4 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 2.7 0.1 0.0 2.4 0.1 3.8 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.7 0.6 0.3 0.8 1.4 0.5 0.3 1.5 0.5 0.9 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" Q5TAG4 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pancreas: 80.7;stomach 1: 57.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favorable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.47e-5)" 9.4 7.9 8.9 9.5 12.4 17.7 10.3 8.0 11.7 10.4 6.9 9.4 8.4 10.9 10.8 7.4 9.9 6.0 5.4 8.7 9.9 7.5 22.5 10.1 11.7 13.6 12.1 7.8 12.4 80.7 9.9 11.0 4.9 13.9 9.6 6.6 14.0 9.8 6.8 5.0 10.7 12.4 9.0 9.7 11.8 57.7 9.7 11.4 10.6 11.3 5.4 9.9 9.6 8.7 18.6 8.1 6.2 13.0 11.1 5.7 5.4 8.5 8.3 6.0 5.7 5.6 5.7 7.4 17.9 5.0 6.9 6.2 5.9 9.4 4.5 5.3 6.7 6.5 7.8 16.1 5.0 4.9 5.9 11.0 5.8 8.1 5.4 12.7 7.2 5.1 12.7 12.6 2.8 4.4 11.9 12.8 7.5 7.5 9.7 8.1 12.3 4.8 4.2 4.1 17.3 6.5 13.5 10.7 9.4 5.5 19.2 7.9 17.5 6.2 4.7 8.1 11.6 11.4 10.5 8.2 7.2 5.1 4.0 5.8 2.9 1.0 0.8 1.2 0.4 0.7 1.5 0.8 0.7 0.4 1.3 0.9 0.7 0.2 0.3 0.6 1.0 0.9 0.3 8.9 12.4 8.0 11.7 8.7 9.9 13.6 12.1 7.8 13.9 9.7 11.4 18.6 6.3 32.1 24.0 18.6 15.2 3.8 3.0 3.3 11.4 17.0 7.0 4.4 10.9 2.8 7.8 5.5 45.9 4.4 12.9 6.2 0.0 11.8 14.0 2.7 4.0 6.1 10.7 12.8 21.4 8.7 4.7 9.2 6.1 5.2 24.6 4.7 7.9 12.9 3.8 10.1 15.1 9.6 0.0 14.0 6.4 3.8 5.6 11.0 1.8 6.5 16.4 9.4 8.2 24.6 29.3 12.7 15.7 10.5 6.4 1.9 15.9 2.0 6.5 16.7 6.6 6.0 8.6 12.2 6.8 11.4 4.3 1.9 12.1 2.6 10.5 1.5 AC008982.1 ENSG00000268083 "Novel protein" 19 38817471-38840178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.1;thalamus: 2.0" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "NB-4: 26.4" "HPA002907, HPA051748" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA002907: AB_1847964, HPA051748: AB_2681588" "unprognostic (1.36e-2)" 0.3 0.2 0.3 0.1 0.3 1.1 0.2 0.3 2.1 0.2 0.3 0.7 0.5 0.3 0.0 0.2 0.1 0.0 0.4 0.3 0.3 0.3 0.2 0.5 0.3 0.4 0.3 0.3 0.2 0.4 0.0 0.1 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.5 0.2 0.3 0.0 0.3 0.2 0.2 0.3 2.0 0.0 0.2 0.4 0.0 0.1 0.2 0.3 1.5 0.0 0.2 0.3 0.1 0.1 1.8 0.5 0.0 0.6 0.1 0.8 0.1 0.2 1.2 0.1 0.1 0.8 0.0 0.0 0.2 1.5 0.5 1.0 0.0 0.0 0.1 0.5 1.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.6 0.5 0.0 0.9 1.3 26.4 1.9 0.0 0.0 1.6 0.8 0.7 0.3 0.3 0.7 2.9 0.0 0.0 6.0 0.0 0.5 3.0 0.0 0.1 2.7 1.6 2.1 1.3 1.0 2.2 0.1 0.8 0.1 0.5 0.7 0.7 0.6 0.5 1.0 0.4 0.7 0.7 0.6 0.5 0.6 0.8 0.0 0.8 0.3 1.5 0.9 0.7 0.3 0.3 0.3 2.1 0.3 0.3 0.4 0.3 0.3 0.4 0.3 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRQ ENSG00000268089 "Gamma-aminobutyric acid type A receptor subunit theta" Q9UN88 X 152637895-152657542 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 52.8" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.0;Glandular and luminal cells: 2.8;Spermatogonia: 1.4;Squamous epithelial cells: 2.5;Suprabasal keratinocytes: 1.8" "Cancer enhanced" "Detected in many" "testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 11.4;SiHa: 11.6;SuSa: 5.0;U-87 MG: 37.2" "Region enriched" "Detected in many" 5 "hypothalamus: 52.6" "Group enriched" "Detected in some" 4 "hypothalamus: 7.7;midbrain: 20.8;pons: 6.3" NA NA "unprognostic (3.68e-3)" "unprognostic (7.78e-2)" "unprognostic (9.16e-2)" "unprognostic (1.17e-4)" "unprognostic (3.38e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-4)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-1)" "unprognostic (3.76e-2)" "unprognostic (3.10e-5)" "unprognostic (3.43e-3)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.70e-2)" 0.0 2.2 18.0 0.0 26.1 0.0 0.0 0.1 28.7 7.8 0.1 0.0 0.0 1.2 0.1 0.6 0.1 0.0 0.0 15.7 52.8 0.0 0.0 0.0 0.0 10.0 18.7 9.1 0.0 0.0 0.0 0.1 0.1 12.4 0.4 0.0 0.2 0.0 0.5 0.0 0.3 0.2 0.8 2.2 0.0 0.0 1.2 30.9 0.0 0.0 0.0 0.1 0.0 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.2 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.0 0.0 2.9 0.0 0.0 0.0 0.0 1.6 11.6 2.1 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 26.1 0.1 28.7 15.7 52.8 10.0 18.7 9.1 12.4 2.2 30.9 4.1 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.6 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.0 1.4 2.5 1.8 0.8 0.0 0.0 0.0 0.5 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436606-116461458 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 16.2;salivary gland: 20.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 115.7;Basal respiratory cells: 94.9;Club cells: 225.6;Pancreatic endocrine cells: 170.4;Respiratory ciliated cells: 58.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.7;Hep G2: 3.4;OE19: 1.2" HPA003193 Uncertain Approved Vesicles NA NA Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.1 2.3 0.0 0.1 7.8 0.3 0.1 7.0 0.0 1.4 0.9 0.2 0.0 2.4 0.2 0.8 0.0 0.1 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 1.0 0.7 0.0 20.8 1.3 0.0 3.0 0.7 0.1 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 1.1 1.6 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 22.4 115.7 0.0 0.1 0.1 0.3 94.9 0.0 0.0 17.6 11.6 0.2 0.0 225.6 0.0 0.0 0.0 0.1 18.1 0.0 17.6 0.1 0.2 0.0 0.5 2.4 0.0 0.0 32.0 0.0 1.0 10.7 0.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.1 0.0 0.0 0.1 0.0 0.5 16.0 0.0 0.0 0.0 0.0 0.0 0.0 170.4 10.2 0.0 0.0 10.5 0.2 0.0 58.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.4 0.0 0.4 0.0 8.9 23.4 AC003002.1 ENSG00000268133 "Novel protein" 19 57363566-57398584 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.7 0.0 0.4 0.0 0.6 1.1 0.4 0.3 0.4 0.5 0.9 0.4 0.5 0.8 1.3 0.2 0.6 0.2 0.5 0.7 0.7 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004076.1 ENSG00000268163 "Novel transcript" 19 57437970-57477536 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.2;retina: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" NA NA "unprognostic (3.02e-1)" "unprognostic (3.67e-2)" "unprognostic (4.50e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.80e-2)" "unprognostic (5.13e-2)" "unprognostic (6.55e-2)" "unprognostic (5.25e-3)" "unprognostic (4.41e-3)" "unprognostic (7.09e-4)" "unprognostic (2.94e-2)" "unprognostic (2.50e-1)" "unprognostic (7.29e-2)" "unprognostic (6.45e-2)" 0.1 0.2 0.5 0.2 0.5 0.0 0.2 1.2 0.8 0.0 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.4 0.5 0.2 0.1 0.0 0.1 0.0 0.3 0.2 0.5 0.1 0.0 0.3 0.1 0.1 0.9 0.1 0.1 1.2 0.0 0.1 1.0 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.9 0.1 0.3 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.5 0.0 0.0 0.7 0.1 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 1.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.5 1.2 0.8 0.5 0.2 0.3 0.2 0.5 0.9 0.2 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643159-56657247 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 11.6" "Group enriched" "Detected in some" 5 "Excitatory neurons: 18.0;Inhibitory neurons: 32.7" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.0;HEK 293: 1.8;SCLC-21H: 1.7" "Low region specificity" "Detected in all" "HPA071857, HPA071861" Enhanced Approved Vesicles NA NA Vesicles "HPA071857: AB_2686461, HPA071861: AB_2686462" "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 0.4 0.3 5.8 0.2 5.7 0.2 0.6 4.4 9.9 0.4 0.0 0.5 0.3 0.6 1.3 0.3 0.5 0.2 0.4 7.3 9.0 0.3 0.2 0.3 0.2 7.7 6.6 5.4 0.5 0.3 0.1 1.6 0.2 7.9 0.4 0.3 2.8 0.4 1.1 0.5 0.8 0.2 0.4 3.9 0.3 0.3 0.5 8.0 0.3 0.3 0.2 0.2 0.4 0.3 11.6 0.1 0.0 2.0 0.5 0.3 0.2 0.5 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.2 0.1 1.8 1.1 0.4 0.4 0.3 1.0 0.3 0.3 0.3 0.1 0.3 0.3 0.2 1.1 0.1 0.0 0.5 0.0 1.3 0.3 0.1 0.0 0.3 0.7 1.2 0.1 0.1 0.0 1.7 0.3 0.6 0.1 0.3 0.3 0.0 0.4 0.4 0.6 0.1 0.2 0.1 0.1 0.3 0.5 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.7 4.4 9.9 7.3 9.0 7.7 6.6 5.4 7.9 3.9 8.0 11.6 0.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 3.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW "CBBM, CBD, COD5, GCP, OPN1MW1" ENSG00000268221 "Opsin 1, medium wave sensitive" P04001 X 154182596-154196861 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 135 "retina: 13.4" "Cell type enriched" "Detected in single" 111 "Cone photoreceptor cells: 33.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ARL14EPL ENSG00000268223 "ADP ribosylation factor like GTPase 14 effector protein like" P0DKL9 5 116032324-116060118 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Collecting duct cells: 1.8;Early spermatids: 3.2;Endometrial ciliated cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "HDLM-2: 81.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.41e-1)" "unprognostic (3.84e-1)" "unprognostic (2.51e-2)" "unprognostic (6.47e-3)" "unprognostic (1.60e-2)" "unprognostic (3.79e-2)" "unprognostic (4.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 81.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 3.2 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 TCP11X1 ENSG00000268235 "T-complex 11 family, X-linked 1" X 102215301-102229532 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048311 Uncertain NA NA "HPA048311: AB_2680351" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCGB1C2 ENSG00000268320 "Secretoglobin family 1C member 2" P0DMR2 17 137569-139067 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 1.5;retina: 1.0" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 5.0" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (4.65e-2)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM156A "PRO0659, TMEM29" ENSG00000268350 "Family with sequence similarity 156 member A" Q8NDB6 X 52926402-52995472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Astrocytes: 16.0;Excitatory neurons: 9.6;Gastric mucus-secreting cells: 11.2;Inhibitory neurons: 11.1;Microglial cells: 8.4;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056640, HPA056643" Approved NA NA "HPA056640: AB_2683200, HPA056643: AB_2683201" "unprognostic (1.80e-1)" "unprognostic (5.58e-2)" "unprognostic (6.36e-3)" "unprognostic (2.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-3)" "unprognostic (6.60e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (8.49e-5)" "unprognostic (1.32e-1)" "unprognostic (3.54e-13)" "unprognostic (6.42e-2)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (6.90e-2)" 33.2 35.4 11.4 10.7 10.7 9.8 33.5 13.5 16.8 35.5 9.0 28.2 12.0 29.9 6.1 22.9 34.3 4.1 21.6 10.4 10.6 26.5 25.0 27.7 5.9 12.5 9.6 8.9 34.9 26.1 11.5 61.8 20.8 12.2 32.7 7.4 6.7 21.4 9.2 12.2 43.2 26.9 8.3 5.8 37.6 25.0 22.7 9.8 6.8 34.4 3.7 6.7 27.6 28.7 16.3 16.8 22.6 13.1 19.5 5.9 24.6 66.8 26.4 11.4 21.5 11.7 13.3 6.9 22.3 11.8 19.7 9.3 27.2 11.8 15.4 9.1 21.1 24.4 14.5 71.9 23.9 8.9 13.6 9.4 15.2 5.8 19.0 5.9 10.1 7.1 17.9 14.0 6.3 17.3 27.1 14.7 24.1 11.2 8.4 31.7 20.8 18.5 21.6 6.6 16.8 12.6 14.1 23.2 12.2 7.4 12.9 25.5 8.3 5.6 18.1 17.9 45.5 9.8 34.2 42.0 17.0 24.1 18.8 16.6 0.0 8.5 1.4 5.5 5.8 4.5 4.3 4.6 4.7 13.8 4.4 7.6 3.4 2.4 7.2 6.5 7.8 3.8 5.3 11.4 10.7 13.5 16.8 10.4 10.6 12.5 9.6 8.9 12.2 5.8 9.8 16.3 0.2 0.0 1.1 16.0 2.1 0.0 0.2 0.0 4.6 0.4 0.2 0.0 4.3 0.0 0.6 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.8 0.0 1.3 9.6 0.0 0.7 1.5 11.2 0.1 0.0 0.2 0.0 0.0 0.3 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 8.4 0.3 0.3 0.0 11.1 11.0 0.1 0.0 0.0 2.9 0.1 0.5 0.0 0.0 0.5 0.0 0.4 0.7 0.0 0.1 3.3 0.1 4.4 1.3 0.2 0.1 0.1 L34079.1 ENSG00000268361 "Novel protein" 19 43554692-43593036 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.3 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011530.1 ENSG00000268434 "Novel protein" 19 45779437-45785973 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.0;skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.2" NA NA "unprognostic (3.77e-2)" "unprognostic (2.87e-1)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.2 1.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.2 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 30.2" "Cell type enriched" "Detected in single" 9 "Spermatogonia: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 30.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.5 0.0 0.2 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.4 0.3 0.4 0.7 0.2 0.0 0.2 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008403.1 ENSG00000268465 "Novel protein" 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 5.2;testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;LHCN-M2: 1.4;NB-4: 1.5;U-698: 2.2" HPA060662 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA060662: AB_2732652" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.8 0.1 0.1 1.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 5.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.1 1.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.9 0.5 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 1.5 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.3 0.3 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NFILZ LINC01862 ENSG00000268480 "NFIL3 like basic leucine zipper" A0A5F9ZHS7 19 8630635-8677708 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 20 "NK-cell: 17.5" "Lineage enriched" "Detected in single" 20 "NK-cells: 17.5" "Group enriched" "Detected in some" 81 "HMC-1: 9.4;NB-4: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 17.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018755.2 ENSG00000268500 "Novel transcript, sense intronic to AC018755.18" 19 51612091-51646889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 26.4;lymphoid tissue: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 4.3" "Immune cell enhanced" "Detected in many" "neutrophil: 180.3" "Group enriched" "Detected in many" 5 "granulocytes: 180.3;monocytes: 70.1" "Group enriched" "Detected in some" 10 "HMC-1: 78.0;U-937: 33.2" HPA009085 Approved NA NA "HPA009085: AB_1079965" 1.4 0.4 0.1 7.2 0.3 26.4 0.1 0.3 4.3 0.3 0.7 0.3 0.8 0.1 0.0 1.0 0.2 1.0 0.3 0.1 0.5 0.1 0.2 1.3 2.9 0.7 0.5 0.0 0.0 0.2 0.1 0.0 0.5 1.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.5 0.4 4.0 0.4 0.1 0.6 0.6 0.0 0.1 0.5 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.6 78.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 33.2 0.1 11.2 32.4 1.0 0.1 32.3 0.0 2.0 0.0 0.0 22.8 2.7 0.0 0.0 180.3 0.8 70.1 4.9 0.0 17.3 0.1 0.3 0.3 4.3 0.1 0.5 0.7 0.5 0.0 1.6 0.4 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC003002.2 ENSG00000268533 "Novel protein" 19 57394183-57438457 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 7.4" NA NA "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.03e-1)" "unprognostic (1.44e-1)" "unprognostic (5.96e-3)" "unprognostic (5.13e-3)" "unprognostic (1.87e-1)" "unprognostic (1.97e-1)" "unprognostic (1.33e-1)" "unprognostic (8.02e-3)" "unprognostic (1.01e-2)" "unprognostic (8.52e-4)" "unprognostic (7.89e-2)" "unprognostic (1.05e-1)" "unprognostic (5.17e-1)" "unprognostic (1.58e-3)" 0.5 1.5 3.4 1.3 2.9 4.4 0.9 6.5 3.4 0.0 2.3 0.8 1.5 0.9 1.8 1.2 1.1 1.6 1.6 2.5 2.4 1.7 0.8 0.8 2.1 2.0 2.2 3.3 1.7 3.0 0.4 0.0 0.8 3.4 1.0 1.3 8.7 0.3 0.7 1.1 7.5 2.2 0.1 1.2 1.8 1.6 3.2 1.6 0.3 3.3 1.7 1.0 0.7 0.0 4.6 1.2 0.1 3.7 3.8 1.3 0.0 1.1 0.4 0.4 0.0 1.5 0.3 1.4 1.6 0.7 1.0 2.1 0.8 0.6 0.0 0.6 0.8 2.4 0.7 7.4 0.0 0.0 1.9 4.8 0.4 0.0 0.0 0.0 3.0 0.0 1.9 0.2 1.9 0.0 1.8 1.3 2.0 1.0 0.3 1.2 0.8 0.8 0.9 0.0 4.6 4.0 0.6 0.5 1.0 0.9 2.2 1.4 1.9 0.0 1.5 1.6 1.6 0.8 1.7 1.5 1.1 1.1 2.0 0.9 0.3 1.0 0.4 1.0 0.4 1.2 0.5 0.8 0.6 0.6 1.4 1.2 1.1 1.8 2.2 1.2 1.4 0.4 0.4 3.4 2.9 6.5 3.4 2.5 2.4 2.0 2.2 3.3 3.4 1.2 1.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA2 "CT1.2, MAGE2, MAGEA2A" ENSG00000268606 "MAGE family member A2" P43356 X 152749863-152753884 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 76.1;HMC-1: 45.6;K-562: 65.7;OE19: 123.5;SH-SY5Y: 49.6;SK-BR-3: 48.6;U-266/70: 120.9;U-266/84: 87.8" NA NA "unprognostic (3.67e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 5.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 45.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.7 27.0 0.0 0.0 0.0 0.0 0.0 123.5 3.2 0.1 0.0 0.1 0.0 0.0 19.6 49.6 0.0 48.6 13.5 0.2 0.0 5.5 0.3 0.5 3.7 1.1 0.4 120.9 87.8 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX13A ENSG00000268629 "Testis expressed 13A" Q9BXU3 X 105218929-105220694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 10.7" "Group enriched" "Detected in some" 37 "Early spermatids: 90.8;Late spermatids: 159.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072257 Enhanced NA NA "HPA072257: AB_2732198" "unprognostic (3.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC006486.1 ENSG00000268643 "Novel protein" 19 42234583-42255132 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 10.9" "Cell type enhanced" "Detected in single" "Suprabasal keratinocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 31.6" NA NA "unprognostic (2.11e-1)" 2.5 1.0 0.4 1.2 0.6 0.9 1.0 0.9 1.6 0.0 0.5 3.9 1.8 4.2 0.0 1.6 0.1 0.1 0.0 0.9 2.2 4.3 1.7 1.1 0.9 0.5 0.5 0.3 0.0 0.0 0.6 0.1 0.5 0.7 0.2 0.8 10.9 0.0 0.3 4.2 0.0 2.1 0.0 0.1 1.7 2.2 1.9 0.4 0.4 0.6 1.1 0.9 0.9 0.0 1.5 13.6 17.0 8.7 5.0 0.0 0.5 1.1 18.3 1.2 0.0 3.1 3.6 1.8 3.8 6.6 1.6 12.3 5.2 3.8 0.0 19.9 7.7 2.6 5.8 12.7 4.6 0.7 19.3 4.6 0.0 0.0 3.1 0.0 6.9 1.2 5.7 2.3 6.8 0.0 2.3 1.8 0.0 8.3 18.1 2.9 6.0 8.0 0.0 0.0 31.6 4.4 5.9 16.0 0.3 3.5 20.9 3.1 0.0 0.0 5.1 7.0 2.9 17.1 7.6 24.7 10.6 5.9 5.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.9 1.6 0.9 2.2 0.5 0.5 0.3 0.7 0.1 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 CTAG1A "ESO1, LAGE2A" ENSG00000268651 "Cancer/testis antigen 1A" P78358 X 154585133-154586816 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "testis: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 173 "U-266/70: 749.2;U-266/84: 332.1" CAB013061 Enhanced NA NA "CAB013061: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 749.2 332.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008687.4 ENSG00000268655 "Novel protein" 19 49017496-49020523 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "pancreas: 8.5;testis: 2.7" "Cell type enriched" "Detected in single" 20 "Pancreatic endocrine cells: 4.1" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.06e-1)" "unprognostic (7.61e-3)" "unprognostic (7.17e-3)" "unprognostic (1.12e-2)" "unprognostic (2.93e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-2)" "unprognostic (4.91e-2)" "unprognostic (3.85e-1)" "unprognostic (7.96e-4)" "unprognostic (9.37e-3)" "unprognostic (4.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 8.5 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 1.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.8 0.3 0.7 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.5 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC213203.1 ENSG00000268674 P0DMU3 Unmapped 35407-35916 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "brain: 1.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043267, HPA043292, HPA077864" Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA043267: , HPA043292: , HPA077864: AB_2686862" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.9 0.2 0.1 0.3 0.3 0.1 0.1 0.7 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF723 ZNF723P ENSG00000268696 "Zinc finger protein 723" P0DPD5 19 22832291-22858667 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 3.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 25 "testis cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.37e-2)" "unprognostic (5.02e-2)" "unprognostic (7.20e-2)" 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFX2 ENSG00000268738 "Heat shock transcription factor family, X-linked 2" Q9UBD0 X 149592512-149595314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 12.4" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HEK 293: 1.1;hTCEpi: 1.5;MCF7: 1.4;U-138 MG: 1.5" "HPA051700, HPA063040" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA051700: AB_2681578, HPA063040: AB_2732695" "unprognostic (7.64e-2)" "unprognostic (6.92e-3)" "unprognostic (2.00e-1)" 0.3 0.4 0.5 0.2 1.0 0.0 0.6 0.9 2.2 0.4 0.8 0.5 0.5 0.6 0.2 0.4 1.0 0.0 1.1 0.8 0.2 0.5 0.5 0.6 0.1 0.5 0.4 0.7 1.1 0.4 1.3 0.4 0.4 0.8 0.9 0.5 1.0 1.0 1.4 0.7 1.2 0.3 0.7 0.1 1.1 0.4 12.4 0.6 0.6 0.5 2.1 0.2 0.4 0.5 2.6 0.5 0.0 1.1 0.6 0.0 0.2 0.0 0.2 0.5 0.2 0.6 0.0 0.0 0.1 0.2 0.3 0.0 1.0 0.0 0.3 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.1 0.3 0.5 1.5 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.3 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.9 2.2 0.8 0.2 0.5 0.4 0.7 0.8 0.1 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010522.1 ENSG00000268750 "Novel protein" 19 57819719-57858941 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 26.8" HPA056213 Uncertain NA NA "HPA056213: AB_2683069" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (2.39e-1)" "unprognostic (1.78e-1)" "unprognostic (1.19e-1)" "unprognostic (1.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.49e-1)" "unprognostic (7.73e-2)" "unprognostic (5.06e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-1)" "unprognostic (9.47e-2)" "unprognostic (4.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.84e-1)" 1.5 1.3 1.1 1.4 1.0 3.1 1.8 1.7 1.5 2.2 3.7 2.3 4.3 2.1 0.0 1.5 1.8 1.2 1.5 0.8 0.9 1.3 1.9 1.9 1.5 0.7 0.8 0.4 2.6 3.7 0.7 3.1 1.3 1.2 2.6 1.1 1.0 3.0 0.4 2.2 1.5 2.0 1.1 0.0 2.4 3.0 1.0 0.9 1.3 1.9 0.6 1.0 2.0 2.0 2.5 4.4 5.4 1.4 4.5 0.4 1.9 3.6 5.4 0.1 1.3 1.3 9.7 1.3 6.2 2.9 1.7 2.0 3.3 2.4 2.1 1.3 6.3 26.8 7.5 16.0 7.4 1.8 4.1 4.0 3.6 1.3 2.9 1.9 1.4 1.0 5.6 8.3 6.6 0.1 5.7 3.5 2.0 0.9 0.8 13.7 5.5 3.1 7.8 1.0 16.9 5.0 3.4 1.1 5.0 2.2 1.1 4.3 3.2 2.5 5.5 3.0 2.4 5.2 11.5 12.2 8.4 3.3 4.4 4.0 0.0 0.7 0.0 1.8 0.9 2.3 2.8 2.0 1.7 1.2 2.2 2.5 2.2 0.0 1.2 1.1 5.1 0.5 0.9 1.1 1.0 1.7 1.5 0.8 0.9 0.7 0.8 0.4 1.2 0.0 0.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008764.4 ENSG00000268790 "Novel protein" 19 16577642-16660115 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "T-47d: 3.3;THP-1: 3.2" NA NA "unprognostic (3.52e-1)" "unprognostic (2.20e-1)" "unprognostic (2.65e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-1)" "unprognostic (6.04e-2)" "unprognostic (2.33e-1)" "unprognostic (3.03e-1)" "unprognostic (7.19e-2)" "unprognostic (1.64e-2)" "unprognostic (1.47e-1)" "unprognostic (5.83e-2)" "unprognostic (7.27e-3)" "unprognostic (5.09e-3)" "unprognostic (4.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" 0.2 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.4 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.4 0.2 0.1 0.1 0.3 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.3 1.9 0.5 0.3 0.2 0.2 0.6 0.4 0.4 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.3 1.6 1.2 0.0 0.2 0.8 0.9 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 1.2 2.5 0.0 0.0 0.0 1.4 0.0 0.9 0.2 0.0 1.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.7 0.9 1.2 0.0 0.0 0.6 1.7 0.0 1.7 0.2 0.1 3.3 3.2 0.0 0.0 0.5 2.2 1.9 1.4 0.0 1.7 0.4 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.4 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3Y2 "H3.X, H3.Y.2" ENSG00000268799 "H3.Y histone 2" P0DPK5 5 17490967-17492076 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008758.5 ENSG00000268870 "Novel zinc finger protein" 19 12391949-12441082 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 4.4;RT4: 4.9" "HPA003150, HPA018683" Uncertain Uncertain "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: AB_2669920" 0.6 0.1 0.3 0.6 0.2 0.2 0.8 0.6 0.6 0.4 0.4 0.9 0.5 0.6 0.2 0.0 0.3 0.1 0.0 0.2 0.2 0.6 0.7 0.4 0.6 0.4 0.3 0.0 0.6 0.2 0.6 0.0 0.8 0.6 0.5 0.8 0.5 0.4 0.4 0.7 0.2 0.3 0.2 0.5 0.6 0.7 0.6 0.4 0.9 0.5 0.0 0.5 0.2 0.1 0.5 1.6 0.0 1.1 1.8 0.1 0.2 2.9 1.2 0.2 0.1 0.5 1.7 0.0 1.4 2.6 0.7 0.6 0.5 0.0 0.4 0.5 0.0 0.9 2.3 0.0 3.2 0.0 2.1 3.1 0.0 0.8 1.1 0.0 0.0 1.0 1.7 1.5 0.0 0.2 0.3 3.3 0.5 1.1 1.9 0.3 0.5 4.4 0.0 0.3 4.9 0.2 0.9 1.1 0.6 0.0 1.6 2.1 2.5 0.3 1.2 0.7 2.5 0.5 0.2 1.5 1.6 0.5 0.9 1.2 0.3 0.5 0.4 0.8 0.1 1.4 1.5 1.6 1.3 0.9 0.9 1.4 0.3 0.2 0.7 0.1 0.2 1.1 0.6 0.3 0.2 0.6 0.6 0.2 0.2 0.4 0.3 0.0 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSAG2 "CSAG3B, CT24.2, TRAG3" ENSG00000268902 "CSAG family member 2" X 152708261-152714549 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 15.3;SK-BR-3: 6.3;U-266/70: 5.1;U-266/84: 7.1" NA NA "unprognostic (5.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.44e-1)" "unprognostic (2.48e-1)" "unprognostic (2.81e-2)" "unprognostic (3.35e-2)" "unprognostic (1.55e-1)" "unprognostic (1.50e-2)" 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 0.0 0.3 2.0 1.9 0.0 0.0 2.3 0.0 0.0 1.2 2.7 0.0 6.3 2.9 0.0 0.0 0.3 0.1 0.1 2.2 0.5 0.1 5.1 7.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSAG3 CSAG3A ENSG00000268916 "CSAG family member 3" Q9Y5P2 X 152753921-152760222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.3;testis: 4.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 44.2;HMC-1: 25.7;OE19: 65.6;SH-SY5Y: 33.7;SK-BR-3: 31.5;U-266/70: 80.5;U-266/84: 44.0" NA NA "unprognostic (1.56e-1)" "unprognostic (9.48e-2)" "unprognostic (1.41e-1)" "unprognostic (7.12e-3)" "unprognostic (4.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.02e-2)" "unprognostic (7.06e-2)" "unprognostic (7.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-2)" 0.2 0.0 0.6 0.1 0.7 0.1 0.0 0.5 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.1 0.1 1.6 0.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.5 2.3 0.0 4.0 0.6 0.1 0.0 0.0 0.2 0.1 0.3 0.9 0.4 0.0 0.0 4.5 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 44.2 0.0 0.0 0.0 0.0 25.5 0.0 0.2 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 21.1 0.0 0.0 0.1 0.0 0.0 65.6 0.3 0.0 0.0 2.9 0.0 0.0 7.0 33.7 0.0 31.5 1.4 0.1 0.0 1.4 0.1 0.1 24.0 0.0 0.0 80.5 44.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.9 0.5 0.5 0.6 0.6 0.5 0.6 0.5 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 7.9" "Group enriched" "Detected in some" 50 "Spermatocytes: 3.5;Spermatogonia: 6.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 246.0;Karpas-707: 112.8" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 246.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 112.8 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 21.5 0.0 0.3 1.7 33.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.6 0.2 0.3 0.2 0.3 0.1 0.3 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044740-53051680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "placenta: 8.5" "Cell type enriched" "Detected in single" 4 "Syncytiotrophoblasts: 3.8" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.9;SuSa: 10.9;T-47d: 4.6;U-266/84: 2.8" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 8.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 10.9 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 SPANXN2 "CT11.7, SPANX-N2" ENSG00000268988 "SPANX family member N2" Q5MJ10 X 143711955-143721423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 3.5" "Group enriched" "Detected in some" 154 "Early spermatids: 58.7;Late spermatids: 126.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236B ENSG00000268994 "Family with sequence similarity 236 member B" A0A1B0GV22 X 72781865-72782660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 34 "testis: 99.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.4" NA NA 0.0 0.0 0.5 0.4 0.5 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.2 1.1 0.0 0.0 0.0 0.0 1.8 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 99.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 2.9 1.9 1.0 0.7 0.3 0.0 0.2 1.8 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC003006.1 ENSG00000269026 "Novel protein" 19 57682045-57753575 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 1.2;RT4: 1.0;U-266/84: 2.1" HPA068553 Approved Nucleoplasm NA NA Nucleoplasm "HPA068553: AB_2686002" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (3.50e-1)" "unprognostic (1.43e-2)" "unprognostic (3.61e-1)" "unprognostic (4.82e-2)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.3 0.4 0.1 0.3 0.1 0.3 0.2 0.1 0.4 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTRNR2L12 ENSG00000269028 "MT-RNR2 like 12" P0DMP1 3 96617188-96618236 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 101422.8;choroid plexus: 51606.2" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 34487.4" "Cancer enhanced" "Detected in all" "stomach cancer: 14.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 23357.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 23357.3" "Cell line enhanced" "Detected in all" "HeLa: 19226.4" "Secreted to blood" NA NA "unprognostic (3.79e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (9.76e-3)" "unprognostic (1.69e-3)" "unprognostic (1.81e-2)" "unprognostic (7.77e-2)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.90e-2)" "unprognostic (9.59e-3)" "unprognostic (1.81e-2)" "unprognostic (2.61e-1)" "unprognostic (2.08e-1)" "unprognostic (1.85e-2)" 7120.5 9579.0 51610.0 1624.6 51611.2 2421.9 2927.0 51618.4 101422.8 1327.3 51606.2 7196.9 3229.9 1509.9 1904.2 3978.8 1605.5 2160.6 24920.5 53545.8 51603.5 11585.0 11053.5 1417.5 1120.3 54530.7 51614.8 51605.7 1484.0 3730.2 5549.5 0.9 1878.1 52543.9 2615.5 5726.5 5562.2 4112.2 3351.7 37038.2 4056.6 3660.9 2302.8 51767.6 2007.2 5188.3 3883.1 51612.3 1103.2 1317.5 22800.5 2003.2 1757.2 0.7 51668.4 3129.7 3743.3 2766.3 9914.1 4165.4 2220.4 2507.6 3970.8 808.2 749.3 954.5 2070.2 4888.5 6887.0 3132.2 1502.3 436.5 8365.9 196.7 1668.9 1010.6 2008.1 3570.2 7299.3 19226.4 8838.4 1579.3 1469.9 3824.2 4061.3 1945.5 784.9 2127.7 4578.8 844.6 3040.7 5258.3 2276.0 2553.9 1634.8 1252.5 4510.6 808.3 1892.5 1113.4 1992.1 2667.8 2102.8 4420.6 2269.6 1246.8 2408.9 2618.4 2595.6 3524.2 2439.6 2667.3 4152.9 3817.7 3062.1 2505.1 3462.1 1143.3 1197.9 802.7 3365.5 1896.5 8908.3 850.3 10533.0 3473.8 6467.2 1043.1 1696.3 1353.8 2636.4 1309.8 1129.5 1256.2 2611.9 1648.9 1580.6 23357.3 1490.6 1781.5 2078.4 1275.7 2740.2 51610.0 51611.2 51618.4 101422.8 53545.8 51603.5 54530.7 51614.8 51605.7 52543.9 51767.6 51612.3 51668.4 1081.2 2705.1 2934.5 0.0 291.8 112.5 420.7 10.3 3.4 0.0 702.7 1431.3 34487.4 147.3 1441.4 84.6 0.0 8.4 394.0 24.5 62.6 1.1 19.7 1096.7 707.4 1236.7 4.9 182.7 0.0 1.8 8.6 1698.5 29.6 1465.4 1715.6 334.8 100.3 171.7 12.3 0.0 0.0 7.1 4.1 126.9 333.5 49.0 42.9 633.1 193.9 0.0 29.8 0.0 28.8 0.0 0.0 1.4 8.4 23.0 213.1 337.3 6.6 521.0 1431.8 0.0 46.0 2907.6 1520.5 36.3 39.6 3.3 80.7 10.5 625.8 220.9 5.2 397.1 AC010319.2 ENSG00000269035 "Novel protein" 19 17436611-17460804 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041580 Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALR3 "CRT2, CT93, FLJ25355, MGC26577" ENSG00000269058 "Calreticulin 3" Q96L12 19 16479061-16496167 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" Chaperone "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "testis: 65.4" "Group enriched" "Detected in some" 7 "Early spermatids: 51.0;Late spermatids: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025749, HPA043355, HPA048460" Enhanced "Intracellular and membrane" NA NA "CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403" "unprognostic (1.19e-1)" "unprognostic (3.84e-1)" "unprognostic (7.17e-2)" "unprognostic (4.34e-1)" "unprognostic (2.32e-1)" "unprognostic (2.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (1.18e-2)" "unprognostic (6.69e-7)" "unprognostic (1.60e-1)" "unprognostic (2.78e-1)" "unprognostic (6.28e-3)" "unprognostic (6.34e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 65.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF728 ENSG00000269067 "Zinc finger protein 728" P0DKX0 19 22974883-23003176 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 10.5" "Cell type enhanced" "Detected in some" "Astrocytes: 3.3;Distal tubular cells: 3.9;Early spermatids: 2.7;Horizontal cells: 8.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.6;Spermatocytes: 4.4" "Cancer enriched" "Detected in single" 8 "testis cancer: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 1.7;SuSa: 1.8;U-266/84: 2.9" NA NA "unprognostic (4.12e-2)" "unprognostic (4.25e-2)" "unprognostic (5.00e-2)" "unprognostic (1.78e-2)" "unprognostic (3.56e-1)" "unprognostic (4.03e-1)" "unprognostic (1.13e-2)" "unprognostic (5.45e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-2)" 1.0 0.1 1.4 0.3 2.3 0.0 0.9 1.0 1.4 0.7 0.3 0.3 0.2 1.1 0.7 0.5 1.4 0.4 1.4 1.4 2.3 0.7 0.1 0.2 0.0 1.8 2.4 0.5 2.7 0.1 1.7 0.3 0.2 1.8 0.9 0.2 0.8 0.3 1.0 0.0 0.1 0.1 1.0 0.9 0.5 0.1 10.5 2.3 0.0 2.1 1.0 0.0 0.3 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 2.3 1.0 1.4 1.4 2.3 1.8 2.4 0.5 1.8 0.9 2.3 2.2 1.3 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.8 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 2.7 0.0 0.6 0.4 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.4 0.0 2.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.5 4.4 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 AC010646.1 ENSG00000269095 "Novel protein" 19 17235940-17255448 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 6.0;EFO-21: 1.7" NA NA 0.0 0.1 0.4 0.0 0.3 0.1 0.1 0.6 0.6 0.0 0.4 0.5 0.9 0.2 1.2 0.2 0.3 0.1 0.3 0.3 0.2 0.1 0.6 0.6 0.2 0.4 0.4 0.2 0.1 0.6 0.3 0.0 0.5 0.3 0.1 0.5 0.2 0.1 0.2 0.2 1.1 0.4 0.4 0.3 0.1 0.8 0.2 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.2 0.3 0.6 0.5 0.3 0.0 6.0 0.2 0.3 0.1 0.0 0.3 0.8 0.1 1.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.6 0.0 0.1 0.3 0.2 0.3 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.4 0.1 0.8 0.2 0.8 0.0 0.1 0.6 0.5 0.8 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.6 0.6 0.3 0.2 0.4 0.4 0.2 0.3 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 9.5" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 94.7;T-47d: 63.5;U-266/84: 308.8" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 1.0 0.0 0.9 0.0 0.0 0.8 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.6 0.0 1.2 1.0 0.7 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 94.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.4 0.0 0.0 2.3 0.0 0.0 0.4 308.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.8 1.1 0.9 0.9 1.2 1.0 0.7 1.1 0.8 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRABD2B TIKI2 ENSG00000269113 "TraB domain containing 2B" A6NFA1 1 47760528-47997385 "Predicted intracellular proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 16.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 7.5;Cholangiocytes: 15.7;Fibroblasts: 6.6;Hepatocytes: 11.3;Microglial cells: 7.5;Proximal tubular cells: 22.8" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 6.7;U-2197: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA045817 Approved "Intracellular and membrane" NA NA 41000 "HPA045817: AB_2679460" "unprognostic (2.38e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-2)" "unprognostic (2.26e-2)" "unprognostic (5.65e-2)" "unprognostic (4.49e-2)" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (2.74e-1)" "unprognostic (3.29e-3)" "unprognostic (1.84e-1)" "unprognostic (2.95e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-2)" "unprognostic (4.77e-1)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" 2.3 0.9 0.1 0.6 0.1 0.0 2.7 1.0 0.3 2.6 0.8 2.4 0.4 1.5 0.8 1.3 1.9 1.6 4.1 0.1 0.4 16.4 4.2 1.7 0.0 0.2 0.2 0.0 0.8 2.7 0.0 1.5 0.4 0.4 3.7 0.7 0.0 1.6 3.3 0.6 1.5 1.6 0.9 0.2 1.2 1.6 0.9 0.1 0.4 1.0 0.6 0.1 3.9 2.6 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.0 6.7 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.4 13.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.1 0.4 0.2 0.2 0.0 0.4 0.2 0.1 0.2 1.6 0.0 0.5 0.3 0.3 0.8 1.4 0.6 2.8 0.0 0.6 2.9 7.5 15.7 0.1 1.8 0.0 0.0 0.0 0.0 5.9 3.8 0.1 0.1 0.5 1.9 0.0 0.0 0.3 2.2 0.0 6.6 0.0 0.1 0.0 0.0 1.4 11.3 0.1 0.0 0.3 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.0 7.5 0.0 0.0 0.0 0.5 0.7 1.3 0.0 2.2 0.1 0.4 0.0 22.8 0.0 0.0 0.0 0.3 4.1 0.0 4.0 0.1 0.3 0.0 0.2 0.1 0.0 0.2 FBXO17 "FBG4, Fbx17, FBXO26, FLJ11798, FLJ25205, MGC9379" ENSG00000269190 "F-box protein 17" Q96EF6 19 38941401-38975742 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 56.7;Hepatocytes: 58.5;Leydig cells: 83.0;Peritubular cells: 74.1;Proximal tubular cells: 70.3" "Cancer enhanced" "Detected in many" "renal cancer: 18.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.68e-1)" "unprognostic (2.62e-2)" "unprognostic (6.97e-3)" "prognostic unfavorable (5.67e-4)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.10e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (4.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.71e-3)" "unprognostic (1.91e-2)" "unprognostic (1.83e-3)" "prognostic unfavorable (5.91e-4)" "unprognostic (5.34e-2)" "unprognostic (4.06e-4)" "unprognostic (2.77e-3)" 21.3 5.2 5.7 1.8 5.1 0.4 17.7 7.5 5.5 28.2 4.6 14.4 2.2 25.3 6.0 7.4 20.9 4.8 9.0 4.9 4.6 42.5 68.4 10.3 1.5 4.3 4.6 5.3 33.8 11.8 4.9 9.2 2.9 5.2 18.7 1.6 3.8 7.1 7.7 3.1 13.6 7.0 9.3 3.9 4.4 10.3 4.4 4.9 0.8 5.6 1.9 1.2 18.2 19.0 4.3 19.7 37.3 0.1 23.4 16.7 11.7 0.5 7.7 7.8 9.8 11.8 17.0 0.3 0.4 6.3 12.6 19.2 5.3 4.2 5.5 8.9 0.1 14.9 0.1 2.8 19.5 10.9 0.2 0.6 10.2 4.6 16.5 7.7 18.9 13.1 0.1 21.5 0.1 10.1 9.8 0.1 0.3 7.9 0.0 0.1 0.0 0.1 0.1 11.8 0.1 0.2 15.3 10.9 0.0 9.1 5.4 9.5 0.3 3.9 24.4 17.8 10.1 10.5 0.3 1.1 0.1 21.7 0.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 5.7 5.1 7.5 5.5 4.9 4.6 4.3 4.6 5.3 5.2 3.9 4.9 4.3 5.3 0.0 1.1 15.0 0.2 18.7 11.3 9.9 33.0 4.1 3.0 14.4 3.1 17.2 5.4 14.7 35.5 6.9 0.2 0.1 56.7 6.7 4.1 0.6 29.6 8.1 0.0 0.0 14.5 2.0 5.4 34.1 0.0 0.5 0.0 20.1 14.6 58.5 38.8 5.0 19.2 0.0 8.2 0.8 8.5 3.4 83.0 1.9 19.6 13.1 0.0 10.2 0.0 16.1 2.0 2.0 0.0 74.1 1.2 15.8 0.0 70.3 2.0 13.0 52.6 20.6 19.8 0.7 4.4 10.0 17.5 5.1 0.9 16.1 0.0 4.1 TMSB15B ENSG00000269226 "Thymosin beta 15B" X 104063871-104076212 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 8.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 13.3;Basal respiratory cells: 12.8;Ionocytes: 20.3;Langerhans cells: 9.3;Melanocytes: 14.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 10.9;AN3-CA: 10.2;Karpas-707: 11.0" NA NA "unprognostic (5.95e-2)" "unprognostic (1.22e-1)" "unprognostic (6.14e-2)" "unprognostic (1.17e-3)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (3.12e-1)" "unprognostic (6.46e-2)" "unprognostic (9.11e-3)" "unprognostic (2.61e-2)" "unprognostic (4.07e-4)" "unprognostic (1.93e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (9.07e-2)" 1.4 0.5 1.4 1.6 1.5 1.2 1.6 4.2 1.8 4.7 0.7 1.7 0.5 4.4 1.2 1.0 3.0 1.6 0.8 1.3 2.0 0.5 0.1 1.0 1.8 1.2 1.9 1.5 8.7 0.5 1.2 1.0 0.5 2.5 2.1 1.0 2.1 0.8 1.4 0.3 1.1 1.6 2.1 0.9 1.2 1.2 0.7 2.0 3.0 0.7 0.2 1.7 2.1 3.0 1.6 0.0 0.4 10.9 10.2 1.8 2.7 0.3 3.1 1.6 1.7 2.3 0.5 0.2 2.3 1.1 0.8 2.0 0.1 0.1 0.0 2.1 1.2 2.1 0.6 0.2 0.0 1.0 0.3 1.0 1.8 0.5 1.8 0.5 6.1 3.2 2.7 0.2 11.0 2.7 0.6 7.1 0.1 2.9 0.0 1.7 6.4 2.6 1.5 2.3 1.7 1.8 7.4 0.2 0.0 0.4 3.2 0.1 1.0 6.2 3.4 1.8 1.7 2.7 0.8 0.0 2.1 1.4 0.5 1.6 0.8 0.1 0.1 0.2 0.1 0.1 0.7 0.2 0.2 0.1 0.4 0.6 0.5 0.3 0.9 0.1 0.3 0.1 0.2 1.4 1.5 4.2 1.8 1.3 2.0 1.2 1.9 1.5 2.5 0.9 2.0 1.6 1.6 0.0 0.0 1.0 2.7 13.3 1.4 12.8 3.4 0.6 1.0 0.9 0.3 0.0 4.2 1.8 0.0 0.1 1.3 0.4 0.0 0.4 0.1 2.9 3.0 1.4 3.0 1.7 2.8 1.2 0.0 5.4 4.1 0.7 1.3 4.6 0.4 0.1 0.2 1.7 2.7 0.2 20.3 0.3 9.3 0.0 2.8 0.2 14.2 0.0 0.6 1.7 2.1 1.5 0.8 0.9 0.1 3.4 2.5 0.7 0.0 0.1 0.5 0.6 0.0 0.5 4.4 0.6 0.6 1.7 6.1 0.1 2.7 2.6 0.6 0.3 MAGIX "FLJ21687, JM10, PDZX" ENSG00000269313 "MAGI family member, X-linked" Q9H6Y5 X 49162564-49168483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007390, HPA035302" Uncertain Approved "Nucleoplasm,Mitotic chromosome" Yes NA Nucleoplasm "Mitotic chromosome" "HPA007390: , HPA035302: AB_10603015" "unprognostic (1.11e-1)" "unprognostic (1.34e-2)" "unprognostic (6.24e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-3)" "unprognostic (2.64e-6)" "unprognostic (6.75e-2)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-1)" "unprognostic (2.33e-2)" "prognostic favorable (6.91e-9)" "unprognostic (4.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.73e-1)" "prognostic favorable (2.10e-4)" 1.0 2.1 3.5 0.7 3.3 1.4 1.9 8.9 4.4 2.1 6.3 2.4 1.7 1.8 1.2 4.4 4.0 1.3 6.6 3.6 3.4 9.7 19.3 2.9 0.4 3.6 3.6 3.2 1.1 14.0 3.8 6.0 0.5 5.5 5.2 1.0 1.1 10.1 2.8 2.1 2.6 1.6 0.3 3.3 1.2 12.5 0.7 3.7 0.6 7.1 0.5 0.3 2.8 2.2 3.7 0.3 1.9 0.4 0.5 0.5 0.1 1.4 0.3 0.3 0.3 0.3 1.1 5.5 0.5 0.5 0.6 0.7 1.2 0.3 1.3 0.0 1.6 1.8 2.4 3.4 0.6 0.2 0.6 4.7 0.5 0.2 0.4 0.1 0.6 0.4 0.8 0.3 2.0 0.4 0.7 0.5 1.7 0.5 1.5 1.0 0.3 0.1 1.0 1.0 12.8 2.4 0.5 1.1 5.7 0.6 0.3 4.5 0.5 0.2 0.6 1.4 0.5 0.4 1.3 0.7 0.4 2.3 0.8 1.8 3.1 1.1 2.0 0.1 1.0 0.4 0.6 0.5 0.0 0.7 0.5 0.3 0.5 4.2 0.7 1.1 1.4 0.1 0.6 3.5 3.3 8.9 4.4 3.6 3.4 3.6 3.6 3.2 5.5 3.3 3.7 3.7 1.6 3.2 5.4 1.0 2.8 3.2 10.3 5.6 4.6 8.0 18.7 10.4 8.5 11.5 7.0 12.9 2.1 2.1 3.9 33.7 46.9 13.1 0.2 24.7 2.5 2.0 17.5 0.4 1.2 20.8 4.1 2.4 28.5 16.0 0.0 0.8 4.2 35.0 5.1 8.4 1.1 23.4 2.0 3.2 5.7 0.0 0.6 5.7 1.8 0.0 4.8 8.3 0.0 1.0 1.3 8.9 30.7 0.4 5.2 5.8 15.2 44.3 20.4 9.7 0.0 6.9 3.8 3.0 2.7 8.0 4.4 3.8 3.9 1.7 15.3 9.9 IKBKG "FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9" ENSG00000269335 "Inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" Q9Y6K9 X 154541199-154565046 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Disease variant, Ectodermal dysplasia, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000426, CAB010373" Uncertain Enhanced Cytosol NA NA Cytosol "CAB010373: AB_2124846, HPA000426: AB_1851572" "unprognostic (7.53e-2)" "unprognostic (2.76e-3)" "unprognostic (1.09e-1)" "unprognostic (3.37e-3)" "unprognostic (9.77e-2)" "unprognostic (3.68e-1)" "unprognostic (9.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (9.87e-2)" "unprognostic (3.57e-2)" "unprognostic (4.41e-2)" "unprognostic (2.78e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-2)" 23.2 32.4 16.4 27.9 17.6 42.8 21.8 16.2 24.0 17.9 15.0 21.5 21.4 24.5 6.2 25.7 19.6 16.1 20.4 16.3 16.4 20.8 63.0 29.9 29.2 21.0 17.9 15.4 18.5 18.9 10.8 20.4 12.0 20.6 20.1 10.8 6.3 20.0 13.4 20.2 28.6 26.8 14.3 16.6 42.2 22.7 19.0 17.7 19.9 23.1 9.9 18.8 25.0 21.3 22.0 45.8 46.6 11.2 37.1 22.2 18.2 29.7 28.2 35.1 29.4 43.9 32.2 26.5 35.6 73.5 32.6 79.6 39.8 15.0 27.3 12.0 39.6 25.2 27.5 65.4 54.9 37.4 29.3 92.7 23.4 25.6 39.9 15.8 19.4 33.2 34.6 16.6 34.3 23.5 43.1 29.7 52.9 10.4 32.5 69.2 35.4 16.7 38.4 27.6 27.4 19.5 19.9 32.7 32.9 23.0 8.7 19.4 33.4 36.4 29.8 33.9 70.6 69.9 67.5 49.0 69.2 41.4 50.6 41.3 24.9 34.2 61.3 35.3 42.2 24.1 21.3 21.4 26.5 29.8 20.9 17.1 21.3 50.4 30.7 51.1 25.4 26.8 31.0 16.4 17.6 16.2 24.0 16.3 16.4 21.0 17.9 15.4 20.6 16.6 17.7 22.0 16.0 3.2 14.3 8.5 22.3 12.4 12.1 20.6 6.2 6.1 8.0 9.8 6.9 10.0 13.6 12.9 10.4 23.3 27.3 14.0 1.9 18.7 0.9 8.0 10.8 15.3 4.9 9.9 5.5 16.9 16.8 12.6 12.8 9.5 29.2 12.0 10.8 36.4 28.3 25.2 4.8 7.7 14.2 17.2 15.9 2.0 14.3 29.4 12.4 4.7 44.5 11.1 48.4 3.0 11.4 23.4 12.8 13.9 13.7 12.5 10.9 7.6 8.3 10.2 6.6 9.6 13.7 4.6 12.8 10.6 10.5 38.0 24.6 10.2 8.5 14.2 ZNF587B ENSG00000269343 "Zinc finger protein 587B" E7ETH6 19 57819721-57846238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 36.2" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "unprognostic (4.13e-3)" "unprognostic (1.43e-1)" "unprognostic (1.36e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (5.69e-2)" "unprognostic (3.22e-3)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (5.47e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.16e-1)" "unprognostic (3.57e-2)" "unprognostic (2.94e-1)" "unprognostic (7.48e-2)" "unprognostic (8.70e-2)" 3.3 3.1 1.5 3.4 1.7 9.5 5.4 3.7 1.4 2.4 3.0 3.6 5.8 3.3 2.5 3.8 3.2 2.6 2.8 1.5 0.8 3.7 6.7 3.8 4.9 0.9 0.9 0.8 3.3 5.7 3.0 3.0 3.1 1.9 4.1 4.4 2.0 6.0 2.3 10.0 6.5 5.6 2.3 0.3 6.4 4.8 5.3 1.1 2.8 4.1 2.0 5.1 3.8 3.0 1.2 5.6 16.3 6.0 13.0 1.5 1.7 7.0 4.5 3.5 4.4 3.0 9.6 8.9 11.9 2.4 6.1 2.4 4.7 5.9 14.1 10.5 2.0 13.8 8.8 15.3 10.1 5.2 15.4 8.3 5.0 2.7 6.8 7.1 1.2 3.7 8.5 10.3 5.5 2.8 6.2 7.2 2.6 15.7 5.2 7.2 5.9 6.5 5.6 5.3 36.2 3.7 6.2 5.0 6.6 4.3 9.4 9.1 5.5 5.1 6.0 6.9 1.4 6.6 7.7 6.6 9.1 4.9 4.5 6.7 2.0 1.8 0.8 1.1 1.6 1.2 1.2 1.2 1.3 1.1 1.2 1.6 1.5 3.0 1.1 0.9 1.2 1.0 1.8 1.5 1.7 3.7 1.4 1.5 0.8 0.9 0.9 0.8 1.9 0.3 1.1 1.2 1.7 6.4 1.5 6.5 3.4 3.2 3.4 2.4 1.2 4.2 2.2 0.6 2.7 4.3 5.4 0.0 0.0 3.5 3.9 1.3 1.9 3.9 4.6 3.1 2.2 2.8 4.2 1.3 11.6 2.0 3.3 2.8 3.1 3.3 0.0 5.8 5.7 3.4 1.4 3.3 12.2 3.7 4.1 2.2 1.0 0.9 0.6 1.9 1.8 4.7 1.8 0.8 2.1 11.1 4.6 2.1 1.4 0.7 2.2 2.9 1.4 3.3 3.2 3.6 6.6 2.3 2.5 4.2 5.8 1.3 3.8 2.5 2.2 4.4 2.4 3.1 SPIB SPI-B ENSG00000269404 "Spi-B transcription factor" Q01892 19 50418938-50431314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 28.1;lymphoid tissue: 100.2" "Cell type enriched" "Detected in many" 4 "Paneth cells: 787.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 54 "memory B-cell: 307.8;naive B-cell: 260.6;plasmacytoid DC: 572.6" "Group enriched" "Detected in many" 106 "B-cells: 307.8;dendritic cells: 572.6" "Cell line enhanced" "Detected in some" "Daudi: 166.3;HDLM-2: 107.3;Karpas-707: 52.8;U-698: 238.2" HPA018523 Uncertain NA NA "HPA018523: AB_1857443" "prognostic favorable (4.76e-5)" "unprognostic (1.06e-5)" "unprognostic (9.15e-3)" "unprognostic (3.70e-2)" "unprognostic (9.72e-3)" "prognostic favorable (2.14e-5)" "unprognostic (2.33e-1)" "unprognostic (4.79e-3)" "unprognostic (1.18e-2)" "unprognostic (7.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (3.96e-8)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" 1.2 0.1 0.4 42.1 0.4 6.1 0.2 1.1 0.6 0.1 0.5 22.4 13.2 0.4 0.2 0.7 0.8 1.7 0.2 0.4 0.7 0.6 0.5 1.1 87.7 1.4 0.4 0.5 0.1 1.5 0.0 0.1 0.2 0.5 1.2 18.4 0.3 2.8 0.2 1.3 0.5 28.1 0.8 0.1 29.5 8.3 0.4 0.4 7.6 0.8 0.2 100.2 4.2 0.3 1.3 0.4 1.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.2 3.1 0.2 166.3 0.2 0.1 0.0 0.2 1.4 0.0 0.0 107.3 0.3 0.7 0.3 0.1 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.8 4.6 52.8 0.1 0.5 0.1 0.6 1.5 0.1 0.0 11.6 0.9 2.0 0.0 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.3 5.4 0.8 0.1 3.0 0.1 0.3 5.0 3.5 238.2 0.1 2.6 0.2 4.1 0.5 0.8 0.5 0.2 0.4 307.8 0.3 0.3 6.9 260.6 0.4 0.3 2.6 3.9 0.3 572.6 0.6 14.8 0.4 0.4 1.1 0.6 0.4 0.7 1.4 0.4 0.5 0.5 0.1 0.4 1.3 0.5 0.0 1.8 0.3 162.7 1.8 2.1 0.0 0.0 0.7 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.3 192.8 28.3 0.0 0.7 0.0 1.1 0.3 0.8 19.8 0.4 0.3 1.1 0.2 1.1 2.6 0.5 4.5 0.2 0.0 0.5 1.4 0.0 0.3 18.4 0.0 0.6 38.0 0.0 0.0 13.0 7.2 0.0 1.6 0.6 1.0 0.0 0.2 0.0 787.8 0.4 2.0 1.4 5.0 0.3 0.7 1.0 0.0 1.3 0.8 0.2 1.1 0.0 1.3 0.3 2.7 0.1 37.6 1.3 NXF2 "CT39, TAPL-2" ENSG00000269405 "Nuclear RNA export factor 2" Q9GZY0 X 102247167-102326722 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 15.4;testis: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "U-266/84: 35.6" HPA002079 Uncertain NA NA "HPA002079: AB_1079515" 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 15.4 0.0 0.9 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.5 0.3 0.2 0.1 0.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW3 ENSG00000269433 "Opsin 1, medium wave sensitive 3" P0DN78 X 154257538-154271805 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 11 "Cone photoreceptor cells: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXF2B bA353J17.1 ENSG00000269437 "Nuclear RNA export factor 2B" Q9GZY0 X 102360396-102439932 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 15.4;testis: 7.2" "Cell type enhanced" "Detected in some" "Late spermatids: 1.8;Respiratory ciliated cells: 1.2;Spermatocytes: 2.1;Spermatogonia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "U-266/84: 35.6" HPA002079 Uncertain NA NA "HPA002079: AB_1079515" 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 15.4 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 2.5 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3Y1 "H3.Y, H3.Y.1" ENSG00000269466 "H3.Y histone 1" P0DPK2 5 17654868-17655849 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2 OS: 1.7" HPA042570 Uncertain NA NA "HPA042570: AB_2678056" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTC1 ENSG00000269502 "DMRT like family C1" Q5HYR2 X 72872025-72943814 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.2;pituitary gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (1.83e-1)" 0.0 0.5 0.6 0.1 0.8 0.0 0.0 0.0 2.2 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.7 0.2 0.0 0.8 1.1 0.1 0.0 0.1 0.3 0.3 0.3 0.6 0.5 0.2 0.2 1.8 0.0 0.2 0.1 0.2 0.8 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.6 0.5 0.2 0.8 0.0 0.3 0.1 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 2.2 0.8 1.1 0.3 0.3 0.6 0.2 0.0 0.5 2.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "placenta: 16.2" "Cell type enriched" "Detected in some" 28 "Syncytiotrophoblasts: 260.9" "Cancer enhanced" "Detected in some" "renal cancer: 0.6;urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 7.9;SuSa: 6.2" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 260.9 0.0 0.0 0.0 0.0 AC003002.3 ENSG00000269533 "Novel transcript" 19 57389884-57419994 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;PC-3: 1.6" NA NA "unprognostic (1.40e-1)" "unprognostic (2.50e-2)" "unprognostic (1.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.91e-2)" "unprognostic (4.56e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "unprognostic (4.42e-3)" "unprognostic (1.71e-1)" "unprognostic (2.92e-1)" "unprognostic (2.52e-2)" "unprognostic (3.09e-1)" "unprognostic (3.88e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.6 0.2 0.5 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.4 0.0 0.0 0.1 0.6 0.4 0.4 0.7 1.0 0.6 0.3 1.0 0.8 1.8 0.5 0.6 0.1 0.5 0.8 0.7 0.7 0.5 0.3 0.4 0.1 0.8 0.4 0.4 0.5 0.3 0.1 0.3 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 AC011455.2 ENSG00000269547 "Novel protein" 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.0" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM185A "CXorf13, FAM11A, FRAXF" ENSG00000269556 "Transmembrane protein 185A" Q8NFB2 X 149596556-149631912 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA048295: AB_2680345, HPA071744: AB_2686441" "unprognostic (9.76e-2)" "unprognostic (2.83e-2)" "unprognostic (7.73e-2)" "unprognostic (2.71e-3)" "unprognostic (4.08e-1)" "unprognostic (1.97e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.78e-2)" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" 13.5 13.9 6.3 8.1 7.3 6.8 13.2 7.6 9.0 13.7 17.4 11.8 7.2 15.1 17.5 15.6 14.5 11.4 30.1 7.3 7.0 10.7 9.0 10.0 10.8 6.7 6.5 6.7 31.2 9.6 16.5 8.1 27.0 7.0 14.0 9.5 10.7 13.0 17.0 13.7 19.2 9.2 16.7 7.1 16.9 9.8 17.2 7.0 10.8 9.9 16.0 11.1 12.9 15.2 6.7 18.0 17.7 20.0 12.4 27.0 17.8 8.2 16.9 20.8 16.6 24.2 10.9 29.9 21.4 37.7 19.0 22.8 22.1 23.1 16.4 17.0 14.3 17.3 12.1 19.6 11.8 19.9 18.5 12.8 17.4 27.6 16.9 10.8 19.8 14.6 16.6 5.1 13.1 12.4 29.5 13.1 13.6 14.9 9.5 19.8 12.1 29.8 12.3 20.1 22.8 6.9 9.9 12.5 21.2 23.1 17.9 11.7 10.4 17.6 13.5 11.8 24.7 21.9 12.7 12.0 30.8 22.6 21.9 18.6 2.2 5.1 12.9 9.9 3.1 8.4 5.2 6.9 10.0 7.5 5.0 9.5 8.9 7.1 14.9 2.7 5.6 9.6 6.4 6.3 7.3 7.6 9.0 7.3 7.0 6.7 6.5 6.7 7.0 7.1 7.0 6.7 13.5 6.4 2.6 5.9 7.6 11.1 12.1 19.8 6.2 17.4 13.5 12.1 12.3 2.8 9.8 14.7 6.2 29.1 13.1 9.6 3.9 4.4 0.6 22.6 10.5 12.1 13.1 6.5 12.1 9.3 10.7 15.4 2.0 11.2 5.7 22.7 23.9 7.2 11.2 18.5 12.3 5.9 18.3 11.7 12.0 3.2 22.7 11.4 14.2 6.5 16.1 12.2 17.5 10.6 8.2 12.7 9.3 23.7 4.1 8.6 8.3 6.8 17.5 9.2 46.0 9.4 14.1 11.7 16.8 11.0 20.0 17.2 9.8 24.3 5.1 17.7 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 9.3" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 47.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.6 0.1 0.6 0.0 0.0 0.5 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.1 0.0 1.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 85.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 94.7 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.4 0.0 0.0 18.5 88.6 0.1 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 1.3 1.2 1.5 1.3 0.8 0.3 2.0 0.6 1.3 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010422.5 ENSG00000269590 "Novel protein" 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.2;lymphoid tissue: 1.4;skeletal muscle: 1.3" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Lineage enhanced" "Detected in single" "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "MCF7: 10.8;RT4: 5.5" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA065685: AB_2685531" 0.1 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 1.4 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 2.4 0.0 0.3 0.7 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.6 0.0 0.3 0.7 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.9 0.1 0.0 0.0 0.1 0.3 2.7 0.0 10.8 2.8 0.3 0.7 0.0 0.0 1.0 0.0 0.0 0.9 5.5 1.6 1.3 0.0 1.3 0.3 0.0 1.7 0.5 0.0 3.7 0.1 1.4 1.7 1.7 2.5 1.3 3.4 0.6 1.5 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774547-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 7.3;testis: 3.8" "Cell type enhanced" "Detected in many" "Early spermatids: 25.0;Inhibitory neurons: 19.2;Late spermatids: 33.7;Spermatocytes: 11.7;Spermatogonia: 19.3;Theca cells: 15.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;Hep G2: 2.5" HPA071856 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA071856: AB_2686460" "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 0.1 2.3 1.6 0.0 1.0 0.0 0.4 1.1 2.4 0.3 2.7 0.2 0.0 0.4 0.0 0.1 0.6 0.0 0.3 1.3 2.6 0.1 0.1 0.0 0.0 1.1 0.7 0.9 7.3 0.1 0.1 0.9 2.0 0.4 0.1 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.8 1.4 0.0 0.2 0.0 0.1 0.2 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 1.1 2.4 1.3 2.6 1.1 0.7 0.9 0.4 0.4 1.4 2.1 0.1 0.0 0.0 5.5 0.0 0.1 0.1 0.0 0.6 7.0 0.4 0.9 0.9 0.0 0.0 0.0 0.0 5.5 0.0 0.0 1.9 0.1 25.0 0.0 1.2 0.3 0.0 0.0 8.8 0.0 1.2 1.8 0.0 0.1 0.0 7.6 0.0 0.0 0.7 10.1 19.2 0.0 0.0 0.0 0.3 33.7 1.8 0.0 0.0 1.0 0.0 3.8 0.0 6.6 5.7 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.0 2.4 0.0 1.5 1.0 11.7 19.3 0.3 0.1 9.9 0.0 15.5 0.0 0.0 AC008763.3 ENSG00000269711 "Novel protein" 19 7678501-7682854 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "bone marrow: 22.8;intestine: 7.8;lung: 18.5;lymphoid tissue: 12.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.3;Club cells: 3.7;Fibroblasts: 1.3;granulocytes: 2.5;Macrophages: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "classical monocyte: 202.7;neutrophil: 90.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "EFO-21: 12.8;HMC-1: 20.9;NB-4: 12.4;THP-1: 33.2;U-937: 24.6" NA NA 1.5 0.8 0.3 4.7 0.3 22.8 0.6 0.2 0.8 0.1 0.1 0.5 7.8 1.1 0.0 0.4 1.8 1.6 1.3 0.2 0.2 0.7 1.9 18.5 0.0 1.0 0.1 0.3 0.1 0.7 0.0 0.3 1.6 0.4 0.5 0.0 0.0 1.3 0.0 0.7 0.9 1.4 0.1 0.1 12.3 0.9 0.6 0.3 0.0 0.6 0.0 0.0 1.2 0.4 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 202.7 1.3 0.2 18.1 0.0 0.0 0.5 0.1 42.9 0.0 0.0 1.4 90.1 0.7 1.7 1.8 0.8 112.3 0.3 0.3 0.2 0.8 0.2 0.2 1.0 0.1 0.3 0.4 0.1 0.3 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 NBPF9 AE01 ENSG00000269713 "NBPF member 9" P0DPF3 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Hepatocytes: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 49.5" "Group enriched" "Detected in all" 4 "granulocytes: 49.5;monocytes: 14.2" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 15.0 10.6 8.8 11.6 8.9 9.0 13.8 17.5 9.1 16.3 10.8 13.9 6.5 14.3 17.2 9.7 14.7 9.6 9.7 9.3 9.3 11.5 34.0 17.3 13.7 9.8 10.0 8.7 15.1 18.7 9.7 13.9 7.6 11.4 12.9 9.1 21.6 10.3 7.3 6.9 12.7 15.3 11.6 8.5 15.7 13.3 10.8 9.6 4.1 26.1 2.7 10.7 12.5 12.7 8.4 50.1 21.4 26.2 35.5 23.0 28.1 20.7 44.7 32.5 23.1 25.0 16.2 21.0 11.9 12.1 23.1 27.8 14.7 18.2 20.9 39.4 30.2 19.1 3.8 41.2 9.7 26.7 5.0 13.8 27.8 15.4 25.4 44.1 42.7 20.5 9.0 14.1 30.1 28.4 38.8 1.4 7.4 9.8 8.8 28.8 13.5 16.3 18.0 18.8 22.9 16.9 34.9 14.8 35.7 19.5 16.0 26.5 9.3 48.6 52.0 15.2 38.2 69.8 36.7 20.8 23.0 18.9 3.2 18.6 49.5 14.2 0.6 0.6 5.1 1.0 2.7 1.8 0.6 1.9 5.5 2.5 1.4 8.2 7.8 2.0 7.7 2.5 1.4 8.8 8.9 17.5 9.1 9.3 9.3 9.8 10.0 8.7 11.4 8.5 9.6 8.4 2.5 38.5 16.0 8.5 9.0 5.5 8.7 2.6 2.8 4.8 4.7 2.8 4.2 4.3 12.5 5.5 6.2 2.9 7.2 0.8 0.0 3.4 11.1 8.6 8.7 5.3 1.8 2.1 8.5 2.0 4.0 12.4 4.1 8.8 18.9 7.3 2.2 28.2 3.6 0.0 6.2 1.0 4.1 12.1 17.0 3.8 7.2 12.7 3.6 6.5 14.3 3.7 3.1 7.5 3.2 2.9 7.7 4.1 9.8 3.6 1.6 1.0 6.8 12.0 6.6 7.0 5.2 9.9 4.2 5.9 14.2 1.4 6.3 3.8 1.1 5.9 CCDC194 ENSG00000269720 "Coiled-coil domain containing 194" A0A1B0GVG4 19 17390509-17394158 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 4.4;ovary: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "ovarian cancer: 1.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-3)" "unprognostic (1.37e-1)" "unprognostic (1.87e-4)" "unprognostic (2.75e-3)" "unprognostic (1.41e-1)" "unprognostic (1.28e-2)" "unprognostic (3.09e-1)" "unprognostic (9.87e-2)" "unprognostic (3.07e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (2.64e-2)" "unprognostic (5.22e-14)" "unprognostic (1.04e-1)" "unprognostic (6.70e-3)" "unprognostic (2.60e-1)" "unprognostic (1.86e-2)" 0.2 0.3 1.5 0.0 0.7 0.0 0.1 0.5 4.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.8 0.1 0.1 0.1 0.0 1.3 0.5 0.0 2.2 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.2 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.5 4.4 2.1 0.8 1.3 0.5 0.0 1.0 1.0 1.4 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 SLC25A53 MCART6 ENSG00000269743 "Solute carrier family 25 member 53" Q5H9E4 X 104099214-104157009 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Daudi: 6.1;Karpas-707: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034959 Uncertain NA NA "HPA034959: AB_10602025" "unprognostic (4.70e-2)" "unprognostic (1.16e-2)" "unprognostic (7.16e-3)" "unprognostic (5.94e-2)" "unprognostic (2.68e-2)" "unprognostic (5.23e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" "unprognostic (4.45e-3)" "unprognostic (7.94e-2)" "unprognostic (9.76e-5)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (3.48e-2)" "unprognostic (1.74e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-2)" 0.1 0.3 1.3 1.1 1.0 0.4 0.2 1.3 1.1 0.2 0.3 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.3 1.1 0.9 0.1 0.1 0.2 1.9 0.9 1.1 0.8 0.4 0.5 0.1 0.2 0.1 1.0 0.2 0.4 0.5 0.1 0.1 0.1 0.2 1.0 0.2 1.1 1.3 0.4 0.6 1.1 0.6 0.1 0.0 1.6 0.2 0.1 1.3 0.0 0.1 1.7 1.1 0.1 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 6.1 0.1 0.0 0.3 0.1 2.0 0.0 0.1 0.5 0.8 0.7 0.2 0.1 0.1 1.1 0.7 0.3 0.0 0.2 0.0 0.3 0.4 0.6 0.1 13.9 0.1 0.1 0.2 0.1 2.2 0.1 0.4 2.5 0.9 0.2 0.3 0.2 1.5 2.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.8 0.1 0.4 0.1 0.0 2.2 0.1 1.6 0.4 0.2 0.1 0.2 0.3 0.1 0.6 0.5 0.3 0.5 0.1 0.4 0.0 0.3 0.7 0.2 0.0 0.0 0.5 0.1 1.3 1.0 1.3 1.1 1.1 0.9 0.9 1.1 0.8 1.0 1.1 1.1 1.3 6.6 6.4 4.6 26.4 11.4 5.2 8.8 6.2 4.0 3.5 7.2 5.7 15.1 5.7 4.6 9.2 0.0 3.7 9.6 17.3 25.4 4.3 6.8 6.9 4.7 5.3 7.2 19.4 15.5 6.0 4.2 7.6 7.7 7.2 7.0 2.7 6.4 25.1 10.6 3.3 14.1 7.8 4.1 8.8 5.7 1.3 3.1 7.5 1.8 16.9 11.4 4.0 17.5 17.1 23.5 7.8 21.8 3.0 10.2 8.8 19.7 25.9 10.8 8.1 0.0 5.2 5.0 4.8 2.3 4.7 5.7 6.2 11.0 3.0 4.5 11.3 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;Karpas-707: 5.4;U-266/70: 1.9;U-266/84: 9.0" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC022150.4 ENSG00000269825 "Novel zinc finger protein" 19 52650447-52690533 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RT4: 15.0" HPA042466 Uncertain Approved "Nucleoli rim" NA NA "Nucleoli rim" "HPA042466: AB_10797497" "unprognostic (2.33e-3)" "unprognostic (9.06e-2)" "unprognostic (4.73e-2)" "unprognostic (8.55e-2)" "unprognostic (8.19e-2)" "unprognostic (1.73e-3)" "unprognostic (3.17e-4)" "unprognostic (1.91e-2)" "unprognostic (6.76e-3)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-1)" "unprognostic (4.76e-2)" "unprognostic (3.28e-1)" "unprognostic (1.09e-2)" "unprognostic (2.89e-1)" 1.2 1.1 3.2 2.0 4.9 3.1 1.6 5.2 6.0 1.0 2.8 0.7 0.8 1.4 2.1 1.1 0.8 1.6 0.8 2.9 2.3 1.4 0.3 1.2 1.7 3.6 2.8 0.8 1.2 1.1 1.2 2.8 4.4 1.5 0.9 3.2 0.9 2.0 0.5 2.1 0.6 1.2 2.8 1.8 1.3 1.9 2.9 2.1 1.6 0.6 1.9 1.1 7.0 5.0 0.0 2.6 6.4 0.6 1.4 6.1 5.1 3.0 3.7 4.5 4.3 2.9 4.1 1.4 2.8 2.5 1.8 4.6 2.4 5.7 0.1 0.4 2.5 14.3 0.8 0.5 3.1 4.0 1.6 0.3 5.4 6.4 1.2 4.0 4.4 4.5 1.7 3.5 2.1 4.4 2.3 1.6 0.0 7.1 6.9 4.7 2.2 2.4 15.0 2.9 1.8 6.4 2.7 0.5 6.4 7.3 2.1 5.7 9.6 4.2 1.8 7.8 0.1 3.0 5.7 0.1 1.5 5.1 0.8 0.3 0.2 0.7 0.3 0.5 0.5 0.5 0.8 0.2 0.5 0.5 0.7 0.7 0.9 0.3 0.4 0.5 0.3 3.2 4.9 5.2 6.0 2.9 2.3 3.6 2.8 0.8 4.4 2.8 2.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF225 ENSG00000269855 "Ring finger protein 225" M0QZC1 19 58396090-58397079 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 6.6;skin 1: 4.4;vagina: 2.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (3.07e-1)" "unprognostic (6.94e-2)" "unprognostic (3.68e-3)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.75e-3)" "unprognostic (1.40e-1)" "unprognostic (3.42e-1)" "unprognostic (9.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.2 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 EGLN2 "HIFPH1, PHD1" ENSG00000269858 "Egl-9 family hypoxia inducible factor 2" Q96KS0 19 40798996-40808434 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 269.1;Late spermatids: 740.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056649 Supported Nucleoplasm NA NA Nucleoplasm "HPA056649: AB_2683203" "unprognostic (1.11e-2)" "prognostic favorable (2.88e-4)" "unprognostic (9.40e-3)" "unprognostic (6.01e-2)" "unprognostic (6.03e-2)" "unprognostic (6.47e-3)" "unprognostic (1.51e-2)" "unprognostic (4.74e-2)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.81e-4)" "unprognostic (7.10e-2)" "unprognostic (7.48e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (9.99e-2)" "unprognostic (1.38e-3)" 54.2 59.0 107.5 50.5 107.6 52.6 48.0 101.7 142.0 67.0 88.3 59.7 34.6 54.3 31.8 40.6 45.9 39.5 58.6 111.6 104.0 54.6 58.1 74.9 62.9 105.4 107.9 103.7 59.5 36.9 27.9 44.9 48.8 109.9 60.4 28.7 16.8 39.5 45.5 40.3 27.2 47.1 41.3 97.4 117.7 48.0 233.9 106.9 42.3 56.3 41.1 44.5 58.4 58.4 106.3 46.5 123.4 55.9 54.4 71.1 51.5 36.5 49.4 41.1 68.9 75.4 102.8 45.7 41.1 41.1 59.3 62.5 29.3 70.8 56.3 36.4 51.7 40.5 54.8 76.4 39.4 76.1 42.7 71.6 63.9 58.5 65.8 37.4 43.3 86.0 44.3 79.3 37.3 73.4 32.9 78.9 70.2 48.7 72.4 42.6 72.7 27.7 27.8 74.0 70.2 51.4 46.9 80.9 62.9 67.2 47.2 83.4 114.0 80.5 85.9 61.7 35.7 59.5 18.7 29.6 75.6 63.0 61.4 65.5 93.2 72.5 190.5 85.8 83.4 91.1 85.2 101.7 90.3 62.6 90.0 105.2 89.6 261.6 61.4 82.3 45.5 100.2 110.5 107.5 107.6 101.7 142.0 111.6 104.0 105.4 107.9 103.7 109.9 97.4 106.9 106.3 2.8 22.4 16.8 0.0 43.9 48.8 55.2 33.8 17.6 40.5 3.3 0.8 22.2 31.5 30.7 3.7 14.6 58.1 19.0 83.0 0.0 15.8 269.1 0.9 1.5 49.9 44.9 30.7 0.0 10.1 26.5 27.6 23.9 1.2 17.2 0.8 72.8 33.7 66.7 21.9 0.0 33.9 48.8 39.8 62.4 740.8 63.0 26.3 40.9 0.0 38.5 24.4 60.8 0.0 0.0 14.0 71.0 52.3 8.7 67.6 54.9 1.4 23.0 17.8 39.5 14.6 17.2 159.4 52.5 14.2 38.4 132.6 33.2 2.1 43.7 69.8 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 10.2;testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;MOLT-4: 12.7;U-937: 23.8" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 0.9 2.2 0.5 1.1 1.3 0.3 0.8 0.9 1.9 1.5 0.6 0.6 0.6 0.4 0.0 1.8 1.3 0.2 3.0 0.3 1.7 0.4 0.5 0.9 1.0 1.3 0.5 0.1 0.6 0.8 0.4 0.1 0.7 0.8 0.5 0.2 10.2 1.8 2.7 6.4 0.6 0.8 0.3 0.7 0.9 1.1 6.8 1.2 2.0 0.4 2.3 1.5 1.0 0.8 1.7 2.1 6.4 3.9 0.2 2.5 2.3 0.4 0.9 1.3 1.4 5.8 7.8 1.2 1.9 0.8 3.0 5.1 1.1 2.8 2.2 1.3 23.3 2.4 5.4 1.5 0.0 1.7 0.6 3.0 2.9 3.2 3.3 0.1 4.3 1.6 8.3 1.4 2.8 0.8 0.0 12.7 0.9 0.4 3.9 2.1 1.7 3.1 1.7 0.5 1.9 0.4 2.7 5.5 1.1 0.2 1.4 0.0 4.7 6.8 2.3 3.9 1.3 0.7 4.9 0.9 3.5 1.2 23.8 0.0 7.4 2.1 3.0 3.4 2.4 3.7 7.5 3.2 4.1 2.2 7.3 2.4 1.8 0.7 4.9 1.3 0.3 6.5 4.9 0.5 1.3 0.9 1.9 0.3 1.7 1.3 0.5 0.1 0.8 0.7 1.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FMC1-LUC7L2 C7orf55-LUC7L2 ENSG00000269955 "FMC1-LUC7L2 readthrough" 7 139341360-139422599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 26.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045663, HPA051631" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045663: AB_2679410, HPA051631: AB_2681558" "unprognostic (2.54e-1)" "unprognostic (5.27e-2)" "unprognostic (3.21e-2)" "unprognostic (1.33e-3)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (1.68e-2)" "unprognostic (4.48e-2)" "unprognostic (2.26e-1)" "unprognostic (1.76e-3)" "unprognostic (1.10e-1)" "unprognostic (3.12e-2)" "unprognostic (6.42e-3)" 16.3 17.9 1.9 8.9 3.6 6.4 16.3 3.3 9.9 15.2 3.1 18.8 11.1 22.0 1.1 13.5 18.3 2.7 21.6 1.6 3.5 14.5 19.5 14.9 6.2 4.3 2.5 0.9 20.6 12.4 12.4 14.2 7.0 3.8 15.4 4.1 14.0 18.3 8.7 57.5 12.9 16.2 6.7 3.6 12.8 16.6 11.8 3.2 14.2 24.9 30.7 4.9 17.9 15.1 4.1 32.6 46.2 55.1 31.7 23.3 16.2 20.8 25.2 17.0 29.9 23.8 36.5 35.8 36.5 44.3 18.6 40.1 25.5 59.7 21.3 9.4 25.2 6.3 48.6 45.9 27.8 21.7 60.2 38.2 12.7 15.3 28.8 18.4 16.9 20.9 19.1 62.1 47.4 18.7 45.6 88.9 3.2 44.5 44.2 9.7 57.5 41.6 48.5 4.8 22.3 45.7 47.5 33.9 26.4 33.8 10.4 20.2 25.1 24.0 21.5 20.2 22.5 38.8 44.4 40.3 70.5 39.9 37.8 40.1 14.6 15.7 22.3 22.2 16.1 21.3 22.2 21.3 23.0 22.8 23.0 23.9 21.7 5.6 24.6 20.4 17.9 25.8 16.4 1.9 3.6 3.3 9.9 1.6 3.5 4.3 2.5 0.9 3.8 3.6 3.2 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEI4 ENSG00000269964 "Meiotic double-stranded break formation protein 4" A8MW99 6 77650274-77927028 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 4.0;testis: 3.7;thyroid gland: 2.2" "Cell type enriched" "Detected in some" 4 "Early spermatids: 86.1" "Cancer enhanced" "Detected in some" "renal cancer: 0.9;testis cancer: 1.3" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.47e-1)" "unprognostic (9.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (1.88e-1)" "unprognostic (4.62e-2)" "unprognostic (9.70e-4)" "unprognostic (3.16e-1)" "unprognostic (2.86e-4)" "unprognostic (3.35e-2)" "unprognostic (4.17e-2)" "unprognostic (4.85e-2)" 0.1 0.7 0.4 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.2 0.7 4.0 0.9 0.0 0.0 0.9 0.5 0.1 0.0 2.0 0.1 1.0 0.0 1.2 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 3.7 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.3 0.2 0.7 0.9 0.5 0.1 1.2 0.5 0.5 0.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 86.1 0.0 0.0 0.1 0.0 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 21.3 0.3 0.0 0.0 9.4 0.0 0.6 0.0 2.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 3.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF559-ZNF177 ENSG00000270011 "ZNF559-ZNF177 readthrough" 19 9324174-9382617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 6.8" "Group enriched" "Detected in some" 5 "Astrocytes: 25.5;Excitatory neurons: 14.8;Inhibitory neurons: 13.6;Microglial cells: 11.2;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 28.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 3.8" HPA003141 Approved NA NA "HPA003141: AB_1859102" "unprognostic (3.30e-1)" "unprognostic (5.38e-2)" "unprognostic (4.38e-1)" "unprognostic (2.43e-1)" "unprognostic (6.75e-2)" "unprognostic (8.20e-2)" "unprognostic (7.27e-2)" "unprognostic (6.83e-3)" "unprognostic (3.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.80e-2)" "unprognostic (1.81e-1)" "unprognostic (4.61e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-2)" "unprognostic (4.17e-5)" 0.7 1.7 2.9 0.5 2.6 0.2 1.6 4.4 3.0 1.2 2.7 0.7 0.0 1.9 3.5 0.2 1.7 0.6 1.8 2.8 2.7 0.8 0.2 0.6 0.6 2.4 3.2 2.8 3.3 0.3 1.1 1.3 1.3 2.7 1.5 0.5 6.8 0.6 0.9 0.4 0.9 0.4 0.9 2.3 0.7 0.5 4.3 2.7 1.0 1.6 0.4 0.3 0.7 0.7 4.0 0.2 0.3 1.3 2.2 0.2 0.5 0.1 0.5 0.2 0.3 0.4 0.0 0.0 0.7 3.3 0.3 0.9 0.0 0.2 0.0 0.5 3.8 2.5 1.4 0.2 0.0 0.2 0.3 0.4 0.3 0.1 0.6 0.8 3.1 0.1 1.5 0.5 1.5 1.2 0.0 1.2 1.9 1.7 0.0 1.3 1.8 1.2 0.1 0.5 0.7 1.7 1.2 0.4 0.0 0.6 1.7 0.1 0.2 0.2 1.5 0.2 3.3 1.4 0.1 0.0 0.2 0.2 0.5 1.3 0.8 0.0 0.2 0.3 0.0 0.5 0.6 0.1 0.5 0.2 0.2 0.2 0.4 0.0 1.1 0.0 0.2 0.0 0.0 2.9 2.6 4.4 3.0 2.8 2.7 2.4 3.2 2.8 2.7 2.3 2.7 4.0 0.0 0.0 0.0 25.5 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.1 0.3 0.0 0.0 14.8 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 11.2 0.0 0.4 0.0 28.1 28.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.1 4.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 NCBP2AS2 "HIAR, KRASIM, NCBP2-AS2" ENSG00000270170 "NCBP2 antisense 2 (head to head)" Q69YL0 3 196942674-196943543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 50.3;Cytotrophoblasts: 53.1;dendritic cells: 22.6;Extravillous trophoblasts: 42.3;Hofbauer cells: 43.0;Syncytiotrophoblasts: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.48e-1)" "unprognostic (4.33e-3)" "unprognostic (4.51e-2)" "unprognostic (1.74e-3)" "unprognostic (4.77e-2)" "unprognostic (2.49e-1)" "unprognostic (2.61e-3)" "unprognostic (1.30e-1)" "unprognostic (1.71e-1)" "unprognostic (2.67e-1)" "unprognostic (5.07e-2)" "unprognostic (3.21e-2)" "prognostic favorable (8.92e-4)" "unprognostic (4.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (8.66e-3)" 18.7 22.8 33.4 9.8 34.8 38.7 19.0 35.6 36.1 12.5 28.9 28.6 16.1 21.9 13.3 22.7 16.3 6.1 25.6 34.4 36.5 24.3 23.7 15.0 14.1 34.5 34.9 35.0 11.6 22.1 20.3 21.6 9.7 35.7 18.8 16.8 13.3 20.0 13.1 45.5 28.4 24.1 10.3 33.9 23.9 24.0 14.1 35.0 18.4 17.1 35.5 10.6 20.9 16.4 38.6 52.7 15.3 26.0 31.3 20.5 18.7 50.0 24.4 16.8 33.2 22.1 29.7 18.7 49.1 87.8 18.3 25.9 41.0 42.8 21.6 26.0 17.5 64.1 39.0 19.3 49.0 23.1 36.4 23.5 30.8 39.4 19.4 24.0 15.1 21.7 45.7 39.7 38.1 14.5 93.9 45.8 65.7 56.9 58.8 74.0 40.7 22.7 60.9 28.0 29.7 59.9 68.0 26.1 39.4 61.3 26.8 80.9 41.4 16.5 15.3 45.4 24.5 52.2 57.1 71.4 119.5 18.0 62.3 20.7 87.4 120.6 116.5 91.6 97.9 99.2 98.3 115.7 106.5 110.0 123.3 141.8 115.3 47.6 127.2 89.7 129.0 118.3 109.7 33.4 34.8 35.6 36.1 34.4 36.5 34.5 34.9 35.0 35.7 33.9 35.0 38.6 10.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 53.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 42.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 34.3 2.9 0.0 0.0 0.0 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.3;Club cells: 2.5;Excitatory neurons: 6.4;granulocytes: 2.5;Inhibitory neurons: 7.5;Oligodendrocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;HMC-1: 1.3;hTERT-RPE1: 1.3;RPTEC TERT1: 2.5;SK-MEL-30: 1.4" "HPA045845, HPA050126, HPA050374" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (6.01e-2)" 10.1 9.6 0.2 0.1 0.0 0.0 9.5 0.5 0.2 9.7 0.0 9.6 0.0 9.8 0.0 8.8 8.6 0.3 8.6 0.1 0.0 9.7 12.5 9.1 0.0 0.0 0.2 0.1 10.6 11.8 0.1 9.4 0.0 0.1 8.9 0.2 0.2 9.4 0.0 12.6 9.6 10.0 0.1 0.0 9.5 9.4 3.2 0.2 0.0 10.0 0.0 0.0 9.3 9.3 0.3 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.4 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 1.3 0.9 0.6 0.7 0.0 0.0 0.1 0.2 0.0 1.3 0.0 0.1 0.3 0.5 1.3 0.3 0.5 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.5 0.5 0.0 0.0 1.4 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.3 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 IGHD1OR15-1B "IGHD1/OR15-1B, IGHD1OR151B" ENSG00000270185 "Immunoglobulin heavy diversity 1/OR15-1B (non-functional)" 15 21017800-21017816 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTRNR2L11 ENSG00000270188 "MT-RNR2 like 11" S4R3Y5 1 237943724-237945275 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "brain: 3322.2" "Group enriched" "Detected in some" 15 "Cardiomyocytes: 1131.8;Proximal tubular cells: 286.7" "Not detected" "Not detected" "Region enriched" "Detected in all" 10 "cerebral cortex: 3322.2" "Group enriched" "Detected in all" 4 "basophil: 95.3;eosinophil: 74.4;neutrophil: 274.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 274.5" "Cell line enhanced" "Detected in many" "HeLa: 302.4;Hep G2: 155.2" "Secreted to blood" NA NA "unprognostic (1.07e-1)" "unprognostic (9.70e-2)" "unprognostic (4.49e-2)" "unprognostic (5.26e-2)" 77.4 75.4 245.7 11.9 245.7 17.0 12.2 245.7 3322.2 4.2 245.8 49.2 23.8 12.9 7.2 6.7 5.4 3.8 89.3 324.9 245.7 74.5 52.7 7.6 5.6 337.0 245.7 245.6 8.7 26.3 25.2 0.0 9.1 267.7 16.2 24.1 41.0 31.2 11.4 327.6 12.6 27.5 9.4 254.1 16.8 33.4 20.1 245.8 4.7 2.5 122.4 8.2 5.9 0.0 246.7 26.2 59.8 27.3 77.1 23.1 5.8 21.8 42.4 3.5 2.4 3.4 25.5 36.7 44.3 26.5 8.4 4.4 77.4 0.9 5.6 2.3 19.5 41.2 44.6 302.4 155.2 7.6 12.6 34.4 23.3 8.1 2.8 10.3 53.2 3.5 28.5 31.8 25.7 7.2 22.3 12.6 42.3 7.4 32.1 10.8 23.6 22.2 18.1 16.4 35.4 10.4 18.2 16.6 19.3 33.0 26.7 23.5 39.1 68.7 30.7 21.6 25.0 12.4 19.4 6.9 17.4 17.0 42.6 7.6 95.3 33.0 74.4 6.0 13.8 6.9 23.9 9.0 8.1 11.9 23.4 12.4 13.3 274.5 12.8 14.4 15.0 8.9 42.9 245.7 245.7 245.7 3322.2 324.9 245.7 337.0 245.7 245.6 267.7 254.1 245.8 246.7 0.2 0.0 0.0 0.0 1.2 4.0 26.3 0.3 0.0 0.0 0.8 0.1 1131.8 0.0 0.0 12.9 0.0 0.1 0.1 0.0 46.9 0.0 0.1 0.2 0.1 22.9 0.0 0.0 0.0 0.0 0.1 33.1 0.0 0.2 0.0 0.0 1.1 1.6 0.1 0.0 0.0 0.0 0.0 0.8 9.0 0.1 0.0 3.0 8.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 286.7 0.0 0.0 0.0 6.5 25.6 0.3 0.3 0.0 4.0 0.0 1.8 0.1 0.0 17.7 AC093668.1 ENSG00000270249 "Novel protein" 7 102541501-102592444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.1;hTERT-RPE1: 1.0;Karpas-707: 1.0" HPA046970 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.3 0.4 0.3 0.4 0.4 0.4 0.3 1.1 1.4 0.6 0.2 0.5 1.0 0.5 1.0 0.2 0.5 0.0 0.2 0.5 0.4 0.5 0.0 0.4 0.3 0.5 0.4 0.3 0.4 0.5 2.1 1.2 0.2 1.0 0.3 0.3 1.8 0.4 0.1 2.1 0.8 0.6 0.0 0.2 0.7 0.6 0.1 0.3 0.3 0.2 0.4 0.1 0.3 0.4 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.1 0.2 0.2 0.2 0.0 0.0 0.7 0.7 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 1.0 0.0 0.1 0.9 0.4 0.1 0.8 0.3 0.4 0.0 0.1 0.1 0.3 0.5 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.1 0.3 0.0 0.0 0.3 0.2 1.4 0.4 1.8 2.0 1.8 1.4 0.8 1.3 2.4 1.4 0.6 0.3 0.4 1.6 2.8 0.6 0.3 0.4 1.1 1.4 0.5 0.4 0.5 0.4 0.3 1.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C15 "H4/o, HIST2H4B" ENSG00000270276 "H4 clustered histone 15" P62805 1 149854045-149861210 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.8;SiHa: 7.5;U-266/70: 8.6;U-266/84: 7.6" "Low region specificity" "Detected in all" HPA042201 Supported NA Yes 25000000 "HPA042201: AB_2677898" "unprognostic (8.20e-2)" "unprognostic (2.69e-1)" "unprognostic (1.77e-1)" 2.0 3.2 1.9 0.1 2.3 2.1 1.7 2.2 3.6 1.9 1.5 3.2 1.7 2.2 2.5 1.0 2.9 0.7 2.3 2.4 1.5 1.6 1.7 1.8 1.3 1.5 1.8 2.6 1.8 1.6 2.0 5.0 0.9 2.1 3.6 1.0 3.1 1.5 1.1 2.4 2.0 1.7 2.2 2.0 2.3 2.2 0.8 1.4 4.6 2.0 1.1 0.7 2.8 1.5 2.1 0.0 0.0 0.8 0.2 0.8 0.8 0.1 1.4 2.6 0.2 0.0 0.0 0.5 0.8 1.3 0.7 0.2 0.0 0.4 0.0 0.1 1.5 0.5 0.0 3.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 1.1 1.0 1.9 0.0 4.5 0.1 3.1 0.2 0.5 0.1 0.8 0.0 1.1 0.3 0.1 0.3 0.6 4.8 2.9 7.5 0.8 0.3 0.0 1.6 0.1 1.8 0.3 1.8 0.5 0.2 8.6 7.6 1.2 0.7 0.2 1.1 1.8 1.3 1.6 1.4 2.1 2.5 1.8 1.6 1.2 1.9 4.3 1.3 2.3 5.8 1.3 1.2 2.4 2.5 3.4 1.9 2.3 2.2 3.6 2.4 1.5 1.5 1.8 2.6 2.1 2.0 1.4 2.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AL121758.1 ENSG00000270299 "Novel protein" 20 646626-675800 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.2;Hep G2: 4.3;Karpas-707: 2.7;SK-BR-3: 2.6;TIME: 2.5;U-266/84: 2.7" NA NA "unprognostic (2.38e-2)" "unprognostic (1.45e-1)" "unprognostic (3.40e-2)" "unprognostic (1.26e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (7.42e-3)" "unprognostic (4.14e-3)" "unprognostic (2.22e-1)" "unprognostic (3.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.87e-3)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.42e-2)" "unprognostic (5.00e-2)" "unprognostic (2.03e-2)" 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 2.0 0.0 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 3.2 0.0 0.0 0.2 0.0 0.3 0.1 2.4 0.2 4.3 0.0 0.3 1.3 0.0 0.0 0.2 0.0 0.1 0.0 1.9 0.3 2.7 0.0 0.0 0.0 0.0 1.3 1.2 0.1 0.0 0.7 1.0 0.0 0.1 0.4 1.0 0.6 2.6 0.5 0.4 0.4 0.5 2.5 0.2 0.4 0.0 0.7 0.2 2.7 0.1 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIAL4H ENSG00000270339 "Peptidylprolyl isomerase A like 4H" A0A075B767 1 146344131-146344790 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "THP-1: 1.2" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (1.35e-1)" "unprognostic (2.13e-3)" "unprognostic (2.34e-1)" "unprognostic (2.76e-2)" "unprognostic (2.34e-1)" "unprognostic (2.84e-2)" 0.0 0.0 1.0 0.0 1.0 0.0 0.1 2.5 1.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.1 0.8 1.0 1.0 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 2.5 1.6 1.2 1.0 0.8 1.0 1.0 1.3 0.7 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEATR9 "C17orf66, FLJ32830" ENSG00000270379 "HEAT repeat containing 9" A2RTY3 17 35854946-35868891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 10.2" "Group enriched" "Detected in some" 17 "Early spermatids: 88.4;Late spermatids: 36.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA023129 Uncertain NA NA "HPA023129: AB_1845599" "unprognostic (1.02e-1)" "unprognostic (2.63e-3)" "unprognostic (5.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (7.44e-4)" "unprognostic (1.30e-3)" "unprognostic (2.43e-2)" "unprognostic (2.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.61e-10)" "unprognostic (6.78e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (5.61e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 88.4 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.0 36.4 0.6 0.1 0.0 0.0 0.1 0.0 3.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 MTRNR2L13 ENSG00000270394 "MT-RNR2 like 13" S4R3P1 4 116298876-116300320 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.4;choroid plexus: 1.3;skeletal muscle: 1.5" "Cell type enriched" "Detected in some" 20 "Cardiomyocytes: 176.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Group enriched" "Detected in some" 6 "HeLa: 4.3;Hep G2: 1.8" "Secreted - unknown location" NA NA "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" 0.2 0.6 1.4 0.0 1.4 0.1 0.0 1.4 2.4 0.0 1.3 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.9 1.4 1.4 0.6 0.3 0.1 0.0 1.4 1.4 1.4 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.2 0.0 0.1 0.0 1.5 0.1 0.2 0.0 1.4 0.0 0.1 0.1 1.4 0.0 0.0 1.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 4.3 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.1 1.4 1.4 1.4 2.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.5 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.0 0.0 176.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.8 0.0 0.0 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.7 IGHD4OR15-4B "IGHD4/OR15-4B, IGHD4OR154B" ENSG00000270451 "Immunoglobulin heavy diversity 4/OR15-4B (non-functional)" 15 21011451-21011469 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-12 IGHV3/OR16-12 ENSG00000270467 "Immunoglobulin heavy variable 3/OR16-12 (non-functional)" 16 33802764-33803217 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "intestine: 13.9;lymphoid tissue: 20.5;stomach 1: 9.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 10 "memory B-cell: 4.5" "Lineage enriched" "Detected in single" 46 "B-cells: 4.5" "Not detected" "Not detected" NA NA "unprognostic (1.38e-2)" "unprognostic (2.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-3)" "unprognostic (1.07e-1)" "unprognostic (7.10e-2)" "unprognostic (5.02e-1)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 7.8 0.0 1.0 3.4 0.0 0.0 1.2 0.0 8.4 13.9 0.0 0.0 1.1 0.1 1.6 0.0 0.0 0.0 0.1 0.3 1.3 1.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 4.1 0.0 2.5 0.0 0.0 0.0 3.6 0.0 0.0 2.1 9.8 0.2 0.0 1.0 0.0 0.0 20.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-9 IGHV3/OR16-9 ENSG00000270472 "Immunoglobulin heavy variable 3/OR16-9 (non-functional)" 16 32066065-32066358 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 73.9;lymphoid tissue: 89.3;stomach 1: 79.7;urinary bladder: 54.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 136 "memory B-cell: 20.0;naive B-cell: 7.1" "Lineage enriched" "Detected in single" 200 "B-cells: 20.0" "Not detected" "Not detected" NA NA "unprognostic (1.32e-3)" "unprognostic (8.31e-2)" "unprognostic (2.49e-3)" "prognostic favorable (1.29e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.31e-1)" "unprognostic (1.01e-5)" "unprognostic (1.57e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (1.55e-1)" 11.2 9.9 0.0 33.2 0.0 13.8 17.2 0.2 0.6 8.4 0.0 73.9 46.3 0.9 0.0 26.7 1.5 8.3 2.9 0.0 0.0 0.8 3.8 9.2 13.1 0.5 0.0 0.0 6.2 1.3 0.1 0.0 0.0 0.5 1.1 38.1 0.0 49.8 0.0 0.0 0.0 38.9 0.3 0.3 27.2 79.7 0.3 0.1 8.7 0.1 0.0 89.3 54.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.6 0.0 0.0 0.5 0.0 0.0 0.5 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1OR15-1 IGHV1/OR15-1 ENSG00000270505 "Immunoglobulin heavy variable 1/OR15-1 (non-functional)" 15 22160431-22160868 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 79.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.0;B-cells: 1.1;granulocytes: 1.3;T-cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 94.3;naive B-cell: 111.6" "Group enriched" "Detected in many" 18 "B-cells: 111.6;T-cells: 60.9" "Group enriched" "Detected in some" 4 "JURKAT: 10.3;Karpas-707: 6.9;MOLT-4: 2.5" NA NA "unprognostic (2.14e-1)" "unprognostic (1.13e-1)" 0.6 0.4 0.0 18.3 0.0 7.1 5.8 0.1 0.1 0.8 0.0 15.8 13.9 0.8 0.0 4.0 0.6 14.5 0.7 0.0 0.1 0.4 0.7 2.8 52.4 0.2 0.1 0.0 1.0 0.4 0.1 0.1 0.1 0.1 2.3 10.3 0.0 4.8 0.4 0.0 0.1 13.8 0.4 0.2 18.3 11.2 0.1 0.1 59.2 1.1 0.0 79.5 9.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.2 0.0 3.3 94.3 54.9 18.1 0.1 111.6 60.9 14.5 0.5 4.8 0.1 3.3 35.9 20.5 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 IGHV3-30 ENSG00000270550 "Immunoglobulin heavy variable 3-30" "P01768, P0DP03" 14 106335082-106335613 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 539.1;lymphoid tissue: 1305.5;salivary gland: 463.6;stomach 1: 577.9;urinary bladder: 382.2" "Cell type enriched" "Detected in some" 184 "Plasma cells: 14426.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 5 "cerebral cortex: 4.8" "Group enriched" "Detected in some" 409 "memory B-cell: 164.0;naive B-cell: 136.6" "Lineage enriched" "Detected in single" 446 "B-cells: 164.0" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3" "Immunoglobulin genes" NA NA 8500000000 "unprognostic (2.12e-3)" "unprognostic (5.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "unprognostic (1.72e-2)" "prognostic favorable (3.23e-5)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.94e-2)" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.32e-1)" "unprognostic (2.16e-1)" "unprognostic (2.01e-1)" "unprognostic (6.96e-2)" 17.2 38.8 0.1 323.5 0.2 120.8 145.4 0.0 4.8 42.0 0.7 539.1 267.9 13.4 0.0 135.9 45.2 147.9 30.6 0.4 0.2 28.5 25.3 129.3 378.0 0.9 0.4 0.1 23.2 12.4 0.7 3.4 0.7 0.2 18.8 257.3 0.0 463.6 20.6 0.9 2.8 298.6 23.8 0.1 803.8 577.9 6.0 0.2 159.7 77.3 0.1 1305.5 382.2 35.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 164.0 0.2 0.0 0.1 136.6 0.3 0.1 0.3 0.0 0.0 0.2 0.0 24.4 0.1 0.2 0.0 4.8 0.4 0.2 0.9 0.4 0.1 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 5.4 16.3 0.0 1.3 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14426.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 PRAMEF5 "PRAMEF23, PRAMEF5L" ENSG00000270601 "PRAME family member 5" Q5TYX0 1 13254212-13263314 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 URGCP-MRPS24 ENSG00000270617 "URGCP-MRPS24 readthrough" 7 43866558-43906589 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 4.6;Club cells: 5.6;Distal tubular cells: 1.9;granulocytes: 1.3;Respiratory ciliated cells: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.4;HBEC3-KT: 2.1;SCLC-21H: 2.5" NA NA "unprognostic (2.69e-2)" "unprognostic (6.74e-3)" "unprognostic (2.14e-2)" "unprognostic (5.06e-2)" "unprognostic (1.80e-1)" "unprognostic (4.92e-2)" "unprognostic (5.11e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (8.57e-4)" "unprognostic (1.37e-1)" "unprognostic (2.20e-5)" "unprognostic (1.82e-1)" "unprognostic (2.67e-2)" "unprognostic (2.40e-1)" "unprognostic (5.46e-2)" 0.3 0.4 0.4 0.1 0.7 0.0 0.3 0.6 1.7 0.6 0.2 0.6 0.0 0.2 0.3 0.2 0.3 0.0 0.6 0.7 0.4 0.7 0.3 0.2 0.1 0.4 0.4 0.4 0.3 0.6 0.4 0.5 0.0 0.4 0.5 0.1 0.8 0.3 0.0 0.8 0.1 0.4 0.1 0.3 0.1 0.6 0.1 0.5 0.0 0.3 0.3 0.1 0.3 0.3 0.8 0.2 0.4 0.4 0.5 0.0 0.6 0.2 0.0 0.6 0.2 0.3 1.5 0.0 0.1 0.2 0.6 2.4 0.6 0.3 2.1 0.0 1.4 0.9 1.4 0.4 0.4 0.3 1.5 0.0 0.5 0.8 0.0 0.5 0.9 0.2 0.5 0.6 0.0 0.8 1.3 0.3 0.3 0.0 0.8 0.3 0.2 0.3 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.9 0.0 0.7 0.2 0.1 0.3 0.0 0.0 0.8 0.3 0.0 0.1 0.0 0.2 0.3 0.1 0.2 0.3 0.8 0.3 0.0 0.1 0.5 0.0 0.3 0.3 0.2 0.0 0.1 0.4 0.7 0.6 1.7 0.7 0.4 0.4 0.4 0.4 0.4 0.3 0.5 0.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 89.8;Astrocytes: 95.0;Paneth cells: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 128.6" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 31.6 10.4 18.2 26.4 17.1 44.6 26.4 12.3 29.2 21.6 38.1 19.7 9.1 29.7 22.6 24.5 22.7 20.1 9.4 21.3 42.8 14.0 21.4 22.3 22.4 20.3 15.0 9.3 45.6 27.2 18.5 3.9 15.8 17.4 19.4 20.3 26.3 16.4 14.9 13.8 52.3 11.4 27.7 12.5 32.2 11.5 23.9 19.6 16.5 16.7 12.3 18.7 16.7 15.8 20.9 80.9 12.9 30.7 21.1 64.1 90.4 14.4 26.5 25.4 16.9 20.2 11.5 21.3 16.0 6.6 32.0 25.1 23.7 20.0 26.4 29.4 29.4 21.3 36.5 47.1 2.3 22.8 30.9 14.9 83.2 23.9 55.7 58.5 97.3 29.2 11.5 13.9 50.8 43.8 44.2 7.8 20.8 13.1 14.8 31.4 11.7 25.4 39.8 17.9 34.0 0.4 0.5 54.4 28.6 15.6 30.2 36.7 26.7 128.6 23.4 23.2 22.9 50.1 41.7 16.2 35.5 39.1 27.0 31.1 11.9 16.2 15.2 2.0 8.3 1.0 11.8 1.5 1.3 4.5 11.3 2.0 1.8 34.9 2.4 15.6 17.7 1.8 1.7 18.2 17.1 12.3 29.2 21.3 42.8 20.3 15.0 9.3 17.4 12.5 19.6 20.9 2.9 89.8 83.7 95.0 34.8 2.2 47.3 0.6 10.8 2.0 16.9 9.3 20.2 11.5 15.2 12.9 4.2 1.3 28.1 10.7 0.0 37.4 47.3 11.4 8.5 3.7 3.6 15.5 3.7 16.2 14.0 31.8 6.1 20.0 53.7 21.2 3.3 9.9 13.7 0.0 4.4 7.4 0.0 45.3 3.4 43.8 28.3 49.6 1.8 17.8 61.8 13.3 6.2 28.1 0.7 26.4 174.5 17.0 13.3 22.2 6.9 8.6 9.1 9.8 13.1 14.0 18.1 47.5 13.0 38.2 6.3 1.5 12.4 8.4 21.0 41.3 TAF15 "hTAFII68, Npl3, RBP56, TAF2N" ENSG00000270647 "TATA-box binding protein associated factor 15" Q92804 17 35713791-35864615 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052059, HPA063647" Supported Enhanced Nucleoplasm NA NA 44000 Nucleoplasm "HPA052059: AB_2681711, HPA063647: AB_2685072" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (1.10e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (8.48e-3)" "unprognostic (4.75e-2)" "unprognostic (8.06e-3)" "unprognostic (2.08e-2)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (1.79e-2)" "unprognostic (1.39e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-2)" "unprognostic (2.99e-1)" 62.5 75.4 63.4 75.2 63.0 69.8 57.8 61.1 62.5 70.7 61.5 71.8 56.9 70.5 41.2 103.5 62.1 33.7 72.6 59.2 61.8 52.4 82.7 57.7 90.8 65.2 61.9 56.1 66.5 74.7 54.8 71.8 48.6 65.1 63.6 49.1 54.7 66.4 38.5 131.4 79.4 79.3 38.3 62.3 77.0 77.2 88.5 64.0 96.4 59.0 38.7 75.8 75.3 72.7 63.1 216.8 347.3 190.2 191.2 149.6 88.5 108.3 247.9 79.1 109.7 107.0 244.5 151.1 440.1 166.9 145.2 122.2 239.6 254.0 232.8 166.0 112.9 187.1 250.6 264.3 261.1 145.3 401.1 168.4 135.7 143.6 155.3 266.0 137.0 140.1 238.5 233.3 188.9 148.1 270.4 442.0 96.0 117.0 205.9 40.2 255.7 279.6 164.7 149.3 399.1 130.1 136.6 299.6 97.8 98.3 231.0 224.5 144.9 214.1 86.1 178.3 115.8 310.1 165.6 198.4 303.4 173.7 190.1 134.1 1.4 1.0 1.2 1.7 1.4 2.0 1.0 1.0 1.2 0.7 1.2 0.9 1.2 0.9 2.0 1.5 1.0 1.5 0.9 63.4 63.0 61.1 62.5 59.2 61.8 65.2 61.9 56.1 65.1 62.3 64.0 63.1 38.1 16.0 55.1 90.4 71.4 36.1 59.7 57.9 93.9 57.8 29.3 31.0 41.6 40.0 57.0 60.7 41.7 82.1 63.1 38.4 3.9 42.7 7.5 51.4 55.0 52.6 49.1 75.3 108.4 29.6 50.8 36.9 66.3 53.8 55.8 32.4 36.8 60.7 43.1 60.6 111.7 52.2 46.8 44.0 32.9 10.4 30.7 49.0 33.8 78.7 56.0 75.1 54.6 100.0 124.2 29.2 29.4 40.6 53.2 43.4 50.3 31.6 47.2 45.4 46.0 48.0 51.7 84.9 74.7 115.3 37.2 78.0 78.8 55.6 58.5 44.8 MTRNR2L6 ENSG00000270672 "MT-RNR2 like 6" P0CJ73 7 142666272-142667718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 962.6;choroid plexus: 385.4;skeletal muscle: 372.8" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 1037.7;Proximal tubular cells: 454.5" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 169.7;eosinophil: 127.3;neutrophil: 431.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 431.2" "Cell line enhanced" "Detected in many" "HeLa: 194.4;Hep G2: 136.7" "Secreted to blood" NA NA "unprognostic (5.34e-2)" "unprognostic (1.34e-3)" "unprognostic (3.80e-1)" "unprognostic (4.45e-3)" "unprognostic (1.33e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-2)" "unprognostic (3.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-2)" "unprognostic (6.02e-2)" "unprognostic (1.04e-1)" "unprognostic (3.69e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-3)" 44.3 73.5 385.4 13.9 385.5 11.9 8.9 385.4 962.6 2.9 385.4 41.7 18.9 11.3 7.2 22.6 7.2 9.6 164.8 435.8 385.4 71.0 53.4 6.6 5.6 421.9 385.4 385.4 7.1 27.8 20.9 0.0 11.3 402.7 13.9 27.5 36.2 28.1 8.8 372.8 22.1 31.0 8.7 389.3 14.9 27.4 24.1 385.4 5.5 3.6 76.7 11.7 6.2 0.0 386.7 17.9 29.5 9.8 67.9 11.2 5.7 16.5 18.3 1.7 1.8 3.1 9.7 31.5 15.2 23.0 3.5 1.4 60.6 0.3 3.6 1.6 9.7 11.2 21.3 194.4 136.7 3.7 4.4 21.7 9.8 4.3 1.5 4.8 37.9 1.7 18.1 18.6 22.2 5.4 9.9 8.8 48.3 3.8 9.6 3.5 14.0 8.4 11.6 11.6 25.5 6.5 24.1 4.9 11.4 39.0 14.1 15.9 29.8 21.3 19.3 19.3 23.2 6.4 8.8 4.2 10.4 11.5 26.9 4.8 169.7 49.8 127.3 12.4 26.8 12.2 45.0 15.0 15.0 23.0 36.7 16.4 21.2 431.2 24.8 25.3 22.9 17.2 62.4 385.4 385.5 385.4 962.6 435.8 385.4 421.9 385.4 385.4 402.7 389.3 385.4 386.7 0.8 38.5 47.7 0.0 1.9 6.4 8.5 1.5 0.0 0.0 1.8 1.9 1037.7 0.0 70.7 33.1 0.0 0.5 0.3 0.1 45.0 0.0 0.3 1.8 0.9 32.4 0.0 2.7 0.0 0.0 0.6 67.0 0.0 2.2 55.5 1.1 1.1 2.7 0.7 0.0 0.0 0.1 2.0 1.6 15.9 2.0 2.5 14.8 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 0.0 454.5 41.3 0.0 0.0 6.6 54.7 1.0 2.3 0.0 4.4 0.3 8.8 4.3 0.0 5.1 HSPE1-MOB4 ENSG00000270757 "HSPE1-MOB4 readthrough" 2 197500413-197550726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.6;Astrocytes: 1.6;Excitatory neurons: 1.5;Inhibitory neurons: 1.7;Oligodendrocytes: 1.6;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038755, HPA044125, HPA048272" Approved NA NA "HPA038755: AB_2676190, HPA044125: AB_2678822, HPA048272: AB_2680336" "unprognostic (7.69e-3)" "unprognostic (4.73e-2)" "unprognostic (2.53e-2)" "unprognostic (9.15e-2)" "unprognostic (8.80e-2)" "unprognostic (3.50e-1)" "unprognostic (4.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "unprognostic (7.91e-2)" "unprognostic (2.48e-1)" "unprognostic (2.32e-1)" "unprognostic (4.12e-1)" "unprognostic (3.52e-1)" "unprognostic (3.20e-2)" "unprognostic (2.26e-2)" 5.9 19.3 3.2 11.3 3.1 2.0 5.1 3.5 5.4 4.4 4.0 4.7 7.8 5.6 0.0 10.7 4.5 1.7 7.3 3.0 4.6 4.9 4.2 4.6 5.5 3.5 3.1 2.8 3.6 4.3 3.7 3.8 7.5 3.4 2.9 3.1 6.5 7.1 2.2 11.7 4.6 4.9 2.4 4.6 5.6 4.4 3.3 3.3 6.9 4.3 3.6 6.9 5.2 6.0 4.0 16.1 8.0 33.1 8.3 12.5 7.5 16.3 28.6 7.0 12.6 9.0 13.5 16.7 14.1 22.2 10.4 24.0 16.7 20.9 4.6 17.0 23.3 4.3 19.4 11.7 8.0 12.2 18.4 24.3 8.0 8.3 15.6 8.8 13.6 7.1 13.0 12.5 8.7 12.2 16.4 21.3 13.2 18.8 16.5 12.4 15.6 12.4 16.5 15.1 28.4 14.4 10.7 13.0 18.9 24.4 27.1 14.5 29.2 14.3 15.9 18.0 19.7 24.4 12.1 24.8 24.3 22.4 8.9 23.7 34.1 13.6 15.6 14.2 16.3 13.9 15.8 16.3 15.8 16.7 12.7 15.6 17.3 17.7 19.6 15.4 11.8 21.9 16.2 3.2 3.1 3.5 5.4 3.0 4.6 3.5 3.1 2.8 3.4 4.6 3.3 4.0 0.0 9.6 2.6 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 GAS2L2 GAR17 ENSG00000270765 "Growth arrest specific 2 like 2" Q8NHY3 17 35744511-35753239 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.4;fallopian tube: 16.5" "Group enriched" "Detected in some" 6 "Endometrial ciliated cells: 23.0;Respiratory ciliated cells: 32.8" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 2.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HaCaT: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044370 Enhanced NA NA "HPA044370: AB_2678915" "unprognostic (3.76e-2)" "unprognostic (1.43e-1)" "unprognostic (5.54e-3)" "prognostic favorable (7.00e-4)" "unprognostic (3.65e-2)" "unprognostic (1.07e-1)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (4.05e-2)" "unprognostic (4.09e-2)" "unprognostic (4.01e-4)" "unprognostic (3.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.16e-1)" "unprognostic (3.92e-2)" 0.6 0.0 2.3 0.0 1.1 0.0 0.5 1.0 1.0 0.5 5.4 0.1 0.0 0.2 1.9 0.0 16.5 0.0 0.1 0.9 1.2 0.1 0.0 2.0 0.0 1.7 2.2 0.7 0.0 0.1 0.1 0.0 0.0 1.6 0.1 0.0 0.2 0.1 1.2 2.8 0.3 0.1 0.0 2.5 0.0 0.1 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 1.0 1.0 0.9 1.2 1.7 2.2 0.7 1.6 2.5 1.0 1.2 0.1 0.0 1.1 1.0 0.1 0.6 0.0 1.3 0.0 0.1 0.6 0.3 0.5 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 23.0 0.2 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.8 0.0 0.0 0.0 0.5 0.2 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 RPS10-NUDT3 ENSG00000270800 "RPS10-NUDT3 readthrough" 6 34284887-34426071 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 58.7;Club cells: 19.2;granulocytes: 10.1;Respiratory ciliated cells: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 27.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047027, HPA047268, HPA048084, HPA055953" Uncertain Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.85e-2)" "unprognostic (7.54e-3)" "unprognostic (1.28e-2)" "unprognostic (6.85e-2)" "unprognostic (8.95e-2)" "unprognostic (2.67e-1)" "unprognostic (5.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.63e-1)" "unprognostic (5.17e-8)" "unprognostic (5.80e-2)" "unprognostic (9.49e-2)" "unprognostic (2.23e-1)" "unprognostic (1.42e-1)" 6.1 6.7 6.8 6.4 5.8 9.5 5.6 3.9 9.1 6.7 0.3 4.8 1.5 4.1 0.1 9.6 4.3 1.5 14.3 6.2 7.2 7.2 10.3 6.3 3.2 7.9 7.0 6.6 6.3 7.8 2.0 6.2 4.6 8.1 5.7 1.3 1.4 5.6 0.6 18.7 4.4 4.5 2.9 6.6 6.8 5.1 9.0 11.4 3.8 5.8 8.7 2.3 5.9 7.2 7.3 17.6 6.0 16.0 27.3 11.6 8.0 16.2 13.0 7.0 10.3 10.3 6.7 9.2 22.9 22.2 8.7 23.4 11.5 23.7 7.1 12.5 15.1 9.9 35.1 11.3 19.4 4.2 33.2 38.4 3.2 14.9 15.2 31.6 14.2 10.1 20.7 35.9 22.7 13.2 17.8 33.9 16.4 7.9 38.5 5.8 18.7 13.5 15.0 10.5 19.1 24.6 8.7 9.6 10.0 34.1 10.1 15.1 59.6 7.9 15.3 22.9 7.0 18.2 11.3 18.3 28.8 2.1 20.2 23.7 11.2 5.9 27.3 3.2 6.8 3.3 6.0 3.7 3.6 7.5 5.9 3.6 3.4 4.3 5.0 6.9 5.3 3.7 5.4 6.8 5.8 3.9 9.1 6.2 7.2 7.9 7.0 6.6 8.1 6.6 11.4 7.3 0.0 35.3 58.7 2.6 0.0 0.8 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 8.3 0.4 0.1 3.8 0.0 0.3 10.1 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.5 0.0 0.0 4.1 0.0 1.0 0.0 0.0 0.0 0.5 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 11.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 2.3 0.0 0.0 0.2 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760887-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 78 "testis: 106.5" "Group enriched" "Detected in some" 45 "Early spermatids: 769.0;Late spermatids: 1197.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HaCaT: 3.7;MOLT-4: 1.0" "Not detected" "Not detected" "HPA043184, HPA063464" Supported Nucleoplasm Yes NA Nucleoplasm "HPA043184: AB_2678358, HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.1 0.1 1.3 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.8 0.4 0.1 0.0 0.1 0.0 0.6 0.5 0.7 0.0 0.2 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.1 106.5 0.5 0.1 0.3 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.7 0.8 0.7 0.4 0.0 0.7 1.2 1.4 0.0 0.1 0.0 1.4 0.0 0.2 1.3 0.8 0.0 1.0 0.8 0.4 0.6 0.5 0.7 0.6 0.0 0.5 0.7 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.4 0.5 0.6 0.3 0.0 0.1 9.2 0.0 0.0 0.2 0.4 0.0 0.0 769.0 1.8 0.0 0.5 1.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.4 2.0 0.0 0.0 1197.7 8.4 0.4 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.2 5.7 0.0 0.1 0.4 1.0 1.5 0.2 6.6 0.0 0.2 21.8 7.2 0.0 0.0 0.0 0.1 0.1 0.5 0.1 IGHD5OR15-5B "IGHD5/OR15-5B, IGHD5OR155B" ENSG00000270824 "Immunoglobulin heavy diversity 5/OR15-5B (non-functional)" 15 21010494-21010516 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C14 "H4/n, H4F2, H4FN, HIST2H4, HIST2H4A" ENSG00000270882 "H4 clustered histone 14" P62805 1 149832659-149839767 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3" "Cell type enriched" "Detected in single" 21 "Cardiomyocytes: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 61.9;U-2 OS: 52.8;U-266/70: 50.6" HPA042201 Approved NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (1.90e-1)" "unprognostic (6.29e-2)" "unprognostic (1.50e-2)" "unprognostic (6.68e-2)" "unprognostic (3.65e-2)" "unprognostic (1.99e-2)" "unprognostic (6.99e-2)" "unprognostic (8.36e-2)" "unprognostic (4.66e-2)" "unprognostic (3.44e-1)" "unprognostic (4.91e-2)" "unprognostic (8.70e-2)" "unprognostic (6.78e-4)" "unprognostic (6.15e-2)" "unprognostic (3.63e-3)" "unprognostic (1.62e-2)" "unprognostic (5.99e-2)" 3.1 5.3 13.9 2.8 11.2 7.4 4.1 46.3 7.2 5.5 6.6 6.3 3.3 4.0 0.0 5.1 8.0 6.6 5.4 8.5 26.1 5.0 5.9 4.8 7.9 14.1 12.1 6.4 4.4 6.9 1.3 7.2 2.9 19.7 12.1 0.2 0.5 4.7 4.6 2.6 5.0 5.4 0.6 8.8 7.3 5.3 1.6 22.9 10.3 6.8 2.5 0.5 5.2 6.8 9.0 7.1 41.9 2.2 7.4 8.4 2.7 3.2 3.4 2.8 11.0 5.2 8.3 11.1 2.7 11.9 1.1 3.5 19.8 0.0 7.4 0.4 16.0 23.4 3.0 33.6 3.3 7.7 2.8 2.5 12.5 9.5 3.7 5.7 0.3 1.9 3.2 13.3 27.8 0.6 38.4 10.5 6.9 9.9 12.8 15.9 9.0 5.7 24.1 1.2 2.8 39.5 11.5 61.9 5.9 9.0 1.3 25.7 5.4 0.0 5.1 52.8 7.1 5.7 50.6 46.6 15.7 5.1 8.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 11.2 46.3 7.2 8.5 26.1 14.1 12.1 6.4 19.7 8.8 22.9 9.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 RASL10B "RRP17, VTS58635" ENSG00000270885 "RAS like family 10 member B" Q96S79 17 35731639-35743521 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;skeletal muscle: 31.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 13.8;Early spermatids: 10.4;Late spermatids: 34.6;Muller glia cells: 29.0" "Cancer enhanced" "Detected in many" "testis cancer: 14.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 24.3;HHSteC: 26.7;NTERA-2: 41.3;REH: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046842, HPA057092" Enhanced Approved Vesicles NA NA Vesicles "HPA046842: AB_2679835, HPA057092: AB_2683332" "unprognostic (5.78e-2)" "unprognostic (2.15e-2)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (8.60e-2)" "unprognostic (1.24e-1)" "unprognostic (2.69e-2)" "unprognostic (4.98e-2)" "unprognostic (1.97e-2)" "unprognostic (7.13e-2)" "unprognostic (2.61e-2)" "unprognostic (3.18e-2)" "unprognostic (1.71e-6)" "unprognostic (2.41e-3)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (9.60e-3)" 15.5 1.7 24.7 0.1 26.9 0.0 11.4 9.2 25.8 3.7 6.7 1.5 0.7 2.9 0.6 0.4 3.9 0.7 16.6 26.8 15.9 1.8 2.1 1.2 0.1 19.4 18.7 18.5 3.7 5.0 5.3 6.7 2.9 18.4 3.0 0.1 9.1 9.2 14.8 31.8 0.7 1.2 0.8 11.4 0.3 1.8 3.0 17.3 0.5 1.7 0.9 0.1 1.4 2.3 14.4 0.0 0.3 6.3 0.0 1.1 0.6 1.8 1.2 0.8 4.3 3.6 8.1 0.0 0.0 0.7 0.2 0.0 0.0 24.3 0.0 1.5 0.0 8.0 0.0 4.1 9.3 26.7 0.0 0.0 19.5 1.5 1.5 0.0 3.4 0.0 13.2 5.5 0.0 0.3 0.5 11.6 0.0 41.3 0.0 0.0 20.8 11.1 18.5 0.0 0.0 18.3 17.8 1.2 0.4 1.7 17.8 2.3 1.2 0.0 2.0 14.5 0.1 0.5 0.0 0.0 5.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 26.9 9.2 25.8 26.8 15.9 19.4 18.7 18.5 18.4 11.4 17.3 14.4 0.3 0.0 0.5 0.3 0.0 0.1 0.5 0.0 0.0 3.9 2.7 1.4 13.8 4.3 0.0 1.8 2.1 0.0 0.0 0.0 0.0 1.3 10.4 1.0 0.7 0.7 0.0 0.0 2.6 0.0 0.0 1.9 0.0 1.4 0.0 2.8 0.0 6.7 0.2 6.7 4.9 0.2 0.0 0.6 0.0 34.6 2.1 0.1 0.0 1.0 0.0 29.0 0.0 0.5 0.5 0.3 0.0 3.0 0.0 0.6 0.4 0.1 0.0 1.2 0.0 1.5 2.3 4.8 0.9 0.0 0.0 0.3 0.1 7.0 0.4 0.2 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863418-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 29.9;HMC-1: 111.3;U-266/84: 49.2" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 4.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 49.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5OR15-5A "IGHD5/OR15-5A, IGHD5OR155A" ENSG00000270961 "Immunoglobulin heavy diversity 5/OR15-5A (non-functional)" 15 20003840-20003862 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE15 CTAGE15P ENSG00000271079 "CTAGE family member 15" A4D2H0 7 143571801-143574387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (2.82e-1)" "unprognostic (8.64e-2)" "unprognostic (3.23e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-1)" "unprognostic (2.23e-1)" "unprognostic (4.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-2)" "unprognostic (3.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.33e-1)" "unprognostic (2.91e-2)" "unprognostic (2.39e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 1.6 0.5 0.0 0.0 0.2 0.6 8.1 0.0 0.0 1.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TLCD4-RWDD3 TMEM56-RWDD3 ENSG00000271092 "TLCD4-RWDD3 readthrough" 1 95117923-95247225 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" "Cytotrophoblasts: 1.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 11.7" NA NA "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.43e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.77e-3)" "unprognostic (4.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.70e-1)" "unprognostic (4.00e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.29e-2)" "unprognostic (3.42e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (1.42e-2)" 1.2 2.6 1.6 1.5 1.8 2.4 2.7 2.2 1.8 1.9 0.7 2.6 2.9 2.2 3.2 1.3 2.1 1.8 3.4 1.3 1.8 1.8 8.8 1.3 2.6 1.6 1.5 1.5 2.3 3.1 2.0 1.6 3.2 1.8 2.5 2.6 3.0 2.4 1.5 3.1 3.2 2.3 1.8 1.5 1.8 2.9 1.8 1.5 1.2 3.1 1.2 2.0 1.3 1.0 2.2 5.8 3.4 3.1 4.1 1.3 2.4 3.5 1.1 0.7 2.1 2.4 5.3 2.3 2.1 3.8 1.2 5.9 1.4 3.0 1.5 2.3 1.6 1.9 2.6 3.8 1.3 1.1 0.8 0.8 1.4 1.7 1.9 0.5 2.5 1.0 1.9 4.3 1.3 1.2 1.6 1.8 2.1 1.5 1.0 1.7 1.5 11.7 0.4 2.9 5.9 3.0 3.4 4.2 3.2 4.1 2.2 2.3 1.9 2.1 2.3 3.1 2.2 3.1 1.9 1.3 1.3 1.1 0.5 1.6 0.1 0.1 0.2 0.2 0.1 0.1 0.6 0.4 0.1 0.3 0.5 0.4 0.1 0.0 0.1 0.1 0.1 0.3 0.2 1.6 1.8 2.2 1.8 1.3 1.8 1.6 1.5 1.5 1.8 1.5 1.5 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 IGHV3OR16-8 IGHV3/OR16-8 ENSG00000271130 "Immunoglobulin heavy variable 3/OR16-8 (non-functional)" 16 33009175-33009620 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 32.3;lymphoid tissue: 49.8;stomach 1: 33.2;urinary bladder: 41.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 13 "memory B-cell: 7.3" "Lineage enriched" "Detected in single" 74 "B-cells: 7.3" "Not detected" "Not detected" NA NA "unprognostic (2.58e-4)" "unprognostic (3.25e-2)" "unprognostic (9.53e-3)" "unprognostic (1.56e-1)" "unprognostic (2.43e-4)" "unprognostic (1.31e-1)" "unprognostic (4.47e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (2.60e-7)" "unprognostic (2.24e-2)" "unprognostic (4.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.16e-2)" 2.3 0.8 0.0 13.9 0.0 5.9 4.5 0.0 0.0 2.8 0.0 30.4 32.3 0.2 0.0 2.0 0.7 5.3 0.0 0.0 0.0 0.1 0.9 3.2 3.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 14.9 0.0 10.1 0.0 0.0 0.0 9.1 1.8 0.0 5.9 33.2 0.1 0.0 3.0 0.7 0.0 49.8 41.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR16-13 IGHV3/OR16-13 ENSG00000271178 "Immunoglobulin heavy variable 3/OR16-13 (non-functional)" 16 33827214-33827661 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 32.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "stomach cancer: 4.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 28 "memory B-cell: 18.1" "Lineage enriched" "Detected in single" 181 "B-cells: 18.1" "Cell line enriched" "Detected in some" 818 "Daudi: 1604.0" NA NA "unprognostic (7.59e-4)" "unprognostic (4.14e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.23e-5)" "unprognostic (1.34e-1)" "unprognostic (2.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "unprognostic (3.26e-5)" "unprognostic (6.83e-2)" "unprognostic (1.71e-1)" "unprognostic (3.09e-1)" "unprognostic (3.04e-1)" 0.1 0.0 0.1 5.4 0.0 0.6 0.4 0.0 0.1 1.3 0.0 6.6 6.1 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.2 0.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.0 7.0 0.0 0.0 0.0 4.0 0.1 0.0 32.5 4.2 0.0 0.0 1.0 0.3 0.0 10.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1604.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC240274.1 ENSG00000271254 "Neuroblastoma breakpoint family member 1" Unmapped 4612-29626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 186.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " 12.1 29.3 16.5 10.5 19.0 9.5 11.1 20.0 16.7 12.8 14.4 21.3 17.2 18.3 13.4 9.7 18.8 12.5 8.0 14.8 17.5 15.1 8.2 12.9 6.6 22.8 21.7 14.0 29.9 5.7 18.2 14.7 27.1 11.7 22.0 13.9 11.3 9.3 11.0 11.9 25.2 16.5 20.0 13.0 8.6 40.9 19.2 6.9 12.1 6.9 7.5 8.6 23.4 25.6 33.3 36.9 26.2 12.1 13.2 8.4 37.6 22.7 34.4 28.8 12.2 9.7 20.0 2.9 34.8 11.9 14.0 14.3 7.0 46.2 13.4 29.2 5.4 19.6 16.7 16.4 17.5 11.4 8.7 10.0 19.6 15.6 22.3 9.8 32.6 24.4 6.7 13.5 35.0 21.5 7.5 5.8 3.6 79.2 38.4 23.5 2.9 8.3 14.0 27.3 44.2 37.2 31.0 16.0 10.8 28.1 5.2 13.3 21.2 21.5 53.0 17.1 7.8 28.3 16.1 5.2 26.3 7.6 1.5 0.8 1.1 0.6 0.8 1.1 0.6 0.4 0.4 0.3 0.9 0.6 0.7 0.7 2.3 0.6 0.5 0.0 0.4 16.5 19.0 20.0 16.7 14.8 17.5 22.8 21.7 14.0 27.1 20.0 19.2 23.4 2.5 22.4 11.6 0.0 1.4 0.0 1.6 0.0 6.8 2.0 4.3 4.8 0.0 1.5 4.3 0.0 4.2 9.5 0.7 12.9 1.9 2.5 46.1 2.1 3.6 4.4 0.0 5.2 0.0 2.7 12.8 6.4 3.6 1.6 15.2 14.3 2.5 2.7 6.9 0.0 0.0 4.3 0.0 4.2 0.0 11.0 16.8 5.2 0.0 0.0 4.0 2.4 2.1 0.0 0.0 2.8 3.4 18.4 0.6 0.9 5.7 1.6 10.9 1.4 6.6 6.1 2.3 186.6 46.2 5.9 0.0 2.6 1.6 33.3 3.6 0.9 UGT2A2 ENSG00000271271 "UDP glucuronosyltransferase family 2 member A2" "P0DTE4, P0DTE5" 4 69588417-69639642 "Enzymes, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "kidney: 6.3;liver: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRXN1 "C20orf139, dJ850E9.2, Npn3, SRX1, YKL086W" ENSG00000271303 "Sulfiredoxin 1" Q9BYN0 20 646615-653200 "Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Ductal cells: 4.4;Erythroid cells: 4.8;Excitatory neurons: 4.5;Exocrine glandular cells: 6.8;Inhibitory neurons: 5.8;Pancreatic endocrine cells: 6.5;Squamous epithelial cells: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 12.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.31e-3)" "unprognostic (6.08e-3)" "unprognostic (2.50e-1)" "unprognostic (5.49e-2)" "unprognostic (1.70e-2)" "unprognostic (1.18e-3)" "prognostic unfavorable (6.22e-5)" "unprognostic (1.37e-3)" "unprognostic (1.69e-1)" "unprognostic (1.58e-2)" "unprognostic (5.26e-2)" "unprognostic (2.48e-1)" "unprognostic (7.71e-2)" "unprognostic (1.79e-2)" "unprognostic (7.57e-2)" "unprognostic (1.57e-2)" "unprognostic (1.52e-3)" 16.6 63.2 27.3 10.4 26.0 24.2 12.5 28.1 28.8 16.0 22.8 16.5 18.2 16.6 15.1 63.5 15.5 16.4 35.8 25.6 32.8 23.4 37.0 21.4 5.7 31.0 31.0 24.9 16.7 16.1 33.0 22.3 14.1 29.4 15.8 15.2 20.1 18.3 18.5 46.0 11.4 16.8 19.4 26.8 14.6 32.3 8.6 30.8 4.6 27.1 21.9 10.6 26.3 22.9 30.0 119.4 201.0 13.2 26.3 54.5 60.3 30.0 83.6 64.9 58.4 34.2 69.4 63.5 21.8 52.3 133.8 260.2 58.5 50.3 132.9 56.0 23.2 28.2 86.6 43.8 221.7 73.4 37.4 51.4 38.7 121.5 79.3 76.5 47.9 64.3 32.5 76.5 88.5 64.8 35.4 0.2 20.5 26.6 183.8 73.8 0.4 18.1 45.7 41.0 42.3 16.8 32.2 65.5 144.5 98.8 35.8 49.3 23.0 66.0 80.9 56.5 73.5 119.6 23.1 63.7 17.3 51.5 18.0 67.8 2.4 2.0 3.0 2.0 1.8 1.4 0.4 1.0 2.5 1.0 0.0 0.0 0.7 12.3 0.5 2.2 0.1 1.1 0.4 27.3 26.0 28.1 28.8 25.6 32.8 31.0 31.0 24.9 29.4 26.8 30.8 30.0 0.2 0.0 0.0 3.3 0.3 0.1 0.1 0.2 1.8 0.7 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 2.9 0.0 4.4 0.0 0.2 0.5 0.6 1.2 4.8 4.5 6.8 0.3 0.8 1.5 0.3 0.0 0.1 0.0 0.4 1.0 0.0 5.8 1.4 0.0 0.0 0.3 0.1 0.0 1.3 0.0 3.7 2.1 0.2 0.0 1.0 0.9 6.5 0.8 0.4 2.4 0.3 2.8 0.2 0.1 0.3 0.0 0.1 1.6 0.0 0.0 9.7 0.0 0.0 0.9 0.1 2.0 0.0 IGHD4OR15-4A "IGHD4/OR15-4A, IGHD4OR154A" ENSG00000271317 "Immunoglobulin heavy diversity 4/OR15-4A (non-functional)" 15 20004797-20004815 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE6 "CTAGE6P, MGC41943" ENSG00000271321 "CTAGE family member 6" Q86UF2 7 143755089-143757696 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 14.5" "Cell type enhanced" "Detected in some" "Early spermatids: 4.1;Microglial cells: 1.0;Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.51e-2)" "unprognostic (8.90e-12)" "unprognostic (1.73e-2)" "unprognostic (2.86e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 14.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 IGHD1OR15-1A "IGHD1/OR15-1A, IGHD1OR151A" ENSG00000271336 "Immunoglobulin heavy diversity 1/OR15-1A (non-functional)" 15 20011153-20011169 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF19 ENSG00000271383 "NBPF member 19" A0A087WUL8 1 149475338-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 73.1;Paneth cells: 123.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (7.92e-3)" "unprognostic (9.12e-2)" "unprognostic (2.95e-2)" "unprognostic (8.53e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-3)" "unprognostic (5.59e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-4)" "unprognostic (3.54e-3)" "unprognostic (2.12e-1)" "unprognostic (1.76e-2)" "unprognostic (1.92e-5)" "unprognostic (1.10e-1)" "unprognostic (3.32e-1)" "unprognostic (8.93e-2)" "unprognostic (4.61e-2)" 38.5 9.1 13.9 31.6 10.5 56.1 29.0 5.1 33.8 26.1 36.5 19.3 10.7 29.1 24.6 24.8 29.7 16.9 10.3 12.3 20.8 14.5 19.1 27.5 30.4 8.0 11.3 3.0 49.2 34.0 17.5 3.8 15.0 12.1 25.0 21.9 58.1 20.8 15.6 15.1 63.9 13.5 30.7 2.3 37.1 13.3 28.9 17.2 33.8 20.9 18.4 26.8 19.3 9.3 14.3 62.9 16.4 33.8 18.0 65.9 55.4 16.0 29.8 22.4 20.2 19.4 14.7 21.9 18.1 7.0 45.4 26.7 27.8 47.8 27.6 30.9 32.6 26.8 51.6 49.1 5.2 13.1 51.9 18.0 38.5 12.1 58.7 73.5 27.6 13.3 25.1 12.7 27.6 43.3 45.9 28.3 31.1 30.7 17.6 25.4 25.5 35.7 29.1 12.5 30.0 2.8 7.1 71.5 23.9 13.0 47.7 44.7 70.4 80.2 40.7 30.5 23.9 46.9 23.1 14.5 54.9 45.6 35.4 12.4 15.1 22.2 7.8 8.9 8.6 6.1 3.3 5.0 3.3 4.4 7.1 6.5 8.6 24.0 9.3 7.1 16.1 2.1 2.4 13.9 10.5 5.1 33.8 12.3 20.8 8.0 11.3 3.0 12.1 2.3 17.2 14.3 2.3 51.3 59.2 61.0 12.9 0.0 18.5 0.0 19.4 8.1 13.9 7.6 22.4 2.8 9.9 3.7 27.1 1.5 24.4 2.6 1.9 21.2 57.8 13.9 13.0 2.6 1.2 12.8 7.6 6.2 7.1 14.0 4.6 23.2 20.2 9.2 2.2 7.3 6.6 3.3 6.7 3.1 0.0 40.9 0.0 8.0 32.3 43.8 0.0 12.2 73.1 16.6 36.0 22.1 0.6 10.0 123.8 30.1 17.1 6.8 6.3 0.5 11.7 48.7 19.7 15.9 12.4 30.4 6.2 33.9 0.0 1.4 26.3 2.8 6.0 11.5 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064711-146229000 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Alveolar cells type 2: 46.1;Basal keratinocytes: 57.0;Langerhans cells: 100.9;Suprabasal keratinocytes: 105.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 3.8 1.2 3.4 2.9 2.8 7.7 4.4 2.1 5.9 5.0 7.1 2.8 1.1 3.5 3.9 2.8 3.1 2.2 1.3 3.6 6.5 2.0 3.2 3.3 2.6 3.7 2.6 1.5 5.4 3.4 3.3 0.3 2.5 3.0 2.7 2.8 4.6 2.0 3.0 1.0 7.4 1.2 3.5 2.2 4.4 1.8 3.4 3.5 2.7 2.4 2.2 2.4 2.2 1.4 4.3 6.4 1.7 3.6 2.4 11.3 13.6 3.0 3.3 4.5 3.3 3.3 1.5 3.0 2.7 0.7 6.4 3.2 3.0 4.0 4.5 6.7 3.4 3.0 6.3 5.0 0.8 4.5 2.7 1.9 12.4 4.1 9.2 8.8 10.6 3.9 1.7 2.0 8.7 7.1 7.3 1.1 2.4 1.5 1.6 4.7 1.4 2.6 3.6 2.3 4.5 0.4 0.4 5.1 4.9 1.8 5.8 4.2 3.6 12.3 3.2 2.9 2.9 4.4 5.8 2.3 3.4 2.9 2.9 2.7 2.2 2.0 2.7 0.3 1.0 0.4 1.5 0.3 0.3 0.8 1.5 0.3 0.2 5.6 0.3 2.3 2.2 0.3 0.1 3.4 2.8 2.1 5.9 3.6 6.5 3.7 2.6 1.5 3.0 2.2 3.5 4.3 0.5 76.9 46.1 13.7 12.8 57.0 4.9 15.4 5.2 0.5 3.7 2.0 8.4 2.8 22.0 0.0 0.0 0.7 9.2 1.5 0.0 5.3 15.1 2.8 2.8 3.4 0.0 10.5 0.8 2.7 5.0 18.2 3.1 6.1 20.2 6.4 0.7 1.8 1.4 0.0 1.1 2.7 14.2 5.0 100.9 3.3 6.5 17.7 30.2 4.7 14.2 2.0 9.2 5.0 0.1 5.5 25.3 8.2 5.7 2.1 2.2 0.2 19.6 2.0 0.0 7.6 9.9 9.9 5.4 23.8 105.8 0.5 6.6 1.4 3.4 4.5 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 47.7;Basal respiratory cells: 56.8;Distal enterocytes: 82.0;Paneth cells: 46.2;Proximal enterocytes: 47.2;Urothelial cells: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 6.3;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 7 "T-cells: 6.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;HaCaT: 86.9;hTCEpi: 38.3;OE19: 41.7;RT4: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" NA NA Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 14.8 2.0 17.6 0.5 15.2 0.2 8.4 11.5 18.9 3.5 11.2 15.8 1.8 5.2 2.1 13.6 6.2 1.4 2.8 15.2 13.6 1.9 0.3 14.2 0.2 14.6 15.3 13.8 1.1 0.8 0.1 1.3 2.0 14.6 5.0 10.6 3.0 2.5 3.5 1.8 22.8 10.3 4.1 12.3 1.1 8.9 22.4 17.5 0.3 6.0 2.4 3.2 16.4 7.6 12.6 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.1 1.5 0.0 0.1 86.9 0.0 0.2 0.0 0.0 0.7 0.0 0.2 0.0 4.3 0.0 0.0 1.2 38.3 0.0 3.1 0.7 0.3 0.3 0.0 0.2 0.0 0.3 0.1 0.3 0.0 41.7 0.1 0.8 0.0 0.0 0.0 15.7 0.2 0.7 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.6 0.2 1.0 0.0 0.4 6.3 3.7 0.0 0.9 0.2 0.9 0.0 0.4 17.6 15.2 11.5 18.9 15.2 13.6 14.6 15.3 13.8 14.6 12.3 17.5 12.6 31.5 28.9 26.5 47.7 0.4 38.5 5.3 56.8 21.1 2.7 1.0 1.5 1.3 7.2 15.2 7.3 0.0 0.0 0.2 82.0 0.0 1.2 6.7 0.1 0.0 16.8 3.6 0.4 2.8 0.4 0.0 4.4 12.2 0.1 0.0 0.0 17.9 0.0 0.1 1.7 4.8 32.9 2.0 0.0 1.8 13.4 1.2 0.5 3.6 10.3 0.4 9.4 1.0 1.0 0.6 16.7 46.2 3.0 0.1 8.6 47.2 0.8 4.5 0.5 6.6 0.7 5.5 1.1 3.7 34.9 33.1 0.0 1.0 0.1 21.5 43.9 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL5 "D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228" ENSG00000271503 "C-C motif chemokine ligand 5" P13501 17 35871491-35880793 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 123.1;lymphoid tissue: 136.3" "Group enriched" "Detected in many" 8 "dendritic cells: 2049.9;NK-cells: 2344.0;T-cells: 1947.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 6788.6;memory CD8 T-cell: 7164.3" "Group enriched" "Detected in all" 7 "NK-cells: 2041.1;T-cells: 7164.3" "Cell line enhanced" "Detected in some" "HL-60: 94.1;NB-4: 539.9;THP-1: 139.9;U-937: 120.1" CAB078447 Enhanced "Secreted to blood" NA NA 20100000 2900000 "CAB078447: AB_223462" "unprognostic (3.91e-3)" "unprognostic (1.50e-3)" "unprognostic (8.63e-2)" "prognostic favorable (1.34e-5)" "unprognostic (1.36e-3)" "unprognostic (6.37e-3)" "unprognostic (8.70e-2)" "unprognostic (2.64e-2)" "prognostic favorable (2.42e-4)" "unprognostic (3.26e-3)" "unprognostic (1.64e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.70e-2)" "unprognostic (7.55e-2)" "unprognostic (8.56e-3)" "unprognostic (3.73e-2)" 11.9 17.2 4.1 36.7 4.8 123.1 19.7 4.0 6.5 15.7 6.8 28.0 49.1 15.9 14.5 16.0 14.2 43.3 8.9 4.2 4.9 7.5 28.6 57.9 136.3 6.7 6.0 3.7 17.1 7.1 3.0 3.9 6.4 6.4 10.5 25.8 0.3 33.8 7.9 4.8 4.0 85.2 10.6 6.1 125.0 48.4 4.6 5.2 29.8 11.6 2.8 33.7 31.7 9.6 7.5 0.7 0.5 0.2 0.0 0.5 0.4 0.8 0.3 4.0 17.8 20.8 0.4 1.7 0.3 1.6 0.9 1.3 0.9 0.0 0.0 2.3 6.5 0.3 0.0 1.5 0.6 0.5 94.1 0.8 0.1 0.2 5.5 0.3 0.0 0.2 0.1 0.1 12.5 0.2 0.6 0.1 539.9 0.5 0.0 0.0 0.6 0.2 14.0 0.2 0.5 0.1 0.5 0.2 1.2 13.4 0.5 0.2 139.9 0.3 0.6 0.3 0.6 0.4 14.2 6.6 0.8 0.4 120.1 1.3 657.8 30.0 35.8 6788.6 21.3 4221.0 61.3 1394.5 7164.3 49.8 41.6 332.4 4032.4 189.9 2041.1 26.1 46.5 25.9 6664.4 4.1 4.8 4.0 6.5 4.2 4.9 6.7 6.0 3.7 6.4 6.1 5.2 7.5 22.4 99.3 244.4 0.3 55.2 7.4 1.3 6.0 4.6 1.3 19.9 18.2 5.4 21.5 41.7 1.8 0.0 1.8 2049.9 3.1 1.9 6.3 1.2 5.5 5.4 24.2 1.8 106.3 0.5 0.2 7.1 26.0 46.9 6.7 80.8 0.2 45.0 7.0 33.8 0.0 0.3 3.5 0.0 48.0 25.0 0.1 0.3 256.3 12.4 2.8 38.5 0.4 2344.0 0.0 0.4 1.6 6.9 0.4 179.5 1.7 2.4 6.7 29.2 1.1 0.0 6.5 28.2 1.1 1.2 5.5 6.3 16.0 1947.0 0.1 3.5 1.9 PPIAL4E ENSG00000271567 "Peptidylprolyl isomerase A like 4E" A0A075B759 1 144372875-144373659 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (6.97e-2)" "unprognostic (5.22e-2)" "unprognostic (2.28e-1)" 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.3 0.2 0.1 0.3 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 LIX1L MGC46719 ENSG00000271601 "Limb and CNS expressed 1 like" Q8IVB5 1 145933423-145958017 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063598 Approved Cytosol NA NA Cytosol "HPA063598: AB_2685055" "unprognostic (5.21e-2)" "unprognostic (4.09e-1)" "unprognostic (6.84e-3)" "unprognostic (2.85e-2)" "unprognostic (3.71e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (9.81e-2)" "unprognostic (3.46e-1)" "unprognostic (3.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.51e-2)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.10e-3)" "unprognostic (4.95e-1)" "unprognostic (1.25e-2)" "prognostic unfavorable (5.27e-4)" 20.1 19.1 14.2 15.3 14.8 6.4 16.1 14.3 13.2 26.2 16.5 18.4 6.8 27.8 11.2 9.9 21.3 15.7 16.1 12.6 13.7 9.8 10.3 15.7 20.6 15.3 15.3 11.5 37.2 5.8 7.5 16.4 16.3 15.0 16.3 9.3 19.2 9.5 21.0 35.1 7.4 13.4 26.0 13.8 21.0 11.4 6.6 15.4 16.8 10.9 31.8 20.9 21.3 17.0 15.3 7.3 10.3 31.0 34.5 63.4 53.5 0.4 16.3 29.4 24.8 18.1 0.8 6.7 19.6 17.5 33.1 9.3 0.4 14.6 13.6 23.3 18.2 4.5 10.9 11.0 10.4 20.8 26.2 24.8 32.9 6.2 20.3 29.3 39.9 48.7 25.8 16.4 30.6 39.9 0.2 34.6 21.8 9.0 0.1 13.2 23.2 15.6 32.4 25.7 0.2 11.1 31.6 33.5 0.1 24.9 12.8 1.2 20.3 38.0 41.9 11.5 27.6 27.8 24.5 18.7 19.9 29.5 21.4 20.7 4.0 2.2 3.9 5.7 2.2 7.0 3.0 6.6 5.8 2.1 3.1 6.1 8.0 3.7 3.8 3.8 3.3 5.4 2.6 14.2 14.8 14.3 13.2 12.6 13.7 15.3 15.3 11.5 15.0 13.8 15.4 15.3 29.7 0.0 5.8 11.1 23.1 11.3 10.6 10.8 11.4 17.1 3.8 7.5 17.5 14.3 4.9 11.0 8.4 1.4 18.6 2.8 3.9 9.6 10.4 2.3 21.6 36.7 12.6 23.5 5.1 10.0 4.3 28.4 2.6 3.5 5.1 10.8 45.7 19.6 21.1 13.5 6.1 1.4 8.2 24.3 43.8 3.6 35.8 18.8 28.4 15.9 27.4 28.1 35.0 8.5 7.0 11.0 1.2 56.4 17.8 7.5 0.1 7.7 3.0 13.6 26.3 16.8 37.9 24.1 4.7 3.1 7.7 0.8 37.4 21.4 2.1 4.2 MILR1 "Allergin-1, C17orf60, MCA-32" ENSG00000271605 "Mast cell immunoglobulin like receptor 1" Q7Z6M3 17 64449037-64468643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in many" "dendritic cells: 40.5;granulocytes: 34.8;Hofbauer cells: 78.5;Kupffer cells: 33.3;Macrophages: 30.1;Microglial cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 85.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 47.4;CAPAN-2: 120.3;Daudi: 60.4;REH: 45.6;U-698: 63.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014347 Enhanced NA NA 50000 "HPA014347: AB_2732408" "unprognostic (8.40e-2)" "unprognostic (9.77e-2)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (1.17e-1)" "unprognostic (1.21e-2)" "unprognostic (1.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.25e-1)" "unprognostic (3.31e-2)" "unprognostic (5.99e-3)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.07e-6)" "unprognostic (2.51e-2)" "unprognostic (7.12e-3)" "unprognostic (1.09e-1)" "unprognostic (5.99e-2)" 8.5 5.1 3.8 25.6 4.2 18.0 5.1 3.8 5.6 7.4 5.3 5.0 4.8 3.4 4.4 3.0 2.7 8.2 3.9 3.8 7.2 2.7 4.0 9.5 24.5 6.3 4.6 3.1 3.0 1.8 1.8 1.8 16.4 6.6 2.8 8.5 0.8 3.5 2.5 1.3 1.8 6.0 8.4 7.1 17.2 3.1 2.4 5.5 4.3 2.7 0.7 21.4 9.0 2.1 7.1 7.2 1.7 0.2 0.3 4.5 47.4 0.6 0.1 5.2 0.9 10.3 0.1 120.3 60.4 2.6 0.5 23.2 1.4 0.0 2.0 3.1 0.0 0.1 1.5 1.2 0.0 1.0 4.0 37.2 4.4 0.3 13.7 2.1 5.8 4.5 0.5 4.4 6.9 29.2 0.0 0.7 8.7 0.4 0.8 8.6 45.6 8.1 27.1 1.8 0.4 0.2 0.1 3.9 0.4 8.2 0.0 0.4 35.0 16.0 0.3 1.5 0.1 2.9 0.4 0.1 63.6 30.3 7.2 0.0 85.0 47.3 2.8 0.9 40.2 0.7 25.9 0.6 0.6 30.6 16.7 0.7 0.8 14.0 1.5 27.8 53.9 0.6 14.5 3.8 4.2 3.8 5.6 3.8 7.2 6.3 4.6 3.1 6.6 7.1 5.5 7.1 3.0 0.0 0.5 0.3 7.5 0.5 2.7 2.7 0.6 0.4 3.1 1.9 0.7 1.5 2.1 0.0 0.0 0.7 40.5 1.1 0.0 0.1 0.7 1.4 2.3 2.7 4.9 1.7 0.5 0.0 2.4 6.1 0.5 2.1 34.8 2.8 1.8 0.1 78.5 0.0 0.5 0.7 2.0 33.3 13.9 0.4 4.1 30.1 0.0 43.1 10.1 0.5 4.1 1.5 0.5 0.0 1.4 1.5 1.2 2.4 0.2 0.0 0.2 1.4 0.0 14.9 3.0 0.3 0.4 0.2 1.7 1.2 1.5 0.1 1.9 2.4 AL603832.3 ENSG00000271810 "Novel protein, PPM1J-RHOC readthrough" 1 112702614-112711433 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.42e-2)" "unprognostic (4.26e-2)" "unprognostic (6.22e-2)" "unprognostic (2.69e-2)" "unprognostic (2.41e-2)" "unprognostic (1.03e-3)" "unprognostic (1.01e-2)" "unprognostic (1.48e-1)" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-4)" "unprognostic (1.53e-3)" "unprognostic (3.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" 0.4 1.8 1.3 0.7 1.3 0.5 1.5 1.1 2.6 0.3 1.0 0.6 1.0 0.5 1.9 0.4 0.2 0.2 0.7 1.2 1.3 0.7 0.4 1.3 0.1 1.3 1.4 0.9 0.8 0.0 2.7 0.0 0.9 1.4 0.5 0.8 1.3 0.1 2.2 1.5 0.1 0.8 0.3 1.3 1.7 0.8 4.6 1.3 0.2 0.4 1.0 0.1 0.4 0.0 1.6 2.7 0.0 0.7 1.5 0.4 2.1 0.1 1.4 1.4 0.2 0.8 0.4 0.5 0.0 0.4 1.8 0.9 0.6 0.6 1.3 0.1 0.0 0.2 0.2 0.0 0.3 1.6 0.0 0.0 3.3 2.7 1.7 1.4 1.7 3.6 0.3 0.6 0.0 1.3 1.9 0.0 0.0 0.3 0.7 1.4 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.6 1.9 1.2 3.5 0.7 0.0 1.7 1.3 1.0 0.0 0.1 0.0 0.0 0.3 2.5 0.1 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.1 1.3 1.3 1.1 2.6 1.2 1.3 1.3 1.4 0.9 1.4 1.3 1.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM32 ENSG00000271824 "Small integral membrane protein 32" A0A1B0GUA5 5 136191468-136193162 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "brain: 14.4;intestine: 13.0;kidney: 48.4" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 394.0" "Cancer enhanced" "Detected in many" "renal cancer: 12.4" "Region enhanced" "Detected in many" "basal ganglia: 14.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.35e-5)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (7.79e-2)" "unprognostic (2.11e-2)" "unprognostic (9.13e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.86e-2)" "unprognostic (1.75e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-3)" "unprognostic (8.05e-2)" 0.0 0.0 1.0 0.2 14.4 0.0 0.0 1.9 2.5 0.0 0.0 3.6 13.0 0.0 0.0 0.0 0.0 2.0 0.0 1.2 0.8 48.4 0.3 0.0 0.0 4.4 1.0 4.1 0.0 0.4 0.0 0.0 0.0 1.2 0.4 1.6 0.0 0.1 0.0 0.6 0.0 6.2 0.0 0.7 0.0 1.4 0.3 0.9 0.0 1.2 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 14.4 1.9 2.5 1.2 0.8 4.4 1.0 4.1 1.2 0.7 0.9 2.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 33.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 394.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959441-145964575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.4;skeletal muscle: 6.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.7;Excitatory neurons: 6.1;Inhibitory neurons: 5.8;Microglial cells: 3.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPMI-8226: 10.7;U-266/84: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol NA NA Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.6 0.7 4.1 1.2 6.3 0.2 0.6 5.8 12.4 0.8 0.0 0.9 0.9 1.6 0.6 0.6 1.1 0.6 1.2 5.5 3.0 0.4 0.5 0.6 0.9 1.4 1.7 7.0 1.2 0.3 0.9 2.9 0.2 2.9 1.2 0.2 3.5 1.0 1.1 6.4 0.4 1.2 0.8 0.0 1.0 0.8 0.4 4.0 0.4 0.6 2.6 0.9 1.1 0.8 5.4 1.2 0.6 0.6 2.0 2.8 2.2 0.3 2.2 4.3 0.5 1.3 0.2 0.6 2.4 0.2 2.9 1.1 0.5 0.9 0.6 0.3 5.0 1.4 0.1 1.8 0.0 0.4 0.3 1.9 2.0 0.2 1.8 2.0 3.0 0.7 1.9 1.2 5.3 3.3 2.2 1.0 0.7 0.2 0.1 2.5 0.2 0.5 10.7 0.9 0.0 2.8 2.0 0.4 0.1 1.3 0.2 3.0 0.3 0.7 5.1 3.5 4.4 1.1 3.6 7.5 0.3 5.0 1.9 0.4 0.0 0.0 0.2 1.1 0.1 0.8 0.5 0.5 0.6 0.1 0.6 0.7 1.1 0.1 0.1 0.0 0.0 0.6 0.3 4.1 6.3 5.8 12.4 5.5 3.0 1.4 1.7 7.0 2.9 0.0 4.0 5.4 0.4 0.0 0.0 0.3 1.4 0.3 0.4 0.3 1.2 9.7 0.6 0.6 3.0 0.0 0.2 0.0 0.0 0.0 1.0 0.3 1.9 0.3 0.8 0.2 0.6 0.8 0.0 0.0 6.1 0.2 0.0 0.6 0.0 0.2 0.0 0.1 0.4 0.1 0.2 0.0 5.8 0.0 0.0 0.0 0.3 0.5 0.3 0.6 0.0 3.7 0.2 2.1 1.0 2.0 1.3 0.1 0.3 1.5 0.1 0.3 0.0 0.5 0.0 2.1 0.0 0.6 0.9 0.7 0.4 0.6 0.1 0.1 1.4 0.7 0.1 0.1 GTF2H5 "bA120J8.2, C6orf175, FLJ30544, TFB5, TFIIH, TTD, TTD-A, TTDA" ENSG00000272047 "General transcription factor IIH subunit 5" Q6ZYL4 6 158168350-158199344 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 425.8;Proximal tubular cells: 504.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.04e-2)" "unprognostic (2.02e-2)" "unprognostic (2.50e-1)" "unprognostic (8.59e-3)" "unprognostic (3.56e-1)" "unprognostic (1.03e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "prognostic unfavorable (6.11e-4)" "unprognostic (3.13e-1)" "unprognostic (8.46e-2)" "unprognostic (3.58e-3)" "unprognostic (1.33e-2)" 18.2 21.7 19.5 8.4 21.3 5.1 14.2 19.7 32.7 9.2 18.5 9.6 7.5 8.1 21.0 10.2 10.8 7.9 14.1 20.3 21.8 17.8 22.0 7.8 10.0 19.9 19.3 20.0 10.3 11.4 13.6 3.2 8.4 20.2 12.9 7.9 18.4 9.1 11.0 28.0 7.3 8.3 9.7 20.3 9.2 9.0 15.2 19.6 15.6 8.5 18.3 9.9 11.4 3.1 22.0 18.5 14.6 24.3 27.5 32.2 40.7 20.8 30.2 26.4 24.7 30.4 10.2 17.4 20.6 48.5 29.6 42.7 13.7 12.0 29.4 29.3 26.6 33.3 28.1 16.1 44.2 29.4 16.1 14.4 36.2 30.2 23.8 29.0 48.5 19.9 29.3 34.3 14.7 46.7 11.1 24.7 39.1 25.2 23.2 17.3 15.6 15.1 32.4 50.3 16.2 18.4 14.7 26.9 26.1 27.0 31.0 21.6 38.1 31.8 18.4 22.5 25.5 39.4 14.1 16.9 30.0 37.1 15.3 38.0 11.6 23.8 16.9 25.4 31.1 22.4 32.7 27.9 25.9 30.6 27.8 33.0 31.7 5.6 31.9 33.4 41.9 35.9 24.3 19.5 21.3 19.7 32.7 20.3 21.8 19.9 19.3 20.0 20.2 20.3 19.6 22.0 79.5 44.8 58.4 16.6 49.6 45.5 113.4 232.9 46.1 45.7 91.3 122.2 86.8 88.6 130.4 141.6 16.7 187.8 62.9 44.6 418.7 130.1 425.8 207.5 76.0 61.8 46.6 33.7 15.6 122.4 167.4 93.0 54.0 120.6 65.2 126.7 92.4 180.4 162.0 47.1 18.7 75.1 166.8 80.0 49.2 103.3 112.5 80.3 80.0 11.2 120.6 120.5 117.4 14.1 25.9 92.1 52.7 110.2 24.6 94.3 71.2 504.1 205.0 50.2 72.3 71.8 87.7 227.3 130.6 98.4 63.1 132.8 57.8 177.5 76.1 127.2 Z84492.1 ENSG00000272104 "Novel protein" 3 50350892-50367923 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 4.8;Karpas-707: 6.5" NA NA "unprognostic (2.51e-1)" "unprognostic (9.06e-2)" 1.7 0.5 2.0 0.9 1.9 1.1 1.7 1.7 3.7 1.5 0.9 2.8 4.6 0.8 4.1 1.3 1.6 0.8 0.3 1.4 2.5 2.6 0.4 0.5 4.5 1.7 1.3 1.9 3.1 3.5 1.2 0.7 0.2 1.9 2.7 1.1 0.4 4.4 1.1 0.6 4.4 4.8 0.5 1.1 2.6 3.6 1.3 1.9 1.2 3.3 0.1 1.8 0.6 0.0 1.8 1.6 0.0 0.0 1.0 1.1 0.0 0.3 1.7 1.1 0.3 1.3 0.0 1.0 0.9 1.5 0.0 0.1 0.9 0.0 0.6 0.9 1.8 0.4 0.0 1.3 0.0 0.4 0.0 4.8 0.0 0.8 0.6 0.0 0.2 0.0 2.4 0.3 6.5 0.0 0.6 1.8 0.0 0.6 1.6 0.0 0.6 0.3 2.6 0.3 0.0 1.2 3.0 0.0 1.2 0.2 0.3 1.1 0.0 0.0 0.3 0.1 0.0 0.5 1.6 2.5 1.1 0.0 0.4 0.0 4.8 0.1 3.6 5.8 0.3 8.4 8.3 10.5 8.6 0.1 9.3 14.2 8.2 0.5 10.4 0.7 1.6 15.4 3.0 2.0 1.9 1.7 3.7 1.4 2.5 1.7 1.3 1.9 1.9 1.1 1.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AC19 "H2A/r, HIST2H2AA4" ENSG00000272196 "H2A clustered histone 19" Q6FI13 1 149851061-149851624 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 26.6" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 1820.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 1820.8" "Cell line enhanced" "Detected in many" "SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.63e-1)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (8.47e-2)" 40.5 28.0 41.6 10.2 33.1 21.1 40.5 56.9 31.6 101.1 39.2 36.2 10.9 10.1 0.0 67.3 45.6 6.9 29.0 29.0 49.8 52.3 58.8 141.7 3.8 53.1 29.4 17.5 53.7 13.8 3.0 27.5 4.8 32.2 157.6 1.0 6.2 41.5 0.0 30.5 81.2 32.2 0.0 45.0 125.6 64.9 110.8 41.6 9.7 29.3 2.6 1.4 47.8 125.3 114.2 14.9 41.0 4.2 9.4 0.0 0.0 12.9 31.6 0.0 0.0 0.0 26.4 13.9 0.0 36.4 0.0 10.0 23.0 0.0 0.0 0.0 20.4 53.9 5.4 35.5 15.5 0.0 5.2 27.4 0.0 0.0 0.0 0.0 9.7 0.0 18.7 32.9 61.2 0.0 85.0 18.5 5.6 15.7 75.7 31.8 14.3 6.4 20.1 0.0 5.9 37.8 16.1 98.8 21.2 9.1 5.3 38.5 8.9 0.0 6.9 71.4 14.1 4.5 270.8 249.5 20.8 0.0 26.9 11.6 314.7 206.9 388.5 34.8 121.2 35.8 72.9 30.4 32.6 135.6 93.1 22.8 21.6 1820.8 41.6 151.6 193.3 48.3 215.9 41.6 33.1 56.9 31.6 29.0 49.8 53.1 29.4 17.5 32.2 45.0 41.6 114.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 AC018709.1 ENSG00000272297 "Novel protein" 4 186426546-186555328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "testis: 30.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 2.6;OE19: 1.3;T-47d: 1.3" NA NA 0.0 0.0 1.3 0.1 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.3 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.7 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 30.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 1.4 1.1 0.0 0.1 0.2 0.6 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUDT3 DIPP ENSG00000272325 "Nudix hydrolase 3" O95989 6 34279679-34392669 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047027, HPA055953" Uncertain Approved Cytosol NA NA 87000 Cytosol "HPA047027: AB_2679907, HPA055953: AB_2682984" "unprognostic (2.42e-1)" "prognostic favorable (5.29e-4)" "unprognostic (9.63e-3)" "unprognostic (4.74e-3)" "unprognostic (3.60e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-3)" "unprognostic (4.21e-2)" "unprognostic (4.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.16e-1)" "unprognostic (4.63e-1)" "unprognostic (1.24e-2)" "unprognostic (3.28e-2)" "unprognostic (1.09e-1)" "unprognostic (1.54e-1)" "unprognostic (6.24e-2)" 12.9 13.0 73.6 11.5 69.3 12.1 14.9 46.2 73.7 17.3 35.5 10.5 9.1 13.3 30.3 12.4 17.5 9.3 20.9 66.7 60.3 18.1 12.2 13.4 13.8 65.0 60.8 60.8 19.9 10.6 30.2 5.7 10.5 62.8 12.9 11.0 43.5 11.5 17.6 71.4 13.5 9.5 13.1 63.5 16.7 9.9 7.7 73.9 11.5 25.5 52.2 15.0 9.5 7.4 62.9 11.0 8.0 20.9 41.2 13.7 22.9 8.7 7.9 13.2 8.0 5.7 9.7 7.2 37.3 10.5 14.3 5.1 9.2 11.0 21.3 14.7 14.5 15.2 42.9 10.4 20.7 13.0 41.5 21.7 20.8 18.8 9.0 16.8 9.9 23.2 20.1 42.5 14.0 12.6 11.4 28.7 48.1 13.4 32.5 7.3 24.7 17.4 39.2 18.2 22.7 29.3 32.4 17.5 24.4 32.1 6.0 23.6 28.2 25.7 15.6 5.7 14.1 17.4 11.7 28.7 27.9 9.7 40.1 25.4 1.4 3.9 9.2 2.1 4.1 2.4 2.2 2.1 1.9 4.4 3.0 1.9 2.2 2.8 1.4 4.2 2.1 1.6 1.8 73.6 69.3 46.2 73.7 66.7 60.3 65.0 60.8 60.8 62.8 63.5 73.9 62.9 36.6 16.0 26.7 0.0 41.4 59.9 72.2 32.4 51.8 117.0 30.5 27.9 47.5 62.9 25.0 42.3 118.9 34.7 28.2 16.1 13.7 19.2 4.1 25.0 38.6 67.0 49.1 40.8 0.0 28.5 32.0 36.4 19.4 37.2 13.9 30.3 109.6 56.1 76.0 169.9 0.0 29.0 22.4 107.1 79.2 8.1 37.6 65.2 53.4 0.0 90.1 137.4 42.2 0.0 0.0 27.9 16.0 63.2 22.8 90.1 25.3 24.4 46.4 126.6 59.2 68.1 35.0 45.6 83.9 58.4 60.2 19.6 26.5 32.8 31.8 64.7 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35717973-35738878 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.5;Rod photoreceptor cells: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 10.9 10.2 13.2 9.9 13.3 14.4 11.9 14.4 23.1 12.5 10.0 13.1 9.9 14.3 4.4 12.9 13.2 6.9 8.3 12.5 11.8 10.4 10.1 12.2 14.6 13.6 12.3 11.6 16.3 16.1 5.2 14.6 5.8 14.0 13.5 3.9 5.9 13.4 5.8 16.3 19.0 14.7 4.6 10.1 15.7 12.8 22.7 12.5 9.4 16.7 5.0 6.9 12.7 12.1 13.3 16.7 36.7 11.1 17.3 6.0 4.3 11.0 6.7 4.7 7.3 5.0 25.3 7.4 15.5 11.8 5.1 8.5 10.8 11.3 5.2 4.2 21.2 13.6 29.7 20.2 24.4 8.6 17.4 26.1 6.9 9.4 8.9 10.7 6.9 5.7 13.5 22.5 15.8 6.4 34.1 15.9 24.4 12.0 18.8 9.2 19.8 8.9 7.6 7.8 21.3 14.0 10.0 13.5 20.6 11.3 7.9 11.8 21.3 12.5 16.3 17.0 10.5 17.4 22.2 15.7 12.4 8.5 18.8 12.2 0.3 0.4 0.4 1.0 0.1 0.5 0.4 0.6 0.7 0.3 0.7 0.6 0.9 1.8 0.5 0.2 2.1 0.8 0.4 13.2 13.3 14.4 23.1 12.5 11.8 13.6 12.3 11.6 14.0 10.1 12.5 13.3 24.6 9.6 15.4 13.7 18.6 12.7 10.0 6.2 9.6 64.5 16.1 14.6 9.2 8.6 6.3 9.2 52.1 6.5 27.4 25.2 0.0 6.4 2.8 17.9 31.6 15.6 20.3 7.4 11.7 7.7 6.1 12.4 27.5 26.0 5.1 30.5 11.0 11.2 8.4 35.3 11.8 14.1 6.1 11.8 7.1 4.7 8.1 13.4 5.4 7.5 9.5 25.7 19.6 7.5 10.0 8.4 16.7 12.4 17.9 19.6 13.9 5.0 6.7 71.2 0.0 25.0 17.3 26.5 38.5 11.9 12.9 9.4 20.6 30.7 16.3 14.8 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" A8CG34 7 75416786-75486299 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 15.0 14.1 2.3 15.7 1.9 29.1 14.3 5.5 8.8 13.6 1.4 13.2 12.1 16.8 9.1 16.0 14.3 12.1 14.0 5.9 2.3 13.2 13.4 13.0 18.4 2.3 0.7 1.0 18.8 18.3 16.9 13.5 16.5 3.5 13.1 13.0 26.5 14.4 11.6 19.8 17.4 14.1 15.2 0.0 15.6 14.1 12.6 2.7 17.7 16.9 10.8 20.1 14.4 14.4 4.1 41.8 34.1 46.3 89.0 17.1 19.0 30.4 29.7 27.3 23.7 22.8 41.2 26.5 73.4 12.0 32.6 37.2 36.7 39.6 36.7 38.9 49.9 55.1 36.4 39.6 27.8 22.5 97.0 49.5 16.2 22.8 36.3 26.8 34.5 24.6 29.9 103.8 39.8 38.9 41.8 59.5 49.3 36.9 32.0 38.4 53.0 30.7 37.6 13.1 56.0 51.4 67.4 34.3 54.0 23.8 41.5 47.1 34.2 27.4 57.4 30.6 42.2 62.3 42.4 54.4 88.2 37.3 49.1 53.9 0.2 0.4 0.5 1.1 0.5 1.0 0.8 0.9 0.3 0.3 1.0 0.5 0.6 1.2 0.9 0.3 1.1 0.2 0.6 2.3 1.9 5.5 8.8 5.9 2.3 2.3 0.7 1.0 3.5 0.0 2.7 4.1 23.1 35.3 26.2 29.4 27.8 18.0 11.8 13.4 33.6 30.7 21.3 23.4 12.6 21.5 21.4 12.9 68.8 13.4 27.2 12.3 5.9 11.8 2.1 14.2 21.3 20.7 28.7 33.9 59.2 17.1 10.2 21.0 31.6 18.3 7.6 28.6 16.8 15.1 12.0 25.2 60.2 17.4 14.2 16.4 15.8 3.8 18.0 21.7 7.2 35.6 17.1 21.3 37.0 28.1 45.6 18.8 8.0 15.4 37.8 24.6 10.0 9.6 18.7 29.4 13.1 26.1 17.4 19.2 12.4 32.9 18.5 17.0 34.0 22.0 17.0 19.7 CD24 CD24A ENSG00000272398 "CD24 molecule" P25063 6 106969831-106975627 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 1645.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7" "Group enriched" "Detected in many" 237 "B-cells: 61.1;granulocytes: 86.2" "Cell line enhanced" "Detected in many" "NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5" "HPA045879, CAB078471" Approved Enhanced Vesicles "Intracellular and membrane" NA NA Vesicles "CAB078471: AB_10983158, HPA045879: AB_2732523" "prognostic unfavorable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 7.2 62.5 37.9 140.4 29.0 711.1 472.9 9.4 32.3 283.1 30.7 1081.8 89.8 183.2 231.6 1468.2 245.0 882.1 5.1 44.7 64.4 698.8 30.5 62.2 78.4 23.3 26.6 12.4 2.2 1395.1 2.5 12.6 153.0 16.5 150.1 747.7 2.6 960.2 551.9 1.4 77.6 70.4 118.7 21.8 29.8 607.2 5.0 24.3 15.4 1645.3 1.1 448.8 170.4 472.2 53.4 363.2 225.2 3.9 28.6 0.7 0.3 405.8 0.4 2.6 2.0 1.2 3.3 1.9 35.4 106.0 0.1 14.6 730.6 124.1 275.6 1.5 1.0 1.7 1.0 254.2 16.3 0.2 5.1 1.8 2.1 316.1 3.6 18.0 16.9 1.6 1.4 8.3 0.8 6.6 465.6 2.4 2.6 989.4 800.1 85.6 846.8 0.5 3.5 4702.6 931.5 612.4 448.7 250.0 1352.5 1.4 437.1 635.6 2.1 1.6 0.8 4.0 3.1 11.8 1.0 2.0 475.2 5.0 2.9 1.6 0.3 0.1 86.2 0.0 0.0 0.0 61.1 0.0 0.0 0.0 39.7 0.0 0.1 2.1 0.1 0.3 0.1 0.0 2.0 37.9 29.0 9.4 32.3 44.7 64.4 23.3 26.6 12.4 16.5 21.8 24.3 53.4 10.2 157.0 83.5 0.7 157.5 0.0 70.4 0.0 7.4 5.8 1109.4 325.4 1.5 1112.3 98.4 1302.1 2.1 749.2 13.7 1572.7 1590.6 1274.1 22.5 1237.6 254.2 38.6 575.4 5.3 0.6 3454.1 885.0 29.9 567.2 1441.8 10.8 0.6 97.5 9.7 70.8 0.0 5.7 463.6 0.0 7.6 0.0 53.4 10.2 17.6 0.0 1.0 32.6 1.0 0.0 0.0 0.1 1694.3 865.2 2.2 1.0 810.2 12.3 538.5 376.8 0.7 6.6 2.9 18.1 0.6 7.2 587.7 0.0 558.3 28.1 0.0 932.8 1043.7 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 41.9;skeletal muscle: 56.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 1.7;Astrocytes: 2.0;Excitatory neurons: 5.1;Inhibitory neurons: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 3.4;Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;OE19: 2.7" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 11.7 1.4 1.7 0.4 1.8 1.0 9.4 1.4 2.5 1.9 1.6 8.3 0.1 2.5 1.3 1.6 2.1 0.6 19.8 1.7 2.3 2.4 41.9 8.4 0.4 2.1 1.8 1.5 1.0 2.3 0.5 0.7 0.6 1.9 4.3 0.4 1.8 2.3 0.5 56.4 0.8 12.5 0.7 1.9 0.9 2.9 2.3 2.0 0.1 1.3 0.5 0.1 6.8 2.0 2.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.2 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.6 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.1 0.1 2.7 0.4 0.0 0.0 0.4 0.0 0.6 0.7 0.5 0.1 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.3 0.1 0.2 0.4 0.3 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 1.7 1.8 1.4 2.5 1.7 2.3 2.1 1.8 1.5 1.9 1.9 2.0 2.3 0.0 6.4 1.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407972-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "fallopian tube: 22.5;testis: 59.6" "Group enriched" "Detected in some" 4 "Early spermatids: 300.7;Spermatocytes: 128.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.3;RPTEC TERT1: 2.6;T-47d: 4.5" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: AB_2686501" "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.1 0.4 2.3 0.0 1.1 0.0 0.3 0.8 0.9 0.6 3.6 0.0 0.0 0.5 0.6 0.0 22.5 0.1 0.1 0.9 1.5 0.9 0.1 1.5 0.0 2.1 1.9 0.8 0.1 0.1 0.8 1.2 0.1 1.5 0.5 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.1 1.7 0.0 0.0 59.6 1.2 0.0 1.4 0.1 0.0 0.2 0.0 1.0 0.0 0.5 0.2 1.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.6 0.5 0.3 0.2 0.2 0.1 0.0 4.5 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.8 0.9 0.9 1.5 2.1 1.9 0.8 1.5 1.7 1.2 1.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.9 0.3 300.7 15.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.5 2.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 1.4 43.7 0.4 0.0 0.0 0.1 128.8 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 MUSTN1 Mustang ENSG00000272573 "Musculoskeletal, embryonic nuclear protein 1" Q8IVN3 3 52833114-52835019 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 1705.5" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4" NA NA "unprognostic (2.79e-2)" "unprognostic (3.73e-2)" "unprognostic (4.11e-1)" "unprognostic (2.60e-2)" "unprognostic (2.34e-2)" "unprognostic (6.21e-3)" "unprognostic (2.78e-1)" "unprognostic (1.13e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-3)" "unprognostic (6.00e-2)" "unprognostic (1.79e-1)" "unprognostic (8.11e-2)" "unprognostic (1.88e-2)" 72.3 10.2 107.2 9.4 111.1 6.6 46.8 105.1 177.5 79.9 109.6 25.5 8.4 45.0 49.5 45.3 52.5 42.9 114.6 102.2 102.6 17.6 12.6 31.3 5.4 118.3 105.2 98.2 37.9 6.6 1.6 12.2 4.5 137.6 44.2 21.4 0.8 26.5 59.8 1705.5 23.1 26.9 30.8 97.5 11.0 22.3 4.3 107.9 5.7 31.3 308.3 4.0 55.0 66.2 108.2 0.0 0.0 4.7 0.0 0.5 2.1 1.9 0.0 0.5 0.2 0.5 0.0 0.5 0.0 0.0 1.4 0.2 0.4 0.6 1.3 0.4 0.1 0.5 0.0 1.4 8.0 0.3 1.0 0.4 4.8 1.0 0.6 0.7 0.9 1.2 0.9 0.0 0.0 0.3 0.1 0.4 1.6 0.1 0.6 1.0 0.3 4.4 0.0 0.9 0.0 0.2 0.3 0.3 0.4 0.4 2.0 0.1 2.6 0.0 0.6 0.2 1.0 0.2 0.0 0.0 0.3 0.5 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 107.2 111.1 105.1 177.5 102.2 102.6 118.3 105.2 98.2 137.6 97.5 107.9 108.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF595 FLJ31740 ENSG00000272602 "Zinc finger protein 595" Q8IYB9 4 53286-88208 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 61.0" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 106.0;K-562: 249.2;SH-SY5Y: 159.9" NA NA "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.95e-1)" "unprognostic (6.98e-2)" "unprognostic (1.03e-2)" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-1)" "unprognostic (6.63e-3)" "unprognostic (2.52e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (4.56e-3)" "unprognostic (2.31e-1)" "unprognostic (2.68e-1)" "unprognostic (6.46e-2)" 7.4 8.5 4.3 7.2 4.9 9.0 10.0 12.1 7.0 8.7 1.7 6.5 4.3 10.8 6.1 5.2 7.7 5.1 4.6 4.4 4.2 4.9 6.3 7.2 10.2 6.2 4.7 3.3 14.8 10.2 5.4 4.2 61.0 7.3 7.5 6.2 10.2 5.7 4.3 5.4 7.2 6.1 11.0 3.7 9.5 6.4 8.8 4.4 10.7 10.4 6.7 10.1 6.0 7.4 6.5 4.0 13.8 8.9 8.3 50.4 61.9 68.3 4.8 4.4 5.3 6.9 6.6 5.7 106.0 7.9 4.0 9.0 3.0 50.3 4.7 7.8 8.5 7.2 0.4 0.1 0.0 3.2 0.1 26.8 6.8 6.1 5.2 5.5 5.7 4.4 47.9 249.2 1.1 4.3 30.5 0.3 29.6 15.6 0.0 6.2 0.1 2.0 0.1 7.7 4.5 7.3 159.9 6.1 7.0 2.8 35.3 50.3 17.1 29.3 5.4 39.3 3.2 6.1 0.4 53.4 12.6 0.2 0.1 18.0 5.9 2.7 16.0 8.5 3.5 3.9 16.3 4.7 5.8 4.3 17.3 6.4 6.3 4.5 23.3 3.2 15.7 4.0 4.9 4.3 4.9 12.1 7.0 4.4 4.2 6.2 4.7 3.3 7.3 3.7 4.4 6.5 9.1 6.4 11.7 10.7 11.3 4.6 10.1 4.3 6.8 8.7 5.0 6.5 5.6 8.6 12.5 3.7 2.1 10.5 10.8 2.9 15.6 8.1 5.4 2.0 7.6 9.9 0.0 1.7 21.9 4.4 9.8 8.2 3.1 2.6 7.6 18.8 10.8 3.8 4.0 3.3 24.0 3.4 2.0 1.8 4.2 6.1 11.1 2.7 5.4 22.5 1.6 11.8 33.0 24.1 34.9 3.1 2.9 9.1 13.2 6.4 3.0 4.6 2.3 6.8 0.0 9.7 5.7 16.0 16.8 2.6 4.5 8.5 5.0 9.3 3.4 6.6 AC026464.6 ENSG00000272617 "Novel protein, COG8-PDF readthrough" 16 69328644-69334871 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA 8.1 9.3 9.4 8.8 9.6 6.4 7.7 9.7 13.8 6.5 9.3 9.1 9.0 5.9 9.6 6.0 5.9 3.8 5.3 9.6 10.7 21.7 23.2 7.2 7.7 9.5 9.4 9.1 5.4 7.0 18.1 4.2 6.6 9.8 7.0 8.8 4.9 8.4 6.4 12.7 5.4 8.0 7.6 8.9 6.2 6.0 21.4 9.4 9.7 7.1 12.2 9.7 8.8 3.0 10.1 24.1 31.8 23.8 28.3 27.3 17.6 18.6 24.3 23.5 35.2 35.2 35.9 34.2 33.3 17.3 26.1 20.7 31.9 38.3 32.1 27.9 8.3 19.1 20.0 27.7 65.2 25.5 38.4 17.7 18.3 35.4 35.9 26.3 17.1 21.2 37.8 34.4 15.0 27.0 51.9 34.5 45.4 34.0 37.0 10.9 48.0 10.4 56.6 52.3 21.4 30.7 25.2 41.0 17.3 25.3 23.4 62.5 34.9 12.5 24.7 22.1 19.6 26.9 24.3 26.2 63.2 21.1 25.0 29.0 0.7 5.2 4.1 3.7 4.3 4.7 4.3 6.4 7.4 6.7 7.4 7.1 5.8 1.3 6.7 4.6 3.0 5.8 4.5 9.4 9.6 9.7 13.8 9.6 10.7 9.5 9.4 9.1 9.8 8.9 9.4 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DOC2B DOC2BL ENSG00000272636 "Double C2 domain beta" Q14184 17 142789-181650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;retina: 24.8" "Group enriched" "Detected in many" 5 "Adipocytes: 49.4;Cone photoreceptor cells: 175.2;Muller glia cells: 146.7;Rod photoreceptor cells: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 37.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 56.1" HPA043168 Uncertain NA NA "HPA043168: AB_2678349" "prognostic favorable (3.45e-4)" "unprognostic (2.28e-3)" "unprognostic (3.17e-1)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "prognostic favorable (8.68e-4)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.78e-3)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (2.27e-3)" "unprognostic (2.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-3)" "unprognostic (4.87e-3)" 15.3 4.6 12.6 3.0 13.8 6.3 14.0 19.8 22.7 3.7 1.2 3.9 0.0 4.1 0.0 14.5 5.8 0.0 4.2 23.9 8.2 6.7 0.7 3.4 1.3 8.6 11.0 10.5 1.1 10.1 0.2 6.7 1.4 12.1 3.6 1.1 24.8 2.1 0.6 2.7 4.5 4.5 1.5 5.8 3.3 3.4 0.3 10.9 0.8 3.0 0.1 2.5 4.5 5.3 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 13.8 19.8 22.7 23.9 8.2 8.6 11.0 10.5 12.1 5.8 10.9 15.4 49.4 0.0 2.3 0.3 0.2 0.0 0.8 0.0 2.2 10.1 1.5 1.3 2.0 0.0 0.0 9.2 175.2 0.0 0.0 0.2 0.0 0.2 1.1 0.7 4.6 22.8 0.0 0.0 3.8 4.2 0.0 2.3 9.2 0.8 0.0 0.1 18.5 0.2 0.1 1.7 2.3 0.0 0.0 0.3 0.0 2.5 0.0 0.5 0.0 1.0 0.6 146.7 0.0 1.5 0.1 4.3 0.0 0.0 0.0 0.9 0.0 0.5 1.5 100.7 0.0 2.3 0.8 0.2 0.1 1.8 0.0 0.3 0.1 0.8 0.2 3.6 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141182387-141186226 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.9;Endometrial stromal cells: 10.0;Fibroblasts: 7.3;Horizontal cells: 8.4;Skeletal myocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 19.4;LHCN-M2: 10.5;U-138 MG: 39.3;U-2197: 11.1;U-87 MG: 9.9" "Low region specificity" "Detected in all" HPA014668 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.1 2.0 0.9 1.2 1.1 0.3 2.4 2.0 1.9 2.5 0.3 1.3 0.5 4.6 4.8 0.7 2.2 2.0 2.6 1.7 2.5 2.0 1.0 2.4 0.6 2.1 0.9 0.5 6.8 1.9 4.3 2.3 1.2 1.6 1.7 0.9 2.2 1.8 0.9 1.0 1.3 0.9 2.8 1.4 1.1 0.9 1.5 1.3 0.4 1.7 3.3 0.2 1.7 1.5 2.3 0.1 0.3 1.0 19.4 7.8 5.2 0.6 0.8 3.8 0.0 0.3 0.1 0.3 0.0 5.0 0.9 2.1 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 3.3 0.1 0.2 0.1 2.0 10.5 0.4 0.0 0.1 1.5 0.0 0.2 0.1 2.8 0.0 0.6 0.2 0.7 2.6 0.3 0.6 3.9 0.5 7.9 0.0 0.6 39.3 1.7 11.1 2.7 0.1 0.1 0.0 9.9 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.9 1.1 2.0 1.9 1.7 2.5 2.1 0.9 0.5 1.6 1.4 1.3 2.3 6.4 3.2 1.5 0.0 0.0 0.8 0.1 1.0 0.0 14.9 1.2 2.4 1.9 5.7 0.6 1.8 0.0 0.0 0.0 0.0 1.9 0.8 1.2 0.6 10.0 4.8 1.8 0.0 0.0 4.7 0.0 7.3 0.5 0.4 0.0 0.2 2.2 0.1 0.1 8.4 0.0 0.0 4.1 0.3 0.9 1.5 4.7 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.7 0.0 5.7 0.1 0.1 0.0 0.7 0.2 1.6 0.0 7.6 5.9 2.9 0.3 0.5 1.4 0.0 0.2 0.4 0.0 0.0 AC104109.3 ENSG00000272772 "Novel protein" 5 134167170-134226071 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;granulocytes: 1.3;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.22e-2)" "unprognostic (2.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.66e-2)" "unprognostic (9.48e-2)" "unprognostic (1.38e-2)" "unprognostic (9.97e-3)" "unprognostic (1.70e-1)" "unprognostic (9.90e-2)" "unprognostic (2.20e-1)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (4.81e-2)" 0.1 0.2 0.1 0.4 0.0 0.2 0.1 0.0 0.9 0.1 0.0 0.1 0.0 0.3 0.0 0.4 0.1 0.0 0.9 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.4 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.5 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.0 0.5 2.9 0.3 0.0 1.6 3.3 0.9 0.9 1.0 0.0 1.4 1.5 0.7 0.0 2.9 1.4 1.5 0.0 0.8 1.4 1.1 3.3 1.5 0.6 0.0 0.9 1.0 0.0 0.0 1.2 0.8 0.7 0.2 0.5 0.9 0.2 1.0 0.6 1.3 0.4 1.4 0.5 0.0 2.4 1.5 0.2 0.0 0.4 2.8 0.7 3.2 0.4 1.0 0.7 1.6 0.6 2.6 1.7 0.3 2.0 2.8 1.0 4.4 2.0 1.1 1.3 1.4 0.0 0.6 0.0 0.3 0.0 0.9 0.5 0.3 0.1 0.3 0.2 0.0 0.8 0.8 1.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 KRTAP10-7 "KAP10.7, KAP18.7, KRTAP18-7" ENSG00000272804 "Keratin associated protein 10-7" P60409 21 44600597-44602174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "skin 1: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073610.1 ENSG00000272822 "Novel protein" 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;hTERT-RPE1: 4.4" HPA068942 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA068942: AB_2732124" "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 0.8 0.3 1.2 0.0 1.2 0.1 0.6 0.2 1.9 0.8 0.1 0.7 0.0 0.8 0.5 0.3 0.9 0.6 0.7 1.4 0.7 0.3 0.6 1.1 0.4 0.4 0.3 1.0 0.8 0.6 0.0 0.8 0.1 0.4 0.6 0.2 1.4 0.4 0.2 0.4 0.6 0.3 0.9 0.2 0.3 0.4 1.1 1.0 0.2 0.3 0.8 0.2 0.6 0.6 0.5 0.5 0.2 2.1 1.6 2.2 0.9 0.0 0.9 4.7 1.2 0.5 0.0 0.6 0.6 1.3 0.8 1.4 0.1 0.8 0.0 1.2 2.8 0.3 0.6 0.3 0.0 1.5 0.0 0.6 0.2 1.1 0.3 0.7 4.4 0.5 1.1 0.0 0.8 0.7 0.2 0.3 0.5 0.0 1.2 0.6 1.3 0.3 0.1 0.1 0.1 0.9 0.3 0.5 0.4 0.4 0.4 0.1 0.3 2.4 0.4 0.3 0.3 0.3 1.1 0.1 0.4 1.0 0.6 0.2 0.3 0.3 0.1 0.6 0.1 0.7 0.2 0.2 0.5 0.2 0.2 0.6 0.6 0.2 0.3 0.1 0.5 0.2 0.7 1.2 1.2 0.2 1.9 1.4 0.7 0.4 0.3 1.0 0.4 0.2 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 DCP1A "HSA275986, SMAD4IP1, SMIF" ENSG00000272886 "Decapping mRNA 1A" Q9NPI6 3 53283429-53347586 "Plasma proteins, Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013202 Approved Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA013202: AB_1857287" "unprognostic (2.10e-1)" "unprognostic (7.61e-2)" "prognostic favorable (9.01e-4)" "unprognostic (9.79e-3)" "unprognostic (7.68e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (3.24e-2)" "unprognostic (1.86e-1)" "unprognostic (8.37e-2)" "unprognostic (7.33e-3)" "unprognostic (9.14e-2)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.95e-1)" 9.4 8.3 4.2 8.8 4.7 30.1 9.0 10.8 6.6 8.6 5.6 8.0 6.2 11.9 5.9 7.9 9.2 8.3 8.1 4.7 8.2 6.0 6.5 7.8 10.4 4.8 4.6 3.9 15.0 6.3 10.4 6.3 10.2 5.8 8.0 8.5 8.6 6.2 6.9 9.6 7.5 7.3 10.5 3.8 9.3 6.8 8.2 4.8 14.3 8.8 9.6 9.9 9.1 7.0 6.3 8.3 8.3 19.4 15.8 13.1 13.5 26.3 9.5 12.5 20.5 19.0 24.7 14.5 18.9 3.7 12.0 12.3 6.8 25.3 9.7 17.8 16.9 11.3 18.5 11.8 12.9 11.4 23.0 24.6 10.7 9.4 18.5 15.0 12.6 15.1 13.2 16.4 20.2 10.1 5.0 30.6 11.2 13.1 8.6 12.1 14.0 12.9 13.2 8.6 18.2 10.1 16.7 16.3 10.7 14.3 14.4 7.0 17.8 16.3 9.8 14.1 10.3 14.5 12.9 11.9 21.9 12.0 12.8 17.8 46.9 25.0 43.0 41.0 25.5 50.4 38.9 41.4 47.8 27.1 48.7 49.6 46.8 26.0 54.3 52.3 31.4 30.9 38.5 4.2 4.7 10.8 6.6 4.7 8.2 4.8 4.6 3.9 5.8 3.8 4.8 6.3 28.6 28.9 30.7 26.4 43.6 57.5 48.5 32.4 48.9 27.5 32.7 25.5 26.4 15.7 24.7 7.3 47.9 41.1 34.5 25.5 3.9 29.2 10.8 21.5 33.4 33.5 51.8 20.2 43.4 35.1 52.3 33.6 18.3 34.0 36.8 34.8 24.7 13.2 19.9 28.6 40.5 27.6 24.4 27.6 48.9 26.3 24.8 29.2 10.6 20.6 35.2 18.3 30.9 40.7 44.2 45.0 19.6 25.9 31.8 48.4 22.3 13.5 14.2 30.3 13.1 39.2 32.5 12.8 19.1 27.4 41.2 64.0 39.1 27.7 27.9 62.1 ATP6V1FNB ENSG00000272899 "ATP6V1F neighbor" A0A1B0GUX0 7 128866330-128872047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.9;kidney: 9.8;skeletal muscle: 11.8" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 2.0;Glandular and luminal cells: 1.9" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;U-266/70: 3.3;U-266/84: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.17e-2)" "unprognostic (3.00e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (8.21e-4)" "unprognostic (1.23e-1)" "unprognostic (9.98e-2)" "unprognostic (5.10e-2)" "unprognostic (1.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.20e-1)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.33e-3)" 1.5 0.4 3.5 0.4 2.8 0.3 0.6 10.9 3.7 1.0 0.1 1.1 1.2 0.5 0.2 1.5 1.1 0.8 5.0 3.1 1.2 9.8 0.1 0.5 0.2 1.2 1.8 2.9 0.3 0.3 0.4 1.0 0.3 7.1 0.9 0.1 0.7 0.6 0.1 11.8 0.7 4.1 0.4 0.6 0.7 1.7 3.7 1.6 0.2 0.6 0.2 0.2 0.8 0.8 2.2 0.6 0.3 0.3 3.0 0.9 0.4 0.0 0.2 0.4 0.4 0.2 0.2 3.9 1.0 0.2 0.1 0.7 0.7 0.3 0.1 0.2 3.0 0.5 1.2 0.2 0.0 0.5 0.1 2.9 0.4 0.2 0.2 0.2 0.5 0.1 0.3 0.8 1.6 0.3 0.2 0.3 1.5 0.0 0.1 0.2 0.5 1.0 0.5 0.1 0.2 1.2 0.6 0.2 1.5 0.2 0.8 0.3 0.5 0.1 1.5 0.3 2.6 0.2 3.3 3.8 0.7 1.5 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 2.8 10.9 3.7 3.1 1.2 1.2 1.8 2.9 7.1 0.6 1.6 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 2.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.9 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 RBAK-RBAKDN ENSG00000272968 "RBAK-RBAKDN readthrough" 7 4983718-5073221 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 26 "testis: 58.1" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 33.6;Spermatocytes: 44.7;Spermatogonia: 39.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 2.7" NA NA "unprognostic (3.78e-2)" "unprognostic (3.57e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (3.23e-1)" "unprognostic (5.44e-3)" "unprognostic (6.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.62e-7)" "unprognostic (2.86e-1)" "unprognostic (4.96e-2)" "unprognostic (9.57e-2)" "unprognostic (3.10e-2)" 0.3 0.3 1.2 0.1 0.6 0.5 0.3 1.0 0.8 0.4 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.1 0.5 2.2 0.2 0.3 0.3 0.3 1.2 0.9 0.6 0.3 0.3 0.1 0.1 0.1 1.1 0.2 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 0.5 0.4 0.3 58.1 2.1 0.4 0.3 0.1 0.2 0.2 0.2 1.2 0.7 0.2 0.2 1.4 0.2 0.5 0.2 0.5 0.3 0.3 0.2 0.9 0.2 0.5 1.6 0.5 0.4 0.6 0.0 0.2 0.6 0.0 0.8 0.4 0.5 0.6 0.6 1.9 1.7 0.0 0.7 0.3 0.9 0.4 0.5 0.7 1.2 0.0 0.0 2.5 0.1 0.3 0.7 0.1 1.5 0.2 0.1 1.0 0.1 0.1 0.6 1.1 0.1 0.7 0.6 0.7 0.6 1.4 0.0 0.5 0.8 0.7 0.5 2.7 1.0 0.5 0.6 0.5 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.4 0.4 0.0 0.2 0.2 0.1 0.0 0.0 1.2 0.6 1.0 0.8 0.5 2.2 1.2 0.9 0.6 1.1 0.5 2.1 1.2 11.2 0.0 1.1 0.7 7.2 7.5 6.7 3.6 0.6 27.9 9.2 11.0 0.0 5.7 2.8 1.8 12.5 2.7 13.2 0.6 5.9 6.6 7.6 3.3 5.6 7.2 2.4 4.8 0.8 5.3 7.1 6.1 1.1 3.3 1.3 6.4 6.8 7.7 6.9 26.9 0.9 2.1 2.0 5.0 9.1 4.5 15.8 5.4 5.4 1.0 6.2 15.0 22.6 0.5 1.0 8.2 6.4 7.5 4.7 10.6 3.6 8.3 2.7 33.6 6.6 8.1 6.3 44.7 39.5 0.8 7.2 2.2 9.7 4.4 2.8 5.3 C2orf15 MGC29762 ENSG00000273045 "Chromosome 2 open reading frame 15" Q8WU43 2 99141707-99151669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6;Proximal tubular cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 12.6;SCLC-21H: 12.2" NA NA "unprognostic (2.61e-2)" "unprognostic (7.88e-2)" "unprognostic (4.22e-2)" "unprognostic (4.85e-2)" "unprognostic (2.06e-1)" "unprognostic (6.99e-2)" "unprognostic (5.37e-2)" "unprognostic (9.05e-3)" "unprognostic (1.62e-2)" "prognostic favorable (4.95e-4)" "unprognostic (2.54e-3)" "unprognostic (1.04e-1)" "prognostic favorable (1.23e-4)" "unprognostic (2.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.08e-1)" "unprognostic (2.97e-2)" 0.4 0.7 1.8 0.8 1.9 1.3 3.5 3.6 2.2 2.4 1.7 2.1 4.1 1.2 6.1 1.4 4.0 1.8 0.3 1.7 1.9 5.4 0.5 1.4 1.5 1.9 1.8 1.5 0.8 3.1 6.1 0.7 1.1 2.2 1.3 2.4 3.9 2.8 1.8 0.3 2.0 3.2 0.3 1.6 1.0 3.8 1.4 2.0 1.2 6.3 0.0 1.6 1.8 0.1 2.8 9.8 1.5 0.3 1.3 0.2 0.0 7.2 0.0 0.7 0.5 0.3 10.1 7.0 4.3 3.0 0.0 0.8 6.0 1.4 1.1 0.0 0.8 4.5 0.3 1.8 6.8 0.1 1.5 1.8 0.2 2.2 0.0 0.7 0.4 0.0 5.5 0.4 0.9 0.4 8.5 1.2 1.9 2.2 5.3 2.1 0.7 0.2 4.8 9.9 12.6 12.2 1.5 1.0 10.2 0.4 1.7 8.2 0.4 0.0 0.5 0.5 0.3 0.4 2.9 4.8 1.5 0.2 1.4 0.1 0.3 0.3 0.2 2.0 0.2 4.7 1.8 3.2 2.5 0.1 2.0 4.3 2.2 0.9 3.8 0.1 0.4 1.7 1.2 1.8 1.9 3.6 2.2 1.7 1.9 1.9 1.8 1.5 2.2 1.6 2.0 2.8 0.4 3.2 3.1 0.7 2.5 1.1 1.7 2.1 0.0 5.6 5.4 4.6 0.4 2.8 2.2 7.3 6.2 6.8 0.7 0.8 15.6 5.5 1.8 3.7 0.4 0.9 1.2 0.8 3.3 2.9 0.7 0.6 1.1 2.5 0.0 1.3 0.4 0.1 0.6 6.7 2.5 2.9 0.0 0.0 1.4 0.3 0.6 0.5 0.0 0.0 0.5 4.1 0.0 0.5 2.8 2.8 3.7 0.4 0.7 1.5 3.7 9.8 7.9 7.7 0.0 0.9 0.5 3.4 3.7 0.9 1.4 2.1 1.8 1.6 3.4 1.3 AL121845.2 ENSG00000273047 "Novel transcript, LIME1-SLC2A4RG readthrough" 20 63738270-63740398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "liver: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.0" "Group enriched" "Detected in many" 31 "dendritic cells: 6.0;T-cells: 4.2" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;HHSteC: 1.2;JURKAT: 1.6;OE19: 2.2;U-266/70: 1.2;U-698: 2.7" NA NA "unprognostic (3.96e-2)" "unprognostic (1.60e-1)" 0.8 0.0 0.1 0.0 0.2 0.1 0.6 0.2 1.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.1 6.8 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.2 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.9 0.1 3.3 4.2 0.0 0.1 2.2 1.3 0.1 0.0 0.1 6.0 3.3 0.6 0.1 0.2 0.2 1.0 0.1 0.1 0.4 0.1 0.1 0.3 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012531.3 ENSG00000273049 "Novel protein, readthrough between HOXC10 and HOXC5" 12 53985845-54034888 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "skeletal muscle: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 8.0;fHDF/TERT166: 2.0;HDLM-2: 3.0" NA NA 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 2.5 0.2 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 8.0 0.6 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.7 0.0 0.1 2.0 0.1 0.9 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.2 0.4 0.1 1.5 0.0 0.0 0.3 1.1 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIN2B "GluN2B, NMDAR2B" ENSG00000273079 "Glutamate ionotropic receptor NMDA type subunit 2B" Q13224 12 13437942-13982002 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "brain: 38.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 625.2;Inhibitory neurons: 882.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;NTERA-2: 1.6;RPTEC TERT1: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069762 Approved NA NA "HPA069762: AB_2686192" "unprognostic (2.01e-2)" "unprognostic (4.07e-2)" "unprognostic (7.89e-2)" "unprognostic (3.77e-3)" "unprognostic (3.39e-3)" "unprognostic (9.36e-2)" "unprognostic (5.92e-2)" "unprognostic (1.77e-2)" "unprognostic (6.85e-2)" "unprognostic (2.24e-1)" "unprognostic (4.68e-2)" "unprognostic (4.12e-2)" "unprognostic (4.48e-5)" "unprognostic (2.43e-1)" "unprognostic (8.76e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-1)" 0.2 0.0 12.5 0.0 16.5 0.0 0.0 0.0 38.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 14.6 0.0 0.1 0.0 0.1 2.6 0.0 21.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 16.5 0.0 38.3 31.0 14.6 2.6 0.0 21.8 4.1 0.0 2.9 7.7 0.1 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 8.8 0.7 0.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.9 0.0 35.0 0.3 0.1 0.4 0.0 0.0 625.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 882.5 0.5 0.0 0.0 0.0 35.8 0.0 0.0 0.0 14.0 0.0 0.1 0.0 173.4 9.9 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.0 1.8 0.0 0.1 0.2 1.0 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 AL713999.1 ENSG00000273088 "Novel protein" 1 155169409-155187272 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 1.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 5.4;U-937: 4.7" NA NA 0.0 0.0 0.7 0.3 0.6 0.0 0.1 0.6 0.9 0.0 0.3 0.1 0.0 0.1 1.6 0.0 0.7 0.1 0.0 0.7 0.8 0.1 0.0 0.3 0.2 0.8 1.0 0.5 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.3 0.6 0.2 0.4 0.4 0.7 0.2 0.0 0.0 0.1 0.0 0.9 1.1 0.0 0.4 0.0 0.4 0.0 0.0 1.4 0.4 1.1 1.4 0.0 0.1 0.0 0.5 0.7 0.2 0.4 0.0 0.7 0.7 3.0 0.3 3.6 1.3 0.5 2.2 0.0 1.8 0.8 0.3 0.4 3.3 0.6 0.0 2.1 0.1 4.1 0.0 0.6 1.3 1.1 1.8 2.1 0.0 1.4 0.0 0.0 0.5 0.0 5.4 3.6 0.3 2.2 3.4 0.0 1.5 0.6 0.0 1.3 0.6 0.0 0.8 1.9 3.0 1.3 0.5 4.7 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.4 0.6 0.0 0.2 0.7 0.6 0.6 0.9 0.7 0.8 0.8 1.0 0.5 0.8 0.6 0.7 0.9 0.0 3.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LYPD4 MGC42718 ENSG00000273111 "LY6/PLAUR domain containing 4" Q6UWN0 19 41837074-41844697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 312 "testis: 105.6" "Group enriched" "Detected in some" 66 "Early spermatids: 283.3;Late spermatids: 869.2;Spermatocytes: 265.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (4.07e-2)" "unprognostic (2.92e-1)" "unprognostic (3.21e-1)" "unprognostic (1.00e-1)" 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 283.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 869.2 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 265.9 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF26 ENSG00000273136 "NBPF member 26" 1 120723949-120842110 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 54.5;B-cells: 36.4;Basal squamous epithelial cells: 37.0;Erythroid cells: 55.5;Macrophages: 54.4;Squamous epithelial cells: 106.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;monocytes: 7.3" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (2.24e-1)" "unprognostic (7.64e-3)" "unprognostic (4.21e-1)" "unprognostic (1.34e-3)" "unprognostic (1.69e-1)" "unprognostic (1.26e-2)" "unprognostic (6.31e-5)" "unprognostic (9.78e-3)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.82e-5)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (8.11e-2)" "unprognostic (1.65e-1)" 14.8 7.2 6.7 22.1 6.3 13.3 11.1 7.7 7.5 15.1 14.0 9.3 2.5 15.2 20.3 20.9 11.3 13.4 6.6 8.4 10.5 4.6 10.5 13.5 12.6 17.3 20.6 2.6 17.2 9.0 4.3 4.7 8.6 18.7 12.7 9.4 23.3 10.3 9.0 6.5 39.3 8.6 17.4 2.7 14.0 7.5 10.4 7.3 12.0 12.3 5.4 8.6 8.0 11.6 5.8 56.7 0.3 16.4 17.8 18.3 16.9 1.3 19.9 10.1 12.5 12.9 12.2 2.3 4.4 17.2 17.5 21.6 14.4 27.8 28.7 17.4 25.1 1.3 40.1 7.5 4.8 9.1 16.0 11.4 10.2 11.8 31.1 32.6 40.5 0.8 10.5 3.0 30.1 29.5 28.7 4.2 24.6 6.3 2.0 21.5 5.5 15.3 8.2 7.3 19.9 1.5 1.3 22.1 30.5 16.6 19.5 1.0 6.7 17.3 14.0 36.3 43.7 15.7 13.5 4.1 16.2 11.6 23.5 2.2 2.4 5.1 4.6 1.4 2.3 0.7 0.8 1.0 1.2 1.4 2.0 1.0 1.5 13.3 1.3 7.3 1.3 0.5 0.7 6.7 6.3 7.7 7.5 8.4 10.5 17.3 20.6 2.6 18.7 2.7 7.3 5.8 0.8 54.5 28.7 3.9 36.4 0.0 2.2 0.0 37.0 0.6 3.9 2.4 2.7 0.0 3.7 0.0 0.0 0.5 4.7 0.6 3.9 4.8 7.6 7.2 4.8 1.4 0.0 55.5 0.4 3.1 2.4 14.9 16.3 7.8 16.4 2.5 1.1 1.4 0.2 0.0 0.3 1.0 0.0 4.4 0.0 0.9 6.5 54.4 0.0 1.0 6.5 0.6 2.1 0.5 0.1 4.0 27.3 4.5 28.0 1.0 1.7 0.7 3.6 2.1 0.0 3.1 6.7 4.9 2.5 106.5 0.0 0.4 21.1 0.9 2.2 0.8 AL121845.3 ENSG00000273154 "Novel protein, ZGPAT-LIME1 readthrough" 20 63708864-63739103 "Predicted intracellular proteins, Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Ductal cells: 1.0;monocytes: 1.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/84: 1.6;U-698: 2.4" "Low region specificity" "Detected in all" NA NA "unprognostic (3.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (2.28e-1)" "unprognostic (3.48e-1)" "unprognostic (4.29e-2)" "unprognostic (7.13e-2)" "unprognostic (2.18e-4)" "unprognostic (3.37e-4)" "unprognostic (1.84e-7)" "unprognostic (7.09e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (1.96e-3)" 0.0 0.9 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.2 0.6 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.9 0.2 0.9 0.0 0.1 0.3 0.2 0.2 0.0 0.3 0.0 0.0 1.2 0.0 0.7 0.7 0.1 0.5 0.6 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.3 0.7 0.0 0.0 0.1 0.0 0.5 1.4 0.0 1.3 0.5 0.5 0.3 0.1 1.6 2.4 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.3 0.1 0.5 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 AC092587.1 ENSG00000273155 "Novel LIPT1-MRPL30 readthrough" 2 99154998-99195298 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Cytotrophoblasts: 1.6;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.5;Proximal tubular cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA "unprognostic (5.56e-3)" "unprognostic (2.80e-1)" "unprognostic (5.47e-2)" "unprognostic (2.46e-1)" "unprognostic (1.32e-1)" "unprognostic (5.70e-2)" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (2.41e-2)" "unprognostic (3.36e-1)" "unprognostic (2.82e-1)" "unprognostic (2.19e-1)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (9.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.25e-1)" 0.6 0.6 0.0 1.1 0.2 0.7 0.5 0.5 0.6 0.5 0.0 0.5 0.1 0.6 0.1 0.5 0.3 0.5 1.3 0.2 0.2 0.4 0.5 0.4 0.3 0.1 0.1 0.1 0.5 0.3 0.3 0.3 0.3 0.5 0.5 0.4 0.2 0.4 0.3 1.2 0.3 0.7 0.3 0.1 0.3 0.4 0.3 0.1 0.0 0.4 0.4 0.5 0.5 0.5 0.3 0.7 1.0 0.7 1.3 0.2 2.1 0.3 0.0 0.4 0.4 0.6 1.0 0.6 0.4 1.1 0.2 0.3 0.9 0.5 0.6 1.1 0.6 0.0 0.0 0.5 1.7 0.0 1.7 0.0 0.3 0.8 0.9 0.2 0.1 0.4 0.4 1.4 0.1 0.2 0.3 1.0 1.4 0.9 0.2 1.3 0.8 0.3 0.8 0.6 0.6 0.2 0.8 0.3 0.7 0.4 1.2 0.9 1.3 0.9 0.6 0.9 0.0 0.3 0.1 0.3 0.5 0.5 1.0 0.2 0.4 1.3 0.8 1.0 0.9 0.7 0.8 1.0 0.9 1.3 0.8 1.0 1.2 0.5 1.0 1.2 0.9 1.3 0.5 0.0 0.2 0.5 0.6 0.2 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 1.8 0.0 1.6 0.1 0.0 3.9 0.9 0.0 0.1 0.3 0.4 0.0 0.0 0.0 2.2 2.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 AC002094.3 ENSG00000273171 "Novel protein, readthrough between VTN and SEBOX" 17 28364288-28368012 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "liver: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SNURF ENSG00000273173 "SNRPN upstream reading frame" Q9Y675 15 24954986-24977850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 63.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 191.3;U-698: 112.1" HPA065733 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA065733: AB_2685548" "unprognostic (2.08e-1)" "unprognostic (2.88e-2)" "unprognostic (6.82e-2)" "unprognostic (4.59e-3)" "unprognostic (4.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.39e-2)" "unprognostic (6.89e-3)" "unprognostic (1.56e-2)" "unprognostic (6.74e-2)" "unprognostic (8.91e-4)" "unprognostic (3.77e-1)" "unprognostic (1.77e-2)" "unprognostic (6.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" 8.2 16.3 3.3 7.0 7.4 12.6 5.4 15.3 16.2 10.6 0.9 14.8 1.9 9.7 55.3 5.3 8.5 13.3 46.9 4.8 8.3 14.7 13.0 9.8 10.3 1.6 4.7 5.4 13.8 13.6 19.9 28.7 2.7 7.7 15.3 2.5 25.5 8.5 8.3 63.5 3.8 6.4 3.8 0.0 17.3 11.6 3.3 4.6 8.2 15.6 7.5 7.1 12.9 7.4 8.6 0.1 11.9 61.9 44.1 3.1 4.1 0.1 40.7 3.3 4.2 2.8 7.0 36.4 0.5 21.0 2.7 6.0 15.3 0.0 9.1 3.2 14.1 0.0 74.3 50.2 1.8 11.0 79.2 25.4 10.0 2.3 7.7 0.5 22.1 5.2 22.4 7.3 0.2 8.3 0.0 55.5 0.5 191.3 0.0 1.9 54.7 84.7 0.9 3.3 82.0 37.1 29.1 0.0 3.8 22.3 75.2 38.7 7.1 75.8 27.2 30.2 1.0 8.9 58.8 81.6 112.1 43.9 33.6 24.5 17.7 1.5 6.3 14.9 0.7 31.0 22.3 32.9 28.4 2.7 27.8 41.2 38.1 1.7 22.4 3.1 23.6 35.7 20.1 3.3 7.4 15.3 16.2 4.8 8.3 1.6 4.7 5.4 7.7 0.0 4.6 8.6 1.0 3.2 3.7 0.0 2.9 0.5 0.6 1.4 2.2 1.6 1.4 1.1 4.1 0.0 1.1 0.0 0.0 0.0 1.1 0.7 3.9 2.1 0.4 0.7 1.2 0.9 0.0 0.8 0.0 2.4 0.0 1.4 1.5 0.7 1.3 2.0 1.1 0.7 0.3 3.3 0.0 2.7 0.0 0.8 0.4 0.3 0.6 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.0 2.2 2.8 0.4 2.7 0.6 1.1 0.7 4.1 1.5 0.0 0.9 2.0 0.3 0.8 0.7 0.3 0.0 2.8 1.9 1.2 0.3 H3-2 "HIST2H3PS2, p06" ENSG00000273213 "H3.2 histone (putative)" 1 143894544-143905966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 13.5;ovary: 16.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 11.8;SH-SY5Y: 11.9;THP-1: 16.3;U-2197: 16.3" "Low region specificity" "Detected in all" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.29e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-2)" "unprognostic (6.76e-3)" "unprognostic (2.57e-2)" "unprognostic (8.78e-2)" "unprognostic (7.82e-3)" "unprognostic (3.07e-1)" "unprognostic (4.90e-2)" "unprognostic (5.44e-2)" 2.1 13.5 5.2 2.3 4.0 0.3 1.3 8.5 4.7 1.3 2.0 0.8 0.4 3.3 1.8 2.3 3.2 1.9 1.2 4.0 7.0 0.8 0.4 1.7 2.3 6.2 6.3 2.8 16.9 1.5 0.9 1.3 7.1 5.6 0.8 1.4 1.7 2.3 0.4 2.7 0.8 4.3 6.8 9.2 4.1 3.1 6.5 0.4 3.5 0.3 1.5 1.4 8.1 0.1 0.0 0.3 0.1 5.9 4.3 0.2 11.8 6.2 7.4 7.0 0.0 2.6 0.0 0.9 5.5 6.9 0.1 0.0 0.5 5.4 0.0 0.6 0.0 0.1 0.0 9.2 0.0 0.0 7.0 0.1 10.9 1.9 1.9 5.7 0.0 0.7 0.1 0.9 0.0 0.0 6.8 0.0 3.0 0.1 0.0 0.0 0.0 4.8 0.2 1.2 11.9 0.0 5.7 0.0 0.0 0.1 16.3 1.9 2.0 0.1 16.3 2.0 0.1 0.0 0.0 7.8 0.0 4.4 0.6 0.3 0.0 0.0 1.0 0.2 0.2 0.1 0.1 0.6 0.5 0.0 0.1 0.3 0.7 1.4 0.6 0.0 0.1 5.2 4.0 8.5 4.7 4.0 7.0 6.2 6.3 2.8 7.1 6.8 6.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008695.1 ENSG00000273217 "Novel protein" 5 131425891-131796983 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 8.2" "Cell line enhanced" "Detected in single" "A549: 2.5" "HPA037982, HPA037983" Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.8 1.9 2.5 0.3 4.4 1.1 2.7 3.0 0.3 1.5 8.2 3.9 0.5 1.9 0.7 0.0 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TMEM271 ENSG00000273238 "Transmembrane protein 271" A0A286YF58 4 573880-576295 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 24.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NB-4: 1.5;NTERA-2: 2.6;SCLC-21H: 5.7;U-2 OS: 1.4;U-251 MG: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.13e-3)" "unprognostic (6.97e-3)" "unprognostic (2.65e-2)" 0.0 0.9 13.4 0.0 12.9 0.0 0.0 0.2 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 7.9 0.0 0.0 0.0 0.0 4.8 5.0 16.4 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 1.5 2.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.9 0.2 24.4 18.7 7.9 4.8 5.0 16.4 5.6 0.5 4.6 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZBTB8B "DKFZp547H154, RP1-27O5.1, ZNF916B" ENSG00000273274 "Zinc finger and BTB domain containing 8B" Q8NAP8 1 32465072-32496686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RT4: 1.0" "HPA055553, HPA071427" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055553: AB_2682848, HPA071427: " "unprognostic (8.32e-4)" "unprognostic (1.23e-1)" "unprognostic (3.83e-1)" "unprognostic (3.83e-5)" "unprognostic (1.86e-2)" "unprognostic (5.65e-2)" "unprognostic (1.67e-4)" "unprognostic (1.57e-2)" "unprognostic (5.94e-2)" "unprognostic (3.43e-3)" "unprognostic (9.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.93e-2)" "unprognostic (3.44e-2)" "unprognostic (6.11e-2)" "unprognostic (3.26e-3)" "unprognostic (5.88e-3)" 0.0 0.1 1.6 0.1 1.1 0.4 0.1 0.8 1.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.0 1.0 1.4 0.0 0.1 0.0 0.1 1.2 0.9 1.1 0.1 0.1 0.1 0.6 0.1 1.1 0.1 0.0 0.5 0.1 0.0 0.6 0.2 0.0 0.0 0.6 0.1 0.0 0.2 1.4 0.0 0.1 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.9 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 1.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.2 0.1 0.0 1.6 1.1 0.8 1.2 1.0 1.4 1.2 0.9 1.1 1.1 0.6 1.4 1.3 0.4 0.0 1.8 0.3 0.2 1.7 1.1 0.1 0.0 2.6 0.3 0.5 0.8 0.0 0.7 0.0 6.2 1.9 1.4 0.3 0.0 0.0 2.1 0.5 1.6 0.7 0.0 0.0 0.8 0.0 1.3 0.8 0.0 0.5 3.8 2.8 0.7 0.2 0.4 3.3 2.2 0.0 0.0 0.3 4.7 2.1 0.6 0.7 1.8 1.9 0.0 1.4 1.0 9.0 0.4 0.0 0.0 0.0 0.3 0.9 0.0 0.1 1.5 2.4 0.0 1.6 0.7 2.2 1.5 0.0 0.6 0.3 0.7 0.9 0.0 0.9 AC092042.3 ENSG00000273291 "Novel protein" 3 42809446-43055871 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.83e-2)" "unprognostic (2.13e-1)" "unprognostic (3.09e-1)" "unprognostic (3.69e-3)" "unprognostic (1.02e-1)" "unprognostic (3.74e-2)" "unprognostic (2.04e-1)" "unprognostic (6.65e-3)" "unprognostic (4.46e-2)" "unprognostic (8.42e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-2)" "unprognostic (2.54e-2)" "unprognostic (2.15e-1)" "unprognostic (4.20e-2)" "unprognostic (2.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011841.1 ENSG00000273496 Unmapped 99351-104855 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;NB-4: 2.3" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.1 0.7 0.8 0.2 0.0 0.6 0.3 0.2 0.2 0.4 1.0 0.2 0.0 0.1 0.0 0.5 0.8 0.6 0.2 0.7 0.6 0.7 0.5 0.7 0.9 0.0 1.0 1.0 0.0 0.3 0.1 0.4 0.4 0.1 0.7 0.1 0.8 0.2 0.1 0.2 2.3 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.3 0.0 0.5 0.0 0.4 0.2 0.2 0.5 0.2 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.2 0.3 0.2 0.1 0.3 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TBC1D3K ENSG00000273513 "TBC1 domain family member 3K" A0A087X1G2 17 37924415-37935365 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 1.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.3 0.0 0.6 0.0 0.5 0.2 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.1 2.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L6 ENSG00000273514 "Forkhead box D4 like 6" Q3SYB3 9 41126435-41128681 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (2.41e-1)" "unprognostic (3.41e-1)" "unprognostic (3.61e-1)" 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.6 1.8 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE8 SPDYE8P ENSG00000273520 "Speedy/RINGO cell cycle regulator family member E8" 7 73020338-73029766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Uncertain NA NA "HPA051750: AB_2681590" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.5 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGBL1 "CCP4, FLJ32310" ENSG00000273540 "ATP/GTP binding protein like 1" Q96MI9 15 86079871-87049169 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 7.9;tongue: 23.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 16.7;Astrocytes: 28.7;Excitatory neurons: 15.6;Inhibitory neurons: 25.6;Oligodendrocyte precursor cells: 47.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.70e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.9 0.0 1.5 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.7 0.0 0.7 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.7 0.0 7.9 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.0 23.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.2 0.6 0.9 0.5 0.7 1.2 0.6 0.4 1.0 0.5 0.4 0.0 3.2 16.7 28.7 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.9 0.0 0.0 0.0 47.3 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 H4C12 "dJ160A22.1, H4/d, H4F2iii, H4FD, HIST1H4K" ENSG00000273542 "H4 clustered histone 12" P62805 6 27831174-27831560 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.4;brain: 20.6" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 160.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 160.3" "Cell line enhanced" "Detected in many" "Hep G2: 63.7;MCF7: 63.3" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (3.19e-1)" "unprognostic (9.09e-3)" "unprognostic (1.16e-1)" "unprognostic (4.84e-3)" "unprognostic (9.63e-2)" "unprognostic (9.13e-2)" "unprognostic (1.48e-1)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.79e-2)" "unprognostic (3.13e-2)" "unprognostic (2.79e-1)" "unprognostic (3.45e-1)" "unprognostic (4.16e-2)" "unprognostic (1.02e-1)" 4.2 5.6 4.7 2.8 9.6 22.4 2.1 2.8 15.7 3.8 0.0 7.6 6.2 3.1 1.0 1.4 3.4 3.7 0.5 17.6 20.6 1.1 8.1 1.2 4.7 0.0 3.4 6.3 0.9 1.0 7.1 0.4 1.5 17.9 5.2 3.4 0.4 1.1 2.0 0.4 0.7 5.8 1.2 2.4 5.8 6.0 1.4 7.8 8.9 2.7 2.0 2.2 2.9 0.4 9.0 8.0 9.9 21.0 35.4 13.3 5.0 12.4 8.9 4.4 8.7 5.6 17.2 2.6 12.6 16.4 3.7 2.1 19.4 0.5 13.1 2.7 18.5 3.7 8.4 19.0 63.7 7.5 12.4 10.8 15.9 3.5 5.4 2.9 1.2 7.8 7.1 16.5 26.6 0.3 63.3 22.8 13.0 13.3 13.3 20.3 9.2 1.5 9.1 1.5 3.6 11.7 15.8 16.3 9.0 12.1 2.9 12.4 6.1 7.9 4.4 21.0 2.3 0.1 14.3 16.7 23.0 5.6 9.2 8.7 160.3 9.4 40.4 29.8 21.3 25.8 33.8 29.0 31.6 18.2 37.1 17.4 22.1 22.9 28.0 26.3 20.0 38.9 24.6 4.7 9.6 2.8 15.7 17.6 20.6 0.0 3.4 6.3 17.9 2.4 7.8 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136616.1 ENSG00000273554 Unmapped 1139577-1147868 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 1.3;testis: 3.6" "Group enriched" "Detected in some" 23 "Early spermatids: 51.1;Late spermatids: 36.8;Spermatocytes: 28.4;Spermatogonia: 15.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AN3-CA: 15.3" NA NA 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 15.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 51.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.4 15.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800441-38825355 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 28.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 12.6 12.7 7.8 10.0 8.7 62.7 12.4 8.4 9.7 11.4 8.6 11.2 10.4 10.4 5.4 12.6 12.0 7.7 8.6 8.1 8.6 11.6 16.3 13.1 12.7 8.5 8.1 7.7 11.3 12.7 7.3 11.1 6.8 8.5 11.8 6.1 8.7 11.0 4.6 12.8 17.1 13.2 6.9 8.1 17.0 11.7 18.5 8.4 14.3 11.4 7.1 9.1 10.9 11.6 9.0 11.2 13.1 8.2 14.1 10.9 7.1 8.3 11.5 7.9 12.0 11.0 8.4 11.7 12.7 7.8 9.2 9.2 25.3 8.2 7.7 14.5 12.0 8.7 9.9 14.9 10.4 10.8 25.2 15.6 8.4 12.3 11.8 9.7 12.7 9.8 13.5 15.5 15.0 10.2 6.2 26.4 25.6 8.5 8.2 6.4 20.0 12.1 11.4 12.0 10.7 9.3 8.2 10.7 7.6 13.8 12.2 12.0 19.8 10.2 10.8 9.9 14.3 17.9 11.9 9.3 18.8 11.4 12.1 10.9 18.0 4.1 10.6 4.6 3.9 4.0 4.5 4.3 4.8 3.5 6.0 4.9 3.7 28.7 5.9 8.1 1.7 2.9 3.0 7.8 8.7 8.4 9.7 8.1 8.6 8.5 8.1 7.7 8.5 8.1 8.4 9.0 50.7 57.7 69.5 10.4 54.2 63.9 61.2 45.9 39.9 37.2 40.8 31.2 18.3 21.5 46.3 23.9 83.4 35.1 60.6 56.6 29.4 27.5 118.4 63.8 51.7 45.3 41.8 34.5 10.0 23.6 35.2 43.8 52.0 100.2 58.9 23.8 37.9 27.2 28.6 26.9 7.9 51.9 26.4 27.0 37.9 31.9 37.3 38.2 26.6 5.6 38.7 30.1 41.2 5.5 8.1 29.3 70.9 34.6 43.2 51.4 61.5 27.2 41.9 43.4 39.5 57.0 45.7 93.9 33.6 30.5 76.7 79.1 54.6 28.8 32.6 72.4 SMIM11B ENSG00000273590 "Small integral membrane protein 11B" Q8TCY0 21 7744962-7777853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 5.6;Club cells: 4.3;Distal tubular cells: 3.9;granulocytes: 5.1;Respiratory ciliated cells: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051321 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA051321: AB_2681440" "unprognostic (1.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.35e-1)" 14.3 17.1 19.4 1.1 19.6 0.5 15.7 19.2 21.6 16.7 17.8 19.6 2.2 17.0 15.2 9.4 19.4 3.1 29.2 18.7 22.0 24.3 20.8 11.4 4.9 20.6 19.5 17.4 20.8 18.7 9.2 21.4 4.3 19.3 17.5 5.8 10.0 15.5 11.3 37.6 9.3 14.0 3.4 16.6 14.1 58.7 6.6 20.4 12.3 19.7 16.5 8.6 18.6 14.4 22.7 23.6 9.6 7.7 17.3 19.0 37.9 0.2 8.8 30.0 11.2 0.8 1.0 1.4 1.1 7.0 14.3 23.8 1.1 17.0 27.7 10.0 34.3 45.9 19.2 1.2 13.8 19.5 3.1 25.9 18.8 26.6 0.4 1.4 7.9 14.5 29.3 31.2 3.6 10.6 11.9 26.6 2.1 0.6 36.3 0.6 1.1 0.4 1.2 34.7 6.2 16.2 1.9 21.6 15.3 17.7 0.6 28.2 0.8 3.1 10.9 4.5 9.2 9.8 19.2 20.6 1.5 0.1 9.9 1.5 1.5 11.0 4.6 11.6 5.8 11.3 19.6 9.1 6.0 11.4 12.2 16.1 9.7 0.9 1.4 5.0 8.4 14.7 6.4 19.4 19.6 19.2 21.6 18.7 22.0 20.6 19.5 17.4 19.3 16.6 20.4 22.7 0.1 16.0 5.6 0.0 0.2 0.0 0.6 0.0 0.0 0.8 0.8 0.3 0.0 1.5 4.3 0.0 0.0 0.3 0.3 0.3 3.9 0.5 0.2 0.2 0.1 0.4 0.0 2.7 0.0 0.4 0.3 2.1 0.0 0.1 5.1 0.1 0.4 0.6 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.3 0.3 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.1 0.4 0.1 0.3 0.3 1.9 10.9 0.3 0.0 0.9 0.1 0.3 0.4 0.0 0.0 0.3 0.6 0.1 0.5 0.3 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38674957 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;testis: 10.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 19.3;Breast myoepithelial cells: 13.6;Glandular and luminal cells: 6.4;Syncytiotrophoblasts: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 47.9;Hep G2: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: AB_2682731, HPA056555: AB_2683172" "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.3 2.2 3.6 1.7 8.7 0.5 1.2 1.7 10.3 0.9 1.5 0.7 0.3 1.2 0.8 2.0 1.1 0.9 1.0 7.6 3.6 0.8 3.9 1.1 2.8 3.6 1.9 9.9 0.8 3.8 4.8 0.8 1.3 4.3 1.4 0.4 2.2 0.8 0.9 0.6 3.1 0.9 0.7 1.8 1.2 1.3 10.1 2.3 1.6 0.6 0.3 3.5 2.9 0.7 6.3 9.2 10.8 6.8 47.9 1.5 0.4 11.7 1.9 0.7 2.1 3.3 10.8 3.3 17.1 11.6 1.2 6.1 7.3 22.6 4.6 3.7 18.2 17.1 3.8 1.5 57.3 3.1 2.1 9.0 1.0 8.0 2.3 4.6 4.4 1.6 18.8 12.0 25.9 1.4 14.4 15.8 5.1 1.5 6.0 9.6 37.3 3.9 37.8 1.3 2.4 10.4 15.8 6.0 7.8 2.1 11.0 11.4 7.2 2.7 2.0 2.0 2.2 1.8 13.5 16.1 21.7 3.9 25.4 7.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.7 1.7 10.3 7.6 3.6 3.6 1.9 9.9 4.3 1.8 2.3 6.3 4.4 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 19.3 13.6 0.0 0.0 1.3 1.8 0.0 1.7 3.5 0.0 0.0 4.2 0.0 3.4 4.8 1.8 0.0 0.0 0.0 4.0 1.5 1.0 0.0 6.4 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 13.1 0.6 0.8 0.0 0.0 ZNHIT3 "Hit1, TRIP3" ENSG00000273611 "Zinc finger HIT-type containing 3" Q15649 17 36486629-36499310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 222.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060019, HPA078211" Approved Approved Mitochondria NA NA Mitochondria "HPA060019: AB_2684188, HPA078211: " "unprognostic (5.47e-2)" "unprognostic (1.29e-1)" "unprognostic (8.87e-2)" "unprognostic (1.20e-1)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (4.75e-3)" "unprognostic (6.03e-2)" "unprognostic (6.48e-3)" "unprognostic (2.55e-1)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (2.81e-2)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (1.84e-1)" "unprognostic (6.19e-2)" 25.8 32.6 34.9 17.7 36.9 31.4 33.0 35.5 43.4 26.2 33.7 28.9 24.3 24.8 40.2 30.7 24.2 20.3 27.5 35.7 37.0 32.2 36.2 19.6 39.4 35.9 36.0 35.5 31.3 33.3 27.7 24.2 21.2 35.6 26.5 30.8 19.6 26.5 20.2 58.5 31.1 24.4 19.1 36.6 25.8 28.5 50.8 35.7 29.7 29.0 32.7 40.0 30.3 26.7 36.7 39.6 39.0 70.4 55.1 38.6 49.4 38.8 35.8 56.0 53.6 55.2 6.9 55.7 67.3 38.8 18.0 66.8 37.1 25.7 30.8 66.5 35.3 25.7 27.2 41.1 54.3 28.2 73.0 37.7 34.4 69.0 22.1 53.6 60.3 37.1 79.6 48.5 39.8 58.3 36.0 98.3 92.5 50.1 38.0 38.0 33.0 71.2 56.1 67.7 35.2 57.6 42.7 42.7 26.3 73.0 59.5 76.3 72.7 36.4 25.2 42.6 50.9 54.3 41.3 57.6 68.8 54.6 44.3 50.5 15.7 14.5 10.3 15.5 11.3 32.4 22.6 27.1 21.5 20.0 21.6 33.9 27.6 7.9 23.8 26.5 20.0 27.2 17.2 34.9 36.9 35.5 43.4 35.7 37.0 35.9 36.0 35.5 35.6 36.6 35.7 36.7 29.0 25.6 27.0 7.5 48.3 46.4 34.1 99.9 38.1 25.4 51.2 75.2 11.8 30.0 47.5 33.1 12.5 93.2 58.1 24.4 88.0 61.1 222.2 37.9 29.9 32.3 43.5 33.9 10.9 51.2 98.5 30.9 21.4 32.3 34.2 48.5 25.4 30.4 67.4 15.2 12.7 33.8 42.7 49.4 36.7 79.1 37.0 34.6 53.4 10.3 66.6 42.5 47.4 12.1 14.7 60.9 36.8 44.4 32.4 47.3 50.6 88.1 33.8 28.3 46.0 36.6 37.5 179.1 71.2 37.2 43.8 77.2 58.3 55.9 44.6 34.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 70.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 70.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2BC14 "dJ160A22.3, H2B/e, H2BFE, HIST1H2BM" ENSG00000273703 "H2B clustered histone 14" Q99879 6 27815022-27815489 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 3.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9" "Not detected" "Not detected" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.2 0.0 0.5 0.3 0.4 3.6 0.0 1.5 0.5 0.6 0.2 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.3 1.3 0.3 0.2 0.5 1.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.4 1.0 0.2 0.4 0.6 3.2 0.2 0.0 1.1 0.0 1.0 0.9 1.5 0.0 0.2 0.0 0.0 0.0 1.0 0.3 0.2 0.3 1.5 0.3 0.2 1.9 0.0 0.0 0.4 0.9 0.0 0.0 0.0 1.1 0.0 0.7 0.2 0.6 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 14.8 0.0 0.4 4.0 9.9 2.8 0.9 0.6 6.2 0.0 0.3 0.0 0.0 0.2 1.7 0.6 0.9 0.0 0.1 0.8 3.0 0.0 0.0 1.6 1.0 0.1 12.3 0.5 5.9 0.9 1.0 0.7 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.4 0.3 0.1 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.4 1.5 0.5 0.3 1.3 0.3 0.4 0.0 0.5 0.4 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "kidney: 10.7" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 361.7" "Group enriched" "Detected in some" 4 "ovarian cancer: 8.1;testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0" "Region enhanced" "Detected in many" "cerebellum: 19.1" "Region enriched" "Detected in many" 4 "cerebellum: 15.7" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 10.7 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.8 0.4 0.2 0.0 0.5 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.4 2.1 0.0 0.0 42.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 361.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 13.0 0.0 1.6 0.0 0.0 0.2 1.1 2.3 0.0 0.0 0.4 0.3 0.0 0.2 0.0 AL592183.1 ENSG00000273748 Unmapped 54224-83311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 37.4;Ionocytes: 42.7;Langerhans cells: 34.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 103.6" "Low region specificity" "Detected in all" HPA049380 Approved NA NA "HPA049380: AB_2680736" 33.5 24.2 8.6 24.6 14.4 27.9 30.3 18.3 22.5 21.6 8.9 28.6 32.8 55.8 69.9 32.6 22.5 71.4 30.9 10.4 12.3 37.7 21.8 13.3 69.8 11.3 16.7 8.0 31.0 24.5 15.2 26.6 13.1 22.8 26.1 49.7 30.5 33.1 20.7 39.3 21.7 20.4 9.6 26.8 29.2 15.4 10.1 18.7 49.5 6.9 43.0 19.1 17.8 60.5 5.9 1.2 33.2 36.7 44.3 7.3 43.9 35.0 23.8 39.4 2.9 44.2 35.5 17.4 11.2 21.1 31.7 8.9 0.9 28.5 73.5 30.9 31.7 10.4 15.5 0.9 47.7 47.9 49.5 5.0 9.2 21.5 60.4 15.2 28.5 64.8 103.6 15.6 2.0 34.3 27.9 4.8 5.0 3.8 46.7 6.6 18.9 31.7 27.8 4.9 45.7 3.4 14.0 5.5 13.6 10.0 30.9 15.5 7.4 3.5 5.5 8.2 56.7 91.6 19.1 42.8 8.7 11.9 9.2 2.5 7.3 3.5 3.0 4.9 8.1 4.7 4.6 2.7 6.8 5.7 5.7 2.4 4.8 5.2 4.2 4.8 3.4 8.6 14.4 18.3 22.5 10.4 12.3 11.3 16.7 8.0 13.1 9.6 10.1 17.8 3.0 6.4 9.5 0.0 5.6 14.8 20.0 37.4 0.6 2.5 3.5 8.4 0.0 5.7 16.9 3.7 2.1 2.2 1.7 0.7 7.9 4.0 0.2 2.1 1.9 7.4 1.2 4.8 0.0 1.3 0.7 5.6 0.0 1.2 16.4 1.7 6.4 1.8 2.5 0.0 0.0 3.4 42.7 12.9 34.4 0.5 5.0 4.1 17.8 0.0 2.8 5.0 1.0 0.0 0.0 2.2 1.3 7.2 2.0 4.8 1.5 3.3 18.2 5.2 13.1 7.8 6.7 0.3 1.6 1.1 12.4 1.9 8.2 1.0 3.4 11.9 CYFIP1 "KIAA0068, P140SRA-1, SHYC" ENSG00000273749 "Cytoplasmic FMR1 interacting protein 1" Q7L576 15 22867052-22981063 "Predicted intracellular proteins" "Cell shape, Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 253.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 23.5;intermediate monocyte: 24.9;myeloid DC: 22.0;non-classical monocyte: 12.5" "Group enriched" "Detected in many" 5 "dendritic cells: 22.0;monocytes: 24.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068106 Approved NA NA 1100000 "HPA068106: AB_2685955" "unprognostic (1.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.85e-1)" "unprognostic (8.20e-3)" "unprognostic (3.94e-1)" "unprognostic (2.09e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (2.93e-1)" "unprognostic (8.56e-2)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "prognostic favorable (4.47e-5)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-3)" 40.0 26.2 14.8 19.9 15.8 4.7 36.7 15.1 20.2 32.2 15.7 37.2 31.8 34.0 24.0 46.6 24.9 24.2 20.8 14.9 18.4 26.0 26.3 40.8 19.4 19.3 17.2 12.1 29.1 42.1 37.6 13.4 39.9 21.4 29.5 28.4 4.4 39.6 24.8 21.4 38.6 29.6 25.1 25.3 26.8 34.0 16.0 17.8 10.3 27.7 14.6 16.3 30.2 36.9 28.2 67.6 74.8 35.5 72.2 42.7 49.3 49.7 47.5 35.7 32.1 31.7 70.0 32.9 0.2 34.1 50.0 32.9 64.2 31.9 58.8 29.7 36.2 45.5 41.3 40.9 51.9 37.3 14.4 29.5 39.3 43.1 25.4 29.7 33.6 48.3 37.0 20.0 23.4 37.8 58.1 1.5 25.7 25.1 87.1 61.8 18.3 45.7 16.6 81.4 114.3 43.1 44.3 40.9 67.2 46.3 35.0 53.1 30.3 49.5 58.7 47.2 24.3 69.6 3.4 7.7 0.7 56.6 32.5 33.7 0.0 23.5 0.4 0.5 24.9 2.4 2.0 2.1 1.0 22.0 0.3 0.4 0.1 0.7 4.3 12.5 3.3 1.6 8.2 14.8 15.8 15.1 20.2 14.9 18.4 19.3 17.2 12.1 21.4 25.3 17.8 28.2 56.7 35.3 37.9 18.6 5.7 20.0 27.3 33.8 23.9 2.3 28.9 29.8 7.4 17.2 37.9 18.4 2.1 38.6 4.1 78.7 11.7 33.5 4.5 33.8 35.8 50.7 17.4 9.2 41.8 35.0 40.0 32.2 42.8 50.6 8.8 99.1 35.3 31.5 108.7 5.0 46.1 34.0 28.5 104.5 29.5 5.3 36.4 73.8 28.4 253.9 43.3 17.9 0.0 19.6 16.0 43.2 43.2 32.4 6.3 33.2 41.9 21.8 39.6 2.0 26.3 29.5 40.8 9.0 17.9 40.4 26.3 31.7 4.8 38.5 33.0 34.8 CEACAM20 UNQ9366 ENSG00000273777 "CEA cell adhesion molecule 20" Q6UY09 19 44501677-44529788 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 38.0" "Cell type enriched" "Detected in single" 97 "Proximal enterocytes: 39.0" "Cancer enriched" "Detected in some" 4 "prostate cancer: 5.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.04e-2)" "unprognostic (5.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (1.23e-2)" "unprognostic (3.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.07e-2)" "unprognostic (7.58e-2)" "unprognostic (2.14e-5)" "unprognostic (7.13e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.1 0.1 0.0 0.0 0.0 0.0 38.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 H2BC8 "H2B.1A, H2B/a, H2BFA, HIST1H2BG" ENSG00000273802 "H2B clustered histone 8" P62807 6 26215159-26216692 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 19.9" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 7.3;Extravillous trophoblasts: 7.4;Hofbauer cells: 22.5;Syncytiotrophoblasts: 24.1" "Cancer enhanced" "Detected in all" "prostate cancer: 23.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 9.6;SiHa: 10.5;T-47d: 21.2;U-266/70: 19.6" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.54e-2)" "unprognostic (6.69e-2)" "unprognostic (1.55e-1)" "unprognostic (2.36e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (1.70e-8)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.97e-2)" 1.6 0.9 0.8 1.2 1.5 6.8 13.3 7.5 1.8 14.8 3.9 4.2 1.2 0.9 2.0 9.2 4.4 0.9 2.8 1.3 1.1 3.4 3.1 7.6 1.6 1.0 2.1 0.6 5.8 1.1 0.1 2.9 1.1 2.5 19.9 2.0 1.6 7.0 0.6 0.1 9.6 3.2 0.4 2.9 7.2 3.8 1.8 2.0 4.2 2.6 0.0 1.4 1.6 18.6 4.5 3.0 0.1 1.4 0.0 4.4 0.2 0.4 3.7 0.3 2.3 0.9 0.4 2.6 0.0 3.7 0.3 1.0 3.2 1.3 1.2 1.3 2.6 1.6 0.8 1.5 1.4 0.7 0.3 2.4 1.7 0.6 0.7 0.1 0.1 0.5 0.1 9.6 0.2 0.0 2.2 2.8 2.1 1.5 7.1 1.9 1.8 0.8 5.4 1.3 0.7 8.5 1.3 10.5 3.8 1.2 3.7 21.2 0.9 0.3 0.0 1.2 0.3 0.5 19.6 0.1 0.0 0.3 1.3 0.7 18.1 1.3 3.2 2.0 0.9 6.4 4.4 3.2 4.0 5.1 5.3 1.5 1.3 5.8 1.4 1.8 16.0 3.0 2.2 0.8 1.5 7.5 1.8 1.3 1.1 1.0 2.1 0.6 2.5 2.9 2.0 4.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 7.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.1 0.2 0.0 0.0 0.0 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27 X-linked" A6NNY8 X 49879484-49882558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.5;Bipolar cells: 15.8;Cytotrophoblasts: 44.5;Syncytiotrophoblasts: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA077264: AB_2686831" "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favorable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.6 2.5 5.9 1.4 6.5 0.5 2.0 8.4 5.9 2.6 3.2 2.7 1.0 3.9 2.9 1.6 3.6 1.6 1.9 5.2 11.5 2.8 1.8 2.7 1.7 5.2 5.8 5.3 6.3 2.6 3.1 7.3 11.8 5.3 3.0 1.4 3.9 1.6 2.8 4.5 2.1 2.1 2.9 3.7 1.8 2.5 1.3 9.0 2.6 2.4 2.1 1.7 3.0 2.2 5.8 1.6 3.8 4.2 4.8 3.8 3.1 3.6 1.6 2.6 1.8 1.4 6.9 1.6 0.9 1.6 4.2 6.0 2.6 6.0 4.0 2.6 2.0 3.1 1.6 1.1 6.2 2.6 0.5 3.4 4.4 2.7 2.6 2.6 4.4 2.5 4.2 3.4 1.5 2.9 3.7 2.5 1.2 4.8 2.7 2.7 2.7 3.7 0.3 2.9 1.4 1.1 3.2 3.4 3.0 4.0 12.9 3.5 1.1 1.9 2.1 4.3 3.8 0.7 1.6 0.4 0.6 2.5 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 6.5 8.4 5.9 5.2 11.5 5.2 5.8 5.3 5.3 3.7 9.0 5.8 3.5 19.2 15.5 0.7 2.5 2.9 4.5 0.3 2.2 15.8 1.9 2.7 2.6 0.0 7.5 0.0 0.0 44.5 1.4 1.7 5.9 1.5 0.1 2.1 4.1 5.2 4.2 0.0 2.9 0.7 3.6 2.7 1.1 2.1 2.5 4.0 2.5 1.9 4.0 5.0 3.3 1.3 0.0 0.6 1.0 0.3 2.1 1.2 0.0 0.0 1.5 8.3 0.0 3.5 0.8 1.2 0.5 3.4 0.5 3.3 0.5 2.9 13.2 2.5 6.6 2.5 2.6 0.2 1.3 0.9 2.3 26.1 2.0 8.8 1.6 1.7 TAF9 "AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32" ENSG00000273841 "TATA-box binding protein associated factor 9" Q16594 5 69364743-69370013 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 550.8;Late spermatids: 924.3;Spermatocytes: 370.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028930, HPA053429, HPA058961, HPA072658" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: " "unprognostic (1.25e-3)" "unprognostic (9.52e-2)" "unprognostic (1.76e-3)" "unprognostic (8.38e-3)" "unprognostic (5.40e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.66e-1)" "unprognostic (9.45e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.58e-1)" "unprognostic (1.97e-1)" "unprognostic (3.02e-2)" "unprognostic (1.79e-1)" 41.5 43.9 38.9 32.2 42.3 109.2 46.5 39.0 41.9 28.6 37.9 42.9 34.5 31.8 50.8 37.7 31.4 29.1 53.2 41.8 44.3 38.2 56.1 27.9 47.0 40.3 40.2 39.3 38.1 41.2 35.8 51.0 38.3 42.3 34.0 48.0 47.6 35.0 27.9 58.5 35.0 33.5 36.2 38.7 35.3 38.3 141.7 40.7 51.4 28.9 42.1 52.8 51.0 30.6 41.5 107.0 109.3 67.7 121.6 114.4 143.5 179.3 100.1 159.8 172.3 227.0 109.7 135.1 135.9 70.2 146.7 322.2 82.2 92.4 208.1 227.4 65.6 111.0 120.4 154.0 157.8 261.3 118.7 168.3 159.4 137.4 117.1 247.7 122.5 143.1 121.4 122.4 119.8 165.9 147.7 126.1 189.5 82.0 42.6 81.6 83.0 119.7 169.0 152.7 120.7 118.1 82.6 108.3 64.3 192.8 111.3 100.9 175.7 103.3 65.9 98.2 78.2 173.1 93.2 118.3 175.6 101.3 145.7 82.8 149.3 107.8 122.5 52.8 101.3 81.2 90.1 79.7 64.2 83.9 75.4 89.6 73.6 16.0 58.7 88.4 47.0 95.5 134.4 38.9 42.3 39.0 41.9 41.8 44.3 40.3 40.2 39.3 42.3 38.7 40.7 41.5 67.4 19.2 29.3 0.0 55.2 174.0 151.4 238.7 39.3 24.1 49.9 81.4 69.3 42.9 108.8 23.9 14.6 118.0 45.1 33.8 90.1 67.1 550.8 47.6 44.9 58.6 30.7 93.2 0.0 80.4 166.7 57.3 36.7 38.1 38.6 53.5 34.6 41.9 107.7 20.2 0.0 49.5 146.5 42.8 99.8 924.3 65.3 55.2 99.6 0.0 66.9 35.1 35.0 0.0 0.0 85.1 37.2 34.3 76.5 87.3 47.4 90.2 85.2 43.0 32.9 49.1 95.5 370.7 78.0 60.7 163.2 104.5 50.7 75.0 64.2 149.6 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693476 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003547 Uncertain Approved "Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles" Yes No "Nucleoli, Mitotic chromosome" "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favorable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favorable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favorable (3.24e-4)" 16.2 29.5 11.8 15.2 12.5 28.9 17.7 12.2 18.2 18.3 9.9 18.0 15.0 15.6 8.0 35.4 16.3 9.1 17.1 12.3 11.9 18.9 16.3 14.4 21.1 12.7 12.1 10.8 18.6 17.7 11.6 16.6 8.2 13.2 20.0 9.6 4.9 20.7 4.4 12.7 22.0 19.7 6.7 11.6 26.7 18.9 10.5 12.3 16.3 23.3 8.3 12.8 17.3 23.5 13.4 38.3 33.5 24.4 29.5 8.1 7.8 32.2 17.1 7.7 7.4 8.4 20.0 15.7 30.2 9.8 6.2 8.1 41.4 11.6 50.0 2.2 34.4 51.9 26.3 28.9 43.6 21.3 59.3 38.2 9.6 12.4 31.2 11.7 10.0 15.3 16.7 19.8 26.9 6.8 32.3 36.4 48.0 29.5 16.6 46.7 48.5 16.7 24.7 18.2 10.1 19.2 40.3 22.1 19.5 30.8 2.7 26.9 31.0 22.9 34.2 32.5 24.8 34.5 24.0 29.9 41.0 33.3 46.2 40.0 57.3 24.4 26.9 15.1 28.4 11.7 14.1 14.8 13.6 17.6 15.8 14.8 12.6 53.1 16.7 33.8 13.6 22.3 11.9 11.8 12.5 12.2 18.2 12.3 11.9 12.7 12.1 10.8 13.2 11.6 12.3 13.4 10.9 3.2 15.3 4.9 15.3 39.0 13.7 33.0 25.0 11.0 10.2 7.7 3.5 7.2 20.3 14.7 6.2 19.4 11.0 35.6 3.9 25.7 105.7 5.4 5.0 12.9 12.6 8.8 11.4 29.1 16.2 10.2 15.8 4.7 15.2 9.7 10.8 6.2 13.9 28.6 10.9 24.8 20.3 10.7 21.8 48.3 9.9 12.7 21.4 2.8 17.7 13.8 18.6 5.5 8.2 22.4 39.9 11.3 14.0 8.6 27.4 7.8 15.9 8.3 13.1 10.0 10.6 14.5 25.9 45.4 39.8 19.8 14.3 9.7 24.1 14.5 IGKV2-40 ENSG00000273962 "Immunoglobulin kappa variable 2-40" A0A087WW87 2 89330110-89330429 "Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2;urinary bladder: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 48 "memory B-cell: 15.4;naive B-cell: 7.1" "Lineage enriched" "Detected in single" 66 "B-cells: 15.4" "Cell line enhanced" "Detected in single" "Daudi: 1.7" "Immunoglobulin genes" NA NA "unprognostic (3.31e-1)" "unprognostic (1.94e-2)" 0.3 0.1 0.0 9.4 0.0 1.1 6.8 0.0 0.1 10.3 0.0 9.8 43.2 0.9 0.0 10.6 15.6 0.1 0.1 0.0 0.0 0.3 1.4 11.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 1.1 7.2 0.0 5.9 2.0 0.0 0.0 6.2 0.0 0.0 18.0 19.7 0.2 0.0 1.9 1.2 0.1 6.3 34.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L1 ENSG00000273976 "Golgin A6 family like 1" Q8N7Z2 15 23127066-23136822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 63 "testis: 28.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "HPA047733: " 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3C8 "H3/h, H3FH, HIST1H3G" ENSG00000273983 "H3 clustered histone 8" P68431 6 26269405-26271815 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.1;Extravillous trophoblasts: 1.8;Hofbauer cells: 1.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.7;SiHa: 6.8;U-266/70: 6.3" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.88e-1)" "prognostic favorable (8.75e-4)" "unprognostic (3.14e-1)" "unprognostic (2.58e-1)" "unprognostic (6.94e-2)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-1)" "unprognostic (2.02e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (1.21e-3)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (3.90e-2)" "unprognostic (7.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.4 0.3 0.1 0.2 0.0 0.1 0.4 0.4 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.0 0.2 0.6 0.7 0.0 0.7 0.0 0.0 0.1 0.3 0.3 0.1 0.7 0.3 2.7 0.0 0.0 0.3 0.0 0.7 2.2 0.9 0.4 0.5 0.6 0.0 0.1 1.9 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.2 0.5 0.0 1.5 0.0 1.6 0.8 0.3 1.3 2.4 0.0 0.6 0.0 1.0 0.5 0.5 0.2 0.3 6.8 2.1 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.0 0.1 6.3 0.2 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 CASTOR2 "GATSL1, GATSL2" ENSG00000274070 "Cytosolic arginine sensor for mTORC1 subunit 2" A6NHX0 7 74964705-75031528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.6;skeletal muscle: 49.0;tongue: 26.5" "Cell type enhanced" "Detected in some" "dendritic cells: 1.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 2.1;Glandular and luminal cells: 5.1" "Cancer enhanced" "Detected in all" "testis cancer: 11.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057229 Approved NA NA "HPA057229: AB_2683374" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (3.23e-1)" "unprognostic (1.31e-1)" "unprognostic (8.28e-2)" "unprognostic (2.78e-5)" "unprognostic (1.28e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-2)" "unprognostic (1.35e-2)" "unprognostic (6.27e-2)" "unprognostic (9.72e-3)" "unprognostic (1.11e-1)" "unprognostic (3.30e-1)" "unprognostic (2.50e-1)" "unprognostic (9.20e-3)" 1.5 1.9 19.2 0.7 17.1 4.8 1.2 11.2 23.2 1.2 0.0 1.1 1.7 2.1 1.6 1.4 1.8 1.6 2.8 22.3 12.7 1.2 0.8 1.2 0.6 23.8 18.6 15.8 4.0 3.2 1.7 1.9 2.0 28.6 2.0 0.6 5.3 2.0 2.4 49.0 2.7 1.5 1.8 10.4 0.8 1.0 2.1 18.4 2.1 0.7 26.5 1.1 0.9 1.4 14.6 2.6 18.9 3.5 12.1 6.7 2.1 7.3 2.4 1.5 0.9 1.2 8.8 1.0 0.7 2.0 4.9 2.4 1.2 4.7 1.7 1.2 2.0 3.1 1.5 8.0 15.5 2.6 0.7 2.5 5.8 0.9 2.8 0.3 1.2 3.1 5.8 2.8 1.0 1.1 8.5 3.6 4.1 6.3 7.1 1.7 7.5 3.0 2.5 8.5 4.2 8.8 5.9 3.2 5.4 0.8 4.9 3.9 0.8 3.9 2.0 4.1 5.5 0.9 1.7 3.7 3.3 1.7 2.8 1.1 1.7 0.2 0.8 0.4 0.2 0.3 0.1 0.2 0.3 0.0 0.2 0.2 0.3 1.8 0.3 0.2 0.2 0.7 0.2 19.2 17.1 11.2 23.2 22.3 12.7 23.8 18.6 15.8 28.6 10.4 18.4 14.6 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 7.4 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 OR4M2 ENSG00000274102 "Olfactory receptor family 4 subfamily M member 2" Q8NGB6 15 22070241-22083221 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "Sertoli cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC133551.1 ENSG00000274175 "TP53-target gene 3 protein" Unmapped 17234-19833 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 28 "epididymis: 6.1;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.0" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NATD1 "C17orf103, Gtlf3b, MGC33894" ENSG00000274180 "N-acetyltransferase domain containing 1" Q8N6N6 17 21238870-21253410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 40.5" "Cell type enhanced" "Detected in many" "Early spermatids: 48.5;Erythroid cells: 52.0;Late spermatids: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 4 "granulocytes: 5.2;monocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 22.9;SuSa: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.16e-1)" "unprognostic (9.40e-2)" "unprognostic (4.69e-2)" "unprognostic (3.17e-2)" "unprognostic (8.22e-3)" "unprognostic (3.99e-2)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (5.93e-2)" "unprognostic (6.81e-2)" "unprognostic (2.48e-2)" "unprognostic (2.51e-1)" "prognostic favorable (3.55e-6)" "unprognostic (2.18e-1)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (3.98e-2)" 15.1 5.1 4.9 2.8 5.2 19.7 7.9 5.8 5.3 4.4 5.1 6.4 4.5 7.0 4.2 4.4 4.8 5.1 12.7 4.3 3.9 7.9 4.9 7.0 3.9 5.7 4.7 3.9 4.2 7.0 9.3 2.6 6.9 4.7 6.1 2.1 3.5 7.4 7.5 40.5 7.4 4.2 4.6 4.5 8.3 7.1 6.3 4.6 4.8 10.2 19.8 3.8 5.8 3.8 4.5 1.3 2.2 2.7 3.4 11.8 10.9 22.9 3.7 4.8 2.6 4.1 6.1 1.0 0.0 5.8 5.2 4.1 1.8 1.8 1.6 1.2 1.7 6.5 0.5 1.2 1.0 10.1 0.1 2.3 16.5 3.5 3.2 2.2 7.8 5.3 5.3 3.5 0.1 3.5 1.1 0.2 1.7 6.0 0.9 0.6 3.0 2.3 0.9 4.4 1.8 0.9 5.8 2.8 0.4 4.9 50.2 1.4 1.7 3.3 1.3 1.7 1.9 0.9 4.8 2.1 1.3 1.6 1.1 2.1 0.7 1.3 1.6 0.7 0.4 0.2 0.1 0.4 0.5 0.2 0.3 0.2 0.3 5.2 0.2 0.4 0.5 0.7 0.8 4.9 5.2 5.8 5.3 4.3 3.9 5.7 4.7 3.9 4.7 4.5 4.6 4.5 4.3 6.4 4.8 1.0 1.5 0.0 0.7 0.0 0.6 3.0 4.6 6.9 10.6 8.6 1.8 5.5 0.0 6.8 7.0 2.9 0.0 3.5 48.5 8.0 4.4 3.3 3.6 52.0 1.3 0.7 3.0 4.1 1.5 17.1 1.3 2.7 5.7 4.6 2.9 1.7 1.7 3.3 0.0 8.2 0.0 62.1 10.2 3.5 0.0 2.8 4.5 2.3 2.1 2.0 1.2 4.3 2.3 15.8 4.2 3.6 6.3 5.3 0.7 3.3 13.1 3.6 3.5 0.6 6.7 1.1 0.0 10.1 3.3 1.9 1.7 2.3 H2AB1 H2AFB1 ENSG00000274183 "H2A.B variant histone 1" P0C5Y9 X 154884972-154885558 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "HDLM-2: 13.2" NA NA 0.1 0.1 0.5 0.1 0.3 0.6 0.1 0.3 0.5 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.3 0.2 0.2 0.1 0.1 0.4 0.4 0.4 0.1 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.4 0.4 0.2 0.1 0.3 0.3 0.1 11.9 0.4 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 13.2 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.5 0.4 0.3 0.4 0.4 0.4 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANTXRL ENSG00000274209 "ANTXR like" A6NF34 10 46286345-46330207 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 12.8" "Group enriched" "Detected in some" 27 "Early spermatids: 58.5;Late spermatids: 28.8" "Cancer enriched" "Detected in single" 6 "ovarian cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (3.65e-3)" "unprognostic (2.59e-2)" "unprognostic (3.40e-1)" "unprognostic (8.11e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 12.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOCS7 "NAP4, NCKAP4" ENSG00000274211 "Suppressor of cytokine signaling 7" O14512 17 38351844-38405593 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 74.7" "Group enriched" "Detected in many" 6 "Early spermatids: 254.0;Late spermatids: 500.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004475 Approved Approved Cytosol NA NA Cytosol "HPA004475: AB_2667194" "prognostic unfavorable (7.49e-4)" "unprognostic (7.93e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.43e-3)" "unprognostic (1.23e-1)" "unprognostic (1.77e-1)" "unprognostic (4.12e-3)" "unprognostic (1.97e-3)" "unprognostic (6.62e-2)" "unprognostic (4.91e-3)" "unprognostic (1.55e-2)" "unprognostic (1.53e-1)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" 4.2 7.2 8.7 4.4 9.7 4.1 4.9 23.8 9.4 5.6 0.4 5.6 3.9 7.3 6.2 6.1 5.4 2.8 5.0 10.8 5.4 3.9 3.7 4.8 3.5 4.5 7.1 8.9 7.3 14.5 11.6 6.6 3.8 9.6 5.2 4.3 12.8 6.2 4.2 14.3 8.0 4.8 5.5 4.0 3.4 7.0 74.7 7.3 6.8 7.8 5.0 4.7 4.9 4.7 7.2 12.3 13.6 14.9 11.1 8.2 6.9 12.2 5.2 4.5 6.2 5.1 10.7 3.6 8.8 7.7 8.4 8.9 7.7 12.8 3.6 7.9 15.6 11.0 8.9 16.4 11.2 2.6 19.7 14.6 4.3 14.2 6.6 8.7 7.8 5.4 4.4 7.2 5.6 7.8 6.7 16.5 12.8 4.8 13.3 2.4 16.7 24.9 7.6 4.1 14.8 26.1 14.1 13.0 8.3 8.7 12.5 15.5 10.3 5.3 6.2 5.2 11.3 16.3 19.0 14.5 12.1 8.4 9.8 12.9 0.0 0.1 0.0 0.3 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 8.7 9.7 23.8 9.4 10.8 5.4 4.5 7.1 8.9 9.6 4.0 7.3 7.2 4.0 16.0 10.1 21.2 3.5 0.8 7.0 0.0 8.6 47.5 11.1 9.8 26.8 5.7 8.1 1.8 29.2 9.5 6.1 5.3 1.9 6.0 254.0 5.9 7.9 5.1 4.9 4.2 39.0 6.5 4.8 6.4 4.1 6.5 0.0 9.8 7.9 7.8 3.2 35.3 30.6 7.0 0.0 6.8 0.7 500.2 10.5 5.0 1.8 13.1 7.4 11.7 6.2 23.1 20.6 6.6 6.2 9.1 2.1 8.3 4.4 2.9 5.3 15.8 0.0 9.1 6.8 62.1 23.9 8.1 0.9 8.1 5.0 6.0 6.8 7.6 TBC1D3H ENSG00000274226 "TBC1 domain family member 3H" P0C7X1 17 36377531-36388423 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "CAPAN-2: 5.9" "HPA046969, HPA047745, HPA052553" Approved Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.1 0.3 1.3 0.0 1.3 0.1 0.1 1.3 1.5 0.5 1.2 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.1 1.3 1.3 0.5 0.5 0.3 0.0 1.3 1.3 1.3 0.2 0.0 0.0 0.5 0.0 1.4 0.6 0.0 0.1 0.2 0.0 0.1 0.4 0.3 0.0 1.3 0.6 0.1 4.7 1.3 0.0 0.2 0.0 0.0 0.5 0.5 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 1.3 1.5 1.3 1.3 1.3 1.3 1.3 1.4 1.3 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GGTLC3 ENSG00000274252 "Gamma-glutamyltransferase light chain family member 3" B5MD39 22 18516344-18518161 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 10.4;thyroid gland: 8.2" "Group enriched" "Detected in some" 10 "Alveolar cells type 1: 3.2;Early spermatids: 5.3;Late spermatids: 12.1;Spermatocytes: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 1.5;U-2197: 1.0" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (1.37e-1)" "unprognostic (2.06e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.3 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 10.4 0.1 2.2 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.9 0.0 0.0 0.6 0.4 0.0 0.1 0.0 0.2 2.3 0.1 0.0 8.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" Q4V321 X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 36.5" "Group enriched" "Detected in some" 22 "Spermatocytes: 4.2;Spermatogonia: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 303.6;T-47d: 165.3;WM-115: 83.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 36.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 303.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 3.6 0.0 2.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 165.3 0.0 0.7 3.4 1.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CBSL ENSG00000274276 "Cystathionine beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 88.8;pancreas: 48.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "cerebral cortex: 12.0;medulla oblongata: 10.5;pons: 12.1;thalamus: 5.0" "Immune cell enriched" "Detected in single" 14 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 105.1;NTERA-2: 246.2;U-266/70: 75.7" HPA001223 Supported Approved Nucleoli,Vesicles NA NA 510000 Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 3.2 1.2 1.3 0.8 0.8 0.1 1.7 1.5 12.0 6.0 0.4 2.3 2.0 1.8 1.4 1.0 5.6 1.0 4.0 0.9 0.8 1.6 88.8 4.9 0.1 10.5 1.7 0.9 14.9 48.9 2.2 4.4 0.8 12.1 6.2 0.0 1.1 4.7 9.0 0.6 1.0 3.7 0.0 0.9 1.2 8.3 1.0 5.0 0.2 12.4 0.0 0.4 5.1 3.2 1.5 0.1 0.0 36.3 105.1 0.0 0.0 1.4 23.3 15.2 8.9 29.3 0.2 18.2 0.0 0.1 0.0 17.1 12.1 0.2 13.5 5.6 0.0 35.4 0.0 0.0 0.0 1.0 0.0 16.1 12.8 51.5 0.1 23.1 0.0 0.2 0.8 0.7 41.5 0.3 0.0 18.9 2.6 246.2 0.5 0.0 0.3 0.0 0.3 40.5 0.0 38.7 58.5 0.0 3.4 44.9 0.0 0.1 0.1 0.0 2.7 0.0 17.3 4.4 75.7 29.6 0.3 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 1.5 12.0 0.9 0.8 10.5 1.7 0.9 12.1 0.9 5.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADRA2B "ADRA2L1, ADRA2RL1, ADRARL1" ENSG00000274286 "Adrenoceptor alpha 2B" P18089 2 96112876-96116571 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;EFO-21: 1.0" "Group enriched" "Detected in some" 6 "basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2" "Low region specificity" "Detected in some" "HPA066029, HPA074948" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA066029: AB_2685599, HPA074948: " "unprognostic (6.16e-2)" "unprognostic (1.31e-2)" "unprognostic (1.76e-2)" "unprognostic (4.93e-4)" "unprognostic (1.84e-2)" "unprognostic (5.24e-2)" "unprognostic (6.80e-5)" "unprognostic (4.85e-2)" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (8.34e-2)" "unprognostic (2.54e-1)" "unprognostic (2.21e-1)" "unprognostic (4.43e-2)" "unprognostic (3.39e-1)" "unprognostic (1.36e-1)" "unprognostic (6.55e-2)" 5.7 2.1 1.5 0.3 1.7 0.9 3.0 1.4 2.8 1.5 4.4 2.3 0.3 2.0 3.8 0.7 3.0 0.6 6.4 1.2 1.8 4.2 7.1 0.5 0.2 1.8 1.6 0.9 1.7 0.8 0.5 0.5 0.8 1.6 1.4 0.3 0.0 2.2 1.5 6.5 1.7 2.7 0.7 1.2 8.7 2.2 1.6 2.4 0.2 1.3 5.1 0.1 2.5 1.8 2.5 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 1.4 2.8 1.2 1.8 1.8 1.6 0.9 1.6 1.2 2.4 2.5 2.9 0.0 0.0 0.0 0.9 1.1 0.7 0.7 0.6 0.0 0.9 0.9 2.5 0.0 1.5 1.8 0.0 0.8 2.9 0.1 0.0 0.2 0.0 2.2 1.0 2.4 2.4 0.0 0.0 0.6 0.2 1.0 1.1 9.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.2 0.0 0.3 8.0 0.0 1.8 5.1 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.4 0.7 0.0 0.1 1.4 0.0 32.9 0.7 13.3 0.0 0.3 0.6 1.4 0.4 2.8 0.1 0.1 0.3 H2BC6 "H2B.h, H2B/h, H2BFH, HIST1H2BE" ENSG00000274290 "H2B clustered histone 6" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 5.3;REH: 5.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.4 0.4 0.8 0.5 1.7 2.7 0.6 3.0 1.2 3.5 2.8 0.5 0.4 0.4 0.4 0.7 0.6 0.4 0.6 1.1 0.2 1.0 0.6 1.3 0.9 1.7 1.4 1.0 0.9 0.2 0.1 0.7 0.3 0.5 2.6 0.5 1.1 1.3 0.2 0.9 1.0 0.3 0.2 1.7 0.9 0.8 0.5 0.6 3.0 0.5 0.6 0.6 0.4 2.1 1.0 0.3 2.1 1.9 0.5 1.6 0.2 0.2 1.9 0.6 0.3 0.1 0.5 1.3 0.4 0.8 0.3 0.9 2.7 0.3 0.7 0.3 0.9 0.5 0.2 1.0 0.1 0.1 0.1 1.6 0.4 0.1 0.4 0.1 0.6 0.2 0.5 1.4 1.0 0.0 1.0 3.0 5.3 1.5 1.0 0.5 5.1 0.1 1.5 0.8 1.1 1.5 2.2 2.3 0.8 0.5 0.8 1.6 1.0 0.5 0.8 1.5 0.6 1.2 1.3 2.7 0.3 0.4 0.8 0.3 2.9 0.6 1.0 0.7 0.5 0.5 1.0 0.7 0.9 0.2 1.2 0.6 0.6 2.1 0.6 0.6 1.2 1.1 0.3 0.8 1.7 3.0 1.2 1.1 0.2 1.7 1.4 1.0 0.5 1.7 0.6 1.0 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 11 "neutrophil: 28.0" "Lineage enriched" "Detected in many" 11 "granulocytes: 28.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047730: AB_2680136, HPA048668: AB_2680487" "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 2.6 2.7 2.4 2.1 2.9 2.0 5.5 4.9 3.1 3.7 2.7 2.6 2.1 3.7 2.7 3.5 4.1 1.9 4.4 2.8 2.6 3.7 2.4 3.0 2.8 1.7 2.0 2.8 6.3 3.3 5.0 2.5 1.9 2.6 4.0 2.7 5.4 4.1 3.4 5.1 8.2 1.8 2.9 0.9 3.5 2.7 3.5 2.6 2.8 4.5 4.4 3.1 2.6 2.1 2.7 2.3 3.9 3.7 7.0 3.7 4.4 2.8 1.8 3.3 2.4 2.7 0.3 1.7 5.3 1.9 1.7 2.6 6.1 3.0 3.5 2.6 0.2 1.9 0.8 3.5 0.8 4.1 3.3 1.8 3.5 7.8 2.4 3.4 5.0 4.8 3.4 1.1 1.0 3.1 1.3 2.7 1.7 3.1 1.6 6.6 0.2 5.9 1.9 2.6 5.9 5.4 3.2 2.8 1.5 2.7 3.9 2.2 8.4 1.1 3.1 4.0 2.8 2.2 0.6 3.2 1.3 1.4 1.2 3.3 0.8 0.7 2.3 0.9 0.6 0.1 0.8 1.3 1.1 0.3 1.6 1.8 1.0 28.0 2.4 0.6 0.6 0.7 0.2 2.4 2.9 4.9 3.1 2.8 2.6 1.7 2.0 2.8 2.6 0.9 2.6 2.7 3.9 3.2 3.2 3.3 2.7 0.9 1.3 1.9 9.6 7.3 2.6 3.8 3.5 2.8 2.4 0.0 0.0 2.7 0.3 0.8 15.6 1.4 0.8 2.3 2.8 2.7 0.0 0.4 6.5 0.7 1.1 2.2 1.5 1.3 1.3 5.8 1.4 2.3 1.8 10.1 7.8 1.8 2.0 2.4 0.3 1.2 3.1 0.8 0.0 1.9 0.2 5.1 0.0 4.0 4.5 0.8 0.3 5.3 2.0 0.9 1.3 4.6 7.5 4.3 0.0 3.9 2.0 3.2 2.9 5.4 2.0 1.0 1.3 3.5 1.4 1.8 TMEM269 ENSG00000274386 "Transmembrane protein 269" A0A1B0GVZ9 1 42785007-42816619 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.1;retina: 1.6" "Cell type enhanced" "Detected in single" "granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/84: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.03e-1)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.26e-1)" "unprognostic (5.97e-2)" "unprognostic (8.28e-2)" "unprognostic (6.27e-2)" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (5.58e-2)" "unprognostic (8.51e-2)" "unprognostic (1.63e-1)" "unprognostic (4.01e-9)" "unprognostic (2.23e-1)" "unprognostic (2.85e-1)" "unprognostic (1.15e-1)" "unprognostic (4.77e-2)" 0.1 0.0 0.5 0.0 0.6 0.5 0.2 1.1 0.6 0.1 0.2 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.6 0.3 0.1 0.2 0.1 0.2 0.4 0.4 0.4 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.2 1.6 0.1 0.1 0.6 0.6 0.1 0.0 0.3 0.2 0.1 0.9 0.4 0.2 0.1 0.0 0.2 0.1 0.1 1.0 0.1 0.6 0.4 0.9 0.4 0.0 0.4 0.1 0.1 0.2 0.2 0.5 0.2 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.9 0.2 1.0 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.0 0.7 0.0 0.0 0.6 0.3 0.7 0.0 0.2 0.1 1.0 0.7 0.1 0.4 0.3 0.4 0.1 0.0 0.1 0.6 0.6 0.2 0.2 0.4 0.3 0.4 0.4 0.1 0.2 0.4 0.8 0.2 1.4 2.6 1.0 0.1 0.3 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.3 0.0 0.4 0.0 0.0 0.5 0.6 1.1 0.6 0.6 0.3 0.4 0.4 0.4 0.5 0.3 0.4 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 201 "testis: 108.2" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 464.7" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA049690: AB_2680850, HPA068342: AB_2685976" "unprognostic (3.63e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 6.4 0.0 4.9 0.0 0.0 1.0 0.0 4.8 0.0 0.0 9.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 7.6 0.0 0.0 0.0 1.8 4.1 2.1 0.0 7.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.6 0.1 0.0 0.1 0.0 0.0 0.7 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 13.9 5.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 13.1 0.0 0.0 464.7 69.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.8;Cholangiocytes: 2.8;Cone photoreceptor cells: 6.2;Pancreatic endocrine cells: 4.1;Rod photoreceptor cells: 1.9;Syncytiotrophoblasts: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.7;HaCaT: 7.0;HeLa: 9.6;RPMI-8226: 4.2;RT4: 4.9" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 1.6 3.2 1.0 0.0 1.3 0.0 1.7 1.5 3.5 1.9 1.0 2.2 1.4 1.7 0.1 4.1 2.0 0.2 1.5 1.2 1.3 2.5 3.4 2.3 0.3 1.6 0.9 1.2 3.1 2.7 0.4 3.3 0.7 1.3 4.1 0.7 2.3 3.2 0.0 2.0 3.9 4.7 0.1 1.0 4.3 2.4 7.3 1.3 0.0 2.2 0.0 0.5 3.5 3.5 3.7 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.9 7.0 0.0 0.0 0.0 0.0 0.0 1.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 4.2 0.0 4.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.4 0.9 0.0 2.9 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 1.5 3.5 1.2 1.3 1.6 0.9 1.2 1.3 1.0 1.3 3.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.8 2.8 1.3 0.0 6.2 0.8 0.1 0.0 0.0 1.0 0.6 0.5 0.1 0.4 0.0 0.0 0.0 1.7 0.3 0.4 0.0 0.8 0.0 0.0 0.7 0.6 0.7 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 C8orf89 ENSG00000274443 "Chromosome 8 open reading frame 89" P0DMQ9 8 73241329-73259502 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 7.9" "Cell type enhanced" "Detected in some" "Early spermatids: 31.8;Late spermatids: 6.5;Oligodendrocyte precursor cells: 6.6;Spermatocytes: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 2.7;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 6 "B-cells: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.52e-3)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" "unprognostic (2.38e-1)" "unprognostic (6.34e-2)" "unprognostic (3.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (3.19e-1)" "unprognostic (1.17e-1)" "unprognostic (4.01e-2)" "unprognostic (4.62e-4)" "unprognostic (5.50e-2)" "unprognostic (2.16e-1)" "unprognostic (9.26e-2)" "unprognostic (6.32e-2)" 0.4 0.2 0.2 0.1 0.1 0.3 0.4 0.1 0.4 1.0 0.1 0.1 0.1 0.5 0.7 0.2 0.2 0.5 0.1 0.1 0.2 0.1 0.0 0.1 1.1 0.2 0.1 0.1 0.6 0.6 0.1 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.3 0.0 0.6 0.1 0.3 0.2 0.3 0.1 7.9 0.3 0.2 0.2 0.0 0.9 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.1 0.0 0.6 4.9 0.2 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.4 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.0 0.0 2.9 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 31.8 0.1 1.4 0.3 0.0 0.0 2.0 0.2 0.1 0.8 0.0 0.1 1.3 0.4 0.0 0.0 0.3 0.0 3.0 0.0 0.0 0.0 0.0 6.5 1.8 0.2 0.0 3.7 0.0 0.0 1.0 6.6 0.8 0.0 0.1 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.1 13.1 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.3 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Gastric mucus-secreting cells: 5.1;Glandular and luminal cells: 2.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 39.1;hTERT-RPE1: 42.8;NB-4: 38.0" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 11.7 26.9 12.0 9.8 12.9 5.8 12.4 14.6 22.1 23.0 12.2 17.9 11.0 9.9 11.5 34.1 19.3 6.2 12.0 12.0 15.3 22.9 30.1 17.9 10.2 11.9 11.2 11.1 17.6 17.8 3.5 29.2 4.7 13.0 31.3 6.7 47.3 20.0 7.2 17.6 36.5 20.5 4.5 16.0 30.5 17.2 26.3 15.0 9.9 16.5 7.7 4.9 20.8 28.2 33.2 12.8 16.7 6.6 10.0 12.3 11.1 39.1 5.7 3.8 5.1 5.9 9.3 0.2 4.3 0.2 7.3 4.5 20.5 6.1 5.4 3.4 12.6 15.5 0.0 31.9 4.0 8.6 1.7 15.4 9.4 13.0 6.6 3.7 42.8 7.0 8.0 3.4 14.6 8.4 6.8 7.6 38.0 6.3 9.6 3.7 5.0 7.7 0.0 16.1 17.2 9.0 12.5 0.0 6.6 7.7 15.3 9.6 2.7 15.7 0.0 8.6 6.7 8.0 10.2 4.8 0.0 10.2 5.3 5.8 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 1.0 0.2 0.2 0.0 0.1 0.1 12.0 12.9 14.6 22.1 12.0 15.3 11.9 11.2 11.1 13.0 16.0 15.0 33.2 0.2 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.2 0.0 0.6 0.9 0.1 0.0 0.0 1.8 0.0 0.1 0.3 0.2 0.0 0.4 5.0 1.1 0.9 0.2 0.0 0.0 1.1 0.0 0.1 0.3 5.1 2.2 0.0 0.9 0.0 0.3 0.1 0.0 1.0 0.3 0.0 0.3 0.0 0.6 0.3 0.4 0.0 1.9 0.0 0.0 0.0 0.5 0.1 0.5 1.3 0.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.7 0.0 0.3 0.6 0.4 0.5 0.0 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 56.0;Distal tubular cells: 49.0;Extravillous trophoblasts: 42.3;Granulosa cells: 46.2;Proximal tubular cells: 37.0;Syncytiotrophoblasts: 54.5;Theca cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052184: AB_2681752, HPA060643: AB_2684335" "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 27.3 46.7 17.2 17.4 18.8 14.1 25.4 17.5 22.6 24.2 20.0 32.1 19.1 28.4 6.8 31.0 22.1 12.8 45.1 16.4 17.5 40.3 60.3 20.4 18.9 19.2 18.0 15.8 29.1 29.0 18.3 27.4 15.5 17.9 30.9 10.4 5.4 23.0 17.7 104.0 21.8 23.4 12.9 18.3 25.5 29.1 21.8 18.8 12.5 26.1 46.3 12.8 32.3 23.3 18.2 44.8 59.2 34.8 54.0 24.5 19.8 45.3 42.9 30.5 36.1 29.5 64.6 53.5 47.2 18.9 34.8 46.9 51.9 29.8 28.8 15.0 52.0 47.7 35.1 41.5 61.3 34.6 56.6 53.7 24.7 23.1 31.4 24.9 24.2 32.4 7.7 113.8 29.5 28.3 92.8 1.5 84.6 80.0 53.2 52.1 24.5 27.4 98.6 31.5 38.9 34.5 55.3 57.1 119.0 54.4 24.3 83.8 58.3 35.8 46.9 38.5 40.7 56.5 32.4 26.7 73.6 35.8 58.3 63.6 3.5 2.3 1.4 4.2 3.1 3.4 3.6 4.6 3.7 3.3 4.2 4.3 5.3 0.8 4.6 2.3 3.3 3.7 1.7 17.2 18.8 17.5 22.6 16.4 17.5 19.2 18.0 15.8 17.9 18.3 18.8 18.2 15.9 0.0 7.3 0.0 5.9 0.0 0.0 0.0 0.0 0.0 15.2 15.5 0.0 0.0 2.5 22.0 0.0 56.0 13.0 0.0 49.0 24.3 0.0 11.7 17.7 8.0 0.0 0.0 0.0 20.6 42.3 10.5 0.0 13.8 5.1 46.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 18.1 0.0 0.0 1.8 0.0 0.0 37.0 2.9 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 54.5 6.6 53.8 0.0 0.0 SEBOX "OG9, OG9X" ENSG00000274529 "SEBOX homeobox" Q9HB31 17 28364268-28365244 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 36.1" "Not detected" "Not detected" HPA045689 Uncertain NA NA "HPA045689: AB_2679419" "unprognostic (8.66e-2)" "unprognostic (3.10e-3)" 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.3 0.3 0.0 0.3 0.1 0.0 0.4 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CU639417.1 ENSG00000274559 "Histone H2B type F-S-like" 21 5972924-5973383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.8;Intestinal goblet cells: 1.4;Paneth cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;T-47d: 2.2;U-2 OS: 1.6;U-266/70: 1.2;U-266/84: 2.2" "HPA042205, HPA043013, HPA048671" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.37e-2)" "unprognostic (2.63e-1)" 0.4 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.3 0.1 0.5 0.5 0.6 0.3 1.3 0.3 0.0 0.2 0.2 1.0 0.5 0.7 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.1 0.3 0.4 0.0 0.0 0.6 0.4 0.5 0.0 0.0 0.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.4 0.2 0.4 0.0 0.0 0.4 0.4 0.0 0.2 0.6 0.0 0.5 0.3 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 1.1 0.3 0.0 0.4 0.1 0.0 0.4 0.1 0.0 2.2 0.0 0.0 0.0 1.6 0.1 0.2 1.2 2.2 0.2 0.3 0.4 0.4 0.6 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.1 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 IGHV2-70 ENSG00000274576 "Immunoglobulin heavy variable 2-70" P01814 14 106770577-106771020 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 733.7;stomach 1: 506.6" "Cell type enriched" "Detected in single" 5 "Plasma cells: 2.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 24 "cerebral cortex: 3.5;hypothalamus: 3.5;midbrain: 7.3;spinal cord: 2.1" "Group enriched" "Detected in some" 241 "memory B-cell: 24.6;naive B-cell: 23.5" "Lineage enriched" "Detected in single" 247 "B-cells: 24.6" "Cell line enriched" "Detected in some" 8 "U-698: 12.4" "Immunoglobulin genes" NA NA 170000000 "unprognostic (8.01e-3)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (2.38e-2)" "unprognostic (1.12e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (9.10e-2)" "unprognostic (2.50e-1)" "unprognostic (8.93e-2)" "unprognostic (2.91e-1)" 7.4 26.0 0.0 97.1 0.0 69.9 87.0 0.1 3.5 62.8 0.0 87.6 53.7 4.1 0.0 44.7 8.2 37.9 2.1 0.0 3.5 4.8 13.4 70.5 83.4 0.1 7.3 0.0 5.0 1.0 0.9 0.4 0.2 0.0 6.8 83.7 0.0 95.4 14.2 0.1 0.9 42.4 2.5 2.1 157.7 506.6 1.2 0.0 60.0 8.6 0.0 733.7 50.8 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.4 0.8 0.0 0.0 0.8 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.7 0.0 0.1 0.0 12.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 3.5 0.0 3.5 0.1 7.3 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DGKK ENSG00000274588 "Diacylglycerol kinase kappa" Q5KSL6 X 50365409-50470825 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "adrenal gland: 3.4;brain: 8.2;pituitary gland: 6.1" "Cell type enriched" "Detected in some" 6 "NK-cells: 13.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "thalamus: 8.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "Hep G2: 34.5" "Region enhanced" "Detected in many" "hypothalamus: 19.8" "Low region specificity" "Detected in some" NA NA "unprognostic (3.99e-1)" "unprognostic (1.18e-1)" "unprognostic (4.18e-3)" "unprognostic (1.23e-1)" "unprognostic (5.83e-3)" "unprognostic (9.58e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-2)" "unprognostic (2.06e-1)" "unprognostic (4.28e-3)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.49e-2)" "unprognostic (4.64e-3)" 0.0 3.4 1.5 0.0 5.3 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.8 0.8 0.1 0.0 0.0 0.0 6.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 5.3 0.0 2.2 0.1 3.0 0.8 0.8 0.1 1.2 0.3 8.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.1 0.0 13.4 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 49 "brain: 40.9;choroid plexus: 18.9;testis: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.2;RH-30: 1.1;THP-1: 2.1" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.1 8.1 0.4 12.6 0.0 0.0 40.9 16.5 0.0 18.9 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 8.0 18.1 0.0 0.0 0.1 0.3 14.8 9.6 7.9 0.0 0.1 0.2 0.0 0.2 18.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 14.3 0.2 0.0 13.7 14.2 0.5 0.1 0.0 0.2 0.0 0.0 28.9 0.0 0.5 0.1 0.1 0.3 0.2 0.1 0.1 0.4 0.2 0.2 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.2 0.9 1.2 0.1 0.2 0.1 0.8 1.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 2.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.2 0.6 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.1 8.1 12.6 40.9 16.5 8.0 18.1 14.8 9.6 7.9 18.1 14.3 14.2 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.6;REH: 5.0;U-138 MG: 6.6;U-266/70: 10.3;U-266/84: 4.3;U-698: 5.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.8 1.9 1.5 0.0 2.0 0.2 0.7 1.7 5.0 1.3 1.5 1.0 0.0 2.4 0.0 2.3 0.7 1.0 0.8 1.9 1.4 1.6 2.0 1.1 1.3 1.5 1.5 1.4 1.5 1.2 1.0 2.1 0.0 1.9 2.0 1.4 2.9 1.4 0.1 1.0 2.2 4.1 0.0 1.4 1.5 1.1 3.7 1.4 0.0 1.3 0.0 2.1 1.7 1.8 1.7 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.6 0.0 0.0 0.0 10.3 4.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 2.0 1.7 5.0 1.9 1.4 1.5 1.5 1.4 1.9 1.4 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C6 "H4, H4/c, H4FC, HIST1H4F" ENSG00000274618 "H4 clustered histone 6" P62805 6 26240393-26240793 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "brain: 6.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in many" 4 "cerebral cortex: 6.4;pons: 2.8;white matter: 4.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "MOLT-4: 4.5;REH: 1.9" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (1.47e-1)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" 0.0 0.0 0.4 0.0 0.4 0.9 0.0 0.4 6.4 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 1.1 0.7 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 4.5 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.5 3.0 2.4 2.3 5.5 3.9 4.0 3.8 6.9 3.2 2.3 10.7 2.1 2.0 6.4 1.1 1.5 0.4 0.4 0.4 6.4 0.7 0.2 0.7 0.8 0.0 2.8 1.0 1.1 4.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 H2BC17 "H2B.2, H2B/n, H2BFN, HIST1H2BO" ENSG00000274641 "H2B clustered histone 17" P23527 6 27893425-27893891 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 2.5;brain: 6.8;lymphoid tissue: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "white matter: 6.8" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 36.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.89e-4)" 0.2 0.1 0.9 0.2 0.4 2.5 0.1 1.1 0.7 0.3 1.5 0.3 0.2 0.1 0.0 0.5 0.0 0.1 0.2 0.2 1.7 0.2 0.4 1.0 0.7 1.1 1.9 0.1 0.0 0.0 0.0 0.0 0.7 1.2 0.5 0.3 0.0 0.2 0.0 0.1 0.4 0.2 0.0 1.2 1.3 0.2 0.2 1.7 2.6 0.2 0.0 0.6 0.3 0.8 6.8 2.8 3.0 1.6 5.1 0.7 0.0 3.0 0.9 0.1 5.3 5.1 1.1 1.5 3.2 2.3 0.2 1.3 2.6 2.9 0.5 1.4 2.4 2.0 1.9 4.7 2.1 0.0 0.3 1.4 0.3 0.0 0.4 0.5 0.1 1.4 2.3 7.6 9.1 0.2 1.3 12.9 10.9 1.8 1.8 2.2 7.4 1.7 5.5 1.1 0.4 7.3 1.4 5.8 1.3 0.8 0.6 2.3 0.2 0.0 1.7 0.3 1.8 2.4 9.1 36.0 8.8 1.0 10.2 0.8 0.6 0.1 1.7 0.3 0.2 0.4 0.5 0.3 0.6 1.0 0.9 0.1 0.2 2.6 0.5 0.3 0.7 0.6 2.0 0.9 0.4 1.1 0.7 0.2 1.7 1.1 1.9 0.1 1.2 1.2 1.7 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CCL23 "Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23" ENSG00000274736 "C-C motif chemokine ligand 23" P55773 17 36013056-36017972 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "Hepatic stellate cells: 243.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 163 "eosinophil: 183.7" "Lineage enriched" "Detected in many" 163 "granulocytes: 183.7" "Group enriched" "Detected in some" 4 "HEL: 17.6;THP-1: 37.4" HPA042015 Uncertain "Secreted to blood" NA NA 937000 130000 "HPA042015: AB_10794039" "unprognostic (1.65e-3)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (9.50e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (1.20e-4)" "unprognostic (2.17e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-2)" "unprognostic (7.05e-2)" "unprognostic (6.93e-2)" "unprognostic (1.35e-3)" "unprognostic (2.18e-1)" "unprognostic (2.76e-1)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" 7.6 6.7 0.0 7.1 0.0 3.7 7.4 0.0 0.2 18.7 0.1 3.6 0.3 14.9 1.6 4.8 12.0 3.3 0.6 0.0 0.0 11.6 7.6 21.6 1.6 0.0 0.0 0.0 2.9 1.0 0.0 0.3 0.3 0.0 8.6 8.8 0.0 3.5 0.3 0.5 3.5 9.4 10.9 0.0 14.2 3.4 0.6 0.1 0.8 3.1 0.1 1.3 5.5 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 1.0 0.7 183.7 0.1 0.7 0.0 1.0 0.0 0.4 0.7 0.0 0.0 0.4 0.7 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.5 3.2 2.3 0.0 0.9 1.7 0.4 0.0 0.0 0.0 0.1 0.3 0.2 1.5 0.6 0.0 0.0 0.0 0.7 1.6 0.0 0.0 1.6 0.0 0.2 44.6 0.0 5.7 0.0 0.0 0.0 0.7 0.0 0.0 10.1 0.0 243.8 2.6 7.0 0.0 0.0 0.5 0.0 14.7 2.7 0.1 0.0 3.7 1.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 21.4 0.0 0.1 0.1 0.5 0.1 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.1 2.7 0.3 0.6 0.0 4.2 0.2 KRTAP7-1 KAP7.1 ENSG00000274749 "Keratin associated protein 7-1" Q8IUC3 21 30829039-30829759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 100 "skin 1: 15.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 16 "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3C6 "H3.1, H3/d, H3FD, HIST1H3E" ENSG00000274750 "H3 clustered histone 6" P68431 6 26224199-26227473 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Hofbauer cells: 1.0;Syncytiotrophoblasts: 1.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 10.5;hTERT-RPE1: 7.5;SCLC-21H: 11.9;T-47d: 7.3" "Low region specificity" "Detected in all" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.42e-2)" "unprognostic (1.78e-1)" "unprognostic (1.78e-3)" "unprognostic (9.07e-2)" "unprognostic (1.34e-1)" "unprognostic (3.65e-1)" "unprognostic (1.23e-1)" "unprognostic (3.90e-1)" "unprognostic (1.83e-1)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (1.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (7.66e-2)" 0.4 3.5 1.9 1.0 1.5 0.5 1.8 3.9 2.6 1.2 2.3 2.9 4.7 0.8 4.9 2.9 1.5 1.0 5.6 1.2 2.7 0.9 2.9 0.5 1.3 2.1 1.8 0.7 1.0 0.7 1.5 0.6 0.9 2.1 3.4 1.9 0.2 1.9 0.7 5.2 1.2 4.7 0.4 2.1 2.2 2.6 1.4 1.6 1.2 2.7 3.7 0.9 1.3 1.2 5.1 1.9 2.0 2.8 1.3 3.3 1.6 0.2 1.3 1.5 0.7 0.5 0.6 1.1 0.0 10.5 0.5 1.0 2.3 0.0 0.3 0.6 2.9 2.5 0.4 1.0 0.6 1.0 0.1 1.7 2.3 2.4 0.3 0.7 7.5 1.1 0.2 0.3 2.2 1.9 1.8 0.4 0.1 0.2 1.4 1.9 1.4 0.6 0.3 5.7 1.1 11.9 1.4 1.9 3.0 3.4 0.4 7.3 1.2 0.6 1.3 0.4 0.4 0.3 0.8 0.3 0.2 0.6 0.1 0.7 0.2 0.7 0.0 0.5 0.6 0.7 0.5 0.7 0.7 0.5 0.9 0.6 0.7 2.7 0.2 0.6 1.7 1.3 0.5 1.9 1.5 3.9 2.6 1.2 2.7 2.1 1.8 0.7 2.1 2.1 1.6 5.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 TRBV12-3 "TCRBV12S3, TCRBV8S1, TRBV123" ENSG00000274752 "T cell receptor beta variable 12-3" P01733 7 142560423-142560931 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "lymphoid tissue: 61.6" "Group enriched" "Detected in some" 19 "Gastric mucus-secreting cells: 4.6;T-cells: 10.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "memory CD4 T-cell: 29.2;memory CD8 T-cell: 14.9;naive CD4 T-cell: 32.5;naive CD8 T-cell: 23.9;T-reg: 46.0" "Lineage enriched" "Detected in many" 11 "T-cells: 46.0" "Cell line enriched" "Detected in some" 339 "JURKAT: 1248.3" NA NA "unprognostic (5.41e-3)" "unprognostic (9.35e-4)" "unprognostic (5.34e-3)" "unprognostic (1.39e-4)" "unprognostic (5.43e-6)" "unprognostic (1.97e-2)" "unprognostic (5.06e-2)" "unprognostic (7.76e-3)" "unprognostic (2.50e-2)" "unprognostic (7.32e-2)" "unprognostic (1.58e-1)" "unprognostic (9.57e-5)" "unprognostic (2.45e-1)" "unprognostic (1.76e-3)" "unprognostic (3.22e-1)" "unprognostic (2.70e-2)" 0.2 0.0 0.0 4.4 0.0 2.4 0.4 0.0 0.0 1.4 0.0 1.0 1.0 0.2 0.3 0.5 0.1 1.3 0.3 0.0 0.0 0.2 0.6 1.4 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.3 0.0 0.8 0.0 0.4 0.1 2.2 0.1 0.0 3.8 2.2 0.2 0.0 61.6 0.3 0.0 12.7 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.2 1.0 0.9 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.7 0.0 1248.3 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 4.0 0.0 0.0 0.5 0.1 1.2 0.0 29.2 14.9 0.0 0.0 32.5 23.9 1.0 0.0 0.0 0.0 46.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 PRAMEF27 ENSG00000274764 "PRAME family member 27" A3QJZ7 1 13049476-13056575 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F8A2 ENSG00000274791 "Coagulation factor VIII associated 2" P23610 X 155382115-155383230 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 116 "brain: 11.6" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "medulla oblongata: 11.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.04e-2)" "unprognostic (5.07e-1)" "unprognostic (8.70e-2)" 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 11.6 1.0 0.0 1.5 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC171558.1 ENSG00000274792 "Olfactory receptor 4N4-like" Unmapped 386278-387620 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "Early spermatids: 6.9;Late spermatids: 16.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.9" "Cell type enriched" "Detected in some" 12 "Early spermatids: 20.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.6;HeLa: 8.7;T-47d: 5.9" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 2.3 4.1 3.6 1.3 2.5 0.9 2.5 3.7 4.4 3.4 2.5 3.5 1.4 2.2 0.2 5.8 3.2 0.7 2.1 4.8 3.8 3.6 4.3 3.1 1.0 4.5 3.1 3.4 4.0 3.6 0.4 5.0 0.5 5.3 5.1 0.5 2.4 4.3 1.0 3.7 5.9 4.3 0.5 0.4 4.9 3.1 13.9 3.1 0.8 3.2 0.3 0.6 4.2 5.1 5.9 1.1 1.8 1.1 1.3 1.1 1.3 3.6 0.9 0.5 1.0 1.5 0.4 8.6 0.2 0.7 0.5 0.4 3.8 0.5 0.8 0.3 1.5 2.8 0.6 8.7 0.5 0.6 0.2 1.0 1.1 1.7 1.1 0.2 2.4 0.7 0.9 0.5 0.8 0.3 0.1 0.8 3.4 0.4 0.3 0.4 1.1 0.3 0.1 1.1 1.1 0.7 0.9 0.8 0.5 0.6 1.4 5.9 0.8 2.0 0.4 0.3 2.9 0.4 1.2 1.0 0.4 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 2.5 3.7 4.4 4.8 3.8 4.5 3.1 3.4 5.3 0.4 3.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NPHP3-ACAD11 ENSG00000274810 "NPHP3-ACAD11 readthrough (NMD candidate)" 3 132558142-132722459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 2.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.9" "Low region specificity" "Detected in many" NA NA "unprognostic (1.50e-1)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.91e-1)" "unprognostic (2.45e-1)" "unprognostic (5.84e-2)" "unprognostic (2.07e-2)" "unprognostic (3.07e-1)" "unprognostic (2.38e-1)" "unprognostic (3.48e-1)" "unprognostic (3.63e-5)" "unprognostic (4.17e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-1)" "unprognostic (2.59e-2)" 2.7 1.0 1.9 0.3 2.4 1.1 2.2 2.0 5.2 1.7 1.9 1.6 0.7 3.1 0.0 0.8 1.6 1.3 0.8 1.8 2.3 0.7 0.7 2.2 0.9 2.3 2.2 1.6 5.8 1.2 1.0 0.3 0.8 2.7 0.6 0.7 2.7 1.6 1.1 3.8 0.3 0.8 1.1 2.2 1.7 0.9 1.3 2.1 0.8 0.6 0.0 0.8 0.7 0.4 2.8 1.5 0.2 3.8 0.3 1.5 7.9 2.0 4.0 3.9 1.0 1.7 0.0 0.8 0.4 1.5 4.1 3.0 0.8 0.2 0.7 1.5 0.5 0.5 0.3 0.0 2.1 2.0 0.0 2.7 5.0 1.5 2.1 2.2 5.1 0.0 1.0 0.3 0.7 2.0 0.0 0.0 1.4 1.1 1.9 0.3 0.0 2.6 0.4 1.8 0.0 0.2 2.8 1.6 0.3 3.6 3.0 0.4 1.1 5.5 3.1 2.4 3.3 0.0 1.1 0.1 0.4 4.3 0.1 1.8 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.9 2.4 2.0 5.2 1.8 2.3 2.3 2.2 1.6 2.7 2.2 2.1 2.8 0.0 3.2 1.1 2.3 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 1.9 0.0 0.8 0.4 0.0 0.0 1.3 0.0 0.0 0.4 0.5 0.0 1.8 0.0 0.0 0.3 0.0 0.7 0.0 0.5 0.0 3.7 0.0 0.6 0.0 4.5 3.7 0.0 0.1 0.0 0.5 0.6 0.4 0.0 0.0 1.1 0.0 0.6 0.3 0.5 0.4 0.7 0.0 0.4 0.6 0.0 0.1 0.6 MAFIP "FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4" ENSG00000274847 "MAFF interacting protein (pseudogene)" Unmapped 53594-115055 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 4.0;Endometrial ciliated cells: 3.9;Endometrial stromal cells: 3.8;Glandular and luminal cells: 5.2;Proximal tubular cells: 3.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA053929 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA053929: AB_2682314" 3.9 5.6 6.2 1.5 6.7 0.9 1.1 6.7 8.2 1.6 6.1 1.2 1.7 1.5 0.8 2.7 1.9 2.3 2.0 6.3 6.6 2.0 1.9 1.9 3.7 7.0 6.4 5.9 3.6 2.7 1.5 1.4 7.0 2.3 0.5 1.4 4.2 1.4 1.8 0.7 2.4 2.2 7.0 3.2 0.8 1.2 6.6 0.4 1.5 1.8 1.3 1.9 9.8 0.0 2.9 0.0 0.9 0.0 0.0 2.0 3.9 1.7 1.1 1.6 6.5 7.5 0.0 6.4 5.1 3.0 0.9 2.3 3.7 0.5 0.0 2.5 1.7 3.0 6.0 0.1 0.0 5.7 0.6 5.7 2.0 0.0 4.7 3.8 0.0 7.6 1.8 2.4 7.8 6.0 0.7 0.0 3.5 1.1 0.0 3.6 1.3 4.1 0.5 1.9 4.2 0.0 2.3 3.6 0.7 5.7 0.1 8.6 2.1 3.4 0.9 2.7 5.6 2.1 0.0 8.7 0.0 1.2 2.1 1.5 1.2 1.3 2.1 0.9 2.1 1.2 1.1 2.5 2.3 1.6 1.6 0.1 1.9 0.9 5.0 2.0 1.4 6.2 6.7 6.7 8.2 6.3 6.6 7.0 6.4 5.9 7.0 7.0 6.6 9.8 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.7 0.0 3.9 3.8 1.2 0.0 0.0 0.0 1.1 0.7 1.1 0.0 5.2 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.0 0.0 TBC1D3I ENSG00000274933 "TBC1 domain family member 3I" A0A087WXS9 17 36253456-36264553 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 7.1" "Cell type enriched" "Detected in some" 12 "Early spermatids: 38.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "CAPAN-2: 5.3" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.1 0.2 0.7 0.0 0.8 0.0 0.1 0.8 1.5 0.2 0.6 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.8 0.8 0.2 0.3 0.1 0.1 1.1 0.8 0.9 0.2 0.2 0.0 0.3 0.0 1.7 0.3 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.3 0.3 0.1 7.1 0.7 0.0 0.1 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.8 1.5 0.8 0.8 1.1 0.8 0.9 1.7 0.3 0.7 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL139260.3 ENSG00000274944 "Novel protein" 1 38864501-38881617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 5.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;Endometrial ciliated cells: 1.3;Glandular and luminal cells: 2.1;Respiratory ciliated cells: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA041188, HPA078331" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (8.00e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (2.00e-1)" "unprognostic (9.72e-3)" "unprognostic (4.27e-4)" "unprognostic (4.64e-7)" "unprognostic (2.59e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (9.54e-3)" "unprognostic (6.09e-6)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.32e-3)" 1.4 2.0 0.0 0.9 0.0 0.4 0.4 0.0 0.9 0.3 0.0 2.7 1.7 0.3 0.0 2.7 0.7 0.2 0.4 0.0 0.0 1.1 1.8 0.4 2.5 0.0 0.0 0.0 0.4 0.5 0.0 0.9 0.6 0.0 0.7 1.6 0.0 2.4 0.0 0.3 1.5 1.2 0.0 0.0 1.2 1.6 5.1 0.0 0.4 0.6 0.0 0.5 0.9 1.0 0.0 16.7 1.3 3.7 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 8.0 17.5 2.8 14.5 0.0 0.3 11.1 0.0 0.0 0.0 9.2 2.3 1.4 2.7 2.2 0.0 19.3 5.4 0.0 0.0 0.8 0.5 1.2 0.9 0.0 6.4 4.7 1.1 4.1 8.7 20.6 7.7 8.5 9.8 9.8 7.7 17.9 0.0 8.6 7.0 3.6 9.2 7.5 2.1 3.1 5.0 6.1 6.8 2.2 7.6 7.7 16.0 1.8 17.3 12.9 8.2 7.5 2.2 0.0 0.4 0.0 0.0 0.5 0.2 1.2 0.0 0.1 1.7 1.3 0.1 0.0 0.9 0.0 1.4 3.1 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 H2AC12 "dJ86C11.1, H2A/S, H2AFALii, HIST1H2AH" ENSG00000274997 "H2A clustered histone 12" Q96KK5 6 27147106-27147562 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.8;brain: 2.6" "Cell type enhanced" "Detected in some" "dendritic cells: 1.6;Extravillous trophoblasts: 2.3;Hofbauer cells: 1.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive B-cell: 11.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 5.4;MOLT-4: 6.2;NB-4: 6.9" "CAB004030, HPA041189" Supported Approved Nucleoplasm NA Yes Nucleoplasm "CAB004030: AB_2118804, HPA041189: AB_2677357" "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.2 0.1 0.8 0.0 0.7 8.8 0.3 0.5 0.4 0.1 0.7 0.4 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.3 1.8 0.0 0.1 0.2 1.2 1.1 1.0 0.0 0.1 0.1 0.1 0.0 0.3 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 2.1 0.1 1.8 0.6 0.2 1.6 2.2 1.5 0.1 0.0 0.2 0.2 0.2 2.6 1.7 2.0 0.7 3.0 0.0 0.0 0.4 0.2 0.3 0.3 0.0 2.0 0.6 2.7 0.6 0.0 0.3 0.2 0.6 0.0 0.0 1.4 5.4 3.0 2.5 0.0 0.0 2.1 1.1 0.0 0.0 0.7 0.0 0.0 0.5 1.1 3.1 1.7 0.5 0.3 6.2 6.9 2.1 0.6 0.7 2.2 1.9 3.2 0.0 0.2 1.5 0.4 0.9 0.3 0.2 0.0 0.6 1.0 0.0 0.6 1.7 0.1 1.8 1.8 2.0 4.0 0.8 2.8 0.6 0.0 0.8 0.0 2.2 2.3 1.0 3.3 4.1 3.8 2.0 11.9 2.1 1.5 0.0 5.1 1.4 1.4 0.7 2.0 0.8 0.7 0.5 0.4 0.3 1.8 1.1 1.0 0.0 1.4 1.8 2.2 2.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 ZNF280B "5'OY11.1, SUHW2, ZNF279, ZNF632" ENSG00000275004 "Zinc finger protein 280B" Q86YH2 22 22484421-22508742 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.5" "Group enriched" "Detected in many" 7 "Early spermatids: 135.6;Late spermatids: 99.3;Spermatocytes: 104.2;Spermatogonia: 161.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 20.9;U-2 OS: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059519 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059519: AB_2684050" "unprognostic (7.32e-2)" "unprognostic (2.99e-2)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (2.65e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-2)" "unprognostic (2.85e-3)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" "unprognostic (3.34e-2)" "unprognostic (4.80e-1)" "unprognostic (2.44e-2)" "unprognostic (5.34e-2)" 0.1 1.7 2.0 0.6 2.6 0.3 0.2 1.7 3.5 0.4 0.1 0.3 0.2 1.1 1.0 0.2 0.8 0.4 0.5 2.3 3.3 0.2 0.1 0.2 1.1 2.5 2.2 2.1 2.1 0.6 1.2 1.4 0.2 3.3 0.9 0.4 3.3 0.2 1.0 0.3 0.3 0.4 0.8 1.3 0.9 0.4 13.5 3.1 0.8 1.9 0.2 0.9 0.2 0.1 3.4 0.0 2.5 3.2 0.0 0.0 0.0 3.7 0.5 0.0 0.0 0.0 1.8 1.1 3.2 3.1 0.1 3.0 0.0 2.8 0.3 0.0 0.0 3.8 4.0 0.6 3.6 2.4 2.5 4.4 1.2 0.0 2.7 0.0 0.5 2.7 3.1 20.9 1.4 1.0 0.0 3.0 1.7 2.4 1.5 0.5 3.0 0.0 0.2 0.8 0.0 2.0 2.2 0.0 0.0 1.1 2.6 0.0 1.9 1.0 4.4 9.8 1.0 0.1 1.7 1.9 1.9 3.0 2.1 0.2 12.9 1.6 2.9 2.6 2.5 4.2 2.8 3.2 2.5 1.5 2.8 3.8 4.5 4.1 5.2 5.4 2.4 2.6 1.8 2.0 2.6 1.7 3.5 2.3 3.3 2.5 2.2 2.1 3.3 1.3 3.1 3.4 0.1 0.0 0.6 3.9 5.3 0.1 0.6 0.4 0.0 7.1 0.9 1.3 2.6 2.8 0.6 0.0 4.2 0.3 0.8 0.3 0.0 2.8 135.6 3.4 2.4 1.8 3.0 0.4 12.7 3.7 0.3 1.3 1.1 3.9 0.0 11.4 1.4 0.2 3.0 5.0 14.6 0.7 0.0 0.8 1.9 99.3 2.5 2.6 5.4 1.0 1.9 6.9 5.2 7.5 4.2 2.3 0.1 7.2 0.7 0.8 0.0 4.4 0.0 8.0 6.6 2.3 0.5 104.2 161.7 0.0 0.0 0.3 2.3 17.2 1.6 0.1 MLLT6 "AF17, FLJ23480" ENSG00000275023 "MLLT6, PHD finger containing" P55198 17 38705273-38729795 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Bipolar cells: 291.2;Cone photoreceptor cells: 204.3;NK-cells: 218.3;Rod photoreceptor cells: 200.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 14.9;U-266/70: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004021 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA004021: AB_1853995" "prognostic favorable (4.18e-4)" "unprognostic (1.50e-1)" "unprognostic (2.53e-1)" "unprognostic (1.44e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (7.12e-3)" "prognostic favorable (7.41e-4)" "unprognostic (1.78e-1)" "unprognostic (1.84e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-3)" 38.2 45.9 2.0 2.9 1.4 2.0 42.9 2.8 2.5 52.4 0.3 45.6 3.1 46.4 1.4 35.5 64.2 0.9 46.9 1.2 0.0 54.0 20.8 45.7 2.2 2.2 0.0 0.1 81.8 53.2 0.9 79.8 1.2 0.9 52.5 0.8 3.8 44.8 1.6 82.5 35.9 54.9 1.1 0.0 67.6 48.8 33.7 0.4 0.8 71.1 1.0 0.9 45.1 41.0 2.9 2.1 3.8 0.8 1.2 0.8 0.8 0.9 3.3 0.3 0.3 0.6 2.3 1.5 5.4 3.7 0.5 1.1 4.2 0.1 1.2 0.6 14.9 6.5 3.2 7.4 3.5 0.0 2.5 2.6 0.7 0.1 1.1 0.5 2.4 0.9 1.5 2.4 4.4 0.5 1.0 3.7 0.8 0.9 0.3 1.3 2.5 2.8 1.5 0.2 4.6 3.8 4.0 2.1 1.2 1.5 0.8 2.2 0.1 3.9 1.3 2.3 3.2 3.4 10.0 5.8 4.6 1.4 1.8 1.0 0.4 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 2.0 1.4 2.8 2.5 1.2 0.0 2.2 0.0 0.1 0.9 0.0 0.4 2.9 60.8 48.1 46.8 46.4 35.3 30.5 25.2 20.2 18.2 291.2 41.2 35.6 32.2 24.3 31.5 33.1 204.3 20.1 69.5 24.4 11.7 25.5 3.2 25.0 35.0 46.0 49.7 9.9 24.5 42.4 4.5 27.9 22.4 35.5 37.3 49.1 31.8 12.6 13.6 119.5 18.8 31.5 10.2 18.0 39.9 6.0 46.9 22.7 19.6 45.0 28.4 36.2 218.3 32.6 26.5 32.2 25.6 42.2 28.0 40.0 37.1 15.7 25.8 200.9 32.9 51.3 37.0 17.1 23.4 27.1 29.1 38.3 65.0 27.9 39.3 29.4 TP53TG3E ENSG00000275034 "TP53 target 3 family member E" Q9ULZ0 16 33303739-33306935 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP4R3B "FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2" ENSG00000275052 "Protein phosphatase 4 regulatory subunit 3B" Q5MIZ7 2 55547292-55618880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001233, CAB017185" Approved Supported "Nucleoplasm,Nuclear speckles,Centrosome" NA NA "Nucleoplasm, Nuclear speckles" Centrosome "CAB017185: , HPA001233: AB_1080033" "unprognostic (9.60e-2)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-2)" "unprognostic (6.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (3.27e-2)" "unprognostic (8.27e-3)" "unprognostic (7.62e-2)" "unprognostic (1.07e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (6.03e-4)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" 29.3 27.6 15.9 28.4 16.2 26.0 29.4 22.2 17.0 27.0 21.0 28.4 31.9 24.0 19.5 32.0 32.6 24.9 14.5 14.6 20.1 33.7 48.4 23.6 38.4 16.3 16.8 13.3 25.9 32.4 27.6 12.6 24.7 16.8 25.1 28.0 35.6 28.3 23.4 14.8 29.9 32.4 22.0 17.3 28.9 31.1 23.9 16.2 42.6 33.3 20.5 39.1 27.0 17.1 19.8 42.8 33.0 35.6 30.0 37.2 38.9 49.1 34.0 35.9 28.2 24.0 39.5 40.9 57.7 67.5 32.7 44.8 36.4 39.9 27.5 41.4 84.6 16.7 56.7 30.0 52.9 60.3 66.0 45.6 29.8 64.9 34.1 60.1 36.9 45.0 31.6 55.2 57.4 37.7 50.9 42.8 43.7 35.1 55.9 25.3 40.1 53.6 44.6 39.3 43.8 43.4 26.9 36.8 49.9 54.8 23.5 31.6 52.0 36.3 43.3 56.8 21.6 47.2 59.1 47.3 22.3 40.8 61.3 47.2 25.6 16.5 26.9 20.4 20.9 23.2 18.1 21.2 21.6 18.4 18.6 24.5 21.5 19.6 22.5 23.0 9.9 24.0 23.9 15.9 16.2 22.2 17.0 14.6 20.1 16.3 16.8 13.3 16.8 17.3 16.2 19.8 46.8 44.8 41.3 0.0 61.8 0.0 48.9 0.0 44.3 44.1 42.7 27.9 0.0 31.5 29.1 16.5 33.3 30.6 51.4 25.3 39.2 32.4 9.5 85.1 43.2 32.9 18.2 46.7 0.0 41.0 28.5 33.9 43.8 39.6 30.3 39.0 26.0 52.5 26.2 53.8 0.0 29.4 0.0 37.7 0.0 7.6 28.0 44.9 0.0 0.0 47.9 53.1 49.4 0.0 0.0 35.4 24.1 36.1 57.2 57.4 46.1 52.9 62.7 38.5 6.6 54.9 28.4 39.1 25.7 53.3 0.0 47.7 56.3 44.6 29.0 57.2 AC233755.1 ENSG00000275063 "Immunoglobulin heavy variable 4-38-2-like" P0DP08 Unmapped 41444-41876 "Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 630.3;lymphoid tissue: 775.3;urinary bladder: 438.4" "Cell type enriched" "Detected in some" 196 "Plasma cells: 4861.5" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 368 "memory B-cell: 403.0;naive B-cell: 259.1" "Lineage enriched" "Detected in single" 447 "B-cells: 403.0" "Cell line enriched" "Detected in some" 7 "REH: 141.7" "Secreted to blood" NA NA 34.1 2.2 0.3 335.5 0.0 87.2 76.9 0.0 1.0 194.9 0.6 630.3 468.4 6.0 0.0 102.7 3.7 40.9 1.7 0.0 0.9 2.4 21.4 37.5 127.6 0.2 0.5 0.0 12.0 1.4 0.0 1.1 0.0 4.4 224.0 0.0 190.4 21.7 0.2 0.7 137.2 30.6 0.1 213.5 244.1 7.9 0.0 34.6 3.3 0.0 775.3 438.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 1.0 0.0 0.0 0.0 19.1 0.4 0.4 0.0 0.0 141.7 1.6 3.2 0.0 0.0 0.2 9.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 3.6 0.0 0.7 0.0 0.3 0.2 0.1 0.1 0.0 0.5 403.0 0.2 0.2 0.2 259.1 0.2 0.1 0.6 0.1 0.1 0.9 0.2 34.3 0.3 0.0 0.0 1.0 0.0 0.9 0.2 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4861.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 SYNRG "AP1GBP1, MGC104959, SYNG" ENSG00000275066 "Synergin gamma" Q9UMZ2 17 37514807-37609472 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023554, HPA023555" Approved Approved Cytosol NA NA Cytosol "HPA023554: AB_1844892, HPA023555: AB_2058337" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "unprognostic (9.25e-2)" "unprognostic (1.11e-1)" "unprognostic (4.99e-2)" "unprognostic (3.44e-2)" "unprognostic (3.71e-2)" "unprognostic (1.90e-1)" "unprognostic (1.40e-1)" "unprognostic (1.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-3)" "unprognostic (8.76e-2)" "unprognostic (2.56e-1)" "unprognostic (2.91e-2)" "prognostic favorable (3.96e-4)" 8.2 9.1 4.5 13.0 6.4 6.7 7.8 5.1 7.0 8.4 6.7 8.8 6.9 7.7 10.9 9.6 7.5 8.1 5.7 3.8 6.0 10.0 8.6 8.9 21.6 6.4 6.8 3.6 8.4 8.9 12.0 11.8 7.8 6.7 8.1 9.6 9.3 9.2 6.7 7.1 8.4 12.2 6.9 5.2 16.7 10.4 13.1 6.5 24.5 9.9 6.0 19.5 8.6 8.4 7.1 7.9 13.1 18.0 12.0 12.0 11.5 7.6 12.3 12.4 13.2 15.1 12.5 11.8 15.5 11.4 11.3 13.5 8.0 15.8 6.5 19.7 14.0 9.1 8.9 8.2 6.0 14.0 14.0 19.2 13.1 14.9 15.5 8.8 12.4 18.3 26.3 18.0 13.3 14.3 6.4 29.4 7.3 7.9 7.3 4.8 19.1 15.3 10.5 12.3 15.4 14.2 13.4 11.5 3.7 10.8 20.5 10.5 11.0 17.4 9.6 12.3 8.0 11.5 14.9 18.5 24.4 10.9 7.1 10.7 12.4 4.0 8.8 12.5 2.9 16.4 10.9 10.9 12.5 3.4 10.9 10.7 10.6 8.3 17.5 3.2 13.2 11.8 4.4 4.5 6.4 5.1 7.0 3.8 6.0 6.4 6.8 3.6 6.7 5.2 6.5 7.1 26.9 54.5 38.7 37.5 64.8 8.5 14.6 17.2 19.9 49.8 22.6 21.2 26.3 20.0 25.1 33.1 54.2 18.5 77.0 24.1 17.6 24.7 43.7 26.4 29.7 28.1 42.6 17.9 36.5 21.8 10.6 20.4 26.0 31.8 25.9 23.5 22.9 23.2 21.8 37.0 42.5 22.4 18.3 40.9 24.7 50.1 22.7 27.2 16.0 40.3 30.4 31.2 108.1 55.3 71.3 26.4 19.6 24.0 67.6 17.5 23.5 29.7 23.4 49.5 13.1 29.3 20.2 65.8 23.9 19.0 9.2 26.5 81.8 21.7 17.1 20.8 NUDT18 "FLJ22494, MTH3" ENSG00000275074 "Nudix hydrolase 18" Q6ZVK8 8 22106874-22109419 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028581, HPA030125" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA028581: AB_10601381, HPA030125: AB_2673324" "unprognostic (9.90e-3)" "prognostic favorable (1.43e-4)" "unprognostic (4.88e-3)" "prognostic favorable (2.49e-6)" "unprognostic (1.29e-2)" "unprognostic (6.82e-3)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (5.30e-2)" "unprognostic (1.67e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.43e-1)" "prognostic favorable (8.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.05e-1)" "unprognostic (6.84e-2)" "unprognostic (2.32e-1)" 6.4 6.4 4.6 4.9 4.7 4.4 6.8 5.0 5.3 4.4 3.9 5.4 6.6 5.5 13.1 8.0 5.3 4.2 4.8 4.7 4.2 6.8 5.6 6.1 8.8 5.0 4.5 4.4 2.3 17.1 2.7 9.2 2.7 5.1 7.8 4.7 1.2 8.6 4.7 2.3 6.9 7.6 3.6 3.9 10.5 9.0 7.8 5.8 6.9 8.2 1.2 6.4 5.7 5.5 4.5 8.1 16.8 0.5 3.6 12.4 4.6 9.0 4.8 12.6 6.1 7.0 4.0 6.3 6.0 7.5 5.7 15.5 13.8 2.3 7.7 2.0 7.5 2.3 5.1 4.9 3.9 8.3 1.7 15.2 8.5 7.2 2.4 6.4 7.9 7.7 13.0 3.8 9.9 6.0 8.6 6.9 4.6 0.9 4.8 4.1 3.0 1.5 6.5 9.0 7.1 1.8 2.8 3.3 4.0 4.2 3.7 9.4 8.3 6.4 4.0 2.2 5.4 2.5 4.4 0.5 1.9 7.0 4.5 9.8 0.0 1.5 3.0 2.2 1.6 2.1 1.4 1.8 1.3 1.0 2.0 2.0 1.1 0.3 4.0 1.3 1.9 0.7 0.9 4.6 4.7 5.0 5.3 4.7 4.2 5.0 4.5 4.4 5.1 3.9 5.8 4.5 5.6 3.2 2.2 1.0 7.3 2.0 3.4 5.2 1.2 3.3 5.9 4.6 1.9 8.6 3.0 5.5 0.0 6.7 6.8 12.5 5.9 9.5 14.6 5.9 2.4 4.7 3.0 5.2 1.6 13.6 9.6 5.9 6.1 4.1 0.0 6.3 5.7 4.0 14.5 3.3 1.7 10.9 2.0 16.8 1.3 15.1 3.1 9.0 5.4 2.8 15.3 4.1 19.6 0.5 1.6 10.1 14.6 3.4 6.2 4.6 41.2 13.6 7.0 1.2 0.0 3.1 3.7 3.5 2.7 6.3 1.8 3.1 7.9 5.3 7.0 2.3 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favorable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 2.1 2.6 2.3 2.3 2.3 0.7 2.6 2.7 2.9 3.2 2.0 2.2 2.1 2.4 3.3 2.3 3.0 1.6 3.1 2.2 2.1 2.7 1.9 2.4 3.1 2.3 2.3 2.3 4.0 2.2 3.9 1.9 2.2 2.4 2.6 1.7 3.0 2.3 3.2 3.4 3.0 1.8 2.7 2.2 3.0 2.5 3.0 2.1 3.2 3.1 3.7 3.3 2.3 1.8 3.1 4.1 3.7 4.5 7.6 6.2 5.1 2.8 4.0 5.7 6.1 7.7 3.9 2.5 2.2 3.0 4.1 4.3 3.0 5.1 3.2 6.1 5.8 4.0 5.8 2.9 4.9 5.1 2.8 3.4 4.4 4.3 5.5 7.8 6.3 5.1 4.6 3.9 1.9 5.9 3.1 4.2 4.1 1.8 3.3 4.9 4.1 7.4 3.3 3.4 2.3 4.0 5.2 4.1 5.7 4.9 3.8 3.6 4.4 4.0 7.0 4.2 5.4 3.6 3.4 3.3 3.0 4.4 3.7 5.2 5.6 3.4 12.9 6.3 4.8 4.4 5.4 4.9 5.5 4.0 5.1 6.3 6.2 2.6 3.5 4.0 3.1 6.2 4.0 2.3 2.3 2.7 2.9 2.2 2.1 2.3 2.3 2.3 2.4 2.2 2.1 3.1 2.1 0.0 1.7 3.3 2.0 1.0 0.7 1.1 1.8 3.3 2.3 1.5 2.6 5.7 2.1 1.8 0.0 1.8 2.9 0.8 5.9 1.8 2.7 1.3 2.0 1.9 0.0 1.3 7.7 2.0 1.4 2.1 1.5 1.2 1.3 4.7 2.5 1.6 2.5 1.7 6.2 0.7 0.0 2.5 1.2 0.8 2.1 2.2 0.0 3.7 0.5 4.2 4.1 7.1 5.7 0.9 0.5 3.0 1.4 0.9 1.5 2.8 2.5 2.7 6.6 1.6 2.0 5.5 7.5 0.9 1.1 1.6 1.6 2.8 1.1 0.7 GAGE2E GAGE8 ENSG00000275113 "G antigen 2E" Q4V326 X 49341192-49345922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 13 "stomach 1: 12.9;testis: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AN3-CA: 2587.1;K-562: 674.0" HPA043232 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 12.9 26.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2587.1 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 4.3 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.7 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 674.0 12.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.0 5.0 0.3 0.3 364.7 0.1 3.3 61.8 2.4 0.2 0.2 0.8 20.9 0.0 0.7 0.2 138.5 0.4 0.6 0.1 0.5 0.0 0.0 0.6 0.1 1.0 0.0 1.2 2.1 0.0 0.4 0.4 0.0 1.5 2.9 0.1 0.1 0.3 0.0 0.3 0.2 0.0 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C13 "H4.k, H4/k, H4FK, HIST1H4L" ENSG00000275126 "H4 clustered histone 13" P62805 6 27873148-27873534 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.4;choroid plexus: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 4.1;NB-4: 2.3;REH: 1.0" "Low region specificity" "Detected in many" HPA042201 Approved NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (1.15e-1)" "unprognostic (6.05e-4)" 0.0 0.0 0.9 0.0 0.7 0.4 0.0 0.4 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.1 2.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.1 2.3 0.0 0.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.5 0.3 0.1 0.8 0.4 0.7 1.1 2.7 0.2 0.6 0.0 0.8 0.7 1.7 0.5 0.1 0.9 0.7 0.4 0.5 0.3 1.9 2.1 1.0 0.0 1.1 1.4 1.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL16 "CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4" ENSG00000275152 "C-C motif chemokine ligand 16" O15467 17 35976493-35981497 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "liver: 121.3" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 262.0" "Cancer enriched" "Detected in single" 154 "liver cancer: 49.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "Hep G2: 10.1" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 2780000 23000000 "unprognostic (3.85e-1)" "unprognostic (4.71e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-2)" "unprognostic (2.72e-1)" "unprognostic (4.58e-2)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-2)" "unprognostic (3.57e-1)" "unprognostic (1.40e-3)" "unprognostic (1.66e-2)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" 0.6 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.2 0.1 0.5 0.0 0.2 0.5 0.2 0.1 0.0 0.0 0.3 121.3 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.0 2.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 262.0 0.0 0.0 0.0 0.2 0.0 4.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 TRBV12-5 "TCRBV12S5, TCRBV8S3, TRBV125" ENSG00000275158 "T cell receptor beta variable 12-5" A0A1B0GX78 7 142580917-142581427 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 74 "lymphoid tissue: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory CD4 T-cell: 4.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 8.7;T-reg: 9.8" "Lineage enriched" "Detected in single" 99 "T-cells: 9.8" "Cell line enhanced" "Detected in single" "Karpas-707: 1.5" NA NA "unprognostic (5.12e-2)" "unprognostic (7.81e-2)" "unprognostic (2.53e-1)" "unprognostic (2.37e-3)" "unprognostic (2.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.55e-7)" "unprognostic (6.99e-2)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 48.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 8.3 8.7 0.0 0.0 0.0 0.0 9.8 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 AC117457.1 ENSG00000275163 "Potassium large conductance calcium-activated channel, subfamily M, beta member 2 (KCNMB2-IT1 - KCNMB2 readthrough transcript)" 3 178419123-178843300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 5.6;kidney: 1.5" "Group enriched" "Detected in some" 5 "Distal tubular cells: 1.9;Endometrial ciliated cells: 7.1;Proximal tubular cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HSkMC: 1.3" NA NA 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.1 0.1 0.2 1.5 0.1 0.2 0.0 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.1 0.2 0.6 0.4 0.0 0.3 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LENG9 ENSG00000275183 "Leukocyte receptor cluster member 9" 19 54461732-54463778 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 29.1" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 29.6;Intestinal goblet cells: 33.8;Proximal enterocytes: 48.2;Rod photoreceptor cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.0;HEK 293: 4.5;Karpas-707: 4.1;RPMI-8226: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051671, HPA053556" Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA051671: AB_2681568, HPA053556: AB_2682187" "unprognostic (8.38e-2)" "unprognostic (8.60e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.99e-5)" "unprognostic (2.43e-2)" "unprognostic (2.21e-3)" "unprognostic (1.09e-1)" "unprognostic (4.88e-2)" "unprognostic (5.73e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (2.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.63e-3)" "unprognostic (2.96e-1)" "unprognostic (9.12e-2)" "unprognostic (2.76e-2)" 4.3 5.0 0.1 1.0 0.3 0.1 3.9 0.4 0.5 4.2 0.0 5.0 2.5 3.0 0.0 7.7 4.2 0.0 3.1 0.3 0.2 3.4 8.2 4.1 0.2 0.5 0.5 0.0 3.4 29.1 0.0 1.7 0.2 0.7 9.1 0.2 0.1 7.1 0.2 2.6 3.6 6.2 0.0 0.1 5.8 7.3 2.3 0.2 0.0 2.4 0.0 0.0 5.5 4.4 1.3 2.7 0.4 0.2 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 1.3 2.7 0.0 1.3 0.5 0.0 5.0 0.0 0.5 0.0 3.2 4.5 0.6 0.7 0.2 0.0 0.3 0.7 0.8 1.1 0.0 0.0 0.2 0.0 0.5 0.0 4.1 0.0 0.0 1.0 0.8 1.1 0.8 1.1 2.1 0.2 5.2 0.3 0.5 0.1 0.3 0.8 2.4 1.3 0.1 0.9 0.8 1.6 0.0 0.1 0.2 1.0 0.8 0.0 0.2 0.3 1.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.5 0.3 0.2 0.5 0.5 0.0 0.7 0.1 0.2 1.3 11.7 0.0 1.1 0.7 5.0 0.9 11.5 2.6 7.4 3.8 5.7 4.2 0.3 4.3 2.8 1.8 2.1 0.3 10.9 20.2 0.0 2.8 1.1 8.6 7.9 5.5 5.4 2.1 2.1 4.3 2.7 5.7 29.6 17.1 0.0 4.4 6.1 2.8 3.5 5.0 1.8 33.8 2.0 10.6 1.9 0.2 6.5 5.2 1.8 3.7 2.9 8.5 7.2 2.5 4.1 2.7 20.9 1.9 7.0 12.9 48.2 3.7 3.5 34.1 0.0 6.3 8.7 0.4 3.6 5.0 3.1 0.4 5.2 11.2 27.0 15.2 H2AC15 "H2A/d, H2AFD, HIST1H2AK" ENSG00000275221 "H2A clustered histone 15" P0C0S8 6 27837880-27838375 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" "dendritic cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 3.3;SCLC-21H: 3.5;U-266/84: 3.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 0.3 1.0 1.0 0.4 0.9 1.0 0.4 2.3 1.0 0.9 1.9 0.4 0.1 0.5 1.8 0.3 1.2 1.0 1.7 0.9 2.4 0.4 0.6 0.8 1.2 1.6 1.4 0.3 2.0 0.6 0.4 1.4 0.4 1.8 1.2 0.4 0.2 0.4 0.3 0.8 0.2 0.6 0.0 2.4 0.8 0.4 2.6 1.9 1.2 1.3 0.4 0.2 0.4 0.7 3.7 0.0 1.3 0.1 1.7 0.3 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.6 0.1 0.2 0.1 1.4 0.5 0.0 0.3 0.4 0.1 0.4 3.3 0.6 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.3 0.4 0.0 0.2 0.0 1.1 0.6 0.2 0.1 0.3 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.4 0.1 0.0 1.2 3.9 0.3 0.0 0.0 0.1 0.0 0.1 0.0 1.4 0.0 1.3 4.1 1.7 1.5 0.0 3.2 2.5 1.8 0.0 0.9 0.4 0.7 1.3 2.6 1.0 0.9 2.3 1.0 0.9 2.4 1.6 1.4 0.3 1.8 2.4 1.9 3.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 TRBV16 "TCRBV16S1, TCRBV25S1A2PT" ENSG00000275243 "T cell receptor beta variable 16" A0A087WV62 7 142598016-142598469 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.5" "Cell type enhanced" "Detected in single" "Early spermatids: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.3;naive CD4 T-cell: 2.3;T-reg: 5.8" "Lineage enriched" "Detected in single" 59 "T-cells: 5.8" "Not detected" "Not detected" NA NA "unprognostic (9.44e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 1.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 4.3 0.0 0.0 2.3 0.8 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 AC171558.3 ENSG00000275249 Unmapped 372322-373405 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL4 "Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4" ENSG00000275302 "C-C motif chemokine ligand 4" P13236 17 36103827-36105621 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 194.6" "Cell type enhanced" "Detected in many" "dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 414.7" "Group enriched" "Detected in all" 6 "granulocytes: 135.0;T-cells: 414.7" "Group enriched" "Detected in some" 6 "U-266/70: 51.6;U-266/84: 13.3" CAB007805 Approved "Secreted to blood" NA NA 144000 "CAB007805: AB_598177" "unprognostic (6.03e-2)" "unprognostic (2.48e-2)" "prognostic favorable (3.54e-4)" "prognostic favorable (1.97e-5)" "unprognostic (2.06e-1)" "unprognostic (7.02e-2)" "unprognostic (9.08e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-1)" "unprognostic (8.57e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (3.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-2)" 39.3 28.3 2.1 32.3 2.4 194.6 10.6 3.6 5.1 16.2 5.1 10.0 7.6 10.4 6.5 15.1 8.2 45.5 3.3 2.1 2.4 6.8 85.0 34.2 34.6 3.4 2.2 1.7 5.0 15.8 12.1 2.5 18.0 3.0 7.6 11.2 0.1 5.1 3.5 1.0 0.9 11.5 18.2 3.5 65.8 10.4 2.7 2.5 24.3 5.9 4.6 15.5 57.0 4.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 51.6 13.3 0.2 0.2 0.1 0.0 14.4 3.4 135.0 414.7 4.8 101.6 8.4 46.0 240.6 2.3 17.7 13.8 181.7 55.8 42.8 11.1 2.6 0.5 138.9 2.1 2.4 3.6 5.1 2.1 2.4 3.4 2.2 1.7 3.0 3.5 2.5 4.2 52.3 0.0 54.5 0.0 135.9 15.6 1.9 0.3 24.5 1.5 26.3 49.3 11.2 14.3 7.2 0.0 0.0 9.7 3753.7 1.2 0.0 0.4 20.8 3.7 4.7 77.6 1.2 60.9 0.0 0.4 11.3 18.9 118.3 5.5 60.8 0.2 21.4 10.5 849.7 1.7 0.0 1.5 0.0 429.4 428.0 32.6 0.9 1168.2 51.6 3.7 10.5 1.1 1232.8 0.0 0.0 0.2 0.1 0.4 974.5 0.8 0.4 2.8 5.8 5.2 0.0 3.9 20.9 0.4 0.4 11.0 14.5 25.9 1948.3 0.0 0.9 1.6 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386439 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4;thyroid gland: 23.4" "Cell type enhanced" "Detected in many" "Adipocytes: 45.9;Breast glandular cells: 14.1;Breast myoepithelial cells: 11.0;Hofbauer cells: 18.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 32.4" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 50.2;NTERA-2: 32.1;SuSa: 32.1" "Low region specificity" "Detected in all" "HPA011776, HPA012066" Uncertain Uncertain "Nucleoli,Focal adhesion sites" NA NA Nucleoli "Focal adhesion sites" "HPA011776: , HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 8.6 1.0 8.3 5.3 9.4 0.6 9.5 32.4 5.6 2.9 0.0 5.2 11.4 1.8 0.3 5.6 5.7 2.4 4.2 4.1 1.9 3.7 2.7 5.2 8.1 4.8 4.8 2.0 3.8 3.3 2.3 1.6 5.7 10.4 2.5 4.1 0.2 5.1 1.6 7.5 7.1 11.7 1.4 0.3 8.5 4.8 2.2 3.7 3.0 23.4 3.5 6.1 2.4 2.8 1.4 6.2 50.2 5.6 0.7 0.0 0.3 14.1 12.8 2.7 4.9 2.0 25.0 14.4 10.2 8.6 6.1 13.5 21.9 1.0 15.3 1.0 0.5 1.6 0.0 6.2 14.2 5.3 1.5 15.4 1.2 9.8 0.8 2.2 2.9 10.2 1.5 0.0 0.1 3.8 8.5 1.4 4.8 32.1 19.5 12.9 6.6 6.0 2.5 7.2 17.5 2.8 1.9 4.9 13.9 5.0 32.1 10.8 6.3 13.7 0.5 12.9 0.0 3.2 0.8 1.1 13.9 3.1 3.4 7.4 0.0 0.2 0.9 0.4 0.0 0.3 1.2 0.6 0.2 0.3 0.9 1.6 1.3 0.0 0.5 0.8 1.9 0.0 0.2 8.3 9.4 32.4 5.6 4.1 1.9 4.8 4.8 2.0 10.4 0.3 3.7 1.4 45.9 9.6 6.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 14.1 11.0 0.0 0.0 0.0 0.0 0.0 7.5 5.3 0.0 0.0 9.0 0.0 3.0 1.4 5.6 0.0 0.0 0.0 3.1 7.2 2.5 0.0 1.7 2.5 1.7 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.9 0.0 0.0 2.7 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 2.3 7.4 0.0 0.0 H3C11 "H3.f, H3/f, H3FF, HIST1H3I" ENSG00000275379 "H3 clustered histone 11" P68431 6 27871845-27872346 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 1.3;brain: 5.0;choroid plexus: 3.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 2.1;MOLT-4: 4.0;NB-4: 2.8;REH: 4.2" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.60e-1)" "unprognostic (5.58e-2)" "unprognostic (8.16e-2)" "unprognostic (1.06e-1)" "unprognostic (6.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-2)" 0.0 0.1 0.9 0.3 1.5 1.3 0.0 1.4 1.2 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 5.0 0.0 0.1 0.0 0.3 3.5 3.1 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.2 0.0 0.0 4.9 0.6 0.0 0.0 0.0 0.0 0.1 4.6 0.6 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 1.3 0.2 0.0 0.2 0.4 0.0 0.0 0.2 0.6 0.7 2.1 0.0 0.0 0.4 1.3 0.3 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.0 2.8 0.6 0.1 0.0 4.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.8 0.4 1.5 0.3 1.2 0.5 1.3 1.0 2.3 2.3 1.1 1.5 0.6 8.2 0.3 3.4 1.2 1.5 0.9 1.5 1.4 1.2 0.5 5.0 3.5 3.1 0.1 2.5 3.4 4.9 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 CCL18 "AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18" ENSG00000275385 "C-C motif chemokine ligand 18" P55774 17 36064272-36072032 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lung: 49.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 189.1;Langerhans cells: 104.3;Macrophages: 153.1" "Cancer enhanced" "Detected in all" "lung cancer: 76.3" "Region enriched" "Detected in single" 17 "cerebral cortex: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 55500000 6400000 "unprognostic (8.91e-2)" "unprognostic (2.96e-2)" "unprognostic (5.71e-2)" "unprognostic (9.64e-2)" "unprognostic (1.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" "unprognostic (2.50e-1)" "unprognostic (3.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.68e-1)" "unprognostic (3.63e-1)" "unprognostic (4.87e-2)" 9.8 0.3 0.0 2.5 0.0 0.3 1.6 0.0 2.7 0.0 0.1 1.9 4.0 0.1 0.0 0.9 0.4 0.0 1.5 0.0 0.1 0.2 0.3 49.2 7.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 2.6 0.0 0.0 0.6 9.3 1.5 0.0 4.0 0.2 0.5 0.1 6.2 1.1 0.0 5.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 25.4 0.0 1.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 13.6 0.0 0.0 0.5 4.2 0.0 0.0 0.0 24.5 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 5.1 0.0 0.4 0.7 189.1 0.0 0.0 0.0 0.0 4.2 104.3 5.3 0.0 153.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.4 0.9 0.0 0.1 0.1 3.4 1.6 2.9 0.0 0.0 0.0 FCGBP FC(GAMMA)BP ENSG00000275395 "Fc fragment of IgG binding protein" 19 39863323-39934626 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 199.2;salivary gland: 86.1;stomach 1: 86.3;thyroid gland: 100.7" "Cell type enriched" "Detected in many" 9 "Intestinal goblet cells: 6081.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 63.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1" "HPA003517, HPA003564" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytokinetic bridge" "Secreted in other tissues" Yes NA "Plasma membrane" "Golgi apparatus, Cytokinetic bridge" "HPA003517: AB_1078838, HPA003564: AB_2231648" "unprognostic (1.65e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-3)" "unprognostic (1.77e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.28e-5)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.36e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (9.70e-6)" "unprognostic (9.44e-2)" "unprognostic (3.03e-2)" "unprognostic (5.92e-3)" "unprognostic (8.60e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.08e-1)" 5.7 10.1 5.1 14.1 7.5 0.4 3.2 3.4 11.6 56.9 15.7 199.2 69.3 1.2 0.6 4.6 9.9 49.7 2.0 5.3 40.6 5.5 1.0 2.0 0.9 21.0 8.1 4.0 3.8 4.9 0.5 3.4 2.9 7.1 3.9 68.3 0.6 86.1 1.4 0.4 14.9 150.0 2.6 12.0 1.5 86.3 2.9 11.7 1.5 100.7 0.0 0.7 3.5 1.6 27.7 0.0 4.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 1.8 0.6 0.1 1.5 0.3 0.1 7.1 1.6 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.1 5.1 7.5 3.4 11.6 5.3 40.6 21.0 8.1 4.0 7.1 12.0 11.7 27.7 0.6 3.2 5.1 2.6 4.6 3.7 1.9 15.8 1.2 1.1 1.3 3.4 2.8 70.1 60.0 25.8 0.0 0.7 1.8 622.2 0.0 5.2 7.2 4.2 0.3 26.7 81.1 0.0 0.6 0.9 0.4 1.9 552.0 4.0 15.9 0.4 0.7 1.3 44.0 0.0 0.4 6081.9 2.0 30.2 12.6 9.2 0.9 21.6 8.8 15.9 0.9 0.4 1.0 0.5 0.2 3.9 253.6 0.0 2.1 13.8 413.5 1.2 11.0 2.0 59.2 0.5 1.1 0.5 2.4 0.4 6.8 0.4 5.6 0.9 191.4 164.1 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686431-37745105 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 55.7;pancreas: 33.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 139.3" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in single" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB068192: AB_2665649, HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favorable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favorable (2.51e-6)" 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 9.3 6.9 1.5 7.6 0.0 5.7 15.2 0.0 0.0 0.1 55.7 13.0 6.8 0.0 0.0 0.0 0.0 0.0 33.3 3.5 0.0 0.0 0.0 2.3 7.2 0.0 0.0 4.4 0.0 0.0 8.7 0.1 0.0 0.0 8.3 3.9 0.1 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 2.2 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 139.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.6 14.1 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.6 78.6 1.9 57.0 0.0 0.0 0.0 15.4 45.0 42.0 32.3 18.5 3.6 0.4 14.4 0.0 0.2 25.4 0.0 0.2 13.7 41.7 5.7 0.0 0.0 5.1 0.1 0.0 0.2 13.5 0.0 0.3 0.0 11.6 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.1 31.7 11.4 0.0 0.0 2.6 14.3 38.2 3.7 0.0 0.0 0.0 0.3 3.0 2.5 0.0 0.0 0.0 0.6 0.0 20.4 2.7 FP565260.1 ENSG00000275464 "Periodic tryptophan protein 2 homolog" 21 5130871-5154658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.4" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 9.0 9.2 6.8 10.0 8.4 12.2 7.4 6.9 8.2 5.9 4.9 7.7 9.1 6.8 1.8 8.4 7.8 7.3 7.0 8.0 7.2 6.2 6.8 7.1 13.5 8.8 9.2 6.5 6.8 7.8 6.6 6.1 8.0 10.6 6.6 8.5 3.5 6.7 4.8 10.2 8.6 8.3 7.4 6.8 11.6 7.7 7.2 7.0 6.8 6.7 3.2 5.4 11.5 7.2 13.9 32.0 24.0 15.4 24.2 6.6 5.0 9.1 0.2 0.0 0.1 0.1 0.4 20.1 0.3 14.1 10.5 20.8 21.0 42.9 19.0 0.0 7.4 15.1 102.4 12.4 11.9 10.4 47.6 29.1 17.8 22.5 25.5 20.1 5.0 20.1 16.5 56.8 11.6 6.6 28.4 34.4 33.1 60.4 36.5 29.3 54.0 14.2 28.8 13.5 25.3 16.6 27.3 25.5 38.4 14.9 4.2 31.5 24.9 10.2 12.0 29.7 0.3 32.9 13.9 16.0 63.5 20.4 62.3 16.7 3.3 7.3 6.9 18.5 12.6 21.2 11.0 11.3 13.5 8.7 11.2 11.1 15.2 4.1 9.9 18.2 5.5 8.5 11.6 6.8 8.4 6.9 8.2 8.0 7.2 8.8 9.2 6.5 10.6 6.8 7.0 13.9 0.9 0.0 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 1.9 0.0 0.0 2.5 0.0 0.0 2.7 1.1 0.8 0.0 9.3 0.0 0.8 1.1 0.9 0.0 0.0 0.0 8.0 1.4 0.9 0.0 0.9 5.1 0.6 0.0 0.0 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.3 1.2 0.4 0.9 0.0 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835086-38841438 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 19.6" "Cell type enriched" "Detected in some" 8 "Early spermatids: 263.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTCEpi: 5.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" NA NA "Intermediate filaments" Nucleoli "HPA051696: AB_2681576" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 19.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 5.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 263.7 0.2 0.1 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.2 29.4 1.2 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 AL627230.1 ENSG00000275493 9 67725914-67726255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "K-562: 14.5;Karpas-707: 19.6;PC-3: 12.0;SCLC-21H: 17.1" NA NA "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (2.79e-3)" "unprognostic (2.78e-1)" "unprognostic (3.24e-2)" 1.2 0.9 3.7 1.4 2.8 1.3 0.4 10.0 10.7 0.4 1.1 1.1 2.1 1.5 0.0 3.6 2.5 1.9 1.1 11.8 0.9 1.6 0.1 0.8 0.9 2.3 1.3 1.9 1.6 4.9 0.2 1.0 4.0 1.1 0.5 1.9 2.2 0.0 0.4 3.8 2.1 0.2 0.4 0.8 1.6 4.2 1.4 0.2 1.3 0.0 0.0 0.9 3.0 2.9 2.3 1.4 5.6 1.6 0.5 0.0 0.8 0.0 0.0 0.9 0.0 2.5 0.7 0.4 0.0 3.9 4.4 6.4 1.6 0.0 1.5 1.1 1.7 10.2 2.4 2.1 0.4 4.2 0.6 6.1 0.0 0.0 1.2 0.6 6.8 14.5 19.6 0.0 0.5 2.9 0.4 0.2 1.8 12.0 0.9 3.8 2.1 2.1 0.3 17.1 4.5 5.0 2.2 1.5 0.5 0.0 0.4 1.7 2.6 6.5 3.7 2.2 0.5 0.1 3.8 1.5 5.8 5.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 3.7 2.8 10.0 10.7 11.8 0.9 2.3 1.3 1.9 4.0 0.4 1.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236A "DMRTC1-AS1, LINC00684" ENSG00000275520 "Family with sequence similarity 235 member A" A0A1B0GUQ0 X 72938163-72938958 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 78 "testis: 156.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.3 0.2 0.6 0.2 0.1 0.0 0.2 1.1 0.0 0.5 0.0 0.1 0.6 0.2 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.2 1.9 0.3 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.4 0.2 0.0 1.6 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.4 0.3 156.5 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 1.1 0.4 0.0 0.3 0.0 0.0 0.4 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3CP ELOA3C ENSG00000275553 "Elongin A3 family member C, pseudogene" 18 46968695-46969912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 60 "brain: 8.4;choroid plexus: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 1.8 0.0 1.7 0.0 0.0 1.0 8.4 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.0 0.0 2.2 2.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.7 1.0 8.4 1.8 0.8 2.2 2.0 0.2 2.1 1.1 2.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIFIN ENSG00000275572 "Galectin-related inter-fiber protein" A4D1Z8 7 2474844-2476894 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Cell type enhanced" "Detected in single" "Astrocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (1.18e-2)" "unprognostic (2.98e-2)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.68e-2)" "unprognostic (4.31e-1)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" 0.3 0.1 0.4 0.0 0.4 0.2 0.0 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.0 0.4 0.7 0.3 0.8 1.0 0.0 1.0 0.2 1.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XKR5 ENSG00000275591 "XK related 5" Q6UX68 8 6808517-6835524 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.95e-2)" "unprognostic (1.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.46e-2)" "unprognostic (1.78e-1)" "unprognostic (6.73e-2)" "unprognostic (9.91e-2)" "unprognostic (2.16e-3)" "unprognostic (1.30e-1)" "unprognostic (7.91e-3)" "unprognostic (3.13e-2)" "unprognostic (9.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-2)" "unprognostic (4.06e-2)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.3 0.2 0.7 0.2 0.0 0.1 0.4 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.4 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 2.8 0.5 0.0 0.0 0.1 0.9 0.2 0.5 0.8 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.4 0.0 0.1 0.4 1.7 0.1 0.0 0.1 0.5 0.1 0.1 0.2 1.3 3.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 H4C7 "H4/l, H4FL, HIST1H4G" ENSG00000275663 "H4 clustered histone 7" Q99525 6 26246611-26246996 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042201 Supported NA NA "HPA042201: AB_2677898" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091167.6 ENSG00000275674 "Novel protein" 15 90266317-90314499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4;intestine: 1.2;pancreas: 1.1" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 1.0;U-266/84: 1.1" NA NA "unprognostic (1.02e-1)" "unprognostic (6.86e-2)" "unprognostic (7.11e-2)" "unprognostic (9.39e-2)" "unprognostic (4.70e-2)" "unprognostic (2.50e-2)" "unprognostic (6.17e-2)" "unprognostic (1.27e-1)" "unprognostic (1.23e-1)" "unprognostic (9.18e-2)" "unprognostic (4.73e-2)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" 0.0 0.0 0.7 0.0 0.5 0.0 0.1 0.2 0.8 0.1 0.0 0.2 1.2 0.1 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.1 0.1 0.1 0.0 0.6 0.1 0.3 0.1 1.1 0.3 0.2 0.0 1.4 0.1 0.0 0.3 0.5 0.2 0.1 0.0 0.7 0.3 0.2 0.0 0.4 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.3 0.2 0.0 0.0 1.9 0.1 0.0 0.1 0.1 1.0 0.3 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.4 1.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.5 0.2 0.8 0.9 0.5 0.6 0.1 0.3 1.4 0.2 0.4 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948925-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 28.6 24.6 23.3 26.6 25.8 35.0 26.9 24.4 25.1 24.8 20.6 26.2 18.6 25.8 17.6 24.6 24.9 15.5 25.1 21.6 23.6 22.2 22.7 23.6 34.4 25.0 24.0 20.0 29.8 37.8 20.5 16.1 23.4 25.3 20.5 24.2 17.4 21.2 24.4 41.1 36.7 24.5 24.7 24.3 27.3 30.2 23.0 24.4 35.6 20.6 14.3 39.5 31.5 23.6 27.8 107.2 174.2 37.0 73.8 49.3 57.0 67.3 61.2 50.4 76.0 67.3 120.3 74.3 178.2 79.5 60.5 123.4 89.9 141.8 80.0 102.6 83.4 97.3 77.1 65.6 85.8 59.4 121.9 73.4 49.5 138.7 98.4 88.4 68.2 56.6 92.3 114.4 51.7 68.6 81.6 162.4 105.0 46.0 62.8 63.3 104.0 96.7 105.6 62.6 93.7 79.0 33.8 90.9 40.8 95.5 79.6 69.6 72.3 50.4 58.1 96.2 122.5 211.9 61.3 83.1 124.2 72.2 101.9 107.1 48.9 55.2 90.2 60.0 74.0 59.6 46.8 53.9 64.0 51.0 51.0 48.1 47.7 67.5 58.1 77.7 45.5 75.7 57.2 23.3 25.8 24.4 25.1 21.6 23.6 25.0 24.0 20.0 25.3 24.3 24.4 27.8 24.5 22.4 34.6 25.1 41.2 43.7 46.3 39.7 29.6 13.4 14.7 13.1 17.8 32.9 37.8 25.8 22.9 72.9 48.5 26.4 9.8 41.6 32.0 23.4 22.9 30.1 16.1 33.7 28.5 48.1 59.8 30.3 23.0 22.0 47.5 37.4 14.6 16.9 46.8 18.5 24.6 26.4 6.1 33.9 30.3 62.0 23.6 33.4 28.4 30.0 54.9 34.3 53.5 29.1 57.7 51.1 26.3 23.3 38.4 52.1 48.8 52.0 31.1 24.0 32.9 32.3 39.0 52.5 40.8 28.2 43.9 163.9 44.3 27.4 31.9 43.6 H2BC9 "H2B/j, H2BFJ, HIST1H2BH" ENSG00000275713 "H2B clustered histone 9" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.2;vagina: 4.4" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "basophil: 3.7;neutrophil: 3.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Cell line enhanced" "Detected in many" "U-266/70: 16.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.2 0.2 0.4 0.6 0.5 1.4 0.6 0.4 0.5 1.2 0.8 1.2 3.0 0.4 0.8 4.2 0.8 0.3 0.1 0.3 1.0 0.7 0.2 1.6 0.8 0.7 0.5 0.2 0.1 0.0 0.1 0.1 0.2 0.7 3.6 0.8 0.0 1.3 0.0 0.0 0.4 1.7 0.1 0.6 3.8 0.7 0.6 0.8 2.9 1.0 0.1 0.5 0.4 4.4 1.2 1.8 0.1 7.0 0.0 0.0 0.1 1.1 0.9 0.3 1.2 0.6 2.4 1.1 0.0 1.7 0.1 1.8 3.4 0.0 0.6 1.7 0.9 0.1 1.3 6.1 0.4 0.0 0.0 4.0 0.3 0.3 0.4 0.5 0.0 0.3 1.0 2.7 6.2 0.1 2.0 3.8 2.7 1.6 0.0 1.8 4.0 0.0 0.9 0.0 2.7 3.2 2.9 4.2 1.4 0.6 0.3 2.0 3.3 0.0 0.6 0.0 0.7 3.1 16.9 4.5 0.0 0.5 1.5 3.8 3.7 0.2 0.6 0.3 0.0 0.1 0.6 0.2 0.4 0.6 0.3 0.0 0.1 3.0 0.8 0.1 0.2 0.4 5.2 0.4 0.5 0.4 0.5 0.3 1.0 0.7 0.5 0.2 0.7 0.6 0.8 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 29.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 H3C1 "H3/A, H3FA, HIST1H3A" ENSG00000275714 "H3 clustered histone 1" P68431 6 26020451-26020958 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 7.9;brain: 18.4" "Cell type enhanced" "Detected in some" "dendritic cells: 1.7;Plasma cells: 1.8" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 18.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-2 OS: 4.0" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (3.07e-1)" "unprognostic (3.47e-2)" "unprognostic (4.60e-2)" "unprognostic (2.36e-5)" "unprognostic (2.85e-2)" "unprognostic (3.48e-1)" "unprognostic (3.48e-1)" "unprognostic (4.02e-2)" "unprognostic (5.03e-3)" "unprognostic (4.39e-2)" "unprognostic (6.34e-3)" "unprognostic (2.00e-2)" "unprognostic (8.85e-3)" "unprognostic (1.58e-2)" "unprognostic (1.39e-1)" "unprognostic (8.15e-2)" "unprognostic (3.21e-2)" 0.2 0.4 1.5 0.1 0.6 7.9 0.1 18.4 3.7 0.3 0.0 0.2 0.0 0.1 0.9 0.3 0.2 0.1 0.3 1.1 2.6 0.1 0.2 0.3 0.4 2.2 5.3 0.9 0.1 0.0 0.0 0.2 0.1 4.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.7 0.2 0.2 2.9 1.8 0.7 0.1 0.0 0.1 0.1 0.1 1.8 0.8 0.0 0.7 0.0 0.5 0.2 0.0 1.0 0.0 0.7 1.7 0.0 0.3 0.6 0.4 0.0 0.3 0.0 1.0 0.2 1.4 0.3 1.2 1.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.2 0.1 0.0 2.2 2.0 1.2 0.9 0.4 0.9 1.1 0.5 0.0 0.7 0.5 0.7 1.0 0.7 1.6 0.2 0.0 0.1 0.9 0.0 0.0 4.0 0.3 0.4 0.3 0.1 0.0 0.4 1.4 1.3 13.6 1.5 4.3 3.5 1.5 3.0 2.2 2.6 2.0 3.1 3.1 1.8 1.7 13.5 8.0 0.9 4.9 3.5 1.3 1.5 0.6 18.4 3.7 1.1 2.6 2.2 5.3 0.9 4.0 0.7 1.8 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36001553 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 83.8;liver: 31.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Hep G2: 35.4;OE19: 28.7" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 3270000 11000000 "Golgi apparatus" Vesicles "HPA058608: AB_2683776" "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favorable (3.02e-4)" 0.2 0.4 0.1 7.9 0.1 0.1 0.4 0.1 0.3 0.2 0.1 60.2 38.0 0.2 0.0 0.2 9.7 9.3 0.0 0.1 0.1 9.8 31.9 2.1 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 83.8 0.0 0.1 0.1 0.0 0.1 62.5 1.4 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 5.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.1 7.2 5.0 0.0 0.0 0.0 0.0 262.6 0.0 0.0 0.0 12.2 0.1 0.7 71.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 8.9 0.0 2.5 40.2 0.1 0.0 0.0 208.3 2.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 380.6 0.0 0.0 0.0 461.4 61.3 76.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 138.2 0.2 LYZL6 "LYC1, PRO1485, TKAL754" ENSG00000275722 "Lysozyme like 6" O75951 17 35934518-35943713 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 132 "testis: 48.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 387.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025734, HPA053073" Enhanced "Secreted in male reproductive system" NA NA "HPA025734: AB_1853444, HPA053073: AB_2682034" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 48.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 387.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 15.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091959.1 ENSG00000275740 "Novel readthrough transcript" 5 146203550-146339251 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (6.42e-2)" "unprognostic (7.72e-4)" "unprognostic (2.05e-2)" "unprognostic (4.95e-2)" "unprognostic (1.51e-2)" "unprognostic (1.13e-2)" "unprognostic (3.24e-2)" "unprognostic (8.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.61e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (1.56e-2)" "unprognostic (2.12e-2)" 0.5 0.5 0.2 1.4 0.5 2.4 0.5 1.9 0.8 1.0 0.8 0.6 1.6 0.5 0.0 1.2 1.0 0.4 0.6 0.3 0.5 0.6 0.4 0.7 1.3 0.5 0.3 0.0 1.4 0.7 0.9 0.0 1.0 0.6 0.5 0.7 0.7 0.9 0.7 0.6 0.3 1.1 1.0 0.0 0.7 1.0 6.8 0.5 1.8 1.5 0.7 1.2 0.8 0.1 0.8 7.2 11.4 5.6 5.5 1.7 1.7 5.0 8.9 5.4 10.4 10.7 12.4 5.9 8.6 5.3 4.8 6.6 5.5 8.2 7.9 8.9 16.0 4.5 10.0 5.5 1.3 1.2 12.0 9.5 2.4 1.0 9.9 6.1 1.7 3.3 3.2 13.1 5.4 3.3 3.7 9.6 0.0 5.1 3.2 7.4 9.6 10.8 4.8 0.7 9.2 5.6 3.9 12.9 2.9 4.0 1.9 9.3 1.7 6.8 5.8 6.7 6.9 8.9 6.4 14.9 13.4 6.3 6.9 6.6 18.2 7.0 14.5 10.4 7.2 11.6 10.3 9.5 8.2 7.5 12.2 10.0 9.9 10.3 10.4 12.0 10.2 9.3 7.8 0.2 0.5 1.9 0.8 0.3 0.5 0.5 0.3 0.0 0.6 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TRBV14 "TCRBV14S1, TCRBV16S1A1N1" ENSG00000275743 "T cell receptor beta variable 14" A0A5B0 7 142587868-142588359 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 46 "lymphoid tissue: 45.8" "Cell type enriched" "Detected in single" 11 "T-cells: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "memory CD4 T-cell: 20.2;memory CD8 T-cell: 24.6;naive CD4 T-cell: 21.6;naive CD8 T-cell: 19.5;T-reg: 27.1" "Lineage enriched" "Detected in single" 60 "T-cells: 27.1" "Not detected" "Not detected" NA NA "unprognostic (1.70e-4)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (8.53e-4)" "unprognostic (3.16e-4)" "unprognostic (5.12e-2)" "unprognostic (6.14e-5)" "unprognostic (1.77e-1)" "unprognostic (9.00e-3)" "unprognostic (3.05e-1)" "unprognostic (3.30e-1)" "unprognostic (2.09e-3)" "unprognostic (8.25e-2)" "unprognostic (6.65e-3)" "unprognostic (4.82e-2)" "unprognostic (5.44e-2)" 0.2 0.0 0.0 2.1 0.0 0.9 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.4 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.6 4.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.0 1.3 0.5 0.1 0.0 45.8 0.1 0.0 5.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 2.2 0.0 20.2 24.6 0.0 0.2 21.6 19.5 0.4 0.0 0.0 0.0 27.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 HNRNPCL2 HNRNPCP5 ENSG00000275774 "Heterogeneous nuclear ribonucleoprotein C like 2" B2RXH8 1 13115488-13116854 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.41e-2)" "unprognostic (2.20e-1)" "unprognostic (7.42e-2)" "unprognostic (3.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 AC018630.2 ENSG00000275778 "PRH1-PRR4 readthrough" 12 10845849-11171600 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "Alveolar cells type 1: 3.2;Club cells: 1.8;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.7;BJ hTERT+ SV40 Large T+ RasG12V: 1.4;GAMG: 2.3;HDLM-2: 2.5;HSkMC: 1.1;MCF7: 1.2;RPMI-8226: 2.0" HPA042133 Uncertain NA NA "HPA042133: AB_10793979" "unprognostic (8.86e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (5.01e-2)" "unprognostic (6.45e-2)" "unprognostic (2.23e-1)" "unprognostic (5.71e-2)" "unprognostic (2.41e-3)" "unprognostic (5.49e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (8.23e-2)" "unprognostic (2.38e-3)" "unprognostic (4.80e-2)" "unprognostic (2.42e-1)" "unprognostic (2.53e-1)" "unprognostic (4.45e-3)" 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.0 0.4 0.3 0.3 0.3 0.3 0.5 0.2 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.5 1.4 0.0 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.2 0.9 0.3 1.3 0.8 1.3 1.8 0.6 1.3 2.0 1.1 0.0 1.9 0.6 1.9 1.1 0.5 0.3 0.1 0.1 0.5 0.1 0.3 0.3 0.3 0.3 0.4 0.4 0.2 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 TRBV10-3 "TCRBV10S3, TCRBV12S1A1N2, TRBV103" ENSG00000275791 "T cell receptor beta variable 10-3" A0A0K0K1G6 7 142544212-142544685 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 31 "lymphoid tissue: 89.5" "Group enriched" "Detected in some" 5 "Late spermatids: 1.7;T-cells: 5.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory CD8 T-cell: 160.1;T-reg: 203.1" "Lineage enriched" "Detected in single" 375 "T-cells: 203.1" "Cell line enriched" "Detected in single" 53 "MOLT-4: 49.7" NA NA "unprognostic (3.61e-3)" "unprognostic (4.86e-3)" "unprognostic (2.44e-2)" "unprognostic (8.96e-3)" "unprognostic (3.16e-1)" "unprognostic (4.23e-6)" "unprognostic (9.84e-4)" "unprognostic (7.96e-2)" "unprognostic (4.05e-2)" "unprognostic (7.99e-4)" "unprognostic (1.52e-1)" "unprognostic (1.66e-1)" "unprognostic (9.59e-6)" "unprognostic (5.93e-2)" "unprognostic (1.69e-1)" "unprognostic (1.05e-1)" "unprognostic (1.80e-3)" 0.2 0.2 0.0 8.1 0.0 2.8 0.2 0.0 0.4 0.4 0.0 1.1 0.0 0.1 0.0 0.3 0.2 1.0 0.1 0.0 0.0 0.1 0.4 0.5 17.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.9 0.1 0.0 0.0 1.4 0.3 0.0 2.1 2.4 0.1 0.0 89.5 0.2 0.0 12.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.9 0.0 49.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 9.3 0.4 77.0 160.1 0.0 0.3 101.7 41.2 0.3 0.1 0.5 0.5 203.1 26.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "brain: 31.8;choroid plexus: 23.4;testis: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 3.0;THP-1: 3.2" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.1 0.2 6.8 0.4 10.9 0.1 0.0 31.8 21.7 0.1 23.4 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 8.4 17.9 0.0 0.0 0.2 0.8 14.7 11.5 9.4 0.1 0.1 0.3 0.1 0.2 24.7 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 17.7 0.7 0.2 28.6 10.7 1.1 0.4 0.0 0.5 0.0 0.0 30.8 0.4 1.3 0.5 0.4 0.7 0.3 0.0 0.5 1.4 0.6 0.7 0.0 0.0 0.3 0.6 0.2 0.4 0.3 0.3 0.0 0.1 1.4 0.4 0.6 0.3 0.5 0.0 2.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 1.1 0.2 0.3 0.5 0.6 3.0 1.7 0.6 0.6 0.1 1.2 1.6 0.2 0.1 0.1 0.8 0.1 1.2 0.0 0.2 0.1 0.1 3.2 0.1 1.0 0.7 0.5 0.3 0.0 0.4 0.3 0.5 0.7 1.1 0.0 0.2 0.2 0.1 0.1 0.4 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.0 0.0 0.2 0.3 6.8 10.9 31.8 21.7 8.4 17.9 14.7 11.5 9.4 24.7 17.7 10.7 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512385 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 93.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 59.4;Hepatic stellate cells: 46.1;Oligodendrocytes: 129.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 296.7;RT4: 115.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 23.8 13.9 35.4 8.4 58.3 10.8 19.0 41.6 47.3 25.2 4.3 18.0 3.0 28.7 3.7 61.3 18.6 7.9 27.0 29.2 42.6 11.6 2.9 28.3 4.1 58.2 55.6 24.5 18.2 3.6 3.1 6.3 19.5 60.0 20.1 2.8 8.6 13.0 12.6 10.7 60.1 10.5 11.7 43.6 31.0 13.5 16.2 51.8 5.4 9.5 5.9 11.1 36.6 29.8 93.7 32.5 17.2 15.2 5.1 9.5 31.1 19.6 44.8 49.5 37.7 21.8 56.8 55.1 0.7 35.2 102.5 18.7 296.7 1.7 62.3 26.6 3.5 3.3 0.0 55.1 0.4 47.2 3.0 0.3 18.8 11.8 27.7 17.3 31.0 39.4 6.0 0.6 8.3 21.6 0.0 10.2 6.3 9.0 1.2 6.3 17.0 33.0 10.4 16.0 115.7 3.7 8.8 26.9 0.1 0.3 21.2 6.7 7.9 57.7 62.6 22.9 12.9 12.1 6.5 7.3 1.9 16.3 8.1 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.4 58.3 41.6 47.3 29.2 42.6 58.2 55.6 24.5 60.0 43.6 51.8 93.7 27.2 12.8 1.5 23.8 0.7 9.9 17.5 10.6 9.1 59.4 1.7 3.9 20.4 1.5 13.2 3.7 0.0 27.0 0.2 0.1 0.0 2.9 7.6 8.5 10.0 34.9 0.0 4.0 9.3 1.4 3.1 11.6 3.1 5.7 0.0 4.9 46.1 0.5 5.1 26.9 16.2 0.4 2.0 2.5 4.2 21.0 9.0 1.2 1.8 9.4 0.2 9.6 0.0 20.1 129.2 7.0 0.1 7.2 1.7 15.4 0.0 0.2 8.3 3.4 0.0 10.9 7.6 13.5 2.7 27.5 25.9 16.6 1.8 1.3 0.3 42.2 TUBGCP5 "GCP5, KIAA1899" ENSG00000275835 "Tubulin gamma complex associated protein 5" Q96RT8 15 22983192-23039572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039366, HPA040366" Supported Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA039366: AB_10673243, HPA040366: AB_2676942" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.30e-1)" "unprognostic (4.27e-3)" "unprognostic (2.94e-1)" "unprognostic (2.79e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.27e-1)" "unprognostic (1.42e-2)" "unprognostic (1.18e-2)" "unprognostic (6.40e-2)" "unprognostic (1.13e-2)" "unprognostic (9.53e-3)" 7.7 9.1 2.5 6.6 3.4 9.1 9.8 2.6 5.5 9.8 0.8 6.8 6.3 9.8 5.7 8.1 6.7 6.1 9.2 2.6 4.0 8.3 9.4 7.0 8.5 4.7 4.3 2.4 7.4 10.7 8.5 8.0 6.9 5.6 9.7 7.4 9.9 6.8 7.7 10.8 10.0 6.4 8.8 2.1 7.3 7.9 13.5 3.5 9.0 11.3 10.3 8.8 7.6 7.7 5.3 20.3 20.8 23.9 14.4 18.3 11.9 13.8 24.3 26.6 26.2 22.7 16.1 9.3 16.0 10.3 22.3 13.8 19.8 16.0 18.8 21.8 23.6 6.6 26.9 21.2 8.8 6.4 27.7 11.6 19.4 7.2 17.5 16.2 8.6 16.1 26.4 19.8 23.6 16.9 13.1 18.8 12.1 14.2 19.8 18.8 22.9 26.1 3.2 15.3 30.6 8.3 14.0 19.7 14.2 12.7 11.8 22.2 13.4 13.9 18.4 11.7 14.0 36.6 18.3 19.8 40.0 23.8 18.3 17.3 0.2 1.4 0.6 2.6 2.1 2.7 2.2 4.0 4.4 2.3 4.2 3.5 4.7 1.5 3.9 2.1 2.5 3.7 1.7 2.5 3.4 2.6 5.5 2.6 4.0 4.7 4.3 2.4 5.6 2.1 3.5 5.3 7.4 16.0 17.7 16.0 11.0 3.3 3.2 4.2 9.1 27.6 5.2 5.0 13.2 7.2 6.3 5.5 14.6 8.3 11.6 3.0 5.9 6.5 7.8 12.5 13.4 6.4 4.2 3.8 21.4 4.6 7.2 10.4 6.1 6.2 6.3 31.4 5.7 10.2 7.9 10.1 29.7 4.7 4.1 5.2 2.9 13.4 11.1 6.2 3.6 12.2 5.1 11.6 7.2 15.6 26.2 6.6 5.0 12.8 7.9 2.3 2.9 7.1 9.0 18.9 0.0 13.6 10.6 35.0 36.7 8.6 2.7 3.4 9.6 14.1 4.6 2.0 AC136612.1 ENSG00000275869 "TP53-target gene 3 protein" Unmapped 933862-936467 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 U2AF1L5 ENSG00000275895 "U2 small nuclear RNA auxiliary factor 1 like 5" P0DN76 21 6484623-6499261 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.0;Club cells: 14.2;granulocytes: 30.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044833, HPA052083" Supported Uncertain Nucleoplasm NA NA 28000 Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (6.54e-2)" "unprognostic (2.42e-1)" "unprognostic (2.75e-2)" "unprognostic (8.31e-3)" "unprognostic (2.80e-1)" "unprognostic (5.99e-2)" "unprognostic (2.02e-1)" "unprognostic (4.54e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.70e-1)" "unprognostic (3.42e-2)" "unprognostic (5.39e-3)" "unprognostic (3.14e-1)" "unprognostic (2.79e-2)" "unprognostic (5.98e-2)" "unprognostic (8.20e-2)" 48.5 41.8 37.4 51.2 37.5 72.1 47.9 36.9 40.4 41.2 34.7 45.7 44.6 43.6 54.9 39.9 47.8 26.3 39.2 36.6 41.3 32.4 44.7 32.3 55.8 39.1 37.3 33.7 58.6 48.0 35.2 42.1 53.3 38.6 34.5 54.6 49.1 32.0 31.3 40.4 41.8 36.7 47.9 38.7 52.8 34.6 40.0 37.8 87.3 49.9 39.3 81.6 56.1 20.0 40.0 195.0 186.6 156.9 128.0 107.5 76.0 80.6 118.0 103.5 164.3 88.2 83.2 88.6 571.9 105.2 149.3 191.6 143.2 275.3 223.6 195.6 143.0 266.8 226.8 170.8 311.9 178.1 401.0 125.5 61.1 64.6 91.6 121.6 77.5 179.7 58.4 479.7 186.2 150.5 85.4 216.3 131.2 212.7 250.6 76.2 277.6 91.4 108.7 167.9 274.8 164.7 124.3 70.3 139.5 91.0 63.8 78.1 222.5 234.7 121.5 217.1 51.1 86.7 184.5 212.6 538.1 105.0 260.3 176.3 175.4 197.4 182.8 147.0 189.1 162.2 210.7 176.6 172.2 207.3 236.6 188.1 165.4 348.0 169.9 127.9 297.9 246.3 235.8 37.4 37.5 36.9 40.4 36.6 41.3 39.1 37.3 33.7 38.6 38.7 37.8 40.0 2.6 12.8 18.0 0.0 0.8 0.0 4.2 0.0 0.0 0.2 4.7 2.7 0.0 2.8 14.2 0.0 0.0 1.4 3.2 0.4 1.9 4.8 0.7 2.8 3.1 2.9 2.4 0.0 0.0 7.1 1.9 7.5 0.0 3.6 30.3 3.8 1.4 1.2 1.1 0.0 0.0 1.5 0.0 0.8 0.0 0.2 0.3 2.9 0.0 0.0 2.9 0.5 1.0 0.0 0.0 6.4 2.1 1.2 0.9 3.8 1.5 1.7 10.2 0.4 0.0 1.8 1.5 1.9 2.0 0.0 0.0 2.1 2.0 3.9 1.4 2.0 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 452 "pancreas: 241429.6" "Cell type enriched" "Detected in some" 11 "Exocrine glandular cells: 108258.7" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 4.1;T-reg: 2.9" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 2.9" "Cell line enhanced" "Detected in some" "OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 890000000 Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "prognostic favorable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 50.8 12.6 0.0 0.2 0.1 3.2 25.6 0.0 0.1 16.6 0.0 11.8 361.7 11.5 0.0 18.4 9.7 0.1 25.3 0.0 0.0 9.4 32.5 8.3 1.3 0.0 0.0 0.0 65.5 241429.6 0.0 13.5 8.2 0.0 17.4 0.0 0.0 25.6 0.9 10.1 10.3 533.8 0.1 0.0 17.0 55.1 8.7 0.0 0.9 8.4 0.0 0.0 7.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.4 4.4 0.5 0.0 0.0 0.0 1.9 0.0 21.0 0.0 0.0 0.0 67.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.9 3.8 0.0 2.9 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 378.7 0.0 0.4 0.1 11.4 0.0 0.0 0.0 108258.7 0.0 0.3 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 348.9 0.0 0.0 0.0 0.0 9565.7 8.9 0.0 0.1 0.0 60.0 0.1 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 85.4 0.2 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.3 0.1 6.8 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A3 "DKFZp434B204, FAM75A3" ENSG00000275969 "SPATA31 subfamily A member 3" Q5VYP0 9 66986304-66992583 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" A0A0B4J2F2 21 6111131-6123778 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 217.2" "Cell type enhanced" "Detected in some" "Adipocytes: 11.9;Alveolar cells type 1: 25.6;Alveolar cells type 2: 27.2;Endometrial ciliated cells: 17.1;Glandular and luminal cells: 30.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "hypothalamus: 72.5" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 95.3;hTERT-RPE1: 117.7;Karpas-707: 120.6;LHCN-M2: 83.0;SiHa: 87.2" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA038211: AB_2675894, HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 66.1 52.5 12.5 16.2 6.2 42.7 54.0 5.7 15.5 17.3 8.7 19.1 7.7 16.4 0.4 32.3 31.3 30.7 42.5 6.1 72.5 19.1 71.8 38.5 9.9 11.5 6.6 4.6 94.3 47.4 8.0 39.8 14.4 7.8 33.8 12.5 21.0 41.8 42.0 40.5 217.2 17.6 10.6 6.2 18.1 37.8 7.3 8.4 8.3 18.1 4.4 4.8 44.7 47.1 14.2 9.5 47.5 3.5 3.0 0.7 0.4 8.3 1.1 0.6 1.7 1.0 53.3 7.0 3.2 1.4 0.2 7.1 0.8 5.5 0.0 0.6 8.9 1.7 7.4 95.3 10.3 3.1 1.2 0.7 1.2 39.6 4.8 26.5 117.7 2.0 1.5 3.0 120.6 83.0 4.7 0.9 2.3 4.9 8.8 5.1 2.0 21.1 14.3 4.6 16.4 4.4 2.1 87.2 5.5 5.0 2.3 0.9 4.1 2.3 1.4 4.4 2.0 19.9 15.9 37.7 1.6 12.6 3.0 5.6 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.6 1.8 0.0 0.0 12.5 6.2 5.7 15.5 6.1 72.5 11.5 6.6 4.6 7.8 6.2 8.4 14.2 11.9 25.6 27.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 4.0 2.7 0.0 0.0 3.7 1.8 0.0 0.7 4.1 0.0 0.0 0.5 0.0 17.1 3.4 1.4 0.0 0.0 0.0 0.2 0.9 1.5 0.0 30.0 6.3 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.2 8.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 2.4 0.0 0.0 0.0 AC007325.1 ENSG00000276017 Unmapped 72411-74814 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 48 "testis: 9.0" "Cell type enriched" "Detected in single" 13 "Spermatocytes: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP14 "MKP-L, MKP6" ENSG00000276023 "Dual specificity phosphatase 14" O95147 17 37489891-37513501 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 40.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019911 Approved Approved Nucleoplasm,Cytosol NA Yes 79000 "Nucleoplasm, Cytosol" "HPA019911: AB_1847888" "unprognostic (1.32e-1)" "unprognostic (3.06e-1)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (4.60e-1)" "unprognostic (3.22e-2)" "unprognostic (3.43e-3)" "unprognostic (2.02e-3)" "unprognostic (2.18e-1)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (3.81e-1)" "prognostic unfavorable (6.97e-9)" "unprognostic (7.93e-2)" "unprognostic (1.97e-1)" "unprognostic (1.73e-1)" "unprognostic (1.41e-3)" 13.9 14.3 11.4 1.3 11.6 0.4 12.5 11.6 17.2 9.5 11.3 8.2 0.0 9.6 5.5 17.6 7.6 1.2 13.2 11.5 13.3 8.6 15.4 8.6 0.4 12.5 11.2 11.6 5.7 6.7 1.1 14.7 1.0 12.0 6.5 1.0 10.0 13.2 0.3 11.1 40.7 5.6 0.8 11.0 2.8 7.7 13.8 11.3 4.4 23.3 4.5 2.7 7.2 17.3 11.7 2.6 0.2 4.9 2.1 0.1 0.6 2.1 10.4 7.8 14.3 15.6 1.2 17.9 0.2 0.9 7.6 0.2 2.8 0.2 6.1 36.4 0.2 0.7 0.0 1.6 6.2 1.5 0.5 3.0 8.5 5.5 4.8 2.5 10.2 0.3 0.2 0.6 3.1 11.4 0.4 9.7 1.7 0.3 3.8 0.0 2.5 0.6 2.5 17.5 2.4 1.9 0.3 0.5 17.6 4.1 24.9 0.8 3.9 1.4 10.8 5.8 0.1 5.8 0.1 0.3 0.1 0.1 0.0 37.5 1.1 0.0 0.7 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.7 1.6 0.0 0.2 0.0 0.0 0.2 11.4 11.6 11.6 17.2 11.5 13.3 12.5 11.2 11.6 12.0 11.0 11.3 11.7 15.0 6.4 5.4 2.9 8.3 179.7 239.3 74.8 129.1 6.8 42.6 46.0 15.0 4.3 39.6 7.3 8.4 162.8 16.6 0.3 29.4 34.8 36.4 146.9 18.5 21.7 2.4 11.4 12.0 15.1 82.1 30.2 3.1 85.3 87.0 10.6 14.6 15.7 19.7 15.2 5.3 1.2 36.7 2.8 34.8 52.5 13.7 5.9 62.2 4.7 25.3 16.1 15.5 3.0 3.3 74.8 2.9 6.0 9.9 64.9 0.1 16.9 61.3 24.5 0.0 13.2 45.2 26.0 33.4 44.0 92.6 67.9 18.2 26.3 1.1 67.0 SPATA31A7 "FAM75A4, FAM75A7, SPATA31A4" ENSG00000276040 "SPATA31 subfamily A member 7" Q8IWB4 9 61190003-61196280 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "bone marrow: 27.2;lymphoid tissue: 67.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Group enriched" "Detected in many" 4 "dendritic cells: 4.8;T-cells: 2.3" "Cell line enhanced" "Detected in all" "MOLT-4: 450.9;REH: 1004.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 1.0 0.9 2.3 9.7 2.8 27.2 1.7 2.5 2.3 0.9 2.4 2.9 3.8 1.0 0.1 6.6 0.4 0.8 0.4 2.1 3.4 0.6 0.9 1.3 15.9 2.8 2.6 1.6 0.3 0.6 0.2 0.2 2.1 3.5 0.6 2.6 0.4 1.6 0.2 1.2 3.4 3.9 1.9 2.2 3.7 3.3 5.2 3.6 67.8 0.3 0.3 10.4 1.7 2.5 4.4 111.3 78.7 116.6 83.4 3.3 13.3 18.5 88.3 42.0 89.9 86.8 94.6 54.9 62.7 21.1 39.4 32.7 54.1 81.2 47.7 63.0 102.7 92.2 54.3 74.3 102.4 1.3 135.1 78.9 6.5 3.5 48.9 12.6 14.1 27.2 97.2 79.3 70.5 54.5 86.7 450.9 82.5 52.5 40.0 84.3 1004.5 259.7 45.4 24.9 80.1 86.0 68.5 69.2 37.7 12.1 18.8 68.2 127.6 34.2 94.6 76.7 124.3 108.3 29.8 33.1 183.5 54.8 129.7 123.3 0.3 0.2 0.1 0.6 0.0 0.0 0.2 0.8 1.0 1.3 0.1 0.2 0.8 0.8 0.5 0.2 4.8 2.3 0.6 2.3 2.8 2.5 2.3 2.1 3.4 2.8 2.6 1.6 3.5 2.2 3.6 4.4 0.2 0.0 0.0 1.6 2.1 0.0 0.8 0.0 3.4 2.5 4.4 2.8 4.3 1.5 0.6 0.0 0.0 6.6 6.9 2.6 0.0 2.2 2.9 1.3 1.8 2.2 0.0 49.7 0.4 0.4 7.8 4.7 8.6 2.4 0.0 10.4 0.4 0.7 8.9 3.3 0.4 2.3 0.0 1.9 0.0 1.8 0.6 3.8 0.0 0.0 2.0 0.6 1.0 3.0 1.3 4.2 1.9 0.4 21.0 0.6 1.4 0.2 0.7 0.7 0.0 1.2 6.1 6.1 11.9 15.8 0.0 1.4 3.7 1.5 8.3 1.3 ORAI1 "CRACM1, FLJ14466, TMEM142A" ENSG00000276045 "ORAI calcium release-activated calcium modulator 1" Q96D31 12 121626550-121642677 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 60.7" "Cell type enhanced" "Detected in many" "dendritic cells: 92.3;NK-cells: 88.6;Theca cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 81.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016583 Approved NA NA "HPA016583: AB_1848720" "unprognostic (2.22e-2)" "unprognostic (3.78e-3)" "unprognostic (7.82e-3)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.99e-3)" "unprognostic (4.25e-3)" "unprognostic (1.92e-1)" "unprognostic (2.00e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "unprognostic (6.84e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" 10.9 5.4 3.9 9.7 3.5 8.9 11.0 4.4 6.9 7.1 18.6 10.4 21.0 7.6 0.0 8.8 7.7 3.3 8.0 2.8 4.4 9.7 12.4 15.6 12.1 4.5 4.0 2.2 6.8 8.2 8.8 2.6 4.5 4.3 6.5 0.3 0.0 15.7 2.6 60.7 46.5 13.9 2.2 4.5 23.3 12.6 11.6 5.2 6.2 10.5 14.1 2.9 11.2 7.8 4.3 18.3 42.0 3.4 16.9 4.0 4.9 18.4 20.5 2.9 8.8 4.7 33.1 16.2 13.3 31.4 3.1 11.8 30.2 3.4 13.7 0.0 41.9 7.8 23.9 6.8 16.6 10.1 18.5 43.7 2.0 5.1 14.4 0.9 4.9 12.9 30.0 16.8 6.9 2.3 41.4 46.1 81.7 19.6 10.3 35.7 16.8 7.9 20.5 5.0 13.4 16.4 3.3 10.7 11.7 17.5 0.2 29.3 11.6 23.5 21.0 8.4 28.6 15.9 9.4 8.7 5.6 15.7 25.9 19.1 9.4 6.3 8.2 18.6 5.4 13.9 6.3 15.4 18.8 7.5 9.0 14.3 12.5 6.9 7.5 5.2 1.9 13.7 7.6 3.9 3.5 4.4 6.9 2.8 4.4 4.5 4.0 2.2 4.3 4.5 5.2 4.3 32.0 28.9 16.4 1.0 41.0 22.6 10.1 3.4 6.8 2.1 48.4 22.9 4.2 18.6 10.3 1.8 4.2 3.7 92.3 8.4 1.9 13.3 3.4 14.1 11.1 40.6 2.4 23.8 0.3 19.5 15.2 9.5 8.6 17.4 7.0 24.0 43.2 17.9 38.6 0.0 0.5 9.3 2.0 28.2 65.0 11.8 13.4 42.8 21.4 4.7 27.2 5.8 88.6 3.0 1.5 29.5 6.3 9.4 30.5 14.8 17.2 12.1 6.3 6.9 0.0 6.3 10.8 1.7 6.0 6.9 37.4 7.8 70.3 86.0 20.1 10.7 CCL4L2 ENSG00000276070 "C-C motif chemokine ligand 4 like 2" Q8NHW4 17 36210924-36212878 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;lymphoid tissue: 20.7" "Group enriched" "Detected in many" 6 "dendritic cells: 488.0;Hofbauer cells: 358.5;Kupffer cells: 163.4;Macrophages: 585.2;NK-cells: 249.3;T-cells: 303.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 7 "eosinophil: 122.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 122.0" "Group enriched" "Detected in some" 4 "Daudi: 4.1;HMC-1: 5.6;U-266/70: 8.8" "Secreted to blood" NA NA "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" "unprognostic (2.46e-2)" "unprognostic (1.44e-2)" "unprognostic (1.16e-1)" "unprognostic (6.07e-2)" "unprognostic (3.82e-1)" "unprognostic (3.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.27e-2)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" "unprognostic (8.51e-2)" "unprognostic (1.99e-3)" 2.9 3.8 0.4 4.4 0.4 32.5 1.5 0.6 1.1 0.8 0.5 1.3 1.5 1.1 0.5 0.7 2.6 6.8 1.0 0.4 0.4 1.9 7.7 12.7 3.2 0.4 0.4 0.4 1.9 0.9 2.1 1.1 2.2 0.4 1.9 1.8 0.0 2.1 0.7 0.2 0.3 3.9 1.5 0.4 20.7 1.8 0.2 0.4 1.6 1.4 1.7 0.8 4.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 1.5 0.7 0.0 0.0 0.0 0.6 0.3 122.0 15.2 0.3 3.6 0.0 0.6 8.9 0.1 0.1 0.1 8.4 18.2 1.2 0.2 0.0 0.0 5.5 0.4 0.4 0.6 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 18.1 0.0 7.7 0.7 13.9 0.4 0.4 0.0 5.7 0.4 13.8 22.9 8.6 4.3 0.0 0.0 0.0 4.2 488.0 0.2 0.0 0.1 0.2 0.4 1.0 38.1 0.0 14.3 1.1 0.0 6.1 3.9 3.1 0.8 5.1 8.2 7.1 1.3 358.5 1.7 0.4 0.1 0.0 163.4 59.1 1.2 0.0 585.2 1.8 6.5 3.3 1.3 249.3 0.0 0.1 0.1 0.1 0.0 50.6 0.4 0.0 0.2 0.0 2.3 13.1 1.1 6.6 0.1 0.1 1.4 0.4 9.6 303.6 0.1 0.0 1.8 CRYAA2 ENSG00000276076 "Crystallin alpha A2" A0A140G945 21 6560714-6564489 "Predicted intracellular proteins" Cataract "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 134 "kidney: 123.5;liver: 42.4;retina: 48.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 207 "Hep G2: 37.5" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 123.5 42.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 37.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL3L3 "CCL3L1, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1" ENSG00000276085 "C-C motif chemokine ligand 3 like 3" P16619 17 36194869-36196758 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 11.2;lung: 5.1;lymphoid tissue: 4.1" "Group enriched" "Detected in some" 6 "Hofbauer cells: 335.4;Kupffer cells: 227.5;Macrophages: 321.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "eosinophil: 4.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.2" "Group enriched" "Detected in some" 41 "U-266/70: 49.4;U-266/84: 107.3" "Secreted to blood" NA NA "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "unprognostic (5.37e-2)" "unprognostic (1.46e-1)" "unprognostic (9.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.36e-2)" "unprognostic (3.69e-1)" "unprognostic (5.75e-2)" "unprognostic (5.55e-2)" "unprognostic (2.40e-2)" "unprognostic (3.66e-1)" "unprognostic (9.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.21e-1)" "unprognostic (1.90e-2)" "unprognostic (8.58e-2)" 1.0 1.0 0.0 0.3 0.0 11.2 0.7 0.0 0.4 0.1 0.0 0.4 0.1 0.2 0.2 0.1 0.7 1.0 0.3 0.0 0.0 0.6 1.2 5.1 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.3 0.1 0.5 0.0 0.0 1.3 0.1 0.1 0.1 0.8 0.1 0.0 4.1 0.5 0.5 0.0 0.1 0.3 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 49.4 107.3 1.2 0.0 0.0 0.0 0.1 0.0 4.2 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.3 0.5 0.0 2.2 0.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 48.8 0.0 16.0 0.0 0.0 4.4 1.3 0.5 0.0 0.0 0.0 8.6 1.0 335.4 0.0 0.0 0.5 0.0 227.5 2.9 0.9 0.6 321.7 1.8 1.9 1.6 0.7 10.3 0.0 0.0 0.0 1.2 0.0 0.8 0.7 0.0 0.0 0.0 2.3 0.0 0.4 0.3 0.4 3.8 0.7 0.1 13.1 31.4 0.0 0.0 0.4 OR13C2 ENSG00000276119 "Olfactory receptor family 13 subfamily C member 2" Q8NGS9 9 104604671-104605627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA078297 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA078297: " 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.2 0.7 0.3 0.1 0.9 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C9 "H4/m, H4FM, HIST1H4I" ENSG00000276180 "H4 clustered histone 9" P62805 6 27138588-27139881 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 2.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 75.5;SiHa: 43.8;U-2 OS: 73.3;U-266/84: 78.9" HPA042201 Approved NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (2.49e-2)" "prognostic favorable (9.70e-4)" "unprognostic (1.97e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (2.85e-1)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (6.28e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-1)" "unprognostic (2.02e-2)" 1.3 3.4 0.4 3.7 0.4 3.3 0.6 0.1 1.5 0.5 0.4 1.9 3.8 2.0 0.0 2.7 0.5 2.3 1.5 0.7 0.8 0.5 2.8 1.7 4.2 0.7 0.7 0.2 1.6 3.7 0.0 0.3 2.5 0.7 3.0 0.2 0.2 2.5 0.0 0.4 1.2 4.0 0.0 1.0 3.6 4.1 2.7 0.9 1.0 3.6 0.0 0.1 1.4 1.1 1.6 4.2 8.5 4.6 3.0 3.2 0.4 5.1 8.1 0.3 0.4 0.3 8.3 6.0 1.3 22.7 0.1 12.5 6.5 0.8 0.2 0.2 5.8 12.5 3.0 13.4 0.4 0.5 2.5 14.8 1.1 0.3 0.0 0.4 7.7 0.4 2.9 75.5 22.2 0.0 12.9 3.8 5.6 1.9 30.2 5.3 3.4 2.7 21.3 0.2 2.2 15.4 5.6 43.8 19.8 5.1 5.2 37.9 1.8 2.7 5.6 73.3 6.8 0.8 22.2 78.9 14.5 3.3 16.8 5.9 14.4 3.0 17.4 1.7 2.4 1.4 5.3 1.5 1.7 3.0 6.6 1.8 1.9 16.5 3.0 5.9 6.4 4.1 3.5 0.4 0.4 0.1 1.5 0.7 0.8 0.7 0.7 0.2 0.7 1.0 0.9 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 ANKRD20A3P ANKRD20A3 ENSG00000276203 "Ankyrin repeat domain 20 family member A3, pseudogene" Q5VUR7 9 66106815-66179474 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.0" "Cell type enriched" "Detected in single" 15 "Cardiomyocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 9.5;U-266/84: 3.7" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753" Uncertain NA NA "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592" "unprognostic (4.27e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.5 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802722-8867677 "Metabolic proteins, Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.9" "Cell type enhanced" "Detected in some" "Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 21.9;eosinophil: 75.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 75.8" "Cell line enriched" "Detected in some" 8 "HMC-1: 148.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 0.4 0.0 1.2 1.9 1.5 2.2 0.4 0.8 1.4 0.6 1.0 0.8 1.5 0.9 0.1 0.5 0.2 1.2 1.3 1.0 1.6 0.0 0.3 1.2 2.1 1.3 1.2 0.7 0.0 0.4 0.1 0.0 0.6 1.3 0.3 0.6 0.0 0.2 0.3 0.6 0.8 2.3 0.7 1.2 2.9 1.0 0.4 1.6 2.1 0.0 0.3 1.5 1.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 14.1 0.0 19.4 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 2.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 21.9 7.2 75.8 0.5 9.6 0.4 2.7 0.1 0.3 10.8 0.3 0.1 0.2 1.1 1.5 7.8 0.0 0.0 3.3 1.2 1.5 0.8 1.4 1.0 1.6 1.3 1.2 0.7 1.3 1.2 1.6 2.7 0.2 0.0 1.3 0.3 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 11.5 0.0 0.1 2.6 0.0 0.4 0.6 0.0 0.1 0.2 0.5 0.0 47.4 0.0 0.4 0.0 7.6 0.0 0.5 0.0 0.0 4.4 1.6 20.6 0.0 3.9 1.8 7.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 1.6 0.1 0.0 0.0 TADA2A "ADA2, ADA2A, hADA2, TADA2L" ENSG00000276234 "Transcriptional adaptor 2A" 17 37406886-37479725 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 125.0;Late spermatids: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076497 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA076497: AB_2686801" "unprognostic (3.49e-1)" "unprognostic (5.12e-2)" "unprognostic (7.32e-2)" "unprognostic (7.86e-2)" "unprognostic (4.80e-1)" "unprognostic (1.23e-3)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (6.13e-3)" "unprognostic (8.18e-2)" "unprognostic (1.10e-3)" "unprognostic (7.81e-2)" "prognostic unfavorable (2.25e-5)" "unprognostic (4.38e-2)" "unprognostic (1.06e-1)" "unprognostic (2.56e-2)" "unprognostic (4.41e-2)" 3.6 3.5 2.9 3.2 3.6 2.6 3.8 5.7 5.3 4.9 1.6 4.9 1.8 5.0 2.6 3.9 4.9 1.6 3.8 3.2 3.2 3.6 4.7 3.3 2.0 2.9 3.3 2.5 4.0 5.0 1.2 4.7 1.6 3.3 4.5 2.8 5.0 4.0 1.7 6.3 4.8 5.4 1.5 2.5 5.5 4.3 10.2 3.2 1.7 5.5 1.5 3.2 5.0 4.3 4.7 0.8 6.4 6.2 4.9 3.0 4.3 6.9 4.0 4.0 6.9 5.0 7.8 0.0 12.7 5.9 2.9 9.0 10.0 8.9 4.9 7.6 8.9 7.6 6.6 8.2 4.3 5.3 10.4 4.0 3.2 3.3 7.9 3.9 3.7 6.9 16.3 11.0 3.7 9.0 3.4 19.7 8.5 4.9 3.1 4.5 13.5 19.3 10.4 4.4 6.5 7.2 6.9 5.3 2.8 4.9 6.4 8.9 3.4 5.7 7.9 6.9 5.7 6.2 6.4 6.1 16.6 7.6 4.4 6.8 2.4 3.8 4.5 5.4 4.2 3.9 3.9 3.4 4.5 4.7 7.1 5.3 5.1 0.5 3.1 5.9 8.6 3.2 2.8 2.9 3.6 5.7 5.3 3.2 3.2 2.9 3.3 2.5 3.3 2.5 3.2 4.7 6.8 6.4 9.3 8.5 6.1 2.5 6.7 9.7 6.8 15.1 3.9 4.4 7.4 8.6 11.3 9.2 16.7 15.2 11.0 4.3 1.9 7.1 125.0 7.5 9.7 8.2 4.2 9.9 22.9 5.9 9.7 5.5 5.1 6.8 10.1 9.1 5.7 3.9 8.0 23.5 19.7 7.3 4.1 5.5 4.7 87.9 8.1 6.5 1.8 20.6 10.5 11.4 5.2 17.6 21.6 6.6 4.0 7.9 7.1 5.3 6.6 5.1 11.4 21.8 13.1 8.7 10.1 27.3 33.5 4.8 3.3 5.1 6.8 7.4 7.4 4.0 OR4E1 OR4E1P ENSG00000276240 "Olfactory receptor family 4 subfamily E member 1" P0C645 14 21667940-21673818 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011043.1 ENSG00000276256 "Uncharacterized LOC389831" Unmapped 42939-49164 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 18.4;Distal tubular cells: 19.6;Proximal tubular cells: 27.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 140.0" NA NA 6.3 12.3 11.1 7.5 10.4 0.8 16.7 11.6 13.6 10.4 8.9 16.8 25.9 15.4 19.4 11.4 16.8 13.4 12.0 10.8 11.1 61.4 43.4 7.3 8.9 11.3 11.4 9.6 20.7 40.6 21.6 21.0 12.1 39.4 20.1 12.8 10.1 32.4 7.0 11.2 15.2 18.7 11.5 10.6 20.6 7.7 11.6 19.1 8.8 23.1 6.9 17.4 12.9 140.0 70.7 76.1 75.6 39.2 40.8 23.0 13.9 9.0 11.2 16.3 80.4 24.2 11.3 45.4 9.6 79.7 50.9 12.6 42.1 18.1 70.7 49.1 24.7 22.5 47.5 8.5 13.6 21.6 14.0 18.1 14.0 36.3 39.1 14.3 17.2 53.7 18.3 48.8 7.8 19.1 65.9 6.4 65.2 7.0 0.0 31.7 5.2 11.8 19.6 28.5 73.8 2.2 26.1 77.6 13.3 25.6 13.6 8.1 32.2 13.9 1.4 31.5 0.7 2.0 0.5 18.7 4.6 20.7 0.0 0.3 0.0 1.2 0.0 2.0 1.1 0.5 1.7 2.0 0.2 0.3 1.3 0.0 7.2 0.1 1.3 2.9 0.8 11.1 10.4 11.6 13.6 10.8 11.1 11.3 11.4 9.6 12.1 11.5 11.6 12.9 1.8 12.8 11.8 0.0 0.9 1.9 2.2 4.7 7.4 2.2 2.5 3.4 0.0 15.7 4.6 18.4 0.0 2.7 1.3 3.7 19.6 14.8 1.4 1.7 2.7 4.2 8.5 7.2 0.0 5.9 5.2 2.9 5.6 2.1 3.8 3.7 4.2 1.8 0.6 0.0 0.0 5.0 4.1 0.3 0.7 2.0 0.9 1.0 0.0 0.0 1.8 9.2 5.2 0.0 0.0 8.6 8.3 3.4 2.9 1.3 6.2 27.9 8.6 1.0 6.6 3.0 2.1 0.1 0.4 4.4 1.7 4.1 1.2 2.3 5.3 1.8 KCNE1B ENSG00000276289 "Potassium voltage-gated channel subfamily E regulatory subunit 1B" A0A087WTH5 21 7816675-7829926 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.8;fallopian tube: 5.7;heart muscle: 6.2" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 1.2;Kupffer cells: 1.2;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 1.0;eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;SuSa: 1.1" NA NA "unprognostic (5.41e-4)" "unprognostic (8.78e-2)" "unprognostic (7.14e-3)" "unprognostic (1.35e-1)" "unprognostic (3.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.08e-1)" "unprognostic (7.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-3)" "unprognostic (6.59e-2)" "unprognostic (1.49e-1)" 0.2 0.0 0.7 0.0 0.4 0.1 0.9 0.4 1.0 0.2 5.8 0.1 0.0 0.1 0.1 0.1 5.7 0.0 6.2 1.0 0.3 2.6 0.9 1.0 0.0 0.9 0.9 0.0 0.0 0.0 0.7 0.3 0.2 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.9 2.1 0.7 0.1 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.4 1.0 1.0 0.3 0.9 0.9 0.0 0.8 2.1 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIP4K2B "PIP5K2B, PIP5KIIB, PIP5KIIbeta" ENSG00000276293 "Phosphatidylinositol-5-phosphate 4-kinase type 2 beta" P78356 17 38765691-38800126 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062220 Supported Nucleoplasm NA NA Nucleoplasm "HPA062220: AB_2684715" "unprognostic (7.77e-2)" "unprognostic (8.37e-2)" "unprognostic (3.74e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.64e-1)" "unprognostic (2.33e-1)" "unprognostic (1.50e-2)" "unprognostic (6.10e-3)" "unprognostic (3.79e-1)" "unprognostic (4.82e-3)" "unprognostic (3.38e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.36e-4)" "unprognostic (2.48e-1)" 20.1 27.2 81.3 15.7 88.0 7.3 21.0 65.0 95.8 29.6 48.4 20.7 10.4 29.1 23.5 15.5 29.4 16.4 30.5 89.3 77.7 18.7 14.5 21.6 20.6 69.6 69.1 85.6 50.3 16.6 16.7 25.4 23.0 75.8 22.4 14.1 36.3 17.0 25.6 99.9 24.8 17.4 29.8 63.3 23.4 16.6 13.2 77.8 23.6 20.4 76.3 20.5 23.1 21.1 84.3 18.1 40.2 66.0 69.9 56.7 45.5 12.2 31.6 38.2 43.1 35.0 28.2 18.4 44.8 17.2 59.8 36.3 35.9 44.9 28.7 41.4 27.8 17.2 38.4 27.3 40.7 26.2 43.7 23.5 40.0 34.2 33.7 24.2 59.2 36.3 48.6 34.2 22.3 46.8 14.2 44.0 34.0 32.0 20.7 15.8 44.6 63.7 25.6 31.3 22.3 34.0 46.1 30.9 13.9 34.5 68.5 43.6 44.5 33.4 35.8 21.6 29.4 28.9 27.4 36.5 19.7 42.0 36.8 32.9 1.3 1.9 0.6 3.4 1.6 3.5 2.3 2.9 3.3 2.4 2.3 3.2 2.9 1.8 2.8 1.4 2.2 3.0 3.3 81.3 88.0 65.0 95.8 89.3 77.7 69.6 69.1 85.6 75.8 63.3 77.8 84.3 15.8 19.2 11.4 21.5 6.7 6.1 3.5 4.6 7.4 31.6 11.5 13.3 23.4 4.3 7.5 5.5 10.4 7.0 14.8 3.7 1.9 5.3 9.2 10.8 17.7 17.3 11.5 9.0 33.5 4.9 5.0 13.8 5.6 9.0 1.3 22.6 18.2 12.7 8.8 43.7 29.1 7.4 2.0 11.3 4.9 21.1 15.2 8.6 1.8 18.7 6.9 14.8 10.3 22.1 24.0 6.0 4.1 16.6 6.2 4.9 5.4 7.7 6.4 14.0 6.6 13.8 13.2 4.6 7.4 9.9 4.4 2.5 8.1 17.3 7.2 2.7 AL021997.2 ENSG00000276302 "Novel protein" 6 28267121-28281580 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.0;U-266/84: 2.0" NA NA "unprognostic (6.64e-2)" "unprognostic (2.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.32e-1)" "unprognostic (5.60e-2)" "unprognostic (3.45e-2)" "unprognostic (4.93e-2)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (8.51e-3)" "unprognostic (1.21e-1)" "unprognostic (3.74e-4)" "unprognostic (7.03e-2)" "unprognostic (1.42e-1)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" 0.5 0.7 0.1 0.5 0.2 0.2 0.3 0.5 0.7 0.2 0.0 0.2 0.7 0.4 0.5 0.1 0.2 0.2 0.1 0.4 0.1 0.4 0.1 0.2 0.2 0.5 0.4 0.2 0.5 0.1 0.4 0.2 0.2 0.5 0.1 0.0 1.0 0.5 0.0 0.4 0.2 0.8 0.0 0.0 0.3 0.5 0.4 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.8 0.2 0.0 0.1 0.9 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.4 0.4 0.1 0.7 2.0 0.0 0.2 0.0 0.2 0.6 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.4 0.3 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.4 0.4 1.3 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.7 0.5 1.3 2.0 0.0 0.1 1.2 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.7 0.4 0.1 0.5 0.4 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004556.3 ENSG00000276345 "39S ribosomal protein L23, mitochondrial" Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.2" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 35.6;Hofbauer cells: 23.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 94.7;K-562: 75.5;MOLT-4: 85.4;NB-4: 160.6;PC-3: 141.1;WM-115: 113.7" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" 3.8 0.0 2.5 4.1 2.8 0.0 19.6 2.6 5.0 0.0 2.2 10.4 0.1 5.1 14.4 0.0 4.9 6.0 24.2 5.1 3.8 6.8 8.6 1.6 0.0 2.8 5.8 2.2 6.4 6.9 0.0 2.1 5.8 5.0 0.0 1.2 7.6 0.3 14.6 5.2 10.0 0.5 5.0 4.2 5.1 2.4 7.1 10.0 2.7 0.0 0.1 4.5 10.8 0.2 0.0 0.1 0.1 0.0 0.0 42.0 27.8 43.4 46.5 33.2 94.7 0.8 0.1 0.1 0.0 0.0 0.6 0.7 0.3 18.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 51.1 0.0 31.4 48.3 75.5 42.5 0.4 0.4 85.4 160.6 0.0 0.2 141.1 0.5 22.8 0.2 44.0 27.1 0.2 0.6 0.0 0.2 0.1 0.0 70.4 0.0 0.0 0.0 0.1 0.3 0.4 0.5 0.3 0.1 0.8 0.3 113.7 12.3 3.4 2.2 1.7 6.2 1.4 1.7 2.5 3.5 3.0 2.0 2.6 2.9 1.0 2.1 2.8 2.8 4.0 2.1 2.5 2.8 2.6 5.0 5.1 3.8 2.8 5.8 2.2 5.8 5.0 7.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 35.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 H2AC14 "H2A/E, H2AFE, HIST1H2AJ" ENSG00000276368 "H2A clustered histone 14" Q99878 6 27814302-27814777 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.3;brain: 1.8;lymphoid tissue: 1.7" "Cell type enhanced" "Detected in single" "Extravillous trophoblasts: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5" "Low region specificity" "Detected in many" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.1 0.0 0.5 0.3 0.3 7.3 0.0 0.5 0.6 0.2 0.5 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.1 0.7 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.6 0.1 0.1 0.7 1.7 0.0 0.0 0.1 0.2 0.1 1.1 3.5 0.0 0.9 0.0 0.0 0.0 0.7 1.0 0.8 0.7 1.8 1.4 0.1 3.1 0.3 0.5 0.1 1.0 0.0 0.8 0.4 1.4 0.3 4.6 0.7 6.9 0.2 0.0 1.7 0.0 0.2 0.5 0.2 0.0 1.0 1.6 0.0 9.8 0.2 11.5 5.0 4.6 1.4 1.5 2.4 4.6 0.0 1.4 0.1 1.9 0.3 0.8 0.8 1.0 0.3 0.2 0.3 3.4 0.0 0.0 1.6 0.3 0.1 4.8 3.1 2.9 0.8 3.2 2.2 0.0 0.0 0.0 0.2 0.2 0.4 0.3 1.3 1.3 1.1 1.3 0.4 0.1 1.1 0.1 0.1 0.1 2.8 1.7 0.5 0.3 0.5 0.6 0.1 1.8 0.5 0.3 0.0 0.8 0.7 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 TRBV13 "TCRBV13S1, TCRBV23S1A2T" ENSG00000276405 "T cell receptor beta variable 13" A0A0A6YYD4 7 142535809-142536292 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 31.1" "Group enriched" "Detected in some" 4 "Erythroid cells: 2.5;Late spermatids: 2.5;T-cells: 4.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "memory CD4 T-cell: 7.9;memory CD8 T-cell: 13.3;naive CD4 T-cell: 11.5;naive CD8 T-cell: 21.0;T-reg: 20.9" "Lineage enriched" "Detected in single" 211 "T-cells: 21.0" "Cell line enriched" "Detected in some" 9 "MOLT-4: 40.6" NA NA "unprognostic (6.74e-5)" "unprognostic (5.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.00e-1)" "unprognostic (5.71e-4)" "unprognostic (8.28e-2)" "unprognostic (7.17e-2)" "unprognostic (2.49e-2)" "unprognostic (1.17e-2)" "unprognostic (3.32e-1)" "unprognostic (1.19e-6)" "unprognostic (1.44e-1)" "unprognostic (3.46e-2)" "unprognostic (6.95e-3)" "unprognostic (7.87e-2)" 0.1 0.3 0.0 1.6 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.8 6.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.0 0.7 0.3 0.1 31.1 0.1 0.0 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.0 0.5 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.9 0.0 0.0 4.4 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 7.9 13.3 0.0 0.0 11.5 21.0 0.0 0.0 0.0 0.0 20.9 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 CCL14 "CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2" ENSG00000276409 "C-C motif chemokine ligand 14" Q16627 17 35983288-35987004 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 637.8" "Cell type enriched" "Detected in many" 5 "Hepatic stellate cells: 1156.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 41 "HUVEC TERT2: 92.1" "Low region specificity" "Detected in all" "CAB004423, HPA030268" Uncertain "Secreted to blood" NA NA 5200000 37000000 "CAB004423: AB_627716, HPA030268: AB_10603782" "unprognostic (4.13e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "unprognostic (3.55e-3)" "unprognostic (2.50e-1)" "unprognostic (1.99e-2)" "unprognostic (8.79e-5)" "unprognostic (1.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (6.33e-3)" "unprognostic (3.00e-2)" "unprognostic (7.27e-3)" "unprognostic (1.36e-2)" "unprognostic (3.95e-1)" "unprognostic (3.52e-1)" "unprognostic (1.14e-1)" 397.9 103.5 0.5 6.5 0.3 3.3 404.1 0.3 1.7 191.6 2.6 57.9 2.9 199.7 59.9 62.5 235.5 69.9 62.1 0.3 1.5 67.3 83.3 67.0 49.3 0.5 0.5 0.3 44.5 22.7 12.5 39.9 0.9 0.6 98.2 9.9 0.0 62.5 50.0 56.4 90.2 50.9 95.1 0.4 637.8 68.1 16.1 0.5 34.7 124.9 24.8 28.4 117.8 179.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 1.7 0.3 1.5 0.5 0.5 0.3 0.6 0.4 0.5 1.2 136.5 0.0 8.2 0.0 2.2 1.9 0.1 0.0 3.4 0.0 0.6 1.1 0.2 18.6 0.6 0.0 0.0 0.0 0.1 2.0 0.0 0.0 24.2 0.4 0.3 203.8 0.0 26.7 0.0 0.0 0.0 9.4 0.0 0.2 1.3 0.0 1156.5 11.0 0.3 0.0 0.0 1.0 0.0 58.8 3.1 63.8 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 2.3 1.1 2.6 0.0 0.0 0.3 2.3 0.0 0.0 2.0 1.4 0.0 1.8 0.1 0.6 0.2 H2BC3 "H2B/f, H2BFF, HIST1H2BB" ENSG00000276410 "H2B clustered histone 3" P33778 6 26043227-26043713 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.1;brain: 3.9;lymphoid tissue: 1.1;testis: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 1.3;Karpas-707: 1.3;MOLT-4: 1.6;NB-4: 1.7;THP-1: 2.0;U-266/84: 2.2" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.0 0.0 0.6 0.0 0.4 1.1 0.0 2.3 0.6 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 1.3 3.9 1.1 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.2 1.3 1.3 0.0 0.0 1.6 1.7 0.7 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 2.0 0.0 0.1 0.1 0.1 0.3 0.3 2.2 0.0 0.2 0.5 0.4 2.6 0.5 0.5 0.8 0.1 2.2 1.4 2.4 0.9 1.9 0.9 1.2 0.5 2.0 0.1 0.2 6.4 1.9 0.3 0.6 0.4 2.3 0.6 0.1 1.0 0.9 1.2 0.0 0.7 0.5 3.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FAM25C bA164N7.4 ENSG00000276430 "Family with sequence similarity 25 member C" B3EWG5 10 47995322-47999791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 30.3;salivary gland: 15.5;skin 1: 38.5;vagina: 13.5" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 1.3;Basal respiratory cells: 3.0;Suprabasal keratinocytes: 3.1" "Cancer enriched" "Detected in single" 5 "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 10.7" HPA044808 Uncertain NA NA "HPA044808: AB_2679096" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 3.6 0.1 0.1 7.0 0.0 0.1 0.0 0.0 0.0 30.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 38.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.0 13.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 3.1 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.5" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Bipolar cells: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 66.3;ASC TERT1: 49.6;BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.8 2.7 3.7 1.1 3.7 0.0 1.9 6.0 2.7 2.1 3.2 1.5 0.7 3.1 2.0 1.9 2.9 1.6 2.9 3.9 7.2 2.2 2.1 2.7 0.4 5.5 4.4 2.4 5.7 3.8 20.5 1.7 4.8 5.1 3.0 0.9 3.2 4.7 3.9 2.1 3.7 0.8 2.8 5.0 1.4 1.5 1.9 4.8 1.4 4.5 1.9 0.8 1.9 2.1 6.3 0.0 2.4 0.3 0.0 66.3 49.6 1.3 18.3 0.0 29.2 32.5 2.9 10.0 10.6 23.4 20.5 0.0 13.9 0.0 7.6 16.4 0.0 3.1 0.0 0.0 0.1 6.9 0.0 6.5 17.6 1.5 1.7 9.4 12.6 9.0 0.0 0.2 0.0 1.0 8.1 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.0 0.1 0.0 0.1 0.0 2.0 19.1 0.1 9.2 0.0 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.7 6.0 2.7 3.9 7.2 5.5 4.4 2.4 5.1 5.0 4.8 6.3 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.2 1.5 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.8 0.5 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.1 TRBV18 TCRBV18S1 ENSG00000276557 "T cell receptor beta variable 18" A0A087X0M5 7 142615716-142616415 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "lymphoid tissue: 27.8" "Cell type enriched" "Detected in single" 13 "T-cells: 6.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 102.0" "Lineage enriched" "Detected in single" 316 "T-cells: 102.0" "Not detected" "Not detected" NA NA "unprognostic (1.55e-2)" "unprognostic (1.14e-3)" "unprognostic (4.53e-3)" "unprognostic (7.74e-4)" "unprognostic (2.60e-2)" "unprognostic (1.08e-4)" "unprognostic (3.11e-1)" "unprognostic (6.76e-3)" "unprognostic (3.67e-2)" "unprognostic (7.81e-4)" "unprognostic (1.41e-1)" "unprognostic (1.72e-1)" "unprognostic (3.28e-6)" "unprognostic (3.80e-1)" "unprognostic (4.42e-2)" "unprognostic (4.02e-2)" "unprognostic (2.47e-2)" 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.1 0.8 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.3 1.6 0.2 0.0 1.8 0.5 0.0 0.0 27.8 0.2 0.0 2.2 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 3.0 0.2 46.6 10.8 0.0 0.0 49.3 16.9 0.2 0.1 0.1 0.0 102.0 14.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 IGKV1D-13 ENSG00000276566 "Immunoglobulin kappa variable 1D-13" "A0A0B4J2D9, P0DP09" 2 90154073-90154574 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.6;lymphoid tissue: 320.4" "Cell type enriched" "Detected in some" 141 "Plasma cells: 6195.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 733 "memory B-cell: 480.8;naive B-cell: 331.6" "Lineage enriched" "Detected in single" 868 "B-cells: 480.8" "Cell line enhanced" "Detected in single" "Daudi: 1.0" HPA048721 Approved "Immunoglobulin genes" NA NA 370000000 "HPA048721: " "prognostic favorable (4.68e-6)" "unprognostic (4.10e-2)" "unprognostic (2.16e-1)" "unprognostic (5.71e-3)" "unprognostic (3.01e-3)" "unprognostic (1.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.14e-2)" "unprognostic (2.50e-1)" "unprognostic (2.27e-1)" "unprognostic (4.68e-3)" "unprognostic (4.68e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.60e-2)" 2.7 0.4 0.0 102.1 0.0 35.1 34.6 0.0 0.0 47.1 0.0 86.4 21.9 5.4 0.0 18.0 10.3 2.5 1.9 0.0 0.0 8.2 6.4 39.8 320.4 0.0 0.0 0.0 1.0 2.0 0.0 0.4 0.0 0.1 3.1 79.1 0.0 54.7 1.4 0.0 1.1 104.6 6.9 0.0 103.7 20.5 2.7 0.0 29.2 7.3 0.0 225.1 46.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.3 0.1 0.1 0.2 480.8 0.2 0.1 0.5 331.6 0.0 0.0 0.4 0.1 0.1 0.2 0.1 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6195.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A5 FAM75A5 ENSG00000276581 "SPATA31 subfamily A member 5" Q5VU36 9 60914407-60920653 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV11-3 "TCRBV11S3, TCRBV21S2A2, TRBV113" ENSG00000276597 "T cell receptor beta variable 11-3" A0A5A6 7 142554836-142555318 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 31 "lymphoid tissue: 22.3" "Group enriched" "Detected in some" 20 "Gastric mucus-secreting cells: 1.5;T-cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "MAIT T-cell: 3.1;memory CD4 T-cell: 12.0;memory CD8 T-cell: 5.2;naive CD4 T-cell: 11.6;naive CD8 T-cell: 5.9;T-reg: 10.1" "Lineage enriched" "Detected in single" 120 "T-cells: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.62e-3)" "unprognostic (9.92e-4)" "unprognostic (5.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.60e-3)" "unprognostic (3.30e-1)" "unprognostic (3.85e-2)" 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.3 0.6 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.7 0.4 0.0 0.0 22.3 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 3.1 0.0 12.0 5.2 0.0 0.0 11.6 5.9 0.0 0.0 0.0 0.0 10.1 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 RAB7B "MGC16212, MGC9726" ENSG00000276600 "RAB7B, member RAS oncogene family" Q96AH8 1 205976740-206003461 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 52.5" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 13.6;Cytotrophoblasts: 29.0;Fibroblasts: 13.6;Hofbauer cells: 32.8;Squamous epithelial cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "myeloid DC: 5.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 5.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 26.3;HBEC3-KT: 33.6;HL-60: 22.0;HMC-1: 89.1;hTCEpi: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.18e-2)" "unprognostic (2.14e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (9.14e-2)" "unprognostic (2.23e-3)" "unprognostic (5.97e-2)" "unprognostic (8.57e-2)" "unprognostic (3.89e-3)" "unprognostic (3.13e-2)" "unprognostic (8.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.82e-3)" 8.0 1.0 2.2 5.2 3.4 1.3 11.1 3.7 3.3 5.8 2.2 2.7 2.8 7.0 5.9 20.4 5.6 15.1 4.8 2.1 2.8 0.6 2.4 8.9 8.6 5.2 3.9 1.5 3.5 1.3 0.6 1.9 7.2 3.7 5.9 3.2 0.8 7.3 7.5 2.1 52.5 2.5 8.0 5.1 3.8 7.1 1.1 4.9 6.8 8.2 2.2 4.9 8.3 15.7 6.5 1.5 0.1 0.7 0.8 1.9 14.5 3.5 6.8 8.1 2.8 2.6 0.9 2.4 0.0 2.3 26.3 2.9 6.6 0.0 33.6 0.9 0.3 0.0 0.0 0.0 0.8 0.1 22.0 89.1 4.9 38.2 5.2 0.1 1.7 0.1 0.0 0.4 0.0 1.9 0.4 0.1 13.3 0.3 1.1 0.0 0.0 1.9 0.7 0.8 0.3 0.0 0.1 0.9 0.0 4.4 6.9 2.3 7.5 0.0 1.9 4.5 1.8 0.5 0.1 0.0 0.0 12.0 9.3 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.2 3.4 3.7 3.3 2.1 2.8 5.2 3.9 1.5 3.7 5.1 4.9 6.5 0.8 3.2 3.9 1.3 0.2 0.0 8.3 0.0 13.6 0.0 1.9 5.5 0.7 4.3 6.2 0.0 0.0 29.0 0.1 0.0 0.0 3.6 0.0 0.8 7.9 0.7 0.0 0.0 1.7 0.2 1.0 13.6 3.6 0.6 2.5 0.4 0.7 0.1 32.8 0.0 0.1 0.0 0.0 6.4 0.0 0.8 1.8 11.0 0.0 1.9 4.1 3.1 0.0 0.0 8.2 0.6 0.1 3.4 0.1 0.7 0.0 0.0 0.0 0.4 0.0 3.2 2.8 0.0 0.1 12.6 0.0 6.3 0.8 0.1 0.0 1.9 FP565260.2 ENSG00000276612 "Novel protein" 21 5116343-5133805 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 11.1;Enteroendocrine cells: 3.5;granulocytes: 11.4;Intestinal goblet cells: 9.0;Paneth cells: 6.6;Undifferentiated cells: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.6;RH-30: 3.4;SK-MEL-30: 2.9;U-937: 2.7" NA NA 0.4 0.7 1.2 0.0 1.2 0.0 0.0 1.5 2.5 0.2 0.7 0.1 0.7 0.1 0.0 0.1 0.2 0.0 0.2 1.6 0.9 0.1 0.2 0.1 0.0 1.1 1.0 1.1 0.1 0.0 0.1 0.1 0.0 1.1 0.1 0.0 1.1 0.0 0.0 0.4 0.1 0.1 0.3 0.8 0.4 0.1 0.2 0.9 0.1 0.1 0.0 0.1 0.2 0.1 1.4 0.0 0.8 0.2 1.1 2.4 0.5 0.3 0.3 0.0 0.3 0.1 0.8 0.0 0.0 0.0 0.0 1.0 0.0 1.6 1.4 0.3 1.0 0.3 2.6 0.4 0.6 1.4 0.0 0.2 0.5 0.0 1.6 1.6 1.2 0.6 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.3 3.4 1.1 0.0 0.0 2.1 0.1 0.5 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.3 0.0 0.7 0.2 2.7 0.8 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.8 0.1 0.0 0.0 1.2 1.2 1.5 2.5 1.6 0.9 1.1 1.0 1.1 1.1 0.8 0.9 1.4 0.0 0.0 3.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.7 3.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 12.5 0.0 DACH1 DACH ENSG00000276644 "Dachshund family transcription factor 1" Q9UI36 13 71437966-71867204 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4" "Group enriched" "Detected in many" 33 "dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2" "Cell line enhanced" "Detected in some" "AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9" "Region enriched" "Detected in all" 5 "basal ganglia: 38.8" "Region enriched" "Detected in all" 5 "basal ganglia: 34.2" "HPA012672, HPA012938, HPA073222" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA012672: AB_1847466, HPA012938: , HPA073222: " "unprognostic (3.16e-1)" "unprognostic (5.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.36e-1)" "unprognostic (4.21e-2)" "unprognostic (5.63e-2)" "unprognostic (2.22e-2)" "unprognostic (8.08e-3)" "unprognostic (2.12e-2)" "unprognostic (2.50e-1)" "unprognostic (3.04e-3)" "unprognostic (4.37e-1)" "unprognostic (2.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-1)" "unprognostic (5.17e-2)" 4.4 11.2 2.3 1.2 11.5 6.1 4.1 1.7 3.3 9.8 0.7 3.1 5.3 3.8 1.3 1.0 2.8 7.3 1.8 1.2 3.9 9.0 2.0 6.0 0.5 6.0 5.0 1.5 0.5 1.9 6.7 3.6 6.9 6.3 7.0 3.3 16.8 2.0 2.3 1.9 1.5 6.8 2.0 1.9 5.4 1.9 6.3 4.8 3.5 0.2 1.2 0.4 2.0 2.7 5.1 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 22.5 0.0 0.0 0.0 16.8 0.2 0.0 0.0 0.4 37.9 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.9 16.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 36.9 29.5 0.0 0.0 0.0 0.1 0.9 26.9 0.0 0.4 0.3 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.2 4.2 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 4.2 0.0 6.4 0.0 0.1 2.3 11.5 1.7 3.3 1.2 3.9 6.0 5.0 1.5 6.3 1.9 4.8 5.1 36.4 0.0 0.6 15.7 0.5 1.7 3.6 0.0 0.0 15.4 19.4 9.3 2.1 1.5 0.0 7.3 4.2 0.0 12.5 0.9 5.9 1.0 88.5 5.0 4.7 34.2 34.1 2.5 77.0 0.0 0.0 4.6 1.1 3.2 5.1 0.3 2.9 0.0 0.2 87.5 28.2 21.4 0.0 1.2 1.2 103.7 3.4 2.5 0.0 143.4 1.1 143.8 0.0 6.6 3.9 0.6 0.3 1.9 0.0 5.8 3.5 6.9 0.7 6.9 13.1 1.5 4.3 58.8 10.2 0.2 1.3 0.0 1.0 1.3 12.6 2.7 TRAJ36 ENSG00000276699 "T cell receptor alpha joining 36" 14 22505110-22505167 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 26.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 24 "memory CD4 T-cell: 61.3;memory CD8 T-cell: 53.5;naive CD4 T-cell: 64.1;naive CD8 T-cell: 46.3;T-reg: 116.9" "Lineage enriched" "Detected in single" 135 "T-cells: 116.9" "Cell line enhanced" "Detected in some" "JURKAT: 6.4;SCLC-21H: 2.2;U-698: 1.2" NA NA "unprognostic (8.03e-3)" 0.0 0.0 0.8 2.2 3.1 3.8 0.6 2.0 1.9 0.0 1.5 0.4 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.8 2.9 0.4 0.0 0.0 3.2 2.8 1.6 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.9 26.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.5 0.0 0.0 1.3 2.0 0.0 0.0 5.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.5 0.0 2.7 0.0 2.5 0.4 61.3 53.5 0.0 0.1 64.1 46.3 0.8 0.1 0.0 0.0 116.9 24.1 0.8 3.1 2.0 1.9 0.8 2.9 2.8 1.6 0.2 1.6 1.6 1.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PADI6 ENSG00000276747 "Peptidyl arginine deiminase 6" Q6TGC4 1 17372196-17401699 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 2.4" "Not detected" "Not detected" NA NA "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (3.02e-2)" "unprognostic (6.56e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.7 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AC136352.2 ENSG00000276760 "POTE ankyrin domain family member B-like" Unmapped 136160-167571 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV4-4 ENSG00000276775 "Immunoglobulin heavy variable 4-4" A0A075B6R2 14 106011922-106012420 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 572.4;urinary bladder: 774.2" "Cell type enriched" "Detected in some" 285 "Plasma cells: 2624.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "midbrain: 3.0" "Group enriched" "Detected in some" 23 "memory B-cell: 56.6;naive B-cell: 31.2" "Lineage enriched" "Detected in many" 30 "B-cells: 56.6" "Cell line enriched" "Detected in some" 18 "Karpas-707: 34.5" "Immunoglobulin genes" NA NA 3800000000 "unprognostic (1.03e-3)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.60e-6)" "unprognostic (2.24e-1)" "unprognostic (6.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.10e-1)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.69e-5)" "unprognostic (3.16e-1)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.05e-1)" 9.5 2.5 0.0 132.7 0.0 18.0 64.2 0.0 0.2 37.9 0.1 207.1 161.3 3.8 0.8 60.3 53.9 105.9 0.8 0.0 0.6 5.4 6.7 37.2 174.6 0.3 3.0 0.0 10.1 6.1 0.4 0.4 0.0 0.1 4.0 141.6 0.0 78.8 15.1 0.3 3.9 79.3 13.5 0.4 187.9 176.6 1.6 0.1 32.1 16.8 0.0 572.4 774.2 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 34.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.6 0.2 0.2 0.0 31.2 0.6 0.0 0.0 0.0 0.0 1.9 0.6 4.1 0.0 0.0 0.0 0.2 0.0 0.6 0.3 3.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2624.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 TRBV15 "TCRBV15S1, TCRBV24S1A3T" ENSG00000276819 "T cell receptor beta variable 15" 7 142592928-142593473 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 67 "lymphoid tissue: 47.3" "Cell type enriched" "Detected in single" 27 "T-cells: 2.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in many" 48 "MAIT T-cell: 21.9;memory CD4 T-cell: 14.6;memory CD8 T-cell: 21.1;naive CD4 T-cell: 18.8;naive CD8 T-cell: 12.3;T-reg: 27.8" "Lineage enriched" "Detected in single" 158 "T-cells: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.07e-2)" "unprognostic (1.03e-3)" "unprognostic (1.89e-3)" "unprognostic (1.39e-3)" "unprognostic (2.09e-4)" "unprognostic (1.08e-2)" "unprognostic (6.75e-2)" "unprognostic (5.47e-3)" "unprognostic (7.77e-2)" "unprognostic (4.14e-2)" "unprognostic (3.86e-1)" "unprognostic (2.52e-3)" "unprognostic (2.38e-1)" "unprognostic (8.34e-2)" "unprognostic (3.23e-1)" "unprognostic (2.55e-2)" 0.0 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 3.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.4 0.1 0.0 47.3 0.1 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.9 0.0 14.6 21.1 0.0 0.0 18.8 12.3 0.1 0.0 0.0 0.0 27.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 H2AC16 "dJ193B12.9, H2A/i, H2AFI, HIST1H2AL" ENSG00000276903 "H2A clustered histone 16" P0C0S8 6 27865317-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.6;brain: 2.8" "Cell type enhanced" "Detected in single" "Extravillous trophoblasts: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 4.8;MOLT-4: 5.2" "Low region specificity" "Detected in single" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.45e-2)" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.46e-3)" "unprognostic (3.17e-1)" "unprognostic (1.82e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-2)" "unprognostic (4.18e-1)" "unprognostic (2.38e-1)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (2.41e-2)" "unprognostic (2.12e-1)" "unprognostic (6.21e-2)" 0.1 0.1 0.6 0.1 0.6 7.6 0.2 0.7 0.5 0.0 1.3 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.3 1.3 0.1 0.1 0.4 0.4 1.4 1.2 0.0 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.3 0.7 0.2 0.3 1.8 0.5 0.0 0.1 0.1 0.0 0.2 2.8 2.8 1.2 0.8 0.0 0.0 0.0 0.5 0.9 0.5 1.5 1.4 0.0 0.7 2.0 0.8 0.2 0.8 0.8 0.0 0.2 1.0 1.9 4.8 0.6 0.2 0.5 0.0 0.4 1.1 0.0 0.0 0.4 0.2 0.0 0.0 1.1 4.5 3.3 0.2 3.0 5.2 3.9 1.6 1.5 0.6 2.6 0.0 0.2 0.3 2.0 1.6 1.4 1.0 0.1 0.4 0.1 0.7 1.1 0.0 0.1 0.0 1.0 1.7 3.7 0.0 4.0 0.8 3.1 0.7 2.0 1.4 1.1 0.1 1.3 0.0 2.4 1.2 1.3 3.6 5.9 0.4 0.7 6.1 0.0 2.9 2.6 1.1 0.7 0.6 0.6 0.7 0.5 0.3 1.3 1.4 1.2 0.0 1.2 1.3 1.8 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 GSTT4 "GSTTP1, HS322B1A" ENSG00000276950 "Glutathione S-transferase theta 4" A0A1W2PR19 22 23998401-24005453 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.66e-2)" "unprognostic (1.77e-2)" "unprognostic (6.83e-4)" "unprognostic (4.36e-1)" "unprognostic (5.47e-1)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV12-4 "TCRBV12S4, TCRBV8S2A1T, TRBV124" ENSG00000276953 "T cell receptor beta variable 12-4" A0A0B4J2E0 7 142563740-142564245 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "lymphoid tissue: 111.3" "Cell type enriched" "Detected in some" 5 "T-cells: 5.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "memory CD4 T-cell: 28.6;memory CD8 T-cell: 38.8;naive CD4 T-cell: 39.7;naive CD8 T-cell: 33.7;T-reg: 54.4" "Lineage enriched" "Detected in single" 68 "T-cells: 54.4" "Cell line enriched" "Detected in some" 11 "LHCN-M2: 51.6" NA NA "unprognostic (6.97e-4)" "unprognostic (1.20e-4)" "unprognostic (7.96e-2)" "unprognostic (1.32e-3)" "unprognostic (3.96e-4)" "unprognostic (1.20e-2)" "unprognostic (5.27e-3)" "unprognostic (1.50e-2)" "unprognostic (9.59e-4)" "unprognostic (1.53e-2)" "unprognostic (1.25e-1)" "unprognostic (8.22e-5)" "unprognostic (4.32e-2)" "unprognostic (5.32e-3)" "unprognostic (1.44e-1)" "unprognostic (5.08e-3)" 0.5 0.0 0.0 6.3 0.0 1.3 0.7 0.0 0.2 0.4 0.1 1.2 0.3 0.4 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.1 1.2 1.1 21.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.2 0.2 0.1 0.3 2.5 0.1 0.0 2.8 2.3 0.6 0.0 111.3 0.3 0.2 2.3 1.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.7 0.0 4.2 1.9 0.4 1.9 0.2 0.0 0.2 51.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 28.6 38.8 0.0 0.0 39.7 33.7 0.7 0.0 0.0 0.2 54.4 10.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 H4C5 "H4/j, H4FJ, HIST1H4E" ENSG00000276966 "H4 clustered histone 5" P62805 6 26204552-26206038 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 67.5" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.2;Cytotrophoblasts: 2.7;dendritic cells: 1.8;Extravillous trophoblasts: 1.6;Hofbauer cells: 4.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 67.5" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 6.1;U-266/70: 11.3" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (8.62e-2)" "unprognostic (4.86e-2)" "unprognostic (5.71e-3)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" "unprognostic (5.08e-3)" "unprognostic (7.99e-2)" "unprognostic (1.21e-1)" "unprognostic (6.57e-2)" "unprognostic (2.34e-3)" "unprognostic (4.34e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" 0.4 0.5 5.5 0.4 11.7 2.1 0.8 67.5 12.2 2.9 0.0 1.4 1.0 0.5 0.8 2.6 2.7 0.2 0.9 6.8 6.4 1.6 1.0 1.0 0.5 2.2 6.1 3.4 2.8 0.5 0.2 2.2 0.5 15.5 7.6 0.5 1.5 1.3 0.3 0.0 1.1 0.9 0.2 12.1 1.6 1.6 2.0 4.1 1.9 1.5 0.0 0.4 0.6 3.7 11.0 1.1 0.7 1.3 3.1 0.5 0.0 0.7 1.1 0.3 0.5 0.4 0.4 1.1 0.4 1.5 0.3 0.7 1.9 0.7 0.1 0.7 0.9 0.8 0.3 1.5 0.7 0.0 0.5 1.2 0.3 0.0 0.4 0.3 0.3 0.4 1.0 2.3 2.6 0.1 0.4 6.1 2.8 1.3 0.5 1.0 2.7 1.4 2.7 0.5 0.4 3.7 0.9 0.8 1.3 0.4 0.4 1.2 0.5 0.5 1.5 2.1 0.4 0.9 11.3 4.7 1.7 0.3 1.1 1.1 2.7 2.1 1.8 2.0 1.8 2.9 2.5 3.0 2.0 3.1 5.4 3.2 2.6 2.6 2.3 5.5 2.7 2.0 1.2 5.5 11.7 67.5 12.2 6.8 6.4 2.2 6.1 3.4 15.5 12.1 4.1 11.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 HNRNPCL3 ENSG00000277058 "Heterogeneous nuclear ribonucleoprotein C like 3" B7ZW38 1 13060769-13062878 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.30e-2)" "unprognostic (3.33e-2)" "unprognostic (2.90e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AC8 "H2A.1, H2A/a, H2AFA, HIST1H2AE" ENSG00000277075 "H2A clustered histone 8" P04908 6 26216975-26217483 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.5;breast: 41.1" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8" "Cancer enhanced" "Detected in all" "prostate cancer: 40.9" "Region enhanced" "Detected in many" "cerebellum: 40.5" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.0" "CAB012242, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012242: AB_470265, HPA041189: AB_2677357" "unprognostic (4.26e-2)" "unprognostic (1.55e-2)" "unprognostic (4.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (1.50e-1)" "unprognostic (2.48e-2)" "unprognostic (7.22e-2)" "unprognostic (1.24e-2)" "unprognostic (6.99e-2)" "unprognostic (1.21e-3)" "unprognostic (1.30e-2)" "unprognostic (7.64e-2)" "unprognostic (1.15e-1)" "unprognostic (2.41e-1)" "unprognostic (2.20e-1)" "unprognostic (9.36e-2)" 2.3 2.4 1.8 1.6 5.1 19.4 41.1 40.5 6.7 11.8 3.4 5.5 3.7 1.6 16.9 8.7 7.8 1.8 3.9 3.7 5.2 5.7 5.7 8.0 2.9 0.2 2.5 3.2 6.8 1.0 0.4 3.4 1.6 4.0 33.1 2.1 1.5 4.8 1.2 0.3 11.4 4.7 0.6 2.3 9.6 5.3 4.3 2.7 9.4 5.9 0.1 0.8 2.3 17.6 10.5 4.1 0.0 3.0 0.0 4.9 0.9 0.8 1.3 2.0 4.3 2.9 2.0 3.3 0.2 10.8 0.4 3.9 3.4 1.5 2.0 1.7 4.5 3.7 2.7 5.9 2.6 0.9 0.3 4.1 8.4 0.9 1.8 0.2 1.2 2.1 0.8 11.4 2.9 0.4 7.5 9.3 7.9 3.5 14.1 3.7 7.3 2.4 14.7 1.8 2.3 11.9 5.0 10.9 3.7 2.4 2.0 14.9 4.1 0.0 0.2 0.8 1.8 1.8 37.0 0.0 0.0 1.5 5.5 2.7 18.2 2.2 8.2 2.8 2.6 4.1 4.7 3.3 4.6 5.9 6.0 1.7 2.3 10.1 4.5 1.6 17.6 4.4 10.4 1.8 5.1 40.5 6.7 3.7 5.2 0.2 2.5 3.2 4.0 2.3 2.7 10.5 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 FP565260.3 ENSG00000277117 "ICOS ligand" 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enriched" "Detected in single" 6 "monocytes: 4.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.8;REH: 18.5;SiHa: 15.6" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "HPA029179: AB_2732445" "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 2.1 1.5 9.0 4.7 10.9 3.7 2.4 7.5 6.4 2.9 2.2 2.9 4.9 1.4 0.7 3.4 2.5 3.2 3.6 5.0 10.9 4.7 2.9 1.9 5.5 11.4 9.9 3.1 0.3 1.3 0.4 1.2 2.5 14.0 2.1 2.1 0.0 2.2 1.5 0.7 3.8 3.5 1.4 7.4 3.2 4.9 0.8 9.0 1.9 2.2 1.1 6.4 3.1 2.6 16.8 0.3 0.8 0.0 1.5 0.4 0.9 22.8 1.8 1.4 0.2 0.1 5.5 0.9 12.7 3.8 0.1 2.8 4.2 1.4 1.9 0.3 0.4 1.3 0.0 0.6 2.9 0.2 9.7 8.8 0.2 2.2 1.2 1.1 0.0 1.2 0.0 1.5 0.5 0.1 3.1 0.0 5.6 0.9 15.1 7.6 18.5 0.6 12.7 0.5 7.6 1.0 0.0 15.6 12.9 0.3 0.8 4.4 12.5 0.4 0.0 3.4 0.0 0.3 8.9 9.5 8.2 9.0 5.6 2.0 0.0 0.3 0.0 0.0 1.2 0.1 1.2 0.2 0.0 0.3 2.1 0.0 0.2 0.0 0.0 0.2 0.4 0.5 0.5 9.0 10.9 7.5 6.4 5.0 10.9 11.4 9.9 3.1 14.0 7.4 9.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" Q6NUM6 7 72558744-72828200 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 21.9;Excitatory neurons: 47.4;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.1 1.8 2.3 1.3 2.2 2.9 2.5 1.9 2.6 3.9 5.8 1.8 1.0 2.4 2.9 2.1 2.3 0.9 1.5 2.5 2.2 1.7 4.5 1.6 1.7 1.8 1.5 1.8 5.3 2.0 1.8 2.2 1.8 2.0 2.6 2.5 2.6 1.9 2.7 3.4 2.5 1.7 1.3 1.3 2.0 2.0 3.0 1.7 2.4 3.4 1.1 2.6 2.6 3.1 3.1 2.4 2.5 1.0 2.0 1.5 0.5 1.1 1.2 0.5 1.0 1.1 8.0 4.1 7.4 0.7 0.8 1.0 1.1 1.9 0.8 1.2 8.0 2.3 0.7 1.2 4.7 0.8 7.6 2.0 3.6 0.5 1.2 0.8 0.6 0.7 1.6 10.3 7.5 1.0 1.0 2.5 3.8 1.8 3.1 4.5 1.4 5.4 2.7 1.1 0.8 1.7 0.9 1.5 8.2 4.5 3.1 2.1 2.6 3.1 1.8 4.1 9.4 1.4 6.5 8.4 8.2 0.5 2.1 9.5 3.0 1.9 3.3 1.5 0.8 1.3 4.7 0.9 0.9 0.7 2.3 1.1 1.4 2.2 1.2 0.8 2.9 1.0 0.6 2.3 2.2 1.9 2.6 2.5 2.2 1.8 1.5 1.8 2.0 1.3 1.7 3.1 3.5 0.0 2.0 21.9 7.2 0.0 1.8 0.0 2.2 4.3 3.4 3.4 5.3 2.8 0.6 0.0 10.4 4.8 5.4 2.1 0.0 2.9 4.9 3.6 7.6 3.2 0.0 3.2 47.4 0.7 1.7 3.3 4.6 5.3 1.3 2.0 1.8 2.7 3.1 1.7 27.7 2.9 0.0 1.0 0.0 1.1 0.9 3.0 0.0 15.0 3.2 0.9 2.1 23.1 41.4 0.8 2.3 0.7 5.8 2.2 2.0 0.7 1.5 8.0 0.0 6.9 5.2 5.6 5.2 5.4 0.0 1.9 5.1 5.4 2.2 1.1 F8A3 ENSG00000277150 "Coagulation factor VIII associated 3" P23610 X 155456914-155458620 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 10.0;dendritic cells: 4.9;Erythroid cells: 8.2;Kupffer cells: 5.1;Plasma cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "eosinophil: 3.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "OE19: 35.9;U-266/70: 43.1;U-266/84: 43.1" NA NA "unprognostic (1.83e-1)" "unprognostic (9.94e-2)" "unprognostic (3.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.94e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (7.03e-2)" "unprognostic (2.03e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-1)" "unprognostic (7.96e-2)" 7.2 6.5 5.7 5.2 6.3 7.1 5.5 4.7 11.0 4.6 4.4 5.6 4.3 5.4 5.0 4.9 4.4 4.1 6.4 7.2 5.6 6.1 11.1 4.2 4.8 5.7 5.2 5.0 3.7 6.6 18.0 3.1 2.9 6.4 4.0 2.6 3.4 5.8 2.9 12.1 4.0 5.6 0.9 4.7 6.5 5.4 1.6 7.7 8.0 5.4 5.0 2.3 4.6 3.8 10.0 0.3 0.1 2.2 0.0 8.9 6.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 12.3 0.1 15.4 0.0 12.1 2.6 0.0 0.0 0.0 6.0 16.0 10.2 0.1 10.1 22.1 7.5 0.0 0.0 9.4 7.1 0.0 5.9 0.0 0.0 0.0 15.5 0.0 23.2 0.1 4.2 35.9 0.0 0.1 0.0 11.9 9.3 7.8 0.0 4.4 8.4 0.0 0.0 19.8 0.0 13.8 5.4 21.1 0.0 15.3 25.4 43.1 43.1 0.1 6.3 0.0 0.1 0.0 0.3 3.2 0.7 0.1 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.4 0.5 0.1 0.2 0.4 0.1 0.1 5.7 6.3 4.7 11.0 7.2 5.6 5.7 5.2 5.0 6.4 4.7 7.7 10.0 1.3 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.6 1.8 1.7 0.6 0.2 10.0 0.0 1.8 0.0 2.0 4.9 2.2 0.0 0.6 0.0 0.2 0.2 0.9 0.0 8.2 0.0 1.5 1.5 1.2 1.1 0.1 0.0 0.1 0.7 3.8 2.3 0.0 0.0 1.3 0.0 5.1 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.6 2.1 0.0 0.0 1.3 0.3 0.0 4.8 0.4 1.2 2.6 0.0 0.9 0.0 1.8 0.8 0.0 0.0 2.1 0.0 2.9 3.4 0.2 0.8 0.3 H4C4 "H4/b, H4FB, HIST1H4D" ENSG00000277157 "H4 clustered histone 4" P62805 6 26188710-26189112 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 33.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "naive B-cell: 3.4" "Lineage enriched" "Detected in single" 4 "B-cells: 3.4" "Cell line enhanced" "Detected in many" "HEK 293: 5.2;HeLa: 5.0;RT4: 8.9" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.09e-2)" "unprognostic (1.98e-2)" "unprognostic (2.06e-2)" "unprognostic (7.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.30e-1)" "unprognostic (7.77e-4)" "unprognostic (1.56e-1)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (6.11e-3)" 0.1 0.5 5.7 0.0 18.2 0.8 0.8 33.1 7.1 0.2 3.6 0.2 0.0 0.2 0.3 0.6 0.7 0.1 0.1 5.7 4.1 0.2 0.4 0.4 0.2 3.4 4.2 5.0 0.1 0.1 0.1 0.3 0.2 9.8 1.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 14.4 0.6 0.2 0.4 5.0 2.1 0.5 0.0 0.1 0.0 0.4 3.4 1.0 1.1 0.8 0.0 1.3 0.0 0.5 0.7 0.4 1.9 0.9 1.8 0.4 4.0 0.3 0.0 1.5 0.5 2.3 0.4 0.6 0.3 5.2 0.6 5.0 1.7 0.0 0.4 0.1 0.4 0.0 0.2 0.7 0.0 1.6 0.5 1.3 1.1 0.0 1.9 1.5 2.7 1.4 0.9 0.3 0.4 0.0 0.5 0.5 8.9 0.5 0.3 0.8 0.5 0.5 0.6 0.9 0.3 0.0 0.4 2.9 0.3 1.1 1.2 1.2 0.0 0.8 1.1 0.7 0.0 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.2 0.2 3.4 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.3 5.7 18.2 33.1 7.1 5.7 4.1 3.4 4.2 5.0 9.8 14.4 5.0 3.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36534987-36539310 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" No Yes "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 4.3 3.9 1.1 3.9 1.2 2.8 3.9 1.4 1.6 3.1 1.6 3.6 2.6 4.2 2.0 7.5 3.4 1.9 3.6 1.1 1.4 4.1 6.5 3.8 3.8 1.6 1.2 0.9 2.6 4.7 2.6 4.0 2.0 1.7 3.3 3.6 1.8 5.0 1.3 8.3 5.7 4.3 2.6 1.2 4.4 4.5 2.8 1.4 2.2 4.2 3.5 3.5 3.6 4.3 1.3 10.8 15.2 9.0 9.2 4.9 4.2 15.0 11.6 6.2 12.2 9.3 11.7 12.2 19.9 3.8 7.9 14.9 15.7 16.5 8.0 16.1 11.3 23.3 14.7 7.3 11.0 3.8 32.2 17.2 5.2 9.6 12.5 5.4 2.5 7.9 6.3 26.9 9.5 8.9 10.1 16.4 11.2 16.5 7.5 13.0 15.3 24.0 18.8 7.6 11.6 20.7 16.7 21.0 8.6 9.3 8.4 27.8 4.7 10.4 21.7 29.1 20.8 26.1 8.8 32.8 22.0 5.2 18.0 19.6 0.8 1.7 0.3 2.0 2.7 2.8 1.5 2.6 2.1 3.5 2.9 3.2 3.1 0.4 2.6 3.5 2.1 1.6 2.2 1.1 1.2 1.4 1.6 1.1 1.4 1.6 1.2 0.9 1.7 1.2 1.4 1.3 3.6 3.2 3.1 1.6 4.6 3.4 9.5 4.6 12.5 2.2 4.3 2.9 1.6 10.0 4.2 0.0 0.0 6.1 5.4 2.9 7.9 6.8 0.2 2.4 3.6 4.7 1.2 12.6 2.0 6.4 6.7 3.8 5.1 2.7 0.0 2.3 1.1 6.0 4.5 3.3 2.6 4.0 0.0 3.3 2.2 0.6 2.8 3.5 0.0 0.0 3.1 4.2 1.0 1.5 2.5 7.1 3.6 2.2 4.9 10.2 1.0 4.9 2.8 3.1 0.0 3.7 3.6 3.4 7.4 9.4 6.8 4.1 3.1 3.5 5.6 5.3 AC007325.2 ENSG00000277196 "Proline dehydrogenase 1, mitochondrial" Unmapped 138082-161852 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 114.7;choroid plexus: 183.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 5.9;Distal tubular cells: 7.9;Endometrial ciliated cells: 2.5;Proximal enterocytes: 5.6;Squamous epithelial cells: 2.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "OE19: 345.1;RPTEC TERT1: 183.1" HPA020361 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" 2.2 0.6 71.2 0.8 68.0 0.7 3.3 64.2 114.7 1.0 183.1 1.1 29.2 0.5 0.1 6.9 1.4 0.4 9.6 79.1 60.7 12.5 6.0 18.9 1.1 74.9 65.0 59.8 0.0 0.1 0.1 0.9 86.4 0.9 1.4 2.0 0.7 2.4 10.2 32.9 33.5 0.2 58.3 0.7 0.8 2.0 70.7 5.6 4.6 24.2 6.4 2.0 68.7 0.0 8.3 0.3 2.5 5.0 0.0 1.6 0.0 0.0 0.0 0.0 5.3 1.8 0.0 0.5 0.0 0.2 10.0 18.8 0.5 0.0 0.0 0.7 0.0 0.2 0.9 3.6 0.0 0.1 0.4 18.5 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 1.5 0.2 0.0 17.5 345.1 0.0 0.1 0.1 0.0 183.1 0.7 0.4 0.5 0.0 6.9 1.5 18.8 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.2 68.0 64.2 114.7 79.1 60.7 74.9 65.0 59.8 86.4 58.3 70.7 68.7 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 2.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.2 0.1 F8A1 "DXS522E, F8A" ENSG00000277203 "Coagulation factor VIII associated 1" P23610 X 154886349-154888061 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 49.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (6.72e-2)" "prognostic favorable (1.67e-6)" "unprognostic (2.92e-2)" "unprognostic (2.57e-1)" "unprognostic (6.88e-2)" "unprognostic (6.61e-2)" "unprognostic (4.18e-3)" "unprognostic (3.31e-2)" "unprognostic (7.96e-2)" "unprognostic (9.23e-3)" "unprognostic (1.20e-1)" "unprognostic (1.80e-1)" "unprognostic (3.68e-2)" "unprognostic (6.28e-2)" "unprognostic (6.16e-2)" "unprognostic (5.61e-2)" "unprognostic (2.69e-1)" 22.0 23.9 30.7 13.0 31.9 33.4 21.2 27.5 39.8 14.0 23.9 19.3 15.3 19.0 22.9 17.8 13.4 7.4 21.7 33.3 31.3 22.9 45.0 17.2 19.4 32.1 30.9 34.0 8.8 22.4 14.1 13.8 13.1 33.5 16.5 15.1 14.9 22.0 18.3 27.9 16.7 20.2 14.9 28.7 23.2 15.7 5.8 33.8 20.8 19.7 18.3 20.1 19.5 13.4 36.2 106.4 47.2 9.1 14.7 31.3 14.8 0.2 27.5 22.9 27.8 36.0 18.6 40.2 11.4 87.9 16.7 36.3 11.0 13.3 12.7 22.8 63.3 6.3 11.6 13.3 18.8 9.5 21.1 5.6 28.6 11.6 9.2 5.2 20.6 6.0 29.1 1.2 41.8 16.2 53.8 34.0 94.9 16.3 0.0 54.7 64.1 9.0 10.0 31.8 35.9 45.7 19.0 16.7 20.1 36.4 0.0 23.7 41.6 17.1 15.7 36.0 11.6 22.1 41.6 43.9 101.4 8.3 76.7 36.0 0.0 3.0 6.8 2.9 3.1 1.6 1.5 3.2 3.5 3.5 2.5 3.6 4.0 6.0 0.8 1.2 4.2 1.6 1.7 30.7 31.9 27.5 39.8 33.3 31.3 32.1 30.9 34.0 33.5 28.7 33.8 36.2 5.5 12.8 2.6 5.5 14.4 6.6 5.2 1.8 2.2 12.1 14.4 12.4 13.6 27.1 1.5 40.5 6.2 4.0 19.5 11.9 49.0 2.7 0.3 9.2 11.9 7.1 6.7 9.5 7.2 2.0 6.2 7.4 6.6 9.7 5.7 7.6 7.5 24.6 11.2 3.3 6.1 10.2 4.1 27.3 16.8 1.5 10.8 16.9 10.6 7.5 16.7 7.3 30.9 6.6 9.6 2.5 5.7 12.4 4.7 3.1 10.4 57.9 2.7 7.0 6.6 4.6 6.1 0.4 1.5 7.6 6.5 1.6 19.0 8.9 9.8 2.8 H2BC7 "H2B/g, H2BFG, HIST1H2BF" ENSG00000277224 "H2B clustered histone 7" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 7.4" "Cell type enhanced" "Detected in single" "Hofbauer cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "U-266/70: 24.8;U-266/84: 18.8" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 0.2 0.5 0.2 0.9 1.3 1.7 4.0 0.9 2.3 1.2 0.9 0.0 0.1 0.0 3.2 1.8 0.2 0.3 1.0 0.5 1.0 0.6 1.7 0.3 1.6 1.0 0.2 0.8 0.2 0.0 0.6 0.2 1.5 7.4 0.3 0.6 1.1 0.0 0.0 0.5 0.7 0.0 2.0 2.4 0.7 0.6 1.7 1.7 0.6 0.1 0.4 0.4 4.5 2.0 0.5 0.3 0.2 0.5 0.3 0.0 0.2 0.2 0.1 0.7 0.1 0.7 0.1 0.6 1.0 0.0 0.3 1.0 0.5 0.1 0.3 0.8 0.2 0.4 1.8 0.2 0.1 0.1 0.9 0.3 0.1 0.2 0.1 0.0 0.1 0.5 2.0 4.5 0.0 0.1 4.0 1.6 0.6 0.8 0.6 1.5 0.7 3.0 0.1 0.1 2.4 0.4 4.9 0.9 0.1 0.3 4.4 0.2 0.1 0.3 2.2 0.0 0.6 24.8 18.8 1.3 0.1 1.2 0.5 0.0 0.0 0.6 0.2 0.1 0.6 0.2 0.2 0.3 0.1 1.0 0.2 0.5 2.4 0.2 0.3 0.3 0.2 0.5 0.5 0.9 4.0 0.9 1.0 0.5 1.6 1.0 0.2 1.5 2.0 1.7 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 PCGF2 "MEL-18, RNF110, ZNF144" ENSG00000277258 "Polycomb group ring finger 2" P35227 17 38733898-38749817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047732, HPA063531" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA047732: AB_2680138, HPA063531: AB_2685031" "unprognostic (1.56e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.45e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-3)" "unprognostic (2.47e-2)" "unprognostic (7.78e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (5.10e-3)" "unprognostic (8.18e-2)" "unprognostic (6.12e-2)" "unprognostic (7.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" 30.7 38.6 3.2 4.6 2.7 0.0 33.3 7.0 5.6 44.5 4.1 24.1 3.8 40.9 2.4 21.6 36.2 6.1 36.0 2.8 3.8 56.5 13.0 33.7 2.2 2.0 2.5 2.3 40.8 23.1 2.9 56.0 6.8 3.3 37.9 1.6 7.2 22.8 2.8 9.4 20.8 22.9 2.1 0.8 28.5 25.6 13.4 2.8 0.2 42.0 0.9 0.8 27.5 31.1 2.9 16.9 38.2 9.2 34.5 7.2 2.3 11.7 13.1 6.2 6.2 7.4 21.1 17.6 1.3 14.3 4.2 16.3 26.2 3.4 6.1 2.5 10.4 20.1 7.9 20.7 52.4 2.3 1.2 9.4 2.5 2.8 9.0 6.1 9.6 7.5 7.9 14.9 21.2 3.9 37.8 1.5 0.2 11.7 7.4 15.3 12.6 14.7 3.3 3.2 22.5 16.4 26.8 12.6 9.0 20.8 9.0 35.4 1.6 22.0 24.8 27.1 24.8 23.2 12.5 4.1 4.3 13.3 2.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2.7 7.0 5.6 2.8 3.8 2.0 2.5 2.3 3.3 0.8 2.8 2.9 49.6 3.2 16.0 2.0 1.1 14.1 11.2 19.7 23.9 59.9 20.6 17.0 2.1 15.7 10.1 20.2 10.4 13.3 0.8 23.7 52.8 24.9 15.1 8.0 22.1 46.4 13.2 0.0 6.5 13.7 26.7 21.9 12.8 12.8 1.3 14.0 51.0 2.9 4.8 35.3 7.0 12.5 22.4 2.9 5.5 5.0 37.0 2.9 14.2 6.5 3.2 26.4 2.1 9.5 2.4 18.9 10.3 29.3 3.8 15.4 22.3 59.6 5.0 16.5 0.0 16.8 16.7 6.1 15.7 9.6 16.9 22.2 0.9 13.3 13.2 11.1 FAM243B ENSG00000277277 "Family with sequence similarity 243 member B" P0DPQ4 21 7768884-7770591 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 1.4" HPA045123 Uncertain NA NA "HPA045123: AB_10961912" 0.9 0.9 0.1 0.4 0.1 0.0 1.1 0.4 0.6 1.5 0.4 1.2 1.1 1.3 0.0 0.7 1.4 0.8 1.0 0.7 0.0 1.0 0.7 0.8 1.1 0.0 0.2 0.1 1.7 1.2 0.0 1.2 0.3 0.3 1.2 0.0 2.4 1.4 0.0 1.6 1.2 0.9 0.0 0.0 0.9 4.7 2.1 0.1 0.0 1.7 0.0 0.0 1.1 1.1 1.0 0.3 0.7 0.3 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.3 1.0 0.0 1.0 0.5 0.3 0.5 0.1 1.4 0.4 0.1 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.6 0.7 0.0 0.0 0.2 0.1 0.3 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1OR21-1 IGHV1/OR21-1 ENSG00000277282 "Immunoglobulin heavy variable 1/OR21-1 (non-functional)" 21 10649400-10649835 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.3;lymphoid tissue: 6.4;stomach 1: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "lung cancer: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "memory B-cell: 2.0;naive B-cell: 1.7" "Lineage enriched" "Detected in single" 15 "B-cells: 2.0" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" NA NA "unprognostic (3.93e-3)" "unprognostic (2.55e-2)" "unprognostic (1.28e-2)" "unprognostic (8.48e-5)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (3.32e-1)" 0.0 0.6 0.0 3.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 3.3 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.0 1.0 3.4 0.1 0.0 0.5 0.0 0.0 6.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L6 FLJ36131 ENSG00000277322 "Golgin A6 family like 6" A8MZA4 15 20531856-20541800 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 41 "testis: 5.2" "Cell type enriched" "Detected in some" 7 "Early spermatids: 27.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "HPA047733: " "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRCIN1 "KIAA1684, p140Cap, SNIP" ENSG00000277363 "SRC kinase signaling inhibitor 1" Q9C0H9 17 38530031-38605952 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 67.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 66.3;Horizontal cells: 102.6;Inhibitory neurons: 58.5;Oligodendrocytes: 261.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009701, HPA063795" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA009701: AB_1857324, HPA063795: AB_2685124" "unprognostic (4.53e-1)" "unprognostic (4.05e-1)" "unprognostic (2.45e-2)" "unprognostic (3.24e-4)" "unprognostic (4.10e-2)" "unprognostic (3.72e-3)" "unprognostic (1.53e-1)" "unprognostic (2.84e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-4)" "unprognostic (1.00e-1)" "unprognostic (5.07e-3)" "unprognostic (9.51e-2)" "unprognostic (6.50e-2)" "unprognostic (2.67e-2)" "prognostic favorable (1.76e-4)" 1.8 1.3 13.2 0.1 27.6 0.2 3.1 21.8 29.4 1.7 0.0 3.3 0.6 1.0 0.6 2.2 3.1 0.0 1.4 14.4 16.9 0.8 14.1 1.3 0.2 35.1 29.5 10.5 0.5 6.6 2.4 15.6 0.2 35.3 2.3 0.2 0.4 7.9 0.8 0.5 5.9 1.5 0.1 18.8 0.6 2.1 1.4 28.0 0.1 0.7 0.0 0.0 1.7 1.1 67.0 0.4 0.4 0.6 2.7 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.4 1.1 0.9 0.0 0.7 1.0 1.2 0.2 0.1 1.1 1.2 0.0 0.5 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.5 0.1 3.9 0.0 2.4 0.0 0.0 1.5 0.5 0.0 0.1 0.0 0.1 0.4 1.7 18.0 2.0 0.0 1.0 0.7 0.6 1.8 0.4 0.0 0.0 1.2 0.0 0.0 0.8 0.2 0.0 0.1 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 27.6 21.8 29.4 14.4 16.9 35.1 29.5 10.5 35.3 18.8 28.0 67.0 0.4 0.0 1.1 5.5 0.3 0.8 1.0 0.3 0.6 31.5 6.1 5.1 2.9 21.5 0.3 3.7 0.0 0.1 0.3 0.7 0.0 2.7 0.2 9.0 1.0 0.6 9.7 0.0 66.3 0.2 0.1 0.9 0.0 0.9 0.0 2.7 0.4 12.6 0.4 102.6 58.5 1.8 2.0 0.0 0.4 0.6 0.6 0.1 0.0 3.7 0.0 1.8 0.0 6.6 261.8 0.3 0.3 0.4 0.1 1.4 0.6 0.2 5.3 3.4 0.0 0.4 0.5 0.9 2.1 0.8 0.9 0.1 0.2 0.0 1.5 1.6 GPR179 "CSNB1E, GPR158L1" ENSG00000277399 "G protein-coupled receptor 179" 17 38324571-38343956 "Human disease related genes, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "retina: 14.0" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 25.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA017885 Uncertain NA NA "HPA017885: AB_2279357" "unprognostic (1.65e-1)" "unprognostic (2.27e-1)" "unprognostic (1.24e-4)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (3.04e-2)" "unprognostic (4.76e-2)" "unprognostic (2.34e-2)" "unprognostic (6.57e-3)" "unprognostic (5.31e-2)" "unprognostic (5.09e-10)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.41e-4)" 0.0 0.0 0.9 0.0 0.7 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.3 0.8 0.5 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 14.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.3 0.8 1.1 1.2 0.3 0.8 0.5 0.5 0.8 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC145212.1 ENSG00000277400 Q8WZ33 Unmapped 53590-115018 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 5.5;Basal respiratory cells: 8.0;Club cells: 4.6;Ionocytes: 8.2;Langerhans cells: 8.0;Melanocytes: 3.6;Respiratory ciliated cells: 5.4;Suprabasal keratinocytes: 6.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 14.1" "Intracellular and membrane" NA NA 3.8 3.2 6.5 2.1 7.3 0.9 1.6 6.4 8.6 3.3 4.9 1.6 1.7 2.6 1.4 5.1 4.3 3.0 3.2 6.6 6.5 1.7 0.9 3.5 4.2 9.4 7.8 5.2 6.5 2.9 3.0 2.3 10.8 3.5 1.1 2.7 4.4 2.1 3.2 4.3 2.8 2.4 6.7 4.6 1.2 3.9 7.9 0.6 3.1 2.0 2.2 2.7 15.2 0.0 2.8 0.0 0.9 0.0 0.0 2.7 3.0 3.7 1.5 1.1 10.4 7.1 0.5 3.5 3.5 0.9 1.5 4.0 2.6 0.4 0.0 3.8 3.7 6.1 14.1 0.2 0.0 8.3 0.9 10.6 2.2 0.0 4.0 3.1 0.0 9.6 2.0 3.9 7.3 9.5 1.7 0.2 3.7 0.6 0.0 4.8 3.5 4.4 0.6 3.2 6.9 0.0 3.0 1.6 0.7 5.2 0.6 5.9 3.4 3.6 1.1 3.9 5.2 1.1 0.0 9.3 0.5 2.6 0.0 0.4 0.2 0.4 0.3 0.1 0.4 0.2 0.3 0.8 0.4 0.5 0.2 0.1 0.7 0.3 1.3 0.8 0.3 6.5 7.3 6.4 8.6 6.6 6.5 9.4 7.8 5.2 10.8 6.7 7.9 15.2 0.4 0.0 0.5 0.0 0.0 5.5 0.0 8.0 0.0 0.0 0.3 0.1 0.0 0.0 4.6 0.0 0.0 0.3 0.0 0.0 0.0 2.9 0.0 0.6 0.7 0.5 0.0 0.0 0.0 1.6 0.2 1.2 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 8.2 0.0 8.0 0.0 0.0 0.4 3.6 0.0 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 5.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 6.1 0.4 0.5 0.0 0.0 0.0 MARCKS "80K-L, MACS, PKCSL" ENSG00000277443 "Myristoylated alanine rich protein kinase C substrate" P29966 6 113857345-113863475 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 12.7;neutrophil: 18.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 405.8;TIME: 326.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022062, HPA054820, HPA067595, HPA069443" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 19000000 "Plasma membrane" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133" "unprognostic (4.71e-1)" "unprognostic (1.91e-2)" "unprognostic (2.46e-1)" "unprognostic (5.51e-3)" "unprognostic (8.22e-3)" "unprognostic (2.38e-2)" "prognostic unfavorable (2.78e-8)" "unprognostic (7.82e-2)" "unprognostic (2.57e-1)" "unprognostic (6.92e-2)" "unprognostic (2.27e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.36e-3)" "unprognostic (2.77e-2)" "unprognostic (8.07e-2)" "unprognostic (2.70e-2)" 43.1 17.0 70.8 58.7 68.4 105.5 50.7 78.2 79.1 29.2 27.6 76.4 39.3 31.5 13.7 45.4 27.6 36.1 18.1 61.6 83.9 18.1 26.4 35.3 45.8 80.6 80.5 66.6 39.4 42.8 7.1 20.8 63.5 77.9 38.1 68.8 22.2 28.3 18.1 15.8 32.4 43.6 30.4 104.6 57.5 63.4 10.4 78.4 45.3 16.3 13.0 45.7 87.0 34.8 113.1 39.2 22.6 405.8 22.3 134.0 86.6 2.2 123.0 171.4 84.9 140.6 40.7 54.1 0.1 25.3 228.0 67.3 118.0 67.9 35.7 109.7 0.3 40.2 0.0 22.2 53.3 89.2 10.3 0.7 90.2 68.8 81.8 77.4 231.9 243.1 0.4 4.6 107.6 122.1 0.4 1.3 0.3 52.7 43.5 29.4 0.2 40.7 4.1 26.9 73.6 56.4 163.4 78.7 39.6 89.6 95.0 2.1 11.3 326.0 78.3 0.5 129.9 212.7 288.3 22.4 11.4 60.2 55.8 153.4 0.0 3.9 0.0 0.0 12.7 0.0 4.6 0.0 0.0 1.1 1.9 0.0 0.0 18.7 0.0 7.5 0.0 0.0 0.5 70.8 68.4 78.2 79.1 61.6 83.9 80.6 80.5 66.6 77.9 104.6 78.4 113.1 211.2 9.6 15.5 44.7 139.0 504.1 540.7 232.3 275.4 157.0 213.2 176.7 16.6 57.2 115.0 38.6 29.2 7.2 5.5 629.5 37.2 144.3 55.7 111.2 444.0 271.6 336.3 2.5 33.0 229.9 11.2 372.6 135.1 130.4 2.5 526.1 236.0 8.8 371.6 84.1 21.0 369.4 126.1 286.3 605.5 35.7 120.5 381.3 273.9 60.0 447.2 315.5 2.1 194.5 9.7 208.1 223.1 67.0 105.2 380.1 89.9 6.9 145.0 37.7 39.5 89.8 222.8 22.7 16.2 326.3 638.5 29.4 22.3 62.3 352.3 620.2 ZNF670 MGC12466 ENSG00000277462 "Zinc finger protein 670" Q9BS34 1 247034637-247078811 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 24.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA003142 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003142: AB_1859404" "unprognostic (2.11e-1)" "unprognostic (8.04e-3)" "unprognostic (2.05e-3)" "unprognostic (9.98e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-1)" "unprognostic (1.26e-2)" "unprognostic (1.50e-2)" "unprognostic (1.63e-2)" "unprognostic (3.23e-2)" "unprognostic (9.88e-2)" "unprognostic (5.21e-3)" "unprognostic (2.19e-2)" "unprognostic (1.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "unprognostic (1.39e-2)" 2.2 1.5 0.6 1.1 0.9 0.5 2.3 2.8 1.2 1.5 0.3 1.5 1.0 2.3 0.6 1.2 1.6 1.4 1.1 0.9 0.8 1.4 1.7 1.5 1.5 0.5 1.0 0.9 2.1 1.8 1.6 1.0 0.7 1.1 1.3 1.3 2.2 1.5 1.2 1.0 1.5 1.5 1.7 0.5 1.4 2.0 2.3 0.8 1.9 1.4 1.5 1.7 1.7 1.5 1.0 2.7 1.7 5.7 6.9 1.3 1.9 12.0 3.1 2.0 3.7 3.6 2.4 2.5 4.5 6.2 1.9 2.2 2.1 6.3 2.4 6.8 3.1 0.7 4.1 1.4 3.4 1.1 4.6 2.6 1.2 2.5 2.3 4.9 0.6 2.4 3.8 5.4 1.9 3.9 1.1 5.7 2.4 9.8 5.5 3.6 5.7 7.5 3.9 2.2 5.7 6.7 5.4 4.5 1.8 2.6 3.0 1.9 9.3 1.7 2.5 2.4 1.8 3.6 3.8 6.8 8.0 0.9 3.4 3.0 0.0 0.6 0.5 1.2 0.7 0.6 2.1 1.1 1.3 1.3 1.5 1.8 1.3 0.3 1.0 0.4 0.7 0.9 0.6 0.6 0.9 2.8 1.2 0.9 0.8 0.5 1.0 0.9 1.1 0.5 0.8 1.0 4.2 3.2 1.7 0.0 2.5 24.2 9.3 6.1 3.4 4.1 5.0 4.8 0.9 4.3 5.1 5.5 0.0 2.3 2.7 0.4 5.9 5.2 8.9 11.9 2.6 5.2 0.0 3.8 0.0 2.9 8.3 6.3 1.5 13.4 0.0 2.0 5.7 2.9 2.5 6.7 0.0 1.8 8.2 1.6 10.2 2.0 1.8 1.5 7.2 0.0 2.0 3.0 1.0 0.0 0.0 3.5 1.8 1.5 0.9 5.2 1.0 3.6 4.7 1.5 0.0 9.3 4.0 3.2 4.0 2.3 11.2 0.8 1.4 2.2 1.8 3.6 AC213203.2 ENSG00000277475 Unmapped 31698-32528 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 5.6;testis: 12.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 4.3" "Immune cell enriched" "Detected in single" 32 "eosinophil: 7.9" "Lineage enriched" "Detected in single" 32 "granulocytes: 7.9" "Cell line enhanced" "Detected in some" "A549: 6.9;HeLa: 2.1;HMC-1: 5.3;SCLC-21H: 4.3" NA NA 0.3 0.8 0.9 0.1 0.2 0.0 0.0 4.3 0.4 0.0 0.2 0.1 1.2 0.3 0.0 0.7 0.6 0.3 0.6 0.5 1.7 1.0 0.2 1.4 0.3 1.0 0.6 0.3 0.8 5.6 0.0 0.1 1.3 0.3 0.0 2.3 1.4 0.0 0.2 0.2 1.2 0.0 0.0 0.5 1.7 12.9 1.7 0.0 0.0 0.0 0.0 0.1 0.2 1.4 6.9 0.8 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.8 0.4 2.1 0.0 0.0 0.0 5.3 0.1 0.0 0.1 0.0 1.4 0.5 1.1 0.6 0.0 0.0 0.0 0.0 0.1 0.8 0.7 0.0 0.7 0.0 0.0 0.0 0.0 4.3 0.0 0.7 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 7.9 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 4.3 0.4 0.5 1.7 1.0 0.6 0.3 1.3 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKD1L3 ENSG00000277481 "Polycystin 1 like 3, transient receptor potential channel interacting" Q7Z443 16 71929538-71999978 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "liver: 1.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.9;Excitatory neurons: 2.5;Inhibitory neurons: 2.2;Microglial cells: 1.9;Oligodendrocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.75e-1)" "unprognostic (1.55e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (7.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.74e-1)" "unprognostic (9.90e-4)" "unprognostic (2.22e-1)" "unprognostic (1.35e-6)" "unprognostic (6.71e-2)" "unprognostic (1.73e-1)" "unprognostic (1.25e-1)" "unprognostic (1.93e-3)" 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.2 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.4 0.3 0.5 0.0 2.2 0.3 0.0 0.0 0.0 0.3 0.3 0.3 0.0 1.9 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 GPIHBP1 "GPI-HBP1, LOC338328" ENSG00000277494 "Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1" Q8IV16 8 143213218-143217170 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 91.5;brain: 55.8;breast: 54.9" "Cell type enriched" "Detected in some" 4 "Adipocytes: 356.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "Karpas-707: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066302 Enhanced "Intracellular and membrane" NA NA "HPA066302: AB_2685654" "unprognostic (2.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.71e-3)" "unprognostic (2.43e-3)" "unprognostic (1.58e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-3)" "unprognostic (8.01e-2)" "unprognostic (2.04e-1)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (8.69e-2)" "unprognostic (5.06e-3)" "unprognostic (9.65e-3)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-3)" 91.5 4.9 16.3 0.4 25.0 0.1 54.9 24.6 23.3 7.8 11.1 4.7 0.6 11.5 0.2 3.5 11.8 6.6 23.8 15.8 21.3 7.9 1.6 27.6 2.5 47.4 24.2 13.0 6.7 1.8 1.1 3.4 6.6 33.7 3.9 0.5 0.1 4.2 1.7 30.5 7.1 3.8 2.4 24.8 19.4 4.1 2.1 25.3 1.9 5.5 29.9 1.0 10.6 8.0 55.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 25.0 24.6 23.3 15.8 21.3 47.4 24.2 13.0 33.7 24.8 25.3 55.8 356.5 0.0 3.2 0.0 0.5 1.5 0.1 0.0 1.2 0.0 1.0 0.6 4.3 0.0 0.6 0.0 0.0 0.0 1.3 0.0 1.9 0.0 0.1 0.0 0.0 77.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 1.3 0.0 35.7 0.4 0.0 0.0 0.1 0.0 0.0 0.8 2.1 0.6 1.5 0.4 0.0 8.4 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.4 3.0 0.0 0.7 0.2 1.1 0.0 0.4 1.1 0.0 0.2 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 14.6;pituitary gland: 8.6" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.3;Endometrial ciliated cells: 1.3" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 1.1;HMC-1: 2.4;SH-SY5Y: 3.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.0 1.1 13.4 0.1 14.6 0.1 0.2 4.3 12.6 0.0 1.8 0.1 0.0 0.1 2.0 0.0 1.2 0.2 0.1 11.2 14.3 0.0 0.0 0.1 0.0 7.4 8.3 11.8 0.1 0.0 0.1 8.6 0.0 8.2 0.3 0.0 2.0 0.0 0.4 0.7 0.1 0.1 0.1 7.3 0.0 0.0 0.6 12.9 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 13.4 14.6 4.3 12.6 11.2 14.3 7.4 8.3 11.8 8.2 7.3 12.9 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 AL772284.1 ENSG00000277535 "Novel cancer/testis antigen family protein" X 119073226-119076373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042483 Supported Approved Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C5 ENSG00000277556 "Olfactory receptor family 13 subfamily C member 5" Q8NGS8 9 104598457-104599413 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA078297 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA078297: " "unprognostic (4.88e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.3 0.3 0.4 0.3 0.0 0.9 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24956721 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 681.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2" "Lineage enriched" "Detected in single" 113 "T-cells: 11.2" "Group enriched" "Detected in some" 4 "HEK 293: 456.2;PC-3: 145.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nucleoplasm,Intermediate filaments,Midbody" Yes NA 200000 "Nucleoplasm, Intermediate filaments" Midbody "HPA014850: AB_1854397, HPA015021: AB_2669135" "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.1 18.2 84.8 1.4 55.5 0.0 0.0 120.6 681.6 2.0 0.0 2.2 0.6 0.1 0.3 5.4 1.3 0.1 0.0 83.2 93.1 5.0 0.0 0.0 0.1 325.5 157.0 45.6 0.2 0.2 0.1 4.0 0.0 260.0 1.9 1.6 90.3 0.0 15.8 0.0 0.5 1.9 1.1 61.6 0.2 0.9 1.7 249.9 12.8 0.7 0.1 0.3 0.0 1.5 640.0 0.0 0.6 68.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.6 0.0 0.0 456.2 0.0 0.0 0.0 21.6 0.0 1.0 8.3 2.0 0.1 1.4 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 18.8 0.0 145.4 0.0 0.0 0.0 31.7 4.2 30.9 31.6 11.2 0.0 1.9 2.2 0.0 0.0 0.0 2.2 31.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.2 1.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.2 1.5 84.8 55.5 120.6 681.6 83.2 93.1 325.5 157.0 45.6 260.0 61.6 249.9 640.0 0.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.6 32.7 0.0 0.0 3.2 0.0 0.0 0.0 8.4 0.0 0.1 0.1 103.7 0.1 0.4 0.1 0.3 3.7 33.3 0.0 64.6 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 30.3 29.1 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 27.2 0.1 27.8 0.0 14.6 18.4 0.0 0.1 9.4 0.0 0.0 0.0 0.2 0.0 110.0 0.0 0.1 0.2 0.0 13.2 1.5 0.0 0.0 1.6 1.4 0.0 0.0 BX072566.1 ENSG00000277630 "POTE ankyrin domain family member D-like" Unmapped 108007-139659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL3 "G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3" ENSG00000277632 "C-C motif chemokine ligand 3" P10147 17 36088256-36090169 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 77.5;lung: 36.1;lymphoid tissue: 49.8" "Cell type enhanced" "Detected in many" "dendritic cells: 441.4;Hofbauer cells: 2084.4;Kupffer cells: 723.2;Langerhans cells: 710.0;Macrophages: 1534.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "gdT-cell: 23.6" "Group enriched" "Detected in many" 4 "B-cells: 10.4;granulocytes: 10.8;T-cells: 23.6" "Cell line enhanced" "Detected in some" "Karpas-707: 443.8;U-266/70: 602.5;U-266/84: 2043.3" "Secreted to blood" NA NA 138000 "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.45e-1)" "unprognostic (7.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.66e-1)" "unprognostic (3.54e-1)" "unprognostic (8.90e-2)" "unprognostic (7.92e-3)" "unprognostic (2.00e-1)" "unprognostic (7.20e-2)" "unprognostic (2.05e-1)" "unprognostic (8.92e-3)" "unprognostic (1.08e-1)" "unprognostic (9.29e-2)" "unprognostic (1.55e-2)" "unprognostic (1.23e-2)" 10.7 16.2 0.0 8.2 0.7 77.5 5.6 0.0 1.1 1.1 0.0 2.1 0.0 1.1 0.0 0.5 2.9 10.4 2.8 0.0 0.0 3.2 13.0 36.1 1.8 0.6 0.0 0.0 1.2 1.3 0.0 1.7 2.4 0.0 2.3 0.0 0.0 5.6 0.0 0.8 0.8 3.2 0.0 0.0 49.8 3.0 0.7 0.4 0.0 2.0 0.0 0.0 3.0 1.4 1.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 443.8 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 55.6 0.0 0.0 1.3 602.5 2043.3 0.0 0.0 0.0 0.0 0.0 2.1 10.8 23.6 1.3 0.0 5.1 0.0 6.1 0.4 10.4 0.1 6.8 10.5 3.5 1.3 0.0 0.0 11.6 0.0 0.7 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.1 33.0 0.0 28.6 0.0 45.3 27.9 2.0 0.2 1.2 1.8 23.1 50.0 2.2 4.3 4.4 0.0 0.0 19.0 441.4 0.7 0.0 0.6 1.5 1.6 2.5 115.9 0.0 61.9 0.0 0.2 22.6 14.5 2.0 2.8 23.5 0.1 27.1 9.1 2084.4 0.0 0.0 0.5 0.0 723.2 710.0 1.9 1.8 1534.2 94.3 2.8 23.5 2.1 106.1 0.0 0.0 0.4 0.0 0.0 344.8 1.2 0.0 0.9 2.2 3.7 6.6 2.3 9.2 0.5 0.6 0.6 28.8 54.3 248.0 0.1 0.2 1.3 AC007906.2 ENSG00000277639 "Novel protein" 16 53035690-53052873 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "choroid plexus: 72.4;fallopian tube: 78.5" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 224.8;Respiratory ciliated cells: 209.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 31.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 8.3;ASC TERT1: 7.0;BEWO: 11.6;HSkMC: 7.1;RPTEC TERT1: 7.5" NA NA "unprognostic (1.97e-2)" "unprognostic (8.34e-3)" "unprognostic (1.63e-1)" "unprognostic (5.38e-3)" "unprognostic (1.70e-1)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (3.34e-1)" "unprognostic (2.25e-2)" "unprognostic (1.54e-2)" "unprognostic (5.02e-2)" "unprognostic (6.07e-2)" "unprognostic (5.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-2)" "unprognostic (4.46e-3)" 0.8 0.3 3.0 0.4 1.3 0.0 6.0 1.9 1.7 11.3 72.4 4.5 0.6 2.8 1.4 9.0 78.5 10.6 1.1 3.2 3.1 11.2 1.4 9.6 0.1 5.5 5.1 0.2 0.3 11.7 0.3 0.3 1.5 3.8 9.5 5.1 0.0 3.6 2.7 1.1 4.6 0.4 0.8 4.3 0.0 0.9 0.2 3.1 0.8 0.3 1.0 1.2 6.8 2.7 1.4 0.1 2.5 4.1 2.1 8.3 7.0 11.6 1.2 0.9 0.1 0.0 0.3 1.7 0.2 2.1 1.7 0.8 0.7 0.0 1.6 0.5 0.2 0.1 0.0 0.1 0.6 1.6 0.0 1.8 7.1 6.2 2.3 0.7 2.3 1.7 0.1 0.1 0.1 3.8 0.1 0.1 0.0 4.6 0.4 0.6 1.0 0.0 0.0 7.5 1.6 0.2 0.0 0.3 0.0 0.1 3.4 0.8 0.1 2.0 2.7 2.7 0.1 0.0 0.0 0.0 0.0 3.3 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.3 1.9 1.7 3.2 3.1 5.5 5.1 0.2 3.8 4.3 3.1 1.4 0.1 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.7 12.7 0.0 0.0 30.3 25.8 0.0 0.1 0.5 0.0 5.9 4.9 0.0 224.8 1.7 0.8 0.0 0.0 0.0 0.0 0.3 3.2 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.4 209.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 AC136352.3 ENSG00000277666 Unmapped 100123-101141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003342 Uncertain NA NA "HPA003342: AB_1078588" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAC ENSG00000277734 "T cell receptor alpha constant" 14 22547506-22552156 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 7 "lymphoid tissue: 795.3" "Cell type enhanced" "Detected in many" "dendritic cells: 166.3;Rod photoreceptor cells: 75.9;T-cells: 428.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "MAIT T-cell: 2123.1;memory CD4 T-cell: 2939.7;memory CD8 T-cell: 2508.6;naive CD4 T-cell: 2671.8;naive CD8 T-cell: 2388.0;T-reg: 4379.2" "Lineage enriched" "Detected in all" 41 "T-cells: 4379.2" "Cell line enhanced" "Detected in many" "HDLM-2: 127.0;JURKAT: 294.7;NB-4: 83.1;U-266/84: 126.2;U-698: 62.1" "Low region specificity" "Detected in all" NA NA "prognostic favorable (3.21e-4)" "prognostic favorable (4.87e-6)" "unprognostic (9.92e-3)" "prognostic favorable (4.15e-6)" "unprognostic (3.71e-2)" "prognostic favorable (5.25e-5)" "unprognostic (2.83e-2)" "unprognostic (9.81e-3)" "unprognostic (2.51e-3)" "unprognostic (1.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.99e-1)" "prognostic unfavorable (3.40e-5)" "unprognostic (2.13e-1)" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (2.75e-2)" 15.3 7.8 5.8 159.0 14.9 29.8 17.1 7.5 3.6 12.1 3.5 34.0 47.0 9.4 39.7 17.4 10.1 42.6 29.0 2.3 2.4 10.4 16.7 47.4 397.5 3.4 8.7 2.1 7.4 3.3 1.9 11.5 2.3 3.9 15.5 43.8 113.7 26.1 5.5 3.3 19.6 79.0 10.5 2.9 135.3 55.4 7.3 3.2 795.3 12.3 2.7 289.9 59.0 9.8 3.9 0.3 0.0 11.6 0.0 0.0 0.0 0.2 0.1 0.4 0.3 0.4 1.8 0.0 11.4 1.5 0.0 0.2 0.0 0.2 0.1 1.1 127.0 0.0 0.2 0.0 0.0 0.0 16.4 0.8 0.0 0.0 4.3 0.2 0.0 3.1 294.7 0.4 0.1 1.2 0.0 45.7 83.1 3.1 0.1 0.6 22.9 2.8 0.2 0.7 0.0 0.0 0.2 0.0 0.0 1.1 1.7 0.0 1.6 8.3 3.4 0.7 0.3 1.0 2.7 126.2 62.1 1.0 0.5 0.1 24.5 10.2 9.8 520.5 6.7 2123.1 105.6 2939.7 2508.6 7.9 94.6 2671.8 2388.0 57.7 89.7 11.0 11.8 4379.2 2965.8 5.8 14.9 7.5 3.6 2.3 2.4 3.4 8.7 2.1 3.9 2.9 3.2 3.9 9.0 3.2 25.6 0.0 46.3 0.0 1.0 0.0 5.7 9.0 4.9 8.5 35.7 0.0 6.2 0.0 12.5 0.2 166.3 0.9 17.6 0.7 46.2 0.9 0.6 3.3 0.0 16.4 0.0 0.0 0.2 15.9 4.1 0.5 10.1 0.0 9.3 1.4 1.3 0.0 0.0 0.9 0.0 8.1 0.0 4.8 1.8 12.2 0.0 0.0 20.2 11.8 44.3 0.0 0.0 0.1 1.2 5.3 25.4 0.2 0.5 4.6 0.0 75.9 0.0 2.6 4.7 2.2 0.8 5.4 0.0 0.3 428.0 0.0 0.7 0.2 H2AB3 "H2AFB, H2AFB3" ENSG00000277745 "H2A.B variant histone 3" P0C5Z0 X 155459415-155460005 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 4.5" NA NA 0.2 0.3 0.3 0.0 0.2 0.1 0.2 0.1 0.6 0.8 0.1 0.6 0.0 0.2 0.0 0.2 0.9 0.0 0.3 0.2 0.2 0.6 0.3 0.3 0.0 0.3 0.2 0.3 0.6 0.2 0.0 0.3 0.0 0.3 0.5 0.0 0.0 0.3 0.0 0.2 0.1 0.6 0.0 0.0 1.5 0.2 31.6 0.2 0.0 0.3 0.0 0.0 0.4 0.2 0.4 0.3 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.6 0.2 0.2 0.3 0.2 0.3 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FO681492.1 ENSG00000277758 Synaptotagmin-15 10 47749758-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.4;lung: 12.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 10.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 68.9" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 2.3 0.7 2.0 1.2 2.0 0.1 2.2 0.0 10.4 2.3 0.0 0.7 0.3 1.3 0.5 2.5 2.1 1.1 1.4 4.0 1.0 0.5 0.4 12.4 3.7 0.0 0.0 0.8 0.7 4.2 0.8 0.3 2.5 0.7 1.1 0.6 0.5 1.9 1.3 0.6 3.2 0.8 0.9 0.0 0.9 0.6 0.3 0.2 0.8 1.1 0.6 2.0 1.1 2.0 0.6 0.4 4.1 0.4 0.5 0.2 0.3 0.2 2.8 0.4 0.3 0.3 4.5 4.0 0.1 0.3 2.2 1.3 0.5 0.0 0.1 0.4 0.1 1.6 0.0 0.8 0.4 3.9 0.3 0.8 0.4 0.2 0.3 0.7 0.4 0.3 1.9 0.1 0.4 0.2 7.6 0.2 0.6 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.6 0.2 5.2 68.9 0.2 0.2 5.4 0.3 0.5 0.3 0.7 0.3 0.2 0.3 0.3 0.2 0.4 0.1 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 2.0 0.0 10.4 4.0 1.0 0.0 0.0 0.8 0.7 0.0 0.2 0.6 0.1 3.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136616.2 ENSG00000277761 Unmapped 1167457-1257196 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 79.9;lymphoid tissue: 57.5;salivary gland: 52.6;stomach 1: 72.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 99 "memory B-cell: 21.7;naive B-cell: 6.8" "Lineage enriched" "Detected in single" 150 "B-cells: 21.7" "Not detected" "Not detected" NA NA 0.4 43.4 0.1 31.3 0.2 8.5 25.8 0.0 0.9 1.7 0.2 79.9 36.4 0.5 8.9 1.7 1.9 7.2 0.6 0.0 0.1 0.4 2.4 11.8 6.2 0.3 0.0 0.0 23.1 2.8 0.1 0.0 0.3 0.7 35.2 0.1 52.6 0.6 0.6 0.5 40.8 1.0 0.0 25.2 72.1 4.9 0.1 26.5 0.6 0.0 57.5 27.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 6.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.2 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3C7 "H3/i, H3FI, HIST1H3F" ENSG00000277775 "H3 clustered histone 7" P68431 6 26250142-26250635 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.6;brain: 2.6;choroid plexus: 2.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 2.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "memory B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 1.8" "Cell line enhanced" "Detected in some" "NB-4: 4.3;U-266/84: 6.2" "HPA042570, CAB070190" Approved NA NA "CAB070190: AB_10001790, HPA042570: AB_2678056" "unprognostic (1.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (6.10e-3)" "unprognostic (1.91e-6)" "unprognostic (9.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (2.14e-1)" "unprognostic (1.00e-1)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.60e-4)" 0.0 0.1 0.8 0.2 0.6 1.6 0.0 1.1 0.9 0.0 2.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.5 2.6 0.0 0.0 0.0 0.4 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.4 0.2 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 1.1 0.0 0.0 0.0 0.8 0.6 0.0 1.1 0.3 0.0 0.0 0.1 0.6 0.0 0.3 0.4 0.0 0.5 0.0 0.9 0.2 0.8 2.6 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.6 0.8 1.2 1.2 0.0 0.9 1.9 4.3 0.1 0.0 1.1 2.1 0.0 0.6 0.0 0.3 2.2 0.5 0.8 0.4 0.0 0.1 1.6 1.6 0.0 0.2 0.0 0.1 1.1 1.2 6.2 0.0 1.2 1.5 0.5 0.0 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.8 0.6 1.1 0.9 0.5 2.6 1.9 0.6 0.0 1.0 1.4 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 PSMB3 "HC10-II, MGC4147" ENSG00000277791 "Proteasome 20S subunit beta 3" P49720 17 38752741-38764225 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042775, HPA048147" Approved NA NA 25000000 "HPA042775: AB_2678158, HPA048147: AB_2680285" "unprognostic (1.86e-1)" "unprognostic (4.84e-3)" "unprognostic (1.44e-1)" "unprognostic (4.80e-2)" "unprognostic (6.68e-2)" "unprognostic (1.14e-3)" "unprognostic (5.46e-2)" "unprognostic (2.46e-2)" "unprognostic (2.02e-1)" "unprognostic (1.75e-2)" "unprognostic (3.65e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.71e-6)" "unprognostic (4.44e-1)" "unprognostic (1.28e-1)" "unprognostic (2.42e-3)" "unprognostic (6.03e-2)" 94.5 140.4 66.1 96.6 71.9 139.9 93.7 70.8 76.1 80.9 73.9 106.6 83.2 91.3 102.7 111.8 82.2 73.7 143.3 74.9 74.6 121.6 188.9 102.7 138.1 69.2 69.8 68.6 59.7 78.8 86.9 82.0 91.7 71.5 86.3 107.1 42.8 84.8 67.3 203.4 99.4 91.0 93.5 71.1 123.0 94.6 53.6 78.9 107.3 88.3 120.5 133.6 103.7 83.7 75.1 246.1 457.3 168.8 277.2 180.9 158.6 237.1 167.6 265.8 563.8 489.1 486.3 324.1 279.5 276.3 228.8 371.1 401.6 279.3 294.3 301.1 373.6 500.2 184.2 226.6 562.5 96.5 289.3 278.1 151.0 184.6 393.5 131.1 132.9 289.3 283.1 301.2 320.4 246.2 319.6 461.1 457.0 250.6 278.8 328.3 261.1 383.3 446.2 312.1 253.4 216.8 145.7 191.8 157.3 201.3 243.8 360.1 356.6 173.1 138.0 269.5 308.9 421.1 202.1 367.2 397.7 285.2 294.8 242.0 227.2 323.7 150.4 176.6 271.4 118.1 148.5 145.2 154.4 274.5 114.6 93.0 94.9 569.6 142.8 209.6 352.6 176.1 372.0 66.1 71.9 70.8 76.1 74.9 74.6 69.2 69.8 68.6 71.5 71.1 78.9 75.1 146.2 76.9 124.5 8.8 142.0 199.6 203.6 517.8 79.1 66.7 100.9 105.8 328.0 104.4 281.6 176.6 25.0 434.0 141.4 215.0 406.9 362.1 51.5 140.6 123.8 185.5 133.4 156.4 8.6 497.7 428.3 160.8 100.9 117.7 154.0 110.0 118.9 247.6 416.7 30.3 7.8 207.1 368.2 161.5 266.5 48.2 149.5 231.8 200.9 7.5 309.8 167.5 179.2 3.0 12.6 401.0 242.9 145.9 205.1 189.9 219.9 642.6 274.9 72.2 124.9 110.2 507.6 152.2 76.7 114.0 201.5 504.2 154.0 186.7 224.7 239.9 AC141272.1 ENSG00000277836 Unmapped 1270984-1271271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "intestine: 96.1;lymphoid tissue: 129.8;salivary gland: 55.7;stomach 1: 68.9;urinary bladder: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "memory B-cell: 17.6;naive B-cell: 8.6" "Lineage enriched" "Detected in single" 176 "B-cells: 17.6" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.0" NA NA 2.9 1.1 0.0 41.5 0.1 15.7 10.6 0.0 0.1 17.0 0.0 96.1 91.7 0.6 0.0 11.7 0.2 4.6 0.0 0.0 0.1 0.6 2.8 3.9 26.2 0.2 0.8 0.0 0.6 0.4 0.0 0.0 0.1 1.2 31.5 0.0 55.7 1.0 0.0 3.2 52.7 2.4 0.0 29.9 68.9 0.3 0.0 31.7 0.0 0.0 129.8 40.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233755.2 ENSG00000277856 Unmapped 26241-26534 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 101.2;lymphoid tissue: 226.6;stomach 1: 94.2" "Cell type enriched" "Detected in some" 136 "Plasma cells: 369.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 309 "memory B-cell: 27.4;naive B-cell: 34.3" "Lineage enriched" "Detected in single" 344 "B-cells: 34.3" "Cell line enhanced" "Detected in some" "JURKAT: 7.7;MOLT-4: 7.6;REH: 2.3;SH-SY5Y: 2.4;TIME: 1.6" NA NA 7.4 2.4 0.0 36.3 0.2 28.6 13.7 0.0 0.2 9.3 0.0 101.2 94.7 3.7 0.0 18.1 0.4 4.2 1.6 0.0 0.0 0.3 4.3 6.4 101.5 0.4 0.0 0.0 2.7 0.0 0.1 0.1 0.0 1.7 20.5 0.0 36.3 3.2 0.0 0.4 33.6 2.5 0.4 37.9 94.2 1.6 0.0 17.3 1.0 0.0 226.6 39.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 7.6 0.4 0.0 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 369.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 H2AB2 H2AFB2 ENSG00000277858 "H2A.B variant histone 2" P0C5Z0 X 155380709-155381299 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 4.5" NA NA 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.1 0.6 0.5 0.1 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.2 0.3 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.6 0.2 4.9 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.4 0.3 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.6 0.2 0.2 0.3 0.2 0.3 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L22 ENSG00000277865 "Golgin A6 family like 22" H0YM25 15 22458903-22469230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 9.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 58.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "HPA047733: " "unprognostic (2.71e-2)" "unprognostic (1.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV17 "TCRBV17S1, TCRBV26S1P" ENSG00000277880 "T cell receptor beta variable 17 (non-functional)" 7 142601628-142602360 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRD5A2 ENSG00000277893 "Steroid 5 alpha-reductase 2" P31213 2 31522480-31580938 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "epididymis: 23.8;fallopian tube: 20.6;liver: 61.3;prostate: 16.9;seminal vesicle: 18.2" "Group enriched" "Detected in some" 5 "Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.75e-3)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-3)" "unprognostic (5.92e-3)" "unprognostic (3.37e-2)" "unprognostic (2.79e-3)" "unprognostic (6.56e-2)" "unprognostic (9.10e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-3)" "unprognostic (6.61e-6)" "unprognostic (4.37e-2)" "unprognostic (2.04e-1)" "unprognostic (3.85e-1)" "unprognostic (3.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 23.8 0.0 20.6 0.0 0.0 0.0 0.0 0.3 61.3 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.1 0.0 18.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.0 0.0 1.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.7 29.6 0.2 0.2 0.0 0.0 0.9 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.4 20.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 59.9 0.6 0.1 0.0 3.7 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.2 0.0 0.7 0.0 0.3 7.3 0.0 0.0 0.0 0.2 1.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 8.6 OR52E5 ENSG00000277932 "Olfactory receptor family 52 subfamily E member 5" Q8NH55 11 5893208-5902730 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CISD3 "Miner2, MiNT" ENSG00000277972 "CDGSH iron sulfur domain 3" P0C7P0 17 38730341-38735605 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Distal enterocytes: 454.6;Hepatocytes: 673.4;Paneth cells: 406.2;Proximal enterocytes: 715.7;Proximal tubular cells: 500.6;Undifferentiated cells: 398.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 5.3;U-138 MG: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053436, HPA054400" Approved NA NA "HPA053436: AB_2682149, HPA054400: AB_2682475" "unprognostic (9.42e-2)" "unprognostic (8.73e-2)" "unprognostic (7.64e-2)" "unprognostic (2.38e-2)" "unprognostic (2.75e-1)" "unprognostic (1.50e-2)" "unprognostic (1.32e-1)" "unprognostic (4.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.76e-1)" "unprognostic (1.95e-1)" "unprognostic (2.88e-2)" "unprognostic (1.31e-2)" "unprognostic (2.12e-2)" "unprognostic (3.34e-1)" "unprognostic (1.42e-1)" 12.8 18.2 0.4 0.1 0.1 0.0 13.6 0.9 0.6 9.7 0.2 13.9 1.4 11.2 0.4 8.3 11.1 1.4 21.3 0.1 0.3 17.7 25.0 8.7 0.3 0.5 0.2 0.1 8.0 19.5 0.1 7.8 1.3 0.7 11.2 0.1 0.6 8.5 0.2 13.4 8.9 13.0 0.1 0.0 8.0 14.9 4.8 0.4 0.0 12.0 0.0 0.0 12.2 8.9 0.5 0.8 1.5 1.6 5.3 0.0 0.1 1.0 0.7 0.0 0.2 0.0 0.4 4.3 0.0 0.1 0.0 3.5 3.7 0.1 0.1 0.4 0.2 0.0 0.6 0.5 1.2 0.2 0.0 2.3 0.1 0.0 0.1 0.0 1.6 0.1 4.8 0.4 1.4 0.2 0.0 0.9 0.0 5.1 0.0 1.2 1.6 0.0 0.3 0.1 0.8 0.8 2.7 1.0 0.7 3.8 0.0 4.3 0.9 0.0 6.5 4.0 4.1 2.8 0.6 0.1 0.5 2.0 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.6 0.1 0.3 0.5 0.2 0.1 0.7 0.0 0.4 0.5 58.6 19.2 23.6 6.2 21.4 26.5 41.4 27.3 22.8 20.0 92.6 86.5 261.4 175.8 29.6 62.5 14.6 26.1 44.7 454.6 205.4 102.1 2.2 34.8 35.8 41.9 129.0 45.5 5.3 241.4 52.3 41.8 111.1 29.1 31.8 34.6 43.9 673.4 136.7 6.7 3.9 262.5 16.2 87.4 47.9 7.0 45.7 58.3 55.2 1.9 73.3 36.7 165.8 2.0 4.9 152.6 406.2 47.8 24.0 95.0 715.7 500.6 21.5 15.2 59.2 31.8 72.2 8.8 31.4 70.9 35.9 13.1 47.2 53.1 398.5 51.5 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 11.9" "Group enriched" "Detected in some" 15 "Early spermatids: 59.4;Late spermatids: 81.9;Spermatocytes: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;JURKAT: 17.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.1 0.1 0.5 0.5 0.3 0.6 0.3 1.1 0.5 0.1 0.0 0.5 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.6 0.3 0.1 0.2 0.1 1.1 0.2 0.2 0.3 0.0 0.0 0.0 0.3 0.4 0.5 0.1 0.9 0.4 0.0 0.1 0.0 0.7 0.6 0.1 0.3 0.3 0.4 11.9 0.4 2.4 0.3 0.0 1.5 0.1 0.1 0.7 4.8 4.2 1.8 2.4 0.1 0.0 1.9 0.9 0.1 1.1 2.1 7.0 6.6 5.6 2.2 0.4 5.1 0.9 3.6 2.9 3.6 2.6 11.5 2.9 2.0 0.0 0.0 0.3 1.5 0.0 0.4 0.3 0.6 1.5 0.1 17.7 2.1 0.0 0.4 4.3 1.5 3.0 0.7 9.0 3.1 1.1 0.0 0.0 1.3 2.4 2.8 1.1 0.4 1.4 3.7 5.1 8.9 0.7 0.0 0.1 2.6 0.0 0.6 5.5 1.5 2.2 2.9 1.7 1.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.8 2.6 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.2 0.5 0.3 1.1 0.5 0.6 0.3 0.2 0.2 0.3 0.5 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.5 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 3.7 0.4 0.1 0.0 0.1 59.4 0.9 0.2 0.1 1.2 0.4 0.6 0.0 1.0 0.3 0.5 0.3 0.0 1.5 0.4 0.6 1.8 0.0 0.3 0.7 0.0 0.0 0.3 81.9 0.6 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.4 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.3 0.2 25.6 2.7 0.4 0.0 0.7 0.6 0.1 1.6 0.7 TRBV7-9 "TCRBV6S4A1, TCRBV7S9, TRBV79" ENSG00000278030 "T cell receptor beta variable 7-9" P04435 7 142529290-142529762 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 55.9" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 9.2;Late spermatids: 5.4;T-cells: 22.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 37 "memory CD4 T-cell: 48.4;memory CD8 T-cell: 81.7;naive CD4 T-cell: 67.3;naive CD8 T-cell: 73.5;T-reg: 95.1" "Lineage enriched" "Detected in many" 87 "T-cells: 95.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.5;HBF TERT88: 1.2;U-2197: 1.1" NA NA "unprognostic (3.18e-3)" "unprognostic (5.05e-3)" "unprognostic (6.66e-3)" "unprognostic (6.48e-5)" "unprognostic (1.04e-1)" "prognostic favorable (4.68e-5)" "unprognostic (1.12e-3)" "unprognostic (1.05e-2)" "unprognostic (7.15e-2)" "unprognostic (2.57e-3)" "unprognostic (6.40e-2)" "unprognostic (9.86e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (3.17e-1)" "unprognostic (6.65e-2)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" 0.5 0.1 0.0 0.5 0.1 4.2 0.7 0.0 0.1 0.6 0.0 1.8 0.0 0.3 0.0 0.4 0.5 4.0 0.1 0.0 0.0 0.3 1.3 1.6 27.4 0.1 0.0 0.0 0.7 0.3 0.0 0.1 0.1 0.0 0.4 1.5 0.0 1.0 0.0 0.2 0.3 3.5 1.1 0.0 5.3 1.3 0.3 0.0 55.9 0.7 0.0 15.6 1.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.0 1.9 0.4 48.4 81.7 0.2 0.2 67.3 73.5 1.0 0.0 0.1 0.5 95.1 26.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643446 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.1;Glandular and luminal cells: 360.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA056173: AB_2683056" "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favorable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 1.8 2.5 1.6 1.1 1.7 4.2 1.7 2.4 2.0 2.0 2.1 2.2 2.0 2.2 3.9 3.1 1.6 1.8 1.7 1.6 1.7 2.5 2.8 1.9 2.1 1.8 1.7 1.6 1.5 3.0 2.2 1.4 1.7 2.1 1.7 2.2 2.1 1.9 1.7 2.5 2.8 3.3 1.8 1.5 2.1 2.4 1.8 1.9 1.5 1.3 1.8 2.2 2.4 1.9 2.8 4.7 10.2 1.0 9.4 5.2 4.6 4.0 6.3 5.4 8.1 7.7 6.6 1.7 2.8 4.2 4.3 1.5 4.4 10.5 7.2 11.0 6.5 12.8 5.9 6.6 4.6 5.1 7.8 3.1 4.5 7.6 5.5 6.3 4.1 9.4 2.7 0.9 1.7 4.7 1.6 11.9 4.3 5.4 2.6 0.8 7.3 8.4 4.9 9.9 5.8 6.6 5.5 7.5 1.8 5.2 5.0 3.3 6.1 6.7 6.6 4.2 3.6 7.3 2.2 3.8 4.9 5.3 4.6 5.2 0.9 0.5 0.7 0.8 0.7 0.6 0.6 0.8 0.6 0.4 0.6 0.7 0.9 0.4 0.8 0.4 1.2 0.5 0.2 1.6 1.7 2.4 2.0 1.6 1.7 1.8 1.7 1.6 2.1 1.5 1.9 2.8 28.5 41.7 19.7 17.3 29.4 34.5 33.9 41.2 26.2 34.0 25.4 22.7 33.3 18.6 41.4 27.6 33.3 35.4 47.4 28.7 35.2 76.6 245.1 105.8 77.7 32.3 26.3 42.7 19.4 52.3 31.1 28.1 29.6 360.4 27.3 40.8 28.5 37.2 26.1 47.1 19.3 30.1 34.6 25.8 12.6 97.8 24.5 24.1 17.8 19.7 53.8 26.0 33.0 29.7 23.0 56.8 20.5 24.0 25.4 35.8 35.7 40.2 32.0 36.0 26.3 26.7 34.1 29.6 56.0 33.4 33.2 25.0 30.3 43.7 46.8 49.5 TEX28 "CXorf2, fTEX" ENSG00000278057 "Testis expressed 28" O15482 X 154271265-154295853 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 9.1" "Group enriched" "Detected in some" 37 "Early spermatids: 47.5;Late spermatids: 88.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 47.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 88.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846497-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HMC-1: 115.3" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF8 "HF.18, Zfp128" ENSG00000278129 "Zinc finger protein 8" P17098 19 58278955-58302791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034797, HPA034798" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA034797: AB_10696364, HPA034798: AB_10602785" "unprognostic (1.41e-1)" "unprognostic (7.27e-2)" "unprognostic (6.66e-2)" "unprognostic (3.03e-2)" "unprognostic (1.52e-2)" "unprognostic (4.16e-3)" "unprognostic (1.09e-2)" "unprognostic (9.20e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (4.98e-2)" "unprognostic (7.16e-3)" "unprognostic (8.56e-2)" "unprognostic (7.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.28e-2)" 1.5 1.8 2.3 1.1 1.9 3.6 1.6 4.0 3.3 1.5 0.8 1.6 1.1 1.8 1.5 1.6 1.7 1.1 2.0 2.9 1.5 1.6 1.1 2.1 1.5 1.8 1.8 2.0 1.9 1.6 2.0 2.3 1.5 2.2 1.6 1.2 4.0 1.7 1.3 0.9 2.5 1.7 1.5 0.8 1.9 1.6 1.4 1.9 2.1 1.8 1.4 1.4 1.7 1.7 2.8 1.8 2.6 3.7 6.9 2.3 1.9 3.1 0.9 1.4 0.9 1.0 2.8 1.3 2.3 1.1 1.5 0.8 1.6 2.7 3.0 1.2 1.8 11.4 4.5 6.0 2.5 2.1 1.5 3.5 3.7 1.8 1.6 3.1 2.7 1.7 3.7 2.4 0.9 1.9 2.1 3.5 2.0 3.3 1.3 1.8 3.9 3.5 1.6 1.8 6.3 6.5 3.5 2.8 1.9 0.9 2.8 1.9 2.8 2.5 6.9 1.7 1.0 1.9 3.4 2.9 3.0 1.1 0.0 1.8 1.4 0.7 0.4 0.4 0.3 0.5 0.4 0.3 0.3 0.4 0.5 0.3 0.4 1.3 0.5 0.3 0.3 0.2 0.7 2.3 1.9 4.0 3.3 2.9 1.5 1.8 1.8 2.0 2.2 0.8 1.9 2.8 4.2 0.0 4.1 2.3 2.3 0.0 2.9 0.0 2.8 11.0 2.5 2.3 3.1 0.0 1.8 5.5 12.5 2.1 1.2 1.4 3.9 4.0 4.0 4.7 5.3 4.5 5.4 10.3 4.2 2.3 1.6 2.8 4.1 3.9 1.3 5.9 6.8 1.7 2.5 11.8 4.3 2.1 0.0 1.9 0.0 0.9 4.1 2.4 0.0 1.9 3.0 3.5 2.1 3.0 3.3 3.1 0.5 1.9 1.7 4.4 1.0 2.5 2.2 10.2 6.6 6.6 2.6 8.0 3.4 2.8 0.0 2.6 3.4 5.1 1.9 2.8 P3R3URF-PIK3R3 ENSG00000278139 "P3R3URF-PIK3R3 readthrough" 1 46043661-46176488 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 3.1;RT4: 10.7" HPA005751 Uncertain NA NA "HPA005751: AB_1855350" 0.4 0.0 0.0 0.4 0.1 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 21.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 1.0 0.0 1.2 0.4 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.0 1.4 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSTR3 ENSG00000278195 "Somatostatin receptor 3" P32745 22 37204237-37212477 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;lymphoid tissue: 11.2;testis: 7.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.3;Late spermatids: 2.0;Microglial cells: 1.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 10 "T-cells: 1.1" "Group enriched" "Detected in some" 11 "RPMI-8226: 23.3;SCLC-21H: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022647 Approved NA NA "CAB022647: " "unprognostic (1.63e-2)" "unprognostic (5.58e-3)" "unprognostic (1.32e-2)" "unprognostic (3.18e-2)" "unprognostic (7.03e-2)" "unprognostic (6.26e-5)" "unprognostic (1.11e-1)" "unprognostic (1.72e-2)" "unprognostic (1.90e-2)" "unprognostic (8.95e-2)" "unprognostic (3.88e-3)" "unprognostic (2.93e-1)" "unprognostic (1.51e-7)" "unprognostic (1.55e-1)" "unprognostic (1.24e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-2)" 0.0 0.3 2.3 1.0 2.6 0.4 0.0 1.5 6.5 0.0 0.0 0.2 1.3 1.1 0.0 0.0 0.1 0.0 0.0 2.0 2.5 0.1 0.0 0.0 1.8 6.2 3.8 2.3 3.4 1.8 0.0 2.6 0.0 6.9 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.5 1.0 1.3 0.6 0.2 7.9 7.6 11.2 0.0 0.0 0.9 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.1 0.9 0.0 0.0 0.0 0.0 0.1 0.2 2.3 2.6 1.5 6.5 2.0 2.5 6.2 3.8 2.3 6.9 1.3 7.6 7.8 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 IGLV2-8 ENSG00000278196 "Immunoglobulin lambda variable 2-8" P01709 22 22822658-22823289 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1152.7;lymphoid tissue: 1021.0" "Cell type enriched" "Detected in some" 80 "Plasma cells: 5288.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 125 "memory B-cell: 1439.0;naive B-cell: 2097.3" "Lineage enriched" "Detected in all" 149 "B-cells: 2097.3" "Group enriched" "Detected in many" 617 "U-266/70: 64161.5;U-266/84: 56786.5" "Immunoglobulin genes" NA NA 1500000000 "prognostic favorable (2.92e-4)" "unprognostic (1.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "prognostic favorable (5.07e-5)" "unprognostic (2.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" "unprognostic (5.05e-2)" "unprognostic (1.61e-1)" "unprognostic (6.55e-2)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.04e-2)" "unprognostic (2.67e-1)" "unprognostic (9.90e-2)" "unprognostic (1.62e-1)" 18.8 7.0 1.1 328.1 0.6 96.8 156.7 0.2 2.4 26.2 1.4 1152.7 985.9 9.5 3.6 92.3 8.0 133.6 30.7 0.2 0.3 15.1 24.5 59.7 230.1 1.0 1.1 0.3 57.7 30.6 1.4 1.4 0.2 0.8 9.0 253.0 0.0 257.8 60.8 0.6 1.9 455.2 20.2 0.4 441.2 437.7 3.4 0.5 91.4 23.9 0.0 1021.0 261.4 10.4 1.2 62.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.6 0.0 0.0 23.1 0.0 0.0 0.0 22.3 0.0 0.5 0.0 0.0 0.0 0.7 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.0 0.0 11.3 1.9 14.8 0.0 0.0 97.9 0.9 10.1 0.0 0.0 1.4 2.8 0.2 0.0 9.3 0.0 0.0 29.5 0.9 0.0 9.8 0.6 38.9 64161.5 56786.5 20.4 0.0 10.1 0.0 1.2 2.4 0.6 2.1 0.7 0.9 1439.0 1.3 1.5 1.9 2097.3 0.4 1.0 14.1 1.3 1.4 0.6 0.7 174.0 1.1 0.6 0.2 2.4 0.2 0.3 1.0 1.1 0.3 0.8 0.4 0.5 1.2 0.0 3.2 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.5 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5288.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 AC011043.2 ENSG00000278198 Unmapped 173872-179372 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;NB-4: 2.3" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.1 0.7 0.8 0.2 0.0 0.6 0.3 0.2 0.2 0.4 1.0 0.2 0.0 0.1 0.0 0.5 0.8 0.6 0.2 0.7 0.6 0.7 0.5 0.7 0.9 0.0 1.0 1.0 0.0 0.3 0.1 0.4 0.4 0.1 0.7 0.1 0.8 0.2 0.1 0.2 2.3 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.3 0.0 0.5 0.0 0.4 0.2 0.2 0.5 0.2 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.2 0.3 0.2 0.1 0.3 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRICKLE4 "C6orf49, DKFZp761H221, OEBT" ENSG00000278224 "Prickle planar cell polarity protein 4" Q2TBC4 6 41780782-41787452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7" "HPA031240, HPA055593" Approved Approved "Mitotic spindle,Centriolar satellite" Yes NA "Centriolar satellite" "Mitotic spindle" "HPA031240: AB_10600929, HPA055593: " "unprognostic (1.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.56e-2)" "unprognostic (6.86e-2)" "unprognostic (1.58e-1)" "unprognostic (2.15e-2)" "unprognostic (6.41e-2)" "unprognostic (1.93e-2)" "unprognostic (3.47e-4)" "unprognostic (4.25e-2)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (1.56e-5)" "unprognostic (3.64e-3)" "unprognostic (5.74e-2)" "unprognostic (1.50e-1)" "unprognostic (2.17e-3)" 1.7 1.2 1.0 0.3 0.8 0.1 1.9 1.2 1.2 1.9 0.5 1.4 1.1 2.4 0.0 3.9 2.3 1.0 1.5 0.8 0.8 1.3 2.0 2.1 0.1 1.1 1.1 0.8 1.3 1.2 0.4 1.0 0.6 1.0 2.4 0.5 0.6 1.7 0.4 1.6 0.8 1.2 1.6 0.5 4.5 2.7 0.8 1.1 0.0 2.6 1.5 0.3 2.6 2.9 1.5 0.2 0.6 1.3 1.2 0.0 0.0 4.0 0.1 0.1 0.0 0.0 0.7 0.9 0.4 1.5 0.0 0.1 2.1 0.0 0.1 0.0 0.3 0.3 0.2 4.6 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.7 0.0 0.5 1.2 0.2 0.0 0.6 0.0 0.7 0.2 1.8 0.2 1.3 0.3 0.0 0.2 1.4 0.1 0.4 0.0 2.4 0.2 1.2 0.6 0.7 0.6 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 1.2 1.2 0.8 0.8 1.1 1.1 0.8 1.0 0.5 1.1 1.5 0.0 0.0 0.0 1.6 15.0 1.5 1.4 2.4 30.7 2.3 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.7 2.6 0.0 0.0 0.3 0.0 0.0 2.8 3.5 17.7 0.2 0.0 0.0 4.8 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 1.5 0.6 1.2 8.4 0.0 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.5 2.6 36.8 1.7 2.2 0.0 0.7 4.1 0.0 1.9 3.7 1.9 1.4 49.4 2.0 0.0 10.9 0.0 3.0 1.4 MYO19 "FLJ22865, MYOHD1" ENSG00000278259 "Myosin XIX" Q96H55 17 36495636-36543435 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021415, HPA059715" Approved Enhanced Mitochondria,Cytosol NA Yes Mitochondria Cytosol "HPA021415: AB_2266815, HPA059715: AB_2684111" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (8.44e-3)" "unprognostic (1.46e-1)" "unprognostic (2.02e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (8.33e-6)" "unprognostic (1.07e-3)" "unprognostic (1.39e-2)" "unprognostic (2.41e-1)" "unprognostic (1.67e-1)" "unprognostic (3.70e-3)" "unprognostic (1.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.57e-1)" "unprognostic (1.89e-1)" "unprognostic (4.17e-2)" 7.6 5.5 2.3 7.1 2.4 13.2 8.0 2.3 2.9 9.8 3.2 11.8 13.1 7.4 5.2 22.2 7.6 5.0 5.6 2.3 2.3 13.5 11.2 7.9 5.7 3.0 2.4 2.3 6.9 13.3 17.1 9.6 6.4 3.1 8.0 14.8 2.1 15.5 3.9 8.5 23.6 13.1 7.3 2.2 8.5 14.5 9.7 2.6 6.5 9.5 4.5 10.1 7.3 14.6 3.1 41.6 47.3 21.7 25.1 10.1 12.5 32.5 34.0 27.0 53.2 57.9 42.6 46.4 21.9 15.6 23.3 20.0 66.5 48.0 38.3 36.8 18.9 24.0 30.6 58.8 29.4 8.4 36.5 40.0 6.9 20.2 41.6 40.8 13.5 22.2 29.7 46.5 24.2 28.2 28.9 25.3 29.4 23.9 44.1 20.4 32.8 30.7 28.4 27.7 32.3 37.9 18.5 44.9 31.7 15.4 30.3 55.2 17.6 15.9 32.8 41.1 47.5 65.3 19.8 41.4 21.3 22.8 24.7 44.5 0.5 0.6 0.4 1.1 0.4 0.9 0.6 0.7 1.1 1.2 0.5 0.6 1.2 0.0 1.4 0.2 0.6 0.6 0.4 2.3 2.4 2.3 2.9 2.3 2.3 3.0 2.4 2.3 3.1 2.2 2.6 3.1 13.1 9.6 12.0 23.8 12.3 29.6 12.3 14.4 23.9 18.4 11.0 12.3 4.4 17.2 8.6 5.5 35.5 12.0 9.6 24.4 1.9 10.7 81.4 10.6 12.7 10.6 10.8 24.6 25.8 13.3 21.6 9.6 23.9 16.7 2.5 20.4 6.8 9.5 10.9 3.3 36.4 23.5 14.2 7.9 10.1 20.8 12.5 7.8 3.6 10.3 11.0 3.9 15.5 22.6 24.4 16.4 13.9 9.8 19.4 26.4 23.0 4.4 6.4 24.8 0.0 13.3 9.0 19.7 19.4 29.1 23.4 7.3 13.0 9.9 32.5 16.3 AC135068.1 ENSG00000278263 "Novel protein, identical to IGHV4-4" 15 21742364-21742799 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 52.7;lymphoid tissue: 58.4;urinary bladder: 98.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 45 "B-cells: 24.0" "Not detected" "Not detected" NA NA "unprognostic (1.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.52e-4)" "unprognostic (1.05e-1)" "unprognostic (9.75e-3)" "unprognostic (1.80e-2)" "unprognostic (5.51e-6)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-1)" 1.0 0.0 0.2 27.6 0.1 4.3 5.4 0.0 0.0 3.7 0.0 52.7 22.8 0.2 0.0 3.7 0.5 0.5 2.1 0.1 0.4 0.2 1.0 5.5 5.5 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.4 22.3 0.0 30.4 2.1 0.0 1.1 6.0 0.0 0.0 9.5 22.5 0.1 0.0 7.8 0.7 0.0 58.4 98.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.2 0.1 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794685-135802787 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 1.3;testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.1;HMC-1: 3.0;Karpas-707: 2.6;RPMI-8226: 4.5;U-266/84: 13.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.9 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 7.1" "Cell type enriched" "Detected in single" 9 "Early spermatids: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CAPAN-2: 34.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 1.0 1.5 1.5 0.5 1.5 1.8 1.2 1.7 2.8 0.9 1.5 1.3 0.5 2.1 0.0 2.3 2.3 0.7 0.9 1.5 1.3 1.5 2.1 1.3 0.7 2.1 2.0 1.5 1.8 1.6 0.0 1.9 0.2 3.0 2.5 0.0 1.6 1.7 0.1 1.3 2.2 2.1 0.2 0.6 2.3 1.3 7.1 1.2 1.5 1.2 0.0 0.6 1.6 2.1 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 7.7 0.1 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.3 0.0 1.2 0.0 0.0 3.3 6.9 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 1.7 2.8 1.5 1.3 2.1 2.0 1.5 3.0 0.6 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GGNBP2 "DIF-3, DIF3, FLJ21230, FLJ22561, LZK1, ZFP403, ZNF403" ENSG00000278311 "Gametogenetin binding protein 2" Q9H3C7 17 36544912-36589848 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 467.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018914, HPA073392" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA018914: AB_2294667, HPA073392: AB_2686599" "unprognostic (2.68e-1)" "unprognostic (5.19e-2)" "unprognostic (2.35e-2)" "unprognostic (1.03e-1)" "unprognostic (3.41e-1)" "unprognostic (6.12e-2)" "unprognostic (1.88e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (3.29e-2)" "unprognostic (3.82e-1)" "unprognostic (1.07e-1)" "unprognostic (4.28e-2)" "unprognostic (3.75e-1)" "unprognostic (1.47e-1)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 39.4 30.8 25.7 29.8 26.1 80.6 35.6 28.2 30.3 32.4 26.9 39.1 34.1 34.3 26.9 34.2 35.0 25.4 30.7 25.6 27.2 31.5 36.9 33.7 50.2 26.5 27.2 24.0 40.3 35.6 31.8 26.9 27.3 27.6 28.1 31.0 27.0 33.5 24.2 53.1 40.4 44.4 27.8 25.9 39.7 35.1 60.6 26.2 36.9 29.7 32.5 46.9 37.5 35.0 27.8 48.0 49.4 45.8 38.9 53.5 63.9 33.0 60.0 48.1 44.4 44.2 48.6 34.5 64.5 37.2 47.7 44.4 46.9 37.2 55.6 58.1 38.9 36.1 36.2 55.1 43.7 55.1 63.1 47.1 62.3 68.4 45.2 61.4 56.6 38.9 46.2 51.2 62.0 62.5 29.5 65.6 51.2 13.9 31.0 26.1 44.3 60.9 42.8 58.6 93.2 37.1 32.3 58.1 33.5 97.1 46.2 63.0 64.2 39.9 62.4 43.0 41.5 62.4 42.2 50.0 48.7 40.9 34.6 38.6 42.8 31.6 67.8 37.1 35.9 43.6 56.6 46.9 41.5 42.0 48.5 66.0 62.0 44.9 40.4 39.9 84.1 50.1 20.8 25.7 26.1 28.2 30.3 25.6 27.2 26.5 27.2 24.0 27.6 25.9 26.2 27.8 85.0 67.3 84.2 38.5 110.2 96.0 98.9 128.8 111.5 70.2 58.9 46.9 81.1 60.1 118.6 31.3 37.5 82.4 132.3 94.7 52.8 74.0 467.4 87.3 84.2 82.2 57.4 71.1 46.9 68.5 77.4 86.6 56.1 104.3 97.5 52.2 65.0 64.7 73.5 57.2 43.3 79.6 101.7 77.9 66.7 130.6 79.6 84.7 58.7 33.7 103.0 71.8 94.7 29.1 48.6 73.2 74.2 72.2 84.4 83.9 124.9 63.6 107.0 71.5 59.2 99.0 114.9 335.2 98.7 91.9 96.5 95.6 117.8 53.5 97.4 102.4 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.9" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favorable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 0.4 1.7 1.2 0.1 1.2 0.1 1.0 1.3 1.5 1.1 1.5 0.7 0.7 1.1 1.1 0.7 1.9 0.5 1.4 1.3 1.3 0.9 0.7 0.6 0.3 1.2 1.2 0.9 2.3 0.8 2.7 1.3 1.1 1.2 1.2 0.1 4.5 0.7 0.8 0.8 0.3 0.4 0.8 1.0 0.6 0.6 0.7 1.4 1.1 2.0 1.2 0.3 0.8 0.5 1.6 0.0 3.7 2.7 0.0 2.9 2.4 0.0 4.4 1.4 2.1 2.8 0.0 0.6 0.0 1.7 2.5 3.4 1.3 0.0 2.8 1.4 0.0 1.4 0.4 1.2 0.3 5.0 0.0 0.0 3.4 0.0 1.7 6.9 2.9 2.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 3.4 0.0 1.0 0.0 0.0 1.3 2.1 5.5 0.7 1.0 1.9 0.3 0.0 2.0 0.0 0.0 1.9 1.3 0.1 0.5 0.1 3.1 2.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.0 1.5 0.0 0.0 0.0 0.1 1.2 1.2 1.3 1.5 1.3 1.3 1.2 1.2 0.9 1.2 1.0 1.4 1.6 1.4 0.0 0.0 5.9 0.4 0.1 0.7 2.0 1.8 5.8 2.1 2.2 3.7 0.0 1.3 0.0 4.2 0.9 0.0 0.2 3.9 1.7 0.7 1.6 1.7 1.3 0.0 2.1 3.1 1.2 0.6 1.0 2.6 1.0 0.0 3.4 1.4 0.2 0.7 1.7 4.5 0.3 0.0 0.6 0.0 0.5 0.9 0.3 0.0 1.0 0.1 4.7 0.0 7.5 2.2 2.0 0.3 1.9 0.0 1.6 0.3 1.6 4.5 6.9 0.0 1.0 1.5 1.8 2.4 1.4 0.0 0.8 0.2 3.4 0.5 0.9 AL354822.1 ENSG00000278384 Unmapped 51867-54893 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 8.1;Granulosa cells: 9.1;Rod photoreceptor cells: 7.5;Theca cells: 8.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" NA NA 0.6 2.3 4.1 1.2 3.4 0.3 0.7 1.1 3.6 0.5 1.5 1.0 0.9 1.3 0.7 1.0 1.1 0.7 1.8 2.3 2.6 0.7 0.7 0.8 1.3 5.4 2.9 0.9 1.4 0.8 0.9 0.7 5.2 1.1 1.1 5.7 1.0 0.5 1.3 2.8 1.5 1.0 1.9 1.8 0.8 1.4 3.1 0.4 1.7 0.5 0.7 0.4 13.8 0.0 0.7 0.0 4.0 0.0 0.0 3.4 0.3 0.8 0.0 0.1 0.8 2.8 1.1 0.9 0.7 0.8 0.3 1.1 1.8 0.1 0.6 2.2 2.2 5.0 2.5 0.1 0.8 4.6 0.1 2.4 0.6 0.0 0.6 0.3 0.1 4.2 5.5 0.5 1.9 0.3 0.3 1.6 1.0 1.7 0.0 0.6 4.4 1.1 0.6 3.2 2.3 0.0 1.6 0.8 1.2 2.1 0.7 2.6 1.2 2.5 0.9 2.1 4.0 3.0 0.0 1.9 0.6 4.5 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 4.1 3.4 1.1 3.6 2.3 2.6 5.4 2.9 0.9 5.2 1.9 3.1 13.8 0.6 3.2 4.1 0.0 1.2 1.7 0.8 2.7 1.2 8.1 0.7 0.8 0.0 1.5 1.7 1.8 4.2 1.3 1.6 0.8 0.0 1.0 0.1 3.6 4.1 1.5 0.0 0.4 0.0 0.9 0.5 2.4 2.0 5.9 0.0 9.1 2.5 0.9 0.4 3.3 0.0 0.5 6.1 0.8 1.9 0.1 2.1 0.7 1.8 0.0 1.2 1.6 5.2 0.0 0.0 1.0 0.3 1.5 1.3 1.4 0.5 0.4 6.9 7.5 0.0 3.9 2.2 0.0 0.1 0.9 2.8 0.4 1.7 8.5 0.5 0.9 H2AC4 "H2A/m, H2AFM, HIST1H2AB" ENSG00000278463 "H2A clustered histone 4" P04908 6 26033092-26033618 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.5;brain: 3.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 2.7;U-2 OS: 1.4" "Not detected" "Not detected" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.53e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (7.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.49e-1)" "unprognostic (1.04e-3)" "unprognostic (3.28e-1)" "unprognostic (7.78e-2)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" 0.1 0.0 0.9 0.0 0.5 1.5 0.0 2.5 0.5 0.1 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.1 0.2 0.3 0.9 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.1 0.7 3.2 0.4 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.6 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.9 0.5 0.2 2.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.4 0.7 0.7 1.2 0.0 1.0 0.4 0.2 0.5 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.1 1.4 0.1 0.1 0.6 0.9 0.0 0.2 1.2 0.1 0.0 0.0 1.0 0.1 0.4 0.0 1.5 0.4 0.6 0.5 0.7 0.1 0.2 0.2 0.5 0.0 0.0 0.2 0.0 0.9 0.5 2.5 0.5 0.6 1.0 0.9 1.3 0.2 1.0 0.5 3.2 3.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 C17orf78 FLJ39647 ENSG00000278505 "Chromosome 17 open reading frame 78" Q8N4C9 17 37375985-37392708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 95 "intestine: 128.6" "Cell type enriched" "Detected in some" 18 "Proximal enterocytes: 223.7" "Group enriched" "Detected in some" 8 "colorectal cancer: 0.8;stomach cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.73e-3)" "unprognostic (1.91e-1)" "unprognostic (8.98e-2)" "unprognostic (4.90e-3)" "unprognostic (5.31e-2)" "unprognostic (7.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.02e-1)" "unprognostic (7.62e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (5.53e-6)" "unprognostic (1.94e-2)" "unprognostic (7.23e-3)" "unprognostic (4.85e-2)" "unprognostic (3.19e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.3 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 0.0 7.5 0.0 0.0 0.0 223.7 0.3 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.1 12.1 0.0 POTEB3 ENSG00000278522 "POTE ankyrin domain family member B3" A0JP26 15 21405401-21440499 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 5.7" "Cell type enriched" "Detected in single" 5 "Spermatocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.5;RPMI-8226: 1.9" NA NA 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.8 0.0 0.1 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591879-36600804 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "intestine: 217.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 129.3;Distal enterocytes: 317.3;Paneth cells: 154.2;Proximal enterocytes: 527.9;Undifferentiated cells: 148.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted to digestive system" NA NA 42000 Cytosol "Golgi apparatus" "HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209" "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 9.8 10.6 6.9 5.5 7.3 4.4 11.0 6.5 9.6 8.1 7.8 67.2 217.9 5.8 2.0 14.7 7.3 2.4 16.5 7.7 8.3 18.6 15.0 4.3 2.4 7.1 7.0 7.2 5.1 15.5 9.5 13.4 2.0 7.8 8.1 57.7 22.6 10.3 4.6 16.8 14.0 178.5 6.3 5.8 4.8 11.8 17.1 7.6 2.1 12.0 10.0 3.6 6.8 10.6 7.6 13.9 10.0 3.6 13.8 1.2 2.5 10.6 3.8 2.6 11.9 10.7 22.2 10.1 0.8 1.9 4.0 4.8 13.9 11.5 6.7 10.5 7.1 15.2 3.7 10.1 35.6 5.5 3.0 1.2 2.2 7.3 8.6 6.5 1.9 8.8 11.2 36.1 9.3 5.9 12.5 12.6 5.5 4.5 14.2 0.4 15.2 12.8 22.0 9.9 11.4 10.4 4.9 16.0 12.9 33.3 6.6 19.1 3.6 4.8 1.6 18.2 7.6 10.0 14.1 16.7 4.4 6.5 9.3 5.5 0.1 0.1 0.4 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.7 0.0 6.9 7.3 6.5 9.6 7.7 8.3 7.1 7.0 7.2 7.8 5.8 7.6 7.6 9.1 0.0 1.5 4.2 3.3 4.2 8.9 2.8 4.0 20.7 14.6 13.3 9.6 2.8 2.4 7.3 129.3 7.9 1.4 317.3 58.7 10.7 22.9 10.2 5.0 6.7 12.1 31.5 8.2 11.4 4.7 3.4 8.6 6.8 0.0 5.3 5.3 12.7 3.5 16.8 9.6 72.2 2.0 1.9 4.2 30.5 4.1 2.6 19.6 2.8 3.6 15.8 1.0 4.0 2.0 7.5 154.2 5.3 9.1 11.7 527.9 43.1 3.8 71.0 0.0 5.9 5.9 27.7 6.5 12.0 6.0 7.0 3.1 9.3 148.5 15.2 ACACA "ACAC, ACC, ACC1" ENSG00000278540 "Acetyl-CoA carboxylase alpha" Q13085 17 37084992-37406836 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 138.1;Excitatory neurons: 230.7;Inhibitory neurons: 197.8;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 186.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013715, HPA036650, HPA063018" Approved Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA 110000 Cytosol "Nucleoli fibrillar center, Actin filaments" "CAB013715: , HPA036650: AB_2675228, HPA063018: AB_2684922" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.04e-2)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.24e-5)" "unprognostic (8.81e-2)" "unprognostic (6.56e-2)" "unprognostic (2.38e-3)" "unprognostic (3.38e-1)" "unprognostic (2.24e-1)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (4.89e-1)" "unprognostic (4.49e-2)" "unprognostic (2.03e-2)" 15.1 25.6 10.1 3.7 10.0 5.0 22.4 7.6 13.6 10.4 8.1 13.4 5.3 12.2 13.9 25.4 10.9 4.9 7.7 8.4 9.0 8.7 23.5 13.4 2.0 10.1 11.7 8.4 11.4 10.6 11.0 19.4 3.8 12.4 26.5 6.5 8.1 14.7 9.7 15.3 14.5 9.6 8.1 8.6 7.4 12.7 16.6 13.1 3.7 9.0 3.6 5.6 20.1 14.7 21.7 34.7 7.0 39.8 42.6 54.7 53.2 13.9 15.2 21.3 15.9 27.5 27.4 5.9 5.0 12.0 24.3 39.4 33.9 7.5 51.1 23.7 13.6 23.2 27.3 15.5 28.0 9.2 14.8 5.3 43.4 29.0 40.2 30.0 18.8 27.5 25.1 66.5 3.2 2.1 27.3 16.3 22.8 30.4 21.5 22.1 24.1 25.3 6.4 36.1 38.5 45.0 17.0 27.8 12.3 12.7 34.8 24.9 16.8 23.8 12.7 20.6 17.3 3.9 8.7 11.5 42.0 11.7 12.3 17.2 0.5 0.8 0.1 0.6 1.3 0.6 0.7 0.7 0.7 1.0 1.1 1.1 0.8 0.3 0.6 0.8 0.7 1.0 0.6 10.1 10.0 7.6 13.6 8.4 9.0 10.1 11.7 8.4 12.4 8.6 13.1 21.7 6.8 32.1 51.7 138.1 8.0 11.6 20.8 14.8 22.2 17.2 17.3 11.7 8.0 2.8 16.5 11.0 27.1 16.0 7.0 5.3 9.8 6.7 66.3 19.1 15.6 8.3 9.0 10.7 230.7 8.3 7.6 10.4 15.8 15.9 7.0 19.5 6.4 17.3 5.8 23.5 197.8 7.3 14.2 3.8 4.3 51.2 9.9 6.1 10.6 58.1 4.3 18.2 4.1 181.0 186.9 7.2 6.4 15.8 9.3 22.8 4.8 7.0 10.5 11.8 6.6 10.0 7.8 20.8 20.5 27.8 15.9 16.3 6.4 43.2 10.0 22.0 TMEM191B ENSG00000278558 "Transmembrane protein 191B" P0C7N4 22 18527802-18530573 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 55 "testis: 93.8" "Group enriched" "Detected in many" 8 "Early spermatids: 425.9;Late spermatids: 489.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.0;CACO-2: 1.2;U-266/70: 1.1" NA NA "unprognostic (1.70e-1)" "unprognostic (8.90e-2)" "unprognostic (3.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.60e-1)" "unprognostic (3.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (6.25e-2)" "unprognostic (4.90e-2)" "unprognostic (4.65e-2)" "unprognostic (4.44e-2)" "unprognostic (2.10e-2)" "unprognostic (3.54e-1)" "unprognostic (9.40e-2)" "unprognostic (9.22e-2)" 0.3 0.3 0.6 0.1 0.6 0.1 0.4 0.1 1.0 0.2 0.0 0.4 0.7 0.1 0.0 0.9 0.7 0.0 0.2 0.5 0.2 0.9 0.7 0.6 0.0 1.2 0.7 0.4 0.3 0.2 0.1 1.6 0.1 0.6 0.4 0.0 0.0 0.4 0.0 0.1 0.7 0.5 0.0 0.1 1.1 0.4 93.8 0.6 0.0 1.0 0.0 0.0 0.2 0.5 0.4 0.4 0.0 0.3 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.2 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 0.4 0.7 0.0 0.2 1.7 1.1 0.6 0.6 2.6 0.3 0.3 0.9 0.6 1.1 0.6 0.7 1.2 0.9 0.3 2.2 1.0 0.6 1.3 0.6 0.6 0.1 1.0 0.5 0.2 1.2 0.7 0.4 0.6 0.1 0.6 0.4 1.4 0.0 0.5 1.0 6.0 0.0 4.4 0.0 3.4 2.7 12.0 16.3 0.9 5.7 0.0 9.2 0.0 28.9 13.1 16.2 3.9 8.4 425.9 4.3 0.3 1.3 10.9 0.0 3.9 8.0 11.7 2.0 2.0 2.7 0.0 0.7 1.1 8.0 8.6 1.7 4.0 14.8 0.0 6.6 0.0 489.3 2.5 6.8 0.0 0.0 12.9 2.1 26.8 0.5 0.9 34.7 5.9 2.2 2.0 5.8 55.9 11.9 0.0 2.7 0.0 1.1 3.0 7.7 5.2 7.3 0.0 10.9 7.6 2.9 11.5 3.4 NR2E3 "PNR, rd7, RP37" ENSG00000278570 "Nuclear receptor subfamily 2 group E member 3" Q9Y5X4 15 71792638-71818259 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "DNA-binding, Receptor, Repressor" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 131 "retina: 132.6" "Cell type enriched" "Detected in some" 30 "Rod photoreceptor cells: 1357.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (9.85e-3)" "unprognostic (3.60e-2)" "unprognostic (2.59e-1)" "unprognostic (2.89e-1)" "unprognostic (3.51e-1)" "unprognostic (3.65e-1)" "unprognostic (4.75e-2)" "unprognostic (2.11e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.4 0.4 0.0 0.1 0.0 0.2 0.3 0.4 0.4 0.1 0.1 0.1 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.0 0.1 132.6 0.4 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.6 0.7 0.0 0.0 0.6 0.0 0.0 0.2 0.3 0.4 0.0 0.5 0.0 0.8 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.7 0.6 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.8 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 2.0 0.0 1.2 33.1 2.1 0.5 0.7 0.0 0.0 0.0 41.7 0.0 0.1 0.7 0.0 0.3 1.1 1.4 1.5 3.9 0.0 0.0 0.3 0.2 0.3 0.3 0.0 1.8 0.0 0.2 0.0 0.4 0.1 30.3 0.2 0.0 0.0 0.3 0.0 0.3 0.6 0.1 0.0 0.0 0.0 45.0 0.0 0.5 0.0 0.6 0.3 1.9 0.0 4.3 0.2 0.0 0.0 1357.8 0.0 3.3 0.3 0.6 0.4 0.8 0.0 0.0 0.0 4.3 0.5 1.1 H2BC10 "H2B/k, H2BFK, HIST1H2BI" ENSG00000278588 "H2B clustered histone 10" P62807 6 26272931-26273412 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 2.1;brain: 3.3;choroid plexus: 1.6;lymphoid tissue: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 8.7;THP-1: 3.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.1 0.0 0.5 0.2 0.4 2.1 0.1 3.3 0.5 0.3 1.6 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 1.7 0.1 0.1 0.4 0.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.9 0.4 0.1 0.3 1.1 2.2 0.2 0.0 0.2 0.1 0.4 1.4 1.1 0.4 0.6 0.0 0.0 0.0 0.1 0.5 0.3 0.9 2.5 0.4 0.1 0.5 0.3 0.2 0.4 0.6 0.9 0.2 0.4 1.6 0.0 0.2 0.5 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.8 1.3 0.0 2.2 0.0 0.3 8.7 1.5 1.6 0.3 0.0 2.3 0.0 2.7 0.0 0.2 0.2 0.5 0.6 0.5 0.0 0.0 0.0 3.7 0.5 0.4 0.0 0.3 1.8 1.9 0.3 0.0 0.5 0.3 1.2 0.0 0.2 0.0 1.2 0.5 0.7 0.7 1.2 1.6 0.2 1.4 0.4 0.3 0.3 0.1 0.0 0.1 0.5 0.1 0.5 0.4 3.3 0.5 0.2 1.7 0.9 0.9 0.0 1.0 0.9 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "HHSteC: 4.1;HL-60: 1.0" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.4 0.8 0.0 0.0 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 1.2 0.3 1.3 0.4 0.0 0.1 0.9 0.9 0.6 0.7 0.2 0.0 0.0 0.6 1.7 0.0 0.7 0.0 0.3 1.4 0.0 0.3 0.5 0.0 0.4 0.9 0.8 0.0 0.0 1.1 0.5 3.3 0.0 0.0 0.6 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf98 C11orf48 ENSG00000278615 "Chromosome 11 open reading frame 98" E9PRG8 11 62662817-62665210 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 33.6;Erythroid cells: 25.2;Gastric mucus-secreting cells: 50.0;Plasma cells: 58.3;Squamous epithelial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (3.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (3.30e-1)" "unprognostic (8.35e-2)" "unprognostic (3.02e-3)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (2.14e-2)" "unprognostic (4.33e-2)" "unprognostic (1.29e-2)" "unprognostic (4.70e-3)" 45.2 63.9 69.4 57.8 70.1 38.3 46.3 71.3 110.2 39.1 66.6 54.8 45.9 38.0 31.9 67.4 41.4 27.4 59.8 67.2 70.3 63.2 74.6 44.7 73.1 70.7 68.6 63.5 35.3 48.0 30.1 36.0 30.0 70.6 56.0 51.0 80.9 43.7 29.5 68.2 50.6 57.5 30.4 68.5 69.2 62.6 66.4 70.6 64.3 41.6 36.2 69.9 50.8 41.6 77.9 265.0 162.8 115.3 140.6 66.5 74.8 63.6 129.6 89.1 145.8 100.2 172.8 144.2 164.3 191.8 81.2 100.6 173.8 115.0 130.5 104.5 178.3 69.2 162.7 101.3 174.9 96.0 254.9 143.0 78.6 150.6 151.7 150.5 87.0 117.1 137.3 202.9 76.1 124.0 337.9 185.1 230.6 188.8 194.6 140.8 139.3 106.1 206.2 163.5 135.0 98.4 110.4 102.5 283.2 182.2 89.4 304.4 91.0 99.4 109.3 147.1 278.7 234.1 74.8 123.9 153.7 141.9 101.4 140.1 340.2 187.3 388.7 202.5 206.3 223.2 352.0 224.4 252.2 166.0 313.6 202.5 250.1 201.9 273.2 217.0 279.3 331.4 288.3 69.4 70.1 71.3 110.2 67.2 70.3 70.7 68.6 63.5 70.6 68.5 70.6 77.9 3.0 9.6 5.1 0.0 20.0 0.0 0.3 0.0 33.6 0.1 2.9 2.2 0.1 2.8 5.6 1.8 0.0 1.6 3.6 0.8 1.9 4.2 1.6 5.2 4.8 4.0 0.0 25.2 0.0 2.3 2.1 6.5 50.0 4.3 11.4 0.7 2.9 12.0 1.5 0.0 0.0 0.9 0.0 5.0 0.0 1.3 1.2 11.3 0.0 0.0 8.2 0.2 2.1 0.0 0.0 4.7 1.7 0.7 58.3 0.3 3.1 7.1 13.1 0.7 6.6 0.2 3.7 1.2 0.8 57.1 0.0 1.8 19.6 1.0 0.8 0.6 MRM1 FLJ22578 ENSG00000278619 "Mitochondrial rRNA methyltransferase 1" Q6IN84 17 36601583-36608964 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021598 Supported Supported Mitochondria NA NA Mitochondria "HPA021598: AB_1854097" "unprognostic (9.07e-3)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (1.19e-1)" "unprognostic (4.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (4.90e-2)" "unprognostic (2.47e-2)" "unprognostic (8.56e-2)" "unprognostic (2.75e-1)" "unprognostic (5.67e-2)" "unprognostic (2.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.74e-2)" 3.4 6.0 2.2 1.1 3.1 2.1 3.9 1.9 5.3 4.4 1.3 5.1 2.8 4.6 1.4 5.3 4.2 0.3 6.1 2.1 2.9 4.9 7.3 2.8 3.0 2.7 3.2 2.2 5.0 6.2 2.7 2.9 0.7 3.7 4.9 3.1 0.6 4.2 2.5 8.2 3.5 6.1 0.7 1.8 6.0 4.6 2.3 2.7 2.0 4.2 4.8 0.6 5.9 4.3 3.6 1.5 8.7 0.0 5.0 4.3 5.1 15.5 0.3 0.0 0.0 0.0 0.7 0.2 0.7 9.5 0.0 4.0 20.0 0.2 0.4 0.0 7.5 2.9 15.2 5.1 8.9 2.2 7.9 7.5 4.0 0.4 10.2 0.0 1.4 5.2 6.7 9.9 4.9 6.0 0.2 14.6 4.6 0.2 19.9 0.1 12.1 0.0 19.5 4.4 9.3 4.1 3.1 0.0 6.1 6.5 5.5 6.8 2.6 2.0 5.0 8.9 5.7 0.1 11.9 15.3 6.5 0.0 8.0 4.0 0.0 2.0 0.0 2.8 3.0 5.3 4.4 2.2 2.7 2.1 3.9 3.5 3.8 0.0 6.0 1.5 2.4 2.0 2.4 2.2 3.1 1.9 5.3 2.1 2.9 2.7 3.2 2.2 3.7 1.8 2.7 3.6 1.3 0.0 1.5 4.9 3.8 1.1 2.9 2.7 2.8 1.1 2.6 1.7 7.8 2.8 1.6 3.7 4.2 7.0 0.6 5.3 9.8 4.2 0.1 1.0 2.9 2.9 1.8 5.0 9.6 1.8 7.4 1.8 3.1 1.3 0.0 3.9 1.8 2.1 6.2 6.7 8.2 5.3 2.0 1.0 0.4 0.0 3.4 1.5 1.8 0.0 2.2 1.7 2.1 5.5 4.0 2.2 5.4 1.5 2.2 5.6 5.4 5.1 0.6 1.2 0.0 1.9 2.0 1.3 3.0 3.3 0.4 1.8 2.2 4.5 9.0 2.2 AC023491.2 ENSG00000278633 "Putative POM121-like protein 1" Unmapped 10598-13001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 200 "testis: 35.6" "Cell type enriched" "Detected in some" 27 "Spermatocytes: 38.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H4C1 "H4FA, HIST1H4A" ENSG00000278637 "H4 clustered histone 1" P62805 6 26021649-26022050 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 21.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 21.8" "Group enriched" "Detected in some" 6 "eosinophil: 2.9;neutrophil: 10.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 10.5" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;NB-4: 8.4;REH: 9.1" "Not detected" "Not detected" "CAB021887, HPA042201" Supported NA NA 25000000 "CAB021887: AB_2279758, HPA042201: AB_2677898" "unprognostic (5.71e-2)" "unprognostic (3.41e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.75e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (9.76e-2)" "unprognostic (5.99e-2)" "unprognostic (6.42e-2)" 0.0 0.0 0.4 1.0 0.4 1.7 0.1 21.8 4.1 0.1 0.0 0.1 1.1 0.1 0.3 0.5 0.0 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.7 0.0 2.9 0.3 0.1 0.0 0.0 0.0 0.1 5.8 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.9 3.4 0.5 0.0 0.9 0.2 0.0 1.5 2.9 1.1 2.2 0.0 0.4 0.0 0.0 0.2 0.7 0.9 1.4 0.0 4.0 2.0 0.7 0.0 0.1 3.4 1.5 0.0 0.3 0.3 1.1 1.8 1.0 0.0 0.0 0.4 4.1 0.0 0.0 0.3 0.0 0.0 0.9 2.3 0.9 3.0 0.0 0.9 10.1 8.4 1.7 0.6 0.0 9.1 1.5 1.6 0.0 0.2 3.0 1.3 1.1 4.3 0.1 0.0 2.3 2.1 0.0 2.2 5.6 2.1 2.4 1.2 2.0 0.0 1.0 3.3 4.3 0.0 0.8 2.9 0.9 0.7 0.2 0.3 0.9 0.3 0.7 0.5 0.3 0.2 10.5 1.1 0.1 0.4 1.1 0.1 0.4 0.4 21.8 4.1 0.5 0.5 0.0 2.9 0.3 5.8 0.4 0.9 1.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 AC008162.2 ENSG00000278646 "Novel protein similar to cancer/testis antigen family 47, member A12 (CT47A12)" X 120877496-120878924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-266/70: 3.8" HPA042483 Supported Uncertain Nucleoli NA NA Nucleoli "HPA042483: AB_2678017" 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAJ37 ENSG00000278661 "T cell receptor alpha joining 37" 14 22503750-22503814 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.9;retina: 28.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 201.9;memory CD8 T-cell: 72.3;naive CD4 T-cell: 140.8;naive CD8 T-cell: 79.5;T-reg: 183.9" "Lineage enriched" "Detected in many" 90 "T-cells: 201.9" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;JURKAT: 2.4;U-266/84: 1.1" NA NA "unprognostic (5.96e-2)" 0.0 4.0 1.6 20.9 1.3 2.0 0.0 1.2 0.8 0.0 0.3 2.1 4.5 0.0 7.5 0.0 0.6 0.0 0.0 0.5 1.3 0.5 0.0 1.9 22.9 1.0 1.3 0.2 0.0 0.0 0.0 0.0 0.4 1.4 1.9 0.7 28.1 4.0 0.0 0.0 0.7 4.2 1.1 0.8 5.9 6.1 0.4 0.6 5.9 0.0 0.0 8.4 0.0 0.0 1.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 1.4 0.0 0.3 10.2 0.1 23.5 0.4 201.9 72.3 1.0 0.2 140.8 79.5 2.2 1.6 0.5 0.0 183.9 34.7 1.6 1.3 1.2 0.8 0.5 1.3 1.0 1.3 0.2 1.4 0.8 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L10 GOLGA6L18 ENSG00000278662 "Golgin A6 family like 10" A6NI86 15 82339993-82349475 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.8" "Cell type enriched" "Detected in many" 5 "Early spermatids: 175.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.3;K-562: 1.1;SuSa: 1.2" NA NA "unprognostic (8.06e-2)" "unprognostic (2.56e-1)" "unprognostic (2.51e-1)" "unprognostic (8.31e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.37e-2)" "unprognostic (6.12e-2)" "unprognostic (7.01e-2)" "unprognostic (4.10e-1)" "unprognostic (2.36e-4)" "unprognostic (8.30e-2)" "unprognostic (6.06e-6)" "unprognostic (4.13e-2)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (5.34e-2)" 1.3 1.9 0.4 0.1 0.4 0.3 1.5 0.3 0.4 3.3 1.1 2.1 0.1 2.1 0.1 6.3 3.3 0.3 1.5 0.3 0.3 1.5 1.3 1.6 0.1 0.3 0.2 0.3 3.6 3.0 0.2 2.1 0.1 0.4 2.2 0.1 0.6 4.7 0.1 1.8 2.3 1.6 0.2 0.2 1.4 2.8 16.8 0.2 0.1 2.0 0.2 0.1 2.6 5.5 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.3 0.6 0.1 0.0 0.0 0.0 3.3 0.0 0.7 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.5 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.7 0.1 0.2 0.0 1.0 1.2 0.2 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.4 0.2 0.2 0.3 1.4 6.4 5.5 2.3 0.9 0.0 4.4 0.0 1.2 6.1 2.2 2.0 2.2 2.8 3.1 5.5 4.2 2.6 2.3 1.0 0.0 2.8 175.7 11.2 3.0 1.1 4.9 0.0 1.9 2.9 0.6 2.6 5.1 6.0 1.3 6.7 2.5 2.0 0.8 3.3 1.5 2.4 0.0 0.3 0.0 26.5 3.7 0.8 0.0 1.0 0.1 4.5 1.0 2.0 0.4 4.8 3.3 1.5 0.7 2.9 2.5 0.5 2.2 7.5 0.0 1.6 1.2 34.0 12.4 3.1 0.0 0.3 0.7 4.6 3.5 3.3 H2AC17 "H2A.1, H2A/n, H2AFN, HIST1H2AM" ENSG00000278677 "H2A clustered histone 17" P0C0S8 6 27892699-27893185 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2;brain: 6.5" "Cell type enhanced" "Detected in some" "dendritic cells: 1.2;Syncytiotrophoblasts: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 63.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 28.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (6.05e-2)" "unprognostic (4.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.79e-1)" "unprognostic (1.26e-1)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.70e-1)" "unprognostic (6.36e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-3)" "unprognostic (4.24e-1)" "unprognostic (8.85e-6)" "unprognostic (2.44e-1)" "unprognostic (3.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.30e-1)" 0.2 0.4 1.4 0.2 1.4 3.2 0.3 1.3 1.2 0.5 2.8 0.8 0.7 0.3 0.2 0.9 0.0 0.0 0.2 0.5 3.6 0.2 0.5 0.7 1.5 2.6 2.9 0.2 0.0 0.3 0.4 0.0 0.9 2.6 0.6 0.6 0.0 0.3 0.0 0.2 0.3 0.8 0.0 3.2 1.2 0.4 0.9 2.6 2.2 0.7 0.0 0.4 0.3 0.8 6.5 3.7 2.6 2.3 5.4 0.3 0.2 4.8 1.2 0.6 2.4 3.1 0.9 1.6 5.8 4.3 0.7 2.9 2.2 2.3 1.6 1.9 4.6 1.3 2.9 3.5 3.9 0.0 2.1 2.4 1.8 0.0 1.7 0.0 0.2 2.3 4.2 12.5 8.0 0.4 6.8 12.6 8.9 4.2 2.1 1.2 7.7 3.6 11.9 1.2 0.9 8.9 1.6 6.5 0.6 0.9 1.2 5.4 1.7 0.0 1.1 0.2 1.2 2.0 9.0 28.9 14.2 1.5 9.7 1.0 63.8 5.0 21.1 10.0 6.0 5.9 13.5 8.8 8.6 18.3 15.3 3.5 4.2 16.7 8.5 10.5 22.5 13.4 9.7 1.4 1.4 1.3 1.2 0.5 3.6 2.6 2.9 0.2 2.6 3.2 2.6 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 IQCA1L "IQCA1P1, TCAG_9762" ENSG00000278685 "IQ motif containing with AAA domain 1 like" A6NCM1 7 151190873-151205496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 4.4" "Group enriched" "Detected in some" 52 "Early spermatids: 46.9;Late spermatids: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX004987.1 ENSG00000278704 Unmapped 56140-58376 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "brain: 16.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.0;Collecting duct cells: 1.8;Cytotrophoblasts: 1.0;Exocrine glandular cells: 1.2" "Region enhanced" "Detected in many" "white matter: 16.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 24.4;SuSa: 10.3;U-2 OS: 17.4" NA NA 1.1 1.1 4.2 0.4 0.9 0.3 0.5 0.3 2.0 0.3 0.0 0.4 0.7 0.4 1.3 0.4 0.4 0.6 0.6 1.8 0.6 0.3 0.4 1.4 0.6 2.9 1.0 0.1 0.4 0.3 0.4 1.7 3.8 0.5 0.5 1.8 0.8 0.2 0.9 1.6 0.6 0.1 0.1 1.2 0.4 1.7 1.3 0.3 1.2 0.2 0.3 0.3 16.9 2.8 6.3 0.2 0.8 0.3 0.2 4.7 0.2 0.1 0.0 0.0 1.1 0.2 0.7 1.0 0.2 0.7 0.3 1.0 1.4 0.0 0.7 2.3 0.8 5.7 5.9 0.3 0.1 3.7 0.2 0.2 0.3 0.2 0.0 0.0 0.4 24.4 7.6 0.0 3.2 1.4 1.0 3.9 0.3 5.5 0.0 0.5 7.8 0.3 0.0 0.0 4.5 0.1 4.4 1.0 10.3 9.1 0.9 0.2 1.9 17.4 1.6 0.4 7.3 9.1 0.8 1.2 0.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.9 0.3 2.0 1.8 0.6 2.9 1.0 0.1 3.8 0.1 1.3 16.9 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 1.8 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.6 0.3 0.5 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 H4C2 "H4/I, H4FI, HIST1H4B" ENSG00000278705 "H4 clustered histone 2" P62805 6 26026815-26027252 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 88.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 88.6" "Immune cell enriched" "Detected in many" 6 "neutrophil: 43.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 43.0" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042201 Supported NA NA 25000000 "HPA042201: AB_2677898" "unprognostic (1.16e-1)" "unprognostic (2.18e-2)" "unprognostic (2.12e-1)" "unprognostic (6.31e-3)" "unprognostic (2.32e-1)" "unprognostic (1.52e-1)" "unprognostic (6.07e-2)" "unprognostic (2.57e-1)" "unprognostic (1.52e-1)" "unprognostic (7.87e-2)" "unprognostic (2.56e-1)" "unprognostic (6.30e-2)" "unprognostic (1.69e-3)" "unprognostic (4.39e-2)" "unprognostic (3.17e-1)" "unprognostic (4.50e-2)" "unprognostic (1.58e-2)" 0.2 0.0 6.3 0.0 4.8 2.0 0.2 88.6 9.9 0.4 9.5 0.2 0.1 0.1 0.0 0.1 0.4 0.0 0.1 3.1 8.6 0.2 0.4 0.2 0.6 5.9 14.6 1.6 0.2 0.1 0.0 0.1 0.1 22.8 0.2 0.0 0.2 0.4 0.0 0.2 0.1 0.1 0.0 8.7 0.2 0.2 0.2 14.4 2.0 0.4 0.0 0.1 0.1 0.2 8.7 0.9 0.0 0.1 1.8 0.0 0.0 0.0 1.4 0.1 0.8 0.5 0.3 0.2 0.7 0.2 0.3 0.5 0.2 0.4 0.0 0.5 0.3 1.9 2.4 1.2 1.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.6 0.2 1.4 2.4 1.9 0.4 0.4 0.3 1.7 0.8 1.5 0.0 0.6 0.5 0.3 0.2 1.0 0.0 0.0 0.2 1.2 0.0 0.5 1.2 1.0 1.8 1.4 1.5 1.2 0.7 0.7 0.9 0.0 0.9 1.3 1.7 1.2 1.5 2.7 1.8 1.3 0.7 6.7 1.4 0.8 43.0 0.3 2.4 2.3 1.3 0.5 6.3 4.8 88.6 9.9 3.1 8.6 5.9 14.6 1.6 22.8 8.7 14.4 8.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 AC136616.3 ENSG00000278782 Unmapped 1157687-1240349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.9;cervix: 5.4;intestine: 4.6;lymphoid tissue: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 11 "naive B-cell: 5.0" "Lineage enriched" "Detected in single" 50 "B-cells: 5.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.5 0.0 0.8 4.9 0.0 0.1 5.4 0.0 2.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.3 0.0 0.0 0.0 4.6 0.0 0.0 2.2 0.4 0.0 0.0 0.6 0.0 0.0 7.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PWWP4 ENSG00000278803 "PWWP domain containing 4" X 153271618-153277803 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "brain: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.3 0.3 0.9 0.2 0.1 0.4 0.3 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007325.4 ENSG00000278817 "Protein DGCR6" Unmapped 131494-137392 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 50.9;choroid plexus: 34.9;heart muscle: 54.8;skeletal muscle: 111.9;tongue: 134.8" "Group enriched" "Detected in many" 13 "Early spermatids: 164.0;Late spermatids: 640.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 16.0;AN3-CA: 9.6;HEK 293: 9.4;T-47d: 11.2" NA NA 3.6 4.4 32.0 0.1 28.8 2.8 6.2 30.3 50.9 1.0 34.9 0.5 0.8 0.4 1.2 3.8 1.6 0.9 54.8 29.6 28.9 2.4 7.0 2.4 0.9 30.9 30.5 29.4 0.1 13.5 3.9 0.7 31.4 2.8 0.3 1.2 9.1 1.0 111.9 6.3 0.3 0.5 28.1 0.9 0.5 3.6 31.7 1.9 6.1 134.8 0.3 0.5 32.6 0.6 16.0 0.3 9.6 2.5 0.0 0.5 1.5 0.0 1.7 0.1 0.8 3.3 0.0 3.9 0.0 1.6 0.1 0.7 0.9 0.1 1.3 9.4 0.1 1.7 0.0 7.2 1.7 0.0 0.7 2.5 0.0 0.1 0.0 0.9 4.7 0.8 7.0 0.1 3.3 0.1 0.5 0.4 5.4 6.8 0.7 7.8 0.1 1.9 0.0 0.1 1.8 5.4 2.7 3.8 1.8 11.2 0.9 0.0 0.2 1.1 0.1 0.2 1.6 0.1 0.0 0.9 4.5 2.3 1.6 6.4 3.7 1.7 7.8 4.0 0.8 2.8 1.9 4.8 1.3 3.7 3.2 0.3 0.8 8.2 0.5 3.1 4.5 32.0 28.8 30.3 50.9 29.6 28.9 30.9 30.5 29.4 31.4 28.1 31.7 32.6 2.0 0.0 5.6 0.0 1.1 0.0 2.2 0.0 0.0 3.0 21.8 23.4 0.0 14.3 1.8 3.7 0.0 8.6 1.1 1.2 25.4 2.8 164.0 4.8 1.6 3.0 0.0 2.7 0.0 9.3 5.7 1.8 0.0 1.0 0.0 0.6 3.3 14.4 5.7 5.0 0.0 3.8 0.0 7.3 0.0 640.5 4.7 2.2 0.0 0.0 2.7 22.4 0.0 0.0 0.0 4.3 2.7 10.1 0.0 0.9 29.4 16.7 10.2 1.2 13.1 12.2 2.8 5.2 6.6 0.0 0.0 4.9 1.1 1.4 1.3 1.6 H3C10 "H3/k, H3F1K, H3FK, HIST1H3H" ENSG00000278828 "H3 clustered histone 10" P68431 6 27810064-27811300 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 6.5" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 4.4;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.3;Syncytiotrophoblasts: 5.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 8 "basophil: 101.9;neutrophil: 37.8" "Lineage enriched" "Detected in all" 12 "granulocytes: 101.9" "Cell line enhanced" "Detected in many" "K-562: 33.7;SiHa: 28.3;U-266/70: 23.5;U-266/84: 61.3" HPA042570 Approved NA Yes "HPA042570: AB_2678056" "unprognostic (1.61e-1)" "prognostic favorable (4.35e-4)" "unprognostic (1.79e-1)" "unprognostic (1.63e-2)" "unprognostic (3.68e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (3.01e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.25e-6)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.73e-5)" "unprognostic (4.09e-1)" "unprognostic (4.94e-1)" "unprognostic (3.70e-1)" "unprognostic (2.82e-2)" 0.9 1.3 0.7 0.4 0.7 4.4 0.8 0.7 1.3 1.5 2.1 2.5 1.3 0.3 0.5 3.3 0.8 0.5 0.7 0.9 1.0 1.1 2.5 4.0 1.0 0.8 0.8 0.5 1.9 0.2 0.8 0.4 0.9 0.8 2.6 2.6 0.1 0.6 0.2 0.6 0.9 1.3 0.2 1.1 6.5 1.5 1.4 0.9 3.1 1.2 1.1 0.4 0.6 2.9 2.3 1.9 7.2 3.0 2.5 4.2 0.5 0.4 1.0 0.7 3.4 1.3 2.2 2.1 1.3 6.5 0.8 2.0 3.9 1.1 1.7 2.2 9.2 4.4 1.8 6.9 9.3 1.1 1.6 2.7 5.6 0.5 0.7 0.8 1.5 1.4 1.7 33.7 15.5 0.7 14.5 3.0 3.6 1.5 13.3 2.7 1.6 0.0 17.0 3.6 0.8 9.3 1.8 28.3 5.7 1.2 1.6 13.4 0.5 1.6 1.5 4.5 0.9 0.4 23.5 61.3 5.0 0.1 7.9 0.3 101.9 4.2 9.2 1.4 1.3 1.7 1.4 2.2 2.0 3.3 5.3 1.4 1.1 37.8 1.7 1.5 7.1 8.1 203.1 0.7 0.7 0.7 1.3 0.9 1.0 0.8 0.8 0.5 0.8 1.1 0.9 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 0.0 MRPL45 MGC11321 ENSG00000278845 "Mitochondrial ribosomal protein L45" 17 38297023-38323217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 35.7;Daudi: 80.9;K-562: 57.0;REH: 43.2;RPMI-8226: 34.4;RT4: 33.9;U-266/84: 52.1;U-698: 56.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023373, HPA023385" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA023373: AB_1854114, HPA023385: AB_1854115" "unprognostic (8.56e-3)" "unprognostic (4.09e-2)" "unprognostic (1.11e-2)" "unprognostic (3.08e-1)" "unprognostic (9.50e-2)" "unprognostic (2.22e-3)" "unprognostic (1.11e-2)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.35e-1)" "unprognostic (6.01e-3)" "unprognostic (3.07e-1)" "unprognostic (1.00e-1)" "unprognostic (2.40e-1)" "unprognostic (8.13e-2)" 24.0 26.9 4.3 2.2 4.0 1.9 24.3 3.4 8.4 20.3 4.0 24.7 0.0 21.6 0.0 25.6 20.0 4.0 28.3 4.0 3.6 26.2 31.0 15.3 8.1 4.1 4.1 3.4 28.5 37.1 9.1 13.2 1.7 4.8 18.2 5.8 1.4 22.6 0.0 62.4 26.4 19.8 0.7 3.4 16.4 30.2 9.6 3.9 2.7 18.4 0.0 7.0 22.3 20.3 6.0 0.0 0.5 35.7 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 26.8 80.9 0.2 0.0 24.2 0.5 0.2 0.0 0.1 0.0 0.3 31.1 0.0 2.1 12.7 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 57.0 0.0 0.2 0.0 23.1 0.0 0.3 0.1 0.0 43.2 0.2 34.4 0.0 33.9 0.1 0.2 0.2 0.6 0.2 0.1 0.1 0.2 0.5 15.1 0.1 0.0 0.3 23.2 52.1 56.9 0.1 0.0 0.4 0.6 6.7 2.2 5.3 8.2 6.4 7.6 7.7 4.1 11.3 6.8 9.8 6.6 0.2 9.8 2.3 4.8 6.6 6.3 4.3 4.0 3.4 8.4 4.0 3.6 4.1 4.1 3.4 4.8 3.4 3.9 6.0 20.4 12.8 12.1 6.8 23.8 30.2 39.3 54.6 42.7 10.9 41.3 37.7 46.5 32.9 23.9 25.8 8.4 69.3 16.3 11.3 60.7 41.5 18.3 21.6 25.6 26.9 16.3 45.9 10.4 37.5 67.7 25.1 24.5 21.1 23.5 31.4 22.5 30.4 42.6 16.8 12.0 27.4 34.6 39.1 21.1 15.0 20.8 22.2 19.6 1.9 43.8 13.0 22.6 7.5 9.2 29.6 15.5 16.6 23.7 28.8 32.0 64.0 21.6 11.1 6.6 28.4 25.2 30.6 18.0 31.9 32.4 71.1 19.3 42.6 41.8 33.3 TP53TG3F ENSG00000278848 "TP53 target 3 family member F" Q9ULZ0 16 33459045-33462249 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "epididymis: 6.1;testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;U-266/84: 1.2" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGKV1D-12 ENSG00000278857 "Immunoglobulin kappa variable 1D-12" P01611 2 90159840-90160335 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.9;lymphoid tissue: 47.9;salivary gland: 34.9" "Cell type enriched" "Detected in some" 178 "Plasma cells: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "memory B-cell: 13.0;naive B-cell: 12.2" "Lineage enriched" "Detected in single" 35 "B-cells: 13.0" "Cell line enhanced" "Detected in single" "RH-30: 2.2" HPA048721 Approved "Immunoglobulin genes" NA NA 12000000000 "HPA048721: " "unprognostic (1.94e-4)" "unprognostic (9.04e-4)" "unprognostic (3.42e-2)" "prognostic favorable (3.23e-4)" "unprognostic (3.09e-2)" "unprognostic (4.66e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (1.61e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 0.9 0.3 0.0 9.7 0.0 0.9 7.7 0.0 0.2 2.4 0.0 17.7 1.6 1.3 0.0 2.2 1.8 0.0 0.2 0.0 0.0 1.7 1.1 11.8 12.6 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.1 0.1 1.1 9.2 0.0 34.9 0.3 0.1 0.2 22.9 5.6 0.0 47.9 9.6 0.2 0.0 1.4 4.0 0.0 9.5 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.1 12.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G1 OR51G3P ENSG00000278870 "Olfactory receptor family 51 subfamily G member 1" Q8NGK1 11 4923374-4924339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2S2 ENSG00000278889 "Olfactory receptor family 2 subfamily S member 2" Q9NQN1 9 35957108-35958154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34B ENSG00000278961 "Small integral membrane protein 34B" P0DPE8 21 7784482-7793954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.9;kidney: 17.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 5.9;Endometrial ciliated cells: 5.0;Respiratory ciliated cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 3.0" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.1 0.2 0.4 0.0 0.7 0.0 4.9 1.2 1.0 0.1 1.6 0.0 0.0 0.1 0.5 0.1 3.2 0.2 0.6 1.0 0.1 17.4 0.3 0.7 0.1 0.6 0.1 0.3 0.1 0.0 0.3 0.1 0.0 0.7 0.1 0.0 1.6 0.1 0.3 0.5 1.2 0.0 0.0 0.1 0.2 0.4 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.7 1.2 1.0 1.0 0.1 0.6 0.1 0.3 0.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A6 ENSG00000279000 "Olfactory receptor family 10 subfamily A member 6 (gene/pseudogene)" Q8NH74 11 7924592-7931268 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B2 OR51B1P ENSG00000279012 "Olfactory receptor family 51 subfamily B member 2" Q9Y5P1 11 5323359-5324297 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6Q1 ENSG00000279051 "Olfactory receptor family 6 subfamily Q member 1" Q8NGQ2 11 58030930-58031931 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10X1 OR10X1P ENSG00000279111 "Olfactory receptor family 10 subfamily X member 1" Q8NGY0 1 158578919-158579899 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D2 ENSG00000279116 "Olfactory receptor family 8 subfamily D member 2" Q9GZM6 11 124319238-124320288 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF13 ENSG00000279169 "PRAME family member 13" Q5VWM6 1 13196188-13201409 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSTD3 ENSG00000279170 "Thiosulfate sulfurtransferase like domain containing 3" H0UI37 6 99520976-99589899 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 81.9;Excitatory neurons: 41.7;Inhibitory neurons: 49.4;Oligodendrocyte precursor cells: 62.8;Oligodendrocytes: 93.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 6.1" NA NA "unprognostic (2.43e-1)" "unprognostic (2.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.70e-2)" "unprognostic (6.01e-2)" "unprognostic (9.22e-2)" "unprognostic (5.74e-2)" "unprognostic (6.38e-2)" "unprognostic (9.44e-3)" "unprognostic (4.70e-2)" "unprognostic (3.56e-2)" "unprognostic (7.83e-3)" "unprognostic (3.13e-1)" "unprognostic (2.00e-1)" "unprognostic (3.62e-2)" "unprognostic (2.88e-3)" 4.0 1.0 1.3 0.8 1.7 1.3 1.2 3.8 2.2 0.5 1.1 1.0 1.2 0.5 1.0 0.4 1.2 1.6 1.6 1.2 1.4 1.4 0.7 1.0 0.6 1.5 1.4 1.1 0.6 1.1 3.2 0.7 1.8 2.6 0.9 1.2 1.2 0.8 2.1 1.1 0.7 0.5 1.2 0.6 1.4 0.4 1.4 0.7 2.0 1.1 0.5 0.7 2.9 0.8 1.5 0.8 2.5 4.7 2.2 1.0 0.6 0.8 0.6 0.5 0.9 2.2 0.2 1.1 0.9 3.3 0.8 0.7 1.0 0.5 0.7 0.4 0.2 4.0 1.5 3.1 1.1 1.4 1.3 2.2 0.3 3.5 3.2 1.0 1.2 1.3 6.1 1.4 1.4 0.5 1.2 0.8 3.8 1.3 0.0 1.0 1.9 3.4 0.5 1.1 0.3 1.0 0.7 1.2 4.7 1.6 0.2 0.7 1.1 0.9 0.5 0.6 0.5 0.4 1.8 2.7 0.8 1.6 1.6 0.4 1.1 0.4 0.1 0.6 0.8 0.4 0.3 0.2 1.6 0.3 0.4 1.1 1.4 0.1 0.5 0.1 0.1 1.3 1.7 3.8 2.2 1.2 1.4 1.5 1.4 1.1 1.8 1.2 1.4 2.9 1.5 3.2 5.4 81.9 5.5 1.9 4.1 5.8 4.6 1.4 6.2 5.2 0.0 11.5 6.4 12.9 0.0 0.0 2.2 5.2 23.5 4.5 0.3 5.4 4.0 4.1 3.6 9.9 41.7 7.8 0.0 3.6 5.6 3.1 1.3 1.9 7.9 3.4 0.0 0.0 49.4 5.6 14.2 3.2 0.8 1.0 6.5 1.7 5.4 26.2 2.5 7.9 2.1 62.8 93.3 6.5 4.2 9.8 1.4 4.8 5.7 16.3 6.7 2.8 13.1 3.8 4.7 0.8 1.9 4.9 2.0 0.0 3.5 3.0 5.7 4.2 OR2L8 ENSG00000279263 "Olfactory receptor family 2 subfamily L member 8" Q8NGY9 1 247948858-247949796 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.3 0.4 0.3 0.0 0.7 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52R1 ENSG00000279270 "Olfactory receptor family 52 subfamily R member 1" Q8NGF1 11 4803433-4804380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T11 OR2T11Q ENSG00000279301 "Olfactory receptor family 2 subfamily T member 11" Q8NH01 1 248623557-248635091 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L1 OST262 ENSG00000279395 "Olfactory receptor family 5 subfamily L member 1" Q8NGL2 11 55811367-55812476 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N4C ENSG00000279408 "Olfactory receptor family 4 subfamily N member 4C" 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AG1 OR2AG3 ENSG00000279486 "Olfactory receptor family 2 subfamily AG member 1" Q9H205 11 6783020-6791558 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FP565260.4 ENSG00000279493 "Novel protein, similar to DNA (cytosine-5-)-methyltransferase 3-like DNMT3L" 21 5011799-5017145 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "brain: 2.5;kidney: 4.1;liver: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "white matter: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;CACO-2: 2.9;HeLa: 1.4;Hep G2: 1.1;MCF7: 2.1;SiHa: 3.3" NA NA 0.0 0.0 0.5 0.3 0.5 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 4.1 6.5 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.4 0.3 0.4 0.4 0.3 0.0 0.4 0.5 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C16 ENSG00000279514 "Olfactory receptor family 4 subfamily C member 16" Q8NGL9 11 55572128-55573060 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D13 ENSG00000279761 "Olfactory receptor family 5 subfamily D member 13" Q8NGL4 11 55773438-55774382 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC013394.1 ENSG00000279765 "Novel protein" 15 92883413-92949230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "bone marrow: 387.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 18.5;Breast myoepithelial cells: 17.1;dendritic cells: 13.0;Endometrial ciliated cells: 25.9;Endometrial stromal cells: 20.7;Glandular and luminal cells: 35.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (7.26e-3)" "unprognostic (1.34e-1)" "unprognostic (1.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.84e-2)" "unprognostic (8.97e-2)" "unprognostic (4.62e-2)" "unprognostic (9.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.12e-2)" "unprognostic (2.33e-2)" "unprognostic (1.46e-6)" "unprognostic (2.74e-1)" "unprognostic (3.13e-1)" "unprognostic (2.94e-2)" "unprognostic (3.12e-2)" 34.9 43.9 60.6 36.8 67.1 387.4 83.7 67.3 72.6 50.0 60.5 48.3 36.0 51.3 48.0 41.3 45.6 47.9 37.4 57.7 69.2 57.0 45.2 69.0 65.8 66.9 63.6 55.5 60.8 40.8 41.4 0.5 55.9 64.9 56.9 53.6 68.7 51.4 45.3 28.0 48.3 39.2 39.6 67.2 58.9 40.9 36.5 63.0 68.9 94.8 36.7 58.5 42.7 0.2 80.3 31.1 23.9 88.6 57.1 27.0 35.0 64.8 30.1 53.6 47.0 35.1 24.5 70.6 32.8 29.3 39.0 35.6 47.2 37.7 30.8 46.9 0.2 37.0 57.7 48.6 23.6 56.0 30.9 36.8 37.5 44.6 17.4 88.5 68.2 45.0 43.0 60.4 92.5 52.5 33.2 36.3 47.6 77.4 68.2 20.1 50.8 44.5 71.0 66.5 59.3 46.9 53.4 64.4 46.0 115.0 82.6 106.4 69.5 31.5 35.0 27.0 27.4 66.7 67.1 86.0 70.9 27.2 58.5 41.2 10.0 0.9 2.9 2.2 0.7 2.4 4.7 2.5 2.6 0.9 2.8 3.2 2.6 5.7 2.7 1.4 3.0 3.1 0.6 60.6 67.1 67.3 72.6 57.7 69.2 66.9 63.6 55.5 64.9 67.2 63.0 80.3 6.9 6.4 11.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 18.5 17.1 0.0 0.0 3.7 1.8 0.0 2.1 13.0 0.0 3.9 1.2 0.0 25.9 20.7 3.5 0.0 0.0 0.0 1.4 2.3 3.8 0.0 35.4 3.8 12.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 2.0 3.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 3.0 8.0 8.4 0.0 0.0 PPIAL4F ENSG00000279782 "Peptidylprolyl isomerase A like 4F" P0DN26 1 144592868-144593652 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (1.08e-1)" "unprognostic (2.22e-2)" "unprognostic (2.02e-1)" 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.3 0.2 0.1 0.3 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF18 ENSG00000279804 "PRAME family member 18" Q5VWM3 1 13222705-13226106 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057423 Uncertain NA NA "HPA057423: AB_2683435" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8U3 "OR5R1, OR5R1P" ENSG00000279961 "Olfactory receptor family 8 subfamily U member 3" Q8NH85 11 56417258-56418232 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC244517.10 ENSG00000279983 "Novel protein" 5 141223372-141245861 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.5 1.6 0.4 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51F1 OR51F1P ENSG00000280021 "Olfactory receptor family 51 subfamily F member 1" A6NGY5 11 4768979-4769938 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GATD3B ENSG00000280071 "Glutamine amidotransferase like class 1 domain containing 3B" A0A0B4J2D5 21 5079294-5128413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Distal tubular cells: 17.6;Ductal cells: 6.9;Hofbauer cells: 8.0;monocytes: 7.8;Proximal tubular cells: 31.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA018517 Uncertain Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (4.87e-2)" "unprognostic (2.69e-3)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (2.96e-1)" "unprognostic (6.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.39e-2)" "unprognostic (7.65e-2)" "unprognostic (1.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.33e-2)" "unprognostic (6.67e-4)" "unprognostic (1.88e-2)" "unprognostic (6.80e-2)" "unprognostic (4.25e-1)" "unprognostic (2.84e-2)" 54.3 78.5 81.1 35.2 83.2 31.9 49.0 85.3 90.9 41.2 73.6 52.9 72.5 37.2 27.7 59.9 44.8 41.6 166.4 78.1 83.3 143.0 241.9 34.8 54.3 89.2 84.4 73.8 67.2 53.2 62.4 55.2 40.5 87.8 44.2 58.1 32.5 60.7 33.7 210.0 38.7 51.7 32.7 80.3 48.6 50.5 33.3 88.4 36.2 55.6 227.6 28.3 40.3 41.5 95.7 55.8 52.7 57.1 98.7 42.8 38.3 23.7 0.0 4.5 1.9 2.9 7.0 54.8 2.6 61.9 62.9 51.7 38.8 77.2 34.7 1.1 36.8 32.8 217.2 60.1 47.6 41.7 94.8 39.7 80.4 69.6 28.3 57.1 39.5 64.4 66.1 86.6 51.2 34.9 118.5 94.4 103.6 110.9 150.0 80.5 190.1 43.1 223.3 72.4 49.8 48.5 96.4 76.7 138.9 52.0 28.4 146.2 131.4 19.7 27.7 39.0 2.5 33.7 80.7 79.2 37.6 64.9 192.0 20.7 87.3 110.4 60.4 102.2 123.5 101.4 153.3 129.7 107.0 147.7 167.1 124.6 95.2 21.7 136.1 167.7 96.3 145.3 190.3 81.1 83.2 85.3 90.9 78.1 83.3 89.2 84.4 73.8 87.8 80.3 88.4 95.7 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.0 0.0 2.9 1.4 0.0 17.6 6.9 0.0 1.1 1.9 0.7 0.0 0.0 0.0 5.0 3.2 0.3 0.0 2.0 0.0 0.5 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 7.8 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.7 0.0 0.0 31.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.4 0.7 1.9 0.0 0.0 OR8B4 OR8B4P ENSG00000280090 "Olfactory receptor family 8 subfamily B member 4" Q96RC9 11 124423904-124424893 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1B1 OR9-B ENSG00000280094 "Olfactory receptor family 1 subfamily B member 1" Q8NGR6 9 122628579-122629573 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;smooth muscle: 9.1" "Cell type enhanced" "Detected in some" "Club cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 7.9;Intestinal goblet cells: 5.3;Ionocytes: 6.1;Oligodendrocyte precursor cells: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 51.3" HPA062669 Approved "Vesicles,Cytokinetic bridge" Yes NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.4 1.1 3.3 0.3 4.9 0.0 0.9 1.3 11.5 2.3 0.2 3.1 0.9 3.1 2.7 0.7 0.5 0.6 3.6 18.1 5.0 0.8 1.3 3.4 0.0 1.8 4.7 4.5 0.3 0.1 0.0 0.5 0.4 1.9 1.0 1.7 0.0 0.7 1.0 0.4 1.0 1.0 9.1 1.8 1.2 1.0 0.1 2.8 0.8 0.2 0.7 0.0 0.6 0.5 2.6 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 51.3 0.0 0.7 1.9 0.0 3.6 0.5 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.9 1.3 11.5 18.1 5.0 1.8 4.7 4.5 1.9 1.8 2.8 2.6 0.0 3.2 0.5 2.3 0.0 0.1 0.1 3.6 0.0 0.0 0.0 0.0 0.6 0.0 6.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 8.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 7.9 5.3 6.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 32.6 1.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.2 OR1S1 OST034 ENSG00000280204 "Olfactory receptor family 1 subfamily S member 1" Q8NH92 11 58212720-58216084 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain NA NA "HPA049304: AB_2680704" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR12D2 hs6M1-20 ENSG00000280236 "Olfactory receptor family 12 subfamily D member 2" P58182 6 29395631-29398008 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF26 ENSG00000280267 "PRAME family member 26" 1 13148905-13155961 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K3 ENSG00000280314 "Olfactory receptor family 8 subfamily K member 3 (gene/pseudogene)" Q8NH51 11 56315144-56320639 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-69D ENSG00000280411 "Immunoglobulin heavy variable 1-69D" A0A0B4J2H0 14 106762092-106762588 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 2903.8;stomach 1: 998.3" "Group enriched" "Detected in some" 6 "Plasma cells: 5.8;T-cells: 1.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 2.6" "Group enriched" "Detected in some" 225 "memory B-cell: 184.5;naive B-cell: 433.4" "Lineage enriched" "Detected in many" 316 "B-cells: 433.4" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HL-60: 2.3;MOLT-4: 4.2;RPMI-8226: 2.5;U-266/70: 3.3;U-698: 7.9" "Immunoglobulin genes" NA NA 1200000000 "unprognostic (3.32e-3)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (2.49e-4)" "prognostic favorable (2.88e-4)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.72e-8)" "unprognostic (5.14e-2)" "unprognostic (9.96e-2)" "unprognostic (2.84e-2)" "unprognostic (2.08e-2)" 21.7 96.2 0.2 467.0 0.1 114.1 148.1 0.0 2.6 37.8 0.9 634.2 495.7 15.2 17.0 99.4 16.1 78.8 20.4 0.1 0.2 17.2 46.9 151.0 2903.8 1.0 0.3 0.0 36.2 3.3 0.6 1.1 0.4 0.1 16.6 410.1 0.0 388.5 101.0 0.5 5.2 122.2 44.2 0.2 456.4 998.3 6.9 0.0 137.0 38.6 0.0 2238.3 297.9 11.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.2 0.3 1.3 0.0 0.0 0.9 0.8 2.5 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.6 0.4 3.3 0.1 7.9 0.0 0.7 0.0 0.8 0.3 0.1 0.0 0.0 0.2 184.5 0.3 0.0 0.2 433.4 0.4 0.1 0.4 0.2 0.4 1.3 0.2 33.5 0.2 0.1 0.0 2.6 0.1 0.2 1.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 FP565260.6 ENSG00000280433 "Novel protein, similar to trafficking protein particle complex 10 TRAPPC10" 21 5155499-5165472 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.3;Collecting duct cells: 3.7;Glandular and luminal cells: 2.4;Pancreatic endocrine cells: 3.9;Proximal tubular cells: 3.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.36e-1)" "unprognostic (2.11e-3)" "unprognostic (1.01e-1)" "unprognostic (2.05e-1)" "unprognostic (5.60e-2)" "unprognostic (7.47e-2)" "unprognostic (9.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.46e-2)" "unprognostic (2.15e-2)" "unprognostic (1.17e-1)" "unprognostic (2.62e-2)" "unprognostic (7.41e-2)" "unprognostic (7.71e-6)" 6.2 6.2 15.5 5.1 16.2 5.0 5.6 15.6 18.8 5.2 15.0 8.8 6.8 5.6 7.2 6.8 5.2 4.3 5.7 15.7 15.7 9.8 10.7 6.4 12.4 16.2 16.0 15.2 4.9 6.1 5.8 8.2 3.3 16.3 5.7 7.6 7.2 5.7 3.0 6.3 6.5 12.0 3.0 15.5 15.3 6.9 6.3 15.8 10.1 8.2 3.8 5.4 5.1 5.2 17.1 7.0 2.1 5.8 4.0 6.7 3.9 3.5 2.3 2.4 1.0 2.0 1.2 3.3 3.3 2.2 5.7 7.4 4.3 5.6 3.8 2.1 2.3 2.9 12.0 3.9 5.2 6.3 9.2 8.6 6.2 8.7 4.6 4.8 4.3 5.8 4.8 5.8 3.8 4.8 6.2 4.8 16.6 7.4 8.3 3.3 4.8 2.8 3.7 10.4 6.1 4.2 7.6 4.2 7.7 8.7 2.6 5.3 16.6 3.7 4.5 3.1 0.9 7.0 3.3 3.8 6.1 4.3 12.6 3.1 0.2 0.1 1.2 1.9 0.4 3.9 1.5 1.0 1.8 0.2 1.2 0.9 1.2 0.6 2.0 0.9 0.4 0.3 0.7 15.5 16.2 15.6 18.8 15.7 15.7 16.2 16.0 15.2 16.3 15.5 15.8 17.1 0.8 0.0 3.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 1.8 3.7 0.0 1.1 2.1 0.0 0.0 1.3 0.0 1.3 1.2 0.9 0.0 0.0 0.0 1.3 0.6 0.8 0.0 2.4 0.0 0.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 3.1 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 1.0 0.5 0.0 0.0 AC006059.2 ENSG00000280571 "Novel protein" 3 42705756-42804518 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.3;retina: 7.7" "Cell type enriched" "Detected in single" 4 "Alveolar cells type 1: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047429 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA047429: AB_2680043" "unprognostic (1.72e-1)" "unprognostic (4.20e-1)" "unprognostic (8.65e-2)" "unprognostic (2.65e-1)" "unprognostic (7.02e-2)" "unprognostic (8.28e-2)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" "unprognostic (4.32e-2)" "unprognostic (5.96e-2)" "unprognostic (6.09e-3)" "unprognostic (2.99e-2)" "unprognostic (3.01e-2)" 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 7.7 0.1 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.2 0.6 0.5 0.5 0.8 0.7 0.1 0.8 0.6 0.8 2.3 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC163 "C1orf231, CCDC163P, LOC126661" ENSG00000280670 "Coiled-coil domain containing 163" A0A0D9SF12 1 45493866-45500079 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Adipocytes: 1.9;Breast glandular cells: 2.3;Breast myoepithelial cells: 3.4;Cytotrophoblasts: 3.2;Distal tubular cells: 1.9;Exocrine glandular cells: 2.0;Extravillous trophoblasts: 2.0;Glandular and luminal cells: 2.0;Theca cells: 1.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 5.2;U-266/70: 5.7" NA NA "unprognostic (5.25e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-3)" "unprognostic (9.50e-8)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "unprognostic (6.23e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-1)" "unprognostic (8.38e-6)" "unprognostic (4.73e-3)" "unprognostic (7.69e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (1.61e-1)" 0.3 0.2 0.2 0.4 0.2 0.8 0.4 0.2 0.5 0.5 0.1 0.2 0.3 0.3 0.3 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.4 0.3 0.5 0.2 0.2 0.2 0.8 0.8 0.2 0.1 0.3 0.1 0.2 0.1 0.7 0.1 0.2 0.3 0.4 0.2 0.2 0.4 0.3 0.1 0.3 0.5 0.8 0.0 0.3 0.1 0.1 0.2 1.7 0.0 0.0 0.2 0.2 0.5 0.6 0.2 0.2 1.6 0.6 1.4 0.7 0.4 0.8 0.2 0.0 1.3 0.2 1.7 1.0 1.3 1.6 0.8 0.7 1.9 1.5 1.4 0.3 0.1 0.1 0.4 0.8 0.4 0.4 1.6 0.6 5.2 0.7 1.3 2.2 0.6 1.1 1.1 1.0 2.0 0.0 0.8 0.5 0.3 0.2 0.8 0.3 2.9 0.9 0.6 0.6 0.0 0.0 0.5 0.7 0.0 0.7 5.7 2.7 1.2 0.4 0.8 0.2 1.0 0.3 0.7 0.7 0.1 0.7 0.4 0.5 0.5 0.0 0.4 0.3 0.6 0.2 0.2 0.0 0.7 0.0 0.4 0.2 0.2 0.2 0.5 0.3 0.2 0.5 0.2 0.2 0.3 0.2 0.3 0.2 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 3.4 0.0 0.0 0.0 0.0 0.0 3.2 1.3 0.0 1.9 1.6 0.0 0.9 1.3 0.6 0.0 0.0 0.0 2.0 2.0 0.4 0.0 2.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.6 1.9 0.0 0.0 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "U-2 OS: 5.2" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC243547.3 ENSG00000280778 "Novel protein, lncRNA-POLR3GL readthrough" 1 145927258-145977811 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 PAGR1 "C16orf53, GAS, MGC4606, PA1" ENSG00000280789 "PAXIP1 associated glutamate rich protein 1" Q9BTK6 16 29816152-29822489 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 167.9" "Cell type enhanced" "Detected in many" "Astrocytes: 66.6;Plasma cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041440, HPA043608" Uncertain NA NA "HPA041440: AB_10795541, HPA043608: AB_10797144" "unprognostic (2.35e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" "unprognostic (1.44e-2)" "unprognostic (4.20e-1)" "unprognostic (1.14e-3)" "unprognostic (7.09e-3)" "unprognostic (5.12e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (1.84e-3)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (8.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (5.39e-2)" 23.4 28.1 10.6 5.6 10.3 6.6 23.4 17.1 12.4 115.6 8.1 41.8 8.7 55.7 7.2 25.9 68.9 6.2 30.8 9.4 15.9 25.8 28.3 23.2 8.7 10.3 10.3 8.9 167.9 26.5 7.5 129.9 3.7 12.3 69.9 5.7 6.8 21.6 8.9 24.8 17.4 31.1 4.8 10.4 23.8 26.7 31.4 9.9 9.3 30.4 9.1 6.9 51.1 74.4 11.9 16.7 24.1 13.9 8.7 7.0 6.7 11.8 12.7 11.5 14.5 12.7 17.1 16.9 33.4 12.7 9.1 7.2 15.4 15.2 19.1 9.2 14.8 31.1 14.8 16.4 16.1 7.3 23.6 26.9 7.5 15.1 10.2 10.0 13.4 12.1 31.0 20.1 10.4 9.9 45.2 18.6 27.6 19.3 14.2 20.4 35.4 24.5 24.9 10.8 7.8 34.9 13.2 9.6 22.4 9.7 10.5 20.9 15.0 9.2 12.0 10.9 15.2 12.9 19.4 21.3 13.1 15.8 24.2 15.0 22.5 16.9 33.0 19.7 17.0 22.1 19.7 16.8 20.0 21.3 19.5 21.7 20.1 11.0 13.9 19.6 21.5 12.7 15.2 10.6 10.3 17.1 12.4 9.4 15.9 10.3 10.3 8.9 12.3 10.4 9.9 11.9 1.3 0.0 9.8 66.6 15.2 0.0 0.3 0.1 18.2 3.5 4.7 2.9 0.6 14.3 6.9 1.8 0.0 5.6 5.3 5.9 0.0 27.9 0.5 1.0 1.3 3.8 14.6 10.7 16.2 21.7 8.2 4.4 13.3 0.8 7.6 0.3 6.1 2.0 7.5 5.0 16.5 11.1 0.0 5.6 0.0 0.6 0.9 7.7 0.0 9.4 22.5 1.9 4.1 11.6 8.6 13.5 15.8 3.4 34.5 0.7 20.7 2.1 3.0 3.3 0.0 0.9 5.0 3.1 1.6 16.7 0.4 6.7 10.9 0.2 13.2 0.2 RPS4Y2 RPS4Y2P ENSG00000280969 "Ribosomal protein S4 Y-linked 2" Q8TD47 Y 20756108-20781032 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "prostate: 1.9;testis: 1.1" "Cell type enhanced" "Detected in some" "B-cells: 3.5;Basal keratinocytes: 3.2;Basal prostatic cells: 3.5;Langerhans cells: 3.4;Prostatic glandular cells: 2.1;Spermatogonia: 2.6;Suprabasal keratinocytes: 5.8" "Cancer enriched" "Detected in single" 9 "prostate cancer: 1.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "neutrophil: 7.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.4" "Cell line enriched" "Detected in single" 5 "U-266/84: 2.0" HPA000857 Uncertain NA NA "HPA000857: AB_1079849" "unprognostic (1.50e-2)" "unprognostic (3.63e-1)" "unprognostic (6.39e-6)" "unprognostic (5.92e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.1 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.2 3.5 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.7 0.6 1.1 2.6 0.0 5.8 0.3 0.4 0.0 0.0 1.3 MATR3 ENSG00000280987 "Matrin 3" 5 139273752-139331671 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA036564, HPA036565" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (3.08e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-2)" "unprognostic (2.37e-2)" "unprognostic (3.64e-1)" "unprognostic (1.10e-1)" "unprognostic (8.69e-9)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.91e-10)" "unprognostic (2.91e-2)" "unprognostic (9.21e-3)" "unprognostic (2.24e-1)" "unprognostic (9.89e-2)" 10.5 13.6 17.3 24.6 16.3 25.3 31.4 11.9 27.9 9.8 8.3 22.7 16.4 15.5 34.3 17.9 19.3 9.7 30.9 18.7 15.3 10.3 9.7 8.5 36.4 20.0 14.5 14.5 14.5 7.6 8.3 2.2 10.3 22.5 15.6 29.5 11.9 26.6 8.7 41.6 20.6 12.2 15.0 16.7 20.0 17.9 18.8 19.0 17.5 9.8 38.7 34.0 14.8 2.8 23.5 81.0 58.9 30.2 162.9 65.9 79.7 58.6 42.8 36.4 69.4 87.0 101.7 71.7 284.8 60.7 61.2 45.0 91.2 257.9 136.3 120.5 48.7 125.6 190.2 100.3 89.8 57.6 176.9 67.9 93.7 95.4 79.6 90.7 38.6 78.9 103.7 143.2 50.3 74.0 31.7 98.5 53.4 122.7 35.4 38.8 199.0 92.8 125.1 40.3 55.7 92.6 56.5 49.4 60.7 113.6 77.3 57.0 71.1 56.3 52.8 78.5 43.7 63.7 23.3 33.6 153.2 45.8 148.1 61.6 0.1 0.8 0.1 0.5 1.2 1.3 3.4 1.7 2.4 3.2 2.0 2.6 1.7 0.2 0.9 0.4 0.1 1.4 1.2 17.3 16.3 11.9 27.9 18.7 15.3 20.0 14.5 14.5 22.5 16.7 19.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 AC005154.5 ENSG00000281039 "Novel protein" 7 30497077-30550761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 9.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 21.4" HPA020735 Uncertain NA NA "HPA020735: AB_1845754" "unprognostic (1.15e-2)" "unprognostic (5.67e-3)" "unprognostic (1.07e-2)" "unprognostic (8.33e-2)" "unprognostic (3.92e-2)" "unprognostic (6.95e-3)" "unprognostic (1.57e-1)" "unprognostic (6.37e-4)" "unprognostic (2.55e-2)" "unprognostic (4.34e-3)" "unprognostic (1.50e-4)" 12.9 9.3 22.9 7.0 22.2 29.0 9.7 20.2 26.3 3.9 22.9 8.2 11.0 8.3 25.1 2.9 6.1 7.7 4.5 21.8 21.0 4.4 6.3 12.9 14.2 20.0 20.9 21.6 9.3 2.6 7.8 3.1 6.2 20.9 7.8 8.7 20.8 7.0 8.5 11.0 15.3 6.9 5.4 19.5 12.4 9.0 5.3 21.6 9.0 8.3 4.0 11.5 5.8 0.7 22.4 2.0 0.0 7.4 7.5 5.1 11.7 2.8 5.0 5.4 2.8 2.0 1.2 0.7 2.6 1.5 4.1 3.6 5.4 1.0 2.3 2.8 3.3 1.4 2.6 6.2 2.4 4.7 5.9 11.6 8.0 7.0 2.1 4.1 5.8 2.8 5.7 2.2 12.0 4.3 0.4 2.3 7.6 1.6 1.2 0.7 2.2 0.5 4.7 4.5 3.3 1.7 2.7 2.6 1.6 3.6 8.6 4.0 8.2 2.8 2.0 1.5 2.0 1.1 21.4 5.2 2.5 3.5 7.2 6.3 0.0 0.2 0.4 0.5 0.1 0.1 0.0 0.1 0.4 0.4 0.3 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.0 22.9 22.2 20.2 26.3 21.8 21.0 20.0 20.9 21.6 20.9 19.5 21.6 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM272 "FLJ37307, LINC00282, NCRNA00282" ENSG00000281106 "Transmembrane protein 272" A0A1B0GTI8 13 51813347-51845177 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 89 "neutrophil: 40.1" "Lineage enriched" "Detected in single" 89 "granulocytes: 40.1" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" "Low region specificity" "Detected in many" NA NA "unprognostic (2.27e-2)" "unprognostic (2.50e-1)" "unprognostic (5.12e-2)" "unprognostic (8.71e-7)" "unprognostic (4.52e-2)" "unprognostic (1.78e-4)" "unprognostic (6.16e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.02e-1)" "unprognostic (3.73e-3)" "unprognostic (1.32e-5)" "unprognostic (2.12e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.58e-2)" 0.1 0.0 4.3 1.0 15.4 1.1 0.1 1.1 7.9 0.0 0.0 0.1 0.4 0.3 0.1 0.1 0.0 0.2 1.4 2.0 5.6 0.1 0.3 0.1 1.1 3.3 1.2 4.3 0.1 0.4 0.0 0.6 0.2 2.9 0.0 0.1 3.0 0.1 0.0 0.5 0.6 0.5 0.0 0.1 0.6 0.1 0.5 2.6 0.7 0.0 0.4 0.9 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 40.1 0.0 0.0 0.0 0.0 0.0 4.3 15.4 1.1 7.9 2.0 5.6 3.3 1.2 4.3 2.9 0.1 2.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.5 ENSG00000281179 "Novel gene identicle to IGHV1OR15-1" 15 21717808-21718245 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 79.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "lung cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 94.3;naive B-cell: 111.6" "Group enriched" "Detected in many" 18 "B-cells: 111.6;T-cells: 60.9" "Group enriched" "Detected in some" 4 "JURKAT: 10.3;Karpas-707: 6.9;MOLT-4: 2.5" NA NA "unprognostic (3.64e-1)" "unprognostic (8.63e-2)" 0.6 0.4 0.0 18.3 0.0 7.1 5.8 0.1 0.1 0.8 0.0 15.8 13.9 0.8 0.0 4.0 0.6 14.5 0.7 0.0 0.1 0.4 0.7 2.8 52.4 0.2 0.1 0.0 1.0 0.4 0.1 0.1 0.1 0.1 2.3 10.3 0.0 5.0 0.4 0.0 0.1 13.8 0.4 0.2 17.7 11.2 0.1 0.1 59.2 1.0 0.0 79.5 9.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.2 0.0 3.3 94.3 54.9 18.1 0.1 111.6 60.9 14.5 0.5 4.8 0.1 3.3 35.9 20.5 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLACAT1 "linc-UBC1, LINC00912, onco-lncRNA-30" ENSG00000281406 "Bladder cancer associated transcript 1" 1 205434885-205457091 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.4;epididymis: 3.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 2.9;Collecting duct cells: 5.5;Horizontal cells: 1.7;Pancreatic endocrine cells: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.2;CAPAN-2: 6.8;NTERA-2: 8.5;SuSa: 4.4;U-2 OS: 4.5" NA NA "unprognostic (3.01e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-3)" "unprognostic (5.22e-2)" "unprognostic (7.97e-2)" "unprognostic (5.59e-2)" "unprognostic (5.02e-2)" "unprognostic (2.13e-2)" "unprognostic (7.37e-3)" "unprognostic (5.36e-2)" "unprognostic (6.23e-7)" "unprognostic (3.09e-2)" "unprognostic (6.78e-2)" "unprognostic (1.84e-2)" "unprognostic (4.59e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.1 5.4 1.2 0.1 0.0 0.0 0.2 0.3 3.8 0.4 1.4 0.3 0.0 0.2 0.5 0.1 0.0 0.2 0.0 3.0 1.1 0.2 0.1 0.0 0.0 0.0 3.8 0.1 0.1 0.7 0.6 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 1.2 1.4 0.0 1.4 0.0 0.2 0.0 2.5 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 6.8 0.0 1.5 0.0 0.0 1.6 0.0 0.2 0.1 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.2 0.0 0.9 0.0 0.0 8.5 1.2 0.2 0.0 1.7 0.1 1.2 0.0 0.5 0.0 0.0 0.0 0.4 4.4 0.0 0.0 0.0 0.0 4.5 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 5.4 1.2 0.2 0.5 3.0 1.1 0.2 3.8 0.2 1.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.9 0.1 0.1 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.8 AL365214.2 ENSG00000281613 "Novel ret finger protein-like 4B" 6 112236806-112350094 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "RPTEC TERT1: 3.4" HPA059324 Uncertain NA NA "HPA059324: " 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIMAP1-GIMAP5 ENSG00000281887 "GIMAP1-GIMAP5 readthrough" 7 150716668-150743646 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.6" "Cell type enhanced" "Detected in some" "Endothelial cells: 1.3;Microglial cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 37.9;NK-cells: 69.5;T-cells: 101.0" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 5.6;JURKAT: 2.3;MOLT-4: 4.5;THP-1: 1.9;TIME: 2.1" HPA053441 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053441: AB_2682152" 7.1 1.4 1.4 5.6 1.2 0.6 5.9 1.4 2.5 3.7 2.1 2.9 3.1 4.0 0.0 1.9 5.2 0.4 4.1 1.0 1.5 2.2 1.4 7.5 5.0 2.0 1.3 0.6 1.2 0.7 0.1 1.5 1.1 1.6 2.2 0.0 0.0 1.7 0.2 2.5 1.9 4.2 0.5 1.6 16.6 1.9 0.4 2.5 1.3 4.7 1.8 0.0 3.7 2.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 2.3 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 37.9 0.0 67.2 32.4 75.1 0.6 73.4 94.4 15.2 0.7 101.0 85.1 4.4 69.5 28.2 1.1 51.5 76.2 1.4 1.2 1.4 2.5 1.0 1.5 2.0 1.3 0.6 1.6 1.6 2.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 TRBJ1-4 "TCRBJ1S4, TRBJ14" ENSG00000281958 "T cell receptor beta joining 1-4" A0A0J9YXG5 7 142788225-142788275 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 224.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "T-reg: 293.2" "Group enriched" "Detected in many" 58 "NK-cells: 133.1;T-cells: 293.2" "Cell line enriched" "Detected in some" 93 "JURKAT: 538.0" NA NA 2.0 1.5 0.3 74.5 0.9 13.7 3.6 0.0 2.0 3.5 2.2 10.1 12.1 4.5 6.0 1.6 1.2 6.7 0.3 0.3 0.4 0.7 5.6 13.3 99.0 0.8 0.2 0.2 2.0 0.0 0.0 0.0 1.0 0.4 6.1 13.3 0.2 7.0 0.0 0.0 0.9 20.0 2.0 0.6 61.5 17.7 1.4 0.4 224.4 3.2 0.0 96.8 5.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 538.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.7 1.8 0.0 0.0 0.0 3.6 1.2 0.3 75.0 0.1 45.3 1.6 205.7 90.2 0.3 0.3 211.3 110.1 2.1 133.1 0.7 0.7 293.2 84.4 0.3 0.9 0.0 2.0 0.3 0.4 0.8 0.2 0.2 0.4 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1-69-2 IGHV1-F ENSG00000281990 "Immunoglobulin heavy variable 1-69-2" A0A0G2JMI3 14 106737110-106737547 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.3;lymphoid tissue: 47.5;salivary gland: 16.5" "Cell type enriched" "Detected in some" 226 "Plasma cells: 10423.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.7;naive B-cell: 5.5" "Lineage enriched" "Detected in many" 6 "B-cells: 6.7" "Cell line enriched" "Detected in some" 6 "MOLT-4: 11.2" "Immunoglobulin genes" NA NA 1100000000 2.9 0.3 0.0 5.9 0.0 2.5 3.7 0.0 0.0 1.4 0.0 12.1 22.3 1.1 0.2 2.1 1.2 14.7 1.6 0.0 0.0 2.6 0.9 4.5 13.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.5 14.5 0.0 16.5 0.9 0.0 0.0 18.2 0.2 0.0 47.5 10.0 0.2 0.0 3.8 1.1 0.0 36.8 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 6.7 0.5 0.9 0.0 5.5 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 1.4 23.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10423.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 TMEM265 ENSG00000281991 "Transmembrane protein 265" A0A087WTH1 16 30740642-30745196 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.6;Astrocytes: 9.8;Club cells: 6.2;Excitatory neurons: 5.6;Inhibitory neurons: 6.1;Microglial cells: 5.6;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 5.9;Respiratory ciliated cells: 5.1" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 47.3;HaCaT: 12.8;HBEC3-KT: 16.2;hTCEpi: 24.2;RT4: 14.4;SK-BR-3: 16.7;T-47d: 19.8" NA NA 3.6 3.7 0.5 0.0 0.6 0.1 8.2 0.6 1.8 8.6 0.5 9.9 0.0 2.9 0.0 31.5 5.7 0.9 7.2 0.5 0.6 19.3 12.4 18.2 0.0 0.6 0.5 0.5 6.6 10.7 2.4 13.0 0.2 0.6 13.7 0.0 0.0 19.3 0.1 8.0 30.3 10.2 0.1 0.5 17.2 12.2 3.6 0.5 0.0 17.9 0.0 0.0 8.8 19.5 0.7 10.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 12.8 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 24.2 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 9.0 14.4 0.0 0.0 0.0 16.7 0.1 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.3 0.3 0.6 0.5 0.6 0.0 0.6 0.3 0.7 0.9 1.7 0.3 0.0 0.4 0.1 0.5 0.6 0.6 1.8 0.5 0.6 0.6 0.5 0.5 0.6 0.5 0.5 0.7 0.0 9.6 4.6 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 2.5 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IGHD3OR15-3B "IGHD3/OR15-3B, IGHD3OR153B" ENSG00000282089 "Immunoglobulin heavy diversity 3/OR15-3B (non-functional)" 15 21012559-21012589 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "brain: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;RPMI-8226: 3.8" NA NA 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 1.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.5 1.4 0.1 0.5 1.8 0.6 0.1 2.5 0.6 1.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV7-4-1 ENSG00000282122 "Immunoglobulin heavy variable 7-4-1" A0A0J9YVY3 14 106025145-106025630 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 98.3;lymphoid tissue: 135.0" "Cell type enriched" "Detected in some" 4 "Plasma cells: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 109 "memory B-cell: 8.3;naive B-cell: 13.5" "Lineage enriched" "Detected in single" 136 "B-cells: 13.5" "Cell line enriched" "Detected in some" 5 "Karpas-707: 5.4" "Immunoglobulin genes" NA NA 560000000 3.9 3.0 0.3 58.8 0.0 39.3 21.3 0.0 0.5 7.8 0.2 61.3 8.4 0.5 0.0 4.8 0.8 3.1 0.4 0.0 0.0 2.1 2.8 49.6 7.6 0.0 0.1 0.0 0.9 0.7 0.0 0.2 0.0 0.0 2.6 98.3 0.0 42.5 8.8 0.3 0.1 43.3 0.2 0.1 69.0 24.4 0.2 0.0 46.0 5.9 0.0 135.0 10.4 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ1-3 "TCRBJ1S3, TRBJ13" ENSG00000282133 "T cell receptor beta joining 1-3" A0A0J9YWP8 7 142787630-142787679 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 230.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Immune cell enhanced" "Detected in many" "T-reg: 172.0" "Lineage enriched" "Detected in many" 6 "T-cells: 172.0" "Cell line enriched" "Detected in some" 121 "JURKAT: 417.6" NA NA 4.5 1.3 0.4 48.7 0.4 9.1 4.9 0.0 2.1 2.9 0.2 11.6 4.8 3.9 1.9 1.2 3.4 10.1 0.4 0.2 0.0 0.4 6.8 12.9 96.1 0.5 0.0 0.0 2.2 0.0 0.0 0.0 1.4 0.9 7.9 18.3 0.5 3.4 1.5 0.0 1.5 12.1 0.6 0.0 51.9 11.6 0.6 0.6 230.3 0.4 0.0 117.4 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 417.6 0.5 0.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.3 0.3 35.2 0.0 15.4 0.1 105.6 62.3 0.5 0.3 122.7 53.7 0.6 30.6 0.7 0.4 172.0 45.3 0.4 0.4 0.0 2.1 0.2 0.0 0.5 0.0 0.0 0.9 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ1-5 "TCRBJ1S5, TRBJ15" ENSG00000282173 "T cell receptor beta joining 1-5" A0A0J9YXM7 7 142788498-142788547 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 325.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 5.6" "Group enriched" "Detected in all" 31 "gdT-cell: 857.2;MAIT T-cell: 363.2;memory CD4 T-cell: 549.3;memory CD8 T-cell: 445.4;naive CD4 T-cell: 513.7;naive CD8 T-cell: 498.0;NK-cell: 363.5;T-reg: 845.4" "Group enriched" "Detected in all" 34 "NK-cells: 363.5;T-cells: 857.2" "Group enriched" "Detected in some" 164 "JURKAT: 425.6;U-266/84: 208.7" NA NA 4.2 3.0 0.3 101.7 0.4 16.7 16.6 0.1 5.6 4.5 0.8 17.1 9.8 3.0 0.0 3.4 1.4 10.6 2.3 0.2 1.7 0.9 8.4 15.9 120.8 0.9 0.4 0.1 3.8 0.0 1.2 0.0 1.6 0.4 8.5 29.0 0.3 4.6 0.5 4.7 1.5 17.7 4.1 0.5 81.4 24.7 2.0 0.3 325.1 1.7 1.3 167.6 8.2 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 425.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.0 208.7 0.5 0.0 0.0 0.0 7.3 3.5 2.2 857.2 1.7 363.2 1.2 549.3 445.4 2.8 2.1 513.7 498.0 17.9 363.5 4.1 3.8 845.4 514.1 0.3 0.4 0.1 5.6 0.2 1.7 0.9 0.4 0.1 0.4 0.5 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL132671.2 ENSG00000282218 "Novel protein, GOPC-ROS1 readthrough" 6 117318211-117573571 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "U-138 MG: 8.9" "Low region specificity" "Detected in all" HPA019477 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA019477: AB_1849890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL157392.5 ENSG00000282246 "Novel protein" 10 13610047-13655929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 2.8;Collecting duct cells: 3.7;granulocytes: 2.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA047950 Uncertain NA NA "HPA047950: AB_2680221" 3.5 1.6 3.8 3.6 3.9 5.1 4.3 4.4 5.9 1.5 3.6 2.4 4.7 2.7 6.8 1.4 1.6 2.3 1.7 3.9 3.6 1.6 1.7 2.3 5.6 3.6 3.5 3.6 2.1 3.3 1.6 0.0 2.4 3.8 2.8 3.6 9.9 5.6 2.1 3.5 12.1 3.4 1.4 2.9 5.3 4.2 5.8 3.9 4.2 2.5 0.5 3.4 2.1 0.0 4.1 1.6 2.1 7.7 1.7 1.6 0.5 4.7 2.5 0.1 1.0 1.1 3.5 2.8 0.6 1.8 1.2 0.7 4.5 1.4 1.8 1.0 1.3 2.7 0.8 4.9 4.4 1.4 1.4 2.6 1.1 4.2 0.4 0.4 6.6 0.4 5.7 2.7 2.4 0.5 1.8 2.3 3.9 0.5 3.2 1.5 0.9 1.3 0.7 1.1 0.9 1.2 1.2 1.0 2.4 2.1 4.8 2.2 1.9 7.0 4.3 1.5 3.6 2.1 2.7 1.8 0.8 1.7 2.4 4.1 1.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.0 1.6 0.0 0.0 0.2 3.8 3.9 4.4 5.9 3.9 3.6 3.6 3.5 3.6 3.8 2.9 3.9 4.1 0.7 9.6 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 1.8 3.7 0.0 0.5 0.6 0.0 0.0 0.6 0.0 1.1 1.0 0.6 0.0 0.0 0.0 0.5 0.5 0.3 0.0 1.7 2.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.9 0.9 0.0 0.0 IGHD2OR15-2B "IGHD2/OR15-2B, IGHD2OR152B" ENSG00000282268 "Immunoglobulin heavy diversity 2/OR15-2B (non-functional)" 15 21015048-21015078 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "brain: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 1.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.8 0.2 0.5 1.3 0.9 0.2 2.0 1.1 1.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC058822.1 ENSG00000282278 "Novel FIP1L1-PDGFRA fusion protein" 4 53377839-54295272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.7;BJ hTERT+: 10.2;fHDF/TERT166: 17.2;HSkMC: 9.8;U-138 MG: 5.4;U-2197: 7.7" HPA058202 Supported Nucleoplasm NA NA Nucleoplasm "HPA058202: AB_2683636" 0.9 0.0 0.9 2.0 1.3 0.0 0.0 0.3 1.9 0.3 1.3 0.4 0.5 0.3 0.0 1.3 0.1 0.4 1.6 0.7 0.8 0.3 0.3 0.8 0.0 1.5 0.4 1.6 1.2 0.8 0.0 0.0 1.3 1.2 0.2 0.0 0.8 0.0 0.0 0.3 0.0 1.0 0.9 0.4 0.2 0.8 2.2 0.4 0.1 0.0 2.0 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.8 4.7 0.0 1.5 10.2 0.0 0.1 0.9 0.0 0.0 0.0 17.2 0.0 0.0 1.5 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 9.8 0.0 3.8 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.1 5.4 0.1 7.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.3 0.3 1.9 0.7 0.8 1.5 0.4 1.6 1.2 0.4 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" 7 99684957-99735102 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 12.8" "Group enriched" "Detected in some" 10 "Cholangiocytes: 4.3;Hepatocytes: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 1.1 0.1 0.0 0.0 1.5 12.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ1-1 "TCRBJ1S1, TRBJ11" ENSG00000282320 "T cell receptor beta joining 1-1" A0A0J9YXA8 7 142786880-142786927 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 84.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 1111.5" "Lineage enriched" "Detected in all" 18 "T-cells: 1111.5" "Cell line enhanced" "Detected in some" "Daudi: 1.2;K-562: 1.2;U-266/84: 4.4;U-698: 1.0" NA NA 2.1 0.0 0.3 33.4 0.2 7.9 0.8 0.0 0.8 1.0 0.3 4.6 5.9 1.7 0.0 2.9 1.0 4.2 0.4 0.2 0.1 0.3 6.2 5.7 45.2 0.3 0.3 0.0 1.6 3.0 0.0 0.0 0.5 0.3 1.6 8.0 0.3 1.4 0.5 3.5 0.0 6.2 0.6 0.2 18.8 9.9 0.3 0.4 84.7 0.1 5.5 49.0 2.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.0 0.0 0.0 0.0 46.7 1.3 2.9 163.0 0.9 240.7 5.8 622.5 480.8 1.9 1.9 690.1 869.6 16.2 62.1 1.5 4.7 1111.5 312.7 0.3 0.2 0.0 0.8 0.2 0.1 0.3 0.3 0.0 0.3 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TEX13D ENSG00000282419 "TEX13 family member D" A0A0J9YY54 X 124246249-124336863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 1.8" "Group enriched" "Detected in some" 14 "Spermatocytes: 16.1;Spermatogonia: 9.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ1-2 "TCRBJ1S2, TRBJ12" ENSG00000282420 "T cell receptor beta joining 1-2" A0A0J9YX06 7 142787017-142787064 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 108.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 8 "memory CD4 T-cell: 495.1;memory CD8 T-cell: 334.7;naive CD4 T-cell: 467.6;naive CD8 T-cell: 296.5;T-reg: 801.8" "Lineage enriched" "Detected in all" 90 "T-cells: 801.8" "Cell line enriched" "Detected in some" 151 "JURKAT: 255.2" NA NA 0.6 1.0 0.2 32.7 0.7 7.7 0.4 0.0 0.7 0.0 0.2 3.5 2.9 0.7 1.6 0.3 0.3 4.4 0.4 0.5 0.5 0.2 2.1 8.4 39.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.7 5.7 0.4 4.8 1.0 0.0 1.1 6.3 1.5 0.1 20.5 10.1 0.2 0.3 108.2 0.3 0.0 46.8 0.8 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.2 0.6 0.6 59.0 0.8 56.9 2.5 495.1 334.7 1.2 2.0 467.6 296.5 7.3 8.9 1.8 1.7 801.8 183.4 0.2 0.7 0.0 0.7 0.5 0.5 0.5 0.1 0.0 0.5 0.1 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRBD1 TCRBD1 ENSG00000282431 "T cell receptor beta diversity 1" P0DPI4 7 142786213-142786224 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV25-1 "TCRBV11S1A1T, TCRBV25S1, TRBV251" ENSG00000282499 "T cell receptor beta variable 25-1" A0A075B6N4 7 142670740-142671244 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 25.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.5;T-cells: 2.7" "Region enhanced" "Detected in some" "basal ganglia: 4.4" "Group enriched" "Detected in many" 51 "MAIT T-cell: 8.3;memory CD4 T-cell: 8.7;memory CD8 T-cell: 13.3;naive CD4 T-cell: 12.4;naive CD8 T-cell: 12.1;T-reg: 25.8" "Lineage enriched" "Detected in single" 106 "T-cells: 25.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.8 0.1 1.7 4.4 0.5 0.0 0.0 1.7 0.0 0.0 0.1 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.9 0.0 0.2 0.3 3.4 1.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.1 0.0 1.0 0.2 0.7 0.6 25.1 0.1 0.9 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.3 0.0 8.7 13.3 0.2 0.0 12.4 12.1 0.2 0.0 0.0 0.0 25.8 2.9 0.1 4.4 0.0 1.7 0.4 0.9 1.3 0.1 0.1 0.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 IGHD3OR15-3A "IGHD3/OR15-3A, IGHD3OR153A" ENSG00000282520 "Immunoglobulin heavy diversity 3/OR15-3A (non-functional)" 15 20005905-20005935 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "brain: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;RPMI-8226: 3.8" NA NA 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 1.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.5 1.4 0.1 0.5 1.8 0.6 0.1 2.5 0.6 1.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2OR15-2A "IGHD2/OR15-2A, IGHD2OR152A" ENSG00000282599 "Immunoglobulin heavy diversity 2/OR15-2A (non-functional)" 15 20008402-20008432 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 27 "brain: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 1.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.8 0.2 0.5 1.3 0.9 0.2 2.0 1.1 1.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADORA3 AD026 ENSG00000282608 "Adenosine A3 receptor" P0DMS8 1 111499429-111503633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in some" "Hofbauer cells: 17.9;Kupffer cells: 79.2;Late spermatids: 18.2;Macrophages: 26.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 40 "eosinophil: 601.6" "Lineage enriched" "Detected in many" 40 "granulocytes: 601.6" "Cell line enriched" "Detected in some" 9 "HMC-1: 108.1" "Low region specificity" "Detected in many" NA NA 4.2 15.2 9.1 4.4 10.9 0.2 5.6 11.5 14.7 4.4 10.4 6.7 4.5 1.9 0.2 2.5 3.6 5.8 2.6 9.2 13.2 1.6 3.3 3.6 6.4 15.3 11.1 7.5 1.8 1.8 3.1 2.6 2.8 14.7 2.4 5.1 1.0 2.8 2.4 0.6 0.8 9.5 4.9 15.6 4.3 3.0 1.2 15.1 3.5 1.4 1.0 2.7 4.3 1.7 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.0 0.0 108.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.0 8.1 601.6 0.0 5.6 0.1 0.2 0.0 0.0 15.0 0.1 0.1 0.1 2.0 0.1 2.1 3.0 0.0 2.5 9.1 10.9 11.5 14.7 9.2 13.2 15.3 11.1 7.5 14.7 15.6 15.1 19.5 0.2 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 7.3 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 0.0 1.8 0.2 17.9 0.0 0.0 0.0 0.0 79.2 4.4 18.2 0.3 26.3 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.2 0.2 0.4 0.3 0.1 0.4 0.0 1.6 0.0 0.0 0.1 IGHV3-64D ENSG00000282639 "Immunoglobulin heavy variable 3-64D" A0A0J9YX35 14 106088122-106088573 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 146.7;lymphoid tissue: 274.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 301 "memory B-cell: 43.3;naive B-cell: 18.7" "Lineage enriched" "Detected in single" 420 "B-cells: 43.3" "Not detected" "Not detected" "Immunoglobulin genes" NA NA 2500000000 5.6 0.5 0.2 141.7 0.1 11.0 85.0 0.0 0.8 13.0 0.3 132.2 20.6 3.3 1.4 35.7 7.9 46.7 4.8 0.5 0.1 1.5 4.3 37.1 49.2 0.1 0.1 0.0 5.1 8.1 0.1 0.1 0.1 0.1 4.1 146.7 0.0 29.1 11.6 0.0 3.8 69.3 3.6 0.1 68.0 75.5 0.5 0.1 16.7 2.9 0.0 274.7 40.9 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.2 0.1 0.0 0.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV5-10-1 IGHV5-A ENSG00000282651 "Immunoglobulin heavy variable 5-10-1" A0A0J9YXX1 14 106107972-106108464 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 319.6;lymphoid tissue: 572.2" "Cell type enriched" "Detected in single" 36 "B-cells: 3.6" "Region enriched" "Detected in single" 6 "cerebral cortex: 1.2" "Group enriched" "Detected in some" 15 "memory B-cell: 74.8;naive B-cell: 66.7" "Lineage enriched" "Detected in many" 16 "B-cells: 74.8" "Group enriched" "Detected in some" 6 "Daudi: 9.4;U-698: 4.8" HPA006014 Approved "Immunoglobulin genes" NA NA 1200000000 "HPA006014: " 3.0 28.7 0.0 232.0 0.0 39.0 103.0 0.0 1.2 69.4 0.0 276.7 1.0 10.9 0.0 112.5 20.1 93.3 6.2 0.0 0.0 5.5 7.4 129.5 122.1 0.1 0.0 0.0 54.5 5.8 0.4 0.3 0.2 0.1 7.0 319.6 0.0 76.1 19.1 0.1 1.6 52.1 11.0 0.0 205.6 149.6 0.1 0.0 39.7 7.4 0.0 572.2 198.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 66.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUXB ENSG00000282757 "Double homeobox B" A0A1W2PPF3 16 75693893-75701461 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBJ1-6 "TCRBJ1S6, TRBJ16" ENSG00000282780 "T cell receptor beta joining 1-6" A0A0J9YWX3 7 142788988-142789040 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 204.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 208.9" "Lineage enriched" "Detected in many" 11 "T-cells: 208.9" "Cell line enriched" "Detected in some" 44 "JURKAT: 278.9" NA NA 0.0 2.5 0.2 56.1 0.4 26.4 9.4 0.0 1.1 14.9 0.3 4.7 33.0 3.4 0.0 3.2 2.3 19.6 0.7 0.4 0.3 2.1 3.6 10.7 146.3 0.8 0.2 0.0 3.6 0.0 0.0 0.0 2.9 0.3 5.1 6.0 0.2 3.9 1.0 0.0 2.4 14.2 0.0 0.1 94.4 25.9 2.0 0.3 204.8 0.0 0.0 107.3 7.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 278.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.3 0.0 0.0 1.6 0.0 1.0 0.0 0.0 36.5 0.0 27.0 1.5 137.3 70.5 0.0 0.2 130.1 54.9 3.2 19.3 0.4 0.0 208.9 40.9 0.2 0.4 0.0 1.1 0.4 0.3 0.8 0.2 0.0 0.3 0.1 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL512428.1 ENSG00000282804 "Novel protein" 6 24797373-24809798 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 0.2 0.4 0.1 0.1 0.2 0.1 0.2 0.3 0.4 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX13C ENSG00000282815 "TEX13 family member C" A0A0J9YWL9 X 125320120-125325214 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 1.6" "Group enriched" "Detected in some" 16 "Spermatocytes: 7.4;Spermatogonia: 5.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "GAMG: 4.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1orf232 ENSG00000282872 "Chromosome 1 open reading frame 230" A0A0U1RR37 1 26164101-26168963 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "SCLC-21H: 2.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TMEM275 ENSG00000282881 "Transmembrane protein 275" A0A0U1RQS6 1 46532166-46543969 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "brain: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.2" NA NA 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.0 0.0 2.2 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.1 0.8 1.8 1.5 2.2 0.7 1.3 0.6 0.7 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004706.3 ENSG00000282936 "Novel protein" 17 6628619-6640456 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.2 0.2 0.7 0.2 0.4 0.3 0.1 0.0 1.0 0.3 0.1 0.2 0.2 0.5 0.3 0.2 0.4 0.3 0.2 1.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.9 0.4 0.5 0.3 0.2 0.1 0.4 0.2 0.5 0.2 0.4 0.3 0.2 0.2 0.3 0.0 0.4 0.2 0.7 0.2 0.7 0.2 0.1 0.2 0.3 0.2 0.4 2.9 1.3 1.9 1.3 0.4 0.9 0.5 1.1 0.6 1.2 0.6 1.5 0.3 0.3 0.8 0.5 1.1 2.7 1.7 0.5 0.8 0.7 1.4 0.6 1.9 0.5 0.3 1.0 0.7 0.7 0.7 1.4 0.4 1.0 0.4 1.3 1.2 0.1 0.5 1.0 0.9 0.5 1.4 0.4 0.6 1.3 0.8 0.0 0.3 1.4 0.7 1.7 1.9 0.2 0.7 0.7 0.7 0.2 0.8 1.1 0.5 0.7 1.8 0.3 0.4 0.4 0.8 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 1.0 1.0 0.2 0.1 0.0 0.4 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TRBV7-2 "TCRBV6S5A1N1, TCRBV7S2, TRBV72" ENSG00000282939 "T cell receptor beta variable 7-2" A0A1B0GXF2 7 142352819-142353358 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "epididymis: 35.9;lymphoid tissue: 86.3" "Cell type enriched" "Detected in some" 5 "T-cells: 33.0" "Region enriched" "Detected in single" 18 "midbrain: 10.9" "Immune cell enhanced" "Detected in many" "memory CD4 T-cell: 397.4;T-reg: 570.3" "Lineage enriched" "Detected in many" 79 "T-cells: 570.3" "Group enriched" "Detected in some" 9 "JURKAT: 55.7;MOLT-4: 93.6;U-937: 49.0" NA NA 0.6 0.1 0.0 15.1 0.1 0.0 2.2 0.0 0.2 2.2 0.0 1.2 1.7 0.0 35.9 0.6 0.6 0.0 0.1 0.0 0.6 0.4 0.3 5.6 49.4 0.2 10.9 0.0 0.1 0.2 0.0 1.0 0.1 0.0 0.3 4.6 0.0 0.4 0.4 0.0 0.2 4.7 1.1 0.0 5.8 4.8 0.0 0.1 86.3 0.7 0.0 43.3 2.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 93.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.3 0.0 0.0 49.0 0.0 1.1 2.3 0.7 11.9 1.2 55.5 0.7 397.4 178.6 2.7 0.7 302.2 110.6 1.2 0.5 1.9 7.2 570.3 104.9 0.0 0.1 0.0 0.2 0.0 0.6 0.2 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 AL031777.2 ENSG00000282988 "Novel protein" 6 26195595-26199293 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.1;Extravillous trophoblasts: 6.7;Hofbauer cells: 9.1;Syncytiotrophoblasts: 20.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 30.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 30.6" "Cell line enhanced" "Detected in some" "K-562: 6.9;SiHa: 7.7;T-47d: 4.6;U-2 OS: 5.1;U-266/70: 9.3;U-266/84: 5.6" HPA041189 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" 0.3 0.3 1.0 0.2 0.7 1.5 1.1 1.4 1.1 1.1 1.4 0.5 0.3 0.1 0.0 3.4 0.4 0.1 0.3 0.7 1.2 0.7 1.9 2.2 0.3 1.3 0.7 0.3 0.4 0.1 0.1 0.3 0.3 1.3 2.5 0.3 0.1 0.5 0.0 0.0 0.5 0.6 0.1 1.9 2.0 0.5 0.7 1.9 0.8 0.4 0.0 0.1 0.4 2.5 4.5 0.2 0.7 0.2 0.7 1.5 0.1 0.5 0.6 0.1 1.2 0.4 0.2 0.5 0.1 2.0 0.1 0.5 1.4 0.1 0.0 0.2 2.6 0.2 0.4 2.1 0.3 0.1 0.1 0.9 1.0 0.0 0.1 0.3 0.2 0.0 0.6 6.9 1.5 0.0 1.0 0.1 0.4 0.2 2.6 1.6 0.2 0.1 3.0 0.0 0.0 0.6 0.2 7.7 0.5 0.3 0.3 4.6 0.0 0.0 0.7 5.1 0.0 0.0 9.3 5.6 0.7 0.0 1.9 0.7 16.9 0.6 5.1 1.6 0.7 3.6 2.1 0.8 1.1 2.3 4.7 0.8 0.5 30.6 0.9 1.5 5.2 2.3 1.1 1.0 0.7 1.4 1.1 0.7 1.2 1.3 0.7 0.3 1.3 1.9 1.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 KLF18 ENSG00000283039 "Kruppel like factor 18" A0A0U1RQI7 1 44137821-44141631 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRBV6-2 "TCRBV13S2A1T, TCRBV6S2, TRBV62" ENSG00000283063 "T cell receptor beta variable 6-2" "A0A0J9YXY3, P0DPF7" 7 142349152-142349664 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 8.3" "Cell type enriched" "Detected in single" 10 "T-cells: 6.2" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 92.1" "Lineage enriched" "Detected in single" 175 "T-cells: 92.1" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 2.4 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.5 8.3 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 2.3 0.2 0.0 0.0 4.7 0.3 0.0 5.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 92.1 0.2 24.0 26.4 0.0 0.0 21.7 17.5 0.5 0.0 0.1 0.1 40.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 LBHD2 ENSG00000283071 "LBH domain containing 2" A0A0U1RRK4 14 103084210-103090027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.0;testis: 3.0" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.3;Proximal tubular cells: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1.1 0.0 2.7 0.2 3.4 0.0 0.5 0.5 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.5 0.1 0.0 0.0 0.1 3.1 1.8 1.2 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 3.0 8.0 0.0 0.0 0.0 0.0 0.4 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 0.5 2.2 3.0 2.5 3.1 1.8 1.2 3.8 0.6 8.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 CENPVL2 CENPVP2 ENSG00000283093 "Centromere protein V like 2" P0DPI3 X 51681212-51682831 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 1.1 0.0 2.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 1.0 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.5 0.0 1.1 0.3 2.0 1.0 0.9 0.6 0.6 0.4 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068631.2 ENSG00000283149 "Novel protein" 3 186581995-186597103 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA010814 Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010814: AB_1078691" 9.0 10.2 5.5 11.7 5.6 9.9 8.0 5.7 15.5 6.0 5.5 18.3 12.2 6.0 14.0 8.6 6.0 7.7 12.5 5.6 5.5 13.3 32.9 9.8 4.5 6.2 5.5 5.3 6.1 22.9 8.0 8.4 6.1 5.9 8.7 6.0 9.0 9.3 4.3 4.7 6.3 10.0 3.0 5.3 13.5 10.7 8.6 5.5 6.1 18.8 0.0 5.3 7.6 6.9 5.5 36.3 28.9 35.7 42.8 29.6 12.9 9.3 71.3 16.4 25.1 16.4 102.9 15.0 21.6 82.1 46.3 40.5 24.3 31.8 25.1 22.6 18.7 0.0 23.6 52.7 102.2 22.7 46.0 11.6 14.0 8.0 32.0 50.5 21.3 13.4 10.6 12.8 81.1 10.7 83.7 23.7 2.0 9.7 93.6 0.0 14.2 37.2 26.9 12.4 69.5 0.3 0.6 30.9 62.2 18.4 35.9 40.0 57.9 7.3 17.9 21.3 13.0 62.9 31.5 88.4 66.5 26.3 33.7 35.2 7.5 6.4 8.6 10.3 8.6 7.0 7.8 6.4 8.8 9.9 4.8 4.2 8.3 1.6 10.2 7.2 15.3 8.4 7.3 5.5 5.6 5.7 15.5 5.6 5.5 6.2 5.5 5.3 5.9 5.3 5.5 5.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCJ-SCHIP1 ENSG00000283154 "IQCJ-SCHIP1 readthrough" B3KU38 3 158962235-159897366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 148.5;choroid plexus: 90.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 7.3;Basal squamous epithelial cells: 12.5;Bipolar cells: 11.5;Excitatory neurons: 11.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA003243, HPA003445" Approved Approved Cytosol NA NA Cytosol "HPA003243: AB_1079877, HPA003445: AB_1079875" 19.9 5.2 113.0 9.8 120.4 2.2 15.5 114.7 148.5 8.9 90.7 35.5 4.5 19.8 6.4 15.6 18.3 12.6 49.8 114.6 110.6 16.8 14.4 19.8 2.2 125.5 120.3 115.9 4.4 2.8 1.1 7.3 23.8 127.3 17.9 6.8 14.3 6.6 20.6 27.8 5.2 12.9 26.2 118.7 4.3 18.5 4.8 117.5 2.6 5.7 3.3 1.8 36.1 10.9 142.6 87.9 14.8 28.9 34.4 6.6 6.3 25.1 73.6 17.3 59.4 40.5 55.6 20.9 4.4 46.4 24.6 22.6 34.8 11.3 24.9 48.5 72.7 27.6 0.1 31.2 2.8 7.7 4.2 0.5 6.5 20.8 26.5 31.1 49.3 44.5 4.9 0.0 0.3 27.7 3.9 0.3 0.0 24.2 7.0 31.9 10.2 58.4 0.0 57.6 4.7 5.8 26.8 39.8 16.7 21.8 32.9 9.8 0.8 37.6 34.0 47.5 22.9 101.5 0.3 0.5 0.4 19.1 12.4 92.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 113.0 120.4 114.7 148.5 114.6 110.6 125.5 120.3 115.9 127.3 118.7 117.5 142.6 4.7 6.4 0.0 1.0 0.1 1.5 7.3 0.8 12.5 11.5 0.3 0.9 0.6 0.0 1.4 1.8 6.2 0.0 0.1 0.3 0.0 0.9 2.0 2.1 0.8 5.7 0.0 0.0 11.3 0.6 0.0 3.1 0.0 2.3 2.5 0.0 1.8 0.6 0.0 0.0 4.7 0.2 0.0 0.3 1.2 0.6 0.3 1.2 0.0 0.0 0.6 0.5 0.0 0.0 0.6 1.2 0.0 1.2 0.0 1.3 0.0 4.2 2.4 0.6 0.0 2.5 5.4 0.1 0.4 3.5 0.9 0.0 0.5 0.0 0.2 1.6 AC104452.1 ENSG00000283189 "Novel protein" 3 49416777-49429314 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;granulocytes: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 C13orf46 ENSG00000283199 "Chromosome 13 open reading frame 46" A0A1B0GUA9 13 113953705-113974076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 9.6;stomach 1: 6.9;testis: 12.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;Exocrine glandular cells: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.1;RPMI-8226: 1.4;T-47d: 1.0;U-138 MG: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.8 0.0 0.2 0.1 0.1 0.6 0.9 0.0 0.1 0.4 1.1 0.3 0.1 0.2 0.0 0.1 0.5 0.4 0.2 0.5 0.0 0.1 0.3 2.6 0.2 0.1 0.1 0.0 0.1 9.6 0.0 0.4 0.0 0.3 1.2 0.1 0.0 1.0 0.0 0.4 0.3 0.3 0.0 0.0 0.3 6.9 12.7 0.1 0.1 2.5 0.0 0.0 1.0 0.3 0.8 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 1.0 0.1 0.2 1.0 0.6 0.2 0.3 0.0 0.0 0.0 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.8 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC092329.3 ENSG00000283201 "Zinc finger protein 724" 19 23222755-23274221 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Club cells: 1.8;Distal tubular cells: 3.9;Proximal tubular cells: 3.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 12.3" NA NA 1.0 0.8 1.1 1.1 1.0 1.9 1.5 2.5 1.2 0.8 0.7 1.4 0.7 1.3 3.7 0.7 1.5 0.6 0.7 1.3 0.6 1.9 1.9 1.2 1.5 0.7 0.5 0.9 2.1 0.8 1.9 0.0 0.6 1.1 1.9 1.6 1.2 0.6 1.0 0.2 1.0 0.7 1.0 0.0 1.1 1.1 1.3 0.8 2.8 2.1 0.3 1.5 1.3 0.0 0.8 2.5 0.7 9.7 5.6 1.4 0.7 6.0 2.6 1.9 4.1 5.5 4.1 1.3 0.2 1.9 1.2 3.0 1.6 7.0 1.8 4.2 1.8 4.5 2.2 0.7 0.9 0.5 0.0 2.3 0.9 0.5 3.9 0.8 1.0 0.1 6.1 2.4 0.0 2.0 1.4 7.0 1.7 6.3 0.0 2.6 8.4 4.8 1.7 1.5 12.3 3.9 3.2 0.0 0.0 0.6 4.2 3.5 0.2 0.1 0.3 0.7 4.4 3.3 0.0 1.9 7.5 0.0 0.6 0.7 0.8 0.4 0.4 0.9 0.2 0.9 0.4 0.6 0.8 0.5 0.9 0.7 0.6 0.3 0.9 0.3 1.4 1.2 0.4 1.1 1.0 2.5 1.2 1.3 0.6 0.7 0.5 0.9 1.1 0.0 0.8 0.8 0.4 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 3.9 0.3 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.8 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 AL353572.3 ENSG00000283205 "Novel protein" 9 87956214-87956883 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC001226.2 ENSG00000283208 "Novel protein" 13 76992078-77129589 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;brain: 3.6" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 1.6;Glandular and luminal cells: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.9 0.2 1.1 0.3 1.5 4.4 0.8 3.6 2.3 0.6 0.0 0.3 0.0 0.3 0.6 0.3 0.4 0.3 0.5 1.2 0.6 0.3 0.2 0.5 0.4 0.0 0.3 1.0 0.6 0.4 0.1 0.3 0.1 0.8 0.2 0.0 1.8 0.3 0.3 0.6 1.7 0.3 0.1 0.0 0.3 0.2 0.3 0.3 0.1 0.5 0.2 0.0 0.4 0.6 2.3 0.2 0.1 0.3 0.0 0.5 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.9 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.8 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.7 0.1 0.5 0.1 0.9 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.5 0.2 0.2 0.2 0.1 0.6 0.1 0.2 0.0 1.1 1.5 3.6 2.3 1.2 0.6 0.0 0.3 1.0 0.8 0.0 0.3 2.3 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 SPRR5 ENSG00000283227 "Small proline rich protein 5" A0A1B0GTR4 1 152947154-152949258 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "skin 1: 91.3" "Cell type enhanced" "Detected in single" "Exocrine glandular cells: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HaCaT: 2.0;hTCEpi: 5.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 91.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC201 ENSG00000283247 "Coiled-coil domain containing 201" A0A1B0GTI1 7 45859994-45873082 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM237B ENSG00000283267 "Family with sequence similarity 237 member B" A0A1B0GVD1 7 90316503-90321308 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 1.6;Respiratory ciliated cells: 1.5" "Region enriched" "Detected in single" 6 "hypothalamus: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 1.6;thalamus: 4.9" "Low region specificity" "Detected in all" NA NA 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.6 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TEX54 ENSG00000283268 "Testis expressed 54" A0A1B0GVG6 11 62832319-62832803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 77.4" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in all" 6 "neutrophil: 147.9" "Lineage enriched" "Detected in all" 17 "granulocytes: 147.9" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" NA NA 0.2 0.3 0.1 0.3 0.2 0.6 0.2 0.8 0.5 0.1 0.5 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.5 0.3 0.4 0.2 0.3 0.5 0.2 0.1 0.4 0.5 0.0 1.1 0.2 0.3 0.6 0.0 0.1 2.1 0.0 0.2 0.9 0.4 0.0 0.1 0.4 0.6 77.4 0.3 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.8 0.2 0.0 1.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.0 0.4 0.4 0.1 0.0 0.5 0.3 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.5 0.2 0.2 0.6 0.0 0.7 0.2 0.3 0.0 0.0 0.6 25.1 8.9 20.3 5.0 6.2 8.4 6.4 5.2 4.5 2.8 6.7 8.8 6.4 147.9 5.2 2.9 7.5 3.9 0.9 0.1 0.2 0.8 0.5 0.3 0.5 0.5 0.2 0.1 0.3 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SMIM33 ENSG00000283288 "Small integral membrane protein 33" A0A1B0GW64 5 139470778-139474772 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.2;salivary gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.4 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.3 0.2 0.2 0.3 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 TEX52 ENSG00000283297 "Testis expressed 52" A6NCN8 12 2849046-2857039 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 1.2" "Immune cell enriched" "Detected in single" 7 "NK-cell: 1.0" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "HeLa: 2.8;Karpas-707: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043581 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043581: " 0.4 0.5 0.1 1.0 0.3 0.8 0.5 0.0 0.3 0.4 1.8 0.5 1.2 0.3 0.0 0.5 0.4 0.3 0.3 0.0 0.0 0.4 0.5 0.3 1.0 0.5 0.1 0.0 0.5 1.1 0.0 0.5 0.1 0.3 0.6 0.0 2.9 1.5 0.0 2.5 3.5 1.0 0.0 0.2 0.9 0.5 8.1 0.2 0.0 1.0 0.0 0.0 0.4 0.5 1.2 0.2 0.8 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.6 0.7 0.1 2.8 0.9 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 2.9 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.6 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.4 0.3 0.0 0.3 0.1 0.7 0.4 0.2 0.5 0.1 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.3 0.2 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC019117.1 ENSG00000283321 "Novel protein" 7 17299295-17467234 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix: 8.5;urinary bladder: 15.3" "Cell type enhanced" "Detected in some" "Ductal cells: 1.1;Early spermatids: 2.1;Endometrial ciliated cells: 1.4;Late spermatids: 1.2;Theca cells: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 55.3" HPA029722 Uncertain NA NA "HPA029722: AB_10599189" 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.0 0.1 8.5 0.0 0.1 0.3 1.6 0.4 0.2 2.0 0.8 0.0 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.3 0.7 0.9 0.3 0.0 0.5 0.1 0.4 0.0 0.2 1.1 0.4 0.0 0.1 0.1 0.0 0.1 15.3 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 55.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 11.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 CTXND2 ENSG00000283324 "Cortexin domain containing 2" A0A1B0GV90 1 150887136-150913292 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "BEWO: 1.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM240B ENSG00000283329 "Family with sequence similarity 240 member B" A0A1B0GVZ2 9 38694263-38720428 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 4.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.8 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.0 4.2 0.3 0.7 0.2 0.3 0.2 0.5 0.2 0.2 0.1 0.6 0.2 0.2 1.6 0.4 0.2 0.7 0.2 0.2 0.2 0.3 0.8 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP97D2 ENSG00000283361 "CFAP97 domain containing 2" A0A1B0GU71 13 114154691-114223084 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;fallopian tube: 20.0;pancreas: 7.2" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 19.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "naive CD8 T-cell: 4.0" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 4.7 0.0 2.2 0.9 0.0 2.6 1.6 0.2 3.5 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 1.6 3.9 0.0 0.0 0.6 0.3 4.1 3.9 1.4 0.0 7.2 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.2 0.0 2.0 1.9 0.4 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 2.2 2.6 1.6 1.6 3.9 4.1 3.9 1.4 3.2 5.7 1.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CNTNAP3C ENSG00000283378 "Contactin associated protein family member 3C" 9 61330717-61453030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 11.1;brain: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 12 "neutrophil: 30.9" "Lineage enriched" "Detected in single" 182 "granulocytes: 30.9" "Cell line enhanced" "Detected in some" "A549: 27.5;SiHa: 6.1;TIME: 8.7;WM-115: 24.0" NA NA 0.2 0.0 1.1 0.1 3.2 11.1 0.2 0.1 0.9 0.2 2.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.9 2.2 0.9 0.1 0.0 0.1 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.3 1.2 0.3 0.0 0.0 0.4 0.1 0.0 1.0 0.2 0.2 0.0 0.4 0.0 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.9 1.3 27.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.9 3.0 0.4 2.1 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 1.8 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.6 0.0 0.9 0.0 0.5 3.3 0.0 0.9 0.4 0.8 6.1 0.1 1.7 0.3 0.1 0.1 8.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 24.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 1.1 3.2 0.1 0.9 2.2 0.9 0.6 1.4 0.6 1.2 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC195 ENSG00000283428 "Coiled-coil domain containing 195" A0A1B0GUA6 2 224703764-224716365 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Daudi: 2.3;RPMI-8226: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSNKA2IP ENSG00000283434 "Casein kinase 2 subunit alpha' interacting protein" A0A1B0GTH6 3 88338416-88467594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 110 "testis: 23.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPEM3 ENSG00000283439 "SPEM family member 3" A0A1B0GUW6 17 7428857-7432820 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 568 "testis: 56.8" "Cell type enriched" "Detected in single" 18 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFX4 ENSG00000283463 "Heat shock transcription factor family, X-linked member 4" A0A1B0GTS1 X 149929573-149931287 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 2.8 0.0 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.4 0.2 0.0 0.2 0.1 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 15.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM240A ENSG00000283473 "Family with sequence similarity 240 member A" A0A1B0GVK7 3 46612435-46626543 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.9" "Cell type enhanced" "Detected in single" "Breast glandular cells: 2.2" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.1 0.0 0.3 0.0 0.4 0.4 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 1.9 0.5 0.1 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 9.3;kidney: 8.4;liver: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;RPMI-8226: 1.0" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 0.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.5 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 30.6 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.1 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LITAFD ENSG00000283516 "LITAF domain containing" A0A1B0GVX0 16 8881634-8885351 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.8 0.2 0.4 0.8 0.0 1.6 1.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.2 0.2 0.1 0.1 0.3 0.2 0.4 0.1 0.4 0.2 0.2 0.1 0.6 0.2 0.1 0.2 0.2 0.0 0.0 0.8 0.3 0.0 0.1 0.1 0.2 7.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.0 0.2 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.6 0.2 0.6 0.1 0.3 0.3 0.4 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.3 0.2 0.6 0.0 0.1 0.3 0.7 0.0 0.0 0.1 0.1 1.1 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.1 0.0 0.5 0.2 0.2 0.7 0.4 0.1 0.3 0.2 0.2 0.8 0.4 1.6 1.2 1.1 0.1 0.3 0.2 0.4 0.6 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRT1B "DSPD2, IFITMD8" ENSG00000283526 "Proline rich transmembrane protein 1B" A0A1B0GWB2 9 131545514-131558620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 6.4;lung: 4.1;pancreas: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 14.7;BEWO: 9.6;MCF7: 3.9;T-47d: 7.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.3 0.0 0.9 0.0 0.2 0.7 0.5 0.5 0.1 1.4 0.5 0.2 0.0 0.0 6.4 0.7 0.0 0.4 0.3 0.3 2.9 4.1 0.0 0.6 0.4 0.2 0.0 4.3 1.6 0.1 0.0 0.2 2.5 1.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.7 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.5 0.4 0.3 0.6 0.4 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCAF2C ENSG00000283528 "TRPM8 channel associated factor 2C" 7 143639230-143647646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.5 0.3 0.8 0.4 0.0 0.3 0.5 0.5 0.0 0.7 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC021072.1 ENSG00000283536 "Novel protein" 12 53241889-53242723 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 89 "retina: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C19orf85 ENSG00000283567 "Chromosome 19 open reading frame 85" A0A1B0GUS0 19 55463002-55464707 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236C ENSG00000283594 "Family with sequence similarity 236 member C" P0DP71 X 72912615-72913401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 23 "brain: 1.3;testis: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.8 0.8 0.9 1.3 0.3 0.1 0.6 0.6 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX276092.9 ENSG00000283599 "Chromosome X open reading frame 49-like" X 71667542-71671524 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" NA NA 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.5 0.3 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" 19 45212370-45245407 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 19.0;thyroid gland: 18.0" "Group enriched" "Detected in some" 4 "Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 19.1;K-562: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: AB_2684431" 3.7 8.4 0.4 2.1 0.6 1.6 2.9 0.4 0.4 4.0 1.4 1.9 2.4 4.9 0.4 2.0 2.9 2.3 1.8 0.4 0.8 19.0 2.7 2.7 1.1 0.7 0.4 0.2 0.9 2.7 3.4 5.1 0.4 0.6 5.2 0.7 0.1 1.8 2.2 0.9 2.1 3.3 1.9 0.3 8.4 3.0 3.3 0.4 0.4 18.0 0.3 0.5 3.3 2.4 0.9 0.1 0.3 2.5 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.1 19.1 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 16.6 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.5 1.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.1 1.0 0.1 0.3 0.6 0.8 1.5 0.2 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.4 0.4 0.4 0.8 0.7 0.4 0.2 0.6 0.3 0.4 0.9 15.3 0.0 1.3 0.7 0.7 0.4 0.3 0.0 0.0 0.7 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 17.7 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.2 0.0 0.4 51.4 0.3 0.0 0.0 1.1 0.6 0.0 1.6 0.0 0.0 1.8 2.8 0.0 0.0 0.1 0.2 2.1 0.5 0.7 0.0 0.0 1.9 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.6 0.4 6.2 0.2 0.9 0.0 0.1 21.2 0.0 0.3 ETDC ENSG00000283644 "Embryonic testis differentiation homolog C" A0A1B0GVM5 X 135309480-135309659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;choroid plexus: 1.5;skin 1: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.2" NA NA 0.0 0.1 0.7 0.0 1.2 0.7 0.0 0.6 2.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 1.6 0.0 0.3 0.0 0.1 1.6 0.9 0.4 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.3 0.0 0.7 0.0 1.1 0.0 0.0 0.4 0.1 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.6 2.0 0.9 1.6 1.6 0.9 0.4 1.1 0.4 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMLN2 ENSG00000283654 "Leishmanolysin like peptidase 2" A0A1B0GTW7 14 23099062-23104989 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "HSkMC: 2.5" "Not detected" "Not detected" NA NA 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.2 0.3 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.1 0.2 0.3 0.3 0.2 0.5 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYOCOS ENSG00000283683 "Myocilin opposite strand" A0A1B0GUC4 1 171600621-171638799 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix: 5.4;epididymis: 3.4;fallopian tube: 3.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Endometrial ciliated cells: 14.7;Glandular and luminal cells: 4.3;Proximal tubular cells: 5.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 27.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.7 0.1 0.7 0.4 0.1 1.3 0.9 5.4 0.5 0.1 0.2 1.2 3.4 0.2 3.1 0.3 0.1 0.7 0.5 1.0 0.2 0.2 0.3 0.6 0.5 0.5 0.2 0.6 0.0 0.0 0.3 0.6 0.2 0.2 0.7 0.1 0.7 0.4 0.2 0.2 0.1 0.4 0.2 0.3 1.1 0.6 0.0 0.8 0.0 0.2 0.3 0.0 1.3 0.0 0.5 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.1 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 27.6 0.5 0.5 0.1 0.1 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.5 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.9 1.8 0.2 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.1 0.0 0.2 0.1 0.7 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.7 0.7 1.3 0.9 0.7 0.5 0.6 0.5 0.5 0.6 0.4 0.6 1.3 0.1 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 HSFX3 ENSG00000283697 "Heat shock transcription factor family, X-linked member 3" A0A1B0GWH4 X 149548210-149549924 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VSIG10L2 ENSG00000283703 "V-set and immunoglobulin domain containing 10 like 2" P0DP72 11 125946056-125958647 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skin 1: 18.8" "Group enriched" "Detected in some" 4 "Breast glandular cells: 11.9;Breast myoepithelial cells: 6.7" "Region enhanced" "Detected in some" "cerebellum: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.1 0.0 0.2 0.0 1.8 3.1 0.8 0.6 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.0 18.8 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.1 0.8 0.3 0.1 0.1 0.4 0.3 1.2 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 6.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PRSS50 "CT20, TSP50" ENSG00000283706 "Serine protease 50" Q9UI38 3 46712117-46717869 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "pituitary gland: 17.3;testis: 52.4;thyroid gland: 16.6" "Group enriched" "Detected in some" 8 "Spermatocytes: 359.2;Spermatogonia: 303.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" HPA040768 Supported "Intracellular and membrane" NA NA "HPA040768: AB_2677126" 0.4 1.2 1.0 0.0 0.8 0.1 1.9 2.4 1.5 3.9 0.4 1.2 0.0 1.5 3.0 0.4 2.3 0.1 2.4 0.9 1.5 5.3 2.8 0.7 0.0 0.9 0.8 0.6 2.3 4.6 1.4 17.3 0.1 0.7 4.6 0.0 0.2 1.9 2.1 1.2 0.4 0.5 0.3 1.1 0.3 1.0 52.4 0.8 0.2 16.6 0.0 0.0 1.7 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 2.4 1.5 0.9 1.5 0.9 0.8 0.6 0.7 1.1 0.8 0.8 0.0 0.0 0.0 1.6 0.0 0.1 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 3.1 0.2 0.0 1.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.1 39.5 0.2 0.0 359.2 303.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 TAF11L11 ENSG00000283740 "TATA-box binding protein associated factor 11 like 11" 5 17604177-17605377 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2 OS: 1.0" NA NA 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPHXL ENSG00000283755 "Cytoplasmic polyadenylated homeobox like" A0A1W2PPM1 16 75714131-75726490 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PMIS2 IFITMD9 ENSG00000283758 "PMIS2 transmembrane protein" A0A1W2PS18 19 35586161-35587296 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118553.2 ENSG00000283761 "Novel protein" 1 99970011-100083321 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 4.1;Collecting duct cells: 1.8;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA073681 Approved Vesicles NA NA Vesicles "HPA073681: AB_2686625" 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.2 0.4 0.2 0.2 0.2 0.1 0.6 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.7 0.0 0.5 0.2 0.0 0.3 0.0 1.0 0.0 0.2 0.6 0.2 0.3 1.0 0.2 0.5 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.4 0.2 0.7 0.1 0.3 0.2 0.6 0.1 0.3 0.5 0.7 0.9 0.2 0.0 0.6 0.8 1.3 0.5 1.3 2.7 0.5 2.0 0.1 3.3 2.0 2.7 2.1 2.6 0.9 1.7 0.9 1.3 2.2 3.7 0.1 0.2 0.5 0.5 0.0 0.8 2.5 2.2 0.7 1.6 0.3 1.8 1.2 0.7 1.2 2.3 0.1 0.1 2.1 1.1 0.5 2.0 0.9 0.7 1.1 0.6 0.7 1.1 0.6 0.5 0.8 0.6 0.1 0.5 0.8 1.3 0.7 1.4 0.7 2.9 0.3 1.0 1.0 0.3 8.4 5.1 3.5 4.4 5.2 5.0 2.8 4.5 5.2 5.8 1.9 4.2 3.6 0.8 6.7 3.2 4.6 5.9 5.0 0.1 0.2 0.1 0.2 0.2 0.2 0.5 0.2 0.0 0.6 0.1 0.2 0.3 0.3 6.4 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 1.3 1.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.2 1.3 0.4 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 AC131160.1 ENSG00000283765 "Presenilin associated rhomboid like" 3 183815568-183884889 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;choroid plexus: 4.5;skeletal muscle: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 15.8" HPA019545 Uncertain Approved Mitochondria NA NA Mitochondria "HPA019545: AB_1855796" 0.5 0.5 6.1 0.4 8.1 0.5 0.3 8.9 9.3 0.2 4.5 0.4 0.1 0.1 0.0 0.6 0.2 0.0 0.5 6.2 6.8 0.2 0.2 0.3 0.2 7.9 7.9 5.9 0.3 2.0 0.4 0.1 0.2 7.9 0.2 0.5 1.0 0.3 0.4 5.6 0.6 0.3 0.4 6.6 0.2 0.4 1.3 7.3 1.7 0.3 1.6 0.2 0.4 0.2 9.6 1.0 0.4 1.3 0.4 0.3 0.3 0.1 0.9 0.4 1.3 0.5 3.3 0.1 1.1 0.3 0.8 1.7 0.0 4.2 0.8 2.1 1.4 1.5 1.6 0.9 0.8 0.0 1.0 0.3 0.6 0.6 1.0 0.0 0.8 0.0 2.7 0.3 1.1 2.0 2.5 3.1 0.7 3.2 0.0 0.5 2.2 1.1 2.1 0.3 1.6 2.3 1.4 0.7 1.2 1.4 0.2 15.8 0.2 0.0 0.1 1.6 0.3 1.5 2.0 2.6 2.1 0.5 2.2 0.6 0.0 0.2 0.6 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 6.1 8.1 8.9 9.3 6.2 6.8 7.9 7.9 5.9 7.9 6.6 7.3 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L13 ENSG00000283776 "TATA-box binding protein associated factor 11 like 13" 5 17632088-17632684 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC116366.1 ENSG00000283782 "Novel protein" 5 132410832-132646079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.0;Breast glandular cells: 6.0;Endometrial ciliated cells: 11.7;Endometrial stromal cells: 10.9;Glandular and luminal cells: 22.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052291 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052291: AB_2681786" 4.0 3.4 2.5 3.6 2.5 2.0 4.2 3.5 2.9 4.4 2.7 3.7 5.0 3.2 3.4 2.0 3.9 3.6 3.6 2.6 3.1 4.3 4.8 4.4 4.8 3.1 2.7 1.8 6.2 1.1 4.3 2.7 3.1 3.8 4.0 2.2 2.8 4.3 3.8 1.8 4.0 3.0 2.7 4.8 4.0 1.9 2.8 6.2 3.3 5.9 5.0 2.9 3.2 3.7 0.2 0.9 2.2 8.0 7.0 5.3 4.0 3.1 6.0 5.7 0.2 7.9 3.7 2.3 3.9 10.2 2.4 2.5 0.9 3.1 7.3 1.2 4.4 0.9 0.5 12.6 2.3 3.1 4.9 1.3 4.1 4.5 6.7 4.7 4.0 0.5 8.6 6.7 0.1 8.6 3.0 1.6 2.2 1.3 7.9 3.2 11.4 1.4 0.3 1.9 1.4 2.0 1.6 3.2 2.6 0.2 3.7 4.4 2.9 1.9 2.0 2.0 12.5 6.7 3.0 3.6 9.0 1.5 2.7 1.1 4.4 4.7 1.9 2.7 3.0 2.6 3.5 0.6 2.9 2.9 3.4 2.7 3.4 1.9 2.0 3.3 2.2 2.5 2.5 3.5 2.9 2.6 3.1 3.1 2.7 1.8 3.1 2.7 2.8 3.2 9.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.7 0.0 11.7 10.9 3.1 0.0 0.0 0.0 0.5 0.0 2.5 0.0 22.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 PRR33 "C11orf89, LOC728008" ENSG00000283787 "Proline rich 33" 11 1888078-1891895 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.6;lymphoid tissue: 28.6;skeletal muscle: 35.6" "Cell type enriched" "Detected in single" 14 "Cardiomyocytes: 2.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Group enriched" "Detected in some" 5 "Daudi: 3.0;HDLM-2: 8.6;Karpas-707: 6.1;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 4.5 23.6 0.0 6.1 0.0 9.7 3.0 0.0 0.2 5.1 0.1 2.4 1.4 2.8 0.0 3.2 3.1 1.5 5.1 0.0 0.1 0.5 1.1 2.7 6.3 0.2 0.0 0.0 0.5 0.6 0.0 0.6 1.4 0.1 1.3 0.0 0.0 3.4 0.0 35.6 11.1 6.1 0.0 0.3 28.6 2.9 1.2 0.1 0.0 1.8 4.1 0.0 6.9 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 AC007326.4 ENSG00000283809 "Novel protein" 22 18906238-18947732 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HAP1: 350.1;NTERA-2: 114.2;SuSa: 77.0" NA NA 9.9 8.9 29.9 9.2 29.9 13.1 9.9 35.7 33.3 3.5 28.7 5.0 15.4 7.2 16.6 4.2 5.2 6.1 7.2 28.8 29.9 16.3 6.8 8.2 13.1 30.4 29.1 29.7 7.5 5.5 4.2 0.1 7.3 31.6 6.8 5.3 42.3 10.4 5.4 17.4 17.3 15.5 4.7 25.1 14.1 8.2 11.4 29.3 8.6 10.2 3.7 6.3 3.6 0.0 38.6 13.0 11.7 8.5 11.8 6.7 8.6 51.6 9.3 3.3 3.2 3.8 10.5 24.9 7.7 17.9 6.6 11.3 11.1 350.1 5.6 4.5 36.7 7.7 6.3 28.3 9.9 6.1 8.0 7.8 7.1 8.2 7.2 2.9 8.8 1.8 14.8 11.3 13.1 3.6 12.0 11.8 8.2 114.2 7.8 8.9 14.2 6.4 15.2 8.8 9.3 14.0 9.8 9.1 7.5 41.0 77.0 12.9 6.8 9.7 12.1 13.0 8.5 7.1 12.0 6.9 10.2 15.7 10.8 6.8 9.3 14.7 7.0 10.1 13.2 7.1 5.8 7.3 7.7 8.6 8.9 8.4 10.2 19.2 7.7 8.9 3.9 6.6 7.0 29.9 29.9 35.7 33.3 28.8 29.9 30.4 29.1 29.7 31.6 25.1 29.3 38.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P4 ENSG00000283873 "SSU72 pseudogene 4" 11 4287499-4288083 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX664615.2 ENSG00000283886 Q8NFD4 9 39816599-39874562 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HDLM-2: 4.8;SCLC-21H: 6.2;SH-SY5Y: 4.5;SiHa: 4.1;WM-115: 8.8" HPA021733 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021733: AB_10602499" 0.4 2.7 1.3 1.6 1.4 0.4 0.7 1.3 2.0 1.5 1.3 0.3 0.4 1.1 1.1 1.2 0.9 1.2 3.5 1.4 1.4 3.8 1.6 0.9 1.4 1.6 1.4 1.2 2.2 1.9 1.4 0.1 1.9 1.1 0.2 5.5 2.1 0.7 0.3 2.4 0.9 0.4 1.1 0.8 0.6 0.4 1.4 0.5 5.4 0.1 0.2 1.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.1 0.1 0.1 6.0 0.0 1.3 0.0 0.0 0.0 0.0 1.0 0.0 4.8 1.3 0.0 2.9 0.0 0.1 0.9 0.1 0.3 3.9 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.4 0.7 6.2 4.5 4.1 2.3 0.2 0.0 0.5 0.0 3.0 0.2 0.4 1.6 0.0 0.0 1.6 2.2 0.0 0.0 8.8 0.9 0.0 0.7 1.0 0.6 0.7 0.7 0.7 0.8 0.6 1.6 0.6 0.8 0.0 0.5 0.4 0.7 0.5 0.2 1.3 1.4 1.3 2.0 1.4 1.4 1.6 1.4 1.2 1.9 1.1 1.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TPTEP2-CSNK1E ENSG00000283900 "TPTEP2-CSNK1E readthrough" 22 38291918-38398522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.4;B-cells: 1.8;Breast glandular cells: 1.9;Collecting duct cells: 9.2;Endometrial ciliated cells: 2.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 4.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 5 "dendritic cells: 3.5;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "AF22: 5.2;Karpas-707: 9.1;U-266/70: 6.4" HPA026288 Uncertain NA NA "HPA026288: AB_1847276" 2.5 0.5 0.7 0.8 1.6 2.5 2.8 0.7 1.4 2.5 0.5 1.0 0.3 2.5 0.8 1.0 2.8 0.9 1.9 0.9 1.6 1.1 0.7 2.0 0.5 1.3 1.0 0.5 1.0 0.6 2.3 1.5 1.1 1.2 1.2 0.3 2.2 1.6 0.6 1.5 1.4 0.9 0.9 0.7 0.9 0.9 1.3 0.9 0.3 1.8 0.9 1.3 1.3 1.4 2.3 0.7 0.0 5.2 0.5 0.8 1.2 0.7 1.5 4.7 0.7 0.7 0.0 0.4 0.0 0.8 1.2 0.7 0.7 0.5 0.7 0.8 3.5 1.4 0.6 2.6 0.2 0.8 1.4 1.1 0.9 2.2 0.2 0.2 3.5 1.5 0.3 0.5 9.1 0.3 0.2 0.0 0.4 0.6 0.0 0.0 1.2 0.8 2.3 0.7 0.0 0.9 0.3 0.2 0.1 1.9 1.5 0.1 0.5 4.3 0.0 0.7 0.1 0.0 6.4 4.8 1.8 1.7 0.5 0.6 0.4 0.2 4.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.3 0.0 0.0 1.1 0.7 0.0 3.5 0.7 0.1 0.7 1.6 0.7 1.4 0.9 1.6 1.3 1.0 0.5 1.2 0.7 0.9 2.3 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 0.9 0.0 2.0 1.0 0.3 0.0 0.0 0.0 1.3 0.0 0.4 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 AC092017.2 ENSG00000283952 "Novel protein" 1 211082872-211188533 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L8 ENSG00000283967 "TATA-box binding protein associated factor 11 like 8" 5 17590364-17590960 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNG14 ENSG00000283980 "G protein subunit gamma 14" A0A1W2PPG7 19 12687998-12688422 "Predicted intracellular proteins" Transducer "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;pancreas: 1.0;skin 1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;HEK 293: 2.1;MCF7: 2.2;U-266/84: 1.2" NA NA 0.1 0.0 1.0 0.0 0.4 0.4 0.0 0.1 0.7 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.2 1.0 0.0 0.1 0.0 0.5 0.1 0.0 0.2 0.3 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.9 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 2.2 0.2 0.5 0.2 0.0 0.6 0.1 0.0 0.3 0.0 0.8 0.3 0.5 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.2 0.8 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.1 0.7 0.5 0.1 0.3 0.1 0.1 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TAF11L9 ENSG00000283988 "TATA-box binding protein associated factor 11 like 9" 5 17593798-17594394 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLURP2 ENSG00000283992 "Secreted LY6/PLAUR domain containing 2" P0DP57 8 142764338-142769828 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 877.8;skin 1: 281.2;vagina: 221.5" "Cell type enhanced" "Detected in single" "Pancreatic endocrine cells: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 28.5" "Secreted in other tissues" NA NA 3100000 0.9 0.1 0.6 0.0 0.6 0.0 2.0 3.0 2.4 91.0 0.0 13.2 0.3 5.0 0.2 877.8 4.1 0.2 0.7 1.2 0.2 0.2 0.3 0.6 0.0 1.5 0.5 0.3 1.0 0.4 0.0 0.2 0.1 1.9 6.5 0.3 0.3 75.8 2.2 0.4 281.2 2.8 0.8 0.2 0.3 5.9 0.3 0.5 1.2 0.6 0.0 23.1 10.0 221.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.1 6.2 0.0 0.0 28.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 3.0 2.4 1.2 0.2 1.5 0.5 0.3 1.9 0.2 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P5 ENSG00000284018 "SSU72 pseudogene 5" 11 4233288-4233872 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC069544.1 ENSG00000284024 "Zinc finger and SCAN domain containing 29" 10 14838302-14846999 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.8;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.2;Granulosa cells: 2.3;Proximal tubular cells: 1.3;Theca cells: 4.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 4.3 4.1 2.8 6.3 2.9 9.0 6.9 6.8 4.7 5.6 2.0 5.9 5.5 6.0 3.4 6.7 3.7 6.1 3.6 3.9 3.2 3.1 3.9 3.1 8.5 2.8 2.7 2.7 7.3 6.0 5.3 3.6 7.9 3.7 5.4 6.4 10.2 3.9 4.3 2.4 7.7 5.2 4.5 2.7 5.8 6.6 6.9 2.9 9.8 5.3 4.3 7.3 6.4 2.9 3.2 13.9 9.7 15.3 14.9 9.1 7.8 15.1 12.6 5.6 15.7 20.3 16.5 10.0 21.5 6.1 7.9 8.4 14.5 24.1 12.5 20.2 11.9 14.3 22.0 20.1 10.8 11.1 8.9 13.3 5.8 10.2 25.0 11.1 7.4 9.9 13.2 25.1 16.8 18.7 12.8 18.2 8.0 13.5 8.0 6.1 15.8 13.2 14.3 8.8 6.4 12.1 14.6 11.8 13.9 12.6 9.7 9.9 10.2 8.1 16.0 16.9 18.2 12.8 9.9 12.9 19.9 8.3 13.5 7.5 2.9 1.6 1.9 1.8 2.0 2.0 2.1 1.7 1.7 1.6 2.2 2.0 2.5 1.6 3.5 2.9 2.2 1.8 1.7 2.8 2.9 6.8 4.7 3.9 3.2 2.8 2.7 2.7 3.7 2.7 2.9 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 TAF11L6 ENSG00000284042 "TATA-box binding protein associated factor 11 like 6" 5 17528669-17529265 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP001273.2 ENSG00000284057 "Novel protein, C11orf54-MED17 readthrough" 11 93741664-93812378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 9.5" "Cell type enriched" "Detected in single" 7 "Respiratory ciliated cells: 4.4" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA040511, HPA046619" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA040511: AB_10795369, HPA046619: " 1.3 2.1 0.6 2.1 0.6 0.0 1.1 0.6 1.0 1.5 0.4 1.9 4.9 1.2 0.4 0.3 1.4 2.0 1.5 0.5 0.6 9.5 4.6 1.1 0.8 0.7 0.6 0.4 2.3 0.3 2.0 0.5 1.7 0.8 2.4 1.6 1.4 1.6 1.0 1.1 1.6 3.4 0.5 0.6 0.8 1.8 1.3 0.6 1.6 1.5 1.8 1.2 0.9 0.2 0.8 0.6 0.0 3.3 0.6 1.9 0.0 1.9 0.0 1.0 0.7 1.3 0.6 1.4 2.2 4.0 2.5 1.0 2.2 4.0 0.9 0.4 3.3 0.3 0.7 1.4 0.0 1.4 0.0 0.7 1.4 0.6 0.0 1.5 2.9 1.0 1.7 1.3 0.5 3.9 0.0 2.6 2.2 1.4 6.0 0.1 0.8 2.3 1.3 3.5 0.0 0.7 0.3 2.1 2.4 4.9 2.8 2.5 0.9 2.8 0.3 0.8 0.4 1.3 0.6 1.3 2.9 0.2 1.8 1.3 1.9 1.2 1.8 1.1 1.2 1.3 1.0 1.1 1.4 1.5 0.4 1.1 1.4 1.8 1.2 1.4 0.8 2.1 1.2 0.6 0.6 0.6 1.0 0.5 0.6 0.7 0.6 0.4 0.8 0.6 0.6 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL451007.3 ENSG00000284188 "Novel protein" 1 244729898-244730962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 8.9" "Cell type enriched" "Detected in single" 4 "Distal tubular cells: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 SCO2 "MYP6, SCO1L" ENSG00000284194 "Synthesis of cytochrome C oxidase 2" O43819 22 50523568-50526461 "Disease related genes, Human disease related genes, Predicted membrane proteins" Chaperone "Cardiomyopathy, Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 112.2;Paneth cells: 131.5;Proximal enterocytes: 110.7;Suprabasal keratinocytes: 98.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046943, HPA056254" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046943: AB_2732536, HPA056254: AB_2683080" 16.9 10.4 15.2 13.5 14.4 36.8 7.9 14.4 16.9 6.9 16.3 22.2 25.9 3.6 4.7 12.5 15.9 7.7 10.4 13.0 15.1 8.2 18.6 14.5 9.1 15.4 16.5 13.1 1.8 11.5 7.2 1.5 8.3 15.3 5.1 10.6 0.1 21.4 6.8 10.3 11.1 19.9 12.8 16.0 11.5 10.2 4.1 15.7 11.3 2.3 10.2 10.3 13.1 2.5 16.7 37.4 29.9 1.3 12.5 17.7 24.2 18.7 19.5 24.1 38.0 32.8 35.3 17.8 42.7 19.7 22.6 9.6 36.0 19.3 31.5 6.1 7.6 82.5 13.8 20.2 46.7 44.6 43.8 18.3 38.4 48.6 19.4 15.8 10.6 24.4 5.8 15.6 32.9 16.8 55.7 13.3 76.5 11.0 15.5 54.8 26.1 7.5 65.0 29.6 21.3 16.6 23.7 24.4 70.7 63.5 1.3 26.1 24.7 25.8 16.3 22.6 30.2 22.2 26.1 15.6 29.2 35.7 28.7 14.5 19.1 21.8 12.2 43.9 19.9 42.2 40.1 38.9 44.1 34.9 33.4 29.2 32.6 21.6 27.7 21.1 56.2 37.0 37.7 15.2 14.4 14.4 16.9 13.0 15.1 15.4 16.5 13.1 15.3 16.0 15.7 16.7 0.0 3.2 2.7 2.9 20.0 85.7 21.6 75.5 44.3 7.3 0.1 0.0 16.8 21.5 31.4 0.0 2.1 0.0 5.3 112.2 0.0 0.0 15.1 0.1 0.2 13.8 25.8 14.1 2.7 0.0 0.0 14.1 24.5 0.1 15.9 0.0 18.2 53.5 0.0 11.8 2.7 63.2 48.8 28.2 63.6 25.6 16.4 29.2 42.7 5.6 47.3 5.5 25.7 5.5 1.4 0.1 131.5 10.9 32.1 40.0 110.7 0.1 42.6 7.1 0.0 30.4 29.5 17.3 35.7 56.1 98.9 0.0 14.9 0.1 90.7 22.3 TAF11L5 ENSG00000284234 "TATA-box binding protein associated factor 11 like 5" 5 17525235-17525831 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.5 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L4 ENSG00000284283 "TATA-box binding protein associated factor 11 like 4" 5 17521801-17522397 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004922.1 ENSG00000284292 "Novel protein, ARPC1A and ARPC1B readthrough" 7 99325879-99394653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Club cells: 2.5;Exocrine glandular cells: 1.5;granulocytes: 1.3;Pancreatic endocrine cells: 1.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004334 Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA004334: AB_1078215" 1.5 1.2 0.1 0.9 0.0 0.5 1.2 0.1 0.3 1.1 0.0 1.2 0.9 0.9 0.0 1.3 1.0 0.1 1.0 0.1 0.2 1.0 1.2 1.9 0.8 0.4 0.1 0.0 0.8 0.9 0.1 0.8 0.2 0.4 0.9 0.0 0.0 1.2 0.0 0.4 0.7 1.9 0.2 0.0 2.9 1.2 0.5 0.2 0.2 1.2 0.0 0.1 1.2 1.0 0.1 1.9 2.1 0.4 0.2 0.3 1.0 2.5 1.6 0.7 0.9 1.0 4.1 3.5 2.5 4.8 1.5 1.7 1.6 0.1 1.1 0.2 1.0 1.7 1.2 1.3 0.9 0.2 1.4 1.4 1.4 0.7 1.3 0.6 0.3 1.0 0.8 1.6 2.2 1.0 5.1 3.8 0.1 0.7 0.7 2.8 1.4 0.3 0.7 0.2 1.0 0.4 0.3 1.3 2.7 6.0 0.3 0.8 0.7 2.0 3.3 1.3 3.6 2.4 0.0 1.0 2.4 1.7 2.5 3.5 11.8 20.7 23.7 8.7 20.4 6.2 9.3 8.5 8.7 16.6 11.1 7.1 6.9 16.9 7.1 18.7 11.2 16.5 31.5 0.1 0.0 0.1 0.3 0.1 0.2 0.4 0.1 0.0 0.4 0.0 0.2 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.5 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL590132.1 ENSG00000284299 "Novel protein" 1 210858125-211134146 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P2 ENSG00000284306 "SSU72 pseudogene 2" 11 4242056-4242640 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" A6NN90 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.8;pituitary gland: 17.7;testis: 27.5" "Cell type enhanced" "Detected in many" "Early spermatids: 45.6;Late spermatids: 31.4;Respiratory ciliated cells: 25.7;Spermatocytes: 20.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 15.1;RPMI-8226: 14.5;SCLC-21H: 17.8;SH-SY5Y: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: AB_2682620" 1.9 1.5 5.9 1.7 3.8 0.5 2.7 3.4 4.7 4.8 8.0 2.7 1.1 5.0 0.8 1.1 17.8 2.4 1.9 4.0 3.7 5.1 0.7 3.8 2.6 5.0 4.8 3.3 4.0 2.2 5.6 17.7 0.6 3.6 5.0 0.4 3.0 2.1 2.6 0.7 1.6 2.5 0.9 4.6 3.7 2.1 27.5 3.1 2.2 3.7 0.5 0.8 3.1 2.5 3.2 4.4 8.0 2.4 8.6 2.6 2.2 0.8 0.6 2.6 0.7 0.8 0.2 4.9 10.5 1.8 1.3 2.1 1.6 0.2 2.1 0.8 5.9 0.4 1.1 0.5 0.0 1.3 2.1 2.1 1.3 5.2 1.0 1.0 3.0 0.1 5.6 0.2 1.6 1.3 15.1 2.7 5.5 4.6 2.4 1.7 1.4 0.8 14.5 3.2 1.9 17.8 19.3 2.4 3.9 1.3 0.3 3.7 1.9 0.0 0.9 3.8 2.7 2.2 3.7 7.4 3.4 5.2 2.0 1.8 0.1 1.9 0.0 0.6 2.0 0.3 6.6 0.7 0.8 6.3 5.8 3.3 1.6 0.1 3.0 1.5 13.3 0.7 1.3 5.9 3.8 3.4 4.7 4.0 3.7 5.0 4.8 3.3 3.6 4.6 3.1 3.2 1.7 0.0 2.4 0.0 0.8 0.6 1.0 2.9 1.8 0.9 1.9 4.7 1.4 4.3 3.6 3.7 0.0 0.0 2.9 0.7 5.9 3.2 45.6 11.7 1.9 2.1 7.2 0.0 1.1 2.2 0.0 4.1 0.5 3.1 0.0 1.1 4.2 0.0 0.0 3.3 0.9 1.7 4.1 1.9 3.4 31.4 3.4 1.1 3.6 1.0 6.1 6.1 1.0 1.0 0.2 2.6 0.3 7.5 0.2 0.7 0.4 5.9 25.7 3.9 6.6 2.4 3.9 20.1 1.5 0.1 0.9 0.0 0.6 1.2 1.2 0.3 TAF11L10 ENSG00000284356 "TATA-box binding protein associated factor 11 like 10" 5 17597232-17597828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.5 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L2 ENSG00000284373 "TATA-box binding protein associated factor 11 like 2" A6NLC8 5 17498231-17498827 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PERCC1 ENSG00000284395 "Proline and glutamate rich with coiled coil 1" A0A1W2PR82 16 1431078-1434441 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "prostate: 1.8;stomach 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 56 "SCLC-21H: 33.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 4.0" NA NA 0.1 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 1.8 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.6 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 33.3 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.4 0.3 0.0 0.3 0.0 0.0 0.5 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P7 ENSG00000284438 "SSU72 pseudogene 7" 11 4338660-4339244 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L3 ENSG00000284439 "TATA-box binding protein associated factor 11 like 3" 5 17518367-17518963 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAF11L7 ENSG00000284465 "TATA-box binding protein associated factor 11 like 7" 5 17585162-17585758 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM39 ENSG00000284479 "Small integral membrane protein 39" A0A1B0GW54 2 131035092-131035262 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;HEK 293: 1.5" "Not detected" "Not detected" NA NA 1.2 0.1 2.1 0.0 2.5 0.0 0.1 0.0 3.9 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 4.9 1.5 0.1 0.0 0.1 0.0 4.1 1.3 1.2 0.2 0.1 0.0 0.1 0.0 3.6 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.9 0.0 0.1 0.1 3.1 0.0 0.2 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.5 0.0 3.9 4.9 1.5 4.1 1.3 1.2 3.6 0.9 3.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC025287.4 ENSG00000284484 "Novel protein similar to cytoplasmic polyadenylated homeobox like CPHXL" 16 75660227-75677009 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.6 0.4 0.1 0.0 0.8 0.2 0.1 0.7 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 THSD8 ENSG00000284491 "Thrombospondin type 1 domain containing 8" A0A1W2PP97 19 12802031-12813581 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Cell type enhanced" "Detected in single" "Breast myoepithelial cells: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LYNX1-SLURP2 ENSG00000284505 "LYNX1-SLURP2 readthrough" 8 142764334-142778224 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 6.3" "Cell type enriched" "Detected in single" 12 "Pancreatic endocrine cells: 10.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 8 "monocytes: 1.4" "Cell line enhanced" "Detected in single" "BJ: 1.0" "Intracellular and membrane" NA NA 1.5 1.0 0.4 0.2 0.3 0.0 0.5 1.0 2.3 1.5 0.1 4.8 0.3 2.0 0.4 6.3 1.4 0.3 1.3 0.6 0.0 0.3 0.9 0.4 0.1 1.0 0.2 0.2 0.6 0.2 0.5 1.0 0.1 1.3 1.8 0.2 0.2 0.7 1.7 0.8 3.4 1.0 0.4 0.3 0.3 2.3 0.6 0.6 0.0 0.4 0.2 0.3 3.8 2.5 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.3 1.0 2.3 0.6 0.0 1.0 0.2 0.2 1.3 0.3 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092718.7 ENSG00000284512 "Novel protein" 16 81022316-81096284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" HPA041368 Uncertain Approved Vesicles NA NA Vesicles "HPA041368: AB_10804001" 0.1 0.2 3.0 0.3 3.6 1.1 0.2 3.1 3.5 0.1 2.3 0.1 0.1 0.3 0.2 0.1 0.2 0.1 0.1 2.6 3.0 0.2 0.2 0.1 0.2 3.2 3.3 2.5 0.3 0.2 0.3 0.3 0.2 3.0 1.3 0.0 0.7 0.1 0.2 0.1 0.2 0.1 0.0 3.0 0.1 0.1 6.6 3.1 0.0 0.5 0.1 0.0 0.1 0.1 4.1 0.4 0.2 0.6 0.5 0.1 0.0 0.5 0.8 0.1 0.1 0.0 0.4 0.6 0.6 0.3 0.2 0.3 0.9 0.0 0.0 0.1 0.1 0.4 0.3 1.0 0.6 0.0 0.6 1.1 0.2 0.0 0.1 0.0 0.3 0.0 0.7 0.3 1.0 0.0 1.3 0.6 1.4 0.6 0.2 0.4 0.5 0.4 0.1 0.0 0.3 0.9 0.2 0.6 0.3 0.1 0.3 0.4 0.2 0.1 0.5 0.6 0.4 0.3 0.5 0.3 1.2 0.2 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.3 0.1 3.0 3.6 3.1 3.5 2.6 3.0 3.2 3.3 2.5 3.0 3.0 3.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC015802.6 ENSG00000284526 "Novel protein" 17 76563710-76570544 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 7.8;Endometrial ciliated cells: 17.7;Endometrial stromal cells: 17.9;Glandular and luminal cells: 12.7;Respiratory ciliated cells: 8.0" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 58.7;SK-MEL-30: 72.7" "Not detected" "Not detected" NA NA 3.4 5.1 0.7 4.8 0.8 7.1 1.0 1.0 0.7 1.6 7.9 1.6 4.4 3.5 0.8 6.2 2.7 3.8 8.9 1.9 0.9 2.8 3.0 4.6 4.8 1.4 0.8 0.3 4.5 11.0 0.3 0.7 3.6 0.6 2.6 0.3 16.7 10.1 0.5 25.3 16.1 3.0 0.1 0.9 3.9 5.2 15.3 0.5 0.0 5.0 0.1 0.2 2.6 2.5 0.5 14.9 11.7 9.2 20.5 0.0 0.0 12.2 6.5 0.0 0.0 0.0 25.5 11.3 15.7 7.7 0.0 7.2 15.2 0.1 0.8 0.0 4.1 13.1 21.9 9.8 58.7 0.0 20.5 13.6 0.0 1.2 0.0 0.1 13.2 0.0 9.3 18.3 17.3 0.0 20.4 18.1 36.0 16.0 16.7 14.6 10.6 24.9 14.4 0.2 13.7 19.6 24.5 8.7 46.7 72.7 18.6 33.5 17.6 10.1 26.4 18.9 18.3 28.3 22.3 9.4 12.6 15.6 16.1 33.4 1.4 7.3 1.8 11.8 7.5 19.4 9.9 12.7 12.9 6.3 7.4 11.6 12.0 16.9 6.5 4.6 6.1 7.1 8.1 0.7 0.8 1.0 0.7 1.9 0.9 1.4 0.8 0.3 0.6 0.9 0.5 0.5 0.3 16.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.4 0.0 0.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 4.2 0.0 17.7 17.9 0.7 0.0 0.0 0.0 0.2 0.0 1.1 0.0 12.7 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.1 8.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.7 2.6 0.0 0.0 SSU72P3 ENSG00000284546 "SSU72 pseudogene 3" 11 4329865-4330449 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL022318.4 ENSG00000284554 "Novel protein" 22 39014363-39033276 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "Karpas-707: 2.7" HPA055116 Uncertain NA NA "HPA055116: AB_2682701" 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.1 1.1 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.1 2.5 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 2.5 2.0 1.3 2.8 2.3 3.6 0.1 2.8 1.5 1.5 0.0 0.6 1.8 1.0 2.8 0.0 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.1 0.4 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B3 ENSG00000284609 "Olfactory receptor family 8 subfamily B member 3" Q8NGG8 11 124395534-124399024 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "Early spermatids: 13.6;Late spermatids: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCYGR1 KRTAP28-1 ENSG00000284629 "Small cysteine and glycine repeat containing 1" A0A286YEY9 2 227387683-227387949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.4 0.7 0.4 0.4 0.7 0.6 0.3 0.9 0.5 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCYGR4 KRTAP28-4 ENSG00000284631 "Small cysteine and glycine repeat containing 4" A0A286YEV6 2 227616998-227618655 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.0;placenta: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "U-2197: 10.7" NA NA 0.1 0.0 1.3 0.6 0.5 1.0 0.0 0.5 1.0 0.0 0.1 0.0 0.2 0.2 2.0 0.1 0.0 0.1 0.1 0.7 0.4 0.1 0.8 0.1 0.2 0.9 0.8 0.4 0.1 0.4 0.0 5.0 1.0 0.1 0.0 1.4 0.1 0.1 0.2 0.6 0.0 0.1 0.3 0.2 0.0 0.4 1.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.5 0.1 0.1 10.7 0.2 0.1 0.0 0.3 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.2 0.0 0.0 1.3 0.5 0.5 1.0 0.7 0.4 0.9 0.8 0.4 1.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 SCYGR8 KRTAP28-8 ENSG00000284635 "Small cysteine and glycine repeat containing 8" A0A286YFG1 2 227745845-227746681 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005551.1 ENSG00000284638 "Novel protein" 19 3482804-3483446 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.0 0.1 0.0 0.1 0.4 2.5 0.0 0.4 0.1 0.1 2.7 1.7 12.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCYGR2 KRTAP28-2 ENSG00000284643 "Small cysteine and glycine repeat containing 2" A0A286YFB4 2 227598893-227599255 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F16 ENSG00000284662 "Olfactory receptor family 4 subfamily F member 16" Q6IEY1 1 685679-686673 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCYGR5 KRTAP28-5 ENSG00000284667 "Small cysteine and glycine repeat containing 5" A0A286YF46 2 227666804-227667061 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B2 ENSG00000284680 "Olfactory receptor family 8 subfamily B member 2" Q96RD0 11 124382394-124384499 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Group enriched" "Detected in some" 63 "Early spermatids: 44.9;Late spermatids: 30.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092442.1 ENSG00000284684 "Novel protein" 4 6064977-6070162 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "brain: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 1.9 0.0 5.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 0.0 0.0 0.0 0.0 1.4 0.1 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.0 0.0 4.6 2.1 1.8 1.4 0.1 0.8 0.7 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073111.3 ENSG00000284691 "Novel zinc finger protein" 7 150400702-150412470 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 3.7;MAIT T-cell: 2.7;memory B-cell: 4.6;memory CD4 T-cell: 4.9;memory CD8 T-cell: 3.3;naive B-cell: 5.8;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.7;plasmacytoid DC: 8.9;T-reg: 3.7" "Group enriched" "Detected in many" 7 "B-cells: 5.8;dendritic cells: 8.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "HDLM-2: 12.5;MOLT-4: 23.5;NTERA-2: 10.2;RPMI-8226: 20.2;U-266/70: 27.0" "Low region specificity" "Detected in all" NA NA 2.8 2.4 1.7 3.8 1.2 2.0 0.4 0.9 5.4 0.6 0.1 2.3 4.7 1.9 0.1 0.4 1.2 0.3 0.6 1.8 0.7 1.1 0.4 1.3 4.8 3.9 1.4 0.9 2.0 2.0 0.6 0.6 3.8 1.5 0.8 0.5 3.7 1.2 3.1 2.8 3.3 0.9 0.1 6.1 3.6 0.5 2.2 2.3 0.3 0.0 2.4 0.4 3.5 0.0 3.2 1.4 0.5 0.4 0.7 1.3 1.2 0.4 0.0 0.1 0.5 2.2 5.0 6.8 0.2 0.4 0.6 0.1 0.3 0.0 12.5 0.8 1.1 0.2 2.4 0.5 2.1 0.9 0.2 0.3 0.0 0.0 0.3 0.1 4.8 2.8 2.5 0.0 0.8 23.5 4.5 10.2 0.5 1.0 6.3 0.6 20.2 0.0 1.0 1.6 2.5 0.4 0.2 0.9 0.6 0.2 2.0 1.6 0.4 0.1 0.0 0.2 27.0 2.2 2.6 0.8 1.0 0.8 0.0 0.3 0.8 3.7 0.7 2.7 4.6 4.9 3.3 0.8 5.8 5.4 3.7 0.0 1.0 0.0 8.9 3.7 2.5 1.7 1.2 0.9 5.4 1.8 0.7 3.9 1.4 0.9 3.8 0.1 2.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM247 ENSG00000284701 "Transmembrane protein 247" A6NEH6 2 46479565-46484425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 22.0" "Group enriched" "Detected in some" 12 "Early spermatids: 443.1;Late spermatids: 400.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "U-266/84: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079482 Enhanced NA NA "HPA079482: " 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 443.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 400.3 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SCYGR3 KRTAP28-3 ENSG00000284704 "Small cysteine and glycine repeat containing 3" A0A286YF60 2 227614538-227614840 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM38 ENSG00000284713 "Small integral membrane protein 38" A0A286YFK9 11 69155478-69159752 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "stomach 1: 23.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.1 0.2 0.0 0.6 0.0 0.1 0.4 1.8 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.1 0.1 0.3 0.0 1.8 0.0 0.1 0.2 0.2 0.1 0.3 1.1 2.9 0.0 0.1 0.6 0.3 0.0 0.3 0.0 0.4 0.4 0.3 0.0 0.2 0.0 0.5 23.0 1.3 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.4 1.8 0.3 0.0 0.2 0.1 0.3 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCYGR7 KRTAP28-7 ENSG00000284718 "Small cysteine and glycine repeat containing 7" A0A286YF01 2 227728335-227728625 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8S1 ENSG00000284723 "Olfactory receptor family 8 subfamily S member 1" Q8NH09 12 48525632-48528103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Spermatocytes: 4.0;Spermatogonia: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045595 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045595: AB_10964447" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCYGR6 KRTAP28-6 ENSG00000284725 "Small cysteine and glycine repeat containing 6" A0A286YF77 2 227724440-227724757 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMDD1 "C12orf81, hCG1648055" ENSG00000284730 "Transmembrane and death domain 1" P0DPE3 12 51813940-51814926 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Fibroblasts: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.6 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.0 0.0 0.3 0.3 0.4 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.6 0.5 0.5 0.3 0.3 0.4 0.2 0.1 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002512.3 ENSG00000284732 "Novel olfactory receptor" 11 56459221-56473352 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F29 ENSG00000284733 "Olfactory receptor family 4 subfamily F member 29" Q6IEY1 1 450740-451678 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDE11A ENSG00000284741 "Phosphodiesterase 11A" 2 177628069-178108339 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "Cardiomyocytes: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034560 Uncertain NA NA "HPA034560: AB_10602140" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" P0DPD7 3 184249672-184258759 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.9;Breast myoepithelial cells: 11.7;Distal tubular cells: 15.6;Ductal cells: 14.7;Exocrine glandular cells: 15.3;Pancreatic endocrine cells: 9.2;Proximal tubular cells: 21.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.4 3.0 1.0 4.1 0.9 5.1 4.4 3.4 1.6 3.1 1.2 5.7 5.3 1.6 1.4 6.1 1.9 2.3 2.0 0.9 1.5 2.9 14.1 2.0 4.3 1.3 1.6 0.9 0.8 12.8 4.9 6.1 1.7 1.9 5.3 0.4 6.7 2.1 2.3 5.4 3.4 3.2 1.2 2.0 3.8 11.5 1.4 4.5 7.3 5.4 5.0 6.3 1.3 50.8 29.9 5.1 17.3 9.9 6.8 41.2 6.4 12.5 10.0 9.4 56.9 7.9 63.7 40.2 7.2 41.8 19.5 31.1 32.2 5.6 23.8 36.9 17.1 18.1 36.8 12.1 43.8 12.8 8.5 39.0 10.8 19.1 3.3 8.2 20.8 33.0 54.7 4.8 84.2 18.6 54.9 11.7 71.0 52.1 32.6 7.0 53.4 11.8 11.2 26.8 9.7 10.8 95.1 24.6 9.2 76.0 21.4 5.8 7.5 11.5 22.4 30.2 33.1 74.5 64.6 7.0 74.9 10.0 0.0 22.9 2.5 8.0 19.1 8.8 8.8 8.4 7.8 19.4 6.5 5.8 9.2 0.5 7.3 13.3 17.5 15.5 10.9 1.0 0.9 3.4 1.6 0.9 1.5 1.3 1.6 0.9 1.7 1.2 1.4 1.3 3.8 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.9 11.7 0.0 0.0 3.1 7.3 0.0 0.0 1.7 0.0 15.6 14.7 0.0 1.8 3.5 2.1 0.0 0.0 0.0 15.3 0.0 1.5 0.0 2.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 21.2 1.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.0 0.0 AC022414.1 ENSG00000284762 "Phosphodiesterase 8B" 5 77086732-77427124 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.4;HeLa: 5.3;SCLC-21H: 2.5" HPA036912 Supported NA NA "HPA036912: AB_10670377" 1.6 0.8 0.6 0.2 1.7 0.0 0.5 0.2 1.2 1.3 0.0 0.2 0.1 2.1 1.9 0.2 3.6 0.7 1.9 1.1 1.6 1.2 0.4 0.6 0.1 1.1 1.4 0.3 1.6 1.1 0.9 1.4 1.3 1.3 0.4 2.8 0.4 1.9 0.1 0.0 0.1 2.5 0.2 0.2 0.8 0.7 0.8 0.2 12.6 0.2 0.4 0.2 2.5 0.1 2.4 0.3 1.0 1.7 0.0 0.0 0.0 0.4 0.3 0.4 0.2 0.2 0.0 0.7 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.6 0.2 5.3 0.1 0.1 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.8 0.4 0.0 0.6 0.0 0.1 0.7 0.2 0.0 0.2 0.0 2.5 0.6 1.9 1.5 0.5 0.2 1.5 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.4 0.6 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.2 1.2 1.1 1.6 1.1 1.4 0.3 1.3 0.2 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBCE "HRD, KCS, KCS1, pac2" ENSG00000284770 "Tubulin folding cofactor E" Q15813 1 235367360-235452443 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Dwarfism, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 14 "Cardiomyocytes: 16.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "HPA026552, HPA026557" Approved NA NA "HPA026552: AB_1857797, HPA026557: AB_1857798" 2.8 4.2 2.2 2.4 2.2 2.1 2.5 3.1 4.1 2.8 2.1 3.9 2.7 2.6 0.6 3.5 1.9 2.4 5.2 2.1 2.5 3.7 5.6 1.9 2.2 2.3 2.3 2.2 2.0 1.6 3.0 3.2 2.4 2.6 3.3 4.5 3.3 1.9 8.0 2.1 1.3 2.0 2.1 2.0 3.7 1.7 2.3 2.1 6.8 1.6 2.9 2.7 2.4 14.5 26.9 12.6 7.9 14.1 15.8 11.2 20.3 9.9 21.6 26.9 23.0 11.1 14.7 36.6 8.7 14.4 7.6 18.6 12.6 16.5 24.8 28.2 15.7 11.4 17.8 20.4 25.0 10.8 17.1 11.7 17.1 17.8 7.9 10.9 18.2 60.5 6.5 21.4 7.6 9.2 10.6 23.8 40.3 2.3 14.1 26.7 30.4 21.2 11.4 10.5 6.5 15.4 8.3 16.9 12.0 21.7 14.0 12.8 13.9 8.7 18.0 17.8 9.8 29.1 16.8 11.4 14.8 20.8 0.3 0.8 0.6 0.5 1.7 0.5 0.1 0.5 0.4 0.9 0.4 0.1 0.3 0.1 0.3 0.7 0.2 0.3 0.4 2.2 2.2 3.1 4.1 2.1 2.5 2.3 2.3 2.2 2.4 2.1 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC114490.2 ENSG00000284773 "Novel protein" 1 34974356-34985313 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Ductal cells: 14.3;Exocrine glandular cells: 7.4;monocytes: 5.2;Pancreatic endocrine cells: 9.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 1.0 0.5 0.7 0.9 0.6 0.9 1.0 1.0 1.0 0.5 0.4 0.6 0.7 1.6 1.3 0.2 1.0 0.7 0.3 0.6 0.6 0.5 0.4 1.1 1.7 0.6 0.4 0.7 1.1 0.4 0.4 0.4 0.6 0.6 0.9 1.0 0.5 0.8 0.5 1.1 1.0 0.8 0.3 1.5 0.4 0.8 0.5 0.7 0.5 0.2 1.1 0.3 0.7 0.2 0.2 0.2 0.3 0.8 1.6 0.1 0.4 1.6 0.2 0.2 0.0 1.0 0.5 0.2 0.5 0.1 0.6 0.1 0.2 0.1 0.9 0.2 0.4 0.3 0.2 1.4 0.7 1.2 1.3 0.5 0.2 0.9 0.8 0.4 1.3 0.1 0.9 0.5 0.3 0.3 0.7 0.3 0.0 0.0 0.6 0.0 0.0 0.4 0.5 0.2 0.5 0.4 0.0 0.1 0.4 0.0 0.5 0.7 0.3 0.3 0.5 0.2 0.9 0.2 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.3 0.0 0.4 0.1 0.6 0.4 0.1 0.3 0.2 0.2 0.2 0.5 0.1 0.2 0.1 0.0 0.7 0.6 1.0 1.0 0.6 0.6 0.6 0.4 0.7 0.6 0.3 0.5 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.3 0.6 0.7 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.2 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL121900.1 ENSG00000284776 "Novel protein" 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040981: AB_10673268" 11.7 15.1 14.2 13.2 15.1 15.4 17.2 14.5 18.5 10.6 12.6 13.2 10.5 12.8 12.9 13.3 11.3 7.9 11.2 15.6 17.9 19.9 8.1 12.5 13.1 16.2 16.2 15.1 15.4 19.2 23.1 11.2 16.1 10.0 14.7 28.5 9.8 10.5 22.1 10.0 8.6 11.9 15.0 12.5 12.6 14.8 16.6 8.6 21.8 18.1 17.1 14.8 19.8 58.0 57.7 65.1 58.3 23.6 55.4 27.8 50.7 50.0 43.6 35.0 39.8 46.0 0.9 33.2 50.6 53.1 32.6 49.7 119.3 68.9 26.6 25.9 65.1 15.8 57.9 72.3 57.9 37.8 32.9 89.5 44.8 154.1 33.8 72.2 10.2 34.6 70.7 59.4 66.0 12.8 55.3 53.3 40.1 93.8 0.6 87.1 51.6 57.1 33.8 82.0 57.5 25.4 69.0 120.5 32.8 42.9 33.6 61.1 55.3 26.1 63.7 69.7 54.8 69.5 31.1 37.8 51.4 45.6 57.6 20.5 15.8 29.8 30.5 30.5 30.5 29.9 29.6 40.1 26.1 20.7 21.9 24.3 25.6 31.3 9.0 24.5 19.2 14.2 15.1 14.5 18.5 15.6 17.9 16.2 16.2 15.1 16.1 15.0 16.6 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC132217.2 ENSG00000284779 "Novel protein" 11 2129112-2158391 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "liver: 37.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.0" "Not detected" "Not detected" "Intracellular and membrane" NA NA 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 37.9 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.7 0.1 0.2 0.3 0.4 0.0 0.3 0.2 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM41 ENSG00000284791 "Small integral membrane protein 41" A0A2R8YCJ5 12 52079704-52108255 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lung: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 56 "plasmacytoid DC: 5.5" "Lineage enriched" "Detected in single" 56 "dendritic cells: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.4 0.0 0.1 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.0 3.5 0.3 0.4 0.0 0.0 1.3 0.1 0.0 0.4 0.1 1.9 0.6 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.1 1.4 0.5 1.1 0.0 1.7 0.0 0.1 0.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008397.1 ENSG00000284797 "Novel protein" 19 18249950-18255419 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "intestine: 3.2" "Group enriched" "Detected in some" 7 "Collecting duct cells: 36.8;Pancreatic endocrine cells: 10.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 535 "OE19: 204.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 204.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.0 36.8 0.0 0.0 0.7 0.0 0.0 1.2 0.0 1.6 0.4 0.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 AP000812.3 ENSG00000284844 "Novel protein, ortholog of mouse Tomt" 11 72105924-72109329 "Metabolic proteins, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC39 "CFAP59, CILD14, DKFZp434A128, FAP59" ENSG00000284862 "Coiled-coil domain containing 39" Q9UFE4 3 180602858-180684942 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.8;retina: 22.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Early spermatids: 106.9;Endometrial ciliated cells: 38.7;Late spermatids: 58.3;Respiratory ciliated cells: 159.7;Rod photoreceptor cells: 40.3;Spermatocytes: 56.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035363, HPA035364" Enhanced NA NA "HPA035363: AB_2674588, HPA035364: AB_10601095" 2.3 4.2 2.0 9.4 0.8 5.6 0.2 1.1 2.7 0.5 4.1 1.8 7.0 5.1 0.4 3.5 11.4 8.0 3.6 0.7 1.6 1.4 0.5 4.4 21.8 3.1 1.3 0.2 7.7 2.7 0.0 1.5 1.4 2.8 0.0 22.1 4.4 0.0 3.0 20.5 7.1 0.1 2.6 10.8 4.3 9.4 0.7 0.0 8.0 0.0 0.0 2.5 2.1 5.1 2.9 11.5 2.6 0.0 0.0 3.5 2.9 0.0 0.0 0.0 3.7 4.3 13.9 4.3 0.0 2.6 4.6 0.1 0.0 0.0 7.6 6.4 6.7 10.7 7.9 0.0 10.4 6.0 0.0 0.0 0.0 0.0 11.9 0.0 13.7 4.5 1.0 0.4 1.3 5.8 0.2 6.6 2.3 6.4 7.4 3.7 16.5 0.0 6.9 5.3 5.8 3.0 2.6 2.2 5.5 7.4 6.9 8.1 8.5 3.6 3.7 9.0 8.5 6.9 13.5 5.6 9.4 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.8 1.1 2.7 0.7 1.6 3.1 1.3 0.2 1.4 2.6 0.7 2.1 0.1 0.0 0.0 1.3 0.2 0.5 0.0 3.3 0.0 7.0 0.0 0.0 0.0 0.0 9.6 0.0 64.6 0.0 0.1 0.0 0.0 0.0 106.9 38.7 0.3 0.4 0.0 0.0 21.8 0.2 0.0 4.0 0.0 0.5 0.0 0.1 12.8 0.1 0.0 1.7 6.8 0.0 0.0 0.9 0.7 58.3 13.4 0.3 1.8 0.0 0.0 2.8 0.0 4.0 1.3 0.0 0.0 9.8 2.4 0.2 0.0 0.0 159.7 40.3 6.6 4.1 1.3 56.0 6.9 0.2 0.6 0.0 0.2 0.2 0.0 0.1 OOSP1 ENSG00000284873 "Oocyte secreted protein 1" 11 59938432-59957480 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.2;Inhibitory neurons: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC119676.1 ENSG00000284895 "Novel protein" 1 41585306-41628816 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.8;ASC diff: 5.8;WM-115: 1.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 1.8 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.9 0.3 0.4 0.7 0.3 0.0 0.6 0.1 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" P0DPD8 3 184249695-184293031 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000812.4 ENSG00000284922 "Leucine rich transmembrane and O-methyltransferase domain containing" Q8WZ04 11 72080331-72110782 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 14.2;testis: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" 0.1 0.0 0.4 0.0 0.4 0.0 0.2 0.5 1.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 14.2 0.0 0.0 0.3 0.3 0.4 0.2 0.6 0.0 0.4 0.3 0.2 0.2 0.0 0.5 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.3 0.2 0.0 9.5 0.3 0.0 0.1 0.0 0.0 0.1 0.5 0.2 0.1 0.0 0.2 0.7 0.2 0.1 0.4 0.5 0.3 1.2 0.2 0.2 0.0 0.1 2.9 0.5 0.6 0.4 2.9 0.3 1.2 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.4 0.1 0.1 0.6 0.0 0.0 0.4 3.0 0.0 0.0 0.1 1.0 0.0 0.6 0.5 0.2 0.9 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.9 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 1.8 0.3 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC104389.6 ENSG00000284931 "Novel protein" 11 5248270-5254783 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 24 "placenta: 4394.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HEL: 7590.9" HPA043234 Uncertain NA NA "HPA043234: AB_2678378" 0.7 2.9 0.8 0.0 0.9 185.9 3.4 1.0 2.0 0.0 0.9 0.1 0.1 0.1 0.4 0.8 1.1 6.7 0.1 0.8 0.9 0.3 2.3 0.7 0.0 1.5 1.0 0.8 0.3 3.0 0.6 4394.6 1.3 0.5 0.2 0.0 0.7 0.1 5.2 0.0 0.2 1.8 1.1 0.0 0.0 0.2 0.9 3.9 0.4 5.4 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7590.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1682.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.8 0.9 1.0 2.0 0.8 0.9 1.5 1.0 0.8 1.3 1.1 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC048338.2 ENSG00000284934 "Novel protein" 12 122207662-122227534 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "adrenal gland: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 19.5" "Low region specificity" "Detected in many" NA NA 0.0 3.0 0.1 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 1.7 19.5 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.3 0.4 0.5 0.3 0.1 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC107959.5 ENSG00000284956 "Novel protein" 8 23084403-23115536 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 1.6;testis: 1.8" "Cell type enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 7 "neutrophil: 221.6" "Lineage enriched" "Detected in many" 142 "granulocytes: 221.6" "Cell line enhanced" "Detected in many" "AN3-CA: 18.5;HDLM-2: 22.7" NA NA 0.2 1.0 0.7 0.5 0.6 1.3 0.0 0.5 0.7 0.1 0.9 0.1 0.2 0.0 0.1 0.1 0.0 1.6 0.0 0.6 0.7 1.0 0.0 0.1 0.0 0.7 0.6 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.5 0.3 0.1 1.8 0.6 0.0 0.2 0.2 0.1 0.0 0.8 3.4 5.6 1.0 18.5 0.0 3.6 3.7 0.0 0.7 0.4 3.4 0.7 1.3 3.7 5.0 1.6 1.2 0.1 0.8 0.8 2.7 22.7 1.9 0.0 2.4 11.5 2.0 0.6 7.5 2.0 2.6 1.1 0.9 4.5 3.6 0.5 0.9 0.0 0.8 0.3 0.0 1.1 4.2 4.4 0.8 0.1 1.1 0.4 1.0 0.2 0.3 0.1 0.4 2.3 5.7 1.3 2.2 0.4 1.4 5.9 7.8 8.2 0.9 7.7 6.6 0.4 7.5 1.7 5.6 2.4 1.5 31.4 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 221.6 0.2 1.4 0.0 0.0 0.4 0.7 0.6 0.5 0.7 0.6 0.7 0.7 0.6 0.5 0.8 0.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL049629.2 ENSG00000284969 "Novel protein" 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 2.5 0.7 1.1 2.3 1.1 1.5 1.1 1.2 1.6 0.6 2.0 0.7 1.5 1.3 1.8 1.2 0.6 2.1 1.1 1.0 1.3 1.6 0.8 1.7 0.3 1.5 1.6 0.9 0.6 0.8 1.0 1.5 1.5 0.5 0.7 0.6 2.4 0.7 3.6 0.3 0.3 0.6 1.4 0.5 2.9 1.1 1.6 0.2 0.8 1.2 1.4 2.4 1.7 1.3 3.3 0.2 2.4 3.4 7.9 0.1 18.5 8.4 2.3 2.2 0.1 9.6 0.0 2.3 12.5 1.1 2.2 0.3 42.8 4.0 2.0 0.4 0.3 7.1 0.8 0.8 0.4 1.2 3.0 2.7 1.0 14.7 1.9 55.1 0.3 0.5 7.4 15.4 1.0 1.8 0.8 0.5 1.3 24.8 0.4 1.5 1.3 4.9 2.2 0.0 0.3 2.0 3.4 7.3 0.2 1.0 0.0 66.2 7.0 2.7 57.6 7.4 3.8 3.7 0.3 16.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 1.1 1.2 1.6 1.0 1.3 1.5 1.6 0.9 1.5 1.4 1.6 1.7 0.5 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.7 0.2 2.1 0.0 0.0 0.0 14.4 0.0 0.2 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 BX255925.3 ENSG00000284976 "Novel RING finger protein" 9 137217452-137219361 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 10.3;Endometrial ciliated cells: 9.0;Exocrine glandular cells: 24.4;Glandular and luminal cells: 10.1;Pancreatic endocrine cells: 33.7;Theca cells: 17.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 3.6 8.3 12.7 5.9 13.3 14.8 3.3 11.7 20.0 3.1 9.8 6.8 13.5 2.8 3.3 15.0 4.4 4.1 3.5 11.5 11.4 2.9 2.1 3.9 7.9 14.5 13.1 11.0 1.7 11.7 3.3 2.7 13.1 7.2 3.2 3.4 13.5 4.4 3.5 15.6 11.8 2.2 12.4 6.8 17.6 8.9 12.5 6.7 2.6 1.3 5.8 3.1 15.4 11.8 18.8 10.9 14.2 5.0 4.9 42.7 13.5 7.2 13.7 9.8 17.5 13.2 17.1 9.3 4.8 10.3 41.7 6.9 9.8 2.9 19.0 19.5 10.0 52.0 15.9 8.3 14.7 32.0 6.5 9.0 15.7 4.2 3.7 6.4 16.3 24.9 14.0 4.8 32.9 13.1 42.3 19.0 26.4 64.6 32.8 14.8 20.0 5.9 11.5 14.2 16.2 12.0 14.4 11.0 3.9 37.3 22.8 7.8 21.1 24.0 34.3 16.9 11.2 20.4 14.8 12.0 16.8 16.1 0.0 0.8 1.8 0.7 1.0 1.1 0.6 0.5 0.4 0.5 0.7 0.3 0.3 1.4 0.9 0.5 2.1 0.6 2.4 12.7 13.3 11.7 20.0 11.5 11.4 14.5 13.1 11.0 13.1 12.4 12.5 15.4 1.5 6.4 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 10.3 8.9 0.0 0.0 0.6 3.7 0.0 0.0 1.6 0.0 5.9 5.8 0.0 9.0 3.0 0.9 0.0 0.0 0.0 24.4 0.0 0.7 0.0 10.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 7.7 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.1 17.8 0.0 0.0 UPK3BL2 ENSG00000284981 "Uroplakin 3B like 2" E5RIL1 7 102538417-102543849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 67.9;lymphoid tissue: 77.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA011403 Approved NA NA "HPA011403: AB_2668503" 11.1 5.4 9.7 16.2 8.6 45.7 11.4 9.2 13.2 6.2 7.5 10.3 12.5 10.3 8.6 67.9 11.5 9.7 6.2 9.0 5.6 5.6 7.4 11.3 28.4 9.1 7.7 6.6 8.3 10.6 9.8 8.4 10.1 12.7 10.7 6.9 13.9 22.7 23.3 22.2 12.1 7.1 3.4 25.3 8.8 4.0 7.9 18.6 29.6 6.6 77.5 18.1 10.7 10.8 16.2 6.9 12.3 3.3 1.1 23.7 19.3 24.2 24.1 29.4 5.6 17.8 12.1 9.5 7.6 2.6 34.1 0.8 9.1 6.6 13.4 19.9 4.3 32.1 9.9 13.9 10.7 12.9 11.4 13.3 6.9 6.4 5.4 10.9 15.7 11.5 27.7 8.7 43.9 12.0 17.9 2.8 5.2 3.4 9.3 3.7 18.0 13.4 41.6 8.8 9.5 10.9 5.2 9.9 11.9 5.7 10.1 5.1 12.7 5.6 8.2 8.0 27.1 9.5 7.7 3.5 19.1 9.4 0.1 2.5 2.0 4.8 1.3 1.9 3.0 2.0 1.7 1.0 3.0 3.4 1.8 4.1 0.7 1.4 5.8 2.0 1.1 9.7 8.6 9.2 13.2 9.0 5.6 9.1 7.7 6.6 10.1 3.4 7.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP4A ENSG00000285010 "Oocyte secreted protein family member 4A" A0A2R8YFL7 11 59964033-59970146 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "basophil: 4.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.1" "Group enriched" "Detected in some" 5 "HEL: 1.0;K-562: 2.6" "Secreted - unknown location" NA NA 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL022312.1 ENSG00000285025 "Novel protein" L0R8F8 22 39504231-39504443 "Predicted intracellular proteins" "Ribosome biogenesis, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.6;choroid plexus: 1.0;skeletal muscle: 4.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.6" "Immune cell enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.8;MOLT-4: 6.6;REH: 1.2;U-698: 1.8" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 1.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.5 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093512.2 ENSG00000285043 "Uncharaterized LOC112694756" 16 30053090-30070420 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "tongue: 95.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 1.5 1.5 8.6 2.0 8.7 3.4 8.0 6.8 10.3 5.5 8.5 2.3 0.6 1.8 1.2 1.7 4.3 2.4 6.8 9.7 8.0 1.3 0.6 3.2 3.1 7.2 8.2 7.4 2.9 1.5 3.0 2.2 8.2 3.1 1.1 2.4 2.3 8.1 17.2 1.3 0.7 2.6 7.5 2.6 2.0 5.3 6.9 9.7 5.6 95.2 3.6 3.7 6.8 7.5 17.6 3.5 11.3 2.6 9.0 2.8 7.5 12.6 9.8 38.2 7.5 9.4 45.6 11.0 12.5 3.3 11.9 25.4 20.2 6.7 8.2 16.4 11.3 15.5 13.1 20.1 19.9 4.2 9.0 0.9 19.3 21.7 8.0 14.0 7.2 2.4 12.9 24.3 9.3 9.6 15.4 3.9 3.2 12.6 14.4 7.2 42.0 27.0 1.6 11.0 9.1 2.0 3.4 2.8 1.1 9.5 7.6 3.3 14.3 4.3 6.8 10.1 13.2 10.7 14.3 14.0 21.1 6.6 0.1 6.3 0.1 4.8 2.6 6.6 6.5 6.3 5.1 6.2 5.7 7.4 5.8 0.8 4.5 2.5 5.3 5.3 15.3 8.6 8.7 6.8 10.3 9.7 8.0 7.2 8.2 7.4 8.2 7.5 6.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBCE "HRD, KCS, KCS1, pac2" ENSG00000285053 "Tubulin folding cofactor E" Q15813 1 235328570-235448952 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Dwarfism, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA026552, HPA026557" Approved NA NA "HPA026552: AB_1857797, HPA026557: AB_1857798" 0.9 0.7 1.5 1.3 1.2 1.3 0.8 2.8 1.9 0.8 0.2 1.0 0.8 1.5 0.5 0.6 0.7 0.7 1.1 1.3 1.4 1.2 0.7 0.8 1.5 2.0 1.5 1.2 1.9 1.7 0.8 1.4 2.5 1.2 0.9 1.9 0.7 0.8 3.6 0.8 1.4 0.7 1.0 1.0 1.2 1.7 1.6 2.4 1.0 2.5 1.3 0.9 2.2 8.4 2.5 8.9 5.7 1.5 2.4 5.9 3.7 1.9 6.3 3.3 2.2 6.6 4.4 9.0 1.5 3.8 3.9 3.4 3.2 4.5 6.3 6.7 2.2 3.5 2.8 0.6 5.6 5.2 0.8 1.0 3.4 3.9 1.3 2.3 5.2 6.2 2.3 3.9 4.2 8.1 2.0 10.0 4.8 1.9 5.2 3.8 2.0 2.2 2.7 9.3 8.5 3.6 6.4 4.0 1.3 9.5 10.8 3.5 4.6 7.8 4.5 5.2 5.6 6.5 5.8 6.2 2.5 6.0 3.0 2.5 2.4 2.3 2.9 2.4 1.8 2.0 2.4 2.6 1.3 2.4 2.1 0.5 1.8 2.5 1.8 2.7 2.1 1.5 1.2 2.8 1.9 1.3 1.4 2.0 1.5 1.2 2.5 1.0 1.6 2.2 10.1 0.0 5.9 17.9 8.9 3.1 5.2 8.2 5.2 9.2 6.9 9.4 0.0 4.3 7.0 7.3 4.2 0.0 8.6 4.3 0.0 3.5 10.9 3.4 12.3 5.9 3.5 6.9 22.4 1.6 0.0 5.5 9.7 4.3 3.8 7.7 2.2 5.9 0.0 6.7 26.1 5.3 4.1 4.7 2.7 6.2 10.8 6.6 8.8 10.3 8.9 8.9 11.3 11.6 22.0 3.1 4.1 7.5 6.6 2.9 5.2 1.4 5.7 13.1 0.0 5.9 7.6 14.0 8.8 7.5 2.8 0.0 8.8 8.5 8.3 3.9 ARHGAP11B "B'-T, FAM7B1" ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30649529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6;lymphoid tissue: 1.4" "Cell type enhanced" "Detected in many" "Early spermatids: 22.6;Erythroid cells: 37.4;Late spermatids: 21.7;Muller glia cells: 17.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 8.9;Karpas-707: 7.1" HPA064479 Uncertain Uncertain Vesicles NA NA Vesicles "HPA064479: AB_2685272" 0.2 0.0 0.0 0.8 0.2 2.6 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.1 1.4 0.1 0.0 0.8 0.1 0.1 1.2 1.0 2.8 1.3 0.0 0.4 0.8 3.2 0.9 1.6 1.8 0.6 1.8 1.5 0.1 0.2 0.9 1.4 1.6 0.6 1.3 3.0 3.9 3.1 8.9 0.2 0.0 2.8 1.8 0.1 0.0 0.4 0.2 0.5 0.9 1.9 0.8 7.1 1.7 1.0 1.0 2.8 0.8 0.7 1.2 1.9 3.2 0.8 0.7 1.3 1.5 0.8 1.9 0.7 0.4 0.7 1.5 1.4 1.0 2.6 1.7 0.5 0.8 1.4 0.5 3.1 0.4 3.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.1 0.3 0.0 1.5 1.0 6.1 2.0 1.0 2.8 1.8 3.2 0.6 0.3 0.7 0.0 0.6 1.8 6.2 0.0 5.1 7.0 0.0 0.4 22.6 0.4 1.3 1.1 0.0 37.4 0.4 0.6 0.0 2.3 15.3 0.7 1.3 6.9 4.2 0.8 0.0 3.3 0.2 8.3 2.0 7.9 3.1 21.7 2.1 3.3 0.0 1.0 4.8 17.3 4.1 0.0 0.7 0.4 2.5 1.2 12.6 1.0 1.6 0.6 1.2 2.3 0.0 1.3 1.5 15.5 12.9 6.9 1.4 0.0 5.8 1.2 12.1 0.9 AL160272.2 ENSG00000285082 "Novel protein" 9 117704157-118072314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 1.8;brain: 6.6;choroid plexus: 1.8;retina: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.6" NA NA 0.2 0.5 2.3 0.3 2.1 1.8 0.4 6.6 3.3 0.1 1.8 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.2 2.3 1.5 0.3 0.2 0.2 0.5 1.8 1.8 2.0 0.1 0.5 0.5 0.2 2.7 0.2 0.2 2.0 0.2 0.1 0.3 0.5 0.4 0.1 0.8 0.5 0.4 0.2 2.1 0.0 0.3 0.2 0.2 0.1 2.8 0.0 1.6 0.5 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.6 0.3 0.2 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.3 0.0 0.5 0.6 0.2 0.0 0.8 0.1 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.1 0.7 0.3 0.5 0.2 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.4 0.2 0.3 0.3 0.6 0.1 0.3 0.1 0.2 0.0 0.4 0.1 0.2 0.1 0.4 0.7 0.2 0.3 0.4 0.1 0.5 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.5 0.0 0.1 0.4 0.1 0.0 2.3 2.1 6.6 3.3 2.3 1.5 1.8 1.8 2.0 2.7 0.8 2.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662884.4 ENSG00000285085 "Novel protein" 6 32150495-32154373 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.4;Breast myoepithelial cells: 6.7;Collecting duct cells: 11.0;Distal tubular cells: 15.6;Endometrial ciliated cells: 4.6;Proximal tubular cells: 4.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 6.7 0.0 0.0 0.0 11.0 0.0 0.0 1.1 0.0 15.6 0.2 0.0 4.6 1.8 0.8 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.0 AL358113.1 ENSG00000285130 "Novel protein" 9 69035747-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;Endometrial ciliated cells: 3.8;Glandular and luminal cells: 3.8;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "REH: 1.0" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161" 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.7 0.0 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.8 0.5 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 3.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 3.8 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.0 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 AC022506.1 ENSG00000285133 "Novel protein" P0DPQ6 12 57517712-57520480 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.6;skeletal muscle: 18.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 6.6" "Group enriched" "Detected in some" 13 "basophil: 9.4;neutrophil: 18.9" "Lineage enriched" "Detected in many" 17 "granulocytes: 18.9" "Cell line enriched" "Detected in some" 13 "U-266/70: 25.8" NA NA 4.4 0.0 1.3 3.6 0.3 0.0 0.0 0.1 6.6 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.0 1.8 0.8 0.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 18.4 0.0 4.6 0.0 1.5 0.4 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 25.8 0.0 0.0 0.0 2.0 0.0 9.4 1.0 0.1 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 18.9 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.1 6.6 0.0 1.3 1.8 0.8 0.6 2.7 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004593.2 ENSG00000285162 "Chimerin 2" 7 29122340-29514667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 3.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 3.2" "Group enriched" "Detected in some" 32 "classical monocyte: 4.1;intermediate monocyte: 3.4;myeloid DC: 4.3;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 42 "dendritic cells: 4.3;monocytes: 4.1" "Cell line enhanced" "Detected in some" "GAMG: 1.0;HaCaT: 1.1;U-266/84: 1.4" HPA019026 Uncertain "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA019026: " 0.0 0.1 0.1 0.1 0.1 0.1 0.0 3.2 0.1 0.0 0.3 0.1 0.8 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.5 0.8 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.8 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.3 0.8 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 1.9 0.1 0.1 3.2 0.1 0.1 0.4 0.2 0.1 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008397.2 ENSG00000285188 "Novel protein" 19 18207961-18255419 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.6" "Cell type enhanced" "Detected in some" "Adipocytes: 2.0;Alveolar cells type 1: 9.6;Alveolar cells type 2: 10.6;Breast glandular cells: 2.2;Breast myoepithelial cells: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.2" "HPA048975, HPA054218" Uncertain Approved "Midbody ring,Centrosome,Cytosol" Yes NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " 0.1 0.0 1.8 0.1 2.3 0.0 0.0 1.4 2.5 0.3 1.4 1.2 0.8 0.7 1.9 0.1 0.7 0.3 0.5 2.1 1.9 0.4 0.0 1.2 0.0 1.8 1.6 2.1 0.2 0.4 0.0 0.6 1.7 0.2 1.0 0.0 0.0 0.7 2.4 0.0 0.5 0.5 1.4 0.4 3.6 0.3 1.7 0.0 0.0 2.6 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.3 1.4 2.5 2.1 1.9 1.8 1.6 2.1 1.7 1.4 1.7 1.8 2.0 9.6 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 AC026316.4 ENSG00000285218 "Novel protein" 3 170418868-170860380 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "brain: 41.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 5.1" "Low region specificity" "Detected in all" NA NA 1.2 1.3 7.0 1.3 15.8 4.1 1.0 12.2 13.0 0.2 3.0 0.6 1.0 1.1 1.2 1.1 0.6 1.2 1.0 7.6 10.6 1.0 0.8 0.8 1.2 19.1 15.0 5.5 3.1 0.5 0.4 0.7 18.3 1.6 0.4 1.6 1.8 0.7 0.9 2.2 1.1 0.7 14.1 0.8 0.7 3.7 13.4 0.1 0.6 0.1 0.6 0.3 41.8 0.7 1.1 0.7 1.0 0.4 0.4 0.9 1.3 0.7 0.3 0.0 0.2 3.0 0.9 3.0 0.6 0.4 1.2 0.0 0.0 0.2 0.9 0.7 1.4 1.7 1.4 0.0 0.7 1.2 0.5 0.1 0.5 0.1 0.4 0.3 0.7 0.5 0.8 0.2 0.2 0.3 1.1 2.4 1.0 1.4 0.6 0.2 0.2 0.3 0.8 5.1 0.5 0.6 0.6 0.4 0.8 0.5 0.2 1.9 0.5 1.0 3.4 0.2 0.6 0.7 0.5 0.4 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.0 7.0 15.8 12.2 13.0 7.6 10.6 19.1 15.0 5.5 18.3 14.1 13.4 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP3 ENSG00000285231 "Oocyte secreted protein family member 3" A0A2R8YFM6 11 59878809-59896481 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162417.1 ENSG00000285245 "Novel protein" 9 133098121-133163914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;REH: 1.1;TIME: 1.1" HPA025961 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA025961: AB_2671795" 0.1 0.2 0.0 0.2 0.3 0.5 0.0 0.3 0.4 0.1 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.6 0.0 1.0 0.6 0.2 0.1 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.5 0.2 0.1 0.1 0.0 0.5 0.0 0.1 0.6 0.0 0.3 0.4 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.6 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.4 0.0 0.4 0.5 0.6 0.0 0.7 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC090517.4 ENSG00000285253 "Zinc finger protein 280D" 15 56652488-56918571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 1.5;Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;Distal tubular cells: 3.9;Endometrial stromal cells: 2.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 6.9" NA NA 1.6 1.2 1.7 1.2 2.7 1.0 1.5 1.6 2.1 2.0 0.2 1.2 1.1 2.1 1.0 1.1 1.7 1.4 1.7 1.2 2.1 1.6 1.2 1.3 1.1 2.0 2.2 0.8 2.4 3.7 1.5 1.5 2.4 1.4 1.3 1.8 4.3 1.4 2.1 0.9 1.3 1.9 1.5 1.4 1.4 2.5 2.0 2.7 2.3 2.3 0.8 1.1 4.6 1.5 4.0 1.3 1.1 2.6 1.7 1.1 1.1 1.4 1.3 0.9 0.9 1.8 0.3 2.1 1.5 1.2 1.3 0.5 1.3 1.0 2.4 0.0 2.2 1.6 0.1 1.0 0.4 2.3 1.7 0.7 1.2 1.3 1.0 2.5 0.4 3.3 6.1 1.7 0.4 1.2 0.3 1.1 1.2 0.5 3.3 0.3 0.5 1.8 0.3 1.9 3.3 2.0 1.2 2.0 2.5 2.7 3.5 1.8 0.4 3.1 1.7 0.4 2.7 6.9 0.2 1.8 2.9 2.5 0.0 1.5 0.7 1.2 1.6 1.8 0.8 1.2 1.1 1.2 0.9 0.5 1.1 0.1 1.2 0.7 0.3 0.7 0.8 1.7 2.7 1.6 2.1 1.2 2.1 2.0 2.2 0.8 2.4 1.5 2.0 4.6 1.5 3.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.9 0.6 0.0 0.8 2.2 0.4 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 AL035078.4 ENSG00000285283 "Novel protein" 11 31812391-32104665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.9;lymphoid tissue: 5.7;retina: 7.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 224.4;RH-30: 110.7;RT4: 139.0;TIME: 116.0" HPA038474 Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038474: AB_10672595" 1.4 0.0 0.6 5.7 0.7 0.5 0.0 2.3 1.1 0.3 0.0 8.9 0.0 2.4 0.1 2.3 0.7 0.0 0.0 0.3 2.4 0.3 1.6 1.0 0.0 1.5 1.0 0.1 1.1 0.0 0.0 0.4 0.9 0.2 0.2 7.5 0.0 0.0 4.2 0.0 1.5 0.2 1.2 0.2 2.2 0.5 0.7 0.4 0.0 0.0 0.5 0.1 1.6 14.7 33.3 4.9 22.6 2.8 0.0 0.6 224.4 40.6 18.6 9.5 11.2 25.0 0.0 46.0 12.7 14.3 7.1 21.8 12.1 14.7 13.1 0.8 13.4 24.1 0.0 0.0 11.3 1.8 0.0 0.0 23.7 6.4 3.8 4.4 0.1 3.7 13.5 0.0 0.2 13.8 0.0 2.6 0.0 0.3 8.7 110.7 2.7 0.0 139.0 12.9 3.7 36.6 1.4 16.3 0.0 13.9 0.5 116.0 62.2 27.3 30.4 64.6 0.0 0.1 0.6 74.6 2.9 24.7 0.0 0.8 0.0 0.3 0.4 0.4 0.2 0.0 0.2 1.0 0.0 0.0 0.1 0.1 0.8 0.3 0.1 0.0 0.4 0.6 0.7 2.3 1.1 0.3 2.4 1.5 1.0 0.1 0.9 1.2 0.7 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABCF2-H2BE1 ENSG00000285292 "ABCF2-H2BE1 readthrough" Q9UG63 7 151207837-151227166 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, HPA021815, HPA030388" Approved Uncertain Cytosol NA NA 51000 Cytosol "HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" 12.1 8.1 1.0 11.2 1.3 5.5 9.1 1.8 5.8 7.5 2.6 9.5 6.8 8.5 2.9 10.2 9.1 7.7 9.9 1.2 4.0 9.8 7.4 8.7 11.5 1.3 1.7 0.7 6.1 4.7 14.1 8.3 2.0 7.3 10.4 10.1 5.5 9.6 30.9 9.1 5.8 12.0 1.3 9.6 6.1 6.9 1.5 10.3 9.6 21.1 13.9 14.6 2.8 45.0 54.8 27.0 71.0 38.7 38.6 22.4 57.1 38.5 43.7 45.1 40.5 33.8 66.4 44.1 59.7 61.1 34.7 57.9 55.3 61.0 29.9 31.8 37.1 30.6 26.6 57.8 76.5 25.8 40.8 40.8 72.5 50.5 28.6 55.4 35.8 89.1 28.4 57.6 68.1 88.9 23.1 36.5 58.4 50.1 36.5 34.6 68.3 21.9 33.8 21.9 34.8 59.5 44.0 30.3 25.1 21.2 33.9 47.5 33.4 11.4 45.2 73.6 41.6 47.5 64.7 55.4 64.7 49.0 22.5 21.3 6.0 22.5 19.1 45.7 17.5 27.9 26.3 24.8 19.9 24.8 24.3 1.6 25.5 18.5 15.4 30.2 30.3 1.0 1.3 1.8 5.8 1.2 4.0 1.3 1.7 0.7 2.0 1.3 1.5 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Z83844.2 ENSG00000285304 "Novel protein" 22 37639693-37666932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000757 Approved Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" 1.0 0.2 0.1 7.3 0.1 8.8 1.0 0.1 1.6 3.2 0.2 5.9 5.6 1.3 0.0 4.0 1.6 1.3 0.6 0.3 0.3 0.0 0.9 3.5 7.4 0.1 0.0 0.0 1.0 0.7 2.6 3.7 0.3 0.9 5.0 0.1 2.1 2.3 0.2 1.7 8.2 2.3 0.4 4.0 1.4 0.7 0.2 6.5 0.5 0.0 6.7 4.2 0.5 14.7 2.1 7.7 5.0 2.3 6.5 8.3 4.1 12.9 15.3 15.8 9.8 3.5 8.4 1.4 4.5 5.1 12.2 9.2 22.3 4.7 10.2 7.0 21.3 0.0 10.7 4.2 33.2 25.5 7.8 9.4 17.7 1.6 6.5 0.9 6.1 5.9 7.5 0.7 13.4 1.2 1.9 7.9 23.9 1.6 12.6 4.9 7.7 1.6 4.5 4.4 7.2 1.1 4.9 8.0 5.4 6.4 14.5 1.5 2.0 7.5 1.2 0.0 12.3 4.7 8.8 5.2 21.5 14.8 0.0 0.6 0.0 0.4 0.3 0.3 0.3 0.2 0.5 0.9 0.2 0.6 0.4 0.0 0.5 0.6 0.4 0.6 0.3 0.1 0.1 0.1 1.6 0.3 0.3 0.1 0.0 0.0 0.3 0.4 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC126283.1 ENSG00000285330 "Novel protein" 4 109713916-109801999 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.4;Breast myoepithelial cells: 1.5;Collecting duct cells: 3.7;Endometrial ciliated cells: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 38.1;HDLM-2: 7.8;Hep G2: 8.4;RPTEC TERT1: 11.2" "HPA001143, HPA024061, HPA035909" Uncertain NA NA "HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074" 1.5 3.5 0.3 3.4 0.4 0.1 1.5 0.3 0.8 1.9 0.7 1.6 6.2 2.1 0.0 3.4 2.1 3.2 4.2 0.3 0.8 3.7 9.8 2.3 1.8 0.9 0.3 0.1 3.3 9.0 1.2 3.6 0.5 2.1 2.1 3.5 2.5 1.2 3.4 0.7 5.4 2.1 0.5 2.4 2.3 1.4 0.3 1.3 1.9 4.2 1.5 4.2 0.6 0.0 1.0 0.0 0.3 0.2 0.4 0.0 1.5 2.9 0.0 0.3 0.2 38.1 0.2 6.5 0.7 0.6 0.1 0.2 0.1 0.0 7.8 0.7 0.1 0.5 8.4 5.8 0.4 0.0 6.0 0.0 0.0 0.1 1.9 4.8 0.1 0.5 2.5 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.3 0.2 11.2 1.1 0.2 0.3 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.5 0.0 0.1 0.1 6.9 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.8 0.3 0.8 0.9 0.3 0.1 0.5 0.5 0.3 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 FO393400.1 ENSG00000285382 "Novel protein" 20 32632183-32743567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;choroid plexus: 1.1;retina: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HEL: 4.6" HPA054119 Approved Vesicles NA NA Vesicles "HPA054119: AB_2682388" 0.0 0.0 1.5 0.0 1.5 0.0 0.1 1.5 1.8 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.4 0.1 0.3 0.0 0.0 1.5 1.4 1.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.5 1.5 1.8 1.4 1.4 1.5 1.4 1.4 1.5 1.3 1.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Z82190.2 ENSG00000285404 "Novel protein, DEPDC5-YWHAH readthrough" 22 31754899-31956243 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054969, HPA055619" Uncertain NA NA "HPA054969: AB_2682655, HPA055619: AB_2682864" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 243.5;Cone photoreceptor cells: 354.5;Rod photoreceptor cells: 343.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 9.8 16.9 21.9 16.1 17.6 38.1 11.6 25.5 75.3 2.1 14.5 26.4 15.9 18.3 22.2 14.1 3.5 8.0 3.4 22.6 16.7 18.6 20.0 8.1 16.0 25.6 22.8 11.4 11.6 7.2 17.9 8.7 22.4 8.7 14.8 44.7 5.2 8.2 85.5 15.7 14.4 4.1 10.9 16.7 12.9 12.3 20.1 34.9 8.1 41.0 12.0 13.0 34.0 49.6 6.2 67.8 60.6 3.3 13.7 26.1 68.1 2.6 14.4 4.2 22.9 37.9 22.2 32.4 11.9 35.0 31.0 8.9 16.7 44.1 2.9 10.5 52.2 90.5 69.1 9.4 89.4 49.4 15.1 19.6 7.7 5.7 38.7 19.8 40.9 46.4 128.3 6.2 25.0 126.1 38.9 20.6 62.5 1.9 58.7 60.9 64.4 19.4 62.0 32.5 48.6 53.6 53.1 53.2 76.1 20.7 50.0 21.3 89.9 40.8 79.2 56.0 57.5 93.7 143.0 49.7 60.0 55.4 41.9 24.9 36.9 20.6 22.4 18.8 29.4 27.0 23.8 22.2 25.3 23.1 22.5 24.9 20.9 33.1 33.7 27.9 22.6 21.9 17.6 25.5 75.3 22.6 16.7 25.6 22.8 11.4 22.4 10.9 20.1 34.0 2.6 6.4 2.6 49.0 58.0 12.2 97.8 32.5 21.6 243.5 4.0 1.3 15.9 105.8 19.9 7.3 354.5 0.0 63.3 55.3 1.9 0.4 8.3 2.2 2.4 43.1 58.4 65.0 43.4 0.4 0.0 23.6 46.9 1.9 13.4 0.3 137.0 43.9 0.0 178.4 40.4 44.1 26.4 85.9 19.0 11.2 90.7 24.6 24.9 30.0 58.9 53.0 178.2 29.1 35.6 0.9 46.5 51.6 25.7 69.3 79.3 3.5 16.6 343.4 26.3 97.3 33.9 84.4 111.1 22.3 14.8 0.0 59.1 0.4 42.5 105.0 Z84488.1 ENSG00000285446 "Novel protein" 6 116399395-116463696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;choroid plexus: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.3;GAMG: 1.1;HDLM-2: 1.4;hTEC/SVTERT24-B: 1.0;Karpas-707: 1.6;RPMI-8226: 1.3" NA NA 0.1 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 1.3 0.0 0.1 0.1 0.0 0.9 0.6 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.2 0.0 1.1 0.1 0.0 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.1 0.5 0.0 0.7 0.3 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.9 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.2 0.6 0.2 1.3 0.9 0.6 0.2 0.9 0.4 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF883 ENSG00000285447 "Zinc finger protein 883" P0CG24 9 112997120-113050043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.0;retina: 1.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 38.2;Distal tubular cells: 21.5;Inhibitory neurons: 25.0;Oligodendrocyte precursor cells: 35.2;Rod photoreceptor cells: 40.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "fHDF/TERT166: 1.0" "Low region specificity" "Detected in all" NA NA 0.1 0.0 0.5 0.0 0.5 0.1 0.0 0.6 1.4 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.7 0.7 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 1.4 0.4 0.4 0.7 0.7 0.1 0.8 0.2 0.5 2.0 1.0 0.0 0.0 19.9 0.7 0.4 0.6 1.2 4.0 38.2 6.0 8.4 9.9 0.0 0.7 3.7 16.7 0.0 0.6 0.0 21.5 8.7 2.0 0.5 5.5 1.3 1.2 1.3 16.7 0.2 0.0 1.6 4.6 0.9 0.0 7.9 3.6 0.0 0.0 16.8 25.0 0.4 0.0 0.6 0.6 2.4 0.3 0.6 0.0 1.9 0.5 14.6 2.1 35.2 17.1 0.1 0.1 4.9 0.0 0.6 0.0 3.7 0.3 40.5 0.0 1.5 2.6 4.2 10.2 8.9 0.6 0.0 0.7 11.8 0.8 1.1 AC093827.5 ENSG00000285458 "Novel protein" 4 86886472-86936178 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 3.1;Distal tubular cells: 5.9;Respiratory ciliated cells: 8.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 5.1" HPA057434 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites" Cytosol "HPA057434: AB_2683438" 1.3 1.2 2.4 0.7 2.7 1.1 1.9 3.7 3.5 1.2 1.5 0.9 1.0 1.1 2.0 1.3 1.0 0.9 2.7 2.6 2.8 1.7 0.7 1.0 0.5 2.2 2.1 3.0 1.1 0.9 1.7 1.0 2.7 1.4 1.2 2.0 1.4 0.9 3.4 2.8 1.0 1.0 1.2 0.9 1.3 1.9 1.8 0.6 2.3 3.8 0.4 0.9 3.8 1.6 1.0 0.4 0.7 1.5 1.3 0.6 1.5 1.6 0.5 0.7 0.7 2.6 0.2 1.3 1.0 1.2 1.1 0.7 0.9 0.6 1.2 0.6 1.2 1.3 0.7 0.8 2.1 0.8 0.9 2.3 0.5 1.7 0.8 0.4 0.6 0.9 5.1 0.3 0.5 0.9 0.7 1.0 1.6 0.5 1.6 0.6 1.3 1.5 1.1 0.5 0.8 1.1 1.0 1.3 0.7 2.0 1.3 0.6 1.1 1.5 0.5 0.7 2.3 1.1 2.3 0.9 1.0 0.6 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.2 0.3 0.3 0.3 0.3 0.6 0.4 0.4 0.2 0.5 0.1 0.1 2.4 2.7 3.7 3.5 2.6 2.8 2.2 2.1 3.0 2.7 1.2 1.8 3.8 0.7 12.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 5.9 0.4 0.0 1.1 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.6 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 8.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 AC007846.2 ENSG00000285471 "Novel protein" 17 5772926-6080792 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RH-30: 38.2" NA NA 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 38.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC134980.2 ENSG00000285472 "Novel protein" 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 48 "testis: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2BE1 ENSG00000285480 "H2B.E variant histone 1" A0A2R8Y619 7 151207837-151210378 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 4.5;U-266/84: 3.3" "Low region specificity" "Detected in some" HPA043013 Uncertain NA NA "HPA043013: AB_2678269" 0.8 0.3 0.8 0.4 1.0 0.6 0.8 1.0 1.3 0.4 0.6 0.1 0.2 1.1 0.2 0.6 0.2 0.9 0.3 0.8 1.0 0.0 0.2 0.8 1.3 1.2 1.0 0.6 0.7 0.0 0.0 0.2 1.2 0.2 0.1 0.0 0.0 0.3 0.9 4.7 0.3 0.5 0.9 1.0 0.2 0.3 1.0 0.5 0.1 0.3 0.4 0.0 1.2 0.0 0.4 0.0 0.3 1.0 1.2 0.0 0.3 0.1 0.1 0.0 1.0 0.6 0.7 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.6 1.8 0.2 0.2 0.0 0.5 0.3 0.8 1.3 0.2 0.0 1.8 0.3 0.4 0.4 0.2 1.5 0.0 0.3 0.1 0.1 0.1 0.0 0.6 0.4 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 1.2 0.5 0.0 0.2 0.6 0.1 4.5 3.3 0.1 0.4 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.0 1.3 0.8 1.0 1.2 1.0 0.6 1.2 0.9 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL034430.1 ENSG00000285508 "Novel protein" 20 10413520-10431922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 8.3;heart muscle: 8.3" "Cell type enhanced" "Detected in single" "granulocytes: 1.3" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 86.5" "Low region specificity" "Detected in all" NA NA 4.9 2.2 0.0 5.6 0.0 8.3 0.0 0.0 0.4 0.0 0.0 2.7 2.0 0.6 0.0 2.8 0.0 0.2 8.3 0.0 0.0 0.3 2.3 0.0 2.0 0.0 0.0 0.0 0.0 4.0 0.0 1.1 0.0 1.8 0.7 0.0 2.3 0.0 0.0 0.3 1.8 0.0 0.0 0.3 4.7 3.2 0.2 0.0 0.0 0.0 0.3 3.7 0.0 27.4 18.8 6.8 9.6 0.0 2.8 14.1 16.0 7.1 11.1 12.5 14.7 34.0 7.2 11.8 5.4 21.9 19.8 0.0 22.4 23.2 2.4 6.1 6.7 16.5 86.5 5.6 27.5 8.7 2.6 0.0 4.3 13.9 2.1 17.2 1.7 20.4 22.6 17.2 16.8 3.3 39.1 16.1 0.0 18.9 11.8 21.3 20.3 11.0 25.3 3.5 4.4 14.6 28.0 43.1 12.8 14.3 12.7 12.7 20.3 22.3 16.1 24.7 8.2 11.2 17.7 9.0 14.4 19.5 33.3 16.7 22.0 3.9 22.4 5.8 8.7 5.2 8.1 16.7 7.8 4.2 6.4 16.6 5.0 19.2 45.0 7.3 4.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TBCEL-TECTA ENSG00000285509 "TBCEL-TECTA readthrough" 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.3" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.1 0.0 0.4 0.1 0.5 0.0 0.1 0.3 0.6 0.2 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.3 0.8 0.3 0.1 0.2 0.0 0.7 0.6 0.1 0.2 0.6 0.4 0.2 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.7 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.5 0.1 0.0 0.1 0.0 0.6 0.7 0.7 0.1 0.3 0.4 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.2 0.0 0.2 0.7 0.9 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.6 0.3 0.8 0.7 0.6 0.1 0.7 0.2 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC020907.6 ENSG00000285526 "Novel protein" 19 35106510-35124297 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2;choroid plexus: 2.5;salivary gland: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 3.9;Club cells: 1.3;Respiratory ciliated cells: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SCLC-21H: 6.2;WM-115: 8.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "spinal cord: 3.8" HPA010856 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" 0.0 0.0 2.2 0.0 2.6 0.0 0.4 2.3 3.2 1.5 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 2.0 0.0 0.1 0.0 0.0 2.6 2.4 1.8 0.0 1.8 0.0 0.2 2.4 0.3 0.0 0.2 7.4 0.1 0.0 1.7 0.0 0.0 2.0 0.0 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.6 2.3 3.2 1.9 2.0 2.6 2.4 1.8 2.4 2.0 2.4 3.0 0.0 6.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL133500.1 ENSG00000285547 "Novel protein" X 72301691-72572843 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;SH-SY5Y: 1.4" "HPA048560, HPA049051" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048560: AB_2680442, HPA049051: AB_2680612" 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.4 0.4 0.1 0.2 0.0 0.0 0.6 0.6 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.2 0.0 0.1 0.1 0.5 1.2 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.1 0.6 0.0 0.1 0.2 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AL445238.1 ENSG00000285566 "Keratin-associated protein 21-1" 13 63832361-63833531 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "breast: 4.2;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.8" NA NA 0.1 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC069444.2 ENSG00000285585 "Novel protein" 3 119703076-119807570 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 9.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074084 Uncertain NA NA "HPA074084: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A9P FAM90A9 ENSG00000285607 "Family with sequence similarity 90 member A9, pseudogene" A6NNJ1 8 7761330-7764340 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A16P FAM90A16 ENSG00000285620 "Family with sequence similarity 90 member A16, pseudogene" A6NEW6 8 7730739-7733749 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC117378.1 ENSG00000285625 "Novel protein" 12 56714612-56741535 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2;skeletal muscle: 3.7" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 17.4;REH: 18.1" HPA073152 Approved Cytosol NA NA Cytosol "HPA073152: AB_2686575" 0.5 0.5 1.0 1.7 1.2 2.0 0.5 1.6 3.2 0.3 0.7 0.8 0.3 0.8 0.0 0.5 0.4 0.0 0.1 0.9 1.1 0.2 0.8 0.6 0.2 1.1 1.2 0.8 0.3 2.6 0.0 0.2 1.3 0.3 0.4 2.7 0.0 0.3 3.7 0.2 0.5 0.2 0.8 0.6 0.2 0.5 1.1 1.9 0.2 0.0 0.7 0.4 1.7 5.6 1.3 3.7 2.2 1.3 0.0 4.0 3.6 0.6 2.0 1.4 0.0 2.9 2.6 5.8 0.5 1.5 8.9 2.2 1.0 1.0 3.8 1.5 6.2 1.3 0.7 0.9 15.8 10.3 0.9 1.4 2.0 2.2 2.5 0.5 8.5 3.0 5.4 2.8 2.6 17.4 9.9 9.3 4.6 1.4 18.1 4.4 2.0 2.6 1.3 3.7 0.6 1.3 0.0 6.6 1.0 1.7 11.3 1.5 1.0 15.3 4.8 5.4 15.1 8.9 4.6 1.7 5.6 1.5 2.6 1.8 3.8 7.2 4.8 9.4 10.7 11.7 8.8 3.7 12.1 13.3 11.0 0.0 6.1 6.3 5.0 12.4 4.9 1.0 1.2 1.6 3.2 0.9 1.1 1.1 1.2 0.8 1.3 0.8 1.1 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC009879.2 ENSG00000285655 "Novel protein" 8 66430185-66445324 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.6 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A19P FAM90A19 ENSG00000285657 "Family with sequence similarity 90 member A19, pseudogene" A6NE21 8 7753682-7756692 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A22P FAM90A22 ENSG00000285687 "Family with sequence similarity 90 member A22, pseudogene" A8MWA6 8 7571995-7575006 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC097634.4 ENSG00000285708 "Novel protein" 3 70959226-71754229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "basal ganglia: 102.6" HPA003876 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA003876: AB_1078907" 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A17P FAM90A17 ENSG00000285720 "Family with sequence similarity 90 member A17, pseudogene" A6NEW6 8 7746034-7749044 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL034430.2 ENSG00000285723 "Novel protein" 20 10420546-10420737 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 26.1 9.0 0.4 14.5 1.9 18.4 0.0 1.7 7.0 0.0 5.3 14.4 31.3 2.3 0.0 0.0 0.0 0.0 9.0 3.8 1.9 6.6 17.4 5.1 3.0 1.5 0.2 0.0 1.1 11.1 9.5 3.0 4.1 6.6 0.0 21.7 7.0 0.0 48.1 0.0 22.0 0.0 0.6 7.4 9.6 12.4 1.0 0.3 0.0 0.0 0.0 2.0 1.4 77.2 33.4 72.7 62.0 0.0 0.0 22.5 111.4 8.2 2.1 0.0 4.3 70.5 42.7 37.2 7.5 77.6 86.2 0.0 0.0 0.0 3.6 16.6 116.4 23.5 135.7 1.2 131.9 36.0 6.3 0.0 6.1 0.0 19.6 0.0 35.5 17.2 58.8 0.0 9.8 94.9 62.5 79.1 54.2 21.4 49.5 161.5 41.9 0.0 35.4 16.4 31.9 96.4 135.8 165.8 27.6 52.7 56.2 68.3 41.6 73.9 48.6 85.7 51.9 76.3 98.5 27.5 86.3 50.3 52.4 33.8 41.6 17.3 43.5 18.5 26.1 20.1 24.3 39.5 24.5 20.8 21.6 22.1 18.0 41.6 67.0 25.0 25.8 0.4 1.9 1.7 7.0 3.8 1.9 1.5 0.2 0.0 4.1 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL031315.1 ENSG00000285733 "Novel protein" 6 169419969-169702047 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 1.5;OE19: 1.4" NA NA 0.2 0.2 0.4 0.1 0.7 0.9 0.1 1.3 1.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.6 0.2 0.6 0.3 0.1 0.0 0.1 0.7 0.1 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.2 0.2 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.8 1.5 0.0 0.1 0.7 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.1 0.1 0.9 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.3 0.4 0.1 1.4 0.6 0.1 0.1 0.3 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.5 0.4 0.1 0.2 0.3 0.1 1.3 0.2 0.2 0.3 0.1 0.2 0.2 0.1 0.3 0.1 0.4 0.2 0.3 0.7 0.5 0.0 0.2 0.1 0.2 0.4 0.7 1.3 1.0 0.5 0.1 0.6 0.2 0.6 0.7 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC097636.1 ENSG00000285749 "Novel protein" 3 51798803-51833389 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.9;testis: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.2 0.2 0.4 0.3 0.7 1.6 0.2 2.9 2.2 0.2 0.0 0.2 0.5 0.2 0.7 0.1 0.1 0.2 0.1 0.8 0.1 0.3 0.8 0.2 0.4 0.3 0.1 0.1 0.1 0.6 0.1 0.2 1.4 0.4 0.1 1.9 0.3 0.1 0.2 0.6 0.4 0.1 0.0 0.5 0.3 3.3 0.1 0.2 0.3 0.0 0.1 0.1 1.9 0.4 0.3 0.5 0.4 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.5 0.5 0.1 0.0 0.3 0.2 0.0 0.1 0.0 0.4 0.1 0.3 0.8 0.4 0.0 0.5 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.5 0.4 1.3 0.0 0.2 0.1 0.3 0.4 0.3 0.2 0.3 0.2 0.5 0.0 0.3 0.4 0.3 0.1 0.0 0.3 0.3 0.3 0.3 0.6 0.3 0.5 0.5 0.2 0.6 0.3 0.2 0.3 1.0 0.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.7 2.9 2.2 0.8 0.1 0.3 0.1 0.1 1.4 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC253536.7 ENSG00000285762 "Novel protein, AP000351.4-DDT readtrhough" 22 23971378-23980469 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 15.4;Club cells: 4.3;granulocytes: 3.8;Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;HaCaT: 1.0;hTERT-RPE1: 2.2;RH-30: 1.2" "HPA049871, HPA074115" Uncertain Approved Mitochondria NA NA Mitochondria "HPA049871: AB_2680926, HPA074115: " 0.1 0.3 0.2 0.3 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.1 0.5 0.0 0.4 0.7 0.0 0.0 0.2 0.8 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.7 0.0 0.2 0.4 0.0 6.4 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 FAM90A23P FAM90A23 ENSG00000285765 "Family with sequence similarity 90 member A23, pseudogene" A8MXZ1 8 7579644-7582653 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC000120.2 ENSG00000285772 "Novel protein" 7 92112159-92179511 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.7;testis: 7.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 25.3;Club cells: 5.6;Respiratory ciliated cells: 2.9" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;HeLa: 1.6;Karpas-707: 1.5;U-266/70: 1.4" NA NA 0.3 0.4 0.2 0.2 0.6 0.2 2.5 0.6 0.8 0.0 0.0 0.1 0.0 0.4 0.8 0.1 0.0 0.8 0.0 0.5 0.4 0.3 0.0 0.5 0.2 2.0 0.5 0.5 0.0 1.4 0.1 0.4 1.6 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 1.6 0.2 0.4 7.5 0.2 0.2 1.0 0.0 0.2 0.1 3.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.7 1.0 0.1 1.6 0.4 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 1.4 0.2 0.4 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.2 0.6 0.6 0.8 0.5 0.4 2.0 0.5 0.5 1.6 1.6 0.2 3.7 0.0 16.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FAM90A14P FAM90A14 ENSG00000285814 "Family with sequence similarity 90 member A14, pseudogene" P0C7W9 8 7715443-7718453 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GET1-SH3BGR ENSG00000285815 "GET1-SH3BGR readthrough" 21 39380332-39515506 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 6.1;skeletal muscle: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.1;U-266/70: 6.7" HPA018527 Uncertain NA NA "HPA018527: AB_1858860" 0.9 1.9 2.9 0.0 2.1 0.2 0.6 2.1 2.1 0.6 2.1 0.3 0.5 0.8 0.6 0.1 0.7 0.7 1.2 1.8 1.9 0.5 0.2 0.2 0.4 2.7 2.1 1.4 1.5 0.6 0.2 0.6 2.3 0.5 0.2 6.1 0.3 0.8 4.9 0.1 0.4 0.2 2.2 0.4 0.5 0.9 2.6 0.2 0.4 1.3 0.4 0.4 3.5 0.4 0.0 0.0 0.9 2.2 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.8 0.7 1.9 0.3 0.3 0.0 0.6 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.3 3.1 0.3 0.1 0.7 1.6 0.0 0.0 1.3 0.1 0.4 0.2 0.0 1.6 0.8 0.2 1.0 0.0 0.5 0.4 0.7 0.4 1.8 0.8 0.0 0.8 0.0 0.5 0.0 0.1 0.4 6.7 1.8 0.9 1.6 1.4 0.2 1.7 0.2 0.0 0.6 0.4 1.2 1.1 0.3 0.3 0.4 0.2 0.9 0.8 1.9 1.0 0.3 4.6 0.3 0.3 2.9 2.1 2.1 2.1 1.8 1.9 2.7 2.1 1.4 2.3 2.2 2.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP001267.5 ENSG00000285827 "Novel protein" 11 118401602-118482737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 24.1;Club cells: 14.9;granulocytes: 20.2;Respiratory ciliated cells: 13.8" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044629 Uncertain Approved Mitochondria NA NA Mitochondria "HPA044629: AB_2679028" 1.2 1.2 0.7 1.6 0.8 7.2 1.3 3.3 1.3 0.8 0.3 1.3 1.8 0.8 1.1 0.6 0.8 0.7 1.2 0.7 0.6 1.3 1.2 0.9 2.4 0.4 0.2 0.5 0.9 0.8 1.6 0.7 1.3 1.4 1.2 1.5 1.4 0.8 1.5 0.5 1.9 0.8 0.0 1.0 1.4 0.8 0.1 2.6 1.2 1.8 1.3 1.0 1.6 3.1 0.7 2.0 2.7 0.9 0.8 3.8 1.5 1.2 1.9 1.9 3.3 2.5 2.6 3.6 1.9 4.0 2.4 2.8 2.4 2.8 4.0 1.8 4.3 1.2 1.6 1.8 2.9 3.0 1.4 1.3 2.3 3.0 1.2 2.4 6.1 3.4 6.7 1.7 2.4 4.5 5.7 1.7 5.5 2.6 3.9 2.2 3.4 3.4 1.2 3.3 2.3 2.4 1.2 1.5 3.0 1.9 1.5 1.3 2.0 4.2 1.1 1.9 1.7 1.6 5.2 0.7 3.1 1.0 5.5 5.1 6.0 4.9 4.2 4.1 6.1 4.4 4.0 5.0 5.1 4.2 4.0 4.1 3.7 4.0 7.2 5.8 10.6 0.7 0.8 3.3 1.3 0.7 0.6 0.4 0.2 0.5 1.3 0.0 0.1 1.6 0.0 16.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 AC024598.1 ENSG00000285837 "Novel protein" 10 62374192-62672011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "gallbladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.1;TIME: 2.5" HPA052446 Uncertain Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA052446: AB_2681836" 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.7 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.3 0.7 0.1 0.4 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.9 0.4 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008676.3 ENSG00000285868 "Novel protein" 5 157341596-157460100 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;retina: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 2.2 0.1 1.5 0.1 0.0 2.6 2.2 0.0 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.4 0.0 1.8 1.1 0.0 0.0 0.0 0.1 1.3 1.3 1.4 0.0 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 1.5 2.6 2.2 1.8 1.1 1.3 1.3 1.4 1.4 0.5 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC144573.1 ENSG00000285880 "ADRB3-GOT1L1 readthrough" 8 37934340-37965953 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061969 Uncertain NA NA "HPA061969: AB_2732674" 0.1 0.1 0.4 0.1 0.2 0.2 0.1 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.5 0.4 0.3 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSANTD5 ENSG00000285891 "Myb/SANT DNA binding domain containing 5" 5 178694605-178697695 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HBEC3-KT: 4.3" NA NA 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.6 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.4 0.2 0.3 0.3 0.1 0.3 0.3 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A18P FAM90A18 ENSG00000285913 "Family with sequence similarity 90 member A18, pseudogene" A6NE21 8 7723091-7726101 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC087721.2 ENSG00000285920 "Novel protein" 15 41284007-41380996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "HPA042904, HPA074847" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" 0.8 1.5 0.3 1.8 0.2 2.9 1.3 2.1 0.9 1.0 0.1 1.8 1.8 0.9 0.3 1.6 0.7 1.1 0.9 0.2 0.3 1.1 1.7 1.0 2.4 0.4 0.7 0.0 1.5 0.6 0.9 1.3 0.6 0.7 1.9 1.8 0.6 1.1 3.1 1.0 1.4 1.1 0.2 1.6 1.2 2.9 0.6 2.6 0.7 1.9 2.5 1.5 0.8 3.7 1.2 6.6 5.5 2.5 3.7 3.4 3.8 2.9 4.8 4.7 2.0 4.1 2.8 4.0 2.2 4.4 8.7 10.1 5.3 4.1 7.2 3.6 9.4 3.8 3.6 2.0 14.2 8.2 2.1 3.3 3.3 8.8 1.9 4.7 10.6 8.7 11.0 4.3 1.8 5.5 4.5 6.9 9.2 5.5 7.6 5.0 4.3 4.6 4.0 6.6 6.0 6.6 3.9 2.6 7.0 6.6 8.5 4.3 2.8 5.5 3.2 5.8 5.6 10.7 9.4 2.4 8.7 5.6 0.1 0.4 1.0 0.2 0.4 0.3 0.4 0.5 0.4 0.6 0.3 0.2 0.2 0.1 0.3 0.5 0.9 0.9 0.5 0.3 0.2 2.1 0.9 0.2 0.3 0.4 0.7 0.0 0.6 0.2 0.6 0.8 0.0 6.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 FAM90A8P FAM90A8 ENSG00000285937 "Family with sequence similarity 90 member A8, pseudogene" A6NJQ4 8 7738387-7741396 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC072022.2 ENSG00000285938 "BCL6 antisense 1" 3 187743686-187746028 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "bone marrow: 7.0;brain: 18.6;skeletal muscle: 23.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "neutrophil: 10.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.3" "Cell line enhanced" "Detected in some" "Daudi: 3.0;U-698: 6.8" NA NA 3.1 1.9 2.6 3.2 1.5 7.0 0.0 3.2 1.7 0.0 0.5 0.1 0.3 0.7 0.0 0.7 0.2 1.6 1.0 0.9 14.4 0.2 0.4 0.5 1.3 18.6 2.8 0.4 0.7 1.7 0.1 0.3 5.4 0.2 0.0 0.8 1.2 0.0 23.1 1.8 0.5 0.0 4.3 1.3 0.2 2.2 4.1 0.0 0.4 0.4 0.2 0.4 12.3 0.0 0.5 1.1 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 3.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.1 1.1 0.9 0.0 0.0 0.9 0.2 0.3 0.2 0.9 0.6 6.8 0.4 0.2 0.4 0.0 0.8 0.9 0.1 0.3 0.8 0.2 0.2 0.3 0.2 0.1 0.0 0.1 10.3 0.1 0.2 0.1 0.1 0.1 2.6 1.5 3.2 1.7 0.9 14.4 18.6 2.8 0.4 5.4 4.3 4.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162596.1 ENSG00000285946 "Novel late cornified envelope family protein" 1 152859996-152860985 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skin 1: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 45 "HaCaT: 4.5" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC127029.3 ENSG00000285947 "Novel protein" 17 63917203-63931385 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 14.0;naive B-cell: 18.4" "Lineage enriched" "Detected in many" 5 "B-cells: 18.4" "Cell line enhanced" "Detected in single" "U-698: 2.2" "HPA009178, HPA043715" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA009178: AB_1078483, HPA043715: AB_2678632" 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.1 0.1 0.0 0.5 2.2 0.4 14.0 0.7 0.3 0.5 18.4 0.4 0.2 0.0 0.5 3.8 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A10P FAM90A10 ENSG00000285950 "Family with sequence similarity 90 member A10, pseudogene" A6NDY2 8 7768977-7771988 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC000120.3 ENSG00000285953 "Novel protein" 7 92131774-92245924 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;granulocytes: 1.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" HPA049606 Uncertain Approved Vesicles NA NA Vesicles "HPA049606: AB_2680832" 2.1 1.0 0.5 1.1 0.9 0.4 2.0 1.8 0.9 3.7 0.2 1.0 0.4 1.8 0.0 1.2 2.1 1.6 1.4 0.2 0.9 2.5 2.1 2.1 1.7 0.8 0.9 0.1 2.6 1.4 3.2 3.0 0.9 1.5 1.3 2.2 0.9 2.0 3.3 0.2 1.1 1.8 0.5 0.7 0.4 5.9 0.6 1.8 2.5 3.8 2.5 1.2 2.1 3.2 2.7 4.2 2.8 4.3 9.2 4.3 5.2 4.9 7.8 7.8 2.2 4.4 5.7 3.2 4.1 4.4 2.6 6.4 5.0 10.9 3.9 3.1 4.9 4.3 1.3 4.2 6.9 2.9 2.1 3.9 5.7 6.7 2.8 5.4 3.3 12.8 3.7 6.0 1.8 4.4 1.1 3.6 4.3 5.0 2.5 7.0 4.8 1.9 2.3 3.3 2.3 8.0 3.0 3.1 8.4 2.9 2.4 2.0 2.6 3.0 7.1 2.5 2.1 3.9 7.6 2.9 3.0 4.6 0.0 0.1 0.2 0.1 0.1 0.5 0.5 0.2 0.2 0.4 0.2 0.3 0.3 0.0 0.3 0.1 0.2 0.2 0.3 0.5 0.9 1.8 0.9 0.2 0.9 0.8 0.9 0.1 0.9 0.5 0.6 2.1 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A7P FAM90A7 ENSG00000285975 "Family with sequence similarity 90 member A7, pseudogene" A6NKC0 8 7556700-7559712 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL135905.2 ENSG00000285976 "Novel protein" 6 63572472-63583587 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 179.4;skeletal muscle: 175.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 64.6;Club cells: 27.2;Respiratory ciliated cells: 10.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA 15.3 46.9 6.7 12.4 8.6 41.5 9.1 8.8 8.8 16.3 4.1 43.5 20.9 16.0 3.1 13.8 14.4 14.8 8.3 7.6 44.1 18.0 179.4 23.0 8.4 11.3 9.5 4.5 10.6 30.2 5.2 20.3 10.6 14.4 39.7 6.5 12.7 10.6 175.4 5.1 20.1 23.1 10.6 8.2 18.7 9.7 8.8 11.5 11.0 41.0 9.6 15.5 13.8 25.3 26.0 36.6 45.1 36.2 35.9 54.2 49.0 42.8 17.0 25.2 21.6 11.3 36.2 19.5 37.1 20.3 9.0 29.4 68.0 25.6 16.9 33.5 21.6 62.9 71.0 66.8 57.1 21.8 47.5 119.4 38.4 112.0 25.7 38.0 25.9 31.9 32.1 59.7 25.8 19.4 20.1 14.1 33.3 26.6 32.6 25.0 19.1 35.6 22.0 16.7 30.5 144.8 22.3 48.8 38.4 22.8 38.3 39.1 49.8 29.4 29.9 40.5 43.5 30.2 36.8 28.1 29.9 42.2 13.6 6.1 4.3 3.9 6.1 5.4 4.1 4.1 3.8 5.2 4.0 4.7 4.8 11.4 5.1 5.0 3.4 5.2 4.0 6.7 8.6 8.8 8.8 7.6 44.1 11.3 9.5 4.5 10.6 10.6 8.8 13.8 0.0 16.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AC012213.5 ENSG00000285982 "Novel protein" 8 103398658-103501895 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.8;SCLC-21H: 17.6" HPA024763 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA024763: " 0.3 2.7 2.3 1.4 2.8 2.7 0.6 5.1 2.9 0.9 1.4 0.7 0.8 1.0 0.8 1.2 0.9 1.3 0.8 2.2 3.3 0.5 0.6 0.6 1.2 2.5 2.4 2.3 0.9 0.9 0.6 1.1 3.0 1.7 1.6 6.9 1.1 0.7 0.4 2.0 1.3 1.5 1.1 0.6 1.5 4.9 2.9 0.2 2.9 0.1 1.3 0.9 2.9 0.2 0.8 5.8 0.6 0.0 0.7 0.4 0.2 0.2 0.5 0.9 0.6 0.6 0.0 0.2 1.0 1.1 0.8 0.7 1.7 0.5 0.2 0.2 0.6 1.3 0.2 0.0 0.6 0.4 1.6 1.4 0.2 0.9 3.9 0.3 1.3 0.3 2.2 0.2 0.2 1.2 0.3 2.5 0.6 0.2 0.2 0.8 0.2 0.8 2.9 17.6 2.6 0.0 0.4 0.6 2.4 0.5 0.1 0.4 1.2 0.4 0.1 0.5 0.6 0.6 0.3 0.8 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 5.1 2.9 2.2 3.3 2.5 2.4 2.3 3.0 1.1 2.9 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE15 SPDYE15P ENSG00000286014 "Speedy/RINGO cell cycle regulator family member E15" 7 75337138-75343016 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Uncertain NA NA "HPA051750: AB_2681590" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CR589904.2 ENSG00000286015 "Novel protein" 1 248681249-248748349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 1.2 0.7 0.2 0.3 0.0 0.9 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOTCH2NLB ENSG00000286019 "Notch 2 N-terminal like B" P0DPK3 1 148607040-148679779 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 26.2;U-266/70: 89.3;U-266/84: 29.2" "Secreted to blood" NA NA 2.4 1.1 3.8 1.2 3.4 4.7 3.7 3.1 4.7 11.5 5.6 1.8 0.9 1.6 3.0 3.0 2.0 3.0 1.2 4.0 7.1 1.9 3.6 2.0 2.2 3.5 3.5 3.2 2.0 3.3 2.3 2.0 4.4 3.7 1.6 1.3 2.0 2.4 2.2 3.1 1.7 2.5 3.6 3.3 1.0 5.6 4.3 0.9 2.1 0.0 2.3 2.7 3.9 8.6 3.4 2.1 2.1 2.7 2.3 1.3 6.1 6.1 4.3 4.2 1.9 6.1 0.7 1.4 1.4 3.7 2.8 2.0 7.1 2.7 3.5 3.2 6.9 7.2 0.8 2.6 4.2 1.9 9.4 3.3 3.4 15.6 6.6 4.8 2.9 1.3 26.2 8.9 6.7 1.2 2.7 1.0 2.6 7.2 2.6 3.7 9.9 7.7 1.8 0.1 0.1 11.9 6.1 0.7 0.8 7.8 2.4 12.8 1.6 3.5 7.4 4.7 89.3 29.2 3.4 5.7 2.9 5.9 11.5 14.1 29.3 2.3 12.6 2.1 18.0 2.6 2.3 14.4 15.5 3.3 3.0 15.8 4.1 13.5 15.2 3.1 3.8 3.8 3.4 3.1 4.7 4.0 7.1 3.5 3.5 3.2 4.4 3.6 4.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121899.2 ENSG00000286022 "Novel protein" 20 2207328-2341059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 3.2;fallopian tube: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.0" HPA004728 Uncertain NA NA "HPA004728: AB_1080360" 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.1 0.3 0.1 0.1 3.2 3.5 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.5 0.4 0.1 0.4 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE13 SPDYE13P ENSG00000286038 "Speedy/RINGO cell cycle regulator family member E13" 7 75281243-75287121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Uncertain NA NA "HPA051750: AB_2681590" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASDURF ENSG00000286053 "ASNSD1 upstream reading frame" L0R819 2 189661452-189666437 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1.3 0.8 1.2 3.5 0.8 3.5 1.9 0.8 1.7 0.0 0.4 3.0 2.1 2.1 2.3 2.4 2.5 5.0 1.0 0.9 0.4 2.1 3.3 0.9 6.3 1.2 0.9 0.3 4.4 3.2 0.6 2.7 2.7 2.2 3.2 3.8 1.3 2.3 3.6 1.4 1.9 3.3 0.5 2.8 0.3 1.9 0.7 0.4 4.4 0.0 3.8 2.3 2.1 3.8 4.6 2.6 4.3 0.8 9.8 2.9 12.3 14.0 13.8 11.1 0.0 1.7 8.5 8.1 3.1 2.7 2.8 0.7 4.8 15.4 14.3 5.6 12.1 2.3 2.4 4.4 10.0 2.7 0.9 0.8 5.3 2.4 3.8 8.3 0.7 7.0 1.1 4.8 5.9 10.2 1.1 2.9 0.0 24.0 3.1 11.2 4.8 5.1 9.6 4.5 8.4 17.2 4.7 6.2 3.3 5.0 3.1 1.8 7.4 5.7 9.1 3.4 2.3 26.5 33.8 10.0 5.9 5.2 0.0 0.5 0.1 0.8 0.8 0.1 0.1 0.8 0.1 0.4 0.2 1.6 1.3 0.8 3.2 2.4 1.6 1.8 0.1 1.2 0.8 0.8 1.7 0.9 0.4 1.2 0.9 0.3 2.7 0.5 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC009412.1 ENSG00000286075 "Novel protein" 7 6331215-6348758 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 2.0;U-2197: 3.9;U-266/70: 2.3;U-698: 1.4" "Low region specificity" "Detected in all" NA NA 0.3 0.0 1.3 0.0 0.9 0.3 0.0 3.3 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.4 0.0 0.1 0.0 0.0 2.7 1.2 1.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 2.3 0.0 1.4 0.0 0.0 0.0 1.3 1.5 1.8 0.4 0.6 0.6 3.3 0.6 1.3 1.8 4.0 1.0 0.9 0.3 2.5 0.7 0.5 2.5 0.9 1.3 0.9 3.3 2.3 2.7 2.4 2.7 1.2 1.9 1.7 1.5 1.9 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL627230.3 ENSG00000286079 9 67718236-67718955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPEGNB ENSG00000286095 "SPEG neighbor" A0A087WV53 2 219496125-219498287 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "skeletal muscle: 2.6;tongue: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.0" "Not detected" "Not detected" NA NA 0.1 0.1 0.3 0.5 0.5 0.0 0.1 0.6 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.1 0.2 0.6 0.2 0.5 0.0 0.0 0.0 0.0 0.8 0.5 0.1 0.3 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 2.6 0.0 0.1 0.1 0.4 0.0 0.0 0.4 0.5 0.0 0.0 2.2 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.2 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.4 0.2 0.5 0.8 0.5 0.1 0.7 0.4 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008770.4 ENSG00000286098 "Zinc finger protein 844" 19 11987641-12078106 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046982 Uncertain NA NA "HPA046982: AB_10964399" 0.9 1.0 0.2 1.4 0.3 3.7 2.2 1.2 0.5 1.1 0.8 1.3 0.8 1.4 0.7 1.1 1.5 0.4 1.2 0.3 0.4 2.2 0.7 0.8 1.4 0.5 0.5 0.1 3.7 0.9 3.8 0.9 0.6 1.9 2.0 4.2 1.0 1.8 1.8 0.0 1.0 1.2 0.5 1.3 1.0 2.0 0.5 2.1 3.4 3.0 1.2 0.8 0.7 0.7 0.0 1.6 1.9 1.6 1.2 1.2 1.1 0.4 0.6 1.0 1.9 0.4 2.5 2.0 0.6 1.5 0.5 0.1 0.5 0.5 0.4 0.5 3.0 0.1 0.1 1.4 1.1 3.3 1.1 0.2 1.1 0.1 0.9 0.6 2.8 0.3 0.0 1.6 0.1 3.9 1.5 1.7 0.0 0.4 1.3 2.5 2.0 0.7 0.1 1.7 1.5 0.0 0.5 1.6 1.5 0.7 1.5 0.4 0.4 1.2 2.3 2.0 3.6 4.4 2.6 0.0 1.4 0.3 2.3 1.3 3.4 1.3 1.8 1.2 2.1 1.2 1.2 1.8 1.4 2.5 1.8 1.8 2.2 1.6 2.0 1.2 0.9 0.2 0.3 1.2 0.5 0.3 0.4 0.5 0.5 0.1 0.6 0.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM246A ENSG00000286102 "Family with sequence similarity 246 member A" A0A494C0Y3 22 21360601-21361299 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "brain: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.2 0.6 0.2 0.1 1.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL353579.1 ENSG00000286105 "Transmembrane protein 217" 6 37212181-37257637 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HBF TERT88: 1.2;HEL: 1.2;hTEC/SVTERT24-B: 1.2;TIME: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.2 0.0 0.3 0.6 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 4.7 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.2 0.0 1.2 0.8 0.1 0.4 0.0 0.4 0.5 0.0 1.2 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.7 0.2 0.4 0.2 0.2 0.1 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOTCH2NLR ENSG00000286106 "Notch 2 N-terminal like R (pseudogene)" 1 120723946-120793874 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "granulocytes: 10.7;monocytes: 7.5" "Low cell line specificity" "Detected in many" NA NA 2.7 1.0 1.1 1.3 0.9 1.6 1.4 0.6 1.6 1.6 1.7 0.6 0.0 1.4 5.0 2.9 2.2 1.2 1.5 1.1 3.9 0.6 1.3 1.6 0.7 1.9 2.8 0.5 0.7 0.3 0.8 1.3 2.0 2.0 1.2 1.1 1.4 1.3 0.2 3.9 0.5 2.3 0.8 1.6 0.6 2.2 1.0 1.1 0.9 0.7 0.7 1.2 1.2 7.2 0.0 1.1 2.1 7.7 4.7 0.0 1.2 1.9 1.7 2.4 1.0 0.1 0.0 3.0 8.5 3.6 2.5 3.5 4.0 2.1 5.3 0.0 3.8 0.0 0.5 2.4 1.5 0.8 2.3 2.1 5.6 7.7 2.5 0.0 0.9 0.6 6.7 8.4 6.8 1.0 2.6 0.1 0.2 3.3 1.1 5.2 2.8 3.9 3.9 0.1 0.0 4.7 4.7 2.4 1.0 0.3 0.8 1.9 1.6 5.8 10.4 2.0 2.5 0.8 1.6 2.5 2.3 0.0 10.7 3.5 4.9 0.7 4.4 1.3 0.6 1.4 1.1 2.0 1.6 1.0 1.1 9.1 1.9 7.5 1.2 0.8 0.5 1.1 0.9 0.6 1.6 1.1 3.9 1.9 2.8 0.5 2.0 0.8 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL441992.2 ENSG00000286112 "Kynurenine aminotransferase 1" 9 128819663-128881931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "HPA021176, HPA021177, HPA027736" Uncertain Approved Cytosol NA NA Cytosol "HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818" 0.3 0.1 0.6 0.2 0.5 0.5 0.2 1.2 1.7 0.2 0.3 0.2 0.2 0.3 0.5 0.2 0.3 0.2 0.1 0.5 0.2 0.1 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.2 0.1 0.3 0.8 0.3 0.2 1.1 0.2 0.4 0.5 0.4 0.1 0.2 0.1 0.2 0.1 0.3 0.3 0.3 0.2 0.4 0.2 0.2 1.2 0.4 1.5 1.0 0.6 1.2 0.4 1.2 1.0 0.1 0.7 0.6 1.1 0.4 1.1 0.5 0.6 0.7 1.2 0.6 1.1 0.1 0.9 1.3 1.0 1.4 0.8 0.2 0.9 0.4 0.4 0.5 0.9 0.4 0.7 0.3 1.0 1.6 0.2 0.2 0.5 0.9 0.7 0.9 1.3 1.1 1.2 1.1 0.3 0.2 0.3 0.6 1.0 0.9 0.0 0.2 0.7 0.2 0.3 1.0 0.7 0.6 0.3 0.7 1.2 2.6 0.9 0.3 0.7 0.3 0.8 0.9 0.2 1.0 0.3 0.9 1.4 0.7 0.7 0.7 1.1 0.8 0.8 0.6 1.3 0.5 1.9 0.8 0.5 0.6 0.5 1.2 1.7 0.5 0.2 0.3 0.3 0.3 0.8 0.1 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC083977.1 ENSG00000286131 "Novel protein" 8 32647202-32647390 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.2 0.1 0.0 1.0 0.0 0.0 1.2 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL603764.2 ENSG00000286135 "Carbohydrate-binding protein AQN-1-like" 10 122672850-122679494 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 837 "epididymis: 119.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE14 SPDYE14P ENSG00000286137 "Speedy/RINGO cell cycle regulator family member E14" 7 75309171-75315049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Uncertain NA NA "HPA051750: AB_2681590" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DERPC ENSG00000286140 "DERPC proline and glycine rich nuclear protein" P0CG12 16 69118010-69132151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051872, HPA065522" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051872: AB_2681647, HPA065522: AB_2685503" 6.7 10.7 13.4 15.4 13.4 9.4 13.5 12.2 14.3 11.8 13.1 10.3 6.7 8.9 26.2 11.7 16.2 10.9 9.0 12.5 12.5 10.5 10.6 9.1 18.0 13.6 12.6 12.0 16.4 10.3 11.7 19.0 12.9 10.3 10.7 9.9 9.6 13.8 2.2 13.3 7.2 11.4 13.3 10.3 6.2 11.1 13.6 17.8 10.1 10.1 18.5 13.1 14.6 15.9 13.1 50.5 39.4 29.0 27.4 24.8 15.3 25.8 54.2 37.6 23.2 50.3 15.8 19.1 27.4 30.5 22.9 62.0 44.9 34.4 7.4 10.8 25.3 8.3 14.4 27.4 16.3 28.7 22.0 41.3 33.1 23.4 35.1 44.2 25.2 25.9 13.1 41.0 11.9 36.5 39.8 51.6 43.8 12.1 65.0 14.6 40.3 35.7 8.6 31.2 28.9 21.8 19.8 38.5 37.3 34.3 69.6 10.9 34.5 20.3 17.2 22.3 9.6 15.3 46.2 31.4 27.6 45.4 2.4 5.3 3.2 2.8 6.0 4.0 2.6 2.7 2.6 5.5 3.1 2.6 3.3 1.3 4.0 6.3 5.1 4.0 4.2 13.4 13.4 12.2 14.3 12.5 12.5 13.6 12.6 12.0 12.9 13.3 13.6 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC053503.6 ENSG00000286143 "Novel protein" 2 219491867-219498244 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "skeletal muscle: 3.4" "Cell type enhanced" "Detected in single" "Early spermatids: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.2 0.2 0.3 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.5 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.2 0.2 0.5 0.2 0.1 0.4 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012488.2 ENSG00000286165 "Novel protein" 2 189661519-189667881 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebral cortex: 2.7" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.2;HDLM-2: 1.2" HPA075042 Approved Cytosol NA NA Cytosol "HPA075042: AB_2686731" 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.2 2.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.2 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.7 1.1 0.4 0.4 0.3 1.3 0.4 0.0 0.2 2.1 0.3 0.2 0.5 0.6 0.2 1.0 2.3 0.4 0.2 0.3 0.2 2.7 0.2 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM246B ENSG00000286175 "Family with sequence similarity 246 member B" A0A494C0N9 22 18633984-18634682 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC242842.3 ENSG00000286185 "Novel protein, identical to neuroblastoma breakpoint family, member 19 NBPF19" 1 149390623-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC055839.2 ENSG00000286190 "Uncharacterized LOC728392" 17 5499427-5501006 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 273.4;choroid plexus: 81.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 4.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.8" "Cell line enhanced" "Detected in many" "AF22: 42.8;BJ: 46.1;hTERT-RPE1: 41.9" "Low region specificity" "Detected in all" NA NA 5.8 66.5 171.7 9.1 192.1 4.6 2.4 107.4 195.7 9.8 81.6 3.6 4.7 15.2 11.8 1.0 18.2 6.0 2.6 167.2 246.6 2.3 0.7 4.1 8.7 182.5 200.9 166.7 31.1 6.9 12.2 7.6 172.3 10.0 2.8 15.4 2.4 18.7 2.9 14.0 4.6 6.7 211.4 11.8 7.5 8.3 273.4 10.0 2.2 1.7 3.8 2.8 222.7 2.3 0.5 42.8 10.6 13.9 7.3 1.7 46.1 29.6 17.3 11.0 0.0 0.4 0.6 9.2 17.4 7.6 1.6 4.1 1.4 9.0 19.5 6.9 0.1 2.2 1.9 4.3 0.0 0.4 6.0 3.6 19.8 1.0 41.9 1.1 3.0 3.2 8.8 11.0 0.8 1.8 2.1 4.9 0.0 0.4 2.8 2.7 7.2 0.0 0.6 15.7 25.7 0.0 0.1 0.2 15.9 0.0 0.0 2.5 6.8 6.1 5.2 1.2 22.9 5.2 0.3 20.9 0.0 0.5 4.8 0.1 0.0 0.3 0.1 0.0 0.8 0.2 0.2 0.1 0.0 0.3 0.1 1.0 0.2 0.0 0.0 0.7 0.1 171.7 192.1 107.4 195.7 167.2 246.6 182.5 200.9 166.7 172.3 211.4 273.4 222.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOTCH2NLC ENSG00000286219 "Notch 2 N-terminal like C" P0DPK4 1 149390614-149468030 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Notch signaling pathway" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 74.2;U-266/70: 121.3" "Secreted to blood" NA NA 7.3 2.0 9.9 5.5 8.5 18.1 12.3 7.1 15.8 13.3 14.6 5.4 3.5 6.4 9.9 9.9 7.8 6.5 7.0 10.9 19.1 3.9 21.7 6.1 8.4 10.0 9.1 7.2 7.2 5.7 7.6 5.6 9.2 9.6 6.2 14.4 6.9 8.2 2.5 12.8 2.6 5.3 8.2 7.4 3.1 21.0 9.4 7.5 6.1 4.0 8.3 8.5 9.2 14.2 6.0 4.0 5.0 9.0 11.1 2.5 4.5 39.9 17.9 23.8 3.6 12.2 2.2 3.6 17.1 9.6 5.0 5.1 19.7 10.8 7.1 3.4 11.7 43.8 1.8 37.9 6.1 3.7 33.5 8.1 28.3 74.2 10.7 14.4 8.3 3.1 50.7 17.0 29.8 5.1 7.7 1.6 8.6 13.6 4.8 7.9 27.3 17.9 16.4 0.5 0.4 12.9 12.3 2.0 5.0 10.6 9.5 12.8 5.4 8.8 9.5 9.8 121.3 35.9 7.6 11.9 6.4 8.0 17.8 29.3 47.3 3.6 21.4 5.0 57.7 5.9 5.8 44.3 26.6 5.9 4.0 14.1 8.3 18.9 23.6 8.2 11.3 9.9 8.5 7.1 15.8 10.9 19.1 10.0 9.1 7.2 9.2 8.2 9.4 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC009070.1 ENSG00000286221 "Novel protein" 16 80828736-81006894 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.4" "Low region specificity" "Detected in all" NA NA 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000471.1 ENSG00000286224 "Novel protein" 21 46326288-46326491 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.2;skin 1: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.4;hTERT-HME1: 1.6;TIME: 2.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.2 0.4 0.9 0.5 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.7 0.4 0.0 0.2 0.0 0.4 0.5 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.9 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 1.0 0.5 0.2 0.5 0.0 0.1 0.7 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE11 ENSG00000286228 "Speedy/RINGO cell cycle regulator family member E11" P0DTA3 7 73048481-73057911 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Excitatory neurons: 1.0;Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051750 Approved NA NA "HPA051750: AB_2681590" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.5 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL035461.3 ENSG00000286235 "Novel protein" 20 5950949-6039856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 18.0" "HPA045141, HPA066433" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045141: AB_2679230, HPA066433: " 0.9 0.9 0.1 1.0 0.1 0.4 2.6 0.1 0.3 1.8 0.1 1.6 1.4 1.3 1.5 1.4 1.3 0.8 1.6 0.1 0.2 1.5 1.1 1.2 1.4 0.1 0.1 0.1 1.6 0.8 1.4 1.8 0.2 1.7 2.6 2.3 0.5 1.5 0.3 0.7 1.6 2.1 0.1 0.9 1.0 2.0 0.1 2.3 1.2 3.0 2.4 1.0 0.2 0.5 5.4 5.0 2.4 5.4 4.7 0.7 1.2 4.5 4.3 4.7 7.3 3.0 1.6 0.1 3.7 3.2 0.4 8.4 6.6 7.1 0.3 0.0 7.2 2.5 18.0 0.8 2.4 1.1 2.8 1.7 4.1 4.0 3.7 2.4 3.0 0.4 2.0 5.2 2.0 3.5 0.7 2.7 6.9 0.1 2.2 3.2 1.8 4.0 4.9 2.6 2.1 0.0 10.8 1.2 6.7 1.4 5.6 0.0 1.6 0.8 0.8 1.2 0.1 0.2 0.9 1.4 4.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARMCX5-GPRASP2 ENSG00000286237 "ARMCX5-GPRASP2 readthrough" X 102712495-102753530 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 470 "Astrocytes: 29.7;Excitatory neurons: 67.9;Inhibitory neurons: 74.3;Microglial cells: 24.4;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 35.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9" HPA000887 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000887: AB_2666130" 0.2 0.6 0.5 0.0 0.7 0.0 0.2 1.4 1.3 0.4 0.0 0.1 0.0 0.8 0.6 0.3 0.6 0.3 0.6 0.7 0.8 0.3 0.0 0.2 0.0 0.7 0.6 0.7 1.2 0.2 0.6 0.2 1.8 0.4 0.2 0.9 0.2 0.7 0.2 0.2 0.1 0.6 0.4 0.1 0.1 0.1 0.6 0.2 0.6 0.6 0.1 0.1 0.9 0.1 0.4 2.9 0.7 1.2 0.7 0.4 0.3 0.5 0.3 0.9 0.0 0.0 0.0 0.1 0.2 1.0 0.1 1.6 0.0 0.2 0.0 0.9 0.0 1.0 0.2 0.1 0.0 0.5 0.5 0.5 0.3 0.0 1.1 0.5 0.1 0.0 0.0 0.8 0.0 0.5 0.1 0.7 0.4 0.7 0.3 0.8 0.0 0.0 0.2 0.4 0.6 0.5 0.1 0.1 0.6 0.2 0.1 0.2 0.4 0.6 0.5 0.3 0.0 0.1 0.0 1.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.4 1.3 0.7 0.8 0.7 0.6 0.7 1.8 0.4 0.6 0.9 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 50.3 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP001453.3 ENSG00000286264 "Uncharacterized protein LOC114841035" 11 64241095-64244132 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 3.4 2.7 3.7 3.1 3.6 2.6 0.8 3.3 6.6 2.2 2.8 3.1 6.9 2.3 0.7 1.6 1.4 1.4 1.9 3.2 3.1 2.1 1.8 1.9 2.1 3.3 3.8 2.3 1.8 3.3 1.3 2.5 3.5 2.5 1.6 0.4 6.0 3.2 3.4 5.5 5.2 1.0 2.5 3.7 3.7 1.1 5.9 1.5 1.7 0.5 1.5 1.2 3.3 4.6 5.0 1.7 2.4 2.2 2.5 7.3 3.4 2.0 0.8 1.0 3.3 7.5 2.8 5.9 2.0 2.0 5.6 0.6 2.4 0.2 4.0 2.7 4.4 8.4 4.9 3.5 1.3 4.1 2.3 4.5 1.7 2.3 3.5 2.1 2.2 3.2 2.4 1.5 4.0 2.6 6.6 1.9 1.4 6.7 4.4 4.9 8.5 3.3 2.7 1.4 3.7 2.6 6.6 4.8 0.4 4.6 1.5 5.6 2.5 4.6 8.6 1.6 11.1 2.1 2.6 7.0 2.4 3.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.1 1.6 0.0 0.0 3.7 3.6 3.3 6.6 3.2 3.1 3.3 3.8 2.3 3.5 2.5 5.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AF196969.1 ENSG00000286268 "Novel protein" X 48521806-48545469 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2197: 2.5" HPA003130 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003130: AB_1078717" 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.2 0.0 0.2 0.0 0.3 2.5 0.1 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.2 0.1 0.1 0.5 0.3 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3C2 "H3/l, H3FL, HIST1H3B" ENSG00000286522 "H3 clustered histone 2" P68431 6 26031589-26032099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 6.4;brain: 9.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "white matter: 9.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 8.4" HPA042570 Approved NA NA "HPA042570: AB_2678056" 0.0 0.1 2.6 0.1 0.6 6.4 0.1 0.2 1.0 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 3.9 0.0 0.0 0.0 0.5 1.0 1.6 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 3.8 1.7 0.1 0.2 0.1 0.0 9.3 1.2 2.7 1.1 2.5 0.0 0.2 0.0 0.1 0.4 0.4 0.4 0.6 0.9 2.0 1.4 0.2 0.7 0.4 0.9 0.7 0.9 1.4 2.7 2.1 4.0 0.8 0.0 1.6 1.4 1.6 0.0 0.3 0.0 0.0 0.5 0.6 4.3 3.8 0.6 0.6 5.0 5.0 2.0 0.5 1.9 2.9 1.8 5.6 0.3 0.0 1.3 1.1 3.9 1.0 0.3 0.0 1.8 1.0 0.9 0.8 3.1 0.4 1.2 6.3 8.4 2.6 2.1 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 2.6 0.6 0.2 1.0 0.6 3.9 1.0 1.6 0.2 1.4 1.8 3.8 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM40 ENSG00000286920 "Small integral membrane protein 40" 6 33323628-33329279 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 472 "retina: 47.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3C3 "H3.1, H3/c, H3FC, HIST1H3C" ENSG00000287080 "H3 clustered histone 3" P68431 6 26045384-26045869 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 4.3;brain: 7.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "white matter: 7.4" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 6.5" HPA042570 Approved NA NA "HPA042570: AB_2678056" 0.1 0.0 2.0 0.0 0.3 4.3 0.0 0.2 0.7 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 2.1 0.0 0.1 0.1 0.6 0.6 1.3 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.0 0.2 0.7 1.4 1.1 0.0 0.0 0.1 0.2 7.4 1.7 0.3 0.8 0.0 0.3 0.0 0.0 1.2 0.5 3.3 2.8 0.0 0.2 0.0 0.0 0.5 1.8 0.7 0.0 0.2 2.4 2.3 0.2 2.5 0.2 2.0 0.2 1.6 1.0 0.3 0.2 1.0 0.0 0.4 0.8 0.3 0.0 0.0 0.0 0.0 2.7 3.3 1.4 1.8 2.7 2.8 0.0 0.2 0.7 3.6 0.0 1.0 3.1 1.8 0.3 0.1 0.8 1.0 0.0 0.0 0.0 1.2 2.1 1.5 0.1 0.0 0.8 6.5 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.3 0.3 0.5 0.1 0.6 0.1 1.1 0.0 0.2 1.1 0.5 2.0 0.3 0.2 0.7 0.3 2.1 0.6 1.3 0.0 1.1 0.6 1.4 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GUCA1ANB ENSG00000287363 "GUCA1A neighbor" 6 42155406-42180056 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 225 "testis: 38.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HERC3 KIAA0032 ENSG00000287542 "HECT and RLD domain containing E3 ubiquitin protein ligase 3" 4 88523810-88708450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 8.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;Excitatory neurons: 73.2;Inhibitory neurons: 101.6;Oligodendrocytes: 113.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA039170 Uncertain Approved Cytosol NA NA Cytosol "HPA039170: AB_10673414" 1.0 1.0 1.2 1.4 1.2 2.1 1.3 1.9 1.7 2.1 1.8 1.2 0.8 0.9 0.9 1.5 0.9 0.8 2.5 1.1 1.4 1.5 1.3 1.2 1.4 1.7 1.5 1.0 1.1 0.6 5.0 1.1 1.9 2.5 1.6 8.6 1.8 1.9 0.9 1.5 0.7 0.9 0.9 1.7 1.2 0.4 1.2 2.1 1.5 1.9 2.1 1.2 2.2 1.9 0.0 0.3 0.5 0.6 4.5 0.5 1.4 4.1 1.8 1.5 0.4 1.4 2.3 0.3 4.6 1.0 0.3 0.0 1.3 1.9 0.4 0.5 1.6 0.1 0.5 0.6 3.4 2.2 1.8 1.9 1.7 5.1 0.9 3.0 0.6 0.7 0.9 3.6 0.0 1.7 0.3 0.0 0.4 0.3 1.8 1.6 0.9 2.3 0.0 0.4 0.7 0.5 0.6 0.8 0.6 0.3 0.5 3.3 1.8 0.7 0.3 2.1 1.4 0.0 0.7 1.5 1.4 0.9 0.0 0.5 0.3 0.3 0.4 0.4 0.3 0.5 0.3 0.6 0.1 0.7 0.8 0.9 0.4 0.7 0.0 0.8 0.4 1.2 1.2 1.9 1.7 1.1 1.4 1.7 1.5 1.0 1.9 0.9 1.2 2.2 8.6 6.4 6.9 35.9 15.5 35.9 10.6 7.6 9.6 23.9 11.3 3.8 0.0 5.7 5.5 9.2 110.5 0.0 11.0 14.6 1.9 4.1 3.6 5.2 7.0 7.3 27.6 8.2 73.2 9.1 0.0 8.1 9.2 9.5 15.8 3.4 7.9 13.5 0.0 32.0 101.6 8.9 8.2 22.3 22.0 3.0 8.4 17.9 14.2 68.4 14.1 14.0 8.2 57.3 113.9 10.9 8.2 13.2 12.3 11.6 10.5 9.2 7.2 70.0 6.6 11.1 8.5 3.5 6.7 16.3 50.7 0.0 16.7 4.9 6.1 11.2 AC231656.1 ENSG00000287585 "Novel protein, similar to CXorf51A" X 149414886-149415495 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL445524.2 ENSG00000287856 "Novel protein" 1 231363797-231528603 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 59.5;neutrophil: 43.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 59.5" "Low cell line specificity" "Detected in all" NA NA 4.6 4.5 2.6 3.7 2.7 3.4 4.6 2.7 3.6 1.5 2.2 4.9 4.6 1.2 5.2 2.8 1.5 1.4 2.0 2.5 2.7 4.2 7.4 1.5 1.7 2.8 2.8 2.3 1.2 1.9 7.6 2.5 2.8 1.8 5.3 1.1 4.2 1.9 7.1 12.4 6.2 3.2 2.8 2.5 3.0 7.4 2.8 2.3 2.0 6.0 4.8 4.2 3.1 15.9 19.3 5.5 7.1 9.6 9.4 6.0 9.9 7.6 7.2 8.6 12.4 15.7 3.9 3.2 11.1 9.3 6.3 8.5 19.5 13.6 20.4 33.9 7.1 14.0 29.5 10.6 8.9 13.0 13.5 13.3 19.7 15.2 11.1 10.1 7.1 8.9 7.5 5.7 3.7 3.1 4.0 8.4 44.9 14.8 2.4 9.6 5.6 15.3 13.6 4.9 7.8 9.6 9.4 28.7 6.6 8.0 19.0 7.2 7.8 8.4 11.6 27.3 7.0 9.9 3.9 12.9 8.4 17.5 59.5 10.3 18.5 1.1 7.2 0.9 2.1 2.2 1.2 6.2 2.0 2.4 1.7 43.9 1.4 8.2 1.3 2.5 3.2 2.6 2.7 2.7 3.6 2.5 2.7 2.8 2.8 2.3 2.8 2.8 2.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL031681.2 ENSG00000288000 "Novel protein" 20 43458054-43541881 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059648 Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA059648: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC231657.3 ENSG00000288053 "Novel protein" X 49071470-49079887 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.6 0.1 0.5 0.4 0.4 0.1 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM42 ENSG00000288460 "Small integral membrane protein 42" 1 158127287-158128301 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 55 "testis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL357075.4 ENSG00000288520 "Novel protein" G9CGD6 6 154159828-154510114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;HMC-1: 1.0" "HPA028708, HPA028710, HPA049651" Uncertain Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" NA NA "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: AB_2732442, HPA049651: AB_2680841" 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.2 0.4 0.5 0.4 0.3 0.5 0.7 0.1 1.0 0.4 0.3 0.2 0.0 0.2 0.9 0.6 0.2 0.0 0.2 0.2 0.0 0.5 1.4 0.0 0.5 0.2 0.4 0.3 0.1 0.0 0.3 0.0 0.0 0.6 0.6 0.2 0.5 0.3 0.6 0.1 0.0 0.2 0.0 0.4 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.1 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL035699.1 ENSG00000288529 "Novel protein" 6 133953304-133980088 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;choroid plexus: 1.9;skeletal muscle: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 10 "REH: 2.7" NA NA 0.0 0.1 2.0 0.0 2.0 0.0 0.0 0.5 5.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 0.0 0.0 0.0 0.0 2.0 1.8 1.1 0.0 1.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 12.5 28.7 23.9 12.4 16.3 44.8 15.9 22.4 9.6 38.7 18.7 19.0 25.7 14.0 14.2 9.4 26.5 28.8 2.0 2.0 0.5 5.1 0.9 1.6 2.0 1.8 1.1 2.4 0.4 1.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUS4L-BCAP29 ENSG00000288558 "DUS4L-BCAP29 readthrough" Q9UHQ4 7 107563971-107623317 "Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 5.8" "Group enriched" "Detected in many" 5 "granulocytes: 5.8;monocytes: 1.5" "Cell line enhanced" "Detected in all" "U-87 MG: 18.7" "HPA029215, HPA044301, HPA049694" Approved Approved Cytosol NA NA Cytosol "HPA029215: AB_10602331, HPA044301: AB_10967460, HPA049694: AB_2680854" 3.5 2.1 8.0 2.0 9.2 2.9 2.8 9.0 11.4 4.0 6.1 2.7 1.2 4.2 2.0 2.2 1.7 1.3 3.4 8.8 7.9 2.0 2.5 4.0 1.3 8.4 8.1 8.6 2.1 0.8 2.4 1.7 8.7 2.0 3.4 3.3 0.8 2.6 5.8 5.9 1.3 3.6 8.4 2.2 1.5 2.5 8.5 1.9 4.4 5.0 1.9 2.0 9.7 7.2 2.8 4.0 1.3 3.0 4.9 1.3 5.7 6.1 4.6 2.9 2.2 3.6 1.9 3.5 5.8 2.1 2.4 3.1 5.1 5.5 2.4 4.3 5.0 2.5 2.0 4.6 6.7 3.2 2.9 3.0 7.4 2.7 5.2 7.2 3.3 7.6 1.8 6.0 3.0 4.9 7.1 2.2 1.7 3.0 3.1 4.4 6.1 5.3 2.0 1.2 6.1 5.3 5.1 4.9 2.1 1.5 6.5 8.8 9.1 2.3 11.0 13.2 2.4 5.0 3.3 18.7 6.3 5.3 5.8 0.4 1.0 0.3 1.1 0.4 0.3 0.4 0.6 0.8 0.5 0.3 0.6 0.0 0.3 1.5 0.5 0.7 0.3 8.0 9.2 9.0 11.4 8.8 7.9 8.4 8.1 8.6 8.7 8.4 8.5 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL359092.3 ENSG00000288570 "Novel protein" 9 130713626-130713724 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.7;stomach 1: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 27 "cerebral cortex: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Karpas-707: 1.1;SK-MEL-30: 1.4;T-47d: 1.1;THP-1: 2.9" NA NA 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP001054.1 ENSG00000288593 "Novel protein" 21 43939919-43959673 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "retina: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.6 0.0 0.8 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 16.5 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.6 0.4 0.3 0.6 0.5 0.4 0.4 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8orf44-SGK3 ENSG00000288602 "C8orf44-SGK3 readthrough" 8 66667596-66860472 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Astrocytes: 17.3;Excitatory neurons: 23.5;Inhibitory neurons: 17.5;Microglial cells: 11.2;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 18.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 31.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006699, HPA027146" Approved Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" 4.1 3.1 5.5 3.2 5.9 6.1 6.4 5.6 7.2 4.5 4.0 3.5 2.8 5.7 11.6 2.1 7.3 3.7 4.4 5.2 4.9 4.2 3.1 3.4 5.7 5.0 4.2 5.4 7.9 2.2 2.9 3.8 5.1 5.1 5.9 9.2 4.3 6.2 4.1 7.0 2.6 5.0 3.9 5.2 4.3 6.6 4.8 5.8 7.7 3.7 5.4 2.6 7.8 6.9 2.4 3.5 2.6 5.8 7.0 1.7 2.3 4.3 5.2 5.8 2.8 8.7 9.8 1.3 5.3 4.1 4.4 5.5 3.1 8.2 8.5 8.3 9.3 7.2 5.5 4.6 5.3 6.0 9.2 9.1 3.3 7.3 9.0 5.3 10.7 9.7 5.6 4.8 2.1 4.6 3.7 3.5 6.6 3.8 3.7 2.4 2.4 5.0 2.0 3.4 3.8 2.9 1.3 3.9 5.3 7.0 3.5 5.1 2.6 2.5 2.2 2.2 5.7 3.8 4.8 4.7 6.0 1.4 31.0 9.8 6.2 4.0 4.1 4.9 7.6 4.5 5.1 7.2 6.1 7.0 5.0 6.9 5.2 2.7 6.9 7.0 4.2 5.5 5.9 5.6 7.2 5.2 4.9 5.0 4.2 5.4 5.1 3.9 4.8 7.8 0.0 0.0 0.0 17.3 0.9 0.0 0.0 0.1 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 23.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.2 0.1 0.5 0.0 15.6 18.0 0.0 1.1 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 1.4 0.1 0.0 0.6 0.0 0.0 0.0 AC012254.6 ENSG00000288607 "Elongin A3 family member B" Q3SY89 18 47022287-47023927 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 14.1 0.0 3.3 0.0 0.0 1.1 5.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.0 0.0 0.0 0.0 0.0 13.9 1.6 0.1 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 3.3 1.1 5.5 6.5 1.0 13.9 1.6 0.1 10.2 1.4 2.9 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010973.3 ENSG00000288608 "Novel protein" 7 151061928-151061978 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPBWR1 GPR7 ENSG00000288611 "Neuropeptides B and W receptor 1" P48145 8 52939182-52943734 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.4;liver: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;SiHa: 1.1;TIME: 1.0" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.2 1.4 0.0 2.1 0.0 0.0 0.9 0.3 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.6 0.2 1.4 0.9 0.3 0.9 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL031178.1 ENSG00000288614 "Novel protein" 6 53041266-53041385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.5;endometrium 1: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebral cortex: 3.5;medulla oblongata: 1.1;pons: 1.6" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 1.2;RH-30: 1.5;RPMI-8226: 1.6" NA NA 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 3.5 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.8 3.1 3.9 2.8 1.9 3.7 4.0 2.1 2.1 1.9 4.4 2.2 2.7 1.3 2.4 1.8 8.4 1.6 1.4 0.1 0.3 0.1 3.5 0.2 0.2 1.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC090373.2 ENSG00000288616 "Elongin A3 family member D" A6NLF2 18 46962768-46964408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 21.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 21.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 1.3 0.0 1.9 0.0 0.0 1.1 21.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 2.0 0.0 0.0 0.0 0.0 3.2 8.5 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.9 1.1 21.3 11.6 2.0 3.2 8.5 0.1 3.7 0.9 2.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC063943.2 ENSG00000288623 "Novel protein" 12 120534697-120534957 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 33.5;choroid plexus: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 22.3" "Cell line enhanced" "Detected in some" "EFO-21: 8.4;MOLT-4: 16.1;REH: 19.4;U-266/70: 26.8;U-266/84: 32.0;U-698: 8.8" NA NA 5.7 0.0 14.5 0.0 12.8 0.0 0.0 4.3 24.7 0.0 10.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 7.2 0.0 0.0 0.9 0.0 33.5 8.9 4.7 0.0 0.0 0.0 0.0 17.8 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 9.9 5.3 6.3 0.0 16.4 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 3.0 0.0 0.0 19.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 26.8 32.0 8.8 0.0 0.0 0.0 19.9 3.3 12.9 1.6 2.3 2.2 4.5 3.0 2.8 3.3 3.6 3.7 3.9 22.3 1.3 3.3 1.7 4.8 2.1 14.5 12.8 4.3 24.7 10.6 7.2 33.5 8.9 4.7 17.8 9.9 16.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068870.4 ENSG00000288625 "Novel protein" 15 81002142-81002279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "brain: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "TIME: 8.9" NA NA 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.1 0.4 0.2 0.3 0.0 0.9 0.2 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC242628.1 ENSG00000288626 "Novel protein" 1 147611590-147611796 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "adipose tissue: 1.3;brain: 2.3;skeletal muscle: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.1;HEL: 1.2;RT4: 2.0;SK-BR-3: 2.5;U-266/70: 6.2" NA NA 1.3 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.5 0.8 2.3 1.8 0.4 0.0 0.9 0.3 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC099569.1 ENSG00000288629 "Novel protein" 1 89579592-89579654 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012254.7 ENSG00000288631 "Elongin A3" Q8NG57 18 47028202-47029842 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 57 "brain: 7.3;choroid plexus: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 3.3 0.0 2.7 0.0 0.0 1.8 4.7 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.9 0.0 0.0 0.0 0.0 3.9 3.2 0.7 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.7 1.8 4.7 1.4 1.9 3.9 3.2 0.7 5.4 1.5 4.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC079741.2 ENSG00000288634 "Novel protein" 7 112450487-112450645 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 27.2;brain: 9.4;skeletal muscle: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 18.6;SiHa: 19.4;U-2197: 19.1;U-266/70: 14.6;U-937: 20.3;WM-115: 27.5" NA NA 0.3 0.0 3.5 0.5 3.9 27.2 0.0 1.8 5.6 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 9.4 0.1 0.5 0.7 0.1 5.3 2.2 2.0 0.4 0.0 0.0 0.2 3.5 0.0 0.0 0.8 0.6 0.0 7.6 0.0 1.1 0.0 2.4 1.2 1.5 0.0 2.3 0.1 0.0 0.0 0.0 0.0 5.4 1.5 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 8.4 13.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 13.5 0.0 0.0 18.6 0.0 12.8 1.3 0.0 8.0 0.0 0.0 0.0 0.0 1.0 0.0 19.4 3.0 0.0 0.0 0.0 0.0 2.9 11.1 10.4 19.1 6.3 14.6 1.0 5.0 0.6 20.3 27.5 8.2 4.2 15.2 3.3 3.8 2.1 7.8 3.5 3.6 3.0 5.6 2.6 1.8 18.0 2.3 2.3 0.9 4.1 1.6 3.5 3.9 1.8 5.6 3.5 9.4 5.3 2.2 2.0 3.5 2.4 2.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC106873.8 ENSG00000288635 "Novel protein, readthrough ST7-OT4 - ST7" 7 116954391-117119719 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" NA NA 0.8 0.8 1.3 0.1 1.2 0.7 0.4 1.1 1.5 0.4 1.2 0.2 0.8 0.7 2.4 0.5 1.2 0.4 1.0 1.1 2.0 0.8 0.5 0.2 0.1 1.2 1.2 0.2 2.0 0.2 0.5 1.0 1.2 0.5 0.2 0.8 0.7 0.5 0.6 0.7 0.5 0.5 1.1 0.2 0.3 13.6 1.3 0.2 1.8 0.1 0.2 0.0 1.1 2.1 0.6 0.3 0.4 1.1 1.5 0.8 1.4 0.5 0.1 0.8 0.0 3.1 0.4 0.6 0.2 2.3 0.2 0.1 1.0 1.7 0.0 1.4 0.9 2.2 1.0 0.4 0.3 0.5 1.0 1.3 1.1 0.2 2.2 1.5 0.0 0.7 2.3 1.2 0.0 0.0 0.1 0.5 0.1 1.8 0.2 0.4 1.0 0.6 0.3 0.3 0.6 0.0 3.3 0.7 1.0 0.2 0.0 1.0 1.0 0.3 0.7 0.9 0.7 1.1 0.9 0.3 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 1.1 1.5 1.1 2.0 1.2 1.2 0.2 1.2 1.1 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL049569.3 ENSG00000288636 "Novel protein" 1 17005068-17011757 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.4;skeletal muscle: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;HAP1: 11.0;hTERT-HME1: 3.9;hTERT-RPE1: 4.1;U-2197: 2.8" NA NA 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.3 0.0 1.4 0.5 0.8 0.1 1.0 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 2.2 0.3 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 11.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.5 3.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 2.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC013477.1 ENSG00000288637 "Novel protein" 4 153152435-153415081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;AN3-CA: 1.0;CACO-2: 1.1;RPTEC TERT1: 1.4;SH-SY5Y: 1.0" "HPA035853, HPA035854, HPA043499" Uncertain Approved Centrosome NA NA Centrosome "HPA035853: AB_10669533, HPA035854: AB_10669659, HPA043499: AB_2732506" 0.0 0.0 0.9 0.0 1.5 0.0 0.0 0.3 1.5 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.7 1.2 0.1 0.0 0.0 0.0 2.3 1.0 0.7 0.1 0.8 0.0 0.0 2.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 1.7 0.0 0.5 0.0 0.0 0.1 2.9 0.1 0.0 1.0 1.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 1.1 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.4 0.0 0.2 1.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.3 1.5 0.7 1.2 2.3 1.0 0.7 2.6 0.5 1.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093246.1 ENSG00000288639 "Novel protein" 5 171420016-171436172 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.0" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.4 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDR1 "CDR, CDR34, CDR62A" ENSG00000288642 "Cerebellar degeneration related protein 1" P51861 X 140783578-140784366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1159 "brain: 38856.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 140.3;Horizontal cells: 35.3;Muller glia cells: 140.9;Rod photoreceptor cells: 34.1" "Region enhanced" "Detected in all" "cerebellum: 38856.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.9;BJ: 16.0;MOLT-4: 10.6;U-87 MG: 61.7" "Not detected" "Not detected" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" NA NA "Golgi apparatus, Centrosome" Nucleoplasm "HPA073147: AB_2686574" 8.0 3.1 2904.9 0.7 7482.4 0.0 0.0 38856.0 9837.1 0.0 0.0 0.3 0.4 1.2 0.0 2.0 0.6 5.1 5.1 1006.7 1856.4 0.2 0.0 1.4 0.2 5765.9 8184.2 74.4 0.3 10.7 0.0 1.1 12864.6 0.4 0.0 20.9 1.4 0.0 0.4 33.5 0.3 0.0 1404.7 2.4 1.2 0.2 3446.3 0.0 2.2 0.0 0.0 1.7 9705.8 0.0 4.2 8.9 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 10.6 0.0 2.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 2.1 3.7 0.1 0.0 0.0 2.9 0.0 3.0 0.0 0.0 0.0 61.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2904.9 7482.4 38856.0 9837.1 1006.7 1856.4 5765.9 8184.2 74.4 12864.6 1404.7 3446.3 9705.8 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 140.3 0.3 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 1.1 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 35.3 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 140.9 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 34.1 0.0 1.6 1.2 0.0 0.0 0.1 3.1 0.0 0.1 0.1 0.0 0.1 AC114402.2 ENSG00000288644 "Novel protein" 1 203802094-203802192 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "brain: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebral cortex: 5.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-698: 7.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC084756.2 ENSG00000288645 "Novel protein" 15 50648802-50686717 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 5.0;choroid plexus: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "U-266/84: 16.0" NA NA 0.0 0.0 2.2 0.0 2.3 0.0 0.0 1.5 3.6 0.0 9.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 0.0 0.0 0.0 0.0 2.4 2.1 2.3 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 16.0 3.6 0.0 0.0 0.0 0.1 1.5 2.9 3.9 0.7 3.3 3.8 2.1 1.6 1.7 4.8 2.4 2.9 1.9 1.7 1.1 2.4 1.1 0.7 2.2 2.3 1.5 3.6 1.7 1.8 2.4 2.1 2.3 2.0 2.1 2.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL031178.2 ENSG00000288646 "Novel protein" 6 53065602-53065673 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTL10 C20orf134 ENSG00000288649 "Actin like 10" 20 33666943-33668525 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;HDLM-2: 2.2;PC-3: 2.3;RPMI-8226: 2.2;SiHa: 3.5" NA NA 0.3 0.1 0.2 0.1 0.3 0.1 0.0 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.3 0.3 0.2 0.2 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.4 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.5 0.2 0.2 0.2 0.4 0.2 1.8 0.0 0.3 0.0 2.2 0.0 0.2 0.0 2.2 0.0 0.8 0.6 0.0 0.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.2 0.0 2.3 0.0 0.0 2.2 0.2 0.1 0.8 0.8 3.5 0.0 0.8 0.0 0.1 0.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.4 0.0 0.0 0.7 1.3 0.7 0.6 0.6 0.6 1.3 2.1 0.6 3.2 0.8 1.2 0.0 3.6 1.2 0.5 4.8 0.5 0.2 0.3 0.2 0.4 0.2 0.3 0.3 0.3 0.2 0.2 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC119733.1 ENSG00000288654 "Novel protein" 3 88058139-88058216 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 50 "skeletal muscle: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC020765.6 ENSG00000288656 "Novel protein" 16 28537040-28623555 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 1.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.1 0.0 0.5 0.1 0.5 0.0 0.1 1.2 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.1 0.0 0.1 0.0 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.0 0.1 0.2 0.3 0.0 0.6 0.1 0.0 0.5 0.2 0.5 0.5 1.2 1.5 0.6 0.2 0.4 0.3 0.3 0.9 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010980.1 ENSG00000288658 "Novel protein, ortholog of Gm2102 (M. musculus)" 2 222317242-222320208 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;NB-4: 1.8;REH: 2.5;SCLC-21H: 3.7;SH-SY5Y: 1.7;SuSa: 1.7" NA NA 0.0 1.2 3.3 0.3 3.2 0.1 0.2 0.3 7.7 0.1 0.0 0.2 0.2 0.3 0.6 0.3 0.2 0.0 0.6 6.8 2.0 0.3 0.0 0.1 0.0 1.8 2.7 3.5 0.0 0.2 0.9 0.1 1.7 0.0 0.2 0.1 0.1 0.4 0.2 0.2 0.1 0.5 1.1 0.0 0.1 0.7 3.8 0.1 0.8 0.3 0.0 0.3 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.4 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 2.5 0.9 0.0 0.5 0.0 3.7 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.2 0.3 7.7 6.8 2.0 1.8 2.7 3.5 1.7 1.1 3.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL451106.1 ENSG00000288661 "Novel protein" X 63754485-63754664 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 4.8;retina: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.0;MOLT-4: 1.1;REH: 1.5;SiHa: 1.0;SuSa: 1.2" NA NA 0.2 0.0 0.1 0.0 1.9 0.0 0.0 0.0 4.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.7 1.2 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.3 0.0 0.1 0.9 0.1 0.0 0.2 1.4 0.4 0.7 0.2 0.3 0.5 0.3 0.2 0.1 1.9 0.0 4.8 2.3 1.5 0.7 1.2 0.2 1.3 0.0 1.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC006486.3 ENSG00000288671 "Novel protein" 19 42215133-42232149 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP006621.6 ENSG00000288675 "Proapoptotic nucleolar protein 1" I0J062 11 797511-799190 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.9;pancreas: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 5.5;SCLC-21H: 4.2" NA NA 0.3 0.6 1.0 0.4 1.1 1.0 0.0 2.9 1.3 0.1 0.5 0.2 0.3 0.3 0.6 0.3 0.2 0.3 0.2 1.2 0.9 0.2 0.2 0.2 0.6 0.7 0.6 1.2 0.3 2.5 0.1 0.2 1.4 0.3 0.0 1.2 0.7 0.1 0.1 1.1 0.2 0.1 0.5 0.7 0.4 0.6 1.2 0.1 0.2 0.0 0.1 0.1 1.0 1.0 0.8 1.4 2.5 0.3 0.6 5.5 1.7 0.2 0.3 0.1 0.6 1.1 1.3 0.6 0.6 0.6 2.5 0.3 0.1 0.1 2.5 2.1 0.9 0.8 0.6 0.3 0.8 2.6 0.9 0.3 0.2 0.2 0.5 0.1 1.3 0.5 1.3 0.4 1.2 1.3 1.6 1.8 1.1 0.5 1.6 0.4 0.1 0.7 0.3 4.2 1.9 0.6 1.1 0.7 0.3 0.8 0.4 0.7 1.0 0.7 0.5 0.8 1.3 0.8 1.0 1.0 1.0 1.0 0.8 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.9 0.5 0.1 0.1 0.0 0.0 1.0 1.1 2.9 1.3 1.2 0.9 0.7 0.6 1.2 1.4 0.5 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC105206.4 ENSG00000288677 "Novel protein" 8 22130604-22130708 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.4;salivary gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 5.1;U-2 OS: 3.4" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136115.4 ENSG00000288678 "Novel protein" 1 31919563-31919628 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136475.9 ENSG00000288681 "Novel protein" 11 308408-315272 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 4.1" "Cell type enhanced" "Detected in single" "dendritic cells: 1.1" "Group enriched" "Detected in some" 5 "cerebral cortex: 4.1;hippocampal formation: 1.5" "Immune cell enhanced" "Detected in all" "neutrophil: 473.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 473.0" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;MCF7: 1.2;NB-4: 1.0;U-698: 2.7" NA NA 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.4 4.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 2.7 0.0 0.0 0.0 151.8 6.4 206.0 16.5 41.9 20.0 12.0 24.2 8.8 6.0 13.3 10.6 29.8 473.0 87.7 53.0 2.8 6.4 170.9 0.2 0.1 0.4 4.1 1.5 0.0 0.2 0.1 0.2 0.1 0.1 0.5 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AL353671.1 ENSG00000288684 "Novel protein" 9 32455323-32552603 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 5.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.4" "Low cell line specificity" "Detected in some" "HPA047193, HPA073217" Uncertain Approved "Plasma membrane,Cytosol" No NA "Plasma membrane, Cytosol" "HPA047193: AB_2679978, HPA073217: " 0.7 0.1 0.4 0.3 0.5 0.2 0.2 0.3 0.4 0.4 0.4 0.3 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.2 0.5 0.3 0.6 0.2 0.0 0.8 0.7 0.1 0.1 0.0 0.8 0.1 0.7 0.2 0.2 0.0 0.2 0.4 0.4 0.2 0.3 0.2 0.6 0.2 0.2 0.1 0.6 0.5 0.1 0.6 0.1 0.2 0.8 0.3 0.5 0.6 0.1 0.8 0.7 0.2 1.4 0.7 0.7 1.4 0.7 0.0 0.4 0.2 0.6 0.9 0.1 0.2 0.7 0.0 1.3 0.4 1.8 0.7 0.0 0.4 0.8 0.1 0.7 0.5 0.6 1.0 0.8 1.1 1.3 0.2 0.1 0.7 0.0 0.3 0.7 0.3 0.9 0.1 1.4 0.3 0.1 0.3 0.7 0.6 1.4 0.5 0.2 0.2 0.1 0.1 0.0 0.5 0.6 0.5 0.6 0.4 0.3 0.5 0.4 0.4 0.2 0.0 1.7 0.4 1.6 0.5 0.4 0.3 0.5 0.5 0.6 0.3 0.3 0.6 0.5 5.4 0.4 0.3 0.1 0.8 0.3 0.4 0.5 0.3 0.4 0.2 0.5 0.8 0.7 0.1 0.7 0.6 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064824.1 ENSG00000288695 "Novel protein, SRD5A3-RP11-177J6.1 readthrough" 4 55346228-55388368 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;skeletal muscle: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.5;JURKAT: 2.1;U-266/70: 1.9" "Low region specificity" "Detected in all" NA NA 0.1 0.0 1.2 0.1 1.7 0.0 0.4 1.2 1.6 0.3 0.4 0.1 0.1 0.2 0.4 0.0 0.1 0.5 0.2 1.3 1.1 0.1 0.1 0.3 0.1 1.3 1.5 0.9 0.1 0.3 0.1 0.1 1.4 0.2 0.1 0.6 0.2 0.2 3.0 0.5 0.0 0.2 1.0 0.2 0.2 0.6 1.3 0.4 0.0 1.6 0.1 0.2 2.0 0.0 0.3 0.2 0.2 1.5 0.7 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.5 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.2 0.4 0.2 0.5 0.2 0.0 0.2 0.2 0.2 2.1 0.4 0.8 0.2 0.2 1.2 0.2 0.4 0.3 0.1 0.4 0.0 0.2 0.1 0.0 0.4 0.1 0.1 0.9 0.2 0.1 0.0 0.8 0.0 0.5 0.0 0.0 0.0 1.9 0.6 0.0 0.3 0.6 0.6 0.0 0.1 0.0 0.2 0.7 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.1 0.3 1.2 1.7 1.2 1.6 1.3 1.1 1.3 1.5 0.9 1.4 1.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0